Psyllid ID: psy1546

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-------460-------470-------480-------490-------500-------510-------520-------530-------540-------550-------560-------570-------580-------590-------600----
Protein Sequence
MVVNLTTKCFAVSRKCDFLTLNPTQFLKFSNSGSSISNQCGSTTASRRNSLKVDPELIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTKLWIIMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPENRPTAKELLKFPFIRKAKKNAYLIDLIDRYKKWKNSRNEESETESETSDNEDSIKTDGDLDEPWIMTVKGKMPNEYGSSPNKKSGGMNGADNIVNNNNLNNNNNHATFISSSEKSHSPARPLSIAPGPPSSAQEKRNSMTRSDSGEHKSNPTSPDREKHKIGSPEREKLKIGSPDREKLKSPDREKHKIGSPDREKNKIGSPDKKQQTRGSPVKASARSPCLSFLIYPLISELQRRHHYTSNNRTSNSGADSSHKADAIEELKNAFDLAERSAPGISGQFVKEVVHKLLPAMSEARVNSVVDKMIRSISSIFVPIKYKF
Secondary Structure (PSIPRED)
cEEccccccEEccccccccccccccEEEccccccccccccccccccccccccccHHHHHEEEEEEcccccEEEEEEEEcccccEEEEEEEEcccccHHHHHHHHHHHHHHHcccccccEEEEEEcccccccHHHHHHcccccccHHHHHHHHHHHHHHHHHcccccccccccccEEccccccEEEEcccccccccccccccccccccccccHHHHHHHcccccccHHHHHHHHHHHHHccccccccccHHHHHHcccccccccccccccHHHHHHHHHHHcccccccccHHHHHcccccccccccHHHHHHHHHHHHHHHHccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccHHcccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHccccccccccccccccccHHHHHHHHHHHHHHHHcccccHHHHHHHHHHHHcccccHHHHHHHHHHHHHHHccccccccccc
Secondary Structure Prediction (SSPRO)
cEEEccccccHHccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHcccccccEEEEEEEcccccEEEEEEEEHHHcHHHHHHHHHHHHHHHHcccccEEEEEEEEEEcccccHHHHHccccccHHHHHHHHHHHHHHHHHHHHccEEcccccHHHEEEcccccEEEccccccHHccccccccccccccHccccHHHHHHcccccHHHHHHHHHHHHHHHccccccccccHHHHHHHccccccccccccccHHHHHHHHHHHcccccccccHHHHHHcHHHHHccccHHHHHccccHHHHHHccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccHHHHHHHHcccccHccccccccccccHHHHHHHHHHHHHHHHHccccHHHHHHHHHHHHcccccHHHHHHHHHHHHccccccEEEccccc
Coil and Loop (DISEMBL)
mvvnlttkcfavsrkcdfltlnptqflkfsnsgssisnqcgsttasrrnslkvdpeliftkqerigkgsfgevfkgidNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLsqcdspygtKLWIIMEYLGggsaldlmkagnfeEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSemgdvkladfgvagtltnttskrntfvgtpfwmapevikqsaydskADIWSLGITAIElakgeppnselhpmrvlflipknnppqltgnYTKQFKEFVEACLnkdpenrptakellkfpfirkakKNAYLIDLIDRYKKwknsrneesetesetsdnedsiktdgdldepwimtvkgkmpneygsspnkksggmngadnivnnnnlnnnnnhatfisssekshsparplsiapgppssaqekrnsmtrsdsgehksnptspdrekhkigspereklkigspdreklkspdrekhkigspdreknkigspdkkqqtrgspvkasarspclsFLIYPLISELqrrhhytsnnrtsnsgadsshKADAIEELKNAFDlaersapgisgQFVKEVVHKLLPAMSEARVNSVVDKMIRSISSifvpikykf
Flexible Loop (DISEMBL)
mvvnlttkcfavsrkcdfLTLNPTQFLkfsnsgssisnqcgsttasrrnslkvdpeliftkqerigkgsfgevfkgidnrtQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTKLWIIMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVagtltnttskrntfvgtpFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLnkdpenrptakellkfpfirkakknaylIDLIDrykkwknsrneesetesetsdnedsiktdgdldepwIMTVKGKMPNEYGSSPNKKSGGMNGADNIVNNNNLNNNNNHATFISSSEKSHSPARPLSiapgppssaqekrnsmtrsdsgehksnptspdrekhkigspereklkigspdreklkspdrekhkigspdreknkigspdkkqqtrgspvkasarspcLSFLIYPLISELQRRHHYtsnnrtsnsgadssHKADAIEELKNAFDLAERSAPGISGQFVKEVVHKLLPAMSEARVNSVVDKMIRsissifvpikykf
Low Complexity Region (SEG)
MVVNLTTKCFAVSRKCDFLTLNPTQFLKFSNSGSSISNQCGSTTASRRNSLKVDPELIFTKQERIGKGSFGEVFKGIDNRTQQVVaikiidleeaedeiediqqeiMVLSQCDSPYGTKLWIIMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPENRPTAKELLKFPFIRKAKKNAYLIDLIDRYKKWKNSRneesetesetsdnedsIKTDGDLDEPWIMTVKGKMPNEYGSSPNKKSGGMngadnivnnnnlnnnnnHATFISSSEKSHSPARPLSIAPGPPSSAQEKRNSMTRSDSGEHKSNPTSPDREKHKIGSPEREKLKIGSPDREKLKSPDREKHKIGSPDREKNKIGSPDKKQQTRGSPVKASARSPCLSFLIYPLISELQRRHHYTSNNRTSNSGADSSHKADAIEELKNAFDLAERSAPGISGQFVKEVVHKLLPAMSEARVNSVVDKMIRSISSIFVPIKYKF
Disordered region (IsUnstruct)
**VNLTTKCFAVSRKCDFLTLNPTQFLKF**************************ELIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTKLWIIMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAK*******LHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLN********AKELLKFPFIRKAKKNAYLIDLIDRYKKW*******************************************************************************************************************************************************************************************CLSFLIYPLISELQ*****************************************ISGQFVKEVVHKLLPAMSEARVNSVVDKMIRSISSIFVPIKY**
Disordered Region (DISOPRED)
*********F***********************************************IFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTKLWIIMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPENRPTAKELLKFPFIRKAKKNAYLIDLID***********************************************************************************************************************************************************************************************************************************************************F*********************DKMIRSISSIFVPIKYK*
Disordered Region (DISEMBL)
MVVNLTTKCFAVSRKCDFLTLNPTQFLKFSNSG***************NSLKVDPELIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTKLWIIMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPENRPTAKELLKFPFIRKAKKNAYLIDLIDRYKKW**********************TDGDLDEPWIMTVKGKMPNEYGSSPNKKSGGMNGADNIVNNNNLNNNNNHATFI*******************************************************EREKLKI**********************************************RSPCLSFLIYPLISELQRRHHYT**************KADAIEELKNAFDLAERSAPGISGQFVKEVVHKLLPAMSEARVNSVVDKMIRSISSIFVPIKYKF
Disordered Region (DISPRO)
MVVNLTTKCF******************************************VDPELIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTKLWIIMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPENRPTAKELLKFPFIRKAKKNAYLIDLIDRYKKWKNS*****************************************************************************************************************************************************************************************L*FLIYPLISELQRRHHY**************HKADAIEELKNAFDLAERSAPGISGQFVKEVVHKLLPAMSEARVNSVVDKMIRSISSIFVPIKY**
Transmembrane Helix (TMHMM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhhhhhooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (MEMSAT_SVM)
SSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (Phobius)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MVVNLTTKCFAVSRKCDFLTLNPTQFLKFSNSGSSISNQCGSTTASRRNSLKVDPELIFTKQERIGKGSFGEVFKGIDNRTQQVxxxxxxxxxxxxxxxxxxxxxxxxxxxxDSPYGTKLWIIMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPENRPTAKELLKFPFIRKAKKNAYLIDLIDRYKKWKNSRNEESETESETSDNEDSIKTDGDLDEPWIMTVKGKMPNEYGSSPNKKSGGMNGADNIVNNNNLNNNNNHATFISSSEKSHSPARPLSIAPGPPSSAQEKRNSMTRSDSGEHKSNPTSPDREKHKIGSPEREKLKIGSPDREKLKSPDREKHKIGSPDREKNKIGSPDKKQQTRGSPVKASARSPCLSFLIYPLISELQRRHHYTSNNRTSNSGADSSHKADAIEELKNAFDLAERSAPGISGQFVKEVVHKLLPAMSEARVNSVVDKMIRSISSIFVPIKYKF
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	604	2.2.26 [Sep-21-2011]
Q99KH8	431	Serine/threonine-protein	yes	N/A	0.513	0.719	0.725	1e-123
B0LT89	431	Serine/threonine-protein	yes	N/A	0.513	0.719	0.722	1e-123
Q9Y6E0	443	Serine/threonine-protein	yes	N/A	0.513	0.699	0.719	1e-123
Q9Z2W1	426	Serine/threonine-protein	no	N/A	0.490	0.694	0.754	1e-122
Q3SWY6	426	Serine/threonine-protein	yes	N/A	0.473	0.671	0.763	1e-122
Q9P289	416	Serine/threonine-protein	no	N/A	0.440	0.639	0.797	1e-122
O00506	426	Serine/threonine-protein	no	N/A	0.490	0.694	0.750	1e-122
Q99JT2	416	Serine/threonine-protein	no	N/A	0.440	0.639	0.797	1e-122
O61122	478	Serine/threonine-protein	yes	N/A	0.445	0.562	0.698	1e-115
Q86IX1	737	Serine/threonine-protein	no	N/A	0.458	0.375	0.527	6e-83

>sp|Q99KH8|STK24_MOUSE Serine/threonine-protein kinase 24 OS=Mus musculus GN=Stk24 PE=1 SV=1

 Score =  444 bits (1141), Expect = e-123,   Method: Compositional matrix adjust.
 Identities = 233/321 (72%), Positives = 261/321 (81%), Gaps = 11/321 (3%)

Query: 49  NSLKVDPELIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMV 108
            +LK DPE +FTK E+IGKGSFGEVFKGIDNRTQ+VVAIKIIDLEEAEDEIEDIQQEI V
Sbjct: 14  QNLKADPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITV 73

Query: 109 LSQCDSPY----------GTKLWIIMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLD 158
           LSQCDSPY           TKLWIIMEYLGGGSALDL++ G  +E+ IA ILRE+LKGLD
Sbjct: 74  LSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDEIQIATILREILKGLD 133

Query: 159 YLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQ 218
           YLHSE+K+HRDIKAANVLLSE G+VKLADFGVAG LT+T  KRNTFVGTPFWMAPEVIKQ
Sbjct: 134 YLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQ 193

Query: 219 SAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEA 278
           SAYDSKADIWSLGITAIELAKGEPP+SELHPM+VLFLIPKNNPP L GNY+K  KEFVEA
Sbjct: 194 SAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEA 253

Query: 279 CLNKDPENRPTAKELLKFPF-IRKAKKNAYLIDLIDRYKKWKNSRNEESETESETSDNED 337
           CLNK+P  RPTAKELLK  F IR AKK +YL +LIDRYK+WK  ++ E  +  ++    D
Sbjct: 254 CLNKEPSFRPTAKELLKHKFIIRNAKKTSYLTELIDRYKRWKAEQSHEDSSSEDSDVETD 313

Query: 338 SIKTDGDLDEPWIMTVKGKMP 358
              + G     WI T++ K P
Sbjct: 314 GQASGGSDSGDWIFTIREKDP 334

Serine/threonine-protein kinase that acts on both serine and threonine residues and promotes apoptosis in response to stress stimuli and caspase activation. Mediates oxidative-stress-induced cell death by modulating phosphorylation of JNK1-JNK2 (MAPK8 and MAPK9), p38 (MAPK11, MAPK12, MAPK13 and MAPK14) during oxidative stress. Plays a role in a staurosporine-induced caspase-independent apoptotic pathway by regulating the nuclear translocation of AIFM1 and ENDOG and the DNase activity associated with ENDOG. Phosphorylates STK38L on 'Thr-442' and stimulates its kinase activity. Regulates cellular migration with alteration of PTPN12 activity and PXN phosphorylation: phosphorylates PTPN12 and inhibits its activity and may regulate PXN phosphorylation through PTPN12. Acts as a key regulator of axon regeneration in the optic nerve and radial nerve.
Mus musculus (taxid: 10090)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|B0LT89|STK24_RAT Serine/threonine-protein kinase 24 OS=Rattus norvegicus GN=Stk24 PE=2 SV=1

 Score =  443 bits (1140), Expect = e-123,   Method: Compositional matrix adjust.
 Identities = 232/321 (72%), Positives = 262/321 (81%), Gaps = 11/321 (3%)

Query: 49  NSLKVDPELIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMV 108
            +LK DPE +FTK E+IGKGSFGEVFKGIDNRTQ+VVAIKIIDLEEAEDEIEDIQQEI V
Sbjct: 14  QTLKADPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITV 73

Query: 109 LSQCDSPY----------GTKLWIIMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLD 158
           LSQCDSPY           TKLWIIMEYLGGGSALDL++ G  +E+ IA ILRE+LKGLD
Sbjct: 74  LSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDEIQIATILREILKGLD 133

Query: 159 YLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQ 218
           YLHSE+K+HRDIKAANVLLSE G+VKLADFGVAG LT+T  KRNTFVGTPFWMAPEVIKQ
Sbjct: 134 YLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQ 193

Query: 219 SAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEA 278
           SAYDSKADIWSLGITAIELAKGEPP+SELHPM+VLFLIPKNNPP L G+Y++  KEFVEA
Sbjct: 194 SAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPTLEGSYSRPLKEFVEA 253

Query: 279 CLNKDPENRPTAKELLKFPF-IRKAKKNAYLIDLIDRYKKWKNSRNEESETESETSDNED 337
           CLNK+P  RPTAKELLK  F IR AKK +YL +LIDRYK+WK  ++ E  +  ++    D
Sbjct: 254 CLNKEPSFRPTAKELLKHKFIIRNAKKTSYLTELIDRYKRWKAEQSHEDSSSEDSDVETD 313

Query: 338 SIKTDGDLDEPWIMTVKGKMP 358
           S  + G     WI T++ K P
Sbjct: 314 SQASGGSDSGDWIFTIREKDP 334

Serine/threonine-protein kinase that acts on both serine and threonine residues and promotes apoptosis in response to stress stimuli and caspase activation. Mediates oxidative-stress-induced cell death by modulating phosphorylation of JNK1-JNK2 (MAPK8 and MAPK9), p38 (MAPK11, MAPK12, MAPK13 and MAPK14) during oxidative stress. Plays a role in a staurosporine-induced caspase-independent apoptotic pathway by regulating the nuclear translocation of AIFM1 and ENDOG and the DNase activity associated with ENDOG. Phosphorylates STK38L on 'Thr-442' and stimulates its kinase activity. Regulates cellular migration with alteration of PTPN12 activity and PXN phosphorylation: phosphorylates PTPN12 and inhibits its activity and may regulate PXN phosphorylation through PTPN12 (By similarity). Acts as a key regulator of axon regeneration in the adult optic nerve and radial nerve.

Rattus norvegicus (taxid: 10116)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9Y6E0|STK24_HUMAN Serine/threonine-protein kinase 24 OS=Homo sapiens GN=STK24 PE=1 SV=1

 Score =  442 bits (1136), Expect = e-123,   Method: Compositional matrix adjust.
 Identities = 231/321 (71%), Positives = 260/321 (80%), Gaps = 11/321 (3%)

Query: 49  NSLKVDPELIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMV 108
            +LK DPE +FTK E+IGKGSFGEVFKGIDNRTQ+VVAIKIIDLEEAEDEIEDIQQEI V
Sbjct: 26  TNLKADPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITV 85

Query: 109 LSQCDSPY----------GTKLWIIMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLD 158
           LSQCDSPY           TKLWIIMEYLGGGSALDL++ G  +E  IA ILRE+LKGLD
Sbjct: 86  LSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLD 145

Query: 159 YLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQ 218
           YLHSE+K+HRDIKAANVLLSE G+VKLADFGVAG LT+T  KRNTFVGTPFWMAPEVIKQ
Sbjct: 146 YLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQ 205

Query: 219 SAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEA 278
           SAYDSKADIWSLGITAIELA+GEPP+SELHPM+VLFLIPKNNPP L GNY+K  KEFVEA
Sbjct: 206 SAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEA 265

Query: 279 CLNKDPENRPTAKELLKFPFI-RKAKKNAYLIDLIDRYKKWKNSRNEESETESETSDNED 337
           CLNK+P  RPTAKELLK  FI R AKK +YL +LIDRYK+WK  ++ +  +  ++    D
Sbjct: 266 CLNKEPSFRPTAKELLKHKFILRNAKKTSYLTELIDRYKRWKAEQSHDDSSSEDSDAETD 325

Query: 338 SIKTDGDLDEPWIMTVKGKMP 358
              + G     WI T++ K P
Sbjct: 326 GQASGGSDSGDWIFTIREKDP 346

Serine/threonine-protein kinase that acts on both serine and threonine residues and promotes apoptosis in response to stress stimuli and caspase activation. Mediates oxidative-stress-induced cell death by modulating phosphorylation of JNK1-JNK2 (MAPK8 and MAPK9), p38 (MAPK11, MAPK12, MAPK13 and MAPK14) during oxidative stress. Plays a role in a staurosporine-induced caspase-independent apoptotic pathway by regulating the nuclear translocation of AIFM1 and ENDOG and the DNase activity associated with ENDOG. Phosphorylates STK38L on 'Thr-442' and stimulates its kinase activity. Regulates cellular migration with alteration of PTPN12 activity and PXN phosphorylation: phosphorylates PTPN12 and inhibits its activity and may regulate PXN phosphorylation through PTPN12. May act as a key regulator of axon regeneration in the optic nerve and radial nerve.

Homo sapiens (taxid: 9606)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9Z2W1|STK25_MOUSE Serine/threonine-protein kinase 25 OS=Mus musculus GN=Stk25 PE=1 SV=2

 Score =  440 bits (1132), Expect = e-122,   Method: Compositional matrix adjust.
 Identities = 233/309 (75%), Positives = 256/309 (82%), Gaps = 13/309 (4%)

Query: 52  KVDPELIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQ 111
           +VDPE +FTK +RIGKGSFGEV+KGIDN T++VVAIKIIDLEEAEDEIEDIQQEI VLSQ
Sbjct: 13  RVDPEELFTKLDRIGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQ 72

Query: 112 CDSPY----------GTKLWIIMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLH 161
           CDSPY           TKLWIIMEYLGGGSALDL+K G  EE +IA ILRE+LKGLDYLH
Sbjct: 73  CDSPYITRYFGSYLKSTKLWIIMEYLGGGSALDLLKPGPLEETYIATILREILKGLDYLH 132

Query: 162 SERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAY 221
           SERK+HRDIKAANVLLSE GDVKLADFGVAG LT+T  KRNTFVGTPFWMAPEVIKQSAY
Sbjct: 133 SERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAY 192

Query: 222 DSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLN 281
           D KADIWSLGITAIELAKGEPPNS+LHPMRVLFLIPKNNPP L G+++K FKEFVEACLN
Sbjct: 193 DFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNNPPTLEGHHSKPFKEFVEACLN 252

Query: 282 KDPENRPTAKELLKFPFI-RKAKKNAYLIDLIDRYKKWKNSRNEESETESETSDNEDSIK 340
           KDP  RPTAKELLK  FI R  KK ++L +LIDRYK+WK+  + E E+ SE SD  D   
Sbjct: 253 KDPRFRPTAKELLKHKFITRYTKKTSFLTELIDRYKRWKSEGHGE-ESSSEDSDI-DGEA 310

Query: 341 TDGDLDEPW 349
            DG+    W
Sbjct: 311 EDGEQGPIW 319

Oxidant stress-activated serine/threonine kinase that may play a role in the response to environmental stress. Targets to the Golgi apparatus where it appears to regulate protein transport events, cell adhesion, and polarity complexes important for cell migration.

Mus musculus (taxid: 10090)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q3SWY6|STK25_BOVIN Serine/threonine-protein kinase 25 OS=Bos taurus GN=STK25 PE=2 SV=1

 Score =  439 bits (1130), Expect = e-122,   Method: Compositional matrix adjust.
 Identities = 232/304 (76%), Positives = 254/304 (83%), Gaps = 18/304 (5%)

Query: 52  KVDPELIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQ 111
           +VDPE +FTK +RIGKGSFGEV+KGIDNRT++VVAIKIIDLEEAEDEIEDIQQEI VLSQ
Sbjct: 13  RVDPEELFTKLDRIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQ 72

Query: 112 CDSPY----------GTKLWIIMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLH 161
           CDSPY           TKLWIIMEYLGGGSALDL+K G  EE +IA ILRE+LKGLDYLH
Sbjct: 73  CDSPYITRYFGSYLKSTKLWIIMEYLGGGSALDLLKPGPLEETYIATILREILKGLDYLH 132

Query: 162 SERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAY 221
           SERK+HRDIKAANVLLSE GDVKLADFGVAG LT+T  KRNTFVGTPFWMAPEVIKQSAY
Sbjct: 133 SERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAY 192

Query: 222 DSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLN 281
           D KADIWSLGITAIELAKGEPPNS+LHPMRVLFLIPKN+PP L G+++K FKEFVEACLN
Sbjct: 193 DFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTLEGHHSKPFKEFVEACLN 252

Query: 282 KDPENRPTAKELLKFPFI-RKAKKNAYLIDLIDRYKKWKNSRNEESETESETSDNEDSIK 340
           KDP  RPTAKELLK  FI R  KK ++L +LIDRYK+W+      SE   E S +EDS  
Sbjct: 253 KDPRFRPTAKELLKHKFITRYTKKTSFLTELIDRYKRWR------SEGHGEESSSEDS-D 305

Query: 341 TDGD 344
            DGD
Sbjct: 306 IDGD 309

Oxidant stress-activated serine/threonine kinase that may play a role in the response to environmental stress. Targets to the Golgi apparatus where it appears to regulate protein transport events, cell adhesion, and polarity complexes important for cell migration.

Bos taurus (taxid: 9913)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9P289|MST4_HUMAN Serine/threonine-protein kinase MST4 OS=Homo sapiens GN=MST4 PE=1 SV=2

 Score =  439 bits (1129), Expect = e-122,   Method: Compositional matrix adjust.
 Identities = 221/277 (79%), Positives = 244/277 (88%), Gaps = 11/277 (3%)

Query: 54  DPELIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCD 113
           DPE +FTK ERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEI VLSQCD
Sbjct: 19  DPEELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCD 78

Query: 114 SPY----------GTKLWIIMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSE 163
           S Y          G+KLWIIMEYLGGGSALDL++AG F+E  IA +L+E+LKGLDYLHSE
Sbjct: 79  SSYVTKYYGSYLKGSKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLKEILKGLDYLHSE 138

Query: 164 RKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDS 223
           +K+HRDIKAANVLLSE GDVKLADFGVAG LT+T  KRNTFVGTPFWMAPEVI+QSAYDS
Sbjct: 139 KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDS 198

Query: 224 KADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKD 283
           KADIWSLGITAIELAKGEPPNS++HPMRVLFLIPKNNPP L G++TK FKEF++ACLNKD
Sbjct: 199 KADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPTLVGDFTKSFKEFIDACLNKD 258

Query: 284 PENRPTAKELLKFPFIRK-AKKNAYLIDLIDRYKKWK 319
           P  RPTAKELLK  FI K +KK +YL +LIDR+K+WK
Sbjct: 259 PSFRPTAKELLKHKFIVKNSKKTSYLTELIDRFKRWK 295

Mediator of cell growth. Modulates apoptosis.

Homo sapiens (taxid: 9606)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O00506|STK25_HUMAN Serine/threonine-protein kinase 25 OS=Homo sapiens GN=STK25 PE=1 SV=1

 Score =  437 bits (1125), Expect = e-122,   Method: Compositional matrix adjust.
 Identities = 232/309 (75%), Positives = 255/309 (82%), Gaps = 13/309 (4%)

Query: 52  KVDPELIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQ 111
           +VDPE +FTK +RIGKGSFGEV+KGIDN T++VVAIKIIDLEEAEDEIEDIQQEI VLSQ
Sbjct: 13  RVDPEELFTKLDRIGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQ 72

Query: 112 CDSPY----------GTKLWIIMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLH 161
           CDSPY           TKLWIIMEYLGGGSALDL+K G  EE +IA ILRE+LKGLDYLH
Sbjct: 73  CDSPYITRYFGSYLKSTKLWIIMEYLGGGSALDLLKPGPLEETYIATILREILKGLDYLH 132

Query: 162 SERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAY 221
           SERK+HRDIKAANVLLSE GDVKLADFGVAG LT+T  KRNTFVGTPFWMAPEVIKQSAY
Sbjct: 133 SERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAY 192

Query: 222 DSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLN 281
           D KADIWSLGITAIELAKGEPPNS+LHPMRVLFLIPKN+PP L G ++K FKEFVEACLN
Sbjct: 193 DFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTLEGQHSKPFKEFVEACLN 252

Query: 282 KDPENRPTAKELLKFPFI-RKAKKNAYLIDLIDRYKKWKNSRNEESETESETSDNEDSIK 340
           KDP  RPTAKELLK  FI R  KK ++L +LIDRYK+WK+  + E E+ SE SD  D   
Sbjct: 253 KDPRFRPTAKELLKHKFITRYTKKTSFLTELIDRYKRWKSEGHGE-ESSSEDSDI-DGEA 310

Query: 341 TDGDLDEPW 349
            DG+    W
Sbjct: 311 EDGEQGPIW 319

Oxidant stress-activated serine/threonine kinase that may play a role in the response to environmental stress. Targets to the Golgi apparatus where it appears to regulate protein transport events, cell adhesion, and polarity complexes important for cell migration.

Homo sapiens (taxid: 9606)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q99JT2|MST4_MOUSE Serine/threonine-protein kinase MST4 OS=Mus musculus GN=Mst4 PE=2 SV=1

 Score =  437 bits (1125), Expect = e-122,   Method: Compositional matrix adjust.
 Identities = 221/277 (79%), Positives = 244/277 (88%), Gaps = 11/277 (3%)

Query: 54  DPELIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCD 113
           DPE +FTK ERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEI VLSQCD
Sbjct: 19  DPEELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCD 78

Query: 114 SPY----------GTKLWIIMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSE 163
           S Y          G+KLWIIMEYLGGGSALDL++AG F+E  IA +L+E+LKGLDYLHSE
Sbjct: 79  SSYVTKYYGSYLKGSKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLKEILKGLDYLHSE 138

Query: 164 RKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDS 223
           +K+HRDIKAANVLLSE GDVKLADFGVAG LT+T  KRNTFVGTPFWMAPEVI+QSAYDS
Sbjct: 139 KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDS 198

Query: 224 KADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKD 283
           KADIWSLGITAIELAKGEPPNS++HPMRVLFLIPKNNPP L G++TK FKEF++ACLNKD
Sbjct: 199 KADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPTLIGDFTKSFKEFIDACLNKD 258

Query: 284 PENRPTAKELLKFPFIRK-AKKNAYLIDLIDRYKKWK 319
           P  RPTAKELLK  FI K +KK +YL +LIDR+K+WK
Sbjct: 259 PSFRPTAKELLKHKFIVKNSKKTSYLTELIDRFKRWK 295

Mediator of cell growth. Modulates apoptosis.

Mus musculus (taxid: 10090)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O61122|SVKA_DICDI Serine/threonine-protein kinase svkA OS=Dictyostelium discoideum GN=svkA PE=1 SV=1

 Score =  415 bits (1066), Expect = e-115,   Method: Compositional matrix adjust.
 Identities = 195/279 (69%), Positives = 230/279 (82%), Gaps = 10/279 (3%)

Query: 50  SLKVDPELIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVL 109
           S K DPE ++ +QE+IGKGSFGEVFKGI+ +T + +AIK IDLE+AEDEIEDIQQEI VL
Sbjct: 3   SKKGDPEELYVRQEKIGKGSFGEVFKGINKKTNETIAIKTIDLEDAEDEIEDIQQEINVL 62

Query: 110 SQCDSPY----------GTKLWIIMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDY 159
           SQC+SP+          G+KLWIIMEYL GGS LDLMK G F+E +IA+ILRE+LKGL+Y
Sbjct: 63  SQCESPFVTKYFGSFLKGSKLWIIMEYLAGGSVLDLMKPGPFDEGYIAIILRELLKGLEY 122

Query: 160 LHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQS 219
           LHSE K+HRDIKAANVLLS  GDVKLADFGV+G LT+  +KRNTFVGTPFWMAPEVIKQ+
Sbjct: 123 LHSEGKIHRDIKAANVLLSASGDVKLADFGVSGQLTDQMTKRNTFVGTPFWMAPEVIKQT 182

Query: 220 AYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEAC 279
            YDSKADIWS+GITA+E+AKGEPP ++LHPMR LFLIPK+ PP L GN++K FKEF   C
Sbjct: 183 GYDSKADIWSMGITALEMAKGEPPRADLHPMRALFLIPKDPPPTLEGNFSKGFKEFCALC 242

Query: 280 LNKDPENRPTAKELLKFPFIRKAKKNAYLIDLIDRYKKW 318
           LNKDP  RPTAK+LLK  FI+ AKK + L DLI+R +KW
Sbjct: 243 LNKDPNQRPTAKDLLKHKFIKAAKKTSSLTDLIERRQKW 281

Involved in regulation of actin cytoskeleton organization during cell motility; F-actin fragmenting and capping protein allowing dynamic rearrangements of the actin cytoskeleton. Also part of a regulatory pathway from the centrosome to the midzone, thus regulating the completion of cell division.

Dictyostelium discoideum (taxid: 44689)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q86IX1|DST1_DICDI Serine/threonine-protein kinase dst1 OS=Dictyostelium discoideum GN=dst1 PE=3 SV=1

 Score =  308 bits (790), Expect = 6e-83,   Method: Compositional matrix adjust.
 Identities = 154/292 (52%), Positives = 206/292 (70%), Gaps = 15/292 (5%)

Query: 54  DPELIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCD 113
           DP+ I+  QER+GKGSFG+VFK +     +VVAIKII L++ E  I+D+++EI +L++C+
Sbjct: 24  DPQTIYHIQERLGKGSFGQVFKAVHFANGKVVAIKIISLDDQE-AIKDVRKEISILAECN 82

Query: 114 SP-----YGT-----KLWIIMEYLGGGSALDLMKA-GNFEEMHIAVILREVLKGLDYLHS 162
            P     +G+     +LWI+MEY GGGS  DL++      E  IA+I RE LKGL+YLH 
Sbjct: 83  YPNIVQYFGSYFKDHQLWIVMEYCGGGSVSDLLQVIDTISEDEIALICREALKGLNYLHE 142

Query: 163 ERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYD 222
            +K+HRDIK  N+LL++ G+VKLADFGV+  L NT SKRNTFVGTP+WMAPEVI+++ YD
Sbjct: 143 FKKIHRDIKGGNILLNDRGEVKLADFGVSAQLFNTFSKRNTFVGTPYWMAPEVIQENKYD 202

Query: 223 SKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGN--YTKQFKEFVEACL 280
            KAD+WSLGITAIE+A+G PPNS +HPMRV+F+IP+   P LT    ++ +F++F+  CL
Sbjct: 203 GKADVWSLGITAIEMAEGLPPNSNVHPMRVIFMIPREESPALTDKSIWSDKFQDFISKCL 262

Query: 281 NKDPENRPTAKELLKFPFIRKAKKNAYLIDLIDRYKKW-KNSRNEESETESE 331
            KDP  RPTAKELL   FI+  K  + L DL++  K    NS   E E E E
Sbjct: 263 TKDPAERPTAKELLNHEFIQTKKPLSILSDLVENCKTLINNSSMFEDEDEEE 314

Dictyostelium discoideum (taxid: 44689)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	604
189237907	4912	PREDICTED: similar to GA18707-PA [Tribol	0.801	0.098	0.666	0.0
270008015	562	hypothetical protein TcasGA2_TC014767 [T	0.796	0.855	0.660	1e-178
345495622	586	PREDICTED: serine/threonine-protein kina	0.867	0.894	0.608	1e-171
383857375	684	PREDICTED: serine/threonine-protein kina	0.872	0.770	0.599	1e-168
195391172	659	GJ22913 [Drosophila virilis] gi|19415232	0.503	0.461	0.874	1e-162
195500104	640	GE24610 [Drosophila yakuba] gi|194183333	0.503	0.475	0.879	1e-162
198450407	617	GA18707 [Drosophila pseudoobscura pseudo	0.503	0.492	0.882	1e-162
195165932	617	GL27268 [Drosophila persimilis] gi|19410	0.503	0.492	0.882	1e-162
195112909	685	GI10558 [Drosophila mojavensis] gi|19391	0.503	0.443	0.871	1e-162
194742309	403	GF17125 [Drosophila ananassae] gi|190626	0.503	0.754	0.882	1e-162

>gi|189237907|ref|XP_969118.2| PREDICTED: similar to GA18707-PA [Tribolium castaneum]

 Score =  653 bits (1684), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 373/560 (66%), Positives = 416/560 (74%), Gaps = 76/560 (13%)

Query: 52  KVDPELIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQ 111
           KVDPELIFTKQERIGKGSFGEVFKGIDNRT QVVAIKIIDLEEAEDEIEDIQQEIMVLSQ
Sbjct: 60  KVDPELIFTKQERIGKGSFGEVFKGIDNRTTQVVAIKIIDLEEAEDEIEDIQQEIMVLSQ 119

Query: 112 CDSPY----------GTKLWIIMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLH 161
           CDSPY          GTKLWIIMEYLGGGSALDLMKAGNFEEMHIA+ILREVLKGLDYLH
Sbjct: 120 CDSPYVTKYFGSYLKGTKLWIIMEYLGGGSALDLMKAGNFEEMHIAIILREVLKGLDYLH 179

Query: 162 SERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAY 221
           SERKLHRDIKAANVLLSEMGDVKLADFGVAG LTNTTSKRNTFVGTPFWMAPEVIKQSAY
Sbjct: 180 SERKLHRDIKAANVLLSEMGDVKLADFGVAGQLTNTTSKRNTFVGTPFWMAPEVIKQSAY 239

Query: 222 DSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLN 281
           DSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTG+YTKQFK+FVEACLN
Sbjct: 240 DSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGSYTKQFKDFVEACLN 299

Query: 282 KDPENRPTAKELLKFPFIRKAKKNAYLIDLIDRYKKWKNSRNEESETESETSDNEDSIKT 341
           KDPENRPTAKELLK+PFIRKAKKN+YLIDLIDRYKKW+ +RNEESETESE SD+E+  K 
Sbjct: 300 KDPENRPTAKELLKYPFIRKAKKNSYLIDLIDRYKKWRCTRNEESETESENSDSEEP-KQ 358

Query: 342 DGDLDEPWIMTVKG----KMPNEYGSSPNKK--SGGMNGAD-NIVNNNNLNNNNNHATFI 394
           + DLD+PWIMTVKG    K+P E   +PN K  +   NG+   I  +   ++N NH    
Sbjct: 359 ESDLDDPWIMTVKGNHSIKLPQE-DLTPNHKIPNKIQNGSGPTIAKSPPKDSNLNH---- 413

Query: 395 SSSEKSHSPARPLSIAPGPPSSAQEKRNSMTRSDSGEHKSNPTSPDREKHKIGSPEREKL 454
                     RP    P   S  Q    S  R D  +  S   SP    H+ G  E EK 
Sbjct: 414 ---------YRPEKATPSKQSVVQSP--SDNRKDREKRISRELSP--LDHRGGELEIEK- 459

Query: 455 KIGSPDREKLKSPDREKHKIGSPDREKNKIGSPDKKQQTRGSPVKASARSPCLSFLIYPL 514
                     K   R +H  G                       K+ ARSPCLS +IYPL
Sbjct: 460 ----------KLNRRREHSNGG----------------------KSDARSPCLSGVIYPL 487

Query: 515 ISELQRRHHYTSNNRTSNSGADSSHKA-DAIEELKNAFDLAERSAPGISGQFVKEVVHKL 573
           ISELQR+HHY  N R     ADSSHK+ DAIEEL+NAF++AER++PGI+  F+ E+V KL
Sbjct: 488 ISELQRKHHY--NGR----AADSSHKSNDAIEELRNAFEIAERASPGITESFISEMVKKL 541

Query: 574 LPAMSEARVNSVVDKMIRSI 593
           +P+++E R++SV++K+ R +
Sbjct: 542 MPSVTEQRLSSVMEKVTRFV 561

Source: Tribolium castaneum

Species: Tribolium castaneum

Genus: Tribolium

Family: Tenebrionidae

Order: Coleoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|270008015|gb|EFA04463.1| hypothetical protein TcasGA2_TC014767 [Tribolium castaneum]

 Score =  632 bits (1629), Expect = e-178,   Method: Compositional matrix adjust.
 Identities = 369/559 (66%), Positives = 413/559 (73%), Gaps = 78/559 (13%)

Query: 52  KVDPELIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQ 111
           KVDPELIFTKQERIGKGSFGEVFKGIDNRT QVVAIKIIDLEEAEDEIEDIQQEIMVLSQ
Sbjct: 60  KVDPELIFTKQERIGKGSFGEVFKGIDNRTTQVVAIKIIDLEEAEDEIEDIQQEIMVLSQ 119

Query: 112 CDSPY----------GTKLWIIMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLH 161
           CDSPY          GTKLWIIMEYLGGGSALDLMKAGNFEEMHIA+ILREVLKGLDYLH
Sbjct: 120 CDSPYVTKYFGSYLKGTKLWIIMEYLGGGSALDLMKAGNFEEMHIAIILREVLKGLDYLH 179

Query: 162 SERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAY 221
           SERKLHRDIKAANVLLSEMGDVKLADFGVAG LTNTTSKRNTFVGTPFWMAPEVIKQSAY
Sbjct: 180 SERKLHRDIKAANVLLSEMGDVKLADFGVAGQLTNTTSKRNTFVGTPFWMAPEVIKQSAY 239

Query: 222 DSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLN 281
           DSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTG+YTKQFK+FVEACLN
Sbjct: 240 DSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGSYTKQFKDFVEACLN 299

Query: 282 KDPENRPTAKELLKFPFIRKAKKNAYLIDLIDRYKKWKNSRNEESETESETSDNEDSIKT 341
           KDPENRPTAKELLK+PFIRKAKKN+YLIDLIDRYKKW+ +RNEESETESE SD+E+  K 
Sbjct: 300 KDPENRPTAKELLKYPFIRKAKKNSYLIDLIDRYKKWRCTRNEESETESENSDSEEP-KQ 358

Query: 342 DGDLDEPWIMTVKG----KMPNEYGSSPNKKSGGMNGADNIVNNNNLNNNNNHATFISSS 397
           + DLD+PWIMTVKG    K+P E   +PN K        N + N             S  
Sbjct: 359 ESDLDDPWIMTVKGNHSIKLPQE-DLTPNHK------IPNKIQNG------------SGP 399

Query: 398 EKSHSPARPLSIAPGPPSSAQEKRNSMTRSDSGEHKSNPTSPDRE----KHKIGSPEREK 453
             + SP +  ++    P  A   + S+ +S S   K       RE     H+ G  E EK
Sbjct: 400 TIAKSPPKDSNLNHYRPEKATPSKQSVVQSPSDNRKDREKRISRELSPLDHRGGELEIEK 459

Query: 454 LKIGSPDREKLKSPDREKHKIGSPDREKNKIGSPDKKQQTRGSPVKASARSPCLSFLIYP 513
                      K   R +H  G                       K+ ARSPCLS +IYP
Sbjct: 460 -----------KLNRRREHSNGG----------------------KSDARSPCLSGVIYP 486

Query: 514 LISELQRRHHYTSNNRTSNSGADSSHKA-DAIEELKNAFDLAERSAPGISGQFVKEVVHK 572
           LISELQR+HHY  N R     ADSSHK+ DAIEEL+NAF++AER++PGI+  F+ E+V K
Sbjct: 487 LISELQRKHHY--NGR----AADSSHKSNDAIEELRNAFEIAERASPGITESFISEMVKK 540

Query: 573 LLPAMSEARVNSVVDKMIR 591
           L+P+++E R++SV++K+ R
Sbjct: 541 LMPSVTEQRLSSVMEKVTR 559

Source: Tribolium castaneum

Species: Tribolium castaneum

Genus: Tribolium

Family: Tenebrionidae

Order: Coleoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|345495622|ref|XP_001605601.2| PREDICTED: serine/threonine-protein kinase 25-like [Nasonia vitripennis]

 Score =  609 bits (1571), Expect = e-171,   Method: Compositional matrix adjust.
 Identities = 360/592 (60%), Positives = 419/592 (70%), Gaps = 68/592 (11%)

Query: 52  KVDPELIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQ 111
           KVDPELIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQ
Sbjct: 6   KVDPELIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQ 65

Query: 112 CDSPY----------GTKLWIIMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLH 161
           CDSPY          GTKLWIIMEYLGGGSALDLMKAG+FEEMHIAVILREVLKGLDYLH
Sbjct: 66  CDSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLMKAGSFEEMHIAVILREVLKGLDYLH 125

Query: 162 SERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAY 221
           SERKLHRDIKAANVLLSEMGDVKLADFGVAG LTNTTSKRNTFVGTPFWMAPEVIKQSAY
Sbjct: 126 SERKLHRDIKAANVLLSEMGDVKLADFGVAGQLTNTTSKRNTFVGTPFWMAPEVIKQSAY 185

Query: 222 DSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLN 281
           DSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLN
Sbjct: 186 DSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLN 245

Query: 282 KDPENRPTAKELLKFPFIRKAKKNAYLIDLIDRYKKWKNSRNEESETESETSDNEDSIKT 341
           KDPENRPTAKELLKF FIRKAKKN+YLIDLIDRYKKWK+ R+EESETESE S + +  K 
Sbjct: 246 KDPENRPTAKELLKFQFIRKAKKNSYLIDLIDRYKKWKSQRSEESETESENS-DSEESKQ 304

Query: 342 DGDLDEPWIMTVKG-----------KMPNE------------YGSSPNKKSGGM------ 372
           D D+DEPWIMTVKG            MP E               +PN +          
Sbjct: 305 DSDMDEPWIMTVKGPHGVKGSSGVPMMPLEEQQQQQQPASLNLSHTPNHRPQHNQHSQQQ 364

Query: 373 -----------NGAD-NIVNNNNLNNNNNHATFIS-SSEKSHSPARPLSIAPGPPSSAQE 419
                      NGA  +    +NLN+  N +   S   +    P+RP   AP PPS+A  
Sbjct: 365 QQQQTQSKPHANGASRSPPKESNLNHYKNDSRDSSRDGQNKLMPSRPHEAAPKPPSTAD- 423

Query: 420 KRNSMTRSDSGEHKSNPTSPDREKHKIGSPEREKLKIGSPDREKLKSPDREKHKIGSPDR 479
                TR     H S+  S  R    +     + L+I   ++ + KS      K   P  
Sbjct: 424 -----TRDSRDYHDSSRDSTLRSAKDLLRRRDQGLEIDEREQRQRKS------KSEVPVE 472

Query: 480 EKNKIGSPDKKQQTRGSPVKASARSPCLSFLIYPLISELQRRHHYTSNNRTSNSGADSSH 539
            ++      ++Q+ R S      RSP L+ +I+PL+S+LQR++ Y +  R +  G ++S 
Sbjct: 473 HRSTSEEKQQQQRPRSSMELKHPRSPVLNGVIFPLLSDLQRKYQYAA--RDNGDGGNTSR 530

Query: 540 KADAIEELKNAFDLAERSAPGISGQFVKEVVHKLLPA-MSEARVNSVVDKMI 590
           ++ A+ EL++AF++AER++PG+S   VKE++  LLP   S+AR++ +++K++
Sbjct: 531 QSGALNELRDAFEVAERTSPGMSENLVKEILKALLPTNHSDARLSMLMEKVV 582

Source: Nasonia vitripennis

Species: Nasonia vitripennis

Genus: Nasonia

Family: Pteromalidae

Order: Hymenoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|383857375|ref|XP_003704180.1| PREDICTED: serine/threonine-protein kinase 25-like [Megachile rotundata]

 Score =  598 bits (1543), Expect = e-168,   Method: Compositional matrix adjust.
 Identities = 358/597 (59%), Positives = 415/597 (69%), Gaps = 70/597 (11%)

Query: 52  KVDPELIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQ 111
           KVDPELIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQ
Sbjct: 98  KVDPELIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQ 157

Query: 112 CDSPY----------GTKLWIIMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLH 161
           CDSPY          GTKLWIIMEYLGGGSALDLMKAG+FEEMHIAVILREVLKGLDYLH
Sbjct: 158 CDSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLMKAGSFEEMHIAVILREVLKGLDYLH 217

Query: 162 SERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAY 221
           SERKLHRDIKAANVLLSEMGDVKLADFGVAG LTNTTSKRNTFVGTPFWMAPEVIKQ++Y
Sbjct: 218 SERKLHRDIKAANVLLSEMGDVKLADFGVAGQLTNTTSKRNTFVGTPFWMAPEVIKQASY 277

Query: 222 DSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLN 281
           DSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLN
Sbjct: 278 DSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLN 337

Query: 282 KDPENRPTAKELLKFPFIRKAKKNAYLIDLIDRYKKWKNSRNEESETESETSDNEDSIKT 341
           KDPENRPTAKELLKF FIRKAKKN+YLIDLIDRYKKWK+ R+EESETESE SD+E+S K 
Sbjct: 338 KDPENRPTAKELLKFQFIRKAKKNSYLIDLIDRYKKWKSQRSEESETESENSDSEES-KQ 396

Query: 342 DGDLDEPWIMTVKG------------------------KMPNEYGSSPNKKSG-GMNGA- 375
           D D+DEPWIMTVKG                          PN   S+ N+++    NGA 
Sbjct: 397 DSDMDEPWIMTVKGPHGVKGSVVPMLPLDEQPASLTLTHTPNHRSSNHNQQTKPHANGAS 456

Query: 376 -----DNIVNNNNLNNNNNHATFISSSEKSHSPARPLSIAPGPPSSAQEKRNSMTRSDSG 430
                D+ +N+    + ++    +   +  H+P+RP   AP PP   +EKR      D  
Sbjct: 457 RSPPKDSTLNHYRSESRDS----VRDGQAKHTPSRPHEAAPPPPVDTREKREDRDYRDFD 512

Query: 431 EHKS---------------NPTSPDREKHKIGSPEREKLKIGSPDREKLKSPDREKHKIG 475
              S                    +  +           + GS  REK +S  RE   + 
Sbjct: 513 RDSSLRELKDMRDTRDARDRERDREGRERDRDRDRGRDREFGS--REKTRSGKREVSVVP 570

Query: 476 SPDREKNKIGSPDKKQQTRGSPVKASARSPCLSFLIYPLISELQRRHHYTS-NNRTSNSG 534
             D         ++KQ+ R S      RS  LS ++ PL++ELQR+H Y++ +N      
Sbjct: 571 MADHRPG-----EEKQRPRSSQELKHPRSAALSGVLLPLLAELQRKHQYSARDNNGEGGS 625

Query: 535 ADSSHKADAIEELKNAFDLAERSAPGISGQFVKEVVHKLLPA-MSEARVNSVVDKMI 590
               +    IEEL+NAF+ AER++PG++   ++E++  LLPA  SE R++ +++K+I
Sbjct: 626 GIGKNGGSTIEELRNAFETAERTSPGMTETLIRELLKSLLPANHSEGRLSMLMEKVI 682

Source: Megachile rotundata

Species: Megachile rotundata

Genus: Megachile

Family: Megachilidae

Order: Hymenoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|195391172|ref|XP_002054237.1| GJ22913 [Drosophila virilis] gi|194152323|gb|EDW67757.1| GJ22913 [Drosophila virilis]

 Score =  579 bits (1492), Expect = e-162,   Method: Compositional matrix adjust.
 Identities = 278/318 (87%), Positives = 290/318 (91%), Gaps = 14/318 (4%)

Query: 52  KVDPELIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQ 111
           KVDPELIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEI+DIQQEIMVLSQ
Sbjct: 6   KVDPELIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIDDIQQEIMVLSQ 65

Query: 112 CDSPY----------GTKLWIIMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLH 161
           CDSPY          GTKLWIIMEYLGGGSALDLMKAG+FEEMHI +ILREVLKGLDYLH
Sbjct: 66  CDSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLMKAGSFEEMHIGIILREVLKGLDYLH 125

Query: 162 SERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAY 221
           SERKLHRDIKAANVLLSE+GDVKLADFGVAG LTNTTSKRNTFVGTPFWMAPEVIKQS Y
Sbjct: 126 SERKLHRDIKAANVLLSELGDVKLADFGVAGQLTNTTSKRNTFVGTPFWMAPEVIKQSQY 185

Query: 222 DSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLN 281
           DSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTK FK+FVEACLN
Sbjct: 186 DSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKSFKDFVEACLN 245

Query: 282 KDPENRPTAKELLKFPFIRKAKKNAYLIDLIDRYKKWKNSRNEESETESETSDNEDSIKT 341
           KDPENRPTAKELLK+PFI+KAKKNAYLIDLIDR+KKWK S+ +ESETESE SD++   K 
Sbjct: 246 KDPENRPTAKELLKYPFIKKAKKNAYLIDLIDRFKKWKLSKGDESETESENSDSDSDAKQ 305

Query: 342 DG----DLDEPWIMTVKG 355
            G      DEPWIMTVKG
Sbjct: 306 SGGGGSSHDEPWIMTVKG 323

Source: Drosophila virilis

Species: Drosophila virilis

Genus: Drosophila

Family: Drosophilidae

Order: Diptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|195500104|ref|XP_002097232.1| GE24610 [Drosophila yakuba] gi|194183333|gb|EDW96944.1| GE24610 [Drosophila yakuba]

 Score =  579 bits (1492), Expect = e-162,   Method: Compositional matrix adjust.
 Identities = 277/315 (87%), Positives = 289/315 (91%), Gaps = 11/315 (3%)

Query: 52  KVDPELIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQ 111
           KVDPELIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEI+DIQQEIMVLSQ
Sbjct: 6   KVDPELIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIDDIQQEIMVLSQ 65

Query: 112 CDSPY----------GTKLWIIMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLH 161
           CDSPY          GTKLWIIMEYLGGGSALDLMKAG+FEEMHI +ILREVLKGLDYLH
Sbjct: 66  CDSPYVTKYYGSFLKGTKLWIIMEYLGGGSALDLMKAGSFEEMHIGIILREVLKGLDYLH 125

Query: 162 SERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAY 221
           SERKLHRDIKAANVLLSE GDVKLADFGVAG LTNTTSKRNTFVGTPFWMAPEVIKQS Y
Sbjct: 126 SERKLHRDIKAANVLLSEQGDVKLADFGVAGQLTNTTSKRNTFVGTPFWMAPEVIKQSQY 185

Query: 222 DSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLN 281
           D+KADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTK FK+FVEACLN
Sbjct: 186 DAKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKSFKDFVEACLN 245

Query: 282 KDPENRPTAKELLKFPFIRKAKKNAYLIDLIDRYKKWKNSRNEESETESETSDNEDSIKT 341
           KDPENRPTAKELLK+PFI+KAKKNAYLIDLIDR+KKWK S+ +ESETESE SD++   K 
Sbjct: 246 KDPENRPTAKELLKYPFIKKAKKNAYLIDLIDRFKKWKLSKGDESETESENSDSDSDAKQ 305

Query: 342 DG-DLDEPWIMTVKG 355
            G   DEPWIMTVKG
Sbjct: 306 GGSSQDEPWIMTVKG 320

Source: Drosophila yakuba

Species: Drosophila yakuba

Genus: Drosophila

Family: Drosophilidae

Order: Diptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|198450407|ref|XP_001357971.2| GA18707 [Drosophila pseudoobscura pseudoobscura] gi|198131023|gb|EAL27107.2| GA18707 [Drosophila pseudoobscura pseudoobscura]

 Score =  578 bits (1489), Expect = e-162,   Method: Compositional matrix adjust.
 Identities = 278/315 (88%), Positives = 289/315 (91%), Gaps = 11/315 (3%)

Query: 52  KVDPELIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQ 111
           KVDPELIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEI+DIQQEIMVLSQ
Sbjct: 6   KVDPELIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIDDIQQEIMVLSQ 65

Query: 112 CDSPY----------GTKLWIIMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLH 161
           CDSPY          GTKLWIIMEYLGGGSALDLMKAG+FEEMHI +ILREVLKGLDYLH
Sbjct: 66  CDSPYVTKYYGSFLKGTKLWIIMEYLGGGSALDLMKAGSFEEMHIGIILREVLKGLDYLH 125

Query: 162 SERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAY 221
           SERKLHRDIKAANVLLSE GDVKLADFGVAG LTNTTSKRNTFVGTPFWMAPEVIKQS Y
Sbjct: 126 SERKLHRDIKAANVLLSEQGDVKLADFGVAGQLTNTTSKRNTFVGTPFWMAPEVIKQSQY 185

Query: 222 DSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLN 281
           DSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTK FK+FVEACLN
Sbjct: 186 DSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKSFKDFVEACLN 245

Query: 282 KDPENRPTAKELLKFPFIRKAKKNAYLIDLIDRYKKWKNSRNEESETESETSDNEDSIKT 341
           KDPENRPTAKELLK+PFI+KAKKNAYLIDLIDR+KKWK S+ +ESETESE SD++   K 
Sbjct: 246 KDPENRPTAKELLKYPFIKKAKKNAYLIDLIDRFKKWKVSKGDESETESENSDSDSDAKQ 305

Query: 342 DG-DLDEPWIMTVKG 355
            G   DEPWIMTVKG
Sbjct: 306 GGSSQDEPWIMTVKG 320

Source: Drosophila pseudoobscura pseudoobscura

Species: Drosophila pseudoobscura

Genus: Drosophila

Family: Drosophilidae

Order: Diptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|195165932|ref|XP_002023792.1| GL27268 [Drosophila persimilis] gi|194105952|gb|EDW27995.1| GL27268 [Drosophila persimilis]

 Score =  577 bits (1488), Expect = e-162,   Method: Compositional matrix adjust.
 Identities = 278/315 (88%), Positives = 289/315 (91%), Gaps = 11/315 (3%)

Query: 52  KVDPELIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQ 111
           KVDPELIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEI+DIQQEIMVLSQ
Sbjct: 6   KVDPELIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIDDIQQEIMVLSQ 65

Query: 112 CDSPY----------GTKLWIIMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLH 161
           CDSPY          GTKLWIIMEYLGGGSALDLMKAG+FEEMHI +ILREVLKGLDYLH
Sbjct: 66  CDSPYVTKYYGSFLKGTKLWIIMEYLGGGSALDLMKAGSFEEMHIGIILREVLKGLDYLH 125

Query: 162 SERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAY 221
           SERKLHRDIKAANVLLSE GDVKLADFGVAG LTNTTSKRNTFVGTPFWMAPEVIKQS Y
Sbjct: 126 SERKLHRDIKAANVLLSEQGDVKLADFGVAGQLTNTTSKRNTFVGTPFWMAPEVIKQSQY 185

Query: 222 DSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLN 281
           DSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTK FK+FVEACLN
Sbjct: 186 DSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKSFKDFVEACLN 245

Query: 282 KDPENRPTAKELLKFPFIRKAKKNAYLIDLIDRYKKWKNSRNEESETESETSDNEDSIKT 341
           KDPENRPTAKELLK+PFI+KAKKNAYLIDLIDR+KKWK S+ +ESETESE SD++   K 
Sbjct: 246 KDPENRPTAKELLKYPFIKKAKKNAYLIDLIDRFKKWKVSKGDESETESENSDSDSDAKQ 305

Query: 342 DG-DLDEPWIMTVKG 355
            G   DEPWIMTVKG
Sbjct: 306 GGSSQDEPWIMTVKG 320

Source: Drosophila persimilis

Species: Drosophila persimilis

Genus: Drosophila

Family: Drosophilidae

Order: Diptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|195112909|ref|XP_002001014.1| GI10558 [Drosophila mojavensis] gi|193917608|gb|EDW16475.1| GI10558 [Drosophila mojavensis]

 Score =  577 bits (1486), Expect = e-162,   Method: Compositional matrix adjust.
 Identities = 277/318 (87%), Positives = 290/318 (91%), Gaps = 14/318 (4%)

Query: 52  KVDPELIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQ 111
           KVDPELIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEI+DIQQEIMVLSQ
Sbjct: 6   KVDPELIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIDDIQQEIMVLSQ 65

Query: 112 CDSPY----------GTKLWIIMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLH 161
           CDSPY          GTKLWIIMEYLGGGSALDLMKAG+FEEMHI +ILREVLKGLDYLH
Sbjct: 66  CDSPYVTKYYGSFLKGTKLWIIMEYLGGGSALDLMKAGSFEEMHIGIILREVLKGLDYLH 125

Query: 162 SERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAY 221
           SERKLHRDIKAANVLLSE+GDVKLADFGVAG LTNTTSKRNTFVGTPFWMAPEVIKQS Y
Sbjct: 126 SERKLHRDIKAANVLLSELGDVKLADFGVAGQLTNTTSKRNTFVGTPFWMAPEVIKQSQY 185

Query: 222 DSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLN 281
           DSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNY+K FK+FVEACLN
Sbjct: 186 DSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNYSKSFKDFVEACLN 245

Query: 282 KDPENRPTAKELLKFPFIRKAKKNAYLIDLIDRYKKWKNSRNEESETESETSDNEDSIKT 341
           KDPENRPTAKELLK+PFI+KAKKNAYLIDLIDR+KKWK S+ +ESETESE SD++   K 
Sbjct: 246 KDPENRPTAKELLKYPFIKKAKKNAYLIDLIDRFKKWKLSKGDESETESENSDSDSDAKQ 305

Query: 342 DG----DLDEPWIMTVKG 355
            G      DEPWIMTVKG
Sbjct: 306 SGVGGSGHDEPWIMTVKG 323

Source: Drosophila mojavensis

Species: Drosophila mojavensis

Genus: Drosophila

Family: Drosophilidae

Order: Diptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|194742309|ref|XP_001953645.1| GF17125 [Drosophila ananassae] gi|190626682|gb|EDV42206.1| GF17125 [Drosophila ananassae]

 Score =  577 bits (1486), Expect = e-162,   Method: Compositional matrix adjust.
 Identities = 278/315 (88%), Positives = 289/315 (91%), Gaps = 11/315 (3%)

Query: 52  KVDPELIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQ 111
           KVDPELIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEI+DIQQEIMVLSQ
Sbjct: 6   KVDPELIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIDDIQQEIMVLSQ 65

Query: 112 CDSPY----------GTKLWIIMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLH 161
           CDSPY          GTKLWIIMEYLGGGSALDLMKAG+FEEMHI +ILREVLKGLDYLH
Sbjct: 66  CDSPYVTKYYGSFLKGTKLWIIMEYLGGGSALDLMKAGSFEEMHIGIILREVLKGLDYLH 125

Query: 162 SERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAY 221
           SERKLHRDIKAANVLLSE GDVKLADFGVAG LTNTTSKRNTFVGTPFWMAPEVIKQS Y
Sbjct: 126 SERKLHRDIKAANVLLSEQGDVKLADFGVAGQLTNTTSKRNTFVGTPFWMAPEVIKQSQY 185

Query: 222 DSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLN 281
           DSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTK FK+FVEACLN
Sbjct: 186 DSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKSFKDFVEACLN 245

Query: 282 KDPENRPTAKELLKFPFIRKAKKNAYLIDLIDRYKKWKNSRNEESETESETSDNEDSIKT 341
           KDPENRPTAKELLK+PFI+KAKKNAYLIDLIDR+KKWK S+ +ESETESE SD++   K 
Sbjct: 246 KDPENRPTAKELLKYPFIKKAKKNAYLIDLIDRFKKWKLSKGDESETESENSDSDSDAKQ 305

Query: 342 DG-DLDEPWIMTVKG 355
            G   DEPWIMTVKG
Sbjct: 306 GGSSQDEPWIMTVKG 320

Source: Drosophila ananassae

Species: Drosophila ananassae

Genus: Drosophila

Family: Drosophilidae

Order: Diptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	604
FB|FBgn0086736	642	GckIII "Germinal centre kinase	0.503	0.473	0.784	6.1e-144
UNIPROTKB|F1N8L1	432	STK25 "Uncharacterized protein	0.445	0.622	0.728	2e-115
UNIPROTKB|F1SIN8	426	STK25 "Uncharacterized protein	0.445	0.631	0.717	6.1e-114
MGI|MGI:1891699	426	Stk25 "serine/threonine kinase	0.445	0.631	0.721	9.9e-114
RGD|727809	426	Stk25 "serine/threonine kinase	0.445	0.631	0.721	9.9e-114
UNIPROTKB|F1P0K4	419	STK24 "Uncharacterized protein	0.511	0.737	0.656	1.3e-113
UNIPROTKB|F1PTW5	426	STK25 "Uncharacterized protein	0.445	0.631	0.717	1.6e-113
UNIPROTKB|G3X7P7	426	STK25 "Serine/threonine-protei	0.445	0.631	0.717	2.1e-113
UNIPROTKB|Q3SWY6	426	STK25 "Serine/threonine-protei	0.445	0.631	0.717	2.1e-113
UNIPROTKB|F1MRQ0	425	STK25 "Serine/threonine-protei	0.445	0.632	0.717	2.6e-113

FB|FBgn0086736 GckIII "Germinal centre kinase III" [Drosophila melanogaster (taxid:7227)]

 Score = 1240 (441.6 bits), Expect = 6.1e-144, Sum P(2) = 6.1e-144
 Identities = 247/315 (78%), Positives = 256/315 (81%)

Query:    52 KVDPELIFTKQERIGKGSFGEVFKGIDNRTQQVVXXXXXXXXXXXXXXXXXXXXXMVLSQ 111
             KVDPELIFTKQERIGKGSFGEVFKGIDNRTQQVV                     MVLSQ
Sbjct:     6 KVDPELIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIDDIQQEIMVLSQ 65

Query:   112 CDSPY----------GTKLWIIMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLH 161
             CDSPY          GTKLWIIMEYLGGGSALDLMKAG+FEEMHI +ILREVLKGLDYLH
Sbjct:    66 CDSPYVTKYYGSFLKGTKLWIIMEYLGGGSALDLMKAGSFEEMHIGIILREVLKGLDYLH 125

Query:   162 SERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAY 221
             SERKLHRDIKAANVLLSE GDVKLADFGVAG LTNTTSKRNTFVGTPFWMAPEVIKQS Y
Sbjct:   126 SERKLHRDIKAANVLLSEQGDVKLADFGVAGQLTNTTSKRNTFVGTPFWMAPEVIKQSQY 185

Query:   222 DSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLN 281
             D+KADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTG+YTK FK+FVEACLN
Sbjct:   186 DAKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGSYTKSFKDFVEACLN 245

Query:   282 KDPENRPTAKELLKFPFIRKAKKNAYLIDLIDRYKKWKNSRXXXXXXXXXXXXXXXXIKT 341
             KDPENRPTAKELLK+PFI+KAKKNAYLIDLIDR+KKWK S+                 K 
Sbjct:   246 KDPENRPTAKELLKYPFIKKAKKNAYLIDLIDRFKKWKVSKGDESETESENSDSDSDAKQ 305

Query:   342 DGDL-DEPWIMTVKG 355
              G   DEPWIMTVKG
Sbjct:   306 GGSSQDEPWIMTVKG 320

GO:0006468 "protein phosphorylation" evidence=IEA;NAS

GO:0004702 "receptor signaling protein serine/threonine kinase activity" evidence=NAS

GO:0007015 "actin filament organization" evidence=IMP

GO:0004672 "protein kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

UNIPROTKB|F1N8L1 STK25 "Uncharacterized protein" [Gallus gallus (taxid:9031)]

 Score = 1024 (365.5 bits), Expect = 2.0e-115, Sum P(2) = 2.0e-115
 Identities = 204/280 (72%), Positives = 225/280 (80%)

Query:    52 KVDPELIFTKQERIGKGSFGEVFKGIDNRTQQVVXXXXXXXXXXXXXXXXXXXXXMVLSQ 111
             +VDPE +FTK ERIGKGSFGEV+KGIDNRT++VV                      VLSQ
Sbjct:    19 RVDPEELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQ 78

Query:   112 CDSPY----------GTKLWIIMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLH 161
             CDSPY          GTKLWIIMEYLGGGSALDL+K G  EE +IA ILRE+LKGLDYLH
Sbjct:    79 CDSPYITRYYGSYLKGTKLWIIMEYLGGGSALDLLKPGPLEETYIATILREILKGLDYLH 138

Query:   162 SERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAY 221
             SERK+HRDIKAANVLLSE GDVKLADFGVAG LT+T  KRNTFVGTPFWMAPEVIKQSAY
Sbjct:   139 SERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAY 198

Query:   222 DSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLN 281
             D KADIWSLGITAIELAKGEPPNS+LHPMRVLFLIPKNNPP L G+++K FKEFVEACLN
Sbjct:   199 DFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNNPPTLEGHHSKPFKEFVEACLN 258

Query:   282 KDPENRPTAKELLKFPFI-RKAKKNAYLIDLIDRYKKWKN 320
             KDP  RPTAKELLK  FI R  KK ++L++LIDR+K+WK+
Sbjct:   259 KDPRFRPTAKELLKHKFITRYTKKTSFLMELIDRFKRWKS 298

GO:0004672 "protein kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

UNIPROTKB|F1SIN8 STK25 "Uncharacterized protein" [Sus scrofa (taxid:9823)]

 Score = 1013 (361.7 bits), Expect = 6.1e-114, Sum P(2) = 6.1e-114
 Identities = 201/280 (71%), Positives = 224/280 (80%)

Query:    52 KVDPELIFTKQERIGKGSFGEVFKGIDNRTQQVVXXXXXXXXXXXXXXXXXXXXXMVLSQ 111
             +VDPE +FTK +RIGKGSFGEV+KGIDNRT++VV                      VLSQ
Sbjct:    13 RVDPEELFTKLDRIGKGSFGEVYKGIDNRTKEVVAIKTIDLEEAEDEIEDIQQEITVLSQ 72

Query:   112 CDSPY----------GTKLWIIMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLH 161
             CDSPY          GTKLWIIMEYLGGGSALDL+K G  EE +IA ILRE+L+GLDYLH
Sbjct:    73 CDSPYITRYFGSYLKGTKLWIIMEYLGGGSALDLLKPGPLEETYIATILREILRGLDYLH 132

Query:   162 SERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAY 221
             SERK+HRDIKAANVLLSE GDVKLADFGVAG LT+T  KRNTFVGTPFWMAPEVIKQSAY
Sbjct:   133 SERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAY 192

Query:   222 DSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLN 281
             D KADIWSLGITAIELAKGEPPNS+LHPMRVLFLIPKN+PP L G+++K FKEFVEACLN
Sbjct:   193 DFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTLEGHHSKPFKEFVEACLN 252

Query:   282 KDPENRPTAKELLKFPFI-RKAKKNAYLIDLIDRYKKWKN 320
             KDP  RPTAKELLK  FI R  KK ++L +LIDRYK+W++
Sbjct:   253 KDPRFRPTAKELLKHKFITRYTKKTSFLTELIDRYKRWRS 292

GO:0051645 "Golgi localization" evidence=IEA

GO:0050772 "positive regulation of axonogenesis" evidence=IEA

GO:0007163 "establishment or maintenance of cell polarity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0004672 "protein kinase activity" evidence=IEA

MGI|MGI:1891699 Stk25 "serine/threonine kinase 25 (yeast)" [Mus musculus (taxid:10090)]

 Score = 1012 (361.3 bits), Expect = 9.9e-114, Sum P(2) = 9.9e-114
 Identities = 202/280 (72%), Positives = 222/280 (79%)

Query:    52 KVDPELIFTKQERIGKGSFGEVFKGIDNRTQQVVXXXXXXXXXXXXXXXXXXXXXMVLSQ 111
             +VDPE +FTK +RIGKGSFGEV+KGIDN T++VV                      VLSQ
Sbjct:    13 RVDPEELFTKLDRIGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQ 72

Query:   112 CDSPY----------GTKLWIIMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLH 161
             CDSPY           TKLWIIMEYLGGGSALDL+K G  EE +IA ILRE+LKGLDYLH
Sbjct:    73 CDSPYITRYFGSYLKSTKLWIIMEYLGGGSALDLLKPGPLEETYIATILREILKGLDYLH 132

Query:   162 SERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAY 221
             SERK+HRDIKAANVLLSE GDVKLADFGVAG LT+T  KRNTFVGTPFWMAPEVIKQSAY
Sbjct:   133 SERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAY 192

Query:   222 DSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLN 281
             D KADIWSLGITAIELAKGEPPNS+LHPMRVLFLIPKNNPP L G+++K FKEFVEACLN
Sbjct:   193 DFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNNPPTLEGHHSKPFKEFVEACLN 252

Query:   282 KDPENRPTAKELLKFPFI-RKAKKNAYLIDLIDRYKKWKN 320
             KDP  RPTAKELLK  FI R  KK ++L +LIDRYK+WK+
Sbjct:   253 KDPRFRPTAKELLKHKFITRYTKKTSFLTELIDRYKRWKS 292

GO:0000166 "nucleotide binding" evidence=IEA

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005515 "protein binding" evidence=IPI

GO:0005524 "ATP binding" evidence=IEA

GO:0005575 "cellular_component" evidence=ND

GO:0005737 "cytoplasm" evidence=IEA

GO:0005794 "Golgi apparatus" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IMP

GO:0007163 "establishment or maintenance of cell polarity" evidence=IMP

GO:0016301 "kinase activity" evidence=IEA

GO:0016310 "phosphorylation" evidence=IEA

GO:0016740 "transferase activity" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0042802 "identical protein binding" evidence=ISO

GO:0046872 "metal ion binding" evidence=IEA

GO:0050772 "positive regulation of axonogenesis" evidence=IGI;IMP

GO:0051645 "Golgi localization" evidence=IMP

RGD|727809 Stk25 "serine/threonine kinase 25" [Rattus norvegicus (taxid:10116)]

 Score = 1012 (361.3 bits), Expect = 9.9e-114, Sum P(2) = 9.9e-114
 Identities = 202/280 (72%), Positives = 222/280 (79%)

Query:    52 KVDPELIFTKQERIGKGSFGEVFKGIDNRTQQVVXXXXXXXXXXXXXXXXXXXXXMVLSQ 111
             +VDPE +FTK +RIGKGSFGEV+KGIDN T++VV                      VLSQ
Sbjct:    13 RVDPEELFTKLDRIGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQ 72

Query:   112 CDSPY----------GTKLWIIMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLH 161
             CDSPY           TKLWIIMEYLGGGSALDL+K G  EE +IA ILRE+LKGLDYLH
Sbjct:    73 CDSPYITRYFGSYLKSTKLWIIMEYLGGGSALDLLKPGPLEETYIATILREILKGLDYLH 132

Query:   162 SERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAY 221
             SERK+HRDIKAANVLLSE GDVKLADFGVAG LT+T  KRNTFVGTPFWMAPEVIKQSAY
Sbjct:   133 SERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAY 192

Query:   222 DSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLN 281
             D KADIWSLGITAIELAKGEPPNS+LHPMRVLFLIPKNNPP L G+++K FKEFVEACLN
Sbjct:   193 DFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNNPPTLEGHHSKPFKEFVEACLN 252

Query:   282 KDPENRPTAKELLKFPFI-RKAKKNAYLIDLIDRYKKWKN 320
             KDP  RPTAKELLK  FI R  KK ++L +LIDRYK+WK+
Sbjct:   253 KDPRFRPTAKELLKHKFITRYTKKTSFLTELIDRYKRWKS 292

GO:0004672 "protein kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=ISO

GO:0007163 "establishment or maintenance of cell polarity" evidence=IEA;ISO

GO:0042802 "identical protein binding" evidence=ISO

GO:0050772 "positive regulation of axonogenesis" evidence=IEA;ISO

GO:0051645 "Golgi localization" evidence=IEA;ISO

UNIPROTKB|F1P0K4 STK24 "Uncharacterized protein" [Gallus gallus (taxid:9031)]

 Score = 1037 (370.1 bits), Expect = 1.3e-113, Sum P(2) = 1.3e-113
 Identities = 210/320 (65%), Positives = 236/320 (73%)

Query:    50 SLKVDPELIFTKQERIGKGSFGEVFKGIDNRTQQVVXXXXXXXXXXXXXXXXXXXXXMVL 109
             +LK DPE +FTK E+IGKGSFGEVFKGIDNRTQ+VV                      VL
Sbjct:     3 TLKADPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVL 62

Query:   110 SQCDSPY-----G-----TKLWIIMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDY 159
             SQCDSPY     G     TKLWIIMEYLGGGSALDL++ G+ +E  IA ILRE+LKGLDY
Sbjct:    63 SQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGSLDETQIATILREILKGLDY 122

Query:   160 LHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQS 219
             LHSE+K+HRDIKAANVLLSE G+VKLADFGVAG LT+T  KRNTFVGTPFWMAPEVIKQS
Sbjct:   123 LHSEKKIHRDIKAANVLLSEQGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQS 182

Query:   220 AYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEAC 279
             AYDSKADIWSLGITAIELAKGEPP+SELHPM+VLFLIPKNNPP L GN++K  KEFVEAC
Sbjct:   183 AYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPTLEGNFSKSLKEFVEAC 242

Query:   280 LNKDPENRPTAKELLKFPFI-RKAKKNAYLIDLIDRYKKWKNSRXXXXXXXXXXXXXXXX 338
             LNKDP  RPTAKELLK  FI R AKK +YL +LIDR+K+WK+ +                
Sbjct:   243 LNKDPSFRPTAKELLKHKFILRNAKKTSYLTELIDRHKRWKSEQSHDDSSSDDSDTEPDG 302

Query:   339 IKTDGDLDEPWIMTVKGKMP 358
               + G     WI T++ K P
Sbjct:   303 QASGGSDSGEWIFTIREKDP 322

GO:0005524 "ATP binding" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005634 "nucleus" evidence=IEA

GO:0005737 "cytoplasm" evidence=IEA

GO:0006917 "induction of apoptosis" evidence=IEA

GO:0008631 "intrinsic apoptotic signaling pathway in response to oxidative stress" evidence=IEA

GO:0030336 "negative regulation of cell migration" evidence=IEA

GO:0046777 "protein autophosphorylation" evidence=IEA

GO:0048679 "regulation of axon regeneration" evidence=IEA

UNIPROTKB|F1PTW5 STK25 "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)]

 Score = 1009 (360.2 bits), Expect = 1.6e-113, Sum P(2) = 1.6e-113
 Identities = 201/280 (71%), Positives = 223/280 (79%)

Query:    52 KVDPELIFTKQERIGKGSFGEVFKGIDNRTQQVVXXXXXXXXXXXXXXXXXXXXXMVLSQ 111
             +VDPE +FTK +RIGKGSFGEV+KGIDNRT++VV                      VLSQ
Sbjct:    13 RVDPEELFTKLDRIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQ 72

Query:   112 CDSPY----------GTKLWIIMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLH 161
             CDSPY           TKLWIIMEYLGGGSALDL+K G  EE +IA ILRE+LKGLDYLH
Sbjct:    73 CDSPYITRYFGSYLKSTKLWIIMEYLGGGSALDLLKPGPLEETYIATILREILKGLDYLH 132

Query:   162 SERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAY 221
             SERK+HRDIKAANVLLSE GDVKLADFGVAG LT+T  KRNTFVGTPFWMAPEVIKQSAY
Sbjct:   133 SERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAY 192

Query:   222 DSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLN 281
             D KADIWSLGITAIELAKGEPPNS+LHPMRVLFLIPKN+PP L G+++K FKEFVEACLN
Sbjct:   193 DFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTLEGHHSKPFKEFVEACLN 252

Query:   282 KDPENRPTAKELLKFPFI-RKAKKNAYLIDLIDRYKKWKN 320
             KDP  RPTAKELLK  FI R  +K ++L +LIDRYK+WK+
Sbjct:   253 KDPRFRPTAKELLKHKFITRYTRKTSFLTELIDRYKRWKS 292

GO:0051645 "Golgi localization" evidence=IEA

GO:0050772 "positive regulation of axonogenesis" evidence=IEA

GO:0007163 "establishment or maintenance of cell polarity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0004672 "protein kinase activity" evidence=IEA

UNIPROTKB|G3X7P7 STK25 "Serine/threonine-protein kinase 25" [Bos taurus (taxid:9913)]

 Score = 1009 (360.2 bits), Expect = 2.1e-113, Sum P(2) = 2.1e-113
 Identities = 201/280 (71%), Positives = 223/280 (79%)

Query:    52 KVDPELIFTKQERIGKGSFGEVFKGIDNRTQQVVXXXXXXXXXXXXXXXXXXXXXMVLSQ 111
             +VDPE +FTK +RIGKGSFGEV+KGIDNRT++VV                      VLSQ
Sbjct:    13 RVDPEELFTKLDRIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQ 72

Query:   112 CDSPY----------GTKLWIIMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLH 161
             CDSPY           TKLWIIMEYLGGGSALDL+K G  EE +IA ILRE+LKGLDYLH
Sbjct:    73 CDSPYITRYFSSYLKSTKLWIIMEYLGGGSALDLLKPGPLEETYIATILREILKGLDYLH 132

Query:   162 SERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAY 221
             SERK+HRDIKAANVLLSE GDVKLADFGVAG LT+T  KRNTFVGTPFWMAPEVIKQSAY
Sbjct:   133 SERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAY 192

Query:   222 DSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLN 281
             D KADIWSLGITAIELAKGEPPNS+LHPMRVLFLIPKN+PP L G+++K FKEFVEACLN
Sbjct:   193 DFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTLEGHHSKPFKEFVEACLN 252

Query:   282 KDPENRPTAKELLKFPFI-RKAKKNAYLIDLIDRYKKWKN 320
             KDP  RPTAKELLK  FI R  KK ++L +LIDRYK+W++
Sbjct:   253 KDPRFRPTAKELLKHKFITRYTKKTSFLTELIDRYKRWRS 292

GO:0051645 "Golgi localization" evidence=IEA

GO:0050772 "positive regulation of axonogenesis" evidence=IEA

GO:0007163 "establishment or maintenance of cell polarity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0004672 "protein kinase activity" evidence=IEA

UNIPROTKB|Q3SWY6 STK25 "Serine/threonine-protein kinase 25" [Bos taurus (taxid:9913)]

 Score = 1009 (360.2 bits), Expect = 2.1e-113, Sum P(2) = 2.1e-113
 Identities = 201/280 (71%), Positives = 223/280 (79%)

Query:    52 KVDPELIFTKQERIGKGSFGEVFKGIDNRTQQVVXXXXXXXXXXXXXXXXXXXXXMVLSQ 111
             +VDPE +FTK +RIGKGSFGEV+KGIDNRT++VV                      VLSQ
Sbjct:    13 RVDPEELFTKLDRIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQ 72

Query:   112 CDSPY----------GTKLWIIMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLH 161
             CDSPY           TKLWIIMEYLGGGSALDL+K G  EE +IA ILRE+LKGLDYLH
Sbjct:    73 CDSPYITRYFGSYLKSTKLWIIMEYLGGGSALDLLKPGPLEETYIATILREILKGLDYLH 132

Query:   162 SERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAY 221
             SERK+HRDIKAANVLLSE GDVKLADFGVAG LT+T  KRNTFVGTPFWMAPEVIKQSAY
Sbjct:   133 SERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAY 192

Query:   222 DSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLN 281
             D KADIWSLGITAIELAKGEPPNS+LHPMRVLFLIPKN+PP L G+++K FKEFVEACLN
Sbjct:   193 DFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTLEGHHSKPFKEFVEACLN 252

Query:   282 KDPENRPTAKELLKFPFI-RKAKKNAYLIDLIDRYKKWKN 320
             KDP  RPTAKELLK  FI R  KK ++L +LIDRYK+W++
Sbjct:   253 KDPRFRPTAKELLKHKFITRYTKKTSFLTELIDRYKRWRS 292

GO:0005794 "Golgi apparatus" evidence=IEA

GO:0046872 "metal ion binding" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

UNIPROTKB|F1MRQ0 STK25 "Serine/threonine-protein kinase 25" [Bos taurus (taxid:9913)]

 Score = 1009 (360.2 bits), Expect = 2.6e-113, Sum P(2) = 2.6e-113
 Identities = 201/280 (71%), Positives = 223/280 (79%)

Query:    52 KVDPELIFTKQERIGKGSFGEVFKGIDNRTQQVVXXXXXXXXXXXXXXXXXXXXXMVLSQ 111
             +VDPE +FTK +RIGKGSFGEV+KGIDNRT++VV                      VLSQ
Sbjct:    13 RVDPEELFTKLDRIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQ 72

Query:   112 CDSPY----------GTKLWIIMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLH 161
             CDSPY           TKLWIIMEYLGGGSALDL+K G  EE +IA ILRE+LKGLDYLH
Sbjct:    73 CDSPYITRYFSSYLKSTKLWIIMEYLGGGSALDLLKPGPLEETYIATILREILKGLDYLH 132

Query:   162 SERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAY 221
             SERK+HRDIKAANVLLSE GDVKLADFGVAG LT+T  KRNTFVGTPFWMAPEVIKQSAY
Sbjct:   133 SERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAY 192

Query:   222 DSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLN 281
             D KADIWSLGITAIELAKGEPPNS+LHPMRVLFLIPKN+PP L G+++K FKEFVEACLN
Sbjct:   193 DFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTLEGHHSKPFKEFVEACLN 252

Query:   282 KDPENRPTAKELLKFPFI-RKAKKNAYLIDLIDRYKKWKN 320
             KDP  RPTAKELLK  FI R  KK ++L +LIDRYK+W++
Sbjct:   253 KDPRFRPTAKELLKHKFITRYTKKTSFLTELIDRYKRWRS 292

GO:0005524 "ATP binding" evidence=IEA

GO:0004672 "protein kinase activity" evidence=IEA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
Q99KH8	STK24_MOUSE	2, ., 7, ., 1, 1, ., 1	0.7258	0.5132	0.7192	yes	N/A
Q3SWY6	STK25_BOVIN	2, ., 7, ., 1, 1, ., 1	0.7631	0.4735	0.6713	yes	N/A
B0LT89	STK24_RAT	2, ., 7, ., 1, 1, ., 1	0.7227	0.5132	0.7192	yes	N/A
O14305	SID1_SCHPO	2, ., 7, ., 1, 1, ., 1	0.5245	0.4205	0.5392	yes	N/A
Q9Y6E0	STK24_HUMAN	2, ., 7, ., 1, 1, ., 1	0.7196	0.5132	0.6997	yes	N/A
O61122	SVKA_DICDI	2, ., 7, ., 1, 1, ., 1	0.6989	0.4453	0.5627	yes	N/A

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	0.914
3rd Layer	2.7.11	0.921

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database

ID	Length	Definition	E-value
Query	604
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	0.0
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	1e-159
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	1e-157
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	1e-152
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	1e-121
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	1e-121
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	1e-119
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	1e-106
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	1e-105
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	1e-102
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	1e-101
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	6e-94
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	1e-91
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	1e-87
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	4e-82
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	3e-80
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	2e-79
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	4e-78
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	2e-75
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	3e-75
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	7e-75
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	2e-74
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	7e-74
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	2e-72
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	4e-72
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	1e-69
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	2e-67
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	4e-67
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	2e-66
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	4e-66
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	5e-66
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	1e-65
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	5e-65
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	5e-65
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	6e-65
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	9e-65
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	1e-64
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	2e-60
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	2e-55
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	3e-55
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	3e-54
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	2e-51
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	1e-50
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	2e-50
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	3e-50
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	5e-50
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	9e-50
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	2e-49
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	2e-48
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	1e-47
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	8e-47
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	8e-47
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	6e-46
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	2e-45
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	3e-45
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	2e-44
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	6e-44
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	2e-43
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	5e-43
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	7e-43
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	1e-42
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	2e-42
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	5e-42
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	4e-41
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	1e-40
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	1e-40
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	2e-40
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	2e-40
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	2e-40
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	9e-40
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	5e-39
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	5e-39
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	7e-39
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	2e-38
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	5e-38
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	2e-37
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	2e-37
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	9e-37
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	2e-36
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	5e-36
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	1e-35
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	6e-35
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	6e-35
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	7e-35
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	1e-33
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	3e-33
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	6e-33
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	1e-32
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	1e-32
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	2e-32
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	3e-32
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	4e-32
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	2e-31
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	4e-31
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	1e-30
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	3e-30
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	5e-30
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	1e-29
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	2e-29
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	2e-29
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	2e-29
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	6e-29
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	8e-29
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	7e-28
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	9e-28
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	1e-27
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	1e-27
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	3e-27
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	3e-27
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	7e-27
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	1e-26
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	1e-26
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	2e-26
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	2e-26
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	3e-26
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	3e-26
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	8e-26
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	1e-25
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	1e-25
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	2e-25
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	2e-25
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	2e-25
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	2e-25
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	2e-25
cd08227	327	cd08227, PK_STRAD_alpha, Pseudokinase domain of ST	3e-25
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	3e-25
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	5e-25
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	5e-25
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	7e-25
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	8e-25
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	9e-25
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	9e-25
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	1e-24
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	1e-24
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	2e-24
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	2e-24
smart00750	176	smart00750, KIND, kinase non-catalytic C-lobe doma	2e-24
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	2e-24
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	3e-24
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	3e-24
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	3e-24
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	3e-24
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	4e-24
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	5e-24
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	6e-24
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	7e-24
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	1e-23
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	2e-23
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	2e-23
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	2e-23
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	2e-23
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	2e-23
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	3e-23
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	3e-23
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	3e-23
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	4e-23
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	5e-23
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	5e-23
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	5e-23
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	5e-23
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	7e-23
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	8e-23
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	1e-22
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	1e-22
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	3e-22
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	3e-22
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	3e-22
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	5e-22
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	5e-22
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	8e-22
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	8e-22
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	1e-21
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	1e-21
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	1e-21
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	1e-21
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	1e-21
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	1e-21
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	2e-21
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	2e-21
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	2e-21
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	3e-21
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	3e-21
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	3e-21
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	4e-21
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	4e-21
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	4e-21
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	6e-21
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	7e-21
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	7e-21
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	1e-20
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	1e-20
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	1e-20
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	1e-20
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	2e-20
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	5e-20
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	6e-20
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	7e-20
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	7e-20
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	1e-19
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	1e-19
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	1e-19
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	1e-19
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	1e-19
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	1e-19
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	2e-19
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	2e-19
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	2e-19
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	3e-19
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	3e-19
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	5e-19
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	5e-19
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	8e-19
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	8e-19
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	8e-19
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	9e-19
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	1e-18
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	2e-18
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	2e-18
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	2e-18
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	4e-18
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	4e-18
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	5e-18
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	7e-18
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	9e-18
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	1e-17
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	1e-17
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	1e-17
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	2e-17
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	2e-17
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	2e-17
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	2e-17
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	3e-17
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	3e-17
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	3e-17
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	3e-17
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	4e-17
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	4e-17
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	5e-17
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	6e-17
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	6e-17
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	8e-17
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	1e-16
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	2e-16
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	9e-16
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	1e-15
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	2e-15
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	2e-15
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	3e-15
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	3e-15
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	4e-15
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	6e-15
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	7e-15
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	1e-14
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	1e-14
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	1e-14
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	1e-14
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	1e-14
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	2e-14
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	2e-14
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	2e-14
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	2e-14
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	2e-14
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	2e-14
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	3e-14
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	6e-14
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	6e-14
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	1e-13
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	1e-13
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	2e-13
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	2e-13
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	3e-13
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	3e-13
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	4e-13
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	5e-13
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	7e-13
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	7e-13
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	8e-13
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	8e-13
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	1e-12
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	2e-12
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	2e-12
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	4e-12
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	1e-11
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	1e-11
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	7e-11
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	7e-11
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	8e-11
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	9e-11
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	9e-11
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	2e-10
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	2e-10
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	3e-10
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	4e-10
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	4e-10
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	5e-10
PTZ00284	467	PTZ00284, PTZ00284, protein kinase; Provisional	2e-09
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	2e-09
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	2e-09
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	5e-09
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	4e-08
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	7e-08
cd05076	274	cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do	1e-07
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	2e-07
PLN03225	566	PLN03225, PLN03225, Serine/threonine-protein kinas	3e-07
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	7e-07
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	9e-06
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	1e-05
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	4e-05
PLN03224	507	PLN03224, PLN03224, probable serine/threonine prot	5e-05
cd05077	262	cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do	6e-05
PRK14879	211	PRK14879, PRK14879, serine/threonine protein kinas	0.001

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score =  538 bits (1388), Expect = 0.0
 Identities = 204/273 (74%), Positives = 225/273 (82%), Gaps = 11/273 (4%)

Query: 58  IFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPY- 116
           +FT  E IGKGSFGEV+K ID RT QVVAIK+IDLEEAEDEIEDIQQEI  LSQC SPY 
Sbjct: 2   LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYI 61

Query: 117 ---------GTKLWIIMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLH 167
                    G+KLWIIMEY GGGS LDL+K G  +E +IA ILREVL GL+YLH E K+H
Sbjct: 62  TKYYGSFLKGSKLWIIMEYCGGGSCLDLLKPGKLDETYIAFILREVLLGLEYLHEEGKIH 121

Query: 168 RDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADI 227
           RDIKAAN+LLSE GDVKLADFGV+G LT+T SKRNTFVGTPFWMAPEVIKQS YD KADI
Sbjct: 122 RDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIKQSGYDEKADI 181

Query: 228 WSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGN-YTKQFKEFVEACLNKDPEN 286
           WSLGITAIELAKGEPP S+LHPMRVLFLIPKNNPP L GN ++K FK+FV  CLNKDP+ 
Sbjct: 182 WSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPPSLEGNKFSKPFKDFVSLCLNKDPKE 241

Query: 287 RPTAKELLKFPFIRKAKKNAYLIDLIDRYKKWK 319
           RP+AKELLK  FI+KAKK +YL  LI+R KKWK
Sbjct: 242 RPSAKELLKHKFIKKAKKTSYLTLLIERIKKWK 274

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score =  457 bits (1177), Expect = e-159
 Identities = 224/277 (80%), Positives = 245/277 (88%), Gaps = 11/277 (3%)

Query: 54  DPELIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCD 113
           DPE +FTK ERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEI VLSQCD
Sbjct: 1   DPEELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCD 60

Query: 114 SPY----------GTKLWIIMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSE 163
           SPY          GTKLWIIMEYLGGGSALDL++AG F+E  IA +L+E+LKGLDYLHSE
Sbjct: 61  SPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLKEILKGLDYLHSE 120

Query: 164 RKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDS 223
           +K+HRDIKAANVLLSE GDVKLADFGVAG LT+T  KRNTFVGTPFWMAPEVI+QSAYDS
Sbjct: 121 KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDS 180

Query: 224 KADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKD 283
           KADIWSLGITAIELAKGEPPNS++HPMRVLFLIPKNNPP LTG ++K FKEF++ACLNKD
Sbjct: 181 KADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPTLTGEFSKPFKEFIDACLNKD 240

Query: 284 PENRPTAKELLKFPFIRK-AKKNAYLIDLIDRYKKWK 319
           P  RPTAKELLK  FI K AKK +YL +LIDR+K+WK
Sbjct: 241 PSFRPTAKELLKHKFIVKNAKKTSYLTELIDRFKRWK 277

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score =  452 bits (1163), Expect = e-157
 Identities = 225/277 (81%), Positives = 241/277 (87%), Gaps = 11/277 (3%)

Query: 54  DPELIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCD 113
           DPE +FTK ERIGKGSFGEV+KGIDNRT++VVAIKIIDLEEAEDEIEDIQQEI VLSQCD
Sbjct: 1   DPEELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCD 60

Query: 114 SPY----------GTKLWIIMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSE 163
           SPY          GTKLWIIMEYLGGGSALDL+K G  EE +IA ILRE+LKGLDYLHSE
Sbjct: 61  SPYITRYYGSYLKGTKLWIIMEYLGGGSALDLLKPGPLEETYIATILREILKGLDYLHSE 120

Query: 164 RKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDS 223
           RK+HRDIKAANVLLSE GDVKLADFGVAG LT+T  KRNTFVGTPFWMAPEVIKQSAYD 
Sbjct: 121 RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDF 180

Query: 224 KADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKD 283
           KADIWSLGITAIELAKGEPPNS+LHPMRVLFLIPKN+PP L G Y+K FKEFVEACLNKD
Sbjct: 181 KADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTLEGQYSKPFKEFVEACLNKD 240

Query: 284 PENRPTAKELLKFPFI-RKAKKNAYLIDLIDRYKKWK 319
           P  RPTAKELLK  FI R  KK ++L +LIDRYK+WK
Sbjct: 241 PRFRPTAKELLKHKFITRYTKKTSFLTELIDRYKRWK 277

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score =  439 bits (1129), Expect = e-152
 Identities = 223/277 (80%), Positives = 241/277 (87%), Gaps = 11/277 (3%)

Query: 54  DPELIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCD 113
           DPE +FTK E+IGKGSFGEVFKGIDNRTQ+VVAIKIIDLEEAEDEIEDIQQEI VLSQCD
Sbjct: 1   DPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCD 60

Query: 114 SPY----------GTKLWIIMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSE 163
           SPY           TKLWIIMEYLGGGSALDL++ G  +E  IA ILRE+LKGLDYLHSE
Sbjct: 61  SPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSE 120

Query: 164 RKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDS 223
           +K+HRDIKAANVLLSE G+VKLADFGVAG LT+T  KRNTFVGTPFWMAPEVIKQSAYDS
Sbjct: 121 KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDS 180

Query: 224 KADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKD 283
           KADIWSLGITAIELAKGEPP+SELHPM+VLFLIPKNNPP L GNY+K  KEFVEACLNK+
Sbjct: 181 KADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLNKE 240

Query: 284 PENRPTAKELLKFPFI-RKAKKNAYLIDLIDRYKKWK 319
           P  RPTAKELLK  FI R AKK +YL +LIDRYK+WK
Sbjct: 241 PSFRPTAKELLKHKFIVRFAKKTSYLTELIDRYKRWK 277

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score =  359 bits (923), Expect = e-121
 Identities = 141/259 (54%), Positives = 188/259 (72%), Gaps = 17/259 (6%)

Query: 55  PELIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDS 114
           PE +F   E++G+GS+G V+K I   T QVVAIK++ +EE   ++++I +EI +L QCDS
Sbjct: 1   PEEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE---DLQEIIKEISILKQCDS 57

Query: 115 PY----------GTKLWIIMEYLGGGSALDLMKAGN--FEEMHIAVILREVLKGLDYLHS 162
           PY           T LWI+MEY G GS  D+MK  N    E  IA IL + LKGL+YLHS
Sbjct: 58  PYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHS 117

Query: 163 ERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYD 222
            +K+HRDIKA N+LL+E G  KLADFGV+G LT+T +KRNT +GTPFWMAPEVI++  Y+
Sbjct: 118 NKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYN 177

Query: 223 SKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLT--GNYTKQFKEFVEACL 280
           +KADIWSLGITAIE+A+G+PP S++HPMR +F+IP   PP L+    ++ +F +FV+ CL
Sbjct: 178 NKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPEKWSPEFNDFVKKCL 237

Query: 281 NKDPENRPTAKELLKFPFI 299
            KDPE RP+A +LL+ PFI
Sbjct: 238 VKDPEERPSAIQLLQHPFI 256

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score =  358 bits (920), Expect = e-121
 Identities = 135/263 (51%), Positives = 179/263 (68%), Gaps = 20/263 (7%)

Query: 55  PELIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDS 114
           P+  +   +RIG G++G+V+K  D  T ++VAIK+I LE   D+ E IQQEI +L +C  
Sbjct: 1   PQEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEP-GDDFEIIQQEISMLKECRH 59

Query: 115 P-----YGT-----KLWIIMEYLGGGSALDLMKA--GNFEEMHIAVILREVLKGLDYLHS 162
           P     +G+     KLWI+MEY GGGS  D+ +   G   E+ IA + RE LKGL YLH 
Sbjct: 60  PNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHE 119

Query: 163 ERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVI---KQS 219
             K+HRDIK AN+LL+E GDVKLADFGV+  LT T +KR +F+GTP+WMAPEV    ++ 
Sbjct: 120 TGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEVAAVERKG 179

Query: 220 AYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNN--PPQLT--GNYTKQFKEF 275
            YD K DIW+LGITAIELA+ +PP  +LHPMR LFLI K+N  PP+L     ++  F +F
Sbjct: 180 GYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWSPVFHDF 239

Query: 276 VEACLNKDPENRPTAKELLKFPF 298
           ++ CL KDP+ RPTA +LL+ PF
Sbjct: 240 IKKCLTKDPKKRPTATKLLQHPF 262

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  354 bits (910), Expect = e-119
 Identities = 134/255 (52%), Positives = 171/255 (67%), Gaps = 16/255 (6%)

Query: 58  IFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPY- 116
           +F   E+IGKG FGEV+K    RT + VAIK+I LE  E + E I  EI +L +C  P  
Sbjct: 1   LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKK-EKIINEIQILKKCKHPNI 59

Query: 117 ---------GTKLWIIMEYLGGGSALDLMKAGN--FEEMHIAVILREVLKGLDYLHSERK 165
                      +LWI+ME+  GGS  DL+K+ N    E  IA + +E+LKGL+YLHS   
Sbjct: 60  VKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGI 119

Query: 166 LHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKA 225
           +HRDIKAAN+LL+  G+VKL DFG++  L++T   RNT VGTP+WMAPEVI    YD KA
Sbjct: 120 IHRDIKAANILLTSDGEVKLIDFGLSAQLSDTK-ARNTMVGTPYWMAPEVINGKPYDYKA 178

Query: 226 DIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNY--TKQFKEFVEACLNKD 283
           DIWSLGITAIELA+G+PP SEL PM+ LF I  N PP L      + +FK+F++ CL K+
Sbjct: 179 DIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNPEKWSDEFKDFLKKCLQKN 238

Query: 284 PENRPTAKELLKFPF 298
           PE RPTA++LLK PF
Sbjct: 239 PEKRPTAEQLLKHPF 253

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score =  322 bits (826), Expect = e-106
 Identities = 136/276 (49%), Positives = 188/276 (68%), Gaps = 17/276 (6%)

Query: 58  IFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQ---CDS 114
           ++ + E IG+G++G V++G    T +VVA+KII+L+  +D++ DIQ+E+ +LSQ      
Sbjct: 2   LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQP 61

Query: 115 P----Y------GTKLWIIMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSER 164
           P    Y      G +LWIIMEY  GGS   LMKAG   E +I+VI+REVL  L Y+H   
Sbjct: 62  PNITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISVIIREVLVALKYIHKVG 121

Query: 165 KLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQ-SAYDS 223
            +HRDIKAAN+L++  G+VKL DFGVA  L   +SKR+TFVGTP+WMAPEVI +   YD+
Sbjct: 122 VIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEGKYYDT 181

Query: 224 KADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGN-YTKQFKEFVEACLNK 282
           KADIWSLGIT  E+A G PP S++   R + LIPK+ PP+L  N Y+K  +EFV ACL++
Sbjct: 182 KADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPPRLEDNGYSKLLREFVAACLDE 241

Query: 283 DPENRPTAKELLKFPFIRKAKKN--AYLIDLIDRYK 316
           +P+ R +A+ELLK  +I+   K   + L +LI RY+
Sbjct: 242 EPKERLSAEELLKSKWIKAHSKTPVSILKELISRYQ 277

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score =  318 bits (816), Expect = e-105
 Identities = 129/275 (46%), Positives = 179/275 (65%), Gaps = 31/275 (11%)

Query: 54  DPELIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQ-C 112
           DP  IF   E IG+G++G+V+K    +T Q+VAIKI+D+ E  DE E+I++E  +L +  
Sbjct: 3   DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE--DEEEEIKEEYNILRKYS 60

Query: 113 DSP-----YGT-----------KLWIIMEYLGGGSALDLMKA-----GNFEEMHIAVILR 151
           + P     YG            +LW++ME  GGGS  DL+K         +E  IA ILR
Sbjct: 61  NHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILR 120

Query: 152 EVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWM 211
           E L+GL YLH  + +HRDIK  N+LL++  +VKL DFGV+  L +T  +RNTF+GTP+WM
Sbjct: 121 ETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFIGTPYWM 180

Query: 212 APEVI-----KQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLT- 265
           APEVI       ++YD+++D+WSLGITAIELA G+PP  ++HPMR LF IP+N PP L  
Sbjct: 181 APEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPPPTLKS 240

Query: 266 -GNYTKQFKEFVEACLNKDPENRPTAKELLKFPFI 299
             N++K+F +F+  CL K+ E RP  +ELL+ PFI
Sbjct: 241 PENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI 275

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  312 bits (801), Expect = e-102
 Identities = 129/274 (47%), Positives = 171/274 (62%), Gaps = 18/274 (6%)

Query: 54  DPELIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCD 113
           DP  ++   E+IG+G+ GEV+K  D  T + VAIK + L +     E I  EI+++  C 
Sbjct: 16  DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRK--QNKELIINEILIMKDCK 73

Query: 114 SP----------YGTKLWIIMEYLGGGSALDLMKAGNFEEM---HIAVILREVLKGLDYL 160
            P           G +LW++MEY+ GGS  D++   NF  M    IA + REVL+GL+YL
Sbjct: 74  HPNIVDYYDSYLVGDELWVVMEYMDGGSLTDII-TQNFVRMNEPQIAYVCREVLQGLEYL 132

Query: 161 HSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSA 220
           HS+  +HRDIK+ N+LLS+ G VKLADFG A  LT   SKRN+ VGTP+WMAPEVIK+  
Sbjct: 133 HSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIKRKD 192

Query: 221 YDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTG--NYTKQFKEFVEA 278
           Y  K DIWSLGI  IE+A+GEPP     P+R LFLI     P L     ++ +FK+F+  
Sbjct: 193 YGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKWSPEFKDFLNK 252

Query: 279 CLNKDPENRPTAKELLKFPFIRKAKKNAYLIDLI 312
           CL KDPE RP+A+ELL+ PF++KA        LI
Sbjct: 253 CLVKDPEKRPSAEELLQHPFLKKACPKEEFAPLI 286

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score =  306 bits (787), Expect = e-101
 Identities = 126/262 (48%), Positives = 165/262 (62%), Gaps = 24/262 (9%)

Query: 62  QERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSP------ 115
            E IG G+   V+  I     + VAIK IDLE+ +  ++++++E+  +SQC+ P      
Sbjct: 6   IEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYY 65

Query: 116 ----YGTKLWIIMEYLGGGSALDLMK----AGNFEEMHIAVILREVLKGLDYLHSERKLH 167
                G +LW++M YL GGS LD+MK     G  +E  IA +L+EVLKGL+YLHS  ++H
Sbjct: 66  TSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIH 125

Query: 168 RDIKAANVLLSEMGDVKLADFGVAGTL----TNTTSKRNTFVGTPFWMAPEVIKQ-SAYD 222
           RDIKA N+LL E G VK+ADFGV+ +L      T   R TFVGTP WMAPEV++Q   YD
Sbjct: 126 RDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYD 185

Query: 223 SKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGN-----YTKQFKEFVE 277
            KADIWS GITAIELA G  P S+  PM+VL L  +N+PP L        Y+K F++ + 
Sbjct: 186 FKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYKKYSKSFRKMIS 245

Query: 278 ACLNKDPENRPTAKELLKFPFI 299
            CL KDP  RPTA+ELLK  F 
Sbjct: 246 LCLQKDPSKRPTAEELLKHKFF 267

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  288 bits (740), Expect = 6e-94
 Identities = 99/255 (38%), Positives = 142/255 (55%), Gaps = 15/255 (5%)

Query: 59  FTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPY-- 116
           +   E++G+GSFG+V+   D +T ++VAIK+I  ++ + + E I +EI +L +   P   
Sbjct: 1   YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60

Query: 117 --------GTKLWIIMEYLGGGSALDLMKA-GNFEEMHIAVILREVLKGLDYLHSERKLH 167
                     KL+++MEY  GG   DL+K  G   E      LR++L  L+YLHS+  +H
Sbjct: 61  RLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLHSKGIVH 120

Query: 168 RDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADI 227
           RD+K  N+LL E G VKLADFG+A  L     K  TFVGTP +MAPEV+    Y    DI
Sbjct: 121 RDLKPENILLDEDGHVKLADFGLARQLDPGE-KLTTFVGTPEYMAPEVLLGKGYGKAVDI 179

Query: 228 WSLGITAIELAKGEPP-NSELHPMRVLFLI--PKNNPPQLTGNYTKQFKEFVEACLNKDP 284
           WSLG+   EL  G+PP   +   + +   I  PK   P    + + + K+ +   L KDP
Sbjct: 180 WSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWDISPEAKDLIRKLLVKDP 239

Query: 285 ENRPTAKELLKFPFI 299
           E R TA+E L+ PF 
Sbjct: 240 EKRLTAEEALQHPFF 254

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score =  283 bits (726), Expect = 1e-91
 Identities = 126/279 (45%), Positives = 175/279 (62%), Gaps = 20/279 (7%)

Query: 53  VDPELIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQC 112
           V+P  I+     +G G+FG+V+K     T    A KII +E  E+E+ED   EI +LS+C
Sbjct: 1   VNPNDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIES-EEELEDFMVEIDILSEC 59

Query: 113 DSP----------YGTKLWIIMEYLGGGSALDLMKA--GNFEEMHIAVILREVLKGLDYL 160
             P          Y  KLWI++E+  GG+   +M        E  I  + R++L+ L++L
Sbjct: 60  KHPNIVGLYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFL 119

Query: 161 HSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVI---- 216
           HS + +HRD+KA N+LL+  GDVKLADFGV+    +T  KR+TF+GTP+WMAPEV+    
Sbjct: 120 HSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACET 179

Query: 217 -KQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQL--TGNYTKQFK 273
            K + YD KADIWSLGIT IELA+ EPP+ EL+PMRVL  I K+ PP L     ++  F 
Sbjct: 180 FKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQPSKWSSSFN 239

Query: 274 EFVEACLNKDPENRPTAKELLKFPFIRKAKKNAYLIDLI 312
           +F+++CL KDP++RPTA ELLK PF+     N  + DL+
Sbjct: 240 DFLKSCLVKDPDDRPTAAELLKHPFVSDQSDNKAIKDLL 278

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  272 bits (698), Expect = 1e-87
 Identities = 112/253 (44%), Positives = 155/253 (61%), Gaps = 12/253 (4%)

Query: 59  FTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE-AEDEIEDIQQEIMVLSQCDSPY- 116
           +   + IG+G+FG V+KG++  T   VAIK I LE+  E+ ++ I QEI +L     P  
Sbjct: 2   YQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNI 61

Query: 117 ---------GTKLWIIMEYLGGGSALDLMKA-GNFEEMHIAVILREVLKGLDYLHSERKL 166
                       L+II+EY   GS   ++K  G F E  +AV + +VL+GL YLH +  +
Sbjct: 62  VKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVI 121

Query: 167 HRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKAD 226
           HRDIKAAN+L ++ G VKLADFGVA  L + +    + VGTP+WMAPEVI+ S   + +D
Sbjct: 122 HRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMSGASTASD 181

Query: 227 IWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPEN 286
           IWSLG T IEL  G PP  +L+PM  LF I +++ P L    + + K+F+  C  KDP  
Sbjct: 182 IWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHPPLPEGISPELKDFLMQCFQKDPNL 241

Query: 287 RPTAKELLKFPFI 299
           RPTAK+LLK P+I
Sbjct: 242 RPTAKQLLKHPWI 254

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  258 bits (661), Expect = 4e-82
 Identities = 111/259 (42%), Positives = 160/259 (61%), Gaps = 18/259 (6%)

Query: 59  FTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE-AEDEIEDIQQEIMVLSQCDSP-- 115
           +T+ E +G+GSFG V+  +D  T +++A+K ++L   +E+E+E +++EI +LS    P  
Sbjct: 2   WTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNI 61

Query: 116 ---YGTK-------LWIIMEYLGGGSALDLMKA-GNFEEMHIAVILREVLKGLDYLHSER 164
              YG++       L I +EY+ GGS   L+K  G   E  I    R++L+GL YLHS  
Sbjct: 62  VRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNG 121

Query: 165 KLHRDIKAANVLLSEMGDVKLADFGVAGTL--TNTTSKRNTFVGTPFWMAPEVIKQSAYD 222
            +HRDIK AN+L+   G VKLADFG A  L    T     +  GTP+WMAPEVI+   Y 
Sbjct: 122 IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYG 181

Query: 223 SKADIWSLGITAIELAKGEPPNSELH-PMRVLFLIPKNN-PPQLTGNYTKQFKEFVEACL 280
             ADIWSLG T IE+A G+PP SEL  PM  L+ I  +  PP++  + +++ K+F+  CL
Sbjct: 182 RAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKDFLRKCL 241

Query: 281 NKDPENRPTAKELLKFPFI 299
            +DP+ RPTA ELL+ PF+
Sbjct: 242 RRDPKKRPTADELLQHPFL 260

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score =  254 bits (649), Expect = 3e-80
 Identities = 129/272 (47%), Positives = 181/272 (66%), Gaps = 28/272 (10%)

Query: 54  DPELIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCD 113
           DP  IF   E +G G++G+V+KG   +T Q+ AIK++D+   EDE E+I+ EI +L +  
Sbjct: 13  DPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDV--TEDEEEEIKLEINMLKKYS 70

Query: 114 ---------------SPYGT--KLWIIMEYLGGGSALDLMK--AGN-FEEMHIAVILREV 153
                          SP G   +LW++ME+ G GS  DL+K   GN  +E  IA I RE+
Sbjct: 71  HHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREI 130

Query: 154 LKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAP 213
           L+GL +LH+ + +HRDIK  NVLL+E  +VKL DFGV+  L  T  +RNTF+GTP+WMAP
Sbjct: 131 LRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAP 190

Query: 214 EVIK-----QSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQL-TGN 267
           EVI       + YD ++DIWSLGITAIE+A+G PP  ++HPMR LFLIP+N PP+L +  
Sbjct: 191 EVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKLKSKK 250

Query: 268 YTKQFKEFVEACLNKDPENRPTAKELLKFPFI 299
           ++K+F +F+E CL K+  +RP+ ++LLK PFI
Sbjct: 251 WSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  251 bits (642), Expect = 2e-79
 Identities = 96/260 (36%), Positives = 143/260 (55%), Gaps = 19/260 (7%)

Query: 59  FTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQ-EIMVLSQCDSPY- 116
           +    ++G GSFG V+K     T ++VA+KI+     + + +   + EI +L +   P  
Sbjct: 1   YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60

Query: 117 ---------GTKLWIIMEYLGGGSALD-LMKAGNFEEMHIAVILREVLKGLDYLHSERKL 166
                       L+++MEY  GG   D L + G   E     I  ++L+GL+YLHS   +
Sbjct: 61  VRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSNGII 120

Query: 167 HRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIK-QSAYDSKA 225
           HRD+K  N+LL E G VK+ADFG+A  L  ++S   TFVGTP++MAPEV+   + Y  K 
Sbjct: 121 HRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGNGYGPKV 180

Query: 226 DIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQ------FKEFVEAC 279
           D+WSLG+   EL  G+PP S  + +  L LI +   P L  +  K        K+ ++ C
Sbjct: 181 DVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWSSGSEEAKDLIKKC 240

Query: 280 LNKDPENRPTAKELLKFPFI 299
           LNKDP  RPTA+E+L+ P+ 
Sbjct: 241 LNKDPSKRPTAEEILQHPWF 260

Length = 260

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score =  249 bits (637), Expect = 4e-78
 Identities = 120/284 (42%), Positives = 173/284 (60%), Gaps = 23/284 (8%)

Query: 52  KVDPELIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDL--EEAEDEIEDIQQEIMVL 109
           K DPE +FT    IG GSFG V+   D RT +VVAIK +    +++ ++ +DI +E+  L
Sbjct: 10  KDDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFL 69

Query: 110 SQCDSPYG----------TKLWIIMEYLGGGSA--LDLMKAGNFEEMHIAVILREVLKGL 157
            Q   P               W++MEY  G ++  L++ K    +E+ IA I    L+GL
Sbjct: 70  QQLRHPNTIEYKGCYLREHTAWLVMEYCLGSASDILEVHKKP-LQEVEIAAICHGALQGL 128

Query: 158 DYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVI- 216
            YLHS  ++HRDIKA N+LL+E G VKLADFG A  +    S  N+FVGTP+WMAPEVI 
Sbjct: 129 AYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLV----SPANSFVGTPYWMAPEVIL 184

Query: 217 --KQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQL-TGNYTKQFK 273
              +  YD K D+WSLGIT IELA+ +PP   ++ M  L+ I +N+ P L + +++  F+
Sbjct: 185 AMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLSSNDWSDYFR 244

Query: 274 EFVEACLNKDPENRPTAKELLKFPFIRKAKKNAYLIDLIDRYKK 317
            FV++CL K P++RP+++ELLK  F+ + +    +IDLI R K 
Sbjct: 245 NFVDSCLQKIPQDRPSSEELLKHRFVLRERPPTVIIDLIQRTKD 288

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score =  241 bits (615), Expect = 2e-75
 Identities = 124/266 (46%), Positives = 174/266 (65%), Gaps = 19/266 (7%)

Query: 51  LKVDPELIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLS 110
           L+ +P+  +   +R+G G++G+V+K  +  T ++ A+KII LE  +D    IQQEI ++ 
Sbjct: 3   LRRNPQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDD-FSLIQQEIFMVK 61

Query: 111 QCD-----SPYGT-----KLWIIMEYLGGGSALDLMK-AGNFEEMHIAVILREVLKGLDY 159
           +C      + +G+     KLWI MEY GGGS  D+    G   E+ IA + RE L+GL Y
Sbjct: 62  ECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAY 121

Query: 160 LHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVI--- 216
           LHS+ K+HRDIK AN+LL++ GDVKLADFGVA  +T T +KR +F+GTP+WMAPEV    
Sbjct: 122 LHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAAVE 181

Query: 217 KQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNN--PPQLTG--NYTKQF 272
           K   Y+   DIW++GITAIELA+ +PP  +LHPMR LFL+ K+N  PP+L     ++  F
Sbjct: 182 KNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSSTF 241

Query: 273 KEFVEACLNKDPENRPTAKELLKFPF 298
             FV+  L K+P+ RPTA+ LL   F
Sbjct: 242 HNFVKISLTKNPKKRPTAERLLTHLF 267

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score =  240 bits (614), Expect = 3e-75
 Identities = 126/271 (46%), Positives = 176/271 (64%), Gaps = 24/271 (8%)

Query: 46  SRRNSLKVDPELIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQE 105
           SRRN     P+  F   +RIG G++G+V+K  +  T ++ AIK+I LE  ED    +QQE
Sbjct: 3   SRRN-----PQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGED-FAVVQQE 56

Query: 106 IMVLSQCDSP-----YGT-----KLWIIMEYLGGGSALDLMK-AGNFEEMHIAVILREVL 154
           I+++  C        +G+     KLWI ME+ GGGS  D+    G   E  IA + RE L
Sbjct: 57  IIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETL 116

Query: 155 KGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPE 214
           +GL YLHS+ K+HRDIK AN+LL++ G VKLADFGV+  +T T +KR +F+GTP+WMAPE
Sbjct: 117 QGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPE 176

Query: 215 VI---KQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNN--PPQLTG--N 267
           V    ++  Y+   DIW++GITAIELA+ +PP  +LHPMR LFL+ K+N  PP+L     
Sbjct: 177 VAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMK 236

Query: 268 YTKQFKEFVEACLNKDPENRPTAKELLKFPF 298
           ++  F  FV+  L K+P+ RPTA++LL+ PF
Sbjct: 237 WSNSFHHFVKMALTKNPKKRPTAEKLLQHPF 267

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score =  239 bits (612), Expect = 7e-75
 Identities = 127/272 (46%), Positives = 179/272 (65%), Gaps = 28/272 (10%)

Query: 54  DPELIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCD 113
           DP  IF   E +G G++G+V+KG   +T Q+ AIK++D+    DE E+I+QEI +L +  
Sbjct: 3   DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDV--TGDEEEEIKQEINMLKKYS 60

Query: 114 ------SPYGT-----------KLWIIMEYLGGGSALDLMK--AGN-FEEMHIAVILREV 153
                 + YG            +LW++ME+ G GS  DL+K   GN  +E  IA I RE+
Sbjct: 61  HHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREI 120

Query: 154 LKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAP 213
           L+GL +LH  + +HRDIK  NVLL+E  +VKL DFGV+  L  T  +RNTF+GTP+WMAP
Sbjct: 121 LRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAP 180

Query: 214 EVIK-----QSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQL-TGN 267
           EVI       + YD K+D+WSLGITAIE+A+G PP  ++HPMR LFLIP+N  P+L +  
Sbjct: 181 EVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSKK 240

Query: 268 YTKQFKEFVEACLNKDPENRPTAKELLKFPFI 299
           ++K+F+ F+E+CL K+   RPT ++L+K PFI
Sbjct: 241 WSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI 272

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score =  239 bits (610), Expect = 2e-74
 Identities = 120/283 (42%), Positives = 179/283 (63%), Gaps = 20/283 (7%)

Query: 53  VDPELIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQC 112
           +DP  ++     +G G+FG+V+K  +  T  + A K+I+  ++E+E+ED   EI +L+ C
Sbjct: 8   LDPNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIE-TKSEEELEDYMVEIEILATC 66

Query: 113 DSPY----------GTKLWIIMEYLGGGS--ALDLMKAGNFEEMHIAVILREVLKGLDYL 160
           + PY            KLWI++E+  GG+  A+ L       E  I VI R++L+ L YL
Sbjct: 67  NHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYL 126

Query: 161 HSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVI---- 216
           HS + +HRD+KA NVLL+  GD+KLADFGV+     T  +R++F+GTP+WMAPEV+    
Sbjct: 127 HSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCET 186

Query: 217 -KQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLT--GNYTKQFK 273
            K + YD KADIWSLGIT IE+A+ EPP+ EL+PMRVL  I K+ PP L+    ++ +F+
Sbjct: 187 MKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPSKWSMEFR 246

Query: 274 EFVEACLNKDPENRPTAKELLKFPFIRKAKKNAYLIDLIDRYK 316
           +F++  L+K PE RP+A +LL+ PF+     N  L +L+   K
Sbjct: 247 DFLKTALDKHPETRPSAAQLLEHPFVSSVTSNRPLRELVAEAK 289

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score =  237 bits (607), Expect = 7e-74
 Identities = 120/276 (43%), Positives = 171/276 (61%), Gaps = 13/276 (4%)

Query: 54  DPELIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCD 113
           DP+  +T+ E+IG+G+ G V+  ID  T Q VAIK ++L++ + + E I  EI+V+ +  
Sbjct: 16  DPKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQ-QPKKELIINEILVMRENK 74

Query: 114 SP----------YGTKLWIIMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSE 163
            P           G +LW++MEYL GGS  D++     +E  IA + RE L+ L++LHS 
Sbjct: 75  HPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSN 134

Query: 164 RKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDS 223
           + +HRDIK+ N+LL   G VKL DFG    +T   SKR+T VGTP+WMAPEV+ + AY  
Sbjct: 135 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGP 194

Query: 224 KADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTG--NYTKQFKEFVEACLN 281
           K DIWSLGI AIE+ +GEPP    +P+R L+LI  N  P+L      +  F++F+  CL 
Sbjct: 195 KVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLE 254

Query: 282 KDPENRPTAKELLKFPFIRKAKKNAYLIDLIDRYKK 317
            D E R +AKELL+ PF++ AK  + L  LI   K+
Sbjct: 255 MDVEKRGSAKELLQHPFLKIAKPLSSLTPLIAAAKE 290

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  233 bits (596), Expect = 2e-72
 Identities = 103/256 (40%), Positives = 158/256 (61%), Gaps = 16/256 (6%)

Query: 65  IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPY-------- 116
           +G+GS G V+K     T ++ A+K I ++  E+  + + +E+  L  C+SPY        
Sbjct: 9   LGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAF 68

Query: 117 --GTKLWIIMEYLGGGSALDLMK-AGNFEEMHIAVILREVLKGLDYLHSERKL-HRDIKA 172
               ++ I++EY+ GGS  DL+K  G   E  +A I R++LKGLDYLH++R + HRDIK 
Sbjct: 69  YKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKP 128

Query: 173 ANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGI 232
           +N+L++  G+VK+ADFG++  L NT  + NTFVGT  +M+PE I+  +Y   ADIWSLG+
Sbjct: 129 SNLLINSKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSPERIQGESYSYAADIWSLGL 188

Query: 233 TAIELAKGE---PPNSELHPMRVLFLIPKNNPPQL-TGNYTKQFKEFVEACLNKDPENRP 288
           T +E A G+    P  +     ++  I    PP L    ++ +F++F+ ACL KDP+ RP
Sbjct: 189 TLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPEFRDFISACLQKDPKKRP 248

Query: 289 TAKELLKFPFIRKAKK 304
           +A ELL+ PFI+KA  
Sbjct: 249 SAAELLQHPFIKKADN 264

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  232 bits (593), Expect = 4e-72
 Identities = 87/257 (33%), Positives = 132/257 (51%), Gaps = 16/257 (6%)

Query: 59  FTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE-AEDEIEDIQQEIMVLSQCDSPY- 116
           +   ++IGKGSFG+V+        ++  +K IDL   +E E ED   E+ +L + + P  
Sbjct: 2   YEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNI 61

Query: 117 ---------GTKLWIIMEYLGGGSALDLMKAGN-----FEEMHIAVILREVLKGLDYLHS 162
                      KL I+MEY  GG     +K        F E  I     ++   L YLHS
Sbjct: 62  IKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHS 121

Query: 163 ERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYD 222
            + LHRDIK  N+ L+  G VKL DFG++  L++T     T VGTP++++PE+ +   Y+
Sbjct: 122 RKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPELCQNKPYN 181

Query: 223 SKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNK 282
            K+DIWSLG    EL   + P    + + +   I K   P +   Y+ + +  V + L K
Sbjct: 182 YKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPPIPSQYSSELRNLVSSLLQK 241

Query: 283 DPENRPTAKELLKFPFI 299
           DPE RP+  ++L+ PFI
Sbjct: 242 DPEERPSIAQILQSPFI 258

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score =  226 bits (578), Expect = 1e-69
 Identities = 120/272 (44%), Positives = 163/272 (59%), Gaps = 26/272 (9%)

Query: 54  DPELIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIID-LEEAEDEIEDIQQEIMVLS-- 110
           DP   +   E IGKG++G+VFK ++ +     A+KI+D + + ++EIE     +  LS  
Sbjct: 15  DPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDH 74

Query: 111 -----------QCDSPYGTKLWIIMEYLGGGSALDLMKA-----GNFEEMHIAVILREVL 154
                      + D   G +LW+++E   GGS  DL+K         EE  IA IL E L
Sbjct: 75  PNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEAL 134

Query: 155 KGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPE 214
            GL +LH  + +HRD+K  N+LL+  G VKL DFGV+  LT+T  +RNT VGTPFWMAPE
Sbjct: 135 MGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPE 194

Query: 215 VIK-----QSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGN-- 267
           VI       S YD++ D+WSLGITAIEL  G+PP ++LHPMR LF IP+N PP L     
Sbjct: 195 VIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNPPPTLHQPEL 254

Query: 268 YTKQFKEFVEACLNKDPENRPTAKELLKFPFI 299
           ++ +F +F+  CL KD E RPT  +LL+  FI
Sbjct: 255 WSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score =  221 bits (564), Expect = 2e-67
 Identities = 119/271 (43%), Positives = 170/271 (62%), Gaps = 13/271 (4%)

Query: 54  DPELIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCD 113
           DP+  +T+ E+IG+G+ G V+  ID  T Q VAIK ++L++ + + E I  EI+V+ +  
Sbjct: 16  DPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQ-QPKKELIINEILVMRENK 74

Query: 114 SP----------YGTKLWIIMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSE 163
           +P           G +LW++MEYL GGS  D++     +E  IA + RE L+ LD+LHS 
Sbjct: 75  NPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALDFLHSN 134

Query: 164 RKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDS 223
           + +HRDIK+ N+LL   G VKL DFG    +T   SKR+T VGTP+WMAPEV+ + AY  
Sbjct: 135 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGP 194

Query: 224 KADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTG--NYTKQFKEFVEACLN 281
           K DIWSLGI AIE+ +GEPP    +P+R L+LI  N  P+L      +  F++F+  CL 
Sbjct: 195 KVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVFRDFLNRCLE 254

Query: 282 KDPENRPTAKELLKFPFIRKAKKNAYLIDLI 312
            D + R +AKELL+ PF++ AK  + L  LI
Sbjct: 255 MDVDRRGSAKELLQHPFLKLAKPLSSLTPLI 285

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score =  219 bits (560), Expect = 4e-67
 Identities = 111/267 (41%), Positives = 167/267 (62%), Gaps = 24/267 (8%)

Query: 54  DPELIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCD 113
           +PE  +     +G G+FG+V+K  +  T  + A K+ID  ++E+E+ED   EI +L+ CD
Sbjct: 2   NPEEFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVID-TKSEEELEDYMVEIDILASCD 60

Query: 114 SP----------YGTKLWIIMEYLGGGSA----LDLMKAGNFEEMHIAVILREVLKGLDY 159
            P          Y   LWI++E+  GG+     L+L +     E  I V+ ++ L+ L+Y
Sbjct: 61  HPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERP--LTEPQIRVVCKQTLEALNY 118

Query: 160 LHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVI--- 216
           LH  + +HRD+KA N+L +  GD+KLADFGV+   T T  +R++F+GTP+WMAPEV+   
Sbjct: 119 LHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCE 178

Query: 217 --KQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLT--GNYTKQF 272
             K   YD KAD+WSLGIT IE+A+ EPP+ EL+PMRVL  I K+ PP L     ++ +F
Sbjct: 179 TSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSEF 238

Query: 273 KEFVEACLNKDPENRPTAKELLKFPFI 299
           K+F++ CL K+ + R T  +LL+ PF+
Sbjct: 239 KDFLKKCLEKNVDARWTTTQLLQHPFV 265

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  215 bits (551), Expect = 2e-66
 Identities = 91/247 (36%), Positives = 129/247 (52%), Gaps = 46/247 (18%)

Query: 65  IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPY-------- 116
           +G+G FG V+   D +T + VAIKII  E++   +E++ +EI +L + + P         
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60

Query: 117 --GTKLWIIMEYLGGGSALDLMKA--GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKA 172
                L+++MEY  GGS  DL+K   G   E  I  IL ++L+GL+YLHS   +HRD+K 
Sbjct: 61  EDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKP 120

Query: 173 ANVLLSEM-GDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSA-YDSKADIWSL 230
            N+LL    G VKLADFG++  LT+  S   T VGTP +MAPEV+     Y  K+DIWSL
Sbjct: 121 ENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSL 180

Query: 231 GITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPENRPTA 290
           G+   EL                                 + K+ +   L KDPE RP+A
Sbjct: 181 GVILYEL--------------------------------PELKDLIRKMLQKDPEKRPSA 208

Query: 291 KELLKFP 297
           KE+L+  
Sbjct: 209 KEILEHL 215

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score =  217 bits (554), Expect = 4e-66
 Identities = 112/273 (41%), Positives = 163/273 (59%), Gaps = 26/273 (9%)

Query: 54  DPELIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIID-LEEAEDEIE---DIQQEIM-- 107
           DP   +   E IGKG++G+V+K  + +   + A+KI+D + + ++EIE   +I Q +   
Sbjct: 19  DPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNH 78

Query: 108 --------VLSQCDSPYGTKLWIIMEYLGGGSALDLMKA-----GNFEEMHIAVILREVL 154
                   +  + D   G +LW+++E   GGS  +L+K         +E  I+ IL   L
Sbjct: 79  PNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGAL 138

Query: 155 KGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPE 214
            GL +LH+ R +HRD+K  N+LL+  G VKL DFGV+  LT+T  +RNT VGTPFWMAPE
Sbjct: 139 LGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPE 198

Query: 215 VIK-----QSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTG--N 267
           VI        +YD++ D+WSLGITAIEL  G+PP  ++HP++ LF IP+N PP L     
Sbjct: 199 VIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNPPPTLLHPEK 258

Query: 268 YTKQFKEFVEACLNKDPENRPTAKELLKFPFIR 300
           + + F  F+  CL KD E RP+   LL+ PFI+
Sbjct: 259 WCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK 291

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score =  217 bits (553), Expect = 5e-66
 Identities = 120/271 (44%), Positives = 170/271 (62%), Gaps = 13/271 (4%)

Query: 54  DPELIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCD 113
           DP+  +T+ E+IG+G+ G VF  ID  T Q VAIK I+L++ + + E I  EI+V+ +  
Sbjct: 16  DPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQK-QPKKELIINEILVMKELK 74

Query: 114 SP----------YGTKLWIIMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSE 163
           +P           G +L+++MEYL GGS  D++     +E  IA + RE L+ L++LH+ 
Sbjct: 75  NPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTETCMDEAQIAAVCRECLQALEFLHAN 134

Query: 164 RKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDS 223
           + +HRDIK+ NVLL   G VKL DFG    +T   SKR+T VGTP+WMAPEV+ + AY  
Sbjct: 135 QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGP 194

Query: 224 KADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTG--NYTKQFKEFVEACLN 281
           K DIWSLGI AIE+ +GEPP    +P+R L+LI  N  P+L      +  F++F+  CL 
Sbjct: 195 KVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFRDFLNRCLE 254

Query: 282 KDPENRPTAKELLKFPFIRKAKKNAYLIDLI 312
            D E R +AKELL+ PF++ AK  + L  LI
Sbjct: 255 MDVEKRGSAKELLQHPFLKLAKPLSSLTPLI 285

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score =  217 bits (553), Expect = 1e-65
 Identities = 121/282 (42%), Positives = 166/282 (58%), Gaps = 21/282 (7%)

Query: 52  KVDPELIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDL--EEAEDEIEDIQQEIMVL 109
           K DPE IF     IG GSFG V+   ++ T +VVA+K +    ++  ++ +DI +E+  L
Sbjct: 16  KDDPEEIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFL 75

Query: 110 SQCDSPYGTKL----------WIIMEY-LGGGSALDLMKAGNFEEMHIAVILREVLKGLD 158
            Q   P   +           W++MEY LG  S L  +     +E+ IA I    L+GL 
Sbjct: 76  QQLKHPNTIEYKGCYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLA 135

Query: 159 YLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVI-- 216
           YLHS   +HRDIKA N+LL+E G VKLADFG A    + +S  N+FVGTP+WMAPEVI  
Sbjct: 136 YLHSHNMIHRDIKAGNILLTEPGQVKLADFGSA----SKSSPANSFVGTPYWMAPEVILA 191

Query: 217 -KQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGN-YTKQFKE 274
             +  YD K D+WSLGIT IELA+ +PP   ++ M  L+ I +N+ P L  N +T  F+ 
Sbjct: 192 MDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEWTDSFRG 251

Query: 275 FVEACLNKDPENRPTAKELLKFPFIRKAKKNAYLIDLIDRYK 316
           FV+ CL K P+ RP + ELL+  F+R+ +    LIDLI R K
Sbjct: 252 FVDYCLQKIPQERPASAELLRHDFVRRDRPARVLIDLIQRTK 293

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score =  214 bits (547), Expect = 5e-65
 Identities = 99/282 (35%), Positives = 155/282 (54%), Gaps = 18/282 (6%)

Query: 48  RNSLKV-----DPELIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDI 102
           R +L++     DP        +IG+GS G V    D  T + VA+K +DL + +   E +
Sbjct: 5   RAALQLVVDPGDPRSYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRR-ELL 63

Query: 103 QQEIMVLSQCDSP----------YGTKLWIIMEYLGGGSALDLMKAGNFEEMHIAVILRE 152
             E++++     P           G +LW++ME+L GG+  D++      E  IA +   
Sbjct: 64  FNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIATVCLA 123

Query: 153 VLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMA 212
           VLK L +LH++  +HRDIK+ ++LL+  G VKL+DFG    ++    +R + VGTP+WMA
Sbjct: 124 VLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMA 183

Query: 213 PEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQL--TGNYTK 270
           PEVI +  Y ++ DIWSLGI  IE+  GEPP     P++ +  I  N PP+L      + 
Sbjct: 184 PEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKNLHKVSP 243

Query: 271 QFKEFVEACLNKDPENRPTAKELLKFPFIRKAKKNAYLIDLI 312
           + + F++  L +DP  R TA ELL  PF+ KA   + ++ L+
Sbjct: 244 RLRSFLDRMLVRDPAQRATAAELLNHPFLAKAGPPSSIVPLM 285

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score =  213 bits (545), Expect = 5e-65
 Identities = 106/256 (41%), Positives = 148/256 (57%), Gaps = 21/256 (8%)

Query: 65  IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPY-------- 116
           +G G+ G V K +   T +++A+K I LE  E   + I +E+ +L +C+SPY        
Sbjct: 9   LGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAF 68

Query: 117 --GTKLWIIMEYLGGGSALDLMK--AGNFEEMHIAVILREVLKGLDYLHSERK-LHRDIK 171
                + I MEY+ GGS   ++K   G   E  +  I   VLKGL YLH + K +HRD+K
Sbjct: 69  YNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVK 128

Query: 172 AANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLG 231
            +N+L++  G +KL DFGV+G L N  S   TFVGT  +MAPE I+ + Y  K+DIWSLG
Sbjct: 129 PSNILVNSRGQIKLCDFGVSGQLVN--SLAKTFVGTSSYMAPERIQGNDYSVKSDIWSLG 186

Query: 232 ITAIELAKGE-P-PNSELHPMRVLFL---IPKNNPPQLT-GNYTKQFKEFVEACLNKDPE 285
           ++ IELA G  P P     P  +  L   I    PP+L  G ++  F++FV  CL KDP 
Sbjct: 187 LSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGKFSPDFQDFVNLCLIKDPR 246

Query: 286 NRPTAKELLKFPFIRK 301
            RP+ KELL+ PFI+K
Sbjct: 247 ERPSYKELLEHPFIKK 262

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score =  213 bits (543), Expect = 6e-65
 Identities = 102/256 (39%), Positives = 153/256 (59%), Gaps = 18/256 (7%)

Query: 61  KQERIGKGSFGEVFKGIDNRTQQVVAIKIIDL----EEAEDEIEDIQQEIMVLSQCDSP- 115
           K E +G GSFG V++G++       A+K + L    +  ++ ++ ++QEI +LS+   P 
Sbjct: 4   KGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPN 63

Query: 116 ----YGT-----KLWIIMEYLGGGSALDLM-KAGNFEEMHIAVILREVLKGLDYLHSERK 165
                GT      L+I +E + GGS   L+ K G+F E  I +  R++L GL+YLH    
Sbjct: 64  IVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNT 123

Query: 166 LHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVI-KQSAYDSK 224
           +HRDIK AN+L+   G VKLADFG+A  +    S   +F G+P+WMAPEVI +Q  Y   
Sbjct: 124 VHRDIKGANILVDTNGVVKLADFGMAKQVV-EFSFAKSFKGSPYWMAPEVIAQQGGYGLA 182

Query: 225 ADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNP-PQLTGNYTKQFKEFVEACLNKD 283
           ADIWSLG T +E+A G+PP S+L  +  +F I ++   P +  + + + K+F+  CL +D
Sbjct: 183 ADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKDFILKCLQRD 242

Query: 284 PENRPTAKELLKFPFI 299
           P  RPTA ELL+ PF+
Sbjct: 243 PSLRPTAAELLEHPFV 258

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score =  214 bits (547), Expect = 9e-65
 Identities = 123/283 (43%), Positives = 169/283 (59%), Gaps = 21/283 (7%)

Query: 51  LKVDPELIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDL--EEAEDEIEDIQQEIMV 108
            K DPE +FT    IG GSFG V+   D RT +VVAIK +    +++ ++ +DI +E+  
Sbjct: 19  FKEDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKF 78

Query: 109 LSQCDSPYGTKL----------WIIMEY-LGGGSALDLMKAGNFEEMHIAVILREVLKGL 157
           L +   P   +           W++MEY LG  S L  +     +E+ IA I    L+GL
Sbjct: 79  LQRIKHPNSIEYKGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGL 138

Query: 158 DYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVI- 216
            YLHS   +HRDIKA N+LL+E G VKLADFG A    +  S  N+FVGTP+WMAPEVI 
Sbjct: 139 AYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSA----SIASPANSFVGTPYWMAPEVIL 194

Query: 217 --KQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGN-YTKQFK 273
              +  YD K D+WSLGIT IELA+ +PP   ++ M  L+ I +N  P L  N ++  F+
Sbjct: 195 AMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFR 254

Query: 274 EFVEACLNKDPENRPTAKELLKFPFIRKAKKNAYLIDLIDRYK 316
            FV++CL K P++RPT++ELLK  F+ + +    LIDLI R K
Sbjct: 255 NFVDSCLQKIPQDRPTSEELLKHMFVLRERPETVLIDLIQRTK 297

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score =  213 bits (544), Expect = 1e-64
 Identities = 117/276 (42%), Positives = 172/276 (62%), Gaps = 13/276 (4%)

Query: 54  DPELIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCD 113
           DP+  +T+ E+IG+G+ G V+  +D  T Q VAI+ ++L++ + + E I  EI+V+ +  
Sbjct: 17  DPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ-QPKKELIINEILVMRENK 75

Query: 114 SP----------YGTKLWIIMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSE 163
           +P           G +LW++MEYL GGS  D++     +E  IA + RE L+ L++LHS 
Sbjct: 76  NPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSN 135

Query: 164 RKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDS 223
           + +HRDIK+ N+LL   G VKL DFG    +T   SKR+T VGTP+WMAPEV+ + AY  
Sbjct: 136 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGP 195

Query: 224 KADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTG--NYTKQFKEFVEACLN 281
           K DIWSLGI AIE+ +GEPP    +P+R L+LI  N  P+L      +  F++F+  CL+
Sbjct: 196 KVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLD 255

Query: 282 KDPENRPTAKELLKFPFIRKAKKNAYLIDLIDRYKK 317
            D E R +AKELL+  F++ AK  + L  LI   K+
Sbjct: 256 MDVEKRGSAKELLQHQFLKIAKPLSSLTPLIAAAKE 291

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score =  203 bits (517), Expect = 2e-60
 Identities = 114/282 (40%), Positives = 165/282 (58%), Gaps = 21/282 (7%)

Query: 52  KVDPELIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDL--EEAEDEIEDIQQEIMVL 109
           K DPE +F+    IG GSFG V+   D R  +VVAIK +    +++ ++ +DI +E+  L
Sbjct: 10  KDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFL 69

Query: 110 SQCDSPYGTKL----------WIIMEY-LGGGSALDLMKAGNFEEMHIAVILREVLKGLD 158
            +   P   +           W++MEY LG  S L  +     +E+ IA +    L+GL 
Sbjct: 70  QKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLA 129

Query: 159 YLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVI-- 216
           YLHS   +HRD+KA N+LLSE G VKL DFG A  +    +  N FVGTP+WMAPEVI  
Sbjct: 130 YLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIM----APANXFVGTPYWMAPEVILA 185

Query: 217 -KQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGN-YTKQFKE 274
             +  YD K D+WSLGIT IELA+ +PP   ++ M  L+ I +N  P L    +++ F+ 
Sbjct: 186 MDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRN 245

Query: 275 FVEACLNKDPENRPTAKELLKFPFIRKAKKNAYLIDLIDRYK 316
           FV++CL K P++RPT++ LLK  F+ + +    ++DLI R K
Sbjct: 246 FVDSCLQKIPQDRPTSEVLLKHRFVLRERPPTVIMDLIQRTK 287

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score =  189 bits (481), Expect = 2e-55
 Identities = 101/275 (36%), Positives = 146/275 (53%), Gaps = 32/275 (11%)

Query: 59  FTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSP--- 115
             +  R+G+G+ G V K     T  + A+K I  +   D  + I +E+ +   C SP   
Sbjct: 3   IVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIV 62

Query: 116 --YGT-------KLWIIMEYLGGGSALD------LMKAGNFEEMHIAVILREVLKGLDYL 160
             YG         + I MEY  GGS LD        + G   E  +  I   VLKGL YL
Sbjct: 63  KYYGAFLDESSSSIGIAMEYCEGGS-LDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYL 121

Query: 161 HSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSA 220
           HS + +HRDIK +N+LL+  G VKL DFGV+G L N+ +   TF GT F+MAPE I+   
Sbjct: 122 HSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAG--TFTGTSFYMAPERIQGKP 179

Query: 221 YDSKADIWSLGITAIELAKGE---PPNSE--LHPMRVLFLIPKNNPPQLTG------NYT 269
           Y   +D+WSLG+T +E+A+     PP  E  L P+ +L  I     P+L         ++
Sbjct: 180 YSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGNGIKWS 239

Query: 270 KQFKEFVEACLNKDPENRPTAKELLKFPFIRKAKK 304
           ++FK+F++ CL KDP  RPT  ++L+ P+I+   K
Sbjct: 240 EEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQMK 274

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score =  187 bits (477), Expect = 3e-55
 Identities = 95/257 (36%), Positives = 146/257 (56%), Gaps = 22/257 (8%)

Query: 65  IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDE-IEDIQQEIMVLSQCDSP-----YGT 118
           IG G+FG+V+  ++  T +++A+K I +++ + + I++I  E+ VL     P     YG 
Sbjct: 8   IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGV 67

Query: 119 -----KLWIIMEYLGGGSALDLMKAGNFEEMH-IAVILREVLKGLDYLHSERKLHRDIKA 172
                K++I MEY  GG+  +L++ G   + H I V   ++L+GL YLHS   +HRDIK 
Sbjct: 68  EVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKP 127

Query: 173 ANVLLSEMGDVKLADFGVAGTLTNTTSKR----NTFVGTPFWMAPEVIKQSAYDSK---A 225
           AN+ L   G +KL DFG A  L N T+       +  GTP +MAPEVI           A
Sbjct: 128 ANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAA 187

Query: 226 DIWSLGITAIELAKGEPPNSEL-HPMRVLFLIPKNNPPQLTGNYTK--QFKEFVEACLNK 282
           DIWSLG   +E+A G+ P SEL +  +++F +   + P +  +     + K+F++ CL  
Sbjct: 188 DIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQLSPEGKDFLDRCLES 247

Query: 283 DPENRPTAKELLKFPFI 299
           DP+ RPTA ELL+ PF+
Sbjct: 248 DPKKRPTASELLQHPFV 264

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score =  186 bits (472), Expect = 3e-54
 Identities = 97/275 (35%), Positives = 156/275 (56%), Gaps = 11/275 (4%)

Query: 54  DPELIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDE---------IEDIQQ 104
           DP  +     +IG+GS G V    +  + + VA+K++DL + +           + D Q 
Sbjct: 18  DPRSLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQH 77

Query: 105 EIMVLSQCDSPYGTKLWIIMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSER 164
           + +V        G +LW++ME+L GG+  D++      E  IA +   VL+ L YLHS+ 
Sbjct: 78  QNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQTRLNEEQIATVCESVLQALCYLHSQG 137

Query: 165 KLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSK 224
            +HRDIK+ ++LL+  G VKL+DFG    ++    KR + VGTP+WMAPEVI ++ Y ++
Sbjct: 138 VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRTPYGTE 197

Query: 225 ADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNY--TKQFKEFVEACLNK 282
            DIWSLGI  IE+  GEPP     P++ +  +  + PP+L   +  +   ++F+E  L +
Sbjct: 198 VDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHKISPVLRDFLERMLTR 257

Query: 283 DPENRPTAKELLKFPFIRKAKKNAYLIDLIDRYKK 317
           +P+ R TA+ELL  PF+ +      L+ LI +Y+K
Sbjct: 258 EPQERATAQELLDHPFLLQTGLPECLVPLIQQYRK 292

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score =  177 bits (451), Expect = 2e-51
 Identities = 87/254 (34%), Positives = 137/254 (53%), Gaps = 19/254 (7%)

Query: 65  IGKGSFGEVFKGIDNRTQQVVAIKIIDLE----EAEDEIEDIQQEIMVLSQCDSP----- 115
           +G+G+FG V+   D  T + +A+K +  +    E + E+  ++ EI +L           
Sbjct: 10  LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQY 69

Query: 116 YGT-----KLWIIMEYLGGGSALDLMKA-GNFEEMHIAVILREVLKGLDYLHSERKLHRD 169
           YG       L I MEY+ GGS  D +KA G   E       R++L+G++YLHS   +HRD
Sbjct: 70  YGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRD 129

Query: 170 IKAANVLLSEMGDVKLADFGVAG---TLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKAD 226
           IK AN+L    G+VKL DFG +    T+ ++ +   +  GTP+WM+PEVI    Y  KAD
Sbjct: 130 IKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKAD 189

Query: 227 IWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNP-PQLTGNYTKQFKEFVEACLNKDPE 285
           +WS+G T +E+   +PP +E   M  +F I      PQL  + +   + F+     ++ +
Sbjct: 190 VWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVSPDARNFLRRTFVENAK 249

Query: 286 NRPTAKELLKFPFI 299
            RP+A+ELL+  F+
Sbjct: 250 KRPSAEELLRHFFV 263

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score =  176 bits (447), Expect = 1e-50
 Identities = 97/270 (35%), Positives = 147/270 (54%), Gaps = 11/270 (4%)

Query: 54  DPELIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDE---------IEDIQQ 104
           DP        +IG+GS G V       + ++VA+K +DL + +           + D Q 
Sbjct: 17  DPRTYLDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQH 76

Query: 105 EIMVLSQCDSPYGTKLWIIMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSER 164
           E +V        G +LW++ME+L GG+  D++      E  IA +   VLK L  LH++ 
Sbjct: 77  ENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLKALSVLHAQG 136

Query: 165 KLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSK 224
            +HRDIK+ ++LL+  G VKL+DFG    ++    +R + VGTP+WMAPE+I +  Y  +
Sbjct: 137 VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPE 196

Query: 225 ADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTG--NYTKQFKEFVEACLNK 282
            DIWSLGI  IE+  GEPP     P++ + +I  N PP+L      +   K F++  L +
Sbjct: 197 VDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKNLHKVSPSLKGFLDRLLVR 256

Query: 283 DPENRPTAKELLKFPFIRKAKKNAYLIDLI 312
           DP  R TA ELLK PF+ KA   + ++ L+
Sbjct: 257 DPAQRATAAELLKHPFLAKAGPPSCIVPLM 286

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score =  175 bits (445), Expect = 2e-50
 Identities = 94/274 (34%), Positives = 153/274 (55%), Gaps = 11/274 (4%)

Query: 54  DPELIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDE---------IEDIQQ 104
           DP        +IG+GS G V    +  T + VA+K +DL + +           + D   
Sbjct: 19  DPREYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHH 78

Query: 105 EIMVLSQCDSPYGTKLWIIMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSER 164
           E +V        G +LW++ME+L GG+  D++      E  IA +   VL+ L YLH++ 
Sbjct: 79  ENVVDMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIATVCLSVLRALSYLHNQG 138

Query: 165 KLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSK 224
            +HRDIK+ ++LL+  G +KL+DFG    ++    KR + VGTP+WMAPEVI +  Y ++
Sbjct: 139 VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLPYGTE 198

Query: 225 ADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNY--TKQFKEFVEACLNK 282
            DIWSLGI  IE+  GEPP     P++ +  I  N PP++  ++  +   + F++  L +
Sbjct: 199 VDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVKDSHKVSSVLRGFLDLMLVR 258

Query: 283 DPENRPTAKELLKFPFIRKAKKNAYLIDLIDRYK 316
           +P  R TA+ELL+ PF++ A   + ++ L+ +Y+
Sbjct: 259 EPSQRATAQELLQHPFLKLAGPPSCIVPLMRQYR 292

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score =  174 bits (443), Expect = 3e-50
 Identities = 92/260 (35%), Positives = 147/260 (56%), Gaps = 25/260 (9%)

Query: 65  IGKGSFGEVFKGIDNRTQQVVAIKIIDL----EEAEDE----IEDIQQEIMVLSQCDSPY 116
           IG GSFG V+ G++  + +++A+K ++L      ++D     ++ + +EI +L +     
Sbjct: 8   IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67

Query: 117 ----------GTKLWIIMEYLGGGSALDLMKA-GNFEEMHIAVILREVLKGLDYLHSERK 165
                        L I +EY+ GGS   L+   G FEE  +   +R++LKGL+YLH+   
Sbjct: 68  IVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGI 127

Query: 166 LHRDIKAANVLLSEMGDVKLADFGVAGTL------TNTTSKRNTFVGTPFWMAPEVIKQS 219
           +HRDIK AN+L+   G +K++DFG++  L      T T   R +  G+ FWMAPEV+KQ+
Sbjct: 128 IHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQT 187

Query: 220 AYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEAC 279
           +Y  KADIWSLG   +E+  G+ P  +   ++ +F I +N  P++  N + +  +F+E  
Sbjct: 188 SYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENASPEIPSNISSEAIDFLEKT 247

Query: 280 LNKDPENRPTAKELLKFPFI 299
              D   RPTA ELLK PF+
Sbjct: 248 FEIDHNKRPTAAELLKHPFL 267

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  173 bits (441), Expect = 5e-50
 Identities = 77/267 (28%), Positives = 130/267 (48%), Gaps = 39/267 (14%)

Query: 59  FTKQERIGKGSFGEVFKGI----DNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDS 114
               +++G+G+FGEV+KG        T+  VA+K +    +E+E E+  +E  ++ +   
Sbjct: 1   LELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSH 60

Query: 115 PY----------GTKLWIIMEYLGGGSALDLMKA--GNFEEMHIAVILREVLKGLDYLHS 162
           P           G  L+I+ EY+ GG  LD ++          +  +  ++ KG++YL S
Sbjct: 61  PNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLES 120

Query: 163 ERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNT---TSKRNTFVGTP-FWMAPEVIKQ 218
           +  +HRD+ A N L++E   VK++DFG++  +        +    +  P  WMAPE +K 
Sbjct: 121 KNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKL--PIKWMAPESLKD 178

Query: 219 SAYDSKADIWSLGITAIELA-KGEPPNSELHPMRVLFLI--------PKNNPPQLTGNYT 269
             + SK+D+WS G+   E+   GE P   +    VL L+        P+N P +L     
Sbjct: 179 GKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELLEDGYRLPRPENCPDEL----- 233

Query: 270 KQFKEFVEACLNKDPENRPTAKELLKF 296
               E +  C   DPE+RPT  EL++ 
Sbjct: 234 ---YELMLQCWAYDPEDRPTFSELVED 257

Length = 258

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score =  173 bits (440), Expect = 9e-50
 Identities = 88/265 (33%), Positives = 128/265 (48%), Gaps = 33/265 (12%)

Query: 63  ERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE-AEDEIEDIQQEIMVLSQCDSP-----Y 116
           E IGKGSFG V K       +++  K ID     E E + +  E+ +L +   P     Y
Sbjct: 6   ETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYY 65

Query: 117 G-------TKLWIIMEYLGGGSALDLMKA-----GNFEEMHIAVILREVLKGLDYLH--- 161
                     L+I+MEY  GG    L++         EE  I  IL ++L  L   H   
Sbjct: 66  DRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRS 125

Query: 162 --SERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQS 219
                 LHRD+K AN+ L    +VKL DFG+A  L + +S   T+VGTP++M+PE +   
Sbjct: 126 DPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYVGTPYYMSPEQLNHM 185

Query: 220 AYDSKADIWSLGITAIELAKGEPP-----NSELHPMRVLFLIPKNNPPQLTGNYTKQFKE 274
           +YD K+DIWSLG    EL    PP       +L        I +    ++   Y+ +  E
Sbjct: 186 SYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASK-----IKEGKFRRIPYRYSSELNE 240

Query: 275 FVEACLNKDPENRPTAKELLKFPFI 299
            +++ LN DP+ RP+ +ELL+ P I
Sbjct: 241 VIKSMLNVDPDKRPSTEELLQLPLI 265

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  171 bits (437), Expect = 2e-49
 Identities = 78/254 (30%), Positives = 126/254 (49%), Gaps = 25/254 (9%)

Query: 65  IGKGSFGEVFKGIDNRTQQVVAIKIID--LEEAEDEIEDIQQEIMVLSQCDSPY------ 116
           +GKGSFG+V       T ++ A+K++         E+E    E  +LS+ + P+      
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60

Query: 117 ----GTKLWIIMEYLGGGSALDLM-KAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIK 171
                 KL++++EY  GG     + K G F E        E++  L+YLHS   ++RD+K
Sbjct: 61  AFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLK 120

Query: 172 AANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLG 231
             N+LL   G +KL DFG+A  L++  S+ NTF GTP ++APEV+    Y    D WSLG
Sbjct: 121 PENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLG 180

Query: 232 ITAIELAKGEPP----NSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPENR 287
           +   E+  G+PP    + +    ++L      +P +     + + ++ +   L KDP  R
Sbjct: 181 VLLYEMLTGKPPFYAEDRKEIYEKIL-----KDPLRFPEFLSPEARDLISGLLQKDPTKR 235

Query: 288 PT---AKELLKFPF 298
                A+E+   PF
Sbjct: 236 LGSGGAEEIKAHPF 249

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score =  169 bits (430), Expect = 2e-48
 Identities = 92/266 (34%), Positives = 145/266 (54%), Gaps = 25/266 (9%)

Query: 58  IFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLE-----EAEDEIEDIQQEIMVLSQC 112
            +TK E +GKG++G V+ G+ N   Q++A+K ++L+      AE E E +Q+E+ +L   
Sbjct: 1   EWTKGEVLGKGAYGTVYCGLTN-QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSL 59

Query: 113 D-----SPYGT-----KLWIIMEYLGGGSALDLMKA-GNFEEMHIAVILREVLKGLDYLH 161
                    GT      + I ME++ GGS   ++   G   E       +++L G+ YLH
Sbjct: 60  KHVNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLH 119

Query: 162 SERKLHRDIKAANVLLSEMGDVKLADFGVAGTL---TNTTSKRN---TFVGTPFWMAPEV 215
           +   +HRDIK  NV+L   G +KL DFG A  L       +  N   +  GTP+WMAPEV
Sbjct: 120 NNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEV 179

Query: 216 IKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNP--PQLTGNYTKQFK 273
           I +S Y  K+DIWS+G T  E+A G+PP + +  +  +F I  +    P+L  +++    
Sbjct: 180 INESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSFSAAAI 239

Query: 274 EFVEACLNKDPENRPTAKELLKFPFI 299
           +FV +CL +D   RP+A +LL+  F+
Sbjct: 240 DFVTSCLTRDQHERPSALQLLRHDFL 265

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score =  167 bits (424), Expect = 1e-47
 Identities = 87/253 (34%), Positives = 136/253 (53%), Gaps = 14/253 (5%)

Query: 59  FTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAED-EIEDIQQEIMVLSQCDSPY- 116
           F    +IGKGSFG VFK +    ++V A+K IDL +    E E+   E  VL++ DS Y 
Sbjct: 2   FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYI 61

Query: 117 ---------GTKLWIIMEYLGGGSALDLMKAGN---FEEMHIAVILREVLKGLDYLHSER 164
                      KL I+MEY   G    L+K        E  +     ++L GL +LHS++
Sbjct: 62  IRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKK 121

Query: 165 KLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSK 224
            LHRDIK+ N+ L    +VK+ D GVA  L++ T+  NT VGTP++++PE+ +   Y+ K
Sbjct: 122 ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELCEDKPYNEK 181

Query: 225 ADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDP 284
           +D+W+LG+   E   G+ P    +   ++  I +   P ++  Y++Q  + ++ CL KD 
Sbjct: 182 SDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVSQMYSQQLAQLIDQCLTKDY 241

Query: 285 ENRPTAKELLKFP 297
             RP   +LL+ P
Sbjct: 242 RQRPDTFQLLRNP 254

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score =  166 bits (422), Expect = 8e-47
 Identities = 102/296 (34%), Positives = 158/296 (53%), Gaps = 53/296 (17%)

Query: 59  FTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSP--- 115
           F K   +G G+ G V K +   +  ++A K+I LE        I +E+ VL +C+SP   
Sbjct: 3   FEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIV 62

Query: 116 --YGT-----KLWIIMEYLGGGSALDLM--KAGNFEEMHIAVILREVLKGLDYLHSERK- 165
             YG      ++ I ME++ GGS LD +  KAG   E  +  I   VL+GL YL  + K 
Sbjct: 63  GFYGAFYSDGEISICMEHMDGGS-LDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKI 121

Query: 166 LHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKA 225
           +HRD+K +N+L++  G++KL DFGV+G L +  S  N+FVGT  +M+PE ++ + Y  ++
Sbjct: 122 MHRDVKPSNILVNSRGEIKLCDFGVSGQLID--SMANSFVGTRSYMSPERLQGTHYTVQS 179

Query: 226 DIWSLGITAIELAKGE----PPN-SELHPM------------------------------ 250
           DIWSLG++ +E+A G     PP+  EL  M                              
Sbjct: 180 DIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSPRPMAI 239

Query: 251 -RVLFLIPKNNPPQL-TGNYTKQFKEFVEACLNKDPENRPTAKELLKFPFIRKAKK 304
             +L  I    PP+L +G ++ +F++FV+ CL K+P+ R   KEL K PFI++A+ 
Sbjct: 240 FELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRAEL 295

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score =  165 bits (420), Expect = 8e-47
 Identities = 94/258 (36%), Positives = 144/258 (55%), Gaps = 23/258 (8%)

Query: 62  QERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTKLW 121
           QE +G G+ G V+K     T++++A+K+I L+   +  + I  E+ +L +CDSPY    +
Sbjct: 6   QEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFY 65

Query: 122 ----------IIMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIK 171
                     I  E++ GGS LD+       E  +  I   V+KGL YL S + LHRD+K
Sbjct: 66  GAFFVENRISICTEFMDGGS-LDVY--RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVK 122

Query: 172 AANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLG 231
            +N+L++  G VKL DFGV+  L N+ +K  T+VGT  +MAPE I    Y   +D+WSLG
Sbjct: 123 PSNMLVNTRGQVKLCDFGVSTQLVNSIAK--TYVGTNAYMAPERISGEQYGIHSDVWSLG 180

Query: 232 ITAIELAKGEPP-------NSELHPMRVLFLIPKNNPPQL-TGNYTKQFKEFVEACLNKD 283
           I+ +ELA G  P          L P+++L  I   +PP L  G ++++F  F+  C+ K 
Sbjct: 181 ISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKFVHFITQCMRKQ 240

Query: 284 PENRPTAKELLKFPFIRK 301
           P+ RP  + L+  PFI +
Sbjct: 241 PKERPAPENLMDHPFIVQ 258

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score =  163 bits (413), Expect = 6e-46
 Identities = 91/268 (33%), Positives = 141/268 (52%), Gaps = 29/268 (10%)

Query: 61  KQERIGKGSFGEVFKGIDNRTQQVVAIKIIDL---------EEAEDEIEDIQQEIMVLSQ 111
           K E IGKG++G V+  ++  T +++A+K ++L            +D ++ ++ EI  L  
Sbjct: 5   KGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKD 64

Query: 112 CDSP-------YGTK---LWIIMEYLGGGS-ALDLMKAGNFEEMHIAVILREVLKGLDYL 160
            D         + T    L I +EY+ GGS    L   G FEE  +     +VL+GL YL
Sbjct: 65  LDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYL 124

Query: 161 HSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTN--TTSKRNTFVGTPFWMAPEVI-- 216
           HS+  LHRD+KA N+L+   G  K++DFG++    +     +  +  G+ FWMAPEVI  
Sbjct: 125 HSKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHS 184

Query: 217 KQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNN-----PPQLTGNYTKQ 271
               Y +K DIWSLG   +E+  G  P S+   +  +F +         PP ++ N +  
Sbjct: 185 YSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVSMNLSPV 244

Query: 272 FKEFVEACLNKDPENRPTAKELLKFPFI 299
             +F+ AC   +P+NRPTA+ELL+ PFI
Sbjct: 245 ALDFLNACFTINPDNRPTARELLQHPFI 272

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score =  162 bits (413), Expect = 2e-45
 Identities = 92/307 (29%), Positives = 149/307 (48%), Gaps = 59/307 (19%)

Query: 65  IGKGSFGE--VFKGIDNRTQQVVAIKIIDLEEAEDE-IEDIQQEIMVLSQCDSP------ 115
           IGK       V       T  +VA+K I+L+    E ++ +QQEI+   Q   P      
Sbjct: 6   IGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYV 65

Query: 116 ----YGTKLWIIMEYLGGGSALDLMKA---GNFEEMHIAVILREVLKGLDYLHSERKLHR 168
                 ++L+++   +  GS  DL+K        E+ IA IL++VL  LDY+HS+  +HR
Sbjct: 66  TSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHR 125

Query: 169 DIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTP-------FWMAPEVIKQS-- 219
            +KA+++LLS  G V L+    + ++     ++      P        W++PEV++Q+  
Sbjct: 126 SVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQ 185

Query: 220 AYDSKADIWSLGITAIELAKGEPPNSELHPMRVLF---------LIPKNNPPQLTGN--- 267
            Y+ K+DI+S+GITA ELA G  P  ++   ++L          L+ K+  P    +   
Sbjct: 186 GYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSMSQ 245

Query: 268 -----------------YTKQFKE----FVEACLNKDPENRPTAKELLKFPFIRKAKK-N 305
                            YT+ F E    FVE CL +DPE+RP+A +LL   F ++ K+ N
Sbjct: 246 SRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQCKRRN 305

Query: 306 AYLIDLI 312
             L+DL+
Sbjct: 306 TSLLDLL 312

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score =  161 bits (409), Expect = 3e-45
 Identities = 94/266 (35%), Positives = 140/266 (52%), Gaps = 28/266 (10%)

Query: 63  ERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPY------ 116
           + +GKG++G V+K +   T   +A+K I LE  E +   I  E+ +L +  SPY      
Sbjct: 7   DELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYG 66

Query: 117 ----GTKLWIIMEYLGGGSALDLMKAGNFE-----EMHIAVILREVLKGLDYLHSERKL- 166
                  +++ MEY+  GS LD + AG        E  +  I   V+KGL +L  E  + 
Sbjct: 67  AFFIEGAVYMCMEYMDAGS-LDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNII 125

Query: 167 HRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIK------QSA 220
           HRD+K  NVL++  G VKL DFGV+G L  + +K N  +G   +MAPE IK         
Sbjct: 126 HRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTN--IGCQSYMAPERIKSGGPNQNPT 183

Query: 221 YDSKADIWSLGITAIELAKGE---PPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVE 277
           Y  ++D+WSLG++ +E+A G    PP +  +    L  I   +PP L   Y+   ++FV 
Sbjct: 184 YTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSGYSDDAQDFVA 243

Query: 278 ACLNKDPENRPTAKELLKFPFIRKAK 303
            CLNK P  RPT  +LL+ P++ K K
Sbjct: 244 KCLNKIPNRRPTYAQLLEHPWLVKYK 269

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  158 bits (402), Expect = 2e-44
 Identities = 76/262 (29%), Positives = 133/262 (50%), Gaps = 30/262 (11%)

Query: 63  ERIGKGSFGEVFKG----IDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSP--- 115
           +++G+G+FGEV+KG     D +T +V A+K +  + +E+E +D  +E  V+ +   P   
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGKTTEV-AVKTLKEDASEEERKDFLKEARVMKKLGHPNVV 59

Query: 116 --YG-----TKLWIIMEYLGGGSALDLMK-----AGNFEEMHIAV-----ILREVLKGLD 158
              G       L++++EY+ GG  LD ++       + E+  +++        ++ KG++
Sbjct: 60  RLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGME 119

Query: 159 YLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPF---WMAPEV 215
           YL S++ +HRD+ A N L+ E   VK++DFG++  + +    R    G      WMAPE 
Sbjct: 120 YLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKK-TGGKLPIRWMAPES 178

Query: 216 IKQSAYDSKADIWSLGITAIEL-AKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKE 274
           +K   + SK+D+WS G+   E+   G  P   L    VL  + K            +  E
Sbjct: 179 LKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRLPKPEYCPDELYE 238

Query: 275 FVEACLNKDPENRPTAKELLKF 296
            + +C   DPE+RPT  EL++ 
Sbjct: 239 LMLSCWQLDPEDRPTFSELVER 260

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score =  158 bits (401), Expect = 6e-44
 Identities = 82/293 (27%), Positives = 131/293 (44%), Gaps = 63/293 (21%)

Query: 59  FTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQ----EIMVLSQCDS 114
           + K E++G+G++G V+K  D +T ++VA+K I L+  E+ I         EI +L +   
Sbjct: 1   YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGI---PSTALREISLLKELKH 57

Query: 115 PY----------GTKLWIIMEYLGGGSALDL-----MKAGNFEEMHIAVILREVLKGLDY 159
           P             KL+++ EY      +DL      + G      I  I+ ++L+GL Y
Sbjct: 58  PNIVKLLDVIHTERKLYLVFEYC----DMDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAY 113

Query: 160 LHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVI-KQ 218
            HS R LHRD+K  N+L++  G +KLADFG+A             V T ++ APE++   
Sbjct: 114 CHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVVTLWYRAPEILLGS 173

Query: 219 SAYDSKADIWSLG-ITAIELAKGEPP---NSELHPMRVLFLI------------------ 256
             Y +  DIWS+G I A E+  G+P    +SE+     LF I                  
Sbjct: 174 KHYSTAVDIWSVGCIFA-EMITGKPLFPGDSEIDQ---LFKIFQILGTPTEESWPGVTKL 229

Query: 257 ----------PKNNPPQLTGNYTKQFKEFVEACLNKDPENRPTAKELLKFPFI 299
                     P  +  ++      +  + +   L  +P  R +AKE LK P+ 
Sbjct: 230 PDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score =  155 bits (394), Expect = 2e-43
 Identities = 85/256 (33%), Positives = 125/256 (48%), Gaps = 20/256 (7%)

Query: 59  FTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAED-EIEDIQQEIMVLSQCDSPY- 116
           F   +++GKGS+G V+K       Q  A+K +DL      E ED   EI +L+  + P  
Sbjct: 2   FKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNI 61

Query: 117 ---------GTKLWIIMEYLGGGSALDLMKAGN-----FEEMHIAVILREVLKGLDYLHS 162
                    G KL I+MEY   G     +           E  I  I  ++L+GL  LH 
Sbjct: 62  ISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHE 121

Query: 163 ERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYD 222
           ++ LHRD+K+AN+LL     VK+ D G++  L    +K  T +GTP +MAPEV K   Y 
Sbjct: 122 QKILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAK--TQIGTPHYMAPEVWKGRPYS 179

Query: 223 SKADIWSLGITAIELAKGEPPNSELHPMRVLFL-IPKNNPPQLTGNYTKQFKEFVEACLN 281
            K+DIWSLG    E+A   PP  E   M+ L   + +   P +   Y++  + F+ + L 
Sbjct: 180 YKSDIWSLGCLLYEMATFAPP-FEARSMQDLRYKVQRGKYPPIPPIYSQDLQNFIRSMLQ 238

Query: 282 KDPENRPTAKELLKFP 297
             P+ RP   ++L  P
Sbjct: 239 VKPKLRPNCDKILASP 254

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score =  155 bits (394), Expect = 5e-43
 Identities = 93/265 (35%), Positives = 147/265 (55%), Gaps = 29/265 (10%)

Query: 65  IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTKLW--- 121
           +G G+ G V K     T  V+A K++ +       + I +E+ ++ +C SPY    +   
Sbjct: 13  LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAF 72

Query: 122 -------IIMEYLGGGSALD--LMKAGNFEEMHIAVILREVLKGLDYLHSE-RKLHRDIK 171
                  + ME++  GS LD    K G      +  I   V++GL YL++  R +HRDIK
Sbjct: 73  LNENNICMCMEFMDCGS-LDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIK 131

Query: 172 AANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLG 231
            +N+L++  G +KL DFGV+G L N+ +  +TFVGT  +M+PE I+   Y  K+D+WSLG
Sbjct: 132 PSNILVNSRGQIKLCDFGVSGELINSIA--DTFVGTSTYMSPERIQGGKYTVKSDVWSLG 189

Query: 232 ITAIELAKGEPP--------NSELHPMRVLFL---IPKNNPPQL-TGNYTKQFKEFVEAC 279
           I+ IELA G+ P        + +  PM +L L   I +  PP+L + ++ +  ++FV+AC
Sbjct: 190 ISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSDFPEDLRDFVDAC 249

Query: 280 LNKDPENRPTAKELLKF-PFIRKAK 303
           L KDP  RPT ++L    PFI+  +
Sbjct: 250 LLKDPTERPTPQQLCAMPPFIQALR 274

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  157 bits (398), Expect = 7e-43
 Identities = 104/385 (27%), Positives = 164/385 (42%), Gaps = 42/385 (10%)

Query: 59  FTKQERIGKGSFGEVFKGIDNRTQQVVAIKII--DLEEAEDEIEDIQQEIMVLSQCDSP- 115
           +    ++G+GSFGEV+   D +    VA+K++   LE    E+E   +EI +L+  + P 
Sbjct: 2   YRILRKLGEGSFGEVYLARDRKL---VALKVLAKKLESKSKEVERFLREIQILASLNHPP 58

Query: 116 ----------YGTKLWIIMEYLGGGSALDLMK----AGNFEEMHIAVILREVLKGLDYLH 161
                         L+++MEY+ GGS  DL+K     G   E     IL ++L  L+YLH
Sbjct: 59  NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH 118

Query: 162 SERKLHRDIKAANVLLSEMGD-VKLADFGVAGTLTNTTSKR------NTFVGTPFWMAPE 214
           S+  +HRDIK  N+LL   G  VKL DFG+A  L +  S        +T VGTP +MAPE
Sbjct: 119 SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPE 178

Query: 215 VIKQS---AYDSKADIWSLGITAIELAKGEPP----NSELHPMRVLFLIPKNNPPQLTGN 267
           V+         S +DIWSLGIT  EL  G PP     +     + L +I +   P L   
Sbjct: 179 VLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASP 238

Query: 268 YTK--------QFKEFVEACLNKDPENRPTAKELLKFPFIRKAKKNAYLIDLIDRYKKWK 319
            +            + ++  L KDP+NR ++   L    +   K     +  + +     
Sbjct: 239 LSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKLKESDLSDLLKPDDSA 298

Query: 320 NSRNEESETESETSDNEDSIKTDGDLDEPWIMTVKGKMPNEYGSSPNKKSGGMNGADNIV 379
             R     +      + +S+   G   +        ++     SS    S  +  +    
Sbjct: 299 PLRLSLPPSLEALISSLNSLAISGSDLKLDDSNFSKELAPNGVSSSPHNSSSLLLSTASS 358

Query: 380 NNNNLNNNNNHATFISSSEKSHSPA 404
             ++L   +  ++  S S  S   A
Sbjct: 359 KRSSLPKISARSSPSSLSSSSRQQA 383

Length = 384

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  153 bits (389), Expect = 1e-42
 Identities = 74/257 (28%), Positives = 128/257 (49%), Gaps = 22/257 (8%)

Query: 60  TKQERIGKGSFGEVFKGI----DNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSP 115
           T  +++G+G+FGEV+KG       + +  VA+K +  + +E +IE+  +E  ++ + D P
Sbjct: 2   TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHP 61

Query: 116 -----YG-----TKLWIIMEYLGGGSALDLMKA--GNFEEMHIAVILREVLKGLDYLHSE 163
                 G       L+I+MEY+ GG  L  ++          +     ++ +G++YL S+
Sbjct: 62  NVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLESK 121

Query: 164 RKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPF---WMAPEVIKQSA 220
             +HRD+ A N L+ E   VK++DFG++  L +    R    G      WMAPE +K+  
Sbjct: 122 NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKR--GGKLPIRWMAPESLKEGK 179

Query: 221 YDSKADIWSLGITAIELA-KGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEAC 279
           + SK+D+WS G+   E+   GE P   +    VL  +          N   +  + +  C
Sbjct: 180 FTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYLKNGYRLPQPPNCPPELYDLMLQC 239

Query: 280 LNKDPENRPTAKELLKF 296
             +DPE+RPT  EL++ 
Sbjct: 240 WAEDPEDRPTFSELVEI 256

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score =  153 bits (388), Expect = 2e-42
 Identities = 80/267 (29%), Positives = 143/267 (53%), Gaps = 25/267 (9%)

Query: 59  FTKQERIGKGSFGEVFKGIDNRTQQVVAIKII-----DLEEAEDEIEDIQQEIMVLSQCD 113
           + K +++G G+F   ++  D +T  ++A+K +        E E+ +E +++EI ++++ +
Sbjct: 2   WLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLN 61

Query: 114 SPYGTKLW----------IIMEYLGGGS-ALDLMKAGNFEEMHIAVILREVLKGLDYLHS 162
            P+  ++           + +E++ GGS +  L K G F+E  I     ++L+GL YLH 
Sbjct: 62  HPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHE 121

Query: 163 ERKLHRDIKAANVLLSEMG-DVKLADFGVAGTLTNTTSKRNTF----VGTPFWMAPEVIK 217
            + +HRD+K AN+L+   G  +++ADFG A  L    +    F    +GT  +MAPEV++
Sbjct: 122 NQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLR 181

Query: 218 QSAYDSKADIWSLGITAIELAKGEPP-NSELHP--MRVLFLIP-KNNPPQLTGNYTKQFK 273
              Y    D+WS+G   IE+A  +PP N+E H   + ++F I      P +  + +   +
Sbjct: 182 GEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSPGLR 241

Query: 274 EFVEACLNKDPENRPTAKELLKFPFIR 300
           +    CL   PE+RP ++ELLK P  R
Sbjct: 242 DVTLRCLELQPEDRPPSRELLKHPVFR 268

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  151 bits (385), Expect = 5e-42
 Identities = 78/259 (30%), Positives = 136/259 (52%), Gaps = 25/259 (9%)

Query: 60  TKQERIGKGSFGEVFKGI----DNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSP 115
           T  +++G+G+FGEV+KG      +  +  VA+K +  + +E +IE+  +E  ++ + D P
Sbjct: 2   TLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHP 61

Query: 116 -----YG-----TKLWIIMEYLGGGSALDLMKAGNFEEMHIAVILR---EVLKGLDYLHS 162
                 G       L I+MEY+ GG  LD ++    +E+ ++ +L    ++ +G++YL S
Sbjct: 62  NIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLES 121

Query: 163 ERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTP-FWMAPEVIKQSAY 221
           +  +HRD+ A N L+ E   VK++DFG++  L +    +      P  WMAPE +K+  +
Sbjct: 122 KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESLKEGKF 181

Query: 222 DSKADIWSLGITAIELA-KGEPPNSELHPMRVLFLIPKNN---PPQLTGNYTKQFKEFVE 277
            SK+D+WS G+   E+   GE P   +    VL  + K      P    N   +  + + 
Sbjct: 182 TSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEYLKKGYRLPKPP---NCPPELYKLML 238

Query: 278 ACLNKDPENRPTAKELLKF 296
            C  +DPE+RPT  EL++ 
Sbjct: 239 QCWAEDPEDRPTFSELVEI 257

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score =  149 bits (378), Expect = 4e-41
 Identities = 92/257 (35%), Positives = 138/257 (53%), Gaps = 26/257 (10%)

Query: 65  IGKGSFGEVFKGIDNRTQQVVAIKIIDLE----EAEDEIEDIQQEIMVLSQ--------- 111
           +G+G+FG V+   D  T + +A K +  +    E   E+  ++ EI +L           
Sbjct: 10  LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQY 69

Query: 112 --CDSPYGTK-LWIIMEYLGGGSALDLMKA-GNFEEMHIAVILREVLKGLDYLHSERKLH 167
             C      K L I MEY+ GGS  D +KA G   E       R++L+G+ YLHS   +H
Sbjct: 70  YGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVH 129

Query: 168 RDIKAANVLLSEMGDVKLADFGVAG---TLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSK 224
           RDIK AN+L    G+VKL DFG +    T+  + +   +  GTP+WM+PEVI    Y  K
Sbjct: 130 RDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRK 189

Query: 225 ADIWSLGITAIELAKGEPPNSELHPMRVLFLI---PKNNPPQLTGNYTKQFKEFVEACLN 281
           AD+WSLG T +E+   +PP +E   M  +F I   P N  PQL  + ++  ++F+  C+ 
Sbjct: 190 ADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTN--PQLPSHISEHARDFL-GCIF 246

Query: 282 KDPENRPTAKELLKFPF 298
            +  +RP+A+ELL+ PF
Sbjct: 247 VEARHRPSAEELLRHPF 263

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score =  149 bits (378), Expect = 1e-40
 Identities = 87/261 (33%), Positives = 136/261 (52%), Gaps = 31/261 (11%)

Query: 65  IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQC-DSPY------- 116
           IG G+ G+V+K    +T  V+A+K +     ++E + I  ++ V+ +  D PY       
Sbjct: 23  IGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGY 82

Query: 117 ---GTKLWIIMEYLGGGSALDLMKA---GNFEEMHIAVILREVLKGLDYLHSERK-LHRD 169
               + ++I ME +   + LD +     G   E  +  +   ++K L YL  +   +HRD
Sbjct: 83  FITDSDVFICMELMS--TCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRD 140

Query: 170 IKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVI----KQSAYDSKA 225
           +K +N+LL   G+VKL DFG++G L ++ +K  +  G   +MAPE I        YD +A
Sbjct: 141 VKPSNILLDASGNVKLCDFGISGRLVDSKAKTRS-AGCAAYMAPERIDPPDPNPKYDIRA 199

Query: 226 DIWSLGITAIELAKGEPP----NSELHPMRVLFLIPKNNPPQLTG--NYTKQFKEFVEAC 279
           D+WSLGI+ +ELA G+ P     +E     VL  I +  PP L     ++  F  FV+ C
Sbjct: 200 DVWSLGISLVELATGQFPYKNCKTEF---EVLTKILQEEPPSLPPNEGFSPDFCSFVDLC 256

Query: 280 LNKDPENRPTAKELLKFPFIR 300
           L KD   RP  +ELL+ PFIR
Sbjct: 257 LTKDHRKRPKYRELLQHPFIR 277

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score =  148 bits (376), Expect = 1e-40
 Identities = 80/263 (30%), Positives = 122/263 (46%), Gaps = 31/263 (11%)

Query: 65  IGKGSFGEVFKGIDNRTQQVVAIKIIDLEE--AEDEIEDIQQEIMVLSQCDSPYGTK--- 119
           I KG++G VF      T  + AIK+I   +   +++++ +  E  +LSQ  SPY  K   
Sbjct: 1   ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYY 60

Query: 120 -------LWIIMEYLGGG---SALDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRD 169
                  L+++MEYL GG   S L+ +  G+ +E    + + E++  L+YLHS   +HRD
Sbjct: 61  SFQGKKNLYLVMEYLPGGDLASLLENV--GSLDEDVARIYIAEIVLALEYLHSNGIIHRD 118

Query: 170 IKAANVLLSEMGDVKLADFGV--------AGTLTNTTSKRNTFVGTPFWMAPEVIKQSAY 221
           +K  N+L+   G +KL DFG+           L +   +    VGTP ++APEVI    +
Sbjct: 119 LKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGH 178

Query: 222 DSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKN--NPPQLTGNYTKQFKEFVEAC 279
               D WSLG    E   G PP     P  +   I       P+     + +  + +   
Sbjct: 179 SKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPED-VEVSDEAIDLISKL 237

Query: 280 LNKDPENRPTAK---ELLKFPFI 299
           L  DPE R  AK   E+   PF 
Sbjct: 238 LVPDPEKRLGAKSIEEIKNHPFF 260

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score =  147 bits (374), Expect = 2e-40
 Identities = 84/251 (33%), Positives = 130/251 (51%), Gaps = 18/251 (7%)

Query: 65  IGKGSFGEVFKGIDNRTQ--QVVAIKIIDLEE-AEDEIEDIQQEIMVLSQCDSP-----Y 116
           +GKG+FGE    +  RT+   +V  K ++L   +E E  D   EI++LS    P     Y
Sbjct: 8   LGKGAFGEAT--LYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYY 65

Query: 117 G-----TKLWIIMEYLGGGSALDLM---KAGNFEEMHIAVILREVLKGLDYLHSERKLHR 168
                   L I MEY  GG+  D +   K   FEE  +   L +++  + Y+H    LHR
Sbjct: 66  NHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHR 125

Query: 169 DIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIW 228
           DIK  N+ L++ G +KL DFG++  L +  S   T VGTP++M+PE+ +   Y+ K+DIW
Sbjct: 126 DIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVVGTPYYMSPELCQGVKYNFKSDIW 185

Query: 229 SLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPENRP 288
           +LG    EL   +      +P+ ++  I + N   +   Y+ +    V + L +DPE RP
Sbjct: 186 ALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVVSVYSSELISLVHSLLQQDPEKRP 245

Query: 289 TAKELLKFPFI 299
           TA E+L  P +
Sbjct: 246 TADEVLDQPLL 256

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score =  148 bits (374), Expect = 2e-40
 Identities = 89/256 (34%), Positives = 135/256 (52%), Gaps = 24/256 (9%)

Query: 65  IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQ-----------CD 113
           +GKG++G V+   D  TQ  +AIK I   ++   ++ + +EI + S             D
Sbjct: 16  LGKGTYGIVYAARDLSTQVRIAIKEIPERDSR-YVQPLHEEIALHSYLKHRNIVQYLGSD 74

Query: 114 SPYGTKLWIIMEYLGGGSALDLMKAG----NFEEMHIAVILREVLKGLDYLHSERKLHRD 169
           S  G    I ME + GGS   L+++        E  I    +++L+GL YLH  + +HRD
Sbjct: 75  SENGF-FKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRD 133

Query: 170 IKAANVLLSEM-GDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQS--AYDSKAD 226
           IK  NVL++   G VK++DFG +  L        TF GT  +MAPEVI +    Y + AD
Sbjct: 134 IKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDKGPRGYGAPAD 193

Query: 227 IWSLGITAIELAKGEPPNSEL-HPMRVLFLIP--KNNPPQLTGNYTKQFKEFVEACLNKD 283
           IWSLG T +E+A G+PP  EL  P   +F +   K +P  +  + + + K F+  C   D
Sbjct: 194 IWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPE-IPESLSAEAKNFILRCFEPD 252

Query: 284 PENRPTAKELLKFPFI 299
           P+ R +A +LL+ PF+
Sbjct: 253 PDKRASAHDLLQDPFL 268

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score =  147 bits (374), Expect = 2e-40
 Identities = 81/256 (31%), Positives = 134/256 (52%), Gaps = 20/256 (7%)

Query: 59  FTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAED--EIEDIQQEIMVLSQCDSP- 115
           F  +++IGKG F  V+K I     +VVA+K + + E  D    +D  +EI +L Q D P 
Sbjct: 4   FKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPN 63

Query: 116 ---------YGTKLWIIMEYLGGGSALDLMKAGN-----FEEMHIAVILREVLKGLDYLH 161
                       +L I++E    G    ++K          E  I     ++   L+++H
Sbjct: 64  VIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMH 123

Query: 162 SERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAY 221
           S+R +HRDIK ANV ++  G VKL D G+    ++ T+  ++ VGTP++M+PE I ++ Y
Sbjct: 124 SKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGY 183

Query: 222 DSKADIWSLGITAIELAKGEPP--NSELHPMRVLFLIPKNNPPQLTGN-YTKQFKEFVEA 278
           + K+DIWSLG    E+A  + P    +++   +   I K + P L  + Y+++ ++ V  
Sbjct: 184 NFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYSEELRDLVSR 243

Query: 279 CLNKDPENRPTAKELL 294
           C+N DPE RP    +L
Sbjct: 244 CINPDPEKRPDISYVL 259

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score =  146 bits (370), Expect = 9e-40
 Identities = 76/281 (27%), Positives = 128/281 (45%), Gaps = 53/281 (18%)

Query: 63  ERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE--AEDEIEDIQQEIMVLSQCD-SP---- 115
           + IG+GSF  V    +  T +  AIKI+D  +   E +++ ++ E  VL++ +  P    
Sbjct: 7   KIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIK 66

Query: 116 -YGT-----KLWIIMEYLGGGSALDLM-KAGNFEEMHIAVILREVLKGLDYLHSERKLHR 168
            Y T      L+ ++EY   G  L  + K G+ +E        E+L  L+YLHS+  +HR
Sbjct: 67  LYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHR 126

Query: 169 DIKAANVLLSEMGDVKLADFGVAGTLTNT--------------------TSKRNTFVGTP 208
           D+K  N+LL +   +K+ DFG A  L                         +  +FVGT 
Sbjct: 127 DLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTA 186

Query: 209 FWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPP---NSELHPM-RVL---FLIPKNNP 261
            +++PE++ +      +D+W+LG    ++  G+PP   ++E     ++L   +  P N P
Sbjct: 187 EYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKLEYSFPPNFP 246

Query: 262 PQLTGNYTKQFKEFVEACLNKDPENRPTAK----ELLKFPF 298
           P          K+ +E  L  DP++R        EL   PF
Sbjct: 247 P--------DAKDLIEKLLVLDPQDRLGVNEGYDELKAHPF 279

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score =  144 bits (365), Expect = 5e-39
 Identities = 89/272 (32%), Positives = 134/272 (49%), Gaps = 33/272 (12%)

Query: 59  FTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQC----DS 114
               E +G+G++G V K     T  ++A+K I    A    ++ ++ +M L       D 
Sbjct: 3   LEVIEELGRGAYGVVDKMRHVPTGTIMAVKRI---RATVNSQEQKRLLMDLDISMRSVDC 59

Query: 115 PYGTK----------LWIIMEYLGGGSALD------LMKAGNFEEMHIAVILREVLKGLD 158
           PY             +WI ME +   ++LD        K     E  +  I   ++K L+
Sbjct: 60  PYTVTFYGALFREGDVWICMEVMD--TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALE 117

Query: 159 YLHSERKL-HRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVI- 216
           YLHS+  + HRD+K +NVL++  G VKL DFG++G L ++ +K     G   +MAPE I 
Sbjct: 118 YLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAK-TIDAGCKPYMAPERIN 176

Query: 217 ---KQSAYDSKADIWSLGITAIELAKGEPPNSELH-PMRVLFLIPKNNPPQL-TGNYTKQ 271
               Q  YD K+D+WSLGIT IELA G  P      P + L  + +   PQL    ++ +
Sbjct: 177 PELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQLPAEKFSPE 236

Query: 272 FKEFVEACLNKDPENRPTAKELLKFPFIRKAK 303
           F++FV  CL K+ + RP   ELL+ PF     
Sbjct: 237 FQDFVNKCLKKNYKERPNYPELLQHPFFELHL 268

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score =  144 bits (363), Expect = 5e-39
 Identities = 87/256 (33%), Positives = 135/256 (52%), Gaps = 22/256 (8%)

Query: 65  IGKGSFGEVFKGIDNRTQQVVAIKII----DLEEAEDEIEDIQQEIMVLSQ--------- 111
           +G+G+FGEV+   D  T + +A+K +    D +E   E+  ++ EI +L           
Sbjct: 10  LGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQY 69

Query: 112 ---CDSPYGTKLWIIMEYLGGGSALDLMKA-GNFEEMHIAVILREVLKGLDYLHSERKLH 167
                 P   KL I +EY+ GGS  D +KA G   E       R++L+G+ YLHS   +H
Sbjct: 70  YGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVH 129

Query: 168 RDIKAANVLLSEMGDVKLADFGVAG---TLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSK 224
           RDIK AN+L    G+VKL DFG +    T+  + +   +  GTP+WM+PEVI    Y  K
Sbjct: 130 RDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRK 189

Query: 225 ADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKN-NPPQLTGNYTKQFKEFVEACLNKD 283
           AD+WS+  T +E+   +PP +E   M  +F I      P L    +   ++F++    ++
Sbjct: 190 ADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDGVSDACRDFLKQIFVEE 249

Query: 284 PENRPTAKELLKFPFI 299
            + RPTA+ LL+ PF+
Sbjct: 250 -KRRPTAEFLLRHPFV 264

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score =  144 bits (364), Expect = 7e-39
 Identities = 87/264 (32%), Positives = 132/264 (50%), Gaps = 30/264 (11%)

Query: 65  IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQE---IMVLSQCDSP---YGT 118
           IG+G+FG V K +   +  ++A+K I     E E + +  +   +M  S C      YG 
Sbjct: 12  IGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGA 71

Query: 119 KL-----WIIMEYLGGGSALDLM-------KAGNFEEMHIAVILREVLKGLDYLHSERKL 166
                  WI ME +    +LD               E  +  I    +K L+YL  E K+
Sbjct: 72  LFREGDCWICMELMD--ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKI 129

Query: 167 -HRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQS---AYD 222
            HRD+K +N+LL   G++KL DFG++G L ++ +K     G   +MAPE I  S    YD
Sbjct: 130 IHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAKTRD-AGCRPYMAPERIDPSARDGYD 188

Query: 223 SKADIWSLGITAIELAKGEPPNSELHPMRV-LFLIPKNNPPQLTGN----YTKQFKEFVE 277
            ++D+WSLGIT  E+A G+ P  + + +   L  + K +PP L+ +    ++  F  F+ 
Sbjct: 189 VRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSEEREFSPSFVNFIN 248

Query: 278 ACLNKDPENRPTAKELLKFPFIRK 301
            CL KD   RP  KELL+ PFI+ 
Sbjct: 249 LCLIKDESKRPKYKELLEHPFIKD 272

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score =  142 bits (359), Expect = 2e-38
 Identities = 71/263 (26%), Positives = 123/263 (46%), Gaps = 40/263 (15%)

Query: 65  IGKGSFGEVFKGIDNRTQQVVAIKIIDLEE--AEDEIEDIQQEIMVLSQCDSPYGTKLW- 121
           IGKG+FG+V       T+++ A+K ++ ++   +  + ++  E  +L + + P+   LW 
Sbjct: 8   IGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWY 67

Query: 122 ---------IIMEYLGGGSALDL----MKAGNFEEMHIAVILREVLKGLDYLHSERKLHR 168
                    ++++ L GG   DL     +   F E  +   + E++  L+YLHS+  +HR
Sbjct: 68  SFQDEENMYLVVDLLLGG---DLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHR 124

Query: 169 DIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIW 228
           DIK  N+LL E G V + DF +A  +T   +   +  GTP +MAPEV+ +  Y    D W
Sbjct: 125 DIKPDNILLDEQGHVHITDFNIATKVT-PDTLTTSTSGTPGYMAPEVLCRQGYSVAVDWW 183

Query: 229 SLGITAIELAKGEPP--------NSELHPMRVL--FLIPKNNPPQLTGNYTKQFKEFVEA 278
           SLG+TA E  +G+ P          ++   +     L P     +          + +  
Sbjct: 184 SLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYPATWSTEAI--------DAINK 235

Query: 279 CLNKDPENR--PTAKELLKFPFI 299
            L +DP+ R     K+L   P+ 
Sbjct: 236 LLERDPQKRLGDNLKDLKNHPYF 258

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score =  143 bits (363), Expect = 5e-38
 Identities = 89/287 (31%), Positives = 147/287 (51%), Gaps = 21/287 (7%)

Query: 34  SSISNQCGSTTASRRNSLKVDPELIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLE 93
           SS S+   S++AS              +  RIG G+ G V+K I   T ++ A+K+I   
Sbjct: 51  SSSSSSSSSSSASGSAPSAAKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGN 110

Query: 94  EAEDEIEDIQQEIMVLSQCDSP----------YGTKLWIIMEYLGGGSALDLMKAGNFEE 143
             +     I +EI +L   + P          +  ++ +++E++ GGS   L      +E
Sbjct: 111 HEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGS---LEGTHIADE 167

Query: 144 MHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNT 203
             +A + R++L G+ YLH    +HRDIK +N+L++   +VK+ADFGV+  L  T    N+
Sbjct: 168 QFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNS 227

Query: 204 FVGTPFWMAPEVI----KQSAYDSKA-DIWSLGITAIELAKGEPP---NSELHPMRVLFL 255
            VGT  +M+PE I       AYD  A DIWSLG++ +E   G  P     +     ++  
Sbjct: 228 SVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCA 287

Query: 256 IPKNNPPQLTGNYTKQFKEFVEACLNKDPENRPTAKELLKFPFIRKA 302
           I  + PP+     +++F+ F+  CL ++P  R +A +LL+ PFI +A
Sbjct: 288 ICMSQPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQHPFILRA 334

Length = 353

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score =  139 bits (352), Expect = 2e-37
 Identities = 92/263 (34%), Positives = 138/263 (52%), Gaps = 36/263 (13%)

Query: 65  IGKGSFGEVFKGIDNRTQQVVAIKIIDLE----EAEDEIEDIQQEIMVLSQC-------- 112
           +G+G+FG V+   D  T + +A+K +  +    E   E+  ++ EI +L           
Sbjct: 10  LGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQY 69

Query: 113 -----DSPYGTKLWIIMEYLGGGSALDLMKA-GNFEEMHIAVILREVLKGLDYLHSERKL 166
                D    T L I ME++ GGS  D +K+ G   E       R++L+G+ YLHS   +
Sbjct: 70  YGCLRDPMERT-LSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIV 128

Query: 167 HRDIKAANVLLSEMGDVKLADFGVAGTLTN---TTSKRNTFVGTPFWMAPEVIKQSAYDS 223
           HRDIK AN+L   +G+VKL DFG +  L     + +   +  GTP+WM+PEVI    Y  
Sbjct: 129 HRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGR 188

Query: 224 KADIWSLGITAIELAKGEPPNSELHPMRVLFLI---PKNN--PPQLTGNYTKQF--KEFV 276
           KADIWS+G T +E+   +PP +E   M  +F I   P N   PP ++ ++ + F  + FV
Sbjct: 189 KADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHVS-DHCRDFLKRIFV 247

Query: 277 EACLNKDPENRPTAKELLKFPFI 299
           EA L      RP+A ELL+  F+
Sbjct: 248 EAKL------RPSADELLRHTFV 264

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score =  139 bits (352), Expect = 2e-37
 Identities = 88/258 (34%), Positives = 127/258 (49%), Gaps = 22/258 (8%)

Query: 62  QERIGKGSFGEVFKGIDNRTQQVVAIKIIDL----EEAEDEIEDIQQEIMVLSQCDSPYG 117
           Q+R+GKGSFG V+   D +      +K++      E   +E     QE  +LS+ D P  
Sbjct: 5   QQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAI 64

Query: 118 TKLW----------IIMEYLGGGSALD-----LMKAGN-FEEMHIAVILREVLKGLDYLH 161
            K            II EY  G   LD     L   G    E  +     ++L G+ Y+H
Sbjct: 65  VKFHASFLERDAFCIITEYCEGRD-LDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMH 123

Query: 162 SERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAY 221
             R LHRD+KA N+ L     +K+ DFGV+  L  +     TF GTP++M+PE +K   Y
Sbjct: 124 QRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGSCDLATTFTGTPYYMSPEALKHQGY 182

Query: 222 DSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLN 281
           DSK+DIWSLG    E+          + + V+  I +   P L   Y++Q    +++ LN
Sbjct: 183 DSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPSLPETYSRQLNSIMQSMLN 242

Query: 282 KDPENRPTAKELLKFPFI 299
           KDP  RP+A E+L+ PFI
Sbjct: 243 KDPSLRPSAAEILRNPFI 260

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score =  138 bits (350), Expect = 9e-37
 Identities = 79/291 (27%), Positives = 137/291 (47%), Gaps = 54/291 (18%)

Query: 59  FTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQ--QEIMVLSQCDSPY 116
           + K  +IG+G++G+V+K  + +T ++VA+K I +E  ++    I   +EI +L +   P 
Sbjct: 1   YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGF-PITAIREIKLLQKLRHPN 59

Query: 117 GTKL------------WIIMEY----LGGGSALDLMKAGNFEEMHIAVILREVLKGLDYL 160
             +L            +++ EY    L G   L       F E  I   ++++L+GL YL
Sbjct: 60  IVRLKEIVTSKGKGSIYMVFEYMDHDLTG---LLDSPEVKFTESQIKCYMKQLLEGLQYL 116

Query: 161 HSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTF-VGTPFWMAPEVI-KQ 218
           HS   LHRDIK +N+L++  G +KLADFG+A   T   S   T  V T ++  PE++   
Sbjct: 117 HSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPELLLGA 176

Query: 219 SAYDSKADIWSLGITAIELAKGEPP---NSELHPMRVLF---------------LIPKNN 260
           + Y  + D+WS+G    EL  G+P    ++EL  +  +F                +P   
Sbjct: 177 TRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFE 236

Query: 261 PPQLTGNYTKQFKEF------------VEACLNKDPENRPTAKELLKFPFI 299
             +    Y ++ +EF            ++  L  DP+ R +A + L+  + 
Sbjct: 237 NLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score =  136 bits (345), Expect = 2e-36
 Identities = 77/248 (31%), Positives = 111/248 (44%), Gaps = 35/248 (14%)

Query: 65  IGKGSFGEVFKGIDNRTQQVVAIKII--------DLEEAEDEIEDIQQEIMVLSQCDSPY 116
           +G G FG V         +  A+K +          +E       I  E  +L +C+ P+
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQE------HIFSEKEILEECNHPF 54

Query: 117 GTKL----------WIIMEYLGGGSALDLM-KAGNFEEMHIAVILREVLKGLDYLHSERK 165
             KL          +++MEY  GG    ++   G F+E      +  V+   +YLH+   
Sbjct: 55  IVKLYRTFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGI 114

Query: 166 LHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKA 225
           ++RD+K  N+LL   G VKL DFG A  L +   K  TF GTP ++APE+I    YD   
Sbjct: 115 IYRDLKPENLLLDSNGYVKLVDFGFAKKLKSG-QKTWTFCGTPEYVAPEIILNKGYDFSV 173

Query: 226 DIWSLGITAIELAKGEPP--NSELHPMRVLFLIPKNNP----PQLTGNYTKQFKEFVEAC 279
           D WSLGI   EL  G PP    +  PM +   I K N     P       K  K+ ++  
Sbjct: 174 DYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPN---YIDKAAKDLIKQL 230

Query: 280 LNKDPENR 287
           L ++PE R
Sbjct: 231 LRRNPEER 238

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score =  136 bits (344), Expect = 5e-36
 Identities = 78/279 (27%), Positives = 123/279 (44%), Gaps = 43/279 (15%)

Query: 63  ERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIED-IQQEIMVLSQCDSPY----- 116
            RIG+G+ G VFK  D  T + VA+K + L   E  I +   +EI  L  C  PY     
Sbjct: 6   GRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLL 65

Query: 117 -----GTKLWIIMEYLGGGSALDLMKAGN-FEEMHIAVILREVLKGLDYLHSERKLHRDI 170
                G+   ++MEY+    +  L        E  +   +R +LKG+ Y+H+   +HRD+
Sbjct: 66  DVFPHGSGFVLVMEYMPSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDL 125

Query: 171 KAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTF-VGTPFWMAPEVI-KQSAYDSKADIW 228
           K AN+L+S  G +K+ADFG+A   +    +  +  V T ++ APE++     YD   D+W
Sbjct: 126 KPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARKYDPGVDLW 185

Query: 229 SLGITAIELAKGEP--------------------PNSELHP-MRVLFLIPK----NNPPQ 263
           ++G    EL  G P                    PN E  P +  L    K     + P 
Sbjct: 186 AVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKITFPESKPI 245

Query: 264 LTGNY----TKQFKEFVEACLNKDPENRPTAKELLKFPF 298
                    + +  + ++  L  DP  R +A E L+ P+
Sbjct: 246 PLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPY 284

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score =  134 bits (339), Expect = 1e-35
 Identities = 79/255 (30%), Positives = 133/255 (52%), Gaps = 21/255 (8%)

Query: 63  ERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAE-DEIEDIQQEIMVLSQCDSP------ 115
           ++IG+GSFG+++        +   IK IDL +    E E  ++E+++L++   P      
Sbjct: 6   KKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFF 65

Query: 116 ----YGTKLWIIMEYLGGGSALDLMKAGN------FEEMHIAVILREVLKGLDYLHSERK 165
                  +L+I+MEY  GG   DLMK  N      F E  I     ++  GL ++H  + 
Sbjct: 66  ASFQENGRLFIVMEYCDGG---DLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKI 122

Query: 166 LHRDIKAANVLLSEMGDV-KLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSK 224
           LHRDIK+ N+ LS+ G V KL DFG+A  L ++     T VGTP++++PE+ +   Y++K
Sbjct: 123 LHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEICQNRPYNNK 182

Query: 225 ADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDP 284
            DIWSLG    EL   + P    +  +++  I +     ++ N+++  +  +       P
Sbjct: 183 TDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPISPNFSRDLRSLISQLFKVSP 242

Query: 285 ENRPTAKELLKFPFI 299
            +RP+   +LK PF+
Sbjct: 243 RDRPSITSILKRPFL 257

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score =  134 bits (338), Expect = 6e-35
 Identities = 95/303 (31%), Positives = 153/303 (50%), Gaps = 61/303 (20%)

Query: 59  FTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGT 118
           F K   +G G+ G VFK     +  ++A K+I LE        I +E+ VL +C+SPY  
Sbjct: 7   FEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 66

Query: 119 KLW----------IIMEYLGGGSALD--LMKAGNFEEMHIAVILREVLKGLDYLHSERK- 165
             +          I ME++ GGS LD  L KAG   E  +  +   V+KGL YL  + K 
Sbjct: 67  GFYGAFYSDGEISICMEHMDGGS-LDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKI 125

Query: 166 LHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKA 225
           +HRD+K +N+L++  G++KL DFGV+G L ++ +  N+FVGT  +M+PE ++ + Y  ++
Sbjct: 126 MHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA--NSFVGTRSYMSPERLQGTHYSVQS 183

Query: 226 DIWSLGITAIELA----------------------KGEPPNSELHP-------------- 249
           DIWS+G++ +E+A                      +G+P  SE  P              
Sbjct: 184 DIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGRPLSSYGP 243

Query: 250 --------MRVLFLIPKNNPPQL-TGNYTKQFKEFVEACLNKDPENRPTAKELLKFPFIR 300
                     +L  I    PP+L +G +  +F++FV  CL K+P  R   K+L+   FI+
Sbjct: 244 DSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIK 303

Query: 301 KAK 303
           +++
Sbjct: 304 RSE 306

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score =  133 bits (336), Expect = 6e-35
 Identities = 80/284 (28%), Positives = 128/284 (45%), Gaps = 44/284 (15%)

Query: 59  FTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQ-QEIMVLSQCDSPY- 116
           + K  +IG+G++G V+K  D  T ++VAIK I L    + I     +EI +L + + P  
Sbjct: 1   YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNI 60

Query: 117 ---------GTKLWIIMEYLGGGSALDLMKAGN--FEEMHIAVILREVLKGLDYLHSERK 165
                       L+++ E++       L+K       E  I   L ++L+GL + HS   
Sbjct: 61  IKLLDVFRHKGDLYLVFEFMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGI 119

Query: 166 LHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVI-KQSAYDSK 224
           LHRD+K  N+L++  G +KLADFG+A +  +       +V T ++ APE++     Y + 
Sbjct: 120 LHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDKGYSTP 179

Query: 225 ADIWSLGITAIELAKGEP--------------------PNSELHP-----MR-VLFLIPK 258
            DIWS+G    EL    P                    P+ E+ P      R   F  PK
Sbjct: 180 VDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSFPK 239

Query: 259 NNP---PQLTGNYTKQFKEFVEACLNKDPENRPTAKELLKFPFI 299
                 P+L  N + Q  + +   L+ DP  R TA++ L  P+ 
Sbjct: 240 KAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score =  134 bits (340), Expect = 7e-35
 Identities = 89/364 (24%), Positives = 150/364 (41%), Gaps = 85/364 (23%)

Query: 59  FTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA--EDEIEDIQQEIMVLSQCDSPY 116
           F   + IG+G+FGEV+   D  T QV A+K++   +    ++I  ++ E  +L+  DSP+
Sbjct: 3   FEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPW 62

Query: 117 GTKL----------WIIMEYLGGGSALDLM----KAGNFEEMHIAVILREVLKGLDYLHS 162
             KL          +++MEY+ GG   DLM    +   F E      + E++  LD +H 
Sbjct: 63  IVKLYYSFQDEEHLYLVMEYMPGG---DLMNLLIRKDVFPEETARFYIAELVLALDSVHK 119

Query: 163 ERKLHRDIKAANVLLSEMGDVKLADFGVA-----------------------------GT 193
              +HRDIK  N+L+   G +KLADFG+                                
Sbjct: 120 LGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRD 179

Query: 194 LTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPP----NSELHP 249
                 + N+ VGTP ++APEV++ + Y  + D WSLG+   E+  G PP      +   
Sbjct: 180 HKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQETY 239

Query: 250 MRVL-----FLIPKNNPPQLTGNYTKQFKEFVEACLNKDPENR-PTAKELLKFPFIRKAK 303
            +++        P + P       + +  + +   L  DPE+R  + +E+   PF +   
Sbjct: 240 NKIINWKESLRFPPDPP------VSPEAIDLICRLL-CDPEDRLGSFEEIKSHPFFKG-- 290

Query: 304 KNAYLIDLIDRYKKWKNSRNEES------ETESETSDNEDSIKTDGDLDEPWIMTVKGKM 357
                ID       W+N R  +        +  +TS+ +D        D     + K   
Sbjct: 291 -----ID-------WENLRETKPPFVPELSSPLDTSNFDDFEDDKDLSDYLSQNSKKLNK 338

Query: 358 PNEY 361
             + 
Sbjct: 339 GKQL 342

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score =  129 bits (327), Expect = 1e-33
 Identities = 79/286 (27%), Positives = 133/286 (46%), Gaps = 47/286 (16%)

Query: 59  FTKQERIGKGSFGEVFKGIDNRTQQVVAIK-IIDLEEAEDEIEDIQQEIMVLSQCDSP-- 115
           +     +G+G++G V K  +  T ++VAIK   + E+ ED  +   +E+ VL Q      
Sbjct: 3   YEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENI 62

Query: 116 --------YGTKLWIIMEYLGGGSALDLMKA--GNFEEMHIAVILREVLKGLDYLHSERK 165
                      +L+++ EY+   + L+L++A  G      +   + ++L+ + Y HS   
Sbjct: 63  VNLKEAFRRKGRLYLVFEYVER-TLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNI 121

Query: 166 LHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNT-FVGTPFWMAPEV-IKQSAYDS 223
           +HRDIK  N+L+SE G +KL DFG A  L    +   T +V T ++ APE+ +  + Y  
Sbjct: 122 IHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTNYGK 181

Query: 224 KADIWSLGITAIELAKGEP--P-NSEL----HPMRVL----------F----------LI 256
             D+W++G    EL  GEP  P +S++       + L          F            
Sbjct: 182 PVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVAFP 241

Query: 257 PKNNPPQLTGNYTKQFK----EFVEACLNKDPENRPTAKELLKFPF 298
             + P  L   Y  +      +F++ACL  DP+ R T  ELL+ P+
Sbjct: 242 EPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPY 287

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score =  127 bits (321), Expect = 3e-33
 Identities = 79/261 (30%), Positives = 134/261 (51%), Gaps = 26/261 (9%)

Query: 59  FTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEI--EDIQQEIMVLSQCDSPY 116
           F  +++IG+G F EV++      ++ VA+K + + E  D    +D  +EI +L Q + P 
Sbjct: 4   FQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPN 63

Query: 117 GTK----------LWIIMEYLGGGSALDLMKAGNFEEMHIAVILREVLK-------GLDY 159
             K          L I++E    G    ++K   F++    +  R V K        +++
Sbjct: 64  VIKYLDSFIEDNELNIVLELADAGDLSQMIK--YFKKQKRLIPERTVWKYFVQLCSAVEH 121

Query: 160 LHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQS 219
           +HS R +HRDIK ANV ++  G VKL D G+    ++ T+  ++ VGTP++M+PE I ++
Sbjct: 122 MHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHEN 181

Query: 220 AYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPK----NNPPQLTGNYTKQFKEF 275
            Y+ K+DIWSLG    E+A  + P      M +  L  K    + PP  T +Y+++ +E 
Sbjct: 182 GYNFKSDIWSLGCLLYEMAALQSPFYG-DKMNLFSLCQKIEQCDYPPLPTEHYSEKLREL 240

Query: 276 VEACLNKDPENRPTAKELLKF 296
           V  C+  DP+ RP    + + 
Sbjct: 241 VSMCIYPDPDQRPDIGYVHQI 261

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score =  127 bits (322), Expect = 6e-33
 Identities = 67/239 (28%), Positives = 109/239 (45%), Gaps = 23/239 (9%)

Query: 65  IGKGSFGEVFKGIDNRTQQVVAIKIIDLEE--AEDEIEDIQQEIMVLSQCDSPYGTKLW- 121
           +G GSFG V       + +  A+KI+   +     ++E +  E  +L     P+   L+ 
Sbjct: 9   LGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYG 68

Query: 122 ---------IIMEYLGGGSALDLM-KAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIK 171
                    ++MEY+ GG     + K+G F E        +V+  L+YLHS   ++RD+K
Sbjct: 69  SFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLK 128

Query: 172 AANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLG 231
             N+LL   G +K+ DFG A  +   T    T  GTP ++APE+I    Y    D W+LG
Sbjct: 129 PENLLLDSDGYIKITDFGFAKRVKGRTY---TLCGTPEYLAPEIILSKGYGKAVDWWALG 185

Query: 232 ITAIELAKGEPPNSELHPMRVLFLIPKNN---PPQLTGNYTKQFKEFVEACLNKDPENR 287
           I   E+  G PP  + +P+++   I +     P      ++   K+ +   L  D   R
Sbjct: 186 ILIYEMLAGYPPFFDDNPIQIYEKILEGKVRFPS----FFSPDAKDLIRNLLQVDLTKR 240

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score =  125 bits (316), Expect = 1e-32
 Identities = 72/243 (29%), Positives = 127/243 (52%), Gaps = 13/243 (5%)

Query: 65  IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPY-------- 116
           +G+GSFG         + Q  A+K I L ++   +ED ++E ++L++   P         
Sbjct: 8   VGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESF 67

Query: 117 --GTKLWIIMEYLGGGSALDLMKAGN---FEEMHIAVILREVLKGLDYLHSERKLHRDIK 171
                L+I+MEY  GG  +  +K      F E  I     ++  G+ ++H +R LHRDIK
Sbjct: 68  EADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIK 127

Query: 172 AANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLG 231
           + N+ L++ G VKL DFG A  LT+  +   T+VGTP+++ PE+ +   Y++K+DIWSLG
Sbjct: 128 SKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEIWENMPYNNKSDIWSLG 187

Query: 232 ITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPENRPTAK 291
               EL   + P        ++  + + +   L  +Y+ + +  ++    ++P +RP+A 
Sbjct: 188 CILYELCTLKHPFQANSWKNLILKVCQGSYKPLPSHYSYELRSLIKQMFKRNPRSRPSAT 247

Query: 292 ELL 294
            +L
Sbjct: 248 TIL 250

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score =  125 bits (316), Expect = 1e-32
 Identities = 73/250 (29%), Positives = 120/250 (48%), Gaps = 15/250 (6%)

Query: 65  IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAED-EIEDIQQEIMVLSQCDSPY------- 116
           +GKGS+GEV         +   IK ++L  A   E +  +QE  +LSQ   P        
Sbjct: 8   VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRES 67

Query: 117 ----GTKLWIIMEYLGGGS---ALDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRD 169
                  L+I+M +  GG     L   K     E  +     ++   L YLH +  LHRD
Sbjct: 68  WEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRD 127

Query: 170 IKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWS 229
           +K  NV L+    +K+ D G+A  L N     +T +GTP++M+PE+     Y+ K+D+W+
Sbjct: 128 LKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPELFSNKPYNYKSDVWA 187

Query: 230 LGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPENRPT 289
           LG    E+A  +   +      +++ I +   P +  +Y+ +  E +   L+K PE RP+
Sbjct: 188 LGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPPMPKDYSPELGELIATMLSKRPEKRPS 247

Query: 290 AKELLKFPFI 299
            K +L+ P+I
Sbjct: 248 VKSILRQPYI 257

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score =  127 bits (320), Expect = 2e-32
 Identities = 82/260 (31%), Positives = 131/260 (50%), Gaps = 30/260 (11%)

Query: 65  IGKGSFGEVFKGIDNRTQQVVAIKII--DLEEAEDEIEDIQQEIMVLSQCDSP------- 115
           +GKGSFG+V       T ++ A+K++  D+   +D++E    E  VL+            
Sbjct: 3   LGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLH 62

Query: 116 --YGTK--LWIIMEYLGGGSALDLM----KAGNFEEMHIAVILREVLKGLDYLHSERKLH 167
             + TK  L+ +MEY+ GG   DLM    ++G F+E        E++ GL +LH    ++
Sbjct: 63  SCFQTKDRLFFVMEYVNGG---DLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIY 119

Query: 168 RDIKAANVLLSEMGDVKLADFGVA--GTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKA 225
           RD+K  NVLL   G +K+ADFG+   G L   T+  +TF GTP ++APE++    Y    
Sbjct: 120 RDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTT--STFCGTPDYIAPEILSYQPYGPAV 177

Query: 226 DIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPE 285
           D W+LG+   E+  G+ P  E      LF     +  +     +K+ K  +++ L K+PE
Sbjct: 178 DWWALGVLLYEMLAGQSP-FEGDDEDELFQSILEDEVRYPRWLSKEAKSILKSFLTKNPE 236

Query: 286 NR----PTAK-ELLKFPFIR 300
            R    PT + ++   PF R
Sbjct: 237 KRLGCLPTGEQDIKGHPFFR 256

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score =  125 bits (314), Expect = 3e-32
 Identities = 79/254 (31%), Positives = 134/254 (52%), Gaps = 28/254 (11%)

Query: 59  FTKQERIGKGSFGEVFKG---IDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSP 115
           F  +++IG+G F EV++    +D     +  ++I DL +A+    D  +EI +L Q + P
Sbjct: 4   FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKAR-ADCIKEIDLLKQLNHP 62

Query: 116 YGTK----------LWIIMEYLGGGSALDLMKAGNFEEMHIAVILREVLK-------GLD 158
              K          L I++E    G    ++K  +F++    +  + V K        L+
Sbjct: 63  NVIKYYASFIEDNELNIVLELADAGDLSRMIK--HFKKQKRLIPEKTVWKYFVQLCSALE 120

Query: 159 YLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQ 218
           ++HS R +HRDIK ANV ++  G VKL D G+    ++ T+  ++ VGTP++M+PE I +
Sbjct: 121 HMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHE 180

Query: 219 SAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPK----NNPPQLTGNYTKQFKE 274
           + Y+ K+DIWSLG    E+A  + P      M +  L  K    + PP  + +Y+++ ++
Sbjct: 181 NGYNFKSDIWSLGCLLYEMAALQSPFYG-DKMNLYSLCKKIEQCDYPPLPSDHYSEELRQ 239

Query: 275 FVEACLNKDPENRP 288
            V  C+N DPE RP
Sbjct: 240 LVNMCINPDPEKRP 253

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score =  125 bits (316), Expect = 4e-32
 Identities = 78/297 (26%), Positives = 129/297 (43%), Gaps = 72/297 (24%)

Query: 59  FTKQERIGKGSFGEVFKGIDNRTQQVVAIKII-----DLEE--AEDEIEDIQQ------- 104
           +   +++G G+FG V+   +  T ++VAIK +       EE     E++ +++       
Sbjct: 1   YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNI 60

Query: 105 ----EIMVLSQCDSPYGTKLWIIMEYLGGGSALDLMKAGN---FEEMHIAVILREVLKGL 157
               E+   +         L+ + EY+ G +   LMK      F E  I  I+ ++L+GL
Sbjct: 61  VKLKEVFRENDE-------LYFVFEYMEG-NLYQLMKDRKGKPFSESVIRSIIYQILQGL 112

Query: 158 DYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTF---VGTPFWMAPE 214
            ++H     HRD+K  N+L+S    VK+ADFG+A  + +    R  +   V T ++ APE
Sbjct: 113 AHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRS----RPPYTDYVSTRWYRAPE 168

Query: 215 VIKQSA-YDSKADIWSLGITAIELAKGEP--P-NSELHPMRVLFLI------PKNNP--- 261
           ++ +S  Y S  DIW+LG    EL    P  P +SE+     L+ I      P       
Sbjct: 169 ILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQ---LYKICSVLGTPTKQDWPE 225

Query: 262 ------------PQLTGNYTKQFK--------EFVEACLNKDPENRPTAKELLKFPF 298
                       PQ       Q          + ++  L  DP+ RPTA + L+ P+
Sbjct: 226 GYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPY 282

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score =  123 bits (311), Expect = 2e-31
 Identities = 77/283 (27%), Positives = 133/283 (46%), Gaps = 48/283 (16%)

Query: 63  ERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEI-EDIQQEIMVLSQCDS---PY-- 116
             IG+G++G V+K  D  T + VA+K + +  +E+ I     +EI +L Q +S   P   
Sbjct: 5   AEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIV 64

Query: 117 -------------GTKLWIIMEYLGGGSALDLMK--AGNFEEMHIAVILREVLKGLDYLH 161
                          KL ++ E++    A  L K          I  ++R++L+G+D+LH
Sbjct: 65  RLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLH 124

Query: 162 SERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAY 221
           S R +HRD+K  N+L++  G VK+ADFG+A   +       + V T ++ APEV+ QS+Y
Sbjct: 125 SHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSF-EMALTSVVVTLWYRAPEVLLQSSY 183

Query: 222 DSKADIWSLGITAIELAKGEP---PNSELHPMRVLF---------------LIPKNNPPQ 263
            +  D+WS+G    EL +  P     SE   +  +F                +P+++ P 
Sbjct: 184 ATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSLPRSSFPS 243

Query: 264 LTG--------NYTKQFKEFVEACLNKDPENRPTAKELLKFPF 298
            T            ++  + ++  L  +P  R +A E L+ P+
Sbjct: 244 YTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPY 286

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score =  123 bits (310), Expect = 4e-31
 Identities = 91/304 (29%), Positives = 149/304 (49%), Gaps = 61/304 (20%)

Query: 59  FTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGT 118
           F +   +G G+ G V K     +  ++A K+I LE        I +E+ VL +C+SPY  
Sbjct: 7   FERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 66

Query: 119 KLW----------IIMEYLGGGSALDLMK-AGNFEEMHIAVILREVLKGLDYLHSERK-L 166
             +          I ME++ GGS   ++K A    E  +  +   VL+GL YL  + + +
Sbjct: 67  GFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIM 126

Query: 167 HRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKAD 226
           HRD+K +N+L++  G++KL DFGV+G L ++ +  N+FVGT  +M+PE ++ + Y  ++D
Sbjct: 127 HRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA--NSFVGTRSYMSPERLQGTHYSVQSD 184

Query: 227 IWSLGITAIELAKGE----PPNS-----------------ELHPM--------------- 250
           IWS+G++ +ELA G     PP++                 E H +               
Sbjct: 185 IWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPPGRPVSGHG 244

Query: 251 ----------RVLFLIPKNNPPQL-TGNYTKQFKEFVEACLNKDPENRPTAKELLKFPFI 299
                      +L  I    PP+L  G +T  F+EFV  CL K+P  R   K L+   FI
Sbjct: 245 MDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFI 304

Query: 300 RKAK 303
           ++++
Sbjct: 305 KRSE 308

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score =  120 bits (302), Expect = 1e-30
 Identities = 77/259 (29%), Positives = 132/259 (50%), Gaps = 22/259 (8%)

Query: 59  FTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAED-EIEDIQQEIMVLSQCDSP-- 115
           + K ++IG+GSFG+          +   IK I++ +    E E+ ++E+ VLS    P  
Sbjct: 2   YVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNI 61

Query: 116 --------YGTKLWIIMEYLGGGSALDLMKAGN------FEEMHIAVILREVLKGLDYLH 161
                       L+I+M+Y  GG   DL K  N      F E  I     ++   L ++H
Sbjct: 62  VQYQESFEENGNLYIVMDYCEGG---DLYKKINAQRGVLFPEDQILDWFVQICLALKHVH 118

Query: 162 SERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAY 221
             + LHRDIK+ N+ L++ G +KL DFG+A  L +T     T +GTP++++PE+ +   Y
Sbjct: 119 DRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCIGTPYYLSPEICENRPY 178

Query: 222 DSKADIWSLGITAIELAKGEPPNSELHPMRVLFL-IPKNNPPQLTGNYTKQFKEFVEACL 280
           ++K+DIW+LG    E+   +    E   M+ L L I + + P ++ +Y+   +  V    
Sbjct: 179 NNKSDIWALGCVLYEMCTLKHA-FEAGNMKNLVLKIIRGSYPPVSSHYSYDLRNLVSQLF 237

Query: 281 NKDPENRPTAKELLKFPFI 299
            ++P +RP+   +L+  FI
Sbjct: 238 KRNPRDRPSVNSILEKNFI 256

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score =  119 bits (299), Expect = 3e-30
 Identities = 80/258 (31%), Positives = 129/258 (50%), Gaps = 21/258 (8%)

Query: 61  KQERI---GKGSFGEVFKGIDNRTQQVVAIKIIDLEE-AEDEIEDIQQEIMVLSQCDSP- 115
           K E+I   G+G+FG V        Q++V IK I +E+  +DE    Q E  VL     P 
Sbjct: 1   KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPN 60

Query: 116 ---------YGTKLWIIMEYLGGGSALDLM-KAGN--FEEMHIAVILREVLKGLDYLHSE 163
                        L I+MEY  GG+  + + K  N   +E  I     ++L  L ++H++
Sbjct: 61  IIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTK 120

Query: 164 RKLHRDIKAANVLLSEMGDV-KLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYD 222
             LHRD+K  N+LL +   V K+ DFG++  L+ + SK  T VGTP +++PE+ +   Y+
Sbjct: 121 LILHRDLKTQNILLDKHKMVVKIGDFGISKILS-SKSKAYTVVGTPCYISPELCEGKPYN 179

Query: 223 SKADIWSLGITAIELAKGEPP-NSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLN 281
            K+DIW+LG    ELA  +    +   P  VL ++     P ++  Y+   ++ + + LN
Sbjct: 180 QKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAP-ISDRYSPDLRQLILSMLN 238

Query: 282 KDPENRPTAKELLKFPFI 299
            DP  RP   +++  P  
Sbjct: 239 LDPSKRPQLSQIMAQPIC 256

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score =  119 bits (301), Expect = 5e-30
 Identities = 77/287 (26%), Positives = 131/287 (45%), Gaps = 51/287 (17%)

Query: 59  FTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQ----EIMVLSQCDS 114
           + K +++G+G++  V+K  D  T ++VAIK I L E ++  + I      EI +L +   
Sbjct: 2   YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKH 61

Query: 115 P--------YGTK--LWIIMEYLGGGSALDLM-----KAGNFEEMHIAVILREVLKGLDY 159
           P        +G K  + ++ E++      DL      K+       I   +   L+GL+Y
Sbjct: 62  PNIIGLLDVFGHKSNINLVFEFMET----DLEKVIKDKSIVLTPADIKSYMLMTLRGLEY 117

Query: 160 LHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVI-KQ 218
           LHS   LHRD+K  N+L++  G +KLADFG+A +  +   K    V T ++ APE++   
Sbjct: 118 LHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVVTRWYRAPELLFGA 177

Query: 219 SAYDSKADIWSLGITAIELAKGEP--P-NSELHPMRVLFLI-----PKNNPPQLTGNYTK 270
             Y    D+WS+G    EL    P  P +S++  +  +F        +N P   +     
Sbjct: 178 RHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYV 237

Query: 271 QFKEF-------------------VEACLNKDPENRPTAKELLKFPF 298
           +FK F                   ++  L  +P  R TA++ L+ P+
Sbjct: 238 EFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPY 284

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score =  119 bits (299), Expect = 1e-29
 Identities = 82/289 (28%), Positives = 132/289 (45%), Gaps = 46/289 (15%)

Query: 59  FTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIE-DIQQEIMVLSQCDSP-- 115
           F K  RIG+G++G V++  D  + ++VA+K + ++   D I     +EI +L     P  
Sbjct: 9   FEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNI 68

Query: 116 -------YGTKL---WIIMEYLGG--GSALDLMKAGNFEEMHIAVILREVLKGLDYLHSE 163
                   G  L   +++MEY      S LD M    F E  +  ++ ++L+GL YLH  
Sbjct: 69  VELKEVVVGKHLDSIFLVMEYCEQDLASLLDNMPT-PFSESQVKCLMLQLLRGLQYLHEN 127

Query: 164 RKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQS-AYD 222
             +HRD+K +N+LL++ G +K+ADFG+A T           V T ++ APE++     Y 
Sbjct: 128 FIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVVTLWYRAPELLLGCTTYT 187

Query: 223 SKADIWSLGITAIELAKGEP--------------------PNSELHP-MRVLFLIPKNN- 260
           +  D+W++G    EL   +P                    PN  + P    L L+ K   
Sbjct: 188 TAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVGKFTL 247

Query: 261 PPQLTGNYTKQFKEFVEACLN-------KDPENRPTAKELLKFPFIRKA 302
           P Q   N   +F    EA L         DP+ R TA+E L+  + ++ 
Sbjct: 248 PKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEK 296

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score =  119 bits (300), Expect = 2e-29
 Identities = 85/306 (27%), Positives = 143/306 (46%), Gaps = 63/306 (20%)

Query: 62  QERIGKGSFGEVFKGIDNRTQQVVAIK-IIDLEEAEDEIEDIQQ---EIMVLSQ-CDSPY 116
            +++GKG++G V+K ID RT++VVA+K I D   A     D Q+   EIM L +  D P 
Sbjct: 12  LQKLGKGAYGIVWKAIDRRTKEVVALKKIFD---AFRNATDAQRTFREIMFLQELGDHPN 68

Query: 117 GTKL------------WIIMEYLGGGSALDL---MKAGNFEEMHIAVILREVLKGLDYLH 161
             KL            +++ EY+      DL   ++A   E++H   I+ ++LK L Y+H
Sbjct: 69  IVKLLNVIKAENDKDIYLVFEYM----ETDLHAVIRANILEDVHKRYIMYQLLKALKYIH 124

Query: 162 SERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNT-----FVGTPFWMAPEVI 216
           S   +HRD+K +N+LL+    VKLADFG+A +L+             +V T ++ APE++
Sbjct: 125 SGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYRAPEIL 184

Query: 217 KQSAYDSKA-DIWSLGITAIELAKGEP--------------------PNSE----LHP-- 249
             S   +K  D+WS+G    E+  G+P                    P++E    +    
Sbjct: 185 LGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKSPF 244

Query: 250 ----MRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPENRPTAKELLKFPFIRKAKKN 305
               +  L   P+    +L    +    + ++  L  +P  R TA+E L+ P++ +    
Sbjct: 245 AATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQFHNP 304

Query: 306 AYLIDL 311
           +    L
Sbjct: 305 SDEPVL 310

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score =  118 bits (297), Expect = 2e-29
 Identities = 78/240 (32%), Positives = 119/240 (49%), Gaps = 21/240 (8%)

Query: 65  IGKGSFGEVFKGIDNRTQQVVAIKII--DLEEAEDEIEDIQQEIMVLS-QCDSPYGTKLW 121
           +GKGSFG+V       T +  AIK +  D+   +D++E    E  VL+   + P+ T L+
Sbjct: 3   LGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLF 62

Query: 122 ----------IIMEYLGGGSALDLM----KAGNFEEMHIAVILREVLKGLDYLHSERKLH 167
                      +MEYL GG   DLM     +G F+E        E++ GL +LH +  ++
Sbjct: 63  CTFQTKEHLFFVMEYLNGG---DLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIY 119

Query: 168 RDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADI 227
           RD+K  NVLL + G +K+ADFG+     N   K +TF GTP ++APE++K   Y+   D 
Sbjct: 120 RDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQKYNESVDW 179

Query: 228 WSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPENR 287
           WS G+   E+  G+ P         LF    N+ P      +K+ K+ +     +DP  R
Sbjct: 180 WSFGVLLYEMLIGQSPFHGEDEDE-LFDSILNDRPHFPRWISKEAKDCLSKLFERDPTKR 238

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score =  116 bits (293), Expect = 2e-29
 Identities = 76/267 (28%), Positives = 122/267 (45%), Gaps = 46/267 (17%)

Query: 48  RNSLKVDPELIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIM 107
           R SLK++         ++G G FGEV+ G  N T +V A+K   L+      E   QE  
Sbjct: 5   RESLKLE--------RKLGAGQFGEVWMGTWNGTTKV-AVKT--LKPGTMSPEAFLQEAQ 53

Query: 108 VLSQCDSPYGTKL----------WIIMEYLGGGSALDLMKAGNFEEMHIAVIL---REVL 154
           ++ +       +L          +I+ EY+  GS LD +K+G  +++ +  ++    ++ 
Sbjct: 54  IMKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIA 113

Query: 155 KGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPF---WM 211
           +G+ YL S   +HRD+ A N+L+ E    K+ADFG+A  + +   +     G  F   W 
Sbjct: 114 EGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIED--DEYTAREGAKFPIKWT 171

Query: 212 APEVIKQSAYDSKADIWSLGITAIEL-AKGEPPNSELHPMRVLFLI--------PKNNPP 262
           APE      +  K+D+WS GI   E+   G  P   +    VL  +        P N P 
Sbjct: 172 APEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMPRPPNCPE 231

Query: 263 QLTGNYTKQFKEFVEACLNKDPENRPT 289
           +L         + +  C +KDPE RPT
Sbjct: 232 EL--------YDLMLQCWDKDPEERPT 250

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score =  117 bits (294), Expect = 6e-29
 Identities = 85/264 (32%), Positives = 128/264 (48%), Gaps = 38/264 (14%)

Query: 65  IGKGSFGEVFKGIDNRTQQVVAIKII--DLEEAEDEIEDIQQEIMVLSQCDSP------- 115
           +GKGSFG+V       T ++ AIKI+  D+   +D++E    E  VL+    P       
Sbjct: 8   LGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLH 67

Query: 116 --YGT--KLWIIMEYLGGGSALDLM----KAGNFEEMHIAVILREVLKGLDYLHSERKLH 167
             + T  +L+ +MEY+ GG   DLM    + G F+E H      E+  GL +LHS+  ++
Sbjct: 68  SCFQTMDRLYFVMEYVNGG---DLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIY 124

Query: 168 RDIKAANVLLSEMGDVKLADFGVA--GTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKA 225
           RD+K  NV+L   G +K+ADFG+         T++  TF GTP ++APE+I    Y    
Sbjct: 125 RDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTR--TFCGTPDYIAPEIIAYQPYGKSV 182

Query: 226 DIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQF-KEFVEAC---LN 281
           D W+ G+   E+  G+PP        +   I ++N      +Y K   KE V  C   L 
Sbjct: 183 DWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNV-----SYPKSLSKEAVSICKGLLT 237

Query: 282 KDPENR----PTAKELLK-FPFIR 300
           K P  R    PT +  ++   F R
Sbjct: 238 KHPAKRLGCGPTGERDIREHAFFR 261

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score =  115 bits (289), Expect = 8e-29
 Identities = 80/260 (30%), Positives = 120/260 (46%), Gaps = 26/260 (10%)

Query: 65  IGKGSFGEVFKGIDNRTQQVVAIKIIDLEE--AEDEIEDIQQE--IMVLSQCDSPYGTKL 120
           I KG+FG V+      T    AIK++   +  A++++ +++ E  IM + Q +SPY  KL
Sbjct: 4   ISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIM-MIQGESPYVAKL 62

Query: 121 W----------IIMEYLGGGSALDLMKA-GNFEEMHIAVILREVLKGLDYLHSERKLHRD 169
           +          ++MEYL GG    L+K  G   E      + EV+ G++ LH    +HRD
Sbjct: 63  YYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRD 122

Query: 170 IKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWS 229
           IK  N+L+ + G +KL DFG    L+    +   FVGTP ++APE I     D  +D WS
Sbjct: 123 IKPENLLIDQTGHLKLTDFG----LSRNGLENKKFVGTPDYLAPETILGVGDDKMSDWWS 178

Query: 230 LGITAIELAKGEPPNSELHPMRVLFLIPKNN---PPQLTGNYTKQFKEFVEACLNKDPEN 286
           LG    E   G PP     P  V   I       P ++    + +  + +   L  DP  
Sbjct: 179 LGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCMDPAK 238

Query: 287 RPTAK---ELLKFPFIRKAK 303
           R  A    E+   PF +   
Sbjct: 239 RLGANGYQEIKSHPFFKSIN 258

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score =  113 bits (284), Expect = 7e-28
 Identities = 83/278 (29%), Positives = 133/278 (47%), Gaps = 45/278 (16%)

Query: 65  IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQ-QEIMVLSQCDSP-------- 115
           +G+GS+G V K     T Q+VAIK     E +  ++ I  +EI +L Q            
Sbjct: 9   VGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEV 68

Query: 116 --YGTKLWIIMEYLGGGSALDLMKAGN-FEEMHIAVILREVLKGLDYLHSERKLHRDIKA 172
                +L+++ E++      DL K  N  +E  +   L ++L+G+++ HS   +HRDIK 
Sbjct: 69  FRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKP 128

Query: 173 ANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPE-VIKQSAYDSKADIWSLG 231
            N+L+S+ G VKL DFG A TL         +V T ++ APE ++  + Y    DIW++G
Sbjct: 129 ENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVG 188

Query: 232 ITAIELAKGEP--P-NSEL----HPMRVL-FLIPKN------NPPQLTGNYTKQFKE--- 274
               E+  GEP  P +S++    H ++ L  LIP++      NP    G    + KE   
Sbjct: 189 CLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPL-FAGMRLPEVKEIEP 247

Query: 275 --------------FVEACLNKDPENRPTAKELLKFPF 298
                           + CL  DP++RP++ +LL   F
Sbjct: 248 LEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEF 285

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score =  114 bits (286), Expect = 9e-28
 Identities = 62/198 (31%), Positives = 97/198 (48%), Gaps = 16/198 (8%)

Query: 59  FTKQERIGKGSFGEVFKGIDNRTQQVVAIKIID--LEEAEDEIEDIQQEIMVLSQCDSPY 116
           F    ++G+G +G+VF      T ++VA+K +   L    +E+  +  E  +L+   S +
Sbjct: 3   FQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEW 62

Query: 117 GTKL----------WIIMEYLGGGSALDLMKA-GNFEEMHIAVILREVLKGLDYLHSERK 165
             KL          ++ MEY+ GG    L+   G   E H    + E+ + +D LH    
Sbjct: 63  LVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGY 122

Query: 166 LHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKA 225
           +HRD+K  N L+   G +KL DFG++       +  N+ VG+P +MAPEV++   YD   
Sbjct: 123 IHRDLKPENFLIDASGHIKLTDFGLS---KGIVTYANSVVGSPDYMAPEVLRGKGYDFTV 179

Query: 226 DIWSLGITAIELAKGEPP 243
           D WSLG    E   G PP
Sbjct: 180 DYWSLGCMLYEFLCGFPP 197

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score =  113 bits (284), Expect = 1e-27
 Identities = 82/293 (27%), Positives = 132/293 (45%), Gaps = 29/293 (9%)

Query: 65  IGKGSFGEVFKGIDNRTQQVVAIKIIDLEE--AEDEIEDIQQEIMVLSQCDSPYGT---- 118
           +GKG+FG+V    +  T +  A+KI+  E   A+DE+     E  VL     P+ T    
Sbjct: 3   LGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKY 62

Query: 119 ------KLWIIMEYLGGGSAL-DLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIK 171
                 +L  +MEY  GG     L +   F E        E++  L YLHS   ++RD+K
Sbjct: 63  SFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLK 122

Query: 172 AANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLG 231
             N++L + G +K+ DFG+     +  +   TF GTP ++APEV++ + Y    D W LG
Sbjct: 123 LENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLG 182

Query: 232 ITAIELAKGEPP--NSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPENR-- 287
           +   E+  G  P  N +   +  L L+ +   P+     + + K  +   L KDP+ R  
Sbjct: 183 VVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPR---TLSPEAKSLLAGLLKKDPKQRLG 239

Query: 288 ---PTAKELLKFPFIRKAK-KNAYLIDLIDRYKKWKNSRNEESETESETSDNE 336
                AKE+++  F      ++     L   +K         SET++   D E
Sbjct: 240 GGPEDAKEIMEHRFFASINWQDVVQKKLEPPFKP-----QVTSETDTRYFDEE 287

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score =  113 bits (283), Expect = 1e-27
 Identities = 83/304 (27%), Positives = 138/304 (45%), Gaps = 24/304 (7%)

Query: 65  IGKGSFGEVFKGIDNRTQQVVAIKIIDLEE--AEDEIEDIQQEIMVLSQCDSPY------ 116
           IGKGSFG+V +     TQ++ A+K I      +  E+     E  VL+Q + P+      
Sbjct: 1   IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60

Query: 117 ----GTKLWIIMEYLGGGSAL-DLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIK 171
                 KL++++ ++ GG     L + G F+         E+L  L+ LH    ++RD+K
Sbjct: 61  SFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLK 120

Query: 172 AANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLG 231
             N+LL   G + L DFG+         K NTF GTP ++APE++    Y    D W+LG
Sbjct: 121 PENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLG 180

Query: 232 ITAIELAKGEPP--NSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPENR-- 287
           +   E+  G PP  +  ++ M    L     P +    + +  K+ +   L++DP  R  
Sbjct: 181 VLLYEMLTGLPPFYDENVNEMYRKIL---QEPLRFPDGFDRDAKDLLIGLLSRDPTRRLG 237

Query: 288 -PTAKELLKFPFIRKAK-KNAYLIDLIDRYKKWKNSRNEESETESETSDNE--DSIKTDG 343
              A+E+   PF  +   K   +  +   +K   +S  + S  + E +  +  DS+  D 
Sbjct: 238 YNGAQEIKNHPFFSQLSWKKLLMKGIQPPFKPAVSSAIDTSNFDEEFTREKPIDSVVDDS 297

Query: 344 DLDE 347
            L E
Sbjct: 298 HLSE 301

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score =  110 bits (278), Expect = 3e-27
 Identities = 74/256 (28%), Positives = 117/256 (45%), Gaps = 33/256 (12%)

Query: 63  ERIGKGSFGEVFKGI---DNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPY--- 116
           + +G G+FG V KG+    +  +  VA+K +  E      ++  +E  V++Q D P    
Sbjct: 1   KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVR 60

Query: 117 ------GTKLWIIMEYLGGGSALD-LMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRD 169
                 G  L ++ME    G  L  L K        +  +  +V  G+ YL S+  +HRD
Sbjct: 61  LIGVCKGEPLMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRD 120

Query: 170 IKAANVLLSEMGDVKLADFGVAGTL-TNTTSKRNTFVGT-PF-WMAPEVIKQSAYDSKAD 226
           + A NVLL      K++DFG++  L   +   R T  G  P  W APE I    + SK+D
Sbjct: 121 LAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKFSSKSD 180

Query: 227 IWSLGITAIE-LAKGEPPNSELHPMRVLFLI--------PKNNPPQLTGNYTKQFKEFVE 277
           +WS G+T  E  + G  P  E+    V+ ++        P+  P ++   Y+      + 
Sbjct: 181 VWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERLPRPEECPQEI---YS-----IML 232

Query: 278 ACLNKDPENRPTAKEL 293
           +C    PE+RPT  EL
Sbjct: 233 SCWKYRPEDRPTFSEL 248

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score =  111 bits (279), Expect = 3e-27
 Identities = 68/277 (24%), Positives = 120/277 (43%), Gaps = 37/277 (13%)

Query: 47  RRNSLKVDPELIFTKQERIGKGSFGEVFKGI-----DNRTQQVVAIKIIDLEEAEDEIED 101
            R  + +  EL        G+GSFG V++G+         +  VAIK ++   +  E  +
Sbjct: 4   PREKITLIREL--------GQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIE 55

Query: 102 IQQEIMVLSQCDSPYGTKLW----------IIMEYLGGGSALDLMKAGNFEEMHIAV--- 148
              E  V+ + +  +  +L           ++ME +  G     +++   E  +      
Sbjct: 56  FLNEASVMKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGP 115

Query: 149 -----ILR---EVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSK 200
                 ++   E+  G+ YL +++ +HRD+ A N +++E   VK+ DFG+   +  T   
Sbjct: 116 PTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYY 175

Query: 201 RNTFVGT-PF-WMAPEVIKQSAYDSKADIWSLGITAIELAK-GEPPNSELHPMRVLFLIP 257
           R    G  P  WMAPE +K   + +K+D+WS G+   E+A   E P   L    VL  + 
Sbjct: 176 RKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVI 235

Query: 258 KNNPPQLTGNYTKQFKEFVEACLNKDPENRPTAKELL 294
                 L  N   +  E +  C   +P+ RPT  E++
Sbjct: 236 DGGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIV 272

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score =  110 bits (276), Expect = 7e-27
 Identities = 61/192 (31%), Positives = 98/192 (51%), Gaps = 16/192 (8%)

Query: 65  IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAED--EIEDIQQEIMVLSQCDSPYGTK--- 119
           +G G+FG V    D  ++   A+K++ + E     + + +  E  VL +   P+  +   
Sbjct: 9   VGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFW 68

Query: 120 -------LWIIMEYLGGGSALD-LMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIK 171
                  L+++MEY+ GG     L  +G F          E++  L+YLHS+  ++RD+K
Sbjct: 69  TEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLK 128

Query: 172 AANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLG 231
             N+LL + G +KL DFG A  L + T    T  GTP ++APEVI+   ++   D W+LG
Sbjct: 129 PENILLDKEGHIKLTDFGFAKKLRDRTW---TLCGTPEYLAPEVIQSKGHNKAVDWWALG 185

Query: 232 ITAIELAKGEPP 243
           I   E+  G PP
Sbjct: 186 ILIYEMLVGYPP 197

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score =  109 bits (274), Expect = 1e-26
 Identities = 66/198 (33%), Positives = 99/198 (50%), Gaps = 18/198 (9%)

Query: 118 TKLWIIMEYLGGGSALD-LMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVL 176
           TKL +I++Y+ GG     L +  +F E  + V + E++  LD+LH    ++RDIK  N+L
Sbjct: 78  TKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENIL 137

Query: 177 LSEMGDVKLADFGVAGT-LTNTTSKRNTFVGTPFWMAPEVIK--QSAYDSKADIWSLGIT 233
           L   G V L DFG++   L     +  +F GT  +MAPEVI+     +D   D WSLG+ 
Sbjct: 138 LDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVL 197

Query: 234 AIELAKGEPP-------NSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPEN 286
             EL  G  P       NS+    R    I K+ PP      + + ++F++  L KDP+ 
Sbjct: 198 TFELLTGASPFTVDGEQNSQSEISR---RILKSKPP-FPKTMSAEARDFIQKLLEKDPKK 253

Query: 287 R---PTAKELLKFPFIRK 301
           R     A E+   PF + 
Sbjct: 254 RLGANGADEIKNHPFFQG 271

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score =  109 bits (274), Expect = 1e-26
 Identities = 84/287 (29%), Positives = 136/287 (47%), Gaps = 51/287 (17%)

Query: 59  FTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQ-QEIMVLSQCDSP-- 115
           +TK E+IG+G++G V+KG + +T Q+VA+K I LE  E+ +     +EI +L +   P  
Sbjct: 2   YTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNI 61

Query: 116 --------YGTKLWIIMEYLGGGSALDLMK-------AGNFEEMHIAVILREVLKGLDYL 160
                     ++L++I E+L    ++DL K           +   +   L ++L+G+ + 
Sbjct: 62  VCLQDVLMQESRLYLIFEFL----SMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFC 117

Query: 161 HSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSA 220
           HS R LHRD+K  N+L+   G +KLADFG+A             V T ++ APEV+  S 
Sbjct: 118 HSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVVTLWYRAPEVLLGSP 177

Query: 221 -YDSKADIWSLGITAIELAKGEP---PNSELHPMRVLFLI---PKNN------------- 260
            Y +  DIWS+G    E+A  +P    +SE+  +  +F I   P  +             
Sbjct: 178 RYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKN 237

Query: 261 --PPQLTGNYTKQFK-------EFVEACLNKDPENRPTAKELLKFPF 298
             P    G+     K       + +E  L  DP  R +AK+ L  P+
Sbjct: 238 TFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPY 284

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score =  110 bits (276), Expect = 2e-26
 Identities = 67/198 (33%), Positives = 104/198 (52%), Gaps = 24/198 (12%)

Query: 65  IGKGSFGEVFKGIDNRTQQVVAIKII--DLEEAEDEIEDIQQEIMVLS-QCDSPYGT--- 118
           +GKGSFG+V       T +V AIK++  D+   +D+++    E  +L+     P+ T   
Sbjct: 3   LGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALH 62

Query: 119 -------KLWIIMEYLGGGSALDLM----KAGNFEEMHIAVILREVLKGLDYLHSERKLH 167
                  +L+ +MEY+ GG   DLM    ++  F+E        EV   L +LH    ++
Sbjct: 63  CCFQTKDRLFFVMEYVNGG---DLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIY 119

Query: 168 RDIKAANVLLSEMGDVKLADFGVA--GTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKA 225
           RD+K  N+LL   G  KLADFG+   G L   T+   TF GTP ++APE++++  Y    
Sbjct: 120 RDLKLDNILLDAEGHCKLADFGMCKEGILNGVTT--TTFCGTPDYIAPEILQELEYGPSV 177

Query: 226 DIWSLGITAIELAKGEPP 243
           D W+LG+   E+  G+PP
Sbjct: 178 DWWALGVLMYEMMAGQPP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score =  108 bits (272), Expect = 2e-26
 Identities = 73/270 (27%), Positives = 119/270 (44%), Gaps = 44/270 (16%)

Query: 65  IGKGSFGEVFKGIDNRTQQVVAIKIID---LEEAEDEIEDIQQEIMVLSQCDSPY----- 116
           +GKG FGEV       T ++ A K +D   L++ + E   + ++ + L +  S +     
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKI-LEKVSSRFIVSLA 59

Query: 117 -----GTKLWIIMEYLGGGSALDL------MKAGNFEEMHIAVILREVLKGLDYLHSERK 165
                   L ++M  + GG   DL      +    F E        +++ GL++LH  R 
Sbjct: 60  YAFETKDDLCLVMTLMNGG---DLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRI 116

Query: 166 LHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKA 225
           ++RD+K  NVLL + G+V+++D G+A  L     K     GTP +MAPEV++   YD   
Sbjct: 117 VYRDLKPENVLLDDHGNVRISDLGLAVELKGGK-KIKGRAGTPGYMAPEVLQGEVYDFSV 175

Query: 226 DIWSLGITAIELAKGEPP---------NSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFV 276
           D ++LG T  E+  G  P           EL               +    ++ + K+  
Sbjct: 176 DWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRR------TLEMAVEYPDKFSPEAKDLC 229

Query: 277 EACLNKDPENR-----PTAKELLKFPFIRK 301
           EA L KDPE R      +A E+ + P  + 
Sbjct: 230 EALLQKDPEKRLGCRGGSADEVREHPLFKD 259

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score =  108 bits (272), Expect = 3e-26
 Identities = 78/284 (27%), Positives = 131/284 (46%), Gaps = 60/284 (21%)

Query: 57  LIFTKQERIGKGSFGEVFKG----IDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQ- 111
           L F KQ  +G+G FG+V       + + T + VA+K ++    E    D ++EI +L   
Sbjct: 6   LKFIKQ--LGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTL 63

Query: 112 -----------CDSPYGTKLWIIMEYLGGGSALDLMKAGNFEEMHIAVILR---EVLKGL 157
                      C+ P G  L +IMEYL  GS  D ++  + +++++  +L    ++ KG+
Sbjct: 64  DHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQ-RHRDQINLKRLLLFSSQICKGM 122

Query: 158 DYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTP-----FWMA 212
           DYL S+R +HRD+ A N+L+     VK++DFG+A  L     K   +V  P     FW A
Sbjct: 123 DYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVL--PEDKDYYYVKEPGESPIFWYA 180

Query: 213 PEVIKQSAYDSKADIWSLGITAIEL-AKGEPPNSELHPMR--VLFLIPKNNPPQLTGNYT 269
           PE ++ S + S +D+WS G+T  EL   G+P      P    +  +        +T    
Sbjct: 181 PECLRTSKFSSASDVWSFGVTLYELFTYGDP---SQSPPAEFLRMIGIAQGQMIVT---- 233

Query: 270 KQFKEFVEA--------------------CLNKDPENRPTAKEL 293
            +  E ++                     C   +P++RP+  +L
Sbjct: 234 -RLLELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADL 276

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score =  109 bits (274), Expect = 3e-26
 Identities = 75/259 (28%), Positives = 119/259 (45%), Gaps = 27/259 (10%)

Query: 65  IGKGSFGEVFKGIDNRTQQVVAIKIIDLEE--AEDEIEDIQQEIMVLSQCDS---PY--- 116
           +G+G FG+V      +T ++ AIK +   +  A DE+E +  E  +    +S   P+   
Sbjct: 7   LGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVN 66

Query: 117 -------GTKLWIIMEYLGGGSALDLM---KAGNFEEMHIAVILREVLKGLDYLHSERKL 166
                     +  +MEY  GG   DLM       F E         V+ GL YLH  + +
Sbjct: 67  LFACFQTEDHVCFVMEYAAGG---DLMMHIHTDVFSEPRAVFYAACVVLGLQYLHENKIV 123

Query: 167 HRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKAD 226
           +RD+K  N+LL   G VK+ADFG+         + +TF GTP ++APEV+ +++Y    D
Sbjct: 124 YRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTSTFCGTPEFLAPEVLTETSYTRAVD 183

Query: 227 IWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPEN 286
            W LG+   E+  GE P        V   I  N+  +     +++    +   L ++PE 
Sbjct: 184 WWGLGVLIYEMLVGESPFPGDDEEEVFDSI-VNDEVRYPRFLSREAISIMRRLLRRNPER 242

Query: 287 R-----PTAKELLKFPFIR 300
           R       A+++ K PF R
Sbjct: 243 RLGSGEKDAEDVKKQPFFR 261

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score =  108 bits (270), Expect = 8e-26
 Identities = 81/257 (31%), Positives = 127/257 (49%), Gaps = 26/257 (10%)

Query: 65  IGKGSFGEVFKGIDNRTQQVVAIKII--DLEEAEDEIEDIQQEIMVLSQC-DSPYGT--- 118
           +GKGSFG+VF      T Q  AIK +  D+   +D++E    E  VLS   + P+ T   
Sbjct: 3   LGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLY 62

Query: 119 -------KLWIIMEYLGGGSALDLM----KAGNFEEMHIAVILREVLKGLDYLHSERKLH 167
                   L+ +MEYL GG   DLM        F+         E++ GL +LHS+  ++
Sbjct: 63  CTFQTKENLFFVMEYLNGG---DLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVY 119

Query: 168 RDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADI 227
           RD+K  N+LL   G +K+ADFG+        +K  TF GTP ++APE++    Y++  D 
Sbjct: 120 RDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQKYNTSVDW 179

Query: 228 WSLGITAIELAKGEPPNSELHPMRVLFLIPKNNP--PQLTGNYTKQFKEFVEACLNKDPE 285
           WS G+   E+  G+ P        +   I  +NP  P+     T++ K+ +     ++PE
Sbjct: 180 WSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYPRW---LTREAKDILVKLFVREPE 236

Query: 286 NRPTAK-ELLKFPFIRK 301
            R   K ++ + PF R+
Sbjct: 237 RRLGVKGDIRQHPFFRE 253

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score =  106 bits (265), Expect = 1e-25
 Identities = 73/254 (28%), Positives = 114/254 (44%), Gaps = 28/254 (11%)

Query: 63  ERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTKL-- 120
           E+IGKG+FG+V+KG+  +    VA+K        D      QE  +L Q D P   KL  
Sbjct: 1   EKIGKGNFGDVYKGV-LKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIG 59

Query: 121 --------WIIMEYLGGGSALDLM--KAGNFEEMHIAVILREVLKGLDYLHSERKLHRDI 170
                   +I+ME + GGS L  +  K        +  +  +   G++YL S+  +HRD+
Sbjct: 60  VCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDL 119

Query: 171 KAANVLLSEMGDVKLADFGVA-----GTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKA 225
            A N L+ E   +K++DFG++     G  T +   +   +    W APE +    Y S++
Sbjct: 120 AARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIK---WTAPEALNYGRYTSES 176

Query: 226 DIWSLGITAIEL-AKGEPPNSELHPMRVLFLIPKN---NPPQLTGNYTKQFKEFVEACLN 281
           D+WS GI   E  + G+ P   +   +    I        PQL      +    +  C  
Sbjct: 177 DVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRMPAPQLCPEEIYR---LMLQCWA 233

Query: 282 KDPENRPTAKELLK 295
            DPENRP+  E+  
Sbjct: 234 YDPENRPSFSEIYN 247

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score =  107 bits (269), Expect = 1e-25
 Identities = 66/203 (32%), Positives = 101/203 (49%), Gaps = 21/203 (10%)

Query: 65  IGKGSFGEVFKGIDNRTQQVVAIKIIDLEE--AEDEIEDIQQEIMVLSQCDSPYGTKL-- 120
           +G+G FGEV    +  T  + A+K++      A++ +   ++E  +LS  +SP+  +L  
Sbjct: 9   VGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQY 68

Query: 121 --------WIIMEYLGGGSALDLMK--AGNFEEMHIAVILREVLKGLDYLHSERKLHRDI 170
                   +++MEY  GG  L L+      F+E      L E++  +  +H    +HRDI
Sbjct: 69  AFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDI 128

Query: 171 KAANVLLSEMGDVKLADFGVAGTLT-NTTSKRNTFVGTPFWMAPEVIK------QSAYDS 223
           K  NVL+   G +KLADFG A  LT N        VGTP ++APEV+       +  Y  
Sbjct: 129 KPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGV 188

Query: 224 KADIWSLGITAIELAKGEPPNSE 246
           + D WSLG+ A E+  G  P  E
Sbjct: 189 ECDWWSLGVIAYEMIYGRSPFHE 211

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score =  107 bits (268), Expect = 2e-25
 Identities = 69/198 (34%), Positives = 108/198 (54%), Gaps = 24/198 (12%)

Query: 65  IGKGSFGEVFKGIDNRTQQVVAIKII--DLEEAEDEIE--DIQQEIMVLS-------QCD 113
           +GKGSFG+V       T ++ AIKI+  D+   +D++E   +++ ++ LS       Q  
Sbjct: 8   LGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLH 67

Query: 114 SPYGT--KLWIIMEYLGGGSALDLM----KAGNFEEMHIAVILREVLKGLDYLHSERKLH 167
           S + T  +L+ +MEY+ GG   DLM    + G F+E H      E+  GL +LHS+  ++
Sbjct: 68  SCFQTMDRLYFVMEYVNGG---DLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIY 124

Query: 168 RDIKAANVLLSEMGDVKLADFGVA--GTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKA 225
           RD+K  NV+L   G +K+ADFG+         T+K  TF GTP ++APE+I    Y    
Sbjct: 125 RDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTK--TFCGTPDYIAPEIIAYQPYGKSV 182

Query: 226 DIWSLGITAIELAKGEPP 243
           D W+ G+   E+  G+ P
Sbjct: 183 DWWAFGVLLYEMLAGQAP 200

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score =  106 bits (266), Expect = 2e-25
 Identities = 81/286 (28%), Positives = 133/286 (46%), Gaps = 49/286 (17%)

Query: 59  FTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDE--IEDIQ-QEIMVLSQCDSP 115
           + K  +IG+GS+G VFK  +  T Q+VAIK     E+ED+  I+ I  +EI +L Q   P
Sbjct: 3   YEKLSKIGEGSYGVVFKCRNRETGQIVAIK--KFVESEDDPVIKKIALREIRMLKQLKHP 60

Query: 116 ----------YGTKLWIIMEYLGGGSALDLMKAG--NFEEMHIAVILREVLKGLDYLHSE 163
                        KL ++ EY    + L+ ++       E  I  I+ + L+ +++ H  
Sbjct: 61  NLVNLIEVFRRKRKLHLVFEYCDH-TVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKH 119

Query: 164 RKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVI-KQSAYD 222
             +HRD+K  N+L+++ G +KL DFG A  LT        +V T ++ APE++   + Y 
Sbjct: 120 NCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVGDTQYG 179

Query: 223 SKADIWSLGITAIELAKGEP--PNS----ELHPMRVLF--LIPKNNPPQLTGNYTKQFK- 273
              D+W++G    EL  G+P  P      +L+ +R     LIP++     T  + K    
Sbjct: 180 PPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLSI 239

Query: 274 ---------------------EFVEACLNKDPENRPTAKELLKFPF 298
                                 F++ CL  DP  R + +ELL+ P+
Sbjct: 240 PEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPY 285

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score =  105 bits (263), Expect = 2e-25
 Identities = 81/261 (31%), Positives = 131/261 (50%), Gaps = 26/261 (9%)

Query: 53  VDP-ELIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQ 111
           ++P EL F K+  +G G FG V  G   R Q  VAIK I+ E A  E ED  +E  V+ +
Sbjct: 1   INPSELTFMKE--LGSGQFGVVHLG-KWRAQIKVAIKAIN-EGAMSE-EDFIEEAKVMMK 55

Query: 112 CDSP-----YGT-----KLWIIMEYLGGGSALDLM--KAGNFEEMHIAVILREVLKGLDY 159
              P     YG       L+I+ E++  G  L+ +  + G   +  +  + ++V +G++Y
Sbjct: 56  LSHPKLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEY 115

Query: 160 LHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPF-WMAPEVIKQ 218
           L     +HRD+ A N L+S  G VK++DFG+   + +     ++    P  W  PEV   
Sbjct: 116 LERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNF 175

Query: 219 SAYDSKADIWSLGITAIEL-AKGEPPNSELHPMRVLFLIPKNN---PPQLTGNYTKQFKE 274
           S Y SK+D+WS G+   E+  +G+ P  +     V+ +I +      P+L    +    E
Sbjct: 176 SKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYRPKLA---SMTVYE 232

Query: 275 FVEACLNKDPENRPTAKELLK 295
            + +C ++ PE RPT  ELL+
Sbjct: 233 VMYSCWHEKPEGRPTFAELLR 253

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score =  106 bits (267), Expect = 2e-25
 Identities = 62/207 (29%), Positives = 99/207 (47%), Gaps = 16/207 (7%)

Query: 59  FTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE--AEDEIEDIQQEIMVLSQCDSPY 116
           F   E +G GSFG V       T +  AIK +   E     +++ + QE  +L +   P+
Sbjct: 20  FEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPF 79

Query: 117 ----------GTKLWIIMEYLGGGSALD-LMKAGNFEEMHIAVILREVLKGLDYLHSERK 165
                       +++ ++E++ GG     L KAG F          E++   +YLHS+  
Sbjct: 80  IVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDI 139

Query: 166 LHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKA 225
           ++RD+K  N+LL   G VK+ DFG A  + + T    T  GTP ++APEVI+   +    
Sbjct: 140 IYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTF---TLCGTPEYLAPEVIQSKGHGKAV 196

Query: 226 DIWSLGITAIELAKGEPPNSELHPMRV 252
           D W++G+   E   G PP  +  P R+
Sbjct: 197 DWWTMGVLLYEFIAGYPPFFDDTPFRI 223

Length = 329

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score =  105 bits (265), Expect = 2e-25
 Identities = 76/294 (25%), Positives = 134/294 (45%), Gaps = 60/294 (20%)

Query: 59  FTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDE---IEDIQQEIMVLSQCDSP 115
           + K  RI +G++G V++  D +T ++VA+K + +E+ E E   I  ++ EI +L +   P
Sbjct: 7   YEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEK-EKEGFPITSLR-EINILLKLQHP 64

Query: 116 ---------YGTKL---WIIMEYLGGG--SALDLMKAGNFEEMHIAVILREVLKGLDYLH 161
                     G+ L   +++MEY+     S ++ MK   F +  +  ++ ++L G+ +LH
Sbjct: 65  NIVTVKEVVVGSNLDKIYMVMEYVEHDLKSLMETMK-QPFLQSEVKCLMLQLLSGVAHLH 123

Query: 162 SERKLHRDIKAANVLLSEMGDVKLADFGVA----GTLTNTTSKRNTFVGTPFWMAPEVI- 216
               LHRD+K +N+LL+  G +K+ DFG+A      L   T      V T ++ APE++ 
Sbjct: 124 DNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQL----VVTLWYRAPELLL 179

Query: 217 KQSAYDSKADIWSLGITAIELAKGEP--------------------PNSELHP-MRVLFL 255
               Y +  D+WS+G    EL   +P                    P  ++ P    L  
Sbjct: 180 GAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPG 239

Query: 256 IPKNNPPQLTGNYTKQ-FKEFVEA-----CLNK----DPENRPTAKELLKFPFI 299
             K    +   N  ++ F     +      LN+    DP  R +A++ LK P+ 
Sbjct: 240 AKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha

 Score =  106 bits (266), Expect = 3e-25
 Identities = 80/294 (27%), Positives = 130/294 (44%), Gaps = 68/294 (23%)

Query: 81  TQQVVAIKIIDLEEAEDEIED-IQQEIMVLSQCDSP----------YGTKLWIIMEYLGG 129
           T + V ++ I+LE   +E+   +Q E+ V    + P             +LW++  ++  
Sbjct: 24  TGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAY 83

Query: 130 GSALDLMK---AGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLA 186
           GSA DL+         E+ IA IL+ VLK LDY+H    +HR +KA+++L+S  G V L+
Sbjct: 84  GSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLS 143

Query: 187 DFGVAGTLTNTTSKRNTFVGTPF-------WMAPEVIKQS--AYDSKADIWSLGITAIEL 237
                 ++ N   +       P        W++PEV++Q+   YD+K+DI+S+GITA EL
Sbjct: 144 GLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACEL 203

Query: 238 AKGEPPNSELHPMRVLF--------------LIPKN----NPPQLTGNY----------- 268
           A G  P  ++   ++L                IP       P +   N            
Sbjct: 204 ANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTP 263

Query: 269 ----------------TKQFKEFVEACLNKDPENRPTAKELLKFPFIRKAKKNA 306
                           +  F  FVE CL ++P+ RP+A  LL   F ++ K+ A
Sbjct: 264 RPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIKRRA 317

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score =  106 bits (266), Expect = 3e-25
 Identities = 73/257 (28%), Positives = 125/257 (48%), Gaps = 25/257 (9%)

Query: 65  IGKGSFGEVFKGIDNRTQQVVAIKIIDLEE--AEDEIEDIQQEIMVL---SQCDSPY--- 116
           IGKG+FG+V++     T+++ A+K++  +E  A+ E+     E  +L      +SP+   
Sbjct: 1   IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60

Query: 117 -------GTKLWIIMEYLGGGSAL-DLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHR 168
                   + L+++ +Y+ GG     L K G F E      + E++  L++LH    ++R
Sbjct: 61  LKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYR 120

Query: 169 DIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEV-IKQSAYDSKADI 227
           D+K  N+LL   G + L DFG++          NTF GT  ++APEV + +  Y    D 
Sbjct: 121 DLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTKHVDF 180

Query: 228 WSLGITAIELAKGEPP--NSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPE 285
           WSLG+   E+  G  P    +   M       K   P+     + + ++FV+  LN++P+
Sbjct: 181 WSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPK--NVLSDEGRQFVKGLLNRNPQ 238

Query: 286 NR----PTAKELLKFPF 298
           +R      A EL + PF
Sbjct: 239 HRLGAHRDAVELKEHPF 255

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score =  104 bits (261), Expect = 5e-25
 Identities = 73/257 (28%), Positives = 116/257 (45%), Gaps = 35/257 (13%)

Query: 63  ERIGKGSFGEVFK-GIDNRTQQVVAIKII---------DLEEAEDEIEDIQQEIMVL-SQ 111
           E +G G+FG V+K    N  Q ++A+K I         D  E +  I DI  E+ ++  Q
Sbjct: 6   EHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQ 65

Query: 112 CDSP----------YGTKLWIIMEYLGGGSALDLM-----KAGNFEEMHIAVILREVLKG 156
              P             +L+I+M+ + G    +       K   F E  I  I  +++  
Sbjct: 66  LRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLA 125

Query: 157 LDYLHSERKL-HRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEV 215
           L YLH E+++ HRD+   N++L E   V + DFG+A       SK  + VGT  +  PE+
Sbjct: 126 LRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQ-KQPESKLTSVVGTILYSCPEI 184

Query: 216 IKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPK----NNPPQLTGNYTKQ 271
           +K   Y  KAD+W+ G    ++   +PP    +   +L L  K       P   G Y++ 
Sbjct: 185 VKNEPYGEKADVWAFGCILYQMCTLQPP---FYSTNMLSLATKIVEAVYEPLPEGMYSED 241

Query: 272 FKEFVEACLNKDPENRP 288
             + + +CL  D E RP
Sbjct: 242 VTDVITSCLTPDAEARP 258

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score =  104 bits (262), Expect = 5e-25
 Identities = 77/266 (28%), Positives = 126/266 (47%), Gaps = 28/266 (10%)

Query: 51  LKVDPELIFTKQERIGKGSFGEVFKGI---DNRTQQV-VAIKIIDLEEAEDEIEDIQQEI 106
           L++  E    K + +G G+FG V+KG+   +    ++ VAIK++  E +    ++I  E 
Sbjct: 1   LRILKETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEA 60

Query: 107 MVLSQCDSPY---------GTKLWIIMEYLGGGSALDLMK--AGNFEEMHIAVILREVLK 155
            V++  D P+          +++ +I + +  G  LD ++    N    ++     ++ K
Sbjct: 61  YVMASVDHPHVVRLLGICLSSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAK 120

Query: 156 GLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVG-TPF-WMAP 213
           G+ YL  +R +HRD+ A NVL+     VK+ DFG+A  L     + +   G  P  WMA 
Sbjct: 121 GMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMAL 180

Query: 214 EVIKQSAYDSKADIWSLGITAIELAK-GEPPNSELHPMRVLFLIPKN----NPPQLTGN- 267
           E I    Y  K+D+WS G+T  EL   G  P   +  + +  L+ K      PP  T + 
Sbjct: 181 ESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGERLPQPPICTIDV 240

Query: 268 YTKQFKEFVEACLNKDPENRPTAKEL 293
           Y       +  C   D E+RPT KEL
Sbjct: 241 YM-----VLVKCWMIDAESRPTFKEL 261

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score =  108 bits (270), Expect = 7e-25
 Identities = 74/261 (28%), Positives = 125/261 (47%), Gaps = 30/261 (11%)

Query: 65  IGKGSFGEVFKGIDNRTQQVVAIKIIDLE-EAEDEIEDIQQEIMVLSQCD---------- 113
           +G G+ G V         +  A+K++D+E  +E +    Q E+  L  CD          
Sbjct: 40  LGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHED 99

Query: 114 -------SPYGTKLW-IIMEYLGGGSALDLMK-----AGNFEEMHIAVILREVLKGLDYL 160
                  +P    +  ++++Y   G     +K        F E    ++  +VL  + ++
Sbjct: 100 FAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHV 159

Query: 161 HSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKR--NTFVGTPFWMAPEVIKQ 218
           HS+  +HRDIK+AN+LL   G VKL DFG +     T S     TF GTP+++APE+ ++
Sbjct: 160 HSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRR 219

Query: 219 SAYDSKADIWSLGITAIELAKGEPP--NSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFV 276
             Y  KAD++SLG+   EL   + P     +  +    L  + +P  L  + + + +E V
Sbjct: 220 KPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYDP--LPPSISPEMQEIV 277

Query: 277 EACLNKDPENRPTAKELLKFP 297
            A L+ DP+ RP++ +LL  P
Sbjct: 278 TALLSSDPKRRPSSSKLLNMP 298

Length = 496

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score =  105 bits (263), Expect = 8e-25
 Identities = 87/314 (27%), Positives = 132/314 (42%), Gaps = 71/314 (22%)

Query: 62  QERIGKG--SFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQC-DSP--- 115
           Q  IG+G  +   V+      T  +V ++I DLE   +E     Q  +VLS     P   
Sbjct: 3   QVEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIM 62

Query: 116 -------YGTKLWIIMEYLGGGSALDLMKAGNFEEMH---IAVILREVLKGLDYLHSERK 165
                   G+ LW+I  ++  GSA  L+K    E M    I  IL   L+GL+YLH    
Sbjct: 63  TSWTVFTTGSWLWVISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGY 122

Query: 166 LHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPF-------WMAPEVIKQ 218
           +HR+IKA+++L+S  G V L+      +L     K       P        W++PE+++Q
Sbjct: 123 IHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQ 182

Query: 219 --SAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNP---------PQ---- 263
               Y+ K+DI+S+GITA ELA G  P  ++   ++L    K  P         P     
Sbjct: 183 DLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEESR 242

Query: 264 ---------------------------------LTGNYTKQFKEFVEACLNKDPENRPTA 290
                                             +  ++  F+  VE CL +DPE RP+A
Sbjct: 243 MKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSA 302

Query: 291 KELLKFPFIRKAKK 304
             LL   F ++ K+
Sbjct: 303 SSLLSHAFFKQVKE 316

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score =  105 bits (263), Expect = 9e-25
 Identities = 74/247 (29%), Positives = 114/247 (46%), Gaps = 25/247 (10%)

Query: 65  IGKGSFGEVFKGIDNRTQQVVAIKIIDLEE--AEDEIEDIQQEIMVLSQ-CDSPY----- 116
           IGKGSFG+V         +  A+K++  +    + E + I  E  VL +    P+     
Sbjct: 3   IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLH 62

Query: 117 -----GTKLWIIMEYLGGGSAL-DLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDI 170
                  KL+ +++Y+ GG     L +  +F E        E+   L YLHS   ++RD+
Sbjct: 63  YSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDL 122

Query: 171 KAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSL 230
           K  N+LL   G V L DFG+       +   +TF GTP ++APEV+++  YD   D W L
Sbjct: 123 KPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCL 182

Query: 231 GITAIELAKGEPP-----NSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPE 285
           G    E+  G PP      +E++   +L     N P +L  N +   +  +E  L KD  
Sbjct: 183 GAVLYEMLYGLPPFYSRDTAEMYD-NIL-----NKPLRLKPNISVSARHLLEGLLQKDRT 236

Query: 286 NRPTAKE 292
            R  AK+
Sbjct: 237 KRLGAKD 243

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score =  105 bits (262), Expect = 9e-25
 Identities = 67/196 (34%), Positives = 100/196 (51%), Gaps = 20/196 (10%)

Query: 65  IGKGSFGEVFKGIDNRTQQVVAIKII--DLEEAEDEIEDIQQEIMVLSQCDSP------- 115
           +GKGSFG+V       T ++ AIKI+  D+   +D++E    E  VL+  D P       
Sbjct: 8   LGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLH 67

Query: 116 --YGT--KLWIIMEYLGGGSALDLM----KAGNFEEMHIAVILREVLKGLDYLHSERKLH 167
             + T  +L+ +MEY+ GG   DLM    + G F+E        E+  GL +LH    ++
Sbjct: 68  SCFQTVDRLYFVMEYVNGG---DLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIY 124

Query: 168 RDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADI 227
           RD+K  NV+L   G +K+ADFG+            TF GTP ++APE+I    Y    D 
Sbjct: 125 RDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIAYQPYGKSVDW 184

Query: 228 WSLGITAIELAKGEPP 243
           W+ G+   E+  G+PP
Sbjct: 185 WAYGVLLYEMLAGQPP 200

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score =  104 bits (261), Expect = 1e-24
 Identities = 85/299 (28%), Positives = 137/299 (45%), Gaps = 30/299 (10%)

Query: 65  IGKGSFGEVFKGIDNRTQQVVAIKIIDLEE--AEDEIEDIQQEIMVLSQCDSPYGT---- 118
           +GKG+FG+V    +  T +  A+KI+  E   A+DE+     E  VL     P+ T    
Sbjct: 3   LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKY 62

Query: 119 ------KLWIIMEYLGGGSAL-DLMKAGNFEEMHIAVILREVLKGLDYLHSERKL-HRDI 170
                 +L  +MEY  GG     L +   F E        E++  LDYLHSE+ + +RD+
Sbjct: 63  SFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDL 122

Query: 171 KAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSL 230
           K  N++L + G +K+ DFG+        +   TF GTP ++APEV++ + Y    D W L
Sbjct: 123 KLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGL 182

Query: 231 GITAIELAKGEPP--NSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPENR- 287
           G+   E+  G  P  N +   +  L L+ +   P+       + K  +   L KDP+ R 
Sbjct: 183 GVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLS---PEAKSLLSGLLKKDPKQRL 239

Query: 288 ----PTAKELLKFPFIRKAK-KNAYLIDLIDRYKKWKNSRNEESETESETSDNEDSIKT 341
                 AKE+++  F      ++ Y   L+  +K         SET++   D E + + 
Sbjct: 240 GGGPDDAKEIMQHKFFAGIVWQDVYEKKLVPPFKP-----QVTSETDTRYFDEEFTAQM 293

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score =  104 bits (261), Expect = 1e-24
 Identities = 76/303 (25%), Positives = 127/303 (41%), Gaps = 73/303 (24%)

Query: 63  ERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAED--------EI--------EDIQQEI 106
            ++G+G+FGEV+K    +T +VVA+K I +   +D        EI         ++   I
Sbjct: 14  GKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLI 73

Query: 107 -MVLSQCDSPYGTK--LWIIMEYLGGGSALDLMKAG-------NFEEMHIAVILREVLKG 156
            M + + D     +  ++++  Y+      DL  +G          E  I   + ++L+G
Sbjct: 74  DMAVERPDKSKRKRGSVYMVTPYM----DHDL--SGLLENPSVKLTESQIKCYMLQLLEG 127

Query: 157 LDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVA-----------GTLTNTTSKRNTFV 205
           ++YLH    LHRDIKAAN+L+   G +K+ADFG+A           G     T K    V
Sbjct: 128 INYLHENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLV 187

Query: 206 GTPFWMAPE-VIKQSAYDSKADIWSLGITAIELAKGEP---PNSELHPMRVLF------- 254
            T ++  PE ++ +  Y +  DIW +G    E+    P     S++  + ++F       
Sbjct: 188 VTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCGTPT 247

Query: 255 ----------------LIPKNNPPQLTGNYTKQFKE---FVEACLNKDPENRPTAKELLK 295
                               N P  L   + K   E    +   L+ DP  R TA + L+
Sbjct: 248 EETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307

Query: 296 FPF 298
            P+
Sbjct: 308 HPY 310

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score =  104 bits (262), Expect = 2e-24
 Identities = 78/290 (26%), Positives = 123/290 (42%), Gaps = 62/290 (21%)

Query: 65  IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIED---IQQEIMVLSQCDSPYGTKL- 120
           IG G++G V   +D RT + VAIK I      D++ D   I +EI +L          L 
Sbjct: 8   IGSGAYGVVCSAVDKRTGRKVAIKKI--SNVFDDLIDAKRILREIKLLRHLRHENIIGLL 65

Query: 121 --------------WIIMEYLGGGSALDL---MKAGNF-EEMHIAVILREVLKGLDYLHS 162
                         +I+ E +      DL   +K+     + HI   L ++L+GL YLHS
Sbjct: 66  DILRPPSPEDFNDVYIVTELME----TDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHS 121

Query: 163 ERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNT---FVGTPFWMAPEVI-KQ 218
              +HRD+K +N+L++   D+K+ DFG+A  +     ++     +V T ++ APE++   
Sbjct: 122 ANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSS 181

Query: 219 SAYDSKADIWSLGITAIELAKGEP--------------------PNSELHP-------MR 251
           S Y    DIWS+G    EL   +P                    P+ E            
Sbjct: 182 SRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKARN 241

Query: 252 VLFLIPKNNPPQLTGNYTK---QFKEFVEACLNKDPENRPTAKELLKFPF 298
            L  +PK     L+  +     +  + +E  L  DP+ R TA E L  P+
Sbjct: 242 YLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPY 291

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score =  102 bits (257), Expect = 2e-24
 Identities = 84/295 (28%), Positives = 129/295 (43%), Gaps = 68/295 (23%)

Query: 59  FTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDE------IEDIQQEIMVLSQC 112
           + K E+IG+G++G V+K  D  T ++VA+K I LE  EDE      I    +EI +L + 
Sbjct: 1   YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLE-TEDEGVPSTAI----REISLLKEL 55

Query: 113 DSPY----------GTKLWIIMEYLGGGSALDLMK------AGNFEEMHIAVILREVLKG 156
           + P             KL+++ E+L     LDL K          +   I   L ++L+G
Sbjct: 56  NHPNIVRLLDVVHSENKLYLVFEFLD----LDLKKYMDSSPLTGLDPPLIKSYLYQLLQG 111

Query: 157 LDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGT----LTNTTSKRNTFVGTPFWMA 212
           + Y HS R LHRD+K  N+L+   G +KLADFG+A      +   T +    V T ++ A
Sbjct: 112 IAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHE----VVTLWYRA 167

Query: 213 PEVIKQSAYDSKA-DIWSLGITAIELAKGEP--------------------PNSELHPMR 251
           PE++  S   S   DIWS+G    E+    P                    P+ ++ P  
Sbjct: 168 PEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGV 227

Query: 252 VLFLIPKNNPPQLTG-NYTKQFKEFVEACLN-------KDPENRPTAKELLKFPF 298
                 K   P+    + +K      E  L+        DP  R +AK  L+ P+
Sbjct: 228 TSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPY 282

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain

 Score = 99.8 bits (249), Expect = 2e-24
 Identities = 51/185 (27%), Positives = 76/185 (41%), Gaps = 24/185 (12%)

Query: 130 GSALDLMKAGN--FEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLAD 187
            S  D+++       E  I  +  + L  L      R+LHR  K+ N+LL+   D  L  
Sbjct: 1   VSLADILEVRGRPLNEEEIWAVCLQCLGAL------RELHRQAKSGNILLTW--DGLLKL 52

Query: 188 FGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSEL 247
            G     T   S+       P++MAPEVI+  +Y  KADI+SLGIT  E    E P +E 
Sbjct: 53  DGSVAFKTPEQSR-----PDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEE 107

Query: 248 HPMRVLFLIPKNNPPQLTGNYTK---------QFKEFVEACLNKDPENRPTAKELLKFPF 298
             +  +  I  N  P                  F++F+  C ++ P+ R  A   L    
Sbjct: 108 RELSAILEILLNGMPADDPRDRSNLEGVSAARSFEDFMRLCASRLPQRREAANHYLAHCR 167

Query: 299 IRKAK 303
              A+
Sbjct: 168 ALFAE 172

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score =  104 bits (259), Expect = 2e-24
 Identities = 84/298 (28%), Positives = 136/298 (45%), Gaps = 29/298 (9%)

Query: 65  IGKGSFGEVFKGIDNRTQQVVAIKIIDLEE--AEDEIEDIQQEIMVLSQCDSPYGT---- 118
           +GKG+FG+V    +  + +  A+KI+  E   A+DE+     E  VL     P+ T    
Sbjct: 3   LGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKY 62

Query: 119 ------KLWIIMEYLGGGSAL-DLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIK 171
                 +L  +MEY+ GG     L +   F E        E++  LDYLHS + ++RD+K
Sbjct: 63  SFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLK 122

Query: 172 AANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLG 231
             N++L + G +K+ DFG+        +   TF GTP ++APEV++ + Y    D W LG
Sbjct: 123 LENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLG 182

Query: 232 ITAIELAKGEPP--NSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPENR-- 287
           +   E+  G  P  N +   +  L L+     P+     +   K  +   L KDP  R  
Sbjct: 183 VVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPR---TLSADAKSLLSGLLIKDPNKRLG 239

Query: 288 ---PTAKELLKFPFIRKAK-KNAYLIDLIDRYKKWKNSRNEESETESETSDNEDSIKT 341
                AKE+++  F      ++ Y   L+  +K         SET++   D E + +T
Sbjct: 240 GGPDDAKEIMRHSFFTGVNWQDVYDKKLVPPFKP-----QVTSETDTRYFDEEFTAQT 292

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score =  103 bits (259), Expect = 3e-24
 Identities = 66/243 (27%), Positives = 117/243 (48%), Gaps = 20/243 (8%)

Query: 65  IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDE--IEDIQQEIMVLSQCDS-PY----- 116
           IG+GS+ +V      +  Q+ A+K++  E   D+  I+ +Q E  V  Q  S P+     
Sbjct: 3   IGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLH 62

Query: 117 -----GTKLWIIMEYLGGGSAL-DLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDI 170
                 ++L++++EY+ GG  +  + +     E H      E+   L++LH    ++RD+
Sbjct: 63  SCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDL 122

Query: 171 KAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSL 230
           K  NVLL   G +KL D+G+           +TF GTP ++APE+++   Y    D W+L
Sbjct: 123 KLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWAL 182

Query: 231 GITAIELAKGEPP------NSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDP 284
           G+   E+  G  P      N +++    LF +    P ++    + +    ++  LNKDP
Sbjct: 183 GVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRFLSVKASHVLKGFLNKDP 242

Query: 285 ENR 287
           + R
Sbjct: 243 KER 245

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score =  103 bits (258), Expect = 3e-24
 Identities = 61/196 (31%), Positives = 101/196 (51%), Gaps = 20/196 (10%)

Query: 65  IGKGSFGEVFKGIDNRTQQVVAIKII--DLEEAEDEIEDIQQEIMVLS-QCDSPYGTKLW 121
           +GKGSFG+V       + ++ A+K++  D+   +D++E    E  +LS   + P+ T+L+
Sbjct: 3   LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLY 62

Query: 122 ----------IIMEYLGGGSALDLM----KAGNFEEMHIAVILREVLKGLDYLHSERKLH 167
                      +ME++ GG   DLM    K+  F+E        E+   L +LH +  ++
Sbjct: 63  CCFQTPDRLFFVMEFVNGG---DLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIY 119

Query: 168 RDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADI 227
           RD+K  NVLL   G  KLADFG+           +TF GTP ++APE++++  Y    D 
Sbjct: 120 RDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEMLYGPSVDW 179

Query: 228 WSLGITAIELAKGEPP 243
           W++G+   E+  G  P
Sbjct: 180 WAMGVLLYEMLCGHAP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score =  103 bits (258), Expect = 3e-24
 Identities = 73/243 (30%), Positives = 119/243 (48%), Gaps = 27/243 (11%)

Query: 65  IGKGSFGEVFKGIDNRTQQVVAIKII--DLEEAEDEIEDIQQEIMVLS-QCDSPYGTK-- 119
           +GKGSFG+V         +  A+K +  D+   +D++E    E  VL+   ++P+ T   
Sbjct: 3   LGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLY 62

Query: 120 --------LWIIMEYLGGGSALDLM----KAGNFEEMHIAVILREVLKGLDYLHSERKLH 167
                   L+ +ME+L GG   DLM      G F+         E++ GL +LHS+  ++
Sbjct: 63  CTFQTKEHLFFVMEFLNGG---DLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIY 119

Query: 168 RDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADI 227
           RD+K  NV+L   G +K+ADFG+        ++ +TF GTP ++APE+++   Y    D 
Sbjct: 120 RDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQGLKYTFSVDW 179

Query: 228 WSLGITAIELAKGEPP---NSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDP 284
           WS G+   E+  G+ P   + E      LF   + + P      TK+ K+ +E    +DP
Sbjct: 180 WSFGVLLYEMLIGQSPFHGDDEDE----LFESIRVDTPHYPRWITKESKDILEKLFERDP 235

Query: 285 ENR 287
             R
Sbjct: 236 TRR 238

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score =  102 bits (256), Expect = 3e-24
 Identities = 83/277 (29%), Positives = 126/277 (45%), Gaps = 46/277 (16%)

Query: 57  LIFTKQERIGKGSFGEV----FKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLS-- 110
           L F +Q  +GKG+FG V    +  + + T +VVA+K +      + + D ++EI +L   
Sbjct: 6   LKFIQQ--LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQ-HSTAEHLRDFEREIEILKSL 62

Query: 111 QCD----------SPYGTKLWIIMEYLGGGSALDLMKAGNFEEMHIAVIL--REVLKGLD 158
           Q D          S     L ++MEYL  GS  D ++       H  ++L   ++ KG++
Sbjct: 63  QHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGME 122

Query: 159 YLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTP-----FWMAP 213
           YL S+R +HRD+   N+L+     VK+ DFG+   L     K    V  P     FW AP
Sbjct: 123 YLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQ--DKEYYKVREPGESPIFWYAP 180

Query: 214 EVIKQSAYDSKADIWSLGITAIEL----AKGEPPNSEL---------HPMRVLFLIP--K 258
           E + +S +   +D+WS G+   EL     K   P +E            M V  LI   K
Sbjct: 181 ESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLK 240

Query: 259 NNP--PQLTGNYTKQFKEFVEACLNKDPENRPTAKEL 293
           NN   P   G   + +   ++ C N DP  RP+  EL
Sbjct: 241 NNGRLPAPPGCPAEIY-AIMKECWNNDPSQRPSFSEL 276

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score =  101 bits (253), Expect = 4e-24
 Identities = 88/271 (32%), Positives = 135/271 (49%), Gaps = 46/271 (16%)

Query: 53  VDP-ELIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQ 111
           +DP EL F K+  +G G FG V  G   R +  VAIK+I  E A  E +D  +E  V+ +
Sbjct: 1   IDPSELTFLKE--LGSGQFGVVHLG-KWRGKIDVAIKMIR-EGAMSE-DDFIEEAKVMMK 55

Query: 112 CDSP-----YG--TK---LWIIMEYLGGGSALDLMKA--GNFEEMHIAVILREVLKGLDY 159
              P     YG  TK   ++I+ EY+  G  L+ ++   G      +  +  +V + ++Y
Sbjct: 56  LSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEY 115

Query: 160 LHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTN---TTSKRNTFVGTPF---WMAP 213
           L S   +HRD+ A N L+ E   VK++DFG+A  + +   T+S      GT F   W  P
Sbjct: 116 LESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSS-----QGTKFPVKWAPP 170

Query: 214 EVIKQSAYDSKADIWSLGITAIEL-AKGEPP-----NSEL--HPMRVLFLI-PKNNPPQL 264
           EV   S + SK+D+WS G+   E+ ++G+ P     NSE+         L  PK  P ++
Sbjct: 171 EVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRLYRPKLAPTEV 230

Query: 265 TGNYTKQFKEFVEACLNKDPENRPTAKELLK 295
              YT  +      C ++ PE+RP  K+LL 
Sbjct: 231 ---YTIMYS-----CWHEKPEDRPAFKKLLS 253

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score =  102 bits (256), Expect = 5e-24
 Identities = 81/289 (28%), Positives = 143/289 (49%), Gaps = 35/289 (12%)

Query: 59  FTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDE----------IEDIQQEIMV 108
           + K E++G+G++  VFKG    T+ +VA+K I LE  E            ++D++   +V
Sbjct: 8   YIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIV 67

Query: 109 LSQCDSPYGTKLWIIMEYLGGGSALDLMKAGNFEEMH-IAVILREVLKGLDYLHSERKLH 167
                      L ++ EYL       +   GN   MH + + L ++L+GL Y H  + LH
Sbjct: 68  TLHDIVHTDKSLTLVFEYLDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLH 127

Query: 168 RDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEV-IKQSAYDSKAD 226
           RD+K  N+L++E G++KLADFG+A   +  T   +  V T ++  P+V +  S Y ++ D
Sbjct: 128 RDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSSEYSTQID 187

Query: 227 IWSLGITAIELAKGEP--PNS----ELHPM-RVLFLIPKNNPPQLTGNYTKQFKEFVEAC 279
           +W +G    E+A G P  P S    ELH + R+L    +   P ++ N   +FK +    
Sbjct: 188 MWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSN--DEFKNY---- 241

Query: 280 LNKDPENRPTAKELLKFPFIRKAKK-NAYLIDLIDRYKKWKNSRNEESE 327
               P+ +P        P I  A + +   I+L+ ++ ++++ +   +E
Sbjct: 242 --NFPKYKPQ-------PLINHAPRLDTEGIELLTKFLQYESKKRISAE 281

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score =  102 bits (256), Expect = 6e-24
 Identities = 87/302 (28%), Positives = 144/302 (47%), Gaps = 58/302 (19%)

Query: 52  KVDPELIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAED--------EIEDIQ 103
             D    + K  +IG+G+FGEVFK    +T+Q+VA+K + +E  ++        EI+ +Q
Sbjct: 7   FCDEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQ 66

Query: 104 Q---EIMV--LSQCDSP------YGTKLWIIMEYLGGGSALDLM-----KAGNFEEMHIA 147
               E +V  +  C +       Y    +++ E+       DL      K   F    I 
Sbjct: 67  LLKHENVVNLIEICRTKATPYNRYKGSFYLVFEF----CEHDLAGLLSNKNVKFTLSEIK 122

Query: 148 VILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTL-TNTTSKRNTF-- 204
            +++ +L GL Y+H  + LHRD+KAAN+L+++ G +KLADFG+A     +  SK N +  
Sbjct: 123 KVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTN 182

Query: 205 -VGTPFWMAPEV-IKQSAYDSKADIWSLGITAIELAKGEP---PNSELHPMRVLFLIPKN 259
            V T ++  PE+ + +  Y    D+W  G    E+    P    N+E H    L LI   
Sbjct: 183 RVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQ---LTLI--- 236

Query: 260 NPPQLTGNYTKQ-------FKEFVEACLNKDPENRPTAKELLKFPFIRKAKKNAYLIDLI 312
              QL G+ T +        + F +  L +  + +   KE LK P++    K+ + +DLI
Sbjct: 237 --SQLCGSITPEVWPGVDKLELFKKMELPQGQKRK--VKERLK-PYV----KDPHALDLI 287

Query: 313 DR 314
           D+
Sbjct: 288 DK 289

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score =  105 bits (262), Expect = 7e-24
 Identities = 66/206 (32%), Positives = 104/206 (50%), Gaps = 41/206 (19%)

Query: 119 KLWIIMEYLGGGSALDLMKAGN--------FEEMHIAVILREVLKGLDYLHSERKLHRDI 170
           KL +IMEY  GG   DL K           F+E  + ++  +++  LD +HS + +HRD+
Sbjct: 139 KLLLIMEYGSGG---DLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDL 195

Query: 171 KAANVLLSEMGDVKLADFGVAGTLTNTTS--KRNTFVGTPFWMAPEVIKQSAYDSKADIW 228
           K+AN+ L   G +KL DFG +   +++ S    ++F GTP+++APE+ ++  Y  KAD+W
Sbjct: 196 KSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMW 255

Query: 229 SLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQ-------LTGNY-------TKQFKE 274
           SLG+   EL         LH        P   P Q       L G Y       +   K 
Sbjct: 256 SLGVILYELLT-------LHR-------PFKGPSQREIMQQVLYGKYDPFPCPVSSGMKA 301

Query: 275 FVEACLNKDPENRPTAKELLKFPFIR 300
            ++  L+K+P  RPT ++LL   F++
Sbjct: 302 LLDPLLSKNPALRPTTQQLLHTEFLK 327

Length = 478

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score =  100 bits (250), Expect = 1e-23
 Identities = 77/261 (29%), Positives = 130/261 (49%), Gaps = 28/261 (10%)

Query: 65  IGKGSFGEVFKGIDNRTQQVVAIKIID---LEEAEDEIEDIQQEIMV--LSQCDSPY--- 116
           IG+G FGEV+      T ++ A+K +D   ++  + E   + + IM+  +S  D P+   
Sbjct: 2   IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61

Query: 117 -------GTKLWIIMEYLGGGSA-LDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHR 168
                    KL  I++ + GG     L + G F E  +     E++ GL+++H+   ++R
Sbjct: 62  MSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYR 121

Query: 169 DIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVI-KQSAYDSKADI 227
           D+K AN+LL E G V+++D G+A   +    K +  VGT  +MAPEV+ K  AYDS AD 
Sbjct: 122 DLKPANILLDEHGHVRISDLGLACDFSK--KKPHASVGTHGYMAPEVLQKGVAYDSSADW 179

Query: 228 WSLGITAIELAKGEPPNSELHPMRVLFLIPK---NNPPQLTGNYTKQFKEFVEACLNKDP 284
           +SLG    +L +G  P    H  +    I +       +L  +++ + +  +E  L +D 
Sbjct: 180 FSLGCMLFKLLRGHSP-FRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQRDV 238

Query: 285 ENR-----PTAKELLKFPFIR 300
             R       A+E+ + PF R
Sbjct: 239 NRRLGCLGRGAQEVKEHPFFR 259

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score =  101 bits (253), Expect = 2e-23
 Identities = 71/242 (29%), Positives = 110/242 (45%), Gaps = 15/242 (6%)

Query: 65  IGKGSFGEVFKGIDNRTQQVVAIKIID---LEEAEDEIEDIQQEIMVLSQCDSPY----- 116
           IGKGSFG+V        ++  A+K++    + + ++E   + +  ++L     P+     
Sbjct: 3   IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 62

Query: 117 -----GTKLWIIMEYLGGGSAL-DLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDI 170
                  KL+ +++Y+ GG     L +   F E        E+   L YLHS   ++RD+
Sbjct: 63  FSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDL 122

Query: 171 KAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSL 230
           K  N+LL   G + L DFG+           +TF GTP ++APEV+ +  YD   D W L
Sbjct: 123 KPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCL 182

Query: 231 GITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPENRPTA 290
           G    E+  G PP    +   +   I  N P QL  N T   +  +E  L KD   R  A
Sbjct: 183 GAVLYEMLYGLPPFYSRNTAEMYDNI-LNKPLQLKPNITNSARHLLEGLLQKDRTKRLGA 241

Query: 291 KE 292
           K+
Sbjct: 242 KD 243

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 99.8 bits (249), Expect = 2e-23
 Identities = 70/267 (26%), Positives = 121/267 (45%), Gaps = 38/267 (14%)

Query: 48  RNSLKVDPELIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIM 107
           R S+++          ++G G FGEV++G+ N T  V A+K   L+    + +D   E  
Sbjct: 5   RTSIQL--------LRKLGAGQFGEVWEGLWNNTTPV-AVKT--LKPGTMDPKDFLAEAQ 53

Query: 108 VLSQCDSPYGTKLW----------IIMEYLGGGSALDLMKAGNFEEMHIAVILR---EVL 154
           ++ +   P   +L+          I+ E +  GS L+ ++ G    + +  ++    +V 
Sbjct: 54  IMKKLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVA 113

Query: 155 KGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPF---WM 211
            G+ YL ++  +HRD+ A NVL+ E    K+ADFG+A  +           G  F   W 
Sbjct: 114 SGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKE--DIYEAREGAKFPIKWT 171

Query: 212 APEVIKQSAYDSKADIWSLGITAIELAK-GEPPNSELHPMRVLFLIPKN----NPPQLTG 266
           APE    + +  K+D+WS GI   E+   G  P   +    VL  + +      PP    
Sbjct: 172 APEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRMPCPP---- 227

Query: 267 NYTKQFKEFVEACLNKDPENRPTAKEL 293
              K+  + +  C  +DP++RPT + L
Sbjct: 228 GCPKELYDIMLDCWKEDPDDRPTFETL 254

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 99.8 bits (249), Expect = 2e-23
 Identities = 81/271 (29%), Positives = 118/271 (43%), Gaps = 45/271 (16%)

Query: 53  VDPELIFTKQERIGKGSFGEVFKGI--DNRTQQV-VAIKIIDLEEAEDEIEDIQQEIMVL 109
           +  E I T    IG+G FG+V++G+      +++ VA+K      +    E   QE  ++
Sbjct: 3   IQREDI-TLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIM 61

Query: 110 SQCDSPYGTKL---------WIIMEYLGGGSALDLMKAGNFEEMHIAVIL--REVLKGLD 158
            Q D P+  KL         WI+ME    G     ++   +     ++IL   ++   L 
Sbjct: 62  RQFDHPHIVKLIGVITENPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALA 121

Query: 159 YLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPF-WMAPEVIK 217
           YL S+R +HRDI A NVL+S    VKL DFG++  L + +  + +    P  WMAPE I 
Sbjct: 122 YLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESIN 181

Query: 218 QSAYDSKADIWSLGITAIE-LAKGEPP--------------NSELHPMRVLFLIPKNNPP 262
              + S +D+W  G+   E L  G  P              N E  PM      P N PP
Sbjct: 182 FRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERLPM------PPNCPP 235

Query: 263 QLTGNYTKQFKEFVEACLNKDPENRPTAKEL 293
            L   Y+      +  C   DP  RP   EL
Sbjct: 236 TL---YS-----LMTKCWAYDPSKRPRFTEL 258

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score =  101 bits (252), Expect = 2e-23
 Identities = 76/254 (29%), Positives = 121/254 (47%), Gaps = 23/254 (9%)

Query: 65  IGKGSFGEVFKGIDNRTQQVVAIKIIDLEE--AEDEIEDIQQEIMVLSQCDSPYGT---- 118
           +GKG+FG+V    +  T +  A+KI+  E   A+DE+     E  VL     P+ T    
Sbjct: 3   LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKY 62

Query: 119 ------KLWIIMEYLGGGSAL-DLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIK 171
                 +L  +MEY  GG     L +   F E        E++  L+YLHS   ++RDIK
Sbjct: 63  AFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIK 122

Query: 172 AANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLG 231
             N++L + G +K+ DFG+     +  +   TF GTP ++APEV++ + Y    D W LG
Sbjct: 123 LENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLG 182

Query: 232 ITAIELAKGEPP--NSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPENR-- 287
           +   E+  G  P  N +   +  L L+ +   P+     + + K  +   L KDP+ R  
Sbjct: 183 VVMYEMMCGRLPFYNQDHERLFELILMEEIRFPR---TLSPEAKSLLAGLLKKDPKQRLG 239

Query: 288 ---PTAKELLKFPF 298
                AKE+++  F
Sbjct: 240 GGPSDAKEVMEHRF 253

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score =  100 bits (250), Expect = 2e-23
 Identities = 68/198 (34%), Positives = 103/198 (52%), Gaps = 22/198 (11%)

Query: 58  IFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLE-EAEDEIEDIQQEIMVLSQCDSP- 115
            F K E+IG+G++G V+K  +  T +VVA+K I L+ E E       +EI +L + + P 
Sbjct: 1   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 60

Query: 116 ---------YGTKLWIIMEYLGGGSALDL---MKAGNFEEMHIAVI---LREVLKGLDYL 160
                       KL+++ E+L      DL   M A     + + +I   L ++L+GL + 
Sbjct: 61  IVKLLDVIHTENKLYLVFEFLHQ----DLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFC 116

Query: 161 HSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSA 220
           HS R LHRD+K  N+L++  G +KLADFG+A             V T ++ APE++    
Sbjct: 117 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCK 176

Query: 221 YDSKA-DIWSLGITAIEL 237
           Y S A DIWSLG    E+
Sbjct: 177 YYSTAVDIWSLGCIFAEM 194

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 99.2 bits (247), Expect = 3e-23
 Identities = 70/256 (27%), Positives = 118/256 (46%), Gaps = 25/256 (9%)

Query: 48  RNSLKVDPELIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIM 107
           R +LK+         +++G G FGEV+ G  N   +V AIK   L++     E    E  
Sbjct: 5   RETLKL--------VKKLGAGQFGEVWMGYYNGHTKV-AIK--SLKQGSMSPEAFLAEAN 53

Query: 108 VLSQCDSPYGTKL---------WIIMEYLGGGSALDLMKAGNFEEMHIAVIL---REVLK 155
           ++ Q   P   +L         +II EY+  GS +D +K     ++ I  ++    ++ +
Sbjct: 54  LMKQLQHPRLVRLYAVVTQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAE 113

Query: 156 GLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPF-WMAPE 214
           G+ ++  +  +HRD++AAN+L+SE    K+ADFG+A  + +           P  W APE
Sbjct: 114 GMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPE 173

Query: 215 VIKQSAYDSKADIWSLGITAIELAK-GEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFK 273
            I    +  K+D+WS GI   E+   G  P   +    V+  + +        N  ++  
Sbjct: 174 AINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMPRPDNCPEELY 233

Query: 274 EFVEACLNKDPENRPT 289
           E +  C  + PE RPT
Sbjct: 234 ELMRLCWKEKPEERPT 249

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score =  101 bits (253), Expect = 3e-23
 Identities = 81/277 (29%), Positives = 126/277 (45%), Gaps = 39/277 (14%)

Query: 65  IGKGSFGEVFKGIDNRTQQVVAIKIID----LEEAED----EIEDI----QQEIMVLSQC 112
           IG+G+FGEV       ++QV A+K++     ++ ++     E  DI      E +V    
Sbjct: 51  IGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHY 110

Query: 113 ---DSPYGTKLWIIMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRD 169
              D  Y   L+++MEY+ GG  ++LM   +  E        EV+  LD +HS   +HRD
Sbjct: 111 AFQDDKY---LYMVMEYMPGGDLVNLMSNYDIPEKWARFYTAEVVLALDAIHSMGFIHRD 167

Query: 170 IKAANVLLSEMGDVKLADFGVAGTLTNTTSKR-NTFVGTPFWMAPEVIKQSA----YDSK 224
           +K  N+LL + G +KLADFG    +      R +T VGTP +++PEV+K       Y  +
Sbjct: 168 VKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRE 227

Query: 225 ADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDP 284
            D WS+G+   E+  G+ P          F         L G Y+K            D 
Sbjct: 228 CDWWSVGVFLYEMLVGDTP----------FY-----ADSLVGTYSKIMDHKNSLTFPDDI 272

Query: 285 ENRPTAKELL-KFPFIRKAKKNAYLIDLIDRYKKWKN 320
           E    AK+L+  F   R+ +     +D I  +  +KN
Sbjct: 273 EISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKN 309

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score =  100 bits (250), Expect = 3e-23
 Identities = 72/242 (29%), Positives = 119/242 (49%), Gaps = 24/242 (9%)

Query: 65  IGKGSFGEVF---KGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIM---VLSQCDSPYGT 118
           +G+GSFG+VF   K       Q+ A+K+  L++A  ++ D  +  M   +L++ + P+  
Sbjct: 4   LGQGSFGKVFLVRKITGPDAGQLYAMKV--LKKATLKVRDRVRTKMERDILAEVNHPFIV 61

Query: 119 ----------KLWIIMEYLGGGSALD-LMKAGNFEEMHIAVILREVLKGLDYLHSERKLH 167
                     KL++I+++L GG     L K   F E  +   L E+   LD+LHS   ++
Sbjct: 62  KLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIY 121

Query: 168 RDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADI 227
           RD+K  N+LL E G +KL DFG++    +   K  +F GT  +MAPEV+ +  +   AD 
Sbjct: 122 RDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADW 181

Query: 228 WSLGITAIELAKGEPPNSELHPMRVLFLIPKNN--PPQLTGNYTKQFKEFVEACLNKDPE 285
           WS G+   E+  G  P         + +I K     PQ     + + +  + A   ++P 
Sbjct: 182 WSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQ---FLSPEAQSLLRALFKRNPA 238

Query: 286 NR 287
           NR
Sbjct: 239 NR 240

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score =  100 bits (250), Expect = 4e-23
 Identities = 72/253 (28%), Positives = 117/253 (46%), Gaps = 38/253 (15%)

Query: 65  IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDI---QQEIMVLSQCDS-PY---- 116
           IG+GS+ +V      +T+++ A+K+I  E   D+ EDI   Q E  V     + P+    
Sbjct: 3   IGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDD-EDIDWVQTEKHVFETASNHPFLVGL 61

Query: 117 ------GTKLWIIMEYLGGGSALDLM----KAGNFEEMHIAVILREVLKGLDYLHSERKL 166
                  ++L+ ++E++ GG   DLM    +     E H      E+   L++LH    +
Sbjct: 62  HSCFQTESRLFFVIEFVSGG---DLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGII 118

Query: 167 HRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKAD 226
           +RD+K  NVLL   G +KL D+G+           +TF GTP ++APE+++   Y    D
Sbjct: 119 YRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRGEDYGFSVD 178

Query: 227 IWSLGITAIELAKGEPP------------NSELHPMRVLFLIPKNNPPQLTGNYTKQFKE 274
            W+LG+   E+  G  P            N+E +  +V+       P  L+   +   K 
Sbjct: 179 WWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPRSLSVKASSVLKG 238

Query: 275 FVEACLNKDPENR 287
           F    LNKDP+ R
Sbjct: 239 F----LNKDPKER 247

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 99.9 bits (249), Expect = 5e-23
 Identities = 78/263 (29%), Positives = 129/263 (49%), Gaps = 33/263 (12%)

Query: 65  IGKGSFGEVF---KGIDNRTQQVVAIKIIDLEEA-----EDEIEDIQQEIMVLSQCDSPY 116
           +GKG +G+VF   K     T ++ A+K+  L++A     + +    + E  +L     P+
Sbjct: 4   LGKGGYGKVFQVRKVTGADTGKIFAMKV--LKKATIVRNQKDTAHTKAERNILEAVKHPF 61

Query: 117 ----------GTKLWIIMEYLGGGSA-LDLMKAGNFEEMHIAVILREVLKGLDYLHSERK 165
                     G KL++I+EYL GG   + L + G F E      L E+   L++LH +  
Sbjct: 62  IVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGI 121

Query: 166 LHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKA 225
           ++RD+K  N+LL   G VKL DFG+     +  +  +TF GT  +MAPE++ +S +    
Sbjct: 122 IYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEILMRSGHGKAV 181

Query: 226 DIWSLGITAIELAKGEPPNSELHPMRVLFLIPK---NNPPQLTGNYTKQFKEFVEACLNK 282
           D WSLG    ++  G PP +  +  + +  I K   N PP L    T + ++ ++  L +
Sbjct: 182 DWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLPPYL----TPEARDLLKKLLKR 237

Query: 283 DPENR-----PTAKELLKFPFIR 300
           +P +R       A E+   PF R
Sbjct: 238 NPSSRLGAGPGDAAEVQSHPFFR 260

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 99.3 bits (247), Expect = 5e-23
 Identities = 74/245 (30%), Positives = 122/245 (49%), Gaps = 21/245 (8%)

Query: 59  FTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQC------ 112
           + K +++G+G++  VFKG    T+ +VA+K I LE  E       +E+ +L         
Sbjct: 7   YVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIV 66

Query: 113 ---DSPYGTK-LWIIMEYLGGGSALDLMKAGNFEEMH-IAVILREVLKGLDYLHSERKLH 167
              D  +  + L ++ EYL       L   GN   MH + + + ++L+GL Y H  + LH
Sbjct: 67  TLHDIIHTERCLTLVFEYLDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILH 126

Query: 168 RDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSA-YDSKAD 226
           RD+K  N+L++E G++KLADFG+A   +  T   +  V T ++  P+V+  S  Y +  D
Sbjct: 127 RDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSTEYSTPID 186

Query: 227 IWSLGITAIELAKGEP--PNS----ELHPMRVLFLIPKNNP-PQLTGNYTKQFKEFVEAC 279
           +W +G    E+A G P  P S    ELH +  L   P     P +T N  ++F+ ++   
Sbjct: 187 MWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSN--EEFRSYLFPQ 244

Query: 280 LNKDP 284
               P
Sbjct: 245 YRAQP 249

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 98.4 bits (245), Expect = 5e-23
 Identities = 70/257 (27%), Positives = 128/257 (49%), Gaps = 33/257 (12%)

Query: 60  TKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTK 119
           T + ++G G +GEV++G+  +    VA+K   L+E   E+E+  +E  V+ +   P   +
Sbjct: 9   TMKHKLGGGQYGEVYEGVWKKYSLTVAVKT--LKEDTMEVEEFLKEAAVMKEIKHPNLVQ 66

Query: 120 L----------WIIMEYLGGGSALDLMKAGNFEEMHIAVILR---EVLKGLDYLHSERKL 166
           L          +II E++  G+ LD ++  N +E++  V+L    ++   ++YL  +  +
Sbjct: 67  LLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFI 126

Query: 167 HRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPF-WMAPEVIKQSAYDSKA 225
           HRD+ A N L+ E   VK+ADFG++  +T  T   +     P  W APE +  + +  K+
Sbjct: 127 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKS 186

Query: 226 DIWSLGITAIELAK-GEPPNSELHPMRVLFLI--------PKNNPPQLTGNYTKQFKEFV 276
           D+W+ G+   E+A  G  P   +   +V  L+        P+  PP++         E +
Sbjct: 187 DVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYRMERPEGCPPKVY--------ELM 238

Query: 277 EACLNKDPENRPTAKEL 293
            AC   +P +RP+  E+
Sbjct: 239 RACWQWNPSDRPSFAEI 255

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 99.7 bits (248), Expect = 5e-23
 Identities = 73/246 (29%), Positives = 110/246 (44%), Gaps = 23/246 (9%)

Query: 65  IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIM-----VLSQCDSPY--- 116
           IGKGSFG+V         +  A+K++  +   +  E  Q+ IM     +L     P+   
Sbjct: 3   IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKE--QKHIMAERNVLLKNVKHPFLVG 60

Query: 117 -------GTKLWIIMEYLGGGSAL-DLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHR 168
                    KL+ +++++ GG     L +  +F E        E+   L YLHS   ++R
Sbjct: 61  LHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYR 120

Query: 169 DIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIW 228
           D+K  N+LL   G V L DFG+       +    TF GTP ++APEVI++  YD+  D W
Sbjct: 121 DLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRKQPYDNTVDWW 180

Query: 229 SLGITAIELAKGEPP--NSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPEN 286
            LG    E+  G PP    ++  M    L   + P  L    +      +E  L KD + 
Sbjct: 181 CLGAVLYEMLYGLPPFYCRDVAEMYDNIL---HKPLVLRPGASLTAWSILEELLEKDRQR 237

Query: 287 RPTAKE 292
           R  AKE
Sbjct: 238 RLGAKE 243

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 98.5 bits (245), Expect = 7e-23
 Identities = 73/245 (29%), Positives = 124/245 (50%), Gaps = 27/245 (11%)

Query: 65  IGKGSFGEVFKGIDNRTQQVVAIKIID---LEEAEDEIEDIQQEIMV--LSQCDSPY--- 116
           IG+G FGEV+      T ++ A+K +D   ++  + E   + + IM+  +S  D P+   
Sbjct: 2   IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61

Query: 117 -------GTKLWIIMEYLGGGSA-LDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHR 168
                    KL  I++ + GG     L + G F E  +     E++ GL+++H+   ++R
Sbjct: 62  MTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYR 121

Query: 169 DIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVI-KQSAYDSKADI 227
           D+K AN+LL E G V+++D G+A   +    K +  VGT  +MAPEV+ K +AYDS AD 
Sbjct: 122 DLKPANILLDEHGHVRISDLGLACDFSK--KKPHASVGTHGYMAPEVLQKGTAYDSSADW 179

Query: 228 WSLGITAIELAKGEPP-----NSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNK 282
           +SLG    +L +G  P       + H +  + L       +L  +++ + K  +E  L +
Sbjct: 180 FSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVN---VELPDSFSPELKSLLEGLLQR 236

Query: 283 DPENR 287
           D   R
Sbjct: 237 DVSKR 241

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 97.9 bits (244), Expect = 8e-23
 Identities = 68/257 (26%), Positives = 113/257 (43%), Gaps = 37/257 (14%)

Query: 60  TKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQ---EIMVLSQCDSP- 115
                IGKG FG+V  G      Q VA+K +     +D+    Q    E  V++    P 
Sbjct: 9   KLGATIGKGEFGDVMLGD--YRGQKVAVKCL-----KDDSTAAQAFLAEASVMTTLRHPN 61

Query: 116 ---------YGTKLWIIMEYLGGGSALDLMK-----AGNFEEMHIAVILREVLKGLDYLH 161
                     G  L+I+ EY+  GS +D ++          +        +V +G++YL 
Sbjct: 62  LVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLG--FALDVCEGMEYLE 119

Query: 162 SERKLHRDIKAANVLLSEMGDVKLADFGVA--GTLTNTTSKRNTFVGTPF-WMAPEVIKQ 218
            +  +HRD+ A NVL+SE    K++DFG+A   +    + K       P  W APE +++
Sbjct: 120 EKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGK------LPVKWTAPEALRE 173

Query: 219 SAYDSKADIWSLGITAIEL-AKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVE 277
             + +K+D+WS GI   E+ + G  P   +    V+  + K    +       +  + ++
Sbjct: 174 KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYRMEAPEGCPPEVYKVMK 233

Query: 278 ACLNKDPENRPTAKELL 294
            C   DP  RPT K+L 
Sbjct: 234 DCWELDPAKRPTFKQLR 250

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 98.9 bits (247), Expect = 1e-22
 Identities = 76/299 (25%), Positives = 119/299 (39%), Gaps = 59/299 (19%)

Query: 59  FTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAE--DEIEDIQQEIMVLSQCDSPY 116
           F K + +GKG  G VF      T ++ A+K++D +E    ++++ +  E  +L+  D P+
Sbjct: 3   FKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPF 62

Query: 117 ----------GTKLWIIMEYLGGG---SALDLMKAGNFEEMHIAVILREVLKGLDYLHSE 163
                      T L ++M+Y  GG     L         E        EVL  L+YLH  
Sbjct: 63  LPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLL 122

Query: 164 RKLHRDIKAANVLLSEMGDVKLADF------GVAGTLT---------------------- 195
             ++RD+K  N+LL E G + L+DF       V                           
Sbjct: 123 GIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFS 182

Query: 196 -NTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPP----NSELHPM 250
              + + N+FVGT  ++APEVI    + S  D W+LGI   E+  G  P    N +    
Sbjct: 183 EEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDETFS 242

Query: 251 RVLFLIPKNNPPQLTGNY--TKQFKEFVEACLNKDPENR----PTAKELLKFPFIRKAK 303
            +L            G+   +   ++ +   L KDP  R      A E+ + PF R   
Sbjct: 243 NIL-----KKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRGVN 296

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 97.3 bits (242), Expect = 1e-22
 Identities = 73/262 (27%), Positives = 134/262 (51%), Gaps = 30/262 (11%)

Query: 53  VDP-ELIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKII-DLEEAEDEIEDIQQEIMVLS 110
           +DP +L F K+  +G G FG V  G   R Q  VAIK+I +   +EDE  +  + +M LS
Sbjct: 1   IDPKDLTFLKE--LGTGQFGVVKYG-KWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMKLS 57

Query: 111 Q---------CDSPYGTKLWIIMEYLGGGSALDLMKAG--NFEEMHIAVILREVLKGLDY 159
                     C       ++I+ EY+  G  L+ ++     F+   +  + ++V +G+ Y
Sbjct: 58  HEKLVQLYGVCTKQR--PIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAY 115

Query: 160 LHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPF---WMAPEVI 216
           L S++ +HRD+ A N L+ + G VK++DFG++  + +   +  + VG+ F   W  PEV+
Sbjct: 116 LESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLD--DEYTSSVGSKFPVRWSPPEVL 173

Query: 217 KQSAYDSKADIWSLGITAIEL-AKGEPPNSELHPMRVLFLIPKNN---PPQLTGNYTKQF 272
             S + SK+D+W+ G+   E+ + G+ P    +    +  + +      P L    +++ 
Sbjct: 174 LYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYRPHLA---SEKV 230

Query: 273 KEFVEACLNKDPENRPTAKELL 294
              + +C ++  E RPT ++LL
Sbjct: 231 YAIMYSCWHEKAEERPTFQQLL 252

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 97.1 bits (242), Expect = 3e-22
 Identities = 75/276 (27%), Positives = 132/276 (47%), Gaps = 50/276 (18%)

Query: 63  ERIGKGSFGEVFK----GIDNRTQ-QVVAIKIIDLEEAEDEIEDIQQE------------ 105
           + +G+G+FG+V K    G+DN  +   VA+K++  +  E ++ D+  E            
Sbjct: 18  KPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 77

Query: 106 IMVLSQCDSPYGTKLWIIMEYLGGGSALDLMKA-----------------GNFEEMHIAV 148
           I+ L    +  G  L++++EY   G+  D ++A                     +  +  
Sbjct: 78  IINLLGVCTQEG-PLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVS 136

Query: 149 ILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVG-T 207
              +V +G+++L S++ +HRD+ A NVL++E   +K+ADFG+A  + +    R T  G  
Sbjct: 137 FAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRL 196

Query: 208 PF-WMAPEVIKQSAYDSKADIWSLGITAIELAK--GEP-PNSELHPMRVLFLIPKN---- 259
           P  WMAPE +    Y  ++D+WS G+   E+    G P P     P+  LF + K     
Sbjct: 197 PVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGI---PVEELFKLLKEGYRM 253

Query: 260 NPPQLTGNYTKQFKEFVEACLNKDPENRPTAKELLK 295
             PQ   N T++    +  C ++ P  RPT K+L++
Sbjct: 254 EKPQ---NCTQELYHLMRDCWHEVPSQRPTFKQLVE 286

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 96.9 bits (241), Expect = 3e-22
 Identities = 72/277 (25%), Positives = 125/277 (45%), Gaps = 43/277 (15%)

Query: 59  FTKQER-IGKGSFGEV----FKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQ-- 111
           F K+ R +G+G FG+V    +    + T + VA+K +  E   + I D+++EI +L    
Sbjct: 5   FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLY 64

Query: 112 ----------CDSPYGTKLWIIMEYLGGGSALDLMKAGNFEEMHIAVILR---EVLKGLD 158
                     C    G  + +IME+L  GS  + +   N  ++++   L+   ++ KG+D
Sbjct: 65  HENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPR-NKNKINLKQQLKYAVQICKGMD 123

Query: 159 YLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTT---SKRNTFVGTPFWMAPEV 215
           YL S + +HRD+ A NVL+     VK+ DFG+   +       + ++      FW APE 
Sbjct: 124 YLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPEC 183

Query: 216 IKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLT---------- 265
           + QS +   +D+WS G+T  EL      +SE  PM +   +      Q+T          
Sbjct: 184 LIQSKFYIASDVWSFGVTLYELLT--YCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEE 241

Query: 266 -------GNYTKQFKEFVEACLNKDPENRPTAKELLK 295
                   N  ++  + +  C    P  R T + L++
Sbjct: 242 GKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIE 278

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 96.7 bits (241), Expect = 3e-22
 Identities = 66/200 (33%), Positives = 104/200 (52%), Gaps = 20/200 (10%)

Query: 59  FTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDE----------IEDIQQEIMV 108
           + K +++G+GS+  V+KG    T Q+VA+K I LE  E            ++D++   +V
Sbjct: 7   YKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIV 66

Query: 109 LSQCDSPYGTK-LWIIMEYLGGGSALDLMKAGNFEEMH-IAVILREVLKGLDYLHSERKL 166
               D  +  K L ++ EYL       +   G    MH + + L ++L+GL Y H  R L
Sbjct: 67  TLH-DIIHTKKTLTLVFEYLDTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVL 125

Query: 167 HRDIKAANVLLSEMGDVKLADFGVA---GTLTNTTSKRNTFVGTPFWMAPEVIKQS-AYD 222
           HRD+K  N+L+SE G++KLADFG+A      + T S     V T ++  P+V+  S  Y 
Sbjct: 126 HRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNE---VVTLWYRPPDVLLGSTEYS 182

Query: 223 SKADIWSLGITAIELAKGEP 242
           +  D+W +G    E+A G P
Sbjct: 183 TSLDMWGVGCIFYEMATGRP 202

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 96.1 bits (239), Expect = 5e-22
 Identities = 69/268 (25%), Positives = 123/268 (45%), Gaps = 34/268 (12%)

Query: 61  KQERIGKGSFGEV----FKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQ----- 111
           K   +G+G FG+V    +   ++ T ++VA+K +  E  +      ++EI +L       
Sbjct: 8   KIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHEN 67

Query: 112 -------CDSPYGTKLWIIMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSER 164
                  C    G  L +IMEY+  GS  D +         + +  +++ +G+ YLHS+ 
Sbjct: 68  IVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQLLLFAQQICEGMAYLHSQH 127

Query: 165 KLHRDIKAANVLLSEMGDVKLADFGVAGTL-TNTTSKRNTFVG-TP-FWMAPEVIKQSAY 221
            +HRD+ A NVLL     VK+ DFG+A  +       R    G +P FW A E +K++ +
Sbjct: 128 YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKF 187

Query: 222 DSKADIWSLGITAIEL-----AKGEPP----------NSELHPMRVLFLIPKNNPPQLTG 266
              +D+WS G+T  EL     +K  PP            ++  +R++ L+ +        
Sbjct: 188 SYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERGMRLPCPK 247

Query: 267 NYTKQFKEFVEACLNKDPENRPTAKELL 294
           N  ++    ++ C   + + RPT + L+
Sbjct: 248 NCPQEVYILMKNCWETEAKFRPTFRSLI 275

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 96.1 bits (239), Expect = 5e-22
 Identities = 73/249 (29%), Positives = 118/249 (47%), Gaps = 32/249 (12%)

Query: 65  IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDE--IEDIQQEIMVLSQCDSPY------ 116
           +GKG FGEV       T ++ A K ++ +  +     E    E  +L++  S +      
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60

Query: 117 ----GTKLWIIMEYLGGGSA------LDLMKAGNFEEMHIAVILREVLKGLDYLHSERKL 166
                T L ++M  + GG        +D    G F E        +++ GL++LH  R +
Sbjct: 61  AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPG-FPEPRACFYTAQIISGLEHLHQRRII 119

Query: 167 HRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKAD 226
           +RD+K  NVLL   G+V+++D G+A  L +  SK   + GTP +MAPE+++   YD   D
Sbjct: 120 YRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQGEEYDFSVD 179

Query: 227 IWSLGITAIEL--------AKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEA 278
            ++LG+T  E+        A+GE   ++    R+L     N+       ++   K F EA
Sbjct: 180 YFALGVTLYEMIAARGPFRARGEKVENKELKQRIL-----NDSVTYPDKFSPASKSFCEA 234

Query: 279 CLNKDPENR 287
            L KDPE R
Sbjct: 235 LLAKDPEKR 243

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 95.1 bits (236), Expect = 8e-22
 Identities = 71/252 (28%), Positives = 116/252 (46%), Gaps = 25/252 (9%)

Query: 63  ERIGKGSFGEVFKGIDNRTQQVVAIKIID---------LEEAED----EIEDIQQEIMVL 109
           +++G G FGEV+ G  N   +V A+K +          LEEA+       + + Q   V+
Sbjct: 12  KKLGNGQFGEVWMGTWNGNTKV-AVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVV 70

Query: 110 SQCDSPYGTKLWIIMEYLGGGSALDLMKAGNFEEMHIAVIL---REVLKGLDYLHSERKL 166
           S+        ++I+ EY+  GS LD +K G    + +  ++    +V  G+ Y+     +
Sbjct: 71  SE------EPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYI 124

Query: 167 HRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPF-WMAPEVIKQSAYDSKA 225
           HRD+++AN+L+ +    K+ADFG+A  + +           P  W APE      +  K+
Sbjct: 125 HRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 184

Query: 226 DIWSLGITAIEL-AKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDP 284
           D+WS GI   EL  KG  P   ++   VL  + +        +      E +  C  KDP
Sbjct: 185 DVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPCPQDCPISLHELMLQCWKKDP 244

Query: 285 ENRPTAKELLKF 296
           E RPT + L  F
Sbjct: 245 EERPTFEYLQSF 256

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 96.0 bits (239), Expect = 8e-22
 Identities = 82/297 (27%), Positives = 138/297 (46%), Gaps = 59/297 (19%)

Query: 59  FTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQ--QEIMVLSQCDSPY 116
           F    +IG+G++G+V+K  D  T ++VA+K + L+  E E   I   +EI +L Q +   
Sbjct: 9   FDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDN-EKEGFPITAIREIKILRQLNHRN 67

Query: 117 GTKL--------------------WIIMEYLGGGSALDLMKAG--NFEEMHIAVILREVL 154
              L                    +++ EY+     + L+++G  +F E HI   ++++L
Sbjct: 68  IVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLL 126

Query: 155 KGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKR--NTFVGTPFWMA 212
           +GL+Y H +  LHRDIK +N+LL+  G +KLADFG+A  L N+   R     V T ++  
Sbjct: 127 EGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLA-RLYNSEESRPYTNKVITLWYRP 185

Query: 213 PE-VIKQSAYDSKADIWSLGITAIELAKGEP---PNSELHPMRVLFLI------------ 256
           PE ++ +  Y    D+WS G    EL   +P    N EL  + ++  +            
Sbjct: 186 PELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAVWPDV 245

Query: 257 ---PKNNPPQLTGNYTKQFKE-----------FVEACLNKDPENRPTAKELLKFPFI 299
              P  N  +    Y ++ +E            ++  L  DP  R TA+E L  P++
Sbjct: 246 IKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL 302

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 94.7 bits (235), Expect = 1e-21
 Identities = 73/263 (27%), Positives = 125/263 (47%), Gaps = 25/263 (9%)

Query: 48  RNSLKVDPELIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIID---------LEEAEDE 98
           R SL++D         ++G+G FGEV+ G  N T +V AIK +          L+EA+  
Sbjct: 5   RESLRLDV--------KLGQGCFGEVWMGTWNGTTKV-AIKTLKPGTMMPEAFLQEAQIM 55

Query: 99  IEDIQQEIMVLSQCDSPYGTKLWIIMEYLGGGSALDLMKAGNFEEMHIAVIL---REVLK 155
            +    +++ L    S     ++I+ E++G GS LD +K G+ + + +  ++    ++  
Sbjct: 56  KKLRHDKLVPLYAVVSE--EPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIAD 113

Query: 156 GLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPF-WMAPE 214
           G+ Y+     +HRD++AAN+L+ +    K+ADFG+A  + +           P  W APE
Sbjct: 114 GMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPE 173

Query: 215 VIKQSAYDSKADIWSLGITAIEL-AKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFK 273
                 +  K+D+WS GI   EL  KG  P   +    VL  + +           +   
Sbjct: 174 AALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMPCPQGCPESLH 233

Query: 274 EFVEACLNKDPENRPTAKELLKF 296
           E ++ C  KDP+ RPT + +  F
Sbjct: 234 ELMKLCWKKDPDERPTFEYIQSF 256

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 96.6 bits (241), Expect = 1e-21
 Identities = 70/310 (22%), Positives = 124/310 (40%), Gaps = 88/310 (28%)

Query: 58  IFTKQERIGKGSFGEVFKGIDNRTQQVVAIK----------------------------- 88
            +     +G G++G+V    D +T + VAIK                             
Sbjct: 16  RYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHEN 75

Query: 89  IIDLEEA---EDEIEDIQQEIMVLSQCDSPYGTKLWIIMEYLGGGSALDL---MKAGNFE 142
           +I L +       +ED Q   +V                  +G     DL   +K     
Sbjct: 76  VIGLLDVFTPASSLEDFQDVYLV---------------THLMGA----DLNNIVKCQKLS 116

Query: 143 EMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRN 202
           + HI  ++ ++L+GL Y+HS   +HRD+K +N+ ++E  ++K+ DFG+A    +T  +  
Sbjct: 117 DDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLA---RHTDDEMT 173

Query: 203 TFVGTPFWMAPEVI-KQSAYDSKADIWSLGITAIELAKGEP------------------- 242
            +V T ++ APE++     Y+   DIWS+G    EL  G+                    
Sbjct: 174 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVG 233

Query: 243 -PNSEL----------HPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPENRPTAK 291
            P+ EL          + ++ L  +PK +  ++         + +E  L  DP+ R TA 
Sbjct: 234 TPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAA 293

Query: 292 ELLKFPFIRK 301
           E L  P++ +
Sbjct: 294 EALAHPYLAE 303

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 94.8 bits (236), Expect = 1e-21
 Identities = 70/264 (26%), Positives = 118/264 (44%), Gaps = 40/264 (15%)

Query: 63  ERIGKGSFGEVFKGI-DNRTQQV--VAIKIIDLEEAEDEIEDIQQEIMVLSQCDSP---- 115
           +++G GSFG V +G       +V  VA+K +  ++  D ++D  +E  ++   D      
Sbjct: 1   KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIR 60

Query: 116 -YGT----KLWIIMEYLGGGSALDLMKAGNFEEMHIAVILR---EVLKGLDYLHSERKLH 167
            YG      L ++ E    GS LD ++        I+ +     ++  G+ YL S+R +H
Sbjct: 61  LYGVVLTHPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIH 120

Query: 168 RDIKAANVLLSEMGDVKLADFGVAGTLTNT----TSKRNTFVGTPF-WMAPEVIKQSAYD 222
           RD+ A N+LL+    VK+ DFG+   L         + +  V  PF W APE ++   + 
Sbjct: 121 RDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKV--PFAWCAPESLRTRTFS 178

Query: 223 SKADIWSLGITAIEL-AKGEPPNSELHPMRVLFLI---------PKNNPPQLTGNYTKQF 272
             +D+W  G+T  E+   GE P + L   ++L  I         P+  P  +   Y    
Sbjct: 179 HASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEACPQDI---YNVML 235

Query: 273 KEFVEACLNKDPENRPTAKELLKF 296
           +     C   +P +RPT   L +F
Sbjct: 236 Q-----CWAHNPADRPTFAALREF 254

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 95.8 bits (238), Expect = 1e-21
 Identities = 74/245 (30%), Positives = 108/245 (44%), Gaps = 23/245 (9%)

Query: 65  IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIM-----VLSQCDSPY--- 116
           IGKGSFG+V            A+K++  +    + E  Q  IM     +L     P+   
Sbjct: 3   IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKE--QNHIMAERNVLLKNLKHPFLVG 60

Query: 117 -------GTKLWIIMEYLGGGSA-LDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHR 168
                    KL+ +++Y+ GG     L +   F E        EV   + YLHS   ++R
Sbjct: 61  LHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYR 120

Query: 169 DIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIW 228
           D+K  N+LL   G V L DFG+           +TF GTP ++APEV+++  YD   D W
Sbjct: 121 DLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRKEPYDRTVDWW 180

Query: 229 SLGITAIELAKGEPP--NSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPEN 286
            LG    E+  G PP  + ++  M    L   + P QL G  T    + +   L+KD   
Sbjct: 181 CLGAVLYEMLYGLPPFYSRDVSQMYDNIL---HKPLQLPGGKTVAACDLLVGLLHKDQRR 237

Query: 287 RPTAK 291
           R  AK
Sbjct: 238 RLGAK 242

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 95.2 bits (237), Expect = 1e-21
 Identities = 64/209 (30%), Positives = 104/209 (49%), Gaps = 36/209 (17%)

Query: 59  FTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSP--- 115
           F + E++G+G++  V+KG +  T ++VA+K I L+  E       +EI ++ +       
Sbjct: 2   FKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIV 61

Query: 116 -------YGTKLWIIMEYL-----------GGGSALDLMKAGNFEEMHIAVILREVLKGL 157
                     KL ++ EY+           G   ALD     +F   +      ++LKG+
Sbjct: 62  RLHDVIHTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSF--TY------QLLKGI 113

Query: 158 DYLHSERKLHRDIKAANVLLSEMGDVKLADFGVA---GTLTNTTSKRNTFVGTPFWMAPE 214
            + H  R LHRD+K  N+L+++ G++KLADFG+A   G   NT S     V T ++ AP+
Sbjct: 114 AFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNE---VVTLWYRAPD 170

Query: 215 VIKQS-AYDSKADIWSLGITAIELAKGEP 242
           V+  S  Y +  DIWS+G    E+  G P
Sbjct: 171 VLLGSRTYSTSIDIWSVGCIMAEMITGRP 199

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 94.2 bits (234), Expect = 1e-21
 Identities = 68/242 (28%), Positives = 117/242 (48%), Gaps = 19/242 (7%)

Query: 65  IGKGSFGEVFKGI-DNRTQQV-VAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPY------ 116
           +G G+FG V KG+   R +Q+ VAIK++  E  +   +++ +E  ++ Q D+PY      
Sbjct: 3   LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62

Query: 117 ---GTKLWIIMEYLGGGSALDLMKAGNFEEM---HIAVILREVLKGLDYLHSERKLHRDI 170
                 L ++ME   GG  L+   +G  +E+   ++  ++ +V  G+ YL  +  +HRD+
Sbjct: 63  VCEAEALMLVMEMASGGP-LNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDL 121

Query: 171 KAANVLLSEMGDVKLADFGVAGTLTNTTS--KRNTFVGTPF-WMAPEVIKQSAYDSKADI 227
            A NVLL      K++DFG++  L    S  K  +    P  W APE I    + S++D+
Sbjct: 122 AARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFSSRSDV 181

Query: 228 WSLGITAIE-LAKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPEN 286
           WS GIT  E  + G+ P  ++    V+  I +            +    ++ C     E+
Sbjct: 182 WSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRLDCPAECPPEMYALMKDCWIYKWED 241

Query: 287 RP 288
           RP
Sbjct: 242 RP 243

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 95.9 bits (239), Expect = 2e-21
 Identities = 68/230 (29%), Positives = 104/230 (45%), Gaps = 51/230 (22%)

Query: 65  IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA--EDEIEDIQQEIMVLSQCDSPYGTK--- 119
           IG+G+FGEV       T  + A+K +   E   ++++  ++ E  +L++ D+P+  K   
Sbjct: 9   IGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYY 68

Query: 120 -------LWIIMEYLGGGSALD-LMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIK 171
                  L++IMEYL GG  +  LMK   F E      + E +  +D +H    +HRDIK
Sbjct: 69  SFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIK 128

Query: 172 AANVLLSEMGDVKLADFG-------------------------VAGTLTNTTSKRNT--- 203
             N+LL   G +KL+DFG                         +       +SKR     
Sbjct: 129 PDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETW 188

Query: 204 ----------FVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPP 243
                      VGTP ++APEV  Q+ Y+ + D WSLG+   E+  G PP
Sbjct: 189 KRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPP 238

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 93.9 bits (233), Expect = 2e-21
 Identities = 66/241 (27%), Positives = 119/241 (49%), Gaps = 16/241 (6%)

Query: 63  ERIGKGSFGEVFKGIDNRTQQVVAIKIID---------LEEAEDEIEDIQQEIMVLSQCD 113
           +++G G FGEV+ G  N + +V A+K +          LEEA + ++ +Q + +V     
Sbjct: 12  KKLGAGQFGEVWMGYYNNSTKV-AVKTLKPGTMSVQAFLEEA-NLMKTLQHDKLVRLYAV 69

Query: 114 SPYGTKLWIIMEYLGGGSALDLMKAGNFEEMHIAVIL---REVLKGLDYLHSERKLHRDI 170
                 ++II EY+  GS LD +K+    ++ +  ++    ++ +G+ Y+  +  +HRD+
Sbjct: 70  VTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDL 129

Query: 171 KAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPF-WMAPEVIKQSAYDSKADIWS 229
           +AANVL+SE    K+ADFG+A  + +           P  W APE I   ++  K+D+WS
Sbjct: 130 RAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWS 189

Query: 230 LGITAIELAK-GEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPENRP 288
            GI   E+   G+ P   +    V+  + +        N   +  + ++ C  +  E RP
Sbjct: 190 FGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMPRMENCPDELYDIMKTCWKEKAEERP 249

Query: 289 T 289
           T
Sbjct: 250 T 250

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 94.7 bits (235), Expect = 2e-21
 Identities = 69/236 (29%), Positives = 121/236 (51%), Gaps = 21/236 (8%)

Query: 59  FTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDE----------IEDIQQEIMV 108
           + K +++G+G++  V+KG    T  +VA+K I LE  E            ++D++   +V
Sbjct: 8   YIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIV 67

Query: 109 LSQCDSPYGTKLWIIMEYLGGGSALDLMKAGNFEEMH-IAVILREVLKGLDYLHSERKLH 167
                      L ++ EYL       L   GN   MH + + L ++L+GL+Y H  + LH
Sbjct: 68  TLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLH 127

Query: 168 RDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSA-YDSKAD 226
           RD+K  N+L++E G++KLADFG+A   +  T   +  V T ++  P+++  S  Y ++ D
Sbjct: 128 RDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLGSTDYSTQID 187

Query: 227 IWSLGITAIELAKGEP--PNS----ELHPM-RVLFLIPKNNPPQLTGNYTKQFKEF 275
           +W +G    E++ G P  P S    +LH + R+L    +   P +  N  ++FK +
Sbjct: 188 MWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSN--EEFKSY 241

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 95.5 bits (237), Expect = 3e-21
 Identities = 75/234 (32%), Positives = 106/234 (45%), Gaps = 50/234 (21%)

Query: 59  FTKQERIGKGSFGEVFKGIDNRTQQVVAIKII---DLEEAEDEIEDIQQEIMVLSQCDSP 115
           F   + IG+G+FGEV       T  V A+KI+   D+ E E ++  I+ E  +L + DS 
Sbjct: 3   FESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKE-QVGHIRAERDILVEADSL 61

Query: 116 YGTK----------LWIIMEYLGGGSALDL-MKAGNFEEMHIAVILREVLKGLDYLHSER 164
           +  K          L++IME+L GG  + L MK     E      + E +  +D +H   
Sbjct: 62  WVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLG 121

Query: 165 KLHRDIKAANVLLSEMGDVKLADFGVAG----------------------TLTNTTSKRN 202
            +HRDIK  N+LL   G VKL+DFG+                        T  N  SKR 
Sbjct: 122 FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRK 181

Query: 203 -------------TFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPP 243
                        + VGTP ++APEV  Q+ Y+   D WSLG+   E+  G PP
Sbjct: 182 AETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 93.6 bits (233), Expect = 3e-21
 Identities = 74/269 (27%), Positives = 121/269 (44%), Gaps = 37/269 (13%)

Query: 53  VDPELIFTKQERIGKGSFGEVFKG---IDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVL 109
           +DP  +  ++  IG G FGEV +G   +  + +  VAIK +    ++ +  D   E  ++
Sbjct: 1   IDPSYVTIEKV-IGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIM 59

Query: 110 SQCDSPYGTKL----------WIIMEYLGGGSALDLM---KAGNFEEMHIAVILREVLKG 156
            Q D P   +L           II EY+  GS LD       G F    +  +LR +  G
Sbjct: 60  GQFDHPNIIRLEGVVTKSRPVMIITEYMENGS-LDKFLRENDGKFTVGQLVGMLRGIASG 118

Query: 157 LDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVG-TPF-WMAPE 214
           + YL     +HRD+ A N+L++     K++DFG++  L ++ +   T  G  P  W APE
Sbjct: 119 MKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPE 178

Query: 215 VIKQSAYDSKADIWSLGITAIE-LAKGEPPNSELHPMRVLFLI--------PKNNPPQLT 265
            I    + S +D+WS GI   E ++ GE P  ++    V+  +        P + P  L 
Sbjct: 179 AIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRLPPPMDCPSAL- 237

Query: 266 GNYTKQFKEFVEACLNKDPENRPTAKELL 294
                   + +  C  KD   RPT  +++
Sbjct: 238 -------YQLMLDCWQKDRNERPTFSQIV 259

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 95.5 bits (237), Expect = 3e-21
 Identities = 83/305 (27%), Positives = 137/305 (44%), Gaps = 44/305 (14%)

Query: 65  IGKGSFGEVFKGIDNRTQQVVAIKIID----LEEAEDEIEDIQQEIMVLSQCDSPYGTKL 120
           IG+G+FGEV       +Q+V A+K++     ++ ++      +++IM  +  +SP+  +L
Sbjct: 51  IGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFA--NSPWVVQL 108

Query: 121 ----------WIIMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDI 170
                     +++MEY+ GG  ++LM   +  E        EV+  LD +HS   +HRD+
Sbjct: 109 FCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDAIHSMGLIHRDV 168

Query: 171 KAANVLLSEMGDVKLADFGVAGTLTNTTSKR-NTFVGTPFWMAPEVIKQSA----YDSKA 225
           K  N+LL + G +KLADFG    +  T   R +T VGTP +++PEV+K       Y  + 
Sbjct: 169 KPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGREC 228

Query: 226 DIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPE 285
           D WS+G+   E+  G+ P                    L G Y+K           +D E
Sbjct: 229 DWWSVGVFLFEMLVGDTPFY---------------ADSLVGTYSKIMDHKNSLNFPEDVE 273

Query: 286 NRPTAKELL-KFPFIRKAKKNAYLIDLIDRYK-------KWKNSRNEESETESETSDNED 337
               AK L+  F   R+ +     ++ I ++         W N R   +    E S + D
Sbjct: 274 ISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKNDQWNWDNIRETAAPVVPELSSDID 333

Query: 338 SIKTD 342
           S   D
Sbjct: 334 SSNFD 338

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 93.5 bits (232), Expect = 4e-21
 Identities = 56/192 (29%), Positives = 104/192 (54%), Gaps = 12/192 (6%)

Query: 63  ERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAE----------DEIEDIQQEIMVLSQC 112
           E++G+GS+  V+KGI     Q+VA+K+I ++  E            ++ ++   +VL   
Sbjct: 11  EKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHD 70

Query: 113 DSPYGTKLWIIMEYLGGGSALDLMK-AGNFEEMHIAVILREVLKGLDYLHSERKLHRDIK 171
                  L  + EY+    A  +++  G     ++ + + ++L+GL Y+H +  LHRD+K
Sbjct: 71  IIHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLK 130

Query: 172 AANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSA-YDSKADIWSL 230
             N+L+S +G++KLADFG+A   +  +   ++ V T ++  P+V+  +  Y S  DIW  
Sbjct: 131 PQNLLISYLGELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGA 190

Query: 231 GITAIELAKGEP 242
           G   IE+ +G+P
Sbjct: 191 GCIFIEMLQGQP 202

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 94.4 bits (234), Expect = 4e-21
 Identities = 65/245 (26%), Positives = 118/245 (48%), Gaps = 22/245 (8%)

Query: 65  IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDE--IEDIQQEIMVLSQC-DSPY----- 116
           IG+GS+ +V      +T+++ A+K++  E   D+  I+ +Q E  V  Q  + P+     
Sbjct: 3   IGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 62

Query: 117 -----GTKLWIIMEYLGGGSAL-DLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDI 170
                 ++L+ ++EY+ GG  +  + +     E H      E+   L+YLH    ++RD+
Sbjct: 63  SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDL 122

Query: 171 KAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSL 230
           K  NVLL   G +KL D+G+           +TF GTP ++APE+++   Y    D W+L
Sbjct: 123 KLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWAL 182

Query: 231 GITAIELAKGEPP--------NSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNK 282
           G+   E+  G  P        N + +    LF +      ++  + + +    +++ LNK
Sbjct: 183 GVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLKSFLNK 242

Query: 283 DPENR 287
           DP+ R
Sbjct: 243 DPKER 247

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 94.5 bits (235), Expect = 4e-21
 Identities = 68/203 (33%), Positives = 104/203 (51%), Gaps = 28/203 (13%)

Query: 65  IGKGSFGEVFKGIDNRTQQVVAIKIID----LEEAEDEIEDIQQEIMVLSQCDSPYGTKL 120
           IG+G+FGEV       T QV A+KI++    L+ AE      ++E  VL   D  + T L
Sbjct: 9   IGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETAC--FREERDVLVNGDRRWITNL 66

Query: 121 ----------WIIMEYLGGGSALDLMKAGNFEEMHIAVILR----EVLKGLDYLHSERKL 166
                     +++M+Y  GG  L L+    FE+     + R    E++  +D +H    +
Sbjct: 67  HYAFQDENNLYLVMDYYVGGDLLTLLS--KFEDRLPEDMARFYLAEMVLAIDSVHQLGYV 124

Query: 167 HRDIKAANVLLSEMGDVKLADFGVAGTL-TNTTSKRNTFVGTPFWMAPEVIK-----QSA 220
           HRDIK  NVLL + G ++LADFG    L  + T + N  VGTP +++PE+++     +  
Sbjct: 125 HRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGKGR 184

Query: 221 YDSKADIWSLGITAIELAKGEPP 243
           Y  + D WSLG+   E+  GE P
Sbjct: 185 YGPECDWWSLGVCMYEMLYGETP 207

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 92.3 bits (229), Expect = 6e-21
 Identities = 82/266 (30%), Positives = 132/266 (49%), Gaps = 36/266 (13%)

Query: 53  VDPELIFTKQERIGKGSFGEVFKGI-DNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQ 111
           + P  +   QE IG G FG V+ G    + +  VAIK I  E A  E ED  +E  V+ +
Sbjct: 1   IHPSELTLVQE-IGSGQFGLVWLGYWLEKRK--VAIKTIR-EGAMSE-EDFIEEAQVMMK 55

Query: 112 CDSP-----YG-----TKLWIIMEYLGGGSALDLMKA--GNFEEMHIAVILREVLKGLDY 159
              P     YG     + + ++ E++  G   D ++A  G F +  +  +  +V +G+ Y
Sbjct: 56  LSHPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAY 115

Query: 160 LHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPF---WMAPEVI 216
           L S   +HRD+ A N L+ E   VK++DFG+   + +     +T  GT F   W +PEV 
Sbjct: 116 LESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSST--GTKFPVKWSSPEVF 173

Query: 217 KQSAYDSKADIWSLGITAIEL-AKGEPP-----NSE-LHPMRVLFLIPKNNPPQLTGNYT 269
             S Y SK+D+WS G+   E+ ++G+ P     NSE +  +   F + K   P+L    +
Sbjct: 174 SFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYK---PRLA---S 227

Query: 270 KQFKEFVEACLNKDPENRPTAKELLK 295
           +   E ++ C  + PE+RP+   LL 
Sbjct: 228 QSVYELMQHCWKERPEDRPSFSLLLH 253

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 93.0 bits (231), Expect = 7e-21
 Identities = 68/205 (33%), Positives = 108/205 (52%), Gaps = 27/205 (13%)

Query: 59  FTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDE------------IEDIQQEI 106
           + K E+IG+G++G V+K  D  T + +A+K I LE+ EDE            ++++Q   
Sbjct: 4   YEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQ-EDEGVPSTAIREISLLKEMQHGN 62

Query: 107 MVLSQCDSPYGTK-LWIIMEYLGGGSALDLMK----AGNFEEMH--IAVILREVLKGLDY 159
           +V  Q D  +  K L+++ EYL     LDL K    + +F +    I   L ++L+G+ Y
Sbjct: 63  IVRLQ-DVVHSEKRLYLVFEYLD----LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAY 117

Query: 160 LHSERKLHRDIKAANVLLSEMGD-VKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQ 218
            HS R LHRD+K  N+L+    + +KLADFG+A             V T ++ APE++  
Sbjct: 118 CHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYRAPEILLG 177

Query: 219 S-AYDSKADIWSLGITAIELAKGEP 242
           S  Y +  DIWS+G    E+   +P
Sbjct: 178 SRHYSTPVDIWSVGCIFAEMVNQKP 202

Length = 294

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 92.7 bits (230), Expect = 7e-21
 Identities = 77/265 (29%), Positives = 118/265 (44%), Gaps = 27/265 (10%)

Query: 61  KQERIGKGSFGEVFKGI---DNRTQQV-VAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPY 116
           K + +G G FG V KGI   +  + ++ VAIK I         ++I   ++ +   D  Y
Sbjct: 11  KLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAY 70

Query: 117 ---------GTKLWIIMEYLGGGSALDLMKA--GNFEEMHIAVILREVLKGLDYLHSERK 165
                    G  L ++ +    GS LD ++    + +   +     ++ KG+ YL   R 
Sbjct: 71  IVRLLGICPGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRM 130

Query: 166 LHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTF--VGTPF-WMAPEVIKQSAYD 222
           +HR++ A N+LL     V++ADFGVA  L     K+  +    TP  WMA E I    Y 
Sbjct: 131 VHRNLAARNILLKSDSIVQIADFGVADLLY-PDDKKYFYSEHKTPIKWMALESILFGRYT 189

Query: 223 SKADIWSLGITAIELAK-GEPPNSELHPMRVLFLIPKNN---PPQLTGNYTKQFKEFVEA 278
            ++D+WS G+T  E+   G  P + + P  V  L+ K      PQ+    T      +  
Sbjct: 190 HQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGERLAQPQIC---TIDVYMVMVK 246

Query: 279 CLNKDPENRPTAKELLKFPFIRKAK 303
           C   D   RPT KEL    F R A+
Sbjct: 247 CWMIDENVRPTFKELAN-EFTRMAR 270

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 93.9 bits (233), Expect = 1e-20
 Identities = 73/234 (31%), Positives = 105/234 (44%), Gaps = 50/234 (21%)

Query: 59  FTKQERIGKGSFGEVFKGIDNRTQQVVAIKII---DLEEAEDEIEDIQQEIMVLSQCDSP 115
           F   + IG+G+FGEV       T  + A+KI+   D+ E E ++  I+ E  +L + D  
Sbjct: 3   FESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKE-QVAHIRAERDILVEADGA 61

Query: 116 YGTK----------LWIIMEYLGGGSALDL-MKAGNFEEMHIAVILREVLKGLDYLHSER 164
           +  K          L++IME+L GG  + L MK     E      + E +  +D +H   
Sbjct: 62  WVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLG 121

Query: 165 KLHRDIKAANVLLSEMGDVKLADFGVAGTLT----------------------NTTSKRN 202
            +HRDIK  N+LL   G VKL+DFG+   L                       N  SKR 
Sbjct: 122 FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRK 181

Query: 203 -------------TFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPP 243
                        + VGTP ++APEV  Q+ Y+   D WSLG+   E+  G PP
Sbjct: 182 AETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 91.7 bits (228), Expect = 1e-20
 Identities = 70/261 (26%), Positives = 124/261 (47%), Gaps = 40/261 (15%)

Query: 59  FTKQERIGKGSFGEVFKGI-DNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPY- 116
           FT + ++G G FGEV++G+  NR +  VAIKI+   +   + +D Q+E+  L +    + 
Sbjct: 8   FTLERKLGSGYFGEVWEGLWKNRVR--VAIKILK-SDDLLKQQDFQKEVQALKRLRHKHL 64

Query: 117 ---------GTKLWIIMEYLGGGSALDLMKAGNFEEMHIAVILR---EVLKGLDYLHSER 164
                    G  ++II E +  GS L  +++   + + +A ++    +V +G+ YL  + 
Sbjct: 65  ISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQN 124

Query: 165 KLHRDIKAANVLLSEMGDVKLADFGVAGTLTN---TTSKRNTFVGTPFWMAPEVIKQSAY 221
            +HRD+ A N+L+ E    K+ADFG+A  +      +S +        W APE      +
Sbjct: 125 SIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYK---WTAPEAASHGTF 181

Query: 222 DSKADIWSLGITAIEL-AKGEPPNSELHPMRVLFLI--------PKNNPPQLTGNYTKQF 272
            +K+D+WS GI   E+   G+ P   ++   V   I        P   P ++        
Sbjct: 182 STKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRMPCPAKCPQEI-------- 233

Query: 273 KEFVEACLNKDPENRPTAKEL 293
            + +  C   +PE+RP+ K L
Sbjct: 234 YKIMLECWAAEPEDRPSFKAL 254

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 91.7 bits (227), Expect = 1e-20
 Identities = 71/248 (28%), Positives = 111/248 (44%), Gaps = 19/248 (7%)

Query: 64  RIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTKLW-- 121
           ++G+G FGEV+ G  N T +V AIK   L+      E   QE  V+ +       +L+  
Sbjct: 13  KLGQGCFGEVWMGTWNGTTRV-AIKT--LKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 69

Query: 122 -------IIMEYLGGGSALDLMKAGNFEEM----HIAVILREVLKGLDYLHSERKLHRDI 170
                  I+ EY+  GS LD +K G   +      +  +  ++  G+ Y+     +HRD+
Sbjct: 70  VSEEPIYIVTEYMSKGSLLDFLK-GEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDL 128

Query: 171 KAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPF-WMAPEVIKQSAYDSKADIWS 229
           +AAN+L+ E    K+ADFG+A  + +           P  W APE      +  K+D+WS
Sbjct: 129 RAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWS 188

Query: 230 LGITAIELA-KGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPENRP 288
            GI   EL  KG  P   +    VL  + +           +   + +  C  K+PE RP
Sbjct: 189 FGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERP 248

Query: 289 TAKELLKF 296
           T + L  F
Sbjct: 249 TFEYLQAF 256

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 91.5 bits (227), Expect = 1e-20
 Identities = 71/257 (27%), Positives = 115/257 (44%), Gaps = 32/257 (12%)

Query: 65  IGKGSFGEVFKGI------DNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGT 118
           +G G+FGEV++G              VA+K +     + E ++  +E  ++S  + P   
Sbjct: 3   LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIV 62

Query: 119 KL----------WIIMEYLGGGSALDLMKAGNFEEMHIAVI-LREVL-------KGLDYL 160
           KL          +IIME + GG  L  ++    E     ++ L+E+L       KG  YL
Sbjct: 63  KLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYL 122

Query: 161 HSERKLHRDIKAANVLLSEMGD-----VKLADFGVAGTL--TNTTSKRNTFVGTPFWMAP 213
                +HRD+ A N L+SE G      VK+ DFG+A  +  ++   K    +    WMAP
Sbjct: 123 EQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWMAP 182

Query: 214 EVIKQSAYDSKADIWSLGITAIE-LAKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQF 272
           E +    + +++D+WS G+   E L  G+ P   L+   VL  +      Q   N   + 
Sbjct: 183 ESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGGRLQKPENCPDKI 242

Query: 273 KEFVEACLNKDPENRPT 289
            + +  C  +DP  RPT
Sbjct: 243 YQLMTNCWAQDPSERPT 259

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 91.2 bits (226), Expect = 2e-20
 Identities = 67/214 (31%), Positives = 100/214 (46%), Gaps = 21/214 (9%)

Query: 60  TKQERIGKGSFGEVFKGI---DNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPY 116
           TKQ+ IG G FGEVF+GI     R +  VAIK +     E + +D   E  ++ Q     
Sbjct: 8   TKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHN 67

Query: 117 GTKL----------WIIMEYLGGGSALDLM---KAGNFEEMHIAVILREVLKGLDYLHSE 163
             +L           II EY+  G ALD       G F    +  +LR +  G+ YL   
Sbjct: 68  IIRLEGVVTKFKPAMIITEYMENG-ALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDM 126

Query: 164 RKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPF---WMAPEVIKQSA 220
             +HRD+ A N+L++   + K++DFG++  L +      T  G      W APE I    
Sbjct: 127 NYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRK 186

Query: 221 YDSKADIWSLGITAIE-LAKGEPPNSELHPMRVL 253
           + S +D+WS GI   E ++ GE P  ++    V+
Sbjct: 187 FTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVM 220

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 90.4 bits (224), Expect = 5e-20
 Identities = 77/274 (28%), Positives = 131/274 (47%), Gaps = 45/274 (16%)

Query: 65  IGKGSFGEVF---KGIDNRTQQVVAIKIID---LEEAEDEIEDIQQEIMVLSQC-DSPY- 116
           +G G++G+VF   K   + + ++ A+K++    + +     E  + E  VL     SP+ 
Sbjct: 8   LGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFL 67

Query: 117 ---------GTKLWIIMEYLGGGSALD-LMKAGNFEEMHIAVILREVLKGLDYLHSERKL 166
                     TKL +I++Y+ GG     L +   F+E  + +   E++  L++LH    +
Sbjct: 68  VTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGII 127

Query: 167 HRDIKAANVLLSEMGDVKLADFGVAGT-LTNTTSKRNTFVGTPFWMAPEVIK--QSAYDS 223
           +RDIK  N+LL   G V L DFG++     +   +  +F GT  +MAP++++     +D 
Sbjct: 128 YRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDK 187

Query: 224 KADIWSLGITAIELAKGEPP-------NSELHPMRVLFLIPKNNPPQLTGNYTKQF---- 272
             D WS+G+   EL  G  P       NS+    R    I K+ PP     Y ++     
Sbjct: 188 AVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISR---RILKSEPP-----YPQEMSALA 239

Query: 273 KEFVEACLNKDPENR----PT-AKELLKFPFIRK 301
           K+ ++  L KDP+ R    P+ A E+ K PF +K
Sbjct: 240 KDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQK 273

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 89.8 bits (223), Expect = 6e-20
 Identities = 59/202 (29%), Positives = 101/202 (50%), Gaps = 21/202 (10%)

Query: 59  FTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEI-EDIQQEIMVLSQCDSP-- 115
           + K E+IG+G++G VFK  +  T ++VA+K + L++ ++ +     +EI +L +      
Sbjct: 2   YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNI 61

Query: 116 --------YGTKLWIIMEYLGGGSALDLMK-----AGNFEEMHIAVILREVLKGLDYLHS 162
                      KL ++ EY       DL K      G+ +   +   + ++LKGL + HS
Sbjct: 62  VRLYDVLHSDKKLTLVFEYCDQ----DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHS 117

Query: 163 ERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVI-KQSAY 221
              LHRD+K  N+L+++ G++KLADFG+A          +  V T ++  P+V+     Y
Sbjct: 118 HNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLY 177

Query: 222 DSKADIWSLGITAIELAKGEPP 243
            +  D+WS G    ELA    P
Sbjct: 178 STSIDMWSAGCIFAELANAGRP 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 89.3 bits (221), Expect = 7e-20
 Identities = 63/241 (26%), Positives = 114/241 (47%), Gaps = 17/241 (7%)

Query: 65  IGKGSFGEVFKGI--DNRTQQVVAIKIIDLEEAEDEIED-IQQEIMVLSQCDSPYGTKL- 120
           +G G+FG V KG+    ++++ VA+KI+  +  +  ++D + +E  V+ Q D+PY  ++ 
Sbjct: 3   LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62

Query: 121 -------WIIMEYLGGGSALD--LMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIK 171
                  W+++  L     L+  L K  +  E +I  ++ +V  G+ YL     +HRD+ 
Sbjct: 63  GICEAESWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLA 122

Query: 172 AANVLLSEMGDVKLADFGVAGTLTNTTS--KRNTFVGTPF-WMAPEVIKQSAYDSKADIW 228
           A NVLL      K++DFG++  L    +  K  T    P  W APE +    + SK+D+W
Sbjct: 123 ARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVW 182

Query: 229 SLGITAIE-LAKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPENR 287
           S G+   E  + G+ P   +    V  +I      +       +  + ++ C     + R
Sbjct: 183 SFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERMECPQRCPPEMYDLMKLCWTYGVDER 242

Query: 288 P 288
           P
Sbjct: 243 P 243

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 89.9 bits (223), Expect = 7e-20
 Identities = 76/273 (27%), Positives = 120/273 (43%), Gaps = 48/273 (17%)

Query: 65  IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIM------VLSQCDSP--- 115
           +GKG FGEV       T ++ A K ++    +  I+  + E M      +L + +S    
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKKLE----KKRIKKRKGEAMALNEKQILEKVNSRFVV 63

Query: 116 -----YGTK--LWIIMEYLGGGSALDL------MKAGNFEEMHIAVILREVLKGLDYLHS 162
                Y TK  L +++  + GG   DL      M    F+E        E+  GL+ LH 
Sbjct: 64  SLAYAYETKDALCLVLTLMNGG---DLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHR 120

Query: 163 ERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYD 222
           ER ++RD+K  N+LL + G ++++D G+A  +    + R   VGT  +MAPEV+K   Y 
Sbjct: 121 ERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGR-VGTVGYMAPEVVKNERYT 179

Query: 223 SKADIWSLGITAIELAKGEPP--------NSELHPMRVLFLIPKNNPPQLTGNYTKQFKE 274
              D W LG    E+ +G+ P          E    RV     K +  + +  +++  + 
Sbjct: 180 FSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRV-----KEDQEEYSEKFSEAARS 234

Query: 275 FVEACLNKDPENR-----PTAKELLKFPFIRKA 302
                L KDP  R       A+E+   PF R A
Sbjct: 235 ICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTA 267

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 88.9 bits (220), Expect = 1e-19
 Identities = 69/256 (26%), Positives = 121/256 (47%), Gaps = 37/256 (14%)

Query: 59  FTKQERIGKGSFGEVFKGIDNRTQQVVAIKIID--------LEEAEDEIEDIQQEIMV-- 108
            T  E IG+G FG V +G    T Q VA+K I         LEE    +  +  + +V  
Sbjct: 8   LTLGEIIGEGEFGAVLQG--EYTGQKVAVKNIKCDVTAQAFLEETA-VMTKLHHKNLVRL 64

Query: 109 ----LSQCDSPYGTKLWIIMEYLGGGSALDLMKAGNFEEMHIAVILR---EVLKGLDYLH 161
               L          L+I+ME +  G+ ++ ++      + +  +L+   +V +G++YL 
Sbjct: 65  LGVILHN-------GLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLE 117

Query: 162 SERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAY 221
           S++ +HRD+ A N+L+SE G  K++DFG+A     +    N+ +    W APE +K   +
Sbjct: 118 SKKLVHRDLAARNILVSEDGVAKVSDFGLAR--VGSMGVDNSKLPVK-WTAPEALKHKKF 174

Query: 222 DSKADIWSLGITAIEL-AKGEPPNSELHPMRVLFLIPKN---NPPQLTGNYTKQFKEFVE 277
            SK+D+WS G+   E+ + G  P  ++    V   + K     PP+            + 
Sbjct: 175 SSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRMEPPE---GCPADVYVLMT 231

Query: 278 ACLNKDPENRPTAKEL 293
           +C   +P+ RP+  +L
Sbjct: 232 SCWETEPKKRPSFHKL 247

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 88.5 bits (219), Expect = 1e-19
 Identities = 70/250 (28%), Positives = 109/250 (43%), Gaps = 31/250 (12%)

Query: 63  ERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTKL-- 120
           ERIG+G+FGEVF G        VA+K        D      QE  +L Q   P   +L  
Sbjct: 1   ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIG 60

Query: 121 --------WIIMEYLGGGSALDLMKAGNFEEMHIAVILREVLK-------GLDYLHSERK 165
                   +I+ME + GG  L  ++    E   + V  +E+++       G++YL S+  
Sbjct: 61  VCTQKQPIYIVMELVQGGDFLTFLRT---EGPRLKV--KELIQMVENAAAGMEYLESKHC 115

Query: 166 LHRDIKAANVLLSEMGDVKLADFGVA-----GTLTNTTSKRNTFVGTPFWMAPEVIKQSA 220
           +HRD+ A N L++E   +K++DFG++     G   +T   +   V    W APE +    
Sbjct: 116 IHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVK---WTAPEALNYGR 172

Query: 221 YDSKADIWSLGITAIE-LAKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEAC 279
           Y S++D+WS GI   E  + G  P + L   +    I +                 +E C
Sbjct: 173 YSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRLPCPELCPDAVYRLMERC 232

Query: 280 LNKDPENRPT 289
              DP  RP+
Sbjct: 233 WEYDPGQRPS 242

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 88.5 bits (219), Expect = 1e-19
 Identities = 65/256 (25%), Positives = 119/256 (46%), Gaps = 25/256 (9%)

Query: 48  RNSLKVDPELIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIID---------LEEAEDE 98
           R SLK++        +++G G FGEV+    N+  +V A+K +          L EA + 
Sbjct: 5   RESLKLE--------KKLGAGQFGEVWMATYNKHTKV-AVKTMKPGSMSVEAFLAEA-NV 54

Query: 99  IEDIQQEIMVLSQCDSPYGTKLWIIMEYLGGGSALDLMKAGNFEEMHIAVIL---REVLK 155
           ++ +Q + +V           ++II E++  GS LD +K+    +  +  ++    ++ +
Sbjct: 55  MKTLQHDKLVKLHA-VVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAE 113

Query: 156 GLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPF-WMAPE 214
           G+ ++     +HRD++AAN+L+S     K+ADFG+A  + +           P  W APE
Sbjct: 114 GMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPE 173

Query: 215 VIKQSAYDSKADIWSLGITAIELAK-GEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFK 273
            I   ++  K+D+WS GI  +E+   G  P   +    V+  + +        N  ++  
Sbjct: 174 AINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELY 233

Query: 274 EFVEACLNKDPENRPT 289
             +  C    PE RPT
Sbjct: 234 NIMMRCWKNRPEERPT 249

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 89.5 bits (222), Expect = 1e-19
 Identities = 67/260 (25%), Positives = 119/260 (45%), Gaps = 33/260 (12%)

Query: 65  IGKGSFGEVFKGID---NRTQQV--VAIKIIDLEEAEDEIEDIQQEIMVLSQCDS----- 114
           +G G+FG+V +      +++  V  VA+K++       E E +  E+ ++S   +     
Sbjct: 43  LGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIV 102

Query: 115 ------PYGTKLWIIMEYLGGGSALDLM--KAGNFEE----MHIAVILREVLKGLDYLHS 162
                   G  + +I EY   G  L+ +  K  +F      +  +    +V KG+ +L S
Sbjct: 103 NLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSY---QVAKGMAFLAS 159

Query: 163 ERKLHRDIKAANVLLSEMGDVKLADFGVAGTL---TNTTSKRNTFVGTPFWMAPEVIKQS 219
           +  +HRD+ A NVLL+    VK+ DFG+A  +   +N   K N  +    WMAPE I   
Sbjct: 160 KNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVK-WMAPESIFNC 218

Query: 220 AYDSKADIWSLGITAIEL-AKGEPPNSELHPMRVLFLIPKNNPPQLTGNY--TKQFKEFV 276
            Y  ++D+WS GI   E+ + G  P   + P+   F        ++        +  + +
Sbjct: 219 VYTFESDVWSYGILLWEIFSLGSNPYPGM-PVDSKFYKLIKEGYRMAQPEHAPAEIYDIM 277

Query: 277 EACLNKDPENRPTAKELLKF 296
           + C + DP  RPT K++++ 
Sbjct: 278 KTCWDADPLKRPTFKQIVQL 297

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 90.6 bits (225), Expect = 1e-19
 Identities = 61/243 (25%), Positives = 105/243 (43%), Gaps = 60/243 (24%)

Query: 59  FTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAE----DEIEDIQQEIMVLSQCDS 114
           F K + IG G+FGEV       T  + A+K   L +A+    ++   ++ E  +L++ D+
Sbjct: 3   FVKIKTIGIGAFGEVCLVRKVDTNALYAMKT--LRKADVLMRNQAAHVKAERDILAEADN 60

Query: 115 PYGTKL----------WIIMEYLGGGSALDLM-KAGNFEEMHIAVILREVLKGLDYLHSE 163
            +  KL          + +M+Y+ GG  + L+ + G FEE      + E+   ++ +H  
Sbjct: 61  EWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKM 120

Query: 164 RKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKR---------------------- 201
             +HRDIK  N+L+   G +KL DFG+      T   +                      
Sbjct: 121 GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEI 180

Query: 202 ---------------------NTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKG 240
                                ++ VGTP ++APEV+ ++ Y    D WS+G+   E+  G
Sbjct: 181 DRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVG 240

Query: 241 EPP 243
           +PP
Sbjct: 241 QPP 243

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 89.7 bits (223), Expect = 1e-19
 Identities = 74/312 (23%), Positives = 120/312 (38%), Gaps = 94/312 (30%)

Query: 59  FTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLS--QCDSPY 116
           +     IG+G++G V       T   VAIK I   E +   +   +EI +L   + ++  
Sbjct: 7   YQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHEN-- 64

Query: 117 GTKLWIIMEYLGGGSALDLMKAGNFEEM--------------------------HIAVIL 150
                II         LD+++  +FE                            HI   L
Sbjct: 65  -----II-------GILDIIRPPSFESFNDVYIVQELMETDLYKLIKTQHLSNDHIQYFL 112

Query: 151 REVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNT---TSKRNTFVGT 207
            ++L+GL Y+HS   LHRD+K +N+LL+   D+K+ DFG+A         T     +V T
Sbjct: 113 YQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVAT 172

Query: 208 PFWMAPEVIKQSAYDSKA-DIWSLGITAIELAKGEP--PNSE-LHPMRVLF--------- 254
            ++ APE++  S   +KA DIWS+G    E+    P  P  + LH + ++          
Sbjct: 173 RWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQE 232

Query: 255 ---------------------------LIPKNNPPQLTGNYTKQFKEFVEACLNKDPENR 287
                                      L P  +P  L         + ++  L  +P  R
Sbjct: 233 DLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKAL---------DLLDKMLTFNPHKR 283

Query: 288 PTAKELLKFPFI 299
            T +E L  P++
Sbjct: 284 ITVEEALAHPYL 295

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 90.5 bits (224), Expect = 2e-19
 Identities = 62/198 (31%), Positives = 105/198 (53%), Gaps = 21/198 (10%)

Query: 65  IGKGSFGEVFKGIDNRTQQVVAIKIID----LEEAEDEIEDIQQEIMVLSQCDSPYGTKL 120
           IG+G+FGEV       T++V A+K++     ++ ++      +++IM  +  +SP+  +L
Sbjct: 51  IGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFA--NSPWVVQL 108

Query: 121 ----------WIIMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDI 170
                     +++MEY+ GG  ++LM   +  E        EV+  LD +HS   +HRD+
Sbjct: 109 FYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDV 168

Query: 171 KAANVLLSEMGDVKLADFGVAGTLTNTTSKR-NTFVGTPFWMAPEVIKQSA----YDSKA 225
           K  N+LL + G +KLADFG    +      R +T VGTP +++PEV+K       Y  + 
Sbjct: 169 KPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGREC 228

Query: 226 DIWSLGITAIELAKGEPP 243
           D WS+G+   E+  G+ P
Sbjct: 229 DWWSVGVFLYEMLVGDTP 246

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 88.5 bits (219), Expect = 2e-19
 Identities = 70/262 (26%), Positives = 116/262 (44%), Gaps = 18/262 (6%)

Query: 51  LKVDPELIFTKQERIGKGSFGEVFKGI---DNRTQQV-VAIKIIDLEEAEDEIEDIQQEI 106
           +++  E    K + +G G+FG V+KGI   D    ++ VAIK++    +    ++I  E 
Sbjct: 1   MRILKETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEA 60

Query: 107 MVLSQCDSPYGTKLW---------IIMEYLGGGSALDLMKA--GNFEEMHIAVILREVLK 155
            V++   SPY  +L          ++ + +  G  LD ++          +     ++ K
Sbjct: 61  YVMAGVGSPYVCRLLGICLTSTVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAK 120

Query: 156 GLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVG-TPF-WMAP 213
           G+ YL   R +HRD+ A NVL+     VK+ DFG+A  L    ++ +   G  P  WMA 
Sbjct: 121 GMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMAL 180

Query: 214 EVIKQSAYDSKADIWSLGITAIELAK-GEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQF 272
           E I    +  ++D+WS G+T  EL   G  P   +    +  L+ K          T   
Sbjct: 181 ESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERLPQPPICTIDV 240

Query: 273 KEFVEACLNKDPENRPTAKELL 294
              +  C   D E RP  +EL+
Sbjct: 241 YMIMVKCWMIDSECRPRFRELV 262

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 88.7 bits (220), Expect = 2e-19
 Identities = 62/211 (29%), Positives = 109/211 (51%), Gaps = 36/211 (17%)

Query: 65  IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA--EDEIEDIQQEIMVLSQCDSPYGTKLW- 121
           I  G++G V+      T+Q  A+K I+ +     ++I+ +  E  +L+  ++P+   ++ 
Sbjct: 9   ISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFC 68

Query: 122 ---------IIMEYLGGGSALDLMK-AG----NFEEMHIAVILREVLKGLDYLHSERKLH 167
                    ++MEY+ GG    L+K  G    +   M+ A    E +  L+YLH+   +H
Sbjct: 69  SFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFA----ETVLALEYLHNYGIVH 124

Query: 168 RDIKAANVLLSEMGDVKLADFGVA--GTLTNTTS------KRNT--FV-----GTPFWMA 212
           RD+K  N+L++ MG +KL DFG++  G ++ TT+      +++T  F+     GTP ++A
Sbjct: 125 RDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIA 184

Query: 213 PEVIKQSAYDSKADIWSLGITAIELAKGEPP 243
           PEVI +  Y    D W++GI   E   G  P
Sbjct: 185 PEVILRQGYGKPVDWWAMGIILYEFLVGCVP 215

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 88.1 bits (218), Expect = 3e-19
 Identities = 70/282 (24%), Positives = 129/282 (45%), Gaps = 49/282 (17%)

Query: 65  IGKGSFGEVFKGIDNRTQ-QVVAIKIIDLEEAEDEIE-DIQQEIMVLSQCDS-------- 114
           IG+G++G+VFK  D +   + VA+K + ++  E+ +     +E+ VL   ++        
Sbjct: 9   IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68

Query: 115 ----------PYGTKLWIIMEYLGGGSALDLMKAGN--FEEMHIAVILREVLKGLDYLHS 162
                        TKL ++ E++       L K          I  ++ ++L+GLD+LHS
Sbjct: 69  LFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHS 128

Query: 163 ERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYD 222
            R +HRD+K  N+L++  G +KLADFG+A  + +      + V T ++ APEV+ QS+Y 
Sbjct: 129 HRVVHRDLKPQNILVTSSGQIKLADFGLA-RIYSFQMALTSVVVTLWYRAPEVLLQSSYA 187

Query: 223 SKADIWSLGITAIELAKGEP---PNSELHPMRVLF---------------LIPKN----N 260
           +  D+WS+G    E+ + +P    +S++  +  +                 +P+      
Sbjct: 188 TPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSK 247

Query: 261 PPQLTGNYTKQF----KEFVEACLNKDPENRPTAKELLKFPF 298
             Q    +        K+ +  CL  +P  R +A   L  P+
Sbjct: 248 SAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPY 289

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 88.9 bits (220), Expect = 3e-19
 Identities = 74/268 (27%), Positives = 123/268 (45%), Gaps = 36/268 (13%)

Query: 65  IGKGSFGEVF---KGIDNRTQQVVAIKIID---LEEAEDEIEDIQQEIMVLSQC-DSPY- 116
           +G G++G+VF   K   + T ++ A+K++    L +    +E  + E  VL     SP+ 
Sbjct: 8   LGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFL 67

Query: 117 ---------GTKLWIIMEYLGGGSALD-LMKAGNFEEMHIAVILREVLKGLDYLHSERKL 166
                      KL +I++Y+ GG     L +  NF E  +     E++  L++LH    +
Sbjct: 68  VTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIV 127

Query: 167 HRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRN-TFVGTPFWMAPEVIK-QSAYDSK 224
           +RDIK  N+LL   G V L DFG++    +   +R  +F GT  +MAPE+I+ +  +   
Sbjct: 128 YRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKA 187

Query: 225 ADIWSLGITAIELAKGEPP-------NSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVE 277
            D WSLGI   EL  G  P       N++    R +       P  +      + ++ + 
Sbjct: 188 VDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFPSFI----GPEAQDLLH 243

Query: 278 ACLNKDPENR-----PTAKELLKFPFIR 300
             L KDP+ R       A E+ + PF +
Sbjct: 244 KLLRKDPKKRLGAGPQGASEIKEHPFFK 271

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 87.8 bits (217), Expect = 5e-19
 Identities = 79/291 (27%), Positives = 135/291 (46%), Gaps = 49/291 (16%)

Query: 51  LKVDPELIFTKQE-----RIGKGSFGEVFK----GIDN---RTQQVVAIKIIDLEEAEDE 98
           L  DP   F++ +      +G+G FG+V      GID    +    VA+K++  +  E +
Sbjct: 4   LPEDPRWEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKD 63

Query: 99  IEDIQQE-------------IMVLSQCDSPYGTKLWIIMEYLGGGSALDLMKAGNFEEMH 145
           + D+  E             I +L  C       L++I+EY   G+  + ++A     M 
Sbjct: 64  LSDLVSEMEMMKMIGKHKNIINLLGACTQ--DGPLYVIVEYASKGNLREYLRARRPPGME 121

Query: 146 IAV-ILR----------------EVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADF 188
            +  I R                +V +G++YL S++ +HRD+ A NVL++E   +K+ADF
Sbjct: 122 YSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADF 181

Query: 189 GVAGTLTNTTSKRNTFVGT-PF-WMAPEVIKQSAYDSKADIWSLGITAIEL-AKGEPPNS 245
           G+A  + N    + T  G  P  WMAPE +    Y  ++D+WS G+   E+   G  P  
Sbjct: 182 GLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYP 241

Query: 246 ELHPMRVLF-LIPKNNPPQLTGNYTKQFKEFVEACLNKDPENRPTAKELLK 295
            + P+  LF L+ + +      N T +    +  C +  P +RPT K+L++
Sbjct: 242 GI-PVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVE 291

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 87.3 bits (216), Expect = 5e-19
 Identities = 73/282 (25%), Positives = 125/282 (44%), Gaps = 48/282 (17%)

Query: 65  IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAED--EIEDIQQEIMV--LSQCDSP----- 115
           IG G++G V+K  D  +   VA+K + ++  ED   +  +++  ++  L   D P     
Sbjct: 8   IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67

Query: 116 ----------YGTKLWIIMEYLGGG--SALDLMKAGNFEEMHIAVILREVLKGLDYLHSE 163
                       TK+ ++ E++     + LD +         I  ++R+ L+GLD+LH+ 
Sbjct: 68  MDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHAN 127

Query: 164 RKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDS 223
             +HRD+K  N+L++  G VKLADFG+A  + +        V T ++ APEV+ QS Y +
Sbjct: 128 CIVHRDLKPENILVTSGGQVKLADFGLA-RIYSCQMALTPVVVTLWYRAPEVLLQSTYAT 186

Query: 224 KADIWSLGITAIELAKGEP---PNSELHPMRVLFLI---------------PKNN-PPQL 264
             D+WS+G    E+ + +P    NSE   +  +F +               P+    P+ 
Sbjct: 187 PVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTLPRGAFSPRG 246

Query: 265 TGNYTKQFKEFVE-------ACLNKDPENRPTAKELLKFPFI 299
                    E  E         L  +P  R +A   L+ PF 
Sbjct: 247 PRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 87.4 bits (216), Expect = 8e-19
 Identities = 74/267 (27%), Positives = 123/267 (46%), Gaps = 28/267 (10%)

Query: 51  LKVDPELIFTKQERIGKGSFGEVFKGIDN----RTQQVVAIKIIDLEEAEDEIEDIQQEI 106
           L++  E  F K + +G G+FG V+KG+      + +  VAIK +    +    ++I  E 
Sbjct: 1   LRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEA 60

Query: 107 MVLSQCDSPYGTKLW---------IIMEYLGGGSALDLMKAG--NFEEMHIAVILREVLK 155
            V++  D+P+  +L          +I + +  G  LD ++    N    ++     ++ K
Sbjct: 61  YVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 120

Query: 156 GLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVG-TPF-WMAP 213
           G++YL   R +HRD+ A NVL+     VK+ DFG+A  L     + +   G  P  WMA 
Sbjct: 121 GMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMAL 180

Query: 214 EVIKQSAYDSKADIWSLGITAIELAK-GEPPNSELHPMRVLFLIPKN----NPPQLTGN- 267
           E I    Y  ++D+WS G+T  EL   G  P   +    +  ++ K      PP  T + 
Sbjct: 181 ESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDV 240

Query: 268 YTKQFKEFVEACLNKDPENRPTAKELL 294
           Y    K     C   D ++RP  +EL+
Sbjct: 241 YMIMVK-----CWMIDADSRPKFRELI 262

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 86.4 bits (214), Expect = 8e-19
 Identities = 80/258 (31%), Positives = 122/258 (47%), Gaps = 37/258 (14%)

Query: 65  IGKGSFGEVFKG--IDNRTQQV-VAIK----IIDLEEAEDEIEDIQQEIMVLSQCDSPYG 117
           IGKG FG V+ G  ID+  Q++  A+K    I DLEE    +E   +E +++     P  
Sbjct: 3   IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEE----VEQFLKEGIIMKDFSHPNV 58

Query: 118 TKLWIIMEYLGGGS--ALDLMKAG---NF--EEMH-------IAVILREVLKGLDYLHSE 163
             L  I     G     L  MK G   NF   E H       I   L +V KG++YL S+
Sbjct: 59  LSLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGL-QVAKGMEYLASK 117

Query: 164 RKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNT---TSKRNTFVGTPF-WMAPEVIKQS 219
           + +HRD+ A N +L E   VK+ADFG+A  + +    +   +T    P  WMA E ++  
Sbjct: 118 KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQ 177

Query: 220 AYDSKADIWSLGITAIEL-AKGEPPNSELHPMRVLFLIPKNN---PPQLTGNYTKQFKEF 275
            + +K+D+WS G+   EL  +G PP  ++    +   + +      P+   +      E 
Sbjct: 178 KFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRLLQPEYCPD---PLYEV 234

Query: 276 VEACLNKDPENRPTAKEL 293
           + +C +  PE RPT  EL
Sbjct: 235 MLSCWHPKPEMRPTFSEL 252

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 87.8 bits (217), Expect = 8e-19
 Identities = 62/204 (30%), Positives = 101/204 (49%), Gaps = 30/204 (14%)

Query: 65  IGKGSFGEVFKGIDNRTQQVVAIKIID----LEEAEDEIEDIQQEIMVLSQC-------- 112
           IG+G+FGEV       T+++ A+KI++    L+ AE      ++ ++V   C        
Sbjct: 9   IGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHY 68

Query: 113 ---DSPYGTKLWIIMEYLGGGSALDLMKAGNFE----EMHIAVILREVLKGLDYLHSERK 165
              D  Y   L+++M+Y  GG  L L+    FE    E      + E++  +  +H    
Sbjct: 69  AFQDENY---LYLVMDYYVGGDLLTLLS--KFEDRLPEDMARFYIAEMVLAIHSIHQLHY 123

Query: 166 LHRDIKAANVLLSEMGDVKLADFGVAGTLT-NTTSKRNTFVGTPFWMAPEVIK-----QS 219
           +HRDIK  NVLL   G ++LADFG    +  + T + +  VGTP +++PE+++       
Sbjct: 124 VHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMG 183

Query: 220 AYDSKADIWSLGITAIELAKGEPP 243
            Y  + D WSLG+   E+  GE P
Sbjct: 184 KYGPECDWWSLGVCMYEMLYGETP 207

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 86.6 bits (215), Expect = 9e-19
 Identities = 72/282 (25%), Positives = 119/282 (42%), Gaps = 53/282 (18%)

Query: 64  RIGKGSFGEVFKGIDNRTQQVVAIKII-----DLEEAEDEIEDIQ--------QEIMVLS 110
           +IG+G+F EV K    +T +  AIK +      LE+  + + +IQ          I+ L 
Sbjct: 6   KIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQV-NNLREIQALRRLSPHPNILRLI 64

Query: 111 QC--DSPYGTKLWIIMEYLGGGSALDLMKAGN--FEEMHIAVILREVLKGLDYLHSERKL 166
           +   D   G +L ++ E L   +  +L+K       E  +   + ++LK LD++H     
Sbjct: 65  EVLFDRKTG-RLALVFE-LMDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIF 122

Query: 167 HRDIKAANVLLSEMGDV-KLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSA-YDSK 224
           HRDIK  N+L+    D+ KLADFG       +      ++ T ++ APE +     Y  K
Sbjct: 123 HRDIKPENILI--KDDILKLADFGSCRG-IYSKPPYTEYISTRWYRAPECLLTDGYYGPK 179

Query: 225 ADIWSLG---------------------ITAIELAKGEPPNSEL---HPMRVL-FLIPKN 259
            DIW++G                     I  I    G P    L      R + +  P  
Sbjct: 180 MDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNFPSK 239

Query: 260 NP---PQLTGNYTKQFKEFVEACLNKDPENRPTAKELLKFPF 298
                 +L  N + +  + ++  L  DP+ R TAK+ L+ P+
Sbjct: 240 KGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPY 281

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 85.4 bits (211), Expect = 1e-18
 Identities = 68/248 (27%), Positives = 112/248 (45%), Gaps = 17/248 (6%)

Query: 63  ERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTKL-- 120
           E +GKG+FGEVFKG   + +  VA+K    +  ++       E  +L Q D P   KL  
Sbjct: 1   ELLGKGNFGEVFKGT-LKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIG 59

Query: 121 --------WIIMEYLGGGSALDLMKAGNFEEMHIAVILR---EVLKGLDYLHSERKLHRD 169
                   +I+ME + GG  L  ++    +E+    +++   +   G+ YL S+  +HRD
Sbjct: 60  VCTQRQPIYIVMELVPGGDFLSFLRKKK-DELKTKQLVKFALDAAAGMAYLESKNCIHRD 118

Query: 170 IKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPF-WMAPEVIKQSAYDSKADIW 228
           + A N L+ E   +K++DFG++    +     +     P  W APE +    Y S++D+W
Sbjct: 119 LAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSESDVW 178

Query: 229 SLGITAIE-LAKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPENR 287
           S GI   E  + G  P   +   +    + K               + ++ C +  PENR
Sbjct: 179 SYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRMSCPQKCPDDVYKVMQRCWDYKPENR 238

Query: 288 PTAKELLK 295
           P   EL K
Sbjct: 239 PKFSELQK 246

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 86.8 bits (215), Expect = 2e-18
 Identities = 74/279 (26%), Positives = 123/279 (44%), Gaps = 49/279 (17%)

Query: 65  IGKGSFGEVFKGIDNRTQQVVAIK-IIDLEEAEDEIEDIQQEIMVLSQ---------CD- 113
           +G G+FG V    D  T Q VAIK I+         +   +E+ +L            D 
Sbjct: 18  VGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDI 77

Query: 114 --SPYGTKLWIIMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIK 171
             SP    ++ + E LG      L+ +   E+  I   L ++L+GL Y+HS   +HRD+K
Sbjct: 78  FISPL-EDIYFVTELLGTDLH-RLLTSRPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLK 135

Query: 172 AANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEV-IKQSAYDSKADIWSL 230
            +N+L++E  D+K+ DFG+A        +   +V T ++ APE+ +    YD + DIWS 
Sbjct: 136 PSNILINENCDLKICDFGLARI---QDPQMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSA 192

Query: 231 GITAIELAKGEP--------------------PNSEL-------HPMRVLFLIPKNNP-- 261
           G    E+ +G+P                    P  ++       + +R +  +PK  P  
Sbjct: 193 GCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFVQSLPKREPVP 252

Query: 262 -PQLTGNYTKQFKEFVEACLNKDPENRPTAKELLKFPFI 299
             +   N      + +E  L  DP+ R +A E L  P++
Sbjct: 253 FSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYL 291

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 87.2 bits (216), Expect = 2e-18
 Identities = 68/242 (28%), Positives = 102/242 (42%), Gaps = 66/242 (27%)

Query: 65  IGKGSFGEVFKGIDNRTQQVVAIKIIDLEE--AEDEIEDIQQEIMVLSQCDSPYGTKLW- 121
           IGKG+FGEV       T ++ A+K +   E   +D++  ++ E  VL++ DSP+   L+ 
Sbjct: 9   IGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYY 68

Query: 122 ---------IIMEYLGGGSALDLM----KAGNFEEMHIAVILREVLKGLDYLHSERKLHR 168
                    +IME+L GG   DLM    K   F E      + E +  ++ +H    +HR
Sbjct: 69  SFQDAQYLYLIMEFLPGG---DLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHR 125

Query: 169 DIKAANVLLSEMGDVKLADFGVA------------------GTLTNTTSKRNTF------ 204
           DIK  N+L+   G +KL+DFG++                   +  N    RN+       
Sbjct: 126 DIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSIN 185

Query: 205 -----------------------VGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGE 241
                                  VGTP ++APE+  Q  Y  + D WSLG    E   G 
Sbjct: 186 LTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMFECLIGW 245

Query: 242 PP 243
           PP
Sbjct: 246 PP 247

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 85.6 bits (212), Expect = 2e-18
 Identities = 63/273 (23%), Positives = 119/273 (43%), Gaps = 56/273 (20%)

Query: 65  IGKGSFGEVF----KGID-NRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTK 119
           +G+G FGEVF    KGI+    + +V +K +   + E+   + ++E+ +  +       +
Sbjct: 13  LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVR 72

Query: 120 L----------WIIMEYLGGG----------SALDLMKAGNFEEMHIAVILREVLKGLDY 159
           L          ++I+EY   G          S  + +K           +  ++  G+D+
Sbjct: 73  LLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDH 132

Query: 160 LHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSK------RNTFVGTPF-WMA 212
           L + R +HRD+ A N L+S   +VK++       L+           RN  +  P  W+A
Sbjct: 133 LSNARFVHRDLAARNCLVSSQREVKVSLLS----LSKDVYNSEYYKLRNALI--PLRWLA 186

Query: 213 PEVIKQSAYDSKADIWSLGITAIEL-AKGEPPNSELHPMRVL---------FLIPKNNPP 262
           PE +++  + +K+D+WS G+   E+  +GE P   L    VL           +P+  P 
Sbjct: 187 PEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLELPVPEGCPS 246

Query: 263 QLTGNYTKQFKEFVEACLNKDPENRPTAKELLK 295
           +L         + +  C   +P++RP+  EL+ 
Sbjct: 247 RLY--------KLMTRCWAVNPKDRPSFSELVS 271

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 85.6 bits (212), Expect = 4e-18
 Identities = 58/220 (26%), Positives = 102/220 (46%), Gaps = 46/220 (20%)

Query: 65  IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQ-------------EIMVLSQ 111
           +G+G++G+V K  D  T ++VAIK + + E  +++   +Q             E+ ++++
Sbjct: 17  LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE 76

Query: 112 CDSP--------YGTKLWI--IMEYLGGGSALDLMKAGN----FEEMHIAVILREVLKGL 157
                       Y    +I  +M+ +      DL K  +      E  +  IL ++L GL
Sbjct: 77  IKHENIMGLVDVYVEGDFINLVMDIMAS----DLKKVVDRKIRLTESQVKCILLQILNGL 132

Query: 158 DYLHSERKLHRDIKAANVLLSEMGDVKLADFGVA-----GTLTNTTSKRNTF-------- 204
           + LH    +HRD+  AN+ ++  G  K+ADFG+A        ++T SK  T         
Sbjct: 133 NVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTS 192

Query: 205 -VGTPFWMAPEVIKQS-AYDSKADIWSLGITAIELAKGEP 242
            V T ++ APE++  +  Y    D+WS+G    EL  G+P
Sbjct: 193 KVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKP 232

Length = 335

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 85.6 bits (212), Expect = 4e-18
 Identities = 82/294 (27%), Positives = 121/294 (41%), Gaps = 53/294 (18%)

Query: 59  FTKQERIGKGSFGEVFKGIDNRTQQVVAIKIID--LEEAEDEIEDIQQEIMVLSQCDSPY 116
           +  QE IGKGS+G V   ID  T + VAIK I+   E   D    I +EI +L     P 
Sbjct: 2   YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATR-ILREIKLLRLLRHPD 60

Query: 117 GTKLWIIM------EYLGGGSALDLM--------KAGN-FEEMHIAVILREVLKGLDYLH 161
             ++  IM      E+       +LM        KA +     H    L ++L+ L Y+H
Sbjct: 61  IVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHHQFFLYQLLRALKYIH 120

Query: 162 SERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKR---NTFVGTPFWMAPEVIKQ 218
           +    HRD+K  N+L +    +K+ DFG+A    N T        +V T ++ APE+   
Sbjct: 121 TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGS 180

Query: 219 --SAYDSKADIWSLGITAIELAKGEP--------------------PNSEL-------HP 249
             S Y    DIWS+G    E+  G+P                    P+ E          
Sbjct: 181 FFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNEKA 240

Query: 250 MRVLFLIPKNNPPQLTGNYTKQFK---EFVEACLNKDPENRPTAKELLKFPFIR 300
            R L  + K  P   +  +          +E  L  DP++RPTA+E L  P+ +
Sbjct: 241 RRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFK 294

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 84.3 bits (208), Expect = 5e-18
 Identities = 75/270 (27%), Positives = 119/270 (44%), Gaps = 34/270 (12%)

Query: 59  FTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQ--QEIMVLSQCDS-- 114
           F +   +GKG FGEV       T ++ A K ++ +  +    +     E  +L + +S  
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61

Query: 115 ------PYGTK--LWIIMEYLGGGS-ALDLMKAGN--FEEMHIAVILREVLKGLDYLHSE 163
                  Y TK  L +++  + GG     +   GN  FEE        E+L GL+ LH E
Sbjct: 62  VVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRE 121

Query: 164 RKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDS 223
             ++RD+K  N+LL + G ++++D G+A  +    S R   VGT  +MAPEV+    Y  
Sbjct: 122 NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGR-VGTVGYMAPEVLNNQRYTL 180

Query: 224 KADIWSLGITAIELAKGEPP--------NSELHPMRVLFLIPKNNPPQLTGNYTKQFKEF 275
             D W LG    E+ +G+ P          E    RVL           +  ++++ K  
Sbjct: 181 SPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVL-----ETEEVYSAKFSEEAKSI 235

Query: 276 VEACLNKDPENR-----PTAKELLKFPFIR 300
            +  L KDP+ R       A E+ + PF R
Sbjct: 236 CKMLLTKDPKQRLGCQEEGAGEVKRHPFFR 265

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 83.8 bits (207), Expect = 7e-18
 Identities = 64/205 (31%), Positives = 97/205 (47%), Gaps = 25/205 (12%)

Query: 62  QERIGKGSFGEVFKG---IDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGT 118
           +E IG G FGEV +G   +  + +  VAIK +     E +  D   E  ++ Q D P   
Sbjct: 9   EEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNII 68

Query: 119 KL----------WIIMEYLGGGSALD---LMKAGNFEEMHIAVILREVLKGLDYLHSERK 165
            L           II E++  G ALD       G F  + +  +LR +  G+ YL     
Sbjct: 69  HLEGVVTKSRPVMIITEFMENG-ALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNY 127

Query: 166 LHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGT-----PF-WMAPEVIKQS 219
           +HRD+ A N+L++     K++DFG++  L + TS   T+  +     P  W APE I   
Sbjct: 128 VHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSD-PTYTSSLGGKIPIRWTAPEAIAYR 186

Query: 220 AYDSKADIWSLGITAIE-LAKGEPP 243
            + S +D+WS GI   E ++ GE P
Sbjct: 187 KFTSASDVWSYGIVMWEVMSYGERP 211

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 84.0 bits (207), Expect = 9e-18
 Identities = 55/194 (28%), Positives = 102/194 (52%), Gaps = 12/194 (6%)

Query: 59  FTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDE----------IEDIQQEIMV 108
           + K E++G+GS+  V+KG      ++VA+K+I L+E E            ++ ++   +V
Sbjct: 7   YEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIV 66

Query: 109 LSQCDSPYGTKLWIIMEYLGGGSALDLMK-AGNFEEMHIAVILREVLKGLDYLHSERKLH 167
           L          L ++ EY+       + K  G     ++ + L ++L+GL Y+H    LH
Sbjct: 67  LLHDIIHTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILH 126

Query: 168 RDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSA-YDSKAD 226
           RD+K  N+L+S+ G++KLADFG+A   +  +   +  V T ++  P+V+  S  Y +  D
Sbjct: 127 RDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLLGSTEYSTCLD 186

Query: 227 IWSLGITAIELAKG 240
           +W +G   +E+ +G
Sbjct: 187 MWGVGCIFVEMIQG 200

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 83.3 bits (206), Expect = 1e-17
 Identities = 70/291 (24%), Positives = 127/291 (43%), Gaps = 51/291 (17%)

Query: 59  FTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQ-QEIMVL-SQCDSPY 116
           + K E+IG+G++G+V+K  D  T ++VA+K   LE  E+ I     +EI +L    +S Y
Sbjct: 3   YEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIY 62

Query: 117 GTKL---------------WIIMEYLGGG--SALDLMKAGNFEEMHIAVILR---EVLKG 156
             +L               +++ EYL       +D    G    +    I     ++LKG
Sbjct: 63  IVRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKG 122

Query: 157 LDYLHSERKLHRDIKAANVLLSEMGDV-KLADFGVAGTLTNTTSKRNTFVGTPFWMAPEV 215
           + + H    +HRD+K  N+L+ +   + K+AD G+    +         + T ++ APEV
Sbjct: 123 VAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIVTLWYRAPEV 182

Query: 216 -IKQSAYDSKADIWSLGITAIELAKGEP--------------------PNSELHP----M 250
            +  + Y +  DIWS+G    E+++ +P                    P  ++ P    +
Sbjct: 183 LLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGVSKL 242

Query: 251 RVLFLIPKNNPPQLTG---NYTKQFKEFVEACLNKDPENRPTAKELLKFPF 298
           R     P+  P  L+    + + +  + ++  L  DP  R +AK  L  P+
Sbjct: 243 RDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPY 293

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 83.1 bits (205), Expect = 1e-17
 Identities = 66/274 (24%), Positives = 125/274 (45%), Gaps = 43/274 (15%)

Query: 65  IGKGSFGEVFKGIDNRTQ-----QVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTK 119
           +G+G FG+V K    R +       VA+K++    +  E+ D+  E  +L Q + P+  K
Sbjct: 8   LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67

Query: 120 LW----------IIMEYLGGGSALDLMK------------AGNFEEMHI------AVILR 151
           L+          +I+EY   GS    ++             GN    ++      A+ + 
Sbjct: 68  LYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMG 127

Query: 152 EVL-------KGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTS--KRN 202
           +++       +G+ YL   + +HRD+ A NVL++E   +K++DFG++  +    S  KR+
Sbjct: 128 DLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRS 187

Query: 203 TFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAK-GEPPNSELHPMRVLFLIPKNNP 261
                  WMA E +    Y +++D+WS G+   E+   G  P   + P R+  L+     
Sbjct: 188 KGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERLFNLLKTGYR 247

Query: 262 PQLTGNYTKQFKEFVEACLNKDPENRPTAKELLK 295
            +   N +++    +  C  ++P+ RPT  ++ K
Sbjct: 248 MERPENCSEEMYNLMLTCWKQEPDKRPTFADISK 281

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 82.9 bits (205), Expect = 1e-17
 Identities = 69/264 (26%), Positives = 120/264 (45%), Gaps = 40/264 (15%)

Query: 65  IGKGSFGEVFKGI---DNRTQQVVAIKIIDLE-EAEDEIEDIQQEIMVLSQCDSPYGTKL 120
           +G+G FG V +G    D+ +Q  VA+K + L+     EIE+   E   +   D P   KL
Sbjct: 7   LGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKL 66

Query: 121 W---IIMEYLGGGSA----LDLMKAGNF-------------EEMHIAVILR---EVLKGL 157
                    L         L  MK G+              E++ +  +L+   ++  G+
Sbjct: 67  IGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGM 126

Query: 158 DYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGT-PF-WMAPEV 215
           +YL +   +HRD+ A N +L E   V +ADFG++  + +    R   +   P  W+A E 
Sbjct: 127 EYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIES 186

Query: 216 IKQSAYDSKADIWSLGITAIELA-KGEPP-----NSELHPMRVLFLIPKNNPPQLTGNYT 269
           +    Y SK+D+W+ G+T  E+A +G+ P     N E++    L    +   P+   +  
Sbjct: 187 LADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIY--DYLRHGNRLKQPE---DCL 241

Query: 270 KQFKEFVEACLNKDPENRPTAKEL 293
            +  + + +C   DP++RPT  +L
Sbjct: 242 DELYDLMYSCWRADPKDRPTFTKL 265

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 83.8 bits (207), Expect = 2e-17
 Identities = 72/282 (25%), Positives = 122/282 (43%), Gaps = 52/282 (18%)

Query: 65  IGKGSFGEVFKGIDNRTQQVVAIKIIDLE-EAEDEIEDIQQEIMVLS--QCDSPYG---- 117
           +G G++G V   +D RT   VAIK +    ++E   +   +E+ +L   + ++  G    
Sbjct: 23  VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDV 82

Query: 118 ----------TKLWIIMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLH 167
                        +++M ++G      LMK     E  I  ++ ++LKGL Y+H+   +H
Sbjct: 83  FTPDLSLDRFHDFYLVMPFMGTDLG-KLMKHEKLSEDRIQFLVYQMLKGLKYIHAAGIIH 141

Query: 168 RDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVI-KQSAYDSKAD 226
           RD+K  N+ ++E  ++K+ DFG+A     T S+   +V T ++ APEVI     Y    D
Sbjct: 142 RDLKPGNLAVNEDCELKILDFGLA---RQTDSEMTGYVVTRWYRAPEVILNWMHYTQTVD 198

Query: 227 IWSLGITAIELAKGEP---PNSELHPMRVLFLIPKNNPPQLTG--------NYTKQFKEF 275
           IWS+G    E+  G+P    +  L  +  +  +      +           NY K+   F
Sbjct: 199 IWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDAKNYVKKLPRF 258

Query: 276 -------------------VEACLNKDPENRPTAKELLKFPF 298
                              +E  L  D E+R TA E L  P+
Sbjct: 259 RKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPY 300

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 82.6 bits (204), Expect = 2e-17
 Identities = 64/273 (23%), Positives = 118/273 (43%), Gaps = 47/273 (17%)

Query: 65  IGKGSFGEVFKG-----IDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSP---- 115
           IG+G+FG VF+      +      +VA+K++  E + D   D Q+E  ++++ D P    
Sbjct: 13  IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72

Query: 116 ------YGTKLWIIMEYLGGGSALDLMKAGN-----------------------FEEMHI 146
                  G  + ++ EY+  G   + ++  +                             
Sbjct: 73  LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132

Query: 147 AVILREVLKGLDYLHSERK-LHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKR---N 202
             I ++V  G+ YL SERK +HRD+   N L+ E   VK+ADFG++  + +    +   N
Sbjct: 133 LCIAKQVAAGMAYL-SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKASEN 191

Query: 203 TFVGTPF-WMAPEVIKQSAYDSKADIWSLGITAIEL-AKGEPPNSELHPMRVLFLIPKNN 260
             +  P  WM PE I  + Y +++D+W+ G+   E+ + G  P   +    V++ +   N
Sbjct: 192 DAI--PIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEVIYYVRDGN 249

Query: 261 PPQLTGNYTKQFKEFVEACLNKDPENRPTAKEL 293
                 N   +    +  C +K P +RP+   +
Sbjct: 250 VLSCPDNCPLELYNLMRLCWSKLPSDRPSFASI 282

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 82.4 bits (203), Expect = 2e-17
 Identities = 73/274 (26%), Positives = 124/274 (45%), Gaps = 40/274 (14%)

Query: 59  FTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIM------VLSQC 112
           F +   +GKG FGEV       T ++ A K ++    +  I+  + E M      +L + 
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATGKMYACKKLE----KKRIKKRKGESMALNEKQILEKV 57

Query: 113 DS--------PYGTK--LWIIMEYLGGGSALDL------MKAGNFEEMHIAVILREVLKG 156
           +S         Y TK  L +++  + GG   DL      M    FEE        E+  G
Sbjct: 58  NSRFVVSLAYAYETKDALCLVLTLMNGG---DLKFHIYHMGEAGFEEGRAVFYAAEICCG 114

Query: 157 LDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVI 216
           L+ LH ER ++RD+K  N+LL + G ++++D G+A  +    + +   VGT  +MAPEV+
Sbjct: 115 LEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGR-VGTVGYMAPEVV 173

Query: 217 KQSAYDSKADIWSLGITAIELAKGEPP----NSELHPMRVLFLIPKNNPPQLTGNYTKQF 272
           K   Y    D W+LG    E+  G+ P      ++    V  L+ K    + +  ++   
Sbjct: 174 KNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLV-KEVQEEYSEKFSPDA 232

Query: 273 KEFVEACLNKDPENR-----PTAKELLKFPFIRK 301
           +   +  L KDP+ R       A+E+ + P  ++
Sbjct: 233 RSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQ 266

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 82.8 bits (204), Expect = 2e-17
 Identities = 74/275 (26%), Positives = 128/275 (46%), Gaps = 50/275 (18%)

Query: 65  IGKGSFGEVFK----GID----NRTQQVVAIKIIDLEEAEDEIEDIQQE----------- 105
           +G+G FG+V      G+D    NR  +V A+K++  +  E ++ D+  E           
Sbjct: 26  LGEGCFGQVVMAEAIGLDKEKPNRVTKV-AVKMLKSDATEKDLSDLISEMEMMKMIGKHK 84

Query: 106 --IMVLSQC--DSPYGTKLWIIMEYLGGGSALDLMKA-----------------GNFEEM 144
             I +L  C  D P    L++I+EY   G+  + ++A                       
Sbjct: 85  NIINLLGACTQDGP----LYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFK 140

Query: 145 HIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTF 204
            +     +V +G++YL S++ +HRD+ A NVL++E   +K+ADFG+A  + +    + T 
Sbjct: 141 DLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 200

Query: 205 VGT-PF-WMAPEVIKQSAYDSKADIWSLGITAIEL-AKGEPPNSELHPMRVLF-LIPKNN 260
            G  P  WMAPE +    Y  ++D+WS G+   E+   G  P   + P+  LF L+ + +
Sbjct: 201 NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV-PVEELFKLLKEGH 259

Query: 261 PPQLTGNYTKQFKEFVEACLNKDPENRPTAKELLK 295
                 N T +    +  C +  P  RPT K+L++
Sbjct: 260 RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 294

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 85.6 bits (211), Expect = 3e-17
 Identities = 80/282 (28%), Positives = 130/282 (46%), Gaps = 45/282 (15%)

Query: 63  ERIGKGSFGEVFKGIDNRTQQVVAIKIID---LEEAEDEIEDIQQEIM-------VLSQC 112
           ++IG G FGEVF     RTQ+    K I    L+E E     I+  +M       ++   
Sbjct: 19  KKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYI 78

Query: 113 D---SPYGTKLWIIMEYLGGGS-ALDLMKA----GNFEEMHIAVILREVLKGLDYLHS-- 162
           D   +    KL+I+ME+   G  + ++ K     G  EE  I  I R++L  L Y H+  
Sbjct: 79  DRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLK 138

Query: 163 -----ERKLHRDIKAANVLLS----EMGDV-------------KLADFGVAGTLTNTTSK 200
                ER LHRD+K  N+ LS     +G +             K+ DFG++  +    S 
Sbjct: 139 DGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNI-GIESM 197

Query: 201 RNTFVGTPFWMAPEVI--KQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPK 258
            ++ VGTP++ +PE++  +  +YD K+D+W+LG    EL  G+ P  + +    L    K
Sbjct: 198 AHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNFSQLISELK 257

Query: 259 NNPPQLTGNYTKQFKEFVEACLNKDPENRPTAKELLKFPFIR 300
             P       +K+    ++  LN   + RP+A + L +  I+
Sbjct: 258 RGPDLPIKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIK 299

Length = 1021

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 82.8 bits (205), Expect = 3e-17
 Identities = 73/301 (24%), Positives = 131/301 (43%), Gaps = 74/301 (24%)

Query: 63  ERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQ---EIMVLS--------- 110
           E IG G++G V   ID R+ + VAIK I    A D     ++   E+ +L          
Sbjct: 11  ENIGSGAYGVVCSAIDTRSGKKVAIKKI--PHAFDVPTLAKRTLRELKILRHFKHDNIIA 68

Query: 111 -----QCDSPYGTKLWIIMEYLGGGSALDLMKA---------GNFEEMHIAVILREVLKG 156
                +        ++++M         DLM++             E HI   L ++L+G
Sbjct: 69  IRDILRPPGADFKDVYVVM---------DLMESDLHHIIHSDQPLTEEHIRYFLYQLLRG 119

Query: 157 LDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTF----VGTPFWMA 212
           L Y+HS   +HRD+K +N+L++E  ++++ DFG+A  L+++ ++   F    V T ++ A
Sbjct: 120 LKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRA 179

Query: 213 PEVIKQS-AYDSKADIWSLG-ITAIELAKGE--PPNSELHPMRVLFLIPKNNPPQ----- 263
           PE++     Y +  D+WS+G I A  L + +  P  + +H ++ L L    +P +     
Sbjct: 180 PELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLK-LILSVLGSPSEEVLNR 238

Query: 264 ----LTGNYTKQFK-------------------EFVEACLNKDPENRPTAKELLKFPFIR 300
                   Y +                      + +   L  DPE R T ++ L+ PF+ 
Sbjct: 239 IGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLA 298

Query: 301 K 301
           +
Sbjct: 299 Q 299

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 83.4 bits (206), Expect = 3e-17
 Identities = 48/197 (24%), Positives = 87/197 (44%), Gaps = 46/197 (23%)

Query: 148 VILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGT 207
           +I +++L+GL YLH++R +HRD+K  N+ ++++  V + D G A       +      GT
Sbjct: 161 IIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLG-LAGT 219

Query: 208 PFWMAPEVIKQSAYDSKADIWSLGITAIEL------------AKGEPP--NSELHPMRVL 253
               APEV+ +  Y+SKADIWS GI   E+            +  E    +   H ++++
Sbjct: 220 VETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKII 279

Query: 254 FLIPKNNPPQLTGN-YTKQFKEFVE------------ACLNK-----------------D 283
             + K +P +   +  ++  + F+E             C  +                 D
Sbjct: 280 STL-KVHPEEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFD 338

Query: 284 PENRPTAKELLKFPFIR 300
              RP+A+E+L +P   
Sbjct: 339 AAMRPSAEEILNYPMFA 355

Length = 357

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 81.5 bits (201), Expect = 3e-17
 Identities = 68/253 (26%), Positives = 110/253 (43%), Gaps = 23/253 (9%)

Query: 65  IGKGSFGEVFKG---IDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTKL- 120
           IG G FGEV  G   +  + +  VAIK +     E +  D   E  ++ Q D P    L 
Sbjct: 12  IGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71

Query: 121 ---------WIIMEYLGGGSALDLMKA--GNFEEMHIAVILREVLKGLDYLHSERKLHRD 169
                     I+ EY+  GS    ++   G F  + +  +LR +  G+ YL     +HRD
Sbjct: 72  GVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRD 131

Query: 170 IKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPF---WMAPEVIKQSAYDSKAD 226
           + A N+L++     K++DFG++  L +      T  G      W APE I    + S +D
Sbjct: 132 LAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASD 191

Query: 227 IWSLGITAIE-LAKGEPPNSELHPMRVLFLIPKNN--PPQLTGNYTKQFKEFVEACLNKD 283
           +WS GI   E ++ GE P  E+    V+  I +    P  +  +      + +  C  KD
Sbjct: 192 VWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYRLPAPM--DCPAALHQLMLDCWQKD 249

Query: 284 PENRPTAKELLKF 296
              RP  ++++  
Sbjct: 250 RNERPKFEQIVSI 262

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 81.7 bits (202), Expect = 4e-17
 Identities = 68/272 (25%), Positives = 108/272 (39%), Gaps = 53/272 (19%)

Query: 65  IGKGSFGEVFKGI------DNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGT 118
           +G G+FGEV++G+      D    QV    + +    +DE  D   E +++S+ +     
Sbjct: 14  LGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDE-SDFLMEALIMSKFNHQNIV 72

Query: 119 KL----------WIIMEYLGGGSALDLMKAGN-----------FEEMHIAVILREVLKGL 157
           +L          +I++E + GG     ++               + +  A   R+V KG 
Sbjct: 73  RLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCA---RDVAKGC 129

Query: 158 DYLHSERKLHRDIKAANVLLSEMGD---VKLADFGVAGTLTNTTSKR-NTFVGTPF-WMA 212
            YL     +HRDI A N LL+  G     K+ADFG+A  +   +  R       P  WM 
Sbjct: 130 KYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMP 189

Query: 213 PEVIKQSAYDSKADIWSLGITAIEL-AKGEPPNSELHPMRVLFLI--------PKNNPPQ 263
           PE      + SK D+WS G+   E+ + G  P        V+  +        PK  P  
Sbjct: 190 PEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGGGRLDPPKGCPGP 249

Query: 264 LTGNYTKQFKEFVEACLNKDPENRPTAKELLK 295
           +    T         C    PE+RP    +L+
Sbjct: 250 VYRIMTD--------CWQHTPEDRPNFATILE 273

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 82.8 bits (205), Expect = 4e-17
 Identities = 61/215 (28%), Positives = 103/215 (47%), Gaps = 32/215 (14%)

Query: 65  IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQ---EIMVLSQCDSPYGTKLW 121
           IG+G++G V    ++ T + VAIK I    A D   D ++   EI +L   D      + 
Sbjct: 13  IGRGAYGIVCSAKNSETNEKVAIKKIA--NAFDNRIDAKRTLREIKLLRHLDHENVIAIK 70

Query: 122 IIME----------YLGGGSALDLM---------KAGNFEEMHIAVILREVLKGLDYLHS 162
            IM           Y+      +LM          +    + H    L ++L+GL Y+HS
Sbjct: 71  DIMPPPHREAFNDVYI----VYELMDTDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHS 126

Query: 163 ERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSA-Y 221
              LHRD+K +N+LL+   D+K+ DFG+A T +        +V T ++ APE++   + Y
Sbjct: 127 ANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVVTRWYRAPELLLNCSEY 186

Query: 222 DSKADIWSLGITAIELAKGEP--PNSE-LHPMRVL 253
            +  D+WS+G    EL   +P  P  + +H ++++
Sbjct: 187 TTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLI 221

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 82.4 bits (203), Expect = 5e-17
 Identities = 72/290 (24%), Positives = 131/290 (45%), Gaps = 47/290 (16%)

Query: 51  LKVDPELIFTKQ-----ERIGKGSFGEVFK----GID-NRTQQ--VVAIKIIDLEEAEDE 98
           L  DP+   ++      + +G+G FG+V      GID ++  +   VA+K++  +  + +
Sbjct: 1   LPADPKWELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKD 60

Query: 99  IEDIQQE-------------IMVLSQCDSPYGTKLWIIMEYLGGGSALDLMKAGNFEEMH 145
           + D+  E             I +L  C       L++++EY   G+  + ++A     M 
Sbjct: 61  LSDLVSEMEMMKMIGKHKNIINLLGACTQ--DGPLYVLVEYASKGNLREYLRARRPPGMD 118

Query: 146 -----------------IAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADF 188
                            +     +V +G++YL S++ +HRD+ A NVL++E   +K+ADF
Sbjct: 119 YSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADF 178

Query: 189 GVAGTLTNTTSKRNTFVGT-PF-WMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSE 246
           G+A  + N    + T  G  P  WMAPE +    Y  ++D+WS G+   E+         
Sbjct: 179 GLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYP 238

Query: 247 LHPMRVLF-LIPKNNPPQLTGNYTKQFKEFVEACLNKDPENRPTAKELLK 295
             P+  LF L+ + +      N T +    +  C +  P  RPT K+L++
Sbjct: 239 GIPVEELFKLLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVE 288

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 82.0 bits (202), Expect = 6e-17
 Identities = 61/199 (30%), Positives = 98/199 (49%), Gaps = 20/199 (10%)

Query: 65  IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIED--IQQEIMVLSQCDSPYGT---- 118
           IG+G+FGEV         +V A+KI++  E     E    ++E  VL   D+ + T    
Sbjct: 9   IGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHY 68

Query: 119 ------KLWIIMEYLGGGSALDLMKA--GNFEEMHIAVILREVLKGLDYLHSERKLHRDI 170
                  L+++M+Y  GG  L L+        E      L E++  +D +H    +HRDI
Sbjct: 69  AFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDI 128

Query: 171 KAANVLLSEMGDVKLADFGVAGTLT-NTTSKRNTFVGTPFWMAPEVIK-----QSAYDSK 224
           K  N+L+   G ++LADFG    L  + T + +  VGTP +++PE+++     +  Y  +
Sbjct: 129 KPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPE 188

Query: 225 ADIWSLGITAIELAKGEPP 243
            D WSLG+   E+  GE P
Sbjct: 189 CDWWSLGVCMYEMLYGETP 207

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 80.4 bits (198), Expect = 6e-17
 Identities = 65/248 (26%), Positives = 113/248 (45%), Gaps = 25/248 (10%)

Query: 62  QERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTKL- 120
            + IGKG FG+V  G D R  +V A+K I   + +   +    E  V++Q       +L 
Sbjct: 11  LQTIGKGEFGDVMLG-DYRGNKV-AVKCI---KNDATAQAFLAEASVMTQLRHSNLVQLL 65

Query: 121 ----------WIIMEYLGGGSALDLMKAGNFEEMHIAVILR---EVLKGLDYLHSERKLH 167
                     +I+ EY+  GS +D +++     +    +L+   +V + ++YL +   +H
Sbjct: 66  GVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVH 125

Query: 168 RDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPF-WMAPEVIKQSAYDSKAD 226
           RD+ A NVL+SE    K++DFG    LT   S        P  W APE +++  + +K+D
Sbjct: 126 RDLAARNVLVSEDNVAKVSDFG----LTKEASSTQDTGKLPVKWTAPEALREKKFSTKSD 181

Query: 227 IWSLGITAIEL-AKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPE 285
           +WS GI   E+ + G  P   +    V+  + K               + ++ C + D  
Sbjct: 182 VWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPVVYDVMKQCWHLDAA 241

Query: 286 NRPTAKEL 293
            RP+  +L
Sbjct: 242 TRPSFLQL 249

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 80.5 bits (198), Expect = 8e-17
 Identities = 66/263 (25%), Positives = 122/263 (46%), Gaps = 39/263 (14%)

Query: 65  IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA---EDEIEDIQQEIMVLSQCDSPYGTKLW 121
           +G+G FG V +G  N+   ++ + +  ++ A     E+ED   E + + + D P   +L 
Sbjct: 7   LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66

Query: 122 ----------------IIMEYLGGG---SALDLMKAGN----FEEMHIAVILREVLKGLD 158
                           +I+ ++  G   S L   + G+         +   + ++  G++
Sbjct: 67  GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126

Query: 159 YLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVG-TPF-WMAPEVI 216
           YL S+  +HRD+ A N +L+E  +V +ADFG++  + N    R   +   P  W+A E +
Sbjct: 127 YLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESL 186

Query: 217 KQSAYDSKADIWSLGITAIELA-KGEPP-----NSELHPMRVLFLIPKNNPPQLTGNYTK 270
               Y +K+D+WS G+T  E+A +G+ P     NSE++         K  P  L G Y  
Sbjct: 187 ADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRLKQPPDCLDGLY-- 244

Query: 271 QFKEFVEACLNKDPENRPTAKEL 293
                + +C   +P++RP+ + L
Sbjct: 245 ---SLMSSCWLLNPKDRPSFETL 264

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 81.2 bits (200), Expect = 1e-16
 Identities = 77/293 (26%), Positives = 132/293 (45%), Gaps = 53/293 (18%)

Query: 51  LKVDPELIFTKQ-----ERIGKGSFGEVFK----GIDNRTQQ---VVAIKIIDLEEAEDE 98
           L +DP+  F +      + +G+G FG+V +    GID         VA+K++     + +
Sbjct: 1   LPLDPKWEFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKD 60

Query: 99  IEDIQQE-------------IMVLSQC--DSPYGTKLWIIMEYLGGGSALDLMKA----- 138
           + D+  E             I +L  C  + P    L++I+EY   G+  + ++A     
Sbjct: 61  LADLISEMELMKLIGKHKNIINLLGVCTQEGP----LYVIVEYAAKGNLREFLRARRPPG 116

Query: 139 ------------GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLA 186
                              +     +V +G++YL S R +HRD+ A NVL++E   +K+A
Sbjct: 117 PDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIA 176

Query: 187 DFGVAGTLTNTTSKRNTFVG-TPF-WMAPEVIKQSAYDSKADIWSLGITAIEL-AKGEPP 243
           DFG+A  + +    + T  G  P  WMAPE +    Y  ++D+WS GI   E+   G  P
Sbjct: 177 DFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSP 236

Query: 244 NSELHPMRVLF-LIPKNNPPQLTGNYTKQFKEFVEACLNKDPENRPTAKELLK 295
              + P+  LF L+ + +      N T +    +  C +  P  RPT K+L++
Sbjct: 237 YPGI-PVEELFKLLREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVE 288

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 80.6 bits (199), Expect = 2e-16
 Identities = 72/300 (24%), Positives = 130/300 (43%), Gaps = 74/300 (24%)

Query: 65  IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCD----------- 113
           +G GS G VF  +D+   + VA+K I L + +  ++   +EI ++ + D           
Sbjct: 13  LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQ-SVKHALREIKIIRRLDHDNIVKVYEVL 71

Query: 114 SPYGTKL-------------WIIMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYL 160
            P G+ L             +I+ EY+    A ++++ G   E H  + + ++L+GL Y+
Sbjct: 72  GPSGSDLTEDVGSLTELNSVYIVQEYMETDLA-NVLEQGPLSEEHARLFMYQLLRGLKYI 130

Query: 161 HSERKLHRDIKAANVLLS-EMGDVKLADFGVA----------GTLTNTTSKRNTFVGTPF 209
           HS   LHRD+K ANV ++ E   +K+ DFG+A          G L+           T +
Sbjct: 131 HSANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLV-------TKW 183

Query: 210 WMAPEVIKQ-SAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNP------- 261
           + +P ++   + Y    D+W+ G    E+  G+P  +  H +  + LI ++ P       
Sbjct: 184 YRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVREEDR 243

Query: 262 -------PQLTGNYTKQFK---------------EFVEACLNKDPENRPTAKELLKFPFI 299
                  P    N   + +               +F+E  L  +P +R TA+E L  P++
Sbjct: 244 NELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYM 303

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 77.7 bits (191), Expect = 9e-16
 Identities = 72/286 (25%), Positives = 125/286 (43%), Gaps = 75/286 (26%)

Query: 63  ERIGKGSFGEVFKG------IDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPY 116
           E +G+ +FG+++KG      +D+   Q+VAIK +       +  + QQE  ++++   P 
Sbjct: 11  EELGECAFGKIYKGHLYLPGMDH--AQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPN 68

Query: 117 GTKLW----------IIMEYLGGG--------------------------SALDLMKAGN 140
              L           ++ EYL  G                          S+LD    G+
Sbjct: 69  IVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLD---HGD 125

Query: 141 FEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSK 200
           F  +HIA+   ++  G++YL S   +H+D+ A N+L+ E   VK++D G++  + +    
Sbjct: 126 F--LHIAI---QIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYY 180

Query: 201 R---NTFVGTPF-WMAPEVIKQSAYDSKADIWSLGITAIEL-AKGEPP-----NSELHPM 250
           R    + +  P  WM PE I    + S +DIWS G+   E+ + G  P     N E+  M
Sbjct: 181 RVQPKSLL--PIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEM 238

Query: 251 ---RVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPENRPTAKEL 293
              R L    ++ PP++    T+        C  + P  RP  K++
Sbjct: 239 VRKRQLLPCSEDCPPRMYSLMTE--------CWQEGPSRRPRFKDI 276

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 77.8 bits (191), Expect = 1e-15
 Identities = 79/290 (27%), Positives = 129/290 (44%), Gaps = 29/290 (10%)

Query: 51  LKVDPELIFTKQERIGKGSFGEVFKGI---DNRTQQV-VAIKIIDLEEAEDEIEDIQQEI 106
           L++  E    + + +G G+FG V+KGI   +  T ++ VAIKI++         +   E 
Sbjct: 1   LRILKETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEA 60

Query: 107 MVLSQCDSPYGTKLW---------IIMEYLGGGSALDLMK--AGNFEEMHIAVILREVLK 155
           ++++  D P+  +L          ++ + +  G  LD +     N     +     ++ K
Sbjct: 61  LIMASMDHPHLVRLLGVCLSPTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAK 120

Query: 156 GLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVG-TPF-WMAP 213
           G+ YL   R +HRD+ A NVL+     VK+ DFG+A  L     + N   G  P  WMA 
Sbjct: 121 GMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMAL 180

Query: 214 EVIKQSAYDSKADIWSLGITAIELAK-GEPPNSELHPMRVLFLIPKN----NPPQLTGN- 267
           E I    +  ++D+WS G+T  EL   G  P   +    +  L+ K      PP  T + 
Sbjct: 181 ECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGERLPQPPICTIDV 240

Query: 268 YTKQFKEFVEACLNKDPENRPTAKEL-LKFPFIRKAKKNAYLIDLIDRYK 316
           Y    K     C   D ++RP  KEL  +F  + +  +   +I   DR K
Sbjct: 241 YMVMVK-----CWMIDADSRPKFKELAAEFSRMARDPQRYLVIQGDDRMK 285

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 77.0 bits (189), Expect = 2e-15
 Identities = 55/193 (28%), Positives = 99/193 (51%), Gaps = 17/193 (8%)

Query: 65  IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDI------------QQEIMVLSQC 112
           +G+G++G V K     T+++VAIK     E  +E+++             Q+ I+ L + 
Sbjct: 9   VGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEA 68

Query: 113 DSPYGTKLWIIMEYLGGG--SALDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDI 170
               G KL+++ EY+       L+ M  G   E  +   + +++K + + H    +HRDI
Sbjct: 69  FRRRG-KLYLVFEYVEKNMLELLEEMPNGVPPE-KVRSYIYQLIKAIHWCHKNDIVHRDI 126

Query: 171 KAANVLLSEMGDVKLADFGVAGTLTNTTSKRNT-FVGTPFWMAPEVIKQSAYDSKADIWS 229
           K  N+L+S    +KL DFG A  L+  ++   T +V T ++ +PE++  + Y    D+WS
Sbjct: 127 KPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAPYGKAVDMWS 186

Query: 230 LGITAIELAKGEP 242
           +G    EL+ G+P
Sbjct: 187 VGCILGELSDGQP 199

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 76.9 bits (190), Expect = 2e-15
 Identities = 60/215 (27%), Positives = 98/215 (45%), Gaps = 43/215 (20%)

Query: 65  IGKGSFGEVFK--GIDNRTQQVVAIKIIDLEEAEDEIEDIQQ----EIMVLSQCDSPYGT 118
           IG+G++G V+K    + +  +  AIK    +  +++   I Q    EI +L +       
Sbjct: 8   IGRGTYGRVYKAKRKNGKDGKEYAIKKF--KGDKEQYTGISQSACREIALLRELKHENVV 65

Query: 119 KL------------WIIMEYLGGGSALDLMKAGNFEEMHIAV---------ILREVLKGL 157
            L            +++ +Y    +  DL +   F      V         +L ++L G+
Sbjct: 66  SLVEVFLEHADKSVYLLFDY----AEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGV 121

Query: 158 DYLHSERKLHRDIKAANVLL----SEMGDVKLADFGVAGTLTNTTSKR----NTFVGTPF 209
            YLHS   LHRD+K AN+L+     E G VK+ D G+A  L N   K     +  V T +
Sbjct: 122 HYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLA-RLFNAPLKPLADLDPVVVTIW 180

Query: 210 WMAPEVIKQSAYDSKA-DIWSLGITAIELAKGEPP 243
           + APE++  + + +KA DIW++G    EL   EP 
Sbjct: 181 YRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPI 215

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 75.7 bits (186), Expect = 3e-15
 Identities = 66/273 (24%), Positives = 123/273 (45%), Gaps = 46/273 (16%)

Query: 59  FTKQERIGKGSFG---EVFKGIDNRTQQVVAIKIIDLE-EAEDEIEDIQQEIMVLSQCDS 114
           FT    +GKG FG   E     ++ + Q VA+K++  +  +  +IE+  +E   + + D 
Sbjct: 1   FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60

Query: 115 PYGTKL----------------WIIMEYLGGGSALDLMKAGNFEEMHIAVILREVLK--- 155
           P   KL                 +I+ ++  G     +      E    + L+ +++   
Sbjct: 61  PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMI 120

Query: 156 ----GLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGT-PF- 209
               G++YL S+  +HRD+ A N +L+E   V +ADFG++  + +    R       P  
Sbjct: 121 DIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVK 180

Query: 210 WMAPEVIKQSAYDSKADIWSLGITAIELA-KGEPP-----NSELHPMRVLFLIPKN---N 260
           W+A E +  + Y + +D+W+ G+T  E+  +G+ P     NSE++     +LI  N    
Sbjct: 181 WLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYN----YLIKGNRLKQ 236

Query: 261 PPQLTGNYTKQFKEFVEACLNKDPENRPTAKEL 293
           PP       +   E +  C + +P+ RP+ + L
Sbjct: 237 PPDC----LEDVYELMCQCWSPEPKCRPSFQHL 265

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 77.1 bits (190), Expect = 3e-15
 Identities = 62/205 (30%), Positives = 93/205 (45%), Gaps = 46/205 (22%)

Query: 65  IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQ---EIMVLSQCDSPYGTKLW 121
           IG G+FG V+   D R  + VA+K   +      +   ++   E+ +L      +   L 
Sbjct: 8   IGYGAFGVVWSVTDPRDGKRVALK--KMPNVFQNLVSCKRVFRELKMLCFFK--HDNVL- 62

Query: 122 IIMEYLGGGSALDLMKAGN---FEEM------------------------HIAVILREVL 154
                    SALD+++  +   FEE+                        H+ V L ++L
Sbjct: 63  ---------SALDILQPPHIDPFEEIYVVTELMQSDLHKIIVSPQPLSSDHVKVFLYQIL 113

Query: 155 KGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTF-VGTPFWMAP 213
           +GL YLHS   LHRDIK  N+L++    +K+ DFG+A       SK  T  V T ++ AP
Sbjct: 114 RGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAP 173

Query: 214 EVIKQSA-YDSKADIWSLGITAIEL 237
           E++  S  Y S  DIWS+G    EL
Sbjct: 174 EILMGSRHYTSAVDIWSVGCIFAEL 198

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 75.8 bits (186), Expect = 4e-15
 Identities = 64/264 (24%), Positives = 117/264 (44%), Gaps = 29/264 (10%)

Query: 60  TKQERIGKGSFGEVFKGI-----DNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDS 114
           T    +G+GSFG V++GI      +  +  VAIK ++   +  E  +   E  V+ + + 
Sbjct: 9   TMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNC 68

Query: 115 PYGTKLW----------IIMEYLGGGSALDLMKAGNFEEMHIAV-----------ILREV 153
            +  +L           +IME +  G     +++   E  +  V           +  E+
Sbjct: 69  HHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEI 128

Query: 154 LKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVG-TPF-WM 211
             G+ YL++ + +HRD+ A N +++E   VK+ DFG+   +  T   R    G  P  WM
Sbjct: 129 ADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM 188

Query: 212 APEVIKQSAYDSKADIWSLGITAIELAK-GEPPNSELHPMRVLFLIPKNNPPQLTGNYTK 270
           +PE +K   + + +D+WS G+   E+A   E P   +   +VL  + +        N   
Sbjct: 189 SPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEGGLLDKPDNCPD 248

Query: 271 QFKEFVEACLNKDPENRPTAKELL 294
              E +  C   +P+ RP+  E++
Sbjct: 249 MLFELMRMCWQYNPKMRPSFLEII 272

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 75.4 bits (185), Expect = 6e-15
 Identities = 66/246 (26%), Positives = 110/246 (44%), Gaps = 29/246 (11%)

Query: 65  IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQ------------- 111
           +GKG FGEV       T ++ A K ++    +  I+  + E M L++             
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKKLE----KKRIKKRKGEAMALNEKRILEKVNSRFVV 63

Query: 112 -CDSPYGTK--LWIIMEYLGGGS-ALDLMKAGN--FEEMHIAVILREVLKGLDYLHSERK 165
                Y TK  L +++  + GG     +   GN  F+E        E+  GL+ L  ER 
Sbjct: 64  SLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERI 123

Query: 166 LHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKA 225
           ++RD+K  N+LL + G ++++D G+A  +    + R   VGT  +MAPEVI    Y    
Sbjct: 124 VYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGR-VGTVGYMAPEVINNEKYTFSP 182

Query: 226 DIWSLGITAIELAKGEPPNSELHPMRV----LFLIPKNNPPQLTGNYTKQFKEFVEACLN 281
           D W LG    E+ +G+ P  +    RV    +    K +  + +  +++  K      L 
Sbjct: 183 DWWGLGCLIYEMIQGQSPFRK-RKERVKREEVDRRVKEDQEEYSEKFSEDAKSICRMLLT 241

Query: 282 KDPENR 287
           K+P+ R
Sbjct: 242 KNPKER 247

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 75.1 bits (185), Expect = 7e-15
 Identities = 71/304 (23%), Positives = 119/304 (39%), Gaps = 91/304 (29%)

Query: 63  ERIGKGSFGEV---------------FKGIDNRTQQV-VAIKIIDLEEAEDEIEDIQQEI 106
           E++G+G FGEV               F   DN    V VA+K++  + +++  ED  +E+
Sbjct: 11  EKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEV 70

Query: 107 MVLSQCDSPYGTKL----------WIIMEYLGGGSALDLMKAGNFEE------------- 143
            +LS+   P   +L           +IMEY+  G     ++    E              
Sbjct: 71  KILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFS 130

Query: 144 --MHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKR 201
             +++A    ++  G+ YL S   +HRD+   N L+ +   +K+ADFG           R
Sbjct: 131 TLLYMAT---QIASGMRYLESLNFVHRDLATRNCLVGKNYTIKIADFG---------MSR 178

Query: 202 NTFVGTPF-----------WMAPEVIKQSAYDSKADIWSLGITAIE---LAKGEPPNSEL 247
           N +    +           WMA E +    + +K+D+W+ G+T  E   L + E P   L
Sbjct: 179 NLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCR-EQPYEHL 237

Query: 248 ---------------HPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPENRPTAKE 292
                             ++    P N P        K   E +  C  +D E+RPT +E
Sbjct: 238 TDQQVIENAGHFFRDDGRQIYLPRPPNCP--------KDIYELMLECWRRDEEDRPTFRE 289

Query: 293 LLKF 296
           +  F
Sbjct: 290 IHLF 293

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 74.4 bits (183), Expect = 1e-14
 Identities = 67/277 (24%), Positives = 118/277 (42%), Gaps = 46/277 (16%)

Query: 58  IFTKQERIGKGSFGEVFKG-----IDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQC 112
           I  K+E +G+G+FG+VF G          +++VA+K +    + D  +D ++E  +L+  
Sbjct: 7   IVLKRE-LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNF 65

Query: 113 D-----SPYGT-----KLWIIMEYLGGG-------------SALDLMKAGNFE-----EM 144
                   YG         ++ EY+  G             + L    +   E      +
Sbjct: 66  QHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLL 125

Query: 145 HIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTF 204
            IAV   ++  G+ YL S+  +HRD+   N L+     VK+ DFG++  +  T   R   
Sbjct: 126 QIAV---QIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYR--- 179

Query: 205 VG----TPF-WMAPEVIKQSAYDSKADIWSLGITAIEL-AKGEPPNSELHPMRVLFLIPK 258
           VG     P  WM PE I    + +++D+WS G+   E+   G+ P   L    V+  I +
Sbjct: 180 VGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQ 239

Query: 259 NNPPQLTGNYTKQFKEFVEACLNKDPENRPTAKELLK 295
               Q       +  + +  C  +DP+ R   K++ +
Sbjct: 240 GRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE 276

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 74.5 bits (183), Expect = 1e-14
 Identities = 71/276 (25%), Positives = 116/276 (42%), Gaps = 58/276 (21%)

Query: 63  ERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQ--QEI------------MV 108
           + IG G FG+V  G  +R      + + +L  +    E +   QE+              
Sbjct: 1   DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQC 60

Query: 109 LSQCDSPYGTKLWIIMEYLGGGSALDL---------MKAGNFEEMHIAVILREVLKGLDY 159
           L QC         +++E+   G   DL         M A   ++  +  +  EV  GL +
Sbjct: 61  LGQCIE--SIPYLLVLEFCPLG---DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLW 115

Query: 160 LHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFV-----GTPF-WMAP 213
           LH    +H D+   N  L+    VK+ D+G+A          + ++       P  W+AP
Sbjct: 116 LHQADFIHSDLALRNCQLTADLSVKIGDYGLA----LEQYPEDYYITKDCHAVPLRWLAP 171

Query: 214 EVIKQSAYD-------SKADIWSLGITAIELAK-GEPPNSELHPMRVL--------FLIP 257
           E+++    D        K++IWSLG+T  EL    + P  +L   +VL          +P
Sbjct: 172 ELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLP 231

Query: 258 KNNPPQLTGNYTKQFKEFVEACLNKDPENRPTAKEL 293
           K   PQL   Y+ ++ E ++ C   DPE RPTA+E+
Sbjct: 232 K---PQLDLKYSDRWYEVMQFCW-LDPETRPTAEEV 263

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 75.8 bits (186), Expect = 1e-14
 Identities = 51/167 (30%), Positives = 72/167 (43%), Gaps = 16/167 (9%)

Query: 146 IAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKR-NTF 204
           I  I R VL+ + YLH  R +HRDIKA N+ ++  GDV L DFG A    +  + +   +
Sbjct: 184 ILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGW 243

Query: 205 VGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPM-------RVLFLI- 256
            GT    APE++ +  Y    DIWS GI   E+A       E   +       R + LI 
Sbjct: 244 AGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLII 303

Query: 257 ------PKNNPPQLTGNYTKQFKEFVEACLNKDPENRPTAKELLKFP 297
                 P   P     N  + +    +    K P +RP    L + P
Sbjct: 304 RRSGTHPNEFPIDAQANLDEIYIGLAKKSSRK-PGSRPLWTNLYELP 349

Length = 391

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 75.4 bits (185), Expect = 1e-14
 Identities = 56/246 (22%), Positives = 106/246 (43%), Gaps = 60/246 (24%)

Query: 58  IFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA--EDEIEDIQQEIMVLSQCDSP 115
           +F K + +G G+FGEV       T+ + A+K +  ++    +++  ++ E  +L++ D+ 
Sbjct: 2   MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNE 61

Query: 116 YGTKLW----------IIMEYLGGGSALDLM-KAGNFEEMHIAVILREVLKGLDYLHSER 164
           +  +L+           +M+Y+ GG  + L+ + G F E      + E+   ++ +H   
Sbjct: 62  WVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMG 121

Query: 165 KLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKR----------------------- 201
            +HRDIK  N+L+   G +KL DFG+      T   +                       
Sbjct: 122 FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPA 181

Query: 202 ------------------------NTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIEL 237
                                   ++ VGTP ++APEV+ ++ Y    D WS+G+   E+
Sbjct: 182 NCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEM 241

Query: 238 AKGEPP 243
             G+PP
Sbjct: 242 LVGQPP 247

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 74.9 bits (184), Expect = 1e-14
 Identities = 74/290 (25%), Positives = 128/290 (44%), Gaps = 57/290 (19%)

Query: 59  FTKQERIGKGSFGEVFKGIDNRTQQVVAIKI--------IDLEEAEDEI--------EDI 102
           +T  +++G G++G V   ID RT + VAIK         I  + A  E+        E++
Sbjct: 17  YTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENV 76

Query: 103 QQEIMVLSQCDSPYGTK-LWIIMEYLGGGSALDLMK--AGNFEEMHIAVILREVLKGLDY 159
              + V +   S    +  +++M Y+      DL K       E  +  ++ ++L GL Y
Sbjct: 77  IGLLDVFTSAVSGDEFQDFYLVMPYM----QTDLQKIMGHPLSEDKVQYLVYQMLCGLKY 132

Query: 160 LHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVI-KQ 218
           +HS   +HRD+K  N+ ++E  ++K+ DFG+A    +  ++   +V T ++ APEVI   
Sbjct: 133 IHSAGIIHRDLKPGNLAVNEDCELKILDFGLA---RHADAEMTGYVVTRWYRAPEVILNW 189

Query: 219 SAYDSKADIWSLG------ITAIELAKGEPPNSEL--------HP--------------- 249
             Y+   DIWS+G      +T   L KG+    +L         P               
Sbjct: 190 MHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAAKS 249

Query: 250 -MRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPENRPTAKELLKFPF 298
            ++ L   P+ +   L    + Q  + +E  L  D + R TA E L+ P+
Sbjct: 250 YIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPY 299

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 75.4 bits (185), Expect = 2e-14
 Identities = 63/267 (23%), Positives = 111/267 (41%), Gaps = 70/267 (26%)

Query: 58  IFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA--EDEIEDIQQEIMVLSQCDSP 115
           +F K + +G G+FGEV       T  + A+K +  ++    +++  ++ E  +L++ D+ 
Sbjct: 2   MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNE 61

Query: 116 YGTKLW----------IIMEYLGGGSALDLM-KAGNFEEMHIAVILREVLKGLDYLHSER 164
           +  KL+           +M+Y+ GG  + L+ +   F E+     + E+   ++ +H   
Sbjct: 62  WVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMG 121

Query: 165 KLHRDIKAANVLLSEMGDVKLADFGV---------------------------------- 190
            +HRDIK  N+L+   G +KL DFG+                                  
Sbjct: 122 FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVS 181

Query: 191 ---AGTLTNTTSKR----------NTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIEL 237
               G    T  +R          ++ VGTP ++APEV+ +  Y    D WS+G+   E+
Sbjct: 182 NCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEM 241

Query: 238 AKGEPPNSELHPMRVLFLIPKNNPPQL 264
             G+PP          FL P     QL
Sbjct: 242 LVGQPP----------FLAPTPTETQL 258

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 75.3 bits (185), Expect = 2e-14
 Identities = 53/199 (26%), Positives = 79/199 (39%), Gaps = 38/199 (19%)

Query: 146 IAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTF- 204
              I R +L+ L YLH    +HRD+K  N+ L E  +  L DFG A  L         + 
Sbjct: 187 AITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYG 246

Query: 205 -VGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAK------GEPPNSELHPMRVLF--- 254
             GT    +PE++    Y +K DIWS G+   E++       G+   S    +R +    
Sbjct: 247 WSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCM 306

Query: 255 -LIPKNNPPQLTGNYTKQFKEF----------------------VEACLNK----DPENR 287
            + P   P   + N  K FK++                      VE  + K    D E R
Sbjct: 307 QVHPLEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFR 366

Query: 288 PTAKELLKFPFIRKAKKNA 306
           P+A+++L  P   K   N 
Sbjct: 367 PSAQDILSLPLFTKEPINL 385

Length = 392

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 74.7 bits (183), Expect = 2e-14
 Identities = 53/220 (24%), Positives = 104/220 (47%), Gaps = 23/220 (10%)

Query: 65  IGKGSFGEVFKGIDNRTQQVVAIK--------IIDLEEAEDEI--------EDIQQEIMV 108
           +G G++G V    D +T   VA+K        II  +    E+        E++   + V
Sbjct: 25  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 84

Query: 109 LSQCDSPYGTKLWIIMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHR 168
            +   S        ++ +L G    +++K     + H+  ++ ++L+GL Y+HS   +HR
Sbjct: 85  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHR 144

Query: 169 DIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEV-IKQSAYDSKADI 227
           D+K +N+ ++E  ++K+ DFG+A    +T  +   +V T ++ APE+ +    Y+   DI
Sbjct: 145 DLKPSNLAVNEDCELKILDFGLA---RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDI 201

Query: 228 WSLGITAIELAKGE---PPNSELHPMRVLFLIPKNNPPQL 264
           WS+G    EL  G    P    +  ++++  +      +L
Sbjct: 202 WSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAEL 241

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 75.0 bits (184), Expect = 2e-14
 Identities = 50/150 (33%), Positives = 79/150 (52%), Gaps = 10/150 (6%)

Query: 152 EVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTL---TNTTSKRNTFVGTP 208
           +V  G+++L S+  +HRD+ A NVL+ E   VK+ DFG+A  +   +N  SK +TF+  P
Sbjct: 247 QVANGMEFLASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFL--P 304

Query: 209 F-WMAPEVIKQSAYDSKADIWSLGITAIEL-AKGEPPNSELHPMRVLFLIPKNNPPQLT- 265
             WMAPE I  + Y + +D+WS GI   E+   G  P  EL PM   F        ++  
Sbjct: 305 LKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPEL-PMNEQFYNAIKRGYRMAK 363

Query: 266 -GNYTKQFKEFVEACLNKDPENRPTAKELL 294
             + + +  E ++ C  +  E RP   +L+
Sbjct: 364 PAHASDEIYEIMQKCWEEKFEIRPDFSQLV 393

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 73.4 bits (180), Expect = 2e-14
 Identities = 68/256 (26%), Positives = 122/256 (47%), Gaps = 38/256 (14%)

Query: 65  IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAE----DEIEDIQQEIMVLSQCDSPY---- 116
           +GKG FGEV       T ++ A K +D +  +    +++  +++EI  L + +SP+    
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEI--LEKVNSPFIVNL 58

Query: 117 ------GTKLWIIMEYLGGGS-ALDLMKAGN--FEEMHIAVILREVLKGLDYLHSERKLH 167
                  T L ++M  + GG     +   G    E   +     ++  G+ +LHS   ++
Sbjct: 59  AYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVY 118

Query: 168 RDIKAANVLLSEMGDVKLADFGVAGTLTN--TTSKRNTFVGTPFWMAPEVIKQSAYDSKA 225
           RD+K  NVLL + G+ +L+D G+A  L +  T ++R    GT  +MAPE++K+  Y    
Sbjct: 119 RDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQR---AGTNGYMAPEILKEEPYSYPV 175

Query: 226 DIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLT---------GNYTKQFKEFV 276
           D +++G +  E+  G  P  + H  +V     K    + T          N+T++ K+  
Sbjct: 176 DWFAMGCSIYEMVAGRTPFKD-HKEKV----AKEELKRRTLEDEVKFEHQNFTEESKDIC 230

Query: 277 EACLNKDPENRPTAKE 292
              L K PE+R  ++E
Sbjct: 231 RLFLAKKPEDRLGSRE 246

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 74.3 bits (182), Expect = 2e-14
 Identities = 61/238 (25%), Positives = 106/238 (44%), Gaps = 39/238 (16%)

Query: 65  IGKGSFGEVFKGIDNRTQQVVAIK--------IIDLEEAEDEI--------EDIQQEIMV 108
           +G G++G V    D R +Q VA+K        +I       E+        E++   + V
Sbjct: 23  VGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDV 82

Query: 109 LSQCDSPYGTKLWIIMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHR 168
            +   S        ++  L G    +++K     + H+  ++ ++L+GL Y+HS   +HR
Sbjct: 83  FTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQLLRGLKYIHSAGIIHR 142

Query: 169 DIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEV-IKQSAYDSKADI 227
           D+K +NV ++E  ++++ DFG+A        +   +V T ++ APE+ +    Y+   DI
Sbjct: 143 DLKPSNVAVNEDCELRILDFGLA---RQADDEMTGYVATRWYRAPEIMLNWMHYNQTVDI 199

Query: 228 WSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPE 285
           WS+G    EL KG          + LF  P N       +Y  Q K  +E      PE
Sbjct: 200 WSVGCIMAELLKG----------KALF--PGN-------DYIDQLKRIMEVVGTPSPE 238

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 74.2 bits (182), Expect = 3e-14
 Identities = 47/157 (29%), Positives = 80/157 (50%), Gaps = 22/157 (14%)

Query: 152 EVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTS---KRNTFVGTP 208
           +V KG+ +L S+  +HRD+ A N+LL+     K+ DFG+A  + N ++   K N  +   
Sbjct: 222 QVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLPVK 281

Query: 209 FWMAPEVIKQSAYDSKADIWSLGITAIELAK-------GEPPNSELHPM---RVLFLIPK 258
            WMAPE I    Y  ++D+WS GI   E+         G P +S+ + M       L P+
Sbjct: 282 -WMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRMLSPE 340

Query: 259 NNPPQLTGNYTKQFKEFVEACLNKDPENRPTAKELLK 295
             P ++         + +++C + DP  RPT K++++
Sbjct: 341 CAPSEMY--------DIMKSCWDADPLKRPTFKQIVQ 369

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 72.7 bits (178), Expect = 6e-14
 Identities = 63/267 (23%), Positives = 115/267 (43%), Gaps = 38/267 (14%)

Query: 62  QERIGKGSFGEVFKGIDNRT--QQVVAIKIIDLEEAEDEIEDIQQEIMVLSQ-------- 111
           Q+ IG+G+FG+V K    +   +   AIK +    ++D+  D   E+ VL +        
Sbjct: 12  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 71

Query: 112 -----CDSPYGTKLWIIMEYLGGGSALDLMK-----------------AGNFEEMHIAVI 149
                C+  +   L++ +EY   G+ LD ++                 A       +   
Sbjct: 72  NLLGACE--HRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHF 129

Query: 150 LREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPF 209
             +V +G+DYL  ++ +HRD+ A N+L+ E    K+ADFG+  +       + T    P 
Sbjct: 130 AADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGL--SRGQEVYVKKTMGRLPV 187

Query: 210 -WMAPEVIKQSAYDSKADIWSLGITAIELAK-GEPPNSELHPMRVLFLIPKNNPPQLTGN 267
            WMA E +  S Y + +D+WS G+   E+   G  P   +    +   +P+    +   N
Sbjct: 188 RWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLN 247

Query: 268 YTKQFKEFVEACLNKDPENRPTAKELL 294
              +  + +  C  + P  RP+  ++L
Sbjct: 248 CDDEVYDLMRQCWREKPYERPSFAQIL 274

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 72.3 bits (177), Expect = 6e-14
 Identities = 71/287 (24%), Positives = 124/287 (43%), Gaps = 42/287 (14%)

Query: 62  QERIGKGSFGEVFKGIDNR--TQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQ-------- 111
           ++ IG+G+FG+V + +  +   +   AIK++    +E++  D   E+ VL +        
Sbjct: 7   EDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNII 66

Query: 112 -----CDSPYGTKLWIIMEYLGGGSALDLMKAGNFEEMHIAV--------------ILR- 151
                C++     L+I +EY   G+ LD ++     E   A               +L+ 
Sbjct: 67  NLLGACENR--GYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQF 124

Query: 152 --EVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPF 209
             +V  G+ YL  ++ +HRD+ A NVL+ E    K+ADFG+  +       + T    P 
Sbjct: 125 ASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGL--SRGEEVYVKKTMGRLPV 182

Query: 210 -WMAPEVIKQSAYDSKADIWSLGITAIELAK-GEPPNSELHPMRVLFLIPKNNPPQLTGN 267
            WMA E +  S Y +K+D+WS G+   E+   G  P   +    +   +P+    +   N
Sbjct: 183 RWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRMEKPRN 242

Query: 268 YTKQFKEFVEACLNKDPENRP----TAKELLKFPFIRKAKKNAYLID 310
              +  E +  C    P  RP     + +L +    RKA  N  L +
Sbjct: 243 CDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEARKAYVNMALFE 289

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 71.3 bits (174), Expect = 1e-13
 Identities = 62/258 (24%), Positives = 110/258 (42%), Gaps = 38/258 (14%)

Query: 65  IGKGSFGEVFKGIDNRT--QQVVAIKIIDLEEAEDEIEDIQQEIMVLSQ----------- 111
           IG+G+FG+V K    +   +   AIK +    ++D+  D   E+ VL +           
Sbjct: 3   IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62

Query: 112 --CDSPYGTKLWIIMEYLGGGSALDLMKAGNFEEMHIA----------VILREVLK---- 155
             C+      L++ +EY   G+ LD ++     E   A          +  +++L     
Sbjct: 63  GACEHR--GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 120

Query: 156 ---GLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPF-WM 211
              G+DYL  ++ +HRD+ A N+L+ E    K+ADFG+  +       + T    P  WM
Sbjct: 121 VARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGL--SRGQEVYVKKTMGRLPVRWM 178

Query: 212 APEVIKQSAYDSKADIWSLGITAIELAK-GEPPNSELHPMRVLFLIPKNNPPQLTGNYTK 270
           A E +  S Y + +D+WS G+   E+   G  P   +    +   +P+    +   N   
Sbjct: 179 AIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLNCDD 238

Query: 271 QFKEFVEACLNKDPENRP 288
           +  + +  C  + P  RP
Sbjct: 239 EVYDLMRQCWREKPYERP 256

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 71.9 bits (176), Expect = 1e-13
 Identities = 60/232 (25%), Positives = 104/232 (44%), Gaps = 34/232 (14%)

Query: 42  STTASRRNSLKVDPELIFTKQERIGKGSFGEV-FKGIDNRTQQVVAIKIIDLEE--AEDE 98
           +    R+N +K +    F     +G GSFG V      N     VAIK  +  +   + +
Sbjct: 18  TKEPKRKNKMKYED---FNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQ 74

Query: 99  IEDIQQEIMVLSQCDSPY----------GTKLWIIMEYLGGGSALDLMK--------AGN 140
           ++ +  E  +L+  + P+           + L++++E++ GG     ++         G 
Sbjct: 75  VDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGC 134

Query: 141 FEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSK 200
           F    I +I        +YL S   ++RD+K  N+LL + G +K+ DFG A  +   T  
Sbjct: 135 FYAAQIVLIF-------EYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTRTY- 186

Query: 201 RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRV 252
             T  GTP ++APE++    +   AD W+LGI   E+  G PP     P+ +
Sbjct: 187 --TLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLI 236

Length = 340

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 70.9 bits (174), Expect = 2e-13
 Identities = 69/286 (24%), Positives = 117/286 (40%), Gaps = 75/286 (26%)

Query: 63  ERIGKGSFGEVFKG-----IDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSP-- 115
           E +G+G+FG+V+KG      +  +   VAIK +         ++ +QE  ++S    P  
Sbjct: 11  EELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNI 70

Query: 116 ---------------------YGTKLWIIMEYL-------------GGGSALDLMKAGNF 141
                                +G     + E+L             G  +    +   +F
Sbjct: 71  VCLLGVCTKEQPTCMLFEYLAHGD----LHEFLVRNSPHSDVGAESGDETVKSSLDCSDF 126

Query: 142 EEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVA-----GTLTN 196
             +HIA+   ++  G++YL S   +HRD+ A N L+ E   VK++DFG++          
Sbjct: 127 --LHIAI---QIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYR 181

Query: 197 TTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIEL-AKGEPP-----NSELHPM 250
             SK    V    WM PE I    + +++DIWS G+   E+ + G  P     N E+  M
Sbjct: 182 VQSKSLLPVR---WMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEM 238

Query: 251 ---RVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPENRPTAKEL 293
              R L   P++ P ++     +        C N+ P  RP  K++
Sbjct: 239 IRSRQLLPCPEDCPARVYALMIE--------CWNEIPARRPRFKDI 276

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 70.9 bits (173), Expect = 2e-13
 Identities = 67/267 (25%), Positives = 119/267 (44%), Gaps = 36/267 (13%)

Query: 58  IFTKQERIGKGSFGEVFKG-----IDNRTQQVVAIKIIDLEEAEDEI-EDIQQEIMVLSQ 111
           I  K+E +G+G+FG+VF          + + +VA+K   L++A D   +D  +E  +L+ 
Sbjct: 7   IVLKRE-LGEGAFGKVFLAECYNLCPEQDKILVAVKT--LKDASDNARKDFHREAELLTN 63

Query: 112 CDSPY----------GTKLWIIMEYLGGGSALDLMKA----------GN----FEEMHIA 147
               +          G  L ++ EY+  G     ++A          GN      +  + 
Sbjct: 64  LQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQML 123

Query: 148 VILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKR-NTFVG 206
            I +++  G+ YL S+  +HRD+   N L+ E   VK+ DFG++  + +T   R      
Sbjct: 124 HIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTM 183

Query: 207 TPF-WMAPEVIKQSAYDSKADIWSLGITAIEL-AKGEPPNSELHPMRVLFLIPKNNPPQL 264
            P  WM PE I    + +++D+WSLG+   E+   G+ P  +L    V+  I +    Q 
Sbjct: 184 LPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRVLQR 243

Query: 265 TGNYTKQFKEFVEACLNKDPENRPTAK 291
                K+  + +  C  ++P  R   K
Sbjct: 244 PRTCPKEVYDLMLGCWQREPHMRLNIK 270

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 70.4 bits (172), Expect = 3e-13
 Identities = 66/274 (24%), Positives = 119/274 (43%), Gaps = 57/274 (20%)

Query: 65  IGKGSFGEVFKG-----IDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTK 119
           +G+GSFG V++G     I    +  VA+K ++      E   +++ I  L++     G  
Sbjct: 14  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVN------ESASLRERIEFLNEASVMKGFT 67

Query: 120 LWIIMEYLGGGS-------ALDLMKAGNFEEM-------------HIAVILREVLK---- 155
              ++  LG  S        ++LM  G+ +                    L+E+++    
Sbjct: 68  CHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAE 127

Query: 156 ---GLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVG-TPF-W 210
              G+ YL++++ +HRD+ A N +++    VK+ DFG+   +  T   R    G  P  W
Sbjct: 128 IADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRW 187

Query: 211 MAPEVIKQSAYDSKADIWSLGITAIELAK-GEPPNSELHPMRVLFLI--------PKNNP 261
           MAPE +K   + + +D+WS G+   E+    E P   L   +VL  +        P N P
Sbjct: 188 MAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQPDNCP 247

Query: 262 PQLTGNYTKQFKEFVEACLNKDPENRPTAKELLK 295
            ++T        + +  C   +P+ RPT  E++ 
Sbjct: 248 ERVT--------DLMRMCWQFNPKMRPTFLEIVN 273

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 69.9 bits (172), Expect = 3e-13
 Identities = 74/260 (28%), Positives = 108/260 (41%), Gaps = 70/260 (26%)

Query: 68  GSFGEVF----KGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTKLW-- 121
           G FG+V     K     TQ++   KII   +  + IE +  ++M     D+P   KL+  
Sbjct: 27  GKFGKVSVLKHKP----TQKLFVQKIIK-AKNFNAIEPMVHQLMK----DNPNFIKLYYS 77

Query: 122 --------IIMEYLGGGSALDLMKA-GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKA 172
                   +IM+Y+  G   DL+K  G   E  +  I+R++++ L+ LH    +H DIK 
Sbjct: 78  VTTLKGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKL 137

Query: 173 ANVLLSE-MGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLG 231
            NVL       + L D+G+      T S  +   GT  + +PE IK   YD   D W++G
Sbjct: 138 ENVLYDRAKDRIYLCDYGLCKI-IGTPSCYD---GTLDYFSPEKIKGHNYDVSFDWWAVG 193

Query: 232 ITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPENRPTAK 291
           +   EL                          LTG +   FKE  +  L  D E      
Sbjct: 194 VLTYEL--------------------------LTGKHP--FKEDEDEEL--DLE------ 217

Query: 292 ELL-----KFPFIRKAKKNA 306
            LL     K PFI+   KNA
Sbjct: 218 SLLKRQQKKLPFIKNVSKNA 237

Length = 267

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 70.0 bits (171), Expect = 4e-13
 Identities = 69/291 (23%), Positives = 123/291 (42%), Gaps = 47/291 (16%)

Query: 58  IFTKQERIGKGSFGEVFKG-----IDNRTQQVVAIKII---------DLEEAEDEIEDIQ 103
           I  K+E +G+G+FG+VF          + + +VA+K +         D +   + + ++Q
Sbjct: 7   IVLKRE-LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQ 65

Query: 104 QEIMVLSQCDSPYGTKLWIIMEYLGGGSALDLMKA--------------------GNFEE 143
            E +V        G  L ++ EY+  G     ++A                    G  + 
Sbjct: 66  HEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQM 125

Query: 144 MHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNT 203
           +HIA    ++  G+ YL S+  +HRD+   N L+     VK+ DFG++  + +T   R  
Sbjct: 126 LHIAS---QIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYR-- 180

Query: 204 FVG----TPF-WMAPEVIKQSAYDSKADIWSLGITAIEL-AKGEPPNSELHPMRVLFLIP 257
            VG     P  WM PE I    + +++D+WS G+   E+   G+ P  +L    V+  I 
Sbjct: 181 -VGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECIT 239

Query: 258 KNNPPQLTGNYTKQFKEFVEACLNKDPENRPTAKELLKFPFIRKAKKNAYL 308
           +    +      K+  + +  C  ++P+ R   KE+ K           YL
Sbjct: 240 QGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKATPIYL 290

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 71.4 bits (175), Expect = 5e-13
 Identities = 44/146 (30%), Positives = 75/146 (51%), Gaps = 13/146 (8%)

Query: 59  FTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDE--IEDIQQEIMVLSQCDSPY 116
           F   + I +G+FG+V+ G      ++ A+K++   +  ++  +  +Q E   L+   SP+
Sbjct: 6   FVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPF 65

Query: 117 ----------GTKLWIIMEYLGGGSALDLMKA-GNFEEMHIAVILREVLKGLDYLHSERK 165
                        ++++MEYL GG    L+   G F+E      + EV   LDYLH    
Sbjct: 66  IVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGI 125

Query: 166 LHRDIKAANVLLSEMGDVKLADFGVA 191
           +HRD+K  N+L+S  G +KL DFG++
Sbjct: 126 IHRDLKPDNMLISNEGHIKLTDFGLS 151

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 69.7 bits (170), Expect = 7e-13
 Identities = 48/151 (31%), Positives = 75/151 (49%), Gaps = 10/151 (6%)

Query: 152 EVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTL-TNTTSKRNTFVGTPF- 209
           +V KG+++L S + +HRD+ A N+LLSE   VK+ DFG+A  +  +    R      P  
Sbjct: 187 QVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLK 246

Query: 210 WMAPEVIKQSAYDSKADIWSLGITAIEL-AKGEPPNSELHP----MRVLFLIPKNNPPQL 264
           WMAPE I    Y  ++D+WS G+   E+ + G  P   +       R L    +   P  
Sbjct: 247 WMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDY 306

Query: 265 TGNYTKQFKEFVEACLNKDPENRPTAKELLK 295
           T   T +  + +  C + +P  RPT  EL++
Sbjct: 307 T---TPEMYQTMLDCWHGEPSQRPTFSELVE 334

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 69.5 bits (170), Expect = 7e-13
 Identities = 47/151 (31%), Positives = 77/151 (50%), Gaps = 10/151 (6%)

Query: 152 EVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTL-TNTTSKRNTFVGTPF- 209
           +V +G+++L S + +HRD+ A N+LLSE   VK+ DFG+A  +  +    R      P  
Sbjct: 181 QVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLK 240

Query: 210 WMAPEVIKQSAYDSKADIWSLGITAIEL-AKGEPPNSELHP----MRVLFLIPKNNPPQL 264
           WMAPE I    Y +++D+WS G+   E+ + G  P   +       R L    +   P+ 
Sbjct: 241 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRAPEY 300

Query: 265 TGNYTKQFKEFVEACLNKDPENRPTAKELLK 295
               T +    +  C + +PE+RPT  EL++
Sbjct: 301 A---TPEIYSIMLDCWHNNPEDRPTFSELVE 328

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 68.8 bits (168), Expect = 8e-13
 Identities = 64/259 (24%), Positives = 108/259 (41%), Gaps = 44/259 (16%)

Query: 61  KQERI-GKGSFGEVFKG---IDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPY 116
           K ERI G G FGE+ +G   + ++ +  VAI  +    ++ +      E + L Q D   
Sbjct: 8   KIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSN 67

Query: 117 ----------GTKLWIIMEYLGGGSALD--LMK-AGNFEEMHIAVILREVLKGLDYLHSE 163
                     G  + I+ EY+  G ALD  L K  G      +  +L  +  G+ YL   
Sbjct: 68  IVRLEGVITRGNTMMIVTEYMSNG-ALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEM 126

Query: 164 RKLHRDIKAANVLLSEMGDVKLADFG-----VAGTLTNTTSKRNTFVGTPFWMAPEVIKQ 218
             +H+ + A  VL++     K++ F       +  +  T S ++  +    W APE I+ 
Sbjct: 127 GYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVL----WAAPEAIQY 182

Query: 219 SAYDSKADIWSLGITAIE-LAKGEPPNSELHPMRVLFLI--------PKNNPPQLTGNYT 269
             + S +D+WS GI   E ++ GE P  ++    V+  +        P+N P  L     
Sbjct: 183 HHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRLPAPRNCPNLL----- 237

Query: 270 KQFKEFVEACLNKDPENRP 288
               + +  C  K+   RP
Sbjct: 238 ---HQLMLDCWQKERGERP 253

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 70.1 bits (171), Expect = 8e-13
 Identities = 47/147 (31%), Positives = 76/147 (51%), Gaps = 6/147 (4%)

Query: 152 EVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTL---TNTTSKRNTFVGTP 208
           +V +G+++L S+  +HRD+ A NVLL++   VK+ DFG+A  +   +N  SK +TF+   
Sbjct: 245 QVARGMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVK 304

Query: 209 FWMAPEVIKQSAYDSKADIWSLGITAIELAK--GEPPNSELHPMRVLFLIPKNNPPQLTG 266
            WMAPE I  + Y + +D+WS GI   E+    G P    +        I          
Sbjct: 305 -WMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKIKSGYRMAKPD 363

Query: 267 NYTKQFKEFVEACLNKDPENRPTAKEL 293
           + T++  + +  C N +PE RP+   L
Sbjct: 364 HATQEVYDIMVKCWNSEPEKRPSFLHL 390

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 68.6 bits (168), Expect = 1e-12
 Identities = 62/274 (22%), Positives = 103/274 (37%), Gaps = 49/274 (17%)

Query: 59  FTKQERIGKGSFGEVFKGI----DNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDS 114
            T  + + +G+FG +F GI        ++ V +K +    +E ++  + QE  +L     
Sbjct: 8   VTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLL--YGL 65

Query: 115 PYGTKLWIIMEYLGGGS----ALDLMKAGNF-----------EEMHIAVILRE------- 152
            +   L I+   +  G         M  GN                 A+  ++       
Sbjct: 66  SHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQ 125

Query: 153 VLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGT----- 207
           +  G+ YLH    +H+DI A N ++ E   VK+ D        N  S R+ F        
Sbjct: 126 IACGMSYLHKRGVIHKDIAARNCVIDEELQVKITD--------NALS-RDLFPMDYHCLG 176

Query: 208 -----PF-WMAPEVIKQSAYDSKADIWSLGITAIELAK-GEPPNSELHPMRVLFLIPKNN 260
                P  WMA E +    Y S +D+WS G+   EL   G+ P  E+ P  +   +    
Sbjct: 177 DNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGY 236

Query: 261 PPQLTGNYTKQFKEFVEACLNKDPENRPTAKELL 294
                 N   +    +  C   DPE RP+  +L+
Sbjct: 237 RLAQPINCPDELFAVMACCWALDPEERPSFSQLV 270

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 68.5 bits (167), Expect = 2e-12
 Identities = 50/160 (31%), Positives = 77/160 (48%), Gaps = 28/160 (17%)

Query: 152 EVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTL-TNTTSKRNTFVGTPF- 209
           +V +G+++L S + +HRD+ A N+LLSE   VK+ DFG+A  +  +    R      P  
Sbjct: 182 QVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLK 241

Query: 210 WMAPEVIKQSAYDSKADIWSLGITAIEL-AKGEPP------NSEL-------HPMRVLFL 255
           WMAPE I    Y +++D+WS G+   E+ + G  P      N E          MR    
Sbjct: 242 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMRA--- 298

Query: 256 IPKNNPPQLTGNYTKQFKEFVEACLNKDPENRPTAKELLK 295
            P+N  P++           + AC   DP+ RPT   L++
Sbjct: 299 -PENATPEIYR--------IMLACWQGDPKERPTFSALVE 329

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 70.3 bits (172), Expect = 2e-12
 Identities = 60/250 (24%), Positives = 106/250 (42%), Gaps = 39/250 (15%)

Query: 81  TQQVVAIKI--IDLEEAEDEIEDIQQEIMVLSQCDSPYGTKL-----------WIIMEYL 127
           T   VAIK+   D  E E +    ++E  + ++   P    L           + + EY+
Sbjct: 2   TGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYV 61

Query: 128 GGGSALDLMKA-GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGD---V 183
            G +  +++ A G         ++ +VL  L   H++  +HRD+K  N+++S+ G     
Sbjct: 62  PGRTLREVLAADGALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPHA 121

Query: 184 KLADFGV-----------AGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGI 232
           K+ DFG+             TLT TT      +GTP + APE ++       +D+++ G+
Sbjct: 122 KVLDFGIGTLLPGVRDADVATLTRTTE----VLGTPTYCAPEQLRGEPVTPNSDLYAWGL 177

Query: 233 TAIELAKGEPPNSELHPMRVLF--LIPKNN--PPQLTGNYTKQFKEFVEACLNKDPENRP 288
             +E   G+          +L+  L P +   PP + G+      + +   LNKDP  R 
Sbjct: 178 IFLECLTGQRVVQGASVAEILYQQLSPVDVSLPPWIAGH---PLGQVLRKALNKDPRQRA 234

Query: 289 TAKELLKFPF 298
            +   L   F
Sbjct: 235 ASAPALAERF 244

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 66.6 bits (162), Expect = 4e-12
 Identities = 63/274 (22%), Positives = 117/274 (42%), Gaps = 57/274 (20%)

Query: 65  IGKGSFGEVFKG-----IDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPY--- 116
           +G+G+FG+VF       +  + + +VA+K +  E +E   +D Q+E  +L+     +   
Sbjct: 13  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALK-EASESARQDFQREAELLTVLQHQHIVR 71

Query: 117 -------GTKLWIIMEYLGGGSALDLMKA----------------GNFEEMHIAVILREV 153
                  G  L ++ EY+  G     +++                G      +  I  ++
Sbjct: 72  FYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQI 131

Query: 154 LKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVG----TPF 209
             G+ YL S   +HRD+   N L+ +   VK+ DFG++  + +T   R   VG     P 
Sbjct: 132 ASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYR---VGGRTMLPI 188

Query: 210 -WMAPEVIKQSAYDSKADIWSLGITAIEL-AKGEPPNSELHPMRVLFLI--------PKN 259
            WM PE I    + +++DIWS G+   E+   G+ P  +L     +  I        P+ 
Sbjct: 189 RWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQGRELERPRT 248

Query: 260 NPPQLTGNYTKQFKEFVEACLNKDPENRPTAKEL 293
            PP++           ++ C  ++P+ R   K++
Sbjct: 249 CPPEVY--------AIMQGCWQREPQQRMVIKDI 274

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 66.6 bits (162), Expect = 1e-11
 Identities = 58/217 (26%), Positives = 92/217 (42%), Gaps = 53/217 (24%)

Query: 133 LDLMKAGNFEEMHI-------AVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKL 185
           ++LM A   + +H+       + +L ++L G+ +LHS   +HRD+K +N+++     +K+
Sbjct: 105 MELMDANLCQVIHMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKI 164

Query: 186 ADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGE---- 241
            DFG+A T   T      +V T ++ APEVI    Y    DIWS+G    EL KG     
Sbjct: 165 LDFGLART-ACTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQ 223

Query: 242 ----------------PPNSELHPMRVLFLIPKN---NPPQLTGNY-------------- 268
                            P++E   M  L    +N   N PQ  G                
Sbjct: 224 GTDHIDQWNKVIEQLGTPSAEF--MNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSES 281

Query: 269 ------TKQFKEFVEACLNKDPENRPTAKELLKFPFI 299
                 T Q ++ +   L  DP+ R +  E L+ P+I
Sbjct: 282 ERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYI 318

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 66.0 bits (161), Expect = 1e-11
 Identities = 49/151 (32%), Positives = 78/151 (51%), Gaps = 22/151 (14%)

Query: 152 EVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTS---KRNTFVGTP 208
           +V +G+D+L S+  +HRD+ A NVLL++    K+ DFG+A  + N ++   K N  +   
Sbjct: 220 QVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLPVK 279

Query: 209 FWMAPEVIKQSAYDSKADIWSLGITAIEL-AKGEPP------NSELHPM---RVLFLIPK 258
            WMAPE I    Y  ++D+WS GI   E+ + G+ P      NS+ + M         P 
Sbjct: 280 -WMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMSRPD 338

Query: 259 NNPPQLTGNYTKQFKEFVEACLNKDPENRPT 289
             PP++   Y+      ++ C N +P  RPT
Sbjct: 339 FAPPEI---YS-----IMKMCWNLEPTERPT 361

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 64.8 bits (158), Expect = 7e-11
 Identities = 56/212 (26%), Positives = 89/212 (41%), Gaps = 46/212 (21%)

Query: 65  IGKGSFGEVFKGIDNRTQQVVAIKIID-------------LEEAEDEIEDIQQEIM-VLS 110
           IGKG  GEV+   D    + VA+K I              L EA+   + I   I+ V S
Sbjct: 10  IGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYS 69

Query: 111 QCDSPYGTKLWIIMEYLGGGSALDLMKA---------GNFEEMHIAVILR---EVLKGLD 158
            C    G  ++  M Y+ G +   L+K+            E+  +   L    ++   ++
Sbjct: 70  ICSD--GDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIE 127

Query: 159 YLHSERKLHRDIKAANVLLSEMGDVKLADFGVA------------------GTLTNTTSK 200
           Y+HS+  LHRD+K  N+LL   G+V + D+G A                      ++ + 
Sbjct: 128 YVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTI 187

Query: 201 RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGI 232
               VGTP +MAPE +         DI++LG+
Sbjct: 188 PGKIVGTPDYMAPERLLGVPASESTDIYALGV 219

Length = 932

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 63.9 bits (155), Expect = 7e-11
 Identities = 39/121 (32%), Positives = 66/121 (54%), Gaps = 3/121 (2%)

Query: 120 LWIIMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSE 179
           ++I+ME +       +    + E M  + +L ++L G+ +LHS   +HRD+K +N+++  
Sbjct: 104 VYIVMELMDANLCQVIQMELDHERM--SYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS 161

Query: 180 MGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAK 239
              +K+ DFG+A T   T+     +V T ++ APEVI    Y    DIWS+G    E+ K
Sbjct: 162 DCTLKILDFGLART-AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIK 220

Query: 240 G 240
           G
Sbjct: 221 G 221

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 63.6 bits (154), Expect = 8e-11
 Identities = 59/231 (25%), Positives = 104/231 (45%), Gaps = 13/231 (5%)

Query: 120 LWIIMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSE 179
           ++++ME +       +    + E M  + +L ++L G+ +LHS   +HRD+K +N+++  
Sbjct: 97  VYLVMELMDANLCQVIQMELDHERM--SYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS 154

Query: 180 MGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAK 239
              +K+ DFG+A T   T+     +V T ++ APEVI    Y    DIWS+G    E+ +
Sbjct: 155 DCTLKILDFGLART-AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVR 213

Query: 240 GEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPENRPTAKELLKFPFI 299
               +  L P R  ++   N   +  G    +F + ++  +    ENRP     L FP +
Sbjct: 214 ----HKILFPGRD-YIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAG-LTFPKL 267

Query: 300 RKAKKNAYLIDLIDRYKKWKNSRNEESETESETSDNEDSIKTDGDLDEPWI 350
                   L      + K K S+  +  ++    D    I  D  L  P+I
Sbjct: 268 FPDS----LFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYI 314

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 63.6 bits (155), Expect = 9e-11
 Identities = 50/197 (25%), Positives = 82/197 (41%), Gaps = 49/197 (24%)

Query: 149 ILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTP 208
           +L ++L G+ +LHS   +HRD+K +N+++     +K+ DFG+A T   T+     +V T 
Sbjct: 123 LLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART-AGTSFMMTPYVVTR 181

Query: 209 FWMAPEVIKQSAYDSKADIWSLGITAIELAK---------------------GEPPN--- 244
           ++ APEVI    Y    DIWS+G    E+ +                     G P +   
Sbjct: 182 YYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFM 241

Query: 245 SELHPMR---------------------VLFLIPKNNPPQLTGNYTKQFKEFVEACLNKD 283
           S L P                       VLF     +  +L  +   Q ++ +   L  D
Sbjct: 242 SRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKAS---QARDLLSKMLVID 298

Query: 284 PENRPTAKELLKFPFIR 300
           PE R +  + L+ P+I 
Sbjct: 299 PEKRISVDDALQHPYIN 315

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 63.2 bits (154), Expect = 9e-11
 Identities = 34/113 (30%), Positives = 57/113 (50%), Gaps = 19/113 (16%)

Query: 142 EEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVA---------- 191
            + H    + ++L GL Y+HS   LHRD+K  N+L++   ++K+ DFG+A          
Sbjct: 103 TDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGEN 162

Query: 192 -GTLTNTTSKRNTFVGTPFWMAPEV-IKQSAYDSKADIWSLGITAIELAKGEP 242
            G +T        +V T ++ APE+ +   +Y    D+WS+G    EL   +P
Sbjct: 163 AGFMTE-------YVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKP 208

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 62.6 bits (152), Expect = 2e-10
 Identities = 35/96 (36%), Positives = 49/96 (51%), Gaps = 2/96 (2%)

Query: 145 HIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTF 204
            +  + R++L  +DY+H E  +HRDIK  NVL++   D+ L DFG A     + S    +
Sbjct: 261 QVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHY 320

Query: 205 --VGTPFWMAPEVIKQSAYDSKADIWSLGITAIELA 238
              GT    APEV+    Y    DIWS G+   E A
Sbjct: 321 GIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAA 356

Length = 461

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 62.0 bits (150), Expect = 2e-10
 Identities = 60/215 (27%), Positives = 99/215 (46%), Gaps = 44/215 (20%)

Query: 64  RIGKGSFGEVFKG--IDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSP------ 115
           ++G+G++G V+K    D + ++  A+K I   E         +EI +L +   P      
Sbjct: 8   KVGRGTYGHVYKAKRKDGKDEKEYALKQI---EGTGISMSACREIALLRELKHPNVIALQ 64

Query: 116 ------YGTKLWIIMEYLGGGSALDLMKAGNFEEMH-------------IAVILREVLKG 156
                    K+W++ +Y    +  DL     F                 +  +L ++L G
Sbjct: 65  KVFLSHSDRKVWLLFDY----AEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDG 120

Query: 157 LDYLHSERKLHRDIKAANVLL----SEMGDVKLADFGVAGTLTNTTSKR----NTFVGTP 208
           + YLH+   LHRD+K AN+L+     E G VK+AD G A  L N+  K     +  V T 
Sbjct: 121 IHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFA-RLFNSPLKPLADLDPVVVTF 179

Query: 209 FWMAPEVIKQSAYDSKA-DIWSLGITAIELAKGEP 242
           ++ APE++  + + +KA DIW++G    EL   EP
Sbjct: 180 WYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEP 214

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 61.5 bits (149), Expect = 3e-10
 Identities = 67/314 (21%), Positives = 123/314 (39%), Gaps = 93/314 (29%)

Query: 57  LIFTKQERIGKGSFGEV-FKGIDNRTQQV---------------VAIKIIDLEEAEDEIE 100
           L+F  +E++G+G FGEV    + N                    VA+KI+  +  ++   
Sbjct: 7   LLF--KEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARN 64

Query: 101 DIQQEIMVLSQCDSPYGTKLW----------IIMEYLGGGSALDLMKAGNFEE------- 143
           D  +E+ +LS+   P   +L           +I EY+  G     + + + ++       
Sbjct: 65  DFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGND 124

Query: 144 ----------------MHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLAD 187
                           +H+A+   ++  G+ YL S   +HRD+   N L+ E   +K+AD
Sbjct: 125 AVPPAHCLPAISYSSLLHVAL---QIASGMKYLSSLNFVHRDLATRNCLVGENLTIKIAD 181

Query: 188 FGVAGTLTNTTSKRNTFVGTPF-----------WMAPEVIKQSAYDSKADIWSLGITAIE 236
           FG++         RN + G  +           WMA E I    + + +D+W+ G+T  E
Sbjct: 182 FGMS---------RNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWE 232

Query: 237 LAK--GEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQ------------FKEFVEACLNK 282
           +     E P  EL   +V+      N  +   +  +Q              E +  C ++
Sbjct: 233 ILMLCKEQPYGELTDEQVI-----ENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSR 287

Query: 283 DPENRPTAKELLKF 296
           D   RP+  ++  F
Sbjct: 288 DCRERPSFSDIHAF 301

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 62.0 bits (150), Expect = 4e-10
 Identities = 28/94 (29%), Positives = 51/94 (54%), Gaps = 1/94 (1%)

Query: 149 ILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRN-TFVGT 207
           I++++L  ++Y+H ++ +HRDIK  N+ L+  G + L DFG A          +  +VGT
Sbjct: 272 IMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAFDYGWVGT 331

Query: 208 PFWMAPEVIKQSAYDSKADIWSLGITAIELAKGE 241
               +PE++    Y    DIWS G+  +++   +
Sbjct: 332 VATNSPEILAGDGYCEITDIWSCGLILLDMLSHD 365

Length = 501

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 60.3 bits (146), Expect = 4e-10
 Identities = 70/278 (25%), Positives = 118/278 (42%), Gaps = 62/278 (22%)

Query: 63  ERIGKGSFGEVFKG---IDNRTQQVVAIKI---IDLEEAEDEIEDIQ--------QEIMV 108
           + IG G FG+V  G         QVV  ++     ++E    +E+ Q          +  
Sbjct: 1   KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQC 60

Query: 109 LSQCD--SPYGTKLWIIME---------YLGGGSALDLMKAGNFEEMHIAVILREVLKGL 157
           L QC   +PY     ++ME         YL      +LM     +   +  +  E+  GL
Sbjct: 61  LGQCTEVTPY----LLVMEFCPLGDLKGYLRSCRKAELMTP---DPTTLQRMACEIALGL 113

Query: 158 DYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGT-----PF-WM 211
            +LH    +H D+   N LL+    VK+ D+G    L++   K + +V       P  W+
Sbjct: 114 LHLHKNNFIHSDLALRNCLLTADLTVKIGDYG----LSHNKYKEDYYVTPDQLWVPLRWI 169

Query: 212 APE----------VIKQSAYDSKADIWSLGITAIELAK-GEPPNSELHPMRVLFLIPKNN 260
           APE          V+ Q+    ++++WSLG+T  EL + G  P   L   +VL    +  
Sbjct: 170 APELVDEVHGNLLVVDQT---KESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQ 226

Query: 261 -----PPQLTGNYTKQFKEFVEACLNKDPENRPTAKEL 293
                 P+L    + ++ E ++ C  + PE RP+A+E+
Sbjct: 227 QLKLPKPRLKLPLSDRWYEVMQFCWLQ-PEQRPSAEEV 263

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 60.8 bits (147), Expect = 5e-10
 Identities = 60/215 (27%), Positives = 98/215 (45%), Gaps = 44/215 (20%)

Query: 64  RIGKGSFGEVFKGI--DNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSP------ 115
           ++G+G++G V+K    D +  +  A+K I   E         +EI +L +   P      
Sbjct: 8   KVGRGTYGHVYKAKRKDGKDDRDYALKQI---EGTGISMSACREIALLRELKHPNVISLQ 64

Query: 116 ------YGTKLWIIMEYLGGGSALDLMKAGNFEEMH-------------IAVILREVLKG 156
                    K+W++ +Y    +  DL     F                 +  +L ++L G
Sbjct: 65  KVFLSHADRKVWLLFDY----AEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDG 120

Query: 157 LDYLHSERKLHRDIKAANVLL----SEMGDVKLADFGVAGTLTNTTSKR----NTFVGTP 208
           + YLH+   LHRD+K AN+L+     E G VK+AD G A  L N+  K     +  V T 
Sbjct: 121 IHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFA-RLFNSPLKPLADLDPVVVTF 179

Query: 209 FWMAPEVIKQSAYDSKA-DIWSLGITAIELAKGEP 242
           ++ APE++  + + +KA DIW++G    EL   EP
Sbjct: 180 WYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEP 214

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional

 Score = 60.0 bits (145), Expect = 2e-09
 Identities = 60/215 (27%), Positives = 98/215 (45%), Gaps = 47/215 (21%)

Query: 65  IGKGSFGEVFKGIDNRTQQVVAIKIID-----LEEAEDEI---EDIQQ----------EI 106
           +G+G+FG+V +  D + ++  A+KI+        +A+ EI   E ++Q          +I
Sbjct: 137 LGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMKI 196

Query: 107 MVLSQCDSPYGTKLWIIM-EYLGGGSALD-LMKAGNFEEMHIAVILREVLKGLDYLHSER 164
               Q ++ +   + I+M +Y  G   LD +MK G F   H+A I+ +    LDY H+E 
Sbjct: 197 QRYFQNETGH---MCIVMPKY--GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTEL 251

Query: 165 KL-HRDIKAANVLLSEMGD-----------------VKLADFGVAGTLTNTTSKRNTFVG 206
            L H D+K  N+L+ E  D                 V++ D G  G      S R   V 
Sbjct: 252 HLMHTDLKPENILM-ETSDTVVDPVTNRALPPDPCRVRICDLG--GCCDERHS-RTAIVS 307

Query: 207 TPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGE 241
           T  + +PEV+    +    D+WS+G    EL  G+
Sbjct: 308 TRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGK 342

Length = 467

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 58.8 bits (142), Expect = 2e-09
 Identities = 57/223 (25%), Positives = 95/223 (42%), Gaps = 42/223 (18%)

Query: 62  QERIGKGSFGEV----------FKGIDNRTQQ----VVAIKIIDLEEAEDEIEDIQQEIM 107
           +E++G+G FGEV          F G           +VA+K++  +  +    D  +EI 
Sbjct: 10  KEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIK 69

Query: 108 VLSQCDSPYGTKLW----------IIMEYLGGGS----------ALDLMKAGNFEEMHIA 147
           ++S+  +P   +L           +I EY+  G                 A N   + IA
Sbjct: 70  IMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIA 129

Query: 148 VILR---EVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKR--N 202
            +L    ++  G+ YL S   +HRD+   N L+     +K+ADFG++  L +    R   
Sbjct: 130 NLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQG 189

Query: 203 TFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIE---LAKGEP 242
             V    WMA E I    + + +D+W+ G+T  E   L K +P
Sbjct: 190 RAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQP 232

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 57.9 bits (140), Expect = 2e-09
 Identities = 61/264 (23%), Positives = 111/264 (42%), Gaps = 39/264 (14%)

Query: 63  ERIGKGSFGEVFKGI-------DNRTQQV-VAIKIIDLEEAEDEIEDIQQEIMVLSQCDS 114
           E +G+G+F  ++KG+       D       V++ +  L     +     +   ++SQ   
Sbjct: 1   EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSH 60

Query: 115 P-----YGTKLW----IIMEYLGGGSALD--LMKAGNFEEMH-IAVILREVLKGLDYLHS 162
                 YG  +     ++ EY+  G  LD  L +  N   +H    + +++   L YL  
Sbjct: 61  KHLVKLYGVCVRDENIMVEEYVKFGP-LDVFLHREKNNVSLHWKLDVAKQLASALHYLED 119

Query: 163 ERKLHRDIKAANVLLSEMG-------DVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEV 215
           ++ +H ++   N+L++  G        +KL+D G+  T+      R   V    W+APE 
Sbjct: 120 KKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVL----SREERVERIPWIAPEC 175

Query: 216 IK--QSAYDSKADIWSLGITAIEL-AKGEPPNSELHPMRVL-FLIPKNNPPQLTGNYTKQ 271
           I+  Q++    AD WS G T +E+ + GE P S L       F   ++  P        +
Sbjct: 176 IRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQDQHRLPMPD---CAE 232

Query: 272 FKEFVEACLNKDPENRPTAKELLK 295
               +  C   DP  RP+ + +L+
Sbjct: 233 LANLINQCWTYDPTKRPSFRAILR 256

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 57.2 bits (138), Expect = 5e-09
 Identities = 45/173 (26%), Positives = 80/173 (46%), Gaps = 22/173 (12%)

Query: 139 GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTN-- 196
            N + + +  +  E+  G+ ++H    LH D+   N  L+    VK+ D+G+  +     
Sbjct: 94  RNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKED 153

Query: 197 --TTSKRNTFVGTPF-WMAPEVIKQ------SAYDSK-ADIWSLGITAIEL-AKGEPPNS 245
              T         P  W+APE++ +      +A  +K +++W+LG+T  EL      P S
Sbjct: 154 YIETEDDKCV---PLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYS 210

Query: 246 ELHPMRVLFLIPKNN-----PPQLTGNYTKQFKEFVEACLNKDPENRPTAKEL 293
            L    VL  + K+       PQL   Y++++ E ++ C    PE R TA+E+
Sbjct: 211 HLSDREVLNHVIKDQQVKLFKPQLELPYSERWYEVLQFCW-LSPEKRATAEEV 262

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 54.7 bits (131), Expect = 4e-08
 Identities = 66/277 (23%), Positives = 113/277 (40%), Gaps = 57/277 (20%)

Query: 63  ERIGKGSFGEVFKG-----IDNRTQQVVAIKIIDLEEAEDEI-EDIQQEIMVLSQCDSP- 115
           E +G+  FG+V+KG           Q VAIK +  ++AE  + E+ + E M+ S+   P 
Sbjct: 11  EELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLK-DKAEGPLREEFKHEAMMRSRLQHPN 69

Query: 116 ----YGT-----KLWIIMEYLG-----------------GGSALDLMKAGNFEEMHIAVI 149
                G       L +I  Y                   G +  D       E      I
Sbjct: 70  IVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHI 129

Query: 150 LREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPF 209
           + ++  G+++L S   +H+D+   NVL+ +  +VK++D G+   +      +   +G   
Sbjct: 130 VTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYK--LMGNSL 187

Query: 210 ----WMAPEVIKQSAYDSKADIWSLGITAIEL-AKGEPP-----NSELHPM---RVLFLI 256
               WM+PE I    +   +DIWS G+   E+ + G  P     N ++  M   R +   
Sbjct: 188 LPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIRNRQVLPC 247

Query: 257 PKNNPPQLTGNYTKQFKEFVEACLNKDPENRPTAKEL 293
           P + P  +   YT   +     C N+ P  RP  K++
Sbjct: 248 PDDCPAWV---YTLMLE-----CWNEFPSRRPRFKDI 276

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 54.1 bits (130), Expect = 7e-08
 Identities = 66/303 (21%), Positives = 124/303 (40%), Gaps = 79/303 (26%)

Query: 55  PELIFTKQERIGKGSFGEV---------------FKGIDNRTQQV-VAIKIIDLEEAEDE 98
           P    T +E++G+G FGEV               F    +  Q V VA+K++  +  ++ 
Sbjct: 3   PRKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNA 62

Query: 99  IEDIQQEIMVLSQCDSPYGTKLW----------IIMEYLGGG------SALDLMKAGNFE 142
             D  +EI ++S+   P   +L           +I EY+  G      S  +  +A    
Sbjct: 63  RNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKA 122

Query: 143 EM------HIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTN 196
           ++       +  +  ++  G+ YL S   +HRD+   N L+ +   +K+ADFG++     
Sbjct: 123 DVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADFGMS----- 177

Query: 197 TTSKRNTFVGTPF-----------WMAPEVIKQSAYDSKADIWSLGITAIELAK--GEPP 243
               RN + G  +           WM+ E I    + + +D+W+ G+T  E+     E P
Sbjct: 178 ----RNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQP 233

Query: 244 NSELHPMRVL-------------FLIPKNNPPQLTGNYTKQFKEFVEACLNKDPENRPTA 290
            S+L   +V+               +PK  P     +  K     + +C  ++ + RP+ 
Sbjct: 234 YSQLSDEQVIENTGEFFRDQGRQVYLPK--PALCPDSLYK----LMLSCWRRNAKERPSF 287

Query: 291 KEL 293
           +E+
Sbjct: 288 QEI 290

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 53.0 bits (127), Expect = 1e-07
 Identities = 43/158 (27%), Positives = 75/158 (47%), Gaps = 17/158 (10%)

Query: 148 VILREVLKGLDYLHSERKLHRDIKAANVLLSEMG-------DVKLADFGVAGTLTNTTSK 200
            + +++   L YL  +  +H ++ A N+LL+ +G        +KL+D GV    + T   
Sbjct: 121 TVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGV----SFTALS 176

Query: 201 RNTFVGTPFWMAPEVIKQ-SAYDSKADIWSLGITAIELA-KGEPPNSELHPM-RVLFLIP 257
           R   V    W+APE +   ++  + AD WS G T +E+   GE P  E  P  +  F   
Sbjct: 177 REERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKERFYEK 236

Query: 258 KNNPPQLTGNYTKQFKEFVEACLNKDPENRPTAKELLK 295
           K+  P+ +    K+    +  CL  +P  RP+ + +L+
Sbjct: 237 KHRLPEPS---CKELATLISQCLTYEPTQRPSFRTILR 271

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 52.2 bits (125), Expect = 2e-07
 Identities = 65/263 (24%), Positives = 115/263 (43%), Gaps = 38/263 (14%)

Query: 63  ERIGKGSFGEVFKGI------DNRTQQV-VAIKIIDLE---------EAEDEIEDIQQEI 106
           E +G+G+F ++FKGI           +  V +K++D           EA   +  +  + 
Sbjct: 1   ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKH 60

Query: 107 MVLSQCDSPYGTKLWIIMEYLGGGSALDLMKAGNFEEMHIAVILREVLK----GLDYLHS 162
           +VL+      G +  ++ EY+  GS LD     N   ++I+  L EV K     L +L  
Sbjct: 61  LVLNYGVCVCGDESIMVQEYVKFGS-LDTYLKKNKNLINISWKL-EVAKQLAWALHFLED 118

Query: 163 ERKLHRDIKAANVLLSEMGD--------VKLADFGVAGTLTNTTSKRNTFVGTPFWMAPE 214
           +   H ++ A NVLL    D        +KL+D G++ T+      +   +    W+ PE
Sbjct: 119 KGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVL----PKEILLERIPWVPPE 174

Query: 215 VIKQSAYDS-KADIWSLGITAIEL-AKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQF 272
            I+     S  AD WS G T  E+ + G+ P S L   + L      +  QL      + 
Sbjct: 175 CIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFYEDRH--QLPAPKWTEL 232

Query: 273 KEFVEACLNKDPENRPTAKELLK 295
              +  C++ +P+ RP+ + +++
Sbjct: 233 ANLINQCMDYEPDFRPSFRAIIR 255

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional

 Score = 53.3 bits (128), Expect = 3e-07
 Identities = 50/198 (25%), Positives = 76/198 (38%), Gaps = 46/198 (23%)

Query: 59  FTKQERIGKGSFGEVFKG-----IDNRTQQVVAIKIIDLEEAE------------DEIED 101
           F   +++G+G+FG V+K         +  + V  K  +    E            +   D
Sbjct: 134 FVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVEIWMNERVRRACPNSCAD 193

Query: 102 IQQEIMVLSQCDSPYGTKLWIIMEYLGGGSALDLMKAGNF----EEMH------------ 145
                  L    S    + W++  Y G  +  DLM++  F    E               
Sbjct: 194 FVYGF--LEPVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLE 251

Query: 146 -----IAVILREVLKGLDYLHSERKLHRDIKAANVLLSE-MGDVKLADFGVAGTL---TN 196
                I  I+R++L  LD LHS   +HRD+K  N++ SE  G  K+ D G A  L    N
Sbjct: 252 RENKIIQTIMRQILFALDGLHSTGIVHRDVKPQNIIFSEGSGSFKIIDLGAAADLRVGIN 311

Query: 197 TTSKRNTFVGTPFWMAPE 214
              K   F+  P + APE
Sbjct: 312 YIPKE--FLLDPRYAAPE 327

Length = 566

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 51.6 bits (123), Expect = 7e-07
 Identities = 54/206 (26%), Positives = 95/206 (46%), Gaps = 38/206 (18%)

Query: 65  IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQ---QEIMVLSQCD-------- 113
           IG GSFG V++ I   T + VAIK +        ++D Q   +E++++   +        
Sbjct: 74  IGNGSFGVVYEAICIDTSEKVAIKKV--------LQDPQYKNRELLIMKNLNHINIIFLK 125

Query: 114 SPYGTK----------LWIIMEYLGGGSALDLMKAGNFEEMHIAVIL-----REVLKGLD 158
             Y T+          L ++ME++   +    MK        + + L      ++ + L 
Sbjct: 126 DYYYTECFKKNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALA 184

Query: 159 YLHSERKLHRDIKAANVLLS-EMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIK 217
           Y+HS+   HRD+K  N+L+      +KL DFG A  L     +  +++ + F+ APE++ 
Sbjct: 185 YIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLL-AGQRSVSYICSRFYRAPELML 243

Query: 218 QSA-YDSKADIWSLGITAIELAKGEP 242
            +  Y +  D+WSLG    E+  G P
Sbjct: 244 GATNYTTHIDLWSLGCIIAEMILGYP 269

Length = 440

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 48.3 bits (115), Expect = 9e-06
 Identities = 28/96 (29%), Positives = 44/96 (45%), Gaps = 2/96 (2%)

Query: 205 VGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQL 264
           +GTP ++APE++    +    D W+LG+   E   G PP ++  P +V   I   + P  
Sbjct: 541 LGTPDYLAPELLLGKPHGPAVDWWALGVCLFEFLTGIPPFNDETPQQVFQNILNRDIPWP 600

Query: 265 TGN--YTKQFKEFVEACLNKDPENRPTAKELLKFPF 298
            G    +   +  +E  L  DP  R   KEL + P 
Sbjct: 601 EGEEKLSVNAQNAIEILLTMDPTKRAGLKELKQHPL 636

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 47.0 bits (112), Expect = 1e-05
 Identities = 42/149 (28%), Positives = 72/149 (48%), Gaps = 13/149 (8%)

Query: 155 KGLDYLH-SERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKR-NTFVGTPFWMA 212
           KGL  L+    K ++++ + + L++E   +K+   G+   L++   K  N  V   + M 
Sbjct: 133 KGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPPFKNVNFMVYFSYKML 192

Query: 213 PEVIKQSAYDSKADIWSLGITAIELAKGEPP-----NSELHPMRVLFLIPKNNPPQLTGN 267
            ++   S Y  K DI+SLG+   E+  G+ P       E++ +    +I KNN  +L  +
Sbjct: 193 NDIF--SEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDL----IINKNNSLKLPLD 246

Query: 268 YTKQFKEFVEACLNKDPENRPTAKELLKF 296
              + K  VEAC + D   RP  KE+L  
Sbjct: 247 CPLEIKCIVEACTSHDSIKRPNIKEILYN 275

Length = 283

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 45.2 bits (107), Expect = 4e-05
 Identities = 36/135 (26%), Positives = 57/135 (42%), Gaps = 13/135 (9%)

Query: 120 LWIIMEYLGGGSALD-LMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLS 178
           +++++++  GG     + K  N  E  +     E++  LD LH E  + RD+   N+LL 
Sbjct: 60  VFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLD 119

Query: 179 EMGDVKLADFG----VAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITA 234
           + G ++L  F     V  +      +         + APEV   S      D WSLG   
Sbjct: 120 DRGHIQLTYFSRWSEVEDSCDGEAVEN-------MYCAPEVGGISEETEACDWWSLGAIL 172

Query: 235 IELAKGEPPNSELHP 249
            EL  G+    E HP
Sbjct: 173 FELLTGKTL-VECHP 186

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional

 Score = 45.8 bits (108), Expect = 5e-05
 Identities = 22/46 (47%), Positives = 30/46 (65%)

Query: 146 IAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVA 191
           I  ++R+VL GL  LH    +HRDIK  N+L++  G VK+ DFG A
Sbjct: 311 IKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAA 356

Length = 507

>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 44.5 bits (105), Expect = 6e-05
 Identities = 41/159 (25%), Positives = 71/159 (44%), Gaps = 21/159 (13%)

Query: 149 ILREVLKGLDYLHSERKLHRDIKAANVLLSEMGD-------VKLADFGVAGTLTNTTSKR 201
           + +++   L YL  +  +H ++   N+LL+  G        +KL+D G+  T+ +    R
Sbjct: 110 VAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLS----R 165

Query: 202 NTFVGTPFWMAPEVIKQSAYDS-KADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKN- 259
              V    W+APE ++ S   S  AD WS G T  E+      N E+ P++   L  K  
Sbjct: 166 QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICY----NGEI-PLKDKTLAEKER 220

Query: 260 ---NPPQLTGNYTKQFKEFVEACLNKDPENRPTAKELLK 295
                  L     K+  + +  C+N DP  RP  + +++
Sbjct: 221 FYEGQCMLVTPSCKELADLMTHCMNYDPNQRPFFRAIMR 259

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262

>gnl|CDD|237847 PRK14879, PRK14879, serine/threonine protein kinase; Provisional

 Score = 40.3 bits (95), Expect = 0.001
 Identities = 25/71 (35%), Positives = 42/71 (59%), Gaps = 4/71 (5%)

Query: 122 IIMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMG 181
           I+MEY+ G    DL+ +   EE+ ++   RE+ + +  LHS   +H D+  +N++LS  G
Sbjct: 76  IVMEYIEGEPLKDLINSNGMEELELS---REIGRLVGKLHSAGIIHGDLTTSNMILSG-G 131

Query: 182 DVKLADFGVAG 192
            + L DFG+A 
Sbjct: 132 KIYLIDFGLAE 142

Length = 211

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	604
KOG0201|consensus	467		100.0
KOG0581|consensus	364		100.0
KOG0598|consensus	357		100.0
KOG0615|consensus	475		100.0
KOG0575|consensus	592		100.0
KOG0593|consensus	396		100.0
KOG0595|consensus	429		100.0
KOG0578|consensus	550		100.0
KOG0592|consensus	604		100.0
KOG0616|consensus	355		100.0
KOG0588|consensus	786		100.0
KOG0583|consensus	370		100.0
KOG0591|consensus	375		100.0
KOG0694|consensus	694		100.0
KOG0582|consensus	516		100.0
KOG0574|consensus	502		100.0
KOG0605|consensus	550		100.0
KOG0033|consensus	355		100.0
KOG0198|consensus	313		100.0
KOG0579|consensus	1187		100.0
KOG0597|consensus	808		100.0
KOG0600|consensus	560		100.0
KOG0577|consensus	948		100.0
KOG0661|consensus	538		100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
KOG0659|consensus	318		100.0
KOG0660|consensus	359		100.0
KOG0585|consensus	576		100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
KOG0663|consensus	419		100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
KOG0192|consensus	362		100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
KOG0690|consensus	516		100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
KOG0610|consensus	459		100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
KOG0032|consensus	382		100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
KOG0580|consensus	281		100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
KOG0589|consensus	426		100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
KOG0658|consensus	364		100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
KOG0594|consensus	323		100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
KOG0611|consensus	668		100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
KOG4717|consensus	864		100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
KOG0599|consensus	411		100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
KOG0667|consensus	586		100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
KOG0197|consensus	468		100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
KOG0587|consensus	953		100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
KOG4279|consensus	1226		100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
KOG4721|consensus	904		100.0
KOG0696|consensus	683		100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
KOG0986|consensus	591		100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
KOG1989|consensus	738		100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
KOG0612|consensus	1317		100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
KOG0596|consensus	677		100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
KOG0193|consensus	678		100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
KOG0983|consensus	391		100.0
KOG0586|consensus	596		100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
KOG0604|consensus	400		100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
KOG0194|consensus	474		100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
KOG1026|consensus	774		100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
KOG4236|consensus	888		100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
KOG1095|consensus	1025		100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
KOG4645|consensus	1509		100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
KOG0584|consensus	632		100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
KOG2345|consensus	302		100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
KOG0614|consensus	732		100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
KOG0662|consensus	292		100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
KOG1035|consensus	1351		100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
KOG0607|consensus	463		100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
KOG0608|consensus	1034		100.0
KOG0695|consensus	593		100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
KOG0671|consensus	415		100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
KOG0603|consensus	612		100.0
KOG1187|consensus	361		100.0
KOG4257|consensus	974		100.0
KOG0666|consensus	438		100.0
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	100.0
KOG0669|consensus	376		100.0
KOG0576|consensus	829		100.0
KOG0199|consensus	1039		100.0
KOG4250|consensus	732		100.0
KOG0196|consensus	996		100.0
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	100.0
KOG1094|consensus	807		100.0
KOG0668|consensus	338		100.0
KOG1006|consensus	361		100.0
KOG4278|consensus	1157		100.0
PLN03224	507	probable serine/threonine protein kinase; Provisio	100.0
KOG1151|consensus	775		100.0
KOG0670|consensus	752		100.0
KOG1290|consensus	590		100.0
KOG0200|consensus	609		99.98
KOG1025|consensus	1177		99.98
KOG0665|consensus	369		99.98
KOG0664|consensus	449		99.98
KOG1027|consensus	903		99.97
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	99.97
KOG3653|consensus	534		99.97
KOG2052|consensus	513		99.97
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.97
KOG0984|consensus	282		99.96
KOG1167|consensus	418		99.96
KOG1165|consensus	449		99.96
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.96
KOG1345|consensus	378		99.96
KOG1024|consensus	563		99.95
KOG1152|consensus	772		99.95
PLN00181	793	protein SPA1-RELATED; Provisional	99.95
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.95
KOG1163|consensus	341		99.94
KOG1164|consensus	322		99.93
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.93
KOG0590|consensus	601		99.93
PRK09188	365	serine/threonine protein kinase; Provisional	99.92
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.89
KOG0606|consensus	1205		99.88
KOG0603|consensus	612		99.88
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.87
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.86
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.84
KOG1240|consensus	1431		99.83
PRK12274	218	serine/threonine protein kinase; Provisional	99.82
KOG1033|consensus	516		99.8
smart00090	237	RIO RIO-like kinase.	99.8
KOG1166|consensus	974		99.79
KOG4158|consensus	598		99.78
PRK10345	210	hypothetical protein; Provisional	99.77
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.76
KOG0195|consensus	448		99.74
PRK14879	211	serine/threonine protein kinase; Provisional	99.72
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.71
KOG0590|consensus	601		99.7
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.69
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.66
KOG1023|consensus	484		99.64
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.61
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.54
KOG0606|consensus	1205		99.44
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.43
KOG0601|consensus	524		99.42
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.35
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.34
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.33
KOG0601|consensus	524		99.25
KOG1243|consensus	690		99.17
KOG1266|consensus	458		99.13
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.07
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.03
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	98.97
KOG3087|consensus	229		98.95
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	98.88
COG4248	637	Uncharacterized protein with protein kinase and he	98.87
KOG2137|consensus	700		98.83
PF06840	154	DUF1241: Protein of unknown function (DUF1241); In	98.82
KOG3741|consensus	655		98.74
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.69
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.62
KOG0576|consensus	829		98.58
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.53
PRK09902	216	hypothetical protein; Provisional	98.46
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.38
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.32
PF01636	239	APH: Phosphotransferase enzyme family This family	98.29
KOG1035|consensus	1351		98.23
KOG1235|consensus	538		98.12
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	97.97
KOG1826|consensus	2724		97.9
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	97.89
PLN02876	822	acyl-CoA dehydrogenase	97.71
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	97.7
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	97.52
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	97.51
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	97.44
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	97.33
KOG2268|consensus	465		97.32
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.23
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	97.2
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	97.19
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.19
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	97.16
PRK05231	319	homoserine kinase; Provisional	97.13
KOG2270|consensus	520		97.09
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.07
PRK10593	297	hypothetical protein; Provisional	96.63
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	96.6
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	96.56
KOG1093|consensus	725		96.42
PLN02236	344	choline kinase	96.37
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	96.32
KOG4025|consensus	207		96.29
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	96.26
KOG1236|consensus	565		96.06
PRK12396	409	5-methylribose kinase; Reviewed	95.39
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	95.14
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	95.05
PLN02756	418	S-methyl-5-thioribose kinase	95.0
COG2334	331	Putative homoserine kinase type II (protein kinase	94.72
PTZ00384	383	choline kinase; Provisional	94.37
PTZ00296	442	choline kinase; Provisional	94.32
PRK06148	1013	hypothetical protein; Provisional	94.31
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	93.16
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	93.03
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	92.28

>KOG0201|consensus

Probab=100.00  E-value=2.6e-66  Score=537.08  Aligned_cols=442  Identities=57%  Similarity=0.880  Sum_probs=346.8

Q ss_pred             ccCccccceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCC----------eEE
Q psy1546          52 KVDPELIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGT----------KLW  121 (604)
Q Consensus        52 ~~~~~~~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~----------~ly  121 (604)
                      +.+....|+..++||+|+||.||+|.+..+++.||||+++.+..+++++.+++|+.+|.+++++|+.          .+|
T Consensus         8 ~~~~~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~Lw   87 (467)
T KOG0201|consen    8 KIDPELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLW   87 (467)
T ss_pred             cCCcccccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHH
Confidence            4566677999999999999999999999999999999999999999999999999999999999854          446


Q ss_pred             EEEEecCCCChhhHhhcCCC-cHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCCC
Q psy1546         122 IIMEYLGGGSALDLMKAGNF-EEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSK  200 (604)
Q Consensus       122 LVmEy~~ggsL~~~l~~~~l-se~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~  200 (604)
                      ++||||.||++.++++.+.+ ++..+..++++++.||.|||.++.+|||||+.||||..+|.+||+|||++..+......
T Consensus        88 iiMey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~r  167 (467)
T KOG0201|consen   88 IIMEYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKR  167 (467)
T ss_pred             HHHHHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeechhhc
Confidence            99999999999999999876 99999999999999999999999999999999999999999999999999999888888


Q ss_pred             CcccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCCCCCCCCccchHHHHHHHHHHh
Q psy1546         201 RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACL  280 (604)
Q Consensus       201 ~~~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~~L  280 (604)
                      +.+++|||.|||||++.+..|+.++||||||++.|||++|.+||...+++.+++.|++..+|.+...+++.+++|+..||
T Consensus       168 r~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk~~PP~L~~~~S~~~kEFV~~CL  247 (467)
T KOG0201|consen  168 RKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPKSAPPRLDGDFSPPFKEFVEACL  247 (467)
T ss_pred             cccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccCCCCCccccccCHHHHHHHHHHh
Confidence            89999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             ccCCCCCCCHHHHhcChhhhhhhhhhhHHHHHHHHHHHhhhccCCcccccccCCCcccccCC--CCCCCCceee--eccC
Q psy1546         281 NKDPENRPTAKELLKFPFIRKAKKNAYLIDLIDRYKKWKNSRNEESETESETSDNEDSIKTD--GDLDEPWIMT--VKGK  356 (604)
Q Consensus       281 ~~dP~~RpT~~elL~hp~f~~~~~~~~l~~~~~~~~~~~~~~~e~~e~~~~~~~~ed~~~~d--~~~~~~~~~~--~~~~  356 (604)
                      .+||+.||++.++|+|+|++.......+.++++++.+|+....+..+......+++.+...+  ......|.+.  +++.
T Consensus       248 ~k~P~~RpsA~~LLKh~FIk~a~k~s~L~~~i~r~~~~~~~~~~~~~~~~s~p~~~~~~~~~~g~~~~~~W~f~~tvR~~  327 (467)
T KOG0201|consen  248 DKNPEFRPSAKELLKHKFIKRAKKTSELKELIDRYKRWRVKKLELPEEISSEPDSDLSLESDNGVRGEPKWDFGSTVRAS  327 (467)
T ss_pred             hcCcccCcCHHHHhhhHHHHhcCCchHHHHHHHHHHHHhhcccCCcccCCCcccccccccccCCCCCCccccccccccCC
Confidence            99999999999999999999999999999999999999986422222222110111111222  2355678875  3322


Q ss_pred             CCCCCCCCCCCCCCCCCCCccccccCCCCCCCCCCccccCCCCCCCCCCCCCCCCCCCCCcccccccCCCCCCCCCCCCC
Q psy1546         357 MPNEYGSSPNKKSGGMNGADNIVNNNNLNNNNNHATFISSSEKSHSPARPLSIAPGPPSSAQEKRNSMTRSDSGEHKSNP  436 (604)
Q Consensus       357 ~~~~~~~~~~~~~~~~~~~~~~~~~n~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  436 (604)
                      .+..      .....+                    ..++...+.+..   .++...+...      .+.+.+.+..+  
T Consensus       328 ~~~~------~~~~~~--------------------~~~s~~~~~~~~---~~~~~~~ss~------~~~s~~~~~~~--  370 (467)
T KOG0201|consen  328 RPPV------LRESSQ--------------------SKSSDSPSQRTS---SPSGSQPSSG------TTASGSGFNKS--  370 (467)
T ss_pred             CChh------hccccc--------------------cCCccccccccc---CCCCcccccC------CCCCcccccCC--
Confidence            1110      000000                    000000000000   0000000000      00011110000  


Q ss_pred             CCCcchhhccCCchhhhccCCCccccccCCCcccccCCCCCCcccCcCCCCCccccCCCCCcccCCCcchhhhhHHHHHH
Q psy1546         437 TSPDREKHKIGSPEREKLKIGSPDREKLKSPDREKHKIGSPDREKNKIGSPDKKQQTRGSPVKASARSPCLSFLIYPLIS  516 (604)
Q Consensus       437 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~  516 (604)
                                                      .+.+..++                      ..++.|+|++++.+|++.
T Consensus       371 --------------------------------~s~q~~s~----------------------~~~~~s~~~~~~~~~v~~  396 (467)
T KOG0201|consen  371 --------------------------------TSLQNESE----------------------YAQPDSACPSPIPSPVFG  396 (467)
T ss_pred             --------------------------------Cccccccc----------------------cCCCccccccCCCCcccc
Confidence                                            00111111                      155789999999999999


Q ss_pred             HHHHhccccCCCCCCCCCCCCCCCcchHHHHHHHHHHHHhhCCCChHHHHHHHHHHhcCcchHHHHHHHHHHHHH
Q psy1546         517 ELQRRHHYTSNNRTSNSGADSSHKADAIEELKNAFDLAERSAPGISGQFVKEVVHKLLPAMSEARVNSVVDKMIR  591 (604)
Q Consensus       517 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ae~~~pg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  591 (604)
                      .|..+..-..+       +.+++..+++++|+++|..||.+|||+||.++.++++..+|+++.+|....++|.+.
T Consensus       397 ~~~~~~~~~~~-------~~s~~~~~~~~~l~~~~~~~~~~~pg~~~~~~~~l~~~~v~~~s~s~~~~~~~~~~~  464 (467)
T KOG0201|consen  397 LLNCKLSSTIR-------DPSAGSSGALDSLRNAFSSAENSCPGICDDLISELMLSRVPQFSQSRSLEEISRNTL  464 (467)
T ss_pred             ccccccccccc-------ccCCccccchHhhhhhHhhhhhcCCCccchhhhHHHHHHhhhhcccccccchhhhcc
Confidence            99988543221       234455669999999999999999999999999999988899999999988888764

>KOG0581|consensus

Probab=100.00  E-value=5.5e-52  Score=424.32  Aligned_cols=244  Identities=41%  Similarity=0.723  Sum_probs=226.4

Q ss_pred             ceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCCe-----------EEEEEEec
Q psy1546          59 FTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTK-----------LWIIMEYL  127 (604)
Q Consensus        59 y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~~-----------lyLVmEy~  127 (604)
                      .+.+..||+|..|+||+|+|+.|++.+|+|+|.........+.+.+|+.+++.+.|||++.           ++|+||||
T Consensus        81 le~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYM  160 (364)
T KOG0581|consen   81 LERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYM  160 (364)
T ss_pred             hhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhc
Confidence            5677899999999999999999999999999976666667789999999999999998554           56999999


Q ss_pred             CCCChhhHhhc-CCCcHHHHHHHHHHHHHHhHHhhh-CCccccccccceeEecCCCCeEEecccccccccCCCCCCcccc
Q psy1546         128 GGGSALDLMKA-GNFEEMHIAVILREVLKGLDYLHS-ERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFV  205 (604)
Q Consensus       128 ~ggsL~~~l~~-~~lse~~i~~i~~qIl~gL~yLHs-~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~~~~~~  205 (604)
                      ++|+|.++++. ++++|..+..++.+|++||.|||. ++||||||||+||||+..|.|||||||.++.+.+.  ...+++
T Consensus       161 DgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS--~a~tfv  238 (364)
T KOG0581|consen  161 DGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS--IANTFV  238 (364)
T ss_pred             CCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh--hccccc
Confidence            99999999876 889999999999999999999995 99999999999999999999999999999988765  667899


Q ss_pred             cCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCC-----ChhhHhhhcCCCCCCCCCcc-chHHHHHHHHHH
Q psy1546         206 GTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSEL-----HPMRVLFLIPKNNPPQLTGN-YTKQFKEFVEAC  279 (604)
Q Consensus       206 GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~-----~~~~~~~~i~~~~~~~~~~~-~s~~l~~Li~~~  279 (604)
                      ||..|||||.+.+..|+.++||||||++++||++|+.||...     ...+.+..|..+.++.++.. ++++|++|+..|
T Consensus       239 GT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP~~~fS~ef~~FV~~C  318 (364)
T KOG0581|consen  239 GTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRLPEGEFSPEFRSFVSCC  318 (364)
T ss_pred             ccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCCCcccCCHHHHHHHHHH
Confidence            999999999999999999999999999999999999999874     66788888989899999987 999999999999


Q ss_pred             hccCCCCCCCHHHHhcChhhhhhhh
Q psy1546         280 LNKDPENRPTAKELLKFPFIRKAKK  304 (604)
Q Consensus       280 L~~dP~~RpT~~elL~hp~f~~~~~  304 (604)
                      |++||.+|||+.|+++|||+++...
T Consensus       319 L~Kdp~~R~s~~qLl~Hpfi~~~~~  343 (364)
T KOG0581|consen  319 LRKDPSERPSAKQLLQHPFIKKFED  343 (364)
T ss_pred             hcCCcccCCCHHHHhcCHHHhhccc
Confidence            9999999999999999999987654

>KOG0598|consensus

Probab=100.00  E-value=2e-51  Score=420.13  Aligned_cols=248  Identities=32%  Similarity=0.572  Sum_probs=229.4

Q ss_pred             cceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhH--HHHHHHHHHHHHHhhCCCCCCC----------eEEEEEE
Q psy1546          58 IFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAE--DEIEDIQQEIMVLSQCDSPYGT----------KLWIIME  125 (604)
Q Consensus        58 ~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~--~~~~~l~~Ei~iL~~l~hp~~~----------~lyLVmE  125 (604)
                      .|+++++||+|+||+||+++.++|++.||+|++++...-  .+.+.+..|..||..++||+++          ++|||+|
T Consensus        26 dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylVld  105 (357)
T KOG0598|consen   26 DFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLVLD  105 (357)
T ss_pred             heeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEEEe
Confidence            499999999999999999999999999999999877543  3478899999999999999854          5689999


Q ss_pred             ecCCCChhhHhh-cCCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCCCCccc
Q psy1546         126 YLGGGSALDLMK-AGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTF  204 (604)
Q Consensus       126 y~~ggsL~~~l~-~~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~~~~~  204 (604)
                      |+.||.|...|+ ++.|+|..++.|+.+|+.||.|||++|||||||||+||||+.+|+|+|+|||+|+..........++
T Consensus       106 ~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~~~t~tf  185 (357)
T KOG0598|consen  106 YLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDGDATRTF  185 (357)
T ss_pred             ccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhcccCCCccccc
Confidence            999999999987 5899999999999999999999999999999999999999999999999999998776666677789


Q ss_pred             ccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCCCCCCCCccchHHHHHHHHHHhccCC
Q psy1546         205 VGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDP  284 (604)
Q Consensus       205 ~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~~L~~dP  284 (604)
                      |||+.|||||++.+..|+..+|+||||+++|||++|.+||.+.+.......|........+..++.++++||.++|..||
T Consensus       186 cGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~~~~p~~ls~~ardll~~LL~rdp  265 (357)
T KOG0598|consen  186 CGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKLPLPPGYLSEEARDLLKKLLKRDP  265 (357)
T ss_pred             cCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcCCCCCccCCHHHHHHHHHHhccCH
Confidence            99999999999999999999999999999999999999999999999999888888777777799999999999999999


Q ss_pred             CCCC----CHHHHhcChhhhhhhhh
Q psy1546         285 ENRP----TAKELLKFPFIRKAKKN  305 (604)
Q Consensus       285 ~~Rp----T~~elL~hp~f~~~~~~  305 (604)
                      ++|.    ++.+|-+||||+...++
T Consensus       266 ~~RLg~~~d~~~ik~HpfF~~inW~  290 (357)
T KOG0598|consen  266 RQRLGGPGDAEEIKRHPFFKGINWE  290 (357)
T ss_pred             HHhcCCCCChHHhhcCcccccCCHH
Confidence            9995    69999999999887664

>KOG0615|consensus

Probab=100.00  E-value=3e-52  Score=428.91  Aligned_cols=246  Identities=33%  Similarity=0.520  Sum_probs=215.0

Q ss_pred             ccceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHH------HHHHHHHHHHHHhhCCCCCCCeE----------
Q psy1546          57 LIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAED------EIEDIQQEIMVLSQCDSPYGTKL----------  120 (604)
Q Consensus        57 ~~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~------~~~~l~~Ei~iL~~l~hp~~~~l----------  120 (604)
                      ..|.+.+.||+|+||.|-+|..+.||+.||||++.+.....      ....+.+|+.||++|.||+++++          
T Consensus       172 d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds~  251 (475)
T KOG0615|consen  172 DYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDSS  251 (475)
T ss_pred             ceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCce
Confidence            45889999999999999999999999999999997654322      23457899999999999997764          


Q ss_pred             EEEEEecCCCChhhHh-hcCCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCC---CCeEEecccccccccC
Q psy1546         121 WIIMEYLGGGSALDLM-KAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEM---GDVKLADFGVAGTLTN  196 (604)
Q Consensus       121 yLVmEy~~ggsL~~~l-~~~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~---g~vKL~DFGlA~~~~~  196 (604)
                      ||||||++||+|.+.+ .++.+.+..-+.+++||+.||.|||++||+||||||+|||+..+   ..+||+|||+|+... 
T Consensus       252 YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~~g-  330 (475)
T KOG0615|consen  252 YMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAKVSG-  330 (475)
T ss_pred             EEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhhccc-
Confidence            8999999999999976 56788999999999999999999999999999999999999766   679999999998776 


Q ss_pred             CCCCCcccccCCCCCChHHhhcCC---CCCcchhhhHHHHHHHHHhCCCCCCCCChhh-HhhhcCCCCC---CCCCccch
Q psy1546         197 TTSKRNTFVGTPFWMAPEVIKQSA---YDSKADIWSLGITAIELAKGEPPNSELHPMR-VLFLIPKNNP---PQLTGNYT  269 (604)
Q Consensus       197 ~~~~~~~~~GT~~Y~APE~l~~~~---~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~-~~~~i~~~~~---~~~~~~~s  269 (604)
                      ......++||||.|.|||++.+..   |..++||||||||||-+|+|.+||.+..... ...+|.++..   +..+..++
T Consensus       331 ~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p~~w~~Is  410 (475)
T KOG0615|consen  331 EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGPLQWDRIS  410 (475)
T ss_pred             cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccccChhhhhhh
Confidence            566778999999999999997655   3347899999999999999999999876655 6667777664   34456789


Q ss_pred             HHHHHHHHHHhccCCCCCCCHHHHhcChhhhhhh
Q psy1546         270 KQFKEFVEACLNKDPENRPTAKELLKFPFIRKAK  303 (604)
Q Consensus       270 ~~l~~Li~~~L~~dP~~RpT~~elL~hp~f~~~~  303 (604)
                      ++..+||.+||..||++|||+.|+|+||||+...
T Consensus       411 eea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~~  444 (475)
T KOG0615|consen  411 EEALDLINWMLVVDPENRPSADEALNHPWFKDAP  444 (475)
T ss_pred             HHHHHHHHHhhEeCcccCcCHHHHhcChhhhccc
Confidence            9999999999999999999999999999998654

>KOG0575|consensus

Probab=100.00  E-value=2.5e-50  Score=432.91  Aligned_cols=248  Identities=29%  Similarity=0.513  Sum_probs=227.6

Q ss_pred             ccceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhh--HHHHHHHHHHHHHHhhCCCCCCCeE----------EEEE
Q psy1546          57 LIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA--EDEIEDIQQEIMVLSQCDSPYGTKL----------WIIM  124 (604)
Q Consensus        57 ~~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~--~~~~~~l~~Ei~iL~~l~hp~~~~l----------yLVm  124 (604)
                      ..|...+.||+|||+.||++++..+|+.||+|++.+...  ....+.+.+||.|.+.|.|||++++          |||+
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL   97 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL   97 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence            459999999999999999999999999999999987543  3346789999999999999997764          7999


Q ss_pred             EecCCCChhhHhhc-CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCCCCcc
Q psy1546         125 EYLGGGSALDLMKA-GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNT  203 (604)
Q Consensus       125 Ey~~ggsL~~~l~~-~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~~~~  203 (604)
                      |+|..++|..+++. +.++|.+++.+++||+.||.|||+++|||||||..|+||+++.+|||+|||+|..+........+
T Consensus        98 ELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~Erk~T  177 (592)
T KOG0575|consen   98 ELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGERKKT  177 (592)
T ss_pred             EecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecCcccccce
Confidence            99999999999975 67999999999999999999999999999999999999999999999999999999888788899


Q ss_pred             cccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCCCCCCCCccchHHHHHHHHHHhccC
Q psy1546         204 FVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKD  283 (604)
Q Consensus       204 ~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~~L~~d  283 (604)
                      .||||.|.|||++....++..+||||+||+||-||+|++||....-.+.+..|..... .+|..++.++++||.+||+.|
T Consensus       178 lCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y-~~P~~ls~~A~dLI~~lL~~~  256 (592)
T KOG0575|consen  178 LCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEY-SMPSHLSAEAKDLIRKLLRPN  256 (592)
T ss_pred             ecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCc-ccccccCHHHHHHHHHHhcCC
Confidence            9999999999999999999999999999999999999999999988888887765543 566789999999999999999


Q ss_pred             CCCCCCHHHHhcChhhhhhhhh
Q psy1546         284 PENRPTAKELLKFPFIRKAKKN  305 (604)
Q Consensus       284 P~~RpT~~elL~hp~f~~~~~~  305 (604)
                      |.+|||+++||.|+||+.....
T Consensus       257 P~~Rpsl~~vL~h~Ff~~g~~p  278 (592)
T KOG0575|consen  257 PSERPSLDEVLDHPFFKSGFTP  278 (592)
T ss_pred             cccCCCHHHHhcCHhhhCCCcC
Confidence            9999999999999999655443

>KOG0593|consensus

Probab=100.00  E-value=4e-49  Score=392.07  Aligned_cols=245  Identities=30%  Similarity=0.508  Sum_probs=212.4

Q ss_pred             cceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHH-HHHHHHHHHHhhCCCCC----------CCeEEEEEEe
Q psy1546          58 IFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEI-EDIQQEIMVLSQCDSPY----------GTKLWIIMEY  126 (604)
Q Consensus        58 ~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~-~~l~~Ei~iL~~l~hp~----------~~~lyLVmEy  126 (604)
                      .|+.+.++|+|+||+||+|+++.||+.||||.+........+ +...|||++|++++|+|          ..+++||+||
T Consensus         3 kYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~   82 (396)
T KOG0593|consen    3 KYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEY   82 (396)
T ss_pred             HHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeee
Confidence            378888999999999999999999999999998655543444 45689999999999998          4578999999


Q ss_pred             cCCCChhhHhhc-CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCCCCcccc
Q psy1546         127 LGGGSALDLMKA-GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFV  205 (604)
Q Consensus       127 ~~ggsL~~~l~~-~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~~~~~~  205 (604)
                      |+..-|.++-+. ..+++..++.+++|++.|+.|||++++|||||||+||||+..|.+||||||+|+.+..+......++
T Consensus        83 ~dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd~YTDYV  162 (396)
T KOG0593|consen   83 CDHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPGDNYTDYV  162 (396)
T ss_pred             cchHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcCCcchhhhhh
Confidence            988877776554 5799999999999999999999999999999999999999999999999999999987777888899


Q ss_pred             cCCCCCChHHhhc-CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCCC------------------------
Q psy1546         206 GTPFWMAPEVIKQ-SAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNN------------------------  260 (604)
Q Consensus       206 GT~~Y~APE~l~~-~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~~------------------------  260 (604)
                      .|.+|+|||++.+ ..|+..+||||+||++.||++|.+.|.+....++++.|.+.-                        
T Consensus       163 ATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv~lP~  242 (396)
T KOG0593|consen  163 ATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGVRLPE  242 (396)
T ss_pred             hhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceeeeecCC
Confidence            9999999999987 789999999999999999999999999998887777553211                        


Q ss_pred             ---CCCCC---ccchHHHHHHHHHHhccCCCCCCCHHHHhcChhhhhh
Q psy1546         261 ---PPQLT---GNYTKQFKEFVEACLNKDPENRPTAKELLKFPFIRKA  302 (604)
Q Consensus       261 ---~~~~~---~~~s~~l~~Li~~~L~~dP~~RpT~~elL~hp~f~~~  302 (604)
                         +..+.   ..++..+.+|++.||..||.+|++.+|+|.|+||...
T Consensus       243 ~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd~~  290 (396)
T KOG0593|consen  243 PEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFDGF  290 (396)
T ss_pred             CCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHHHH
Confidence               01111   2335578899999999999999999999999999543

>KOG0595|consensus

Probab=100.00  E-value=2.7e-49  Score=407.73  Aligned_cols=245  Identities=32%  Similarity=0.597  Sum_probs=220.6

Q ss_pred             cceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchh-hHHHHHHHHHHHHHHhhCCCCCCCe----------EEEEEEe
Q psy1546          58 IFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE-AEDEIEDIQQEIMVLSQCDSPYGTK----------LWIIMEY  126 (604)
Q Consensus        58 ~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~-~~~~~~~l~~Ei~iL~~l~hp~~~~----------lyLVmEy  126 (604)
                      .|.+.+.||+|+||+||+|+++.++..||||.|.+.. .....+.+..||.+|+.++|||++.          +||||||
T Consensus        11 ~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVMEy   90 (429)
T KOG0595|consen   11 DYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVMEY   90 (429)
T ss_pred             cceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEEe
Confidence            3888899999999999999999999999999998776 4556688899999999999999765          4899999


Q ss_pred             cCCCChhhHhhc-CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCC------CCeEEecccccccccCCCC
Q psy1546         127 LGGGSALDLMKA-GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEM------GDVKLADFGVAGTLTNTTS  199 (604)
Q Consensus       127 ~~ggsL~~~l~~-~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~------g~vKL~DFGlA~~~~~~~~  199 (604)
                      |.||+|.++|+. +.+++..++.++.||+.||++||+++||||||||+||||+..      -.+||+|||+|+.+. ...
T Consensus        91 C~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~-~~~  169 (429)
T KOG0595|consen   91 CNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQ-PGS  169 (429)
T ss_pred             CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhCC-chh
Confidence            999999999976 589999999999999999999999999999999999999864      358999999998886 445


Q ss_pred             CCcccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCCC--CCCCCccchHHHHHHHH
Q psy1546         200 KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNN--PPQLTGNYTKQFKEFVE  277 (604)
Q Consensus       200 ~~~~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~~--~~~~~~~~s~~l~~Li~  277 (604)
                      ...+.||+|.|||||++...+|+.|+|+||+|+|||+|++|++||...+..+.+..+.++.  .+.++..++..+.+|+.
T Consensus       170 ~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~~~~~~~~s~~~~~Ll~  249 (429)
T KOG0595|consen  170 MAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIVPVLPAELSNPLRELLI  249 (429)
T ss_pred             HHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccccCchhhhccCchhhhhh
Confidence            5678999999999999999999999999999999999999999999999999888776654  45556667778889999


Q ss_pred             HHhccCCCCCCCHHHHhcChhhhhhh
Q psy1546         278 ACLNKDPENRPTAKELLKFPFIRKAK  303 (604)
Q Consensus       278 ~~L~~dP~~RpT~~elL~hp~f~~~~  303 (604)
                      ..|..++.+|.+..+.+.|+++....
T Consensus       250 ~ll~~~~~~~~~~~~~~~~~~l~~~p  275 (429)
T KOG0595|consen  250 SLLQRNPKDRISFEDFFDHPFLAANP  275 (429)
T ss_pred             HHHhcCccccCchHHhhhhhhcccCc
Confidence            99999999999999999999986543

>KOG0578|consensus

Probab=100.00  E-value=1.4e-48  Score=416.57  Aligned_cols=263  Identities=43%  Similarity=0.759  Sum_probs=241.9

Q ss_pred             CccccceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCC----------CeEEEE
Q psy1546          54 DPELIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYG----------TKLWII  123 (604)
Q Consensus        54 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~----------~~lyLV  123 (604)
                      |+...|...++||+|+.|.||.|+...+++.||||.++...... .+.+..|+.+|+.+.|+|+          ..+|+|
T Consensus       270 dP~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~-keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVV  348 (550)
T KOG0578|consen  270 DPRSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPK-KELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVV  348 (550)
T ss_pred             ChhhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCc-hhhhHHHHHHHHhccchHHHHHHHHhcccceeEEE
Confidence            44456888899999999999999999999999999998765443 3778999999999999984          457999


Q ss_pred             EEecCCCChhhHhhcCCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCCCCcc
Q psy1546         124 MEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNT  203 (604)
Q Consensus       124 mEy~~ggsL~~~l~~~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~~~~  203 (604)
                      |||++||+|.+++....++|.++..|+++++.||+|||.+||+|||||.+|||++.+|.+||+|||+|..+......+.+
T Consensus       349 MEym~ggsLTDvVt~~~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~KR~T  428 (550)
T KOG0578|consen  349 MEYMEGGSLTDVVTKTRMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQSKRST  428 (550)
T ss_pred             EeecCCCchhhhhhcccccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeeccccccCcccc
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999888889999


Q ss_pred             cccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCCCCCCC--CccchHHHHHHHHHHhc
Q psy1546         204 FVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQL--TGNYTKQFKEFVEACLN  281 (604)
Q Consensus       204 ~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~--~~~~s~~l~~Li~~~L~  281 (604)
                      .+|||.|||||++....|++++||||||++++||+-|++||-..++...+++|.....+.+  +..++..|++||.+||.
T Consensus       429 mVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~lk~~~klS~~~kdFL~~cL~  508 (550)
T KOG0578|consen  429 MVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKLKNPEKLSPELKDFLDRCLV  508 (550)
T ss_pred             ccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCcCCccccCHHHHHHHHHHhh
Confidence            9999999999999999999999999999999999999999999999999998887776544  56789999999999999


Q ss_pred             cCCCCCCCHHHHhcChhhhhhhhhhhHHHHHHHHHH
Q psy1546         282 KDPENRPTAKELLKFPFIRKAKKNAYLIDLIDRYKK  317 (604)
Q Consensus       282 ~dP~~RpT~~elL~hp~f~~~~~~~~l~~~~~~~~~  317 (604)
                      .|+.+|+++.|||+||||+.+.....+..++..+++
T Consensus       509 ~dv~~RasA~eLL~HpFl~~a~p~ssL~pLi~~~~~  544 (550)
T KOG0578|consen  509 VDVEQRASAKELLEHPFLKMAKPESSLNPLILAARK  544 (550)
T ss_pred             cchhcCCCHHHHhcChhhhhcCCHHHhHHHHHHHHH
Confidence            999999999999999999988888888887776653

>KOG0592|consensus

Probab=100.00  E-value=9.3e-49  Score=414.69  Aligned_cols=248  Identities=29%  Similarity=0.532  Sum_probs=222.2

Q ss_pred             cceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhH--HHHHHHHHHHHHHhhC-CCCCCCeE----------EEEE
Q psy1546          58 IFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAE--DEIEDIQQEIMVLSQC-DSPYGTKL----------WIIM  124 (604)
Q Consensus        58 ~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~--~~~~~l~~Ei~iL~~l-~hp~~~~l----------yLVm  124 (604)
                      .|.+++.||+|+|++||+|+++.+++.||||++.+.-.-  ...+.+.+|-.+|.+| .||.+++|          |+|+
T Consensus        74 DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFvL  153 (604)
T KOG0592|consen   74 DFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFVL  153 (604)
T ss_pred             hcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEEE
Confidence            499999999999999999999999999999999776443  3356678899999999 89987664          7999


Q ss_pred             EecCCCChhhHhhc-CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCC-----
Q psy1546         125 EYLGGGSALDLMKA-GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTT-----  198 (604)
Q Consensus       125 Ey~~ggsL~~~l~~-~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~-----  198 (604)
                      ||+++|+|.++|++ |.|++..++.++.||+.||+|||++|||||||||+||||+.+|++||+|||.|+.+....     
T Consensus       154 e~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~~~~~~~  233 (604)
T KOG0592|consen  154 EYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILSPSQKSQEN  233 (604)
T ss_pred             EecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccCChhhccccC
Confidence            99999999999976 899999999999999999999999999999999999999999999999999998775321     


Q ss_pred             --------CCCcccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCCCCCCCCccchH
Q psy1546         199 --------SKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTK  270 (604)
Q Consensus       199 --------~~~~~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~  270 (604)
                              ..+.+++||..|.+||+|.....++.+|||+||||||.|+.|.+||.+.++.-++..|.... ..++..+++
T Consensus       234 ~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l~-y~fp~~fp~  312 (604)
T KOG0592|consen  234 PVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQALD-YEFPEGFPE  312 (604)
T ss_pred             ccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHhc-ccCCCCCCH
Confidence                    11256999999999999999999999999999999999999999999999988888776554 356778899


Q ss_pred             HHHHHHHHHhccCCCCCCCHHHHhcChhhhhhhhhh
Q psy1546         271 QFKEFVEACLNKDPENRPTAKELLKFPFIRKAKKNA  306 (604)
Q Consensus       271 ~l~~Li~~~L~~dP~~RpT~~elL~hp~f~~~~~~~  306 (604)
                      .+++||+++|..||.+|+|+.||.+||||....+..
T Consensus       313 ~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~Vdw~n  348 (604)
T KOG0592|consen  313 DARDLIKKLLVRDPSDRLTSQQIKAHPFFEGVDWEN  348 (604)
T ss_pred             HHHHHHHHHHccCccccccHHHHhhCcccccCChhh
Confidence            999999999999999999999999999998876553

>KOG0616|consensus

Probab=100.00  E-value=5e-48  Score=383.64  Aligned_cols=243  Identities=28%  Similarity=0.559  Sum_probs=222.4

Q ss_pred             ceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhH--HHHHHHHHHHHHHhhCCCCCCCe----------EEEEEEe
Q psy1546          59 FTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAE--DEIEDIQQEIMVLSQCDSPYGTK----------LWIIMEY  126 (604)
Q Consensus        59 y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~--~~~~~l~~Ei~iL~~l~hp~~~~----------lyLVmEy  126 (604)
                      |.+++.||.|+||.|.+++++.+|..||+|++++...-  .+.+....|..+|+.+.||+..+          +||||||
T Consensus        46 fe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvmey  125 (355)
T KOG0616|consen   46 FERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVMEY  125 (355)
T ss_pred             hhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEEec
Confidence            89999999999999999999999999999999877543  45678889999999999998554          5799999


Q ss_pred             cCCCChhhHhhc-CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCCCCcccc
Q psy1546         127 LGGGSALDLMKA-GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFV  205 (604)
Q Consensus       127 ~~ggsL~~~l~~-~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~~~~~~  205 (604)
                      ++||.|..++++ ++|++..++.++.||+.||+|||+++|++|||||+|||||.+|.+||+|||+|+.+...   ..+.|
T Consensus       126 v~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r---T~TlC  202 (355)
T KOG0616|consen  126 VPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR---TWTLC  202 (355)
T ss_pred             cCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEecCc---EEEec
Confidence            999999999977 89999999999999999999999999999999999999999999999999999877543   56889


Q ss_pred             cCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCCCCCCCCccchHHHHHHHHHHhccCCC
Q psy1546         206 GTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPE  285 (604)
Q Consensus       206 GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~~L~~dP~  285 (604)
                      |||.|+|||++....|+.++|+|+|||++|||+.|.+||...++..+...|..+.. .+|..++.++++||.++|+.|-.
T Consensus       203 GTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v-~fP~~fs~~~kdLl~~LL~vD~t  281 (355)
T KOG0616|consen  203 GTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKV-KFPSYFSSDAKDLLKKLLQVDLT  281 (355)
T ss_pred             CCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCcc-cCCcccCHHHHHHHHHHHhhhhH
Confidence            99999999999999999999999999999999999999999999999988877654 56788999999999999999999


Q ss_pred             CC-----CCHHHHhcChhhhhhhhh
Q psy1546         286 NR-----PTAKELLKFPFIRKAKKN  305 (604)
Q Consensus       286 ~R-----pT~~elL~hp~f~~~~~~  305 (604)
                      +|     ....+|..||||+...+.
T Consensus       282 ~R~gnlknG~~dIk~H~wF~~v~W~  306 (355)
T KOG0616|consen  282 KRFGNLKNGVEDIKNHPWFKGVDWE  306 (355)
T ss_pred             hhhcCcCCCccccccCcccccccHH
Confidence            99     357899999999876554

>KOG0588|consensus

Probab=100.00  E-value=2.2e-47  Score=411.32  Aligned_cols=243  Identities=30%  Similarity=0.535  Sum_probs=220.9

Q ss_pred             ceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhh--HHHHHHHHHHHHHHhhCCCCCCC----------eEEEEEEe
Q psy1546          59 FTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA--EDEIEDIQQEIMVLSQCDSPYGT----------KLWIIMEY  126 (604)
Q Consensus        59 y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~--~~~~~~l~~Ei~iL~~l~hp~~~----------~lyLVmEy  126 (604)
                      |.+++.||.|+-|.|-+|++..||+.+|||+|.+...  ......+.+||.||+.|.|||..          ++|+|.||
T Consensus        14 wkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlEy   93 (786)
T KOG0588|consen   14 WKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLEY   93 (786)
T ss_pred             eeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEEe
Confidence            8999999999999999999999999999999976632  23357789999999999999854          46899999


Q ss_pred             cCCCChhhHh-hcCCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCCCCcccc
Q psy1546         127 LGGGSALDLM-KAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFV  205 (604)
Q Consensus       127 ~~ggsL~~~l-~~~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~~~~~~  205 (604)
                      ++||.|++++ ++|+|++.++.++++||+.||.|||..+|+||||||+|+||+..++|||+|||+|. +........+.|
T Consensus        94 v~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAs-Le~~gklLeTSC  172 (786)
T KOG0588|consen   94 VPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMAS-LEVPGKLLETSC  172 (786)
T ss_pred             cCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceee-cccCCccccccC
Confidence            9999999976 67999999999999999999999999999999999999999999999999999994 444666677899


Q ss_pred             cCCCCCChHHhhcCCCC-CcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCCCCCCCCccchHHHHHHHHHHhccCC
Q psy1546         206 GTPFWMAPEVIKQSAYD-SKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDP  284 (604)
Q Consensus       206 GT~~Y~APE~l~~~~~~-~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~~L~~dP  284 (604)
                      |+|.|.+||++.+..|+ .++||||.|||||.||+|.+||.+.+...++..+..+.. .++..++.++++||.+||..||
T Consensus       173 GSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f-~MPs~Is~eaQdLLr~ml~VDp  251 (786)
T KOG0588|consen  173 GSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVF-EMPSNISSEAQDLLRRMLDVDP  251 (786)
T ss_pred             CCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcc-cCCCcCCHHHHHHHHHHhccCc
Confidence            99999999999999996 689999999999999999999999988888888877664 5678999999999999999999


Q ss_pred             CCCCCHHHHhcChhhhhhh
Q psy1546         285 ENRPTAKELLKFPFIRKAK  303 (604)
Q Consensus       285 ~~RpT~~elL~hp~f~~~~  303 (604)
                      .+|+|++||++|||+.+..
T Consensus       252 ~~RiT~~eI~kHP~l~g~~  270 (786)
T KOG0588|consen  252 STRITTEEILKHPFLSGYT  270 (786)
T ss_pred             cccccHHHHhhCchhhcCC
Confidence            9999999999999998653

>KOG0583|consensus

Probab=100.00  E-value=2.8e-47  Score=406.86  Aligned_cols=243  Identities=31%  Similarity=0.526  Sum_probs=217.5

Q ss_pred             cceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhh----HHHHHHHHHHHHHHhhCC-CCCCCe----------EEE
Q psy1546          58 IFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA----EDEIEDIQQEIMVLSQCD-SPYGTK----------LWI  122 (604)
Q Consensus        58 ~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~----~~~~~~l~~Ei~iL~~l~-hp~~~~----------lyL  122 (604)
                      .|.+.+.||+|+||+|++|.+..++..||||+++....    ....+.+.+|+.+++.+. |||+.+          +|+
T Consensus        18 ~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~~~i   97 (370)
T KOG0583|consen   18 KYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTKIYI   97 (370)
T ss_pred             ceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCeEEE
Confidence            49999999999999999999999999999998876522    133567789999999999 999655          479


Q ss_pred             EEEecCCCChhhHhhc-CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCC-CCeEEecccccccccCCCCC
Q psy1546         123 IMEYLGGGSALDLMKA-GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEM-GDVKLADFGVAGTLTNTTSK  200 (604)
Q Consensus       123 VmEy~~ggsL~~~l~~-~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~-g~vKL~DFGlA~~~~~~~~~  200 (604)
                      |||||.||+|.+++.. +++.|..++.+|+||+.||+|||++||+||||||+|||++.+ +++||+|||++.........
T Consensus        98 vmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~~~~~~  177 (370)
T KOG0583|consen   98 VMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAISPGEDGL  177 (370)
T ss_pred             EEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEeccccccccCCCCCc
Confidence            9999999999999876 899999999999999999999999999999999999999999 99999999999776445556


Q ss_pred             CcccccCCCCCChHHhhcCC-CC-CcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCCCCCCCCccc-hHHHHHHHH
Q psy1546         201 RNTFVGTPFWMAPEVIKQSA-YD-SKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNY-TKQFKEFVE  277 (604)
Q Consensus       201 ~~~~~GT~~Y~APE~l~~~~-~~-~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~-s~~l~~Li~  277 (604)
                      ..++|||+.|+|||++.+.. |+ .++||||+||+||.|++|..||...+...+...+..+. ..++..+ +.++++|+.
T Consensus       178 l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~-~~~p~~~~S~~~~~Li~  256 (370)
T KOG0583|consen  178 LKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGE-FKIPSYLLSPEARSLIE  256 (370)
T ss_pred             ccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCC-ccCCCCcCCHHHHHHHH
Confidence            77899999999999999987 86 78999999999999999999999988777777765543 3566667 999999999


Q ss_pred             HHhccCCCCCCCHHHHhcChhhhh
Q psy1546         278 ACLNKDPENRPTAKELLKFPFIRK  301 (604)
Q Consensus       278 ~~L~~dP~~RpT~~elL~hp~f~~  301 (604)
                      +||..||.+|+|+.+|+.||||+.
T Consensus       257 ~mL~~~P~~R~t~~~i~~h~w~~~  280 (370)
T KOG0583|consen  257 KMLVPDPSTRITLLEILEHPWFQK  280 (370)
T ss_pred             HHcCCCcccCCCHHHHhhChhhcc
Confidence            999999999999999999999986

>KOG0591|consensus

Probab=100.00  E-value=1.1e-48  Score=385.69  Aligned_cols=232  Identities=33%  Similarity=0.541  Sum_probs=214.9

Q ss_pred             ceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhh-HHHHHHHHHHHHHHhhCCCCCCCe------------EEEEEE
Q psy1546          59 FTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA-EDEIEDIQQEIMVLSQCDSPYGTK------------LWIIME  125 (604)
Q Consensus        59 y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~-~~~~~~l~~Ei~iL~~l~hp~~~~------------lyLVmE  125 (604)
                      |.+.++||+|+||.||++.+..+|..||.|.+..... ....+.+..||.+|++|+|||+++            ++||||
T Consensus        21 y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivmE  100 (375)
T KOG0591|consen   21 YQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVME  100 (375)
T ss_pred             HHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHHH
Confidence            9999999999999999999999999999999975543 334577889999999999999655            469999


Q ss_pred             ecCCCChhhHhhc-----CCCcHHHHHHHHHHHHHHhHHhhh--CC--ccccccccceeEecCCCCeEEecccccccccC
Q psy1546         126 YLGGGSALDLMKA-----GNFEEMHIAVILREVLKGLDYLHS--ER--KLHRDIKAANVLLSEMGDVKLADFGVAGTLTN  196 (604)
Q Consensus       126 y~~ggsL~~~l~~-----~~lse~~i~~i~~qIl~gL~yLHs--~g--IiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~  196 (604)
                      ||++|+|..+++.     ..++|..++.++.|++.||.+||.  ..  |+||||||.||+|+.+|.|||+|||+++.+..
T Consensus       101 ~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l~s  180 (375)
T KOG0591|consen  101 LCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFLSS  180 (375)
T ss_pred             hhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHhcc
Confidence            9999999999864     569999999999999999999999  44  89999999999999999999999999999988


Q ss_pred             CCCCCcccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCCCCCCCC-ccchHHHHHH
Q psy1546         197 TTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLT-GNYTKQFKEF  275 (604)
Q Consensus       197 ~~~~~~~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~-~~~s~~l~~L  275 (604)
                      ......+++|||.||+||.+....|+.++|||||||++|||+.-++||.+.+-......|..+..+.++ ..|+.++..|
T Consensus       181 ~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~~~~p~~~YS~~l~~l  260 (375)
T KOG0591|consen  181 KTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDYPPLPDEHYSTDLREL  260 (375)
T ss_pred             hhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCCCCCcHHHhhhHHHHH
Confidence            888888899999999999999999999999999999999999999999999999999999999888888 7899999999


Q ss_pred             HHHHhccCCCCCCCH
Q psy1546         276 VEACLNKDPENRPTA  290 (604)
Q Consensus       276 i~~~L~~dP~~RpT~  290 (604)
                      |..|+..||+.||+.
T Consensus       261 i~~ci~vd~~~RP~t  275 (375)
T KOG0591|consen  261 INMCIAVDPEQRPDT  275 (375)
T ss_pred             HHHHccCCcccCCCc
Confidence            999999999999985

>KOG0694|consensus

Probab=100.00  E-value=4.8e-47  Score=411.64  Aligned_cols=247  Identities=30%  Similarity=0.514  Sum_probs=224.6

Q ss_pred             cceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhh--HHHHHHHHHHHHHHhhCC-CCC----------CCeEEEEE
Q psy1546          58 IFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA--EDEIEDIQQEIMVLSQCD-SPY----------GTKLWIIM  124 (604)
Q Consensus        58 ~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~--~~~~~~l~~Ei~iL~~l~-hp~----------~~~lyLVm  124 (604)
                      .|.++++||+|+||+|+++..+.+++.||||++++...  .++++..+.|..|+.... ||+          ..++|+||
T Consensus       369 ~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~fvm  448 (694)
T KOG0694|consen  369 DFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFFVM  448 (694)
T ss_pred             ceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEEEE
Confidence            49999999999999999999999999999999987754  456788888888888775 997          45678999


Q ss_pred             EecCCCChhhHhhcCCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCCCCccc
Q psy1546         125 EYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTF  204 (604)
Q Consensus       125 Ey~~ggsL~~~l~~~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~~~~~  204 (604)
                      ||+.||++..+++.+.|++..++.|+..|+.||+|||++||||||||.+|||||.+|++||+|||+++..........++
T Consensus       449 ey~~Ggdm~~~~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~g~~TsTf  528 (694)
T KOG0694|consen  449 EYVAGGDLMHHIHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQGDRTSTF  528 (694)
T ss_pred             EecCCCcEEEEEecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEecccccccccCCCCCccccc
Confidence            99999997777777999999999999999999999999999999999999999999999999999998877667788899


Q ss_pred             ccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCCCCCCCCccchHHHHHHHHHHhccCC
Q psy1546         205 VGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDP  284 (604)
Q Consensus       205 ~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~~L~~dP  284 (604)
                      ||||.|||||++.+..|+.++|+|+|||+|||||.|+.||.+.++.++...|.... +.+|..++.++.++|+++|.++|
T Consensus       529 CGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~-~~yP~~ls~ea~~il~~ll~k~p  607 (694)
T KOG0694|consen  529 CGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDE-VRYPRFLSKEAIAIMRRLLRKNP  607 (694)
T ss_pred             cCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCC-CCCCCcccHHHHHHHHHHhccCc
Confidence            99999999999999999999999999999999999999999999999988876544 46778899999999999999999


Q ss_pred             CCCCC-----HHHHhcChhhhhhhhh
Q psy1546         285 ENRPT-----AKELLKFPFIRKAKKN  305 (604)
Q Consensus       285 ~~RpT-----~~elL~hp~f~~~~~~  305 (604)
                      ++|..     +++|.+||||+...+.
T Consensus       608 ~kRLG~~e~d~~~i~~hpFFr~i~w~  633 (694)
T KOG0694|consen  608 EKRLGSGERDAEDIKKHPFFRSIDWD  633 (694)
T ss_pred             ccccCCCCCCchhhhhCCccccCCHH
Confidence            99975     6889999999876554

>KOG0582|consensus

Probab=100.00  E-value=1.8e-45  Score=382.05  Aligned_cols=252  Identities=50%  Similarity=0.855  Sum_probs=225.7

Q ss_pred             cceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCCe----------EEEEEEec
Q psy1546          58 IFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTK----------LWIIMEYL  127 (604)
Q Consensus        58 ~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~~----------lyLVmEy~  127 (604)
                      .|++.++||.|..++||+|++..++++||||+++.+.....+..+.+|+..|+.++|||+..          +|+||.||
T Consensus        27 ~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmpfM  106 (516)
T KOG0582|consen   27 DYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMPFM  106 (516)
T ss_pred             ceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeehhh
Confidence            49999999999999999999999999999999999988888999999999999999999765          57999999


Q ss_pred             CCCChhhHhhc---CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCCC---C
Q psy1546         128 GGGSALDLMKA---GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSK---R  201 (604)
Q Consensus       128 ~ggsL~~~l~~---~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~---~  201 (604)
                      .+|++.++++.   ..|+|..+..|++++++||.|||.+|.||||||+.||||+.+|.|||+|||.+-.+......   +
T Consensus       107 a~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~R~~~r  186 (516)
T KOG0582|consen  107 AGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGDRQVTR  186 (516)
T ss_pred             cCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeeeeecccCceeeEe
Confidence            99999999975   46999999999999999999999999999999999999999999999999988666543321   2


Q ss_pred             -cccccCCCCCChHHhhc--CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCCCCCCC---------Cccch
Q psy1546         202 -NTFVGTPFWMAPEVIKQ--SAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQL---------TGNYT  269 (604)
Q Consensus       202 -~~~~GT~~Y~APE~l~~--~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~---------~~~~s  269 (604)
                       .+++||+.|||||++..  ..|+.|+||||||++..||.+|..||....+++++.+...+.++.+         ...++
T Consensus       187 f~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~t~~~~~d~~k~~~  266 (516)
T KOG0582|consen  187 FNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLLTSGLDKDEDKKFS  266 (516)
T ss_pred             eccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCcccccCChHHhhhhc
Confidence             67899999999999754  4699999999999999999999999999999999888777776522         12467


Q ss_pred             HHHHHHHHHHhccCCCCCCCHHHHhcChhhhhhhhhhhHH
Q psy1546         270 KQFKEFVEACLNKDPENRPTAKELLKFPFIRKAKKNAYLI  309 (604)
Q Consensus       270 ~~l~~Li~~~L~~dP~~RpT~~elL~hp~f~~~~~~~~l~  309 (604)
                      ..++.++..||.+||.+|||+.++|+|+||++.+...++.
T Consensus       267 ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k~~~~~~  306 (516)
T KOG0582|consen  267 KSFREMIALCLVKDPSKRPTASKLLKHAFFKKAKSKEYLV  306 (516)
T ss_pred             HHHHHHHHHHhhcCcccCCCHHHHhccHHHhhccchhhcc
Confidence            7899999999999999999999999999999888766554

>KOG0574|consensus

Probab=100.00  E-value=3.4e-48  Score=384.14  Aligned_cols=269  Identities=47%  Similarity=0.859  Sum_probs=245.7

Q ss_pred             CccccCccccceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCCe---------
Q psy1546          49 NSLKVDPELIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTK---------  119 (604)
Q Consensus        49 ~~~~~~~~~~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~~---------  119 (604)
                      .++...++..|.++.+||+|+||.||+|.++.+|+.+|||.+..+   ..++.+..||.|+.+|+.++.++         
T Consensus        25 ~sL~K~PEEVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~---sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~s  101 (502)
T KOG0574|consen   25 SALNKPPEEVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD---TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHS  101 (502)
T ss_pred             hhhcCChHHHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc---chHHHHHHHHHHHHHcCCchhhhhhhhhccCC
Confidence            345556788899999999999999999999999999999998655   35688899999999999998654         


Q ss_pred             -EEEEEEecCCCChhhHhh--cCCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccC
Q psy1546         120 -LWIIMEYLGGGSALDLMK--AGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTN  196 (604)
Q Consensus       120 -lyLVmEy~~ggsL~~~l~--~~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~  196 (604)
                       +|||||||..|++.++++  +..+++.++..+++..+.||+|||...-||||||..|||+..+|..||+|||.|..+.+
T Consensus       102 DLWIVMEYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTD  181 (502)
T KOG0574|consen  102 DLWIVMEYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTD  181 (502)
T ss_pred             ceEeehhhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhh
Confidence             579999999999999985  46799999999999999999999999999999999999999999999999999999999


Q ss_pred             CCCCCcccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCCCCCCCC--ccchHHHHH
Q psy1546         197 TTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLT--GNYTKQFKE  274 (604)
Q Consensus       197 ~~~~~~~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~--~~~s~~l~~  274 (604)
                      .-.++++.+|||.|||||++..-.|+.++||||||++..||..|++||.+.+++...++|+...++.+.  ..++.++.+
T Consensus       182 TMAKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT~PPPTF~KPE~WS~~F~D  261 (502)
T KOG0574|consen  182 TMAKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPTKPPPTFKKPEEWSSEFND  261 (502)
T ss_pred             hHHhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEeccCCCCCCCCChHhhhhHHHH
Confidence            999999999999999999999999999999999999999999999999999999999999998887664  467899999


Q ss_pred             HHHHHhccCCCCCCCHHHHhcChhhhhhhhhhhHHHHHHHHHHHhh
Q psy1546         275 FVEACLNKDPENRPTAKELLKFPFIRKAKKNAYLIDLIDRYKKWKN  320 (604)
Q Consensus       275 Li~~~L~~dP~~RpT~~elL~hp~f~~~~~~~~l~~~~~~~~~~~~  320 (604)
                      |++.||.+.|++|-|+.++++|||++.+..-..+.+++..-.+.+.
T Consensus       262 Fi~~CLiK~PE~R~TA~~L~~H~FiknA~g~~I~~~~I~~A~e~~~  307 (502)
T KOG0574|consen  262 FIRSCLIKKPEERKTALRLCEHTFIKNAPGCDIMQLMIQDAQEKAI  307 (502)
T ss_pred             HHHHHhcCCHHHHHHHHHHhhhhhhcCCCcccHHHHHHHHHHHHHH
Confidence            9999999999999999999999999999888777777665544433

>KOG0605|consensus

Probab=100.00  E-value=1.5e-46  Score=398.17  Aligned_cols=247  Identities=32%  Similarity=0.530  Sum_probs=214.0

Q ss_pred             cceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhh--HHHHHHHHHHHHHHhhCCCCCCCeE----------EEEEE
Q psy1546          58 IFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA--EDEIEDIQQEIMVLSQCDSPYGTKL----------WIIME  125 (604)
Q Consensus        58 ~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~--~~~~~~l~~Ei~iL~~l~hp~~~~l----------yLVmE  125 (604)
                      .|.++++||+|+||.||+|+.+.||..||+|++++...  ..+++.+..|-.+|...++|+++++          |||||
T Consensus       142 DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLiME  221 (550)
T KOG0605|consen  142 DFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLIME  221 (550)
T ss_pred             cchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEEEE
Confidence            39999999999999999999999999999999987754  3457889999999999999987665          79999


Q ss_pred             ecCCCChhhHhh-cCCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccC--------
Q psy1546         126 YLGGGSALDLMK-AGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTN--------  196 (604)
Q Consensus       126 y~~ggsL~~~l~-~~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~--------  196 (604)
                      |++||++..+|. .+.|++..+++++.+++.||.-||+.|+|||||||+|+|||..|++||+|||+|.-+..        
T Consensus       222 ylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~~~~~~  301 (550)
T KOG0605|consen  222 YLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHRIESYR  301 (550)
T ss_pred             ecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccchhhhhhhhhhhc
Confidence            999999999875 58899999999999999999999999999999999999999999999999999843211        


Q ss_pred             -------C-------C-C-----C-------------------CcccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHH
Q psy1546         197 -------T-------T-S-----K-------------------RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIEL  237 (604)
Q Consensus       197 -------~-------~-~-----~-------------------~~~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eL  237 (604)
                             .       . .     .                   ....+|||.|||||++.+..|+..+|+||||||+|||
T Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG~ImyEm  381 (550)
T KOG0605|consen  302 LDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLGCIMYEM  381 (550)
T ss_pred             chhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHHHHHHHH
Confidence                   0       0 0     0                   1235799999999999999999999999999999999


Q ss_pred             HhCCCCCCCCChhhHhhhcCCCC---CCCCCccchHHHHHHHHHHhccCCCCCC---CHHHHhcChhhhhhhhh
Q psy1546         238 AKGEPPNSELHPMRVLFLIPKNN---PPQLTGNYTKQFKEFVEACLNKDPENRP---TAKELLKFPFIRKAKKN  305 (604)
Q Consensus       238 ltG~~Pf~~~~~~~~~~~i~~~~---~~~~~~~~s~~l~~Li~~~L~~dP~~Rp---T~~elL~hp~f~~~~~~  305 (604)
                      |.|.+||.+.++.+....|....   ..+-...++++++|||.+||. ||.+|.   .++||-+||||+...++
T Consensus       382 LvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~HPfF~~v~W~  454 (550)
T KOG0605|consen  382 LVGYPPFCSETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKKHPFFKGVDWD  454 (550)
T ss_pred             HhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhcCCccccCCcc
Confidence            99999999999998887665433   112223567899999999999 999997   49999999999987654

>KOG0033|consensus

Probab=100.00  E-value=8.1e-48  Score=372.86  Aligned_cols=267  Identities=28%  Similarity=0.477  Sum_probs=231.5

Q ss_pred             cccceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhH-HHHHHHHHHHHHHhhCCCCCCCeE----------EEEE
Q psy1546          56 ELIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAE-DEIEDIQQEIMVLSQCDSPYGTKL----------WIIM  124 (604)
Q Consensus        56 ~~~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~-~~~~~l~~Ei~iL~~l~hp~~~~l----------yLVm  124 (604)
                      ++.|.+.+.||+|.|+.||++.+..||+.+|+|+++..... ...+.+.+|+.|-+.|+|||++++          |||+
T Consensus        10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF   89 (355)
T KOG0033|consen   10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF   89 (355)
T ss_pred             chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence            34588999999999999999999999999999999765432 356889999999999999998765          8999


Q ss_pred             EecCCCChhhH-hhcCCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecC---CCCeEEecccccccccCCCCC
Q psy1546         125 EYLGGGSALDL-MKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSE---MGDVKLADFGVAGTLTNTTSK  200 (604)
Q Consensus       125 Ey~~ggsL~~~-l~~~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~---~g~vKL~DFGlA~~~~~~~~~  200 (604)
                      |++.|++|..- +++--++|..+-.+++||+++|.|||.+||||||+||+|+|+..   ..-+||+|||+|..+. ....
T Consensus        90 e~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~-~g~~  168 (355)
T KOG0033|consen   90 DLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN-DGEA  168 (355)
T ss_pred             ecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeC-Cccc
Confidence            99999998764 45567899999999999999999999999999999999999953   3359999999998887 4444


Q ss_pred             CcccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCCC---CCCCCccchHHHHHHHH
Q psy1546         201 RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNN---PPQLTGNYTKQFKEFVE  277 (604)
Q Consensus       201 ~~~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~~---~~~~~~~~s~~l~~Li~  277 (604)
                      -..++|||.|||||+++...|+..+|||+.|||||-||.|.+||.+.+..++...|..+.   +...+..+++++++|++
T Consensus       169 ~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w~~is~~Ak~Lvr  248 (355)
T KOG0033|consen  169 WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEWDTVTPEAKSLIR  248 (355)
T ss_pred             cccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCcccCcCCHHHHHHHH
Confidence            456789999999999999999999999999999999999999999988888888887665   34456788999999999


Q ss_pred             HHhccCCCCCCCHHHHhcChhhhhhhhhhhHH---HHHHHHHHHhhhcc
Q psy1546         278 ACLNKDPENRPTAKELLKFPFIRKAKKNAYLI---DLIDRYKKWKNSRN  323 (604)
Q Consensus       278 ~~L~~dP~~RpT~~elL~hp~f~~~~~~~~l~---~~~~~~~~~~~~~~  323 (604)
                      +||..||.+|+|+.|+|+|||++......+.+   +..++++++.+.+.
T Consensus       249 rML~~dP~kRIta~EAL~HpWi~~r~~~As~~H~~dtvd~lrkfNarRK  297 (355)
T KOG0033|consen  249 RMLTVNPKKRITADEALKHPWICNRERVASAIHRQDTVDCLKKFNARRK  297 (355)
T ss_pred             HHhccChhhhccHHHHhCCchhcchHHHHHHhhhHHHHHHHHHhhHHHH
Confidence            99999999999999999999998876655543   56777777765544

>KOG0198|consensus

Probab=100.00  E-value=1.4e-46  Score=389.03  Aligned_cols=245  Identities=40%  Similarity=0.722  Sum_probs=211.5

Q ss_pred             cceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCC------------eEEEEEE
Q psy1546          58 IFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGT------------KLWIIME  125 (604)
Q Consensus        58 ~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~------------~lyLVmE  125 (604)
                      .|..++.||+|+||.||++.+..+|..+|||.+....... .+.+.+|+.+|+++.||+++            .++|+||
T Consensus        18 ~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~-~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE   96 (313)
T KOG0198|consen   18 NWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPT-SESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME   96 (313)
T ss_pred             hhhhhccccCccceEEEEEEecCCCcceeeeeeecccchh-HHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence            3788899999999999999999999999999997764333 67899999999999999843            4679999


Q ss_pred             ecCCCChhhHhhc-C-CCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecC-CCCeEEecccccccccC---CCC
Q psy1546         126 YLGGGSALDLMKA-G-NFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSE-MGDVKLADFGVAGTLTN---TTS  199 (604)
Q Consensus       126 y~~ggsL~~~l~~-~-~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~-~g~vKL~DFGlA~~~~~---~~~  199 (604)
                      |+.+|+|.++++. + .|++..++.+.+||++||.|||++|||||||||+||||+. ++.+||+|||+++....   ...
T Consensus        97 y~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~~~~  176 (313)
T KOG0198|consen   97 YAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGTKSD  176 (313)
T ss_pred             ccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCcccccccccccccc
Confidence            9999999999976 3 6999999999999999999999999999999999999999 79999999999987663   122


Q ss_pred             CCcccccCCCCCChHHhhcC-CCCCcchhhhHHHHHHHHHhCCCCCCC-CChhhHhhhcC-CCCCCCCCccchHHHHHHH
Q psy1546         200 KRNTFVGTPFWMAPEVIKQS-AYDSKADIWSLGITAIELAKGEPPNSE-LHPMRVLFLIP-KNNPPQLTGNYTKQFKEFV  276 (604)
Q Consensus       200 ~~~~~~GT~~Y~APE~l~~~-~~~~~sDVwSLGviL~eLltG~~Pf~~-~~~~~~~~~i~-~~~~~~~~~~~s~~l~~Li  276 (604)
                      ....+.||+.|||||++..+ ..+.++|||||||++.||+||.+||.. .........+. ....+.++..++.++++||
T Consensus       177 ~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~P~ip~~ls~~a~~Fl  256 (313)
T KOG0198|consen  177 SELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSLPEIPDSLSDEAKDFL  256 (313)
T ss_pred             ccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCCCCCCCcccCHHHHHHH
Confidence            34467899999999999853 344599999999999999999999998 44444333333 3345688899999999999


Q ss_pred             HHHhccCCCCCCCHHHHhcChhhhhhh
Q psy1546         277 EACLNKDPENRPTAKELLKFPFIRKAK  303 (604)
Q Consensus       277 ~~~L~~dP~~RpT~~elL~hp~f~~~~  303 (604)
                      .+||..||.+|||+.++|.|||.+...
T Consensus       257 ~~C~~~~p~~Rpta~eLL~hpf~~~~~  283 (313)
T KOG0198|consen  257 RKCFKRDPEKRPTAEELLEHPFLKQNS  283 (313)
T ss_pred             HHHhhcCcccCcCHHHHhhChhhhccc
Confidence            999999999999999999999997643

>KOG0579|consensus

Probab=100.00  E-value=2e-46  Score=399.23  Aligned_cols=262  Identities=44%  Similarity=0.841  Sum_probs=235.7

Q ss_pred             cCccccceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCC----------CeEEE
Q psy1546          53 VDPELIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYG----------TKLWI  122 (604)
Q Consensus        53 ~~~~~~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~----------~~lyL  122 (604)
                      +++.+.|.++..||.|+||.||+|..+.++-..|.|+|.... +.+++.+.-||.||..|+||++          .++||
T Consensus        28 lnP~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetks-eEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwi  106 (1187)
T KOG0579|consen   28 LNPRDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKS-EEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWI  106 (1187)
T ss_pred             CCHHHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccc-hhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEE
Confidence            566778999999999999999999999999999999996554 4567899999999999999974          45689


Q ss_pred             EEEecCCCChhhHhhc--CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCCC
Q psy1546         123 IMEYLGGGSALDLMKA--GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSK  200 (604)
Q Consensus       123 VmEy~~ggsL~~~l~~--~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~  200 (604)
                      +.|||+||-+..+|-.  ..|.+.++..+++|+|.||.|||+++|||||||..|||++-+|.|+|+|||++.........
T Consensus       107 liEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~qk  186 (1187)
T KOG0579|consen  107 LIEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTRQK  186 (1187)
T ss_pred             EEeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccchhHHhh
Confidence            9999999998887743  67999999999999999999999999999999999999999999999999998776666677


Q ss_pred             CcccccCCCCCChHHhh-----cCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCCCCCCC--CccchHHHH
Q psy1546         201 RNTFVGTPFWMAPEVIK-----QSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQL--TGNYTKQFK  273 (604)
Q Consensus       201 ~~~~~GT~~Y~APE~l~-----~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~--~~~~s~~l~  273 (604)
                      +.+|+|||+|||||++.     ..+|++++||||||++|+||..+.+|....+++.++..|.+..++.+  +..++..|.
T Consensus       187 RDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePPTLlqPS~Ws~~F~  266 (1187)
T KOG0579|consen  187 RDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLLQPSHWSRSFS  266 (1187)
T ss_pred             hccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCCcccCcchhhhHHH
Confidence            88999999999999874     56799999999999999999999999999999999999999888765  567899999


Q ss_pred             HHHHHHhccCCCCCCCHHHHhcChhhhhhhhhhhHHHHHHHH
Q psy1546         274 EFVEACLNKDPENRPTAKELLKFPFIRKAKKNAYLIDLIDRY  315 (604)
Q Consensus       274 ~Li~~~L~~dP~~RpT~~elL~hp~f~~~~~~~~l~~~~~~~  315 (604)
                      |||.+||.+||..||++.+||+||||.....+..+.+++...
T Consensus       267 DfLk~cL~Knp~~Rp~aaqll~Hpfv~~~~SnK~ireLlAEa  308 (1187)
T KOG0579|consen  267 DFLKRCLVKNPRNRPPAAQLLKHPFVQNAPSNKMIRELLAEA  308 (1187)
T ss_pred             HHHHHHHhcCCccCCCHHHHhhCcccccCCcchHHHHHHHHH
Confidence            999999999999999999999999999877776666665443

>KOG0597|consensus

Probab=100.00  E-value=3.6e-46  Score=394.83  Aligned_cols=244  Identities=36%  Similarity=0.624  Sum_probs=222.7

Q ss_pred             cceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchh-hHHHHHHHHHHHHHHhhCCCCCCC----------eEEEEEEe
Q psy1546          58 IFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE-AEDEIEDIQQEIMVLSQCDSPYGT----------KLWIIMEY  126 (604)
Q Consensus        58 ~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~-~~~~~~~l~~Ei~iL~~l~hp~~~----------~lyLVmEy  126 (604)
                      .|-+.+.||+|+||.||+|+.+.+.+.||||.+++.. .+++++.+.+|+.|++.++|||++          .+|+|+||
T Consensus         3 ~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte~   82 (808)
T KOG0597|consen    3 QYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTEY   82 (808)
T ss_pred             chhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEehh
Confidence            3778889999999999999999999999999997664 456789999999999999999954          56899999


Q ss_pred             cCCCChhhHhhc-CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCCCCcccc
Q psy1546         127 LGGGSALDLMKA-GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFV  205 (604)
Q Consensus       127 ~~ggsL~~~l~~-~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~~~~~~  205 (604)
                      |.| +|..++.. +.++|+.++.++.|++.||.|||+++|+|||+||.|||+...|.+||||||+|+.+...........
T Consensus        83 a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t~vltsik  161 (808)
T KOG0597|consen   83 AVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNTSVLTSIK  161 (808)
T ss_pred             hhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhcccCceeeeecc
Confidence            976 89998864 8999999999999999999999999999999999999999999999999999998887777777888


Q ss_pred             cCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCCCCCCCCccchHHHHHHHHHHhccCCC
Q psy1546         206 GTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPE  285 (604)
Q Consensus       206 GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~~L~~dP~  285 (604)
                      |||.|||||++.+..|+..+|+||||||||||+.|++||...........|.+.. ...+...+..+..||+.+|.+||.
T Consensus       162 GtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~-v~~p~~~S~~f~nfl~gLL~kdP~  240 (808)
T KOG0597|consen  162 GTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDP-VKPPSTASSSFVNFLQGLLIKDPA  240 (808)
T ss_pred             CcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCC-CCCcccccHHHHHHHHHHhhcChh
Confidence            9999999999999999999999999999999999999999988888877776544 345568899999999999999999


Q ss_pred             CCCCHHHHhcChhhhhhh
Q psy1546         286 NRPTAKELLKFPFIRKAK  303 (604)
Q Consensus       286 ~RpT~~elL~hp~f~~~~  303 (604)
                      +|.|..+++.|||+++..
T Consensus       241 ~RltW~~Ll~HpF~k~~~  258 (808)
T KOG0597|consen  241 QRLTWTDLLGHPFWKGKI  258 (808)
T ss_pred             hcccHHHHhcChHHhhhh
Confidence            999999999999998653

>KOG0600|consensus

Probab=100.00  E-value=3.2e-46  Score=392.65  Aligned_cols=244  Identities=31%  Similarity=0.508  Sum_probs=209.3

Q ss_pred             ccceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHH-HHHHHHHHHHHHhhCCCCCCCe------------EEEE
Q psy1546          57 LIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAED-EIEDIQQEIMVLSQCDSPYGTK------------LWII  123 (604)
Q Consensus        57 ~~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~-~~~~l~~Ei~iL~~l~hp~~~~------------lyLV  123 (604)
                      ..|+.+++||+|.||.||+|++..+|+.||+|.+.....+. ......|||.||++|+|||+.+            +|||
T Consensus       117 ~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlV  196 (560)
T KOG0600|consen  117 DSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLV  196 (560)
T ss_pred             HHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEE
Confidence            45999999999999999999999999999999998776433 3466789999999999999655            5999


Q ss_pred             EEecCCCChhhHhhcC--CCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCC-C
Q psy1546         124 MEYLGGGSALDLMKAG--NFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTS-K  200 (604)
Q Consensus       124 mEy~~ggsL~~~l~~~--~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~-~  200 (604)
                      +|||+. +|.-++...  +|++.+++.||+||+.||.|||++||+|||||.+||||+.+|.+||+|||+|+.+..... .
T Consensus       197 FeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~~~~  275 (560)
T KOG0600|consen  197 FEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSGSAP  275 (560)
T ss_pred             Eecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccceeeccCCCCcc
Confidence            999965 477777664  799999999999999999999999999999999999999999999999999987764443 3


Q ss_pred             CcccccCCCCCChHHhhcC-CCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCCC-------CC--CC------
Q psy1546         201 RNTFVGTPFWMAPEVIKQS-AYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNN-------PP--QL------  264 (604)
Q Consensus       201 ~~~~~GT~~Y~APE~l~~~-~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~~-------~~--~~------  264 (604)
                      ....+-|++|+|||+|.+. .|+.++|+||+||||.||++|++.|.+.++.+++..|.+..       ++  .+      
T Consensus       276 ~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~~~~~  355 (560)
T KOG0600|consen  276 YTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPHATIF  355 (560)
T ss_pred             cccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCCccccc
Confidence            5567889999999999875 59999999999999999999999999999887776553211       00  01      


Q ss_pred             -------------CccchHHHHHHHHHHhccCCCCCCCHHHHhcChhhhh
Q psy1546         265 -------------TGNYTKQFKEFVEACLNKDPENRPTAKELLKFPFIRK  301 (604)
Q Consensus       265 -------------~~~~s~~l~~Li~~~L~~dP~~RpT~~elL~hp~f~~  301 (604)
                                   ...++....+|+..||.+||.+|.|+.++|+++||..
T Consensus       356 kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~t  405 (560)
T KOG0600|consen  356 KPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFTT  405 (560)
T ss_pred             CCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCccccc
Confidence                         1245677889999999999999999999999999943

>KOG0577|consensus

Probab=100.00  E-value=1.5e-45  Score=390.86  Aligned_cols=260  Identities=46%  Similarity=0.809  Sum_probs=231.0

Q ss_pred             ccCccccceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchh--hHHHHHHHHHHHHHHhhCCCCCCCeE---------
Q psy1546          52 KVDPELIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE--AEDEIEDIQQEIMVLSQCDSPYGTKL---------  120 (604)
Q Consensus        52 ~~~~~~~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~--~~~~~~~l~~Ei~iL~~l~hp~~~~l---------  120 (604)
                      +.|++..|.-++.||.|+||.||.|++..+.+.||||.+....  .......+..|+..|+++.|||.+.+         
T Consensus        21 k~DPEklf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~T  100 (948)
T KOG0577|consen   21 KDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHT  100 (948)
T ss_pred             cCCHHHHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccch
Confidence            4578888999999999999999999999999999999987653  33456889999999999999995543         


Q ss_pred             -EEEEEecCCCChhhHhh--cCCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCC
Q psy1546         121 -WIIMEYLGGGSALDLMK--AGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNT  197 (604)
Q Consensus       121 -yLVmEy~~ggsL~~~l~--~~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~  197 (604)
                       ||||||| -|+..|++.  +.++.+.+|..|+.+.+.||.|||+++.||||||..|||+++.|.|||+|||.|....  
T Consensus       101 aWLVMEYC-lGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~--  177 (948)
T KOG0577|consen  101 AWLVMEYC-LGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIMA--  177 (948)
T ss_pred             HHHHHHHH-hccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhcC--
Confidence             7999999 677777774  4679999999999999999999999999999999999999999999999999995443  


Q ss_pred             CCCCcccccCCCCCChHHhh---cCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCCCCCCCC-ccchHHHH
Q psy1546         198 TSKRNTFVGTPFWMAPEVIK---QSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLT-GNYTKQFK  273 (604)
Q Consensus       198 ~~~~~~~~GT~~Y~APE~l~---~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~-~~~s~~l~  273 (604)
                        ...+|+|||+|||||++.   .+.|+-++||||||++.+||.-.++|+-..+.+..++.|..+..+.+. ..+++.|+
T Consensus       178 --PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesPtLqs~eWS~~F~  255 (948)
T KOG0577|consen  178 --PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFR  255 (948)
T ss_pred             --chhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCCCCCCchhHHHHH
Confidence              345789999999999985   567999999999999999999999999999999999999888877665 46899999


Q ss_pred             HHHHHHhccCCCCCCCHHHHhcChhhhhhhhhhhHHHHHHHHH
Q psy1546         274 EFVEACLNKDPENRPTAKELLKFPFIRKAKKNAYLIDLIDRYK  316 (604)
Q Consensus       274 ~Li~~~L~~dP~~RpT~~elL~hp~f~~~~~~~~l~~~~~~~~  316 (604)
                      .|+..||++-|.+|||.+++|+|+|+..-+....+.+++.+.+
T Consensus       256 ~Fvd~CLqKipqeRptse~ll~H~fv~R~Rp~tvi~dLIqRTK  298 (948)
T KOG0577|consen  256 NFVDSCLQKIPQERPTSEELLKHRFVLRERPPTVIMDLIQRTK  298 (948)
T ss_pred             HHHHHHHhhCcccCCcHHHHhhcchhccCCCchHHHHHHHHHH
Confidence            9999999999999999999999999988887777777766543

>KOG0661|consensus

Probab=100.00  E-value=7.7e-46  Score=387.33  Aligned_cols=248  Identities=28%  Similarity=0.432  Sum_probs=209.7

Q ss_pred             CccccceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCC-CCCCC-----------eEE
Q psy1546          54 DPELIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCD-SPYGT-----------KLW  121 (604)
Q Consensus        54 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~-hp~~~-----------~ly  121 (604)
                      .....|.++++||.|.||.||+|+...++..||||.++.+...-+.-.-.||+..|++|. |||++           .+|
T Consensus         7 ~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~   86 (538)
T KOG0661|consen    7 IFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILY   86 (538)
T ss_pred             hHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEe
Confidence            334569999999999999999999999999999999866543322233469999999999 99854           569


Q ss_pred             EEEEecCCCChhhHhhc--CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCC
Q psy1546         122 IIMEYLGGGSALDLMKA--GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTS  199 (604)
Q Consensus       122 LVmEy~~ggsL~~~l~~--~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~  199 (604)
                      +||||| ..+|.++|+.  ..|++..++.|+.||+.||+|+|.+|++||||||+|||+.....|||+|||+|+.+... .
T Consensus        87 fVfE~M-d~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~Sk-p  164 (538)
T KOG0661|consen   87 FVFEFM-DCNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREVRSK-P  164 (538)
T ss_pred             eeHHhh-hhhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEecccccccccccC-C
Confidence            999999 5679999976  46999999999999999999999999999999999999998899999999999877643 3


Q ss_pred             CCcccccCCCCCChHHhh-cCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCC-------------------
Q psy1546         200 KRNTFVGTPFWMAPEVIK-QSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKN-------------------  259 (604)
Q Consensus       200 ~~~~~~GT~~Y~APE~l~-~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~-------------------  259 (604)
                      ....++.|.+|+|||+|. ...|+.++|||++|||++|+++-++.|.+.++.+.++.|...                   
T Consensus       165 PYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~~m  244 (538)
T KOG0661|consen  165 PYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLASAM  244 (538)
T ss_pred             CcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHHHHh
Confidence            455788999999999985 567999999999999999999999999999887776654210                   


Q ss_pred             -------C---CCCCCccchHHHHHHHHHHhccCCCCCCCHHHHhcChhhhhhh
Q psy1546         260 -------N---PPQLTGNYTKQFKEFVEACLNKDPENRPTAKELLKFPFIRKAK  303 (604)
Q Consensus       260 -------~---~~~~~~~~s~~l~~Li~~~L~~dP~~RpT~~elL~hp~f~~~~  303 (604)
                             .   ...+....+.++.+||.+||..||.+|||+.|+|+||||.-..
T Consensus       245 nf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~~  298 (538)
T KOG0661|consen  245 NFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVGR  298 (538)
T ss_pred             ccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCccccccc
Confidence                   0   0112234678999999999999999999999999999997543

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=1.3e-44  Score=380.02  Aligned_cols=240  Identities=30%  Similarity=0.486  Sum_probs=208.5

Q ss_pred             eEEcccCcEEEEEEEECCCCcEEEEEEecchhh--HHHHHHHHHHHHHHhhCCCCCCCe----------EEEEEEecCCC
Q psy1546          63 ERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA--EDEIEDIQQEIMVLSQCDSPYGTK----------LWIIMEYLGGG  130 (604)
Q Consensus        63 ~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~--~~~~~~l~~Ei~iL~~l~hp~~~~----------lyLVmEy~~gg  130 (604)
                      +.||+|+||.||+|.+..+++.||||++.....  ......+.+|+.+++.+.||++.+          +||||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   80 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence            469999999999999999999999999976532  334567789999999999998654          47999999999


Q ss_pred             ChhhHhhc-CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCCCCcccccCCC
Q psy1546         131 SALDLMKA-GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPF  209 (604)
Q Consensus       131 sL~~~l~~-~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~~~~~~GT~~  209 (604)
                      +|.+++.. +.+++..+..++.||+.||+|||++||+||||||+||||+.++.+||+|||+++............+||+.
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~  160 (323)
T cd05571          81 ELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPE  160 (323)
T ss_pred             cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCcccceecCcc
Confidence            99988855 67999999999999999999999999999999999999999999999999999754433344456789999


Q ss_pred             CCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCCCCCCCCccchHHHHHHHHHHhccCCCCCC-
Q psy1546         210 WMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPENRP-  288 (604)
Q Consensus       210 Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rp-  288 (604)
                      |||||++.+..++.++|||||||++|||++|..||...+.......+... ...++..++.++.+||.+||..||++|| 
T Consensus       161 y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~-~~~~p~~~~~~~~~li~~~L~~dP~~R~~  239 (323)
T cd05571         161 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME-EIRFPRTLSPEAKSLLAGLLKKDPKQRLG  239 (323)
T ss_pred             ccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcC-CCCCCCCCCHHHHHHHHHHccCCHHHcCC
Confidence            99999999999999999999999999999999999887766655544333 3355677899999999999999999999 


Q ss_pred             ----CHHHHhcChhhhhhh
Q psy1546         289 ----TAKELLKFPFIRKAK  303 (604)
Q Consensus       289 ----T~~elL~hp~f~~~~  303 (604)
                          ++.++++||||....
T Consensus       240 ~~~~~~~~ll~h~~f~~~~  258 (323)
T cd05571         240 GGPEDAKEIMEHRFFASIN  258 (323)
T ss_pred             CCCCCHHHHHcCCCcCCCC
Confidence                899999999997653

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>KOG0659|consensus

Probab=100.00  E-value=1e-44  Score=355.54  Aligned_cols=245  Identities=29%  Similarity=0.431  Sum_probs=210.4

Q ss_pred             cceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHH-HHHHHHHHHHhhCCCCCCCeE----------EEEEEe
Q psy1546          58 IFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEI-EDIQQEIMVLSQCDSPYGTKL----------WIIMEY  126 (604)
Q Consensus        58 ~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~-~~l~~Ei~iL~~l~hp~~~~l----------yLVmEy  126 (604)
                      .|...++||+|.||.||+|++..||+.||||.|......+-+ ....|||+.|+.++|+|+..+          .||+||
T Consensus         3 rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfEf   82 (318)
T KOG0659|consen    3 RYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFEF   82 (318)
T ss_pred             hhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEEe
Confidence            378889999999999999999999999999999876554332 457899999999999996554          699999


Q ss_pred             cCCCChhhHhhcC--CCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCCCCccc
Q psy1546         127 LGGGSALDLMKAG--NFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTF  204 (604)
Q Consensus       127 ~~ggsL~~~l~~~--~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~~~~~  204 (604)
                      + ..+|...++..  .++..+++.|+.+++.||+|||++.|+||||||.|+||+.+|.+||+|||+|+.+..........
T Consensus        83 m-~tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~~~~~  161 (318)
T KOG0659|consen   83 M-PTDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRIQTHQ  161 (318)
T ss_pred             c-cccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCCCcccccc
Confidence            9 56799999764  58999999999999999999999999999999999999999999999999999988777666666


Q ss_pred             ccCCCCCChHHhhcC-CCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCCC-----------------------
Q psy1546         205 VGTPFWMAPEVIKQS-AYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNN-----------------------  260 (604)
Q Consensus       205 ~GT~~Y~APE~l~~~-~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~~-----------------------  260 (604)
                      +-|.+|+|||++.|. .|+..+||||.|||+.||+.|.+-|.+.+..+++..|...-                       
T Consensus       162 V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~~~~~  241 (318)
T KOG0659|consen  162 VVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVKIQQF  241 (318)
T ss_pred             eeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHHHhcC
Confidence            899999999999875 59999999999999999999999999988777665442110                       


Q ss_pred             ----CCCCCccchHHHHHHHHHHhccCCCCCCCHHHHhcChhhhhhh
Q psy1546         261 ----PPQLTGNYTKQFKEFVEACLNKDPENRPTAKELLKFPFIRKAK  303 (604)
Q Consensus       261 ----~~~~~~~~s~~l~~Li~~~L~~dP~~RpT~~elL~hp~f~~~~  303 (604)
                          ...+....+.++.+|+.+||..||.+|+|+.|+|+|+||+...
T Consensus       242 P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~P  288 (318)
T KOG0659|consen  242 PKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKSLP  288 (318)
T ss_pred             CCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhcCC
Confidence                0112233466789999999999999999999999999998643

>KOG0660|consensus

Probab=100.00  E-value=6.9e-45  Score=370.85  Aligned_cols=247  Identities=28%  Similarity=0.439  Sum_probs=209.8

Q ss_pred             cceeeeEEcccCcEEEEEEEECCCCcEEEEEEec-chhhHHHHHHHHHHHHHHhhCCCCCCCe---------------EE
Q psy1546          58 IFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIID-LEEAEDEIEDIQQEIMVLSQCDSPYGTK---------------LW  121 (604)
Q Consensus        58 ~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~-~~~~~~~~~~l~~Ei~iL~~l~hp~~~~---------------ly  121 (604)
                      .|..++.||+|+||.|+.|.++.+|+.||||.+. .-......++..||+++|+.++|+|+..               +|
T Consensus        23 ~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvY  102 (359)
T KOG0660|consen   23 YYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVY  102 (359)
T ss_pred             eecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeE
Confidence            4666889999999999999999999999999985 2333445688899999999999998543               58


Q ss_pred             EEEEecCCCChhhHhhcCC-CcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccC--CC
Q psy1546         122 IIMEYLGGGSALDLMKAGN-FEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTN--TT  198 (604)
Q Consensus       122 LVmEy~~ggsL~~~l~~~~-lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~--~~  198 (604)
                      +|+|+| +.+|..+++.+. +++..+..+++||++||+|+|+.||+||||||.|+|++.+..+||+|||+|+....  ..
T Consensus       103 iV~elM-etDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~~~~  181 (359)
T KOG0660|consen  103 LVFELM-ETDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLARYLDKFFED  181 (359)
T ss_pred             EehhHH-hhHHHHHHHcCccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccceeeccccCcc
Confidence            999999 788999999887 99999999999999999999999999999999999999999999999999987753  23


Q ss_pred             CCCcccccCCCCCChHHhh-cCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCC------------------
Q psy1546         199 SKRNTFVGTPFWMAPEVIK-QSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKN------------------  259 (604)
Q Consensus       199 ~~~~~~~GT~~Y~APE~l~-~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~------------------  259 (604)
                      ......+.|.+|+|||++. ...|+.+.||||+||||.||++|++.|.+.+....+..|...                  
T Consensus       182 ~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~ar  261 (359)
T KOG0660|consen  182 GFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEKAR  261 (359)
T ss_pred             cchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHHHH
Confidence            3345678999999999885 567999999999999999999999999988766555433211                  


Q ss_pred             ------------CCCCCCccchHHHHHHHHHHhccCCCCCCCHHHHhcChhhhhhhhh
Q psy1546         260 ------------NPPQLTGNYTKQFKEFVEACLNKDPENRPTAKELLKFPFIRKAKKN  305 (604)
Q Consensus       260 ------------~~~~~~~~~s~~l~~Li~~~L~~dP~~RpT~~elL~hp~f~~~~~~  305 (604)
                                  ....+..+.++.+.+|+++||..||.+|+|++|+|.||||......
T Consensus       262 ~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp  319 (359)
T KOG0660|consen  262 PYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDP  319 (359)
T ss_pred             HHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCC
Confidence                        0112234567889999999999999999999999999999876543

>KOG0585|consensus

Probab=100.00  E-value=7.1e-45  Score=379.61  Aligned_cols=244  Identities=30%  Similarity=0.496  Sum_probs=209.3

Q ss_pred             cceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHH-------------HHHHHHHHHHHHhhCCCCCCCe-----
Q psy1546          58 IFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAED-------------EIEDIQQEIMVLSQCDSPYGTK-----  119 (604)
Q Consensus        58 ~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~-------------~~~~l~~Ei~iL~~l~hp~~~~-----  119 (604)
                      .|++++.||+|.||.|-+|++..+++.||||++.+.....             .++.+.+||.||++|.|||+++     
T Consensus        98 qy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiEvL  177 (576)
T KOG0585|consen   98 QYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIEVL  177 (576)
T ss_pred             heehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEEee
Confidence            4999999999999999999999999999999997654321             2468999999999999999765     


Q ss_pred             -------EEEEEEecCCCChhhHhhcCC-CcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEeccccc
Q psy1546         120 -------LWIIMEYLGGGSALDLMKAGN-FEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVA  191 (604)
Q Consensus       120 -------lyLVmEy~~ggsL~~~l~~~~-lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA  191 (604)
                             +|||+|||..|.+...=..+. +++.+++.|+++++.||+|||.+|||||||||+|+||+.+|+|||+|||.+
T Consensus       178 DDP~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~VKIsDFGVs  257 (576)
T KOG0585|consen  178 DDPESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGTVKISDFGVS  257 (576)
T ss_pred             cCcccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCcEEeecccee
Confidence                   489999999998876666666 999999999999999999999999999999999999999999999999999


Q ss_pred             ccccCC-----CCCCcccccCCCCCChHHhhcCC----CCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCCCCC
Q psy1546         192 GTLTNT-----TSKRNTFVGTPFWMAPEVIKQSA----YDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPP  262 (604)
Q Consensus       192 ~~~~~~-----~~~~~~~~GT~~Y~APE~l~~~~----~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~~~~  262 (604)
                      ......     .......+|||.|||||.+.++.    .+.+.|||||||+||.|+.|+.||-+....+....|.... .
T Consensus       258 ~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~KIvn~p-L  336 (576)
T KOG0585|consen  258 NEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELFDKIVNDP-L  336 (576)
T ss_pred             eecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHHHHHhcCc-c
Confidence            655221     12223368999999999997633    3467899999999999999999999999888888775543 2


Q ss_pred             CCC--ccchHHHHHHHHHHhccCCCCCCCHHHHhcChhhhhh
Q psy1546         263 QLT--GNYTKQFKEFVEACLNKDPENRPTAKELLKFPFIRKA  302 (604)
Q Consensus       263 ~~~--~~~s~~l~~Li~~~L~~dP~~RpT~~elL~hp~f~~~  302 (604)
                      .++  +.+.+.+++||.+||.+||++|+++.+|..|||....
T Consensus       337 ~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~  378 (576)
T KOG0585|consen  337 EFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRD  378 (576)
T ss_pred             cCCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccC
Confidence            233  2467899999999999999999999999999999654

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=5.2e-44  Score=376.53  Aligned_cols=241  Identities=27%  Similarity=0.497  Sum_probs=211.7

Q ss_pred             ceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhh--HHHHHHHHHHHHHHhhCCCCCCCe----------EEEEEEe
Q psy1546          59 FTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA--EDEIEDIQQEIMVLSQCDSPYGTK----------LWIIMEY  126 (604)
Q Consensus        59 y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~--~~~~~~l~~Ei~iL~~l~hp~~~~----------lyLVmEy  126 (604)
                      |.+.+.||+|+||.||+|++..+++.||||++.....  ....+.+.+|+.+++.+.||++.+          +|+||||
T Consensus        20 y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~   99 (329)
T PTZ00263         20 FEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLEF   99 (329)
T ss_pred             eEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEEcC
Confidence            8999999999999999999999999999999975532  234567889999999999999655          4799999


Q ss_pred             cCCCChhhHhhc-CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCCCCcccc
Q psy1546         127 LGGGSALDLMKA-GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFV  205 (604)
Q Consensus       127 ~~ggsL~~~l~~-~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~~~~~~  205 (604)
                      +.+|+|.+++.. +.+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.....   ....+
T Consensus       100 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~---~~~~~  176 (329)
T PTZ00263        100 VVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR---TFTLC  176 (329)
T ss_pred             CCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcCCC---cceec
Confidence            999999998865 67899999999999999999999999999999999999999999999999999765432   23568


Q ss_pred             cCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCCCCCCCCccchHHHHHHHHHHhccCCC
Q psy1546         206 GTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPE  285 (604)
Q Consensus       206 GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~~L~~dP~  285 (604)
                      ||+.|+|||++.+..++.++|||||||+||+|++|..||.+.........+.... ..++..++..+++||.+||..||.
T Consensus       177 gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~-~~~p~~~~~~~~~li~~~L~~dP~  255 (329)
T PTZ00263        177 GTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGR-LKFPNWFDGRARDLVKGLLQTDHT  255 (329)
T ss_pred             CChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcCC-cCCCCCCCHHHHHHHHHHhhcCHH
Confidence            9999999999999999999999999999999999999999887776666554443 345667889999999999999999


Q ss_pred             CCCC-----HHHHhcChhhhhhh
Q psy1546         286 NRPT-----AKELLKFPFIRKAK  303 (604)
Q Consensus       286 ~RpT-----~~elL~hp~f~~~~  303 (604)
                      +|++     +++|+.||||++..
T Consensus       256 ~R~~~~~~~~~~ll~hp~f~~~~  278 (329)
T PTZ00263        256 KRLGTLKGGVADVKNHPYFHGAN  278 (329)
T ss_pred             HcCCCCCCCHHHHhcCCccCCCC
Confidence            9986     89999999997643

>KOG0663|consensus

Probab=100.00  E-value=6e-45  Score=366.44  Aligned_cols=243  Identities=30%  Similarity=0.482  Sum_probs=208.8

Q ss_pred             ceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHH-HHHHHHHHHHhhCCCCCCCe------------EEEEEE
Q psy1546          59 FTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEI-EDIQQEIMVLSQCDSPYGTK------------LWIIME  125 (604)
Q Consensus        59 y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~-~~l~~Ei~iL~~l~hp~~~~------------lyLVmE  125 (604)
                      |..+.+|++|+||.||+|+|+.|++.||+|.++.+....-+ -.-.|||.+|.+++|||++.            +|||||
T Consensus        78 fe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VMe  157 (419)
T KOG0663|consen   78 FEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIVME  157 (419)
T ss_pred             HHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeeeHH
Confidence            89999999999999999999999999999999876533221 23469999999999999654            599999


Q ss_pred             ecCCCChhhHhhc--CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCCCCcc
Q psy1546         126 YLGGGSALDLMKA--GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNT  203 (604)
Q Consensus       126 y~~ggsL~~~l~~--~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~~~~  203 (604)
                      ||+. +|..+|..  .+|...+++.++.|++.||+|||.+.|+|||||++|+|++..|.+||+|||+|+.+..+......
T Consensus       158 ~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~k~~T~  236 (419)
T KOG0663|consen  158 YVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREYGSPLKPYTP  236 (419)
T ss_pred             HHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhhhcCCcccCcc
Confidence            9965 57777754  58999999999999999999999999999999999999999999999999999999988877888


Q ss_pred             cccCCCCCChHHhhcC-CCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCCC-------CC-------------
Q psy1546         204 FVGTPFWMAPEVIKQS-AYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNN-------PP-------------  262 (604)
Q Consensus       204 ~~GT~~Y~APE~l~~~-~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~~-------~~-------------  262 (604)
                      .+-|.+|+|||++.+. .|+.++|+||+|||+.||+++.+.|.+....+.+..|....       ++             
T Consensus       237 lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~~k~~~f  316 (419)
T KOG0663|consen  237 LVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPAVKKMTF  316 (419)
T ss_pred             eEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccchhhcccc
Confidence            8999999999999875 59999999999999999999999999988776665442110       00             


Q ss_pred             ----------CCCc-cchHHHHHHHHHHhccCCCCCCCHHHHhcChhhhhh
Q psy1546         263 ----------QLTG-NYTKQFKEFVEACLNKDPENRPTAKELLKFPFIRKA  302 (604)
Q Consensus       263 ----------~~~~-~~s~~l~~Li~~~L~~dP~~RpT~~elL~hp~f~~~  302 (604)
                                .+.. .+++...+|+..+|.+||.+|.|+.|.|+|.||...
T Consensus       317 ~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~  367 (419)
T KOG0663|consen  317 SEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRET  367 (419)
T ss_pred             CCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccC
Confidence                      0011 145778899999999999999999999999999753

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1e-43  Score=367.30  Aligned_cols=242  Identities=27%  Similarity=0.486  Sum_probs=210.7

Q ss_pred             cceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhh--HHHHHHHHHHHHHHhhCCCCCCC----------eEEEEEE
Q psy1546          58 IFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA--EDEIEDIQQEIMVLSQCDSPYGT----------KLWIIME  125 (604)
Q Consensus        58 ~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~--~~~~~~l~~Ei~iL~~l~hp~~~----------~lyLVmE  125 (604)
                      .|.+.+.||+|+||.||+|.+..+++.||||++.....  ....+.+.+|+.+++.+.||++.          .+|+|||
T Consensus         2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   81 (291)
T cd05612           2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLME   81 (291)
T ss_pred             CceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEe
Confidence            38889999999999999999999999999999965432  23456788999999999999854          4689999


Q ss_pred             ecCCCChhhHhhc-CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCCCCccc
Q psy1546         126 YLGGGSALDLMKA-GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTF  204 (604)
Q Consensus       126 y~~ggsL~~~l~~-~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~~~~~  204 (604)
                      |+.+|+|.+++.. +.+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.+...   ....
T Consensus        82 ~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~---~~~~  158 (291)
T cd05612          82 YVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR---TWTL  158 (291)
T ss_pred             CCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccCC---cccc
Confidence            9999999998865 67999999999999999999999999999999999999999999999999999765432   2346


Q ss_pred             ccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCCCCCCCCccchHHHHHHHHHHhccCC
Q psy1546         205 VGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDP  284 (604)
Q Consensus       205 ~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~~L~~dP  284 (604)
                      +||+.|+|||++.+..++.++|||||||+||+|++|..||...........+.... ..++..++..+++||.+||..||
T Consensus       159 ~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~li~~~l~~dp  237 (291)
T cd05612         159 CGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGK-LEFPRHLDLYAKDLIKKLLVVDR  237 (291)
T ss_pred             cCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-cCCCccCCHHHHHHHHHHcCCCH
Confidence            79999999999999999999999999999999999999999887766665554433 34556778999999999999999


Q ss_pred             CCCCC-----HHHHhcChhhhhhh
Q psy1546         285 ENRPT-----AKELLKFPFIRKAK  303 (604)
Q Consensus       285 ~~RpT-----~~elL~hp~f~~~~  303 (604)
                      .+|++     ++++++||||....
T Consensus       238 ~~R~~~~~~~~~~~l~h~~~~~~~  261 (291)
T cd05612         238 TRRLGNMKNGADDVKNHRWFKSVD  261 (291)
T ss_pred             HHccCCccCCHHHHhcCccccCCC
Confidence            99995     99999999997643

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=1.5e-43  Score=371.97  Aligned_cols=244  Identities=29%  Similarity=0.487  Sum_probs=210.1

Q ss_pred             ceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhh--HHHHHHHHHHHHHH---hhCCCCCCCe----------EEEE
Q psy1546          59 FTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA--EDEIEDIQQEIMVL---SQCDSPYGTK----------LWII  123 (604)
Q Consensus        59 y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~--~~~~~~l~~Ei~iL---~~l~hp~~~~----------lyLV  123 (604)
                      |.+.+.||+|+||.||+|.+..+++.||||++.....  ....+.+.+|+.++   +.+.||++.+          +|+|
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv   80 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV   80 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence            6788999999999999999999999999999975532  23345666666554   5678998554          5899


Q ss_pred             EEecCCCChhhHhhcCCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCCCCcc
Q psy1546         124 MEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNT  203 (604)
Q Consensus       124 mEy~~ggsL~~~l~~~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~~~~  203 (604)
                      |||+++++|..++..+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...........
T Consensus        81 ~E~~~~~~L~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~  160 (324)
T cd05589          81 MEYAAGGDLMMHIHTDVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTST  160 (324)
T ss_pred             EcCCCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCCCCcccc
Confidence            99999999999998889999999999999999999999999999999999999999999999999998754433444456


Q ss_pred             cccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCCCCCCCCccchHHHHHHHHHHhccC
Q psy1546         204 FVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKD  283 (604)
Q Consensus       204 ~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~~L~~d  283 (604)
                      .+||+.|||||++.+..++.++|||||||+||+|++|..||.+.........+.... ..++..++..+.+||.+||..|
T Consensus       161 ~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~-~~~p~~~~~~~~~li~~~L~~d  239 (324)
T cd05589         161 FCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDE-VRYPRFLSREAISIMRRLLRRN  239 (324)
T ss_pred             cccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-CCCCCCCCHHHHHHHHHHhhcC
Confidence            789999999999999999999999999999999999999999887766665554433 2355678999999999999999


Q ss_pred             CCCCC-----CHHHHhcChhhhhhh
Q psy1546         284 PENRP-----TAKELLKFPFIRKAK  303 (604)
Q Consensus       284 P~~Rp-----T~~elL~hp~f~~~~  303 (604)
                      |.+||     ++.++++||||+...
T Consensus       240 P~~R~~~~~~~~~~l~~~~~f~~~~  264 (324)
T cd05589         240 PERRLGSGEKDAEDVKKQPFFRDIN  264 (324)
T ss_pred             HhHcCCCCCCCHHHHhhCCCcCCCC
Confidence            99999     799999999997653

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1e-43  Score=371.10  Aligned_cols=237  Identities=30%  Similarity=0.541  Sum_probs=206.2

Q ss_pred             EcccCcEEEEEEEECCCCcEEEEEEecchh--hHHHHHHHHHHHHHHhhCCCCCCCe----------EEEEEEecCCCCh
Q psy1546          65 IGKGSFGEVFKGIDNRTQQVVAIKIIDLEE--AEDEIEDIQQEIMVLSQCDSPYGTK----------LWIIMEYLGGGSA  132 (604)
Q Consensus        65 LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~--~~~~~~~l~~Ei~iL~~l~hp~~~~----------lyLVmEy~~ggsL  132 (604)
                      ||+|+||.||+|.+..+++.||||++....  .......+.+|+.++.+++||++.+          +|+||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L   80 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL   80 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence            699999999999999999999999996543  2334567789999999999998554          4799999999999


Q ss_pred             hhHhhc-CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCCCCcccccCCCCC
Q psy1546         133 LDLMKA-GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWM  211 (604)
Q Consensus       133 ~~~l~~-~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~~~~~~GT~~Y~  211 (604)
                      .+++.. +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++............+||+.|+
T Consensus        81 ~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~  160 (312)
T cd05585          81 FHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYL  160 (312)
T ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCCccccccCCcccC
Confidence            998854 6799999999999999999999999999999999999999999999999999976543334445678999999


Q ss_pred             ChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCCCCCCCCccchHHHHHHHHHHhccCCCCCC---
Q psy1546         212 APEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPENRP---  288 (604)
Q Consensus       212 APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rp---  288 (604)
                      |||++.+..++.++|||||||++|+|++|..||...........+... ...++..++..+.+||.+||..||.+||   
T Consensus       161 aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~L~~dp~~R~~~~  239 (312)
T cd05585         161 APELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQE-PLRFPDGFDRDAKDLLIGLLSRDPTRRLGYN  239 (312)
T ss_pred             CHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcC-CCCCCCcCCHHHHHHHHHHcCCCHHHcCCCC
Confidence            999999999999999999999999999999999887776665554433 3456677899999999999999999997   


Q ss_pred             CHHHHhcChhhhhh
Q psy1546         289 TAKELLKFPFIRKA  302 (604)
Q Consensus       289 T~~elL~hp~f~~~  302 (604)
                      ++.|+|.||||.+.
T Consensus       240 ~~~e~l~hp~~~~~  253 (312)
T cd05585         240 GAQEIKNHPFFSQL  253 (312)
T ss_pred             CHHHHHcCCCcCCC
Confidence            58999999999764

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=1.9e-43  Score=372.22  Aligned_cols=240  Identities=30%  Similarity=0.502  Sum_probs=207.8

Q ss_pred             eEEcccCcEEEEEEEECCCCcEEEEEEecchhh--HHHHHHHHHHHHHHhhCCCCCCCe----------EEEEEEecCCC
Q psy1546          63 ERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA--EDEIEDIQQEIMVLSQCDSPYGTK----------LWIIMEYLGGG  130 (604)
Q Consensus        63 ~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~--~~~~~~l~~Ei~iL~~l~hp~~~~----------lyLVmEy~~gg  130 (604)
                      +.||+|+||.||+|.+..+++.||||++.....  ......+.+|+.+++.+.||++.+          +||||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g   80 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG   80 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence            469999999999999999999999999975432  334567889999999999998654          47999999999


Q ss_pred             ChhhHhhc-CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCCCCcccccCCC
Q psy1546         131 SALDLMKA-GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPF  209 (604)
Q Consensus       131 sL~~~l~~-~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~~~~~~GT~~  209 (604)
                      +|..++.. +.+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++............+||+.
T Consensus        81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~  160 (328)
T cd05593          81 ELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTPE  160 (328)
T ss_pred             CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCcccccccccCCcC
Confidence            99988854 57999999999999999999999999999999999999999999999999999754433333445689999


Q ss_pred             CCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCCCCCCCCccchHHHHHHHHHHhccCCCCCC-
Q psy1546         210 WMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPENRP-  288 (604)
Q Consensus       210 Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rp-  288 (604)
                      |+|||++.+..++.++|||||||+||+|++|..||...+.......+... ...++..++.++.+||.+||..||.+|+ 
T Consensus       161 y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~-~~~~p~~~~~~~~~li~~~L~~dP~~R~~  239 (328)
T cd05593         161 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME-DIKFPRTLSADAKSLLSGLLIKDPNKRLG  239 (328)
T ss_pred             ccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccC-CccCCCCCCHHHHHHHHHHcCCCHHHcCC
Confidence            99999999999999999999999999999999999887776665554433 3356677899999999999999999997 


Q ss_pred             ----CHHHHhcChhhhhhh
Q psy1546         289 ----TAKELLKFPFIRKAK  303 (604)
Q Consensus       289 ----T~~elL~hp~f~~~~  303 (604)
                          ++.|+++||||....
T Consensus       240 ~~~~~~~~il~h~~~~~~~  258 (328)
T cd05593         240 GGPDDAKEIMRHSFFTGVN  258 (328)
T ss_pred             CCCCCHHHHhcCCCcCCCC
Confidence                899999999997643

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>KOG0192|consensus

Probab=100.00  E-value=2.1e-43  Score=374.69  Aligned_cols=235  Identities=32%  Similarity=0.550  Sum_probs=205.7

Q ss_pred             ceeeeEEcccCcEEEEEEEECCCCcE-EEEEEecchhhH-HHHHHHHHHHHHHhhCCCCCCCe-----------EEEEEE
Q psy1546          59 FTKQERIGKGSFGEVFKGIDNRTQQV-VAIKIIDLEEAE-DEIEDIQQEIMVLSQCDSPYGTK-----------LWIIME  125 (604)
Q Consensus        59 y~i~~~LG~G~fG~Vy~a~~~~t~~~-vAVK~i~~~~~~-~~~~~l~~Ei~iL~~l~hp~~~~-----------lyLVmE  125 (604)
                      +.+.+.||.|+||+||+|.+.  |+. ||||++...... ...+.+.+|+.+|.+++|||+++           ++||||
T Consensus        43 l~~~~~iG~G~~g~V~~~~~~--g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtE  120 (362)
T KOG0192|consen   43 LPIEEVLGSGSFGTVYKGKWR--GTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTE  120 (362)
T ss_pred             hhhhhhcccCCceeEEEEEeC--CceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEE
Confidence            355567999999999999987  445 999999755432 22678999999999999999654           469999


Q ss_pred             ecCCCChhhHhhc---CCCcHHHHHHHHHHHHHHhHHhhhCC-ccccccccceeEecCCC-CeEEecccccccccCCCCC
Q psy1546         126 YLGGGSALDLMKA---GNFEEMHIAVILREVLKGLDYLHSER-KLHRDIKAANVLLSEMG-DVKLADFGVAGTLTNTTSK  200 (604)
Q Consensus       126 y~~ggsL~~~l~~---~~lse~~i~~i~~qIl~gL~yLHs~g-IiHrDLKp~NILl~~~g-~vKL~DFGlA~~~~~~~~~  200 (604)
                      |+++|+|.+++..   +.++...+..|+.||++||.|||+++ ||||||||+||||+.++ ++||+|||+++........
T Consensus       121 y~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~~~  200 (362)
T KOG0192|consen  121 YMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISKTS  200 (362)
T ss_pred             eCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCccceeecccccc
Confidence            9999999999954   78999999999999999999999999 99999999999999998 9999999999876654333


Q ss_pred             CcccccCCCCCChHHhh--cCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhc-CCCCCCCCCccchHHHHHHHH
Q psy1546         201 RNTFVGTPFWMAPEVIK--QSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLI-PKNNPPQLTGNYTKQFKEFVE  277 (604)
Q Consensus       201 ~~~~~GT~~Y~APE~l~--~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i-~~~~~~~~~~~~s~~l~~Li~  277 (604)
                      .....||+.|||||++.  ...|+.++||||||++||||+||..||.......+...+ ..+.++.++..+++.+..|+.
T Consensus       201 ~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~~p~~~~~~l~~l~~  280 (362)
T KOG0192|consen  201 MTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPPIPKECPPHLSSLME  280 (362)
T ss_pred             ccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCccCCHHHHHHHH
Confidence            44478999999999999  669999999999999999999999999999986666655 466677888889999999999


Q ss_pred             HHhccCCCCCCCHHHHhc
Q psy1546         278 ACLNKDPENRPTAKELLK  295 (604)
Q Consensus       278 ~~L~~dP~~RpT~~elL~  295 (604)
                      +||..||.+||++.+|+.
T Consensus       281 ~CW~~dp~~RP~f~ei~~  298 (362)
T KOG0192|consen  281 RCWLVDPSRRPSFLEIVS  298 (362)
T ss_pred             HhCCCCCCcCCCHHHHHH
Confidence            999999999999999976

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=3.7e-43  Score=361.83  Aligned_cols=245  Identities=24%  Similarity=0.387  Sum_probs=205.0

Q ss_pred             ceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhH--HHHHHHHHHHHHHhhCCCCCCCe----------EEEEEEe
Q psy1546          59 FTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAE--DEIEDIQQEIMVLSQCDSPYGTK----------LWIIMEY  126 (604)
Q Consensus        59 y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~--~~~~~l~~Ei~iL~~l~hp~~~~----------lyLVmEy  126 (604)
                      |.+.+.||+|+||.||+|.+..+++.||||++......  .....+.+|+.++..+.|+++..          +|+||||
T Consensus         2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~   81 (285)
T cd05631           2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence            78889999999999999999999999999998755432  22345778999999999998543          5799999


Q ss_pred             cCCCChhhHhhc---CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCCCCcc
Q psy1546         127 LGGGSALDLMKA---GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNT  203 (604)
Q Consensus       127 ~~ggsL~~~l~~---~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~~~~  203 (604)
                      +++|+|.+++..   ..+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++...... .....
T Consensus        82 ~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~-~~~~~  160 (285)
T cd05631          82 MNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEG-ETVRG  160 (285)
T ss_pred             cCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCC-CeecC
Confidence            999999887743   35899999999999999999999999999999999999999999999999999765322 22234


Q ss_pred             cccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhH---hhhcCCCCCCCCCccchHHHHHHHHHHh
Q psy1546         204 FVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRV---LFLIPKNNPPQLTGNYTKQFKEFVEACL  280 (604)
Q Consensus       204 ~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~---~~~i~~~~~~~~~~~~s~~l~~Li~~~L  280 (604)
                      ..||+.|||||++.+..++.++|||||||+||+|++|..||........   ...........++..++..+.+||.+||
T Consensus       161 ~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l  240 (285)
T cd05631         161 RVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKSICRMLL  240 (285)
T ss_pred             CCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccccCCccCCHHHHHHHHHHh
Confidence            5799999999999999999999999999999999999999987554221   1111122233455678999999999999


Q ss_pred             ccCCCCCCC-----HHHHhcChhhhhhhh
Q psy1546         281 NKDPENRPT-----AKELLKFPFIRKAKK  304 (604)
Q Consensus       281 ~~dP~~RpT-----~~elL~hp~f~~~~~  304 (604)
                      ..||.+||+     ++++++||||.....
T Consensus       241 ~~~P~~R~~~~~~~~~~~~~h~~~~~~~~  269 (285)
T cd05631         241 TKNPKERLGCRGNGAAGVKQHPIFKNINF  269 (285)
T ss_pred             hcCHHHhcCCCCCCHHHHhcCHhhcCCCH
Confidence            999999997     899999999977543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=2.2e-43  Score=370.84  Aligned_cols=240  Identities=30%  Similarity=0.497  Sum_probs=207.3

Q ss_pred             eEEcccCcEEEEEEEECCCCcEEEEEEecchhh--HHHHHHHHHHHHHHhhCCCCCCCe----------EEEEEEecCCC
Q psy1546          63 ERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA--EDEIEDIQQEIMVLSQCDSPYGTK----------LWIIMEYLGGG  130 (604)
Q Consensus        63 ~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~--~~~~~~l~~Ei~iL~~l~hp~~~~----------lyLVmEy~~gg  130 (604)
                      +.||+|+||.||+|.+..+++.||+|++.....  ......+.+|+.+++.+.||++.+          +||||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence            469999999999999999999999999976532  334567788999999999998654          47999999999


Q ss_pred             ChhhHhhc-CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCCCCcccccCCC
Q psy1546         131 SALDLMKA-GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPF  209 (604)
Q Consensus       131 sL~~~l~~-~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~~~~~~GT~~  209 (604)
                      +|..++.. +.+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++............+||+.
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~  160 (323)
T cd05595          81 ELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPE  160 (323)
T ss_pred             cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCCccccccCCcC
Confidence            99988855 57999999999999999999999999999999999999999999999999998754333333445689999


Q ss_pred             CCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCCCCCCCCccchHHHHHHHHHHhccCCCCCC-
Q psy1546         210 WMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPENRP-  288 (604)
Q Consensus       210 Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rp-  288 (604)
                      |+|||++.+..++.++|||||||+||||++|..||...+.......+.... ..++..+++++.+||.+||..||.+|+ 
T Consensus       161 y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~-~~~p~~~~~~~~~li~~~L~~dP~~R~~  239 (323)
T cd05595         161 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEE-IRFPRTLSPEAKSLLAGLLKKDPKQRLG  239 (323)
T ss_pred             cCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC-CCCCCCCCHHHHHHHHHHccCCHHHhCC
Confidence            999999999999999999999999999999999998877766555443322 345667899999999999999999998 


Q ss_pred             ----CHHHHhcChhhhhhh
Q psy1546         289 ----TAKELLKFPFIRKAK  303 (604)
Q Consensus       289 ----T~~elL~hp~f~~~~  303 (604)
                          ++.++++|+||.+..
T Consensus       240 ~~~~~~~~~l~h~~~~~~~  258 (323)
T cd05595         240 GGPSDAKEVMEHRFFLSIN  258 (323)
T ss_pred             CCCCCHHHHHcCCCcCCCC
Confidence                899999999998754

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=3.6e-43  Score=368.99  Aligned_cols=244  Identities=30%  Similarity=0.505  Sum_probs=210.4

Q ss_pred             ceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhh--HHHHHHHHHHHHHHhhCCCCC-C----------CeEEEEEE
Q psy1546          59 FTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA--EDEIEDIQQEIMVLSQCDSPY-G----------TKLWIIME  125 (604)
Q Consensus        59 y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~--~~~~~~l~~Ei~iL~~l~hp~-~----------~~lyLVmE  125 (604)
                      |.+.+.||+|+||.||+|.+..+++.||||++.....  ....+.+..|+.++..+.|++ +          ..+|+|||
T Consensus         2 y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E   81 (324)
T cd05587           2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVME   81 (324)
T ss_pred             ceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEEc
Confidence            7899999999999999999999999999999976432  234567788999999998764 2          34589999


Q ss_pred             ecCCCChhhHhhc-CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCCCCccc
Q psy1546         126 YLGGGSALDLMKA-GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTF  204 (604)
Q Consensus       126 y~~ggsL~~~l~~-~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~~~~~  204 (604)
                      |+++|+|.+++.. +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++............
T Consensus        82 ~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~  161 (324)
T cd05587          82 YVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTF  161 (324)
T ss_pred             CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCCCceeee
Confidence            9999999998854 678999999999999999999999999999999999999999999999999986543333334456


Q ss_pred             ccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCCCCCCCCccchHHHHHHHHHHhccCC
Q psy1546         205 VGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDP  284 (604)
Q Consensus       205 ~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~~L~~dP  284 (604)
                      +||+.|+|||++.+..++.++|||||||++|+|++|..||...........+.... ..++..++.++.+||.+||..||
T Consensus       162 ~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~li~~~l~~~P  240 (324)
T cd05587         162 CGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHN-VSYPKSLSKEAVSICKGLLTKHP  240 (324)
T ss_pred             cCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC-CCCCCCCCHHHHHHHHHHhhcCH
Confidence            89999999999999999999999999999999999999999888776666554433 34566789999999999999999


Q ss_pred             CCCCCH-----HHHhcChhhhhhh
Q psy1546         285 ENRPTA-----KELLKFPFIRKAK  303 (604)
Q Consensus       285 ~~RpT~-----~elL~hp~f~~~~  303 (604)
                      .+|++.     +++++||||....
T Consensus       241 ~~R~~~~~~~~~~~~~hp~~~~~~  264 (324)
T cd05587         241 AKRLGCGPTGERDIREHAFFRRID  264 (324)
T ss_pred             HHcCCCCCCCHHHHhcCCCcCCCC
Confidence            999976     8999999997653

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>KOG0690|consensus

Probab=100.00  E-value=3.6e-44  Score=358.84  Aligned_cols=246  Identities=30%  Similarity=0.509  Sum_probs=223.9

Q ss_pred             ceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhh--HHHHHHHHHHHHHHhhCCCCC----------CCeEEEEEEe
Q psy1546          59 FTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA--EDEIEDIQQEIMVLSQCDSPY----------GTKLWIIMEY  126 (604)
Q Consensus        59 y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~--~~~~~~l~~Ei~iL~~l~hp~----------~~~lyLVmEy  126 (604)
                      |..+++||+|.||+|.+|+.+.+++.||||+++++..  .+++..-..|-.+|+.++||+          ..++|+||||
T Consensus       170 FdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVMey  249 (516)
T KOG0690|consen  170 FDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVMEY  249 (516)
T ss_pred             hhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEEEE
Confidence            8889999999999999999999999999999987643  456677788999999999996          5678999999


Q ss_pred             cCCCChhhHhhc-CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCCCCcccc
Q psy1546         127 LGGGSALDLMKA-GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFV  205 (604)
Q Consensus       127 ~~ggsL~~~l~~-~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~~~~~~  205 (604)
                      ..||.|...+.+ ..|++...+.+...|+.||.|||+++||+||||.+|+|++.+|++||+|||+++.-........++|
T Consensus       250 anGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~g~t~kTFC  329 (516)
T KOG0690|consen  250 ANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIKYGDTTKTFC  329 (516)
T ss_pred             ccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchhcccccceecccc
Confidence            999999887754 6799999999999999999999999999999999999999999999999999987776777788999


Q ss_pred             cCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCCCCCCCCccchHHHHHHHHHHhccCCC
Q psy1546         206 GTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPE  285 (604)
Q Consensus       206 GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~~L~~dP~  285 (604)
                      |||.|+|||++....|+.++|+|.+||++|||++|++||+..+...+...|... ...++..++++++.|+..+|.+||.
T Consensus       330 GTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~e-d~kFPr~ls~eAktLLsGLL~kdP~  408 (516)
T KOG0690|consen  330 GTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILME-DLKFPRTLSPEAKTLLSGLLKKDPK  408 (516)
T ss_pred             CChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhh-hccCCccCCHHHHHHHHHHhhcChH
Confidence            999999999999999999999999999999999999999999988877776543 3467788999999999999999999


Q ss_pred             CCC-----CHHHHhcChhhhhhhhh
Q psy1546         286 NRP-----TAKELLKFPFIRKAKKN  305 (604)
Q Consensus       286 ~Rp-----T~~elL~hp~f~~~~~~  305 (604)
                      +|.     .+.||.+|+||....+.
T Consensus       409 kRLGgGpdDakEi~~h~FF~~v~W~  433 (516)
T KOG0690|consen  409 KRLGGGPDDAKEIMRHRFFASVDWE  433 (516)
T ss_pred             hhcCCCchhHHHHHhhhhhccCCHH
Confidence            995     49999999999876554

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=4.8e-43  Score=358.37  Aligned_cols=263  Identities=83%  Similarity=1.282  Sum_probs=231.1

Q ss_pred             cccceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCC----------eEEEEEE
Q psy1546          56 ELIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGT----------KLWIIME  125 (604)
Q Consensus        56 ~~~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~----------~lyLVmE  125 (604)
                      ...|...+.||+|+||.||+|.+..+++.||||++.........+.+.+|+.+++.++|+++.          .+|+|||
T Consensus         3 ~~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (277)
T cd06642           3 EELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIME   82 (277)
T ss_pred             HHHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEE
Confidence            345888899999999999999999999999999987665555667889999999999999743          4689999


Q ss_pred             ecCCCChhhHhhcCCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCCCCcccc
Q psy1546         126 YLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFV  205 (604)
Q Consensus       126 y~~ggsL~~~l~~~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~~~~~~  205 (604)
                      |+++++|.+++..+.+++..+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++..+...........
T Consensus        83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~  162 (277)
T cd06642          83 YLGGGSALDLLKPGPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV  162 (277)
T ss_pred             ccCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCcchhhhccc
Confidence            99999999999888899999999999999999999999999999999999999999999999999976654443344567


Q ss_pred             cCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCCCCCCCCccchHHHHHHHHHHhccCCC
Q psy1546         206 GTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPE  285 (604)
Q Consensus       206 GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~~L~~dP~  285 (604)
                      |+..|+|||++.+..++.++|||||||++|||++|..||...........+.....+.+...++..+.++|.+||..+|.
T Consensus       163 ~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~  242 (277)
T cd06642         163 GTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTLEGQYSKPFKEFVEACLNKDPR  242 (277)
T ss_pred             CcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcCCCCCCCcccCHHHHHHHHHHccCCcc
Confidence            89999999999998999999999999999999999999988777666666666666666677889999999999999999


Q ss_pred             CCCCHHHHhcChhhhhhhhh-hhHHHHHHHHHHH
Q psy1546         286 NRPTAKELLKFPFIRKAKKN-AYLIDLIDRYKKW  318 (604)
Q Consensus       286 ~RpT~~elL~hp~f~~~~~~-~~l~~~~~~~~~~  318 (604)
                      +||++.++++||||...... .++.+++.+|++|
T Consensus       243 ~Rp~~~~il~~~~~~~~~~~~~~~~~~~~~~~~~  276 (277)
T cd06642         243 FRPTAKELLKHKFITRYTKKTSFLTELIDRYKRW  276 (277)
T ss_pred             cCcCHHHHHHhHHHHHHhhhHHHHHHHHHHhhcc
Confidence            99999999999999877654 5667888888776

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=8.7e-43  Score=356.78  Aligned_cols=264  Identities=83%  Similarity=1.299  Sum_probs=233.4

Q ss_pred             cccceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCC----------eEEEEEE
Q psy1546          56 ELIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGT----------KLWIIME  125 (604)
Q Consensus        56 ~~~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~----------~lyLVmE  125 (604)
                      +..|...++||.|+||.||+|.+..++..||||++...........+.+|+.+++.+.|+++.          .+|+|||
T Consensus         3 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (277)
T cd06640           3 EELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIME   82 (277)
T ss_pred             HHhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEe
Confidence            445888999999999999999999999999999997665556678899999999999999854          4589999


Q ss_pred             ecCCCChhhHhhcCCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCCCCcccc
Q psy1546         126 YLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFV  205 (604)
Q Consensus       126 y~~ggsL~~~l~~~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~~~~~~  205 (604)
                      |+++++|.+++..+.+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++..+...........
T Consensus        83 ~~~~~~L~~~i~~~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~  162 (277)
T cd06640          83 YLGGGSALDLLRAGPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV  162 (277)
T ss_pred             cCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCCcccccccc
Confidence            99999999999988999999999999999999999999999999999999999999999999999976654443344557


Q ss_pred             cCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCCCCCCCCccchHHHHHHHHHHhccCCC
Q psy1546         206 GTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPE  285 (604)
Q Consensus       206 GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~~L~~dP~  285 (604)
                      ++..|+|||++.+..++.++|||||||++|||++|..||...........+.....+.+...++..+.+|+.+||..+|+
T Consensus       163 ~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~  242 (277)
T cd06640         163 GTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPTLTGEFSKPFKEFIDACLNKDPS  242 (277)
T ss_pred             CcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhcCCCCCCchhhhHHHHHHHHHHcccCcc
Confidence            89999999999988899999999999999999999999998877776666666666677778899999999999999999


Q ss_pred             CCCCHHHHhcChhhhhhhh-hhhHHHHHHHHHHHh
Q psy1546         286 NRPTAKELLKFPFIRKAKK-NAYLIDLIDRYKKWK  319 (604)
Q Consensus       286 ~RpT~~elL~hp~f~~~~~-~~~l~~~~~~~~~~~  319 (604)
                      +||++.++++|+||..... ..++.+.++++++|+
T Consensus       243 ~Rp~~~~il~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (277)
T cd06640         243 FRPTAKELLKHKFIVKNAKKTSYLTELIDRFKRWK  277 (277)
T ss_pred             cCcCHHHHHhChHhhhcchhhhHHHHHHHHHHhcC
Confidence            9999999999999976654 567778889998874

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-42  Score=354.93  Aligned_cols=262  Identities=78%  Similarity=1.211  Sum_probs=233.0

Q ss_pred             cceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCCe----------EEEEEEec
Q psy1546          58 IFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTK----------LWIIMEYL  127 (604)
Q Consensus        58 ~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~~----------lyLVmEy~  127 (604)
                      .|.+.+.||.|+||.||+|.+..+++.||+|++...........+.+|+.+++.+.|+++.+          +|+|+||+
T Consensus         2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~   81 (274)
T cd06609           2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYC   81 (274)
T ss_pred             hhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEee
Confidence            37888999999999999999999999999999976654555677889999999999998543          57999999


Q ss_pred             CCCChhhHhhcCCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCCCCcccccC
Q psy1546         128 GGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGT  207 (604)
Q Consensus       128 ~ggsL~~~l~~~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~~~~~~GT  207 (604)
                      ++++|.+++..+.+++..+..++.||+.||.|||+++++||||+|+||+++.++.++|+|||+++.+...........|+
T Consensus        82 ~~~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~  161 (274)
T cd06609          82 GGGSCLDLLKPGKLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFVGT  161 (274)
T ss_pred             CCCcHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeecccccccccccCC
Confidence            99999999988899999999999999999999999999999999999999999999999999998776554445566789


Q ss_pred             CCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCCCCCCCCcc-chHHHHHHHHHHhccCCCC
Q psy1546         208 PFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGN-YTKQFKEFVEACLNKDPEN  286 (604)
Q Consensus       208 ~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~-~s~~l~~Li~~~L~~dP~~  286 (604)
                      +.|+|||++.+..++.++|||||||++|+|++|..||...+.......+.....+.+... ++..+.+++.+||..||++
T Consensus       162 ~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~p~~  241 (274)
T cd06609         162 PFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPPSLEGNKFSKPFKDFVSLCLNKDPKE  241 (274)
T ss_pred             ccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcCCCCCcccccCHHHHHHHHHHhhCChhh
Confidence            999999999988899999999999999999999999988777766666666656555555 8899999999999999999


Q ss_pred             CCCHHHHhcChhhhhhhhhhhHHHHHHHHHHHh
Q psy1546         287 RPTAKELLKFPFIRKAKKNAYLIDLIDRYKKWK  319 (604)
Q Consensus       287 RpT~~elL~hp~f~~~~~~~~l~~~~~~~~~~~  319 (604)
                      |||++++++||||.+.....++..+...+++|+
T Consensus       242 Rpt~~~il~~~~~~~~~~~~~~~~~~~~~~~~~  274 (274)
T cd06609         242 RPSAKELLKHKFIKKAKKTSYLTLLIERIKKWK  274 (274)
T ss_pred             CcCHHHHhhChhhcCCCcccHHHHHHHHHHhcC
Confidence            999999999999999998888888888887763

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=3.7e-43  Score=362.37  Aligned_cols=240  Identities=26%  Similarity=0.448  Sum_probs=198.9

Q ss_pred             ceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCCe----------EEEEEEecC
Q psy1546          59 FTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTK----------LWIIMEYLG  128 (604)
Q Consensus        59 y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~~----------lyLVmEy~~  128 (604)
                      |.+.++||.|+||.||+|.+..+++.||+|++...........+.+|+.+++.++|||+.+          +|+||||++
T Consensus         7 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   86 (288)
T cd07871           7 YVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEYLD   86 (288)
T ss_pred             ceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeCCC
Confidence            8999999999999999999999999999999975543333456779999999999999655          479999997


Q ss_pred             CCChhhHhhc--CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCCCCccccc
Q psy1546         129 GGSALDLMKA--GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVG  206 (604)
Q Consensus       129 ggsL~~~l~~--~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~~~~~~G  206 (604)
                      + +|.+++..  ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.............|
T Consensus        87 ~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~~~~~~~~  165 (288)
T cd07871          87 S-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV  165 (288)
T ss_pred             c-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCCccccCcee
Confidence            5 88888754  34789999999999999999999999999999999999999999999999999765443333445678


Q ss_pred             CCCCCChHHhhc-CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCC---------------------CCC--
Q psy1546         207 TPFWMAPEVIKQ-SAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKN---------------------NPP--  262 (604)
Q Consensus       207 T~~Y~APE~l~~-~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~---------------------~~~--  262 (604)
                      ++.|+|||++.+ ..++.++|||||||++|+|++|.+||......+....+...                     ..+  
T Consensus       166 ~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (288)
T cd07871         166 TLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRSYLFPQY  245 (288)
T ss_pred             cccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhhccccCcc
Confidence            999999999875 56899999999999999999999999876654433221100                     000  


Q ss_pred             ------CCCccchHHHHHHHHHHhccCCCCCCCHHHHhcChhh
Q psy1546         263 ------QLTGNYTKQFKEFVEACLNKDPENRPTAKELLKFPFI  299 (604)
Q Consensus       263 ------~~~~~~s~~l~~Li~~~L~~dP~~RpT~~elL~hp~f  299 (604)
                            .....++.++++||.+||..||.+|||++|+|+||||
T Consensus       246 ~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f  288 (288)
T cd07871         246 RAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF  288 (288)
T ss_pred             CCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence                  0112457789999999999999999999999999998

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>KOG0610|consensus

Probab=100.00  E-value=1.9e-43  Score=364.48  Aligned_cols=247  Identities=30%  Similarity=0.429  Sum_probs=215.4

Q ss_pred             ceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhH--HHHHHHHHHHHHHhhCCCCCCCeE----------EEEEEe
Q psy1546          59 FTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAE--DEIEDIQQEIMVLSQCDSPYGTKL----------WIIMEY  126 (604)
Q Consensus        59 y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~--~~~~~l~~Ei~iL~~l~hp~~~~l----------yLVmEy  126 (604)
                      |+++++||.|.-|+||+|....++..+|+|++++....  +.+.+++.|-.||+.++||+...|          ||||||
T Consensus        79 f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~mey  158 (459)
T KOG0610|consen   79 FRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVMEY  158 (459)
T ss_pred             HHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEec
Confidence            88999999999999999999999999999999887654  446778899999999999985544          799999


Q ss_pred             cCCCChhhHhhc---CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccC-------
Q psy1546         127 LGGGSALDLMKA---GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTN-------  196 (604)
Q Consensus       127 ~~ggsL~~~l~~---~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~-------  196 (604)
                      |.||+|..+.++   +.|++..+++|+.+++.||+|||..|||+|||||+||||.++|+|.|+||.++.....       
T Consensus       159 CpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~~~~~~Pt~~~s  238 (459)
T KOG0610|consen  159 CPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSPTLVKS  238 (459)
T ss_pred             CCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeeccccccCCCCCeeecc
Confidence            999999998875   5699999999999999999999999999999999999999999999999998743210       


Q ss_pred             ----------------------------C---------------------CCCCcccccCCCCCChHHhhcCCCCCcchh
Q psy1546         197 ----------------------------T---------------------TSKRNTFVGTPFWMAPEVIKQSAYDSKADI  227 (604)
Q Consensus       197 ----------------------------~---------------------~~~~~~~~GT~~Y~APE~l~~~~~~~~sDV  227 (604)
                                                  .                     ......++||-.|.|||++.+...+.++|+
T Consensus       239 ~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHgsAVDW  318 (459)
T KOG0610|consen  239 SSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHGSAVDW  318 (459)
T ss_pred             CCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCCchhhH
Confidence                                        0                     011235789999999999999999999999


Q ss_pred             hhHHHHHHHHHhCCCCCCCCChhhHhhhcCCCCCCCC-CccchHHHHHHHHHHhccCCCCCCC----HHHHhcChhhhhh
Q psy1546         228 WSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQL-TGNYTKQFKEFVEACLNKDPENRPT----AKELLKFPFIRKA  302 (604)
Q Consensus       228 wSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~-~~~~s~~l~~Li~~~L~~dP~~RpT----~~elL~hp~f~~~  302 (604)
                      |+|||+|||||.|..||.+.+..+.+..|........ ...++..++|||+++|.+||.+|..    +.||-+||||+..
T Consensus       319 WtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~HpFF~gV  398 (459)
T KOG0610|consen  319 WTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKRHPFFEGV  398 (459)
T ss_pred             HHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCCCcchhHHHHHHHHHhccChhhhhccccchHHhhcCccccCC
Confidence            9999999999999999999999988888766543211 1256789999999999999999998    9999999999887


Q ss_pred             hhh
Q psy1546         303 KKN  305 (604)
Q Consensus       303 ~~~  305 (604)
                      .|.
T Consensus       399 nWa  401 (459)
T KOG0610|consen  399 NWA  401 (459)
T ss_pred             Chh
Confidence            653

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=7.5e-43  Score=372.61  Aligned_cols=246  Identities=30%  Similarity=0.466  Sum_probs=204.9

Q ss_pred             cceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhh--HHHHHHHHHHHHHHhhCCCCCCCe----------EEEEEE
Q psy1546          58 IFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA--EDEIEDIQQEIMVLSQCDSPYGTK----------LWIIME  125 (604)
Q Consensus        58 ~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~--~~~~~~l~~Ei~iL~~l~hp~~~~----------lyLVmE  125 (604)
                      .|++.+.||+|+||+||+|.+..+++.||||++.....  ......+.+|+.++..++|+++.+          +|||||
T Consensus         2 ~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~E   81 (363)
T cd05628           2 DFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIME   81 (363)
T ss_pred             CceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEEc
Confidence            48899999999999999999999999999999975432  233467889999999999998654          479999


Q ss_pred             ecCCCChhhHhhc-CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCC-----
Q psy1546         126 YLGGGSALDLMKA-GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTS-----  199 (604)
Q Consensus       126 y~~ggsL~~~l~~-~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~-----  199 (604)
                      ||+||+|.+++.. +.+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+++.+.....     
T Consensus        82 ~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~~~  161 (363)
T cd05628          82 FLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYR  161 (363)
T ss_pred             CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCcccccccccccccc
Confidence            9999999998854 6799999999999999999999999999999999999999999999999999975432110     


Q ss_pred             ------------------------------CCcccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCCh
Q psy1546         200 ------------------------------KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHP  249 (604)
Q Consensus       200 ------------------------------~~~~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~  249 (604)
                                                    .....+||+.|+|||++.+..++.++|||||||+||||++|..||.+...
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~~~~~  241 (363)
T cd05628         162 NLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETP  241 (363)
T ss_pred             cccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCCCCCH
Confidence                                          01245899999999999999999999999999999999999999998877


Q ss_pred             hhHhhhcCCCC-CCCCC--ccchHHHHHHHHHHhccCCC---CCCCHHHHhcChhhhhhhh
Q psy1546         250 MRVLFLIPKNN-PPQLT--GNYTKQFKEFVEACLNKDPE---NRPTAKELLKFPFIRKAKK  304 (604)
Q Consensus       250 ~~~~~~i~~~~-~~~~~--~~~s~~l~~Li~~~L~~dP~---~RpT~~elL~hp~f~~~~~  304 (604)
                      .+....+.... ...++  ..+++++++||.+|+. +|.   .||+++||++||||+...+
T Consensus       242 ~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~~hp~f~~~~~  301 (363)
T cd05628         242 QETYKKVMNWKETLIFPPEVPISEKAKDLILRFCC-EWEHRIGAPGVEEIKTNPFFEGVDW  301 (363)
T ss_pred             HHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhCCCCCCCCCH
Confidence            66655544321 11222  2468899999999775 444   4589999999999987543

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>KOG0032|consensus

Probab=100.00  E-value=3.4e-43  Score=375.89  Aligned_cols=248  Identities=31%  Similarity=0.546  Sum_probs=221.5

Q ss_pred             CccccceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHH--HHHHHHHHHHHHhhCC-CCCCCeE----------
Q psy1546          54 DPELIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAED--EIEDIQQEIMVLSQCD-SPYGTKL----------  120 (604)
Q Consensus        54 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~--~~~~l~~Ei~iL~~l~-hp~~~~l----------  120 (604)
                      +....|.+.+.||.|.||.||+|+++.+|+.||+|++.+.....  ..+.+.+|+.+|+++. |||++.+          
T Consensus        32 ~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~  111 (382)
T KOG0032|consen   32 DIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSV  111 (382)
T ss_pred             cccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeE
Confidence            34456999999999999999999999999999999997765533  3578999999999999 9996654          


Q ss_pred             EEEEEecCCCChhhHhhcCCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCC----CCeEEecccccccccC
Q psy1546         121 WIIMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEM----GDVKLADFGVAGTLTN  196 (604)
Q Consensus       121 yLVmEy~~ggsL~~~l~~~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~----g~vKL~DFGlA~~~~~  196 (604)
                      |+|||+|.||.|.+.+....+++.++..++.||+.+++|||+.||+||||||+|+|+...    +.+|++|||+|.....
T Consensus       112 ~lvmEL~~GGeLfd~i~~~~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~  191 (382)
T KOG0032|consen  112 YLVMELCEGGELFDRIVKKHYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKP  191 (382)
T ss_pred             EEEEEecCCchHHHHHHHccCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEccC
Confidence            799999999999998866469999999999999999999999999999999999999643    4799999999987765


Q ss_pred             CCCCCcccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCCCC---CCCCccchHHHH
Q psy1546         197 TTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNP---PQLTGNYTKQFK  273 (604)
Q Consensus       197 ~~~~~~~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~~~---~~~~~~~s~~l~  273 (604)
                       .....+.+||+.|+|||++....|+..+||||+||++|.|++|.+||.+.........+..+..   ...+..++..++
T Consensus       192 -~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~~w~~is~~ak  270 (382)
T KOG0032|consen  192 -GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTSEPWDDISESAK  270 (382)
T ss_pred             -CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCCCCccccCHHHH
Confidence             5567789999999999999999999999999999999999999999999998887777766643   345567899999


Q ss_pred             HHHHHHhccCCCCCCCHHHHhcChhhhhh
Q psy1546         274 EFVEACLNKDPENRPTAKELLKFPFIRKA  302 (604)
Q Consensus       274 ~Li~~~L~~dP~~RpT~~elL~hp~f~~~  302 (604)
                      +||.+||..||.+|+|+.++|+|||++..
T Consensus       271 d~i~~ll~~dp~~R~ta~~~L~HpWi~~~  299 (382)
T KOG0032|consen  271 DFIRKLLEFDPRKRLTAAQALQHPWIKSI  299 (382)
T ss_pred             HHHHHhcccCcccCCCHHHHhcCccccCC
Confidence            99999999999999999999999999864

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7e-43  Score=367.96  Aligned_cols=243  Identities=28%  Similarity=0.484  Sum_probs=208.5

Q ss_pred             cceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhh--HHHHHHHHHHHHHHhhCCCCCCCe----------EEEEEE
Q psy1546          58 IFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA--EDEIEDIQQEIMVLSQCDSPYGTK----------LWIIME  125 (604)
Q Consensus        58 ~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~--~~~~~~l~~Ei~iL~~l~hp~~~~----------lyLVmE  125 (604)
                      .|.+.++||+|+||.||+|.+..+++.||||++.....  ......+.+|+.++..+.||++.+          +|||||
T Consensus         2 ~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e   81 (333)
T cd05600           2 DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAME   81 (333)
T ss_pred             CcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEe
Confidence            38999999999999999999999999999999976532  234567889999999999998654          479999


Q ss_pred             ecCCCChhhHhhc-CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCCCCccc
Q psy1546         126 YLGGGSALDLMKA-GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTF  204 (604)
Q Consensus       126 y~~ggsL~~~l~~-~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~~~~~  204 (604)
                      |++||+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....   .....
T Consensus        82 ~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~---~~~~~  158 (333)
T cd05600          82 YVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT---YANSV  158 (333)
T ss_pred             CCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCccccc---ccCCc
Confidence            9999999999865 6789999999999999999999999999999999999999999999999999976543   33456


Q ss_pred             ccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCCC----CCCC---CccchHHHHHHHH
Q psy1546         205 VGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNN----PPQL---TGNYTKQFKEFVE  277 (604)
Q Consensus       205 ~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~~----~~~~---~~~~s~~l~~Li~  277 (604)
                      +||+.|+|||++.+..++.++|||||||+||||++|..||......+....+....    .+..   ...++.++.+||.
T Consensus       159 ~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~~~~li~  238 (333)
T cd05600         159 VGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAWDLIT  238 (333)
T ss_pred             ccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCCccccccCHHHHHHHH
Confidence            89999999999999999999999999999999999999999877665543332211    1111   1256889999999


Q ss_pred             HHhccCCCCCCCHHHHhcChhhhhhh
Q psy1546         278 ACLNKDPENRPTAKELLKFPFIRKAK  303 (604)
Q Consensus       278 ~~L~~dP~~RpT~~elL~hp~f~~~~  303 (604)
                      +||..+|.+||++.+|++||||....
T Consensus       239 ~~l~~~~~rr~s~~~ll~h~~~~~~~  264 (333)
T cd05600         239 KLINDPSRRFGSLEDIKNHPFFKEVD  264 (333)
T ss_pred             HHhhChhhhcCCHHHHHhCcccCCCC
Confidence            99999999999999999999998653

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=3.2e-43  Score=369.48  Aligned_cols=240  Identities=30%  Similarity=0.495  Sum_probs=206.8

Q ss_pred             eEEcccCcEEEEEEEECCCCcEEEEEEecchhh--HHHHHHHHHHHHHHhhCCCCCCCe----------EEEEEEecCCC
Q psy1546          63 ERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA--EDEIEDIQQEIMVLSQCDSPYGTK----------LWIIMEYLGGG  130 (604)
Q Consensus        63 ~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~--~~~~~~l~~Ei~iL~~l~hp~~~~----------lyLVmEy~~gg  130 (604)
                      +.||+|+||.||+|.+..+++.||+|++.....  ......+..|+.++..+.||++.+          +||||||+++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence            469999999999999999999999999976532  234566788999999999998654          47999999999


Q ss_pred             ChhhHhhc-CCCcHHHHHHHHHHHHHHhHHhhh-CCccccccccceeEecCCCCeEEecccccccccCCCCCCcccccCC
Q psy1546         131 SALDLMKA-GNFEEMHIAVILREVLKGLDYLHS-ERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTP  208 (604)
Q Consensus       131 sL~~~l~~-~~lse~~i~~i~~qIl~gL~yLHs-~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~~~~~~GT~  208 (604)
                      +|..++.. +.+++..+..++.||+.||.|||+ +||+||||||+||||+.++.+||+|||+++............+||+
T Consensus        81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~  160 (325)
T cd05594          81 ELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTP  160 (325)
T ss_pred             cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCcccccccCCc
Confidence            99988854 579999999999999999999997 7999999999999999999999999999875443333344567999


Q ss_pred             CCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCCCCCCCCccchHHHHHHHHHHhccCCCCCC
Q psy1546         209 FWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPENRP  288 (604)
Q Consensus       209 ~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rp  288 (604)
                      .|||||++.+..++.++|||||||+||+|++|..||...........+... ...++..+++++.+||.+||..||.+|+
T Consensus       161 ~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~-~~~~p~~~~~~~~~li~~~L~~dP~~R~  239 (325)
T cd05594         161 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME-EIRFPRTLSPEAKSLLSGLLKKDPKQRL  239 (325)
T ss_pred             ccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcC-CCCCCCCCCHHHHHHHHHHhhcCHHHhC
Confidence            999999999999999999999999999999999999887776655554332 3345667899999999999999999997


Q ss_pred             -----CHHHHhcChhhhhhh
Q psy1546         289 -----TAKELLKFPFIRKAK  303 (604)
Q Consensus       289 -----T~~elL~hp~f~~~~  303 (604)
                           ++.++++||||....
T Consensus       240 ~~~~~~~~~il~h~~~~~~~  259 (325)
T cd05594         240 GGGPDDAKEIMQHKFFAGIV  259 (325)
T ss_pred             CCCCCCHHHHhcCCCcCCCC
Confidence                 999999999997644

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=7.5e-43  Score=362.41  Aligned_cols=246  Identities=26%  Similarity=0.449  Sum_probs=198.3

Q ss_pred             ccceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCCe----------EEEEEEe
Q psy1546          57 LIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTK----------LWIIMEY  126 (604)
Q Consensus        57 ~~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~~----------lyLVmEy  126 (604)
                      +.|.+.++||+|+||.||+|.+..+++.||||++...........+.+|+.+++.+.|||+.+          +|+||||
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~   84 (303)
T cd07869           5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEY   84 (303)
T ss_pred             ccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEEC
Confidence            448999999999999999999999999999999975543333456778999999999999655          4799999


Q ss_pred             cCCCChhhHhhc--CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCCCCccc
Q psy1546         127 LGGGSALDLMKA--GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTF  204 (604)
Q Consensus       127 ~~ggsL~~~l~~--~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~~~~~  204 (604)
                      +. ++|.+++..  +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.............
T Consensus        85 ~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~  163 (303)
T cd07869          85 VH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNE  163 (303)
T ss_pred             CC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccCCCccCCCC
Confidence            95 567776654  568999999999999999999999999999999999999999999999999997554333334456


Q ss_pred             ccCCCCCChHHhhc-CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhH-hhhc----CCC--------------CCCC-
Q psy1546         205 VGTPFWMAPEVIKQ-SAYDSKADIWSLGITAIELAKGEPPNSELHPMRV-LFLI----PKN--------------NPPQ-  263 (604)
Q Consensus       205 ~GT~~Y~APE~l~~-~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~-~~~i----~~~--------------~~~~-  263 (604)
                      +||+.|+|||++.+ ..++.++|||||||+||+|++|..||.+...... ...+    ...              .+.. 
T Consensus       164 ~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (303)
T cd07869         164 VVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFKPERF  243 (303)
T ss_pred             cccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhccccccccc
Confidence            78999999999875 4588899999999999999999999987543211 1100    000              0000 


Q ss_pred             ---CC---------ccchHHHHHHHHHHhccCCCCCCCHHHHhcChhhhhhh
Q psy1546         264 ---LT---------GNYTKQFKEFVEACLNKDPENRPTAKELLKFPFIRKAK  303 (604)
Q Consensus       264 ---~~---------~~~s~~l~~Li~~~L~~dP~~RpT~~elL~hp~f~~~~  303 (604)
                         .+         ..++..+.+||.+||+.||.+|||+.|+|+||||+...
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~~  295 (303)
T cd07869         244 TLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDLP  295 (303)
T ss_pred             cccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccCC
Confidence               00         12356789999999999999999999999999998654

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=6.8e-43  Score=366.66  Aligned_cols=240  Identities=27%  Similarity=0.490  Sum_probs=206.4

Q ss_pred             eEEcccCcEEEEEEEECCCCcEEEEEEecchhh--HHHHHHHHHHHHHHhhC-CCCCCCe----------EEEEEEecCC
Q psy1546          63 ERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA--EDEIEDIQQEIMVLSQC-DSPYGTK----------LWIIMEYLGG  129 (604)
Q Consensus        63 ~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~--~~~~~~l~~Ei~iL~~l-~hp~~~~----------lyLVmEy~~g  129 (604)
                      +.||+|+||.||+|.++.+++.||||++.....  ......+..|+.++..+ .||++.+          +|+||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~   80 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG   80 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence            469999999999999999999999999975432  23456677888888766 6998554          5799999999


Q ss_pred             CChhhHhhc-CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCCCCcccccCC
Q psy1546         130 GSALDLMKA-GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTP  208 (604)
Q Consensus       130 gsL~~~l~~-~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~~~~~~GT~  208 (604)
                      |+|.+++.. +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++............+||+
T Consensus        81 g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~  160 (320)
T cd05590          81 GDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTP  160 (320)
T ss_pred             chHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCcccccccCc
Confidence            999998854 6799999999999999999999999999999999999999999999999999875443333445568999


Q ss_pred             CCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCCCCCCCCccchHHHHHHHHHHhccCCCCCC
Q psy1546         209 FWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPENRP  288 (604)
Q Consensus       209 ~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rp  288 (604)
                      .|+|||++.+..++.++|||||||++|+|++|..||...+.......+.... ..++..++.++.+||.+||..||.+||
T Consensus       161 ~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~li~~~L~~dP~~R~  239 (320)
T cd05590         161 DYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDE-VVYPTWLSQDAVDILKAFMTKNPTMRL  239 (320)
T ss_pred             cccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCC-CCCCCCCCHHHHHHHHHHcccCHHHCC
Confidence            9999999999999999999999999999999999999888777666654433 345567899999999999999999999


Q ss_pred             CH------HHHhcChhhhhhh
Q psy1546         289 TA------KELLKFPFIRKAK  303 (604)
Q Consensus       289 T~------~elL~hp~f~~~~  303 (604)
                      ++      +++++||||....
T Consensus       240 ~~~~~~~~~~~~~h~~f~~~~  260 (320)
T cd05590         240 GSLTLGGEEAILRHPFFKELD  260 (320)
T ss_pred             CCCCCCCHHHHHcCCCcCCCC
Confidence            98      9999999997653

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>KOG0580|consensus

Probab=100.00  E-value=2e-43  Score=342.06  Aligned_cols=246  Identities=27%  Similarity=0.476  Sum_probs=219.3

Q ss_pred             ccccCccccceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHH--HHHHHHHHHHHHhhCCCCCCC---------
Q psy1546          50 SLKVDPELIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAED--EIEDIQQEIMVLSQCDSPYGT---------  118 (604)
Q Consensus        50 ~~~~~~~~~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~--~~~~l~~Ei~iL~~l~hp~~~---------  118 (604)
                      .+.++.   |++++.||+|-||.||+|+.+.++-.||+|++.+.....  ....+.+|+.|-+.|+|||+.         
T Consensus        18 ~~~l~d---feigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~   94 (281)
T KOG0580|consen   18 TWTLDD---FEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDS   94 (281)
T ss_pred             ccchhh---ccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheecc
Confidence            344444   999999999999999999999999999999997765432  246788999999999999854         


Q ss_pred             -eEEEEEEecCCCChhhHhhc---CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccc
Q psy1546         119 -KLWIIMEYLGGGSALDLMKA---GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTL  194 (604)
Q Consensus       119 -~lyLVmEy~~ggsL~~~l~~---~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~  194 (604)
                       ++||++||...|.|...++.   .+|++...+.+++|++.||.|||.++||||||||+|+|++..|.+||+|||.+-. 
T Consensus        95 ~riyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~-  173 (281)
T KOG0580|consen   95 KRIYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSVH-  173 (281)
T ss_pred             ceeEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCceee-
Confidence             46899999999999998873   5699999999999999999999999999999999999999999999999999833 


Q ss_pred             cCCCCCCcccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCCCCCCCCccchHHHHH
Q psy1546         195 TNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKE  274 (604)
Q Consensus       195 ~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~  274 (604)
                       .+...+.+.|||..|.|||+..+..++..+|+|++|++.||++.|.+||......+....|.+.. ..++..++.+++|
T Consensus       174 -~p~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~-~~~p~~is~~a~d  251 (281)
T KOG0580|consen  174 -APSNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVD-LKFPSTISGGAAD  251 (281)
T ss_pred             -cCCCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHcc-ccCCcccChhHHH
Confidence             34677889999999999999999999999999999999999999999999988777776665443 3556889999999


Q ss_pred             HHHHHhccCCCCCCCHHHHhcChhhhh
Q psy1546         275 FVEACLNKDPENRPTAKELLKFPFIRK  301 (604)
Q Consensus       275 Li~~~L~~dP~~RpT~~elL~hp~f~~  301 (604)
                      ||.+||.++|.+|.+..|++.|||+.+
T Consensus       252 lI~~ll~~~p~~r~~l~~v~~hpwI~a  278 (281)
T KOG0580|consen  252 LISRLLVKNPIERLALTEVMDHPWIVA  278 (281)
T ss_pred             HHHHHhccCccccccHHHHhhhHHHHh
Confidence            999999999999999999999999965

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.2e-43  Score=371.63  Aligned_cols=245  Identities=30%  Similarity=0.517  Sum_probs=206.5

Q ss_pred             cceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhh--HHHHHHHHHHHHHHhhCCCCCCCe----------EEEEEE
Q psy1546          58 IFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA--EDEIEDIQQEIMVLSQCDSPYGTK----------LWIIME  125 (604)
Q Consensus        58 ~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~--~~~~~~l~~Ei~iL~~l~hp~~~~----------lyLVmE  125 (604)
                      .|.+.+.||+|+||+||+|++..+++.||||++.....  ......+.+|+.+|..++|+++.+          +|||||
T Consensus         2 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E   81 (364)
T cd05599           2 DFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIME   81 (364)
T ss_pred             CceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEEC
Confidence            38899999999999999999999999999999975432  234567889999999999998655          479999


Q ss_pred             ecCCCChhhHhhc-CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCC-----
Q psy1546         126 YLGGGSALDLMKA-GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTS-----  199 (604)
Q Consensus       126 y~~ggsL~~~l~~-~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~-----  199 (604)
                      ||.+|+|.+++.. +.+++..++.++.||+.||+|||++||+||||||+||||+.++.++|+|||+++.+.....     
T Consensus        82 ~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~  161 (364)
T cd05599          82 YLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYR  161 (364)
T ss_pred             CCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceeccccccccccc
Confidence            9999999998865 6799999999999999999999999999999999999999999999999999865432110     


Q ss_pred             ---------------------------------CCcccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCC
Q psy1546         200 ---------------------------------KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSE  246 (604)
Q Consensus       200 ---------------------------------~~~~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~  246 (604)
                                                       .....+||+.|+|||++.+..++.++|||||||++|||++|.+||..
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~Pf~~  241 (364)
T cd05599         162 ILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPFCS  241 (364)
T ss_pred             cccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCCCCCC
Confidence                                             11235799999999999999999999999999999999999999998


Q ss_pred             CChhhHhhhcCCCC-CCCC--CccchHHHHHHHHHHhccCCCCCCC---HHHHhcChhhhhhh
Q psy1546         247 LHPMRVLFLIPKNN-PPQL--TGNYTKQFKEFVEACLNKDPENRPT---AKELLKFPFIRKAK  303 (604)
Q Consensus       247 ~~~~~~~~~i~~~~-~~~~--~~~~s~~l~~Li~~~L~~dP~~RpT---~~elL~hp~f~~~~  303 (604)
                      .........+.... ...+  ...+++++++||.+||. +|.+|++   +.|++.||||+...
T Consensus       242 ~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~~~~~~~  303 (364)
T cd05599         242 DNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPFFKGVD  303 (364)
T ss_pred             CCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCCCcCCCC
Confidence            87766554443221 1112  22468899999999996 9999998   99999999998653

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=9.4e-43  Score=357.66  Aligned_cols=242  Identities=25%  Similarity=0.431  Sum_probs=200.4

Q ss_pred             cceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhh-HHHHHHHHHHHHHHhhCCCCCCCe----------EEEEEEe
Q psy1546          58 IFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA-EDEIEDIQQEIMVLSQCDSPYGTK----------LWIIMEY  126 (604)
Q Consensus        58 ~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~-~~~~~~l~~Ei~iL~~l~hp~~~~----------lyLVmEy  126 (604)
                      .|.+.+.||+|+||.||+|++..+++.||||++..... ....+.+.+|+.+++.++|+++.+          +|+||||
T Consensus         2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (287)
T cd07848           2 KFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEY   81 (287)
T ss_pred             CceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEec
Confidence            38899999999999999999999999999999865432 223467789999999999998543          5899999


Q ss_pred             cCCCChhhHhhc-CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCC-CCccc
Q psy1546         127 LGGGSALDLMKA-GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTS-KRNTF  204 (604)
Q Consensus       127 ~~ggsL~~~l~~-~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~-~~~~~  204 (604)
                      ++++.+..+... +.+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++..+..... .....
T Consensus        82 ~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  161 (287)
T cd07848          82 VEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEY  161 (287)
T ss_pred             CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCccccccccccccccc
Confidence            998877766543 5699999999999999999999999999999999999999999999999999976643222 22346


Q ss_pred             ccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCC---------------------CCC-
Q psy1546         205 VGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKN---------------------NPP-  262 (604)
Q Consensus       205 ~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~---------------------~~~-  262 (604)
                      .||+.|+|||++.+..++.++|||||||++|||++|++||...........+...                     ..+ 
T Consensus       162 ~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (287)
T cd07848         162 VATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLRFPA  241 (287)
T ss_pred             ccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhcccccCc
Confidence            7999999999999989999999999999999999999999876543332211100                     000 


Q ss_pred             ---------CCCccchHHHHHHHHHHhccCCCCCCCHHHHhcChhh
Q psy1546         263 ---------QLTGNYTKQFKEFVEACLNKDPENRPTAKELLKFPFI  299 (604)
Q Consensus       263 ---------~~~~~~s~~l~~Li~~~L~~dP~~RpT~~elL~hp~f  299 (604)
                               .....++..+.+||.+||..||.+|||++|+|+||||
T Consensus       242 ~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f  287 (287)
T cd07848         242 VNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF  287 (287)
T ss_pred             ccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence                     1112367889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=9.8e-43  Score=369.17  Aligned_cols=242  Identities=24%  Similarity=0.426  Sum_probs=209.3

Q ss_pred             cceeeeEEcccCcEEEEEEEECCCC-cEEEEEEecchhh--HHHHHHHHHHHHHHhhCCCCCCCe----------EEEEE
Q psy1546          58 IFTKQERIGKGSFGEVFKGIDNRTQ-QVVAIKIIDLEEA--EDEIEDIQQEIMVLSQCDSPYGTK----------LWIIM  124 (604)
Q Consensus        58 ~y~i~~~LG~G~fG~Vy~a~~~~t~-~~vAVK~i~~~~~--~~~~~~l~~Ei~iL~~l~hp~~~~----------lyLVm  124 (604)
                      .|.+.+.||+|+||.||+|.+..++ ..||||++.....  ......+.+|+.++..++||++.+          +|+||
T Consensus        31 ~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~  110 (340)
T PTZ00426         31 DFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVL  110 (340)
T ss_pred             hcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEEE
Confidence            3899999999999999999876654 6899999865432  234567889999999999999655          47999


Q ss_pred             EecCCCChhhHhhc-CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCCCCcc
Q psy1546         125 EYLGGGSALDLMKA-GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNT  203 (604)
Q Consensus       125 Ey~~ggsL~~~l~~-~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~~~~  203 (604)
                      ||+.+|+|.+++.. +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+..   ....
T Consensus       111 Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~---~~~~  187 (340)
T PTZ00426        111 EFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT---RTYT  187 (340)
T ss_pred             eCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCeecCC---Ccce
Confidence            99999999999865 6799999999999999999999999999999999999999999999999999976532   2235


Q ss_pred             cccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCCCCCCCCccchHHHHHHHHHHhccC
Q psy1546         204 FVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKD  283 (604)
Q Consensus       204 ~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~~L~~d  283 (604)
                      .+||+.|||||++.+..++.++|||||||+||||++|.+||...+.......+.... ..++..++..+.++|++||..|
T Consensus       188 ~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~~~~~~~li~~~l~~d  266 (340)
T PTZ00426        188 LCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGI-IYFPKFLDNNCKHLMKKLLSHD  266 (340)
T ss_pred             ecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCC-CCCCCCCCHHHHHHHHHHcccC
Confidence            689999999999999999999999999999999999999999887766555554433 3456678899999999999999


Q ss_pred             CCCCC-----CHHHHhcChhhhhhh
Q psy1546         284 PENRP-----TAKELLKFPFIRKAK  303 (604)
Q Consensus       284 P~~Rp-----T~~elL~hp~f~~~~  303 (604)
                      |.+|+     +++++++||||....
T Consensus       267 p~~R~~~~~~~~~~~~~hp~f~~~~  291 (340)
T PTZ00426        267 LTKRYGNLKKGAQNVKEHPWFGNID  291 (340)
T ss_pred             HHHcCCCCCCCHHHHHcCCCcCCCC
Confidence            99995     899999999997644

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=9.3e-43  Score=365.00  Aligned_cols=240  Identities=31%  Similarity=0.551  Sum_probs=203.9

Q ss_pred             eEEcccCcEEEEEEEECCCCcEEEEEEecchhh--HHHHHHHHHHHHHHhh-CCCCCCCe----------EEEEEEecCC
Q psy1546          63 ERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA--EDEIEDIQQEIMVLSQ-CDSPYGTK----------LWIIMEYLGG  129 (604)
Q Consensus        63 ~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~--~~~~~~l~~Ei~iL~~-l~hp~~~~----------lyLVmEy~~g  129 (604)
                      ++||+|+||.||+|.+..+++.||||++.....  ....+.+..|..++.. +.||++.+          +|+||||++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g   80 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            469999999999999999999999999976532  2234455666666654 58998654          4799999999


Q ss_pred             CChhhHhhc-CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCCCCcccccCC
Q psy1546         130 GSALDLMKA-GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTP  208 (604)
Q Consensus       130 gsL~~~l~~-~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~~~~~~GT~  208 (604)
                      |+|..++.. +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++............+||+
T Consensus        81 g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~gt~  160 (316)
T cd05592          81 GDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGTP  160 (316)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCccccccCCc
Confidence            999998864 6799999999999999999999999999999999999999999999999999976544444445678999


Q ss_pred             CCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCCCCCCCCccchHHHHHHHHHHhccCCCCCC
Q psy1546         209 FWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPENRP  288 (604)
Q Consensus       209 ~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rp  288 (604)
                      .|+|||++.+..++.++|||||||++|||++|..||.+.+..+....+.. ..+.++..++.++.+||.+||..||.+||
T Consensus       161 ~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~-~~~~~~~~~~~~~~~ll~~~l~~~P~~R~  239 (316)
T cd05592         161 DYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILN-DRPHFPRWISKEAKDCLSKLFERDPTKRL  239 (316)
T ss_pred             cccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHc-CCCCCCCCCCHHHHHHHHHHccCCHHHcC
Confidence            99999999999999999999999999999999999998887666655543 33456677899999999999999999999


Q ss_pred             CH-HHHhcChhhhhhh
Q psy1546         289 TA-KELLKFPFIRKAK  303 (604)
Q Consensus       289 T~-~elL~hp~f~~~~  303 (604)
                      ++ .++++||||....
T Consensus       240 ~~~~~l~~h~~~~~~~  255 (316)
T cd05592         240 GVDGDIRQHPFFRGID  255 (316)
T ss_pred             CChHHHHcCcccCCCC
Confidence            86 5888999997653

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=8.7e-43  Score=365.61  Aligned_cols=240  Identities=28%  Similarity=0.490  Sum_probs=206.1

Q ss_pred             eEEcccCcEEEEEEEECCCCcEEEEEEecchhh--HHHHHHHHHHHHHHhhC-CCCCCCe----------EEEEEEecCC
Q psy1546          63 ERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA--EDEIEDIQQEIMVLSQC-DSPYGTK----------LWIIMEYLGG  129 (604)
Q Consensus        63 ~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~--~~~~~~l~~Ei~iL~~l-~hp~~~~----------lyLVmEy~~g  129 (604)
                      ++||+|+||.||+|++..+++.||||++.....  ......+..|+.++..+ .||++.+          +|+||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~   80 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG   80 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence            369999999999999999999999999976532  23445677888888765 7888544          5799999999


Q ss_pred             CChhhHhhc-CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCCCCcccccCC
Q psy1546         130 GSALDLMKA-GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTP  208 (604)
Q Consensus       130 gsL~~~l~~-~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~~~~~~GT~  208 (604)
                      |+|..++.. +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.............+||+
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~  160 (321)
T cd05591          81 GDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTP  160 (321)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceecccCCccccccccCc
Confidence            999988754 6799999999999999999999999999999999999999999999999999976544444445678999


Q ss_pred             CCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCCCCCCCCccchHHHHHHHHHHhccCCCCCC
Q psy1546         209 FWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPENRP  288 (604)
Q Consensus       209 ~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rp  288 (604)
                      .|+|||++.+..++.++|||||||++|+|++|..||...........+.... ..++..++.++.+||.+||..||.+|+
T Consensus       161 ~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~-~~~p~~~~~~~~~ll~~~L~~dp~~R~  239 (321)
T cd05591         161 DYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDD-VLYPVWLSKEAVSILKAFMTKNPNKRL  239 (321)
T ss_pred             cccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCC-CCCCCCCCHHHHHHHHHHhccCHHHcC
Confidence            9999999999999999999999999999999999999888777766654433 234556789999999999999999999


Q ss_pred             -------CHHHHhcChhhhhhh
Q psy1546         289 -------TAKELLKFPFIRKAK  303 (604)
Q Consensus       289 -------T~~elL~hp~f~~~~  303 (604)
                             ++.++++||||....
T Consensus       240 ~~~~~~~~~~~~~~hp~~~~~~  261 (321)
T cd05591         240 GCVASQGGEDAIKQHPFFKEID  261 (321)
T ss_pred             CCCCCCCCHHHHhcCCccCCCC
Confidence                   999999999996643

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=1e-42  Score=373.97  Aligned_cols=246  Identities=26%  Similarity=0.503  Sum_probs=205.5

Q ss_pred             cceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhh--HHHHHHHHHHHHHHhhCCCCCCCeE----------EEEEE
Q psy1546          58 IFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA--EDEIEDIQQEIMVLSQCDSPYGTKL----------WIIME  125 (604)
Q Consensus        58 ~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~--~~~~~~l~~Ei~iL~~l~hp~~~~l----------yLVmE  125 (604)
                      .|.++++||+|+||.||+|.+..+++.||||++.....  ......+.+|+.+++.+.|++++++          |||||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E   81 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD   81 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence            38899999999999999999999999999999975432  3345778899999999999986654          79999


Q ss_pred             ecCCCChhhHhhc-CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCC------
Q psy1546         126 YLGGGSALDLMKA-GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTT------  198 (604)
Q Consensus       126 y~~ggsL~~~l~~-~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~------  198 (604)
                      ||++|+|.+++.. +.+++..++.++.||+.||+|||++||+||||||+||||+.+|.+||+|||+|..+....      
T Consensus        82 ~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~~~  161 (382)
T cd05625          82 YIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQ  161 (382)
T ss_pred             CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCccccccccccccc
Confidence            9999999998865 678999999999999999999999999999999999999999999999999975331000      


Q ss_pred             -----------------------------------------CCCcccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHH
Q psy1546         199 -----------------------------------------SKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIEL  237 (604)
Q Consensus       199 -----------------------------------------~~~~~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eL  237 (604)
                                                               ......+||+.|||||++.+..|+.++|||||||+||||
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil~el  241 (382)
T cd05625         162 SGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEM  241 (382)
T ss_pred             cccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHHHHHH
Confidence                                                     001235799999999999999999999999999999999


Q ss_pred             HhCCCCCCCCChhhHhhhcCCC-CCC--CCCccchHHHHHHHHHHhccCCCCCCC---HHHHhcChhhhhhhh
Q psy1546         238 AKGEPPNSELHPMRVLFLIPKN-NPP--QLTGNYTKQFKEFVEACLNKDPENRPT---AKELLKFPFIRKAKK  304 (604)
Q Consensus       238 ltG~~Pf~~~~~~~~~~~i~~~-~~~--~~~~~~s~~l~~Li~~~L~~dP~~RpT---~~elL~hp~f~~~~~  304 (604)
                      ++|.+||...+.......+... ...  .....+++++.+||.+|+ .+|.+|++   +.++++||||+....
T Consensus       242 ltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~~~~  313 (382)
T cd05625         242 LVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAHPFFKTIDF  313 (382)
T ss_pred             HhCCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcCCCcCCcCh
Confidence            9999999987766554443321 111  122457899999999976 59999987   999999999976543

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1e-42  Score=368.16  Aligned_cols=245  Identities=31%  Similarity=0.512  Sum_probs=209.3

Q ss_pred             cceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhh--HHHHHHHHHHHHHHhhCCCCCCCe----------EEEEEE
Q psy1546          58 IFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA--EDEIEDIQQEIMVLSQCDSPYGTK----------LWIIME  125 (604)
Q Consensus        58 ~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~--~~~~~~l~~Ei~iL~~l~hp~~~~----------lyLVmE  125 (604)
                      .|.+.+.||+|+||+||+|++..+++.||||++.....  ......+..|+.++..+.|+++.+          +|+|||
T Consensus         2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   81 (350)
T cd05573           2 DFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVME   81 (350)
T ss_pred             CceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEEc
Confidence            38899999999999999999999999999999976532  234567889999999999998544          589999


Q ss_pred             ecCCCChhhHhhc-CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCC------
Q psy1546         126 YLGGGSALDLMKA-GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTT------  198 (604)
Q Consensus       126 y~~ggsL~~~l~~-~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~------  198 (604)
                      |+.+++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+....      
T Consensus        82 ~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~  161 (350)
T cd05573          82 YMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYL  161 (350)
T ss_pred             CCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCcccccc
Confidence            9999999999865 589999999999999999999999999999999999999999999999999997665433      


Q ss_pred             -----------------------CCCcccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhh
Q psy1546         199 -----------------------SKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFL  255 (604)
Q Consensus       199 -----------------------~~~~~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~  255 (604)
                                             .......||+.|+|||++.+..++.++|||||||+||||++|..||...........
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~  241 (350)
T cd05573         162 NDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQETYNK  241 (350)
T ss_pred             cccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHHHHHHH
Confidence                                   123456799999999999999999999999999999999999999998876655544


Q ss_pred             cCC---CCCCCCCccchHHHHHHHHHHhccCCCCCCC-HHHHhcChhhhhhh
Q psy1546         256 IPK---NNPPQLTGNYTKQFKEFVEACLNKDPENRPT-AKELLKFPFIRKAK  303 (604)
Q Consensus       256 i~~---~~~~~~~~~~s~~l~~Li~~~L~~dP~~RpT-~~elL~hp~f~~~~  303 (604)
                      +..   .........+++++.+||.+||. ||.+|++ ++++++||||+...
T Consensus       242 i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~~~~~  292 (350)
T cd05573         242 IINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFKGID  292 (350)
T ss_pred             HhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCcCCCC
Confidence            433   11112223368999999999997 9999999 99999999997653

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=1.6e-42  Score=372.55  Aligned_cols=246  Identities=25%  Similarity=0.490  Sum_probs=203.4

Q ss_pred             cceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhh--HHHHHHHHHHHHHHhhCCCCCCCe----------EEEEEE
Q psy1546          58 IFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA--EDEIEDIQQEIMVLSQCDSPYGTK----------LWIIME  125 (604)
Q Consensus        58 ~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~--~~~~~~l~~Ei~iL~~l~hp~~~~----------lyLVmE  125 (604)
                      .|.++++||+|+||+||+|++..+++.||||++.....  ......+.+|+.++..++|+++++          +|+|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E   81 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence            38899999999999999999999999999999976532  334577899999999999998655          479999


Q ss_pred             ecCCCChhhHhhc-CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCC------
Q psy1546         126 YLGGGSALDLMKA-GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTT------  198 (604)
Q Consensus       126 y~~ggsL~~~l~~-~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~------  198 (604)
                      ||+||+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.+....      
T Consensus        82 ~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~~~  161 (381)
T cd05626          82 YIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQ  161 (381)
T ss_pred             cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCccccccccccccc
Confidence            9999999998855 679999999999999999999999999999999999999999999999999975431100      


Q ss_pred             -----------------------------------------CCCcccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHH
Q psy1546         199 -----------------------------------------SKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIEL  237 (604)
Q Consensus       199 -----------------------------------------~~~~~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eL  237 (604)
                                                               ......+||+.|||||++.+..++.++|||||||+||||
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~il~el  241 (381)
T cd05626         162 KGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEM  241 (381)
T ss_pred             ccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhHHHHH
Confidence                                                     001245799999999999999999999999999999999


Q ss_pred             HhCCCCCCCCChhhHhhhcCC-CCCCCC--CccchHHHHHHHHHHhc--cCCCCCCCHHHHhcChhhhhhh
Q psy1546         238 AKGEPPNSELHPMRVLFLIPK-NNPPQL--TGNYTKQFKEFVEACLN--KDPENRPTAKELLKFPFIRKAK  303 (604)
Q Consensus       238 ltG~~Pf~~~~~~~~~~~i~~-~~~~~~--~~~~s~~l~~Li~~~L~--~dP~~RpT~~elL~hp~f~~~~  303 (604)
                      ++|..||...........+.. .....+  ...++.++.+||.+|+.  .++..|+++.+|+.||||....
T Consensus       242 ltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp~f~~~~  312 (381)
T cd05626         242 LVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFSEVD  312 (381)
T ss_pred             HhCCCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCcccCCCC
Confidence            999999988776554443322 111122  23578999999999654  4555699999999999997643

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=1.1e-42  Score=366.56  Aligned_cols=240  Identities=27%  Similarity=0.504  Sum_probs=201.1

Q ss_pred             eEEcccCcEEEEEEEECCCCcEEEEEEecchhh--HHHHHHHHHHHHHHhhC-CCCCCCe----------EEEEEEecCC
Q psy1546          63 ERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA--EDEIEDIQQEIMVLSQC-DSPYGTK----------LWIIMEYLGG  129 (604)
Q Consensus        63 ~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~--~~~~~~l~~Ei~iL~~l-~hp~~~~----------lyLVmEy~~g  129 (604)
                      ++||+|+||.||+|.+..+++.||||++.....  ......+.+|+.++..+ +||++.+          +|||||||++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~   80 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG   80 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            469999999999999999999999999976532  23456688999999888 6998654          5799999999


Q ss_pred             CChhhHhh-cCCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCCCCcccccCC
Q psy1546         130 GSALDLMK-AGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTP  208 (604)
Q Consensus       130 gsL~~~l~-~~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~~~~~~GT~  208 (604)
                      |+|.+++. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++............+||+
T Consensus        81 g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~  160 (329)
T cd05588          81 GDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGTP  160 (329)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCccccccccCCCccccccCCc
Confidence            99998875 46899999999999999999999999999999999999999999999999999975433333445678999


Q ss_pred             CCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCCh--------hhHhhhcCCCCCCCCCccchHHHHHHHHHHh
Q psy1546         209 FWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHP--------MRVLFLIPKNNPPQLTGNYTKQFKEFVEACL  280 (604)
Q Consensus       209 ~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~--------~~~~~~i~~~~~~~~~~~~s~~l~~Li~~~L  280 (604)
                      .|+|||++.+..++.++|||||||++|+|++|..||.....        ..............++..++..+.+||.+||
T Consensus       161 ~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L  240 (329)
T cd05588         161 NYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPRSLSVKASSVLKGFL  240 (329)
T ss_pred             cccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHHHHh
Confidence            99999999999999999999999999999999999963221        1111111222334566778899999999999


Q ss_pred             ccCCCCCCC------HHHHhcChhhhhh
Q psy1546         281 NKDPENRPT------AKELLKFPFIRKA  302 (604)
Q Consensus       281 ~~dP~~RpT------~~elL~hp~f~~~  302 (604)
                      ..||.+|++      ++++++||||...
T Consensus       241 ~~dP~~R~~~~~~~~~~~i~~hp~~~~~  268 (329)
T cd05588         241 NKDPKERLGCHPQTGFRDIKSHPFFRNI  268 (329)
T ss_pred             ccCHHHcCCCCCCCCHHHHhcCCCCCCC
Confidence            999999987      8999999999654

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=2.8e-42  Score=353.00  Aligned_cols=265  Identities=83%  Similarity=1.284  Sum_probs=232.4

Q ss_pred             ccccceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCCe----------EEEEE
Q psy1546          55 PELIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTK----------LWIIM  124 (604)
Q Consensus        55 ~~~~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~~----------lyLVm  124 (604)
                      .+..|.+.++||.|+||.||+|.+..+++.||||++...........+.+|+.++..+.|+++.+          +|+||
T Consensus         2 ~~~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   81 (277)
T cd06641           2 PEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIM   81 (277)
T ss_pred             HHHhhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEE
Confidence            45678999999999999999999999999999999876655556678899999999999998543          57999


Q ss_pred             EecCCCChhhHhhcCCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCCCCccc
Q psy1546         125 EYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTF  204 (604)
Q Consensus       125 Ey~~ggsL~~~l~~~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~~~~~  204 (604)
                      ||+++++|.+++..+.+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++..+..........
T Consensus        82 e~~~~~~l~~~i~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~  161 (277)
T cd06641          82 EYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTF  161 (277)
T ss_pred             EeCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccchhhhccc
Confidence            99999999999988889999999999999999999999999999999999999999999999999997665443334456


Q ss_pred             ccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCCCCCCCCccchHHHHHHHHHHhccCC
Q psy1546         205 VGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDP  284 (604)
Q Consensus       205 ~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~~L~~dP  284 (604)
                      .++..|+|||.+.+..++.++|||||||++|+|++|..||...........+.....+.+...++.++.+++.+||..+|
T Consensus       162 ~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p  241 (277)
T cd06641         162 VGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLNKEP  241 (277)
T ss_pred             cCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcCCCCCCCcccCHHHHHHHHHHccCCh
Confidence            78999999999988888999999999999999999999998877776666666666666777889999999999999999


Q ss_pred             CCCCCHHHHhcChhhhhhhh-hhhHHHHHHHHHHHh
Q psy1546         285 ENRPTAKELLKFPFIRKAKK-NAYLIDLIDRYKKWK  319 (604)
Q Consensus       285 ~~RpT~~elL~hp~f~~~~~-~~~l~~~~~~~~~~~  319 (604)
                      .+||++.++++||||.+... ..++..++++|++|+
T Consensus       242 ~~Rp~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (277)
T cd06641         242 SFRPTAKELLKHKFIVRFAKKTSYLTELIDRYKRWK  277 (277)
T ss_pred             hhCcCHHHHHhCHHHhhhhhccchHHHHHHHhhccC
Confidence            99999999999999987654 456677888888773

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=1.8e-42  Score=371.26  Aligned_cols=245  Identities=29%  Similarity=0.458  Sum_probs=208.7

Q ss_pred             cceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhh--HHHHHHHHHHHHHHhhCCCCCCCe----------EEEEEE
Q psy1546          58 IFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA--EDEIEDIQQEIMVLSQCDSPYGTK----------LWIIME  125 (604)
Q Consensus        58 ~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~--~~~~~~l~~Ei~iL~~l~hp~~~~----------lyLVmE  125 (604)
                      .|.+.++||+|+||.||+|.+..+++.||||++.....  ......+.+|+.+++.++||++.+          +|+|||
T Consensus        44 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv~E  123 (370)
T cd05596          44 DFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVME  123 (370)
T ss_pred             HcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEEc
Confidence            48999999999999999999999999999999965432  223456788999999999998655          479999


Q ss_pred             ecCCCChhhHhhcCCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCC-CCccc
Q psy1546         126 YLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTS-KRNTF  204 (604)
Q Consensus       126 y~~ggsL~~~l~~~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~-~~~~~  204 (604)
                      ||+||+|.+++....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+..... .....
T Consensus       124 y~~gg~L~~~l~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~~~~~~~~  203 (370)
T cd05596         124 YMPGGDLVNLMSNYDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTA  203 (370)
T ss_pred             CCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceeeccCCCcccCCCC
Confidence            99999999999888899999999999999999999999999999999999999999999999999976543222 23456


Q ss_pred             ccCCCCCChHHhhcC----CCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCCC-CCCCCc--cchHHHHHHHH
Q psy1546         205 VGTPFWMAPEVIKQS----AYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNN-PPQLTG--NYTKQFKEFVE  277 (604)
Q Consensus       205 ~GT~~Y~APE~l~~~----~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~~-~~~~~~--~~s~~l~~Li~  277 (604)
                      +||+.|||||++.+.    .++.++|||||||+||||++|.+||...........+.... ...++.  .++.++++||.
T Consensus       204 ~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~  283 (370)
T cd05596         204 VGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDIEISKQAKDLIC  283 (370)
T ss_pred             CCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcCCCCCcCCCCHHHHHHHH
Confidence            899999999999754    37889999999999999999999999887766555554322 122222  57899999999


Q ss_pred             HHhccCCCC--CCCHHHHhcChhhhhh
Q psy1546         278 ACLNKDPEN--RPTAKELLKFPFIRKA  302 (604)
Q Consensus       278 ~~L~~dP~~--RpT~~elL~hp~f~~~  302 (604)
                      +||..+|.+  |++++++++||||+..
T Consensus       284 ~~L~~~p~r~~R~s~~ell~h~~~~~~  310 (370)
T cd05596         284 AFLTDREVRLGRNGVDEIKSHPFFKND  310 (370)
T ss_pred             HHccChhhccCCCCHHHHhcCcccCCC
Confidence            999999988  9999999999999764

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=5.2e-42  Score=361.44  Aligned_cols=246  Identities=34%  Similarity=0.602  Sum_probs=207.1

Q ss_pred             ccceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCCe----------EEEEEEe
Q psy1546          57 LIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTK----------LWIIMEY  126 (604)
Q Consensus        57 ~~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~~----------lyLVmEy  126 (604)
                      +.|++.+.||+|+||.||+|.+..++..||+|++...........+.+|+.+|+.++||++.+          +|+||||
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   84 (331)
T cd06649           5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH   84 (331)
T ss_pred             ccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEeec
Confidence            458999999999999999999999999999999976544445577899999999999999655          4799999


Q ss_pred             cCCCChhhHhhc-CCCcHHHHHHHHHHHHHHhHHhhhC-CccccccccceeEecCCCCeEEecccccccccCCCCCCccc
Q psy1546         127 LGGGSALDLMKA-GNFEEMHIAVILREVLKGLDYLHSE-RKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTF  204 (604)
Q Consensus       127 ~~ggsL~~~l~~-~~lse~~i~~i~~qIl~gL~yLHs~-gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~~~~~  204 (604)
                      +++++|.+++.. +.+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||++..+...  .....
T Consensus        85 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~~~  162 (331)
T cd06649          85 MDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--MANSF  162 (331)
T ss_pred             CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCccccccccc--ccccC
Confidence            999999999865 5689999999999999999999986 6999999999999999999999999999765432  23356


Q ss_pred             ccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcC---------------------------
Q psy1546         205 VGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIP---------------------------  257 (604)
Q Consensus       205 ~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~---------------------------  257 (604)
                      .||+.|+|||++.+..++.++|||||||+||||++|..||......+....+.                           
T Consensus       163 ~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (331)
T cd06649         163 VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPPGRPVSG  242 (331)
T ss_pred             CCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCcccccccccccc
Confidence            79999999999999999999999999999999999999997655433321110                           


Q ss_pred             -------------------CCCCCC-CCccchHHHHHHHHHHhccCCCCCCCHHHHhcChhhhhhhh
Q psy1546         258 -------------------KNNPPQ-LTGNYTKQFKEFVEACLNKDPENRPTAKELLKFPFIRKAKK  304 (604)
Q Consensus       258 -------------------~~~~~~-~~~~~s~~l~~Li~~~L~~dP~~RpT~~elL~hp~f~~~~~  304 (604)
                                         ....+. ....++.++++||.+||..||++|||+.|||+||||+....
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~~  309 (331)
T cd06649         243 HGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRSEV  309 (331)
T ss_pred             cccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhccc
Confidence                               000111 12246789999999999999999999999999999986543

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=1.3e-42  Score=363.89  Aligned_cols=240  Identities=29%  Similarity=0.507  Sum_probs=203.8

Q ss_pred             eEEcccCcEEEEEEEECCCCcEEEEEEecchhh--HHHHHHHHHHHHHHhh-CCCCCCCe----------EEEEEEecCC
Q psy1546          63 ERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA--EDEIEDIQQEIMVLSQ-CDSPYGTK----------LWIIMEYLGG  129 (604)
Q Consensus        63 ~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~--~~~~~~l~~Ei~iL~~-l~hp~~~~----------lyLVmEy~~g  129 (604)
                      ++||+|+||.||+|.+..+++.||||++.....  ......+..|+.++.. ++||++.+          +|+||||+.+
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   80 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence            469999999999999999999999999976532  2334566778877765 58998654          4799999999


Q ss_pred             CChhhHhhc-CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCCCCcccccCC
Q psy1546         130 GSALDLMKA-GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTP  208 (604)
Q Consensus       130 gsL~~~l~~-~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~~~~~~GT~  208 (604)
                      |+|..++.. +.+++..+..++.||+.||+|||++||+||||||+|||++.++.++|+|||+++............+||+
T Consensus        81 g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~  160 (316)
T cd05620          81 GDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGTP  160 (316)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCCCceeccCCCc
Confidence            999988865 6799999999999999999999999999999999999999999999999999865433333445678999


Q ss_pred             CCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCCCCCCCCccchHHHHHHHHHHhccCCCCCC
Q psy1546         209 FWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPENRP  288 (604)
Q Consensus       209 ~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rp  288 (604)
                      .|+|||++.+..++.++|||||||++|||++|..||...........+... .+.++..++.++++||.+||..||.+||
T Consensus       161 ~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~dP~~R~  239 (316)
T cd05620         161 DYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVD-TPHYPRWITKESKDILEKLFERDPTRRL  239 (316)
T ss_pred             CccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-CCCCCCCCCHHHHHHHHHHccCCHHHcC
Confidence            999999999999999999999999999999999999887776665554333 3455667899999999999999999999


Q ss_pred             CH-HHHhcChhhhhhh
Q psy1546         289 TA-KELLKFPFIRKAK  303 (604)
Q Consensus       289 T~-~elL~hp~f~~~~  303 (604)
                      ++ +++++||||....
T Consensus       240 ~~~~~~~~h~~f~~~~  255 (316)
T cd05620         240 GVVGNIRGHPFFKTIN  255 (316)
T ss_pred             CChHHHHcCCCcCCCC
Confidence            97 5899999997643

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=2.3e-42  Score=367.33  Aligned_cols=242  Identities=33%  Similarity=0.560  Sum_probs=201.1

Q ss_pred             cceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCCe----------EEEEEEec
Q psy1546          58 IFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTK----------LWIIMEYL  127 (604)
Q Consensus        58 ~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~~----------lyLVmEy~  127 (604)
                      .|.+.++||+|+||.||+|++..+++.||||++...........+.+|+.+++.++|+|+.+          +|+||||+
T Consensus        75 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  154 (353)
T PLN00034         75 ELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFM  154 (353)
T ss_pred             HHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecC
Confidence            37888999999999999999999999999999966554445577899999999999998654          47999999


Q ss_pred             CCCChhhHhhcCCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCCCCcccccC
Q psy1546         128 GGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGT  207 (604)
Q Consensus       128 ~ggsL~~~l~~~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~~~~~~GT  207 (604)
                      .+++|....   .+.+..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.+...........||
T Consensus       155 ~~~~L~~~~---~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt  231 (353)
T PLN00034        155 DGGSLEGTH---IADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSVGT  231 (353)
T ss_pred             CCCcccccc---cCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceecccccccccccccC
Confidence            999986532   35677888999999999999999999999999999999999999999999997665443334456899


Q ss_pred             CCCCChHHhhc-----CCCCCcchhhhHHHHHHHHHhCCCCCCCCChh---hHhhhcCCCCCCCCCccchHHHHHHHHHH
Q psy1546         208 PFWMAPEVIKQ-----SAYDSKADIWSLGITAIELAKGEPPNSELHPM---RVLFLIPKNNPPQLTGNYTKQFKEFVEAC  279 (604)
Q Consensus       208 ~~Y~APE~l~~-----~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~---~~~~~i~~~~~~~~~~~~s~~l~~Li~~~  279 (604)
                      ..|+|||++..     ..++.++|||||||+||||++|..||......   .....+........+..++.++++||.+|
T Consensus       232 ~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~  311 (353)
T PLN00034        232 IAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEAPATASREFRHFISCC  311 (353)
T ss_pred             ccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCCCCCCCccCHHHHHHHHHH
Confidence            99999999843     23446899999999999999999999743322   22222333344455667889999999999


Q ss_pred             hccCCCCCCCHHHHhcChhhhhh
Q psy1546         280 LNKDPENRPTAKELLKFPFIRKA  302 (604)
Q Consensus       280 L~~dP~~RpT~~elL~hp~f~~~  302 (604)
                      |..||++|||+.|||+||||.+.
T Consensus       312 l~~~P~~Rpt~~ell~hp~~~~~  334 (353)
T PLN00034        312 LQREPAKRWSAMQLLQHPFILRA  334 (353)
T ss_pred             ccCChhhCcCHHHHhcCcccccC
Confidence            99999999999999999999764

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=1.6e-42  Score=364.16  Aligned_cols=244  Identities=31%  Similarity=0.472  Sum_probs=198.7

Q ss_pred             ceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhh-HHHHHHHHHHHHHHhhCCCCCCCe---------------EEE
Q psy1546          59 FTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA-EDEIEDIQQEIMVLSQCDSPYGTK---------------LWI  122 (604)
Q Consensus        59 y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~-~~~~~~l~~Ei~iL~~l~hp~~~~---------------lyL  122 (604)
                      |++.++||+|+||.||+|.+..+++.||||++..... ......+.+|+.+++.++||++.+               +|+
T Consensus         2 y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~l   81 (338)
T cd07859           2 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYV   81 (338)
T ss_pred             eEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEEE
Confidence            8899999999999999999999999999999864321 223456789999999999998542               589


Q ss_pred             EEEecCCCChhhHhhc-CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCC--
Q psy1546         123 IMEYLGGGSALDLMKA-GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTS--  199 (604)
Q Consensus       123 VmEy~~ggsL~~~l~~-~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~--  199 (604)
                      |||||+ ++|.+++.. +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.......  
T Consensus        82 v~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~  160 (338)
T cd07859          82 VFELME-SDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTA  160 (338)
T ss_pred             EEecCC-CCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCccccccccccCcc
Confidence            999995 678887754 5799999999999999999999999999999999999999999999999999975432211  


Q ss_pred             -CCcccccCCCCCChHHhhc--CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhc--------------------
Q psy1546         200 -KRNTFVGTPFWMAPEVIKQ--SAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLI--------------------  256 (604)
Q Consensus       200 -~~~~~~GT~~Y~APE~l~~--~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i--------------------  256 (604)
                       .....+||+.|+|||++.+  ..++.++|||||||++|+|++|.+||.+.........+                    
T Consensus       161 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~  240 (338)
T cd07859         161 IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNEKA  240 (338)
T ss_pred             ccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhH
Confidence             2234679999999999876  67899999999999999999999999876543221110                    


Q ss_pred             -------CCCCCCC---CCccchHHHHHHHHHHhccCCCCCCCHHHHhcChhhhhhh
Q psy1546         257 -------PKNNPPQ---LTGNYTKQFKEFVEACLNKDPENRPTAKELLKFPFIRKAK  303 (604)
Q Consensus       257 -------~~~~~~~---~~~~~s~~l~~Li~~~L~~dP~~RpT~~elL~hp~f~~~~  303 (604)
                             ....+..   ....++..+.+||.+||..||.+|||+.|+|+||||+...
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~  297 (338)
T cd07859         241 RRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLA  297 (338)
T ss_pred             HHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcC
Confidence                   0001111   1124567889999999999999999999999999997543

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=2.3e-42  Score=362.75  Aligned_cols=244  Identities=30%  Similarity=0.505  Sum_probs=208.2

Q ss_pred             ceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhh--HHHHHHHHHHHHHHhhCC-CCCCC----------eEEEEEE
Q psy1546          59 FTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA--EDEIEDIQQEIMVLSQCD-SPYGT----------KLWIIME  125 (604)
Q Consensus        59 y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~--~~~~~~l~~Ei~iL~~l~-hp~~~----------~lyLVmE  125 (604)
                      |.+.+.||+|+||.||+|.+..+++.||||++.....  ......+..|+.++..+. |+++.          .+|+|||
T Consensus         2 f~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E   81 (323)
T cd05616           2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVME   81 (323)
T ss_pred             ceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEEc
Confidence            7889999999999999999999999999999976532  233455677888887775 55533          3579999


Q ss_pred             ecCCCChhhHhhc-CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCCCCccc
Q psy1546         126 YLGGGSALDLMKA-GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTF  204 (604)
Q Consensus       126 y~~ggsL~~~l~~-~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~~~~~  204 (604)
                      |+++|+|.+++.. +.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++............
T Consensus        82 ~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~~~~~~  161 (323)
T cd05616          82 YVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTF  161 (323)
T ss_pred             CCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCCCCCccccC
Confidence            9999999988854 679999999999999999999999999999999999999999999999999997544333344567


Q ss_pred             ccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCCCCCCCCccchHHHHHHHHHHhccCC
Q psy1546         205 VGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDP  284 (604)
Q Consensus       205 ~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~~L~~dP  284 (604)
                      +||+.|+|||++.+..++.++|||||||++|||++|..||.+.........+.... ..++..++.++.+|+.+||..||
T Consensus       162 ~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~~~l~~~p  240 (323)
T cd05616         162 CGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHN-VAYPKSMSKEAVAICKGLMTKHP  240 (323)
T ss_pred             CCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-CCCCCcCCHHHHHHHHHHcccCH
Confidence            89999999999999999999999999999999999999999888777666555433 34556789999999999999999


Q ss_pred             CCCCC-----HHHHhcChhhhhhh
Q psy1546         285 ENRPT-----AKELLKFPFIRKAK  303 (604)
Q Consensus       285 ~~RpT-----~~elL~hp~f~~~~  303 (604)
                      .+|++     ..++++||||+...
T Consensus       241 ~~R~~~~~~~~~~i~~h~~~~~~~  264 (323)
T cd05616         241 GKRLGCGPEGERDIKEHAFFRYID  264 (323)
T ss_pred             HhcCCCCCCCHHHHhcCCCcCCCC
Confidence            99997     58999999997643

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=1.8e-42  Score=363.74  Aligned_cols=240  Identities=29%  Similarity=0.508  Sum_probs=206.2

Q ss_pred             eEEcccCcEEEEEEEEC---CCCcEEEEEEecchhh---HHHHHHHHHHHHHHhhCCCCCCCe----------EEEEEEe
Q psy1546          63 ERIGKGSFGEVFKGIDN---RTQQVVAIKIIDLEEA---EDEIEDIQQEIMVLSQCDSPYGTK----------LWIIMEY  126 (604)
Q Consensus        63 ~~LG~G~fG~Vy~a~~~---~t~~~vAVK~i~~~~~---~~~~~~l~~Ei~iL~~l~hp~~~~----------lyLVmEy  126 (604)
                      ++||+|+||.||+|++.   .+++.||||++.....   ......+..|+.+|+.+.|||+.+          +|+||||
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~   81 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY   81 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence            67999999999999864   5788999999975432   223456788999999999998654          4799999


Q ss_pred             cCCCChhhHhhc-CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCCCCcccc
Q psy1546         127 LGGGSALDLMKA-GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFV  205 (604)
Q Consensus       127 ~~ggsL~~~l~~-~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~~~~~~  205 (604)
                      +.+++|.+++.. +.+.+..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++............+
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  161 (323)
T cd05584          82 LSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFC  161 (323)
T ss_pred             CCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCCcccccC
Confidence            999999998865 6688999999999999999999999999999999999999999999999999975544444445568


Q ss_pred             cCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCCCCCCCCccchHHHHHHHHHHhccCCC
Q psy1546         206 GTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPE  285 (604)
Q Consensus       206 GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~~L~~dP~  285 (604)
                      ||+.|+|||++.+..++.++|||||||+||||++|..||...+.......+.... ..++..++..+.+||.+||..||.
T Consensus       162 gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~  240 (323)
T cd05584         162 GTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGK-LNLPPYLTPEARDLLKKLLKRNPS  240 (323)
T ss_pred             CCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC-CCCCCCCCHHHHHHHHHHcccCHh
Confidence            9999999999999889999999999999999999999999887766665554443 345667889999999999999999


Q ss_pred             CCC-----CHHHHhcChhhhhhh
Q psy1546         286 NRP-----TAKELLKFPFIRKAK  303 (604)
Q Consensus       286 ~Rp-----T~~elL~hp~f~~~~  303 (604)
                      +||     ++++++.||||+...
T Consensus       241 ~R~~~~~~~~~~l~~h~~~~~~~  263 (323)
T cd05584         241 SRLGAGPGDAAEVQSHPFFRHVN  263 (323)
T ss_pred             HcCCCCCCCHHHHhcCCCcCCCC
Confidence            999     899999999997654

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=2.7e-42  Score=354.56  Aligned_cols=238  Identities=29%  Similarity=0.459  Sum_probs=200.6

Q ss_pred             EcccCcEEEEEEEECCCCcEEEEEEecchhhH--HHHHHHHHHHHHHhhCCCCCCC----------eEEEEEEecCCCCh
Q psy1546          65 IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAE--DEIEDIQQEIMVLSQCDSPYGT----------KLWIIMEYLGGGSA  132 (604)
Q Consensus        65 LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~--~~~~~l~~Ei~iL~~l~hp~~~----------~lyLVmEy~~ggsL  132 (604)
                      ||+|+||+||+|.+..+++.||||++......  ...+.+..|+.+++.++|+++.          .+|+||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L   80 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL   80 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence            69999999999999999999999998654332  2345678899999999999854          35799999999999


Q ss_pred             hhHhh-----cCCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCCCCcccccC
Q psy1546         133 LDLMK-----AGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGT  207 (604)
Q Consensus       133 ~~~l~-----~~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~~~~~~GT  207 (604)
                      ..++.     ...+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++..+...........||
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~g~  160 (280)
T cd05608          81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGT  160 (280)
T ss_pred             HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCccccccCCC
Confidence            88763     2468999999999999999999999999999999999999999999999999997665444444456899


Q ss_pred             CCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChh----hHhhhcCCCCCCCCCccchHHHHHHHHHHhccC
Q psy1546         208 PFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPM----RVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKD  283 (604)
Q Consensus       208 ~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~----~~~~~i~~~~~~~~~~~~s~~l~~Li~~~L~~d  283 (604)
                      +.|+|||++.+..++.++|||||||++|+|++|..||......    .....+. .....++..++..+.+|+.+||+.|
T Consensus       161 ~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~  239 (280)
T cd05608         161 PGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRIL-NDSVTYPDKFSPASKSFCEALLAKD  239 (280)
T ss_pred             cCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhc-ccCCCCcccCCHHHHHHHHHHhcCC
Confidence            9999999999999999999999999999999999999765322    2222222 1233455678999999999999999


Q ss_pred             CCCCC-----CHHHHhcChhhhhhh
Q psy1546         284 PENRP-----TAKELLKFPFIRKAK  303 (604)
Q Consensus       284 P~~Rp-----T~~elL~hp~f~~~~  303 (604)
                      |.+||     +++++++||||+...
T Consensus       240 P~~R~~~~~~~~~~~l~h~~~~~~~  264 (280)
T cd05608         240 PEKRLGFRDGNCDGLRTHPLFRDLN  264 (280)
T ss_pred             HHHhcCCCCCCHHHHhcChhhhcCC
Confidence            99999     889999999997643

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=1.3e-42  Score=372.02  Aligned_cols=244  Identities=27%  Similarity=0.482  Sum_probs=204.2

Q ss_pred             cceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhh--HHHHHHHHHHHHHHhhCCCCCCCe----------EEEEEE
Q psy1546          58 IFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA--EDEIEDIQQEIMVLSQCDSPYGTK----------LWIIME  125 (604)
Q Consensus        58 ~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~--~~~~~~l~~Ei~iL~~l~hp~~~~----------lyLVmE  125 (604)
                      .|++++.||+|+||.||+|++..+++.||||++.....  ......+.+|+.+|+.+.|+++.+          +|||||
T Consensus         2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E   81 (376)
T cd05598           2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (376)
T ss_pred             CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEe
Confidence            48999999999999999999999999999999965432  223567889999999999998655          479999


Q ss_pred             ecCCCChhhHhhc-CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCC------
Q psy1546         126 YLGGGSALDLMKA-GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTT------  198 (604)
Q Consensus       126 y~~ggsL~~~l~~-~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~------  198 (604)
                      ||++|+|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|..+....      
T Consensus        82 ~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~~~~  161 (376)
T cd05598          82 YIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQ  161 (376)
T ss_pred             CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCccccccccccccc
Confidence            9999999999865 568999999999999999999999999999999999999999999999999985331000      


Q ss_pred             -------------------------------------CCCcccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCC
Q psy1546         199 -------------------------------------SKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGE  241 (604)
Q Consensus       199 -------------------------------------~~~~~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~  241 (604)
                                                           ......+||+.|||||++.+..++.++|||||||+||||++|.
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyell~G~  241 (376)
T cd05598         162 KGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQ  241 (376)
T ss_pred             cccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeehhhCC
Confidence                                                 0012357999999999999999999999999999999999999


Q ss_pred             CCCCCCChhhHhhhcCCCC---CCCCCccchHHHHHHHHHHhccCCCCCC---CHHHHhcChhhhhh
Q psy1546         242 PPNSELHPMRVLFLIPKNN---PPQLTGNYTKQFKEFVEACLNKDPENRP---TAKELLKFPFIRKA  302 (604)
Q Consensus       242 ~Pf~~~~~~~~~~~i~~~~---~~~~~~~~s~~l~~Li~~~L~~dP~~Rp---T~~elL~hp~f~~~  302 (604)
                      .||...........+....   .......++.++.+||.+|+ .+|.+|+   ++.++++||||+..
T Consensus       242 ~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h~~~~~~  307 (376)
T cd05598         242 PPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAHPFFKGI  307 (376)
T ss_pred             CCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCCCCcCCC
Confidence            9999887665544332211   11223457889999999977 5999999   99999999999764

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.4e-42  Score=370.43  Aligned_cols=244  Identities=29%  Similarity=0.478  Sum_probs=203.2

Q ss_pred             cceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhh--HHHHHHHHHHHHHHhhCCCCCCCe----------EEEEEE
Q psy1546          58 IFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA--EDEIEDIQQEIMVLSQCDSPYGTK----------LWIIME  125 (604)
Q Consensus        58 ~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~--~~~~~~l~~Ei~iL~~l~hp~~~~----------lyLVmE  125 (604)
                      .|.++++||+|+||.||+|.+..+++.||||++.....  ......+.+|+.++..++||++++          +|||||
T Consensus         2 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E   81 (377)
T cd05629           2 DFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIME   81 (377)
T ss_pred             CceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEe
Confidence            48899999999999999999999999999999865432  334567889999999999999765          479999


Q ss_pred             ecCCCChhhHhhc-CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCC-----
Q psy1546         126 YLGGGSALDLMKA-GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTS-----  199 (604)
Q Consensus       126 y~~ggsL~~~l~~-~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~-----  199 (604)
                      ||+||+|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.+.....     
T Consensus        82 ~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~  161 (377)
T cd05629          82 FLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQ  161 (377)
T ss_pred             CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeeccccccccccccccccc
Confidence            9999999998865 6789999999999999999999999999999999999999999999999999963321000     


Q ss_pred             ------------------------------------------CCcccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHH
Q psy1546         200 ------------------------------------------KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIEL  237 (604)
Q Consensus       200 ------------------------------------------~~~~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eL  237 (604)
                                                                .....+||+.|+|||++.+..++.++|||||||+||||
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~el  241 (377)
T cd05629         162 KLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMFEC  241 (377)
T ss_pred             ccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchhhhhh
Confidence                                                      00125799999999999999999999999999999999


Q ss_pred             HhCCCCCCCCChhhHhhhcCCC-CCCCCC--ccchHHHHHHHHHHhccCCCCC---CCHHHHhcChhhhhh
Q psy1546         238 AKGEPPNSELHPMRVLFLIPKN-NPPQLT--GNYTKQFKEFVEACLNKDPENR---PTAKELLKFPFIRKA  302 (604)
Q Consensus       238 ltG~~Pf~~~~~~~~~~~i~~~-~~~~~~--~~~s~~l~~Li~~~L~~dP~~R---pT~~elL~hp~f~~~  302 (604)
                      ++|.+||...........+... ....++  ..++.++++||.+||. +|.+|   +++.|++.||||+..
T Consensus       242 ltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~hp~~~~~  311 (377)
T cd05629         242 LIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSHPFFRGV  311 (377)
T ss_pred             hcCCCCCCCCCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcCCCcCCC
Confidence            9999999887766554443321 111222  2478899999999997 67765   599999999999754

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=5.2e-42  Score=360.44  Aligned_cols=244  Identities=29%  Similarity=0.512  Sum_probs=208.6

Q ss_pred             ceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhh--HHHHHHHHHHHHHHhhCCCC-CC----------CeEEEEEE
Q psy1546          59 FTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA--EDEIEDIQQEIMVLSQCDSP-YG----------TKLWIIME  125 (604)
Q Consensus        59 y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~--~~~~~~l~~Ei~iL~~l~hp-~~----------~~lyLVmE  125 (604)
                      |...+.||+|+||.||+|.+..+++.||||++.....  ....+.+..|+.++..+.|+ ++          ..+|+|||
T Consensus         2 f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E   81 (323)
T cd05615           2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVME   81 (323)
T ss_pred             ceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEc
Confidence            7788999999999999999999999999999976432  23446677888898888764 32          34689999


Q ss_pred             ecCCCChhhHhhc-CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCCCCccc
Q psy1546         126 YLGGGSALDLMKA-GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTF  204 (604)
Q Consensus       126 y~~ggsL~~~l~~-~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~~~~~  204 (604)
                      |+++|+|.+++.. +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++............
T Consensus        82 y~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~~~~~~  161 (323)
T cd05615          82 YVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTF  161 (323)
T ss_pred             CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCCCCccccCc
Confidence            9999999998865 679999999999999999999999999999999999999999999999999997544333334456


Q ss_pred             ccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCCCCCCCCccchHHHHHHHHHHhccCC
Q psy1546         205 VGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDP  284 (604)
Q Consensus       205 ~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~~L~~dP  284 (604)
                      +||+.|+|||++.+..++.++|||||||++|+|++|..||...........+.... ..++..++.++.+|+.+||..||
T Consensus       162 ~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~-~~~p~~~~~~~~~li~~~l~~~p  240 (323)
T cd05615         162 CGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHN-VSYPKSLSKEAVSICKGLMTKHP  240 (323)
T ss_pred             cCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-CCCCccCCHHHHHHHHHHcccCH
Confidence            79999999999999999999999999999999999999999887766665554433 34556788999999999999999


Q ss_pred             CCCCC-----HHHHhcChhhhhhh
Q psy1546         285 ENRPT-----AKELLKFPFIRKAK  303 (604)
Q Consensus       285 ~~RpT-----~~elL~hp~f~~~~  303 (604)
                      .+|++     .+++++||||....
T Consensus       241 ~~R~~~~~~~~~~i~~h~~f~~~~  264 (323)
T cd05615         241 SKRLGCGPEGERDIREHAFFRRID  264 (323)
T ss_pred             hhCCCCCCCCHHHHhcCcccCCCC
Confidence            99997     58999999997653

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=2.5e-42  Score=362.47  Aligned_cols=239  Identities=29%  Similarity=0.474  Sum_probs=202.1

Q ss_pred             eEEcccCcEEEEEEEECCCCcEEEEEEecchhhH--HHHHHHHHHHH-HHhhCCCCCCCe----------EEEEEEecCC
Q psy1546          63 ERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAE--DEIEDIQQEIM-VLSQCDSPYGTK----------LWIIMEYLGG  129 (604)
Q Consensus        63 ~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~--~~~~~l~~Ei~-iL~~l~hp~~~~----------lyLVmEy~~g  129 (604)
                      +.||+|+||+||+|.+..+++.||||++......  .....+..|.. +++.++||++.+          +|+||||+.+
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence            4699999999999999999999999999754321  22344455544 568899998654          4799999999


Q ss_pred             CChhhHhhc-CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCCCCcccccCC
Q psy1546         130 GSALDLMKA-GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTP  208 (604)
Q Consensus       130 gsL~~~l~~-~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~~~~~~GT~  208 (604)
                      |+|..++.. +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++............+||+
T Consensus        81 g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~  160 (323)
T cd05575          81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTP  160 (323)
T ss_pred             CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCCccccccCCh
Confidence            999988865 5799999999999999999999999999999999999999999999999999975444444445678999


Q ss_pred             CCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCCCCCCCCccchHHHHHHHHHHhccCCCCCC
Q psy1546         209 FWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPENRP  288 (604)
Q Consensus       209 ~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rp  288 (604)
                      .|+|||++.+..++.++|||||||+||+|++|..||...+..+....+.... ..+...++..+.+||.+||+.||.+||
T Consensus       161 ~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~li~~~l~~~p~~R~  239 (323)
T cd05575         161 EYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKP-LRLKPNISVSARHLLEGLLQKDRTKRL  239 (323)
T ss_pred             hhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCC-CCCCCCCCHHHHHHHHHHhhcCHHhCC
Confidence            9999999999999999999999999999999999999887766655544332 344566799999999999999999999


Q ss_pred             CH----HHHhcChhhhhh
Q psy1546         289 TA----KELLKFPFIRKA  302 (604)
Q Consensus       289 T~----~elL~hp~f~~~  302 (604)
                      ++    .+++.||||...
T Consensus       240 ~~~~~~~~il~~~~~~~~  257 (323)
T cd05575         240 GAKDDFLEIKNHVFFSSI  257 (323)
T ss_pred             CCCCCHHHHHcCCCcCCC
Confidence            87    699999999764

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=2.9e-42  Score=363.44  Aligned_cols=240  Identities=28%  Similarity=0.513  Sum_probs=200.3

Q ss_pred             eEEcccCcEEEEEEEECCCCcEEEEEEecchhh--HHHHHHHHHHHHHHhhC-CCCCCCe----------EEEEEEecCC
Q psy1546          63 ERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA--EDEIEDIQQEIMVLSQC-DSPYGTK----------LWIIMEYLGG  129 (604)
Q Consensus        63 ~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~--~~~~~~l~~Ei~iL~~l-~hp~~~~----------lyLVmEy~~g  129 (604)
                      +.||+|+||.||+|.+..+++.||+|++.+...  ......+.+|+.++.++ .||++.+          +|+||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~   80 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG   80 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence            469999999999999999999999999976532  23456678899888776 7998654          4799999999


Q ss_pred             CChhhHhhc-CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCCCCcccccCC
Q psy1546         130 GSALDLMKA-GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTP  208 (604)
Q Consensus       130 gsL~~~l~~-~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~~~~~~GT~  208 (604)
                      |+|..++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++............+||+
T Consensus        81 ~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~  160 (329)
T cd05618          81 GDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTP  160 (329)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCccccccCCc
Confidence            999988754 6799999999999999999999999999999999999999999999999999975443333445678999


Q ss_pred             CCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCCh--------hhHhhhcCCCCCCCCCccchHHHHHHHHHHh
Q psy1546         209 FWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHP--------MRVLFLIPKNNPPQLTGNYTKQFKEFVEACL  280 (604)
Q Consensus       209 ~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~--------~~~~~~i~~~~~~~~~~~~s~~l~~Li~~~L  280 (604)
                      .|+|||++.+..++.++|||||||++|+|++|..||.....        ..............++..++..+.+||.+||
T Consensus       161 ~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ll~~~L  240 (329)
T cd05618         161 NYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLKSFL  240 (329)
T ss_pred             cccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHh
Confidence            99999999999999999999999999999999999953211        1111111122334566778899999999999


Q ss_pred             ccCCCCCCC------HHHHhcChhhhhh
Q psy1546         281 NKDPENRPT------AKELLKFPFIRKA  302 (604)
Q Consensus       281 ~~dP~~RpT------~~elL~hp~f~~~  302 (604)
                      ..||.+||+      +.++++||||+..
T Consensus       241 ~~dP~~R~~~~~~~~~~~i~~hp~f~~~  268 (329)
T cd05618         241 NKDPKERLGCHPQTGFADIQGHPFFRNV  268 (329)
T ss_pred             cCCHHHcCCCCCCCCHHHHhcCCCCCCC
Confidence            999999998      6899999999764

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=3.3e-42  Score=361.05  Aligned_cols=240  Identities=32%  Similarity=0.536  Sum_probs=204.8

Q ss_pred             eEEcccCcEEEEEEEECCCCcEEEEEEecchhh--HHHHHHHHHHHHHHhh-CCCCCCCe----------EEEEEEecCC
Q psy1546          63 ERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA--EDEIEDIQQEIMVLSQ-CDSPYGTK----------LWIIMEYLGG  129 (604)
Q Consensus        63 ~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~--~~~~~~l~~Ei~iL~~-l~hp~~~~----------lyLVmEy~~g  129 (604)
                      +.||+|+||+||+|.+..+++.||||++.....  .........|..++.. +.||++.+          +|+||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~   80 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence            469999999999999999999999999976532  2334556677778775 58998654          4799999999


Q ss_pred             CChhhHhhc-CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCCCCcccccCC
Q psy1546         130 GSALDLMKA-GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTP  208 (604)
Q Consensus       130 gsL~~~l~~-~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~~~~~~GT~  208 (604)
                      |+|.+++.. +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++............+||+
T Consensus        81 g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~  160 (316)
T cd05619          81 GDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTP  160 (316)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCceeeecCCc
Confidence            999999875 5799999999999999999999999999999999999999999999999999975433333445668999


Q ss_pred             CCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCCCCCCCCccchHHHHHHHHHHhccCCCCCC
Q psy1546         209 FWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPENRP  288 (604)
Q Consensus       209 ~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rp  288 (604)
                      .|+|||++.+..++.++|||||||++|+|++|..||...+.......+.... +.++..++.++++||.+||..||.+||
T Consensus       161 ~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~li~~~l~~~P~~R~  239 (316)
T cd05619         161 DYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDN-PCYPRWLTREAKDILVKLFVREPERRL  239 (316)
T ss_pred             cccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-CCCCccCCHHHHHHHHHHhccCHhhcC
Confidence            9999999999999999999999999999999999999887766665554333 345567889999999999999999999


Q ss_pred             CHH-HHhcChhhhhhh
Q psy1546         289 TAK-ELLKFPFIRKAK  303 (604)
Q Consensus       289 T~~-elL~hp~f~~~~  303 (604)
                      ++. ++++||||+...
T Consensus       240 ~~~~~l~~h~~~~~~~  255 (316)
T cd05619         240 GVKGDIRQHPFFREID  255 (316)
T ss_pred             CChHHHHcCcccCCCC
Confidence            996 899999997643

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=5.6e-42  Score=381.01  Aligned_cols=246  Identities=29%  Similarity=0.477  Sum_probs=215.9

Q ss_pred             ccceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhh-HHHHHHHHHHHHHHhhCCCCCCCe----------------
Q psy1546          57 LIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA-EDEIEDIQQEIMVLSQCDSPYGTK----------------  119 (604)
Q Consensus        57 ~~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~-~~~~~~l~~Ei~iL~~l~hp~~~~----------------  119 (604)
                      ..|.+.+.||+|+||+||+|.+..+++.||||++..... ......+.+|+.++..+.|+++.+                
T Consensus        32 ~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~~  111 (496)
T PTZ00283         32 KKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENV  111 (496)
T ss_pred             CCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcccc
Confidence            459999999999999999999999999999999966532 344567889999999999987443                


Q ss_pred             --EEEEEEecCCCChhhHhhc-----CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccc
Q psy1546         120 --LWIIMEYLGGGSALDLMKA-----GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAG  192 (604)
Q Consensus       120 --lyLVmEy~~ggsL~~~l~~-----~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~  192 (604)
                        +++||||+.+|+|.+++..     ..+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++
T Consensus       112 ~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL~DFGls~  191 (496)
T PTZ00283        112 LMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSK  191 (496)
T ss_pred             eEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEEEecccCe
Confidence              5799999999999998853     468999999999999999999999999999999999999999999999999997


Q ss_pred             cccCC--CCCCcccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCCCCCCCCccchH
Q psy1546         193 TLTNT--TSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTK  270 (604)
Q Consensus       193 ~~~~~--~~~~~~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~  270 (604)
                      .+...  .......+||+.|+|||++.+..|+.++|||||||+||||++|..||...........+.......++..+++
T Consensus       192 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  271 (496)
T PTZ00283        192 MYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYDPLPPSISP  271 (496)
T ss_pred             eccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCH
Confidence            65432  2223457899999999999999999999999999999999999999998887777666666666667788999


Q ss_pred             HHHHHHHHHhccCCCCCCCHHHHhcChhhhhh
Q psy1546         271 QFKEFVEACLNKDPENRPTAKELLKFPFIRKA  302 (604)
Q Consensus       271 ~l~~Li~~~L~~dP~~RpT~~elL~hp~f~~~  302 (604)
                      ++.+|+.+||..||.+||++.++++|||++..
T Consensus       272 ~l~~li~~~L~~dP~~RPs~~ell~~p~~~~~  303 (496)
T PTZ00283        272 EMQEIVTALLSSDPKRRPSSSKLLNMPICKLF  303 (496)
T ss_pred             HHHHHHHHHcccChhhCcCHHHHHhCHHHHHh
Confidence            99999999999999999999999999998754

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=3.5e-42  Score=360.78  Aligned_cols=239  Identities=30%  Similarity=0.531  Sum_probs=205.8

Q ss_pred             eEEcccCcEEEEEEEECCCCcEEEEEEecchhh--HHHHHHHHHHHHHHhhC-CCCCCCe----------EEEEEEecCC
Q psy1546          63 ERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA--EDEIEDIQQEIMVLSQC-DSPYGTK----------LWIIMEYLGG  129 (604)
Q Consensus        63 ~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~--~~~~~~l~~Ei~iL~~l-~hp~~~~----------lyLVmEy~~g  129 (604)
                      +.||+|+||+||+|.+..+++.||||++.....  ......+.+|+.++..+ .||++.+          +|+||||+.+
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   80 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG   80 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            469999999999999999999999999976532  23456677888888877 6998544          5799999999


Q ss_pred             CChhhHhhc-CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCCCCcccccCC
Q psy1546         130 GSALDLMKA-GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTP  208 (604)
Q Consensus       130 gsL~~~l~~-~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~~~~~~GT~  208 (604)
                      |+|..++.. +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++............+||+
T Consensus        81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g~~  160 (318)
T cd05570          81 GDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCGTP  160 (318)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCCcccceecCc
Confidence            999998865 4799999999999999999999999999999999999999999999999999865433333344568999


Q ss_pred             CCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCCCCCCCCccchHHHHHHHHHHhccCCCCCC
Q psy1546         209 FWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPENRP  288 (604)
Q Consensus       209 ~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rp  288 (604)
                      .|+|||++.+..++.++|||||||++|+|++|..||...........+.... ..++..++..+.+||.+||..||.+||
T Consensus       161 ~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~li~~~l~~dP~~R~  239 (318)
T cd05570         161 DYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDE-VRYPRWLSKEAKSILKSFLTKNPEKRL  239 (318)
T ss_pred             cccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCC-CCCCCcCCHHHHHHHHHHccCCHHHcC
Confidence            9999999999999999999999999999999999998877766655544332 345567899999999999999999999


Q ss_pred             CH-----HHHhcChhhhhh
Q psy1546         289 TA-----KELLKFPFIRKA  302 (604)
Q Consensus       289 T~-----~elL~hp~f~~~  302 (604)
                      ++     .+++.||||+..
T Consensus       240 s~~~~~~~~ll~~~~~~~~  258 (318)
T cd05570         240 GCLPTGEQDIKGHPFFREI  258 (318)
T ss_pred             CCCCCCHHHHhcCCCcCCC
Confidence            99     999999999764

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=4.8e-42  Score=361.20  Aligned_cols=243  Identities=29%  Similarity=0.471  Sum_probs=200.7

Q ss_pred             ceeeeEEcccCcEEEEEEEEC---CCCcEEEEEEecchhh---HHHHHHHHHHHHHHhhCC-CCCCCe----------EE
Q psy1546          59 FTKQERIGKGSFGEVFKGIDN---RTQQVVAIKIIDLEEA---EDEIEDIQQEIMVLSQCD-SPYGTK----------LW  121 (604)
Q Consensus        59 y~i~~~LG~G~fG~Vy~a~~~---~t~~~vAVK~i~~~~~---~~~~~~l~~Ei~iL~~l~-hp~~~~----------ly  121 (604)
                      |++.++||+|+||.||+|++.   .+++.||+|++.....   ....+.+..|+.++..+. |+++.+          +|
T Consensus         2 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~   81 (332)
T cd05614           2 FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKLH   81 (332)
T ss_pred             ceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEEE
Confidence            789999999999999999864   5789999999965432   223466788999999995 787544          47


Q ss_pred             EEEEecCCCChhhHhhc-CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCC-C
Q psy1546         122 IIMEYLGGGSALDLMKA-GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTT-S  199 (604)
Q Consensus       122 LVmEy~~ggsL~~~l~~-~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~-~  199 (604)
                      +||||+.+|+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.+.... .
T Consensus        82 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~~~~  161 (332)
T cd05614          82 LILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKE  161 (332)
T ss_pred             EEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCccccccCCC
Confidence            99999999999998854 679999999999999999999999999999999999999999999999999997653322 2


Q ss_pred             CCcccccCCCCCChHHhhcC-CCCCcchhhhHHHHHHHHHhCCCCCCCCCh----hhHhhhcCCCCCCCCCccchHHHHH
Q psy1546         200 KRNTFVGTPFWMAPEVIKQS-AYDSKADIWSLGITAIELAKGEPPNSELHP----MRVLFLIPKNNPPQLTGNYTKQFKE  274 (604)
Q Consensus       200 ~~~~~~GT~~Y~APE~l~~~-~~~~~sDVwSLGviL~eLltG~~Pf~~~~~----~~~~~~i~~~~~~~~~~~~s~~l~~  274 (604)
                      .....+||+.|||||++.+. .++.++|||||||+||||++|..||.....    ......+. ...+.++..++..+.+
T Consensus       162 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~  240 (332)
T cd05614         162 RTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRIL-KCDPPFPSFIGPEAQD  240 (332)
T ss_pred             ccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHh-cCCCCCCCCCCHHHHH
Confidence            23356899999999999865 478899999999999999999999964322    12222222 2234456678999999


Q ss_pred             HHHHHhccCCCCCC-----CHHHHhcChhhhhh
Q psy1546         275 FVEACLNKDPENRP-----TAKELLKFPFIRKA  302 (604)
Q Consensus       275 Li~~~L~~dP~~Rp-----T~~elL~hp~f~~~  302 (604)
                      ||.+||..||++||     +++++++||||+..
T Consensus       241 li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~  273 (332)
T cd05614         241 LLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGL  273 (332)
T ss_pred             HHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence            99999999999999     89999999999764

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=5.7e-42  Score=367.50  Aligned_cols=246  Identities=29%  Similarity=0.463  Sum_probs=206.9

Q ss_pred             ccceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhh--HHHHHHHHHHHHHHhhCCCCCCCe----------EEEEE
Q psy1546          57 LIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA--EDEIEDIQQEIMVLSQCDSPYGTK----------LWIIM  124 (604)
Q Consensus        57 ~~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~--~~~~~~l~~Ei~iL~~l~hp~~~~----------lyLVm  124 (604)
                      ..|++.+.||+|+||.||+|.+..+++.||+|++.+...  ......+.+|+.+++.+.||++.+          +|+||
T Consensus        43 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~  122 (370)
T cd05621          43 EDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVM  122 (370)
T ss_pred             HHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            349999999999999999999999999999999965432  223456789999999999998655          57999


Q ss_pred             EecCCCChhhHhhcCCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCC-CCcc
Q psy1546         125 EYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTS-KRNT  203 (604)
Q Consensus       125 Ey~~ggsL~~~l~~~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~-~~~~  203 (604)
                      |||++|+|.+++....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+|..+..... ...+
T Consensus       123 Ey~~gg~L~~~l~~~~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~~~~~~~  202 (370)
T cd05621         123 EYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDT  202 (370)
T ss_pred             cCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceecccCCceeccc
Confidence            999999999999888899999999999999999999999999999999999999999999999999976643322 2346


Q ss_pred             cccCCCCCChHHhhcCC----CCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCCC-CCCCC--ccchHHHHHHH
Q psy1546         204 FVGTPFWMAPEVIKQSA----YDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNN-PPQLT--GNYTKQFKEFV  276 (604)
Q Consensus       204 ~~GT~~Y~APE~l~~~~----~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~~-~~~~~--~~~s~~l~~Li  276 (604)
                      .+||+.|||||++.+..    ++.++|||||||+||+|++|..||...........+.... ...++  ..++..+++++
T Consensus       203 ~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li  282 (370)
T cd05621         203 AVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPEDVEISKHAKNLI  282 (370)
T ss_pred             CCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccCCCCcccCCHHHHHHH
Confidence            68999999999997643    7889999999999999999999999887665555544322 12222  24688999999


Q ss_pred             HHHhccCCCC--CCCHHHHhcChhhhhh
Q psy1546         277 EACLNKDPEN--RPTAKELLKFPFIRKA  302 (604)
Q Consensus       277 ~~~L~~dP~~--RpT~~elL~hp~f~~~  302 (604)
                      .+||..++.+  |+++.|+++||||+..
T Consensus       283 ~~~L~~~~~r~~R~~~~e~l~hp~~~~~  310 (370)
T cd05621         283 CAFLTDREVRLGRNGVEEIKQHPFFKND  310 (370)
T ss_pred             HHHccCchhccCCCCHHHHhcCcccCCC
Confidence            9999865544  8999999999999763

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=8.2e-42  Score=374.45  Aligned_cols=240  Identities=25%  Similarity=0.391  Sum_probs=196.0

Q ss_pred             ccceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCCe-----------------
Q psy1546          57 LIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTK-----------------  119 (604)
Q Consensus        57 ~~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~~-----------------  119 (604)
                      ..|.++++||+|+||.||+|.+..+++.||||++....     ....+|+.+|+.++|+++++                 
T Consensus        66 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~-----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~  140 (440)
T PTZ00036         66 KSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNI  140 (440)
T ss_pred             CeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc-----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCce
Confidence            45999999999999999999999999999999885432     23457999999999999654                 


Q ss_pred             -EEEEEEecCCCChhhHhh-----cCCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCC-CeEEecccccc
Q psy1546         120 -LWIIMEYLGGGSALDLMK-----AGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMG-DVKLADFGVAG  192 (604)
Q Consensus       120 -lyLVmEy~~ggsL~~~l~-----~~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g-~vKL~DFGlA~  192 (604)
                       +|+||||+++ +|.+++.     ...+++..++.++.||+.||.|||++||+||||||+||||+.++ .+||+|||+|+
T Consensus       141 ~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~DFGla~  219 (440)
T PTZ00036        141 FLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAK  219 (440)
T ss_pred             EEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeeccccch
Confidence             4589999975 5666553     35689999999999999999999999999999999999998665 69999999997


Q ss_pred             cccCCCCCCcccccCCCCCChHHhhcC-CCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCC------------
Q psy1546         193 TLTNTTSKRNTFVGTPFWMAPEVIKQS-AYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKN------------  259 (604)
Q Consensus       193 ~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~------------  259 (604)
                      .+.... .....+||+.|||||++.+. .|+.++|||||||+||||++|.+||.+....+.+..+...            
T Consensus       220 ~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~  298 (440)
T PTZ00036        220 NLLAGQ-RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEM  298 (440)
T ss_pred             hccCCC-CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHh
Confidence            664322 23356789999999998764 6899999999999999999999999887654333221100            


Q ss_pred             -------C---------CCCCCccchHHHHHHHHHHhccCCCCCCCHHHHhcChhhhhhh
Q psy1546         260 -------N---------PPQLTGNYTKQFKEFVEACLNKDPENRPTAKELLKFPFIRKAK  303 (604)
Q Consensus       260 -------~---------~~~~~~~~s~~l~~Li~~~L~~dP~~RpT~~elL~hp~f~~~~  303 (604)
                             .         ...++...+.++.+||.+||..||.+|||+.|+|+||||....
T Consensus       299 ~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~  358 (440)
T PTZ00036        299 NPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLR  358 (440)
T ss_pred             chhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhh
Confidence                   0         0112334678999999999999999999999999999997654

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=3.1e-42  Score=362.29  Aligned_cols=245  Identities=30%  Similarity=0.486  Sum_probs=206.5

Q ss_pred             cceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhh--HHHHHHHHHHHHHHhhCCCCCCCe----------EEEEEE
Q psy1546          58 IFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA--EDEIEDIQQEIMVLSQCDSPYGTK----------LWIIME  125 (604)
Q Consensus        58 ~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~--~~~~~~l~~Ei~iL~~l~hp~~~~----------lyLVmE  125 (604)
                      .|.+.+.||+|+||.||+|.+..+++.||||++.....  ......+.+|+.+++.+.|+++.+          +|||||
T Consensus         2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e   81 (330)
T cd05601           2 DFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVME   81 (330)
T ss_pred             CceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEEC
Confidence            38899999999999999999999999999999976543  234567889999999999998543          579999


Q ss_pred             ecCCCChhhHhhc--CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCC-CCc
Q psy1546         126 YLGGGSALDLMKA--GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTS-KRN  202 (604)
Q Consensus       126 y~~ggsL~~~l~~--~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~-~~~  202 (604)
                      |+++|+|.+++..  +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+..... ...
T Consensus        82 ~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~  161 (330)
T cd05601          82 YQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSK  161 (330)
T ss_pred             CCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCCCceeee
Confidence            9999999999865  5799999999999999999999999999999999999999999999999999976643322 223


Q ss_pred             ccccCCCCCChHHhh------cCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCCC-CCCC--CccchHHHH
Q psy1546         203 TFVGTPFWMAPEVIK------QSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNN-PPQL--TGNYTKQFK  273 (604)
Q Consensus       203 ~~~GT~~Y~APE~l~------~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~~-~~~~--~~~~s~~l~  273 (604)
                      ...||+.|+|||++.      ...++.++|||||||+||+|++|..||...........+.... ...+  ...++..+.
T Consensus       162 ~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  241 (330)
T cd05601         162 LPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKVSSDFL  241 (330)
T ss_pred             cccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHHH
Confidence            457999999999997      4567889999999999999999999998877665554433221 1112  235788999


Q ss_pred             HHHHHHhccCCCCCCCHHHHhcChhhhhhh
Q psy1546         274 EFVEACLNKDPENRPTAKELLKFPFIRKAK  303 (604)
Q Consensus       274 ~Li~~~L~~dP~~RpT~~elL~hp~f~~~~  303 (604)
                      +||.+||. +|.+|||+++++.||||....
T Consensus       242 ~li~~ll~-~p~~R~t~~~l~~h~~~~~~~  270 (330)
T cd05601         242 DLIQSLLC-GQKERLGYEGLCCHPFFSKID  270 (330)
T ss_pred             HHHHHHcc-ChhhCCCHHHHhCCCCcCCCC
Confidence            99999998 999999999999999997643

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>KOG0589|consensus

Probab=100.00  E-value=1.1e-42  Score=368.93  Aligned_cols=245  Identities=33%  Similarity=0.556  Sum_probs=226.0

Q ss_pred             cceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhH-HHHHHHHHHHHHHhhCCCCCCCe-----------EEEEEE
Q psy1546          58 IFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAE-DEIEDIQQEIMVLSQCDSPYGTK-----------LWIIME  125 (604)
Q Consensus        58 ~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~-~~~~~l~~Ei~iL~~l~hp~~~~-----------lyLVmE  125 (604)
                      .|..+++||+|+||.+++++++..+..||+|.|...... .......+|+.+++++.|||++.           +||||+
T Consensus         5 ~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm~   84 (426)
T KOG0589|consen    5 NYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVME   84 (426)
T ss_pred             hhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEEe
Confidence            488999999999999999999999999999999766543 33457889999999999998543           689999


Q ss_pred             ecCCCChhhHhhc---CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCCCCc
Q psy1546         126 YLGGGSALDLMKA---GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRN  202 (604)
Q Consensus       126 y~~ggsL~~~l~~---~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~~~  202 (604)
                      ||+||+|.+.|..   ..|+++.+..|+.||+.||.|||+++|+|||||+.|||++.++.|+|+|||+|+.+........
T Consensus        85 Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~~~a~  164 (426)
T KOG0589|consen   85 YCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPEDSLAS  164 (426)
T ss_pred             ecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcCCchhhhh
Confidence            9999999999865   4599999999999999999999999999999999999999999999999999999987776788


Q ss_pred             ccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCCCCCCCCccchHHHHHHHHHHhcc
Q psy1546         203 TFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNK  282 (604)
Q Consensus       203 ~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~~L~~  282 (604)
                      +.+||+.||.||++.+.+|+.++|||||||++|||++-+++|.+.+.......+.......++..++.+++.||..||..
T Consensus       165 tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~Plp~~ys~el~~lv~~~l~~  244 (426)
T KOG0589|consen  165 TVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSPLPSMYSSELRSLVKSMLRK  244 (426)
T ss_pred             eecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCCCCccccHHHHHHHHHHhhc
Confidence            89999999999999999999999999999999999999999999999999998888888899999999999999999999


Q ss_pred             CCCCCCCHHHHhcChhhhhh
Q psy1546         283 DPENRPTAKELLKFPFIRKA  302 (604)
Q Consensus       283 dP~~RpT~~elL~hp~f~~~  302 (604)
                      +|..||++.+||.+|.+...
T Consensus       245 ~P~~RPsa~~LL~~P~l~~~  264 (426)
T KOG0589|consen  245 NPEHRPSALELLRRPHLLRY  264 (426)
T ss_pred             CCccCCCHHHHhhChhhhhH
Confidence            99999999999999877543

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=4.8e-42  Score=365.86  Aligned_cols=246  Identities=30%  Similarity=0.484  Sum_probs=205.9

Q ss_pred             cceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhh--HHHHHHHHHHHHHHhhCCCCCCCe----------EEEEEE
Q psy1546          58 IFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA--EDEIEDIQQEIMVLSQCDSPYGTK----------LWIIME  125 (604)
Q Consensus        58 ~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~--~~~~~~l~~Ei~iL~~l~hp~~~~----------lyLVmE  125 (604)
                      .|++.+.||+|+||.||+|.+..+++.||||++.....  ......+.+|+.++..++|+++.+          +|||||
T Consensus         2 ~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E   81 (360)
T cd05627           2 DFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIME   81 (360)
T ss_pred             CceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEe
Confidence            38899999999999999999999999999999975432  234567889999999999998554          589999


Q ss_pred             ecCCCChhhHhhc-CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCC------
Q psy1546         126 YLGGGSALDLMKA-GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTT------  198 (604)
Q Consensus       126 y~~ggsL~~~l~~-~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~------  198 (604)
                      ||+||+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+||||+.+|.++|+|||+++.+....      
T Consensus        82 ~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~~~~  161 (360)
T cd05627          82 FLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYR  161 (360)
T ss_pred             CCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCccccccccccccc
Confidence            9999999998854 679999999999999999999999999999999999999999999999999986543211      


Q ss_pred             -----------------------------CCCcccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCCh
Q psy1546         199 -----------------------------SKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHP  249 (604)
Q Consensus       199 -----------------------------~~~~~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~  249 (604)
                                                   ......+||+.|+|||++.+..++.++|||||||+||||++|.+||.....
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~~~~~  241 (360)
T cd05627         162 NLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETP  241 (360)
T ss_pred             ccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCCCCCH
Confidence                                         001245799999999999999999999999999999999999999998877


Q ss_pred             hhHhhhcCCCC-CCCCC--ccchHHHHHHHHHHhccCCCCCC---CHHHHhcChhhhhhhh
Q psy1546         250 MRVLFLIPKNN-PPQLT--GNYTKQFKEFVEACLNKDPENRP---TAKELLKFPFIRKAKK  304 (604)
Q Consensus       250 ~~~~~~i~~~~-~~~~~--~~~s~~l~~Li~~~L~~dP~~Rp---T~~elL~hp~f~~~~~  304 (604)
                      ......+.... ...++  ..++.++++||.+|+. ||.+|+   ++.++++||||....+
T Consensus       242 ~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~hp~f~~~~~  301 (360)
T cd05627         242 QETYRKVMNWKETLVFPPEVPISEKAKDLILRFCT-DSENRIGSNGVEEIKSHPFFEGVDW  301 (360)
T ss_pred             HHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhcCCCCCCCCH
Confidence            66655443321 11122  2368899999999874 999998   5899999999987543

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=6.4e-42  Score=359.66  Aligned_cols=240  Identities=30%  Similarity=0.498  Sum_probs=201.7

Q ss_pred             eEEcccCcEEEEEEEECCCCcEEEEEEecchhhH--HHHHHHHHH-HHHHhhCCCCCCCe----------EEEEEEecCC
Q psy1546          63 ERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAE--DEIEDIQQE-IMVLSQCDSPYGTK----------LWIIMEYLGG  129 (604)
Q Consensus        63 ~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~--~~~~~l~~E-i~iL~~l~hp~~~~----------lyLVmEy~~g  129 (604)
                      +.||+|+||+||+|.+..+++.||+|++......  .....+..| ..+++.+.|+++.+          +|+||||+.+
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING   80 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence            4699999999999999999999999999754321  222334444 44578899998654          4799999999


Q ss_pred             CChhhHhhc-CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCCCCcccccCC
Q psy1546         130 GSALDLMKA-GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTP  208 (604)
Q Consensus       130 gsL~~~l~~-~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~~~~~~GT~  208 (604)
                      |+|.+++.. +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++............+||+
T Consensus        81 ~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~  160 (325)
T cd05602          81 GELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTP  160 (325)
T ss_pred             CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCCCcccccCCc
Confidence            999998865 6689999999999999999999999999999999999999999999999999976544444455678999


Q ss_pred             CCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCCCCCCCCccchHHHHHHHHHHhccCCCCCC
Q psy1546         209 FWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPENRP  288 (604)
Q Consensus       209 ~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rp  288 (604)
                      .|||||++.+..++.++|||||||++|+|++|.+||......+....+... ...+...++..+.++|.+||+.||.+|+
T Consensus       161 ~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~li~~~l~~~p~~R~  239 (325)
T cd05602         161 EYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNK-PLQLKPNITNSARHLLEGLLQKDRTKRL  239 (325)
T ss_pred             cccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhC-CcCCCCCCCHHHHHHHHHHcccCHHHCC
Confidence            999999999999999999999999999999999999988776665554332 2344567899999999999999999999


Q ss_pred             CHH----HHhcChhhhhhh
Q psy1546         289 TAK----ELLKFPFIRKAK  303 (604)
Q Consensus       289 T~~----elL~hp~f~~~~  303 (604)
                      ++.    ++++|+||....
T Consensus       240 ~~~~~~~~i~~~~~~~~~~  258 (325)
T cd05602         240 GAKDDFMEIKNHIFFSPIN  258 (325)
T ss_pred             CCCCCHHHHhcCcccCCCC
Confidence            865    899999997643

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.7e-42  Score=362.98  Aligned_cols=239  Identities=28%  Similarity=0.508  Sum_probs=199.5

Q ss_pred             EcccCcEEEEEEEECCCCcEEEEEEecchhhH--HHHHHHHHHHHHHhhC---CCCCCCe----------EEEEEEecCC
Q psy1546          65 IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAE--DEIEDIQQEIMVLSQC---DSPYGTK----------LWIIMEYLGG  129 (604)
Q Consensus        65 LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~--~~~~~l~~Ei~iL~~l---~hp~~~~----------lyLVmEy~~g  129 (604)
                      ||+|+||+||+|++..+++.||||++......  .....+..|..++..+   .||++..          +|+||||+.+
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            69999999999999999999999999654322  2334455666776655   6887543          5899999999


Q ss_pred             CChhhHhhc-CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCCCCcccccCC
Q psy1546         130 GSALDLMKA-GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTP  208 (604)
Q Consensus       130 gsL~~~l~~-~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~~~~~~GT~  208 (604)
                      |+|..++.. +.+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++............+||+
T Consensus        81 g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~  160 (330)
T cd05586          81 GELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGTT  160 (330)
T ss_pred             ChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCCccCccCCc
Confidence            999988754 6799999999999999999999999999999999999999999999999999976443344445678999


Q ss_pred             CCCChHHhhcC-CCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCCCCCCCCccchHHHHHHHHHHhccCCCCC
Q psy1546         209 FWMAPEVIKQS-AYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPENR  287 (604)
Q Consensus       209 ~Y~APE~l~~~-~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R  287 (604)
                      .|||||++.+. .++.++|||||||+||+|++|..||......+....+...........+++++.+||.+||..||.+|
T Consensus       161 ~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~~L~~~P~~R  240 (330)
T cd05586         161 EYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPKNVLSDEGRQFVKGLLNRNPQHR  240 (330)
T ss_pred             cccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCCHHHC
Confidence            99999999764 48899999999999999999999999887766665554443333334578999999999999999999


Q ss_pred             C----CHHHHhcChhhhhhh
Q psy1546         288 P----TAKELLKFPFIRKAK  303 (604)
Q Consensus       288 p----T~~elL~hp~f~~~~  303 (604)
                      |    ++.++++||||....
T Consensus       241 ~~~~~~~~~ll~h~~~~~~~  260 (330)
T cd05586         241 LGAHRDAVELKEHPFFADID  260 (330)
T ss_pred             CCCCCCHHHHhcCccccCCC
Confidence            8    799999999997643

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>KOG0658|consensus

Probab=100.00  E-value=1.3e-42  Score=354.70  Aligned_cols=240  Identities=28%  Similarity=0.456  Sum_probs=203.5

Q ss_pred             cceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCCeE---------------EE
Q psy1546          58 IFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTKL---------------WI  122 (604)
Q Consensus        58 ~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~~l---------------yL  122 (604)
                      .|...+++|.|+||.||+|....+++.||||.+-.+..     .-.+|+.+|+.++|||++++               .+
T Consensus        25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r-----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnl   99 (364)
T KOG0658|consen   25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR-----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNL   99 (364)
T ss_pred             EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC-----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHH
Confidence            47888999999999999999999999999999865542     23479999999999998776               28


Q ss_pred             EEEecCCCChhhHhh-----cCCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCC-CCeEEecccccccccC
Q psy1546         123 IMEYLGGGSALDLMK-----AGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEM-GDVKLADFGVAGTLTN  196 (604)
Q Consensus       123 VmEy~~ggsL~~~l~-----~~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~-g~vKL~DFGlA~~~~~  196 (604)
                      ||||++ .+|.++++     +.+++...++.++.||++||.|||+.||+||||||.|+|||.+ |.+||||||.|+.+..
T Consensus       100 VleymP-~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~  178 (364)
T KOG0658|consen  100 VLEYMP-ETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVK  178 (364)
T ss_pred             HHHhch-HHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcceeecc
Confidence            999994 56888877     4689999999999999999999999999999999999999976 9999999999998875


Q ss_pred             CCCCCcccccCCCCCChHHhhcC-CCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCC----------------
Q psy1546         197 TTSKRNTFVGTPFWMAPEVIKQS-AYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKN----------------  259 (604)
Q Consensus       197 ~~~~~~~~~GT~~Y~APE~l~~~-~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~----------------  259 (604)
                      ... ..+...|..|+|||.+.+. .|+.+.||||.|||+.||+.|++.|.+.+...++..|.+.                
T Consensus       179 ~ep-niSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~y  257 (364)
T KOG0658|consen  179 GEP-NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNPNY  257 (364)
T ss_pred             CCC-ceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCccc
Confidence            443 3567789999999999765 6999999999999999999999999998776555433110                


Q ss_pred             ---CCC---------CCCccchHHHHHHHHHHhccCCCCCCCHHHHhcChhhhhhhh
Q psy1546         260 ---NPP---------QLTGNYTKQFKEFVEACLNKDPENRPTAKELLKFPFIRKAKK  304 (604)
Q Consensus       260 ---~~~---------~~~~~~s~~l~~Li~~~L~~dP~~RpT~~elL~hp~f~~~~~  304 (604)
                         ..+         .+....++++.+|+.++|..+|.+|.++.|+|.||||...+.
T Consensus       258 ~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~  314 (364)
T KOG0658|consen  258 TEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRD  314 (364)
T ss_pred             ccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhC
Confidence               001         134567889999999999999999999999999999976654

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=7.8e-42  Score=359.70  Aligned_cols=241  Identities=27%  Similarity=0.511  Sum_probs=202.6

Q ss_pred             eEEcccCcEEEEEEEECCCCcEEEEEEecchhh--HHHHHHHHHHHHHHhhC-CCCCCC----------eEEEEEEecCC
Q psy1546          63 ERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA--EDEIEDIQQEIMVLSQC-DSPYGT----------KLWIIMEYLGG  129 (604)
Q Consensus        63 ~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~--~~~~~~l~~Ei~iL~~l-~hp~~~----------~lyLVmEy~~g  129 (604)
                      ++||+|+||.||+|.+..+++.||||++.....  ......+.+|+.++.++ .|+++.          .+|+||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG   80 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence            469999999999999999999999999976533  23456788999999887 588754          35799999999


Q ss_pred             CChhhHhhc-CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCCCCcccccCC
Q psy1546         130 GSALDLMKA-GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTP  208 (604)
Q Consensus       130 gsL~~~l~~-~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~~~~~~GT~  208 (604)
                      |+|..++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++............+||+
T Consensus        81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~  160 (327)
T cd05617          81 GDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGTP  160 (327)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCCceecccCCc
Confidence            999988754 6799999999999999999999999999999999999999999999999999975433333445678999


Q ss_pred             CCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCC------hhhHhhhcCCCCCCCCCccchHHHHHHHHHHhcc
Q psy1546         209 FWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELH------PMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNK  282 (604)
Q Consensus       209 ~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~------~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~~L~~  282 (604)
                      .|+|||++.+..++.++|||||||+||+|++|..||....      ............+..++..++..+.++|.+||..
T Consensus       161 ~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~  240 (327)
T cd05617         161 NYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRFLSVKASHVLKGFLNK  240 (327)
T ss_pred             ccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcc
Confidence            9999999999999999999999999999999999996422      1222222223334456677889999999999999


Q ss_pred             CCCCCCC------HHHHhcChhhhhhh
Q psy1546         283 DPENRPT------AKELLKFPFIRKAK  303 (604)
Q Consensus       283 dP~~RpT------~~elL~hp~f~~~~  303 (604)
                      ||.+|++      +.+++.||||+...
T Consensus       241 dP~~R~~~~~~~~~~~i~~h~~f~~~~  267 (327)
T cd05617         241 DPKERLGCQPQTGFSDIKSHTFFRSID  267 (327)
T ss_pred             CHHHcCCCCCCCCHHHHHcCCCCCCCC
Confidence            9999997      67999999998754

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>KOG0594|consensus

Probab=100.00  E-value=3e-42  Score=352.26  Aligned_cols=246  Identities=31%  Similarity=0.468  Sum_probs=207.1

Q ss_pred             cceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhh-HHHHHHHHHHHHHHhhCCCCC-CC----------------e
Q psy1546          58 IFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA-EDEIEDIQQEIMVLSQCDSPY-GT----------------K  119 (604)
Q Consensus        58 ~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~-~~~~~~l~~Ei~iL~~l~hp~-~~----------------~  119 (604)
                      .|..+++||+|+||+||+|+++.+|+.||+|.+..... +..-....+|+.+|+.+.|++ ++                .
T Consensus        12 ~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~   91 (323)
T KOG0594|consen   12 DYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGK   91 (323)
T ss_pred             HHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccce
Confidence            37888899999999999999999999999999976654 223356789999999999998 33                5


Q ss_pred             EEEEEEecCCCChhhHhhc-----CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccc
Q psy1546         120 LWIIMEYLGGGSALDLMKA-----GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTL  194 (604)
Q Consensus       120 lyLVmEy~~ggsL~~~l~~-----~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~  194 (604)
                      +|+||||+ .-+|..++..     ..++...++.+++||+.||+|||+++|+||||||+||||++.|.+||+|||+|+.+
T Consensus        92 l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGlAra~  170 (323)
T KOG0594|consen   92 LYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFGLARAF  170 (323)
T ss_pred             EEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccchHHHh
Confidence            67999999 5678888865     24777899999999999999999999999999999999999999999999999877


Q ss_pred             cCCCCCCcccccCCCCCChHHhhcC-CCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCCC-------------
Q psy1546         195 TNTTSKRNTFVGTPFWMAPEVIKQS-AYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNN-------------  260 (604)
Q Consensus       195 ~~~~~~~~~~~GT~~Y~APE~l~~~-~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~~-------------  260 (604)
                      .-+.......++|.+|+|||++.+. .|+..+||||+|||++||+++++.|.+....+.+..|....             
T Consensus       171 ~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~v~~  250 (323)
T KOG0594|consen  171 SIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPGVSS  250 (323)
T ss_pred             cCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCCccc
Confidence            7666666778899999999999887 69999999999999999999999999988776665442110             


Q ss_pred             -------CCCC--C-------ccchHHHHHHHHHHhccCCCCCCCHHHHhcChhhhhhhh
Q psy1546         261 -------PPQL--T-------GNYTKQFKEFVEACLNKDPENRPTAKELLKFPFIRKAKK  304 (604)
Q Consensus       261 -------~~~~--~-------~~~s~~l~~Li~~~L~~dP~~RpT~~elL~hp~f~~~~~  304 (604)
                             .+..  +       ........+++.+||+.+|.+|.|++.+|.||||.....
T Consensus       251 ~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~~  310 (323)
T KOG0594|consen  251 LPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELPE  310 (323)
T ss_pred             cccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhccccc
Confidence                   0000  0       112247889999999999999999999999999976543

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=8.8e-42  Score=357.76  Aligned_cols=240  Identities=30%  Similarity=0.470  Sum_probs=202.2

Q ss_pred             eEEcccCcEEEEEEEECCCCcEEEEEEecchhhH--HHHHHHHHHH-HHHhhCCCCCCCe----------EEEEEEecCC
Q psy1546          63 ERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAE--DEIEDIQQEI-MVLSQCDSPYGTK----------LWIIMEYLGG  129 (604)
Q Consensus        63 ~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~--~~~~~l~~Ei-~iL~~l~hp~~~~----------lyLVmEy~~g  129 (604)
                      ++||+|+||.||+|++..+++.||||++......  .....+..|+ .+++.+.||++.+          +|+|||||++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG   80 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            4699999999999999999999999999755322  2234455554 4678899998655          4799999999


Q ss_pred             CChhhHhhc-CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCCCCcccccCC
Q psy1546         130 GSALDLMKA-GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTP  208 (604)
Q Consensus       130 gsL~~~l~~-~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~~~~~~GT~  208 (604)
                      ++|..++.. +.+++..+..++.||+.||.|||++||+||||||+||||+.+|.+||+|||+++............+||+
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~  160 (321)
T cd05603          81 GELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGTP  160 (321)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCCccccccCCc
Confidence            999887754 6789999999999999999999999999999999999999999999999999875433333445678999


Q ss_pred             CCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCCCCCCCCccchHHHHHHHHHHhccCCCCCC
Q psy1546         209 FWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPENRP  288 (604)
Q Consensus       209 ~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rp  288 (604)
                      .|+|||++.+..++.++|||||||+||||++|..||...+.......+... +..++...+..+.++|.+||+.||.+|+
T Consensus       161 ~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~li~~~l~~~p~~R~  239 (321)
T cd05603         161 EYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHK-PLQLPGGKTVAACDLLVGLLHKDQRRRL  239 (321)
T ss_pred             ccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcC-CCCCCCCCCHHHHHHHHHHccCCHhhcC
Confidence            999999999999999999999999999999999999988766655554433 3455667888999999999999999998


Q ss_pred             CH----HHHhcChhhhhhh
Q psy1546         289 TA----KELLKFPFIRKAK  303 (604)
Q Consensus       289 T~----~elL~hp~f~~~~  303 (604)
                      ++    .++++|+||....
T Consensus       240 ~~~~~~~~~~~~~~~~~~~  258 (321)
T cd05603         240 GAKADFLEIKNHVFFSPIN  258 (321)
T ss_pred             CCCCCHHHHhCCCCcCCCC
Confidence            64    6999999997643

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>KOG0611|consensus

Probab=100.00  E-value=9.7e-43  Score=356.50  Aligned_cols=243  Identities=26%  Similarity=0.506  Sum_probs=217.3

Q ss_pred             ccccceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHH--HHHHHHHHHHHHhhCCCCCCCe----------EEE
Q psy1546          55 PELIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAED--EIEDIQQEIMVLSQCDSPYGTK----------LWI  122 (604)
Q Consensus        55 ~~~~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~--~~~~l~~Ei~iL~~l~hp~~~~----------lyL  122 (604)
                      ....|++.+.||+|.||.|-+|+....|+.||||.|.+...++  .+-.+.+||.||+.|+||++..          +.|
T Consensus        51 lkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvi  130 (668)
T KOG0611|consen   51 LKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVI  130 (668)
T ss_pred             hhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEE
Confidence            3445999999999999999999999999999999998776544  4567889999999999998654          569


Q ss_pred             EEEecCCCChhhHhhc-CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCCCC
Q psy1546         123 IMEYLGGGSALDLMKA-GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKR  201 (604)
Q Consensus       123 VmEy~~ggsL~~~l~~-~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~~  201 (604)
                      ||||..+|.|++++.. +.+++.+++.||+||..|+.|||.++++|||||.+|||++.++++||+|||++..+. .....
T Consensus       131 vMEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~-~~kfL  209 (668)
T KOG0611|consen  131 VMEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYA-DKKFL  209 (668)
T ss_pred             EEEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhhc-cccHH
Confidence            9999999999999954 889999999999999999999999999999999999999999999999999996554 44556


Q ss_pred             cccccCCCCCChHHhhcCCCC-CcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCCCCCCCCccchHHHHHHHHHHh
Q psy1546         202 NTFVGTPFWMAPEVIKQSAYD-SKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACL  280 (604)
Q Consensus       202 ~~~~GT~~Y~APE~l~~~~~~-~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~~L  280 (604)
                      .+|||+|.|.+||++.+..|. +.+|.|||||+||-|+.|..||.+.+...+...|..+.+..  +.-+..+.-||+.||
T Consensus       210 qTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYrE--P~~PSdA~gLIRwmL  287 (668)
T KOG0611|consen  210 QTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYRE--PETPSDASGLIRWML  287 (668)
T ss_pred             HHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccccC--CCCCchHHHHHHHHH
Confidence            799999999999999999985 78999999999999999999999999999999988876432  233567889999999


Q ss_pred             ccCCCCCCCHHHHhcChhhh
Q psy1546         281 NKDPENRPTAKELLKFPFIR  300 (604)
Q Consensus       281 ~~dP~~RpT~~elL~hp~f~  300 (604)
                      ..||++|.|+++|..|=|+.
T Consensus       288 mVNP~RRATieDiAsHWWvN  307 (668)
T KOG0611|consen  288 MVNPERRATIEDIASHWWVN  307 (668)
T ss_pred             hcCcccchhHHHHhhhheee
Confidence            99999999999999997764

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=2e-41  Score=363.38  Aligned_cols=246  Identities=28%  Similarity=0.442  Sum_probs=206.9

Q ss_pred             ccceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhh--HHHHHHHHHHHHHHhhCCCCCCCe----------EEEEE
Q psy1546          57 LIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA--EDEIEDIQQEIMVLSQCDSPYGTK----------LWIIM  124 (604)
Q Consensus        57 ~~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~--~~~~~~l~~Ei~iL~~l~hp~~~~----------lyLVm  124 (604)
                      ..|++.+.||+|+||.||+|.+..+++.||+|++.....  ......+.+|+.++..+.||++.+          +|+||
T Consensus        43 ~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~  122 (371)
T cd05622          43 EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVM  122 (371)
T ss_pred             hhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence            349999999999999999999999999999999865432  223456788999999999999655          47999


Q ss_pred             EecCCCChhhHhhcCCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCC-CCcc
Q psy1546         125 EYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTS-KRNT  203 (604)
Q Consensus       125 Ey~~ggsL~~~l~~~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~-~~~~  203 (604)
                      |||++|+|.+++....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+..... ....
T Consensus       123 Ey~~gg~L~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~~~~~~~~  202 (371)
T cd05622         123 EYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDT  202 (371)
T ss_pred             cCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcCCcccccC
Confidence            999999999999888899999999999999999999999999999999999999999999999999976643222 2345


Q ss_pred             cccCCCCCChHHhhcCC----CCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCCC-CCC--CCccchHHHHHHH
Q psy1546         204 FVGTPFWMAPEVIKQSA----YDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNN-PPQ--LTGNYTKQFKEFV  276 (604)
Q Consensus       204 ~~GT~~Y~APE~l~~~~----~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~~-~~~--~~~~~s~~l~~Li  276 (604)
                      .+||+.|||||++.+..    ++.++|||||||+||||++|.+||...+.......+.... ...  ....++..+++||
T Consensus       203 ~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li  282 (371)
T cd05622         203 AVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLI  282 (371)
T ss_pred             cccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCcccCCCcCCCCHHHHHHH
Confidence            68999999999997643    7889999999999999999999999887766555554322 112  2246889999999


Q ss_pred             HHHhccCCCC--CCCHHHHhcChhhhhh
Q psy1546         277 EACLNKDPEN--RPTAKELLKFPFIRKA  302 (604)
Q Consensus       277 ~~~L~~dP~~--RpT~~elL~hp~f~~~  302 (604)
                      ..||..++.+  |+++++|++|+||+..
T Consensus       283 ~~~L~~~~~r~~r~~~~ei~~h~~~~~~  310 (371)
T cd05622         283 CAFLTDREVRLGRNGVEEIKRHLFFKND  310 (371)
T ss_pred             HHHcCChhhhcCCCCHHHHhcCcccCCC
Confidence            9999844443  7899999999999763

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=1.5e-41  Score=349.32  Aligned_cols=240  Identities=28%  Similarity=0.450  Sum_probs=193.7

Q ss_pred             cceeeeEEcccCcEEEEEEEECC-CCcEEEEEEecchhhHH-HHHHHHHHHHHHhhC---CCCCCCe-------------
Q psy1546          58 IFTKQERIGKGSFGEVFKGIDNR-TQQVVAIKIIDLEEAED-EIEDIQQEIMVLSQC---DSPYGTK-------------  119 (604)
Q Consensus        58 ~y~i~~~LG~G~fG~Vy~a~~~~-t~~~vAVK~i~~~~~~~-~~~~l~~Ei~iL~~l---~hp~~~~-------------  119 (604)
                      .|++.+.||+|+||.||+|.+.. +++.||||++....... ....+.+|+.+++.+   .|||+.+             
T Consensus         2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~   81 (290)
T cd07862           2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE   81 (290)
T ss_pred             CcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCC
Confidence            48899999999999999999864 56889999986543221 223455677666654   6998654             


Q ss_pred             --EEEEEEecCCCChhhHhhc---CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccc
Q psy1546         120 --LWIIMEYLGGGSALDLMKA---GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTL  194 (604)
Q Consensus       120 --lyLVmEy~~ggsL~~~l~~---~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~  194 (604)
                        +|+||||+. ++|.+++..   ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus        82 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~~  160 (290)
T cd07862          82 TKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIY  160 (290)
T ss_pred             CcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccceEec
Confidence              479999996 578888754   45899999999999999999999999999999999999999999999999999765


Q ss_pred             cCCCCCCcccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCCC--------------
Q psy1546         195 TNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNN--------------  260 (604)
Q Consensus       195 ~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~~--------------  260 (604)
                      ... .......||+.|+|||++.+..++.++|||||||++|||++|.+||.+....+....+....              
T Consensus       161 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  239 (290)
T cd07862         161 SFQ-MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVAL  239 (290)
T ss_pred             cCC-cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhhhcc
Confidence            433 33345679999999999999999999999999999999999999998876544433221100              


Q ss_pred             ------------CCCCCccchHHHHHHHHHHhccCCCCCCCHHHHhcChhh
Q psy1546         261 ------------PPQLTGNYTKQFKEFVEACLNKDPENRPTAKELLKFPFI  299 (604)
Q Consensus       261 ------------~~~~~~~~s~~l~~Li~~~L~~dP~~RpT~~elL~hp~f  299 (604)
                                  ...+...++..+++||.+||+.||++|||+.|+|+||||
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f  290 (290)
T cd07862         240 PRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF  290 (290)
T ss_pred             cchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence                        001123467889999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=5.4e-42  Score=358.89  Aligned_cols=239  Identities=28%  Similarity=0.486  Sum_probs=205.8

Q ss_pred             eEEcccCcEEEEEEEE---CCCCcEEEEEEecchhhH-HHHHHHHHHHHHHhhCCCCCCCe----------EEEEEEecC
Q psy1546          63 ERIGKGSFGEVFKGID---NRTQQVVAIKIIDLEEAE-DEIEDIQQEIMVLSQCDSPYGTK----------LWIIMEYLG  128 (604)
Q Consensus        63 ~~LG~G~fG~Vy~a~~---~~t~~~vAVK~i~~~~~~-~~~~~l~~Ei~iL~~l~hp~~~~----------lyLVmEy~~  128 (604)
                      +.||+|+||.||++++   ..+++.||||++...... .....+.+|+.+|+++.|||+.+          +|+||||++
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   81 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR   81 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence            5799999999999986   357899999999765432 23456778999999999998654          479999999


Q ss_pred             CCChhhHhhc-CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCCCCcccccC
Q psy1546         129 GGSALDLMKA-GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGT  207 (604)
Q Consensus       129 ggsL~~~l~~-~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~~~~~~GT  207 (604)
                      +|+|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++............+||
T Consensus        82 ~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g~  161 (318)
T cd05582          82 GGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGT  161 (318)
T ss_pred             CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCceecccCC
Confidence            9999998854 579999999999999999999999999999999999999999999999999997665443444567899


Q ss_pred             CCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCCCCCCCCccchHHHHHHHHHHhccCCCCC
Q psy1546         208 PFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPENR  287 (604)
Q Consensus       208 ~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R  287 (604)
                      +.|+|||++.+..++.++|||||||++|+|++|..||...........+.... ..++..++..+.+||.+||+.||.+|
T Consensus       162 ~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~-~~~p~~~~~~~~~li~~~l~~~P~~R  240 (318)
T cd05582         162 VEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAK-LGMPQFLSPEAQSLLRALFKRNPANR  240 (318)
T ss_pred             hhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCC-CCCCCCCCHHHHHHHHHHhhcCHhHc
Confidence            99999999999899999999999999999999999999887766665554433 34556788999999999999999999


Q ss_pred             CC-----HHHHhcChhhhhh
Q psy1546         288 PT-----AKELLKFPFIRKA  302 (604)
Q Consensus       288 pT-----~~elL~hp~f~~~  302 (604)
                      |+     +.+++.||||...
T Consensus       241 ~~a~~~~~~~~~~~~~~~~~  260 (318)
T cd05582         241 LGAGPDGVEEIKRHPFFSTI  260 (318)
T ss_pred             CCCCCCCHHHHhCCCCcCCC
Confidence            99     8889999999764

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=7.1e-42  Score=359.32  Aligned_cols=240  Identities=29%  Similarity=0.454  Sum_probs=201.7

Q ss_pred             eEEcccCcEEEEEEEECCCCcEEEEEEecchhh--HHHHHHHHHHHH-HHhhCCCCCCCe----------EEEEEEecCC
Q psy1546          63 ERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA--EDEIEDIQQEIM-VLSQCDSPYGTK----------LWIIMEYLGG  129 (604)
Q Consensus        63 ~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~--~~~~~~l~~Ei~-iL~~l~hp~~~~----------lyLVmEy~~g  129 (604)
                      +.||+|+||+||+|.+..+++.||||++.....  ......+..|.. +++.++||++.+          +|+||||+.+
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG   80 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence            469999999999999999999999999965432  222344455554 577899998654          4799999999


Q ss_pred             CChhhHhhc-CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCCCCcccccCC
Q psy1546         130 GSALDLMKA-GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTP  208 (604)
Q Consensus       130 gsL~~~l~~-~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~~~~~~GT~  208 (604)
                      |+|..++.. +.+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++............+||+
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~  160 (325)
T cd05604          81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTP  160 (325)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCCcccccCCh
Confidence            999988754 6799999999999999999999999999999999999999999999999999975443334445678999


Q ss_pred             CCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCCCCCCCCccchHHHHHHHHHHhccCCCCCC
Q psy1546         209 FWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPENRP  288 (604)
Q Consensus       209 ~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rp  288 (604)
                      .|||||++.+..++.++|||||||++|+|++|..||...+..+....+.... ..+...++..+.++|.+||..||.+||
T Consensus       161 ~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ll~~ll~~~p~~R~  239 (325)
T cd05604         161 EYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKP-LVLRPGASLTAWSILEELLEKDRQRRL  239 (325)
T ss_pred             hhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCC-ccCCCCCCHHHHHHHHHHhccCHHhcC
Confidence            9999999999999999999999999999999999999887766655554433 234456788999999999999999998


Q ss_pred             CH----HHHhcChhhhhhh
Q psy1546         289 TA----KELLKFPFIRKAK  303 (604)
Q Consensus       289 T~----~elL~hp~f~~~~  303 (604)
                      ++    .++++||||....
T Consensus       240 ~~~~~~~~i~~h~~f~~~~  258 (325)
T cd05604         240 GAKEDFLEIQEHPFFESLS  258 (325)
T ss_pred             CCCCCHHHHhcCCCcCCCC
Confidence            75    6999999997643

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=6.9e-41  Score=337.29  Aligned_cols=241  Identities=30%  Similarity=0.537  Sum_probs=211.5

Q ss_pred             ceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhh-HHHHHHHHHHHHHHhhCCCCCCC-----------eEEEEEEe
Q psy1546          59 FTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA-EDEIEDIQQEIMVLSQCDSPYGT-----------KLWIIMEY  126 (604)
Q Consensus        59 y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~-~~~~~~l~~Ei~iL~~l~hp~~~-----------~lyLVmEy  126 (604)
                      |++.+.||.|+||.||+|.+..+++.||||.+..... ....+.+.+|+.+++.++|++..           .+|+||||
T Consensus         2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~   81 (257)
T cd08223           2 YCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGF   81 (257)
T ss_pred             ceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEecc
Confidence            8899999999999999999999999999999865433 33456788999999999999733           35799999


Q ss_pred             cCCCChhhHhhc---CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCCCCcc
Q psy1546         127 LGGGSALDLMKA---GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNT  203 (604)
Q Consensus       127 ~~ggsL~~~l~~---~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~~~~  203 (604)
                      +++++|.+++..   ..+++.+++.++.||+.||.|||++||+||||||+||+++.++.++|+|||++..+.........
T Consensus        82 ~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~  161 (257)
T cd08223          82 CEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMAST  161 (257)
T ss_pred             cCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEecccCCcccc
Confidence            999999998864   35899999999999999999999999999999999999999999999999999776544444456


Q ss_pred             cccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCCCCCCCCccchHHHHHHHHHHhccC
Q psy1546         204 FVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKD  283 (604)
Q Consensus       204 ~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~~L~~d  283 (604)
                      ..|++.|+|||++.+..++.++|||||||++|+|++|..||...+.......+..+..+..+..++..+.+|+.+||..|
T Consensus       162 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~  241 (257)
T cd08223         162 LIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPPMPKDYSPELGELIATMLSKR  241 (257)
T ss_pred             ccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCccccCHHHHHHHHHHhccC
Confidence            67999999999999999999999999999999999999999887766665555555555566778999999999999999


Q ss_pred             CCCCCCHHHHhcChhh
Q psy1546         284 PENRPTAKELLKFPFI  299 (604)
Q Consensus       284 P~~RpT~~elL~hp~f  299 (604)
                      |.+|||+.++++||||
T Consensus       242 p~~Rp~~~~~l~~~~~  257 (257)
T cd08223         242 PEKRPSVKSILRQPYI  257 (257)
T ss_pred             cccCCCHHHHhcCCCC
Confidence            9999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>KOG4717|consensus

Probab=100.00  E-value=3.9e-42  Score=360.30  Aligned_cols=243  Identities=26%  Similarity=0.472  Sum_probs=219.9

Q ss_pred             ccceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHH-HHHHHHHHHHHhhCCCCCCCeE----------EEEEE
Q psy1546          57 LIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDE-IEDIQQEIMVLSQCDSPYGTKL----------WIIME  125 (604)
Q Consensus        57 ~~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~-~~~l~~Ei~iL~~l~hp~~~~l----------yLVmE  125 (604)
                      ..|.+.+.||+|-|++|.+|++.-||+.||||+|++...... ...+.+|+..|+.+.|||++++          |||+|
T Consensus        18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE   97 (864)
T KOG4717|consen   18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE   97 (864)
T ss_pred             eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence            458999999999999999999999999999999988765442 4678899999999999997654          79999


Q ss_pred             ecCCCChhhHhhc--CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEe-cCCCCeEEecccccccccCCCCCCc
Q psy1546         126 YLGGGSALDLMKA--GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLL-SEMGDVKLADFGVAGTLTNTTSKRN  202 (604)
Q Consensus       126 y~~ggsL~~~l~~--~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl-~~~g~vKL~DFGlA~~~~~~~~~~~  202 (604)
                      +-++|+|+++|-+  ..+.|..++.||.||+.|+.|||+..+|||||||+||++ .+-|.|||+|||++..+. +..+..
T Consensus        98 LGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~-PG~kL~  176 (864)
T KOG4717|consen   98 LGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQ-PGKKLT  176 (864)
T ss_pred             ecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCC-Ccchhh
Confidence            9999999998854  579999999999999999999999999999999999977 466899999999997664 556678


Q ss_pred             ccccCCCCCChHHhhcCCCC-CcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCCCCCCCCccchHHHHHHHHHHhc
Q psy1546         203 TFVGTPFWMAPEVIKQSAYD-SKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLN  281 (604)
Q Consensus       203 ~~~GT~~Y~APE~l~~~~~~-~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~~L~  281 (604)
                      +.||++.|-|||++.+..|+ +++||||||||||-|++|++||+..+..+.+.+|....+ .++..++.++++||..||.
T Consensus       177 TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKY-tvPshvS~eCrdLI~sMLv  255 (864)
T KOG4717|consen  177 TSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKY-TVPSHVSKECRDLIQSMLV  255 (864)
T ss_pred             cccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcccc-cCchhhhHHHHHHHHHHHh
Confidence            99999999999999999998 578999999999999999999999999999988876554 5678899999999999999


Q ss_pred             cCCCCCCCHHHHhcChhhhh
Q psy1546         282 KDPENRPTAKELLKFPFIRK  301 (604)
Q Consensus       282 ~dP~~RpT~~elL~hp~f~~  301 (604)
                      .||++|.+++||..++|++.
T Consensus       256 RdPkkRAslEeI~s~~Wlq~  275 (864)
T KOG4717|consen  256 RDPKKRASLEEIVSTSWLQA  275 (864)
T ss_pred             cCchhhccHHHHhccccccC
Confidence            99999999999999999974

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.3e-41  Score=347.37  Aligned_cols=243  Identities=27%  Similarity=0.414  Sum_probs=204.1

Q ss_pred             ceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHH--HHHHHHHHHHHHhhCCCCCCC----------eEEEEEEe
Q psy1546          59 FTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAED--EIEDIQQEIMVLSQCDSPYGT----------KLWIIMEY  126 (604)
Q Consensus        59 y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~--~~~~l~~Ei~iL~~l~hp~~~----------~lyLVmEy  126 (604)
                      |++.++||+|+||+||++.+..+++.||||++.......  ....+.+|+.+++.++|+++.          .+|+||||
T Consensus         2 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (285)
T cd05605           2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL   81 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEec
Confidence            788999999999999999999999999999986543322  234567899999999999854          35799999


Q ss_pred             cCCCChhhHhhc---CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCCCCcc
Q psy1546         127 LGGGSALDLMKA---GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNT  203 (604)
Q Consensus       127 ~~ggsL~~~l~~---~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~~~~  203 (604)
                      +++|+|.+++..   ..+++..+..++.||+.||.|||++||+||||||+|||+++++.++|+|||++..+... .....
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~-~~~~~  160 (285)
T cd05605          82 MNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEG-ETIRG  160 (285)
T ss_pred             cCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCC-Ccccc
Confidence            999999988743   46899999999999999999999999999999999999999999999999999765322 22234


Q ss_pred             cccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhh---cCCCCCCCCCccchHHHHHHHHHHh
Q psy1546         204 FVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFL---IPKNNPPQLTGNYTKQFKEFVEACL  280 (604)
Q Consensus       204 ~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~---i~~~~~~~~~~~~s~~l~~Li~~~L  280 (604)
                      .+|++.|+|||++.+..++.++|||||||++|||++|..||.+.........   ........++..++..+.+||.+||
T Consensus       161 ~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l  240 (285)
T cd05605         161 RVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAARSICRQLL  240 (285)
T ss_pred             ccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcccccCcccCHHHHHHHHHHc
Confidence            5799999999999998999999999999999999999999987654322211   1122233455678899999999999


Q ss_pred             ccCCCCCC-----CHHHHhcChhhhhh
Q psy1546         281 NKDPENRP-----TAKELLKFPFIRKA  302 (604)
Q Consensus       281 ~~dP~~Rp-----T~~elL~hp~f~~~  302 (604)
                      ..||.+||     +++++++||||.+.
T Consensus       241 ~~~P~~R~~~~~~~~~~l~~~~~~~~~  267 (285)
T cd05605         241 TKDPGFRLGCRGEGAEEVKAHPFFRTA  267 (285)
T ss_pred             cCCHHHhcCCCCCCHHHHhcCcCccCC
Confidence            99999999     89999999999764

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=2.5e-41  Score=351.96  Aligned_cols=245  Identities=29%  Similarity=0.469  Sum_probs=200.4

Q ss_pred             cceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCCe----------EEEEEEec
Q psy1546          58 IFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTK----------LWIIMEYL  127 (604)
Q Consensus        58 ~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~~----------lyLVmEy~  127 (604)
                      .|.+.++||+|+||.||+|++..+++.||||.+...........+.+|+.+++.++|+++.+          +|+||||+
T Consensus         7 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   86 (309)
T cd07872           7 TYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYL   86 (309)
T ss_pred             ceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeCC
Confidence            48999999999999999999999999999999875544333456778999999999998655          47999999


Q ss_pred             CCCChhhHhhc--CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCCCCcccc
Q psy1546         128 GGGSALDLMKA--GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFV  205 (604)
Q Consensus       128 ~ggsL~~~l~~--~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~~~~~~  205 (604)
                      ++ +|.+++..  ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.............
T Consensus        87 ~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  165 (309)
T cd07872          87 DK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEV  165 (309)
T ss_pred             CC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCCCcccccccc
Confidence            75 67777654  3488999999999999999999999999999999999999999999999999976544433344567


Q ss_pred             cCCCCCChHHhhc-CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCC---------------------CCC-
Q psy1546         206 GTPFWMAPEVIKQ-SAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKN---------------------NPP-  262 (604)
Q Consensus       206 GT~~Y~APE~l~~-~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~---------------------~~~-  262 (604)
                      +|+.|+|||++.+ ..++.++|||||||++|+|++|.+||...+..+....+...                     ..+ 
T Consensus       166 ~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (309)
T cd07872         166 VTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKNYNFPK  245 (309)
T ss_pred             ccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhhhhcCc
Confidence            8999999999865 45889999999999999999999999876653332211100                     000 


Q ss_pred             -------CCCccchHHHHHHHHHHhccCCCCCCCHHHHhcChhhhhhh
Q psy1546         263 -------QLTGNYTKQFKEFVEACLNKDPENRPTAKELLKFPFIRKAK  303 (604)
Q Consensus       263 -------~~~~~~s~~l~~Li~~~L~~dP~~RpT~~elL~hp~f~~~~  303 (604)
                             .....++.++++||.+||..||.+|||+.|+|+||||+...
T Consensus       246 ~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~  293 (309)
T cd07872         246 YKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLG  293 (309)
T ss_pred             cCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhcc
Confidence                   01124678899999999999999999999999999997643

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=5.6e-41  Score=354.22  Aligned_cols=245  Identities=35%  Similarity=0.643  Sum_probs=204.3

Q ss_pred             ccceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCCe----------EEEEEEe
Q psy1546          57 LIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTK----------LWIIMEY  126 (604)
Q Consensus        57 ~~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~~----------lyLVmEy  126 (604)
                      ..|++.++||+|+||.||+|.+..++..||+|++...........+.+|+.+++.++|+|+.+          +|+||||
T Consensus         5 ~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   84 (333)
T cd06650           5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH   84 (333)
T ss_pred             hhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEec
Confidence            448999999999999999999999999999999876544445577899999999999998655          4799999


Q ss_pred             cCCCChhhHhhc-CCCcHHHHHHHHHHHHHHhHHhhhC-CccccccccceeEecCCCCeEEecccccccccCCCCCCccc
Q psy1546         127 LGGGSALDLMKA-GNFEEMHIAVILREVLKGLDYLHSE-RKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTF  204 (604)
Q Consensus       127 ~~ggsL~~~l~~-~~lse~~i~~i~~qIl~gL~yLHs~-gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~~~~~  204 (604)
                      +.+++|.+++.. +.+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++..+...  .....
T Consensus        85 ~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~--~~~~~  162 (333)
T cd06650          85 MDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--MANSF  162 (333)
T ss_pred             CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh--ccccC
Confidence            999999999865 5689999999999999999999975 7999999999999999999999999999765332  22345


Q ss_pred             ccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhc----------------------------
Q psy1546         205 VGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLI----------------------------  256 (604)
Q Consensus       205 ~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i----------------------------  256 (604)
                      .||+.|+|||++.+..++.++|||||||++|+|++|..||...........+                            
T Consensus       163 ~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (333)
T cd06650         163 VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGRPLSSYG  242 (333)
T ss_pred             CCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCccchhhhhc
Confidence            7999999999999989999999999999999999999999765433221110                            


Q ss_pred             ----------------CCCCCCCC-CccchHHHHHHHHHHhccCCCCCCCHHHHhcChhhhhhh
Q psy1546         257 ----------------PKNNPPQL-TGNYTKQFKEFVEACLNKDPENRPTAKELLKFPFIRKAK  303 (604)
Q Consensus       257 ----------------~~~~~~~~-~~~~s~~l~~Li~~~L~~dP~~RpT~~elL~hp~f~~~~  303 (604)
                                      .....+.+ ...++.++++||.+||+.||.+|||+.|++.||||+...
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~  306 (333)
T cd06650         243 PDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSE  306 (333)
T ss_pred             ccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcCc
Confidence                            01111111 123678899999999999999999999999999997653

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=1.4e-41  Score=342.03  Aligned_cols=241  Identities=41%  Similarity=0.665  Sum_probs=202.0

Q ss_pred             ceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHH-HHHHHHHHHHhhCCCCCCCe----------EEEEEEec
Q psy1546          59 FTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEI-EDIQQEIMVLSQCDSPYGTK----------LWIIMEYL  127 (604)
Q Consensus        59 y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~-~~l~~Ei~iL~~l~hp~~~~----------lyLVmEy~  127 (604)
                      |++++.||+|+||+||+|.+..+++.||+|++......... ....+|+.+++++.|+++.+          +|+||||+
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~   80 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC   80 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence            78899999999999999999999999999999877554433 34466999999999998554          47999999


Q ss_pred             CCCChhhHhh-cCCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCCCCccccc
Q psy1546         128 GGGSALDLMK-AGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVG  206 (604)
Q Consensus       128 ~ggsL~~~l~-~~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~~~~~~G  206 (604)
                      ++++|.+++. .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||.+..............+
T Consensus        81 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~  160 (260)
T PF00069_consen   81 PGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSENNENFNPFVG  160 (260)
T ss_dssp             TTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEESTSTTSEBSSSSS
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            9999999997 688999999999999999999999999999999999999999999999999999654333444556789


Q ss_pred             CCCCCChHHhh-cCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCCC------CCCCCccchHHHHHHHHHH
Q psy1546         207 TPFWMAPEVIK-QSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNN------PPQLTGNYTKQFKEFVEAC  279 (604)
Q Consensus       207 T~~Y~APE~l~-~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~~------~~~~~~~~s~~l~~Li~~~  279 (604)
                      +..|+|||++. +..++.++||||||+++|+|++|..||...........+....      ...........+.++|.+|
T Consensus       161 ~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~  240 (260)
T PF00069_consen  161 TPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSREKSEELRDLIKKM  240 (260)
T ss_dssp             SGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHHHHHHHHHHH
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccccchhHHHHHHHHHHH
Confidence            99999999998 8889999999999999999999999999873222222111100      0001111247999999999


Q ss_pred             hccCCCCCCCHHHHhcChhh
Q psy1546         280 LNKDPENRPTAKELLKFPFI  299 (604)
Q Consensus       280 L~~dP~~RpT~~elL~hp~f  299 (604)
                      |+.||++||++.++++||||
T Consensus       241 l~~~p~~R~~~~~l~~~~~~  260 (260)
T PF00069_consen  241 LSKDPEQRPSAEELLKHPWF  260 (260)
T ss_dssp             SSSSGGGSTTHHHHHTSGGG
T ss_pred             ccCChhHCcCHHHHhcCCCC
Confidence            99999999999999999998

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=3.5e-41  Score=355.30  Aligned_cols=238  Identities=25%  Similarity=0.432  Sum_probs=196.7

Q ss_pred             cceeeeEEcccCcEEEEEEEEC-----CCCcEEEEEEecchhhHHHHHHHHHHHHHHhhC-CCCCCCe-----------E
Q psy1546          58 IFTKQERIGKGSFGEVFKGIDN-----RTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQC-DSPYGTK-----------L  120 (604)
Q Consensus        58 ~y~i~~~LG~G~fG~Vy~a~~~-----~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l-~hp~~~~-----------l  120 (604)
                      .|.+.++||+|+||.||+|.+.     .++..||||++...........+.+|+.+|..+ .|||+++           +
T Consensus         8 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~   87 (338)
T cd05102           8 RLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNGPL   87 (338)
T ss_pred             HceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCCce
Confidence            4899999999999999999752     345789999997554445567789999999999 8998654           4


Q ss_pred             EEEEEecCCCChhhHhhcC-------------------------------------------------------------
Q psy1546         121 WIIMEYLGGGSALDLMKAG-------------------------------------------------------------  139 (604)
Q Consensus       121 yLVmEy~~ggsL~~~l~~~-------------------------------------------------------------  139 (604)
                      |+|||||++|+|.+++...                                                             
T Consensus        88 ~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  167 (338)
T cd05102          88 MVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLW  167 (338)
T ss_pred             EEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccccc
Confidence            7999999999999988531                                                             


Q ss_pred             --CCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCC--CCcccccCCCCCChHH
Q psy1546         140 --NFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTS--KRNTFVGTPFWMAPEV  215 (604)
Q Consensus       140 --~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~--~~~~~~GT~~Y~APE~  215 (604)
                        .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+.....  ......+++.|||||+
T Consensus       168 ~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~  247 (338)
T cd05102         168 KSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPES  247 (338)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccccCcHH
Confidence              367778889999999999999999999999999999999999999999999976533221  1223456788999999


Q ss_pred             hhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhh-HhhhcCCCCCCCCCccchHHHHHHHHHHhccCCCCCCCHHHH
Q psy1546         216 IKQSAYDSKADIWSLGITAIELAK-GEPPNSELHPMR-VLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPENRPTAKEL  293 (604)
Q Consensus       216 l~~~~~~~~sDVwSLGviL~eLlt-G~~Pf~~~~~~~-~~~~i~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~RpT~~el  293 (604)
                      +.+..++.++|||||||+||||++ |..||.+..... ....+..+.....+..+++.+.+|+.+||..||.+|||+.||
T Consensus       248 ~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~el  327 (338)
T cd05102         248 IFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMRAPENATPEIYRIMLACWQGDPKERPTFSAL  327 (338)
T ss_pred             hhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHH
Confidence            999999999999999999999997 999998765432 223333344445566788999999999999999999999999


Q ss_pred             hc
Q psy1546         294 LK  295 (604)
Q Consensus       294 L~  295 (604)
                      ++
T Consensus       328 ~~  329 (338)
T cd05102         328 VE  329 (338)
T ss_pred             HH
Confidence            86

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.3e-41  Score=343.43  Aligned_cols=256  Identities=47%  Similarity=0.846  Sum_probs=216.5

Q ss_pred             ccccceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCCe----------EEEEE
Q psy1546          55 PELIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTK----------LWIIM  124 (604)
Q Consensus        55 ~~~~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~~----------lyLVm  124 (604)
                      +.+.|.+.+.||.|+||.||+|.+..++..||+|++.... ....+.+.+|+.+++.++|++..+          +|+||
T Consensus         3 ~~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   81 (280)
T cd06611           3 PNDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIES-EEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILI   81 (280)
T ss_pred             chhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCC-HHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEe
Confidence            3455999999999999999999999899999999986543 334577889999999999998544          47999


Q ss_pred             EecCCCChhhHhhc--CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCCCCc
Q psy1546         125 EYLGGGSALDLMKA--GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRN  202 (604)
Q Consensus       125 Ey~~ggsL~~~l~~--~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~~~  202 (604)
                      ||+++++|.+++..  ..+++..++.++.|++.||.|||++||+||||+|+||+++.++.++|+|||++...........
T Consensus        82 e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~  161 (280)
T cd06611          82 EFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRD  161 (280)
T ss_pred             eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhcccccccc
Confidence            99999999999865  4699999999999999999999999999999999999999999999999999876554444445


Q ss_pred             ccccCCCCCChHHhh-----cCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCCCCCC--CCccchHHHHHH
Q psy1546         203 TFVGTPFWMAPEVIK-----QSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQ--LTGNYTKQFKEF  275 (604)
Q Consensus       203 ~~~GT~~Y~APE~l~-----~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~--~~~~~s~~l~~L  275 (604)
                      ...|++.|+|||++.     ...++.++|||||||++|+|++|.+||...........+.....+.  .+..++.++.+|
T Consensus       162 ~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  241 (280)
T cd06611         162 TFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQPSKWSSSFNDF  241 (280)
T ss_pred             eeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCCCCcCCcccCCHHHHHH
Confidence            567999999999985     3446778999999999999999999999887766655555444332  245678899999


Q ss_pred             HHHHhccCCCCCCCHHHHhcChhhhhhhhhhhHHHH
Q psy1546         276 VEACLNKDPENRPTAKELLKFPFIRKAKKNAYLIDL  311 (604)
Q Consensus       276 i~~~L~~dP~~RpT~~elL~hp~f~~~~~~~~l~~~  311 (604)
                      |.+||..+|.+||++.++++||||........+.++
T Consensus       242 i~~~l~~~p~~Rps~~~il~~~~~~~~~~~~~~~~~  277 (280)
T cd06611         242 LKSCLVKDPDDRPTAAELLKHPFVSDQSDNKAIKDL  277 (280)
T ss_pred             HHHHhccChhhCcCHHHHhcChhhcccchhHHHHHH
Confidence            999999999999999999999999887655444443

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>KOG0599|consensus

Probab=100.00  E-value=2e-42  Score=339.74  Aligned_cols=243  Identities=31%  Similarity=0.520  Sum_probs=212.7

Q ss_pred             ceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchh-------hHHHHHHHHHHHHHHhhC-CCCCCCeE----------
Q psy1546          59 FTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE-------AEDEIEDIQQEIMVLSQC-DSPYGTKL----------  120 (604)
Q Consensus        59 y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~-------~~~~~~~l~~Ei~iL~~l-~hp~~~~l----------  120 (604)
                      |.-.+.||.|..+.|-++.++.+++.+|+|+|....       .....+.-.+|+.||+++ .||++..+          
T Consensus        19 y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~sF~   98 (411)
T KOG0599|consen   19 YEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDAFV   98 (411)
T ss_pred             cChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcchh
Confidence            566678999999999999999999999999985432       223345667899999986 69987654          


Q ss_pred             EEEEEecCCCChhhHhhc-CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCC
Q psy1546         121 WIIMEYLGGGSALDLMKA-GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTS  199 (604)
Q Consensus       121 yLVmEy~~ggsL~~~l~~-~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~  199 (604)
                      |+|+|.|+.|.|.+++.. -.++++..+.||+|+++|+.|||.++||||||||+|||++++.++||+|||+|+.+.. ..
T Consensus        99 FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa~~l~~-Ge  177 (411)
T KOG0599|consen   99 FLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFACQLEP-GE  177 (411)
T ss_pred             hhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccceeeccCC-ch
Confidence            699999999999999976 5799999999999999999999999999999999999999999999999999988864 44


Q ss_pred             CCcccccCCCCCChHHhhcC------CCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCCCCC---CCCccchH
Q psy1546         200 KRNTFVGTPFWMAPEVIKQS------AYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPP---QLTGNYTK  270 (604)
Q Consensus       200 ~~~~~~GT~~Y~APE~l~~~------~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~~~~---~~~~~~s~  270 (604)
                      +....||||+|+|||.+...      .|+..+|+|++|||+|-||.|.+||.....+-++.+|..+...   +-+.+++.
T Consensus       178 kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~speWadis~  257 (411)
T KOG0599|consen  178 KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFRSPEWADISA  257 (411)
T ss_pred             hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccCCcchhhccc
Confidence            55688999999999998643      4778899999999999999999999998888888888877643   33457888


Q ss_pred             HHHHHHHHHhccCCCCCCCHHHHhcChhhhhh
Q psy1546         271 QFKEFVEACLNKDPENRPTAKELLKFPFIRKA  302 (604)
Q Consensus       271 ~l~~Li~~~L~~dP~~RpT~~elL~hp~f~~~  302 (604)
                      ..++||.+||+.||.+|.|++|+|.||||.+.
T Consensus       258 ~~KdLIsrlLqVdp~~Ritake~LaHpff~q~  289 (411)
T KOG0599|consen  258 TVKDLISRLLQVDPTKRITAKEALAHPFFIQI  289 (411)
T ss_pred             cHHHHHHHHHeeCchhcccHHHHhcChHHHHH
Confidence            99999999999999999999999999999653

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8e-41  Score=352.58  Aligned_cols=246  Identities=29%  Similarity=0.446  Sum_probs=202.6

Q ss_pred             cceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhh--HHHHHHHHHHHHHHhhCCCCCCCe----------EEEEEE
Q psy1546          58 IFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA--EDEIEDIQQEIMVLSQCDSPYGTK----------LWIIME  125 (604)
Q Consensus        58 ~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~--~~~~~~l~~Ei~iL~~l~hp~~~~----------lyLVmE  125 (604)
                      .|.+.+.||+|+||.||+|++..+++.||||++.+...  ......+.+|+.++..++|+++..          +|+|||
T Consensus         2 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   81 (331)
T cd05597           2 DFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVMD   81 (331)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEEe
Confidence            48899999999999999999999999999999975332  223466889999999999998654          589999


Q ss_pred             ecCCCChhhHhhc--CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCC-CCc
Q psy1546         126 YLGGGSALDLMKA--GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTS-KRN  202 (604)
Q Consensus       126 y~~ggsL~~~l~~--~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~-~~~  202 (604)
                      |+.||+|.+++..  ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++..+..... ...
T Consensus        82 ~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  161 (331)
T cd05597          82 YYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSN  161 (331)
T ss_pred             cCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCCcccc
Confidence            9999999999864  5799999999999999999999999999999999999999999999999999866543322 223


Q ss_pred             ccccCCCCCChHHhhc-----CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCCC----CCCCCccchHHHH
Q psy1546         203 TFVGTPFWMAPEVIKQ-----SAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNN----PPQLTGNYTKQFK  273 (604)
Q Consensus       203 ~~~GT~~Y~APE~l~~-----~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~~----~~~~~~~~s~~l~  273 (604)
                      ..+||+.|||||++..     ..++.++|||||||+||+|++|..||......+....+....    .+.....++..++
T Consensus       162 ~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  241 (331)
T cd05597         162 VAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTDVSEEAK  241 (331)
T ss_pred             ceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcccCCCccCCCCHHHH
Confidence            3579999999999973     457889999999999999999999998876655444332211    1222335789999


Q ss_pred             HHHHHHhccCCCC--CCCHHHHhcChhhhhhh
Q psy1546         274 EFVEACLNKDPEN--RPTAKELLKFPFIRKAK  303 (604)
Q Consensus       274 ~Li~~~L~~dP~~--RpT~~elL~hp~f~~~~  303 (604)
                      +||.+||..++++  |+++.++++||||....
T Consensus       242 ~li~~ll~~~~~r~~r~~~~~~l~hp~~~~~~  273 (331)
T cd05597         242 DLIRRLICSPETRLGRNGLQDFKDHPFFEGID  273 (331)
T ss_pred             HHHHHHccCcccccCCCCHHHHhcCCCCCCCC
Confidence            9999998764444  78999999999997643

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=8e-41  Score=370.35  Aligned_cols=245  Identities=27%  Similarity=0.492  Sum_probs=212.8

Q ss_pred             ccceeeeEEcccCcEEEEEEEECCC-CcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCCe----------EEEEEE
Q psy1546          57 LIFTKQERIGKGSFGEVFKGIDNRT-QQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTK----------LWIIME  125 (604)
Q Consensus        57 ~~y~i~~~LG~G~fG~Vy~a~~~~t-~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~~----------lyLVmE  125 (604)
                      ..|.+.+.||+|+||.||+|.+..+ ++.||+|.+.... ......+.+|+.+|+.++||++++          +|||||
T Consensus        67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~-~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E  145 (478)
T PTZ00267         67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLND-ERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIME  145 (478)
T ss_pred             eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCC-HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEE
Confidence            3499999999999999999998877 7889999875443 334467788999999999999665          479999


Q ss_pred             ecCCCChhhHhhc-----CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCC-
Q psy1546         126 YLGGGSALDLMKA-----GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTS-  199 (604)
Q Consensus       126 y~~ggsL~~~l~~-----~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~-  199 (604)
                      |++||+|.+++..     ..+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.+..... 
T Consensus       146 ~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~  225 (478)
T PTZ00267        146 YGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSL  225 (478)
T ss_pred             CCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCcccc
Confidence            9999999987743     4689999999999999999999999999999999999999999999999999976643322 


Q ss_pred             -CCcccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCCCCCCCCccchHHHHHHHHH
Q psy1546         200 -KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEA  278 (604)
Q Consensus       200 -~~~~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~  278 (604)
                       .....+||+.|+|||++.+..++.++|||||||++|+|++|..||.......+...+..+....++..++.++.+||.+
T Consensus       226 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~  305 (478)
T PTZ00267        226 DVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDPFPCPVSSGMKALLDP  305 (478)
T ss_pred             ccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCccCCHHHHHHHHH
Confidence             2345679999999999999999999999999999999999999999888777776665555556667789999999999


Q ss_pred             HhccCCCCCCCHHHHhcChhhhhh
Q psy1546         279 CLNKDPENRPTAKELLKFPFIRKA  302 (604)
Q Consensus       279 ~L~~dP~~RpT~~elL~hp~f~~~  302 (604)
                      ||..||++||++.+++.|+|++..
T Consensus       306 ~L~~dP~~Rps~~~~l~~~~~~~~  329 (478)
T PTZ00267        306 LLSKNPALRPTTQQLLHTEFLKYV  329 (478)
T ss_pred             HhccChhhCcCHHHHHhCHHHHHH
Confidence            999999999999999999999653

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=7.8e-41  Score=352.64  Aligned_cols=246  Identities=27%  Similarity=0.444  Sum_probs=204.2

Q ss_pred             cceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhh--HHHHHHHHHHHHHHhhCCCCCCC----------eEEEEEE
Q psy1546          58 IFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA--EDEIEDIQQEIMVLSQCDSPYGT----------KLWIIME  125 (604)
Q Consensus        58 ~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~--~~~~~~l~~Ei~iL~~l~hp~~~----------~lyLVmE  125 (604)
                      .|.+.++||+|+||.||++.+..+++.||+|++.+...  ......+..|+.++..+.|+++.          .+|+|||
T Consensus         2 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   81 (332)
T cd05623           2 DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMD   81 (332)
T ss_pred             CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEe
Confidence            48899999999999999999999999999999965332  22345578899999999999854          3579999


Q ss_pred             ecCCCChhhHhhc--CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCC-CCc
Q psy1546         126 YLGGGSALDLMKA--GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTS-KRN  202 (604)
Q Consensus       126 y~~ggsL~~~l~~--~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~-~~~  202 (604)
                      |+.+|+|.+++..  +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+..... ...
T Consensus        82 y~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~~~~~  161 (332)
T cd05623          82 YYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSS  161 (332)
T ss_pred             ccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccCCcceec
Confidence            9999999999965  5789999999999999999999999999999999999999999999999999976533222 223


Q ss_pred             ccccCCCCCChHHhh-----cCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCCC----CCCCCccchHHHH
Q psy1546         203 TFVGTPFWMAPEVIK-----QSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNN----PPQLTGNYTKQFK  273 (604)
Q Consensus       203 ~~~GT~~Y~APE~l~-----~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~~----~~~~~~~~s~~l~  273 (604)
                      ..+||+.|||||++.     ...++.++|||||||+||||++|..||......+....+....    .+.....++.+++
T Consensus       162 ~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~~~~  241 (332)
T cd05623         162 VAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDVSEDAK  241 (332)
T ss_pred             ccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccccCCCccccCCHHHH
Confidence            457999999999986     3468889999999999999999999999887766665543322    1222345789999


Q ss_pred             HHHHHHhccCCCC--CCCHHHHhcChhhhhhh
Q psy1546         274 EFVEACLNKDPEN--RPTAKELLKFPFIRKAK  303 (604)
Q Consensus       274 ~Li~~~L~~dP~~--RpT~~elL~hp~f~~~~  303 (604)
                      +||.+||..++.+  |++++|+++||||....
T Consensus       242 ~li~~ll~~~~~r~~r~~~~~~~~h~~f~~~~  273 (332)
T cd05623         242 DLIRRLICSREHRLGQNGIEDFKQHPFFTGID  273 (332)
T ss_pred             HHHHHHccChhhhcCCCCHHHHhCCCCcCCCC
Confidence            9999999765554  68999999999997643

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=2.4e-40  Score=343.01  Aligned_cols=250  Identities=44%  Similarity=0.769  Sum_probs=212.9

Q ss_pred             ccccceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCC----------eEEEEE
Q psy1546          55 PELIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGT----------KLWIIM  124 (604)
Q Consensus        55 ~~~~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~----------~lyLVm  124 (604)
                      ....|++.+.||+|+||.||+|.+..+++.||+|.+....... ...+.+|+.+++.+.|++..          .+|+||
T Consensus        18 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~-~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~   96 (296)
T cd06654          18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK-KELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM   96 (296)
T ss_pred             cccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcch-HHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEee
Confidence            3446999999999999999999999999999999987654333 46788999999999999844          458999


Q ss_pred             EecCCCChhhHhhcCCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCCCCccc
Q psy1546         125 EYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTF  204 (604)
Q Consensus       125 Ey~~ggsL~~~l~~~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~~~~~  204 (604)
                      ||+++++|.+++..+.+++.++..++.||+.||.|||+.||+||||||+|||++.++.++|+|||++.............
T Consensus        97 e~~~~~~L~~~~~~~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~  176 (296)
T cd06654          97 EYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM  176 (296)
T ss_pred             cccCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhccccccccCcc
Confidence            99999999999988889999999999999999999999999999999999999999999999999987654433334456


Q ss_pred             ccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCCC--CCCCCccchHHHHHHHHHHhcc
Q psy1546         205 VGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNN--PPQLTGNYTKQFKEFVEACLNK  282 (604)
Q Consensus       205 ~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~~--~~~~~~~~s~~l~~Li~~~L~~  282 (604)
                      .|++.|+|||.+.+..++.++|||||||++|+|++|..||...........+....  ....+..++..+.+||.+||..
T Consensus       177 ~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~  256 (296)
T cd06654         177 VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDM  256 (296)
T ss_pred             cCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCCCCCCCccccCHHHHHHHHHHCcC
Confidence            79999999999998889999999999999999999999998776644433322222  1223456788999999999999


Q ss_pred             CCCCCCCHHHHhcChhhhhhhhh
Q psy1546         283 DPENRPTAKELLKFPFIRKAKKN  305 (604)
Q Consensus       283 dP~~RpT~~elL~hp~f~~~~~~  305 (604)
                      ||++|||+.+|++||||......
T Consensus       257 ~p~~Rpt~~eil~~~~~~~~~~~  279 (296)
T cd06654         257 DVEKRGSAKELLQHQFLKIAKPL  279 (296)
T ss_pred             CcccCcCHHHHhhChhhhccCCc
Confidence            99999999999999999876543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=8.1e-41  Score=356.07  Aligned_cols=243  Identities=24%  Similarity=0.366  Sum_probs=196.9

Q ss_pred             ccceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchh-hHHHHHHHHHHHHHHhhCCCCCCC----------------e
Q psy1546          57 LIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE-AEDEIEDIQQEIMVLSQCDSPYGT----------------K  119 (604)
Q Consensus        57 ~~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~-~~~~~~~l~~Ei~iL~~l~hp~~~----------------~  119 (604)
                      ..|.+.+.||+|+||.||+|.+..+++.||||++.... .......+.+|+.+++.++||++.                .
T Consensus        21 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  100 (359)
T cd07876          21 KRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQD  100 (359)
T ss_pred             hceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccce
Confidence            34999999999999999999999999999999986542 223346778999999999999843                3


Q ss_pred             EEEEEEecCCCChhhHhhcCCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCC
Q psy1546         120 LWIIMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTS  199 (604)
Q Consensus       120 lyLVmEy~~ggsL~~~l~~~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~  199 (604)
                      +|+||||++++ |...+. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..... .
T Consensus       101 ~~lv~e~~~~~-l~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~~~-~  177 (359)
T cd07876         101 VYLVMELMDAN-LCQVIH-MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTN-F  177 (359)
T ss_pred             eEEEEeCCCcC-HHHHHh-ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCccccccC-c
Confidence            58999999764 555553 35889999999999999999999999999999999999999999999999999654322 2


Q ss_pred             CCcccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcC----------------------
Q psy1546         200 KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIP----------------------  257 (604)
Q Consensus       200 ~~~~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~----------------------  257 (604)
                      ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+.                      
T Consensus       178 ~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (359)
T cd07876         178 MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVRNYV  257 (359)
T ss_pred             cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHH
Confidence            2344678999999999999999999999999999999999999998765432211000                      


Q ss_pred             CC--CC-----------------CCCCccchHHHHHHHHHHhccCCCCCCCHHHHhcChhhhhh
Q psy1546         258 KN--NP-----------------PQLTGNYTKQFKEFVEACLNKDPENRPTAKELLKFPFIRKA  302 (604)
Q Consensus       258 ~~--~~-----------------~~~~~~~s~~l~~Li~~~L~~dP~~RpT~~elL~hp~f~~~  302 (604)
                      ..  ..                 .......+..+++||.+||..||++|||+.|+|+||||..+
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~  321 (359)
T cd07876         258 ENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITVW  321 (359)
T ss_pred             hhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhhh
Confidence            00  00                 00111245788999999999999999999999999999754

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=2.7e-40  Score=332.35  Aligned_cols=241  Identities=36%  Similarity=0.613  Sum_probs=212.8

Q ss_pred             ceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchh-hHHHHHHHHHHHHHHhhCCCCCCC----------eEEEEEEec
Q psy1546          59 FTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE-AEDEIEDIQQEIMVLSQCDSPYGT----------KLWIIMEYL  127 (604)
Q Consensus        59 y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~-~~~~~~~l~~Ei~iL~~l~hp~~~----------~lyLVmEy~  127 (604)
                      |.+.+.||+|+||.||+|.+..+++.||+|.+.... .......+.+|+.+++.++||++.          .+|+||||+
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   81 (256)
T cd08529           2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYA   81 (256)
T ss_pred             ceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEeC
Confidence            788899999999999999999999999999986543 234457788999999999999844          358999999


Q ss_pred             CCCChhhHhhc---CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCCCCccc
Q psy1546         128 GGGSALDLMKA---GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTF  204 (604)
Q Consensus       128 ~ggsL~~~l~~---~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~~~~~  204 (604)
                      ++++|.+++..   ..+++..+..++.||+.||.|||+.||+||||||+||+++.++.++|+|||+++.+..........
T Consensus        82 ~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~~~~~  161 (256)
T cd08529          82 ENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTI  161 (256)
T ss_pred             CCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCccchhhcc
Confidence            99999999865   468899999999999999999999999999999999999999999999999998766544444556


Q ss_pred             ccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCCCCCCCCccchHHHHHHHHHHhccCC
Q psy1546         205 VGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDP  284 (604)
Q Consensus       205 ~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~~L~~dP  284 (604)
                      .|++.|+|||++.+..++.++|||||||++|+|++|..||...........+.....+.+...++..+.++|.+||+.+|
T Consensus       162 ~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p  241 (256)
T cd08529         162 VGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVSQMYSQQLAQLIDQCLTKDY  241 (256)
T ss_pred             ccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccccCHHHHHHHHHHccCCc
Confidence            78999999999999999999999999999999999999998888766666666666666666889999999999999999


Q ss_pred             CCCCCHHHHhcChhh
Q psy1546         285 ENRPTAKELLKFPFI  299 (604)
Q Consensus       285 ~~RpT~~elL~hp~f  299 (604)
                      ++||++.++++|||+
T Consensus       242 ~~Rp~~~~ll~~~~~  256 (256)
T cd08529         242 RQRPDTFQLLRNPSL  256 (256)
T ss_pred             ccCcCHHHHhhCCCC
Confidence            999999999999985

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=1.7e-40  Score=350.16  Aligned_cols=246  Identities=26%  Similarity=0.435  Sum_probs=204.0

Q ss_pred             cceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhh--HHHHHHHHHHHHHHhhCCCCCCCe----------EEEEEE
Q psy1546          58 IFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA--EDEIEDIQQEIMVLSQCDSPYGTK----------LWIIME  125 (604)
Q Consensus        58 ~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~--~~~~~~l~~Ei~iL~~l~hp~~~~----------lyLVmE  125 (604)
                      .|.+.+.||+|+||.||+|++..+++.||||++.....  ......+.+|+.++..+.|+++..          +|||||
T Consensus         2 ~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~E   81 (331)
T cd05624           2 DFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVMD   81 (331)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEe
Confidence            48999999999999999999999999999999965332  223456788999999999998544          579999


Q ss_pred             ecCCCChhhHhhc--CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCC-CCc
Q psy1546         126 YLGGGSALDLMKA--GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTS-KRN  202 (604)
Q Consensus       126 y~~ggsL~~~l~~--~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~-~~~  202 (604)
                      |+.||+|.+++..  +.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.+..... ...
T Consensus        82 y~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~  161 (331)
T cd05624          82 YYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSS  161 (331)
T ss_pred             CCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCceeec
Confidence            9999999999965  5789999999999999999999999999999999999999999999999999976643322 223


Q ss_pred             ccccCCCCCChHHhhc-----CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCCC----CCCCCccchHHHH
Q psy1546         203 TFVGTPFWMAPEVIKQ-----SAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNN----PPQLTGNYTKQFK  273 (604)
Q Consensus       203 ~~~GT~~Y~APE~l~~-----~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~~----~~~~~~~~s~~l~  273 (604)
                      ..+||+.|||||++.+     ..++.++|||||||+||+|++|..||......+....+....    .+.....++++++
T Consensus       162 ~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~~~  241 (331)
T cd05624         162 VAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITDVSEEAK  241 (331)
T ss_pred             cccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcccCCCccccCCHHHH
Confidence            4579999999999976     467889999999999999999999998877665554443221    1222245688999


Q ss_pred             HHHHHHhccCCCC--CCCHHHHhcChhhhhhh
Q psy1546         274 EFVEACLNKDPEN--RPTAKELLKFPFIRKAK  303 (604)
Q Consensus       274 ~Li~~~L~~dP~~--RpT~~elL~hp~f~~~~  303 (604)
                      +||.+||..++.+  |++++++++||||....
T Consensus       242 ~li~~ll~~~~~~~~~~~~~~~~~h~~f~~~~  273 (331)
T cd05624         242 DLIQRLICSRERRLGQNGIEDFKKHAFFEGID  273 (331)
T ss_pred             HHHHHHccCchhhcCCCCHHHHhcCCCcCCCC
Confidence            9999999876654  47999999999997643

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=4.9e-41  Score=355.07  Aligned_cols=243  Identities=24%  Similarity=0.428  Sum_probs=200.7

Q ss_pred             ccceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhH-HHHHHHHHHHHHHhhCCCCCCCe----------------
Q psy1546          57 LIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAE-DEIEDIQQEIMVLSQCDSPYGTK----------------  119 (604)
Q Consensus        57 ~~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~-~~~~~l~~Ei~iL~~l~hp~~~~----------------  119 (604)
                      ..|.+.+.||.|+||.||+|.+..+++.||||++...... .....+.+|+.+|+.+.|+++.+                
T Consensus        15 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   94 (343)
T cd07878          15 ERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNE   94 (343)
T ss_pred             hhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccCc
Confidence            3489999999999999999999999999999998654322 23456778999999999998432                


Q ss_pred             EEEEEEecCCCChhhHhhcCCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCC
Q psy1546         120 LWIIMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTS  199 (604)
Q Consensus       120 lyLVmEy~~ggsL~~~l~~~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~  199 (604)
                      +|++||++ +++|.++++.+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....  
T Consensus        95 ~~~~~~~~-~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~--  171 (343)
T cd07878          95 VYLVTNLM-GADLNNIVKCQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQADDE--  171 (343)
T ss_pred             EEEEeecC-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCccceecCCC--
Confidence            47999988 788999998889999999999999999999999999999999999999999999999999999765432  


Q ss_pred             CCcccccCCCCCChHHhhc-CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCC-------------------
Q psy1546         200 KRNTFVGTPFWMAPEVIKQ-SAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKN-------------------  259 (604)
Q Consensus       200 ~~~~~~GT~~Y~APE~l~~-~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~-------------------  259 (604)
                       ....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||...+.......+...                   
T Consensus       172 -~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (343)
T cd07878         172 -MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEHARK  250 (343)
T ss_pred             -cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcchhhHHH
Confidence             335679999999999977 56889999999999999999999999876543322211000                   


Q ss_pred             ---CCC--------CCCccchHHHHHHHHHHhccCCCCCCCHHHHhcChhhhhhh
Q psy1546         260 ---NPP--------QLTGNYTKQFKEFVEACLNKDPENRPTAKELLKFPFIRKAK  303 (604)
Q Consensus       260 ---~~~--------~~~~~~s~~l~~Li~~~L~~dP~~RpT~~elL~hp~f~~~~  303 (604)
                         ..+        .+....++.+.+||.+||..||.+|||+.|+|.||||....
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~~  305 (343)
T cd07878         251 YIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYH  305 (343)
T ss_pred             HhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhccC
Confidence               000        01123456789999999999999999999999999997643

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=3.9e-41  Score=371.61  Aligned_cols=240  Identities=25%  Similarity=0.399  Sum_probs=189.3

Q ss_pred             ccceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCC-----------------CCe
Q psy1546          57 LIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPY-----------------GTK  119 (604)
Q Consensus        57 ~~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~-----------------~~~  119 (604)
                      ..|.+.++||+|+||+||+|.+..+++.||||++....  .....+..|+.++..+.|.+                 ...
T Consensus       129 ~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~  206 (467)
T PTZ00284        129 QRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP--KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGH  206 (467)
T ss_pred             CcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch--hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCce
Confidence            35999999999999999999999999999999986432  22234556777777665543                 134


Q ss_pred             EEEEEEecCCCChhhHh-hcCCCcHHHHHHHHHHHHHHhHHhhh-CCccccccccceeEecCCC----------------
Q psy1546         120 LWIIMEYLGGGSALDLM-KAGNFEEMHIAVILREVLKGLDYLHS-ERKLHRDIKAANVLLSEMG----------------  181 (604)
Q Consensus       120 lyLVmEy~~ggsL~~~l-~~~~lse~~i~~i~~qIl~gL~yLHs-~gIiHrDLKp~NILl~~~g----------------  181 (604)
                      +|||||++ |++|.+++ +.+.+++..++.|+.||+.||.|||+ .|||||||||+||||+.++                
T Consensus       207 ~~iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~~  285 (467)
T PTZ00284        207 MCIVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPC  285 (467)
T ss_pred             EEEEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccCCCCc
Confidence            68999998 66777766 45789999999999999999999998 5999999999999998765                


Q ss_pred             CeEEecccccccccCCCCCCcccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCCC-
Q psy1546         182 DVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNN-  260 (604)
Q Consensus       182 ~vKL~DFGlA~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~~-  260 (604)
                      .+||+|||++....   ......+||+.|||||++.+..|+.++|||||||+||||++|++||...+..+.+..+.... 
T Consensus       286 ~vkl~DfG~~~~~~---~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g  362 (467)
T PTZ00284        286 RVRICDLGGCCDER---HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEKTLG  362 (467)
T ss_pred             eEEECCCCccccCc---cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcC
Confidence            49999999885432   22345789999999999999999999999999999999999999998766544332211100 


Q ss_pred             -------------------------CCCC---------------CccchHHHHHHHHHHhccCCCCCCCHHHHhcChhhh
Q psy1546         261 -------------------------PPQL---------------TGNYTKQFKEFVEACLNKDPENRPTAKELLKFPFIR  300 (604)
Q Consensus       261 -------------------------~~~~---------------~~~~s~~l~~Li~~~L~~dP~~RpT~~elL~hp~f~  300 (604)
                                               .+..               .......+.+||.+||..||.+|||++|+|+||||.
T Consensus       363 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~Hp~~~  442 (467)
T PTZ00284        363 RLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTTHPYVL  442 (467)
T ss_pred             CCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhcCcccc
Confidence                                     0000               001134678999999999999999999999999997


Q ss_pred             hh
Q psy1546         301 KA  302 (604)
Q Consensus       301 ~~  302 (604)
                      +.
T Consensus       443 ~~  444 (467)
T PTZ00284        443 KY  444 (467)
T ss_pred             cc
Confidence            64

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=1.1e-40  Score=339.07  Aligned_cols=244  Identities=50%  Similarity=0.901  Sum_probs=205.2

Q ss_pred             CccccceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhC-CCCCCC--------------
Q psy1546          54 DPELIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQC-DSPYGT--------------  118 (604)
Q Consensus        54 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l-~hp~~~--------------  118 (604)
                      +++..|.+.+.||+|+||.||+|.+..+++.||+|++.....  ....+.+|+.++..+ .|++..              
T Consensus         3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~--~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~   80 (272)
T cd06637           3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD--EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGM   80 (272)
T ss_pred             ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCc--cHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCC
Confidence            445678999999999999999999999999999999865432  235678899999988 688733              


Q ss_pred             --eEEEEEEecCCCChhhHhhc---CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEeccccccc
Q psy1546         119 --KLWIIMEYLGGGSALDLMKA---GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGT  193 (604)
Q Consensus       119 --~lyLVmEy~~ggsL~~~l~~---~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~  193 (604)
                        .+|+||||+.+++|.+++..   ..+++..+..++.||+.||.|||+++|+||||||+||++++++.++|+|||++..
T Consensus        81 ~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~  160 (272)
T cd06637          81 DDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQ  160 (272)
T ss_pred             CcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCcee
Confidence              36799999999999998875   3589999999999999999999999999999999999999999999999999976


Q ss_pred             ccCCCCCCcccccCCCCCChHHhh-----cCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCCC-CCCCCcc
Q psy1546         194 LTNTTSKRNTFVGTPFWMAPEVIK-----QSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNN-PPQLTGN  267 (604)
Q Consensus       194 ~~~~~~~~~~~~GT~~Y~APE~l~-----~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~~-~~~~~~~  267 (604)
                      +...........|++.|+|||++.     +..++.++|||||||++|||++|..||...........+.... .......
T Consensus       161 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  240 (272)
T cd06637         161 LDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSKK  240 (272)
T ss_pred             cccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcCCCCCCCCCC
Confidence            654444445678999999999986     3457889999999999999999999998766555444333322 2233346


Q ss_pred             chHHHHHHHHHHhccCCCCCCCHHHHhcChhh
Q psy1546         268 YTKQFKEFVEACLNKDPENRPTAKELLKFPFI  299 (604)
Q Consensus       268 ~s~~l~~Li~~~L~~dP~~RpT~~elL~hp~f  299 (604)
                      ++..+.+||.+||..||.+|||+.++++||||
T Consensus       241 ~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~  272 (272)
T cd06637         241 WSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI  272 (272)
T ss_pred             cCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence            78899999999999999999999999999997

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=1.1e-40  Score=357.01  Aligned_cols=244  Identities=27%  Similarity=0.425  Sum_probs=199.6

Q ss_pred             ceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchh-hHHHHHHHHHHHHHHhhCCCCCCC---------------eEEE
Q psy1546          59 FTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE-AEDEIEDIQQEIMVLSQCDSPYGT---------------KLWI  122 (604)
Q Consensus        59 y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~-~~~~~~~l~~Ei~iL~~l~hp~~~---------------~lyL  122 (604)
                      |.+.++||+|+||.||+|.+..+++.||||++.... .......+.+|+.+++.++|+|+.               .+|+
T Consensus         2 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l   81 (372)
T cd07853           2 VEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYV   81 (372)
T ss_pred             CcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEEE
Confidence            678899999999999999999999999999986432 223346788999999999999843               5689


Q ss_pred             EEEecCCCChhhHhh-cCCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCC-CC
Q psy1546         123 IMEYLGGGSALDLMK-AGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTT-SK  200 (604)
Q Consensus       123 VmEy~~ggsL~~~l~-~~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~-~~  200 (604)
                      ||||+. ++|..++. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...... ..
T Consensus        82 v~e~~~-~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~~~~  160 (372)
T cd07853          82 VTELMQ-SDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKH  160 (372)
T ss_pred             Eeeccc-cCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeecccCcccc
Confidence            999996 56766664 4679999999999999999999999999999999999999999999999999997654322 22


Q ss_pred             CcccccCCCCCChHHhhcC-CCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCC---------------------
Q psy1546         201 RNTFVGTPFWMAPEVIKQS-AYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPK---------------------  258 (604)
Q Consensus       201 ~~~~~GT~~Y~APE~l~~~-~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~---------------------  258 (604)
                      .....+|+.|+|||++.+. .++.++|||||||++|||++|++||.+.+.......+..                     
T Consensus       161 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~  240 (372)
T cd07853         161 MTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGARAHI  240 (372)
T ss_pred             CCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHHHHHH
Confidence            2345689999999999874 478999999999999999999999987765443322210                     


Q ss_pred             ---C-CCC------CCCccchHHHHHHHHHHhccCCCCCCCHHHHhcChhhhhhh
Q psy1546         259 ---N-NPP------QLTGNYTKQFKEFVEACLNKDPENRPTAKELLKFPFIRKAK  303 (604)
Q Consensus       259 ---~-~~~------~~~~~~s~~l~~Li~~~L~~dP~~RpT~~elL~hp~f~~~~  303 (604)
                         . .++      .+....++++.+||.+||..||.+|||+.|+|+||||....
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~  295 (372)
T cd07853         241 LRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEGR  295 (372)
T ss_pred             HhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCCc
Confidence               0 000      12334578899999999999999999999999999997653

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>KOG0667|consensus

Probab=100.00  E-value=3.8e-41  Score=365.59  Aligned_cols=239  Identities=31%  Similarity=0.483  Sum_probs=198.7

Q ss_pred             cceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCC-CCC---------------CCeEE
Q psy1546          58 IFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCD-SPY---------------GTKLW  121 (604)
Q Consensus        58 ~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~-hp~---------------~~~ly  121 (604)
                      .|.+.+.||+|+||+|.+|.+..|++.||||+++...  ........|+.+|..|+ |..               ..++|
T Consensus       187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k--~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlc  264 (586)
T KOG0667|consen  187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK--RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLC  264 (586)
T ss_pred             EEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh--HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccccccee
Confidence            3789999999999999999999999999999996553  34567778999999988 432               45578


Q ss_pred             EEEEecCCCChhhHhhc---CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCC--CeEEecccccccccC
Q psy1546         122 IIMEYLGGGSALDLMKA---GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMG--DVKLADFGVAGTLTN  196 (604)
Q Consensus       122 LVmEy~~ggsL~~~l~~---~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g--~vKL~DFGlA~~~~~  196 (604)
                      ||+|++ .-+|.++++.   ..|+...++.|+.||+.||.+||+.||||+||||+||||.+.+  .|||+|||.|.....
T Consensus       265 iVfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~~q  343 (586)
T KOG0667|consen  265 IVFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFESQ  343 (586)
T ss_pred             eeehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEecccccccCC
Confidence            999999 7789999986   4588899999999999999999999999999999999997544  699999999976543


Q ss_pred             CCCCCcccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCC------------------
Q psy1546         197 TTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPK------------------  258 (604)
Q Consensus       197 ~~~~~~~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~------------------  258 (604)
                      ...   +.+.+..|+|||++.+..|+.+.||||||||+.||++|.+.|.+.++.+++..|..                  
T Consensus       344 ~vy---tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~~~~k  420 (586)
T KOG0667|consen  344 RVY---TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTAKKAHK  420 (586)
T ss_pred             cce---eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhccccce
Confidence            332   77899999999999999999999999999999999999999998887655543210                  


Q ss_pred             ------CCC---------------------------CCCC-----------ccchHHHHHHHHHHhccCCCCCCCHHHHh
Q psy1546         259 ------NNP---------------------------PQLT-----------GNYTKQFKEFVEACLNKDPENRPTAKELL  294 (604)
Q Consensus       259 ------~~~---------------------------~~~~-----------~~~s~~l~~Li~~~L~~dP~~RpT~~elL  294 (604)
                            ..+                           ...+           ..-...|.+||++||..||.+|+|+.|+|
T Consensus       421 ff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~tp~qal  500 (586)
T KOG0667|consen  421 FFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERITPAQAL  500 (586)
T ss_pred             ehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCCHHHHh
Confidence                  000                           0000           01124688999999999999999999999


Q ss_pred             cChhhhhh
Q psy1546         295 KFPFIRKA  302 (604)
Q Consensus       295 ~hp~f~~~  302 (604)
                      +||||...
T Consensus       501 ~Hpfl~~~  508 (586)
T KOG0667|consen  501 NHPFLTGT  508 (586)
T ss_pred             cCcccccc
Confidence            99999754

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.1e-40  Score=360.09  Aligned_cols=237  Identities=30%  Similarity=0.404  Sum_probs=192.3

Q ss_pred             cceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCCeE----------EEEEEec
Q psy1546          58 IFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTKL----------WIIMEYL  127 (604)
Q Consensus        58 ~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~~l----------yLVmEy~  127 (604)
                      .|.+.++||+|+||.||+|.+..+++.||||....       ..+.+|+.+|+.++|||++++          |+|||++
T Consensus        93 ~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~-------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~  165 (391)
T PHA03212         93 GFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR-------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRY  165 (391)
T ss_pred             CcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh-------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecC
Confidence            49999999999999999999999999999997532       346789999999999997665          6999999


Q ss_pred             CCCChhhHhh-cCCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCC-CCCcccc
Q psy1546         128 GGGSALDLMK-AGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTT-SKRNTFV  205 (604)
Q Consensus       128 ~ggsL~~~l~-~~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~-~~~~~~~  205 (604)
                      . ++|..++. .+.+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+|+...... ......+
T Consensus       166 ~-~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~~~~~~~  244 (391)
T PHA03212        166 K-TDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWA  244 (391)
T ss_pred             C-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCccccccccccccccccc
Confidence            5 67777664 4679999999999999999999999999999999999999999999999999996543222 2334568


Q ss_pred             cCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChh-------hHhhhc----------------------
Q psy1546         206 GTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPM-------RVLFLI----------------------  256 (604)
Q Consensus       206 GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~-------~~~~~i----------------------  256 (604)
                      ||+.|+|||++.+..|+.++|||||||+||||++|..||......       ..+..+                      
T Consensus       245 gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~~~~~  324 (391)
T PHA03212        245 GTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQANLDEI  324 (391)
T ss_pred             CccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhHHHHHH
Confidence            999999999999999999999999999999999999876532210       000000                      


Q ss_pred             -------CCCCCCCC-----CccchHHHHHHHHHHhccCCCCCCCHHHHhcChhhhhh
Q psy1546         257 -------PKNNPPQL-----TGNYTKQFKEFVEACLNKDPENRPTAKELLKFPFIRKA  302 (604)
Q Consensus       257 -------~~~~~~~~-----~~~~s~~l~~Li~~~L~~dP~~RpT~~elL~hp~f~~~  302 (604)
                             ....+...     ...++.++.+||.+||..||.+|||+.|+|+||||+..
T Consensus       325 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~  382 (391)
T PHA03212        325 YIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDI  382 (391)
T ss_pred             HHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccC
Confidence                   00000000     01246689999999999999999999999999999764

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=1.1e-40  Score=345.13  Aligned_cols=257  Identities=35%  Similarity=0.667  Sum_probs=215.9

Q ss_pred             ccccceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCC----------CeEEEEE
Q psy1546          55 PELIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYG----------TKLWIIM  124 (604)
Q Consensus        55 ~~~~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~----------~~lyLVm  124 (604)
                      ..+.|.....||+|+||.||++.+..++..||||.+.... ....+.+.+|+.+++.+.|+++          ..+|+||
T Consensus        20 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~   98 (292)
T cd06658          20 PREYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK-QQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVM   98 (292)
T ss_pred             hHHHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecch-HHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEE
Confidence            3445677788999999999999999999999999986543 3345678899999999999983          4568999


Q ss_pred             EecCCCChhhHhhcCCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCCCCccc
Q psy1546         125 EYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTF  204 (604)
Q Consensus       125 Ey~~ggsL~~~l~~~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~~~~~  204 (604)
                      ||+++++|.+++..+.+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++.............
T Consensus        99 e~~~~~~L~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~~  178 (292)
T cd06658          99 EFLEGGALTDIVTHTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSL  178 (292)
T ss_pred             eCCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhcccccccCcee
Confidence            99999999999988889999999999999999999999999999999999999999999999999997654444444456


Q ss_pred             ccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCCCCCC--CCccchHHHHHHHHHHhcc
Q psy1546         205 VGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQ--LTGNYTKQFKEFVEACLNK  282 (604)
Q Consensus       205 ~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~--~~~~~s~~l~~Li~~~L~~  282 (604)
                      .|++.|+|||++.+..++.++|||||||++|||++|..||...........+.......  ....++..+.++|.+||..
T Consensus       179 ~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  258 (292)
T cd06658         179 VGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVKDSHKVSSVLRGFLDLMLVR  258 (292)
T ss_pred             ecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCccccccccCHHHHHHHHHHccC
Confidence            79999999999998889999999999999999999999998776655444333222222  2235688999999999999


Q ss_pred             CCCCCCCHHHHhcChhhhhhhhhhhHHHHH
Q psy1546         283 DPENRPTAKELLKFPFIRKAKKNAYLIDLI  312 (604)
Q Consensus       283 dP~~RpT~~elL~hp~f~~~~~~~~l~~~~  312 (604)
                      ||.+|||++++++||||+..........++
T Consensus       259 ~P~~Rpt~~~il~~~~~~~~~~~~~~~~~~  288 (292)
T cd06658         259 EPSQRATAQELLQHPFLKLAGPPSCIVPLM  288 (292)
T ss_pred             ChhHCcCHHHHhhChhhhccCCccccchhh
Confidence            999999999999999998776665444443

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.5e-40  Score=337.59  Aligned_cols=247  Identities=53%  Similarity=0.929  Sum_probs=213.5

Q ss_pred             cceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCC---CCCCCe----------EEEEE
Q psy1546          58 IFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCD---SPYGTK----------LWIIM  124 (604)
Q Consensus        58 ~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~---hp~~~~----------lyLVm  124 (604)
                      .|.+.+.||.|+||.||+|.+..+++.||||++...........+.+|+.+++.+.   ||+..+          +|+||
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~   81 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM   81 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence            47888999999999999999999999999999876655556677889999999987   887443          57999


Q ss_pred             EecCCCChhhHhhcCCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCCCCccc
Q psy1546         125 EYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTF  204 (604)
Q Consensus       125 Ey~~ggsL~~~l~~~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~~~~~  204 (604)
                      ||+++++|.++++.+.+++..+..++.||+.||.|||+.||+||||+|+||+++.++.++|+|||++..+..........
T Consensus        82 e~~~~~~L~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~  161 (277)
T cd06917          82 EYAEGGSVRTLMKAGPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTF  161 (277)
T ss_pred             ecCCCCcHHHHHHccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCccccccc
Confidence            99999999999988889999999999999999999999999999999999999999999999999997766544444556


Q ss_pred             ccCCCCCChHHhhc-CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCCCCCCCCcc-chHHHHHHHHHHhcc
Q psy1546         205 VGTPFWMAPEVIKQ-SAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGN-YTKQFKEFVEACLNK  282 (604)
Q Consensus       205 ~GT~~Y~APE~l~~-~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~-~s~~l~~Li~~~L~~  282 (604)
                      .|+..|+|||++.+ ..++.++|||||||++|+|++|..||...........+....++.+... ++.++.+++.+||..
T Consensus       162 ~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~  241 (277)
T cd06917         162 VGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPPRLEDNGYSKLLREFVAACLDE  241 (277)
T ss_pred             cCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccCCCCCCCcccCCHHHHHHHHHHcCC
Confidence            79999999999865 4468899999999999999999999988776655554444444444443 788999999999999


Q ss_pred             CCCCCCCHHHHhcChhhhhhhh
Q psy1546         283 DPENRPTAKELLKFPFIRKAKK  304 (604)
Q Consensus       283 dP~~RpT~~elL~hp~f~~~~~  304 (604)
                      ||.+||++.++++|+||+....
T Consensus       242 ~p~~R~~~~~il~~~~~~~~~~  263 (277)
T cd06917         242 EPKERLSAEELLKSKWIKAHSK  263 (277)
T ss_pred             CcccCcCHHHHhhChHhhcccc
Confidence            9999999999999999977554

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=1.8e-40  Score=342.07  Aligned_cols=243  Identities=26%  Similarity=0.422  Sum_probs=202.6

Q ss_pred             ceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhH--HHHHHHHHHHHHHhhCCCCCCC----------eEEEEEEe
Q psy1546          59 FTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAE--DEIEDIQQEIMVLSQCDSPYGT----------KLWIIMEY  126 (604)
Q Consensus        59 y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~--~~~~~l~~Ei~iL~~l~hp~~~----------~lyLVmEy  126 (604)
                      |++.+.||+|+||.||+|.+..+++.||||.+......  .....+.+|+.+++.++|+++.          .+|+||||
T Consensus         2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05630           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL   81 (285)
T ss_pred             ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence            77889999999999999999999999999998654322  2235567899999999999854          35799999


Q ss_pred             cCCCChhhHhhc---CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCCCCcc
Q psy1546         127 LGGGSALDLMKA---GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNT  203 (604)
Q Consensus       127 ~~ggsL~~~l~~---~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~~~~  203 (604)
                      +.+++|.+++..   ..+++..+..++.||+.||.|||+.||+||||||+|||++.++.++|+|||++....... ....
T Consensus        82 ~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~-~~~~  160 (285)
T cd05630          82 MNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ-TIKG  160 (285)
T ss_pred             cCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCc-cccC
Confidence            999999998843   358999999999999999999999999999999999999999999999999986543222 2234


Q ss_pred             cccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChh---hHhhhcCCCCCCCCCccchHHHHHHHHHHh
Q psy1546         204 FVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPM---RVLFLIPKNNPPQLTGNYTKQFKEFVEACL  280 (604)
Q Consensus       204 ~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~---~~~~~i~~~~~~~~~~~~s~~l~~Li~~~L  280 (604)
                      ..|++.|+|||++.+..++.++|||||||++|+|++|..||......   .............++..++.++.+|+.+||
T Consensus       161 ~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l  240 (285)
T cd05630         161 RVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSEKFSPDARSLCKMLL  240 (285)
T ss_pred             CCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhhhhcCccCCHHHHHHHHHHh
Confidence            57999999999999999999999999999999999999999865421   112222222223445678889999999999


Q ss_pred             ccCCCCCCC-----HHHHhcChhhhhh
Q psy1546         281 NKDPENRPT-----AKELLKFPFIRKA  302 (604)
Q Consensus       281 ~~dP~~RpT-----~~elL~hp~f~~~  302 (604)
                      +.||.+|||     ++|+++||||++.
T Consensus       241 ~~~p~~R~s~~~~~~~~~~~h~~~~~~  267 (285)
T cd05630         241 CKDPKERLGCQGGGAREVKEHPLFKQI  267 (285)
T ss_pred             hcCHHHccCCCCCchHHHHcChhhhcc
Confidence            999999999     9999999999764

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=1.8e-40  Score=344.07  Aligned_cols=251  Identities=45%  Similarity=0.781  Sum_probs=213.7

Q ss_pred             ccccceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCCe----------EEEEE
Q psy1546          55 PELIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTK----------LWIIM  124 (604)
Q Consensus        55 ~~~~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~~----------lyLVm  124 (604)
                      ....|.+.+.||+|+||.||+|.+..+++.||||.+...... ..+.+.+|+.+++.++|+++.+          +|+||
T Consensus        17 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~   95 (297)
T cd06656          17 PKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQP-KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM   95 (297)
T ss_pred             hhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccc-hHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEee
Confidence            345599999999999999999999999999999998654432 3466889999999999998544          57999


Q ss_pred             EecCCCChhhHhhcCCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCCCCccc
Q psy1546         125 EYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTF  204 (604)
Q Consensus       125 Ey~~ggsL~~~l~~~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~~~~~  204 (604)
                      ||+++++|.+++....+++..+..++.|++.||.|||+.||+||||||+|||++.++.++|+|||++.............
T Consensus        96 e~~~~~~L~~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~  175 (297)
T cd06656          96 EYLAGGSLTDVVTETCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM  175 (297)
T ss_pred             cccCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccCCccCcCcc
Confidence            99999999999988889999999999999999999999999999999999999999999999999997655443334456


Q ss_pred             ccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCCCC--CCCCccchHHHHHHHHHHhcc
Q psy1546         205 VGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNP--PQLTGNYTKQFKEFVEACLNK  282 (604)
Q Consensus       205 ~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~~~--~~~~~~~s~~l~~Li~~~L~~  282 (604)
                      .+++.|+|||.+.+..++.++|||||||++|+|++|..||...+.......+.....  ...+..++..+.+|+.+||..
T Consensus       176 ~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  255 (297)
T cd06656         176 VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVFRDFLNRCLEM  255 (297)
T ss_pred             cCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCCCCCCCCccccCHHHHHHHHHHccC
Confidence            789999999999998899999999999999999999999987665444333332221  223456788999999999999


Q ss_pred             CCCCCCCHHHHhcChhhhhhhhhh
Q psy1546         283 DPENRPTAKELLKFPFIRKAKKNA  306 (604)
Q Consensus       283 dP~~RpT~~elL~hp~f~~~~~~~  306 (604)
                      +|.+||++.+|++||||+......
T Consensus       256 ~p~~Rps~~~il~~~~~~~~~~~~  279 (297)
T cd06656         256 DVDRRGSAKELLQHPFLKLAKPLS  279 (297)
T ss_pred             ChhhCcCHHHHhcCchhccccccc
Confidence            999999999999999998766543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=1.5e-40  Score=354.72  Aligned_cols=243  Identities=23%  Similarity=0.362  Sum_probs=198.3

Q ss_pred             ccceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchh-hHHHHHHHHHHHHHHhhCCCCCCC----------------e
Q psy1546          57 LIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE-AEDEIEDIQQEIMVLSQCDSPYGT----------------K  119 (604)
Q Consensus        57 ~~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~-~~~~~~~l~~Ei~iL~~l~hp~~~----------------~  119 (604)
                      ..|.+.+.||+|+||.||+|.+..+++.||||++.... .......+.+|+.+++.+.||++.                .
T Consensus        24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~~  103 (364)
T cd07875          24 KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQD  103 (364)
T ss_pred             cceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccCe
Confidence            34999999999999999999999999999999986542 223346778999999999999853                3


Q ss_pred             EEEEEEecCCCChhhHhhcCCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCC
Q psy1546         120 LWIIMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTS  199 (604)
Q Consensus       120 lyLVmEy~~ggsL~~~l~~~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~  199 (604)
                      +|+||||+++ +|..++.. .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..... .
T Consensus       104 ~~lv~e~~~~-~l~~~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~-~  180 (364)
T cd07875         104 VYIVMELMDA-NLCQVIQM-ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS-F  180 (364)
T ss_pred             EEEEEeCCCC-CHHHHHHh-cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCccccCCC-C
Confidence            5899999965 56666643 5888999999999999999999999999999999999999999999999999765432 2


Q ss_pred             CCcccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCCC-------------------
Q psy1546         200 KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNN-------------------  260 (604)
Q Consensus       200 ~~~~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~~-------------------  260 (604)
                      ......||+.|+|||++.+..++.++|||||||+||+|++|..||.+.+.......+....                   
T Consensus       181 ~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  260 (364)
T cd07875         181 MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYV  260 (364)
T ss_pred             cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhHHHHHHH
Confidence            2345679999999999999999999999999999999999999998766543332211100                   


Q ss_pred             ---C-------------------CCCCccchHHHHHHHHHHhccCCCCCCCHHHHhcChhhhhh
Q psy1546         261 ---P-------------------PQLTGNYTKQFKEFVEACLNKDPENRPTAKELLKFPFIRKA  302 (604)
Q Consensus       261 ---~-------------------~~~~~~~s~~l~~Li~~~L~~dP~~RpT~~elL~hp~f~~~  302 (604)
                         +                   .......+..+++||.+||..||.+|||+.|+|+||||..+
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~~  324 (364)
T cd07875         261 ENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVW  324 (364)
T ss_pred             hhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCcccccc
Confidence               0                   00011134678999999999999999999999999999643

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=1.6e-40  Score=340.56  Aligned_cols=249  Identities=43%  Similarity=0.819  Sum_probs=210.9

Q ss_pred             ccccceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCCe----------EEEEE
Q psy1546          55 PELIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTK----------LWIIM  124 (604)
Q Consensus        55 ~~~~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~~----------lyLVm  124 (604)
                      +++.|++.+.||.|+||.||+|.+..++..+|+|.+.... ....+.+.+|+.+++.++|++..+          .|+||
T Consensus         3 ~~~~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~   81 (282)
T cd06643           3 PEEFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKS-EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILI   81 (282)
T ss_pred             HHHHHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCC-HHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEE
Confidence            3455889999999999999999999999999999986543 344577889999999999998554          47999


Q ss_pred             EecCCCChhhHhhc--CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCCCCc
Q psy1546         125 EYLGGGSALDLMKA--GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRN  202 (604)
Q Consensus       125 Ey~~ggsL~~~l~~--~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~~~  202 (604)
                      ||+++++|..++..  +.+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++...........
T Consensus        82 e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~  161 (282)
T cd06643          82 EFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRD  161 (282)
T ss_pred             EecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEccccccccccccccccc
Confidence            99999999988753  5689999999999999999999999999999999999999999999999999976654444445


Q ss_pred             ccccCCCCCChHHhh-----cCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCCCCC--CCCccchHHHHHH
Q psy1546         203 TFVGTPFWMAPEVIK-----QSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPP--QLTGNYTKQFKEF  275 (604)
Q Consensus       203 ~~~GT~~Y~APE~l~-----~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~~~~--~~~~~~s~~l~~L  275 (604)
                      ...|++.|+|||++.     +..++.++|||||||++|+|++|.+||...........+.....+  ..+..++..+.+|
T Consensus       162 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  241 (282)
T cd06643         162 SFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSEFKDF  241 (282)
T ss_pred             cccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCCCCCccccCHHHHHH
Confidence            567999999999984     445778999999999999999999999887766655544333222  2345678999999


Q ss_pred             HHHHhccCCCCCCCHHHHhcChhhhhhhh
Q psy1546         276 VEACLNKDPENRPTAKELLKFPFIRKAKK  304 (604)
Q Consensus       276 i~~~L~~dP~~RpT~~elL~hp~f~~~~~  304 (604)
                      |.+||..||.+||++.++++||||+....
T Consensus       242 i~~~l~~~p~~Rp~~~~il~~~~~~~~~~  270 (282)
T cd06643         242 LKKCLEKNVDARWTTTQLLQHPFVTVNSN  270 (282)
T ss_pred             HHHHccCChhhCcCHHHHhcCCCEeccCC
Confidence            99999999999999999999999986543

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>KOG0197|consensus

Probab=100.00  E-value=3e-41  Score=359.36  Aligned_cols=233  Identities=28%  Similarity=0.467  Sum_probs=205.8

Q ss_pred             ceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCCe----------EEEEEEecC
Q psy1546          59 FTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTK----------LWIIMEYLG  128 (604)
Q Consensus        59 y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~~----------lyLVmEy~~  128 (604)
                      +.+++.||+|-||.||+|.++.+ ..||+|.+......  .+.+.+|+.+|++|.|+++++          +|||||||.
T Consensus       208 l~l~~~LG~G~FG~V~~g~~~~~-~~vavk~ik~~~m~--~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~  284 (468)
T KOG0197|consen  208 LKLIRELGSGQFGEVWLGKWNGS-TKVAVKTIKEGSMS--PEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMP  284 (468)
T ss_pred             HHHHHHhcCCccceEEEEEEcCC-CcccceEEeccccC--hhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecc
Confidence            67889999999999999998743 36999999765332  256779999999999999665          479999999


Q ss_pred             CCChhhHhhc---CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCCC-Cccc
Q psy1546         129 GGSALDLMKA---GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSK-RNTF  204 (604)
Q Consensus       129 ggsL~~~l~~---~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~-~~~~  204 (604)
                      .|+|.++++.   +.+...+.+.++.|||+|++||+++++|||||.+.||||+++..+||+|||+|+...+.... +...
T Consensus       285 ~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~~~~~  364 (468)
T KOG0197|consen  285 KGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTASEGG  364 (468)
T ss_pred             cCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccccccccCCCceeecCCC
Confidence            9999999986   56899999999999999999999999999999999999999999999999999844333221 1222


Q ss_pred             ccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHhhhcCCCCCCCCCccchHHHHHHHHHHhccC
Q psy1546         205 VGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAK-GEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKD  283 (604)
Q Consensus       205 ~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~~L~~d  283 (604)
                      .-...|+|||.+....++.++|||||||+||||+| |+.||.+....+++..+..+.+...|..+|+++.+++..||..+
T Consensus       365 kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRlp~P~~CP~~vY~lM~~CW~~~  444 (468)
T KOG0197|consen  365 KFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRLPRPEGCPDEVYELMKSCWHED  444 (468)
T ss_pred             CCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcCCCCCCCCHHHHHHHHHHhhCC
Confidence            23556999999999999999999999999999998 99999999999999999999999999999999999999999999


Q ss_pred             CCCCCCHHHHh
Q psy1546         284 PENRPTAKELL  294 (604)
Q Consensus       284 P~~RpT~~elL  294 (604)
                      |++|||++.+.
T Consensus       445 P~~RPtF~~L~  455 (468)
T KOG0197|consen  445 PEDRPTFETLR  455 (468)
T ss_pred             cccCCCHHHHH
Confidence            99999999664

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=1.2e-40  Score=341.82  Aligned_cols=239  Identities=27%  Similarity=0.429  Sum_probs=192.0

Q ss_pred             ceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHH-HHHHHHHHHHHHhh---CCCCCCCe---------------
Q psy1546          59 FTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAED-EIEDIQQEIMVLSQ---CDSPYGTK---------------  119 (604)
Q Consensus        59 y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~-~~~~l~~Ei~iL~~---l~hp~~~~---------------  119 (604)
                      |++.+.||+|+||+||+|.+..+++.||||++....... ....+.+|+.+++.   ++|||+.+               
T Consensus         2 y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~~   81 (288)
T cd07863           2 YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRETK   81 (288)
T ss_pred             ceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCce
Confidence            889999999999999999999999999999986542221 12234556666554   47997543               


Q ss_pred             EEEEEEecCCCChhhHhhc---CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccC
Q psy1546         120 LWIIMEYLGGGSALDLMKA---GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTN  196 (604)
Q Consensus       120 lyLVmEy~~ggsL~~~l~~---~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~  196 (604)
                      +|+||||+.+ +|..++..   ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+..
T Consensus        82 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~~~  160 (288)
T cd07863          82 VTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYSC  160 (288)
T ss_pred             EEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCccccccC
Confidence            4799999974 78887754   3589999999999999999999999999999999999999999999999999976543


Q ss_pred             CCCCCcccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCC------------------
Q psy1546         197 TTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPK------------------  258 (604)
Q Consensus       197 ~~~~~~~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~------------------  258 (604)
                      . .......||+.|+|||++.+..++.++|||||||++|+|++|.+||...........+..                  
T Consensus       161 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (288)
T cd07863         161 Q-MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTLPR  239 (288)
T ss_pred             c-ccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcccccccc
Confidence            2 222345789999999999999999999999999999999999999977654433221100                  


Q ss_pred             CC--------CCCCCccchHHHHHHHHHHhccCCCCCCCHHHHhcChhh
Q psy1546         259 NN--------PPQLTGNYTKQFKEFVEACLNKDPENRPTAKELLKFPFI  299 (604)
Q Consensus       259 ~~--------~~~~~~~~s~~l~~Li~~~L~~dP~~RpT~~elL~hp~f  299 (604)
                      ..        ...+...++..+.+||.+||..||.+|||+.|++.||||
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f  288 (288)
T cd07863         240 GAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF  288 (288)
T ss_pred             cccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence            00        001223567889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=2.1e-40  Score=352.13  Aligned_cols=242  Identities=22%  Similarity=0.358  Sum_probs=197.2

Q ss_pred             cceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchh-hHHHHHHHHHHHHHHhhCCCCCCCe----------------E
Q psy1546          58 IFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE-AEDEIEDIQQEIMVLSQCDSPYGTK----------------L  120 (604)
Q Consensus        58 ~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~-~~~~~~~l~~Ei~iL~~l~hp~~~~----------------l  120 (604)
                      .|.+.+.||+|+||.||+|.+..+++.||||++.... .......+.+|+.+++.++||++.+                +
T Consensus        18 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   97 (355)
T cd07874          18 RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDV   97 (355)
T ss_pred             ceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccccee
Confidence            4999999999999999999999999999999986543 2334567789999999999998533                4


Q ss_pred             EEEEEecCCCChhhHhhcCCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCCC
Q psy1546         121 WIIMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSK  200 (604)
Q Consensus       121 yLVmEy~~ggsL~~~l~~~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~  200 (604)
                      |+||||+++ +|.+.+.. .+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++..... ..
T Consensus        98 ~lv~e~~~~-~l~~~~~~-~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~~~~~~~-~~  174 (355)
T cd07874          98 YLVMELMDA-NLCQVIQM-ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS-FM  174 (355)
T ss_pred             EEEhhhhcc-cHHHHHhh-cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCcccccCCCc-cc
Confidence            799999965 46665543 5889999999999999999999999999999999999999999999999999765432 22


Q ss_pred             CcccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCC----------------------
Q psy1546         201 RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPK----------------------  258 (604)
Q Consensus       201 ~~~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~----------------------  258 (604)
                      .....||+.|+|||++.+..++.++|||||||+||+|++|..||.+.........+..                      
T Consensus       175 ~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (355)
T cd07874         175 MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVE  254 (355)
T ss_pred             cCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcHHHHHHHh
Confidence            3456799999999999999999999999999999999999999987654322211000                      


Q ss_pred             CC-------------------CCCCCccchHHHHHHHHHHhccCCCCCCCHHHHhcChhhhhh
Q psy1546         259 NN-------------------PPQLTGNYTKQFKEFVEACLNKDPENRPTAKELLKFPFIRKA  302 (604)
Q Consensus       259 ~~-------------------~~~~~~~~s~~l~~Li~~~L~~dP~~RpT~~elL~hp~f~~~  302 (604)
                      ..                   ........+..+++||.+||..||.+|||+.|+|+||||...
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~~  317 (355)
T cd07874         255 NRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINVW  317 (355)
T ss_pred             cCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhcc
Confidence            00                   000112235678999999999999999999999999999754

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3e-40  Score=333.79  Aligned_cols=242  Identities=35%  Similarity=0.647  Sum_probs=206.4

Q ss_pred             cceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhh----HHHHHHHHHHHHHHhhCCCCCCCe----------EEEE
Q psy1546          58 IFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA----EDEIEDIQQEIMVLSQCDSPYGTK----------LWII  123 (604)
Q Consensus        58 ~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~----~~~~~~l~~Ei~iL~~l~hp~~~~----------lyLV  123 (604)
                      .|.+.+.||+|+||.||+|.+..+++.||||.+.....    ......+.+|+.++++++||++.+          +|+|
T Consensus         3 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v   82 (263)
T cd06625           3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSIF   82 (263)
T ss_pred             cccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEEE
Confidence            38889999999999999999999999999999864422    223567889999999999998544          4799


Q ss_pred             EEecCCCChhhHhhc-CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCCC--
Q psy1546         124 MEYLGGGSALDLMKA-GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSK--  200 (604)
Q Consensus       124 mEy~~ggsL~~~l~~-~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~--  200 (604)
                      |||+++++|.+++.. +.+++..+..++.||+.||.|||+.||+||||+|+|||++.++.++|+|||+++.+......  
T Consensus        83 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~~~~  162 (263)
T cd06625          83 MEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGT  162 (263)
T ss_pred             EEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceeccccccccc
Confidence            999999999998865 67899999999999999999999999999999999999999999999999999765432211  


Q ss_pred             -CcccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcC-CCCCCCCCccchHHHHHHHHH
Q psy1546         201 -RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIP-KNNPPQLTGNYTKQFKEFVEA  278 (604)
Q Consensus       201 -~~~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~-~~~~~~~~~~~s~~l~~Li~~  278 (604)
                       .....|+..|+|||++.+..++.++|||||||++|+|++|..||...........+. ......++..++..+.+||.+
T Consensus       163 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  242 (263)
T cd06625         163 GMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVSPDARNFLRR  242 (263)
T ss_pred             cccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCCCCCCCccCCHHHHHHHHH
Confidence             134568899999999999889999999999999999999999998766554433332 223445667789999999999


Q ss_pred             HhccCCCCCCCHHHHhcChhh
Q psy1546         279 CLNKDPENRPTAKELLKFPFI  299 (604)
Q Consensus       279 ~L~~dP~~RpT~~elL~hp~f  299 (604)
                      ||..+|.+|||+.++++|+||
T Consensus       243 ~l~~~p~~Rpt~~~ll~~~~~  263 (263)
T cd06625         243 TFVENAKKRPSAEELLRHFFV  263 (263)
T ss_pred             HhhcCcccCCCHHHHhhCCCC
Confidence            999999999999999999997

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=3.5e-40  Score=340.05  Aligned_cols=252  Identities=45%  Similarity=0.852  Sum_probs=212.1

Q ss_pred             CccccceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCCe----------EEEE
Q psy1546          54 DPELIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTK----------LWII  123 (604)
Q Consensus        54 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~~----------lyLV  123 (604)
                      .+...|++.++||.|+||.||+|.+..+++.||+|++.... ....+.+.+|+.+++.+.|+++.+          +|+|
T Consensus         9 ~~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   87 (292)
T cd06644           9 DPNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKS-EEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIM   87 (292)
T ss_pred             CcchhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCC-HHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEE
Confidence            45567999999999999999999999999999999986543 344677889999999999998544          5799


Q ss_pred             EEecCCCChhhHhhc--CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCCCC
Q psy1546         124 MEYLGGGSALDLMKA--GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKR  201 (604)
Q Consensus       124 mEy~~ggsL~~~l~~--~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~~  201 (604)
                      |||+++++|..++..  ..+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++..........
T Consensus        88 ~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~  167 (292)
T cd06644          88 IEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRR  167 (292)
T ss_pred             EecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceecccccccc
Confidence            999999999887753  568999999999999999999999999999999999999999999999999986654443344


Q ss_pred             cccccCCCCCChHHhh-----cCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCCCCC--CCCccchHHHHH
Q psy1546         202 NTFVGTPFWMAPEVIK-----QSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPP--QLTGNYTKQFKE  274 (604)
Q Consensus       202 ~~~~GT~~Y~APE~l~-----~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~~~~--~~~~~~s~~l~~  274 (604)
                      ....+++.|+|||++.     ...++.++|||||||++|+|++|.+||...+.......+.....+  ..+..++.++.+
T Consensus       168 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (292)
T cd06644         168 DSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPSKWSMEFRD  247 (292)
T ss_pred             ceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCCccCCCCcccCHHHHH
Confidence            5567899999999985     345778999999999999999999999887765554444333322  234567889999


Q ss_pred             HHHHHhccCCCCCCCHHHHhcChhhhhhhhhh
Q psy1546         275 FVEACLNKDPENRPTAKELLKFPFIRKAKKNA  306 (604)
Q Consensus       275 Li~~~L~~dP~~RpT~~elL~hp~f~~~~~~~  306 (604)
                      ||.+||..||++||+++++++||||.....+.
T Consensus       248 li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~~  279 (292)
T cd06644         248 FLKTALDKHPETRPSAAQLLEHPFVSSVTSNR  279 (292)
T ss_pred             HHHHHhcCCcccCcCHHHHhcCccccccccch
Confidence            99999999999999999999999998765543

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=4.7e-40  Score=333.43  Aligned_cols=241  Identities=37%  Similarity=0.717  Sum_probs=208.1

Q ss_pred             ceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhh--------HHHHHHHHHHHHHHhhCCCCCCCeE----------
Q psy1546          59 FTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA--------EDEIEDIQQEIMVLSQCDSPYGTKL----------  120 (604)
Q Consensus        59 y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~--------~~~~~~l~~Ei~iL~~l~hp~~~~l----------  120 (604)
                      |.+...||.|+||.||+|.+..+++.||+|.+.....        ....+.+.+|+.+++.++||++.++          
T Consensus         2 ~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   81 (267)
T cd06628           2 WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHL   81 (267)
T ss_pred             ccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCcc
Confidence            6788899999999999999999999999998854321        1234678899999999999986554          


Q ss_pred             EEEEEecCCCChhhHhhc-CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCC-
Q psy1546         121 WIIMEYLGGGSALDLMKA-GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTT-  198 (604)
Q Consensus       121 yLVmEy~~ggsL~~~l~~-~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~-  198 (604)
                      |+||||+++++|.+++.. +.+++..+..++.||+.||.|||++|++||||+|+|||++.++.++|+|||+++.+.... 
T Consensus        82 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~  161 (267)
T cd06628          82 NIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSL  161 (267)
T ss_pred             EEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCcccccccc
Confidence            699999999999999965 678999999999999999999999999999999999999999999999999997664221 


Q ss_pred             -----CCCcccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCCCCCCCCccchHHHH
Q psy1546         199 -----SKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFK  273 (604)
Q Consensus       199 -----~~~~~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~  273 (604)
                           .......|+..|+|||.+.+..++.++|||||||++|+|++|..||...........+.....+.++..++..+.
T Consensus       162 ~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (267)
T cd06628         162 STKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENASPEIPSNISSEAI  241 (267)
T ss_pred             cCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhccCCCcCCcccCHHHH
Confidence                 112245688999999999988899999999999999999999999988776665555545555566778899999


Q ss_pred             HHHHHHhccCCCCCCCHHHHhcChhh
Q psy1546         274 EFVEACLNKDPENRPTAKELLKFPFI  299 (604)
Q Consensus       274 ~Li~~~L~~dP~~RpT~~elL~hp~f  299 (604)
                      ++|.+||+.||.+||++.||++||||
T Consensus       242 ~li~~~l~~~p~~Rp~~~~il~~~~~  267 (267)
T cd06628         242 DFLEKTFEIDHNKRPTAAELLKHPFL  267 (267)
T ss_pred             HHHHHHccCCchhCcCHHHHhhCCCC
Confidence            99999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=4.9e-40  Score=340.90  Aligned_cols=247  Identities=46%  Similarity=0.778  Sum_probs=213.1

Q ss_pred             ccceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCC----------eEEEEEEe
Q psy1546          57 LIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGT----------KLWIIMEY  126 (604)
Q Consensus        57 ~~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~----------~lyLVmEy  126 (604)
                      ..|.+.+.||.|+||.||+|.+..+++.||||.+...... ..+.+.+|+.+++.+.|+++.          .+|+||||
T Consensus        19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   97 (296)
T cd06655          19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQP-KKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEY   97 (296)
T ss_pred             ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCc-hHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEe
Confidence            4599999999999999999999999999999998654332 346788999999999999844          35799999


Q ss_pred             cCCCChhhHhhcCCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCCCCccccc
Q psy1546         127 LGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVG  206 (604)
Q Consensus       127 ~~ggsL~~~l~~~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~~~~~~G  206 (604)
                      +.+++|..++....+++.++..++.||+.||.|||++|++||||||+||+++.++.++|+|||++..+...........|
T Consensus        98 ~~~~~L~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~  177 (296)
T cd06655          98 LAGGSLTDVVTETCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVG  177 (296)
T ss_pred             cCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhcccccccCCCcCC
Confidence            99999999998888999999999999999999999999999999999999999999999999998766544444445678


Q ss_pred             CCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCCC--CCCCCccchHHHHHHHHHHhccCC
Q psy1546         207 TPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNN--PPQLTGNYTKQFKEFVEACLNKDP  284 (604)
Q Consensus       207 T~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~~--~~~~~~~~s~~l~~Li~~~L~~dP  284 (604)
                      ++.|+|||.+.+..++.++|||||||++|+|++|..||...+.......+....  ....+..++..+.+||.+||..||
T Consensus       178 ~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp  257 (296)
T cd06655         178 TPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFRDFLNRCLEMDV  257 (296)
T ss_pred             CccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCcccCCcccCCHHHHHHHHHHhhcCh
Confidence            999999999998889999999999999999999999998877655444333222  223345678899999999999999


Q ss_pred             CCCCCHHHHhcChhhhhhhh
Q psy1546         285 ENRPTAKELLKFPFIRKAKK  304 (604)
Q Consensus       285 ~~RpT~~elL~hp~f~~~~~  304 (604)
                      .+|||+.+|+.||||+....
T Consensus       258 ~~Rpt~~~il~~~~~~~~~~  277 (296)
T cd06655         258 EKRGSAKELLQHPFLKLAKP  277 (296)
T ss_pred             hhCCCHHHHhhChHhhhccc
Confidence            99999999999999986553

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=2.7e-40  Score=339.14  Aligned_cols=237  Identities=25%  Similarity=0.377  Sum_probs=194.9

Q ss_pred             EcccCcEEEEEEEECCCCcEEEEEEecchhhH--HHHHHHHHHHHHHhhCCCCCCCe----------EEEEEEecCCCCh
Q psy1546          65 IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAE--DEIEDIQQEIMVLSQCDSPYGTK----------LWIIMEYLGGGSA  132 (604)
Q Consensus        65 LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~--~~~~~l~~Ei~iL~~l~hp~~~~----------lyLVmEy~~ggsL  132 (604)
                      ||+|+||.||++.+..+++.||+|.+......  .....+..|+.+++.++||++.+          +|+||||+.|++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L   80 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL   80 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence            69999999999999999999999998654322  12345567999999999998544          4799999999999


Q ss_pred             hhHhhc---CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCCCCcccccCCC
Q psy1546         133 LDLMKA---GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPF  209 (604)
Q Consensus       133 ~~~l~~---~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~~~~~~GT~~  209 (604)
                      .+++..   ..+++..+..++.||+.||+|||+.||+||||||+|||++.++.++|+|||++..+.... ......|++.
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~-~~~~~~~~~~  159 (277)
T cd05607          81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK-TITQRAGTNG  159 (277)
T ss_pred             HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc-eeeccCCCCC
Confidence            988743   358889999999999999999999999999999999999999999999999997654322 2234578999


Q ss_pred             CCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCCh----hhHhhhcCCCCCCCCCccchHHHHHHHHHHhccCCC
Q psy1546         210 WMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHP----MRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPE  285 (604)
Q Consensus       210 Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~----~~~~~~i~~~~~~~~~~~~s~~l~~Li~~~L~~dP~  285 (604)
                      |+|||++.+..++.++|||||||++|+|++|..||.....    ..+...............++.++++||.+||+.||.
T Consensus       160 y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~  239 (277)
T cd05607         160 YMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEHQNFTEESKDICRLFLAKKPE  239 (277)
T ss_pred             ccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccccccccccCCHHHHHHHHHHhccCHh
Confidence            9999999998899999999999999999999999976432    222222222222222346889999999999999999


Q ss_pred             CCCCH----HHHhcChhhhhh
Q psy1546         286 NRPTA----KELLKFPFIRKA  302 (604)
Q Consensus       286 ~RpT~----~elL~hp~f~~~  302 (604)
                      +||++    +++++|+||+..
T Consensus       240 ~R~~~~~~~~~~~~h~~f~~~  260 (277)
T cd05607         240 DRLGSREKNDDPRKHEFFKTI  260 (277)
T ss_pred             hCCCCccchhhhhcChhhcCC
Confidence            99999    678899999764

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=3.4e-40  Score=341.95  Aligned_cols=245  Identities=27%  Similarity=0.457  Sum_probs=200.2

Q ss_pred             cceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCCe----------EEEEEEec
Q psy1546          58 IFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTK----------LWIIMEYL  127 (604)
Q Consensus        58 ~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~~----------lyLVmEy~  127 (604)
                      .|.+.++||.|+||.||+|.+..+++.||+|.+...........+.+|+.+++.++|+++.+          +|+||||+
T Consensus         7 ~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~~   86 (301)
T cd07873           7 TYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYL   86 (301)
T ss_pred             ceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEecc
Confidence            38999999999999999999999999999999875543333456778999999999999655          47999999


Q ss_pred             CCCChhhHhhc--CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCCCCcccc
Q psy1546         128 GGGSALDLMKA--GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFV  205 (604)
Q Consensus       128 ~ggsL~~~l~~--~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~~~~~~  205 (604)
                      + ++|..++..  ..+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++..............
T Consensus        87 ~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~  165 (301)
T cd07873          87 D-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEV  165 (301)
T ss_pred             c-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCCcccccc
Confidence            6 578887754  4688999999999999999999999999999999999999999999999999976543333334456


Q ss_pred             cCCCCCChHHhhcC-CCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCC---------------------CCCC-
Q psy1546         206 GTPFWMAPEVIKQS-AYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPK---------------------NNPP-  262 (604)
Q Consensus       206 GT~~Y~APE~l~~~-~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~---------------------~~~~-  262 (604)
                      +++.|+|||++.+. .++.++|||||||++|+|++|.+||...+..+....+..                     ...+ 
T Consensus       166 ~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (301)
T cd07873         166 VTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKSYNYPK  245 (301)
T ss_pred             eeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccccccccccCc
Confidence            78999999998754 478899999999999999999999987665433211100                     0000 


Q ss_pred             -------CCCccchHHHHHHHHHHhccCCCCCCCHHHHhcChhhhhhh
Q psy1546         263 -------QLTGNYTKQFKEFVEACLNKDPENRPTAKELLKFPFIRKAK  303 (604)
Q Consensus       263 -------~~~~~~s~~l~~Li~~~L~~dP~~RpT~~elL~hp~f~~~~  303 (604)
                             .....++..+++||.+||..||.+|||+.|+|+||||+...
T Consensus       246 ~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~~  293 (301)
T cd07873         246 YRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLG  293 (301)
T ss_pred             cccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence                   11234678899999999999999999999999999997543

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=6.1e-40  Score=332.94  Aligned_cols=244  Identities=49%  Similarity=0.880  Sum_probs=202.7

Q ss_pred             CccccceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCCe----------EEEE
Q psy1546          54 DPELIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTK----------LWII  123 (604)
Q Consensus        54 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~~----------lyLV  123 (604)
                      .....|++.+.||+|+||.||+|++..+++.||+|++..... .....+.+|+.+++.++||++.+          +|+|
T Consensus         6 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~-~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv   84 (267)
T cd06646           6 NPQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPG-DDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWIC   84 (267)
T ss_pred             CchhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCcc-chHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEE
Confidence            344569999999999999999999999999999999865432 23456889999999999998554          5799


Q ss_pred             EEecCCCChhhHhhc-CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCCCCc
Q psy1546         124 MEYLGGGSALDLMKA-GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRN  202 (604)
Q Consensus       124 mEy~~ggsL~~~l~~-~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~~~  202 (604)
                      |||+++++|.+++.. +.+++..+..++.|++.||.|||+.||+||||+|+|||++.++.++|+|||++..+........
T Consensus        85 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~~~  164 (267)
T cd06646          85 MEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRK  164 (267)
T ss_pred             EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeecccccccC
Confidence            999999999998854 6789999999999999999999999999999999999999999999999999976654433344


Q ss_pred             ccccCCCCCChHHhh---cCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCCC--CC--CCCccchHHHHHH
Q psy1546         203 TFVGTPFWMAPEVIK---QSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNN--PP--QLTGNYTKQFKEF  275 (604)
Q Consensus       203 ~~~GT~~Y~APE~l~---~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~~--~~--~~~~~~s~~l~~L  275 (604)
                      ...|++.|+|||.+.   ...++.++|||||||++|||++|..||...........+....  ++  .....++..+.+|
T Consensus       165 ~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  244 (267)
T cd06646         165 SFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSSTFHNF  244 (267)
T ss_pred             ccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCCccccccCHHHHHH
Confidence            567999999999984   3457789999999999999999999987665444333222221  11  1123568899999


Q ss_pred             HHHHhccCCCCCCCHHHHhcChh
Q psy1546         276 VEACLNKDPENRPTAKELLKFPF  298 (604)
Q Consensus       276 i~~~L~~dP~~RpT~~elL~hp~  298 (604)
                      |.+||..+|++|||+++||+|+|
T Consensus       245 i~~~l~~~P~~Rp~~~~il~~l~  267 (267)
T cd06646         245 VKISLTKNPKKRPTAERLLTHLF  267 (267)
T ss_pred             HHHHhhCChhhCcCHHHHhcCCC
Confidence            99999999999999999999987

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=1.1e-39  Score=340.08  Aligned_cols=244  Identities=37%  Similarity=0.670  Sum_probs=204.2

Q ss_pred             cceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCCe----------EEEEEEec
Q psy1546          58 IFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTK----------LWIIMEYL  127 (604)
Q Consensus        58 ~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~~----------lyLVmEy~  127 (604)
                      .|.+.++||+|+||.||+|.+..++..||+|.+...........+.+|+.++++++||++.+          +|+||||+
T Consensus         2 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey~   81 (308)
T cd06615           2 DFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHM   81 (308)
T ss_pred             CceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeecc
Confidence            38899999999999999999999999999999876544445567889999999999998655          47999999


Q ss_pred             CCCChhhHhhc-CCCcHHHHHHHHHHHHHHhHHhhh-CCccccccccceeEecCCCCeEEecccccccccCCCCCCcccc
Q psy1546         128 GGGSALDLMKA-GNFEEMHIAVILREVLKGLDYLHS-ERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFV  205 (604)
Q Consensus       128 ~ggsL~~~l~~-~~lse~~i~~i~~qIl~gL~yLHs-~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~~~~~~  205 (604)
                      ++++|.+++.. +.+++..+..++.||+.||.|||+ .+++||||||+|||++.++.++|+|||++..+...  .....+
T Consensus        82 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~--~~~~~~  159 (308)
T cd06615          82 DGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--MANSFV  159 (308)
T ss_pred             CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCccccccc--ccccCC
Confidence            99999999865 678999999999999999999997 59999999999999999999999999998765332  224567


Q ss_pred             cCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCC---------------------------
Q psy1546         206 GTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPK---------------------------  258 (604)
Q Consensus       206 GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~---------------------------  258 (604)
                      |++.|+|||++.+..++.++|||||||++|+|++|..||...+.......+..                           
T Consensus       160 ~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (308)
T cd06615         160 GTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSPRPMAI  239 (308)
T ss_pred             CCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCCccchhhH
Confidence            99999999999888899999999999999999999999875543332221111                           


Q ss_pred             ---------CCCCCCC-ccchHHHHHHHHHHhccCCCCCCCHHHHhcChhhhhhh
Q psy1546         259 ---------NNPPQLT-GNYTKQFKEFVEACLNKDPENRPTAKELLKFPFIRKAK  303 (604)
Q Consensus       259 ---------~~~~~~~-~~~s~~l~~Li~~~L~~dP~~RpT~~elL~hp~f~~~~  303 (604)
                               ...+.++ ..++.++++|+.+||..||++|||+.+|++||||....
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~  294 (308)
T cd06615         240 FELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRAE  294 (308)
T ss_pred             HHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhcc
Confidence                     0011111 23677899999999999999999999999999997653

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=8.8e-40  Score=330.30  Aligned_cols=242  Identities=52%  Similarity=0.907  Sum_probs=207.2

Q ss_pred             cceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCCe----------EEEEEEec
Q psy1546          58 IFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTK----------LWIIMEYL  127 (604)
Q Consensus        58 ~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~~----------lyLVmEy~  127 (604)
                      .|++.+.||.|+||+||+|.+..++..||+|++...........+.+|+.+++.++|+++.+          +|+||||+
T Consensus         2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~   81 (267)
T cd06610           2 DYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYL   81 (267)
T ss_pred             cceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEecc
Confidence            38899999999999999999998999999999976554446788999999999999998544          47999999


Q ss_pred             CCCChhhHhhc----CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCCC---
Q psy1546         128 GGGSALDLMKA----GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSK---  200 (604)
Q Consensus       128 ~ggsL~~~l~~----~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~---  200 (604)
                      ++++|.++++.    +.+++..+..++.||+.||.|||+.||+||||+|+||++++++.++|+|||++..+......   
T Consensus        82 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~  161 (267)
T cd06610          82 SGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRK  161 (267)
T ss_pred             CCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCcccccc
Confidence            99999999865    45899999999999999999999999999999999999999999999999999766543322   


Q ss_pred             -CcccccCCCCCChHHhhcC-CCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCCCCCCCC-----ccchHHHH
Q psy1546         201 -RNTFVGTPFWMAPEVIKQS-AYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLT-----GNYTKQFK  273 (604)
Q Consensus       201 -~~~~~GT~~Y~APE~l~~~-~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~-----~~~s~~l~  273 (604)
                       .....|+..|+|||++... .++.++|+|||||++|+|++|..||...........+....+..+.     ..++..+.
T Consensus       162 ~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (267)
T cd06610         162 VRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYKKYSKSFR  241 (267)
T ss_pred             ccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCCCCCcCCccccccccHHHH
Confidence             2445789999999999876 7889999999999999999999999887665544443333322222     35678999


Q ss_pred             HHHHHHhccCCCCCCCHHHHhcChhh
Q psy1546         274 EFVEACLNKDPENRPTAKELLKFPFI  299 (604)
Q Consensus       274 ~Li~~~L~~dP~~RpT~~elL~hp~f  299 (604)
                      +|+.+||..||.+|||+.+|++||||
T Consensus       242 ~li~~~l~~~p~~Rp~~~~ll~~p~~  267 (267)
T cd06610         242 KMISLCLQKDPSKRPTAEELLKHKFF  267 (267)
T ss_pred             HHHHHHcCCChhhCcCHHHHhhCCCC
Confidence            99999999999999999999999997

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=9.1e-40  Score=329.00  Aligned_cols=241  Identities=36%  Similarity=0.602  Sum_probs=213.2

Q ss_pred             ceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchh-hHHHHHHHHHHHHHHhhCCCCCCCe------------EEEEEE
Q psy1546          59 FTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE-AEDEIEDIQQEIMVLSQCDSPYGTK------------LWIIME  125 (604)
Q Consensus        59 y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~-~~~~~~~l~~Ei~iL~~l~hp~~~~------------lyLVmE  125 (604)
                      |.+.+.||.|+||.||+|.+..+++.||+|++.... .....+.+..|+.+++.+.|+++.+            +|+|||
T Consensus         2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~e   81 (265)
T cd08217           2 YEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVME   81 (265)
T ss_pred             ceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEeh
Confidence            788899999999999999999999999999986543 2344567889999999999998543            479999


Q ss_pred             ecCCCChhhHhhc-----CCCcHHHHHHHHHHHHHHhHHhh-----hCCccccccccceeEecCCCCeEEeccccccccc
Q psy1546         126 YLGGGSALDLMKA-----GNFEEMHIAVILREVLKGLDYLH-----SERKLHRDIKAANVLLSEMGDVKLADFGVAGTLT  195 (604)
Q Consensus       126 y~~ggsL~~~l~~-----~~lse~~i~~i~~qIl~gL~yLH-----s~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~  195 (604)
                      |+++++|.+++..     +.+++..++.++.||+.||.|||     +.+|+||||+|+||+++.++.+||+|||++..+.
T Consensus        82 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~~  161 (265)
T cd08217          82 YCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILG  161 (265)
T ss_pred             hccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEeccccccccc
Confidence            9999999998853     57899999999999999999999     8999999999999999999999999999998766


Q ss_pred             CCCCCCcccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCCCCCCCCccchHHHHHH
Q psy1546         196 NTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEF  275 (604)
Q Consensus       196 ~~~~~~~~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~L  275 (604)
                      ..........|++.|+|||++.+..++.++||||||+++|+|++|..||...........+.....+.++..++..+.++
T Consensus       162 ~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  241 (265)
T cd08217         162 HDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFRRIPYRYSSELNEV  241 (265)
T ss_pred             CCcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcCCCCCCccccCHHHHHH
Confidence            54443445679999999999998889999999999999999999999999887766666666666667778889999999


Q ss_pred             HHHHhccCCCCCCCHHHHhcChhh
Q psy1546         276 VEACLNKDPENRPTAKELLKFPFI  299 (604)
Q Consensus       276 i~~~L~~dP~~RpT~~elL~hp~f  299 (604)
                      +.+||..+|.+|||+.+|++|||+
T Consensus       242 ~~~~l~~~p~~Rp~~~~il~~~~~  265 (265)
T cd08217         242 IKSMLNVDPDKRPSTEELLQLPLI  265 (265)
T ss_pred             HHHHccCCcccCCCHHHHhhCCCC
Confidence            999999999999999999999995

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=8.6e-40  Score=328.72  Aligned_cols=241  Identities=57%  Similarity=1.029  Sum_probs=208.5

Q ss_pred             cccceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCCe----------EEEEEE
Q psy1546          56 ELIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTK----------LWIIME  125 (604)
Q Consensus        56 ~~~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~~----------lyLVmE  125 (604)
                      ++.|.+.+.||.|+||.||+|.+..+++.||+|.+.....   .+.+.+|+.+++.++|+++.+          +|+|+|
T Consensus         2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e   78 (256)
T cd06612           2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED---LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVME   78 (256)
T ss_pred             cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH---HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEe
Confidence            4568999999999999999999998899999999865532   578899999999999998544          479999


Q ss_pred             ecCCCChhhHhhc--CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCCCCcc
Q psy1546         126 YLGGGSALDLMKA--GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNT  203 (604)
Q Consensus       126 y~~ggsL~~~l~~--~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~~~~  203 (604)
                      |+.+++|.+++..  ..+++..+..++.||+.||.|||+.+|+||||+|.||+++.++.++|+|||++............
T Consensus        79 ~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~  158 (256)
T cd06612          79 YCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNT  158 (256)
T ss_pred             cCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccCcccccc
Confidence            9999999999864  56899999999999999999999999999999999999999999999999999776554434445


Q ss_pred             cccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCCCCC--CCCccchHHHHHHHHHHhc
Q psy1546         204 FVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPP--QLTGNYTKQFKEFVEACLN  281 (604)
Q Consensus       204 ~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~~~~--~~~~~~s~~l~~Li~~~L~  281 (604)
                      ..|+..|+|||++.+..++.++|||||||++|+|++|..||...........+......  ..+..++..+.++|.+||.
T Consensus       159 ~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~  238 (256)
T cd06612         159 VIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPEKWSPEFNDFVKKCLV  238 (256)
T ss_pred             ccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCCCCCCCchhhcCHHHHHHHHHHHh
Confidence            66899999999999999999999999999999999999999877665555444333222  2234577899999999999


Q ss_pred             cCCCCCCCHHHHhcChhh
Q psy1546         282 KDPENRPTAKELLKFPFI  299 (604)
Q Consensus       282 ~dP~~RpT~~elL~hp~f  299 (604)
                      .||.+|||+.|||.||||
T Consensus       239 ~~P~~Rps~~~il~~~~~  256 (256)
T cd06612         239 KDPEERPSAIQLLQHPFI  256 (256)
T ss_pred             cChhhCcCHHHHhcCCCC
Confidence            999999999999999997

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=1.1e-39  Score=336.11  Aligned_cols=245  Identities=26%  Similarity=0.416  Sum_probs=204.7

Q ss_pred             ceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhH--HHHHHHHHHHHHHhhCCCCCCCe----------EEEEEEe
Q psy1546          59 FTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAE--DEIEDIQQEIMVLSQCDSPYGTK----------LWIIMEY  126 (604)
Q Consensus        59 y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~--~~~~~l~~Ei~iL~~l~hp~~~~----------lyLVmEy  126 (604)
                      |+..+.||+|+||+||+|.+..+++.||+|++......  .....+.+|+.+|+.+.|+++..          +|+||||
T Consensus         2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05632           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence            77889999999999999999999999999998654332  22355778999999999998543          4799999


Q ss_pred             cCCCChhhHhhc---CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCCCCcc
Q psy1546         127 LGGGSALDLMKA---GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNT  203 (604)
Q Consensus       127 ~~ggsL~~~l~~---~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~~~~  203 (604)
                      +.+++|.+++..   ..+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++...... .....
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~-~~~~~  160 (285)
T cd05632          82 MNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEG-ESIRG  160 (285)
T ss_pred             ccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCCC-CcccC
Confidence            999999988743   36999999999999999999999999999999999999999999999999998654322 22234


Q ss_pred             cccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcC---CCCCCCCCccchHHHHHHHHHHh
Q psy1546         204 FVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIP---KNNPPQLTGNYTKQFKEFVEACL  280 (604)
Q Consensus       204 ~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~---~~~~~~~~~~~s~~l~~Li~~~L  280 (604)
                      ..|++.|+|||++.+..++.++|||||||++|+|++|..||...........+.   ......+...++..+.+|+.+||
T Consensus       161 ~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l  240 (285)
T cd05632         161 RVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSICKMLL  240 (285)
T ss_pred             CCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccccCccCCHHHHHHHHHHc
Confidence            579999999999999999999999999999999999999998765543222211   11123345668889999999999


Q ss_pred             ccCCCCCCC-----HHHHhcChhhhhhhh
Q psy1546         281 NKDPENRPT-----AKELLKFPFIRKAKK  304 (604)
Q Consensus       281 ~~dP~~RpT-----~~elL~hp~f~~~~~  304 (604)
                      ..||.+||+     +.+++.|+||+....
T Consensus       241 ~~~P~~R~~~~~~~~~~l~~~~~~~~~~~  269 (285)
T cd05632         241 TKDPKQRLGCQEEGAGEVKRHPFFRNMNF  269 (285)
T ss_pred             cCCHhHcCCCcccChHHHHcChhhhcCCH
Confidence            999999999     899999999987643

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>KOG0587|consensus

Probab=100.00  E-value=2.7e-40  Score=365.73  Aligned_cols=248  Identities=52%  Similarity=0.948  Sum_probs=226.4

Q ss_pred             CccccceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhC-CCCC---------------C
Q psy1546          54 DPELIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQC-DSPY---------------G  117 (604)
Q Consensus        54 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l-~hp~---------------~  117 (604)
                      ++...|++.+.||.|.+|.||+++++.+++.+|||+.......+  +.+..|+.+|+.+ +|||               .
T Consensus        16 dp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~d--eEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~   93 (953)
T KOG0587|consen   16 DPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEE--EEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNG   93 (953)
T ss_pred             CCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcccc--HHHHHHHHHHHhccCCCCcceEEEEEEEecCCCC
Confidence            56677999999999999999999999999999999998776544  5667788888765 5665               4


Q ss_pred             CeEEEEEEecCCCChhhHhhc---CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccc
Q psy1546         118 TKLWIIMEYLGGGSALDLMKA---GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTL  194 (604)
Q Consensus       118 ~~lyLVmEy~~ggsL~~~l~~---~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~  194 (604)
                      .+||||||||.||+..|+++.   +++.|..+..|++.++.||.|||.+.++|||||-.|||++.+|.|||+|||++..+
T Consensus        94 DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFGvSaQl  173 (953)
T KOG0587|consen   94 DQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL  173 (953)
T ss_pred             CeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeeeeeeee
Confidence            567999999999999999875   67999999999999999999999999999999999999999999999999999999


Q ss_pred             cCCCCCCcccccCCCCCChHHhhcC-----CCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCCCCCCC--Ccc
Q psy1546         195 TNTTSKRNTFVGTPFWMAPEVIKQS-----AYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQL--TGN  267 (604)
Q Consensus       195 ~~~~~~~~~~~GT~~Y~APE~l~~~-----~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~--~~~  267 (604)
                      +.+...+.+++|||.|||||++...     .|+..+|+||||++..||.-|.+|+-+.+++..++.|+.+.++.+  +..
T Consensus       174 dsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpRNPPPkLkrp~k  253 (953)
T KOG0587|consen  174 DSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKLKRPKK  253 (953)
T ss_pred             ecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCCCCCCccccchhh
Confidence            9888899999999999999999643     478899999999999999999999999999999999999998876  467


Q ss_pred             chHHHHHHHHHHhccCCCCCCCHHHHhcChhhhhhh
Q psy1546         268 YTKQFKEFVEACLNKDPENRPTAKELLKFPFIRKAK  303 (604)
Q Consensus       268 ~s~~l~~Li~~~L~~dP~~RpT~~elL~hp~f~~~~  303 (604)
                      ++++|.+||..||.+|..+||++.++|+|||++...
T Consensus       254 Ws~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~e~~  289 (953)
T KOG0587|consen  254 WSKKFNDFISTCLVKDYEQRPSTEELLKHPFITEQP  289 (953)
T ss_pred             HHHHHHHHHHHHHhhccccCcchhhhccCCcccccc
Confidence            899999999999999999999999999999998655

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=6.3e-40  Score=340.25  Aligned_cols=259  Identities=35%  Similarity=0.669  Sum_probs=217.7

Q ss_pred             ccceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCC----------CeEEEEEEe
Q psy1546          57 LIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYG----------TKLWIIMEY  126 (604)
Q Consensus        57 ~~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~----------~~lyLVmEy  126 (604)
                      ..|.....||+|+||.||+|.+..+++.||||++...... ..+.+.+|+.++..+.||+.          ..+|+||||
T Consensus        21 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~-~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~   99 (297)
T cd06659          21 SLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQ-RRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEF   99 (297)
T ss_pred             hhHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccc-hHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEec
Confidence            3466667899999999999999999999999998654332 34668899999999999984          346899999


Q ss_pred             cCCCChhhHhhcCCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCCCCccccc
Q psy1546         127 LGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVG  206 (604)
Q Consensus       127 ~~ggsL~~~l~~~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~~~~~~G  206 (604)
                      +++++|..++....+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++..+...........|
T Consensus       100 ~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~~~~  179 (297)
T cd06659         100 LQGGALTDIVSQTRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVG  179 (297)
T ss_pred             CCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhcccccccccceec
Confidence            99999999998888999999999999999999999999999999999999999999999999999765544444445679


Q ss_pred             CCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCCCC--CCCCccchHHHHHHHHHHhccCC
Q psy1546         207 TPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNP--PQLTGNYTKQFKEFVEACLNKDP  284 (604)
Q Consensus       207 T~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~~~--~~~~~~~s~~l~~Li~~~L~~dP  284 (604)
                      +..|+|||++.+..++.++|||||||++|||++|..||...........+.....  ......++..+.++|.+||..+|
T Consensus       180 ~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~P  259 (297)
T cd06659         180 TPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHKISPVLRDFLERMLTREP  259 (297)
T ss_pred             CccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCccccCCCCHHHHHHHHHHhcCCc
Confidence            9999999999988999999999999999999999999987766555444433221  12234578899999999999999


Q ss_pred             CCCCCHHHHhcChhhhhhhhhhhHHHHHHHHH
Q psy1546         285 ENRPTAKELLKFPFIRKAKKNAYLIDLIDRYK  316 (604)
Q Consensus       285 ~~RpT~~elL~hp~f~~~~~~~~l~~~~~~~~  316 (604)
                      .+||++.++++||||.+.....-+..+..++.
T Consensus       260 ~~Rps~~~ll~~~~~~~~~~~~~~~~~~~~~~  291 (297)
T cd06659         260 QERATAQELLDHPFLLQTGLPECLVPLIQQYR  291 (297)
T ss_pred             ccCcCHHHHhhChhhccCCCcccccchHHHHh
Confidence            99999999999999988876655555555553

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=1.2e-39  Score=334.08  Aligned_cols=243  Identities=37%  Similarity=0.644  Sum_probs=201.7

Q ss_pred             cceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCCe----------EEEEEEec
Q psy1546          58 IFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTK----------LWIIMEYL  127 (604)
Q Consensus        58 ~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~~----------lyLVmEy~  127 (604)
                      .|.+.++||+|+||.||+|.+..+++.||||++...........+.+|+.++.+++||++.+          +++||||+
T Consensus         2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   81 (279)
T cd06619           2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFM   81 (279)
T ss_pred             cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecC
Confidence            37788999999999999999999999999999876544444567889999999999998654          47999999


Q ss_pred             CCCChhhHhhcCCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCCCCcccccC
Q psy1546         128 GGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGT  207 (604)
Q Consensus       128 ~ggsL~~~l~~~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~~~~~~GT  207 (604)
                      ++++|..+   ..+++..+..++.||+.||.|||+.||+|+||||+|||++.++.++|+|||++..+...  .....+||
T Consensus        82 ~~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~--~~~~~~~~  156 (279)
T cd06619          82 DGGSLDVY---RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS--IAKTYVGT  156 (279)
T ss_pred             CCCChHHh---hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceecccc--cccCCCCC
Confidence            99998655   35788899999999999999999999999999999999999999999999999765432  23346899


Q ss_pred             CCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChh-------hHhhhcCCCCCCCC-CccchHHHHHHHHHH
Q psy1546         208 PFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPM-------RVLFLIPKNNPPQL-TGNYTKQFKEFVEAC  279 (604)
Q Consensus       208 ~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~-------~~~~~i~~~~~~~~-~~~~s~~l~~Li~~~  279 (604)
                      ..|+|||++.+..++.++|||||||++|+|++|..||......       .....+.......+ ...++.++.+||.+|
T Consensus       157 ~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  236 (279)
T cd06619         157 NAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKFVHFITQC  236 (279)
T ss_pred             hhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCCCCCcCCHHHHHHHHHH
Confidence            9999999999989999999999999999999999998653221       11111111122222 345778999999999


Q ss_pred             hccCCCCCCCHHHHhcChhhhhhhhh
Q psy1546         280 LNKDPENRPTAKELLKFPFIRKAKKN  305 (604)
Q Consensus       280 L~~dP~~RpT~~elL~hp~f~~~~~~  305 (604)
                      |..||.+||+++|+++||||......
T Consensus       237 l~~~P~~Rp~~~eil~~~~~~~~~~~  262 (279)
T cd06619         237 MRKQPKERPAPENLMDHPFIVQYNDG  262 (279)
T ss_pred             hhCChhhCCCHHHHhcCcccccccCc
Confidence            99999999999999999999766443

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=4.9e-40  Score=333.66  Aligned_cols=240  Identities=49%  Similarity=0.900  Sum_probs=201.3

Q ss_pred             cceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCC----------eEEEEEEec
Q psy1546          58 IFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGT----------KLWIIMEYL  127 (604)
Q Consensus        58 ~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~----------~lyLVmEy~  127 (604)
                      .|.+.++||+|+||.||+|.+..+++.||+|++..... .....+.+|+.+++.++||++.          .+|+||||+
T Consensus        10 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~   88 (267)
T cd06645          10 DFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPG-EDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC   88 (267)
T ss_pred             HHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence            48899999999999999999999999999999865532 3345678999999999999854          457999999


Q ss_pred             CCCChhhHhhc-CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCCCCccccc
Q psy1546         128 GGGSALDLMKA-GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVG  206 (604)
Q Consensus       128 ~ggsL~~~l~~-~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~~~~~~G  206 (604)
                      ++++|.+++.. +.+++..++.++.||+.||.|||++||+|+||||+|||++.++.++|+|||++..+...........|
T Consensus        89 ~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~  168 (267)
T cd06645          89 GGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFIG  168 (267)
T ss_pred             CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccCcccccccccC
Confidence            99999998854 67999999999999999999999999999999999999999999999999999766544444455679


Q ss_pred             CCCCCChHHhh---cCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCCC--CCCC--CccchHHHHHHHHHH
Q psy1546         207 TPFWMAPEVIK---QSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNN--PPQL--TGNYTKQFKEFVEAC  279 (604)
Q Consensus       207 T~~Y~APE~l~---~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~~--~~~~--~~~~s~~l~~Li~~~  279 (604)
                      ++.|+|||++.   ...++.++|||||||++|+|++|..||................  ++.+  ...++..+.+||.+|
T Consensus       169 ~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  248 (267)
T cd06645         169 TPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNSFHHFVKMA  248 (267)
T ss_pred             cccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCcccccCCCCHHHHHHHHHH
Confidence            99999999984   4568889999999999999999999987665443333221111  1111  124678899999999


Q ss_pred             hccCCCCCCCHHHHhcChh
Q psy1546         280 LNKDPENRPTAKELLKFPF  298 (604)
Q Consensus       280 L~~dP~~RpT~~elL~hp~  298 (604)
                      |..+|++|||+++|++|||
T Consensus       249 l~~~P~~R~~~~~ll~~~~  267 (267)
T cd06645         249 LTKNPKKRPTAEKLLQHPF  267 (267)
T ss_pred             ccCCchhCcCHHHHhcCCC
Confidence            9999999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=1.2e-39  Score=328.62  Aligned_cols=238  Identities=30%  Similarity=0.540  Sum_probs=210.2

Q ss_pred             ceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCCe----------EEEEEEecC
Q psy1546          59 FTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTK----------LWIIMEYLG  128 (604)
Q Consensus        59 y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~~----------lyLVmEy~~  128 (604)
                      |.+.++||.|+||.||++.+..+++.||+|.+.........+.+.+|+.+++.++|++..+          +|+||||++
T Consensus         2 y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   81 (255)
T cd08219           2 YNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCD   81 (255)
T ss_pred             ceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeCC
Confidence            7889999999999999999999999999999876554555678889999999999998544          589999999


Q ss_pred             CCChhhHhhc---CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCCCCcccc
Q psy1546         129 GGSALDLMKA---GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFV  205 (604)
Q Consensus       129 ggsL~~~l~~---~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~~~~~~  205 (604)
                      +++|.+++..   ..+++..+..++.||+.||.|||++||+|+||||+|||++.++.++|+|||++..+...........
T Consensus        82 ~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~  161 (255)
T cd08219          82 GGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYV  161 (255)
T ss_pred             CCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeeccccccccccc
Confidence            9999998753   4589999999999999999999999999999999999999999999999999976655444445567


Q ss_pred             cCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCCCCCCCCccchHHHHHHHHHHhccCCC
Q psy1546         206 GTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPE  285 (604)
Q Consensus       206 GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~~L~~dP~  285 (604)
                      |++.|+|||++.+..++.++||||||+++|+|++|..||...+.......+..+....++..++..+.+||.+||..||.
T Consensus       162 ~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~  241 (255)
T cd08219         162 GTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPLPSHYSYELRSLIKQMFKRNPR  241 (255)
T ss_pred             CCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCCCCCCcccCHHHHHHHHHHHhCCcc
Confidence            99999999999998999999999999999999999999998877766666666666666778889999999999999999


Q ss_pred             CCCCHHHHhcC
Q psy1546         286 NRPTAKELLKF  296 (604)
Q Consensus       286 ~RpT~~elL~h  296 (604)
                      +|||+.+|+.-
T Consensus       242 ~Rp~~~~il~~  252 (255)
T cd08219         242 SRPSATTILSR  252 (255)
T ss_pred             cCCCHHHHhhc
Confidence            99999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=7.5e-40  Score=335.30  Aligned_cols=243  Identities=50%  Similarity=0.896  Sum_probs=203.5

Q ss_pred             ccccceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhC-CCCCCC---------------
Q psy1546          55 PELIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQC-DSPYGT---------------  118 (604)
Q Consensus        55 ~~~~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l-~hp~~~---------------  118 (604)
                      +...|++.+.||.|+||.||+|.+..+++.||+|++....  .....+..|+.++..+ +|+++.               
T Consensus        14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~   91 (282)
T cd06636          14 PAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE--DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHD   91 (282)
T ss_pred             hhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh--HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCC
Confidence            3456899999999999999999999999999999986543  2335678899999888 688743               


Q ss_pred             -eEEEEEEecCCCChhhHhhc---CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccc
Q psy1546         119 -KLWIIMEYLGGGSALDLMKA---GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTL  194 (604)
Q Consensus       119 -~lyLVmEy~~ggsL~~~l~~---~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~  194 (604)
                       .+|+||||+++|+|.+++..   ..+++..+..++.||+.||.|||+.||+||||+|+||+++.++.++|+|||++...
T Consensus        92 ~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg~~~~~  171 (282)
T cd06636          92 DQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL  171 (282)
T ss_pred             CEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCcchhhh
Confidence             35899999999999998864   45888889999999999999999999999999999999999999999999998765


Q ss_pred             cCCCCCCcccccCCCCCChHHhh-----cCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCCCC-CCCCccc
Q psy1546         195 TNTTSKRNTFVGTPFWMAPEVIK-----QSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNP-PQLTGNY  268 (604)
Q Consensus       195 ~~~~~~~~~~~GT~~Y~APE~l~-----~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~~~-~~~~~~~  268 (604)
                      ...........|++.|+|||++.     ...++.++|||||||++|+|++|..||...........+..... ......+
T Consensus       172 ~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (282)
T cd06636         172 DRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKLKSKKW  251 (282)
T ss_pred             hccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhCCCCCCccccc
Confidence            44333445567999999999986     34678899999999999999999999987665554443333322 2233467


Q ss_pred             hHHHHHHHHHHhccCCCCCCCHHHHhcChhh
Q psy1546         269 TKQFKEFVEACLNKDPENRPTAKELLKFPFI  299 (604)
Q Consensus       269 s~~l~~Li~~~L~~dP~~RpT~~elL~hp~f  299 (604)
                      +..+.+||.+||..||.+|||+.|||+||||
T Consensus       252 ~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~  282 (282)
T cd06636         252 SKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI  282 (282)
T ss_pred             CHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence            8999999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.1e-39  Score=334.82  Aligned_cols=245  Identities=36%  Similarity=0.620  Sum_probs=207.9

Q ss_pred             cceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCC----------CeEEEEEEec
Q psy1546          58 IFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYG----------TKLWIIMEYL  127 (604)
Q Consensus        58 ~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~----------~~lyLVmEy~  127 (604)
                      .|++.+.||+|+||.||+|.+..+++.||+|.+...........+.+|+.++++++|+++          ..+|+||||+
T Consensus         2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~   81 (286)
T cd06622           2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYM   81 (286)
T ss_pred             hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeec
Confidence            378899999999999999999999999999998765444456778899999999999984          4468999999


Q ss_pred             CCCChhhHhhcC----CCcHHHHHHHHHHHHHHhHHhhh-CCccccccccceeEecCCCCeEEecccccccccCCCCCCc
Q psy1546         128 GGGSALDLMKAG----NFEEMHIAVILREVLKGLDYLHS-ERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRN  202 (604)
Q Consensus       128 ~ggsL~~~l~~~----~lse~~i~~i~~qIl~gL~yLHs-~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~~~  202 (604)
                      ++++|..++..+    .+++..+..++.||+.||.|||+ .||+||||||+|||++.++.++|+|||++..+...  ...
T Consensus        82 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~--~~~  159 (286)
T cd06622          82 DAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS--LAK  159 (286)
T ss_pred             CCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCC--ccc
Confidence            999999998764    79999999999999999999996 59999999999999999999999999999765432  223


Q ss_pred             ccccCCCCCChHHhhcCC------CCCcchhhhHHHHHHHHHhCCCCCCCCChhhHh---hhcCCCCCCCCCccchHHHH
Q psy1546         203 TFVGTPFWMAPEVIKQSA------YDSKADIWSLGITAIELAKGEPPNSELHPMRVL---FLIPKNNPPQLTGNYTKQFK  273 (604)
Q Consensus       203 ~~~GT~~Y~APE~l~~~~------~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~---~~i~~~~~~~~~~~~s~~l~  273 (604)
                      ...+++.|+|||++.+..      ++.++|||||||++|+|++|..||.........   ..+....++.++..++.++.
T Consensus       160 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (286)
T cd06622         160 TNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSGYSDDAQ  239 (286)
T ss_pred             cCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCCCCCCcccCHHHH
Confidence            456889999999985543      578999999999999999999999765443322   23334455566777999999


Q ss_pred             HHHHHHhccCCCCCCCHHHHhcChhhhhhhh
Q psy1546         274 EFVEACLNKDPENRPTAKELLKFPFIRKAKK  304 (604)
Q Consensus       274 ~Li~~~L~~dP~~RpT~~elL~hp~f~~~~~  304 (604)
                      +||.+||..+|.+||++.+++.||||.....
T Consensus       240 ~li~~~l~~~p~~Rp~~~~l~~~~~~~~~~~  270 (286)
T cd06622         240 DFVAKCLNKIPNRRPTYAQLLEHPWLVKYKN  270 (286)
T ss_pred             HHHHHHcccCcccCCCHHHHhcChhhhhccC
Confidence            9999999999999999999999999977654

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>KOG4279|consensus

Probab=100.00  E-value=1.5e-40  Score=357.54  Aligned_cols=238  Identities=36%  Similarity=0.629  Sum_probs=208.4

Q ss_pred             EEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCCeE----------EEEEEecCCCChh
Q psy1546          64 RIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTKL----------WIIMEYLGGGSAL  133 (604)
Q Consensus        64 ~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~~l----------yLVmEy~~ggsL~  133 (604)
                      +||+|.||+||-|+|..|...+|||.|.... ....+-+..||.+.++|+|.|++++          -|.||-++||+|.
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekd-sr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLS  660 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKD-SREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLS  660 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeeccccc-chhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHH
Confidence            7999999999999999999999999996543 3445778999999999999996654          5899999999999


Q ss_pred             hHhhc--CCC--cHHHHHHHHHHHHHHhHHhhhCCccccccccceeEec-CCCCeEEecccccccccCCCCCCcccccCC
Q psy1546         134 DLMKA--GNF--EEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLS-EMGDVKLADFGVAGTLTNTTSKRNTFVGTP  208 (604)
Q Consensus       134 ~~l~~--~~l--se~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~-~~g~vKL~DFGlA~~~~~~~~~~~~~~GT~  208 (604)
                      .+++.  |++  .|..+.++.+||++||+|||++.|||||||.+||||+ -.|.+||.|||-++.+..-.....++.||.
T Consensus       661 sLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TETFTGTL  740 (1226)
T KOG4279|consen  661 SLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTETFTGTL  740 (1226)
T ss_pred             HHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhccCCccccccccch
Confidence            99975  777  7889999999999999999999999999999999996 468999999999999887777778999999


Q ss_pred             CCCChHHhhcC--CCCCcchhhhHHHHHHHHHhCCCCCCCCChh-hHhhhcCC-CCCCCCCccchHHHHHHHHHHhccCC
Q psy1546         209 FWMAPEVIKQS--AYDSKADIWSLGITAIELAKGEPPNSELHPM-RVLFLIPK-NNPPQLTGNYTKQFKEFVEACLNKDP  284 (604)
Q Consensus       209 ~Y~APE~l~~~--~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~-~~~~~i~~-~~~~~~~~~~s~~l~~Li~~~L~~dP  284 (604)
                      .|||||++..+  .|+.++|||||||++.||.||++||.+.... ..++.+.. ..-+.++..++.+++.||.+|+..||
T Consensus       741 QYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP~iPeelsaeak~FilrcFepd~  820 (1226)
T KOG4279|consen  741 QYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHPPIPEELSAEAKNFILRCFEPDP  820 (1226)
T ss_pred             hhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceecCCCCcHHHHHHHHHHHHHHcCCCc
Confidence            99999999765  4889999999999999999999999876543 33333322 23467888999999999999999999


Q ss_pred             CCCCCHHHHhcChhhhhh
Q psy1546         285 ENRPTAKELLKFPFIRKA  302 (604)
Q Consensus       285 ~~RpT~~elL~hp~f~~~  302 (604)
                      .+||++.++|.+||+...
T Consensus       821 ~~R~sA~~LL~DpFlq~~  838 (1226)
T KOG4279|consen  821 CDRPSAKDLLQDPFLQHN  838 (1226)
T ss_pred             ccCccHHHhccCcccccC
Confidence            999999999999999643

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=1.6e-39  Score=335.18  Aligned_cols=243  Identities=27%  Similarity=0.484  Sum_probs=210.7

Q ss_pred             cceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhh--HHHHHHHHHHHHHHhhCCCCCCCe----------EEEEEE
Q psy1546          58 IFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA--EDEIEDIQQEIMVLSQCDSPYGTK----------LWIIME  125 (604)
Q Consensus        58 ~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~--~~~~~~l~~Ei~iL~~l~hp~~~~----------lyLVmE  125 (604)
                      .|++.+.||+|+||.||+|.+..+++.||||++.....  ......+.+|+.+++++.||++.+          +|+|||
T Consensus         2 ~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   81 (290)
T cd05580           2 DFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVME   81 (290)
T ss_pred             ceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEe
Confidence            38899999999999999999999999999999865432  234567889999999999998544          479999


Q ss_pred             ecCCCChhhHhhc-CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCCCCccc
Q psy1546         126 YLGGGSALDLMKA-GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTF  204 (604)
Q Consensus       126 y~~ggsL~~~l~~-~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~~~~~  204 (604)
                      |+++++|.+++.. +.+++..+..++.||+.||.|||++||+||||+|.||||+.++.+||+|||++......   ....
T Consensus        82 ~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~---~~~~  158 (290)
T cd05580          82 YVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR---TYTL  158 (290)
T ss_pred             cCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC---CCCC
Confidence            9999999999865 67999999999999999999999999999999999999999999999999999766443   3355


Q ss_pred             ccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCCCCCCCCccchHHHHHHHHHHhccCC
Q psy1546         205 VGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDP  284 (604)
Q Consensus       205 ~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~~L~~dP  284 (604)
                      +|++.|+|||.+.+..++.++||||||+++|+|++|..||...........+... ...++..++..++++|.+||..||
T Consensus       159 ~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~~p  237 (290)
T cd05580         159 CGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEG-KVRFPSFFSPDAKDLIRNLLQVDL  237 (290)
T ss_pred             CCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC-CccCCccCCHHHHHHHHHHccCCH
Confidence            7999999999998888899999999999999999999999887765555444332 334566778999999999999999


Q ss_pred             CCCC-----CHHHHhcChhhhhhhh
Q psy1546         285 ENRP-----TAKELLKFPFIRKAKK  304 (604)
Q Consensus       285 ~~Rp-----T~~elL~hp~f~~~~~  304 (604)
                      .+|+     +++|+++||||....+
T Consensus       238 ~~R~~~~~~~~~~l~~~~~~~~~~~  262 (290)
T cd05580         238 TKRLGNLKNGVNDIKNHPWFAGIDW  262 (290)
T ss_pred             HHccCcccCCHHHHHcCcccccCCH
Confidence            9999     9999999999976544

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=7.6e-40  Score=335.09  Aligned_cols=238  Identities=24%  Similarity=0.417  Sum_probs=205.7

Q ss_pred             ceeeeEEcccCcEEEEEEEECCCC-----cEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCCe----------EEEE
Q psy1546          59 FTKQERIGKGSFGEVFKGIDNRTQ-----QVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTK----------LWII  123 (604)
Q Consensus        59 y~i~~~LG~G~fG~Vy~a~~~~t~-----~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~~----------lyLV  123 (604)
                      |.+.+.||+|+||.||+|.+...+     ..||+|.+...........+.+|+.++..+.||++.+          .|++
T Consensus         7 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~   86 (283)
T cd05048           7 VRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCML   86 (283)
T ss_pred             cchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceEEE
Confidence            788999999999999999876554     6899999876555555677899999999999998654          4799


Q ss_pred             EEecCCCChhhHhhc-----------------CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEe
Q psy1546         124 MEYLGGGSALDLMKA-----------------GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLA  186 (604)
Q Consensus       124 mEy~~ggsL~~~l~~-----------------~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~  186 (604)
                      |||+++++|.+++..                 +.+++..+..++.||+.||.|||++|++||||||+|||+++++.++|+
T Consensus        87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~~~~~L~  166 (283)
T cd05048          87 FEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKIS  166 (283)
T ss_pred             EecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCCCcEEEC
Confidence            999999999998854                 347888899999999999999999999999999999999999999999


Q ss_pred             cccccccccCCC--CCCcccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHhhhcCCCCCCC
Q psy1546         187 DFGVAGTLTNTT--SKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAK-GEPPNSELHPMRVLFLIPKNNPPQ  263 (604)
Q Consensus       187 DFGlA~~~~~~~--~~~~~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~  263 (604)
                      |||+++......  .......+++.|+|||++.+..++.++|||||||++|||++ |..||.+....+....+.......
T Consensus       167 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~i~~~~~~~  246 (283)
T cd05048         167 DFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIRSRQLLP  246 (283)
T ss_pred             CCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcCC
Confidence            999997553322  12233457889999999998899999999999999999998 999999888877777776666666


Q ss_pred             CCccchHHHHHHHHHHhccCCCCCCCHHHHhcC
Q psy1546         264 LTGNYTKQFKEFVEACLNKDPENRPTAKELLKF  296 (604)
Q Consensus       264 ~~~~~s~~l~~Li~~~L~~dP~~RpT~~elL~h  296 (604)
                      .+..++.++.+|+.+||+.||.+||++.||+++
T Consensus       247 ~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~  279 (283)
T cd05048         247 CPEDCPARVYALMIECWNEIPARRPRFKDIHTR  279 (283)
T ss_pred             CcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            777899999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=5.7e-40  Score=342.41  Aligned_cols=234  Identities=26%  Similarity=0.440  Sum_probs=182.2

Q ss_pred             eeEEcccCcEEEEEEEEC--CCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCCe------------EEEEEEec
Q psy1546          62 QERIGKGSFGEVFKGIDN--RTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTK------------LWIIMEYL  127 (604)
Q Consensus        62 ~~~LG~G~fG~Vy~a~~~--~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~~------------lyLVmEy~  127 (604)
                      +++||+|+||+||+|.+.  .+++.||||.+......   ..+.+|+.+|+.++|||+.+            +|+||||+
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~   82 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGIS---MSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYA   82 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCCc---HHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEecc
Confidence            468999999999999965  46789999998654322   34678999999999998654            47999999


Q ss_pred             CCCChhhHhhc----------CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEe----cCCCCeEEeccccccc
Q psy1546         128 GGGSALDLMKA----------GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLL----SEMGDVKLADFGVAGT  193 (604)
Q Consensus       128 ~ggsL~~~l~~----------~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl----~~~g~vKL~DFGlA~~  193 (604)
                      + ++|.+++..          ..+++..++.++.||+.||.|||++||+||||||+|||+    +..+.+||+|||+|+.
T Consensus        83 ~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~  161 (317)
T cd07868          83 E-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARL  161 (317)
T ss_pred             C-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCceec
Confidence            5 577777642          248899999999999999999999999999999999999    4567899999999976


Q ss_pred             ccCCCC---CCcccccCCCCCChHHhhc-CCCCCcchhhhHHHHHHHHHhCCCCCCCCChh---------hHhhhc----
Q psy1546         194 LTNTTS---KRNTFVGTPFWMAPEVIKQ-SAYDSKADIWSLGITAIELAKGEPPNSELHPM---------RVLFLI----  256 (604)
Q Consensus       194 ~~~~~~---~~~~~~GT~~Y~APE~l~~-~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~---------~~~~~i----  256 (604)
                      +.....   ......||+.|+|||++.+ ..++.++|||||||++|+|++|.+||......         .....+    
T Consensus       162 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~  241 (317)
T cd07868         162 FNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVM  241 (317)
T ss_pred             cCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHHhc
Confidence            543221   2335678999999999977 45899999999999999999999999643321         000000    


Q ss_pred             --------------CC----------CCC---------CCCCccchHHHHHHHHHHhccCCCCCCCHHHHhcChhh
Q psy1546         257 --------------PK----------NNP---------PQLTGNYTKQFKEFVEACLNKDPENRPTAKELLKFPFI  299 (604)
Q Consensus       257 --------------~~----------~~~---------~~~~~~~s~~l~~Li~~~L~~dP~~RpT~~elL~hp~f  299 (604)
                                    ..          ...         .......+..+.+||.+||..||.+|||++|+|+||||
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f  317 (317)
T cd07868         242 GFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF  317 (317)
T ss_pred             CCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence                          00          000         00001224568899999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=1.3e-39  Score=328.13  Aligned_cols=241  Identities=29%  Similarity=0.551  Sum_probs=210.9

Q ss_pred             ceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhh-HHHHHHHHHHHHHHhhCCCCCCCe----------EEEEEEec
Q psy1546          59 FTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA-EDEIEDIQQEIMVLSQCDSPYGTK----------LWIIMEYL  127 (604)
Q Consensus        59 y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~-~~~~~~l~~Ei~iL~~l~hp~~~~----------lyLVmEy~  127 (604)
                      |++.++||+|+||.||++.+..+++.||||.+..... ......+.+|+.+++.+.|+++.+          +|+||||+
T Consensus         2 y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~   81 (256)
T cd08218           2 YVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYC   81 (256)
T ss_pred             ceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEecC
Confidence            7889999999999999999999999999999865432 334567889999999999998544          57999999


Q ss_pred             CCCChhhHhhc---CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCCCCccc
Q psy1546         128 GGGSALDLMKA---GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTF  204 (604)
Q Consensus       128 ~ggsL~~~l~~---~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~~~~~  204 (604)
                      .+++|.+++..   ..+++..+..++.||+.||.|||++|++|+||+|+|||++.++.++|+|||++..+..........
T Consensus        82 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~  161 (256)
T cd08218          82 EGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTC  161 (256)
T ss_pred             CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchhhhhhc
Confidence            99999998864   257899999999999999999999999999999999999999999999999997665443333445


Q ss_pred             ccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCCCCCCCCccchHHHHHHHHHHhccCC
Q psy1546         205 VGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDP  284 (604)
Q Consensus       205 ~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~~L~~dP  284 (604)
                      .|++.|+|||++.+..++.++|||||||++|+|++|..||...........+..+..+..+..++.++.++|.+||..+|
T Consensus       162 ~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p  241 (256)
T cd08218         162 IGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPPVSSHYSYDLRNLVSQLFKRNP  241 (256)
T ss_pred             cCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCCCCCCcccCCHHHHHHHHHHhhCCh
Confidence            68999999999998889999999999999999999999998877766666665566566677889999999999999999


Q ss_pred             CCCCCHHHHhcChhh
Q psy1546         285 ENRPTAKELLKFPFI  299 (604)
Q Consensus       285 ~~RpT~~elL~hp~f  299 (604)
                      .+||++.+|++||||
T Consensus       242 ~~Rp~~~~vl~~~~~  256 (256)
T cd08218         242 RDRPSVNSILEKNFI  256 (256)
T ss_pred             hhCcCHHHHhhCcCC
Confidence            999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=7.4e-40  Score=335.16  Aligned_cols=240  Identities=33%  Similarity=0.498  Sum_probs=195.8

Q ss_pred             ceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhH-HHHHHHHHHHHHHhhCCCCCCCe----------EEEEEEec
Q psy1546          59 FTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAE-DEIEDIQQEIMVLSQCDSPYGTK----------LWIIMEYL  127 (604)
Q Consensus        59 y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~-~~~~~l~~Ei~iL~~l~hp~~~~----------lyLVmEy~  127 (604)
                      |.+.+.||+|+||.||+|++..+++.||||++...... .....+.+|+.+++.++||+..+          +|+||||+
T Consensus         2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~   81 (285)
T cd07861           2 YTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEFL   81 (285)
T ss_pred             ceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEecC
Confidence            78899999999999999999999999999998654322 22456788999999999998544          57999999


Q ss_pred             CCCChhhHhhc----CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCCCCcc
Q psy1546         128 GGGSALDLMKA----GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNT  203 (604)
Q Consensus       128 ~ggsL~~~l~~----~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~~~~  203 (604)
                      . ++|.+++..    +.+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++............
T Consensus        82 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~  160 (285)
T cd07861          82 S-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTH  160 (285)
T ss_pred             C-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCcccccC
Confidence            7 578877753    56899999999999999999999999999999999999999999999999999765433333334


Q ss_pred             cccCCCCCChHHhhcC-CCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcC-------------------------
Q psy1546         204 FVGTPFWMAPEVIKQS-AYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIP-------------------------  257 (604)
Q Consensus       204 ~~GT~~Y~APE~l~~~-~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~-------------------------  257 (604)
                      ..+++.|+|||++.+. .++.++|||||||++|+|++|.+||.+.........+.                         
T Consensus       161 ~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (285)
T cd07861         161 EVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKNTFP  240 (285)
T ss_pred             CcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHHhhcc
Confidence            5678999999998654 47889999999999999999999998765432221100                         


Q ss_pred             ---CCCCCCCCccchHHHHHHHHHHhccCCCCCCCHHHHhcChhh
Q psy1546         258 ---KNNPPQLTGNYTKQFKEFVEACLNKDPENRPTAKELLKFPFI  299 (604)
Q Consensus       258 ---~~~~~~~~~~~s~~l~~Li~~~L~~dP~~RpT~~elL~hp~f  299 (604)
                         ..........++.++.+||.+||..||.+|||+.+|+.||||
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~  285 (285)
T cd07861         241 KWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF  285 (285)
T ss_pred             ccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence               000011123468899999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-39  Score=328.17  Aligned_cols=241  Identities=54%  Similarity=0.942  Sum_probs=206.8

Q ss_pred             ccceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCCe----------EEEEEEe
Q psy1546          57 LIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTK----------LWIIMEY  126 (604)
Q Consensus        57 ~~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~~----------lyLVmEy  126 (604)
                      ..|.+.+.||.|+||.||+|.+..+++.||+|++...... ....+.+|+.+++.++||++.+          +|+||||
T Consensus         3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~   81 (262)
T cd06613           3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGD-DFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEY   81 (262)
T ss_pred             cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchh-hHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeC
Confidence            4589999999999999999999999999999999755433 5578899999999999998544          5799999


Q ss_pred             cCCCChhhHhhc--CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCCCCccc
Q psy1546         127 LGGGSALDLMKA--GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTF  204 (604)
Q Consensus       127 ~~ggsL~~~l~~--~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~~~~~  204 (604)
                      +++++|.+++..  ..+++..+..++.|++.||.|||++||+||||+|+||+++.++.++|+|||++..+..........
T Consensus        82 ~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~~  161 (262)
T cd06613          82 CGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSF  161 (262)
T ss_pred             CCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhhhhhccccc
Confidence            999999998865  579999999999999999999999999999999999999999999999999997665444344556


Q ss_pred             ccCCCCCChHHhhcC---CCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCC--CCC--CCCccchHHHHHHHH
Q psy1546         205 VGTPFWMAPEVIKQS---AYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKN--NPP--QLTGNYTKQFKEFVE  277 (604)
Q Consensus       205 ~GT~~Y~APE~l~~~---~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~--~~~--~~~~~~s~~l~~Li~  277 (604)
                      .++..|+|||++.+.   .++.++|||||||++|+|++|.+||...........+...  .+.  .....++.++.+||.
T Consensus       162 ~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  241 (262)
T cd06613         162 IGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWSPVFHDFIK  241 (262)
T ss_pred             cCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCccccchhhhhHHHHHHHH
Confidence            789999999999777   7889999999999999999999999887765554443333  111  123456788999999


Q ss_pred             HHhccCCCCCCCHHHHhcChh
Q psy1546         278 ACLNKDPENRPTAKELLKFPF  298 (604)
Q Consensus       278 ~~L~~dP~~RpT~~elL~hp~  298 (604)
                      +||..+|.+|||+.+|+.|+|
T Consensus       242 ~~l~~~p~~Rpt~~~il~~~~  262 (262)
T cd06613         242 KCLTKDPKKRPTATKLLQHPF  262 (262)
T ss_pred             HHcCCChhhCCCHHHHhcCCC
Confidence            999999999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=6e-39  Score=371.42  Aligned_cols=245  Identities=30%  Similarity=0.510  Sum_probs=203.3

Q ss_pred             cceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhh-HHHHHHHHHHHHHHhhCCCCCCCe------------EEEEE
Q psy1546          58 IFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA-EDEIEDIQQEIMVLSQCDSPYGTK------------LWIIM  124 (604)
Q Consensus        58 ~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~-~~~~~~l~~Ei~iL~~l~hp~~~~------------lyLVm  124 (604)
                      .|.++++||+|+||+||+|.+..+++.||+|++..... ......+.+|+.+|..|.||++++            +||||
T Consensus        14 ~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~lyIVM   93 (1021)
T PTZ00266         14 EYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILM   93 (1021)
T ss_pred             CEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEEEEE
Confidence            39999999999999999999999999999999875432 334577889999999999998654            47999


Q ss_pred             EecCCCChhhHhhc-----CCCcHHHHHHHHHHHHHHhHHhhhC-------CccccccccceeEecC-------------
Q psy1546         125 EYLGGGSALDLMKA-----GNFEEMHIAVILREVLKGLDYLHSE-------RKLHRDIKAANVLLSE-------------  179 (604)
Q Consensus       125 Ey~~ggsL~~~l~~-----~~lse~~i~~i~~qIl~gL~yLHs~-------gIiHrDLKp~NILl~~-------------  179 (604)
                      |||++|+|.++|..     +.+++..++.|+.||+.||.|||+.       +||||||||+||||+.             
T Consensus        94 EY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~~~  173 (1021)
T PTZ00266         94 EFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQAN  173 (1021)
T ss_pred             eCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccccccc
Confidence            99999999998864     5799999999999999999999984       4999999999999964             


Q ss_pred             ----CCCeEEecccccccccCCCCCCcccccCCCCCChHHhhc--CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHh
Q psy1546         180 ----MGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQ--SAYDSKADIWSLGITAIELAKGEPPNSELHPMRVL  253 (604)
Q Consensus       180 ----~g~vKL~DFGlA~~~~~~~~~~~~~~GT~~Y~APE~l~~--~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~  253 (604)
                          .+.+||+|||++..+... ......+||+.|+|||++.+  ..++.++||||||||||+|++|..||........+
T Consensus       174 n~ng~~iVKLsDFGlAr~l~~~-s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~~~ql  252 (1021)
T PTZ00266        174 NLNGRPIAKIGDFGLSKNIGIE-SMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNFSQL  252 (1021)
T ss_pred             ccCCCCceEEccCCcccccccc-ccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCcHHHH
Confidence                234899999999765432 22345679999999999964  45889999999999999999999999876654443


Q ss_pred             hhcCCCCCCCCCccchHHHHHHHHHHhccCCCCCCCHHHHhcChhhhhhh
Q psy1546         254 FLIPKNNPPQLTGNYTKQFKEFVEACLNKDPENRPTAKELLKFPFIRKAK  303 (604)
Q Consensus       254 ~~i~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~RpT~~elL~hp~f~~~~  303 (604)
                      .......+......++.++.+||..||..+|.+||++.|+|.|+||+...
T Consensus       253 i~~lk~~p~lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i~  302 (1021)
T PTZ00266        253 ISELKRGPDLPIKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNVG  302 (1021)
T ss_pred             HHHHhcCCCCCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhcC
Confidence            33222222222345788999999999999999999999999999997553

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=2.9e-39  Score=325.64  Aligned_cols=241  Identities=33%  Similarity=0.550  Sum_probs=212.0

Q ss_pred             ceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchh-hHHHHHHHHHHHHHHhhCCCCCCCe----------EEEEEEec
Q psy1546          59 FTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE-AEDEIEDIQQEIMVLSQCDSPYGTK----------LWIIMEYL  127 (604)
Q Consensus        59 y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~-~~~~~~~l~~Ei~iL~~l~hp~~~~----------lyLVmEy~  127 (604)
                      |++.+.||.|+||.||.+++..+++.|++|.+.... .......+.+|+.++++++|+++.+          +++|||||
T Consensus         2 y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~~   81 (256)
T cd08221           2 YIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYA   81 (256)
T ss_pred             ceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEec
Confidence            889999999999999999999999999999986543 2344567889999999999998654          47999999


Q ss_pred             CCCChhhHhhc---CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCCCCccc
Q psy1546         128 GGGSALDLMKA---GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTF  204 (604)
Q Consensus       128 ~ggsL~~~l~~---~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~~~~~  204 (604)
                      ++++|.+++..   ..+++..+..++.|++.||.|||+.|++||||+|+||+++.++.+||+|||++.............
T Consensus        82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~~~~~~  161 (256)
T cd08221          82 NGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETV  161 (256)
T ss_pred             CCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEccccccccccc
Confidence            99999999865   358999999999999999999999999999999999999999999999999997665444344556


Q ss_pred             ccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCCCCCCCCccchHHHHHHHHHHhccCC
Q psy1546         205 VGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDP  284 (604)
Q Consensus       205 ~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~~L~~dP  284 (604)
                      .|++.|+|||++.+..++.++|||||||++|+|++|..||......+....+...........++.++.++|.+||..+|
T Consensus       162 ~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p  241 (256)
T cd08221         162 VGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVVSVYSSELISLVHSLLQQDP  241 (256)
T ss_pred             CCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccCHHHHHHHHHHcccCc
Confidence            79999999999998889999999999999999999999998877777666665555555557788999999999999999


Q ss_pred             CCCCCHHHHhcChhh
Q psy1546         285 ENRPTAKELLKFPFI  299 (604)
Q Consensus       285 ~~RpT~~elL~hp~f  299 (604)
                      .+||++.++|+|+|+
T Consensus       242 ~~R~s~~~ll~~~~l  256 (256)
T cd08221         242 EKRPTADEVLDQPLL  256 (256)
T ss_pred             ccCCCHHHHhhCcCC
Confidence            999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=1.2e-39  Score=329.73  Aligned_cols=242  Identities=42%  Similarity=0.726  Sum_probs=206.6

Q ss_pred             ceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCC----------eEEEEEEecC
Q psy1546          59 FTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGT----------KLWIIMEYLG  128 (604)
Q Consensus        59 y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~----------~lyLVmEy~~  128 (604)
                      |++.+.||.|+||.||+|.+..+++.||+|.+...........+.+|+.+++.+.||++.          .+|+|+||++
T Consensus         3 ~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   82 (265)
T cd06605           3 LEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYMD   82 (265)
T ss_pred             chHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEecC
Confidence            677889999999999999999999999999987665555567788999999999999854          4589999999


Q ss_pred             CCChhhHhhc--CCCcHHHHHHHHHHHHHHhHHhhh-CCccccccccceeEecCCCCeEEecccccccccCCCCCCcccc
Q psy1546         129 GGSALDLMKA--GNFEEMHIAVILREVLKGLDYLHS-ERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFV  205 (604)
Q Consensus       129 ggsL~~~l~~--~~lse~~i~~i~~qIl~gL~yLHs-~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~~~~~~  205 (604)
                      +++|.+++..  ..+++..+..++.||+.||.|||+ .|++||||||+||+++.++.++|+|||.+..+......  ...
T Consensus        83 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~--~~~  160 (265)
T cd06605          83 GGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAK--TFV  160 (265)
T ss_pred             CCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHhh--ccc
Confidence            9999999965  578999999999999999999999 99999999999999999999999999998665432222  267


Q ss_pred             cCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCC-----hhhHhhhcCCCCCCCCCcc-chHHHHHHHHHH
Q psy1546         206 GTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELH-----PMRVLFLIPKNNPPQLTGN-YTKQFKEFVEAC  279 (604)
Q Consensus       206 GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~-----~~~~~~~i~~~~~~~~~~~-~s~~l~~Li~~~  279 (604)
                      ++..|+|||++.+..++.++|||||||++|+|++|..||....     .......+.....+.++.. ++.++.+||.+|
T Consensus       161 ~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  240 (265)
T cd06605         161 GTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGKFSPDFQDFVNLC  240 (265)
T ss_pred             CChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCCCCChhhcCHHHHHHHHHH
Confidence            8999999999999999999999999999999999999987652     2233333333333444444 889999999999


Q ss_pred             hccCCCCCCCHHHHhcChhhhhh
Q psy1546         280 LNKDPENRPTAKELLKFPFIRKA  302 (604)
Q Consensus       280 L~~dP~~RpT~~elL~hp~f~~~  302 (604)
                      |..||.+|||+.+++.||||++.
T Consensus       241 l~~~p~~Rpt~~~ll~~~~~~~~  263 (265)
T cd06605         241 LIKDPRERPSYKELLEHPFIKKY  263 (265)
T ss_pred             cCCCchhCcCHHHHhhCchhhcc
Confidence            99999999999999999999754

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=3e-39  Score=332.67  Aligned_cols=242  Identities=45%  Similarity=0.807  Sum_probs=203.0

Q ss_pred             ccceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhC-CCCCCCe---------------E
Q psy1546          57 LIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQC-DSPYGTK---------------L  120 (604)
Q Consensus        57 ~~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l-~hp~~~~---------------l  120 (604)
                      ..|.+.+.||+|+||.||+|.+..+++.||+|++.....  ....+.+|+.++..+ +||+..+               +
T Consensus        22 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~--~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~   99 (291)
T cd06639          22 DTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISD--VDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQL   99 (291)
T ss_pred             CCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccccc--HHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCee
Confidence            449999999999999999999999999999999865422  235667889999988 7987433               5


Q ss_pred             EEEEEecCCCChhhHhh-----cCCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEeccccccccc
Q psy1546         121 WIIMEYLGGGSALDLMK-----AGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLT  195 (604)
Q Consensus       121 yLVmEy~~ggsL~~~l~-----~~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~  195 (604)
                      |+||||+++++|.++++     ...+++..++.++.||+.||.|||+.||+||||||+||+++.++.+||+|||++..+.
T Consensus       100 ~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~dfg~~~~~~  179 (291)
T cd06639         100 WLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLT  179 (291)
T ss_pred             EEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEeecccchhcc
Confidence            79999999999999875     2568999999999999999999999999999999999999999999999999997665


Q ss_pred             CCCCCCcccccCCCCCChHHhhcCC-----CCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCCCCCC--CCccc
Q psy1546         196 NTTSKRNTFVGTPFWMAPEVIKQSA-----YDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQ--LTGNY  268 (604)
Q Consensus       196 ~~~~~~~~~~GT~~Y~APE~l~~~~-----~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~--~~~~~  268 (604)
                      ..........|+..|+|||++....     ++.++|||||||++|+|++|.+||...........+.....+.  .+..+
T Consensus       180 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (291)
T cd06639         180 STRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNPPPTLLHPEKW  259 (291)
T ss_pred             cccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcCCCCCCCccccc
Confidence            4433344567899999999986433     6789999999999999999999998877655555544433322  23456


Q ss_pred             hHHHHHHHHHHhccCCCCCCCHHHHhcChhhh
Q psy1546         269 TKQFKEFVEACLNKDPENRPTAKELLKFPFIR  300 (604)
Q Consensus       269 s~~l~~Li~~~L~~dP~~RpT~~elL~hp~f~  300 (604)
                      +..+.+||.+||..+|++||++.||++||||+
T Consensus       260 ~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~  291 (291)
T cd06639         260 CRSFNHFISQCLIKDFEARPSVTHLLEHPFIK  291 (291)
T ss_pred             CHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence            77899999999999999999999999999984

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=4.2e-39  Score=324.82  Aligned_cols=245  Identities=42%  Similarity=0.736  Sum_probs=213.3

Q ss_pred             cceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCCe----------EEEEEEec
Q psy1546          58 IFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTK----------LWIIMEYL  127 (604)
Q Consensus        58 ~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~~----------lyLVmEy~  127 (604)
                      .|.+.+.||.|+||.||+|.+..+++.||||++...........+.+|+.++..+.|++..+          +|+||||+
T Consensus         2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~   81 (264)
T cd06623           2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYM   81 (264)
T ss_pred             cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEec
Confidence            37888999999999999999999999999999976654445678899999999999998544          47999999


Q ss_pred             CCCChhhHhhc-CCCcHHHHHHHHHHHHHHhHHhhh-CCccccccccceeEecCCCCeEEecccccccccCCCCCCcccc
Q psy1546         128 GGGSALDLMKA-GNFEEMHIAVILREVLKGLDYLHS-ERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFV  205 (604)
Q Consensus       128 ~ggsL~~~l~~-~~lse~~i~~i~~qIl~gL~yLHs-~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~~~~~~  205 (604)
                      ++++|.+++.. +.+++..++.++.||+.||.|||+ .|++||||+|+||+++.++.++|+|||++..+...........
T Consensus        82 ~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~~~  161 (264)
T cd06623          82 DGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFV  161 (264)
T ss_pred             CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCCccccee
Confidence            99999999965 789999999999999999999999 9999999999999999999999999999977654444444567


Q ss_pred             cCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCC---hhhHhhhcCCCCCCCCCcc-chHHHHHHHHHHhc
Q psy1546         206 GTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELH---PMRVLFLIPKNNPPQLTGN-YTKQFKEFVEACLN  281 (604)
Q Consensus       206 GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~---~~~~~~~i~~~~~~~~~~~-~s~~l~~Li~~~L~  281 (604)
                      ++..|+|||.+.+..++.++||||||+++|+|++|..||....   ..+....+.....+.+... ++..+.++|.+||.
T Consensus       162 ~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~  241 (264)
T cd06623         162 GTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPEFRDFISACLQ  241 (264)
T ss_pred             ecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCCCCCCcccCCHHHHHHHHHHcc
Confidence            8999999999999899999999999999999999999998773   3344444444444555556 88999999999999


Q ss_pred             cCCCCCCCHHHHhcChhhhhh
Q psy1546         282 KDPENRPTAKELLKFPFIRKA  302 (604)
Q Consensus       282 ~dP~~RpT~~elL~hp~f~~~  302 (604)
                      .+|.+||++.++++||||+..
T Consensus       242 ~~p~~R~~~~~ll~~~~~~~~  262 (264)
T cd06623         242 KDPKKRPSAAELLQHPFIKKA  262 (264)
T ss_pred             CChhhCCCHHHHHhCHHHHhc
Confidence            999999999999999999754

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=2.7e-39  Score=329.23  Aligned_cols=238  Identities=21%  Similarity=0.364  Sum_probs=202.8

Q ss_pred             cceeeeEEcccCcEEEEEEEEC---CCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCCe----------EEEEE
Q psy1546          58 IFTKQERIGKGSFGEVFKGIDN---RTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTK----------LWIIM  124 (604)
Q Consensus        58 ~y~i~~~LG~G~fG~Vy~a~~~---~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~~----------lyLVm  124 (604)
                      .|.+.+.||+|+||.||+|.+.   ..+..||+|++...........+.+|+.++.+++||++.+          +|+||
T Consensus         6 ~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   85 (266)
T cd05064           6 SIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIVT   85 (266)
T ss_pred             HeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEEE
Confidence            3889999999999999999865   4567899999976654455577889999999999999665          47999


Q ss_pred             EecCCCChhhHhhc--CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCC-CCC
Q psy1546         125 EYLGGGSALDLMKA--GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTT-SKR  201 (604)
Q Consensus       125 Ey~~ggsL~~~l~~--~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~-~~~  201 (604)
                      ||+++|+|.+++..  +.+++..++.++.||+.||.|||++|++||||||+|||++.++.++|+|||.+....... ...
T Consensus        86 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~~~~~~  165 (266)
T cd05064          86 EYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTT  165 (266)
T ss_pred             EeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCcccccccccchhcc
Confidence            99999999998865  468999999999999999999999999999999999999999999999999875432211 111


Q ss_pred             cccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHhhhcCCCCCCCCCccchHHHHHHHHHHh
Q psy1546         202 NTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAK-GEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACL  280 (604)
Q Consensus       202 ~~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~~L  280 (604)
                      ....++..|+|||++.+..++.++|||||||++|||++ |..||...........+........+..++..+.+++.+||
T Consensus       166 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c~  245 (266)
T cd05064         166 MSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRLPAPRNCPNLLHQLMLDCW  245 (266)
T ss_pred             cCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHc
Confidence            12345678999999999999999999999999999775 99999988877766666665555667788999999999999


Q ss_pred             ccCCCCCCCHHHHhc
Q psy1546         281 NKDPENRPTAKELLK  295 (604)
Q Consensus       281 ~~dP~~RpT~~elL~  295 (604)
                      ..+|.+||++.+|++
T Consensus       246 ~~~p~~RP~~~~i~~  260 (266)
T cd05064         246 QKERGERPRFSQIHS  260 (266)
T ss_pred             CCCchhCCCHHHHHH
Confidence            999999999999976

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=1.7e-39  Score=341.33  Aligned_cols=243  Identities=32%  Similarity=0.537  Sum_probs=194.8

Q ss_pred             eeeEEccc--CcEEEEEEEECCCCcEEEEEEecchhh-HHHHHHHHHHHHHHhhCCCCCCCe----------EEEEEEec
Q psy1546          61 KQERIGKG--SFGEVFKGIDNRTQQVVAIKIIDLEEA-EDEIEDIQQEIMVLSQCDSPYGTK----------LWIIMEYL  127 (604)
Q Consensus        61 i~~~LG~G--~fG~Vy~a~~~~t~~~vAVK~i~~~~~-~~~~~~l~~Ei~iL~~l~hp~~~~----------lyLVmEy~  127 (604)
                      ++++||+|  +|++||++.+..+++.||||++..... ......+.+|+.+++.++|||+.+          +|+||||+
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~   81 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM   81 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence            45789999  789999999999999999999976543 334467788999999999999654          47999999


Q ss_pred             CCCChhhHhhc---CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCC-----
Q psy1546         128 GGGSALDLMKA---GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTS-----  199 (604)
Q Consensus       128 ~ggsL~~~l~~---~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~-----  199 (604)
                      ++|+|.+++..   ..+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||.+........     
T Consensus        82 ~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~  161 (327)
T cd08227          82 AYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRVV  161 (327)
T ss_pred             CCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhcccccccccccc
Confidence            99999999854   4589999999999999999999999999999999999999999999999987644322111     


Q ss_pred             --CCcccccCCCCCChHHhhc--CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCCCC--------------
Q psy1546         200 --KRNTFVGTPFWMAPEVIKQ--SAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNP--------------  261 (604)
Q Consensus       200 --~~~~~~GT~~Y~APE~l~~--~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~~~--------------  261 (604)
                        ......++..|+|||++.+  ..++.++|||||||++|||++|..||.................              
T Consensus       162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (327)
T cd08227         162 HDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPAEEL  241 (327)
T ss_pred             ccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchhhhhc
Confidence              1122357788999999976  4588999999999999999999999976543322111110000              


Q ss_pred             -------------------------------CCCCccchHHHHHHHHHHhccCCCCCCCHHHHhcChhhhhhh
Q psy1546         262 -------------------------------PQLTGNYTKQFKEFVEACLNKDPENRPTAKELLKFPFIRKAK  303 (604)
Q Consensus       262 -------------------------------~~~~~~~s~~l~~Li~~~L~~dP~~RpT~~elL~hp~f~~~~  303 (604)
                                                     ......+++.+.+||.+||..||.+|||++||++||||+...
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~~~  314 (327)
T cd08227         242 TMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIK  314 (327)
T ss_pred             ccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhhcc
Confidence                                           011223567899999999999999999999999999997654

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=3.4e-39  Score=327.95  Aligned_cols=242  Identities=36%  Similarity=0.666  Sum_probs=203.3

Q ss_pred             cceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchh----hHHHHHHHHHHHHHHhhCCCCCCC------------eEE
Q psy1546          58 IFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE----AEDEIEDIQQEIMVLSQCDSPYGT------------KLW  121 (604)
Q Consensus        58 ~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~----~~~~~~~l~~Ei~iL~~l~hp~~~------------~ly  121 (604)
                      .|.+.+.||+|+||.||+|.+..++..||+|++....    .......+.+|+.+++.++|+++.            .+|
T Consensus         3 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   82 (266)
T cd06651           3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLT   82 (266)
T ss_pred             CccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEE
Confidence            3888999999999999999999999999999986432    223456788999999999999843            357


Q ss_pred             EEEEecCCCChhhHhhc-CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCC--
Q psy1546         122 IIMEYLGGGSALDLMKA-GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTT--  198 (604)
Q Consensus       122 LVmEy~~ggsL~~~l~~-~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~--  198 (604)
                      +||||+++++|.+++.. +.+++..++.++.||+.||.|||+.+|+||||+|+||+++.++.++|+|||+++.+....  
T Consensus        83 l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~~~  162 (266)
T cd06651          83 IFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMS  162 (266)
T ss_pred             EEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCcccccccccc
Confidence            89999999999998865 568999999999999999999999999999999999999999999999999997553211  


Q ss_pred             -CCCcccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhc-CCCCCCCCCccchHHHHHHH
Q psy1546         199 -SKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLI-PKNNPPQLTGNYTKQFKEFV  276 (604)
Q Consensus       199 -~~~~~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i-~~~~~~~~~~~~s~~l~~Li  276 (604)
                       .......++..|+|||++.+..++.++|||||||++|+|++|..||...........+ .....+.++..+++.+++||
T Consensus       163 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  242 (266)
T cd06651         163 GTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHISEHARDFL  242 (266)
T ss_pred             CCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCCCCCCCchhcCHHHHHHH
Confidence             1122356889999999999988999999999999999999999999877654443332 22334555667788999999


Q ss_pred             HHHhccCCCCCCCHHHHhcChhhh
Q psy1546         277 EACLNKDPENRPTAKELLKFPFIR  300 (604)
Q Consensus       277 ~~~L~~dP~~RpT~~elL~hp~f~  300 (604)
                       +||..+|++||+++||++||||+
T Consensus       243 -~~~~~~p~~Rp~~~eil~hp~~~  265 (266)
T cd06651         243 -GCIFVEARHRPSAEELLRHPFAQ  265 (266)
T ss_pred             -HHhcCChhhCcCHHHHhcCcccc
Confidence             67778999999999999999985

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.5e-39  Score=336.35  Aligned_cols=246  Identities=30%  Similarity=0.457  Sum_probs=207.3

Q ss_pred             cceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhH--HHHHHHHHHHHHHhhCCCCCCCe----------EEEEEE
Q psy1546          58 IFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAE--DEIEDIQQEIMVLSQCDSPYGTK----------LWIIME  125 (604)
Q Consensus        58 ~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~--~~~~~l~~Ei~iL~~l~hp~~~~----------lyLVmE  125 (604)
                      .|.+.+.||+|+||.||+|.+..+++.||||.+......  .....+..|+.+++.++|+++.+          +|+|||
T Consensus         2 ~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   81 (316)
T cd05574           2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMD   81 (316)
T ss_pred             ceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEE
Confidence            388999999999999999999999999999999765433  35577889999999999998543          589999


Q ss_pred             ecCCCChhhHhhc---CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCC---
Q psy1546         126 YLGGGSALDLMKA---GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTS---  199 (604)
Q Consensus       126 y~~ggsL~~~l~~---~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~---  199 (604)
                      |+.+++|.+++..   ..+++..+..++.||+.||.|||+.|++||||||+||||+.++.++|+|||++........   
T Consensus        82 ~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~  161 (316)
T cd05574          82 YCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVS  161 (316)
T ss_pred             ecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhcccccccccc
Confidence            9999999999865   4689999999999999999999999999999999999999999999999999865432111   


Q ss_pred             --------------------------CCcccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHh
Q psy1546         200 --------------------------KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVL  253 (604)
Q Consensus       200 --------------------------~~~~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~  253 (604)
                                                ....+.||..|+|||++.+..++.++|||||||++|+|++|..||.........
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~  241 (316)
T cd05574         162 KALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDETF  241 (316)
T ss_pred             cccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCchHHHH
Confidence                                      112357899999999999988999999999999999999999999887766555


Q ss_pred             hhcCCCCC-CCCCccchHHHHHHHHHHhccCCCCCCC----HHHHhcChhhhhhh
Q psy1546         254 FLIPKNNP-PQLTGNYTKQFKEFVEACLNKDPENRPT----AKELLKFPFIRKAK  303 (604)
Q Consensus       254 ~~i~~~~~-~~~~~~~s~~l~~Li~~~L~~dP~~RpT----~~elL~hp~f~~~~  303 (604)
                      ..+..... ......++..+.+||.+||..||++|||    ++|+|.||||+...
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~~~~  296 (316)
T cd05574         242 SNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRGVN  296 (316)
T ss_pred             HHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhhcCC
Confidence            44332221 1112236899999999999999999999    99999999997654

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.7e-39  Score=327.76  Aligned_cols=241  Identities=51%  Similarity=0.930  Sum_probs=204.5

Q ss_pred             ccceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhC-CCCCCCe----------------
Q psy1546          57 LIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQC-DSPYGTK----------------  119 (604)
Q Consensus        57 ~~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l-~hp~~~~----------------  119 (604)
                      ..|.+.+.||.|+||.||+|.+..+++.||+|++.....  ....+.+|+.+++.+ .|+++.+                
T Consensus         6 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~   83 (275)
T cd06608           6 GIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED--EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQ   83 (275)
T ss_pred             hheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch--hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceE
Confidence            459999999999999999999999999999999875543  336788999999998 6997433                


Q ss_pred             EEEEEEecCCCChhhHhhc-----CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccc
Q psy1546         120 LWIIMEYLGGGSALDLMKA-----GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTL  194 (604)
Q Consensus       120 lyLVmEy~~ggsL~~~l~~-----~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~  194 (604)
                      +|+||||+++++|.+++..     ..+++..+..++.||+.||.|||+.|++||||+|+||+++.++.++|+|||++...
T Consensus        84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~~~~~~~  163 (275)
T cd06608          84 LWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQL  163 (275)
T ss_pred             EEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCCccceec
Confidence            5899999999999998753     57899999999999999999999999999999999999999999999999999766


Q ss_pred             cCCCCCCcccccCCCCCChHHhhc-----CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCCCCCCC--Ccc
Q psy1546         195 TNTTSKRNTFVGTPFWMAPEVIKQ-----SAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQL--TGN  267 (604)
Q Consensus       195 ~~~~~~~~~~~GT~~Y~APE~l~~-----~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~--~~~  267 (604)
                      ...........|++.|+|||++..     ..++.++|||||||+||+|++|.+||...........+.....+.+  ...
T Consensus       164 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (275)
T cd06608         164 DSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPPPTLKSPEN  243 (275)
T ss_pred             ccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccCCCCCCchhh
Confidence            544444556679999999999854     3467889999999999999999999987766555555444433222  234


Q ss_pred             chHHHHHHHHHHhccCCCCCCCHHHHhcChhh
Q psy1546         268 YTKQFKEFVEACLNKDPENRPTAKELLKFPFI  299 (604)
Q Consensus       268 ~s~~l~~Li~~~L~~dP~~RpT~~elL~hp~f  299 (604)
                      ++..+++||.+||..||.+|||+.+|++|||+
T Consensus       244 ~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~  275 (275)
T cd06608         244 WSKKFNDFISECLIKNYEQRPFMEELLEHPFI  275 (275)
T ss_pred             cCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence            77899999999999999999999999999996

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=3.3e-39  Score=330.83  Aligned_cols=243  Identities=49%  Similarity=0.845  Sum_probs=202.3

Q ss_pred             ccccceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhC-CCCCCCe--------------
Q psy1546          55 PELIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQC-DSPYGTK--------------  119 (604)
Q Consensus        55 ~~~~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l-~hp~~~~--------------  119 (604)
                      ....|.+.+.||+|+||.||+|.+..+++.||+|++.....  ....+..|+.+++.+ +|+++.+              
T Consensus        16 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~--~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~   93 (286)
T cd06638          16 PSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHD--IDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGD   93 (286)
T ss_pred             cccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccc--hHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCC
Confidence            34558999999999999999999999999999999864322  235677899999998 6997443              


Q ss_pred             -EEEEEEecCCCChhhHhh-----cCCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEeccccccc
Q psy1546         120 -LWIIMEYLGGGSALDLMK-----AGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGT  193 (604)
Q Consensus       120 -lyLVmEy~~ggsL~~~l~-----~~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~  193 (604)
                       +|+||||+++++|.+++.     ...+++..+..++.||+.||.|||+++|+||||||+||+++.++.++|+|||++..
T Consensus        94 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~  173 (286)
T cd06638          94 QLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQ  173 (286)
T ss_pred             eEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEccCCceee
Confidence             589999999999998764     24688999999999999999999999999999999999999999999999999976


Q ss_pred             ccCCCCCCcccccCCCCCChHHhhc-----CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCCCCC--CCCc
Q psy1546         194 LTNTTSKRNTFVGTPFWMAPEVIKQ-----SAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPP--QLTG  266 (604)
Q Consensus       194 ~~~~~~~~~~~~GT~~Y~APE~l~~-----~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~~~~--~~~~  266 (604)
                      +...........|++.|+|||++..     ..++.++|||||||++|+|++|..||...........+.....+  ..+.
T Consensus       174 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  253 (286)
T cd06638         174 LTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNPPPTLHQPE  253 (286)
T ss_pred             cccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhccccCCCcccCCC
Confidence            6544333445679999999999853     45788999999999999999999999877665554443333222  2234


Q ss_pred             cchHHHHHHHHHHhccCCCCCCCHHHHhcChhh
Q psy1546         267 NYTKQFKEFVEACLNKDPENRPTAKELLKFPFI  299 (604)
Q Consensus       267 ~~s~~l~~Li~~~L~~dP~~RpT~~elL~hp~f  299 (604)
                      .++..+.+||.+||..||++|||+.||++|+||
T Consensus       254 ~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~  286 (286)
T cd06638         254 LWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI  286 (286)
T ss_pred             CcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence            567899999999999999999999999999997

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=3e-39  Score=332.74  Aligned_cols=248  Identities=38%  Similarity=0.688  Sum_probs=211.0

Q ss_pred             ccceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCCe----------EEEEEEe
Q psy1546          57 LIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTK----------LWIIMEY  126 (604)
Q Consensus        57 ~~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~~----------lyLVmEy  126 (604)
                      ..|...+.||+|+||.||+|.+..+++.||||.+..... ...+.+.+|+.+++.+.|++..+          .|+|+||
T Consensus        19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~   97 (285)
T cd06648          19 SYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQ-QRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEF   97 (285)
T ss_pred             HhhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccch-hHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEec
Confidence            346667899999999999999999999999999864432 23466889999999999998544          4699999


Q ss_pred             cCCCChhhHhhcCCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCCCCccccc
Q psy1546         127 LGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVG  206 (604)
Q Consensus       127 ~~ggsL~~~l~~~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~~~~~~G  206 (604)
                      +.+++|.+++..+.+++..+..++.||+.||.|||++||+||||+|+||+++.++.++|+|||++..............|
T Consensus        98 ~~~~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~  177 (285)
T cd06648          98 LEGGALTDIVTHTRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLVG  177 (285)
T ss_pred             cCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccCCcccccccC
Confidence            99999999998888999999999999999999999999999999999999999999999999998665443333445679


Q ss_pred             CCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCCCCCCC--CccchHHHHHHHHHHhccCC
Q psy1546         207 TPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQL--TGNYTKQFKEFVEACLNKDP  284 (604)
Q Consensus       207 T~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~--~~~~s~~l~~Li~~~L~~dP  284 (604)
                      ++.|+|||++.+..++.++|||||||++|+|++|..||...+.......+.....+.+  ...++..+.+||.+||..+|
T Consensus       178 ~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p  257 (285)
T cd06648         178 TPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKNLHKVSPRLRSFLDRMLVRDP  257 (285)
T ss_pred             CccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcCCCCCcccccCCHHHHHHHHHHcccCh
Confidence            9999999999988899999999999999999999999987776555544443332222  22377899999999999999


Q ss_pred             CCCCCHHHHhcChhhhhhhhh
Q psy1546         285 ENRPTAKELLKFPFIRKAKKN  305 (604)
Q Consensus       285 ~~RpT~~elL~hp~f~~~~~~  305 (604)
                      ++|||+.++++||||++....
T Consensus       258 ~~Rpt~~~il~~~~~~~~~~~  278 (285)
T cd06648         258 AQRATAAELLNHPFLAKAGPP  278 (285)
T ss_pred             hhCcCHHHHccCcccccCCCc
Confidence            999999999999999876643

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=2.3e-39  Score=331.27  Aligned_cols=242  Identities=31%  Similarity=0.521  Sum_probs=199.8

Q ss_pred             cceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhH-HHHHHHHHHHHHHhhCCCCCCC----------eEEEEEEe
Q psy1546          58 IFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAE-DEIEDIQQEIMVLSQCDSPYGT----------KLWIIMEY  126 (604)
Q Consensus        58 ~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~-~~~~~l~~Ei~iL~~l~hp~~~----------~lyLVmEy  126 (604)
                      .|++.+.||+|+||.||+|.+..+++.||+|++...... ...+.+.+|+.+++.+.|++..          .+|+||||
T Consensus         2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~   81 (286)
T cd07847           2 KYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEY   81 (286)
T ss_pred             ceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEec
Confidence            388899999999999999999999999999998644321 2235578899999999999844          35799999


Q ss_pred             cCCCChhhHhhc-CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCCCCcccc
Q psy1546         127 LGGGSALDLMKA-GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFV  205 (604)
Q Consensus       127 ~~ggsL~~~l~~-~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~~~~~~  205 (604)
                      +++++|..++.. ..+++..++.++.||+.||.|||+.||+||||||+||+++.++.++|+|||++..+...........
T Consensus        82 ~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~  161 (286)
T cd07847          82 CDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYV  161 (286)
T ss_pred             cCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCCcccccCcc
Confidence            999988888754 5699999999999999999999999999999999999999999999999999977654443334556


Q ss_pred             cCCCCCChHHhhc-CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCC----------------------CCC
Q psy1546         206 GTPFWMAPEVIKQ-SAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKN----------------------NPP  262 (604)
Q Consensus       206 GT~~Y~APE~l~~-~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~----------------------~~~  262 (604)
                      ++..|+|||++.+ ..++.++|||||||++|+|++|.+||.+....+....+...                      .+.
T Consensus       162 ~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (286)
T cd07847         162 ATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLSIPE  241 (286)
T ss_pred             cccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccccccCCC
Confidence            8899999999876 45788999999999999999999999876654333221100                      000


Q ss_pred             --------CCCccchHHHHHHHHHHhccCCCCCCCHHHHhcChhh
Q psy1546         263 --------QLTGNYTKQFKEFVEACLNKDPENRPTAKELLKFPFI  299 (604)
Q Consensus       263 --------~~~~~~s~~l~~Li~~~L~~dP~~RpT~~elL~hp~f  299 (604)
                              .....++..+.+||.+||..||++|||+.|++.||||
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f  286 (286)
T cd07847         242 PETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF  286 (286)
T ss_pred             cccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence                    0113457889999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=3e-39  Score=334.31  Aligned_cols=255  Identities=45%  Similarity=0.779  Sum_probs=215.2

Q ss_pred             ccceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCC----------eEEEEEEe
Q psy1546          57 LIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGT----------KLWIIMEY  126 (604)
Q Consensus        57 ~~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~----------~lyLVmEy  126 (604)
                      ..|.+.+.||+|+||.||+|.+..+++.||+|.+..... ...+.+.+|+.+++.+.||+..          .+|+|+||
T Consensus        19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~   97 (293)
T cd06647          19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQ-PKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEY   97 (293)
T ss_pred             hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccc-hHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEec
Confidence            458999999999999999999988999999999864432 2346788999999999999843          35899999


Q ss_pred             cCCCChhhHhhcCCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCCCCccccc
Q psy1546         127 LGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVG  206 (604)
Q Consensus       127 ~~ggsL~~~l~~~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~~~~~~G  206 (604)
                      +++++|.+++....+++..+..++.||+.||.|||++|++||||+|+||+++.++.++|+|||++..+...........|
T Consensus        98 ~~~~~L~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~~~~~~~~  177 (293)
T cd06647          98 LAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVG  177 (293)
T ss_pred             CCCCcHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceecccccccccccccC
Confidence            99999999998888999999999999999999999999999999999999999999999999998766544444455679


Q ss_pred             CCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCCCCCC--CCccchHHHHHHHHHHhccCC
Q psy1546         207 TPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQ--LTGNYTKQFKEFVEACLNKDP  284 (604)
Q Consensus       207 T~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~--~~~~~s~~l~~Li~~~L~~dP  284 (604)
                      ++.|+|||.+....++.++|||||||++|+|++|..||...........+.....+.  .+..++..+.++|.+||..+|
T Consensus       178 ~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p  257 (293)
T cd06647         178 TPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLEMDV  257 (293)
T ss_pred             ChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCCCCCCCCccccCHHHHHHHHHHccCCh
Confidence            999999999988889999999999999999999999998766554443332222222  234567889999999999999


Q ss_pred             CCCCCHHHHhcChhhhhhhhhhhHHHHH
Q psy1546         285 ENRPTAKELLKFPFIRKAKKNAYLIDLI  312 (604)
Q Consensus       285 ~~RpT~~elL~hp~f~~~~~~~~l~~~~  312 (604)
                      .+||++.+++.|+||+..+....+..++
T Consensus       258 ~~Rp~~~~il~h~~~~~~~~~~~~~~~~  285 (293)
T cd06647         258 EKRGSAKELLQHPFLKIAKPLSSLTPLI  285 (293)
T ss_pred             hhCcCHHHHhcCHHHhcCcccccccchH
Confidence            9999999999999999887655554443

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=3.2e-39  Score=326.04  Aligned_cols=239  Identities=28%  Similarity=0.510  Sum_probs=207.2

Q ss_pred             ceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhh--HHHHHHHHHHHHHHhhCCCCCC----------CeEEEEEEe
Q psy1546          59 FTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA--EDEIEDIQQEIMVLSQCDSPYG----------TKLWIIMEY  126 (604)
Q Consensus        59 y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~--~~~~~~l~~Ei~iL~~l~hp~~----------~~lyLVmEy  126 (604)
                      |.+.+.||.|+||.||+|.+..+++.||+|++.....  ....+.+.+|+.++++++||++          ..+|+||||
T Consensus         2 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   81 (258)
T cd05578           2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVDL   81 (258)
T ss_pred             ceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEeC
Confidence            7899999999999999999999999999999975432  2346788999999999999984          347899999


Q ss_pred             cCCCChhhHhhcC-CCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCCCCcccc
Q psy1546         127 LGGGSALDLMKAG-NFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFV  205 (604)
Q Consensus       127 ~~ggsL~~~l~~~-~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~~~~~~  205 (604)
                      +.|++|.+++... .+++..+..++.||+.||.|||++|++|+||+|+||++++++.++|+|||++....... ......
T Consensus        82 ~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~-~~~~~~  160 (258)
T cd05578          82 LLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT-LTTSTS  160 (258)
T ss_pred             CCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCc-cccccC
Confidence            9999999999765 89999999999999999999999999999999999999999999999999986654332 233456


Q ss_pred             cCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCCh---hhHhhhcCCCCCCCCCccchHHHHHHHHHHhcc
Q psy1546         206 GTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHP---MRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNK  282 (604)
Q Consensus       206 GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~---~~~~~~i~~~~~~~~~~~~s~~l~~Li~~~L~~  282 (604)
                      |+..|+|||++.+..++.++|+||||+++|+|++|..||.....   ....... .......+..++..+.++|.+||..
T Consensus       161 ~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~i~~~l~~  239 (258)
T cd05578         161 GTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQ-ETADVLYPATWSTEAIDAINKLLER  239 (258)
T ss_pred             CChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHh-ccccccCcccCcHHHHHHHHHHccC
Confidence            88999999999988899999999999999999999999987763   3332222 2244556667889999999999999


Q ss_pred             CCCCCCCH--HHHhcChhh
Q psy1546         283 DPENRPTA--KELLKFPFI  299 (604)
Q Consensus       283 dP~~RpT~--~elL~hp~f  299 (604)
                      ||.+||++  .|++.||||
T Consensus       240 ~p~~R~~~~~~~l~~~~~~  258 (258)
T cd05578         240 DPQKRLGDNLKDLKNHPYF  258 (258)
T ss_pred             ChhHcCCccHHHHhcCCCC
Confidence            99999999  999999997

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=3.5e-39  Score=327.00  Aligned_cols=240  Identities=37%  Similarity=0.691  Sum_probs=202.8

Q ss_pred             ceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchh-----hHHHHHHHHHHHHHHhhCCCCCCCe----------EEEE
Q psy1546          59 FTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE-----AEDEIEDIQQEIMVLSQCDSPYGTK----------LWII  123 (604)
Q Consensus        59 y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~-----~~~~~~~l~~Ei~iL~~l~hp~~~~----------lyLV  123 (604)
                      |.+.+.||.|+||.||+|.+ .+++.||||.+....     .......+.+|+.+++.++|+++.+          +|+|
T Consensus         2 ~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   80 (265)
T cd06631           2 WTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF   80 (265)
T ss_pred             ccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence            77889999999999999986 478899999986432     2234567889999999999998543          5799


Q ss_pred             EEecCCCChhhHhhc-CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCC-----
Q psy1546         124 MEYLGGGSALDLMKA-GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNT-----  197 (604)
Q Consensus       124 mEy~~ggsL~~~l~~-~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~-----  197 (604)
                      |||+++++|.+++.. +.+++..+..++.||+.||.|||+.+|+|+||+|+||+++.++.++|+|||++......     
T Consensus        81 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~  160 (265)
T cd06631          81 MEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGT  160 (265)
T ss_pred             EecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhcccccc
Confidence            999999999999865 67899999999999999999999999999999999999999999999999998654321     


Q ss_pred             -CCCCcccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCC--CCCCCCCccchHHHHH
Q psy1546         198 -TSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPK--NNPPQLTGNYTKQFKE  274 (604)
Q Consensus       198 -~~~~~~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~--~~~~~~~~~~s~~l~~  274 (604)
                       ........|+..|+|||++.+..++.++|||||||++|+|++|..||...........+..  ...+.++..++.++.+
T Consensus       161 ~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (265)
T cd06631         161 HSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSFSAAAID  240 (265)
T ss_pred             ccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCCCCCCCCCCHHHHH
Confidence             1112345689999999999998999999999999999999999999987665544333222  2234566778999999


Q ss_pred             HHHHHhccCCCCCCCHHHHhcChhh
Q psy1546         275 FVEACLNKDPENRPTAKELLKFPFI  299 (604)
Q Consensus       275 Li~~~L~~dP~~RpT~~elL~hp~f  299 (604)
                      ||.+||..+|.+||++.+++.||||
T Consensus       241 ~i~~~l~~~p~~Rp~~~~~l~~~~~  265 (265)
T cd06631         241 FVTSCLTRDQHERPSALQLLRHDFL  265 (265)
T ss_pred             HHHHHhcCCcccCCCHHHHhcCCCC
Confidence            9999999999999999999999997

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>KOG4721|consensus

Probab=100.00  E-value=1.1e-40  Score=352.90  Aligned_cols=225  Identities=31%  Similarity=0.564  Sum_probs=200.7

Q ss_pred             eeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCCe----------EEEEEEecCCC
Q psy1546          61 KQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTK----------LWIIMEYLGGG  130 (604)
Q Consensus        61 i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~~----------lyLVmEy~~gg  130 (604)
                      .++-||.|+.|.||+|+..  ++.||||.++        +.-..+|+-|++|+|+|+..          +|||||||..|
T Consensus       128 ELeWlGSGaQGAVF~Grl~--netVAVKKV~--------elkETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~G  197 (904)
T KOG4721|consen  128 ELEWLGSGAQGAVFLGRLH--NETVAVKKVR--------ELKETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQG  197 (904)
T ss_pred             hhhhhccCcccceeeeecc--CceehhHHHh--------hhhhhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccc
Confidence            4578999999999999855  7889999874        22345789999999999765          47999999999


Q ss_pred             ChhhHhhcC-CCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCCCCcccccCCC
Q psy1546         131 SALDLMKAG-NFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPF  209 (604)
Q Consensus       131 sL~~~l~~~-~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~~~~~~GT~~  209 (604)
                      .|..+++.+ .+.......|..+|+.|+.|||.+.|||||||.-||||+.+..|||+|||-++.+.+. .....|+||..
T Consensus       198 qL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~-STkMSFaGTVa  276 (904)
T KOG4721|consen  198 QLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSKELSDK-STKMSFAGTVA  276 (904)
T ss_pred             cHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchHhhhhh-hhhhhhhhhHh
Confidence            999999874 6888899999999999999999999999999999999999999999999999877655 55678999999


Q ss_pred             CCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCCC-CCCCCccchHHHHHHHHHHhccCCCCCC
Q psy1546         210 WMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNN-PPQLTGNYTKQFKEFVEACLNKDPENRP  288 (604)
Q Consensus       210 Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~~-~~~~~~~~s~~l~~Li~~~L~~dP~~Rp  288 (604)
                      |||||++++...+.++|||||||||||||||..||.+.+...+.+-+-.+. -...+..+++.|+-||+.||.-.|..||
T Consensus       277 WMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGsNsL~LpvPstcP~GfklL~Kqcw~sKpRNRP  356 (904)
T KOG4721|consen  277 WMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSNSLHLPVPSTCPDGFKLLLKQCWNSKPRNRP  356 (904)
T ss_pred             hhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEEeccCCcccccCcccCchHHHHHHHHHHhcCCCCCc
Confidence            999999999999999999999999999999999999998888777665544 2356778999999999999999999999


Q ss_pred             CHHHHhcC
Q psy1546         289 TAKELLKF  296 (604)
Q Consensus       289 T~~elL~h  296 (604)
                      ++.+||.|
T Consensus       357 SFrqil~H  364 (904)
T KOG4721|consen  357 SFRQILLH  364 (904)
T ss_pred             cHHHHHHH
Confidence            99999998

>KOG0696|consensus

Probab=100.00  E-value=3.4e-40  Score=338.43  Aligned_cols=246  Identities=30%  Similarity=0.492  Sum_probs=214.8

Q ss_pred             cceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhh--HHHHHHHHHHHHHHhhCCCCC-----------CCeEEEEE
Q psy1546          58 IFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA--EDEIEDIQQEIMVLSQCDSPY-----------GTKLWIIM  124 (604)
Q Consensus        58 ~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~--~~~~~~l~~Ei~iL~~l~hp~-----------~~~lyLVm  124 (604)
                      .|..+.+||+|+||.|.+|..+.+.+.||||+++++..  .+.++--..|-.+|.....|-           ..++|+||
T Consensus       350 DFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFVM  429 (683)
T KOG0696|consen  350 DFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFVM  429 (683)
T ss_pred             ccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeEE
Confidence            38999999999999999999999999999999976643  223344445666666554432           46789999


Q ss_pred             EecCCCChhhHhhc-CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCCCCcc
Q psy1546         125 EYLGGGSALDLMKA-GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNT  203 (604)
Q Consensus       125 Ey~~ggsL~~~l~~-~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~~~~  203 (604)
                      ||+.||+|-..|+. |+|.|..+..++..|+-||-|||++|||+||||.+|||++.+|++||+|||+++.-........+
T Consensus       430 EyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~~~TTkT  509 (683)
T KOG0696|consen  430 EYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIFDGVTTKT  509 (683)
T ss_pred             EEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeecccccccccCCcceee
Confidence            99999999988866 99999999999999999999999999999999999999999999999999999876666666789


Q ss_pred             cccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCCCCCCCCccchHHHHHHHHHHhccC
Q psy1546         204 FVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKD  283 (604)
Q Consensus       204 ~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~~L~~d  283 (604)
                      +||||.|+|||++..++|+.++|+||+||+||||+.|++||.+.+..++...|..... .++..++.++.++++..|.+.
T Consensus       510 FCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnv-syPKslSkEAv~ickg~ltK~  588 (683)
T KOG0696|consen  510 FCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNV-SYPKSLSKEAVAICKGLLTKH  588 (683)
T ss_pred             ecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccC-cCcccccHHHHHHHHHHhhcC
Confidence            9999999999999999999999999999999999999999999999998888765543 567889999999999999999


Q ss_pred             CCCCCC-----HHHHhcChhhhhhhh
Q psy1546         284 PENRPT-----AKELLKFPFIRKAKK  304 (604)
Q Consensus       284 P~~RpT-----~~elL~hp~f~~~~~  304 (604)
                      |.+|..     -.+|-.||||+...+
T Consensus       589 P~kRLGcg~~ge~di~~H~FFR~iDW  614 (683)
T KOG0696|consen  589 PGKRLGCGPEGERDIREHPFFRRIDW  614 (683)
T ss_pred             CccccCCCCccccchhhCcchhhccH
Confidence            999964     467889999976543

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=2.3e-39  Score=331.64  Aligned_cols=240  Identities=27%  Similarity=0.443  Sum_probs=193.0

Q ss_pred             ceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhH-HHHHHHHHHHHHHhhCCCCCCC----------eEEEEEEec
Q psy1546          59 FTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAE-DEIEDIQQEIMVLSQCDSPYGT----------KLWIIMEYL  127 (604)
Q Consensus        59 y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~-~~~~~l~~Ei~iL~~l~hp~~~----------~lyLVmEy~  127 (604)
                      |.+.+.||+|+||.||+|.+..+|+.||+|.+...... .....+.+|+.+++.++|+++.          .+|+|+||+
T Consensus         2 y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   81 (284)
T cd07839           2 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEYC   81 (284)
T ss_pred             ceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEecC
Confidence            78889999999999999999999999999998654322 2235577899999999999854          468999999


Q ss_pred             CCCChhhHhh--cCCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCCCCcccc
Q psy1546         128 GGGSALDLMK--AGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFV  205 (604)
Q Consensus       128 ~ggsL~~~l~--~~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~~~~~~  205 (604)
                      ++ +|.+++.  .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||+++.+...........
T Consensus        82 ~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~  160 (284)
T cd07839          82 DQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEV  160 (284)
T ss_pred             CC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCCCcCCCc
Confidence            75 6777664  36799999999999999999999999999999999999999999999999999976544333334456


Q ss_pred             cCCCCCChHHhhcCC-CCCcchhhhHHHHHHHHHhCCCCCC-CCChhhHhhhcC------------------C-CCC---
Q psy1546         206 GTPFWMAPEVIKQSA-YDSKADIWSLGITAIELAKGEPPNS-ELHPMRVLFLIP------------------K-NNP---  261 (604)
Q Consensus       206 GT~~Y~APE~l~~~~-~~~~sDVwSLGviL~eLltG~~Pf~-~~~~~~~~~~i~------------------~-~~~---  261 (604)
                      +++.|+|||++.+.. ++.++|||||||++|+|++|..||. +.+.......+.                  . ...   
T Consensus       161 ~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (284)
T cd07839         161 VTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPYPMY  240 (284)
T ss_pred             cccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccccccCCC
Confidence            889999999987654 7899999999999999999988853 333222111110                  0 000   


Q ss_pred             ------CCCCccchHHHHHHHHHHhccCCCCCCCHHHHhcChhh
Q psy1546         262 ------PQLTGNYTKQFKEFVEACLNKDPENRPTAKELLKFPFI  299 (604)
Q Consensus       262 ------~~~~~~~s~~l~~Li~~~L~~dP~~RpT~~elL~hp~f  299 (604)
                            ......++.++.+||.+||..||.+|||++++++||||
T Consensus       241 ~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f  284 (284)
T cd07839         241 PATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF  284 (284)
T ss_pred             CCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence                  11123467899999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=6.5e-39  Score=322.31  Aligned_cols=240  Identities=30%  Similarity=0.503  Sum_probs=208.0

Q ss_pred             ceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhh-HHHHHHHHHHHHHHhhCCCCCCC----------eEEEEEEec
Q psy1546          59 FTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA-EDEIEDIQQEIMVLSQCDSPYGT----------KLWIIMEYL  127 (604)
Q Consensus        59 y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~-~~~~~~l~~Ei~iL~~l~hp~~~----------~lyLVmEy~  127 (604)
                      |.+.+.||+|+||.||+|.+..+++.||||.+..... ......+.+|+.+++.++||+..          .+|+||||+
T Consensus         2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~   81 (256)
T cd08220           2 YEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYA   81 (256)
T ss_pred             ceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEecC
Confidence            7889999999999999999999999999999875532 23457788999999999999743          458999999


Q ss_pred             CCCChhhHhhc---CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCC-CeEEecccccccccCCCCCCcc
Q psy1546         128 GGGSALDLMKA---GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMG-DVKLADFGVAGTLTNTTSKRNT  203 (604)
Q Consensus       128 ~ggsL~~~l~~---~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g-~vKL~DFGlA~~~~~~~~~~~~  203 (604)
                      ++++|.+++..   ..+++..+..++.|++.||.|||++||+||||+|+||+++.++ .++|+|||++....... ....
T Consensus        82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~-~~~~  160 (256)
T cd08220          82 PGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS-KAYT  160 (256)
T ss_pred             CCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc-cccc
Confidence            99999999965   2489999999999999999999999999999999999998654 57999999997664332 2234


Q ss_pred             cccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCCCCCCCCccchHHHHHHHHHHhccC
Q psy1546         204 FVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKD  283 (604)
Q Consensus       204 ~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~~L~~d  283 (604)
                      ..|+..|+|||.+.+..++.++||||||+++|+|++|..||...+.......+.......++..++..+.+++.+||..|
T Consensus       161 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~  240 (256)
T cd08220         161 VVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPISDRYSPDLRQLILSMLNLD  240 (256)
T ss_pred             cccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCCCCCCCCcCHHHHHHHHHHccCC
Confidence            57899999999999888999999999999999999999999887776666665555555666778999999999999999


Q ss_pred             CCCCCCHHHHhcChhh
Q psy1546         284 PENRPTAKELLKFPFI  299 (604)
Q Consensus       284 P~~RpT~~elL~hp~f  299 (604)
                      |.+|||+.|++.||||
T Consensus       241 p~~Rpt~~~ll~~p~~  256 (256)
T cd08220         241 PSKRPQLSQIMAQPIC  256 (256)
T ss_pred             hhhCCCHHHHhhCCCC
Confidence            9999999999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>KOG0986|consensus

Probab=100.00  E-value=1.8e-40  Score=344.68  Aligned_cols=247  Identities=28%  Similarity=0.444  Sum_probs=211.1

Q ss_pred             ccceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHH--HHHHHHHHHHHhhCCCCCCC----------eEEEEE
Q psy1546          57 LIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDE--IEDIQQEIMVLSQCDSPYGT----------KLWIIM  124 (604)
Q Consensus        57 ~~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~--~~~l~~Ei~iL~~l~hp~~~----------~lyLVm  124 (604)
                      ..|..-++||+||||.||-+..+.||+.||+|.+.++.....  ......|-.||.++..++++          .+|+||
T Consensus       185 n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVL  264 (591)
T KOG0986|consen  185 NTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVL  264 (591)
T ss_pred             cceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEE
Confidence            458888999999999999999999999999999876654332  34567899999999998755          458999


Q ss_pred             EecCCCChhhHhhc-C--CCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCCCC
Q psy1546         125 EYLGGGSALDLMKA-G--NFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKR  201 (604)
Q Consensus       125 Ey~~ggsL~~~l~~-~--~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~~  201 (604)
                      ..|.||+|...|.+ |  .|++..+.+++.+|+.||++||..+||+|||||+|||+|+.|+|+|+|+|+|..+.......
T Consensus       265 tlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~~~~  344 (591)
T KOG0986|consen  265 TLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVEIPEGKPIR  344 (591)
T ss_pred             EeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEecCCCCccc
Confidence            99999999988754 4  79999999999999999999999999999999999999999999999999998776554443


Q ss_pred             cccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhh---HhhhcCCCCCCCCCccchHHHHHHHHH
Q psy1546         202 NTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMR---VLFLIPKNNPPQLTGNYTKQFKEFVEA  278 (604)
Q Consensus       202 ~~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~---~~~~i~~~~~~~~~~~~s~~l~~Li~~  278 (604)
                       ..+||.+|||||++.+..|+...|+|+|||+||||+.|+.||.......   .+.......+..++..+++++++|++.
T Consensus       345 -~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~~ey~~kFS~eakslc~~  423 (591)
T KOG0986|consen  345 -GRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDPEEYSDKFSEEAKSLCEG  423 (591)
T ss_pred             -cccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcchhhcccccCHHHHHHHHH
Confidence             3489999999999999999999999999999999999999997654321   222222334556678999999999999


Q ss_pred             HhccCCCCCCC-----HHHHhcChhhhhhhh
Q psy1546         279 CLNKDPENRPT-----AKELLKFPFIRKAKK  304 (604)
Q Consensus       279 ~L~~dP~~RpT-----~~elL~hp~f~~~~~  304 (604)
                      +|.+||.+|..     +.++-+||||+...+
T Consensus       424 LL~Kdp~~RLGcrg~ga~evk~HpfFk~lnw  454 (591)
T KOG0986|consen  424 LLTKDPEKRLGCRGEGAQEVKEHPFFKDLNW  454 (591)
T ss_pred             HHccCHHHhccCCCcCcchhhhCcccccCCH
Confidence            99999999964     789999999987543

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=6e-39  Score=322.58  Aligned_cols=240  Identities=41%  Similarity=0.768  Sum_probs=206.2

Q ss_pred             ceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhh----HHHHHHHHHHHHHHhhCCCCCCC----------eEEEEE
Q psy1546          59 FTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA----EDEIEDIQQEIMVLSQCDSPYGT----------KLWIIM  124 (604)
Q Consensus        59 y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~----~~~~~~l~~Ei~iL~~l~hp~~~----------~lyLVm  124 (604)
                      |...+.||+|+||+||+|.+..++..||+|.+.....    ....+.+.+|+.+++.++|+++.          .+|+||
T Consensus         2 ~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~   81 (258)
T cd06632           2 WRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFL   81 (258)
T ss_pred             ccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEEE
Confidence            6777899999999999999998999999999865432    33457789999999999999854          357999


Q ss_pred             EecCCCChhhHhhc-CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCCCCcc
Q psy1546         125 EYLGGGSALDLMKA-GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNT  203 (604)
Q Consensus       125 Ey~~ggsL~~~l~~-~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~~~~  203 (604)
                      ||+++++|.+++.. +.+++..+..++.||+.||.|||+.||+|+||+|+||+++.++.+||+|||++....... ....
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~-~~~~  160 (258)
T cd06632          82 ELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS-FAKS  160 (258)
T ss_pred             EecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceeccccc-cccc
Confidence            99999999999876 458999999999999999999999999999999999999999999999999987654333 2345


Q ss_pred             cccCCCCCChHHhhcCC-CCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCC-CCCCCCCccchHHHHHHHHHHhc
Q psy1546         204 FVGTPFWMAPEVIKQSA-YDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPK-NNPPQLTGNYTKQFKEFVEACLN  281 (604)
Q Consensus       204 ~~GT~~Y~APE~l~~~~-~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~-~~~~~~~~~~s~~l~~Li~~~L~  281 (604)
                      ..|+..|+|||.+.... ++.++|+|||||++|+|++|..||...........+.. ...+.++..++..+.+|+.+||.
T Consensus       161 ~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~  240 (258)
T cd06632         161 FKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKDFILKCLQ  240 (258)
T ss_pred             cCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcccCCCcCCCcCHHHHHHHHHHhh
Confidence            67899999999997766 88999999999999999999999987765555544443 33445666788999999999999


Q ss_pred             cCCCCCCCHHHHhcChhh
Q psy1546         282 KDPENRPTAKELLKFPFI  299 (604)
Q Consensus       282 ~dP~~RpT~~elL~hp~f  299 (604)
                      .+|.+||++.+++.|||+
T Consensus       241 ~~p~~Rp~~~~~l~~~~~  258 (258)
T cd06632         241 RDPSLRPTAAELLEHPFV  258 (258)
T ss_pred             cCcccCcCHHHHhcCCCC
Confidence            999999999999999996

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=8.8e-39  Score=324.42  Aligned_cols=242  Identities=34%  Similarity=0.612  Sum_probs=203.2

Q ss_pred             cceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchh----hHHHHHHHHHHHHHHhhCCCCCCC------------eEE
Q psy1546          58 IFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE----AEDEIEDIQQEIMVLSQCDSPYGT------------KLW  121 (604)
Q Consensus        58 ~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~----~~~~~~~l~~Ei~iL~~l~hp~~~------------~ly  121 (604)
                      .|.+.+.||+|+||.||+|.+..++..||||.+....    .....+.+.+|+.+++.+.|+++.            .+|
T Consensus         3 ~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~   82 (265)
T cd06652           3 NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLS   82 (265)
T ss_pred             cceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceEE
Confidence            3889999999999999999999999999999885432    223457888999999999999733            357


Q ss_pred             EEEEecCCCChhhHhhc-CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCC--
Q psy1546         122 IIMEYLGGGSALDLMKA-GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTT--  198 (604)
Q Consensus       122 LVmEy~~ggsL~~~l~~-~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~--  198 (604)
                      +||||+++++|.+++.. +.+++..+..++.||+.||.|||+++|+|+||||+|||++.++.++|+|||++..+....  
T Consensus        83 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~  162 (265)
T cd06652          83 IFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLS  162 (265)
T ss_pred             EEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCcccccccccccc
Confidence            99999999999998865 568999999999999999999999999999999999999999999999999997553221  


Q ss_pred             -CCCcccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCC-CCCCCCCccchHHHHHHH
Q psy1546         199 -SKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPK-NNPPQLTGNYTKQFKEFV  276 (604)
Q Consensus       199 -~~~~~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~-~~~~~~~~~~s~~l~~Li  276 (604)
                       .......|+..|+|||++.+..++.++|||||||++|+|++|..||...........+.. ...+.++..++..+.++|
T Consensus       163 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i  242 (265)
T cd06652         163 GTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHVSDHCRDFL  242 (265)
T ss_pred             ccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhcCCCCCCCchhhCHHHHHHH
Confidence             122345689999999999988899999999999999999999999987655444333322 223445667788999999


Q ss_pred             HHHhccCCCCCCCHHHHhcChhhh
Q psy1546         277 EACLNKDPENRPTAKELLKFPFIR  300 (604)
Q Consensus       277 ~~~L~~dP~~RpT~~elL~hp~f~  300 (604)
                      .+||. +|++||++++|++|||+.
T Consensus       243 ~~~l~-~p~~Rp~~~~il~~~~~~  265 (265)
T cd06652         243 KRIFV-EAKLRPSADELLRHTFVH  265 (265)
T ss_pred             HHHhc-ChhhCCCHHHHhcCcccC
Confidence            99995 999999999999999973

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=5.4e-39  Score=335.72  Aligned_cols=240  Identities=28%  Similarity=0.415  Sum_probs=202.9

Q ss_pred             ccceeeeEEcccCcEEEEEEEECCCCcE----EEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCCeE---------EEE
Q psy1546          57 LIFTKQERIGKGSFGEVFKGIDNRTQQV----VAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTKL---------WII  123 (604)
Q Consensus        57 ~~y~i~~~LG~G~fG~Vy~a~~~~t~~~----vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~~l---------yLV  123 (604)
                      ..|.+.+.||+|+||.||+|.+..+++.    ||||++.........+.+.+|+.+++.+.|||+.++         ++|
T Consensus         7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~~~~~v   86 (316)
T cd05108           7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLI   86 (316)
T ss_pred             hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCCCceee
Confidence            4489999999999999999998666554    899998755444555778899999999999997765         589


Q ss_pred             EEecCCCChhhHhhc--CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCCC-
Q psy1546         124 MEYLGGGSALDLMKA--GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSK-  200 (604)
Q Consensus       124 mEy~~ggsL~~~l~~--~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~-  200 (604)
                      +||+.+|+|.+++..  ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.+...... 
T Consensus        87 ~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~  166 (316)
T cd05108          87 TQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEY  166 (316)
T ss_pred             eecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEccccccccccCCCcce
Confidence            999999999999875  35888999999999999999999999999999999999999999999999999766432221 


Q ss_pred             -CcccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHhhhcCCCCCCCCCccchHHHHHHHHH
Q psy1546         201 -RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAK-GEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEA  278 (604)
Q Consensus       201 -~~~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~  278 (604)
                       .....++..|+|||++.+..++.++|||||||+||||++ |..||.+....+....+........+..++..+.+++.+
T Consensus       167 ~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  246 (316)
T cd05108         167 HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVK  246 (316)
T ss_pred             eccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhCCCCCCCCCCCCHHHHHHHHH
Confidence             112234678999999999999999999999999999997 999998877666555555554445556778899999999


Q ss_pred             HhccCCCCCCCHHHHhcC
Q psy1546         279 CLNKDPENRPTAKELLKF  296 (604)
Q Consensus       279 ~L~~dP~~RpT~~elL~h  296 (604)
                      ||..||.+||++.+++.+
T Consensus       247 cl~~~p~~Rps~~~l~~~  264 (316)
T cd05108         247 CWMIDADSRPKFRELIIE  264 (316)
T ss_pred             HccCChhhCcCHHHHHHH
Confidence            999999999999999975

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=6.7e-39  Score=332.66  Aligned_cols=239  Identities=24%  Similarity=0.377  Sum_probs=193.4

Q ss_pred             ccceeeeEEcccCcEEEEEEEECC----------------CCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCCe-
Q psy1546          57 LIFTKQERIGKGSFGEVFKGIDNR----------------TQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTK-  119 (604)
Q Consensus        57 ~~y~i~~~LG~G~fG~Vy~a~~~~----------------t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~~-  119 (604)
                      ..|.+.++||+|+||.||+|.+..                ++..||||++...........+.+|+.+|..+.||++.+ 
T Consensus         5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~   84 (304)
T cd05096           5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL   84 (304)
T ss_pred             hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence            348899999999999999997532                345799999976554555677899999999999999655 


Q ss_pred             ---------EEEEEEecCCCChhhHhhcC--------------------CCcHHHHHHHHHHHHHHhHHhhhCCcccccc
Q psy1546         120 ---------LWIIMEYLGGGSALDLMKAG--------------------NFEEMHIAVILREVLKGLDYLHSERKLHRDI  170 (604)
Q Consensus       120 ---------lyLVmEy~~ggsL~~~l~~~--------------------~lse~~i~~i~~qIl~gL~yLHs~gIiHrDL  170 (604)
                               +|+||||+.+|+|.+++...                    .+++..+..++.||+.||.|||++||+||||
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~ivH~dl  164 (304)
T cd05096          85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDL  164 (304)
T ss_pred             EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCccccCc
Confidence                     47999999999999988542                    2566788999999999999999999999999


Q ss_pred             ccceeEecCCCCeEEecccccccccCCCC--CCcccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHh--CCCCCCC
Q psy1546         171 KAANVLLSEMGDVKLADFGVAGTLTNTTS--KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAK--GEPPNSE  246 (604)
Q Consensus       171 Kp~NILl~~~g~vKL~DFGlA~~~~~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLlt--G~~Pf~~  246 (604)
                      ||+|||++.++.+||+|||+++.+.....  ......++..|||||++.+..++.++|||||||++|||++  +..||..
T Consensus       165 kp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~  244 (304)
T cd05096         165 ATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPYGE  244 (304)
T ss_pred             chhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCCCCc
Confidence            99999999999999999999976543221  1223456788999999999999999999999999999986  6678887


Q ss_pred             CChhhHhhhcC-------CCCCCCCCccchHHHHHHHHHHhccCCCCCCCHHHHhc
Q psy1546         247 LHPMRVLFLIP-------KNNPPQLTGNYTKQFKEFVEACLNKDPENRPTAKELLK  295 (604)
Q Consensus       247 ~~~~~~~~~i~-------~~~~~~~~~~~s~~l~~Li~~~L~~dP~~RpT~~elL~  295 (604)
                      .........+.       .......+..++..+.+|+.+||..||.+|||+.+|.+
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~  300 (304)
T cd05096         245 LTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHA  300 (304)
T ss_pred             CCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHH
Confidence            66554432211       11112234567889999999999999999999999954

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=9.9e-39  Score=319.72  Aligned_cols=241  Identities=36%  Similarity=0.615  Sum_probs=213.4

Q ss_pred             ceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhh-HHHHHHHHHHHHHHhhCCCCCC----------CeEEEEEEec
Q psy1546          59 FTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA-EDEIEDIQQEIMVLSQCDSPYG----------TKLWIIMEYL  127 (604)
Q Consensus        59 y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~-~~~~~~l~~Ei~iL~~l~hp~~----------~~lyLVmEy~  127 (604)
                      |.+.+.||.|+||.||+|.+..++..||+|++..... ......+.+|+.+++.++|++.          ..+|+|+||+
T Consensus         2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~~   81 (258)
T cd08215           2 YEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEYA   81 (258)
T ss_pred             ceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEec
Confidence            7889999999999999999999999999999976543 2445678899999999999984          3457999999


Q ss_pred             CCCChhhHhhc-----CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCCCCc
Q psy1546         128 GGGSALDLMKA-----GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRN  202 (604)
Q Consensus       128 ~ggsL~~~l~~-----~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~~~  202 (604)
                      ++++|.+++..     ..+++..+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++...........
T Consensus        82 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~  161 (258)
T cd08215          82 DGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAK  161 (258)
T ss_pred             CCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeecccCcceec
Confidence            99999998864     5699999999999999999999999999999999999999999999999999977655443445


Q ss_pred             ccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCCCCCCCCccchHHHHHHHHHHhcc
Q psy1546         203 TFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNK  282 (604)
Q Consensus       203 ~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~~L~~  282 (604)
                      ...|++.|+|||.+.+..++.++||||||+++|+|++|..||...........+.......++..++..+.+++.+||..
T Consensus       162 ~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~  241 (258)
T cd08215         162 TVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPPIPSQYSSELRNLVSSLLQK  241 (258)
T ss_pred             ceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCC
Confidence            56789999999999988899999999999999999999999988877666666656556667778899999999999999


Q ss_pred             CCCCCCCHHHHhcChhh
Q psy1546         283 DPENRPTAKELLKFPFI  299 (604)
Q Consensus       283 dP~~RpT~~elL~hp~f  299 (604)
                      +|.+|||+.++|+||||
T Consensus       242 ~p~~Rp~~~~ll~~~~~  258 (258)
T cd08215         242 DPEERPSIAQILQSPFI  258 (258)
T ss_pred             ChhhCcCHHHHhcCCCC
Confidence            99999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=4.8e-39  Score=328.31  Aligned_cols=238  Identities=24%  Similarity=0.420  Sum_probs=203.8

Q ss_pred             cceeeeEEcccCcEEEEEEEECC-----CCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCCe----------EEE
Q psy1546          58 IFTKQERIGKGSFGEVFKGIDNR-----TQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTK----------LWI  122 (604)
Q Consensus        58 ~y~i~~~LG~G~fG~Vy~a~~~~-----t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~~----------lyL  122 (604)
                      .|.+.+.||+|+||.||+|.+..     ++..||||++.........+.+.+|+.+|+.+.|+++.+          +|+
T Consensus         6 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l   85 (280)
T cd05049           6 TIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPIM   85 (280)
T ss_pred             HhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeEE
Confidence            38888999999999999998743     467899999976555545678899999999999998544          479


Q ss_pred             EEEecCCCChhhHhhc---------------CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEec
Q psy1546         123 IMEYLGGGSALDLMKA---------------GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLAD  187 (604)
Q Consensus       123 VmEy~~ggsL~~~l~~---------------~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~D  187 (604)
                      ||||+++++|.+++..               ..+++..+..++.||+.||.|||++|++||||||+|||++.++.++|+|
T Consensus        86 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~kl~d  165 (280)
T cd05049          86 VFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGD  165 (280)
T ss_pred             EEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCeEEECC
Confidence            9999999999999864               2378889999999999999999999999999999999999999999999


Q ss_pred             ccccccccCCCC--CCcccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHhhhcCCCCCCCC
Q psy1546         188 FGVAGTLTNTTS--KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAK-GEPPNSELHPMRVLFLIPKNNPPQL  264 (604)
Q Consensus       188 FGlA~~~~~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~  264 (604)
                      ||++..+.....  ......+++.|+|||++.+..++.++|||||||++|||++ |..||......+....+..+.....
T Consensus       166 ~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~~~~~~~~  245 (280)
T cd05049         166 FGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQGRLLQR  245 (280)
T ss_pred             cccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCcCCC
Confidence            999975432221  1233456788999999999999999999999999999998 9999988887777776666665566


Q ss_pred             CccchHHHHHHHHHHhccCCCCCCCHHHHhc
Q psy1546         265 TGNYTKQFKEFVEACLNKDPENRPTAKELLK  295 (604)
Q Consensus       265 ~~~~s~~l~~Li~~~L~~dP~~RpT~~elL~  295 (604)
                      +..++..+.+|+.+||..||.+|||+.|+++
T Consensus       246 ~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~  276 (280)
T cd05049         246 PRTCPSEVYDIMLGCWKRDPQQRINIKDIHE  276 (280)
T ss_pred             CCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            6778999999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=4.7e-39  Score=347.22  Aligned_cols=241  Identities=23%  Similarity=0.346  Sum_probs=194.0

Q ss_pred             cceeeeEEcccCcEEEEEEEEC--CCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCCe----------EEEEEE
Q psy1546          58 IFTKQERIGKGSFGEVFKGIDN--RTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTK----------LWIIME  125 (604)
Q Consensus        58 ~y~i~~~LG~G~fG~Vy~a~~~--~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~~----------lyLVmE  125 (604)
                      .|.+++.||+|+||.||+|...  .++..||||.+...      ....+|+.+|+.++||++++          +|+|||
T Consensus        93 ~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~------~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e  166 (392)
T PHA03207         93 QYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG------KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMP  166 (392)
T ss_pred             ceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc------ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEeh
Confidence            4999999999999999999754  45678999988543      23468999999999998665          479999


Q ss_pred             ecCCCChhhHhh-cCCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCC--CCc
Q psy1546         126 YLGGGSALDLMK-AGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTS--KRN  202 (604)
Q Consensus       126 y~~ggsL~~~l~-~~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~--~~~  202 (604)
                      |+. ++|.+++. .+.+++..++.|+.||+.||.|||++||+||||||+||||+.++.++|+|||++..+.....  ...
T Consensus       167 ~~~-~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~~~~~~  245 (392)
T PHA03207        167 KYK-CDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCY  245 (392)
T ss_pred             hcC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccCccccccccc
Confidence            995 56777774 46799999999999999999999999999999999999999999999999999976543322  223


Q ss_pred             ccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhh-------Hhhhc-------------------
Q psy1546         203 TFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMR-------VLFLI-------------------  256 (604)
Q Consensus       203 ~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~-------~~~~i-------------------  256 (604)
                      ...||+.|+|||++.+..|+.++|||||||+||||++|..||.+.....       +...+                   
T Consensus       246 ~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~  325 (392)
T PHA03207        246 GWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTNLCKHF  325 (392)
T ss_pred             ccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchhHHHHH
Confidence            4679999999999999999999999999999999999999997653211       00000                   


Q ss_pred             ---CCCCCC--CC-----CccchHHHHHHHHHHhccCCCCCCCHHHHhcChhhhhhhhh
Q psy1546         257 ---PKNNPP--QL-----TGNYTKQFKEFVEACLNKDPENRPTAKELLKFPFIRKAKKN  305 (604)
Q Consensus       257 ---~~~~~~--~~-----~~~~s~~l~~Li~~~L~~dP~~RpT~~elL~hp~f~~~~~~  305 (604)
                         .....+  .+     ...++.++.+||.+||..||++|||+.|+|.||||.+...+
T Consensus       326 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~~~~  384 (392)
T PHA03207        326 KQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKEPIN  384 (392)
T ss_pred             HhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhccchh
Confidence               000000  00     12346788999999999999999999999999999875443

>KOG1989|consensus

Probab=100.00  E-value=3.1e-39  Score=360.34  Aligned_cols=237  Identities=27%  Similarity=0.435  Sum_probs=200.1

Q ss_pred             ccceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCC-CCCCCeE---------------
Q psy1546          57 LIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCD-SPYGTKL---------------  120 (604)
Q Consensus        57 ~~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~-hp~~~~l---------------  120 (604)
                      ..+++.+.|.+|||+.||+|.+...+..||+|++-.. .+..++.+.+||.+|++|. |+|++.+               
T Consensus        37 ~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~-de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~  115 (738)
T KOG1989|consen   37 HRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN-DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVW  115 (738)
T ss_pred             EEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC-CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCcee
Confidence            3478999999999999999999988899999998655 6677899999999999998 9986544               


Q ss_pred             --EEEEEecCCCChhhHhhc---CCCcHHHHHHHHHHHHHHhHHhhhCC--ccccccccceeEecCCCCeEEeccccccc
Q psy1546         121 --WIIMEYLGGGSALDLMKA---GNFEEMHIAVILREVLKGLDYLHSER--KLHRDIKAANVLLSEMGDVKLADFGVAGT  193 (604)
Q Consensus       121 --yLVmEy~~ggsL~~~l~~---~~lse~~i~~i~~qIl~gL~yLHs~g--IiHrDLKp~NILl~~~g~vKL~DFGlA~~  193 (604)
                        +|+||||.||.|.++|..   .+|++.+++.||.|+++||.+||...  |||||||-+||||+.+|+.||||||.|..
T Consensus       116 EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLCDFGSatt  195 (738)
T KOG1989|consen  116 EVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLCDFGSATT  195 (738)
T ss_pred             EEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeCccccccc
Confidence              599999999999999963   56999999999999999999999997  99999999999999999999999999965


Q ss_pred             ccCCCCCC---------cccccCCCCCChHHh---hcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCCCC
Q psy1546         194 LTNTTSKR---------NTFVGTPFWMAPEVI---KQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNP  261 (604)
Q Consensus       194 ~~~~~~~~---------~~~~GT~~Y~APE~l---~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~~~  261 (604)
                      ........         .....|+.|+|||++   .+...+.|+|||+|||+||-|+....||.+.....++    .+.+
T Consensus       196 ~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~laIl----ng~Y  271 (738)
T KOG1989|consen  196 KILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLAIL----NGNY  271 (738)
T ss_pred             ccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcceeEE----eccc
Confidence            43322111         112479999999998   4678999999999999999999999999876443332    2222


Q ss_pred             C-CCCccchHHHHHHHHHHhccCCCCCCCHHHHhcChh
Q psy1546         262 P-QLTGNYTKQFKEFVEACLNKDPENRPTAKELLKFPF  298 (604)
Q Consensus       262 ~-~~~~~~s~~l~~Li~~~L~~dP~~RpT~~elL~hp~  298 (604)
                      . +....|+..+++||..||+.||.+||++-|++.+-+
T Consensus       272 ~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~  309 (738)
T KOG1989|consen  272 SFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIF  309 (738)
T ss_pred             cCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHH
Confidence            1 222579999999999999999999999999998644

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=8.4e-39  Score=323.71  Aligned_cols=238  Identities=33%  Similarity=0.547  Sum_probs=203.5

Q ss_pred             EcccCcEEEEEEEECCCCcEEEEEEecchhh--HHHHHHHHHHHHHHhhCCCCCCCe----------EEEEEEecCCCCh
Q psy1546          65 IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA--EDEIEDIQQEIMVLSQCDSPYGTK----------LWIIMEYLGGGSA  132 (604)
Q Consensus        65 LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~--~~~~~~l~~Ei~iL~~l~hp~~~~----------lyLVmEy~~ggsL  132 (604)
                      ||.|+||.||+|.+..+++.||+|++.....  ....+.+.+|+.+++.++||++.+          +|+||||+++++|
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL   80 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence            6999999999999999999999999975442  234577899999999999998554          4799999999999


Q ss_pred             hhHhhc-CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCCCCcccccCCCCC
Q psy1546         133 LDLMKA-GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWM  211 (604)
Q Consensus       133 ~~~l~~-~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~~~~~~GT~~Y~  211 (604)
                      .+++.. ..+++..+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++....... ......|++.|+
T Consensus        81 ~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~  159 (262)
T cd05572          81 WTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ-KTWTFCGTPEYV  159 (262)
T ss_pred             HHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc-ccccccCCcCcc
Confidence            999865 568999999999999999999999999999999999999999999999999997665432 233457899999


Q ss_pred             ChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCC--hhhHhhhcCC-CCCCCCCccchHHHHHHHHHHhccCCCCCC
Q psy1546         212 APEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELH--PMRVLFLIPK-NNPPQLTGNYTKQFKEFVEACLNKDPENRP  288 (604)
Q Consensus       212 APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~--~~~~~~~i~~-~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rp  288 (604)
                      |||++.+..++.++|+||||+++|+|++|..||....  .......+.. ......+...+.++.++|.+||..+|.+||
T Consensus       160 ~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~  239 (262)
T cd05572         160 APEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRRNPEERL  239 (262)
T ss_pred             ChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCCCcccCHHHHHHHHHHccCChhhCc
Confidence            9999988889999999999999999999999998776  4444444332 233445556688999999999999999999


Q ss_pred             C-----HHHHhcChhhhhhh
Q psy1546         289 T-----AKELLKFPFIRKAK  303 (604)
Q Consensus       289 T-----~~elL~hp~f~~~~  303 (604)
                      +     ++|+++||||+...
T Consensus       240 ~~~~~~~~~l~~~~~~~~~~  259 (262)
T cd05572         240 GNLKGGIKDIKKHKWFNGFD  259 (262)
T ss_pred             CCcccCHHHHhcChhhhCCC
Confidence            9     99999999997643

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=1.3e-38  Score=321.67  Aligned_cols=241  Identities=39%  Similarity=0.713  Sum_probs=204.1

Q ss_pred             ceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhH-HHHHHHHHHHHHHhhCCCCCCC----------eEEEEEEec
Q psy1546          59 FTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAE-DEIEDIQQEIMVLSQCDSPYGT----------KLWIIMEYL  127 (604)
Q Consensus        59 y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~-~~~~~l~~Ei~iL~~l~hp~~~----------~lyLVmEy~  127 (604)
                      |.+.+.||+|+||.||+|.+..+++.||+|++...... .....+..|+.+++.++|+++.          .+|+|+||+
T Consensus         2 y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~~   81 (264)
T cd06626           2 WQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEYC   81 (264)
T ss_pred             ceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEecC
Confidence            78889999999999999999999999999998765432 4568899999999999999843          458999999


Q ss_pred             CCCChhhHhhcC-CCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCCCC----c
Q psy1546         128 GGGSALDLMKAG-NFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKR----N  202 (604)
Q Consensus       128 ~ggsL~~~l~~~-~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~~----~  202 (604)
                      ++++|.+++..+ .+++..+..++.||+.||.|||+.||+|+||+|+||+++.++.+||+|||++..........    .
T Consensus        82 ~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~  161 (264)
T cd06626          82 SGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQ  161 (264)
T ss_pred             CCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCccccccc
Confidence            999999999764 58889999999999999999999999999999999999999999999999997665433322    2


Q ss_pred             ccccCCCCCChHHhhcCC---CCCcchhhhHHHHHHHHHhCCCCCCCCC-hhhHhhhcCCCCCCCCCcc--chHHHHHHH
Q psy1546         203 TFVGTPFWMAPEVIKQSA---YDSKADIWSLGITAIELAKGEPPNSELH-PMRVLFLIPKNNPPQLTGN--YTKQFKEFV  276 (604)
Q Consensus       203 ~~~GT~~Y~APE~l~~~~---~~~~sDVwSLGviL~eLltG~~Pf~~~~-~~~~~~~i~~~~~~~~~~~--~s~~l~~Li  276 (604)
                      ...+++.|+|||++.+..   ++.++||||||+++|+|++|..||.... .......+.....+.++..  ++..+.+||
T Consensus       162 ~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  241 (264)
T cd06626         162 SLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQLSPEGKDFL  241 (264)
T ss_pred             CCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhcCCCCCCCcccccCHHHHHHH
Confidence            356889999999998766   8899999999999999999999997653 3333333333444444444  488999999


Q ss_pred             HHHhccCCCCCCCHHHHhcChhh
Q psy1546         277 EACLNKDPENRPTAKELLKFPFI  299 (604)
Q Consensus       277 ~~~L~~dP~~RpT~~elL~hp~f  299 (604)
                      .+||+.+|.+|||+.+++.|||+
T Consensus       242 ~~~l~~~p~~R~~~~~i~~~~~~  264 (264)
T cd06626         242 DRCLESDPKKRPTASELLQHPFV  264 (264)
T ss_pred             HHHccCCcccCCCHHHHhcCCCC
Confidence            99999999999999999999996

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=1.2e-38  Score=320.51  Aligned_cols=241  Identities=30%  Similarity=0.576  Sum_probs=207.9

Q ss_pred             ceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhh-HHHHHHHHHHHHHHhhCCCCCCC----------eEEEEEEec
Q psy1546          59 FTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA-EDEIEDIQQEIMVLSQCDSPYGT----------KLWIIMEYL  127 (604)
Q Consensus        59 y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~-~~~~~~l~~Ei~iL~~l~hp~~~----------~lyLVmEy~  127 (604)
                      |.+.+.||.|+||.||+|.++.++..||+|.+..... ....+.+.+|+.+++.++|+++.          .+|+|+||+
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~   81 (257)
T cd08225           2 YEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYC   81 (257)
T ss_pred             ceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEecC
Confidence            7889999999999999999999999999999865432 12346678999999999999844          457999999


Q ss_pred             CCCChhhHhhcC---CCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCC-eEEecccccccccCCCCCCcc
Q psy1546         128 GGGSALDLMKAG---NFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGD-VKLADFGVAGTLTNTTSKRNT  203 (604)
Q Consensus       128 ~ggsL~~~l~~~---~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~-vKL~DFGlA~~~~~~~~~~~~  203 (604)
                      .+++|.+++...   .+++..+..++.||+.||.|||+.+++|+||||+||+++.++. ++|+|||.+............
T Consensus        82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~~~~  161 (257)
T cd08225          82 DGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYT  161 (257)
T ss_pred             CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCCcccccc
Confidence            999999988642   4789999999999999999999999999999999999998764 699999999776544434445


Q ss_pred             cccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCCCCCCCCccchHHHHHHHHHHhccC
Q psy1546         204 FVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKD  283 (604)
Q Consensus       204 ~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~~L~~d  283 (604)
                      ..|++.|+|||++.+..++.++|||||||++|+|++|..||......+....+...........++..+.++|.+||..+
T Consensus       162 ~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~  241 (257)
T cd08225         162 CVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPISPNFSRDLRSLISQLFKVS  241 (257)
T ss_pred             cCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcccCCCCCCCCCHHHHHHHHHHhccC
Confidence            57899999999998888999999999999999999999999887766666555555555566678899999999999999


Q ss_pred             CCCCCCHHHHhcChhh
Q psy1546         284 PENRPTAKELLKFPFI  299 (604)
Q Consensus       284 P~~RpT~~elL~hp~f  299 (604)
                      |++|||+.+|++||||
T Consensus       242 p~~Rpt~~~ll~~~~~  257 (257)
T cd08225         242 PRDRPSITSILKRPFL  257 (257)
T ss_pred             hhhCcCHHHHhhCCCC
Confidence            9999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=3.7e-39  Score=343.71  Aligned_cols=236  Identities=26%  Similarity=0.406  Sum_probs=187.1

Q ss_pred             ccceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCCeE----------EEEEEe
Q psy1546          57 LIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTKL----------WIIMEY  126 (604)
Q Consensus        57 ~~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~~l----------yLVmEy  126 (604)
                      ..|.+.+.||+|+||.||+|.+..+++.||+|+.....       ...|+.+++.+.|+++.++          |+||||
T Consensus        66 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~~-------~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  138 (357)
T PHA03209         66 LGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGT-------TLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPH  138 (357)
T ss_pred             cCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCccc-------cHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEc
Confidence            34999999999999999999999999999999864332       3468999999999997654          699999


Q ss_pred             cCCCChhhHhhc--CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCCCCccc
Q psy1546         127 LGGGSALDLMKA--GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTF  204 (604)
Q Consensus       127 ~~ggsL~~~l~~--~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~~~~~  204 (604)
                      +. ++|.+++..  +.+++..+..|+.||+.||.|||++||+||||||+|||++.++.+||+|||+++.... .......
T Consensus       139 ~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~-~~~~~~~  216 (357)
T PHA03209        139 YS-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVV-APAFLGL  216 (357)
T ss_pred             cC-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCcccccccc-Ccccccc
Confidence            95 577777643  5689999999999999999999999999999999999999999999999999964332 2223356


Q ss_pred             ccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCC-CCCCChh----------hHhhhcC--CCCCCCC-------
Q psy1546         205 VGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPP-NSELHPM----------RVLFLIP--KNNPPQL-------  264 (604)
Q Consensus       205 ~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~P-f~~~~~~----------~~~~~i~--~~~~~~~-------  264 (604)
                      .||+.|+|||++.+..++.++|||||||+||||+++..+ |......          .+...+.  ...+..+       
T Consensus       217 ~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~  296 (357)
T PHA03209        217 AGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRDPGSR  296 (357)
T ss_pred             cccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCCCCccH
Confidence            799999999999999999999999999999999985444 3321110          0000000  0000000       


Q ss_pred             -----------------------CccchHHHHHHHHHHhccCCCCCCCHHHHhcChhhhh
Q psy1546         265 -----------------------TGNYTKQFKEFVEACLNKDPENRPTAKELLKFPFIRK  301 (604)
Q Consensus       265 -----------------------~~~~s~~l~~Li~~~L~~dP~~RpT~~elL~hp~f~~  301 (604)
                                             ...++.++.+||.+||..||.+|||+.|||+||||++
T Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~  356 (357)
T PHA03209        297 LVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQ  356 (357)
T ss_pred             HHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhcc
Confidence                                   0134567788999999999999999999999999974

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=1.2e-38  Score=322.99  Aligned_cols=242  Identities=31%  Similarity=0.615  Sum_probs=202.3

Q ss_pred             ceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhh-----HHHHHHHHHHHHHHhhCCCCCCC----------eEEEE
Q psy1546          59 FTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA-----EDEIEDIQQEIMVLSQCDSPYGT----------KLWII  123 (604)
Q Consensus        59 y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~-----~~~~~~l~~Ei~iL~~l~hp~~~----------~lyLV  123 (604)
                      |+..+.||+|+||.||+|.+..+++.||+|++.....     ....+.+.+|+.+++.++|+++.          .+++|
T Consensus         2 ~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v   81 (268)
T cd06630           2 WLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLF   81 (268)
T ss_pred             ccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEEE
Confidence            7788999999999999999999999999999864331     22457789999999999999843          45899


Q ss_pred             EEecCCCChhhHhhc-CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCC-CeEEecccccccccCCCC--
Q psy1546         124 MEYLGGGSALDLMKA-GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMG-DVKLADFGVAGTLTNTTS--  199 (604)
Q Consensus       124 mEy~~ggsL~~~l~~-~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g-~vKL~DFGlA~~~~~~~~--  199 (604)
                      |||+.+++|.+++.. +.+++..+..++.||+.||.|||++|++||||+|+||+++.++ .++|+|||++..+.....  
T Consensus        82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~~~  161 (268)
T cd06630          82 VEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGA  161 (268)
T ss_pred             EeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEcccccccccccccccC
Confidence            999999999999865 6789999999999999999999999999999999999998776 599999999976653321  


Q ss_pred             --CCcccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhh---hc-CCCCCCCCCccchHHHH
Q psy1546         200 --KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLF---LI-PKNNPPQLTGNYTKQFK  273 (604)
Q Consensus       200 --~~~~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~---~i-~~~~~~~~~~~~s~~l~  273 (604)
                        ......|+..|+|||++.+..++.++|||||||++|+|++|..||..........   .+ .....+.++..++.++.
T Consensus       162 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (268)
T cd06630         162 GEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSPGLR  241 (268)
T ss_pred             CccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCCCchhhCHHHH
Confidence              1234568899999999998889999999999999999999999997544322111   11 12223455567889999


Q ss_pred             HHHHHHhccCCCCCCCHHHHhcChhhh
Q psy1546         274 EFVEACLNKDPENRPTAKELLKFPFIR  300 (604)
Q Consensus       274 ~Li~~~L~~dP~~RpT~~elL~hp~f~  300 (604)
                      +++.+||..+|.+|||+.++++||||+
T Consensus       242 ~~i~~~l~~~p~~R~~~~~ll~~~~~~  268 (268)
T cd06630         242 DVTLRCLELQPEDRPPSRELLKHPVFR  268 (268)
T ss_pred             HHHHHHcCCCcccCcCHHHHhcCcccC
Confidence            999999999999999999999999984

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=1e-38  Score=339.09  Aligned_cols=245  Identities=23%  Similarity=0.354  Sum_probs=199.4

Q ss_pred             ccceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchh-hHHHHHHHHHHHHHHhhCCCCCCCe----------------
Q psy1546          57 LIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE-AEDEIEDIQQEIMVLSQCDSPYGTK----------------  119 (604)
Q Consensus        57 ~~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~-~~~~~~~l~~Ei~iL~~l~hp~~~~----------------  119 (604)
                      ..|.+.+.||+|+||.||+|.+..+++.||||++.... .......+.+|+.+++.+.|+++.+                
T Consensus        16 ~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   95 (353)
T cd07850          16 KRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQD   95 (353)
T ss_pred             cceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccCc
Confidence            34999999999999999999999999999999986432 2233456778999999999998543                


Q ss_pred             EEEEEEecCCCChhhHhhcCCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCC
Q psy1546         120 LWIIMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTS  199 (604)
Q Consensus       120 lyLVmEy~~ggsL~~~l~~~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~  199 (604)
                      +|+||||+. ++|.+++... +++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...... 
T Consensus        96 ~~lv~e~~~-~~l~~~~~~~-l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~-  172 (353)
T cd07850          96 VYLVMELMD-ANLCQVIQMD-LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF-  172 (353)
T ss_pred             EEEEEeccC-CCHHHHHhhc-CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCccceeCCCCC-
Confidence            589999995 5788777654 8999999999999999999999999999999999999999999999999997654322 


Q ss_pred             CCcccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCC---------------------
Q psy1546         200 KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPK---------------------  258 (604)
Q Consensus       200 ~~~~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~---------------------  258 (604)
                      ......+++.|+|||++.+..++.++|||||||++|+|++|..||...+.......+..                     
T Consensus       173 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (353)
T cd07850         173 MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTVRNYV  252 (353)
T ss_pred             CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhhhhHHh
Confidence            23345789999999999999999999999999999999999999986654322111100                     


Q ss_pred             -----CCC----------------CCCCccchHHHHHHHHHHhccCCCCCCCHHHHhcChhhhhhhh
Q psy1546         259 -----NNP----------------PQLTGNYTKQFKEFVEACLNKDPENRPTAKELLKFPFIRKAKK  304 (604)
Q Consensus       259 -----~~~----------------~~~~~~~s~~l~~Li~~~L~~dP~~RpT~~elL~hp~f~~~~~  304 (604)
                           ...                .......+..+.+||.+||..||.+|||+.|+|.||||+.+..
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~~~~  319 (353)
T cd07850         253 ENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINVWYD  319 (353)
T ss_pred             hcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhhccC
Confidence                 000                0001234667899999999999999999999999999976543

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=6.1e-39  Score=338.37  Aligned_cols=246  Identities=27%  Similarity=0.426  Sum_probs=200.4

Q ss_pred             ccceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCC---------------eEE
Q psy1546          57 LIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGT---------------KLW  121 (604)
Q Consensus        57 ~~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~---------------~ly  121 (604)
                      ..|.+.++||+|+||.||+|.+..+++.||||++...........+.+|+.+++.++|+++.               .+|
T Consensus         5 ~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   84 (336)
T cd07849           5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVY   84 (336)
T ss_pred             cceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceEE
Confidence            35999999999999999999999999999999986544344456678899999999999743               358


Q ss_pred             EEEEecCCCChhhHhhcCCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCC--
Q psy1546         122 IIMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTS--  199 (604)
Q Consensus       122 LVmEy~~ggsL~~~l~~~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~--  199 (604)
                      +|+||+. ++|..++..+.+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++........  
T Consensus        85 lv~e~~~-~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~  163 (336)
T cd07849          85 IVQELME-TDLYKLIKTQHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHT  163 (336)
T ss_pred             EEehhcc-cCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeecccccccc
Confidence            9999995 5888888888999999999999999999999999999999999999999999999999999976543222  


Q ss_pred             -CCcccccCCCCCChHHhhc-CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhc---------------C-----
Q psy1546         200 -KRNTFVGTPFWMAPEVIKQ-SAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLI---------------P-----  257 (604)
Q Consensus       200 -~~~~~~GT~~Y~APE~l~~-~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i---------------~-----  257 (604)
                       ......||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+.......+               .     
T Consensus       164 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (336)
T cd07849         164 GFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIISLRAR  243 (336)
T ss_pred             CCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhchhhh
Confidence             1233578999999998765 56889999999999999999999999765432211110               0     


Q ss_pred             -------CCCC---CCCCccchHHHHHHHHHHhccCCCCCCCHHHHhcChhhhhhh
Q psy1546         258 -------KNNP---PQLTGNYTKQFKEFVEACLNKDPENRPTAKELLKFPFIRKAK  303 (604)
Q Consensus       258 -------~~~~---~~~~~~~s~~l~~Li~~~L~~dP~~RpT~~elL~hp~f~~~~  303 (604)
                             ....   ......++.++.+||.+||..||.+|||+.|+++||||+...
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~  299 (336)
T cd07849         244 NYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYH  299 (336)
T ss_pred             hHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccC
Confidence                   0000   001124567899999999999999999999999999997654

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=1e-38  Score=327.36  Aligned_cols=238  Identities=23%  Similarity=0.419  Sum_probs=202.5

Q ss_pred             ceeeeEEcccCcEEEEEEEEC----CCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCCe----------EEEEE
Q psy1546          59 FTKQERIGKGSFGEVFKGIDN----RTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTK----------LWIIM  124 (604)
Q Consensus        59 y~i~~~LG~G~fG~Vy~a~~~----~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~~----------lyLVm  124 (604)
                      |++.++||+|+||+||+|.+.    .++..||+|.+...........+.+|+.+++.+.|||+.+          .|+||
T Consensus         7 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~   86 (283)
T cd05090           7 VRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCMLF   86 (283)
T ss_pred             ceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEEEE
Confidence            788899999999999999853    4567899999976554555677889999999999998654          47999


Q ss_pred             EecCCCChhhHhhc------------------CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEe
Q psy1546         125 EYLGGGSALDLMKA------------------GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLA  186 (604)
Q Consensus       125 Ey~~ggsL~~~l~~------------------~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~  186 (604)
                      ||+++++|.+++..                  ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+
T Consensus        87 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~~~~kl~  166 (283)
T cd05090          87 EYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKIS  166 (283)
T ss_pred             EcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCCCcEEec
Confidence            99999999998842                  237788899999999999999999999999999999999999999999


Q ss_pred             cccccccccCCC--CCCcccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHhhhcCCCCCCC
Q psy1546         187 DFGVAGTLTNTT--SKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAK-GEPPNSELHPMRVLFLIPKNNPPQ  263 (604)
Q Consensus       187 DFGlA~~~~~~~--~~~~~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~  263 (604)
                      |||+++.+....  .......++..|+|||++.+..++.++|||||||+||||++ |.+||.+.....+...+.......
T Consensus       167 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~  246 (283)
T cd05090         167 DLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVRKRQLLP  246 (283)
T ss_pred             cccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcCC
Confidence            999997654322  12233456778999999998889999999999999999998 999998877766666665555556


Q ss_pred             CCccchHHHHHHHHHHhccCCCCCCCHHHHhcC
Q psy1546         264 LTGNYTKQFKEFVEACLNKDPENRPTAKELLKF  296 (604)
Q Consensus       264 ~~~~~s~~l~~Li~~~L~~dP~~RpT~~elL~h  296 (604)
                      .+..++..+.+++.+||+.||.+||++.+|+++
T Consensus       247 ~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~  279 (283)
T cd05090         247 CSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR  279 (283)
T ss_pred             CCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence            677889999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=8.6e-39  Score=328.41  Aligned_cols=243  Identities=36%  Similarity=0.606  Sum_probs=204.3

Q ss_pred             cceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCCe----------EEEEEEec
Q psy1546          58 IFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTK----------LWIIMEYL  127 (604)
Q Consensus        58 ~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~~----------lyLVmEy~  127 (604)
                      .|++.+.||+|+||+||+|.+..+++.||+|++.........+.+.+|+.+++.++||++.+          +|+||||+
T Consensus         6 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   85 (284)
T cd06620           6 DLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEFM   85 (284)
T ss_pred             HHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEecC
Confidence            48889999999999999999999999999999866544445578899999999999998544          57999999


Q ss_pred             CCCChhhHhhc-CCCcHHHHHHHHHHHHHHhHHhhh-CCccccccccceeEecCCCCeEEecccccccccCCCCCCcccc
Q psy1546         128 GGGSALDLMKA-GNFEEMHIAVILREVLKGLDYLHS-ERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFV  205 (604)
Q Consensus       128 ~ggsL~~~l~~-~~lse~~i~~i~~qIl~gL~yLHs-~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~~~~~~  205 (604)
                      ++++|.+++.. +.+++..+..++.+++.||.|||+ .+++||||+|+||+++.++.++|+|||++......  .....+
T Consensus        86 ~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~--~~~~~~  163 (284)
T cd06620          86 DCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS--IADTFV  163 (284)
T ss_pred             CCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhhh--ccCccc
Confidence            99999998865 578999999999999999999997 69999999999999999999999999998654322  223457


Q ss_pred             cCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChh-----------hHhhhcCCCCCCCCCc-cchHHHH
Q psy1546         206 GTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPM-----------RVLFLIPKNNPPQLTG-NYTKQFK  273 (604)
Q Consensus       206 GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~-----------~~~~~i~~~~~~~~~~-~~s~~l~  273 (604)
                      |+..|+|||++.+..++.++|||||||++|+|++|..||......           .....+.....+.++. .++..+.
T Consensus       164 ~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (284)
T cd06620         164 GTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSDFPEDLR  243 (284)
T ss_pred             cCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCCCCCchhcCHHHH
Confidence            999999999998888999999999999999999999999865431           2222222222333333 3788999


Q ss_pred             HHHHHHhccCCCCCCCHHHHhcChhhhhh
Q psy1546         274 EFVEACLNKDPENRPTAKELLKFPFIRKA  302 (604)
Q Consensus       274 ~Li~~~L~~dP~~RpT~~elL~hp~f~~~  302 (604)
                      +|+.+||..||.+|||+.|+++|+||.+.
T Consensus       244 ~li~~~l~~dp~~Rpt~~e~~~~~~~~~~  272 (284)
T cd06620         244 DFVDACLLKDPTERPTPQQLCAMPPFIQA  272 (284)
T ss_pred             HHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence            99999999999999999999999999654

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=1.9e-38  Score=324.79  Aligned_cols=238  Identities=28%  Similarity=0.431  Sum_probs=202.7

Q ss_pred             cceeeeEEcccCcEEEEEEEECCCCc----EEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCCeE---------EEEE
Q psy1546          58 IFTKQERIGKGSFGEVFKGIDNRTQQ----VVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTKL---------WIIM  124 (604)
Q Consensus        58 ~y~i~~~LG~G~fG~Vy~a~~~~t~~----~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~~l---------yLVm  124 (604)
                      .|.+.++||+|+||+||+|.+..++.    .||||++...........+.+|+.++..+.|+++..+         +++|
T Consensus         8 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~l~~   87 (279)
T cd05109           8 ELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTSTVQLVT   87 (279)
T ss_pred             heeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCCCcEEEE
Confidence            48899999999999999999876665    4899998765555556778899999999999997654         6999


Q ss_pred             EecCCCChhhHhhc--CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCCC--
Q psy1546         125 EYLGGGSALDLMKA--GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSK--  200 (604)
Q Consensus       125 Ey~~ggsL~~~l~~--~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~--  200 (604)
                      ||+++|+|.+++..  +.+++..+..++.||+.||.|||++||+||||||+|||+++++.+||+|||+++.+......  
T Consensus        88 ~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~~~~~~  167 (279)
T cd05109          88 QLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYH  167 (279)
T ss_pred             EcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCceeecccccceee
Confidence            99999999999865  46899999999999999999999999999999999999999999999999999766432221  


Q ss_pred             CcccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHhhhcCCCCCCCCCccchHHHHHHHHHH
Q psy1546         201 RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAK-GEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEAC  279 (604)
Q Consensus       201 ~~~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~~  279 (604)
                      .....+++.|+|||++.+..++.++|||||||++|||++ |..||...........+........+..++..+.+++.+|
T Consensus       168 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  247 (279)
T cd05109         168 ADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERLPQPPICTIDVYMIMVKC  247 (279)
T ss_pred             cCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCCCccCCHHHHHHHHHH
Confidence            112235678999999999999999999999999999998 9999988776666555555555555667889999999999


Q ss_pred             hccCCCCCCCHHHHhc
Q psy1546         280 LNKDPENRPTAKELLK  295 (604)
Q Consensus       280 L~~dP~~RpT~~elL~  295 (604)
                      |..||++||++.+++.
T Consensus       248 l~~dp~~Rp~~~~l~~  263 (279)
T cd05109         248 WMIDSECRPRFRELVD  263 (279)
T ss_pred             cCCChhhCcCHHHHHH
Confidence            9999999999999985

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=6.7e-39  Score=344.20  Aligned_cols=239  Identities=26%  Similarity=0.426  Sum_probs=195.6

Q ss_pred             cceeeeEEcccCcEEEEEEEE-----CCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhC-CCCCCCeE----------E
Q psy1546          58 IFTKQERIGKGSFGEVFKGID-----NRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQC-DSPYGTKL----------W  121 (604)
Q Consensus        58 ~y~i~~~LG~G~fG~Vy~a~~-----~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l-~hp~~~~l----------y  121 (604)
                      .|.+.++||+|+||.||+|++     ..++..||||++.........+.+.+|+.+|..+ .|||++++          |
T Consensus        36 ~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~~  115 (375)
T cd05104          36 RLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGPTL  115 (375)
T ss_pred             HeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCcce
Confidence            388999999999999999974     3567789999997554444557788999999999 89997665          6


Q ss_pred             EEEEecCCCChhhHhhcC--------------------------------------------------------------
Q psy1546         122 IIMEYLGGGSALDLMKAG--------------------------------------------------------------  139 (604)
Q Consensus       122 LVmEy~~ggsL~~~l~~~--------------------------------------------------------------  139 (604)
                      +|||||++|+|.++++..                                                              
T Consensus       116 lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (375)
T cd05104         116 VITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSYI  195 (375)
T ss_pred             eeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccceec
Confidence            999999999999888531                                                              


Q ss_pred             --------------CCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCCC--Ccc
Q psy1546         140 --------------NFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSK--RNT  203 (604)
Q Consensus       140 --------------~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~--~~~  203 (604)
                                    .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+......  ...
T Consensus       196 ~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~  275 (375)
T cd05104         196 DQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGN  275 (375)
T ss_pred             ccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceeccCcccccccCC
Confidence                          3677888999999999999999999999999999999999999999999999765433221  122


Q ss_pred             cccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhh-HhhhcCCCCCCCCCccchHHHHHHHHHHhc
Q psy1546         204 FVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAK-GEPPNSELHPMR-VLFLIPKNNPPQLTGNYTKQFKEFVEACLN  281 (604)
Q Consensus       204 ~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLlt-G~~Pf~~~~~~~-~~~~i~~~~~~~~~~~~s~~l~~Li~~~L~  281 (604)
                      ..++..|+|||++.+..++.++|||||||+||||++ |..||....... ....+........+...+.++.+||.+||.
T Consensus       276 ~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~  355 (375)
T cd05104         276 ARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRMLSPECAPSEMYDIMKSCWD  355 (375)
T ss_pred             CCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccCCCCCCCCHHHHHHHHHHcc
Confidence            345677999999999999999999999999999997 899997765432 223333333334445668899999999999


Q ss_pred             cCCCCCCCHHHHhcC
Q psy1546         282 KDPENRPTAKELLKF  296 (604)
Q Consensus       282 ~dP~~RpT~~elL~h  296 (604)
                      .||++|||+.||++.
T Consensus       356 ~dP~~RPs~~eil~~  370 (375)
T cd05104         356 ADPLKRPTFKQIVQL  370 (375)
T ss_pred             CChhHCcCHHHHHHH
Confidence            999999999999874

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=1.5e-38  Score=323.22  Aligned_cols=238  Identities=24%  Similarity=0.442  Sum_probs=199.8

Q ss_pred             ceeeeEEcccCcEEEEEEEECCCCc--EEEEEEecchh-hHHHHHHHHHHHHHHhhCCCCCCCeE---------------
Q psy1546          59 FTKQERIGKGSFGEVFKGIDNRTQQ--VVAIKIIDLEE-AEDEIEDIQQEIMVLSQCDSPYGTKL---------------  120 (604)
Q Consensus        59 y~i~~~LG~G~fG~Vy~a~~~~t~~--~vAVK~i~~~~-~~~~~~~l~~Ei~iL~~l~hp~~~~l---------------  120 (604)
                      |.+.++||+|+||.||+|.+..++.  .||||.+.... .....+.+.+|+.+++.++|+++.++               
T Consensus         1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   80 (272)
T cd05075           1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS   80 (272)
T ss_pred             CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence            3567899999999999999887765  69999986542 23446788899999999999986653               


Q ss_pred             -EEEEEecCCCChhhHhhc-------CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccc
Q psy1546         121 -WIIMEYLGGGSALDLMKA-------GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAG  192 (604)
Q Consensus       121 -yLVmEy~~ggsL~~~l~~-------~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~  192 (604)
                       ++||||+.+|+|.+++..       ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus        81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~  160 (272)
T cd05075          81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSK  160 (272)
T ss_pred             cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCCccc
Confidence             589999999999987732       347899999999999999999999999999999999999999999999999997


Q ss_pred             cccCCCCC--CcccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHhhhcCCCCCCCCCccch
Q psy1546         193 TLTNTTSK--RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAK-GEPPNSELHPMRVLFLIPKNNPPQLTGNYT  269 (604)
Q Consensus       193 ~~~~~~~~--~~~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s  269 (604)
                      .+......  .....+++.|+|||++.+..++.++|||||||++|||++ |..||...........+........+..++
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (272)
T cd05075         161 KIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRLKQPPDCL  240 (272)
T ss_pred             ccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCC
Confidence            65432211  122346778999999999999999999999999999999 899998877766666665555555566788


Q ss_pred             HHHHHHHHHHhccCCCCCCCHHHHhcC
Q psy1546         270 KQFKEFVEACLNKDPENRPTAKELLKF  296 (604)
Q Consensus       270 ~~l~~Li~~~L~~dP~~RpT~~elL~h  296 (604)
                      ..+.++|.+||..||++|||+.+|+++
T Consensus       241 ~~~~~li~~~l~~~p~~Rps~~~l~~~  267 (272)
T cd05075         241 DGLYSLMSSCWLLNPKDRPSFETLRCE  267 (272)
T ss_pred             HHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=5.5e-39  Score=344.83  Aligned_cols=238  Identities=25%  Similarity=0.425  Sum_probs=195.7

Q ss_pred             cceeeeEEcccCcEEEEEEEECCC-----CcEEEEEEecchhhHHHHHHHHHHHHHHhhC-CCCCCCe----------EE
Q psy1546          58 IFTKQERIGKGSFGEVFKGIDNRT-----QQVVAIKIIDLEEAEDEIEDIQQEIMVLSQC-DSPYGTK----------LW  121 (604)
Q Consensus        58 ~y~i~~~LG~G~fG~Vy~a~~~~t-----~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l-~hp~~~~----------ly  121 (604)
                      .|.+.+.||+|+||.||+|.+..+     +..||||++...........+.+|+.+++.+ .|+|+++          +|
T Consensus        39 ~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~~~  118 (374)
T cd05106          39 NLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGPVL  118 (374)
T ss_pred             HceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCCeE
Confidence            489999999999999999986443     3579999997665555567788999999999 8998665          47


Q ss_pred             EEEEecCCCChhhHhhc---------------------------------------------------------------
Q psy1546         122 IIMEYLGGGSALDLMKA---------------------------------------------------------------  138 (604)
Q Consensus       122 LVmEy~~ggsL~~~l~~---------------------------------------------------------------  138 (604)
                      +|||||.+|+|.+++..                                                               
T Consensus       119 lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  198 (374)
T cd05106         119 VITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDSK  198 (374)
T ss_pred             EeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccccccc
Confidence            99999999999998743                                                               


Q ss_pred             --------CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCC--CCcccccCC
Q psy1546         139 --------GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTS--KRNTFVGTP  208 (604)
Q Consensus       139 --------~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~--~~~~~~GT~  208 (604)
                              ..+++..++.++.||+.||.|||++||+||||||+|||+++++.+||+|||+++.+.....  ......+++
T Consensus       199 ~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~  278 (374)
T cd05106         199 DEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLPV  278 (374)
T ss_pred             chhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCCCCcc
Confidence                    1367788999999999999999999999999999999999999999999999976543221  112234567


Q ss_pred             CCCChHHhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHhh-hcCCCCCCCCCccchHHHHHHHHHHhccCCCC
Q psy1546         209 FWMAPEVIKQSAYDSKADIWSLGITAIELAK-GEPPNSELHPMRVLF-LIPKNNPPQLTGNYTKQFKEFVEACLNKDPEN  286 (604)
Q Consensus       209 ~Y~APE~l~~~~~~~~sDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~-~i~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~  286 (604)
                      .|||||++.+..++.++|||||||++|+|++ |..||.......... .+........+..++.++.++|.+||+.||.+
T Consensus       279 ~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~  358 (374)
T cd05106         279 KWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMSRPDFAPPEIYSIMKMCWNLEPTE  358 (374)
T ss_pred             ceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCccCCCCCCHHHHHHHHHHcCCChhh
Confidence            8999999999999999999999999999997 999998765443322 22223333445567899999999999999999


Q ss_pred             CCCHHHHhc
Q psy1546         287 RPTAKELLK  295 (604)
Q Consensus       287 RpT~~elL~  295 (604)
                      |||+.+|++
T Consensus       359 RPs~~~l~~  367 (374)
T cd05106         359 RPTFSQISQ  367 (374)
T ss_pred             CcCHHHHHH
Confidence            999999976

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=1.3e-38  Score=327.10  Aligned_cols=248  Identities=50%  Similarity=0.887  Sum_probs=211.9

Q ss_pred             ccccceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCCe----------EEEEE
Q psy1546          55 PELIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTK----------LWIIM  124 (604)
Q Consensus        55 ~~~~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~~----------lyLVm  124 (604)
                      ....|.+.+.||+|+||.||+|.+..++..||+|++.....  ....+.+|+.+++.++|++..+          +|+|+
T Consensus        17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   94 (286)
T cd06614          17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ--NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVM   94 (286)
T ss_pred             ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch--hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEE
Confidence            34458888999999999999999998999999999976543  4567889999999999998544          57999


Q ss_pred             EecCCCChhhHhhcC--CCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCCCCc
Q psy1546         125 EYLGGGSALDLMKAG--NFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRN  202 (604)
Q Consensus       125 Ey~~ggsL~~~l~~~--~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~~~  202 (604)
                      ||+++++|.+++...  .+++..+..++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++...........
T Consensus        95 e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~  174 (286)
T cd06614          95 EYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRN  174 (286)
T ss_pred             eccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhccchhhhc
Confidence            999999999999875  799999999999999999999999999999999999999999999999999866554433444


Q ss_pred             ccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCCCCCCC--CccchHHHHHHHHHHh
Q psy1546         203 TFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQL--TGNYTKQFKEFVEACL  280 (604)
Q Consensus       203 ~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~--~~~~s~~l~~Li~~~L  280 (604)
                      ...++..|+|||++.+..++.++|||||||++|+|++|..||...........+........  ...++..+.+||.+||
T Consensus       175 ~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l  254 (286)
T cd06614         175 SVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKWSPEFKDFLNKCL  254 (286)
T ss_pred             cccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCcchhhCCHHHHHHHHHHh
Confidence            56688999999999988899999999999999999999999988776655544433332222  2237889999999999


Q ss_pred             ccCCCCCCCHHHHhcChhhhhhhh
Q psy1546         281 NKDPENRPTAKELLKFPFIRKAKK  304 (604)
Q Consensus       281 ~~dP~~RpT~~elL~hp~f~~~~~  304 (604)
                      +.+|.+|||+.+++.|+||.+.-.
T Consensus       255 ~~~p~~Rpt~~~il~~~~~~~~~~  278 (286)
T cd06614         255 VKDPEKRPSAEELLQHPFLKKACP  278 (286)
T ss_pred             ccChhhCcCHHHHhhChHhhccCc
Confidence            999999999999999999987443

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=1.3e-38  Score=320.38  Aligned_cols=233  Identities=27%  Similarity=0.450  Sum_probs=197.0

Q ss_pred             eEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCCeE----------EEEEEecCCCCh
Q psy1546          63 ERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTKL----------WIIMEYLGGGSA  132 (604)
Q Consensus        63 ~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~~l----------yLVmEy~~ggsL  132 (604)
                      ++||+|+||.||+|.+..+++.||+|.+...........+.+|+.+++.+.|+++.++          |+||||+.+++|
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF   80 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence            3699999999999999999999999998655444455778899999999999996654          699999999999


Q ss_pred             hhHhhc--CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCCCC--cccccCC
Q psy1546         133 LDLMKA--GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKR--NTFVGTP  208 (604)
Q Consensus       133 ~~~l~~--~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~~--~~~~GT~  208 (604)
                      .+++..  ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..........  ....++.
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~  160 (252)
T cd05084          81 LTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPV  160 (252)
T ss_pred             HHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcccccccccccCCCCCCce
Confidence            999864  358999999999999999999999999999999999999999999999999986543221110  1112345


Q ss_pred             CCCChHHhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHhhhcCCCCCCCCCccchHHHHHHHHHHhccCCCCC
Q psy1546         209 FWMAPEVIKQSAYDSKADIWSLGITAIELAK-GEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPENR  287 (604)
Q Consensus       209 ~Y~APE~l~~~~~~~~sDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R  287 (604)
                      .|+|||.+.+..++.++|||||||++|+|++ |..||...........+........+..++..+.+|+.+||..+|++|
T Consensus       161 ~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R  240 (252)
T cd05084         161 KWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRLPCPELCPDAVYRLMERCWEYDPGQR  240 (252)
T ss_pred             eecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCcccCCHHHHHHHHHHcCCChhhC
Confidence            6999999998889999999999999999997 999998777666655555555555667788999999999999999999


Q ss_pred             CCHHHHhc
Q psy1546         288 PTAKELLK  295 (604)
Q Consensus       288 pT~~elL~  295 (604)
                      ||+.+|++
T Consensus       241 ps~~~~~~  248 (252)
T cd05084         241 PSFSTVHQ  248 (252)
T ss_pred             cCHHHHHH
Confidence            99999975

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=8.6e-39  Score=332.62  Aligned_cols=244  Identities=28%  Similarity=0.462  Sum_probs=198.5

Q ss_pred             cceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHH-HHHHHHHHHHHHhhCCCCCCC------------eEEEEE
Q psy1546          58 IFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAED-EIEDIQQEIMVLSQCDSPYGT------------KLWIIM  124 (604)
Q Consensus        58 ~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~-~~~~l~~Ei~iL~~l~hp~~~------------~lyLVm  124 (604)
                      .|.+.+.||+|+||.||+|.+..+++.||+|++....... ....+.+|+.++++++|+++.            .+|+||
T Consensus         8 ~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~   87 (309)
T cd07845           8 EFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLVM   87 (309)
T ss_pred             ceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEEEE
Confidence            3899999999999999999999999999999986543222 123456799999999999843            358999


Q ss_pred             EecCCCChhhHhhc--CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCCCCc
Q psy1546         125 EYLGGGSALDLMKA--GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRN  202 (604)
Q Consensus       125 Ey~~ggsL~~~l~~--~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~~~  202 (604)
                      ||+.+ +|.+++..  ..+++..+..++.||+.||.|||+.|++||||||+|||++.++.+||+|||++..+........
T Consensus        88 e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~~~~~  166 (309)
T cd07845          88 EYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMT  166 (309)
T ss_pred             ecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeecCCccCCCC
Confidence            99964 78877754  5689999999999999999999999999999999999999999999999999977654433333


Q ss_pred             ccccCCCCCChHHhhc-CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCCC------------------C--
Q psy1546         203 TFVGTPFWMAPEVIKQ-SAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNN------------------P--  261 (604)
Q Consensus       203 ~~~GT~~Y~APE~l~~-~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~~------------------~--  261 (604)
                      ...+++.|+|||++.+ ..++.++|||||||++|+|++|.+||...+.......+....                  .  
T Consensus       167 ~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (309)
T cd07845         167 PKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVGKFT  246 (309)
T ss_pred             cccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhccccccccc
Confidence            4456888999999875 457899999999999999999999998776654433221100                  0  


Q ss_pred             -C--------CCCccchHHHHHHHHHHhccCCCCCCCHHHHhcChhhhhh
Q psy1546         262 -P--------QLTGNYTKQFKEFVEACLNKDPENRPTAKELLKFPFIRKA  302 (604)
Q Consensus       262 -~--------~~~~~~s~~l~~Li~~~L~~dP~~RpT~~elL~hp~f~~~  302 (604)
                       .        .....+++.+.+||.+||..||++|||+.+++.||||++.
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~  296 (309)
T cd07845         247 LPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEK  296 (309)
T ss_pred             ccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccC
Confidence             0        0012357889999999999999999999999999999754

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=1.7e-38  Score=324.78  Aligned_cols=246  Identities=34%  Similarity=0.592  Sum_probs=196.4

Q ss_pred             cceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHH-HhhCCCCCCCe----------EEEEEEe
Q psy1546          58 IFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMV-LSQCDSPYGTK----------LWIIMEY  126 (604)
Q Consensus        58 ~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~i-L~~l~hp~~~~----------lyLVmEy  126 (604)
                      .|.+.+.||+|+||.||+|.+..+++.||||++...........+..|+.+ ++.+.||++.+          +|+||||
T Consensus         2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~   81 (283)
T cd06617           2 DLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICMEV   81 (283)
T ss_pred             CceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhhh
Confidence            388999999999999999999999999999998765433333445555554 67788998654          5799999


Q ss_pred             cCCCChhhHhhc-----CCCcHHHHHHHHHHHHHHhHHhhhC-CccccccccceeEecCCCCeEEecccccccccCCCCC
Q psy1546         127 LGGGSALDLMKA-----GNFEEMHIAVILREVLKGLDYLHSE-RKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSK  200 (604)
Q Consensus       127 ~~ggsL~~~l~~-----~~lse~~i~~i~~qIl~gL~yLHs~-gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~  200 (604)
                      ++ |+|.+++..     ..+++..++.++.||+.||.|||++ +++||||||+|||++.++.+||+|||++..+.... .
T Consensus        82 ~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~-~  159 (283)
T cd06617          82 MD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSV-A  159 (283)
T ss_pred             hc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeeccccccccccc-c
Confidence            96 667766643     3689999999999999999999998 99999999999999999999999999997654322 2


Q ss_pred             CcccccCCCCCChHHhhc----CCCCCcchhhhHHHHHHHHHhCCCCCCCCC-hhhHhhhcCCCCCCCC-CccchHHHHH
Q psy1546         201 RNTFVGTPFWMAPEVIKQ----SAYDSKADIWSLGITAIELAKGEPPNSELH-PMRVLFLIPKNNPPQL-TGNYTKQFKE  274 (604)
Q Consensus       201 ~~~~~GT~~Y~APE~l~~----~~~~~~sDVwSLGviL~eLltG~~Pf~~~~-~~~~~~~i~~~~~~~~-~~~~s~~l~~  274 (604)
                      .....|+..|+|||++.+    ..++.++|+|||||++|+|++|..||.... ..+....+.....+.+ ...++.++.+
T Consensus       160 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  239 (283)
T cd06617         160 KTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQLPAEKFSPEFQD  239 (283)
T ss_pred             cccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCCCCCCccccCHHHHH
Confidence            233568999999999865    456889999999999999999999997532 2222222222222222 2457899999


Q ss_pred             HHHHHhccCCCCCCCHHHHhcChhhhhhhhh
Q psy1546         275 FVEACLNKDPENRPTAKELLKFPFIRKAKKN  305 (604)
Q Consensus       275 Li~~~L~~dP~~RpT~~elL~hp~f~~~~~~  305 (604)
                      ||.+||..+|.+||++.+|+.||||.+....
T Consensus       240 li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~  270 (283)
T cd06617         240 FVNKCLKKNYKERPNYPELLQHPFFELHLSK  270 (283)
T ss_pred             HHHHHccCChhhCcCHHHHhcCchhhhcccc
Confidence            9999999999999999999999999876543

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>KOG0612|consensus

Probab=100.00  E-value=1.5e-39  Score=366.94  Aligned_cols=246  Identities=30%  Similarity=0.461  Sum_probs=210.6

Q ss_pred             cceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhH--HHHHHHHHHHHHHhhCCCCC----------CCeEEEEEE
Q psy1546          58 IFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAE--DEIEDIQQEIMVLSQCDSPY----------GTKLWIIME  125 (604)
Q Consensus        58 ~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~--~~~~~l~~Ei~iL~~l~hp~----------~~~lyLVmE  125 (604)
                      .|.++++||+|+||.|.+++++.|++.||+|++.+...-  .+...|..|-.||...+.+.          ...+|+|||
T Consensus        76 DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYlVMd  155 (1317)
T KOG0612|consen   76 DFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYLVMD  155 (1317)
T ss_pred             hhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEEEEe
Confidence            399999999999999999999999999999999764322  23456778888887766543          567899999


Q ss_pred             ecCCCChhhHhhc-CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEeccccccccc-CCCCCCcc
Q psy1546         126 YLGGGSALDLMKA-GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLT-NTTSKRNT  203 (604)
Q Consensus       126 y~~ggsL~~~l~~-~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~-~~~~~~~~  203 (604)
                      |++||+|..+|.+ +++++..+++|+..|+.||.-||+.|+|||||||+||||+..|+|||+|||.|-.+. ++.-....
T Consensus       156 Y~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~dG~V~s~~  235 (1317)
T KOG0612|consen  156 YMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDADGTVRSSV  235 (1317)
T ss_pred             cccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHHhcCCCCcEEecc
Confidence            9999999999966 569999999999999999999999999999999999999999999999999997766 34445567


Q ss_pred             cccCCCCCChHHhh----c-CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCCC-CCCCC--ccchHHHHHH
Q psy1546         204 FVGTPFWMAPEVIK----Q-SAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNN-PPQLT--GNYTKQFKEF  275 (604)
Q Consensus       204 ~~GT~~Y~APE~l~----~-~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~~-~~~~~--~~~s~~l~~L  275 (604)
                      .+|||.|.+||++.    + +.|+..+|+|||||++|||+.|..||+...-.+.+..|.... ...+|  ..+++++++|
T Consensus       236 aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~FP~~~~VSeeakdL  315 (1317)
T KOG0612|consen  236 AVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLSFPDETDVSEEAKDL  315 (1317)
T ss_pred             ccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcCCCcccccCHHHHHH
Confidence            79999999999995    3 569999999999999999999999999988888877776542 22333  4589999999


Q ss_pred             HHHHhccCCCCCCC---HHHHhcChhhhhhhh
Q psy1546         276 VEACLNKDPENRPT---AKELLKFPFIRKAKK  304 (604)
Q Consensus       276 i~~~L~~dP~~RpT---~~elL~hp~f~~~~~  304 (604)
                      |.+++. +|..|..   ++++-.||||....|
T Consensus       316 I~~ll~-~~e~RLgrngiedik~HpFF~g~~W  346 (1317)
T KOG0612|consen  316 IEALLC-DREVRLGRNGIEDIKNHPFFEGIDW  346 (1317)
T ss_pred             HHHHhc-ChhhhcccccHHHHHhCccccCCCh
Confidence            999775 6888888   999999999987655

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=8e-39  Score=333.19  Aligned_cols=234  Identities=25%  Similarity=0.431  Sum_probs=180.9

Q ss_pred             eeEEcccCcEEEEEEEECC--CCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCCe------------EEEEEEec
Q psy1546          62 QERIGKGSFGEVFKGIDNR--TQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTK------------LWIIMEYL  127 (604)
Q Consensus        62 ~~~LG~G~fG~Vy~a~~~~--t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~~------------lyLVmEy~  127 (604)
                      ..+||+|+||.||+|.+..  ++..||+|.+.....   ...+.+|+.+++.+.||++.+            +|+||||+
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~   82 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI---SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYA   82 (317)
T ss_pred             ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCC---cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeee
Confidence            3689999999999999654  568899999865432   235678999999999998543            47999999


Q ss_pred             CCCChhhHhhc----------CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEe----cCCCCeEEeccccccc
Q psy1546         128 GGGSALDLMKA----------GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLL----SEMGDVKLADFGVAGT  193 (604)
Q Consensus       128 ~ggsL~~~l~~----------~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl----~~~g~vKL~DFGlA~~  193 (604)
                      ++ +|.+++..          ..+++..++.++.||+.||.|||++||+||||||+|||+    +.++.+||+|||+++.
T Consensus        83 ~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~  161 (317)
T cd07867          83 EH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARL  161 (317)
T ss_pred             CC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccceec
Confidence            65 67666531          247888999999999999999999999999999999999    4567899999999976


Q ss_pred             ccCCCC---CCcccccCCCCCChHHhhc-CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhh---------Hh----hhc
Q psy1546         194 LTNTTS---KRNTFVGTPFWMAPEVIKQ-SAYDSKADIWSLGITAIELAKGEPPNSELHPMR---------VL----FLI  256 (604)
Q Consensus       194 ~~~~~~---~~~~~~GT~~Y~APE~l~~-~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~---------~~----~~i  256 (604)
                      +.....   ......||+.|+|||++.+ ..++.++|||||||++|||++|.+||.......         ..    ..+
T Consensus       162 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~  241 (317)
T cd07867         162 FNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVM  241 (317)
T ss_pred             cCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHHhc
Confidence            643322   2234578999999999976 458899999999999999999999997533210         00    000


Q ss_pred             C------------------------CCC---------CCCCCccchHHHHHHHHHHhccCCCCCCCHHHHhcChhh
Q psy1546         257 P------------------------KNN---------PPQLTGNYTKQFKEFVEACLNKDPENRPTAKELLKFPFI  299 (604)
Q Consensus       257 ~------------------------~~~---------~~~~~~~~s~~l~~Li~~~L~~dP~~RpT~~elL~hp~f  299 (604)
                      .                        ...         ........+..+.+||.+||..||.+|||+.|+|+||||
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f  317 (317)
T cd07867         242 GFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF  317 (317)
T ss_pred             CCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence            0                        000         000011234568899999999999999999999999998

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=2.5e-38  Score=329.07  Aligned_cols=259  Identities=46%  Similarity=0.825  Sum_probs=213.4

Q ss_pred             CccccceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchh--hHHHHHHHHHHHHHHhhCCCCCCCe----------EE
Q psy1546          54 DPELIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE--AEDEIEDIQQEIMVLSQCDSPYGTK----------LW  121 (604)
Q Consensus        54 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~--~~~~~~~l~~Ei~iL~~l~hp~~~~----------ly  121 (604)
                      +++..|.+.+.||+|+||.||+|++..+++.||+|++....  .......+.+|+.+++.++||++.+          .|
T Consensus        12 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~   91 (307)
T cd06607          12 DPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAW   91 (307)
T ss_pred             CcchhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEE
Confidence            45566999999999999999999999999999999986432  2334467889999999999998554          47


Q ss_pred             EEEEecCCCChhhHhh--cCCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCC
Q psy1546         122 IIMEYLGGGSALDLMK--AGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTS  199 (604)
Q Consensus       122 LVmEy~~ggsL~~~l~--~~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~  199 (604)
                      +||||+. |+|.+++.  .+.+++..+..++.||+.||.|||+.||+||||+|+||+++.++.++|+|||++......  
T Consensus        92 lv~e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~--  168 (307)
T cd06607          92 LVMEYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA--  168 (307)
T ss_pred             EEHHhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecCCC--
Confidence            9999996 45666553  357899999999999999999999999999999999999999999999999998654322  


Q ss_pred             CCcccccCCCCCChHHhh---cCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCCCCCCC-CccchHHHHHH
Q psy1546         200 KRNTFVGTPFWMAPEVIK---QSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQL-TGNYTKQFKEF  275 (604)
Q Consensus       200 ~~~~~~GT~~Y~APE~l~---~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~-~~~~s~~l~~L  275 (604)
                        ....+++.|+|||++.   ...++.++||||||+++|||++|.+||...+.......+.....+.+ ...++..+.+|
T Consensus       169 --~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  246 (307)
T cd06607         169 --NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLSSNDWSDYFRNF  246 (307)
T ss_pred             --CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCchhhCHHHHHH
Confidence              2457889999999874   45688899999999999999999999988776665554444333332 34578899999


Q ss_pred             HHHHhccCCCCCCCHHHHhcChhhhhhhhhhhHHHHHHHHHH
Q psy1546         276 VEACLNKDPENRPTAKELLKFPFIRKAKKNAYLIDLIDRYKK  317 (604)
Q Consensus       276 i~~~L~~dP~~RpT~~elL~hp~f~~~~~~~~l~~~~~~~~~  317 (604)
                      |.+||..||.+||++.+|+.||||........+.++..+.+.
T Consensus       247 i~~~l~~~p~~Rp~~~~il~~~~~~~~~~~~~~~~~~~~~~~  288 (307)
T cd06607         247 VDSCLQKIPQDRPSSEELLKHRFVLRERPPTVIIDLIQRTKD  288 (307)
T ss_pred             HHHHhcCChhhCcCHHHHhcChhhcccCCcHHHHHHHHHHHH
Confidence            999999999999999999999999887766666666665554

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=2.1e-38  Score=326.42  Aligned_cols=245  Identities=23%  Similarity=0.411  Sum_probs=202.0

Q ss_pred             cceeeeEEcccCcEEEEEEEECC-----CCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCCeE----------EE
Q psy1546          58 IFTKQERIGKGSFGEVFKGIDNR-----TQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTKL----------WI  122 (604)
Q Consensus        58 ~y~i~~~LG~G~fG~Vy~a~~~~-----t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~~l----------yL  122 (604)
                      .|.+.++||+|+||.||+|.++.     .+..||+|.+...........+.+|+.+++.+.|+++.++          |+
T Consensus         7 ~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l   86 (288)
T cd05061           7 KITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLV   86 (288)
T ss_pred             HceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEE
Confidence            48999999999999999997652     3558999998655444444567889999999999986554          79


Q ss_pred             EEEecCCCChhhHhhcC-----------CCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEeccccc
Q psy1546         123 IMEYLGGGSALDLMKAG-----------NFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVA  191 (604)
Q Consensus       123 VmEy~~ggsL~~~l~~~-----------~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA  191 (604)
                      ||||+.+|+|.++++..           .++...+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++
T Consensus        87 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~~L~Dfg~~  166 (288)
T cd05061          87 VMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMT  166 (288)
T ss_pred             EEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcEEECcCCcc
Confidence            99999999999998641           2355678889999999999999999999999999999999999999999999


Q ss_pred             ccccCCCCC--CcccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHhhhcCCCCCCCCCccc
Q psy1546         192 GTLTNTTSK--RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAK-GEPPNSELHPMRVLFLIPKNNPPQLTGNY  268 (604)
Q Consensus       192 ~~~~~~~~~--~~~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~  268 (604)
                      +.+......  .....++..|+|||.+.+..++.++|||||||++|||++ |..||......+....+........+..+
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~  246 (288)
T cd05061         167 RDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQPDNC  246 (288)
T ss_pred             ccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCC
Confidence            755332211  122345778999999999899999999999999999998 78999888777766655555445556677


Q ss_pred             hHHHHHHHHHHhccCCCCCCCHHHHhc------Chhhhhh
Q psy1546         269 TKQFKEFVEACLNKDPENRPTAKELLK------FPFIRKA  302 (604)
Q Consensus       269 s~~l~~Li~~~L~~dP~~RpT~~elL~------hp~f~~~  302 (604)
                      +..+.+++.+||+.||++|||+.++++      ||||+..
T Consensus       247 ~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~~  286 (288)
T cd05061         247 PERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPEV  286 (288)
T ss_pred             CHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCCC
Confidence            899999999999999999999999986      7777643

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=2.3e-38  Score=329.06  Aligned_cols=247  Identities=26%  Similarity=0.435  Sum_probs=206.8

Q ss_pred             cceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhh--HHHHHHHHHHHHHHhhCCCCCCCe----------EEEEEE
Q psy1546          58 IFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA--EDEIEDIQQEIMVLSQCDSPYGTK----------LWIIME  125 (604)
Q Consensus        58 ~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~--~~~~~~l~~Ei~iL~~l~hp~~~~----------lyLVmE  125 (604)
                      .|.+.+.||+|+||.||+|.+..+++.||||.+.....  ......+.+|+.+++.+.||++.+          +|+|||
T Consensus         2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   81 (305)
T cd05609           2 DFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVME   81 (305)
T ss_pred             CceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEe
Confidence            38889999999999999999999999999999876542  234567889999999999998554          479999


Q ss_pred             ecCCCChhhHhhc-CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCC------
Q psy1546         126 YLGGGSALDLMKA-GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTT------  198 (604)
Q Consensus       126 y~~ggsL~~~l~~-~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~------  198 (604)
                      |++|++|.++++. +.+++..+..++.|++.||.|||++||+||||||+|||++.++.++|+|||+++......      
T Consensus        82 ~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~~~~  161 (305)
T cd05609          82 YVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYE  161 (305)
T ss_pred             cCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCccccccc
Confidence            9999999999965 678999999999999999999999999999999999999999999999999986321000      


Q ss_pred             ---------CCCcccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCCC--CCCCCcc
Q psy1546         199 ---------SKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNN--PPQLTGN  267 (604)
Q Consensus       199 ---------~~~~~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~~--~~~~~~~  267 (604)
                               .......|+..|+|||.+.+..++.++|||||||++|+|++|..||.+....+....+....  .+.....
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  241 (305)
T cd05609         162 GHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEGDEA  241 (305)
T ss_pred             cccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCcccc
Confidence                     01123467889999999998889999999999999999999999998877666555543332  2222336


Q ss_pred             chHHHHHHHHHHhccCCCCCCC---HHHHhcChhhhhhhh
Q psy1546         268 YTKQFKEFVEACLNKDPENRPT---AKELLKFPFIRKAKK  304 (604)
Q Consensus       268 ~s~~l~~Li~~~L~~dP~~RpT---~~elL~hp~f~~~~~  304 (604)
                      ++.++.+||.+||..||.+||+   +.++|.||||.....
T Consensus       242 ~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~~~~  281 (305)
T cd05609         242 LPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGLDW  281 (305)
T ss_pred             CCHHHHHHHHHHhccChhhccCccCHHHHHhCccccCCCH
Confidence            7889999999999999999998   799999999976543

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=1.2e-38  Score=326.52  Aligned_cols=238  Identities=23%  Similarity=0.366  Sum_probs=203.6

Q ss_pred             ceeeeEEcccCcEEEEEEEECC-----CCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCCeE----------EEE
Q psy1546          59 FTKQERIGKGSFGEVFKGIDNR-----TQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTKL----------WII  123 (604)
Q Consensus        59 y~i~~~LG~G~fG~Vy~a~~~~-----t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~~l----------yLV  123 (604)
                      |.+.+.||+|+||.||+|.+..     .++.||||++...........+.+|+.++..++||++.++          +++
T Consensus         7 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~~   86 (283)
T cd05091           7 VRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMI   86 (283)
T ss_pred             HHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEEE
Confidence            7888999999999999998754     3578999999765444445678899999999999997654          689


Q ss_pred             EEecCCCChhhHhhc-----------------CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEe
Q psy1546         124 MEYLGGGSALDLMKA-----------------GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLA  186 (604)
Q Consensus       124 mEy~~ggsL~~~l~~-----------------~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~  186 (604)
                      +||+.+++|.+++..                 ..+++..+..++.|++.||.|||++||+||||||+|||+++++.+||+
T Consensus        87 ~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~kl~  166 (283)
T cd05091          87 FSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKIS  166 (283)
T ss_pred             EEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCCCceEec
Confidence            999999999998742                 247888899999999999999999999999999999999999999999


Q ss_pred             cccccccccCCCC--CCcccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHhhhcCCCCCCC
Q psy1546         187 DFGVAGTLTNTTS--KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAK-GEPPNSELHPMRVLFLIPKNNPPQ  263 (604)
Q Consensus       187 DFGlA~~~~~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~  263 (604)
                      |||+++.+.....  ......+++.|+|||++.+..++.++|||||||++|||++ |..||.+....+....+.......
T Consensus       167 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~~  246 (283)
T cd05091         167 DLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIRNRQVLP  246 (283)
T ss_pred             ccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcCC
Confidence            9999876543221  1233456789999999998889999999999999999998 899999888877777776666666


Q ss_pred             CCccchHHHHHHHHHHhccCCCCCCCHHHHhcC
Q psy1546         264 LTGNYTKQFKEFVEACLNKDPENRPTAKELLKF  296 (604)
Q Consensus       264 ~~~~~s~~l~~Li~~~L~~dP~~RpT~~elL~h  296 (604)
                      .+..++..+.+|+.+||+.+|.+||++.+|+..
T Consensus       247 ~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~  279 (283)
T cd05091         247 CPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSR  279 (283)
T ss_pred             CCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHH
Confidence            778899999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=2.7e-38  Score=317.29  Aligned_cols=234  Identities=30%  Similarity=0.539  Sum_probs=205.6

Q ss_pred             eEEcccCcEEEEEEEECCC---CcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCCe----------EEEEEEecCC
Q psy1546          63 ERIGKGSFGEVFKGIDNRT---QQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTK----------LWIIMEYLGG  129 (604)
Q Consensus        63 ~~LG~G~fG~Vy~a~~~~t---~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~~----------lyLVmEy~~g  129 (604)
                      +.||+|+||.||+|.+...   +..||||++...........+.+|+.+++.+.|+++.+          +|+||||+++
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG   80 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence            4699999999999998866   88999999977655545688899999999999998554          4799999999


Q ss_pred             CChhhHhhc----------CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCC-
Q psy1546         130 GSALDLMKA----------GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTT-  198 (604)
Q Consensus       130 gsL~~~l~~----------~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~-  198 (604)
                      ++|.+++..          ..+++..+..++.||+.||.|||++||+||||+|+||+++.++.++|+|||.+....... 
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~  160 (262)
T cd00192          81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDY  160 (262)
T ss_pred             CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEcccccccccccccc
Confidence            999999865          568999999999999999999999999999999999999999999999999997665432 


Q ss_pred             -CCCcccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHhhhcCCCCCCCCCccchHHHHHHH
Q psy1546         199 -SKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAK-GEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFV  276 (604)
Q Consensus       199 -~~~~~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li  276 (604)
                       .......+++.|+|||.+....++.++|||||||++|+|++ |..||...........+........+..++.++.+++
T Consensus       161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  240 (262)
T cd00192         161 YRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRLPKPEYCPDELYELM  240 (262)
T ss_pred             cccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCccCChHHHHHH
Confidence             22334567889999999998889999999999999999999 6999999887777777766666667778899999999


Q ss_pred             HHHhccCCCCCCCHHHHhcC
Q psy1546         277 EACLNKDPENRPTAKELLKF  296 (604)
Q Consensus       277 ~~~L~~dP~~RpT~~elL~h  296 (604)
                      .+||..+|.+|||+.|++++
T Consensus       241 ~~~l~~~p~~Rps~~~l~~~  260 (262)
T cd00192         241 LSCWQLDPEDRPTFSELVER  260 (262)
T ss_pred             HHHccCCcccCcCHHHHHHh
Confidence            99999999999999999875

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=3.1e-38  Score=325.05  Aligned_cols=245  Identities=39%  Similarity=0.669  Sum_probs=203.1

Q ss_pred             cceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCC------------eEEEEEE
Q psy1546          58 IFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGT------------KLWIIME  125 (604)
Q Consensus        58 ~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~------------~lyLVmE  125 (604)
                      .|...++||.|+||.||+|.+..+++.||+|++...........+.+|+.+++.++||++.            .+|+|||
T Consensus         2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e   81 (287)
T cd06621           2 KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAME   81 (287)
T ss_pred             ceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEE
Confidence            3788999999999999999999999999999997655445567789999999999999843            3579999


Q ss_pred             ecCCCChhhHhhc-----CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCCC
Q psy1546         126 YLGGGSALDLMKA-----GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSK  200 (604)
Q Consensus       126 y~~ggsL~~~l~~-----~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~  200 (604)
                      |+++++|.+++..     ..+++..+..++.||+.||.|||+.|++|+||+|.||+++.++.++|+|||++.......  
T Consensus        82 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~--  159 (287)
T cd06621          82 YCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSL--  159 (287)
T ss_pred             ecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeeccccccccccc--
Confidence            9999999887642     458999999999999999999999999999999999999999999999999986554322  


Q ss_pred             CcccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCC-----hhhHhhhcCCCCCCCCC------ccch
Q psy1546         201 RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELH-----PMRVLFLIPKNNPPQLT------GNYT  269 (604)
Q Consensus       201 ~~~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~-----~~~~~~~i~~~~~~~~~------~~~s  269 (604)
                      .....++..|+|||.+.+..++.++|||||||++|+|++|..||....     ..+....+.....+.+.      ..++
T Consensus       160 ~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (287)
T cd06621         160 AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGNGIKWS  239 (287)
T ss_pred             cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhccCCCCCCchH
Confidence            224568899999999999999999999999999999999999997652     12222222221111111      2357


Q ss_pred             HHHHHHHHHHhccCCCCCCCHHHHhcChhhhhhhh
Q psy1546         270 KQFKEFVEACLNKDPENRPTAKELLKFPFIRKAKK  304 (604)
Q Consensus       270 ~~l~~Li~~~L~~dP~~RpT~~elL~hp~f~~~~~  304 (604)
                      +.+.+||.+||..+|.+|||+.|+++||||+....
T Consensus       240 ~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~~  274 (287)
T cd06621         240 EEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQMK  274 (287)
T ss_pred             HHHHHHHHHHcCCCcccCCCHHHHHhCcccccccc
Confidence            88999999999999999999999999999966544

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.4e-38  Score=315.94  Aligned_cols=241  Identities=47%  Similarity=0.799  Sum_probs=211.8

Q ss_pred             ceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhh-HHHHHHHHHHHHHHhhCCCCCCCe----------EEEEEEec
Q psy1546          59 FTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA-EDEIEDIQQEIMVLSQCDSPYGTK----------LWIIMEYL  127 (604)
Q Consensus        59 y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~-~~~~~~l~~Ei~iL~~l~hp~~~~----------lyLVmEy~  127 (604)
                      |.+.+.||+|+||.||+|.+..+++.||+|.+..... ......+.+|+.++.++.|++..+          +|+||||+
T Consensus         2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   81 (254)
T cd06627           2 YQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYA   81 (254)
T ss_pred             ceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEecC
Confidence            7888999999999999999999999999999866543 234578899999999999998544          47999999


Q ss_pred             CCCChhhHhhc-CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCCCCccccc
Q psy1546         128 GGGSALDLMKA-GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVG  206 (604)
Q Consensus       128 ~ggsL~~~l~~-~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~~~~~~G  206 (604)
                      ++++|.+++.. +.+++..+..++.|++.||.|||++||+||||+|+||+++.++.++|+|||++..............+
T Consensus        82 ~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~  161 (254)
T cd06627          82 ENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVVG  161 (254)
T ss_pred             CCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCccccccccc
Confidence            99999998865 67999999999999999999999999999999999999999999999999999776654444455678


Q ss_pred             CCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCCCCCCCCccchHHHHHHHHHHhccCCCC
Q psy1546         207 TPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPEN  286 (604)
Q Consensus       207 T~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~  286 (604)
                      +..|+|||.+.+..++.++|||+||+++|+|++|..||...................++..++..+.+++.+||..+|++
T Consensus       162 ~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~  241 (254)
T cd06627         162 TPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHPPLPEGISPELKDFLMQCFQKDPNL  241 (254)
T ss_pred             chhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccCCCCCCCCCCHHHHHHHHHHHhCChhh
Confidence            99999999998888899999999999999999999999877766555554445555667788999999999999999999


Q ss_pred             CCCHHHHhcChhh
Q psy1546         287 RPTAKELLKFPFI  299 (604)
Q Consensus       287 RpT~~elL~hp~f  299 (604)
                      |||+.+++.||||
T Consensus       242 R~~~~~~l~~~~~  254 (254)
T cd06627         242 RPTAKQLLKHPWI  254 (254)
T ss_pred             CcCHHHHhcCCCC
Confidence            9999999999997

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=2.8e-38  Score=320.89  Aligned_cols=239  Identities=27%  Similarity=0.444  Sum_probs=203.3

Q ss_pred             cceeeeEEcccCcEEEEEEEECCC---CcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCCeE----------EEEE
Q psy1546          58 IFTKQERIGKGSFGEVFKGIDNRT---QQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTKL----------WIIM  124 (604)
Q Consensus        58 ~y~i~~~LG~G~fG~Vy~a~~~~t---~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~~l----------yLVm  124 (604)
                      .|++.+.||+|+||.||+|.+..+   ...||||++...........+.+|+.+++.++|+++.++          |+||
T Consensus         5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~   84 (266)
T cd05033           5 YVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMIIT   84 (266)
T ss_pred             HceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEEE
Confidence            488999999999999999998654   458999998765555556778899999999999986554          7999


Q ss_pred             EecCCCChhhHhhc--CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCCC--
Q psy1546         125 EYLGGGSALDLMKA--GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSK--  200 (604)
Q Consensus       125 Ey~~ggsL~~~l~~--~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~--  200 (604)
                      ||+++++|.+++..  +.+++..+..++.|++.||.|||++||+||||||+|||++.++.++|+|||++..+......  
T Consensus        85 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~  164 (266)
T cd05033          85 EYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYT  164 (266)
T ss_pred             EcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhccccccccee
Confidence            99999999999865  57899999999999999999999999999999999999999999999999999776422221  


Q ss_pred             CcccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHhhhcCCCCCCCCCccchHHHHHHHHHH
Q psy1546         201 RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAK-GEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEAC  279 (604)
Q Consensus       201 ~~~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~~  279 (604)
                      .....+++.|+|||.+.+..++.++||||||+++|+|++ |..||...........+........+..++..+.+|+.+|
T Consensus       165 ~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c  244 (266)
T cd05033         165 TKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRLPPPMDCPSALYQLMLDC  244 (266)
T ss_pred             ccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHH
Confidence            112335678999999999999999999999999999998 9999987777666666655544455667899999999999


Q ss_pred             hccCCCCCCCHHHHhcC
Q psy1546         280 LNKDPENRPTAKELLKF  296 (604)
Q Consensus       280 L~~dP~~RpT~~elL~h  296 (604)
                      |+.+|++||++.||+++
T Consensus       245 l~~~p~~Rp~~~ei~~~  261 (266)
T cd05033         245 WQKDRNERPTFSQIVST  261 (266)
T ss_pred             cCCCcccCcCHHHHHHH
Confidence            99999999999999874

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=1.3e-38  Score=326.22  Aligned_cols=242  Identities=30%  Similarity=0.485  Sum_probs=198.8

Q ss_pred             cceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhH-HHHHHHHHHHHHHhhCCCCCCC----------eEEEEEEe
Q psy1546          58 IFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAE-DEIEDIQQEIMVLSQCDSPYGT----------KLWIIMEY  126 (604)
Q Consensus        58 ~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~-~~~~~l~~Ei~iL~~l~hp~~~----------~lyLVmEy  126 (604)
                      .|++.++||+|+||.||+|.+..+++.||+|++...... ...+.+.+|+.+++.++||++.          .+|+||||
T Consensus         2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   81 (286)
T cd07846           2 KYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEF   81 (286)
T ss_pred             ceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEec
Confidence            488999999999999999999999999999998654322 2345678899999999999843          46899999


Q ss_pred             cCCCChhhHhhc-CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCCCCcccc
Q psy1546         127 LGGGSALDLMKA-GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFV  205 (604)
Q Consensus       127 ~~ggsL~~~l~~-~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~~~~~~  205 (604)
                      +++++|..+... +.+++..++.++.||+.||.|||+.||+||||+|+||+++.++.++|+|||++..+...........
T Consensus        82 ~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~  161 (286)
T cd07846          82 VDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYV  161 (286)
T ss_pred             CCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCccccCccc
Confidence            999999888754 4689999999999999999999999999999999999999999999999999976654444444567


Q ss_pred             cCCCCCChHHhhc-CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCC---------------------CCC--
Q psy1546         206 GTPFWMAPEVIKQ-SAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPK---------------------NNP--  261 (604)
Q Consensus       206 GT~~Y~APE~l~~-~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~---------------------~~~--  261 (604)
                      ++..|+|||++.+ ..++.++|||||||++|||++|.+||......+....+..                     ...  
T Consensus       162 ~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (286)
T cd07846         162 ATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRLPE  241 (286)
T ss_pred             ceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhcccccc
Confidence            8999999999875 3477889999999999999999999976554322111100                     000  


Q ss_pred             -------CCCCccchHHHHHHHHHHhccCCCCCCCHHHHhcChhh
Q psy1546         262 -------PQLTGNYTKQFKEFVEACLNKDPENRPTAKELLKFPFI  299 (604)
Q Consensus       262 -------~~~~~~~s~~l~~Li~~~L~~dP~~RpT~~elL~hp~f  299 (604)
                             ......++..+.+|+.+||..+|.+||++.++++||||
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~  286 (286)
T cd07846         242 VKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF  286 (286)
T ss_pred             ccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence                   01123567889999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=2e-38  Score=324.26  Aligned_cols=239  Identities=24%  Similarity=0.421  Sum_probs=199.9

Q ss_pred             cceeeeEEcccCcEEEEEEEEC-----CCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCCe----------EEE
Q psy1546          58 IFTKQERIGKGSFGEVFKGIDN-----RTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTK----------LWI  122 (604)
Q Consensus        58 ~y~i~~~LG~G~fG~Vy~a~~~-----~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~~----------lyL  122 (604)
                      .|++.+.||+|+||.||+|.+.     .++..||||++...........+.+|+.+++.+.|+++.+          +|+
T Consensus         7 ~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~l   86 (277)
T cd05062           7 KITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLV   86 (277)
T ss_pred             HceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCeEE
Confidence            4899999999999999999864     2456799999865444444566889999999999998654          479


Q ss_pred             EEEecCCCChhhHhhcC-----------CCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEeccccc
Q psy1546         123 IMEYLGGGSALDLMKAG-----------NFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVA  191 (604)
Q Consensus       123 VmEy~~ggsL~~~l~~~-----------~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA  191 (604)
                      ||||+++++|.+++...           .++...+..++.|++.||.|||+.|++||||||+|||++.++.++|+|||++
T Consensus        87 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~~l~dfg~~  166 (277)
T cd05062          87 IMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMT  166 (277)
T ss_pred             EEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCEEECCCCCc
Confidence            99999999999998642           2466788899999999999999999999999999999999999999999998


Q ss_pred             ccccCCCCC--CcccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHhhhcCCCCCCCCCccc
Q psy1546         192 GTLTNTTSK--RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAK-GEPPNSELHPMRVLFLIPKNNPPQLTGNY  268 (604)
Q Consensus       192 ~~~~~~~~~--~~~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~  268 (604)
                      +.+......  .....+++.|||||++.+..++.++|||||||++|||++ |..||.+.........+........+..+
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~  246 (277)
T cd05062         167 RDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEGGLLDKPDNC  246 (277)
T ss_pred             cccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcCCCCCCC
Confidence            755432221  122345788999999999899999999999999999998 78999888777766655555555566778


Q ss_pred             hHHHHHHHHHHhccCCCCCCCHHHHhcC
Q psy1546         269 TKQFKEFVEACLNKDPENRPTAKELLKF  296 (604)
Q Consensus       269 s~~l~~Li~~~L~~dP~~RpT~~elL~h  296 (604)
                      +..+.+|+.+||..||.+|||+.|++++
T Consensus       247 ~~~~~~li~~~l~~~p~~Rps~~e~l~~  274 (277)
T cd05062         247 PDMLFELMRMCWQYNPKMRPSFLEIISS  274 (277)
T ss_pred             CHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            8999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=2e-38  Score=324.50  Aligned_cols=239  Identities=26%  Similarity=0.451  Sum_probs=201.8

Q ss_pred             cceeeeEEcccCcEEEEEEEECC-----CCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCCeE----------EE
Q psy1546          58 IFTKQERIGKGSFGEVFKGIDNR-----TQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTKL----------WI  122 (604)
Q Consensus        58 ~y~i~~~LG~G~fG~Vy~a~~~~-----t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~~l----------yL  122 (604)
                      .|.+.+.||+|+||.||+|.+..     ++..||+|.+...........+.+|+.+++.++|+++.++          |+
T Consensus         7 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l   86 (277)
T cd05036           7 SITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPRFI   86 (277)
T ss_pred             HcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCcEE
Confidence            38899999999999999999887     7789999998755444445678899999999999986554          69


Q ss_pred             EEEecCCCChhhHhhcC--------CCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCC---CeEEeccccc
Q psy1546         123 IMEYLGGGSALDLMKAG--------NFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMG---DVKLADFGVA  191 (604)
Q Consensus       123 VmEy~~ggsL~~~l~~~--------~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g---~vKL~DFGlA  191 (604)
                      ||||+.+++|.+++...        .+++..+..++.||+.||.|||+++++||||||+|||++.++   .+||+|||++
T Consensus        87 v~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~dfg~~  166 (277)
T cd05036          87 LLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMA  166 (277)
T ss_pred             EEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEeccCccc
Confidence            99999999999998653        488899999999999999999999999999999999998755   5999999999


Q ss_pred             ccccCCCCC--CcccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHhhhcCCCCCCCCCccc
Q psy1546         192 GTLTNTTSK--RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAK-GEPPNSELHPMRVLFLIPKNNPPQLTGNY  268 (604)
Q Consensus       192 ~~~~~~~~~--~~~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~  268 (604)
                      +.+......  ......+..|+|||++.+..++.++|||||||++|+|++ |..||...........+........+..+
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  246 (277)
T cd05036         167 RDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGGGRLDPPKGC  246 (277)
T ss_pred             cccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcCCCCCCC
Confidence            766322211  112234567999999999999999999999999999997 99999988777666666555555566778


Q ss_pred             hHHHHHHHHHHhccCCCCCCCHHHHhcC
Q psy1546         269 TKQFKEFVEACLNKDPENRPTAKELLKF  296 (604)
Q Consensus       269 s~~l~~Li~~~L~~dP~~RpT~~elL~h  296 (604)
                      +..+.+|+.+||..+|++||++.+|++|
T Consensus       247 ~~~~~~~i~~cl~~~p~~Rps~~~vl~~  274 (277)
T cd05036         247 PGPVYRIMTDCWQHTPEDRPNFATILER  274 (277)
T ss_pred             CHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            8999999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=3e-38  Score=321.00  Aligned_cols=238  Identities=36%  Similarity=0.613  Sum_probs=196.7

Q ss_pred             eeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCCe----------EEEEEEecCCC
Q psy1546          61 KQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTK----------LWIIMEYLGGG  130 (604)
Q Consensus        61 i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~~----------lyLVmEy~~gg  130 (604)
                      ....||+|+||.||+|.+..++..||+|.+..... ...+.+.+|+.+++.++|+++.+          +|+||||++++
T Consensus        12 ~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~   90 (268)
T cd06624          12 ERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDS-RYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGG   90 (268)
T ss_pred             ceEEEecCCceEEEEeEecCCCcEEEEEEecCCCH-HHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecCCCC
Confidence            34579999999999999999999999999865442 34567889999999999998544          47999999999


Q ss_pred             ChhhHhhc--CCC--cHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecC-CCCeEEecccccccccCCCCCCcccc
Q psy1546         131 SALDLMKA--GNF--EEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSE-MGDVKLADFGVAGTLTNTTSKRNTFV  205 (604)
Q Consensus       131 sL~~~l~~--~~l--se~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~-~g~vKL~DFGlA~~~~~~~~~~~~~~  205 (604)
                      +|.+++..  +.+  ++..+..++.||+.||.|||++||+||||||+|||++. ++.++|+|||++..+...........
T Consensus        91 ~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~  170 (268)
T cd06624          91 SLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFT  170 (268)
T ss_pred             CHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheecccCCCccccCC
Confidence            99999875  345  78888999999999999999999999999999999976 67899999999976543333333456


Q ss_pred             cCCCCCChHHhhcCC--CCCcchhhhHHHHHHHHHhCCCCCCCCChhhH-hhhc-CCCCCCCCCccchHHHHHHHHHHhc
Q psy1546         206 GTPFWMAPEVIKQSA--YDSKADIWSLGITAIELAKGEPPNSELHPMRV-LFLI-PKNNPPQLTGNYTKQFKEFVEACLN  281 (604)
Q Consensus       206 GT~~Y~APE~l~~~~--~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~-~~~i-~~~~~~~~~~~~s~~l~~Li~~~L~  281 (604)
                      |++.|+|||++.+..  ++.++||||||+++|+|++|..||........ .... .....+.++..+++++.+|+.+||.
T Consensus       171 ~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~  250 (268)
T cd06624         171 GTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESLSAEAKNFILRCFE  250 (268)
T ss_pred             CCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhccCCCCCcccCHHHHHHHHHHcC
Confidence            899999999986644  78899999999999999999999976543221 1111 1222344566788999999999999


Q ss_pred             cCCCCCCCHHHHhcChhh
Q psy1546         282 KDPENRPTAKELLKFPFI  299 (604)
Q Consensus       282 ~dP~~RpT~~elL~hp~f  299 (604)
                      .+|.+|||+.|++.||||
T Consensus       251 ~~p~~Rpt~~~ll~~~~~  268 (268)
T cd06624         251 PDPDKRASAHDLLQDPFL  268 (268)
T ss_pred             CCchhCCCHHHHHhCCCC
Confidence            999999999999999997

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=1.4e-38  Score=325.62  Aligned_cols=240  Identities=29%  Similarity=0.523  Sum_probs=198.0

Q ss_pred             ceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhh-HHHHHHHHHHHHHHhhCCCCCCCe----------EEEEEEec
Q psy1546          59 FTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA-EDEIEDIQQEIMVLSQCDSPYGTK----------LWIIMEYL  127 (604)
Q Consensus        59 y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~-~~~~~~l~~Ei~iL~~l~hp~~~~----------lyLVmEy~  127 (604)
                      |.+.+.||.|+||.||+|.+..+++.||||++..... ......+.+|+.+++.+.|+++.+          +|+||||+
T Consensus         2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~   81 (286)
T cd07832           2 YKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEYM   81 (286)
T ss_pred             ceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEeccc
Confidence            7889999999999999999999999999999876543 233567889999999999998543          47999999


Q ss_pred             CCCChhhHhhc--CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCC-CCccc
Q psy1546         128 GGGSALDLMKA--GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTS-KRNTF  204 (604)
Q Consensus       128 ~ggsL~~~l~~--~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~-~~~~~  204 (604)
                       +++|.+++..  ..+++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||++........ .....
T Consensus        82 -~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~  160 (286)
T cd07832          82 -PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQ  160 (286)
T ss_pred             -CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCCccccc
Confidence             9999998854  5689999999999999999999999999999999999999999999999999976643321 23345


Q ss_pred             ccCCCCCChHHhhcC-CCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCC------------------------
Q psy1546         205 VGTPFWMAPEVIKQS-AYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKN------------------------  259 (604)
Q Consensus       205 ~GT~~Y~APE~l~~~-~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~------------------------  259 (604)
                      .|+..|+|||++.+. .++.++|||||||++|+|++|.+||...........+...                        
T Consensus       161 ~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (286)
T cd07832         161 VATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKITFP  240 (286)
T ss_pred             cCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhcccCC
Confidence            789999999998654 4688999999999999999998888766543322211100                        


Q ss_pred             -CC----CCCCccchHHHHHHHHHHhccCCCCCCCHHHHhcChhh
Q psy1546         260 -NP----PQLTGNYTKQFKEFVEACLNKDPENRPTAKELLKFPFI  299 (604)
Q Consensus       260 -~~----~~~~~~~s~~l~~Li~~~L~~dP~~RpT~~elL~hp~f  299 (604)
                       ..    .......+..+.+||.+||..||.+|||++++|.||||
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~  285 (286)
T cd07832         241 ESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYF  285 (286)
T ss_pred             CCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCc
Confidence             00    01123456889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=2.3e-38  Score=326.63  Aligned_cols=228  Identities=25%  Similarity=0.315  Sum_probs=194.7

Q ss_pred             eEEcccCcEEEEEEEECCCCcEEEEEEecchhh--HHHHHHHHHHHHHHhhCCCCCCCe--------------EEEEEEe
Q psy1546          63 ERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA--EDEIEDIQQEIMVLSQCDSPYGTK--------------LWIIMEY  126 (604)
Q Consensus        63 ~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~--~~~~~~l~~Ei~iL~~l~hp~~~~--------------lyLVmEy  126 (604)
                      ..||+|++|.||+|.+  +|+.||||++.....  ....+.+.+|+.+|++++|||+.+              +++||||
T Consensus        26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey  103 (283)
T PHA02988         26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY  103 (283)
T ss_pred             eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence            5799999999999987  588999999865432  223577889999999999998543              4699999


Q ss_pred             cCCCChhhHhhc-CCCcHHHHHHHHHHHHHHhHHhhhC-CccccccccceeEecCCCCeEEecccccccccCCCCCCccc
Q psy1546         127 LGGGSALDLMKA-GNFEEMHIAVILREVLKGLDYLHSE-RKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTF  204 (604)
Q Consensus       127 ~~ggsL~~~l~~-~~lse~~i~~i~~qIl~gL~yLHs~-gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~~~~~  204 (604)
                      |.+|+|.+++.. +.+++.....++.|++.||.|||+. +++||||||+|||++.++.+||+|||+++.+....   ...
T Consensus       104 ~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~---~~~  180 (283)
T PHA02988        104 CTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP---FKN  180 (283)
T ss_pred             CCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhhhcccc---ccc
Confidence            999999999865 5689999999999999999999984 99999999999999999999999999997654322   245


Q ss_pred             ccCCCCCChHHhhc--CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcC-CCCCCCCCccchHHHHHHHHHHhc
Q psy1546         205 VGTPFWMAPEVIKQ--SAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIP-KNNPPQLTGNYTKQFKEFVEACLN  281 (604)
Q Consensus       205 ~GT~~Y~APE~l~~--~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~-~~~~~~~~~~~s~~l~~Li~~~L~  281 (604)
                      .|++.|+|||++.+  ..++.++|||||||++|||++|..||......+....+. ......++..++..+++|+.+||+
T Consensus       181 ~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~~cl~  260 (283)
T PHA02988        181 VNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLPLDCPLEIKCIVEACTS  260 (283)
T ss_pred             cCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCCcCcHHHHHHHHHHhc
Confidence            68999999999976  689999999999999999999999999887766655543 233445555789999999999999


Q ss_pred             cCCCCCCCHHHHhc
Q psy1546         282 KDPENRPTAKELLK  295 (604)
Q Consensus       282 ~dP~~RpT~~elL~  295 (604)
                      .||++|||+.||++
T Consensus       261 ~dp~~Rps~~ell~  274 (283)
T PHA02988        261 HDSIKRPNIKEILY  274 (283)
T ss_pred             CCcccCcCHHHHHH
Confidence            99999999999986

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=2.2e-38  Score=328.08  Aligned_cols=248  Identities=36%  Similarity=0.664  Sum_probs=209.5

Q ss_pred             cceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCC----------eEEEEEEec
Q psy1546          58 IFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGT----------KLWIIMEYL  127 (604)
Q Consensus        58 ~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~----------~lyLVmEy~  127 (604)
                      .|....+||+|+||.||+|.+..+++.||||.+.... ......+.+|+.+++.+.|+++.          .+|+||||+
T Consensus        21 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   99 (292)
T cd06657          21 YLDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRK-QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL   99 (292)
T ss_pred             HhhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccc-hhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecC
Confidence            3555578999999999999999999999999985433 23446788999999999999843          457999999


Q ss_pred             CCCChhhHhhcCCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCCCCcccccC
Q psy1546         128 GGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGT  207 (604)
Q Consensus       128 ~ggsL~~~l~~~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~~~~~~GT  207 (604)
                      ++++|.+++..+.+++..+..++.||+.||+|||+.|++||||+|+||+++.++.++|+|||++..+...........|+
T Consensus       100 ~~~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~  179 (292)
T cd06657         100 EGGALTDIVTHTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGT  179 (292)
T ss_pred             CCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceecccccccccccccC
Confidence            99999999988889999999999999999999999999999999999999999999999999987654433333456789


Q ss_pred             CCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCCCCCC--CCccchHHHHHHHHHHhccCCC
Q psy1546         208 PFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQ--LTGNYTKQFKEFVEACLNKDPE  285 (604)
Q Consensus       208 ~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~--~~~~~s~~l~~Li~~~L~~dP~  285 (604)
                      +.|+|||.+.+..++.++|||||||++|+|++|..||...........+....+..  ....++..+.+++.+||..||.
T Consensus       180 ~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~  259 (292)
T cd06657         180 PYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKNLHKVSPSLKGFLDRLLVRDPA  259 (292)
T ss_pred             ccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCcccCCcccCCHHHHHHHHHHHhCCcc
Confidence            99999999988889999999999999999999999998776655444433322222  2245688999999999999999


Q ss_pred             CCCCHHHHhcChhhhhhhhhh
Q psy1546         286 NRPTAKELLKFPFIRKAKKNA  306 (604)
Q Consensus       286 ~RpT~~elL~hp~f~~~~~~~  306 (604)
                      +||++.+++.||||.+.....
T Consensus       260 ~R~~~~~ll~~~~~~~~~~~~  280 (292)
T cd06657         260 QRATAAELLKHPFLAKAGPPS  280 (292)
T ss_pred             cCcCHHHHhcChHHhccCCCc
Confidence            999999999999998876543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=1.3e-38  Score=325.83  Aligned_cols=240  Identities=28%  Similarity=0.477  Sum_probs=197.1

Q ss_pred             ceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCCe----------EEEEEEecC
Q psy1546          59 FTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTK----------LWIIMEYLG  128 (604)
Q Consensus        59 y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~~----------lyLVmEy~~  128 (604)
                      |.+.++||.|+||.||+|++..+++.||||++...........+.+|+.++++++|+++.+          +|+||||++
T Consensus         2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   81 (284)
T cd07836           2 FKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYMD   81 (284)
T ss_pred             ceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecCC
Confidence            7889999999999999999999999999999876544434466778999999999998544          489999997


Q ss_pred             CCChhhHhhc----CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCCCCccc
Q psy1546         129 GGSALDLMKA----GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTF  204 (604)
Q Consensus       129 ggsL~~~l~~----~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~~~~~  204 (604)
                      + +|.+++..    ..+++..+..++.||+.||.|||++|++||||||+||+++.++.++|+|||++.............
T Consensus        82 ~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~~~  160 (284)
T cd07836          82 K-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNE  160 (284)
T ss_pred             c-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCccccccc
Confidence            5 78887754    358999999999999999999999999999999999999999999999999997654433333445


Q ss_pred             ccCCCCCChHHhhcC-CCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCC--------------------CC--
Q psy1546         205 VGTPFWMAPEVIKQS-AYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKN--------------------NP--  261 (604)
Q Consensus       205 ~GT~~Y~APE~l~~~-~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~--------------------~~--  261 (604)
                      .+++.|++||++.+. .++.++|||||||++|+|++|..||.+.+..+....+...                    ..  
T Consensus       161 ~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (284)
T cd07836         161 VVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKPTFPR  240 (284)
T ss_pred             cccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhcccccC
Confidence            688999999998664 5788999999999999999999999876644332211100                    00  


Q ss_pred             ------CCCCccchHHHHHHHHHHhccCCCCCCCHHHHhcChhh
Q psy1546         262 ------PQLTGNYTKQFKEFVEACLNKDPENRPTAKELLKFPFI  299 (604)
Q Consensus       262 ------~~~~~~~s~~l~~Li~~~L~~dP~~RpT~~elL~hp~f  299 (604)
                            ..+...++..++++|.+||+.||.+||++.++++||||
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f  284 (284)
T cd07836         241 YPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF  284 (284)
T ss_pred             CChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence                  00112456788999999999999999999999999998

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=2.3e-38  Score=324.01  Aligned_cols=238  Identities=29%  Similarity=0.454  Sum_probs=197.8

Q ss_pred             EcccCcEEEEEEEECCCCcEEEEEEecchhh--HHHHHHHHHHHHHHhhCCCCCCC----------eEEEEEEecCCCCh
Q psy1546          65 IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA--EDEIEDIQQEIMVLSQCDSPYGT----------KLWIIMEYLGGGSA  132 (604)
Q Consensus        65 LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~--~~~~~~l~~Ei~iL~~l~hp~~~----------~lyLVmEy~~ggsL  132 (604)
                      ||+|+||+||+|.+..+++.||+|++.....  ......+..|+.+++.++||++.          .+|+||||+++++|
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL   80 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence            6999999999999999999999999865432  22345567899999999999844          35799999999999


Q ss_pred             hhHhhc-C--CCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCCCCcccccCCC
Q psy1546         133 LDLMKA-G--NFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPF  209 (604)
Q Consensus       133 ~~~l~~-~--~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~~~~~~GT~~  209 (604)
                      .+++.. +  .+++..+..++.||+.||.|||++|++||||+|+|||++.++.++|+|||++..... ........++..
T Consensus        81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~-~~~~~~~~~~~~  159 (277)
T cd05577          81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKG-GKKIKGRAGTPG  159 (277)
T ss_pred             HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhcc-CCccccccCCCC
Confidence            998854 3  689999999999999999999999999999999999999999999999999876543 222234568889


Q ss_pred             CCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChh---hHhhhcCCCCCCCCCccchHHHHHHHHHHhccCCCC
Q psy1546         210 WMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPM---RVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPEN  286 (604)
Q Consensus       210 Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~---~~~~~i~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~  286 (604)
                      |+|||++.+..++.++|||||||++|+|++|..||......   ..............+..+++.+.++|.+||..||.+
T Consensus       160 y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~  239 (277)
T cd05577         160 YMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEALLQKDPEK  239 (277)
T ss_pred             cCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccccccCCccCCHHHHHHHHHHccCChhH
Confidence            99999998888999999999999999999999999765431   111111122334455677899999999999999999


Q ss_pred             CC-----CHHHHhcChhhhhhh
Q psy1546         287 RP-----TAKELLKFPFIRKAK  303 (604)
Q Consensus       287 Rp-----T~~elL~hp~f~~~~  303 (604)
                      ||     ++.+++.||||+...
T Consensus       240 R~~~~~~~~~~ll~h~~~~~~~  261 (277)
T cd05577         240 RLGCRGGSADEVREHPLFKDLN  261 (277)
T ss_pred             ccCCCcccHHHHHhChhhhcCC
Confidence            99     899999999997543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=1.9e-38  Score=327.44  Aligned_cols=244  Identities=27%  Similarity=0.419  Sum_probs=200.3

Q ss_pred             ceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhH----HHHHHHHHHHHHHhhCCCCCCC----------eEEEEE
Q psy1546          59 FTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAE----DEIEDIQQEIMVLSQCDSPYGT----------KLWIIM  124 (604)
Q Consensus        59 y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~----~~~~~l~~Ei~iL~~l~hp~~~----------~lyLVm  124 (604)
                      |.+.+.||+|+||.||+|.+..+++.||||.+......    .....+..|+.+++.++|+++.          .+|+||
T Consensus         2 y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~   81 (298)
T cd07841           2 YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLVF   81 (298)
T ss_pred             ceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEEE
Confidence            78889999999999999999999999999999655432    1235567899999999999854          458999


Q ss_pred             EecCCCChhhHhhcC--CCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCCCCc
Q psy1546         125 EYLGGGSALDLMKAG--NFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRN  202 (604)
Q Consensus       125 Ey~~ggsL~~~l~~~--~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~~~  202 (604)
                      ||+ +++|..++...  .+++..+..++.||+.||.|||++||+||||+|+|||++.++.++|+|||++...........
T Consensus        82 e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~~~  160 (298)
T cd07841          82 EFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMT  160 (298)
T ss_pred             ccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCCcccc
Confidence            999 99999999764  599999999999999999999999999999999999999999999999999977655443344


Q ss_pred             ccccCCCCCChHHhhc-CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCC----------------------
Q psy1546         203 TFVGTPFWMAPEVIKQ-SAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKN----------------------  259 (604)
Q Consensus       203 ~~~GT~~Y~APE~l~~-~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~----------------------  259 (604)
                      ...+++.|+|||++.+ ..++.++|||||||++|+|++|.+||...........+...                      
T Consensus       161 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (298)
T cd07841         161 HQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYVEFK  240 (298)
T ss_pred             ccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhccccccccccc
Confidence            4567889999999865 45788999999999999999998888766543322211100                      


Q ss_pred             C-----CCCCCccchHHHHHHHHHHhccCCCCCCCHHHHhcChhhhhhh
Q psy1546         260 N-----PPQLTGNYTKQFKEFVEACLNKDPENRPTAKELLKFPFIRKAK  303 (604)
Q Consensus       260 ~-----~~~~~~~~s~~l~~Li~~~L~~dP~~RpT~~elL~hp~f~~~~  303 (604)
                      .     ........+..+.+||.+||..||++|||+.|+|.|+||+...
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~  289 (298)
T cd07841         241 PFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDP  289 (298)
T ss_pred             ccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCC
Confidence            0     0011234567899999999999999999999999999997654

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=3.7e-38  Score=323.44  Aligned_cols=238  Identities=29%  Similarity=0.416  Sum_probs=202.3

Q ss_pred             cceeeeEEcccCcEEEEEEEECCCCc----EEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCCeE---------EEEE
Q psy1546          58 IFTKQERIGKGSFGEVFKGIDNRTQQ----VVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTKL---------WIIM  124 (604)
Q Consensus        58 ~y~i~~~LG~G~fG~Vy~a~~~~t~~----~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~~l---------yLVm  124 (604)
                      .|.+.+.||+|+||+||+|.+..+++    .|++|.+...........+..|+.++..+.|||+.++         ++|+
T Consensus         8 ~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~~~~~~i~   87 (279)
T cd05111           8 ELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPGASLQLVT   87 (279)
T ss_pred             hceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECCCccEEEE
Confidence            47888999999999999999877776    4777877544444455778889999999999997664         5999


Q ss_pred             EecCCCChhhHhhc--CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCC--C
Q psy1546         125 EYLGGGSALDLMKA--GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTS--K  200 (604)
Q Consensus       125 Ey~~ggsL~~~l~~--~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~--~  200 (604)
                      ||+.+|+|.+++..  +.+++..+..|+.||+.||.|||++|++||||||+|||++.++.+||+|||+++.+.....  .
T Consensus        88 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~~~~~~  167 (279)
T cd05111          88 QLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYF  167 (279)
T ss_pred             EeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccceeccCCCcccc
Confidence            99999999999964  5689999999999999999999999999999999999999999999999999976543221  1


Q ss_pred             CcccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHhhhcCCCCCCCCCccchHHHHHHHHHH
Q psy1546         201 RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAK-GEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEAC  279 (604)
Q Consensus       201 ~~~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~~  279 (604)
                      .....++..|+|||++.+..++.++|||||||++|||++ |..||.+.........+..+.....+..++..+.+++.+|
T Consensus       168 ~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c  247 (279)
T cd05111         168 YSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGERLAQPQICTIDVYMVMVKC  247 (279)
T ss_pred             cCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCCCCCCCHHHHHHHHHH
Confidence            223457788999999998899999999999999999998 9999998877766666655555555566788999999999


Q ss_pred             hccCCCCCCCHHHHhc
Q psy1546         280 LNKDPENRPTAKELLK  295 (604)
Q Consensus       280 L~~dP~~RpT~~elL~  295 (604)
                      |..||.+|||+.|+++
T Consensus       248 ~~~~p~~Rps~~el~~  263 (279)
T cd05111         248 WMIDENVRPTFKELAN  263 (279)
T ss_pred             cCCCcccCcCHHHHHH
Confidence            9999999999999977

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=3.3e-38  Score=321.15  Aligned_cols=241  Identities=37%  Similarity=0.688  Sum_probs=199.7

Q ss_pred             ceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhh---------HHHHHHHHHHHHHHhhCCCCCCCe----------
Q psy1546          59 FTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA---------EDEIEDIQQEIMVLSQCDSPYGTK----------  119 (604)
Q Consensus        59 y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~---------~~~~~~l~~Ei~iL~~l~hp~~~~----------  119 (604)
                      |.+.+.||.|+||.||+|.+..+++.||||.+.....         ....+.+.+|+.+++.++|++..+          
T Consensus         3 ~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   82 (272)
T cd06629           3 WVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEEY   82 (272)
T ss_pred             eeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCCc
Confidence            7888999999999999999999999999998854211         112456788999999999998654          


Q ss_pred             EEEEEEecCCCChhhHhhc-CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCC
Q psy1546         120 LWIIMEYLGGGSALDLMKA-GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTT  198 (604)
Q Consensus       120 lyLVmEy~~ggsL~~~l~~-~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~  198 (604)
                      +|+||||+.+++|.++++. +.+++..+..++.||+.||.|||++|++||||+|+||+++.++.++|+|||+++......
T Consensus        83 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~  162 (272)
T cd06629          83 LSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDIY  162 (272)
T ss_pred             eEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeeccccccccccc
Confidence            4799999999999998866 678999999999999999999999999999999999999999999999999997654321


Q ss_pred             C--CCcccccCCCCCChHHhhcCC--CCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCC-C----CCCCCccch
Q psy1546         199 S--KRNTFVGTPFWMAPEVIKQSA--YDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKN-N----PPQLTGNYT  269 (604)
Q Consensus       199 ~--~~~~~~GT~~Y~APE~l~~~~--~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~-~----~~~~~~~~s  269 (604)
                      .  ......|+..|+|||++....  ++.++||||||+++|+|++|..||...........+... .    +......++
T Consensus       163 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (272)
T cd06629         163 DNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVSMNLS  242 (272)
T ss_pred             cccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcCCccccccCC
Confidence            1  123456899999999997655  788999999999999999999999766554433332211 1    122234568


Q ss_pred             HHHHHHHHHHhccCCCCCCCHHHHhcChhh
Q psy1546         270 KQFKEFVEACLNKDPENRPTAKELLKFPFI  299 (604)
Q Consensus       270 ~~l~~Li~~~L~~dP~~RpT~~elL~hp~f  299 (604)
                      ..+.+||.+||..+|.+|||+++||+||||
T Consensus       243 ~~~~~li~~~l~~~p~~Rps~~~il~~~~~  272 (272)
T cd06629         243 PVALDFLNACFTINPDNRPTARELLQHPFI  272 (272)
T ss_pred             HHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence            899999999999999999999999999996

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=5.8e-38  Score=312.36  Aligned_cols=238  Identities=55%  Similarity=0.970  Sum_probs=204.9

Q ss_pred             ceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCC----------eEEEEEEecC
Q psy1546          59 FTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGT----------KLWIIMEYLG  128 (604)
Q Consensus        59 y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~----------~lyLVmEy~~  128 (604)
                      |.+.+.||+|+||.||+|.+..+++.|++|++..... .....+.+|+.+++.+.|++..          ..|+|+||++
T Consensus         2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~   80 (253)
T cd05122           2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK-EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS   80 (253)
T ss_pred             ceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch-hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence            7888999999999999999998999999999976543 3457888999999999999843          4579999999


Q ss_pred             CCChhhHhhcC--CCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCCCCccccc
Q psy1546         129 GGSALDLMKAG--NFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVG  206 (604)
Q Consensus       129 ggsL~~~l~~~--~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~~~~~~G  206 (604)
                      +++|.+++...  .+++..+..++.|++.||.|||.+|++||||+|+||+++.++.++|+|||.+........ .....+
T Consensus        81 ~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-~~~~~~  159 (253)
T cd05122          81 GGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA-RNTMVG  159 (253)
T ss_pred             CCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeecccccccccccc-ccceec
Confidence            99999998764  799999999999999999999999999999999999999999999999999976654332 345678


Q ss_pred             CCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCCCCCCCCcc--chHHHHHHHHHHhccCC
Q psy1546         207 TPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGN--YTKQFKEFVEACLNKDP  284 (604)
Q Consensus       207 T~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~--~s~~l~~Li~~~L~~dP  284 (604)
                      +..|+|||++.+..++.++||||||+++|+|++|..||...+.............+.+...  ++..+.++|.+||..||
T Consensus       160 ~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p  239 (253)
T cd05122         160 TPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNPEKWSDEFKDFLKKCLQKNP  239 (253)
T ss_pred             CCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcCCCCcCcccccCHHHHHHHHHHccCCh
Confidence            9999999999988899999999999999999999999988755554444333333333333  37899999999999999


Q ss_pred             CCCCCHHHHhcChh
Q psy1546         285 ENRPTAKELLKFPF  298 (604)
Q Consensus       285 ~~RpT~~elL~hp~  298 (604)
                      .+|||+.++++|||
T Consensus       240 ~~R~t~~~~l~~~~  253 (253)
T cd05122         240 EKRPTAEQLLKHPF  253 (253)
T ss_pred             hhCCCHHHHhcCCC
Confidence            99999999999998

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.6e-38  Score=349.51  Aligned_cols=236  Identities=26%  Similarity=0.349  Sum_probs=189.5

Q ss_pred             cceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCCeE----------EEEEEec
Q psy1546          58 IFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTKL----------WIIMEYL  127 (604)
Q Consensus        58 ~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~~l----------yLVmEy~  127 (604)
                      .|.+.+.||+|+||.||+|.+..+++.||||....       ..+.+|+.+|++++|+|++++          |||||++
T Consensus       170 gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~-------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~  242 (461)
T PHA03211        170 GFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY-------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKY  242 (461)
T ss_pred             CeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc-------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEcc
Confidence            49999999999999999999999999999996432       335689999999999997654          6999999


Q ss_pred             CCCChhhHhhc--CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCC--CCcc
Q psy1546         128 GGGSALDLMKA--GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTS--KRNT  203 (604)
Q Consensus       128 ~ggsL~~~l~~--~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~--~~~~  203 (604)
                      . ++|..++..  +.+++..++.|+.||+.||.|||++||+||||||+||||+.++.+||+|||+++.+.....  ....
T Consensus       243 ~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~  321 (461)
T PHA03211        243 R-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYG  321 (461)
T ss_pred             C-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceecccccccccccc
Confidence            5 677777754  4699999999999999999999999999999999999999999999999999976543222  1234


Q ss_pred             cccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCC--------hhhHhhhcCCCC-----CC--------
Q psy1546         204 FVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELH--------PMRVLFLIPKNN-----PP--------  262 (604)
Q Consensus       204 ~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~--------~~~~~~~i~~~~-----~~--------  262 (604)
                      .+||+.|||||++.+..++.++|||||||+||||++|..++....        ...+...+....     .+        
T Consensus       322 ~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~~l~  401 (461)
T PHA03211        322 IAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGSRLV  401 (461)
T ss_pred             cCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcchHHH
Confidence            679999999999999999999999999999999999876532211        111111111000     00        


Q ss_pred             -------------C-----C--CccchHHHHHHHHHHhccCCCCCCCHHHHhcChhhhh
Q psy1546         263 -------------Q-----L--TGNYTKQFKEFVEACLNKDPENRPTAKELLKFPFIRK  301 (604)
Q Consensus       263 -------------~-----~--~~~~s~~l~~Li~~~L~~dP~~RpT~~elL~hp~f~~  301 (604)
                                   .     +  ...++..+.+||.+||..||.+|||+.|||+||||+.
T Consensus       402 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~  460 (461)
T PHA03211        402 SQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS  460 (461)
T ss_pred             HHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence                         0     0  0124557899999999999999999999999999964

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=6.5e-38  Score=314.67  Aligned_cols=239  Identities=33%  Similarity=0.547  Sum_probs=210.6

Q ss_pred             ceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchh-hHHHHHHHHHHHHHHhhCCCCCCC----------eEEEEEEec
Q psy1546          59 FTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE-AEDEIEDIQQEIMVLSQCDSPYGT----------KLWIIMEYL  127 (604)
Q Consensus        59 y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~-~~~~~~~l~~Ei~iL~~l~hp~~~----------~lyLVmEy~  127 (604)
                      |.+.++||+|+||.||++.+..+++.||||.+.... .......+.+|+.+++.++|+++.          .+|+||||+
T Consensus         2 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   81 (256)
T cd08530           2 FKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEYA   81 (256)
T ss_pred             ceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehhc
Confidence            788999999999999999999999999999986543 233456678899999999999844          458999999


Q ss_pred             CCCChhhHhhc-----CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCCCCc
Q psy1546         128 GGGSALDLMKA-----GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRN  202 (604)
Q Consensus       128 ~ggsL~~~l~~-----~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~~~  202 (604)
                      ++++|..++..     ..+++..++.++.||+.||.|||+.|++||||+|.||+++.++.+||+|||++......  ...
T Consensus        82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~--~~~  159 (256)
T cd08530          82 PFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN--MAK  159 (256)
T ss_pred             CCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhccC--Ccc
Confidence            99999998865     56899999999999999999999999999999999999999999999999999766544  223


Q ss_pred             ccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCCCCCCCCccchHHHHHHHHHHhcc
Q psy1546         203 TFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNK  282 (604)
Q Consensus       203 ~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~~L~~  282 (604)
                      ...+++.|+|||.+.+..++.++|+||||+++|+|++|..||...+..+....+.....+.++..++.++.+++.+||..
T Consensus       160 ~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  239 (256)
T cd08530         160 TQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPIPPIYSQDLQNFIRSMLQV  239 (256)
T ss_pred             cccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCchhhCHHHHHHHHHHcCC
Confidence            45689999999999999999999999999999999999999998887776666666666666678899999999999999


Q ss_pred             CCCCCCCHHHHhcChhh
Q psy1546         283 DPENRPTAKELLKFPFI  299 (604)
Q Consensus       283 dP~~RpT~~elL~hp~f  299 (604)
                      +|.+|||+.++++||++
T Consensus       240 ~p~~Rp~~~~~l~~p~~  256 (256)
T cd08530         240 KPKLRPNCDKILASPAV  256 (256)
T ss_pred             CcccCCCHHHHhcCCCC
Confidence            99999999999999974

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-38  Score=327.42  Aligned_cols=241  Identities=29%  Similarity=0.474  Sum_probs=192.4

Q ss_pred             cceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCCe----------EEEEEEec
Q psy1546          58 IFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTK----------LWIIMEYL  127 (604)
Q Consensus        58 ~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~~----------lyLVmEy~  127 (604)
                      .|.+.+.||+|+||.||+|.+..+++.||||.+...........+.+|+.+++.++|+++.+          +|+||||+
T Consensus         6 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   85 (291)
T cd07844           6 TYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEYL   85 (291)
T ss_pred             ceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEecC
Confidence            48999999999999999999999999999999865433322345678999999999998554          47999999


Q ss_pred             CCCChhhHhhc--CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCCCCcccc
Q psy1546         128 GGGSALDLMKA--GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFV  205 (604)
Q Consensus       128 ~ggsL~~~l~~--~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~~~~~~  205 (604)
                      .+ +|.+++..  +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.............
T Consensus        86 ~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~  164 (291)
T cd07844          86 DT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEV  164 (291)
T ss_pred             CC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCCCCccccccc
Confidence            75 88888754  4689999999999999999999999999999999999999999999999999865433322223345


Q ss_pred             cCCCCCChHHhhc-CCCCCcchhhhHHHHHHHHHhCCCCCCCCCh-hhHhhhcC----CC--------------------
Q psy1546         206 GTPFWMAPEVIKQ-SAYDSKADIWSLGITAIELAKGEPPNSELHP-MRVLFLIP----KN--------------------  259 (604)
Q Consensus       206 GT~~Y~APE~l~~-~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~-~~~~~~i~----~~--------------------  259 (604)
                      ++..|+|||++.+ ..++.++|||||||++|+|++|..||..... .+....+.    ..                    
T Consensus       165 ~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (291)
T cd07844         165 VTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFKPYSFP  244 (291)
T ss_pred             cccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhcccccccccc
Confidence            7889999999875 4588899999999999999999999976542 11111000    00                    


Q ss_pred             --CCC---CCCccch--HHHHHHHHHHhccCCCCCCCHHHHhcChhh
Q psy1546         260 --NPP---QLTGNYT--KQFKEFVEACLNKDPENRPTAKELLKFPFI  299 (604)
Q Consensus       260 --~~~---~~~~~~s--~~l~~Li~~~L~~dP~~RpT~~elL~hp~f  299 (604)
                        ...   .....++  ..+.++|.+||..+|.+|||+.|++.||||
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f  291 (291)
T cd07844         245 FYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF  291 (291)
T ss_pred             ccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence              000   0001223  788899999999999999999999999998

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=3.6e-38  Score=319.66  Aligned_cols=232  Identities=27%  Similarity=0.474  Sum_probs=198.2

Q ss_pred             EEcccCcEEEEEEEEC--CCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCCe---------EEEEEEecCCCCh
Q psy1546          64 RIGKGSFGEVFKGIDN--RTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTK---------LWIIMEYLGGGSA  132 (604)
Q Consensus        64 ~LG~G~fG~Vy~a~~~--~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~~---------lyLVmEy~~ggsL  132 (604)
                      .||+|+||.||+|.+.  ..+..||+|++.........+.+.+|+.+++.++|+++.+         +|+||||+++++|
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~lv~e~~~~~~L   81 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEAEALMLVMEMASGGPL   81 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcCCCeEEEEEeCCCCCH
Confidence            3899999999999765  4456799999876654445577899999999999998654         4699999999999


Q ss_pred             hhHhhc--CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCCC---CcccccC
Q psy1546         133 LDLMKA--GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSK---RNTFVGT  207 (604)
Q Consensus       133 ~~~l~~--~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~---~~~~~GT  207 (604)
                      .+++..  +.+++..++.++.||+.||.|||++|++||||||+|||++.++.+||+|||++..+......   .....++
T Consensus        82 ~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~  161 (257)
T cd05115          82 NKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWP  161 (257)
T ss_pred             HHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCCCCCC
Confidence            998853  57899999999999999999999999999999999999999999999999999755433221   1112235


Q ss_pred             CCCCChHHhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHhhhcCCCCCCCCCccchHHHHHHHHHHhccCCCC
Q psy1546         208 PFWMAPEVIKQSAYDSKADIWSLGITAIELAK-GEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPEN  286 (604)
Q Consensus       208 ~~Y~APE~l~~~~~~~~sDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~  286 (604)
                      +.|+|||++.+..++.++|||||||++|+|++ |..||...........+..+....++..++.++.++|.+||..||++
T Consensus       162 ~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~~~~  241 (257)
T cd05115         162 LKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRLDCPAECPPEMYALMKDCWIYKWED  241 (257)
T ss_pred             cccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHcCCChhh
Confidence            78999999998889999999999999999996 99999988887777777666666777788999999999999999999


Q ss_pred             CCCHHHHhc
Q psy1546         287 RPTAKELLK  295 (604)
Q Consensus       287 RpT~~elL~  295 (604)
                      ||++.+|++
T Consensus       242 Rp~~~~i~~  250 (257)
T cd05115         242 RPNFAKVEE  250 (257)
T ss_pred             CcCHHHHHH
Confidence            999999976

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=4.5e-38  Score=319.17  Aligned_cols=235  Identities=26%  Similarity=0.478  Sum_probs=201.8

Q ss_pred             ceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCCe----------EEEEEEecC
Q psy1546          59 FTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTK----------LWIIMEYLG  128 (604)
Q Consensus        59 y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~~----------lyLVmEy~~  128 (604)
                      |.+.++||+|+||.||+|.+..+++.||+|++....  .....+.+|+.+++.++|+++.+          +|+||||++
T Consensus         8 ~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   85 (263)
T cd05052           8 ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMT   85 (263)
T ss_pred             eEEeeecCCcccceEEEEEEecCCceEEEEEecCCc--hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCC
Confidence            788899999999999999999999999999986442  23467889999999999998554          469999999


Q ss_pred             CCChhhHhhc---CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCCC-Cccc
Q psy1546         129 GGSALDLMKA---GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSK-RNTF  204 (604)
Q Consensus       129 ggsL~~~l~~---~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~-~~~~  204 (604)
                      +++|.+++..   ..+++..+..++.|++.||.|||++|++||||||+|||+++++.+||+|||++......... ....
T Consensus        86 ~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~  165 (263)
T cd05052          86 YGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGA  165 (263)
T ss_pred             CCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCccccccccceeeccCCC
Confidence            9999999864   35889999999999999999999999999999999999999999999999999766433221 1122


Q ss_pred             ccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHhhhcCCCCCCCCCccchHHHHHHHHHHhccC
Q psy1546         205 VGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAK-GEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKD  283 (604)
Q Consensus       205 ~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~~L~~d  283 (604)
                      .++..|+|||++.+..++.++|||||||++|||++ |..||.+....+....+........+..++.++.++|.+||..|
T Consensus       166 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~  245 (263)
T cd05052         166 KFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYRMERPEGCPPKVYELMRACWQWN  245 (263)
T ss_pred             CCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHccCC
Confidence            34678999999999999999999999999999998 99999887776666666555555666778999999999999999


Q ss_pred             CCCCCCHHHHhc
Q psy1546         284 PENRPTAKELLK  295 (604)
Q Consensus       284 P~~RpT~~elL~  295 (604)
                      |.+|||+.++++
T Consensus       246 p~~Rp~~~~l~~  257 (263)
T cd05052         246 PSDRPSFAEIHQ  257 (263)
T ss_pred             cccCCCHHHHHH
Confidence            999999999976

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=2.8e-38  Score=324.78  Aligned_cols=238  Identities=29%  Similarity=0.479  Sum_probs=190.0

Q ss_pred             EEcccCcEEEEEEEECCCCcEEEEEEecchhhH--HHHHHHHHHHH---HHhhCCCCCCC----------eEEEEEEecC
Q psy1546          64 RIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAE--DEIEDIQQEIM---VLSQCDSPYGT----------KLWIIMEYLG  128 (604)
Q Consensus        64 ~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~--~~~~~l~~Ei~---iL~~l~hp~~~----------~lyLVmEy~~  128 (604)
                      .||+|+||.||+|.+..+++.||||++......  .......+|..   ++....|+++.          .+|+||||+.
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            389999999999999999999999998654321  11122334433   34445788743          4579999999


Q ss_pred             CCChhhHhhc-CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCCCCcccccC
Q psy1546         129 GGSALDLMKA-GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGT  207 (604)
Q Consensus       129 ggsL~~~l~~-~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~~~~~~GT  207 (604)
                      +++|.+++.. +.+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++.......  .....||
T Consensus        81 ~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~--~~~~~~~  158 (279)
T cd05633          81 GGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--PHASVGT  158 (279)
T ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceeccccC--ccCcCCC
Confidence            9999988854 679999999999999999999999999999999999999999999999999986554322  2345799


Q ss_pred             CCCCChHHhh-cCCCCCcchhhhHHHHHHHHHhCCCCCCCCChh--hHhhhcCCCCCCCCCccchHHHHHHHHHHhccCC
Q psy1546         208 PFWMAPEVIK-QSAYDSKADIWSLGITAIELAKGEPPNSELHPM--RVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDP  284 (604)
Q Consensus       208 ~~Y~APE~l~-~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~--~~~~~i~~~~~~~~~~~~s~~l~~Li~~~L~~dP  284 (604)
                      +.|+|||++. +..++.++|||||||++|+|++|..||......  .............++..++.++.++|.+||..||
T Consensus       159 ~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p  238 (279)
T cd05633         159 HGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPDSFSPELKSLLEGLLQRDV  238 (279)
T ss_pred             cCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhhcCCcCCccccCHHHHHHHHHHhcCCH
Confidence            9999999986 456889999999999999999999999754321  1111122222345566788999999999999999


Q ss_pred             CCCC-----CHHHHhcChhhhhhh
Q psy1546         285 ENRP-----TAKELLKFPFIRKAK  303 (604)
Q Consensus       285 ~~Rp-----T~~elL~hp~f~~~~  303 (604)
                      .+|+     ++.|+++||||+...
T Consensus       239 ~~R~~~~~~~~~~~~~h~~~~~~~  262 (279)
T cd05633         239 SKRLGCLGRGAQEVKEHVFFKGID  262 (279)
T ss_pred             HHhcCCCCCCHHHHHhCccccCCC
Confidence            9999     699999999998754

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.3e-38  Score=320.09  Aligned_cols=238  Identities=27%  Similarity=0.471  Sum_probs=203.2

Q ss_pred             cceeeeEEcccCcEEEEEEEECCC-----CcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCCeE----------EE
Q psy1546          58 IFTKQERIGKGSFGEVFKGIDNRT-----QQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTKL----------WI  122 (604)
Q Consensus        58 ~y~i~~~LG~G~fG~Vy~a~~~~t-----~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~~l----------yL  122 (604)
                      .|.+.+.||+|+||.||+|.+...     +..||+|.+...........+.+|+.++..+.|+++.++          |+
T Consensus         7 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~   86 (277)
T cd05032           7 KITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPTLV   86 (277)
T ss_pred             HeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCcEE
Confidence            488999999999999999987644     478999998655444445678899999999999986654          79


Q ss_pred             EEEecCCCChhhHhhc-----------CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEeccccc
Q psy1546         123 IMEYLGGGSALDLMKA-----------GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVA  191 (604)
Q Consensus       123 VmEy~~ggsL~~~l~~-----------~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA  191 (604)
                      ||||+.+|+|.+++..           +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus        87 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~kl~dfg~~  166 (277)
T cd05032          87 VMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMT  166 (277)
T ss_pred             EEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCEEECCcccc
Confidence            9999999999998853           23677889999999999999999999999999999999999999999999999


Q ss_pred             ccccCCCC--CCcccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHhhhcCCCCCCCCCccc
Q psy1546         192 GTLTNTTS--KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAK-GEPPNSELHPMRVLFLIPKNNPPQLTGNY  268 (604)
Q Consensus       192 ~~~~~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~  268 (604)
                      +.+.....  ......++..|+|||.+.+..++.++|||||||++|||++ |..||...........+........+..+
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  246 (277)
T cd05032         167 RDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDGGHLDLPENC  246 (277)
T ss_pred             hhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHhcCCCCCCCCCC
Confidence            76543321  2234457889999999998889999999999999999998 99999888777766666655555667778


Q ss_pred             hHHHHHHHHHHhccCCCCCCCHHHHhc
Q psy1546         269 TKQFKEFVEACLNKDPENRPTAKELLK  295 (604)
Q Consensus       269 s~~l~~Li~~~L~~dP~~RpT~~elL~  295 (604)
                      +..+.+|+.+||..+|++|||+.+|+.
T Consensus       247 ~~~~~~li~~~l~~~p~~Rpt~~~l~~  273 (277)
T cd05032         247 PDKLLELMRMCWQYNPKMRPTFLEIVS  273 (277)
T ss_pred             CHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            999999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=4e-38  Score=317.03  Aligned_cols=237  Identities=32%  Similarity=0.562  Sum_probs=202.0

Q ss_pred             EcccCcEEEEEEEECCCCcEEEEEEecchhh--HHHHHHHHHHHHHHhhCCCCCCC----------eEEEEEEecCCCCh
Q psy1546          65 IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA--EDEIEDIQQEIMVLSQCDSPYGT----------KLWIIMEYLGGGSA  132 (604)
Q Consensus        65 LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~--~~~~~~l~~Ei~iL~~l~hp~~~----------~lyLVmEy~~ggsL  132 (604)
                      ||.|+||.||+|.+..+++.||+|++.....  ......+.+|+.+++.+.|+++.          .+|+||||+.+++|
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL   80 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence            6899999999999999999999999965543  24457788999999999999843          46899999999999


Q ss_pred             hhHhhc-CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCC--------CCcc
Q psy1546         133 LDLMKA-GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTS--------KRNT  203 (604)
Q Consensus       133 ~~~l~~-~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~--------~~~~  203 (604)
                      .+++.. +.+++..+..++.||+.||.|||+.|++||||+|+|||++.++.++|+|||++........        ....
T Consensus        81 ~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~  160 (265)
T cd05579          81 ASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKR  160 (265)
T ss_pred             HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccccccC
Confidence            999876 6789999999999999999999999999999999999999999999999999865433211        2234


Q ss_pred             cccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCCCCCCCCcc--chHHHHHHHHHHhc
Q psy1546         204 FVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGN--YTKQFKEFVEACLN  281 (604)
Q Consensus       204 ~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~--~s~~l~~Li~~~L~  281 (604)
                      ..++..|+|||++....++.++||||||+++|+|++|..||...........+.... ...+..  ++..+.+|+.+||+
T Consensus       161 ~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~  239 (265)
T cd05579         161 IVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGK-IEWPEDVEVSDEAIDLISKLLV  239 (265)
T ss_pred             cccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC-cCCCccccCCHHHHHHHHHHhc
Confidence            568899999999988889999999999999999999999998877766655544322 122233  48899999999999


Q ss_pred             cCCCCCCCH---HHHhcChhhhhh
Q psy1546         282 KDPENRPTA---KELLKFPFIRKA  302 (604)
Q Consensus       282 ~dP~~RpT~---~elL~hp~f~~~  302 (604)
                      .+|.+|||+   .++|+||||++.
T Consensus       240 ~~p~~Rpt~~~~~~~l~~~~~~~~  263 (265)
T cd05579         240 PDPEKRLGAKSIEEIKNHPFFKGI  263 (265)
T ss_pred             CCHhhcCCCccHHHHhcCccccCC
Confidence            999999999   999999999754

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=1.6e-38  Score=325.39  Aligned_cols=240  Identities=31%  Similarity=0.489  Sum_probs=195.7

Q ss_pred             ceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhH-HHHHHHHHHHHHHhhCCCCCCCe----------EEEEEEec
Q psy1546          59 FTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAE-DEIEDIQQEIMVLSQCDSPYGTK----------LWIIMEYL  127 (604)
Q Consensus        59 y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~-~~~~~l~~Ei~iL~~l~hp~~~~----------lyLVmEy~  127 (604)
                      |++.+.||.|+||.||+|++..+++.||||.+...... .....+.+|+.++++++||++.+          +|+||||+
T Consensus         2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~   81 (284)
T cd07860           2 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL   81 (284)
T ss_pred             ceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeecc
Confidence            78899999999999999999999999999998654322 22356889999999999998544          57999999


Q ss_pred             CCCChhhHhhc---CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCCCCccc
Q psy1546         128 GGGSALDLMKA---GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTF  204 (604)
Q Consensus       128 ~ggsL~~~l~~---~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~~~~~  204 (604)
                      . ++|..++..   +.+++..+..++.||+.||+|||+.|++||||+|+||+++.++.+||+|||++..+..........
T Consensus        82 ~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~~~~~  160 (284)
T cd07860          82 H-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHE  160 (284)
T ss_pred             c-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCccccccc
Confidence            5 578887753   568999999999999999999999999999999999999999999999999997664433333445


Q ss_pred             ccCCCCCChHHhhcCC-CCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCC-------------------------
Q psy1546         205 VGTPFWMAPEVIKQSA-YDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPK-------------------------  258 (604)
Q Consensus       205 ~GT~~Y~APE~l~~~~-~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~-------------------------  258 (604)
                      .+++.|+|||++.+.. ++.++|||||||++|+|++|..||...........+..                         
T Consensus       161 ~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (284)
T cd07860         161 VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPSFPK  240 (284)
T ss_pred             cccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHhhccc
Confidence            6789999999887644 57889999999999999999999987654332221110                         


Q ss_pred             ---CCCCCCCccchHHHHHHHHHHhccCCCCCCCHHHHhcChhh
Q psy1546         259 ---NNPPQLTGNYTKQFKEFVEACLNKDPENRPTAKELLKFPFI  299 (604)
Q Consensus       259 ---~~~~~~~~~~s~~l~~Li~~~L~~dP~~RpT~~elL~hp~f  299 (604)
                         .....+...++.+++++|.+||..||.+|||++++++||||
T Consensus       241 ~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f  284 (284)
T cd07860         241 WARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF  284 (284)
T ss_pred             ccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence               00001123467789999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>KOG0596|consensus

Probab=100.00  E-value=5.7e-39  Score=340.28  Aligned_cols=257  Identities=25%  Similarity=0.444  Sum_probs=197.7

Q ss_pred             ccceeeeEEcccCcEEEEEEEECCCCcEEEEEEe-cchhhHHHHHHHHHHHHHHhhCCCC-C----------CCeEEEEE
Q psy1546          57 LIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKII-DLEEAEDEIEDIQQEIMVLSQCDSP-Y----------GTKLWIIM  124 (604)
Q Consensus        57 ~~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i-~~~~~~~~~~~l~~Ei~iL~~l~hp-~----------~~~lyLVm  124 (604)
                      ..|+++++||+||.+.||++.....+ .||+|.+ ........+.-+..||.+|.+|+.. .          ...+||||
T Consensus       361 ~~Yeilk~iG~GGSSkV~kV~~s~~~-iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvm  439 (677)
T KOG0596|consen  361 REYEILKQIGSGGSSKVFKVLNSDKQ-IYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVM  439 (677)
T ss_pred             chhhHHHhhcCCCcceeeeeecCCCc-chhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEe
Confidence            45999999999999999999866554 4555544 4444455678899999999998753 2          34568999


Q ss_pred             EecCCCChhhHhhcCC--CcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCC--CC
Q psy1546         125 EYLGGGSALDLMKAGN--FEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTT--SK  200 (604)
Q Consensus       125 Ey~~ggsL~~~l~~~~--lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~--~~  200 (604)
                      ||- ..+|..+++.+.  .+...++.|.+|||.++.++|++||||.||||.|+|+-. |.+||+|||+|..+....  ..
T Consensus       440 E~G-d~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlVk-G~LKLIDFGIA~aI~~DTTsI~  517 (677)
T KOG0596|consen  440 ECG-DIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLVK-GRLKLIDFGIANAIQPDTTSIV  517 (677)
T ss_pred             ecc-cccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEEe-eeEEeeeechhcccCcccccee
Confidence            974 678999997754  333488899999999999999999999999999999987 999999999998775433  24


Q ss_pred             CcccccCCCCCChHHhhcCC-----------CCCcchhhhHHHHHHHHHhCCCCCCCCChh-hHhhhcCCC----CCCCC
Q psy1546         201 RNTFVGTPFWMAPEVIKQSA-----------YDSKADIWSLGITAIELAKGEPPNSELHPM-RVLFLIPKN----NPPQL  264 (604)
Q Consensus       201 ~~~~~GT~~Y~APE~l~~~~-----------~~~~sDVwSLGviL~eLltG~~Pf~~~~~~-~~~~~i~~~----~~~~~  264 (604)
                      +.+.+||+.||+||.+....           .+.++||||||||||+|+.|++||...... .-+..|...    ..+.+
T Consensus       518 kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~~P~~~Iefp~~  597 (677)
T KOG0596|consen  518 KDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAITDPNHEIEFPDI  597 (677)
T ss_pred             eccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhcCCCccccccCC
Confidence            56789999999999997544           346899999999999999999999876532 222222222    12333


Q ss_pred             CccchHHHHHHHHHHhccCCCCCCCHHHHhcChhhhh-hhhhhhHHHHHHHHHHH
Q psy1546         265 TGNYTKQFKEFVEACLNKDPENRPTAKELLKFPFIRK-AKKNAYLIDLIDRYKKW  318 (604)
Q Consensus       265 ~~~~s~~l~~Li~~~L~~dP~~RpT~~elL~hp~f~~-~~~~~~l~~~~~~~~~~  318 (604)
                      +...  ++.++++.||..||++||++.|||+|||+.- ......+.++.....++
T Consensus       598 ~~~~--~li~~mK~CL~rdPkkR~si~eLLqhpFl~~~~i~~~~m~~~~~~~~k~  650 (677)
T KOG0596|consen  598 PEND--ELIDVMKCCLARDPKKRWSIPELLQHPFLQIQPIPVEQMAKLTTNEMKY  650 (677)
T ss_pred             CCch--HHHHHHHHHHhcCcccCCCcHHHhcCcccccccccchHHHHHHHHHHHh
Confidence            3322  4999999999999999999999999999976 33344444554444443

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.2e-38  Score=317.36  Aligned_cols=233  Identities=28%  Similarity=0.451  Sum_probs=199.4

Q ss_pred             eEEcccCcEEEEEEEECCCC---cEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCCeE---------EEEEEecCCC
Q psy1546          63 ERIGKGSFGEVFKGIDNRTQ---QVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTKL---------WIIMEYLGGG  130 (604)
Q Consensus        63 ~~LG~G~fG~Vy~a~~~~t~---~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~~l---------yLVmEy~~gg  130 (604)
                      ++||+|+||.||+|.+..++   ..||+|.+.........+.+.+|+.+++.+.|++..++         ++||||+.++
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~v~e~~~~~   80 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCKGEPLMLVMELAPLG   80 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEcCCceEEEEEeCCCC
Confidence            46999999999999876554   78999999766554455778899999999999986554         6999999999


Q ss_pred             ChhhHhhc-CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCCCC---ccccc
Q psy1546         131 SALDLMKA-GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKR---NTFVG  206 (604)
Q Consensus       131 sL~~~l~~-~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~~---~~~~G  206 (604)
                      +|.+++.. +.+++..+..++.||+.||.|||..+++||||||+|||++.++.+||+|||+++.+.......   ....+
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~  160 (257)
T cd05060          81 PLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRW  160 (257)
T ss_pred             cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCcccccccCccc
Confidence            99999966 459999999999999999999999999999999999999999999999999997664333221   11223


Q ss_pred             CCCCCChHHhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHhhhcCCCCCCCCCccchHHHHHHHHHHhccCCC
Q psy1546         207 TPFWMAPEVIKQSAYDSKADIWSLGITAIELAK-GEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPE  285 (604)
Q Consensus       207 T~~Y~APE~l~~~~~~~~sDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~~L~~dP~  285 (604)
                      +..|+|||.+.+..++.++|||||||++|+|++ |.+||...+..+....+........+..++..+.++|.+||..+|.
T Consensus       161 ~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~  240 (257)
T cd05060         161 PLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERLPRPEECPQEIYSIMLSCWKYRPE  240 (257)
T ss_pred             cccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHhcCChh
Confidence            567999999999999999999999999999997 9999988887777666666655566677889999999999999999


Q ss_pred             CCCCHHHHhc
Q psy1546         286 NRPTAKELLK  295 (604)
Q Consensus       286 ~RpT~~elL~  295 (604)
                      +||++.+|++
T Consensus       241 ~Rp~~~~l~~  250 (257)
T cd05060         241 DRPTFSELES  250 (257)
T ss_pred             hCcCHHHHHH
Confidence            9999999976

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=5.1e-38  Score=318.55  Aligned_cols=239  Identities=30%  Similarity=0.512  Sum_probs=198.7

Q ss_pred             cceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchh--hHHHHHHHHHHHHHHhhCCCCCCCe----------EEEEEE
Q psy1546          58 IFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE--AEDEIEDIQQEIMVLSQCDSPYGTK----------LWIIME  125 (604)
Q Consensus        58 ~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~--~~~~~~~l~~Ei~iL~~l~hp~~~~----------lyLVmE  125 (604)
                      .|.+.++||+|+||.||+|++..+++.||||.+....  .......+.+|+.+++.++||++.+          +|+|||
T Consensus         3 ~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   82 (267)
T cd08228           3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLE   82 (267)
T ss_pred             ceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEEE
Confidence            3889999999999999999999999999999875432  2334466789999999999998543          579999


Q ss_pred             ecCCCChhhHhhc-----CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCCC
Q psy1546         126 YLGGGSALDLMKA-----GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSK  200 (604)
Q Consensus       126 y~~ggsL~~~l~~-----~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~  200 (604)
                      |+++++|.+++..     ..+++..+..++.||+.||.|||++|++||||||+|||++.++.++|+|||++..+......
T Consensus        83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~~~  162 (267)
T cd08228          83 LADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTA  162 (267)
T ss_pred             ecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceeccchhHH
Confidence            9999999988742     44889999999999999999999999999999999999999999999999998766543333


Q ss_pred             CcccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCCh--hhHhhhcCCCCC-CCCCccchHHHHHHHH
Q psy1546         201 RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHP--MRVLFLIPKNNP-PQLTGNYTKQFKEFVE  277 (604)
Q Consensus       201 ~~~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~--~~~~~~i~~~~~-~~~~~~~s~~l~~Li~  277 (604)
                      .....|++.|+|||.+.+..++.++||||||+++|+|++|..||.....  ......+..... +.....++..+.+++.
T Consensus       163 ~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  242 (267)
T cd08228         163 AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEKLRELVS  242 (267)
T ss_pred             HhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCCCChhhcCHHHHHHHH
Confidence            3345789999999999988899999999999999999999999865432  233333333222 2333467889999999


Q ss_pred             HHhccCCCCCCCHHHHhcC
Q psy1546         278 ACLNKDPENRPTAKELLKF  296 (604)
Q Consensus       278 ~~L~~dP~~RpT~~elL~h  296 (604)
                      +||..+|.+||++.+|++.
T Consensus       243 ~cl~~~p~~Rp~~~~vl~~  261 (267)
T cd08228         243 MCIYPDPDQRPDIGYVHQI  261 (267)
T ss_pred             HHCCCCcccCcCHHHHHHH
Confidence            9999999999999999873

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=2e-38  Score=326.56  Aligned_cols=242  Identities=27%  Similarity=0.474  Sum_probs=192.3

Q ss_pred             ccceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCCe----------EEEEEEe
Q psy1546          57 LIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTK----------LWIIMEY  126 (604)
Q Consensus        57 ~~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~~----------lyLVmEy  126 (604)
                      ..|.+.+.||+|+||.||+|.+..+++.||||++...........+.+|+.+++.++|+++.+          .|+||||
T Consensus         5 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~   84 (291)
T cd07870           5 TSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFEY   84 (291)
T ss_pred             ceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEec
Confidence            348999999999999999999999999999999865543333345678999999999998543          5799999


Q ss_pred             cCCCChhhHhhc--CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCCCCccc
Q psy1546         127 LGGGSALDLMKA--GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTF  204 (604)
Q Consensus       127 ~~ggsL~~~l~~--~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~~~~~  204 (604)
                      +. ++|..++..  +.+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||+++............
T Consensus        85 ~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~  163 (291)
T cd07870          85 MH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSE  163 (291)
T ss_pred             cc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCCCCCCCCCc
Confidence            96 566665533  457888899999999999999999999999999999999999999999999997654433334455


Q ss_pred             ccCCCCCChHHhhcC-CCCCcchhhhHHHHHHHHHhCCCCCCCCChh-hHhhhc------------------CCCC----
Q psy1546         205 VGTPFWMAPEVIKQS-AYDSKADIWSLGITAIELAKGEPPNSELHPM-RVLFLI------------------PKNN----  260 (604)
Q Consensus       205 ~GT~~Y~APE~l~~~-~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~-~~~~~i------------------~~~~----  260 (604)
                      .+++.|+|||++.+. .++.++|||||||+||+|++|..||...... +....+                  ....    
T Consensus       164 ~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (291)
T cd07870         164 VVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKPEWF  243 (291)
T ss_pred             cccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcccccchhc
Confidence            689999999998754 5788999999999999999999999765432 111000                  0000    


Q ss_pred             ----CC---CCC--ccchHHHHHHHHHHhccCCCCCCCHHHHhcChhh
Q psy1546         261 ----PP---QLT--GNYTKQFKEFVEACLNKDPENRPTAKELLKFPFI  299 (604)
Q Consensus       261 ----~~---~~~--~~~s~~l~~Li~~~L~~dP~~RpT~~elL~hp~f  299 (604)
                          +.   .+.  -..+..+.+|+.+||..||.+|||+.|++.||||
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~  291 (291)
T cd07870         244 LPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF  291 (291)
T ss_pred             cccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence                00   000  0125688999999999999999999999999997

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=5e-38  Score=317.73  Aligned_cols=232  Identities=25%  Similarity=0.438  Sum_probs=198.8

Q ss_pred             EEcccCcEEEEEEEE--CCCCcEEEEEEecchhh-HHHHHHHHHHHHHHhhCCCCCCCeE---------EEEEEecCCCC
Q psy1546          64 RIGKGSFGEVFKGID--NRTQQVVAIKIIDLEEA-EDEIEDIQQEIMVLSQCDSPYGTKL---------WIIMEYLGGGS  131 (604)
Q Consensus        64 ~LG~G~fG~Vy~a~~--~~t~~~vAVK~i~~~~~-~~~~~~l~~Ei~iL~~l~hp~~~~l---------yLVmEy~~ggs  131 (604)
                      +||+|+||.||+|.+  ..++..||||++..... ....+.+..|+.+++.+.|+++.++         ++||||+++++
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~lv~e~~~~~~   81 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEAESWMLVMELAELGP   81 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCcEEEEecCCCCc
Confidence            589999999999964  46788999999865433 2345678899999999999996654         69999999999


Q ss_pred             hhhHhhc-CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCCC---CcccccC
Q psy1546         132 ALDLMKA-GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSK---RNTFVGT  207 (604)
Q Consensus       132 L~~~l~~-~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~---~~~~~GT  207 (604)
                      |.+++.. +.+++..+..++.||+.||.|||++||+||||||.|||++.++.+||+|||+++.+......   .....++
T Consensus        82 L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~  161 (257)
T cd05116          82 LNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWP  161 (257)
T ss_pred             HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCCCCCC
Confidence            9998865 57899999999999999999999999999999999999999999999999999766433221   1223346


Q ss_pred             CCCCChHHhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHhhhcCCCCCCCCCccchHHHHHHHHHHhccCCCC
Q psy1546         208 PFWMAPEVIKQSAYDSKADIWSLGITAIELAK-GEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPEN  286 (604)
Q Consensus       208 ~~Y~APE~l~~~~~~~~sDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~  286 (604)
                      +.|+|||.+....++.++|||||||++|||++ |..||...........+........+..++.++.+||.+||+.||.+
T Consensus       162 ~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~~~~~p~~  241 (257)
T cd05116         162 VKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERMECPQRCPPEMYDLMKLCWTYGVDE  241 (257)
T ss_pred             ccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHhccCchh
Confidence            78999999988889999999999999999998 99999988777777777766666677789999999999999999999


Q ss_pred             CCCHHHHhc
Q psy1546         287 RPTAKELLK  295 (604)
Q Consensus       287 RpT~~elL~  295 (604)
                      ||++.+|.+
T Consensus       242 Rp~~~~i~~  250 (257)
T cd05116         242 RPGFAVVEL  250 (257)
T ss_pred             CcCHHHHHH
Confidence            999999865

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.4e-38  Score=317.45  Aligned_cols=238  Identities=32%  Similarity=0.549  Sum_probs=196.1

Q ss_pred             eEEcccCcEEEEEEEECCCCcEEEEEEecchhh--HHHHHHHHHHHHH-HhhCCCCCCCe----------EEEEEEecCC
Q psy1546          63 ERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA--EDEIEDIQQEIMV-LSQCDSPYGTK----------LWIIMEYLGG  129 (604)
Q Consensus        63 ~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~--~~~~~~l~~Ei~i-L~~l~hp~~~~----------lyLVmEy~~g  129 (604)
                      +.||.|+||.||+|.+..+++.||||++.....  ......+..|..+ ...+.|++..+          +|+||||+++
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG   81 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence            569999999999999999999999999865432  2223334445443 45668888544          4799999999


Q ss_pred             CChhhHhhc-CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCCCCcccccCC
Q psy1546         130 GSALDLMKA-GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTP  208 (604)
Q Consensus       130 gsL~~~l~~-~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~~~~~~GT~  208 (604)
                      ++|..++.. +.+++..+..++.||+.||.|||+.|++||||+|+|||++.++.++|+|||++.....    .....|++
T Consensus        82 ~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~----~~~~~~~~  157 (260)
T cd05611          82 GDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE----NKKFVGTP  157 (260)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceeccc----cccCCCCc
Confidence            999999865 6789999999999999999999999999999999999999999999999999865432    23456889


Q ss_pred             CCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCCC---CCCCCccchHHHHHHHHHHhccCCC
Q psy1546         209 FWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNN---PPQLTGNYTKQFKEFVEACLNKDPE  285 (604)
Q Consensus       209 ~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~~---~~~~~~~~s~~l~~Li~~~L~~dP~  285 (604)
                      .|+|||.+.+..++.++||||||+++|+|++|..||...........+....   .......++..+.++|.+||..||+
T Consensus       158 ~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~  237 (260)
T cd05611         158 DYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCMDPA  237 (260)
T ss_pred             CccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCCcccccCCHHHHHHHHHHccCCHH
Confidence            9999999988889999999999999999999999998877665544432221   2233446789999999999999999


Q ss_pred             CCC---CHHHHhcChhhhhhhh
Q psy1546         286 NRP---TAKELLKFPFIRKAKK  304 (604)
Q Consensus       286 ~Rp---T~~elL~hp~f~~~~~  304 (604)
                      +||   +++|++.||||++..+
T Consensus       238 ~R~~~~~~~~~l~~~~~~~~~~  259 (260)
T cd05611         238 KRLGANGYQEIKSHPFFKSINW  259 (260)
T ss_pred             HccCCCcHHHHHcChHhhcCCC
Confidence            999   5689999999976543

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.5e-38  Score=316.97  Aligned_cols=241  Identities=34%  Similarity=0.632  Sum_probs=205.1

Q ss_pred             cceeeeEEcccCcEEEEEEEECCCCcEEEEEEecch----hhHHHHHHHHHHHHHHhhCCCCCCCe------------EE
Q psy1546          58 IFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLE----EAEDEIEDIQQEIMVLSQCDSPYGTK------------LW  121 (604)
Q Consensus        58 ~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~----~~~~~~~~l~~Ei~iL~~l~hp~~~~------------ly  121 (604)
                      .|.+.+.||+|+||.||+|++..++..||+|++...    ........+.+|+.++++++|+++.+            ++
T Consensus         3 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~   82 (264)
T cd06653           3 NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLS   82 (264)
T ss_pred             ceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEEE
Confidence            488999999999999999999999999999987532    12344578889999999999997443            57


Q ss_pred             EEEEecCCCChhhHhhc-CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCC--
Q psy1546         122 IIMEYLGGGSALDLMKA-GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTT--  198 (604)
Q Consensus       122 LVmEy~~ggsL~~~l~~-~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~--  198 (604)
                      +||||+++++|.+++.. +.+++..+..++.||+.||.|||+.|++||||||+||+++.++.++|+|||+++......  
T Consensus        83 ~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~  162 (264)
T cd06653          83 IFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMS  162 (264)
T ss_pred             EEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcccccccccccccc
Confidence            89999999999998865 568999999999999999999999999999999999999999999999999997653211  


Q ss_pred             -CCCcccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcC-CCCCCCCCccchHHHHHHH
Q psy1546         199 -SKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIP-KNNPPQLTGNYTKQFKEFV  276 (604)
Q Consensus       199 -~~~~~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~-~~~~~~~~~~~s~~l~~Li  276 (604)
                       .......|+..|+|||++.+..++.++|||||||++|+|++|..||...........+. ....+.++..+++.+.++|
T Consensus       163 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~i  242 (264)
T cd06653         163 GTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDGVSDACRDFL  242 (264)
T ss_pred             CccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHcCCCCCCCCcccCHHHHHHH
Confidence             11224568999999999998889999999999999999999999998876555444333 2334566778899999999


Q ss_pred             HHHhccCCCCCCCHHHHhcChhh
Q psy1546         277 EACLNKDPENRPTAKELLKFPFI  299 (604)
Q Consensus       277 ~~~L~~dP~~RpT~~elL~hp~f  299 (604)
                      .+||. ++..||++.+++.|||+
T Consensus       243 ~~~l~-~~~~r~~~~~~~~~~~~  264 (264)
T cd06653         243 KQIFV-EEKRRPTAEFLLRHPFV  264 (264)
T ss_pred             HHHhc-CcccCccHHHHhcCCCC
Confidence            99999 57999999999999984

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=2.9e-38  Score=319.27  Aligned_cols=236  Identities=27%  Similarity=0.453  Sum_probs=203.8

Q ss_pred             cceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCCe----------EEEEEEec
Q psy1546          58 IFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTK----------LWIIMEYL  127 (604)
Q Consensus        58 ~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~~----------lyLVmEy~  127 (604)
                      .|.+.++||.|+||.||+|.+.. +..||+|++..... .....+..|+.+++.++|+++.+          +|+||||+
T Consensus         7 ~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~   84 (261)
T cd05148           7 EFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDL-LKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELM   84 (261)
T ss_pred             HHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccch-hhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeec
Confidence            48899999999999999999887 88999999865543 23467889999999999998554          47999999


Q ss_pred             CCCChhhHhhc---CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCCCCccc
Q psy1546         128 GGGSALDLMKA---GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTF  204 (604)
Q Consensus       128 ~ggsL~~~l~~---~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~~~~~  204 (604)
                      ++++|.+++..   ..+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+..........
T Consensus        85 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~~~~~  164 (261)
T cd05148          85 EKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDK  164 (261)
T ss_pred             ccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcCCccccccCC
Confidence            99999999965   458999999999999999999999999999999999999999999999999997665433333334


Q ss_pred             ccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHhhhcCCCCCCCCCccchHHHHHHHHHHhccC
Q psy1546         205 VGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAK-GEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKD  283 (604)
Q Consensus       205 ~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~~L~~d  283 (604)
                      .++..|+|||++.+..++.++|||||||++|+|++ |..||......+....+........+..+++.+.+++.+||..|
T Consensus       165 ~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~  244 (261)
T cd05148         165 KIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRMPCPAKCPQEIYKIMLECWAAE  244 (261)
T ss_pred             CCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCCcCCCCCCCCHHHHHHHHHHcCCC
Confidence            56778999999998899999999999999999998 89999888777666666555555566788999999999999999


Q ss_pred             CCCCCCHHHHhc
Q psy1546         284 PENRPTAKELLK  295 (604)
Q Consensus       284 P~~RpT~~elL~  295 (604)
                      |.+|||+.+|++
T Consensus       245 p~~Rpt~~~l~~  256 (261)
T cd05148         245 PEDRPSFKALRE  256 (261)
T ss_pred             chhCcCHHHHHH
Confidence            999999999976

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=7e-38  Score=322.54  Aligned_cols=237  Identities=24%  Similarity=0.421  Sum_probs=200.9

Q ss_pred             cceeeeEEcccCcEEEEEEEE-----CCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCCeE----------EE
Q psy1546          58 IFTKQERIGKGSFGEVFKGID-----NRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTKL----------WI  122 (604)
Q Consensus        58 ~y~i~~~LG~G~fG~Vy~a~~-----~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~~l----------yL  122 (604)
                      .|.+.+.||+|+||.||++.+     ..++..||+|.+.... ......+.+|+.+++.+.|+++.++          |+
T Consensus         6 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (288)
T cd05093           6 NIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS-DNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM   84 (288)
T ss_pred             HeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence            488999999999999999985     3355679999986543 3345678999999999999986554          79


Q ss_pred             EEEecCCCChhhHhhcC--------------CCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecc
Q psy1546         123 IMEYLGGGSALDLMKAG--------------NFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADF  188 (604)
Q Consensus       123 VmEy~~ggsL~~~l~~~--------------~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DF  188 (604)
                      ||||+++++|.+++...              .+++..+..++.||+.||+|||++|++||||||+|||++.++.++|+||
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~~kl~df  164 (288)
T cd05093          85 VFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDF  164 (288)
T ss_pred             EEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcEEeccC
Confidence            99999999999998642              3899999999999999999999999999999999999999999999999


Q ss_pred             cccccccCCCC--CCcccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHhhhcCCCCCCCCC
Q psy1546         189 GVAGTLTNTTS--KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAK-GEPPNSELHPMRVLFLIPKNNPPQLT  265 (604)
Q Consensus       189 GlA~~~~~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~  265 (604)
                      |+++.......  ......+++.|+|||++.+..++.++|||||||++|+|++ |.+||...........+..+.....+
T Consensus       165 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~~~~~~~~  244 (288)
T cd05093         165 GMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRVLQRP  244 (288)
T ss_pred             CccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCcCCCC
Confidence            99975533221  1223446788999999999999999999999999999998 99999888777666666666555566


Q ss_pred             ccchHHHHHHHHHHhccCCCCCCCHHHHhc
Q psy1546         266 GNYTKQFKEFVEACLNKDPENRPTAKELLK  295 (604)
Q Consensus       266 ~~~s~~l~~Li~~~L~~dP~~RpT~~elL~  295 (604)
                      ..++.++.+|+.+||+.||.+|||+.+++.
T Consensus       245 ~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~  274 (288)
T cd05093         245 RTCPKEVYDLMLGCWQREPHMRLNIKEIHS  274 (288)
T ss_pred             CCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            678899999999999999999999999965

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=2.8e-38  Score=334.51  Aligned_cols=239  Identities=24%  Similarity=0.424  Sum_probs=196.3

Q ss_pred             cceeeeEEcccCcEEEEEEEEC-----CCCcEEEEEEecchhhHHHHHHHHHHHHHHhhC-CCCCCC-----------eE
Q psy1546          58 IFTKQERIGKGSFGEVFKGIDN-----RTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQC-DSPYGT-----------KL  120 (604)
Q Consensus        58 ~y~i~~~LG~G~fG~Vy~a~~~-----~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l-~hp~~~-----------~l  120 (604)
                      .|.+.+.||+|+||.||+|.+.     .+++.||+|++...........+.+|+.++.++ .|+|+.           .+
T Consensus         8 ~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~~   87 (337)
T cd05054           8 RLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGPL   87 (337)
T ss_pred             HhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCCE
Confidence            4899999999999999999754     345789999987554445567788999999999 788743           35


Q ss_pred             EEEEEecCCCChhhHhhc--------------------------------------------------------------
Q psy1546         121 WIIMEYLGGGSALDLMKA--------------------------------------------------------------  138 (604)
Q Consensus       121 yLVmEy~~ggsL~~~l~~--------------------------------------------------------------  138 (604)
                      |+||||+++++|.+++..                                                              
T Consensus        88 ~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  167 (337)
T cd05054          88 MVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYK  167 (337)
T ss_pred             EEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHhh
Confidence            799999999999988742                                                              


Q ss_pred             CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCC--CCcccccCCCCCChHHh
Q psy1546         139 GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTS--KRNTFVGTPFWMAPEVI  216 (604)
Q Consensus       139 ~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~--~~~~~~GT~~Y~APE~l  216 (604)
                      ..+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||+++.+.....  ......++..|||||++
T Consensus       168 ~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~  247 (337)
T cd05054         168 EPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPESI  247 (337)
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccCcHHh
Confidence            2578888999999999999999999999999999999999999999999999976543221  12234567789999999


Q ss_pred             hcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhH-hhhcCCCCCCCCCccchHHHHHHHHHHhccCCCCCCCHHHHh
Q psy1546         217 KQSAYDSKADIWSLGITAIELAK-GEPPNSELHPMRV-LFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPENRPTAKELL  294 (604)
Q Consensus       217 ~~~~~~~~sDVwSLGviL~eLlt-G~~Pf~~~~~~~~-~~~i~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~RpT~~elL  294 (604)
                      .+..++.++|||||||+||||++ |..||.+....+. ...+........+..++.++.+++.+||+.+|++||++.||+
T Consensus       248 ~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~ell  327 (337)
T cd05054         248 FDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRAPEYATPEIYSIMLDCWHNNPEDRPTFSELV  327 (337)
T ss_pred             cCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHH
Confidence            99999999999999999999997 9999987543332 223333334444566788999999999999999999999999


Q ss_pred             cC
Q psy1546         295 KF  296 (604)
Q Consensus       295 ~h  296 (604)
                      +|
T Consensus       328 ~~  329 (337)
T cd05054         328 EI  329 (337)
T ss_pred             HH
Confidence            85

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=6.8e-38  Score=317.94  Aligned_cols=238  Identities=24%  Similarity=0.432  Sum_probs=201.5

Q ss_pred             ceeeeEEcccCcEEEEEEEECC---CCcEEEEEEecchhh-HHHHHHHHHHHHHHhhCCCCCCCe---------------
Q psy1546          59 FTKQERIGKGSFGEVFKGIDNR---TQQVVAIKIIDLEEA-EDEIEDIQQEIMVLSQCDSPYGTK---------------  119 (604)
Q Consensus        59 y~i~~~LG~G~fG~Vy~a~~~~---t~~~vAVK~i~~~~~-~~~~~~l~~Ei~iL~~l~hp~~~~---------------  119 (604)
                      |.+.+.||+|+||.||+|.+..   ++..||||++..... ......+.+|+.+++.++|+++.+               
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   80 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP   80 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence            5678899999999999998765   347899999875432 344677899999999999998544               


Q ss_pred             -EEEEEEecCCCChhhHhhc-------CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEeccccc
Q psy1546         120 -LWIIMEYLGGGSALDLMKA-------GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVA  191 (604)
Q Consensus       120 -lyLVmEy~~ggsL~~~l~~-------~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA  191 (604)
                       .++||||+++|+|..++..       ..+++..+..++.||+.||.|||+++|+||||||+|||+++++.+||+|||++
T Consensus        81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~  160 (273)
T cd05035          81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLS  160 (273)
T ss_pred             ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCccce
Confidence             4689999999999988733       35888999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCCCC--CcccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHhhhcCCCCCCCCCccc
Q psy1546         192 GTLTNTTSK--RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAK-GEPPNSELHPMRVLFLIPKNNPPQLTGNY  268 (604)
Q Consensus       192 ~~~~~~~~~--~~~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~  268 (604)
                      +.+......  .....++..|+|||++.+..++.++|||||||++|||++ |.+||.+....+....+........+..+
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  240 (273)
T cd05035         161 KKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNRLKQPEDC  240 (273)
T ss_pred             eeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCcCC
Confidence            766433221  112235678999999988889999999999999999999 99999888877777666666666667788


Q ss_pred             hHHHHHHHHHHhccCCCCCCCHHHHhcC
Q psy1546         269 TKQFKEFVEACLNKDPENRPTAKELLKF  296 (604)
Q Consensus       269 s~~l~~Li~~~L~~dP~~RpT~~elL~h  296 (604)
                      +..+.+++.+||..||.+|||+.|++++
T Consensus       241 ~~~~~~li~~~l~~~p~~Rp~~~e~~~~  268 (273)
T cd05035         241 LDELYDLMYSCWRADPKDRPTFTKLREV  268 (273)
T ss_pred             CHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            9999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=6e-38  Score=326.12  Aligned_cols=237  Identities=26%  Similarity=0.439  Sum_probs=196.8

Q ss_pred             ceeeeEEcccCcEEEEEEEECCCCcE--EEEEEecchhhHHHHHHHHHHHHHHhhC-CCCCCCeE----------EEEEE
Q psy1546          59 FTKQERIGKGSFGEVFKGIDNRTQQV--VAIKIIDLEEAEDEIEDIQQEIMVLSQC-DSPYGTKL----------WIIME  125 (604)
Q Consensus        59 y~i~~~LG~G~fG~Vy~a~~~~t~~~--vAVK~i~~~~~~~~~~~l~~Ei~iL~~l-~hp~~~~l----------yLVmE  125 (604)
                      |.+.+.||+|+||.||+|.+..++..  +|+|.+...........+.+|+.++.++ .|+++.++          |+|||
T Consensus         9 ~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e   88 (303)
T cd05088           9 IKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIE   88 (303)
T ss_pred             ceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEEEE
Confidence            88899999999999999998877754  5777765443344557788999999999 89986554          79999


Q ss_pred             ecCCCChhhHhhcC-----------------CCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecc
Q psy1546         126 YLGGGSALDLMKAG-----------------NFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADF  188 (604)
Q Consensus       126 y~~ggsL~~~l~~~-----------------~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DF  188 (604)
                      |+++++|.+++...                 .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+||
T Consensus        89 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~~~kl~df  168 (303)
T cd05088          89 YAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADF  168 (303)
T ss_pred             eCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCCcEEeCcc
Confidence            99999999998642                 4788899999999999999999999999999999999999999999999


Q ss_pred             cccccccCCCCCCcccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHhhhcCCCCCCCCCcc
Q psy1546         189 GVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAK-GEPPNSELHPMRVLFLIPKNNPPQLTGN  267 (604)
Q Consensus       189 GlA~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~  267 (604)
                      |++...... .......++..|+|||++.+..++.++|||||||+||||++ |.+||......+....+........+..
T Consensus       169 g~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  247 (303)
T cd05088         169 GLSRGQEVY-VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLN  247 (303)
T ss_pred             ccCcccchh-hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCcCCCCCC
Confidence            998543211 11122234677999999988889999999999999999998 9999988776666655544434444556


Q ss_pred             chHHHHHHHHHHhccCCCCCCCHHHHhcC
Q psy1546         268 YTKQFKEFVEACLNKDPENRPTAKELLKF  296 (604)
Q Consensus       268 ~s~~l~~Li~~~L~~dP~~RpT~~elL~h  296 (604)
                      ++..+.+|+.+||..+|++||++.+++.+
T Consensus       248 ~~~~~~~li~~~l~~~p~~Rp~~~~il~~  276 (303)
T cd05088         248 CDDEVYDLMRQCWREKPYERPSFAQILVS  276 (303)
T ss_pred             CCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            78899999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=8e-38  Score=318.18  Aligned_cols=241  Identities=29%  Similarity=0.508  Sum_probs=206.6

Q ss_pred             cceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhh--HHHHHHHHHHHHHHhhCC-CCCC----------CeEEEEE
Q psy1546          58 IFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA--EDEIEDIQQEIMVLSQCD-SPYG----------TKLWIIM  124 (604)
Q Consensus        58 ~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~--~~~~~~l~~Ei~iL~~l~-hp~~----------~~lyLVm  124 (604)
                      .|.+.+.||+|+||.||+|.+..+++.||+|++.....  ......+.+|+.+++.+. |+++          ..+|+||
T Consensus         2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~   81 (280)
T cd05581           2 DFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVL   81 (280)
T ss_pred             CceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEE
Confidence            38889999999999999999999999999999876432  233467889999999998 9974          3568999


Q ss_pred             EecCCCChhhHhhc-CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCC-----
Q psy1546         125 EYLGGGSALDLMKA-GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTT-----  198 (604)
Q Consensus       125 Ey~~ggsL~~~l~~-~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~-----  198 (604)
                      ||+.+++|.+++.. +.+++..++.++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++.......     
T Consensus        82 e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~~~~  161 (280)
T cd05581          82 EYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESN  161 (280)
T ss_pred             cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCccccccC
Confidence            99999999999876 489999999999999999999999999999999999999999999999999997654322     


Q ss_pred             ---------------CCCcccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCCCCCC
Q psy1546         199 ---------------SKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQ  263 (604)
Q Consensus       199 ---------------~~~~~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~  263 (604)
                                     .....+.|+..|+|||++....++.++||||||+++|+|++|..||...........+.. ....
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~-~~~~  240 (280)
T cd05581         162 KGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILK-LEYS  240 (280)
T ss_pred             CCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHh-cCCC
Confidence                           223345688999999999888899999999999999999999999988776554443332 2234


Q ss_pred             CCccchHHHHHHHHHHhccCCCCCCCH----HHHhcChhh
Q psy1546         264 LTGNYTKQFKEFVEACLNKDPENRPTA----KELLKFPFI  299 (604)
Q Consensus       264 ~~~~~s~~l~~Li~~~L~~dP~~RpT~----~elL~hp~f  299 (604)
                      ++..+++.+.+||.+||..+|.+||++    +++++||||
T Consensus       241 ~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~  280 (280)
T cd05581         241 FPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF  280 (280)
T ss_pred             CCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence            556778999999999999999999999    999999997

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=4e-38  Score=322.44  Aligned_cols=242  Identities=31%  Similarity=0.521  Sum_probs=200.2

Q ss_pred             cceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhh-HHHHHHHHHHHHHHhhCCCCCCC----------eEEEEEEe
Q psy1546          58 IFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA-EDEIEDIQQEIMVLSQCDSPYGT----------KLWIIMEY  126 (604)
Q Consensus        58 ~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~-~~~~~~l~~Ei~iL~~l~hp~~~----------~lyLVmEy  126 (604)
                      .|.+.+.||+|+||.||+|.+..+++.||||++..... ......+.+|+.+++.+.|+++.          .+|+||||
T Consensus         2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   81 (288)
T cd07833           2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEY   81 (288)
T ss_pred             ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEec
Confidence            38899999999999999999999999999999865432 22346788999999999999843          35899999


Q ss_pred             cCCCChhhHhhc-CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCC-CCccc
Q psy1546         127 LGGGSALDLMKA-GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTS-KRNTF  204 (604)
Q Consensus       127 ~~ggsL~~~l~~-~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~-~~~~~  204 (604)
                      ++++.+..++.. ..+++..+..++.||+.||.|||++|++||||+|+||+++.++.+||+|||++........ .....
T Consensus        82 ~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~~~~~  161 (288)
T cd07833          82 VERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDY  161 (288)
T ss_pred             CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCccccccCc
Confidence            998877776654 5699999999999999999999999999999999999999999999999999976654432 33456


Q ss_pred             ccCCCCCChHHhhcC-CCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCC--------------------C-C--
Q psy1546         205 VGTPFWMAPEVIKQS-AYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPK--------------------N-N--  260 (604)
Q Consensus       205 ~GT~~Y~APE~l~~~-~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~--------------------~-~--  260 (604)
                      .++..|+|||++.+. .++.++||||||+++|+|++|.+||...........+..                    . .  
T Consensus       162 ~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (288)
T cd07833         162 VATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVAFP  241 (288)
T ss_pred             ccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccccccccC
Confidence            789999999999888 789999999999999999999999986554332211100                    0 0  


Q ss_pred             --------CCCCCccchHHHHHHHHHHhccCCCCCCCHHHHhcChhh
Q psy1546         261 --------PPQLTGNYTKQFKEFVEACLNKDPENRPTAKELLKFPFI  299 (604)
Q Consensus       261 --------~~~~~~~~s~~l~~Li~~~L~~dP~~RpT~~elL~hp~f  299 (604)
                              ....+..++.++.+||++||..+|++|||+.++++||||
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f  288 (288)
T cd07833         242 EPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF  288 (288)
T ss_pred             CCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence                    001223357889999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=1.5e-37  Score=310.55  Aligned_cols=241  Identities=44%  Similarity=0.791  Sum_probs=208.1

Q ss_pred             ceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhh-HHHHHHHHHHHHHHhhCCCCCC------------CeEEEEEE
Q psy1546          59 FTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA-EDEIEDIQQEIMVLSQCDSPYG------------TKLWIIME  125 (604)
Q Consensus        59 y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~-~~~~~~l~~Ei~iL~~l~hp~~------------~~lyLVmE  125 (604)
                      |.+.+.||+|+||.||+|.+..+++.|++|++..... ....+.+.+|+.+++++.|+++            ..+|+|||
T Consensus         2 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e   81 (260)
T cd06606           2 WTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLE   81 (260)
T ss_pred             ceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEEE
Confidence            7788999999999999999999999999999865543 3456788999999999999972            45689999


Q ss_pred             ecCCCChhhHhhcC-CCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCC--CCc
Q psy1546         126 YLGGGSALDLMKAG-NFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTS--KRN  202 (604)
Q Consensus       126 y~~ggsL~~~l~~~-~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~--~~~  202 (604)
                      |+++++|.+++... .+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+........  ...
T Consensus        82 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~  161 (260)
T cd06606          82 YVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTG  161 (260)
T ss_pred             ecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEeccccccccccc
Confidence            99999999998764 799999999999999999999999999999999999999999999999999976654432  134


Q ss_pred             ccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCC-hhhHhhhcCC-CCCCCCCccchHHHHHHHHHHh
Q psy1546         203 TFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELH-PMRVLFLIPK-NNPPQLTGNYTKQFKEFVEACL  280 (604)
Q Consensus       203 ~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~-~~~~~~~i~~-~~~~~~~~~~s~~l~~Li~~~L  280 (604)
                      ...++..|+|||.+.+..++.++||||||+++|+|++|..||.... .......+.. .....++..++..+.+||.+||
T Consensus       162 ~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l  241 (260)
T cd06606         162 SVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKDFLRKCL  241 (260)
T ss_pred             CCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccccCCCcCCCcccCHHHHHHHHHhC
Confidence            5678999999999998889999999999999999999999998765 2233333322 3445566778999999999999


Q ss_pred             ccCCCCCCCHHHHhcChhh
Q psy1546         281 NKDPENRPTAKELLKFPFI  299 (604)
Q Consensus       281 ~~dP~~RpT~~elL~hp~f  299 (604)
                      ..||.+||++.++++||||
T Consensus       242 ~~~p~~Rp~~~~ll~~~~~  260 (260)
T cd06606         242 RRDPKKRPTADELLQHPFL  260 (260)
T ss_pred             cCChhhCCCHHHHhhCCCC
Confidence            9999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=3.9e-38  Score=324.38  Aligned_cols=242  Identities=27%  Similarity=0.451  Sum_probs=194.1

Q ss_pred             cceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhH-HHHHHHHHHHHHHhhCC-CCCCC---------------eE
Q psy1546          58 IFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAE-DEIEDIQQEIMVLSQCD-SPYGT---------------KL  120 (604)
Q Consensus        58 ~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~-~~~~~l~~Ei~iL~~l~-hp~~~---------------~l  120 (604)
                      .|.+.+.||+|+||.||+|.+..+++.||||++...... .....+.+|+.+++.+. |+++.               .+
T Consensus         2 ~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~   81 (295)
T cd07837           2 AYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSL   81 (295)
T ss_pred             CceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceE
Confidence            388999999999999999999999999999998654322 22356788999999995 47632               15


Q ss_pred             EEEEEecCCCChhhHhhc------CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecC-CCCeEEeccccccc
Q psy1546         121 WIIMEYLGGGSALDLMKA------GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSE-MGDVKLADFGVAGT  193 (604)
Q Consensus       121 yLVmEy~~ggsL~~~l~~------~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~-~g~vKL~DFGlA~~  193 (604)
                      |+||||+++ +|.+++..      ..+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||++..
T Consensus        82 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~~~  160 (295)
T cd07837          82 YLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRA  160 (295)
T ss_pred             EEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeeccccee
Confidence            899999986 68777642      34799999999999999999999999999999999999998 88999999999976


Q ss_pred             ccCCCCCCcccccCCCCCChHHhhc-CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCC-------------
Q psy1546         194 LTNTTSKRNTFVGTPFWMAPEVIKQ-SAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKN-------------  259 (604)
Q Consensus       194 ~~~~~~~~~~~~GT~~Y~APE~l~~-~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~-------------  259 (604)
                      +...........+++.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.........+...             
T Consensus       161 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (295)
T cd07837         161 FSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGVS  240 (295)
T ss_pred             cCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCcchh
Confidence            5433333334467899999999865 45789999999999999999999999876554433211000             


Q ss_pred             -----------C---CCCCCccchHHHHHHHHHHhccCCCCCCCHHHHhcChhhh
Q psy1546         260 -----------N---PPQLTGNYTKQFKEFVEACLNKDPENRPTAKELLKFPFIR  300 (604)
Q Consensus       260 -----------~---~~~~~~~~s~~l~~Li~~~L~~dP~~RpT~~elL~hp~f~  300 (604)
                                 .   .......++..+.+||.+||..||.+||++.|+|.||||+
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~  295 (295)
T cd07837         241 KLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD  295 (295)
T ss_pred             hccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence                       0   0001134678899999999999999999999999999984

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=5.3e-38  Score=322.57  Aligned_cols=244  Identities=34%  Similarity=0.607  Sum_probs=197.1

Q ss_pred             ceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCC-CCCCCeE----------EEEEEec
Q psy1546          59 FTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCD-SPYGTKL----------WIIMEYL  127 (604)
Q Consensus        59 y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~-hp~~~~l----------yLVmEy~  127 (604)
                      |...+.||+|+||.||++.+..+++.||||.+...........+.+|+.++.++. |+++.++          |++|||+
T Consensus         6 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~~   85 (288)
T cd06616           6 LKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMELM   85 (288)
T ss_pred             hHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEecc
Confidence            5667889999999999999999999999999876554455677889999999986 9986653          6899998


Q ss_pred             CCCChhhHh------hcCCCcHHHHHHHHHHHHHHhHHhhhC-CccccccccceeEecCCCCeEEecccccccccCCCCC
Q psy1546         128 GGGSALDLM------KAGNFEEMHIAVILREVLKGLDYLHSE-RKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSK  200 (604)
Q Consensus       128 ~ggsL~~~l------~~~~lse~~i~~i~~qIl~gL~yLHs~-gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~  200 (604)
                      .+ ++.++.      ..+.+++..+..++.|++.||+|||+. +|+||||||+|||++.++.++|+|||+++.+..... 
T Consensus        86 ~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~-  163 (288)
T cd06616          86 DI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIA-  163 (288)
T ss_pred             cC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHhccCCc-
Confidence            54 444432      236799999999999999999999975 999999999999999999999999999976543322 


Q ss_pred             CcccccCCCCCChHHhhcC---CCCCcchhhhHHHHHHHHHhCCCCCCCCCh-hhHhhhcCCCCCCCC----CccchHHH
Q psy1546         201 RNTFVGTPFWMAPEVIKQS---AYDSKADIWSLGITAIELAKGEPPNSELHP-MRVLFLIPKNNPPQL----TGNYTKQF  272 (604)
Q Consensus       201 ~~~~~GT~~Y~APE~l~~~---~~~~~sDVwSLGviL~eLltG~~Pf~~~~~-~~~~~~i~~~~~~~~----~~~~s~~l  272 (604)
                      .....|++.|+|||++.+.   .++.++|||||||++|+|++|.+||..... ......+.....+.+    ...++.++
T Consensus       164 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  243 (288)
T cd06616         164 KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSEEREFSPSF  243 (288)
T ss_pred             cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCCCCCcCCCcCCCccCHHH
Confidence            2334689999999999776   688999999999999999999999976542 122222222222222    23478899


Q ss_pred             HHHHHHHhccCCCCCCCHHHHhcChhhhhhhh
Q psy1546         273 KEFVEACLNKDPENRPTAKELLKFPFIRKAKK  304 (604)
Q Consensus       273 ~~Li~~~L~~dP~~RpT~~elL~hp~f~~~~~  304 (604)
                      .+||.+||..||.+|||+++|++||||+....
T Consensus       244 ~~li~~~l~~~p~~Rpt~~~i~~~~~~~~~~~  275 (288)
T cd06616         244 VNFINLCLIKDESKRPKYKELLEHPFIKDYEE  275 (288)
T ss_pred             HHHHHHHccCChhhCcCHHHHhcChhhhchhh
Confidence            99999999999999999999999999987543

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=1.7e-38  Score=322.91  Aligned_cols=236  Identities=30%  Similarity=0.543  Sum_probs=198.7

Q ss_pred             eeeeEEcccCcEEEEEEEEC----CCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCCeE----------EEEEE
Q psy1546          60 TKQERIGKGSFGEVFKGIDN----RTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTKL----------WIIME  125 (604)
Q Consensus        60 ~i~~~LG~G~fG~Vy~a~~~----~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~~l----------yLVmE  125 (604)
                      .+.+.||.|.||.||+|...    ..+..|+||++.........+.+.+|+.++++++|||+.++          ++|||
T Consensus         2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e   81 (259)
T PF07714_consen    2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVME   81 (259)
T ss_dssp             EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE
T ss_pred             EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccc
Confidence            46789999999999999987    45678999999665555567889999999999999996554          69999


Q ss_pred             ecCCCChhhHhhcC---CCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCC--CC
Q psy1546         126 YLGGGSALDLMKAG---NFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTT--SK  200 (604)
Q Consensus       126 y~~ggsL~~~l~~~---~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~--~~  200 (604)
                      ||++|+|.+++...   .+++..+..|+.||+.||.|||+++|+|+||+++||||+.++.+||+|||++.......  ..
T Consensus        82 ~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~~~  161 (259)
T PF07714_consen   82 YCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKYKN  161 (259)
T ss_dssp             --TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSEEE
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            99999999999764   79999999999999999999999999999999999999999999999999997663221  12


Q ss_pred             CcccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHhhhcCCCCCCCCCccchHHHHHHHHHH
Q psy1546         201 RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAK-GEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEAC  279 (604)
Q Consensus       201 ~~~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~~  279 (604)
                      .....+...|+|||.+....++.++||||||+++|||++ |..||...........+........+..++..+.++|..|
T Consensus       162 ~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~C  241 (259)
T PF07714_consen  162 DSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQRLPIPDNCPKDIYSLIQQC  241 (259)
T ss_dssp             STTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEETTSBTTSBHHHHHHHHHH
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccceeccchhHHHHHHHHHH
Confidence            233457788999999999999999999999999999999 7899999888887777766666667778999999999999


Q ss_pred             hccCCCCCCCHHHHhc
Q psy1546         280 LNKDPENRPTAKELLK  295 (604)
Q Consensus       280 L~~dP~~RpT~~elL~  295 (604)
                      |..||++|||+.+|++
T Consensus       242 ~~~~p~~RPs~~~i~~  257 (259)
T PF07714_consen  242 WSHDPEKRPSFQEILQ  257 (259)
T ss_dssp             T-SSGGGS--HHHHHH
T ss_pred             cCCChhhCcCHHHHHh
Confidence            9999999999999975

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=4.9e-38  Score=332.67  Aligned_cols=245  Identities=27%  Similarity=0.452  Sum_probs=199.3

Q ss_pred             cccceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCCe----------------
Q psy1546          56 ELIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTK----------------  119 (604)
Q Consensus        56 ~~~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~~----------------  119 (604)
                      ...|.+.+.||.|+||.||+|.+..+++.||+|++..... ...+.+.+|+.+++.++||++.+                
T Consensus         4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~-~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~   82 (342)
T cd07854           4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP-QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDV   82 (342)
T ss_pred             CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC-chHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccc
Confidence            4559999999999999999999999999999999865543 34567889999999999998443                


Q ss_pred             --------EEEEEEecCCCChhhHhhcCCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecC-CCCeEEecccc
Q psy1546         120 --------LWIIMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSE-MGDVKLADFGV  190 (604)
Q Consensus       120 --------lyLVmEy~~ggsL~~~l~~~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~-~g~vKL~DFGl  190 (604)
                              +|+||||++ ++|..++..+.+++..++.++.||+.||.|||+.||+||||||+|||++. ++.++|+|||+
T Consensus        83 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~dfg~  161 (342)
T cd07854          83 GSLTELNSVYIVQEYME-TDLANVLEQGPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGL  161 (342)
T ss_pred             ccccccceEEEEeeccc-ccHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEECCccc
Confidence                    579999996 58999988888999999999999999999999999999999999999974 55789999999


Q ss_pred             cccccCCCC---CCcccccCCCCCChHHhhc-CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCC-------
Q psy1546         191 AGTLTNTTS---KRNTFVGTPFWMAPEVIKQ-SAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKN-------  259 (604)
Q Consensus       191 A~~~~~~~~---~~~~~~GT~~Y~APE~l~~-~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~-------  259 (604)
                      +..+.....   ......|+..|+|||++.+ ..++.++|||||||++|+|++|..||...+.......+...       
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  241 (342)
T cd07854         162 ARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVREE  241 (342)
T ss_pred             ceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChH
Confidence            976532211   1123467889999998754 56788999999999999999999999876543332211110       


Q ss_pred             -----------------CC-----CCCCccchHHHHHHHHHHhccCCCCCCCHHHHhcChhhhhh
Q psy1546         260 -----------------NP-----PQLTGNYTKQFKEFVEACLNKDPENRPTAKELLKFPFIRKA  302 (604)
Q Consensus       260 -----------------~~-----~~~~~~~s~~l~~Li~~~L~~dP~~RpT~~elL~hp~f~~~  302 (604)
                                       ..     ..+...++.++.+||.+||..||.+|||+.++|.||||+..
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~  306 (342)
T cd07854         242 DRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCY  306 (342)
T ss_pred             HhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCccccc
Confidence                             00     01123467889999999999999999999999999999754

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=6.9e-38  Score=324.26  Aligned_cols=238  Identities=26%  Similarity=0.432  Sum_probs=198.5

Q ss_pred             cceeeeEEcccCcEEEEEEEECCCCc--EEEEEEecchhhHHHHHHHHHHHHHHhhC-CCCCCCeE----------EEEE
Q psy1546          58 IFTKQERIGKGSFGEVFKGIDNRTQQ--VVAIKIIDLEEAEDEIEDIQQEIMVLSQC-DSPYGTKL----------WIIM  124 (604)
Q Consensus        58 ~y~i~~~LG~G~fG~Vy~a~~~~t~~--~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l-~hp~~~~l----------yLVm  124 (604)
                      .|.+.+.||+|+||.||+|.+..++.  .+++|.+.........+.+.+|+.++.++ .||++.++          |+||
T Consensus         3 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~   82 (297)
T cd05089           3 DIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAI   82 (297)
T ss_pred             cceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEEE
Confidence            37889999999999999999887765  46888876433344456788999999999 79986554          7999


Q ss_pred             EecCCCChhhHhhcC-----------------CCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEec
Q psy1546         125 EYLGGGSALDLMKAG-----------------NFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLAD  187 (604)
Q Consensus       125 Ey~~ggsL~~~l~~~-----------------~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~D  187 (604)
                      ||+++++|.+++...                 .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|
T Consensus        83 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~d  162 (297)
T cd05089          83 EYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIAD  162 (297)
T ss_pred             EecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCeEEECC
Confidence            999999999998642                 478889999999999999999999999999999999999999999999


Q ss_pred             ccccccccCCCCCCcccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHhhhcCCCCCCCCCc
Q psy1546         188 FGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAK-GEPPNSELHPMRVLFLIPKNNPPQLTG  266 (604)
Q Consensus       188 FGlA~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~  266 (604)
                      ||++....... .......+..|+|||++.+..++.++|||||||++|||++ |..||...........+........+.
T Consensus       163 fg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~~~~~~~~~  241 (297)
T cd05089         163 FGLSRGEEVYV-KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRMEKPR  241 (297)
T ss_pred             cCCCcccccee-ccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCCCCC
Confidence            99985432111 1112233567999999999899999999999999999997 999998887777666665555555666


Q ss_pred             cchHHHHHHHHHHhccCCCCCCCHHHHhcC
Q psy1546         267 NYTKQFKEFVEACLNKDPENRPTAKELLKF  296 (604)
Q Consensus       267 ~~s~~l~~Li~~~L~~dP~~RpT~~elL~h  296 (604)
                      .++..+.+|+.+||..+|.+|||++++++.
T Consensus       242 ~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~  271 (297)
T cd05089         242 NCDDEVYELMRQCWRDRPYERPPFAQISVQ  271 (297)
T ss_pred             CCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            788999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=8.4e-38  Score=320.82  Aligned_cols=238  Identities=29%  Similarity=0.488  Sum_probs=192.2

Q ss_pred             EEcccCcEEEEEEEECCCCcEEEEEEecchhhH--HHHHHHH---HHHHHHhhCCCCCCC----------eEEEEEEecC
Q psy1546          64 RIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAE--DEIEDIQ---QEIMVLSQCDSPYGT----------KLWIIMEYLG  128 (604)
Q Consensus        64 ~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~--~~~~~l~---~Ei~iL~~l~hp~~~----------~lyLVmEy~~  128 (604)
                      .||+|+||.||+|.+..+++.||||++......  .......   ..+.+++...||++.          .+|+||||+.
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            389999999999999999999999998654322  1111222   234455566788744          4589999999


Q ss_pred             CCChhhHhhc-CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCCCCcccccC
Q psy1546         129 GGSALDLMKA-GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGT  207 (604)
Q Consensus       129 ggsL~~~l~~-~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~~~~~~GT  207 (604)
                      |++|.+++.. +.+++..++.++.|++.||.|||+.+|+||||||+|||++.++.++|+|||++..+...  .....+|+
T Consensus        81 g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~--~~~~~~~~  158 (278)
T cd05606          81 GGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK--KPHASVGT  158 (278)
T ss_pred             CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCcc--CCcCcCCC
Confidence            9999988854 57899999999999999999999999999999999999999999999999998755432  22345799


Q ss_pred             CCCCChHHhhcC-CCCCcchhhhHHHHHHHHHhCCCCCCCCCh---hhHhhhcCCCCCCCCCccchHHHHHHHHHHhccC
Q psy1546         208 PFWMAPEVIKQS-AYDSKADIWSLGITAIELAKGEPPNSELHP---MRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKD  283 (604)
Q Consensus       208 ~~Y~APE~l~~~-~~~~~sDVwSLGviL~eLltG~~Pf~~~~~---~~~~~~i~~~~~~~~~~~~s~~l~~Li~~~L~~d  283 (604)
                      ..|+|||++.+. .++.++|||||||++|+|++|..||.....   ......+ ......++..++..+.+++.+||..+
T Consensus       159 ~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~s~~~~~li~~~l~~~  237 (278)
T cd05606         159 HGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT-LTMAVELPDSFSPELRSLLEGLLQRD  237 (278)
T ss_pred             cCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHh-hccCCCCCCcCCHHHHHHHHHHhhcC
Confidence            999999999754 689999999999999999999999987632   2222222 22334556667899999999999999


Q ss_pred             CCCCC-----CHHHHhcChhhhhhhh
Q psy1546         284 PENRP-----TAKELLKFPFIRKAKK  304 (604)
Q Consensus       284 P~~Rp-----T~~elL~hp~f~~~~~  304 (604)
                      |.+||     ++.++++||||+...+
T Consensus       238 p~~R~~~~~~~~~~ll~~~~~~~~~~  263 (278)
T cd05606         238 VNRRLGCLGRGAQEVKEHPFFRSLDW  263 (278)
T ss_pred             HHhccCCCCCCHHHHHhCccccCCCc
Confidence            99999     9999999999987654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=8.3e-38  Score=322.03  Aligned_cols=237  Identities=27%  Similarity=0.486  Sum_probs=200.8

Q ss_pred             ceeeeEEcccCcEEEEEEEECC-----CCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCCeE----------EEE
Q psy1546          59 FTKQERIGKGSFGEVFKGIDNR-----TQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTKL----------WII  123 (604)
Q Consensus        59 y~i~~~LG~G~fG~Vy~a~~~~-----t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~~l----------yLV  123 (604)
                      |.+.+.||+|+||.||+|.+..     ....+|+|.+...........+.+|+.+++.+.||++.++          |+|
T Consensus         2 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv   81 (290)
T cd05045           2 LVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLI   81 (290)
T ss_pred             ccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEEE
Confidence            6788999999999999998753     3357999998765545556788999999999999997664          699


Q ss_pred             EEecCCCChhhHhhc-------------------------CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEec
Q psy1546         124 MEYLGGGSALDLMKA-------------------------GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLS  178 (604)
Q Consensus       124 mEy~~ggsL~~~l~~-------------------------~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~  178 (604)
                      |||+.+++|.+++..                         ..+++..++.++.|++.||.|||++||+||||||+|||++
T Consensus        82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~nill~  161 (290)
T cd05045          82 VEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVA  161 (290)
T ss_pred             EEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheEEEc
Confidence            999999999998753                         2477888999999999999999999999999999999999


Q ss_pred             CCCCeEEecccccccccCCCC--CCcccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHhhh
Q psy1546         179 EMGDVKLADFGVAGTLTNTTS--KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAK-GEPPNSELHPMRVLFL  255 (604)
Q Consensus       179 ~~g~vKL~DFGlA~~~~~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~~  255 (604)
                      +++.+||+|||+++.......  ......++..|+|||++.+..++.++|||||||++|+|++ |..||.+.....+...
T Consensus       162 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~  241 (290)
T cd05045         162 EGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERLFNL  241 (290)
T ss_pred             CCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Confidence            999999999999976533222  1223356778999999998889999999999999999998 9999998887776666


Q ss_pred             cCCCCCCCCCccchHHHHHHHHHHhccCCCCCCCHHHHhc
Q psy1546         256 IPKNNPPQLTGNYTKQFKEFVEACLNKDPENRPTAKELLK  295 (604)
Q Consensus       256 i~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~RpT~~elL~  295 (604)
                      +........+..++.++.+|+.+||+.+|.+||++.++++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~  281 (290)
T cd05045         242 LKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISK  281 (290)
T ss_pred             HhCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence            6555445556778899999999999999999999999976

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=1.1e-37  Score=314.91  Aligned_cols=234  Identities=29%  Similarity=0.464  Sum_probs=198.8

Q ss_pred             ceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCCe----------EEEEEEecC
Q psy1546          59 FTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTK----------LWIIMEYLG  128 (604)
Q Consensus        59 y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~~----------lyLVmEy~~  128 (604)
                      |++.+.||+|+||.||+|.+.. +..||+|.+......  ...+.+|+.+++.++||++.+          +|+||||++
T Consensus         6 ~~~~~~lg~G~~~~vy~~~~~~-~~~~a~K~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~   82 (256)
T cd05114           6 LTFMKELGSGQFGVVHLGKWRA-QIKVAIKAINEGAMS--EEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME   82 (256)
T ss_pred             cEEeeEecCCcCceEEEEEecc-CceEEEEecccCCcc--HHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence            7889999999999999998754 557999988644322  356788999999999998655          479999999


Q ss_pred             CCChhhHhhc--CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCCC-Ccccc
Q psy1546         129 GGSALDLMKA--GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSK-RNTFV  205 (604)
Q Consensus       129 ggsL~~~l~~--~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~-~~~~~  205 (604)
                      +|+|.+++..  +.+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||+++........ .....
T Consensus        83 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~~~~~~  162 (256)
T cd05114          83 NGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAK  162 (256)
T ss_pred             CCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCCceeccCCCC
Confidence            9999999864  46899999999999999999999999999999999999999999999999999765332221 11223


Q ss_pred             cCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHhhhcCCCCCCCCCccchHHHHHHHHHHhccCC
Q psy1546         206 GTPFWMAPEVIKQSAYDSKADIWSLGITAIELAK-GEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDP  284 (604)
Q Consensus       206 GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~~L~~dP  284 (604)
                      ++..|+|||++.+..++.++||||||+++|+|++ |..||......+....+..+.....+...+..+.+|+.+||..+|
T Consensus       163 ~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~c~~~~p  242 (256)
T cd05114         163 FPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYRPKLASMTVYEVMYSCWHEKP  242 (256)
T ss_pred             CchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHccCCc
Confidence            5668999999998889999999999999999999 999999888777777766665555566678899999999999999


Q ss_pred             CCCCCHHHHhc
Q psy1546         285 ENRPTAKELLK  295 (604)
Q Consensus       285 ~~RpT~~elL~  295 (604)
                      .+||++.+|++
T Consensus       243 ~~Rps~~~l~~  253 (256)
T cd05114         243 EGRPTFAELLR  253 (256)
T ss_pred             ccCcCHHHHHH
Confidence            99999999986

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=1.1e-37  Score=316.66  Aligned_cols=235  Identities=29%  Similarity=0.449  Sum_probs=198.8

Q ss_pred             cceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCCeE---------EEEEEecC
Q psy1546          58 IFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTKL---------WIIMEYLG  128 (604)
Q Consensus        58 ~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~~l---------yLVmEy~~  128 (604)
                      .|++.++||+|+||.||+|.+..++ .||||++......  .+.+.+|+.+++.+.|+++.++         |+||||+.
T Consensus         7 ~~~~~~~lg~g~~~~v~~~~~~~~~-~valK~~~~~~~~--~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~lv~e~~~   83 (262)
T cd05071           7 SLRLEVKLGQGCFGEVWMGTWNGTT-RVAIKTLKPGTMS--PEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMS   83 (262)
T ss_pred             HeeEeeecCCCCCCcEEEEEecCCc-eEEEEecccCccC--HHHHHHHHHHHHhCCCCCcceEEEEECCCCcEEEEEcCC
Confidence            3899999999999999999887654 5999998754322  2567889999999999986553         69999999


Q ss_pred             CCChhhHhhc---CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCCC-Cccc
Q psy1546         129 GGSALDLMKA---GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSK-RNTF  204 (604)
Q Consensus       129 ggsL~~~l~~---~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~-~~~~  204 (604)
                      +|+|.+++..   ..+++..+..++.|++.||.|||+.+|+||||||+|||++.++.++|+|||++..+...... ....
T Consensus        84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~~~~~~  163 (262)
T cd05071          84 KGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGA  163 (262)
T ss_pred             CCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeeccccccccccCC
Confidence            9999999965   35788999999999999999999999999999999999999999999999999765433221 1233


Q ss_pred             ccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHhhhcCCCCCCCCCccchHHHHHHHHHHhccC
Q psy1546         205 VGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAK-GEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKD  283 (604)
Q Consensus       205 ~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~~L~~d  283 (604)
                      .++..|+|||++.+..++.++|||||||++|+|++ |..||...........+...........++..+.+|+.+||+.|
T Consensus       164 ~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~  243 (262)
T cd05071         164 KFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKE  243 (262)
T ss_pred             cccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCCCCCCccccCHHHHHHHHHHccCC
Confidence            46678999999998899999999999999999999 89999887776666555544444555678899999999999999


Q ss_pred             CCCCCCHHHHhc
Q psy1546         284 PENRPTAKELLK  295 (604)
Q Consensus       284 P~~RpT~~elL~  295 (604)
                      |.+||++.+++.
T Consensus       244 p~~Rp~~~~~~~  255 (262)
T cd05071         244 PEERPTFEYLQA  255 (262)
T ss_pred             cccCCCHHHHHH
Confidence            999999999876

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>KOG0193|consensus

Probab=100.00  E-value=1.1e-38  Score=341.86  Aligned_cols=234  Identities=30%  Similarity=0.537  Sum_probs=201.3

Q ss_pred             ceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhh-HHHHHHHHHHHHHHhhCCCCCCCe---------EEEEEEecC
Q psy1546          59 FTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA-EDEIEDIQQEIMVLSQCDSPYGTK---------LWIIMEYLG  128 (604)
Q Consensus        59 y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~-~~~~~~l~~Ei~iL~~l~hp~~~~---------lyLVmEy~~  128 (604)
                      +.+.+.||+|.||+||+|++-.   .||||+++.... ...++.|+.|+.++++-+|.|+.-         +.||+.||+
T Consensus       394 v~l~~rIGsGsFGtV~Rg~whG---dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~AIiTqwCe  470 (678)
T KOG0193|consen  394 VLLGERIGSGSFGTVYRGRWHG---DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPLAIITQWCE  470 (678)
T ss_pred             hhccceeccccccceeeccccc---ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCceeeeehhcc
Confidence            5678999999999999998763   499999976643 346789999999999999998543         369999999


Q ss_pred             CCChhhHhhc--CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEeccccccccc--CCCCCCccc
Q psy1546         129 GGSALDLMKA--GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLT--NTTSKRNTF  204 (604)
Q Consensus       129 ggsL~~~l~~--~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~--~~~~~~~~~  204 (604)
                      |.+|+.++.-  .+|.......|++||+.|+.|||.++|||||||..|||+.+++.|||+|||++..-.  .........
T Consensus       471 GsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g~~q~~qp  550 (678)
T KOG0193|consen  471 GSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSGEQQLEQP  550 (678)
T ss_pred             CchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccceeeeeeeccccccCCC
Confidence            9999998854  679999999999999999999999999999999999999999999999999995322  223334455


Q ss_pred             ccCCCCCChHHhhc---CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCCC----CCCCCccchHHHHHHHH
Q psy1546         205 VGTPFWMAPEVIKQ---SAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNN----PPQLTGNYTKQFKEFVE  277 (604)
Q Consensus       205 ~GT~~Y~APE~l~~---~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~~----~~~~~~~~s~~l~~Li~  277 (604)
                      .|...|||||+++.   .+|++.+||||||||+|||++|..||.......+++++..+.    ......++++++++|+.
T Consensus       551 ~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd~s~~~s~~pk~mk~Ll~  630 (678)
T KOG0193|consen  551 HGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPDLSKIRSNCPKAMKRLLS  630 (678)
T ss_pred             ccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCccchhhhccCHHHHHHHHH
Confidence            68889999999974   458899999999999999999999999888888888887773    22344578889999999


Q ss_pred             HHhccCCCCCCCHHHHhc
Q psy1546         278 ACLNKDPENRPTAKELLK  295 (604)
Q Consensus       278 ~~L~~dP~~RpT~~elL~  295 (604)
                      .||..++++||.+.+||.
T Consensus       631 ~C~~~~~~eRP~F~~il~  648 (678)
T KOG0193|consen  631 DCWKFDREERPLFPQLLS  648 (678)
T ss_pred             HHHhcCcccCccHHHHHH
Confidence            999999999999999986

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=7.9e-38  Score=322.10  Aligned_cols=239  Identities=25%  Similarity=0.466  Sum_probs=202.1

Q ss_pred             cceeeeEEcccCcEEEEEEEECCC-----CcEEEEEEecchhhHHHHHHHHHHHHHHhhC-CCCCCCe----------EE
Q psy1546          58 IFTKQERIGKGSFGEVFKGIDNRT-----QQVVAIKIIDLEEAEDEIEDIQQEIMVLSQC-DSPYGTK----------LW  121 (604)
Q Consensus        58 ~y~i~~~LG~G~fG~Vy~a~~~~t-----~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l-~hp~~~~----------ly  121 (604)
                      .|.+.+.||+|+||.||+|.+...     ...||+|++...........+.+|+.++..+ +|+++.+          +|
T Consensus        13 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~   92 (293)
T cd05053          13 RLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLY   92 (293)
T ss_pred             HeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCCeE
Confidence            488999999999999999987643     3789999987654445567788999999999 7998654          47


Q ss_pred             EEEEecCCCChhhHhhc-----------------CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeE
Q psy1546         122 IIMEYLGGGSALDLMKA-----------------GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVK  184 (604)
Q Consensus       122 LVmEy~~ggsL~~~l~~-----------------~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vK  184 (604)
                      +||||+.+|+|..++..                 +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+|
T Consensus        93 li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~~~~~~~k  172 (293)
T cd05053          93 VVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMK  172 (293)
T ss_pred             EEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEEcCCCeEE
Confidence            99999999999998853                 3588899999999999999999999999999999999999999999


Q ss_pred             EecccccccccCCCCC--CcccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHhhhcCCCCC
Q psy1546         185 LADFGVAGTLTNTTSK--RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAK-GEPPNSELHPMRVLFLIPKNNP  261 (604)
Q Consensus       185 L~DFGlA~~~~~~~~~--~~~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~~i~~~~~  261 (604)
                      |+|||+++.+......  .....++..|+|||++.+..++.++|||||||++|||++ |..||......+....+.....
T Consensus       173 L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~  252 (293)
T cd05053         173 IADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKEGYR  252 (293)
T ss_pred             eCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHHHHHHHcCCc
Confidence            9999999766433221  122235678999999999999999999999999999997 9999988877666666555554


Q ss_pred             CCCCccchHHHHHHHHHHhccCCCCCCCHHHHhcC
Q psy1546         262 PQLTGNYTKQFKEFVEACLNKDPENRPTAKELLKF  296 (604)
Q Consensus       262 ~~~~~~~s~~l~~Li~~~L~~dP~~RpT~~elL~h  296 (604)
                      ...+..++..+.+|+.+||..||++|||+.|++++
T Consensus       253 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~  287 (293)
T cd05053         253 MEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED  287 (293)
T ss_pred             CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence            45566778899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=4.9e-38  Score=321.71  Aligned_cols=240  Identities=31%  Similarity=0.501  Sum_probs=195.9

Q ss_pred             ceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhH-HHHHHHHHHHHHHhhCCCCCCC----------eEEEEEEec
Q psy1546          59 FTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAE-DEIEDIQQEIMVLSQCDSPYGT----------KLWIIMEYL  127 (604)
Q Consensus        59 y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~-~~~~~l~~Ei~iL~~l~hp~~~----------~lyLVmEy~  127 (604)
                      |++.+.||.|++|.||+|.+..+|..||||++...... .....+.+|+.+++.++|++..          ..|+||||+
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~   80 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL   80 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence            67788999999999999999999999999998755322 2235677899999999999854          358999999


Q ss_pred             CCCChhhHhhcC---CCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCCCCccc
Q psy1546         128 GGGSALDLMKAG---NFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTF  204 (604)
Q Consensus       128 ~ggsL~~~l~~~---~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~~~~~  204 (604)
                      + ++|.+++...   .+++..+..++.||+.||.|||+++++||||+|+|||++.++.++|+|||++..+..........
T Consensus        81 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~  159 (283)
T cd07835          81 D-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHE  159 (283)
T ss_pred             C-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCccccCcc
Confidence            5 6888888653   58999999999999999999999999999999999999999999999999997654333333344


Q ss_pred             ccCCCCCChHHhhcC-CCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCC-------------------------
Q psy1546         205 VGTPFWMAPEVIKQS-AYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPK-------------------------  258 (604)
Q Consensus       205 ~GT~~Y~APE~l~~~-~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~-------------------------  258 (604)
                      .+++.|+|||++.+. .++.++|||||||++|+|++|.+||...........+..                         
T Consensus       160 ~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (283)
T cd07835         160 VVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPTFPK  239 (283)
T ss_pred             ccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhhhccc
Confidence            678999999988654 578899999999999999999999987655332221100                         


Q ss_pred             C---CCCCCCccchHHHHHHHHHHhccCCCCCCCHHHHhcChhh
Q psy1546         259 N---NPPQLTGNYTKQFKEFVEACLNKDPENRPTAKELLKFPFI  299 (604)
Q Consensus       259 ~---~~~~~~~~~s~~l~~Li~~~L~~dP~~RpT~~elL~hp~f  299 (604)
                      .   ........++..+.++|.+||+.||.+|||++|++.||||
T Consensus       240 ~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~  283 (283)
T cd07835         240 WARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF  283 (283)
T ss_pred             ccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence            0   0111234567889999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=5.9e-38  Score=331.20  Aligned_cols=245  Identities=28%  Similarity=0.441  Sum_probs=199.8

Q ss_pred             cceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchh-hHHHHHHHHHHHHHHhhCCCCCCC---------------eEE
Q psy1546          58 IFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE-AEDEIEDIQQEIMVLSQCDSPYGT---------------KLW  121 (604)
Q Consensus        58 ~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~-~~~~~~~l~~Ei~iL~~l~hp~~~---------------~ly  121 (604)
                      .|.+.+.||+|+||+||+|.+..+++.||||.+.... .......+.+|+.+++.++|+++.               .+|
T Consensus         6 ~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~   85 (337)
T cd07858           6 KYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDVY   85 (337)
T ss_pred             ceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcEE
Confidence            4899999999999999999999999999999986532 222345677899999999999854               268


Q ss_pred             EEEEecCCCChhhHhhc-CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCCC
Q psy1546         122 IIMEYLGGGSALDLMKA-GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSK  200 (604)
Q Consensus       122 LVmEy~~ggsL~~~l~~-~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~  200 (604)
                      +||||+. ++|.+++.. +.+++..+..++.||+.||.|||+++++||||||+|||++.++.+||+|||++.........
T Consensus        86 lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~  164 (337)
T cd07858          86 IVYELMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDF  164 (337)
T ss_pred             EEEeCCC-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccccccCCCccc
Confidence            9999995 678887754 67999999999999999999999999999999999999999999999999999766544333


Q ss_pred             CcccccCCCCCChHHhhc-CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhc-----------------------
Q psy1546         201 RNTFVGTPFWMAPEVIKQ-SAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLI-----------------------  256 (604)
Q Consensus       201 ~~~~~GT~~Y~APE~l~~-~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i-----------------------  256 (604)
                      .....++..|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+.......+                       
T Consensus       165 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (337)
T cd07858         165 MTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKARRY  244 (337)
T ss_pred             ccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCchhhhHH
Confidence            445678999999999865 46889999999999999999999999765432111100                       


Q ss_pred             ----CCCCC---CCCCccchHHHHHHHHHHhccCCCCCCCHHHHhcChhhhhhh
Q psy1546         257 ----PKNNP---PQLTGNYTKQFKEFVEACLNKDPENRPTAKELLKFPFIRKAK  303 (604)
Q Consensus       257 ----~~~~~---~~~~~~~s~~l~~Li~~~L~~dP~~RpT~~elL~hp~f~~~~  303 (604)
                          .....   ......++..+.+||.+||..||.+|||++++++||||....
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~  298 (337)
T cd07858         245 IRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLH  298 (337)
T ss_pred             HHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhc
Confidence                00000   112235788899999999999999999999999999997643

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=1.3e-37  Score=314.95  Aligned_cols=236  Identities=28%  Similarity=0.473  Sum_probs=200.3

Q ss_pred             ccceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCCe---------EEEEEEec
Q psy1546          57 LIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTK---------LWIIMEYL  127 (604)
Q Consensus        57 ~~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~~---------lyLVmEy~  127 (604)
                      ..|.+.++||+|+||.||+|.+. +++.||+|.+......  ...+.+|+.+++.+.|+++.+         +|+||||+
T Consensus         6 ~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~~~--~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~v~e~~   82 (260)
T cd05067           6 ETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGSMS--PEAFLAEANLMKQLQHPRLVRLYAVVTQEPIYIITEYM   82 (260)
T ss_pred             HHceeeeeeccCccceEEeeecC-CCceEEEEEecCCCCc--HHHHHHHHHHHHhcCCcCeeeEEEEEccCCcEEEEEcC
Confidence            45899999999999999999865 5678999998654432  356888999999999998544         47999999


Q ss_pred             CCCChhhHhhc---CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCC-CCCcc
Q psy1546         128 GGGSALDLMKA---GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTT-SKRNT  203 (604)
Q Consensus       128 ~ggsL~~~l~~---~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~-~~~~~  203 (604)
                      .+++|.+++..   ..+++..+..++.|++.||+|||+.|++||||||+||+++.++.++|+|||++....... .....
T Consensus        83 ~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~  162 (260)
T cd05067          83 ENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREG  162 (260)
T ss_pred             CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeecCCCCcccccC
Confidence            99999998854   468899999999999999999999999999999999999999999999999997654222 12223


Q ss_pred             cccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHhhhcCCCCCCCCCccchHHHHHHHHHHhcc
Q psy1546         204 FVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAK-GEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNK  282 (604)
Q Consensus       204 ~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~~L~~  282 (604)
                      ..++..|+|||++....++.++||||||+++|||++ |.+||.+.........+........+..++.++.+++.+||..
T Consensus       163 ~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  242 (260)
T cd05067         163 AKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMPRPDNCPEELYELMRLCWKE  242 (260)
T ss_pred             CcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHccC
Confidence            346778999999998889999999999999999998 9999988877666665555555556677889999999999999


Q ss_pred             CCCCCCCHHHHhc
Q psy1546         283 DPENRPTAKELLK  295 (604)
Q Consensus       283 dP~~RpT~~elL~  295 (604)
                      +|++|||+++++.
T Consensus       243 ~p~~Rp~~~~l~~  255 (260)
T cd05067         243 KPEERPTFEYLRS  255 (260)
T ss_pred             ChhhCCCHHHHHH
Confidence            9999999999976

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=8.3e-38  Score=325.20  Aligned_cols=239  Identities=25%  Similarity=0.444  Sum_probs=200.1

Q ss_pred             cceeeeEEcccCcEEEEEEEECC-------CCcEEEEEEecchhhHHHHHHHHHHHHHHhhC-CCCCCCe----------
Q psy1546          58 IFTKQERIGKGSFGEVFKGIDNR-------TQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQC-DSPYGTK----------  119 (604)
Q Consensus        58 ~y~i~~~LG~G~fG~Vy~a~~~~-------t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l-~hp~~~~----------  119 (604)
                      .|.+.+.||+|+||.||+|.+..       +...||+|++...........+.+|+.+++.+ .|+++.+          
T Consensus        19 ~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~   98 (307)
T cd05098          19 RLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGP   98 (307)
T ss_pred             HeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCc
Confidence            48999999999999999998643       23579999997654445567788999999999 7998544          


Q ss_pred             EEEEEEecCCCChhhHhhcC-----------------CCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCC
Q psy1546         120 LWIIMEYLGGGSALDLMKAG-----------------NFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGD  182 (604)
Q Consensus       120 lyLVmEy~~ggsL~~~l~~~-----------------~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~  182 (604)
                      +|+||||+.+|+|.+++...                 .+++..++.++.||+.||+|||++|++||||||+|||++.++.
T Consensus        99 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~~~~~  178 (307)
T cd05098          99 LYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNV  178 (307)
T ss_pred             eEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHheEEcCCCc
Confidence            57999999999999998642                 3788899999999999999999999999999999999999999


Q ss_pred             eEEecccccccccCCCCCC--cccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHhhhcCCC
Q psy1546         183 VKLADFGVAGTLTNTTSKR--NTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAK-GEPPNSELHPMRVLFLIPKN  259 (604)
Q Consensus       183 vKL~DFGlA~~~~~~~~~~--~~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~~i~~~  259 (604)
                      +||+|||+++.+.......  ....+++.|+|||++.+..++.++|||||||++|+|++ |..||......+....+...
T Consensus       179 ~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~  258 (307)
T cd05098         179 MKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEG  258 (307)
T ss_pred             EEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHcC
Confidence            9999999997654322111  12234578999999999999999999999999999998 89999887776666655555


Q ss_pred             CCCCCCccchHHHHHHHHHHhccCCCCCCCHHHHhcC
Q psy1546         260 NPPQLTGNYTKQFKEFVEACLNKDPENRPTAKELLKF  296 (604)
Q Consensus       260 ~~~~~~~~~s~~l~~Li~~~L~~dP~~RpT~~elL~h  296 (604)
                      .....+..++.++.+|+.+||..+|.+|||+.+|+++
T Consensus       259 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~  295 (307)
T cd05098         259 HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED  295 (307)
T ss_pred             CCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence            5555666788999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=2.5e-37  Score=312.71  Aligned_cols=238  Identities=34%  Similarity=0.548  Sum_probs=199.4

Q ss_pred             cceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchh--hHHHHHHHHHHHHHHhhCCCCCCC----------eEEEEEE
Q psy1546          58 IFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE--AEDEIEDIQQEIMVLSQCDSPYGT----------KLWIIME  125 (604)
Q Consensus        58 ~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~--~~~~~~~l~~Ei~iL~~l~hp~~~----------~lyLVmE  125 (604)
                      .|.+.+.||+|+||.||+|.+..+++.||+|.+....  .....+.+.+|+.++++++|++..          .+|+|||
T Consensus         3 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   82 (267)
T cd08224           3 NFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVLE   82 (267)
T ss_pred             ceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEe
Confidence            4889999999999999999999999999999886432  223356788999999999999743          3579999


Q ss_pred             ecCCCChhhHhhc-----CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCCC
Q psy1546         126 YLGGGSALDLMKA-----GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSK  200 (604)
Q Consensus       126 y~~ggsL~~~l~~-----~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~  200 (604)
                      |+++++|..++..     ..+++..+..++.||+.||.|||+.||+||||+|+||+++.++.++|+|||++..+......
T Consensus        83 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~  162 (267)
T cd08224          83 LADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTA  162 (267)
T ss_pred             cCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeeccCCCcc
Confidence            9999999998853     45899999999999999999999999999999999999999999999999999766544433


Q ss_pred             CcccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCCh--hhHhhhcCCCCCCCCCc-cchHHHHHHHH
Q psy1546         201 RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHP--MRVLFLIPKNNPPQLTG-NYTKQFKEFVE  277 (604)
Q Consensus       201 ~~~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~--~~~~~~i~~~~~~~~~~-~~s~~l~~Li~  277 (604)
                      .....+++.|+|||.+.+..++.++|||||||++|+|++|..||.....  ......+.....+..+. .++..+.++|.
T Consensus       163 ~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~  242 (267)
T cd08224         163 AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYSEELRDLVS  242 (267)
T ss_pred             cceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCCCCCCChhhcCHHHHHHHH
Confidence            4456789999999999998999999999999999999999999865432  23333333333333333 67889999999


Q ss_pred             HHhccCCCCCCCHHHHhc
Q psy1546         278 ACLNKDPENRPTAKELLK  295 (604)
Q Consensus       278 ~~L~~dP~~RpT~~elL~  295 (604)
                      +||..+|.+|||+.+|++
T Consensus       243 ~cl~~~p~~Rp~~~~il~  260 (267)
T cd08224         243 RCINPDPEKRPDISYVLQ  260 (267)
T ss_pred             HHcCCCcccCCCHHHHHH
Confidence            999999999999999876

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>KOG0983|consensus

Probab=100.00  E-value=9.4e-39  Score=314.08  Aligned_cols=244  Identities=34%  Similarity=0.619  Sum_probs=206.1

Q ss_pred             ceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCC-CCCCCeEE----------EEEEec
Q psy1546          59 FTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCD-SPYGTKLW----------IIMEYL  127 (604)
Q Consensus        59 y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~-hp~~~~ly----------LVmEy~  127 (604)
                      ...+..||.|+.|+|++++.+.+|..+|||.+.......+.+++...+.++.... .|++++.|          |.||.|
T Consensus        94 l~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelM  173 (391)
T KOG0983|consen   94 LENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELM  173 (391)
T ss_pred             hhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHH
Confidence            3556789999999999999999999999999988877777888888888876654 89887763          556666


Q ss_pred             CCCChhhHhhc--CCCcHHHHHHHHHHHHHHhHHhhhC-CccccccccceeEecCCCCeEEecccccccccCCCCCCccc
Q psy1546         128 GGGSALDLMKA--GNFEEMHIAVILREVLKGLDYLHSE-RKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTF  204 (604)
Q Consensus       128 ~ggsL~~~l~~--~~lse~~i~~i~~qIl~gL~yLHs~-gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~~~~~  204 (604)
                       ...+..+++.  +.++|..+-.+...++.||.||.++ ||||||+||+|||+++.|++||||||++..+.+..... ..
T Consensus       174 -s~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkAht-rs  251 (391)
T KOG0983|consen  174 -STCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKAHT-RS  251 (391)
T ss_pred             -HHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccceeecccccc-cc
Confidence             2334445443  6799999999999999999999865 89999999999999999999999999998887655433 44


Q ss_pred             ccCCCCCChHHhh---cCCCCCcchhhhHHHHHHHHHhCCCCCCCC-ChhhHhhhcCCCCCCCCCc--cchHHHHHHHHH
Q psy1546         205 VGTPFWMAPEVIK---QSAYDSKADIWSLGITAIELAKGEPPNSEL-HPMRVLFLIPKNNPPQLTG--NYTKQFKEFVEA  278 (604)
Q Consensus       205 ~GT~~Y~APE~l~---~~~~~~~sDVwSLGviL~eLltG~~Pf~~~-~~~~~~~~i~~~~~~~~~~--~~s~~l~~Li~~  278 (604)
                      .|.+.|||||.+.   ...|+-++||||||++|+||.||+.||.+. ...+++..+....++.++.  .+++.|++|+..
T Consensus       252 AGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~ePP~L~~~~gFSp~F~~fv~~  331 (391)
T KOG0983|consen  252 AGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEPPLLPGHMGFSPDFQSFVKD  331 (391)
T ss_pred             cCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCCCCCCcccCcCHHHHHHHHH
Confidence            7999999999985   456999999999999999999999999874 4567777777777766654  389999999999


Q ss_pred             HhccCCCCCCCHHHHhcChhhhhhhh
Q psy1546         279 CLNKDPENRPTAKELLKFPFIRKAKK  304 (604)
Q Consensus       279 ~L~~dP~~RpT~~elL~hp~f~~~~~  304 (604)
                      ||.+|+.+||.+.++|+|||++....
T Consensus       332 CL~kd~r~RP~Y~~Ll~h~Fi~~ye~  357 (391)
T KOG0983|consen  332 CLTKDHRKRPKYNKLLEHPFIKRYET  357 (391)
T ss_pred             HhhcCcccCcchHHHhcCcceeecch
Confidence            99999999999999999999976543

>KOG0586|consensus

Probab=100.00  E-value=1.3e-38  Score=342.75  Aligned_cols=244  Identities=27%  Similarity=0.467  Sum_probs=215.4

Q ss_pred             cceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHH-HHHHHHHHHHHHhhCCCCCCCeE----------EEEEEe
Q psy1546          58 IFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAED-EIEDIQQEIMVLSQCDSPYGTKL----------WIIMEY  126 (604)
Q Consensus        58 ~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~-~~~~l~~Ei~iL~~l~hp~~~~l----------yLVmEy  126 (604)
                      .|.+.+.||+|.|++|.+|++..++..||||+|++..... ....+.+|+.+|+.+.|||++++          |+||||
T Consensus        57 ~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~ey  136 (596)
T KOG0586|consen   57 LYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVMEY  136 (596)
T ss_pred             ceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEEEe
Confidence            4999999999999999999999999999999998775433 34668999999999999998775          799999


Q ss_pred             cCCCChhhHhh-cCCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCCCCcccc
Q psy1546         127 LGGGSALDLMK-AGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFV  205 (604)
Q Consensus       127 ~~ggsL~~~l~-~~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~~~~~~  205 (604)
                      +.+|.+++++. .++..+..+..++.|++.|++|||+++|||||||++||||+.+.++||+|||++..+. ......++|
T Consensus       137 a~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~-~~~~lqt~c  215 (596)
T KOG0586|consen  137 ASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFD-YGLMLQTFC  215 (596)
T ss_pred             ccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeec-ccccccccC
Confidence            99999999885 4888889999999999999999999999999999999999999999999999997776 556677899


Q ss_pred             cCCCCCChHHhhcCCCC-CcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCCCCCCCCccchHHHHHHHHHHhccCC
Q psy1546         206 GTPFWMAPEVIKQSAYD-SKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDP  284 (604)
Q Consensus       206 GT~~Y~APE~l~~~~~~-~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~~L~~dP  284 (604)
                      |++.|.|||++.+..|+ +.+|+||+|++||-|+.|.+||.+.+.......+..+. ..++-.++-++.+||+++|.++|
T Consensus       216 gsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk-~rIp~~ms~dce~lLrk~lvl~P  294 (596)
T KOG0586|consen  216 GSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGK-YRIPFYMSCDCEDLLRKFLVLNP  294 (596)
T ss_pred             CCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheeee-ecccceeechhHHHHHHhhccCc
Confidence            99999999999998875 78999999999999999999999877655554443332 24455678899999999999999


Q ss_pred             CCCCCHHHHhcChhhhhhh
Q psy1546         285 ENRPTAKELLKFPFIRKAK  303 (604)
Q Consensus       285 ~~RpT~~elL~hp~f~~~~  303 (604)
                      .+|++++++++|.|.....
T Consensus       295 skr~~~dqim~~~W~n~~~  313 (596)
T KOG0586|consen  295 SKRGPCDQIMKDRWRNDLL  313 (596)
T ss_pred             cccCCHHHhhhhcccchhh
Confidence            9999999999999986543

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=1.3e-37  Score=314.75  Aligned_cols=235  Identities=27%  Similarity=0.470  Sum_probs=198.9

Q ss_pred             cceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCCeE----------EEEEEec
Q psy1546          58 IFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTKL----------WIIMEYL  127 (604)
Q Consensus        58 ~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~~l----------yLVmEy~  127 (604)
                      .|++.++||+|+||.||+|.+. ++..||+|.+.....  ..+.+.+|+.+++.++|+++.++          |+||||+
T Consensus         7 ~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   83 (261)
T cd05072           7 SIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGTM--SVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYM   83 (261)
T ss_pred             HeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCch--hHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecC
Confidence            4899999999999999999865 456799998865432  34678899999999999996654          6999999


Q ss_pred             CCCChhhHhhc---CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCC-CCcc
Q psy1546         128 GGGSALDLMKA---GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTS-KRNT  203 (604)
Q Consensus       128 ~ggsL~~~l~~---~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~-~~~~  203 (604)
                      .+++|.+++..   ..+++..+..++.||+.||.|||+.+++||||||+|||++.++.++|+|||++........ ....
T Consensus        84 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~  163 (261)
T cd05072          84 AKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREG  163 (261)
T ss_pred             CCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceecCCCceeccCC
Confidence            99999999854   4588889999999999999999999999999999999999999999999999976543221 1122


Q ss_pred             cccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHhhhcCCCCCCCCCccchHHHHHHHHHHhcc
Q psy1546         204 FVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAK-GEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNK  282 (604)
Q Consensus       204 ~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~~L~~  282 (604)
                      ..++..|+|||++.+..++.++|||||||++|+|++ |..||...........+...........++.++.+|+.+||..
T Consensus       164 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  243 (261)
T cd05072         164 AKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMPRMENCPDELYDIMKTCWKE  243 (261)
T ss_pred             CccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHccC
Confidence            346678999999998889999999999999999998 9999988777666665555544445567889999999999999


Q ss_pred             CCCCCCCHHHHhc
Q psy1546         283 DPENRPTAKELLK  295 (604)
Q Consensus       283 dP~~RpT~~elL~  295 (604)
                      +|++||+++++++
T Consensus       244 ~p~~Rp~~~~i~~  256 (261)
T cd05072         244 KAEERPTFDYLQS  256 (261)
T ss_pred             CcccCcCHHHHHH
Confidence            9999999999875

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=8.5e-38  Score=323.45  Aligned_cols=241  Identities=27%  Similarity=0.442  Sum_probs=192.0

Q ss_pred             cceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhH-HHHHHHHHHHHHHhhCCCCCCCe-----------------
Q psy1546          58 IFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAE-DEIEDIQQEIMVLSQCDSPYGTK-----------------  119 (604)
Q Consensus        58 ~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~-~~~~~l~~Ei~iL~~l~hp~~~~-----------------  119 (604)
                      .|.+.++||+|+||.||+|.+..+++.||||++...... .....+.+|+.+++.+.||++.+                 
T Consensus        13 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   92 (310)
T cd07865          13 KYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYKG   92 (310)
T ss_pred             heEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCCc
Confidence            489999999999999999999999999999998644322 22245568999999999998543                 


Q ss_pred             -EEEEEEecCCCChhhHhhcC--CCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccC
Q psy1546         120 -LWIIMEYLGGGSALDLMKAG--NFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTN  196 (604)
Q Consensus       120 -lyLVmEy~~ggsL~~~l~~~--~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~  196 (604)
                       .|+||||+. ++|.+++...  .+++..++.++.||+.||.|||++|++|+||||+|||++.++.+||+|||++..+..
T Consensus        93 ~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~  171 (310)
T cd07865          93 SFYLVFEFCE-HDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAFSL  171 (310)
T ss_pred             eEEEEEcCCC-cCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcCCCcccccC
Confidence             389999996 4777777553  689999999999999999999999999999999999999999999999999976543


Q ss_pred             CCC----CCcccccCCCCCChHHhhcC-CCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCC---CCC-------
Q psy1546         197 TTS----KRNTFVGTPFWMAPEVIKQS-AYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPK---NNP-------  261 (604)
Q Consensus       197 ~~~----~~~~~~GT~~Y~APE~l~~~-~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~---~~~-------  261 (604)
                      ...    ......++..|+|||++.+. .++.++||||||+++|+|++|.+||...........+..   ..+       
T Consensus       172 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (310)
T cd07865         172 SKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEVWPGV  251 (310)
T ss_pred             CcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcccc
Confidence            222    12234678899999998764 478899999999999999999999987665432221110   000       


Q ss_pred             ------------C----CC-----CccchHHHHHHHHHHhccCCCCCCCHHHHhcChhh
Q psy1546         262 ------------P----QL-----TGNYTKQFKEFVEACLNKDPENRPTAKELLKFPFI  299 (604)
Q Consensus       262 ------------~----~~-----~~~~s~~l~~Li~~~L~~dP~~RpT~~elL~hp~f  299 (604)
                                  .    ..     ....+..+.+||.+||..||.+|||++|+|+||||
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f  310 (310)
T cd07865         252 DKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF  310 (310)
T ss_pred             cchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence                        0    00     01124677899999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=1.5e-37  Score=316.09  Aligned_cols=238  Identities=27%  Similarity=0.440  Sum_probs=200.4

Q ss_pred             cceeeeEEcccCcEEEEEEEECCCC---cEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCCeE----------EEEE
Q psy1546          58 IFTKQERIGKGSFGEVFKGIDNRTQ---QVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTKL----------WIIM  124 (604)
Q Consensus        58 ~y~i~~~LG~G~fG~Vy~a~~~~t~---~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~~l----------yLVm  124 (604)
                      .|.+.+.||+|+||.||+|.+..++   ..||+|.+...........+..|+.+++.++||++.++          |+||
T Consensus         5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   84 (267)
T cd05066           5 CIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVT   84 (267)
T ss_pred             HeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEE
Confidence            3788999999999999999986544   37999998765444556788999999999999996654          7999


Q ss_pred             EecCCCChhhHhhc--CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCCCCc
Q psy1546         125 EYLGGGSALDLMKA--GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRN  202 (604)
Q Consensus       125 Ey~~ggsL~~~l~~--~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~~~  202 (604)
                      ||+++++|.+++..  +.+++..+..++.||+.||.|||++|++||||||+|||++.++.++|+|||++..+........
T Consensus        85 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~  164 (267)
T cd05066          85 EYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAY  164 (267)
T ss_pred             EcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCcccccccccceee
Confidence            99999999999865  4689999999999999999999999999999999999999999999999999976643322111


Q ss_pred             ---ccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHhhhcCCCCCCCCCccchHHHHHHHHH
Q psy1546         203 ---TFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAK-GEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEA  278 (604)
Q Consensus       203 ---~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~  278 (604)
                         ...++..|+|||++.+..++.++|||||||++|++++ |..||......+....+........+..++..+.+++.+
T Consensus       165 ~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  244 (267)
T cd05066         165 TTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYRLPAPMDCPAALHQLMLD  244 (267)
T ss_pred             ecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCCcCCCCCCCCHHHHHHHHH
Confidence               1223567999999998899999999999999999886 999998877666555555544444556778999999999


Q ss_pred             HhccCCCCCCCHHHHhc
Q psy1546         279 CLNKDPENRPTAKELLK  295 (604)
Q Consensus       279 ~L~~dP~~RpT~~elL~  295 (604)
                      ||..+|.+||++.++++
T Consensus       245 ~l~~~p~~Rp~~~~i~~  261 (267)
T cd05066         245 CWQKDRNERPKFEQIVS  261 (267)
T ss_pred             HcccCchhCCCHHHHHH
Confidence            99999999999999976

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=2.7e-37  Score=322.94  Aligned_cols=258  Identities=45%  Similarity=0.787  Sum_probs=210.3

Q ss_pred             cCccccceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchh--hHHHHHHHHHHHHHHhhCCCCCCCe----------E
Q psy1546          53 VDPELIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE--AEDEIEDIQQEIMVLSQCDSPYGTK----------L  120 (604)
Q Consensus        53 ~~~~~~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~--~~~~~~~l~~Ei~iL~~l~hp~~~~----------l  120 (604)
                      .+.++.|...++||+|+||.||+|++..+++.||||++....  .......+.+|+.+++.++|++...          .
T Consensus        17 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   96 (313)
T cd06633          17 DDPEEIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTA   96 (313)
T ss_pred             CCHHHHhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEE
Confidence            455566888899999999999999999999999999986542  2334567888999999999998543          5


Q ss_pred             EEEEEecCCCChhhHhhc--CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCC
Q psy1546         121 WIIMEYLGGGSALDLMKA--GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTT  198 (604)
Q Consensus       121 yLVmEy~~ggsL~~~l~~--~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~  198 (604)
                      |+||||+. |+|.+++..  ..+++..+..++.||+.||.|||++||+||||+|+||+++.++.++|+|||++....   
T Consensus        97 ~lv~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~---  172 (313)
T cd06633          97 WLVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSS---  172 (313)
T ss_pred             EEEEecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcccC---
Confidence            79999995 566666643  568999999999999999999999999999999999999999999999999985432   


Q ss_pred             CCCcccccCCCCCChHHhh---cCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCCCC-CCCCccchHHHHH
Q psy1546         199 SKRNTFVGTPFWMAPEVIK---QSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNP-PQLTGNYTKQFKE  274 (604)
Q Consensus       199 ~~~~~~~GT~~Y~APE~l~---~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~~~-~~~~~~~s~~l~~  274 (604)
                       ......|+..|+|||++.   ...++.++|||||||++|+|++|..||...+.......+..... ......++..+++
T Consensus       173 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  251 (313)
T cd06633         173 -PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEWTDSFRG  251 (313)
T ss_pred             -CCCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCHHHHH
Confidence             223567899999999984   45688899999999999999999999988776555544433332 2233457788999


Q ss_pred             HHHHHhccCCCCCCCHHHHhcChhhhhhhhhhhHHHHHHHH
Q psy1546         275 FVEACLNKDPENRPTAKELLKFPFIRKAKKNAYLIDLIDRY  315 (604)
Q Consensus       275 Li~~~L~~dP~~RpT~~elL~hp~f~~~~~~~~l~~~~~~~  315 (604)
                      |+.+||+.+|.+||++.+++.||||+.......+.+..+..
T Consensus       252 li~~~l~~~P~~Rp~~~~~l~~~~~~~~~~~~~~~~~~~~~  292 (313)
T cd06633         252 FVDYCLQKIPQERPASAELLRHDFVRRDRPARVLIDLIQRT  292 (313)
T ss_pred             HHHHHccCChhhCcCHHHHhcCcccCCCchhHHHHHHHHHH
Confidence            99999999999999999999999998776555555544443

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>KOG0604|consensus

Probab=100.00  E-value=6.3e-39  Score=318.82  Aligned_cols=238  Identities=27%  Similarity=0.453  Sum_probs=196.9

Q ss_pred             ceee-eEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhh-CCCCCCCe--------------EEE
Q psy1546          59 FTKQ-ERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQ-CDSPYGTK--------------LWI  122 (604)
Q Consensus        59 y~i~-~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~-l~hp~~~~--------------lyL  122 (604)
                      |.+. ++||-|--|.|..|.++.|++.+|+|++.-.      ....+|+.+.-. -.|||++.              +.+
T Consensus        63 Y~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds------~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLi  136 (400)
T KOG0604|consen   63 YSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS------PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLI  136 (400)
T ss_pred             heehhhhhccccCCceEEEEeccchhhhHHHHHhcC------HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEe
Confidence            4443 6899999999999999999999999997422      345566666443 35776543              469


Q ss_pred             EEEecCCCChhhHhhc---CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecC---CCCeEEecccccccccC
Q psy1546         123 IMEYLGGGSALDLMKA---GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSE---MGDVKLADFGVAGTLTN  196 (604)
Q Consensus       123 VmEy~~ggsL~~~l~~---~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~---~g~vKL~DFGlA~~~~~  196 (604)
                      |||.++||.|+..++.   +.|+|.++..|++||+.||.|||+.+|.||||||+|+|...   +..+||+|||+|+.-..
T Consensus       137 VmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~  216 (400)
T KOG0604|consen  137 VMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQE  216 (400)
T ss_pred             eeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEecccccccccCC
Confidence            9999999999999865   34999999999999999999999999999999999999964   45699999999976543


Q ss_pred             CCCCCcccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhH----hhhcCCCC---CCCCCccch
Q psy1546         197 TTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRV----LFLIPKNN---PPQLTGNYT  269 (604)
Q Consensus       197 ~~~~~~~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~----~~~i~~~~---~~~~~~~~s  269 (604)
                       .....+.|-||.|.|||++...+|+..+|+||+||++|.||+|.+||+..+...+    ...|..+.   +..-+..++
T Consensus       217 -~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP~pEWs~VS  295 (400)
T KOG0604|consen  217 -PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFPEPEWSCVS  295 (400)
T ss_pred             -CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccCCChhHhHHH
Confidence             3445678999999999999999999999999999999999999999998765322    22333332   233345678


Q ss_pred             HHHHHHHHHHhccCCCCCCCHHHHhcChhhhhhh
Q psy1546         270 KQFKEFVEACLNKDPENRPTAKELLKFPFIRKAK  303 (604)
Q Consensus       270 ~~l~~Li~~~L~~dP~~RpT~~elL~hp~f~~~~  303 (604)
                      +.++++|+.+|..+|.+|.|+.+++.|||+....
T Consensus       296 e~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~  329 (400)
T KOG0604|consen  296 EAAKDLIRKLLKTEPTERLTIEEVMDHPWINQYE  329 (400)
T ss_pred             HHHHHHHHHHhcCCchhheeHHHhhcCchhcccc
Confidence            9999999999999999999999999999998654

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=1.8e-37  Score=313.63  Aligned_cols=240  Identities=34%  Similarity=0.574  Sum_probs=204.5

Q ss_pred             ceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchh----hHHHHHHHHHHHHHHhhCCCCCCC----------eEEEEE
Q psy1546          59 FTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE----AEDEIEDIQQEIMVLSQCDSPYGT----------KLWIIM  124 (604)
Q Consensus        59 y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~----~~~~~~~l~~Ei~iL~~l~hp~~~----------~lyLVm  124 (604)
                      |.+.+.||+|+||.||+|.+..++..+++|+++...    .......+.+|+.+++.++||++.          ..|+||
T Consensus         2 y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   81 (260)
T cd08222           2 YILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCIIT   81 (260)
T ss_pred             ceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEEE
Confidence            788899999999999999998887777777764322    122334567899999999999843          458999


Q ss_pred             EecCCCChhhHhhc-----CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCC
Q psy1546         125 EYLGGGSALDLMKA-----GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTS  199 (604)
Q Consensus       125 Ey~~ggsL~~~l~~-----~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~  199 (604)
                      ||+++++|.+++..     ..+++..++.++.|++.||.|||++|++|+||+|+||+++. +.++|+|||++..+.....
T Consensus        82 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~~~  160 (260)
T cd08222          82 EYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGSCD  160 (260)
T ss_pred             EeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCceeecCCCcc
Confidence            99999999988752     56899999999999999999999999999999999999975 6799999999977654444


Q ss_pred             CCcccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCCCCCCCCccchHHHHHHHHHH
Q psy1546         200 KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEAC  279 (604)
Q Consensus       200 ~~~~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~~  279 (604)
                      ......|++.|+|||.+.+..++.++|+||||+++|+|++|..||...........+.....+.++..++.++.++|.+|
T Consensus       161 ~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  240 (260)
T cd08222         161 LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPSLPETYSRQLNSIMQSM  240 (260)
T ss_pred             cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCCCcchhcHHHHHHHHHH
Confidence            44556789999999999888899999999999999999999999987776666665555556666778899999999999


Q ss_pred             hccCCCCCCCHHHHhcChhh
Q psy1546         280 LNKDPENRPTAKELLKFPFI  299 (604)
Q Consensus       280 L~~dP~~RpT~~elL~hp~f  299 (604)
                      |..+|.+||++.++++||||
T Consensus       241 l~~~p~~Rp~~~~il~~~~~  260 (260)
T cd08222         241 LNKDPSLRPSAAEILRNPFI  260 (260)
T ss_pred             hcCChhhCcCHHHHhhCCCC
Confidence            99999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=5.6e-38  Score=323.48  Aligned_cols=241  Identities=27%  Similarity=0.459  Sum_probs=197.4

Q ss_pred             cceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHH-HHHHHHHHHHHHhhCCCCCC------------CeEEEEE
Q psy1546          58 IFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAED-EIEDIQQEIMVLSQCDSPYG------------TKLWIIM  124 (604)
Q Consensus        58 ~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~-~~~~l~~Ei~iL~~l~hp~~------------~~lyLVm  124 (604)
                      .|.+.+.||.|+||.||+|.+..+++.||||.+....... ....+.+|+.++..+.||++            ..+|+||
T Consensus         6 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv~   85 (293)
T cd07843           6 EYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMVM   85 (293)
T ss_pred             hhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEEe
Confidence            3888999999999999999999999999999996543322 23456789999999999983            4568999


Q ss_pred             EecCCCChhhHhhc--CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCCCCc
Q psy1546         125 EYLGGGSALDLMKA--GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRN  202 (604)
Q Consensus       125 Ey~~ggsL~~~l~~--~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~~~  202 (604)
                      ||+. ++|.+++..  ..+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++..+........
T Consensus        86 e~~~-~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~  164 (293)
T cd07843          86 EYVE-HDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYT  164 (293)
T ss_pred             hhcC-cCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeeccCCccccc
Confidence            9996 488888754  3589999999999999999999999999999999999999999999999999977655433334


Q ss_pred             ccccCCCCCChHHhhcCC-CCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCC-----------------------
Q psy1546         203 TFVGTPFWMAPEVIKQSA-YDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPK-----------------------  258 (604)
Q Consensus       203 ~~~GT~~Y~APE~l~~~~-~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~-----------------------  258 (604)
                      ...+++.|+|||++.+.. ++.++|||||||++|+|++|.+||...........+..                       
T Consensus       165 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (293)
T cd07843         165 QLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAKKKT  244 (293)
T ss_pred             cccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccchhcccc
Confidence            456889999999987644 68899999999999999999999987665433321100                       


Q ss_pred             ---CC----CCCCCcc-chHHHHHHHHHHhccCCCCCCCHHHHhcChhh
Q psy1546         259 ---NN----PPQLTGN-YTKQFKEFVEACLNKDPENRPTAKELLKFPFI  299 (604)
Q Consensus       259 ---~~----~~~~~~~-~s~~l~~Li~~~L~~dP~~RpT~~elL~hp~f  299 (604)
                         ..    ...++.. +++.+.+||.+||+.||++|||+.|+|.||||
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f  293 (293)
T cd07843         245 FTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF  293 (293)
T ss_pred             cccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence               00    0112222 57889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=2.8e-37  Score=323.16  Aligned_cols=261  Identities=46%  Similarity=0.799  Sum_probs=212.7

Q ss_pred             cccCccccceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchh--hHHHHHHHHHHHHHHhhCCCCCCCe---------
Q psy1546          51 LKVDPELIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE--AEDEIEDIQQEIMVLSQCDSPYGTK---------  119 (604)
Q Consensus        51 ~~~~~~~~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~--~~~~~~~l~~Ei~iL~~l~hp~~~~---------  119 (604)
                      +..+++..|...+.||+|+||.||+|.+..++..||||++....  .......+.+|+.+++.++|++..+         
T Consensus        19 ~~~~~~~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~   98 (317)
T cd06635          19 FKEDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREH   98 (317)
T ss_pred             cCCCchhhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCC
Confidence            34566667999999999999999999999999999999986432  2334567889999999999998543         


Q ss_pred             -EEEEEEecCCCChhhHhh--cCCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccC
Q psy1546         120 -LWIIMEYLGGGSALDLMK--AGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTN  196 (604)
Q Consensus       120 -lyLVmEy~~ggsL~~~l~--~~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~  196 (604)
                       .|+||||+.| +|.+++.  ...+++..+..++.||+.||.|||++||+||||+|+||+++.++.++|+|||++.....
T Consensus        99 ~~~lv~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~  177 (317)
T cd06635          99 TAWLVMEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASP  177 (317)
T ss_pred             eEEEEEeCCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccCC
Confidence             4799999975 6666663  35689999999999999999999999999999999999999999999999999864432


Q ss_pred             CCCCCcccccCCCCCChHHhh---cCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCCCC-CCCCccchHHH
Q psy1546         197 TTSKRNTFVGTPFWMAPEVIK---QSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNP-PQLTGNYTKQF  272 (604)
Q Consensus       197 ~~~~~~~~~GT~~Y~APE~l~---~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~~~-~~~~~~~s~~l  272 (604)
                          .....|++.|+|||++.   ...++.++|||||||++|+|++|..||...........+..... ......++..+
T Consensus       178 ----~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  253 (317)
T cd06635         178 ----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYF  253 (317)
T ss_pred             ----cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCCCCCccccHHH
Confidence                23457899999999984   45688999999999999999999999987766555554444332 23344678899


Q ss_pred             HHHHHHHhccCCCCCCCHHHHhcChhhhhhhhhhhHHHHHHHHH
Q psy1546         273 KEFVEACLNKDPENRPTAKELLKFPFIRKAKKNAYLIDLIDRYK  316 (604)
Q Consensus       273 ~~Li~~~L~~dP~~RpT~~elL~hp~f~~~~~~~~l~~~~~~~~  316 (604)
                      .+|+.+||..+|.+||++.++++|+|+........+.+...+.+
T Consensus       254 ~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~~~~~~~~~~~~~  297 (317)
T cd06635         254 RNFVDSCLQKIPQDRPTSEELLKHMFVLRERPETVLIDLIQRTK  297 (317)
T ss_pred             HHHHHHHccCCcccCcCHHHHHhChhhhccCcccchhhHHHHHH
Confidence            99999999999999999999999999977666555544444443

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>KOG0194|consensus

Probab=100.00  E-value=1.8e-38  Score=342.48  Aligned_cols=253  Identities=29%  Similarity=0.481  Sum_probs=214.7

Q ss_pred             CCccccCCccccCccccceeeeEEcccCcEEEEEEEECCCCc---E-EEEEEecc--hhhHHHHHHHHHHHHHHhhCCCC
Q psy1546          42 STTASRRNSLKVDPELIFTKQERIGKGSFGEVFKGIDNRTQQ---V-VAIKIIDL--EEAEDEIEDIQQEIMVLSQCDSP  115 (604)
Q Consensus        42 ~~~~~~~~~~~~~~~~~y~i~~~LG~G~fG~Vy~a~~~~t~~---~-vAVK~i~~--~~~~~~~~~l~~Ei~iL~~l~hp  115 (604)
                      ...+..+..|.+..+++ .+.++||+|+||.||+|..+..+.   . ||||....  ......+..+.+|.++|++++||
T Consensus       143 L~~PI~r~~Wel~H~~v-~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~  221 (474)
T KOG0194|consen  143 LKRPIPRQKWELSHSDI-ELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHP  221 (474)
T ss_pred             ecccccccccEEeccCc-cccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCC
Confidence            34455666777766654 556999999999999998765422   3 89999875  24466788999999999999999


Q ss_pred             CCCeE----------EEEEEecCCCChhhHhhcC--CCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCe
Q psy1546         116 YGTKL----------WIIMEYLGGGSALDLMKAG--NFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDV  183 (604)
Q Consensus       116 ~~~~l----------yLVmEy~~ggsL~~~l~~~--~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~v  183 (604)
                      |++++          |||||+|.||+|.++|+..  .++..+...++.+.+.||+|||++++|||||-.+|||++.++.+
T Consensus       222 NVVr~yGVa~~~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~v  301 (474)
T KOG0194|consen  222 NVVRFYGVAVLEEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVV  301 (474)
T ss_pred             CEEEEEEEEcCCCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeE
Confidence            98775          6999999999999999874  49999999999999999999999999999999999999999999


Q ss_pred             EEecccccccccCCCCCCcccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHhhhc-CCCCC
Q psy1546         184 KLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAK-GEPPNSELHPMRVLFLI-PKNNP  261 (604)
Q Consensus       184 KL~DFGlA~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~~i-~~~~~  261 (604)
                      ||+|||+++.-...........-...|+|||.+....|+.++|||||||++||+++ |..||.+....++...+ ..+.+
T Consensus       302 KISDFGLs~~~~~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r  381 (474)
T KOG0194|consen  302 KISDFGLSRAGSQYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYR  381 (474)
T ss_pred             EeCccccccCCcceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCcc
Confidence            99999998654311111111234578999999999999999999999999999998 88999999999998888 66777


Q ss_pred             CCCCccchHHHHHHHHHHhccCCCCCCCHHHHhc
Q psy1546         262 PQLTGNYTKQFKEFVEACLNKDPENRPTAKELLK  295 (604)
Q Consensus       262 ~~~~~~~s~~l~~Li~~~L~~dP~~RpT~~elL~  295 (604)
                      ...+...+.++..++..||..||++|||+.++.+
T Consensus       382 ~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~  415 (474)
T KOG0194|consen  382 MPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKK  415 (474)
T ss_pred             CCCCCCCHHHHHHHHHHhccCChhhccCHHHHHH
Confidence            7778888999999999999999999999999876

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=1e-37  Score=318.41  Aligned_cols=238  Identities=26%  Similarity=0.421  Sum_probs=190.5

Q ss_pred             ceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCC-CCCC------------CeEEEEEE
Q psy1546          59 FTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCD-SPYG------------TKLWIIME  125 (604)
Q Consensus        59 y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~-hp~~------------~~lyLVmE  125 (604)
                      |.+.++||+|+||.||+|.+..+++.||+|++.............+|+.++.++. |++.            ..+|+|||
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e   80 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE   80 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence            6788999999999999999999999999999865432222234457888888885 8873            45689999


Q ss_pred             ecCCCChhhHhhc--CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCCCCcc
Q psy1546         126 YLGGGSALDLMKA--GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNT  203 (604)
Q Consensus       126 y~~ggsL~~~l~~--~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~~~~  203 (604)
                      |+++ +|.+++..  +.+++..+..++.||+.||.|||++|++||||+|+||+++. +.+||+|||++..+..... ...
T Consensus        81 ~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~-~~~  157 (282)
T cd07831          81 LMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPP-YTE  157 (282)
T ss_pred             cCCc-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEecccccccccCCC-cCC
Confidence            9974 67777654  46899999999999999999999999999999999999999 9999999999976643322 234


Q ss_pred             cccCCCCCChHHhhc-CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCC---------------C--CC----
Q psy1546         204 FVGTPFWMAPEVIKQ-SAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPK---------------N--NP----  261 (604)
Q Consensus       204 ~~GT~~Y~APE~l~~-~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~---------------~--~~----  261 (604)
                      ..+++.|+|||++.. ..++.++|||||||++|||++|.+||...+..+....+..               .  ..    
T Consensus       158 ~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (282)
T cd07831         158 YISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNFP  237 (282)
T ss_pred             CCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccccccccCc
Confidence            568999999998754 4578899999999999999999999987665432221100               0  00    


Q ss_pred             -------CCCCccchHHHHHHHHHHhccCCCCCCCHHHHhcChhh
Q psy1546         262 -------PQLTGNYTKQFKEFVEACLNKDPENRPTAKELLKFPFI  299 (604)
Q Consensus       262 -------~~~~~~~s~~l~~Li~~~L~~dP~~RpT~~elL~hp~f  299 (604)
                             ..+...++..+.+||.+||..+|.+|||+.++++||||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~  282 (282)
T cd07831         238 SKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF  282 (282)
T ss_pred             ccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence                   01123467899999999999999999999999999997

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=1.5e-37  Score=318.78  Aligned_cols=237  Identities=27%  Similarity=0.432  Sum_probs=193.7

Q ss_pred             ceeeeEEcccCcEEEEEEE----ECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCCe------------EEE
Q psy1546          59 FTKQERIGKGSFGEVFKGI----DNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTK------------LWI  122 (604)
Q Consensus        59 y~i~~~LG~G~fG~Vy~a~----~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~~------------lyL  122 (604)
                      |.+.+.||+|+||+||++.    ...++..||+|++...........+.+|+.+|+.++||++.+            +|+
T Consensus         6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (283)
T cd05080           6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL   85 (283)
T ss_pred             ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence            4888999999999998865    345788999999976544344567889999999999998433            579


Q ss_pred             EEEecCCCChhhHhhcCCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCCC--
Q psy1546         123 IMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSK--  200 (604)
Q Consensus       123 VmEy~~ggsL~~~l~~~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~--  200 (604)
                      ||||+.+++|.+++....+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||+++.+......  
T Consensus        86 v~e~~~~~~l~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~  165 (283)
T cd05080          86 IMEYVPLGSLRDYLPKHKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYR  165 (283)
T ss_pred             EecCCCCCCHHHHHHHcCCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeecccccccCCcchhhc
Confidence            999999999999998888999999999999999999999999999999999999999999999999999766432221  


Q ss_pred             -CcccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChh---------------hHhhhcCCCCCCCC
Q psy1546         201 -RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPM---------------RVLFLIPKNNPPQL  264 (604)
Q Consensus       201 -~~~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~---------------~~~~~i~~~~~~~~  264 (604)
                       .....++..|+|||++.+..++.++|||||||++|+|++|..||......               .....+........
T Consensus       166 ~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (283)
T cd05080         166 VREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERGMRLPC  245 (283)
T ss_pred             cCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhhcCCCCCC
Confidence             12234567799999999889999999999999999999999997653321               01111111222234


Q ss_pred             CccchHHHHHHHHHHhccCCCCCCCHHHHhc
Q psy1546         265 TGNYTKQFKEFVEACLNKDPENRPTAKELLK  295 (604)
Q Consensus       265 ~~~~s~~l~~Li~~~L~~dP~~RpT~~elL~  295 (604)
                      +..++..+.+|+.+||..||.+|||+++|+.
T Consensus       246 ~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~  276 (283)
T cd05080         246 PKNCPQEVYILMKNCWETEAKFRPTFRSLIP  276 (283)
T ss_pred             CCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence            5567899999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=1.8e-37  Score=313.84  Aligned_cols=235  Identities=27%  Similarity=0.450  Sum_probs=199.5

Q ss_pred             cceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCCe---------EEEEEEecC
Q psy1546          58 IFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTK---------LWIIMEYLG  128 (604)
Q Consensus        58 ~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~~---------lyLVmEy~~  128 (604)
                      .|.+.++||+|+||.||+|.+. .+..||+|.+......  .+.+.+|+.+++.++|++..+         .|+||||+.
T Consensus         7 ~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~--~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~lv~e~~~   83 (260)
T cd05070           7 SLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTMS--PESFLEEAQIMKKLRHDKLVQLYAVVSEEPIYIVTEYMS   83 (260)
T ss_pred             HhhhhheeccccCceEEEEEec-CCceeEEEEecCCCCC--HHHHHHHHHHHHhcCCCceEEEEeEECCCCcEEEEEecC
Confidence            4888999999999999999876 4567999998654332  256889999999999998544         379999999


Q ss_pred             CCChhhHhhc---CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCC-CCccc
Q psy1546         129 GGSALDLMKA---GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTS-KRNTF  204 (604)
Q Consensus       129 ggsL~~~l~~---~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~-~~~~~  204 (604)
                      +++|.+++..   ..+++..+..++.||+.||.|||++||+||||||+|||+++++.++|+|||++..+..... .....
T Consensus        84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~  163 (260)
T cd05070          84 KGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGA  163 (260)
T ss_pred             CCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeeccCcccccccCC
Confidence            9999999864   3589999999999999999999999999999999999999999999999999976543221 11223


Q ss_pred             ccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHhhhcCCCCCCCCCccchHHHHHHHHHHhccC
Q psy1546         205 VGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAK-GEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKD  283 (604)
Q Consensus       205 ~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~~L~~d  283 (604)
                      .++..|+|||++.+..++.++||||||+++|+|++ |.+||......+....+........+..++..+.+|+.+||..+
T Consensus       164 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~  243 (260)
T cd05070         164 KFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPCPQDCPISLHELMLQCWKKD  243 (260)
T ss_pred             CCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHHHHHHcccC
Confidence            45678999999998899999999999999999999 99999888777766666655555666778899999999999999


Q ss_pred             CCCCCCHHHHhc
Q psy1546         284 PENRPTAKELLK  295 (604)
Q Consensus       284 P~~RpT~~elL~  295 (604)
                      |.+|||+.+++.
T Consensus       244 p~~Rpt~~~l~~  255 (260)
T cd05070         244 PEERPTFEYLQS  255 (260)
T ss_pred             cccCcCHHHHHH
Confidence            999999999874

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=2.7e-37  Score=313.70  Aligned_cols=238  Identities=27%  Similarity=0.452  Sum_probs=200.8

Q ss_pred             cceeeeEEcccCcEEEEEEEECCCCc---EEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCCe----------EEEEE
Q psy1546          58 IFTKQERIGKGSFGEVFKGIDNRTQQ---VVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTK----------LWIIM  124 (604)
Q Consensus        58 ~y~i~~~LG~G~fG~Vy~a~~~~t~~---~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~~----------lyLVm  124 (604)
                      .|+..+.||+|+||.||+|.+..++.   .||||.+...........+..|+.+++.+.|++..+          +|+||
T Consensus         6 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   85 (268)
T cd05063           6 HITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMIIT   85 (268)
T ss_pred             HceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEEE
Confidence            47888999999999999999876654   799999876544455677889999999999998554          47999


Q ss_pred             EecCCCChhhHhhc--CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCCCCc
Q psy1546         125 EYLGGGSALDLMKA--GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRN  202 (604)
Q Consensus       125 Ey~~ggsL~~~l~~--~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~~~  202 (604)
                      ||+++++|.+++..  +.+++..+..++.|++.||.|||+.|++||||||+|||++.++.+||+|||++...........
T Consensus        86 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~  165 (268)
T cd05063          86 EYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTY  165 (268)
T ss_pred             EcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceecccccccce
Confidence            99999999999864  5689999999999999999999999999999999999999999999999999976543222111


Q ss_pred             ---ccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHhhhcCCCCCCCCCccchHHHHHHHHH
Q psy1546         203 ---TFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAK-GEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEA  278 (604)
Q Consensus       203 ---~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~  278 (604)
                         ....++.|+|||++.+..++.++|||||||++|||++ |..||...........+...........++..+.+|+.+
T Consensus       166 ~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~  245 (268)
T cd05063         166 TTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRLPAPMDCPSAVYQLMLQ  245 (268)
T ss_pred             eccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHH
Confidence               1123457999999998889999999999999999997 999998877766666665544444455678999999999


Q ss_pred             HhccCCCCCCCHHHHhc
Q psy1546         279 CLNKDPENRPTAKELLK  295 (604)
Q Consensus       279 ~L~~dP~~RpT~~elL~  295 (604)
                      ||..+|.+||++.+|++
T Consensus       246 c~~~~p~~Rp~~~~i~~  262 (268)
T cd05063         246 CWQQDRARRPRFVDIVN  262 (268)
T ss_pred             HcCCCcccCcCHHHHHH
Confidence            99999999999999986

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=2.4e-37  Score=310.55  Aligned_cols=237  Identities=31%  Similarity=0.542  Sum_probs=204.0

Q ss_pred             ceeeeEEcccCcEEEEEEEECCCC----cEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCCe----------EEEEE
Q psy1546          59 FTKQERIGKGSFGEVFKGIDNRTQ----QVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTK----------LWIIM  124 (604)
Q Consensus        59 y~i~~~LG~G~fG~Vy~a~~~~t~----~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~~----------lyLVm  124 (604)
                      +++.+.||.|+||.||+|.+...+    ..||+|++...........+..|+.++..+.|+++.+          .|+||
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~   80 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM   80 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence            356788999999999999998766    8999999976655546688999999999999998554          47999


Q ss_pred             EecCCCChhhHhhcCC---CcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCCCC
Q psy1546         125 EYLGGGSALDLMKAGN---FEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKR  201 (604)
Q Consensus       125 Ey~~ggsL~~~l~~~~---lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~~  201 (604)
                      ||+++++|.+++....   +++..+..++.||+.||.|||+.|++||||||+||+++.++.++|+|||++..........
T Consensus        81 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~  160 (258)
T smart00219       81 EYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYK  160 (258)
T ss_pred             eccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceecccccccc
Confidence            9999999999986532   9999999999999999999999999999999999999999999999999997665432221


Q ss_pred             c-ccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHhhhcCCCCCCCCCccchHHHHHHHHHH
Q psy1546         202 N-TFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAK-GEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEAC  279 (604)
Q Consensus       202 ~-~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~~  279 (604)
                      . ...+++.|+|||.+.+..++.++|||||||++|+|++ |.+||...........+........+..++.++.+++.+|
T Consensus       161 ~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~  240 (258)
T smart00219      161 KKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYRLPKPENCPPEIYKLMLQC  240 (258)
T ss_pred             cccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCcCCHHHHHHHHHH
Confidence            1 2237789999999988889999999999999999998 8999988777776666666555566667899999999999


Q ss_pred             hccCCCCCCCHHHHhc
Q psy1546         280 LNKDPENRPTAKELLK  295 (604)
Q Consensus       280 L~~dP~~RpT~~elL~  295 (604)
                      |..||.+|||+.|+++
T Consensus       241 l~~~p~~Rpt~~~ll~  256 (258)
T smart00219      241 WAEDPEDRPTFSELVE  256 (258)
T ss_pred             CcCChhhCcCHHHHHh
Confidence            9999999999999986

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=2.2e-37  Score=319.36  Aligned_cols=236  Identities=25%  Similarity=0.422  Sum_probs=200.4

Q ss_pred             ceeeeEEcccCcEEEEEEEEC-----CCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCCe----------EEEE
Q psy1546          59 FTKQERIGKGSFGEVFKGIDN-----RTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTK----------LWII  123 (604)
Q Consensus        59 y~i~~~LG~G~fG~Vy~a~~~-----~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~~----------lyLV  123 (604)
                      |.+.+.||+|+||.||+|.+.     .++..+++|.+..... ...+.+.+|+.+++.+.|+++.+          +++|
T Consensus         7 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   85 (291)
T cd05094           7 IVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTL-AARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMV   85 (291)
T ss_pred             eEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccH-HHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEEE
Confidence            788899999999999999854     3456799999865433 33467889999999999998655          4799


Q ss_pred             EEecCCCChhhHhhc-----------------CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEe
Q psy1546         124 MEYLGGGSALDLMKA-----------------GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLA  186 (604)
Q Consensus       124 mEy~~ggsL~~~l~~-----------------~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~  186 (604)
                      |||+++++|.+++..                 +.+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+
T Consensus        86 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~~~~~l~  165 (291)
T cd05094          86 FEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIG  165 (291)
T ss_pred             EecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcEEEC
Confidence            999999999999854                 237889999999999999999999999999999999999999999999


Q ss_pred             cccccccccCCCC--CCcccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHhhhcCCCCCCC
Q psy1546         187 DFGVAGTLTNTTS--KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAK-GEPPNSELHPMRVLFLIPKNNPPQ  263 (604)
Q Consensus       187 DFGlA~~~~~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~  263 (604)
                      |||++........  ......++..|+|||++.+..++.++|||||||++|+|++ |..||......+....+.......
T Consensus       166 dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~  245 (291)
T cd05094         166 DFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQGRVLE  245 (291)
T ss_pred             CCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhCCCCCC
Confidence            9999975543221  1233457888999999999999999999999999999998 999998887776666665655555


Q ss_pred             CCccchHHHHHHHHHHhccCCCCCCCHHHHhc
Q psy1546         264 LTGNYTKQFKEFVEACLNKDPENRPTAKELLK  295 (604)
Q Consensus       264 ~~~~~s~~l~~Li~~~L~~dP~~RpT~~elL~  295 (604)
                      ....++..+.+|+.+||..||.+|||+.+|++
T Consensus       246 ~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~  277 (291)
T cd05094         246 RPRVCPKEVYDIMLGCWQREPQQRLNIKEIYK  277 (291)
T ss_pred             CCccCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence            66678899999999999999999999999976

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.5e-37  Score=314.09  Aligned_cols=235  Identities=27%  Similarity=0.429  Sum_probs=197.6

Q ss_pred             ceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCCeE----------EEEEEecC
Q psy1546          59 FTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTKL----------WIIMEYLG  128 (604)
Q Consensus        59 y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~~l----------yLVmEy~~  128 (604)
                      |++.+.||+|+||.||+|.+. ++..+|||++......  ...+.+|+.+++.+.|+++.++          |+||||++
T Consensus         6 ~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~~--~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~   82 (256)
T cd05059           6 LTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAMS--EDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMA   82 (256)
T ss_pred             cchhhhhccCCCceEEEeEec-CCccEEEEEeccCCCC--HHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCC
Confidence            788899999999999999876 4668999998644322  2457789999999999986554          69999999


Q ss_pred             CCChhhHhhc--CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCCCC-cccc
Q psy1546         129 GGSALDLMKA--GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKR-NTFV  205 (604)
Q Consensus       129 ggsL~~~l~~--~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~~-~~~~  205 (604)
                      +++|.+++..  +.+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++......... ....
T Consensus        83 ~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~~~~~  162 (256)
T cd05059          83 NGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTK  162 (256)
T ss_pred             CCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceecccccccccCCCC
Confidence            9999999864  468999999999999999999999999999999999999999999999999997654322111 1122


Q ss_pred             cCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHhhhcCCCCCCCCCccchHHHHHHHHHHhccCC
Q psy1546         206 GTPFWMAPEVIKQSAYDSKADIWSLGITAIELAK-GEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDP  284 (604)
Q Consensus       206 GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~~L~~dP  284 (604)
                      ++..|+|||++.+..++.++|||||||++|+|++ |.+||......+....+........+..++..+.+++.+||..+|
T Consensus       163 ~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p  242 (256)
T cd05059         163 FPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRLYRPKLAPTEVYTIMYSCWHEKP  242 (256)
T ss_pred             CCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHhcCCh
Confidence            3457999999999999999999999999999998 899998877766666665555555566789999999999999999


Q ss_pred             CCCCCHHHHhcC
Q psy1546         285 ENRPTAKELLKF  296 (604)
Q Consensus       285 ~~RpT~~elL~h  296 (604)
                      ++|||+.|+++.
T Consensus       243 ~~Rpt~~~~l~~  254 (256)
T cd05059         243 EDRPAFKKLLSQ  254 (256)
T ss_pred             hhCcCHHHHHHH
Confidence            999999999874

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=2.7e-37  Score=322.66  Aligned_cols=239  Identities=25%  Similarity=0.459  Sum_probs=200.3

Q ss_pred             ccceeeeEEcccCcEEEEEEEEC-------CCCcEEEEEEecchhhHHHHHHHHHHHHHHhhC-CCCCCCe---------
Q psy1546          57 LIFTKQERIGKGSFGEVFKGIDN-------RTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQC-DSPYGTK---------  119 (604)
Q Consensus        57 ~~y~i~~~LG~G~fG~Vy~a~~~-------~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l-~hp~~~~---------  119 (604)
                      ..|.+.++||+|+||.||+|.+.       .....||+|++...........+..|+.+++.+ .||++.+         
T Consensus        12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~   91 (314)
T cd05099          12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEG   91 (314)
T ss_pred             HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCC
Confidence            35889999999999999999863       234579999987654455567788999999999 5998654         


Q ss_pred             -EEEEEEecCCCChhhHhhc-----------------CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCC
Q psy1546         120 -LWIIMEYLGGGSALDLMKA-----------------GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMG  181 (604)
Q Consensus       120 -lyLVmEy~~ggsL~~~l~~-----------------~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g  181 (604)
                       +|+||||+.+|+|.+++..                 ..+++..+..++.||+.||.|||++||+||||||+|||++.++
T Consensus        92 ~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~~~~  171 (314)
T cd05099          92 PLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDN  171 (314)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEEEcCCC
Confidence             4799999999999999854                 2478888999999999999999999999999999999999999


Q ss_pred             CeEEecccccccccCCCCCC--cccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHhhhcCC
Q psy1546         182 DVKLADFGVAGTLTNTTSKR--NTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAK-GEPPNSELHPMRVLFLIPK  258 (604)
Q Consensus       182 ~vKL~DFGlA~~~~~~~~~~--~~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~~i~~  258 (604)
                      .+||+|||+++.........  ....++..|||||++.+..++.++|||||||++|+|++ |..||...........+..
T Consensus       172 ~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~  251 (314)
T cd05099         172 VMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFKLLRE  251 (314)
T ss_pred             cEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc
Confidence            99999999997664322211  12234567999999999899999999999999999999 8999988877766666655


Q ss_pred             CCCCCCCccchHHHHHHHHHHhccCCCCCCCHHHHhc
Q psy1546         259 NNPPQLTGNYTKQFKEFVEACLNKDPENRPTAKELLK  295 (604)
Q Consensus       259 ~~~~~~~~~~s~~l~~Li~~~L~~dP~~RpT~~elL~  295 (604)
                      ......+..++.++.+|+.+||..||.+|||+.++++
T Consensus       252 ~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~  288 (314)
T cd05099         252 GHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVE  288 (314)
T ss_pred             CCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence            5555556778899999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=2.4e-37  Score=313.64  Aligned_cols=237  Identities=30%  Similarity=0.512  Sum_probs=197.7

Q ss_pred             ceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhh--HHHHHHHHHHHHHHhhCCCCCCC----------eEEEEEEe
Q psy1546          59 FTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA--EDEIEDIQQEIMVLSQCDSPYGT----------KLWIIMEY  126 (604)
Q Consensus        59 y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~--~~~~~~l~~Ei~iL~~l~hp~~~----------~lyLVmEy  126 (604)
                      |.+.+.||.|+||.||+|.+..++..||||.+.....  ......+.+|+.+++.+.|+++.          .+|+||||
T Consensus         4 y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~   83 (267)
T cd08229           4 FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLEL   83 (267)
T ss_pred             hhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEEEe
Confidence            7888999999999999999999999999998764322  23346788999999999999854          35899999


Q ss_pred             cCCCChhhHhhc-----CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCCCC
Q psy1546         127 LGGGSALDLMKA-----GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKR  201 (604)
Q Consensus       127 ~~ggsL~~~l~~-----~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~~  201 (604)
                      +++++|.+++..     ..+++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||++..+.......
T Consensus        84 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~  163 (267)
T cd08229          84 ADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAA  163 (267)
T ss_pred             cCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhccccCCccc
Confidence            999999998852     468999999999999999999999999999999999999999999999999987665444333


Q ss_pred             cccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCCh--hhHhhhcCCCCCC-CCCccchHHHHHHHHH
Q psy1546         202 NTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHP--MRVLFLIPKNNPP-QLTGNYTKQFKEFVEA  278 (604)
Q Consensus       202 ~~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~--~~~~~~i~~~~~~-~~~~~~s~~l~~Li~~  278 (604)
                      ....|+..|+|||++.+..++.++||||||+++|+|++|..||.....  ......+.....+ .....++..+.+|+.+
T Consensus       164 ~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  243 (267)
T cd08229         164 HSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNM  243 (267)
T ss_pred             ccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCCCCCCCcccccHHHHHHHHH
Confidence            456799999999999988899999999999999999999999875433  2222222222222 2234578899999999


Q ss_pred             HhccCCCCCCCHHHHhc
Q psy1546         279 CLNKDPENRPTAKELLK  295 (604)
Q Consensus       279 ~L~~dP~~RpT~~elL~  295 (604)
                      ||..||.+|||+.+|++
T Consensus       244 ~l~~~p~~Rpt~~~i~~  260 (267)
T cd08229         244 CINPDPEKRPDITYVYD  260 (267)
T ss_pred             hcCCCcccCCCHHHHHH
Confidence            99999999999998875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=3.2e-37  Score=312.45  Aligned_cols=235  Identities=28%  Similarity=0.457  Sum_probs=197.8

Q ss_pred             cceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCCeE---------EEEEEecC
Q psy1546          58 IFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTKL---------WIIMEYLG  128 (604)
Q Consensus        58 ~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~~l---------yLVmEy~~  128 (604)
                      .|.+.+.||+|+||.||+|.+..+. .||+|.+.....  ..+.+.+|+.+++.+.|++..++         |+||||+.
T Consensus         7 ~~~~~~~ig~g~~~~v~~~~~~~~~-~~~lK~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~v~e~~~   83 (260)
T cd05069           7 SLRLDVKLGQGCFGEVWMGTWNGTT-KVAIKTLKPGTM--MPEAFLQEAQIMKKLRHDKLVPLYAVVSEEPIYIVTEFMG   83 (260)
T ss_pred             HeeeeeeecCcCCCeEEEEEEcCCc-eEEEEEcccCCc--cHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCcEEEEEcCC
Confidence            3889999999999999999876654 589998765432  23567889999999999986544         79999999


Q ss_pred             CCChhhHhhc---CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCC-CCccc
Q psy1546         129 GGSALDLMKA---GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTS-KRNTF  204 (604)
Q Consensus       129 ggsL~~~l~~---~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~-~~~~~  204 (604)
                      +++|.+++..   ..+++..+..++.||+.||.|||+.||+||||||+|||+++++.++|+|||++..+..... .....
T Consensus        84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~~~~~~  163 (260)
T cd05069          84 KGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGA  163 (260)
T ss_pred             CCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEccCCcccccCCC
Confidence            9999999865   2478889999999999999999999999999999999999999999999999976543221 11223


Q ss_pred             ccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHhhhcCCCCCCCCCccchHHHHHHHHHHhccC
Q psy1546         205 VGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAK-GEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKD  283 (604)
Q Consensus       205 ~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~~L~~d  283 (604)
                      .++..|+|||++.+..++.++|||||||++|+|++ |..||.+....+....+........+..++..+.+|+.+||..|
T Consensus       164 ~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~  243 (260)
T cd05069         164 KFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMPCPQGCPESLHELMKLCWKKD  243 (260)
T ss_pred             ccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHHHHHHHccCC
Confidence            46678999999998899999999999999999999 99999887776666655555444556678899999999999999


Q ss_pred             CCCCCCHHHHhc
Q psy1546         284 PENRPTAKELLK  295 (604)
Q Consensus       284 P~~RpT~~elL~  295 (604)
                      |.+||++++|++
T Consensus       244 p~~Rp~~~~i~~  255 (260)
T cd05069         244 PDERPTFEYIQS  255 (260)
T ss_pred             cccCcCHHHHHH
Confidence            999999999976

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=8.2e-38  Score=329.51  Aligned_cols=247  Identities=26%  Similarity=0.478  Sum_probs=200.6

Q ss_pred             ccceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhh-HHHHHHHHHHHHHHhhCCCCCCC--------------eEE
Q psy1546          57 LIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA-EDEIEDIQQEIMVLSQCDSPYGT--------------KLW  121 (604)
Q Consensus        57 ~~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~-~~~~~~l~~Ei~iL~~l~hp~~~--------------~ly  121 (604)
                      ..|.+.+.||.|+||.||+|.+..+++.||+|++..... ......+.+|+.+|+.+.||++.              .+|
T Consensus         5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   84 (334)
T cd07855           5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVY   84 (334)
T ss_pred             hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEE
Confidence            458999999999999999999999999999999865432 22346677899999999999854              358


Q ss_pred             EEEEecCCCChhhHhhc-CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCCC
Q psy1546         122 IIMEYLGGGSALDLMKA-GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSK  200 (604)
Q Consensus       122 LVmEy~~ggsL~~~l~~-~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~  200 (604)
                      +||||+. ++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.........
T Consensus        85 lv~e~~~-~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~  163 (334)
T cd07855          85 VVMDLME-SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTE  163 (334)
T ss_pred             EEEehhh-hhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceeecccCcC
Confidence            9999995 578888854 56899999999999999999999999999999999999999999999999999765433221


Q ss_pred             ----CcccccCCCCCChHHhhc-CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhc-------------------
Q psy1546         201 ----RNTFVGTPFWMAPEVIKQ-SAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLI-------------------  256 (604)
Q Consensus       201 ----~~~~~GT~~Y~APE~l~~-~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i-------------------  256 (604)
                          .....|+..|+|||++.+ ..++.++|||||||++|+|++|.+||...........+                   
T Consensus       164 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~  243 (334)
T cd07855         164 HKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSDR  243 (334)
T ss_pred             CCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhchhh
Confidence                234578999999999865 45889999999999999999999999776543221110                   


Q ss_pred             --------CCCCC---CCCCccchHHHHHHHHHHhccCCCCCCCHHHHhcChhhhhhhh
Q psy1546         257 --------PKNNP---PQLTGNYTKQFKEFVEACLNKDPENRPTAKELLKFPFIRKAKK  304 (604)
Q Consensus       257 --------~~~~~---~~~~~~~s~~l~~Li~~~L~~dP~~RpT~~elL~hp~f~~~~~  304 (604)
                              .....   ..+...++.++.++|.+||+.+|.+|||+.+++.||||.+...
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~~  302 (334)
T cd07855         244 VRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYHD  302 (334)
T ss_pred             HHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhccC
Confidence                    00000   0112346889999999999999999999999999999976544

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=1.9e-37  Score=319.69  Aligned_cols=244  Identities=29%  Similarity=0.453  Sum_probs=195.0

Q ss_pred             cceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhH-HHHHHHHHHHHHHhhCCCCCCCe----------EEEEEEe
Q psy1546          58 IFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAE-DEIEDIQQEIMVLSQCDSPYGTK----------LWIIMEY  126 (604)
Q Consensus        58 ~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~-~~~~~l~~Ei~iL~~l~hp~~~~----------lyLVmEy  126 (604)
                      .|.+.+.||+|+||.||+|.+..+++.||||.+...... .....+.+|+.+++.++|+++.+          +|+||||
T Consensus         3 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   82 (294)
T PLN00009          3 QYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFEY   82 (294)
T ss_pred             ceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEec
Confidence            388999999999999999999999999999998654322 23456788999999999998544          4799999


Q ss_pred             cCCCChhhHhhc-C--CCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecC-CCCeEEecccccccccCCCCCCc
Q psy1546         127 LGGGSALDLMKA-G--NFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSE-MGDVKLADFGVAGTLTNTTSKRN  202 (604)
Q Consensus       127 ~~ggsL~~~l~~-~--~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~-~g~vKL~DFGlA~~~~~~~~~~~  202 (604)
                      ++ ++|.+++.. .  .+++..+..++.||+.||.|||++||+||||+|+||+++. ++.+||+|||++...........
T Consensus        83 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~~~~  161 (294)
T PLN00009         83 LD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFT  161 (294)
T ss_pred             cc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCccccc
Confidence            96 467776643 2  3578888999999999999999999999999999999985 45799999999976543333333


Q ss_pred             ccccCCCCCChHHhhcC-CCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCC---CC-----------------C
Q psy1546         203 TFVGTPFWMAPEVIKQS-AYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPK---NN-----------------P  261 (604)
Q Consensus       203 ~~~GT~~Y~APE~l~~~-~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~---~~-----------------~  261 (604)
                      ...+++.|+|||++.+. .++.++|||||||++|+|++|.+||...........+..   ..                 .
T Consensus       162 ~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (294)
T PLN00009        162 HEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDYKSAF  241 (294)
T ss_pred             cCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchhhhhhc
Confidence            45678999999998764 578899999999999999999999987655433322110   00                 0


Q ss_pred             C--------CCCccchHHHHHHHHHHhccCCCCCCCHHHHhcChhhhhh
Q psy1546         262 P--------QLTGNYTKQFKEFVEACLNKDPENRPTAKELLKFPFIRKA  302 (604)
Q Consensus       262 ~--------~~~~~~s~~l~~Li~~~L~~dP~~RpT~~elL~hp~f~~~  302 (604)
                      +        .....++..+.+++.+||+.+|++||++.++++||||+..
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~  290 (294)
T PLN00009        242 PKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDL  290 (294)
T ss_pred             ccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhHH
Confidence            0        0123467889999999999999999999999999999764

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=2.9e-37  Score=315.85  Aligned_cols=239  Identities=22%  Similarity=0.376  Sum_probs=203.2

Q ss_pred             ccceeeeEEcccCcEEEEEEEECC----CCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCCeE-----------E
Q psy1546          57 LIFTKQERIGKGSFGEVFKGIDNR----TQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTKL-----------W  121 (604)
Q Consensus        57 ~~y~i~~~LG~G~fG~Vy~a~~~~----t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~~l-----------y  121 (604)
                      ..|.+.+.||+|+||.||+|.+..    ++..||+|++...........+.+|+.+++.+.|+++.++           |
T Consensus         6 ~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~   85 (280)
T cd05043           6 DRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPPF   85 (280)
T ss_pred             hheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCCE
Confidence            348899999999999999999876    3688999998765555667888999999999999996654           5


Q ss_pred             EEEEecCCCChhhHhhc---------CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccc
Q psy1546         122 IIMEYLGGGSALDLMKA---------GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAG  192 (604)
Q Consensus       122 LVmEy~~ggsL~~~l~~---------~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~  192 (604)
                      +++||+.+++|.+++..         ..+++..++.++.||+.||.|||+++++||||||+|||++.++.+||+|||+++
T Consensus        86 ~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~d~g~~~  165 (280)
T cd05043          86 VLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNALSR  165 (280)
T ss_pred             EEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEECCCCCcc
Confidence            89999999999998854         358899999999999999999999999999999999999999999999999997


Q ss_pred             cccCCCCC--CcccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHhhhcCCCCCCCCCccch
Q psy1546         193 TLTNTTSK--RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAK-GEPPNSELHPMRVLFLIPKNNPPQLTGNYT  269 (604)
Q Consensus       193 ~~~~~~~~--~~~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s  269 (604)
                      .+......  .....++..|+|||++.+..++.++|||||||++||+++ |.+||......+....+...........++
T Consensus       166 ~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (280)
T cd05043         166 DLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGYRLAQPINCP  245 (280)
T ss_pred             cccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcCCCCCCCCcCC
Confidence            65432211  122346778999999999899999999999999999998 999999887777666555554444556678


Q ss_pred             HHHHHHHHHHhccCCCCCCCHHHHhc
Q psy1546         270 KQFKEFVEACLNKDPENRPTAKELLK  295 (604)
Q Consensus       270 ~~l~~Li~~~L~~dP~~RpT~~elL~  295 (604)
                      +++.+++.+||..||++|||+.++++
T Consensus       246 ~~~~~li~~~l~~~p~~Rps~~~~~~  271 (280)
T cd05043         246 DELFAVMACCWALDPEERPSFSQLVQ  271 (280)
T ss_pred             HHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            99999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=2.7e-37  Score=317.62  Aligned_cols=239  Identities=24%  Similarity=0.443  Sum_probs=201.2

Q ss_pred             ccceeeeEEcccCcEEEEEEEEC-----CCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCCe----------EE
Q psy1546          57 LIFTKQERIGKGSFGEVFKGIDN-----RTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTK----------LW  121 (604)
Q Consensus        57 ~~y~i~~~LG~G~fG~Vy~a~~~-----~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~~----------ly  121 (604)
                      ..|.+.+.||+|+||.||+|.+.     .++..||||++...........+.+|+.+++.+.||++.+          +|
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~~   84 (288)
T cd05050           5 NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMC   84 (288)
T ss_pred             HhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCccE
Confidence            34889999999999999999874     3678999999876554445577889999999999998654          47


Q ss_pred             EEEEecCCCChhhHhhcC-----------------------CCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEec
Q psy1546         122 IIMEYLGGGSALDLMKAG-----------------------NFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLS  178 (604)
Q Consensus       122 LVmEy~~ggsL~~~l~~~-----------------------~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~  178 (604)
                      +||||+++++|.+++...                       .+++..++.++.||+.||.|||++|++||||||+|||++
T Consensus        85 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~nil~~  164 (288)
T cd05050          85 LLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVG  164 (288)
T ss_pred             EEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhheEec
Confidence            999999999999998632                       367888899999999999999999999999999999999


Q ss_pred             CCCCeEEecccccccccCCCC--CCcccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHhhh
Q psy1546         179 EMGDVKLADFGVAGTLTNTTS--KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAK-GEPPNSELHPMRVLFL  255 (604)
Q Consensus       179 ~~g~vKL~DFGlA~~~~~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~~  255 (604)
                      .++.++|+|||++..+.....  ......++..|+|||++.+..++.++|||||||++|+|++ |..||.+....+....
T Consensus       165 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~~~~~  244 (288)
T cd05050         165 ENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEVIYY  244 (288)
T ss_pred             CCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence            999999999999875532221  1122345677999999999999999999999999999997 8889988777776666


Q ss_pred             cCCCCCCCCCccchHHHHHHHHHHhccCCCCCCCHHHHhc
Q psy1546         256 IPKNNPPQLTGNYTKQFKEFVEACLNKDPENRPTAKELLK  295 (604)
Q Consensus       256 i~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~RpT~~elL~  295 (604)
                      +........+..++.++.+||.+||..||.+|||+.||++
T Consensus       245 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~  284 (288)
T cd05050         245 VRDGNVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINR  284 (288)
T ss_pred             HhcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence            6555555556678899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>KOG1026|consensus

Probab=100.00  E-value=1.5e-38  Score=353.63  Aligned_cols=236  Identities=25%  Similarity=0.468  Sum_probs=210.7

Q ss_pred             ceeeeEEcccCcEEEEEEEEC-----CCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCCeE----------EEE
Q psy1546          59 FTKQERIGKGSFGEVFKGIDN-----RTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTKL----------WII  123 (604)
Q Consensus        59 y~i~~~LG~G~fG~Vy~a~~~-----~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~~l----------yLV  123 (604)
                      ....+.||+|.||+||+|+..     .....||||.++.........+|+||+.+|..|+|||++++          |||
T Consensus       488 i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~Mv  567 (774)
T KOG1026|consen  488 IVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLCMV  567 (774)
T ss_pred             eeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeEEE
Confidence            456788999999999999743     34578999999877766678999999999999999998876          699


Q ss_pred             EEecCCCChhhHhhc---------------CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecc
Q psy1546         124 MEYLGGGSALDLMKA---------------GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADF  188 (604)
Q Consensus       124 mEy~~ggsL~~~l~~---------------~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DF  188 (604)
                      +|||..|||.++++.               ..++..+.+.|+.||+.|+.||-++.+|||||-.+|+||.+...|||+||
T Consensus       568 FEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge~l~VKIsDf  647 (774)
T KOG1026|consen  568 FEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGENLVVKISDF  647 (774)
T ss_pred             EEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceeccceEEEeccc
Confidence            999999999999852               12788899999999999999999999999999999999999999999999


Q ss_pred             cccccccCCCCCCc--ccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHhhhcCCCCCCCCC
Q psy1546         189 GVAGTLTNTTSKRN--TFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAK-GEPPNSELHPMRVLFLIPKNNPPQLT  265 (604)
Q Consensus       189 GlA~~~~~~~~~~~--~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~  265 (604)
                      |+++.....+..+.  .-.-..+|||||.+..++|+.++|||||||+|||+++ |..||.+....++...+..+.....+
T Consensus       648 GLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~~g~lL~~P  727 (774)
T KOG1026|consen  648 GLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIRAGQLLSCP  727 (774)
T ss_pred             ccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHHHHHcCCcccCC
Confidence            99987754443321  2234678999999999999999999999999999998 99999999999999999999988999


Q ss_pred             ccchHHHHHHHHHHhccCCCCCCCHHHHh
Q psy1546         266 GNYTKQFKEFVEACLNKDPENRPTAKELL  294 (604)
Q Consensus       266 ~~~s~~l~~Li~~~L~~dP~~RpT~~elL  294 (604)
                      .++|.++.+|+..||+.+|.+||++.||-
T Consensus       728 e~CP~~vY~LM~~CW~~~P~~RPsF~eI~  756 (774)
T KOG1026|consen  728 ENCPTEVYSLMLECWNENPKRRPSFKEIH  756 (774)
T ss_pred             CCCCHHHHHHHHHHhhcCcccCCCHHHHH
Confidence            99999999999999999999999999984

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=3e-37  Score=312.53  Aligned_cols=235  Identities=26%  Similarity=0.461  Sum_probs=198.1

Q ss_pred             cceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCCe----------EEEEEEec
Q psy1546          58 IFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTK----------LWIIMEYL  127 (604)
Q Consensus        58 ~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~~----------lyLVmEy~  127 (604)
                      .|++.+.||+|+||.||+|.+.. ++.||||.+.....  ..+.+.+|+.+++++.|+++.+          +|+||||+
T Consensus         7 ~~~~~~~lg~g~~~~v~~~~~~~-~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   83 (261)
T cd05068           7 SIQLLRKLGAGQFGEVWEGLWNN-TTPVAVKTLKPGTM--DPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELM   83 (261)
T ss_pred             heeeEEEecccCCccEEEEEecC-CeEEEEEeeCCCcc--cHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecc
Confidence            38999999999999999998754 56799999865432  2356788999999999998654          47999999


Q ss_pred             CCCChhhHhhcC---CCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCCC-Ccc
Q psy1546         128 GGGSALDLMKAG---NFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSK-RNT  203 (604)
Q Consensus       128 ~ggsL~~~l~~~---~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~-~~~  203 (604)
                      ++++|.+++...   .+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||+++.+...... ...
T Consensus        84 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~  163 (261)
T cd05068          84 KYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREG  163 (261)
T ss_pred             cCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCcccccCC
Confidence            999999998653   5899999999999999999999999999999999999999999999999999766532211 111


Q ss_pred             cccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHhhhcCCCCCCCCCccchHHHHHHHHHHhcc
Q psy1546         204 FVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAK-GEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNK  282 (604)
Q Consensus       204 ~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~~L~~  282 (604)
                      ...+..|+|||++.+..++.++|||||||++|+|++ |..||.+.........+........+..++..+.+++.+||..
T Consensus       164 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  243 (261)
T cd05068         164 AKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRMPCPPGCPKELYDIMLDCWKE  243 (261)
T ss_pred             CcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHHHHHHhhc
Confidence            223457999999999899999999999999999999 9999998877766666655544445567889999999999999


Q ss_pred             CCCCCCCHHHHhc
Q psy1546         283 DPENRPTAKELLK  295 (604)
Q Consensus       283 dP~~RpT~~elL~  295 (604)
                      +|.+||++.+|++
T Consensus       244 ~P~~Rp~~~~l~~  256 (261)
T cd05068         244 DPDDRPTFETLQW  256 (261)
T ss_pred             CcccCCCHHHHHH
Confidence            9999999999975

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=1.6e-37  Score=336.54  Aligned_cols=239  Identities=25%  Similarity=0.408  Sum_probs=196.0

Q ss_pred             ccceeeeEEcccCcEEEEEEEECCC-----CcEEEEEEecchhhHHHHHHHHHHHHHHhhCC-CCCCCeE----------
Q psy1546          57 LIFTKQERIGKGSFGEVFKGIDNRT-----QQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCD-SPYGTKL----------  120 (604)
Q Consensus        57 ~~y~i~~~LG~G~fG~Vy~a~~~~t-----~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~-hp~~~~l----------  120 (604)
                      ..|.++++||+|+||.||+|.+...     +..||||++.........+.+.+|+.+|..+. |||++++          
T Consensus        37 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~~  116 (400)
T cd05105          37 DGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGPI  116 (400)
T ss_pred             cceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCce
Confidence            3488999999999999999987432     35799999976555555678899999999996 9996654          


Q ss_pred             EEEEEecCCCChhhHhhc--------------------------------------------------------------
Q psy1546         121 WIIMEYLGGGSALDLMKA--------------------------------------------------------------  138 (604)
Q Consensus       121 yLVmEy~~ggsL~~~l~~--------------------------------------------------------------  138 (604)
                      |||||||++|+|.+++..                                                              
T Consensus       117 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  196 (400)
T cd05105         117 YIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIKE  196 (400)
T ss_pred             EEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhhh
Confidence            799999999999988743                                                              


Q ss_pred             -----------------------------------CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCe
Q psy1546         139 -----------------------------------GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDV  183 (604)
Q Consensus       139 -----------------------------------~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~v  183 (604)
                                                         ..+++..+..++.||+.||.|||+++|+||||||+|||++.++.+
T Consensus       197 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill~~~~~~  276 (400)
T cd05105         197 ASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQGKIV  276 (400)
T ss_pred             hhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEEeCCCEE
Confidence                                               136777888999999999999999999999999999999999999


Q ss_pred             EEecccccccccCCCC--CCcccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhH-hhhcCCC
Q psy1546         184 KLADFGVAGTLTNTTS--KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAK-GEPPNSELHPMRV-LFLIPKN  259 (604)
Q Consensus       184 KL~DFGlA~~~~~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLlt-G~~Pf~~~~~~~~-~~~i~~~  259 (604)
                      ||+|||+++.+.....  ......+++.|||||++.+..++.++|||||||+||||++ |..||........ ...+...
T Consensus       277 kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~~~~~~~  356 (400)
T cd05105         277 KICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKIKSG  356 (400)
T ss_pred             EEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHHHHHHhcC
Confidence            9999999976543221  1223457788999999999999999999999999999997 9999887544332 2233333


Q ss_pred             CCCCCCccchHHHHHHHHHHhccCCCCCCCHHHHhc
Q psy1546         260 NPPQLTGNYTKQFKEFVEACLNKDPENRPTAKELLK  295 (604)
Q Consensus       260 ~~~~~~~~~s~~l~~Li~~~L~~dP~~RpT~~elL~  295 (604)
                      .....+..++..+.+++.+||..||++|||+.+|.+
T Consensus       357 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  392 (400)
T cd05105         357 YRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD  392 (400)
T ss_pred             CCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence            344455678899999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=3.1e-37  Score=311.91  Aligned_cols=234  Identities=26%  Similarity=0.435  Sum_probs=193.1

Q ss_pred             eEEcccCcEEEEEEEECC---CCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCCe-----------EEEEEEecC
Q psy1546          63 ERIGKGSFGEVFKGIDNR---TQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTK-----------LWIIMEYLG  128 (604)
Q Consensus        63 ~~LG~G~fG~Vy~a~~~~---t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~~-----------lyLVmEy~~  128 (604)
                      +.||+|+||.||+|.+..   ....||||.+.........+.+.+|+.+++.++||++.+           .|+||||+.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~   80 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK   80 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence            368999999999998653   345799999865444445678889999999999998554           369999999


Q ss_pred             CCChhhHhhc--CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCC----CCc
Q psy1546         129 GGSALDLMKA--GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTS----KRN  202 (604)
Q Consensus       129 ggsL~~~l~~--~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~----~~~  202 (604)
                      +++|.+++..  ..+++..+..++.||+.||.|||+.+++||||||+|||++.++.+||+|||+++.+.....    ...
T Consensus        81 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~  160 (262)
T cd05058          81 HGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHT  160 (262)
T ss_pred             CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCcceeecccc
Confidence            9999999865  3467778888999999999999999999999999999999999999999999975543211    112


Q ss_pred             ccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHhhhcCCCCCCCCCccchHHHHHHHHHHhc
Q psy1546         203 TFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAK-GEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLN  281 (604)
Q Consensus       203 ~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~~L~  281 (604)
                      ...++..|+|||++.+..++.++|||||||++|||++ |.+||...........+........+..++..+.+++.+||.
T Consensus       161 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  240 (262)
T cd05058         161 GAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRLLQPEYCPDPLYEVMLSCWH  240 (262)
T ss_pred             cCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCCCCCcCCHHHHHHHHHHcC
Confidence            3346778999999998899999999999999999999 567787777666665555555555556678899999999999


Q ss_pred             cCCCCCCCHHHHhcC
Q psy1546         282 KDPENRPTAKELLKF  296 (604)
Q Consensus       282 ~dP~~RpT~~elL~h  296 (604)
                      .+|++||++.+|++.
T Consensus       241 ~~p~~Rp~~~~il~~  255 (262)
T cd05058         241 PKPEMRPTFSELVSR  255 (262)
T ss_pred             CChhhCCCHHHHHHH
Confidence            999999999999873

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>KOG4236|consensus

Probab=100.00  E-value=9.8e-39  Score=335.45  Aligned_cols=245  Identities=27%  Similarity=0.472  Sum_probs=208.1

Q ss_pred             ccee--eeEEcccCcEEEEEEEECCCCcEEEEEEecchhhH-HHHHHHHHHHHHHhhCCCCCCC----------eEEEEE
Q psy1546          58 IFTK--QERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAE-DEIEDIQQEIMVLSQCDSPYGT----------KLWIIM  124 (604)
Q Consensus        58 ~y~i--~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~-~~~~~l~~Ei~iL~~l~hp~~~----------~lyLVm  124 (604)
                      .|.+  .++||+|-||+||-|+++.+|+.||||+|++.... +....+..|+.||..+.||.++          ++|+||
T Consensus       563 vYQif~devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVM  642 (888)
T KOG4236|consen  563 VYQIFADEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVM  642 (888)
T ss_pred             HHHhhhHhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEe
Confidence            3554  37899999999999999999999999999876542 3347789999999999999855          458999


Q ss_pred             EecCCCChhhHh--hcCCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCC---CCeEEecccccccccCCCC
Q psy1546         125 EYLGGGSALDLM--KAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEM---GDVKLADFGVAGTLTNTTS  199 (604)
Q Consensus       125 Ey~~ggsL~~~l--~~~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~---g~vKL~DFGlA~~~~~~~~  199 (604)
                      |-+.|..|.-++  +.|++++...++++.||+.||.|||-+||+|+||||+|||+...   -++||||||+|+.+... .
T Consensus       643 EKl~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEk-s  721 (888)
T KOG4236|consen  643 EKLHGDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEK-S  721 (888)
T ss_pred             hhhcchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchh-h
Confidence            999766666555  45899999999999999999999999999999999999999654   36999999999877644 4


Q ss_pred             CCcccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChh-hHhhhcCCCCCCCCCccchHHHHHHHHH
Q psy1546         200 KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPM-RVLFLIPKNNPPQLTGNYTKQFKEFVEA  278 (604)
Q Consensus       200 ~~~~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~-~~~~~i~~~~~~~~~~~~s~~l~~Li~~  278 (604)
                      .+.+.+|||.|+|||++++..|+..-|+||+|||+|.-|.|..||.+.... +......-..++..+..++.++.|||..
T Consensus       722 FRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQIQNAaFMyPp~PW~eis~~AidlIn~  801 (888)
T KOG4236|consen  722 FRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQIQNAAFMYPPNPWSEISPEAIDLINN  801 (888)
T ss_pred             hhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchhHHhhccccccCCCchhhcCHHHHHHHHH
Confidence            566789999999999999999999999999999999999999999865432 2222222234556667889999999999


Q ss_pred             HhccCCCCCCCHHHHhcChhhhhhh
Q psy1546         279 CLNKDPENRPTAKELLKFPFIRKAK  303 (604)
Q Consensus       279 ~L~~dP~~RpT~~elL~hp~f~~~~  303 (604)
                      +|+..-.+|.++++.|.|||++...
T Consensus       802 LLqVkm~kRysvdk~lsh~Wlq~yq  826 (888)
T KOG4236|consen  802 LLQVKMRKRYSVDKSLSHPWLQDYQ  826 (888)
T ss_pred             HHHHHHHHhcchHhhccchhhhcch
Confidence            9999999999999999999997654

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=2.6e-37  Score=320.71  Aligned_cols=240  Identities=25%  Similarity=0.448  Sum_probs=201.8

Q ss_pred             ccceeeeEEcccCcEEEEEEEEC-------CCCcEEEEEEecchhhHHHHHHHHHHHHHHhhC-CCCCCCe---------
Q psy1546          57 LIFTKQERIGKGSFGEVFKGIDN-------RTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQC-DSPYGTK---------  119 (604)
Q Consensus        57 ~~y~i~~~LG~G~fG~Vy~a~~~-------~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l-~hp~~~~---------  119 (604)
                      ..|.+.+.||+|+||.||+|++.       ..+..||+|.+...........+.+|+.+++.+ .||++.+         
T Consensus        15 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~   94 (304)
T cd05101          15 DKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG   94 (304)
T ss_pred             HHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecCC
Confidence            34889999999999999999753       234579999987554445567889999999999 8998655         


Q ss_pred             -EEEEEEecCCCChhhHhhcC-----------------CCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCC
Q psy1546         120 -LWIIMEYLGGGSALDLMKAG-----------------NFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMG  181 (604)
Q Consensus       120 -lyLVmEy~~ggsL~~~l~~~-----------------~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g  181 (604)
                       +|+||||+.+|+|.+++...                 .++...+..++.||+.||.|||++||+||||||+|||++.++
T Consensus        95 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nili~~~~  174 (304)
T cd05101          95 PLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTENN  174 (304)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceEEEcCCC
Confidence             47999999999999998642                 367778899999999999999999999999999999999999


Q ss_pred             CeEEecccccccccCCCCC--CcccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHhhhcCC
Q psy1546         182 DVKLADFGVAGTLTNTTSK--RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAK-GEPPNSELHPMRVLFLIPK  258 (604)
Q Consensus       182 ~vKL~DFGlA~~~~~~~~~--~~~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~~i~~  258 (604)
                      .+||+|||+++.+......  .....+++.|+|||++.+..++.++|||||||++|+|++ |..||......+....+..
T Consensus       175 ~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~  254 (304)
T cd05101         175 VMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKE  254 (304)
T ss_pred             cEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHc
Confidence            9999999999766433221  222346678999999999889999999999999999998 8899988877777766655


Q ss_pred             CCCCCCCccchHHHHHHHHHHhccCCCCCCCHHHHhcC
Q psy1546         259 NNPPQLTGNYTKQFKEFVEACLNKDPENRPTAKELLKF  296 (604)
Q Consensus       259 ~~~~~~~~~~s~~l~~Li~~~L~~dP~~RpT~~elL~h  296 (604)
                      ......+..++..+.+|+.+||..+|.+|||+.||++.
T Consensus       255 ~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~  292 (304)
T cd05101         255 GHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVED  292 (304)
T ss_pred             CCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence            55555566788999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=2.7e-37  Score=316.96  Aligned_cols=236  Identities=22%  Similarity=0.399  Sum_probs=198.8

Q ss_pred             ceeeeEEcccCcEEEEEEEEC-----CCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCCeE----------EEE
Q psy1546          59 FTKQERIGKGSFGEVFKGIDN-----RTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTKL----------WII  123 (604)
Q Consensus        59 y~i~~~LG~G~fG~Vy~a~~~-----~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~~l----------yLV  123 (604)
                      |.+.++||+|+||.||+|...     .++..||+|.+.... ......+.+|+.+++.+.|+++.++          |+|
T Consensus         7 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   85 (280)
T cd05092           7 IVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS-ESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMV   85 (280)
T ss_pred             ceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCC-HHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEEE
Confidence            677899999999999999743     356789999886443 3445788999999999999986554          799


Q ss_pred             EEecCCCChhhHhhcC----------------CCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEec
Q psy1546         124 MEYLGGGSALDLMKAG----------------NFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLAD  187 (604)
Q Consensus       124 mEy~~ggsL~~~l~~~----------------~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~D  187 (604)
                      |||+++++|.+++...                .+++..+..++.||+.||+|||++||+||||||+|||+++++.+||+|
T Consensus        86 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~~~kL~d  165 (280)
T cd05092          86 FEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGD  165 (280)
T ss_pred             EecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCCCEEECC
Confidence            9999999999998642                378899999999999999999999999999999999999999999999


Q ss_pred             ccccccccCCCC--CCcccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHhhhcCCCCCCCC
Q psy1546         188 FGVAGTLTNTTS--KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAK-GEPPNSELHPMRVLFLIPKNNPPQL  264 (604)
Q Consensus       188 FGlA~~~~~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~  264 (604)
                      ||++..+.....  ......+++.|+|||++.+..++.++|||||||++|+|++ |.+||...........+........
T Consensus       166 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~  245 (280)
T cd05092         166 FGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQGRELER  245 (280)
T ss_pred             CCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHHHcCccCCC
Confidence            999975532221  1223345788999999999999999999999999999998 9999988777666665555555555


Q ss_pred             CccchHHHHHHHHHHhccCCCCCCCHHHHhc
Q psy1546         265 TGNYTKQFKEFVEACLNKDPENRPTAKELLK  295 (604)
Q Consensus       265 ~~~~s~~l~~Li~~~L~~dP~~RpT~~elL~  295 (604)
                      +..++..+.+||.+||..||.+||++.+|+.
T Consensus       246 ~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~  276 (280)
T cd05092         246 PRTCPPEVYAIMQGCWQREPQQRMVIKDIHS  276 (280)
T ss_pred             CCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            6678899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=1.6e-37  Score=329.09  Aligned_cols=239  Identities=24%  Similarity=0.410  Sum_probs=194.3

Q ss_pred             cceeeeEEcccCcEEEEEEEE-----CCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhC-CCCCCC-----------eE
Q psy1546          58 IFTKQERIGKGSFGEVFKGID-----NRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQC-DSPYGT-----------KL  120 (604)
Q Consensus        58 ~y~i~~~LG~G~fG~Vy~a~~-----~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l-~hp~~~-----------~l  120 (604)
                      .|.+.+.||+|+||+||+|.+     ..+++.||||++...........+.+|+.+|.++ .|+++.           .+
T Consensus         8 ~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~   87 (343)
T cd05103           8 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPL   87 (343)
T ss_pred             HhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCce
Confidence            489999999999999999984     3467899999997655455567788999999999 578743           35


Q ss_pred             EEEEEecCCCChhhHhhcC-------------------------------------------------------------
Q psy1546         121 WIIMEYLGGGSALDLMKAG-------------------------------------------------------------  139 (604)
Q Consensus       121 yLVmEy~~ggsL~~~l~~~-------------------------------------------------------------  139 (604)
                      |+|||||++|+|.+++...                                                             
T Consensus        88 ~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  167 (343)
T cd05103          88 MVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAE  167 (343)
T ss_pred             EEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhhh
Confidence            7999999999999987531                                                             


Q ss_pred             -------CCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCC--CCcccccCCCC
Q psy1546         140 -------NFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTS--KRNTFVGTPFW  210 (604)
Q Consensus       140 -------~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~--~~~~~~GT~~Y  210 (604)
                             .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+.....  ......+++.|
T Consensus       168 ~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y  247 (343)
T cd05103         168 QEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKW  247 (343)
T ss_pred             hhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCCCcce
Confidence                   256777888999999999999999999999999999999999999999999976533221  12223456789


Q ss_pred             CChHHhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChh-hHhhhcCCCCCCCCCccchHHHHHHHHHHhccCCCCCC
Q psy1546         211 MAPEVIKQSAYDSKADIWSLGITAIELAK-GEPPNSELHPM-RVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPENRP  288 (604)
Q Consensus       211 ~APE~l~~~~~~~~sDVwSLGviL~eLlt-G~~Pf~~~~~~-~~~~~i~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rp  288 (604)
                      +|||++.+..++.++|||||||++|+|++ |..||...... .....+........+..++.++.+++.+||..||.+||
T Consensus       248 ~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~~p~~Rp  327 (343)
T cd05103         248 MAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRP  327 (343)
T ss_pred             ECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCCCCCCCCCHHHHHHHHHHccCChhhCc
Confidence            99999999999999999999999999996 99999765432 22222333333344556778999999999999999999


Q ss_pred             CHHHHhcC
Q psy1546         289 TAKELLKF  296 (604)
Q Consensus       289 T~~elL~h  296 (604)
                      |+.||++|
T Consensus       328 s~~eil~~  335 (343)
T cd05103         328 TFSELVEH  335 (343)
T ss_pred             CHHHHHHH
Confidence            99999986

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=4.8e-37  Score=308.35  Aligned_cols=232  Identities=28%  Similarity=0.454  Sum_probs=195.8

Q ss_pred             eEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCCeE----------EEEEEecCCCCh
Q psy1546          63 ERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTKL----------WIIMEYLGGGSA  132 (604)
Q Consensus        63 ~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~~l----------yLVmEy~~ggsL  132 (604)
                      ++||+|+||.||+|... ++..||+|++...........+.+|+.+++.++||++.++          |+||||+++++|
T Consensus         1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   79 (250)
T cd05085           1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDF   79 (250)
T ss_pred             CccCCCCCceEEEEEec-CCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcH
Confidence            36899999999999864 6789999998765444444578899999999999986654          699999999999


Q ss_pred             hhHhhc--CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCCCC-cccccCCC
Q psy1546         133 LDLMKA--GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKR-NTFVGTPF  209 (604)
Q Consensus       133 ~~~l~~--~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~~-~~~~GT~~  209 (604)
                      .+++..  ..+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++.......... ....++..
T Consensus        80 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~  159 (250)
T cd05085          80 LSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIK  159 (250)
T ss_pred             HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCCCccc
Confidence            998864  458899999999999999999999999999999999999999999999999986543322111 12244677


Q ss_pred             CCChHHhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHhhhcCCCCCCCCCccchHHHHHHHHHHhccCCCCCC
Q psy1546         210 WMAPEVIKQSAYDSKADIWSLGITAIELAK-GEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPENRP  288 (604)
Q Consensus       210 Y~APE~l~~~~~~~~sDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rp  288 (604)
                      |+|||++.+..++.++|||||||++|+|++ |..||...........+........+..++..+.+|+.+||..+|++||
T Consensus       160 y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp  239 (250)
T cd05085         160 WTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRMSCPQKCPDDVYKVMQRCWDYKPENRP  239 (250)
T ss_pred             ccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcccCcccCC
Confidence            999999998889999999999999999998 9999988777666665555555555667889999999999999999999


Q ss_pred             CHHHHhc
Q psy1546         289 TAKELLK  295 (604)
Q Consensus       289 T~~elL~  295 (604)
                      ++.++++
T Consensus       240 ~~~~l~~  246 (250)
T cd05085         240 KFSELQK  246 (250)
T ss_pred             CHHHHHH
Confidence            9999976

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=3.7e-37  Score=311.79  Aligned_cols=236  Identities=25%  Similarity=0.412  Sum_probs=198.5

Q ss_pred             cceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCCeE----------EEEEEec
Q psy1546          58 IFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTKL----------WIIMEYL  127 (604)
Q Consensus        58 ~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~~l----------yLVmEy~  127 (604)
                      .|++.+.||+|+||.||+|.+.. +..||||.+.....  ....+.+|+.+++.++||++.++          |+||||+
T Consensus         5 ~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   81 (256)
T cd05113           5 DLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSM--SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYM   81 (256)
T ss_pred             HeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCcc--cHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcC
Confidence            37889999999999999998754 44699999864432  23568899999999999986654          6999999


Q ss_pred             CCCChhhHhhc--CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCCC-Cccc
Q psy1546         128 GGGSALDLMKA--GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSK-RNTF  204 (604)
Q Consensus       128 ~ggsL~~~l~~--~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~-~~~~  204 (604)
                      .+++|.+++..  ..+++..++.++.||+.||.|||++|++|+||||.|||++.++.+||+|||+++........ ....
T Consensus        82 ~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~~  161 (256)
T cd05113          82 SNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGS  161 (256)
T ss_pred             CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCCceeecCCC
Confidence            99999999865  36899999999999999999999999999999999999999999999999998765432211 1122


Q ss_pred             ccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHhhhcCCCCCCCCCccchHHHHHHHHHHhccC
Q psy1546         205 VGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAK-GEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKD  283 (604)
Q Consensus       205 ~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~~L~~d  283 (604)
                      .++..|+|||++.+..++.++|||||||++|+|++ |..||...........+........+...+..+.+++.+||..|
T Consensus       162 ~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~  241 (256)
T cd05113         162 KFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYRPHLASEKVYAIMYSCWHEK  241 (256)
T ss_pred             ccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCC
Confidence            35677999999998889999999999999999998 99999887776666666555555556667899999999999999


Q ss_pred             CCCCCCHHHHhcC
Q psy1546         284 PENRPTAKELLKF  296 (604)
Q Consensus       284 P~~RpT~~elL~h  296 (604)
                      |.+|||+.+|+.+
T Consensus       242 p~~Rp~~~~ll~~  254 (256)
T cd05113         242 AEERPTFQQLLSS  254 (256)
T ss_pred             cccCCCHHHHHHh
Confidence            9999999999864

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=3.7e-37  Score=313.17  Aligned_cols=237  Identities=28%  Similarity=0.468  Sum_probs=200.0

Q ss_pred             ceeeeEEcccCcEEEEEEEECCCCc---EEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCCeE----------EEEEE
Q psy1546          59 FTKQERIGKGSFGEVFKGIDNRTQQ---VVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTKL----------WIIME  125 (604)
Q Consensus        59 y~i~~~LG~G~fG~Vy~a~~~~t~~---~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~~l----------yLVmE  125 (604)
                      |.+.+.||+|+||.||+|.+..++.   .||||++...........+..|+.+++.+.|||+.++          |+|||
T Consensus         6 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e   85 (269)
T cd05065           6 VKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIITE   85 (269)
T ss_pred             eEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEEe
Confidence            7889999999999999999887664   6999998765445556788999999999999996654          79999


Q ss_pred             ecCCCChhhHhhc--CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCCCC--
Q psy1546         126 YLGGGSALDLMKA--GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKR--  201 (604)
Q Consensus       126 y~~ggsL~~~l~~--~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~~--  201 (604)
                      |+++++|.++++.  +.+++..+..++.|++.||.|||++|++||||||+|||++.++.++|+|||++..+.......  
T Consensus        86 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~~~~  165 (269)
T cd05065          86 FMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTY  165 (269)
T ss_pred             cCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCccccccccCcccccc
Confidence            9999999999864  568999999999999999999999999999999999999999999999999987554322111  


Q ss_pred             -cccc--cCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHhhhcCCCCCCCCCccchHHHHHHHH
Q psy1546         202 -NTFV--GTPFWMAPEVIKQSAYDSKADIWSLGITAIELAK-GEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVE  277 (604)
Q Consensus       202 -~~~~--GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~  277 (604)
                       ....  .+..|+|||++.+..++.++|||||||++|||++ |..||...........+........+..++..+.+++.
T Consensus       166 ~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~  245 (269)
T cd05065         166 TSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYRLPPPMDCPTALHQLML  245 (269)
T ss_pred             ccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCcCCCcccCCHHHHHHHH
Confidence             1111  2457999999999999999999999999999886 99999887776666655544444455677889999999


Q ss_pred             HHhccCCCCCCCHHHHhc
Q psy1546         278 ACLNKDPENRPTAKELLK  295 (604)
Q Consensus       278 ~~L~~dP~~RpT~~elL~  295 (604)
                      +||..+|.+||++.+|+.
T Consensus       246 ~~l~~~p~~Rp~~~~i~~  263 (269)
T cd05065         246 DCWQKDRNARPKFGQIVS  263 (269)
T ss_pred             HHcCCChhhCcCHHHHHH
Confidence            999999999999999986

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>KOG1095|consensus

Probab=100.00  E-value=8.5e-38  Score=358.49  Aligned_cols=238  Identities=30%  Similarity=0.532  Sum_probs=211.8

Q ss_pred             cceeeeEEcccCcEEEEEEEECCCC-----cEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCCeE----------EE
Q psy1546          58 IFTKQERIGKGSFGEVFKGIDNRTQ-----QVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTKL----------WI  122 (604)
Q Consensus        58 ~y~i~~~LG~G~fG~Vy~a~~~~t~-----~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~~l----------yL  122 (604)
                      ..++.+.||+|.||.||.|....-.     ..||||.+.......+...|.+|..+|+.++|||++++          +|
T Consensus       693 ~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~i  772 (1025)
T KOG1095|consen  693 NVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPLI  772 (1025)
T ss_pred             heEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcEE
Confidence            4577889999999999999865432     34999999888778888999999999999999998876          69


Q ss_pred             EEEecCCCChhhHhhcC--------CCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccc
Q psy1546         123 IMEYLGGGSALDLMKAG--------NFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTL  194 (604)
Q Consensus       123 VmEy~~ggsL~~~l~~~--------~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~  194 (604)
                      ++|||+||+|..+|++.        .++..++..++.||+.|+.||+++++|||||..+|+||+....|||+|||+|+.+
T Consensus       773 ~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIaDFGlArDi  852 (1025)
T KOG1095|consen  773 LLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIADFGLARDI  852 (1025)
T ss_pred             EehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEcccchhHhh
Confidence            99999999999999764        4888999999999999999999999999999999999999999999999999855


Q ss_pred             cCCCCCCcccc--cCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHhhhcCCCCCCCCCccchHH
Q psy1546         195 TNTTSKRNTFV--GTPFWMAPEVIKQSAYDSKADIWSLGITAIELAK-GEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQ  271 (604)
Q Consensus       195 ~~~~~~~~~~~--GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~  271 (604)
                      ......+....  -...|||||.+..+.++.++|||||||+|||+++ |..||...+..+++..+..+.+...+..+++.
T Consensus       853 y~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~ggRL~~P~~CP~~  932 (1025)
T KOG1095|consen  853 YDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGGRLDPPSYCPEK  932 (1025)
T ss_pred             hhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCCccCCCCCCChH
Confidence            54443333222  2357999999999999999999999999999998 99999999999999877777788888999999


Q ss_pred             HHHHHHHHhccCCCCCCCHHHHhc
Q psy1546         272 FKEFVEACLNKDPENRPTAKELLK  295 (604)
Q Consensus       272 l~~Li~~~L~~dP~~RpT~~elL~  295 (604)
                      +.++|..||+.+|++||++..|++
T Consensus       933 ly~lM~~CW~~~pe~RP~F~~i~~  956 (1025)
T KOG1095|consen  933 LYQLMLQCWKHDPEDRPSFRTIVE  956 (1025)
T ss_pred             HHHHHHHHccCChhhCccHHHHHh
Confidence            999999999999999999999987

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=2.7e-37  Score=317.23  Aligned_cols=240  Identities=25%  Similarity=0.421  Sum_probs=195.1

Q ss_pred             ccceeeeEEcccCcEEEEEEEE----CCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCC------------eE
Q psy1546          57 LIFTKQERIGKGSFGEVFKGID----NRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGT------------KL  120 (604)
Q Consensus        57 ~~y~i~~~LG~G~fG~Vy~a~~----~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~------------~l  120 (604)
                      ..|.++++||+|+||.||+|..    ..++..||+|.+...........+.+|+.+++.+.|++..            .+
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (284)
T cd05079           4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI   83 (284)
T ss_pred             hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence            3488999999999999999974    4578899999997665555567899999999999999843            35


Q ss_pred             EEEEEecCCCChhhHhhc--CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCC
Q psy1546         121 WIIMEYLGGGSALDLMKA--GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTT  198 (604)
Q Consensus       121 yLVmEy~~ggsL~~~l~~--~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~  198 (604)
                      |+||||++|++|.+++..  ..+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++..+....
T Consensus        84 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~  163 (284)
T cd05079          84 KLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDK  163 (284)
T ss_pred             EEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCccccccccCc
Confidence            799999999999999865  358999999999999999999999999999999999999999999999999997664332


Q ss_pred             C---CCcccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCCh---------------hhHhhhcCCCC
Q psy1546         199 S---KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHP---------------MRVLFLIPKNN  260 (604)
Q Consensus       199 ~---~~~~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~---------------~~~~~~i~~~~  260 (604)
                      .   ......++..|+|||++.+..++.++|||||||++|+|+++..|+.....               ......+....
T Consensus       164 ~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (284)
T cd05079         164 EYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEEGK  243 (284)
T ss_pred             cceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHHHcCc
Confidence            2   12245577889999999988899999999999999999998766432110               01111112222


Q ss_pred             CCCCCccchHHHHHHHHHHhccCCCCCCCHHHHhcC
Q psy1546         261 PPQLTGNYTKQFKEFVEACLNKDPENRPTAKELLKF  296 (604)
Q Consensus       261 ~~~~~~~~s~~l~~Li~~~L~~dP~~RpT~~elL~h  296 (604)
                      ....+..++..+.+|+.+||+.||.+|||+.++++.
T Consensus       244 ~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~  279 (284)
T cd05079         244 RLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG  279 (284)
T ss_pred             cCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence            333455688999999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=3.9e-37  Score=317.07  Aligned_cols=238  Identities=26%  Similarity=0.429  Sum_probs=197.0

Q ss_pred             cceeeeEEcccCcEEEEEEEECCCC----------------cEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCCe--
Q psy1546          58 IFTKQERIGKGSFGEVFKGIDNRTQ----------------QVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTK--  119 (604)
Q Consensus        58 ~y~i~~~LG~G~fG~Vy~a~~~~t~----------------~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~~--  119 (604)
                      .|.+.++||+|+||.||+|.+..++                ..||+|++.........+.+.+|+.++..+.||++.+  
T Consensus         6 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~   85 (296)
T cd05051           6 PLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLL   85 (296)
T ss_pred             hCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEEE
Confidence            4889999999999999999876543                5689999876655556678899999999999998654  


Q ss_pred             --------EEEEEEecCCCChhhHhhcC------------CCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecC
Q psy1546         120 --------LWIIMEYLGGGSALDLMKAG------------NFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSE  179 (604)
Q Consensus       120 --------lyLVmEy~~ggsL~~~l~~~------------~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~  179 (604)
                              +|+||||+.+++|.+++...            .+++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus        86 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~Nili~~  165 (296)
T cd05051          86 GVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVGK  165 (296)
T ss_pred             EEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhceeecC
Confidence                    47999999999999998653            4899999999999999999999999999999999999999


Q ss_pred             CCCeEEecccccccccCCC--CCCcccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHh--CCCCCCCCChhhHhhh
Q psy1546         180 MGDVKLADFGVAGTLTNTT--SKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAK--GEPPNSELHPMRVLFL  255 (604)
Q Consensus       180 ~g~vKL~DFGlA~~~~~~~--~~~~~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLlt--G~~Pf~~~~~~~~~~~  255 (604)
                      ++.++|+|||+++.+....  .......+++.|||||++.+..++.++|||||||++|||++  |..||...........
T Consensus       166 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~~~~~  245 (296)
T cd05051         166 NYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQVIEN  245 (296)
T ss_pred             CCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChHHHHHH
Confidence            9999999999997654322  12234456788999999998889999999999999999998  7788887665554433


Q ss_pred             cCCC-------CCCCCCccchHHHHHHHHHHhccCCCCCCCHHHHhc
Q psy1546         256 IPKN-------NPPQLTGNYTKQFKEFVEACLNKDPENRPTAKELLK  295 (604)
Q Consensus       256 i~~~-------~~~~~~~~~s~~l~~Li~~~L~~dP~~RpT~~elL~  295 (604)
                      +...       .....+..++.++.+|+.+||+.||.+|||+.||++
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~  292 (296)
T cd05051         246 AGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL  292 (296)
T ss_pred             HHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence            2211       112233456789999999999999999999999965

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.6e-37  Score=327.32  Aligned_cols=244  Identities=25%  Similarity=0.436  Sum_probs=201.7

Q ss_pred             ccceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchh-hHHHHHHHHHHHHHHhhCCCCCCC----------------e
Q psy1546          57 LIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE-AEDEIEDIQQEIMVLSQCDSPYGT----------------K  119 (604)
Q Consensus        57 ~~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~-~~~~~~~l~~Ei~iL~~l~hp~~~----------------~  119 (604)
                      ..|.+.+.||+|+||.||+|.+..+++.||||++.... .......+.+|+.+++.+.|+++.                .
T Consensus        15 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   94 (343)
T cd07851          15 DRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQD   94 (343)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccccc
Confidence            34899999999999999999999999999999986532 122346677899999999999731                3


Q ss_pred             EEEEEEecCCCChhhHhhcCCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCC
Q psy1546         120 LWIIMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTS  199 (604)
Q Consensus       120 lyLVmEy~~ggsL~~~l~~~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~  199 (604)
                      +|+|+||+ +++|.+++..+.+++..+..++.||+.||.|||+.||+||||||+||+++.++.++|+|||++......  
T Consensus        95 ~~lv~e~~-~~~L~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~~~~--  171 (343)
T cd07851          95 VYLVTHLM-GADLNNIVKCQKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDE--  171 (343)
T ss_pred             EEEEEecC-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEcccccccccccc--
Confidence            79999999 679999998889999999999999999999999999999999999999999999999999999765432  


Q ss_pred             CCcccccCCCCCChHHhhc-CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCCC------------------
Q psy1546         200 KRNTFVGTPFWMAPEVIKQ-SAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNN------------------  260 (604)
Q Consensus       200 ~~~~~~GT~~Y~APE~l~~-~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~~------------------  260 (604)
                       .....++..|+|||++.+ ..++.++|||||||++|+|++|..||...........+....                  
T Consensus       172 -~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  250 (343)
T cd07851         172 -MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSESARN  250 (343)
T ss_pred             -ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhccchhHHH
Confidence             234578899999999865 367889999999999999999999998766543332211100                  


Q ss_pred             ---------C---CCCCccchHHHHHHHHHHhccCCCCCCCHHHHhcChhhhhhhh
Q psy1546         261 ---------P---PQLTGNYTKQFKEFVEACLNKDPENRPTAKELLKFPFIRKAKK  304 (604)
Q Consensus       261 ---------~---~~~~~~~s~~l~~Li~~~L~~dP~~RpT~~elL~hp~f~~~~~  304 (604)
                               .   ......++..+.+||.+||..||.+|||+.+|+.||||.+...
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~~  306 (343)
T cd07851         251 YIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYHD  306 (343)
T ss_pred             HHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccccCC
Confidence                     0   0111245789999999999999999999999999999986543

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3.5e-37  Score=326.49  Aligned_cols=243  Identities=28%  Similarity=0.423  Sum_probs=200.7

Q ss_pred             ccceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhh-HHHHHHHHHHHHHHhhCCCCCCCe----------------
Q psy1546          57 LIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA-EDEIEDIQQEIMVLSQCDSPYGTK----------------  119 (604)
Q Consensus        57 ~~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~-~~~~~~l~~Ei~iL~~l~hp~~~~----------------  119 (604)
                      ..|.+.+.||+|+||.||+|.+..++..||||++..... ......+.+|+.+|+.+.|+++.+                
T Consensus        15 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   94 (343)
T cd07880          15 DRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHD   94 (343)
T ss_pred             cceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccce
Confidence            349999999999999999999999999999999854322 223456789999999999998533                


Q ss_pred             EEEEEEecCCCChhhHhhcCCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCC
Q psy1546         120 LWIIMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTS  199 (604)
Q Consensus       120 lyLVmEy~~ggsL~~~l~~~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~  199 (604)
                      +|+||||+ +++|.+++..+.+++..++.++.||+.||.|||+.||+||||||+|||++.++.++|+|||++......  
T Consensus        95 ~~lv~e~~-~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~--  171 (343)
T cd07880          95 FYLVMPFM-GTDLGKLMKHEKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDSE--  171 (343)
T ss_pred             EEEEEecC-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccccccccC--
Confidence            47999999 789999998889999999999999999999999999999999999999999999999999999755322  


Q ss_pred             CCcccccCCCCCChHHhhc-CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCC--------------------
Q psy1546         200 KRNTFVGTPFWMAPEVIKQ-SAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPK--------------------  258 (604)
Q Consensus       200 ~~~~~~GT~~Y~APE~l~~-~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~--------------------  258 (604)
                       .....+++.|+|||++.+ ..++.++|||||||++|+|++|.+||...........+..                    
T Consensus       172 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (343)
T cd07880         172 -MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDAKN  250 (343)
T ss_pred             -ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcchhHHH
Confidence             234568899999999876 4578899999999999999999999987654322211100                    


Q ss_pred             -------CC---CCCCCccchHHHHHHHHHHhccCCCCCCCHHHHhcChhhhhhh
Q psy1546         259 -------NN---PPQLTGNYTKQFKEFVEACLNKDPENRPTAKELLKFPFIRKAK  303 (604)
Q Consensus       259 -------~~---~~~~~~~~s~~l~~Li~~~L~~dP~~RpT~~elL~hp~f~~~~  303 (604)
                             ..   ...+...++..+.++|.+||..||.+|||+.+++.||||+...
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~  305 (343)
T cd07880         251 YVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFH  305 (343)
T ss_pred             HHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhc
Confidence                   00   0112235677899999999999999999999999999997654

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=5.2e-37  Score=309.83  Aligned_cols=230  Identities=26%  Similarity=0.427  Sum_probs=197.1

Q ss_pred             cceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCCe-----------EEEEEEe
Q psy1546          58 IFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTK-----------LWIIMEY  126 (604)
Q Consensus        58 ~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~~-----------lyLVmEy  126 (604)
                      .|.+.+.||+|+||.||+|...  +..||+|.+....   ..+.+.+|+.+++.+.|++..+           +|+||||
T Consensus         7 ~~~~~~~lg~g~~~~v~~~~~~--~~~~~~k~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~   81 (256)
T cd05082           7 ELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY   81 (256)
T ss_pred             hCeeeeeecccCCCeEEEEEEc--CCcEEEEEeCCCc---hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEEC
Confidence            3888999999999999999765  7789999986443   2356889999999999997433           5799999


Q ss_pred             cCCCChhhHhhcC---CCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCCCCcc
Q psy1546         127 LGGGSALDLMKAG---NFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNT  203 (604)
Q Consensus       127 ~~ggsL~~~l~~~---~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~~~~  203 (604)
                      +++++|.++++..   .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......   ..
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~---~~  158 (256)
T cd05082          82 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ---DT  158 (256)
T ss_pred             CCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceeccccC---CC
Confidence            9999999998653   37889999999999999999999999999999999999999999999999987543322   23


Q ss_pred             cccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHhhhcCCCCCCCCCccchHHHHHHHHHHhcc
Q psy1546         204 FVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAK-GEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNK  282 (604)
Q Consensus       204 ~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~~L~~  282 (604)
                      ..++..|+|||++.+..++.++|||||||++|+|++ |..||...........+........+..++..+.+++.+||..
T Consensus       159 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  238 (256)
T cd05082         159 GKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPVVYDVMKQCWHL  238 (256)
T ss_pred             CccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhcC
Confidence            345678999999999899999999999999999997 9999988777666666655555566677899999999999999


Q ss_pred             CCCCCCCHHHHhc
Q psy1546         283 DPENRPTAKELLK  295 (604)
Q Consensus       283 dP~~RpT~~elL~  295 (604)
                      +|++|||+.++++
T Consensus       239 ~p~~Rpt~~~l~~  251 (256)
T cd05082         239 DAATRPSFLQLRE  251 (256)
T ss_pred             ChhhCcCHHHHHH
Confidence            9999999999976

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=2.9e-37  Score=314.96  Aligned_cols=240  Identities=31%  Similarity=0.513  Sum_probs=197.7

Q ss_pred             ceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhH-HHHHHHHHHHHHHhhCCCCCCC----------eEEEEEEec
Q psy1546          59 FTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAE-DEIEDIQQEIMVLSQCDSPYGT----------KLWIIMEYL  127 (604)
Q Consensus        59 y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~-~~~~~l~~Ei~iL~~l~hp~~~----------~lyLVmEy~  127 (604)
                      |.+.+.||.|++|.||+|.+..+++.+|+|.+...... .....+.+|+.+++.++|+++.          .+|+||||+
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   80 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM   80 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence            56778999999999999999999999999998654332 3346788899999999999844          458999999


Q ss_pred             CCCChhhHhhc--CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCCCCcccc
Q psy1546         128 GGGSALDLMKA--GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFV  205 (604)
Q Consensus       128 ~ggsL~~~l~~--~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~~~~~~  205 (604)
                      ++ +|.+++..  +.+++..+..++.||+.||.|||++||+|+||||+||+++.++.++|+|||.+..+...........
T Consensus        81 ~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~~~~~~~  159 (283)
T cd05118          81 DT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYV  159 (283)
T ss_pred             CC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcccccCcc
Confidence            75 77777755  4789999999999999999999999999999999999999999999999999976654432333456


Q ss_pred             cCCCCCChHHhhcC-CCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCC-------------------------
Q psy1546         206 GTPFWMAPEVIKQS-AYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKN-------------------------  259 (604)
Q Consensus       206 GT~~Y~APE~l~~~-~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~-------------------------  259 (604)
                      ++..|+|||.+.+. .++.++||||||+++|+|++|+.||...+..+....+...                         
T Consensus       160 ~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (283)
T cd05118         160 VTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSFPK  239 (283)
T ss_pred             CcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhhhhcc
Confidence            88899999999876 7889999999999999999999999876654332211000                         


Q ss_pred             -C---CCCCCccchHHHHHHHHHHhccCCCCCCCHHHHhcChhh
Q psy1546         260 -N---PPQLTGNYTKQFKEFVEACLNKDPENRPTAKELLKFPFI  299 (604)
Q Consensus       260 -~---~~~~~~~~s~~l~~Li~~~L~~dP~~RpT~~elL~hp~f  299 (604)
                       .   ...+...++.++.+||.+||..||.+||++.+++.||||
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~  283 (283)
T cd05118         240 KAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF  283 (283)
T ss_pred             ccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence             0   001223467899999999999999999999999999997

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=6.6e-37  Score=319.05  Aligned_cols=249  Identities=44%  Similarity=0.789  Sum_probs=205.8

Q ss_pred             cCccccceeeeEEcccCcEEEEEEEECCCCcEEEEEEecch--hhHHHHHHHHHHHHHHhhCCCCCCCe----------E
Q psy1546          53 VDPELIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLE--EAEDEIEDIQQEIMVLSQCDSPYGTK----------L  120 (604)
Q Consensus        53 ~~~~~~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~--~~~~~~~~l~~Ei~iL~~l~hp~~~~----------l  120 (604)
                      ..++..|...+.||+|+||.||+|++..+++.||||.+...  ........+.+|+.+++.+.|++..+          +
T Consensus        11 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   90 (308)
T cd06634          11 DDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTA   90 (308)
T ss_pred             CCcHHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCee
Confidence            34556688899999999999999999999999999998643  22334567788999999999998544          4


Q ss_pred             EEEEEecCCCChhhHhh--cCCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCC
Q psy1546         121 WIIMEYLGGGSALDLMK--AGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTT  198 (604)
Q Consensus       121 yLVmEy~~ggsL~~~l~--~~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~  198 (604)
                      |+||||+. |+|.+++.  ...+++..+..++.|++.||.|||+.+++||||+|+|||++.++.++|+|||++...... 
T Consensus        91 ~lv~e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~-  168 (308)
T cd06634          91 WLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-  168 (308)
T ss_pred             EEEEEccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeecCc-
Confidence            79999996 56776653  356899999999999999999999999999999999999999999999999998655322 


Q ss_pred             CCCcccccCCCCCChHHhh---cCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCCCCC-CCCccchHHHHH
Q psy1546         199 SKRNTFVGTPFWMAPEVIK---QSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPP-QLTGNYTKQFKE  274 (604)
Q Consensus       199 ~~~~~~~GT~~Y~APE~l~---~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~~~~-~~~~~~s~~l~~  274 (604)
                         ....|++.|+|||++.   ...++.++|||||||++|+|++|..||...........+.....+ .....++..+.+
T Consensus       169 ---~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (308)
T cd06634         169 ---NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRN  245 (308)
T ss_pred             ---ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCCCCcCcccccHHHHH
Confidence               2456899999999985   356788999999999999999999999877665554444443332 234468889999


Q ss_pred             HHHHHhccCCCCCCCHHHHhcChhhhhhhhhh
Q psy1546         275 FVEACLNKDPENRPTAKELLKFPFIRKAKKNA  306 (604)
Q Consensus       275 Li~~~L~~dP~~RpT~~elL~hp~f~~~~~~~  306 (604)
                      ||.+||..+|.+||++.++++|||+.......
T Consensus       246 li~~cl~~~P~~Rp~~~~ll~~~~~~~~~~~~  277 (308)
T cd06634         246 FVDSCLQKIPQDRPTSEVLLKHRFVLRERPPT  277 (308)
T ss_pred             HHHHHhhCCcccCCCHHHHhhCccccccCChh
Confidence            99999999999999999999999998765544

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>KOG4645|consensus

Probab=100.00  E-value=1.6e-39  Score=370.72  Aligned_cols=244  Identities=35%  Similarity=0.634  Sum_probs=212.9

Q ss_pred             ceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhh-HHHHHHHHHHHHHHhhCCCCCCCeEE----------EEEEec
Q psy1546          59 FTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA-EDEIEDIQQEIMVLSQCDSPYGTKLW----------IIMEYL  127 (604)
Q Consensus        59 y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~-~~~~~~l~~Ei~iL~~l~hp~~~~ly----------LVmEy~  127 (604)
                      |..+..||.|.||.||.|.+..+|+..|+|-|..... ...+..+.+|..+|..++|||.+++|          |.||||
T Consensus      1237 Wqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEyC 1316 (1509)
T KOG4645|consen 1237 WQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEYC 1316 (1509)
T ss_pred             eccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHHh
Confidence            5566789999999999999999999999998865432 34467788999999999999987765          779999


Q ss_pred             CCCChhhHhhcCC-CcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCC----CCc
Q psy1546         128 GGGSALDLMKAGN-FEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTS----KRN  202 (604)
Q Consensus       128 ~ggsL~~~l~~~~-lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~----~~~  202 (604)
                      ++|+|.++++.++ .++.....+..|++.||.|||++|||||||||+|||++.+|.+|++|||.|..+.....    ...
T Consensus      1317 ~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~~el~ 1396 (1509)
T KOG4645|consen 1317 EGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMPGELQ 1396 (1509)
T ss_pred             ccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecCchhcCCHHHH
Confidence            9999999999876 55556666789999999999999999999999999999999999999999987765432    234


Q ss_pred             ccccCCCCCChHHhhcCC---CCCcchhhhHHHHHHHHHhCCCCCCCCC-hhhHhhhcCCCCCCCCCccchHHHHHHHHH
Q psy1546         203 TFVGTPFWMAPEVIKQSA---YDSKADIWSLGITAIELAKGEPPNSELH-PMRVLFLIPKNNPPQLTGNYTKQFKEFVEA  278 (604)
Q Consensus       203 ~~~GT~~Y~APE~l~~~~---~~~~sDVwSLGviL~eLltG~~Pf~~~~-~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~  278 (604)
                      ...||+.|||||++.+..   ...++||||||||+.||+||+.||...+ ...+++.+..+..|++|..++.+-++||.+
T Consensus      1397 ~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq~P~~ls~~g~dFle~ 1476 (1509)
T KOG4645|consen 1397 SMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQIPERLSSEGRDFLEH 1476 (1509)
T ss_pred             hhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCCCCchhhhHhHHHHHHH
Confidence            568999999999997654   4568999999999999999999998765 568888888999999999999999999999


Q ss_pred             HhccCCCCCCCHHHHhcChhhhhh
Q psy1546         279 CLNKDPENRPTAKELLKFPFIRKA  302 (604)
Q Consensus       279 ~L~~dP~~RpT~~elL~hp~f~~~  302 (604)
                      ||..||++|.++.|||.|.|-+..
T Consensus      1477 Cl~~dP~~Rw~~~qlle~~f~~~~ 1500 (1509)
T KOG4645|consen 1477 CLEQDPKMRWTASQLLEHAFGKSC 1500 (1509)
T ss_pred             HHhcCchhhhHHHHHHHhhccccc
Confidence            999999999999999999886543

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=5.4e-37  Score=318.99  Aligned_cols=238  Identities=26%  Similarity=0.439  Sum_probs=197.3

Q ss_pred             cceeeeEEcccCcEEEEEEEE-----CCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhC-CCCCCCeE----------E
Q psy1546          58 IFTKQERIGKGSFGEVFKGID-----NRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQC-DSPYGTKL----------W  121 (604)
Q Consensus        58 ~y~i~~~LG~G~fG~Vy~a~~-----~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l-~hp~~~~l----------y  121 (604)
                      .|.+.+.||+|+||.||+|.+     ..++..||||++.........+.+.+|+.+++++ .|+++.++          |
T Consensus        36 ~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~  115 (302)
T cd05055          36 NLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPIL  115 (302)
T ss_pred             HeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCceE
Confidence            488999999999999999975     3456689999987654455567889999999999 79996654          7


Q ss_pred             EEEEecCCCChhhHhhcC---CCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCC
Q psy1546         122 IIMEYLGGGSALDLMKAG---NFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTT  198 (604)
Q Consensus       122 LVmEy~~ggsL~~~l~~~---~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~  198 (604)
                      +||||+.+|+|.+++...   .+++.++..++.||+.||.|||+++|+|+||||+|||++.++.++|+|||+++.+....
T Consensus       116 lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~  195 (302)
T cd05055         116 VITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDS  195 (302)
T ss_pred             EEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCCcccccccCCC
Confidence            999999999999998652   38999999999999999999999999999999999999999999999999997654332


Q ss_pred             C--CCcccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHhh-hcCCCCCCCCCccchHHHHH
Q psy1546         199 S--KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAK-GEPPNSELHPMRVLF-LIPKNNPPQLTGNYTKQFKE  274 (604)
Q Consensus       199 ~--~~~~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~-~i~~~~~~~~~~~~s~~l~~  274 (604)
                      .  ......++..|+|||++.+..++.++|||||||++|+|++ |..||.......... .+........+...+..+.+
T Consensus       196 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (302)
T cd05055         196 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMAQPEHAPAEIYD  275 (302)
T ss_pred             ceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCcCCCCCCCCHHHHH
Confidence            1  1223346788999999999999999999999999999998 999998766543332 22223333344567889999


Q ss_pred             HHHHHhccCCCCCCCHHHHhc
Q psy1546         275 FVEACLNKDPENRPTAKELLK  295 (604)
Q Consensus       275 Li~~~L~~dP~~RpT~~elL~  295 (604)
                      |+.+||..+|++|||+.||++
T Consensus       276 li~~cl~~~p~~Rpt~~ell~  296 (302)
T cd05055         276 IMKTCWDADPLKRPTFKQIVQ  296 (302)
T ss_pred             HHHHHcCCCchhCcCHHHHHH
Confidence            999999999999999999986

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.3e-37  Score=306.77  Aligned_cols=234  Identities=33%  Similarity=0.584  Sum_probs=203.0

Q ss_pred             EcccCcEEEEEEEECCCCcEEEEEEecchhhH--HHHHHHHHHHHHHhhCCCCCC----------CeEEEEEEecCCCCh
Q psy1546          65 IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAE--DEIEDIQQEIMVLSQCDSPYG----------TKLWIIMEYLGGGSA  132 (604)
Q Consensus        65 LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~--~~~~~l~~Ei~iL~~l~hp~~----------~~lyLVmEy~~ggsL  132 (604)
                      ||.|+||.||+|.+..+++.||+|++......  .....+..|+.+++.+.|++.          ..+|+||||+++++|
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   80 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL   80 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence            69999999999999989999999998765432  345678899999999999973          446899999999999


Q ss_pred             hhHhhc-CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCCCCcccccCCCCC
Q psy1546         133 LDLMKA-GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWM  211 (604)
Q Consensus       133 ~~~l~~-~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~~~~~~GT~~Y~  211 (604)
                      .+++.. +.+++..+..++.||+.||.|||+.+++|+||+|+||+++.++.++|+|||++..............++..|+
T Consensus        81 ~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~  160 (250)
T cd05123          81 FSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYL  160 (250)
T ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCCCcccCCcCCcccc
Confidence            999876 4789999999999999999999999999999999999999999999999999976654433344567899999


Q ss_pred             ChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCCCCCCCCccchHHHHHHHHHHhccCCCCCCCH-
Q psy1546         212 APEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPENRPTA-  290 (604)
Q Consensus       212 APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~RpT~-  290 (604)
                      |||.+.+...+.++|+||||+++|+|++|..||...........+.. ....++..++..+.++|.+||..||++||++ 
T Consensus       161 ~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~~i~~~l~~~p~~R~~~~  239 (250)
T cd05123         161 APEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILK-DPLRFPEFLSPEARDLISGLLQKDPTKRLGSG  239 (250)
T ss_pred             ChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhc-CCCCCCCCCCHHHHHHHHHHhcCCHhhCCCcc
Confidence            99999888889999999999999999999999987776555444433 3345666778999999999999999999999 


Q ss_pred             --HHHhcChhh
Q psy1546         291 --KELLKFPFI  299 (604)
Q Consensus       291 --~elL~hp~f  299 (604)
                        ++++.||||
T Consensus       240 ~~~~l~~~~~f  250 (250)
T cd05123         240 GAEEIKAHPFF  250 (250)
T ss_pred             cHHHHHhCCCC
Confidence              999999998

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=3.2e-37  Score=324.22  Aligned_cols=242  Identities=32%  Similarity=0.567  Sum_probs=192.1

Q ss_pred             eEEccc--CcEEEEEEEECCCCcEEEEEEecchh-hHHHHHHHHHHHHHHhhCCCCCCCeE----------EEEEEecCC
Q psy1546          63 ERIGKG--SFGEVFKGIDNRTQQVVAIKIIDLEE-AEDEIEDIQQEIMVLSQCDSPYGTKL----------WIIMEYLGG  129 (604)
Q Consensus        63 ~~LG~G--~fG~Vy~a~~~~t~~~vAVK~i~~~~-~~~~~~~l~~Ei~iL~~l~hp~~~~l----------yLVmEy~~g  129 (604)
                      ..||.|  +||+||+|.+..+++.||||++.... .....+.+.+|+.+++.++||++.++          |+||||+.+
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~   83 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY   83 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence            356666  99999999999999999999987543 23445788999999999999997654          699999999


Q ss_pred             CChhhHhhc---CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCCC------
Q psy1546         130 GSALDLMKA---GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSK------  200 (604)
Q Consensus       130 gsL~~~l~~---~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~------  200 (604)
                      ++|.+++..   ..+++..+..++.||+.||.|||++||+||||||+|||++.++.++++||+.+.........      
T Consensus        84 ~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (328)
T cd08226          84 GSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYD  163 (328)
T ss_pred             CCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccccccc
Confidence            999998865   35899999999999999999999999999999999999999999999999865433221111      


Q ss_pred             -CcccccCCCCCChHHhhcC--CCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCCC-----------------
Q psy1546         201 -RNTFVGTPFWMAPEVIKQS--AYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNN-----------------  260 (604)
Q Consensus       201 -~~~~~GT~~Y~APE~l~~~--~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~~-----------------  260 (604)
                       .....++..|||||++.+.  .++.++|||||||++|+|++|.+||................                 
T Consensus       164 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (328)
T cd08226         164 FPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEESRM  243 (328)
T ss_pred             ccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhhhhh
Confidence             1112356679999999764  47889999999999999999999998765433221111000                 


Q ss_pred             -----------------------------CCCCCccchHHHHHHHHHHhccCCCCCCCHHHHhcChhhhhhhh
Q psy1546         261 -----------------------------PPQLTGNYTKQFKEFVEACLNKDPENRPTAKELLKFPFIRKAKK  304 (604)
Q Consensus       261 -----------------------------~~~~~~~~s~~l~~Li~~~L~~dP~~RpT~~elL~hp~f~~~~~  304 (604)
                                                   .......++..+.+||.+||..||.+|||+.|+|+||||+....
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~~  316 (328)
T cd08226         244 KNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVKE  316 (328)
T ss_pred             ccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHHHH
Confidence                                         00112335678999999999999999999999999999976544

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=4.4e-37  Score=313.41  Aligned_cols=231  Identities=26%  Similarity=0.449  Sum_probs=192.3

Q ss_pred             EEcccCcEEEEEEEECCCCc--EEEEEEecchhhHHHHHHHHHHHHHHhhC-CCCCCCeE----------EEEEEecCCC
Q psy1546          64 RIGKGSFGEVFKGIDNRTQQ--VVAIKIIDLEEAEDEIEDIQQEIMVLSQC-DSPYGTKL----------WIIMEYLGGG  130 (604)
Q Consensus        64 ~LG~G~fG~Vy~a~~~~t~~--~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l-~hp~~~~l----------yLVmEy~~gg  130 (604)
                      .||+|+||.||+|.+..++.  .+|+|.+...........+.+|+.++.++ .||++.++          |+||||+.+|
T Consensus         2 ~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~   81 (270)
T cd05047           2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHG   81 (270)
T ss_pred             cCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCCC
Confidence            58999999999999988775  46888886544444557788999999999 89987654          6999999999


Q ss_pred             ChhhHhhcC-----------------CCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEeccccccc
Q psy1546         131 SALDLMKAG-----------------NFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGT  193 (604)
Q Consensus       131 sL~~~l~~~-----------------~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~  193 (604)
                      +|.+++...                 .+++..+..++.||+.||+|||++|++||||||+|||++.++.+||+|||++..
T Consensus        82 ~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~dfgl~~~  161 (270)
T cd05047          82 NLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRG  161 (270)
T ss_pred             cHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECCCCCccc
Confidence            999998642                 378889999999999999999999999999999999999999999999999853


Q ss_pred             ccCCCCCCcccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHhhhcCCCCCCCCCccchHHH
Q psy1546         194 LTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAK-GEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQF  272 (604)
Q Consensus       194 ~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l  272 (604)
                      .... ........+..|+|||++....++.++|||||||++|||++ |..||...........+........+..++.++
T Consensus       162 ~~~~-~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (270)
T cd05047         162 QEVY-VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLNCDDEV  240 (270)
T ss_pred             cchh-hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCCCCCCCCCcCCHHH
Confidence            3211 11112234667999999998899999999999999999997 999998877666666555544444556678899


Q ss_pred             HHHHHHHhccCCCCCCCHHHHhc
Q psy1546         273 KEFVEACLNKDPENRPTAKELLK  295 (604)
Q Consensus       273 ~~Li~~~L~~dP~~RpT~~elL~  295 (604)
                      .+|+.+||..||.+|||+.+++.
T Consensus       241 ~~li~~~l~~~p~~Rps~~~il~  263 (270)
T cd05047         241 YDLMRQCWREKPYERPSFAQILV  263 (270)
T ss_pred             HHHHHHHcccChhhCCCHHHHHH
Confidence            99999999999999999999986

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=2.9e-37  Score=320.70  Aligned_cols=240  Identities=25%  Similarity=0.399  Sum_probs=190.4

Q ss_pred             ceeeeEEcccCcEEEEEEEECC--CCcEEEEEEecchh--hHHHHHHHHHHHHHHhhCCCCCC------------CeEEE
Q psy1546          59 FTKQERIGKGSFGEVFKGIDNR--TQQVVAIKIIDLEE--AEDEIEDIQQEIMVLSQCDSPYG------------TKLWI  122 (604)
Q Consensus        59 y~i~~~LG~G~fG~Vy~a~~~~--t~~~vAVK~i~~~~--~~~~~~~l~~Ei~iL~~l~hp~~------------~~lyL  122 (604)
                      |.+.++||+|+||.||+|.+..  +++.||||.+....  .......+.+|+.+++.++||++            ..+|+
T Consensus         2 y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   81 (316)
T cd07842           2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYL   81 (316)
T ss_pred             ceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEE
Confidence            7888999999999999999988  89999999987632  12223567889999999999974            34689


Q ss_pred             EEEecCCCChhhHhhc------CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecC----CCCeEEecccccc
Q psy1546         123 IMEYLGGGSALDLMKA------GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSE----MGDVKLADFGVAG  192 (604)
Q Consensus       123 VmEy~~ggsL~~~l~~------~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~----~g~vKL~DFGlA~  192 (604)
                      ||||+++ +|.+++..      ..+++..++.++.||+.||.|||+++|+||||||+|||++.    ++.+||+|||++.
T Consensus        82 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~~  160 (316)
T cd07842          82 LFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLAR  160 (316)
T ss_pred             EEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCcccc
Confidence            9999975 56665532      36899999999999999999999999999999999999999    8999999999997


Q ss_pred             cccCCCC---CCcccccCCCCCChHHhhcC-CCCCcchhhhHHHHHHHHHhCCCCCCCCChhh-------------Hhhh
Q psy1546         193 TLTNTTS---KRNTFVGTPFWMAPEVIKQS-AYDSKADIWSLGITAIELAKGEPPNSELHPMR-------------VLFL  255 (604)
Q Consensus       193 ~~~~~~~---~~~~~~GT~~Y~APE~l~~~-~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~-------------~~~~  255 (604)
                      .+.....   .....++++.|+|||++.+. .++.++|||||||+||+|++|.+||.......             +...
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (316)
T cd07842         161 LFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFEV  240 (316)
T ss_pred             ccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHHHH
Confidence            6543322   22345789999999998764 57899999999999999999999997654321             0000


Q ss_pred             cC---------------------CCCCCCCC-----------ccchHHHHHHHHHHhccCCCCCCCHHHHhcChhh
Q psy1546         256 IP---------------------KNNPPQLT-----------GNYTKQFKEFVEACLNKDPENRPTAKELLKFPFI  299 (604)
Q Consensus       256 i~---------------------~~~~~~~~-----------~~~s~~l~~Li~~~L~~dP~~RpT~~elL~hp~f  299 (604)
                      +.                     ........           ...+..+.++|.+||..||++|||+.|++.||||
T Consensus       241 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~f  316 (316)
T cd07842         241 LGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPYF  316 (316)
T ss_pred             hCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCCC
Confidence            00                     00000000           1456689999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=8.4e-37  Score=312.54  Aligned_cols=239  Identities=30%  Similarity=0.438  Sum_probs=204.3

Q ss_pred             ccceeeeEEcccCcEEEEEEEECCCCc----EEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCCeE---------EEE
Q psy1546          57 LIFTKQERIGKGSFGEVFKGIDNRTQQ----VVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTKL---------WII  123 (604)
Q Consensus        57 ~~y~i~~~LG~G~fG~Vy~a~~~~t~~----~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~~l---------yLV  123 (604)
                      ..|.+.+.||+|+||.||+|.+..++.    .||+|.+...........+.+|+.++..+.|+++.++         |+|
T Consensus         7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~v   86 (279)
T cd05057           7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLSSQVQLI   86 (279)
T ss_pred             HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCceEEE
Confidence            348899999999999999999876654    5899998766555556778899999999999997654         699


Q ss_pred             EEecCCCChhhHhhc--CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCCCC
Q psy1546         124 MEYLGGGSALDLMKA--GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKR  201 (604)
Q Consensus       124 mEy~~ggsL~~~l~~--~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~~  201 (604)
                      |||+.+|+|.+++..  +.+++..+..++.||+.||+|||+.||+||||||+|||++.++.+||+|||+++.+.......
T Consensus        87 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~~~~~  166 (279)
T cd05057          87 TQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEY  166 (279)
T ss_pred             EecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCcccccccCcccce
Confidence            999999999999865  468999999999999999999999999999999999999999999999999997664322211


Q ss_pred             --cccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHhhhcCCCCCCCCCccchHHHHHHHHH
Q psy1546         202 --NTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAK-GEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEA  278 (604)
Q Consensus       202 --~~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~  278 (604)
                        ....++..|+|||.+....++.++|||||||++|||++ |..||......+....+........+..++..+.+++.+
T Consensus       167 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (279)
T cd05057         167 HAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGERLPQPPICTIDVYMVLVK  246 (279)
T ss_pred             ecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCCCCCCCCCCHHHHHHHHH
Confidence              11224567999999988889999999999999999998 999999888777776666655555566788899999999


Q ss_pred             HhccCCCCCCCHHHHhc
Q psy1546         279 CLNKDPENRPTAKELLK  295 (604)
Q Consensus       279 ~L~~dP~~RpT~~elL~  295 (604)
                      ||..||.+||++.++++
T Consensus       247 ~l~~~p~~Rp~~~~l~~  263 (279)
T cd05057         247 CWMIDAESRPTFKELIN  263 (279)
T ss_pred             HcCCChhhCCCHHHHHH
Confidence            99999999999999976

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=6.3e-37  Score=324.76  Aligned_cols=244  Identities=23%  Similarity=0.401  Sum_probs=199.4

Q ss_pred             ccceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhh-HHHHHHHHHHHHHHhhCCCCCCCe----------------
Q psy1546          57 LIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA-EDEIEDIQQEIMVLSQCDSPYGTK----------------  119 (604)
Q Consensus        57 ~~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~-~~~~~~l~~Ei~iL~~l~hp~~~~----------------  119 (604)
                      ..|.+.+.||+|+||.||+|.+..+++.||||++..... ....+.+.+|+.++++++|+++.+                
T Consensus        17 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   96 (345)
T cd07877          17 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND   96 (345)
T ss_pred             CceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeeccccccccc
Confidence            449999999999999999999999999999999865422 223456788999999999998544                


Q ss_pred             EEEEEEecCCCChhhHhhcCCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCC
Q psy1546         120 LWIIMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTS  199 (604)
Q Consensus       120 lyLVmEy~~ggsL~~~l~~~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~  199 (604)
                      +|++++++ +++|.++++.+.+++..+..++.||+.||.|||+.||+||||||+||+++.++.+||+|||++.....   
T Consensus        97 ~~lv~~~~-~~~L~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~~---  172 (345)
T cd07877          97 VYLVTHLM-GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD---  172 (345)
T ss_pred             EEEEehhc-ccCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEecccccccccc---
Confidence            46778877 78899998888899999999999999999999999999999999999999999999999999865432   


Q ss_pred             CCcccccCCCCCChHHhhc-CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCC--------------------
Q psy1546         200 KRNTFVGTPFWMAPEVIKQ-SAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPK--------------------  258 (604)
Q Consensus       200 ~~~~~~GT~~Y~APE~l~~-~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~--------------------  258 (604)
                      ......+++.|+|||++.+ ..++.++|||||||++|+|++|.+||...........+..                    
T Consensus       173 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (345)
T cd07877         173 EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN  252 (345)
T ss_pred             cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhcccHhHHH
Confidence            2234578999999999876 5688899999999999999999999976554332211100                    


Q ss_pred             ----------CCCCCCCccchHHHHHHHHHHhccCCCCCCCHHHHhcChhhhhhhh
Q psy1546         259 ----------NNPPQLTGNYTKQFKEFVEACLNKDPENRPTAKELLKFPFIRKAKK  304 (604)
Q Consensus       259 ----------~~~~~~~~~~s~~l~~Li~~~L~~dP~~RpT~~elL~hp~f~~~~~  304 (604)
                                ..........+..+.+||.+||..||.+||++.+++.||||.+...
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~~~  308 (345)
T cd07877         253 YIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD  308 (345)
T ss_pred             HHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhcCC
Confidence                      0000111235778999999999999999999999999999986543

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>KOG0584|consensus

Probab=100.00  E-value=2.8e-38  Score=340.61  Aligned_cols=246  Identities=31%  Similarity=0.562  Sum_probs=207.6

Q ss_pred             cCccccc-eeeeEEcccCcEEEEEEEECCCCcEEEEE---EecchhhHHHHHHHHHHHHHHhhCCCCCCCeEE-------
Q psy1546          53 VDPELIF-TKQERIGKGSFGEVFKGIDNRTQQVVAIK---IIDLEEAEDEIEDIQQEIMVLSQCDSPYGTKLW-------  121 (604)
Q Consensus        53 ~~~~~~y-~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK---~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~~ly-------  121 (604)
                      .++...| +...+||+|+|-+||+|.|..+|..||--   +-+.......++++..|+.+|+.|.|+|+.++|       
T Consensus        35 ~~p~gRy~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~  114 (632)
T KOG0584|consen   35 KDPTGRYLKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTD  114 (632)
T ss_pred             cCCCCceeehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCC
Confidence            3443333 45678999999999999999999988843   333444556678999999999999999988875       


Q ss_pred             -----EEEEecCCCChhhHhhc-CCCcHHHHHHHHHHHHHHhHHhhhCC--ccccccccceeEec-CCCCeEEecccccc
Q psy1546         122 -----IIMEYLGGGSALDLMKA-GNFEEMHIAVILREVLKGLDYLHSER--KLHRDIKAANVLLS-EMGDVKLADFGVAG  192 (604)
Q Consensus       122 -----LVmEy~~ggsL~~~l~~-~~lse~~i~~i~~qIl~gL~yLHs~g--IiHrDLKp~NILl~-~~g~vKL~DFGlA~  192 (604)
                           +|+|++..|+|+.|+++ ++++...++.|++||+.||.|||++.  |||||||.+||+|+ ..|.|||+|+|+|.
T Consensus       115 n~~in~iTEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAt  194 (632)
T KOG0584|consen  115 NKTINFITELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLAT  194 (632)
T ss_pred             CceeeeeeecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHH
Confidence                 89999999999999866 78999999999999999999999985  99999999999996 45899999999997


Q ss_pred             cccCCCCCCcccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCC-hhhHhhhcCCCCCCC-CCccchH
Q psy1546         193 TLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELH-PMRVLFLIPKNNPPQ-LTGNYTK  270 (604)
Q Consensus       193 ~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~-~~~~~~~i~~~~~~~-~~~~~s~  270 (604)
                      .+.....  ...+|||.|||||+.. ..|+..+||||||++++||+|+..||.... +.++...+..+..|. +..--.+
T Consensus       195 l~r~s~a--ksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~kV~dP  271 (632)
T KOG0584|consen  195 LLRKSHA--KSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSKVKDP  271 (632)
T ss_pred             Hhhcccc--ceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhccCCH
Confidence            7654433  3479999999999987 789999999999999999999999998765 455666666665443 3333367


Q ss_pred             HHHHHHHHHhccCCCCCCCHHHHhcChhhhhh
Q psy1546         271 QFKEFVEACLNKDPENRPTAKELLKFPFIRKA  302 (604)
Q Consensus       271 ~l~~Li~~~L~~dP~~RpT~~elL~hp~f~~~  302 (604)
                      ++++||.+||.. ...|+|+.|||+||||..-
T Consensus       272 evr~fIekCl~~-~~~R~sa~eLL~d~Ff~~d  302 (632)
T KOG0584|consen  272 EVREFIEKCLAT-KSERLSAKELLKDPFFDED  302 (632)
T ss_pred             HHHHHHHHHhcC-chhccCHHHHhhChhhccc
Confidence            999999999999 9999999999999999763

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=7.7e-37  Score=311.05  Aligned_cols=239  Identities=28%  Similarity=0.419  Sum_probs=202.9

Q ss_pred             cceeeeEEcccCcEEEEEEEECCC---CcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCCeE---------EEEEE
Q psy1546          58 IFTKQERIGKGSFGEVFKGIDNRT---QQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTKL---------WIIME  125 (604)
Q Consensus        58 ~y~i~~~LG~G~fG~Vy~a~~~~t---~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~~l---------yLVmE  125 (604)
                      .|.+.++||+|+||.||+|.+...   ...||||.+.........+.+.+|+.+++.+.|+++.++         |+|||
T Consensus         7 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~lv~e   86 (270)
T cd05056           7 DITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITENPVWIVME   86 (270)
T ss_pred             hceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcCCCcEEEEE
Confidence            378899999999999999987544   457999998765545556788999999999999996654         69999


Q ss_pred             ecCCCChhhHhhc--CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCCCC-c
Q psy1546         126 YLGGGSALDLMKA--GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKR-N  202 (604)
Q Consensus       126 y~~ggsL~~~l~~--~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~~-~  202 (604)
                      |+++++|.+++..  ..+++..+..++.||+.||.|||+.|++||||||+|||++..+.++|+|||+++......... .
T Consensus        87 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~  166 (270)
T cd05056          87 LAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKAS  166 (270)
T ss_pred             cCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeecccccceecC
Confidence            9999999999975  358999999999999999999999999999999999999999999999999997654332211 1


Q ss_pred             ccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHhhhcCCCCCCCCCccchHHHHHHHHHHhc
Q psy1546         203 TFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAK-GEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLN  281 (604)
Q Consensus       203 ~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~~L~  281 (604)
                      ...++..|+|||.+....++.++|||||||++|+|++ |..||......+....+........+..++..+.++|.+||.
T Consensus       167 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~  246 (270)
T cd05056         167 KGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTKCWA  246 (270)
T ss_pred             CCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcC
Confidence            2234567999999988889999999999999999986 999998887776666666665556677889999999999999


Q ss_pred             cCCCCCCCHHHHhcC
Q psy1546         282 KDPENRPTAKELLKF  296 (604)
Q Consensus       282 ~dP~~RpT~~elL~h  296 (604)
                      .+|.+|||+.+++..
T Consensus       247 ~~P~~Rpt~~~~~~~  261 (270)
T cd05056         247 YDPSKRPRFTELKAQ  261 (270)
T ss_pred             CChhhCcCHHHHHHH
Confidence            999999999998763

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=7.3e-37  Score=308.44  Aligned_cols=231  Identities=27%  Similarity=0.443  Sum_probs=199.4

Q ss_pred             cceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCCe----------EEEEEEec
Q psy1546          58 IFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTK----------LWIIMEYL  127 (604)
Q Consensus        58 ~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~~----------lyLVmEy~  127 (604)
                      .|.+.+.||.|+||.||+|...  ++.||||.+.....  ..+.+.+|+.+++.+.|+++.+          .|+||||+
T Consensus         7 ~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   82 (256)
T cd05039           7 ELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDST--AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYM   82 (256)
T ss_pred             hccceeeeecCCCceEEEEEec--CcEEEEEEeccchh--HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEec
Confidence            4788999999999999999865  78999999976543  4577889999999999998554          47999999


Q ss_pred             CCCChhhHhhcC---CCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCCCCccc
Q psy1546         128 GGGSALDLMKAG---NFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTF  204 (604)
Q Consensus       128 ~ggsL~~~l~~~---~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~~~~~  204 (604)
                      ++++|.++++..   .+++..+..++.|++.||.|||++||+||||||+|||++.++.++|+|||+++.......   ..
T Consensus        83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~---~~  159 (256)
T cd05039          83 AKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD---SG  159 (256)
T ss_pred             CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEcccccccccccccc---cC
Confidence            999999998653   589999999999999999999999999999999999999999999999999976632222   23


Q ss_pred             ccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHhhhcCCCCCCCCCccchHHHHHHHHHHhccC
Q psy1546         205 VGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAK-GEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKD  283 (604)
Q Consensus       205 ~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~~L~~d  283 (604)
                      .++..|+|||++....++.++|||||||++|+|++ |..||...........+........+..+++.+.+||.+||..+
T Consensus       160 ~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~  239 (256)
T cd05039         160 KLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYRMEAPEGCPPEVYKVMKDCWELD  239 (256)
T ss_pred             CCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCccCCCHHHHHHHHHHhccC
Confidence            45667999999998889999999999999999997 99999888777666655555445556678899999999999999


Q ss_pred             CCCCCCHHHHhc
Q psy1546         284 PENRPTAKELLK  295 (604)
Q Consensus       284 P~~RpT~~elL~  295 (604)
                      |.+|||+.++++
T Consensus       240 p~~Rp~~~~l~~  251 (256)
T cd05039         240 PAKRPTFKQLRE  251 (256)
T ss_pred             hhhCcCHHHHHH
Confidence            999999999986

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>KOG2345|consensus

Probab=100.00  E-value=1.6e-37  Score=302.27  Aligned_cols=241  Identities=28%  Similarity=0.395  Sum_probs=195.9

Q ss_pred             ccccceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCC---------------e
Q psy1546          55 PELIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGT---------------K  119 (604)
Q Consensus        55 ~~~~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~---------------~  119 (604)
                      .+..|++.++||+|||+-||++++..++..||+|++.... .+.++...+||...++++|||..               .
T Consensus        19 n~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~-~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~   97 (302)
T KOG2345|consen   19 NNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS-QEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHE   97 (302)
T ss_pred             cCceEEEeeeecCCCceeeeeecccCcccchhhheeeccc-hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCcee
Confidence            3455999999999999999999999999999999997766 45678899999999999999832               3


Q ss_pred             EEEEEEecCCCChhhHhhc----C-CCcHHHHHHHHHHHHHHhHHhhhCC--ccccccccceeEecCCCCeEEecccccc
Q psy1546         120 LWIIMEYLGGGSALDLMKA----G-NFEEMHIAVILREVLKGLDYLHSER--KLHRDIKAANVLLSEMGDVKLADFGVAG  192 (604)
Q Consensus       120 lyLVmEy~~ggsL~~~l~~----~-~lse~~i~~i~~qIl~gL~yLHs~g--IiHrDLKp~NILl~~~g~vKL~DFGlA~  192 (604)
                      +||+++|...|+|.+.++.    | -+++.+++.|+.+|++||++||+..  ++||||||.|||+++.+.++|.|||.+.
T Consensus        98 ~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D~GS~~  177 (302)
T KOG2345|consen   98 AYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMDLGSAT  177 (302)
T ss_pred             EEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEeccCcc
Confidence            6999999999999998753    3 5999999999999999999999998  9999999999999999999999999986


Q ss_pred             cccCCCCCC---------cccccCCCCCChHHhhc---CCCCCcchhhhHHHHHHHHHhCCCCCCCCChh--hHhhhcCC
Q psy1546         193 TLTNTTSKR---------NTFVGTPFWMAPEVIKQ---SAYDSKADIWSLGITAIELAKGEPPNSELHPM--RVLFLIPK  258 (604)
Q Consensus       193 ~~~~~~~~~---------~~~~GT~~Y~APE~l~~---~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~--~~~~~i~~  258 (604)
                      ...-.....         .....|..|+|||++.-   ...+.++|||||||+||.|+.|..||...-..  .+...+..
T Consensus       178 ~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaLAv~n  257 (302)
T KOG2345|consen  178 QAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLALAVQN  257 (302)
T ss_pred             ccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEEeeec
Confidence            543211111         12246889999999964   45688999999999999999999998643221  11111111


Q ss_pred             CC-CCCCCccchHHHHHHHHHHhccCCCCCCCHHHHhcC
Q psy1546         259 NN-PPQLTGNYTKQFKEFVEACLNKDPENRPTAKELLKF  296 (604)
Q Consensus       259 ~~-~~~~~~~~s~~l~~Li~~~L~~dP~~RpT~~elL~h  296 (604)
                      .. ..+-...+++.+.+||+.||+.||.+||++.+++.+
T Consensus       258 ~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~  296 (302)
T KOG2345|consen  258 AQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSK  296 (302)
T ss_pred             cccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence            11 111123489999999999999999999999999863

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=4.9e-37  Score=323.63  Aligned_cols=239  Identities=25%  Similarity=0.448  Sum_probs=200.5

Q ss_pred             cceeeeEEcccCcEEEEEEEECCC-------CcEEEEEEecchhhHHHHHHHHHHHHHHhhC-CCCCCCe----------
Q psy1546          58 IFTKQERIGKGSFGEVFKGIDNRT-------QQVVAIKIIDLEEAEDEIEDIQQEIMVLSQC-DSPYGTK----------  119 (604)
Q Consensus        58 ~y~i~~~LG~G~fG~Vy~a~~~~t-------~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l-~hp~~~~----------  119 (604)
                      .|++++.||+|+||.||+|.+...       +..||+|++...........+.+|+.+++++ .|+++.+          
T Consensus        13 ~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~   92 (334)
T cd05100          13 RLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGP   92 (334)
T ss_pred             HeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCCc
Confidence            489999999999999999986432       2368999987654455567889999999999 7998654          


Q ss_pred             EEEEEEecCCCChhhHhhcC-----------------CCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCC
Q psy1546         120 LWIIMEYLGGGSALDLMKAG-----------------NFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGD  182 (604)
Q Consensus       120 lyLVmEy~~ggsL~~~l~~~-----------------~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~  182 (604)
                      +|+||||+.+|+|.+++...                 .++...+..++.||+.||.|||++||+||||||+|||++.++.
T Consensus        93 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nill~~~~~  172 (334)
T cd05100          93 LYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNV  172 (334)
T ss_pred             eEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCc
Confidence            57999999999999998642                 3677888899999999999999999999999999999999999


Q ss_pred             eEEecccccccccCCCCCC--cccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHhhhcCCC
Q psy1546         183 VKLADFGVAGTLTNTTSKR--NTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAK-GEPPNSELHPMRVLFLIPKN  259 (604)
Q Consensus       183 vKL~DFGlA~~~~~~~~~~--~~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~~i~~~  259 (604)
                      +||+|||+++.+.......  ....++..|||||++.+..++.++|||||||+||||++ |..||......+....+...
T Consensus       173 ~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~  252 (334)
T cd05100         173 MKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKEG  252 (334)
T ss_pred             EEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC
Confidence            9999999997654322211  12234567999999999999999999999999999998 89999888877776666555


Q ss_pred             CCCCCCccchHHHHHHHHHHhccCCCCCCCHHHHhcC
Q psy1546         260 NPPQLTGNYTKQFKEFVEACLNKDPENRPTAKELLKF  296 (604)
Q Consensus       260 ~~~~~~~~~s~~l~~Li~~~L~~dP~~RpT~~elL~h  296 (604)
                      .....+..++..+.+|+.+||..+|.+|||+.||+.+
T Consensus       253 ~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~  289 (334)
T cd05100         253 HRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVED  289 (334)
T ss_pred             CCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence            5555666788999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.1e-37  Score=317.25  Aligned_cols=239  Identities=24%  Similarity=0.380  Sum_probs=193.6

Q ss_pred             ccceeeeEEcccCcEEEEEEEECCCC--------------cEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCCeE--
Q psy1546          57 LIFTKQERIGKGSFGEVFKGIDNRTQ--------------QVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTKL--  120 (604)
Q Consensus        57 ~~y~i~~~LG~G~fG~Vy~a~~~~t~--------------~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~~l--  120 (604)
                      ..|.+.++||+|+||.||+|.+..++              ..||||++...........+.+|+.+++.++|++..++  
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~   84 (295)
T cd05097           5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG   84 (295)
T ss_pred             HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence            35899999999999999999875432              35999999765445555778999999999999986554  


Q ss_pred             --------EEEEEecCCCChhhHhhcC-------------CCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecC
Q psy1546         121 --------WIIMEYLGGGSALDLMKAG-------------NFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSE  179 (604)
Q Consensus       121 --------yLVmEy~~ggsL~~~l~~~-------------~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~  179 (604)
                              |+||||+.+++|.+++...             .+++..+..++.||+.||.|||++|++||||||+|||++.
T Consensus        85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nill~~  164 (295)
T cd05097          85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGN  164 (295)
T ss_pred             EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhEEEcC
Confidence                    6999999999999988542             3677888999999999999999999999999999999999


Q ss_pred             CCCeEEecccccccccCCCC--CCcccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHh--CCCCCCCCChhhHhhh
Q psy1546         180 MGDVKLADFGVAGTLTNTTS--KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAK--GEPPNSELHPMRVLFL  255 (604)
Q Consensus       180 ~g~vKL~DFGlA~~~~~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLlt--G~~Pf~~~~~~~~~~~  255 (604)
                      ++.+||+|||++..+.....  ......++..|+|||++.+..++.++|||||||++|+|++  |..||......+....
T Consensus       165 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~~~~~  244 (295)
T cd05097         165 HYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQVIEN  244 (295)
T ss_pred             CCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHHHHHH
Confidence            99999999999976533221  1222345778999999998899999999999999999988  6778887665544332


Q ss_pred             cC-------CCCCCCCCccchHHHHHHHHHHhccCCCCCCCHHHHhc
Q psy1546         256 IP-------KNNPPQLTGNYTKQFKEFVEACLNKDPENRPTAKELLK  295 (604)
Q Consensus       256 i~-------~~~~~~~~~~~s~~l~~Li~~~L~~dP~~RpT~~elL~  295 (604)
                      +.       .......+..++..+.+|+.+||..||.+||++.+|++
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~  291 (295)
T cd05097         245 TGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH  291 (295)
T ss_pred             HHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence            21       11112234457889999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=7.3e-37  Score=307.20  Aligned_cols=232  Identities=28%  Similarity=0.460  Sum_probs=196.0

Q ss_pred             eEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCCe----------EEEEEEecCCCCh
Q psy1546          63 ERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTK----------LWIIMEYLGGGSA  132 (604)
Q Consensus        63 ~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~~----------lyLVmEy~~ggsL  132 (604)
                      ++||.|+||.||+|.+.. ++.||+|++...........+.+|+.+++++.|+++.+          .|+||||+.+++|
T Consensus         1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l   79 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSL   79 (251)
T ss_pred             CccccCCCceEEEEEEeC-CCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcH
Confidence            469999999999999887 99999999876554445578899999999999998554          4799999999999


Q ss_pred             hhHhhc--CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCCCC--cccccCC
Q psy1546         133 LDLMKA--GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKR--NTFVGTP  208 (604)
Q Consensus       133 ~~~l~~--~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~~--~~~~GT~  208 (604)
                      .+++..  ..+++..+..++.+++.||.|||+++++||||||+|||++.++.++|+|||++..........  ....++.
T Consensus        80 ~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~  159 (251)
T cd05041          80 LTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPI  159 (251)
T ss_pred             HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCccee
Confidence            999854  458889999999999999999999999999999999999999999999999997554221111  1223456


Q ss_pred             CCCChHHhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHhhhcCCCCCCCCCccchHHHHHHHHHHhccCCCCC
Q psy1546         209 FWMAPEVIKQSAYDSKADIWSLGITAIELAK-GEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPENR  287 (604)
Q Consensus       209 ~Y~APE~l~~~~~~~~sDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R  287 (604)
                      .|+|||++.+..++.++|||||||++|+|++ |..||...........+........+..++..+.+|+.+||..+|.+|
T Consensus       160 ~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R  239 (251)
T cd05041         160 KWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRMPAPQLCPEEIYRLMLQCWAYDPENR  239 (251)
T ss_pred             ccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHhccChhhC
Confidence            7999999998899999999999999999998 899998877666655555444444556788999999999999999999


Q ss_pred             CCHHHHhc
Q psy1546         288 PTAKELLK  295 (604)
Q Consensus       288 pT~~elL~  295 (604)
                      ||+.|+++
T Consensus       240 p~~~ell~  247 (251)
T cd05041         240 PSFSEIYN  247 (251)
T ss_pred             cCHHHHHH
Confidence            99999986

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3.5e-37  Score=323.25  Aligned_cols=244  Identities=29%  Similarity=0.440  Sum_probs=202.4

Q ss_pred             ceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhh-HHHHHHHHHHHHHHhhCCCCCC---------------CeEEE
Q psy1546          59 FTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA-EDEIEDIQQEIMVLSQCDSPYG---------------TKLWI  122 (604)
Q Consensus        59 y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~-~~~~~~l~~Ei~iL~~l~hp~~---------------~~lyL  122 (604)
                      |.+.+.||.|+||.||+|++..+++.||||++..... ....+.+.+|+.+++.++|++.               ..+|+
T Consensus         2 y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~l   81 (330)
T cd07834           2 YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVYI   81 (330)
T ss_pred             ceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceEE
Confidence            7889999999999999999999999999999865432 3345678899999999999972               25799


Q ss_pred             EEEecCCCChhhHhhc-CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCC---
Q psy1546         123 IMEYLGGGSALDLMKA-GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTT---  198 (604)
Q Consensus       123 VmEy~~ggsL~~~l~~-~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~---  198 (604)
                      ||||++ ++|..++.. +.+++..++.++.||+.||.|||++||+||||||.|||++.++.++|+|||++.......   
T Consensus        82 v~e~~~-~~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~~~  160 (330)
T cd07834          82 VTELME-TDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEK  160 (330)
T ss_pred             Eecchh-hhHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeeccccccc
Confidence            999997 578888765 479999999999999999999999999999999999999999999999999997665443   


Q ss_pred             CCCcccccCCCCCChHHhhcC-CCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCCC-----------------
Q psy1546         199 SKRNTFVGTPFWMAPEVIKQS-AYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNN-----------------  260 (604)
Q Consensus       199 ~~~~~~~GT~~Y~APE~l~~~-~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~~-----------------  260 (604)
                      .......+++.|+|||++.+. .++.++|||||||++|+|++|.+||......+....+....                 
T Consensus       161 ~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  240 (330)
T cd07834         161 GFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKAR  240 (330)
T ss_pred             ccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccccchh
Confidence            123345689999999999887 78999999999999999999999998776543322211100                 


Q ss_pred             -------------CCCCCccchHHHHHHHHHHhccCCCCCCCHHHHhcChhhhhhh
Q psy1546         261 -------------PPQLTGNYTKQFKEFVEACLNKDPENRPTAKELLKFPFIRKAK  303 (604)
Q Consensus       261 -------------~~~~~~~~s~~l~~Li~~~L~~dP~~RpT~~elL~hp~f~~~~  303 (604)
                                   .......++..+.+||.+||..+|.+|||+.+++.||||+...
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~  296 (330)
T cd07834         241 NYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLH  296 (330)
T ss_pred             hHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhc
Confidence                         0011234678899999999999999999999999999997654

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=3.4e-37  Score=319.06  Aligned_cols=241  Identities=29%  Similarity=0.482  Sum_probs=192.2

Q ss_pred             cceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHH-HHHHHHHHHHHHhhCCCCCCCe-----------------
Q psy1546          58 IFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAED-EIEDIQQEIMVLSQCDSPYGTK-----------------  119 (604)
Q Consensus        58 ~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~-~~~~l~~Ei~iL~~l~hp~~~~-----------------  119 (604)
                      .|.+.++||.|+||.||+|.+..+++.||||++....... ....+.+|+.+++.++|+++.+                 
T Consensus         9 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   88 (311)
T cd07866           9 DYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRKRG   88 (311)
T ss_pred             cEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheecccccccccCc
Confidence            3999999999999999999999999999999986543222 2245678999999999998543                 


Q ss_pred             -EEEEEEecCCCChhhHhhc--CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccC
Q psy1546         120 -LWIIMEYLGGGSALDLMKA--GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTN  196 (604)
Q Consensus       120 -lyLVmEy~~ggsL~~~l~~--~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~  196 (604)
                       +|+||||+.+ +|...+..  ..+++..++.++.||++||.|||++||+||||||+|||++.++.++|+|||+++....
T Consensus        89 ~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~  167 (311)
T cd07866          89 SVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYDG  167 (311)
T ss_pred             eEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCccchhccC
Confidence             4899999965 56655543  5799999999999999999999999999999999999999999999999999975543


Q ss_pred             CCC-----------CCcccccCCCCCChHHhhcC-CCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCC-----
Q psy1546         197 TTS-----------KRNTFVGTPFWMAPEVIKQS-AYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKN-----  259 (604)
Q Consensus       197 ~~~-----------~~~~~~GT~~Y~APE~l~~~-~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~-----  259 (604)
                      ...           ......|++.|+|||++.+. .++.++|||||||++|+|++|.+||.+.........+...     
T Consensus       168 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~  247 (311)
T cd07866         168 PPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCGTPT  247 (311)
T ss_pred             CCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence            221           11234678899999998654 5789999999999999999999999876654332221100     


Q ss_pred             ---------------------CCCC---CCccchHHHHHHHHHHhccCCCCCCCHHHHhcChhh
Q psy1546         260 ---------------------NPPQ---LTGNYTKQFKEFVEACLNKDPENRPTAKELLKFPFI  299 (604)
Q Consensus       260 ---------------------~~~~---~~~~~s~~l~~Li~~~L~~dP~~RpT~~elL~hp~f  299 (604)
                                           .+..   ....+...+.+||.+||..||.+|||+.|++.||||
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f  311 (311)
T cd07866         248 EETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF  311 (311)
T ss_pred             hhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence                                 0000   012344678899999999999999999999999998

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=5.7e-37  Score=313.07  Aligned_cols=231  Identities=29%  Similarity=0.457  Sum_probs=186.8

Q ss_pred             ceeeeE--EcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHh-hCCCCCCC----------eEEEEEE
Q psy1546          59 FTKQER--IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLS-QCDSPYGT----------KLWIIME  125 (604)
Q Consensus        59 y~i~~~--LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~-~l~hp~~~----------~lyLVmE  125 (604)
                      |.+.+.  ||.|+||.||++.+..++..||+|++....... .     |+.+.. ..+|+++.          .+|+|||
T Consensus        16 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-~-----e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~e   89 (267)
T PHA03390         16 CEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-I-----EPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMD   89 (267)
T ss_pred             hccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-h-----hHHHHHHhhcCCCEEEEEEEEecCCeeEEEEE
Confidence            444444  599999999999999999999999986543211 1     222222 12688754          3579999


Q ss_pred             ecCCCChhhHhhcC-CCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCC-CeEEecccccccccCCCCCCcc
Q psy1546         126 YLGGGSALDLMKAG-NFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMG-DVKLADFGVAGTLTNTTSKRNT  203 (604)
Q Consensus       126 y~~ggsL~~~l~~~-~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g-~vKL~DFGlA~~~~~~~~~~~~  203 (604)
                      |+++++|.+++... .+++..+..++.||+.||.|||+.|++||||||+||+++.++ .++|+|||++......    ..
T Consensus        90 ~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~----~~  165 (267)
T PHA03390         90 YIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP----SC  165 (267)
T ss_pred             cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecCCC----cc
Confidence            99999999999764 799999999999999999999999999999999999999988 9999999998765422    23


Q ss_pred             cccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhH----hhhcCCCCCCCCCccchHHHHHHHHHH
Q psy1546         204 FVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRV----LFLIPKNNPPQLTGNYTKQFKEFVEAC  279 (604)
Q Consensus       204 ~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~----~~~i~~~~~~~~~~~~s~~l~~Li~~~  279 (604)
                      ..|+..|+|||++.+..++.++|||||||++|+|++|..||........    ..... .........++..+.+||.+|
T Consensus       166 ~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~  244 (267)
T PHA03390        166 YDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQ-QKKLPFIKNVSKNANDFVQSM  244 (267)
T ss_pred             CCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhh-cccCCcccccCHHHHHHHHHH
Confidence            4689999999999999999999999999999999999999975543221    11111 223344557899999999999


Q ss_pred             hccCCCCCCC-HHHHhcChhhh
Q psy1546         280 LNKDPENRPT-AKELLKFPFIR  300 (604)
Q Consensus       280 L~~dP~~RpT-~~elL~hp~f~  300 (604)
                      |+.||.+||+ ++|+|+||||+
T Consensus       245 l~~~p~~R~~~~~~~l~h~~~~  266 (267)
T PHA03390        245 LKYNINYRLTNYNEIIKHPFLK  266 (267)
T ss_pred             hccChhhCCchHHHHhcCCccc
Confidence            9999999996 69999999995

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=8.4e-37  Score=317.83  Aligned_cols=242  Identities=33%  Similarity=0.554  Sum_probs=190.1

Q ss_pred             eeeeEEcccCcEEEEEEEECCCCcEEEEEEecch-hhHHHHHHHHHHHHHHhhCCCCCCC----------eEEEEEEecC
Q psy1546          60 TKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLE-EAEDEIEDIQQEIMVLSQCDSPYGT----------KLWIIMEYLG  128 (604)
Q Consensus        60 ~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~-~~~~~~~~l~~Ei~iL~~l~hp~~~----------~lyLVmEy~~  128 (604)
                      .+++.+|.  +|.||.+++..+++.||||++... ........+.+|+.+++.++|+++.          .+|++|||++
T Consensus         5 ~i~~~~~~--~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~   82 (314)
T cd08216           5 LIGKCFED--LMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMA   82 (314)
T ss_pred             hhhHhhcC--CceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccC
Confidence            33444444  455666666678999999999765 2344567899999999999999844          3589999999


Q ss_pred             CCChhhHhhc---CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCC------
Q psy1546         129 GGSALDLMKA---GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTS------  199 (604)
Q Consensus       129 ggsL~~~l~~---~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~------  199 (604)
                      +++|.+++..   ..+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||.+..+.....      
T Consensus        83 ~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~  162 (314)
T cd08216          83 YGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVH  162 (314)
T ss_pred             CCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeeccccccccccc
Confidence            9999999865   4689999999999999999999999999999999999999999999999999865532221      


Q ss_pred             -CCcccccCCCCCChHHhhc--CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCC-----------------
Q psy1546         200 -KRNTFVGTPFWMAPEVIKQ--SAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKN-----------------  259 (604)
Q Consensus       200 -~~~~~~GT~~Y~APE~l~~--~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~-----------------  259 (604)
                       ......++..|+|||++.+  ..++.++|||||||++|+|++|..||..............+                 
T Consensus       163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (314)
T cd08216         163 DFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDS  242 (314)
T ss_pred             cccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcCC
Confidence             1233457888999999976  35889999999999999999999999876543322110000                 


Q ss_pred             ----------------CCCCCCccchHHHHHHHHHHhccCCCCCCCHHHHhcChhhhhhh
Q psy1546         260 ----------------NPPQLTGNYTKQFKEFVEACLNKDPENRPTAKELLKFPFIRKAK  303 (604)
Q Consensus       260 ----------------~~~~~~~~~s~~l~~Li~~~L~~dP~~RpT~~elL~hp~f~~~~  303 (604)
                                      ........++.++.+|+.+||..||.+|||++++|+||||+..+
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~~  302 (314)
T cd08216         243 MSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQCK  302 (314)
T ss_pred             cCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhhc
Confidence                            00111223467889999999999999999999999999998765

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=6.4e-37  Score=312.26  Aligned_cols=240  Identities=31%  Similarity=0.507  Sum_probs=197.4

Q ss_pred             ceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhh-HHHHHHHHHHHHHHhhCCCCCC----------CeEEEEEEec
Q psy1546          59 FTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA-EDEIEDIQQEIMVLSQCDSPYG----------TKLWIIMEYL  127 (604)
Q Consensus        59 y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~-~~~~~~l~~Ei~iL~~l~hp~~----------~~lyLVmEy~  127 (604)
                      |++.+.||+|+||.||+|++..+++.||+|++..... ......+..|+.+++.+.|++.          ..+|+||||+
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~   80 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC   80 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence            5677889999999999999999999999999976542 2234667789999999999974          3568999999


Q ss_pred             CCCChhhHhhcC--CCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCCCCcccc
Q psy1546         128 GGGSALDLMKAG--NFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFV  205 (604)
Q Consensus       128 ~ggsL~~~l~~~--~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~~~~~~  205 (604)
                      + ++|.+++...  .+++..+..++.||+.||.|||++||+||||+|+||+++.++.++|+|||++..............
T Consensus        81 ~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~~~~  159 (282)
T cd07829          81 D-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEV  159 (282)
T ss_pred             C-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCCccccCccc
Confidence            7 5899998764  799999999999999999999999999999999999999999999999999976654433333456


Q ss_pred             cCCCCCChHHhhcC-CCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCC--------------------CCCC--
Q psy1546         206 GTPFWMAPEVIKQS-AYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPK--------------------NNPP--  262 (604)
Q Consensus       206 GT~~Y~APE~l~~~-~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~--------------------~~~~--  262 (604)
                      ++..|+|||++.+. .++.++|||||||++|||++|.+||...........+..                    ...+  
T Consensus       160 ~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (282)
T cd07829         160 VTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTFPKF  239 (282)
T ss_pred             cCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhccccccccccccc
Confidence            78889999999776 788999999999999999999999987654332221100                    0000  


Q ss_pred             ------CCCccchHHHHHHHHHHhccCCCCCCCHHHHhcChhh
Q psy1546         263 ------QLTGNYTKQFKEFVEACLNKDPENRPTAKELLKFPFI  299 (604)
Q Consensus       263 ------~~~~~~s~~l~~Li~~~L~~dP~~RpT~~elL~hp~f  299 (604)
                            .....++..+.++|.+||..||.+||++.+++.||||
T Consensus       240 ~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~  282 (282)
T cd07829         240 PPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF  282 (282)
T ss_pred             CccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence                  1112347789999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=1.1e-36  Score=307.07  Aligned_cols=233  Identities=26%  Similarity=0.451  Sum_probs=195.5

Q ss_pred             eEEcccCcEEEEEEEECC-CC--cEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCCe---------EEEEEEecCCC
Q psy1546          63 ERIGKGSFGEVFKGIDNR-TQ--QVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTK---------LWIIMEYLGGG  130 (604)
Q Consensus        63 ~~LG~G~fG~Vy~a~~~~-t~--~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~~---------lyLVmEy~~gg  130 (604)
                      ++||+|+||.||+|.+.. .+  ..||||.+.........+.+.+|+.++++++|+++.+         +|+||||++++
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~v~e~~~~~   80 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLTHPLMMVTELAPLG   80 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcCCeEEEEEEecCCC
Confidence            468999999999998765 33  3699999977665456678999999999999998654         46999999999


Q ss_pred             ChhhHhhcC---CCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCCC---Cccc
Q psy1546         131 SALDLMKAG---NFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSK---RNTF  204 (604)
Q Consensus       131 sL~~~l~~~---~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~---~~~~  204 (604)
                      +|.+++...   .+++..++.++.||+.||.|||++|++||||||+|||++.++.+||+|||+++.+......   ....
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~  160 (257)
T cd05040          81 SLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHL  160 (257)
T ss_pred             cHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEeccccccccccccccceecccCC
Confidence            999998653   5899999999999999999999999999999999999999999999999999776432211   1234


Q ss_pred             ccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHhhhcCC-CCCCCCCccchHHHHHHHHHHhcc
Q psy1546         205 VGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAK-GEPPNSELHPMRVLFLIPK-NNPPQLTGNYTKQFKEFVEACLNK  282 (604)
Q Consensus       205 ~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~~i~~-~~~~~~~~~~s~~l~~Li~~~L~~  282 (604)
                      .++..|+|||++.+..++.++|||||||++|+|++ |..||......+....+.. ......+..++..+.+++.+||..
T Consensus       161 ~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  240 (257)
T cd05040         161 KVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEACPQDIYNVMLQCWAH  240 (257)
T ss_pred             CCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCcCCCCccCCHHHHHHHHHHCCC
Confidence            57788999999999999999999999999999998 9999987776665544432 222334456788999999999999


Q ss_pred             CCCCCCCHHHHhc
Q psy1546         283 DPENRPTAKELLK  295 (604)
Q Consensus       283 dP~~RpT~~elL~  295 (604)
                      +|.+||++.+++.
T Consensus       241 ~p~~Rps~~~~~~  253 (257)
T cd05040         241 NPADRPTFAALRE  253 (257)
T ss_pred             CcccCCCHHHHHH
Confidence            9999999999976

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=8.5e-37  Score=352.21  Aligned_cols=239  Identities=23%  Similarity=0.312  Sum_probs=193.8

Q ss_pred             cceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhh--HHHHHHHHHHHHHHhhCCCCCCCe----------EEEEEE
Q psy1546          58 IFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA--EDEIEDIQQEIMVLSQCDSPYGTK----------LWIIME  125 (604)
Q Consensus        58 ~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~--~~~~~~l~~Ei~iL~~l~hp~~~~----------lyLVmE  125 (604)
                      .|.+.++||+|+||.||+|.+..+++.||||++.....  ....+.+.+|+.+++.+.||++.+          +|+|||
T Consensus         3 rYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVME   82 (932)
T PRK13184          3 RYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTMP   82 (932)
T ss_pred             CeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEEE
Confidence            38999999999999999999999999999999865422  233467889999999999998665          479999


Q ss_pred             ecCCCChhhHhhc------------CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEeccccccc
Q psy1546         126 YLGGGSALDLMKA------------GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGT  193 (604)
Q Consensus       126 y~~ggsL~~~l~~------------~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~  193 (604)
                      |++||+|.+++..            ..++...+..++.||+.||.|||++||+||||||+|||++.++.++|+|||+++.
T Consensus        83 Y~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDFGLAk~  162 (932)
T PRK13184         83 YIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIF  162 (932)
T ss_pred             cCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEecCccee
Confidence            9999999998853            2345567788999999999999999999999999999999999999999999976


Q ss_pred             ccCCC------------------CCCcccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhh
Q psy1546         194 LTNTT------------------SKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFL  255 (604)
Q Consensus       194 ~~~~~------------------~~~~~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~  255 (604)
                      .....                  ......+||+.|||||++.+..++.++|||||||++|||++|..||...........
T Consensus       163 i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ki~~~  242 (932)
T PRK13184        163 KKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRKISYR  242 (932)
T ss_pred             cccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhhhhhh
Confidence            52110                  111235799999999999999999999999999999999999999987655443332


Q ss_pred             cCCCCCCC--CCccchHHHHHHHHHHhccCCCCCCCHHHHhcC
Q psy1546         256 IPKNNPPQ--LTGNYTKQFKEFVEACLNKDPENRPTAKELLKF  296 (604)
Q Consensus       256 i~~~~~~~--~~~~~s~~l~~Li~~~L~~dP~~RpT~~elL~h  296 (604)
                      .....+..  ....++..+.+++.+||..||++|++..+.+..
T Consensus       243 ~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~  285 (932)
T PRK13184        243 DVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQ  285 (932)
T ss_pred             hhccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            21111111  123678899999999999999999876665543

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=1.2e-36  Score=314.56  Aligned_cols=238  Identities=23%  Similarity=0.401  Sum_probs=192.3

Q ss_pred             cceeeeEEcccCcEEEEEEEECC----------------CCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCCeE-
Q psy1546          58 IFTKQERIGKGSFGEVFKGIDNR----------------TQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTKL-  120 (604)
Q Consensus        58 ~y~i~~~LG~G~fG~Vy~a~~~~----------------t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~~l-  120 (604)
                      .|++.++||+|+||.||+|.+..                +...||+|++...........+.+|+.+++.++|+++.++ 
T Consensus         6 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~   85 (296)
T cd05095           6 RLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLL   85 (296)
T ss_pred             hceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEE
Confidence            48999999999999999986432                3457999998765444556788999999999999996554 


Q ss_pred             ---------EEEEEecCCCChhhHhhcC------------CCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecC
Q psy1546         121 ---------WIIMEYLGGGSALDLMKAG------------NFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSE  179 (604)
Q Consensus       121 ---------yLVmEy~~ggsL~~~l~~~------------~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~  179 (604)
                               |+||||+.+++|.+++...            .+++..+..++.||+.||+|||++||+||||||+|||++.
T Consensus        86 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Nili~~  165 (296)
T cd05095          86 AVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGK  165 (296)
T ss_pred             EEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheEEEcC
Confidence                     6999999999999988652            3566789999999999999999999999999999999999


Q ss_pred             CCCeEEecccccccccCCCC--CCcccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHh--CCCCCCCCChhhHhhh
Q psy1546         180 MGDVKLADFGVAGTLTNTTS--KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAK--GEPPNSELHPMRVLFL  255 (604)
Q Consensus       180 ~g~vKL~DFGlA~~~~~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLlt--G~~Pf~~~~~~~~~~~  255 (604)
                      ++.++|+|||+++.+.....  ......+++.|++||++.+..++.++|||||||++|||++  |..||......+....
T Consensus       166 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~~~~~  245 (296)
T cd05095         166 NYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQVIEN  245 (296)
T ss_pred             CCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHHHHHH
Confidence            99999999999976543221  1222345678999999988899999999999999999998  7789877665443322


Q ss_pred             cC-------CCCCCCCCccchHHHHHHHHHHhccCCCCCCCHHHHhc
Q psy1546         256 IP-------KNNPPQLTGNYTKQFKEFVEACLNKDPENRPTAKELLK  295 (604)
Q Consensus       256 i~-------~~~~~~~~~~~s~~l~~Li~~~L~~dP~~RpT~~elL~  295 (604)
                      ..       .......+..++..+.+|+.+||..||.+||++.+|++
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~  292 (296)
T cd05095         246 TGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA  292 (296)
T ss_pred             HHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            11       11112234567789999999999999999999999975

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=1e-36  Score=316.66  Aligned_cols=240  Identities=27%  Similarity=0.405  Sum_probs=200.4

Q ss_pred             ccceeeeEEcccCcEEEEEEEECCCCc----EEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCCeE---------EEE
Q psy1546          57 LIFTKQERIGKGSFGEVFKGIDNRTQQ----VVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTKL---------WII  123 (604)
Q Consensus        57 ~~y~i~~~LG~G~fG~Vy~a~~~~t~~----~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~~l---------yLV  123 (604)
                      ..|+..+.||+|+||.||+|.+..++.    .||+|++...........+.+|+.+++.+.|||+.++         ++|
T Consensus         7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~v   86 (303)
T cd05110           7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSPTIQLV   86 (303)
T ss_pred             hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCCCceee
Confidence            347888999999999999999887776    4788988665544445568899999999999997665         489


Q ss_pred             EEecCCCChhhHhhc--CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCCC-
Q psy1546         124 MEYLGGGSALDLMKA--GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSK-  200 (604)
Q Consensus       124 mEy~~ggsL~~~l~~--~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~-  200 (604)
                      +||+++|+|.+++..  ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+...... 
T Consensus        87 ~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~  166 (303)
T cd05110          87 TQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEY  166 (303)
T ss_pred             ehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEccccccccccCccccc
Confidence            999999999999865  35889999999999999999999999999999999999999999999999999765432221 


Q ss_pred             -CcccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHhhhcCCCCCCCCCccchHHHHHHHHH
Q psy1546         201 -RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAK-GEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEA  278 (604)
Q Consensus       201 -~~~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~  278 (604)
                       .....++..|+|||++.+..++.++|||||||++|||++ |..||.+.........+........+..++..+.+++.+
T Consensus       167 ~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  246 (303)
T cd05110         167 NADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGERLPQPPICTIDVYMVMVK  246 (303)
T ss_pred             ccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHH
Confidence             122345778999999999999999999999999999997 999998776655555554444444456678899999999


Q ss_pred             HhccCCCCCCCHHHHhcC
Q psy1546         279 CLNKDPENRPTAKELLKF  296 (604)
Q Consensus       279 ~L~~dP~~RpT~~elL~h  296 (604)
                      ||..+|++||++.++++.
T Consensus       247 c~~~~p~~Rp~~~~l~~~  264 (303)
T cd05110         247 CWMIDADSRPKFKELAAE  264 (303)
T ss_pred             HcCCChhhCcCHHHHHHH
Confidence            999999999999999873

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>KOG0614|consensus

Probab=100.00  E-value=8.5e-39  Score=335.33  Aligned_cols=245  Identities=28%  Similarity=0.488  Sum_probs=220.3

Q ss_pred             ceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhh--HHHHHHHHHHHHHHhhCCCCCCCe----------EEEEEEe
Q psy1546          59 FTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA--EDEIEDIQQEIMVLSQCDSPYGTK----------LWIIMEY  126 (604)
Q Consensus        59 y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~--~~~~~~l~~Ei~iL~~l~hp~~~~----------lyLVmEy  126 (604)
                      +.++..||-||||.|-++..+.....+|+|++++...  .+..+.+..|-.||..+..|++++          +|++||-
T Consensus       422 l~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmEa  501 (732)
T KOG0614|consen  422 LKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLMEA  501 (732)
T ss_pred             hhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHHh
Confidence            5677889999999999998776665699999987654  345678899999999999998665          4799999


Q ss_pred             cCCCChhhHhhc-CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCCCCcccc
Q psy1546         127 LGGGSALDLMKA-GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFV  205 (604)
Q Consensus       127 ~~ggsL~~~l~~-~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~~~~~~  205 (604)
                      |-||.|+..++. |.|++..+++++..+++|++|||++|||+|||||+|+|++.+|-+||.|||+|+.+. ...+..++|
T Consensus       502 ClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~-~g~KTwTFc  580 (732)
T KOG0614|consen  502 CLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIG-SGRKTWTFC  580 (732)
T ss_pred             hcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHhc-cCCceeeec
Confidence            999999999865 789999999999999999999999999999999999999999999999999998886 445678999


Q ss_pred             cCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCCC-CCCCCccchHHHHHHHHHHhccCC
Q psy1546         206 GTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNN-PPQLTGNYTKQFKEFVEACLNKDP  284 (604)
Q Consensus       206 GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~~-~~~~~~~~s~~l~~Li~~~L~~dP  284 (604)
                      |||.|.|||++.+...+.++|.||||+++|||++|.+||++.+++.....|.++. ...+|..++..+.+||+++...+|
T Consensus       581 GTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~~Pr~I~k~a~~Lik~LCr~~P  660 (732)
T KOG0614|consen  581 GTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIEFPRRITKTATDLIKKLCRDNP  660 (732)
T ss_pred             CCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhhcccccchhHHHHHHHHHhcCc
Confidence            9999999999999999999999999999999999999999999999998888775 346678899999999999999999


Q ss_pred             CCCCC-----HHHHhcChhhhhhhh
Q psy1546         285 ENRPT-----AKELLKFPFIRKAKK  304 (604)
Q Consensus       285 ~~RpT-----~~elL~hp~f~~~~~  304 (604)
                      .+|..     +.+|-+|-||....+
T Consensus       661 ~ERLG~~~~gI~DIkkH~Wf~gfdw  685 (732)
T KOG0614|consen  661 TERLGYQKGGINDIKKHRWFEGFDW  685 (732)
T ss_pred             HhhhccccCChHHHHhhhhhhcCCh
Confidence            99976     899999999976544

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=3.9e-37  Score=324.55  Aligned_cols=244  Identities=30%  Similarity=0.516  Sum_probs=198.5

Q ss_pred             cceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchh-hHHHHHHHHHHHHHHhhC-CCCCCC------------eEEEE
Q psy1546          58 IFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE-AEDEIEDIQQEIMVLSQC-DSPYGT------------KLWII  123 (604)
Q Consensus        58 ~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~-~~~~~~~l~~Ei~iL~~l-~hp~~~------------~lyLV  123 (604)
                      .|.+.+.||+|+||.||+|.+..+++.||||.+.... .......+.+|+.+++++ +|+++.            .+|+|
T Consensus         8 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~lv   87 (337)
T cd07852           8 KYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIYLV   87 (337)
T ss_pred             HHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEEEE
Confidence            4889999999999999999999999999999885431 223345677899999999 999743            35899


Q ss_pred             EEecCCCChhhHhhcCCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCC----
Q psy1546         124 MEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTS----  199 (604)
Q Consensus       124 mEy~~ggsL~~~l~~~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~----  199 (604)
                      |||++ ++|..++..+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+.....    
T Consensus        88 ~e~~~-~~L~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~~~~~~  166 (337)
T cd07852          88 FEYME-TDLHAVIRANILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPEN  166 (337)
T ss_pred             ecccc-cCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhccccccccccC
Confidence            99996 5899998887889999999999999999999999999999999999999999999999999976543321    


Q ss_pred             -CCcccccCCCCCChHHhhc-CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhc---------------------
Q psy1546         200 -KRNTFVGTPFWMAPEVIKQ-SAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLI---------------------  256 (604)
Q Consensus       200 -~~~~~~GT~~Y~APE~l~~-~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i---------------------  256 (604)
                       ......||+.|+|||++.+ ..++.++|||||||++|+|++|++||...........+                     
T Consensus       167 ~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (337)
T cd07852         167 PVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKSPFAA  246 (337)
T ss_pred             cchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHHhhhHH
Confidence             2234568999999998765 45788999999999999999999999765543221111                     


Q ss_pred             ------CCC---CCCCCCccchHHHHHHHHHHhccCCCCCCCHHHHhcChhhhhh
Q psy1546         257 ------PKN---NPPQLTGNYTKQFKEFVEACLNKDPENRPTAKELLKFPFIRKA  302 (604)
Q Consensus       257 ------~~~---~~~~~~~~~s~~l~~Li~~~L~~dP~~RpT~~elL~hp~f~~~  302 (604)
                            ...   ........++.++.+||.+||+.||.+|||+.++++||||++.
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~  301 (337)
T cd07852         247 TMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQF  301 (337)
T ss_pred             HhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhh
Confidence                  000   0112223468899999999999999999999999999999764

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=5.9e-37  Score=324.45  Aligned_cols=241  Identities=27%  Similarity=0.432  Sum_probs=195.3

Q ss_pred             cceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhh-HHHHHHHHHHHHHHhhCCCCCCC----------------eE
Q psy1546          58 IFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA-EDEIEDIQQEIMVLSQCDSPYGT----------------KL  120 (604)
Q Consensus        58 ~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~-~~~~~~l~~Ei~iL~~l~hp~~~----------------~l  120 (604)
                      .|.+.+.||+|+||.||+|.+..+++.||||++..... ......+.+|+.+++.+.|+++.                .+
T Consensus        16 ~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   95 (342)
T cd07879          16 RYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDF   95 (342)
T ss_pred             ceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCceE
Confidence            48899999999999999999999999999999865322 22235678999999999999853                24


Q ss_pred             EEEEEecCCCChhhHhhcCCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCCC
Q psy1546         121 WIIMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSK  200 (604)
Q Consensus       121 yLVmEy~~ggsL~~~l~~~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~  200 (604)
                      |+||||+. .+|..++ ...+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||+++....   .
T Consensus        96 ~lv~e~~~-~~l~~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~---~  170 (342)
T cd07879          96 YLVMPYMQ-TDLQKIM-GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHADA---E  170 (342)
T ss_pred             EEEecccc-cCHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCCCcCCCC---C
Confidence            79999995 4666655 34689999999999999999999999999999999999999999999999999865432   2


Q ss_pred             CcccccCCCCCChHHhhc-CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCC--------------------
Q psy1546         201 RNTFVGTPFWMAPEVIKQ-SAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKN--------------------  259 (604)
Q Consensus       201 ~~~~~GT~~Y~APE~l~~-~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~--------------------  259 (604)
                      .....+++.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+.......+...                    
T Consensus       171 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (342)
T cd07879         171 MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAAKSY  250 (342)
T ss_pred             CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcccchHHH
Confidence            234578899999999876 46889999999999999999999999876643332211100                    


Q ss_pred             ----------CCCCCCccchHHHHHHHHHHhccCCCCCCCHHHHhcChhhhhhh
Q psy1546         260 ----------NPPQLTGNYTKQFKEFVEACLNKDPENRPTAKELLKFPFIRKAK  303 (604)
Q Consensus       260 ----------~~~~~~~~~s~~l~~Li~~~L~~dP~~RpT~~elL~hp~f~~~~  303 (604)
                                ........++..+.+||.+||+.||.+||++.+++.||||....
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~  304 (342)
T cd07879         251 IKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFR  304 (342)
T ss_pred             HhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcc
Confidence                      00011124567899999999999999999999999999997654

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.5e-36  Score=306.64  Aligned_cols=236  Identities=28%  Similarity=0.458  Sum_probs=198.9

Q ss_pred             ccceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCCe----------EEEEEEe
Q psy1546          57 LIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTK----------LWIIMEY  126 (604)
Q Consensus        57 ~~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~~----------lyLVmEy  126 (604)
                      +.|.+.++||+|+||.||+|.+. .++.||||.+.....  ..+.+.+|+.+++.+.|+++.+          +|+||||
T Consensus         6 ~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   82 (261)
T cd05034           6 ESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTM--SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEY   82 (261)
T ss_pred             hheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCcc--CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEec
Confidence            34899999999999999999976 457799999875433  2356889999999999998544          4799999


Q ss_pred             cCCCChhhHhhc---CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCC-CCc
Q psy1546         127 LGGGSALDLMKA---GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTS-KRN  202 (604)
Q Consensus       127 ~~ggsL~~~l~~---~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~-~~~  202 (604)
                      +++++|.+++..   ..+++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||++..+..... ...
T Consensus        83 ~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~  162 (261)
T cd05034          83 MSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTARE  162 (261)
T ss_pred             cCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceeccchhhhhhh
Confidence            999999999865   3689999999999999999999999999999999999999999999999999976543211 111


Q ss_pred             ccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHhhhcCCCCCCCCCccchHHHHHHHHHHhc
Q psy1546         203 TFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAK-GEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLN  281 (604)
Q Consensus       203 ~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~~L~  281 (604)
                      ...++..|+|||.+.+..++.++|||||||++|+|++ |..||.+.........+........+..++..+.+++.+||.
T Consensus       163 ~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~  242 (261)
T cd05034         163 GAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMPRPPNCPEELYDLMLQCWD  242 (261)
T ss_pred             ccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcc
Confidence            2234578999999999899999999999999999998 999998887776666665554445556678999999999999


Q ss_pred             cCCCCCCCHHHHhc
Q psy1546         282 KDPENRPTAKELLK  295 (604)
Q Consensus       282 ~dP~~RpT~~elL~  295 (604)
                      .+|.+||++++++.
T Consensus       243 ~~p~~Rp~~~~l~~  256 (261)
T cd05034         243 KDPEERPTFEYLQS  256 (261)
T ss_pred             cCcccCCCHHHHHH
Confidence            99999999999875

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=7.9e-37  Score=310.14  Aligned_cols=232  Identities=29%  Similarity=0.498  Sum_probs=195.5

Q ss_pred             EEcccCcEEEEEEEECCCC------cEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCCe----------EEEEEEec
Q psy1546          64 RIGKGSFGEVFKGIDNRTQ------QVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTK----------LWIIMEYL  127 (604)
Q Consensus        64 ~LG~G~fG~Vy~a~~~~t~------~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~~----------lyLVmEy~  127 (604)
                      .||+|+||.||+|++....      +.||||.+...........+.+|+.+++.++||++.+          .|+||||+
T Consensus         2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~   81 (269)
T cd05044           2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELM   81 (269)
T ss_pred             ccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEecc
Confidence            5899999999999876544      7899999865544445677889999999999998654          47999999


Q ss_pred             CCCChhhHhhc--------CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCC-----CeEEecccccccc
Q psy1546         128 GGGSALDLMKA--------GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMG-----DVKLADFGVAGTL  194 (604)
Q Consensus       128 ~ggsL~~~l~~--------~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g-----~vKL~DFGlA~~~  194 (604)
                      ++++|.+++..        ..+++..+..++.||+.||.|||+++++|+||||+|||++.++     .++|+|||+++.+
T Consensus        82 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~~~  161 (269)
T cd05044          82 EGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDI  161 (269)
T ss_pred             CCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCccccccc
Confidence            99999998853        2378889999999999999999999999999999999999877     8999999999765


Q ss_pred             cCCCC--CCcccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHhhhcCCCCCCCCCccchHH
Q psy1546         195 TNTTS--KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAK-GEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQ  271 (604)
Q Consensus       195 ~~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~  271 (604)
                      .....  ......++..|+|||++.+..++.++|||||||++|+|++ |..||......+....+........+..++..
T Consensus       162 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (269)
T cd05044         162 YKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGGRLQKPENCPDK  241 (269)
T ss_pred             ccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcCCccCCcccchHH
Confidence            43221  1223356788999999999999999999999999999998 99999887777766665555555566778899


Q ss_pred             HHHHHHHHhccCCCCCCCHHHHhc
Q psy1546         272 FKEFVEACLNKDPENRPTAKELLK  295 (604)
Q Consensus       272 l~~Li~~~L~~dP~~RpT~~elL~  295 (604)
                      +.+||.+||..+|.+||++.+|++
T Consensus       242 ~~~li~~~l~~~p~~Rp~~~~i~~  265 (269)
T cd05044         242 IYQLMTNCWAQDPSERPTFDRIQE  265 (269)
T ss_pred             HHHHHHHHcCCCcccCCCHHHHHH
Confidence            999999999999999999999875

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=1.4e-36  Score=319.98  Aligned_cols=245  Identities=24%  Similarity=0.385  Sum_probs=195.5

Q ss_pred             ceeeeEEcccCcEEEEEEEECCC--CcEEEEEEecchhh-HHHHHHHHHHHHHHhhC-CCCCCCe--------------E
Q psy1546          59 FTKQERIGKGSFGEVFKGIDNRT--QQVVAIKIIDLEEA-EDEIEDIQQEIMVLSQC-DSPYGTK--------------L  120 (604)
Q Consensus        59 y~i~~~LG~G~fG~Vy~a~~~~t--~~~vAVK~i~~~~~-~~~~~~l~~Ei~iL~~l-~hp~~~~--------------l  120 (604)
                      |.+.+.||+|+||.||+|.+..+  +..||||.+..... ......+.+|+.+++++ .|+++.+              +
T Consensus         2 y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~   81 (332)
T cd07857           2 YELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNEL   81 (332)
T ss_pred             ceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCcE
Confidence            78899999999999999999888  89999999864322 22345677899999998 5887443              4


Q ss_pred             EEEEEecCCCChhhHhhc-CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCC
Q psy1546         121 WIIMEYLGGGSALDLMKA-GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTS  199 (604)
Q Consensus       121 yLVmEy~~ggsL~~~l~~-~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~  199 (604)
                      |+++||++ ++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||+++.+.....
T Consensus        82 ~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~  160 (332)
T cd07857          82 YLYEELME-ADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPG  160 (332)
T ss_pred             EEEEeccc-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceecccccc
Confidence            68889885 678887754 6789999999999999999999999999999999999999999999999999976543221


Q ss_pred             ----CCcccccCCCCCChHHhhc-CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcC-----------------
Q psy1546         200 ----KRNTFVGTPFWMAPEVIKQ-SAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIP-----------------  257 (604)
Q Consensus       200 ----~~~~~~GT~~Y~APE~l~~-~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~-----------------  257 (604)
                          ......||+.|+|||++.+ ..++.++|||||||++|+|++|.+||...........+.                 
T Consensus       161 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (332)
T cd07857         161 ENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIGSP  240 (332)
T ss_pred             cccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhhhhh
Confidence                1234578999999998865 468899999999999999999999998755322211100                 


Q ss_pred             ----------CCC---CCCCCccchHHHHHHHHHHhccCCCCCCCHHHHhcChhhhhhhh
Q psy1546         258 ----------KNN---PPQLTGNYTKQFKEFVEACLNKDPENRPTAKELLKFPFIRKAKK  304 (604)
Q Consensus       258 ----------~~~---~~~~~~~~s~~l~~Li~~~L~~dP~~RpT~~elL~hp~f~~~~~  304 (604)
                                ...   .......++..+.+|+.+||+.||.+|||+.+++.||||+++..
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~~~  300 (332)
T cd07857         241 KAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIWHD  300 (332)
T ss_pred             hHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhhcC
Confidence                      000   01122345788999999999999999999999999999976653

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=1.3e-36  Score=312.80  Aligned_cols=245  Identities=28%  Similarity=0.484  Sum_probs=199.3

Q ss_pred             ceeeeEEcccCcEEEEEEEEC---CCCcEEEEEEecchhh---HHHHHHHHHHHHHHhhC-CCCCCCe----------EE
Q psy1546          59 FTKQERIGKGSFGEVFKGIDN---RTQQVVAIKIIDLEEA---EDEIEDIQQEIMVLSQC-DSPYGTK----------LW  121 (604)
Q Consensus        59 y~i~~~LG~G~fG~Vy~a~~~---~t~~~vAVK~i~~~~~---~~~~~~l~~Ei~iL~~l-~hp~~~~----------ly  121 (604)
                      |++.+.||.|+||.||+|.+.   .+|+.||+|++.....   ....+.+.+|+.++..+ .|+++..          +|
T Consensus         2 y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~   81 (290)
T cd05613           2 FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLH   81 (290)
T ss_pred             ceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeEE
Confidence            788999999999999999875   4789999999865432   12346678899999999 5787543          47


Q ss_pred             EEEEecCCCChhhHhhc-CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCC-C
Q psy1546         122 IIMEYLGGGSALDLMKA-GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTT-S  199 (604)
Q Consensus       122 LVmEy~~ggsL~~~l~~-~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~-~  199 (604)
                      +||||+++++|.+++.. +.+++..+..++.||+.||.|||+.|++||||+|+|||++.++.+||+|||++....... .
T Consensus        82 lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~  161 (290)
T cd05613          82 LILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVE  161 (290)
T ss_pred             EEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceeccccccc
Confidence            99999999999998854 568999999999999999999999999999999999999999999999999997654322 2


Q ss_pred             CCcccccCCCCCChHHhhcC--CCCCcchhhhHHHHHHHHHhCCCCCCCCCh----hhHhhhcCCCCCCCCCccchHHHH
Q psy1546         200 KRNTFVGTPFWMAPEVIKQS--AYDSKADIWSLGITAIELAKGEPPNSELHP----MRVLFLIPKNNPPQLTGNYTKQFK  273 (604)
Q Consensus       200 ~~~~~~GT~~Y~APE~l~~~--~~~~~sDVwSLGviL~eLltG~~Pf~~~~~----~~~~~~i~~~~~~~~~~~~s~~l~  273 (604)
                      ......|+..|+|||.+.+.  .++.++||||||+++|+|++|..||.....    ......+.. ..+.++..++..+.
T Consensus       162 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~  240 (290)
T cd05613         162 RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILK-SEPPYPQEMSALAK  240 (290)
T ss_pred             ccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhc-cCCCCCccCCHHHH
Confidence            22346789999999998753  467889999999999999999999864322    222222222 22344566888999


Q ss_pred             HHHHHHhccCCCCCC-----CHHHHhcChhhhhhhh
Q psy1546         274 EFVEACLNKDPENRP-----TAKELLKFPFIRKAKK  304 (604)
Q Consensus       274 ~Li~~~L~~dP~~Rp-----T~~elL~hp~f~~~~~  304 (604)
                      +|+.+||..||.+||     ++.+++.||||.+..+
T Consensus       241 ~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~  276 (290)
T cd05613         241 DIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKINW  276 (290)
T ss_pred             HHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccCCH
Confidence            999999999999997     8999999999987653

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=9.6e-37  Score=311.37  Aligned_cols=240  Identities=29%  Similarity=0.478  Sum_probs=194.9

Q ss_pred             ceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchh-hHHHHHHHHHHHHHHhhCCCCCC------------CeEEEEEE
Q psy1546          59 FTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE-AEDEIEDIQQEIMVLSQCDSPYG------------TKLWIIME  125 (604)
Q Consensus        59 y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~-~~~~~~~l~~Ei~iL~~l~hp~~------------~~lyLVmE  125 (604)
                      |.+.+.||.|+||.||+|.+..+++.||+|++.... .......+.+|+.+++.+.|++.            ..+|+|||
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e   80 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE   80 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence            678899999999999999999999999999997653 22234567889999999999972            45789999


Q ss_pred             ecCCCChhhHhhc--CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCC-CCc
Q psy1546         126 YLGGGSALDLMKA--GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTS-KRN  202 (604)
Q Consensus       126 y~~ggsL~~~l~~--~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~-~~~  202 (604)
                      |+++ +|..++..  ..+++..++.++.||+.||.|||+.|++|+||+|+|||+++++.++|+|||++........ ...
T Consensus        81 ~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~  159 (287)
T cd07840          81 YMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYT  159 (287)
T ss_pred             cccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCccccc
Confidence            9974 78888765  4799999999999999999999999999999999999999999999999999976654321 122


Q ss_pred             ccccCCCCCChHHhhc-CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCCC-------C-------------
Q psy1546         203 TFVGTPFWMAPEVIKQ-SAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNN-------P-------------  261 (604)
Q Consensus       203 ~~~GT~~Y~APE~l~~-~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~~-------~-------------  261 (604)
                      ...++..|+|||.+.+ ..++.++|||||||++|+|++|..||...........+....       .             
T Consensus       160 ~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (287)
T cd07840         160 NRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFENLK  239 (287)
T ss_pred             ccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhhhcc
Confidence            3457889999998765 457889999999999999999999998766543322211100       0             


Q ss_pred             ----------CCCCccchHHHHHHHHHHhccCCCCCCCHHHHhcChhh
Q psy1546         262 ----------PQLTGNYTKQFKEFVEACLNKDPENRPTAKELLKFPFI  299 (604)
Q Consensus       262 ----------~~~~~~~s~~l~~Li~~~L~~dP~~RpT~~elL~hp~f  299 (604)
                                ..+...++..+.+++.+||..+|.+||++.+++.||||
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~  287 (287)
T cd07840         240 PKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF  287 (287)
T ss_pred             ccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence                      00111137889999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=2.3e-36  Score=304.46  Aligned_cols=236  Identities=28%  Similarity=0.430  Sum_probs=197.7

Q ss_pred             cceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCCe----------EEEEEEec
Q psy1546          58 IFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTK----------LWIIMEYL  127 (604)
Q Consensus        58 ~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~~----------lyLVmEy~  127 (604)
                      .|++.+.||+|+||.||+|.+. .+..+|+|++......  ...+.+|+.+++++.||++.+          +|+||||+
T Consensus         5 ~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~~--~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   81 (256)
T cd05112           5 ELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAMS--EEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFM   81 (256)
T ss_pred             HeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCCC--HHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcC
Confidence            3788999999999999999875 4678999998654332  246788999999999998544          47999999


Q ss_pred             CCCChhhHhhc--CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCCC-Cccc
Q psy1546         128 GGGSALDLMKA--GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSK-RNTF  204 (604)
Q Consensus       128 ~ggsL~~~l~~--~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~-~~~~  204 (604)
                      .+++|.+++..  +.+++..+..++.|++.||.|||+.+++||||||+||+++.++.++|+|||++......... ....
T Consensus        82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~~~  161 (256)
T cd05112          82 EHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGT  161 (256)
T ss_pred             CCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccCcccccCCC
Confidence            99999999864  46899999999999999999999999999999999999999999999999998755432211 1223


Q ss_pred             ccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHhhhcCCCCCCCCCccchHHHHHHHHHHhccC
Q psy1546         205 VGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAK-GEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKD  283 (604)
Q Consensus       205 ~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~~L~~d  283 (604)
                      .++..|+|||++.+..++.++|||||||++|||++ |..||...........+..+.....+...+..+.+|+.+||..+
T Consensus       162 ~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~  241 (256)
T cd05112         162 KFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYKPRLASQSVYELMQHCWKER  241 (256)
T ss_pred             ccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHHcccC
Confidence            35678999999998889999999999999999998 99999887776666666554444445567899999999999999


Q ss_pred             CCCCCCHHHHhcC
Q psy1546         284 PENRPTAKELLKF  296 (604)
Q Consensus       284 P~~RpT~~elL~h  296 (604)
                      |++|||+.+++++
T Consensus       242 p~~Rp~~~~~l~~  254 (256)
T cd05112         242 PEDRPSFSLLLHQ  254 (256)
T ss_pred             hhhCCCHHHHHHh
Confidence            9999999999873

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=2.7e-36  Score=311.95  Aligned_cols=245  Identities=35%  Similarity=0.622  Sum_probs=195.1

Q ss_pred             cceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhC-CCCCCC----------eEEEEEEe
Q psy1546          58 IFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQC-DSPYGT----------KLWIIMEY  126 (604)
Q Consensus        58 ~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l-~hp~~~----------~lyLVmEy  126 (604)
                      .|.+.+.||+|+||.||+|.+..+++.||||++...........+.+|+.++... .|+++.          .+|+||||
T Consensus        16 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~   95 (296)
T cd06618          16 DLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICMEL   95 (296)
T ss_pred             hheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEeec
Confidence            3899999999999999999999999999999997654444445566677666555 488743          45899999


Q ss_pred             cCCCChhhHhhc--CCCcHHHHHHHHHHHHHHhHHhhh-CCccccccccceeEecCCCCeEEecccccccccCCCCCCcc
Q psy1546         127 LGGGSALDLMKA--GNFEEMHIAVILREVLKGLDYLHS-ERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNT  203 (604)
Q Consensus       127 ~~ggsL~~~l~~--~~lse~~i~~i~~qIl~gL~yLHs-~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~~~~  203 (604)
                      +. ++|..++..  +.+++..+..++.||+.||.|||+ .||+||||+|+|||++.++.+||+|||++..+..... ...
T Consensus        96 ~~-~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~~-~~~  173 (296)
T cd06618          96 MS-TCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKA-KTR  173 (296)
T ss_pred             cC-cCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchhccCCCc-ccC
Confidence            84 567776644  568999999999999999999997 5999999999999999999999999999976543322 223


Q ss_pred             cccCCCCCChHHhhcCC----CCCcchhhhHHHHHHHHHhCCCCCCCCCh-hhHhhhcCCCCCCCC--CccchHHHHHHH
Q psy1546         204 FVGTPFWMAPEVIKQSA----YDSKADIWSLGITAIELAKGEPPNSELHP-MRVLFLIPKNNPPQL--TGNYTKQFKEFV  276 (604)
Q Consensus       204 ~~GT~~Y~APE~l~~~~----~~~~sDVwSLGviL~eLltG~~Pf~~~~~-~~~~~~i~~~~~~~~--~~~~s~~l~~Li  276 (604)
                      ..++..|+|||++.+..    ++.++||||||+++|+|++|..||..... .+....+.....+.+  ...++.++.+||
T Consensus       174 ~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  253 (296)
T cd06618         174 SAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSLPPNEGFSPDFCSFV  253 (296)
T ss_pred             CCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCCCCCCCCCCCCHHHHHHH
Confidence            45788999999997554    78899999999999999999999976432 223322222222222  224788999999


Q ss_pred             HHHhccCCCCCCCHHHHhcChhhhhhhh
Q psy1546         277 EACLNKDPENRPTAKELLKFPFIRKAKK  304 (604)
Q Consensus       277 ~~~L~~dP~~RpT~~elL~hp~f~~~~~  304 (604)
                      .+||..||.+||+++++++||||.....
T Consensus       254 ~~~l~~~p~~Rp~~~~il~~~~~~~~~~  281 (296)
T cd06618         254 DLCLTKDHRKRPKYRELLQHPFIRRYET  281 (296)
T ss_pred             HHHccCChhhCCCHHHHhcChhhhccch
Confidence            9999999999999999999999976543

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>KOG0662|consensus

Probab=100.00  E-value=4.1e-38  Score=293.16  Aligned_cols=243  Identities=26%  Similarity=0.455  Sum_probs=202.1

Q ss_pred             ceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHH-HHHHHHHHHHHhhCCCCCCCeE----------EEEEEec
Q psy1546          59 FTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDE-IEDIQQEIMVLSQCDSPYGTKL----------WIIMEYL  127 (604)
Q Consensus        59 y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~-~~~l~~Ei~iL~~l~hp~~~~l----------yLVmEy~  127 (604)
                      |...++||+|.||+||+|++..+++.||+|.+......+- -....+||-+|+.++|.|++++          -+|+|||
T Consensus         4 ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~c   83 (292)
T KOG0662|consen    4 YDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFC   83 (292)
T ss_pred             hHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHHh
Confidence            6778899999999999999999999999999976654332 3567899999999999997765          5999999


Q ss_pred             CCCChhhHhh--cCCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCCCCcccc
Q psy1546         128 GGGSALDLMK--AGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFV  205 (604)
Q Consensus       128 ~ggsL~~~l~--~~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~~~~~~  205 (604)
                       ..+|..+..  +|.++...++.++.|+++||.|+|++++.||||||.|+||..+|.+||+|||+|+-++-+.......+
T Consensus        84 -dqdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgipvrcysaev  162 (292)
T KOG0662|consen   84 -DQDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYSAEV  162 (292)
T ss_pred             -hHHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCCceEeeecee
Confidence             455777765  48899999999999999999999999999999999999999999999999999998876665556667


Q ss_pred             cCCCCCChHHhhcCC-CCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHhhhcCCC-------CCC------------CC
Q psy1546         206 GTPFWMAPEVIKQSA-YDSKADIWSLGITAIELAK-GEPPNSELHPMRVLFLIPKN-------NPP------------QL  264 (604)
Q Consensus       206 GT~~Y~APE~l~~~~-~~~~sDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~~i~~~-------~~~------------~~  264 (604)
                      -|.+|++|.++.+.+ |+...|+||.|||+.|+.. |.+.|.+.+..+.+..|...       ..+            .+
T Consensus       163 vtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~yp~y  242 (292)
T KOG0662|consen  163 VTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKPYPIY  242 (292)
T ss_pred             eeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCcccCCc
Confidence            899999999998765 8899999999999999986 78889988776655543211       011            00


Q ss_pred             C---------ccchHHHHHHHHHHhccCCCCCCCHHHHhcChhhhhh
Q psy1546         265 T---------GNYTKQFKEFVEACLNKDPENRPTAKELLKFPFIRKA  302 (604)
Q Consensus       265 ~---------~~~s~~l~~Li~~~L~~dP~~RpT~~elL~hp~f~~~  302 (604)
                      +         +.+...-++|++++|..+|.+|++++++|+||||...
T Consensus       243 pattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d~  289 (292)
T KOG0662|consen  243 PATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSDF  289 (292)
T ss_pred             cccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCcccccc
Confidence            1         1122345799999999999999999999999999653

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=2.6e-36  Score=307.67  Aligned_cols=239  Identities=22%  Similarity=0.419  Sum_probs=199.1

Q ss_pred             cceeeeEEcccCcEEEEEEEECC-----CCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCCe----------EEE
Q psy1546          58 IFTKQERIGKGSFGEVFKGIDNR-----TQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTK----------LWI  122 (604)
Q Consensus        58 ~y~i~~~LG~G~fG~Vy~a~~~~-----t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~~----------lyL  122 (604)
                      .|.+.+.||.|+||.||+|+.+.     +.+.||+|.+...........+.+|+.+++++.|+++.+          .|+
T Consensus         6 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   85 (275)
T cd05046           6 NLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHYM   85 (275)
T ss_pred             hceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcceE
Confidence            48889999999999999999653     356799999876555545678899999999999998554          379


Q ss_pred             EEEecCCCChhhHhhcC----------CCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccc
Q psy1546         123 IMEYLGGGSALDLMKAG----------NFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAG  192 (604)
Q Consensus       123 VmEy~~ggsL~~~l~~~----------~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~  192 (604)
                      ||||+++|+|.+++...          .+++..+..++.||+.||+|||++||+||||||+|||++.++.++|+|||++.
T Consensus        86 v~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~~~~~~~  165 (275)
T cd05046          86 ILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLSK  165 (275)
T ss_pred             EEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEEccccccc
Confidence            99999999999998642          48999999999999999999999999999999999999999999999999986


Q ss_pred             cccCCC-CCCcccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHhhhcCCCC-CCCCCccch
Q psy1546         193 TLTNTT-SKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAK-GEPPNSELHPMRVLFLIPKNN-PPQLTGNYT  269 (604)
Q Consensus       193 ~~~~~~-~~~~~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~~i~~~~-~~~~~~~~s  269 (604)
                      ...... .......++..|+|||.+.+..++.++||||||+++|+|++ |..||...........+.... .......++
T Consensus       166 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (275)
T cd05046         166 DVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLELPVPEGCP  245 (275)
T ss_pred             ccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcCCcCCCCCCCCC
Confidence            543221 12233456788999999988888999999999999999998 888998766655555544332 123345678


Q ss_pred             HHHHHHHHHHhccCCCCCCCHHHHhcC
Q psy1546         270 KQFKEFVEACLNKDPENRPTAKELLKF  296 (604)
Q Consensus       270 ~~l~~Li~~~L~~dP~~RpT~~elL~h  296 (604)
                      ..+.+++.+||..+|.+|||+.|++.+
T Consensus       246 ~~l~~~i~~~l~~~p~~Rp~~~~~l~~  272 (275)
T cd05046         246 SRLYKLMTRCWAVNPKDRPSFSELVSA  272 (275)
T ss_pred             HHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence            999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=2.6e-36  Score=309.42  Aligned_cols=238  Identities=27%  Similarity=0.470  Sum_probs=190.8

Q ss_pred             ccceeeeEEcccCcEEEEEEE----ECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCCe------------E
Q psy1546          57 LIFTKQERIGKGSFGEVFKGI----DNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTK------------L  120 (604)
Q Consensus        57 ~~y~i~~~LG~G~fG~Vy~a~----~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~~------------l  120 (604)
                      ..|.+.+.||+|+||.||+|.    +..++..||||.+.... ....+.+.+|+.+++.++||+..+            +
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   82 (284)
T cd05081           4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHST-AEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL   82 (284)
T ss_pred             ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCC-HHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCce
Confidence            358899999999999999997    44578899999986543 344577889999999999998543            4


Q ss_pred             EEEEEecCCCChhhHhhc--CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCC
Q psy1546         121 WIIMEYLGGGSALDLMKA--GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTT  198 (604)
Q Consensus       121 yLVmEy~~ggsL~~~l~~--~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~  198 (604)
                      |+||||+++++|.+++..  +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+....
T Consensus        83 ~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~  162 (284)
T cd05081          83 RLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDK  162 (284)
T ss_pred             EEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCcccccccCCC
Confidence            799999999999999864  458999999999999999999999999999999999999999999999999997654322


Q ss_pred             CC---CcccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChh----------------hHhhhcCCC
Q psy1546         199 SK---RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPM----------------RVLFLIPKN  259 (604)
Q Consensus       199 ~~---~~~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~----------------~~~~~i~~~  259 (604)
                      ..   .....++..|+|||++.+..++.++|||||||++|||++|..++......                .....+...
T Consensus       163 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (284)
T cd05081         163 EYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLKNN  242 (284)
T ss_pred             cceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHHHhcC
Confidence            21   11122445699999999889999999999999999999987765432211                001111122


Q ss_pred             CCCCCCccchHHHHHHHHHHhccCCCCCCCHHHHhc
Q psy1546         260 NPPQLTGNYTKQFKEFVEACLNKDPENRPTAKELLK  295 (604)
Q Consensus       260 ~~~~~~~~~s~~l~~Li~~~L~~dP~~RpT~~elL~  295 (604)
                      .....+..++..+.+|+.+||..+|++|||+.||++
T Consensus       243 ~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  278 (284)
T cd05081         243 GRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELAL  278 (284)
T ss_pred             CcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            222344567889999999999999999999999976

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=1.3e-36  Score=314.04  Aligned_cols=241  Identities=29%  Similarity=0.475  Sum_probs=193.9

Q ss_pred             cceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhH-HHHHHHHHHHHHHhhCCCCCCC------------------
Q psy1546          58 IFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAE-DEIEDIQQEIMVLSQCDSPYGT------------------  118 (604)
Q Consensus        58 ~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~-~~~~~l~~Ei~iL~~l~hp~~~------------------  118 (604)
                      .|.+.+.||+|+||.||+|.+..+++.||||++...... .....+.+|+.+++.++||+..                  
T Consensus         8 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~~~   87 (302)
T cd07864           8 KFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFKKD   87 (302)
T ss_pred             hhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhcccc
Confidence            388999999999999999999999999999998654322 2235667899999999999844                  


Q ss_pred             --eEEEEEEecCCCChhhHhhc--CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccc
Q psy1546         119 --KLWIIMEYLGGGSALDLMKA--GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTL  194 (604)
Q Consensus       119 --~lyLVmEy~~ggsL~~~l~~--~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~  194 (604)
                        .+|+||||+++ ++..++..  ..+++..+..++.||+.||.|||+.||+||||||+||++++++.+||+|||++..+
T Consensus        88 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~  166 (302)
T cd07864          88 KGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLY  166 (302)
T ss_pred             CCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCcccccccc
Confidence              46799999976 56666653  46899999999999999999999999999999999999999999999999999766


Q ss_pred             cCCCC-CCcccccCCCCCChHHhhcC-CCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCC---CC--------
Q psy1546         195 TNTTS-KRNTFVGTPFWMAPEVIKQS-AYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKN---NP--------  261 (604)
Q Consensus       195 ~~~~~-~~~~~~GT~~Y~APE~l~~~-~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~---~~--------  261 (604)
                      ..... ......++..|+|||++.+. .++.++|||||||++|+|++|.+||........+..+...   ..        
T Consensus       167 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (302)
T cd07864         167 NSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAVWPDVI  246 (302)
T ss_pred             cCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhccccc
Confidence            43332 11223567889999988653 5788999999999999999999999876544332211110   00        


Q ss_pred             ------------------CCCCccchHHHHHHHHHHhccCCCCCCCHHHHhcChhh
Q psy1546         262 ------------------PQLTGNYTKQFKEFVEACLNKDPENRPTAKELLKFPFI  299 (604)
Q Consensus       262 ------------------~~~~~~~s~~l~~Li~~~L~~dP~~RpT~~elL~hp~f  299 (604)
                                        ......++..+.+||.+||..||.+|||+.+++.||||
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~  302 (302)
T cd07864         247 KLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL  302 (302)
T ss_pred             ccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence                              00122467899999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=2.3e-36  Score=304.74  Aligned_cols=230  Identities=27%  Similarity=0.465  Sum_probs=196.7

Q ss_pred             cceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCCeE---------EEEEEecC
Q psy1546          58 IFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTKL---------WIIMEYLG  128 (604)
Q Consensus        58 ~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~~l---------yLVmEy~~  128 (604)
                      .|++.+.||+|+||.||+|.  .+++.||+|++....   ....+.+|+.+++.++|++..++         |+||||+.
T Consensus         7 ~~~~~~~lg~g~~g~v~~~~--~~~~~~~iK~~~~~~---~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~v~e~~~   81 (254)
T cd05083           7 KLTLGEIIGEGEFGAVLQGE--YTGQKVAVKNIKCDV---TAQAFLEETAVMTKLHHKNLVRLLGVILHNGLYIVMELMS   81 (254)
T ss_pred             HceeeeeeccCCCCceEecc--cCCCceEEEeecCcc---hHHHHHHHHHHHHhCCCCCcCeEEEEEcCCCcEEEEECCC
Confidence            38999999999999999986  467889999986543   23567889999999999986654         69999999


Q ss_pred             CCChhhHhhc---CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCCCCcccc
Q psy1546         129 GGSALDLMKA---GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFV  205 (604)
Q Consensus       129 ggsL~~~l~~---~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~~~~~~  205 (604)
                      +++|.+++..   ..+++..+..++.||+.||.|||+.|++||||||+|||++.++.++|+|||++......   .....
T Consensus        82 ~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~---~~~~~  158 (254)
T cd05083          82 KGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG---VDNSK  158 (254)
T ss_pred             CCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceecccc---CCCCC
Confidence            9999999865   24788999999999999999999999999999999999999999999999998654322   12233


Q ss_pred             cCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHhhhcCCCCCCCCCccchHHHHHHHHHHhccCC
Q psy1546         206 GTPFWMAPEVIKQSAYDSKADIWSLGITAIELAK-GEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDP  284 (604)
Q Consensus       206 GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~~L~~dP  284 (604)
                      .+..|+|||++.+..++.++|||||||++|+|++ |.+||......+....+........+..++..+.+|+.+||..+|
T Consensus       159 ~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p  238 (254)
T cd05083         159 LPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRMEPPEGCPADVYVLMTSCWETEP  238 (254)
T ss_pred             CCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHHcCCCh
Confidence            4577999999998899999999999999999997 999999887776666665555555566788999999999999999


Q ss_pred             CCCCCHHHHhc
Q psy1546         285 ENRPTAKELLK  295 (604)
Q Consensus       285 ~~RpT~~elL~  295 (604)
                      .+||++.+|+.
T Consensus       239 ~~Rp~~~~l~~  249 (254)
T cd05083         239 KKRPSFHKLRE  249 (254)
T ss_pred             hhCcCHHHHHH
Confidence            99999999976

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=1.6e-36  Score=328.63  Aligned_cols=238  Identities=26%  Similarity=0.438  Sum_probs=195.6

Q ss_pred             ceeeeEEcccCcEEEEEEEEC-----CCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCC-CCCCCeE----------EE
Q psy1546          59 FTKQERIGKGSFGEVFKGIDN-----RTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCD-SPYGTKL----------WI  122 (604)
Q Consensus        59 y~i~~~LG~G~fG~Vy~a~~~-----~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~-hp~~~~l----------yL  122 (604)
                      |.+.++||+|+||.||+|++.     .+++.||||++.........+.+.+|+.+|..+. |||++++          |+
T Consensus        39 ~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~~~i  118 (401)
T cd05107          39 LVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGPIYI  118 (401)
T ss_pred             eehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCCcEE
Confidence            778899999999999999854     3557899999976544444567889999999998 9986554          79


Q ss_pred             EEEecCCCChhhHhhcC---------------------------------------------------------------
Q psy1546         123 IMEYLGGGSALDLMKAG---------------------------------------------------------------  139 (604)
Q Consensus       123 VmEy~~ggsL~~~l~~~---------------------------------------------------------------  139 (604)
                      |||||.+|+|.+++...                                                               
T Consensus       119 v~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  198 (401)
T cd05107         119 ITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDMKGT  198 (401)
T ss_pred             EEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcchhh
Confidence            99999999999988532                                                               


Q ss_pred             ------------------------------------CCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCe
Q psy1546         140 ------------------------------------NFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDV  183 (604)
Q Consensus       140 ------------------------------------~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~v  183 (604)
                                                          .+++..+..|+.||+.||.|||+.+|+||||||+|||++.++.+
T Consensus       199 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~NiLl~~~~~~  278 (401)
T cd05107         199 VKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLICEGKLV  278 (401)
T ss_pred             hhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceEEEeCCCEE
Confidence                                                24566778899999999999999999999999999999999999


Q ss_pred             EEecccccccccCCCC--CCcccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHh-hhcCCC
Q psy1546         184 KLADFGVAGTLTNTTS--KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAK-GEPPNSELHPMRVL-FLIPKN  259 (604)
Q Consensus       184 KL~DFGlA~~~~~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLlt-G~~Pf~~~~~~~~~-~~i~~~  259 (604)
                      ||+|||+++.+.....  ......+++.|||||++.+..++.++|||||||++|||++ |..||......+.. ..+..+
T Consensus       279 kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~~~~~~~~  358 (401)
T cd05107         279 KICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNAIKRG  358 (401)
T ss_pred             EEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHHcC
Confidence            9999999976532221  1223457889999999998889999999999999999998 89999775544432 223333


Q ss_pred             CCCCCCccchHHHHHHHHHHhccCCCCCCCHHHHhcC
Q psy1546         260 NPPQLTGNYTKQFKEFVEACLNKDPENRPTAKELLKF  296 (604)
Q Consensus       260 ~~~~~~~~~s~~l~~Li~~~L~~dP~~RpT~~elL~h  296 (604)
                      .....+..++.++.+|+.+||..+|.+||++.+|++.
T Consensus       359 ~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~  395 (401)
T cd05107         359 YRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHL  395 (401)
T ss_pred             CCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            3444566788999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=6.2e-36  Score=302.97  Aligned_cols=236  Identities=26%  Similarity=0.442  Sum_probs=197.7

Q ss_pred             ccceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCCeE---------EEEEEec
Q psy1546          57 LIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTKL---------WIIMEYL  127 (604)
Q Consensus        57 ~~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~~l---------yLVmEy~  127 (604)
                      ..|.+.++||+|+||.||+|.+. .+..||+|.+....  .....+.+|+.+++.+.|+++.++         |+||||+
T Consensus         6 ~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~v~e~~   82 (260)
T cd05073           6 ESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGS--MSVEAFLAEANVMKTLQHDKLVKLHAVVTKEPIYIITEFM   82 (260)
T ss_pred             cceeEEeEecCccceEEEEEEec-CCccEEEEecCCCh--hHHHHHHHHHHHHHhcCCCCcceEEEEEcCCCeEEEEEeC
Confidence            34899999999999999999865 45569999886543  234678889999999999986654         7999999


Q ss_pred             CCCChhhHhhc---CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCC-CCcc
Q psy1546         128 GGGSALDLMKA---GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTS-KRNT  203 (604)
Q Consensus       128 ~ggsL~~~l~~---~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~-~~~~  203 (604)
                      ++++|.+++..   ..+++..+..++.||+.||.|||+.|++||||||+||+++.++.+||+|||++..+..... ....
T Consensus        83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~  162 (260)
T cd05073          83 AKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREG  162 (260)
T ss_pred             CCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeeccCCCcccccC
Confidence            99999999865   3478888999999999999999999999999999999999999999999999976543221 1122


Q ss_pred             cccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHhhhcCCCCCCCCCccchHHHHHHHHHHhcc
Q psy1546         204 FVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAK-GEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNK  282 (604)
Q Consensus       204 ~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~~L~~  282 (604)
                      ..++..|+|||++....++.++|||||||++|+|++ |..||...+.......+...........++.++.+++.+||..
T Consensus       163 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~  242 (260)
T cd05073         163 AKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELYNIMMRCWKN  242 (260)
T ss_pred             CcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCCCCCcccCCHHHHHHHHHHccc
Confidence            345677999999998889999999999999999998 9999988777666655555544455667889999999999999


Q ss_pred             CCCCCCCHHHHhc
Q psy1546         283 DPENRPTAKELLK  295 (604)
Q Consensus       283 dP~~RpT~~elL~  295 (604)
                      +|++||++.+++.
T Consensus       243 ~p~~Rp~~~~l~~  255 (260)
T cd05073         243 RPEERPTFEYIQS  255 (260)
T ss_pred             CcccCcCHHHHHH
Confidence            9999999999875

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=9.1e-37  Score=321.24  Aligned_cols=243  Identities=26%  Similarity=0.418  Sum_probs=194.2

Q ss_pred             ce-eeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHH-------------HHHHHHHHHHHhhCCCCCCCe-----
Q psy1546          59 FT-KQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDE-------------IEDIQQEIMVLSQCDSPYGTK-----  119 (604)
Q Consensus        59 y~-i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~-------------~~~l~~Ei~iL~~l~hp~~~~-----  119 (604)
                      |. +.+.||.|+||+||+|.+..+++.||||++........             ...+.+|+.+++.+.|+++.+     
T Consensus        10 y~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~   89 (335)
T PTZ00024         10 YIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVY   89 (335)
T ss_pred             hhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEE
Confidence            54 45779999999999999999999999999864432210             124678999999999998543     


Q ss_pred             -----EEEEEEecCCCChhhHhhc-CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEeccccccc
Q psy1546         120 -----LWIIMEYLGGGSALDLMKA-GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGT  193 (604)
Q Consensus       120 -----lyLVmEy~~ggsL~~~l~~-~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~  193 (604)
                           +|+||||+. ++|.+++.. ..+++..+..++.||+.||.|||++||+||||+|+|||++.++.++|+|||++..
T Consensus        90 ~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl~dfg~~~~  168 (335)
T PTZ00024         90 VEGDFINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARR  168 (335)
T ss_pred             ecCCcEEEEEeccc-cCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEECCccceee
Confidence                 479999996 578888755 5799999999999999999999999999999999999999999999999999976


Q ss_pred             ccC--------------CCCCCcccccCCCCCChHHhhcC-CCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCC
Q psy1546         194 LTN--------------TTSKRNTFVGTPFWMAPEVIKQS-AYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPK  258 (604)
Q Consensus       194 ~~~--------------~~~~~~~~~GT~~Y~APE~l~~~-~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~  258 (604)
                      +..              .........+++.|+|||++.+. .++.++|||||||++|+|++|.+||...+..+....+..
T Consensus       169 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~i~~  248 (335)
T PTZ00024        169 YGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRIFE  248 (335)
T ss_pred             cccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence            541              11122234578899999998764 468899999999999999999999987765543322110


Q ss_pred             ----CC--------------------C---CCCCccchHHHHHHHHHHhccCCCCCCCHHHHhcChhhhhh
Q psy1546         259 ----NN--------------------P---PQLTGNYTKQFKEFVEACLNKDPENRPTAKELLKFPFIRKA  302 (604)
Q Consensus       259 ----~~--------------------~---~~~~~~~s~~l~~Li~~~L~~dP~~RpT~~elL~hp~f~~~  302 (604)
                          ..                    +   ......++..+.++|.+||..+|.+|||++|+|.||||+..
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~~~  319 (335)
T PTZ00024        249 LLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFKSD  319 (335)
T ss_pred             HhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcccCCC
Confidence                00                    0   01123457889999999999999999999999999999754

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=3.3e-36  Score=306.21  Aligned_cols=231  Identities=27%  Similarity=0.447  Sum_probs=183.8

Q ss_pred             EEcccCcEEEEEEEECC--CCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCCe----------EEEEEEecCCCC
Q psy1546          64 RIGKGSFGEVFKGIDNR--TQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTK----------LWIIMEYLGGGS  131 (604)
Q Consensus        64 ~LG~G~fG~Vy~a~~~~--t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~~----------lyLVmEy~~ggs  131 (604)
                      .||+|+||.||+|....  ....+|+|.+...........+.+|+.+++.++|+|+.+          +|+||||+.+|+
T Consensus         2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~   81 (269)
T cd05042           2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD   81 (269)
T ss_pred             cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence            58999999999996432  445789998765544445567889999999999999765          479999999999


Q ss_pred             hhhHhhcC------CCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCC--CCcc
Q psy1546         132 ALDLMKAG------NFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTS--KRNT  203 (604)
Q Consensus       132 L~~~l~~~------~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~--~~~~  203 (604)
                      |.+++...      .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++........  ....
T Consensus        82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~  161 (269)
T cd05042          82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDC  161 (269)
T ss_pred             HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccchheeccCC
Confidence            99998652      246777889999999999999999999999999999999999999999999865432211  1223


Q ss_pred             cccCCCCCChHHhhc-------CCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHhhhcCCCC-----CCCCCccchH
Q psy1546         204 FVGTPFWMAPEVIKQ-------SAYDSKADIWSLGITAIELAK-GEPPNSELHPMRVLFLIPKNN-----PPQLTGNYTK  270 (604)
Q Consensus       204 ~~GT~~Y~APE~l~~-------~~~~~~sDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~~i~~~~-----~~~~~~~~s~  270 (604)
                      ..+++.|+|||++..       ..++.++|||||||++|||++ |..||...........+....     .+.+...++.
T Consensus       162 ~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (269)
T cd05042         162 HAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQLDLKYSD  241 (269)
T ss_pred             CCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCCcccccCCH
Confidence            346778999999853       346789999999999999999 888998776655444322221     2334556788


Q ss_pred             HHHHHHHHHhccCCCCCCCHHHHhc
Q psy1546         271 QFKEFVEACLNKDPENRPTAKELLK  295 (604)
Q Consensus       271 ~l~~Li~~~L~~dP~~RpT~~elL~  295 (604)
                      .+.+++..|| .||++|||+++|++
T Consensus       242 ~~~~~~~~~~-~dp~~Rpt~~~v~~  265 (269)
T cd05042         242 RWYEVMQFCW-LDPETRPTAEEVHE  265 (269)
T ss_pred             HHHHHHHHHh-cCcccccCHHHHHH
Confidence            9999999999 59999999999986

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1e-36  Score=339.41  Aligned_cols=245  Identities=22%  Similarity=0.333  Sum_probs=181.5

Q ss_pred             cceeeeEEcccCcEEEEEEEECCC-CcEEEEEEe--------------cc--hhhHHHHHHHHHHHHHHhhCCCCCCCeE
Q psy1546          58 IFTKQERIGKGSFGEVFKGIDNRT-QQVVAIKII--------------DL--EEAEDEIEDIQQEIMVLSQCDSPYGTKL  120 (604)
Q Consensus        58 ~y~i~~~LG~G~fG~Vy~a~~~~t-~~~vAVK~i--------------~~--~~~~~~~~~l~~Ei~iL~~l~hp~~~~l  120 (604)
                      .|.++++||+|+||+||+|..+.. +..+++|.+              .+  .........+.+|+.+|++++|+|++++
T Consensus       149 ~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l  228 (501)
T PHA03210        149 HFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENILKI  228 (501)
T ss_pred             ccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcCcE
Confidence            499999999999999999876532 222222211              00  0111234567899999999999997664


Q ss_pred             ----------EEEEEecCCCChhhHhhcCC------CcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeE
Q psy1546         121 ----------WIIMEYLGGGSALDLMKAGN------FEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVK  184 (604)
Q Consensus       121 ----------yLVmEy~~ggsL~~~l~~~~------lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vK  184 (604)
                                |+|+|++. ++|..++..+.      .....++.|+.||+.||.|||++|||||||||+||||+.++.+|
T Consensus       229 ~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~~~vk  307 (501)
T PHA03210        229 EEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIV  307 (501)
T ss_pred             eEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEE
Confidence                      68999984 56666664332      34566788999999999999999999999999999999999999


Q ss_pred             EecccccccccCCCC-CCcccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCC-CCCCC--hh-hHhhhcC--
Q psy1546         185 LADFGVAGTLTNTTS-KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPP-NSELH--PM-RVLFLIP--  257 (604)
Q Consensus       185 L~DFGlA~~~~~~~~-~~~~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~P-f~~~~--~~-~~~~~i~--  257 (604)
                      |+|||+++.+..... .....+||+.|+|||++.+..|+.++|||||||+||||++|..+ |....  .. .....+.  
T Consensus       308 L~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~~~~~~  387 (501)
T PHA03210        308 LGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKIIDSL  387 (501)
T ss_pred             EEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHHHHHhc
Confidence            999999977654322 23356899999999999999999999999999999999998754 43221  11 1111000  


Q ss_pred             -------------------CCCC----CCC-----CccchHHHHHHHHHHhccCCCCCCCHHHHhcChhhhhhh
Q psy1546         258 -------------------KNNP----PQL-----TGNYTKQFKEFVEACLNKDPENRPTAKELLKFPFIRKAK  303 (604)
Q Consensus       258 -------------------~~~~----~~~-----~~~~s~~l~~Li~~~L~~dP~~RpT~~elL~hp~f~~~~  303 (604)
                                         ....    ..+     ...++..+.++|.+||..||.+|||+.|+|.||||....
T Consensus       388 ~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f~~~~  461 (501)
T PHA03210        388 SVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLFSAEE  461 (501)
T ss_pred             ccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChhhhcCC
Confidence                               0000    000     012456788899999999999999999999999997654

>KOG1035|consensus

Probab=100.00  E-value=2.5e-37  Score=351.42  Aligned_cols=241  Identities=30%  Similarity=0.499  Sum_probs=197.7

Q ss_pred             cceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCC-------------------
Q psy1546          58 IFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGT-------------------  118 (604)
Q Consensus        58 ~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~-------------------  118 (604)
                      .|+.++.||+||||.||+|+++-+|+.||||.|...........+.+|+.+|.+|+|||.+                   
T Consensus       480 DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ei~  559 (1351)
T KOG1035|consen  480 DFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLEIV  559 (1351)
T ss_pred             hhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccccccc
Confidence            3888899999999999999999999999999998877666778899999999999998611                   


Q ss_pred             --------------------------------------------------------------------------------
Q psy1546         119 --------------------------------------------------------------------------------  118 (604)
Q Consensus       119 --------------------------------------------------------------------------------  118 (604)
                                                                                                      
T Consensus       560 ~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e~~  639 (1351)
T KOG1035|consen  560 ASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSEGS  639 (1351)
T ss_pred             ccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccCCc
Confidence                                                                                            


Q ss_pred             ------------------------------eEEEEEEecCCCChhhHhhcCCCc--HHHHHHHHHHHHHHhHHhhhCCcc
Q psy1546         119 ------------------------------KLWIIMEYLGGGSALDLMKAGNFE--EMHIAVILREVLKGLDYLHSERKL  166 (604)
Q Consensus       119 ------------------------------~lyLVmEy~~ggsL~~~l~~~~ls--e~~i~~i~~qIl~gL~yLHs~gIi  166 (604)
                                                    .+||=||||+..+|.+++..+.+.  ...++.++++|++||.|+|++|||
T Consensus       640 ~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~giI  719 (1351)
T KOG1035|consen  640 VILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQGII  719 (1351)
T ss_pred             cccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhCcee
Confidence                                          137889999999999999887775  788999999999999999999999


Q ss_pred             ccccccceeEecCCCCeEEeccccccccc------C------------CCCCCcccccCCCCCChHHhhcCC---CCCcc
Q psy1546         167 HRDIKAANVLLSEMGDVKLADFGVAGTLT------N------------TTSKRNTFVGTPFWMAPEVIKQSA---YDSKA  225 (604)
Q Consensus       167 HrDLKp~NILl~~~g~vKL~DFGlA~~~~------~------------~~~~~~~~~GT~~Y~APE~l~~~~---~~~~s  225 (604)
                      ||||||.||+++.++.|||+|||+|....      +            ........+||..|+|||++.+..   |+.++
T Consensus       720 HRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~Ki  799 (1351)
T KOG1035|consen  720 HRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNSKI  799 (1351)
T ss_pred             eccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccchh
Confidence            99999999999999999999999997621      0            011234578999999999997654   99999


Q ss_pred             hhhhHHHHHHHHHhCCCCCCC-CChhhHhhhcCCCCCCCC---CccchHHHHHHHHHHhccCCCCCCCHHHHhcChhhhh
Q psy1546         226 DIWSLGITAIELAKGEPPNSE-LHPMRVLFLIPKNNPPQL---TGNYTKQFKEFVEACLNKDPENRPTAKELLKFPFIRK  301 (604)
Q Consensus       226 DVwSLGviL~eLltG~~Pf~~-~~~~~~~~~i~~~~~~~~---~~~~s~~l~~Li~~~L~~dP~~RpT~~elL~hp~f~~  301 (604)
                      ||||||+||+||+.-   |.. .....++..+.++..+..   ...--+.-..+|++||+.||.+|||+.|+|++.||-.
T Consensus       800 DmYSLGIVlFEM~yP---F~TsMERa~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~s~llpp  876 (1351)
T KOG1035|consen  800 DMYSLGIVLFEMLYP---FGTSMERASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTATELLNSELLPP  876 (1351)
T ss_pred             hhHHHHHHHHHHhcc---CCchHHHHHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCccCCCHHHHhhccCCCc
Confidence            999999999999753   432 233334444444433322   2222234568999999999999999999999999963

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=4e-36  Score=305.89  Aligned_cols=232  Identities=24%  Similarity=0.385  Sum_probs=184.2

Q ss_pred             eEEcccCcEEEEEEEEC--CCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCCeE----------EEEEEecCCC
Q psy1546          63 ERIGKGSFGEVFKGIDN--RTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTKL----------WIIMEYLGGG  130 (604)
Q Consensus        63 ~~LG~G~fG~Vy~a~~~--~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~~l----------yLVmEy~~gg  130 (604)
                      +.||+|+||.||+|.+.  .++..+|+|.+...........+.+|+.+++.++||++.++          |+||||+++|
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG   80 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence            35899999999999854  35678999998765544444578889999999999996554          6999999999


Q ss_pred             ChhhHhhcC------CCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCC--CCc
Q psy1546         131 SALDLMKAG------NFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTS--KRN  202 (604)
Q Consensus       131 sL~~~l~~~------~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~--~~~  202 (604)
                      +|.+++...      .+++..+..++.|++.||.|||+.|++||||||+|||++.++.++|+|||+++.......  ...
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~  160 (269)
T cd05087          81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPD  160 (269)
T ss_pred             cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCcceeecCC
Confidence            999998642      356677888999999999999999999999999999999999999999999965432221  122


Q ss_pred             ccccCCCCCChHHhhcC-------CCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHhhhcCCC-----CCCCCCccch
Q psy1546         203 TFVGTPFWMAPEVIKQS-------AYDSKADIWSLGITAIELAK-GEPPNSELHPMRVLFLIPKN-----NPPQLTGNYT  269 (604)
Q Consensus       203 ~~~GT~~Y~APE~l~~~-------~~~~~sDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~~i~~~-----~~~~~~~~~s  269 (604)
                      ...|+..|+|||++.+.       .++.++|||||||++|||++ |..||......+........     ..+.+...++
T Consensus       161 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (269)
T cd05087         161 QLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPRLKLPLS  240 (269)
T ss_pred             CcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCCccCCCCC
Confidence            34678899999998643       35789999999999999996 99999877655543322111     1223334567


Q ss_pred             HHHHHHHHHHhccCCCCCCCHHHHhc
Q psy1546         270 KQFKEFVEACLNKDPENRPTAKELLK  295 (604)
Q Consensus       270 ~~l~~Li~~~L~~dP~~RpT~~elL~  295 (604)
                      +.+.+++.+|| .+|.+|||++||+.
T Consensus       241 ~~~~~l~~~c~-~~P~~Rpt~~~l~~  265 (269)
T cd05087         241 DRWYEVMQFCW-LQPEQRPSAEEVHL  265 (269)
T ss_pred             hHHHHHHHHHh-cCcccCCCHHHHHH
Confidence            88999999999 68999999999975

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=2.8e-36  Score=308.38  Aligned_cols=239  Identities=31%  Similarity=0.499  Sum_probs=192.3

Q ss_pred             ceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCC-CCCC----------CeEEEEEEec
Q psy1546          59 FTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCD-SPYG----------TKLWIIMEYL  127 (604)
Q Consensus        59 y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~-hp~~----------~~lyLVmEy~  127 (604)
                      |.+.+.||.|+||.||+|.+..+++.||||.+.............+|+..+..+. |++.          ..+|+||||+
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~   80 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM   80 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence            6788999999999999999999999999999865433222334567899999999 9974          3468999999


Q ss_pred             CCCChhhHhhcC---CCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCCCCccc
Q psy1546         128 GGGSALDLMKAG---NFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTF  204 (604)
Q Consensus       128 ~ggsL~~~l~~~---~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~~~~~  204 (604)
                       +|+|.+++...   .+++..+..++.||+.+|.|||++|++|+||+|+||+++.++.++|+|||++....... .....
T Consensus        81 -~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~-~~~~~  158 (283)
T cd07830          81 -EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP-PYTDY  158 (283)
T ss_pred             -CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccCCC-CcCCC
Confidence             78888877552   68999999999999999999999999999999999999999999999999997654322 22345


Q ss_pred             ccCCCCCChHHhh-cCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCC-------------------------
Q psy1546         205 VGTPFWMAPEVIK-QSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPK-------------------------  258 (604)
Q Consensus       205 ~GT~~Y~APE~l~-~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~-------------------------  258 (604)
                      .++..|+|||++. ...++.++||||||+++|+|++|.+||......+....+..                         
T Consensus       159 ~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (283)
T cd07830         159 VSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFRFP  238 (283)
T ss_pred             CCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcccccccc
Confidence            6899999999885 44578899999999999999999999976654333221100                         


Q ss_pred             -CCC---CCCCccchHHHHHHHHHHhccCCCCCCCHHHHhcChhh
Q psy1546         259 -NNP---PQLTGNYTKQFKEFVEACLNKDPENRPTAKELLKFPFI  299 (604)
Q Consensus       259 -~~~---~~~~~~~s~~l~~Li~~~L~~dP~~RpT~~elL~hp~f  299 (604)
                       ...   .......+..+.+||.+||..||.+|||++|++.||||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~  283 (283)
T cd07830         239 QFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF  283 (283)
T ss_pred             ccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence             000   00111235789999999999999999999999999997

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=4.1e-36  Score=345.05  Aligned_cols=135  Identities=33%  Similarity=0.617  Sum_probs=121.5

Q ss_pred             cceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhh--HHHHHHHHHHHHHHhhCCCCCCCe----------EEEEEE
Q psy1546          58 IFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA--EDEIEDIQQEIMVLSQCDSPYGTK----------LWIIME  125 (604)
Q Consensus        58 ~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~--~~~~~~l~~Ei~iL~~l~hp~~~~----------lyLVmE  125 (604)
                      .|.+.++||+|+||+||+|.+..+++.||||++.....  ......+..|+.++..++|+++.+          +|||||
T Consensus         5 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVmE   84 (669)
T cd05610           5 EFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVME   84 (669)
T ss_pred             CEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEEe
Confidence            38999999999999999999999999999999965432  334567889999999999998665          479999


Q ss_pred             ecCCCChhhHhhc-CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccc
Q psy1546         126 YLGGGSALDLMKA-GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAG  192 (604)
Q Consensus       126 y~~ggsL~~~l~~-~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~  192 (604)
                      |+.|++|.+++.. +.+++..++.|+.||+.||.|||.+|||||||||+||||+.++.+||+|||+++
T Consensus        85 y~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          85 YLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             CCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            9999999999864 678999999999999999999999999999999999999999999999999985

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>KOG0607|consensus

Probab=100.00  E-value=5.1e-37  Score=307.18  Aligned_cols=245  Identities=24%  Similarity=0.475  Sum_probs=201.2

Q ss_pred             ccee-eeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCC-CCC----------CCeEEEEEE
Q psy1546          58 IFTK-QERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCD-SPY----------GTKLWIIME  125 (604)
Q Consensus        58 ~y~i-~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~-hp~----------~~~lyLVmE  125 (604)
                      .|.+ .+.||+|+|+.|-.+....++..||||+|++.. .....++.+|+.++.++. |+|          ..++|||||
T Consensus        78 ~YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~-gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfE  156 (463)
T KOG0607|consen   78 MYKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQP-GHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFE  156 (463)
T ss_pred             HHHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcCC-chHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEe
Confidence            4544 367999999999999999999999999998774 334578899999999985 776          457899999


Q ss_pred             ecCCCChhhHhhc-CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCC---eEEecccccccccCCC---
Q psy1546         126 YLGGGSALDLMKA-GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGD---VKLADFGVAGTLTNTT---  198 (604)
Q Consensus       126 y~~ggsL~~~l~~-~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~---vKL~DFGlA~~~~~~~---  198 (604)
                      -|.||.|...|.+ ..|+|.++..++++|+.||.|||.+||.||||||+|||-.....   ||||||.+...+....   
T Consensus       157 Km~GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~s  236 (463)
T KOG0607|consen  157 KMRGGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCS  236 (463)
T ss_pred             cccCchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCCCCC
Confidence            9999999887755 67999999999999999999999999999999999999976554   7999999885443221   


Q ss_pred             ----CCCcccccCCCCCChHHhh-----cCCCCCcchhhhHHHHHHHHHhCCCCCCCCCh---------------hhHhh
Q psy1546         199 ----SKRNTFVGTPFWMAPEVIK-----QSAYDSKADIWSLGITAIELAKGEPPNSELHP---------------MRVLF  254 (604)
Q Consensus       199 ----~~~~~~~GT~~Y~APE~l~-----~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~---------------~~~~~  254 (604)
                          ....+.+|+..|||||+..     ...|+.++|+||||||||.||.|.+||.+.=.               ..++.
T Consensus       237 pastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFe  316 (463)
T KOG0607|consen  237 PASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFE  316 (463)
T ss_pred             CCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHH
Confidence                2234678999999999873     34599999999999999999999999976421               12333


Q ss_pred             hcCCCCC---CCCCccchHHHHHHHHHHhccCCCCCCCHHHHhcChhhhhhh
Q psy1546         255 LIPKNNP---PQLTGNYTKQFKEFVEACLNKDPENRPTAKELLKFPFIRKAK  303 (604)
Q Consensus       255 ~i~~~~~---~~~~~~~s~~l~~Li~~~L~~dP~~RpT~~elL~hp~f~~~~  303 (604)
                      .|..+..   ..-+..++.+.++|+..+|..|+.+|.++.++++|||+....
T Consensus       317 sIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~  368 (463)
T KOG0607|consen  317 SIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCA  368 (463)
T ss_pred             HHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccccc
Confidence            4444443   233456889999999999999999999999999999997653

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=2.4e-36  Score=318.27  Aligned_cols=245  Identities=28%  Similarity=0.449  Sum_probs=199.7

Q ss_pred             cccceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhh-HHHHHHHHHHHHHHhhCCCCCCCe-----------EEEE
Q psy1546          56 ELIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA-EDEIEDIQQEIMVLSQCDSPYGTK-----------LWII  123 (604)
Q Consensus        56 ~~~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~-~~~~~~l~~Ei~iL~~l~hp~~~~-----------lyLV  123 (604)
                      ...|.+.+.||.|+||.||+|.+..+++.||||++..... ....+.+.+|+.+++.++||++.+           +|+|
T Consensus         9 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~lv   88 (328)
T cd07856           9 TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFV   88 (328)
T ss_pred             ccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEEE
Confidence            3459999999999999999999999999999998854322 223466789999999999998443           4799


Q ss_pred             EEecCCCChhhHhhcCCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCCCCcc
Q psy1546         124 MEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNT  203 (604)
Q Consensus       124 mEy~~ggsL~~~l~~~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~~~~  203 (604)
                      |||+ +++|..+++.+.+++..+..++.||+.||.|||++||+||||+|.|||++.++.++|+|||++.....   ....
T Consensus        89 ~e~~-~~~L~~~~~~~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~---~~~~  164 (328)
T cd07856          89 TELL-GTDLHRLLTSRPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDP---QMTG  164 (328)
T ss_pred             eehh-ccCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccCC---CcCC
Confidence            9999 56899999888899999999999999999999999999999999999999999999999999865432   2234


Q ss_pred             cccCCCCCChHHhhc-CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhh---------------------------
Q psy1546         204 FVGTPFWMAPEVIKQ-SAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFL---------------------------  255 (604)
Q Consensus       204 ~~GT~~Y~APE~l~~-~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~---------------------------  255 (604)
                      ..+++.|+|||++.+ ..++.++|||||||++|+|++|.+||...........                           
T Consensus       165 ~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (328)
T cd07856         165 YVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFVQS  244 (328)
T ss_pred             CcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHHHHhh
Confidence            567899999998865 5688999999999999999999999976654221110                           


Q ss_pred             cCCCCCC---CCCccchHHHHHHHHHHhccCCCCCCCHHHHhcChhhhhhhh
Q psy1546         256 IPKNNPP---QLTGNYTKQFKEFVEACLNKDPENRPTAKELLKFPFIRKAKK  304 (604)
Q Consensus       256 i~~~~~~---~~~~~~s~~l~~Li~~~L~~dP~~RpT~~elL~hp~f~~~~~  304 (604)
                      .......   .....++..+.++|.+||..+|++|||+.+++.||||.....
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~~~  296 (328)
T cd07856         245 LPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYHD  296 (328)
T ss_pred             ccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccccC
Confidence            0000000   112346789999999999999999999999999999975543

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=6.7e-36  Score=307.28  Aligned_cols=245  Identities=30%  Similarity=0.501  Sum_probs=197.6

Q ss_pred             ceeeeEEcccCcEEEEEEEEC---CCCcEEEEEEecchhh---HHHHHHHHHHHHHHhhC-CCCCC----------CeEE
Q psy1546          59 FTKQERIGKGSFGEVFKGIDN---RTQQVVAIKIIDLEEA---EDEIEDIQQEIMVLSQC-DSPYG----------TKLW  121 (604)
Q Consensus        59 y~i~~~LG~G~fG~Vy~a~~~---~t~~~vAVK~i~~~~~---~~~~~~l~~Ei~iL~~l-~hp~~----------~~ly  121 (604)
                      |.+.+.||+|+||.||+|.+.   .+++.||||++.....   ......+.+|+.++..+ .|+++          ..+|
T Consensus         2 ~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~   81 (288)
T cd05583           2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLH   81 (288)
T ss_pred             ceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEE
Confidence            788999999999999999864   4678899999865432   22345678899999999 57763          3468


Q ss_pred             EEEEecCCCChhhHhhc-CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCC-
Q psy1546         122 IIMEYLGGGSALDLMKA-GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTS-  199 (604)
Q Consensus       122 LVmEy~~ggsL~~~l~~-~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~-  199 (604)
                      +||||+.+++|.+++.. +.+++..++.++.|++.||.|||+.|++||||+|.||+++.++.++|+|||+++.+..... 
T Consensus        82 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~  161 (288)
T cd05583          82 LILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEE  161 (288)
T ss_pred             EEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECcccccccccccc
Confidence            99999999999998865 5689999999999999999999999999999999999999999999999999876543322 


Q ss_pred             CCcccccCCCCCChHHhhcCC--CCCcchhhhHHHHHHHHHhCCCCCCCCCh----hhHhhhcCCCCCCCCCccchHHHH
Q psy1546         200 KRNTFVGTPFWMAPEVIKQSA--YDSKADIWSLGITAIELAKGEPPNSELHP----MRVLFLIPKNNPPQLTGNYTKQFK  273 (604)
Q Consensus       200 ~~~~~~GT~~Y~APE~l~~~~--~~~~sDVwSLGviL~eLltG~~Pf~~~~~----~~~~~~i~~~~~~~~~~~~s~~l~  273 (604)
                      ......|+..|+|||.+.+..  .+.++||||||+++|+|++|..||.....    ......+... ....+..++..+.
T Consensus       162 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~  240 (288)
T cd05583         162 RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKS-KPPFPKTMSAEAR  240 (288)
T ss_pred             ccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHcc-CCCCCcccCHHHH
Confidence            223356899999999987665  77899999999999999999999864322    1211122111 2344556788999


Q ss_pred             HHHHHHhccCCCCCCC---HHHHhcChhhhhhhh
Q psy1546         274 EFVEACLNKDPENRPT---AKELLKFPFIRKAKK  304 (604)
Q Consensus       274 ~Li~~~L~~dP~~RpT---~~elL~hp~f~~~~~  304 (604)
                      ++|.+||+.||++|||   +.++|+||||+...+
T Consensus       241 ~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~~~  274 (288)
T cd05583         241 DFIQKLLEKDPKKRLGANGADEIKNHPFFQGIDW  274 (288)
T ss_pred             HHHHHHhcCCHhhccCcchHHHHhcCcccccCCH
Confidence            9999999999999998   577899999987654

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=3.7e-36  Score=302.84  Aligned_cols=225  Identities=24%  Similarity=0.410  Sum_probs=183.1

Q ss_pred             eEEcccCcEEEEEEEECCCC----------cEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCCe---------EEEE
Q psy1546          63 ERIGKGSFGEVFKGIDNRTQ----------QVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTK---------LWII  123 (604)
Q Consensus        63 ~~LG~G~fG~Vy~a~~~~t~----------~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~~---------lyLV  123 (604)
                      +.||+|+||.||+|.+..++          ..|++|++......  ...+.+|+.+++.+.|+++.+         .|+|
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~lv   78 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD--SLAFFETASLMSQLSHKHLVKLYGVCVRDENIMV   78 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh--HHHHHHHHHHHHcCCCcchhheeeEEecCCcEEE
Confidence            46999999999999998776          35888887544322  577889999999999998654         3799


Q ss_pred             EEecCCCChhhHhhcC--CCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCC-------CeEEecccccccc
Q psy1546         124 MEYLGGGSALDLMKAG--NFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMG-------DVKLADFGVAGTL  194 (604)
Q Consensus       124 mEy~~ggsL~~~l~~~--~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g-------~vKL~DFGlA~~~  194 (604)
                      |||+++|+|.+++...  .+++..+..++.||+.||+|||++||+||||||+|||++.++       .+||+|||++...
T Consensus        79 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~~~  158 (259)
T cd05037          79 EEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITV  158 (259)
T ss_pred             EEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCccccc
Confidence            9999999999998653  589999999999999999999999999999999999999887       7999999999765


Q ss_pred             cCCCCCCcccccCCCCCChHHhhcC--CCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHhhhcCCCCCCCCCccchHH
Q psy1546         195 TNTTSKRNTFVGTPFWMAPEVIKQS--AYDSKADIWSLGITAIELAK-GEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQ  271 (604)
Q Consensus       195 ~~~~~~~~~~~GT~~Y~APE~l~~~--~~~~~sDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~  271 (604)
                      ..    .....++..|+|||++.+.  .++.++|||||||++|+|++ |..||.................  .+......
T Consensus       159 ~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~  232 (259)
T cd05037         159 LS----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQDQHR--LPMPDCAE  232 (259)
T ss_pred             cc----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHhcCCC--CCCCCchH
Confidence            43    2234577889999999876  78899999999999999999 6888877654333222221111  11222378


Q ss_pred             HHHHHHHHhccCCCCCCCHHHHhc
Q psy1546         272 FKEFVEACLNKDPENRPTAKELLK  295 (604)
Q Consensus       272 l~~Li~~~L~~dP~~RpT~~elL~  295 (604)
                      +.+||.+||..+|.+|||+.+|++
T Consensus       233 ~~~li~~~l~~~p~~Rpt~~~il~  256 (259)
T cd05037         233 LANLINQCWTYDPTKRPSFRAILR  256 (259)
T ss_pred             HHHHHHHHhccChhhCCCHHHHHH
Confidence            999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=6e-36  Score=305.84  Aligned_cols=239  Identities=28%  Similarity=0.444  Sum_probs=191.4

Q ss_pred             ceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHH-HHHHHHHHHHHHhhC---CCCCCCe---------------
Q psy1546          59 FTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAED-EIEDIQQEIMVLSQC---DSPYGTK---------------  119 (604)
Q Consensus        59 y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~-~~~~l~~Ei~iL~~l---~hp~~~~---------------  119 (604)
                      |.+.+.||.|+||.||+|.+..+++.||||++....... ....+.+|+.+++++   .|++..+               
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   80 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK   80 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence            678899999999999999999899999999996543222 224455677776655   5887322               


Q ss_pred             EEEEEEecCCCChhhHhhc---CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccC
Q psy1546         120 LWIIMEYLGGGSALDLMKA---GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTN  196 (604)
Q Consensus       120 lyLVmEy~~ggsL~~~l~~---~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~  196 (604)
                      +|+||||+.+ +|.+++..   ..+++..++.++.||+.||.|||+.+++|+||+|+|||++.++.++|+|||++..+..
T Consensus        81 ~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~~  159 (287)
T cd07838          81 LTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSF  159 (287)
T ss_pred             eEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcceeccC
Confidence            6799999964 78887754   3589999999999999999999999999999999999999999999999999976643


Q ss_pred             CCCCCcccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCC-----------------
Q psy1546         197 TTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKN-----------------  259 (604)
Q Consensus       197 ~~~~~~~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~-----------------  259 (604)
                      .. ......++..|+|||++.+..++.++|||||||++|+|++|.+||......+....+...                 
T Consensus       160 ~~-~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (287)
T cd07838         160 EM-ALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSLPR  238 (287)
T ss_pred             Cc-ccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCcccch
Confidence            32 223446889999999999999999999999999999999999999876654433222110                 


Q ss_pred             ------C---CCCCCccchHHHHHHHHHHhccCCCCCCCHHHHhcChhh
Q psy1546         260 ------N---PPQLTGNYTKQFKEFVEACLNKDPENRPTAKELLKFPFI  299 (604)
Q Consensus       260 ------~---~~~~~~~~s~~l~~Li~~~L~~dP~~RpT~~elL~hp~f  299 (604)
                            .   .......++..+.+||.+||..||.+||++.+++.||||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~  287 (287)
T cd07838         239 SSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF  287 (287)
T ss_pred             hhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence                  0   000112345778999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=6.1e-36  Score=304.27  Aligned_cols=238  Identities=24%  Similarity=0.421  Sum_probs=196.5

Q ss_pred             ceeeeEEcccCcEEEEEEEEC---CCCcEEEEEEecchhh-HHHHHHHHHHHHHHhhCCCCCCCeE--------------
Q psy1546          59 FTKQERIGKGSFGEVFKGIDN---RTQQVVAIKIIDLEEA-EDEIEDIQQEIMVLSQCDSPYGTKL--------------  120 (604)
Q Consensus        59 y~i~~~LG~G~fG~Vy~a~~~---~t~~~vAVK~i~~~~~-~~~~~~l~~Ei~iL~~l~hp~~~~l--------------  120 (604)
                      |.+.++||+|+||.||+|.+.   .+++.||||++..... ....+.+.+|+.+++.+.||++.++              
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   80 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP   80 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence            567889999999999999864   3578999999865432 3345778899999999999985443              


Q ss_pred             --EEEEEecCCCChhhHhhc-------CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEeccccc
Q psy1546         121 --WIIMEYLGGGSALDLMKA-------GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVA  191 (604)
Q Consensus       121 --yLVmEy~~ggsL~~~l~~-------~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA  191 (604)
                        ++++||+.+|+|.+++..       ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~dfg~~  160 (273)
T cd05074          81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLS  160 (273)
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECccccc
Confidence              578899999999887632       24788899999999999999999999999999999999999999999999999


Q ss_pred             ccccCCCC--CCcccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHhhhcCCCCCCCCCccc
Q psy1546         192 GTLTNTTS--KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAK-GEPPNSELHPMRVLFLIPKNNPPQLTGNY  268 (604)
Q Consensus       192 ~~~~~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~  268 (604)
                      +.+.....  ......+++.|++||.+.+..++.++|||||||++|+|++ |.+||...........+...........+
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  240 (273)
T cd05074         161 KKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNRLKQPPDC  240 (273)
T ss_pred             ccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCcCCCCCCC
Confidence            76543221  1123345678999999999999999999999999999999 89999887776665555444444445567


Q ss_pred             hHHHHHHHHHHhccCCCCCCCHHHHhcC
Q psy1546         269 TKQFKEFVEACLNKDPENRPTAKELLKF  296 (604)
Q Consensus       269 s~~l~~Li~~~L~~dP~~RpT~~elL~h  296 (604)
                      +..+.+++.+||..+|.+||++.++++.
T Consensus       241 ~~~~~~l~~~~l~~~p~~Rps~~~~~~~  268 (273)
T cd05074         241 LEDVYELMCQCWSPEPKCRPSFQHLRDQ  268 (273)
T ss_pred             CHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            8899999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=6.2e-36  Score=309.86  Aligned_cols=236  Identities=20%  Similarity=0.261  Sum_probs=180.4

Q ss_pred             ccceeeeEEcccCcEEEEEEEECCC---CcEEEEEEecchhhHHHH----------HHHHHHHHHHhhCCCCCCCeE---
Q psy1546          57 LIFTKQERIGKGSFGEVFKGIDNRT---QQVVAIKIIDLEEAEDEI----------EDIQQEIMVLSQCDSPYGTKL---  120 (604)
Q Consensus        57 ~~y~i~~~LG~G~fG~Vy~a~~~~t---~~~vAVK~i~~~~~~~~~----------~~l~~Ei~iL~~l~hp~~~~l---  120 (604)
                      ..|.+.++||+|+||+||+|.+..+   +..+|+|+..........          .....++..+..+.|+++..+   
T Consensus        12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~   91 (294)
T PHA02882         12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC   91 (294)
T ss_pred             CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence            4599999999999999999998877   677888875433211100          112234455667788875443   


Q ss_pred             -----------EEEEEecCCCChhhHhhcC-CCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecc
Q psy1546         121 -----------WIIMEYLGGGSALDLMKAG-NFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADF  188 (604)
Q Consensus       121 -----------yLVmEy~~ggsL~~~l~~~-~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DF  188 (604)
                                 |+++|++. .++.+++... .+++..++.++.||+.||.|||+++|+||||||+|||++.++.++|+||
T Consensus        92 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~~~l~DF  170 (294)
T PHA02882         92 GSFKRCRMYYRFILLEKLV-ENTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYIIDY  170 (294)
T ss_pred             eeEecCCceEEEEEEehhc-cCHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCcEEEEEc
Confidence                       56777763 4566666543 4788889999999999999999999999999999999999999999999


Q ss_pred             cccccccCCC-------CCCcccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChh-h--------H
Q psy1546         189 GVAGTLTNTT-------SKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPM-R--------V  252 (604)
Q Consensus       189 GlA~~~~~~~-------~~~~~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~-~--------~  252 (604)
                      |+|+.+....       .......||+.|+|||++.+..++.++|||||||+||||++|.+||...... .        .
T Consensus       171 Gla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~~~~~  250 (294)
T PHA02882        171 GIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAAKCDF  250 (294)
T ss_pred             CCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHhHHHH
Confidence            9997664221       1123357999999999999999999999999999999999999999876321 1        1


Q ss_pred             hhhcCCCCCCCCCccchHHHHHHHHHHhccCCCCCCCHHHHhc
Q psy1546         253 LFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPENRPTAKELLK  295 (604)
Q Consensus       253 ~~~i~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~RpT~~elL~  295 (604)
                      ...+....  .....+++.+.+++..||..+|++||++.+|++
T Consensus       251 ~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~  291 (294)
T PHA02882        251 IKRLHEGK--IKIKNANKFIYDFIECVTKLSYEEKPDYDALIK  291 (294)
T ss_pred             HHHhhhhh--hccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence            12222211  122456789999999999999999999999976

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=7.5e-36  Score=304.70  Aligned_cols=238  Identities=28%  Similarity=0.477  Sum_probs=193.9

Q ss_pred             cceeeeEEcccCcEEEEEEEEC----CCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCCe------------EE
Q psy1546          58 IFTKQERIGKGSFGEVFKGIDN----RTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTK------------LW  121 (604)
Q Consensus        58 ~y~i~~~LG~G~fG~Vy~a~~~----~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~~------------ly  121 (604)
                      .|.+.+.||+|+||.||+|.+.    .++..||||++...........+.+|+.+++.+.|+++.+            +|
T Consensus         5 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~   84 (284)
T cd05038           5 HLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLR   84 (284)
T ss_pred             hchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceE
Confidence            4778899999999999999864    3588999999976654445678899999999999998543            47


Q ss_pred             EEEEecCCCChhhHhhcCC--CcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCC
Q psy1546         122 IIMEYLGGGSALDLMKAGN--FEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTS  199 (604)
Q Consensus       122 LVmEy~~ggsL~~~l~~~~--lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~  199 (604)
                      +||||+++++|.+++....  +++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++........
T Consensus        85 lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~  164 (284)
T cd05038          85 LIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKD  164 (284)
T ss_pred             EEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccccccccccCCc
Confidence            9999999999999997644  99999999999999999999999999999999999999999999999999976652221


Q ss_pred             C---CcccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhh---------------HhhhcCCCCC
Q psy1546         200 K---RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMR---------------VLFLIPKNNP  261 (604)
Q Consensus       200 ~---~~~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~---------------~~~~i~~~~~  261 (604)
                      .   .....++..|+|||.+.+..++.++|||||||++|||++|..|+.......               ....+.....
T Consensus       165 ~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (284)
T cd05038         165 YYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKEGER  244 (284)
T ss_pred             ceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHHHcCCc
Confidence            1   112345567999999998899999999999999999999999976532211               1111222222


Q ss_pred             CCCCccchHHHHHHHHHHhccCCCCCCCHHHHhc
Q psy1546         262 PQLTGNYTKQFKEFVEACLNKDPENRPTAKELLK  295 (604)
Q Consensus       262 ~~~~~~~s~~l~~Li~~~L~~dP~~RpT~~elL~  295 (604)
                      ...+..++.++.+|+.+||..+|.+|||+.||++
T Consensus       245 ~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  278 (284)
T cd05038         245 LPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL  278 (284)
T ss_pred             CCCCccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence            2334567789999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=2.2e-36  Score=306.26  Aligned_cols=227  Identities=24%  Similarity=0.400  Sum_probs=183.6

Q ss_pred             eEEcccCcEEEEEEEECCCCc-------EEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCCeE----------EEEEE
Q psy1546          63 ERIGKGSFGEVFKGIDNRTQQ-------VVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTKL----------WIIME  125 (604)
Q Consensus        63 ~~LG~G~fG~Vy~a~~~~t~~-------~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~~l----------yLVmE  125 (604)
                      +.||.|+||.||+|.+...+.       .||+|.+.... ....+.+..|+.+++.+.||+..++          |+|||
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e   79 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH-RNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQE   79 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchh-HHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEe
Confidence            368999999999998865543       48888875433 2344677889999999999985544          69999


Q ss_pred             ecCCCChhhHhhcC--CCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCC--------eEEeccccccccc
Q psy1546         126 YLGGGSALDLMKAG--NFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGD--------VKLADFGVAGTLT  195 (604)
Q Consensus       126 y~~ggsL~~~l~~~--~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~--------vKL~DFGlA~~~~  195 (604)
                      |+++|+|..++...  .+++..+..++.||+.||.|||++||+||||||+|||++.++.        ++|+|||++....
T Consensus        80 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~~~  159 (258)
T cd05078          80 YVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVL  159 (258)
T ss_pred             cCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecccccccccC
Confidence            99999999999653  4899999999999999999999999999999999999987665        6999999986543


Q ss_pred             CCCCCCcccccCCCCCChHHhhc-CCCCCcchhhhHHHHHHHHHhC-CCCCCCCChhhHhhhcCCCCCCCCCccchHHHH
Q psy1546         196 NTTSKRNTFVGTPFWMAPEVIKQ-SAYDSKADIWSLGITAIELAKG-EPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFK  273 (604)
Q Consensus       196 ~~~~~~~~~~GT~~Y~APE~l~~-~~~~~~sDVwSLGviL~eLltG-~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~  273 (604)
                      .    .....+++.|+|||++.+ ..++.++|||||||++|+|++| .+||..............  ...++...+.++.
T Consensus       160 ~----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~  233 (258)
T cd05078         160 P----KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFYED--RHQLPAPKWTELA  233 (258)
T ss_pred             C----chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHHHHc--cccCCCCCcHHHH
Confidence            2    224568899999999976 4578899999999999999998 577776655443332221  2334455668899


Q ss_pred             HHHHHHhccCCCCCCCHHHHhcC
Q psy1546         274 EFVEACLNKDPENRPTAKELLKF  296 (604)
Q Consensus       274 ~Li~~~L~~dP~~RpT~~elL~h  296 (604)
                      +||.+||+.||++|||+++|++.
T Consensus       234 ~li~~~l~~~p~~Rps~~~il~~  256 (258)
T cd05078         234 NLINQCMDYEPDFRPSFRAIIRD  256 (258)
T ss_pred             HHHHHHhccChhhCCCHHHHHHh
Confidence            99999999999999999999873

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=9.4e-36  Score=302.55  Aligned_cols=237  Identities=28%  Similarity=0.530  Sum_probs=196.6

Q ss_pred             ceeeeEEcccCcEEEEEEEECC-CCcEEEEEEecch---------hhHHHHHHHHHHHHHHhh-CCCCCCC---------
Q psy1546          59 FTKQERIGKGSFGEVFKGIDNR-TQQVVAIKIIDLE---------EAEDEIEDIQQEIMVLSQ-CDSPYGT---------  118 (604)
Q Consensus        59 y~i~~~LG~G~fG~Vy~a~~~~-t~~~vAVK~i~~~---------~~~~~~~~l~~Ei~iL~~-l~hp~~~---------  118 (604)
                      |++.+.||+|+||.||+|.+.. +++.+|||.+...         ........+.+|+.++.. +.|+++.         
T Consensus         2 y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~   81 (269)
T cd08528           2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLEN   81 (269)
T ss_pred             chhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccC
Confidence            7788999999999999999987 7889999987532         123345667788888864 8999844         


Q ss_pred             -eEEEEEEecCCCChhhHhh-----cCCCcHHHHHHHHHHHHHHhHHhhh-CCccccccccceeEecCCCCeEEeccccc
Q psy1546         119 -KLWIIMEYLGGGSALDLMK-----AGNFEEMHIAVILREVLKGLDYLHS-ERKLHRDIKAANVLLSEMGDVKLADFGVA  191 (604)
Q Consensus       119 -~lyLVmEy~~ggsL~~~l~-----~~~lse~~i~~i~~qIl~gL~yLHs-~gIiHrDLKp~NILl~~~g~vKL~DFGlA  191 (604)
                       .+|+||||+++++|.+++.     ...+++..++.++.|++.||.|||+ .+++||||+|+|||++.++.++|+|||++
T Consensus        82 ~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~dfg~~  161 (269)
T cd08528          82 DRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLA  161 (269)
T ss_pred             CeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEecccce
Confidence             4579999999999998873     2468999999999999999999996 78999999999999999999999999999


Q ss_pred             ccccCCCCCCcccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCCCCCCC-CccchH
Q psy1546         192 GTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQL-TGNYTK  270 (604)
Q Consensus       192 ~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~-~~~~s~  270 (604)
                      ....... ......|+..|+|||++.+..++.++||||||+++|+|++|.+||...........+........ ...++.
T Consensus       162 ~~~~~~~-~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (269)
T cd08528         162 KQKQPES-KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPEGMYSE  240 (269)
T ss_pred             eeccccc-ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCcCCcccCCH
Confidence            7654433 33456789999999999988899999999999999999999999987776655554443332222 236788


Q ss_pred             HHHHHHHHHhccCCCCCCCHHHHhcC
Q psy1546         271 QFKEFVEACLNKDPENRPTAKELLKF  296 (604)
Q Consensus       271 ~l~~Li~~~L~~dP~~RpT~~elL~h  296 (604)
                      .+.+||.+||..||++||++.|+..+
T Consensus       241 ~l~~li~~cl~~~p~~Rp~~~e~~~~  266 (269)
T cd08528         241 DVTDVITSCLTPDAEARPDIIQVSAM  266 (269)
T ss_pred             HHHHHHHHHCCCCCccCCCHHHHHHH
Confidence            99999999999999999999998753

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=1.2e-35  Score=302.33  Aligned_cols=227  Identities=22%  Similarity=0.358  Sum_probs=181.7

Q ss_pred             eEEcccCcEEEEEEEECC------------CCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCCeE----------
Q psy1546          63 ERIGKGSFGEVFKGIDNR------------TQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTKL----------  120 (604)
Q Consensus        63 ~~LG~G~fG~Vy~a~~~~------------t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~~l----------  120 (604)
                      +.||+|+||.||+|+...            ....||+|++.... ......+.+|+.++..++|||+.++          
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~-~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~   79 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH-RDISLAFFETASMMRQVSHKHIVLLYGVCVRDVEN   79 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh-hhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCC
Confidence            368999999999998532            23358999876543 3344677889999999999996654          


Q ss_pred             EEEEEecCCCChhhHhhc--CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCC-------eEEeccccc
Q psy1546         121 WIIMEYLGGGSALDLMKA--GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGD-------VKLADFGVA  191 (604)
Q Consensus       121 yLVmEy~~ggsL~~~l~~--~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~-------vKL~DFGlA  191 (604)
                      |+||||+++++|..++..  +.+++..++.++.||+.||+|||++||+||||||+|||++.++.       ++|+|||++
T Consensus        80 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g~~  159 (262)
T cd05077          80 IMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIP  159 (262)
T ss_pred             EEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCCCCC
Confidence            699999999999988864  56899999999999999999999999999999999999987664       899999998


Q ss_pred             ccccCCCCCCcccccCCCCCChHHhh-cCCCCCcchhhhHHHHHHHHH-hCCCCCCCCChhhHhhhcCCCCCCCCCccch
Q psy1546         192 GTLTNTTSKRNTFVGTPFWMAPEVIK-QSAYDSKADIWSLGITAIELA-KGEPPNSELHPMRVLFLIPKNNPPQLTGNYT  269 (604)
Q Consensus       192 ~~~~~~~~~~~~~~GT~~Y~APE~l~-~~~~~~~sDVwSLGviL~eLl-tG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s  269 (604)
                      ..+...    ....++..|+|||++. +..++.++|||||||+||||+ .|..||......+........  .......+
T Consensus       160 ~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~--~~~~~~~~  233 (262)
T cd05077         160 ITVLSR----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKERFYEGQ--CMLVTPSC  233 (262)
T ss_pred             ccccCc----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHHHHhcC--ccCCCCCh
Confidence            654322    2346888999999986 566889999999999999997 588998776544433222111  11223346


Q ss_pred             HHHHHHHHHHhccCCCCCCCHHHHhcC
Q psy1546         270 KQFKEFVEACLNKDPENRPTAKELLKF  296 (604)
Q Consensus       270 ~~l~~Li~~~L~~dP~~RpT~~elL~h  296 (604)
                      .++.+||.+||..||.+||++.+|+++
T Consensus       234 ~~~~~li~~cl~~dp~~Rp~~~~il~~  260 (262)
T cd05077         234 KELADLMTHCMNYDPNQRPFFRAIMRD  260 (262)
T ss_pred             HHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence            789999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>KOG0608|consensus

Probab=100.00  E-value=1.5e-36  Score=324.44  Aligned_cols=247  Identities=27%  Similarity=0.501  Sum_probs=205.0

Q ss_pred             ccceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhh--HHHHHHHHHHHHHHhhCCCCCCCe----------EEEEE
Q psy1546          57 LIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA--EDEIEDIQQEIMVLSQCDSPYGTK----------LWIIM  124 (604)
Q Consensus        57 ~~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~--~~~~~~l~~Ei~iL~~l~hp~~~~----------lyLVm  124 (604)
                      ..|..++.||-|+||+|.++...+|..+||+|.+.+...  ......++.|..||..-+.+.+++          ||+||
T Consensus       629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVM  708 (1034)
T KOG0608|consen  629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM  708 (1034)
T ss_pred             cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEE
Confidence            358999999999999999999999999999999876543  345677889999999988886655          47999


Q ss_pred             EecCCCChhhHh-hcCCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCC-----
Q psy1546         125 EYLGGGSALDLM-KAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTT-----  198 (604)
Q Consensus       125 Ey~~ggsL~~~l-~~~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~-----  198 (604)
                      ||++||++-.+| +.|-|+|..+++++.++.+|++++|..|+|||||||+|||||.+|+|||+|||+|.-+.-..     
T Consensus       709 dYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdskYY  788 (1034)
T KOG0608|consen  709 DYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYY  788 (1034)
T ss_pred             eccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccccceeccccccc
Confidence            999999998865 66899999999999999999999999999999999999999999999999999995432110     


Q ss_pred             ---C-C---------------------------------CcccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCC
Q psy1546         199 ---S-K---------------------------------RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGE  241 (604)
Q Consensus       199 ---~-~---------------------------------~~~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~  241 (604)
                         . .                                 ....+||+.|+|||++....|+..+|+||.|||||||+.|+
T Consensus       789 q~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~~g~  868 (1034)
T KOG0608|consen  789 QEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEMLVGQ  868 (1034)
T ss_pred             cCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHhhCC
Confidence               0 0                                 02357999999999999999999999999999999999999


Q ss_pred             CCCCCCChhhHhhhcCCCC---CCCCCccchHHHHHHHHHHhccCCCCCCC---HHHHhcChhhhhhhh
Q psy1546         242 PPNSELHPMRVLFLIPKNN---PPQLTGNYTKQFKEFVEACLNKDPENRPT---AKELLKFPFIRKAKK  304 (604)
Q Consensus       242 ~Pf~~~~~~~~~~~i~~~~---~~~~~~~~s~~l~~Li~~~L~~dP~~RpT---~~elL~hp~f~~~~~  304 (604)
                      +||....+.+....+....   ......++++++.+||.++. .+++.|..   ++||-.||||+....
T Consensus       869 ~pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~kLc-~sad~RLGkng~d~vKaHpfFkgIDf  936 (1034)
T KOG0608|consen  869 PPFLADTPGETQYKVINWRNFLHIPYQGNLSKEALDLIQKLC-CSADSRLGKNGADQVKAHPFFKGIDF  936 (1034)
T ss_pred             CCccCCCCCcceeeeeehhhccccccccccCHHHHHHHHHHh-cChhhhhcccchhhhhcCccccccch
Confidence            9999888766555443221   12334678999999998854 56778864   778999999987543

>KOG0695|consensus

Probab=100.00  E-value=1.9e-36  Score=304.21  Aligned_cols=247  Identities=27%  Similarity=0.500  Sum_probs=211.5

Q ss_pred             cceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhh--HHHHHHHHHHHHHHhhC-CCCC----------CCeEEEEE
Q psy1546          58 IFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA--EDEIEDIQQEIMVLSQC-DSPY----------GTKLWIIM  124 (604)
Q Consensus        58 ~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~--~~~~~~l~~Ei~iL~~l-~hp~----------~~~lyLVm  124 (604)
                      .|.++++||+|+|++|.+++++.|.+.||+|+++++-.  ...+.-++.|-.+..+- +||+          ..++++|.
T Consensus       251 df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffvi  330 (593)
T KOG0695|consen  251 DFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFVI  330 (593)
T ss_pred             cceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEEE
Confidence            38999999999999999999999999999999976633  22345566677666553 5665          46789999


Q ss_pred             EecCCCChhhHhhc-CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCCCCcc
Q psy1546         125 EYLGGGSALDLMKA-GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNT  203 (604)
Q Consensus       125 Ey~~ggsL~~~l~~-~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~~~~  203 (604)
                      ||++||+|-..++. ++++++.++.+...|+.||.|||+.|||+||||.+|||++..|++||+|+|+++.-..+.....+
T Consensus       331 eyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmcke~l~~gd~tst  410 (593)
T KOG0695|consen  331 EYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGPGDTTST  410 (593)
T ss_pred             EEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhhcCCCCCccccc
Confidence            99999999887765 78999999999999999999999999999999999999999999999999999877667777889


Q ss_pred             cccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCC-------CChhhHhhhcCCCCCCCCCccchHHHHHHH
Q psy1546         204 FVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSE-------LHPMRVLFLIPKNNPPQLTGNYTKQFKEFV  276 (604)
Q Consensus       204 ~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~-------~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li  276 (604)
                      +||||.|.|||++++..|+..+|+|+|||+++||+.|+.||.-       .+..+.++.+.-.....++..++-.+..++
T Consensus       411 fcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqiriprslsvkas~vl  490 (593)
T KOG0695|consen  411 FCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIRIPRSLSVKASHVL  490 (593)
T ss_pred             ccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcccccceeehhhHHHH
Confidence            9999999999999999999999999999999999999999863       233444444444445567788888899999


Q ss_pred             HHHhccCCCCCC------CHHHHhcChhhhhhhh
Q psy1546         277 EACLNKDPENRP------TAKELLKFPFIRKAKK  304 (604)
Q Consensus       277 ~~~L~~dP~~Rp------T~~elL~hp~f~~~~~  304 (604)
                      +..|.+||.+|.      .+.++-.|+||+...+
T Consensus       491 kgflnkdp~erlgc~~~~g~~dik~h~ffr~idw  524 (593)
T KOG0695|consen  491 KGFLNKDPKERLGCRPQTGFSDIKSHAFFRSIDW  524 (593)
T ss_pred             HHhhcCCcHHhcCCCcccchhhhhcchhhhhCCH
Confidence            999999999995      3789999999985544

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=8.7e-36  Score=298.79  Aligned_cols=218  Identities=22%  Similarity=0.322  Sum_probs=179.1

Q ss_pred             cCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCC----------eEEEEEEecCCCChhhHhh
Q psy1546          68 GSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGT----------KLWIIMEYLGGGSALDLMK  137 (604)
Q Consensus        68 G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~----------~lyLVmEy~~ggsL~~~l~  137 (604)
                      |.||.||+|.+..+++.||+|.+....      ...+|...+....||++.          .+|+||||++||+|.+++.
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~   77 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHIS   77 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHH
Confidence            899999999999999999999996543      122344445555677743          4689999999999999875


Q ss_pred             c-CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCCCCcccccCCCCCChHHh
Q psy1546         138 A-GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVI  216 (604)
Q Consensus       138 ~-~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~~~~~~GT~~Y~APE~l  216 (604)
                      . ..+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||.+..+...   .....++..|+|||.+
T Consensus        78 ~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~---~~~~~~~~~y~aPE~~  154 (237)
T cd05576          78 KFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS---CDGEAVENMYCAPEVG  154 (237)
T ss_pred             HhcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhccccc---cccCCcCccccCCccc
Confidence            4 57999999999999999999999999999999999999999999999999988655432   2234567889999999


Q ss_pred             hcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCCCCCCCCccchHHHHHHHHHHhccCCCCCCCH-----H
Q psy1546         217 KQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPENRPTA-----K  291 (604)
Q Consensus       217 ~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~RpT~-----~  291 (604)
                      .+..++.++|||||||++|||++|..|+......     +.......++..++..+++||.+||+.||.+||++     +
T Consensus       155 ~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~  229 (237)
T cd05576         155 GISEETEACDWWSLGAILFELLTGKTLVECHPSG-----INTHTTLNIPEWVSEEARSLLQQLLQFNPTERLGAGVAGVE  229 (237)
T ss_pred             CCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh-----cccccccCCcccCCHHHHHHHHHHccCCHHHhcCCCccchH
Confidence            8888999999999999999999999887543211     11111223456688999999999999999999985     9


Q ss_pred             HHhcChhh
Q psy1546         292 ELLKFPFI  299 (604)
Q Consensus       292 elL~hp~f  299 (604)
                      ++++||||
T Consensus       230 ~~~~h~~~  237 (237)
T cd05576         230 DIKSHPFF  237 (237)
T ss_pred             HHHcCCCC
Confidence            99999997

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=1.7e-35  Score=303.37  Aligned_cols=226  Identities=23%  Similarity=0.393  Sum_probs=180.0

Q ss_pred             EEcccCcEEEEEEEECC------------------------CCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCCe
Q psy1546          64 RIGKGSFGEVFKGIDNR------------------------TQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTK  119 (604)
Q Consensus        64 ~LG~G~fG~Vy~a~~~~------------------------t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~~  119 (604)
                      .||+|+||.||+|....                        ....||+|++..... .....+.+|+.+++.+.|||+.+
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~-~~~~~~~~~~~~~~~l~h~niv~   80 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHR-DIALAFFETASLMSQVSHIHLAF   80 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHH-HHHHHHHHHHHHHhcCCCCCeee
Confidence            58999999999997432                        124589999865432 33456788999999999999665


Q ss_pred             E----------EEEEEecCCCChhhHhhc--CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCC------
Q psy1546         120 L----------WIIMEYLGGGSALDLMKA--GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMG------  181 (604)
Q Consensus       120 l----------yLVmEy~~ggsL~~~l~~--~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g------  181 (604)
                      +          |+||||+++|+|..++..  +.+++..+..++.||+.||+|||++||+||||||+|||++..+      
T Consensus        81 ~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~~~~  160 (274)
T cd05076          81 VHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEGTS  160 (274)
T ss_pred             EEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcccCcc
Confidence            4          699999999999998854  5689999999999999999999999999999999999997644      


Q ss_pred             -CeEEecccccccccCCCCCCcccccCCCCCChHHhhc-CCCCCcchhhhHHHHHHHHH-hCCCCCCCCChhhHhhhcCC
Q psy1546         182 -DVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQ-SAYDSKADIWSLGITAIELA-KGEPPNSELHPMRVLFLIPK  258 (604)
Q Consensus       182 -~vKL~DFGlA~~~~~~~~~~~~~~GT~~Y~APE~l~~-~~~~~~sDVwSLGviL~eLl-tG~~Pf~~~~~~~~~~~i~~  258 (604)
                       .+||+|||++......    ....++..|+|||.+.+ ..++.++|||||||++|||+ +|..||..............
T Consensus       161 ~~~kl~d~g~~~~~~~~----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~  236 (274)
T cd05076         161 PFIKLSDPGVSFTALSR----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKERFYEK  236 (274)
T ss_pred             ceeeecCCccccccccc----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHHHHHh
Confidence             3899999988544322    23357888999999865 56889999999999999985 69999987665443332221


Q ss_pred             CCCCCCCccchHHHHHHHHHHhccCCCCCCCHHHHhcC
Q psy1546         259 NNPPQLTGNYTKQFKEFVEACLNKDPENRPTAKELLKF  296 (604)
Q Consensus       259 ~~~~~~~~~~s~~l~~Li~~~L~~dP~~RpT~~elL~h  296 (604)
                      .  ..++......+.+||.+||..+|.+|||+.+||++
T Consensus       237 ~--~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~  272 (274)
T cd05076         237 K--HRLPEPSCKELATLISQCLTYEPTQRPSFRTILRD  272 (274)
T ss_pred             c--cCCCCCCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence            1  12233456789999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>KOG0671|consensus

Probab=100.00  E-value=9.5e-37  Score=312.38  Aligned_cols=239  Identities=29%  Similarity=0.432  Sum_probs=193.2

Q ss_pred             cceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCC--CC--------------CCeEE
Q psy1546          58 IFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDS--PY--------------GTKLW  121 (604)
Q Consensus        58 ~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~h--p~--------------~~~ly  121 (604)
                      .|.+..+||+|.||.|..+.+..++..||||+++.-  ....+...-||.+|.++.+  |+              ..++|
T Consensus        90 Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V--~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghiC  167 (415)
T KOG0671|consen   90 RYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV--DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHIC  167 (415)
T ss_pred             ceehhhhhcCCcccceEEEeecCCCceehHHHHHHH--HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCceE
Confidence            488889999999999999999999999999998533  3444566779999999843  22              34568


Q ss_pred             EEEEecCCCChhhHhhcC---CCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecC-------------------
Q psy1546         122 IIMEYLGGGSALDLMKAG---NFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSE-------------------  179 (604)
Q Consensus       122 LVmEy~~ggsL~~~l~~~---~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~-------------------  179 (604)
                      ||+|.+ |.++.++++.+   .|+...++.+++||+++++|||+.+++|-||||+|||+.+                   
T Consensus       168 ivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~~~~~r~~  246 (415)
T KOG0671|consen  168 IVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKKVCFIRPL  246 (415)
T ss_pred             EEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCccceeccC
Confidence            999998 77999999874   5899999999999999999999999999999999999942                   


Q ss_pred             -CCCeEEecccccccccCCCCCCcccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHh---hh
Q psy1546         180 -MGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVL---FL  255 (604)
Q Consensus       180 -~g~vKL~DFGlA~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~---~~  255 (604)
                       .-.|+|+|||.|....   ....+.+.|..|+|||++.+-.++..+||||+||||+||++|...|+..+..+.+   ..
T Consensus       247 ks~~I~vIDFGsAtf~~---e~hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EHLaMMer  323 (415)
T KOG0671|consen  247 KSTAIKVIDFGSATFDH---EHHSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLEHLAMMER  323 (415)
T ss_pred             CCcceEEEecCCcceec---cCcceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHHHHHHHHH
Confidence             2358999999995543   2336788999999999999999999999999999999999999999887754422   22


Q ss_pred             cCCCCCC-----------------CCC-------------------------ccchHHHHHHHHHHhccCCCCCCCHHHH
Q psy1546         256 IPKNNPP-----------------QLT-------------------------GNYTKQFKEFVEACLNKDPENRPTAKEL  293 (604)
Q Consensus       256 i~~~~~~-----------------~~~-------------------------~~~s~~l~~Li~~~L~~dP~~RpT~~el  293 (604)
                      |....+.                 .++                         .....++.|||++||..||.+|+|+.|+
T Consensus       324 IlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~RiTl~EA  403 (415)
T KOG0671|consen  324 ILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRITLREA  403 (415)
T ss_pred             hhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccccccHHHH
Confidence            2111000                 000                         0012358899999999999999999999


Q ss_pred             hcChhhhhh
Q psy1546         294 LKFPFIRKA  302 (604)
Q Consensus       294 L~hp~f~~~  302 (604)
                      |.||||...
T Consensus       404 L~HpFF~~~  412 (415)
T KOG0671|consen  404 LSHPFFARL  412 (415)
T ss_pred             hcCHHhhcC
Confidence            999999754

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=3.9e-35  Score=299.03  Aligned_cols=231  Identities=24%  Similarity=0.384  Sum_probs=182.4

Q ss_pred             EEcccCcEEEEEEEECCC--CcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCCe----------EEEEEEecCCCC
Q psy1546          64 RIGKGSFGEVFKGIDNRT--QQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTK----------LWIIMEYLGGGS  131 (604)
Q Consensus        64 ~LG~G~fG~Vy~a~~~~t--~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~~----------lyLVmEy~~ggs  131 (604)
                      .||+|+||.||+|.....  ...+++|.+.........+.+.+|+.+++.++||++.+          +|+||||+.+|+
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~   81 (268)
T cd05086           2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD   81 (268)
T ss_pred             cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence            589999999999975433  34567787765544445678899999999999998654          479999999999


Q ss_pred             hhhHhhc-----CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCC--CCCccc
Q psy1546         132 ALDLMKA-----GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTT--SKRNTF  204 (604)
Q Consensus       132 L~~~l~~-----~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~--~~~~~~  204 (604)
                      |.+++..     ..+++..++.++.||+.||.|||+++|+||||||+|||++.++.++|+|||++.......  ......
T Consensus        82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~  161 (268)
T cd05086          82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDK  161 (268)
T ss_pred             HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcchhhhcccCC
Confidence            9999864     235667788999999999999999999999999999999999999999999985432111  122345


Q ss_pred             ccCCCCCChHHhhc-------CCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHhhhcCCCC-----CCCCCccchHH
Q psy1546         205 VGTPFWMAPEVIKQ-------SAYDSKADIWSLGITAIELAK-GEPPNSELHPMRVLFLIPKNN-----PPQLTGNYTKQ  271 (604)
Q Consensus       205 ~GT~~Y~APE~l~~-------~~~~~~sDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~~i~~~~-----~~~~~~~~s~~  271 (604)
                      +|+..|+|||++..       ..++.++|||||||++|||++ |..||......+....+....     .+.+...+++.
T Consensus       162 ~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (268)
T cd05086         162 CVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLELPYSER  241 (268)
T ss_pred             cCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCccCCCCcHH
Confidence            78899999999853       235678999999999999996 677888776655444332221     23444567889


Q ss_pred             HHHHHHHHhccCCCCCCCHHHHhc
Q psy1546         272 FKEFVEACLNKDPENRPTAKELLK  295 (604)
Q Consensus       272 l~~Li~~~L~~dP~~RpT~~elL~  295 (604)
                      +.+++..|| .+|.+||++.+|++
T Consensus       242 ~~~l~~~c~-~~P~~Rp~~~~i~~  264 (268)
T cd05086         242 WYEVLQFCW-LSPEKRATAEEVHR  264 (268)
T ss_pred             HHHHHHHHh-hCcccCCCHHHHHH
Confidence            999999999 68999999999976

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>KOG0603|consensus

Probab=100.00  E-value=3e-36  Score=326.16  Aligned_cols=232  Identities=28%  Similarity=0.402  Sum_probs=197.0

Q ss_pred             ccceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHH-hhCCCCCCC----------eEEEEEE
Q psy1546          57 LIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVL-SQCDSPYGT----------KLWIIME  125 (604)
Q Consensus        57 ~~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL-~~l~hp~~~----------~lyLVmE  125 (604)
                      ..|.+...||.|+|+.|-.+.+..+++.+++|++....     ....+|+.++ ..-.||+++          .+|+|||
T Consensus       322 ~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~-----~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e  396 (612)
T KOG0603|consen  322 ESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA-----DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVME  396 (612)
T ss_pred             hhhccccccCCCCccceeeeeccccccchhheeccccc-----cccccccchhhhhcCCCcceeecceecCCceeeeeeh
Confidence            34778888999999999999999999999999997662     2334566444 344678754          4589999


Q ss_pred             ecCCCChhhHhhcCCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEe-cCCCCeEEecccccccccCCCCCCccc
Q psy1546         126 YLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLL-SEMGDVKLADFGVAGTLTNTTSKRNTF  204 (604)
Q Consensus       126 y~~ggsL~~~l~~~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl-~~~g~vKL~DFGlA~~~~~~~~~~~~~  204 (604)
                      ++.|+.|.+.+...+.....+..|+++|+.||.|||++|||||||||+|||+ +..|+++|+|||.++.....   ..+.
T Consensus       397 ~l~g~ell~ri~~~~~~~~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~---~~tp  473 (612)
T KOG0603|consen  397 LLDGGELLRRIRSKPEFCSEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS---CDTP  473 (612)
T ss_pred             hccccHHHHHHHhcchhHHHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCchh---hccc
Confidence            9999999888877665557888899999999999999999999999999999 68999999999999776543   3455


Q ss_pred             ccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChh-hHhhhcCCCCCCCCCccchHHHHHHHHHHhccC
Q psy1546         205 VGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPM-RVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKD  283 (604)
Q Consensus       205 ~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~-~~~~~i~~~~~~~~~~~~s~~l~~Li~~~L~~d  283 (604)
                      |-|..|.|||++....|+.++||||||++||+||+|..||...... ++...+...   .+...+++.+++||..||+.|
T Consensus       474 ~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~~~---~~s~~vS~~AKdLl~~LL~~d  550 (612)
T KOG0603|consen  474 ALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQMP---KFSECVSDEAKDLLQQLLQVD  550 (612)
T ss_pred             chhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhhcCC---ccccccCHHHHHHHHHhccCC
Confidence            7789999999999999999999999999999999999999876555 444444333   334788999999999999999


Q ss_pred             CCCCCCHHHHhcChhh
Q psy1546         284 PENRPTAKELLKFPFI  299 (604)
Q Consensus       284 P~~RpT~~elL~hp~f  299 (604)
                      |.+|+++.+++.||||
T Consensus       551 P~~Rl~~~~i~~h~w~  566 (612)
T KOG0603|consen  551 PALRLGADEIGAHPWF  566 (612)
T ss_pred             hhhCcChhhhccCcch
Confidence            9999999999999999

>KOG1187|consensus

Probab=100.00  E-value=2.5e-35  Score=314.14  Aligned_cols=236  Identities=31%  Similarity=0.505  Sum_probs=186.5

Q ss_pred             cceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCCe-----------EEEEEEe
Q psy1546          58 IFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTK-----------LWIIMEY  126 (604)
Q Consensus        58 ~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~~-----------lyLVmEy  126 (604)
                      .|....+||+|+||.||+|..... ..||||.+....... ...|..|+.+|.+++|+|.++           .+||+||
T Consensus        76 ~Fs~~~~ig~Ggfg~VYkG~l~~~-~~vAVK~~~~~~~~~-~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~~LVYEy  153 (361)
T KOG1187|consen   76 NFSESNLIGEGGFGTVYKGVLSDG-TVVAVKRLSSNSGQG-EREFLNEVEILSRLRHPNLVKLLGYCLEGGEHRLLVYEY  153 (361)
T ss_pred             CCchhcceecCCCeEEEEEEECCC-CEEEEEEecCCCCcc-hhHHHHHHHHHhcCCCcCcccEEEEEecCCceEEEEEEc
Confidence            477778999999999999987654 899999887655432 455999999999999999443           6799999


Q ss_pred             cCCCChhhHhhcC---CCcHHHHHHHHHHHHHHhHHhhhCC---ccccccccceeEecCCCCeEEecccccccccCCCCC
Q psy1546         127 LGGGSALDLMKAG---NFEEMHIAVILREVLKGLDYLHSER---KLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSK  200 (604)
Q Consensus       127 ~~ggsL~~~l~~~---~lse~~i~~i~~qIl~gL~yLHs~g---IiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~  200 (604)
                      +++|+|.+++...   .++|.....|+.+++.||+|||...   |||||||++|||||++++.||+|||+|+........
T Consensus       154 m~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~~~~~~~  233 (361)
T KOG1187|consen  154 MPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLGPEGDTS  233 (361)
T ss_pred             cCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcccCCccccc
Confidence            9999999998653   7899999999999999999999864   999999999999999999999999999655431222


Q ss_pred             Cccc-ccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCC---hhhHhh----hcCC-----CCCCCCC-c
Q psy1546         201 RNTF-VGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELH---PMRVLF----LIPK-----NNPPQLT-G  266 (604)
Q Consensus       201 ~~~~-~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~---~~~~~~----~i~~-----~~~~~~~-~  266 (604)
                      ..+. .||.+|+|||++..+..+.++||||||++|.||++|+.+.....   ......    .+..     -..+.+. .
T Consensus       234 ~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~~~eiiD~~l~~~  313 (361)
T KOG1187|consen  234 VSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGKLREIVDPRLKEG  313 (361)
T ss_pred             eeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcchhheeCCCccCC
Confidence            2223 89999999999999999999999999999999999998766432   111111    1111     1122222 2


Q ss_pred             cch--H---HHHHHHHHHhccCCCCCCCHHHHhc
Q psy1546         267 NYT--K---QFKEFVEACLNKDPENRPTAKELLK  295 (604)
Q Consensus       267 ~~s--~---~l~~Li~~~L~~dP~~RpT~~elL~  295 (604)
                      .++  .   .+..+..+|++.+|..||++.||++
T Consensus       314 ~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~  347 (361)
T KOG1187|consen  314 EYPDEKEVKKLAELALRCLRPDPKERPTMSQVVK  347 (361)
T ss_pred             CCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHH
Confidence            333  2   3557788999999999999999754

>KOG4257|consensus

Probab=100.00  E-value=5.4e-36  Score=320.06  Aligned_cols=236  Identities=28%  Similarity=0.457  Sum_probs=209.5

Q ss_pred             eeeeEEcccCcEEEEEEEECCC----CcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCCeE---------EEEEEe
Q psy1546          60 TKQERIGKGSFGEVFKGIDNRT----QQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTKL---------WIIMEY  126 (604)
Q Consensus        60 ~i~~~LG~G~fG~Vy~a~~~~t----~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~~l---------yLVmEy  126 (604)
                      +..++||.|-||.||+|.....    .-.||||.-+.+...+..+.|..|..+|+.++||+++++         |||||+
T Consensus       392 tl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~P~WivmEL  471 (974)
T KOG4257|consen  392 TLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQPMWIVMEL  471 (974)
T ss_pred             cHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeeccceeEEEec
Confidence            5567899999999999986432    335899998776666667999999999999999998775         799999


Q ss_pred             cCCCChhhHhhc--CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCCCCcc-
Q psy1546         127 LGGGSALDLMKA--GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNT-  203 (604)
Q Consensus       127 ~~ggsL~~~l~~--~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~~~~-  203 (604)
                      ++-|.|..+++.  ..++......++.||+.||.|||++.+|||||...||||....-|||+|||+++.+.+......+ 
T Consensus       472 ~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~yYkaS~  551 (974)
T KOG4257|consen  472 APLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDDAYYKASR  551 (974)
T ss_pred             ccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccchhhhccccchhhccc
Confidence            999999999976  46888889999999999999999999999999999999999999999999999888765543332 


Q ss_pred             cccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHhhhcCCCCCCCCCccchHHHHHHHHHHhcc
Q psy1546         204 FVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAK-GEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNK  282 (604)
Q Consensus       204 ~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~~L~~  282 (604)
                      ..-..-|||||.+.-..++.++|||.|||++||++. |..||.+....++...+..+.+.+.++++|+.+..|+.+||++
T Consensus       552 ~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGeRlP~P~nCPp~LYslmskcWay  631 (974)
T KOG4257|consen  552 GKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGERLPCPPNCPPALYSLMSKCWAY  631 (974)
T ss_pred             cccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCCCCCCCCCCCChHHHHHHHHHhcc
Confidence            223456999999999999999999999999999875 9999999999999999999999999999999999999999999


Q ss_pred             CCCCCCCHHHHhc
Q psy1546         283 DPENRPTAKELLK  295 (604)
Q Consensus       283 dP~~RpT~~elL~  295 (604)
                      ||.+||++.||..
T Consensus       632 eP~kRPrftei~~  644 (974)
T KOG4257|consen  632 EPSKRPRFTEIKA  644 (974)
T ss_pred             CcccCCcHHHHHH
Confidence            9999999998854

>KOG0666|consensus

Probab=100.00  E-value=2.7e-36  Score=301.16  Aligned_cols=245  Identities=28%  Similarity=0.488  Sum_probs=190.8

Q ss_pred             ccceeeeEEcccCcEEEEEEEECCCCc----EEEEEEecchhhHHHH-HHHHHHHHHHhhCCCCCC-----------CeE
Q psy1546          57 LIFTKQERIGKGSFGEVFKGIDNRTQQ----VVAIKIIDLEEAEDEI-EDIQQEIMVLSQCDSPYG-----------TKL  120 (604)
Q Consensus        57 ~~y~i~~~LG~G~fG~Vy~a~~~~t~~----~vAVK~i~~~~~~~~~-~~l~~Ei~iL~~l~hp~~-----------~~l  120 (604)
                      ..|+++..||+|.||.||+|..+.++.    .||||.++..+...-+ ....|||.+++.+.|+|.           .++
T Consensus        24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v  103 (438)
T KOG0666|consen   24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKV  103 (438)
T ss_pred             HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceE
Confidence            348999999999999999997655433    7899998765432222 456799999999999984           457


Q ss_pred             EEEEEecCCCChhhHhhc------CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCC----CCeEEecccc
Q psy1546         121 WIIMEYLGGGSALDLMKA------GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEM----GDVKLADFGV  190 (604)
Q Consensus       121 yLVmEy~~ggsL~~~l~~------~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~----g~vKL~DFGl  190 (604)
                      ||++||.+. +|..+|+.      ..++...++.|+.||+.|+.|||++=|+||||||.||||..+    |.|||+|||+
T Consensus       104 ~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDlGl  182 (438)
T KOG0666|consen  104 WLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADLGL  182 (438)
T ss_pred             EEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeecccH
Confidence            999999965 47777743      458889999999999999999999999999999999999877    8999999999


Q ss_pred             cccccCCCC---CCcccccCCCCCChHHhhcC-CCCCcchhhhHHHHHHHHHhCCCCCCCCChh-------------hHh
Q psy1546         191 AGTLTNTTS---KRNTFVGTPFWMAPEVIKQS-AYDSKADIWSLGITAIELAKGEPPNSELHPM-------------RVL  253 (604)
Q Consensus       191 A~~~~~~~~---~~~~~~GT~~Y~APE~l~~~-~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~-------------~~~  253 (604)
                      |+.+.++-.   .....+-|.+|+|||++.+. .|+.+.|||++|||+.||++-.+.|.+....             .++
T Consensus       183 aR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~rIf  262 (438)
T KOG0666|consen  183 ARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDRIF  262 (438)
T ss_pred             HHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHHHH
Confidence            988765433   23456789999999999875 5999999999999999999998877654321             111


Q ss_pred             hhcCC---CCCCCC---C--------------cc------------chHHHHHHHHHHhccCCCCCCCHHHHhcChhhhh
Q psy1546         254 FLIPK---NNPPQL---T--------------GN------------YTKQFKEFVEACLNKDPENRPTAKELLKFPFIRK  301 (604)
Q Consensus       254 ~~i~~---~~~~~~---~--------------~~------------~s~~l~~Li~~~L~~dP~~RpT~~elL~hp~f~~  301 (604)
                      ..+-.   ...+.+   +              .+            -++...+|+.+||..||.+|+|++++|+|+||++
T Consensus       263 ~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~yF~~  342 (438)
T KOG0666|consen  263 EVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHPYFTE  342 (438)
T ss_pred             HHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhccccccc
Confidence            11100   000000   0              00            1234679999999999999999999999999976


Q ss_pred             h
Q psy1546         302 A  302 (604)
Q Consensus       302 ~  302 (604)
                      .
T Consensus       343 d  343 (438)
T KOG0666|consen  343 D  343 (438)
T ss_pred             C
Confidence            4

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=100.00  E-value=3.2e-35  Score=330.83  Aligned_cols=246  Identities=24%  Similarity=0.336  Sum_probs=173.7

Q ss_pred             ccceeeeEEcccCcEEEEEEEECCC----CcEEEEEEecchhhHHH-H-HHHHHH-----HHHHhhCC----CCCCCeEE
Q psy1546          57 LIFTKQERIGKGSFGEVFKGIDNRT----QQVVAIKIIDLEEAEDE-I-EDIQQE-----IMVLSQCD----SPYGTKLW  121 (604)
Q Consensus        57 ~~y~i~~~LG~G~fG~Vy~a~~~~t----~~~vAVK~i~~~~~~~~-~-~~l~~E-----i~iL~~l~----hp~~~~ly  121 (604)
                      ..|.+.++||+|+||.||+|.+..+    +..||||.+........ . +.+.+.     ...+..+.    ......+|
T Consensus       132 ~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~e~~~~e~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~  211 (566)
T PLN03225        132 DDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVEIWMNERVRRACPNSCADFVYGFLEPVSSKKEDEYW  211 (566)
T ss_pred             CCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchhHHHHHHHHHhhchhhHHHHHHhhhcccccccCCceE
Confidence            3599999999999999999999988    89999998754321111 0 111110     01111111    13456789


Q ss_pred             EEEEecCCCChhhHhhcCCC---------------------cHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecC-
Q psy1546         122 IIMEYLGGGSALDLMKAGNF---------------------EEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSE-  179 (604)
Q Consensus       122 LVmEy~~ggsL~~~l~~~~l---------------------se~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~-  179 (604)
                      |||||+++++|.+++....+                     .+..+..++.||+.||.|||++||+||||||+||||+. 
T Consensus       212 LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLKP~NILl~~~  291 (566)
T PLN03225        212 LVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQNIIFSEG  291 (566)
T ss_pred             EEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCCHHHEEEeCC
Confidence            99999999999998865432                     13346679999999999999999999999999999985 


Q ss_pred             CCCeEEecccccccccCCC-CCCcccccCCCCCChHHhhcC----------------------CCCCcchhhhHHHHHHH
Q psy1546         180 MGDVKLADFGVAGTLTNTT-SKRNTFVGTPFWMAPEVIKQS----------------------AYDSKADIWSLGITAIE  236 (604)
Q Consensus       180 ~g~vKL~DFGlA~~~~~~~-~~~~~~~GT~~Y~APE~l~~~----------------------~~~~~sDVwSLGviL~e  236 (604)
                      ++.+||+|||+|+.+.... .....+++|+.|||||.+...                      .++.++|||||||+|||
T Consensus       292 ~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlGviL~e  371 (566)
T PLN03225        292 SGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQ  371 (566)
T ss_pred             CCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHHHHHHHH
Confidence            5799999999997654322 233567899999999976432                      23456699999999999


Q ss_pred             HHhCCCCCCCCChhhHhhhc--------------CCCCCCC------CCccchHHHHHHHHHHhccCCCCCCCHHHHhcC
Q psy1546         237 LAKGEPPNSELHPMRVLFLI--------------PKNNPPQ------LTGNYTKQFKEFVEACLNKDPENRPTAKELLKF  296 (604)
Q Consensus       237 LltG~~Pf~~~~~~~~~~~i--------------~~~~~~~------~~~~~s~~l~~Li~~~L~~dP~~RpT~~elL~h  296 (604)
                      |+++..++..... .....+              .......      +.........+||.+||.+||.+|||+.|+|+|
T Consensus       372 l~~~~~~~~~~~~-~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR~ta~e~L~H  450 (566)
T PLN03225        372 MAFPNLRSDSNLI-QFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQRISAKAALAH  450 (566)
T ss_pred             HHhCcCCCchHHH-HHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcccCCCHHHHhCC
Confidence            9998776543211 000000              0000000      011122345689999999999999999999999


Q ss_pred             hhhhhhh
Q psy1546         297 PFIRKAK  303 (604)
Q Consensus       297 p~f~~~~  303 (604)
                      |||....
T Consensus       451 pff~~~~  457 (566)
T PLN03225        451 PYFDREG  457 (566)
T ss_pred             cCcCCCC
Confidence            9997643

>KOG0669|consensus

Probab=100.00  E-value=5.3e-37  Score=298.72  Aligned_cols=255  Identities=28%  Similarity=0.421  Sum_probs=201.2

Q ss_pred             cccceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhh-HHHHHHHHHHHHHHhhCCCCCC-----------------
Q psy1546          56 ELIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA-EDEIEDIQQEIMVLSQCDSPYG-----------------  117 (604)
Q Consensus        56 ~~~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~-~~~~~~l~~Ei~iL~~l~hp~~-----------------  117 (604)
                      ...|....+||+|.||.||+|+.+.+++.||+|++-.+.. +..-....+|+.+|..++|++.                 
T Consensus        16 ~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~   95 (376)
T KOG0669|consen   16 VSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRD   95 (376)
T ss_pred             chHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccc
Confidence            3458888999999999999999999999999987644321 1122456789999999999972                 


Q ss_pred             -CeEEEEEEecCCCChhhHhhc--CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccc
Q psy1546         118 -TKLWIIMEYLGGGSALDLMKA--GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTL  194 (604)
Q Consensus       118 -~~lyLVmEy~~ggsL~~~l~~--~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~  194 (604)
                       ..+|+||.+|+. +|..++..  .+|+..+++.++++++.||.|+|...|+|||+|++|+||+.+|.+||+|||+|+.+
T Consensus        96 r~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADFGlar~f  174 (376)
T KOG0669|consen   96 RATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADFGLARAF  174 (376)
T ss_pred             cceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeeccccccce
Confidence             237999999964 57777754  57999999999999999999999999999999999999999999999999999766


Q ss_pred             cCCCC----CCcccccCCCCCChHHhhcC-CCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCC-------CC-
Q psy1546         195 TNTTS----KRNTFVGTPFWMAPEVIKQS-AYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKN-------NP-  261 (604)
Q Consensus       195 ~~~~~----~~~~~~GT~~Y~APE~l~~~-~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~-------~~-  261 (604)
                      .....    .....+-|.+|++||.+.+. .|+++.|||..|||+.||++|.+-+++......+..|...       .+ 
T Consensus       175 s~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkevWP  254 (376)
T KOG0669|consen  175 STSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVWP  254 (376)
T ss_pred             ecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcccCC
Confidence            43221    12334679999999999764 6999999999999999999999999888776655433210       00 


Q ss_pred             -------------CCCCc-------------cchHHHHHHHHHHhccCCCCCCCHHHHhcChhhhhhhhh-hhHHHH
Q psy1546         262 -------------PQLTG-------------NYTKQFKEFVEACLNKDPENRPTAKELLKFPFIRKAKKN-AYLIDL  311 (604)
Q Consensus       262 -------------~~~~~-------------~~s~~l~~Li~~~L~~dP~~RpT~~elL~hp~f~~~~~~-~~l~~~  311 (604)
                                   ++++.             .-++++.+|+.++|..||.+|+++.++|.|.||.+-... ..+.++
T Consensus       255 ~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kdp~pqanl~~m  331 (376)
T KOG0669|consen  255 NVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWKDPMPQANLQDM  331 (376)
T ss_pred             CcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhcCCcchhhHHHH
Confidence                         00110             013477899999999999999999999999999765543 334433

>KOG0576|consensus

Probab=100.00  E-value=1.6e-36  Score=327.04  Aligned_cols=263  Identities=46%  Similarity=0.870  Sum_probs=234.4

Q ss_pred             CccccceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCC----------eEEEE
Q psy1546          54 DPELIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGT----------KLWII  123 (604)
Q Consensus        54 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~----------~lyLV  123 (604)
                      ++...|..+.++|.|.||.||+|+++.++++.|+|+++.... +.+..+++||.+++.++|||++          ++|++
T Consensus        12 nP~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~-dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwic   90 (829)
T KOG0576|consen   12 NPQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPG-DDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWIC   90 (829)
T ss_pred             CCccchhheeeecCCcccchhhhcccccCchhhheeeeccCC-ccccccccceeeeecCCCcChHHHHhhhhhhcCcEEE
Confidence            666779999999999999999999999999999999977653 4568899999999999999954          56899


Q ss_pred             EEecCCCChhhHhhc-CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCCCCc
Q psy1546         124 MEYLGGGSALDLMKA-GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRN  202 (604)
Q Consensus       124 mEy~~ggsL~~~l~~-~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~~~  202 (604)
                      ||||+||+|.+.-.- +.+++.++....+..++||+|||++|-+|||||..|||+++.|.+||+|||.+..++....++.
T Consensus        91 MEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqitati~Krk  170 (829)
T KOG0576|consen   91 MEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQITATIAKRK  170 (829)
T ss_pred             EEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhhhhhhhhh
Confidence            999999999997654 8899999999999999999999999999999999999999999999999999999988888899


Q ss_pred             ccccCCCCCChHHh---hcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCCCCC--CC--CccchHHHHHH
Q psy1546         203 TFVGTPFWMAPEVI---KQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPP--QL--TGNYTKQFKEF  275 (604)
Q Consensus       203 ~~~GT~~Y~APE~l---~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~~~~--~~--~~~~s~~l~~L  275 (604)
                      .+.||+.|||||+-   +...|...+|||++|++..||---++|-...++++.+++..+..+.  .+  ...+++.|.+|
T Consensus       171 sfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lkDk~kws~~fh~f  250 (829)
T KOG0576|consen  171 SFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLKDKTKWSEFFHNF  250 (829)
T ss_pred             cccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcccCCccchHHHHHH
Confidence            99999999999986   4667999999999999999999999999899999998887665532  22  34578899999


Q ss_pred             HHHHhccCCCCCCCHHHHhcChhhhhhhhhhhHHHHHHHHHH
Q psy1546         276 VEACLNKDPENRPTAKELLKFPFIRKAKKNAYLIDLIDRYKK  317 (604)
Q Consensus       276 i~~~L~~dP~~RpT~~elL~hp~f~~~~~~~~l~~~~~~~~~  317 (604)
                      ++.+|.++|++|||++.+|.|||+..-....-.++++++++.
T Consensus       251 vK~altknpKkRptaeklL~h~fvs~~l~~rl~~eLLdK~n~  292 (829)
T KOG0576|consen  251 VKGALTKNPKKRPTAEKLLQHPFVSQTLSRRLAIELLDKVNN  292 (829)
T ss_pred             HHHHhcCCCccCCChhhheeceeeccchhhHHHHHHHHHccC
Confidence            999999999999999999999999877655566677777653

>KOG0199|consensus

Probab=100.00  E-value=2e-35  Score=319.09  Aligned_cols=246  Identities=24%  Similarity=0.396  Sum_probs=216.3

Q ss_pred             ccccceeeeEEcccCcEEEEEEEECCCC---cEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCCeEE---------E
Q psy1546          55 PELIFTKQERIGKGSFGEVFKGIDNRTQ---QVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTKLW---------I  122 (604)
Q Consensus        55 ~~~~y~i~~~LG~G~fG~Vy~a~~~~t~---~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~~ly---------L  122 (604)
                      ++....+.++||+|.||.|++|.+...+   ..||||++...........|.+|+.+|.+|+|++..+||         |
T Consensus       108 pee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~qp~mM  187 (1039)
T KOG0199|consen  108 PEEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLDQPAMM  187 (1039)
T ss_pred             cHHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeeccchhhH
Confidence            3444677889999999999999987533   359999998776666789999999999999999988886         8


Q ss_pred             EEEecCCCChhhHhhc---CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCC
Q psy1546         123 IMEYLGGGSALDLMKA---GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTS  199 (604)
Q Consensus       123 VmEy~~ggsL~~~l~~---~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~  199 (604)
                      |||+++.|+|.+.+++   ..|....+..|+.||+.||.||.++++|||||-..||||-....|||+|||+.+-+.....
T Consensus       188 V~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned  267 (1039)
T KOG0199|consen  188 VFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLMRALGENED  267 (1039)
T ss_pred             HhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecccceeccCCCCc
Confidence            9999999999999876   4578888899999999999999999999999999999999999999999999998875544


Q ss_pred             CCccc----ccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHhhhcCCCCCCCCCccchHHHHH
Q psy1546         200 KRNTF----VGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAK-GEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKE  274 (604)
Q Consensus       200 ~~~~~----~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~  274 (604)
                      .. .+    .-...|+|||.|+...++.++|||+|||+||||++ |..||.+.....++..|..+....-+..+++++.+
T Consensus       268 ~Y-vm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~erLpRPk~csedIY~  346 (1039)
T KOG0199|consen  268 MY-VMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAGERLPRPKYCSEDIYQ  346 (1039)
T ss_pred             ce-EecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhccccccCCCCCCChHHHHH
Confidence            33 21    12345999999999999999999999999999998 89999999999999999988888889999999999


Q ss_pred             HHHHHhccCCCCCCCHHHHhcChhhhh
Q psy1546         275 FVEACLNKDPENRPTAKELLKFPFIRK  301 (604)
Q Consensus       275 Li~~~L~~dP~~RpT~~elL~hp~f~~  301 (604)
                      ++..||..+|.+|||+..|...-+...
T Consensus       347 imk~cWah~paDRptFsair~~~~l~e  373 (1039)
T KOG0199|consen  347 IMKNCWAHNPADRPTFSAIREDLVLAE  373 (1039)
T ss_pred             HHHHhccCCccccccHHHHHHhHHHHh
Confidence            999999999999999999876545443

>KOG4250|consensus

Probab=100.00  E-value=7.9e-36  Score=325.17  Aligned_cols=231  Identities=29%  Similarity=0.536  Sum_probs=189.5

Q ss_pred             cceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCCeE----------------E
Q psy1546          58 IFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTKL----------------W  121 (604)
Q Consensus        58 ~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~~l----------------y  121 (604)
                      .|...+.||+|+||.||+|+++.+|+.||||.+.........+...+|+.+|++++|+|++++                .
T Consensus        14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~v   93 (732)
T KOG4250|consen   14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPV   93 (732)
T ss_pred             ceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccce
Confidence            467778899999999999999999999999999877666667888999999999999998776                4


Q ss_pred             EEEEecCCCChhhHhhc----CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEec--CCCC--eEEeccccccc
Q psy1546         122 IIMEYLGGGSALDLMKA----GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLS--EMGD--VKLADFGVAGT  193 (604)
Q Consensus       122 LVmEy~~ggsL~~~l~~----~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~--~~g~--vKL~DFGlA~~  193 (604)
                      +|||||.||+|+.+++.    .++++.+++.++.++..||.|||++|||||||||.||++-  .+|+  -||+|||.|+.
T Consensus        94 lvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Are  173 (732)
T KOG4250|consen   94 LVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAARE  173 (732)
T ss_pred             EEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeeccccccc
Confidence            99999999999999975    5799999999999999999999999999999999999983  4454  69999999998


Q ss_pred             ccCCCCCCcccccCCCCCChHHhh-cCCCCCcchhhhHHHHHHHHHhCCCCCCCCChh----hHhhhcCCCCC-------
Q psy1546         194 LTNTTSKRNTFVGTPFWMAPEVIK-QSAYDSKADIWSLGITAIELAKGEPPNSELHPM----RVLFLIPKNNP-------  261 (604)
Q Consensus       194 ~~~~~~~~~~~~GT~~Y~APE~l~-~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~----~~~~~i~~~~~-------  261 (604)
                      +.+.. ....++||+.|++||++. ...|+..+|.|||||++|+++||..||--....    ++...+....+       
T Consensus       174 l~d~s-~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v~i~~  252 (732)
T KOG4250|consen  174 LDDNS-LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGVAIGA  252 (732)
T ss_pred             CCCCC-eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCceeEee
Confidence            87555 667889999999999998 588999999999999999999999998643322    12222211111       


Q ss_pred             -------------CCCCccchH----HHHHHHHHHhccCCCCCCC
Q psy1546         262 -------------PQLTGNYTK----QFKEFVEACLNKDPENRPT  289 (604)
Q Consensus       262 -------------~~~~~~~s~----~l~~Li~~~L~~dP~~RpT  289 (604)
                                   .+.+..++.    .+...+..+|..+|++|..
T Consensus       253 ~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~  297 (732)
T KOG4250|consen  253 QEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGH  297 (732)
T ss_pred             ecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCC
Confidence                         111223333    3446778889999999973

>KOG0196|consensus

Probab=100.00  E-value=1.1e-35  Score=325.04  Aligned_cols=238  Identities=28%  Similarity=0.467  Sum_probs=215.4

Q ss_pred             ceeeeEEcccCcEEEEEEEECCCC---cEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCCeE----------EEEEE
Q psy1546          59 FTKQERIGKGSFGEVFKGIDNRTQ---QVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTKL----------WIIME  125 (604)
Q Consensus        59 y~i~~~LG~G~fG~Vy~a~~~~t~---~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~~l----------yLVmE  125 (604)
                      ..+.++||.|.||+||+|+.+..+   ..||||.++..-.++....|..|..||-+++|||+.+|          +||+|
T Consensus       631 i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiTE  710 (996)
T KOG0196|consen  631 VKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIITE  710 (996)
T ss_pred             eEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEhh
Confidence            477899999999999999988666   46999999888778888999999999999999997765          79999


Q ss_pred             ecCCCChhhHhhc--CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCCCCcc
Q psy1546         126 YLGGGSALDLMKA--GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNT  203 (604)
Q Consensus       126 y~~ggsL~~~l~~--~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~~~~  203 (604)
                      ||++|+|..+|+.  |.|+..++.-+++.|+.|++||-++|+|||||...||||+.+-.+|++|||+++.+.+......+
T Consensus       711 yMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~~~~yt  790 (996)
T KOG0196|consen  711 YMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYT  790 (996)
T ss_pred             hhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEeccccceeecccCCCcccc
Confidence            9999999999975  78999999999999999999999999999999999999999999999999999988655432222


Q ss_pred             cc-c--CCCCCChHHhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHhhhcCCCCCCCCCccchHHHHHHHHHH
Q psy1546         204 FV-G--TPFWMAPEVIKQSAYDSKADIWSLGITAIELAK-GEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEAC  279 (604)
Q Consensus       204 ~~-G--T~~Y~APE~l~~~~~~~~sDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~~  279 (604)
                      .. |  ..+|.|||.+...+++.++||||+|++|||.+. |..||-+....++...|..+.+.+.+-++|..+..|+..|
T Consensus       791 t~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyRLPpPmDCP~aL~qLMldC  870 (996)
T KOG0196|consen  791 TLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYRLPPPMDCPAALYQLMLDC  870 (996)
T ss_pred             ccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHHHHhccCCCCCCCCcHHHHHHHHHH
Confidence            22 2  467999999999999999999999999999765 9999999999999999999998888899999999999999


Q ss_pred             hccCCCCCCCHHHHhcC
Q psy1546         280 LNKDPENRPTAKELLKF  296 (604)
Q Consensus       280 L~~dP~~RpT~~elL~h  296 (604)
                      |++|-.+||.+.||+.+
T Consensus       871 WqkdR~~RP~F~qiV~~  887 (996)
T KOG0196|consen  871 WQKDRNRRPKFAQIVST  887 (996)
T ss_pred             HHHHhhcCCCHHHHHHH
Confidence            99999999999999764

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=100.00  E-value=1.1e-33  Score=279.11  Aligned_cols=230  Identities=40%  Similarity=0.656  Sum_probs=195.3

Q ss_pred             CcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCC----------CeEEEEEEecCCCChhhHhhc
Q psy1546          69 SFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYG----------TKLWIIMEYLGGGSALDLMKA  138 (604)
Q Consensus        69 ~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~----------~~lyLVmEy~~ggsL~~~l~~  138 (604)
                      +||.||+|.+..+++.||+|++...........+.+|+.+++.+.|++.          ...++||||+++++|..++..
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~   80 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK   80 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence            6899999999989999999999765443335788999999999999973          456899999999999999876


Q ss_pred             CC-CcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCCCCcccccCCCCCChHHhh
Q psy1546         139 GN-FEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIK  217 (604)
Q Consensus       139 ~~-lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~~~~~~GT~~Y~APE~l~  217 (604)
                      .. ++...+..++.+++.+|.|||+.+++|+||+|.||+++.++.++|+|||.+....... ......++..|++||.+.
T Consensus        81 ~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~~pE~~~  159 (244)
T smart00220       81 RGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG-LLTTFVGTPEYMAPEVLL  159 (244)
T ss_pred             ccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeecccc-ccccccCCcCCCCHHHHc
Confidence            44 8999999999999999999999999999999999999999999999999997665432 334567889999999999


Q ss_pred             cCCCCCcchhhhHHHHHHHHHhCCCCCCC-CChhhHhhhcCCCCCCCCCcc--chHHHHHHHHHHhccCCCCCCCHHHHh
Q psy1546         218 QSAYDSKADIWSLGITAIELAKGEPPNSE-LHPMRVLFLIPKNNPPQLTGN--YTKQFKEFVEACLNKDPENRPTAKELL  294 (604)
Q Consensus       218 ~~~~~~~sDVwSLGviL~eLltG~~Pf~~-~~~~~~~~~i~~~~~~~~~~~--~s~~l~~Li~~~L~~dP~~RpT~~elL  294 (604)
                      +..++.++|||+||+++|+|++|..||.. .........+...........  ++..+.+++.+||..+|++||++.+++
T Consensus       160 ~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~  239 (244)
T smart00220      160 GKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWKISPEAKDLIRKLLVKDPEKRLTAEEAL  239 (244)
T ss_pred             cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCccccccCCHHHHHHHHHHccCCchhccCHHHHh
Confidence            88899999999999999999999999987 444444444433333222222  788999999999999999999999999


Q ss_pred             cChhh
Q psy1546         295 KFPFI  299 (604)
Q Consensus       295 ~hp~f  299 (604)
                      +||||
T Consensus       240 ~~~~~  244 (244)
T smart00220      240 QHPFF  244 (244)
T ss_pred             hCCCC
Confidence            99997

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG1094|consensus

Probab=100.00  E-value=3e-34  Score=305.43  Aligned_cols=238  Identities=27%  Similarity=0.386  Sum_probs=202.1

Q ss_pred             ccceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCCeE----------EEEEEe
Q psy1546          57 LIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTKL----------WIIMEY  126 (604)
Q Consensus        57 ~~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~~l----------yLVmEy  126 (604)
                      ....+.++||+|-||.|.+|.-. .+.+||||+++..........|.+||++|.+|+|||++++          ++|+||
T Consensus       538 s~L~~~ekiGeGqFGEVhLCeve-g~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EY  616 (807)
T KOG1094|consen  538 SRLRFKEKIGEGQFGEVHLCEVE-GPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEY  616 (807)
T ss_pred             hheehhhhhcCcccceeEEEEec-CceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHH
Confidence            34678899999999999999854 3689999999888777777899999999999999998776          589999


Q ss_pred             cCCCChhhHhhcCC---CcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCCCC--
Q psy1546         127 LGGGSALDLMKAGN---FEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKR--  201 (604)
Q Consensus       127 ~~ggsL~~~l~~~~---lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~~--  201 (604)
                      ++.|+|..++....   +.......|+.||+.||+||.+.++|||||.+.|||++.++++||+|||+++.+......+  
T Consensus       617 mEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~vq  696 (807)
T KOG1094|consen  617 MENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYRVQ  696 (807)
T ss_pred             HhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCcccccccccCCceeee
Confidence            99999999987653   2445566799999999999999999999999999999999999999999998776544332  


Q ss_pred             cccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHH--hCCCCCCCCChhhHhhhcCC-------CCCCCCCccchHHH
Q psy1546         202 NTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELA--KGEPPNSELHPMRVLFLIPK-------NNPPQLTGNYTKQF  272 (604)
Q Consensus       202 ~~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLl--tG~~Pf~~~~~~~~~~~i~~-------~~~~~~~~~~s~~l  272 (604)
                      ...+-..+|||+|.+..++++.++|||+||++|||++  +...||......++......       ......+.-++..+
T Consensus       697 gr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l~~P~~cp~~l  776 (807)
T KOG1094|consen  697 GRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVLSRPPACPQGL  776 (807)
T ss_pred             cceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceeccCCCcCcHHH
Confidence            3355678999999999999999999999999999975  58899999888776654321       11334567789999


Q ss_pred             HHHHHHHhccCCCCCCCHHHHhc
Q psy1546         273 KEFVEACLNKDPENRPTAKELLK  295 (604)
Q Consensus       273 ~~Li~~~L~~dP~~RpT~~elL~  295 (604)
                      .++|.+||..|-.+||++++|..
T Consensus       777 yelml~Cw~~es~~RPsFe~lh~  799 (807)
T KOG1094|consen  777 YELMLRCWRRESEQRPSFEQLHL  799 (807)
T ss_pred             HHHHHHHhchhhhcCCCHHHHHH
Confidence            99999999999999999999855

>KOG0668|consensus

Probab=100.00  E-value=9.1e-35  Score=279.82  Aligned_cols=241  Identities=27%  Similarity=0.447  Sum_probs=196.7

Q ss_pred             cccceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCC-CCCCCeEE------------E
Q psy1546          56 ELIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCD-SPYGTKLW------------I  122 (604)
Q Consensus        56 ~~~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~-hp~~~~ly------------L  122 (604)
                      .+.|++.+++|+|.|++||.|.+..+++.++||++++-.    .+.+.+|+.||..|. |||+.+++            |
T Consensus        37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk----kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaL  112 (338)
T KOG0668|consen   37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK----KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSL  112 (338)
T ss_pred             cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH----HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchh
Confidence            345999999999999999999999999999999996543    367899999999997 99988774            8


Q ss_pred             EEEecCCCChhhHhhcCCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCC-CCeEEecccccccccCCCCCC
Q psy1546         123 IMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEM-GDVKLADFGVAGTLTNTTSKR  201 (604)
Q Consensus       123 VmEy~~ggsL~~~l~~~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~-g~vKL~DFGlA~~~~~~~~~~  201 (604)
                      |+||+.+.+...+..  .|+..+++.++.+++.||.|||++||+|||+||.|++|+.. ..++|+|+|+|..+. +....
T Consensus       113 iFE~v~n~Dfk~ly~--tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYH-p~~eY  189 (338)
T KOG0668|consen  113 IFEYVNNTDFKQLYP--TLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH-PGKEY  189 (338)
T ss_pred             HhhhhccccHHHHhh--hhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhhcC-CCcee
Confidence            999998888777665  48899999999999999999999999999999999999854 569999999996664 44555


Q ss_pred             cccccCCCCCChHHhhc-CCCCCcchhhhHHHHHHHHHhCCCCC-CCCChhhHhhhcCCC----------------CCCC
Q psy1546         202 NTFVGTPFWMAPEVIKQ-SAYDSKADIWSLGITAIELAKGEPPN-SELHPMRVLFLIPKN----------------NPPQ  263 (604)
Q Consensus       202 ~~~~GT~~Y~APE~l~~-~~~~~~sDVwSLGviL~eLltG~~Pf-~~~~~~~~~~~i~~~----------------~~~~  263 (604)
                      +..+.+..|--||++.. ..|+...|+|||||+|..|+..+.|| .+.+..+++..|.+.                -.+.
T Consensus       190 nVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~Ldp~  269 (338)
T KOG0668|consen  190 NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQIDLDPQ  269 (338)
T ss_pred             eeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccCCChh
Confidence            66678889999999864 56899999999999999999988885 444443333221100                0000


Q ss_pred             ------------C--------CccchHHHHHHHHHHhccCCCCCCCHHHHhcChhhhhhh
Q psy1546         264 ------------L--------TGNYTKQFKEFVEACLNKDPENRPTAKELLKFPFIRKAK  303 (604)
Q Consensus       264 ------------~--------~~~~s~~l~~Li~~~L~~dP~~RpT~~elL~hp~f~~~~  303 (604)
                                  +        ..-.++++.|||.++|..|..+|+|+.|++.||||....
T Consensus       270 ~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~~~  329 (338)
T KOG0668|consen  270 FEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAPVR  329 (338)
T ss_pred             HhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHHHH
Confidence                        0        112357899999999999999999999999999997543

>KOG1006|consensus

Probab=100.00  E-value=1.6e-35  Score=290.56  Aligned_cols=241  Identities=34%  Similarity=0.576  Sum_probs=200.4

Q ss_pred             eeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHH-hhCCCCCCCeE----------EEEEEecCC
Q psy1546          61 KQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVL-SQCDSPYGTKL----------WIIMEYLGG  129 (604)
Q Consensus        61 i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL-~~l~hp~~~~l----------yLVmEy~~g  129 (604)
                      -+..||.|+||+|++-.++.+|+..|||.|.....+.+..++..|.... +.-+.|+++++          ||.||+| .
T Consensus        68 dlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELM-d  146 (361)
T KOG1006|consen   68 DLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELM-D  146 (361)
T ss_pred             HHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHH-h
Confidence            3467999999999999999999999999998887777777788887654 55567776654          7999999 4


Q ss_pred             CChhhHh------hcCCCcHHHHHHHHHHHHHHhHHhhhC-CccccccccceeEecCCCCeEEecccccccccCCCCCCc
Q psy1546         130 GSALDLM------KAGNFEEMHIAVILREVLKGLDYLHSE-RKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRN  202 (604)
Q Consensus       130 gsL~~~l------~~~~lse~~i~~i~~qIl~gL~yLHs~-gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~~~  202 (604)
                      .+|..+.      ++..++|..+-.|...++.||.||... .||||||||+||||+..|.|||||||++..+.+.... .
T Consensus       147 ~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~SiAk-T  225 (361)
T KOG1006|consen  147 ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDSIAK-T  225 (361)
T ss_pred             hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecccchHhHHHHHHh-h
Confidence            4555433      346799999999999999999999865 8999999999999999999999999999888654433 2


Q ss_pred             ccccCCCCCChHHhhc--CCCCCcchhhhHHHHHHHHHhCCCCCCCCCh-hhHhhhcCCCCCCCCCc-----cchHHHHH
Q psy1546         203 TFVGTPFWMAPEVIKQ--SAYDSKADIWSLGITAIELAKGEPPNSELHP-MRVLFLIPKNNPPQLTG-----NYTKQFKE  274 (604)
Q Consensus       203 ~~~GT~~Y~APE~l~~--~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~-~~~~~~i~~~~~~~~~~-----~~s~~l~~  274 (604)
                      .-.|...|||||.+..  ..|+-++||||||++|||+.||..||...+. .+.+..+..+.++.+..     .++..+..
T Consensus       226 ~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l~~~~~~~~~s~~~~~  305 (361)
T KOG1006|consen  226 VDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPILLFDKECVHYSFSMVR  305 (361)
T ss_pred             hccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCeecCcccccccCHHHHH
Confidence            3468899999999953  3599999999999999999999999987654 56666666666655432     37889999


Q ss_pred             HHHHHhccCCCCCCCHHHHhcChhhhhhh
Q psy1546         275 FVEACLNKDPENRPTAKELLKFPFIRKAK  303 (604)
Q Consensus       275 Li~~~L~~dP~~RpT~~elL~hp~f~~~~  303 (604)
                      +|.-||.+|-..||.+.+++++||++...
T Consensus       306 fintCl~Kd~~~Rpky~~Lk~~~fyr~y~  334 (361)
T KOG1006|consen  306 FINTCLIKDRSDRPKYDDLKKFPFYRMYA  334 (361)
T ss_pred             HHHHHhhcccccCcchhhhhcCchhhhhh
Confidence            99999999999999999999999997654

>KOG4278|consensus

Probab=100.00  E-value=8e-34  Score=302.74  Aligned_cols=244  Identities=25%  Similarity=0.455  Sum_probs=210.7

Q ss_pred             CccccCccccceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCCe---------
Q psy1546          49 NSLKVDPELIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTK---------  119 (604)
Q Consensus        49 ~~~~~~~~~~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~~---------  119 (604)
                      +.|.++..+ .+...+||-|-||.||.|.++.-.-.||||.++.+.  -.++.|..|..+|+.++|||.++         
T Consensus       260 DkWEmeRtd-ItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt--MeveEFLkEAAvMKeikHpNLVqLLGVCT~Ep  336 (1157)
T KOG4278|consen  260 DKWEMERTD-ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--MEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEP  336 (1157)
T ss_pred             chhhccchh-eeeeeccCCCcccceeeeeeeccceeeehhhhhhcc--hhHHHHHHHHHHHHhhcCccHHHHhhhhccCC
Confidence            344444433 356678999999999999999988899999986543  35688999999999999999544         


Q ss_pred             -EEEEEEecCCCChhhHhhcC---CCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEeccccccccc
Q psy1546         120 -LWIIMEYLGGGSALDLMKAG---NFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLT  195 (604)
Q Consensus       120 -lyLVmEy~~ggsL~~~l~~~---~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~  195 (604)
                       +|||+|||..|+|.++++..   .++...++.++.||..|+.||..+++|||||...|+||.++..||++|||+++.+.
T Consensus       337 PFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsRlMt  416 (1157)
T KOG4278|consen  337 PFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSRLMT  416 (1157)
T ss_pred             CeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhhhhc
Confidence             59999999999999999863   46667778889999999999999999999999999999999999999999998886


Q ss_pred             CCCCCC-cccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHhhhcCCCCCCCCCccchHHHH
Q psy1546         196 NTTSKR-NTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAK-GEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFK  273 (604)
Q Consensus       196 ~~~~~~-~~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~  273 (604)
                      ...... ....-.+-|.|||-|-...++.++|||+|||+|||+.| |-.||.+.+..++..++.++.+..-+..|++.+.
T Consensus       417 gDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkgyRM~~PeGCPpkVY  496 (1157)
T KOG4278|consen  417 GDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKGYRMDGPEGCPPKVY  496 (1157)
T ss_pred             CCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhccccccCCCCCCHHHH
Confidence            443221 11123456999999999999999999999999999988 8899999999999999999999889999999999


Q ss_pred             HHHHHHhccCCCCCCCHHHHhc
Q psy1546         274 EFVEACLNKDPENRPTAKELLK  295 (604)
Q Consensus       274 ~Li~~~L~~dP~~RpT~~elL~  295 (604)
                      +|++.||+..|.+||++.||-+
T Consensus       497 eLMraCW~WsPsDRPsFaeiHq  518 (1157)
T KOG4278|consen  497 ELMRACWNWSPSDRPSFAEIHQ  518 (1157)
T ss_pred             HHHHHHhcCCcccCccHHHHHH
Confidence            9999999999999999999854

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=100.00  E-value=1.2e-32  Score=304.24  Aligned_cols=244  Identities=20%  Similarity=0.290  Sum_probs=176.3

Q ss_pred             cceeeeEEcccCcEEEEEEEEC----------------CCCcEEEEEEecchhhHHH-------------HHHHHHHHHH
Q psy1546          58 IFTKQERIGKGSFGEVFKGIDN----------------RTQQVVAIKIIDLEEAEDE-------------IEDIQQEIMV  108 (604)
Q Consensus        58 ~y~i~~~LG~G~fG~Vy~a~~~----------------~t~~~vAVK~i~~~~~~~~-------------~~~l~~Ei~i  108 (604)
                      .|.+.++||+|+||+||+|.+.                ..++.||||.+........             .+....|+.+
T Consensus       146 ~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~~~  225 (507)
T PLN03224        146 DFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEAYM  225 (507)
T ss_pred             CceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHHHH
Confidence            4999999999999999999752                2456799999864322111             1122346666


Q ss_pred             HhhCCCCCC-----------------------CeEEEEEEecCCCChhhHhhcC-------------------------C
Q psy1546         109 LSQCDSPYG-----------------------TKLWIIMEYLGGGSALDLMKAG-------------------------N  140 (604)
Q Consensus       109 L~~l~hp~~-----------------------~~lyLVmEy~~ggsL~~~l~~~-------------------------~  140 (604)
                      +.++.|.+.                       ...||||||+++++|.+++...                         .
T Consensus       226 l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~~  305 (507)
T PLN03224        226 CAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDK  305 (507)
T ss_pred             HHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhccccc
Confidence            666665431                       2468999999999999887531                         2


Q ss_pred             CcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCCC-CcccccCCCCCChHHhhcC
Q psy1546         141 FEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSK-RNTFVGTPFWMAPEVIKQS  219 (604)
Q Consensus       141 lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~-~~~~~GT~~Y~APE~l~~~  219 (604)
                      +++..++.++.||+.||.|||+.+|+||||||+|||++.++.+||+|||++..+...... .....+|+.|+|||++...
T Consensus       306 ~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~l~~~  385 (507)
T PLN03224        306 RDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEELVMP  385 (507)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChhhhcCC
Confidence            345678889999999999999999999999999999999999999999999655332211 1123458999999998543


Q ss_pred             C--------------------CC--CcchhhhHHHHHHHHHhCCC-CCCCCChhhHh-----------hhcCCC-CCCCC
Q psy1546         220 A--------------------YD--SKADIWSLGITAIELAKGEP-PNSELHPMRVL-----------FLIPKN-NPPQL  264 (604)
Q Consensus       220 ~--------------------~~--~~sDVwSLGviL~eLltG~~-Pf~~~~~~~~~-----------~~i~~~-~~~~~  264 (604)
                      .                    |+  ...||||+||+||+|++|.. ||.........           ..+... .....
T Consensus       386 ~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~~~~~~~  465 (507)
T PLN03224        386 QSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQKYDFSL  465 (507)
T ss_pred             CCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcccCCCccc
Confidence            2                    12  24699999999999999886 66543211111           011111 11123


Q ss_pred             CccchHHHHHHHHHHhccCC---CCCCCHHHHhcChhhhh
Q psy1546         265 TGNYTKQFKEFVEACLNKDP---ENRPTAKELLKFPFIRK  301 (604)
Q Consensus       265 ~~~~s~~l~~Li~~~L~~dP---~~RpT~~elL~hp~f~~  301 (604)
                      ....++..++|+.+||..+|   .+|+|+.|+|.||||..
T Consensus       466 ~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~  505 (507)
T PLN03224        466 LDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLP  505 (507)
T ss_pred             ccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCC
Confidence            34568899999999999876   68999999999999953

>KOG1151|consensus

Probab=100.00  E-value=4.6e-34  Score=295.35  Aligned_cols=243  Identities=26%  Similarity=0.432  Sum_probs=200.2

Q ss_pred             ceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhh------HHHHHHHHHHHHHHhhCCCCCCCeE-----------E
Q psy1546          59 FTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA------EDEIEDIQQEIMVLSQCDSPYGTKL-----------W  121 (604)
Q Consensus        59 y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~------~~~~~~l~~Ei~iL~~l~hp~~~~l-----------y  121 (604)
                      |-++.+||+|||+.||+|.|....++||||+-.....      +...+...+|..|.+.|+||.++++           |
T Consensus       465 YLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtdsFC  544 (775)
T KOG1151|consen  465 YLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDSFC  544 (775)
T ss_pred             HHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccccce
Confidence            7788899999999999999999999999999654332      3345678899999999999998876           4


Q ss_pred             EEEEecCCCChhhHhhc-CCCcHHHHHHHHHHHHHHhHHhhhC--CccccccccceeEecC---CCCeEEeccccccccc
Q psy1546         122 IIMEYLGGGSALDLMKA-GNFEEMHIAVILREVLKGLDYLHSE--RKLHRDIKAANVLLSE---MGDVKLADFGVAGTLT  195 (604)
Q Consensus       122 LVmEy~~ggsL~~~l~~-~~lse~~i~~i~~qIl~gL~yLHs~--gIiHrDLKp~NILl~~---~g~vKL~DFGlA~~~~  195 (604)
                      -|+|||+|.+|..+++. ..+++.+++.|+.||+.||.||.+.  .|||-||||.|||+..   -|.+||+|||+++.+.
T Consensus       545 TVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGLSKIMd  624 (775)
T KOG1151|consen  545 TVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGLSKIMD  624 (775)
T ss_pred             eeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecchhhhcc
Confidence            79999999999999976 5689999999999999999999987  5999999999999953   4789999999998876


Q ss_pred             CCCCC-------CcccccCCCCCChHHhhcC----CCCCcchhhhHHHHHHHHHhCCCCCCCCChh-hHhh--hcCCCCC
Q psy1546         196 NTTSK-------RNTFVGTPFWMAPEVIKQS----AYDSKADIWSLGITAIELAKGEPPNSELHPM-RVLF--LIPKNNP  261 (604)
Q Consensus       196 ~~~~~-------~~~~~GT~~Y~APE~l~~~----~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~-~~~~--~i~~~~~  261 (604)
                      +....       ...+.||.+|++||.+.-.    +.+.++||||+|||+|.++.|+-||...... +++.  .|.+...
T Consensus       625 ddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNTIlkAtE  704 (775)
T KOG1151|consen  625 DDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENTILKATE  704 (775)
T ss_pred             CCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhchhccee
Confidence            54332       3456799999999988533    4678999999999999999999999765432 2222  1222221


Q ss_pred             CCC--CccchHHHHHHHHHHhccCCCCCCCHHHHhcChhhhh
Q psy1546         262 PQL--TGNYTKQFKEFVEACLNKDPENRPTAKELLKFPFIRK  301 (604)
Q Consensus       262 ~~~--~~~~s~~l~~Li~~~L~~dP~~RpT~~elL~hp~f~~  301 (604)
                      -.+  .+.++.++++||++||++.-++|..+.++..||||..
T Consensus       705 VqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyllP  746 (775)
T KOG1151|consen  705 VQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLLP  746 (775)
T ss_pred             ccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccCccccc
Confidence            222  2457889999999999999999999999999999964

>KOG0670|consensus

Probab=100.00  E-value=1.9e-33  Score=295.82  Aligned_cols=239  Identities=28%  Similarity=0.399  Sum_probs=190.8

Q ss_pred             cceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCC----------------CCCeEE
Q psy1546          58 IFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSP----------------YGTKLW  121 (604)
Q Consensus        58 ~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp----------------~~~~ly  121 (604)
                      .|.+....|+|-||+|..|.+..-|+.||||+|.....  ..+.=.+|+.||++|...                +..+||
T Consensus       433 RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~--M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknHLC  510 (752)
T KOG0670|consen  433 RYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEV--MHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNHLC  510 (752)
T ss_pred             eeEEEeccccceeeeeeeccccCCCCeeEEEEeecchH--HhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcceeE
Confidence            37788888999999999999999999999999975532  224445677777776532                257899


Q ss_pred             EEEEecCCCChhhHhhc----CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCC-CeEEecccccccccC
Q psy1546         122 IIMEYLGGGSALDLMKA----GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMG-DVKLADFGVAGTLTN  196 (604)
Q Consensus       122 LVmEy~~ggsL~~~l~~----~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g-~vKL~DFGlA~~~~~  196 (604)
                      ||+|-+ ..+|.++++.    -.|....+..|+.||.-||..|...||+|.||||.||||.+.. .+||||||.|.....
T Consensus       511 lVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKLCDfGSA~~~~e  589 (752)
T KOG0670|consen  511 LVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKLCDFGSASFASE  589 (752)
T ss_pred             EEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeeeccCcccccccc
Confidence            999998 6779999865    3588999999999999999999999999999999999998754 579999999966543


Q ss_pred             CCCCCcccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcC--CCCC-------------
Q psy1546         197 TTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIP--KNNP-------------  261 (604)
Q Consensus       197 ~~~~~~~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~--~~~~-------------  261 (604)
                      .  ....+.-+.+|.|||++.+..|+...|+||+||+||||.||+..|.+...-.++....  ++..             
T Consensus       590 n--eitPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlRKgqF~dq  667 (752)
T KOG0670|consen  590 N--EITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLRKGQFKDQ  667 (752)
T ss_pred             c--cccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhhhcchhhh
Confidence            3  2334566788999999999999999999999999999999999998876544443211  0000             


Q ss_pred             -----------------------------------------CCCCc---cchHHHHHHHHHHhccCCCCCCCHHHHhcCh
Q psy1546         262 -----------------------------------------PQLTG---NYTKQFKEFVEACLNKDPENRPTAKELLKFP  297 (604)
Q Consensus       262 -----------------------------------------~~~~~---~~s~~l~~Li~~~L~~dP~~RpT~~elL~hp  297 (604)
                                                               +.++.   ..-..|++||.+||.+||.+|.|+.++|+||
T Consensus       668 HFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~nqAL~Hp  747 (752)
T KOG0670|consen  668 HFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITVNQALKHP  747 (752)
T ss_pred             hcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCHHHHhcCC
Confidence                                                     00000   1123688999999999999999999999999


Q ss_pred             hhhh
Q psy1546         298 FIRK  301 (604)
Q Consensus       298 ~f~~  301 (604)
                      ||..
T Consensus       748 Fi~~  751 (752)
T KOG0670|consen  748 FITE  751 (752)
T ss_pred             cccC
Confidence            9964

>KOG1290|consensus

Probab=100.00  E-value=1.1e-32  Score=289.02  Aligned_cols=240  Identities=35%  Similarity=0.535  Sum_probs=183.1

Q ss_pred             cceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCC----------------------CC
Q psy1546          58 IFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCD----------------------SP  115 (604)
Q Consensus        58 ~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~----------------------hp  115 (604)
                      .|.+.++||.|-|++||+|.|..+.+.||+|+.+..  +...+....||++|+++.                      .|
T Consensus        79 RY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA--qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGp  156 (590)
T KOG1290|consen   79 RYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA--QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGP  156 (590)
T ss_pred             eEEEEEeccccccceeEEEeeccCCeEEEEEEEehh--hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCC
Confidence            488999999999999999999999999999998643  344567788999988753                      24


Q ss_pred             CCCeEEEEEEecCCCChhhHhhc---CCCcHHHHHHHHHHHHHHhHHhhhC-CccccccccceeEecCC-----------
Q psy1546         116 YGTKLWIIMEYLGGGSALDLMKA---GNFEEMHIAVILREVLKGLDYLHSE-RKLHRDIKAANVLLSEM-----------  180 (604)
Q Consensus       116 ~~~~lyLVmEy~~ggsL~~~l~~---~~lse~~i~~i~~qIl~gL~yLHs~-gIiHrDLKp~NILl~~~-----------  180 (604)
                      |+.++|||+|++ |..|..+|+.   +.++...++.|++|||.||.|||.+ ||||-||||+|||+...           
T Consensus       157 NG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~~~e~~~~~~~~~a  235 (590)
T KOG1290|consen  157 NGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLCSTEIDPAKDAREA  235 (590)
T ss_pred             CCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeeeccccchhhhhhhh
Confidence            688899999999 7778888754   6799999999999999999999975 99999999999999300           


Q ss_pred             C-------------------------------------------------------------------------------
Q psy1546         181 G-------------------------------------------------------------------------------  181 (604)
Q Consensus       181 g-------------------------------------------------------------------------------  181 (604)
                      +                                                                               
T Consensus       236 ~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~~~~n~~~~~  315 (590)
T KOG1290|consen  236 GEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNNEPRINGNEST  315 (590)
T ss_pred             ccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccccccccccCCCccccc
Confidence            0                                                                               


Q ss_pred             ----------------------------------------------------------------------------CeEE
Q psy1546         182 ----------------------------------------------------------------------------DVKL  185 (604)
Q Consensus       182 ----------------------------------------------------------------------------~vKL  185 (604)
                                                                                                  .|||
T Consensus       316 v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~~~~di~vKI  395 (590)
T KOG1290|consen  316 VERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIPLPECDIRVKI  395 (590)
T ss_pred             hhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCCCCccceeEEE
Confidence                                                                                        1344


Q ss_pred             ecccccccccCCCCCCcccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCC-------h------hhH
Q psy1546         186 ADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELH-------P------MRV  252 (604)
Q Consensus       186 ~DFGlA~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~-------~------~~~  252 (604)
                      +|||.|.....   ....-+.|..|+|||++.+..|+..+||||++|++|||+||...|.-..       .      +++
T Consensus       396 aDlGNACW~~k---hFT~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDEDHiA~i~EL  472 (590)
T KOG1290|consen  396 ADLGNACWVHK---HFTEDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEPHSGENYSRDEDHIALIMEL  472 (590)
T ss_pred             eeccchhhhhh---hhchhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccHHHHHHHHHH
Confidence            55555443221   1122357888999999999999999999999999999999998775321       1      111


Q ss_pred             hhhcC------------------------CCCCC----------CCCccchHHHHHHHHHHhccCCCCCCCHHHHhcChh
Q psy1546         253 LFLIP------------------------KNNPP----------QLTGNYTKQFKEFVEACLNKDPENRPTAKELLKFPF  298 (604)
Q Consensus       253 ~~~i~------------------------~~~~~----------~~~~~~s~~l~~Li~~~L~~dP~~RpT~~elL~hp~  298 (604)
                      +-.++                        +..+.          .++..-..++.+||.-||+.+|++|||+.++|+|||
T Consensus       473 LG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~tA~~cl~hPw  552 (590)
T KOG1290|consen  473 LGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRPTAAQCLKHPW  552 (590)
T ss_pred             HhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCccccccHHHHhcCcc
Confidence            11111                        00000          111112346889999999999999999999999999


Q ss_pred             hhhhh
Q psy1546         299 IRKAK  303 (604)
Q Consensus       299 f~~~~  303 (604)
                      +....
T Consensus       553 Ln~~~  557 (590)
T KOG1290|consen  553 LNPVA  557 (590)
T ss_pred             ccCCC
Confidence            97544

>KOG0200|consensus

Probab=99.98  E-value=8.4e-32  Score=305.77  Aligned_cols=245  Identities=28%  Similarity=0.503  Sum_probs=207.0

Q ss_pred             ccccCccccceeeeEEcccCcEEEEEEEEC----C---CCcEEEEEEecchhhHHHHHHHHHHHHHHhhCC-CCCCC---
Q psy1546          50 SLKVDPELIFTKQERIGKGSFGEVFKGIDN----R---TQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCD-SPYGT---  118 (604)
Q Consensus        50 ~~~~~~~~~y~i~~~LG~G~fG~Vy~a~~~----~---t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~-hp~~~---  118 (604)
                      .|.++.+.. .+.+.||+|.||.|++|.-.    .   ....||||.++......+.+.+..|+.+|+.+. |+|+.   
T Consensus       290 ~~e~~~~~l-~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~ll  368 (609)
T KOG0200|consen  290 KWEIPRENL-KLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLL  368 (609)
T ss_pred             ceeechhhc-cccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhhe
Confidence            344444433 56679999999999999733    1   145799999987766677899999999999975 88843   


Q ss_pred             -------eEEEEEEecCCCChhhHhhcCC-----------------CcHHHHHHHHHHHHHHhHHhhhCCccccccccce
Q psy1546         119 -------KLWIIMEYLGGGSALDLMKAGN-----------------FEEMHIAVILREVLKGLDYLHSERKLHRDIKAAN  174 (604)
Q Consensus       119 -------~lyLVmEy~~ggsL~~~l~~~~-----------------lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~N  174 (604)
                             .+++|+|||..|+|..+++..+                 ++..+...++.||+.|++||+++.+|||||-.+|
T Consensus       369 G~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRN  448 (609)
T KOG0200|consen  369 GACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARN  448 (609)
T ss_pred             eeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhh
Confidence                   4689999999999999998766                 8899999999999999999999999999999999


Q ss_pred             eEecCCCCeEEecccccccccCCCCCC-ccccc--CCCCCChHHhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCC-h
Q psy1546         175 VLLSEMGDVKLADFGVAGTLTNTTSKR-NTFVG--TPFWMAPEVIKQSAYDSKADIWSLGITAIELAK-GEPPNSELH-P  249 (604)
Q Consensus       175 ILl~~~g~vKL~DFGlA~~~~~~~~~~-~~~~G--T~~Y~APE~l~~~~~~~~sDVwSLGviL~eLlt-G~~Pf~~~~-~  249 (604)
                      |||..+..+||+|||+|+......... ....|  ...|||||.+....|+.++||||||++||||++ |..||.+.. .
T Consensus       449 VLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~  528 (609)
T KOG0200|consen  449 VLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPT  528 (609)
T ss_pred             EEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcH
Confidence            999999999999999998654433322 11222  334999999999999999999999999999998 899999865 5


Q ss_pred             hhHhhhcCCCCCCCCCccchHHHHHHHHHHhccCCCCCCCHHHHhc
Q psy1546         250 MRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPENRPTAKELLK  295 (604)
Q Consensus       250 ~~~~~~i~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~RpT~~elL~  295 (604)
                      .++...+..+.....+..+++++.++++.||+.+|++||++.++.+
T Consensus       529 ~~l~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~  574 (609)
T KOG0200|consen  529 EELLEFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVE  574 (609)
T ss_pred             HHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence            5566678888888889999999999999999999999999999976

>KOG1025|consensus

Probab=99.98  E-value=1.6e-32  Score=301.04  Aligned_cols=246  Identities=28%  Similarity=0.409  Sum_probs=216.4

Q ss_pred             ccccCccccceeeeEEcccCcEEEEEEEECCCC----cEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCCeE-----
Q psy1546          50 SLKVDPELIFTKQERIGKGSFGEVFKGIDNRTQ----QVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTKL-----  120 (604)
Q Consensus        50 ~~~~~~~~~y~i~~~LG~G~fG~Vy~a~~~~t~----~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~~l-----  120 (604)
                      .+.+..+......++||+|+||+||+|.+.-.+    .+||||++........-..+..|+.+|..++|||..++     
T Consensus       689 ~lrI~kEtelkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~  768 (1177)
T KOG1025|consen  689 LLRILKETELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCM  768 (1177)
T ss_pred             heeechhhhhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcc
Confidence            445566667788899999999999999876444    46899998777666667889999999999999997665     


Q ss_pred             ----EEEEEecCCCChhhHhhc--CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccc
Q psy1546         121 ----WIIMEYLGGGSALDLMKA--GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTL  194 (604)
Q Consensus       121 ----yLVmEy~~ggsL~~~l~~--~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~  194 (604)
                          .||++|+++|.|.++++.  +.+-....+.|..||++||.|||+++++||||-.+||||..-.++||.|||+|+.+
T Consensus       769 ~s~~qlvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll  848 (1177)
T KOG1025|consen  769 LSTLQLVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLL  848 (1177)
T ss_pred             cchHHHHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhcc
Confidence                489999999999999975  56888999999999999999999999999999999999999999999999999877


Q ss_pred             cCCCCCCcccc--cCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHhhhcCCCCCCCCCccchHH
Q psy1546         195 TNTTSKRNTFV--GTPFWMAPEVIKQSAYDSKADIWSLGITAIELAK-GEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQ  271 (604)
Q Consensus       195 ~~~~~~~~~~~--GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~  271 (604)
                      ...........  -.+-|||-|.+....|+.++|||||||++|||+| |..|+.+....++-..+.++.+...+..++-+
T Consensus       849 ~~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~geRLsqPpiCtiD  928 (1177)
T KOG1025|consen  849 APDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGERLSQPPICTID  928 (1177)
T ss_pred             CcccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhccccCCCCCCccHH
Confidence            65444333322  3456999999999999999999999999999988 99999999999999999999888888999999


Q ss_pred             HHHHHHHHhccCCCCCCCHHHHhc
Q psy1546         272 FKEFVEACLNKDPENRPTAKELLK  295 (604)
Q Consensus       272 l~~Li~~~L~~dP~~RpT~~elL~  295 (604)
                      +.-++.+||..|+..||+++++..
T Consensus       929 Vy~~mvkCwmid~~~rp~fkel~~  952 (1177)
T KOG1025|consen  929 VYMVMVKCWMIDADSRPTFKELAE  952 (1177)
T ss_pred             HHHHHHHHhccCcccCccHHHHHH
Confidence            999999999999999999999865

>KOG0665|consensus

Probab=99.98  E-value=2.1e-33  Score=282.11  Aligned_cols=239  Identities=24%  Similarity=0.370  Sum_probs=195.7

Q ss_pred             cceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchh-hHHHHHHHHHHHHHHhhCCCCCCCeE----------------
Q psy1546          58 IFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE-AEDEIEDIQQEIMVLSQCDSPYGTKL----------------  120 (604)
Q Consensus        58 ~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~-~~~~~~~l~~Ei~iL~~l~hp~~~~l----------------  120 (604)
                      .|..++.+|.|.- .|.-|.|.-.++.||+|...... .....+...+|..++..+.|+|+.++                
T Consensus        18 Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~   96 (369)
T KOG0665|consen   18 RYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEV   96 (369)
T ss_pred             eeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhH
Confidence            4777788999998 88899999999999999874432 12335778999999999999997664                


Q ss_pred             EEEEEecCCCChhhHhhcCCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCCC
Q psy1546         121 WIIMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSK  200 (604)
Q Consensus       121 yLVmEy~~ggsL~~~l~~~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~  200 (604)
                      |+||||| ..+|...+. -.++...+..|+.|+++|++|||+.||+||||||+||+|..++.+||.|||+|+..... ..
T Consensus        97 y~v~e~m-~~nl~~vi~-~elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~-~~  173 (369)
T KOG0665|consen   97 YLVMELM-DANLCQVIL-MELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLARTEDTD-FM  173 (369)
T ss_pred             HHHHHhh-hhHHHHHHH-HhcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhhcccCcc-cc
Confidence            6999999 566777766 46788999999999999999999999999999999999999999999999999765433 45


Q ss_pred             CcccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCC---------------------
Q psy1546         201 RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKN---------------------  259 (604)
Q Consensus       201 ~~~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~---------------------  259 (604)
                      ....+.|..|.|||++.+..|...+||||+||++.||++|...|.+.+..+...++...                     
T Consensus       174 mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r~yv~  253 (369)
T KOG0665|consen  174 MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVRNYVE  253 (369)
T ss_pred             cCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHHHHHhh
Confidence            56788999999999999988999999999999999999999988876654433322100                     


Q ss_pred             -CC--------CCCC-----------ccchHHHHHHHHHHhccCCCCCCCHHHHhcChhhh
Q psy1546         260 -NP--------PQLT-----------GNYTKQFKEFVEACLNKDPENRPTAKELLKFPFIR  300 (604)
Q Consensus       260 -~~--------~~~~-----------~~~s~~l~~Li~~~L~~dP~~RpT~~elL~hp~f~  300 (604)
                       .+        ..++           ..-...+++|+.+||..||++|.+++++|+||||+
T Consensus       254 ~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~  314 (369)
T KOG0665|consen  254 NRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIK  314 (369)
T ss_pred             cChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeee
Confidence             00        0000           01134678999999999999999999999999997

>KOG0664|consensus

Probab=99.98  E-value=1.1e-33  Score=277.99  Aligned_cols=242  Identities=26%  Similarity=0.416  Sum_probs=194.4

Q ss_pred             eeeeEEcccCcEEEEEEEECCCCcEEEEEEecchh-hHHHHHHHHHHHHHHhhCCCCCCC---------------eEEEE
Q psy1546          60 TKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE-AEDEIEDIQQEIMVLSQCDSPYGT---------------KLWII  123 (604)
Q Consensus        60 ~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~-~~~~~~~l~~Ei~iL~~l~hp~~~---------------~lyLV  123 (604)
                      +-.+.||-|+||+||.++|.++|+.||+|.+..-. .-...+.+.+|+++|..++|.|..               .+|+|
T Consensus        56 ~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~  135 (449)
T KOG0664|consen   56 QPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVL  135 (449)
T ss_pred             CCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHH
Confidence            33478999999999999999999999999874221 122347788999999999998732               24788


Q ss_pred             EEecCCCChhhHhh-cCCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCCC-C
Q psy1546         124 MEYLGGGSALDLMK-AGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSK-R  201 (604)
Q Consensus       124 mEy~~ggsL~~~l~-~~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~-~  201 (604)
                      +|++ ..+|..+|- -..++...++-+++||++||+|||+.||.||||||.|+||+.+..+||||||+|+........ .
T Consensus       136 TELm-QSDLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~~hM  214 (449)
T KOG0664|consen  136 TELM-QSDLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDRLNM  214 (449)
T ss_pred             HHHH-HhhhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccchhhhhhh
Confidence            8888 556766664 467999999999999999999999999999999999999999999999999999876543332 3


Q ss_pred             cccccCCCCCChHHhhcC-CCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCC---------------------
Q psy1546         202 NTFVGTPFWMAPEVIKQS-AYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKN---------------------  259 (604)
Q Consensus       202 ~~~~GT~~Y~APE~l~~~-~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~---------------------  259 (604)
                      ...+-|..|+|||++.+. .|+.++||||+|||+.||+..+..|+...+.+.+.+|...                     
T Consensus       215 TqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~H~L  294 (449)
T KOG0664|consen  215 THEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAKNHVL  294 (449)
T ss_pred             HHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhHHHhh
Confidence            334678999999999875 5999999999999999999999999988877666544211                     


Q ss_pred             ----CCCCCC--------ccchHHHHHHHHHHhccCCCCCCCHHHHhcChhhhhh
Q psy1546         260 ----NPPQLT--------GNYTKQFKEFVEACLNKDPENRPTAKELLKFPFIRKA  302 (604)
Q Consensus       260 ----~~~~~~--------~~~s~~l~~Li~~~L~~dP~~RpT~~elL~hp~f~~~  302 (604)
                          ..+.+.        ..-..+...++..+|..||++|.+.++.+.|++..+.
T Consensus       295 R~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e~  349 (449)
T KOG0664|consen  295 RAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEEG  349 (449)
T ss_pred             ccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccccccc
Confidence                011111        1223467789999999999999999999999998654

>KOG1027|consensus

Probab=99.97  E-value=2.7e-32  Score=301.23  Aligned_cols=251  Identities=29%  Similarity=0.453  Sum_probs=194.0

Q ss_pred             ceeeeEEcccCcE-EEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhC-CCCCCCeE----------EEEEEe
Q psy1546          59 FTKQERIGKGSFG-EVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQC-DSPYGTKL----------WIIMEY  126 (604)
Q Consensus        59 y~i~~~LG~G~fG-~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l-~hp~~~~l----------yLVmEy  126 (604)
                      |.-.+.+|.|+-| .||+|...  ++.||||.+-.    ......++||..|+.. .|||++++          ||..|+
T Consensus       511 ~~~~eilG~Gs~Gt~Vf~G~ye--~R~VAVKrll~----e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalEL  584 (903)
T KOG1027|consen  511 FSPKEILGYGSNGTVVFRGVYE--GREVAVKRLLE----EFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALEL  584 (903)
T ss_pred             eccHHHcccCCCCcEEEEEeeC--CceehHHHHhh----HhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehH
Confidence            4555678999887 57999754  78999998743    3346778999999987 59997664          799999


Q ss_pred             cCCCChhhHhhcC--CC---cHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecC---CC--CeEEecccccccccC
Q psy1546         127 LGGGSALDLMKAG--NF---EEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSE---MG--DVKLADFGVAGTLTN  196 (604)
Q Consensus       127 ~~ggsL~~~l~~~--~l---se~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~---~g--~vKL~DFGlA~~~~~  196 (604)
                      | ..+|.++++..  .+   .....+.++.|++.||+|||+.+||||||||+||||+.   ++  .++|+|||+++.+..
T Consensus       585 C-~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~  663 (903)
T KOG1027|consen  585 C-ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAG  663 (903)
T ss_pred             h-hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccccCC
Confidence            9 67899999763  11   11445778899999999999999999999999999976   34  589999999998865


Q ss_pred             CCC---CCcccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhC-CCCCCCCChhhHhhhcCCCCCCCCCccchHHH
Q psy1546         197 TTS---KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKG-EPPNSELHPMRVLFLIPKNNPPQLTGNYTKQF  272 (604)
Q Consensus       197 ~~~---~~~~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG-~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l  272 (604)
                      ...   ......||-+|+|||++.......++||||||||+|+.++| ..||......+............+......++
T Consensus       664 ~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NIl~~~~~L~~L~~~~d~eA  743 (903)
T KOG1027|consen  664 GKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANILTGNYTLVHLEPLPDCEA  743 (903)
T ss_pred             CcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhhhhcCccceeeeccCchHHH
Confidence            432   34567899999999999998888899999999999999885 88998765544333222211112222222289


Q ss_pred             HHHHHHHhccCCCCCCCHHHHhcChhhhhhhh-hhhHHHHHHHHH
Q psy1546         273 KEFVEACLNKDPENRPTAKELLKFPFIRKAKK-NAYLIDLIDRYK  316 (604)
Q Consensus       273 ~~Li~~~L~~dP~~RpT~~elL~hp~f~~~~~-~~~l~~~~~~~~  316 (604)
                      .+||.+|++.||..||++.+||.||||....+ -.++.+..||.+
T Consensus       744 ~dLI~~ml~~dP~~RPsa~~VL~HPlFW~~ekrL~Fl~dvSDRvE  788 (903)
T KOG1027|consen  744 KDLISRMLNPDPQLRPSATDVLNHPLFWDSEKRLSFLRDVSDRVE  788 (903)
T ss_pred             HHHHHHhcCCCcccCCCHHHHhCCCccCChHHHHHHHHhhhhhhh
Confidence            99999999999999999999999999976543 355566666553

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=99.97  E-value=2.5e-31  Score=317.93  Aligned_cols=226  Identities=21%  Similarity=0.347  Sum_probs=177.4

Q ss_pred             ceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCCeE----------EEEEEecC
Q psy1546          59 FTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTKL----------WIIMEYLG  128 (604)
Q Consensus        59 y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~~l----------yLVmEy~~  128 (604)
                      |...+.||+|+||.||+|.+..++..||||.+.....     ....|+.++++++|||++++          |+||||++
T Consensus       692 ~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~  766 (968)
T PLN00113        692 LKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS-----IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIE  766 (968)
T ss_pred             CCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc-----ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCC
Confidence            4556789999999999999999999999999864332     12346889999999997765          69999999


Q ss_pred             CCChhhHhhcCCCcHHHHHHHHHHHHHHhHHhh---hCCccccccccceeEecCCCCeEEecccccccccCCCCCCcccc
Q psy1546         129 GGSALDLMKAGNFEEMHIAVILREVLKGLDYLH---SERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFV  205 (604)
Q Consensus       129 ggsL~~~l~~~~lse~~i~~i~~qIl~gL~yLH---s~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~~~~~~  205 (604)
                      +|+|.++++.  +++..+..++.||+.||+|||   +.+|+||||||+|||++.++..++. ||.+.....    .....
T Consensus       767 ~g~L~~~l~~--l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~----~~~~~  839 (968)
T PLN00113        767 GKNLSEVLRN--LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT----DTKCF  839 (968)
T ss_pred             CCcHHHHHhc--CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc----CCCcc
Confidence            9999999964  889999999999999999999   6799999999999999998888776 666543321    12336


Q ss_pred             cCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChh-----hHhhh-cCCC-----CCC------CCCccc
Q psy1546         206 GTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPM-----RVLFL-IPKN-----NPP------QLTGNY  268 (604)
Q Consensus       206 GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~-----~~~~~-i~~~-----~~~------~~~~~~  268 (604)
                      ||+.|||||++.+..|+.++|||||||++|||++|+.||......     +.... ....     ..+      ......
T Consensus       840 ~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  919 (968)
T PLN00113        840 ISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNE  919 (968)
T ss_pred             ccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCCCCccHHH
Confidence            899999999999999999999999999999999999998542211     00000 0000     001      111123


Q ss_pred             hHHHHHHHHHHhccCCCCCCCHHHHhcC
Q psy1546         269 TKQFKEFVEACLNKDPENRPTAKELLKF  296 (604)
Q Consensus       269 s~~l~~Li~~~L~~dP~~RpT~~elL~h  296 (604)
                      ..++.+++.+||+.||++|||+.||++.
T Consensus       920 ~~~~~~l~~~Cl~~~P~~RPt~~evl~~  947 (968)
T PLN00113        920 IVEVMNLALHCTATDPTARPCANDVLKT  947 (968)
T ss_pred             HHHHHHHHHhhCcCCchhCcCHHHHHHH
Confidence            3467789999999999999999999873

>KOG3653|consensus

Probab=99.97  E-value=8.8e-31  Score=274.38  Aligned_cols=230  Identities=29%  Similarity=0.427  Sum_probs=176.5

Q ss_pred             ceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHh--hCCCCCC--------------CeEEE
Q psy1546          59 FTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLS--QCDSPYG--------------TKLWI  122 (604)
Q Consensus        59 y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~--~l~hp~~--------------~~lyL  122 (604)
                      ..+.++||+|.||.||+|...  ++.||||++....    .+.++.|-.|.+  .+.|+|+              ..++|
T Consensus       212 l~l~eli~~Grfg~V~KaqL~--~~~VAVKifp~~~----kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywL  285 (534)
T KOG3653|consen  212 LQLLELIGRGRFGCVWKAQLD--NRLVAVKIFPEQE----KQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWL  285 (534)
T ss_pred             hhhHHHhhcCccceeehhhcc--CceeEEEecCHHH----HHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeE
Confidence            566788999999999999754  6999999997543    345555655554  5678873              25689


Q ss_pred             EEEecCCCChhhHhhcCCCcHHHHHHHHHHHHHHhHHhhhC---------CccccccccceeEecCCCCeEEeccccccc
Q psy1546         123 IMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSE---------RKLHRDIKAANVLLSEMGDVKLADFGVAGT  193 (604)
Q Consensus       123 VmEy~~ggsL~~~l~~~~lse~~i~~i~~qIl~gL~yLHs~---------gIiHrDLKp~NILl~~~g~vKL~DFGlA~~  193 (604)
                      |+||.+.|+|.++++...+++....+++..|++||+|||+.         .|+|||||..||||..|+++.|+|||+|..
T Consensus       286 Vt~fh~kGsL~dyL~~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~  365 (534)
T KOG3653|consen  286 VTEFHPKGSLCDYLKANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALR  365 (534)
T ss_pred             EeeeccCCcHHHHHHhccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEE
Confidence            99999999999999999999999999999999999999973         599999999999999999999999999977


Q ss_pred             ccCCC--CCCcccccCCCCCChHHhhcCC-CC-----CcchhhhHHHHHHHHHhCCC------------CCCC---CC--
Q psy1546         194 LTNTT--SKRNTFVGTPFWMAPEVIKQSA-YD-----SKADIWSLGITAIELAKGEP------------PNSE---LH--  248 (604)
Q Consensus       194 ~~~~~--~~~~~~~GT~~Y~APE~l~~~~-~~-----~~sDVwSLGviL~eLltG~~------------Pf~~---~~--  248 (604)
                      +....  ......+||.+|||||+|.+.. +.     .+.||||+|.|||||++...            ||..   .+  
T Consensus       366 ~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt  445 (534)
T KOG3653|consen  366 LEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHPT  445 (534)
T ss_pred             ecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCCC
Confidence            75332  2223378999999999997643 22     35899999999999987432            2221   11  


Q ss_pred             hhhHhh-hcCCCCCCCCCccc-----hHHHHHHHHHHhccCCCCCCCHHHHh
Q psy1546         249 PMRVLF-LIPKNNPPQLTGNY-----TKQFKEFVEACLNKDPENRPTAKELL  294 (604)
Q Consensus       249 ~~~~~~-~i~~~~~~~~~~~~-----s~~l~~Li~~~L~~dP~~RpT~~elL  294 (604)
                      ..++.. .+.+..++.++..+     ...+++.+..||..||+.|.|+.=+.
T Consensus       446 ~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~  497 (534)
T KOG3653|consen  446 LEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVE  497 (534)
T ss_pred             HHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHH
Confidence            111111 12233344444332     45688999999999999999987664

>KOG2052|consensus

Probab=99.97  E-value=6.3e-30  Score=266.24  Aligned_cols=232  Identities=28%  Similarity=0.464  Sum_probs=178.5

Q ss_pred             cceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHh--hCCCCCC--------------CeEE
Q psy1546          58 IFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLS--QCDSPYG--------------TKLW  121 (604)
Q Consensus        58 ~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~--~l~hp~~--------------~~ly  121 (604)
                      ...+.+.||+|.||.||+|.+.  |+.||||++.....    ....+|.+|..  -|+|+|+              .++|
T Consensus       212 qI~L~e~IGkGRyGEVwrG~wr--Ge~VAVKiF~srdE----~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLw  285 (513)
T KOG2052|consen  212 QIVLQEIIGKGRFGEVWRGRWR--GEDVAVKIFSSRDE----RSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLW  285 (513)
T ss_pred             eeEEEEEecCccccceeecccc--CCceEEEEecccch----hhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEE
Confidence            3688899999999999999887  88999999965432    34455555554  4788873              4689


Q ss_pred             EEEEecCCCChhhHhhcCCCcHHHHHHHHHHHHHHhHHhhhC--------CccccccccceeEecCCCCeEEeccccccc
Q psy1546         122 IIMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSE--------RKLHRDIKAANVLLSEMGDVKLADFGVAGT  193 (604)
Q Consensus       122 LVmEy~~ggsL~~~l~~~~lse~~i~~i~~qIl~gL~yLHs~--------gIiHrDLKp~NILl~~~g~vKL~DFGlA~~  193 (604)
                      ||++|-+.|+|.|++....++......++..++.||+|||..        .|.|||||..||||..+|.+.|+|+|+|-.
T Consensus       286 LvTdYHe~GSL~DyL~r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv~  365 (513)
T KOG2052|consen  286 LVTDYHEHGSLYDYLNRNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR  365 (513)
T ss_pred             EeeecccCCcHHHHHhhccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeEE
Confidence            999999999999999999999999999999999999999963        499999999999999999999999999965


Q ss_pred             ccCCC----CCCcccccCCCCCChHHhhcCC----CC--CcchhhhHHHHHHHHHhC----------CCCCCCCChh---
Q psy1546         194 LTNTT----SKRNTFVGTPFWMAPEVIKQSA----YD--SKADIWSLGITAIELAKG----------EPPNSELHPM---  250 (604)
Q Consensus       194 ~~~~~----~~~~~~~GT~~Y~APE~l~~~~----~~--~~sDVwSLGviL~eLltG----------~~Pf~~~~~~---  250 (604)
                      .....    ...+..+||.+|||||+|...-    +.  ..+||||||.|+||++..          ++||++..+.   
T Consensus       366 h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DPs  445 (513)
T KOG2052|consen  366 HDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSDPS  445 (513)
T ss_pred             ecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCCCC
Confidence            54332    2345679999999999996543    11  358999999999999752          4677765432   


Q ss_pred             --hHhhhcC-CCCCCCCCccc-----hHHHHHHHHHHhccCCCCCCCHHHHhc
Q psy1546         251 --RVLFLIP-KNNPPQLTGNY-----TKQFKEFVEACLNKDPENRPTAKELLK  295 (604)
Q Consensus       251 --~~~~~i~-~~~~~~~~~~~-----s~~l~~Li~~~L~~dP~~RpT~~elL~  295 (604)
                        ++...+- +..++.++..+     -..+..|++.||..+|.-|.|+-.|-+
T Consensus       446 ~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKK  498 (513)
T KOG2052|consen  446 FEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKK  498 (513)
T ss_pred             HHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHH
Confidence              2221111 11223333222     235668999999999999999776643

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.97  E-value=3.5e-29  Score=240.10  Aligned_cols=201  Identities=45%  Similarity=0.755  Sum_probs=177.2

Q ss_pred             EcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCC----------eEEEEEEecCCCChhh
Q psy1546          65 IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGT----------KLWIIMEYLGGGSALD  134 (604)
Q Consensus        65 LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~----------~lyLVmEy~~ggsL~~  134 (604)
                      ||+|++|.||+|.+..+++.++||++...........+.+|+.+++.+.|++..          ..++||||+.+++|.+
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~   80 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD   80 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence            689999999999998889999999997665443457789999999999998633          4589999999999999


Q ss_pred             HhhcC--CCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecC-CCCeEEecccccccccCCCCCCcccccCCCCC
Q psy1546         135 LMKAG--NFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSE-MGDVKLADFGVAGTLTNTTSKRNTFVGTPFWM  211 (604)
Q Consensus       135 ~l~~~--~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~-~g~vKL~DFGlA~~~~~~~~~~~~~~GT~~Y~  211 (604)
                      ++...  .++...+..++.+++.+|.|||+.|++|+||+|.||+++. ++.++|+|||.+..............+...|+
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~  160 (215)
T cd00180          81 LLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYM  160 (215)
T ss_pred             HHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhcccCCCCcc
Confidence            99775  7899999999999999999999999999999999999999 89999999999976654332233456888999


Q ss_pred             ChHHhhcC-CCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCCCCCCCCccchHHHHHHHHHHhccCCCCCCCH
Q psy1546         212 APEVIKQS-AYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPENRPTA  290 (604)
Q Consensus       212 APE~l~~~-~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~RpT~  290 (604)
                      +||.+... .++.+.|+|+||+++++|                                ..+.+++..||..||.+||++
T Consensus       161 ~pe~~~~~~~~~~~~D~~~lg~~~~~l--------------------------------~~~~~~l~~~l~~~p~~R~~~  208 (215)
T cd00180         161 APEVLLGKGYYSEKSDIWSLGVILYEL--------------------------------PELKDLIRKMLQKDPEKRPSA  208 (215)
T ss_pred             ChhHhcccCCCCchhhhHHHHHHHHHH--------------------------------HHHHHHHHHHhhCCcccCcCH
Confidence            99999887 788999999999999999                                588999999999999999999


Q ss_pred             HHHhcCh
Q psy1546         291 KELLKFP  297 (604)
Q Consensus       291 ~elL~hp  297 (604)
                      .++++++
T Consensus       209 ~~l~~~~  215 (215)
T cd00180         209 KEILEHL  215 (215)
T ss_pred             HHHhhCC
Confidence            9999874

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG0984|consensus

Probab=99.96  E-value=4.9e-30  Score=244.09  Aligned_cols=205  Identities=32%  Similarity=0.549  Sum_probs=167.9

Q ss_pred             ceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhh-CCCCCCC----------eEEEEEEec
Q psy1546          59 FTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQ-CDSPYGT----------KLWIIMEYL  127 (604)
Q Consensus        59 y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~-l~hp~~~----------~lyLVmEy~  127 (604)
                      ...+..||+|+||.|-+.++..+|+..|+|.+...-.....+++.+|+.+..+ ..+|+.+          .+||.||.|
T Consensus        48 L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M  127 (282)
T KOG0984|consen   48 LVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELM  127 (282)
T ss_pred             hhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHh
Confidence            45567899999999999999999999999999776666666788888887665 4567644          457999999


Q ss_pred             CCCChhhHhh-----cCCCcHHHHHHHHHHHHHHhHHhhhC-CccccccccceeEecCCCCeEEecccccccccCCCCCC
Q psy1546         128 GGGSALDLMK-----AGNFEEMHIAVILREVLKGLDYLHSE-RKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKR  201 (604)
Q Consensus       128 ~ggsL~~~l~-----~~~lse~~i~~i~~qIl~gL~yLHs~-gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~~  201 (604)
                       ..+|..+.+     .+.++|..+-+|+..++.||.|||++ .+||||+||+||||+.+|+||+||||++..+.+.....
T Consensus       128 -~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSiAkt  206 (282)
T KOG0984|consen  128 -DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISGYLVDSIAKT  206 (282)
T ss_pred             -hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccccceeehhhhHHH
Confidence             455655432     36799999999999999999999987 89999999999999999999999999998876544332


Q ss_pred             cccccCCCCCChHHhh----cCCCCCcchhhhHHHHHHHHHhCCCCCCC-CChhhHhhhcCCCCCCCCC
Q psy1546         202 NTFVGTPFWMAPEVIK----QSAYDSKADIWSLGITAIELAKGEPPNSE-LHPMRVLFLIPKNNPPQLT  265 (604)
Q Consensus       202 ~~~~GT~~Y~APE~l~----~~~~~~~sDVwSLGviL~eLltG~~Pf~~-~~~~~~~~~i~~~~~~~~~  265 (604)
                       ...|...|||||.+.    ...|+-++||||||++++||.+++.||.. ..+.+++..+.....+.++
T Consensus       207 -~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVeep~P~Lp  274 (282)
T KOG0984|consen  207 -MDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVEEPSPQLP  274 (282)
T ss_pred             -HhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhcCCCCCCc
Confidence             246888999999985    34689999999999999999999999865 4567777777666666554

>KOG1167|consensus

Probab=99.96  E-value=1e-29  Score=263.82  Aligned_cols=243  Identities=28%  Similarity=0.440  Sum_probs=187.5

Q ss_pred             ccceeeeEEcccCcEEEEEEEECC---CCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCC-----------CCCeEEE
Q psy1546          57 LIFTKQERIGKGSFGEVFKGIDNR---TQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSP-----------YGTKLWI  122 (604)
Q Consensus        57 ~~y~i~~~LG~G~fG~Vy~a~~~~---t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp-----------~~~~lyL  122 (604)
                      ..|.++.+||+|.|++||++++..   ..+.||+|.+......   ..+..|+.+|..+...           |..++.+
T Consensus        36 ~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p---~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~i  112 (418)
T KOG1167|consen   36 NAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSP---SRILNELEMLYRLGGSDNIIKLNGCFRNNDQVAI  112 (418)
T ss_pred             hhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCc---hHHHHHHHHHHHhccchhhhcchhhhccCCeeEE
Confidence            348899999999999999999877   7889999998765533   5578899888887543           3567899


Q ss_pred             EEEecCCCChhhHhhcCCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecC-CCCeEEecccccccccCC----
Q psy1546         123 IMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSE-MGDVKLADFGVAGTLTNT----  197 (604)
Q Consensus       123 VmEy~~ggsL~~~l~~~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~-~g~vKL~DFGlA~~~~~~----  197 (604)
                      ||||++.....++...  ++...++.+++.++.||.++|.+|||||||||.|+|.+. .+.-.|+|||+|......    
T Consensus       113 vlp~~~H~~f~~l~~~--l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~~~~  190 (418)
T KOG1167|consen  113 VLPYFEHDRFRDLYRS--LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQQTE  190 (418)
T ss_pred             EecccCccCHHHHHhc--CCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHHHHhhhhhh
Confidence            9999999999998876  667889999999999999999999999999999999974 467899999999521100    


Q ss_pred             -----------C---C--------------------------CCcccccCCCCCChHHhhc-CCCCCcchhhhHHHHHHH
Q psy1546         198 -----------T---S--------------------------KRNTFVGTPFWMAPEVIKQ-SAYDSKADIWSLGITAIE  236 (604)
Q Consensus       198 -----------~---~--------------------------~~~~~~GT~~Y~APE~l~~-~~~~~~sDVwSLGviL~e  236 (604)
                                 .   .                          ......||++|+|||++.. ...++++||||.|||+..
T Consensus       191 ~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI~Ls  270 (418)
T KOG1167|consen  191 HSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVILLS  270 (418)
T ss_pred             hhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeeccceeeh
Confidence                       0   0                          0112359999999999864 557889999999999999


Q ss_pred             HHhCCCCCCCCCh-hhHhh----------------------hcCCCC----------------------------CCCCC
Q psy1546         237 LAKGEPPNSELHP-MRVLF----------------------LIPKNN----------------------------PPQLT  265 (604)
Q Consensus       237 LltG~~Pf~~~~~-~~~~~----------------------~i~~~~----------------------------~~~~~  265 (604)
                      ++++..||-.... ...+.                      .+.+..                            .....
T Consensus       271 lls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~~~~~~  350 (418)
T KOG1167|consen  271 LLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTEREIGS  350 (418)
T ss_pred             hhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccceeecccc
Confidence            9999999753221 00000                      000000                            00111


Q ss_pred             ccchHHHHHHHHHHhccCCCCCCCHHHHhcChhhhhhhh
Q psy1546         266 GNYTKQFKEFVEACLNKDPENRPTAKELLKFPFIRKAKK  304 (604)
Q Consensus       266 ~~~s~~l~~Li~~~L~~dP~~RpT~~elL~hp~f~~~~~  304 (604)
                      ..++..+.+|+.+||..||.+|+|++++|+||||.....
T Consensus       351 d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~~~~  389 (418)
T KOG1167|consen  351 DVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDEADR  389 (418)
T ss_pred             ccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcchhh
Confidence            234557899999999999999999999999999986543

>KOG1165|consensus

Probab=99.96  E-value=5e-28  Score=244.17  Aligned_cols=234  Identities=22%  Similarity=0.345  Sum_probs=189.1

Q ss_pred             ccceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCCeE----------EEEEEe
Q psy1546          57 LIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTKL----------WIIMEY  126 (604)
Q Consensus        57 ~~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~~l----------yLVmEy  126 (604)
                      ..|.++++||+|+||++|+|++.-++++||||.-..++....+....+-.++|...  +.+..+          .||||+
T Consensus        28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~APQLrdEYr~YKlL~g~--~GIP~vYYFGqeG~~NiLVidL  105 (449)
T KOG1165|consen   28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSEAPQLRDEYRTYKLLGGT--EGIPQVYYFGQEGKYNILVIDL  105 (449)
T ss_pred             ccceeccccccCcceeeecccccccCceEEEEeccccCCcchHHHHHHHHHHHcCC--CCCCceeeeccccchhhhhhhh
Confidence            35999999999999999999999999999999987665554444444555555433  233333          399999


Q ss_pred             cCCCChhhHhh--cCCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCC-----CeEEecccccccccCCCC
Q psy1546         127 LGGGSALDLMK--AGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMG-----DVKLADFGVAGTLTNTTS  199 (604)
Q Consensus       127 ~~ggsL~~~l~--~~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g-----~vKL~DFGlA~~~~~~~~  199 (604)
                      + |.+|.|++.  .++|+.++++.++.||+.-++|+|++.+|+|||||+|+||...+     .|.|+|||+|+.+.++..
T Consensus       106 L-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp~T  184 (449)
T KOG1165|consen  106 L-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDPKT  184 (449)
T ss_pred             h-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhhcCccc
Confidence            9 899999875  47899999999999999999999999999999999999997443     589999999998876654


Q ss_pred             C-------CcccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhH---hhhcCCCC----CCCCC
Q psy1546         200 K-------RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRV---LFLIPKNN----PPQLT  265 (604)
Q Consensus       200 ~-------~~~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~---~~~i~~~~----~~~~~  265 (604)
                      +       .....||.+||+-..+.+.+.+...|+-|||.+++++|.|.+||++......   ...|-...    ...+.
T Consensus       185 kqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~T~i~~Lc  264 (449)
T KOG1165|consen  185 KQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRSTPIEVLC  264 (449)
T ss_pred             cccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccccccCCHHHHH
Confidence            3       4567899999999999999999999999999999999999999998765332   23332222    22345


Q ss_pred             ccchHHHHHHHHHHhccCCCCCCCHHHH
Q psy1546         266 GNYTKQFKEFVEACLNKDPENRPTAKEL  293 (604)
Q Consensus       266 ~~~s~~l~~Li~~~L~~dP~~RpT~~el  293 (604)
                      ..+|.++...|...-.++..+-|..+-+
T Consensus       265 ~g~P~efa~Yl~yvR~L~F~E~PDYdyl  292 (449)
T KOG1165|consen  265 EGFPEEFATYLRYVRRLDFFETPDYDYL  292 (449)
T ss_pred             hcCHHHHHHHHHHHHhcCcccCCCHHHH
Confidence            5788999999999888888888876543

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.96  E-value=1.3e-27  Score=234.15  Aligned_cols=202  Identities=35%  Similarity=0.576  Sum_probs=170.2

Q ss_pred             ceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCC----------eEEEEEEecC
Q psy1546          59 FTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGT----------KLWIIMEYLG  128 (604)
Q Consensus        59 y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~----------~lyLVmEy~~  128 (604)
                      |.+.+.||.|+||.||+|.+..+++.+|||.+.........+.+.+|+..+..++|++..          ..|+|+||++
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE   80 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence            567889999999999999999889999999997654433467888999999999999743          4579999999


Q ss_pred             CCChhhHhhcCC--CcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCC-CCCcccc
Q psy1546         129 GGSALDLMKAGN--FEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTT-SKRNTFV  205 (604)
Q Consensus       129 ggsL~~~l~~~~--lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~-~~~~~~~  205 (604)
                      +++|.+++....  +++..+..++.+++.+|.|||+.+++|+||+|.||+++.++.++|+|||++..+.... .......
T Consensus        81 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~~~~~  160 (225)
T smart00221       81 GGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALLKTVK  160 (225)
T ss_pred             CCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccccccccee
Confidence            999999997643  8999999999999999999999999999999999999999999999999997665432 1233457


Q ss_pred             cCCCCCChHHh-hcCCCCCcchhhhHHHHHHHHHhCCCCCCC-CChh-hHhhhcCCCC
Q psy1546         206 GTPFWMAPEVI-KQSAYDSKADIWSLGITAIELAKGEPPNSE-LHPM-RVLFLIPKNN  260 (604)
Q Consensus       206 GT~~Y~APE~l-~~~~~~~~sDVwSLGviL~eLltG~~Pf~~-~~~~-~~~~~i~~~~  260 (604)
                      ++..|++||.+ ....++.++|||+||+++++|++|+.||.. .... .+...+..+.
T Consensus       161 ~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~  218 (225)
T smart00221      161 GTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWSFGV  218 (225)
T ss_pred             ccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHhcCC
Confidence            88899999999 667788899999999999999999999977 4443 4444454443

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG1345|consensus

Probab=99.96  E-value=1.5e-28  Score=242.06  Aligned_cols=232  Identities=21%  Similarity=0.327  Sum_probs=181.4

Q ss_pred             ccCccccceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCC-CCCC-----------Ce
Q psy1546          52 KVDPELIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCD-SPYG-----------TK  119 (604)
Q Consensus        52 ~~~~~~~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~-hp~~-----------~~  119 (604)
                      +++..+.|.+.+.||+|.||.+-+|+|+.++..+|+|.+....  ..+..+.+|...--.|. |.++           ..
T Consensus        19 kv~l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~--tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~   96 (378)
T KOG1345|consen   19 KVDLEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ--TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDA   96 (378)
T ss_pred             ccchhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch--hhHHHHHHHhccceeeccchhhhHHHHHHhhcCce
Confidence            4566778999999999999999999999999999999986543  34577888876544443 3332           34


Q ss_pred             EEEEEEecCCCChhhHhhcCCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEec--CCCCeEEecccccccccCC
Q psy1546         120 LWIIMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLS--EMGDVKLADFGVAGTLTNT  197 (604)
Q Consensus       120 lyLVmEy~~ggsL~~~l~~~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~--~~g~vKL~DFGlA~~~~~~  197 (604)
                      +++++||++-|+|..-+....+-|...+.++.|++.||.|||++++||||||.+||||-  +.-.|||||||..+..+..
T Consensus        97 YvF~qE~aP~gdL~snv~~~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~t  176 (378)
T KOG1345|consen   97 YVFVQEFAPRGDLRSNVEAAGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTT  176 (378)
T ss_pred             EEEeeccCccchhhhhcCcccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccccCce
Confidence            56899999999999999988899999999999999999999999999999999999994  3347999999998654433


Q ss_pred             CCCCcccccCCCCCChHHhhcC-----CCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHh----hhcCCC---CCCCCC
Q psy1546         198 TSKRNTFVGTPFWMAPEVIKQS-----AYDSKADIWSLGITAIELAKGEPPNSELHPMRVL----FLIPKN---NPPQLT  265 (604)
Q Consensus       198 ~~~~~~~~GT~~Y~APE~l~~~-----~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~----~~i~~~---~~~~~~  265 (604)
                      ...   .--+..|.+||+....     ..++..|||.||+|+|.+++|.+||+....+...    ..+...   ..+...
T Consensus       177 V~~---~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~P~~F  253 (378)
T KOG1345|consen  177 VKY---LEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPALPKKF  253 (378)
T ss_pred             ehh---hhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCccCchhh
Confidence            222   2345679999987532     2467899999999999999999999854432211    112222   233444


Q ss_pred             ccchHHHHHHHHHHhccCCCCCC
Q psy1546         266 GNYTKQFKEFVEACLNKDPENRP  288 (604)
Q Consensus       266 ~~~s~~l~~Li~~~L~~dP~~Rp  288 (604)
                      ..+++.+..++++-|..++++|-
T Consensus       254 ~~fs~~a~r~Fkk~lt~~~~drc  276 (378)
T KOG1345|consen  254 NPFSEKALRLFKKSLTPRFKDRC  276 (378)
T ss_pred             cccCHHHHHHHHHhcCCcccccc
Confidence            56788999999999999999993

>KOG1024|consensus

Probab=99.95  E-value=2.6e-28  Score=250.22  Aligned_cols=237  Identities=21%  Similarity=0.382  Sum_probs=201.1

Q ss_pred             ceeeeEEcccCcEEEEEEEECCCC-----cEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCCeE-----------EE
Q psy1546          59 FTKQERIGKGSFGEVFKGIDNRTQ-----QVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTKL-----------WI  122 (604)
Q Consensus        59 y~i~~~LG~G~fG~Vy~a~~~~t~-----~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~~l-----------yL  122 (604)
                      ++...++-+|.||.||.|.+++..     +.|-+|.++....+-+...+..|-.+|..+.|||...+           ++
T Consensus       286 v~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~P~V  365 (563)
T KOG1024|consen  286 VRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYATPFV  365 (563)
T ss_pred             eechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCcceE
Confidence            566678899999999999765432     34556666555555567788999999999999995443           58


Q ss_pred             EEEecCCCChhhHhhc---------CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEeccccccc
Q psy1546         123 IMEYLGGGSALDLMKA---------GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGT  193 (604)
Q Consensus       123 VmEy~~ggsL~~~l~~---------~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~  193 (604)
                      ++.++.-|+|..++..         +.++-.++..++.|++.|++|||.+||||.||..+|++|++.-+|||+|=.+++.
T Consensus       366 ~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~LqVkltDsaLSRD  445 (563)
T KOG1024|consen  366 LYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQVKLTDSALSRD  445 (563)
T ss_pred             EEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhheeEEeccchhccc
Confidence            8899999999999872         2366677888999999999999999999999999999999999999999999987


Q ss_pred             ccCCCCCC-c-ccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHhhhcCCCCCCCCCccchH
Q psy1546         194 LTNTTSKR-N-TFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAK-GEPPNSELHPMRVLFLIPKNNPPQLTGNYTK  270 (604)
Q Consensus       194 ~~~~~~~~-~-~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~  270 (604)
                      +-...... . ..-....||+||.+.+..|+.++|||||||+||||+| |+.||.+.++.++...+.++.+...+-++|+
T Consensus       446 LFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkdGyRlaQP~NCPD  525 (563)
T KOG1024|consen  446 LFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKDGYRLAQPFNCPD  525 (563)
T ss_pred             cCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhccceecCCCCCcH
Confidence            65332211 1 1123456999999999999999999999999999998 9999999999999999999999999999999


Q ss_pred             HHHHHHHHHhccCCCCCCCHHHHhc
Q psy1546         271 QFKEFVEACLNKDPENRPTAKELLK  295 (604)
Q Consensus       271 ~l~~Li~~~L~~dP~~RpT~~elL~  295 (604)
                      ++..++..||..+|++||+++|+..
T Consensus       526 eLf~vMacCWallpeeRPsf~Qlv~  550 (563)
T KOG1024|consen  526 ELFTVMACCWALLPEERPSFSQLVI  550 (563)
T ss_pred             HHHHHHHHHHhcCcccCCCHHHHHH
Confidence            9999999999999999999999865

>KOG1152|consensus

Probab=99.95  E-value=3.8e-29  Score=266.46  Aligned_cols=186  Identities=30%  Similarity=0.472  Sum_probs=161.1

Q ss_pred             ceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhH-------HHHHHHHHHHHHHhhCC---CCCCCe---------
Q psy1546          59 FTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAE-------DEIEDIQQEIMVLSQCD---SPYGTK---------  119 (604)
Q Consensus        59 y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~-------~~~~~l~~Ei~iL~~l~---hp~~~~---------  119 (604)
                      |+.++.||+|+||.|++|.++.+...|+||+|.++..-       ..+-.+-.||.||..++   |+|+.+         
T Consensus       563 yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEddd  642 (772)
T KOG1152|consen  563 YTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDDD  642 (772)
T ss_pred             ceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecCC
Confidence            89999999999999999999999999999999766431       11233557999999998   888665         


Q ss_pred             -EEEEEEec-CCCChhhHhhc-CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccC
Q psy1546         120 -LWIIMEYL-GGGSALDLMKA-GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTN  196 (604)
Q Consensus       120 -lyLVmEy~-~ggsL~~~l~~-~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~  196 (604)
                       +||+||-- +|.+|.++|.. ..++|.+++.|++|++.|+++||+.||||||||-+||.|+.+|.+||+|||.|.....
T Consensus       643 ~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klidfgsaa~~ks  722 (772)
T KOG1152|consen  643 YYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLIDFGSAAYTKS  722 (772)
T ss_pred             eeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEeeccchhhhcC
Confidence             47999975 67789999975 5799999999999999999999999999999999999999999999999999854432


Q ss_pred             CCCCCcccccCCCCCChHHhhcCCCC-CcchhhhHHHHHHHHHhCCCCCCC
Q psy1546         197 TTSKRNTFVGTPFWMAPEVIKQSAYD-SKADIWSLGITAIELAKGEPPNSE  246 (604)
Q Consensus       197 ~~~~~~~~~GT~~Y~APE~l~~~~~~-~~sDVwSLGviL~eLltG~~Pf~~  246 (604)
                        ....+++||..|.|||++.+.+|- ..-|||+||++||-++....||+.
T Consensus       723 --gpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn  771 (772)
T KOG1152|consen  723 --GPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN  771 (772)
T ss_pred             --CCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence              334578999999999999999875 567999999999999999999864

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.95  E-value=3.4e-28  Score=285.17  Aligned_cols=181  Identities=17%  Similarity=0.247  Sum_probs=136.7

Q ss_pred             CeEEEEEEecCCCChhhHhhc--CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCC---------------
Q psy1546         118 TKLWIIMEYLGGGSALDLMKA--GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEM---------------  180 (604)
Q Consensus       118 ~~lyLVmEy~~ggsL~~~l~~--~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~---------------  180 (604)
                      ..++++|||+ +++|.+++..  +.+++.+++.|++||+.||.|||++|||||||||+||||+..               
T Consensus        53 ~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~  131 (793)
T PLN00181         53 DSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVRPSCFVMSSFNHVSFIESASCSDSG  131 (793)
T ss_pred             chhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccCCchhEEEcccCcEEEeeccccCccc
Confidence            4578889987 6699999964  459999999999999999999999999999999999999654               


Q ss_pred             ----CCeEEecccccccccCCC----------------CCCcccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhC
Q psy1546         181 ----GDVKLADFGVAGTLTNTT----------------SKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKG  240 (604)
Q Consensus       181 ----g~vKL~DFGlA~~~~~~~----------------~~~~~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG  240 (604)
                          +.+||+|||+++......                ......+||+.|||||++.+..|+.++|||||||+||||++|
T Consensus       132 ~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~  211 (793)
T PLN00181        132 SDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEEDNGSSSNCASDVYRLGVLLFELFCP  211 (793)
T ss_pred             ccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhhccCCCCchhhhhhHHHHHHHHhhC
Confidence                445666666664321100                001124689999999999999999999999999999999999


Q ss_pred             CCCCCCCChhhHhhhcCCCC-CCCCCccchHHHHHHHHHHhccCCCCCCCHHHHhcChhhhhh
Q psy1546         241 EPPNSELHPMRVLFLIPKNN-PPQLTGNYTKQFKEFVEACLNKDPENRPTAKELLKFPFIRKA  302 (604)
Q Consensus       241 ~~Pf~~~~~~~~~~~i~~~~-~~~~~~~~s~~l~~Li~~~L~~dP~~RpT~~elL~hp~f~~~  302 (604)
                      .+|+......  ...+.... ++.... ......+++.+||..||.+||++.|||+||||...
T Consensus       212 ~~~~~~~~~~--~~~~~~~~~~~~~~~-~~~~~~~~~~~~L~~~P~~Rps~~eil~h~~~~~~  271 (793)
T PLN00181        212 VSSREEKSRT--MSSLRHRVLPPQILL-NWPKEASFCLWLLHPEPSCRPSMSELLQSEFINEP  271 (793)
T ss_pred             CCchhhHHHH--HHHHHHhhcChhhhh-cCHHHHHHHHHhCCCChhhCcChHHHhhchhhhhh
Confidence            9987643221  11111111 111111 23456789999999999999999999999999753

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.95  E-value=9.6e-28  Score=228.90  Aligned_cols=159  Identities=30%  Similarity=0.397  Sum_probs=129.0

Q ss_pred             CChhhHhhc--CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCCCCcccccC
Q psy1546         130 GSALDLMKA--GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGT  207 (604)
Q Consensus       130 gsL~~~l~~--~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~~~~~~GT  207 (604)
                      |+|.+++..  +.+++..++.|+.||+.||.|||+++      ||+|||++.++.+|+  ||+++......     ..||
T Consensus         1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~~-----~~g~   67 (176)
T smart00750        1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTPEQ-----SRVD   67 (176)
T ss_pred             CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeecccc-----CCCc
Confidence            688999874  45999999999999999999999999      999999999999999  99997654322     2689


Q ss_pred             CCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhH-hhhcCCCCCC------CCCccchH--HHHHHHHH
Q psy1546         208 PFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRV-LFLIPKNNPP------QLTGNYTK--QFKEFVEA  278 (604)
Q Consensus       208 ~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~-~~~i~~~~~~------~~~~~~s~--~l~~Li~~  278 (604)
                      +.|||||++.+..|+.++|||||||++|||++|..||........ ...+......      .....++.  .+.++|.+
T Consensus        68 ~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~  147 (176)
T smart00750       68 PYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFADFMRV  147 (176)
T ss_pred             ccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHHHHH
Confidence            999999999999999999999999999999999999976543221 1111111111      11223444  69999999


Q ss_pred             HhccCCCCCCCHHHHhcChhhhh
Q psy1546         279 CLNKDPENRPTAKELLKFPFIRK  301 (604)
Q Consensus       279 ~L~~dP~~RpT~~elL~hp~f~~  301 (604)
                      ||..||.+||++.|+++|+|+..
T Consensus       148 cl~~~p~~Rp~~~~ll~~~~~~~  170 (176)
T smart00750      148 CASRLPQRREAANHYLAHCRALF  170 (176)
T ss_pred             HHhcccccccCHHHHHHHHHHHH
Confidence            99999999999999999999864

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG1163|consensus

Probab=99.94  E-value=9e-27  Score=226.27  Aligned_cols=257  Identities=21%  Similarity=0.318  Sum_probs=202.2

Q ss_pred             ccceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCC----C-------CeEEEEEE
Q psy1546          57 LIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPY----G-------TKLWIIME  125 (604)
Q Consensus        57 ~~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~----~-------~~lyLVmE  125 (604)
                      ..|.++++||.|+||.+|+|....+|+.||||+-......   ..+..|..+.+.|.+-.    +       ..-.+||+
T Consensus        15 gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~h---pqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMd   91 (341)
T KOG1163|consen   15 GKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKH---PQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMD   91 (341)
T ss_pred             cceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCC---cchhHHHHHHHHhccCCCCchhhhhccccccceeeee
Confidence            3499999999999999999999999999999997554332   34555666666655432    2       22259999


Q ss_pred             ecCCCChhhHhh--cCCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCC---CCeEEecccccccccCCCC-
Q psy1546         126 YLGGGSALDLMK--AGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEM---GDVKLADFGVAGTLTNTTS-  199 (604)
Q Consensus       126 y~~ggsL~~~l~--~~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~---g~vKL~DFGlA~~~~~~~~-  199 (604)
                      ++ |.+|.+++.  .+.|+.++++.++-|++.-|+|+|.+++|||||||+|+|+.-+   ..+.|+|||+|+.+.+... 
T Consensus        92 LL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~t~  170 (341)
T KOG1163|consen   92 LL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIRTR  170 (341)
T ss_pred             cc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhhcccccc
Confidence            99 899999874  5789999999999999999999999999999999999999643   4589999999987754432 


Q ss_pred             ------CCcccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhH-------hhhcCCCCCCCCCc
Q psy1546         200 ------KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRV-------LFLIPKNNPPQLTG  266 (604)
Q Consensus       200 ------~~~~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~-------~~~i~~~~~~~~~~  266 (604)
                            ......||.+|.+-..+.+...+...|+-|+|.+|.++..|.+||++......       ...........+..
T Consensus       171 ~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s~~ie~LC~  250 (341)
T KOG1163|consen  171 QHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMSTPIEVLCK  250 (341)
T ss_pred             ccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcCCCHHHHhC
Confidence                  23456799999999999999999999999999999999999999998765322       22222333445667


Q ss_pred             cchHHHHHHHHHHhccCCCCCCCH---HHHhcChhhhhhhhhhhHHHHHHHHHH
Q psy1546         267 NYTKQFKEFVEACLNKDPENRPTA---KELLKFPFIRKAKKNAYLIDLIDRYKK  317 (604)
Q Consensus       267 ~~s~~l~~Li~~~L~~dP~~RpT~---~elL~hp~f~~~~~~~~l~~~~~~~~~  317 (604)
                      .+|.++.-.|..|-..-.++-|..   .+++..-|+.-....+++.||.-..++
T Consensus       251 G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr~ln~~~d~iyDW~~lkqk  304 (341)
T KOG1163|consen  251 GFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFRTLNHQYDYIYDWTMLKQK  304 (341)
T ss_pred             CCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHhhccccCCeEeeHHHHHHH
Confidence            889999999999999999999984   455555565555666777776544443

>KOG1164|consensus

Probab=99.93  E-value=1.8e-25  Score=235.49  Aligned_cols=237  Identities=26%  Similarity=0.334  Sum_probs=183.6

Q ss_pred             cceeeeEEcccCcEEEEEEEECCCC-cEEEEEEecchhhHHHHHHHHHHHHHHhhCCC------C---------CCCeEE
Q psy1546          58 IFTKQERIGKGSFGEVFKGIDNRTQ-QVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDS------P---------YGTKLW  121 (604)
Q Consensus        58 ~y~i~~~LG~G~fG~Vy~a~~~~t~-~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~h------p---------~~~~ly  121 (604)
                      .|.+.++||+|+||.||+|.+..++ ..+|+|+......... ..+..|+.++..+..      -         ....-|
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~-~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~   97 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKP-SVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNF   97 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCC-ccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeE
Confidence            5999999999999999999988774 6799998765432222 156777777777762      1         122358


Q ss_pred             EEEEecCCCChhhHhhc---CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCC-----CCeEEecccccc-
Q psy1546         122 IIMEYLGGGSALDLMKA---GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEM-----GDVKLADFGVAG-  192 (604)
Q Consensus       122 LVmEy~~ggsL~~~l~~---~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~-----g~vKL~DFGlA~-  192 (604)
                      |||+.+ |.+|.++.+.   +.|+..++..++.|++.+|++||+.|++||||||.|+++...     ..++|+|||+|+ 
T Consensus        98 iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar~  176 (322)
T KOG1164|consen   98 IVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLARR  176 (322)
T ss_pred             EEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCCcc
Confidence            999998 8899998743   679999999999999999999999999999999999999865     469999999998 


Q ss_pred             -cccCCCC-------C-CcccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhc---CCCC
Q psy1546         193 -TLTNTTS-------K-RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLI---PKNN  260 (604)
Q Consensus       193 -~~~~~~~-------~-~~~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i---~~~~  260 (604)
                       .+.....       . ...+.||..|+++.++.+...+.+.|+||++.++.+|+.|.+||............   ....
T Consensus       177 ~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~~~~  256 (322)
T KOG1164|consen  177 FKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDPRKL  256 (322)
T ss_pred             ccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHhhhh
Confidence             3321111       1 23466999999999999999999999999999999999999999776542222111   1111


Q ss_pred             CCC-CCccchHHHHHHHHHHhccCCCCCCCHHHHhcC
Q psy1546         261 PPQ-LTGNYTKQFKEFVEACLNKDPENRPTAKELLKF  296 (604)
Q Consensus       261 ~~~-~~~~~s~~l~~Li~~~L~~dP~~RpT~~elL~h  296 (604)
                      ... .....+.++..++..+-..+...+|....+...
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~  293 (322)
T KOG1164|consen  257 LTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAEL  293 (322)
T ss_pred             ccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHH
Confidence            111 334456788899999888999999998887663

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.93  E-value=2.3e-24  Score=217.71  Aligned_cols=240  Identities=38%  Similarity=0.595  Sum_probs=196.0

Q ss_pred             ceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHH--HHHHHHHHHHHHhhCCCC-CCCe----------EEEEEE
Q psy1546          59 FTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAED--EIEDIQQEIMVLSQCDSP-YGTK----------LWIIME  125 (604)
Q Consensus        59 y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~--~~~~l~~Ei~iL~~l~hp-~~~~----------lyLVmE  125 (604)
                      |.+.+.||.|+||.||++.+.   ..+|+|.+.......  ....+.+|+.++..+.|+ ++.+          .+++++
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~   78 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVME   78 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEe
Confidence            678899999999999999987   789999997665443  467889999999999988 4443          479999


Q ss_pred             ecCCCChhhHhhcC----CCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCC-CeEEecccccccccCCCC-
Q psy1546         126 YLGGGSALDLMKAG----NFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMG-DVKLADFGVAGTLTNTTS-  199 (604)
Q Consensus       126 y~~ggsL~~~l~~~----~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g-~vKL~DFGlA~~~~~~~~-  199 (604)
                      |+.++++.+++...    .+.+..+..++.|++.+|.|+|+.+++||||||+|||++..+ .++++|||+++.+..... 
T Consensus        79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~  158 (384)
T COG0515          79 YVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGST  158 (384)
T ss_pred             cCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCcc
Confidence            99999999887764    699999999999999999999999999999999999999988 799999999976554332 


Q ss_pred             -----CCcccccCCCCCChHHhhc---CCCCCcchhhhHHHHHHHHHhCCCCCCCCCh----hhHhhhcCCCCCC----C
Q psy1546         200 -----KRNTFVGTPFWMAPEVIKQ---SAYDSKADIWSLGITAIELAKGEPPNSELHP----MRVLFLIPKNNPP----Q  263 (604)
Q Consensus       200 -----~~~~~~GT~~Y~APE~l~~---~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~----~~~~~~i~~~~~~----~  263 (604)
                           .....+||..|++||.+.+   ..+....|+|++|++++++++|..||.....    ......+......    .
T Consensus       159 ~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (384)
T COG0515         159 SSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASP  238 (384)
T ss_pred             ccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCcccccc
Confidence                 3467789999999999987   5788899999999999999999999877653    2333322222211    1


Q ss_pred             CCccc----hHHHHHHHHHHhccCCCCCCCHHHHhcChhhhh
Q psy1546         264 LTGNY----TKQFKEFVEACLNKDPENRPTAKELLKFPFIRK  301 (604)
Q Consensus       264 ~~~~~----s~~l~~Li~~~L~~dP~~RpT~~elL~hp~f~~  301 (604)
                      .....    ...+.+++..++..+|..|.+..+...++|...
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~  280 (384)
T COG0515         239 LSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAH  280 (384)
T ss_pred             cCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhC
Confidence            11111    257899999999999999999999988866543

>KOG0590|consensus

Probab=99.93  E-value=2e-26  Score=259.71  Aligned_cols=243  Identities=25%  Similarity=0.370  Sum_probs=192.8

Q ss_pred             eeeeEEcccCcEEEEEEEECCCCcEEEEEEec----chhh-HHHHHHHHHHHHHHhhCCCCCCCe----------EEEEE
Q psy1546          60 TKQERIGKGSFGEVFKGIDNRTQQVVAIKIID----LEEA-EDEIEDIQQEIMVLSQCDSPYGTK----------LWIIM  124 (604)
Q Consensus        60 ~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~----~~~~-~~~~~~l~~Ei~iL~~l~hp~~~~----------lyLVm  124 (604)
                      ....++|.|+||.|+.+........++.|.+.    .... ......+..|+.+-..+.|+++..          .+-+|
T Consensus       321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m  400 (601)
T KOG0590|consen  321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM  400 (601)
T ss_pred             CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence            34578999999989888877766666666553    1211 222233667888888899998432          24559


Q ss_pred             EecCCCChhhHhhcC-CCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCC----
Q psy1546         125 EYLGGGSALDLMKAG-NFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTS----  199 (604)
Q Consensus       125 Ey~~ggsL~~~l~~~-~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~----  199 (604)
                      |||++ +|..++... .+...++..+++||+.||+|||+.||.|||||++|+|+...|.+||+|||.+..+.....    
T Consensus       401 E~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~~~~  479 (601)
T KOG0590|consen  401 EYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEKNIH  479 (601)
T ss_pred             hcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeeccCcchhhh
Confidence            99999 999988775 899999999999999999999999999999999999999999999999999976543332    


Q ss_pred             CCcccccCCCCCChHHhhcCCCCC-cchhhhHHHHHHHHHhCCCCCCCCChhhHhh--hcC------CCCCCCCCccchH
Q psy1546         200 KRNTFVGTPFWMAPEVIKQSAYDS-KADIWSLGITAIELAKGEPPNSELHPMRVLF--LIP------KNNPPQLTGNYTK  270 (604)
Q Consensus       200 ~~~~~~GT~~Y~APE~l~~~~~~~-~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~--~i~------~~~~~~~~~~~s~  270 (604)
                      ....++|+-.|+|||++.+..|++ .+||||.|++++.|++|+.||......+..+  ...      ...+..+...++.
T Consensus       480 ~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~lp~  559 (601)
T KOG0590|consen  480 ESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNRLLSLLPR  559 (601)
T ss_pred             hhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChHHHHHhchh
Confidence            345678999999999999999986 4799999999999999999997655443321  110      1112334455678


Q ss_pred             HHHHHHHHHhccCCCCCCCHHHHhcChhhhhhh
Q psy1546         271 QFKEFVEACLNKDPENRPTAKELLKFPFIRKAK  303 (604)
Q Consensus       271 ~l~~Li~~~L~~dP~~RpT~~elL~hp~f~~~~  303 (604)
                      ..+.+|.+||+.||.+|.|+++|++.+||+...
T Consensus       560 ~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i~  592 (601)
T KOG0590|consen  560 ETRIIIYRMLQLDPTKRITIEQILNDEWIRSIE  592 (601)
T ss_pred             hHHHHHHHHccCChhheecHHHHhhChHhhhcc
Confidence            889999999999999999999999999998643

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.92  E-value=1.1e-24  Score=231.71  Aligned_cols=156  Identities=17%  Similarity=0.139  Sum_probs=125.9

Q ss_pred             cceeeeEEcccCcEEEEEEEECC-CCcEEEEEEecchh----hHHHHHHHHHHHHHHhhCCCCCCCe-------EEEEEE
Q psy1546          58 IFTKQERIGKGSFGEVFKGIDNR-TQQVVAIKIIDLEE----AEDEIEDIQQEIMVLSQCDSPYGTK-------LWIIME  125 (604)
Q Consensus        58 ~y~i~~~LG~G~fG~Vy~a~~~~-t~~~vAVK~i~~~~----~~~~~~~l~~Ei~iL~~l~hp~~~~-------lyLVmE  125 (604)
                      .|.+.+.||+|+||+||+|.+.. +++.||||++....    .....+.+.+|+.+|+.+.|+++..       .|||||
T Consensus        19 ~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~~~~~LVmE   98 (365)
T PRK09188         19 RFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLATGKDGLVRG   98 (365)
T ss_pred             CceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEcCCcEEEEE
Confidence            39999999999999999999876 78888999875331    1233567899999999999998663       589999


Q ss_pred             ecCCCChhhHhhcCCCcHHHHHHHHHHHHHHhHHhhhCCcccccc-ccceeEecCCCCeEEecccccccccCCCCC----
Q psy1546         126 YLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDI-KAANVLLSEMGDVKLADFGVAGTLTNTTSK----  200 (604)
Q Consensus       126 y~~ggsL~~~l~~~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDL-Kp~NILl~~~g~vKL~DFGlA~~~~~~~~~----  200 (604)
                      ||+|++|......+      ...++.|++.||.|||++||+|||| ||+|||++.++.+||+|||+|+.+......    
T Consensus        99 ~~~G~~L~~~~~~~------~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~~~~~~~~~~  172 (365)
T PRK09188         99 WTEGVPLHLARPHG------DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLASVFRRRGALYRIA  172 (365)
T ss_pred             ccCCCCHHHhCccc------hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECccceecccCcchhhhh
Confidence            99999997331111      2467899999999999999999999 999999999999999999999866543211    


Q ss_pred             ----CcccccCCCCCChHHhhcC
Q psy1546         201 ----RNTFVGTPFWMAPEVIKQS  219 (604)
Q Consensus       201 ----~~~~~GT~~Y~APE~l~~~  219 (604)
                          ....++++.|+|||++.-.
T Consensus       173 ~~~d~~~~~~~~~~~~pe~~~~~  195 (365)
T PRK09188        173 AYEDLRHLLKHKRTYAPDALTPR  195 (365)
T ss_pred             hhhhhhhhhccCccCCcccCChh
Confidence                1356788999999998643

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.89  E-value=6.9e-23  Score=210.02  Aligned_cols=221  Identities=24%  Similarity=0.313  Sum_probs=150.8

Q ss_pred             cceeeeEEcccCcEEEEEEEECCCCcEEEEEEecch--hhHHHHHHHHHHHHHHhhCCCC---------------C----
Q psy1546          58 IFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLE--EAEDEIEDIQQEIMVLSQCDSP---------------Y----  116 (604)
Q Consensus        58 ~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~--~~~~~~~~l~~Ei~iL~~l~hp---------------~----  116 (604)
                      .+...+.||.|+|+.||.++|..|++.+|||++...  .....++.+.+|......+.+.               .    
T Consensus        13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~   92 (288)
T PF14531_consen   13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR   92 (288)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred             EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence            367788999999999999999999999999997433  3334567777776555443331               0    


Q ss_pred             ------------------CCeEEEEEEecCCCChhhHhhc----CC----CcHHHHHHHHHHHHHHhHHhhhCCcccccc
Q psy1546         117 ------------------GTKLWIIMEYLGGGSALDLMKA----GN----FEEMHIAVILREVLKGLDYLHSERKLHRDI  170 (604)
Q Consensus       117 ------------------~~~lyLVmEy~~ggsL~~~l~~----~~----lse~~i~~i~~qIl~gL~yLHs~gIiHrDL  170 (604)
                                        ....+++|+-+ .++|.+++..    ..    +.......+..|+++.+++||..|++|+||
T Consensus        93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi  171 (288)
T PF14531_consen   93 IPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDI  171 (288)
T ss_dssp             ETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-
T ss_pred             EcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEeccc
Confidence                              01235778877 6778777542    11    222223445689999999999999999999


Q ss_pred             ccceeEecCCCCeEEecccccccccCCCCCCcccccCCCCCChHHhhcC--------CCCCcchhhhHHHHHHHHHhCCC
Q psy1546         171 KAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQS--------AYDSKADIWSLGITAIELAKGEP  242 (604)
Q Consensus       171 Kp~NILl~~~g~vKL~DFGlA~~~~~~~~~~~~~~GT~~Y~APE~l~~~--------~~~~~sDVwSLGviL~eLltG~~  242 (604)
                      +|+|+|++.+|.++|+||+..........   ....+..|.|||.....        .++.+.|.|+||+++|.|+||..
T Consensus       172 ~~~nfll~~~G~v~Lg~F~~~~r~g~~~~---~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~l  248 (288)
T PF14531_consen  172 KPENFLLDQDGGVFLGDFSSLVRAGTRYR---CSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRL  248 (288)
T ss_dssp             SGGGEEE-TTS-EEE--GGGEEETTEEEE---GGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-
T ss_pred             ceeeEEEcCCCCEEEcChHHHeecCceee---ccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccC
Confidence            99999999999999999998755433221   13455789999987542        47788999999999999999999


Q ss_pred             CCCCCChhhHhhhcCCCCCCCCCccchHHHHHHHHHHhccCCCCC
Q psy1546         243 PNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPENR  287 (604)
Q Consensus       243 Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R  287 (604)
                      ||...........    ....+. ++|+.++.||..+|+.||.+|
T Consensus       249 Pf~~~~~~~~~~~----~f~~C~-~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  249 PFGLSSPEADPEW----DFSRCR-DMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             STCCCGGGSTSGG----GGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred             CCCCCCccccccc----cchhcC-CcCHHHHHHHHHHccCCcccC
Confidence            9987654333221    112233 788999999999999999987

>KOG0606|consensus

Probab=99.88  E-value=4.8e-23  Score=233.23  Aligned_cols=224  Identities=27%  Similarity=0.449  Sum_probs=173.4

Q ss_pred             CccccceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCCeEEEEEEecCCCChh
Q psy1546          54 DPELIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTKLWIIMEYLGGGSAL  133 (604)
Q Consensus        54 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~~lyLVmEy~~ggsL~  133 (604)
                      ..+..|..++.|..|+||.||+++|+.+.+.+|+|+- +...      +.+-  +|..-..|+     .|      |+..
T Consensus        80 p~e~df~~IklisngAygavylvrh~~trqrfa~kiN-kq~l------ilRn--ilt~a~npf-----vv------gDc~  139 (1205)
T KOG0606|consen   80 PSESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKIN-KQNL------ILRN--ILTFAGNPF-----VV------GDCA  139 (1205)
T ss_pred             CCccccceeEeeccCCCCceeeeeccccccchhhccc-ccch------hhhc--cccccCCcc-----ee------chhh
Confidence            3455689999999999999999999999999999553 2211      1111  333333333     22      6666


Q ss_pred             hHhhc-CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCC--------------
Q psy1546         134 DLMKA-GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTT--------------  198 (604)
Q Consensus       134 ~~l~~-~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~--------------  198 (604)
                      .+++. +.++..        ++.+++|||+.||+|||+||+|.||+.-|++|++|||+.+..-...              
T Consensus       140 tllk~~g~lPvd--------mvla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg~I~k~t~  211 (1205)
T KOG0606|consen  140 TLLKNIGPLPVD--------MVLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEGHIEKDTH  211 (1205)
T ss_pred             hhcccCCCCcch--------hhHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhccchhhhcchHHHHH
Confidence            66665 455543        3889999999999999999999999999999999999985321110              


Q ss_pred             -CCCcccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCCC--CCCCCccchHHHHHH
Q psy1546         199 -SKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNN--PPQLTGNYTKQFKEF  275 (604)
Q Consensus       199 -~~~~~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~~--~~~~~~~~s~~l~~L  275 (604)
                       ......||||.|.|||++..+.|+..+|+|++|+|+||++.|..||.+..+++++..+....  ++.-...++.+++++
T Consensus       212 Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wpE~dea~p~Ea~dl  291 (1205)
T KOG0606|consen  212 EFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEEDEALPPEAQDL  291 (1205)
T ss_pred             HhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhccccccCcCCCHHHHHH
Confidence             01234689999999999999999999999999999999999999999998888776554332  233355678899999


Q ss_pred             HHHHhccCCCCC---CCHHHHhcChhhhhhhhh
Q psy1546         276 VEACLNKDPENR---PTAKELLKFPFIRKAKKN  305 (604)
Q Consensus       276 i~~~L~~dP~~R---pT~~elL~hp~f~~~~~~  305 (604)
                      |.++|+.+|..|   ..+-+|.+|+||+...+.
T Consensus       292 i~~LL~qnp~~Rlgt~ga~evk~h~ff~~LDw~  324 (1205)
T KOG0606|consen  292 IEQLLRQNPLCRLGTGGALEVKQHGFFQLLDWK  324 (1205)
T ss_pred             HHHHHHhChHhhcccchhhhhhhccceeecccc
Confidence            999999999999   457888999999765444

>KOG0603|consensus

Probab=99.88  E-value=8.2e-24  Score=229.82  Aligned_cols=230  Identities=29%  Similarity=0.460  Sum_probs=187.7

Q ss_pred             EcccCcEEEEEEE---ECCCCcEEEEEEecchhhHHH-HHHHHHHHHHHhhCC-CCCC----------CeEEEEEEecCC
Q psy1546          65 IGKGSFGEVFKGI---DNRTQQVVAIKIIDLEEAEDE-IEDIQQEIMVLSQCD-SPYG----------TKLWIIMEYLGG  129 (604)
Q Consensus        65 LG~G~fG~Vy~a~---~~~t~~~vAVK~i~~~~~~~~-~~~l~~Ei~iL~~l~-hp~~----------~~lyLVmEy~~g  129 (604)
                      +|.|+||.|+++.   -...+..||+|+..+...... ......|..++..+. ||+.          .++|++++|..|
T Consensus         2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rg   81 (612)
T KOG0603|consen    2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRG   81 (612)
T ss_pred             CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhccc
Confidence            7999999999874   335678899999866543221 124456777787777 7764          455899999999


Q ss_pred             CChhhHhhc-CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCCCCcccccCC
Q psy1546         130 GSALDLMKA-GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTP  208 (604)
Q Consensus       130 gsL~~~l~~-~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~~~~~~GT~  208 (604)
                      |.|...+.. ..+.+.....+...++-+++++|+.+|+|||+|++||+++.+|++++.|||+++........    |||.
T Consensus        82 g~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~----cgt~  157 (612)
T KOG0603|consen   82 GDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA----CGTY  157 (612)
T ss_pred             chhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhhhhc----ccch
Confidence            988877654 67889999999999999999999999999999999999999999999999999876544332    9999


Q ss_pred             CCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCCCCCCCCccchHHHHHHHHHHhccCCCCCC
Q psy1546         209 FWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPENRP  288 (604)
Q Consensus       209 ~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rp  288 (604)
                      .|||||++.  .....+|.||||+++|||++|..||..    ++...|.+.. ...+..++..+++++..++..+|..|.
T Consensus       158 eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~~-~~~p~~l~~~a~~~~~~l~~r~p~nrL  230 (612)
T KOG0603|consen  158 EYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKAE-LEMPRELSAEARSLFRQLFKRNPENRL  230 (612)
T ss_pred             hhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhhc-cCCchhhhHHHHHHHHHHHhhCHHHHh
Confidence            999999998  567789999999999999999999998    4444443322 345677888999999999999999996


Q ss_pred             C-----HHHHhcChhhhhhhhh
Q psy1546         289 T-----AKELLKFPFIRKAKKN  305 (604)
Q Consensus       289 T-----~~elL~hp~f~~~~~~  305 (604)
                      -     +.|+++|+||....++
T Consensus       231 g~~~~~~~eik~h~f~~~i~~~  252 (612)
T KOG0603|consen  231 GAGPDGVDEIKQHEFFQSIDWN  252 (612)
T ss_pred             ccCcchhHHHhccchheeeeHh
Confidence            4     6899999999776543

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.87  E-value=4.8e-22  Score=194.00  Aligned_cols=131  Identities=18%  Similarity=0.219  Sum_probs=105.7

Q ss_pred             eeEEcccCcEEEEEEEECCCCcEEEEEEecchhhH--H---------H--------------HHHHHHHHHHHhhCCCCC
Q psy1546          62 QERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAE--D---------E--------------IEDIQQEIMVLSQCDSPY  116 (604)
Q Consensus        62 ~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~--~---------~--------------~~~l~~Ei~iL~~l~hp~  116 (604)
                      ...||+|+||.||+|.+. +|+.||||++......  .         .              .....+|+.++..+.+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   80 (190)
T cd05147           2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG   80 (190)
T ss_pred             CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence            457999999999999986 8999999999654211  0         0              122345999999887654


Q ss_pred             C--------CeEEEEEEecCCCChhhH-hhcCCCcHHHHHHHHHHHHHHhHHh-hhCCccccccccceeEecCCCCeEEe
Q psy1546         117 G--------TKLWIIMEYLGGGSALDL-MKAGNFEEMHIAVILREVLKGLDYL-HSERKLHRDIKAANVLLSEMGDVKLA  186 (604)
Q Consensus       117 ~--------~~lyLVmEy~~ggsL~~~-l~~~~lse~~i~~i~~qIl~gL~yL-Hs~gIiHrDLKp~NILl~~~g~vKL~  186 (604)
                      .        ...||||||++|+++... +..+.+++..+..++.||+.+|.|| |+.||+||||||+|||+++ +.++|+
T Consensus        81 v~~p~~~~~~~~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~~-~~v~Li  159 (190)
T cd05147          81 IPCPEPILLKSHVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYHD-GKLYII  159 (190)
T ss_pred             CCCCcEEEecCCEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEEC-CcEEEE
Confidence            2        122799999998877654 5667899999999999999999999 7999999999999999984 889999


Q ss_pred             cccccccc
Q psy1546         187 DFGVAGTL  194 (604)
Q Consensus       187 DFGlA~~~  194 (604)
                      |||+|...
T Consensus       160 DFG~a~~~  167 (190)
T cd05147         160 DVSQSVEH  167 (190)
T ss_pred             EccccccC
Confidence            99999544

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.86  E-value=2.9e-21  Score=188.30  Aligned_cols=132  Identities=19%  Similarity=0.223  Sum_probs=108.4

Q ss_pred             eeEEcccCcEEEEEEEECCCCcEEEEEEecchhhH------------------------H-HHHHHHHHHHHHhhCCCCC
Q psy1546          62 QERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAE------------------------D-EIEDIQQEIMVLSQCDSPY  116 (604)
Q Consensus        62 ~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~------------------------~-~~~~l~~Ei~iL~~l~hp~  116 (604)
                      .+.||+|+||.||+|.+. +|+.||||++......                        . ....+.+|+..+.++.|++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   80 (190)
T cd05145           2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG   80 (190)
T ss_pred             CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence            467999999999999987 8999999998654210                        0 0123467899999988876


Q ss_pred             CC--------eEEEEEEecCCCChh-hHhhcCCCcHHHHHHHHHHHHHHhHHhhh-CCccccccccceeEecCCCCeEEe
Q psy1546         117 GT--------KLWIIMEYLGGGSAL-DLMKAGNFEEMHIAVILREVLKGLDYLHS-ERKLHRDIKAANVLLSEMGDVKLA  186 (604)
Q Consensus       117 ~~--------~lyLVmEy~~ggsL~-~~l~~~~lse~~i~~i~~qIl~gL~yLHs-~gIiHrDLKp~NILl~~~g~vKL~  186 (604)
                      ..        ..||||||++|+++. ..+....++...+..++.|++.+|.+||. .||+||||||+|||++ ++.++|+
T Consensus        81 i~~p~~~~~~~~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~~~~li  159 (190)
T cd05145          81 VPVPEPILLKKNVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DGKPYII  159 (190)
T ss_pred             CCCceEEEecCCEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CCCEEEE
Confidence            42        127999999888554 34666788889999999999999999999 9999999999999999 7999999


Q ss_pred             ccccccccc
Q psy1546         187 DFGVAGTLT  195 (604)
Q Consensus       187 DFGlA~~~~  195 (604)
                      |||+|..+.
T Consensus       160 DFG~a~~~~  168 (190)
T cd05145         160 DVSQAVELD  168 (190)
T ss_pred             EcccceecC
Confidence            999997654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.84  E-value=7.6e-21  Score=189.61  Aligned_cols=159  Identities=14%  Similarity=0.142  Sum_probs=122.6

Q ss_pred             ccceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHH--HHHH------HHHHHHHHhhCCCCCC-----------
Q psy1546          57 LIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAED--EIED------IQQEIMVLSQCDSPYG-----------  117 (604)
Q Consensus        57 ~~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~--~~~~------l~~Ei~iL~~l~hp~~-----------  117 (604)
                      ..|.+.++||.|+||.||++.+  ++..||||++.......  ....      +.+|+..+.++.|+++           
T Consensus        31 ~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~  108 (232)
T PRK10359         31 YNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAE  108 (232)
T ss_pred             CceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeecc
Confidence            3599999999999999999755  46689999996543222  2222      5789999999988862           


Q ss_pred             -------CeEEEEEEecCCCChhhHhhcCCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccc
Q psy1546         118 -------TKLWIIMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGV  190 (604)
Q Consensus       118 -------~~lyLVmEy~~ggsL~~~l~~~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGl  190 (604)
                             ...||||||++|.+|.++..   +++    ..+.+|+.+|..||..|++||||||.||+++.+| ++|+|||.
T Consensus       109 ~~~~~~~~~~~lvmEyi~G~tL~~~~~---~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-i~liDfg~  180 (232)
T PRK10359        109 RKTLRYAHTYIMLIEYIEGVELNDMPE---ISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG-LRIIDLSG  180 (232)
T ss_pred             cccccccCCeEEEEEEECCccHHHhhh---ccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-EEEEECCC
Confidence                   13579999999999988742   333    2466999999999999999999999999999988 99999998


Q ss_pred             cccccCCCCCCcccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHH
Q psy1546         191 AGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIEL  237 (604)
Q Consensus       191 A~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eL  237 (604)
                      ..........            ..++....|+.++|+|+||++|..+
T Consensus       181 ~~~~~e~~a~------------d~~vler~y~~~~di~~lg~~~~~~  215 (232)
T PRK10359        181 KRCTAQRKAK------------DRIDLERHYGIKNEIKDLGYYLLIY  215 (232)
T ss_pred             cccccchhhH------------HHHHHHhHhcccccccceeEeehHH
Confidence            8554321111            1135566688899999999998765

>KOG1240|consensus

Probab=99.83  E-value=7.2e-21  Score=215.75  Aligned_cols=223  Identities=21%  Similarity=0.304  Sum_probs=163.6

Q ss_pred             ceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhH---HHHHHHHHHHHHHhhCCCCCCCeE----------EEEEE
Q psy1546          59 FTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAE---DEIEDIQQEIMVLSQCDSPYGTKL----------WIIME  125 (604)
Q Consensus        59 y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~---~~~~~l~~Ei~iL~~l~hp~~~~l----------yLVmE  125 (604)
                      |...+.||.+.|=+|.+|++.. | .|+||++-+....   ..+.+...|++ ...+++||...+          |||-+
T Consensus        25 ~~~~~~LGstRFlKv~r~k~~e-G-~vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRq  101 (1431)
T KOG1240|consen   25 CHYVENLGSTRFLKVARAKDRE-G-LVVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQ  101 (1431)
T ss_pred             eeeecccCchhhhhhhhccCCC-c-eEEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHH
Confidence            6677889999999999998753 3 4899998544322   22333444555 666788874433          78888


Q ss_pred             ecCCCChhhHhhcCC-CcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCC---CCC
Q psy1546         126 YLGGGSALDLMKAGN-FEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTT---SKR  201 (604)
Q Consensus       126 y~~ggsL~~~l~~~~-lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~---~~~  201 (604)
                      |+ .-+|.|.+..++ +...+.+.|+.||+.||.-+|..||+|||||.+||||+.-+-+.|+||..-+-..-+.   ...
T Consensus       102 yv-khnLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPadf  180 (1431)
T KOG1240|consen  102 YV-KHNLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNPADF  180 (1431)
T ss_pred             HH-hhhhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCccCCCCCcccc
Confidence            88 556888776655 5667788899999999999999999999999999999999999999998765322111   111


Q ss_pred             cccccC----CCCCChHHhhcCC-----------CCCcchhhhHHHHHHHHHh-CCCCCCCC-----------ChhhHhh
Q psy1546         202 NTFVGT----PFWMAPEVIKQSA-----------YDSKADIWSLGITAIELAK-GEPPNSEL-----------HPMRVLF  254 (604)
Q Consensus       202 ~~~~GT----~~Y~APE~l~~~~-----------~~~~sDVwSLGviL~eLlt-G~~Pf~~~-----------~~~~~~~  254 (604)
                      ..+..|    ..|.|||.+....           ..++.||||+||+++||++ |++||.-.           +....+.
T Consensus       181 ~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~aYr~~~~~~~e~~Le  260 (1431)
T KOG1240|consen  181 TFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLLAYRSGNADDPEQLLE  260 (1431)
T ss_pred             eEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHHhHhccCccCHHHHHH
Confidence            222222    3499999885421           4578999999999999988 78887532           1122222


Q ss_pred             hcCCCCCCCCCccchHHHHHHHHHHhccCCCCCCCHHHHhcC
Q psy1546         255 LIPKNNPPQLTGNYTKQFKEFVEACLNKDPENRPTAKELLKF  296 (604)
Q Consensus       255 ~i~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~RpT~~elL~h  296 (604)
                      .|           -+..++.||..|++.||.+|.++++.|+-
T Consensus       261 ~I-----------ed~~~Rnlil~Mi~rdPs~RlSAedyL~~  291 (1431)
T KOG1240|consen  261 KI-----------EDVSLRNLILSMIQRDPSKRLSAEDYLQK  291 (1431)
T ss_pred             hC-----------cCccHHHHHHHHHccCchhccCHHHHHHh
Confidence            22           13478999999999999999999999874

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.82  E-value=7.6e-20  Score=179.29  Aligned_cols=180  Identities=18%  Similarity=0.146  Sum_probs=134.4

Q ss_pred             eeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhH---HHHHHHHHHHHHHhhCCC-CCCCe------EEEEEEecCC
Q psy1546          60 TKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAE---DEIEDIQQEIMVLSQCDS-PYGTK------LWIIMEYLGG  129 (604)
Q Consensus        60 ~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~---~~~~~l~~Ei~iL~~l~h-p~~~~------lyLVmEy~~g  129 (604)
                      .+...|++|+||+||++..  .+..++.+.+......   -....+.+|+.+|++|.| +++.+      .|++|||+.|
T Consensus         5 ~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~~~~~lvmeyI~G   82 (218)
T PRK12274          5 AVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHWDGRHLDRSYLAG   82 (218)
T ss_pred             ccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEEcCEEEEEeeecC
Confidence            4567899999999998864  6778887777554431   112367899999999965 43433      3899999999


Q ss_pred             CChhhHhhcCCCcHHHHHHHHHHHHHHhHHhhhCCcccccc-ccceeEecCCCCeEEecccccccccCCCCC-----C--
Q psy1546         130 GSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDI-KAANVLLSEMGDVKLADFGVAGTLTNTTSK-----R--  201 (604)
Q Consensus       130 gsL~~~l~~~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDL-Kp~NILl~~~g~vKL~DFGlA~~~~~~~~~-----~--  201 (604)
                      .+|...+..+      ...++.|++.+|.+||++||+|||| ||+|||++.+|.++|+|||+|.........     .  
T Consensus        83 ~~L~~~~~~~------~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r~L~~rD  156 (218)
T PRK12274         83 AAMYQRPPRG------DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMRLLARED  156 (218)
T ss_pred             ccHHhhhhhh------hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHHHHHHHH
Confidence            9987654322      2357889999999999999999999 799999999999999999999754432210     0  


Q ss_pred             ------cccccCCCCCChHHhhcC-CCC-CcchhhhHHHHHHHHHhCCCCCCCC
Q psy1546         202 ------NTFVGTPFWMAPEVIKQS-AYD-SKADIWSLGITAIELAKGEPPNSEL  247 (604)
Q Consensus       202 ------~~~~GT~~Y~APE~l~~~-~~~-~~sDVwSLGviL~eLltG~~Pf~~~  247 (604)
                            .-...++.|+.|+...-- ..+ ...++++.|+-+|.++|+..++.+.
T Consensus       157 l~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~  210 (218)
T PRK12274        157 LRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWED  210 (218)
T ss_pred             HHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcccc
Confidence                  011268889999875432 223 4568889999999999999885443

>KOG1033|consensus

Probab=99.80  E-value=2.8e-20  Score=199.02  Aligned_cols=174  Identities=25%  Similarity=0.430  Sum_probs=136.8

Q ss_pred             eEEEEEEecCCCChhhHhhcC----CCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccc
Q psy1546         119 KLWIIMEYLGGGSALDLMKAG----NFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTL  194 (604)
Q Consensus       119 ~lyLVmEy~~ggsL~~~l~~~----~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~  194 (604)
                      .+||.|++|...+|.+||...    ..+....+.++.|+..|++|   ++.+|||+||.||++..++.+||.|||+....
T Consensus       330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgDFgl~ts~  406 (516)
T KOG1033|consen  330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIGDFGLVTSQ  406 (516)
T ss_pred             chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhhhhhheeec
Confidence            478999999999999999753    36667888999999999999   99999999999999999999999999998665


Q ss_pred             cCCC------CCCcccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHhhhcCCCCCC-CCCc
Q psy1546         195 TNTT------SKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAK-GEPPNSELHPMRVLFLIPKNNPP-QLTG  266 (604)
Q Consensus       195 ~~~~------~~~~~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~-~~~~  266 (604)
                      ....      ......+||.+||+||.+.+..|+.++|||+||+||+||+. =...+..   ...+..+..+..+ .+..
T Consensus       407 ~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er---~~t~~d~r~g~ip~~~~~  483 (516)
T KOG1033|consen  407 DKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFER---IATLTDIRDGIIPPEFLQ  483 (516)
T ss_pred             ccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHH---HHhhhhhhcCCCChHHhh
Confidence            4333      23456789999999999999999999999999999999987 3333322   1222223333322 2333


Q ss_pred             cchHHHHHHHHHHhccCCCCCCCHHHHhcChhh
Q psy1546         267 NYTKQFKEFVEACLNKDPENRPTAKELLKFPFI  299 (604)
Q Consensus       267 ~~s~~l~~Li~~~L~~dP~~RpT~~elL~hp~f  299 (604)
                      +++ .-..|+..||...|.+||++.+.-.|+|.
T Consensus       484 d~p-~e~~ll~~lls~~p~~RP~~~~~~~~~~~  515 (516)
T KOG1033|consen  484 DYP-EEYTLLQQLLSPSPEERPSAIEVALHEFL  515 (516)
T ss_pred             cCc-HHHHHHHHhcCCCcccCchHHHHhhhhhc
Confidence            333 34589999999999999987777777664

>smart00090 RIO RIO-like kinase

Probab=99.80  E-value=2.7e-19  Score=180.64  Aligned_cols=137  Identities=20%  Similarity=0.200  Sum_probs=111.2

Q ss_pred             cceeeeEEcccCcEEEEEEE-ECCCCcEEEEEEecchhhH----------------------H-HHHHHHHHHHHHhhCC
Q psy1546          58 IFTKQERIGKGSFGEVFKGI-DNRTQQVVAIKIIDLEEAE----------------------D-EIEDIQQEIMVLSQCD  113 (604)
Q Consensus        58 ~y~i~~~LG~G~fG~Vy~a~-~~~t~~~vAVK~i~~~~~~----------------------~-~~~~l~~Ei~iL~~l~  113 (604)
                      .|.+.+.||+|+||.||+|. +..+|+.||||++......                      . ....+.+|+.++.++.
T Consensus        29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~  108 (237)
T smart00090       29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY  108 (237)
T ss_pred             hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            48888999999999999998 6778999999998643210                      0 1134578999999887


Q ss_pred             CCCC--------CeEEEEEEecCCCChhhHh-hcCCCcHHHHHHHHHHHHHHhHHhhhCC-ccccccccceeEecCCCCe
Q psy1546         114 SPYG--------TKLWIIMEYLGGGSALDLM-KAGNFEEMHIAVILREVLKGLDYLHSER-KLHRDIKAANVLLSEMGDV  183 (604)
Q Consensus       114 hp~~--------~~lyLVmEy~~ggsL~~~l-~~~~lse~~i~~i~~qIl~gL~yLHs~g-IiHrDLKp~NILl~~~g~v  183 (604)
                      +...        ...||||||++|++|..++ ....+....+..++.||+.+|.+||++| |+||||||+|||++ ++.+
T Consensus       109 ~~~i~~p~~~~~~~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli~-~~~i  187 (237)
T smart00090      109 EAGVPVPKPIAWRRNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILVH-DGKV  187 (237)
T ss_pred             hcCCCCCeeeEecCceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEEE-CCCE
Confidence            5321        1347999999998887754 4456677778899999999999999999 99999999999999 7899


Q ss_pred             EEeccccccccc
Q psy1546         184 KLADFGVAGTLT  195 (604)
Q Consensus       184 KL~DFGlA~~~~  195 (604)
                      +|+|||+|....
T Consensus       188 ~LiDFg~a~~~~  199 (237)
T smart00090      188 VIIDVSQSVELD  199 (237)
T ss_pred             EEEEChhhhccC
Confidence            999999986544

>KOG1166|consensus

Probab=99.79  E-value=5.3e-19  Score=204.21  Aligned_cols=228  Identities=21%  Similarity=0.286  Sum_probs=163.6

Q ss_pred             ccceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHH------HHHHHHHHHHHHhhCCC-----CCCCeEEEEEE
Q psy1546          57 LIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAED------EIEDIQQEIMVLSQCDS-----PYGTKLWIIME  125 (604)
Q Consensus        57 ~~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~------~~~~l~~Ei~iL~~l~h-----p~~~~lyLVmE  125 (604)
                      ..|.|.+.||+|+||.||+|.+.. |+.||||+-......+      ...++.  ..++..+-|     -+...-+||+|
T Consensus       698 ~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WEfYI~~q~~~RLk--~~~~~~~~~~~~a~~~~~~S~lv~e  774 (974)
T KOG1166|consen  698 EKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWEFYICLQVMERLK--PQMLPSIMHISSAHVFQNASVLVSE  774 (974)
T ss_pred             eeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCceeeeehHHHHHhhc--hhhhcchHHHHHHHccCCcceeeee
Confidence            358899999999999999999887 9999999976543221      111221  222222222     23344579999


Q ss_pred             ecCCCChhhHhhc-CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecC-------CCCeEEeccccccccc--
Q psy1546         126 YLGGGSALDLMKA-GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSE-------MGDVKLADFGVAGTLT--  195 (604)
Q Consensus       126 y~~ggsL~~~l~~-~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~-------~g~vKL~DFGlA~~~~--  195 (604)
                      |.+.|+|.+++.. +.+++..+..+..||+..|++||..+|||+||||+|+||..       .--++|+|||.+-.+.  
T Consensus       775 y~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~siDm~lf  854 (974)
T KOG1166|consen  775 YSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSIDMKLF  854 (974)
T ss_pred             ccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEecccceeeeEc
Confidence            9999999999975 56889999999999999999999999999999999999952       2348999999985432  


Q ss_pred             CCCCCCcccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCCCCCCCCccch-HHHHH
Q psy1546         196 NTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNYT-KQFKE  274 (604)
Q Consensus       196 ~~~~~~~~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s-~~l~~  274 (604)
                      .........++|-.+-.+|+..|..+++.+|.|.|+-+++.||.|+.--       +..--.......++..+- +-+.+
T Consensus       855 p~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~q-------~~~g~~~~~~~~~~Ry~~~~~W~~  927 (974)
T KOG1166|consen  855 PDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYME-------VKNGSSWMVKTNFPRYWKRDMWNK  927 (974)
T ss_pred             CCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHHH-------hcCCcceeccccchhhhhHHHHHH
Confidence            2223445667899999999999999999999999999999999997531       000000000111122222 23567


Q ss_pred             HHHHHhccCCCCCCCHHHHh
Q psy1546         275 FVEACLNKDPENRPTAKELL  294 (604)
Q Consensus       275 Li~~~L~~dP~~RpT~~elL  294 (604)
                      |+..+|..|-..=|.+.+|.
T Consensus       928 ~F~~lLN~~~~~~p~l~~lr  947 (974)
T KOG1166|consen  928 FFDLLLNPDCDTLPNLQELR  947 (974)
T ss_pred             HHHHHhCcCcccchhHHHHH
Confidence            88888985555556665553

>KOG4158|consensus

Probab=99.78  E-value=6.2e-19  Score=182.03  Aligned_cols=171  Identities=25%  Similarity=0.322  Sum_probs=132.7

Q ss_pred             EEEEEEecCCCChhhHhhcCCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEec--CCC--CeEEeccccccccc
Q psy1546         120 LWIIMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLS--EMG--DVKLADFGVAGTLT  195 (604)
Q Consensus       120 lyLVmEy~~ggsL~~~l~~~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~--~~g--~vKL~DFGlA~~~~  195 (604)
                      +|+||... ..+|.+++.....+......++.|+++|+.|||.+||.|||||.+||||.  +|+  .+.|+|||.|---.
T Consensus       318 lylvMkrY-~~tLr~yl~~~~~s~r~~~~~laQlLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~  396 (598)
T KOG4158|consen  318 LYLVMKRY-RQTLREYLWTRHRSYRTGRVILAQLLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADD  396 (598)
T ss_pred             EEEehhcc-hhhHHHHHhcCCCchHHHHHHHHHHHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeecc
Confidence            47999877 56799999888889999999999999999999999999999999999993  333  47899999873211


Q ss_pred             C------CCCCCcccccCCCCCChHHhhcCCC------CCcchhhhHHHHHHHHHhCCCCCCCCChhhHhh-hcCCCCCC
Q psy1546         196 N------TTSKRNTFVGTPFWMAPEVIKQSAY------DSKADIWSLGITAIELAKGEPPNSELHPMRVLF-LIPKNNPP  262 (604)
Q Consensus       196 ~------~~~~~~~~~GT~~Y~APE~l~~~~~------~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~-~i~~~~~~  262 (604)
                      .      ........-|.-.-||||+.....-      -.++|.|+.|.+.||+++...||+....+.... .......+
T Consensus       397 ~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe~qLP  476 (598)
T KOG4158|consen  397 NHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQESQLP  476 (598)
T ss_pred             ccccccccccccccCCCcceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhhhhCC
Confidence            1      1112223447778999999875431      147899999999999999999999844332211 12233456


Q ss_pred             CCCccchHHHHHHHHHHhccCCCCCCCHH
Q psy1546         263 QLTGNYTKQFKEFVEACLNKDPENRPTAK  291 (604)
Q Consensus       263 ~~~~~~s~~l~~Li~~~L~~dP~~RpT~~  291 (604)
                      .++..++..+++|+..+|+.||.+|++..
T Consensus       477 alp~~vpp~~rqlV~~lL~r~pskRvsp~  505 (598)
T KOG4158|consen  477 ALPSRVPPVARQLVFDLLKRDPSKRVSPN  505 (598)
T ss_pred             CCcccCChHHHHHHHHHhcCCccccCCcc
Confidence            78889999999999999999999998843

>PRK10345 hypothetical protein; Provisional

Probab=99.77  E-value=1.8e-18  Score=171.17  Aligned_cols=126  Identities=20%  Similarity=0.278  Sum_probs=100.4

Q ss_pred             eeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhC-----CCCCCCeEE-------------
Q psy1546          60 TKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQC-----DSPYGTKLW-------------  121 (604)
Q Consensus        60 ~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l-----~hp~~~~ly-------------  121 (604)
                      .-.+.||+|+||.||.  +..+... +||++...... ..+.+.+|+.+++.+     .|||+.++|             
T Consensus         5 ~~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~-~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~   80 (210)
T PRK10345          5 SEQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDG-GDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVY   80 (210)
T ss_pred             CCcceecCCCceEEEE--CCCCcCe-EEEEEeccccc-hHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEE
Confidence            3456899999999995  6777666 69998664322 346789999999999     568866653             


Q ss_pred             -EEEEe--cCCCChhhHhhcCCCcHHHHHHHHHHHHHHh-HHhhhCCccccccccceeEecCC----CCeEEeccccc
Q psy1546         122 -IIMEY--LGGGSALDLMKAGNFEEMHIAVILREVLKGL-DYLHSERKLHRDIKAANVLLSEM----GDVKLADFGVA  191 (604)
Q Consensus       122 -LVmEy--~~ggsL~~~l~~~~lse~~i~~i~~qIl~gL-~yLHs~gIiHrDLKp~NILl~~~----g~vKL~DFGlA  191 (604)
                       +||||  +.+++|.++++.+.+++.  ..++.|++.++ +|||+++|+||||||+|||++..    +.++|+||+.+
T Consensus        81 ~~I~e~~G~~~~tL~~~l~~~~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~  156 (210)
T PRK10345         81 DVIADFDGKPSITLTEFAEQCRYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIGE  156 (210)
T ss_pred             EEEecCCCCcchhHHHHHHcccccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence             68999  458999999988777766  36688888888 99999999999999999999743    37999995544

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.76  E-value=5.1e-18  Score=166.19  Aligned_cols=132  Identities=18%  Similarity=0.221  Sum_probs=106.0

Q ss_pred             cceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhh-----H----------------HHHHHHHHHHHHHhhCCCCC
Q psy1546          58 IFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA-----E----------------DEIEDIQQEIMVLSQCDSPY  116 (604)
Q Consensus        58 ~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~-----~----------------~~~~~l~~Ei~iL~~l~hp~  116 (604)
                      .|.+.+.||+|+||.||+|.+. +|+.||||++.....     .                .......+|+.++..+.+.+
T Consensus        16 ~~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   94 (198)
T cd05144          16 VESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEG   94 (198)
T ss_pred             hhhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcC
Confidence            4788899999999999999874 799999998754320     0                01123567888888887653


Q ss_pred             --------CCeEEEEEEecCCCChhhHhhcCCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecc
Q psy1546         117 --------GTKLWIIMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADF  188 (604)
Q Consensus       117 --------~~~lyLVmEy~~ggsL~~~l~~~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DF  188 (604)
                              ....|+||||++|++|..+...     .....++.+|+.++.++|+.||+||||||+||+++.++.++|+||
T Consensus        95 i~v~~~~~~~~~~lv~e~~~g~~L~~~~~~-----~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~~~~liDf  169 (198)
T cd05144          95 FPVPKPIDWNRHAVVMEYIDGVELYRVRVL-----EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDEKIYIIDW  169 (198)
T ss_pred             CCCCceeecCCceEEEEEeCCcchhhcccc-----ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCCcEEEEEC
Confidence                    1345899999999998776531     345678899999999999999999999999999999999999999


Q ss_pred             ccccccc
Q psy1546         189 GVAGTLT  195 (604)
Q Consensus       189 GlA~~~~  195 (604)
                      |++..+.
T Consensus       170 g~~~~~~  176 (198)
T cd05144         170 PQMVSTD  176 (198)
T ss_pred             CccccCC
Confidence            9996554

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>KOG0195|consensus

Probab=99.74  E-value=4e-18  Score=168.53  Aligned_cols=227  Identities=22%  Similarity=0.382  Sum_probs=179.9

Q ss_pred             ceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHH-HHHHHHHHHHHhhCCCCCCC----------eEEEEEEec
Q psy1546          59 FTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDE-IEDIQQEIMVLSQCDSPYGT----------KLWIIMEYL  127 (604)
Q Consensus        59 y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~-~~~l~~Ei~iL~~l~hp~~~----------~lyLVmEy~  127 (604)
                      ..+..+|.+...|+.|+|++..  .-+++|++........ -..|..|.-.|+-+.|||+.          .+.+|..||
T Consensus       192 lnl~tkl~e~hsgelwrgrwqg--ndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~m  269 (448)
T KOG0195|consen  192 LNLITKLAESHSGELWRGRWQG--NDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYM  269 (448)
T ss_pred             hhhhhhhccCCCcccccccccC--cchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeec
Confidence            4556778999999999998874  3466788765544332 36688899999999999854          357999999


Q ss_pred             CCCChhhHhhcCC---CcHHHHHHHHHHHHHHhHHhhhCC--ccccccccceeEecCCCCeEE--ecccccccccCCCCC
Q psy1546         128 GGGSALDLMKAGN---FEEMHIAVILREVLKGLDYLHSER--KLHRDIKAANVLLSEMGDVKL--ADFGVAGTLTNTTSK  200 (604)
Q Consensus       128 ~ggsL~~~l~~~~---lse~~i~~i~~qIl~gL~yLHs~g--IiHrDLKp~NILl~~~g~vKL--~DFGlA~~~~~~~~~  200 (604)
                      +.|+|+.++..+.   .+..++..++.+|++|+.|||+..  |.--.|....|+|+++.+.+|  +|--++-+.      
T Consensus       270 p~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfsfqe------  343 (448)
T KOG0195|consen  270 PFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFSFQE------  343 (448)
T ss_pred             cchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceeeeec------
Confidence            9999999997643   677889999999999999999974  444568899999999887665  343332111      


Q ss_pred             CcccccCCCCCChHHhhcCCCC---CcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhc-CCCCCCCCCccchHHHHHHH
Q psy1546         201 RNTFVGTPFWMAPEVIKQSAYD---SKADIWSLGITAIELAKGEPPNSELHPMRVLFLI-PKNNPPQLTGNYTKQFKEFV  276 (604)
Q Consensus       201 ~~~~~GT~~Y~APE~l~~~~~~---~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i-~~~~~~~~~~~~s~~l~~Li  276 (604)
                       ....-.|.||+||.+....-+   .++|+|||+++||||.|...||.+..+++.-..+ ..+.+..+++.++.....|+
T Consensus       344 -~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeglrv~ippgis~hm~klm  422 (448)
T KOG0195|consen  344 -VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLRVHIPPGISRHMNKLM  422 (448)
T ss_pred             -cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhccccccCCCCccHHHHHHH
Confidence             112346889999999876644   4789999999999999999999999998876554 34557788899999999999


Q ss_pred             HHHhccCCCCCCCHHHHh
Q psy1546         277 EACLNKDPENRPTAKELL  294 (604)
Q Consensus       277 ~~~L~~dP~~RpT~~elL  294 (604)
                      .-|+..||.+||.+..|+
T Consensus       423 ~icmnedpgkrpkfdmiv  440 (448)
T KOG0195|consen  423 NICMNEDPGKRPKFDMIV  440 (448)
T ss_pred             HHHhcCCCCcCCCcceeh
Confidence            999999999999988764

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.72  E-value=5.1e-17  Score=159.87  Aligned_cols=125  Identities=26%  Similarity=0.339  Sum_probs=102.3

Q ss_pred             eEEcccCcEEEEEEEECCCCcEEEEEEecchhh-----H--HHHHHHHHHHHHHhhCCCCCC----------CeEEEEEE
Q psy1546          63 ERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA-----E--DEIEDIQQEIMVLSQCDSPYG----------TKLWIIME  125 (604)
Q Consensus        63 ~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~-----~--~~~~~l~~Ei~iL~~l~hp~~----------~~lyLVmE  125 (604)
                      +.||+|++|.||+|.+  .+..|+||+......     .  .....+.+|+.++..+.|++.          ...++|||
T Consensus         2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e   79 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVME   79 (211)
T ss_pred             cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEE
Confidence            5799999999999986  577899998653321     1  122457789999999887652          22469999


Q ss_pred             ecCCCChhhHhhcCCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEeccccccc
Q psy1546         126 YLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGT  193 (604)
Q Consensus       126 y~~ggsL~~~l~~~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~  193 (604)
                      |++|++|.+++.....   ....++.+|+.+|.+||+.|++|||++|.|||++ ++.++|+|||++..
T Consensus        80 ~~~G~~L~~~~~~~~~---~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         80 YIEGEPLKDLINSNGM---EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             EeCCcCHHHHHHhccH---HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            9999999999865432   7788999999999999999999999999999999 78999999999854

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.71  E-value=5.2e-17  Score=158.47  Aligned_cols=121  Identities=25%  Similarity=0.296  Sum_probs=98.4

Q ss_pred             EEcccCcEEEEEEEECCCCcEEEEEEecchhh-------HHHHHHHHHHHHHHhhCCCCCC----------CeEEEEEEe
Q psy1546          64 RIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA-------EDEIEDIQQEIMVLSQCDSPYG----------TKLWIIMEY  126 (604)
Q Consensus        64 ~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~-------~~~~~~l~~Ei~iL~~l~hp~~----------~~lyLVmEy  126 (604)
                      .||+|+||.||+|..  ++..|++|+......       ......+.+|+.++..+.|++.          ...++||||
T Consensus         1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~   78 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEY   78 (199)
T ss_pred             CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEE
Confidence            389999999999984  567899998643211       1123667889999999887642          223799999


Q ss_pred             cCCCChhhHhhcCCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEeccccccc
Q psy1546         127 LGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGT  193 (604)
Q Consensus       127 ~~ggsL~~~l~~~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~  193 (604)
                      ++|++|.+++.....      .++.+++.+|.+||+.|++|||++|.|||++ ++.++|+|||+++.
T Consensus        79 ~~g~~l~~~~~~~~~------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~  138 (199)
T TIGR03724        79 IEGKPLKDVIEEGND------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY  138 (199)
T ss_pred             ECCccHHHHHhhcHH------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence            999999998765322      7899999999999999999999999999999 79999999999855

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>KOG0590|consensus

Probab=99.70  E-value=1.7e-18  Score=195.55  Aligned_cols=246  Identities=26%  Similarity=0.374  Sum_probs=195.6

Q ss_pred             cccceeeeEEcccCcEEEEEEEEC-CCCcEEEEEEecchh-hHHHHHHHHHHHHHHhhCC-CCCCCe----------EEE
Q psy1546          56 ELIFTKQERIGKGSFGEVFKGIDN-RTQQVVAIKIIDLEE-AEDEIEDIQQEIMVLSQCD-SPYGTK----------LWI  122 (604)
Q Consensus        56 ~~~y~i~~~LG~G~fG~Vy~a~~~-~t~~~vAVK~i~~~~-~~~~~~~l~~Ei~iL~~l~-hp~~~~----------lyL  122 (604)
                      ...|.+.+.||+|+|+.|-++... .+...+|+|.+.... .......+..|..+-+.+. |.+..+          .++
T Consensus        19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~   98 (601)
T KOG0590|consen   19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLL   98 (601)
T ss_pred             cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccc
Confidence            445888889999999999998764 345567778775443 3344566667777777777 777444          479


Q ss_pred             EEEecCCCChhhHh-hcC--CCcHHHHHHHHHHHHHHhHHhh-hCCccccccccceeEecCCC-CeEEecccccccccC-
Q psy1546         123 IMEYLGGGSALDLM-KAG--NFEEMHIAVILREVLKGLDYLH-SERKLHRDIKAANVLLSEMG-DVKLADFGVAGTLTN-  196 (604)
Q Consensus       123 VmEy~~ggsL~~~l-~~~--~lse~~i~~i~~qIl~gL~yLH-s~gIiHrDLKp~NILl~~~g-~vKL~DFGlA~~~~~-  196 (604)
                      +++|..|+++.+.+ ...  ..+...+..++.|+..+|.|+| ..++.||||||+|.+++..+ .++++|||+|..+.. 
T Consensus        99 ~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~  178 (601)
T KOG0590|consen   99 SLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAYRNK  178 (601)
T ss_pred             ccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhcccccc
Confidence            99999999999988 443  6788889999999999999999 99999999999999999999 999999999977655 


Q ss_pred             CC--CCCccccc-CCCCCChHHhhcCC-CCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCCC----CCCCCccc
Q psy1546         197 TT--SKRNTFVG-TPFWMAPEVIKQSA-YDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNN----PPQLTGNY  268 (604)
Q Consensus       197 ~~--~~~~~~~G-T~~Y~APE~l~~~~-~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~~----~~~~~~~~  268 (604)
                      ..  ......+| ++.|+|||.+.+.. .....|+||.|+++.-+++|..||.........+.-....    ....+..+
T Consensus       179 ~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (601)
T KOG0590|consen  179 NGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRFTQLPWNSI  258 (601)
T ss_pred             CCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccccccccCccccC
Confidence            22  22345678 99999999998854 4678899999999999999999987665544332111111    23445677


Q ss_pred             hHHHHHHHHHHhccCCCCCCCHHHHhcChhhhh
Q psy1546         269 TKQFKEFVEACLNKDPENRPTAKELLKFPFIRK  301 (604)
Q Consensus       269 s~~l~~Li~~~L~~dP~~RpT~~elL~hp~f~~  301 (604)
                      +....+++.+++..+|..|.+.+++-.++|+..
T Consensus       259 ~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~  291 (601)
T KOG0590|consen  259 SDQAHDLLHKILKENPSNRLSIEELKLDNWLSS  291 (601)
T ss_pred             ChhhhhcccccccCCchhccccccccccccccc
Confidence            889999999999999999999999999999865

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.69  E-value=9.8e-17  Score=154.83  Aligned_cols=132  Identities=20%  Similarity=0.257  Sum_probs=95.8

Q ss_pred             eeEEcccCcEEEEEEEECCCCcEEEEEEecchhhH--HHHH---------------------HHHHHHHHHhhCCCCC--
Q psy1546          62 QERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAE--DEIE---------------------DIQQEIMVLSQCDSPY--  116 (604)
Q Consensus        62 ~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~--~~~~---------------------~l~~Ei~iL~~l~hp~--  116 (604)
                      .+.||+|+||+||+|.+. +++.||||++......  ....                     ....|...+..+.+..  
T Consensus         2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~   80 (187)
T cd05119           2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP   80 (187)
T ss_pred             CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence            467999999999999876 7899999998643211  0001                     1134555555554331  


Q ss_pred             ------CCeEEEEEEecCCCChhh-HhhcCCCcHHHHHHHHHHHHHHhHHhhh-CCccccccccceeEecCCCCeEEecc
Q psy1546         117 ------GTKLWIIMEYLGGGSALD-LMKAGNFEEMHIAVILREVLKGLDYLHS-ERKLHRDIKAANVLLSEMGDVKLADF  188 (604)
Q Consensus       117 ------~~~lyLVmEy~~ggsL~~-~l~~~~lse~~i~~i~~qIl~gL~yLHs-~gIiHrDLKp~NILl~~~g~vKL~DF  188 (604)
                            ....++||||++++.+.. .+...... ..+..++.+++.++.++|. .||+||||||+|||++ ++.++|+||
T Consensus        81 ~~~~~~~~~~~lv~e~~~g~~~~~~~l~~~~~~-~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~~~~liDf  158 (187)
T cd05119          81 VPKPIDLNRHVLVMEFIGGDGIPAPRLKDVRLL-EDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DGKVYIIDV  158 (187)
T ss_pred             CCceEecCCCEEEEEEeCCCCccChhhhhhhhc-ccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CCcEEEEEC
Confidence                  124589999999854432 22221111 6678899999999999999 9999999999999999 899999999


Q ss_pred             cccccccC
Q psy1546         189 GVAGTLTN  196 (604)
Q Consensus       189 GlA~~~~~  196 (604)
                      |.+.....
T Consensus       159 g~a~~~~~  166 (187)
T cd05119         159 PQAVEIDH  166 (187)
T ss_pred             cccccccC
Confidence            99965543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.66  E-value=5.2e-16  Score=174.66  Aligned_cols=126  Identities=24%  Similarity=0.278  Sum_probs=100.2

Q ss_pred             ceeeeEEcccCcEEEEEEEECCCCcEEEEEEecch--h---hH--HHHHHHHHHHHHHhhCCCCCCC----------eEE
Q psy1546          59 FTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLE--E---AE--DEIEDIQQEIMVLSQCDSPYGT----------KLW  121 (604)
Q Consensus        59 y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~--~---~~--~~~~~l~~Ei~iL~~l~hp~~~----------~ly  121 (604)
                      |...++||+|+||+||+|.+...  .+++|+....  .   ..  ...+.+.+|+.++..+.|++..          ..+
T Consensus       335 ~~~~~~iG~G~~g~Vy~~~~~~~--~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~  412 (535)
T PRK09605        335 KIPDHLIGKGAEADIKKGEYLGR--DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKT  412 (535)
T ss_pred             cCccceeccCCcEEEEEEeecCc--cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCE
Confidence            45678999999999999986543  3444432111  1   11  1235678999999999998743          347


Q ss_pred             EEEEecCCCChhhHhhcCCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccc
Q psy1546         122 IIMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTL  194 (604)
Q Consensus       122 LVmEy~~ggsL~~~l~~~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~  194 (604)
                      +||||++|++|.+++.       ....++.+|+.+|.|||+.||+||||||+|||+ .++.++|+|||+++..
T Consensus       413 lv~E~~~g~~L~~~l~-------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFGla~~~  477 (535)
T PRK09605        413 IVMEYIGGKDLKDVLE-------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKYS  477 (535)
T ss_pred             EEEEecCCCcHHHHHH-------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCcccccC
Confidence            9999999999999886       356789999999999999999999999999999 5789999999999653

>KOG1023|consensus

Probab=99.64  E-value=8.7e-16  Score=167.22  Aligned_cols=178  Identities=26%  Similarity=0.500  Sum_probs=136.9

Q ss_pred             CeEEEEEEecCCCChhhHhhc--CCCcHHHHHHHHHHHHHHhHHhhhCCc-cccccccceeEecCCCCeEEecccccccc
Q psy1546         118 TKLWIIMEYLGGGSALDLMKA--GNFEEMHIAVILREVLKGLDYLHSERK-LHRDIKAANVLLSEMGDVKLADFGVAGTL  194 (604)
Q Consensus       118 ~~lyLVmEy~~ggsL~~~l~~--~~lse~~i~~i~~qIl~gL~yLHs~gI-iHrDLKp~NILl~~~g~vKL~DFGlA~~~  194 (604)
                      ..+++|.+||.-|+|.+.+..  -.+++.-...++++|+.||.|||.-.| .|+.|+..|++++....+||+|||+....
T Consensus        20 ~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nClvd~~w~lklt~~Gl~~~~   99 (484)
T KOG1023|consen   20 PEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNCLVDSRWVLKLTDFGLNSLL   99 (484)
T ss_pred             CceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccceeeeeEEEEechhhhcccc
Confidence            345799999999999999976  457788888899999999999998866 99999999999999999999999998655


Q ss_pred             cCCC--CCCcccccCCCCCChHHhhcCC-------CCCcchhhhHHHHHHHHHhCCCCCCCCC----hhhHhhhcCC-CC
Q psy1546         195 TNTT--SKRNTFVGTPFWMAPEVIKQSA-------YDSKADIWSLGITAIELAKGEPPNSELH----PMRVLFLIPK-NN  260 (604)
Q Consensus       195 ~~~~--~~~~~~~GT~~Y~APE~l~~~~-------~~~~sDVwSLGviL~eLltG~~Pf~~~~----~~~~~~~i~~-~~  260 (604)
                      ....  .......-...|.|||++....       .+.+.||||||++++|+++..-||....    +.++...+.+ +.
T Consensus       100 ~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~~~~~~~~~~eii~~~~~~~~  179 (484)
T KOG1023|consen  100 EETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPFDLRNLVEDPDEIILRVKKGGS  179 (484)
T ss_pred             cccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCccccccccCChHHHHHHHHhcCC
Confidence            3211  1111122345699999997642       3556899999999999999999987632    2345554444 22


Q ss_pred             C---CCCC--ccchHHHHHHHHHHhccCCCCCCCHHHHhc
Q psy1546         261 P---PQLT--GNYTKQFKEFVEACLNKDPENRPTAKELLK  295 (604)
Q Consensus       261 ~---~~~~--~~~s~~l~~Li~~~L~~dP~~RpT~~elL~  295 (604)
                      .   +.+.  ....+++..++..||..+|.+||+++++-.
T Consensus       180 ~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~  219 (484)
T KOG1023|consen  180 NPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRS  219 (484)
T ss_pred             CCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHh
Confidence            1   1111  134557899999999999999999999854

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.61  E-value=4.8e-15  Score=149.90  Aligned_cols=126  Identities=17%  Similarity=0.164  Sum_probs=100.2

Q ss_pred             eeEEc-ccCcEEEEEEEECCCCcEEEEEEecchhh------------HHHHHHHHHHHHHHhhCCCCCCC----------
Q psy1546          62 QERIG-KGSFGEVFKGIDNRTQQVVAIKIIDLEEA------------EDEIEDIQQEIMVLSQCDSPYGT----------  118 (604)
Q Consensus        62 ~~~LG-~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~------------~~~~~~l~~Ei~iL~~l~hp~~~----------  118 (604)
                      ...|| .||.|+||.+...  +..+|||.+.....            ......+.+|+.++..+.|+++.          
T Consensus        36 ~~~lg~~~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~  113 (239)
T PRK01723         36 ARVVGSAKGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVV  113 (239)
T ss_pred             CceeecCCCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeee
Confidence            45688 8999999999764  77899998853211            11235678899999999876521          


Q ss_pred             ------eEEEEEEecCC-CChhhHhhcCCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEeccccc
Q psy1546         119 ------KLWIIMEYLGG-GSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVA  191 (604)
Q Consensus       119 ------~lyLVmEy~~g-gsL~~~l~~~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA  191 (604)
                            +.+|||||++| .+|.+++..+.+++..    +.+|+.+|.+||++||+||||||.|||++.++.++|+|||.+
T Consensus       114 ~~~~~~~~~lV~e~l~G~~~L~~~l~~~~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LIDfg~~  189 (239)
T PRK01723        114 RHGLFYRADILIERIEGARDLVALLQEAPLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLIDFDRG  189 (239)
T ss_pred             ecCcceeeeEEEEecCCCCCHHHHHhcCCCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEECCCc
Confidence                  12499999997 6899998877666543    578999999999999999999999999999899999999988


Q ss_pred             cc
Q psy1546         192 GT  193 (604)
Q Consensus       192 ~~  193 (604)
                      ..
T Consensus       190 ~~  191 (239)
T PRK01723        190 EL  191 (239)
T ss_pred             cc
Confidence            54

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.54  E-value=4.1e-14  Score=129.30  Aligned_cols=121  Identities=19%  Similarity=0.207  Sum_probs=98.8

Q ss_pred             eeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCC--CC----------CeEEEEEEecC
Q psy1546          61 KQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSP--YG----------TKLWIIMEYLG  128 (604)
Q Consensus        61 i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp--~~----------~~lyLVmEy~~  128 (604)
                      +.+.||.|.++.||++.+..  ..++||.+.....   ...+.+|+.++..+.+.  ..          ...|++|||+.
T Consensus         2 ~~~~i~~g~~~~v~~~~~~~--~~~~iK~~~~~~~---~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~   76 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTKD--EDYVLKINPSREK---GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIE   76 (155)
T ss_pred             cceecccccccceEEEEecC--CeEEEEecCCCCc---hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecC
Confidence            35789999999999998754  6799999865543   35677888888887653  22          23689999999


Q ss_pred             CCChhhHhhcCCCcHHHHHHHHHHHHHHhHHhhhC---CccccccccceeEecCCCCeEEecccccc
Q psy1546         129 GGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSE---RKLHRDIKAANVLLSEMGDVKLADFGVAG  192 (604)
Q Consensus       129 ggsL~~~l~~~~lse~~i~~i~~qIl~gL~yLHs~---gIiHrDLKp~NILl~~~g~vKL~DFGlA~  192 (604)
                      |+.+..+      +......++.+++.+|.+||..   +++|+||+|.|||++..+.++|+|||.+.
T Consensus        77 g~~~~~~------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~  137 (155)
T cd05120          77 GETLDEV------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAG  137 (155)
T ss_pred             CeecccC------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEeccccc
Confidence            8877665      5566677899999999999985   79999999999999998999999999884

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>KOG0606|consensus

Probab=99.44  E-value=2.9e-14  Score=162.70  Aligned_cols=246  Identities=24%  Similarity=0.383  Sum_probs=193.2

Q ss_pred             ceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhh--HHHHHHHHHHHHHHhhCCCCC----------CCeEEEEEEe
Q psy1546          59 FTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA--EDEIEDIQQEIMVLSQCDSPY----------GTKLWIIMEY  126 (604)
Q Consensus        59 y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~--~~~~~~l~~Ei~iL~~l~hp~----------~~~lyLVmEy  126 (604)
                      +.+.+-+-+|+|+.++.+.-..++...++|+......  ....+.+.++-.++-...+|.          ...++||++|
T Consensus       806 ~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~~~~  885 (1205)
T KOG0606|consen  806 FEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLVGHY  885 (1205)
T ss_pred             ceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchhhHH
Confidence            6667789999999999998877887777776533211  112233333433433333343          3456899999


Q ss_pred             cCCCChhhHhhc-CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCC--------
Q psy1546         127 LGGGSALDLMKA-GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNT--------  197 (604)
Q Consensus       127 ~~ggsL~~~l~~-~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~--------  197 (604)
                      +.+++|...+.. +..++..++.++..+..+++|||...++|||++|.|+|+..+|+.++.|||........        
T Consensus       886 ~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~~~~sg  965 (1205)
T KOG0606|consen  886 LNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPTTDLSG  965 (1205)
T ss_pred             hccCCchhhhhcCCCcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCccccccccccccCcCCccc
Confidence            999999998876 55788888888899999999999999999999999999999999999999844322100        


Q ss_pred             -----------------------CCCCcccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhh
Q psy1546         198 -----------------------TSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLF  254 (604)
Q Consensus       198 -----------------------~~~~~~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~  254 (604)
                                             ........||+.|.+||.+.+......+|+|++|++++|.++|.+||....+.++..
T Consensus       966 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~tpq~~f~ 1045 (1205)
T KOG0606|consen  966 PSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAETPQQIFE 1045 (1205)
T ss_pred             ccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCCcchhhhhh
Confidence                                   001234579999999999999999999999999999999999999999999999888


Q ss_pred             hcCCCCC--CCCCccchHHHHHHHHHHhccCCCCCCCHH---HHhcChhhhhhhh
Q psy1546         255 LIPKNNP--PQLTGNYTKQFKEFVEACLNKDPENRPTAK---ELLKFPFIRKAKK  304 (604)
Q Consensus       255 ~i~~~~~--~~~~~~~s~~l~~Li~~~L~~dP~~RpT~~---elL~hp~f~~~~~  304 (604)
                      .+.....  +.-+...+...++++.++|..++.+|..+.   ++-.|+||+...+
T Consensus      1046 ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~~~~~~~~~ 1100 (1205)
T KOG0606|consen 1046 NILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAKGAAEVKGHPFFQDVDW 1100 (1205)
T ss_pred             ccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcccccccccCCccCCCCc
Confidence            7766543  344556788999999999999999999877   8899999987654

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.43  E-value=3.7e-13  Score=147.65  Aligned_cols=131  Identities=18%  Similarity=0.307  Sum_probs=92.3

Q ss_pred             eEEcccCcEEEEEEEECCCCcEEEEEEecchhhHH---HH------------------------------H------HHH
Q psy1546          63 ERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAED---EI------------------------------E------DIQ  103 (604)
Q Consensus        63 ~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~---~~------------------------------~------~l~  103 (604)
                      +.||.|++|+||+|+.. +|+.||||+........   ++                              .      .+.
T Consensus       123 ~plasaSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~  201 (437)
T TIGR01982       123 KPLAAASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR  201 (437)
T ss_pred             cceeeeehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence            57999999999999864 68999999985432110   00                              0      123


Q ss_pred             HHHHHHhhCC----CCCC-----------CeEEEEEEecCCCChhhHhhcCCCcHHHHHHHHHHHHH-HhHHhhhCCccc
Q psy1546         104 QEIMVLSQCD----SPYG-----------TKLWIIMEYLGGGSALDLMKAGNFEEMHIAVILREVLK-GLDYLHSERKLH  167 (604)
Q Consensus       104 ~Ei~iL~~l~----hp~~-----------~~lyLVmEy~~ggsL~~~l~~~~lse~~i~~i~~qIl~-gL~yLHs~gIiH  167 (604)
                      +|...+.++.    +...           ..-+|||||++|++|.++........ ....++..++. .+..+|..|++|
T Consensus       202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~-~~~~ia~~~~~~~l~ql~~~g~~H  280 (437)
T TIGR01982       202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGL-DRKALAENLARSFLNQVLRDGFFH  280 (437)
T ss_pred             HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCC-CHHHHHHHHHHHHHHHHHhCCcee
Confidence            3444444432    2211           12369999999999988764321111 23456666665 478899999999


Q ss_pred             cccccceeEecCCCCeEEeccccccccc
Q psy1546         168 RDIKAANVLLSEMGDVKLADFGVAGTLT  195 (604)
Q Consensus       168 rDLKp~NILl~~~g~vKL~DFGlA~~~~  195 (604)
                      +|+||.||+++.+|.++|+|||++..+.
T Consensus       281 ~D~hPgNilv~~~g~i~liDfG~~~~l~  308 (437)
T TIGR01982       281 ADLHPGNIFVLKDGKIIALDFGIVGRLS  308 (437)
T ss_pred             CCCCcccEEECCCCcEEEEeCCCeeECC
Confidence            9999999999999999999999997664

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>KOG0601|consensus

Probab=99.42  E-value=2.9e-13  Score=147.82  Aligned_cols=241  Identities=23%  Similarity=0.268  Sum_probs=172.8

Q ss_pred             cceeeeEEcc--cCcEEEEEEEE--CCCCcEEEEEEecchhhH-HHHHHHHHHHHHHhhCC-CCC----------CCeEE
Q psy1546          58 IFTKQERIGK--GSFGEVFKGID--NRTQQVVAIKIIDLEEAE-DEIEDIQQEIMVLSQCD-SPY----------GTKLW  121 (604)
Q Consensus        58 ~y~i~~~LG~--G~fG~Vy~a~~--~~t~~~vAVK~i~~~~~~-~~~~~l~~Ei~iL~~l~-hp~----------~~~ly  121 (604)
                      .|.+...+|.  |.+|.||.+..  ..++..+|+|.-+..... ..-..-.+|+.....++ |++          ...+|
T Consensus       115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lf  194 (524)
T KOG0601|consen  115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILF  194 (524)
T ss_pred             hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcce
Confidence            4777889999  99999999998  889999999983211110 00011123333333322 222          34568


Q ss_pred             EEEEecCCCChhhHhhc-C-CCcHHHHHHHHHHHHH----HhHHhhhCCccccccccceeEecCC-CCeEEecccccccc
Q psy1546         122 IIMEYLGGGSALDLMKA-G-NFEEMHIAVILREVLK----GLDYLHSERKLHRDIKAANVLLSEM-GDVKLADFGVAGTL  194 (604)
Q Consensus       122 LVmEy~~ggsL~~~l~~-~-~lse~~i~~i~~qIl~----gL~yLHs~gIiHrDLKp~NILl~~~-g~vKL~DFGlA~~~  194 (604)
                      +-+|+|. .+|..+... . -+++..++.++.+...    ||.++|..+++|-|+||.||++..+ ..++++|||+...+
T Consensus       195 iqtE~~~-~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df~~v~~i  273 (524)
T KOG0601|consen  195 IQTELCG-ESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDFGLVSKI  273 (524)
T ss_pred             eeecccc-chhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCcceeEEc
Confidence            9999994 667666543 3 3888999999999999    9999999999999999999999998 88999999999877


Q ss_pred             cCCCCCCcc-----cccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCC-CCCCCCccc
Q psy1546         195 TNTTSKRNT-----FVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKN-NPPQLTGNY  268 (604)
Q Consensus       195 ~~~~~~~~~-----~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~-~~~~~~~~~  268 (604)
                      .........     ..|...|++||++.+ .++...|+|+||.++.+-.+|.-++...... ....+... .+..+....
T Consensus       274 ~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~-~W~~~r~~~ip~e~~~~~  351 (524)
T KOG0601|consen  274 SDGNFSSVFKVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILGSHLPSVGKNS-SWSQLRQGYIPLEFCEGG  351 (524)
T ss_pred             cCCccccceeeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhhcccccCCCCC-CccccccccCchhhhcCc
Confidence            655533322     267788999998754 5778899999999999998876553322100 00001010 122333344


Q ss_pred             hHHHHHHHHHHhccCCCCCCCHHHHhcChhhhh
Q psy1546         269 TKQFKEFVEACLNKDPENRPTAKELLKFPFIRK  301 (604)
Q Consensus       269 s~~l~~Li~~~L~~dP~~RpT~~elL~hp~f~~  301 (604)
                      +.++...+..|++.++..|++.+.++.|+++..
T Consensus       352 s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s  384 (524)
T KOG0601|consen  352 SSSLRSVTSQMLDEDPRLRLTAQILTALNVIHS  384 (524)
T ss_pred             chhhhhHHHHhcCcchhhhhHHHHHhccccccc
Confidence            566777999999999999999999999999863

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.35  E-value=2.4e-12  Score=143.53  Aligned_cols=129  Identities=19%  Similarity=0.283  Sum_probs=90.2

Q ss_pred             ceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhH---------------------------------HHHHH----
Q psy1546          59 FTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAE---------------------------------DEIED----  101 (604)
Q Consensus        59 y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~---------------------------------~~~~~----  101 (604)
                      |.. +.||+|++|+||+|+.+.+|+.||||++.+....                                 ...+.    
T Consensus       122 fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~E  200 (537)
T PRK04750        122 FDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHDE  200 (537)
T ss_pred             cCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHHh
Confidence            444 6899999999999999888999999998644210                                 00111    


Q ss_pred             --HHHHHHHHhhCC----CCC---C--------CeEEEEEEecCCCChhhH--hhcCC-----CcHHHHHHHHHHHHHHh
Q psy1546         102 --IQQEIMVLSQCD----SPY---G--------TKLWIIMEYLGGGSALDL--MKAGN-----FEEMHIAVILREVLKGL  157 (604)
Q Consensus       102 --l~~Ei~iL~~l~----hp~---~--------~~lyLVmEy~~ggsL~~~--l~~~~-----lse~~i~~i~~qIl~gL  157 (604)
                        +.+|...+.++.    +..   +        .+.+|||||++|+.+.++  +....     +.+..+..++.|++   
T Consensus       201 lD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif---  277 (537)
T PRK04750        201 LDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVF---  277 (537)
T ss_pred             hCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHH---
Confidence              233444444432    221   1        122599999999999774  33322     44444555566654   


Q ss_pred             HHhhhCCccccccccceeEecCCC----CeEEeccccccccc
Q psy1546         158 DYLHSERKLHRDIKAANVLLSEMG----DVKLADFGVAGTLT  195 (604)
Q Consensus       158 ~yLHs~gIiHrDLKp~NILl~~~g----~vKL~DFGlA~~~~  195 (604)
                          ..|++|+|+||.||+|+.+|    .++++|||++..+.
T Consensus       278 ----~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~  315 (537)
T PRK04750        278 ----RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN  315 (537)
T ss_pred             ----hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence                58999999999999999888    99999999997764

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.34  E-value=3e-12  Score=121.15  Aligned_cols=119  Identities=19%  Similarity=0.187  Sum_probs=89.9

Q ss_pred             eeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCC---------CCeEEEEEEecCCCCh
Q psy1546          62 QERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPY---------GTKLWIIMEYLGGGSA  132 (604)
Q Consensus        62 ~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~---------~~~lyLVmEy~~ggsL  132 (604)
                      ++.|+.|.++.||++...  +..|+||+......  ....+.+|+.++..+.+..         ...-++||||++|.++
T Consensus         3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~--~~~~~~~E~~~l~~l~~~~~~P~~~~~~~~~~~lv~e~i~G~~l   78 (170)
T cd05151           3 ISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTE--LLINRENEAENSKLAAEAGIGPKLYYFDPETGVLITEFIEGSEL   78 (170)
T ss_pred             eeecCCcccCceEEEEEC--CeEEEEEeCCCCcc--cccCHHHHHHHHHHHHHhCCCCceEEEeCCCCeEEEEecCCCcc
Confidence            367899999999999864  77899999754431  1234567777777764432         1123799999999887


Q ss_pred             hhHhhcCCCcHHHHHHHHHHHHHHhHHhhhCCc-----cccccccceeEecCCCCeEEecccccc
Q psy1546         133 LDLMKAGNFEEMHIAVILREVLKGLDYLHSERK-----LHRDIKAANVLLSEMGDVKLADFGVAG  192 (604)
Q Consensus       133 ~~~l~~~~lse~~i~~i~~qIl~gL~yLHs~gI-----iHrDLKp~NILl~~~g~vKL~DFGlA~  192 (604)
                      ...       ......++.+++.+|..||..++     +|+|++|.||+++ ++.++|+|||.+.
T Consensus        79 ~~~-------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~  135 (170)
T cd05151          79 LTE-------DFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG  135 (170)
T ss_pred             ccc-------cccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence            653       11123457899999999999985     9999999999999 6789999999884

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.33  E-value=7.5e-12  Score=122.44  Aligned_cols=132  Identities=18%  Similarity=0.212  Sum_probs=96.4

Q ss_pred             eEEcccCcEEEEEEEECC------CCcEEEEEEecchhh---------------------HHHHHHHH----HHHHHHhh
Q psy1546          63 ERIGKGSFGEVFKGIDNR------TQQVVAIKIIDLEEA---------------------EDEIEDIQ----QEIMVLSQ  111 (604)
Q Consensus        63 ~~LG~G~fG~Vy~a~~~~------t~~~vAVK~i~~~~~---------------------~~~~~~l~----~Ei~iL~~  111 (604)
                      ..||.|--+.||.|....      .+..+|||+......                     ......+.    +|+..|++
T Consensus         3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r   82 (197)
T cd05146           3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR   82 (197)
T ss_pred             CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence            468999999999997543      357899999742110                     01122233    78888888


Q ss_pred             CCCCC--------CCeEEEEEEecCCCChh-hHhhcCCCcHHHHHHHHHHHHHHhHHh-hhCCccccccccceeEecCCC
Q psy1546         112 CDSPY--------GTKLWIIMEYLGGGSAL-DLMKAGNFEEMHIAVILREVLKGLDYL-HSERKLHRDIKAANVLLSEMG  181 (604)
Q Consensus       112 l~hp~--------~~~lyLVmEy~~ggsL~-~~l~~~~lse~~i~~i~~qIl~gL~yL-Hs~gIiHrDLKp~NILl~~~g  181 (604)
                      +..-.        ...-+|||||++++.+. ..++...+++..+..++.+++.+|..| |..|||||||++.|||+.+ +
T Consensus        83 l~~~Gv~vP~pi~~~~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NIL~~~-~  161 (197)
T cd05146          83 MQKAGIPCPEVVVLKKHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNMLWHD-G  161 (197)
T ss_pred             HHHcCCCCCeEEEecCCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEC-C
Confidence            75432        12237999999765442 244555566667788889999999999 8999999999999999974 7


Q ss_pred             CeEEeccccccccc
Q psy1546         182 DVKLADFGVAGTLT  195 (604)
Q Consensus       182 ~vKL~DFGlA~~~~  195 (604)
                      .++|+|||.|-...
T Consensus       162 ~v~iIDF~qav~~~  175 (197)
T cd05146         162 KVWFIDVSQSVEPT  175 (197)
T ss_pred             cEEEEECCCceeCC
Confidence            89999999885443

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>KOG0601|consensus

Probab=99.25  E-value=8.9e-12  Score=136.30  Aligned_cols=236  Identities=26%  Similarity=0.287  Sum_probs=168.1

Q ss_pred             ccceeeeEEcccCcEEEEEEEEC-CCCcEEEEEEecchhhHH--H---HHHHHHHHHHHhhCCCCC-------CCeEEEE
Q psy1546          57 LIFTKQERIGKGSFGEVFKGIDN-RTQQVVAIKIIDLEEAED--E---IEDIQQEIMVLSQCDSPY-------GTKLWII  123 (604)
Q Consensus        57 ~~y~i~~~LG~G~fG~Vy~a~~~-~t~~~vAVK~i~~~~~~~--~---~~~l~~Ei~iL~~l~hp~-------~~~lyLV  123 (604)
                      ..|..+..||.|.|+.||.+... .++..|++|.........  +   +....-|..+...+.+..       ..+.||=
T Consensus       265 ~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip  344 (524)
T KOG0601|consen  265 TDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIP  344 (524)
T ss_pred             CCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccCc
Confidence            34888899999999999998755 678889999874432211  1   122223333333333222       3345788


Q ss_pred             EEecCCCChhhHhh-cCCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCC-CCeEEecccccccccCCCCCC
Q psy1546         124 MEYLGGGSALDLMK-AGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEM-GDVKLADFGVAGTLTNTTSKR  201 (604)
Q Consensus       124 mEy~~ggsL~~~l~-~~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~-g~vKL~DFGlA~~~~~~~~~~  201 (604)
                      .|||+++++...+. ...+++...+.+..|++.++.++|++.++|+|+||+||++..+ +..++.|||.+..+.   ...
T Consensus       345 ~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~---~~~  421 (524)
T KOG0601|consen  345 LEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLA---FSS  421 (524)
T ss_pred             hhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhccccccccccc---eec
Confidence            99999998776552 2457888899999999999999999999999999999999886 778999999986432   112


Q ss_pred             cccccCCCCC--ChHHhhcCCCCCcchhhhHHHHHHHHHhCCCC-CCCCChhhHhhhcCCCCCCCCCccchHHHHHHHHH
Q psy1546         202 NTFVGTPFWM--APEVIKQSAYDSKADIWSLGITAIELAKGEPP-NSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEA  278 (604)
Q Consensus       202 ~~~~GT~~Y~--APE~l~~~~~~~~sDVwSLGviL~eLltG~~P-f~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~  278 (604)
                      ..+.+.-+++  ++.......+..++|+++||..+.+.++|.+. +.+.    ....+..+..+..+.. ..++..+.+.
T Consensus       422 ~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~----~~~~i~~~~~p~~~~~-~~~~q~~~kv  496 (524)
T KOG0601|consen  422 GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGV----QSLTIRSGDTPNLPGL-KLQLQVLLKV  496 (524)
T ss_pred             ccccccccccccchhhccccccccccccccccccccccccCcccCcccc----cceeeecccccCCCch-HHhhhhhhhh
Confidence            2333444444  55556677788999999999999999998763 2221    1222333333333333 3788999999


Q ss_pred             HhccCCCCCCCHHHHhcChhhh
Q psy1546         279 CLNKDPENRPTAKELLKFPFIR  300 (604)
Q Consensus       279 ~L~~dP~~RpT~~elL~hp~f~  300 (604)
                      ++..++..|+.+.++..|.-|.
T Consensus       497 ~~~~~~~~~~l~~~l~~~~~~~  518 (524)
T KOG0601|consen  497 MINPDRKRRPSAVELSLHSEFY  518 (524)
T ss_pred             hcCCccccchhhhhhcccchhh
Confidence            9999999999999999887653

>KOG1243|consensus

Probab=99.17  E-value=5.5e-10  Score=123.66  Aligned_cols=170  Identities=18%  Similarity=0.239  Sum_probs=123.9

Q ss_pred             EcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCC----------eEEEEEEecCCCChhh
Q psy1546          65 IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGT----------KLWIIMEYLGGGSALD  134 (604)
Q Consensus        65 LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~----------~lyLVmEy~~ggsL~~  134 (604)
                      .+-++.+..-.|..+.++.+|.|..++.... .....+.+-++-|+.++||++.          .+|||+|.+.  -|..
T Consensus        20 ~~~~~~a~~~~~t~k~~~~~vsVF~~~~~~~-~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~   96 (690)
T KOG1243|consen   20 TAFSSEALWPDGTRKADGGPVSVFVYKRSNG-EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLET   96 (690)
T ss_pred             ccCCCcccccccceeccCCceEEEEEeCCCc-hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHH
Confidence            3444444332567778899999999876655 4456778889999999999854          4699999983  3455


Q ss_pred             HhhcCCCcHHHHHHHHHHHHHHhHHhh-hCCccccccccceeEecCCCCeEEecccccccccCCCCCCcccccCCCCCCh
Q psy1546         135 LMKAGNFEEMHIAVILREVLKGLDYLH-SERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAP  213 (604)
Q Consensus       135 ~l~~~~lse~~i~~i~~qIl~gL~yLH-s~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~~~~~~GT~~Y~AP  213 (604)
                      +++.  +....+...+.||+.||.||| +.+++|+.|.-.-|+|+..|..||++|.++..............---.|..|
T Consensus        97 ~lk~--l~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P  174 (690)
T KOG1243|consen   97 VLKE--LGKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPAKSLYLIESFDDP  174 (690)
T ss_pred             HHHH--hHHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcccccchhhhcccCh
Confidence            5554  336777888999999999997 6789999999999999999999999999885544332211111122236666


Q ss_pred             HHhhcCCCCCcchhhhHHHHHHHHHhCC
Q psy1546         214 EVIKQSAYDSKADIWSLGITAIELAKGE  241 (604)
Q Consensus       214 E~l~~~~~~~~sDVwSLGviL~eLltG~  241 (604)
                      +.+....  -..|.|.|||++++++.|.
T Consensus       175 ~~~~~s~--~s~D~~~Lg~li~el~ng~  200 (690)
T KOG1243|consen  175 EEIDPSE--WSIDSWGLGCLIEELFNGS  200 (690)
T ss_pred             hhcCccc--cchhhhhHHHHHHHHhCcc
Confidence            6553332  3469999999999999993

>KOG1266|consensus

Probab=99.13  E-value=1.4e-10  Score=118.44  Aligned_cols=183  Identities=22%  Similarity=0.346  Sum_probs=128.8

Q ss_pred             CCeEEEEEEecCCCChhhHhhc-----CCCcHHHHHHHHHHHHHHhHHhhhC--CccccccccceeEecCCCCeEEeccc
Q psy1546         117 GTKLWIIMEYLGGGSALDLMKA-----GNFEEMHIAVILREVLKGLDYLHSE--RKLHRDIKAANVLLSEMGDVKLADFG  189 (604)
Q Consensus       117 ~~~lyLVmEy~~ggsL~~~l~~-----~~lse~~i~~i~~qIl~gL~yLHs~--gIiHrDLKp~NILl~~~g~vKL~DFG  189 (604)
                      ..++.+++||+..|+|..++++     ..+....+.+|+-||+.||.|||+.  -|+|+.+..+-|++..+|-+|+.--.
T Consensus       144 ~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~PpiihgnlTc~tifiq~ngLIkig~~a  223 (458)
T KOG1266|consen  144 KPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPIIHGNLTCDTIFIQHNGLIKIGSVA  223 (458)
T ss_pred             ccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccccCCcchhheeecCCceEEecccC
Confidence            4566899999999999999965     3588889999999999999999988  49999999999999999988875321


Q ss_pred             cccccc--C--CCCCCcccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCC-CCChhhHhhhcCCCCCCCC
Q psy1546         190 VAGTLT--N--TTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNS-ELHPMRVLFLIPKNNPPQL  264 (604)
Q Consensus       190 lA~~~~--~--~~~~~~~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~-~~~~~~~~~~i~~~~~~~~  264 (604)
                      -.....  .  .........+-++|.+||.=.....+.++|||+||+...+|..+..--. .......-..+...    +
T Consensus       224 p~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemailEiq~tnseS~~~~ee~ia~~----i  299 (458)
T KOG1266|consen  224 PDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAILEIQSTNSESKVEVEENIANV----I  299 (458)
T ss_pred             ccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHheeccCCCcceeehhhhhhhh----e
Confidence            110000  0  0011223346788999998766677789999999999999988765321 11111111111000    0


Q ss_pred             CccchHHHHHHHHHHhccCCCCCCCHHHHhcChhhhhhh
Q psy1546         265 TGNYTKQFKEFVEACLNKDPENRPTAKELLKFPFIRKAK  303 (604)
Q Consensus       265 ~~~~s~~l~~Li~~~L~~dP~~RpT~~elL~hp~f~~~~  303 (604)
                      ..--...-++++.+||.-.|..||++.++|.||.+-...
T Consensus       300 ~~len~lqr~~i~kcl~~eP~~rp~ar~llfHpllfeVh  338 (458)
T KOG1266|consen  300 IGLENGLQRGSITKCLEGEPNGRPDARLLLFHPLLFEVH  338 (458)
T ss_pred             eeccCccccCcCcccccCCCCCCcchhhhhcCceeeecc
Confidence            000011225789999999999999999999999875443

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.07  E-value=6.4e-10  Score=109.43  Aligned_cols=129  Identities=18%  Similarity=0.201  Sum_probs=97.4

Q ss_pred             eEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCC-----CC------C----CeEEEEEEec
Q psy1546          63 ERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDS-----PY------G----TKLWIIMEYL  127 (604)
Q Consensus        63 ~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~h-----p~------~----~~lyLVmEy~  127 (604)
                      +.||.|.++.||++.... |+.|+||+............+.+|+.++..+.+     |.      .    ...|+||||+
T Consensus         4 ~~l~~G~~n~~~~v~~~~-g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i   82 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGG-GRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERV   82 (223)
T ss_pred             eecCCCccceEEEEEecC-CcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEe
Confidence            568999999999998643 578999997654322223567888888888764     21      1    1458999999


Q ss_pred             CCCChhhHhhcCCCcHHHHHHHHHHHHHHhHHhhh---------------------------------------------
Q psy1546         128 GGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHS---------------------------------------------  162 (604)
Q Consensus       128 ~ggsL~~~l~~~~lse~~i~~i~~qIl~gL~yLHs---------------------------------------------  162 (604)
                      +|.++.+.+..+.+++.+...++.+++.+|.+||+                                             
T Consensus        83 ~G~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (223)
T cd05154          83 DGRVLRDRLLRPELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERLLR  162 (223)
T ss_pred             CCEecCCCCCCCCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHHHH
Confidence            99988876543456777777777788888877774                                             


Q ss_pred             -----------CCccccccccceeEecC--CCCeEEecccccc
Q psy1546         163 -----------ERKLHRDIKAANVLLSE--MGDVKLADFGVAG  192 (604)
Q Consensus       163 -----------~gIiHrDLKp~NILl~~--~g~vKL~DFGlA~  192 (604)
                                 ..++|+|+++.|||++.  ++.+.|+||+.+.
T Consensus       163 ~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~  205 (223)
T cd05154         163 WLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELAT  205 (223)
T ss_pred             HHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccc
Confidence                       23589999999999998  6678999999873

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.03  E-value=1.8e-09  Score=103.24  Aligned_cols=120  Identities=22%  Similarity=0.271  Sum_probs=89.7

Q ss_pred             EEcccCcEEEEEEEECCCCcEEEEEEecchh-----hHHH--HHHHHHHHHHHhhCCCCC----------CCeEEEEEEe
Q psy1546          64 RIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE-----AEDE--IEDIQQEIMVLSQCDSPY----------GTKLWIIMEY  126 (604)
Q Consensus        64 ~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~-----~~~~--~~~l~~Ei~iL~~l~hp~----------~~~lyLVmEy  126 (604)
                      .|++|+-+.||.+...  |..+++|.-.++.     ....  .....+|..++..+.--.          .....|+|||
T Consensus         3 ~i~~GAEa~i~~~~~~--g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~   80 (204)
T COG3642           3 LIKQGAEAIIYLTDFL--GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY   80 (204)
T ss_pred             hhhCCcceeEEeeecc--CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence            5789999999999654  4457777642221     1111  245668888888765321          1122499999


Q ss_pred             cCCCChhhHhhcCCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccc
Q psy1546         127 LGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAG  192 (604)
Q Consensus       127 ~~ggsL~~~l~~~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~  192 (604)
                      ++|..|.+++...      ...+++.+-.-+.-||..||||+||.++||++... .+.++|||++.
T Consensus        81 I~G~~lkd~l~~~------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~-~i~~IDfGLg~  139 (204)
T COG3642          81 IEGELLKDALEEA------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGG-RIYFIDFGLGE  139 (204)
T ss_pred             eCChhHHHHHHhc------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCC-cEEEEECCccc
Confidence            9999999988765      25667788888899999999999999999999984 49999999984

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.97  E-value=6.6e-09  Score=101.20  Aligned_cols=120  Identities=27%  Similarity=0.306  Sum_probs=81.0

Q ss_pred             EEEEEEECCCCcEEEEEEecchhh-------------------------HHHHHHHHHHHHHHhhCCCCC--CCeE----
Q psy1546          72 EVFKGIDNRTQQVVAIKIIDLEEA-------------------------EDEIEDIQQEIMVLSQCDSPY--GTKL----  120 (604)
Q Consensus        72 ~Vy~a~~~~t~~~vAVK~i~~~~~-------------------------~~~~~~l~~Ei~iL~~l~hp~--~~~l----  120 (604)
                      .||.|.. ..+..+|||+......                         ........+|...|.++..-.  ..++    
T Consensus         1 ~Vy~~~~-~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~   79 (188)
T PF01163_consen    1 DVYHAID-PDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN   79 (188)
T ss_dssp             EEEEEEE-CTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred             CEEEEEC-CCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence            4899986 3577999999742100                         001234678999999987653  2222    


Q ss_pred             --EEEEEecC--CCChhhHhhcCCCcHHHHHHHHHHHHHHhHH-hhhCCccccccccceeEecCCCCeEEecccccccc
Q psy1546         121 --WIIMEYLG--GGSALDLMKAGNFEEMHIAVILREVLKGLDY-LHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTL  194 (604)
Q Consensus       121 --yLVmEy~~--ggsL~~~l~~~~lse~~i~~i~~qIl~gL~y-LHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~  194 (604)
                        +|||||++  |..+. .+....++......++.+++..+.. +|..||+|+||.+.|||++++ .+.|+|||.|...
T Consensus        80 ~~~ivME~I~~~G~~~~-~l~~~~~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~~~iIDf~qav~~  156 (188)
T PF01163_consen   80 RNVIVMEYIGEDGVPLP-RLKDVDLSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-KVYIIDFGQAVDS  156 (188)
T ss_dssp             TTEEEEE--EETTEEGG-CHHHCGGGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-CEEE--GTTEEET
T ss_pred             CCEEEEEecCCCccchh-hHHhccccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-eEEEEecCcceec
Confidence              59999998  55444 4444445566778888899986655 579999999999999999986 9999999988544

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>KOG3087|consensus

Probab=98.95  E-value=7.2e-09  Score=98.87  Aligned_cols=130  Identities=24%  Similarity=0.317  Sum_probs=94.9

Q ss_pred             eeeEEcccCcEEEEEEEECCCCcEEEEEEecchhh-------HHHHHHHHHHHHHHhhCCCCCC--Ce--------EEEE
Q psy1546          61 KQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA-------EDEIEDIQQEIMVLSQCDSPYG--TK--------LWII  123 (604)
Q Consensus        61 i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~-------~~~~~~l~~Ei~iL~~l~hp~~--~~--------lyLV  123 (604)
                      ....|-+|+-+.|+++.+  .|+.++||.-..+.-       .-...+..+|+.+|.++.--.+  ..        -.|+
T Consensus        11 ~l~likQGAEArv~~~~~--~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~   88 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSF--SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIY   88 (229)
T ss_pred             cceeeeccceeeEeeecc--CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEE
Confidence            456789999999999974  488888886432211       1123567789999888653221  11        2589


Q ss_pred             EEecCC-CChhhHhhc---CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCC---eEEecccccc
Q psy1546         124 MEYLGG-GSALDLMKA---GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGD---VKLADFGVAG  192 (604)
Q Consensus       124 mEy~~g-gsL~~~l~~---~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~---vKL~DFGlA~  192 (604)
                      |||++| .++.+++..   ..........+++.|-+.|.-||..+|||+||..+||++..+|.   +.|+|||++.
T Consensus        89 ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~  164 (229)
T KOG3087|consen   89 MEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSS  164 (229)
T ss_pred             EEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchh
Confidence            999977 467777654   22333344788999999999999999999999999999976653   5899999983

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=98.88  E-value=2.4e-08  Score=102.65  Aligned_cols=120  Identities=14%  Similarity=0.048  Sum_probs=87.0

Q ss_pred             EEEEEEEECCCCcEEEEEEecchhhHHHHH----------HHHHHHHHHhhCC---C--CC------------CCeEEEE
Q psy1546          71 GEVFKGIDNRTQQVVAIKIIDLEEAEDEIE----------DIQQEIMVLSQCD---S--PY------------GTKLWII  123 (604)
Q Consensus        71 G~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~----------~l~~Ei~iL~~l~---h--p~------------~~~lyLV  123 (604)
                      ..|+++..  .|+.|.||...........+          ...+|...+..|.   .  |.            ...-|||
T Consensus        36 rrvvr~~~--~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LV  113 (268)
T PRK15123         36 RRTLRFEL--AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFII  113 (268)
T ss_pred             ceEEEEEE--CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEE
Confidence            34666543  46789999764333211111          3667777766552   2  21            1235799


Q ss_pred             EEecCCC-ChhhHhhc---CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecC-------CCCeEEecccccc
Q psy1546         124 MEYLGGG-SALDLMKA---GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSE-------MGDVKLADFGVAG  192 (604)
Q Consensus       124 mEy~~gg-sL~~~l~~---~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~-------~g~vKL~DFGlA~  192 (604)
                      ||++++. +|.+++..   ...+......++.+++..+.-||..||+|+||++.||||+.       ++.+.|+||+.++
T Consensus       114 te~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~  193 (268)
T PRK15123        114 TEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQ  193 (268)
T ss_pred             EeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCccc
Confidence            9999876 78888753   44566677889999999999999999999999999999975       4679999999874

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=98.87  E-value=7.8e-08  Score=101.59  Aligned_cols=231  Identities=14%  Similarity=0.191  Sum_probs=149.1

Q ss_pred             cceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHH-------------HHHHHHhhCCCCCCCe-EEEE
Q psy1546          58 IFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQ-------------QEIMVLSQCDSPYGTK-LWII  123 (604)
Q Consensus        58 ~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~-------------~Ei~iL~~l~hp~~~~-lyLV  123 (604)
                      .....+.||+|+-+.+|-.-..  +. .+.|++.........+.+.             +-..=+..|..++..+ +-++
T Consensus        12 ~i~~gr~LgqGgea~ly~l~e~--~d-~VAKIYh~Pppa~~aqk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGfl   88 (637)
T COG4248          12 PIPPGRPLGQGGEADLYTLGEV--RD-QVAKIYHAPPPAAQAQKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFL   88 (637)
T ss_pred             ccCCCccccCCccceeeecchh--hc-hhheeecCCCchHHHHHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEe
Confidence            3456678999999999976432  22 3458875433221111110             0011112233344444 5578


Q ss_pred             EEecCCCC-hhhHhh----c---CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEeccccccccc
Q psy1546         124 MEYLGGGS-ALDLMK----A---GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLT  195 (604)
Q Consensus       124 mEy~~ggs-L~~~l~----~---~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~  195 (604)
                      |..+.|.. +..+..    .   ..+.+.-+.+.++.|+.+.+.||..|.+-+|+.++|+||++++.|.|+|=..- .+.
T Consensus        89 mP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsf-qi~  167 (637)
T COG4248          89 MPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDSF-QIN  167 (637)
T ss_pred             cccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEcccce-eec
Confidence            88876653 222221    1   23667788889999999999999999999999999999999999999974432 222


Q ss_pred             CCCCCCcccccCCCCCChHHhh-----cCCCCCcchhhhHHHHHHHHHhC-CCCCCCCCh-------hh--Hhh---h-c
Q psy1546         196 NTTSKRNTFVGTPFWMAPEVIK-----QSAYDSKADIWSLGITAIELAKG-EPPNSELHP-------MR--VLF---L-I  256 (604)
Q Consensus       196 ~~~~~~~~~~GT~~Y~APE~l~-----~~~~~~~sDVwSLGviL~eLltG-~~Pf~~~~~-------~~--~~~---~-i  256 (604)
                      .........+|...|.+||.-+     +..-+...|.|.||+++|+||.| +.||.+...       .+  +..   . -
T Consensus       168 ~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~f~ya  247 (637)
T COG4248         168 ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGRFAYA  247 (637)
T ss_pred             cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcceeeec
Confidence            3344445678999999999764     34456778999999999999886 889876431       11  000   0 0


Q ss_pred             CCCC----C-C--CCCccchHHHHHHHHHHhcc--CCCCCCCHHH
Q psy1546         257 PKNN----P-P--QLTGNYTKQFKEFVEACLNK--DPENRPTAKE  292 (604)
Q Consensus       257 ~~~~----~-~--~~~~~~s~~l~~Li~~~L~~--dP~~RpT~~e  292 (604)
                      .+..    + +  .-..-+++.+..|+.+|+..  ++.-|||++.
T Consensus       248 ~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~a  292 (637)
T COG4248         248 SDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKA  292 (637)
T ss_pred             hhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHH
Confidence            0000    0 0  11124678899999999985  3568999875

>KOG2137|consensus

Probab=98.83  E-value=1.9e-09  Score=119.77  Aligned_cols=151  Identities=23%  Similarity=0.336  Sum_probs=112.4

Q ss_pred             HHHHHHhHHhhhC-CccccccccceeEecCCCCeEEecccccccccCCCCC---------CcccccCCCCCChHHhhcCC
Q psy1546         151 REVLKGLDYLHSE-RKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSK---------RNTFVGTPFWMAPEVIKQSA  220 (604)
Q Consensus       151 ~qIl~gL~yLHs~-gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~---------~~~~~GT~~Y~APE~l~~~~  220 (604)
                      .+++.||.|+|.. ++||+.|.|++|.++..|.+||+.|+++-........         .....-...|.|||++....
T Consensus       106 ~~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~~  185 (700)
T KOG2137|consen  106 GNVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGTT  185 (700)
T ss_pred             hcccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcccc
Confidence            3455999999976 8999999999999999999999999988544332111         01112445699999999988


Q ss_pred             CCCcchhhhHHHHHHHHH-hCCCCCCCCCh---hhHhhhcCCCCCCCCCccchHHHHHHHHHHhccCCCCCCCHHHHhcC
Q psy1546         221 YDSKADIWSLGITAIELA-KGEPPNSELHP---MRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPENRPTAKELLKF  296 (604)
Q Consensus       221 ~~~~sDVwSLGviL~eLl-tG~~Pf~~~~~---~~~~~~i~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~RpT~~elL~h  296 (604)
                      .+.++|+|||||++|.+. .|+.-+.....   ..................++.++++=|.++|..+...||++.+++..
T Consensus       186 ~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~~~l~~~  265 (700)
T KOG2137|consen  186 NTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTLDLLLSI  265 (700)
T ss_pred             ccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccccccccccccCcHHHHHHHHHHhcCCcccCcchhhhhcc
Confidence            899999999999999998 45544433221   11111111222223346789999999999999999999999999999


Q ss_pred             hhhhh
Q psy1546         297 PFIRK  301 (604)
Q Consensus       297 p~f~~  301 (604)
                      |||..
T Consensus       266 ~ff~D  270 (700)
T KOG2137|consen  266 PFFSD  270 (700)
T ss_pred             cccCC
Confidence            99964

>PF06840 DUF1241: Protein of unknown function (DUF1241); InterPro: IPR009652 This family consists of several programmed cell death 10 protein (PDCD10 or TFAR15) sequences

Probab=98.82  E-value=3.9e-09  Score=97.78  Aligned_cols=54  Identities=39%  Similarity=0.684  Sum_probs=49.5

Q ss_pred             CCcchhhhhHHHHHHHHHHhccccCCCCCCCCCCCCCCCcchHHHHHHHHHHHHhhCCCChHHHHHHHHHHh
Q psy1546         502 ARSPCLSFLIYPLISELQRRHHYTSNNRTSNSGADSSHKADAIEELKNAFDLAERSAPGISGQFVKEVVHKL  573 (604)
Q Consensus       502 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ae~~~pg~~~~~~~~~~~~~  573 (604)
                      -.|.||..+|.|+|.+|+++                  ..+|+++|+.||..||.++||||+.||+.||++.
T Consensus         8 v~s~~L~~li~Pvl~eL~~~------------------d~~A~q~Lr~Af~kAE~~~PGft~d~v~~ll~~~   61 (154)
T PF06840_consen    8 VASLALQCLIRPVLDELEQK------------------DSDAIQTLRAAFTKAEKSSPGFTDDFVKGLLERS   61 (154)
T ss_dssp             GGGHHHHHTHHHHHHHHHTT------------------HHHHHHHHHHHHHHHHHHSTTHHHHHHHHHHHTH
T ss_pred             hHHHHHHHHHHHHHHHHHHh------------------hHHHHHHHHHHHHHHHHhCCCcHHHHHHHHHHhc
Confidence            34689999999999999996                  3349999999999999999999999999999998

The function of this family is unknown.; PDB: 3L8I_A 3RQG_B 3RQE_B 3L8J_A 3RQF_B 3AJM_B.

>KOG3741|consensus

Probab=98.74  E-value=3.9e-07  Score=98.66  Aligned_cols=200  Identities=15%  Similarity=0.211  Sum_probs=144.2

Q ss_pred             cEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCCe--------------EEEEEEecCC-CChhh
Q psy1546          70 FGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTK--------------LWIIMEYLGG-GSALD  134 (604)
Q Consensus        70 fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~~--------------lyLVmEy~~g-gsL~~  134 (604)
                      -.+.|+|....+|..|++|++....... ....-.-+..++++.|+|.+.              +++|++|.++ ++|.+
T Consensus       289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~-~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d  367 (655)
T KOG3741|consen  289 SITTYKATSNVDGNAYVLKRLHGDRDQS-TNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYD  367 (655)
T ss_pred             cceeEeeeeccCCceeeeeeeccccccC-cccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHH
Confidence            3588999999999999999994332211 112234467788888887443              5799999864 56666


Q ss_pred             Hh----------------hcCCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCC
Q psy1546         135 LM----------------KAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTT  198 (604)
Q Consensus       135 ~l----------------~~~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~  198 (604)
                      +.                ...+.+|..+|.|+.||..||.++|+.|+.-+-|.|.+||++.+..++|...|+...+....
T Consensus       368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d~  447 (655)
T KOG3741|consen  368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQEDP  447 (655)
T ss_pred             HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccceeeecCCC
Confidence            43                12357889999999999999999999999999999999999988889998888765443322


Q ss_pred             CCCcccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCC-CCCCChhhH-hhhcCCCCCCCCCccchHHHHHHH
Q psy1546         199 SKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPP-NSELHPMRV-LFLIPKNNPPQLTGNYTKQFKEFV  276 (604)
Q Consensus       199 ~~~~~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~P-f~~~~~~~~-~~~i~~~~~~~~~~~~s~~l~~Li  276 (604)
                             +       |.+.+.   .+-|.-.||.+++.|.||..- +........ +.        .+...++.+++++|
T Consensus       448 -------~-------~~le~~---Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~~--------~I~~~yS~D~rn~v  502 (655)
T KOG3741|consen  448 -------T-------EPLESQ---QQNDLRDLGLLLLALATGTENSNRTDSTQSSHLT--------RITTTYSTDLRNVV  502 (655)
T ss_pred             -------C-------cchhHH---hhhhHHHHHHHHHHHhhcccccccccchHHHHHH--------HhhhhhhHHHHHHH
Confidence                   1       112221   244889999999999999653 111111111 11        23457888999999


Q ss_pred             HHHhccCCCCCCCHHHHhcC
Q psy1546         277 EACLNKDPENRPTAKELLKF  296 (604)
Q Consensus       277 ~~~L~~dP~~RpT~~elL~h  296 (604)
                      ..+...++++ -++.+++.+
T Consensus       503 ~yl~s~~~~~-ksI~~llp~  521 (655)
T KOG3741|consen  503 EYLESLNFRE-KSIQDLLPM  521 (655)
T ss_pred             HHHHhcCccc-ccHHHHHHH
Confidence            9999999987 688888875

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.69  E-value=9.3e-08  Score=96.64  Aligned_cols=129  Identities=22%  Similarity=0.299  Sum_probs=96.5

Q ss_pred             cceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhh-----------------H----HHHHHHHHHHHHHhhCCCC-
Q psy1546          58 IFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA-----------------E----DEIEDIQQEIMVLSQCDSP-  115 (604)
Q Consensus        58 ~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~-----------------~----~~~~~l~~Ei~iL~~l~hp-  115 (604)
                      .+.++..||.|--|.||.|.+. .|..+|||+=..-..                 .    -.....++|..+|..|... 
T Consensus        92 ve~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G  170 (304)
T COG0478          92 VEAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEG  170 (304)
T ss_pred             HHhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcC
Confidence            4677899999999999999875 688999997421100                 0    0123457899999988643 


Q ss_pred             -C------CCeEEEEEEecCCCChhhHhhcCCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecc
Q psy1546         116 -Y------GTKLWIIMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADF  188 (604)
Q Consensus       116 -~------~~~lyLVmEy~~ggsL~~~l~~~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DF  188 (604)
                       .      ..+-.+||||++|-.|...-    ++......++..|++-+..+-..||||+|+.+-||||+++|.+.++||
T Consensus       171 ~~VP~P~~~nRHaVvMe~ieG~eL~~~r----~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~~~vIDw  246 (304)
T COG0478         171 VKVPKPIAWNRHAVVMEYIEGVELYRLR----LDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGDIVVIDW  246 (304)
T ss_pred             CCCCCccccccceeeeehcccceeeccc----CcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCCCEEEEeC
Confidence             1      23457999999886665432    245556666777777777777899999999999999999999999999


Q ss_pred             ccc
Q psy1546         189 GVA  191 (604)
Q Consensus       189 GlA  191 (604)
                      --+
T Consensus       247 PQ~  249 (304)
T COG0478         247 PQA  249 (304)
T ss_pred             ccc
Confidence            655

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.62  E-value=1.8e-07  Score=92.55  Aligned_cols=75  Identities=21%  Similarity=0.336  Sum_probs=65.4

Q ss_pred             eEEEEEEecCCC-ChhhHhhc-CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCC---CeEEeccccccc
Q psy1546         119 KLWIIMEYLGGG-SALDLMKA-GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMG---DVKLADFGVAGT  193 (604)
Q Consensus       119 ~lyLVmEy~~gg-sL~~~l~~-~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g---~vKL~DFGlA~~  193 (604)
                      .-|||+|++++. +|.+++.. ..++......++.+++..+.-||..||+|+|+++.||||+.++   .+.|+||+-++.
T Consensus        91 ~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~lH~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~  170 (206)
T PF06293_consen   91 RSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAKLHDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF  170 (206)
T ss_pred             eEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHHHHHCcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence            348999999874 78988876 3466777888999999999999999999999999999999887   899999998754

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>KOG0576|consensus

Probab=98.58  E-value=1.7e-08  Score=111.21  Aligned_cols=231  Identities=31%  Similarity=0.381  Sum_probs=167.8

Q ss_pred             cceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCC-C----------CeEEEEEEe
Q psy1546          58 IFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPY-G----------TKLWIIMEY  126 (604)
Q Consensus        58 ~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~-~----------~~lyLVmEy  126 (604)
                      .+....-+++|+++.+++.+...+...+ .+++...      ....-++.+|.+++||+ .          ..++++|++
T Consensus       243 ws~~fh~fvK~altknpKkRptaeklL~-h~fvs~~------l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i  315 (829)
T KOG0576|consen  243 WSEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT------LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRI  315 (829)
T ss_pred             chHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc------hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhh
Confidence            3455556899999999999877666555 7776443      34456889999999998 2          234688999


Q ss_pred             cCCC-ChhhHhh--cCCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCCCCcc
Q psy1546         127 LGGG-SALDLMK--AGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNT  203 (604)
Q Consensus       127 ~~gg-sL~~~l~--~~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~~~~  203 (604)
                      +.++ +....+.  .-.|.+.+...+.+.-+++|+|||+.--+|||    |||.++ +..++.||+.+..+.... ...+
T Consensus       316 ~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~-~~~t  389 (829)
T KOG0576|consen  316 CSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM-KPRT  389 (829)
T ss_pred             hcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----cccccc-cccccccccCCcccCccc-cccc
Confidence            9777 3332221  12355566666778888999999999889999    888776 789999999997776544 5667


Q ss_pred             cccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCCC-CCCCCc--cchHHHH-HHHHHH
Q psy1546         204 FVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNN-PPQLTG--NYTKQFK-EFVEAC  279 (604)
Q Consensus       204 ~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~~-~~~~~~--~~s~~l~-~Li~~~  279 (604)
                      +.+|+.|+|||+.....++.+.|+|++|+--.+|.-|.+|-..  +......+..+. .+.+..  .....+. ++...|
T Consensus       390 ~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~~--P~~~~~~~g~~p~s~~L~~~~aw~~~~~~~~~~~~  467 (829)
T KOG0576|consen  390 AIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRSS--PPAVLPMIGNGPNSPMLTDKSAWSPVFHRDFPAPC  467 (829)
T ss_pred             CCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCCC--CccccCCCCCCCCccccchhhhcCcccccCCcccc
Confidence            8899999999999999999999999999988888888887554  233333322222 111111  1111122 477889


Q ss_pred             hccCCCCCCCHHHHhcChhhhhhh
Q psy1546         280 LNKDPENRPTAKELLKFPFIRKAK  303 (604)
Q Consensus       280 L~~dP~~RpT~~elL~hp~f~~~~  303 (604)
                      +..-|..|+..-.++.|.+|..+.
T Consensus       468 ~~g~P~~pkv~mgacfsKvfngCp  491 (829)
T KOG0576|consen  468 LNGLPPTPKVHMGACFSKVFNGCP  491 (829)
T ss_pred             cCCCCCCCcchhhHHHHHHhccCc
Confidence            999999999999999999997654

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.53  E-value=5.5e-07  Score=100.25  Aligned_cols=131  Identities=24%  Similarity=0.385  Sum_probs=86.8

Q ss_pred             eEEcccCcEEEEEEEECCCCcEEEEEEecchhhH---HHH------------------------------H------HHH
Q psy1546          63 ERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAE---DEI------------------------------E------DIQ  103 (604)
Q Consensus        63 ~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~---~~~------------------------------~------~l~  103 (604)
                      +.|+.++-|+||+|+... |+.||||+..+.-.+   ..+                              +      ++.
T Consensus       131 ~PiAsASIaQVH~A~L~s-G~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~  209 (517)
T COG0661         131 EPIASASIAQVHRAVLKS-GEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR  209 (517)
T ss_pred             CchhhhhHhhheeEEecC-CCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence            578999999999999764 999999997543211   011                              1      122


Q ss_pred             HHHHHHhhCCCCC-------CCe--------EEEEEEecCCCChhhH--hhcCCCcHHHHHHHHHHHHHHhHHhhhCCcc
Q psy1546         104 QEIMVLSQCDSPY-------GTK--------LWIIMEYLGGGSALDL--MKAGNFEEMHIAVILREVLKGLDYLHSERKL  166 (604)
Q Consensus       104 ~Ei~iL~~l~hp~-------~~~--------lyLVmEy~~ggsL~~~--l~~~~lse~~i~~i~~qIl~gL~yLHs~gIi  166 (604)
                      +|...+.++.+-+       +.+        -.|+|||++|--+.++  ++...++...+.....++.  +..+=..|++
T Consensus       210 ~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~~~~~~f--~~q~~~dgff  287 (517)
T COG0661         210 REAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGIDRKELAELLVRAF--LRQLLRDGFF  287 (517)
T ss_pred             HHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCCHHHHHHHHHHHH--HHHHHhcCcc
Confidence            3333333332111       122        2599999999998887  4555666444433222221  2233348999


Q ss_pred             ccccccceeEecCCCCeEEecccccccccC
Q psy1546         167 HRDIKAANVLLSEMGDVKLADFGVAGTLTN  196 (604)
Q Consensus       167 HrDLKp~NILl~~~g~vKL~DFGlA~~~~~  196 (604)
                      |.|.+|.||++..+|.+.+.|||+...+..
T Consensus       288 HaDpHpGNi~v~~~g~i~~lDfGi~g~l~~  317 (517)
T COG0661         288 HADPHPGNILVRSDGRIVLLDFGIVGRLDP  317 (517)
T ss_pred             ccCCCccceEEecCCcEEEEcCcceecCCH
Confidence            999999999999999999999999876653

>PRK09902 hypothetical protein; Provisional

Probab=98.46  E-value=1.6e-06  Score=85.58  Aligned_cols=126  Identities=13%  Similarity=0.101  Sum_probs=93.5

Q ss_pred             cccCcEEEEEEEECCCCcEEEEEEecchhh-----HHHHHHHHHHHHHHhhCCCCC----------------CCeEEEEE
Q psy1546          66 GKGSFGEVFKGIDNRTQQVVAIKIIDLEEA-----EDEIEDIQQEIMVLSQCDSPY----------------GTKLWIIM  124 (604)
Q Consensus        66 G~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~-----~~~~~~l~~Ei~iL~~l~hp~----------------~~~lyLVm  124 (604)
                      |+||.+-|+.....  |+.|=||.-...-.     ..-...+.+|+..|.+|..-.                ..+-+||+
T Consensus        27 ~rgG~SgV~r~~~~--g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT  104 (216)
T PRK09902         27 RRNGMSGVQCVERN--GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT  104 (216)
T ss_pred             CCCCcceEEEEEeC--CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence            67999999997644  34677887531100     112356888888888764321                22357999


Q ss_pred             EecC-CCChhhHhhcCC---CcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCC--eEEeccccccc
Q psy1546         125 EYLG-GGSALDLMKAGN---FEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGD--VKLADFGVAGT  193 (604)
Q Consensus       125 Ey~~-ggsL~~~l~~~~---lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~--vKL~DFGlA~~  193 (604)
                      |-++ --+|.+++....   .++.....++.+|+..|.-||+.|+.|+|+-+.|||++.+|.  |+++||.-++.
T Consensus       105 e~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~  179 (216)
T PRK09902        105 EDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR  179 (216)
T ss_pred             EeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence            9774 357888886644   466777789999999999999999999999999999986677  99999987643

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.38  E-value=3.5e-06  Score=83.60  Aligned_cols=124  Identities=15%  Similarity=0.172  Sum_probs=81.2

Q ss_pred             ceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHH--HHHH------HHHHHHHHhhC-----CCCC---------
Q psy1546          59 FTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAED--EIED------IQQEIMVLSQC-----DSPY---------  116 (604)
Q Consensus        59 y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~--~~~~------l~~Ei~iL~~l-----~hp~---------  116 (604)
                      |.+.+++-......|.+..  -.|+.+++|.........  .+..      ..+++..+..+     ..++         
T Consensus        33 ~~~~kv~k~~~r~~ValIe--i~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ekk  110 (229)
T PF06176_consen   33 YKIIKVFKNTKRNYVALIE--IDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAEKK  110 (229)
T ss_pred             ceEEEeecCCCccEEEEEE--ECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeeeee
Confidence            6666777776666777664  446889999875433211  1111      12223222222     2221         


Q ss_pred             ----CCeEEEEEEecCCCChhhHhhcCCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccc
Q psy1546         117 ----GTKLWIIMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAG  192 (604)
Q Consensus       117 ----~~~lyLVmEy~~ggsL~~~l~~~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~  192 (604)
                          ....+|||||++|..|.++..   +++    .+...|.++|.-||..|++|+|.+|.|+++++ +.++++||+..+
T Consensus       111 ~~~~~~~~~ll~EYIeG~~l~d~~~---i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~-~~i~iID~~~k~  182 (229)
T PF06176_consen  111 IFRYTSSYVLLMEYIEGVELNDIED---IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSN-NGIRIIDTQGKR  182 (229)
T ss_pred             eccceeEEEEEEEEecCeecccchh---cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEEC-CcEEEEECcccc
Confidence                233458999999998877642   222    24456778899999999999999999999996 459999998764

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.32  E-value=5.3e-06  Score=83.28  Aligned_cols=131  Identities=19%  Similarity=0.205  Sum_probs=91.9

Q ss_pred             eEEcccCcEEEEEEEECCCCcEEEEEEecchhhHH---------------------HHHH--HHHHHHHHhhCCCC----
Q psy1546          63 ERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAED---------------------EIED--IQQEIMVLSQCDSP----  115 (604)
Q Consensus        63 ~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~---------------------~~~~--l~~Ei~iL~~l~hp----  115 (604)
                      -.|..|--+.||+|.. ..+..||||++.......                     .+..  ...|+.-|+++..-    
T Consensus        54 g~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrv  132 (268)
T COG1718          54 GCISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRV  132 (268)
T ss_pred             eeecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCC
Confidence            3677888899999974 467899999985432210                     0001  23566667665422    


Q ss_pred             -C---CCeEEEEEEecCCC-ChhhHhhcCCCcHHHHHHHHHHHHHHhHHhhh-CCccccccccceeEecCCCCeEEeccc
Q psy1546         116 -Y---GTKLWIIMEYLGGG-SALDLMKAGNFEEMHIAVILREVLKGLDYLHS-ERKLHRDIKAANVLLSEMGDVKLADFG  189 (604)
Q Consensus       116 -~---~~~lyLVmEy~~gg-sL~~~l~~~~lse~~i~~i~~qIl~gL~yLHs-~gIiHrDLKp~NILl~~~g~vKL~DFG  189 (604)
                       -   ..+-.|||||++.. .-.-.|+.-.+...++..+..++++.+.-|-. .++||+||..-|||+. ++.+.|+|||
T Consensus       133 P~Pi~~~~nVLvMEfIg~~g~pAP~LkDv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~~~p~iID~~  211 (268)
T COG1718         133 PEPIAFRNNVLVMEFIGDDGLPAPRLKDVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-DGEPYIIDVS  211 (268)
T ss_pred             CCceeecCCeEEEEeccCCCCCCCCcccCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-CCeEEEEECc
Confidence             1   12236999999543 33334555455555788888999999998876 8999999999999999 7999999999


Q ss_pred             cccccc
Q psy1546         190 VAGTLT  195 (604)
Q Consensus       190 lA~~~~  195 (604)
                      -|....
T Consensus       212 QaV~~~  217 (268)
T COG1718         212 QAVTID  217 (268)
T ss_pred             cccccC
Confidence            885443

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.29  E-value=6.8e-06  Score=80.99  Aligned_cols=126  Identities=22%  Similarity=0.319  Sum_probs=74.0

Q ss_pred             eeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCC-----C----------CCeEEEEEEe
Q psy1546          62 QERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSP-----Y----------GTKLWIIMEY  126 (604)
Q Consensus        62 ~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp-----~----------~~~lyLVmEy  126 (604)
                      ++.|+.|..+.||++....  ..+++|+....   .....+.+|..+++.+...     .          ....|++|++
T Consensus         2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~---~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~   76 (239)
T PF01636_consen    2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPP---DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEY   76 (239)
T ss_dssp             EEEEEESSSSEEEEEEETT--SEEEEEEESSH---HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEE
T ss_pred             CccCCCCCeeeEEEEEECC--cEEEEEEeCCC---CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEE
Confidence            4679999999999998664  48999998655   2335566777666654321     1          2235799999


Q ss_pred             cCCCChhh----------------Hhh---cC-----CCcHHH------HHH---H------------HHHHHH-HhHHh
Q psy1546         127 LGGGSALD----------------LMK---AG-----NFEEMH------IAV---I------------LREVLK-GLDYL  160 (604)
Q Consensus       127 ~~ggsL~~----------------~l~---~~-----~lse~~------i~~---i------------~~qIl~-gL~yL  160 (604)
                      ++|..+..                .+.   ..     .+....      ...   .            ...+.. .+..+
T Consensus        77 i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (239)
T PF01636_consen   77 IPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQEL  156 (239)
T ss_dssp             ESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHH
T ss_pred             eccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHH
Confidence            99987776                110   00     000000      000   0            011222 23333


Q ss_pred             h-------hCCccccccccceeEec-CCCCeEEecccccc
Q psy1546         161 H-------SERKLHRDIKAANVLLS-EMGDVKLADFGVAG  192 (604)
Q Consensus       161 H-------s~gIiHrDLKp~NILl~-~~g~vKL~DFGlA~  192 (604)
                      +       ...++|+|+.|.|||++ .++.+.|+||+.+.
T Consensus       157 ~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~  196 (239)
T PF01636_consen  157 EALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG  196 (239)
T ss_dssp             HHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred             HhhhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence            3       24589999999999999 66667899999873

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>KOG1035|consensus

Probab=98.23  E-value=6.4e-06  Score=96.71  Aligned_cols=194  Identities=24%  Similarity=0.355  Sum_probs=137.0

Q ss_pred             HHHHHHHHHHHHHhhCCCCCCCeEE--------------EEEEecCCCChhhHhhc-CCCcHHHHHHHHHHHHHHhHHhh
Q psy1546          97 DEIEDIQQEIMVLSQCDSPYGTKLW--------------IIMEYLGGGSALDLMKA-GNFEEMHIAVILREVLKGLDYLH  161 (604)
Q Consensus        97 ~~~~~l~~Ei~iL~~l~hp~~~~ly--------------LVmEy~~ggsL~~~l~~-~~lse~~i~~i~~qIl~gL~yLH  161 (604)
                      .++....-|+..+..+.|++.+.+|              +..|+|...++...+.. +.++...++.+..++++||.|+|
T Consensus       224 ~~i~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h  303 (1351)
T KOG1035|consen  224 KEIQTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLH  303 (1351)
T ss_pred             HHHHHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHH
Confidence            3455566788889999999876654              33456666666666655 67888889999999999999999


Q ss_pred             hCCccccccccc---eeEecCCCCeEEe--cccccccccCCCCCCcccccCCCCCChHHhhcCCCCCc--chhhhHHHHH
Q psy1546         162 SERKLHRDIKAA---NVLLSEMGDVKLA--DFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSK--ADIWSLGITA  234 (604)
Q Consensus       162 s~gIiHrDLKp~---NILl~~~g~vKL~--DFGlA~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~--sDVwSLGviL  234 (604)
                      +....|.-|...   +..++..+.+.+.  ||+..+.+.+..... ....+..|.++|......++.+  .|+|++|..+
T Consensus       304 ~~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~-~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~  382 (1351)
T KOG1035|consen  304 SLSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSF-SDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLL  382 (1351)
T ss_pred             HhccceeEEecccccccccCccceeecchhhhcccccCCCcccch-hhcCccccccccccccccchhhhhhHHHHHHHHH
Confidence            997666666555   4444556667776  998887665444332 3344566778888876666654  6999999999


Q ss_pred             HHHHhCCCCCCCCChhhHhhhcCCCCCCCCCccchHHHHHHHHHHhccCCCCCCCHHHHhcChhhhh
Q psy1546         235 IELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPENRPTAKELLKFPFIRK  301 (604)
Q Consensus       235 ~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~RpT~~elL~hp~f~~  301 (604)
                      ..+..|..+-.....          ....++........+++.+|+..++++|+++.+++.|+|.+.
T Consensus       383 ~~~~~~~~i~~~~~~----------~~~~l~~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~f~~~  439 (1351)
T KOG1035|consen  383 LQLSQGEDISEKSAV----------PVSLLDVLSTSELLDALPKCLDEDSEERLSALELLTHPFLRF  439 (1351)
T ss_pred             hhhhhcCcccccccc----------hhhhhccccchhhhhhhhhhcchhhhhccchhhhhhchhccc
Confidence            999887654211100          001111122226788999999999999999999999999863

>KOG1235|consensus

Probab=98.12  E-value=2.3e-05  Score=87.40  Aligned_cols=131  Identities=21%  Similarity=0.241  Sum_probs=86.0

Q ss_pred             eEEcccCcEEEEEEEECCCCcEEEEEEecchhhHH-----------------------------H-HHHHHHHHHHH---
Q psy1546          63 ERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAED-----------------------------E-IEDIQQEIMVL---  109 (604)
Q Consensus        63 ~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~-----------------------------~-~~~l~~Ei~iL---  109 (604)
                      +.||.-+.|+||+|+.+. |+.||||+-.+.-...                             + .+.+..|+..+   
T Consensus       167 ~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA  245 (538)
T KOG1235|consen  167 EPIAAASLAQVHRARLKN-GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA  245 (538)
T ss_pred             chhhhcchhheEEEEecC-CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence            579999999999998765 9999999964321110                             0 01122222211   


Q ss_pred             -------hhCCCCC------CCeE--------EEEEEecCCCChhhH--hhcCCCcHHHHHHHHHHHHHHhHHhhhCCcc
Q psy1546         110 -------SQCDSPY------GTKL--------WIIMEYLGGGSALDL--MKAGNFEEMHIAVILREVLKGLDYLHSERKL  166 (604)
Q Consensus       110 -------~~l~hp~------~~~l--------yLVmEy~~ggsL~~~--l~~~~lse~~i~~i~~qIl~gL~yLHs~gIi  166 (604)
                             +.+.|-.      +.++        .|+||||+|.-+.++  |++..++...+...+.++..-+  |=..|++
T Consensus       246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~~~gi~~~~i~~~l~~~~~~q--If~~Gff  323 (538)
T KOG1235|consen  246 KNAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAIDKRGISPHDILNKLVEAYLEQ--IFKTGFF  323 (538)
T ss_pred             HhHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHHHHcCCCHHHHHHHHHHHHHHH--HHhcCCc
Confidence                   1122222      2222        599999999987764  5667777776655444433222  2346799


Q ss_pred             ccccccceeEecC----CCCeEEecccccccccC
Q psy1546         167 HRDIKAANVLLSE----MGDVKLADFGVAGTLTN  196 (604)
Q Consensus       167 HrDLKp~NILl~~----~g~vKL~DFGlA~~~~~  196 (604)
                      |+|=+|.||+++.    ++.+.|.|||+...+..
T Consensus       324 HaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~  357 (538)
T KOG1235|consen  324 HADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH  357 (538)
T ss_pred             cCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence            9999999999984    56899999999876643

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=97.97  E-value=9.6e-05  Score=74.26  Aligned_cols=121  Identities=20%  Similarity=0.251  Sum_probs=71.2

Q ss_pred             eEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCC-----CC-------CCeEEEEEEecCCC
Q psy1546          63 ERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDS-----PY-------GTKLWIIMEYLGGG  130 (604)
Q Consensus        63 ~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~h-----p~-------~~~lyLVmEy~~gg  130 (604)
                      ..||+|..+.||+.    .+..+++|+......   ...+.+|..+++.+..     |.       ...+.+|||+++|.
T Consensus         7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~~---~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~   79 (226)
T TIGR02172         7 TQTGEGGNGESYTH----KTGKWMLKLYNPGFD---KETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGK   79 (226)
T ss_pred             eeecCCCCcceeEe----cCCCEEEEeCCCCCC---HHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCc
Confidence            57899999999984    244678898765332   2345778888776542     21       23347899999886


Q ss_pred             C-hhhHhh---------------------cC---CCcHHH-HHHHHH----------HHHHH-hHHhh----hCCccccc
Q psy1546         131 S-ALDLMK---------------------AG---NFEEMH-IAVILR----------EVLKG-LDYLH----SERKLHRD  169 (604)
Q Consensus       131 s-L~~~l~---------------------~~---~lse~~-i~~i~~----------qIl~g-L~yLH----s~gIiHrD  169 (604)
                      . +...+.                     .-   ...... ...+..          .+... ..+|.    ...++|+|
T Consensus        80 ~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD  159 (226)
T TIGR02172        80 RSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGD  159 (226)
T ss_pred             cchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecC
Confidence            3 211110                     00   000000 000100          01111 11222    12468999


Q ss_pred             cccceeEecCCCCeEEeccccc
Q psy1546         170 IKAANVLLSEMGDVKLADFGVA  191 (604)
Q Consensus       170 LKp~NILl~~~g~vKL~DFGlA  191 (604)
                      +.|.||++++++ +.|+||+.+
T Consensus       160 ~~~~Nii~~~~~-~~iIDwe~a  180 (226)
T TIGR02172       160 FQIGNLITSGKG-TYWIDLGDF  180 (226)
T ss_pred             CCCCcEEEcCCC-cEEEechhc
Confidence            999999999888 999999987

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>KOG1826|consensus

Probab=97.90  E-value=2e-06  Score=102.53  Aligned_cols=201  Identities=11%  Similarity=0.044  Sum_probs=145.1

Q ss_pred             HHHHHHHHHHhhCCCCCCCe------------EEEEEEecCCCChhhHhhcC-----CCcHHHHHHHHHHHHHHhHHhhh
Q psy1546         100 EDIQQEIMVLSQCDSPYGTK------------LWIIMEYLGGGSALDLMKAG-----NFEEMHIAVILREVLKGLDYLHS  162 (604)
Q Consensus       100 ~~l~~Ei~iL~~l~hp~~~~------------lyLVmEy~~ggsL~~~l~~~-----~lse~~i~~i~~qIl~gL~yLHs  162 (604)
                      +.+..|...++...|+....            .|.+++||.+|.+...+-+|     .+.+.-+.....+.+.+..-+|+
T Consensus      1274 emll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls 1353 (2724)
T KOG1826|consen 1274 EMLLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILS 1353 (2724)
T ss_pred             HhhhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhh
Confidence            34445555566667765332            37899999999999988553     23333344444454777777775


Q ss_pred             C-C----ccccccccceeEecCCCCeEEecccccccccCCCCCCcccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHH
Q psy1546         163 E-R----KLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIEL  237 (604)
Q Consensus       163 ~-g----IiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eL  237 (604)
                      . +    .+|++||+-|.+|..+..+|++++|+.+.........+...+++.|+.|++...-.++.++|+|..|+.+|++
T Consensus      1354 ~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~r 1433 (2724)
T KOG1826|consen 1354 LTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLR 1433 (2724)
T ss_pred             cccCCccchhhhhhhhccceecCCcccccccccccccCchHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHH
Confidence            4 2    6999999999999999999999999998555555667778899999999999999999999999999999999


Q ss_pred             HhCCCCCCCCChhhHhhhcCCCCCCCCCccchHHHHHHHHHHhccCCCCCCCHHHHhcChhhh
Q psy1546         238 AKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPENRPTAKELLKFPFIR  300 (604)
Q Consensus       238 ltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~RpT~~elL~hp~f~  300 (604)
                      ..|..+|-..........+.....-.++.-.|.+.......+|-.....||.-..++.-+.|-
T Consensus      1434 s~~n~~fi~flq~~Lkgiidn~tf~sIe~l~pgdaNve~~~~Ll~K~~~rp~q~isls~d~~a 1496 (2724)
T KOG1826|consen 1434 SDGNAYFIFFLQPALKGIIDNHTFFSIEKLKPGDANVEALHRLLWKYMERPGQYISLSRDHFA 1496 (2724)
T ss_pred             hcccHHHHHHHHHHHcCcccccccccccccCCCcccHHHHHHHHHHhhhcchhhhhccccccc
Confidence            999888765544444444444444444444455555555555666667888888887766653

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=97.89  E-value=7.9e-05  Score=71.29  Aligned_cols=123  Identities=25%  Similarity=0.311  Sum_probs=87.4

Q ss_pred             ceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCC-eE------EEEEEecCCCC
Q psy1546          59 FTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGT-KL------WIIMEYLGGGS  131 (604)
Q Consensus        59 y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~-~l------yLVmEy~~ggs  131 (604)
                      ..+.+.||+|.+|.||+|.+.  |..+|+|+-..+.   ....+..|.++|..+...... ++      ++.|||+.|-.
T Consensus        24 ~~v~~~L~KG~~s~Vyl~~~~--~~~~a~Kvrr~ds---~r~~l~kEakiLeil~g~~~~p~vy~yg~~~i~me~i~G~~   98 (201)
T COG2112          24 LRVEKELAKGTTSVVYLGEWR--GGEVALKVRRRDS---PRRNLEKEAKILEILAGEGVTPEVYFYGEDFIRMEYIDGRP   98 (201)
T ss_pred             hhhhhhhhcccccEEEEeecc--CceEEEEEecCCc---chhhHHHHHHHHHHhhhcCCCceEEEechhhhhhhhhcCcc
Confidence            355678999999999999866  6689999865443   336678899988888766532 23      37799999988


Q ss_pred             hhhHhhcCCCcHHHHHHHHHHHHHHhHHhhhCCccccccc-c-ceeEecCCCCeEEeccccccc
Q psy1546         132 ALDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIK-A-ANVLLSEMGDVKLADFGVAGT  193 (604)
Q Consensus       132 L~~~l~~~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLK-p-~NILl~~~g~vKL~DFGlA~~  193 (604)
                      |..+-..+  +..+    +..+++.-.-|-..||-|+.|. | .||++. ++.+.|+||..|+.
T Consensus        99 L~~~~~~~--~rk~----l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~-~~~~~iIDFd~At~  155 (201)
T COG2112          99 LGKLEIGG--DRKH----LLRVLEKAYKLDRLGIEHGELSRPWKNVLVN-DRDVYIIDFDSATF  155 (201)
T ss_pred             hhhhhhcc--cHHH----HHHHHHHHHHHHHhccchhhhcCCceeEEec-CCcEEEEEccchhh
Confidence            87766543  2222    3345555455667799999886 3 455554 46999999999853

>PLN02876 acyl-CoA dehydrogenase

Probab=97.71  E-value=0.00023  Score=84.57  Aligned_cols=72  Identities=18%  Similarity=0.165  Sum_probs=48.9

Q ss_pred             eeeEEcccCcEEEEEEEECCCC--cEEEEEEecchhhHHHHHHHHHHHHHHhhCC-CCCC---------------CeEEE
Q psy1546          61 KQERIGKGSFGEVFKGIDNRTQ--QVVAIKIIDLEEAEDEIEDIQQEIMVLSQCD-SPYG---------------TKLWI  122 (604)
Q Consensus        61 i~~~LG~G~fG~Vy~a~~~~t~--~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~-hp~~---------------~~lyL  122 (604)
                      ..+.|+.|.+..+|+......+  ..+++|+............+.+|+.+|+.+. |.+.               ...|+
T Consensus        42 ~v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~fl  121 (822)
T PLN02876         42 KVSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFY  121 (822)
T ss_pred             eEEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceE
Confidence            3577899999999998765432  4678887654332222356788999998885 4431               23579


Q ss_pred             EEEecCCCCh
Q psy1546         123 IMEYLGGGSA  132 (604)
Q Consensus       123 VmEy~~ggsL  132 (604)
                      ||||++|..+
T Consensus       122 VME~v~G~~~  131 (822)
T PLN02876        122 IMEYLEGRIF  131 (822)
T ss_pred             EEEecCCccc
Confidence            9999988653

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=97.70  E-value=0.00019  Score=72.38  Aligned_cols=28  Identities=18%  Similarity=0.143  Sum_probs=25.6

Q ss_pred             CccccccccceeEecCCCCeEEeccccc
Q psy1546         164 RKLHRDIKAANVLLSEMGDVKLADFGVA  191 (604)
Q Consensus       164 gIiHrDLKp~NILl~~~g~vKL~DFGlA  191 (604)
                      .++|+|+.|.|||+++++.+.|+||+.|
T Consensus       164 ~l~HgD~~~~Nil~~~~~~~~iIDwe~a  191 (244)
T cd05150         164 VVTHGDACLPNIIVDPGKFSGFIDLGRL  191 (244)
T ss_pred             EEECCCCCCccEEEeCCcEEEEEEcccc
Confidence            4899999999999999777899999987

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=97.52  E-value=0.00059  Score=68.60  Aligned_cols=28  Identities=25%  Similarity=0.381  Sum_probs=24.6

Q ss_pred             CccccccccceeEecCCCCeEEeccccc
Q psy1546         164 RKLHRDIKAANVLLSEMGDVKLADFGVA  191 (604)
Q Consensus       164 gIiHrDLKp~NILl~~~g~vKL~DFGlA  191 (604)
                      +++|+|+.+.|||++.++..-|+||+.|
T Consensus       165 ~l~HGD~~~~Nvlv~~~~i~giIDw~~a  192 (235)
T cd05155         165 VWFHGDLAPGNLLVQDGRLSAVIDFGCL  192 (235)
T ss_pred             eEEeCCCCCCcEEEECCCEEEEEeCccc
Confidence            5899999999999987655679999987

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=97.51  E-value=0.0014  Score=63.95  Aligned_cols=90  Identities=23%  Similarity=0.214  Sum_probs=71.8

Q ss_pred             HHHHHHHhhCCCC-CCCeE------EEEEEecCCCChhh----HhhcCCCcHHHHHHHHHHHHHHhHHhhh---CCcccc
Q psy1546         103 QQEIMVLSQCDSP-YGTKL------WIIMEYLGGGSALD----LMKAGNFEEMHIAVILREVLKGLDYLHS---ERKLHR  168 (604)
Q Consensus       103 ~~Ei~iL~~l~hp-~~~~l------yLVmEy~~ggsL~~----~l~~~~lse~~i~~i~~qIl~gL~yLHs---~gIiHr  168 (604)
                      ..|..+|+.+.+. +..++      ++|.||+..+++..    +.+-...++..+..|+.++++.+.+|+.   ..+...
T Consensus         7 ~~E~lll~~l~~~~~~pk~lG~CG~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~~~lc   86 (188)
T PF12260_consen    7 NNEPLLLQLLQGSEPFPKLLGSCGRFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGFFYLC   86 (188)
T ss_pred             ccHHHHHHHcCCCCCCCCeeeECCCEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCcEEEe
Confidence            3577888888773 34444      58999998776642    2222456899999999999999999987   458899


Q ss_pred             ccccceeEecCCCCeEEecccccc
Q psy1546         169 DIKAANVLLSEMGDVKLADFGVAG  192 (604)
Q Consensus       169 DLKp~NILl~~~g~vKL~DFGlA~  192 (604)
                      |++++|+-|+++|.+|++|...+.
T Consensus        87 Dv~~~nfgv~~~~~lk~iDld~v~  110 (188)
T PF12260_consen   87 DVSPDNFGVNDDGRLKLIDLDDVF  110 (188)
T ss_pred             ecchHHeEEeCCCcEEEEechhcc
Confidence            999999999999999999999874

Proteins in this uncharacterised family are described as transmembrane proteins.

>TIGR02721 ycfN_thiK thiamine kinase

Probab=97.44  E-value=0.00038  Score=70.85  Aligned_cols=123  Identities=19%  Similarity=0.209  Sum_probs=70.8

Q ss_pred             EcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCC----CCC---eEEEEEEecCCCChhhH--
Q psy1546          65 IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSP----YGT---KLWIIMEYLGGGSALDL--  135 (604)
Q Consensus        65 LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp----~~~---~lyLVmEy~~ggsL~~~--  135 (604)
                      +..|-.+.+|+..  .+++.+++|+.......-. -...+|..+++.+...    ...   .-++||||++|..+...  
T Consensus         4 ~~~G~tn~~y~~~--~~~~~~vlR~~~~~~~~~~-~~r~~E~~~l~~l~~~g~~P~~i~~~~~~~v~e~i~G~~~~~~~~   80 (256)
T TIGR02721         4 LSGGLTNRSWRIE--HPGISFVWRPQSPVCKALG-VDRQREYQILQALSALGLAPKPILVNEHWLLVEWLEGEVITLDQF   80 (256)
T ss_pred             CCCcCcCCeEEEE--eCCccEEEeeCCccccccc-CcHHHHHHHHHHHHhcCCCCceEEEeCCEEEEEeccCcccccccc
Confidence            5667788999886  4466788998643321110 1346777777776532    111   12589999998765321  


Q ss_pred             ------------hh---cC-----CCcHH-HHHHHHHHH---------HHHhHHhhh--------CCccccccccceeEe
Q psy1546         136 ------------MK---AG-----NFEEM-HIAVILREV---------LKGLDYLHS--------ERKLHRDIKAANVLL  177 (604)
Q Consensus       136 ------------l~---~~-----~lse~-~i~~i~~qI---------l~gL~yLHs--------~gIiHrDLKp~NILl  177 (604)
                                  +.   .-     .++.. .+..+..++         ...+..+-.        ..++|+|+.|.|||+
T Consensus        81 ~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~Nil~  160 (256)
T TIGR02721        81 VALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYNLVV  160 (256)
T ss_pred             cCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCcEEE
Confidence                        11   00     11111 111221111         111222211        248999999999999


Q ss_pred             cCCCCeEEeccccc
Q psy1546         178 SEMGDVKLADFGVA  191 (604)
Q Consensus       178 ~~~g~vKL~DFGlA  191 (604)
                      ++++ +.|+||+.|
T Consensus       161 ~~~~-~~lIDwE~a  173 (256)
T TIGR02721       161 TPQG-LKLIDWEYA  173 (256)
T ss_pred             eCCC-CEEEecccc
Confidence            9877 899999988

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=97.33  E-value=0.0009  Score=66.90  Aligned_cols=69  Identities=19%  Similarity=0.249  Sum_probs=44.1

Q ss_pred             eeEEcccCcEEEEEEEECC-CCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCC-CCeE------EEEEEecCCCCh
Q psy1546          62 QERIGKGSFGEVFKGIDNR-TQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPY-GTKL------WIIMEYLGGGSA  132 (604)
Q Consensus        62 ~~~LG~G~fG~Vy~a~~~~-t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~-~~~l------yLVmEy~~ggsL  132 (604)
                      ++.|..|-...||++.... .++.|++|+......  ..-...+|+.++..+.... ..++      .+||||++|.++
T Consensus         3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~--~~~d~~~E~~~~~~l~~~gl~P~v~~~~~~~~l~e~i~G~~l   79 (235)
T cd05157           3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTE--LIIDRERELRIHKLLSKHGLAPKLYATFQNGLIYEFIPGRTL   79 (235)
T ss_pred             EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCcc--ceecHHHHHHHHHHHHhCCCCCeEEEEeCCcEEEEeeCCCcC
Confidence            4568888889999986443 356788998754321  1123346777777764321 1222      489999998765

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>KOG2268|consensus

Probab=97.32  E-value=0.00022  Score=74.24  Aligned_cols=128  Identities=13%  Similarity=0.213  Sum_probs=91.8

Q ss_pred             cceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchh--------h-----------HHHHH--HHHHHHHHHhhCCCC-
Q psy1546          58 IFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE--------A-----------EDEIE--DIQQEIMVLSQCDSP-  115 (604)
Q Consensus        58 ~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~--------~-----------~~~~~--~l~~Ei~iL~~l~hp-  115 (604)
                      .+.+++.||-|.-+.||.+-+. .|...++|+-..-.        .           .-.+.  ...+|...|+.|... 
T Consensus        93 v~svGnqIGVGKESDIY~v~d~-~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~g  171 (465)
T KOG2268|consen   93 VESVGNQIGVGKESDIYVVADE-EGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERG  171 (465)
T ss_pred             hhhhccccccccccceEEEecC-CCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcC
Confidence            4788899999999999999764 47788898632110        0           00111  234777777776431 


Q ss_pred             C-------CCeEEEEEEecCCCChhhHhhcCCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecc
Q psy1546         116 Y-------GTKLWIIMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADF  188 (604)
Q Consensus       116 ~-------~~~lyLVmEy~~ggsL~~~l~~~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DF  188 (604)
                      +       ..+-++|||++.|..|...-.-     ..+..+...++.-+--|-.+|+||+|..--||+|++++.++++||
T Consensus       172 fpVPkpiD~~RH~Vvmelv~g~Pl~~v~~v-----~d~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd~~i~vIDF  246 (465)
T KOG2268|consen  172 FPVPKPIDHNRHCVVMELVDGYPLRQVRHV-----EDPPTLYDDLMGLIVRLANHGLIHGDFNEFNIMVKDDDKIVVIDF  246 (465)
T ss_pred             CCCCCcccccceeeHHHhhcccceeeeeec-----CChHHHHHHHHHHHHHHHHcCceecccchheeEEecCCCEEEeec
Confidence            1       3456899999988877655322     223445556666677888999999999999999999999999999


Q ss_pred             ccc
Q psy1546         189 GVA  191 (604)
Q Consensus       189 GlA  191 (604)
                      --+
T Consensus       247 PQm  249 (465)
T KOG2268|consen  247 PQM  249 (465)
T ss_pred             hHh
Confidence            644

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.23  E-value=0.0014  Score=67.87  Aligned_cols=124  Identities=16%  Similarity=0.137  Sum_probs=73.4

Q ss_pred             eeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCC---C--C-------------CCeEEEE
Q psy1546          62 QERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDS---P--Y-------------GTKLWII  123 (604)
Q Consensus        62 ~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~h---p--~-------------~~~lyLV  123 (604)
                      .+.|..|....+|+....  +..+++|+.....    ...+..|+.++..+.+   |  .             ....++|
T Consensus        19 i~~i~~G~~n~~y~v~~~--~~~~vLr~~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l   92 (296)
T cd05153          19 FEGISAGIENTNYFVTTD--SGRYVLTLFEKVS----AEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAAL   92 (296)
T ss_pred             eecccCccccceEEEEeC--CCcEEEEEcCCCC----hHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEE
Confidence            456788888899998643  4468899876421    2344555555555422   1  0             1234799


Q ss_pred             EEecCCCChhh----Hh----h------c--CCCc----------HHHH--H--------HHHHHHHHHhHHhhh-----
Q psy1546         124 MEYLGGGSALD----LM----K------A--GNFE----------EMHI--A--------VILREVLKGLDYLHS-----  162 (604)
Q Consensus       124 mEy~~ggsL~~----~l----~------~--~~ls----------e~~i--~--------~i~~qIl~gL~yLHs-----  162 (604)
                      ++|++|..+..    .+    +      .  ..+.          +...  .        .....+..++.++..     
T Consensus        93 ~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~  172 (296)
T cd05153          93 VEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSD  172 (296)
T ss_pred             EEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhc
Confidence            99999876532    00    0      0  0010          0000  0        011112333444443     


Q ss_pred             --CCccccccccceeEecCCCCeEEeccccc
Q psy1546         163 --ERKLHRDIKAANVLLSEMGDVKLADFGVA  191 (604)
Q Consensus       163 --~gIiHrDLKp~NILl~~~g~vKL~DFGlA  191 (604)
                        .++||+|+.|.|||++.++.+.|+||+.+
T Consensus       173 ~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a  203 (296)
T cd05153         173 LPRGVIHADLFRDNVLFDGDELSGVIDFYFA  203 (296)
T ss_pred             CCCcCCccCcCcccEEEeCCceEEEeehhhh
Confidence              47999999999999998777789999987

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=97.20  E-value=0.0033  Score=65.87  Aligned_cols=126  Identities=19%  Similarity=0.201  Sum_probs=72.7

Q ss_pred             eeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCC-----CC-------------CCeEEE
Q psy1546          61 KQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDS-----PY-------------GTKLWI  122 (604)
Q Consensus        61 i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~h-----p~-------------~~~lyL  122 (604)
                      ..+.|+.|-...||++.. . +..+++|+.......   ..+..|+.++..|..     |.             ..+.|+
T Consensus        26 ~i~~~~~G~~n~~y~v~t-~-~~~~vLK~~~~~~~~---~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~  100 (307)
T TIGR00938        26 SLKGIAEGVENSNYLLTT-D-VGRYILTLYEKRVKA---EELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPAC  100 (307)
T ss_pred             eccccCCccccceEEEEe-C-CCcEEEEEecCCCCH---HHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEE
Confidence            356677887789999864 2 335788987543212   223344555544421     11             234579


Q ss_pred             EEEecCCCChhh----H-------h---hc--CCCc--------HHHHHH---------------HHHHHHHHhHHhh--
Q psy1546         123 IMEYLGGGSALD----L-------M---KA--GNFE--------EMHIAV---------------ILREVLKGLDYLH--  161 (604)
Q Consensus       123 VmEy~~ggsL~~----~-------l---~~--~~ls--------e~~i~~---------------i~~qIl~gL~yLH--  161 (604)
                      ||||++|..+..    .       +   ..  ..++        ......               ....+...++++.  
T Consensus       101 l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~  180 (307)
T TIGR00938       101 LVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKF  180 (307)
T ss_pred             EEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhh
Confidence            999998865321    0       0   00  1110        000000               0112233455553  


Q ss_pred             -----hCCccccccccceeEecCCCCeEEeccccc
Q psy1546         162 -----SERKLHRDIKAANVLLSEMGDVKLADFGVA  191 (604)
Q Consensus       162 -----s~gIiHrDLKp~NILl~~~g~vKL~DFGlA  191 (604)
                           ..++||+|+++.||+++.++.+.|+||+.+
T Consensus       181 ~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~  215 (307)
T TIGR00938       181 WPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFA  215 (307)
T ss_pred             hhhcCCCccCCCCCCcCcEEEECCceEEEeecccc
Confidence                 258999999999999998877789999987

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=97.19  E-value=0.0023  Score=62.94  Aligned_cols=128  Identities=20%  Similarity=0.203  Sum_probs=75.6

Q ss_pred             ccceeeeEEcccCc-EEEEEEEECCCCcEEEEEEec---chhh-------H----------HHHHHHHHHHHHHhhCCCC
Q psy1546          57 LIFTKQERIGKGSF-GEVFKGIDNRTQQVVAIKIID---LEEA-------E----------DEIEDIQQEIMVLSQCDSP  115 (604)
Q Consensus        57 ~~y~i~~~LG~G~f-G~Vy~a~~~~t~~~vAVK~i~---~~~~-------~----------~~~~~l~~Ei~iL~~l~hp  115 (604)
                      ..++.++.||.|.- |.||+++..  |+.||||++.   ....       .          ....-+..|.....+|+.-
T Consensus        37 ~~I~flefLg~g~~~~~V~kv~I~--g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~  114 (207)
T PF13095_consen   37 DDIEFLEFLGHGSHDGYVFKVEID--GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA  114 (207)
T ss_pred             CcEeeeeecCCCCceeEEEEEEEC--CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence            45889999999999 999999754  7899999931   1100       0          1123455666666655544


Q ss_pred             CC-----CeE--EEEEEe---c----------CCCChhhHhhc-CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccce
Q psy1546         116 YG-----TKL--WIIMEY---L----------GGGSALDLMKA-GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAAN  174 (604)
Q Consensus       116 ~~-----~~l--yLVmEy---~----------~ggsL~~~l~~-~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~N  174 (604)
                      +.     ++.  |+.+.-   +          .+..+..+++. ..-.......-+.+|++-|..+|..||+-+|+++.|
T Consensus       115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~~~~~~~~~~~~~dl~~~~k~gI~~~Dv~~~n  194 (207)
T PF13095_consen  115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDPPLQIRDIPQMLRDLKILHKLGIVPRDVKPRN  194 (207)
T ss_pred             cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCccccchhHHHHHHHHHHHHHHCCeeeccCcccc
Confidence            32     121  222211   0          00000000000 000001123346688888999999999999999999


Q ss_pred             eEecCCCCeEEeccccc
Q psy1546         175 VLLSEMGDVKLADFGVA  191 (604)
Q Consensus       175 ILl~~~g~vKL~DFGlA  191 (604)
                      ..     .=+|+|||.+
T Consensus       195 y~-----~G~lvDfs~~  206 (207)
T PF13095_consen  195 YR-----GGKLVDFSSS  206 (207)
T ss_pred             cc-----CCEEEecccC
Confidence            86     2389999864

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.19  E-value=0.0055  Score=66.63  Aligned_cols=70  Identities=20%  Similarity=0.149  Sum_probs=45.6

Q ss_pred             eeEEcccCcEEEEEEEECCCCcEEEEEEecch------hhHHHHHHHHHHHHHHhhCCC---CCCCe--------EEEEE
Q psy1546          62 QERIGKGSFGEVFKGIDNRTQQVVAIKIIDLE------EAEDEIEDIQQEIMVLSQCDS---PYGTK--------LWIIM  124 (604)
Q Consensus        62 ~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~------~~~~~~~~l~~Ei~iL~~l~h---p~~~~--------lyLVm  124 (604)
                      .+.||.|.+..||++.+...++.|+||.-...      ...-..++...|...|..+.-   ....+        -++||
T Consensus        31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D~~~~~lVM  110 (401)
T PRK09550         31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYDEELAVTVM  110 (401)
T ss_pred             eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEECCCCCEEEE
Confidence            36799999999999998654468999985321      111234566677777776421   12222        36999


Q ss_pred             EecCCCC
Q psy1546         125 EYLGGGS  131 (604)
Q Consensus       125 Ey~~ggs  131 (604)
                      ||+++..
T Consensus       111 E~L~~~~  117 (401)
T PRK09550        111 EDLSDHK  117 (401)
T ss_pred             ecCCCcc
Confidence            9997643

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=97.16  E-value=0.0038  Score=61.50  Aligned_cols=118  Identities=15%  Similarity=0.291  Sum_probs=77.9

Q ss_pred             eEEcccCcEEEEEEEECCCCcEEEEEEecchh---------------hHHHHHHHHHHHHHHhhCC------CCCCCeEE
Q psy1546          63 ERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE---------------AEDEIEDIQQEIMVLSQCD------SPYGTKLW  121 (604)
Q Consensus        63 ~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~---------------~~~~~~~l~~Ei~iL~~l~------hp~~~~ly  121 (604)
                      ..||+|+.=.||.--   .....+||+.....               .........+|+.....+.      +.++.++|
T Consensus         7 ~~i~~G~~R~cy~HP---~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~   83 (199)
T PF10707_consen    7 DLIAQGGERDCYQHP---DDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY   83 (199)
T ss_pred             cccccCCCceEEECC---CCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence            469999999999742   23345789986654               0112345556666555554      33344443


Q ss_pred             ----------EEEEecC------CCChhhHhhcCCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCC----
Q psy1546         122 ----------IIMEYLG------GGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMG----  181 (604)
Q Consensus       122 ----------LVmEy~~------ggsL~~~l~~~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g----  181 (604)
                                +|+|.+.      .-+|.++++.+.+++ .+.   ..+-+-.+||-+++|+.+||+|.||++...+    
T Consensus        84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~~~~~-~~~---~~L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~~~~  159 (199)
T PF10707_consen   84 GFVETNLGLGLVVELIRDADGNISPTLEDYLKEGGLTE-ELR---QALDEFKRYLLDHHIVIRDLNPHNIVVQRRDSGEF  159 (199)
T ss_pred             EEEecCCceEEEEEEEECCCCCcCccHHHHHHcCCccH-HHH---HHHHHHHHHHHHcCCeecCCCcccEEEEecCCCce
Confidence                      7788763      236888888888877 333   3344456688899999999999999996432    


Q ss_pred             CeEEec
Q psy1546         182 DVKLAD  187 (604)
Q Consensus       182 ~vKL~D  187 (604)
                      .+.|+|
T Consensus       160 ~lvlID  165 (199)
T PF10707_consen  160 RLVLID  165 (199)
T ss_pred             EEEEEe
Confidence            477777

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>PRK05231 homoserine kinase; Provisional

Probab=97.13  E-value=0.0049  Score=64.73  Aligned_cols=29  Identities=28%  Similarity=0.267  Sum_probs=25.4

Q ss_pred             CCccccccccceeEecCCCCeEEeccccc
Q psy1546         163 ERKLHRDIKAANVLLSEMGDVKLADFGVA  191 (604)
Q Consensus       163 ~gIiHrDLKp~NILl~~~g~vKL~DFGlA  191 (604)
                      .++||+|++|.|||++.+...-|+||+.+
T Consensus       187 ~~liHgD~~~~Nil~~~~~~~~iIDf~~~  215 (319)
T PRK05231        187 RGVIHADLFRDNVLFEGDRLSGFIDFYFA  215 (319)
T ss_pred             cccCCCCCCCCcEEEECCceEEEEecccc
Confidence            48999999999999997655689999987

>KOG2270|consensus

Probab=97.09  E-value=0.0062  Score=64.66  Aligned_cols=131  Identities=18%  Similarity=0.261  Sum_probs=90.8

Q ss_pred             eeeeEEcccCcEEEEEEEECCCCcEEEEEEecchh-----------------------hHHHHHH--HHHHHHHHhhCCC
Q psy1546          60 TKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE-----------------------AEDEIED--IQQEIMVLSQCDS  114 (604)
Q Consensus        60 ~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~-----------------------~~~~~~~--l~~Ei~iL~~l~h  114 (604)
                      .+.-.|..|--+.||.|.. .+|..+|||+++..-                       ....+-.  ...|+.-|.++..
T Consensus       147 ~inGCiSTGKEANVYHat~-~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~  225 (520)
T KOG2270|consen  147 EINGCISTGKEANVYHATE-EDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNN  225 (520)
T ss_pred             ecccccccCccceeEeeec-CCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHh
Confidence            3445677888899999974 567789999984221                       0111111  2356666666543


Q ss_pred             CC-----CC---eEEEEEEecCCC-ChhhHhhcCCCcHHHHHHHHHHHHHHhHHh-hhCCccccccccceeEecCCCCeE
Q psy1546         115 PY-----GT---KLWIIMEYLGGG-SALDLMKAGNFEEMHIAVILREVLKGLDYL-HSERKLHRDIKAANVLLSEMGDVK  184 (604)
Q Consensus       115 p~-----~~---~lyLVmEy~~gg-sL~~~l~~~~lse~~i~~i~~qIl~gL~yL-Hs~gIiHrDLKp~NILl~~~g~vK  184 (604)
                      ..     ..   .-.|||+|+... -..-.|+.-.++...+..+-.|++.-+.-| |..++||.||.--|+|+-+ |.++
T Consensus       226 aGIP~PePIlLk~hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Lyhd-G~ly  304 (520)
T KOG2270|consen  226 AGIPCPEPILLKNHVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLYHD-GKLY  304 (520)
T ss_pred             cCCCCCCceeeecceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheEEC-CEEE
Confidence            22     11   126999999532 233456667788778888888888888877 4569999999999999987 8999


Q ss_pred             Eecccccc
Q psy1546         185 LADFGVAG  192 (604)
Q Consensus       185 L~DFGlA~  192 (604)
                      |+|.+-+-
T Consensus       305 iIDVSQSV  312 (520)
T KOG2270|consen  305 IIDVSQSV  312 (520)
T ss_pred             EEEccccc
Confidence            99998663

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.07  E-value=0.0037  Score=65.10  Aligned_cols=69  Identities=19%  Similarity=0.257  Sum_probs=43.1

Q ss_pred             eEEcccCcEEEEEEEECC------CCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCC-CCeE------EEEEEecCC
Q psy1546          63 ERIGKGSFGEVFKGIDNR------TQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPY-GTKL------WIIMEYLGG  129 (604)
Q Consensus        63 ~~LG~G~fG~Vy~a~~~~------t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~-~~~l------yLVmEy~~g  129 (604)
                      +.|..|-...||++....      .++.|++|+.....  .......+|+.++..+.... ..++      .+|+||++|
T Consensus         4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~--~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~~~v~e~i~G   81 (302)
T cd05156           4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV--ELLIDRERELVVFARLSERNLGPKLYGIFPNGRIEEFIPS   81 (302)
T ss_pred             EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC--cceechHHHHHHHHHHHhCCCCCceEEEeCCCchhheeCC
Confidence            456777777999987543      25789999975432  12244567777776654321 1122      368999988


Q ss_pred             CChh
Q psy1546         130 GSAL  133 (604)
Q Consensus       130 gsL~  133 (604)
                      ..+.
T Consensus        82 ~~l~   85 (302)
T cd05156          82 RTLT   85 (302)
T ss_pred             CcCC
Confidence            7664

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>PRK10593 hypothetical protein; Provisional

Probab=96.63  E-value=0.024  Score=59.30  Aligned_cols=68  Identities=21%  Similarity=0.121  Sum_probs=44.6

Q ss_pred             eeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCC------CC----------CCeEEEE
Q psy1546          60 TKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDS------PY----------GTKLWII  123 (604)
Q Consensus        60 ~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~h------p~----------~~~lyLV  123 (604)
                      ...+.||.|..+.||.....  +..+.+|+.+...   ....+..|...|+.+..      |.          ...-|||
T Consensus        17 ~~~~~i~~G~~~~vy~~~~~--~~~~~~k~~~~~~---~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LV   91 (297)
T PRK10593         17 SRVECISEQPYAALWALYDS--QGNPMPLMARSFS---TPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLL   91 (297)
T ss_pred             heeeecCCccceeEEEEEcC--CCCEEEEEecccc---cchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEE
Confidence            34567999999999998643  2346778753311   12467778777776532      21          1235899


Q ss_pred             EEecCCCCh
Q psy1546         124 MEYLGGGSA  132 (604)
Q Consensus       124 mEy~~ggsL  132 (604)
                      ||+++|+++
T Consensus        92 mE~i~G~~~  100 (297)
T PRK10593         92 LERLRGVSV  100 (297)
T ss_pred             EeccCCEec
Confidence            999998765

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=96.60  E-value=0.0084  Score=63.69  Aligned_cols=28  Identities=29%  Similarity=0.506  Sum_probs=24.8

Q ss_pred             ccccccccceeEecC-CCCeEEecccccc
Q psy1546         165 KLHRDIKAANVLLSE-MGDVKLADFGVAG  192 (604)
Q Consensus       165 IiHrDLKp~NILl~~-~g~vKL~DFGlA~  192 (604)
                      ++|.||.+.|||+++ ++.++|+||+.|.
T Consensus       184 ~CHnDl~~~NiL~~~~~~~l~lID~EYag  212 (330)
T PLN02421        184 FAHNDLLSGNLMLNEDEGKLYFIDFEYGS  212 (330)
T ss_pred             EEECCCCcccEEEeCCCCcEEEEcccccC
Confidence            699999999999974 5789999999883

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=96.56  E-value=0.018  Score=60.82  Aligned_cols=28  Identities=18%  Similarity=0.328  Sum_probs=26.4

Q ss_pred             CccccccccceeEecCCCCeEEeccccc
Q psy1546         164 RKLHRDIKAANVLLSEMGDVKLADFGVA  191 (604)
Q Consensus       164 gIiHrDLKp~NILl~~~g~vKL~DFGlA  191 (604)
                      .++|+|+.+.||+|+..+-+-|+||+++
T Consensus       199 ~lvHGD~~~gNlii~~~~~~gVlDwe~~  226 (321)
T COG3173         199 VLVHGDYRPGNLIIDPGRPTGVLDWELA  226 (321)
T ss_pred             eeeeCCcccCCEEEeCCCeeEEEecccc
Confidence            4799999999999999888999999998

>KOG1093|consensus

Probab=96.42  E-value=0.0059  Score=67.18  Aligned_cols=80  Identities=28%  Similarity=0.328  Sum_probs=58.9

Q ss_pred             CcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCCCCC-----------CCCccchHHHHHHHHHHhccCCCCCCCHH
Q psy1546         223 SKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPP-----------QLTGNYTKQFKEFVEACLNKDPENRPTAK  291 (604)
Q Consensus       223 ~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~~~~-----------~~~~~~s~~l~~Li~~~L~~dP~~RpT~~  291 (604)
                      +++|||++|.++.++..|...|......+....+.+-...           .+.-.++..+.+++.+|+-..|..||...
T Consensus       110 pKsdVwsl~~i~~el~L~~~l~~~~~~s~~l~~i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~  189 (725)
T KOG1093|consen  110 PKSDVWSLGFIILELYLGISLEAELTESEYLEILLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPM  189 (725)
T ss_pred             cchhhhhHHHHHHHHHHhhHHHHHHHHHHHHHHHHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccchh
Confidence            4899999999999999998777666555544433221110           01112455677899999999999999999


Q ss_pred             HHhcChhhhhh
Q psy1546         292 ELLKFPFIRKA  302 (604)
Q Consensus       292 elL~hp~f~~~  302 (604)
                      ++.+++-|...
T Consensus       190 ~~~k~~i~~ev  200 (725)
T KOG1093|consen  190 ELSKRCSFTEV  200 (725)
T ss_pred             HHhcCccHHHH
Confidence            99999988765

>PLN02236 choline kinase

Probab=96.37  E-value=0.012  Score=62.92  Aligned_cols=129  Identities=16%  Similarity=0.162  Sum_probs=73.3

Q ss_pred             eeEEcccCcEEEEEEEECC----CCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCC-CCeE------EEEEEecCCC
Q psy1546          62 QERIGKGSFGEVFKGIDNR----TQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPY-GTKL------WIIMEYLGGG  130 (604)
Q Consensus        62 ~~~LG~G~fG~Vy~a~~~~----t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~-~~~l------yLVmEy~~gg  130 (604)
                      .+.|-.|-.-.+|++....    .++.|++|+..... . ..-...+|+.+++.+..-. ..++      ..|.||+++.
T Consensus        41 i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t-~-~~idR~~E~~~~~~l~~~gl~P~~~~~~~~g~v~efi~g~  118 (344)
T PLN02236         41 VIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGV-E-LFFDRDDEIRTFECMSRHGQGPRLLGRFPNGRVEEFIHAR  118 (344)
T ss_pred             EEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCC-C-eeechHHHHHHHHHHHHcCCCCceEEEECCceEEEeeCCC
Confidence            3456568888999986432    34689999875432 2 1122356777777654322 1111      2689999877


Q ss_pred             ChhhH--------------hh---cCC------Cc-HHHHHHHHHHH-----------------HHHhHHh--------h
Q psy1546         131 SALDL--------------MK---AGN------FE-EMHIAVILREV-----------------LKGLDYL--------H  161 (604)
Q Consensus       131 sL~~~--------------l~---~~~------ls-e~~i~~i~~qI-----------------l~gL~yL--------H  161 (604)
                      +|...              +.   ...      +. ...+..++.++                 ...+..|        +
T Consensus       119 ~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~~~  198 (344)
T PLN02236        119 TLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGDDQ  198 (344)
T ss_pred             CCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcccCC
Confidence            65421              00   000      11 12222232111                 1111111        1


Q ss_pred             hCCccccccccceeEecC-CCCeEEecccccc
Q psy1546         162 SERKLHRDIKAANVLLSE-MGDVKLADFGVAG  192 (604)
Q Consensus       162 s~gIiHrDLKp~NILl~~-~g~vKL~DFGlA~  192 (604)
                      ...++|+|+++.|||+++ ++.+.|+||..|.
T Consensus       199 ~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~  230 (344)
T PLN02236        199 EIGFCHNDLQYGNIMIDEETRAITIIDYEYAS  230 (344)
T ss_pred             CceEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence            235899999999999986 4689999999883

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=96.32  E-value=0.02  Score=61.30  Aligned_cols=66  Identities=18%  Similarity=0.213  Sum_probs=41.6

Q ss_pred             EEcccCcEEEEEEEECCCCcEEEEEEecch------hhHHHHHHHHHHHHHHhhCCC--C-CCCeE--------EEEEEe
Q psy1546          64 RIGKGSFGEVFKGIDNRTQQVVAIKIIDLE------EAEDEIEDIQQEIMVLSQCDS--P-YGTKL--------WIIMEY  126 (604)
Q Consensus        64 ~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~------~~~~~~~~l~~Ei~iL~~l~h--p-~~~~l--------yLVmEy  126 (604)
                      .||.|-...||++.+...++.|+||.-...      ...-...+...|...|+...-  | ...++        .+|||+
T Consensus         2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~D~e~~~~vMEd   81 (370)
T TIGR01767         2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHFDTEMAVTVMED   81 (370)
T ss_pred             cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEEccccceehHhh
Confidence            479999999999997544467999974321      112234555667777765432  2 22333        389999


Q ss_pred             cCC
Q psy1546         127 LGG  129 (604)
Q Consensus       127 ~~g  129 (604)
                      ++.
T Consensus        82 L~~   84 (370)
T TIGR01767        82 LSH   84 (370)
T ss_pred             Ccc
Confidence            954

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>KOG4025|consensus

Probab=96.29  E-value=0.0064  Score=56.63  Aligned_cols=61  Identities=23%  Similarity=0.375  Sum_probs=51.5

Q ss_pred             CcchhhhhHHHHHHHHHHhccccCCCCCCCCCCCCCCCcchHHHHHHHHHHHHhhCCCChHHHHHHHHHHhc--CcchHH
Q psy1546         503 RSPCLSFLIYPLISELQRRHHYTSNNRTSNSGADSSHKADAIEELKNAFDLAERSAPGISGQFVKEVVHKLL--PAMSEA  580 (604)
Q Consensus       503 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ae~~~pg~~~~~~~~~~~~~~--~~~~~~  580 (604)
                      -++||-.+++|+|.+|.|.                  ..+|.-.|+.||--+|...||+|-.|++-++.+--  =++.|+
T Consensus        12 v~~~Ly~~~~p~f~qleR~------------------d~~Aaq~LrtA~~k~Eq~nPgf~yD~~~~il~~~~l~VNl~Es   73 (207)
T KOG4025|consen   12 VYQCLYSPVMPKFKQLERD------------------DPRAAQALRTALTKCEQANPGFLYDFTKVILDDSELSVNLQES   73 (207)
T ss_pred             hhhhhhHHHHHHHHHHhcc------------------ChhHHHHHHHHHHHHhhcCCcHHHHHHHHHHhhhccccchHHH
Confidence            4799999999999999995                  67889999999999999999999999998887633  244444


Q ss_pred             H
Q psy1546         581 R  581 (604)
Q Consensus       581 ~  581 (604)
                      =
T Consensus        74 ~   74 (207)
T KOG4025|consen   74 Y   74 (207)
T ss_pred             H
Confidence            3

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=96.26  E-value=0.032  Score=57.78  Aligned_cols=28  Identities=25%  Similarity=0.404  Sum_probs=24.3

Q ss_pred             CccccccccceeEecCCCC-eEEeccccc
Q psy1546         164 RKLHRDIKAANVLLSEMGD-VKLADFGVA  191 (604)
Q Consensus       164 gIiHrDLKp~NILl~~~g~-vKL~DFGlA  191 (604)
                      .++|+|+++.|||++.++. .-|+||+.+
T Consensus       186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a  214 (276)
T cd05152         186 VLVHGDLHPGHILIDEDARVTGLIDWTEA  214 (276)
T ss_pred             eeEeCCCCCCcEEEeCCCCEEEEECcHhc
Confidence            4799999999999997555 579999988

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>KOG1236|consensus

Probab=96.06  E-value=0.015  Score=62.62  Aligned_cols=61  Identities=23%  Similarity=0.252  Sum_probs=47.7

Q ss_pred             eEEEEEEecCCCChhhHhhcCCCcHHHHHHHHHHHHHHhHH-hhhCCccccccccceeEecC
Q psy1546         119 KLWIIMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDY-LHSERKLHRDIKAANVLLSE  179 (604)
Q Consensus       119 ~lyLVmEy~~ggsL~~~l~~~~lse~~i~~i~~qIl~gL~y-LHs~gIiHrDLKp~NILl~~  179 (604)
                      ...|+-+|..|..+..+++....++.....++.-...||.- |--.+++|.|++|.||++.-
T Consensus       319 ~~vl~E~~~~Gl~v~~~v~~~~~pe~l~kkva~lg~~AllkMl~vDNFvHaDlHPGNVlirf  380 (565)
T KOG1236|consen  319 DLVLVETYERGLSVLRFVKWKSQPEALVKKVAKLGVNALLKMLIVDNFVHADLHPGNVLIRF  380 (565)
T ss_pred             cceeeeeccccccHHhhhhcccChHHHHHHHHHHHHHHHHHHHHhhcceecccCCCcEEEEe
Confidence            34578889999999999988878887777777666666543 34468999999999999953

>PRK12396 5-methylribose kinase; Reviewed

Probab=95.39  E-value=0.075  Score=57.71  Aligned_cols=68  Identities=26%  Similarity=0.319  Sum_probs=43.5

Q ss_pred             eeEEcccCcEEEEEEEECCCCcEEEEEEecch-----hhHHHHHHHHHHHHHHhhCCC--C-CCCeEE--------EEEE
Q psy1546          62 QERIGKGSFGEVFKGIDNRTQQVVAIKIIDLE-----EAEDEIEDIQQEIMVLSQCDS--P-YGTKLW--------IIME  125 (604)
Q Consensus        62 ~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~-----~~~~~~~~l~~Ei~iL~~l~h--p-~~~~ly--------LVmE  125 (604)
                      .+.||-|--..||++.+...++-|+||.-...     ...-..++...|..+|+...-  | ...++|        +|||
T Consensus        34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~D~e~~~~vME  113 (409)
T PRK12396         34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLFDSVMNCCVME  113 (409)
T ss_pred             eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEECcHHhhHHHH
Confidence            46789999999999987544567999974211     112234666677777765431  2 233443        8899


Q ss_pred             ecCC
Q psy1546         126 YLGG  129 (604)
Q Consensus       126 y~~g  129 (604)
                      +++.
T Consensus       114 dL~~  117 (409)
T PRK12396        114 DLSD  117 (409)
T ss_pred             hCcc
Confidence            9853

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=95.14  E-value=0.13  Score=53.99  Aligned_cols=28  Identities=18%  Similarity=0.226  Sum_probs=26.6

Q ss_pred             CccccccccceeEecCCCCeEEeccccc
Q psy1546         164 RKLHRDIKAANVLLSEMGDVKLADFGVA  191 (604)
Q Consensus       164 gIiHrDLKp~NILl~~~g~vKL~DFGlA  191 (604)
                      ++||+|+.++|||++.++.+.|+||..+
T Consensus       197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~  224 (309)
T TIGR02904       197 VLVHGKLSLSHFLYDETRGGYFINFEKA  224 (309)
T ss_pred             eeeCCCCcHHhEEEcCCCCEEEEEhhhc
Confidence            7999999999999999999999999987

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=95.05  E-value=0.067  Score=53.37  Aligned_cols=110  Identities=18%  Similarity=0.112  Sum_probs=64.2

Q ss_pred             cCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhC------CCCCCCeEEEEEEecCCCChhhHhhcCCC
Q psy1546          68 GSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQC------DSPYGTKLWIIMEYLGGGSALDLMKAGNF  141 (604)
Q Consensus        68 G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l------~hp~~~~lyLVmEy~~ggsL~~~l~~~~l  141 (604)
                      |+-++.-.+..+. |- ..+|.+......-....+..+..++.++      ...+..++-+|+|+|-....         
T Consensus        73 ~gNsTl~~~kt~i-G~-L~lKKi~slp~~~~~~~y~nky~v~ArmhGilrL~NDn~~~yGvIlE~Cy~~~i---------  141 (308)
T PF07387_consen   73 NGNSTLLIGKTKI-GP-LFLKKIRSLPCCINDALYFNKYRVFARMHGILRLKNDNNYKYGVILERCYKIKI---------  141 (308)
T ss_pred             CCceEEEEecccc-ch-hhhhhccCCCcccchhhhhhhhhHHHHhhheeEeecCCCceeEEEEeeccCccc---------
Confidence            4444444444332 33 3445543322221123344555555543      34467778899999932211         


Q ss_pred             cHHHHHHHHHHHHHHhHHhhhC--CccccccccceeEecCCCCeEEeccccc
Q psy1546         142 EEMHIAVILREVLKGLDYLHSE--RKLHRDIKAANVLLSEMGDVKLADFGVA  191 (604)
Q Consensus       142 se~~i~~i~~qIl~gL~yLHs~--gIiHrDLKp~NILl~~~g~vKL~DFGlA  191 (604)
                        ...- ++.-=+.+|.-.|+.  +.+|+|-.|+|||-+..|.+||.|=+..
T Consensus       142 --~~~N-~i~agi~~L~~fH~~~~~~lHGD~np~NiM~D~~G~lKlVDP~~L  190 (308)
T PF07387_consen  142 --NFSN-FITAGIKDLMDFHSENQHCLHGDCNPDNIMCDKFGYLKLVDPVCL  190 (308)
T ss_pred             --chhH-HHHHhHHHHHHhhccCCCeecCCCChhheeecCCCCEEecChhhh
Confidence              0011 111114667778843  6999999999999999999999998753

The function of this family is unknown.

>PLN02756 S-methyl-5-thioribose kinase

Probab=95.00  E-value=0.36  Score=52.74  Aligned_cols=66  Identities=18%  Similarity=0.102  Sum_probs=41.1

Q ss_pred             eeEEcccCcEEEEEEEECCCCcEEEEEEecchhh------HHHHHHHHHHHHHHhhCCC---CCCCe--------EEEEE
Q psy1546          62 QERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA------EDEIEDIQQEIMVLSQCDS---PYGTK--------LWIIM  124 (604)
Q Consensus        62 ~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~------~~~~~~l~~Ei~iL~~l~h---p~~~~--------lyLVm  124 (604)
                      .+.||.|-...||+..+.  +..|+||.-.....      .....+...|...|..+.-   ....+        -++||
T Consensus        37 ~~eiggGn~N~VyrV~~~--~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded~~vlvM  114 (418)
T PLN02756         37 IKEVGDGNLNFVYIVVSS--SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDRTMALIGM  114 (418)
T ss_pred             EEEcCCCceeeEEEEEcC--CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECCCCCEEEE
Confidence            567899999999999863  45688998641111      1123445556666665431   12222        25899


Q ss_pred             EecCC
Q psy1546         125 EYLGG  129 (604)
Q Consensus       125 Ey~~g  129 (604)
                      ||+++
T Consensus       115 E~L~~  119 (418)
T PLN02756        115 RYLEP  119 (418)
T ss_pred             eecCC
Confidence            99976

>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

Probab=94.72  E-value=0.34  Score=51.52  Aligned_cols=122  Identities=20%  Similarity=0.200  Sum_probs=71.8

Q ss_pred             EEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCC------------------CCCC--eEEEE
Q psy1546          64 RIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDS------------------PYGT--KLWII  123 (604)
Q Consensus        64 ~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~h------------------p~~~--~lyLV  123 (604)
                      .|.+ .-..||+.... .| .+++|+.......   ..+.-|+..|..|.-                  ....  +.+-|
T Consensus        33 ~l~s-~eN~~f~~~~~-~g-~~iLki~~~~~~~---~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~l  106 (331)
T COG2334          33 GLNS-EENSNFRVQTE-DG-RYILKIYRPGWTR---AEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAAL  106 (331)
T ss_pred             cccc-ccCceEEEEec-CC-CeEEEEecCCCCH---HHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEE
Confidence            3444 55678888644 33 3499999776222   334445555444321                  1133  77899


Q ss_pred             EEecCCCChhh-Hh----h------------cCC-----------CcHH----HH---------HHHHHHHHHHhHHhhh
Q psy1546         124 MEYLGGGSALD-LM----K------------AGN-----------FEEM----HI---------AVILREVLKGLDYLHS  162 (604)
Q Consensus       124 mEy~~ggsL~~-~l----~------------~~~-----------lse~----~i---------~~i~~qIl~gL~yLHs  162 (604)
                      ++|++|..+.. ..    .            ...           ..+.    ..         .....++...++.+.+
T Consensus       107 f~~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~  186 (331)
T COG2334         107 FEYLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLA  186 (331)
T ss_pred             EEecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHh
Confidence            99999988772 11    0            001           1111    00         0022334444444443


Q ss_pred             --------CC--ccccccccceeEecCCCC-eEEeccccc
Q psy1546         163 --------ER--KLHRDIKAANVLLSEMGD-VKLADFGVA  191 (604)
Q Consensus       163 --------~g--IiHrDLKp~NILl~~~g~-vKL~DFGlA  191 (604)
                              .+  +||+|+.|.|||++.+.. +-++|||-|
T Consensus       187 ~~~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa  226 (331)
T COG2334         187 RLPAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDA  226 (331)
T ss_pred             hchhhCCcccceeeecCCCccceeEcCCCCeeeEEEcccc
Confidence                    24  999999999999998775 899999977

>PTZ00384 choline kinase; Provisional

Probab=94.37  E-value=0.14  Score=55.69  Aligned_cols=28  Identities=25%  Similarity=0.246  Sum_probs=24.1

Q ss_pred             CCccccccccceeEecCCCCeEEeccccc
Q psy1546         163 ERKLHRDIKAANVLLSEMGDVKLADFGVA  191 (604)
Q Consensus       163 ~gIiHrDLKp~NILl~~~g~vKL~DFGlA  191 (604)
                      ..++|.||-+.|||+++ +.++|+||..|
T Consensus       227 ~VfCHNDL~~gNIL~~~-~~l~lID~EYA  254 (383)
T PTZ00384        227 VLFCHNDLFFTNILDFN-QGIYFIDFDFA  254 (383)
T ss_pred             eeeeeccCCcccEEecC-CCEEEEEeccc
Confidence            45799999999999865 56999999887

>PTZ00296 choline kinase; Provisional

Probab=94.32  E-value=0.13  Score=56.97  Aligned_cols=70  Identities=19%  Similarity=0.186  Sum_probs=42.2

Q ss_pred             eeeEEcccCcEEEEEEEECC--------CCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCC-CCeE------EEEEE
Q psy1546          61 KQERIGKGSFGEVFKGIDNR--------TQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPY-GTKL------WIIME  125 (604)
Q Consensus        61 i~~~LG~G~fG~Vy~a~~~~--------t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~-~~~l------yLVmE  125 (604)
                      .++.|..|-.-.+|++....        .++.|.+++.-... + .+-...+|..++..+..-. ..++      +.|.|
T Consensus       109 ~i~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~t-e-~lIdR~~E~~v~~~ls~~gi~P~l~~~f~gg~I~e  186 (442)
T PTZ00296        109 RVNQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDV-D-ELYNPISEFEVYKTMSKYRIAPQLLNTFSGGRIEE  186 (442)
T ss_pred             EEEEecCcccCceEEEEecCCCCccccCcCceEEEEecCCCc-c-ceeCHHHHHHHHHHHHHCCCCCceEEEeCCCEEEE
Confidence            55677788888999987542        14678999874432 1 1123345666665554322 1222      47899


Q ss_pred             ecCCCCh
Q psy1546         126 YLGGGSA  132 (604)
Q Consensus       126 y~~ggsL  132 (604)
                      |++|-.|
T Consensus       187 fi~g~~l  193 (442)
T PTZ00296        187 WLYGDPL  193 (442)
T ss_pred             eeCCccC
Confidence            9988744

>PRK06148 hypothetical protein; Provisional

Probab=94.31  E-value=0.3  Score=59.59  Aligned_cols=30  Identities=30%  Similarity=0.468  Sum_probs=25.6

Q ss_pred             CCccccccccceeEecCCC--CeE-Eecccccc
Q psy1546         163 ERKLHRDIKAANVLLSEMG--DVK-LADFGVAG  192 (604)
Q Consensus       163 ~gIiHrDLKp~NILl~~~g--~vK-L~DFGlA~  192 (604)
                      .++||+|+.+.|||++.++  .+. |+|||-+.
T Consensus       203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~  235 (1013)
T PRK06148        203 AQVIHNDANDYNILVDADDGERISGLIDFGDAV  235 (1013)
T ss_pred             cceECCCCCcccEEEcCCCCcceEEEEECcccc
Confidence            4799999999999999875  555 99999873

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=93.16  E-value=0.12  Score=53.64  Aligned_cols=28  Identities=29%  Similarity=0.441  Sum_probs=25.3

Q ss_pred             CCccccccccceeEecCCCCeEEeccccc
Q psy1546         163 ERKLHRDIKAANVLLSEMGDVKLADFGVA  191 (604)
Q Consensus       163 ~gIiHrDLKp~NILl~~~g~vKL~DFGlA  191 (604)
                      .+++|+|+.+.|||++. +.+.|+||+.+
T Consensus       187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~  214 (313)
T TIGR02906       187 RGFCHQDYAYHNILLKD-NEVYVIDFDYC  214 (313)
T ss_pred             CceEcCCCCcccEEEeC-CcEEEEECccc
Confidence            47899999999999988 67899999976

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=93.03  E-value=0.69  Score=48.27  Aligned_cols=65  Identities=17%  Similarity=0.245  Sum_probs=37.7

Q ss_pred             eeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCC--CCC-----------CCeEEEEEEe
Q psy1546          60 TKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCD--SPY-----------GTKLWIIMEY  126 (604)
Q Consensus        60 ~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~--hp~-----------~~~lyLVmEy  126 (604)
                      +..+.|+.|....+|+..  .+++.|.||+-...    ....+..|..-|+.|.  .+-           ...-||||||
T Consensus        20 ~~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~~~----~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~   93 (288)
T PF03881_consen   20 TSIEPVSGGDINEAYRLD--TDGGSYFVKVNSES----GRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEF   93 (288)
T ss_dssp             -EEEEE--SSSSEEEEEE--TTS-EEEEEEEEGG----GCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE-
T ss_pred             eeeEecCCCChhheEEEE--CCCccEEEEecChh----hHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEe
Confidence            456789999999999987  66788999987622    1245666777776663  221           1122799999


Q ss_pred             cCCC
Q psy1546         127 LGGG  130 (604)
Q Consensus       127 ~~gg  130 (604)
                      ++.+
T Consensus        94 l~~~   97 (288)
T PF03881_consen   94 LEMG   97 (288)
T ss_dssp             ----
T ss_pred             ecCC
Confidence            9776

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=92.28  E-value=0.51  Score=50.51  Aligned_cols=70  Identities=23%  Similarity=0.338  Sum_probs=51.4

Q ss_pred             EEEEEEecCCCChhhHhhcCCCcHHHHHHHHHHHHHHhHHhhhC-CccccccccceeEecCCCCeEEecccccccc
Q psy1546         120 LWIIMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSE-RKLHRDIKAANVLLSEMGDVKLADFGVAGTL  194 (604)
Q Consensus       120 lyLVmEy~~ggsL~~~l~~~~lse~~i~~i~~qIl~gL~yLHs~-gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~  194 (604)
                      +|++|++- |+.+ ..++.  -...++..|+.+.+..+.-+..+ .+-||++...||||+ .|+|-|+||-+++.-
T Consensus       301 ~yl~~kdh-gt~i-s~ik~--~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~GnvtLIDfklsRl~  371 (488)
T COG5072         301 LYLHFKDH-GTPI-SIIKA--DRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EGNVTLIDFKLSRLS  371 (488)
T ss_pred             EEEEEecC-Ccee-eeeec--ccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cCceEEEEeeeeecc
Confidence            46677764 3333 33332  23566778888888777777655 578999999999999 799999999999743

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	604
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		1e-115
3a7f_A	303	Human Mst3 Kinase Length = 303		1e-113
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		1e-113
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		1e-112
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		1e-112
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		1e-109
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		2e-69
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		2e-58
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		6e-54
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		8e-54
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		1e-52
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		2e-52
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		6e-52
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		8e-52
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		9e-52
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		2e-51
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		2e-51
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		6e-50
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		2e-49
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		4e-49
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		8e-48
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		8e-48
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		3e-47
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		7e-43
4fie_A	423	Full-Length Human Pak4 Length = 423		2e-41
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		6e-41
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		6e-41
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		8e-41
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		1e-40
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		1e-40
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		1e-39
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		4e-32
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		5e-32
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		8e-32
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-28
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-28
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-28
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		3e-28
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		3e-28
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		6e-28
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		1e-26
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-25
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		4e-25
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		1e-24
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		1e-24
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		4e-24
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		5e-24
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		5e-24
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		6e-24
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		8e-24
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		8e-24
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		1e-23
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		1e-23
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		1e-23
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		1e-23
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		1e-23
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		1e-23
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		1e-23
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		2e-23
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		2e-23
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		2e-23
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		2e-23
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		2e-23
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		3e-23
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		3e-23
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		4e-23
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		5e-23
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		5e-23
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		6e-23
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		6e-23
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		6e-23
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		6e-23
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		7e-23
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		7e-23
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		8e-23
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		9e-23
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		9e-23
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		1e-22
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		1e-22
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		1e-22
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		1e-22
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		1e-22
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		1e-22
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		2e-22
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		2e-22
2wtk_B	373	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		2e-22
3gni_B	389	Structure Of Strad And Mo25 Length = 389		2e-22
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		2e-22
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		2e-22
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		2e-22
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		2e-22
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		2e-22
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		4e-22
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		4e-22
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		7e-22
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		9e-22
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		4e-21
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		9e-21
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		1e-20
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		1e-20
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		1e-20
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		1e-20
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		1e-20
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		1e-20
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		2e-20
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		2e-20
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		2e-20
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		4e-20
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		4e-20
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		4e-20
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		5e-20
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		5e-20
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		5e-20
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		5e-20
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		6e-20
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		6e-20
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		6e-20
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		7e-20
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		7e-20
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		8e-20
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		9e-20
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		9e-20
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		1e-19
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		1e-19
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		1e-19
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		1e-19
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		1e-19
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		1e-19
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		1e-19
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		1e-19
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		2e-19
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		2e-19
4h58_A	275	Braf In Complex With Compound 3 Length = 275		2e-19
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		2e-19
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-19
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		2e-19
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		3e-19
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		3e-19
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		3e-19
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		3e-19
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		3e-19
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		4e-19
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		4e-19
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		4e-19
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		4e-19
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		4e-19
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		5e-19
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		5e-19
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		5e-19
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		5e-19
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		5e-19
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		6e-19
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		6e-19
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		6e-19
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		6e-19
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		6e-19
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		6e-19
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		6e-19
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		6e-19
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		7e-19
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		7e-19
3g51_A	325	Structural Diversity Of The Active Conformation Of		7e-19
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		7e-19
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		7e-19
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		7e-19
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		7e-19
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		7e-19
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		7e-19
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		7e-19
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		8e-19
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		8e-19
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		8e-19
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		8e-19
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		8e-19
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		9e-19
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		9e-19
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		9e-19
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		9e-19
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		1e-18
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		1e-18
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		1e-18
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		1e-18
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		1e-18
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		1e-18
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		1e-18
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		1e-18
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		1e-18
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		1e-18
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		1e-18
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		1e-18
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		1e-18
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		1e-18
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		1e-18
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		1e-18
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		1e-18
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		1e-18
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		2e-18
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		2e-18
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		2e-18
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		2e-18
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		2e-18
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		2e-18
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		2e-18
4ae6_A	343	Structure And Function Of The Human Sperm-specific		2e-18
4ae9_A	343	Structure And Function Of The Human Sperm-specific		2e-18
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		2e-18
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		2e-18
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		2e-18
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		2e-18
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		2e-18
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		2e-18
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		2e-18
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		3e-18
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		3e-18
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		3e-18
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		3e-18
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		3e-18
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		3e-18
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		3e-18
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		3e-18
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		3e-18
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		3e-18
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		4e-18
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		4e-18
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		4e-18
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		4e-18
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		4e-18
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		4e-18
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		4e-18
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		4e-18
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		5e-18
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		5e-18
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		5e-18
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		5e-18
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		6e-18
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		6e-18
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		6e-18
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		6e-18
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		6e-18
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		6e-18
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		6e-18
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		6e-18
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		7e-18
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		7e-18
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		7e-18
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		7e-18
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		7e-18
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		7e-18
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		7e-18
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		8e-18
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		8e-18
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		1e-17
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		1e-17
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		1e-17
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		1e-17
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		1e-17
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		1e-17
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		1e-17
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		1e-17
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		1e-17
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		2e-17
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		2e-17
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		2e-17
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		2e-17
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		2e-17
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		2e-17
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		2e-17
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		2e-17
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		2e-17
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-17
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		2e-17
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		2e-17
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		2e-17
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		2e-17
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		2e-17
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		2e-17
3kk8_A	284	Camkii Substrate Complex A Length = 284		2e-17
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		2e-17
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		2e-17
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		2e-17
3kk9_A	282	Camkii Substrate Complex B Length = 282		3e-17
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		3e-17
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		3e-17
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		3e-17
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		3e-17
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		3e-17
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		3e-17
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		3e-17
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		3e-17
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		3e-17
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		3e-17
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-17
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		3e-17
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		3e-17
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		4e-17
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		4e-17
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		4e-17
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		4e-17
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		4e-17
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		4e-17
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		4e-17
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		4e-17
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		4e-17
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		4e-17
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		4e-17
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		4e-17
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		4e-17
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		4e-17
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		4e-17
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		4e-17
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		5e-17
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		5e-17
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		5e-17
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		5e-17
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		5e-17
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		5e-17
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		6e-17
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		6e-17
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		6e-17
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		6e-17
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		6e-17
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		7e-17
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		7e-17
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		7e-17
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		7e-17
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		7e-17
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		7e-17
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		7e-17
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		7e-17
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		8e-17
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		8e-17
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		8e-17
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		8e-17
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		1e-16
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		1e-16
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		1e-16
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		1e-16
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		1e-16
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		1e-16
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-16
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		2e-16
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		2e-16
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		2e-16
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		2e-16
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		2e-16
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		2e-16
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		2e-16
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		2e-16
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		2e-16
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		2e-16
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		2e-16
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		2e-16
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		2e-16
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		2e-16
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		2e-16
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		2e-16
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		3e-16
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		3e-16
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		3e-16
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		3e-16
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		3e-16
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		3e-16
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		4e-16
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		4e-16
2pl0_A	289	Lck Bound To Imatinib Length = 289		4e-16
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		4e-16
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		4e-16
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		4e-16
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		4e-16
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		4e-16
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		4e-16
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		4e-16
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		4e-16
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		4e-16
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		4e-16
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		4e-16
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		4e-16
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		4e-16
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		4e-16
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		4e-16
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		4e-16
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		4e-16
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		4e-16
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		4e-16
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		5e-16
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		5e-16
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		5e-16
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		5e-16
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		5e-16
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		5e-16
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		5e-16
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		5e-16
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		5e-16
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		6e-16
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		6e-16
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		6e-16
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		6e-16
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		6e-16
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		7e-16
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		7e-16
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		7e-16
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		7e-16
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		8e-16
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		8e-16
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		8e-16
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		9e-16
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		9e-16
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		9e-16
2oza_A	356	Structure Of P38alpha Complex Length = 356		1e-15
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		1e-15
3a4o_X	286	Lyn Kinase Domain Length = 286		1e-15
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		1e-15
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		1e-15
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		1e-15
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		1e-15
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		1e-15
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		1e-15
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		1e-15
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		1e-15
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		1e-15
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		1e-15
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		1e-15
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		1e-15
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		1e-15
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		2e-15
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		2e-15
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		2e-15
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		2e-15
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		2e-15
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		2e-15
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		2e-15
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		2e-15
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		2e-15
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		2e-15
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		2e-15
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		2e-15
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		3e-15
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		3e-15
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		3e-15
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		3e-15
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		3e-15
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		3e-15
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		3e-15
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		3e-15
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		3e-15
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		3e-15
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		3e-15
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		3e-15
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-15
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		4e-15
3b2t_A	311	Structure Of Phosphotransferase Length = 311		4e-15
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-15
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-15
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		4e-15
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		4e-15
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-15
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		4e-15
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		4e-15
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		4e-15
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-15
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		4e-15
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		4e-15
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		4e-15
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		5e-15
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		5e-15
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		5e-15
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		5e-15
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		5e-15
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		5e-15
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		6e-15
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		6e-15
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		6e-15
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		6e-15
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		6e-15
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		6e-15
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		6e-15
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		7e-15
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		7e-15
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		7e-15
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		7e-15
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		7e-15
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		8e-15
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		8e-15
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		8e-15
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		8e-15
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		8e-15
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		8e-15
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		8e-15
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		8e-15
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		8e-15
3soa_A	444	Full-Length Human Camkii Length = 444		8e-15
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		8e-15
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		8e-15
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		8e-15
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		8e-15
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		8e-15
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		8e-15
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		8e-15
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		8e-15
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		9e-15
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		9e-15
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		9e-15
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		9e-15
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		9e-15
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		9e-15
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		9e-15
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		9e-15
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		9e-15
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-14
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		1e-14
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		1e-14
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		1e-14
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		1e-14
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		1e-14
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		1e-14
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		1e-14
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		1e-14
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		1e-14
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		1e-14
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		1e-14
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		1e-14
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		1e-14
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		1e-14
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		1e-14
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		1e-14
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		1e-14
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		1e-14
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		1e-14
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-14
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		1e-14
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		1e-14
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		1e-14
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		1e-14
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		1e-14
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		1e-14
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-14
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		2e-14
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		2e-14
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		2e-14
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		2e-14
1nxk_A	400	Crystal Structure Of Staurosporine Bound To Map Kap		2e-14
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		2e-14
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		2e-14
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		2e-14
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		2e-14
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		2e-14
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		2e-14
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		2e-14
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-14
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		2e-14
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		3e-14
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		3e-14
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		3e-14
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		3e-14
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		3e-14
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		3e-14
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		3e-14
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		3e-14
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		3e-14
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		3e-14
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		3e-14
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		3e-14
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		3e-14
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		3e-14
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		3e-14
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		3e-14
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		3e-14
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		3e-14
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		3e-14
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		3e-14
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		4e-14
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		4e-14
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		4e-14
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		4e-14
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		4e-14
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		4e-14
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		4e-14
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		4e-14
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		4e-14
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		4e-14
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		4e-14
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		4e-14
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		4e-14
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		4e-14
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		4e-14
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		5e-14
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		5e-14
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		5e-14
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		5e-14
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		5e-14
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		5e-14
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		5e-14
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		5e-14
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		5e-14
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		6e-14
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		6e-14
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		6e-14
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		6e-14
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		6e-14
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		6e-14
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		6e-14
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		6e-14
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		6e-14
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		6e-14
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		6e-14
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		6e-14
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		6e-14
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		6e-14
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		7e-14
4fl3_A	635	Structural And Biophysical Characterization Of The		7e-14
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		7e-14
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		7e-14
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		7e-14
4fl2_A	636	Structural And Biophysical Characterization Of The		7e-14
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		7e-14
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		7e-14
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		8e-14
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		8e-14
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		9e-14
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		9e-14
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		9e-14
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		9e-14
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		1e-13
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		1e-13
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		1e-13
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		1e-13
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		1e-13
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		1e-13
2oza_B	366	Structure Of P38alpha Complex Length = 366		1e-13
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		1e-13
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		1e-13
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		1e-13
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		1e-13
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		1e-13
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		1e-13
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		1e-13
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		1e-13
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		1e-13
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		1e-13
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		1e-13
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		1e-13
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		1e-13
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		1e-13
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		1e-13
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		1e-13
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		1e-13
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		1e-13
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		1e-13
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		1e-13
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		1e-13
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		1e-13
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		1e-13
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		1e-13
3hec_A	348	P38 In Complex With Imatinib Length = 348		1e-13
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		1e-13
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		1e-13
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		1e-13
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		1e-13
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		1e-13
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		1e-13
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		1e-13
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		1e-13
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		1e-13
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		1e-13
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		1e-13
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		1e-13
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		1e-13
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		1e-13
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		1e-13
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		2e-13
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		2e-13
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		2e-13
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-13
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		2e-13
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		2e-13
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		2e-13
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		2e-13
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		2e-13
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		3e-13
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		3e-13
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		3e-13
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		3e-13
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		3e-13
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		3e-13
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		3e-13
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		3e-13
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		3e-13
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		3e-13
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		3e-13
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		3e-13
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		3e-13
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		3e-13
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		3e-13
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		3e-13
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		3e-13
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		4e-13
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		4e-13
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		4e-13
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		4e-13
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		4e-13
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		4e-13
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		5e-13
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		5e-13
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		5e-13
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		5e-13
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		5e-13
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		5e-13
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		5e-13
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		5e-13
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		5e-13
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		5e-13
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		5e-13
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		5e-13
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		5e-13
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		5e-13
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		6e-13
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		6e-13
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		6e-13
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		6e-13
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		6e-13
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		6e-13
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		6e-13
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		6e-13
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		6e-13
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		6e-13
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		6e-13
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		6e-13
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		6e-13
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		6e-13
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		6e-13
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		6e-13
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		7e-13
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		7e-13
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		7e-13
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		7e-13
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		8e-13
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		8e-13
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		8e-13
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		8e-13
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		8e-13
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		8e-13
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		9e-13
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		9e-13
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		9e-13
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		9e-13
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		9e-13
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		1e-12
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		1e-12
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		1e-12
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		1e-12
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		1e-12
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		1e-12
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		1e-12
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		1e-12
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		1e-12
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		1e-12
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		1e-12
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		1e-12
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		1e-12
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		1e-12
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		1e-12
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		1e-12
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		1e-12
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		1e-12
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		1e-12
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		1e-12
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		1e-12
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		1e-12
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		1e-12
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		1e-12
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		1e-12
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		1e-12
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		1e-12
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		2e-12
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		2e-12
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		2e-12
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		2e-12
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		2e-12
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		2e-12
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		2e-12
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		2e-12
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		2e-12
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-12
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		2e-12
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-12
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		2e-12
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		3e-12
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		3e-12
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		3e-12
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-12
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-12
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		3e-12
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		3e-12
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		3e-12
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		3e-12
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		3e-12
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		3e-12
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		3e-12
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		3e-12
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		3e-12
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-12
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		3e-12
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		3e-12
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		3e-12
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-12
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		3e-12
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-12
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-12
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		4e-12
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-12
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		4e-12
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		4e-12
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		4e-12
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		4e-12
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		4e-12
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		4e-12
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		4e-12
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		4e-12
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		5e-12
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		5e-12
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		5e-12
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		5e-12
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		5e-12
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		6e-12
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		6e-12
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		6e-12
4exu_A	371	Mapk13, Inactive Form Length = 371		6e-12
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		7e-12
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		7e-12
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		8e-12
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		8e-12
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		9e-12
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		1e-11
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		1e-11
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		1e-11
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		1e-11
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		1e-11
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		1e-11
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		1e-11
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		1e-11
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		1e-11
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		1e-11
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		1e-11
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		1e-11
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		1e-11
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		1e-11
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		1e-11
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		1e-11
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		1e-11
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		1e-11
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		1e-11
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		1e-11
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		1e-11
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		1e-11
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		1e-11
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		1e-11
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		1e-11
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		1e-11
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		1e-11
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		1e-11
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		1e-11
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		2e-11
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		2e-11
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		2e-11
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		2e-11
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		2e-11
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		2e-11
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		2e-11
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		2e-11
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		2e-11
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		2e-11
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		2e-11
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		2e-11
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		2e-11
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		2e-11
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		2e-11
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		2e-11
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		2e-11
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		2e-11
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		2e-11
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		2e-11
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		2e-11
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		2e-11
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		2e-11
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		2e-11
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-11
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		2e-11
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-11
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		2e-11
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		2e-11
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		3e-11
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		3e-11
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		3e-11
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		3e-11
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		3e-11
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		3e-11
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		3e-11
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		3e-11
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		3e-11
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		3e-11
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		3e-11
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		3e-11
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		3e-11
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		3e-11
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		3e-11
2z2w_A	285	Humand Wee1 Kinase Complexed With Inhibitor Pf03357		3e-11
1fvr_A	327	Tie2 Kinase Domain Length = 327		3e-11
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		3e-11
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		3e-11
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		3e-11
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		3e-11
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		3e-11
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		3e-11
4alu_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		3e-11
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		3e-11
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		3e-11
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		3e-11
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		3e-11
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		3e-11
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		4e-11
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		4e-11
3kvw_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		4e-11
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		4e-11
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		4e-11
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		4e-11
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		5e-11
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		5e-11
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		5e-11
2in6_A	287	Wee1 Kinase Complex With Inhibitor Pd311839 Length		5e-11
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		5e-11
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		5e-11
1x8b_A	289	Structure Of Human Wee1a Kinase: Kinase Domain Comp		5e-11
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		5e-11
3bi6_A	287	Wee1 Kinase Complex With Inhibitor Pd352396 Length		5e-11
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		5e-11
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		5e-11
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		6e-11
4azf_A	417	Human Dyrk2 In Complex With Leucettine L41 Length =		6e-11
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		6e-11
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		6e-11
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		8e-11
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		9e-11
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		9e-11
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		9e-11
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		1e-10
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		1e-10
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		1e-10
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		1e-10
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		1e-10
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		1e-10
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		2e-10
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		2e-10
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		2e-10
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		2e-10
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		2e-10
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		2e-10
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		2e-10
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		2e-10
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		2e-10
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		3e-10
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		4e-10
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		4e-10
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		4e-10
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		4e-10
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		4e-10
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		4e-10
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		4e-10
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		4e-10
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		5e-10
3k2l_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		5e-10
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		8e-10
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		8e-10
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		9e-10
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		1e-09
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		1e-09
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		1e-09
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		1e-09
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		1e-09
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		1e-09
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		1e-09
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		1e-09
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		1e-09
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		1e-09
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		1e-09
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		1e-09
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		1e-09
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		1e-09
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		1e-09
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		1e-09
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		2e-09
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		2e-09
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		2e-09
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		2e-09
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		2e-09
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		2e-09
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		2e-09
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		2e-09
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		2e-09
1z57_A	339	Crystal Structure Of Human Clk1 In Complex With 10z		2e-09
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		3e-09

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score =  411 bits (1057), Expect = e-115,   Method: Compositional matrix adjust.
 Identities = 200/277 (72%), Positives = 223/277 (80%), Gaps = 11/277 (3%)
Query: 54  DPELIFTKQERIGKGSFGEVFKGIDNRTQQVVXXXXXXXXXXXXXXXXXXXXXMVLSQCD 113
           DPE +FTK ERIGKGSFGEVFKGIDNRTQQVV                      VLSQCD
Sbjct: 20  DPEELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCD 79
Query: 114 SPY----------GTKLWIIMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSE 163
           S Y          G+KLWIIMEYLGGGSALDL++AG F+E  IA +L+E+LKGLDYLHSE
Sbjct: 80  SSYVTKYYGSYLKGSKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLKEILKGLDYLHSE 139
Query: 164 RKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDS 223
           +K+HRDIKAANVLLSE GDVKLADFGVAG LT+T  KRNTFVGTPFWMAPEVI+QSAYDS
Sbjct: 140 KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDS 199
Query: 224 KADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKD 283
           KADIWSLGITAIELAKGEPPNS++HPMRVLFLIPKNNPP L G++TK FKEF++ACLNKD
Sbjct: 200 KADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPTLVGDFTKSFKEFIDACLNKD 259
Query: 284 PENRPTAKELLKFPFIRK-AKKNAYLIDLIDRYKKWK 319
           P  RPTAKELLK  FI K +KK +YL +LIDR+K+WK
Sbjct: 260 PSFRPTAKELLKHKFIVKNSKKTSYLTELIDRFKRWK 296

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score =  406 bits (1044), Expect = e-113,   Method: Compositional matrix adjust.
 Identities = 202/282 (71%), Positives = 222/282 (78%), Gaps = 11/282 (3%)
Query: 49  NSLKVDPELIFTKQERIGKGSFGEVFKGIDNRTQQVVXXXXXXXXXXXXXXXXXXXXXMV 108
            +LK DPE +FTK E+IGKGSFGEVFKGIDNRTQ+VV                      V
Sbjct: 14  QNLKADPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITV 73
Query: 109 LSQCDSPY----------GTKLWIIMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLD 158
           LSQCDSPY           TKLWIIMEYLGGGSALDL++ G  +E  IA ILRE+LKGLD
Sbjct: 74  LSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLD 133
Query: 159 YLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQ 218
           YLHSE+K+HRDIKAANVLLSE G+VKLADFGVAG LT+T  KRN FVGTPFWMAPEVIKQ
Sbjct: 134 YLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVIKQ 193
Query: 219 SAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEA 278
           SAYDSKADIWSLGITAIELA+GEPP+SELHPM+VLFLIPKNNPP L GNY+K  KEFVEA
Sbjct: 194 SAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEA 253
Query: 279 CLNKDPENRPTAKELLKFPFI-RKAKKNAYLIDLIDRYKKWK 319
           CLNK+P  RPTAKELLK  FI R AKK +YL +LIDRYK+WK
Sbjct: 254 CLNKEPSFRPTAKELLKHKFILRNAKKTSYLTELIDRYKRWK 295

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score =  405 bits (1041), Expect = e-113,   Method: Compositional matrix adjust.
 Identities = 201/280 (71%), Positives = 222/280 (79%), Gaps = 11/280 (3%)
Query: 51  LKVDPELIFTKQERIGKGSFGEVFKGIDNRTQQVVXXXXXXXXXXXXXXXXXXXXXMVLS 110
           + +DPE +FTK E+IGKGSFGEVFKGIDNRTQ+VV                      VLS
Sbjct: 1   MSLDPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLS 60
Query: 111 QCDSPY----------GTKLWIIMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYL 160
           QCDSPY           TKLWIIMEYLGGGSALDL++ G  +E  IA ILRE+LKGLDYL
Sbjct: 61  QCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYL 120
Query: 161 HSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSA 220
           HSE+K+HRDIKAANVLLSE G+VKLADFGVAG LT+T  KRNTFVGTPFWMAPEVIKQSA
Sbjct: 121 HSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSA 180
Query: 221 YDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACL 280
           YDSKADIWSLGITAIELA+GEPP+SELHPM+VLFLIPKNNPP L GNY+K  KEFVEACL
Sbjct: 181 YDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACL 240
Query: 281 NKDPENRPTAKELLKFPFI-RKAKKNAYLIDLIDRYKKWK 319
           NK+P  RPTAKELLK  FI R AKK +YL +LIDRYK+WK
Sbjct: 241 NKEPSFRPTAKELLKHKFILRNAKKTSYLTELIDRYKRWK 280

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score =  403 bits (1036), Expect = e-112,   Method: Compositional matrix adjust.
 Identities = 200/280 (71%), Positives = 221/280 (78%), Gaps = 11/280 (3%)
Query: 51  LKVDPELIFTKQERIGKGSFGEVFKGIDNRTQQVVXXXXXXXXXXXXXXXXXXXXXMVLS 110
           + +DPE +FTK E+IGKGSFGEVFKGIDNRTQ+VV                      VLS
Sbjct: 1   MSLDPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLS 60
Query: 111 QCDSPY----------GTKLWIIMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYL 160
           QCDSPY           TKLWIIMEYLGGGSALDL++ G  +E  IA ILRE+LKGLDYL
Sbjct: 61  QCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYL 120
Query: 161 HSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSA 220
           HSE+K+HRDIKAANVLLSE G+VKLADFGVAG LT+T  KRN FVGTPFWMAPEVIKQSA
Sbjct: 121 HSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVIKQSA 180
Query: 221 YDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACL 280
           YDSKADIWSLGITAIELA+GEPP+SELHPM+VLFLIPKNNPP L GNY+K  KEFVEACL
Sbjct: 181 YDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACL 240
Query: 281 NKDPENRPTAKELLKFPFI-RKAKKNAYLIDLIDRYKKWK 319
           NK+P  RPTAKELLK  FI R AKK +YL +LIDRYK+WK
Sbjct: 241 NKEPSFRPTAKELLKHKFILRNAKKTSYLTELIDRYKRWK 280

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score =  402 bits (1032), Expect = e-112,   Method: Compositional matrix adjust.
 Identities = 200/280 (71%), Positives = 220/280 (78%), Gaps = 11/280 (3%)
Query: 52  KVDPELIFTKQERIGKGSFGEVFKGIDNRTQQVVXXXXXXXXXXXXXXXXXXXXXMVLSQ 111
           +VDPE +FTK +RIGKGSFGEV+KGIDN T++VV                      VLSQ
Sbjct: 14  RVDPEELFTKLDRIGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQ 73
Query: 112 CDSPY----------GTKLWIIMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLH 161
           CDSPY           TKLWIIMEYLGGGSALDL+K G  EE +IA ILRE+LKGLDYLH
Sbjct: 74  CDSPYITRYFGSYLKSTKLWIIMEYLGGGSALDLLKPGPLEETYIATILREILKGLDYLH 133
Query: 162 SERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAY 221
           SERK+HRDIKAANVLLSE GDVKLADFGVAG LT+T  KRN FVGTPFWMAPEVIKQSAY
Sbjct: 134 SERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVIKQSAY 193
Query: 222 DSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLN 281
           D KADIWSLGITAIELAKGEPPNS+LHPMRVLFLIPKN+PP L G ++K FKEFVEACLN
Sbjct: 194 DFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTLEGQHSKPFKEFVEACLN 253
Query: 282 KDPENRPTAKELLKFPFI-RKAKKNAYLIDLIDRYKKWKN 320
           KDP  RPTAKELLK  FI R  KK ++L +LIDRYK+WK+
Sbjct: 254 KDPRFRPTAKELLKHKFITRYTKKTSFLTELIDRYKRWKS 293

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score =  391 bits (1005), Expect = e-109,   Method: Compositional matrix adjust.
 Identities = 196/272 (72%), Positives = 215/272 (79%), Gaps = 11/272 (4%)
Query: 53  VDPELIFTKQERIGKGSFGEVFKGIDNRTQQVVXXXXXXXXXXXXXXXXXXXXXMVLSQC 112
           +DPE +FTK E+IGKGSFGEVFKGIDNRTQ+VV                      VLSQC
Sbjct: 23  MDPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQC 82
Query: 113 DSPY----------GTKLWIIMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHS 162
           DSPY           TKLWIIMEYLGGGSALDL++ G  +E  IA ILRE+LKGLDYLHS
Sbjct: 83  DSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHS 142
Query: 163 ERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYD 222
           E+K+HRDIKAANVLLSE G+VKLADFGVAG LT+T  KRNTFVGTPFWMAPEVIKQSAYD
Sbjct: 143 EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYD 202
Query: 223 SKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNK 282
           SKADIWSLGITAIELA+GEPP+SELHPM+VLFLIPKNNPP L GNY+K  KEFVEACLNK
Sbjct: 203 SKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLNK 262
Query: 283 DPENRPTAKELLKFPFI-RKAKKNAYLIDLID 313
           +P  RPTAKELLK  FI R AKK +YL +LID
Sbjct: 263 EPSFRPTAKELLKHKFILRNAKKTSYLTELID 294

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score =  260 bits (664), Expect = 2e-69,   Method: Compositional matrix adjust.
 Identities = 133/279 (47%), Positives = 175/279 (62%), Gaps = 17/279 (6%)
Query: 49  NSLKVDPELIFTKQERIGKGSFGEVFKGIDNRTQQVVXXXXXXXXXXXXXXXXXXXXXMV 108
           +SL   PE +F   E++G+GS+G V+K I   T Q+V                      +
Sbjct: 21  DSLTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEIS---I 77
Query: 109 LSQCDSP-----YG-----TKLWIIMEYLGGGSALDLMKAGN--FEEMHIAVILREVLKG 156
           + QCDSP     YG     T LWI+MEY G GS  D+++  N    E  IA IL+  LKG
Sbjct: 78  MQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKG 137
Query: 157 LDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVI 216
           L+YLH  RK+HRDIKA N+LL+  G  KLADFGVAG LT+  +KRN  +GTPFWMAPEVI
Sbjct: 138 LEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDXMAKRNXVIGTPFWMAPEVI 197
Query: 217 KQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGN--YTKQFKE 274
           ++  Y+  ADIWSLGITAIE+A+G+PP +++HPMR +F+IP N PP       ++  F +
Sbjct: 198 QEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELWSDNFTD 257
Query: 275 FVEACLNKDPENRPTAKELLKFPFIRKAKKNAYLIDLID 313
           FV+ CL K PE R TA +LL+ PF+R AK  + L DLI+
Sbjct: 258 FVKQCLVKSPEQRATATQLLQHPFVRSAKGVSILRDLIN 296

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score =  223 bits (569), Expect = 2e-58,   Method: Compositional matrix adjust.
 Identities = 122/292 (41%), Positives = 170/292 (58%), Gaps = 28/292 (9%)
Query: 54  DPELIFTKQERIGKGSFGEVFKGIDNRTQQVVXXXXXXXXXXXXXXXXXXXXXMV----L 109
           DP  IF   E +G G++G+V+KG   +T Q+                      +      
Sbjct: 21  DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHH 80
Query: 110 SQCDSPYGT-----------KLWIIMEYLGGGSALDLMK--AGN-FEEMHIAVILREVLK 155
               + YG            +LW++ME+ G GS  DL+K   GN  +E  IA I RE+L+
Sbjct: 81  RNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILR 140
Query: 156 GLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEV 215
           GL +LH  + +HRDIK  NVLL+E  +VKL DFGV+  L  T  +RNTF+GTP+WMAPEV
Sbjct: 141 GLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEV 200
Query: 216 IK-----QSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQL-TGNYT 269
           I       + YD K+D+WSLGITAIE+A+G PP  ++HPMR LFLIP+N  P+L +  ++
Sbjct: 201 IACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSKKWS 260
Query: 270 KQFKEFVEACLNKDPENRPTAKELLKFPFIR----KAKKNAYLIDLIDRYKK 317
           K+F+ F+E+CL K+   RP  ++L+K PFIR    + +    L D IDR KK
Sbjct: 261 KKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQPNERQVRIQLKDHIDRTKK 312

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score =  208 bits (530), Expect = 6e-54,   Method: Compositional matrix adjust.
 Identities = 110/283 (38%), Positives = 167/283 (59%), Gaps = 20/283 (7%)
Query: 53  VDPELIFTKQERIGKGSFGEVFKGIDNRTQQVVXXXXXXXXXXXXXXXXXXXXXMVLSQC 112
           +DP  ++     +G G+FG+V+K   N+    +                      +L+ C
Sbjct: 15  LDPNEVWEIVGELGDGAFGKVYKA-KNKETGALAAAKVIETKSEEELEDYIVEIEILATC 73
Query: 113 DSPYGTKL----------WIIMEYLGGGS--ALDLMKAGNFEEMHIAVILREVLKGLDYL 160
           D PY  KL          WI++E+  GG+  A+ L       E  I V+ R++L+ L++L
Sbjct: 74  DHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFL 133
Query: 161 HSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVI---- 216
           HS+R +HRD+KA NVL++  GD++LADFGV+     T  KR++F+GTP+WMAPEV+    
Sbjct: 134 HSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCET 193
Query: 217 -KQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLT--GNYTKQFK 273
            K + YD KADIWSLGIT IE+A+ EPP+ EL+PMRVL  I K++PP L     ++ +F+
Sbjct: 194 MKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKWSVEFR 253
Query: 274 EFVEACLNKDPENRPTAKELLKFPFIRKAKKNAYLIDLIDRYK 316
           +F++  L+K+PE RP+A +LL+ PF+     N  L +L+   K
Sbjct: 254 DFLKIALDKNPETRPSAAQLLEHPFVSSITSNKALRELVAEAK 296

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score =  208 bits (529), Expect = 8e-54,   Method: Compositional matrix adjust.
 Identities = 110/283 (38%), Positives = 167/283 (59%), Gaps = 20/283 (7%)
Query: 53  VDPELIFTKQERIGKGSFGEVFKGIDNRTQQVVXXXXXXXXXXXXXXXXXXXXXMVLSQC 112
           +DP  ++     +G G+FG+V+K   N+    +                      +L+ C
Sbjct: 7   LDPNEVWEIVGELGDGAFGKVYKA-KNKETGALAAAKVIETKSEEELEDYIVEIEILATC 65
Query: 113 DSPYGTKL----------WIIMEYLGGGS--ALDLMKAGNFEEMHIAVILREVLKGLDYL 160
           D PY  KL          WI++E+  GG+  A+ L       E  I V+ R++L+ L++L
Sbjct: 66  DHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFL 125
Query: 161 HSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVI---- 216
           HS+R +HRD+KA NVL++  GD++LADFGV+     T  KR++F+GTP+WMAPEV+    
Sbjct: 126 HSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCET 185
Query: 217 -KQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLT--GNYTKQFK 273
            K + YD KADIWSLGIT IE+A+ EPP+ EL+PMRVL  I K++PP L     ++ +F+
Sbjct: 186 MKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKWSVEFR 245
Query: 274 EFVEACLNKDPENRPTAKELLKFPFIRKAKKNAYLIDLIDRYK 316
           +F++  L+K+PE RP+A +LL+ PF+     N  L +L+   K
Sbjct: 246 DFLKIALDKNPETRPSAAQLLEHPFVSSITSNKALRELVAEAK 288

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score =  204 bits (519), Expect = 1e-52,   Method: Compositional matrix adjust.
 Identities = 110/276 (39%), Positives = 158/276 (57%), Gaps = 13/276 (4%)
Query: 54  DPELIFTKQERIGKGSFGEVFKGIDNRTQQVVXXXXXXXXXXXXXXXXXXXXXMVLSQCD 113
           DP+  +T+ E+IG+G+ G V+  +D  T Q V                     +V+ +  
Sbjct: 17  DPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEI-LVMRENK 75
Query: 114 SP----------YGTKLWIIMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSE 163
           +P           G +LW++MEYL GGS  D++     +E  IA + RE L+ L++LHS 
Sbjct: 76  NPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSN 135
Query: 164 RKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDS 223
           + +HRDIK+ N+LL   G VKL DFG    +T   SKR+T VGTP+WMAPEV+ + AY  
Sbjct: 136 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGP 195
Query: 224 KADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTG--NYTKQFKEFVEACLN 281
           K DIWSLGI AIE+ +GEPP    +P+R L+LI  N  P+L      +  F++F+  CL+
Sbjct: 196 KVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLD 255
Query: 282 KDPENRPTAKELLKFPFIRKAKKNAYLIDLIDRYKK 317
            D E R +AKELL+  F++ AK  + L  LI   K+
Sbjct: 256 MDVEKRGSAKELLQHQFLKIAKPLSSLTPLIAAAKE 291

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score =  203 bits (517), Expect = 2e-52,   Method: Compositional matrix adjust.
 Identities = 114/234 (48%), Positives = 145/234 (61%), Gaps = 34/234 (14%)
Query: 109 LSQCDSP----YGT------KLWIIMEYLGGGSALDLMK---------AGNFEEMHIAVI 149
           +SQC  P    Y T      +LW++M+ L GGS LD++K         +G  +E  IA I
Sbjct: 67  MSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATI 126
Query: 150 LREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTN----TTSK-RNTF 204
           LREVL+GL+YLH   ++HRD+KA N+LL E G V++ADFGV+  L      T +K R TF
Sbjct: 127 LREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTF 186
Query: 205 VGTPFWMAPEVIKQ-SAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQ 263
           VGTP WMAPEV++Q   YD KADIWS GITAIELA G  P  +  PM+VL L  +N+PP 
Sbjct: 187 VGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPS 246
Query: 264 L-TG--------NYTKQFKEFVEACLNKDPENRPTAKELLKFPFIRKAKKNAYL 308
           L TG         Y K F++ +  CL KDPE RPTA ELL+  F +KAK   +L
Sbjct: 247 LETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAKNKEFL 300

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score =  202 bits (513), Expect = 6e-52,   Method: Compositional matrix adjust.
 Identities = 109/276 (39%), Positives = 157/276 (56%), Gaps = 13/276 (4%)
Query: 54  DPELIFTKQERIGKGSFGEVFKGIDNRTQQVVXXXXXXXXXXXXXXXXXXXXXMVLSQCD 113
           DP+  +T+ E+IG+G+ G V+  +D  T Q V                     +V+ +  
Sbjct: 17  DPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEI-LVMRENK 75
Query: 114 SP----------YGTKLWIIMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSE 163
           +P           G +LW++MEYL GGS  D++     +E  IA + RE L+ L++LHS 
Sbjct: 76  NPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSN 135
Query: 164 RKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDS 223
           + +HRDIK+ N+LL   G VKL DFG    +T   SKR+  VGTP+WMAPEV+ + AY  
Sbjct: 136 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSEMVGTPYWMAPEVVTRKAYGP 195
Query: 224 KADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTG--NYTKQFKEFVEACLN 281
           K DIWSLGI AIE+ +GEPP    +P+R L+LI  N  P+L      +  F++F+  CL+
Sbjct: 196 KVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLD 255
Query: 282 KDPENRPTAKELLKFPFIRKAKKNAYLIDLIDRYKK 317
            D E R +AKELL+  F++ AK  + L  LI   K+
Sbjct: 256 MDVEKRGSAKELLQHQFLKIAKPLSSLTPLIAAAKE 291

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score =  201 bits (512), Expect = 8e-52,   Method: Compositional matrix adjust.
 Identities = 109/276 (39%), Positives = 156/276 (56%), Gaps = 13/276 (4%)
Query: 54  DPELIFTKQERIGKGSFGEVFKGIDNRTQQVVXXXXXXXXXXXXXXXXXXXXXMVLSQCD 113
           DP+  +T+ E+IG+G+ G V+  +D  T Q V                     +V+ +  
Sbjct: 17  DPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEI-LVMRENK 75
Query: 114 SP----------YGTKLWIIMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSE 163
           +P           G +LW++MEYL GGS  D++     +E  IA + RE L+ L++LHS 
Sbjct: 76  NPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSN 135
Query: 164 RKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDS 223
           + +HRDIK+ N+LL   G VKL DFG    +T   SKR+  VGTP+WMAPEV+ + AY  
Sbjct: 136 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMVGTPYWMAPEVVTRKAYGP 195
Query: 224 KADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTG--NYTKQFKEFVEACLN 281
           K DIWSLGI AIE+ +GEPP    +P+R L+LI  N  P+L      +  F++F+  CL 
Sbjct: 196 KVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLE 255
Query: 282 KDPENRPTAKELLKFPFIRKAKKNAYLIDLIDRYKK 317
            D E R +AKELL+  F++ AK  + L  LI   K+
Sbjct: 256 MDVEKRGSAKELLQHQFLKIAKPLSSLTPLIAAAKE 291

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score =  201 bits (511), Expect = 9e-52,   Method: Compositional matrix adjust.
 Identities = 113/229 (49%), Positives = 143/229 (62%), Gaps = 34/229 (14%)
Query: 109 LSQCDSP----YGT------KLWIIMEYLGGGSALDLMK---------AGNFEEMHIAVI 149
           +SQC  P    Y T      +LW++M+ L GGS LD++K         +G  +E  IA I
Sbjct: 62  MSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATI 121
Query: 150 LREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTN----TTSK-RNTF 204
           LREVL+GL+YLH   ++HRD+KA N+LL E G V++ADFGV+  L      T +K R TF
Sbjct: 122 LREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTF 181
Query: 205 VGTPFWMAPEVIKQ-SAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQ 263
           VGTP WMAPEV++Q   YD KADIWS GITAIELA G  P  +  PM+VL L  +N+PP 
Sbjct: 182 VGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPS 241
Query: 264 L-TG--------NYTKQFKEFVEACLNKDPENRPTAKELLKFPFIRKAK 303
           L TG         Y K F++ +  CL KDPE RPTA ELL+  F +KAK
Sbjct: 242 LETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAK 290

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score =  200 bits (508), Expect = 2e-51,   Method: Compositional matrix adjust.
 Identities = 108/276 (39%), Positives = 157/276 (56%), Gaps = 13/276 (4%)
Query: 54  DPELIFTKQERIGKGSFGEVFKGIDNRTQQVVXXXXXXXXXXXXXXXXXXXXXMVLSQCD 113
           DP+  +T+ E+IG+G+ G V+  +D  T Q V                     +V+ +  
Sbjct: 18  DPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEI-LVMRENK 76
Query: 114 SP----------YGTKLWIIMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSE 163
           +P           G +LW++MEYL GGS  D++     +E  IA + RE L+ L++LHS 
Sbjct: 77  NPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSN 136
Query: 164 RKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDS 223
           + +HR+IK+ N+LL   G VKL DFG    +T   SKR+T VGTP+WMAPEV+ + AY  
Sbjct: 137 QVIHRNIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGP 196
Query: 224 KADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTG--NYTKQFKEFVEACLN 281
           K DIWSLGI AIE+ +GEPP    +P+R L+LI  N  P+L      +  F++F+  CL 
Sbjct: 197 KVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLE 256
Query: 282 KDPENRPTAKELLKFPFIRKAKKNAYLIDLIDRYKK 317
            D E R +AKEL++  F++ AK  + L  LI   K+
Sbjct: 257 MDVEKRGSAKELIQHQFLKIAKPLSSLTPLIAAAKE 292

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score =  200 bits (508), Expect = 2e-51,   Method: Compositional matrix adjust.
 Identities = 108/276 (39%), Positives = 156/276 (56%), Gaps = 13/276 (4%)
Query: 54  DPELIFTKQERIGKGSFGEVFKGIDNRTQQVVXXXXXXXXXXXXXXXXXXXXXMVLSQCD 113
           DP+  +T+ E+IG+G+ G V+  +D  T Q V                     +V+ +  
Sbjct: 18  DPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEI-LVMRENK 76
Query: 114 SP----------YGTKLWIIMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSE 163
           +P           G +LW++MEYL GGS  D++     +E  IA + RE L+ L++LHS 
Sbjct: 77  NPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSN 136
Query: 164 RKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDS 223
           + +HRDIK+ N+LL   G VKL DFG    +T   SKR+  VGTP+WMAPEV+ + AY  
Sbjct: 137 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMVGTPYWMAPEVVTRKAYGP 196
Query: 224 KADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTG--NYTKQFKEFVEACLN 281
           K DIWSLGI AIE+ +GEPP    +P+R L+LI  N  P+L      +  F++F+  CL 
Sbjct: 197 KVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLE 256
Query: 282 KDPENRPTAKELLKFPFIRKAKKNAYLIDLIDRYKK 317
            D E R +AKEL++  F++ AK  + L  LI   K+
Sbjct: 257 MDVEKRGSAKELIQHQFLKIAKPLSSLTPLIAAAKE 292

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score =  195 bits (496), Expect = 6e-50,   Method: Compositional matrix adjust.
 Identities = 102/266 (38%), Positives = 151/266 (56%), Gaps = 20/266 (7%)
Query: 53  VDPELIFTKQERIGKGSFGEVFKGIDNRTQQVVXXXXXXXXXXXXXXXXXXXXXMVLSQC 112
           ++PE  +     +G G+FG+V+K   N+   V+                      +L+ C
Sbjct: 33  LNPEDFWEIIGELGDGAFGKVYKA-QNKETSVLAAAKVIDTKSEEELEDYMVEIDILASC 91
Query: 113 DSP----------YGTKLWIIMEYLGGGS--ALDLMKAGNFEEMHIAVILREVLKGLDYL 160
           D P          Y   LWI++E+  GG+  A+ L       E  I V+ ++ L  L+YL
Sbjct: 92  DHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYL 151
Query: 161 HSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVI---- 216
           H  + +HRD+KA N+L +  GD+KLADFGV+   T T  +R++F+GTP+WMAPEV+    
Sbjct: 152 HDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCET 211
Query: 217 -KQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLT--GNYTKQFK 273
            K   YD KAD+WSLGIT IE+A+ EPP+ EL+PMRVL  I K+ PP L     ++  FK
Sbjct: 212 SKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFK 271
Query: 274 EFVEACLNKDPENRPTAKELLKFPFI 299
           +F++ CL K+ + R T  +LL+ PF+
Sbjct: 272 DFLKKCLEKNVDARWTTSQLLQHPFV 297

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score =  193 bits (491), Expect = 2e-49,   Method: Compositional matrix adjust.
 Identities = 101/266 (37%), Positives = 150/266 (56%), Gaps = 20/266 (7%)
Query: 53  VDPELIFTKQERIGKGSFGEVFKGIDNRTQQVVXXXXXXXXXXXXXXXXXXXXXMVLSQC 112
           ++PE  +     +G G+FG+V+K   N+   V+                      +L+ C
Sbjct: 33  LNPEDFWEIIGELGDGAFGKVYKA-QNKETSVLAAAKVIDTKSEEELEDYMVEIDILASC 91
Query: 113 DSP----------YGTKLWIIMEYLGGGS--ALDLMKAGNFEEMHIAVILREVLKGLDYL 160
           D P          Y   LWI++E+  GG+  A+ L       E  I V+ ++ L  L+YL
Sbjct: 92  DHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYL 151
Query: 161 HSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVI---- 216
           H  + +HRD+KA N+L +  GD+KLADFGV+   T    +R++F+GTP+WMAPEV+    
Sbjct: 152 HDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDSFIGTPYWMAPEVVMCET 211
Query: 217 -KQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLT--GNYTKQFK 273
            K   YD KAD+WSLGIT IE+A+ EPP+ EL+PMRVL  I K+ PP L     ++  FK
Sbjct: 212 SKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFK 271
Query: 274 EFVEACLNKDPENRPTAKELLKFPFI 299
           +F++ CL K+ + R T  +LL+ PF+
Sbjct: 272 DFLKKCLEKNVDARWTTSQLLQHPFV 297

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score =  192 bits (488), Expect = 4e-49,   Method: Compositional matrix adjust.
 Identities = 101/266 (37%), Positives = 149/266 (56%), Gaps = 20/266 (7%)
Query: 53  VDPELIFTKQERIGKGSFGEVFKGIDNRTQQVVXXXXXXXXXXXXXXXXXXXXXMVLSQC 112
           ++PE  +     +G G+FG+V+K   N+   V+                      +L+ C
Sbjct: 33  LNPEDFWEIIGELGDGAFGKVYKA-QNKETSVLAAAKVIDTKSEEELEDYMVEIDILASC 91
Query: 113 DSP----------YGTKLWIIMEYLGGGS--ALDLMKAGNFEEMHIAVILREVLKGLDYL 160
           D P          Y   LWI++E+  GG+  A+ L       E  I V+ ++ L  L+YL
Sbjct: 92  DHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYL 151
Query: 161 HSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVI---- 216
           H  + +HRD+KA N+L +  GD+KLADFGV+   T    +R+ F+GTP+WMAPEV+    
Sbjct: 152 HDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDXFIGTPYWMAPEVVMCET 211
Query: 217 -KQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLT--GNYTKQFK 273
            K   YD KAD+WSLGIT IE+A+ EPP+ EL+PMRVL  I K+ PP L     ++  FK
Sbjct: 212 SKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFK 271
Query: 274 EFVEACLNKDPENRPTAKELLKFPFI 299
           +F++ CL K+ + R T  +LL+ PF+
Sbjct: 272 DFLKKCLEKNVDARWTTSQLLQHPFV 297

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score =  188 bits (477), Expect = 8e-48,   Method: Compositional matrix adjust.
 Identities = 113/284 (39%), Positives = 157/284 (55%), Gaps = 23/284 (8%)
Query: 51  LKVDPELIFTKQERIGKGSFGEVFKGIDNRTQQVVXXXXXXXXXXXXXXXXXXXXXMV-- 108
            K DPE +F+    IG GSFG V+   D R  +VV                      V  
Sbjct: 9   FKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRF 68
Query: 109 LSQCDSP-----YGTKL-----WIIMEYLGGGSALDLMKAGN--FEEMHIAVILREVLKG 156
           L +   P      G  L     W++MEY  G SA DL++      +E+ IA +    L+G
Sbjct: 69  LQKLRHPNTIQYRGCYLREHTAWLVMEYCLG-SASDLLEVHKKPLQEVEIAAVTHGALQG 127
Query: 157 LDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVI 216
           L YLHS   +HRD+KA N+LLSE G VKL DFG A  +    +  N FVGTP+WMAPEVI
Sbjct: 128 LAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIM----APANXFVGTPYWMAPEVI 183
Query: 217 ---KQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQL-TGNYTKQF 272
               +  YD K D+WSLGIT IELA+ +PP   ++ M  L+ I +N  P L +G++++ F
Sbjct: 184 LAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYF 243
Query: 273 KEFVEACLNKDPENRPTAKELLKFPFIRKAKKNAYLIDLIDRYK 316
           + FV++CL K P++RPT++ LLK  F+ + +    ++DLI R K
Sbjct: 244 RNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPTVIMDLIQRTK 287

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score =  188 bits (477), Expect = 8e-48,   Method: Compositional matrix adjust.
 Identities = 113/284 (39%), Positives = 157/284 (55%), Gaps = 23/284 (8%)
Query: 51  LKVDPELIFTKQERIGKGSFGEVFKGIDNRTQQVVXXXXXXXXXXXXXXXXXXXXXMV-- 108
            K DPE +F+    IG GSFG V+   D R  +VV                      V  
Sbjct: 48  FKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRF 107
Query: 109 LSQCDSP-----YGTKL-----WIIMEYLGGGSALDLMKAGN--FEEMHIAVILREVLKG 156
           L +   P      G  L     W++MEY  G SA DL++      +E+ IA +    L+G
Sbjct: 108 LQKLRHPNTIQYRGCYLREHTAWLVMEYCLG-SASDLLEVHKKPLQEVEIAAVTHGALQG 166
Query: 157 LDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVI 216
           L YLHS   +HRD+KA N+LLSE G VKL DFG A  +    +  N FVGTP+WMAPEVI
Sbjct: 167 LAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIM----APANXFVGTPYWMAPEVI 222
Query: 217 ---KQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQL-TGNYTKQF 272
               +  YD K D+WSLGIT IELA+ +PP   ++ M  L+ I +N  P L +G++++ F
Sbjct: 223 LAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYF 282
Query: 273 KEFVEACLNKDPENRPTAKELLKFPFIRKAKKNAYLIDLIDRYK 316
           + FV++CL K P++RPT++ LLK  F+ + +    ++DLI R K
Sbjct: 283 RNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPTVIMDLIQRTK 326

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score =  171 bits (434), Expect = 7e-43,   Method: Compositional matrix adjust.
 Identities = 82/203 (40%), Positives = 125/203 (61%), Gaps = 2/203 (0%)
Query: 117 GTKLWIIMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVL 176
           G +LW++ME+L GG+  D++      E  IA +   VL+ L YLH++  +HRDIK+ ++L
Sbjct: 114 GEELWVLMEFLQGGALTDIVSQVRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSIL 173
Query: 177 LSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIE 236
           L+  G VKL+DFG    ++    KR   VGTP+WMAPEVI +S Y ++ DIWSLGI  IE
Sbjct: 174 LTLDGRVKLSDFGFCAQISKDVPKRKXLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIE 233
Query: 237 LAKGEPPNSELHPMRVLFLIPKNNPPQLTGNY--TKQFKEFVEACLNKDPENRPTAKELL 294
           +  GEPP     P++ +  +  + PP+L  ++  +   ++F+E  L +DP+ R TA+ELL
Sbjct: 234 MVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKVSPVLRDFLERMLVRDPQERATAQELL 293
Query: 295 KFPFIRKAKKNAYLIDLIDRYKK 317
             PF+ +      L+ LI  Y+K
Sbjct: 294 DHPFLLQTGLPECLVPLIQLYRK 316

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score =  167 bits (422), Expect = 2e-41,   Method: Compositional matrix adjust.
 Identities = 80/198 (40%), Positives = 119/198 (60%), Gaps = 2/198 (1%)
Query: 117 GTKLWIIMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVL 176
           G +LW++ME+L GG+  D++      E  IA +   VL+ L  LH++  +HRDIK+ ++L
Sbjct: 220 GDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSIL 279
Query: 177 LSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIE 236
           L+  G VKL+DFG    ++    +R   VGTP+WMAPE+I +  Y  + DIWSLGI  IE
Sbjct: 280 LTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIE 339
Query: 237 LAKGEPPNSELHPMRVLFLIPKNNPPQLTGNY--TKQFKEFVEACLNKDPENRPTAKELL 294
           +  GEPP     P++ + +I  N PP+L   +  +   K F++  L +DP  R TA ELL
Sbjct: 340 MVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELL 399
Query: 295 KFPFIRKAKKNAYLIDLI 312
           K PF+ KA   A ++ L+
Sbjct: 400 KHPFLAKAGPPASIVPLM 417

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score =  165 bits (418), Expect = 6e-41,   Method: Compositional matrix adjust.
 Identities = 80/198 (40%), Positives = 119/198 (60%), Gaps = 2/198 (1%)
Query: 117 GTKLWIIMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVL 176
           G +LW++ME+L GG+  D++      E  IA +   VL+ L  LH++  +HRDIK+ ++L
Sbjct: 143 GDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSIL 202
Query: 177 LSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIE 236
           L+  G VKL+DFG    ++    +R   VGTP+WMAPE+I +  Y  + DIWSLGI  IE
Sbjct: 203 LTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIE 262
Query: 237 LAKGEPPNSELHPMRVLFLIPKNNPPQLTGNY--TKQFKEFVEACLNKDPENRPTAKELL 294
           +  GEPP     P++ + +I  N PP+L   +  +   K F++  L +DP  R TA ELL
Sbjct: 263 MVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELL 322
Query: 295 KFPFIRKAKKNAYLIDLI 312
           K PF+ KA   A ++ L+
Sbjct: 323 KHPFLAKAGPPASIVPLM 340

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score =  165 bits (418), Expect = 6e-41,   Method: Compositional matrix adjust.
 Identities = 80/198 (40%), Positives = 119/198 (60%), Gaps = 2/198 (1%)
Query: 117 GTKLWIIMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVL 176
           G +LW++ME+L GG+  D++      E  IA +   VL+ L  LH++  +HRDIK+ ++L
Sbjct: 100 GDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSIL 159
Query: 177 LSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIE 236
           L+  G VKL+DFG    ++    +R   VGTP+WMAPE+I +  Y  + DIWSLGI  IE
Sbjct: 160 LTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIE 219
Query: 237 LAKGEPPNSELHPMRVLFLIPKNNPPQLTGNY--TKQFKEFVEACLNKDPENRPTAKELL 294
           +  GEPP     P++ + +I  N PP+L   +  +   K F++  L +DP  R TA ELL
Sbjct: 220 MVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELL 279
Query: 295 KFPFIRKAKKNAYLIDLI 312
           K PF+ KA   A ++ L+
Sbjct: 280 KHPFLAKAGPPASIVPLM 297

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score =  165 bits (417), Expect = 8e-41,   Method: Compositional matrix adjust.
 Identities = 80/198 (40%), Positives = 119/198 (60%), Gaps = 2/198 (1%)
Query: 117 GTKLWIIMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVL 176
           G +LW++ME+L GG+  D++      E  IA +   VL+ L  LH++  +HRDIK+ ++L
Sbjct: 98  GDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSIL 157
Query: 177 LSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIE 236
           L+  G VKL+DFG    ++    +R   VGTP+WMAPE+I +  Y  + DIWSLGI  IE
Sbjct: 158 LTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIE 217
Query: 237 LAKGEPPNSELHPMRVLFLIPKNNPPQLTGNY--TKQFKEFVEACLNKDPENRPTAKELL 294
           +  GEPP     P++ + +I  N PP+L   +  +   K F++  L +DP  R TA ELL
Sbjct: 218 MVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELL 277
Query: 295 KFPFIRKAKKNAYLIDLI 312
           K PF+ KA   A ++ L+
Sbjct: 278 KHPFLAKAGPPASIVPLM 295

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score =  164 bits (415), Expect = 1e-40,   Method: Compositional matrix adjust.
 Identities = 80/198 (40%), Positives = 119/198 (60%), Gaps = 2/198 (1%)
Query: 117 GTKLWIIMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVL 176
           G +LW++ME+L GG+  D++      E  IA +   VL+ L  LH++  +HRDIK+ ++L
Sbjct: 89  GDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSIL 148
Query: 177 LSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIE 236
           L+  G VKL+DFG    ++    +R   VGTP+WMAPE+I +  Y  + DIWSLGI  IE
Sbjct: 149 LTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIE 208
Query: 237 LAKGEPPNSELHPMRVLFLIPKNNPPQLTGNY--TKQFKEFVEACLNKDPENRPTAKELL 294
           +  GEPP     P++ + +I  N PP+L   +  +   K F++  L +DP  R TA ELL
Sbjct: 209 MVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELL 268
Query: 295 KFPFIRKAKKNAYLIDLI 312
           K PF+ KA   A ++ L+
Sbjct: 269 KHPFLAKAGPPASIVPLM 286

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score =  164 bits (415), Expect = 1e-40,   Method: Compositional matrix adjust.
 Identities = 80/198 (40%), Positives = 119/198 (60%), Gaps = 2/198 (1%)
Query: 117 GTKLWIIMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVL 176
           G +LW++ME+L GG+  D++      E  IA +   VL+ L  LH++  +HRDIK+ ++L
Sbjct: 93  GDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSIL 152
Query: 177 LSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIE 236
           L+  G VKL+DFG    ++    +R   VGTP+WMAPE+I +  Y  + DIWSLGI  IE
Sbjct: 153 LTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIE 212
Query: 237 LAKGEPPNSELHPMRVLFLIPKNNPPQLTGNY--TKQFKEFVEACLNKDPENRPTAKELL 294
           +  GEPP     P++ + +I  N PP+L   +  +   K F++  L +DP  R TA ELL
Sbjct: 213 MVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELL 272
Query: 295 KFPFIRKAKKNAYLIDLI 312
           K PF+ KA   A ++ L+
Sbjct: 273 KHPFLAKAGPPASIVPLM 290

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score =  161 bits (407), Expect = 1e-39,   Method: Compositional matrix adjust.
 Identities = 76/202 (37%), Positives = 123/202 (60%), Gaps = 2/202 (0%)
Query: 117 GTKLWIIMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVL 176
           G +LW++ME+L GG+  D++      E  IA +   VL+ L YLH++  +HRDIK+ ++L
Sbjct: 114 GDELWVVMEFLEGGALTDIVTHTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSIL 173
Query: 177 LSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIE 236
           L+  G +KL+DFG    ++    KR   VGTP+WMAPEVI +  Y ++ DIWSLGI  IE
Sbjct: 174 LTSDGRIKLSDFGFCAQVSKEVPKRKXLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIE 233
Query: 237 LAKGEPPNSELHPMRVLFLIPKNNPPQLTGNY--TKQFKEFVEACLNKDPENRPTAKELL 294
           +  GEPP     P++ +  I  + PP++   +  +   + F++  L ++P  R TA+ELL
Sbjct: 234 MIDGEPPYFNEPPLQAMRRIRDSLPPRVKDLHKVSSVLRGFLDLMLVREPSQRATAQELL 293
Query: 295 KFPFIRKAKKNAYLIDLIDRYK 316
             PF++ A   + ++ L+ +Y+
Sbjct: 294 GHPFLKLAGPPSCIVPLMRQYR 315

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score =  135 bits (341), Expect = 4e-32,   Method: Compositional matrix adjust.
 Identities = 85/258 (32%), Positives = 136/258 (52%), Gaps = 17/258 (6%)
Query: 59  FTKQERIGKGSFGEVFKGIDNRTQQVVXXXXXXXXXXXXXXXXXXXXXMVLSQCDSPYGT 118
           F K   +G G+ G VFK     +  V+                      VL +C+SPY  
Sbjct: 11  FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 70
Query: 119 KLW----------IIMEYLGGGSALD--LMKAGNFEEMHIAVILREVLKGLDYLHSERK- 165
             +          I ME++ GGS LD  L KAG   E  +  +   V+KGL YL  + K 
Sbjct: 71  GFYGAFYSDGEISICMEHMDGGS-LDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKI 129
Query: 166 LHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKA 225
           +HRD+K +N+L++  G++KL DFGV+G L +  +  N FVGT  +M+PE ++ + Y  ++
Sbjct: 130 MHRDVKPSNILVNSRGEIKLCDFGVSGQLIDEMA--NEFVGTRSYMSPERLQGTHYSVQS 187
Query: 226 DIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQL-TGNYTKQFKEFVEACLNKDP 284
           DIWS+G++ +E+A G  P   +    +L  I    PP+L +  ++ +F++FV  CL K+P
Sbjct: 188 DIWSMGLSLVEMAVGRYPRPPMAIFELLDYIVNEPPPKLPSAVFSLEFQDFVNKCLIKNP 247
Query: 285 ENRPTAKELLKFPFIRKA 302
             R   K+L+   FI+++
Sbjct: 248 AERADLKQLMVHAFIKRS 265

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score =  135 bits (341), Expect = 5e-32,   Method: Compositional matrix adjust.
 Identities = 86/262 (32%), Positives = 140/262 (53%), Gaps = 21/262 (8%)
Query: 59  FTKQERIGKGSFGEVFKGIDNRTQQVVXXXXXXXXXXXXXXXXXXXXXMVLSQCDSPYGT 118
           F K   +G G+ G VFK     +  V+                      VL +C+SPY  
Sbjct: 27  FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 86
Query: 119 KLW----------IIMEYLGGGSALD--LMKAGNFEEMHIAVILREVLKGLDYLHSERK- 165
             +          I ME++ GGS LD  L KAG   E  +  +   V+KGL YL  + K 
Sbjct: 87  GFYGAFYSDGEISICMEHMDGGS-LDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKI 145
Query: 166 LHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKA 225
           +HRD+K +N+L++  G++KL DFGV+G L ++ +  N+FVGT  +M+PE ++ + Y  ++
Sbjct: 146 MHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA--NSFVGTRSYMSPERLQGTHYSVQS 203
Query: 226 DIWSLGITAIELAKGEPP----NSELHPMRVLFLIPKNNPPQL-TGNYTKQFKEFVEACL 280
           DIWS+G++ +E+A G  P    +  +    +L  I    PP+L +G ++ +F++FV  CL
Sbjct: 204 DIWSMGLSLVEMAVGRYPIGSGSGSMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCL 263
Query: 281 NKDPENRPTAKELLKFPFIRKA 302
            K+P  R   K+L+   FI+++
Sbjct: 264 IKNPAERADLKQLMVHAFIKRS 285

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score =  135 bits (339), Expect = 8e-32,   Method: Compositional matrix adjust.
 Identities = 89/268 (33%), Positives = 144/268 (53%), Gaps = 27/268 (10%)
Query: 59  FTKQERIGKGSFGEVFKGIDNRTQQVVXXXXXXXXXXXXXXXXXXXXXMVLSQCDSPYGT 118
           F K   +G G+ G VFK     +  V+                      VL +C+SPY  
Sbjct: 8   FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 67
Query: 119 KLW----------IIMEYLGGGSALD--LMKAGNFEEMHIAVILREVLKGLDYLHSERK- 165
             +          I ME++ GGS LD  L KAG   E  +  +   V+KGL YL  + K 
Sbjct: 68  GFYGAFYSDGEISICMEHMDGGS-LDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKI 126
Query: 166 LHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKA 225
           +HRD+K +N+L++  G++KL DFGV+G L ++ +  N+FVGT  +M+PE ++ + Y  ++
Sbjct: 127 MHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA--NSFVGTRSYMSPERLQGTHYSVQS 184
Query: 226 DIWSLGITAIELAKGE----PPNSELH---PMRVLFL---IPKNNPPQL-TGNYTKQFKE 274
           DIWS+G++ +E+A G     PP+++     PM +  L   I    PP+L +G ++ +F++
Sbjct: 185 DIWSMGLSLVEMAVGRYPIPPPDAKEDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQD 244
Query: 275 FVEACLNKDPENRPTAKELLKFPFIRKA 302
           FV  CL K+P  R   K+L+   FI+++
Sbjct: 245 FVNKCLIKNPAERADLKQLMVHAFIKRS 272

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score =  124 bits (310), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 91/300 (30%), Positives = 145/300 (48%), Gaps = 59/300 (19%)
Query: 59  FTKQERIGKGSFGEVFKGIDNRTQQVVXXXXXXXXXXXXXXXXXXXXXMVLSQCDSPYGT 118
           F K   +G G+ G VFK     +  V+                      VL +C+SPY  
Sbjct: 35  FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 94
Query: 119 KLW----------IIMEYLGGGSALD--LMKAGNFEEMHIAVILREVLKGLDYLHSERK- 165
             +          I ME++ GGS LD  L KAG   E  +  +   V+KGL YL  + K 
Sbjct: 95  GFYGAFYSDGEISICMEHMDGGS-LDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKI 153
Query: 166 LHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKA 225
           +HRD+K +N+L++  G++KL DFGV+G L ++ +  N+FVGT  +M+PE ++ + Y  ++
Sbjct: 154 MHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA--NSFVGTRSYMSPERLQGTHYSVQS 211
Query: 226 DIWSLGITAIELAKGE----PPNS-ELH-------------------------------- 248
           DIWS+G++ +E+A G     PP++ EL                                 
Sbjct: 212 DIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDS 271
Query: 249 --PMRVLFL---IPKNNPPQL-TGNYTKQFKEFVEACLNKDPENRPTAKELLKFPFIRKA 302
             PM +  L   I    PP+L +G ++ +F++FV  CL K+P  R   K+L+   FI+++
Sbjct: 272 RPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 331

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score =  123 bits (309), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 91/300 (30%), Positives = 145/300 (48%), Gaps = 59/300 (19%)
Query: 59  FTKQERIGKGSFGEVFKGIDNRTQQVVXXXXXXXXXXXXXXXXXXXXXMVLSQCDSPYGT 118
           F K   +G G+ G VFK     +  V+                      VL +C+SPY  
Sbjct: 8   FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 67
Query: 119 KLW----------IIMEYLGGGSALD--LMKAGNFEEMHIAVILREVLKGLDYLHSERK- 165
             +          I ME++ GGS LD  L KAG   E  +  +   V+KGL YL  + K 
Sbjct: 68  GFYGAFYSDGEISICMEHMDGGS-LDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKI 126
Query: 166 LHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKA 225
           +HRD+K +N+L++  G++KL DFGV+G L ++ +  N+FVGT  +M+PE ++ + Y  ++
Sbjct: 127 MHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA--NSFVGTRSYMSPERLQGTHYSVQS 184
Query: 226 DIWSLGITAIELAKGE----PPNS-ELH-------------------------------- 248
           DIWS+G++ +E+A G     PP++ EL                                 
Sbjct: 185 DIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDS 244
Query: 249 --PMRVLFL---IPKNNPPQL-TGNYTKQFKEFVEACLNKDPENRPTAKELLKFPFIRKA 302
             PM +  L   I    PP+L +G ++ +F++FV  CL K+P  R   K+L+   FI+++
Sbjct: 245 RPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 304

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score =  123 bits (309), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 91/300 (30%), Positives = 145/300 (48%), Gaps = 59/300 (19%)
Query: 59  FTKQERIGKGSFGEVFKGIDNRTQQVVXXXXXXXXXXXXXXXXXXXXXMVLSQCDSPYGT 118
           F K   +G G+ G VFK     +  V+                      VL +C+SPY  
Sbjct: 8   FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 67
Query: 119 KLW----------IIMEYLGGGSALD--LMKAGNFEEMHIAVILREVLKGLDYLHSERK- 165
             +          I ME++ GGS LD  L KAG   E  +  +   V+KGL YL  + K 
Sbjct: 68  GFYGAFYSDGEISICMEHMDGGS-LDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKI 126
Query: 166 LHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKA 225
           +HRD+K +N+L++  G++KL DFGV+G L ++ +  N+FVGT  +M+PE ++ + Y  ++
Sbjct: 127 MHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA--NSFVGTRSYMSPERLQGTHYSVQS 184
Query: 226 DIWSLGITAIELAKGE----PPNS-ELH-------------------------------- 248
           DIWS+G++ +E+A G     PP++ EL                                 
Sbjct: 185 DIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDS 244
Query: 249 --PMRVLFL---IPKNNPPQL-TGNYTKQFKEFVEACLNKDPENRPTAKELLKFPFIRKA 302
             PM +  L   I    PP+L +G ++ +F++FV  CL K+P  R   K+L+   FI+++
Sbjct: 245 RPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 304

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score =  123 bits (308), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 91/300 (30%), Positives = 145/300 (48%), Gaps = 59/300 (19%)
Query: 59  FTKQERIGKGSFGEVFKGIDNRTQQVVXXXXXXXXXXXXXXXXXXXXXMVLSQCDSPYGT 118
           F K   +G G+ G VFK     +  V+                      VL +C+SPY  
Sbjct: 8   FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 67
Query: 119 KLW----------IIMEYLGGGSALD--LMKAGNFEEMHIAVILREVLKGLDYLHSERK- 165
             +          I ME++ GGS LD  L KAG   E  +  +   V+KGL YL  + K 
Sbjct: 68  GFYGAFYSDGEISICMEHMDGGS-LDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKI 126
Query: 166 LHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKA 225
           +HRD+K +N+L++  G++KL DFGV+G L ++ +  N+FVGT  +M+PE ++ + Y  ++
Sbjct: 127 MHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA--NSFVGTRSYMSPERLQGTHYSVQS 184
Query: 226 DIWSLGITAIELAKGE----PPNS-ELH-------------------------------- 248
           DIWS+G++ +E+A G     PP++ EL                                 
Sbjct: 185 DIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDS 244
Query: 249 --PMRVLFL---IPKNNPPQL-TGNYTKQFKEFVEACLNKDPENRPTAKELLKFPFIRKA 302
             PM +  L   I    PP+L +G ++ +F++FV  CL K+P  R   K+L+   FI+++
Sbjct: 245 RPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 304

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score =  123 bits (308), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 91/300 (30%), Positives = 145/300 (48%), Gaps = 59/300 (19%)
Query: 59  FTKQERIGKGSFGEVFKGIDNRTQQVVXXXXXXXXXXXXXXXXXXXXXMVLSQCDSPYGT 118
           F K   +G G+ G VFK     +  V+                      VL +C+SPY  
Sbjct: 8   FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 67
Query: 119 KLW----------IIMEYLGGGSALD--LMKAGNFEEMHIAVILREVLKGLDYLHSERK- 165
             +          I ME++ GGS LD  L KAG   E  +  +   V+KGL YL  + K 
Sbjct: 68  GFYGAFYSDGEISICMEHMDGGS-LDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKI 126
Query: 166 LHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKA 225
           +HRD+K +N+L++  G++KL DFGV+G L ++ +  N+FVGT  +M+PE ++ + Y  ++
Sbjct: 127 MHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA--NSFVGTRSYMSPERLQGTHYSVQS 184
Query: 226 DIWSLGITAIELAKGE----PPNS-ELH-------------------------------- 248
           DIWS+G++ +E+A G     PP++ EL                                 
Sbjct: 185 DIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDS 244
Query: 249 --PMRVLFL---IPKNNPPQL-TGNYTKQFKEFVEACLNKDPENRPTAKELLKFPFIRKA 302
             PM +  L   I    PP+L +G ++ +F++FV  CL K+P  R   K+L+   FI+++
Sbjct: 245 RPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 304

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score =  122 bits (306), Expect = 6e-28,   Method: Compositional matrix adjust.
 Identities = 90/300 (30%), Positives = 144/300 (48%), Gaps = 59/300 (19%)
Query: 59  FTKQERIGKGSFGEVFKGIDNRTQQVVXXXXXXXXXXXXXXXXXXXXXMVLSQCDSPYGT 118
           F K   +G G+ G VFK     +  V+                      VL +C+SPY  
Sbjct: 70  FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 129
Query: 119 KLW----------IIMEYLGGGSALD--LMKAGNFEEMHIAVILREVLKGLDYLHSERK- 165
             +          I ME++ GGS LD  L KAG   E  +  +   V+KGL YL  + K 
Sbjct: 130 GFYGAFYSDGEISICMEHMDGGS-LDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKI 188
Query: 166 LHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKA 225
           +HRD+K +N+L++  G++KL DFGV+G L ++ +  N+FVGT  +M+PE ++ + Y  ++
Sbjct: 189 MHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA--NSFVGTRSYMSPERLQGTHYSVQS 246
Query: 226 DIWSLGITAIELAKGE----PPNS-ELH-------------------------------- 248
           DIWS+G++ +E+A G     PP++ EL                                 
Sbjct: 247 DIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDS 306
Query: 249 --PMRVLFL---IPKNNPPQL-TGNYTKQFKEFVEACLNKDPENRPTAKELLKFPFIRKA 302
             PM +  L   I    PP+L +  ++ +F++FV  CL K+P  R   K+L+   FI+++
Sbjct: 307 RPPMAIFELLDYIVNEPPPKLPSAVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 366

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score =  118 bits (295), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 95/306 (31%), Positives = 141/306 (46%), Gaps = 47/306 (15%)
Query: 51  LKVDPE--LIFTKQE-----RIGKGSFGEVFKGIDNRTQQVVXXXXXXXXXXXXXXXXXX 103
           LK+ PE    FT ++      IG+G++G V K +   + Q++                  
Sbjct: 9   LKISPEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLL 68
Query: 104 XXX-MVLSQCDSPYGTKL----------WIIMEYLGGG---------SALDLMKAGNFEE 143
               +V+   D PY  +           WI ME +            S LD        E
Sbjct: 69  MDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLD----DVIPE 124
Query: 144 MHIAVILREVLKGLDYLHSERKL-HRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRN 202
             +  I    +K L++L    K+ HRDIK +N+LL   G++KL DFG++G L ++ +K  
Sbjct: 125 EILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTR 184
Query: 203 TFVGTPFWMAPEVIKQSA----YDSKADIWSLGITAIELAKGEPPNSELHPM-RVLFLIP 257
                P+ MAPE I  SA    YD ++D+WSLGIT  ELA G  P  + + +   L  + 
Sbjct: 185 DAGCRPY-MAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVV 243
Query: 258 KNNPPQLTGN----YTKQFKEFVEACLNKDPENRPTAKELLKFPFI-----RKAKKNAYL 308
           K +PPQL+ +    ++  F  FV  CL KD   RP  KELLK PFI     R  +   Y+
Sbjct: 244 KGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMYEERAVEVACYV 303
Query: 309 IDLIDR 314
             ++D+
Sbjct: 304 CKILDQ 309

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score =  114 bits (284), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 81/255 (31%), Positives = 127/255 (49%), Gaps = 61/255 (23%)
Query: 108 VLSQCDSPYGTKLW----------IIMEYLGGGSALDLMK-AGNFEEMHIAVILREVLKG 156
           VL +C+SPY    +          I ME++ GGS   ++K A    E  +  +   VL+G
Sbjct: 67  VLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRG 126
Query: 157 LDYLHSERK-LHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEV 215
           L YL  + + +HRD+K +N+L++  G++KL DFGV+G L ++ +  N+FVGT  +MAPE 
Sbjct: 127 LAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA--NSFVGTRSYMAPER 184
Query: 216 IKQSAYDSKADIWSLGITAIELAKGE----PPNS-EL----------------------- 247
           ++ + Y  ++DIWS+G++ +ELA G     PP++ EL                       
Sbjct: 185 LQGTHYSVQSDIWSMGLSLVELAVGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRP 244
Query: 248 ---------HPM---------RVLFLIPKNNPPQL-TGNYTKQFKEFVEACLNKDPENRP 288
                    H M          +L  I    PP+L  G +T  F+EFV  CL K+P  R 
Sbjct: 245 RPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERA 304
Query: 289 TAKELLKFPFIRKAK 303
             K L    FI++++
Sbjct: 305 DLKMLTNHTFIKRSE 319

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score =  112 bits (281), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 70/192 (36%), Positives = 105/192 (54%), Gaps = 9/192 (4%)
Query: 122 IIMEYLGGGSALDLMKA--GNFE--EMHIAVILREVLKGLDYLHSERKLHRDIKAANVLL 177
           I ME + GGS   L+++  G  +  E  I    +++L+GL YLH  + +HRDIK  NVL+
Sbjct: 96  IFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLI 155
Query: 178 SEM-GDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQS--AYDSKADIWSLGITA 234
           +   G +K++DFG +  L        TF GT  +MAPE+I +    Y   ADIWSLG T 
Sbjct: 156 NTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTI 215
Query: 235 IELAKGEPPNSEL-HPMRVLFLIPKNNP-PQLTGNYTKQFKEFVEACLNKDPENRPTAKE 292
           IE+A G+PP  EL  P   +F +      P++  + + + K F+  C   DP+ R  A +
Sbjct: 216 IEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAEAKAFILKCFEPDPDKRACAND 275
Query: 293 LLKFPFIRKAKK 304
           LL   F++ + K
Sbjct: 276 LLVDEFLKVSSK 287

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score =  111 bits (278), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 80/258 (31%), Positives = 123/258 (47%), Gaps = 22/258 (8%)
Query: 65  IGKGSFGEVFKGIDNRTQQVVXXXXXXXX-XXXXXXXXXXXXXMVLSQCDSPY------- 116
           +G G+ G+V+K    +T  V+                      +VL   D PY       
Sbjct: 33  MGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGT 92
Query: 117 ---GTKLWIIMEYLG-GGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERK-LHRDIK 171
               T ++I ME +G     L     G   E  +  +   ++K L YL  +   +HRD+K
Sbjct: 93  FITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVK 152
Query: 172 AANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIK-----QSAYDSKAD 226
            +N+LL E G +KL DFG++G L +  +K  +  G   +MAPE I      +  YD +AD
Sbjct: 153 PSNILLDERGQIKLCDFGISGRLVDDKAKDRS-AGCAAYMAPERIDPPDPTKPDYDIRAD 211
Query: 227 IWSLGITAIELAKGEPPNSELHP-MRVLFLIPKNNPPQLTGN--YTKQFKEFVEACLNKD 283
           +WSLGI+ +ELA G+ P         VL  + +  PP L G+  ++  F+ FV+ CL KD
Sbjct: 212 VWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMGFSGDFQSFVKDCLTKD 271
Query: 284 PENRPTAKELLKFPFIRK 301
              RP   +LL+  FI++
Sbjct: 272 HRKRPKYNKLLEHSFIKR 289

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score =  111 bits (277), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 69/188 (36%), Positives = 103/188 (54%), Gaps = 9/188 (4%)
Query: 122 IIMEYLGGGSALDLMKA--GNFE--EMHIAVILREVLKGLDYLHSERKLHRDIKAANVLL 177
           I ME + GGS   L+++  G  +  E  I    +++L+GL YLH  + +HRDIK  NVL+
Sbjct: 82  IFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLI 141
Query: 178 SEM-GDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQS--AYDSKADIWSLGITA 234
           +   G +K++DFG +  L        TF GT  +MAPE+I +    Y   ADIWSLG T 
Sbjct: 142 NTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTI 201
Query: 235 IELAKGEPPNSEL-HPMRVLFLIPKNNP-PQLTGNYTKQFKEFVEACLNKDPENRPTAKE 292
           IE+A G+PP  EL  P   +F +      P++  + + + K F+  C   DP+ R  A +
Sbjct: 202 IEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAEAKAFILKCFEPDPDKRACAND 261
Query: 293 LLKFPFIR 300
           LL   F++
Sbjct: 262 LLVDEFLK 269

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score =  109 bits (273), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 70/193 (36%), Positives = 108/193 (55%), Gaps = 16/193 (8%)
Query: 120 LWIIMEYLGGGSALD------LMKAGNFEEMHIAVILREVLKGLDYLHSERK-LHRDIKA 172
           +WI ME +   ++LD      + K     E  +  I   ++K L++LHS+   +HRD+K 
Sbjct: 125 VWICMELMD--TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKP 182
Query: 173 ANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVI----KQSAYDSKADIW 228
           +NVL++ +G VK+ DFG++G L ++ +K     G   +MAPE I     Q  Y  K+DIW
Sbjct: 183 SNVLINALGQVKMCDFGISGYLVDSVAK-TIDAGCKPYMAPERINPELNQKGYSVKSDIW 241
Query: 229 SLGITAIELAKGE-PPNSELHPMRVLFLIPKNNPPQLTGN-YTKQFKEFVEACLNKDPEN 286
           SLGIT IELA    P +S   P + L  + +   PQL  + ++ +F +F   CL K+ + 
Sbjct: 242 SLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKFSAEFVDFTSQCLKKNSKE 301
Query: 287 RPTAKELLKFPFI 299
           RPT  EL++ PF 
Sbjct: 302 RPTYPELMQHPFF 314

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score =  109 bits (272), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 61/189 (32%), Positives = 102/189 (53%), Gaps = 11/189 (5%)
Query: 120 LWIIMEYLGGGSALDLMKAGN------FEEMHIAVILREVLKGLDYLHSERKLHRDIKAA 173
           L+I+M+Y  GG   DL K  N      F+E  I     ++   L ++H  + LHRDIK+ 
Sbjct: 98  LYIVMDYCEGG---DLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQ 154
Query: 174 NVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGIT 233
           N+ L++ G V+L DFG+A  L +T       +GTP++++PE+ +   Y++K+DIW+LG  
Sbjct: 155 NIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICENKPYNNKSDIWALGCV 214
Query: 234 AIELAKGEPPNSELHPMRVLFL-IPKNNPPQLTGNYTKQFKEFVEACLNKDPENRPTAKE 292
             EL   +    E   M+ L L I   + P ++ +Y+   +  V     ++P +RP+   
Sbjct: 215 LYELCTLKHA-FEAGSMKNLVLKIISGSFPPVSLHYSYDLRSLVSQLFKRNPRDRPSVNS 273
Query: 293 LLKFPFIRK 301
           +L+  FI K
Sbjct: 274 ILEKGFIAK 282

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score =  109 bits (272), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 63/192 (32%), Positives = 98/192 (51%), Gaps = 10/192 (5%)
Query: 118 TKLWIIMEYLGGGSALDLMKAGN-----FEEMHIAVILREVLKGLDYLHSERK-----LH 167
           T L+I+MEY  GG    ++  G       +E  +  ++ ++   L   H         LH
Sbjct: 80  TTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLH 139
Query: 168 RDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADI 227
           RD+K ANV L    +VKL DFG+A  L + TS   TFVGTP++M+PE + + +Y+ K+DI
Sbjct: 140 RDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDI 199
Query: 228 WSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPENR 287
           WSLG    EL    PP +      +   I +    ++   Y+ +  E +   LN    +R
Sbjct: 200 WSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSDELNEIITRMLNLKDYHR 259
Query: 288 PTAKELLKFPFI 299
           P+ +E+L+ P I
Sbjct: 260 PSVEEILENPLI 271

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score =  109 bits (272), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 62/191 (32%), Positives = 100/191 (52%), Gaps = 18/191 (9%)
Query: 117 GTKLWIIMEYLGGGSAL-DLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANV 175
            T++++I+EY   G+   +L K   F+E   A  + E+   L Y HS+R +HRDIK  N+
Sbjct: 106 ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENL 165
Query: 176 LLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAI 235
           LL   G++K+ADFG   ++   +S+R T  GT  ++ PE+I+   +D K D+WSLG+   
Sbjct: 166 LLGSAGELKIADFG--WSVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCY 223
Query: 236 ELAKGEPP-------NSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPENRP 288
           E   G+PP        +     RV F  P           T+  ++ +   L  +P  RP
Sbjct: 224 EFLVGKPPFEANTYQETYKRISRVEFTFP--------DFVTEGARDLISRLLKHNPSQRP 275
Query: 289 TAKELLKFPFI 299
             +E+L+ P+I
Sbjct: 276 MLREVLEHPWI 286

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score =  108 bits (270), Expect = 8e-24,   Method: Compositional matrix adjust.
 Identities = 62/191 (32%), Positives = 100/191 (52%), Gaps = 18/191 (9%)
Query: 117 GTKLWIIMEYLGGGSAL-DLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANV 175
            T++++I+EY   G+   +L K   F+E   A  + E+   L Y HS+R +HRDIK  N+
Sbjct: 97  ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENL 156
Query: 176 LLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAI 235
           LL   G++K+ADFG   ++   +S+R T  GT  ++ PE+I+   +D K D+WSLG+   
Sbjct: 157 LLGSAGELKIADFG--WSVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCY 214
Query: 236 ELAKGEPP-------NSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPENRP 288
           E   G+PP        +     RV F  P           T+  ++ +   L  +P  RP
Sbjct: 215 EFLVGKPPFEANTYQETYKRISRVEFTFP--------DFVTEGARDLISRLLKHNPSQRP 266
Query: 289 TAKELLKFPFI 299
             +E+L+ P+I
Sbjct: 267 MLREVLEHPWI 277

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score =  108 bits (270), Expect = 8e-24,   Method: Compositional matrix adjust.
 Identities = 62/191 (32%), Positives = 101/191 (52%), Gaps = 18/191 (9%)
Query: 117 GTKLWIIMEYLGGGSAL-DLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANV 175
            T++++I+EY   G+   +L K   F+E   A  + E+   L Y HS+R +HRDIK  N+
Sbjct: 81  ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENL 140
Query: 176 LLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAI 235
           LL   G++K+ADFG   ++   +S+R+T  GT  ++ PE+I+   +D K D+WSLG+   
Sbjct: 141 LLGSAGELKIADFG--WSVHAPSSRRDTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCY 198
Query: 236 ELAKGEPP-------NSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPENRP 288
           E   G+PP        +     RV F  P           T+  ++ +   L  +P  RP
Sbjct: 199 EFLVGKPPFEANTYQETYKRISRVEFTFP--------DFVTEGARDLISRLLKHNPSQRP 250
Query: 289 TAKELLKFPFI 299
             +E+L+ P+I
Sbjct: 251 MLREVLEHPWI 261

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score =  108 bits (269), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 62/191 (32%), Positives = 100/191 (52%), Gaps = 18/191 (9%)
Query: 117 GTKLWIIMEYLGGGSAL-DLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANV 175
            T++++I+EY   G+   +L K   F+E   A  + E+   L Y HS+R +HRDIK  N+
Sbjct: 83  ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENL 142
Query: 176 LLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAI 235
           LL   G++K+ADFG   ++   +S+R T  GT  ++ PE+I+   +D K D+WSLG+   
Sbjct: 143 LLGSAGELKIADFG--WSVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCY 200
Query: 236 ELAKGEPP-------NSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPENRP 288
           E   G+PP        +     RV F  P           T+  ++ +   L  +P  RP
Sbjct: 201 EFLVGKPPFEANTYQETYKRISRVEFTFP--------DFVTEGARDLISRLLKHNPSQRP 252
Query: 289 TAKELLKFPFI 299
             +E+L+ P+I
Sbjct: 253 MLREVLEHPWI 263

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score =  108 bits (269), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 62/191 (32%), Positives = 100/191 (52%), Gaps = 18/191 (9%)
Query: 117 GTKLWIIMEYLGGGSAL-DLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANV 175
            T++++I+EY   G+   +L K   F+E   A  + E+   L Y HS+R +HRDIK  N+
Sbjct: 85  ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENL 144
Query: 176 LLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAI 235
           LL   G++K+ADFG   ++   +S+R T  GT  ++ PE+I+   +D K D+WSLG+   
Sbjct: 145 LLGSAGELKIADFG--WSVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCY 202
Query: 236 ELAKGEPP-------NSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPENRP 288
           E   G+PP        +     RV F  P           T+  ++ +   L  +P  RP
Sbjct: 203 EFLVGKPPFEANTYQETYKRISRVEFTFPD--------FVTEGARDLISRLLKHNPSQRP 254
Query: 289 TAKELLKFPFI 299
             +E+L+ P+I
Sbjct: 255 MLREVLEHPWI 265

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score =  108 bits (269), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 62/191 (32%), Positives = 100/191 (52%), Gaps = 18/191 (9%)
Query: 117 GTKLWIIMEYLGGGSAL-DLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANV 175
            T++++I+EY   G+   +L K   F+E   A  + E+   L Y HS+R +HRDIK  N+
Sbjct: 80  ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENL 139
Query: 176 LLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAI 235
           LL   G++K+ADFG   ++   +S+R T  GT  ++ PE+I+   +D K D+WSLG+   
Sbjct: 140 LLGSAGELKIADFG--WSVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCY 197
Query: 236 ELAKGEPP-------NSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPENRP 288
           E   G+PP        +     RV F  P           T+  ++ +   L  +P  RP
Sbjct: 198 EFLVGKPPFEANTYQETYKRISRVEFTFPD--------FVTEGARDLISRLLKHNPSQRP 249
Query: 289 TAKELLKFPFI 299
             +E+L+ P+I
Sbjct: 250 MLREVLEHPWI 260

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score =  108 bits (269), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 52/141 (36%), Positives = 85/141 (60%), Gaps = 5/141 (3%)
Query: 152 EVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWM 211
           ++   L+++HS R +HRDIK ANV ++  G VKL D G+    ++ T+  ++ VGTP++M
Sbjct: 144 QLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYM 203
Query: 212 APEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPK----NNPPQLTGN 267
           +PE I ++ Y+ K+DIWSLG    E+A  + P      M +  L  K    + PP  + +
Sbjct: 204 SPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYG-DKMNLYSLCKKIEQCDYPPLPSDH 262
Query: 268 YTKQFKEFVEACLNKDPENRP 288
           Y+++ ++ V  C+N DPE RP
Sbjct: 263 YSEELRQLVNMCINPDPEKRP 283

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score =  108 bits (269), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 70/192 (36%), Positives = 108/192 (56%), Gaps = 16/192 (8%)
Query: 120 LWIIMEYLGGGSALD------LMKAGNFEEMHIAVILREVLKGLDYLHSERK-LHRDIKA 172
           +WI ME +   ++LD      + K     E  +  I   ++K L++LHS+   +HRD+K 
Sbjct: 81  VWICMELMD--TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKP 138
Query: 173 ANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVI----KQSAYDSKADIW 228
           +NVL++ +G VK+ DFG++G L +  +K +   G   +MAPE I     Q  Y  K+DIW
Sbjct: 139 SNVLINALGQVKMCDFGISGYLVDDVAK-DIDAGCKPYMAPERINPELNQKGYSVKSDIW 197
Query: 229 SLGITAIELAKGE-PPNSELHPMRVLFLIPKNNPPQLTGN-YTKQFKEFVEACLNKDPEN 286
           SLGIT IELA    P +S   P + L  + +   PQL  + ++ +F +F   CL K+ + 
Sbjct: 198 SLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKFSAEFVDFTSQCLKKNSKE 257
Query: 287 RPTAKELLKFPF 298
           RPT  EL++ PF
Sbjct: 258 RPTYPELMQHPF 269

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score =  108 bits (269), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 62/191 (32%), Positives = 99/191 (51%), Gaps = 18/191 (9%)
Query: 117 GTKLWIIMEYLGGGSAL-DLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANV 175
            T++++I+EY   G    +L K   F+E   A  + E+   L Y HS+R +HRDIK  N+
Sbjct: 85  ATRVYLILEYAPRGEVYKELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENL 144
Query: 176 LLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAI 235
           LL   G++K+ADFG   ++   +S+R T  GT  ++ PE+I+   +D K D+WSLG+   
Sbjct: 145 LLGSAGELKIADFG--WSVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCY 202
Query: 236 ELAKGEPP-------NSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPENRP 288
           E   G+PP        +     RV F  P           T+  ++ +   L  +P  RP
Sbjct: 203 EFLVGKPPFEANTYQETYKRISRVEFTFPD--------FVTEGARDLISRLLKHNPSQRP 254
Query: 289 TAKELLKFPFI 299
             +E+L+ P+I
Sbjct: 255 MLREVLEHPWI 265

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score =  107 bits (268), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 62/191 (32%), Positives = 99/191 (51%), Gaps = 18/191 (9%)
Query: 117 GTKLWIIMEYLGGGSAL-DLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANV 175
            T++++I+EY   G+   +L K   F+E   A  + E+   L Y HS+R +HRDIK  N+
Sbjct: 85  ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENL 144
Query: 176 LLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAI 235
           LL   G++K+ADFG   ++   +S+R T  GT  ++ PE I+   +D K D+WSLG+   
Sbjct: 145 LLGSAGELKIADFG--WSVHAPSSRRTTLCGTLDYLPPEXIEGRXHDEKVDLWSLGVLCY 202
Query: 236 ELAKGEPP-------NSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPENRP 288
           E   G+PP        +     RV F  P           T+  ++ +   L  +P  RP
Sbjct: 203 EFLVGKPPFEANTYQETYKRISRVEFTFPD--------FVTEGARDLISRLLKHNPSQRP 254
Query: 289 TAKELLKFPFI 299
             +E+L+ P+I
Sbjct: 255 XLREVLEHPWI 265

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score =  107 bits (267), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 62/192 (32%), Positives = 97/192 (50%), Gaps = 10/192 (5%)
Query: 118 TKLWIIMEYLGGGSALDLMKAGN-----FEEMHIAVILREVLKGLDYLHSERK-----LH 167
           T L+I+MEY  GG    ++  G       +E  +  ++ ++   L   H         LH
Sbjct: 80  TTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLH 139
Query: 168 RDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADI 227
           RD+K ANV L    +VKL DFG+A  L + TS    FVGTP++M+PE + + +Y+ K+DI
Sbjct: 140 RDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDI 199
Query: 228 WSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPENR 287
           WSLG    EL    PP +      +   I +    ++   Y+ +  E +   LN    +R
Sbjct: 200 WSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSDELNEIITRMLNLKDYHR 259
Query: 288 PTAKELLKFPFI 299
           P+ +E+L+ P I
Sbjct: 260 PSVEEILENPLI 271

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score =  107 bits (267), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 61/191 (31%), Positives = 100/191 (52%), Gaps = 18/191 (9%)
Query: 117 GTKLWIIMEYLGGGSAL-DLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANV 175
            T++++I+EY   G+   +L K   F+E   A  + E+   L Y HS+R +HRDIK  N+
Sbjct: 106 ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENL 165
Query: 176 LLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAI 235
           LL   G++K+ADFG   ++   +S+R+   GT  ++ PE+I+   +D K D+WSLG+   
Sbjct: 166 LLGSAGELKIADFG--WSVHAPSSRRDDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCY 223
Query: 236 ELAKGEPP-------NSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPENRP 288
           E   G+PP        +     RV F  P           T+  ++ +   L  +P  RP
Sbjct: 224 EFLVGKPPFEANTYQETYKRISRVEFTFP--------DFVTEGARDLISRLLKHNPSQRP 275
Query: 289 TAKELLKFPFI 299
             +E+L+ P+I
Sbjct: 276 MLREVLEHPWI 286

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score =  107 bits (267), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 62/191 (32%), Positives = 100/191 (52%), Gaps = 18/191 (9%)
Query: 117 GTKLWIIMEYLGGGSAL-DLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANV 175
            T++++I+EY   G+   +L K   F+E   A  + E+   L Y HS+R +HRDIK  N+
Sbjct: 84  ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENL 143
Query: 176 LLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAI 235
           LL   G++K+ADFG   ++   +S+R T  GT  ++ PE+I+   +D K D+WSLG+   
Sbjct: 144 LLGSAGELKIADFG--WSVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCY 201
Query: 236 ELAKGEPP-------NSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPENRP 288
           E   G+PP        +     RV F  P           T+  ++ +   L  +P  RP
Sbjct: 202 EFLVGKPPFEANTYQETYKRISRVEFTFPD--------FVTEGARDLISRLLKHNPSQRP 253
Query: 289 TAKELLKFPFI 299
             +E+L+ P+I
Sbjct: 254 MLREVLEHPWI 264

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score =  107 bits (266), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 62/191 (32%), Positives = 100/191 (52%), Gaps = 18/191 (9%)
Query: 117 GTKLWIIMEYLGGGSAL-DLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANV 175
            T++++I+EY   G+   +L K   F+E   A  + E+   L Y HS+R +HRDIK  N+
Sbjct: 79  ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENL 138
Query: 176 LLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAI 235
           LL   G++K+ADFG   ++   +S+R T  GT  ++ PE+I+   +D K D+WSLG+   
Sbjct: 139 LLGSAGELKIADFG--WSVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCY 196
Query: 236 ELAKGEPP-------NSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPENRP 288
           E   G+PP        +     RV F  P           T+  ++ +   L  +P  RP
Sbjct: 197 EFLVGKPPFEANTYQETYKRISRVEFTFPD--------FVTEGARDLISRLLKHNPSQRP 248
Query: 289 TAKELLKFPFI 299
             +E+L+ P+I
Sbjct: 249 MLREVLEHPWI 259

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score =  107 bits (266), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 62/191 (32%), Positives = 100/191 (52%), Gaps = 18/191 (9%)
Query: 117 GTKLWIIMEYLGGGSAL-DLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANV 175
            T++++I+EY   G+   +L K   F+E   A  + E+   L Y HS+R +HRDIK  N+
Sbjct: 83  ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENL 142
Query: 176 LLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAI 235
           LL   G++K+ADFG   ++   +S+R T  GT  ++ PE+I+   +D K D+WSLG+   
Sbjct: 143 LLGSAGELKIADFG--WSVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCY 200
Query: 236 ELAKGEPP-------NSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPENRP 288
           E   G+PP        +     RV F  P           T+  ++ +   L  +P  RP
Sbjct: 201 EFLVGKPPFEANTYQETYKRISRVEFTFPD--------FVTEGARDLISRLLKHNPSQRP 252
Query: 289 TAKELLKFPFI 299
             +E+L+ P+I
Sbjct: 253 MLREVLEHPWI 263

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score =  107 bits (266), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 62/191 (32%), Positives = 99/191 (51%), Gaps = 18/191 (9%)
Query: 117 GTKLWIIMEYLGGGSAL-DLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANV 175
            T++++I+EY   G+   +L K   F+E   A  + E+   L Y HS+R +HRDIK  N+
Sbjct: 81  ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENL 140
Query: 176 LLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAI 235
           LL   G++K+ADFG   +    +S+R T  GT  ++ PE+I+   +D K D+WSLG+   
Sbjct: 141 LLGSAGELKIADFG--WSCHAPSSRRTTLSGTLDYLPPEMIEGRMHDEKVDLWSLGVLCY 198
Query: 236 ELAKGEPP-------NSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPENRP 288
           E   G+PP        +     RV F  P           T+  ++ +   L  +P  RP
Sbjct: 199 EFLVGKPPFEANTYQETYKRISRVEFTFPD--------FVTEGARDLISRLLKHNPSQRP 250
Query: 289 TAKELLKFPFI 299
             +E+L+ P+I
Sbjct: 251 MLREVLEHPWI 261

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score =  106 bits (265), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 62/191 (32%), Positives = 100/191 (52%), Gaps = 18/191 (9%)
Query: 117 GTKLWIIMEYLGGGSAL-DLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANV 175
            T++++I+EY   G+   +L K   F+E   A  + E+   L Y HS+R +HRDIK  N+
Sbjct: 77  ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENL 136
Query: 176 LLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAI 235
           LL   G++K+ADFG   ++   +S+R T  GT  ++ PE+I+   +D K D+WSLG+   
Sbjct: 137 LLGSAGELKIADFG--WSVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCY 194
Query: 236 ELAKGEPP-------NSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPENRP 288
           E   G+PP        +     RV F  P           T+  ++ +   L  +P  RP
Sbjct: 195 EFLVGKPPFEANTYQETYKRISRVEFTFPD--------FVTEGARDLISRLLKHNPSQRP 246
Query: 289 TAKELLKFPFI 299
             +E+L+ P+I
Sbjct: 247 MLREVLEHPWI 257

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score =  106 bits (265), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 61/191 (31%), Positives = 100/191 (52%), Gaps = 18/191 (9%)
Query: 117 GTKLWIIMEYLGGGSAL-DLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANV 175
            T++++I+EY   G+   +L K   F+E   A  + E+   L Y HS+R +HRDIK  N+
Sbjct: 82  ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENL 141
Query: 176 LLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAI 235
           LL   G++K+A+FG   ++   +S+R T  GT  ++ PE+I+   +D K D+WSLG+   
Sbjct: 142 LLGSAGELKIANFG--WSVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCY 199
Query: 236 ELAKGEPP-------NSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPENRP 288
           E   G+PP        +     RV F  P           T+  ++ +   L  +P  RP
Sbjct: 200 EFLVGKPPFEANTYQETYKRISRVEFTFP--------DFVTEGARDLISRLLKHNPSQRP 251
Query: 289 TAKELLKFPFI 299
             +E+L+ P+I
Sbjct: 252 MLREVLEHPWI 262

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score =  105 bits (263), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 61/191 (31%), Positives = 99/191 (51%), Gaps = 18/191 (9%)
Query: 117 GTKLWIIMEYLGGGSAL-DLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANV 175
            T++++I+EY   G+   +L K   F+E   A  + E+   L Y HS+R +HRDIK  N+
Sbjct: 82  ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENL 141
Query: 176 LLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAI 235
           LL   G++K+ADFG   ++   +S+R    GT  ++ PE+I+   +D K D+WSLG+   
Sbjct: 142 LLGSAGELKIADFG--WSVHAPSSRRXXLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCY 199
Query: 236 ELAKGEPP-------NSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPENRP 288
           E   G+PP        +     RV F  P           T+  ++ +   L  +P  RP
Sbjct: 200 EFLVGKPPFEANTYQETYKRISRVEFTFP--------DFVTEGARDLISRLLKHNPSQRP 251
Query: 289 TAKELLKFPFI 299
             +E+L+ P+I
Sbjct: 252 MLREVLEHPWI 262

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score =  105 bits (263), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 61/191 (31%), Positives = 99/191 (51%), Gaps = 18/191 (9%)
Query: 117 GTKLWIIMEYLGGGSAL-DLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANV 175
            T++++I+EY   G+   +L K   F+E   A  + E+   L Y HS+R +HRDIK  N+
Sbjct: 85  ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENL 144
Query: 176 LLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAI 235
           LL   G++K+ADFG   ++   +S+R    GT  ++ PE+I+   +D K D+WSLG+   
Sbjct: 145 LLGSAGELKIADFG--WSVHAPSSRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCY 202
Query: 236 ELAKGEPP-------NSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPENRP 288
           E   G+PP        +     RV F  P           T+  ++ +   L  +P  RP
Sbjct: 203 EFLVGKPPFEANTYQETYKRISRVEFTFPD--------FVTEGARDLISRLLKHNPSQRP 254
Query: 289 TAKELLKFPFI 299
             +E+L+ P+I
Sbjct: 255 MLREVLEHPWI 265

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score =  105 bits (263), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 61/191 (31%), Positives = 99/191 (51%), Gaps = 18/191 (9%)
Query: 117 GTKLWIIMEYLGGGSAL-DLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANV 175
            T++++I+EY   G+   +L K   F+E   A  + E+   L Y HS+R +HRDIK  N+
Sbjct: 80  ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENL 139
Query: 176 LLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAI 235
           LL   G++K+ADFG   ++   +S+R    GT  ++ PE+I+   +D K D+WSLG+   
Sbjct: 140 LLGSAGELKIADFG--WSVHAPSSRRTELCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCY 197
Query: 236 ELAKGEPP-------NSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPENRP 288
           E   G+PP        +     RV F  P           T+  ++ +   L  +P  RP
Sbjct: 198 EFLVGKPPFEANTYQETYKRISRVEFTFPD--------FVTEGARDLISRLLKHNPSQRP 249
Query: 289 TAKELLKFPFI 299
             +E+L+ P+I
Sbjct: 250 MLREVLEHPWI 260

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score =  105 bits (263), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 61/191 (31%), Positives = 99/191 (51%), Gaps = 18/191 (9%)
Query: 117 GTKLWIIMEYLGGGSAL-DLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANV 175
            T++++I+EY   G+   +L K   F+E   A  + E+   L Y HS+R +HRDIK  N+
Sbjct: 81  ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENL 140
Query: 176 LLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAI 235
           LL   G++K+ADFG   ++   +S+R    GT  ++ PE+I+   +D K D+WSLG+   
Sbjct: 141 LLGSAGELKIADFG--WSVHAPSSRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCY 198
Query: 236 ELAKGEPP-------NSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPENRP 288
           E   G+PP        +     RV F  P           T+  ++ +   L  +P  RP
Sbjct: 199 EFLVGKPPFEANTYQETYKRISRVEFTFP--------DFVTEGARDLISRLLKHNPSQRP 250
Query: 289 TAKELLKFPFI 299
             +E+L+ P+I
Sbjct: 251 MLREVLEHPWI 261

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score =  105 bits (263), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 61/191 (31%), Positives = 99/191 (51%), Gaps = 18/191 (9%)
Query: 117 GTKLWIIMEYLGGGSAL-DLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANV 175
            T++++I+EY   G+   +L K   F+E   A  + E+   L Y HS+R +HRDIK  N+
Sbjct: 83  ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENL 142
Query: 176 LLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAI 235
           LL   G++K+ADFG   ++   +S+R    GT  ++ PE+I+   +D K D+WSLG+   
Sbjct: 143 LLGSAGELKIADFG--WSVHAPSSRRAALCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCY 200
Query: 236 ELAKGEPP-------NSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPENRP 288
           E   G+PP        +     RV F  P           T+  ++ +   L  +P  RP
Sbjct: 201 EFLVGKPPFEANTYQETYKRISRVEFTFPD--------FVTEGARDLISRLLKHNPSQRP 252
Query: 289 TAKELLKFPFI 299
             +E+L+ P+I
Sbjct: 253 MLREVLEHPWI 263

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score =  105 bits (262), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 76/263 (28%), Positives = 122/263 (46%), Gaps = 23/263 (8%)
Query: 59  FTKQERIGKGSFGEVFKGIDNRT--QQVVXXXXXXXXXXXXXXXXXXXXXMVLSQCDSPY 116
           + + +++G G++GEV    D  T  ++ +                      VL Q D P 
Sbjct: 23  YQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDHPN 82
Query: 117 GTKLW----------IIMEYLGGGSALD-LMKAGNFEEMHIAVILREVLKGLDYLHSERK 165
             KL+          ++ME   GG   D ++    F E+  AVI+++VL G  YLH    
Sbjct: 83  IMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVIMKQVLSGTTYLHKHNI 142
Query: 166 LHRDIKAANVLL---SEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYD 222
           +HRD+K  N+LL   S    +K+ DFG++        K    +GT +++APEV+++  YD
Sbjct: 143 VHRDLKPENLLLESKSRDALIKIVDFGLSAHF-EVGGKMKERLGTAYYIAPEVLRKK-YD 200
Query: 223 SKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKN----NPPQLTGNYTKQFKEFVEA 278
            K D+WS G+    L  G PP        +L  + K     +PP  T   + + K+ V+ 
Sbjct: 201 EKCDVWSCGVILYILLCGYPPFGGQTDQEILKRVEKGKFSFDPPDWT-QVSDEAKQLVKL 259
Query: 279 CLNKDPENRPTAKELLKFPFIRK 301
            L  +P  R +A+E L  P+I K
Sbjct: 260 MLTYEPSKRISAEEALNHPWIVK 282

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score =  105 bits (262), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 61/191 (31%), Positives = 99/191 (51%), Gaps = 18/191 (9%)
Query: 117 GTKLWIIMEYLGGGSAL-DLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANV 175
            T++++I+EY   G+   +L K   F+E   A  + E+   L Y HS+R +HRDIK  N+
Sbjct: 80  ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENL 139
Query: 176 LLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAI 235
           LL   G++K+ADFG   ++   +S+R    GT  ++ PE+I+   +D K D+WSLG+   
Sbjct: 140 LLGSAGELKIADFG--WSVHAPSSRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCY 197
Query: 236 ELAKGEPP-------NSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPENRP 288
           E   G+PP        +     RV F  P           T+  ++ +   L  +P  RP
Sbjct: 198 EFLVGKPPFEANTYQETYKRISRVEFTFP--------DFVTEGARDLISRLLKHNPSQRP 249
Query: 289 TAKELLKFPFI 299
             +E+L+ P+I
Sbjct: 250 MLREVLEHPWI 260

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score =  105 bits (262), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 61/191 (31%), Positives = 100/191 (52%), Gaps = 18/191 (9%)
Query: 117 GTKLWIIMEYLGGGSAL-DLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANV 175
            T++++I+EY   G+   +L K   F+E   A  + E+   L Y HS+R +HRDIK  N+
Sbjct: 83  ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENL 142
Query: 176 LLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAI 235
           LL   G++K+A+FG   ++   +S+R T  GT  ++ PE+I+   +D K D+WSLG+   
Sbjct: 143 LLGSAGELKIANFG--WSVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCY 200
Query: 236 ELAKGEPP-------NSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPENRP 288
           E   G+PP        +     RV F  P           T+  ++ +   L  +P  RP
Sbjct: 201 EFLVGKPPFEANTYQETYKRISRVEFTFPD--------FVTEGARDLISRLLKHNPSQRP 252
Query: 289 TAKELLKFPFI 299
             +E+L+ P+I
Sbjct: 253 MLREVLEHPWI 263

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score =  105 bits (262), Expect = 8e-23,   Method: Compositional matrix adjust.
 Identities = 61/191 (31%), Positives = 100/191 (52%), Gaps = 18/191 (9%)
Query: 117 GTKLWIIMEYLGGGSAL-DLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANV 175
            T++++I+EY   G+   +L K   F+E   A  + E+   L Y HS+R +HRDIK  N+
Sbjct: 83  ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENL 142
Query: 176 LLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAI 235
           LL   G++K+ADFG   ++   +S+R+   GT  ++ PE+I+   +D K D+WSLG+   
Sbjct: 143 LLGSAGELKIADFG--WSVHAPSSRRDDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCY 200
Query: 236 ELAKGEPP-------NSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPENRP 288
           E   G+PP        +     RV F  P           T+  ++ +   L  +P  RP
Sbjct: 201 EFLVGKPPFEANTYQETYKRISRVEFTFPD--------FVTEGARDLISRLLKHNPSQRP 252
Query: 289 TAKELLKFPFI 299
             +E+L+ P+I
Sbjct: 253 MLREVLEHPWI 263

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score =  105 bits (261), Expect = 9e-23,   Method: Compositional matrix adjust.
 Identities = 61/191 (31%), Positives = 98/191 (51%), Gaps = 18/191 (9%)
Query: 117 GTKLWIIMEYLGGGSAL-DLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANV 175
            T++++I+EY   G    +L K   F+E   A  + E+   L Y HS+R +HRDIK  N+
Sbjct: 85  ATRVYLILEYAPRGEVYKELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENL 144
Query: 176 LLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAI 235
           LL   G++K+ADFG   ++   +S+R    GT  ++ PE+I+   +D K D+WSLG+   
Sbjct: 145 LLGSAGELKIADFG--WSVHAPSSRRXXLXGTLDYLPPEMIEGRMHDEKVDLWSLGVLCY 202
Query: 236 ELAKGEPP-------NSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPENRP 288
           E   G+PP        +     RV F  P           T+  ++ +   L  +P  RP
Sbjct: 203 EFLVGKPPFEANTYQETYKRISRVEFTFP--------DFVTEGARDLISRLLKHNPSQRP 254
Query: 289 TAKELLKFPFI 299
             +E+L+ P+I
Sbjct: 255 MLREVLEHPWI 265

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score =  105 bits (261), Expect = 9e-23,   Method: Compositional matrix adjust.
 Identities = 61/191 (31%), Positives = 99/191 (51%), Gaps = 18/191 (9%)
Query: 117 GTKLWIIMEYLGGGSAL-DLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANV 175
            T++++I+EY   G+   +L K   F+E   A  + E+   L Y HS+R +HRDIK  N+
Sbjct: 80  ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENL 139
Query: 176 LLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAI 235
           LL   G++K+ADFG   ++   +S+R    GT  ++ PE+I+   +D K D+WSLG+   
Sbjct: 140 LLGSAGELKIADFG--WSVHAPSSRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCY 197
Query: 236 ELAKGEPP-------NSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPENRP 288
           E   G+PP        +     RV F  P           T+  ++ +   L  +P  RP
Sbjct: 198 EFLVGKPPFEANTYQETYKRISRVEFTFPD--------FVTEGARDLISRLLKHNPSQRP 249
Query: 289 TAKELLKFPFI 299
             +E+L+ P+I
Sbjct: 250 MLREVLEHPWI 260

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score =  105 bits (261), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 61/191 (31%), Positives = 99/191 (51%), Gaps = 18/191 (9%)
Query: 117 GTKLWIIMEYLGGGSAL-DLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANV 175
            T++++I+EY   G+   +L K   F+E   A  + E+   L Y HS+R +HRDIK  N+
Sbjct: 80  ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENL 139
Query: 176 LLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAI 235
           LL   G++K+ADFG   ++   +S+R    GT  ++ PE+I+   +D K D+WSLG+   
Sbjct: 140 LLGSAGELKIADFG--WSVHAPSSRRTXLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCY 197
Query: 236 ELAKGEPP-------NSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPENRP 288
           E   G+PP        +     RV F  P           T+  ++ +   L  +P  RP
Sbjct: 198 EFLVGKPPFEANTYQETYKRISRVEFTFPD--------FVTEGARDLISRLLKHNPSQRP 249
Query: 289 TAKELLKFPFI 299
             +E+L+ P+I
Sbjct: 250 MLREVLEHPWI 260

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score =  104 bits (260), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 76/263 (28%), Positives = 122/263 (46%), Gaps = 23/263 (8%)
Query: 59  FTKQERIGKGSFGEVFKGIDNRT--QQVVXXXXXXXXXXXXXXXXXXXXXMVLSQCDSPY 116
           + + +++G G++GEV    D  T  ++ +                      VL Q D P 
Sbjct: 6   YQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDHPN 65
Query: 117 GTKLW----------IIMEYLGGGSALD-LMKAGNFEEMHIAVILREVLKGLDYLHSERK 165
             KL+          ++ME   GG   D ++    F E+  AVI+++VL G  YLH    
Sbjct: 66  IMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVIMKQVLSGTTYLHKHNI 125
Query: 166 LHRDIKAANVLL---SEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYD 222
           +HRD+K  N+LL   S    +K+ DFG++        K    +GT +++APEV+++  YD
Sbjct: 126 VHRDLKPENLLLESKSRDALIKIVDFGLSAHF-EVGGKMKERLGTAYYIAPEVLRKK-YD 183
Query: 223 SKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKN----NPPQLTGNYTKQFKEFVEA 278
            K D+WS G+    L  G PP        +L  + K     +PP  T   + + K+ V+ 
Sbjct: 184 EKCDVWSCGVILYILLCGYPPFGGQTDQEILKRVEKGKFSFDPPDWT-QVSDEAKQLVKL 242
Query: 279 CLNKDPENRPTAKELLKFPFIRK 301
            L  +P  R +A+E L  P+I K
Sbjct: 243 MLTYEPSKRISAEEALNHPWIVK 265

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score =  104 bits (260), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 61/191 (31%), Positives = 99/191 (51%), Gaps = 18/191 (9%)
Query: 117 GTKLWIIMEYLGGGSAL-DLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANV 175
            T++++I+EY   G+   +L K   F+E   A  + E+   L Y HS+R +HRDIK  N+
Sbjct: 80  ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENL 139
Query: 176 LLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAI 235
           LL   G++K+ADFG   ++   +S+R    GT  ++ PE+I+   +D K D+WSLG+   
Sbjct: 140 LLGSAGELKIADFG--WSVHAPSSRRAALCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCY 197
Query: 236 ELAKGEPP-------NSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPENRP 288
           E   G+PP        +     RV F  P           T+  ++ +   L  +P  RP
Sbjct: 198 EFLVGKPPFEANTYQETYKRISRVEFTFPD--------FVTEGARDLISRLLKHNPSQRP 249
Query: 289 TAKELLKFPFI 299
             +E+L+ P+I
Sbjct: 250 MLREVLEHPWI 260

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score =  104 bits (260), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 61/191 (31%), Positives = 99/191 (51%), Gaps = 18/191 (9%)
Query: 117 GTKLWIIMEYLGGGSAL-DLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANV 175
            T++++I+EY   G+   +L K   F+E   A  + E+   L Y HS+R +HRDIK  N+
Sbjct: 80  ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENL 139
Query: 176 LLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAI 235
           LL   G++K+ADFG   ++   +S+R    GT  ++ PE+I+   +D K D+WSLG+   
Sbjct: 140 LLGSAGELKIADFG--WSVHAPSSRRXXLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCY 197
Query: 236 ELAKGEPP-------NSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPENRP 288
           E   G+PP        +     RV F  P           T+  ++ +   L  +P  RP
Sbjct: 198 EFLVGKPPFEANTYQETYKRISRVEFTFPD--------FVTEGARDLISRLLKHNPSQRP 249
Query: 289 TAKELLKFPFI 299
             +E+L+ P+I
Sbjct: 250 MLREVLEHPWI 260

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score =  104 bits (260), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 73/261 (27%), Positives = 125/261 (47%), Gaps = 22/261 (8%)
Query: 58  IFTKQERIGKGSFGEVFKGIDNRTQQVVXXXXXXXXXXXXXXXXXXXXXMVLSQCDSP-- 115
           I+  ++ +G G+F EV    D RTQ++V                      VL +   P  
Sbjct: 19  IYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNI 78
Query: 116 --------YGTKLWIIMEYLGGGSALD-LMKAGNFEEMHIAVILREVLKGLDYLHSERKL 166
                    G  L++IM+ + GG   D +++ G + E   + ++ +VL  + YLH    +
Sbjct: 79  VALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIV 138
Query: 167 HRDIKAANVL---LSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDS 223
           HRD+K  N+L   L E   + ++DFG++  + +  S  +T  GTP ++APEV+ Q  Y  
Sbjct: 139 HRDLKPENLLYYSLDEDSKIMISDFGLS-KMEDPGSVLSTACGTPGYVAPEVLAQKPYSK 197
Query: 224 KADIWSLGITAIELAKGEPPNSELHPMRVLFLIPK-----NNPPQLTGNYTKQFKEFVEA 278
             D WS+G+ A  L  G PP  + +  ++   I K     ++P     + +   K+F+  
Sbjct: 198 AVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSP--YWDDISDSAKDFIRH 255
Query: 279 CLNKDPENRPTAKELLKFPFI 299
            + KDPE R T ++ L+ P+I
Sbjct: 256 LMEKDPEKRFTCEQALQHPWI 276

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score =  104 bits (259), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 61/191 (31%), Positives = 99/191 (51%), Gaps = 18/191 (9%)
Query: 117 GTKLWIIMEYLGGGSAL-DLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANV 175
            T++++I+EY   G+   +L K   F+E   A  + E+   L Y HS+R +HRDIK  N+
Sbjct: 83  ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENL 142
Query: 176 LLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAI 235
           LL   G++K+ADFG   ++   +S+R    GT  ++ PE+I+   +D K D+WSLG+   
Sbjct: 143 LLGSAGELKIADFG--WSVHAPSSRRXXLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCY 200
Query: 236 ELAKGEPP-------NSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPENRP 288
           E   G+PP        +     RV F  P           T+  ++ +   L  +P  RP
Sbjct: 201 EFLVGKPPFEANTYQETYKRISRVEFTFPD--------FVTEGARDLISRLLKHNPSQRP 252
Query: 289 TAKELLKFPFI 299
             +E+L+ P+I
Sbjct: 253 MLREVLEHPWI 263

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score =  103 bits (258), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 73/261 (27%), Positives = 125/261 (47%), Gaps = 22/261 (8%)
Query: 58  IFTKQERIGKGSFGEVFKGIDNRTQQVVXXXXXXXXXXXXXXXXXXXXXMVLSQCDSP-- 115
           I+  ++ +G G+F EV    D RTQ++V                      VL +   P  
Sbjct: 19  IYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNI 78
Query: 116 --------YGTKLWIIMEYLGGGSALD-LMKAGNFEEMHIAVILREVLKGLDYLHSERKL 166
                    G  L++IM+ + GG   D +++ G + E   + ++ +VL  + YLH    +
Sbjct: 79  VALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIV 138
Query: 167 HRDIKAANVL---LSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDS 223
           HRD+K  N+L   L E   + ++DFG++  + +  S  +T  GTP ++APEV+ Q  Y  
Sbjct: 139 HRDLKPENLLYYSLDEDSKIMISDFGLS-KMEDPGSVLSTACGTPGYVAPEVLAQKPYSK 197
Query: 224 KADIWSLGITAIELAKGEPPNSELHPMRVLFLIPK-----NNPPQLTGNYTKQFKEFVEA 278
             D WS+G+ A  L  G PP  + +  ++   I K     ++P     + +   K+F+  
Sbjct: 198 AVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSP--YWDDISDSAKDFIRH 255
Query: 279 CLNKDPENRPTAKELLKFPFI 299
            + KDPE R T ++ L+ P+I
Sbjct: 256 LMEKDPEKRFTCEQALQHPWI 276

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score =  103 bits (258), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 73/261 (27%), Positives = 125/261 (47%), Gaps = 22/261 (8%)
Query: 58  IFTKQERIGKGSFGEVFKGIDNRTQQVVXXXXXXXXXXXXXXXXXXXXXMVLSQCDSP-- 115
           I+  ++ +G G+F EV    D RTQ++V                      VL +   P  
Sbjct: 19  IYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNI 78
Query: 116 --------YGTKLWIIMEYLGGGSALD-LMKAGNFEEMHIAVILREVLKGLDYLHSERKL 166
                    G  L++IM+ + GG   D +++ G + E   + ++ +VL  + YLH    +
Sbjct: 79  VALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIV 138
Query: 167 HRDIKAANVL---LSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDS 223
           HRD+K  N+L   L E   + ++DFG++  + +  S  +T  GTP ++APEV+ Q  Y  
Sbjct: 139 HRDLKPENLLYYSLDEDSKIMISDFGLS-KMEDPGSVLSTACGTPGYVAPEVLAQKPYSK 197
Query: 224 KADIWSLGITAIELAKGEPPNSELHPMRVLFLIPK-----NNPPQLTGNYTKQFKEFVEA 278
             D WS+G+ A  L  G PP  + +  ++   I K     ++P     + +   K+F+  
Sbjct: 198 AVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSP--YWDDISDSAKDFIRH 255
Query: 279 CLNKDPENRPTAKELLKFPFI 299
            + KDPE R T ++ L+ P+I
Sbjct: 256 LMEKDPEKRFTCEQALQHPWI 276

>pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373

Iteration: 1
 Score =  103 bits (258), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 72/247 (29%), Positives = 116/247 (46%), Gaps = 61/247 (24%)
Query: 119 KLWIIMEYLGGGSALDLMKA---GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANV 175
           +LW++  ++  GSA DL+         E+ IA IL+ VLK LDY+H    +HR +KA+++
Sbjct: 84  ELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHI 143
Query: 176 LLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPF---------WMAPEVIKQS--AYDSK 224
           L+S  G V L+  G+   L+  +  +   V   F         W++PEV++Q+   YD+K
Sbjct: 144 LISVDGKVYLS--GLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAK 201
Query: 225 ADIWSLGITAIELAKGEPPNSELHPMRVLF--------------LIPKN----NPPQLTG 266
           +DI+S+GITA ELA G  P  ++   ++L                IP      +P +   
Sbjct: 202 SDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVA 261
Query: 267 N---------------------------YTKQFKEFVEACLNKDPENRPTAKELLKFPFI 299
           N                           ++  F  FVE CL ++P+ RP+A  LL   F 
Sbjct: 262 NSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFF 321
Query: 300 RKAKKNA 306
           ++ K+ A
Sbjct: 322 KQIKRRA 328

>pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389

Iteration: 1
 Score =  103 bits (258), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 72/247 (29%), Positives = 116/247 (46%), Gaps = 61/247 (24%)
Query: 119 KLWIIMEYLGGGSALDLMKA---GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANV 175
           +LW++  ++  GSA DL+         E+ IA IL+ VLK LDY+H    +HR +KA+++
Sbjct: 100 ELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHI 159
Query: 176 LLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPF---------WMAPEVIKQS--AYDSK 224
           L+S  G V L+  G+   L+  +  +   V   F         W++PEV++Q+   YD+K
Sbjct: 160 LISVDGKVYLS--GLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAK 217
Query: 225 ADIWSLGITAIELAKGEPPNSELHPMRVLF--------------LIPKN----NPPQLTG 266
           +DI+S+GITA ELA G  P  ++   ++L                IP      +P +   
Sbjct: 218 SDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVA 277
Query: 267 N---------------------------YTKQFKEFVEACLNKDPENRPTAKELLKFPFI 299
           N                           ++  F  FVE CL ++P+ RP+A  LL   F 
Sbjct: 278 NSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFF 337
Query: 300 RKAKKNA 306
           ++ K+ A
Sbjct: 338 KQIKRRA 344

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score =  103 bits (258), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 75/256 (29%), Positives = 117/256 (45%), Gaps = 22/256 (8%)
Query: 65  IGKGSFGEVFKGIDNRTQQVVXXXXXXXXXXXXXXXXXXXXXM-VLSQCDSPYGTKLWII 123
           +GKGSFGEV K  D  TQQ                       + +L + D P   KL+ I
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 124 ME-----------YLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKA 172
           +E           Y GG    +++K   F E   A I+++V  G+ Y+H    +HRD+K 
Sbjct: 90  LEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKP 149
Query: 173 ANVLLSEM---GDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWS 229
            N+LL       D+K+ DFG++      T  ++  +GT +++APEV++   YD K D+WS
Sbjct: 150 ENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDR-IGTAYYIAPEVLR-GTYDEKCDVWS 207
Query: 230 LGITAIELAKGEPPNSELHPMRVLFLIPKN----NPPQLTGNYTKQFKEFVEACLNKDPE 285
            G+    L  G PP    +   +L  +       + PQ     +   K+ +   L   P 
Sbjct: 208 AGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWR-TISDDAKDLIRKMLTFHPS 266
Query: 286 NRPTAKELLKFPFIRK 301
            R TA + L+ P+I+K
Sbjct: 267 LRITATQCLEHPWIQK 282

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score =  103 bits (258), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 75/256 (29%), Positives = 117/256 (45%), Gaps = 22/256 (8%)
Query: 65  IGKGSFGEVFKGIDNRTQQVVXXXXXXXXXXXXXXXXXXXXXM-VLSQCDSPYGTKLWII 123
           +GKGSFGEV K  D  TQQ                       + +L + D P   KL+ I
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 124 ME-----------YLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKA 172
           +E           Y GG    +++K   F E   A I+++V  G+ Y+H    +HRD+K 
Sbjct: 90  LEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKP 149
Query: 173 ANVLLSEM---GDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWS 229
            N+LL       D+K+ DFG++      T  ++  +GT +++APEV++   YD K D+WS
Sbjct: 150 ENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDR-IGTAYYIAPEVLR-GTYDEKCDVWS 207
Query: 230 LGITAIELAKGEPPNSELHPMRVLFLIPKN----NPPQLTGNYTKQFKEFVEACLNKDPE 285
            G+    L  G PP    +   +L  +       + PQ     +   K+ +   L   P 
Sbjct: 208 AGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWR-TISDDAKDLIRKMLTFHPS 266
Query: 286 NRPTAKELLKFPFIRK 301
            R TA + L+ P+I+K
Sbjct: 267 LRITATQCLEHPWIQK 282

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score =  103 bits (258), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 73/261 (27%), Positives = 125/261 (47%), Gaps = 22/261 (8%)
Query: 58  IFTKQERIGKGSFGEVFKGIDNRTQQVVXXXXXXXXXXXXXXXXXXXXXMVLSQCDSP-- 115
           I+  ++ +G G+F EV    D RTQ++V                      VL +   P  
Sbjct: 19  IYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNI 78
Query: 116 --------YGTKLWIIMEYLGGGSALD-LMKAGNFEEMHIAVILREVLKGLDYLHSERKL 166
                    G  L++IM+ + GG   D +++ G + E   + ++ +VL  + YLH    +
Sbjct: 79  VALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIV 138
Query: 167 HRDIKAANVL---LSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDS 223
           HRD+K  N+L   L E   + ++DFG++  + +  S  +T  GTP ++APEV+ Q  Y  
Sbjct: 139 HRDLKPENLLYYSLDEDSKIMISDFGLS-KMEDPGSVLSTACGTPGYVAPEVLAQKPYSK 197
Query: 224 KADIWSLGITAIELAKGEPPNSELHPMRVLFLIPK-----NNPPQLTGNYTKQFKEFVEA 278
             D WS+G+ A  L  G PP  + +  ++   I K     ++P     + +   K+F+  
Sbjct: 198 AVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSP--YWDDISDSAKDFIRH 255
Query: 279 CLNKDPENRPTAKELLKFPFI 299
            + KDPE R T ++ L+ P+I
Sbjct: 256 LMEKDPEKRFTCEQALQHPWI 276

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score =  103 bits (258), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 75/256 (29%), Positives = 117/256 (45%), Gaps = 22/256 (8%)
Query: 65  IGKGSFGEVFKGIDNRTQQVVXXXXXXXXXXXXXXXXXXXXXM-VLSQCDSPYGTKLWII 123
           +GKGSFGEV K  D  TQQ                       + +L + D P   KL+ I
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 124 ME-----------YLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKA 172
           +E           Y GG    +++K   F E   A I+++V  G+ Y+H    +HRD+K 
Sbjct: 90  LEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKP 149
Query: 173 ANVLLSEM---GDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWS 229
            N+LL       D+K+ DFG++      T  ++  +GT +++APEV++   YD K D+WS
Sbjct: 150 ENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDR-IGTAYYIAPEVLR-GTYDEKCDVWS 207
Query: 230 LGITAIELAKGEPPNSELHPMRVLFLIPKN----NPPQLTGNYTKQFKEFVEACLNKDPE 285
            G+    L  G PP    +   +L  +       + PQ     +   K+ +   L   P 
Sbjct: 208 AGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWR-TISDDAKDLIRKMLTFHPS 266
Query: 286 NRPTAKELLKFPFIRK 301
            R TA + L+ P+I+K
Sbjct: 267 LRITATQCLEHPWIQK 282

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score =  103 bits (258), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 60/190 (31%), Positives = 100/190 (52%), Gaps = 18/190 (9%)
Query: 118 TKLWIIMEYLGGGSAL-DLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVL 176
           T++++I+EY   G+   +L K   F+E   A  + E+   L Y HS++ +HRDIK  N+L
Sbjct: 81  TRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKKVIHRDIKPENLL 140
Query: 177 LSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIE 236
           L   G++K+ADFG   ++   +S+R    GT  ++ PE+I+   +D K D+WSLG+   E
Sbjct: 141 LGSAGELKIADFG--WSVHAPSSRRAALCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYE 198
Query: 237 LAKGEPP-------NSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPENRPT 289
              G+PP       ++     RV F  P           T+  ++ +   L  +P  RP 
Sbjct: 199 FLVGKPPFEANTYQDTYKRISRVEFTFPD--------FVTEGARDLISRLLKHNPSQRPM 250
Query: 290 AKELLKFPFI 299
            +E+L+ P+I
Sbjct: 251 LREVLEHPWI 260

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score =  103 bits (256), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 60/192 (31%), Positives = 95/192 (49%), Gaps = 10/192 (5%)
Query: 118 TKLWIIMEYLGGGSALDLMKAGN-----FEEMHIAVILREVLKGLDYLHSERK-----LH 167
           T L+I+MEY  GG    ++  G       +E  +  ++ ++   L   H         LH
Sbjct: 80  TTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLH 139
Query: 168 RDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADI 227
           RD+K ANV L    +VKL DFG+A  L +       FVGTP++M+PE + + +Y+ K+DI
Sbjct: 140 RDLKPANVFLDGKQNVKLGDFGLARILNHDEDFAKEFVGTPYYMSPEQMNRMSYNEKSDI 199
Query: 228 WSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPENR 287
           WSLG    EL    PP +      +   I +    ++   Y+ +  E +   LN    +R
Sbjct: 200 WSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSDELNEIITRMLNLKDYHR 259
Query: 288 PTAKELLKFPFI 299
           P+ +E+L+ P I
Sbjct: 260 PSVEEILENPLI 271

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score =  102 bits (255), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 80/291 (27%), Positives = 142/291 (48%), Gaps = 29/291 (9%)
Query: 58  IFTKQERIGKGSFGEVFKGIDNRTQ-QVVXXXXXXXXXXXXXXXXXXXXXMVLSQCDSPY 116
           ++ + +++G G++GEV    D  T  +                        VL   D P 
Sbjct: 38  MYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPN 97
Query: 117 GTKLW----------IIMEYLGGGSALD-LMKAGNFEEMHIAVILREVLKGLDYLHSERK 165
             KL+          ++ME   GG   D ++    F E+  AVI+++VL G+ YLH    
Sbjct: 98  IMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNI 157
Query: 166 LHRDIKAANVLL-SEMGD--VKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYD 222
           +HRD+K  N+LL S+  D  +K+ DFG++    N   K    +GT +++APEV+++  YD
Sbjct: 158 VHRDLKPENLLLESKEKDALIKIVDFGLSAVFEN-QKKMKERLGTAYYIAPEVLRKK-YD 215
Query: 223 SKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKN----NPPQLTGNYTKQFKEFVEA 278
            K D+WS+G+    L  G PP        +L  + K     + P+   N ++  K+ ++ 
Sbjct: 216 EKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWK-NVSEGAKDLIKQ 274
Query: 279 CLNKDPENRPTAKELLKFPFIRK--AKKNA-----YLIDLIDRYKKWKNSR 322
            L  D + R +A++ L+ P+I++  +KK +      L + I+  +K++NS+
Sbjct: 275 MLQFDSQRRISAQQALEHPWIKEMCSKKESGIELPSLANAIENMRKFQNSQ 325

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score =  102 bits (254), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 59/185 (31%), Positives = 98/185 (52%), Gaps = 4/185 (2%)
Query: 117 GTKLWIIMEYLGGGSAL-DLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANV 175
            T++++I+EY   G+   +L K   F+E   A  + E+   L Y HS+R +HRDIK  N+
Sbjct: 84  ATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYITELANALSYCHSKRVIHRDIKPENL 143
Query: 176 LLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAI 235
           LL   G++K+ADFG   ++   +S+R+T  GT  ++ PE+I+   +D K D+WSLG+   
Sbjct: 144 LLGSNGELKIADFG--WSVHAPSSRRDTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCY 201
Query: 236 ELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPENRPTAKELLK 295
           E   G PP  E H  +  +              T+  ++ +   L  +   R T  E+L+
Sbjct: 202 EFLVGMPP-FEAHTYQETYRRISRVEFTFPDFVTEGARDLISRLLKHNASQRLTLAEVLE 260
Query: 296 FPFIR 300
            P+I+
Sbjct: 261 HPWIK 265

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score =  101 bits (252), Expect = 9e-22,   Method: Compositional matrix adjust.
 Identities = 63/193 (32%), Positives = 99/193 (51%), Gaps = 20/193 (10%)
Query: 117 GTKLWIIMEYLGGGSAL-DLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANV 175
            T++++I+EY   G+   +L K   F+E   A  + E+   L Y HS+R +HRDIK  N+
Sbjct: 84  ATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYITELANALSYCHSKRVIHRDIKPENL 143
Query: 176 LLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAI 235
           LL   G++K+ADFG   ++   +S+R T  GT  ++ PE+I+   +D K D+WSLG+   
Sbjct: 144 LLGSNGELKIADFG--WSVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCY 201
Query: 236 ELAKGEPPNSELHPM--------RVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPENR 287
           E   G PP  E H          RV F  P           T+  ++ +   L  +   R
Sbjct: 202 EFLVGMPP-FEAHTYQETYRRISRVEFTFPD--------FVTEGARDLISRLLKHNASQR 252
Query: 288 PTAKELLKFPFIR 300
            T  E+L+ P+I+
Sbjct: 253 LTLAEVLEHPWIK 265

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 99.8 bits (247), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 61/158 (38%), Positives = 91/158 (57%), Gaps = 8/158 (5%)
Query: 149 ILREVLKGLDYLHSERK-LHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGT 207
           I   ++K L++LHS+   +HRD+K +NVL++ +G VK  DFG++G L +  +K +   G 
Sbjct: 141 IAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKXCDFGISGYLVDDVAK-DIDAGC 199
Query: 208 PFWMAPEVI----KQSAYDSKADIWSLGITAIELAKGE-PPNSELHPMRVLFLIPKNNPP 262
             + APE I     Q  Y  K+DIWSLGIT IELA    P +S   P + L  + +   P
Sbjct: 200 KPYXAPERINPELNQKGYSVKSDIWSLGITXIELAILRFPYDSWGTPFQQLKQVVEEPSP 259
Query: 263 QLTGN-YTKQFKEFVEACLNKDPENRPTAKELLKFPFI 299
           QL  + ++ +F +F   CL K+ + RPT  EL + PF 
Sbjct: 260 QLPADKFSAEFVDFTSQCLKKNSKERPTYPELXQHPFF 297

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 98.6 bits (244), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 59/175 (33%), Positives = 83/175 (47%), Gaps = 2/175 (1%)
Query: 119 KLWIIMEYLGGGSAL-DLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLL 177
           KL+ +++Y+ GG     L +   F E        E+   L YLHS   ++RD+K  N+LL
Sbjct: 113 KLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILL 172
Query: 178 SEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIEL 237
              G + L DFG+        S  +TF GTP ++APEV+ +  YD   D W LG    E+
Sbjct: 173 DSQGHIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEM 232
Query: 238 AKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPENRPTAKE 292
             G PP    +   +   I  N P QL  N T   +  +E  L KD   R  AK+
Sbjct: 233 LYGLPPFYSRNTAEMYDNI-LNKPLQLKPNITNSARHLLEGLLQKDRTKRLGAKD 286

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 98.6 bits (244), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 78/284 (27%), Positives = 128/284 (45%), Gaps = 30/284 (10%)
Query: 42  STTASRRNSLKVDPELIFTKQERIGKGSFGEVF---KGIDNRTQQVVXXXXXXXXXXXXX 98
           S T+  R   K+ PE  F     +GKG +G+VF   K     T ++              
Sbjct: 3   SETSVNRGPEKIRPE-CFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRN 61
Query: 99  XXXXXXXXM---VLSQCDSPY----------GTKLWIIMEYLGGGSA-LDLMKAGNFEEM 144
                       +L +   P+          G KL++I+EYL GG   + L + G F E 
Sbjct: 62  AKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMED 121
Query: 145 HIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTF 204
                L E+   L +LH +  ++RD+K  N++L+  G VKL DFG+     +  +  +TF
Sbjct: 122 TACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTF 181
Query: 205 VGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPK---NNP 261
            GT  +MAPE++ +S ++   D WSLG    ++  G PP +  +  + +  I K   N P
Sbjct: 182 CGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLP 241
Query: 262 PQLTGNYTKQFKEFVEACLNKDPENR-----PTAKELLKFPFIR 300
           P L    T++ ++ ++  L ++  +R       A E+   PF R
Sbjct: 242 PYL----TQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFR 281

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 98.2 bits (243), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 55/176 (31%), Positives = 90/176 (51%), Gaps = 2/176 (1%)
Query: 120 LWIIMEYLGGGSALDLMKAGN-FEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLS 178
           +++++E     S L+L K      E      LR+++ G  YLH  R +HRD+K  N+ L+
Sbjct: 92  VFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLN 151
Query: 179 EMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELA 238
           E  +VK+ DFG+A  +     ++ T  GTP ++APEV+ +  +  + D+WS+G     L 
Sbjct: 152 EDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLL 211
Query: 239 KGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPENRPTAKELL 294
            G+PP  E   ++  +L  K N   +  +        ++  L  DP  RPT  ELL
Sbjct: 212 VGKPP-FETSCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQTDPTARPTINELL 266

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 98.2 bits (243), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 77/279 (27%), Positives = 122/279 (43%), Gaps = 35/279 (12%)
Query: 59  FTKQERIGKGSFGEVFKGIDNRTQQ--VVXXXXXXXXXXXXXXXXXXXXXMVLSQCDSPY 116
           +  Q  +GKGSFGEV    D  T Q   V                      +L Q D P 
Sbjct: 52  YKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPN 111
Query: 117 GTKLWIIME-----------YLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERK 165
             KL+   E           Y GG    +++    F E+  A I+R+VL G+ Y+H  + 
Sbjct: 112 IMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKI 171
Query: 166 LHRDIKAANVLL---SEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYD 222
           +HRD+K  N+LL   S+  ++++ DFG++ T    + K    +GT +++APEV+    YD
Sbjct: 172 VHRDLKPENLLLESKSKDANIRIIDFGLS-THFEASKKMKDKIGTAYYIAPEVL-HGTYD 229
Query: 223 SKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQF---------- 272
            K D+WS G+    L  G PP +  +   +L  + K       G YT +           
Sbjct: 230 EKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEK-------GKYTFELPQWKKVSESA 282
Query: 273 KEFVEACLNKDPENRPTAKELLKFPFIRKAKKNAYLIDL 311
           K+ +   L   P  R +A++ L   +I+   K    +D+
Sbjct: 283 KDLIRKMLTYVPSMRISARDALDHEWIQTYTKEQISVDV 321

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 98.2 bits (243), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 55/176 (31%), Positives = 90/176 (51%), Gaps = 2/176 (1%)
Query: 120 LWIIMEYLGGGSALDLMKAGN-FEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLS 178
           +++++E     S L+L K      E      LR+++ G  YLH  R +HRD+K  N+ L+
Sbjct: 92  VFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLN 151
Query: 179 EMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELA 238
           E  +VK+ DFG+A  +     ++ T  GTP ++APEV+ +  +  + D+WS+G     L 
Sbjct: 152 EDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLL 211
Query: 239 KGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPENRPTAKELL 294
            G+PP  E   ++  +L  K N   +  +        ++  L  DP  RPT  ELL
Sbjct: 212 VGKPP-FETSCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQTDPTARPTINELL 266

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 98.2 bits (243), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 55/176 (31%), Positives = 90/176 (51%), Gaps = 2/176 (1%)
Query: 120 LWIIMEYLGGGSALDLMKAGN-FEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLS 178
           +++++E     S L+L K      E      LR+++ G  YLH  R +HRD+K  N+ L+
Sbjct: 96  VFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLN 155
Query: 179 EMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELA 238
           E  +VK+ DFG+A  +     ++ T  GTP ++APEV+ +  +  + D+WS+G     L 
Sbjct: 156 EDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLL 215
Query: 239 KGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPENRPTAKELL 294
            G+PP  E   ++  +L  K N   +  +        ++  L  DP  RPT  ELL
Sbjct: 216 VGKPP-FETSCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQTDPTARPTINELL 270

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 77/279 (27%), Positives = 122/279 (43%), Gaps = 35/279 (12%)
Query: 59  FTKQERIGKGSFGEVFKGIDNRTQQ--VVXXXXXXXXXXXXXXXXXXXXXMVLSQCDSPY 116
           +  Q  +GKGSFGEV    D  T Q   V                      +L Q D P 
Sbjct: 51  YKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPN 110
Query: 117 GTKLWIIME-----------YLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERK 165
             KL+   E           Y GG    +++    F E+  A I+R+VL G+ Y+H  + 
Sbjct: 111 IMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKI 170
Query: 166 LHRDIKAANVLL---SEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYD 222
           +HRD+K  N+LL   S+  ++++ DFG++ T    + K    +GT +++APEV+    YD
Sbjct: 171 VHRDLKPENLLLESKSKDANIRIIDFGLS-THFEASKKMKDKIGTAYYIAPEVL-HGTYD 228
Query: 223 SKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQF---------- 272
            K D+WS G+    L  G PP +  +   +L  + K       G YT +           
Sbjct: 229 EKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEK-------GKYTFELPQWKKVSESA 281
Query: 273 KEFVEACLNKDPENRPTAKELLKFPFIRKAKKNAYLIDL 311
           K+ +   L   P  R +A++ L   +I+   K    +D+
Sbjct: 282 KDLIRKMLTYVPSMRISARDALDHEWIQTYTKEQISVDV 320

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 97.8 bits (242), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 77/279 (27%), Positives = 122/279 (43%), Gaps = 35/279 (12%)
Query: 59  FTKQERIGKGSFGEVFKGIDNRTQQ--VVXXXXXXXXXXXXXXXXXXXXXMVLSQCDSPY 116
           +  Q  +GKGSFGEV    D  T Q   V                      +L Q D P 
Sbjct: 28  YKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPN 87
Query: 117 GTKLWIIME-----------YLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERK 165
             KL+   E           Y GG    +++    F E+  A I+R+VL G+ Y+H  + 
Sbjct: 88  IMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKI 147
Query: 166 LHRDIKAANVLL---SEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYD 222
           +HRD+K  N+LL   S+  ++++ DFG++ T    + K    +GT +++APEV+    YD
Sbjct: 148 VHRDLKPENLLLESKSKDANIRIIDFGLS-THFEASKKMKDKIGTAYYIAPEVL-HGTYD 205
Query: 223 SKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQF---------- 272
            K D+WS G+    L  G PP +  +   +L  + K       G YT +           
Sbjct: 206 EKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEK-------GKYTFELPQWKKVSESA 258
Query: 273 KEFVEACLNKDPENRPTAKELLKFPFIRKAKKNAYLIDL 311
           K+ +   L   P  R +A++ L   +I+   K    +D+
Sbjct: 259 KDLIRKMLTYVPSMRISARDALDHEWIQTYTKEQISVDV 297

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 77/279 (27%), Positives = 121/279 (43%), Gaps = 35/279 (12%)
Query: 59  FTKQERIGKGSFGEVFKGIDNRTQQ--VVXXXXXXXXXXXXXXXXXXXXXMVLSQCDSPY 116
           +  Q  +GKGSFGEV    D  T Q   V                      +L Q D P 
Sbjct: 28  YKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPN 87
Query: 117 GTKLWIIME-----------YLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERK 165
             KL+   E           Y GG    +++    F E+  A I+R+VL G+ Y H  + 
Sbjct: 88  IXKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYXHKNKI 147
Query: 166 LHRDIKAANVLL---SEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYD 222
           +HRD+K  N+LL   S+  ++++ DFG++ T    + K    +GT +++APEV+    YD
Sbjct: 148 VHRDLKPENLLLESKSKDANIRIIDFGLS-THFEASKKXKDKIGTAYYIAPEVL-HGTYD 205
Query: 223 SKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQF---------- 272
            K D+WS G+    L  G PP +  +   +L  + K       G YT +           
Sbjct: 206 EKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEK-------GKYTFELPQWKKVSESA 258
Query: 273 KEFVEACLNKDPENRPTAKELLKFPFIRKAKKNAYLIDL 311
           K+ +   L   P  R +A++ L   +I+   K    +D+
Sbjct: 259 KDLIRKXLTYVPSXRISARDALDHEWIQTYTKEQISVDV 297

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 54/176 (30%), Positives = 92/176 (52%), Gaps = 2/176 (1%)
Query: 120 LWIIMEYLGGGSALDLMKAGN-FEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLS 178
           +++++E     S L+L K      E      +R+ ++G+ YLH+ R +HRD+K  N+ L+
Sbjct: 117 VYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLHNNRVIHRDLKLGNLFLN 176
Query: 179 EMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELA 238
           +  DVK+ DFG+A  +     ++ T  GTP ++APEV+ +  +  + DIWSLG     L 
Sbjct: 177 DDMDVKIGDFGLATKIEFDGERKKTLCGTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLL 236
Query: 239 KGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPENRPTAKELL 294
            G+PP  E   ++  ++  K N   +  +        +   L+ DP  RP+  ELL
Sbjct: 237 VGKPP-FETSCLKETYIRIKKNEYSVPRHINPVASALIRRMLHADPTLRPSVAELL 291

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 96.7 bits (239), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 54/176 (30%), Positives = 89/176 (50%), Gaps = 2/176 (1%)
Query: 120 LWIIMEYLGGGSALDLMKAGN-FEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLS 178
           +++++E     S L+L K      E      LR+++ G  YLH  R +HRD+K  N+ L+
Sbjct: 114 VFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLN 173
Query: 179 EMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELA 238
           E  +VK+ DFG+A  +     ++    GTP ++APEV+ +  +  + D+WS+G     L 
Sbjct: 174 EDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLL 233
Query: 239 KGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPENRPTAKELL 294
            G+PP  E   ++  +L  K N   +  +        ++  L  DP  RPT  ELL
Sbjct: 234 VGKPP-FETSCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQTDPTARPTINELL 288

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 96.3 bits (238), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 54/176 (30%), Positives = 89/176 (50%), Gaps = 2/176 (1%)
Query: 120 LWIIMEYLGGGSALDLMKAGN-FEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLS 178
           +++++E     S L+L K      E      LR+++ G  YLH  R +HRD+K  N+ L+
Sbjct: 116 VFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLN 175
Query: 179 EMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELA 238
           E  +VK+ DFG+A  +     ++    GTP ++APEV+ +  +  + D+WS+G     L 
Sbjct: 176 EDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLL 235
Query: 239 KGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPENRPTAKELL 294
            G+PP  E   ++  +L  K N   +  +        ++  L  DP  RPT  ELL
Sbjct: 236 VGKPP-FETSCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQTDPTARPTINELL 290

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 96.3 bits (238), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 77/284 (27%), Positives = 127/284 (44%), Gaps = 30/284 (10%)
Query: 42  STTASRRNSLKVDPELIFTKQERIGKGSFGEVF---KGIDNRTQQVVXXXXXXXXXXXXX 98
           S T+  R   K+ PE  F     +GKG +G+VF   K     T ++              
Sbjct: 3   SETSVNRGPEKIRPE-CFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRN 61
Query: 99  XXXXXXXXM---VLSQCDSPY----------GTKLWIIMEYLGGGSA-LDLMKAGNFEEM 144
                       +L +   P+          G KL++I+EYL GG   + L + G F E 
Sbjct: 62  AKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMED 121
Query: 145 HIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTF 204
                L E+   L +LH +  ++RD+K  N++L+  G VKL DFG+     +  +  + F
Sbjct: 122 TACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHXF 181
Query: 205 VGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPK---NNP 261
            GT  +MAPE++ +S ++   D WSLG    ++  G PP +  +  + +  I K   N P
Sbjct: 182 CGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLP 241
Query: 262 PQLTGNYTKQFKEFVEACLNKDPENR-----PTAKELLKFPFIR 300
           P L    T++ ++ ++  L ++  +R       A E+   PF R
Sbjct: 242 PYL----TQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFR 281

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 96.3 bits (238), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 54/176 (30%), Positives = 89/176 (50%), Gaps = 2/176 (1%)
Query: 120 LWIIMEYLGGGSALDLMKAGN-FEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLS 178
           +++++E     S L+L K      E      LR+++ G  YLH  R +HRD+K  N+ L+
Sbjct: 90  VFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLN 149
Query: 179 EMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELA 238
           E  +VK+ DFG+A  +     ++    GTP ++APEV+ +  +  + D+WS+G     L 
Sbjct: 150 EDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLL 209
Query: 239 KGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPENRPTAKELL 294
            G+PP  E   ++  +L  K N   +  +        ++  L  DP  RPT  ELL
Sbjct: 210 VGKPP-FETSCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQTDPTARPTINELL 264

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 95.9 bits (237), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 62/199 (31%), Positives = 103/199 (51%), Gaps = 11/199 (5%)
Query: 117 GTKLWIIMEYLGGGSALD-LMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANV 175
           G  ++++ E + GG  LD +++   F E   + +L  + K ++YLHS+  +HRD+K +N+
Sbjct: 93  GKHVYLVTELMRGGELLDKILRQKFFSEREASFVLHTIGKTVEYLHSQGVVHRDLKPSNI 152
Query: 176 L-LSEMGD---VKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLG 231
           L + E G+   +++ DFG A  L        T   T  ++APEV+K+  YD   DIWSLG
Sbjct: 153 LYVDESGNPECLRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLKRQGYDEGCDIWSLG 212
Query: 232 ITAIELAKGEPPNSEL---HPMRVLFLIPKNNPPQLTGNY---TKQFKEFVEACLNKDPE 285
           I    +  G  P +      P  +L  I         GN+   ++  K+ V   L+ DP 
Sbjct: 213 ILLYTMLAGYTPFANGPSDTPEEILTRIGSGKFTLSGGNWNTVSETAKDLVSKMLHVDPH 272
Query: 286 NRPTAKELLKFPFIRKAKK 304
            R TAK++L+ P++ +  K
Sbjct: 273 QRLTAKQVLQHPWVTQKDK 291

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 95.9 bits (237), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 94/207 (45%), Gaps = 16/207 (7%)
Query: 59  FTKQERIGKGSFGEVF--KGIDNRTQQVVXXXXXXXXXXXXXXXXXXXXXMVLSQCDSPY 116
           F + + IG GSFG V   K ++      +                      +L   + P+
Sbjct: 43  FERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 117 GTKL----------WIIMEYLGGGSALD-LMKAGNFEEMHIAVILREVLKGLDYLHSERK 165
             KL          +++MEY+ GG     L + G F E H      +++   +YLHS   
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDL 162
Query: 166 LHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKA 225
           ++RD+K  N+L+ + G +K+ADFG A  +   T       GTP ++APE+I    Y+   
Sbjct: 163 IYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTW---XLCGTPEYLAPEIILSKGYNKAV 219
Query: 226 DIWSLGITAIELAKGEPPNSELHPMRV 252
           D W+LG+   E+A G PP     P+++
Sbjct: 220 DWWALGVLIYEMAAGYPPFFADQPIQI 246

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 95.9 bits (237), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 57/172 (33%), Positives = 87/172 (50%), Gaps = 6/172 (3%)
Query: 119 KLWIIMEYLGGGSALD-LMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLL 177
           KL++I+++L GG     L K   F E  +   L E+  GLD+LHS   ++RD+K  N+LL
Sbjct: 104 KLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALGLDHLHSLGIIYRDLKPENILL 163
Query: 178 SEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIEL 237
            E G +KL DFG++    +   K  +F GT  +MAPEV+ +  +   AD WS G+   E+
Sbjct: 164 DEEGHIKLTDFGLSKEAIDHEKKAYSFCGTVEYMAPEVVNRQGHSHSADWWSYGVLMFEM 223
Query: 238 AKGEPP--NSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPENR 287
             G  P    +      L L  K   PQ     + + +  + A   ++P NR
Sbjct: 224 LTGSLPFQGKDRKETMTLILKAKLGMPQFL---STEAQSLLRALFKRNPANR 272

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 95.9 bits (237), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 76/272 (27%), Positives = 119/272 (43%), Gaps = 35/272 (12%)
Query: 59  FTKQERIGKGSFGEVFKGIDNRTQQ--VVXXXXXXXXXXXXXXXXXXXXXMVLSQCDSPY 116
           +  Q  +GKGSFGEV    D  T Q   V                      +L Q D P 
Sbjct: 34  YKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPN 93
Query: 117 GTKLWIIME-----------YLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERK 165
             KL+   E           Y GG    +++    F E+  A I+R+VL G+ Y+H  + 
Sbjct: 94  IMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKI 153
Query: 166 LHRDIKAANVLL---SEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYD 222
           +HRD+K  N+LL   S+  ++++ DFG++ T    + K    +GT +++APEV+    YD
Sbjct: 154 VHRDLKPENLLLESKSKDANIRIIDFGLS-THFEASKKMKDKIGTAYYIAPEVL-HGTYD 211
Query: 223 SKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQF---------- 272
            K D+WS G+    L  G PP +  +   +L  + K       G YT +           
Sbjct: 212 EKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEK-------GKYTFELPQWKKVSESA 264
Query: 273 KEFVEACLNKDPENRPTAKELLKFPFIRKAKK 304
           K+ +   L   P  R +A++ L   +I+   K
Sbjct: 265 KDLIRKMLTYVPSMRISARDALDHEWIQTYTK 296

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 95.9 bits (237), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 62/199 (31%), Positives = 103/199 (51%), Gaps = 11/199 (5%)
Query: 117 GTKLWIIMEYLGGGSALD-LMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANV 175
           G  ++++ E + GG  LD +++   F E   + +L  + K ++YLHS+  +HRD+K +N+
Sbjct: 93  GKHVYLVTELMRGGELLDKILRQKFFSEREASFVLHTIGKTVEYLHSQGVVHRDLKPSNI 152
Query: 176 L-LSEMGD---VKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLG 231
           L + E G+   +++ DFG A  L        T   T  ++APEV+K+  YD   DIWSLG
Sbjct: 153 LYVDESGNPECLRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLKRQGYDEGCDIWSLG 212
Query: 232 ITAIELAKGEPPNSEL---HPMRVLFLIPKNNPPQLTGNY---TKQFKEFVEACLNKDPE 285
           I    +  G  P +      P  +L  I         GN+   ++  K+ V   L+ DP 
Sbjct: 213 ILLYTMLAGYTPFANGPSDTPEEILTRIGSGKFTLSGGNWNTVSETAKDLVSKMLHVDPH 272
Query: 286 NRPTAKELLKFPFIRKAKK 304
            R TAK++L+ P++ +  K
Sbjct: 273 QRLTAKQVLQHPWVTQKDK 291

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 95.9 bits (237), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 94/207 (45%), Gaps = 16/207 (7%)
Query: 59  FTKQERIGKGSFGEVF--KGIDNRTQQVVXXXXXXXXXXXXXXXXXXXXXMVLSQCDSPY 116
           F + + IG GSFG V   K ++      +                      +L   + P+
Sbjct: 43  FERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 117 GTKL----------WIIMEYLGGGSALD-LMKAGNFEEMHIAVILREVLKGLDYLHSERK 165
             KL          +++MEY+ GG     L + G F E H      +++   +YLHS   
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDL 162
Query: 166 LHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKA 225
           ++RD+K  N+L+ + G +K+ADFG A  +   T       GTP ++APE+I    Y+   
Sbjct: 163 IYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTW---XLCGTPEYLAPEIILSKGYNKAV 219
Query: 226 DIWSLGITAIELAKGEPPNSELHPMRV 252
           D W+LG+   E+A G PP     P+++
Sbjct: 220 DWWALGVLIYEMAAGYPPFFADQPIQI 246

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 95.9 bits (237), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 94/207 (45%), Gaps = 16/207 (7%)
Query: 59  FTKQERIGKGSFGEVF--KGIDNRTQQVVXXXXXXXXXXXXXXXXXXXXXMVLSQCDSPY 116
           F + + IG GSFG V   K ++      +                      +L   + P+
Sbjct: 43  FERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 117 GTKL----------WIIMEYLGGGSALD-LMKAGNFEEMHIAVILREVLKGLDYLHSERK 165
             KL          +++MEY+ GG     L + G F E H      +++   +YLHS   
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDL 162
Query: 166 LHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKA 225
           ++RD+K  N+L+ + G +K+ADFG A  +   T       GTP ++APE+I    Y+   
Sbjct: 163 IYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTW---XLCGTPEYLAPEIILSKGYNKAV 219
Query: 226 DIWSLGITAIELAKGEPPNSELHPMRV 252
           D W+LG+   E+A G PP     P+++
Sbjct: 220 DWWALGVLIYEMAAGYPPFFADQPIQI 246

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 95.5 bits (236), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 75/260 (28%), Positives = 123/260 (47%), Gaps = 21/260 (8%)
Query: 55  PELIFTKQERIGKGSFGEVFKG-----IDNRTQQVVXXXXXXXXXXXXXXXXXXXXXMVL 109
           P+   T  +RIG GSFG V+KG     +  +   V                       V 
Sbjct: 33  PDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 92
Query: 110 SQCDSPYGTK--LWIIMEYLGGGSALDLMKA--GNFEEMHIAVILREVLKGLDYLHSERK 165
                 Y TK  L I+ ++  G S    +      FE + +  I R+  +G+DYLH++  
Sbjct: 93  ILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSI 152
Query: 166 LHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTF---VGTPFWMAPEVIK---QS 219
           +HRD+K+ N+ L E   VK+ DFG+A T+ +  S  + F    G+  WMAPEVI+   ++
Sbjct: 153 IHRDLKSNNIFLHEDLTVKIGDFGLA-TVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKN 211
Query: 220 AYDSKADIWSLGITAIELAKGEPPNSELHPM-RVLFLIPKNN-PPQLT---GNYTKQFKE 274
            Y  ++D+++ GI   EL  G+ P S ++   +++F++ +    P L+    N  K  K 
Sbjct: 212 PYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKR 271
Query: 275 FVEACLNKDPENRPTAKELL 294
            +  CL K  + RP   ++L
Sbjct: 272 LMAECLKKKRDERPLFPQIL 291

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 95.5 bits (236), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 75/260 (28%), Positives = 123/260 (47%), Gaps = 21/260 (8%)
Query: 55  PELIFTKQERIGKGSFGEVFKG-----IDNRTQQVVXXXXXXXXXXXXXXXXXXXXXMVL 109
           P+   T  +RIG GSFG V+KG     +  +   V                       V 
Sbjct: 34  PDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 93
Query: 110 SQCDSPYGTK--LWIIMEYLGGGSALDLMKA--GNFEEMHIAVILREVLKGLDYLHSERK 165
                 Y TK  L I+ ++  G S    +      FE + +  I R+  +G+DYLH++  
Sbjct: 94  ILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSI 153
Query: 166 LHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTF---VGTPFWMAPEVIK---QS 219
           +HRD+K+ N+ L E   VK+ DFG+A T+ +  S  + F    G+  WMAPEVI+   ++
Sbjct: 154 IHRDLKSNNIFLHEDLTVKIGDFGLA-TVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKN 212
Query: 220 AYDSKADIWSLGITAIELAKGEPPNSELHPM-RVLFLIPKNN-PPQLT---GNYTKQFKE 274
            Y  ++D+++ GI   EL  G+ P S ++   +++F++ +    P L+    N  K  K 
Sbjct: 213 PYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKR 272
Query: 275 FVEACLNKDPENRPTAKELL 294
            +  CL K  + RP   ++L
Sbjct: 273 LMAECLKKKRDERPLFPQIL 292

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 95.1 bits (235), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 53/176 (30%), Positives = 91/176 (51%), Gaps = 2/176 (1%)
Query: 120 LWIIMEYLGGGSALDLMKAGN-FEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLS 178
           +++++E     S L+L K      E      +R+ ++G+ YLH+ R +HRD+K  N+ L+
Sbjct: 117 VYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLHNNRVIHRDLKLGNLFLN 176
Query: 179 EMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELA 238
           +  DVK+ DFG+A  +     ++    GTP ++APEV+ +  +  + DIWSLG     L 
Sbjct: 177 DDMDVKIGDFGLATKIEFDGERKKXLCGTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLL 236
Query: 239 KGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPENRPTAKELL 294
            G+PP  E   ++  ++  K N   +  +        +   L+ DP  RP+  ELL
Sbjct: 237 VGKPP-FETSCLKETYIRIKKNEYSVPRHINPVASALIRRMLHADPTLRPSVAELL 291

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 95.1 bits (235), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 71/250 (28%), Positives = 117/250 (46%), Gaps = 19/250 (7%)
Query: 64  RIGKGSFGEVFKG-----IDNRTQQVVXXXXXXXXXXXXXXXXXXXXXMVLSQCDSPYGT 118
           RIG GSFG V+KG     +  +  +VV                      V       Y T
Sbjct: 43  RIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMT 102
Query: 119 K--LWIIMEYLGGGSALDLM--KAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAAN 174
           K  L I+ ++  G S    +  +   F+   +  I R+  +G+DYLH++  +HRD+K+ N
Sbjct: 103 KDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNN 162
Query: 175 VLLSEMGDVKLADFGVAGTLTNTTSKRNTF--VGTPFWMAPEVIKQ---SAYDSKADIWS 229
           + L E   VK+ DFG+A   +  +  +      G+  WMAPEVI+    + +  ++D++S
Sbjct: 163 IFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYS 222
Query: 230 LGITAIELAKGEPPNSELHPM-RVLFLIPKN----NPPQLTGNYTKQFKEFVEACLNKDP 284
            GI   EL  GE P S ++   +++F++ +     +  +L  N  K  K  V  C+ K  
Sbjct: 223 YGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVK 282
Query: 285 ENRPTAKELL 294
           E RP   ++L
Sbjct: 283 EERPLFPQIL 292

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 95.1 bits (235), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 53/176 (30%), Positives = 91/176 (51%), Gaps = 2/176 (1%)
Query: 120 LWIIMEYLGGGSALDLMKAGN-FEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLS 178
           +++++E     S L+L K      E      +R+ ++G+ YLH+ R +HRD+K  N+ L+
Sbjct: 117 VYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLHNNRVIHRDLKLGNLFLN 176
Query: 179 EMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELA 238
           +  DVK+ DFG+A  +     ++    GTP ++APEV+ +  +  + DIWSLG     L 
Sbjct: 177 DDMDVKIGDFGLATKIEFDGERKKDLCGTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLL 236
Query: 239 KGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPENRPTAKELL 294
            G+PP  E   ++  ++  K N   +  +        +   L+ DP  RP+  ELL
Sbjct: 237 VGKPP-FETSCLKETYIRIKKNEYSVPRHINPVASALIRRMLHADPTLRPSVAELL 291

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 95.1 bits (235), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 75/260 (28%), Positives = 123/260 (47%), Gaps = 21/260 (8%)
Query: 55  PELIFTKQERIGKGSFGEVFKG-----IDNRTQQVVXXXXXXXXXXXXXXXXXXXXXMVL 109
           P+   T  +RIG GSFG V+KG     +  +   V                       V 
Sbjct: 10  PDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 69
Query: 110 SQCDSPYGTK--LWIIMEYLGGGSALDLMKAGN--FEEMHIAVILREVLKGLDYLHSERK 165
                 Y TK  L I+ ++  G S    + A    FE   +  I R+  +G+DYLH++  
Sbjct: 70  ILLFMGYSTKPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSI 129
Query: 166 LHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTF---VGTPFWMAPEVIKQ---S 219
           +HRD+K+ N+ L E   VK+ DFG+A T+ +  S  + F    G+  WMAPEVI+    +
Sbjct: 130 IHRDLKSNNIFLHEDNTVKIGDFGLA-TVKSRWSGSHQFEQLSGSILWMAPEVIRMQDSN 188
Query: 220 AYDSKADIWSLGITAIELAKGEPPNSELHPM-RVLFLIPKNN-PPQLT---GNYTKQFKE 274
            Y  ++D+++ GI   EL  G+ P S ++   +++ ++ + +  P L+    N  K+ K 
Sbjct: 189 PYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKRMKR 248
Query: 275 FVEACLNKDPENRPTAKELL 294
            +  CL K  + RP+   +L
Sbjct: 249 LMAECLKKKRDERPSFPRIL 268

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 95.1 bits (235), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 75/260 (28%), Positives = 123/260 (47%), Gaps = 21/260 (8%)
Query: 55  PELIFTKQERIGKGSFGEVFKG-----IDNRTQQVVXXXXXXXXXXXXXXXXXXXXXMVL 109
           P+   T  +RIG GSFG V+KG     +  +   V                       V 
Sbjct: 8   PDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 67
Query: 110 SQCDSPYGTK--LWIIMEYLGGGSALDLMKA--GNFEEMHIAVILREVLKGLDYLHSERK 165
                 Y TK  L I+ ++  G S    +      FE + +  I R+  +G+DYLH++  
Sbjct: 68  ILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSI 127
Query: 166 LHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTF---VGTPFWMAPEVIK---QS 219
           +HRD+K+ N+ L E   VK+ DFG+A T+ +  S  + F    G+  WMAPEVI+   ++
Sbjct: 128 IHRDLKSNNIFLHEDLTVKIGDFGLA-TVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKN 186
Query: 220 AYDSKADIWSLGITAIELAKGEPPNSELHPM-RVLFLIPKNN-PPQLT---GNYTKQFKE 274
            Y  ++D+++ GI   EL  G+ P S ++   +++F++ +    P L+    N  K  K 
Sbjct: 187 PYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKR 246
Query: 275 FVEACLNKDPENRPTAKELL 294
            +  CL K  + RP   ++L
Sbjct: 247 LMAECLKKKRDERPLFPQIL 266

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 75/260 (28%), Positives = 123/260 (47%), Gaps = 21/260 (8%)
Query: 55  PELIFTKQERIGKGSFGEVFKG-----IDNRTQQVVXXXXXXXXXXXXXXXXXXXXXMVL 109
           P+   T  +RIG GSFG V+KG     +  +   V                       V 
Sbjct: 11  PDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 70
Query: 110 SQCDSPYGTK--LWIIMEYLGGGSALDLMKA--GNFEEMHIAVILREVLKGLDYLHSERK 165
                 Y TK  L I+ ++  G S    +      FE + +  I R+  +G+DYLH++  
Sbjct: 71  ILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSI 130
Query: 166 LHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTF---VGTPFWMAPEVIK---QS 219
           +HRD+K+ N+ L E   VK+ DFG+A T+ +  S  + F    G+  WMAPEVI+   ++
Sbjct: 131 IHRDLKSNNIFLHEDLTVKIGDFGLA-TVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKN 189
Query: 220 AYDSKADIWSLGITAIELAKGEPPNSELHPM-RVLFLIPKNN-PPQLT---GNYTKQFKE 274
            Y  ++D+++ GI   EL  G+ P S ++   +++F++ +    P L+    N  K  K 
Sbjct: 190 PYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKR 249
Query: 275 FVEACLNKDPENRPTAKELL 294
            +  CL K  + RP   ++L
Sbjct: 250 LMAECLKKKRDERPLFPQIL 269

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 76/261 (29%), Positives = 126/261 (48%), Gaps = 23/261 (8%)
Query: 55  PELIFTKQERIGKGSFGEVFKG-----IDNRTQQVVXXXXXXXXXXXXXXXXXXXXXMVL 109
           P+   T  +RIG GSFG V+KG     +  +   V                       V 
Sbjct: 11  PDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 70
Query: 110 SQCDSPYGTK--LWIIMEYLGGGSA---LDLMKAGNFEEMHIAVILREVLKGLDYLHSER 164
                 Y TK  L I+ ++  G S    L +++   FE + +  I R+  +G+DYLH++ 
Sbjct: 71  ILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIET-KFEMIKLIDIARQTAQGMDYLHAKS 129
Query: 165 KLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTF---VGTPFWMAPEVIK---Q 218
            +HRD+K+ N+ L E   VK+ DFG+A T+ +  S  + F    G+  WMAPEVI+   +
Sbjct: 130 IIHRDLKSNNIFLHEDLTVKIGDFGLA-TVKSRWSGSHQFEQLSGSILWMAPEVIRMQDK 188
Query: 219 SAYDSKADIWSLGITAIELAKGEPPNSELHPM-RVLFLIPKNN-PPQLT---GNYTKQFK 273
           + Y  ++D+++ GI   EL  G+ P S ++   +++F++ +    P L+    N  K  K
Sbjct: 189 NPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMK 248
Query: 274 EFVEACLNKDPENRPTAKELL 294
             +  CL K  + RP   ++L
Sbjct: 249 RLMAECLKKKRDERPLFPQIL 269

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 53/176 (30%), Positives = 91/176 (51%), Gaps = 2/176 (1%)
Query: 120 LWIIMEYLGGGSALDLMKAGN-FEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLS 178
           +++++E     S L+L K      E      +R+ ++G+ YLH+ R +HRD+K  N+ L+
Sbjct: 101 VYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLHNNRVIHRDLKLGNLFLN 160
Query: 179 EMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELA 238
           +  DVK+ DFG+A  +     ++    GTP ++APEV+ +  +  + DIWSLG     L 
Sbjct: 161 DDMDVKIGDFGLATKIEFDGERKKDLCGTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLL 220
Query: 239 KGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPENRPTAKELL 294
            G+PP  E   ++  ++  K N   +  +        +   L+ DP  RP+  ELL
Sbjct: 221 VGKPP-FETSCLKETYIRIKKNEYSVPRHINPVASALIRRMLHADPTLRPSVAELL 275

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 91/199 (45%), Gaps = 14/199 (7%)
Query: 59  FTKQERIGKGSFGEVFKGIDNRTQQ-----------VVXXXXXXXXXXXXXXXXXXXXXM 107
           F   + +GKGSFG+VF     +T Q           V+                      
Sbjct: 19  FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP 78
Query: 108 VLSQCDSPYGTK--LWIIMEYLGGGSAL-DLMKAGNFEEMHIAVILREVLKGLDYLHSER 164
            L+     + TK  L+ +MEYL GG  +  +     F+         E++ GL +LHS+ 
Sbjct: 79  FLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKG 138
Query: 165 KLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSK 224
            ++RD+K  N+LL + G +K+ADFG+        +K N F GTP ++APE++    Y+  
Sbjct: 139 IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNXFCGTPDYIAPEILLGQKYNHS 198
Query: 225 ADIWSLGITAIELAKGEPP 243
            D WS G+   E+  G+ P
Sbjct: 199 VDWWSFGVLLYEMLIGQSP 217

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 45/136 (33%), Positives = 75/136 (55%), Gaps = 4/136 (2%)
Query: 118 TKLWIIMEYLGGGSALD-LMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVL 176
           + L+++MEY+ GG     L + G F E H      +++   +YLHS   ++RD+K  N+L
Sbjct: 135 SNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLL 194
Query: 177 LSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIE 236
           + + G +++ DFG A  +   T    T  GTP ++APE+I    Y+   D W+LG+   E
Sbjct: 195 IDQQGYIQVTDFGFAKRVKGATW---TLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYE 251
Query: 237 LAKGEPPNSELHPMRV 252
           +A G PP     P+++
Sbjct: 252 MAAGYPPFFADQPIQI 267

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 91/199 (45%), Gaps = 14/199 (7%)
Query: 59  FTKQERIGKGSFGEVFKGIDNRTQQ-----------VVXXXXXXXXXXXXXXXXXXXXXM 107
           F   + +GKGSFG+VF     +T Q           V+                      
Sbjct: 20  FELHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP 79
Query: 108 VLSQCDSPYGTK--LWIIMEYLGGGSAL-DLMKAGNFEEMHIAVILREVLKGLDYLHSER 164
            L+     + TK  L+ +MEYL GG  +  +     F+         E++ GL +LHS+ 
Sbjct: 80  FLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKG 139
Query: 165 KLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSK 224
            ++RD+K  N+LL + G +K+ADFG+        +K N F GTP ++APE++    Y+  
Sbjct: 140 IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNEFCGTPDYIAPEILLGQKYNHS 199
Query: 225 ADIWSLGITAIELAKGEPP 243
            D WS G+   E+  G+ P
Sbjct: 200 VDWWSFGVLLYEMLIGQSP 218

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 60/195 (30%), Positives = 92/195 (47%), Gaps = 17/195 (8%)
Query: 65  IGKGSFGEVFKGIDNRTQQV--VXXXXXXXXXXXXXXXXXXXXXMVLSQCDSPYGTKLW- 121
           IGKGSFG+V     N T+++  +                      ++   + P+   LW 
Sbjct: 23  IGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWY 82
Query: 122 ----------IIMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIK 171
                     ++   LGG     L +  +F+E  + + + E++  LDYL ++R +HRD+K
Sbjct: 83  SFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMK 142
Query: 172 AANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVI---KQSAYDSKADIW 228
             N+LL E G V + DF +A  L   T +  T  GT  +MAPE+    K + Y    D W
Sbjct: 143 PDNILLDEHGHVHITDFNIAAMLPRET-QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWW 201
Query: 229 SLGITAIELAKGEPP 243
           SLG+TA EL +G  P
Sbjct: 202 SLGVTAYELLRGRRP 216

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 75/260 (28%), Positives = 123/260 (47%), Gaps = 21/260 (8%)
Query: 55  PELIFTKQERIGKGSFGEVFKG-----IDNRTQQVVXXXXXXXXXXXXXXXXXXXXXMVL 109
           P+   T  +RIG GSFG V+KG     +  +   V                       V 
Sbjct: 6   PDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 65
Query: 110 SQCDSPYGTK--LWIIMEYLGGGSALDLMKA--GNFEEMHIAVILREVLKGLDYLHSERK 165
                 Y TK  L I+ ++  G S    +      FE + +  I R+  +G+DYLH++  
Sbjct: 66  ILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSI 125
Query: 166 LHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTF---VGTPFWMAPEVIK---QS 219
           +HRD+K+ N+ L E   VK+ DFG+A T+ +  S  + F    G+  WMAPEVI+   ++
Sbjct: 126 IHRDLKSNNIFLHEDLTVKIGDFGLA-TVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKN 184
Query: 220 AYDSKADIWSLGITAIELAKGEPPNSELHPM-RVLFLIPKNN-PPQLT---GNYTKQFKE 274
            Y  ++D+++ GI   EL  G+ P S ++   +++F++ +    P L+    N  K  K 
Sbjct: 185 PYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKR 244
Query: 275 FVEACLNKDPENRPTAKELL 294
            +  CL K  + RP   ++L
Sbjct: 245 LMAECLKKKRDERPLFPQIL 264

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 70/259 (27%), Positives = 119/259 (45%), Gaps = 19/259 (7%)
Query: 55  PELIFTKQERIGKGSFGEVFKG-----IDNRTQQVVXXXXXXXXXXXXXXXXXXXXXMVL 109
           P+   T  +RIG GSFG V+KG     +  +   V                       V 
Sbjct: 34  PDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 93
Query: 110 SQCDSPYGTK--LWIIMEYLGGGSALDLMKA--GNFEEMHIAVILREVLKGLDYLHSERK 165
                 Y TK  L I+ ++  G S    +      FE + +  I R+  +G+DYLH++  
Sbjct: 94  ILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSI 153
Query: 166 LHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRN--TFVGTPFWMAPEVIK---QSA 220
           +HRD+K+ N+ L E   VK+ DFG+A   +  +         G+  WMAPEVI+   ++ 
Sbjct: 154 IHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNP 213
Query: 221 YDSKADIWSLGITAIELAKGEPPNSELHPM-RVLFLIPKN----NPPQLTGNYTKQFKEF 275
           Y  ++D+++ GI   EL  G+ P S ++   +++F++ +     +  ++  N  K  K  
Sbjct: 214 YSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRL 273
Query: 276 VEACLNKDPENRPTAKELL 294
           +  CL K  + RP   ++L
Sbjct: 274 MAECLKKKRDERPLFPQIL 292

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 64/251 (25%), Positives = 116/251 (46%), Gaps = 21/251 (8%)
Query: 60  TKQERIGKGSFGEVFKGIDNRTQQVVXXXXXXXXXXXXXXXXXXXXXM----------VL 109
           T + ++G G FGEV++G+  +    V                     M          +L
Sbjct: 14  TMKHKLGGGQFGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLL 73
Query: 110 SQC--DSPYGTKLWIIMEYLGGGSALDLMKAGNFEEMHIAVILR---EVLKGLDYLHSER 164
             C  + P+    +II E++  G+ LD ++  N +E+   V+L    ++   ++YL  + 
Sbjct: 74  GVCTREPPF----YIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN 129
Query: 165 KLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPF-WMAPEVIKQSAYDS 223
            +HRD+ A N L+ E   VK+ADFG++  +T  T   +     P  W APE +  + +  
Sbjct: 130 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAYNKFSI 189
Query: 224 KADIWSLGITAIELAK-GEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNK 282
           K+D+W+ G+   E+A  G  P   + P +V  L+ K+   +      ++  E + AC   
Sbjct: 190 KSDVWAFGVLLWEIATYGMSPYPGIDPSQVYELLEKDYRMERPEGCPEKVYELMRACWQW 249
Query: 283 DPENRPTAKEL 293
           +P +RP+  E+
Sbjct: 250 NPSDRPSFAEI 260

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 70/259 (27%), Positives = 119/259 (45%), Gaps = 19/259 (7%)
Query: 55  PELIFTKQERIGKGSFGEVFKG-----IDNRTQQVVXXXXXXXXXXXXXXXXXXXXXMVL 109
           P+   T  +RIG GSFG V+KG     +  +   V                       V 
Sbjct: 26  PDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 85
Query: 110 SQCDSPYGTK--LWIIMEYLGGGSALDLMKA--GNFEEMHIAVILREVLKGLDYLHSERK 165
                 Y TK  L I+ ++  G S    +      FE + +  I R+  +G+DYLH++  
Sbjct: 86  ILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSI 145
Query: 166 LHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRN--TFVGTPFWMAPEVIK---QSA 220
           +HRD+K+ N+ L E   VK+ DFG+A   +  +         G+  WMAPEVI+   ++ 
Sbjct: 146 IHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNP 205
Query: 221 YDSKADIWSLGITAIELAKGEPPNSELHPM-RVLFLIPKN----NPPQLTGNYTKQFKEF 275
           Y  ++D+++ GI   EL  G+ P S ++   +++F++ +     +  ++  N  K  K  
Sbjct: 206 YSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRL 265
Query: 276 VEACLNKDPENRPTAKELL 294
           +  CL K  + RP   ++L
Sbjct: 266 MAECLKKKRDERPLFPQIL 284

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 93.6 bits (231), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 94/207 (45%), Gaps = 16/207 (7%)
Query: 59  FTKQERIGKGSFGEVF--KGIDNRTQQVVXXXXXXXXXXXXXXXXXXXXXMVLSQCDSPY 116
           F + + +G GSFG V   K ++      +                      +L   + P+
Sbjct: 44  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 103
Query: 117 GTKL----------WIIMEYLGGGSALD-LMKAGNFEEMHIAVILREVLKGLDYLHSERK 165
             KL          +++MEY+ GG     L + G F E H      +++   +YLHS   
Sbjct: 104 LVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDL 163
Query: 166 LHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKA 225
           ++RD+K  N+L+ + G +++ DFG A  +   T    T  GTP ++APE+I    Y+   
Sbjct: 164 IYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW---TLCGTPEYLAPEIILSKGYNKAV 220
Query: 226 DIWSLGITAIELAKGEPPNSELHPMRV 252
           D W+LG+   E+A G PP     P+++
Sbjct: 221 DWWALGVLIYEMAAGYPPFFADQPIQI 247

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 93.6 bits (231), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 94/207 (45%), Gaps = 16/207 (7%)
Query: 59  FTKQERIGKGSFGEVF--KGIDNRTQQVVXXXXXXXXXXXXXXXXXXXXXMVLSQCDSPY 116
           F + + +G GSFG V   K ++      +                      +L   + P+
Sbjct: 29  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 88
Query: 117 GTKL----------WIIMEYLGGGSALD-LMKAGNFEEMHIAVILREVLKGLDYLHSERK 165
             KL          +++MEY+ GG     L + G F E H      +++   +YLHS   
Sbjct: 89  LVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDL 148
Query: 166 LHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKA 225
           ++RD+K  N+L+ + G +++ DFG A  +   T    T  GTP ++APE+I    Y+   
Sbjct: 149 IYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW---TLCGTPEYLAPEIILSKGYNKAV 205
Query: 226 DIWSLGITAIELAKGEPPNSELHPMRV 252
           D W+LG+   E+A G PP     P+++
Sbjct: 206 DWWALGVLIYEMAAGYPPFFADQPIQI 232

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 93.6 bits (231), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 45/136 (33%), Positives = 74/136 (54%), Gaps = 4/136 (2%)
Query: 118 TKLWIIMEYLGGGSALD-LMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVL 176
           + L+++MEY+ GG     L + G F E H      +++   +YLHS   ++RD+K  N+L
Sbjct: 101 SNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLL 160
Query: 177 LSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIE 236
           + E G +++ DFG A  +   T       GTP ++APE+I    Y+   D W+LG+   E
Sbjct: 161 IDEQGYIQVTDFGFAKRVKGRTW---XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYE 217
Query: 237 LAKGEPPNSELHPMRV 252
           +A G PP     P+++
Sbjct: 218 MAAGYPPFFADQPIQI 233

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 93.6 bits (231), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 63/251 (25%), Positives = 117/251 (46%), Gaps = 21/251 (8%)
Query: 60  TKQERIGKGSFGEVFKGIDNRTQQVVXXXXXXXXXXXXXXXXXXXXXM----------VL 109
           T + ++G G +GEV++G+  +    V                     M          +L
Sbjct: 14  TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLL 73
Query: 110 SQC--DSPYGTKLWIIMEYLGGGSALDLMKAGNFEEMHIAVILR---EVLKGLDYLHSER 164
             C  + P+    +II+E++  G+ LD ++  N +E+   V+L    ++   ++YL  + 
Sbjct: 74  GVCTREPPF----YIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN 129
Query: 165 KLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPF-WMAPEVIKQSAYDS 223
            +HRD+ A N L+ E   VK+ADFG++  +T  T   +     P  W APE +  + +  
Sbjct: 130 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAYNKFSI 189
Query: 224 KADIWSLGITAIELAK-GEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNK 282
           K+D+W+ G+   E+A  G  P   + P +V  L+ K+   +      ++  E + AC   
Sbjct: 190 KSDVWAFGVLLWEIATYGMSPYPGIDPSQVYELLEKDYRMERPEGCPEKVYELMRACWQW 249
Query: 283 DPENRPTAKEL 293
           +P +RP+  E+
Sbjct: 250 NPSDRPSFAEI 260

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 93.6 bits (231), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 72/259 (27%), Positives = 119/259 (45%), Gaps = 19/259 (7%)
Query: 55  PELIFTKQERIGKGSFGEVFKG-----IDNRTQQVVXXXXXXXXXXXXXXXXXXXXXMVL 109
           P+   T  +RIG GSFG V+KG     +  +   V                       V 
Sbjct: 22  PDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 81
Query: 110 SQCDSPYGTK--LWIIMEYLGGGSALDLMKAGN--FEEMHIAVILREVLKGLDYLHSERK 165
                 Y TK  L I+ ++  G S    + A    FE   +  I R+  +G+DYLH++  
Sbjct: 82  ILLFMGYSTKPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSI 141
Query: 166 LHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRN--TFVGTPFWMAPEVIKQ---SA 220
           +HRD+K+ N+ L E   VK+ DFG+A   +  +         G+  WMAPEVI+    + 
Sbjct: 142 IHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNP 201
Query: 221 YDSKADIWSLGITAIELAKGEPPNSELHPM-RVLFLIPKNN-PPQLT---GNYTKQFKEF 275
           Y  ++D+++ GI   EL  G+ P S ++   +++ ++ + +  P L+    N  K+ K  
Sbjct: 202 YSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKRMKRL 261
Query: 276 VEACLNKDPENRPTAKELL 294
           +  CL K  + RP+   +L
Sbjct: 262 MAECLKKKRDERPSFPRIL 280

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 93.2 bits (230), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 54/196 (27%), Positives = 103/196 (52%), Gaps = 10/196 (5%)
Query: 113 DSPYGTKLWIIMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKA 172
           D P    L+++ E +  G  +++       E       ++++KG++YLH ++ +HRDIK 
Sbjct: 106 DDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKP 165
Query: 173 ANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQS--AYDSKA-DIWS 229
           +N+L+ E G +K+ADFGV+     + +  +  VGTP +MAPE + ++   +  KA D+W+
Sbjct: 166 SNLLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWA 225
Query: 230 LGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQL----TGNYTKQFKEFVEACLNKDPE 285
           +G+T      G+ P  +    R++ L  K     L      +  +  K+ +   L+K+PE
Sbjct: 226 MGVTLYCFVFGQCPFMD---ERIMCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPE 282
Query: 286 NRPTAKELLKFPFIRK 301
           +R    E+   P++ +
Sbjct: 283 SRIVVPEIKLHPWVTR 298

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 93.2 bits (230), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 72/254 (28%), Positives = 115/254 (45%), Gaps = 28/254 (11%)
Query: 62  QERIGKGSFGEVFKGIDNRTQQVVXXXXXXXXXXXXXXXXXXXXXMVLSQCDSPYGTKLW 121
           +E +G+G+FG V K    R + V                        LS+ + P   KL+
Sbjct: 14  EEVVGRGAFGVVCKA-KWRAKDVAIKQIESESERKAFIVELRQ----LSRVNHPNIVKLY 68
Query: 122 --------IIMEYLGGGSALDLMKAGN----FEEMHIAVILREVLKGLDYLHSERK---L 166
                   ++MEY  GGS  +++        +   H      +  +G+ YLHS +    +
Sbjct: 69  GACLNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALI 128
Query: 167 HRDIKAANVLLSEMGDV-KLADFGVAGTL-TNTTSKRNTFVGTPFWMAPEVIKQSAYDSK 224
           HRD+K  N+LL   G V K+ DFG A  + T+ T+ +    G+  WMAPEV + S Y  K
Sbjct: 129 HRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNK----GSAAWMAPEVFEGSNYSEK 184
Query: 225 ADIWSLGITAIELAKGEPPNSELH--PMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNK 282
            D++S GI   E+     P  E+     R+++ +     P L  N  K  +  +  C +K
Sbjct: 185 CDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPIESLMTRCWSK 244
Query: 283 DPENRPTAKELLKF 296
           DP  RP+ +E++K 
Sbjct: 245 DPSQRPSMEEIVKI 258

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 93.2 bits (230), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 72/254 (28%), Positives = 115/254 (45%), Gaps = 28/254 (11%)
Query: 62  QERIGKGSFGEVFKGIDNRTQQVVXXXXXXXXXXXXXXXXXXXXXMVLSQCDSPYGTKLW 121
           +E +G+G+FG V K    R + V                        LS+ + P   KL+
Sbjct: 13  EEVVGRGAFGVVCKA-KWRAKDVAIKQIESESERKAFIVELRQ----LSRVNHPNIVKLY 67
Query: 122 --------IIMEYLGGGSALDLMKAGN----FEEMHIAVILREVLKGLDYLHSERK---L 166
                   ++MEY  GGS  +++        +   H      +  +G+ YLHS +    +
Sbjct: 68  GACLNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALI 127
Query: 167 HRDIKAANVLLSEMGDV-KLADFGVAGTL-TNTTSKRNTFVGTPFWMAPEVIKQSAYDSK 224
           HRD+K  N+LL   G V K+ DFG A  + T+ T+ +    G+  WMAPEV + S Y  K
Sbjct: 128 HRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNK----GSAAWMAPEVFEGSNYSEK 183
Query: 225 ADIWSLGITAIELAKGEPPNSELH--PMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNK 282
            D++S GI   E+     P  E+     R+++ +     P L  N  K  +  +  C +K
Sbjct: 184 CDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPIESLMTRCWSK 243
Query: 283 DPENRPTAKELLKF 296
           DP  RP+ +E++K 
Sbjct: 244 DPSQRPSMEEIVKI 257

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 93.2 bits (230), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 74/260 (28%), Positives = 123/260 (47%), Gaps = 21/260 (8%)
Query: 55  PELIFTKQERIGKGSFGEVFKG-----IDNRTQQVVXXXXXXXXXXXXXXXXXXXXXMVL 109
           P+   T  +RIG GSFG V+KG     +  +   V                       V 
Sbjct: 6   PDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 65
Query: 110 SQCDSPYGT--KLWIIMEYLGGGSALDLMKA--GNFEEMHIAVILREVLKGLDYLHSERK 165
                 Y T  +L I+ ++  G S    +      FE + +  I R+  +G+DYLH++  
Sbjct: 66  ILLFMGYSTAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSI 125
Query: 166 LHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTF---VGTPFWMAPEVIK---QS 219
           +HRD+K+ N+ L E   VK+ DFG+A T+ +  S  + F    G+  WMAPEVI+   ++
Sbjct: 126 IHRDLKSNNIFLHEDLTVKIGDFGLA-TVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKN 184
Query: 220 AYDSKADIWSLGITAIELAKGEPPNSELHPM-RVLFLIPKNN-PPQLT---GNYTKQFKE 274
            Y  ++D+++ GI   EL  G+ P S ++   +++F++ +    P L+    N  K  K 
Sbjct: 185 PYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKR 244
Query: 275 FVEACLNKDPENRPTAKELL 294
            +  CL K  + RP   ++L
Sbjct: 245 LMAECLKKKRDERPLFPQIL 264

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 92.8 bits (229), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 53/191 (27%), Positives = 99/191 (51%), Gaps = 8/191 (4%)
Query: 111 QCDSPYGTKLWIIMEYLGGGSALDLMKA-GNFEEMHIAVILREVLKGLDYLHSERKLHRD 169
           + ++P G   +I+MEY+ G +  D++   G         ++ +  + L++ H    +HRD
Sbjct: 82  EAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRD 141
Query: 170 IKAANVLLSEMGDVKLADFGVAGTLT---NTTSKRNTFVGTPFWMAPEVIKQSAYDSKAD 226
           +K AN+L+S    VK+ DFG+A  +    N+  +    +GT  +++PE  +  + D+++D
Sbjct: 142 VKPANILISATNAVKVVDFGIARAIADSGNSVXQTAAVIGTAQYLSPEQARGDSVDARSD 201
Query: 227 IWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNY---TKQFKEFVEACLNKD 283
           ++SLG    E+  GEPP +   P+ V +   + +P   +  +   +      V   L K+
Sbjct: 202 VYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKN 261
Query: 284 PENR-PTAKEL 293
           PENR  TA E+
Sbjct: 262 PENRYQTAAEM 272

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 92.8 bits (229), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 93/207 (44%), Gaps = 16/207 (7%)
Query: 59  FTKQERIGKGSFGEVF--KGIDNRTQQVVXXXXXXXXXXXXXXXXXXXXXMVLSQCDSPY 116
           F + + +G GSFG V   K ++      +                      +L   + P+
Sbjct: 44  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 103
Query: 117 GTKL----------WIIMEYLGGGSALD-LMKAGNFEEMHIAVILREVLKGLDYLHSERK 165
            TKL          +++MEY  GG     L + G F E H      +++   +YLHS   
Sbjct: 104 LTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDL 163
Query: 166 LHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKA 225
           ++RD+K  N+++ + G +K+ DFG A  +   T       GTP ++APE+I    Y+   
Sbjct: 164 IYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTW---XLCGTPEYLAPEIILSKGYNKAV 220
Query: 226 DIWSLGITAIELAKGEPPNSELHPMRV 252
           D W+LG+   E+A G PP     P+++
Sbjct: 221 DWWALGVLIYEMAAGYPPFFADQPIQI 247

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 92.8 bits (229), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 93/207 (44%), Gaps = 16/207 (7%)
Query: 59  FTKQERIGKGSFGEVF--KGIDNRTQQVVXXXXXXXXXXXXXXXXXXXXXMVLSQCDSPY 116
           F + + +G GSFG V   K ++      +                      +L   + P+
Sbjct: 43  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 117 GTKL----------WIIMEYLGGGSALD-LMKAGNFEEMHIAVILREVLKGLDYLHSERK 165
             KL          +++MEY+ GG     L + G F E H      +++   +YLHS   
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDL 162
Query: 166 LHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKA 225
           ++RD+K  N+L+ + G +++ DFG A  +   T       GTP ++APE+I    Y+   
Sbjct: 163 IYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW---XLCGTPEYLAPEIILSKGYNKAV 219
Query: 226 DIWSLGITAIELAKGEPPNSELHPMRV 252
           D W+LG+   E+A G PP     P+++
Sbjct: 220 DWWALGVLIYEMAAGYPPFFADQPIQI 246

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 92.8 bits (229), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 57/193 (29%), Positives = 88/193 (45%), Gaps = 14/193 (7%)
Query: 65  IGKGSFGEVF----KGIDN-------RTQQVVXXXXXXXXXXXXXXXXXXXXXMVLSQCD 113
           +GKGSFG+V     KG D        +   V+                       L+Q  
Sbjct: 349 LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLH 408
Query: 114 SPYGT--KLWIIMEYLGGGSAL-DLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDI 170
           S + T  +L+ +MEY+ GG  +  + + G F+E H      E+  GL +L S+  ++RD+
Sbjct: 409 SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDL 468
Query: 171 KAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSL 230
           K  NV+L   G +K+ADFG+             F GTP ++APE+I    Y    D W+ 
Sbjct: 469 KLDNVMLDSEGHIKIADFGMCKENIWDGVTTKXFCGTPDYIAPEIIAYQPYGKSVDWWAF 528
Query: 231 GITAIELAKGEPP 243
           G+   E+  G+ P
Sbjct: 529 GVLLYEMLAGQAP 541

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 92.8 bits (229), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 93/207 (44%), Gaps = 16/207 (7%)
Query: 59  FTKQERIGKGSFGEVF--KGIDNRTQQVVXXXXXXXXXXXXXXXXXXXXXMVLSQCDSPY 116
           F + + +G GSFG V   K ++      +                      +L   + P+
Sbjct: 44  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 103
Query: 117 GTKL----------WIIMEYLGGGSALD-LMKAGNFEEMHIAVILREVLKGLDYLHSERK 165
            TKL          +++MEY  GG     L + G F E H      +++   +YLHS   
Sbjct: 104 LTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDL 163
Query: 166 LHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKA 225
           ++RD+K  N+++ + G +K+ DFG A  +   T       GTP ++APE+I    Y+   
Sbjct: 164 IYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTW---XLCGTPEYLAPEIILSKGYNKAV 220
Query: 226 DIWSLGITAIELAKGEPPNSELHPMRV 252
           D W+LG+   E+A G PP     P+++
Sbjct: 221 DWWALGVLIYEMAAGYPPFFADQPIQI 247

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 92.8 bits (229), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 93/207 (44%), Gaps = 16/207 (7%)
Query: 59  FTKQERIGKGSFGEVF--KGIDNRTQQVVXXXXXXXXXXXXXXXXXXXXXMVLSQCDSPY 116
           F + + +G GSFG V   K ++      +                      +L   + P+
Sbjct: 44  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 103
Query: 117 GTKL----------WIIMEYLGGGSALD-LMKAGNFEEMHIAVILREVLKGLDYLHSERK 165
            TKL          +++MEY  GG     L + G F E H      +++   +YLHS   
Sbjct: 104 LTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDL 163
Query: 166 LHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKA 225
           ++RD+K  N+++ + G +K+ DFG A  +   T       GTP ++APE+I    Y+   
Sbjct: 164 IYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTW---XLCGTPEYLAPEIILSKGYNKAV 220
Query: 226 DIWSLGITAIELAKGEPPNSELHPMRV 252
           D W+LG+   E+A G PP     P+++
Sbjct: 221 DWWALGVLIYEMAAGYPPFFADQPIQI 247

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 92.4 bits (228), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 72/259 (27%), Positives = 119/259 (45%), Gaps = 19/259 (7%)
Query: 55  PELIFTKQERIGKGSFGEVFKG-----IDNRTQQVVXXXXXXXXXXXXXXXXXXXXXMVL 109
           P+   T  +RIG GSFG V+KG     +  +   V                       V 
Sbjct: 6   PDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 65
Query: 110 SQCDSPYGTK--LWIIMEYLGGGSALDLMKA--GNFEEMHIAVILREVLKGLDYLHSERK 165
                 Y TK  L I+ ++  G S    +      FE + +  I R+  +G+DYLH++  
Sbjct: 66  ILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSI 125
Query: 166 LHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRN--TFVGTPFWMAPEVIK---QSA 220
           +HRD+K+ N+ L E   VK+ DFG+A   +  +         G+  WMAPEVI+   ++ 
Sbjct: 126 IHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNP 185
Query: 221 YDSKADIWSLGITAIELAKGEPPNSELHPM-RVLFLIPKNN-PPQLT---GNYTKQFKEF 275
           Y  ++D+++ GI   EL  G+ P S ++   +++F++ +    P L+    N  K  K  
Sbjct: 186 YSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRL 245
Query: 276 VEACLNKDPENRPTAKELL 294
           +  CL K  + RP   ++L
Sbjct: 246 MAECLKKKRDERPLFPQIL 264

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 92.4 bits (228), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 61/191 (31%), Positives = 101/191 (52%), Gaps = 11/191 (5%)
Query: 122 IIMEYLGGGSALDLM-KAG---NFEEMHIAVILREVLKGLDYLHSERK--LHRDIKAANV 175
           I+ EYL  GS   L+ K+G     +E     +  +V KG++YLH+     +HR++K+ N+
Sbjct: 111 IVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNL 170
Query: 176 LLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAI 235
           L+ +   VK+ DFG++    +T     +  GTP WMAPEV++    + K+D++S G+   
Sbjct: 171 LVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILW 230
Query: 236 ELAKGEPPNSELHPMRVLFLIP-KNNPPQLTGNYTKQFKEFVEACLNKDPENRP---TAK 291
           ELA  + P   L+P +V+  +  K    ++  N   Q    +E C   +P  RP   T  
Sbjct: 231 ELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIM 290
Query: 292 ELLKFPFIRKA 302
           +LL+ P I+ A
Sbjct: 291 DLLR-PLIKSA 300

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 92.4 bits (228), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 44/136 (32%), Positives = 74/136 (54%), Gaps = 4/136 (2%)
Query: 118 TKLWIIMEYLGGGSALD-LMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVL 176
           + L+++MEY+ GG     L + G F E H      +++   +YLHS   ++RD+K  N+L
Sbjct: 114 SNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLL 173
Query: 177 LSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIE 236
           + + G +++ DFG A  +   T       GTP ++APE+I    Y+   D W+LG+   E
Sbjct: 174 IDQQGYIQVTDFGFAKRVKGRTW---XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYE 230
Query: 237 LAKGEPPNSELHPMRV 252
           +A G PP     P+++
Sbjct: 231 MAAGYPPFFADQPIQI 246

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 92.4 bits (228), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 44/136 (32%), Positives = 74/136 (54%), Gaps = 4/136 (2%)
Query: 118 TKLWIIMEYLGGGSALD-LMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVL 176
           + L+++MEY+ GG     L + G F E H      +++   +YLHS   ++RD+K  N+L
Sbjct: 114 SNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLL 173
Query: 177 LSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIE 236
           + + G +++ DFG A  +   T       GTP ++APE+I    Y+   D W+LG+   E
Sbjct: 174 IDQQGYIQVTDFGFAKRVKGRTW---XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYE 230
Query: 237 LAKGEPPNSELHPMRV 252
           +A G PP     P+++
Sbjct: 231 MAAGYPPFFADQPIQI 246

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 92.4 bits (228), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 44/136 (32%), Positives = 74/136 (54%), Gaps = 4/136 (2%)
Query: 118 TKLWIIMEYLGGGSALD-LMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVL 176
           + L+++MEY+ GG     L + G F E H      +++   +YLHS   ++RD+K  N+L
Sbjct: 114 SNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLL 173
Query: 177 LSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIE 236
           + + G +++ DFG A  +   T       GTP ++APE+I    Y+   D W+LG+   E
Sbjct: 174 IDQQGYIQVTDFGFAKRVKGRTW---XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYE 230
Query: 237 LAKGEPPNSELHPMRV 252
           +A G PP     P+++
Sbjct: 231 MAAGYPPFFADQPIQI 246

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 92.4 bits (228), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 44/136 (32%), Positives = 74/136 (54%), Gaps = 4/136 (2%)
Query: 118 TKLWIIMEYLGGGSALD-LMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVL 176
           + L+++MEY+ GG     L + G F E H      +++   +YLHS   ++RD+K  N+L
Sbjct: 109 SNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLL 168
Query: 177 LSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIE 236
           + + G +++ DFG A  +   T       GTP ++APE+I    Y+   D W+LG+   E
Sbjct: 169 IDQQGYIQVTDFGFAKRVKGRTW---XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYE 225
Query: 237 LAKGEPPNSELHPMRV 252
           +A G PP     P+++
Sbjct: 226 MAAGYPPFFADQPIQI 241

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 92.4 bits (228), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 52/191 (27%), Positives = 100/191 (52%), Gaps = 8/191 (4%)
Query: 111 QCDSPYGTKLWIIMEYLGGGSALDLMKA-GNFEEMHIAVILREVLKGLDYLHSERKLHRD 169
           + ++P G   +I+MEY+ G +  D++   G         ++ +  + L++ H    +HRD
Sbjct: 82  EAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRD 141
Query: 170 IKAANVLLSEMGDVKLADFGVAGTLT---NTTSKRNTFVGTPFWMAPEVIKQSAYDSKAD 226
           +K AN+++S    VK+ DFG+A  +    N+ ++    +GT  +++PE  +  + D+++D
Sbjct: 142 VKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSD 201
Query: 227 IWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNY---TKQFKEFVEACLNKD 283
           ++SLG    E+  GEPP +   P+ V +   + +P   +  +   +      V   L K+
Sbjct: 202 VYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKN 261
Query: 284 PENR-PTAKEL 293
           PENR  TA E+
Sbjct: 262 PENRYQTAAEM 272

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 92.4 bits (228), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 44/136 (32%), Positives = 74/136 (54%), Gaps = 4/136 (2%)
Query: 118 TKLWIIMEYLGGGSALD-LMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVL 176
           + L+++MEY+ GG     L + G F E H      +++   +YLHS   ++RD+K  N+L
Sbjct: 115 SNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLL 174
Query: 177 LSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIE 236
           + + G +++ DFG A  +   T       GTP ++APE+I    Y+   D W+LG+   E
Sbjct: 175 IDQQGYIQVTDFGFAKRVKGRTW---XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYE 231
Query: 237 LAKGEPPNSELHPMRV 252
           +A G PP     P+++
Sbjct: 232 MAAGYPPFFADQPIQI 247

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 92.4 bits (228), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 44/136 (32%), Positives = 74/136 (54%), Gaps = 4/136 (2%)
Query: 118 TKLWIIMEYLGGGSALD-LMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVL 176
           + L+++MEY+ GG     L + G F E H      +++   +YLHS   ++RD+K  N+L
Sbjct: 114 SNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLL 173
Query: 177 LSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIE 236
           + + G +++ DFG A  +   T       GTP ++APE+I    Y+   D W+LG+   E
Sbjct: 174 IDQQGYIQVTDFGFAKRVKGRTW---XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYE 230
Query: 237 LAKGEPPNSELHPMRV 252
           +A G PP     P+++
Sbjct: 231 MAAGYPPFFADQPIQI 246

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 92.4 bits (228), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 44/136 (32%), Positives = 74/136 (54%), Gaps = 4/136 (2%)
Query: 118 TKLWIIMEYLGGGSALD-LMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVL 176
           + L+++MEY+ GG     L + G F E H      +++   +YLHS   ++RD+K  N+L
Sbjct: 114 SNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLL 173
Query: 177 LSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIE 236
           + + G +++ DFG A  +   T       GTP ++APE+I    Y+   D W+LG+   E
Sbjct: 174 IDQQGYIQVTDFGFAKRVKGRTW---XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYE 230
Query: 237 LAKGEPPNSELHPMRV 252
           +A G PP     P+++
Sbjct: 231 MAAGYPPFFADQPIQI 246

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 92.4 bits (228), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 95/208 (45%), Gaps = 18/208 (8%)
Query: 52  KVDPELIFTKQERIGKGSFGEVF-----KGIDNRTQQVVXXXXXXXXXXXXXXXXXXXXX 106
           K DP   F   + +G+GSFG+VF      G D R Q                        
Sbjct: 20  KADPSQ-FELLKVLGQGSFGKVFLVKKISGSDAR-QLYAMKVLKKATLKVRDRVRTKMER 77
Query: 107 MVLSQCDSPYGTKL----------WIIMEYLGGGSALD-LMKAGNFEEMHIAVILREVLK 155
            +L + + P+  KL          ++I+++L GG     L K   F E  +   L E+  
Sbjct: 78  DILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELAL 137
Query: 156 GLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEV 215
            LD+LHS   ++RD+K  N+LL E G +KL DFG++    +   K  +F GT  +MAPEV
Sbjct: 138 ALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEV 197
Query: 216 IKQSAYDSKADIWSLGITAIELAKGEPP 243
           + +  +   AD WS G+   E+  G  P
Sbjct: 198 VNRRGHTQSADWWSFGVLMFEMLTGTLP 225

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 92.4 bits (228), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 44/136 (32%), Positives = 74/136 (54%), Gaps = 4/136 (2%)
Query: 118 TKLWIIMEYLGGGSALD-LMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVL 176
           + L+++MEY+ GG     L + G F E H      +++   +YLHS   ++RD+K  N+L
Sbjct: 114 SNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLL 173
Query: 177 LSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIE 236
           + + G +++ DFG A  +   T       GTP ++APE+I    Y+   D W+LG+   E
Sbjct: 174 IDQQGYIQVTDFGFAKRVKGRTW---XLAGTPEYLAPEIILSKGYNKAVDWWALGVLIYE 230
Query: 237 LAKGEPPNSELHPMRV 252
           +A G PP     P+++
Sbjct: 231 MAAGYPPFFADQPIQI 246

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 92.4 bits (228), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 44/136 (32%), Positives = 74/136 (54%), Gaps = 4/136 (2%)
Query: 118 TKLWIIMEYLGGGSALD-LMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVL 176
           + L+++MEY+ GG     L + G F E H      +++   +YLHS   ++RD+K  N+L
Sbjct: 114 SNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLL 173
Query: 177 LSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIE 236
           + + G +++ DFG A  +   T       GTP ++APE+I    Y+   D W+LG+   E
Sbjct: 174 IDQQGYIQVTDFGFAKRVKGRTW---XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYE 230
Query: 237 LAKGEPPNSELHPMRV 252
           +A G PP     P+++
Sbjct: 231 MAAGYPPFFADQPIQI 246

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 92.4 bits (228), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 44/136 (32%), Positives = 74/136 (54%), Gaps = 4/136 (2%)
Query: 118 TKLWIIMEYLGGGSALD-LMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVL 176
           + L+++MEY+ GG     L + G F E H      +++   +YLHS   ++RD+K  N+L
Sbjct: 114 SNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLL 173
Query: 177 LSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIE 236
           + + G +++ DFG A  +   T       GTP ++APE+I    Y+   D W+LG+   E
Sbjct: 174 IDQQGYIQVTDFGFAKRVKGRTW---XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYE 230
Query: 237 LAKGEPPNSELHPMRV 252
           +A G PP     P+++
Sbjct: 231 MAAGYPPFFADQPIQI 246

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 92.4 bits (228), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 47/126 (37%), Positives = 71/126 (56%), Gaps = 3/126 (2%)
Query: 120 LWIIMEYLGGGSALDLMKA-GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLS 178
           L++IMEY  GG   D + A G  +E       R+++  + Y H +R +HRD+KA N+LL 
Sbjct: 86  LYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLD 145
Query: 179 EMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDS-KADIWSLGITAIEL 237
              ++K+ADFG +   T    K +TF G+P + APE+ +   YD  + D+WSLG+    L
Sbjct: 146 ADMNIKIADFGFSNEFT-VGGKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTL 204
Query: 238 AKGEPP 243
             G  P
Sbjct: 205 VSGSLP 210

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 92.4 bits (228), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 65/217 (29%), Positives = 106/217 (48%), Gaps = 15/217 (6%)
Query: 120 LWIIMEYLGGGS-ALDLMKAGN----FEEMHIAVILREVLKGLDYLHSERKLHRDIKAAN 174
           L+++ E++ G     +++K  +    + E   +  +R++L+ L Y H    +HRD+K  N
Sbjct: 101 LYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPEN 160
Query: 175 VLLSEMGD---VKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLG 231
           VLL+   +   VKL DFGVA  L  +       VGTP +MAPEV+K+  Y    D+W  G
Sbjct: 161 VLLASKENSAPVKLGDFGVAIQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCG 220
Query: 232 ITAIELAKGEPPNSELHPMRVLFLIP---KNNPPQLTGNYTKQFKEFVEACLNKDPENRP 288
           +    L  G  P           +I    K NP Q + + ++  K+ V   L  DP  R 
Sbjct: 221 VILFILLSGCLPFYGTKERLFEGIIKGKYKMNPRQWS-HISESAKDLVRRMLMLDPAERI 279
Query: 289 TAKELLKFPFIRKAKKNAYLIDL---IDRYKKWKNSR 322
           T  E L  P++++  + AY I L   +++ +K+   R
Sbjct: 280 TVYEALNHPWLKERDRYAYKIHLPETVEQLRKFNARR 316

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 92.4 bits (228), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 52/191 (27%), Positives = 100/191 (52%), Gaps = 8/191 (4%)
Query: 111 QCDSPYGTKLWIIMEYLGGGSALDLMKA-GNFEEMHIAVILREVLKGLDYLHSERKLHRD 169
           + ++P G   +I+MEY+ G +  D++   G         ++ +  + L++ H    +HRD
Sbjct: 82  EAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRD 141
Query: 170 IKAANVLLSEMGDVKLADFGVAGTLT---NTTSKRNTFVGTPFWMAPEVIKQSAYDSKAD 226
           +K AN+++S    VK+ DFG+A  +    N+ ++    +GT  +++PE  +  + D+++D
Sbjct: 142 VKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSD 201
Query: 227 IWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNY---TKQFKEFVEACLNKD 283
           ++SLG    E+  GEPP +   P+ V +   + +P   +  +   +      V   L K+
Sbjct: 202 VYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKN 261
Query: 284 PENR-PTAKEL 293
           PENR  TA E+
Sbjct: 262 PENRYQTAAEM 272

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 92.4 bits (228), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 52/191 (27%), Positives = 100/191 (52%), Gaps = 8/191 (4%)
Query: 111 QCDSPYGTKLWIIMEYLGGGSALDLMKA-GNFEEMHIAVILREVLKGLDYLHSERKLHRD 169
           + ++P G   +I+MEY+ G +  D++   G         ++ +  + L++ H    +HRD
Sbjct: 82  EAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRD 141
Query: 170 IKAANVLLSEMGDVKLADFGVAGTLT---NTTSKRNTFVGTPFWMAPEVIKQSAYDSKAD 226
           +K AN+++S    VK+ DFG+A  +    N+ ++    +GT  +++PE  +  + D+++D
Sbjct: 142 VKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSD 201
Query: 227 IWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNY---TKQFKEFVEACLNKD 283
           ++SLG    E+  GEPP +   P+ V +   + +P   +  +   +      V   L K+
Sbjct: 202 VYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKN 261
Query: 284 PENR-PTAKEL 293
           PENR  TA E+
Sbjct: 262 PENRYQTAAEM 272

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 92.0 bits (227), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 44/136 (32%), Positives = 74/136 (54%), Gaps = 4/136 (2%)
Query: 118 TKLWIIMEYLGGGSALD-LMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVL 176
           + L+++MEY+ GG     L + G F E H      +++   +YLHS   ++RD+K  N+L
Sbjct: 114 SNLYMVMEYVAGGEMFSHLRRIGRFAEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLL 173
Query: 177 LSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIE 236
           + + G +++ DFG A  +   T       GTP ++APE+I    Y+   D W+LG+   E
Sbjct: 174 IDQQGYIQVTDFGFAKRVKGRTW---XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYE 230
Query: 237 LAKGEPPNSELHPMRV 252
           +A G PP     P+++
Sbjct: 231 MAAGYPPFFADQPIQI 246

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 92.0 bits (227), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 44/136 (32%), Positives = 74/136 (54%), Gaps = 4/136 (2%)
Query: 118 TKLWIIMEYLGGGSALD-LMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVL 176
           + L+++MEY+ GG     L + G F E H      +++   +YLHS   ++RD+K  N+L
Sbjct: 135 SNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLL 194
Query: 177 LSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIE 236
           + + G +++ DFG A  +   T       GTP ++APE+I    Y+   D W+LG+   E
Sbjct: 195 IDQQGYIQVTDFGFAKRVKGRTW---XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYE 251
Query: 237 LAKGEPPNSELHPMRV 252
           +A G PP     P+++
Sbjct: 252 MAAGYPPFFADQPIQI 267

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 92.0 bits (227), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 59/190 (31%), Positives = 93/190 (48%), Gaps = 12/190 (6%)
Query: 119 KLWIIMEYLGGGSAL-DLMKAGNFEEMHIAVILREVLKGLDYLHSERKL-HRDIKAANVL 176
           +L  +MEY  GG     L +   F E        E++  LDYLHSE+ + +RD+K  N++
Sbjct: 222 RLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLM 281
Query: 177 LSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIE 236
           L + G +K+ DFG+        +   TF GTP ++APEV++ + Y    D W LG+   E
Sbjct: 282 LDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYE 341
Query: 237 LAKGEPP--NSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPENR-----PT 289
           +  G  P  N +   +  L L+ +   P+  G    + K  +   L KDP+ R       
Sbjct: 342 MMCGRLPFYNQDHEKLFELILMEEIRFPRTLG---PEAKSLLSGLLKKDPKQRLGGGSED 398
Query: 290 AKELLKFPFI 299
           AKE+++  F 
Sbjct: 399 AKEIMQHRFF 408

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 92.0 bits (227), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 71/259 (27%), Positives = 119/259 (45%), Gaps = 19/259 (7%)
Query: 55  PELIFTKQERIGKGSFGEVFKG-----IDNRTQQVVXXXXXXXXXXXXXXXXXXXXXMVL 109
           P+   T  +RIG GSFG V+KG     +  +   V                       V 
Sbjct: 22  PDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 81
Query: 110 SQCDSPYGT--KLWIIMEYLGGGSALDLMKAGN--FEEMHIAVILREVLKGLDYLHSERK 165
                 Y T  +L I+ ++  G S    + A    FE   +  I R+  +G+DYLH++  
Sbjct: 82  ILLFMGYSTAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSI 141
Query: 166 LHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRN--TFVGTPFWMAPEVIKQ---SA 220
           +HRD+K+ N+ L E   VK+ DFG+A   +  +         G+  WMAPEVI+    + 
Sbjct: 142 IHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNP 201
Query: 221 YDSKADIWSLGITAIELAKGEPPNSELHPM-RVLFLIPKNN-PPQLT---GNYTKQFKEF 275
           Y  ++D+++ GI   EL  G+ P S ++   +++ ++ + +  P L+    N  K+ K  
Sbjct: 202 YSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKRMKRL 261
Query: 276 VEACLNKDPENRPTAKELL 294
           +  CL K  + RP+   +L
Sbjct: 262 MAECLKKKRDERPSFPRIL 280

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 92.0 bits (227), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 59/190 (31%), Positives = 93/190 (48%), Gaps = 12/190 (6%)
Query: 119 KLWIIMEYLGGGSAL-DLMKAGNFEEMHIAVILREVLKGLDYLHSERKL-HRDIKAANVL 176
           +L  +MEY  GG     L +   F E        E++  LDYLHSE+ + +RD+K  N++
Sbjct: 225 RLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLM 284
Query: 177 LSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIE 236
           L + G +K+ DFG+        +   TF GTP ++APEV++ + Y    D W LG+   E
Sbjct: 285 LDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYE 344
Query: 237 LAKGEPP--NSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPENR-----PT 289
           +  G  P  N +   +  L L+ +   P+  G    + K  +   L KDP+ R       
Sbjct: 345 MMCGRLPFYNQDHEKLFELILMEEIRFPRTLG---PEAKSLLSGLLKKDPKQRLGGGSED 401
Query: 290 AKELLKFPFI 299
           AKE+++  F 
Sbjct: 402 AKEIMQHRFF 411

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 92.0 bits (227), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 63/251 (25%), Positives = 116/251 (46%), Gaps = 21/251 (8%)
Query: 60  TKQERIGKGSFGEVFKGIDNRTQQVVXXXXXXXXXXXXXXXXXXXXXM----------VL 109
           T + ++G G +GEV++G+  +    V                     M          +L
Sbjct: 14  TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLL 73
Query: 110 SQC--DSPYGTKLWIIMEYLGGGSALDLMKAGNFEEMHIAVILR---EVLKGLDYLHSER 164
             C  + P+    +II E++  G+ LD ++  N +E+   V+L    ++   ++YL  + 
Sbjct: 74  GVCTREPPF----YIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN 129
Query: 165 KLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPF-WMAPEVIKQSAYDS 223
            +HRD+ A N L+ E   VK+ADFG++  +T  T   +     P  W APE +  + +  
Sbjct: 130 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTFTAHAGAKFPIKWTAPESLAYNKFSI 189
Query: 224 KADIWSLGITAIELAK-GEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNK 282
           K+D+W+ G+   E+A  G  P   + P +V  L+ K+   +      ++  E + AC   
Sbjct: 190 KSDVWAFGVLLWEIATYGMSPYPGIDPSQVYELLEKDYRMERPEGCPEKVYELMRACWQW 249
Query: 283 DPENRPTAKEL 293
           +P +RP+  E+
Sbjct: 250 NPSDRPSFAEI 260

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 92.0 bits (227), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 44/136 (32%), Positives = 74/136 (54%), Gaps = 4/136 (2%)
Query: 118 TKLWIIMEYLGGGSALD-LMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVL 176
           + L+++MEY+ GG     L + G F E H      +++   +YLHS   ++RD+K  N+L
Sbjct: 114 SNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLL 173
Query: 177 LSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIE 236
           + + G +++ DFG A  +   T       GTP ++APE+I    Y+   D W+LG+   E
Sbjct: 174 IDQQGYIQVTDFGFAKRVKGRTW---XLXGTPEYLAPEIILSKGYNKAVDWWALGVLIYE 230
Query: 237 LAKGEPPNSELHPMRV 252
           +A G PP     P+++
Sbjct: 231 MAAGYPPFFADQPIQI 246

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 92.0 bits (227), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 44/136 (32%), Positives = 74/136 (54%), Gaps = 4/136 (2%)
Query: 118 TKLWIIMEYLGGGSALD-LMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVL 176
           + L+++MEY+ GG     L + G F E H      +++   +YLHS   ++RD+K  N+L
Sbjct: 114 SNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLL 173
Query: 177 LSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIE 236
           + + G +++ DFG A  +   T       GTP ++APE+I    Y+   D W+LG+   E
Sbjct: 174 IDQQGYIQVTDFGFAKRVKGRTW---XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYE 230
Query: 237 LAKGEPPNSELHPMRV 252
           +A G PP     P+++
Sbjct: 231 MAAGYPPFFADEPIQI 246

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 92.0 bits (227), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 72/257 (28%), Positives = 111/257 (43%), Gaps = 23/257 (8%)
Query: 52  KVDPELIFTKQERIGKGSFGEVF-----KGIDNRTQQVVXXXXXXXXXXXXXXXXXXXXX 106
           K DP   F   + +G+GSFG+VF      G D R Q                        
Sbjct: 21  KADPSQ-FELLKVLGQGSFGKVFLVKKISGSDAR-QLYAMKVLKKATLKVRDRVRTKMER 78
Query: 107 MVLSQCDSPYGTKL----------WIIMEYLGGGSALD-LMKAGNFEEMHIAVILREVLK 155
            +L + + P+  KL          ++I+++L GG     L K   F E  +   L E+  
Sbjct: 79  DILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELAL 138
Query: 156 GLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEV 215
            LD+LHS   ++RD+K  N+LL E G +KL DFG++    +   K  +F GT  +MAPEV
Sbjct: 139 ALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEV 198
Query: 216 IKQSAYDSKADIWSLGITAIELAKGEPP--NSELHPMRVLFLIPKNNPPQLTGNYTKQFK 273
           + +  +   AD WS G+   E+  G  P    +      + L  K   PQ     + + +
Sbjct: 199 VNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQFL---SPEAQ 255
Query: 274 EFVEACLNKDPENRPTA 290
             +     ++P NR  A
Sbjct: 256 SLLRMLFKRNPANRLGA 272

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 72/257 (28%), Positives = 111/257 (43%), Gaps = 23/257 (8%)
Query: 52  KVDPELIFTKQERIGKGSFGEVF-----KGIDNRTQQVVXXXXXXXXXXXXXXXXXXXXX 106
           K DP   F   + +G+GSFG+VF      G D R Q                        
Sbjct: 20  KADPSQ-FELLKVLGQGSFGKVFLVKKISGSDAR-QLYAMKVLKKATLKVRDRVRTKMER 77
Query: 107 MVLSQCDSPYGTKL----------WIIMEYLGGGSALD-LMKAGNFEEMHIAVILREVLK 155
            +L + + P+  KL          ++I+++L GG     L K   F E  +   L E+  
Sbjct: 78  DILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELAL 137
Query: 156 GLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEV 215
            LD+LHS   ++RD+K  N+LL E G +KL DFG++    +   K  +F GT  +MAPEV
Sbjct: 138 ALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEV 197
Query: 216 IKQSAYDSKADIWSLGITAIELAKGEPP--NSELHPMRVLFLIPKNNPPQLTGNYTKQFK 273
           + +  +   AD WS G+   E+  G  P    +      + L  K   PQ     + + +
Sbjct: 198 VNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQFL---SPEAQ 254
Query: 274 EFVEACLNKDPENRPTA 290
             +     ++P NR  A
Sbjct: 255 SLLRMLFKRNPANRLGA 271

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 45/136 (33%), Positives = 74/136 (54%), Gaps = 4/136 (2%)
Query: 118 TKLWIIMEYLGGGSALD-LMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVL 176
           + L++++EY  GG     L + G F E H      +++   +YLHS   ++RD+K  N+L
Sbjct: 115 SNLYMVLEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLL 174
Query: 177 LSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIE 236
           + + G +K+ADFG A  +   T       GTP ++APE+I    Y+   D W+LG+   E
Sbjct: 175 IDQQGYIKVADFGFAKRVKGRTW---XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYE 231
Query: 237 LAKGEPPNSELHPMRV 252
           +A G PP     P+++
Sbjct: 232 MAAGYPPFFADQPIQI 247

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 93/207 (44%), Gaps = 16/207 (7%)
Query: 59  FTKQERIGKGSFGEVF--KGIDNRTQQVVXXXXXXXXXXXXXXXXXXXXXMVLSQCDSPY 116
           F + + +G GSFG V   K ++      +                      +L   + P+
Sbjct: 43  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 117 GTKL----------WIIMEYLGGGSALD-LMKAGNFEEMHIAVILREVLKGLDYLHSERK 165
             KL          +++MEY+ GG     L + G F E H      +++   +YLHS   
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDL 162
Query: 166 LHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKA 225
           ++RD+K  N+L+ + G +++ DFG A  +   T       GTP ++APE+I    Y+   
Sbjct: 163 IYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW---XLCGTPEYLAPEIILSKGYNKAV 219
Query: 226 DIWSLGITAIELAKGEPPNSELHPMRV 252
           D W+LG+   E+A G PP     P+++
Sbjct: 220 DWWALGVLIYEMAAGYPPFFADQPIQI 246

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 93/207 (44%), Gaps = 16/207 (7%)
Query: 59  FTKQERIGKGSFGEVF--KGIDNRTQQVVXXXXXXXXXXXXXXXXXXXXXMVLSQCDSPY 116
           F + + +G GSFG V   K ++      +                      +L   + P+
Sbjct: 44  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 103
Query: 117 GTKL----------WIIMEYLGGGSALD-LMKAGNFEEMHIAVILREVLKGLDYLHSERK 165
             KL          +++MEY+ GG     L + G F E H      +++   +YLHS   
Sbjct: 104 LVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDL 163
Query: 166 LHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKA 225
           ++RD+K  N+L+ + G +++ DFG A  +   T       GTP ++APE+I    Y+   
Sbjct: 164 IYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW---XLCGTPEYLAPEIILSKGYNKAV 220
Query: 226 DIWSLGITAIELAKGEPPNSELHPMRV 252
           D W+LG+   E+A G PP     P+++
Sbjct: 221 DWWALGVLIYEMAAGYPPFFADQPIQI 247

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 93/207 (44%), Gaps = 16/207 (7%)
Query: 59  FTKQERIGKGSFGEVF--KGIDNRTQQVVXXXXXXXXXXXXXXXXXXXXXMVLSQCDSPY 116
           F + + +G GSFG V   K ++      +                      +L   + P+
Sbjct: 44  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 103
Query: 117 GTKL----------WIIMEYLGGGSALD-LMKAGNFEEMHIAVILREVLKGLDYLHSERK 165
             KL          +++MEY+ GG     L + G F E H      +++   +YLHS   
Sbjct: 104 LVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDL 163
Query: 166 LHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKA 225
           ++RD+K  N+L+ + G +++ DFG A  +   T       GTP ++APE+I    Y+   
Sbjct: 164 IYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW---XLCGTPEYLAPEIILSKGYNKAV 220
Query: 226 DIWSLGITAIELAKGEPPNSELHPMRV 252
           D W+LG+   E+A G PP     P+++
Sbjct: 221 DWWALGVLIYEMAAGYPPFFADQPIQI 247

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 93/207 (44%), Gaps = 16/207 (7%)
Query: 59  FTKQERIGKGSFGEVF--KGIDNRTQQVVXXXXXXXXXXXXXXXXXXXXXMVLSQCDSPY 116
           F + + +G GSFG V   K ++      +                      +L   + P+
Sbjct: 43  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 117 GTKL----------WIIMEYLGGGSALD-LMKAGNFEEMHIAVILREVLKGLDYLHSERK 165
             KL          +++MEY+ GG     L + G F E H      +++   +YLHS   
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDL 162
Query: 166 LHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKA 225
           ++RD+K  N+L+ + G +++ DFG A  +   T       GTP ++APE+I    Y+   
Sbjct: 163 IYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW---XLCGTPEYLAPEIILSKGYNKAV 219
Query: 226 DIWSLGITAIELAKGEPPNSELHPMRV 252
           D W+LG+   E+A G PP     P+++
Sbjct: 220 DWWALGVLIYEMAAGYPPFFADQPIQI 246

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 93/207 (44%), Gaps = 16/207 (7%)
Query: 59  FTKQERIGKGSFGEVF--KGIDNRTQQVVXXXXXXXXXXXXXXXXXXXXXMVLSQCDSPY 116
           F + + +G GSFG V   K ++      +                      +L   + P+
Sbjct: 43  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 117 GTKL----------WIIMEYLGGGSALD-LMKAGNFEEMHIAVILREVLKGLDYLHSERK 165
             KL          +++MEY+ GG     L + G F E H      +++   +YLHS   
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDL 162
Query: 166 LHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKA 225
           ++RD+K  N+L+ + G +++ DFG A  +   T       GTP ++APE+I    Y+   
Sbjct: 163 IYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW---XLCGTPEYLAPEIILSKGYNKAV 219
Query: 226 DIWSLGITAIELAKGEPPNSELHPMRV 252
           D W+LG+   E+A G PP     P+++
Sbjct: 220 DWWALGVLIYEMAAGYPPFFADQPIQI 246

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 56/193 (29%), Positives = 100/193 (51%), Gaps = 9/193 (4%)
Query: 120 LWIIMEYLGGGSALD-LMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLL- 177
            +++ E+  GG   + ++    F+E   A I++++L G+ YLH    +HRDIK  N+LL 
Sbjct: 121 FYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLE 180
Query: 178 --SEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAI 235
             + + ++K+ DFG++   +     R+  +GT +++APEV+K+  Y+ K D+WS G+   
Sbjct: 181 NKNSLLNIKIVDFGLSSFFSKDYKLRDR-LGTAYYIAPEVLKKK-YNEKCDVWSCGVIMY 238
Query: 236 ELAKGEPPNSELHPMRVLFLIPKNN---PPQLTGNYTKQFKEFVEACLNKDPENRPTAKE 292
            L  G PP    +   ++  + K           N + + KE ++  L  D   R TA+E
Sbjct: 239 ILLCGYPPFGGQNDQDIIKKVEKGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEE 298
Query: 293 LLKFPFIRKAKKN 305
            L   +I+K   N
Sbjct: 299 ALNSRWIKKYANN 311

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 93/207 (44%), Gaps = 16/207 (7%)
Query: 59  FTKQERIGKGSFGEVF--KGIDNRTQQVVXXXXXXXXXXXXXXXXXXXXXMVLSQCDSPY 116
           F + + +G GSFG V   K ++      +                      +L   + P+
Sbjct: 43  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 117 GTKL----------WIIMEYLGGGSALD-LMKAGNFEEMHIAVILREVLKGLDYLHSERK 165
             KL          +++MEY+ GG     L + G F E H      +++   +YLHS   
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDL 162
Query: 166 LHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKA 225
           ++RD+K  N+L+ + G +++ DFG A  +   T       GTP ++APE+I    Y+   
Sbjct: 163 IYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW---XLCGTPEYLAPEIILSKGYNKAV 219
Query: 226 DIWSLGITAIELAKGEPPNSELHPMRV 252
           D W+LG+   E+A G PP     P+++
Sbjct: 220 DWWALGVLIYEMAAGYPPFFADQPIQI 246

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 52/191 (27%), Positives = 100/191 (52%), Gaps = 8/191 (4%)
Query: 111 QCDSPYGTKLWIIMEYLGGGSALDLMKA-GNFEEMHIAVILREVLKGLDYLHSERKLHRD 169
           + ++P G   +I+MEY+ G +  D++   G         ++ +  + L++ H    +HRD
Sbjct: 99  EAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRD 158
Query: 170 IKAANVLLSEMGDVKLADFGVAGTLT---NTTSKRNTFVGTPFWMAPEVIKQSAYDSKAD 226
           +K AN+++S    VK+ DFG+A  +    N+ ++    +GT  +++PE  +  + D+++D
Sbjct: 159 VKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSD 218
Query: 227 IWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNY---TKQFKEFVEACLNKD 283
           ++SLG    E+  GEPP +   P+ V +   + +P   +  +   +      V   L K+
Sbjct: 219 VYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKN 278
Query: 284 PENR-PTAKEL 293
           PENR  TA E+
Sbjct: 279 PENRYQTAAEM 289

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 46/138 (33%), Positives = 72/138 (52%), Gaps = 3/138 (2%)
Query: 109 LSQCDSPYGT--KLWIIMEYLGGGSAL-DLMKAGNFEEMHIAVILREVLKGLDYLHSERK 165
           L+Q  S + T  +L+ +MEY+ GG  +  + + G F+E        E+  GL +LH    
Sbjct: 82  LTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISIGLFFLHKRGI 141
Query: 166 LHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKA 225
           ++RD+K  NV+L   G +K+ADFG+             F GTP ++APE+I    Y    
Sbjct: 142 IYRDLKLDNVMLDSEGHIKIADFGMCKEHMMDGVTTREFCGTPDYIAPEIIAYQPYGKSV 201
Query: 226 DIWSLGITAIELAKGEPP 243
           D W+ G+   E+  G+PP
Sbjct: 202 DWWAYGVLLYEMLAGQPP 219

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 93/207 (44%), Gaps = 16/207 (7%)
Query: 59  FTKQERIGKGSFGEVF--KGIDNRTQQVVXXXXXXXXXXXXXXXXXXXXXMVLSQCDSPY 116
           F + + +G GSFG V   K ++      +                      +L   + P+
Sbjct: 43  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 117 GTKL----------WIIMEYLGGGSALD-LMKAGNFEEMHIAVILREVLKGLDYLHSERK 165
             KL          +++MEY+ GG     L + G F E H      +++   +YLHS   
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDL 162
Query: 166 LHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKA 225
           ++RD+K  N+L+ + G +++ DFG A  +   T       GTP ++APE+I    Y+   
Sbjct: 163 IYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW---XLCGTPEYLAPEIILSKGYNKAV 219
Query: 226 DIWSLGITAIELAKGEPPNSELHPMRV 252
           D W+LG+   E+A G PP     P+++
Sbjct: 220 DWWALGVLIYEMAAGYPPFFADQPIQI 246

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 43/136 (31%), Positives = 74/136 (54%), Gaps = 4/136 (2%)
Query: 118 TKLWIIMEYLGGGSALD-LMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVL 176
           + L+++MEY+ GG     L + G F E H      +++   +YLHS   ++RD+K  N++
Sbjct: 114 SNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLI 173
Query: 177 LSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIE 236
           + + G +++ DFG A  +   T       GTP ++APE+I    Y+   D W+LG+   E
Sbjct: 174 IDQQGYIQVTDFGFAKRVKGRTW---XLCGTPEYLAPEIIISKGYNKAVDWWALGVLIYE 230
Query: 237 LAKGEPPNSELHPMRV 252
           +A G PP     P+++
Sbjct: 231 MAAGYPPFFADQPIQI 246

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 93/207 (44%), Gaps = 16/207 (7%)
Query: 59  FTKQERIGKGSFGEVF--KGIDNRTQQVVXXXXXXXXXXXXXXXXXXXXXMVLSQCDSPY 116
           F + + +G GSFG V   K ++      +                      +L   + P+
Sbjct: 43  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNFPF 102
Query: 117 GTKL----------WIIMEYLGGGSALD-LMKAGNFEEMHIAVILREVLKGLDYLHSERK 165
             KL          +++MEY  GG     L + G F E H      +++   +YLHS   
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDL 162
Query: 166 LHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKA 225
           ++RD+K  N+++ + G +K+ DFG+A  +   T       GTP ++APE+I    Y+   
Sbjct: 163 IYRDLKPENLMIDQQGYIKVTDFGLAKRVKGRTW---XLCGTPEYLAPEIILSKGYNKAV 219
Query: 226 DIWSLGITAIELAKGEPPNSELHPMRV 252
           D W+LG+   E+A G PP     P+++
Sbjct: 220 DWWALGVLIYEMAAGYPPFFADQPIQI 246

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 61/191 (31%), Positives = 99/191 (51%), Gaps = 11/191 (5%)
Query: 122 IIMEYLGGGSALDLM-KAG---NFEEMHIAVILREVLKGLDYLHSERK--LHRDIKAANV 175
           I+ EYL  GS   L+ K+G     +E     +  +V KG++YLH+     +HRD+K+ N+
Sbjct: 111 IVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRDLKSPNL 170
Query: 176 LLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAI 235
           L+ +   VK+ DFG++    +         GTP WMAPEV++    + K+D++S G+   
Sbjct: 171 LVDKKYTVKVCDFGLSRLKASXFLXSKXAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILW 230
Query: 236 ELAKGEPPNSELHPMRVLFLIP-KNNPPQLTGNYTKQFKEFVEACLNKDPENRP---TAK 291
           ELA  + P   L+P +V+  +  K    ++  N   Q    +E C   +P  RP   T  
Sbjct: 231 ELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIM 290
Query: 292 ELLKFPFIRKA 302
           +LL+ P I+ A
Sbjct: 291 DLLR-PLIKSA 300

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 43/136 (31%), Positives = 74/136 (54%), Gaps = 4/136 (2%)
Query: 118 TKLWIIMEYLGGGSALD-LMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVL 176
           + L+++MEY+ GG     L + G F E H      +++   +YLHS   ++RD+K  N+L
Sbjct: 114 SNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLL 173
Query: 177 LSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIE 236
           + + G +++ DFG A  +   T       GTP ++APE+I    Y+   D W+LG+   +
Sbjct: 174 IDQQGYIQVTDFGFAKRVKGRTW---XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYQ 230
Query: 237 LAKGEPPNSELHPMRV 252
           +A G PP     P+++
Sbjct: 231 MAAGYPPFFADQPIQI 246

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 44/136 (32%), Positives = 74/136 (54%), Gaps = 4/136 (2%)
Query: 118 TKLWIIMEYLGGGSALD-LMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVL 176
           + L+++MEY+ GG     L + G F E H      +++   +YLHS   ++RD+K  N+L
Sbjct: 114 SNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLL 173
Query: 177 LSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIE 236
           + + G +++ DFG A  +   T       GTP ++APE+I    Y+   D W+LG+   E
Sbjct: 174 IDQQGYIQVTDFGFAKRVKGRTW---XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYE 230
Query: 237 LAKGEPPNSELHPMRV 252
           +A G PP     P+++
Sbjct: 231 MAAGYPPFFADQPIQI 246

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 44/136 (32%), Positives = 74/136 (54%), Gaps = 4/136 (2%)
Query: 118 TKLWIIMEYLGGGSALD-LMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVL 176
           + L+++MEY+ GG     L + G F E H      +++   +YLHS   ++RD+K  N+L
Sbjct: 114 SNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLL 173
Query: 177 LSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIE 236
           + + G +++ DFG A  +   T       GTP ++APE+I    Y+   D W+LG+   E
Sbjct: 174 IDQQGYIQVTDFGFAKRVKGRTW---XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYE 230
Query: 237 LAKGEPPNSELHPMRV 252
           +A G PP     P+++
Sbjct: 231 MAAGYPPFFADQPIQI 246

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 91.3 bits (225), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 44/136 (32%), Positives = 74/136 (54%), Gaps = 4/136 (2%)
Query: 118 TKLWIIMEYLGGGSALD-LMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVL 176
           + L+++MEY+ GG     L + G F E H      +++   +YLHS   ++RD+K  N+L
Sbjct: 114 SNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLL 173
Query: 177 LSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIE 236
           + + G +++ DFG A  +   T       GTP ++APE+I    Y+   D W+LG+   E
Sbjct: 174 IDQQGYIQVTDFGFAKRVKGRTW---XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYE 230
Query: 237 LAKGEPPNSELHPMRV 252
           +A G PP     P+++
Sbjct: 231 MAAGYPPFFADQPIQI 246

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 91.3 bits (225), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 44/136 (32%), Positives = 74/136 (54%), Gaps = 4/136 (2%)
Query: 118 TKLWIIMEYLGGGSALD-LMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVL 176
           + L+++MEY+ GG     L + G F E H      +++   +YLHS   ++RD+K  N+L
Sbjct: 115 SNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLL 174
Query: 177 LSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIE 236
           + + G +++ DFG A  +   T       GTP ++APE+I    Y+   D W+LG+   E
Sbjct: 175 IDQQGYIQVTDFGFAKRVKGRTW---XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYE 231
Query: 237 LAKGEPPNSELHPMRV 252
           +A G PP     P+++
Sbjct: 232 MAAGYPPFFADQPIQI 247

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 91.3 bits (225), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 71/286 (24%), Positives = 132/286 (46%), Gaps = 27/286 (9%)
Query: 35  SISNQCGSTTASRRNSLKVDPELIFTKQERIGKGSFGEVFKGIDNRTQQVVXXXXXXXXX 94
           S++ + G +++S +   + D + IF  +E +G G+F EV    +  T ++          
Sbjct: 1   SMARENGESSSSWKKQAE-DIKKIFEFKETLGTGAFSEVVLAEEKATGKLFAVKCIPKKA 59
Query: 95  XXXXXXXXXXXXMVLSQC------------DSPYGTKLWIIMEYLGGGSALD-LMKAGNF 141
                        VL +             +SP    L+++M+ + GG   D +++ G +
Sbjct: 60  LKGKESSIENEIAVLRKIKHENIVALEDIYESP--NHLYLVMQLVSGGELFDRIVEKGFY 117
Query: 142 EEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLL---SEMGDVKLADFGVAGTLTNTT 198
            E   + ++R+VL  + YLH    +HRD+K  N+L     E   + ++DFG++  +    
Sbjct: 118 TEKDASTLIRQVLDAVYYLHRMGIVHRDLKPENLLYYSQDEESKIMISDFGLS-KMEGKG 176
Query: 199 SKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPK 258
              +T  GTP ++APEV+ Q  Y    D WS+G+ A  L  G PP  + +  ++   I K
Sbjct: 177 DVMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDSKLFEQILK 236
Query: 259 -----NNPPQLTGNYTKQFKEFVEACLNKDPENRPTAKELLKFPFI 299
                ++P     + +   K+F+   + KDP  R T ++  + P+I
Sbjct: 237 AEYEFDSP--YWDDISDSAKDFIRNLMEKDPNKRYTCEQAARHPWI 280

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 91.3 bits (225), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 44/136 (32%), Positives = 74/136 (54%), Gaps = 4/136 (2%)
Query: 118 TKLWIIMEYLGGGSALD-LMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVL 176
           + L+++MEY+ GG     L + G F E H      +++   +YLHS   ++RD+K  N+L
Sbjct: 115 SNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLL 174
Query: 177 LSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIE 236
           + + G +++ DFG A  +   T       GTP ++APE+I    Y+   D W+LG+   E
Sbjct: 175 IDQQGYIQVTDFGFAKRVKGRTW---XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYE 231
Query: 237 LAKGEPPNSELHPMRV 252
           +A G PP     P+++
Sbjct: 232 MAAGYPPFFADQPIQI 247

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 91.3 bits (225), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 44/136 (32%), Positives = 74/136 (54%), Gaps = 4/136 (2%)
Query: 118 TKLWIIMEYLGGGSALD-LMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVL 176
           + L+++MEY+ GG     L + G F E H      +++   +YLHS   ++RD+K  N+L
Sbjct: 115 SNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLL 174
Query: 177 LSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIE 236
           + + G +++ DFG A  +   T       GTP ++APE+I    Y+   D W+LG+   E
Sbjct: 175 IDQQGYIQVTDFGFAKRVKGRTW---XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYE 231
Query: 237 LAKGEPPNSELHPMRV 252
           +A G PP     P+++
Sbjct: 232 MAAGYPPFFADQPIQI 247

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 91.3 bits (225), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 57/193 (29%), Positives = 88/193 (45%), Gaps = 14/193 (7%)
Query: 65  IGKGSFGEVF----KGIDN-------RTQQVVXXXXXXXXXXXXXXXXXXXXXMVLSQCD 113
           +GKGSFG+V     KG D        +   V+                       L+Q  
Sbjct: 28  LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLH 87
Query: 114 SPYGT--KLWIIMEYLGGGSAL-DLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDI 170
           S + T  +L+ +MEY+ GG  +  + + G F+E H      E+  GL +L S+  ++RD+
Sbjct: 88  SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDL 147
Query: 171 KAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSL 230
           K  NV+L   G +K+ADFG+             F GTP ++APE+I    Y    D W+ 
Sbjct: 148 KLDNVMLDSEGHIKIADFGMCKENIWDGVTTKXFCGTPDYIAPEIIAYQPYGKSVDWWAF 207
Query: 231 GITAIELAKGEPP 243
           G+   E+  G+ P
Sbjct: 208 GVLLYEMLAGQAP 220

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 92/207 (44%), Gaps = 16/207 (7%)
Query: 59  FTKQERIGKGSFGEVF--KGIDNRTQQVVXXXXXXXXXXXXXXXXXXXXXMVLSQCDSPY 116
           F + + +G GSFG V   K ++      +                      +L   + P+
Sbjct: 43  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 117 GTKL----------WIIMEYLGGGSALD-LMKAGNFEEMHIAVILREVLKGLDYLHSERK 165
             KL          +++MEY  GG     L + G F E H      +++   +YLHS   
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDL 162
Query: 166 LHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKA 225
           ++RD+K  N+++ + G +K+ DFG A  +   T       GTP ++APE+I    Y+   
Sbjct: 163 IYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTW---XLCGTPEYLAPEIILSKGYNKAV 219
Query: 226 DIWSLGITAIELAKGEPPNSELHPMRV 252
           D W+LG+   E+A G PP     P+++
Sbjct: 220 DWWALGVLIYEMAAGYPPFFADQPIQI 246

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 44/136 (32%), Positives = 74/136 (54%), Gaps = 4/136 (2%)
Query: 118 TKLWIIMEYLGGGSALD-LMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVL 176
           + L+++MEY+ GG     L + G F E H      +++   +YLHS   ++RD+K  N+L
Sbjct: 107 SNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLL 166
Query: 177 LSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIE 236
           + + G +++ DFG A  +   T       GTP ++APE+I    Y+   D W+LG+   E
Sbjct: 167 IDQQGYIQVTDFGFAKRVKGRTW---XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYE 223
Query: 237 LAKGEPPNSELHPMRV 252
           +A G PP     P+++
Sbjct: 224 MAAGYPPFFADQPIQI 239

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 44/136 (32%), Positives = 74/136 (54%), Gaps = 4/136 (2%)
Query: 118 TKLWIIMEYLGGGSALD-LMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVL 176
           + L+++MEY+ GG     L + G F E H      +++   +YLHS   ++RD+K  N+L
Sbjct: 107 SNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLL 166
Query: 177 LSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIE 236
           + + G +++ DFG A  +   T       GTP ++APE+I    Y+   D W+LG+   E
Sbjct: 167 IDQQGYIQVTDFGFAKRVKGRTW---XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYE 223
Query: 237 LAKGEPPNSELHPMRV 252
           +A G PP     P+++
Sbjct: 224 MAAGYPPFFADQPIQI 239

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 44/136 (32%), Positives = 74/136 (54%), Gaps = 4/136 (2%)
Query: 118 TKLWIIMEYLGGGSALD-LMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVL 176
           + L+++MEY+ GG     L + G F E H      +++   +YLHS   ++RD+K  N+L
Sbjct: 135 SNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLL 194
Query: 177 LSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIE 236
           + + G +++ DFG A  +   T       GTP ++APE+I    Y+   D W+LG+   E
Sbjct: 195 IDQQGYIQVTDFGFAKRVKGRTW---XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYE 251
Query: 237 LAKGEPPNSELHPMRV 252
           +A G PP     P+++
Sbjct: 252 MAAGYPPFFADQPIQI 267

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 92/207 (44%), Gaps = 16/207 (7%)
Query: 59  FTKQERIGKGSFGEVF--KGIDNRTQQVVXXXXXXXXXXXXXXXXXXXXXMVLSQCDSPY 116
           F + + +G GSFG V   K ++      +                      +L   + P+
Sbjct: 43  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 117 GTKL----------WIIMEYLGGGSALD-LMKAGNFEEMHIAVILREVLKGLDYLHSERK 165
             KL          +++MEY  GG     L + G F E H      +++   +YLHS   
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDL 162
Query: 166 LHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKA 225
           ++RD+K  N+++ + G +K+ DFG A  +   T       GTP ++APE+I    Y+   
Sbjct: 163 IYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTW---XLCGTPEYLAPEIILSKGYNKAV 219
Query: 226 DIWSLGITAIELAKGEPPNSELHPMRV 252
           D W+LG+   E+A G PP     P+++
Sbjct: 220 DWWALGVLIYEMAAGYPPFFADQPIQI 246

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 55/178 (30%), Positives = 88/178 (49%), Gaps = 4/178 (2%)
Query: 118 TKLWIIMEYLGGGSALD-LMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVL 176
           T  +++MEY+ GG   D + K G  EEM    + +++L  +DY H    +HRD+K  NVL
Sbjct: 84  TDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVL 143
Query: 177 LSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDS-KADIWSLGITAI 235
           L    + K+ADFG++  +++    R++  G+P + APEVI    Y   + DIWS G+   
Sbjct: 144 LDAHMNAKIADFGLSNMMSDGEFLRDS-CGSPNYAAPEVISGRLYAGPEVDIWSCGVILY 202
Query: 236 ELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPENRPTAKEL 293
            L  G  P  + H +  LF   +     +     +     +   L  DP  R T K++
Sbjct: 203 ALLCGTLPFDDEH-VPTLFKKIRGGVFYIPEYLNRSVATLLMHMLQVDPLKRATIKDI 259

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 52/191 (27%), Positives = 99/191 (51%), Gaps = 8/191 (4%)
Query: 111 QCDSPYGTKLWIIMEYLGGGSALDLMKA-GNFEEMHIAVILREVLKGLDYLHSERKLHRD 169
           + ++P G   +I+MEY+ G +  D++   G         ++ +  + L++ H    +HRD
Sbjct: 82  EAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRD 141
Query: 170 IKAANVLLSEMGDVKLADFGVAGTLT---NTTSKRNTFVGTPFWMAPEVIKQSAYDSKAD 226
           +K AN+++S    VK+ DFG+A  +    N+ ++    +GT  +++PE  +  + D+++D
Sbjct: 142 VKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSD 201
Query: 227 IWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNY---TKQFKEFVEACLNKD 283
           ++SLG    E+  GEPP +   P  V +   + +P   +  +   +      V   L K+
Sbjct: 202 VYSLGCVLYEVLTGEPPFTGDSPDSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKN 261
Query: 284 PENR-PTAKEL 293
           PENR  TA E+
Sbjct: 262 PENRYQTAAEM 272

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 106/212 (50%), Gaps = 11/212 (5%)
Query: 121 WIIMEYLGGGSAL-DLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSE 179
           +++ + + GG    D++    + E   +  ++++L+ + Y HS   +HR++K  N+LL+ 
Sbjct: 104 YLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLAS 163
Query: 180 MGD---VKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIE 236
                 VKLADFG+A    N +   + F GTP +++PEV+K+  Y    DIW+ G+    
Sbjct: 164 KAKGAAVKLADFGLA-IEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYI 222
Query: 237 LAKGEPPNSELHPMRVLFLI---PKNNPPQLTGNYTKQFKEFVEACLNKDPENRPTAKEL 293
           L  G PP  +    R+   I     + P       T + K  +++ L  +P+ R TA + 
Sbjct: 223 LLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQA 282
Query: 294 LKFPFIRKAKKNAYLI---DLIDRYKKWKNSR 322
           LK P+I   ++ A  I   D +D  KK+   R
Sbjct: 283 LKVPWICNRERVASAIHRQDTVDCLKKFNARR 314

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 59/195 (30%), Positives = 102/195 (52%), Gaps = 13/195 (6%)
Query: 117 GTKLWIIMEYLGGGSALD-LMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANV 175
           G  ++++ E + GG  LD +++   F E   + +L  + K ++YLH++  +HRD+K +N+
Sbjct: 88  GKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNI 147
Query: 176 L-LSEMGD---VKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLG 231
           L + E G+   +++ DFG A  L        T   T  ++APEV+++  YD+  DIWSLG
Sbjct: 148 LYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLG 207
Query: 232 ITAIELAKGEPPNS---ELHPMRVLFLIPKNNPPQLTGNY----TKQFKEFVEACLNKDP 284
           +    +  G  P +   +  P  +L  I  +    L+G Y    +   K+ V   L+ DP
Sbjct: 208 VLLYTMLTGYTPFANGPDDTPEEILARI-GSGKFSLSGGYWNSVSDTAKDLVSKMLHVDP 266
Query: 285 ENRPTAKELLKFPFI 299
             R TA  +L+ P+I
Sbjct: 267 HQRLTAALVLRHPWI 281

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 62/251 (24%), Positives = 117/251 (46%), Gaps = 21/251 (8%)
Query: 60  TKQERIGKGSFGEVFKGIDNRTQQVVXXXXXXXXXXXXXXXXXXXXXM----------VL 109
           T + ++G G +GEV++G+  +    V                     M          +L
Sbjct: 17  TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLL 76
Query: 110 SQC--DSPYGTKLWIIMEYLGGGSALDLMKAGNFEEMHIAVILR---EVLKGLDYLHSER 164
             C  + P+    +II+E++  G+ LD ++  N +E++  V+L    ++   ++YL  + 
Sbjct: 77  GVCTREPPF----YIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN 132
Query: 165 KLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPF-WMAPEVIKQSAYDS 223
            +HRD+ A N L+ E   VK+ADFG++  +T  T   +     P  W APE +  + +  
Sbjct: 133 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAYNKFSI 192
Query: 224 KADIWSLGITAIELAK-GEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNK 282
           K+D+W+ G+   E+A  G  P   +   +V  L+ K+   +      ++  E + AC   
Sbjct: 193 KSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQW 252
Query: 283 DPENRPTAKEL 293
           +P +RP+  E+
Sbjct: 253 NPSDRPSFAEI 263

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 90.1 bits (222), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 93/207 (44%), Gaps = 16/207 (7%)
Query: 59  FTKQERIGKGSFGEVF--KGIDNRTQQVVXXXXXXXXXXXXXXXXXXXXXMVLSQCDSPY 116
           F + + +G GSFG V   K ++      +                      +L   + P+
Sbjct: 43  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNFPF 102
Query: 117 GTKL----------WIIMEYLGGGSALD-LMKAGNFEEMHIAVILREVLKGLDYLHSERK 165
             KL          +++MEY  GG     L + G F E H      +++   +YLHS   
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDL 162
Query: 166 LHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKA 225
           ++RD+K  N+++ + G +++ DFG+A  +   T       GTP ++APE+I    Y+   
Sbjct: 163 IYRDLKPENLMIDQQGYIQVTDFGLAKRVKGRTW---XLCGTPEYLAPEIILSKGYNKAV 219
Query: 226 DIWSLGITAIELAKGEPPNSELHPMRV 252
           D W+LG+   E+A G PP     P+++
Sbjct: 220 DWWALGVLIYEMAAGYPPFFADQPIQI 246

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 90.1 bits (222), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 44/136 (32%), Positives = 73/136 (53%), Gaps = 4/136 (2%)
Query: 118 TKLWIIMEYLGGGSALD-LMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVL 176
           + L+++MEY  GG     L + G F E H      +++   +YLHS   ++RD+K  N++
Sbjct: 115 SNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLM 174
Query: 177 LSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIE 236
           + + G +K+ DFG A  +   T       GTP ++APE+I    Y+   D W+LG+   E
Sbjct: 175 IDQQGYIKVTDFGFAKRVKGRTW---XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYE 231
Query: 237 LAKGEPPNSELHPMRV 252
           +A G PP     P+++
Sbjct: 232 MAAGYPPFFADQPIQI 247

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 90.1 bits (222), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 44/136 (32%), Positives = 73/136 (53%), Gaps = 4/136 (2%)
Query: 118 TKLWIIMEYLGGGSALD-LMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVL 176
           + L+++MEY+ GG     L + G F E H      +++   +YLHS   ++RD+K  N+L
Sbjct: 114 SNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLL 173
Query: 177 LSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIE 236
           + + G +++ DFG A  +   T       GTP  +APE+I    Y+   D W+LG+   E
Sbjct: 174 IDQQGYIQVTDFGFAKRVKGRTW---XLCGTPEALAPEIILSKGYNKAVDWWALGVLIYE 230
Query: 237 LAKGEPPNSELHPMRV 252
           +A G PP     P+++
Sbjct: 231 MAAGYPPFFADQPIQI 246

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 90.1 bits (222), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 62/251 (24%), Positives = 117/251 (46%), Gaps = 21/251 (8%)
Query: 60  TKQERIGKGSFGEVFKGIDNRTQQVVXXXXXXXXXXXXXXXXXXXXXM----------VL 109
           T + ++G G +GEV++G+  +    V                     M          +L
Sbjct: 21  TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLL 80
Query: 110 SQC--DSPYGTKLWIIMEYLGGGSALDLMKAGNFEEMHIAVILR---EVLKGLDYLHSER 164
             C  + P+    +II+E++  G+ LD ++  N +E++  V+L    ++   ++YL  + 
Sbjct: 81  GVCTREPPF----YIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN 136
Query: 165 KLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPF-WMAPEVIKQSAYDS 223
            +HRD+ A N L+ E   VK+ADFG++  +T  T   +     P  W APE +  + +  
Sbjct: 137 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSI 196
Query: 224 KADIWSLGITAIELAK-GEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNK 282
           K+D+W+ G+   E+A  G  P   +   +V  L+ K+   +      ++  E + AC   
Sbjct: 197 KSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQW 256
Query: 283 DPENRPTAKEL 293
           +P +RP+  E+
Sbjct: 257 NPSDRPSFAEI 267

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 90.1 bits (222), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 46/126 (36%), Positives = 69/126 (54%), Gaps = 3/126 (2%)
Query: 120 LWIIMEYLGGGSALDLMKA-GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLS 178
           L++IMEY  GG   D + A G  +E       R+++  + Y H +R +HRD+KA N+LL 
Sbjct: 89  LYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLD 148
Query: 179 EMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDS-KADIWSLGITAIEL 237
              ++K+ADFG +   T    K + F G P + APE+ +   YD  + D+WSLG+    L
Sbjct: 149 ADMNIKIADFGFSNEFT-VGGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTL 207
Query: 238 AKGEPP 243
             G  P
Sbjct: 208 VSGSLP 213

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 90.1 bits (222), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 45/126 (35%), Positives = 71/126 (56%), Gaps = 3/126 (2%)
Query: 120 LWIIMEYLGGGSALDLMKA-GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLS 178
           L+++MEY  GG   D + A G  +E       R+++  + Y H +  +HRD+KA N+LL 
Sbjct: 89  LYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKYIVHRDLKAENLLLD 148
Query: 179 EMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDS-KADIWSLGITAIEL 237
              ++K+ADFG +   T   +K +TF G+P + APE+ +   YD  + D+WSLG+    L
Sbjct: 149 GDMNIKIADFGFSNEFT-VGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTL 207
Query: 238 AKGEPP 243
             G  P
Sbjct: 208 VSGSLP 213

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 90.1 bits (222), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 43/136 (31%), Positives = 73/136 (53%), Gaps = 4/136 (2%)
Query: 118 TKLWIIMEYLGGGSALD-LMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVL 176
           + L+++MEY+ GG     L + G F E H      +++   +YLHS   ++RD+K  N+L
Sbjct: 114 SNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLL 173
Query: 177 LSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIE 236
           + + G +++ DFG A  +   T       GTP ++AP +I    Y+   D W+LG+   E
Sbjct: 174 IDQQGYIQVTDFGFAKRVKGRTW---XLCGTPEYLAPAIILSKGYNKAVDWWALGVLIYE 230
Query: 237 LAKGEPPNSELHPMRV 252
           +A G PP     P+++
Sbjct: 231 MAAGYPPFFADQPIQI 246

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 90.1 bits (222), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 58/190 (30%), Positives = 92/190 (48%), Gaps = 12/190 (6%)
Query: 119 KLWIIMEYLGGGSAL-DLMKAGNFEEMHIAVILREVLKGLDYLHSERKL-HRDIKAANVL 176
           +L  +MEY  GG     L +   F E        E++  LDYLHSE+ + +RD+K  N++
Sbjct: 83  RLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLM 142
Query: 177 LSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIE 236
           L + G +K+ DFG+        +    F GTP ++APEV++ + Y    D W LG+   E
Sbjct: 143 LDKDGHIKITDFGLCKEGIKDGATMKXFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYE 202
Query: 237 LAKGEPP--NSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPENR-----PT 289
           +  G  P  N +   +  L L+ +   P+  G    + K  +   L KDP+ R       
Sbjct: 203 MMCGRLPFYNQDHEKLFELILMEEIRFPRTLG---PEAKSLLSGLLKKDPKQRLGGGSED 259
Query: 290 AKELLKFPFI 299
           AKE+++  F 
Sbjct: 260 AKEIMQHRFF 269

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 90.1 bits (222), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 58/190 (30%), Positives = 92/190 (48%), Gaps = 12/190 (6%)
Query: 119 KLWIIMEYLGGGSAL-DLMKAGNFEEMHIAVILREVLKGLDYLHSERKL-HRDIKAANVL 176
           +L  +MEY  GG     L +   F E        E++  LDYLHSE+ + +RD+K  N++
Sbjct: 84  RLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLM 143
Query: 177 LSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIE 236
           L + G +K+ DFG+        +    F GTP ++APEV++ + Y    D W LG+   E
Sbjct: 144 LDKDGHIKITDFGLCKEGIKDGATMKXFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYE 203
Query: 237 LAKGEPP--NSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPENR-----PT 289
           +  G  P  N +   +  L L+ +   P+  G    + K  +   L KDP+ R       
Sbjct: 204 MMCGRLPFYNQDHEKLFELILMEEIRFPRTLG---PEAKSLLSGLLKKDPKQRLGGGSED 260
Query: 290 AKELLKFPFI 299
           AKE+++  F 
Sbjct: 261 AKEIMQHRFF 270

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 90.1 bits (222), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 55/194 (28%), Positives = 99/194 (51%), Gaps = 12/194 (6%)
Query: 113 DSPYGTKLWIIMEYLGGGSALDLMK--AGNFEEMHIAVILREVLKGLDYLHSERKLHRDI 170
           DS Y   +++++E    G     +K     F E      + +++ G+ YLHS   LHRD+
Sbjct: 82  DSNY---VYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDL 138
Query: 171 KAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSL 230
             +N+LL+   ++K+ADFG+A  L     K  T  GTP +++PE+  +SA+  ++D+WSL
Sbjct: 139 TLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATRSAHGLESDVWSL 198
Query: 231 GITAIELAKGEPP---NSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPENR 287
           G     L  G PP   ++  + +  + L     P  L    + + K+ +   L ++P +R
Sbjct: 199 GCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPSFL----SIEAKDLIHQLLRRNPADR 254
Query: 288 PTAKELLKFPFIRK 301
            +   +L  PF+ +
Sbjct: 255 LSLSSVLDHPFMSR 268

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 90.1 bits (222), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 58/190 (30%), Positives = 92/190 (48%), Gaps = 12/190 (6%)
Query: 119 KLWIIMEYLGGGSAL-DLMKAGNFEEMHIAVILREVLKGLDYLHSERKL-HRDIKAANVL 176
           +L  +MEY  GG     L +   F E        E++  LDYLHSE+ + +RD+K  N++
Sbjct: 82  RLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLM 141
Query: 177 LSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIE 236
           L + G +K+ DFG+        +    F GTP ++APEV++ + Y    D W LG+   E
Sbjct: 142 LDKDGHIKITDFGLCKEGIKDGATMKXFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYE 201
Query: 237 LAKGEPP--NSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPENR-----PT 289
           +  G  P  N +   +  L L+ +   P+  G    + K  +   L KDP+ R       
Sbjct: 202 MMCGRLPFYNQDHEKLFELILMEEIRFPRTLG---PEAKSLLSGLLKKDPKQRLGGGSED 258
Query: 290 AKELLKFPFI 299
           AKE+++  F 
Sbjct: 259 AKEIMQHRFF 268

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 89.7 bits (221), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 92/207 (44%), Gaps = 16/207 (7%)
Query: 59  FTKQERIGKGSFGEVF--KGIDNRTQQVVXXXXXXXXXXXXXXXXXXXXXMVLSQCDSPY 116
           F + + +G GSFG V   K ++      +                      +L   + P+
Sbjct: 43  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 117 GTKL----------WIIMEYLGGGSALD-LMKAGNFEEMHIAVILREVLKGLDYLHSERK 165
             KL          +++MEY  GG     L + G F E H      +++   +YLHS   
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDL 162
Query: 166 LHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKA 225
           ++RD+K  N+++ + G +++ DFG A  +   T       GTP ++APE+I    Y+   
Sbjct: 163 IYRDLKPENLMIDQQGYIQVTDFGFAKRVKGRTW---XLCGTPEYLAPEIILSKGYNKAV 219
Query: 226 DIWSLGITAIELAKGEPPNSELHPMRV 252
           D W+LG+   E+A G PP     P+++
Sbjct: 220 DWWALGVLIYEMAAGYPPFFADQPIQI 246

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 89.7 bits (221), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 75/259 (28%), Positives = 103/259 (39%), Gaps = 44/259 (16%)
Query: 65  IGKGSFGEVFKGIDNRTQ---QVVXXXXXXXXXXXXXXXXXXXXXMVLSQCDSPYGTKL- 120
           IG+G FG+V +GI    +     V                     + + Q D P+  KL 
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 121 --------WIIMEYLGGGSALDLMKAGNFEEMHIAVILR--EVLKGLDYLHSERKLHRDI 170
                   WIIME    G     ++   F     ++IL   ++   L YL S+R +HRDI
Sbjct: 78  GVITENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDI 137
Query: 171 KAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPF-WMAPEVIKQSAYDSKADIWS 229
            A NVL+S    VKL DFG++  + ++T  + +    P  WMAPE I    + S +D+W 
Sbjct: 138 AARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWM 197
Query: 230 LGITAIEL---------------AKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKE 274
            G+   E+                 G   N E  PM      P N PP L    TK    
Sbjct: 198 FGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPM------PPNCPPTLYSLMTK---- 247
Query: 275 FVEACLNKDPENRPTAKEL 293
               C   DP  RP   EL
Sbjct: 248 ----CWAYDPSRRPRFTEL 262

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 89.7 bits (221), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 62/251 (24%), Positives = 116/251 (46%), Gaps = 21/251 (8%)
Query: 60  TKQERIGKGSFGEVFKGIDNRTQQVVXXXXXXXXXXXXXXXXXXXXXM----------VL 109
           T + ++G G +GEV++G+  +    V                     M          +L
Sbjct: 16  TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLL 75
Query: 110 SQC--DSPYGTKLWIIMEYLGGGSALDLMKAGNFEEMHIAVILR---EVLKGLDYLHSER 164
             C  + P+    +II+E++  G+ LD ++  N +E+   V+L    ++   ++YL  + 
Sbjct: 76  GVCTREPPF----YIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN 131
Query: 165 KLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPF-WMAPEVIKQSAYDS 223
            +HRD+ A N L+ E   VK+ADFG++  +T  T   +     P  W APE +  + +  
Sbjct: 132 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSI 191
Query: 224 KADIWSLGITAIELAK-GEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNK 282
           K+D+W+ G+   E+A  G  P   +   +V  L+ K+   +      ++  E + AC   
Sbjct: 192 KSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQW 251
Query: 283 DPENRPTAKEL 293
           +P +RP+  E+
Sbjct: 252 NPSDRPSFAEI 262

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 89.7 bits (221), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 55/178 (30%), Positives = 87/178 (48%), Gaps = 4/178 (2%)
Query: 118 TKLWIIMEYLGGGSALD-LMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVL 176
           T  +++MEY+ GG   D + K G  EEM    + +++L  +DY H    +HRD+K  NVL
Sbjct: 84  TDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVL 143
Query: 177 LSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDS-KADIWSLGITAI 235
           L    + K+ADFG++  +++    R +  G+P + APEVI    Y   + DIWS G+   
Sbjct: 144 LDAHMNAKIADFGLSNMMSDGEFLRTS-CGSPNYAAPEVISGRLYAGPEVDIWSCGVILY 202
Query: 236 ELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPENRPTAKEL 293
            L  G  P  + H +  LF   +     +     +     +   L  DP  R T K++
Sbjct: 203 ALLCGTLPFDDEH-VPTLFKKIRGGVFYIPEYLNRSVATLLMHMLQVDPLKRATIKDI 259

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 89.7 bits (221), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 75/259 (28%), Positives = 103/259 (39%), Gaps = 44/259 (16%)
Query: 65  IGKGSFGEVFKGIDNRTQ---QVVXXXXXXXXXXXXXXXXXXXXXMVLSQCDSPYGTKL- 120
           IG+G FG+V +GI    +     V                     + + Q D P+  KL 
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 121 --------WIIMEYLGGGSALDLMKAGNFEEMHIAVILR--EVLKGLDYLHSERKLHRDI 170
                   WIIME    G     ++   F     ++IL   ++   L YL S+R +HRDI
Sbjct: 78  GVITENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDI 137
Query: 171 KAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPF-WMAPEVIKQSAYDSKADIWS 229
            A NVL+S    VKL DFG++  + ++T  + +    P  WMAPE I    + S +D+W 
Sbjct: 138 AARNVLVSSNDCVKLGDFGLSRYMEDSTXXKASKGKLPIKWMAPESINFRRFTSASDVWM 197
Query: 230 LGITAIEL---------------AKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKE 274
            G+   E+                 G   N E  PM      P N PP L    TK    
Sbjct: 198 FGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPM------PPNCPPTLYSLMTK---- 247
Query: 275 FVEACLNKDPENRPTAKEL 293
               C   DP  RP   EL
Sbjct: 248 ----CWAYDPSRRPRFTEL 262

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 89.7 bits (221), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 71/262 (27%), Positives = 110/262 (41%), Gaps = 35/262 (13%)
Query: 63  ERIGKGSFGEVFKGIDNRTQQVVXXXXXXXXXXXXXXXXXXXXXM--------VLSQCDS 114
           E +GKG FG+  K     T +V+                     +        VL     
Sbjct: 16  EVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGV 75
Query: 115 PYGTK-LWIIMEYLGGGSALDLMKA--GNFEEMHIAVILREVLKGLDYLHSERKLHRDIK 171
            Y  K L  I EY+ GG+   ++K+    +         +++  G+ YLHS   +HRD+ 
Sbjct: 76  LYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLN 135
Query: 172 AANVLLSEMGDVKLADFGVAGTLTNTTS--------------KRNTFVGTPFWMAPEVIK 217
           + N L+ E  +V +ADFG+A  + +  +              KR T VG P+WMAPE+I 
Sbjct: 136 SHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMIN 195
Query: 218 QSAYDSKADIWSLGITAIEL---AKGEP---PNSELHPMRVLFLIPKNNPPQLTGNYTKQ 271
             +YD K D++S GI   E+      +P   P +    + V   + +  PP    N    
Sbjct: 196 GRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRYCPP----NCPPS 251
Query: 272 FKEFVEACLNKDPENRPTAKEL 293
           F      C + DPE RP+  +L
Sbjct: 252 FFPITVRCCDLDPEKRPSFVKL 273

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 89.7 bits (221), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 75/259 (28%), Positives = 103/259 (39%), Gaps = 44/259 (16%)
Query: 65  IGKGSFGEVFKGIDNRTQ---QVVXXXXXXXXXXXXXXXXXXXXXMVLSQCDSPYGTKL- 120
           IG+G FG+V +GI    +     V                     + + Q D P+  KL 
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 121 --------WIIMEYLGGGSALDLMKAGNFEEMHIAVILR--EVLKGLDYLHSERKLHRDI 170
                   WIIME    G     ++   F     ++IL   ++   L YL S+R +HRDI
Sbjct: 458 GVITENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDI 517
Query: 171 KAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPF-WMAPEVIKQSAYDSKADIWS 229
            A NVL+S    VKL DFG++  + ++T  + +    P  WMAPE I    + S +D+W 
Sbjct: 518 AARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWM 577
Query: 230 LGITAIEL---------------AKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKE 274
            G+   E+                 G   N E  PM      P N PP L    TK    
Sbjct: 578 FGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPM------PPNCPPTLYSLMTK---- 627
Query: 275 FVEACLNKDPENRPTAKEL 293
               C   DP  RP   EL
Sbjct: 628 ----CWAYDPSRRPRFTEL 642

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 89.7 bits (221), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 62/251 (24%), Positives = 116/251 (46%), Gaps = 21/251 (8%)
Query: 60  TKQERIGKGSFGEVFKGIDNRTQQVVXXXXXXXXXXXXXXXXXXXXXM----------VL 109
           T + ++G G +GEV++G+  +    V                     M          +L
Sbjct: 21  TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLL 80
Query: 110 SQC--DSPYGTKLWIIMEYLGGGSALDLMKAGNFEEMHIAVILR---EVLKGLDYLHSER 164
             C  + P+    +II E++  G+ LD ++  N +E++  V+L    ++   ++YL  + 
Sbjct: 81  GVCTREPPF----YIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN 136
Query: 165 KLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPF-WMAPEVIKQSAYDS 223
            +HRD+ A N L+ E   VK+ADFG++  +T  T   +     P  W APE +  + +  
Sbjct: 137 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAYNKFSI 196
Query: 224 KADIWSLGITAIELAK-GEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNK 282
           K+D+W+ G+   E+A  G  P   +   +V  L+ K+   +      ++  E + AC   
Sbjct: 197 KSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQW 256
Query: 283 DPENRPTAKEL 293
           +P +RP+  E+
Sbjct: 257 NPSDRPSFAEI 267

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 89.4 bits (220), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 62/251 (24%), Positives = 116/251 (46%), Gaps = 21/251 (8%)
Query: 60  TKQERIGKGSFGEVFKGIDNRTQQVVXXXXXXXXXXXXXXXXXXXXXM----------VL 109
           T + ++G G +GEV++G+  +    V                     M          +L
Sbjct: 16  TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLL 75
Query: 110 SQC--DSPYGTKLWIIMEYLGGGSALDLMKAGNFEEMHIAVILR---EVLKGLDYLHSER 164
             C  + P+    +II+E++  G+ LD ++  N +E+   V+L    ++   ++YL  + 
Sbjct: 76  GVCTREPPF----YIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN 131
Query: 165 KLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPF-WMAPEVIKQSAYDS 223
            +HRD+ A N L+ E   VK+ADFG++  +T  T   +     P  W APE +  + +  
Sbjct: 132 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSI 191
Query: 224 KADIWSLGITAIELAK-GEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNK 282
           K+D+W+ G+   E+A  G  P   +   +V  L+ K+   +      ++  E + AC   
Sbjct: 192 KSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQW 251
Query: 283 DPENRPTAKEL 293
           +P +RP+  E+
Sbjct: 252 NPSDRPSFAEI 262

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 89.4 bits (220), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 62/251 (24%), Positives = 116/251 (46%), Gaps = 21/251 (8%)
Query: 60  TKQERIGKGSFGEVFKGIDNRTQQVVXXXXXXXXXXXXXXXXXXXXXM----------VL 109
           T + ++G G +GEV++G+  +    V                     M          +L
Sbjct: 21  TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLL 80
Query: 110 SQC--DSPYGTKLWIIMEYLGGGSALDLMKAGNFEEMHIAVILR---EVLKGLDYLHSER 164
             C  + P+    +II E++  G+ LD ++  N +E++  V+L    ++   ++YL  + 
Sbjct: 81  GVCTREPPF----YIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN 136
Query: 165 KLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPF-WMAPEVIKQSAYDS 223
            +HRD+ A N L+ E   VK+ADFG++  +T  T   +     P  W APE +  + +  
Sbjct: 137 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSI 196
Query: 224 KADIWSLGITAIELAK-GEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNK 282
           K+D+W+ G+   E+A  G  P   +   +V  L+ K+   +      ++  E + AC   
Sbjct: 197 KSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQW 256
Query: 283 DPENRPTAKEL 293
           +P +RP+  E+
Sbjct: 257 NPSDRPSFAEI 267

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 89.4 bits (220), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 57/189 (30%), Positives = 92/189 (48%), Gaps = 11/189 (5%)
Query: 119 KLWIIMEYLGGGSAL-DLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLL 177
           +L  +MEY  GG     L +   F E        E++  L+YLHS   ++RDIK  N++L
Sbjct: 82  RLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLML 141
Query: 178 SEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIEL 237
            + G +K+ DFG+     +  +   TF GTP ++APEV++ + Y    D W LG+   E+
Sbjct: 142 DKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEM 201
Query: 238 AKGEPP--NSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPENR-----PTA 290
             G  P  N +   +  L L+ +   P+     + + K  +   L KDP+ R       A
Sbjct: 202 MCGRLPFYNQDHERLFELILMEEIRFPR---TLSPEAKSLLAGLLKKDPKQRLGGGPSDA 258
Query: 291 KELLKFPFI 299
           KE+++  F 
Sbjct: 259 KEVMEHRFF 267

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 89.4 bits (220), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 62/251 (24%), Positives = 116/251 (46%), Gaps = 21/251 (8%)
Query: 60  TKQERIGKGSFGEVFKGIDNRTQQVVXXXXXXXXXXXXXXXXXXXXXM----------VL 109
           T + ++G G +GEV++G+  +    V                     M          +L
Sbjct: 20  TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLL 79
Query: 110 SQC--DSPYGTKLWIIMEYLGGGSALDLMKAGNFEEMHIAVILR---EVLKGLDYLHSER 164
             C  + P+    +II E++  G+ LD ++  N +E++  V+L    ++   ++YL  + 
Sbjct: 80  GVCTREPPF----YIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN 135
Query: 165 KLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPF-WMAPEVIKQSAYDS 223
            +HRD+ A N L+ E   VK+ADFG++  +T  T   +     P  W APE +  + +  
Sbjct: 136 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSI 195
Query: 224 KADIWSLGITAIELAK-GEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNK 282
           K+D+W+ G+   E+A  G  P   +   +V  L+ K+   +      ++  E + AC   
Sbjct: 196 KSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQW 255
Query: 283 DPENRPTAKEL 293
           +P +RP+  E+
Sbjct: 256 NPSDRPSFAEI 266

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 89.4 bits (220), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 57/189 (30%), Positives = 92/189 (48%), Gaps = 11/189 (5%)
Query: 119 KLWIIMEYLGGGSAL-DLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLL 177
           +L  +MEY  GG     L +   F E        E++  L+YLHS   ++RDIK  N++L
Sbjct: 79  RLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLML 138
Query: 178 SEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIEL 237
            + G +K+ DFG+     +  +   TF GTP ++APEV++ + Y    D W LG+   E+
Sbjct: 139 DKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEM 198
Query: 238 AKGEPP--NSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPENR-----PTA 290
             G  P  N +   +  L L+ +   P+     + + K  +   L KDP+ R       A
Sbjct: 199 MCGRLPFYNQDHERLFELILMEEIRFPR---TLSPEAKSLLAGLLKKDPKQRLGGGPSDA 255
Query: 291 KELLKFPFI 299
           KE+++  F 
Sbjct: 256 KEVMEHRFF 264

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 89.4 bits (220), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 45/126 (35%), Positives = 71/126 (56%), Gaps = 3/126 (2%)
Query: 120 LWIIMEYLGGGSALDLMKA-GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLS 178
           L+++MEY  GG   D + A G  +E       R+++  + Y H +  +HRD+KA N+LL 
Sbjct: 88  LYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKFIVHRDLKAENLLLD 147
Query: 179 EMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDS-KADIWSLGITAIEL 237
              ++K+ADFG +   T   +K +TF G+P + APE+ +   YD  + D+WSLG+    L
Sbjct: 148 ADMNIKIADFGFSNEFT-FGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTL 206
Query: 238 AKGEPP 243
             G  P
Sbjct: 207 VSGSLP 212

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 89.4 bits (220), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 45/126 (35%), Positives = 71/126 (56%), Gaps = 3/126 (2%)
Query: 120 LWIIMEYLGGGSALDLMKA-GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLS 178
           L+++MEY  GG   D + A G  +E       R+++  + Y H +  +HRD+KA N+LL 
Sbjct: 88  LYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKFIVHRDLKAENLLLD 147
Query: 179 EMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDS-KADIWSLGITAIEL 237
              ++K+ADFG +   T   +K +TF G+P + APE+ +   YD  + D+WSLG+    L
Sbjct: 148 ADMNIKIADFGFSNEFT-FGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTL 206
Query: 238 AKGEPP 243
             G  P
Sbjct: 207 VSGSLP 212

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 89.4 bits (220), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 45/126 (35%), Positives = 71/126 (56%), Gaps = 3/126 (2%)
Query: 120 LWIIMEYLGGGSALDLMKA-GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLS 178
           L+++MEY  GG   D + A G  +E       R+++  + Y H +  +HRD+KA N+LL 
Sbjct: 88  LYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKFIVHRDLKAENLLLD 147
Query: 179 EMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDS-KADIWSLGITAIEL 237
              ++K+ADFG +   T   +K +TF G+P + APE+ +   YD  + D+WSLG+    L
Sbjct: 148 ADMNIKIADFGFSNEFT-FGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTL 206
Query: 238 AKGEPP 243
             G  P
Sbjct: 207 VSGSLP 212

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 89.0 bits (219), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 57/189 (30%), Positives = 92/189 (48%), Gaps = 11/189 (5%)
Query: 119 KLWIIMEYLGGGSAL-DLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLL 177
           +L  +MEY  GG     L +   F E        E++  L+YLHS   ++RDIK  N++L
Sbjct: 79  RLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLML 138
Query: 178 SEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIEL 237
            + G +K+ DFG+     +  +   TF GTP ++APEV++ + Y    D W LG+   E+
Sbjct: 139 DKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEM 198
Query: 238 AKGEPP--NSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPENR-----PTA 290
             G  P  N +   +  L L+ +   P+     + + K  +   L KDP+ R       A
Sbjct: 199 MCGRLPFYNQDHERLFELILMEEIRFPR---TLSPEAKSLLAGLLKKDPKQRLGGGPSDA 255
Query: 291 KELLKFPFI 299
           KE+++  F 
Sbjct: 256 KEVMEHRFF 264

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 89.0 bits (219), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 62/251 (24%), Positives = 116/251 (46%), Gaps = 21/251 (8%)
Query: 60  TKQERIGKGSFGEVFKGIDNRTQQVVXXXXXXXXXXXXXXXXXXXXXM----------VL 109
           T + ++G G +GEV++G+  +    V                     M          +L
Sbjct: 18  TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLL 77
Query: 110 SQC--DSPYGTKLWIIMEYLGGGSALDLMKAGNFEEMHIAVILR---EVLKGLDYLHSER 164
             C  + P+    +II E++  G+ LD ++  N +E++  V+L    ++   ++YL  + 
Sbjct: 78  GVCTREPPF----YIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN 133
Query: 165 KLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPF-WMAPEVIKQSAYDS 223
            +HRD+ A N L+ E   VK+ADFG++  +T  T   +     P  W APE +  + +  
Sbjct: 134 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSI 193
Query: 224 KADIWSLGITAIELAK-GEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNK 282
           K+D+W+ G+   E+A  G  P   +   +V  L+ K+   +      ++  E + AC   
Sbjct: 194 KSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQW 253
Query: 283 DPENRPTAKEL 293
           +P +RP+  E+
Sbjct: 254 NPSDRPSFAEI 264

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 89.0 bits (219), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 62/251 (24%), Positives = 116/251 (46%), Gaps = 21/251 (8%)
Query: 60  TKQERIGKGSFGEVFKGIDNRTQQVVXXXXXXXXXXXXXXXXXXXXXM----------VL 109
           T + ++G G +GEV++G+  +    V                     M          +L
Sbjct: 21  TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLL 80
Query: 110 SQC--DSPYGTKLWIIMEYLGGGSALDLMKAGNFEEMHIAVILR---EVLKGLDYLHSER 164
             C  + P+    +II E++  G+ LD ++  N +E++  V+L    ++   ++YL  + 
Sbjct: 81  GVCTREPPF----YIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN 136
Query: 165 KLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPF-WMAPEVIKQSAYDS 223
            +HRD+ A N L+ E   VK+ADFG++  +T  T   +     P  W APE +  + +  
Sbjct: 137 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSI 196
Query: 224 KADIWSLGITAIELAK-GEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNK 282
           K+D+W+ G+   E+A  G  P   +   +V  L+ K+   +      ++  E + AC   
Sbjct: 197 KSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQW 256
Query: 283 DPENRPTAKEL 293
           +P +RP+  E+
Sbjct: 257 NPSDRPSFAEI 267

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 89.0 bits (219), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 62/251 (24%), Positives = 116/251 (46%), Gaps = 21/251 (8%)
Query: 60  TKQERIGKGSFGEVFKGIDNRTQQVVXXXXXXXXXXXXXXXXXXXXXM----------VL 109
           T + ++G G +GEV++G+  +    V                     M          +L
Sbjct: 16  TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLL 75
Query: 110 SQC--DSPYGTKLWIIMEYLGGGSALDLMKAGNFEEMHIAVILR---EVLKGLDYLHSER 164
             C  + P+    +II E++  G+ LD ++  N +E++  V+L    ++   ++YL  + 
Sbjct: 76  GVCTREPPF----YIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN 131
Query: 165 KLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPF-WMAPEVIKQSAYDS 223
            +HRD+ A N L+ E   VK+ADFG++  +T  T   +     P  W APE +  + +  
Sbjct: 132 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSI 191
Query: 224 KADIWSLGITAIELAK-GEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNK 282
           K+D+W+ G+   E+A  G  P   +   +V  L+ K+   +      ++  E + AC   
Sbjct: 192 KSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQW 251
Query: 283 DPENRPTAKEL 293
           +P +RP+  E+
Sbjct: 252 NPSDRPSFAEI 262

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 89.0 bits (219), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 75/259 (28%), Positives = 103/259 (39%), Gaps = 44/259 (16%)
Query: 65  IGKGSFGEVFKGIDNRTQ---QVVXXXXXXXXXXXXXXXXXXXXXMVLSQCDSPYGTKL- 120
           IG+G FG+V +GI    +     V                     + + Q D P+  KL 
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 121 --------WIIMEYLGGGSALDLMKAGNFEEMHIAVILR--EVLKGLDYLHSERKLHRDI 170
                   WIIME    G     ++   F     ++IL   ++   L YL S+R +HRDI
Sbjct: 458 GVITENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDI 517
Query: 171 KAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPF-WMAPEVIKQSAYDSKADIWS 229
            A NVL+S    VKL DFG++  + ++T  + +    P  WMAPE I    + S +D+W 
Sbjct: 518 AARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWM 577
Query: 230 LGITAIEL---------------AKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKE 274
            G+   E+                 G   N E  PM      P N PP L    TK    
Sbjct: 578 FGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPM------PPNCPPTLYSLMTK---- 627
Query: 275 FVEACLNKDPENRPTAKEL 293
               C   DP  RP   EL
Sbjct: 628 ----CWAYDPSRRPRFTEL 642

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 89.0 bits (219), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 62/251 (24%), Positives = 115/251 (45%), Gaps = 21/251 (8%)
Query: 60  TKQERIGKGSFGEVFKGIDNRTQQVVXXXXXXXXXXXXXXXXXXXXXM----------VL 109
           T + ++G G +GEV++G+  +    V                     M          +L
Sbjct: 21  TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLL 80
Query: 110 SQC--DSPYGTKLWIIMEYLGGGSALDLMKAGNFEEMHIAVILR---EVLKGLDYLHSER 164
             C  + P+    +II E++  G+ LD ++  N +E+   V+L    ++   ++YL  + 
Sbjct: 81  GVCTREPPF----YIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN 136
Query: 165 KLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPF-WMAPEVIKQSAYDS 223
            +HRD+ A N L+ E   VK+ADFG++  +T  T   +     P  W APE +  + +  
Sbjct: 137 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSI 196
Query: 224 KADIWSLGITAIELAK-GEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNK 282
           K+D+W+ G+   E+A  G  P   +   +V  L+ K+   +      ++  E + AC   
Sbjct: 197 KSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQW 256
Query: 283 DPENRPTAKEL 293
           +P +RP+  E+
Sbjct: 257 NPSDRPSFAEI 267

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 89.0 bits (219), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 62/251 (24%), Positives = 116/251 (46%), Gaps = 21/251 (8%)
Query: 60  TKQERIGKGSFGEVFKGIDNRTQQVVXXXXXXXXXXXXXXXXXXXXXM----------VL 109
           T + ++G G +GEV++G+  +    V                     M          +L
Sbjct: 16  TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLL 75
Query: 110 SQC--DSPYGTKLWIIMEYLGGGSALDLMKAGNFEEMHIAVILR---EVLKGLDYLHSER 164
             C  + P+    +II E++  G+ LD ++  N +E++  V+L    ++   ++YL  + 
Sbjct: 76  GVCTREPPF----YIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN 131
Query: 165 KLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPF-WMAPEVIKQSAYDS 223
            +HRD+ A N L+ E   VK+ADFG++  +T  T   +     P  W APE +  + +  
Sbjct: 132 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSI 191
Query: 224 KADIWSLGITAIELAK-GEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNK 282
           K+D+W+ G+   E+A  G  P   +   +V  L+ K+   +      ++  E + AC   
Sbjct: 192 KSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQW 251
Query: 283 DPENRPTAKEL 293
           +P +RP+  E+
Sbjct: 252 NPSDRPSFAEI 262

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 89.0 bits (219), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 62/251 (24%), Positives = 116/251 (46%), Gaps = 21/251 (8%)
Query: 60  TKQERIGKGSFGEVFKGIDNRTQQVVXXXXXXXXXXXXXXXXXXXXXM----------VL 109
           T + ++G G +GEV++G+  +    V                     M          +L
Sbjct: 18  TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLL 77
Query: 110 SQC--DSPYGTKLWIIMEYLGGGSALDLMKAGNFEEMHIAVILR---EVLKGLDYLHSER 164
             C  + P+    +II E++  G+ LD ++  N +E++  V+L    ++   ++YL  + 
Sbjct: 78  GVCTREPPF----YIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN 133
Query: 165 KLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPF-WMAPEVIKQSAYDS 223
            +HRD+ A N L+ E   VK+ADFG++  +T  T   +     P  W APE +  + +  
Sbjct: 134 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSI 193
Query: 224 KADIWSLGITAIELAK-GEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNK 282
           K+D+W+ G+   E+A  G  P   +   +V  L+ K+   +      ++  E + AC   
Sbjct: 194 KSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQW 253
Query: 283 DPENRPTAKEL 293
           +P +RP+  E+
Sbjct: 254 NPSDRPSFAEI 264

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 89.0 bits (219), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 62/251 (24%), Positives = 116/251 (46%), Gaps = 21/251 (8%)
Query: 60  TKQERIGKGSFGEVFKGIDNRTQQVVXXXXXXXXXXXXXXXXXXXXXM----------VL 109
           T + ++G G +GEV++G+  +    V                     M          +L
Sbjct: 29  TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLL 88
Query: 110 SQC--DSPYGTKLWIIMEYLGGGSALDLMKAGNFEEMHIAVILR---EVLKGLDYLHSER 164
             C  + P+    +II E++  G+ LD ++  N +E++  V+L    ++   ++YL  + 
Sbjct: 89  GVCTREPPF----YIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN 144
Query: 165 KLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPF-WMAPEVIKQSAYDS 223
            +HRD+ A N L+ E   VK+ADFG++  +T  T   +     P  W APE +  + +  
Sbjct: 145 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSI 204
Query: 224 KADIWSLGITAIELAK-GEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNK 282
           K+D+W+ G+   E+A  G  P   +   +V  L+ K+   +      ++  E + AC   
Sbjct: 205 KSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQW 264
Query: 283 DPENRPTAKEL 293
           +P +RP+  E+
Sbjct: 265 NPSDRPSFAEI 275

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 89.0 bits (219), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 103/203 (50%), Gaps = 30/203 (14%)
Query: 118 TKLWIIMEYLGGGSALDLMK---AGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAAN 174
           +++ +I+EY  GG    L     A    E  +  +++++L+G+ YLH    +H D+K  N
Sbjct: 102 SEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQN 161
Query: 175 VLLSE---MGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLG 231
           +LLS    +GD+K+ DFG++  + +    R   +GTP ++APE++      +  D+W++G
Sbjct: 162 ILLSSIYPLGDIKIVDFGMSRKIGHACELRE-IMGTPEYLAPEILNYDPITTATDMWNIG 220
Query: 232 ITAIELAKGEPP-----NSELHPMRVLFLIPKNNPPQLTGNYTKQF--------KEFVEA 278
           I A  L     P     N E +           N  Q+  +Y+++          +F+++
Sbjct: 221 IIAYMLLTHTSPFVGEDNQETYL----------NISQVNVDYSEETFSSVSQLATDFIQS 270
Query: 279 CLNKDPENRPTAKELLKFPFIRK 301
            L K+PE RPTA+  L   ++++
Sbjct: 271 LLVKNPEKRPTAEICLSHSWLQQ 293

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 89.0 bits (219), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 62/251 (24%), Positives = 115/251 (45%), Gaps = 21/251 (8%)
Query: 60  TKQERIGKGSFGEVFKGIDNRTQQVVXXXXXXXXXXXXXXXXXXXXXM----------VL 109
           T + ++G G +GEV++G+  +    V                     M          +L
Sbjct: 16  TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLL 75
Query: 110 SQC--DSPYGTKLWIIMEYLGGGSALDLMKAGNFEEMHIAVILR---EVLKGLDYLHSER 164
             C  + P+    +II E++  G+ LD ++  N +E+   V+L    ++   ++YL  + 
Sbjct: 76  GVCTREPPF----YIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN 131
Query: 165 KLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPF-WMAPEVIKQSAYDS 223
            +HRD+ A N L+ E   VK+ADFG++  +T  T   +     P  W APE +  + +  
Sbjct: 132 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSI 191
Query: 224 KADIWSLGITAIELAK-GEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNK 282
           K+D+W+ G+   E+A  G  P   +   +V  L+ K+   +      ++  E + AC   
Sbjct: 192 KSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQW 251
Query: 283 DPENRPTAKEL 293
           +P +RP+  E+
Sbjct: 252 NPSDRPSFAEI 262

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 88.6 bits (218), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 61/251 (24%), Positives = 116/251 (46%), Gaps = 21/251 (8%)
Query: 60  TKQERIGKGSFGEVFKGIDNRTQQVVXXXXXXXXXXXXXXXXXXXXXM----------VL 109
           T + ++G G +GEV++G+  +    V                     M          +L
Sbjct: 262 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLL 321
Query: 110 SQC--DSPYGTKLWIIMEYLGGGSALDLMKAGNFEEMHIAVILR---EVLKGLDYLHSER 164
             C  + P+    +II E++  G+ LD ++  N +E++  V+L    ++   ++YL  + 
Sbjct: 322 GVCTREPPF----YIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN 377
Query: 165 KLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPF-WMAPEVIKQSAYDS 223
            +HR++ A N L+ E   VK+ADFG++  +T  T   +     P  W APE +  + +  
Sbjct: 378 FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSI 437
Query: 224 KADIWSLGITAIELAK-GEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNK 282
           K+D+W+ G+   E+A  G  P   +   +V  L+ K+   +      ++  E + AC   
Sbjct: 438 KSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQW 497
Query: 283 DPENRPTAKEL 293
           +P +RP+  E+
Sbjct: 498 NPSDRPSFAEI 508

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 59/195 (30%), Positives = 100/195 (51%), Gaps = 13/195 (6%)
Query: 117 GTKLWIIMEYLGGGSALD-LMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANV 175
           G  ++++ E   GG  LD +++   F E   + +L  + K ++YLH++  +HRD+K +N+
Sbjct: 88  GKYVYVVTELXKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNI 147
Query: 176 L-LSEMGD---VKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLG 231
           L + E G+   +++ DFG A  L        T   T  ++APEV+++  YD+  DIWSLG
Sbjct: 148 LYVDESGNPESIRICDFGFAKQLRAENGLLXTPCYTANFVAPEVLERQGYDAACDIWSLG 207
Query: 232 ITAIELAKGEPPNS---ELHPMRVLFLIPKNNPPQLTGNY----TKQFKEFVEACLNKDP 284
           +       G  P +   +  P  +L  I  +    L+G Y    +   K+ V   L+ DP
Sbjct: 208 VLLYTXLTGYTPFANGPDDTPEEILARI-GSGKFSLSGGYWNSVSDTAKDLVSKXLHVDP 266
Query: 285 ENRPTAKELLKFPFI 299
             R TA  +L+ P+I
Sbjct: 267 HQRLTAALVLRHPWI 281

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 77/253 (30%), Positives = 108/253 (42%), Gaps = 25/253 (9%)
Query: 60  TKQERIGKGSFGEVFKGIDNRTQQVVXXXXXXXXXXXXXXXXXXXXXMVLSQCDSPYGTK 119
           T Q R+G+GSFGEV +  D +T                         M  +   SP    
Sbjct: 96  THQLRLGRGSFGEVHRMEDKQT------GFQCAVKKVRLEVFRAEELMACAGLTSPRIVP 149
Query: 120 LW----------IIMEYLGGGSALDLMK-AGNFEEMHIAVILREVLKGLDYLHSERKLHR 168
           L+          I ME L GGS   L+K  G   E      L + L+GL+YLHS R LH 
Sbjct: 150 LYGAVREGPWVNIFMELLEGGSLGQLVKEQGCLPEDRALYYLGQALEGLEYLHSRRILHG 209
Query: 169 DIKAANVLLSEMGD-VKLADFGVAGTLTNTTSKRNTFV-----GTPFWMAPEVIKQSAYD 222
           D+KA NVLLS  G    L DFG A  L      ++        GT   MAPEV+   + D
Sbjct: 210 DVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKSLLTGDYIPGTETHMAPEVVLGRSCD 269
Query: 223 SKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPP--QLTGNYTKQFKEFVEACL 280
           +K D+WS     + +  G  P ++     +   I    PP  ++  +      + ++  L
Sbjct: 270 AKVDVWSSCCMMLHMLNGCHPWTQFFRGPLCLKIASEPPPVREIPPSCAPLTAQAIQEGL 329
Query: 281 NKDPENRPTAKEL 293
            K+P +R +A EL
Sbjct: 330 RKEPIHRVSAAEL 342

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 62/251 (24%), Positives = 115/251 (45%), Gaps = 21/251 (8%)
Query: 60  TKQERIGKGSFGEVFKGIDNRTQQVVXXXXXXXXXXXXXXXXXXXXXM----------VL 109
           T + ++G G +GEV++G+  +    V                     M          +L
Sbjct: 16  TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLL 75
Query: 110 SQC--DSPYGTKLWIIMEYLGGGSALDLMKAGNFEEMHIAVILR---EVLKGLDYLHSER 164
             C  + P+    +II E++  G+ LD ++  N +E+   V+L    ++   ++YL  + 
Sbjct: 76  GVCTREPPF----YIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN 131
Query: 165 KLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPF-WMAPEVIKQSAYDS 223
            +HRD+ A N L+ E   VK+ADFG++  +T  T   +     P  W APE +  + +  
Sbjct: 132 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSI 191
Query: 224 KADIWSLGITAIELAK-GEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNK 282
           K+D+W+ G+   E+A  G  P   +   +V  L+ K+   +      ++  E + AC   
Sbjct: 192 KSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQW 251
Query: 283 DPENRPTAKEL 293
           +P +RP+  E+
Sbjct: 252 NPSDRPSFAEI 262

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 77/253 (30%), Positives = 108/253 (42%), Gaps = 25/253 (9%)
Query: 60  TKQERIGKGSFGEVFKGIDNRTQQVVXXXXXXXXXXXXXXXXXXXXXMVLSQCDSPYGTK 119
           T Q R+G+GSFGEV +  D +T                         M  +   SP    
Sbjct: 77  THQLRLGRGSFGEVHRMEDKQT------GFQCAVKKVRLEVFRAEELMACAGLTSPRIVP 130
Query: 120 LW----------IIMEYLGGGSALDLMK-AGNFEEMHIAVILREVLKGLDYLHSERKLHR 168
           L+          I ME L GGS   L+K  G   E      L + L+GL+YLHS R LH 
Sbjct: 131 LYGAVREGPWVNIFMELLEGGSLGQLVKEQGCLPEDRALYYLGQALEGLEYLHSRRILHG 190
Query: 169 DIKAANVLLSEMGD-VKLADFGVAGTLTNTTSKRNTFV-----GTPFWMAPEVIKQSAYD 222
           D+KA NVLLS  G    L DFG A  L      ++        GT   MAPEV+   + D
Sbjct: 191 DVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKDLLTGDYIPGTETHMAPEVVLGRSCD 250
Query: 223 SKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPP--QLTGNYTKQFKEFVEACL 280
           +K D+WS     + +  G  P ++     +   I    PP  ++  +      + ++  L
Sbjct: 251 AKVDVWSSCCMMLHMLNGCHPWTQFFRGPLCLKIASEPPPVREIPPSCAPLTAQAIQEGL 310
Query: 281 NKDPENRPTAKEL 293
            K+P +R +A EL
Sbjct: 311 RKEPIHRVSAAEL 323

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 61/252 (24%), Positives = 115/252 (45%), Gaps = 21/252 (8%)
Query: 59  FTKQERIGKGSFGEVFKGIDNRTQQVVXXXXXXXXXXXXXXXXXXXXXM----------V 108
            T + ++G G +GEV++G+  +    V                     M          +
Sbjct: 222 ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQL 281
Query: 109 LSQC--DSPYGTKLWIIMEYLGGGSALDLMKAGNFEEMHIAVILR---EVLKGLDYLHSE 163
           L  C  + P+    +II E++  G+ LD ++  N +E+   V+L    ++   ++YL  +
Sbjct: 282 LGVCTREPPF----YIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK 337
Query: 164 RKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPF-WMAPEVIKQSAYD 222
             +HR++ A N L+ E   VK+ADFG++  +T  T   +     P  W APE +  + + 
Sbjct: 338 NFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFS 397
Query: 223 SKADIWSLGITAIELAK-GEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLN 281
            K+D+W+ G+   E+A  G  P   +   +V  L+ K+   +      ++  E + AC  
Sbjct: 398 IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQ 457
Query: 282 KDPENRPTAKEL 293
            +P +RP+  E+
Sbjct: 458 WNPSDRPSFAEI 469

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 57/180 (31%), Positives = 85/180 (47%), Gaps = 20/180 (11%)
Query: 120 LWIIMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSE 179
           L+++MEY+ GG  ++LM   +  E        EV+  LD +HS   +HRD+K  N+LL +
Sbjct: 150 LYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDK 209
Query: 180 MGDVKLADFGVAGTLTNTTSKR-NTFVGTPFWMAPEVIKQSA----YDSKADIWSLGITA 234
            G +KLADFG    +  T     +T VGTP +++PEV+K       Y  + D WS+G+  
Sbjct: 210 HGHLKLADFGTCMKMDETGMVHCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFL 269
Query: 235 IELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPENRPTAKELL 294
            E+  G+ P                    L G Y+K        C  +D E    AK L+
Sbjct: 270 FEMLVGDTPFY---------------ADSLVGTYSKIMDHKNSLCFPEDAEISKHAKNLI 314

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 74/259 (28%), Positives = 103/259 (39%), Gaps = 44/259 (16%)
Query: 65  IGKGSFGEVFKGIDNRTQ---QVVXXXXXXXXXXXXXXXXXXXXXMVLSQCDSPYGTKL- 120
           IG+G FG+V +GI    +     V                     + + Q D P+  KL 
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 121 --------WIIMEYLGGGSALDLMKAGNFEEMHIAVILR--EVLKGLDYLHSERKLHRDI 170
                   WIIME    G     ++   +     ++IL   ++   L YL S+R +HRDI
Sbjct: 78  GVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDI 137
Query: 171 KAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPF-WMAPEVIKQSAYDSKADIWS 229
            A NVL+S    VKL DFG++  + ++T  + +    P  WMAPE I    + S +D+W 
Sbjct: 138 AARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWM 197
Query: 230 LGITAIEL---------------AKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKE 274
            G+   E+                 G   N E  PM      P N PP L    TK    
Sbjct: 198 FGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPM------PPNCPPTLYSLMTK---- 247
Query: 275 FVEACLNKDPENRPTAKEL 293
               C   DP  RP   EL
Sbjct: 248 ----CWAYDPSRRPRFTEL 262

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 47/149 (31%), Positives = 82/149 (55%), Gaps = 13/149 (8%)
Query: 108 VLSQCDSPYGTKLWIIME-----YLG-----GGSALDLM-KAGNFEEMHIAVILREVLKG 156
           V+S+ D P+  KL+   +     Y G      G  L  + K G+F+E        E++  
Sbjct: 85  VMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGCLLKYIRKIGSFDETCTRFYTAEIVSA 144
Query: 157 LDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLT--NTTSKRNTFVGTPFWMAPE 214
           L+YLH +  +HRD+K  N+LL+E   +++ DFG A  L+  +  ++ N+FVGT  +++PE
Sbjct: 145 LEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPE 204
Query: 215 VIKQSAYDSKADIWSLGITAIELAKGEPP 243
           ++ + +    +D+W+LG    +L  G PP
Sbjct: 205 LLTEKSASKSSDLWALGCIIYQLVAGLPP 233

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 54/189 (28%), Positives = 94/189 (49%), Gaps = 9/189 (4%)
Query: 118 TKLWIIMEYLGGGSALD-LMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVL 176
           T  +++M+ + GG   D +++ G + E   ++++++VL  + YLH    +HRD+K  N+L
Sbjct: 79  THYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLL 138
Query: 177 L---SEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGIT 233
                E   + + DFG++    N     +T  GTP ++APEV+ Q  Y    D WS+G+ 
Sbjct: 139 YLTPEENSKIMITDFGLSKMEQNGI--MSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVI 196
Query: 234 AIELAKGEPPNSELHPMRVLFLIPKNN---PPQLTGNYTKQFKEFVEACLNKDPENRPTA 290
              L  G PP  E    ++   I +           + ++  K+F+   L KDP  R T 
Sbjct: 197 TYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISESAKDFICHLLEKDPNERYTC 256
Query: 291 KELLKFPFI 299
           ++ L  P+I
Sbjct: 257 EKALSHPWI 265

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 62/251 (24%), Positives = 115/251 (45%), Gaps = 21/251 (8%)
Query: 60  TKQERIGKGSFGEVFKGIDNRTQQVVXXXXXXXXXXXXXXXXXXXXXM----------VL 109
           T + ++G G +GEV++G+  +    V                     M          +L
Sbjct: 18  TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLL 77
Query: 110 SQC--DSPYGTKLWIIMEYLGGGSALDLMKAGNFEEMHIAVILR---EVLKGLDYLHSER 164
             C  + P+    +II E++  G+ LD ++  N +E++  V+L    ++   ++YL  + 
Sbjct: 78  GVCTREPPF----YIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN 133
Query: 165 KLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPF-WMAPEVIKQSAYDS 223
            +HRD+ A N L+ E   VK+ADFG++  +T  T         P  W APE +  + +  
Sbjct: 134 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPIKWTAPESLAYNKFSI 193
Query: 224 KADIWSLGITAIELAK-GEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNK 282
           K+D+W+ G+   E+A  G  P   +   +V  L+ K+   +      ++  E + AC   
Sbjct: 194 KSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQW 253
Query: 283 DPENRPTAKEL 293
           +P +RP+  E+
Sbjct: 254 NPSDRPSFAEI 264

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 56/166 (33%), Positives = 85/166 (51%), Gaps = 18/166 (10%)
Query: 143 EMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRN 202
           E  +   LR+ L  L +LHS+  +H D+K AN+ L   G  KL DFG+   L  T     
Sbjct: 156 EAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVEL-GTAGAGE 214
Query: 203 TFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSEL-------HPMRVLFL 255
              G P +MAPE++ Q +Y + AD++SLG+T +E+A     N EL         +R  +L
Sbjct: 215 VQEGDPRYMAPELL-QGSYGTAADVFSLGLTILEVAC----NMELPHGGEGWQQLRQGYL 269
Query: 256 IPKNNPPQLTGNYTKQFKEFVEACLNKDPENRPTAKELLKFPFIRK 301
                PP+ T   + + +  +   L  DP+ R TA+ LL  P +R+
Sbjct: 270 -----PPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLALPVLRQ 310

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 74/259 (28%), Positives = 103/259 (39%), Gaps = 44/259 (16%)
Query: 65  IGKGSFGEVFKGIDNRTQQ---VVXXXXXXXXXXXXXXXXXXXXXMVLSQCDSPYGTKL- 120
           IG+G FG+V +GI    +     V                     + + Q D P+  KL 
Sbjct: 18  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 121 --------WIIMEYLGGGSALDLMKAGNFEEMHIAVILR--EVLKGLDYLHSERKLHRDI 170
                   WIIME    G     ++   +     ++IL   ++   L YL S+R +HRDI
Sbjct: 78  GVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDI 137
Query: 171 KAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPF-WMAPEVIKQSAYDSKADIWS 229
            A NVL+S    VKL DFG++  + ++T  + +    P  WMAPE I    + S +D+W 
Sbjct: 138 AARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWM 197
Query: 230 LGITAIEL---------------AKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKE 274
            G+   E+                 G   N E  PM      P N PP L    TK    
Sbjct: 198 FGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPM------PPNCPPTLYSLMTK---- 247
Query: 275 FVEACLNKDPENRPTAKEL 293
               C   DP  RP   EL
Sbjct: 248 ----CWAYDPSRRPRFTEL 262

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 62/251 (24%), Positives = 115/251 (45%), Gaps = 21/251 (8%)
Query: 60  TKQERIGKGSFGEVFKGIDNRTQQVVXXXXXXXXXXXXXXXXXXXXXM----------VL 109
           T + ++G G +GEV++G+  +    V                     M          +L
Sbjct: 17  TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLL 76
Query: 110 SQC--DSPYGTKLWIIMEYLGGGSALDLMKAGNFEEMHIAVILR---EVLKGLDYLHSER 164
             C  + P+    +II E++  G+ LD ++  N +E++  V+L    ++   ++YL  + 
Sbjct: 77  GVCTREPPF----YIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN 132
Query: 165 KLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPF-WMAPEVIKQSAYDS 223
            +HRD+ A N L+ E   VK+ADFG++  +T  T         P  W APE +  + +  
Sbjct: 133 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPIKWTAPESLAYNKFSI 192
Query: 224 KADIWSLGITAIELAK-GEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNK 282
           K+D+W+ G+   E+A  G  P   +   +V  L+ K+   +      ++  E + AC   
Sbjct: 193 KSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQW 252
Query: 283 DPENRPTAKEL 293
           +P +RP+  E+
Sbjct: 253 NPSDRPSFAEI 263

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 52/188 (27%), Positives = 94/188 (50%), Gaps = 14/188 (7%)
Query: 119 KLWIIMEYLGGGSAL-DLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLL 177
           ++++++E+   G    +L K G F+E   A  + E+   L Y H  + +HRDIK  N+L+
Sbjct: 89  RIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLM 148
Query: 178 SEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIEL 237
              G++K+ADFG   ++   + +R    GT  ++ PE+I+   +D K D+W  G+   E 
Sbjct: 149 GYKGELKIADFG--WSVHAPSLRRRXMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEF 206
Query: 238 AKGEPP-----NSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPENRPTAKE 292
             G PP     ++E H  R +  +    PP L+       K+ +   L   P  R   K 
Sbjct: 207 LVGMPPFDSPSHTETH--RRIVNVDLKFPPFLSDGS----KDLISKLLRYHPPQRLPLKG 260
Query: 293 LLKFPFIR 300
           +++ P+++
Sbjct: 261 VMEHPWVK 268

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 74/259 (28%), Positives = 103/259 (39%), Gaps = 44/259 (16%)
Query: 65  IGKGSFGEVFKGIDNRTQQ---VVXXXXXXXXXXXXXXXXXXXXXMVLSQCDSPYGTKL- 120
           IG+G FG+V +GI    +     V                     + + Q D P+  KL 
Sbjct: 15  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 74
Query: 121 --------WIIMEYLGGGSALDLMKAGNFEEMHIAVILR--EVLKGLDYLHSERKLHRDI 170
                   WIIME    G     ++   +     ++IL   ++   L YL S+R +HRDI
Sbjct: 75  GVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDI 134
Query: 171 KAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPF-WMAPEVIKQSAYDSKADIWS 229
            A NVL+S    VKL DFG++  + ++T  + +    P  WMAPE I    + S +D+W 
Sbjct: 135 AARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWM 194
Query: 230 LGITAIEL---------------AKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKE 274
            G+   E+                 G   N E  PM      P N PP L    TK    
Sbjct: 195 FGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPM------PPNCPPTLYSLMTK---- 244
Query: 275 FVEACLNKDPENRPTAKEL 293
               C   DP  RP   EL
Sbjct: 245 ----CWAYDPSRRPRFTEL 259

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 74/259 (28%), Positives = 103/259 (39%), Gaps = 44/259 (16%)
Query: 65  IGKGSFGEVFKGIDNRTQQ---VVXXXXXXXXXXXXXXXXXXXXXMVLSQCDSPYGTKL- 120
           IG+G FG+V +GI    +     V                     + + Q D P+  KL 
Sbjct: 20  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 79
Query: 121 --------WIIMEYLGGGSALDLMKAGNFEEMHIAVILR--EVLKGLDYLHSERKLHRDI 170
                   WIIME    G     ++   +     ++IL   ++   L YL S+R +HRDI
Sbjct: 80  GVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDI 139
Query: 171 KAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPF-WMAPEVIKQSAYDSKADIWS 229
            A NVL+S    VKL DFG++  + ++T  + +    P  WMAPE I    + S +D+W 
Sbjct: 140 AARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWM 199
Query: 230 LGITAIEL---------------AKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKE 274
            G+   E+                 G   N E  PM      P N PP L    TK    
Sbjct: 200 FGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPM------PPNCPPTLYSLMTK---- 249
Query: 275 FVEACLNKDPENRPTAKEL 293
               C   DP  RP   EL
Sbjct: 250 ----CWAYDPSRRPRFTEL 264

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 74/259 (28%), Positives = 103/259 (39%), Gaps = 44/259 (16%)
Query: 65  IGKGSFGEVFKGIDNRTQQ---VVXXXXXXXXXXXXXXXXXXXXXMVLSQCDSPYGTKL- 120
           IG+G FG+V +GI    +     V                     + + Q D P+  KL 
Sbjct: 21  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 80
Query: 121 --------WIIMEYLGGGSALDLMKAGNFEEMHIAVILR--EVLKGLDYLHSERKLHRDI 170
                   WIIME    G     ++   +     ++IL   ++   L YL S+R +HRDI
Sbjct: 81  GVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDI 140
Query: 171 KAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPF-WMAPEVIKQSAYDSKADIWS 229
            A NVL+S    VKL DFG++  + ++T  + +    P  WMAPE I    + S +D+W 
Sbjct: 141 AARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWM 200
Query: 230 LGITAIEL---------------AKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKE 274
            G+   E+                 G   N E  PM      P N PP L    TK    
Sbjct: 201 FGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPM------PPNCPPTLYSLMTK---- 250
Query: 275 FVEACLNKDPENRPTAKEL 293
               C   DP  RP   EL
Sbjct: 251 ----CWAYDPSRRPRFTEL 265

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 74/259 (28%), Positives = 103/259 (39%), Gaps = 44/259 (16%)
Query: 65  IGKGSFGEVFKGIDNRTQQ---VVXXXXXXXXXXXXXXXXXXXXXMVLSQCDSPYGTKL- 120
           IG+G FG+V +GI    +     V                     + + Q D P+  KL 
Sbjct: 23  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 82
Query: 121 --------WIIMEYLGGGSALDLMKAGNFEEMHIAVILR--EVLKGLDYLHSERKLHRDI 170
                   WIIME    G     ++   +     ++IL   ++   L YL S+R +HRDI
Sbjct: 83  GVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDI 142
Query: 171 KAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPF-WMAPEVIKQSAYDSKADIWS 229
            A NVL+S    VKL DFG++  + ++T  + +    P  WMAPE I    + S +D+W 
Sbjct: 143 AARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWM 202
Query: 230 LGITAIEL---------------AKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKE 274
            G+   E+                 G   N E  PM      P N PP L    TK    
Sbjct: 203 FGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPM------PPNCPPTLYSLMTK---- 252
Query: 275 FVEACLNKDPENRPTAKEL 293
               C   DP  RP   EL
Sbjct: 253 ----CWAYDPSRRPRFTEL 267

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 74/259 (28%), Positives = 103/259 (39%), Gaps = 44/259 (16%)
Query: 65  IGKGSFGEVFKGIDNRTQQ---VVXXXXXXXXXXXXXXXXXXXXXMVLSQCDSPYGTKL- 120
           IG+G FG+V +GI    +     V                     + + Q D P+  KL 
Sbjct: 46  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 105
Query: 121 --------WIIMEYLGGGSALDLMKAGNFEEMHIAVILR--EVLKGLDYLHSERKLHRDI 170
                   WIIME    G     ++   +     ++IL   ++   L YL S+R +HRDI
Sbjct: 106 GVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDI 165
Query: 171 KAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPF-WMAPEVIKQSAYDSKADIWS 229
            A NVL+S    VKL DFG++  + ++T  + +    P  WMAPE I    + S +D+W 
Sbjct: 166 AARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWM 225
Query: 230 LGITAIEL---------------AKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKE 274
            G+   E+                 G   N E  PM      P N PP L    TK    
Sbjct: 226 FGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPM------PPNCPPTLYSLMTK---- 275
Query: 275 FVEACLNKDPENRPTAKEL 293
               C   DP  RP   EL
Sbjct: 276 ----CWAYDPSRRPRFTEL 290

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 52/188 (27%), Positives = 94/188 (50%), Gaps = 14/188 (7%)
Query: 119 KLWIIMEYLGGGSAL-DLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLL 177
           ++++++E+   G    +L K G F+E   A  + E+   L Y H  + +HRDIK  N+L+
Sbjct: 88  RIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLM 147
Query: 178 SEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIEL 237
              G++K+ADFG   ++   + +R    GT  ++ PE+I+   +D K D+W  G+   E 
Sbjct: 148 GYKGELKIADFG--WSVHAPSLRRRXMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEF 205
Query: 238 AKGEPP-----NSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPENRPTAKE 292
             G PP     ++E H  R +  +    PP L+       K+ +   L   P  R   K 
Sbjct: 206 LVGMPPFDSPSHTETH--RRIVNVDLKFPPFLSDGS----KDLISKLLRYHPPQRLPLKG 259
Query: 293 LLKFPFIR 300
           +++ P+++
Sbjct: 260 VMEHPWVK 267

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 46/149 (30%), Positives = 80/149 (53%), Gaps = 13/149 (8%)
Query: 108 VLSQCDSPYGTKLWIIME----------YLGGGSALDLM-KAGNFEEMHIAVILREVLKG 156
           V+S+ D P+  KL+   +          Y   G  L  + K G+F+E        E++  
Sbjct: 63  VMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSA 122
Query: 157 LDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLT--NTTSKRNTFVGTPFWMAPE 214
           L+YLH +  +HRD+K  N+LL+E   +++ DFG A  L+  +  ++ N FVGT  +++PE
Sbjct: 123 LEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE 182
Query: 215 VIKQSAYDSKADIWSLGITAIELAKGEPP 243
           ++ + +    +D+W+LG    +L  G PP
Sbjct: 183 LLTEKSACKSSDLWALGCIIYQLVAGLPP 211

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 45/126 (35%), Positives = 71/126 (56%), Gaps = 3/126 (2%)
Query: 120 LWIIMEYLGGGSALDLMKA-GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLS 178
           L+++MEY  GG   D + A G  +E       R+++  + Y H +  +HRD+KA N+LL 
Sbjct: 81  LYLVMEYASGGEVFDYLVAHGWMKEKEARAKFRQIVSAVQYCHQKFIVHRDLKAENLLLD 140
Query: 179 EMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDS-KADIWSLGITAIEL 237
              ++K+ADFG +   T   +K +TF G+P + APE+ +   YD  + D+WSLG+    L
Sbjct: 141 ADMNIKIADFGFSNEFT-FGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTL 199
Query: 238 AKGEPP 243
             G  P
Sbjct: 200 VSGSLP 205

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 56/189 (29%), Positives = 91/189 (48%), Gaps = 11/189 (5%)
Query: 119 KLWIIMEYLGGGSAL-DLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLL 177
           +L  +MEY  GG     L +   F E        E++  L+YLHS   ++RDIK  N++L
Sbjct: 79  RLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLML 138
Query: 178 SEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIEL 237
            + G +K+ DFG+     +  +    F GTP ++APEV++ + Y    D W LG+   E+
Sbjct: 139 DKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEM 198
Query: 238 AKGEPP--NSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPENR-----PTA 290
             G  P  N +   +  L L+ +   P+     + + K  +   L KDP+ R       A
Sbjct: 199 MCGRLPFYNQDHERLFELILMEEIRFPR---TLSPEAKSLLAGLLKKDPKQRLGGGPSDA 255
Query: 291 KELLKFPFI 299
           KE+++  F 
Sbjct: 256 KEVMEHRFF 264

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 54/186 (29%), Positives = 96/186 (51%), Gaps = 8/186 (4%)
Query: 121 WIIMEYLGGGSAL-DLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSE 179
           +++ + + GG    D++    + E   +  ++++L+ + Y HS   +HR++K  N+LL+ 
Sbjct: 81  YLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLAS 140
Query: 180 MGD---VKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIE 236
                 VKLADFG+A  + N +   + F GTP +++PEV+K+  Y    DIW+ G+    
Sbjct: 141 KAKGAAVKLADFGLAIEV-NDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYI 199
Query: 237 LAKGEPPNSELHPMRVLFLI---PKNNPPQLTGNYTKQFKEFVEACLNKDPENRPTAKEL 293
           L  G PP  +    R+   I     + P       T + K  +++ L  +P+ R TA + 
Sbjct: 200 LLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQA 259
Query: 294 LKFPFI 299
           LK P+I
Sbjct: 260 LKVPWI 265

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 104/217 (47%), Gaps = 15/217 (6%)
Query: 120 LWIIMEYLGGGS-ALDLMKAGN----FEEMHIAVILREVLKGLDYLHSERKLHRDIKAAN 174
           L+++ E++ G     +++K  +    + E   +  +R++L+ L Y H    +HRD+K   
Sbjct: 103 LYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHC 162
Query: 175 VLLSEMGD---VKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLG 231
           VLL+   +   VKL  FGVA  L  +       VGTP +MAPEV+K+  Y    D+W  G
Sbjct: 163 VLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCG 222
Query: 232 ITAIELAKGEPPNSELHPMRVLFLIP---KNNPPQLTGNYTKQFKEFVEACLNKDPENRP 288
           +    L  G  P           +I    K NP Q + + ++  K+ V   L  DP  R 
Sbjct: 223 VILFILLSGCLPFYGTKERLFEGIIKGKYKMNPRQWS-HISESAKDLVRRMLMLDPAERI 281
Query: 289 TAKELLKFPFIRKAKKNAYLIDL---IDRYKKWKNSR 322
           T  E L  P++++  + AY I L   +++ +K+   R
Sbjct: 282 TVYEALNHPWLKERDRYAYKIHLPETVEQLRKFNARR 318

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 46/149 (30%), Positives = 80/149 (53%), Gaps = 13/149 (8%)
Query: 108 VLSQCDSPYGTKLWIIME----------YLGGGSALDLM-KAGNFEEMHIAVILREVLKG 156
           V+S+ D P+  KL+   +          Y   G  L  + K G+F+E        E++  
Sbjct: 62  VMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSA 121
Query: 157 LDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLT--NTTSKRNTFVGTPFWMAPE 214
           L+YLH +  +HRD+K  N+LL+E   +++ DFG A  L+  +  ++ N FVGT  +++PE
Sbjct: 122 LEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE 181
Query: 215 VIKQSAYDSKADIWSLGITAIELAKGEPP 243
           ++ + +    +D+W+LG    +L  G PP
Sbjct: 182 LLTEKSACKSSDLWALGCIIYQLVAGLPP 210

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 46/149 (30%), Positives = 80/149 (53%), Gaps = 13/149 (8%)
Query: 108 VLSQCDSPYGTKLWIIME----------YLGGGSALDLM-KAGNFEEMHIAVILREVLKG 156
           V+S+ D P+  KL+   +          Y   G  L  + K G+F+E        E++  
Sbjct: 61  VMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSA 120
Query: 157 LDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLT--NTTSKRNTFVGTPFWMAPE 214
           L+YLH +  +HRD+K  N+LL+E   +++ DFG A  L+  +  ++ N FVGT  +++PE
Sbjct: 121 LEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE 180
Query: 215 VIKQSAYDSKADIWSLGITAIELAKGEPP 243
           ++ + +    +D+W+LG    +L  G PP
Sbjct: 181 LLTEKSACKSSDLWALGCIIYQLVAGLPP 209

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 54/186 (29%), Positives = 96/186 (51%), Gaps = 8/186 (4%)
Query: 121 WIIMEYLGGGSAL-DLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSE 179
           +++ + + GG    D++    + E   +  ++++L+ + Y HS   +HR++K  N+LL+ 
Sbjct: 80  YLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLAS 139
Query: 180 MGD---VKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIE 236
                 VKLADFG+A  + N +   + F GTP +++PEV+K+  Y    DIW+ G+    
Sbjct: 140 KAKGAAVKLADFGLAIEV-NDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYI 198
Query: 237 LAKGEPPNSELHPMRVLFLI---PKNNPPQLTGNYTKQFKEFVEACLNKDPENRPTAKEL 293
           L  G PP  +    R+   I     + P       T + K  +++ L  +P+ R TA + 
Sbjct: 199 LLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQA 258
Query: 294 LKFPFI 299
           LK P+I
Sbjct: 259 LKVPWI 264

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 47/149 (31%), Positives = 82/149 (55%), Gaps = 13/149 (8%)
Query: 108 VLSQCDSPYGTKLWIIME-----YLG-----GGSALDLM-KAGNFEEMHIAVILREVLKG 156
           V+S+ D P+  KL+   +     Y G      G  L  + K G+F+E        E++  
Sbjct: 86  VMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSA 145
Query: 157 LDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLT--NTTSKRNTFVGTPFWMAPE 214
           L+YLH +  +HRD+K  N+LL+E   +++ DFG A  L+  +  ++ N+FVGT  +++PE
Sbjct: 146 LEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPE 205
Query: 215 VIKQSAYDSKADIWSLGITAIELAKGEPP 243
           ++ + +    +D+W+LG    +L  G PP
Sbjct: 206 LLTEKSACKSSDLWALGCIIYQLVAGLPP 234

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 56/189 (29%), Positives = 91/189 (48%), Gaps = 11/189 (5%)
Query: 119 KLWIIMEYLGGGSAL-DLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLL 177
           +L  +MEY  GG     L +   F E        E++  L+YLHS   ++RDIK  N++L
Sbjct: 79  RLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLML 138
Query: 178 SEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIEL 237
            + G +K+ DFG+     +  +    F GTP ++APEV++ + Y    D W LG+   E+
Sbjct: 139 DKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEM 198
Query: 238 AKGEPP--NSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPENR-----PTA 290
             G  P  N +   +  L L+ +   P+     + + K  +   L KDP+ R       A
Sbjct: 199 MCGRLPFYNQDHERLFELILMEEIRFPR---TLSPEAKSLLAGLLKKDPKQRLGGGPSDA 255
Query: 291 KELLKFPFI 299
           KE+++  F 
Sbjct: 256 KEVMEHRFF 264

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 57/181 (31%), Positives = 93/181 (51%), Gaps = 10/181 (5%)
Query: 120 LWIIMEYLGGGSALDLMKA-GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLS 178
           L+++MEY  GG   D + A G  +E       R+++  + Y H +  +HRD+KA N+LL 
Sbjct: 88  LYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKFIVHRDLKAENLLLD 147
Query: 179 EMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDS-KADIWSLGITAIEL 237
              ++K+ADFG +   T   +K + F G+P + APE+ +   YD  + D+WSLG+    L
Sbjct: 148 ADMNIKIADFGFSNEFT-FGNKLDEFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTL 206
Query: 238 AKGEPP--NSELHPMRVLFLIPKNNPP-QLTGNYTKQFKEFVEACLNKDPENRPTAKELL 294
             G  P     L  +R   L  K   P  ++ +     K+F+   LN  P  R T ++++
Sbjct: 207 VSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENLLKKFL--ILN--PSKRGTLEQIM 262
Query: 295 K 295
           K
Sbjct: 263 K 263

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 47/149 (31%), Positives = 82/149 (55%), Gaps = 13/149 (8%)
Query: 108 VLSQCDSPYGTKLWIIME-----YLG-----GGSALDLM-KAGNFEEMHIAVILREVLKG 156
           V+S+ D P+  KL+   +     Y G      G  L  + K G+F+E        E++  
Sbjct: 82  VMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSA 141
Query: 157 LDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLT--NTTSKRNTFVGTPFWMAPE 214
           L+YLH +  +HRD+K  N+LL+E   +++ DFG A  L+  +  ++ N+FVGT  +++PE
Sbjct: 142 LEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPE 201
Query: 215 VIKQSAYDSKADIWSLGITAIELAKGEPP 243
           ++ + +    +D+W+LG    +L  G PP
Sbjct: 202 LLTEKSACKSSDLWALGCIIYQLVAGLPP 230

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 46/149 (30%), Positives = 80/149 (53%), Gaps = 13/149 (8%)
Query: 108 VLSQCDSPYGTKLWIIME----------YLGGGSALDLM-KAGNFEEMHIAVILREVLKG 156
           V+S+ D P+  KL+   +          Y   G  L  + K G+F+E        E++  
Sbjct: 60  VMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSA 119
Query: 157 LDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLT--NTTSKRNTFVGTPFWMAPE 214
           L+YLH +  +HRD+K  N+LL+E   +++ DFG A  L+  +  ++ N FVGT  +++PE
Sbjct: 120 LEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE 179
Query: 215 VIKQSAYDSKADIWSLGITAIELAKGEPP 243
           ++ + +    +D+W+LG    +L  G PP
Sbjct: 180 LLTEKSACKSSDLWALGCIIYQLVAGLPP 208

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 54/186 (29%), Positives = 96/186 (51%), Gaps = 8/186 (4%)
Query: 121 WIIMEYLGGGSAL-DLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSE 179
           +++ + + GG    D++    + E   +  ++++L+ + Y HS   +HR++K  N+LL+ 
Sbjct: 81  YLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLAS 140
Query: 180 MGD---VKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIE 236
                 VKLADFG+A  + N +   + F GTP +++PEV+K+  Y    DIW+ G+    
Sbjct: 141 KAKGAAVKLADFGLAIEV-NDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYI 199
Query: 237 LAKGEPPNSELHPMRVLFLI---PKNNPPQLTGNYTKQFKEFVEACLNKDPENRPTAKEL 293
           L  G PP  +    R+   I     + P       T + K  +++ L  +P+ R TA + 
Sbjct: 200 LLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQA 259
Query: 294 LKFPFI 299
           LK P+I
Sbjct: 260 LKVPWI 265

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 101/205 (49%), Gaps = 16/205 (7%)
Query: 121 WIIMEYLGGGSALDLMKAGN--FEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLS 178
           +I++E + GG   D +  GN   +E    +   ++L  + YLH    +HRD+K  NVLLS
Sbjct: 90  YIVLELMEGGELFDKV-VGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLS 148
Query: 179 EMGD---VKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEV---IKQSAYDSKADIWSLGI 232
              +   +K+ DFG +  L  T+  R T  GTP ++APEV   +  + Y+   D WSLG+
Sbjct: 149 SQEEDCLIKITDFGHSKILGETSLMR-TLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGV 207
Query: 233 TAIELAKGEPPNSELHPMRV-----LFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPENR 287
                  G PP SE H  +V     +     N  P++    +++  + V+  L  DP+ R
Sbjct: 208 ILFICLSGYPPFSE-HRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKAR 266
Query: 288 PTAKELLKFPFIRKAKKNAYLIDLI 312
            T +E L+ P+++         DL+
Sbjct: 267 FTTEEALRHPWLQDEDMKRKFQDLL 291

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 101/205 (49%), Gaps = 16/205 (7%)
Query: 121 WIIMEYLGGGSALDLMKAGN--FEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLS 178
           +I++E + GG   D +  GN   +E    +   ++L  + YLH    +HRD+K  NVLLS
Sbjct: 96  YIVLELMEGGELFDKV-VGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLS 154
Query: 179 EMGD---VKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEV---IKQSAYDSKADIWSLGI 232
              +   +K+ DFG +  L  T+  R T  GTP ++APEV   +  + Y+   D WSLG+
Sbjct: 155 SQEEDCLIKITDFGHSKILGETSLMR-TLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGV 213
Query: 233 TAIELAKGEPPNSELHPMRV-----LFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPENR 287
                  G PP SE H  +V     +     N  P++    +++  + V+  L  DP+ R
Sbjct: 214 ILFICLSGYPPFSE-HRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKAR 272
Query: 288 PTAKELLKFPFIRKAKKNAYLIDLI 312
            T +E L+ P+++         DL+
Sbjct: 273 FTTEEALRHPWLQDEDMKRKFQDLL 297

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 101/205 (49%), Gaps = 16/205 (7%)
Query: 121 WIIMEYLGGGSALDLMKAGN--FEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLS 178
           +I++E + GG   D +  GN   +E    +   ++L  + YLH    +HRD+K  NVLLS
Sbjct: 90  YIVLELMEGGELFDKV-VGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLS 148
Query: 179 EMGD---VKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEV---IKQSAYDSKADIWSLGI 232
              +   +K+ DFG +  L  T+  R T  GTP ++APEV   +  + Y+   D WSLG+
Sbjct: 149 SQEEDCLIKITDFGHSKILGETSLMR-TLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGV 207
Query: 233 TAIELAKGEPPNSELHPMRV-----LFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPENR 287
                  G PP SE H  +V     +     N  P++    +++  + V+  L  DP+ R
Sbjct: 208 ILFICLSGYPPFSE-HRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKAR 266
Query: 288 PTAKELLKFPFIRKAKKNAYLIDLI 312
            T +E L+ P+++         DL+
Sbjct: 267 FTTEEALRHPWLQDEDMKRKFQDLL 291

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 101/205 (49%), Gaps = 16/205 (7%)
Query: 121 WIIMEYLGGGSALDLMKAGN--FEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLS 178
           +I++E + GG   D +  GN   +E    +   ++L  + YLH    +HRD+K  NVLLS
Sbjct: 89  YIVLELMEGGELFDKV-VGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLS 147
Query: 179 EMGD---VKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEV---IKQSAYDSKADIWSLGI 232
              +   +K+ DFG +  L  T+  R T  GTP ++APEV   +  + Y+   D WSLG+
Sbjct: 148 SQEEDCLIKITDFGHSKILGETSLMR-TLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGV 206
Query: 233 TAIELAKGEPPNSELHPMRV-----LFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPENR 287
                  G PP SE H  +V     +     N  P++    +++  + V+  L  DP+ R
Sbjct: 207 ILFICLSGYPPFSE-HRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKAR 265
Query: 288 PTAKELLKFPFIRKAKKNAYLIDLI 312
            T +E L+ P+++         DL+
Sbjct: 266 FTTEEALRHPWLQDEDMKRKFQDLL 290

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 44/126 (34%), Positives = 69/126 (54%), Gaps = 3/126 (2%)
Query: 120 LWIIMEYLGGGSALDLMKA-GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLS 178
           L+++MEY  GG   D + A G  +E       R+++  + Y H +  +HRD+KA N+LL 
Sbjct: 88  LYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKFIVHRDLKAENLLLD 147
Query: 179 EMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDS-KADIWSLGITAIEL 237
              ++K+ADFG +   T   +K + F G P + APE+ +   YD  + D+WSLG+    L
Sbjct: 148 ADMNIKIADFGFSNEFT-FGNKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTL 206
Query: 238 AKGEPP 243
             G  P
Sbjct: 207 VSGSLP 212

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 101/205 (49%), Gaps = 16/205 (7%)
Query: 121 WIIMEYLGGGSALDLMKAGN--FEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLS 178
           +I++E + GG   D +  GN   +E    +   ++L  + YLH    +HRD+K  NVLLS
Sbjct: 90  YIVLELMEGGELFDKV-VGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLS 148
Query: 179 EMGD---VKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEV---IKQSAYDSKADIWSLGI 232
              +   +K+ DFG +  L  T+  R T  GTP ++APEV   +  + Y+   D WSLG+
Sbjct: 149 SQEEDCLIKITDFGHSKILGETSLMR-TLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGV 207
Query: 233 TAIELAKGEPPNSELHPMRV-----LFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPENR 287
                  G PP SE H  +V     +     N  P++    +++  + V+  L  DP+ R
Sbjct: 208 ILFICLSGYPPFSE-HRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKAR 266
Query: 288 PTAKELLKFPFIRKAKKNAYLIDLI 312
            T +E L+ P+++         DL+
Sbjct: 267 FTTEEALRHPWLQDEDMKRKFQDLL 291

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 53/183 (28%), Positives = 85/183 (46%), Gaps = 17/183 (9%)
Query: 118 TKLWIIMEYLGGGSAL-DLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVL 176
           ++L+ ++EY+ GG  +  + +     E H      E+   L+YLH    ++RD+K  NVL
Sbjct: 126 SRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVL 185
Query: 177 LSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIE 236
           L   G +KL D+G+           +TF GTP ++APE+++   Y    D W+LG+   E
Sbjct: 186 LDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFE 245
Query: 237 LAKGEPP------------NSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDP 284
           +  G  P            N+E +  +V+       P  L+       K F    LNKDP
Sbjct: 246 MMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLKSF----LNKDP 301
Query: 285 ENR 287
           + R
Sbjct: 302 KER 304

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 86.7 bits (213), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 47/149 (31%), Positives = 81/149 (54%), Gaps = 13/149 (8%)
Query: 108 VLSQCDSPYGTKLWIIME-----YLG-----GGSALDLM-KAGNFEEMHIAVILREVLKG 156
           V+S+ D P+  KL+   +     Y G      G  L  + K G+F+E        E++  
Sbjct: 85  VMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSA 144
Query: 157 LDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLT--NTTSKRNTFVGTPFWMAPE 214
           L+YLH +  +HRD+K  N+LL+E   +++ DFG A  L+  +  ++ N FVGT  +++PE
Sbjct: 145 LEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE 204
Query: 215 VIKQSAYDSKADIWSLGITAIELAKGEPP 243
           ++ + +    +D+W+LG    +L  G PP
Sbjct: 205 LLTEKSAXKSSDLWALGCIIYQLVAGLPP 233

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 86.7 bits (213), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 56/189 (29%), Positives = 91/189 (48%), Gaps = 11/189 (5%)
Query: 119 KLWIIMEYLGGGSAL-DLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLL 177
           +L  +MEY  GG     L +   F E        E++  L+YLHS   ++RDIK  N++L
Sbjct: 84  RLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLML 143
Query: 178 SEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIEL 237
            + G +K+ DFG+     +  +    F GTP ++APEV++ + Y    D W LG+   E+
Sbjct: 144 DKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEM 203
Query: 238 AKGEPP--NSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPENR-----PTA 290
             G  P  N +   +  L L+ +   P+     + + K  +   L KDP+ R       A
Sbjct: 204 MCGRLPFYNQDHERLFELILMEEIRFPR---TLSPEAKSLLAGLLKKDPKQRLGGGPSDA 260
Query: 291 KELLKFPFI 299
           KE+++  F 
Sbjct: 261 KEVMEHRFF 269

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 86.7 bits (213), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 47/149 (31%), Positives = 81/149 (54%), Gaps = 13/149 (8%)
Query: 108 VLSQCDSPYGTKLWIIME-----YLG-----GGSALDLM-KAGNFEEMHIAVILREVLKG 156
           V+S+ D P+  KL+   +     Y G      G  L  + K G+F+E        E++  
Sbjct: 83  VMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSA 142
Query: 157 LDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLT--NTTSKRNTFVGTPFWMAPE 214
           L+YLH +  +HRD+K  N+LL+E   +++ DFG A  L+  +  ++ N FVGT  +++PE
Sbjct: 143 LEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVGTAQYVSPE 202
Query: 215 VIKQSAYDSKADIWSLGITAIELAKGEPP 243
           ++ + +    +D+W+LG    +L  G PP
Sbjct: 203 LLTEKSACKSSDLWALGCIIYQLVAGLPP 231

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 86.7 bits (213), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 101/205 (49%), Gaps = 16/205 (7%)
Query: 121 WIIMEYLGGGSALDLMKAGN--FEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLS 178
           +I++E + GG   D +  GN   +E    +   ++L  + YLH    +HRD+K  NVLLS
Sbjct: 215 YIVLELMEGGELFDKV-VGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLS 273
Query: 179 EMGD---VKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEV---IKQSAYDSKADIWSLGI 232
              +   +K+ DFG +  L  T+  R T  GTP ++APEV   +  + Y+   D WSLG+
Sbjct: 274 SQEEDCLIKITDFGHSKILGETSLMR-TLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGV 332
Query: 233 TAIELAKGEPPNSELHPMRV-----LFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPENR 287
                  G PP SE H  +V     +     N  P++    +++  + V+  L  DP+ R
Sbjct: 333 ILFICLSGYPPFSE-HRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKAR 391
Query: 288 PTAKELLKFPFIRKAKKNAYLIDLI 312
            T +E L+ P+++         DL+
Sbjct: 392 FTTEEALRHPWLQDEDMKRKFQDLL 416

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 86.7 bits (213), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 47/149 (31%), Positives = 81/149 (54%), Gaps = 13/149 (8%)
Query: 108 VLSQCDSPYGTKLWIIME-----YLG-----GGSALDLM-KAGNFEEMHIAVILREVLKG 156
           V+S+ D P+  KL+   +     Y G      G  L  + K G+F+E        E++  
Sbjct: 83  VMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSA 142
Query: 157 LDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLT--NTTSKRNTFVGTPFWMAPE 214
           L+YLH +  +HRD+K  N+LL+E   +++ DFG A  L+  +  ++ N FVGT  +++PE
Sbjct: 143 LEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE 202
Query: 215 VIKQSAYDSKADIWSLGITAIELAKGEPP 243
           ++ + +    +D+W+LG    +L  G PP
Sbjct: 203 LLTEKSACKSSDLWALGCIIYQLVAGLPP 231

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 86.7 bits (213), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 56/189 (29%), Positives = 91/189 (48%), Gaps = 11/189 (5%)
Query: 119 KLWIIMEYLGGGSAL-DLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLL 177
           +L  +MEY  GG     L +   F E        E++  L+YLHS   ++RDIK  N++L
Sbjct: 79  RLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLML 138
Query: 178 SEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIEL 237
            + G +K+ DFG+     +  +    F GTP ++APEV++ + Y    D W LG+   E+
Sbjct: 139 DKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEM 198
Query: 238 AKGEPP--NSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPENR-----PTA 290
             G  P  N +   +  L L+ +   P+     + + K  +   L KDP+ R       A
Sbjct: 199 MCGRLPFYNQDHERLFELILMEEIRFPR---TLSPEAKSLLAGLLKKDPKQRLGGGPSDA 255
Query: 291 KELLKFPFI 299
           KE+++  F 
Sbjct: 256 KEVMEHRFF 264

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 86.7 bits (213), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 47/149 (31%), Positives = 81/149 (54%), Gaps = 13/149 (8%)
Query: 108 VLSQCDSPYGTKLWIIME-----YLG-----GGSALDLM-KAGNFEEMHIAVILREVLKG 156
           V+S+ D P+  KL+   +     Y G      G  L  + K G+F+E        E++  
Sbjct: 67  VMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSA 126
Query: 157 LDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLT--NTTSKRNTFVGTPFWMAPE 214
           L+YLH +  +HRD+K  N+LL+E   +++ DFG A  L+  +  ++ N FVGT  +++PE
Sbjct: 127 LEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE 186
Query: 215 VIKQSAYDSKADIWSLGITAIELAKGEPP 243
           ++ + +    +D+W+LG    +L  G PP
Sbjct: 187 LLTEKSACKSSDLWALGCIIYQLVAGLPP 215

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 86.7 bits (213), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 47/149 (31%), Positives = 81/149 (54%), Gaps = 13/149 (8%)
Query: 108 VLSQCDSPYGTKLWIIME-----YLG-----GGSALDLM-KAGNFEEMHIAVILREVLKG 156
           V+S+ D P+  KL+   +     Y G      G  L  + K G+F+E        E++  
Sbjct: 83  VMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSA 142
Query: 157 LDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLT--NTTSKRNTFVGTPFWMAPE 214
           L+YLH +  +HRD+K  N+LL+E   +++ DFG A  L+  +  ++ N FVGT  +++PE
Sbjct: 143 LEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE 202
Query: 215 VIKQSAYDSKADIWSLGITAIELAKGEPP 243
           ++ + +    +D+W+LG    +L  G PP
Sbjct: 203 LLTEKSACKSSDLWALGCIIYQLVAGLPP 231

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 86.3 bits (212), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 59/185 (31%), Positives = 93/185 (50%), Gaps = 23/185 (12%)
Query: 118 TKLWIIMEYLGGGSAL-DLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVL 176
           TKL +I++Y+ GG     L +   F E  + + + E++  L++LH    ++RDIK  N+L
Sbjct: 132 TKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENIL 191
Query: 177 LSEMGDVKLADFGVAGTLT-NTTSKRNTFVGTPFWMAPEVIK--QSAYDSKADIWSLGIT 233
           L   G V L DFG++     + T +   F GT  +MAP++++   S +D   D WSLG+ 
Sbjct: 192 LDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVL 251
Query: 234 AIELAKGEPP-------NSELHPMRVLFLIPKNNPPQLTGNYTKQF----KEFVEACLNK 282
             EL  G  P       NS+    R    I K+ PP     Y ++     K+ ++  L K
Sbjct: 252 MYELLTGASPFTVDGEKNSQAEISR---RILKSEPP-----YPQEMSALAKDLIQRLLMK 303
Query: 283 DPENR 287
           DP+ R
Sbjct: 304 DPKKR 308

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 86.3 bits (212), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 47/149 (31%), Positives = 81/149 (54%), Gaps = 13/149 (8%)
Query: 108 VLSQCDSPYGTKLWIIME-----YLG-----GGSALDLM-KAGNFEEMHIAVILREVLKG 156
           V+S+ D P+  KL+   +     Y G      G  L  + K G+F+E        E++  
Sbjct: 90  VMSRLDHPFFVKLYFCFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSA 149
Query: 157 LDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLT--NTTSKRNTFVGTPFWMAPE 214
           L+YLH +  +HRD+K  N+LL+E   +++ DFG A  L+  +  ++ N FVGT  +++PE
Sbjct: 150 LEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE 209
Query: 215 VIKQSAYDSKADIWSLGITAIELAKGEPP 243
           ++ + +    +D+W+LG    +L  G PP
Sbjct: 210 LLTEKSACKSSDLWALGCIIYQLVAGLPP 238

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 86.3 bits (212), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 47/149 (31%), Positives = 81/149 (54%), Gaps = 13/149 (8%)
Query: 108 VLSQCDSPYGTKLWIIME-----YLG-----GGSALDLM-KAGNFEEMHIAVILREVLKG 156
           V+S+ D P+  KL+   +     Y G      G  L  + K G+F+E        E++  
Sbjct: 82  VMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSA 141
Query: 157 LDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLT--NTTSKRNTFVGTPFWMAPE 214
           L+YLH +  +HRD+K  N+LL+E   +++ DFG A  L+  +  ++ N FVGT  +++PE
Sbjct: 142 LEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE 201
Query: 215 VIKQSAYDSKADIWSLGITAIELAKGEPP 243
           ++ + +    +D+W+LG    +L  G PP
Sbjct: 202 LLTEKSACKSSDLWALGCIIYQLVAGLPP 230

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 86.3 bits (212), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 104/217 (47%), Gaps = 15/217 (6%)
Query: 120 LWIIMEYLGGGS-ALDLMKAGN----FEEMHIAVILREVLKGLDYLHSERKLHRDIKAAN 174
           L+++ E++ G     +++K  +    + E   +  +R++L+ L Y H    +HRD+K   
Sbjct: 101 LYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHC 160
Query: 175 VLLSEMGD---VKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLG 231
           VLL+   +   VKL  FGVA  L  +       VGTP +MAPEV+K+  Y    D+W  G
Sbjct: 161 VLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCG 220
Query: 232 ITAIELAKGEPPNSELHPMRVLFLIP---KNNPPQLTGNYTKQFKEFVEACLNKDPENRP 288
           +    L  G  P           +I    K NP Q + + ++  K+ V   L  DP  R 
Sbjct: 221 VILFILLSGCLPFYGTKERLFEGIIKGKYKMNPRQWS-HISESAKDLVRRMLMLDPAERI 279
Query: 289 TAKELLKFPFIRKAKKNAYLIDL---IDRYKKWKNSR 322
           T  E L  P++++  + AY I L   +++ +K+   R
Sbjct: 280 TVYEALNHPWLKERDRYAYKIHLPETVEQLRKFNARR 316

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 86.3 bits (212), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 47/149 (31%), Positives = 81/149 (54%), Gaps = 13/149 (8%)
Query: 108 VLSQCDSPYGTKLWIIME-----YLG-----GGSALDLM-KAGNFEEMHIAVILREVLKG 156
           V+S+ D P+  KL+   +     Y G      G  L  + K G+F+E        E++  
Sbjct: 85  VMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSA 144
Query: 157 LDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLT--NTTSKRNTFVGTPFWMAPE 214
           L+YLH +  +HRD+K  N+LL+E   +++ DFG A  L+  +  ++ N FVGT  +++PE
Sbjct: 145 LEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE 204
Query: 215 VIKQSAYDSKADIWSLGITAIELAKGEPP 243
           ++ + +    +D+W+LG    +L  G PP
Sbjct: 205 LLTEKSACKSSDLWALGCIIYQLVAGLPP 233

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 86.3 bits (212), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 47/149 (31%), Positives = 81/149 (54%), Gaps = 13/149 (8%)
Query: 108 VLSQCDSPYGTKLWIIME-----YLG-----GGSALDLM-KAGNFEEMHIAVILREVLKG 156
           V+S+ D P+  KL+   +     Y G      G  L  + K G+F+E        E++  
Sbjct: 86  VMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSA 145
Query: 157 LDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLT--NTTSKRNTFVGTPFWMAPE 214
           L+YLH +  +HRD+K  N+LL+E   +++ DFG A  L+  +  ++ N FVGT  +++PE
Sbjct: 146 LEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE 205
Query: 215 VIKQSAYDSKADIWSLGITAIELAKGEPP 243
           ++ + +    +D+W+LG    +L  G PP
Sbjct: 206 LLTEKSACKSSDLWALGCIIYQLVAGLPP 234

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 86.3 bits (212), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 47/149 (31%), Positives = 81/149 (54%), Gaps = 13/149 (8%)
Query: 108 VLSQCDSPYGTKLWIIME-----YLG-----GGSALDLM-KAGNFEEMHIAVILREVLKG 156
           V+S+ D P+  KL+   +     Y G      G  L  + K G+F+E        E++  
Sbjct: 83  VMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSA 142
Query: 157 LDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLT--NTTSKRNTFVGTPFWMAPE 214
           L+YLH +  +HRD+K  N+LL+E   +++ DFG A  L+  +  ++ N FVGT  +++PE
Sbjct: 143 LEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE 202
Query: 215 VIKQSAYDSKADIWSLGITAIELAKGEPP 243
           ++ + +    +D+W+LG    +L  G PP
Sbjct: 203 LLTEKSACKSSDLWALGCIIYQLVAGLPP 231

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 86.3 bits (212), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 47/149 (31%), Positives = 81/149 (54%), Gaps = 13/149 (8%)
Query: 108 VLSQCDSPYGTKLWIIME-----YLG-----GGSALDLM-KAGNFEEMHIAVILREVLKG 156
           V+S+ D P+  KL+   +     Y G      G  L  + K G+F+E        E++  
Sbjct: 85  VMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSA 144
Query: 157 LDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLT--NTTSKRNTFVGTPFWMAPE 214
           L+YLH +  +HRD+K  N+LL+E   +++ DFG A  L+  +  ++ N FVGT  +++PE
Sbjct: 145 LEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE 204
Query: 215 VIKQSAYDSKADIWSLGITAIELAKGEPP 243
           ++ + +    +D+W+LG    +L  G PP
Sbjct: 205 LLTEKSACKSSDLWALGCIIYQLVAGLPP 233

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 86.3 bits (212), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 101/205 (49%), Gaps = 16/205 (7%)
Query: 121 WIIMEYLGGGSALDLMKAGN--FEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLS 178
           +I++E + GG   D +  GN   +E    +   ++L  + YLH    +HRD+K  NVLLS
Sbjct: 229 YIVLELMEGGELFDKV-VGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLS 287
Query: 179 EMGD---VKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEV---IKQSAYDSKADIWSLGI 232
              +   +K+ DFG +  L  T+  R T  GTP ++APEV   +  + Y+   D WSLG+
Sbjct: 288 SQEEDCLIKITDFGHSKILGETSLMR-TLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGV 346
Query: 233 TAIELAKGEPPNSELHPMRV-----LFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPENR 287
                  G PP SE H  +V     +     N  P++    +++  + V+  L  DP+ R
Sbjct: 347 ILFICLSGYPPFSE-HRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKAR 405
Query: 288 PTAKELLKFPFIRKAKKNAYLIDLI 312
            T +E L+ P+++         DL+
Sbjct: 406 FTTEEALRHPWLQDEDMKRKFQDLL 430

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 86.3 bits (212), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 43/128 (33%), Positives = 71/128 (55%), Gaps = 5/128 (3%)
Query: 119 KLWIIMEYLGGGSAL-DLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLL 177
           +L+ +ME++ GG  +  + K+  F+E        E++  L +LH +  ++RD+K  NVLL
Sbjct: 98  RLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLL 157
Query: 178 SEMGDVKLADFGVA--GTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAI 235
              G  KLADFG+   G     T+   TF GTP ++APE++++  Y    D W++G+   
Sbjct: 158 DHEGHCKLADFGMCKEGICNGVTTA--TFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLY 215
Query: 236 ELAKGEPP 243
           E+  G  P
Sbjct: 216 EMLCGHAP 223

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 86.3 bits (212), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 49/156 (31%), Positives = 78/156 (50%), Gaps = 14/156 (8%)
Query: 107 MVLSQCDSPYGTKLW----------IIMEYLGGGSALDLM-KAGNFEEMHIAVILREVLK 155
           ++LS    P+  ++W          +IM+Y+ GG    L+ K+  F          EV  
Sbjct: 58  LMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCL 117
Query: 156 GLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEV 215
            L+YLHS+  ++RD+K  N+LL + G +K+ DFG A  + + T       GTP ++APEV
Sbjct: 118 ALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTY---XLCGTPDYIAPEV 174
Query: 216 IKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMR 251
           +    Y+   D WS GI   E+  G  P  + + M+
Sbjct: 175 VSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMK 210

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 86.3 bits (212), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 47/149 (31%), Positives = 81/149 (54%), Gaps = 13/149 (8%)
Query: 108 VLSQCDSPYGTKLWIIME-----YLG-----GGSALDLM-KAGNFEEMHIAVILREVLKG 156
           V+S+ D P+  KL+   +     Y G      G  L  + K G+F+E        E++  
Sbjct: 88  VMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSA 147
Query: 157 LDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLT--NTTSKRNTFVGTPFWMAPE 214
           L+YLH +  +HRD+K  N+LL+E   +++ DFG A  L+  +  ++ N FVGT  +++PE
Sbjct: 148 LEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE 207
Query: 215 VIKQSAYDSKADIWSLGITAIELAKGEPP 243
           ++ + +    +D+W+LG    +L  G PP
Sbjct: 208 LLTEKSACKSSDLWALGCIIYQLVAGLPP 236

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 86.3 bits (212), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 47/149 (31%), Positives = 81/149 (54%), Gaps = 13/149 (8%)
Query: 108 VLSQCDSPYGTKLWIIME-----YLG-----GGSALDLM-KAGNFEEMHIAVILREVLKG 156
           V+S+ D P+  KL+   +     Y G      G  L  + K G+F+E        E++  
Sbjct: 85  VMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSA 144
Query: 157 LDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLT--NTTSKRNTFVGTPFWMAPE 214
           L+YLH +  +HRD+K  N+LL+E   +++ DFG A  L+  +  ++ N FVGT  +++PE
Sbjct: 145 LEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE 204
Query: 215 VIKQSAYDSKADIWSLGITAIELAKGEPP 243
           ++ + +    +D+W+LG    +L  G PP
Sbjct: 205 LLTEKSACKSSDLWALGCIIYQLVAGLPP 233

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 85.9 bits (211), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 97/199 (48%), Gaps = 26/199 (13%)
Query: 118 TKLWIIMEYLGGGSALDLMKAGNFEEMHIAV--ILREVLKGLDYLHSERKLHRDIKAANV 175
           + L+I MEY   G+  DL+ + N  +       + R++L+ L Y+HS+  +HRD+K  N+
Sbjct: 88  STLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNI 147
Query: 176 LLSEMGDVKLADFGVA------------------GTLTNTTSKRNTFVGTPFWMAPEVIK 217
            + E  +VK+ DFG+A                  G+  N TS     +GT  ++A EV+ 
Sbjct: 148 FIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSA----IGTAMYVATEVLD 203
Query: 218 QSA-YDSKADIWSLGITAIELAKGEPPNSE-LHPMRVLFLIPKNNPPQLTGNYTKQFKEF 275
            +  Y+ K D++SLGI   E+        E ++ ++ L  +    PP    N  K  K+ 
Sbjct: 204 GTGHYNEKIDMYSLGIIFFEMIYPFSTGMERVNILKKLRSVSIEFPPDFDDNKMKVEKKI 263
Query: 276 VEACLNKDPENRPTAKELL 294
           +   ++ DP  RP A+ LL
Sbjct: 264 IRLLIDHDPNKRPGARTLL 282

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 85.9 bits (211), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 47/149 (31%), Positives = 81/149 (54%), Gaps = 13/149 (8%)
Query: 108 VLSQCDSPYGTKLWIIME-----YLG-----GGSALDLM-KAGNFEEMHIAVILREVLKG 156
           V+S+ D P+  KL+   +     Y G      G  L  + K G+F+E        E++  
Sbjct: 85  VMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSA 144
Query: 157 LDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLT--NTTSKRNTFVGTPFWMAPE 214
           L+YLH +  +HRD+K  N+LL+E   +++ DFG A  L+  +  ++ N FVGT  +++PE
Sbjct: 145 LEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE 204
Query: 215 VIKQSAYDSKADIWSLGITAIELAKGEPP 243
           ++ + +    +D+W+LG    +L  G PP
Sbjct: 205 LLTEKSACKSSDLWALGCIIYQLVAGLPP 233

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 85.9 bits (211), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 65/258 (25%), Positives = 113/258 (43%), Gaps = 37/258 (14%)
Query: 60  TKQERIGKGSFGEVFKGIDNRTQQVVXXXXXXXXXXXXXXXXXXXXXM----------VL 109
           T + ++G G +GEV+ G+  +    V                     M          +L
Sbjct: 35  TMKHKLGGGQYGEVYVGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLL 94
Query: 110 SQC--DSPYGTKLWIIMEYLGGGSALDLMKAGNFEEMHIAVILR---EVLKGLDYLHSER 164
             C  + P+    +I+ EY+  G+ LD ++  N EE+   V+L    ++   ++YL  + 
Sbjct: 95  GVCTLEPPF----YIVTEYMPYGNLLDYLRECNREEVTAVVLLYMATQISSAMEYLEKKN 150
Query: 165 KLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPF-WMAPEVIKQSAYDS 223
            +HRD+ A N L+ E   VK+ADFG++  +T  T   +     P  W APE +  + +  
Sbjct: 151 FIHRDLAARNCLVGENHVVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNTFSI 210
Query: 224 KADIWSLGITAIELAK-GEPPNSELHPMRVLFLI--------PKNNPPQLTGNYTKQFKE 274
           K+D+W+ G+   E+A  G  P   +   +V  L+        P+  PP++         E
Sbjct: 211 KSDVWAFGVLLWEIATYGMSPYPGIDLSQVYDLLEKGYRMEQPEGCPPKV--------YE 262
Query: 275 FVEACLNKDPENRPTAKE 292
            + AC    P +RP+  E
Sbjct: 263 LMRACWKWSPADRPSFAE 280

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 85.9 bits (211), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 72/272 (26%), Positives = 122/272 (44%), Gaps = 38/272 (13%)
Query: 59  FTKQERIGKGSFGEVF--KGIDNRTQQVVXXXXXXXXXXXXXXXXXXXXXMVLSQC---D 113
           F+    IG+G FGEV+  +  D      +                     ++LS     D
Sbjct: 190 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 249
Query: 114 SPYGT----------KLWIIMEYLGGGSA-LDLMKAGNFEEMHIAVILREVLKGLDYLHS 162
            P+            KL  I++ + GG     L + G F E  +     E++ GL+++H+
Sbjct: 250 CPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHN 309
Query: 163 ERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQS-AY 221
              ++RD+K AN+LL E G V+++D G+A   +    K +  VGT  +MAPEV+++  AY
Sbjct: 310 RFVVYRDLKPANILLDEHGHVRISDLGLACDFSK--KKPHASVGTHGYMAPEVLQKGVAY 367
Query: 222 DSKADIWSLGITAIELAKGEPP--------NSELHPMRVLFLIPKNNPPQLTGNYTKQFK 273
           DS AD +SLG    +L +G  P          E+  M +   +      +L  +++ + +
Sbjct: 368 DSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAV------ELPDSFSPELR 421
Query: 274 EFVEACLNKDPENR-----PTAKELLKFPFIR 300
             +E  L +D   R       A+E+ + PF R
Sbjct: 422 SLLEGLLQRDVNRRLGCLGRGAQEVKESPFFR 453

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 85.9 bits (211), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 57/184 (30%), Positives = 91/184 (49%), Gaps = 20/184 (10%)
Query: 118 TKLWIIMEYLGGGSA------LDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIK 171
           T L ++M  + GG        +D    G F+E        +++ GL++LH    ++RD+K
Sbjct: 258 TDLCLVMTIMNGGDIRYHIYNVDEDNPG-FQEPRAIFYTAQIVSGLEHLHQRNIIYRDLK 316
Query: 172 AANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLG 231
             NVLL + G+V+++D G+A  L    +K   + GTP +MAPE++    YD   D ++LG
Sbjct: 317 PENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALG 376
Query: 232 ITAIEL--------AKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKD 283
           +T  E+        A+GE   ++    RVL              ++   K+F EA L KD
Sbjct: 377 VTLYEMIAARGPFRARGEKVENKELKQRVL-----EQAVTYPDKFSPASKDFCEALLQKD 431
Query: 284 PENR 287
           PE R
Sbjct: 432 PEKR 435

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 85.9 bits (211), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 72/272 (26%), Positives = 122/272 (44%), Gaps = 38/272 (13%)
Query: 59  FTKQERIGKGSFGEVF--KGIDNRTQQVVXXXXXXXXXXXXXXXXXXXXXMVLSQC---D 113
           F+    IG+G FGEV+  +  D      +                     ++LS     D
Sbjct: 191 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 250
Query: 114 SPYGT----------KLWIIMEYLGGGSA-LDLMKAGNFEEMHIAVILREVLKGLDYLHS 162
            P+            KL  I++ + GG     L + G F E  +     E++ GL+++H+
Sbjct: 251 CPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHN 310
Query: 163 ERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQS-AY 221
              ++RD+K AN+LL E G V+++D G+A   +    K +  VGT  +MAPEV+++  AY
Sbjct: 311 RFVVYRDLKPANILLDEHGHVRISDLGLACDFSK--KKPHASVGTHGYMAPEVLQKGVAY 368
Query: 222 DSKADIWSLGITAIELAKGEPP--------NSELHPMRVLFLIPKNNPPQLTGNYTKQFK 273
           DS AD +SLG    +L +G  P          E+  M +   +      +L  +++ + +
Sbjct: 369 DSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAV------ELPDSFSPELR 422
Query: 274 EFVEACLNKDPENR-----PTAKELLKFPFIR 300
             +E  L +D   R       A+E+ + PF R
Sbjct: 423 SLLEGLLQRDVNRRLGCLGRGAQEVKESPFFR 454

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 85.5 bits (210), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 57/184 (30%), Positives = 91/184 (49%), Gaps = 20/184 (10%)
Query: 118 TKLWIIMEYLGGGSA------LDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIK 171
           T L ++M  + GG        +D    G F+E        +++ GL++LH    ++RD+K
Sbjct: 258 TDLCLVMTIMNGGDIRYHIYNVDEDNPG-FQEPRAIFYTAQIVSGLEHLHQRNIIYRDLK 316
Query: 172 AANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLG 231
             NVLL + G+V+++D G+A  L    +K   + GTP +MAPE++    YD   D ++LG
Sbjct: 317 PENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALG 376
Query: 232 ITAIEL--------AKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKD 283
           +T  E+        A+GE   ++    RVL              ++   K+F EA L KD
Sbjct: 377 VTLYEMIAARGPFRARGEKVENKELKQRVL-----EQAVTYPDKFSPASKDFCEALLQKD 431
Query: 284 PENR 287
           PE R
Sbjct: 432 PEKR 435

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 85.5 bits (210), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 57/184 (30%), Positives = 91/184 (49%), Gaps = 20/184 (10%)
Query: 118 TKLWIIMEYLGGGSA------LDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIK 171
           T L ++M  + GG        +D    G F+E        +++ GL++LH    ++RD+K
Sbjct: 258 TDLCLVMTIMNGGDIRYHIYNVDEDNPG-FQEPRAIFYTAQIVSGLEHLHQRNIIYRDLK 316
Query: 172 AANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLG 231
             NVLL + G+V+++D G+A  L    +K   + GTP +MAPE++    YD   D ++LG
Sbjct: 317 PENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALG 376
Query: 232 ITAIEL--------AKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKD 283
           +T  E+        A+GE   ++    RVL              ++   K+F EA L KD
Sbjct: 377 VTLYEMIAARGPFRARGEKVENKELKQRVL-----EQAVTYPDKFSPASKDFCEALLQKD 431
Query: 284 PENR 287
           PE R
Sbjct: 432 PEKR 435

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 85.5 bits (210), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 53/195 (27%), Positives = 99/195 (50%), Gaps = 9/195 (4%)
Query: 118 TKLWIIMEYLGGGSALDLM-KAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVL 176
           T + +I+E + GG   D + +  +  E      L+++L G+ YLHS+R  H D+K  N++
Sbjct: 81  TDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIM 140
Query: 177 LSEMG----DVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGI 232
           L +       +KL DFG+A  +      +N F GTP ++APE++       +AD+WS+G+
Sbjct: 141 LLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIF-GTPEFVAPEIVNYEPLGLEADMWSIGV 199
Query: 233 TAIELAKGEPP---NSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPENRPT 289
               L  G  P    ++   +  +  +  +   +   N ++  K+F+   L KDP+ R T
Sbjct: 200 ITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSELAKDFIRRLLVKDPKRRMT 259
Query: 290 AKELLKFPFIRKAKK 304
             + L+  +I+  ++
Sbjct: 260 IAQSLEHSWIKAIRR 274

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 85.5 bits (210), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 57/184 (30%), Positives = 91/184 (49%), Gaps = 20/184 (10%)
Query: 118 TKLWIIMEYLGGGSA------LDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIK 171
           T L ++M  + GG        +D    G F+E        +++ GL++LH    ++RD+K
Sbjct: 258 TDLCLVMTIMNGGDIRYHIYNVDEDNPG-FQEPRAIFYTAQIVSGLEHLHQRNIIYRDLK 316
Query: 172 AANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLG 231
             NVLL + G+V+++D G+A  L    +K   + GTP +MAPE++    YD   D ++LG
Sbjct: 317 PENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALG 376
Query: 232 ITAIEL--------AKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKD 283
           +T  E+        A+GE   ++    RVL              ++   K+F EA L KD
Sbjct: 377 VTLYEMIAARGPFRARGEKVENKELKQRVL-----EQAVTYPDKFSPASKDFCEALLQKD 431
Query: 284 PENR 287
           PE R
Sbjct: 432 PEKR 435

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 85.5 bits (210), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 54/185 (29%), Positives = 90/185 (48%), Gaps = 18/185 (9%)
Query: 118 TKLWIIMEYLGGGSALD-LMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVL 176
           + ++++MEY+ GG   D + K G  +E     + +++L G+DY H    +HRD+K  NVL
Sbjct: 89  SDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVL 148
Query: 177 LSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDS-KADIWSLGITAI 235
           L    + K+ADFG++  +++    R +  G+P + APEVI    Y   + DIWS G+   
Sbjct: 149 LDAHMNAKIADFGLSNMMSDGEFLRXS-CGSPNYAAPEVISGRLYAGPEVDIWSSGVILY 207
Query: 236 ELAKGEPPNSELHPMRV-------LFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPENRP 288
            L  G  P  + H   +       +F  P+   P +           ++  L  DP  R 
Sbjct: 208 ALLCGTLPFDDDHVPTLFKKICDGIFYTPQYLNPSVIS--------LLKHMLQVDPMKRA 259
Query: 289 TAKEL 293
           T K++
Sbjct: 260 TIKDI 264

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 85.5 bits (210), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 50/130 (38%), Positives = 72/130 (55%), Gaps = 5/130 (3%)
Query: 118 TKLWIIMEYLGGGSALD-LMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVL 176
           T L IIMEY  GG   + +  AG F E       +++L G+ Y HS +  HRD+K  N L
Sbjct: 89  THLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTL 148
Query: 177 L--SEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSK-ADIWSLGIT 233
           L  S    +K+ DFG + +    +  ++T VGTP ++APEV+ +  YD K AD+WS G+T
Sbjct: 149 LDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLRQEYDGKIADVWSCGVT 207
Query: 234 AIELAKGEPP 243
              +  G  P
Sbjct: 208 LYVMLVGAYP 217

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 85.5 bits (210), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 72/272 (26%), Positives = 122/272 (44%), Gaps = 38/272 (13%)
Query: 59  FTKQERIGKGSFGEVF--KGIDNRTQQVVXXXXXXXXXXXXXXXXXXXXXMVLSQC---D 113
           F+    IG+G FGEV+  +  D      +                     ++LS     D
Sbjct: 191 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 250
Query: 114 SPYGT----------KLWIIMEYLGGGSA-LDLMKAGNFEEMHIAVILREVLKGLDYLHS 162
            P+            KL  I++ + GG     L + G F E  +     E++ GL+++H+
Sbjct: 251 CPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHN 310
Query: 163 ERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQS-AY 221
              ++RD+K AN+LL E G V+++D G+A   +    K +  VGT  +MAPEV+++  AY
Sbjct: 311 RFVVYRDLKPANILLDEHGHVRISDLGLACDFSK--KKPHASVGTHGYMAPEVLQKGVAY 368
Query: 222 DSKADIWSLGITAIELAKGEPP--------NSELHPMRVLFLIPKNNPPQLTGNYTKQFK 273
           DS AD +SLG    +L +G  P          E+  M +   +      +L  +++ + +
Sbjct: 369 DSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAV------ELPDSFSPELR 422
Query: 274 EFVEACLNKDPENR-----PTAKELLKFPFIR 300
             +E  L +D   R       A+E+ + PF R
Sbjct: 423 SLLEGLLQRDVNRRLGCLGRGAQEVKESPFFR 454

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 85.5 bits (210), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 72/272 (26%), Positives = 122/272 (44%), Gaps = 38/272 (13%)
Query: 59  FTKQERIGKGSFGEVF--KGIDNRTQQVVXXXXXXXXXXXXXXXXXXXXXMVLSQC---D 113
           F+    IG+G FGEV+  +  D      +                     ++LS     D
Sbjct: 191 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 250
Query: 114 SPYGT----------KLWIIMEYLGGGSA-LDLMKAGNFEEMHIAVILREVLKGLDYLHS 162
            P+            KL  I++ + GG     L + G F E  +     E++ GL+++H+
Sbjct: 251 CPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHN 310
Query: 163 ERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQS-AY 221
              ++RD+K AN+LL E G V+++D G+A   +    K +  VGT  +MAPEV+++  AY
Sbjct: 311 RFVVYRDLKPANILLDEHGHVRISDLGLACDFSK--KKPHASVGTHGYMAPEVLQKGVAY 368
Query: 222 DSKADIWSLGITAIELAKGEPP--------NSELHPMRVLFLIPKNNPPQLTGNYTKQFK 273
           DS AD +SLG    +L +G  P          E+  M +   +      +L  +++ + +
Sbjct: 369 DSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAV------ELPDSFSPELR 422
Query: 274 EFVEACLNKDPENR-----PTAKELLKFPFIR 300
             +E  L +D   R       A+E+ + PF R
Sbjct: 423 SLLEGLLQRDVNRRLGCLGRGAQEVKESPFFR 454

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 85.5 bits (210), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 53/199 (26%), Positives = 93/199 (46%), Gaps = 25/199 (12%)
Query: 120 LWIIMEYLGGGSALD-LMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLS 178
           ++++ + +  G   D L +     E     I+R +L+ + +LH+   +HRD+K  N+LL 
Sbjct: 175 MFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLD 234
Query: 179 EMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQS------AYDSKADIWSLGI 232
           +   ++L+DFG +  L     K     GTP ++APE++K S       Y  + D+W+ G+
Sbjct: 235 DNMQIRLSDFGFSCHL-EPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGV 293
Query: 233 TAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNY----------TKQFKEFVEACLNK 282
               L  G PP      + +L +I       + G Y          +   K+ +   L  
Sbjct: 294 ILFTLLAGSPPFWHRRQILMLRMI-------MEGQYQFSSPEWDDRSSTVKDLISRLLQV 346
Query: 283 DPENRPTAKELLKFPFIRK 301
           DPE R TA++ L+ PF  +
Sbjct: 347 DPEARLTAEQALQHPFFER 365

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 85.5 bits (210), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 47/129 (36%), Positives = 72/129 (55%), Gaps = 5/129 (3%)
Query: 120 LWIIMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSE 179
           L+++MEY+ GG  ++LM   +  E        EV+  LD +HS   +HRD+K  N+LL +
Sbjct: 144 LYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDK 203
Query: 180 MGDVKLADFGVAGTLTNTTSKR-NTFVGTPFWMAPEVIKQSA----YDSKADIWSLGITA 234
            G +KLADFG    +      R +T VGTP +++PEV+K       Y  + D WS+G+  
Sbjct: 204 SGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFL 263
Query: 235 IELAKGEPP 243
            E+  G+ P
Sbjct: 264 YEMLVGDTP 272

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 85.5 bits (210), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 49/190 (25%), Positives = 99/190 (52%), Gaps = 9/190 (4%)
Query: 118 TKLWIIMEYLGGGSALDLM-KAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVL 176
           T + +I+E + GG   D + +  +  E      ++++L G++YLH+++  H D+K  N++
Sbjct: 88  TDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIM 147
Query: 177 LSE----MGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGI 232
           L +    +  +KL DFG+A  + +    +N F GTP ++APE++       +AD+WS+G+
Sbjct: 148 LLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIF-GTPEFVAPEIVNYEPLGLEADMWSIGV 206
Query: 233 TAIELAKGEPP---NSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPENRPT 289
               L  G  P   +++   +  +  +  +   +     ++  K+F+   L K+   R T
Sbjct: 207 ITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQTSELAKDFIRKLLVKETRKRLT 266
Query: 290 AKELLKFPFI 299
            +E L+ P+I
Sbjct: 267 IQEALRHPWI 276

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 85.5 bits (210), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 47/129 (36%), Positives = 72/129 (55%), Gaps = 5/129 (3%)
Query: 120 LWIIMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSE 179
           L+++MEY+ GG  ++LM   +  E        EV+  LD +HS   +HRD+K  N+LL +
Sbjct: 149 LYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDK 208
Query: 180 MGDVKLADFGVAGTLTNTTSKR-NTFVGTPFWMAPEVIKQSA----YDSKADIWSLGITA 234
            G +KLADFG    +      R +T VGTP +++PEV+K       Y  + D WS+G+  
Sbjct: 209 SGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFL 268
Query: 235 IELAKGEPP 243
            E+  G+ P
Sbjct: 269 YEMLVGDTP 277

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 67/248 (27%), Positives = 106/248 (42%), Gaps = 19/248 (7%)
Query: 64  RIGKGSFGEVFKGIDNRTQQVVXXXXXXXXXXXXXXXXXXXXXMVL--SQCDSPYGT--- 118
           ++G+G FGEV+ G  N T +V                        L   +    Y     
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 84
Query: 119 -KLWIIMEYLGGGSALDLMKA--GNFEEM-HIAVILREVLKGLDYLHSERKLHRDIKAAN 174
             ++I+MEY+  G  LD +K   G +  +  +  +  ++  G+ Y+     +HRD++AAN
Sbjct: 85  EPIYIVMEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAAN 144
Query: 175 VLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPF-WMAPEVIKQSAYDSKADIWSLGIT 233
           +L+ E    K+ADFG+A  + +           P  W APE      +  K+D+WS GI 
Sbjct: 145 ILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGIL 204
Query: 234 AIEL-AKGEPPNSELHPMRVLFLIPKNN----PPQLTGNYTKQFKEFVEACLNKDPENRP 288
             EL  KG  P   +    VL  + +      PP+      +   + +  C  KDPE RP
Sbjct: 205 LTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPEC----PESLHDLMCQCWRKDPEERP 260
Query: 289 TAKELLKF 296
           T + L  F
Sbjct: 261 TFEYLQAF 268

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 67/248 (27%), Positives = 107/248 (43%), Gaps = 19/248 (7%)
Query: 64  RIGKGSFGEVFKGIDNRTQQVVXXXXXXXXXXXXXXXXXXXXXMVL--SQCDSPYGT--- 118
           ++G+G FGEV+ G  N T +V                        L   +    Y     
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 84
Query: 119 -KLWIIMEYLGGGSALDLMKA--GNFEEM-HIAVILREVLKGLDYLHSERKLHRDIKAAN 174
             ++I++EY+  GS LD +K   G +  +  +  +  ++  G+ Y+     +HRD++AAN
Sbjct: 85  EPIYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAAN 144
Query: 175 VLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPF-WMAPEVIKQSAYDSKADIWSLGIT 233
           +L+ E    K+ADFG+A  + +           P  W APE      +  K+D+WS GI 
Sbjct: 145 ILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGIL 204
Query: 234 AIEL-AKGEPPNSELHPMRVLFLIPKNN----PPQLTGNYTKQFKEFVEACLNKDPENRP 288
             EL  KG  P   +    VL  + +      PP+      +   + +  C  KDPE RP
Sbjct: 205 LTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPEC----PESLHDLMCQCWRKDPEERP 260
Query: 289 TAKELLKF 296
           T + L  F
Sbjct: 261 TFEYLQAF 268

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 67/248 (27%), Positives = 107/248 (43%), Gaps = 19/248 (7%)
Query: 64  RIGKGSFGEVFKGIDNRTQQVVXXXXXXXXXXXXXXXXXXXXXMVL--SQCDSPYGT--- 118
           ++G+G FGEV+ G  N T +V                        L   +    Y     
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 84
Query: 119 -KLWIIMEYLGGGSALDLMKA--GNFEEM-HIAVILREVLKGLDYLHSERKLHRDIKAAN 174
             ++I++EY+  GS LD +K   G +  +  +  +  ++  G+ Y+     +HRD++AAN
Sbjct: 85  EPIYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAAN 144
Query: 175 VLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPF-WMAPEVIKQSAYDSKADIWSLGIT 233
           +L+ E    K+ADFG+A  + +           P  W APE      +  K+D+WS GI 
Sbjct: 145 ILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGIL 204
Query: 234 AIEL-AKGEPPNSELHPMRVLFLIPKNN----PPQLTGNYTKQFKEFVEACLNKDPENRP 288
             EL  KG  P   +    VL  + +      PP+      +   + +  C  KDPE RP
Sbjct: 205 LTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPEC----PESLHDLMCQCWRKDPEERP 260
Query: 289 TAKELLKF 296
           T + L  F
Sbjct: 261 TFEYLQAF 268

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 58/195 (29%), Positives = 94/195 (48%), Gaps = 13/195 (6%)
Query: 118 TKLWIIMEYLGGGSALD-LMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVL 176
           T  +++ + +  G   D L +     E     I+R +L+ +  LH    +HRD+K  N+L
Sbjct: 97  TFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENIL 156
Query: 177 LSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQS------AYDSKADIWSL 230
           L +  ++KL DFG +  L +   K  +  GTP ++APE+I+ S       Y  + D+WS 
Sbjct: 157 LDDDMNIKLTDFGFSCQL-DPGEKLRSVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWST 215
Query: 231 GITAIELAKGEPPNSELHPMRVLFLIPKNN----PPQLTGNYTKQFKEFVEACLNKDPEN 286
           G+    L  G PP      M +L +I   N     P+   +Y+   K+ V   L   P+ 
Sbjct: 216 GVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEW-DDYSDTVKDLVSRFLVVQPQK 274
Query: 287 RPTAKELLKFPFIRK 301
           R TA+E L  PF ++
Sbjct: 275 RYTAEEALAHPFFQQ 289

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 47/129 (36%), Positives = 72/129 (55%), Gaps = 5/129 (3%)
Query: 120 LWIIMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSE 179
           L+++MEY+ GG  ++LM   +  E        EV+  LD +HS   +HRD+K  N+LL +
Sbjct: 149 LYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDK 208
Query: 180 MGDVKLADFGVAGTLTNTTSKR-NTFVGTPFWMAPEVIKQSA----YDSKADIWSLGITA 234
            G +KLADFG    +      R +T VGTP +++PEV+K       Y  + D WS+G+  
Sbjct: 209 SGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFL 268
Query: 235 IELAKGEPP 243
            E+  G+ P
Sbjct: 269 YEMLVGDTP 277

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 49/190 (25%), Positives = 99/190 (52%), Gaps = 9/190 (4%)
Query: 118 TKLWIIMEYLGGGSALDLM-KAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVL 176
           T + +I+E + GG   D + +  +  E      ++++L G++YLH+++  H D+K  N++
Sbjct: 88  TDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIM 147
Query: 177 LSE----MGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGI 232
           L +    +  +KL DFG+A  + +    +N F GTP ++APE++       +AD+WS+G+
Sbjct: 148 LLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIF-GTPEFVAPEIVNYEPLGLEADMWSIGV 206
Query: 233 TAIELAKGEPP---NSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPENRPT 289
               L  G  P   +++   +  +  +  +   +     ++  K+F+   L K+   R T
Sbjct: 207 ITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQTSELAKDFIRKLLVKETRKRLT 266
Query: 290 AKELLKFPFI 299
            +E L+ P+I
Sbjct: 267 IQEALRHPWI 276

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 43/126 (34%), Positives = 68/126 (53%), Gaps = 3/126 (2%)
Query: 120 LWIIMEYLGGGSALDLMKA-GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLS 178
           L+++ EY  GG   D + A G  +E       R+++  + Y H +  +HRD+KA N+LL 
Sbjct: 88  LYLVXEYASGGEVFDYLVAHGRXKEKEARAKFRQIVSAVQYCHQKFIVHRDLKAENLLLD 147
Query: 179 EMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDS-KADIWSLGITAIEL 237
              ++K+ADFG +   T   +K + F G P + APE+ +   YD  + D+WSLG+    L
Sbjct: 148 ADXNIKIADFGFSNEFT-FGNKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTL 206
Query: 238 AKGEPP 243
             G  P
Sbjct: 207 VSGSLP 212

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 49/190 (25%), Positives = 99/190 (52%), Gaps = 9/190 (4%)
Query: 118 TKLWIIMEYLGGGSALDLM-KAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVL 176
           T + +I+E + GG   D + +  +  E      ++++L G++YLH+++  H D+K  N++
Sbjct: 88  TDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIM 147
Query: 177 LSE----MGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGI 232
           L +    +  +KL DFG+A  + +    +N F GTP ++APE++       +AD+WS+G+
Sbjct: 148 LLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIF-GTPEFVAPEIVNYEPLGLEADMWSIGV 206
Query: 233 TAIELAKGEPP---NSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPENRPT 289
               L  G  P   +++   +  +  +  +   +     ++  K+F+   L K+   R T
Sbjct: 207 ITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQTSELAKDFIRKLLVKETRKRLT 266
Query: 290 AKELLKFPFI 299
            +E L+ P+I
Sbjct: 267 IQEALRHPWI 276

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 49/190 (25%), Positives = 100/190 (52%), Gaps = 9/190 (4%)
Query: 118 TKLWIIMEYLGGGSALDLM-KAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVL 176
           T + +I+E + GG   D + +  +  E      ++++L G++YLH+++  H D+K  N++
Sbjct: 88  TDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIM 147
Query: 177 LSE----MGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGI 232
           L +    +  +KL DFG+A  + +    +N F GTP ++APE++       +AD+WS+G+
Sbjct: 148 LLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIF-GTPEFVAPEIVNYEPLGLEADMWSIGV 206
Query: 233 TAIELAKGEPP---NSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPENRPT 289
               L  G  P   +++   +  +  +  +   +   + ++  K+F+   L K+   R T
Sbjct: 207 ITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTSELAKDFIRKLLVKETRKRLT 266
Query: 290 AKELLKFPFI 299
            +E L+ P+I
Sbjct: 267 IQEALRHPWI 276

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 66/248 (26%), Positives = 106/248 (42%), Gaps = 19/248 (7%)
Query: 64  RIGKGSFGEVFKGIDNRTQQVVXXXXXXXXXXXXXXXXXXXXXMVL--SQCDSPYGT--- 118
           ++G+G FGEV+ G  N T +V                        L   +    Y     
Sbjct: 274 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 333
Query: 119 -KLWIIMEYLGGGSALDLMKA--GNFEEM-HIAVILREVLKGLDYLHSERKLHRDIKAAN 174
             ++I+ EY+  GS LD +K   G +  +  +  +  ++  G+ Y+     +HRD++AAN
Sbjct: 334 EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAAN 393
Query: 175 VLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPF-WMAPEVIKQSAYDSKADIWSLGIT 233
           +L+ E    K+ADFG+A  + +           P  W APE      +  K+D+WS GI 
Sbjct: 394 ILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGIL 453
Query: 234 AIEL-AKGEPPNSELHPMRVLFLIPKNN----PPQLTGNYTKQFKEFVEACLNKDPENRP 288
             EL  KG  P   +    VL  + +      PP+      +   + +  C  K+PE RP
Sbjct: 454 LTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPEC----PESLHDLMCQCWRKEPEERP 509
Query: 289 TAKELLKF 296
           T + L  F
Sbjct: 510 TFEYLQAF 517

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 49/190 (25%), Positives = 100/190 (52%), Gaps = 9/190 (4%)
Query: 118 TKLWIIMEYLGGGSALDLM-KAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVL 176
           T + +I+E + GG   D + +  +  E      ++++L G++YLH+++  H D+K  N++
Sbjct: 88  TDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIM 147
Query: 177 LSE----MGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGI 232
           L +    +  +KL DFG+A  + +    +N F GTP ++APE++       +AD+WS+G+
Sbjct: 148 LLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIF-GTPEFVAPEIVNYEPLGLEADMWSIGV 206
Query: 233 TAIELAKGEPP---NSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPENRPT 289
               L  G  P   +++   +  +  +  +   +   + ++  K+F+   L K+   R T
Sbjct: 207 ITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTSELAKDFIRKLLVKETRKRLT 266
Query: 290 AKELLKFPFI 299
            +E L+ P+I
Sbjct: 267 IQEALRHPWI 276

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 67/248 (27%), Positives = 106/248 (42%), Gaps = 19/248 (7%)
Query: 64  RIGKGSFGEVFKGIDNRTQQVVXXXXXXXXXXXXXXXXXXXXXMVL--SQCDSPYGT--- 118
           ++G+G FGEV+ G  N T +V                        L   +    Y     
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 84
Query: 119 -KLWIIMEYLGGGSALDLMKA--GNFEEM-HIAVILREVLKGLDYLHSERKLHRDIKAAN 174
             ++I+ EY+  GS LD +K   G +  +  +  +  ++  G+ Y+     +HRD++AAN
Sbjct: 85  EPIYIVCEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAAN 144
Query: 175 VLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPF-WMAPEVIKQSAYDSKADIWSLGIT 233
           +L+ E    K+ADFG+A  + +           P  W APE      +  K+D+WS GI 
Sbjct: 145 ILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGIL 204
Query: 234 AIEL-AKGEPPNSELHPMRVLFLIPKNN----PPQLTGNYTKQFKEFVEACLNKDPENRP 288
             EL  KG  P   +    VL  + +      PP+      +   + +  C  KDPE RP
Sbjct: 205 LTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPEC----PESLHDLMCQCWRKDPEERP 260
Query: 289 TAKELLKF 296
           T + L  F
Sbjct: 261 TFEYLQAF 268

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 49/190 (25%), Positives = 100/190 (52%), Gaps = 9/190 (4%)
Query: 118 TKLWIIMEYLGGGSALDLM-KAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVL 176
           T + +I+E + GG   D + +  +  E      ++++L G++YLH+++  H D+K  N++
Sbjct: 88  TDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIM 147
Query: 177 LSE----MGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGI 232
           L +    +  +KL DFG+A  + +    +N F GTP ++APE++       +AD+WS+G+
Sbjct: 148 LLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIF-GTPEFVAPEIVNYEPLGLEADMWSIGV 206
Query: 233 TAIELAKGEPP---NSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPENRPT 289
               L  G  P   +++   +  +  +  +   +   + ++  K+F+   L K+   R T
Sbjct: 207 ITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTSELAKDFIRKLLVKETRKRLT 266
Query: 290 AKELLKFPFI 299
            +E L+ P+I
Sbjct: 267 IQEALRHPWI 276

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 55/183 (30%), Positives = 92/183 (50%), Gaps = 17/183 (9%)
Query: 120 LWIIMEYLGGGSALDLMKAGNFEEMHIAVILR---EVLKGLDYLHSERKLHRDIKAANVL 176
           L+I ME+   G+    ++    E++   + L    ++ KG+DY+HS++ +HRD+K +N+ 
Sbjct: 109 LFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIF 168
Query: 177 LSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIE 236
           L +   VK+ DFG+  +L N   KR    GT  +M+PE I    Y  + D+++LG+   E
Sbjct: 169 LVDTKQVKIGDFGLVTSLKN-DGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAE 227
Query: 237 LAKGEPPNSELHPMRVLFLIPKNNPPQLTG----NYTKQFKEFVEACLNKDPENRPTAKE 292
           L         LH     F   K       G     + K+ K  ++  L+K PE+RP   E
Sbjct: 228 L---------LHVCDTAFETSKFFTDLRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSE 278
Query: 293 LLK 295
           +L+
Sbjct: 279 ILR 281

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 58/195 (29%), Positives = 93/195 (47%), Gaps = 13/195 (6%)
Query: 118 TKLWIIMEYLGGGSALD-LMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVL 176
           T  +++ + +  G   D L +     E     I+R +L+ +  LH    +HRD+K  N+L
Sbjct: 97  TFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENIL 156
Query: 177 LSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQS------AYDSKADIWSL 230
           L +  ++KL DFG +  L +   K     GTP ++APE+I+ S       Y  + D+WS 
Sbjct: 157 LDDDMNIKLTDFGFSCQL-DPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWST 215
Query: 231 GITAIELAKGEPPNSELHPMRVLFLIPKNN----PPQLTGNYTKQFKEFVEACLNKDPEN 286
           G+    L  G PP      M +L +I   N     P+   +Y+   K+ V   L   P+ 
Sbjct: 216 GVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEW-DDYSDTVKDLVSRFLVVQPQK 274
Query: 287 RPTAKELLKFPFIRK 301
           R TA+E L  PF ++
Sbjct: 275 RYTAEEALAHPFFQQ 289

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 52/191 (27%), Positives = 97/191 (50%), Gaps = 9/191 (4%)
Query: 118 TKLWIIMEYLGGGSALDLM-KAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVL 176
           T + +I+E + GG   D + +  +  E      L+++L G+ YLHS +  H D+K  N++
Sbjct: 87  TDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIM 146
Query: 177 LSEMG----DVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGI 232
           L +       +K+ DFG+A  +      +N F GTP ++APE++       +AD+WS+G+
Sbjct: 147 LLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF-GTPAFVAPEIVNYEPLGLEADMWSIGV 205
Query: 233 TAIELAKGEPP---NSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPENRPT 289
               L  G  P   +++   +  +  +      +   N +   K+F+   L KDP+ R T
Sbjct: 206 ITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMT 265
Query: 290 AKELLKFPFIR 300
            ++ L+ P+I+
Sbjct: 266 IQDSLQHPWIK 276

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 52/183 (28%), Positives = 84/183 (45%), Gaps = 17/183 (9%)
Query: 118 TKLWIIMEYLGGGSAL-DLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVL 176
           ++L+ ++EY+ GG  +  + +     E H      E+   L+YLH    ++RD+K  NVL
Sbjct: 79  SRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVL 138
Query: 177 LSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIE 236
           L   G +KL D+G+           + F GTP ++APE+++   Y    D W+LG+   E
Sbjct: 139 LDSEGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFE 198
Query: 237 LAKGEPP------------NSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDP 284
           +  G  P            N+E +  +V+       P  L+       K F    LNKDP
Sbjct: 199 MMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLKSF----LNKDP 254
Query: 285 ENR 287
           + R
Sbjct: 255 KER 257

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 75/284 (26%), Positives = 127/284 (44%), Gaps = 45/284 (15%)
Query: 59  FTKQERIGKGSFGEVFKGIDNRTQQVVXXXXXXXXXXXXXXXXXXXXXMVLSQC------ 112
           + K +++G+G++  V+KG    T  +V                      +L         
Sbjct: 4   YIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIV 63
Query: 113 ---DSPYGTK-LWIIMEYLGGGSALDLMKAGNFEEMH-IAVILREVLKGLDYLHSERKLH 167
              D  +  K L ++ EYL       L   GN   MH + + L ++L+GL Y H ++ LH
Sbjct: 64  TLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLH 123
Query: 168 RDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSA-YDSKAD 226
           RD+K  N+L++E G++KLADFG+A   +  T   +  V T ++  P+++  S  Y ++ D
Sbjct: 124 RDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVVTLWYRPPDILLGSTDYSTQID 183
Query: 227 IWSLGITAIELAKGEP--PNS----ELHPM-RVLFLIPKNNPPQLTGNYTKQFKEF---- 275
           +W +G    E+A G P  P S    +LH + R+L    +   P +  N  ++FK +    
Sbjct: 184 MWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSN--EEFKTYNYPK 241
Query: 276 --VEACLNKDP------------------ENRPTAKELLKFPFI 299
              EA L+  P                   NR +A++ +K PF 
Sbjct: 242 YRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFF 285

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 67/248 (27%), Positives = 106/248 (42%), Gaps = 19/248 (7%)
Query: 64  RIGKGSFGEVFKGIDNRTQQVVXXXXXXXXXXXXXXXXXXXXXMVL--SQCDSPYGT--- 118
           ++G+G FGEV+ G  N T +V                        L   +    Y     
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 84
Query: 119 -KLWIIMEYLGGGSALDLMKA--GNFEEM-HIAVILREVLKGLDYLHSERKLHRDIKAAN 174
             ++I+ EY+  GS LD +K   G +  +  +  +  ++  G+ Y+     +HRD++AAN
Sbjct: 85  EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAAN 144
Query: 175 VLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPF-WMAPEVIKQSAYDSKADIWSLGIT 233
           +L+ E    K+ADFG+A  + +           P  W APE      +  K+D+WS GI 
Sbjct: 145 ILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGIL 204
Query: 234 AIEL-AKGEPPNSELHPMRVLFLIPKNN----PPQLTGNYTKQFKEFVEACLNKDPENRP 288
             EL  KG  P   +    VL  + +      PP+      +   + +  C  KDPE RP
Sbjct: 205 LTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPEC----PESLHDLMCQCWRKDPEERP 260
Query: 289 TAKELLKF 296
           T + L  F
Sbjct: 261 TFEYLQAF 268

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 67/248 (27%), Positives = 106/248 (42%), Gaps = 19/248 (7%)
Query: 64  RIGKGSFGEVFKGIDNRTQQVVXXXXXXXXXXXXXXXXXXXXXMVL--SQCDSPYGT--- 118
           ++G+G FGEV+ G  N T +V                        L   +    Y     
Sbjct: 16  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 75
Query: 119 -KLWIIMEYLGGGSALDLMKA--GNFEEM-HIAVILREVLKGLDYLHSERKLHRDIKAAN 174
             ++I+ EY+  GS LD +K   G +  +  +  +  ++  G+ Y+     +HRD++AAN
Sbjct: 76  EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAAN 135
Query: 175 VLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPF-WMAPEVIKQSAYDSKADIWSLGIT 233
           +L+ E    K+ADFG+A  + +           P  W APE      +  K+D+WS GI 
Sbjct: 136 ILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGIL 195
Query: 234 AIEL-AKGEPPNSELHPMRVLFLIPKNN----PPQLTGNYTKQFKEFVEACLNKDPENRP 288
             EL  KG  P   +    VL  + +      PP+      +   + +  C  KDPE RP
Sbjct: 196 LTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPEC----PESLHDLMCQCWRKDPEERP 251
Query: 289 TAKELLKF 296
           T + L  F
Sbjct: 252 TFEYLQAF 259

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 67/248 (27%), Positives = 106/248 (42%), Gaps = 19/248 (7%)
Query: 64  RIGKGSFGEVFKGIDNRTQQVVXXXXXXXXXXXXXXXXXXXXXMVL--SQCDSPYGT--- 118
           ++G+G FGEV+ G  N T +V                        L   +    Y     
Sbjct: 14  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 73
Query: 119 -KLWIIMEYLGGGSALDLMKA--GNFEEM-HIAVILREVLKGLDYLHSERKLHRDIKAAN 174
             ++I+ EY+  GS LD +K   G +  +  +  +  ++  G+ Y+     +HRD++AAN
Sbjct: 74  EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAAN 133
Query: 175 VLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPF-WMAPEVIKQSAYDSKADIWSLGIT 233
           +L+ E    K+ADFG+A  + +           P  W APE      +  K+D+WS GI 
Sbjct: 134 ILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGIL 193
Query: 234 AIEL-AKGEPPNSELHPMRVLFLIPKNN----PPQLTGNYTKQFKEFVEACLNKDPENRP 288
             EL  KG  P   +    VL  + +      PP+      +   + +  C  KDPE RP
Sbjct: 194 LTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPEC----PESLHDLMCQCWRKDPEERP 249
Query: 289 TAKELLKF 296
           T + L  F
Sbjct: 250 TFEYLQAF 257

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 52/183 (28%), Positives = 84/183 (45%), Gaps = 17/183 (9%)
Query: 118 TKLWIIMEYLGGGSAL-DLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVL 176
           ++L+ ++EY+ GG  +  + +     E H      E+   L+YLH    ++RD+K  NVL
Sbjct: 83  SRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVL 142
Query: 177 LSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIE 236
           L   G +KL D+G+           + F GTP ++APE+++   Y    D W+LG+   E
Sbjct: 143 LDSEGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFE 202
Query: 237 LAKGEPP------------NSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDP 284
           +  G  P            N+E +  +V+       P  L+       K F    LNKDP
Sbjct: 203 MMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLKSF----LNKDP 258
Query: 285 ENR 287
           + R
Sbjct: 259 KER 261

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/244 (26%), Positives = 101/244 (41%), Gaps = 11/244 (4%)
Query: 64  RIGKGSFGEVFKGIDNRTQQVVXXXXXXXXXXXXXXXXXXXXXMVL--SQCDSPYGT--- 118
           R+G G FGEV+ G  N   +V                        L   +    Y     
Sbjct: 16  RLGNGQFGEVWMGTWNGNTKVAIKTLKPGTMSPESFLEEAQIMKKLKHDKLVQLYAVVSE 75
Query: 119 -KLWIIMEYLGGGSALDLMKAGNFEEMHIAVIL---REVLKGLDYLHSERKLHRDIKAAN 174
             ++I+ EY+  GS LD +K G    + +  ++    +V  G+ Y+     +HRD+++AN
Sbjct: 76  EPIYIVTEYMNKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSAN 135
Query: 175 VLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPF-WMAPEVIKQSAYDSKADIWSLGIT 233
           +L+      K+ADFG+A  + +           P  W APE      +  K+D+WS GI 
Sbjct: 136 ILVGNGLICKIADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGIL 195
Query: 234 AIELA-KGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPENRPTAKE 292
             EL  KG  P   ++   VL  + +        +      E +  C  KDPE RPT + 
Sbjct: 196 LTELVTKGRVPYPGMNNREVLEQVERGYRMPCPQDCPISLHELMIHCWKKDPEERPTFEY 255
Query: 293 LLKF 296
           L  F
Sbjct: 256 LQSF 259

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 51/183 (27%), Positives = 84/183 (45%), Gaps = 17/183 (9%)
Query: 118 TKLWIIMEYLGGGSAL-DLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVL 176
           ++L+ ++EY+ GG  +  + +     E H      E+   L+YLH    ++RD+K  NVL
Sbjct: 94  SRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVL 153
Query: 177 LSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIE 236
           L   G +KL D+G+           + F GTP ++APE+++   Y    D W+LG+   E
Sbjct: 154 LDSEGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFE 213
Query: 237 LAKGEPP------------NSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDP 284
           +  G  P            N+E +  +V+       P  ++       K F    LNKDP
Sbjct: 214 MMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSMSVKAASVLKSF----LNKDP 269
Query: 285 ENR 287
           + R
Sbjct: 270 KER 272

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 52/191 (27%), Positives = 97/191 (50%), Gaps = 9/191 (4%)
Query: 118 TKLWIIMEYLGGGSALDLM-KAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVL 176
           T + +I+E + GG   D + +  +  E      L+++L G+ YLHS +  H D+K  N++
Sbjct: 87  TDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIM 146
Query: 177 LSEMG----DVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGI 232
           L +       +K+ DFG+A  +      +N F GTP ++APE++       +AD+WS+G+
Sbjct: 147 LLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF-GTPEFVAPEIVNYEPLGLEADMWSIGV 205
Query: 233 TAIELAKGEPP---NSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPENRPT 289
               L  G  P   +++   +  +  +      +   N +   K+F+   L KDP+ R T
Sbjct: 206 ITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMT 265
Query: 290 AKELLKFPFIR 300
            ++ L+ P+I+
Sbjct: 266 IQDSLQHPWIK 276

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 58/195 (29%), Positives = 93/195 (47%), Gaps = 13/195 (6%)
Query: 118 TKLWIIMEYLGGGSALD-LMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVL 176
           T  +++ + +  G   D L +     E     I+R +L+ +  LH    +HRD+K  N+L
Sbjct: 84  TFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENIL 143
Query: 177 LSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQS------AYDSKADIWSL 230
           L +  ++KL DFG +  L +   K     GTP ++APE+I+ S       Y  + D+WS 
Sbjct: 144 LDDDMNIKLTDFGFSCQL-DPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWST 202
Query: 231 GITAIELAKGEPPNSELHPMRVLFLIPKNN----PPQLTGNYTKQFKEFVEACLNKDPEN 286
           G+    L  G PP      M +L +I   N     P+   +Y+   K+ V   L   P+ 
Sbjct: 203 GVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEW-DDYSDTVKDLVSRFLVVQPQK 261
Query: 287 RPTAKELLKFPFIRK 301
           R TA+E L  PF ++
Sbjct: 262 RYTAEEALAHPFFQQ 276

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 52/195 (26%), Positives = 98/195 (50%), Gaps = 9/195 (4%)
Query: 118 TKLWIIMEYLGGGSALDLM-KAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVL 176
           T + +I+E + GG   D + +  +  E      L+++L G+ YLHS+R  H D+K  N++
Sbjct: 102 TDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIM 161
Query: 177 LSEMG----DVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGI 232
           L +       +KL DFG+A  +      +N F GTP ++APE++       +AD+WS+G+
Sbjct: 162 LLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIF-GTPEFVAPEIVNYEPLGLEADMWSIGV 220
Query: 233 TAIELAKGEPP---NSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPENRPT 289
               L  G  P    ++   +  +  +  +   +   N ++  K+F+   L KDP+ R  
Sbjct: 221 ITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSELAKDFIRRLLVKDPKRRMX 280
Query: 290 AKELLKFPFIRKAKK 304
             + L+  +I+  ++
Sbjct: 281 IAQSLEHSWIKAIRR 295

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 63/259 (24%), Positives = 112/259 (43%), Gaps = 23/259 (8%)
Query: 63  ERIGKGSFGEVFKGIDNRTQQVVXXXXXXXXXXXXXXXXXXXXXMVLSQCDSPYGTKLW- 121
           ER+G G FGEV+ G  N   +V                       ++ Q       +L+ 
Sbjct: 27  ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEAN---LMKQLQHQRLVRLYA 83
Query: 122 --------IIMEYLGGGSALDLMKAGNFEEMHIAVIL---REVLKGLDYLHSERKLHRDI 170
                   II EY+  GS +D +K  +  ++ I  +L    ++ +G+ ++     +HRD+
Sbjct: 84  VVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDL 143
Query: 171 KAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPF-WMAPEVIKQSAYDSKADIWS 229
           +AAN+L+S+    K+ADFG+A  + +           P  W APE I    +  K+D+WS
Sbjct: 144 RAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWS 203
Query: 230 LGITAIELA-KGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPENRP 288
            GI   E+   G  P   +    V+  + +        N  ++  + +  C  + PE+RP
Sbjct: 204 FGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRP 263
Query: 289 TAKELLKFPFIRKAKKNAY 307
           T      F ++R   ++ +
Sbjct: 264 T------FDYLRSVLEDFF 276

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 66/248 (26%), Positives = 105/248 (42%), Gaps = 19/248 (7%)
Query: 64  RIGKGSFGEVFKGIDNRTQQVVXXXXXXXXXXXXXXXXXXXXXMVL--SQCDSPYGT--- 118
           ++G+G FGEV+ G  N T +V                        L   +    Y     
Sbjct: 192 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGNMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 251
Query: 119 -KLWIIMEYLGGGSALDLMKA--GNFEEM-HIAVILREVLKGLDYLHSERKLHRDIKAAN 174
             ++I+ EY+  GS LD +K   G +  +  +  +  ++  G+ Y+     +HRD++AAN
Sbjct: 252 EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAAN 311
Query: 175 VLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPF-WMAPEVIKQSAYDSKADIWSLGIT 233
           +L+ E    K+ADFG+   + +           P  W APE      +  K+D+WS GI 
Sbjct: 312 ILVGENLVCKVADFGLGRLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGIL 371
Query: 234 AIEL-AKGEPPNSELHPMRVLFLIPKNN----PPQLTGNYTKQFKEFVEACLNKDPENRP 288
             EL  KG  P   +    VL  + +      PP+      +   + +  C  KDPE RP
Sbjct: 372 LTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPEC----PESLHDLMCQCWRKDPEERP 427
Query: 289 TAKELLKF 296
           T + L  F
Sbjct: 428 TFEYLQAF 435

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 66/248 (26%), Positives = 106/248 (42%), Gaps = 19/248 (7%)
Query: 64  RIGKGSFGEVFKGIDNRTQQVVXXXXXXXXXXXXXXXXXXXXXMVL--SQCDSPYGTK-- 119
           ++G+G FGEV+ G  N T +V                        L   +    Y     
Sbjct: 191 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 250
Query: 120 --LWIIMEYLGGGSALDLMKA--GNFEEM-HIAVILREVLKGLDYLHSERKLHRDIKAAN 174
             ++I+ EY+  GS LD +K   G +  +  +  +  ++  G+ Y+     +HRD++AAN
Sbjct: 251 EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAAN 310
Query: 175 VLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPF-WMAPEVIKQSAYDSKADIWSLGIT 233
           +L+ E    K+ADFG+A  + +           P  W APE      +  K+D+WS GI 
Sbjct: 311 ILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGIL 370
Query: 234 AIEL-AKGEPPNSELHPMRVLFLIPKNN----PPQLTGNYTKQFKEFVEACLNKDPENRP 288
             EL  KG  P   +    VL  + +      PP+      +   + +  C  K+PE RP
Sbjct: 371 LTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPEC----PESLHDLMCQCWRKEPEERP 426
Query: 289 TAKELLKF 296
           T + L  F
Sbjct: 427 TFEYLQAF 434

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 66/252 (26%), Positives = 106/252 (42%), Gaps = 27/252 (10%)
Query: 64  RIGKGSFGEVFKGIDNRTQQVVXXXX----------XXXXXXXXXXXXXXXXXMVLSQCD 113
           ++G+G FGEV+ G  N T +V                                +     +
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKIRHEKLVQLYAVVSE 84
Query: 114 SPYGTKLWIIMEYLGGGSALDLMKA--GNFEEM-HIAVILREVLKGLDYLHSERKLHRDI 170
            P    ++I+ EY+  GS LD +K   G +  +  +  +  ++  G+ Y+     +HRD+
Sbjct: 85  EP----IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDL 140
Query: 171 KAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPF-WMAPEVIKQSAYDSKADIWS 229
           +AAN+L+ E    K+ADFG+A  + +           P  W APE      +  K+D+WS
Sbjct: 141 RAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWS 200
Query: 230 LGITAIEL-AKGEPPNSELHPMRVLFLIPKNN----PPQLTGNYTKQFKEFVEACLNKDP 284
            GI   EL  KG  P   +    VL  + +      PP+      +   + +  C  KDP
Sbjct: 201 FGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPEC----PESLHDLMCQCWRKDP 256
Query: 285 ENRPTAKELLKF 296
           E RPT + L  F
Sbjct: 257 EERPTFEYLQAF 268

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 63/259 (24%), Positives = 112/259 (43%), Gaps = 23/259 (8%)
Query: 63  ERIGKGSFGEVFKGIDNRTQQVVXXXXXXXXXXXXXXXXXXXXXMVLSQCDSPYGTKLW- 121
           ER+G G FGEV+ G  N   +V                       ++ Q       +L+ 
Sbjct: 29  ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEAN---LMKQLQHQRLVRLYA 85
Query: 122 --------IIMEYLGGGSALDLMKAGNFEEMHIAVIL---REVLKGLDYLHSERKLHRDI 170
                   II EY+  GS +D +K  +  ++ I  +L    ++ +G+ ++     +HRD+
Sbjct: 86  VVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDL 145
Query: 171 KAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPF-WMAPEVIKQSAYDSKADIWS 229
           +AAN+L+S+    K+ADFG+A  + +           P  W APE I    +  K+D+WS
Sbjct: 146 RAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWS 205
Query: 230 LGITAIELA-KGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPENRP 288
            GI   E+   G  P   +    V+  + +        N  ++  + +  C  + PE+RP
Sbjct: 206 FGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRP 265
Query: 289 TAKELLKFPFIRKAKKNAY 307
           T      F ++R   ++ +
Sbjct: 266 T------FDYLRSVLEDFF 278

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 63/259 (24%), Positives = 112/259 (43%), Gaps = 23/259 (8%)
Query: 63  ERIGKGSFGEVFKGIDNRTQQVVXXXXXXXXXXXXXXXXXXXXXMVLSQCDSPYGTKLW- 121
           ER+G G FGEV+ G  N   +V                       ++ Q       +L+ 
Sbjct: 25  ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEAN---LMKQLQHQRLVRLYA 81
Query: 122 --------IIMEYLGGGSALDLMKAGNFEEMHIAVIL---REVLKGLDYLHSERKLHRDI 170
                   II EY+  GS +D +K  +  ++ I  +L    ++ +G+ ++     +HRD+
Sbjct: 82  VVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDL 141
Query: 171 KAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPF-WMAPEVIKQSAYDSKADIWS 229
           +AAN+L+S+    K+ADFG+A  + +           P  W APE I    +  K+D+WS
Sbjct: 142 RAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWS 201
Query: 230 LGITAIELA-KGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPENRP 288
            GI   E+   G  P   +    V+  + +        N  ++  + +  C  + PE+RP
Sbjct: 202 FGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRP 261
Query: 289 TAKELLKFPFIRKAKKNAY 307
           T      F ++R   ++ +
Sbjct: 262 T------FDYLRSVLEDFF 274

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 66/248 (26%), Positives = 106/248 (42%), Gaps = 19/248 (7%)
Query: 64  RIGKGSFGEVFKGIDNRTQQVVXXXXXXXXXXXXXXXXXXXXXMVL--SQCDSPYGT--- 118
           ++G+G FGEV+ G  N T +V                        L   +    Y     
Sbjct: 191 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 250
Query: 119 -KLWIIMEYLGGGSALDLMKA--GNFEEM-HIAVILREVLKGLDYLHSERKLHRDIKAAN 174
             ++I+ EY+  GS LD +K   G +  +  +  +  ++  G+ Y+     +HRD++AAN
Sbjct: 251 EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAAN 310
Query: 175 VLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPF-WMAPEVIKQSAYDSKADIWSLGIT 233
           +L+ E    K+ADFG+A  + +           P  W APE      +  K+D+WS GI 
Sbjct: 311 ILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGIL 370
Query: 234 AIEL-AKGEPPNSELHPMRVLFLIPKNN----PPQLTGNYTKQFKEFVEACLNKDPENRP 288
             EL  KG  P   +    VL  + +      PP+      +   + +  C  K+PE RP
Sbjct: 371 LTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPEC----PESLHDLMCQCWRKEPEERP 426
Query: 289 TAKELLKF 296
           T + L  F
Sbjct: 427 TFEYLQAF 434

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 63/259 (24%), Positives = 112/259 (43%), Gaps = 23/259 (8%)
Query: 63  ERIGKGSFGEVFKGIDNRTQQVVXXXXXXXXXXXXXXXXXXXXXMVLSQCDSPYGTKLW- 121
           ER+G G FGEV+ G  N   +V                       ++ Q       +L+ 
Sbjct: 19  ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEAN---LMKQLQHQRLVRLYA 75
Query: 122 --------IIMEYLGGGSALDLMKAGNFEEMHIAVIL---REVLKGLDYLHSERKLHRDI 170
                   II EY+  GS +D +K  +  ++ I  +L    ++ +G+ ++     +HRD+
Sbjct: 76  VVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDL 135
Query: 171 KAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPF-WMAPEVIKQSAYDSKADIWS 229
           +AAN+L+S+    K+ADFG+A  + +           P  W APE I    +  K+D+WS
Sbjct: 136 RAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWS 195
Query: 230 LGITAIELA-KGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPENRP 288
            GI   E+   G  P   +    V+  + +        N  ++  + +  C  + PE+RP
Sbjct: 196 FGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRP 255
Query: 289 TAKELLKFPFIRKAKKNAY 307
           T      F ++R   ++ +
Sbjct: 256 T------FDYLRSVLEDFF 268

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 63/259 (24%), Positives = 112/259 (43%), Gaps = 23/259 (8%)
Query: 63  ERIGKGSFGEVFKGIDNRTQQVVXXXXXXXXXXXXXXXXXXXXXMVLSQCDSPYGTKLW- 121
           ER+G G FGEV+ G  N   +V                       ++ Q       +L+ 
Sbjct: 28  ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEAN---LMKQLQHQRLVRLYA 84
Query: 122 --------IIMEYLGGGSALDLMKAGNFEEMHIAVIL---REVLKGLDYLHSERKLHRDI 170
                   II EY+  GS +D +K  +  ++ I  +L    ++ +G+ ++     +HRD+
Sbjct: 85  VVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDL 144
Query: 171 KAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPF-WMAPEVIKQSAYDSKADIWS 229
           +AAN+L+S+    K+ADFG+A  + +           P  W APE I    +  K+D+WS
Sbjct: 145 RAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWS 204
Query: 230 LGITAIELA-KGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPENRP 288
            GI   E+   G  P   +    V+  + +        N  ++  + +  C  + PE+RP
Sbjct: 205 FGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRP 264
Query: 289 TAKELLKFPFIRKAKKNAY 307
           T      F ++R   ++ +
Sbjct: 265 T------FDYLRSVLEDFF 277

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 103/212 (48%), Gaps = 10/212 (4%)
Query: 121 WIIMEYLGGGSAL-DLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLL-- 177
           +++ + + GG    D++    + E   +  ++++L+ +++ H    +HRD+K  N+LL  
Sbjct: 79  YLVFDLVTGGELFEDIVAREYYSEADASHCIQQILESVNHCHLNGIVHRDLKPENLLLAS 138
Query: 178 -SEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIE 236
            S+   VKLADFG+A  +         F GTP +++PEV+++  Y    D+W+ G+    
Sbjct: 139 KSKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVLRKDPYGKPVDMWACGVILYI 198
Query: 237 LAKGEPPNSELHPMRVLFLI---PKNNPPQLTGNYTKQFKEFVEACLNKDPENRPTAKEL 293
           L  G PP  +    R+   I     + P       T + K+ +   L  +P  R TA E 
Sbjct: 199 LLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDLINKMLTINPAKRITASEA 258
Query: 294 LKFPFIRKAKKNAYLI---DLIDRYKKWKNSR 322
           LK P+I +    A ++   + +D  KK+   R
Sbjct: 259 LKHPWICQRSTVASMMHRQETVDCLKKFNARR 290

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 63/259 (24%), Positives = 112/259 (43%), Gaps = 23/259 (8%)
Query: 63  ERIGKGSFGEVFKGIDNRTQQVVXXXXXXXXXXXXXXXXXXXXXMVLSQCDSPYGTKLW- 121
           ER+G G FGEV+ G  N   +V                       ++ Q       +L+ 
Sbjct: 21  ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEAN---LMKQLQHQRLVRLYA 77
Query: 122 --------IIMEYLGGGSALDLMKAGNFEEMHIAVIL---REVLKGLDYLHSERKLHRDI 170
                   II EY+  GS +D +K  +  ++ I  +L    ++ +G+ ++     +HRD+
Sbjct: 78  VVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDL 137
Query: 171 KAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPF-WMAPEVIKQSAYDSKADIWS 229
           +AAN+L+S+    K+ADFG+A  + +           P  W APE I    +  K+D+WS
Sbjct: 138 RAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWS 197
Query: 230 LGITAIELA-KGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPENRP 288
            GI   E+   G  P   +    V+  + +        N  ++  + +  C  + PE+RP
Sbjct: 198 FGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRP 257
Query: 289 TAKELLKFPFIRKAKKNAY 307
           T      F ++R   ++ +
Sbjct: 258 T------FDYLRSVLEDFF 270

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 63/259 (24%), Positives = 112/259 (43%), Gaps = 23/259 (8%)
Query: 63  ERIGKGSFGEVFKGIDNRTQQVVXXXXXXXXXXXXXXXXXXXXXMVLSQCDSPYGTKLW- 121
           ER+G G FGEV+ G  N   +V                       ++ Q       +L+ 
Sbjct: 25  ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEAN---LMKQLQHQRLVRLYA 81
Query: 122 --------IIMEYLGGGSALDLMKAGNFEEMHIAVIL---REVLKGLDYLHSERKLHRDI 170
                   II EY+  GS +D +K  +  ++ I  +L    ++ +G+ ++     +HRD+
Sbjct: 82  VVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDL 141
Query: 171 KAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPF-WMAPEVIKQSAYDSKADIWS 229
           +AAN+L+S+    K+ADFG+A  + +           P  W APE I    +  K+D+WS
Sbjct: 142 RAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWS 201
Query: 230 LGITAIELA-KGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPENRP 288
            GI   E+   G  P   +    V+  + +        N  ++  + +  C  + PE+RP
Sbjct: 202 FGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRP 261
Query: 289 TAKELLKFPFIRKAKKNAY 307
           T      F ++R   ++ +
Sbjct: 262 T------FDYLRSVLEDFF 274

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 52/191 (27%), Positives = 97/191 (50%), Gaps = 9/191 (4%)
Query: 118 TKLWIIMEYLGGGSALDLM-KAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVL 176
           T + +I+E + GG   D + +  +  E      L+++L G+ YLHS +  H D+K  N++
Sbjct: 87  TDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIM 146
Query: 177 LSEMG----DVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGI 232
           L +       +K+ DFG+A  +      +N F GTP ++APE++       +AD+WS+G+
Sbjct: 147 LLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF-GTPEFVAPEIVNYEPLGLEADMWSIGV 205
Query: 233 TAIELAKGEPP---NSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPENRPT 289
               L  G  P   +++   +  +  +      +   N +   K+F+   L KDP+ R T
Sbjct: 206 ITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMT 265
Query: 290 AKELLKFPFIR 300
            ++ L+ P+I+
Sbjct: 266 IQDSLQHPWIK 276

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 52/191 (27%), Positives = 97/191 (50%), Gaps = 9/191 (4%)
Query: 118 TKLWIIMEYLGGGSALDLM-KAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVL 176
           T + +I+E + GG   D + +  +  E      L+++L G+ YLHS +  H D+K  N++
Sbjct: 86  TDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIM 145
Query: 177 LSEMG----DVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGI 232
           L +       +K+ DFG+A  +      +N F GTP ++APE++       +AD+WS+G+
Sbjct: 146 LLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF-GTPEFVAPEIVNYEPLGLEADMWSIGV 204
Query: 233 TAIELAKGEPP---NSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPENRPT 289
               L  G  P   +++   +  +  +      +   N +   K+F+   L KDP+ R T
Sbjct: 205 ITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMT 264
Query: 290 AKELLKFPFIR 300
            ++ L+ P+I+
Sbjct: 265 IQDSLQHPWIK 275

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 55/187 (29%), Positives = 93/187 (49%), Gaps = 14/187 (7%)
Query: 120 LWIIMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERK---LHRDIKAANVL 176
           L ++ME+  GG    ++         +     ++ +G++YLH E     +HRD+K++N+L
Sbjct: 81  LCLVMEFARGGPLNRVLSGKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNIL 140
Query: 177 L---SEMGDV-----KLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIW 228
           +    E GD+     K+ DFG+A     TT  + +  G   WMAPEVI+ S +   +D+W
Sbjct: 141 ILQKVENGDLSNKILKITDFGLAREWHRTT--KMSAAGAYAWMAPEVIRASMFSKGSDVW 198
Query: 229 SLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQ-LTGNYTKQFKEFVEACLNKDPENR 287
           S G+   EL  GE P   +  + V + +  N     +     + F + +E C N DP +R
Sbjct: 199 SYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIPSTCPEPFAKLMEDCWNPDPHSR 258
Query: 288 PTAKELL 294
           P+   +L
Sbjct: 259 PSFTNIL 265

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 52/191 (27%), Positives = 97/191 (50%), Gaps = 9/191 (4%)
Query: 118 TKLWIIMEYLGGGSALDLM-KAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVL 176
           T + +I+E + GG   D + +  +  E      L+++L G+ YLHS +  H D+K  N++
Sbjct: 86  TDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIM 145
Query: 177 LSEMG----DVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGI 232
           L +       +K+ DFG+A  +      +N F GTP ++APE++       +AD+WS+G+
Sbjct: 146 LLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF-GTPEFVAPEIVNYEPLGLEADMWSIGV 204
Query: 233 TAIELAKGEPP---NSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPENRPT 289
               L  G  P   +++   +  +  +      +   N +   K+F+   L KDP+ R T
Sbjct: 205 ITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMT 264
Query: 290 AKELLKFPFIR 300
            ++ L+ P+I+
Sbjct: 265 IQDSLQHPWIK 275

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 63/259 (24%), Positives = 112/259 (43%), Gaps = 23/259 (8%)
Query: 63  ERIGKGSFGEVFKGIDNRTQQVVXXXXXXXXXXXXXXXXXXXXXMVLSQCDSPYGTKLW- 121
           ER+G G FGEV+ G  N   +V                       ++ Q       +L+ 
Sbjct: 19  ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEAN---LMKQLQHQRLVRLYA 75
Query: 122 --------IIMEYLGGGSALDLMKAGNFEEMHIAVIL---REVLKGLDYLHSERKLHRDI 170
                   II EY+  GS +D +K  +  ++ I  +L    ++ +G+ ++     +HRD+
Sbjct: 76  VVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDL 135
Query: 171 KAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPF-WMAPEVIKQSAYDSKADIWS 229
           +AAN+L+S+    K+ADFG+A  + +           P  W APE I    +  K+D+WS
Sbjct: 136 RAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWS 195
Query: 230 LGITAIELA-KGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPENRP 288
            GI   E+   G  P   +    V+  + +        N  ++  + +  C  + PE+RP
Sbjct: 196 FGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRP 255
Query: 289 TAKELLKFPFIRKAKKNAY 307
           T      F ++R   ++ +
Sbjct: 256 T------FDYLRSVLEDFF 268

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 52/191 (27%), Positives = 97/191 (50%), Gaps = 9/191 (4%)
Query: 118 TKLWIIMEYLGGGSALDLM-KAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVL 176
           T + +I+E + GG   D + +  +  E      L+++L G+ YLHS +  H D+K  N++
Sbjct: 87  TDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIM 146
Query: 177 LSEMG----DVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGI 232
           L +       +K+ DFG+A  +      +N F GTP ++APE++       +AD+WS+G+
Sbjct: 147 LLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF-GTPEFVAPEIVNYEPLGLEADMWSIGV 205
Query: 233 TAIELAKGEPP---NSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPENRPT 289
               L  G  P   +++   +  +  +      +   N +   K+F+   L KDP+ R T
Sbjct: 206 ITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMT 265
Query: 290 AKELLKFPFIR 300
            ++ L+ P+I+
Sbjct: 266 IQDSLQHPWIK 276

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 63/259 (24%), Positives = 112/259 (43%), Gaps = 23/259 (8%)
Query: 63  ERIGKGSFGEVFKGIDNRTQQVVXXXXXXXXXXXXXXXXXXXXXMVLSQCDSPYGTKLW- 121
           ER+G G FGEV+ G  N   +V                       ++ Q       +L+ 
Sbjct: 20  ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEAN---LMKQLQHQRLVRLYA 76
Query: 122 --------IIMEYLGGGSALDLMKAGNFEEMHIAVIL---REVLKGLDYLHSERKLHRDI 170
                   II EY+  GS +D +K  +  ++ I  +L    ++ +G+ ++     +HRD+
Sbjct: 77  VVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDL 136
Query: 171 KAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPF-WMAPEVIKQSAYDSKADIWS 229
           +AAN+L+S+    K+ADFG+A  + +           P  W APE I    +  K+D+WS
Sbjct: 137 RAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWS 196
Query: 230 LGITAIELA-KGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPENRP 288
            GI   E+   G  P   +    V+  + +        N  ++  + +  C  + PE+RP
Sbjct: 197 FGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRP 256
Query: 289 TAKELLKFPFIRKAKKNAY 307
           T      F ++R   ++ +
Sbjct: 257 T------FDYLRSVLEDFF 269

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 52/191 (27%), Positives = 97/191 (50%), Gaps = 9/191 (4%)
Query: 118 TKLWIIMEYLGGGSALDLM-KAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVL 176
           T + +I+E + GG   D + +  +  E      L+++L G+ YLHS +  H D+K  N++
Sbjct: 87  TDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIM 146
Query: 177 LSEMG----DVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGI 232
           L +       +K+ DFG+A  +      +N F GTP ++APE++       +AD+WS+G+
Sbjct: 147 LLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF-GTPEFVAPEIVNYEPLGLEADMWSIGV 205
Query: 233 TAIELAKGEPP---NSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPENRPT 289
               L  G  P   +++   +  +  +      +   N +   K+F+   L KDP+ R T
Sbjct: 206 ITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMT 265
Query: 290 AKELLKFPFIR 300
            ++ L+ P+I+
Sbjct: 266 IQDSLQHPWIK 276

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 63/259 (24%), Positives = 112/259 (43%), Gaps = 23/259 (8%)
Query: 63  ERIGKGSFGEVFKGIDNRTQQVVXXXXXXXXXXXXXXXXXXXXXMVLSQCDSPYGTKLW- 121
           ER+G G FGEV+ G  N   +V                       ++ Q       +L+ 
Sbjct: 24  ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEAN---LMKQLQHQRLVRLYA 80
Query: 122 --------IIMEYLGGGSALDLMKAGNFEEMHIAVIL---REVLKGLDYLHSERKLHRDI 170
                   II EY+  GS +D +K  +  ++ I  +L    ++ +G+ ++     +HRD+
Sbjct: 81  VVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDL 140
Query: 171 KAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPF-WMAPEVIKQSAYDSKADIWS 229
           +AAN+L+S+    K+ADFG+A  + +           P  W APE I    +  K+D+WS
Sbjct: 141 RAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWS 200
Query: 230 LGITAIELA-KGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPENRP 288
            GI   E+   G  P   +    V+  + +        N  ++  + +  C  + PE+RP
Sbjct: 201 FGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRP 260
Query: 289 TAKELLKFPFIRKAKKNAY 307
           T      F ++R   ++ +
Sbjct: 261 T------FDYLRSVLEDFF 273

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 52/191 (27%), Positives = 97/191 (50%), Gaps = 9/191 (4%)
Query: 118 TKLWIIMEYLGGGSALDLM-KAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVL 176
           T + +I+E + GG   D + +  +  E      L+++L G+ YLHS +  H D+K  N++
Sbjct: 87  TDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIM 146
Query: 177 LSEMG----DVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGI 232
           L +       +K+ DFG+A  +      +N F GTP ++APE++       +AD+WS+G+
Sbjct: 147 LLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF-GTPEFVAPEIVNYEPLGLEADMWSIGV 205
Query: 233 TAIELAKGEPP---NSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPENRPT 289
               L  G  P   +++   +  +  +      +   N +   K+F+   L KDP+ R T
Sbjct: 206 ITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMT 265
Query: 290 AKELLKFPFIR 300
            ++ L+ P+I+
Sbjct: 266 IQDSLQHPWIK 276

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 47/130 (36%), Positives = 72/130 (55%), Gaps = 5/130 (3%)
Query: 118 TKLWIIMEYLGGGSALD-LMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVL 176
           T L I+MEY  GG   + +  AG F E       ++++ G+ Y H+ +  HRD+K  N L
Sbjct: 88  THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTL 147
Query: 177 L--SEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSK-ADIWSLGIT 233
           L  S    +K+ DFG + +    +  ++T VGTP ++APEV+ +  YD K AD+WS G+T
Sbjct: 148 LDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEYDGKVADVWSCGVT 206
Query: 234 AIELAKGEPP 243
              +  G  P
Sbjct: 207 LYVMLVGAYP 216

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 52/191 (27%), Positives = 97/191 (50%), Gaps = 9/191 (4%)
Query: 118 TKLWIIMEYLGGGSALDLM-KAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVL 176
           T + +I+E + GG   D + +  +  E      L+++L G+ YLHS +  H D+K  N++
Sbjct: 87  TDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIM 146
Query: 177 LSEMG----DVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGI 232
           L +       +K+ DFG+A  +      +N F GTP ++APE++       +AD+WS+G+
Sbjct: 147 LLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF-GTPEFVAPEIVNYEPLGLEADMWSIGV 205
Query: 233 TAIELAKGEPP---NSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPENRPT 289
               L  G  P   +++   +  +  +      +   N +   K+F+   L KDP+ R T
Sbjct: 206 ITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMT 265
Query: 290 AKELLKFPFIR 300
            ++ L+ P+I+
Sbjct: 266 IQDSLQHPWIK 276

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 82.8 bits (203), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 52/191 (27%), Positives = 97/191 (50%), Gaps = 9/191 (4%)
Query: 118 TKLWIIMEYLGGGSALDLM-KAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVL 176
           T + +I+E + GG   D + +  +  E      L+++L G+ YLHS +  H D+K  N++
Sbjct: 87  TDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIM 146
Query: 177 LSEMG----DVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGI 232
           L +       +K+ DFG+A  +      +N F GTP ++APE++       +AD+WS+G+
Sbjct: 147 LLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF-GTPEFVAPEIVNYEPLGLEADMWSIGV 205
Query: 233 TAIELAKGEPP---NSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPENRPT 289
               L  G  P   +++   +  +  +      +   N +   K+F+   L KDP+ R T
Sbjct: 206 ITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMT 265
Query: 290 AKELLKFPFIR 300
            ++ L+ P+I+
Sbjct: 266 IQDSLQHPWIK 276

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 82.8 bits (203), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 67/248 (27%), Positives = 105/248 (42%), Gaps = 19/248 (7%)
Query: 64  RIGKGSFGEVFKGIDNRTQQVVXXXXXXXXXXXXXXXXXXXXXMVL--SQCDSPYGT--- 118
           ++G+G FGEV+ G  N T +V                        L   +    Y     
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 84
Query: 119 -KLWIIMEYLGGGSALDLMKA--GNFEEM-HIAVILREVLKGLDYLHSERKLHRDIKAAN 174
             ++I+ EY+  GS LD +K   G +  +  +  +  ++  G+ Y+     +HRD+ AAN
Sbjct: 85  EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLAAAN 144
Query: 175 VLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPF-WMAPEVIKQSAYDSKADIWSLGIT 233
           +L+ E    K+ADFG+A  + +           P  W APE      +  K+D+WS GI 
Sbjct: 145 ILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGIL 204
Query: 234 AIEL-AKGEPPNSELHPMRVLFLIPKNN----PPQLTGNYTKQFKEFVEACLNKDPENRP 288
             EL  KG  P   +    VL  + +      PP+      +   + +  C  KDPE RP
Sbjct: 205 LTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPEC----PESLHDLMCQCWRKDPEERP 260
Query: 289 TAKELLKF 296
           T + L  F
Sbjct: 261 TFEYLQAF 268

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 82.8 bits (203), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 52/191 (27%), Positives = 97/191 (50%), Gaps = 9/191 (4%)
Query: 118 TKLWIIMEYLGGGSALDLM-KAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVL 176
           T + +I+E + GG   D + +  +  E      L+++L G+ YLHS +  H D+K  N++
Sbjct: 87  TDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIM 146
Query: 177 LSEMG----DVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGI 232
           L +       +K+ DFG+A  +      +N F GTP ++APE++       +AD+WS+G+
Sbjct: 147 LLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF-GTPEFVAPEIVNYEPLGLEADMWSIGV 205
Query: 233 TAIELAKGEPP---NSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPENRPT 289
               L  G  P   +++   +  +  +      +   N +   K+F+   L KDP+ R T
Sbjct: 206 ITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMT 265
Query: 290 AKELLKFPFIR 300
            ++ L+ P+I+
Sbjct: 266 IQDSLQHPWIK 276

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 82.8 bits (203), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 47/130 (36%), Positives = 72/130 (55%), Gaps = 5/130 (3%)
Query: 118 TKLWIIMEYLGGGSALD-LMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVL 176
           T L I+MEY  GG   + +  AG F E       ++++ G+ Y H+ +  HRD+K  N L
Sbjct: 87  THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTL 146
Query: 177 L--SEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSK-ADIWSLGIT 233
           L  S    +K+ DFG + +    +  ++T VGTP ++APEV+ +  YD K AD+WS G+T
Sbjct: 147 LDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEYDGKVADVWSCGVT 205
Query: 234 AIELAKGEPP 243
              +  G  P
Sbjct: 206 LYVMLVGAYP 215

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 82.8 bits (203), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 63/259 (24%), Positives = 112/259 (43%), Gaps = 23/259 (8%)
Query: 63  ERIGKGSFGEVFKGIDNRTQQVVXXXXXXXXXXXXXXXXXXXXXMVLSQCDSPYGTKLW- 121
           ER+G G FGEV+ G  N   +V                       ++ Q       +L+ 
Sbjct: 19  ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEAN---LMKQLQHQRLVRLYA 75
Query: 122 --------IIMEYLGGGSALDLMKAGNFEEMHIAVIL---REVLKGLDYLHSERKLHRDI 170
                   II EY+  GS +D +K  +  ++ I  +L    ++ +G+ ++     +HRD+
Sbjct: 76  VVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDL 135
Query: 171 KAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPF-WMAPEVIKQSAYDSKADIWS 229
           +AAN+L+S+    K+ADFG+A  + +           P  W APE I    +  K+D+WS
Sbjct: 136 RAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWS 195
Query: 230 LGITAIELA-KGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPENRP 288
            GI   E+   G  P   +    V+  + +        N  ++  + +  C  + PE+RP
Sbjct: 196 FGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRP 255
Query: 289 TAKELLKFPFIRKAKKNAY 307
           T      F ++R   ++ +
Sbjct: 256 T------FDYLRSVLEDFF 268

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 82.8 bits (203), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 63/259 (24%), Positives = 112/259 (43%), Gaps = 23/259 (8%)
Query: 63  ERIGKGSFGEVFKGIDNRTQQVVXXXXXXXXXXXXXXXXXXXXXMVLSQCDSPYGTKLW- 121
           ER+G G FGEV+ G  N   +V                       ++ Q       +L+ 
Sbjct: 14  ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEAN---LMKQLQHQRLVRLYA 70
Query: 122 --------IIMEYLGGGSALDLMKAGNFEEMHIAVIL---REVLKGLDYLHSERKLHRDI 170
                   II EY+  GS +D +K  +  ++ I  +L    ++ +G+ ++     +HRD+
Sbjct: 71  VVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDL 130
Query: 171 KAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPF-WMAPEVIKQSAYDSKADIWS 229
           +AAN+L+S+    K+ADFG+A  + +           P  W APE I    +  K+D+WS
Sbjct: 131 RAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWS 190
Query: 230 LGITAIELA-KGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPENRP 288
            GI   E+   G  P   +    V+  + +        N  ++  + +  C  + PE+RP
Sbjct: 191 FGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRP 250
Query: 289 TAKELLKFPFIRKAKKNAY 307
           T      F ++R   ++ +
Sbjct: 251 T------FDYLRSVLEDFF 263

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 82.8 bits (203), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 96/199 (48%), Gaps = 26/199 (13%)
Query: 118 TKLWIIMEYLGGGSALDLMKAGNFEEMHIAV--ILREVLKGLDYLHSERKLHRDIKAANV 175
           + L+I MEY    +  DL+ + N  +       + R++L+ L Y+HS+  +HRD+K  N+
Sbjct: 88  STLFIQMEYCENRTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNI 147
Query: 176 LLSEMGDVKLADFGVA------------------GTLTNTTSKRNTFVGTPFWMAPEVIK 217
            + E  +VK+ DFG+A                  G+  N TS     +GT  ++A EV+ 
Sbjct: 148 FIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSA----IGTAMYVATEVLD 203
Query: 218 QSA-YDSKADIWSLGITAIELAKGEPPNSE-LHPMRVLFLIPKNNPPQLTGNYTKQFKEF 275
            +  Y+ K D++SLGI   E+        E ++ ++ L  +    PP    N  K  K+ 
Sbjct: 204 GTGHYNEKIDMYSLGIIFFEMIYPFSTGMERVNILKKLRSVSIEFPPDFDDNKMKVEKKI 263
Query: 276 VEACLNKDPENRPTAKELL 294
           +   ++ DP  RP A+ LL
Sbjct: 264 IRLLIDHDPNKRPGARTLL 282

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 82.8 bits (203), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 66/248 (26%), Positives = 105/248 (42%), Gaps = 19/248 (7%)
Query: 64  RIGKGSFGEVFKGIDNRTQQVVXXXXXXXXXXXXXXXXXXXXXMVL--SQCDSPYGT--- 118
           ++G+G FGEV+ G  N T +V                        L   +    Y     
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 84
Query: 119 -KLWIIMEYLGGGSALDLMKA--GNFEEM-HIAVILREVLKGLDYLHSERKLHRDIKAAN 174
             ++I+ EY+  G  LD +K   G +  +  +  +  ++  G+ Y+     +HRD++AAN
Sbjct: 85  EPIYIVTEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAAN 144
Query: 175 VLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPF-WMAPEVIKQSAYDSKADIWSLGIT 233
           +L+ E    K+ADFG+A  + +           P  W APE      +  K+D+WS GI 
Sbjct: 145 ILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGIL 204
Query: 234 AIEL-AKGEPPNSELHPMRVLFLIPKNN----PPQLTGNYTKQFKEFVEACLNKDPENRP 288
             EL  KG  P   +    VL  + +      PP+      +   + +  C  KDPE RP
Sbjct: 205 LTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPEC----PESLHDLMCQCWRKDPEERP 260
Query: 289 TAKELLKF 296
           T + L  F
Sbjct: 261 TFEYLQAF 268

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 82.8 bits (203), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 52/191 (27%), Positives = 97/191 (50%), Gaps = 9/191 (4%)
Query: 118 TKLWIIMEYLGGGSALDLM-KAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVL 176
           T + +I+E + GG   D + +  +  E      L+++L G+ YLHS +  H D+K  N++
Sbjct: 87  TDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIM 146
Query: 177 LSEMG----DVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGI 232
           L +       +K+ DFG+A  +      +N F GTP ++APE++       +AD+WS+G+
Sbjct: 147 LLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF-GTPEFVAPEIVNYEPLGLEADMWSIGV 205
Query: 233 TAIELAKGEPP---NSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPENRPT 289
               L  G  P   +++   +  +  +      +   N +   K+F+   L KDP+ R T
Sbjct: 206 ITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMT 265
Query: 290 AKELLKFPFIR 300
            ++ L+ P+I+
Sbjct: 266 IQDSLQHPWIK 276

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 82.8 bits (203), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 52/191 (27%), Positives = 97/191 (50%), Gaps = 9/191 (4%)
Query: 118 TKLWIIMEYLGGGSALDLM-KAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVL 176
           T + +I+E + GG   D + +  +  E      L+++L G+ YLHS +  H D+K  N++
Sbjct: 87  TDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIM 146
Query: 177 LSEMG----DVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGI 232
           L +       +K+ DFG+A  +      +N F GTP ++APE++       +AD+WS+G+
Sbjct: 147 LLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF-GTPEFVAPEIVNYEPLGLEADMWSIGV 205
Query: 233 TAIELAKGEPP---NSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPENRPT 289
               L  G  P   +++   +  +  +      +   N +   K+F+   L KDP+ R T
Sbjct: 206 ITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMT 265
Query: 290 AKELLKFPFIR 300
            ++ L+ P+I+
Sbjct: 266 IQDSLQHPWIK 276

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 82.8 bits (203), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 103/212 (48%), Gaps = 10/212 (4%)
Query: 121 WIIMEYLGGGSAL-DLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLL-- 177
           +++ + + GG    D++    + E   +  ++++L+ +++ H    +HRD+K  N+LL  
Sbjct: 79  YLVFDLVTGGELFEDIVAREYYSEADASHCIQQILESVNHCHLNGIVHRDLKPENLLLAS 138
Query: 178 -SEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIE 236
            S+   VKLADFG+A  +         F GTP +++PEV+++  Y    D+W+ G+    
Sbjct: 139 KSKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVLRKDPYGKPVDMWACGVILYI 198
Query: 237 LAKGEPPNSELHPMRVLFLI---PKNNPPQLTGNYTKQFKEFVEACLNKDPENRPTAKEL 293
           L  G PP  +    R+   I     + P       T + K+ +   L  +P  R TA E 
Sbjct: 199 LLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDLINKMLTINPAKRITASEA 258
Query: 294 LKFPFIRKAKKNAYLI---DLIDRYKKWKNSR 322
           LK P+I +    A ++   + +D  KK+   R
Sbjct: 259 LKHPWICQRSTVASMMHRQETVDCLKKFNARR 290

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 82.4 bits (202), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 66/248 (26%), Positives = 106/248 (42%), Gaps = 19/248 (7%)
Query: 64  RIGKGSFGEVFKGIDNRTQQVVXXXXXXXXXXXXXXXXXXXXXMVL--SQCDSPYGT--- 118
           ++G+G FGEV+ G  N T +V                        L   +    Y     
Sbjct: 191 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 250
Query: 119 -KLWIIMEYLGGGSALDLMKA--GNFEEM-HIAVILREVLKGLDYLHSERKLHRDIKAAN 174
             ++I+ EY+  GS LD +K   G +  +  +  +  ++  G+ Y+     +HRD++AAN
Sbjct: 251 EPIYIVGEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAAN 310
Query: 175 VLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPF-WMAPEVIKQSAYDSKADIWSLGIT 233
           +L+ E    K+ADFG+A  + +           P  W APE      +  K+D+WS GI 
Sbjct: 311 ILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGIL 370
Query: 234 AIEL-AKGEPPNSELHPMRVLFLIPKNN----PPQLTGNYTKQFKEFVEACLNKDPENRP 288
             EL  KG  P   +    VL  + +      PP+      +   + +  C  K+PE RP
Sbjct: 371 LTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPEC----PESLHDLMCQCWRKEPEERP 426
Query: 289 TAKELLKF 296
           T + L  F
Sbjct: 427 TFEYLQAF 434

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 82.4 bits (202), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 54/193 (27%), Positives = 94/193 (48%), Gaps = 12/193 (6%)
Query: 120 LWIIMEYLGGGSALDLMKAGN-----FEEMHIAVILREVLKGLDYLHSERKLHRDIKAAN 174
           ++I+ME   GG  L+ + +         E ++A ++++++  L Y HS+  +H+D+K  N
Sbjct: 95  MYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPEN 154
Query: 175 VLLSEM---GDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLG 231
           +L  +      +K+ DFG+A    +     N   GT  +MAPEV K+     K DIWS G
Sbjct: 155 ILFQDTSPHSPIKIIDFGLAELFKSDEHSTNA-AGTALYMAPEVFKRDV-TFKCDIWSAG 212
Query: 232 ITAIELAKGEPP--NSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPENRPT 289
           +    L  G  P   + L  ++      + N        T Q  + ++  L KDPE RP+
Sbjct: 213 VVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECRPLTPQAVDLLKQMLTKDPERRPS 272
Query: 290 AKELLKFPFIRKA 302
           A ++L   + ++A
Sbjct: 273 AAQVLHHEWFKQA 285

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 82.4 bits (202), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 66/248 (26%), Positives = 106/248 (42%), Gaps = 19/248 (7%)
Query: 64  RIGKGSFGEVFKGIDNRTQQVVXXXXXXXXXXXXXXXXXXXXXMVL--SQCDSPYGT--- 118
           ++G+G FGEV+ G  N T +V                        L   +    Y     
Sbjct: 18  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 77
Query: 119 -KLWIIMEYLGGGSALDLMKA--GNFEEM-HIAVILREVLKGLDYLHSERKLHRDIKAAN 174
             ++I+ EY+  GS LD +K   G +  +  +  +  ++  G+ Y+     +HRD++AAN
Sbjct: 78  EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAAN 137
Query: 175 VLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPF-WMAPEVIKQSAYDSKADIWSLGIT 233
           +L+ E    K+ADFG+A  + +           P  W APE      +  K+D+WS GI 
Sbjct: 138 ILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGIL 197
Query: 234 AIEL-AKGEPPNSELHPMRVLFLIPKNN----PPQLTGNYTKQFKEFVEACLNKDPENRP 288
             EL  KG  P   +    VL  + +      PP+      +   + +  C  K+PE RP
Sbjct: 198 LTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPEC----PESLHDLMCQCWRKEPEERP 253
Query: 289 TAKELLKF 296
           T + L  F
Sbjct: 254 TFEYLQAF 261

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 82.4 bits (202), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 49/148 (33%), Positives = 82/148 (55%), Gaps = 5/148 (3%)
Query: 152 EVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVG-TPF- 209
           ++ +G++YL S++ +HRD+ A NVL++E   +K+ADFG+A  + N    +NT  G  P  
Sbjct: 165 QLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKNTTNGRLPVK 224
Query: 210 WMAPEVIKQSAYDSKADIWSLGITAIEL-AKGEPPNSELHPMRVLF-LIPKNNPPQLTGN 267
           WMAPE +    Y  ++D+WS G+   E+   G  P   + P+  LF L+ + +      N
Sbjct: 225 WMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI-PVEELFKLLKEGHRMDKPAN 283
Query: 268 YTKQFKEFVEACLNKDPENRPTAKELLK 295
            T +    +  C +  P  RPT K+L++
Sbjct: 284 CTNELYMMMRDCWHAVPSQRPTFKQLVE 311

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 82.4 bits (202), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 52/191 (27%), Positives = 96/191 (50%), Gaps = 9/191 (4%)
Query: 118 TKLWIIMEYLGGGSALDLM-KAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVL 176
           T + +I+E + GG   D + +  +  E      L+++L G+ YLHS+R  H D+K  N++
Sbjct: 88  TDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIM 147
Query: 177 LSEMG----DVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGI 232
           L +       +KL DFG+A  +      +N F GTP ++APE++       +AD+WS+G+
Sbjct: 148 LLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIF-GTPEFVAPEIVNYEPLGLEADMWSIGV 206
Query: 233 TAIELAKGEPP---NSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPENRPT 289
               L  G  P    ++   +  +  +  +   +   N ++  K+F+   L KDP+ R  
Sbjct: 207 ITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSELAKDFIRRLLVKDPKRRMX 266
Query: 290 AKELLKFPFIR 300
             + L+  +I+
Sbjct: 267 IAQSLEHSWIK 277

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 82.4 bits (202), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 56/182 (30%), Positives = 81/182 (44%), Gaps = 31/182 (17%)
Query: 150 LREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPF 209
           L +++ G+ + HS   +HRDIK  N+L+S+ G VKL DFG A TL       +  V T +
Sbjct: 130 LFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRW 189
Query: 210 WMAPE-VIKQSAYDSKADIWSLGITAIELAKGEP-------PNSELHPMRVLF-LIPK-- 258
           + APE ++    Y    D+W++G    E+  GEP        +   H M  L  LIP+  
Sbjct: 190 YRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQ 249
Query: 259 ---NNPPQLTGNYTKQFKE-----------------FVEACLNKDPENRPTAKELLKFPF 298
              N  P   G    + KE                   + CL+ DP+ RP   ELL   F
Sbjct: 250 ELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDF 309
Query: 299 IR 300
            +
Sbjct: 310 FQ 311

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score = 82.4 bits (202), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 60/201 (29%), Positives = 90/201 (44%), Gaps = 20/201 (9%)
Query: 120 LWIIMEYLGGGSALDLMKAGN---FEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVL 176
           L I+ME L GG     ++      F E   + I++ + + + YLHS    HRD+K  N+L
Sbjct: 140 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLL 199
Query: 177 LSEM---GDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGIT 233
            +       +KL DFG A   T+  S   T   TP+++APEV+    YD   D+WSLG+ 
Sbjct: 200 YTSKRPNAILKLTDFGFAKETTSHNS-LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVI 258
Query: 234 AIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNY----------TKQFKEFVEACLNKD 283
              L  G PP    H    L + P        G Y          +++ K  +   L  +
Sbjct: 259 MYILLCGYPPFYSNHG---LAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTE 315
Query: 284 PENRPTAKELLKFPFIRKAKK 304
           P  R T  E +  P+I ++ K
Sbjct: 316 PTQRMTITEFMNHPWIMQSTK 336

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 82.0 bits (201), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 65/248 (26%), Positives = 106/248 (42%), Gaps = 19/248 (7%)
Query: 64  RIGKGSFGEVFKGIDNRTQQVVXXXXXXXXXXXXXXXXXXXXXMVL--SQCDSPYGT--- 118
           ++G+G FGEV+ G  N T +V                        L   +    Y     
Sbjct: 22  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 81
Query: 119 -KLWIIMEYLGGGSALDLMKAGNFEEMHIAVIL---REVLKGLDYLHSERKLHRDIKAAN 174
             ++I+ EY+  GS LD +K    + + +  ++    ++  G+ Y+     +HRD++AAN
Sbjct: 82  EPIYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVERMNYVHRDLRAAN 141
Query: 175 VLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPF-WMAPEVIKQSAYDSKADIWSLGIT 233
           +L+ E    K+ADFG+A  + +           P  W APE      +  K+D+WS GI 
Sbjct: 142 ILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGIL 201
Query: 234 AIEL-AKGEPPNSELHPMRVLFLIPKNN----PPQLTGNYTKQFKEFVEACLNKDPENRP 288
             EL  KG  P   +    VL  + +      PP+      +   + +  C  K+PE RP
Sbjct: 202 LTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPEC----PESLHDLMCQCWRKEPEERP 257
Query: 289 TAKELLKF 296
           T + L  F
Sbjct: 258 TFEYLQAF 265

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score = 82.0 bits (201), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 60/201 (29%), Positives = 90/201 (44%), Gaps = 20/201 (9%)
Query: 120 LWIIMEYLGGGSALDLMKAGN---FEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVL 176
           L I+ME L GG     ++      F E   + I++ + + + YLHS    HRD+K  N+L
Sbjct: 134 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLL 193
Query: 177 LSEM---GDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGIT 233
            +       +KL DFG A   T+  S   T   TP+++APEV+    YD   D+WSLG+ 
Sbjct: 194 YTSKRPNAILKLTDFGFAKETTSHNS-LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVI 252
Query: 234 AIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNY----------TKQFKEFVEACLNKD 283
              L  G PP    H    L + P        G Y          +++ K  +   L  +
Sbjct: 253 MYILLCGYPPFYSNHG---LAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTE 309
Query: 284 PENRPTAKELLKFPFIRKAKK 304
           P  R T  E +  P+I ++ K
Sbjct: 310 PTQRMTITEFMNHPWIMQSTK 330

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 82.0 bits (201), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 42/124 (33%), Positives = 66/124 (53%), Gaps = 4/124 (3%)
Query: 123 IMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGD 182
           ++ +L G     L+K  +    HI   L ++L+GL Y+HS   LHRD+K +N+LL+   D
Sbjct: 123 LVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTXD 182
Query: 183 VKLADFGVAGTLT---NTTSKRNTFVGTPFWMAPEVIKQS-AYDSKADIWSLGITAIELA 238
           +K+ DFG+A       + T     +V T ++ APE++  S  Y    DIWS+G    E+ 
Sbjct: 183 LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEML 242
Query: 239 KGEP 242
              P
Sbjct: 243 SNRP 246

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 82.0 bits (201), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 65/248 (26%), Positives = 106/248 (42%), Gaps = 19/248 (7%)
Query: 64  RIGKGSFGEVFKGIDNRTQQVVXXXXXXXXXXXXXXXXXXXXXMVL--SQCDSPYGT--- 118
           ++G+G FGEV+ G  N T +V                        L   +    Y     
Sbjct: 22  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 81
Query: 119 -KLWIIMEYLGGGSALDLMKAGNFEEMHIAVIL---REVLKGLDYLHSERKLHRDIKAAN 174
             ++I+ EY+  GS LD +K    + + +  ++    ++  G+ Y+     +HRD++AAN
Sbjct: 82  EPIYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVERMNYVHRDLRAAN 141
Query: 175 VLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPF-WMAPEVIKQSAYDSKADIWSLGIT 233
           +L+ E    K+ADFG+A  + +           P  W APE      +  K+D+WS GI 
Sbjct: 142 ILVGENLVCKVADFGLARLIEDNEWTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGIL 201
Query: 234 AIEL-AKGEPPNSELHPMRVLFLIPKNN----PPQLTGNYTKQFKEFVEACLNKDPENRP 288
             EL  KG  P   +    VL  + +      PP+      +   + +  C  K+PE RP
Sbjct: 202 LTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPEC----PESLHDLMCQCWRKEPEERP 257
Query: 289 TAKELLKF 296
           T + L  F
Sbjct: 258 TFEYLQAF 265

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score = 82.0 bits (201), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 60/201 (29%), Positives = 90/201 (44%), Gaps = 20/201 (9%)
Query: 120 LWIIMEYLGGGSALDLMKAGN---FEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVL 176
           L I+ME L GG     ++      F E   + I++ + + + YLHS    HRD+K  N+L
Sbjct: 96  LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLL 155
Query: 177 LSEM---GDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGIT 233
            +       +KL DFG A   T+  S   T   TP+++APEV+    YD   D+WSLG+ 
Sbjct: 156 YTSKRPNAILKLTDFGFAKETTSHNS-LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVI 214
Query: 234 AIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNY----------TKQFKEFVEACLNKD 283
              L  G PP    H    L + P        G Y          +++ K  +   L  +
Sbjct: 215 MYILLCGYPPFYSNHG---LAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTE 271
Query: 284 PENRPTAKELLKFPFIRKAKK 304
           P  R T  E +  P+I ++ K
Sbjct: 272 PTQRMTITEFMNHPWIMQSTK 292

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 82.0 bits (201), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 44/127 (34%), Positives = 76/127 (59%), Gaps = 3/127 (2%)
Query: 118 TKLWIIMEYLGGG--SALDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANV 175
           TKL ++ E++     + LD +         I  ++ ++L+GLD+LHS R +HRD+K  N+
Sbjct: 92  TKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNI 151
Query: 176 LLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAI 235
           L++  G +KLADFG+A   +   +  +  V T ++ APEV+ QS+Y +  D+WS+G    
Sbjct: 152 LVTSSGQIKLADFGLARIYSFQMALTSVVV-TLWYRAPEVLLQSSYATPVDLWSVGCIFA 210
Query: 236 ELAKGEP 242
           E+ + +P
Sbjct: 211 EMFRRKP 217

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 60/201 (29%), Positives = 90/201 (44%), Gaps = 20/201 (9%)
Query: 120 LWIIMEYLGGGSALDLMKAGN---FEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVL 176
           L I+ME L GG     ++      F E   + I++ + + + YLHS    HRD+K  N+L
Sbjct: 90  LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLL 149
Query: 177 LSEM---GDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGIT 233
            +       +KL DFG A   T+  S   T   TP+++APEV+    YD   D+WSLG+ 
Sbjct: 150 YTSKRPNAILKLTDFGFAKETTSHNS-LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVI 208
Query: 234 AIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNY----------TKQFKEFVEACLNKD 283
              L  G PP    H    L + P        G Y          +++ K  +   L  +
Sbjct: 209 MYILLCGYPPFYSNHG---LAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTE 265
Query: 284 PENRPTAKELLKFPFIRKAKK 304
           P  R T  E +  P+I ++ K
Sbjct: 266 PTQRMTITEFMNHPWIMQSTK 286

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 60/201 (29%), Positives = 90/201 (44%), Gaps = 20/201 (9%)
Query: 120 LWIIMEYLGGGSALDLMKAGN---FEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVL 176
           L I+ME L GG     ++      F E   + I++ + + + YLHS    HRD+K  N+L
Sbjct: 94  LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLL 153
Query: 177 LSEM---GDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGIT 233
            +       +KL DFG A   T+  S   T   TP+++APEV+    YD   D+WSLG+ 
Sbjct: 154 YTSKRPNAILKLTDFGFAKETTSHNS-LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVI 212
Query: 234 AIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNY----------TKQFKEFVEACLNKD 283
              L  G PP    H    L + P        G Y          +++ K  +   L  +
Sbjct: 213 MYILLCGYPPFYSNHG---LAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTE 269
Query: 284 PENRPTAKELLKFPFIRKAKK 304
           P  R T  E +  P+I ++ K
Sbjct: 270 PTQRMTITEFMNHPWIMQSTK 290

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 62/242 (25%), Positives = 104/242 (42%), Gaps = 12/242 (4%)
Query: 64  RIGKGSFGEVFKGIDNRTQQVVXXXXXXXXXXXXXXXXXXXXXMVLS--QCDSPYGTK-- 119
           R+G G FGEV+ G  N + +V                        L   +    Y     
Sbjct: 20  RLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTR 79
Query: 120 ---LWIIMEYLGGGSALDLMKAGNFEEMHIAVIL---REVLKGLDYLHSERKLHRDIKAA 173
              ++II EY+  GS LD +K+    ++ +  ++    ++ +G+ Y+  +  +HRD++AA
Sbjct: 80  EEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAA 139
Query: 174 NVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPF-WMAPEVIKQSAYDSKADIWSLGI 232
           NVL+SE    K+ADFG+A  + +           P  W APE I    +  K+D+WS GI
Sbjct: 140 NVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGCFTIKSDVWSFGI 199
Query: 233 TAIELAK-GEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPENRPTAK 291
              E+   G+ P        V+  + +        N   +  + ++ C  +  E RPT  
Sbjct: 200 LLYEIVTYGKIPYPGRTNADVMTALSQGYRMPRVENCPDELYDIMKMCWKEKAEERPTFD 259
Query: 292 EL 293
            L
Sbjct: 260 YL 261

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 73/277 (26%), Positives = 119/277 (42%), Gaps = 28/277 (10%)
Query: 41  GSTTASRRNSLKVDPELIFTKQERIGKGSFGEVFKGI----DNRTQQVVXXXXXXXXXXX 96
           GS  A  +  L++  E  F K + +G G+FG V+KG+      + +  V           
Sbjct: 1   GSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSP 60
Query: 97  XXXXXXXXXXMVLSQCDSPYGTKLW---------IIMEYLGGGSALDLMKA--GNFEEMH 145
                      V++  D+P+  +L          +IM+ +  G  LD ++    N    +
Sbjct: 61  KANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQY 120
Query: 146 IAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFV 205
           +     ++ KG++YL   R +HRD+ A NVL+     VK+ DFG+A  L     + +   
Sbjct: 121 LLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG 180
Query: 206 G-TPF-WMAPEVIKQSAYDSKADIWSLGITAIELAK-GEPPNSELHPMRVLFLIPKN--- 259
           G  P  WMA E I    Y  ++D+WS G+T  EL   G  P   +    +  ++ K    
Sbjct: 181 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL 240
Query: 260 -NPPQLTGN-YTKQFKEFVEACLNKDPENRPTAKELL 294
             PP  T + Y    K     C   D ++RP  +EL+
Sbjct: 241 PQPPICTIDVYMIMVK-----CWMIDADSRPKFRELI 272

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 60/201 (29%), Positives = 90/201 (44%), Gaps = 20/201 (9%)
Query: 120 LWIIMEYLGGGSALDLMKAGN---FEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVL 176
           L I+ME L GG     ++      F E   + I++ + + + YLHS    HRD+K  N+L
Sbjct: 104 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLL 163
Query: 177 LSEM---GDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGIT 233
            +       +KL DFG A   T+  S   T   TP+++APEV+    YD   D+WSLG+ 
Sbjct: 164 YTSKRPNAILKLTDFGFAKETTSHNS-LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVI 222
Query: 234 AIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNY----------TKQFKEFVEACLNKD 283
              L  G PP    H    L + P        G Y          +++ K  +   L  +
Sbjct: 223 MYILLCGYPPFYSNHG---LAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTE 279
Query: 284 PENRPTAKELLKFPFIRKAKK 304
           P  R T  E +  P+I ++ K
Sbjct: 280 PTQRMTITEFMNHPWIMQSTK 300

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 76/274 (27%), Positives = 128/274 (46%), Gaps = 32/274 (11%)
Query: 42  STTASRRNSLKVDP-ELIFTKQERIGKGSFGEVFKGIDNRTQQVVXXXXXXXXXXXXXXX 100
           ST      S ++DP +L F K+  +G G FG V  G       V                
Sbjct: 10  STAGLGYGSWEIDPKDLTFLKE--LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFI 67
Query: 101 XXXXXXMVLS--QCDSPYGTK-----LWIIMEYLGGGSALDLMKA--GNFEEMHIAVILR 151
                 M LS  +    YG       ++II EY+  G  L+ ++     F+   +  + +
Sbjct: 68  EEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCK 127
Query: 152 EVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPF-- 209
           +V + ++YL S++ LHRD+ A N L+++ G VK++DFG++  + +   +  + VG+ F  
Sbjct: 128 DVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD--DEETSSVGSKFPV 185
Query: 210 -WMAPEVIKQSAYDSKADIWSLGITAIEL-AKGEPP-----NSEL--HPMRVLFLIPKNN 260
            W  PEV+  S + SK+DIW+ G+   E+ + G+ P     NSE   H  + L L     
Sbjct: 186 RWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLY---- 241
Query: 261 PPQLTGNYTKQFKEFVEACLNKDPENRPTAKELL 294
            P L    +++    + +C ++  + RPT K LL
Sbjct: 242 RPHLA---SEKVYTIMYSCWHEKADERPTFKILL 272

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 60/201 (29%), Positives = 90/201 (44%), Gaps = 20/201 (9%)
Query: 120 LWIIMEYLGGGSALDLMKAGN---FEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVL 176
           L I+ME L GG     ++      F E   + I++ + + + YLHS    HRD+K  N+L
Sbjct: 88  LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLL 147
Query: 177 LSEM---GDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGIT 233
            +       +KL DFG A   T+  S   T   TP+++APEV+    YD   D+WSLG+ 
Sbjct: 148 YTSKRPNAILKLTDFGFAKETTSHNS-LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVI 206
Query: 234 AIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNY----------TKQFKEFVEACLNKD 283
              L  G PP    H    L + P        G Y          +++ K  +   L  +
Sbjct: 207 MYILLCGYPPFYSNHG---LAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTE 263
Query: 284 PENRPTAKELLKFPFIRKAKK 304
           P  R T  E +  P+I ++ K
Sbjct: 264 PTQRMTITEFMNHPWIMQSTK 284

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 48/130 (36%), Positives = 72/130 (55%), Gaps = 5/130 (3%)
Query: 118 TKLWIIMEYLGGGSALD-LMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVL 176
           T L I+MEY  GG   + +  AG F E       ++++ G+ Y H+ +  HRD+K  N L
Sbjct: 88  THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYAHAMQVAHRDLKLENTL 147
Query: 177 L--SEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSK-ADIWSLGIT 233
           L  S    +K+ADFG +   +   S+  + VGTP ++APEV+ +  YD K AD+WS G+T
Sbjct: 148 LDGSPAPRLKIADFGYSKA-SVLHSQPKSAVGTPAYIAPEVLLKKEYDGKVADVWSCGVT 206
Query: 234 AIELAKGEPP 243
              +  G  P
Sbjct: 207 LYVMLVGAYP 216

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 60/201 (29%), Positives = 90/201 (44%), Gaps = 20/201 (9%)
Query: 120 LWIIMEYLGGGSALDLMKAGN---FEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVL 176
           L I+ME L GG     ++      F E   + I++ + + + YLHS    HRD+K  N+L
Sbjct: 90  LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLL 149
Query: 177 LSEM---GDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGIT 233
            +       +KL DFG A   T+  S   T   TP+++APEV+    YD   D+WSLG+ 
Sbjct: 150 YTSKRPNAILKLTDFGFAKETTSHNS-LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVI 208
Query: 234 AIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNY----------TKQFKEFVEACLNKD 283
              L  G PP    H    L + P        G Y          +++ K  +   L  +
Sbjct: 209 MYILLCGYPPFYSNHG---LAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTE 265
Query: 284 PENRPTAKELLKFPFIRKAKK 304
           P  R T  E +  P+I ++ K
Sbjct: 266 PTQRMTITEFMNHPWIMQSTK 286

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 60/201 (29%), Positives = 90/201 (44%), Gaps = 20/201 (9%)
Query: 120 LWIIMEYLGGGSALDLMKAGN---FEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVL 176
           L I+ME L GG     ++      F E   + I++ + + + YLHS    HRD+K  N+L
Sbjct: 89  LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLL 148
Query: 177 LSEM---GDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGIT 233
            +       +KL DFG A   T+  S   T   TP+++APEV+    YD   D+WSLG+ 
Sbjct: 149 YTSKRPNAILKLTDFGFAKETTSHNS-LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVI 207
Query: 234 AIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNY----------TKQFKEFVEACLNKD 283
              L  G PP    H    L + P        G Y          +++ K  +   L  +
Sbjct: 208 MYILLCGYPPFYSNHG---LAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTE 264
Query: 284 PENRPTAKELLKFPFIRKAKK 304
           P  R T  E +  P+I ++ K
Sbjct: 265 PTQRMTITEFMNHPWIMQSTK 285

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 60/201 (29%), Positives = 90/201 (44%), Gaps = 20/201 (9%)
Query: 120 LWIIMEYLGGGSALDLMKAGN---FEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVL 176
           L I+ME L GG     ++      F E   + I++ + + + YLHS    HRD+K  N+L
Sbjct: 95  LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLL 154
Query: 177 LSEM---GDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGIT 233
            +       +KL DFG A   T+  S   T   TP+++APEV+    YD   D+WSLG+ 
Sbjct: 155 YTSKRPNAILKLTDFGFAKETTSHNS-LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVI 213
Query: 234 AIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNY----------TKQFKEFVEACLNKD 283
              L  G PP    H    L + P        G Y          +++ K  +   L  +
Sbjct: 214 MYILLCGYPPFYSNHG---LAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTE 270
Query: 284 PENRPTAKELLKFPFIRKAKK 304
           P  R T  E +  P+I ++ K
Sbjct: 271 PTQRMTITEFMNHPWIMQSTK 291

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 76/274 (27%), Positives = 128/274 (46%), Gaps = 32/274 (11%)
Query: 42  STTASRRNSLKVDP-ELIFTKQERIGKGSFGEVFKGIDNRTQQVVXXXXXXXXXXXXXXX 100
           ST      S ++DP +L F K+  +G G FG V  G       V                
Sbjct: 10  STAGLGYGSWEIDPKDLTFLKE--LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFI 67
Query: 101 XXXXXXMVLS--QCDSPYGTK-----LWIIMEYLGGGSALDLMKA--GNFEEMHIAVILR 151
                 M LS  +    YG       ++II EY+  G  L+ ++     F+   +  + +
Sbjct: 68  EEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCK 127
Query: 152 EVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPF-- 209
           +V + ++YL S++ LHRD+ A N L+++ G VK++DFG++  + +   +  + VG+ F  
Sbjct: 128 DVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD--DEYTSSVGSKFPV 185
Query: 210 -WMAPEVIKQSAYDSKADIWSLGITAIEL-AKGEPP-----NSEL--HPMRVLFLIPKNN 260
            W  PEV+  S + SK+DIW+ G+   E+ + G+ P     NSE   H  + L L     
Sbjct: 186 RWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLY---- 241
Query: 261 PPQLTGNYTKQFKEFVEACLNKDPENRPTAKELL 294
            P L    +++    + +C ++  + RPT K LL
Sbjct: 242 RPHLA---SEKVYTIMYSCWHEKADERPTFKILL 272

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 100/214 (46%), Gaps = 19/214 (8%)
Query: 59  FTKQERIGKGSFGEVFKGIDNRTQQVVXXXXXXXXXXXXXXXXXXXXXM-VLSQCDSP-- 115
           F K E+IG+G++G V+K  +  T +VV                     + +L + + P  
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 67
Query: 116 --------YGTKLWIIMEYLGGGSALDLMKAGNFEEMHIAVI---LREVLKGLDYLHSER 164
                      KL+++ E+L      D M A     + + +I   L ++L+GL + HS R
Sbjct: 68  VKLLDVIHTENKLYLVFEFLSMDLK-DFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 126
Query: 165 KLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSK 224
            LHRD+K  N+L++  G +KLADFG+A             V T ++ APE++    Y S 
Sbjct: 127 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYST 186
Query: 225 A-DIWSLGITAIELAKGE---PPNSELHPMRVLF 254
           A DIWSLG    E+       P +SE+  +  +F
Sbjct: 187 AVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIF 220

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 100/214 (46%), Gaps = 19/214 (8%)
Query: 59  FTKQERIGKGSFGEVFKGIDNRTQQVVXXXXXXXXXXXXXXXXXXXXXM-VLSQCDSP-- 115
           F K E+IG+G++G V+K  +  T +VV                     + +L + + P  
Sbjct: 7   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 66
Query: 116 --------YGTKLWIIMEYLGGGSALDLMKAGNFEEMHIAVI---LREVLKGLDYLHSER 164
                      KL+++ E+L      D M A     + + +I   L ++L+GL + HS R
Sbjct: 67  VKLLDVIHTENKLYLVFEFLSMDLK-DFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 125
Query: 165 KLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSK 224
            LHRD+K  N+L++  G +KLADFG+A             V T ++ APE++    Y S 
Sbjct: 126 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYST 185
Query: 225 A-DIWSLGITAIELAKGE---PPNSELHPMRVLF 254
           A DIWSLG    E+       P +SE+  +  +F
Sbjct: 186 AVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIF 219

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 44/127 (34%), Positives = 76/127 (59%), Gaps = 3/127 (2%)
Query: 118 TKLWIIMEYLGGG--SALDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANV 175
           TKL ++ E++     + LD +         I  ++ ++L+GLD+LHS R +HRD+K  N+
Sbjct: 92  TKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNI 151
Query: 176 LLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAI 235
           L++  G +KLADFG+A   +   +  +  V T ++ APEV+ QS+Y +  D+WS+G    
Sbjct: 152 LVTSSGQIKLADFGLARIYSFQMALTSVVV-TLWYRAPEVLLQSSYATPVDLWSVGCIFA 210
Query: 236 ELAKGEP 242
           E+ + +P
Sbjct: 211 EMFRRKP 217

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 37/94 (39%), Positives = 63/94 (67%), Gaps = 1/94 (1%)
Query: 149 ILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTP 208
           ++ ++L+GLD+LHS R +HRD+K  N+L++  G +KLADFG+A   +   +  +  V T 
Sbjct: 125 MMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVV-TL 183
Query: 209 FWMAPEVIKQSAYDSKADIWSLGITAIELAKGEP 242
           ++ APEV+ QS+Y +  D+WS+G    E+ + +P
Sbjct: 184 WYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKP 217

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 58/196 (29%), Positives = 90/196 (45%), Gaps = 15/196 (7%)
Query: 120 LWIIMEYLGGGSALD-LMKAGN--FEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVL 176
           L IIME + GG     + + G+  F E   A I+R++   + +LHS    HRD+K  N+L
Sbjct: 101 LLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLL 160
Query: 177 LSEM---GDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGIT 233
            +       +KL DFG A   T    +   +  TP+++APEV+    YD   D+WSLG+ 
Sbjct: 161 YTSKEKDAVLKLTDFGFAKETTQNALQTPCY--TPYYVAPEVLGPEKYDKSCDMWSLGVI 218
Query: 234 AIELAKGEPP-----NSELHP--MRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPEN 286
              L  G PP        + P   R + L     P       ++  K+ +   L  DP  
Sbjct: 219 MYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTE 278
Query: 287 RPTAKELLKFPFIRKA 302
           R T  + +  P+I ++
Sbjct: 279 RLTITQFMNHPWINQS 294

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 100/214 (46%), Gaps = 19/214 (8%)
Query: 59  FTKQERIGKGSFGEVFKGIDNRTQQVVXXXXXXXXXXXXXXXXXXXXXM-VLSQCDSP-- 115
           F K E+IG+G++G V+K  +  T +VV                     + +L + + P  
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 116 --------YGTKLWIIMEYLGGGSALDLMKAGNFEEMHIAVI---LREVLKGLDYLHSER 164
                      KL+++ E+L      D M A     + + +I   L ++L+GL + HS R
Sbjct: 65  VKLLDVIHTENKLYLVFEFLHQDLK-DFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 123
Query: 165 KLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSK 224
            LHRD+K  N+L++  G +KLADFG+A             V T ++ APE++    Y S 
Sbjct: 124 VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYST 183
Query: 225 A-DIWSLGITAIELAKGE---PPNSELHPMRVLF 254
           A DIWSLG    E+       P +SE+  +  +F
Sbjct: 184 AVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIF 217

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 71/276 (25%), Positives = 118/276 (42%), Gaps = 26/276 (9%)
Query: 41  GSTTASRRNSLKVDPELIFTKQERIGKGSFGEVFKGI----DNRTQQVVXXXXXXXXXXX 96
           GS  A  +  L++  E  F K + +G G+FG V+KG+      + +  V           
Sbjct: 1   GSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSP 60
Query: 97  XXXXXXXXXXMVLSQCDSPYGTKLW---------IIMEYLGGGSALDLMKA--GNFEEMH 145
                      V++  D+P+  +L          +IM+ +  G  LD ++    N    +
Sbjct: 61  KANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQY 120
Query: 146 IAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFV 205
           +     ++ KG++YL   R +HRD+ A NVL+     VK+ DFG A  L     + +   
Sbjct: 121 LLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEG 180
Query: 206 G-TPF-WMAPEVIKQSAYDSKADIWSLGITAIELAK-GEPPNSELHPMRVLFLIPKN--- 259
           G  P  WMA E I    Y  ++D+WS G+T  EL   G  P   +    +  ++ K    
Sbjct: 181 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL 240
Query: 260 -NPPQLTGNYTKQFKEFVEACLNKDPENRPTAKELL 294
             PP  T +     ++    C   D ++RP  +EL+
Sbjct: 241 PQPPICTIDVYMIMRK----CWMIDADSRPKFRELI 272

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 58/196 (29%), Positives = 90/196 (45%), Gaps = 15/196 (7%)
Query: 120 LWIIMEYLGGGSALD-LMKAGN--FEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVL 176
           L IIME + GG     + + G+  F E   A I+R++   + +LHS    HRD+K  N+L
Sbjct: 82  LLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLL 141
Query: 177 LSEM---GDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGIT 233
            +       +KL DFG A   T    +   +  TP+++APEV+    YD   D+WSLG+ 
Sbjct: 142 YTSKEKDAVLKLTDFGFAKETTQNALQTPCY--TPYYVAPEVLGPEKYDKSCDMWSLGVI 199
Query: 234 AIELAKGEPP-----NSELHP--MRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPEN 286
              L  G PP        + P   R + L     P       ++  K+ +   L  DP  
Sbjct: 200 MYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTE 259
Query: 287 RPTAKELLKFPFIRKA 302
           R T  + +  P+I ++
Sbjct: 260 RLTITQFMNHPWINQS 275

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 51/186 (27%), Positives = 91/186 (48%), Gaps = 7/186 (3%)
Query: 121 WIIMEYLGGGSAL-DLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLS- 178
           +++ + + GG    D++    + E   +  ++++L+ + + H    +HRD+K  N+LL+ 
Sbjct: 79  YLVFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRDLKPENLLLAS 138
Query: 179 --EMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIE 236
             +   VKLADFG+A  +         F GTP +++PEV+++ AY    DIW+ G+    
Sbjct: 139 KCKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVLRKEAYGKPVDIWACGVILYI 198
Query: 237 LAKGEPPNSELHPMRVLFLI---PKNNPPQLTGNYTKQFKEFVEACLNKDPENRPTAKEL 293
           L  G PP  +    ++   I     + P       T + K  +   L  +P  R TA E 
Sbjct: 199 LLVGYPPFWDEDQHKLYQQIKAGAYDFPSPEWDTVTPEAKNLINQMLTINPAKRITAHEA 258
Query: 294 LKFPFI 299
           LK P++
Sbjct: 259 LKHPWV 264

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 64/247 (25%), Positives = 104/247 (42%), Gaps = 17/247 (6%)
Query: 64  RIGKGSFGEVFKGIDNRTQQVVXXXXXXXXXXXXXXXXXXXXXMVLSQCDSPYGTKLW-- 121
           ++G+G FGEV+ G  N T +V                       V+ +       +L+  
Sbjct: 15  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQ---VMKKLRHEKLVQLYAV 71
Query: 122 -------IIMEYLGGGSALDLMKA--GNFEEM-HIAVILREVLKGLDYLHSERKLHRDIK 171
                  I+ EY+  GS LD +K   G +  +  +  +  ++  G+ Y+     +HRD++
Sbjct: 72  VSEEPIXIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLR 131
Query: 172 AANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPF-WMAPEVIKQSAYDSKADIWSL 230
           AAN+L+ E    K+ADFG+A  + +           P  W APE      +  K+D+WS 
Sbjct: 132 AANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGRFTIKSDVWSF 191
Query: 231 GITAIEL-AKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPENRPT 289
           GI   EL  KG  P   +    VL  + +           +   + +  C  K+PE RPT
Sbjct: 192 GILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPT 251
Query: 290 AKELLKF 296
            + L  F
Sbjct: 252 FEYLQAF 258

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 52/186 (27%), Positives = 91/186 (48%), Gaps = 7/186 (3%)
Query: 121 WIIMEYLGGGSAL-DLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLS- 178
           ++I + + GG    D++    + E   +  ++++L+ + + H    +HRD+K  N+LL+ 
Sbjct: 97  YLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRDLKPENLLLAS 156
Query: 179 --EMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIE 236
             +   VKLADFG+A  +         F GTP +++PEV+++  Y    D+W+ G+    
Sbjct: 157 KLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYI 216
Query: 237 LAKGEPPNSELHPMRVLFLI---PKNNPPQLTGNYTKQFKEFVEACLNKDPENRPTAKEL 293
           L  G PP  +    R+   I     + P       T + K+ +   L  +P  R TA E 
Sbjct: 217 LLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEA 276
Query: 294 LKFPFI 299
           LK P+I
Sbjct: 277 LKHPWI 282

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 52/191 (27%), Positives = 96/191 (50%), Gaps = 9/191 (4%)
Query: 118 TKLWIIMEYLGGGSALDLM-KAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVL 176
           T + +I E + GG   D + +  +  E      L+++L G+ YLHS +  H D+K  N++
Sbjct: 87  TDVILIGELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIM 146
Query: 177 LSEMG----DVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGI 232
           L +       +K+ DFG+A  +      +N F GTP ++APE++       +AD+WS+G+
Sbjct: 147 LLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF-GTPEFVAPEIVNYEPLGLEADMWSIGV 205
Query: 233 TAIELAKGEPP---NSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPENRPT 289
               L  G  P   +++   +  +  +      +   N +   K+F+   L KDP+ R T
Sbjct: 206 ITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMT 265
Query: 290 AKELLKFPFIR 300
            ++ L+ P+I+
Sbjct: 266 IQDSLQHPWIK 276

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/259 (23%), Positives = 112/259 (43%), Gaps = 23/259 (8%)
Query: 63  ERIGKGSFGEVFKGIDNRTQQVVXXXXXXXXXXXXXXXXXXXXXMVLSQCDSPYGTKLW- 121
           ER+G G FGEV+ G  N   +V                       ++ Q       +L+ 
Sbjct: 15  ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEAN---LMKQLQHQRLVRLYA 71
Query: 122 --------IIMEYLGGGSALDLMKAGNFEEMHIAVIL---REVLKGLDYLHSERKLHRDI 170
                   II EY+  GS +D +K  +  ++ I  +L    ++ +G+ ++     +HR++
Sbjct: 72  VVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRNL 131
Query: 171 KAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPF-WMAPEVIKQSAYDSKADIWS 229
           +AAN+L+S+    K+ADFG+A  + +           P  W APE I    +  K+D+WS
Sbjct: 132 RAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWS 191
Query: 230 LGITAIELA-KGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPENRP 288
            GI   E+   G  P   +    V+  + +        N  ++  + +  C  + PE+RP
Sbjct: 192 FGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRP 251
Query: 289 TAKELLKFPFIRKAKKNAY 307
           T      F ++R   ++ +
Sbjct: 252 T------FDYLRSVLEDFF 264

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 95/200 (47%), Gaps = 16/200 (8%)
Query: 116 YGTK--LWIIMEYLGGGSA---LDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDI 170
           Y TK  L +++  + GG     +  M    F E        E+  GL+ LH ER ++RD+
Sbjct: 253 YETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDL 312
Query: 171 KAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSL 230
           K  N+LL + G ++++D G+A  +    + +   VGT  +MAPEV+K   Y    D W+L
Sbjct: 313 KPENILLDDHGHIRISDLGLAVHVPEGQTIKGR-VGTVGYMAPEVVKNERYTFSPDWWAL 371
Query: 231 GITAIELAKGEPPNSE----LHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPEN 286
           G    E+  G+ P  +    +    V  L+ K  P + +  ++ Q +      L KDP  
Sbjct: 372 GCLLYEMIAGQSPFQQRKKKIKREEVERLV-KEVPEEYSERFSPQARSLCSQLLCKDPAE 430
Query: 287 R-----PTAKELLKFPFIRK 301
           R      +A+E+ + P  +K
Sbjct: 431 RLGCRGGSAREVKEHPLFKK 450

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 95/200 (47%), Gaps = 16/200 (8%)
Query: 116 YGTK--LWIIMEYLGGGSA---LDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDI 170
           Y TK  L +++  + GG     +  M    F E        E+  GL+ LH ER ++RD+
Sbjct: 253 YETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDL 312
Query: 171 KAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSL 230
           K  N+LL + G ++++D G+A  +    + +   VGT  +MAPEV+K   Y    D W+L
Sbjct: 313 KPENILLDDHGHIRISDLGLAVHVPEGQTIKGR-VGTVGYMAPEVVKNERYTFSPDWWAL 371
Query: 231 GITAIELAKGEPPNSE----LHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPEN 286
           G    E+  G+ P  +    +    V  L+ K  P + +  ++ Q +      L KDP  
Sbjct: 372 GCLLYEMIAGQSPFQQRKKKIKREEVERLV-KEVPEEYSERFSPQARSLCSQLLCKDPAE 430
Query: 287 R-----PTAKELLKFPFIRK 301
           R      +A+E+ + P  +K
Sbjct: 431 RLGCRGGSAREVKEHPLFKK 450

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 73/277 (26%), Positives = 118/277 (42%), Gaps = 28/277 (10%)
Query: 41  GSTTASRRNSLKVDPELIFTKQERIGKGSFGEVFKGI----DNRTQQVVXXXXXXXXXXX 96
           GS  A  +  L++  E  F K + +G G+FG V+KG+      + +  V           
Sbjct: 1   GSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSP 60
Query: 97  XXXXXXXXXXMVLSQCDSPYGTKLW---------IIMEYLGGGSALDLMKA--GNFEEMH 145
                      V++  D+P+  +L          +IM+ +  G  LD ++    N    +
Sbjct: 61  KANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQY 120
Query: 146 IAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFV 205
           +     ++ KG++YL   R +HRD+ A NVL+     VK+ DFG A  L     + +   
Sbjct: 121 LLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEG 180
Query: 206 G-TPF-WMAPEVIKQSAYDSKADIWSLGITAIELAK-GEPPNSELHPMRVLFLIPKN--- 259
           G  P  WMA E I    Y  ++D+WS G+T  EL   G  P   +    +  ++ K    
Sbjct: 181 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL 240
Query: 260 -NPPQLTGN-YTKQFKEFVEACLNKDPENRPTAKELL 294
             PP  T + Y    K     C   D ++RP  +EL+
Sbjct: 241 PQPPICTIDVYMIMVK-----CWMIDADSRPKFRELI 272

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 54/183 (29%), Positives = 92/183 (50%), Gaps = 17/183 (9%)
Query: 120 LWIIMEYLGGGSALDLMKAGNFEEMHIAVILR---EVLKGLDYLHSERKLHRDIKAANVL 176
           L+I ME+   G+    ++    E++   + L    ++ KG+DY+HS++ ++RD+K +N+ 
Sbjct: 95  LFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIF 154
Query: 177 LSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIE 236
           L +   VK+ DFG+  +L N   KR    GT  +M+PE I    Y  + D+++LG+   E
Sbjct: 155 LVDTKQVKIGDFGLVTSLKN-DGKRXRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAE 213
Query: 237 LAKGEPPNSELHPMRVLFLIPKNNPPQLTG----NYTKQFKEFVEACLNKDPENRPTAKE 292
           L         LH     F   K       G     + K+ K  ++  L+K PE+RP   E
Sbjct: 214 L---------LHVCDTAFETSKFFTDLRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSE 264
Query: 293 LLK 295
           +L+
Sbjct: 265 ILR 267

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 48/148 (32%), Positives = 81/148 (54%), Gaps = 5/148 (3%)
Query: 152 EVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVG-TPF- 209
           ++ +G++YL S++ +HRD+ A NVL++E   +K+ADFG+A  + N    + T  G  P  
Sbjct: 165 QLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTNGRLPVK 224
Query: 210 WMAPEVIKQSAYDSKADIWSLGITAIEL-AKGEPPNSELHPMRVLF-LIPKNNPPQLTGN 267
           WMAPE +    Y  ++D+WS G+   E+   G  P   + P+  LF L+ + +      N
Sbjct: 225 WMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI-PVEELFKLLKEGHRMDKPAN 283
Query: 268 YTKQFKEFVEACLNKDPENRPTAKELLK 295
            T +    +  C +  P  RPT K+L++
Sbjct: 284 CTNELYMMMRDCWHAVPSQRPTFKQLVE 311

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 49/186 (26%), Positives = 91/186 (48%), Gaps = 7/186 (3%)
Query: 121 WIIMEYLGGGSAL-DLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLS- 178
           +++ + + GG    D++    + E   +  + ++L+ ++++H    +HRD+K  N+LL+ 
Sbjct: 106 YLVFDLVTGGELFEDIVAREYYSEADASHCIHQILESVNHIHQHDIVHRDLKPENLLLAS 165
Query: 179 --EMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIE 236
             +   VKLADFG+A  +         F GTP +++PEV+++  Y    DIW+ G+    
Sbjct: 166 KCKGAAVKLADFGLAIEVQGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDIWACGVILYI 225
Query: 237 LAKGEPPNSELHPMRVLFLI---PKNNPPQLTGNYTKQFKEFVEACLNKDPENRPTAKEL 293
           L  G PP  +    ++   I     + P       T + K  +   L  +P  R TA + 
Sbjct: 226 LLVGYPPFWDEDQHKLYQQIKAGAYDFPSPEWDTVTPEAKNLINQMLTINPAKRITADQA 285
Query: 294 LKFPFI 299
           LK P++
Sbjct: 286 LKHPWV 291

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 50/193 (25%), Positives = 94/193 (48%), Gaps = 11/193 (5%)
Query: 120 LWIIMEYLGGGSALDLMKAGNFEEMHIAVIL---REVLKGLDYLHSERKLHRDIKAANVL 176
           ++II EY+  GS +D +K  +  ++ I  +L    ++ +G+ ++     +HRD++AAN+L
Sbjct: 82  IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANIL 141
Query: 177 LSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPF-WMAPEVIKQSAYDSKADIWSLGITAI 235
           +S+    K+ADFG+A  + +           P  W APE I    +  K+D+WS GI   
Sbjct: 142 VSDTLSCKIADFGLARLIEDAEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLT 201
Query: 236 ELA-KGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPENRPTAKELL 294
           E+   G  P   +    V+  + +        N  ++  + +  C  + PE+RPT     
Sbjct: 202 EIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPT----- 256
Query: 295 KFPFIRKAKKNAY 307
            F ++R   ++ +
Sbjct: 257 -FDYLRSVLEDFF 268

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 46/130 (35%), Positives = 71/130 (54%), Gaps = 5/130 (3%)
Query: 118 TKLWIIMEYLGGGSALD-LMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVL 176
           T L I+MEY  GG   + +  AG F E       ++++ G+ Y H+ +  HRD+K  N L
Sbjct: 88  THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTL 147
Query: 177 L--SEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSK-ADIWSLGIT 233
           L  S    +K+  FG + +    +  ++T VGTP ++APEV+ +  YD K AD+WS G+T
Sbjct: 148 LDGSPAPRLKICAFGYSKSSVLHSQPKDT-VGTPAYIAPEVLLKKEYDGKVADVWSCGVT 206
Query: 234 AIELAKGEPP 243
              +  G  P
Sbjct: 207 LYVMLVGAYP 216

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 74/254 (29%), Positives = 106/254 (41%), Gaps = 25/254 (9%)
Query: 59  FTKQERIGKGSFGEVFKGIDNRTQQVVXXXXXXXXXXXXXXXXXXXXXMVLSQCDSPYGT 118
            T Q R+G+GSFGEV +  D +T                         +  +   SP   
Sbjct: 76  MTHQPRVGRGSFGEVHRMKDKQT------GFQCAVKKVRLEVFRVEELVACAGLSSPRIV 129
Query: 119 KLW----------IIMEYLGGGSALDLMK-AGNFEEMHIAVILREVLKGLDYLHSERKLH 167
            L+          I ME L GGS   L+K  G   E      L + L+GL+YLH+ R LH
Sbjct: 130 PLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILH 189
Query: 168 RDIKAANVLLSEMGD-VKLADFGVAGTLTNTTSKRNTFV-----GTPFWMAPEVIKQSAY 221
            D+KA NVLLS  G    L DFG A  L      ++        GT   MAPEV+     
Sbjct: 190 GDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPC 249
Query: 222 DSKADIWSLGITAIELAKGEPPNSELH--PMRVLFLIPKNNPPQLTGNYTKQFKEFVEAC 279
           D+K DIWS     + +  G  P ++    P+ +          ++  +      + ++  
Sbjct: 250 DAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCAPLTAQAIQEG 309
Query: 280 LNKDPENRPTAKEL 293
           L K+P +R +A EL
Sbjct: 310 LRKEPVHRASAMEL 323

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 48/148 (32%), Positives = 81/148 (54%), Gaps = 5/148 (3%)
Query: 152 EVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVG-TPF- 209
           ++ +G++YL S++ +HRD+ A NVL++E   +K+ADFG+A  + N    + T  G  P  
Sbjct: 165 QLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTNGRLPVK 224
Query: 210 WMAPEVIKQSAYDSKADIWSLGITAIEL-AKGEPPNSELHPMRVLF-LIPKNNPPQLTGN 267
           WMAPE +    Y  ++D+WS G+   E+   G  P   + P+  LF L+ + +      N
Sbjct: 225 WMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI-PVEELFKLLKEGHRMDKPAN 283
Query: 268 YTKQFKEFVEACLNKDPENRPTAKELLK 295
            T +    +  C +  P  RPT K+L++
Sbjct: 284 CTNELYMMMRDCWHAVPSQRPTFKQLVE 311

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 74/254 (29%), Positives = 106/254 (41%), Gaps = 25/254 (9%)
Query: 59  FTKQERIGKGSFGEVFKGIDNRTQQVVXXXXXXXXXXXXXXXXXXXXXMVLSQCDSPYGT 118
            T Q R+G+GSFGEV +  D +T                         +  +   SP   
Sbjct: 60  MTHQPRVGRGSFGEVHRMKDKQT------GFQCAVKKVRLEVFRVEELVACAGLSSPRIV 113
Query: 119 KLW----------IIMEYLGGGSALDLMK-AGNFEEMHIAVILREVLKGLDYLHSERKLH 167
            L+          I ME L GGS   L+K  G   E      L + L+GL+YLH+ R LH
Sbjct: 114 PLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILH 173
Query: 168 RDIKAANVLLSEMGD-VKLADFGVAGTLTNTTSKRNTFV-----GTPFWMAPEVIKQSAY 221
            D+KA NVLLS  G    L DFG A  L      ++        GT   MAPEV+     
Sbjct: 174 GDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPC 233
Query: 222 DSKADIWSLGITAIELAKGEPPNSELH--PMRVLFLIPKNNPPQLTGNYTKQFKEFVEAC 279
           D+K DIWS     + +  G  P ++    P+ +          ++  +      + ++  
Sbjct: 234 DAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCAPLTAQAIQEG 293
Query: 280 LNKDPENRPTAKEL 293
           L K+P +R +A EL
Sbjct: 294 LRKEPVHRASAMEL 307

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 67/264 (25%), Positives = 112/264 (42%), Gaps = 36/264 (13%)
Query: 65  IGKGSFGEVFKGIDNRTQ-QVVXXXXXXXXXXXXXXXXXXXXXMVLSQCDSPYGTKLW-- 121
           IG+GSF  V+KG+D  T  +V                        L     P   + +  
Sbjct: 34  IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEXLKGLQHPNIVRFYDS 93
Query: 122 ------------IIMEYLGGGSALDLMKAGNFEEMHIAVI---LREVLKGLDYLHSERK- 165
                       ++ E    G+    +K   F+   I V+    R++LKGL +LH+    
Sbjct: 94  WESTVKGKKCIVLVTELXTSGTLKTYLK--RFKVXKIKVLRSWCRQILKGLQFLHTRTPP 151
Query: 166 -LHRDIKAANVLLSE-MGDVKLADFGVAGTLTNTTSKRNTF----VGTPFWMAPEVIKQS 219
            +HRD+K  N+ ++   G VK+ D G+A      T KR +F    +GTP + APE  ++ 
Sbjct: 152 IIHRDLKCDNIFITGPTGSVKIGDLGLA------TLKRASFAKAVIGTPEFXAPEXYEEK 205
Query: 220 AYDSKADIWSLGITAIELAKGEPPNSELHPMRVLF--LIPKNNPPQLTGNYTKQFKEFVE 277
            YD   D+++ G   +E A  E P SE      ++  +     P         + KE +E
Sbjct: 206 -YDESVDVYAFGXCXLEXATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIE 264
Query: 278 ACLNKDPENRPTAKELLKFPFIRK 301
            C+ ++ + R + K+LL   F ++
Sbjct: 265 GCIRQNKDERYSIKDLLNHAFFQE 288

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 89/201 (44%), Gaps = 20/201 (9%)
Query: 120 LWIIMEYLGGGSALDLMKAGN---FEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVL 176
           L I+ME L GG     ++      F E   + I++ + + + YLHS    HRD+K  N+L
Sbjct: 88  LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLL 147
Query: 177 LSEM---GDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGIT 233
            +       +KL DFG A   T+  S       TP+++APEV+    YD   D+WSLG+ 
Sbjct: 148 YTSKRPNAILKLTDFGFAKETTSHNSLTEP-CYTPYYVAPEVLGPEKYDKSCDMWSLGVI 206
Query: 234 AIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNY----------TKQFKEFVEACLNKD 283
              L  G PP    H    L + P        G Y          +++ K  +   L  +
Sbjct: 207 MYILLCGYPPFYSNHG---LAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTE 263
Query: 284 PENRPTAKELLKFPFIRKAKK 304
           P  R T  E +  P+I ++ K
Sbjct: 264 PTQRMTITEFMNHPWIMQSTK 284

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 48/148 (32%), Positives = 81/148 (54%), Gaps = 5/148 (3%)
Query: 152 EVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVG-TPF- 209
           ++ +G++YL S++ +HRD+ A NVL++E   +K+ADFG+A  + N    + T  G  P  
Sbjct: 154 QLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVK 213
Query: 210 WMAPEVIKQSAYDSKADIWSLGITAIEL-AKGEPPNSELHPMRVLF-LIPKNNPPQLTGN 267
           WMAPE +    Y  ++D+WS G+   E+   G  P   + P+  LF L+ + +      N
Sbjct: 214 WMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI-PVEELFKLLKEGHRMDKPAN 272
Query: 268 YTKQFKEFVEACLNKDPENRPTAKELLK 295
            T +    +  C +  P  RPT K+L++
Sbjct: 273 CTNELYMMMRDCWHAVPSQRPTFKQLVE 300

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 80.1 bits (196), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 48/148 (32%), Positives = 81/148 (54%), Gaps = 5/148 (3%)
Query: 152 EVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVG-TPF- 209
           ++ +G++YL S++ +HRD+ A NVL++E   +K+ADFG+A  + N    + T  G  P  
Sbjct: 165 QLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVK 224
Query: 210 WMAPEVIKQSAYDSKADIWSLGITAIEL-AKGEPPNSELHPMRVLF-LIPKNNPPQLTGN 267
           WMAPE +    Y  ++D+WS G+   E+   G  P   + P+  LF L+ + +      N
Sbjct: 225 WMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI-PVEELFKLLKEGHRMDKPAN 283
Query: 268 YTKQFKEFVEACLNKDPENRPTAKELLK 295
            T +    +  C +  P  RPT K+L++
Sbjct: 284 CTNELYMMMRDCWHAVPSQRPTFKQLVE 311

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 80.1 bits (196), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 48/148 (32%), Positives = 81/148 (54%), Gaps = 5/148 (3%)
Query: 152 EVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVG-TPF- 209
           ++ +G++YL S++ +HRD+ A NVL++E   +K+ADFG+A  + N    + T  G  P  
Sbjct: 157 QLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVK 216
Query: 210 WMAPEVIKQSAYDSKADIWSLGITAIEL-AKGEPPNSELHPMRVLF-LIPKNNPPQLTGN 267
           WMAPE +    Y  ++D+WS G+   E+   G  P   + P+  LF L+ + +      N
Sbjct: 217 WMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI-PVEELFKLLKEGHRMDKPAN 275
Query: 268 YTKQFKEFVEACLNKDPENRPTAKELLK 295
            T +    +  C +  P  RPT K+L++
Sbjct: 276 CTNELYMMMRDCWHAVPSQRPTFKQLVE 303

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 48/148 (32%), Positives = 81/148 (54%), Gaps = 5/148 (3%)
Query: 152 EVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVG-TPF- 209
           ++ +G++YL S++ +HRD+ A NVL++E   +K+ADFG+A  + N    + T  G  P  
Sbjct: 152 QLARGMEYLASQKCIHRDLTARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVK 211
Query: 210 WMAPEVIKQSAYDSKADIWSLGITAIEL-AKGEPPNSELHPMRVLF-LIPKNNPPQLTGN 267
           WMAPE +    Y  ++D+WS G+   E+   G  P   + P+  LF L+ + +      N
Sbjct: 212 WMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI-PVEELFKLLKEGHRMDKPAN 270
Query: 268 YTKQFKEFVEACLNKDPENRPTAKELLK 295
            T +    +  C +  P  RPT K+L++
Sbjct: 271 CTNELYMMMRDCWHAVPSQRPTFKQLVE 298

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 48/148 (32%), Positives = 81/148 (54%), Gaps = 5/148 (3%)
Query: 152 EVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVG-TPF- 209
           ++ +G++YL S++ +HRD+ A NVL++E   +K+ADFG+A  + N    + T  G  P  
Sbjct: 165 QLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVK 224
Query: 210 WMAPEVIKQSAYDSKADIWSLGITAIEL-AKGEPPNSELHPMRVLF-LIPKNNPPQLTGN 267
           WMAPE +    Y  ++D+WS G+   E+   G  P   + P+  LF L+ + +      N
Sbjct: 225 WMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI-PVEELFKLLKEGHRMDKPAN 283
Query: 268 YTKQFKEFVEACLNKDPENRPTAKELLK 295
            T +    +  C +  P  RPT K+L++
Sbjct: 284 CTNELYMMMRDCWHAVPSQRPTFKQLVE 311

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 48/148 (32%), Positives = 81/148 (54%), Gaps = 5/148 (3%)
Query: 152 EVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVG-TPF- 209
           ++ +G++YL S++ +HRD+ A NVL++E   +K+ADFG+A  + N    + T  G  P  
Sbjct: 165 QLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVK 224
Query: 210 WMAPEVIKQSAYDSKADIWSLGITAIEL-AKGEPPNSELHPMRVLF-LIPKNNPPQLTGN 267
           WMAPE +    Y  ++D+WS G+   E+   G  P   + P+  LF L+ + +      N
Sbjct: 225 WMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI-PVEELFKLLKEGHRMDKPAN 283
Query: 268 YTKQFKEFVEACLNKDPENRPTAKELLK 295
            T +    +  C +  P  RPT K+L++
Sbjct: 284 CTNELYMMMRDCWHAVPSQRPTFKQLVE 311

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 74/266 (27%), Positives = 126/266 (47%), Gaps = 32/266 (12%)
Query: 50  SLKVDP-ELIFTKQERIGKGSFGEVFKGIDNRTQQVVXXXXXXXXXXXXXXXXXXXXXMV 108
           S ++DP +L F K+  +G G FG V  G       V                      M 
Sbjct: 2   SWEIDPKDLTFLKE--LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMN 59
Query: 109 LS--QCDSPYGTK-----LWIIMEYLGGGSALDLMKA--GNFEEMHIAVILREVLKGLDY 159
           LS  +    YG       ++II EY+  G  L+ ++     F+   +  + ++V + ++Y
Sbjct: 60  LSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEY 119
Query: 160 LHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPF---WMAPEVI 216
           L S++ LHRD+ A N L+++ G VK++DFG++  + +   +  + VG+ F   W  PEV+
Sbjct: 120 LESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD--DEYTSSVGSKFPVRWSPPEVL 177
Query: 217 KQSAYDSKADIWSLGITAIEL-AKGEPP-----NSEL--HPMRVLFLIPKNNPPQLTGNY 268
             S + SK+DIW+ G+   E+ + G+ P     NSE   H  + L L      P L    
Sbjct: 178 MYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLY----RPHLA--- 230
Query: 269 TKQFKEFVEACLNKDPENRPTAKELL 294
           +++    + +C ++  + RPT K LL
Sbjct: 231 SEKVYTIMYSCWHEKADERPTFKILL 256

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 46/130 (35%), Positives = 71/130 (54%), Gaps = 5/130 (3%)
Query: 118 TKLWIIMEYLGGGSALD-LMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVL 176
           T L I+MEY  GG   + +  AG F E       ++++ G+ Y H+ +  HRD+K  N L
Sbjct: 88  THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTL 147
Query: 177 L--SEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSK-ADIWSLGIT 233
           L  S    +K+  FG + +    +  ++T VGTP ++APEV+ +  YD K AD+WS G+T
Sbjct: 148 LDGSPAPRLKICAFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEYDGKVADVWSCGVT 206
Query: 234 AIELAKGEPP 243
              +  G  P
Sbjct: 207 LYVMLVGAYP 216

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 48/148 (32%), Positives = 81/148 (54%), Gaps = 5/148 (3%)
Query: 152 EVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVG-TPF- 209
           ++ +G++YL S++ +HRD+ A NVL++E   +K+ADFG+A  + N    + T  G  P  
Sbjct: 165 QLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVK 224
Query: 210 WMAPEVIKQSAYDSKADIWSLGITAIEL-AKGEPPNSELHPMRVLF-LIPKNNPPQLTGN 267
           WMAPE +    Y  ++D+WS G+   E+   G  P   + P+  LF L+ + +      N
Sbjct: 225 WMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI-PVEELFKLLKEGHRMDKPAN 283
Query: 268 YTKQFKEFVEACLNKDPENRPTAKELLK 295
            T +    +  C +  P  RPT K+L++
Sbjct: 284 CTNELYMMMRDCWHAVPSQRPTFKQLVE 311

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 103/217 (47%), Gaps = 25/217 (11%)
Query: 59  FTKQERIGKGSFGEVFKGIDNRTQQVVXXXXXXXXXXXXXXXXXXXXXM-VLSQCDSP-- 115
           F K E+IG+G++G V+K  +  T +VV                     + +L + + P  
Sbjct: 6   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 65
Query: 116 --------YGTKLWIIMEYLGGGSALDL---MKAGNFEEMHIAVI---LREVLKGLDYLH 161
                      KL+++ E+L    ++DL   M A     + + +I   L ++L+GL + H
Sbjct: 66  VKLLDVIHTENKLYLVFEFL----SMDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 121
Query: 162 SERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAY 221
           S R LHRD+K  N+L++  G +KLADFG+A             V T ++ APE++    Y
Sbjct: 122 SHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKY 181
Query: 222 DSKA-DIWSLGITAIELAKGE---PPNSELHPMRVLF 254
            S A DIWSLG    E+       P +SE+  +  +F
Sbjct: 182 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIF 218

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 48/148 (32%), Positives = 81/148 (54%), Gaps = 5/148 (3%)
Query: 152 EVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVG-TPF- 209
           ++ +G++YL S++ +HRD+ A NVL++E   +K+ADFG+A  + N    + T  G  P  
Sbjct: 211 QLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVK 270
Query: 210 WMAPEVIKQSAYDSKADIWSLGITAIEL-AKGEPPNSELHPMRVLF-LIPKNNPPQLTGN 267
           WMAPE +    Y  ++D+WS G+   E+   G  P   + P+  LF L+ + +      N
Sbjct: 271 WMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI-PVEELFKLLKEGHRMDKPAN 329
Query: 268 YTKQFKEFVEACLNKDPENRPTAKELLK 295
            T +    +  C +  P  RPT K+L++
Sbjct: 330 CTNELYMMMRDCWHAVPSQRPTFKQLVE 357

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 103/217 (47%), Gaps = 25/217 (11%)
Query: 59  FTKQERIGKGSFGEVFKGIDNRTQQVVXXXXXXXXXXXXXXXXXXXXXM-VLSQCDSP-- 115
           F K E+IG+G++G V+K  +  T +VV                     + +L + + P  
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 67
Query: 116 --------YGTKLWIIMEYLGGGSALDL---MKAGNFEEMHIAVI---LREVLKGLDYLH 161
                      KL+++ E+L    ++DL   M A     + + +I   L ++L+GL + H
Sbjct: 68  VKLLDVIHTENKLYLVFEFL----SMDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 123
Query: 162 SERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAY 221
           S R LHRD+K  N+L++  G +KLADFG+A             V T ++ APE++    Y
Sbjct: 124 SHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKY 183
Query: 222 DSKA-DIWSLGITAIELAKGE---PPNSELHPMRVLF 254
            S A DIWSLG    E+       P +SE+  +  +F
Sbjct: 184 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIF 220

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 48/148 (32%), Positives = 81/148 (54%), Gaps = 5/148 (3%)
Query: 152 EVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVG-TPF- 209
           ++ +G++YL S++ +HRD+ A NVL++E   +K+ADFG+A  + N    + T  G  P  
Sbjct: 165 QLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVK 224
Query: 210 WMAPEVIKQSAYDSKADIWSLGITAIEL-AKGEPPNSELHPMRVLF-LIPKNNPPQLTGN 267
           WMAPE +    Y  ++D+WS G+   E+   G  P   + P+  LF L+ + +      N
Sbjct: 225 WMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI-PVEELFKLLKEGHRMDKPAN 283
Query: 268 YTKQFKEFVEACLNKDPENRPTAKELLK 295
            T +    +  C +  P  RPT K+L++
Sbjct: 284 CTNELYMMMRDCWHAVPSQRPTFKQLVE 311

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 74/268 (27%), Positives = 112/268 (41%), Gaps = 43/268 (16%)
Query: 47  RRNSLKVDPELIFTKQERIGKGSFGEVFKGIDN-RTQQV-VXXXXXXXXXXXXXXXXXXX 104
           R N L  D EL        G G+FG V +G+   R +Q+ V                   
Sbjct: 8   RDNLLIADIEL--------GCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMR 59
Query: 105 XXMVLSQCDSPYGTKL---------WIIMEYLGGGSALDLMKAGNFEEM---HIAVILRE 152
              ++ Q D+PY  +L          ++ME  GGG  L     G  EE+   ++A +L +
Sbjct: 60  EAQIMHQLDNPYIVRLIGVCQAEALMLVMEMAGGGP-LHKFLVGKREEIPVSNVAELLHQ 118
Query: 153 VLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPF--- 209
           V  G+ YL  +  +HRD+ A NVLL      K++DFG++  L    S         +   
Sbjct: 119 VSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLK 178
Query: 210 WMAPEVIKQSAYDSKADIWSLGITAIE-LAKGEPPNSELHPMRVLFLI--------PKNN 260
           W APE I    + S++D+WS G+T  E L+ G+ P  ++    V+  I        P   
Sbjct: 179 WYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPEC 238
Query: 261 PPQLTGNYTKQFKEFVEACLNKDPENRP 288
           PP+L           +  C     E+RP
Sbjct: 239 PPELYA--------LMSDCWIYKWEDRP 258

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 72/276 (26%), Positives = 118/276 (42%), Gaps = 28/276 (10%)
Query: 42  STTASRRNSLKVDPELIFTKQERIGKGSFGEVFKGI----DNRTQQVVXXXXXXXXXXXX 97
           S  A  +  L++  E  F K + +G G+FG V+KG+      + +  V            
Sbjct: 1   SGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPK 60
Query: 98  XXXXXXXXXMVLSQCDSPYGTKLW---------IIMEYLGGGSALDLMKA--GNFEEMHI 146
                     V++  D+P+  +L          +IM+ +  G  LD ++    N    ++
Sbjct: 61  ANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYL 120
Query: 147 AVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVG 206
                ++ KG++YL   R +HRD+ A NVL+     VK+ DFG+A  L     + +   G
Sbjct: 121 LNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 180
Query: 207 -TPF-WMAPEVIKQSAYDSKADIWSLGITAIELAK-GEPPNSELHPMRVLFLIPKN---- 259
             P  WMA E I    Y  ++D+WS G+T  EL   G  P   +    +  ++ K     
Sbjct: 181 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLP 240
Query: 260 NPPQLTGN-YTKQFKEFVEACLNKDPENRPTAKELL 294
            PP  T + Y    K     C   D ++RP  +EL+
Sbjct: 241 QPPICTIDVYMIMVK-----CWMIDADSRPKFRELI 271

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 56/188 (29%), Positives = 102/188 (54%), Gaps = 22/188 (11%)
Query: 120 LWIIMEYLGGGSALDLMKA--GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLL 177
           ++II EY+  G  L+ ++     F+   +  + ++V + ++YL S++ LHRD+ A N L+
Sbjct: 74  IFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLV 133
Query: 178 SEMGDVKLADFGVAGTLTNTTSKRNTFVGTPF---WMAPEVIKQSAYDSKADIWSLGITA 234
           ++ G VK++DFG++  + +   +  + VG+ F   W  PEV+  S + SK+DIW+ G+  
Sbjct: 134 NDQGVVKVSDFGLSRYVLD--DEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLM 191
Query: 235 IEL-AKGEPP-----NSEL--HPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPEN 286
            E+ + G+ P     NSE   H  + L L      P L    +++    + +C ++  + 
Sbjct: 192 WEIYSLGKMPYERFTNSETAEHIAQGLRLY----RPHLA---SEKVYTIMYSCWHEKADE 244
Query: 287 RPTAKELL 294
           RPT K LL
Sbjct: 245 RPTFKILL 252

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 79.7 bits (195), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 72/276 (26%), Positives = 118/276 (42%), Gaps = 28/276 (10%)
Query: 42  STTASRRNSLKVDPELIFTKQERIGKGSFGEVFKGI----DNRTQQVVXXXXXXXXXXXX 97
           S  A  +  L++  E  F K + +G G+FG V+KG+      + +  V            
Sbjct: 4   SGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPK 63
Query: 98  XXXXXXXXXMVLSQCDSPYGTKLW---------IIMEYLGGGSALDLMKA--GNFEEMHI 146
                     V++  D+P+  +L          +IM+ +  G  LD ++    N    ++
Sbjct: 64  ANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYL 123
Query: 147 AVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVG 206
                ++ KG++YL   R +HRD+ A NVL+     VK+ DFG+A  L     + +   G
Sbjct: 124 LNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 183
Query: 207 -TPF-WMAPEVIKQSAYDSKADIWSLGITAIELAK-GEPPNSELHPMRVLFLIPKN---- 259
             P  WMA E I    Y  ++D+WS G+T  EL   G  P   +    +  ++ K     
Sbjct: 184 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLP 243
Query: 260 NPPQLTGN-YTKQFKEFVEACLNKDPENRPTAKELL 294
            PP  T + Y    K     C   D ++RP  +EL+
Sbjct: 244 QPPICTIDVYMIMVK-----CWMIDADSRPKFRELI 274

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 79.7 bits (195), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 44/126 (34%), Positives = 74/126 (58%), Gaps = 3/126 (2%)
Query: 119 KLWIIMEYLGGGSAL-DLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLL 177
           ++++I+EY   G    +L K+  F+E   A I+ E+   L Y H ++ +HRDIK  N+LL
Sbjct: 97  RIYLILEYAPRGELYKELQKSCTFDEQRTATIMEELADALMYCHGKKVIHRDIKPENLLL 156
Query: 178 SEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIEL 237
              G++K+ADFG   ++   + +R T  GT  ++ PE+I+   ++ K D+W +G+   EL
Sbjct: 157 GLKGELKIADFG--WSVHAPSLRRKTMCGTLDYLPPEMIEGRMHNEKVDLWCIGVLCYEL 214
Query: 238 AKGEPP 243
             G PP
Sbjct: 215 LVGNPP 220

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 79.7 bits (195), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 76/254 (29%), Positives = 107/254 (42%), Gaps = 25/254 (9%)
Query: 59  FTKQERIGKGSFGEVFKGIDNRTQQVVXXXXXXXXXXXXXXXXXXXXXMVLSQCDSP--- 115
            T Q R+G+GSFGEV +  D +T                         +  +   SP   
Sbjct: 74  MTHQPRLGRGSFGEVHRMKDKQT------GFQCAVKKVRLEVFRVEELVACAGLSSPRIV 127
Query: 116 --YGTKL---W--IIMEYLGGGSALDLMK-AGNFEEMHIAVILREVLKGLDYLHSERKLH 167
             YG      W  I ME L GGS   L+K  G   E      L + L+GL+YLH+ R LH
Sbjct: 128 PLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILH 187
Query: 168 RDIKAANVLLSEMGD-VKLADFGVAGTLTNTTSKRNTFV-----GTPFWMAPEVIKQSAY 221
            D+KA NVLLS  G    L DFG A  L      ++        GT   MAPEV+     
Sbjct: 188 GDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPC 247
Query: 222 DSKADIWSLGITAIELAKGEPPNSELH--PMRVLFLIPKNNPPQLTGNYTKQFKEFVEAC 279
           D+K DIWS     + +  G  P ++    P+ +          ++  +      + ++  
Sbjct: 248 DAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCAPLTAQAIQEG 307
Query: 280 LNKDPENRPTAKEL 293
           L K+P +R +A EL
Sbjct: 308 LRKEPVHRASAMEL 321

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 79.7 bits (195), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 74/266 (27%), Positives = 126/266 (47%), Gaps = 32/266 (12%)
Query: 50  SLKVDP-ELIFTKQERIGKGSFGEVFKGIDNRTQQVVXXXXXXXXXXXXXXXXXXXXXMV 108
           S ++DP +L F K+  +G G FG V  G       V                      M 
Sbjct: 3   SWEIDPKDLTFLKE--LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMN 60
Query: 109 LS--QCDSPYGTK-----LWIIMEYLGGGSALDLMKA--GNFEEMHIAVILREVLKGLDY 159
           LS  +    YG       ++II EY+  G  L+ ++     F+   +  + ++V + ++Y
Sbjct: 61  LSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEY 120
Query: 160 LHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPF---WMAPEVI 216
           L S++ LHRD+ A N L+++ G VK++DFG++  + +   +  + VG+ F   W  PEV+
Sbjct: 121 LESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD--DEYTSSVGSKFPVRWSPPEVL 178
Query: 217 KQSAYDSKADIWSLGITAIEL-AKGEPP-----NSEL--HPMRVLFLIPKNNPPQLTGNY 268
             S + SK+DIW+ G+   E+ + G+ P     NSE   H  + L L      P L    
Sbjct: 179 MYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLY----RPHLA--- 231
Query: 269 TKQFKEFVEACLNKDPENRPTAKELL 294
           +++    + +C ++  + RPT K LL
Sbjct: 232 SEKVYTIMYSCWHEKADERPTFKILL 257

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 74/267 (27%), Positives = 126/267 (47%), Gaps = 32/267 (11%)
Query: 49  NSLKVDP-ELIFTKQERIGKGSFGEVFKGIDNRTQQVVXXXXXXXXXXXXXXXXXXXXXM 107
            S ++DP +L F K+  +G G FG V  G       V                      M
Sbjct: 8   GSWEIDPKDLTFLKE--LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMM 65
Query: 108 VLS--QCDSPYGTK-----LWIIMEYLGGGSALDLMKA--GNFEEMHIAVILREVLKGLD 158
            LS  +    YG       ++II EY+  G  L+ ++     F+   +  + ++V + ++
Sbjct: 66  NLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAME 125
Query: 159 YLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPF---WMAPEV 215
           YL S++ LHRD+ A N L+++ G VK++DFG++  + +   +  + VG+ F   W  PEV
Sbjct: 126 YLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD--DEYTSSVGSKFPVRWSPPEV 183
Query: 216 IKQSAYDSKADIWSLGITAIEL-AKGEPP-----NSEL--HPMRVLFLIPKNNPPQLTGN 267
           +  S + SK+DIW+ G+   E+ + G+ P     NSE   H  + L L      P L   
Sbjct: 184 LMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLY----RPHLA-- 237
Query: 268 YTKQFKEFVEACLNKDPENRPTAKELL 294
            +++    + +C ++  + RPT K LL
Sbjct: 238 -SEKVYTIMYSCWHEKADERPTFKILL 263

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 108/216 (50%), Gaps = 34/216 (15%)
Query: 119 KLWIIMEYLGGGSALD-LMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLL 177
           + +++ E + GGS L  + K  +F E+  +V++++V   LD+LH++   HRD+K  N+L 
Sbjct: 85  RFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILC 144
Query: 178 ---SEMGDVKLADFGV-AGTLTN------TTSKRNTFVGTPFWMAPEVI-----KQSAYD 222
              +++  VK+ DFG+ +G   N      +T +  T  G+  +MAPEV+     + S YD
Sbjct: 145 EHPNQVSPVKICDFGLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYD 204
Query: 223 SKADIWSLGITAIELAKGEPP------------NSELHP--MRVLFLIPKNN----PPQL 264
            + D+WSLG+    L  G PP              E  P    +LF   +      P + 
Sbjct: 205 KRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKD 264
Query: 265 TGNYTKQFKEFVEACLNKDPENRPTAKELLKFPFIR 300
             + +   K+ +   L +D + R +A ++L+ P+++
Sbjct: 265 WAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQ 300

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 79.3 bits (194), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 72/277 (25%), Positives = 118/277 (42%), Gaps = 28/277 (10%)
Query: 41  GSTTASRRNSLKVDPELIFTKQERIGKGSFGEVFKGI----DNRTQQVVXXXXXXXXXXX 96
           GS  A  +  L++  E  F K + +G G+FG V+KG+      + +  V           
Sbjct: 1   GSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSP 60
Query: 97  XXXXXXXXXXMVLSQCDSPYGTKLW---------IIMEYLGGGSALDLMKA--GNFEEMH 145
                      V++  D+P+  +L          +I + +  G  LD ++    N    +
Sbjct: 61  KANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQY 120
Query: 146 IAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFV 205
           +     ++ KG++YL   R +HRD+ A NVL+     VK+ DFG+A  L     + +   
Sbjct: 121 LLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG 180
Query: 206 G-TPF-WMAPEVIKQSAYDSKADIWSLGITAIELAK-GEPPNSELHPMRVLFLIPKN--- 259
           G  P  WMA E I    Y  ++D+WS G+T  EL   G  P   +    +  ++ K    
Sbjct: 181 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL 240
Query: 260 -NPPQLTGN-YTKQFKEFVEACLNKDPENRPTAKELL 294
             PP  T + Y    K     C   D ++RP  +EL+
Sbjct: 241 PQPPICTIDVYMIMVK-----CWMIDADSRPKFRELI 272

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 79.3 bits (194), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 72/277 (25%), Positives = 118/277 (42%), Gaps = 28/277 (10%)
Query: 41  GSTTASRRNSLKVDPELIFTKQERIGKGSFGEVFKGI----DNRTQQVVXXXXXXXXXXX 96
           GS  A  +  L++  E  F K + +G G+FG V+KG+      + +  V           
Sbjct: 24  GSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSP 83
Query: 97  XXXXXXXXXXMVLSQCDSPYGTKLW---------IIMEYLGGGSALDLMKA--GNFEEMH 145
                      V++  D+P+  +L          +I + +  G  LD ++    N    +
Sbjct: 84  KANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQY 143
Query: 146 IAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFV 205
           +     ++ KG++YL   R +HRD+ A NVL+     VK+ DFG+A  L     + +   
Sbjct: 144 LLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG 203
Query: 206 G-TPF-WMAPEVIKQSAYDSKADIWSLGITAIELAK-GEPPNSELHPMRVLFLIPKN--- 259
           G  P  WMA E I    Y  ++D+WS G+T  EL   G  P   +    +  ++ K    
Sbjct: 204 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL 263
Query: 260 -NPPQLTGN-YTKQFKEFVEACLNKDPENRPTAKELL 294
             PP  T + Y    K     C   D ++RP  +EL+
Sbjct: 264 PQPPICTIDVYMIMVK-----CWMIDADSRPKFRELI 295

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 79.3 bits (194), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 72/276 (26%), Positives = 118/276 (42%), Gaps = 28/276 (10%)
Query: 42  STTASRRNSLKVDPELIFTKQERIGKGSFGEVFKGI----DNRTQQVVXXXXXXXXXXXX 97
           S  A  +  L++  E  F K + +G G+FG V+KG+      + +  V            
Sbjct: 1   SGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPK 60
Query: 98  XXXXXXXXXMVLSQCDSPYGTKLW---------IIMEYLGGGSALDLMKA--GNFEEMHI 146
                     V++  D+P+  +L          +IM+ +  G  LD ++    N    ++
Sbjct: 61  ANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIMQLMPFGXLLDYVREHKDNIGSQYL 120
Query: 147 AVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVG 206
                ++ KG++YL   R +HRD+ A NVL+     VK+ DFG+A  L     + +   G
Sbjct: 121 LNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 180
Query: 207 -TPF-WMAPEVIKQSAYDSKADIWSLGITAIELAK-GEPPNSELHPMRVLFLIPKN---- 259
             P  WMA E I    Y  ++D+WS G+T  EL   G  P   +    +  ++ K     
Sbjct: 181 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLP 240
Query: 260 NPPQLTGN-YTKQFKEFVEACLNKDPENRPTAKELL 294
            PP  T + Y    K     C   D ++RP  +EL+
Sbjct: 241 QPPICTIDVYMIMVK-----CWMIDADSRPKFRELI 271

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 79.3 bits (194), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 40/112 (35%), Positives = 61/112 (54%), Gaps = 4/112 (3%)
Query: 135 LMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTL 194
           L+K  +    HI   L ++L+GL Y+HS   LHRD+K +N+LL+   D+K+ DFG+A   
Sbjct: 119 LLKCQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVA 178
Query: 195 T---NTTSKRNTFVGTPFWMAPEVIKQS-AYDSKADIWSLGITAIELAKGEP 242
               + T     +V T ++ APE++  S  Y    DIWS+G    E+    P
Sbjct: 179 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP 230

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 79.3 bits (194), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 99/214 (46%), Gaps = 19/214 (8%)
Query: 59  FTKQERIGKGSFGEVFKGIDNRTQQVVXXXXXXXXXXXXXXXXXXXXXM-VLSQCDSP-- 115
           F K E+IG+G++G V+K  +  T +VV                     + +L + + P  
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 116 --------YGTKLWIIMEYLGGGSALDLMKAGNFEEMHIAVI---LREVLKGLDYLHSER 164
                      KL+++ E+L        M A     + + +I   L ++L+GL + HS R
Sbjct: 65  VKLLDVIHTENKLYLVFEFLHQDLK-KFMDASALTGIPLPLIKSYLFQLLQGLSFCHSHR 123
Query: 165 KLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSK 224
            LHRD+K  N+L++  G +KLADFG+A             V T ++ APE++    Y S 
Sbjct: 124 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYST 183
Query: 225 A-DIWSLGITAIELAKGE---PPNSELHPMRVLF 254
           A DIWSLG    E+       P +SE+  +  +F
Sbjct: 184 AVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIF 217

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 52/184 (28%), Positives = 94/184 (51%), Gaps = 14/184 (7%)
Query: 120 LWIIMEYLGGGSALDLMKAGN--FEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLL 177
           ++I+ EY+  G  L+ +++     E   +  +  +V +G+ +L S + +HRD+ A N L+
Sbjct: 78  IYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLV 137
Query: 178 SEMGDVKLADFGVAGTLTNTTSKRNTFVGTPF---WMAPEVIKQSAYDSKADIWSLGITA 234
                VK++DFG+   + +   +  + VGT F   W APEV     Y SK+D+W+ GI  
Sbjct: 138 DRDLCVKVSDFGMTRYVLD--DQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILM 195
Query: 235 IEL-AKGEPPNSELHPMRVLFLIPKNN---PPQLTGNYTKQFKEFVEACLNKDPENRPTA 290
            E+ + G+ P        V+  + + +    P L  +   Q    + +C ++ PE RPT 
Sbjct: 196 WEVFSLGKMPYDLYTNSEVVLKVSQGHRLYRPHLASDTIYQ---IMYSCWHELPEKRPTF 252
Query: 291 KELL 294
           ++LL
Sbjct: 253 QQLL 256

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 99/214 (46%), Gaps = 19/214 (8%)
Query: 59  FTKQERIGKGSFGEVFKGIDNRTQQVVXXXXXXXXXXXXXXXXXXXXXM-VLSQCDSP-- 115
           F K E+IG+G++G V+K  +  T +VV                     + +L + + P  
Sbjct: 9   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 68
Query: 116 --------YGTKLWIIMEYLGGGSALDLMKAGNFEEMHIAVI---LREVLKGLDYLHSER 164
                      KL+++ E+L        M A     + + +I   L ++L+GL + HS R
Sbjct: 69  VKLLDVIHTENKLYLVFEFLHQDLK-KFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 127
Query: 165 KLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSK 224
            LHRD+K  N+L++  G +KLADFG+A             V T ++ APE++    Y S 
Sbjct: 128 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYST 187
Query: 225 A-DIWSLGITAIELAKGE---PPNSELHPMRVLF 254
           A DIWSLG    E+       P +SE+  +  +F
Sbjct: 188 AVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIF 221

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 79.0 bits (193), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 47/148 (31%), Positives = 81/148 (54%), Gaps = 5/148 (3%)
Query: 152 EVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVG-TPF- 209
           ++ +G++YL S++ +HRD+ A NVL++E   +++ADFG+A  + N    + T  G  P  
Sbjct: 165 QLARGMEYLASQKCIHRDLAARNVLVTENNVMRIADFGLARDINNIDYYKKTTNGRLPVK 224
Query: 210 WMAPEVIKQSAYDSKADIWSLGITAIEL-AKGEPPNSELHPMRVLF-LIPKNNPPQLTGN 267
           WMAPE +    Y  ++D+WS G+   E+   G  P   + P+  LF L+ + +      N
Sbjct: 225 WMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI-PVEELFKLLKEGHRMDKPAN 283
Query: 268 YTKQFKEFVEACLNKDPENRPTAKELLK 295
            T +    +  C +  P  RPT K+L++
Sbjct: 284 CTNELYMMMRDCWHAVPSQRPTFKQLVE 311

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 79.0 bits (193), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 41/125 (32%), Positives = 72/125 (57%), Gaps = 2/125 (1%)
Query: 121 WIIMEYLGGGSALDLMKAGNFEEMHIAV-ILREVLKGLDYLHSERKLHRDIKAANVLLSE 179
           +++MEY+ G +  + +++     +  A+    ++L G+ + H  R +HRDIK  N+L+  
Sbjct: 87  YLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDS 146
Query: 180 MGDVKLADFGVAGTLTNTT-SKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELA 238
              +K+ DFG+A  L+ T+ ++ N  +GT  + +PE  K  A D   DI+S+GI   E+ 
Sbjct: 147 NKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEML 206
Query: 239 KGEPP 243
            GEPP
Sbjct: 207 VGEPP 211

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 79.0 bits (193), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 71/273 (26%), Positives = 117/273 (42%), Gaps = 28/273 (10%)
Query: 45  ASRRNSLKVDPELIFTKQERIGKGSFGEVFKGI----DNRTQQVVXXXXXXXXXXXXXXX 100
           A  +  L++  E  F K + +G G+FG V+KG+      + +  V               
Sbjct: 3   APNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK 62
Query: 101 XXXXXXMVLSQCDSPYGTKLW---------IIMEYLGGGSALDLMKA--GNFEEMHIAVI 149
                  V++  D+P+  +L          +IM+ +  G  LD ++    N    ++   
Sbjct: 63  EILDEAYVMASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNW 122
Query: 150 LREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVG-TP 208
             ++ KG++YL   R +HRD+ A NVL+     VK+ DFG+A  L     + +   G  P
Sbjct: 123 CVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 182
Query: 209 F-WMAPEVIKQSAYDSKADIWSLGITAIELAK-GEPPNSELHPMRVLFLIPKN----NPP 262
             WMA E I    Y  ++D+WS G+T  EL   G  P   +    +  ++ K      PP
Sbjct: 183 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPP 242
Query: 263 QLTGN-YTKQFKEFVEACLNKDPENRPTAKELL 294
             T + Y    K     C   D ++RP  +EL+
Sbjct: 243 ICTIDVYMIMVK-----CWMIDADSRPKFRELI 270

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 79.0 bits (193), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 64/220 (29%), Positives = 102/220 (46%), Gaps = 21/220 (9%)
Query: 55  PELI--FTKQERIGKGSFGEVFKGIDNRTQQVVXXXXXXXXXXXXXXXXXXXXXM-VLSQ 111
           PE +  F K E+IG+G++G V+K  +  T +VV                     + +L +
Sbjct: 6   PEFMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKE 65
Query: 112 CDSP----------YGTKLWIIMEYLGGGSALDLMKAGNFEEMHIAVI---LREVLKGLD 158
            + P             KL+++ E+L        M A     + + +I   L ++L+GL 
Sbjct: 66  LNHPNIVKLLDVIHTENKLYLVFEFLHQDLK-KFMDASALTGIPLPLIKSYLFQLLQGLA 124
Query: 159 YLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQ 218
           + HS R LHRD+K  N+L++  G +KLADFG+A             V T ++ APE++  
Sbjct: 125 FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG 184
Query: 219 SAYDSKA-DIWSLGITAIELAKGE---PPNSELHPMRVLF 254
             Y S A DIWSLG    E+       P +SE+  +  +F
Sbjct: 185 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIF 224

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 79.0 bits (193), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 40/112 (35%), Positives = 61/112 (54%), Gaps = 4/112 (3%)
Query: 135 LMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTL 194
           L+K  +    HI   L ++L+GL Y+HS   LHRD+K +N+LL+   D+K+ DFG+A   
Sbjct: 117 LLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTSDLKICDFGLARVA 176
Query: 195 T---NTTSKRNTFVGTPFWMAPEVIKQS-AYDSKADIWSLGITAIELAKGEP 242
               + T     +V T ++ APE++  S  Y    DIWS+G    E+    P
Sbjct: 177 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP 228

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 79.0 bits (193), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 40/112 (35%), Positives = 61/112 (54%), Gaps = 4/112 (3%)
Query: 135 LMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTL 194
           L+K  +    HI   L ++L+GL Y+HS   LHRD+K +N+LL+   D+K+ DFG+A   
Sbjct: 115 LLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVA 174
Query: 195 T---NTTSKRNTFVGTPFWMAPEVIKQS-AYDSKADIWSLGITAIELAKGEP 242
               + T     +V T ++ APE++  S  Y    DIWS+G    E+    P
Sbjct: 175 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP 226

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 79.0 bits (193), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 99/214 (46%), Gaps = 19/214 (8%)
Query: 59  FTKQERIGKGSFGEVFKGIDNRTQQVVXXXXXXXXXXXXXXXXXXXXXM-VLSQCDSP-- 115
           F K E+IG+G++G V+K  +  T +VV                     + +L + + P  
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 116 --------YGTKLWIIMEYLGGGSALDLMKAGNFEEMHIAVI---LREVLKGLDYLHSER 164
                      KL+++ E+L        M A     + + +I   L ++L+GL + HS R
Sbjct: 64  VKLLDVIHTENKLYLVFEFLHQDLK-KFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 122
Query: 165 KLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSK 224
            LHRD+K  N+L++  G +KLADFG+A             V T ++ APE++    Y S 
Sbjct: 123 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYST 182
Query: 225 A-DIWSLGITAIELAKGE---PPNSELHPMRVLF 254
           A DIWSLG    E+       P +SE+  +  +F
Sbjct: 183 AVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIF 216

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 79.0 bits (193), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 71/273 (26%), Positives = 117/273 (42%), Gaps = 28/273 (10%)
Query: 45  ASRRNSLKVDPELIFTKQERIGKGSFGEVFKGI----DNRTQQVVXXXXXXXXXXXXXXX 100
           A  +  L++  E  F K + +G G+FG V+KG+      + +  V               
Sbjct: 6   APNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK 65
Query: 101 XXXXXXMVLSQCDSPYGTKLW---------IIMEYLGGGSALDLMKA--GNFEEMHIAVI 149
                  V++  D+P+  +L          +IM+ +  G  LD ++    N    ++   
Sbjct: 66  EILDEAYVMASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNW 125
Query: 150 LREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVG-TP 208
             ++ KG++YL   R +HRD+ A NVL+     VK+ DFG+A  L     + +   G  P
Sbjct: 126 CVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 185
Query: 209 F-WMAPEVIKQSAYDSKADIWSLGITAIELAK-GEPPNSELHPMRVLFLIPKN----NPP 262
             WMA E I    Y  ++D+WS G+T  EL   G  P   +    +  ++ K      PP
Sbjct: 186 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPP 245
Query: 263 QLTGN-YTKQFKEFVEACLNKDPENRPTAKELL 294
             T + Y    K     C   D ++RP  +EL+
Sbjct: 246 ICTIDVYMIMVK-----CWMIDADSRPKFRELI 273

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 79.0 bits (193), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 40/112 (35%), Positives = 61/112 (54%), Gaps = 4/112 (3%)
Query: 135 LMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTL 194
           L+K  +    HI   L ++L+GL Y+HS   LHRD+K +N+LL+   D+K+ DFG+A   
Sbjct: 119 LLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVA 178
Query: 195 T---NTTSKRNTFVGTPFWMAPEVIKQS-AYDSKADIWSLGITAIELAKGEP 242
               + T     +V T ++ APE++  S  Y    DIWS+G    E+    P
Sbjct: 179 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP 230

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 79.0 bits (193), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 40/112 (35%), Positives = 61/112 (54%), Gaps = 4/112 (3%)
Query: 135 LMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTL 194
           L+K  +    HI   L ++L+GL Y+HS   LHRD+K +N+LL+   D+K+ DFG+A   
Sbjct: 117 LLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVA 176
Query: 195 T---NTTSKRNTFVGTPFWMAPEVIKQS-AYDSKADIWSLGITAIELAKGEP 242
               + T     +V T ++ APE++  S  Y    DIWS+G    E+    P
Sbjct: 177 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP 228

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 79.0 bits (193), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 40/112 (35%), Positives = 61/112 (54%), Gaps = 4/112 (3%)
Query: 135 LMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTL 194
           L+K  +    HI   L ++L+GL Y+HS   LHRD+K +N+LL+   D+K+ DFG+A   
Sbjct: 120 LLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVA 179
Query: 195 T---NTTSKRNTFVGTPFWMAPEVIKQS-AYDSKADIWSLGITAIELAKGEP 242
               + T     +V T ++ APE++  S  Y    DIWS+G    E+    P
Sbjct: 180 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP 231

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 79.0 bits (193), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 40/112 (35%), Positives = 61/112 (54%), Gaps = 4/112 (3%)
Query: 135 LMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTL 194
           L+K  +    HI   L ++L+GL Y+HS   LHRD+K +N+LL+   D+K+ DFG+A   
Sbjct: 121 LLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVA 180
Query: 195 T---NTTSKRNTFVGTPFWMAPEVIKQS-AYDSKADIWSLGITAIELAKGEP 242
               + T     +V T ++ APE++  S  Y    DIWS+G    E+    P
Sbjct: 181 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP 232

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 79.0 bits (193), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 40/112 (35%), Positives = 61/112 (54%), Gaps = 4/112 (3%)
Query: 135 LMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTL 194
           L+K  +    HI   L ++L+GL Y+HS   LHRD+K +N+LL+   D+K+ DFG+A   
Sbjct: 112 LLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVA 171
Query: 195 T---NTTSKRNTFVGTPFWMAPEVIKQS-AYDSKADIWSLGITAIELAKGEP 242
               + T     +V T ++ APE++  S  Y    DIWS+G    E+    P
Sbjct: 172 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP 223

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 79.0 bits (193), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 40/112 (35%), Positives = 61/112 (54%), Gaps = 4/112 (3%)
Query: 135 LMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTL 194
           L+K  +    HI   L ++L+GL Y+HS   LHRD+K +N+LL+   D+K+ DFG+A   
Sbjct: 119 LLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVA 178
Query: 195 T---NTTSKRNTFVGTPFWMAPEVIKQS-AYDSKADIWSLGITAIELAKGEP 242
               + T     +V T ++ APE++  S  Y    DIWS+G    E+    P
Sbjct: 179 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP 230

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 79.0 bits (193), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 51/186 (27%), Positives = 91/186 (48%), Gaps = 7/186 (3%)
Query: 121 WIIMEYLGGGSAL-DLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLS- 178
           ++I + + GG    D++    + E   +  ++++L+ + + H    +HR++K  N+LL+ 
Sbjct: 86  YLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLAS 145
Query: 179 --EMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIE 236
             +   VKLADFG+A  +         F GTP +++PEV+++  Y    D+W+ G+    
Sbjct: 146 KLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYI 205
Query: 237 LAKGEPPNSELHPMRVLFLI---PKNNPPQLTGNYTKQFKEFVEACLNKDPENRPTAKEL 293
           L  G PP  +    R+   I     + P       T + K+ +   L  +P  R TA E 
Sbjct: 206 LLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEA 265
Query: 294 LKFPFI 299
           LK P+I
Sbjct: 266 LKHPWI 271

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 79.0 bits (193), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 40/112 (35%), Positives = 61/112 (54%), Gaps = 4/112 (3%)
Query: 135 LMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTL 194
           L+K  +    HI   L ++L+GL Y+HS   LHRD+K +N+LL+   D+K+ DFG+A   
Sbjct: 113 LLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVA 172
Query: 195 T---NTTSKRNTFVGTPFWMAPEVIKQS-AYDSKADIWSLGITAIELAKGEP 242
               + T     +V T ++ APE++  S  Y    DIWS+G    E+    P
Sbjct: 173 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP 224

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 79.0 bits (193), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 40/112 (35%), Positives = 61/112 (54%), Gaps = 4/112 (3%)
Query: 135 LMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTL 194
           L+K  +    HI   L ++L+GL Y+HS   LHRD+K +N+LL+   D+K+ DFG+A   
Sbjct: 113 LLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVA 172
Query: 195 T---NTTSKRNTFVGTPFWMAPEVIKQS-AYDSKADIWSLGITAIELAKGEP 242
               + T     +V T ++ APE++  S  Y    DIWS+G    E+    P
Sbjct: 173 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP 224

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 79.0 bits (193), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 100/214 (46%), Gaps = 19/214 (8%)
Query: 59  FTKQERIGKGSFGEVFKGIDNRTQQVVXXXXXXXXXXXXXXXXXXXXXM-VLSQCDSP-- 115
           F K E+IG+G++G V+K  +  T +VV                     + +L + + P  
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 116 --------YGTKLWIIMEYLGGGSALDLMKAGNFEEMHIAVI---LREVLKGLDYLHSER 164
                      KL+++ E+L        M A     + + +I   L ++L+GL + HS R
Sbjct: 65  VKLLDVIHTENKLYLVFEFLHQDLK-KFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 123
Query: 165 KLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSK 224
            LHRD+K  N+L++  G +KLADFG+A             V T ++ APE++    Y S 
Sbjct: 124 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYST 183
Query: 225 A-DIWSLGITAIELAKGE---PPNSELHPMRVLF 254
           A DIWSLG    E+       P +SE+  +  +F
Sbjct: 184 AVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIF 217

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 79.0 bits (193), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 100/214 (46%), Gaps = 19/214 (8%)
Query: 59  FTKQERIGKGSFGEVFKGIDNRTQQVVXXXXXXXXXXXXXXXXXXXXXM-VLSQCDSP-- 115
           F K E+IG+G++G V+K  +  T +VV                     + +L + + P  
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 116 --------YGTKLWIIMEYLGGGSALDLMKAGNFEEMHIAVI---LREVLKGLDYLHSER 164
                      KL+++ E+L        M A     + + +I   L ++L+GL + HS R
Sbjct: 64  VKLLDVIHTENKLYLVFEFLHQDLK-KFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 122
Query: 165 KLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSK 224
            LHRD+K  N+L++  G +KLADFG+A             V T ++ APE++    Y S 
Sbjct: 123 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYST 182
Query: 225 A-DIWSLGITAIELAKGE---PPNSELHPMRVLF 254
           A DIWSLG    E+       P +SE+  +  +F
Sbjct: 183 AVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIF 216

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 79.0 bits (193), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 40/112 (35%), Positives = 61/112 (54%), Gaps = 4/112 (3%)
Query: 135 LMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTL 194
           L+K  +    HI   L ++L+GL Y+HS   LHRD+K +N+LL+   D+K+ DFG+A   
Sbjct: 117 LLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVA 176
Query: 195 T---NTTSKRNTFVGTPFWMAPEVIKQS-AYDSKADIWSLGITAIELAKGEP 242
               + T     +V T ++ APE++  S  Y    DIWS+G    E+    P
Sbjct: 177 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP 228

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 78.6 bits (192), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 64/220 (29%), Positives = 102/220 (46%), Gaps = 21/220 (9%)
Query: 55  PELI--FTKQERIGKGSFGEVFKGIDNRTQQVVXXXXXXXXXXXXXXXXXXXXXM-VLSQ 111
           PE +  F K E+IG+G++G V+K  +  T +VV                     + +L +
Sbjct: 6   PEFMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKE 65
Query: 112 CDSP----------YGTKLWIIMEYLGGGSALDLMKAGNFEEMHIAVI---LREVLKGLD 158
            + P             KL+++ E+L        M A     + + +I   L ++L+GL 
Sbjct: 66  LNHPNIVKLLDVIHTENKLYLVFEFLHQDLK-KFMDASALTGIPLPLIKSYLFQLLQGLA 124
Query: 159 YLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQ 218
           + HS R LHRD+K  N+L++  G +KLADFG+A             V T ++ APE++  
Sbjct: 125 FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG 184
Query: 219 SAYDSKA-DIWSLGITAIELAKGE---PPNSELHPMRVLF 254
             Y S A DIWSLG    E+       P +SE+  +  +F
Sbjct: 185 XKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIF 224

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 78.6 bits (192), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 99/214 (46%), Gaps = 19/214 (8%)
Query: 59  FTKQERIGKGSFGEVFKGIDNRTQQVVXXXXXXXXXXXXXXXXXXXXXM-VLSQCDSP-- 115
           F K E+IG+G++G V+K  +  T +VV                     + +L + + P  
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 116 --------YGTKLWIIMEYLGGGSALDLMKAGNFEEMHIAVI---LREVLKGLDYLHSER 164
                      KL+++ E+L        M A     + + +I   L ++L+GL + HS R
Sbjct: 65  VKLLDVIHTENKLYLVFEFLHQDLK-KFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 123
Query: 165 KLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSK 224
            LHRD+K  N+L++  G +KLADFG+A             V T ++ APE++    Y S 
Sbjct: 124 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYST 183
Query: 225 A-DIWSLGITAIELAKGE---PPNSELHPMRVLF 254
           A DIWSLG    E+       P +SE+  +  +F
Sbjct: 184 AVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIF 217

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 78.6 bits (192), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 99/214 (46%), Gaps = 19/214 (8%)
Query: 59  FTKQERIGKGSFGEVFKGIDNRTQQVVXXXXXXXXXXXXXXXXXXXXXM-VLSQCDSP-- 115
           F K E+IG+G++G V+K  +  T +VV                     + +L + + P  
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 116 --------YGTKLWIIMEYLGGGSALDLMKAGNFEEMHIAVI---LREVLKGLDYLHSER 164
                      KL+++ E+L        M A     + + +I   L ++L+GL + HS R
Sbjct: 64  VKLLDVIHTENKLYLVFEFLHQDLK-KFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 122
Query: 165 KLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSK 224
            LHRD+K  N+L++  G +KLADFG+A             V T ++ APE++    Y S 
Sbjct: 123 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYST 182
Query: 225 A-DIWSLGITAIELAKGE---PPNSELHPMRVLF 254
           A DIWSLG    E+       P +SE+  +  +F
Sbjct: 183 AVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIF 216

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 78.6 bits (192), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 40/112 (35%), Positives = 61/112 (54%), Gaps = 4/112 (3%)
Query: 135 LMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTL 194
           L+K  +    HI   L ++L+GL Y+HS   LHRD+K +N+LL+   D+K+ DFG+A   
Sbjct: 135 LLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVA 194
Query: 195 T---NTTSKRNTFVGTPFWMAPEVIKQS-AYDSKADIWSLGITAIELAKGEP 242
               + T     +V T ++ APE++  S  Y    DIWS+G    E+    P
Sbjct: 195 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP 246

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 78.6 bits (192), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 99/214 (46%), Gaps = 19/214 (8%)
Query: 59  FTKQERIGKGSFGEVFKGIDNRTQQVVXXXXXXXXXXXXXXXXXXXXXM-VLSQCDSP-- 115
           F K E+IG+G++G V+K  +  T +VV                     + +L + + P  
Sbjct: 6   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 65
Query: 116 --------YGTKLWIIMEYLGGGSALDLMKAGNFEEMHIAVI---LREVLKGLDYLHSER 164
                      KL+++ E+L        M A     + + +I   L ++L+GL + HS R
Sbjct: 66  VKLLDVIHTENKLYLVFEFLHQDLK-KFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 124
Query: 165 KLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSK 224
            LHRD+K  N+L++  G +KLADFG+A             V T ++ APE++    Y S 
Sbjct: 125 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYST 184
Query: 225 A-DIWSLGITAIELAKGE---PPNSELHPMRVLF 254
           A DIWSLG    E+       P +SE+  +  +F
Sbjct: 185 AVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIF 218

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 78.6 bits (192), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 40/112 (35%), Positives = 61/112 (54%), Gaps = 4/112 (3%)
Query: 135 LMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTL 194
           L+K  +    HI   L ++L+GL Y+HS   LHRD+K +N+LL+   D+K+ DFG+A   
Sbjct: 123 LLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVA 182
Query: 195 T---NTTSKRNTFVGTPFWMAPEVIKQS-AYDSKADIWSLGITAIELAKGEP 242
               + T     +V T ++ APE++  S  Y    DIWS+G    E+    P
Sbjct: 183 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP 234

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 78.6 bits (192), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 40/112 (35%), Positives = 61/112 (54%), Gaps = 4/112 (3%)
Query: 135 LMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTL 194
           L+K  +    HI   L ++L+GL Y+HS   LHRD+K +N+LL+   D+K+ DFG+A   
Sbjct: 115 LLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVA 174
Query: 195 T---NTTSKRNTFVGTPFWMAPEVIKQS-AYDSKADIWSLGITAIELAKGEP 242
               + T     +V T ++ APE++  S  Y    DIWS+G    E+    P
Sbjct: 175 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP 226

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 78.6 bits (192), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 108/219 (49%), Gaps = 21/219 (9%)
Query: 118 TKLWIIMEYLGGGSALD-LMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVL 176
           T++ +++E + GG   D +++ G + E   A  ++++L+ + YLH    +HRD+K  N+L
Sbjct: 121 TEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLL 180
Query: 177 LSE---MGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLG-I 232
            +       +K+ADFG++  + +    + T  GTP + APE+++  AY  + D+WS+G I
Sbjct: 181 YATPAPDAPLKIADFGLSKIVEHQVLMK-TVCGTPGYCAPEILRGCAYGPEVDMWSVGII 239
Query: 233 TAIELAKGEPPNSE----LHPMRVL-----FLIPKNNPPQLTGNYTKQFKEFVEACLNKD 283
           T I L   EP   E        R+L     F+ P  +   L        K+ V   +  D
Sbjct: 240 TYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLNA------KDLVRKLIVLD 293
Query: 284 PENRPTAKELLKFPFIRKAKKNAYLIDLIDRYKKWKNSR 322
           P+ R T  + L+ P++     N   +D   +  +  N+R
Sbjct: 294 PKKRLTTFQALQHPWVTGKAANFVHMDTAQKKLQEFNAR 332

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 78.6 bits (192), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 99/214 (46%), Gaps = 19/214 (8%)
Query: 59  FTKQERIGKGSFGEVFKGIDNRTQQVVXXXXXXXXXXXXXXXXXXXXXM-VLSQCDSP-- 115
           F K E+IG+G++G V+K  +  T +VV                     + +L + + P  
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 116 --------YGTKLWIIMEYLGGGSALDLMKAGNFEEMHIAVI---LREVLKGLDYLHSER 164
                      KL+++ E+L        M A     + + +I   L ++L+GL + HS R
Sbjct: 65  VKLLDVIHTENKLYLVFEFLHQDLK-KFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 123
Query: 165 KLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSK 224
            LHRD+K  N+L++  G +KLADFG+A             V T ++ APE++    Y S 
Sbjct: 124 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYST 183
Query: 225 A-DIWSLGITAIELAKGE---PPNSELHPMRVLF 254
           A DIWSLG    E+       P +SE+  +  +F
Sbjct: 184 AVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIF 217

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 78.6 bits (192), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 99/214 (46%), Gaps = 19/214 (8%)
Query: 59  FTKQERIGKGSFGEVFKGIDNRTQQVVXXXXXXXXXXXXXXXXXXXXXM-VLSQCDSP-- 115
           F K E+IG+G++G V+K  +  T +VV                     + +L + + P  
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 116 --------YGTKLWIIMEYLGGGSALDLMKAGNFEEMHIAVI---LREVLKGLDYLHSER 164
                      KL+++ E+L        M A     + + +I   L ++L+GL + HS R
Sbjct: 65  VKLLDVIHTENKLYLVFEFLHQDLK-KFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 123
Query: 165 KLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSK 224
            LHRD+K  N+L++  G +KLADFG+A             V T ++ APE++    Y S 
Sbjct: 124 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYST 183
Query: 225 A-DIWSLGITAIELAKGE---PPNSELHPMRVLF 254
           A DIWSLG    E+       P +SE+  +  +F
Sbjct: 184 AVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIF 217

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 78.6 bits (192), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 40/112 (35%), Positives = 61/112 (54%), Gaps = 4/112 (3%)
Query: 135 LMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTL 194
           L+K  +    HI   L ++L+GL Y+HS   LHRD+K +N+LL+   D+K+ DFG+A   
Sbjct: 115 LLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLARVA 174
Query: 195 T---NTTSKRNTFVGTPFWMAPEVIKQS-AYDSKADIWSLGITAIELAKGEP 242
               + T     +V T ++ APE++  S  Y    DIWS+G    E+    P
Sbjct: 175 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP 226

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 78.6 bits (192), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 76/268 (28%), Positives = 126/268 (47%), Gaps = 36/268 (13%)
Query: 50  SLKVDP-ELIFTKQERIGKGSFGEVFKGIDNRTQQVVXXXXXXXXXXXXXXXXXXXXXMV 108
           S ++DP +L F K+  +G G FG V  G       V                      M 
Sbjct: 3   SWEIDPKDLTFLKE--LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMN 60
Query: 109 LS--QCDSPYGTK-----LWIIMEYLGGGSALDLMKA--GNFEEMHIAVILREVLKGLDY 159
           LS  +    YG       ++II EY+  G  L+ ++     F+   +  + ++V + ++Y
Sbjct: 61  LSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEY 120
Query: 160 LHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTN--TTSKRNTFVGTPF---WMAPE 214
           L S++ LHRD+ A N L+++ G VK++DFG++  + +   TS R    G+ F   W  PE
Sbjct: 121 LESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSR----GSKFPVRWSPPE 176
Query: 215 VIKQSAYDSKADIWSLGITAIEL-AKGEPP-----NSEL--HPMRVLFLIPKNNPPQLTG 266
           V+  S + SK+DIW+ G+   E+ + G+ P     NSE   H  + L L      P L  
Sbjct: 177 VLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLY----RPHLA- 231
Query: 267 NYTKQFKEFVEACLNKDPENRPTAKELL 294
             +++    + +C ++  + RPT K LL
Sbjct: 232 --SEKVYTIMYSCWHEKADERPTFKILL 257

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 37/94 (39%), Positives = 61/94 (64%), Gaps = 1/94 (1%)
Query: 149 ILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTP 208
           ++R+ L+GLD+LH+   +HRD+K  N+L++  G VKLADFG+A   +   +  +  V T 
Sbjct: 117 LMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMAL-DPVVVTL 175
Query: 209 FWMAPEVIKQSAYDSKADIWSLGITAIELAKGEP 242
           ++ APEV+ QS Y +  D+WS+G    E+ + +P
Sbjct: 176 WYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKP 209

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 40/112 (35%), Positives = 61/112 (54%), Gaps = 4/112 (3%)
Query: 135 LMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTL 194
           L+K  +    HI   L ++L+GL Y+HS   LHRD+K +N+LL+   D+K+ DFG+A   
Sbjct: 119 LLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLARVA 178
Query: 195 T---NTTSKRNTFVGTPFWMAPEVIKQS-AYDSKADIWSLGITAIELAKGEP 242
               + T     +V T ++ APE++  S  Y    DIWS+G    E+    P
Sbjct: 179 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP 230

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 99/214 (46%), Gaps = 19/214 (8%)
Query: 59  FTKQERIGKGSFGEVFKGIDNRTQQVVXXXXXXXXXXXXXXXXXXXXXM-VLSQCDSP-- 115
           F K E+IG+G++G V+K  +  T +VV                     + +L + + P  
Sbjct: 7   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 66
Query: 116 --------YGTKLWIIMEYLGGGSALDLMKAGNFEEMHIAVI---LREVLKGLDYLHSER 164
                      KL+++ E+L        M A     + + +I   L ++L+GL + HS R
Sbjct: 67  VKLLDVIHTENKLYLVFEFLHQDLK-KFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 125
Query: 165 KLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSK 224
            LHRD+K  N+L++  G +KLADFG+A             V T ++ APE++    Y S 
Sbjct: 126 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYST 185
Query: 225 A-DIWSLGITAIELAKGE---PPNSELHPMRVLF 254
           A DIWSLG    E+       P +SE+  +  +F
Sbjct: 186 AVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIF 219

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 99/214 (46%), Gaps = 19/214 (8%)
Query: 59  FTKQERIGKGSFGEVFKGIDNRTQQVVXXXXXXXXXXXXXXXXXXXXXM-VLSQCDSP-- 115
           F K E+IG+G++G V+K  +  T +VV                     + +L + + P  
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 116 --------YGTKLWIIMEYLGGGSALDLMKAGNFEEMHIAVI---LREVLKGLDYLHSER 164
                      KL+++ E+L        M A     + + +I   L ++L+GL + HS R
Sbjct: 64  VKLLDVIHTENKLYLVFEFLHQDLK-KFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 122
Query: 165 KLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSK 224
            LHRD+K  N+L++  G +KLADFG+A             V T ++ APE++    Y S 
Sbjct: 123 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYST 182
Query: 225 A-DIWSLGITAIELAKGE---PPNSELHPMRVLF 254
           A DIWSLG    E+       P +SE+  +  +F
Sbjct: 183 AVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIF 216

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 40/112 (35%), Positives = 61/112 (54%), Gaps = 4/112 (3%)
Query: 135 LMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTL 194
           L+K  +    HI   L ++L+GL Y+HS   LHRD+K +N+LL+   D+K+ DFG+A   
Sbjct: 115 LLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLARVA 174
Query: 195 T---NTTSKRNTFVGTPFWMAPEVIKQS-AYDSKADIWSLGITAIELAKGEP 242
               + T     +V T ++ APE++  S  Y    DIWS+G    E+    P
Sbjct: 175 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP 226

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 99/214 (46%), Gaps = 19/214 (8%)
Query: 59  FTKQERIGKGSFGEVFKGIDNRTQQVVXXXXXXXXXXXXXXXXXXXXXM-VLSQCDSP-- 115
           F K E+IG+G++G V+K  +  T +VV                     + +L + + P  
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 116 --------YGTKLWIIMEYLGGGSALDLMKAGNFEEMHIAVI---LREVLKGLDYLHSER 164
                      KL+++ E+L        M A     + + +I   L ++L+GL + HS R
Sbjct: 64  VKLLDVIHTENKLYLVFEFLHQDLK-KFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 122
Query: 165 KLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSK 224
            LHRD+K  N+L++  G +KLADFG+A             V T ++ APE++    Y S 
Sbjct: 123 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYST 182
Query: 225 A-DIWSLGITAIELAKGE---PPNSELHPMRVLF 254
           A DIWSLG    E+       P +SE+  +  +F
Sbjct: 183 AVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIF 216

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 99/214 (46%), Gaps = 19/214 (8%)
Query: 59  FTKQERIGKGSFGEVFKGIDNRTQQVVXXXXXXXXXXXXXXXXXXXXXM-VLSQCDSP-- 115
           F K E+IG+G++G V+K  +  T +VV                     + +L + + P  
Sbjct: 7   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 66
Query: 116 --------YGTKLWIIMEYLGGGSALDLMKAGNFEEMHIAVI---LREVLKGLDYLHSER 164
                      KL+++ E+L        M A     + + +I   L ++L+GL + HS R
Sbjct: 67  VKLLDVIHTENKLYLVFEFLHQDLK-KFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 125
Query: 165 KLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSK 224
            LHRD+K  N+L++  G +KLADFG+A             V T ++ APE++    Y S 
Sbjct: 126 VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYST 185
Query: 225 A-DIWSLGITAIELAKGE---PPNSELHPMRVLF 254
           A DIWSLG    E+       P +SE+  +  +F
Sbjct: 186 AVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIF 219

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 99/214 (46%), Gaps = 19/214 (8%)
Query: 59  FTKQERIGKGSFGEVFKGIDNRTQQVVXXXXXXXXXXXXXXXXXXXXXM-VLSQCDSP-- 115
           F K E+IG+G++G V+K  +  T +VV                     + +L + + P  
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 116 --------YGTKLWIIMEYLGGGSALDLMKAGNFEEMHIAVI---LREVLKGLDYLHSER 164
                      KL+++ E+L        M A     + + +I   L ++L+GL + HS R
Sbjct: 65  VKLLDVIHTENKLYLVFEFLHQDLK-KFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 123
Query: 165 KLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSK 224
            LHRD+K  N+L++  G +KLADFG+A             V T ++ APE++    Y S 
Sbjct: 124 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGXKYYST 183
Query: 225 A-DIWSLGITAIELAKGE---PPNSELHPMRVLF 254
           A DIWSLG    E+       P +SE+  +  +F
Sbjct: 184 AVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIF 217

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 99/214 (46%), Gaps = 19/214 (8%)
Query: 59  FTKQERIGKGSFGEVFKGIDNRTQQVVXXXXXXXXXXXXXXXXXXXXXM-VLSQCDSP-- 115
           F K E+IG+G++G V+K  +  T +VV                     + +L + + P  
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 116 --------YGTKLWIIMEYLGGGSALDLMKAGNFEEMHIAVI---LREVLKGLDYLHSER 164
                      KL+++ E+L        M A     + + +I   L ++L+GL + HS R
Sbjct: 65  VKLLDVIHTENKLYLVFEFLHQDLK-KFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 123
Query: 165 KLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSK 224
            LHRD+K  N+L++  G +KLADFG+A             V T ++ APE++    Y S 
Sbjct: 124 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYST 183
Query: 225 A-DIWSLGITAIELAKGE---PPNSELHPMRVLF 254
           A DIWSLG    E+       P +SE+  +  +F
Sbjct: 184 AVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIF 217

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 40/112 (35%), Positives = 61/112 (54%), Gaps = 4/112 (3%)
Query: 135 LMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTL 194
           L+K  +    HI   L ++L+GL Y+HS   LHRD+K +N+LL+   D+K+ DFG+A   
Sbjct: 119 LLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLARVA 178
Query: 195 T---NTTSKRNTFVGTPFWMAPEVIKQS-AYDSKADIWSLGITAIELAKGEP 242
               + T     +V T ++ APE++  S  Y    DIWS+G    E+    P
Sbjct: 179 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP 230

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 99/214 (46%), Gaps = 19/214 (8%)
Query: 59  FTKQERIGKGSFGEVFKGIDNRTQQVVXXXXXXXXXXXXXXXXXXXXXM-VLSQCDSP-- 115
           F K E+IG+G++G V+K  +  T +VV                     + +L + + P  
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 116 --------YGTKLWIIMEYLGGGSALDLMKAGNFEEMHIAVI---LREVLKGLDYLHSER 164
                      KL+++ E+L        M A     + + +I   L ++L+GL + HS R
Sbjct: 65  VKLLDVIHTENKLYLVFEFLHQDLK-KFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 123
Query: 165 KLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSK 224
            LHRD+K  N+L++  G +KLADFG+A             V T ++ APE++    Y S 
Sbjct: 124 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYST 183
Query: 225 A-DIWSLGITAIELAKGE---PPNSELHPMRVLF 254
           A DIWSLG    E+       P +SE+  +  +F
Sbjct: 184 AVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIF 217

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 99/214 (46%), Gaps = 19/214 (8%)
Query: 59  FTKQERIGKGSFGEVFKGIDNRTQQVVXXXXXXXXXXXXXXXXXXXXXM-VLSQCDSP-- 115
           F K E+IG+G++G V+K  +  T +VV                     + +L + + P  
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 67
Query: 116 --------YGTKLWIIMEYLGGGSALDLMKAGNFEEMHIAVI---LREVLKGLDYLHSER 164
                      KL+++ E+L        M A     + + +I   L ++L+GL + HS R
Sbjct: 68  VKLLDVIHTENKLYLVFEFLHQDLK-KFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 126
Query: 165 KLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSK 224
            LHRD+K  N+L++  G +KLADFG+A             V T ++ APE++    Y S 
Sbjct: 127 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYST 186
Query: 225 A-DIWSLGITAIELAKGE---PPNSELHPMRVLF 254
           A DIWSLG    E+       P +SE+  +  +F
Sbjct: 187 AVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIF 220

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 99/214 (46%), Gaps = 19/214 (8%)
Query: 59  FTKQERIGKGSFGEVFKGIDNRTQQVVXXXXXXXXXXXXXXXXXXXXXM-VLSQCDSP-- 115
           F K E+IG+G++G V+K  +  T +VV                     + +L + + P  
Sbjct: 7   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 66
Query: 116 --------YGTKLWIIMEYLGGGSALDLMKAGNFEEMHIAVI---LREVLKGLDYLHSER 164
                      KL+++ E+L        M A     + + +I   L ++L+GL + HS R
Sbjct: 67  VKLLDVIHTENKLYLVFEFLHQDLK-KFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 125
Query: 165 KLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSK 224
            LHRD+K  N+L++  G +KLADFG+A             V T ++ APE++    Y S 
Sbjct: 126 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYST 185
Query: 225 A-DIWSLGITAIELAKGE---PPNSELHPMRVLF 254
           A DIWSLG    E+       P +SE+  +  +F
Sbjct: 186 AVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIF 219

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 37/94 (39%), Positives = 60/94 (63%), Gaps = 1/94 (1%)
Query: 149 ILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTP 208
           ++R+ L+GLD+LH+   +HRD+K  N+L++  G VKLADFG+A   +   +     V T 
Sbjct: 125 LMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVVV-TL 183
Query: 209 FWMAPEVIKQSAYDSKADIWSLGITAIELAKGEP 242
           ++ APEV+ QS Y +  D+WS+G    E+ + +P
Sbjct: 184 WYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKP 217

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 99/214 (46%), Gaps = 19/214 (8%)
Query: 59  FTKQERIGKGSFGEVFKGIDNRTQQVVXXXXXXXXXXXXXXXXXXXXXM-VLSQCDSP-- 115
           F K E+IG+G++G V+K  +  T +VV                     + +L + + P  
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 67
Query: 116 --------YGTKLWIIMEYLGGGSALDLMKAGNFEEMHIAVI---LREVLKGLDYLHSER 164
                      KL+++ E+L        M A     + + +I   L ++L+GL + HS R
Sbjct: 68  VKLLDVIHTENKLYLVFEFLHQDLK-KFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 126
Query: 165 KLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSK 224
            LHRD+K  N+L++  G +KLADFG+A             V T ++ APE++    Y S 
Sbjct: 127 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYST 186
Query: 225 A-DIWSLGITAIELAKGE---PPNSELHPMRVLF 254
           A DIWSLG    E+       P +SE+  +  +F
Sbjct: 187 AVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIF 220

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 69/244 (28%), Positives = 106/244 (43%), Gaps = 35/244 (14%)
Query: 47  RRNSLKVDPELIFTKQERIGKGSFGEVFKGIDN-RTQQV-VXXXXXXXXXXXXXXXXXXX 104
           R N L  D EL        G G+FG V +G+   R +Q+ V                   
Sbjct: 334 RDNLLIADIEL--------GCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMR 385
Query: 105 XXMVLSQCDSPYGTKL---------WIIMEYLGGGSALDLMKAGNFEEM---HIAVILRE 152
              ++ Q D+PY  +L          ++ME  GGG  L     G  EE+   ++A +L +
Sbjct: 386 EAQIMHQLDNPYIVRLIGVCQAEALMLVMEMAGGGP-LHKFLVGKREEIPVSNVAELLHQ 444
Query: 153 VLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPF--- 209
           V  G+ YL  +  +HR++ A NVLL      K++DFG++  L    S         +   
Sbjct: 445 VSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLK 504
Query: 210 WMAPEVIKQSAYDSKADIWSLGITAIE-LAKGEPPNSELHPMRVLFLI--------PKNN 260
           W APE I    + S++D+WS G+T  E L+ G+ P  ++    V+  I        P   
Sbjct: 505 WYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPEC 564
Query: 261 PPQL 264
           PP+L
Sbjct: 565 PPEL 568

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 99/214 (46%), Gaps = 19/214 (8%)
Query: 59  FTKQERIGKGSFGEVFKGIDNRTQQVVXXXXXXXXXXXXXXXXXXXXXM-VLSQCDSP-- 115
           F K E+IG+G++G V+K  +  T +VV                     + +L + + P  
Sbjct: 9   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 68
Query: 116 --------YGTKLWIIMEYLGGGSALDLMKAGNFEEMHIAVI---LREVLKGLDYLHSER 164
                      KL+++ E+L        M A     + + +I   L ++L+GL + HS R
Sbjct: 69  VKLLDVIHTENKLYLVFEFLHQDLK-KFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 127
Query: 165 KLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSK 224
            LHRD+K  N+L++  G +KLADFG+A             V T ++ APE++    Y S 
Sbjct: 128 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYST 187
Query: 225 A-DIWSLGITAIELAKGE---PPNSELHPMRVLF 254
           A DIWSLG    E+       P +SE+  +  +F
Sbjct: 188 AVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIF 221

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 99/214 (46%), Gaps = 19/214 (8%)
Query: 59  FTKQERIGKGSFGEVFKGIDNRTQQVVXXXXXXXXXXXXXXXXXXXXXM-VLSQCDSP-- 115
           F K E+IG+G++G V+K  +  T +VV                     + +L + + P  
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 67
Query: 116 --------YGTKLWIIMEYLGGGSALDLMKAGNFEEMHIAVI---LREVLKGLDYLHSER 164
                      KL+++ E+L        M A     + + +I   L ++L+GL + HS R
Sbjct: 68  VKLLDVIHTENKLYLVFEFLHQDLK-TFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 126
Query: 165 KLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSK 224
            LHRD+K  N+L++  G +KLADFG+A             V T ++ APE++    Y S 
Sbjct: 127 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYST 186
Query: 225 A-DIWSLGITAIELAKGE---PPNSELHPMRVLF 254
           A DIWSLG    E+       P +SE+  +  +F
Sbjct: 187 AVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIF 220

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 70/276 (25%), Positives = 117/276 (42%), Gaps = 26/276 (9%)
Query: 41  GSTTASRRNSLKVDPELIFTKQERIGKGSFGEVFKGI----DNRTQQVVXXXXXXXXXXX 96
           GS  A  +  L++  E  F K + +G G+FG V+KG+      + +  V           
Sbjct: 1   GSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSP 60
Query: 97  XXXXXXXXXXMVLSQCDSPYGTKLW---------IIMEYLGGGSALDLMKA--GNFEEMH 145
                      V++  D+P+  +L          +I + +  G  LD ++    N    +
Sbjct: 61  KANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQY 120
Query: 146 IAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFV 205
           +     ++ KG++YL   R +HRD+ A NVL+     VK+ DFG A  L     + +   
Sbjct: 121 LLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEG 180
Query: 206 G-TPF-WMAPEVIKQSAYDSKADIWSLGITAIELAK-GEPPNSELHPMRVLFLIPKN--- 259
           G  P  WMA E I    Y  ++D+WS G+T  EL   G  P   +    +  ++ K    
Sbjct: 181 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL 240
Query: 260 -NPPQLTGNYTKQFKEFVEACLNKDPENRPTAKELL 294
             PP  T +     ++    C   D ++RP  +EL+
Sbjct: 241 PQPPICTIDVYMIMRK----CWMIDADSRPKFRELI 272

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 99/214 (46%), Gaps = 19/214 (8%)
Query: 59  FTKQERIGKGSFGEVFKGIDNRTQQVVXXXXXXXXXXXXXXXXXXXXXM-VLSQCDSP-- 115
           F K E+IG+G++G V+K  +  T +VV                     + +L + + P  
Sbjct: 6   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 65
Query: 116 --------YGTKLWIIMEYLGGGSALDLMKAGNFEEMHIAVI---LREVLKGLDYLHSER 164
                      KL+++ E+L        M A     + + +I   L ++L+GL + HS R
Sbjct: 66  VKLLDVIHTENKLYLVFEFLHQDLK-KFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 124
Query: 165 KLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSK 224
            LHRD+K  N+L++  G +KLADFG+A             V T ++ APE++    Y S 
Sbjct: 125 VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYST 184
Query: 225 A-DIWSLGITAIELAKGE---PPNSELHPMRVLF 254
           A DIWSLG    E+       P +SE+  +  +F
Sbjct: 185 AVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIF 218

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 37/94 (39%), Positives = 60/94 (63%), Gaps = 1/94 (1%)
Query: 149 ILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTP 208
           ++R+ L+GLD+LH+   +HRD+K  N+L++  G VKLADFG+A   +   +     V T 
Sbjct: 117 LMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALAPVVV-TL 175
Query: 209 FWMAPEVIKQSAYDSKADIWSLGITAIELAKGEP 242
           ++ APEV+ QS Y +  D+WS+G    E+ + +P
Sbjct: 176 WYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKP 209

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 48/142 (33%), Positives = 76/142 (53%), Gaps = 16/142 (11%)
Query: 118 TKLWIIMEYLGGGSAL-DLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVL 176
           T+ +++ E L GGS L  + K  +F E   + ++R+V   LD+LH++   HRD+K  N+L
Sbjct: 84  TRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENIL 143
Query: 177 L---SEMGDVKLADF--GVAGTLTN-----TTSKRNTFVGTPFWMAPEVI-----KQSAY 221
                ++  VK+ DF  G    L N     TT +  T  G+  +MAPEV+     + + Y
Sbjct: 144 CESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFY 203
Query: 222 DSKADIWSLGITAIELAKGEPP 243
           D + D+WSLG+    +  G PP
Sbjct: 204 DKRCDLWSLGVVLYIMLSGYPP 225

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 99/214 (46%), Gaps = 19/214 (8%)
Query: 59  FTKQERIGKGSFGEVFKGIDNRTQQVVXXXXXXXXXXXXXXXXXXXXXM-VLSQCDSP-- 115
           F K E+IG+G++G V+K  +  T +VV                     + +L + + P  
Sbjct: 6   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 65
Query: 116 --------YGTKLWIIMEYLGGGSALDLMKAGNFEEMHIAVI---LREVLKGLDYLHSER 164
                      KL+++ E+L        M A     + + +I   L ++L+GL + HS R
Sbjct: 66  VKLLDVIHTENKLYLVFEFLHQDLK-KFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 124
Query: 165 KLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSK 224
            LHRD+K  N+L++  G +KLADFG+A             V T ++ APE++    Y S 
Sbjct: 125 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYST 184
Query: 225 A-DIWSLGITAIELAKGE---PPNSELHPMRVLF 254
           A DIWSLG    E+       P +SE+  +  +F
Sbjct: 185 AVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIF 218

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 99/214 (46%), Gaps = 19/214 (8%)
Query: 59  FTKQERIGKGSFGEVFKGIDNRTQQVVXXXXXXXXXXXXXXXXXXXXXM-VLSQCDSP-- 115
           F K E+IG+G++G V+K  +  T +VV                     + +L + + P  
Sbjct: 6   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 65
Query: 116 --------YGTKLWIIMEYLGGGSALDLMKAGNFEEMHIAVI---LREVLKGLDYLHSER 164
                      KL+++ E+L        M A     + + +I   L ++L+GL + HS R
Sbjct: 66  VKLLDVIHTENKLYLVFEFLHQDLK-KFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 124
Query: 165 KLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSK 224
            LHRD+K  N+L++  G +KLADFG+A             V T ++ APE++    Y S 
Sbjct: 125 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYST 184
Query: 225 A-DIWSLGITAIELAKGE---PPNSELHPMRVLF 254
           A DIWSLG    E+       P +SE+  +  +F
Sbjct: 185 AVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIF 218

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 91/200 (45%), Gaps = 18/200 (9%)
Query: 64  RIGKGSFGEVFKG-IDNRTQQVVXXXXXXXXXXXXXXXXXXXXXMVLSQCD--------- 113
           ++G+G FG V+KG ++N T  V                       V+++C          
Sbjct: 38  KMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLG 97
Query: 114 -SPYGTKLWIIMEYLGGGSALDLMKAGNFE---EMHIAV-ILREVLKGLDYLHSERKLHR 168
            S  G  L ++  Y+  GS LD +   +       H+   I +    G+++LH    +HR
Sbjct: 98  FSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHR 157
Query: 169 DIKAANVLLSEMGDVKLADFGVAGTLTN--TTSKRNTFVGTPFWMAPEVIKQSAYDSKAD 226
           DIK+AN+LL E    K++DFG+A        T   +  VGT  +MAPE ++      K+D
Sbjct: 158 DIKSANILLDEAFTAKISDFGLARASEKFAQTVMXSRIVGTTAYMAPEALR-GEITPKSD 216
Query: 227 IWSLGITAIELAKGEPPNSE 246
           I+S G+  +E+  G P   E
Sbjct: 217 IYSFGVVLLEIITGLPAVDE 236

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 99/214 (46%), Gaps = 19/214 (8%)
Query: 59  FTKQERIGKGSFGEVFKGIDNRTQQVVXXXXXXXXXXXXXXXXXXXXXM-VLSQCDSP-- 115
           F K E+IG+G++G V+K  +  T +VV                     + +L + + P  
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 116 --------YGTKLWIIMEYLGGGSALDLMKAGNFEEMHIAVI---LREVLKGLDYLHSER 164
                      KL+++ E+L        M A     + + +I   L ++L+GL + HS R
Sbjct: 65  VKLLDVIHTENKLYLVFEFLHQDLK-KFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 123
Query: 165 KLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSK 224
            LHRD+K  N+L++  G +KLADFG+A             V T ++ APE++    Y S 
Sbjct: 124 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYST 183
Query: 225 A-DIWSLGITAIELAKGE---PPNSELHPMRVLF 254
           A DIWSLG    E+       P +SE+  +  +F
Sbjct: 184 AVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIF 217

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 40/129 (31%), Positives = 66/129 (51%), Gaps = 3/129 (2%)
Query: 112 CDSPYGTKLWIIMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIK 171
           C+      L ++MEY+  GS  D +   +     + +  +++ +G+ YLH++  +HRD+ 
Sbjct: 102 CEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLA 161
Query: 172 AANVLLSEMGDVKLADFGVAGTLTNTTSK---RNTFVGTPFWMAPEVIKQSAYDSKADIW 228
           A NVLL     VK+ DFG+A  +         R       FW APE +K+  +   +D+W
Sbjct: 162 ARNVLLDNDRLVKIGDFGLAKAVPEGHEXYRVREDGDSPVFWYAPECLKEYKFYYASDVW 221
Query: 229 SLGITAIEL 237
           S G+T  EL
Sbjct: 222 SFGVTLYEL 230

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 37/94 (39%), Positives = 60/94 (63%), Gaps = 1/94 (1%)
Query: 149 ILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTP 208
           ++R+ L+GLD+LH+   +HRD+K  N+L++  G VKLADFG+A   +   +     V T 
Sbjct: 117 LMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALFPVVV-TL 175
Query: 209 FWMAPEVIKQSAYDSKADIWSLGITAIELAKGEP 242
           ++ APEV+ QS Y +  D+WS+G    E+ + +P
Sbjct: 176 WYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKP 209

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 40/112 (35%), Positives = 61/112 (54%), Gaps = 4/112 (3%)
Query: 135 LMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTL 194
           L+K  +    HI   L ++L+GL Y+HS   LHRD+K +N+LL+   D+K+ DFG+A   
Sbjct: 115 LLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKIXDFGLARVA 174
Query: 195 T---NTTSKRNTFVGTPFWMAPEVIKQS-AYDSKADIWSLGITAIELAKGEP 242
               + T     +V T ++ APE++  S  Y    DIWS+G    E+    P
Sbjct: 175 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP 226

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 73/263 (27%), Positives = 116/263 (44%), Gaps = 30/263 (11%)
Query: 53  VDP-ELIFTKQERIGKGSFGEVFKGIDNRTQQVVXXXXXXXXXXXXXXXXXXXXXMVLS- 110
           +DP EL F ++  IG G FG V  G      +V                      M LS 
Sbjct: 4   IDPSELTFVQE--IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSH 61
Query: 111 -QCDSPYGTKL-----WIIMEYLGGGSALDLMKA--GNFEEMHIAVILREVLKGLDYLHS 162
            +    YG  L      ++ E++  G   D ++   G F    +  +  +V +G+ YL  
Sbjct: 62  PKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE 121
Query: 163 ERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPF---WMAPEVIKQS 219
              +HRD+ A N L+ E   +K++DFG+   + +     +T  GT F   W +PEV   S
Sbjct: 122 ASVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST--GTKFPVKWASPEVFSFS 179
Query: 220 AYDSKADIWSLGITAIEL-AKGEPP-----NSE-LHPMRVLFLIPKNNPPQLTGNYTKQF 272
            Y SK+D+WS G+   E+ ++G+ P     NSE +  +   F + K   P+L   +  Q 
Sbjct: 180 RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYK---PRLASTHVYQ- 235
Query: 273 KEFVEACLNKDPENRPTAKELLK 295
              +  C  + PE+RP    LL+
Sbjct: 236 --IMNHCWKERPEDRPAFSRLLR 256

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 64/206 (31%), Positives = 96/206 (46%), Gaps = 27/206 (13%)
Query: 112 CDSPYGTKLWIIMEYLGGGSALDLMKAGNFEEMHIAVI--LREVLKGLDYLHSERKLHRD 169
           C S     L +IMEYL  GS  D ++A      HI ++    ++ KG++YL ++R +HRD
Sbjct: 83  CYSAGRRNLKLIMEYLPYGSLRDYLQAHAERIDHIKLLQYTSQICKGMEYLGTKRYIHRD 142
Query: 170 IKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTP-----FWMAPEVIKQSAYDSK 224
           +   N+L+     VK+ DFG+   L     K    V  P     FW APE + +S +   
Sbjct: 143 LATRNILVENENRVKIGDFGLTKVLPQ--DKEXXKVKEPGESPIFWYAPESLTESKFSVA 200
Query: 225 ADIWSLGI------TAIELAKGEPP-------NSELHPMRVLFLIP--KNNP--PQLTGN 267
           +D+WS G+      T IE +K  P        N +   M V  LI   KNN   P+  G 
Sbjct: 201 SDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGC 260
Query: 268 YTKQFKEFVEACLNKDPENRPTAKEL 293
             + +    E C N +   RP+ ++L
Sbjct: 261 PDEIYMIMTE-CWNNNVNQRPSFRDL 285

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 63/266 (23%), Positives = 119/266 (44%), Gaps = 19/266 (7%)
Query: 60  TKQERIGKGSFGEVFKGIDNRTQQVVXXXXXXXXXXXXXXXXXXXXXMVLSQCDSPYGTK 119
           +K E +G G FG+V K  +  T   +                      V++Q D     +
Sbjct: 92  SKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEIS-VMNQLDHANLIQ 150
Query: 120 LW----------IIMEYLGGGSALDLM--KAGNFEEMHIAVILREVLKGLDYLHSERKLH 167
           L+          ++MEY+ GG   D +  ++ N  E+   + ++++ +G+ ++H    LH
Sbjct: 151 LYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILH 210
Query: 168 RDIKAANVLL--SEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKA 225
            D+K  N+L    +   +K+ DFG+A         +  F GTP ++APEV+         
Sbjct: 211 LDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNF-GTPEFLAPEVVNYDFVSFPT 269
Query: 226 DIWSLGITAIELAKGEPP---NSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNK 282
           D+WS+G+ A  L  G  P   +++   +  +     +   +   + +++ KEF+   L K
Sbjct: 270 DMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEAKEFISKLLIK 329
Query: 283 DPENRPTAKELLKFPFIRKAKKNAYL 308
           +   R +A E LK P++   K ++ L
Sbjct: 330 EKSWRISASEALKHPWLSDHKLHSRL 355

>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 86/201 (42%), Gaps = 20/201 (9%)
Query: 120 LWIIMEYLGGGSALDLMKAGN---FEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVL 176
           L I+ E L GG     ++      F E   + I + + + + YLHS    HRD+K  N+L
Sbjct: 134 LLIVXECLDGGELFSRIQDRGDQAFTEREASEIXKSIGEAIQYLHSINIAHRDVKPENLL 193
Query: 177 LSEM---GDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGIT 233
            +       +KL DFG A   T+  S   T   TP+++APEV+    YD   D WSLG+ 
Sbjct: 194 YTSKRPNAILKLTDFGFAKETTSHNS-LTTPCYTPYYVAPEVLGPEKYDKSCDXWSLGVI 252
Query: 234 AIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNY----------TKQFKEFVEACLNKD 283
              L  G PP    H    L + P        G Y          +++ K  +   L  +
Sbjct: 253 XYILLCGYPPFYSNHG---LAISPGXKTRIRXGQYEFPNPEWSEVSEEVKXLIRNLLKTE 309
Query: 284 PENRPTAKELLKFPFIRKAKK 304
           P  R T  E    P+I ++ K
Sbjct: 310 PTQRXTITEFXNHPWIXQSTK 330

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 90/200 (45%), Gaps = 18/200 (9%)
Query: 64  RIGKGSFGEVFKG-IDNRTQQVVXXXXXXXXXXXXXXXXXXXXXMVLSQCD--------- 113
           ++G+G FG V+KG ++N T  V                       V+++C          
Sbjct: 38  KMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLG 97
Query: 114 -SPYGTKLWIIMEYLGGGSALDLMKAGNFE---EMHIAV-ILREVLKGLDYLHSERKLHR 168
            S  G  L ++  Y+  GS LD +   +       H+   I +    G+++LH    +HR
Sbjct: 98  FSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHR 157
Query: 169 DIKAANVLLSEMGDVKLADFGVAGTLTN--TTSKRNTFVGTPFWMAPEVIKQSAYDSKAD 226
           DIK+AN+LL E    K++DFG+A        T      VGT  +MAPE ++      K+D
Sbjct: 158 DIKSANILLDEAFTAKISDFGLARASEKFAQTVMXXRIVGTTAYMAPEALR-GEITPKSD 216
Query: 227 IWSLGITAIELAKGEPPNSE 246
           I+S G+  +E+  G P   E
Sbjct: 217 IYSFGVVLLEIITGLPAVDE 236

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 71/273 (26%), Positives = 116/273 (42%), Gaps = 28/273 (10%)
Query: 45  ASRRNSLKVDPELIFTKQERIGKGSFGEVFKGI----DNRTQQVVXXXXXXXXXXXXXXX 100
           A  +  L++  E  F K + +G G+FG V+KG+      + +  V               
Sbjct: 7   APNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK 66
Query: 101 XXXXXXMVLSQCDSPYGTKLW---------IIMEYLGGGSALDLMKA--GNFEEMHIAVI 149
                  V++  D+P+  +L          +IM+ +  G  LD ++    N    ++   
Sbjct: 67  EILDEAYVMASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNW 126
Query: 150 LREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVG-TP 208
             ++ KG++YL   R +HRD+ A NVL+     VK+ DFG A  L     + +   G  P
Sbjct: 127 CVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVP 186
Query: 209 F-WMAPEVIKQSAYDSKADIWSLGITAIELAK-GEPPNSELHPMRVLFLIPKN----NPP 262
             WMA E I    Y  ++D+WS G+T  EL   G  P   +    +  ++ K      PP
Sbjct: 187 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPP 246
Query: 263 QLTGN-YTKQFKEFVEACLNKDPENRPTAKELL 294
             T + Y    K     C   D ++RP  +EL+
Sbjct: 247 ICTIDVYMIMVK-----CWMIDADSRPKFRELI 274

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 48/148 (32%), Positives = 81/148 (54%), Gaps = 5/148 (3%)
Query: 152 EVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVG-TPF- 209
           +V +G++YL S++ +HRD+ A NVL++E   +K+ADFG+A  + +    + T  G  P  
Sbjct: 158 QVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDXXKKTTNGRLPVK 217
Query: 210 WMAPEVIKQSAYDSKADIWSLGITAIEL-AKGEPPNSELHPMRVLF-LIPKNNPPQLTGN 267
           WMAPE +    Y  ++D+WS G+   E+   G  P   + P+  LF L+ + +      N
Sbjct: 218 WMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV-PVEELFKLLKEGHRMDKPSN 276
Query: 268 YTKQFKEFVEACLNKDPENRPTAKELLK 295
            T +    +  C +  P  RPT K+L++
Sbjct: 277 CTNELYMMMRDCWHAVPSQRPTFKQLVE 304

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 66/272 (24%), Positives = 115/272 (42%), Gaps = 27/272 (9%)
Query: 48  RNSLKVDPELIFTKQERIGKGSFGEVFKGIDNRTQQVVXXXXXXXXXXXXXXXXXXXXXM 107
           R SLK+        ++++G G FGEV+    N+  +V                       
Sbjct: 187 RESLKL--------EKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMK 238
Query: 108 VLSQCDS-----PYGTK--LWIIMEYLGGGSALDLMKAGNFEEMHIAVIL---REVLKGL 157
            L Q D         TK  ++II E++  GS LD +K+    +  +  ++    ++ +G+
Sbjct: 239 TL-QHDKLVKLHAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGM 297
Query: 158 DYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPF-WMAPEVI 216
            ++     +HRD++AAN+L+S     K+ADFG+A  + +           P  W APE I
Sbjct: 298 AFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAI 357
Query: 217 KQSAYDSKADIWSLGITAIELAK-GEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEF 275
              ++  K+D+WS GI  +E+   G  P   +    V+  + +        N  ++    
Sbjct: 358 NFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELYNI 417
Query: 276 VEACLNKDPENRPTAKELLKFPFIRKAKKNAY 307
           +  C    PE RPT      F +I+    + Y
Sbjct: 418 MMRCWKNRPEERPT------FEYIQSVLDDFY 443

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 41/126 (32%), Positives = 66/126 (52%), Gaps = 9/126 (7%)
Query: 119 KLWIIMEYLGGGSALDLMKA--GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVL 176
           +L ++MEYL  G   D ++      +   + +   ++ KG++YL S R +HRD+ A N+L
Sbjct: 84  ELRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNIL 143
Query: 177 LSEMGDVKLADFGVAGTLTNTTSKRNTFVGTP-----FWMAPEVIKQSAYDSKADIWSLG 231
           +     VK+ADFG+A  L     K    V  P     FW APE +  + +  ++D+WS G
Sbjct: 144 VESEAHVKIADFGLAKLL--PLDKDXXVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFG 201
Query: 232 ITAIEL 237
           +   EL
Sbjct: 202 VVLYEL 207

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 45/134 (33%), Positives = 72/134 (53%), Gaps = 12/134 (8%)
Query: 120 LWIIMEYLGGGSALDLMKAGNFE----EMHIAVILREVLKGLDYLHSERKLHRDIKAANV 175
           L+++M+Y  GG  L L+    FE    E      L E++  +D +H    +HRDIK  N+
Sbjct: 149 LYLVMDYYVGGDLLTLLS--KFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNI 206
Query: 176 LLSEMGDVKLADFGVAGTLT-NTTSKRNTFVGTPFWMAPEVIK-----QSAYDSKADIWS 229
           L+   G ++LADFG    L  + T + +  VGTP +++PE+++     +  Y  + D WS
Sbjct: 207 LMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWS 266
Query: 230 LGITAIELAKGEPP 243
           LG+   E+  GE P
Sbjct: 267 LGVCMYEMLYGETP 280

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 73/263 (27%), Positives = 116/263 (44%), Gaps = 30/263 (11%)
Query: 53  VDP-ELIFTKQERIGKGSFGEVFKGIDNRTQQVVXXXXXXXXXXXXXXXXXXXXXMVLS- 110
           +DP EL F ++  IG G FG V  G      +V                      M LS 
Sbjct: 4   IDPSELTFVQE--IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSH 61
Query: 111 -QCDSPYGTKL-----WIIMEYLGGGSALDLMKA--GNFEEMHIAVILREVLKGLDYLHS 162
            +    YG  L      ++ E++  G   D ++   G F    +  +  +V +G+ YL  
Sbjct: 62  PKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE 121
Query: 163 ERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPF---WMAPEVIKQS 219
              +HRD+ A N L+ E   +K++DFG+   + +     +T  GT F   W +PEV   S
Sbjct: 122 ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST--GTKFPVKWASPEVFSFS 179
Query: 220 AYDSKADIWSLGITAIEL-AKGEPP-----NSE-LHPMRVLFLIPKNNPPQLTGNYTKQF 272
            Y SK+D+WS G+   E+ ++G+ P     NSE +  +   F + K   P+L   +  Q 
Sbjct: 180 RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYK---PRLASTHVYQ- 235
Query: 273 KEFVEACLNKDPENRPTAKELLK 295
              +  C  + PE+RP    LL+
Sbjct: 236 --IMNHCWKERPEDRPAFSRLLR 256

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 48/148 (32%), Positives = 81/148 (54%), Gaps = 5/148 (3%)
Query: 152 EVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVG-TPF- 209
           +V +G++YL S++ +HRD+ A NVL++E   +K+ADFG+A  + +    + T  G  P  
Sbjct: 151 QVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVK 210
Query: 210 WMAPEVIKQSAYDSKADIWSLGITAIEL-AKGEPPNSELHPMRVLF-LIPKNNPPQLTGN 267
           WMAPE +    Y  ++D+WS G+   E+   G  P   + P+  LF L+ + +      N
Sbjct: 211 WMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV-PVEELFKLLKEGHRMDKPSN 269
Query: 268 YTKQFKEFVEACLNKDPENRPTAKELLK 295
            T +    +  C +  P  RPT K+L++
Sbjct: 270 CTNELYMMMRDCWHAVPSQRPTFKQLVE 297

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 48/148 (32%), Positives = 81/148 (54%), Gaps = 5/148 (3%)
Query: 152 EVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVG-TPF- 209
           +V +G++YL S++ +HRD+ A NVL++E   +K+ADFG+A  + +    + T  G  P  
Sbjct: 158 QVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVK 217
Query: 210 WMAPEVIKQSAYDSKADIWSLGITAIEL-AKGEPPNSELHPMRVLF-LIPKNNPPQLTGN 267
           WMAPE +    Y  ++D+WS G+   E+   G  P   + P+  LF L+ + +      N
Sbjct: 218 WMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV-PVEELFKLLKEGHRMDKPSN 276
Query: 268 YTKQFKEFVEACLNKDPENRPTAKELLK 295
            T +    +  C +  P  RPT K+L++
Sbjct: 277 CTNELYMMMRDCWHAVPSQRPTFKQLVE 304

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 48/148 (32%), Positives = 81/148 (54%), Gaps = 5/148 (3%)
Query: 152 EVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVG-TPF- 209
           +V +G++YL S++ +HRD+ A NVL++E   +K+ADFG+A  + +    + T  G  P  
Sbjct: 158 QVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVK 217
Query: 210 WMAPEVIKQSAYDSKADIWSLGITAIEL-AKGEPPNSELHPMRVLF-LIPKNNPPQLTGN 267
           WMAPE +    Y  ++D+WS G+   E+   G  P   + P+  LF L+ + +      N
Sbjct: 218 WMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV-PVEELFKLLKEGHRMDKPSN 276
Query: 268 YTKQFKEFVEACLNKDPENRPTAKELLK 295
            T +    +  C +  P  RPT K+L++
Sbjct: 277 CTNELYMMMRDCWHAVPSQRPTFKQLVE 304

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 71/277 (25%), Positives = 117/277 (42%), Gaps = 28/277 (10%)
Query: 41  GSTTASRRNSLKVDPELIFTKQERIGKGSFGEVFKGI----DNRTQQVVXXXXXXXXXXX 96
            S  A  +  L++  E  F K + +G G+FG V+KG+      + +  V           
Sbjct: 5   ASGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSP 64
Query: 97  XXXXXXXXXXMVLSQCDSPYGTKLW---------IIMEYLGGGSALDLMKA--GNFEEMH 145
                      V++  D+P+  +L          +I + +  G  LD ++    N    +
Sbjct: 65  KANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQY 124
Query: 146 IAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFV 205
           +     ++ KG++YL   R +HRD+ A NVL+     VK+ DFG+A  L     + +   
Sbjct: 125 LLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG 184
Query: 206 G-TPF-WMAPEVIKQSAYDSKADIWSLGITAIELAK-GEPPNSELHPMRVLFLIPKN--- 259
           G  P  WMA E I    Y  ++D+WS G+T  EL   G  P   +    +  ++ K    
Sbjct: 185 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL 244
Query: 260 -NPPQLTGN-YTKQFKEFVEACLNKDPENRPTAKELL 294
             PP  T + Y    K     C   D ++RP  +EL+
Sbjct: 245 PQPPICTIDVYMIMVK-----CWMIDADSRPKFRELI 276

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 48/148 (32%), Positives = 81/148 (54%), Gaps = 5/148 (3%)
Query: 152 EVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVG-TPF- 209
           +V +G++YL S++ +HRD+ A NVL++E   +K+ADFG+A  + +    + T  G  P  
Sbjct: 150 QVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVK 209
Query: 210 WMAPEVIKQSAYDSKADIWSLGITAIEL-AKGEPPNSELHPMRVLF-LIPKNNPPQLTGN 267
           WMAPE +    Y  ++D+WS G+   E+   G  P   + P+  LF L+ + +      N
Sbjct: 210 WMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV-PVEELFKLLKEGHRMDKPSN 268
Query: 268 YTKQFKEFVEACLNKDPENRPTAKELLK 295
            T +    +  C +  P  RPT K+L++
Sbjct: 269 CTNELYMMMRDCWHAVPSQRPTFKQLVE 296

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 48/148 (32%), Positives = 81/148 (54%), Gaps = 5/148 (3%)
Query: 152 EVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVG-TPF- 209
           +V +G++YL S++ +HRD+ A NVL++E   +K+ADFG+A  + +    + T  G  P  
Sbjct: 143 QVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVK 202
Query: 210 WMAPEVIKQSAYDSKADIWSLGITAIEL-AKGEPPNSELHPMRVLF-LIPKNNPPQLTGN 267
           WMAPE +    Y  ++D+WS G+   E+   G  P   + P+  LF L+ + +      N
Sbjct: 203 WMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV-PVEELFKLLKEGHRMDKPSN 261
Query: 268 YTKQFKEFVEACLNKDPENRPTAKELLK 295
            T +    +  C +  P  RPT K+L++
Sbjct: 262 CTNELYMMMRDCWHAVPSQRPTFKQLVE 289

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 73/263 (27%), Positives = 116/263 (44%), Gaps = 30/263 (11%)
Query: 53  VDP-ELIFTKQERIGKGSFGEVFKGIDNRTQQVVXXXXXXXXXXXXXXXXXXXXXMVLS- 110
           +DP EL F ++  IG G FG V  G      +V                      M LS 
Sbjct: 2   IDPSELTFVQE--IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSH 59
Query: 111 -QCDSPYGTKL-----WIIMEYLGGGSALDLMKA--GNFEEMHIAVILREVLKGLDYLHS 162
            +    YG  L      ++ E++  G   D ++   G F    +  +  +V +G+ YL  
Sbjct: 60  PKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE 119
Query: 163 ERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPF---WMAPEVIKQS 219
              +HRD+ A N L+ E   +K++DFG+   + +     +T  GT F   W +PEV   S
Sbjct: 120 ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST--GTKFPVKWASPEVFSFS 177
Query: 220 AYDSKADIWSLGITAIEL-AKGEPP-----NSE-LHPMRVLFLIPKNNPPQLTGNYTKQF 272
            Y SK+D+WS G+   E+ ++G+ P     NSE +  +   F + K   P+L   +  Q 
Sbjct: 178 RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYK---PRLASTHVYQ- 233
Query: 273 KEFVEACLNKDPENRPTAKELLK 295
              +  C  + PE+RP    LL+
Sbjct: 234 --IMNHCWKERPEDRPAFSRLLR 254

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 48/148 (32%), Positives = 81/148 (54%), Gaps = 5/148 (3%)
Query: 152 EVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVG-TPF- 209
           +V +G++YL S++ +HRD+ A NVL++E   +K+ADFG+A  + +    + T  G  P  
Sbjct: 147 QVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVK 206
Query: 210 WMAPEVIKQSAYDSKADIWSLGITAIEL-AKGEPPNSELHPMRVLF-LIPKNNPPQLTGN 267
           WMAPE +    Y  ++D+WS G+   E+   G  P   + P+  LF L+ + +      N
Sbjct: 207 WMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV-PVEELFKLLKEGHRMDKPSN 265
Query: 268 YTKQFKEFVEACLNKDPENRPTAKELLK 295
            T +    +  C +  P  RPT K+L++
Sbjct: 266 CTNELYMMMRDCWHAVPSQRPTFKQLVE 293

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 73/263 (27%), Positives = 116/263 (44%), Gaps = 30/263 (11%)
Query: 53  VDP-ELIFTKQERIGKGSFGEVFKGIDNRTQQVVXXXXXXXXXXXXXXXXXXXXXMVLS- 110
           +DP EL F ++  IG G FG V  G      +V                      M LS 
Sbjct: 7   IDPSELTFVQE--IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSH 64
Query: 111 -QCDSPYGTKL-----WIIMEYLGGGSALDLMKA--GNFEEMHIAVILREVLKGLDYLHS 162
            +    YG  L      ++ E++  G   D ++   G F    +  +  +V +G+ YL  
Sbjct: 65  PKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE 124
Query: 163 ERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPF---WMAPEVIKQS 219
              +HRD+ A N L+ E   +K++DFG+   + +     +T  GT F   W +PEV   S
Sbjct: 125 ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST--GTKFPVKWASPEVFSFS 182
Query: 220 AYDSKADIWSLGITAIEL-AKGEPP-----NSE-LHPMRVLFLIPKNNPPQLTGNYTKQF 272
            Y SK+D+WS G+   E+ ++G+ P     NSE +  +   F + K   P+L   +  Q 
Sbjct: 183 RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYK---PRLASTHVYQ- 238
Query: 273 KEFVEACLNKDPENRPTAKELLK 295
              +  C  + PE+RP    LL+
Sbjct: 239 --IMNHCWRERPEDRPAFSRLLR 259

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 41/125 (32%), Positives = 65/125 (52%), Gaps = 9/125 (7%)
Query: 120 LWIIMEYLGGGSALDLMKA--GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLL 177
           L ++MEYL  G   D ++      +   + +   ++ KG++YL S R +HRD+ A N+L+
Sbjct: 88  LRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILV 147
Query: 178 SEMGDVKLADFGVAGTLTNTTSKRNTFVGTP-----FWMAPEVIKQSAYDSKADIWSLGI 232
                VK+ADFG+A  L     K    V  P     FW APE +  + +  ++D+WS G+
Sbjct: 148 ESEAHVKIADFGLAKLL--PLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGV 205
Query: 233 TAIEL 237
              EL
Sbjct: 206 VLYEL 210

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 68/272 (25%), Positives = 116/272 (42%), Gaps = 26/272 (9%)
Query: 45  ASRRNSLKVDPELIFTKQERIGKGSFGEVFKGI----DNRTQQVVXXXXXXXXXXXXXXX 100
           A  +  L++  E  F K + +G G+FG V+KG+      + +  V               
Sbjct: 13  APNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK 72
Query: 101 XXXXXXMVLSQCDSPYGTKLW---------IIMEYLGGGSALDLMKA--GNFEEMHIAVI 149
                  V++  D+P+  +L          +I + +  G  LD ++    N    ++   
Sbjct: 73  EILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW 132
Query: 150 LREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVG-TP 208
             ++ KG++YL   R +HRD+ A NVL+     VK+ DFG+A  L     + +   G  P
Sbjct: 133 CVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 192
Query: 209 F-WMAPEVIKQSAYDSKADIWSLGITAIELAK-GEPPNSELHPMRVLFLIPKN----NPP 262
             WMA E I    Y  ++D+WS G+T  EL   G  P   +    +  ++ K      PP
Sbjct: 193 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPP 252
Query: 263 QLTGNYTKQFKEFVEACLNKDPENRPTAKELL 294
             T +     ++    C   D ++RP  +EL+
Sbjct: 253 ICTIDVYMIMRK----CWMIDADSRPKFRELI 280

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 71/271 (26%), Positives = 117/271 (43%), Gaps = 20/271 (7%)
Query: 48  RNSLKVDPELIFTKQERIGKGSFGEVFKGIDNRTQQVVXXXXXXXXXXXXXXXXXXXXXM 107
           + S K D    +T +  IG+GS+GEV   +   T+ +                       
Sbjct: 17  QGSTKGDINQYYTLENTIGRGSWGEVKIAVQKGTR-IRRAAKKIPKYFVEDVDRFKQEIE 75
Query: 108 VLSQCDSPY----------GTKLWIIMEYLGGGSALD-LMKAGNFEEMHIAVILREVLKG 156
           ++   D P            T ++++ME   GG   + ++    F E   A I+++VL  
Sbjct: 76  IMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSA 135
Query: 157 LDYLHSERKLHRDIKAANVL-LSEMGD--VKLADFGVAGTLTNTTSKRNTFVGTPFWMAP 213
           + Y H     HRD+K  N L L++  D  +KL DFG+A         R T VGTP++++P
Sbjct: 136 VAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMR-TKVGTPYYVSP 194
Query: 214 EVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNN---PPQLTGNYTK 270
           +V+ +  Y  + D WS G+    L  G PP S      V+  I +     P +   N + 
Sbjct: 195 QVL-EGLYGPECDEWSAGVMMYVLLCGYPPFSAPTDXEVMLKIREGTFTFPEKDWLNVSP 253
Query: 271 QFKEFVEACLNKDPENRPTAKELLKFPFIRK 301
           Q +  +   L K P+ R T+ + L+  +  K
Sbjct: 254 QAESLIRRLLTKSPKQRITSLQALEHEWFEK 284

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 41/125 (32%), Positives = 65/125 (52%), Gaps = 9/125 (7%)
Query: 120 LWIIMEYLGGGSALDLMKA--GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLL 177
           L ++MEYL  G   D ++      +   + +   ++ KG++YL S R +HRD+ A N+L+
Sbjct: 89  LRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILV 148
Query: 178 SEMGDVKLADFGVAGTLTNTTSKRNTFVGTP-----FWMAPEVIKQSAYDSKADIWSLGI 232
                VK+ADFG+A  L     K    V  P     FW APE +  + +  ++D+WS G+
Sbjct: 149 ESEAHVKIADFGLAKLL--PLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGV 206
Query: 233 TAIEL 237
              EL
Sbjct: 207 VLYEL 211

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 48/148 (32%), Positives = 81/148 (54%), Gaps = 5/148 (3%)
Query: 152 EVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVG-TPF- 209
           +V +G++YL S++ +HRD+ A NVL++E   +K+ADFG+A  + +    + T  G  P  
Sbjct: 158 QVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVK 217
Query: 210 WMAPEVIKQSAYDSKADIWSLGITAIEL-AKGEPPNSELHPMRVLF-LIPKNNPPQLTGN 267
           WMAPE +    Y  ++D+WS G+   E+   G  P   + P+  LF L+ + +      N
Sbjct: 218 WMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV-PVEELFKLLKEGHRMDKPSN 276
Query: 268 YTKQFKEFVEACLNKDPENRPTAKELLK 295
            T +    +  C +  P  RPT K+L++
Sbjct: 277 CTNELYMMMRDCWHAVPSQRPTFKQLVE 304

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 76/270 (28%), Positives = 119/270 (44%), Gaps = 32/270 (11%)
Query: 48  RNSLK--VDP-ELIFTKQERIGKGSFGEVFKGIDNRTQQVVXXXXXXXXXXXXXXXXXXX 104
           R SL   +DP EL F ++  IG G FG V  G      +V                    
Sbjct: 17  RGSLHMVIDPSELTFVQE--IGSGQFGLVHLGYWLNKDKVAIKTIKEGSMSEDDFIEEAE 74
Query: 105 XXMVLS--QCDSPYGTKL-----WIIMEYLGGGSALDLMKA--GNFEEMHIAVILREVLK 155
             M LS  +    YG  L      ++ E++  G   D ++   G F    +  +  +V +
Sbjct: 75  VMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCE 134
Query: 156 GLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPF---WMA 212
           G+ YL     +HRD+ A N L+ E   +K++DFG+   + +     +T  GT F   W +
Sbjct: 135 GMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST--GTKFPVKWAS 192
Query: 213 PEVIKQSAYDSKADIWSLGITAIEL-AKGEPP-----NSE-LHPMRVLFLIPKNNPPQLT 265
           PEV   S Y SK+D+WS G+   E+ ++G+ P     NSE +  +   F + K   P+L 
Sbjct: 193 PEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYK---PRLA 249
Query: 266 GNYTKQFKEFVEACLNKDPENRPTAKELLK 295
             +  Q    +  C  + PE+RP    LL+
Sbjct: 250 STHVYQ---IMNHCWKERPEDRPAFSRLLR 276

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 68/272 (25%), Positives = 116/272 (42%), Gaps = 26/272 (9%)
Query: 45  ASRRNSLKVDPELIFTKQERIGKGSFGEVFKGI----DNRTQQVVXXXXXXXXXXXXXXX 100
           A  +  L++  E  F K + +G G+FG V+KG+      + +  V               
Sbjct: 6   APNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK 65
Query: 101 XXXXXXMVLSQCDSPYGTKLW---------IIMEYLGGGSALDLMKA--GNFEEMHIAVI 149
                  V++  D+P+  +L          +I + +  G  LD ++    N    ++   
Sbjct: 66  EILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW 125
Query: 150 LREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVG-TP 208
             ++ KG++YL   R +HRD+ A NVL+     VK+ DFG+A  L     + +   G  P
Sbjct: 126 CVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 185
Query: 209 F-WMAPEVIKQSAYDSKADIWSLGITAIELAK-GEPPNSELHPMRVLFLIPKN----NPP 262
             WMA E I    Y  ++D+WS G+T  EL   G  P   +    +  ++ K      PP
Sbjct: 186 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPP 245
Query: 263 QLTGNYTKQFKEFVEACLNKDPENRPTAKELL 294
             T +     ++    C   D ++RP  +EL+
Sbjct: 246 ICTIDVYMIMRK----CWMIDADSRPKFRELI 273

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 71/276 (25%), Positives = 117/276 (42%), Gaps = 28/276 (10%)
Query: 42  STTASRRNSLKVDPELIFTKQERIGKGSFGEVFKGI----DNRTQQVVXXXXXXXXXXXX 97
           S  A  +  L++  E  F K + +  G+FG V+KG+      + +  V            
Sbjct: 7   SGEAPNQALLRILKETEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPK 66
Query: 98  XXXXXXXXXMVLSQCDSPYGTKLW---------IIMEYLGGGSALDLMKA--GNFEEMHI 146
                     V++  D+P+  +L          +IM+ +  G  LD ++    N    ++
Sbjct: 67  ANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYL 126
Query: 147 AVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVG 206
                ++ KG++YL   R +HRD+ A NVL+     VK+ DFG+A  L     + +   G
Sbjct: 127 LNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 186
Query: 207 -TPF-WMAPEVIKQSAYDSKADIWSLGITAIELAK-GEPPNSELHPMRVLFLIPKN---- 259
             P  WMA E I    Y  ++D+WS G+T  EL   G  P   +    +  ++ K     
Sbjct: 187 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLP 246
Query: 260 NPPQLTGN-YTKQFKEFVEACLNKDPENRPTAKELL 294
            PP  T + Y    K     C   D ++RP  +EL+
Sbjct: 247 QPPICTIDVYMIMVK-----CWMIDADSRPKFRELI 277

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 99/214 (46%), Gaps = 19/214 (8%)
Query: 59  FTKQERIGKGSFGEVFKGIDNRTQQVVXXXXXXXXXXXXXXXXXXXXXM-VLSQCDSP-- 115
           F K E+IG+G++G V+K  +  T +VV                     + +L + + P  
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 116 --------YGTKLWIIMEYLGGGSALDLMKAGNFEEMHIAVI---LREVLKGLDYLHSER 164
                      KL+++ E++        M A     + + +I   L ++L+GL + HS R
Sbjct: 64  VKLLDVIHTENKLYLVFEHVHQDLK-TFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 122
Query: 165 KLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSK 224
            LHRD+K  N+L++  G +KLADFG+A             V T ++ APE++    Y S 
Sbjct: 123 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYST 182
Query: 225 A-DIWSLGITAIELAKGE---PPNSELHPMRVLF 254
           A DIWSLG    E+       P +SE+  +  +F
Sbjct: 183 AVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIF 216

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 53/197 (26%), Positives = 91/197 (46%), Gaps = 14/197 (7%)
Query: 59  FTKQERIGKGSFGEVFKGIDNRTQQVVXXXXXXXXXXXXXXXXXXXXXMVLSQCDSPYGT 118
           + K E++G+G++G V+K  D++ + V                       +L +   P   
Sbjct: 23  YQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIV 82
Query: 119 KLW----------IIMEYLGGG--SALDLMKAGNFEEMHIAVILREVLKGLDYLHSERKL 166
            L           ++ E++       LD  K G  ++  I + L ++L+G+ + H  R L
Sbjct: 83  SLIDVIHSERCLTLVFEFMEKDLKKVLDENKTG-LQDSQIKIYLYQLLRGVAHCHQHRIL 141
Query: 167 HRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQS-AYDSKA 225
           HRD+K  N+L++  G +KLADFG+A             V T ++ AP+V+  S  Y +  
Sbjct: 142 HRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSV 201
Query: 226 DIWSLGITAIELAKGEP 242
           DIWS+G    E+  G+P
Sbjct: 202 DIWSIGCIFAEMITGKP 218

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 71/269 (26%), Positives = 116/269 (43%), Gaps = 20/269 (7%)
Query: 50  SLKVDPELIFTKQERIGKGSFGEVFKGIDNRTQQVVXXXXXXXXXXXXXXXXXXXXXMVL 109
           S K D    +T +  IG+GS+GEV   +   T+ +                       ++
Sbjct: 2   STKGDINQYYTLENTIGRGSWGEVKIAVQKGTR-IRRAAKKIPKYFVEDVDRFKQEIEIM 60
Query: 110 SQCDSPY----------GTKLWIIMEYLGGGSALD-LMKAGNFEEMHIAVILREVLKGLD 158
              D P            T ++++ME   GG   + ++    F E   A I+++VL  + 
Sbjct: 61  KSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVA 120
Query: 159 YLHSERKLHRDIKAANVL-LSEMGD--VKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEV 215
           Y H     HRD+K  N L L++  D  +KL DFG+A         R T VGTP++++P+V
Sbjct: 121 YCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMR-TKVGTPYYVSPQV 179
Query: 216 IKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNN---PPQLTGNYTKQF 272
           + +  Y  + D WS G+    L  G PP S      V+  I +     P +   N + Q 
Sbjct: 180 L-EGLYGPECDEWSAGVMMYVLLCGYPPFSAPTDXEVMLKIREGTFTFPEKDWLNVSPQA 238
Query: 273 KEFVEACLNKDPENRPTAKELLKFPFIRK 301
           +  +   L K P+ R T+ + L+  +  K
Sbjct: 239 ESLIRRLLTKSPKQRITSLQALEHEWFEK 267

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 71/276 (25%), Positives = 117/276 (42%), Gaps = 28/276 (10%)
Query: 42  STTASRRNSLKVDPELIFTKQERIGKGSFGEVFKGI----DNRTQQVVXXXXXXXXXXXX 97
           S  A  +  L++  E  F K + +G G+FG V+KG+      + +  V            
Sbjct: 34  SGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPK 93
Query: 98  XXXXXXXXXMVLSQCDSPYGTKLW---------IIMEYLGGGSALDLMKA--GNFEEMHI 146
                     V++  D+P+  +L          +I + +  G  LD ++    N    ++
Sbjct: 94  ANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYL 153
Query: 147 AVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVG 206
                ++ KG++YL   R +HRD+ A NVL+     VK+ DFG+A  L     + +   G
Sbjct: 154 LNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 213
Query: 207 -TPF-WMAPEVIKQSAYDSKADIWSLGITAIELAK-GEPPNSELHPMRVLFLIPKN---- 259
             P  WMA E I    Y  ++D+WS G+T  EL   G  P   +    +  ++ K     
Sbjct: 214 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLP 273
Query: 260 NPPQLTGN-YTKQFKEFVEACLNKDPENRPTAKELL 294
            PP  T + Y    K     C   D ++RP  +EL+
Sbjct: 274 QPPICTIDVYMIMVK-----CWMIDADSRPKFRELI 304

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 41/125 (32%), Positives = 65/125 (52%), Gaps = 9/125 (7%)
Query: 120 LWIIMEYLGGGSALDLMKA--GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLL 177
           L ++MEYL  G   D ++      +   + +   ++ KG++YL S R +HRD+ A N+L+
Sbjct: 101 LRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILV 160
Query: 178 SEMGDVKLADFGVAGTLTNTTSKRNTFVGTP-----FWMAPEVIKQSAYDSKADIWSLGI 232
                VK+ADFG+A  L     K    V  P     FW APE +  + +  ++D+WS G+
Sbjct: 161 ESEAHVKIADFGLAKLL--PLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGV 218
Query: 233 TAIEL 237
              EL
Sbjct: 219 VLYEL 223

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 99/214 (46%), Gaps = 19/214 (8%)
Query: 59  FTKQERIGKGSFGEVFKGIDNRTQQVVXXXXXXXXXXXXXXXXXXXXXM-VLSQCDSP-- 115
           F K E+IG+G++G V+K  +  T +VV                     + +L + + P  
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 67
Query: 116 --------YGTKLWIIMEYLGGGSALDLMKAGNFEEMHIAVI---LREVLKGLDYLHSER 164
                      KL+++ E++        M A     + + +I   L ++L+GL + HS R
Sbjct: 68  VKLLDVIHTENKLYLVFEHVDQDLK-KFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 126
Query: 165 KLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSK 224
            LHRD+K  N+L++  G +KLADFG+A             V T ++ APE++    Y S 
Sbjct: 127 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYST 186
Query: 225 A-DIWSLGITAIELAKGE---PPNSELHPMRVLF 254
           A DIWSLG    E+       P +SE+  +  +F
Sbjct: 187 AVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIF 220

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 65/249 (26%), Positives = 106/249 (42%), Gaps = 29/249 (11%)
Query: 63  ERIGKGSFGEVFKGIDNRTQQVVXXXXXXXXXXXXXXXXXXXXXMVLSQCDSPYGTKL-- 120
           E+IG+G+FGEVF G       +V                      +L Q   P   +L  
Sbjct: 120 EQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIG 179
Query: 121 --------WIIMEYLGGGSALDLMKAGNFEEMHIAVILREV---LKGLDYLHSERKLHRD 169
                   +I+ME + GG  L  ++      + +  +L+ V     G++YL S+  +HRD
Sbjct: 180 VCTQKQPIYIVMELVQGGDFLTFLRTEG-ARLRVKTLLQMVGDAAAGMEYLESKCCIHRD 238
Query: 170 IKAANVLLSEMGDVKLADFGVA-----GTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSK 224
           + A N L++E   +K++DFG++     G    +   R   V    W APE +    Y S+
Sbjct: 239 LAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVK---WTAPEALNYGRYSSE 295
Query: 225 ADIWSLGITAIE-LAKGEPPNSELHPMRVLFLIPKNN---PPQLTGNYTKQFKEFVEACL 280
           +D+WS GI   E  + G  P   L   +    + K      P+L  +    F+  +E C 
Sbjct: 296 SDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLPCPELCPDAV--FR-LMEQCW 352
Query: 281 NKDPENRPT 289
             +P  RP+
Sbjct: 353 AYEPGQRPS 361

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 65/249 (26%), Positives = 106/249 (42%), Gaps = 29/249 (11%)
Query: 63  ERIGKGSFGEVFKGIDNRTQQVVXXXXXXXXXXXXXXXXXXXXXMVLSQCDSPYGTKL-- 120
           E+IG+G+FGEVF G       +V                      +L Q   P   +L  
Sbjct: 120 EQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIG 179
Query: 121 --------WIIMEYLGGGSALDLMKAGNFEEMHIAVILREV---LKGLDYLHSERKLHRD 169
                   +I+ME + GG  L  ++      + +  +L+ V     G++YL S+  +HRD
Sbjct: 180 VCTQKQPIYIVMELVQGGDFLTFLRTEG-ARLRVKTLLQMVGDAAAGMEYLESKCCIHRD 238
Query: 170 IKAANVLLSEMGDVKLADFGVA-----GTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSK 224
           + A N L++E   +K++DFG++     G    +   R   V    W APE +    Y S+
Sbjct: 239 LAARNCLVTEKNVLKISDFGMSREEADGVXAASGGLRQVPVK---WTAPEALNYGRYSSE 295
Query: 225 ADIWSLGITAIE-LAKGEPPNSELHPMRVLFLIPKNN---PPQLTGNYTKQFKEFVEACL 280
           +D+WS GI   E  + G  P   L   +    + K      P+L  +    F+  +E C 
Sbjct: 296 SDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLPCPELCPDAV--FR-LMEQCW 352
Query: 281 NKDPENRPT 289
             +P  RP+
Sbjct: 353 AYEPGQRPS 361

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 69/251 (27%), Positives = 107/251 (42%), Gaps = 28/251 (11%)
Query: 24  TQFLKFSNSGSSISNQCGSTTASRRNSLKVDPELIFTKQERIGKGSFGEVFKGI----DN 79
           T+ L F  +  S  NQ     A  + + ++ P  + T+Q+ IG G FGEV+KG+      
Sbjct: 17  TENLYFQGAMGSDPNQ-----AVLKFTTEIHPSCV-TRQKVIGAGEFGEVYKGMLKTSSG 70
Query: 80  RTQQVVXXXXXXXXXXXXXXXXXXXXXMVLSQCDSPYGTKL----------WIIMEYLGG 129
           + +  V                      ++ Q       +L           II EY+  
Sbjct: 71  KKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMEN 130
Query: 130 GSALDLM---KAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLA 186
           G ALD     K G F  + +  +LR +  G+ YL +   +HRD+ A N+L++     K++
Sbjct: 131 G-ALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVS 189
Query: 187 DFGVAGTLTNTTSKRNTFVGTPF---WMAPEVIKQSAYDSKADIWSLGITAIE-LAKGEP 242
           DFG++  L +      T  G      W APE I    + S +D+WS GI   E +  GE 
Sbjct: 190 DFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGER 249
Query: 243 PNSELHPMRVL 253
           P  EL    V+
Sbjct: 250 PYWELSNHEVM 260

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 71/276 (25%), Positives = 117/276 (42%), Gaps = 28/276 (10%)
Query: 42  STTASRRNSLKVDPELIFTKQERIGKGSFGEVFKGI----DNRTQQVVXXXXXXXXXXXX 97
           S  A  +  L++  E  F K + +G G+FG V+KG+      + +  V            
Sbjct: 7   SGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPK 66
Query: 98  XXXXXXXXXMVLSQCDSPYGTKLW---------IIMEYLGGGSALDLMKA--GNFEEMHI 146
                     V++  D+P+  +L          +I + +  G  LD ++    N    ++
Sbjct: 67  ANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYL 126
Query: 147 AVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVG 206
                ++ KG++YL   R +HRD+ A NVL+     VK+ DFG+A  L     + +   G
Sbjct: 127 LNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 186
Query: 207 -TPF-WMAPEVIKQSAYDSKADIWSLGITAIELAK-GEPPNSELHPMRVLFLIPKN---- 259
             P  WMA E I    Y  ++D+WS G+T  EL   G  P   +    +  ++ K     
Sbjct: 187 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLP 246
Query: 260 NPPQLTGN-YTKQFKEFVEACLNKDPENRPTAKELL 294
            PP  T + Y    K     C   D ++RP  +EL+
Sbjct: 247 QPPICTIDVYMIMVK-----CWMIDADSRPKFRELI 277

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 68/290 (23%), Positives = 118/290 (40%), Gaps = 45/290 (15%)
Query: 59  FTKQERIGKGSFGEVFKGIDNRTQQVVXXXXXXXXXXXXXXXXXXXXXM-VLSQCDSPYG 117
           + K  +IG+GS+G VFK  +  T Q+V                     + +L Q   P  
Sbjct: 5   YEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNL 64
Query: 118 T----------KLWIIMEYLGGG--SALDLMKAGNFEEMHIAVILREVLKGLDYLHSERK 165
                      +L ++ EY        LD  + G  E + +  I  + L+ +++ H    
Sbjct: 65  VNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHL-VKSITWQTLQAVNFCHKHNC 123
Query: 166 LHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEV-IKQSAYDSK 224
           +HRD+K  N+L+++   +KL DFG A  LT  +   +  V T ++ +PE+ +  + Y   
Sbjct: 124 IHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGDTQYGPP 183
Query: 225 ADIWSLGITAIELAKGEP------PNSELHPMRVLF--LIPKNNPPQLTGNYTKQFK--- 273
            D+W++G    EL  G P         +L+ +R     LIP++     T  Y    K   
Sbjct: 184 VDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVKIPD 243
Query: 274 -------------------EFVEACLNKDPENRPTAKELLKFPFIRKAKK 304
                                ++ CL+ DP  R T ++LL  P+    ++
Sbjct: 244 PEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIRE 293

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 107/216 (49%), Gaps = 34/216 (15%)
Query: 119 KLWIIMEYLGGGSALD-LMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLL 177
           + +++ E + GGS L  + K  +F E+  +V++++V   LD+LH++   HRD+K  N+L 
Sbjct: 85  RFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILC 144
Query: 178 ---SEMGDVKLADFGV-AGTLTN------TTSKRNTFVGTPFWMAPEVI-----KQSAYD 222
              +++  VK+ DF + +G   N      +T +  T  G+  +MAPEV+     + S YD
Sbjct: 145 EHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYD 204
Query: 223 SKADIWSLGITAIELAKGEPP------------NSELHP--MRVLFLIPKNN----PPQL 264
            + D+WSLG+    L  G PP              E  P    +LF   +      P + 
Sbjct: 205 KRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKD 264
Query: 265 TGNYTKQFKEFVEACLNKDPENRPTAKELLKFPFIR 300
             + +   K+ +   L +D + R +A ++L+ P+++
Sbjct: 265 WAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQ 300

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 48/148 (32%), Positives = 81/148 (54%), Gaps = 5/148 (3%)
Query: 152 EVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVG-TPF- 209
           +V +G++YL S++ +HRD+ A NVL++E   +K+ADFG+A  + +    + T  G  P  
Sbjct: 199 QVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVK 258
Query: 210 WMAPEVIKQSAYDSKADIWSLGITAIEL-AKGEPPNSELHPMRVLF-LIPKNNPPQLTGN 267
           WMAPE +    Y  ++D+WS G+   E+   G  P   + P+  LF L+ + +      N
Sbjct: 259 WMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV-PVEELFKLLKEGHRMDKPSN 317
Query: 268 YTKQFKEFVEACLNKDPENRPTAKELLK 295
            T +    +  C +  P  RPT K+L++
Sbjct: 318 CTNELYMMMRDCWHAVPSQRPTFKQLVE 345

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 53/197 (26%), Positives = 91/197 (46%), Gaps = 14/197 (7%)
Query: 59  FTKQERIGKGSFGEVFKGIDNRTQQVVXXXXXXXXXXXXXXXXXXXXXMVLSQCDSPYGT 118
           + K E++G+G++G V+K  D++ + V                       +L +   P   
Sbjct: 23  YQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIV 82
Query: 119 KLW----------IIMEYLGGG--SALDLMKAGNFEEMHIAVILREVLKGLDYLHSERKL 166
            L           ++ E++       LD  K G  ++  I + L ++L+G+ + H  R L
Sbjct: 83  SLIDVIHSERCLTLVFEFMEKDLKKVLDENKTG-LQDSQIKIYLYQLLRGVAHCHQHRIL 141
Query: 167 HRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQS-AYDSKA 225
           HRD+K  N+L++  G +KLADFG+A             V T ++ AP+V+  S  Y +  
Sbjct: 142 HRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSV 201
Query: 226 DIWSLGITAIELAKGEP 242
           DIWS+G    E+  G+P
Sbjct: 202 DIWSIGCIFAEMITGKP 218

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 63/254 (24%), Positives = 109/254 (42%), Gaps = 21/254 (8%)
Query: 48  RNSLKVDPELIFTKQERIGKGSFGEVFKGIDNRTQQVVXXXXXXXXXXXXXXXXXXXXXM 107
           R SLK+        ++++G G FGEV+    N+  +V                       
Sbjct: 14  RESLKL--------EKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMK 65
Query: 108 VLSQCDS-----PYGTK--LWIIMEYLGGGSALDLMKAGNFEEMHIAVIL---REVLKGL 157
            L Q D         TK  ++II E++  GS LD +K+    +  +  ++    ++ +G+
Sbjct: 66  TL-QHDKLVKLHAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGM 124
Query: 158 DYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPF-WMAPEVI 216
            ++     +HRD++AAN+L+S     K+ADFG+A  + +           P  W APE I
Sbjct: 125 AFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAI 184
Query: 217 KQSAYDSKADIWSLGITAIELAK-GEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEF 275
              ++  K+D+WS GI  +E+   G  P   +    V+  + +        N  ++    
Sbjct: 185 NFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELYNI 244
Query: 276 VEACLNKDPENRPT 289
           +  C    PE RPT
Sbjct: 245 MMRCWKNRPEERPT 258

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 73/280 (26%), Positives = 120/280 (42%), Gaps = 42/280 (15%)
Query: 63  ERIGKGSFGEVFKGIDNRTQQVVXXXXXXXXXXXXXXXXXXXXXMVLSQCDSPYGTKLW- 121
           E+IG+G++G V+K  +N  +                         +L +       KL+ 
Sbjct: 8   EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYD 67
Query: 122 ---------IIMEYLGGG--SALDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDI 170
                    ++ E+L       LD+ + G  E +     L ++L G+ Y H  R LHRD+
Sbjct: 68  VIHTKKRLVLVFEHLDQDLKKLLDVCEGG-LESVTAKSFLLQLLNGIAYCHDRRVLHRDL 126
Query: 171 KAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQS-AYDSKADIWS 229
           K  N+L++  G++K+ADFG+A        K    V T ++ AP+V+  S  Y +  DIWS
Sbjct: 127 KPQNLLINREGELKIADFGLARAFGIPVRKYTHEVVTLWYRAPDVLMGSKKYSTTIDIWS 186
Query: 230 LGITAIELAKGEP--PN-SELHPMRVLFLI-----PKNNP-----PQLTGNYTKQ----F 272
           +G    E+  G P  P  SE   +  +F I      KN P     P+   N+T      +
Sbjct: 187 VGCIFAEMVNGAPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPW 246
Query: 273 KEFVEAC-----------LNKDPENRPTAKELLKFPFIRK 301
           + F++             L  DP  R TAK+ L+  + ++
Sbjct: 247 ESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 70/273 (25%), Positives = 116/273 (42%), Gaps = 28/273 (10%)
Query: 45  ASRRNSLKVDPELIFTKQERIGKGSFGEVFKGI----DNRTQQVVXXXXXXXXXXXXXXX 100
           A  +  L++  E  F K + +G G+FG V+KG+      + +  V               
Sbjct: 3   APNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK 62
Query: 101 XXXXXXMVLSQCDSPYGTKLW---------IIMEYLGGGSALDLMKA--GNFEEMHIAVI 149
                  V++  D+P+  +L          +I + +  G  LD ++    N    ++   
Sbjct: 63  EILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW 122
Query: 150 LREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVG-TP 208
             ++ KG++YL   R +HRD+ A NVL+     VK+ DFG+A  L     + +   G  P
Sbjct: 123 CVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 182
Query: 209 F-WMAPEVIKQSAYDSKADIWSLGITAIELAK-GEPPNSELHPMRVLFLIPKN----NPP 262
             WMA E I    Y  ++D+WS G+T  EL   G  P   +    +  ++ K      PP
Sbjct: 183 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPP 242
Query: 263 QLTGN-YTKQFKEFVEACLNKDPENRPTAKELL 294
             T + Y    K     C   D ++RP  +EL+
Sbjct: 243 ICTIDVYMIMVK-----CWMIDADSRPKFRELI 270

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 73/263 (27%), Positives = 116/263 (44%), Gaps = 30/263 (11%)
Query: 53  VDP-ELIFTKQERIGKGSFGEVFKGIDNRTQQVVXXXXXXXXXXXXXXXXXXXXXMVLS- 110
           +DP EL F ++  IG G FG V  G      +V                      M LS 
Sbjct: 5   IDPSELTFVQE--IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSH 62
Query: 111 -QCDSPYGTKL-----WIIMEYLGGGSALDLMKA--GNFEEMHIAVILREVLKGLDYLHS 162
            +    YG  L      ++ E++  G   D ++   G F    +  +  +V +G+ YL  
Sbjct: 63  PKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE 122
Query: 163 ERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPF---WMAPEVIKQS 219
              +HRD+ A N L+ E   +K++DFG+   + +     +T  GT F   W +PEV   S
Sbjct: 123 ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST--GTKFPVKWASPEVFSFS 180
Query: 220 AYDSKADIWSLGITAIEL-AKGEPP-----NSE-LHPMRVLFLIPKNNPPQLTGNYTKQF 272
            Y SK+D+WS G+   E+ ++G+ P     NSE +  +   F + K   P+L   +  Q 
Sbjct: 181 RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYK---PRLASTHVYQ- 236
Query: 273 KEFVEACLNKDPENRPTAKELLK 295
              +  C  + PE+RP    LL+
Sbjct: 237 --IMNHCWRERPEDRPAFSRLLR 257

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 73/280 (26%), Positives = 120/280 (42%), Gaps = 42/280 (15%)
Query: 63  ERIGKGSFGEVFKGIDNRTQQVVXXXXXXXXXXXXXXXXXXXXXMVLSQCDSPYGTKLW- 121
           E+IG+G++G V+K  +N  +                         +L +       KL+ 
Sbjct: 8   EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYD 67
Query: 122 ---------IIMEYLGGG--SALDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDI 170
                    ++ E+L       LD+ + G  E +     L ++L G+ Y H  R LHRD+
Sbjct: 68  VIHTKKRLVLVFEHLDQDLKKLLDVCEGG-LESVTAKSFLLQLLNGIAYCHDRRVLHRDL 126
Query: 171 KAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQS-AYDSKADIWS 229
           K  N+L++  G++K+ADFG+A        K    V T ++ AP+V+  S  Y +  DIWS
Sbjct: 127 KPQNLLINREGELKIADFGLARAFGIPVRKYTHEVVTLWYRAPDVLMGSKKYSTTIDIWS 186
Query: 230 LGITAIELAKGEP--PN-SELHPMRVLFLI-----PKNNP-----PQLTGNYTKQ----F 272
           +G    E+  G P  P  SE   +  +F I      KN P     P+   N+T      +
Sbjct: 187 VGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPW 246
Query: 273 KEFVEAC-----------LNKDPENRPTAKELLKFPFIRK 301
           + F++             L  DP  R TAK+ L+  + ++
Sbjct: 247 ESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 68/272 (25%), Positives = 116/272 (42%), Gaps = 26/272 (9%)
Query: 45  ASRRNSLKVDPELIFTKQERIGKGSFGEVFKGI----DNRTQQVVXXXXXXXXXXXXXXX 100
           A  +  L++  E  F K + +G G+FG V+KG+      + +  V               
Sbjct: 3   APNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK 62
Query: 101 XXXXXXMVLSQCDSPYGTKLW---------IIMEYLGGGSALDLMKA--GNFEEMHIAVI 149
                  V++  D+P+  +L          +I + +  G  LD ++    N    ++   
Sbjct: 63  EILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW 122
Query: 150 LREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVG-TP 208
             ++ KG++YL   R +HRD+ A NVL+     VK+ DFG+A  L     + +   G  P
Sbjct: 123 CVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 182
Query: 209 F-WMAPEVIKQSAYDSKADIWSLGITAIELAK-GEPPNSELHPMRVLFLIPKN----NPP 262
             WMA E I    Y  ++D+WS G+T  EL   G  P   +    +  ++ K      PP
Sbjct: 183 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPP 242
Query: 263 QLTGNYTKQFKEFVEACLNKDPENRPTAKELL 294
             T +     ++    C   D ++RP  +EL+
Sbjct: 243 ICTIDVYMIMRK----CWMIDADSRPKFRELI 270

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 40/112 (35%), Positives = 60/112 (53%), Gaps = 4/112 (3%)
Query: 135 LMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTL 194
           L+K  +    HI   L ++L+GL Y+HS   LHRD+K +N+LL+   D+K+ DFG+A   
Sbjct: 119 LLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVA 178
Query: 195 T---NTTSKRNTFVGTPFWMAPEVIKQS-AYDSKADIWSLGITAIELAKGEP 242
               + T      V T ++ APE++  S  Y    DIWS+G    E+    P
Sbjct: 179 DPDHDHTGFLXEXVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP 230

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 40/112 (35%), Positives = 60/112 (53%), Gaps = 4/112 (3%)
Query: 135 LMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTL 194
           L+K  +    HI   L ++L+GL Y+HS   LHRD+K +N+LL+   D+K+ DFG+A   
Sbjct: 120 LLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVA 179
Query: 195 T---NTTSKRNTFVGTPFWMAPEVIKQS-AYDSKADIWSLGITAIELAKGEP 242
               + T      V T ++ APE++  S  Y    DIWS+G    E+    P
Sbjct: 180 DPDHDHTGFLXEXVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP 231

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 70/273 (25%), Positives = 116/273 (42%), Gaps = 28/273 (10%)
Query: 45  ASRRNSLKVDPELIFTKQERIGKGSFGEVFKGI----DNRTQQVVXXXXXXXXXXXXXXX 100
           A  +  L++  E  F K + +G G+FG V+KG+      + +  V               
Sbjct: 6   APNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK 65
Query: 101 XXXXXXMVLSQCDSPYGTKLW---------IIMEYLGGGSALDLMKA--GNFEEMHIAVI 149
                  V++  D+P+  +L          +I + +  G  LD ++    N    ++   
Sbjct: 66  EILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW 125
Query: 150 LREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVG-TP 208
             ++ KG++YL   R +HRD+ A NVL+     VK+ DFG+A  L     + +   G  P
Sbjct: 126 CVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 185
Query: 209 F-WMAPEVIKQSAYDSKADIWSLGITAIELAK-GEPPNSELHPMRVLFLIPKN----NPP 262
             WMA E I    Y  ++D+WS G+T  EL   G  P   +    +  ++ K      PP
Sbjct: 186 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPP 245
Query: 263 QLTGN-YTKQFKEFVEACLNKDPENRPTAKELL 294
             T + Y    K     C   D ++RP  +EL+
Sbjct: 246 ICTIDVYMIMVK-----CWMIDADSRPKFRELI 273

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 70/273 (25%), Positives = 116/273 (42%), Gaps = 28/273 (10%)
Query: 45  ASRRNSLKVDPELIFTKQERIGKGSFGEVFKGI----DNRTQQVVXXXXXXXXXXXXXXX 100
           A  +  L++  E  F K + +G G+FG V+KG+      + +  V               
Sbjct: 3   APNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK 62
Query: 101 XXXXXXMVLSQCDSPYGTKLW---------IIMEYLGGGSALDLMKA--GNFEEMHIAVI 149
                  V++  D+P+  +L          +I + +  G  LD ++    N    ++   
Sbjct: 63  EILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGXLLDYVREHKDNIGSQYLLNW 122
Query: 150 LREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVG-TP 208
             ++ KG++YL   R +HRD+ A NVL+     VK+ DFG+A  L     + +   G  P
Sbjct: 123 CVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 182
Query: 209 F-WMAPEVIKQSAYDSKADIWSLGITAIELAK-GEPPNSELHPMRVLFLIPKN----NPP 262
             WMA E I    Y  ++D+WS G+T  EL   G  P   +    +  ++ K      PP
Sbjct: 183 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPP 242
Query: 263 QLTGN-YTKQFKEFVEACLNKDPENRPTAKELL 294
             T + Y    K     C   D ++RP  +EL+
Sbjct: 243 ICTIDVYMIMVK-----CWMIDADSRPKFRELI 270

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 63/206 (30%), Positives = 95/206 (46%), Gaps = 27/206 (13%)
Query: 112 CDSPYGTKLWIIMEYLGGGSALDLMKAGNFEEMHIAVI--LREVLKGLDYLHSERKLHRD 169
           C S     L +IMEYL  GS  D ++       HI ++    ++ KG++YL ++R +HRD
Sbjct: 83  CYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRD 142
Query: 170 IKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTP-----FWMAPEVIKQSAYDSK 224
           +   N+L+     VK+ DFG+   L     K    V  P     FW APE + +S +   
Sbjct: 143 LATRNILVENENRVKIGDFGLTKVLPQ--DKEXXKVKEPGESPIFWYAPESLTESKFSVA 200
Query: 225 ADIWSLGI------TAIELAKGEPP-------NSELHPMRVLFLIP--KNNP--PQLTGN 267
           +D+WS G+      T IE +K  P        N +   M V  LI   KNN   P+  G 
Sbjct: 201 SDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGC 260
Query: 268 YTKQFKEFVEACLNKDPENRPTAKEL 293
             + +    E C N +   RP+ ++L
Sbjct: 261 PDEIYMIMTE-CWNNNVNQRPSFRDL 285

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 63/206 (30%), Positives = 95/206 (46%), Gaps = 27/206 (13%)
Query: 112 CDSPYGTKLWIIMEYLGGGSALDLMKAGNFEEMHIAVI--LREVLKGLDYLHSERKLHRD 169
           C S     L +IMEYL  GS  D ++       HI ++    ++ KG++YL ++R +HRD
Sbjct: 85  CYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRD 144
Query: 170 IKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTP-----FWMAPEVIKQSAYDSK 224
           +   N+L+     VK+ DFG+   L     K    V  P     FW APE + +S +   
Sbjct: 145 LATRNILVENENRVKIGDFGLTKVLPQ--DKEXXKVKEPGESPIFWYAPESLTESKFSVA 202
Query: 225 ADIWSLGI------TAIELAKGEPP-------NSELHPMRVLFLIP--KNNP--PQLTGN 267
           +D+WS G+      T IE +K  P        N +   M V  LI   KNN   P+  G 
Sbjct: 203 SDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGC 262
Query: 268 YTKQFKEFVEACLNKDPENRPTAKEL 293
             + +    E C N +   RP+ ++L
Sbjct: 263 PDEIYMIMTE-CWNNNVNQRPSFRDL 287

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 70/273 (25%), Positives = 116/273 (42%), Gaps = 28/273 (10%)
Query: 45  ASRRNSLKVDPELIFTKQERIGKGSFGEVFKGI----DNRTQQVVXXXXXXXXXXXXXXX 100
           A  +  L++  E  F K + +G G+FG V+KG+      + +  V               
Sbjct: 6   APNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK 65
Query: 101 XXXXXXMVLSQCDSPYGTKLW---------IIMEYLGGGSALDLMKA--GNFEEMHIAVI 149
                  V++  D+P+  +L          +I + +  G  LD ++    N    ++   
Sbjct: 66  EILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW 125
Query: 150 LREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVG-TP 208
             ++ KG++YL   R +HRD+ A NVL+     VK+ DFG+A  L     + +   G  P
Sbjct: 126 CVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 185
Query: 209 F-WMAPEVIKQSAYDSKADIWSLGITAIELAK-GEPPNSELHPMRVLFLIPKN----NPP 262
             WMA E I    Y  ++D+WS G+T  EL   G  P   +    +  ++ K      PP
Sbjct: 186 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPP 245
Query: 263 QLTGN-YTKQFKEFVEACLNKDPENRPTAKELL 294
             T + Y    K     C   D ++RP  +EL+
Sbjct: 246 ICTIDVYMIMVK-----CWMIDADSRPKFRELI 273

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 69/267 (25%), Positives = 114/267 (42%), Gaps = 28/267 (10%)
Query: 51  LKVDPELIFTKQERIGKGSFGEVFKGI----DNRTQQVVXXXXXXXXXXXXXXXXXXXXX 106
           L++  E  F K + +G G+FG V+KG+      + +  V                     
Sbjct: 3   LRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEA 62
Query: 107 MVLSQCDSPYGTKLW---------IIMEYLGGGSALDLMKA--GNFEEMHIAVILREVLK 155
            V++  D+P+  +L          +I + +  G  LD ++    N    ++     ++ K
Sbjct: 63  YVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 122
Query: 156 GLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVG-TPF-WMAP 213
           G++YL   R +HRD+ A NVL+     VK+ DFG+A  L     + +   G  P  WMA 
Sbjct: 123 GMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 182
Query: 214 EVIKQSAYDSKADIWSLGITAIELAK-GEPPNSELHPMRVLFLIPKN----NPPQLTGN- 267
           E I    Y  ++D+WS G+T  EL   G  P   +    +  ++ K      PP  T + 
Sbjct: 183 ESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDV 242
Query: 268 YTKQFKEFVEACLNKDPENRPTAKELL 294
           Y    K     C   D ++RP  +EL+
Sbjct: 243 YMIMVK-----CWMIDADSRPKFRELI 264

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 63/206 (30%), Positives = 95/206 (46%), Gaps = 27/206 (13%)
Query: 112 CDSPYGTKLWIIMEYLGGGSALDLMKAGNFEEMHIAVI--LREVLKGLDYLHSERKLHRD 169
           C S     L +IMEYL  GS  D ++       HI ++    ++ KG++YL ++R +HRD
Sbjct: 87  CYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRD 146
Query: 170 IKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTP-----FWMAPEVIKQSAYDSK 224
           +   N+L+     VK+ DFG+   L     K    V  P     FW APE + +S +   
Sbjct: 147 LATRNILVENENRVKIGDFGLTKVLPQ--DKEXXKVKEPGESPIFWYAPESLTESKFSVA 204
Query: 225 ADIWSLGI------TAIELAKGEPP-------NSELHPMRVLFLIP--KNNP--PQLTGN 267
           +D+WS G+      T IE +K  P        N +   M V  LI   KNN   P+  G 
Sbjct: 205 SDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGC 264
Query: 268 YTKQFKEFVEACLNKDPENRPTAKEL 293
             + +    E C N +   RP+ ++L
Sbjct: 265 PDEIYMIMTE-CWNNNVNQRPSFRDL 289

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 75.9 bits (185), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 58/238 (24%), Positives = 103/238 (43%), Gaps = 12/238 (5%)
Query: 64  RIGKGSFGEVFKGIDNRTQQVVXXXXXXXXXXXXXXXXXXXXXMVLS--QCDSPYGTK-- 119
           ++G G FGEV+ G  N + +V                        L   +    Y     
Sbjct: 19  KLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTK 78
Query: 120 ---LWIIMEYLGGGSALDLMKAGNFEEMHIAVIL---REVLKGLDYLHSERKLHRDIKAA 173
              ++II E++  GS LD +K+    ++ +  ++    ++ +G+ Y+  +  +HRD++AA
Sbjct: 79  EEPIYIITEFMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAA 138
Query: 174 NVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPF-WMAPEVIKQSAYDSKADIWSLGI 232
           NVL+SE    K+ADFG+A  + +           P  W APE I    +  K+++WS GI
Sbjct: 139 NVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGCFTIKSNVWSFGI 198
Query: 233 TAIELAK-GEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPENRPT 289
              E+   G+ P        V+  + +        N   +  + ++ C  +  E RPT
Sbjct: 199 LLYEIVTYGKIPYPGRTNADVMSALSQGYRMPRMENCPDELYDIMKMCWKEKAEERPT 256

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 75.9 bits (185), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 63/206 (30%), Positives = 95/206 (46%), Gaps = 27/206 (13%)
Query: 112 CDSPYGTKLWIIMEYLGGGSALDLMKAGNFEEMHIAVI--LREVLKGLDYLHSERKLHRD 169
           C S     L +IMEYL  GS  D ++       HI ++    ++ KG++YL ++R +HRD
Sbjct: 79  CYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRD 138
Query: 170 IKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTP-----FWMAPEVIKQSAYDSK 224
           +   N+L+     VK+ DFG+   L     K    V  P     FW APE + +S +   
Sbjct: 139 LATRNILVENENRVKIGDFGLTKVLPQ--DKEXXKVKEPGESPIFWYAPESLTESKFSVA 196
Query: 225 ADIWSLGI------TAIELAKGEPP-------NSELHPMRVLFLIP--KNNP--PQLTGN 267
           +D+WS G+      T IE +K  P        N +   M V  LI   KNN   P+  G 
Sbjct: 197 SDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGC 256
Query: 268 YTKQFKEFVEACLNKDPENRPTAKEL 293
             + +    E C N +   RP+ ++L
Sbjct: 257 PDEIYMIMTE-CWNNNVNQRPSFRDL 281

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 75.9 bits (185), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 63/206 (30%), Positives = 95/206 (46%), Gaps = 27/206 (13%)
Query: 112 CDSPYGTKLWIIMEYLGGGSALDLMKAGNFEEMHIAVI--LREVLKGLDYLHSERKLHRD 169
           C S     L +IMEYL  GS  D ++       HI ++    ++ KG++YL ++R +HRD
Sbjct: 80  CYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRD 139
Query: 170 IKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTP-----FWMAPEVIKQSAYDSK 224
           +   N+L+     VK+ DFG+   L     K    V  P     FW APE + +S +   
Sbjct: 140 LATRNILVENENRVKIGDFGLTKVLPQ--DKEXXKVKEPGESPIFWYAPESLTESKFSVA 197
Query: 225 ADIWSLGI------TAIELAKGEPP-------NSELHPMRVLFLIP--KNNP--PQLTGN 267
           +D+WS G+      T IE +K  P        N +   M V  LI   KNN   P+  G 
Sbjct: 198 SDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGC 257
Query: 268 YTKQFKEFVEACLNKDPENRPTAKEL 293
             + +    E C N +   RP+ ++L
Sbjct: 258 PDEIYMIMTE-CWNNNVNQRPSFRDL 282

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 75.9 bits (185), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 63/206 (30%), Positives = 95/206 (46%), Gaps = 27/206 (13%)
Query: 112 CDSPYGTKLWIIMEYLGGGSALDLMKAGNFEEMHIAVI--LREVLKGLDYLHSERKLHRD 169
           C S     L +IMEYL  GS  D ++       HI ++    ++ KG++YL ++R +HRD
Sbjct: 86  CYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRD 145
Query: 170 IKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTP-----FWMAPEVIKQSAYDSK 224
           +   N+L+     VK+ DFG+   L     K    V  P     FW APE + +S +   
Sbjct: 146 LATRNILVENENRVKIGDFGLTKVLPQ--DKEXXKVKEPGESPIFWYAPESLTESKFSVA 203
Query: 225 ADIWSLGI------TAIELAKGEPP-------NSELHPMRVLFLIP--KNNP--PQLTGN 267
           +D+WS G+      T IE +K  P        N +   M V  LI   KNN   P+  G 
Sbjct: 204 SDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGC 263
Query: 268 YTKQFKEFVEACLNKDPENRPTAKEL 293
             + +    E C N +   RP+ ++L
Sbjct: 264 PDEIYMIMTE-CWNNNVNQRPSFRDL 288

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 75.9 bits (185), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 93/199 (46%), Gaps = 26/199 (13%)
Query: 118 TKLWIIMEYLGGGSALDLMKAGNFEEMHIAV--ILREVLKGLDYLHSERKLHRDIKAANV 175
           + L+I  EY    +  DL+ + N  +       + R++L+ L Y+HS+  +HR++K  N+
Sbjct: 88  STLFIQXEYCENRTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRNLKPXNI 147
Query: 176 LLSEMGDVKLADFGVA------------------GTLTNTTSKRNTFVGTPFWMAPEVIK 217
            + E  +VK+ DFG+A                  G+  N TS     +GT  ++A EV+ 
Sbjct: 148 FIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSA----IGTAXYVATEVLD 203
Query: 218 QSA-YDSKADIWSLGITAIELAKGEPPNSE-LHPMRVLFLIPKNNPPQLTGNYTKQFKEF 275
            +  Y+ K D +SLGI   E         E ++ ++ L  +    PP    N  K  K+ 
Sbjct: 204 GTGHYNEKIDXYSLGIIFFEXIYPFSTGXERVNILKKLRSVSIEFPPDFDDNKXKVEKKI 263
Query: 276 VEACLNKDPENRPTAKELL 294
           +   ++ DP  RP A+ LL
Sbjct: 264 IRLLIDHDPNKRPGARTLL 282

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 75.9 bits (185), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 63/206 (30%), Positives = 95/206 (46%), Gaps = 27/206 (13%)
Query: 112 CDSPYGTKLWIIMEYLGGGSALDLMKAGNFEEMHIAVI--LREVLKGLDYLHSERKLHRD 169
           C S     L +IMEYL  GS  D ++       HI ++    ++ KG++YL ++R +HRD
Sbjct: 80  CYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRD 139
Query: 170 IKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTP-----FWMAPEVIKQSAYDSK 224
           +   N+L+     VK+ DFG+   L     K    V  P     FW APE + +S +   
Sbjct: 140 LATRNILVENENRVKIGDFGLTKVLPQ--DKEXXKVKEPGESPIFWYAPESLTESKFSVA 197
Query: 225 ADIWSLGI------TAIELAKGEPP-------NSELHPMRVLFLIP--KNNP--PQLTGN 267
           +D+WS G+      T IE +K  P        N +   M V  LI   KNN   P+  G 
Sbjct: 198 SDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGC 257
Query: 268 YTKQFKEFVEACLNKDPENRPTAKEL 293
             + +    E C N +   RP+ ++L
Sbjct: 258 PDEIYMIMTE-CWNNNVNQRPSFRDL 282

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 75.9 bits (185), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 36/119 (30%), Positives = 70/119 (58%), Gaps = 4/119 (3%)
Query: 123 IMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGD 182
           ++ +L G    +++K     + H+  ++ ++L+GL Y+HS   +HRD+K +N+ ++E  +
Sbjct: 104 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCE 163
Query: 183 VKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSA-YDSKADIWSLGITAIELAKG 240
           +K+ DFG+A    +T  +   +V T ++ APE++  +  Y+   DIWS+G    EL  G
Sbjct: 164 LKILDFGLA---RHTDDEMTGYVATRWYRAPEIMLNAMHYNQTVDIWSVGCIMAELLTG 219

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 75.9 bits (185), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 63/206 (30%), Positives = 95/206 (46%), Gaps = 27/206 (13%)
Query: 112 CDSPYGTKLWIIMEYLGGGSALDLMKAGNFEEMHIAVI--LREVLKGLDYLHSERKLHRD 169
           C S     L +IMEYL  GS  D ++       HI ++    ++ KG++YL ++R +HRD
Sbjct: 84  CYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRD 143
Query: 170 IKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTP-----FWMAPEVIKQSAYDSK 224
           +   N+L+     VK+ DFG+   L     K    V  P     FW APE + +S +   
Sbjct: 144 LATRNILVENENRVKIGDFGLTKVLPQ--DKEXXKVKEPGESPIFWYAPESLTESKFSVA 201
Query: 225 ADIWSLGI------TAIELAKGEPP-------NSELHPMRVLFLIP--KNNP--PQLTGN 267
           +D+WS G+      T IE +K  P        N +   M V  LI   KNN   P+  G 
Sbjct: 202 SDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGC 261
Query: 268 YTKQFKEFVEACLNKDPENRPTAKEL 293
             + +    E C N +   RP+ ++L
Sbjct: 262 PDEIYMIMTE-CWNNNVNQRPSFRDL 286

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 75.9 bits (185), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 63/206 (30%), Positives = 95/206 (46%), Gaps = 27/206 (13%)
Query: 112 CDSPYGTKLWIIMEYLGGGSALDLMKAGNFEEMHIAVI--LREVLKGLDYLHSERKLHRD 169
           C S     L +IMEYL  GS  D ++       HI ++    ++ KG++YL ++R +HRD
Sbjct: 111 CYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRD 170
Query: 170 IKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTP-----FWMAPEVIKQSAYDSK 224
           +   N+L+     VK+ DFG+   L     K    V  P     FW APE + +S +   
Sbjct: 171 LATRNILVENENRVKIGDFGLTKVLPQ--DKEXXKVKEPGESPIFWYAPESLTESKFSVA 228
Query: 225 ADIWSLGI------TAIELAKGEPP-------NSELHPMRVLFLIP--KNNP--PQLTGN 267
           +D+WS G+      T IE +K  P        N +   M V  LI   KNN   P+  G 
Sbjct: 229 SDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGC 288
Query: 268 YTKQFKEFVEACLNKDPENRPTAKEL 293
             + +    E C N +   RP+ ++L
Sbjct: 289 PDEIYMIMTE-CWNNNVNQRPSFRDL 313

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 75.9 bits (185), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 63/206 (30%), Positives = 95/206 (46%), Gaps = 27/206 (13%)
Query: 112 CDSPYGTKLWIIMEYLGGGSALDLMKAGNFEEMHIAVI--LREVLKGLDYLHSERKLHRD 169
           C S     L +IMEYL  GS  D ++       HI ++    ++ KG++YL ++R +HRD
Sbjct: 78  CYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRD 137
Query: 170 IKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTP-----FWMAPEVIKQSAYDSK 224
           +   N+L+     VK+ DFG+   L     K    V  P     FW APE + +S +   
Sbjct: 138 LATRNILVENENRVKIGDFGLTKVLPQ--DKEXXKVKEPGESPIFWYAPESLTESKFSVA 195
Query: 225 ADIWSLGI------TAIELAKGEPP-------NSELHPMRVLFLIP--KNNP--PQLTGN 267
           +D+WS G+      T IE +K  P        N +   M V  LI   KNN   P+  G 
Sbjct: 196 SDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGC 255
Query: 268 YTKQFKEFVEACLNKDPENRPTAKEL 293
             + +    E C N +   RP+ ++L
Sbjct: 256 PDEIYMIMTE-CWNNNVNQRPSFRDL 280

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 75.9 bits (185), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 72/280 (25%), Positives = 120/280 (42%), Gaps = 42/280 (15%)
Query: 63  ERIGKGSFGEVFKGIDNRTQQVVXXXXXXXXXXXXXXXXXXXXXMVLSQCDSPYGTKLW- 121
           E+IG+G++G V+K  +N  +                         +L +       KL+ 
Sbjct: 8   EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYD 67
Query: 122 ---------IIMEYLGGG--SALDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDI 170
                    ++ E+L       LD+ + G  E +     L ++L G+ Y H  R LHRD+
Sbjct: 68  VIHTKKRLVLVFEHLDQDLKKLLDVCEGG-LESVTAKSFLLQLLNGIAYCHDRRVLHRDL 126
Query: 171 KAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQS-AYDSKADIWS 229
           K  N+L++  G++K+ADFG+A        K    + T ++ AP+V+  S  Y +  DIWS
Sbjct: 127 KPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWS 186
Query: 230 LGITAIELAKGEP--PN-SELHPMRVLFLI-----PKNNP-----PQLTGNYTKQ----F 272
           +G    E+  G P  P  SE   +  +F I      KN P     P+   N+T      +
Sbjct: 187 VGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPW 246
Query: 273 KEFVEAC-----------LNKDPENRPTAKELLKFPFIRK 301
           + F++             L  DP  R TAK+ L+  + ++
Sbjct: 247 ESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 75.9 bits (185), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 40/129 (31%), Positives = 66/129 (51%), Gaps = 3/129 (2%)
Query: 112 CDSPYGTKLWIIMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIK 171
           C+      L ++MEY+  GS  D +   +     + +  +++ +G+ YLHS+  +HR++ 
Sbjct: 85  CEDQGEKSLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEGMAYLHSQHYIHRNLA 144
Query: 172 AANVLLSEMGDVKLADFGVAGTL---TNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIW 228
           A NVLL     VK+ DFG+A  +         R       FW APE +K+  +   +D+W
Sbjct: 145 ARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVW 204
Query: 229 SLGITAIEL 237
           S G+T  EL
Sbjct: 205 SFGVTLYEL 213

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 75.9 bits (185), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 63/206 (30%), Positives = 95/206 (46%), Gaps = 27/206 (13%)
Query: 112 CDSPYGTKLWIIMEYLGGGSALDLMKAGNFEEMHIAVI--LREVLKGLDYLHSERKLHRD 169
           C S     L +IMEYL  GS  D ++       HI ++    ++ KG++YL ++R +HRD
Sbjct: 98  CYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRD 157
Query: 170 IKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTP-----FWMAPEVIKQSAYDSK 224
           +   N+L+     VK+ DFG+   L     K    V  P     FW APE + +S +   
Sbjct: 158 LATRNILVENENRVKIGDFGLTKVLPQ--DKEXXKVKEPGESPIFWYAPESLTESKFSVA 215
Query: 225 ADIWSLGI------TAIELAKGEPP-------NSELHPMRVLFLIP--KNNP--PQLTGN 267
           +D+WS G+      T IE +K  P        N +   M V  LI   KNN   P+  G 
Sbjct: 216 SDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGC 275
Query: 268 YTKQFKEFVEACLNKDPENRPTAKEL 293
             + +    E C N +   RP+ ++L
Sbjct: 276 PDEIYMIMTE-CWNNNVNQRPSFRDL 300

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 75.9 bits (185), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 63/206 (30%), Positives = 95/206 (46%), Gaps = 27/206 (13%)
Query: 112 CDSPYGTKLWIIMEYLGGGSALDLMKAGNFEEMHIAVI--LREVLKGLDYLHSERKLHRD 169
           C S     L +IMEYL  GS  D ++       HI ++    ++ KG++YL ++R +HRD
Sbjct: 98  CYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRD 157
Query: 170 IKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTP-----FWMAPEVIKQSAYDSK 224
           +   N+L+     VK+ DFG+   L     K    V  P     FW APE + +S +   
Sbjct: 158 LATRNILVENENRVKIGDFGLTKVLPQ--DKEXXKVKEPGESPIFWYAPESLTESKFSVA 215
Query: 225 ADIWSLGI------TAIELAKGEPP-------NSELHPMRVLFLIP--KNNP--PQLTGN 267
           +D+WS G+      T IE +K  P        N +   M V  LI   KNN   P+  G 
Sbjct: 216 SDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGC 275
Query: 268 YTKQFKEFVEACLNKDPENRPTAKEL 293
             + +    E C N +   RP+ ++L
Sbjct: 276 PDEIYMIMTE-CWNNNVNQRPSFRDL 300

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 75.9 bits (185), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 37/119 (31%), Positives = 69/119 (57%), Gaps = 4/119 (3%)
Query: 123 IMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGD 182
           ++ +L G    +++K     + H+  ++ ++L+GL Y+HS   +HRD+K +N+ ++E  +
Sbjct: 104 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCE 163
Query: 183 VKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEV-IKQSAYDSKADIWSLGITAIELAKG 240
           +K+ DFG+A    +T  +   FV T ++ APE+ +    Y+   DIWS+G    EL  G
Sbjct: 164 LKILDFGLA---RHTDDEMAGFVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 75.5 bits (184), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 62/259 (23%), Positives = 109/259 (42%), Gaps = 17/259 (6%)
Query: 47  RRNSLKVDPELIFTKQERIGKGSFGEVFKG---IDNRTQQVVXXXXXXXXXXXXXXXXXX 103
           R   + +D +L+  + + +G G+FG V KG   +    + V                   
Sbjct: 359 RPKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELL 418
Query: 104 XXXMVLSQCDSPYGTKL--------WIIMEYLGGGSALD--LMKAGNFEEMHIAVILREV 153
               V+ Q D+PY  ++        W+++  +     L+  L +  + ++ +I  ++ +V
Sbjct: 419 AEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQV 478
Query: 154 LKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTL--TNTTSKRNTFVGTPF-W 210
             G+ YL     +HRD+ A NVLL      K++DFG++  L       K  T    P  W
Sbjct: 479 SMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKW 538
Query: 211 MAPEVIKQSAYDSKADIWSLGITAIE-LAKGEPPNSELHPMRVLFLIPKNNPPQLTGNYT 269
            APE I    + SK+D+WS G+   E  + G+ P   +    V  ++ K           
Sbjct: 539 YAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCP 598
Query: 270 KQFKEFVEACLNKDPENRP 288
           ++  + +  C   D ENRP
Sbjct: 599 REMYDLMNLCWTYDVENRP 617

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 75.5 bits (184), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 37/119 (31%), Positives = 69/119 (57%), Gaps = 4/119 (3%)
Query: 123 IMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGD 182
           ++ +L G    +++K     + H+  ++ ++L+GL Y+HS   +HRD+K +N+ ++E  +
Sbjct: 104 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCE 163
Query: 183 VKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEV-IKQSAYDSKADIWSLGITAIELAKG 240
           +K+ DFG+A    +T  +   FV T ++ APE+ +    Y+   DIWS+G    EL  G
Sbjct: 164 LKILDFGLA---RHTDDEMAGFVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 75.5 bits (184), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 63/256 (24%), Positives = 111/256 (43%), Gaps = 25/256 (9%)
Query: 62  QERIGKGSFGEVFKG---IDNRTQQVVXXXXXXXXXXXXXXXXXXXXXMVLSQCDSPY-- 116
           ++ IG G FGEV  G   +  + +  V                      ++ Q D P   
Sbjct: 38  EQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVI 97
Query: 117 --------GTKLWIIMEYLGGGSALDLMKA--GNFEEMHIAVILREVLKGLDYLHSERKL 166
                    T + II E++  GS    ++   G F  + +  +LR +  G+ YL     +
Sbjct: 98  HLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYV 157
Query: 167 HRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSK--RNTFVGTPF---WMAPEVIKQSAY 221
           HRD+ A N+L++     K++DFG++  L + TS     + +G      W APE I+   +
Sbjct: 158 HRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKF 217
Query: 222 DSKADIWSLGITAIE-LAKGEPPNSELHPMRVLFLIPKNN--PPQLTGNYTKQFKEFVEA 278
            S +D+WS GI   E ++ GE P  ++    V+  I ++   PP +  +      + +  
Sbjct: 218 TSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPM--DCPSALHQLMLD 275
Query: 279 CLNKDPENRPTAKELL 294
           C  KD  +RP   +++
Sbjct: 276 CWQKDRNHRPKFGQIV 291

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 75.5 bits (184), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 37/119 (31%), Positives = 69/119 (57%), Gaps = 4/119 (3%)
Query: 123 IMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGD 182
           ++ +L G    +++K     + H+  ++ ++L+GL Y+HS   +HRD+K +N+ ++E  +
Sbjct: 100 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCE 159
Query: 183 VKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEV-IKQSAYDSKADIWSLGITAIELAKG 240
           +K+ DFG+A    +T  +   FV T ++ APE+ +    Y+   DIWS+G    EL  G
Sbjct: 160 LKILDFGLA---RHTDDEMAGFVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 215

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 75.5 bits (184), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 62/259 (23%), Positives = 109/259 (42%), Gaps = 17/259 (6%)
Query: 47  RRNSLKVDPELIFTKQERIGKGSFGEVFKG---IDNRTQQVVXXXXXXXXXXXXXXXXXX 103
           R   + +D +L+  + + +G G+FG V KG   +    + V                   
Sbjct: 360 RPKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELL 419
Query: 104 XXXMVLSQCDSPYGTKL--------WIIMEYLGGGSALD--LMKAGNFEEMHIAVILREV 153
               V+ Q D+PY  ++        W+++  +     L+  L +  + ++ +I  ++ +V
Sbjct: 420 AEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQV 479
Query: 154 LKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTL--TNTTSKRNTFVGTPF-W 210
             G+ YL     +HRD+ A NVLL      K++DFG++  L       K  T    P  W
Sbjct: 480 SMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKW 539
Query: 211 MAPEVIKQSAYDSKADIWSLGITAIE-LAKGEPPNSELHPMRVLFLIPKNNPPQLTGNYT 269
            APE I    + SK+D+WS G+   E  + G+ P   +    V  ++ K           
Sbjct: 540 YAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCP 599
Query: 270 KQFKEFVEACLNKDPENRP 288
           ++  + +  C   D ENRP
Sbjct: 600 REMYDLMNLCWTYDVENRP 618

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score = 75.5 bits (184), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 89/200 (44%), Gaps = 18/200 (9%)
Query: 64  RIGKGSFGEVFKG-IDNRTQQVVXXXXXXXXXXXXXXXXXXXXXMVLSQCD--------- 113
           ++G+G FG V+KG ++N T  V                       V+++C          
Sbjct: 32  KMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLG 91
Query: 114 -SPYGTKLWIIMEYLGGGSALDLMKAGNFE---EMHIAV-ILREVLKGLDYLHSERKLHR 168
            S  G  L ++  Y+  GS LD +   +       H+   I +    G+++LH    +HR
Sbjct: 92  FSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHR 151
Query: 169 DIKAANVLLSEMGDVKLADFGVAGTLTNTTSK--RNTFVGTPFWMAPEVIKQSAYDSKAD 226
           DIK+AN+LL E    K++DFG+A               VGT  +MAPE ++      K+D
Sbjct: 152 DIKSANILLDEAFTAKISDFGLARASEKFAQXVMXXRIVGTTAYMAPEALR-GEITPKSD 210
Query: 227 IWSLGITAIELAKGEPPNSE 246
           I+S G+  +E+  G P   E
Sbjct: 211 IYSFGVVLLEIITGLPAVDE 230

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 75.5 bits (184), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 36/119 (30%), Positives = 69/119 (57%), Gaps = 4/119 (3%)
Query: 123 IMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGD 182
           ++ +L G    +++K     + H+  ++ ++L+GL Y+HS   +HRD+K +N+ ++E  +
Sbjct: 133 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCE 192
Query: 183 VKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEV-IKQSAYDSKADIWSLGITAIELAKG 240
           +K+ DFG+A    +T  +   +V T ++ APE+ +    Y+   DIWS+G    EL  G
Sbjct: 193 LKILDFGLA---RHTDDEMTGYVATRWYRAPEIMLNWMHYNMTVDIWSVGCIMAELLTG 248

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 75.5 bits (184), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 36/119 (30%), Positives = 69/119 (57%), Gaps = 4/119 (3%)
Query: 123 IMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGD 182
           ++ +L G    +++K     + H+  ++ ++L+GL Y+HS   +HRD+K +N+ ++E  +
Sbjct: 100 LVTHLMGADLNNIVKCAKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCE 159
Query: 183 VKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEV-IKQSAYDSKADIWSLGITAIELAKG 240
           +K+ DFG+A    +T  +   +V T ++ APE+ +    Y+   DIWS+G    EL  G
Sbjct: 160 LKILDFGLA---RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 215

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 75.5 bits (184), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 68/274 (24%), Positives = 115/274 (41%), Gaps = 41/274 (14%)
Query: 48  RNSLKVDPELIFTKQERIGKGSFGEVFKGIDNRTQQVVXXXXXXXXXXXXXXXXXXXXXM 107
           R SLK+        ++++G G FGEV+    N+  +V                       
Sbjct: 181 RESLKL--------EKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMK 232
Query: 108 VLSQCDS-----PYGTK--LWIIMEYLGGGSALDLMKAGNFEEMHIAVIL---REVLKGL 157
            L Q D         TK  ++II E++  GS LD +K+    +  +  ++    ++ +G+
Sbjct: 233 TL-QHDKLVKLHAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGM 291
Query: 158 DYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPF---WMAPE 214
            ++     +HRD++AAN+L+S     K+ADFG+A             VG  F   W APE
Sbjct: 292 AFIEQRNYIHRDLRAANILVSASLVCKIADFGLAR------------VGAKFPIKWTAPE 339
Query: 215 VIKQSAYDSKADIWSLGITAIELAK-GEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFK 273
            I   ++  K+D+WS GI  +E+   G  P   +    V+  + +        N  ++  
Sbjct: 340 AINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELY 399
Query: 274 EFVEACLNKDPENRPTAKELLKFPFIRKAKKNAY 307
             +  C    PE RPT      F +I+    + Y
Sbjct: 400 NIMMRCWKNRPEERPT------FEYIQSVLDDFY 427

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 75.5 bits (184), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 36/119 (30%), Positives = 69/119 (57%), Gaps = 4/119 (3%)
Query: 123 IMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGD 182
           ++ +L G    +++K     + H+  ++ ++L+GL Y+HS   +HRD+K +N+ ++E  +
Sbjct: 111 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCE 170
Query: 183 VKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEV-IKQSAYDSKADIWSLGITAIELAKG 240
           +K+ DFG+A    +T  +   +V T ++ APE+ +    Y+   DIWS+G    EL  G
Sbjct: 171 LKILDFGLA---RHTADEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 226

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 75.5 bits (184), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 36/119 (30%), Positives = 69/119 (57%), Gaps = 4/119 (3%)
Query: 123 IMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGD 182
           ++ +L G    +++K     + H+  ++ ++L+GL Y+HS   +HRD+K +N+ ++E  +
Sbjct: 111 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCE 170
Query: 183 VKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEV-IKQSAYDSKADIWSLGITAIELAKG 240
           +K+ DFG+A    +T  +   +V T ++ APE+ +    Y+   DIWS+G    EL  G
Sbjct: 171 LKILDFGLA---RHTADEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 226

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 75.1 bits (183), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 36/119 (30%), Positives = 69/119 (57%), Gaps = 4/119 (3%)
Query: 123 IMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGD 182
           ++ +L G    +++K     + H+  ++ ++L+GL Y+HS   +HRD+K +N+ ++E  +
Sbjct: 106 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDSE 165
Query: 183 VKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEV-IKQSAYDSKADIWSLGITAIELAKG 240
           +K+ DFG+A    +T  +   +V T ++ APE+ +    Y+   DIWS+G    EL  G
Sbjct: 166 LKILDFGLA---RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 221

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 75.1 bits (183), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 36/119 (30%), Positives = 69/119 (57%), Gaps = 4/119 (3%)
Query: 123 IMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGD 182
           ++ +L G    +++K     + H+  ++ ++L+GL Y+HS   +HRD+K +N+ ++E  +
Sbjct: 111 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCE 170
Query: 183 VKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEV-IKQSAYDSKADIWSLGITAIELAKG 240
           +K+ DFG+A    +T  +   +V T ++ APE+ +    Y+   DIWS+G    EL  G
Sbjct: 171 LKILDFGLA---RHTADEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 226

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 45/134 (33%), Positives = 71/134 (52%), Gaps = 12/134 (8%)
Query: 120 LWIIMEYLGGGSALDLMKAGNFE----EMHIAVILREVLKGLDYLHSERKLHRDIKAANV 175
           L+++M+Y  GG  L L+    FE    E      + E++  +D +H    +HRDIK  NV
Sbjct: 165 LYLVMDYYVGGDLLTLLS--KFEDKLPEDMARFYIGEMVLAIDSIHQLHYVHRDIKPDNV 222
Query: 176 LLSEMGDVKLADFGVAGTLTNT-TSKRNTFVGTPFWMAPEVIK-----QSAYDSKADIWS 229
           LL   G ++LADFG    + +  T + +  VGTP +++PE+++        Y  + D WS
Sbjct: 223 LLDVNGHIRLADFGSCLKMNDDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWS 282
Query: 230 LGITAIELAKGEPP 243
           LG+   E+  GE P
Sbjct: 283 LGVCMYEMLYGETP 296

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 38/127 (29%), Positives = 67/127 (52%), Gaps = 4/127 (3%)
Query: 121 WIIMEYLGGGSALD-LMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSE 179
           +++ME L GG   + + K  +F E   + I+R+++  + ++H    +HRD+K  N+L ++
Sbjct: 82  FLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTD 141
Query: 180 MGD---VKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIE 236
             D   +K+ DFG A           T   T  + APE++ Q+ YD   D+WSLG+    
Sbjct: 142 ENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYT 201
Query: 237 LAKGEPP 243
           +  G+ P
Sbjct: 202 MLSGQVP 208

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 36/119 (30%), Positives = 69/119 (57%), Gaps = 4/119 (3%)
Query: 123 IMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGD 182
           ++ +L G    +++K     + H+  ++ ++L+GL Y+HS   +HRD+K +N+ ++E  +
Sbjct: 110 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDSE 169
Query: 183 VKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEV-IKQSAYDSKADIWSLGITAIELAKG 240
           +K+ DFG+A    +T  +   +V T ++ APE+ +    Y+   DIWS+G    EL  G
Sbjct: 170 LKILDFGLA---RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 225

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 71/276 (25%), Positives = 116/276 (42%), Gaps = 28/276 (10%)
Query: 42  STTASRRNSLKVDPELIFTKQERIGKGSFGEVFKGI----DNRTQQVVXXXXXXXXXXXX 97
           S  A  +  L++  E  F K + +G G+FG V+KG+      + +  V            
Sbjct: 7   SGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPK 66
Query: 98  XXXXXXXXXMVLSQCDSPYGTKLW---------IIMEYLGGGSALDLMKA--GNFEEMHI 146
                     V++  D+P+  +L          +I + +  G  LD ++    N    ++
Sbjct: 67  ANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYL 126
Query: 147 AVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVG 206
                ++ KG++YL   R +HRD+ A NVL+     VK+ DFG A  L     + +   G
Sbjct: 127 LNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGG 186
Query: 207 -TPF-WMAPEVIKQSAYDSKADIWSLGITAIELAK-GEPPNSELHPMRVLFLIPKN---- 259
             P  WMA E I    Y  ++D+WS G+T  EL   G  P   +    +  ++ K     
Sbjct: 187 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLP 246
Query: 260 NPPQLTGN-YTKQFKEFVEACLNKDPENRPTAKELL 294
            PP  T + Y    K     C   D ++RP  +EL+
Sbjct: 247 QPPICTIDVYMIMVK-----CWMIDADSRPKFRELI 277

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 36/119 (30%), Positives = 69/119 (57%), Gaps = 4/119 (3%)
Query: 123 IMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGD 182
           ++ +L G    +++K     + H+  ++ ++L+GL Y+HS   +HRD+K +N+ ++E  +
Sbjct: 110 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCE 169
Query: 183 VKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEV-IKQSAYDSKADIWSLGITAIELAKG 240
           +K+ DFG+A    +T  +   +V T ++ APE+ +    Y+   DIWS+G    EL  G
Sbjct: 170 LKILDFGLA---RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 225

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 68/300 (22%), Positives = 123/300 (41%), Gaps = 54/300 (18%)
Query: 59  FTKQERIGKGSFGEVFKGIDNRTQQVVXXXXXXXXXXXXXXXXXXXXXMVLSQCDSPYGT 118
           F + E++G G++  V+KG++  T   V                      ++ +       
Sbjct: 7   FKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIV 66
Query: 119 KLW----------IIMEYLGGG--SALDLMKAGN----FEEMHIAVILREVLKGLDYLHS 162
           +L+          ++ E++       +D    GN     E   +     ++L+GL + H 
Sbjct: 67  RLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHE 126
Query: 163 ERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQS-AY 221
            + LHRD+K  N+L+++ G +KL DFG+A       +  ++ V T ++ AP+V+  S  Y
Sbjct: 127 NKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVTLWYRAPDVLMGSRTY 186
Query: 222 DSKADIWSLGITAIELAKGEP--------------------PNSELHPMRVLFLIPKNNP 261
            +  DIWS G    E+  G+P                    PN  L P   +  +PK NP
Sbjct: 187 STSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWP--SVTKLPKYNP 244
Query: 262 P----------QLTGNYTKQ-----FKEFVEACLNKDPENRPTAKELLKFPFIRKAKKNA 306
                      Q+   +TK+       +F+   L  +P+ R +AK+ L  P+  +   +A
Sbjct: 245 NIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYYHHA 304

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 36/119 (30%), Positives = 69/119 (57%), Gaps = 4/119 (3%)
Query: 123 IMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGD 182
           ++ +L G    +++K     + H+  ++ ++L+GL Y+HS   +HRD+K +N+ ++E  +
Sbjct: 110 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCE 169
Query: 183 VKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEV-IKQSAYDSKADIWSLGITAIELAKG 240
           +K+ DFG+A    +T  +   +V T ++ APE+ +    Y+   DIWS+G    EL  G
Sbjct: 170 LKILDFGLA---RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 225

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 36/119 (30%), Positives = 69/119 (57%), Gaps = 4/119 (3%)
Query: 123 IMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGD 182
           ++ +L G    +++K     + H+  ++ ++L+GL Y+HS   +HRD+K +N+ ++E  +
Sbjct: 109 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCE 168
Query: 183 VKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEV-IKQSAYDSKADIWSLGITAIELAKG 240
           +K+ DFG+A    +T  +   +V T ++ APE+ +    Y+   DIWS+G    EL  G
Sbjct: 169 LKILDFGLA---RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 224

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 36/119 (30%), Positives = 69/119 (57%), Gaps = 4/119 (3%)
Query: 123 IMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGD 182
           ++ +L G    +++K     + H+  ++ ++L+GL Y+HS   +HRD+K +N+ ++E  +
Sbjct: 103 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCE 162
Query: 183 VKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEV-IKQSAYDSKADIWSLGITAIELAKG 240
           +K+ DFG+A    +T  +   +V T ++ APE+ +    Y+   DIWS+G    EL  G
Sbjct: 163 LKILDFGLA---RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 218

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 39/112 (34%), Positives = 60/112 (53%), Gaps = 4/112 (3%)
Query: 135 LMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTL 194
           L+K+      HI   L ++L+GL Y+HS   LHRD+K +N+L++   D+K+ DFG+A   
Sbjct: 135 LLKSQQLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLINTTCDLKICDFGLARIA 194
Query: 195 T---NTTSKRNTFVGTPFWMAPEVIKQS-AYDSKADIWSLGITAIELAKGEP 242
               + T      V T ++ APE++  S  Y    DIWS+G    E+    P
Sbjct: 195 DPEHDHTGFLTEXVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP 246

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 36/119 (30%), Positives = 69/119 (57%), Gaps = 4/119 (3%)
Query: 123 IMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGD 182
           ++ +L G    +++K     + H+  ++ ++L+GL Y+HS   +HRD+K +N+ ++E  +
Sbjct: 106 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCE 165
Query: 183 VKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEV-IKQSAYDSKADIWSLGITAIELAKG 240
           +K+ DFG+A    +T  +   +V T ++ APE+ +    Y+   DIWS+G    EL  G
Sbjct: 166 LKILDFGLA---RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 221

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 36/119 (30%), Positives = 69/119 (57%), Gaps = 4/119 (3%)
Query: 123 IMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGD 182
           ++ +L G    +++K     + H+  ++ ++L+GL Y+HS   +HRD+K +N+ ++E  +
Sbjct: 104 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCE 163
Query: 183 VKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEV-IKQSAYDSKADIWSLGITAIELAKG 240
           +K+ DFG+A    +T  +   +V T ++ APE+ +    Y+   DIWS+G    EL  G
Sbjct: 164 LKILDFGLA---RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 36/119 (30%), Positives = 69/119 (57%), Gaps = 4/119 (3%)
Query: 123 IMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGD 182
           ++ +L G    +++K     + H+  ++ ++L+GL Y+HS   +HRD+K +N+ ++E  +
Sbjct: 111 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCE 170
Query: 183 VKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEV-IKQSAYDSKADIWSLGITAIELAKG 240
           +K+ DFG+A    +T  +   +V T ++ APE+ +    Y+   DIWS+G    EL  G
Sbjct: 171 LKILDFGLA---RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 226

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 36/119 (30%), Positives = 69/119 (57%), Gaps = 4/119 (3%)
Query: 123 IMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGD 182
           ++ +L G    +++K     + H+  ++ ++L+GL Y+HS   +HRD+K +N+ ++E  +
Sbjct: 104 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCE 163
Query: 183 VKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEV-IKQSAYDSKADIWSLGITAIELAKG 240
           +K+ DFG+A    +T  +   +V T ++ APE+ +    Y+   DIWS+G    EL  G
Sbjct: 164 LKILDFGLA---RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 36/119 (30%), Positives = 69/119 (57%), Gaps = 4/119 (3%)
Query: 123 IMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGD 182
           ++ +L G    +++K     + H+  ++ ++L+GL Y+HS   +HRD+K +N+ ++E  +
Sbjct: 110 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCE 169
Query: 183 VKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEV-IKQSAYDSKADIWSLGITAIELAKG 240
           +K+ DFG+A    +T  +   +V T ++ APE+ +    Y+   DIWS+G    EL  G
Sbjct: 170 LKILDFGLA---RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 225

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 36/119 (30%), Positives = 69/119 (57%), Gaps = 4/119 (3%)
Query: 123 IMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGD 182
           ++ +L G    +++K     + H+  ++ ++L+GL Y+HS   +HRD+K +N+ ++E  +
Sbjct: 101 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCE 160
Query: 183 VKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEV-IKQSAYDSKADIWSLGITAIELAKG 240
           +K+ DFG+A    +T  +   +V T ++ APE+ +    Y+   DIWS+G    EL  G
Sbjct: 161 LKILDFGLA---RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 216

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 45/134 (33%), Positives = 71/134 (52%), Gaps = 12/134 (8%)
Query: 120 LWIIMEYLGGGSALDLMKAGNFE----EMHIAVILREVLKGLDYLHSERKLHRDIKAANV 175
           L+++M+Y  GG  L L+    FE    E      + E++  +D +H    +HRDIK  NV
Sbjct: 149 LYLVMDYYVGGDLLTLLS--KFEDKLPEDMARFYIGEMVLAIDSIHQLHYVHRDIKPDNV 206
Query: 176 LLSEMGDVKLADFGVAGTLTNT-TSKRNTFVGTPFWMAPEVIK-----QSAYDSKADIWS 229
           LL   G ++LADFG    + +  T + +  VGTP +++PE+++        Y  + D WS
Sbjct: 207 LLDVNGHIRLADFGSCLKMNDDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWS 266
Query: 230 LGITAIELAKGEPP 243
           LG+   E+  GE P
Sbjct: 267 LGVCMYEMLYGETP 280

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 36/119 (30%), Positives = 69/119 (57%), Gaps = 4/119 (3%)
Query: 123 IMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGD 182
           ++ +L G    +++K     + H+  ++ ++L+GL Y+HS   +HRD+K +N+ ++E  +
Sbjct: 104 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCE 163
Query: 183 VKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEV-IKQSAYDSKADIWSLGITAIELAKG 240
           +K+ DFG+A    +T  +   +V T ++ APE+ +    Y+   DIWS+G    EL  G
Sbjct: 164 LKILDFGLA---RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 36/119 (30%), Positives = 69/119 (57%), Gaps = 4/119 (3%)
Query: 123 IMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGD 182
           ++ +L G    +++K     + H+  ++ ++L+GL Y+HS   +HRD+K +N+ ++E  +
Sbjct: 114 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCE 173
Query: 183 VKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEV-IKQSAYDSKADIWSLGITAIELAKG 240
           +K+ DFG+A    +T  +   +V T ++ APE+ +    Y+   DIWS+G    EL  G
Sbjct: 174 LKILDFGLA---RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 229

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 36/119 (30%), Positives = 69/119 (57%), Gaps = 4/119 (3%)
Query: 123 IMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGD 182
           ++ +L G    +++K     + H+  ++ ++L+GL Y+HS   +HRD+K +N+ ++E  +
Sbjct: 106 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCE 165
Query: 183 VKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEV-IKQSAYDSKADIWSLGITAIELAKG 240
           +K+ DFG+A    +T  +   +V T ++ APE+ +    Y+   DIWS+G    EL  G
Sbjct: 166 LKILDFGLA---RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 221

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 36/119 (30%), Positives = 69/119 (57%), Gaps = 4/119 (3%)
Query: 123 IMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGD 182
           ++ +L G    +++K     + H+  ++ ++L+GL Y+HS   +HRD+K +N+ ++E  +
Sbjct: 104 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCE 163
Query: 183 VKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEV-IKQSAYDSKADIWSLGITAIELAKG 240
           +K+ DFG+A    +T  +   +V T ++ APE+ +    Y+   DIWS+G    EL  G
Sbjct: 164 LKILDFGLA---RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 36/119 (30%), Positives = 69/119 (57%), Gaps = 4/119 (3%)
Query: 123 IMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGD 182
           ++ +L G    +++K     + H+  ++ ++L+GL Y+HS   +HRD+K +N+ ++E  +
Sbjct: 109 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDXE 168
Query: 183 VKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEV-IKQSAYDSKADIWSLGITAIELAKG 240
           +K+ DFG+A    +T  +   +V T ++ APE+ +    Y+   DIWS+G    EL  G
Sbjct: 169 LKILDFGLA---RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 224

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 36/119 (30%), Positives = 69/119 (57%), Gaps = 4/119 (3%)
Query: 123 IMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGD 182
           ++ +L G    +++K     + H+  ++ ++L+GL Y+HS   +HRD+K +N+ ++E  +
Sbjct: 106 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCE 165
Query: 183 VKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEV-IKQSAYDSKADIWSLGITAIELAKG 240
           +K+ DFG+A    +T  +   +V T ++ APE+ +    Y+   DIWS+G    EL  G
Sbjct: 166 LKILDFGLA---RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 221

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 36/119 (30%), Positives = 69/119 (57%), Gaps = 4/119 (3%)
Query: 123 IMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGD 182
           ++ +L G    +++K     + H+  ++ ++L+GL Y+HS   +HRD+K +N+ ++E  +
Sbjct: 100 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCE 159
Query: 183 VKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEV-IKQSAYDSKADIWSLGITAIELAKG 240
           +K+ DFG+A    +T  +   +V T ++ APE+ +    Y+   DIWS+G    EL  G
Sbjct: 160 LKILDFGLA---RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 215

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 97/216 (44%), Gaps = 37/216 (17%)
Query: 63  ERIGKGSFGEVFKGIDNRTQQVVXXXXXXXXXXXXXXXXXX-XXXMVLSQCD-------- 113
           +++GKG++G V+K ID RT +VV                      M+L++          
Sbjct: 15  KKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNL 74
Query: 114 -----SPYGTKLWIIMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHR 168
                +     ++++ +Y+       +++A   E +H   ++ +++K + YLHS   LHR
Sbjct: 75  LNVLRADNDRDVYLVFDYMETDLHA-VIRANILEPVHKQYVVYQLIKVIKYLHSGGLLHR 133
Query: 169 DIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNT---------------------FVGT 207
           D+K +N+LL+    VK+ADFG++ +  N     N                      +V T
Sbjct: 134 DMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVAT 193
Query: 208 PFWMAPEVIKQSA-YDSKADIWSLGITAIELAKGEP 242
            ++ APE++  S  Y    D+WSLG    E+  G+P
Sbjct: 194 RWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKP 229

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 36/119 (30%), Positives = 69/119 (57%), Gaps = 4/119 (3%)
Query: 123 IMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGD 182
           ++ +L G    +++K     + H+  ++ ++L+GL Y+HS   +HRD+K +N+ ++E  +
Sbjct: 104 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCE 163
Query: 183 VKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEV-IKQSAYDSKADIWSLGITAIELAKG 240
           +K+ DFG+A    +T  +   +V T ++ APE+ +    Y+   DIWS+G    EL  G
Sbjct: 164 LKILDFGLA---RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 36/119 (30%), Positives = 69/119 (57%), Gaps = 4/119 (3%)
Query: 123 IMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGD 182
           ++ +L G    +++K     + H+  ++ ++L+GL Y+HS   +HRD+K +N+ ++E  +
Sbjct: 116 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCE 175
Query: 183 VKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEV-IKQSAYDSKADIWSLGITAIELAKG 240
           +K+ DFG+A    +T  +   +V T ++ APE+ +    Y+   DIWS+G    EL  G
Sbjct: 176 LKILDFGLA---RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 231

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 36/119 (30%), Positives = 69/119 (57%), Gaps = 4/119 (3%)
Query: 123 IMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGD 182
           ++ +L G    +++K     + H+  ++ ++L+GL Y+HS   +HRD+K +N+ ++E  +
Sbjct: 104 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCE 163
Query: 183 VKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEV-IKQSAYDSKADIWSLGITAIELAKG 240
           +K+ DFG+A    +T  +   +V T ++ APE+ +    Y+   DIWS+G    EL  G
Sbjct: 164 LKILDFGLA---RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 36/119 (30%), Positives = 69/119 (57%), Gaps = 4/119 (3%)
Query: 123 IMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGD 182
           ++ +L G    +++K     + H+  ++ ++L+GL Y+HS   +HRD+K +N+ ++E  +
Sbjct: 104 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCE 163
Query: 183 VKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEV-IKQSAYDSKADIWSLGITAIELAKG 240
           +K+ DFG+A    +T  +   +V T ++ APE+ +    Y+   DIWS+G    EL  G
Sbjct: 164 LKILDFGLA---RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 36/119 (30%), Positives = 69/119 (57%), Gaps = 4/119 (3%)
Query: 123 IMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGD 182
           ++ +L G    +++K     + H+  ++ ++L+GL Y+HS   +HRD+K +N+ ++E  +
Sbjct: 116 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCE 175
Query: 183 VKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEV-IKQSAYDSKADIWSLGITAIELAKG 240
           +K+ DFG+A    +T  +   +V T ++ APE+ +    Y+   DIWS+G    EL  G
Sbjct: 176 LKILDFGLA---RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 231

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 36/119 (30%), Positives = 69/119 (57%), Gaps = 4/119 (3%)
Query: 123 IMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGD 182
           ++ +L G    +++K     + H+  ++ ++L+GL Y+HS   +HRD+K +N+ ++E  +
Sbjct: 101 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCE 160
Query: 183 VKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEV-IKQSAYDSKADIWSLGITAIELAKG 240
           +K+ DFG+A    +T  +   +V T ++ APE+ +    Y+   DIWS+G    EL  G
Sbjct: 161 LKILDFGLA---RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 216

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 36/119 (30%), Positives = 69/119 (57%), Gaps = 4/119 (3%)
Query: 123 IMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGD 182
           ++ +L G    +++K     + H+  ++ ++L+GL Y+HS   +HRD+K +N+ ++E  +
Sbjct: 100 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCE 159
Query: 183 VKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEV-IKQSAYDSKADIWSLGITAIELAKG 240
           +K+ DFG+A    +T  +   +V T ++ APE+ +    Y+   DIWS+G    EL  G
Sbjct: 160 LKILDFGLA---RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 215

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 36/119 (30%), Positives = 69/119 (57%), Gaps = 4/119 (3%)
Query: 123 IMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGD 182
           ++ +L G    +++K     + H+  ++ ++L+GL Y+HS   +HRD+K +N+ ++E  +
Sbjct: 109 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDXE 168
Query: 183 VKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEV-IKQSAYDSKADIWSLGITAIELAKG 240
           +K+ DFG+A    +T  +   +V T ++ APE+ +    Y+   DIWS+G    EL  G
Sbjct: 169 LKILDFGLA---RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 224

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 36/119 (30%), Positives = 69/119 (57%), Gaps = 4/119 (3%)
Query: 123 IMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGD 182
           ++ +L G    +++K     + H+  ++ ++L+GL Y+HS   +HRD+K +N+ ++E  +
Sbjct: 109 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCE 168
Query: 183 VKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEV-IKQSAYDSKADIWSLGITAIELAKG 240
           +K+ DFG+A    +T  +   +V T ++ APE+ +    Y+   DIWS+G    EL  G
Sbjct: 169 LKILDFGLA---RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 224

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 36/119 (30%), Positives = 69/119 (57%), Gaps = 4/119 (3%)
Query: 123 IMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGD 182
           ++ +L G    +++K     + H+  ++ ++L+GL Y+HS   +HRD+K +N+ ++E  +
Sbjct: 115 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCE 174
Query: 183 VKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEV-IKQSAYDSKADIWSLGITAIELAKG 240
           +K+ DFG+A    +T  +   +V T ++ APE+ +    Y+   DIWS+G    EL  G
Sbjct: 175 LKILDFGLA---RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 230

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 36/119 (30%), Positives = 69/119 (57%), Gaps = 4/119 (3%)
Query: 123 IMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGD 182
           ++ +L G    +++K     + H+  ++ ++L+GL Y+HS   +HRD+K +N+ ++E  +
Sbjct: 104 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCE 163
Query: 183 VKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEV-IKQSAYDSKADIWSLGITAIELAKG 240
           +K+ DFG+A    +T  +   +V T ++ APE+ +    Y+   DIWS+G    EL  G
Sbjct: 164 LKILDFGLA---RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 36/119 (30%), Positives = 69/119 (57%), Gaps = 4/119 (3%)
Query: 123 IMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGD 182
           ++ +L G    +++K     + H+  ++ ++L+GL Y+HS   +HRD+K +N+ ++E  +
Sbjct: 116 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCE 175
Query: 183 VKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEV-IKQSAYDSKADIWSLGITAIELAKG 240
           +K+ DFG+A    +T  +   +V T ++ APE+ +    Y+   DIWS+G    EL  G
Sbjct: 176 LKILDFGLA---RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 231

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 70/273 (25%), Positives = 115/273 (42%), Gaps = 28/273 (10%)
Query: 45  ASRRNSLKVDPELIFTKQERIGKGSFGEVFKGI----DNRTQQVVXXXXXXXXXXXXXXX 100
           A  +  L++  E  F K + +G G+FG V+KG+      + +  V               
Sbjct: 3   APNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK 62
Query: 101 XXXXXXMVLSQCDSPYGTKLW---------IIMEYLGGGSALDLMKA--GNFEEMHIAVI 149
                  V++  D+P+  +L          +I + +  G  LD ++    N    ++   
Sbjct: 63  EILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW 122
Query: 150 LREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVG-TP 208
             ++ KG++YL   R +HRD+ A NVL+     VK+ DFG A  L     + +   G  P
Sbjct: 123 CVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVP 182
Query: 209 F-WMAPEVIKQSAYDSKADIWSLGITAIELAK-GEPPNSELHPMRVLFLIPKN----NPP 262
             WMA E I    Y  ++D+WS G+T  EL   G  P   +    +  ++ K      PP
Sbjct: 183 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPP 242
Query: 263 QLTGN-YTKQFKEFVEACLNKDPENRPTAKELL 294
             T + Y    K     C   D ++RP  +EL+
Sbjct: 243 ICTIDVYMIMVK-----CWMIDADSRPKFRELI 270

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 36/119 (30%), Positives = 69/119 (57%), Gaps = 4/119 (3%)
Query: 123 IMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGD 182
           ++ +L G    +++K     + H+  ++ ++L+GL Y+HS   +HRD+K +N+ ++E  +
Sbjct: 102 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCE 161
Query: 183 VKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEV-IKQSAYDSKADIWSLGITAIELAKG 240
           +K+ DFG+A    +T  +   +V T ++ APE+ +    Y+   DIWS+G    EL  G
Sbjct: 162 LKILDFGLA---RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 217

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 36/119 (30%), Positives = 69/119 (57%), Gaps = 4/119 (3%)
Query: 123 IMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGD 182
           ++ +L G    +++K     + H+  ++ ++L+GL Y+HS   +HRD+K +N+ ++E  +
Sbjct: 123 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCE 182
Query: 183 VKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEV-IKQSAYDSKADIWSLGITAIELAKG 240
           +K+ DFG+A    +T  +   +V T ++ APE+ +    Y+   DIWS+G    EL  G
Sbjct: 183 LKILDFGLA---RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 238

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 36/119 (30%), Positives = 69/119 (57%), Gaps = 4/119 (3%)
Query: 123 IMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGD 182
           ++ +L G    +++K     + H+  ++ ++L+GL Y+HS   +HRD+K +N+ ++E  +
Sbjct: 124 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCE 183
Query: 183 VKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEV-IKQSAYDSKADIWSLGITAIELAKG 240
           +K+ DFG+A    +T  +   +V T ++ APE+ +    Y+   DIWS+G    EL  G
Sbjct: 184 LKILDFGLA---RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 239

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 36/119 (30%), Positives = 69/119 (57%), Gaps = 4/119 (3%)
Query: 123 IMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGD 182
           ++ +L G    +++K     + H+  ++ ++L+GL Y+HS   +HRD+K +N+ ++E  +
Sbjct: 115 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDXE 174
Query: 183 VKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEV-IKQSAYDSKADIWSLGITAIELAKG 240
           +K+ DFG+A    +T  +   +V T ++ APE+ +    Y+   DIWS+G    EL  G
Sbjct: 175 LKILDFGLA---RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 230

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 36/119 (30%), Positives = 69/119 (57%), Gaps = 4/119 (3%)
Query: 123 IMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGD 182
           ++ +L G    +++K     + H+  ++ ++L+GL Y+HS   +HRD+K +N+ ++E  +
Sbjct: 123 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCE 182
Query: 183 VKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEV-IKQSAYDSKADIWSLGITAIELAKG 240
           +K+ DFG+A    +T  +   +V T ++ APE+ +    Y+   DIWS+G    EL  G
Sbjct: 183 LKILDFGLA---RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 238

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 39/129 (30%), Positives = 66/129 (51%), Gaps = 3/129 (2%)
Query: 112 CDSPYGTKLWIIMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIK 171
           C+      L ++MEY+  GS  D +   +     + +  +++ +G+ YLH++  +HR++ 
Sbjct: 85  CEDQGEKSLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEGMAYLHAQHYIHRNLA 144
Query: 172 AANVLLSEMGDVKLADFGVAGTL---TNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIW 228
           A NVLL     VK+ DFG+A  +         R       FW APE +K+  +   +D+W
Sbjct: 145 ARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVW 204
Query: 229 SLGITAIEL 237
           S G+T  EL
Sbjct: 205 SFGVTLYEL 213

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 63/206 (30%), Positives = 95/206 (46%), Gaps = 27/206 (13%)
Query: 112 CDSPYGTKLWIIMEYLGGGSALDLMKAGNFEEMHIAVI--LREVLKGLDYLHSERKLHRD 169
           C S     L +IMEYL  GS  D ++       HI ++    ++ KG++YL ++R +HRD
Sbjct: 80  CYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRD 139
Query: 170 IKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTP-----FWMAPEVIKQSAYDSK 224
           +   N+L+     VK+ DFG+   L     K    V  P     FW APE + +S +   
Sbjct: 140 LATRNILVENENRVKIGDFGLTKVLPQ--DKEFFKVKEPGESPIFWYAPESLTESKFSVA 197
Query: 225 ADIWSLGI------TAIELAKGEPP-------NSELHPMRVLFLIP--KNNP--PQLTGN 267
           +D+WS G+      T IE +K  P        N +   M V  LI   KNN   P+  G 
Sbjct: 198 SDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGC 257
Query: 268 YTKQFKEFVEACLNKDPENRPTAKEL 293
             + +    E C N +   RP+ ++L
Sbjct: 258 PDEIYMIMTE-CWNNNVNQRPSFRDL 282

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 36/119 (30%), Positives = 69/119 (57%), Gaps = 4/119 (3%)
Query: 123 IMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGD 182
           ++ +L G    +++K     + H+  ++ ++L+GL Y+HS   +HRD+K +N+ ++E  +
Sbjct: 124 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCE 183
Query: 183 VKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEV-IKQSAYDSKADIWSLGITAIELAKG 240
           +K+ DFG+A    +T  +   +V T ++ APE+ +    Y+   DIWS+G    EL  G
Sbjct: 184 LKILDFGLA---RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 239

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 36/119 (30%), Positives = 69/119 (57%), Gaps = 4/119 (3%)
Query: 123 IMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGD 182
           ++ +L G    +++K     + H+  ++ ++L+GL Y+HS   +HRD+K +N+ ++E  +
Sbjct: 127 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCE 186
Query: 183 VKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEV-IKQSAYDSKADIWSLGITAIELAKG 240
           +K+ DFG+A    +T  +   +V T ++ APE+ +    Y+   DIWS+G    EL  G
Sbjct: 187 LKILDFGLA---RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 242

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 36/119 (30%), Positives = 69/119 (57%), Gaps = 4/119 (3%)
Query: 123 IMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGD 182
           ++ +L G    +++K     + H+  ++ ++L+GL Y+HS   +HRD+K +N+ ++E  +
Sbjct: 127 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCE 186
Query: 183 VKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEV-IKQSAYDSKADIWSLGITAIELAKG 240
           +K+ DFG+A    +T  +   +V T ++ APE+ +    Y+   DIWS+G    EL  G
Sbjct: 187 LKILDFGLA---RHTDDEMXGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 242

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 68/267 (25%), Positives = 114/267 (42%), Gaps = 28/267 (10%)
Query: 51  LKVDPELIFTKQERIGKGSFGEVFKGI----DNRTQQVVXXXXXXXXXXXXXXXXXXXXX 106
           L++  E  F K + +G G+FG V+KG+      + +  V                     
Sbjct: 6   LRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEA 65
Query: 107 MVLSQCDSPYGTKLW---------IIMEYLGGGSALDLMKA--GNFEEMHIAVILREVLK 155
            V++  D+P+  +L          +I + +  G  LD ++    N    ++     ++ +
Sbjct: 66  YVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAE 125
Query: 156 GLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVG-TPF-WMAP 213
           G++YL   R +HRD+ A NVL+     VK+ DFG+A  L     + +   G  P  WMA 
Sbjct: 126 GMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 185
Query: 214 EVIKQSAYDSKADIWSLGITAIELAK-GEPPNSELHPMRVLFLIPKN----NPPQLTGN- 267
           E I    Y  ++D+WS G+T  EL   G  P   +    +  ++ K      PP  T + 
Sbjct: 186 ESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDV 245
Query: 268 YTKQFKEFVEACLNKDPENRPTAKELL 294
           Y    K     C   D ++RP  +EL+
Sbjct: 246 YMIMVK-----CWMIDADSRPKFRELI 267

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 36/119 (30%), Positives = 69/119 (57%), Gaps = 4/119 (3%)
Query: 123 IMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGD 182
           ++ +L G    +++K     + H+  ++ ++L+GL Y+HS   +HRD+K +N+ ++E  +
Sbjct: 104 LVTHLMGADLNNIVKXQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCE 163
Query: 183 VKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEV-IKQSAYDSKADIWSLGITAIELAKG 240
           +K+ DFG+A    +T  +   +V T ++ APE+ +    Y+   DIWS+G    EL  G
Sbjct: 164 LKILDFGLA---RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 61/251 (24%), Positives = 105/251 (41%), Gaps = 23/251 (9%)
Query: 65  IGKGSFGEVFKG---IDNRTQQVVXXXXXXXXXXXXXXXXXXXXXMVLSQCDSPYGTKL- 120
           +G G FGEV  G   + ++ +  V                      ++ Q D P   +L 
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 112
Query: 121 ---------WIIMEYLGGGSALDLMKA--GNFEEMHIAVILREVLKGLDYLHSERKLHRD 169
                     I+ EY+  GS    ++     F  + +  +LR +  G+ YL     +HRD
Sbjct: 113 GVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRD 172
Query: 170 IKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPF---WMAPEVIKQSAYDSKAD 226
           + A N+L++     K++DFG+A  L +      T  G      W +PE I    + S +D
Sbjct: 173 LAARNILINSNLVCKVSDFGLARVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASD 232
Query: 227 IWSLGITAIE-LAKGEPPNSELHPMRVLFLIPKNN--PPQLTGNYTKQFKEFVEACLNKD 283
           +WS GI   E ++ GE P  E+    V+  + +    PP +  +      + +  C  KD
Sbjct: 233 VWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPM--DCPAALYQLMLDCWQKD 290
Query: 284 PENRPTAKELL 294
             NRP  ++++
Sbjct: 291 RNNRPKFEQIV 301

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 36/119 (30%), Positives = 69/119 (57%), Gaps = 4/119 (3%)
Query: 123 IMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGD 182
           ++ +L G    +++K     + H+  ++ ++L+GL Y+HS   +HRD+K +N+ ++E  +
Sbjct: 104 LVTHLMGADLNNIVKXQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDXE 163
Query: 183 VKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEV-IKQSAYDSKADIWSLGITAIELAKG 240
           +K+ DFG+A    +T  +   +V T ++ APE+ +    Y+   DIWS+G    EL  G
Sbjct: 164 LKILDFGLA---RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 70/276 (25%), Positives = 116/276 (42%), Gaps = 28/276 (10%)
Query: 42  STTASRRNSLKVDPELIFTKQERIGKGSFGEVFKGI----DNRTQQVVXXXXXXXXXXXX 97
           S  A  +  L++  E  F K + +  G+FG V+KG+      + +  V            
Sbjct: 7   SGEAPNQALLRILKETEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPK 66
Query: 98  XXXXXXXXXMVLSQCDSPYGTKLW---------IIMEYLGGGSALDLMKA--GNFEEMHI 146
                     V++  D+P+  +L          +I + +  G  LD ++    N    ++
Sbjct: 67  ANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYL 126
Query: 147 AVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVG 206
                ++ KG++YL   R +HRD+ A NVL+     VK+ DFG+A  L     + +   G
Sbjct: 127 LNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 186
Query: 207 -TPF-WMAPEVIKQSAYDSKADIWSLGITAIELAK-GEPPNSELHPMRVLFLIPKN---- 259
             P  WMA E I    Y  ++D+WS G+T  EL   G  P   +    +  ++ K     
Sbjct: 187 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLP 246
Query: 260 NPPQLTGN-YTKQFKEFVEACLNKDPENRPTAKELL 294
            PP  T + Y    K     C   D ++RP  +EL+
Sbjct: 247 QPPICTIDVYMIMVK-----CWMIDADSRPKFRELI 277

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 69/273 (25%), Positives = 115/273 (42%), Gaps = 28/273 (10%)
Query: 45  ASRRNSLKVDPELIFTKQERIGKGSFGEVFKGI----DNRTQQVVXXXXXXXXXXXXXXX 100
           A  +  L++  E  F K + +  G+FG V+KG+      + +  V               
Sbjct: 3   APNQALLRILKETEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK 62
Query: 101 XXXXXXMVLSQCDSPYGTKLW---------IIMEYLGGGSALDLMKA--GNFEEMHIAVI 149
                  V++  D+P+  +L          +I + +  G  LD ++    N    ++   
Sbjct: 63  EILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW 122
Query: 150 LREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVG-TP 208
             ++ KG++YL   R +HRD+ A NVL+     VK+ DFG+A  L     + +   G  P
Sbjct: 123 CVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 182
Query: 209 F-WMAPEVIKQSAYDSKADIWSLGITAIELAK-GEPPNSELHPMRVLFLIPKN----NPP 262
             WMA E I    Y  ++D+WS G+T  EL   G  P   +    +  ++ K      PP
Sbjct: 183 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPP 242
Query: 263 QLTGN-YTKQFKEFVEACLNKDPENRPTAKELL 294
             T + Y    K     C   D ++RP  +EL+
Sbjct: 243 ICTIDVYMIMVK-----CWMIDADSRPKFRELI 270

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 62/259 (23%), Positives = 109/259 (42%), Gaps = 17/259 (6%)
Query: 47  RRNSLKVDPELIFTKQERIGKGSFGEVFKG---IDNRTQQVVXXXXXXXXXXXXXXXXXX 103
           R   + +D +L+  + + +G G+FG V KG   +    + V                   
Sbjct: 15  RPKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELL 74
Query: 104 XXXMVLSQCDSPYGTKL--------WIIMEYLGGGSALD--LMKAGNFEEMHIAVILREV 153
               V+ Q D+PY  ++        W+++  +     L+  L +  + ++ +I  ++ +V
Sbjct: 75  AEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQV 134
Query: 154 LKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTL--TNTTSKRNTFVGTPF-W 210
             G+ YL     +HRD+ A NVLL      K++DFG++  L       K  T    P  W
Sbjct: 135 SMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKW 194
Query: 211 MAPEVIKQSAYDSKADIWSLGITAIE-LAKGEPPNSELHPMRVLFLIPKNNPPQLTGNYT 269
            APE I    + SK+D+WS G+   E  + G+ P   +    V  ++ K           
Sbjct: 195 YAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCP 254
Query: 270 KQFKEFVEACLNKDPENRP 288
           ++  + +  C   D ENRP
Sbjct: 255 REMYDLMNLCWTYDVENRP 273

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 48/158 (30%), Positives = 79/158 (50%), Gaps = 22/158 (13%)
Query: 152 EVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTL---TNTTSKRNTFVGTP 208
           +V KG+ +L S+  +HRD+ A N+LL+     K+ DFG+A  +   +N   K N  +   
Sbjct: 153 QVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVK 212
Query: 209 FWMAPEVIKQSAYDSKADIWSLGITAIELAK-------GEPPNSELHPM---RVLFLIPK 258
            WMAPE I    Y  ++D+WS GI   EL         G P +S+ + M       L P+
Sbjct: 213 -WMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSPE 271
Query: 259 NNPPQLTGNYTKQFKEFVEACLNKDPENRPTAKELLKF 296
           + P ++         + ++ C + DP  RPT K++++ 
Sbjct: 272 HAPAEMY--------DIMKTCWDADPLKRPTFKQIVQL 301

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 35/119 (29%), Positives = 69/119 (57%), Gaps = 4/119 (3%)
Query: 123 IMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGD 182
           ++ +L G    +++K+    + H+  ++ ++L+GL Y+HS   +HRD+K +N+ ++E  +
Sbjct: 104 LVTHLMGADLNNIVKSQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDSE 163
Query: 183 VKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEV-IKQSAYDSKADIWSLGITAIELAKG 240
           +K+ DFG+     +T  +   +V T ++ APE+ +    Y+   DIWS+G    EL  G
Sbjct: 164 LKILDFGLC---RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 48/158 (30%), Positives = 79/158 (50%), Gaps = 22/158 (13%)
Query: 152 EVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTL---TNTTSKRNTFVGTP 208
           +V KG+ +L S+  +HRD+ A N+LL+     K+ DFG+A  +   +N   K N  +   
Sbjct: 171 QVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVK 230
Query: 209 FWMAPEVIKQSAYDSKADIWSLGITAIELAK-------GEPPNSELHPM---RVLFLIPK 258
            WMAPE I    Y  ++D+WS GI   EL         G P +S+ + M       L P+
Sbjct: 231 -WMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSPE 289
Query: 259 NNPPQLTGNYTKQFKEFVEACLNKDPENRPTAKELLKF 296
           + P ++         + ++ C + DP  RPT K++++ 
Sbjct: 290 HAPAEMY--------DIMKTCWDADPLKRPTFKQIVQL 319

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 48/158 (30%), Positives = 79/158 (50%), Gaps = 22/158 (13%)
Query: 152 EVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTL---TNTTSKRNTFVGTP 208
           +V KG+ +L S+  +HRD+ A N+LL+     K+ DFG+A  +   +N   K N  +   
Sbjct: 169 QVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVK 228
Query: 209 FWMAPEVIKQSAYDSKADIWSLGITAIELAK-------GEPPNSELHPM---RVLFLIPK 258
            WMAPE I    Y  ++D+WS GI   EL         G P +S+ + M       L P+
Sbjct: 229 -WMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSPE 287
Query: 259 NNPPQLTGNYTKQFKEFVEACLNKDPENRPTAKELLKF 296
           + P ++         + ++ C + DP  RPT K++++ 
Sbjct: 288 HAPAEMY--------DIMKTCWDADPLKRPTFKQIVQL 317

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 48/158 (30%), Positives = 79/158 (50%), Gaps = 22/158 (13%)
Query: 152 EVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTL---TNTTSKRNTFVGTP 208
           +V KG+ +L S+  +HRD+ A N+LL+     K+ DFG+A  +   +N   K N  +   
Sbjct: 176 QVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVK 235
Query: 209 FWMAPEVIKQSAYDSKADIWSLGITAIELAK-------GEPPNSELHPM---RVLFLIPK 258
            WMAPE I    Y  ++D+WS GI   EL         G P +S+ + M       L P+
Sbjct: 236 -WMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSPE 294
Query: 259 NNPPQLTGNYTKQFKEFVEACLNKDPENRPTAKELLKF 296
           + P ++         + ++ C + DP  RPT K++++ 
Sbjct: 295 HAPAEMY--------DIMKTCWDADPLKRPTFKQIVQL 324

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 62/206 (30%), Positives = 95/206 (46%), Gaps = 27/206 (13%)
Query: 112 CDSPYGTKLWIIMEYLGGGSALDLMKAGNFEEMHIAVI--LREVLKGLDYLHSERKLHRD 169
           C S     L +IMEYL  GS  D ++       HI ++    ++ KG++YL ++R +HR+
Sbjct: 81  CYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRN 140
Query: 170 IKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTP-----FWMAPEVIKQSAYDSK 224
           +   N+L+     VK+ DFG+   L     K    V  P     FW APE + +S +   
Sbjct: 141 LATRNILVENENRVKIGDFGLTKVLPQ--DKEYYKVKEPGESPIFWYAPESLTESKFSVA 198
Query: 225 ADIWSLGI------TAIELAKGEPP-------NSELHPMRVLFLIP--KNNP--PQLTGN 267
           +D+WS G+      T IE +K  P        N +   M V  LI   KNN   P+  G 
Sbjct: 199 SDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGC 258
Query: 268 YTKQFKEFVEACLNKDPENRPTAKEL 293
             + +    E C N +   RP+ ++L
Sbjct: 259 PDEIYMIMTE-CWNNNVNQRPSFRDL 283

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 62/259 (23%), Positives = 109/259 (42%), Gaps = 17/259 (6%)
Query: 47  RRNSLKVDPELIFTKQERIGKGSFGEVFKG---IDNRTQQVVXXXXXXXXXXXXXXXXXX 103
           R   + +D +L+  + + +G G+FG V KG   +    + V                   
Sbjct: 17  RPKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELL 76
Query: 104 XXXMVLSQCDSPYGTKL--------WIIMEYLGGGSALD--LMKAGNFEEMHIAVILREV 153
               V+ Q D+PY  ++        W+++  +     L+  L +  + ++ +I  ++ +V
Sbjct: 77  AEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQV 136
Query: 154 LKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTL--TNTTSKRNTFVGTPF-W 210
             G+ YL     +HRD+ A NVLL      K++DFG++  L       K  T    P  W
Sbjct: 137 SMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKW 196
Query: 211 MAPEVIKQSAYDSKADIWSLGITAIE-LAKGEPPNSELHPMRVLFLIPKNNPPQLTGNYT 269
            APE I    + SK+D+WS G+   E  + G+ P   +    V  ++ K           
Sbjct: 197 YAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCP 256
Query: 270 KQFKEFVEACLNKDPENRP 288
           ++  + +  C   D ENRP
Sbjct: 257 REMYDLMNLCWTYDVENRP 275

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 47/136 (34%), Positives = 71/136 (52%), Gaps = 15/136 (11%)
Query: 112 CDSPYGTKLWIIMEYLGGGSALDLM-----KAGNFEEMHIAVILREVLKGLDYLHSERKL 166
           C    G  + +IME+L  GS  + +     K    +++  AV   ++ KG+DYL S + +
Sbjct: 92  CTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAV---QICKGMDYLGSRQYV 148
Query: 167 HRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFV----GTP-FWMAPEVIKQSAY 221
           HRD+ A NVL+     VK+ DFG+   +   T K    V     +P FW APE + QS +
Sbjct: 149 HRDLAARNVLVESEHQVKIGDFGLTKAI--ETDKEXXTVKDDRDSPVFWYAPECLMQSKF 206
Query: 222 DSKADIWSLGITAIEL 237
              +D+WS G+T  EL
Sbjct: 207 YIASDVWSFGVTLHEL 222

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 62/259 (23%), Positives = 109/259 (42%), Gaps = 17/259 (6%)
Query: 47  RRNSLKVDPELIFTKQERIGKGSFGEVFKG---IDNRTQQVVXXXXXXXXXXXXXXXXXX 103
           R   + +D +L+  + + +G G+FG V KG   +    + V                   
Sbjct: 17  RPKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELL 76
Query: 104 XXXMVLSQCDSPYGTKL--------WIIMEYLGGGSALD--LMKAGNFEEMHIAVILREV 153
               V+ Q D+PY  ++        W+++  +     L+  L +  + ++ +I  ++ +V
Sbjct: 77  AEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQV 136
Query: 154 LKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTL--TNTTSKRNTFVGTPF-W 210
             G+ YL     +HRD+ A NVLL      K++DFG++  L       K  T    P  W
Sbjct: 137 SMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKW 196
Query: 211 MAPEVIKQSAYDSKADIWSLGITAIE-LAKGEPPNSELHPMRVLFLIPKNNPPQLTGNYT 269
            APE I    + SK+D+WS G+   E  + G+ P   +    V  ++ K           
Sbjct: 197 YAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCP 256
Query: 270 KQFKEFVEACLNKDPENRP 288
           ++  + +  C   D ENRP
Sbjct: 257 REMYDLMNLCWTYDVENRP 275

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 35/119 (29%), Positives = 69/119 (57%), Gaps = 4/119 (3%)
Query: 123 IMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGD 182
           ++ +L G    +++K     + H+  ++ ++L+GL Y+HS   +HRD+K +N+ ++E  +
Sbjct: 104 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCE 163
Query: 183 VKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEV-IKQSAYDSKADIWSLGITAIELAKG 240
           +K+ D+G+A    +T  +   +V T ++ APE+ +    Y+   DIWS+G    EL  G
Sbjct: 164 LKILDYGLA---RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 42/146 (28%), Positives = 72/146 (49%), Gaps = 3/146 (2%)
Query: 152 EVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVG-TPF- 209
           E+  G+ YL++ + +HRD+ A N +++E   VK+ DFG+   +  T   R    G  P  
Sbjct: 131 EIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVR 190
Query: 210 WMAPEVIKQSAYDSKADIWSLGITAIELAK-GEPPNSELHPMRVLFLIPKNNPPQLTGNY 268
           WM+PE +K   + + +D+WS G+   E+A   E P   L   +VL  + +        N 
Sbjct: 191 WMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPDNC 250
Query: 269 TKQFKEFVEACLNKDPENRPTAKELL 294
                E +  C   +P+ RP+  E++
Sbjct: 251 PDMLLELMRMCWQYNPKMRPSFLEII 276

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 48/158 (30%), Positives = 79/158 (50%), Gaps = 22/158 (13%)
Query: 152 EVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTL---TNTTSKRNTFVGTP 208
           +V KG+ +L S+  +HRD+ A N+LL+     K+ DFG+A  +   +N   K N  +   
Sbjct: 176 QVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARHIKNDSNYVVKGNARLPVK 235
Query: 209 FWMAPEVIKQSAYDSKADIWSLGITAIELAK-------GEPPNSELHPM---RVLFLIPK 258
            WMAPE I    Y  ++D+WS GI   EL         G P +S+ + M       L P+
Sbjct: 236 -WMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSPE 294
Query: 259 NNPPQLTGNYTKQFKEFVEACLNKDPENRPTAKELLKF 296
           + P ++         + ++ C + DP  RPT K++++ 
Sbjct: 295 HAPAEMY--------DIMKTCWDADPLKRPTFKQIVQL 324

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 47/136 (34%), Positives = 71/136 (52%), Gaps = 15/136 (11%)
Query: 112 CDSPYGTKLWIIMEYLGGGSALDLM-----KAGNFEEMHIAVILREVLKGLDYLHSERKL 166
           C    G  + +IME+L  GS  + +     K    +++  AV   ++ KG+DYL S + +
Sbjct: 80  CTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAV---QICKGMDYLGSRQYV 136
Query: 167 HRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFV----GTP-FWMAPEVIKQSAY 221
           HRD+ A NVL+     VK+ DFG+   +   T K    V     +P FW APE + QS +
Sbjct: 137 HRDLAARNVLVESEHQVKIGDFGLTKAI--ETDKEXXTVKDDRDSPVFWYAPECLMQSKF 194
Query: 222 DSKADIWSLGITAIEL 237
              +D+WS G+T  EL
Sbjct: 195 YIASDVWSFGVTLHEL 210

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 42/146 (28%), Positives = 72/146 (49%), Gaps = 3/146 (2%)
Query: 152 EVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVG-TPF- 209
           E+  G+ YL++ + +HRD+ A N +++E   VK+ DFG+   +  T   R    G  P  
Sbjct: 140 EIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVR 199
Query: 210 WMAPEVIKQSAYDSKADIWSLGITAIELAK-GEPPNSELHPMRVLFLIPKNNPPQLTGNY 268
           WM+PE +K   + + +D+WS G+   E+A   E P   L   +VL  + +        N 
Sbjct: 200 WMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPDNC 259
Query: 269 TKQFKEFVEACLNKDPENRPTAKELL 294
                E +  C   +P+ RP+  E++
Sbjct: 260 PDMLFELMRMCWQYNPKMRPSFLEII 285

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 60/254 (23%), Positives = 111/254 (43%), Gaps = 32/254 (12%)
Query: 65  IGKGSFGEVFKGI--DNRTQQV-VXXXXXXXXXXXXXXXXXXXXXMVLSQCDSPYGTKL- 120
           +G+G FGEV++G+  +++ +++ V                     +++   D P+  KL 
Sbjct: 32  LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 91
Query: 121 --------WIIMEYLGGGSALDLMK--AGNFEEMHIAVILREVLKGLDYLHSERKLHRDI 170
                   WIIME    G     ++    + + + + +   ++ K + YL S   +HRDI
Sbjct: 92  GIIEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDI 151
Query: 171 KAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPF-WMAPEVIKQSAYDSKADIWS 229
              N+L++    VKL DFG++  + +    + +    P  WM+PE I    + + +D+W 
Sbjct: 152 AVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWM 211
Query: 230 LGITAIE-LAKGEPPNSELHPMRVLFLIPKNN--------PPQLTGNYTKQFKEFVEACL 280
             +   E L+ G+ P   L    V+ ++ K +        PP L    T+        C 
Sbjct: 212 FAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPKPDLCPPVLYTLMTR--------CW 263
Query: 281 NKDPENRPTAKELL 294
           + DP +RP   EL+
Sbjct: 264 DYDPSDRPRFTELV 277

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 39/121 (32%), Positives = 68/121 (56%), Gaps = 3/121 (2%)
Query: 120 LWIIMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSE 179
           ++I+ME +    +  +    + E M  + +L ++L G+ +LHS   +HRD+K +N+++  
Sbjct: 104 VYIVMELMDANLSQVIQMELDHERM--SYLLYQMLVGIKHLHSAGIIHRDLKPSNIVVKS 161
Query: 180 MGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAK 239
              +K+ DFG+A T   T+     +V T ++ APEVI    Y    DIWS+G+   E+ K
Sbjct: 162 DATLKILDFGLART-AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGVIMGEMIK 220
Query: 240 G 240
           G
Sbjct: 221 G 221

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 60/254 (23%), Positives = 111/254 (43%), Gaps = 32/254 (12%)
Query: 65  IGKGSFGEVFKGI--DNRTQQV-VXXXXXXXXXXXXXXXXXXXXXMVLSQCDSPYGTKL- 120
           +G+G FGEV++G+  +++ +++ V                     +++   D P+  KL 
Sbjct: 20  LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 79
Query: 121 --------WIIMEYLGGGSALDLMK--AGNFEEMHIAVILREVLKGLDYLHSERKLHRDI 170
                   WIIME    G     ++    + + + + +   ++ K + YL S   +HRDI
Sbjct: 80  GIIEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDI 139
Query: 171 KAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPF-WMAPEVIKQSAYDSKADIWS 229
              N+L++    VKL DFG++  + +    + +    P  WM+PE I    + + +D+W 
Sbjct: 140 AVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWM 199
Query: 230 LGITAIE-LAKGEPPNSELHPMRVLFLIPKNN--------PPQLTGNYTKQFKEFVEACL 280
             +   E L+ G+ P   L    V+ ++ K +        PP L    T+        C 
Sbjct: 200 FAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPKPDLCPPVLYTLMTR--------CW 251
Query: 281 NKDPENRPTAKELL 294
           + DP +RP   EL+
Sbjct: 252 DYDPSDRPRFTELV 265

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 60/254 (23%), Positives = 111/254 (43%), Gaps = 32/254 (12%)
Query: 65  IGKGSFGEVFKGI--DNRTQQV-VXXXXXXXXXXXXXXXXXXXXXMVLSQCDSPYGTKL- 120
           +G+G FGEV++G+  +++ +++ V                     +++   D P+  KL 
Sbjct: 16  LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 75
Query: 121 --------WIIMEYLGGGSALDLMK--AGNFEEMHIAVILREVLKGLDYLHSERKLHRDI 170
                   WIIME    G     ++    + + + + +   ++ K + YL S   +HRDI
Sbjct: 76  GIIEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDI 135
Query: 171 KAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPF-WMAPEVIKQSAYDSKADIWS 229
              N+L++    VKL DFG++  + +    + +    P  WM+PE I    + + +D+W 
Sbjct: 136 AVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWM 195
Query: 230 LGITAIE-LAKGEPPNSELHPMRVLFLIPKNN--------PPQLTGNYTKQFKEFVEACL 280
             +   E L+ G+ P   L    V+ ++ K +        PP L    T+        C 
Sbjct: 196 FAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPKPDLCPPVLYTLMTR--------CW 247
Query: 281 NKDPENRPTAKELL 294
           + DP +RP   EL+
Sbjct: 248 DYDPSDRPRFTELV 261

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 55/177 (31%), Positives = 86/177 (48%), Gaps = 13/177 (7%)
Query: 130 GSALDLM----KAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKL 185
           GS LDL     +    +E   + I R+++  + YL  +  +HRDIK  N++++E   +KL
Sbjct: 112 GSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKL 171
Query: 186 ADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDS-KADIWSLGITAIELAKGEPPN 244
            DFG A  L        TF GT  + APEV+  + Y   + ++WSLG+T   L   E P 
Sbjct: 172 IDFGSAAYLER-GKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPF 230
Query: 245 SELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPENRPTAKELLKFPFIRK 301
            EL       +    +PP L    +K+    V   L   PE R T ++L+  P++ +
Sbjct: 231 CELEET----VEAAIHPPYLV---SKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQ 280

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 50/179 (27%), Positives = 79/179 (44%), Gaps = 6/179 (3%)
Query: 122 IIMEYLGGGSALDLMKA--GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSE 179
           I+ EY+  GS    ++   G F  M +  +LR V  G+ YL     +HRD+ A NVL+  
Sbjct: 127 IVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDS 186
Query: 180 MGDVKLADFGVAGTLTNTTSKRNTFVGTPF---WMAPEVIKQSAYDSKADIWSLGITAIE 236
               K++DFG++  L +      T  G      W APE I    + S +D+WS G+   E
Sbjct: 187 NLVCKVSDFGLSRVLEDDPDAAXTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWE 246
Query: 237 -LAKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPENRPTAKELL 294
            LA GE P   +    V+  + +               + +  C +KD   RP   +++
Sbjct: 247 VLAYGERPYWNMTNRDVISSVEEGYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIV 305

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 39/121 (32%), Positives = 68/121 (56%), Gaps = 3/121 (2%)
Query: 120 LWIIMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSE 179
           ++I+ME +    +  +    + E M  + +L ++L G+ +LHS   +HRD+K +N+++  
Sbjct: 104 VYIVMELMDANLSQVIQMELDHERM--SYLLYQMLVGIKHLHSAGIIHRDLKPSNIVVKS 161
Query: 180 MGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAK 239
              +K+ DFG+A T   T+     +V T ++ APEVI    Y    DIWS+G+   E+ K
Sbjct: 162 DATLKILDFGLART-AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGVIMGEMIK 220
Query: 240 G 240
           G
Sbjct: 221 G 221

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 52/198 (26%), Positives = 90/198 (45%), Gaps = 14/198 (7%)
Query: 59  FTKQERIGKGSFGEVFKGIDNRTQQVVXXXXXXXXXXXXXXXXXXXXXMV--LSQCDSPY 116
           +  +E +G+GSFG+V      +TQQ V                      +  L     P+
Sbjct: 11  YIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPH 70
Query: 117 GTKLW----------IIMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERKL 166
             KL+          +++EY GG     +++     E       ++++  ++Y H  + +
Sbjct: 71  IIKLYDVITTPTDIVMVIEYAGGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIV 130
Query: 167 HRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDS-KA 225
           HRD+K  N+LL +  +VK+ADFG++  +T+    + T  G+P + APEVI    Y   + 
Sbjct: 131 HRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLK-TSCGSPNYAAPEVINGKLYAGPEV 189
Query: 226 DIWSLGITAIELAKGEPP 243
           D+WS GI    +  G  P
Sbjct: 190 DVWSCGIVLYVMLVGRLP 207

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 76/285 (26%), Positives = 120/285 (42%), Gaps = 29/285 (10%)
Query: 42  STTASRRNSLKVDPELIFTKQERIGKGSFGEVFKGI---DNRTQQV-VXXXXXXXXXXXX 97
           S  A  +  L++  E    K + +G G+FG V+KGI   D    ++ V            
Sbjct: 2   SGAAPNQALLRILKETELRKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPK 61
Query: 98  XXXXXXXXXMVLSQCDSPYGTKLW---------IIMEYLGGGSALDLMKA--GNFEEMHI 146
                     V++   SPY ++L          ++ + +  G  LD ++   G      +
Sbjct: 62  ANKEILDEAYVMAGVGSPYVSRLLGICLTSTVQLVTQLMPYGCLLDHVRENRGRLGSQDL 121
Query: 147 AVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVG 206
                ++ KG+ YL   R +HRD+ A NVL+     VK+ DFG+A  L    ++ +   G
Sbjct: 122 LNWCMQIAKGMSYLEDVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGG 181
Query: 207 -TPF-WMAPEVIKQSAYDSKADIWSLGITAIELAK-GEPPNSELHPMRVLFLIPKN---- 259
             P  WMA E I +  +  ++D+WS G+T  EL   G  P   +    +  L+ K     
Sbjct: 182 KVPIKWMALESILRRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERLP 241
Query: 260 NPPQLTGN-YTKQFKEFVEACLNKDPENRPTAKELLKFPFIRKAK 303
            PP  T + Y    K     C   D E RP  +EL+   F R A+
Sbjct: 242 QPPICTIDVYMIMVK-----CWMIDSECRPRFRELVS-EFSRMAR 280

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 50/179 (27%), Positives = 79/179 (44%), Gaps = 6/179 (3%)
Query: 122 IIMEYLGGGSALDLMKA--GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSE 179
           I+ EY+  GS    ++   G F  M +  +LR V  G+ YL     +HRD+ A NVL+  
Sbjct: 127 IVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDS 186
Query: 180 MGDVKLADFGVAGTLTNTTSKRNTFVGTPF---WMAPEVIKQSAYDSKADIWSLGITAIE 236
               K++DFG++  L +      T  G      W APE I    + S +D+WS G+   E
Sbjct: 187 NLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWE 246
Query: 237 -LAKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPENRPTAKELL 294
            LA GE P   +    V+  + +               + +  C +KD   RP   +++
Sbjct: 247 VLAYGERPYWNMTNRDVISSVEEGYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIV 305

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 60/251 (23%), Positives = 105/251 (41%), Gaps = 23/251 (9%)
Query: 65  IGKGSFGEVFKG---IDNRTQQVVXXXXXXXXXXXXXXXXXXXXXMVLSQCDSPYGTKL- 120
           +G G FGEV  G   + ++ +  V                      ++ Q D P   +L 
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 112
Query: 121 ---------WIIMEYLGGGSALDLMKA--GNFEEMHIAVILREVLKGLDYLHSERKLHRD 169
                     I+ EY+  GS    ++     F  + +  +LR +  G+ YL     +HRD
Sbjct: 113 GVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRD 172
Query: 170 IKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPF---WMAPEVIKQSAYDSKAD 226
           + A N+L++     K++DFG++  L +      T  G      W +PE I    + S +D
Sbjct: 173 LAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASD 232
Query: 227 IWSLGITAIE-LAKGEPPNSELHPMRVLFLIPKNN--PPQLTGNYTKQFKEFVEACLNKD 283
           +WS GI   E ++ GE P  E+    V+  + +    PP +  +      + +  C  KD
Sbjct: 233 VWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPM--DCPAALYQLMLDCWQKD 290
Query: 284 PENRPTAKELL 294
             NRP  ++++
Sbjct: 291 RNNRPKFEQIV 301

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 60/251 (23%), Positives = 105/251 (41%), Gaps = 23/251 (9%)
Query: 65  IGKGSFGEVFKG---IDNRTQQVVXXXXXXXXXXXXXXXXXXXXXMVLSQCDSPYGTKL- 120
           +G G FGEV  G   + ++ +  V                      ++ Q D P   +L 
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 112
Query: 121 ---------WIIMEYLGGGSALDLMKA--GNFEEMHIAVILREVLKGLDYLHSERKLHRD 169
                     I+ EY+  GS    ++     F  + +  +LR +  G+ YL     +HRD
Sbjct: 113 GVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRD 172
Query: 170 IKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPF---WMAPEVIKQSAYDSKAD 226
           + A N+L++     K++DFG++  L +      T  G      W +PE I    + S +D
Sbjct: 173 LAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASD 232
Query: 227 IWSLGITAIE-LAKGEPPNSELHPMRVLFLIPKNN--PPQLTGNYTKQFKEFVEACLNKD 283
           +WS GI   E ++ GE P  E+    V+  + +    PP +  +      + +  C  KD
Sbjct: 233 VWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPM--DCPAALYQLMLDCWQKD 290
Query: 284 PENRPTAKELL 294
             NRP  ++++
Sbjct: 291 RNNRPKFEQIV 301

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 60/251 (23%), Positives = 105/251 (41%), Gaps = 23/251 (9%)
Query: 65  IGKGSFGEVFKG---IDNRTQQVVXXXXXXXXXXXXXXXXXXXXXMVLSQCDSPYGTKL- 120
           +G G FGEV  G   + ++ +  V                      ++ Q D P   +L 
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 112
Query: 121 ---------WIIMEYLGGGSALDLMKA--GNFEEMHIAVILREVLKGLDYLHSERKLHRD 169
                     I+ EY+  GS    ++     F  + +  +LR +  G+ YL     +HRD
Sbjct: 113 GVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRD 172
Query: 170 IKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPF---WMAPEVIKQSAYDSKAD 226
           + A N+L++     K++DFG++  L +      T  G      W +PE I    + S +D
Sbjct: 173 LAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASD 232
Query: 227 IWSLGITAIE-LAKGEPPNSELHPMRVLFLIPKNN--PPQLTGNYTKQFKEFVEACLNKD 283
           +WS GI   E ++ GE P  E+    V+  + +    PP +  +      + +  C  KD
Sbjct: 233 VWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPM--DCPAALYQLMLDCWQKD 290
Query: 284 PENRPTAKELL 294
             NRP  ++++
Sbjct: 291 RNNRPKFEQIV 301

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 60/251 (23%), Positives = 105/251 (41%), Gaps = 23/251 (9%)
Query: 65  IGKGSFGEVFKG---IDNRTQQVVXXXXXXXXXXXXXXXXXXXXXMVLSQCDSPYGTKL- 120
           +G G FGEV  G   + ++ +  V                      ++ Q D P   +L 
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 112
Query: 121 ---------WIIMEYLGGGSALDLMKA--GNFEEMHIAVILREVLKGLDYLHSERKLHRD 169
                     I+ EY+  GS    ++     F  + +  +LR +  G+ YL     +HRD
Sbjct: 113 GVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRD 172
Query: 170 IKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPF---WMAPEVIKQSAYDSKAD 226
           + A N+L++     K++DFG++  L +      T  G      W +PE I    + S +D
Sbjct: 173 LAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASD 232
Query: 227 IWSLGITAIE-LAKGEPPNSELHPMRVLFLIPKNN--PPQLTGNYTKQFKEFVEACLNKD 283
           +WS GI   E ++ GE P  E+    V+  + +    PP +  +      + +  C  KD
Sbjct: 233 VWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPM--DCPAALYQLMLDCWQKD 290
Query: 284 PENRPTAKELL 294
             NRP  ++++
Sbjct: 291 RNNRPKFEQIV 301

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 62/259 (23%), Positives = 109/259 (42%), Gaps = 17/259 (6%)
Query: 47  RRNSLKVDPELIFTKQERIGKGSFGEVFKG---IDNRTQQVVXXXXXXXXXXXXXXXXXX 103
           R   + +D +L+  + + +G G+FG V KG   +    + V                   
Sbjct: 7   RPKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELL 66
Query: 104 XXXMVLSQCDSPYGTKL--------WIIMEYLGGGSALD--LMKAGNFEEMHIAVILREV 153
               V+ Q D+PY  ++        W+++  +     L+  L +  + ++ +I  ++ +V
Sbjct: 67  AEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQV 126
Query: 154 LKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTL--TNTTSKRNTFVGTPF-W 210
             G+ YL     +HRD+ A NVLL      K++DFG++  L       K  T    P  W
Sbjct: 127 SMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKW 186
Query: 211 MAPEVIKQSAYDSKADIWSLGITAIE-LAKGEPPNSELHPMRVLFLIPKNNPPQLTGNYT 269
            APE I    + SK+D+WS G+   E  + G+ P   +    V  ++ K           
Sbjct: 187 YAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCP 246
Query: 270 KQFKEFVEACLNKDPENRP 288
           ++  + +  C   D ENRP
Sbjct: 247 REMYDLMNLCWTYDVENRP 265

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 42/146 (28%), Positives = 72/146 (49%), Gaps = 3/146 (2%)
Query: 152 EVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVG-TPF- 209
           E+  G+ YL++ + +HRD+ A N +++E   VK+ DFG+   +  T   R    G  P  
Sbjct: 140 EIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 199
Query: 210 WMAPEVIKQSAYDSKADIWSLGITAIELAK-GEPPNSELHPMRVLFLIPKNNPPQLTGNY 268
           WM+PE +K   + + +D+WS G+   E+A   E P   L   +VL  + +        N 
Sbjct: 200 WMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPDNC 259
Query: 269 TKQFKEFVEACLNKDPENRPTAKELL 294
                E +  C   +P+ RP+  E++
Sbjct: 260 PDMLFELMRMCWQYNPKMRPSFLEII 285

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 36/119 (30%), Positives = 68/119 (57%), Gaps = 4/119 (3%)
Query: 123 IMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGD 182
           ++ +L G    +++K     + H+  ++ ++L+GL Y+HS   +HRD+K +N+ ++E  +
Sbjct: 104 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCE 163
Query: 183 VKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEV-IKQSAYDSKADIWSLGITAIELAKG 240
           +K+ DFG+A    +T  +    V T ++ APE+ +    Y+   DIWS+G    EL  G
Sbjct: 164 LKILDFGLA---RHTDDEMTGXVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 61/253 (24%), Positives = 107/253 (42%), Gaps = 17/253 (6%)
Query: 53  VDPELIFTKQERIGKGSFGEVFKG---IDNRTQQVVXXXXXXXXXXXXXXXXXXXXXMVL 109
           +D +L+  + + +G G+FG V KG   +    + V                       V+
Sbjct: 7   LDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVM 66
Query: 110 SQCDSPYGTKL--------WIIMEYLGGGSALD--LMKAGNFEEMHIAVILREVLKGLDY 159
            Q D+PY  ++        W+++  +     L+  L +  + ++ +I  ++ +V  G+ Y
Sbjct: 67  QQLDNPYIVRMIGICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKY 126
Query: 160 LHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTL--TNTTSKRNTFVGTPF-WMAPEVI 216
           L     +HRD+ A NVLL      K++DFG++  L       K  T    P  W APE I
Sbjct: 127 LEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENXYKAQTHGKWPVKWYAPECI 186
Query: 217 KQSAYDSKADIWSLGITAIE-LAKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEF 275
               + SK+D+WS G+   E  + G+ P   +    V  ++ K           ++  + 
Sbjct: 187 NYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDL 246
Query: 276 VEACLNKDPENRP 288
           +  C   D ENRP
Sbjct: 247 MNLCWTYDVENRP 259

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 61/253 (24%), Positives = 107/253 (42%), Gaps = 17/253 (6%)
Query: 53  VDPELIFTKQERIGKGSFGEVFKG---IDNRTQQVVXXXXXXXXXXXXXXXXXXXXXMVL 109
           +D +L+  + + +G G+FG V KG   +    + V                       V+
Sbjct: 7   LDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVM 66
Query: 110 SQCDSPYGTKL--------WIIMEYLGGGSALD--LMKAGNFEEMHIAVILREVLKGLDY 159
            Q D+PY  ++        W+++  +     L+  L +  + ++ +I  ++ +V  G+ Y
Sbjct: 67  QQLDNPYIVRMIGICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKY 126
Query: 160 LHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTL--TNTTSKRNTFVGTPF-WMAPEVI 216
           L     +HRD+ A NVLL      K++DFG++  L       K  T    P  W APE I
Sbjct: 127 LEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI 186
Query: 217 KQSAYDSKADIWSLGITAIE-LAKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEF 275
               + SK+D+WS G+   E  + G+ P   +    V  ++ K           ++  + 
Sbjct: 187 NYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDL 246
Query: 276 VEACLNKDPENRP 288
           +  C   D ENRP
Sbjct: 247 MNLCWTYDVENRP 259

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 60/251 (23%), Positives = 105/251 (41%), Gaps = 23/251 (9%)
Query: 65  IGKGSFGEVFKG---IDNRTQQVVXXXXXXXXXXXXXXXXXXXXXMVLSQCDSPYGTKL- 120
           +G G FGEV  G   + ++ +  V                      ++ Q D P   +L 
Sbjct: 51  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 110
Query: 121 ---------WIIMEYLGGGSALDLMKA--GNFEEMHIAVILREVLKGLDYLHSERKLHRD 169
                     I+ EY+  GS    ++     F  + +  +LR +  G+ YL     +HRD
Sbjct: 111 GVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRD 170
Query: 170 IKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPF---WMAPEVIKQSAYDSKAD 226
           + A N+L++     K++DFG++  L +      T  G      W +PE I    + S +D
Sbjct: 171 LAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASD 230
Query: 227 IWSLGITAIE-LAKGEPPNSELHPMRVLFLIPKNN--PPQLTGNYTKQFKEFVEACLNKD 283
           +WS GI   E ++ GE P  E+    V+  + +    PP +  +      + +  C  KD
Sbjct: 231 VWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPM--DCPAALYQLMLDCWQKD 288
Query: 284 PENRPTAKELL 294
             NRP  ++++
Sbjct: 289 RNNRPKFEQIV 299

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 45/134 (33%), Positives = 71/134 (52%), Gaps = 10/134 (7%)
Query: 120 LWIIMEYLGGGSALDLM-KAGNFEEMHIA-VILREVLKGLDYLHSERKLHRDIKAANVLL 177
           L+++MEY  GG  L L+ K G      +A   L E++  +D +H    +HRDIK  N+LL
Sbjct: 136 LYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILL 195
Query: 178 SEMGDVKLADFGVAGTL-TNTTSKRNTFVGTPFWMAPEVIKQSAYDS-------KADIWS 229
              G ++LADFG    L  + T +    VGTP +++PE+++             + D W+
Sbjct: 196 DRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWA 255
Query: 230 LGITAIELAKGEPP 243
           LG+ A E+  G+ P
Sbjct: 256 LGVFAYEMFYGQTP 269

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 42/146 (28%), Positives = 72/146 (49%), Gaps = 3/146 (2%)
Query: 152 EVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVG-TPF- 209
           E+  G+ YL++ + +HRD+ A N +++E   VK+ DFG+   +  T   R    G  P  
Sbjct: 133 EIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 192
Query: 210 WMAPEVIKQSAYDSKADIWSLGITAIELAK-GEPPNSELHPMRVLFLIPKNNPPQLTGNY 268
           WM+PE +K   + + +D+WS G+   E+A   E P   L   +VL  + +        N 
Sbjct: 193 WMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPDNC 252
Query: 269 TKQFKEFVEACLNKDPENRPTAKELL 294
                E +  C   +P+ RP+  E++
Sbjct: 253 PDMLFELMRMCWQYNPKMRPSFLEII 278

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 60/251 (23%), Positives = 104/251 (41%), Gaps = 23/251 (9%)
Query: 65  IGKGSFGEVFKG---IDNRTQQVVXXXXXXXXXXXXXXXXXXXXXMVLSQCDSPYGTKL- 120
           +G G FGEV  G   + ++ +  V                      ++ Q D P   +L 
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 112
Query: 121 ---------WIIMEYLGGGSALDLMKA--GNFEEMHIAVILREVLKGLDYLHSERKLHRD 169
                     I+ EY+  GS    ++     F  + +  +LR +  G+ YL     +HRD
Sbjct: 113 GVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRD 172
Query: 170 IKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPF---WMAPEVIKQSAYDSKAD 226
           + A N+L++     K++DFG+   L +      T  G      W +PE I    + S +D
Sbjct: 173 LAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASD 232
Query: 227 IWSLGITAIE-LAKGEPPNSELHPMRVLFLIPKNN--PPQLTGNYTKQFKEFVEACLNKD 283
           +WS GI   E ++ GE P  E+    V+  + +    PP +  +      + +  C  KD
Sbjct: 233 VWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPM--DCPAALYQLMLDCWQKD 290
Query: 284 PENRPTAKELL 294
             NRP  ++++
Sbjct: 291 RNNRPKFEQIV 301

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 42/146 (28%), Positives = 72/146 (49%), Gaps = 3/146 (2%)
Query: 152 EVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVG-TPF- 209
           E+  G+ YL++ + +HRD+ A N +++E   VK+ DFG+   +  T   R    G  P  
Sbjct: 139 EIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 198
Query: 210 WMAPEVIKQSAYDSKADIWSLGITAIELAK-GEPPNSELHPMRVLFLIPKNNPPQLTGNY 268
           WM+PE +K   + + +D+WS G+   E+A   E P   L   +VL  + +        N 
Sbjct: 199 WMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPDNC 258
Query: 269 TKQFKEFVEACLNKDPENRPTAKELL 294
                E +  C   +P+ RP+  E++
Sbjct: 259 PDMLFELMRMCWQYNPKMRPSFLEII 284

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 42/146 (28%), Positives = 72/146 (49%), Gaps = 3/146 (2%)
Query: 152 EVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVG-TPF- 209
           E+  G+ YL++ + +HRD+ A N +++E   VK+ DFG+   +  T   R    G  P  
Sbjct: 137 EIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 196
Query: 210 WMAPEVIKQSAYDSKADIWSLGITAIELAK-GEPPNSELHPMRVLFLIPKNNPPQLTGNY 268
           WM+PE +K   + + +D+WS G+   E+A   E P   L   +VL  + +        N 
Sbjct: 197 WMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPDNC 256
Query: 269 TKQFKEFVEACLNKDPENRPTAKELL 294
                E +  C   +P+ RP+  E++
Sbjct: 257 PDMLFELMRMCWQYNPKMRPSFLEII 282

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 37/119 (31%), Positives = 61/119 (51%), Gaps = 3/119 (2%)
Query: 122 IIMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMG 181
           ++MEY+  GS  D +         + +  +++ +G+ YLH++  +HR + A NVLL    
Sbjct: 90  LVMEYVPLGSLRDYLPRHCVGLAQLLLFAQQICEGMAYLHAQHYIHRALAARNVLLDNDR 149
Query: 182 DVKLADFGVAGTL---TNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIEL 237
            VK+ DFG+A  +         R       FW APE +K+  +   +D+WS G+T  EL
Sbjct: 150 LVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKECKFYYASDVWSFGVTLYEL 208

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 95/206 (46%), Gaps = 27/206 (13%)
Query: 112 CDSPYGTKLWIIMEYLGGGSALDLMKAGNFEEMHIAVI--LREVLKGLDYLHSERKLHRD 169
           C S     L +IME+L  GS  + ++       HI ++    ++ KG++YL ++R +HRD
Sbjct: 83  CYSAGRRNLKLIMEFLPYGSLREYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRD 142
Query: 170 IKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTP-----FWMAPEVIKQSAYDSK 224
           +   N+L+     VK+ DFG+   L     K    V  P     FW APE + +S +   
Sbjct: 143 LATRNILVENENRVKIGDFGLTKVLPQ--DKEXXKVKEPGESPIFWYAPESLTESKFSVA 200
Query: 225 ADIWSLGI------TAIELAKGEPP-------NSELHPMRVLFLIP--KNNP--PQLTGN 267
           +D+WS G+      T IE +K  P        N +   M V  LI   KNN   P+  G 
Sbjct: 201 SDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGC 260
Query: 268 YTKQFKEFVEACLNKDPENRPTAKEL 293
             + +    E C N +   RP+ ++L
Sbjct: 261 PDEIYMIMTE-CWNNNVNQRPSFRDL 285

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 60/251 (23%), Positives = 105/251 (41%), Gaps = 23/251 (9%)
Query: 65  IGKGSFGEVFKG---IDNRTQQVVXXXXXXXXXXXXXXXXXXXXXMVLSQCDSPYGTKL- 120
           +G G FGEV  G   + ++ +  V                      ++ Q D P   +L 
Sbjct: 24  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 83
Query: 121 ---------WIIMEYLGGGSALDLMKA--GNFEEMHIAVILREVLKGLDYLHSERKLHRD 169
                     I+ EY+  GS    ++     F  + +  +LR +  G+ YL     +HRD
Sbjct: 84  GVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRD 143
Query: 170 IKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPF---WMAPEVIKQSAYDSKAD 226
           + A N+L++     K++DFG++  L +      T  G      W +PE I    + S +D
Sbjct: 144 LAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASD 203
Query: 227 IWSLGITAIE-LAKGEPPNSELHPMRVLFLIPKNN--PPQLTGNYTKQFKEFVEACLNKD 283
           +WS GI   E ++ GE P  E+    V+  + +    PP +  +      + +  C  KD
Sbjct: 204 VWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPM--DCPAALYQLMLDCWQKD 261
Query: 284 PENRPTAKELL 294
             NRP  ++++
Sbjct: 262 RNNRPKFEQIV 272

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 41/131 (31%), Positives = 67/131 (51%), Gaps = 4/131 (3%)
Query: 117 GTKLWIIMEYLGGGSALDLMKAG-NFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANV 175
           G   ++ +EY  GG   D ++      E        +++ G+ YLH     HRDIK  N+
Sbjct: 76  GNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENL 135
Query: 176 LLSEMGDVKLADFGVAGTLTNTTSKR--NTFVGTPFWMAPEVIKQSAYDSK-ADIWSLGI 232
           LL E  ++K++DFG+A        +R  N   GT  ++APE++K+  + ++  D+WS GI
Sbjct: 136 LLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGI 195
Query: 233 TAIELAKGEPP 243
               +  GE P
Sbjct: 196 VLTAMLAGELP 206

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 37/119 (31%), Positives = 61/119 (51%), Gaps = 3/119 (2%)
Query: 122 IIMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMG 181
           ++MEY+  GS  D +         + +  +++ +G+ YLH++  +HR + A NVLL    
Sbjct: 89  LVMEYVPLGSLRDYLPRHCVGLAQLLLFAQQICEGMAYLHAQHYIHRALAARNVLLDNDR 148
Query: 182 DVKLADFGVAGTL---TNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIEL 237
            VK+ DFG+A  +         R       FW APE +K+  +   +D+WS G+T  EL
Sbjct: 149 LVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKECKFYYASDVWSFGVTLYEL 207

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 62/256 (24%), Positives = 110/256 (42%), Gaps = 25/256 (9%)
Query: 62  QERIGKGSFGEVFKG---IDNRTQQVVXXXXXXXXXXXXXXXXXXXXXMVLSQCDSPY-- 116
           ++ IG G FGEV  G   +  + +  V                      ++ Q D P   
Sbjct: 12  EQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVI 71
Query: 117 --------GTKLWIIMEYLGGGSALDLMKA--GNFEEMHIAVILREVLKGLDYLHSERKL 166
                    T + II E++  GS    ++   G F  + +  +LR +  G+ YL     +
Sbjct: 72  HLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYV 131
Query: 167 HRDIKAANVLLSEMGDVKLADFGVAGTLTNTTS--KRNTFVGTPF---WMAPEVIKQSAY 221
           HR + A N+L++     K++DFG++  L + TS     + +G      W APE I+   +
Sbjct: 132 HRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKF 191
Query: 222 DSKADIWSLGITAIE-LAKGEPPNSELHPMRVLFLIPKNN--PPQLTGNYTKQFKEFVEA 278
            S +D+WS GI   E ++ GE P  ++    V+  I ++   PP +  +      + +  
Sbjct: 192 TSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPM--DCPSALHQLMLD 249
Query: 279 CLNKDPENRPTAKELL 294
           C  KD  +RP   +++
Sbjct: 250 CWQKDRNHRPKFGQIV 265

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 61/253 (24%), Positives = 107/253 (42%), Gaps = 17/253 (6%)
Query: 53  VDPELIFTKQERIGKGSFGEVFKG---IDNRTQQVVXXXXXXXXXXXXXXXXXXXXXMVL 109
           +D +L+  + + +G G+FG V KG   +    + V                       V+
Sbjct: 1   LDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVM 60
Query: 110 SQCDSPYGTKL--------WIIMEYLGGGSALD--LMKAGNFEEMHIAVILREVLKGLDY 159
            Q D+PY  ++        W+++  +     L+  L +  + ++ +I  ++ +V  G+ Y
Sbjct: 61  QQLDNPYIVRMIGICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKY 120
Query: 160 LHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTL--TNTTSKRNTFVGTPF-WMAPEVI 216
           L     +HRD+ A NVLL      K++DFG++  L       K  T    P  W APE I
Sbjct: 121 LEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI 180
Query: 217 KQSAYDSKADIWSLGITAIE-LAKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEF 275
               + SK+D+WS G+   E  + G+ P   +    V  ++ K           ++  + 
Sbjct: 181 NYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDL 240
Query: 276 VEACLNKDPENRP 288
           +  C   D ENRP
Sbjct: 241 MNLCWTYDVENRP 253

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 61/253 (24%), Positives = 107/253 (42%), Gaps = 17/253 (6%)
Query: 53  VDPELIFTKQERIGKGSFGEVFKG---IDNRTQQVVXXXXXXXXXXXXXXXXXXXXXMVL 109
           +D +L+  + + +G G+FG V KG   +    + V                       V+
Sbjct: 3   LDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVM 62
Query: 110 SQCDSPYGTKL--------WIIMEYLGGGSALD--LMKAGNFEEMHIAVILREVLKGLDY 159
            Q D+PY  ++        W+++  +     L+  L +  + ++ +I  ++ +V  G+ Y
Sbjct: 63  QQLDNPYIVRMIGICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKY 122
Query: 160 LHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTL--TNTTSKRNTFVGTPF-WMAPEVI 216
           L     +HRD+ A NVLL      K++DFG++  L       K  T    P  W APE I
Sbjct: 123 LEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI 182
Query: 217 KQSAYDSKADIWSLGITAIE-LAKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEF 275
               + SK+D+WS G+   E  + G+ P   +    V  ++ K           ++  + 
Sbjct: 183 NYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDL 242
Query: 276 VEACLNKDPENRP 288
           +  C   D ENRP
Sbjct: 243 MNLCWTYDVENRP 255

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 42/146 (28%), Positives = 72/146 (49%), Gaps = 3/146 (2%)
Query: 152 EVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVG-TPF- 209
           E+  G+ YL++ + +HRD+ A N +++E   VK+ DFG+   +  T   R    G  P  
Sbjct: 168 EIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 227
Query: 210 WMAPEVIKQSAYDSKADIWSLGITAIELAK-GEPPNSELHPMRVLFLIPKNNPPQLTGNY 268
           WM+PE +K   + + +D+WS G+   E+A   E P   L   +VL  + +        N 
Sbjct: 228 WMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPDNC 287
Query: 269 TKQFKEFVEACLNKDPENRPTAKELL 294
                E +  C   +P+ RP+  E++
Sbjct: 288 PDMLFELMRMCWQYNPKMRPSFLEII 313

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 60/251 (23%), Positives = 105/251 (41%), Gaps = 23/251 (9%)
Query: 65  IGKGSFGEVFKG---IDNRTQQVVXXXXXXXXXXXXXXXXXXXXXMVLSQCDSPYGTKL- 120
           +G G FGEV  G   + ++ +  V                      ++ Q D P   +L 
Sbjct: 41  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 100
Query: 121 ---------WIIMEYLGGGSALDLMKA--GNFEEMHIAVILREVLKGLDYLHSERKLHRD 169
                     I+ EY+  GS    ++     F  + +  +LR +  G+ YL     +HRD
Sbjct: 101 GVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRD 160
Query: 170 IKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPF---WMAPEVIKQSAYDSKAD 226
           + A N+L++     K++DFG++  L +      T  G      W +PE I    + S +D
Sbjct: 161 LAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASD 220
Query: 227 IWSLGITAIE-LAKGEPPNSELHPMRVLFLIPKNN--PPQLTGNYTKQFKEFVEACLNKD 283
           +WS GI   E ++ GE P  E+    V+  + +    PP +  +      + +  C  KD
Sbjct: 221 VWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPM--DCPAALYQLMLDCWQKD 278
Query: 284 PENRPTAKELL 294
             NRP  ++++
Sbjct: 279 RNNRPKFEQIV 289

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 60/251 (23%), Positives = 105/251 (41%), Gaps = 23/251 (9%)
Query: 65  IGKGSFGEVFKG---IDNRTQQVVXXXXXXXXXXXXXXXXXXXXXMVLSQCDSPYGTKL- 120
           +G G FGEV  G   + ++ +  V                      ++ Q D P   +L 
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 112
Query: 121 ---------WIIMEYLGGGSALDLMKA--GNFEEMHIAVILREVLKGLDYLHSERKLHRD 169
                     I+ EY+  GS    ++     F  + +  +LR +  G+ YL     +HRD
Sbjct: 113 GVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGFVHRD 172
Query: 170 IKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPF---WMAPEVIKQSAYDSKAD 226
           + A N+L++     K++DFG++  L +      T  G      W +PE I    + S +D
Sbjct: 173 LAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASD 232
Query: 227 IWSLGITAIE-LAKGEPPNSELHPMRVLFLIPKNN--PPQLTGNYTKQFKEFVEACLNKD 283
           +WS GI   E ++ GE P  E+    V+  + +    PP +  +      + +  C  KD
Sbjct: 233 VWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPM--DCPAALYQLMLDCWQKD 290
Query: 284 PENRPTAKELL 294
             NRP  ++++
Sbjct: 291 RNNRPKFEQIV 301

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 42/146 (28%), Positives = 72/146 (49%), Gaps = 3/146 (2%)
Query: 152 EVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVG-TPF- 209
           E+  G+ YL++ + +HRD+ A N +++E   VK+ DFG+   +  T   R    G  P  
Sbjct: 136 EIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 195
Query: 210 WMAPEVIKQSAYDSKADIWSLGITAIELAK-GEPPNSELHPMRVLFLIPKNNPPQLTGNY 268
           WM+PE +K   + + +D+WS G+   E+A   E P   L   +VL  + +        N 
Sbjct: 196 WMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPDNC 255
Query: 269 TKQFKEFVEACLNKDPENRPTAKELL 294
                E +  C   +P+ RP+  E++
Sbjct: 256 PDMLFELMRMCWQYNPKMRPSFLEII 281

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 41/131 (31%), Positives = 67/131 (51%), Gaps = 4/131 (3%)
Query: 117 GTKLWIIMEYLGGGSALDLMKAG-NFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANV 175
           G   ++ +EY  GG   D ++      E        +++ G+ YLH     HRDIK  N+
Sbjct: 77  GNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENL 136
Query: 176 LLSEMGDVKLADFGVAGTLTNTTSKR--NTFVGTPFWMAPEVIKQSAYDSK-ADIWSLGI 232
           LL E  ++K++DFG+A        +R  N   GT  ++APE++K+  + ++  D+WS GI
Sbjct: 137 LLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGI 196
Query: 233 TAIELAKGEPP 243
               +  GE P
Sbjct: 197 VLTAMLAGELP 207

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 36/119 (30%), Positives = 68/119 (57%), Gaps = 4/119 (3%)
Query: 123 IMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGD 182
           ++ +L G    +++K     + H+  ++ ++L+GL Y+HS   +HRD+K +N+ ++E  +
Sbjct: 124 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCE 183
Query: 183 VKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEV-IKQSAYDSKADIWSLGITAIELAKG 240
           +K+ DFG+A    +T  +    V T ++ APE+ +    Y+   DIWS+G    EL  G
Sbjct: 184 LKILDFGLA---RHTDDEMXGXVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 239

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 42/146 (28%), Positives = 72/146 (49%), Gaps = 3/146 (2%)
Query: 152 EVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVG-TPF- 209
           E+  G+ YL++ + +HRD+ A N +++E   VK+ DFG+   +  T   R    G  P  
Sbjct: 139 EIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 198
Query: 210 WMAPEVIKQSAYDSKADIWSLGITAIELAK-GEPPNSELHPMRVLFLIPKNNPPQLTGNY 268
           WM+PE +K   + + +D+WS G+   E+A   E P   L   +VL  + +        N 
Sbjct: 199 WMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPDNC 258
Query: 269 TKQFKEFVEACLNKDPENRPTAKELL 294
                E +  C   +P+ RP+  E++
Sbjct: 259 PDMLFELMRMCWQYNPKMRPSFLEII 284

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 42/146 (28%), Positives = 72/146 (49%), Gaps = 3/146 (2%)
Query: 152 EVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVG-TPF- 209
           E+  G+ YL++ + +HRD+ A N +++E   VK+ DFG+   +  T   R    G  P  
Sbjct: 146 EIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 205
Query: 210 WMAPEVIKQSAYDSKADIWSLGITAIELAK-GEPPNSELHPMRVLFLIPKNNPPQLTGNY 268
           WM+PE +K   + + +D+WS G+   E+A   E P   L   +VL  + +        N 
Sbjct: 206 WMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPDNC 265
Query: 269 TKQFKEFVEACLNKDPENRPTAKELL 294
                E +  C   +P+ RP+  E++
Sbjct: 266 PDMLFELMRMCWQYNPKMRPSFLEII 291

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 71/275 (25%), Positives = 115/275 (41%), Gaps = 28/275 (10%)
Query: 42  STTASRRNSLKVDPELIFTKQERIGKGSFGEVFKGI---DNRTQQV-VXXXXXXXXXXXX 97
           S TA  +  L++  E    + + +G G+FG V+KGI   +  T ++ V            
Sbjct: 23  SGTAPNQAQLRILKETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPK 82
Query: 98  XXXXXXXXXMVLSQCDSPYGTKLW---------IIMEYLGGGSALDLMKA--GNFEEMHI 146
                    ++++  D P+  +L          ++ + +  G  L+ +     N     +
Sbjct: 83  ANVEFMDEALIMASMDHPHLVRLLGVCLSPTIQLVTQLMPHGCLLEYVHEHKDNIGSQLL 142
Query: 147 AVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVG 206
                ++ KG+ YL   R +HRD+ A NVL+     VK+ DFG+A  L     + N   G
Sbjct: 143 LNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGG 202
Query: 207 -TPF-WMAPEVIKQSAYDSKADIWSLGITAIELAK-GEPPNSELHPMRVLFLIPKN---- 259
             P  WMA E I    +  ++D+WS G+T  EL   G  P   +    +  L+ K     
Sbjct: 203 KMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGERLP 262
Query: 260 NPPQLTGN-YTKQFKEFVEACLNKDPENRPTAKEL 293
            PP  T + Y    K     C   D ++RP  KEL
Sbjct: 263 QPPICTIDVYMVMVK-----CWMIDADSRPKFKEL 292

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 45/150 (30%), Positives = 77/150 (51%), Gaps = 9/150 (6%)
Query: 152 EVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTN---TTSKRNTFVGTP 208
           +V +G++YL  ++ +HRD+ A N +L E   VK+ADFG+A  + +    + +++     P
Sbjct: 132 QVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLP 191
Query: 209 F-WMAPEVIKQSAYDSKADIWSLGITAIE-LAKGEPPNSELHPMRVL-FLIPKNNPPQLT 265
             W A E ++   + +K+D+WS G+   E L +G PP   + P  +  FL      PQ  
Sbjct: 192 VKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRLPQ-- 249
Query: 266 GNYT-KQFKEFVEACLNKDPENRPTAKELL 294
             Y      + ++ C   DP  RPT + L+
Sbjct: 250 PEYCPDSLYQVMQQCWEADPAVRPTFRVLV 279

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 42/146 (28%), Positives = 72/146 (49%), Gaps = 3/146 (2%)
Query: 152 EVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVG-TPF- 209
           E+  G+ YL++ + +HRD+ A N +++E   VK+ DFG+   +  T   R    G  P  
Sbjct: 146 EIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 205
Query: 210 WMAPEVIKQSAYDSKADIWSLGITAIELAK-GEPPNSELHPMRVLFLIPKNNPPQLTGNY 268
           WM+PE +K   + + +D+WS G+   E+A   E P   L   +VL  + +        N 
Sbjct: 206 WMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPDNC 265
Query: 269 TKQFKEFVEACLNKDPENRPTAKELL 294
                E +  C   +P+ RP+  E++
Sbjct: 266 PDMLFELMRMCWQYNPKMRPSFLEII 291

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 72.0 bits (175), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 41/131 (31%), Positives = 67/131 (51%), Gaps = 4/131 (3%)
Query: 117 GTKLWIIMEYLGGGSALDLMKAG-NFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANV 175
           G   ++ +EY  GG   D ++      E        +++ G+ YLH     HRDIK  N+
Sbjct: 75  GNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENL 134
Query: 176 LLSEMGDVKLADFGVAGTLTNTTSKR--NTFVGTPFWMAPEVIKQSAYDSK-ADIWSLGI 232
           LL E  ++K++DFG+A        +R  N   GT  ++APE++K+  + ++  D+WS GI
Sbjct: 135 LLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGI 194
Query: 233 TAIELAKGEPP 243
               +  GE P
Sbjct: 195 VLTAMLAGELP 205

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 72.0 bits (175), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 41/131 (31%), Positives = 67/131 (51%), Gaps = 4/131 (3%)
Query: 117 GTKLWIIMEYLGGGSALDLMKAG-NFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANV 175
           G   ++ +EY  GG   D ++      E        +++ G+ YLH     HRDIK  N+
Sbjct: 76  GNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENL 135
Query: 176 LLSEMGDVKLADFGVAGTLTNTTSKR--NTFVGTPFWMAPEVIKQSAYDSK-ADIWSLGI 232
           LL E  ++K++DFG+A        +R  N   GT  ++APE++K+  + ++  D+WS GI
Sbjct: 136 LLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGI 195
Query: 233 TAIELAKGEPP 243
               +  GE P
Sbjct: 196 VLTAMLAGELP 206

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 72.0 bits (175), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 71/291 (24%), Positives = 119/291 (40%), Gaps = 59/291 (20%)
Query: 59  FTKQERIGKGSFGEVFKGIDNRTQQVVXXXXXXXXXXXXXXXXXXXXXM---------VL 109
            T  E +GKG +GEV++G        V                     M         + 
Sbjct: 10  ITLLECVGKGRYGEVWRGSWQGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIA 69
Query: 110 SQCDSPYG-TKLWIIMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSE----- 163
           S   S +  T+LW+I  Y   GS  D ++    + +    I+  +  GL +LH E     
Sbjct: 70  SDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQ 129
Query: 164 ---RKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSK----RNTFVGTPFWMAPEVI 216
                 HRD+K+ N+L+ + G   +AD G+A   + +T++     N  VGT  +MAPEV+
Sbjct: 130 GKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVL 189
Query: 217 KQS----AYDS--KADIWSLGITAIELAK----------GEPPNSELHP-------MRVL 253
            ++     +DS  + DIW+ G+   E+A+           +PP  ++ P       MR +
Sbjct: 190 DETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKV 249
Query: 254 FLIPKNNP---------PQLTGNYTKQFKEFVEACLNKDPENRPTAKELLK 295
             + +  P         P LT        + ++ C  ++P  R TA  + K
Sbjct: 250 VCVDQQRPNIPNRWFSDPTLTS-----LAKLMKECWYQNPSARLTALRIKK 295

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 72.0 bits (175), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 41/131 (31%), Positives = 67/131 (51%), Gaps = 4/131 (3%)
Query: 117 GTKLWIIMEYLGGGSALDLMKAG-NFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANV 175
           G   ++ +EY  GG   D ++      E        +++ G+ YLH     HRDIK  N+
Sbjct: 76  GNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENL 135
Query: 176 LLSEMGDVKLADFGVAGTLTNTTSKR--NTFVGTPFWMAPEVIKQSAYDSK-ADIWSLGI 232
           LL E  ++K++DFG+A        +R  N   GT  ++APE++K+  + ++  D+WS GI
Sbjct: 136 LLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGI 195
Query: 233 TAIELAKGEPP 243
               +  GE P
Sbjct: 196 VLTAMLAGELP 206

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 72.0 bits (175), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 71/291 (24%), Positives = 119/291 (40%), Gaps = 59/291 (20%)
Query: 59  FTKQERIGKGSFGEVFKGIDNRTQQVVXXXXXXXXXXXXXXXXXXXXXM---------VL 109
            T  E +GKG +GEV++G        V                     M         + 
Sbjct: 10  ITLLECVGKGRYGEVWRGSWQGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIA 69
Query: 110 SQCDSPYG-TKLWIIMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSE----- 163
           S   S +  T+LW+I  Y   GS  D ++    + +    I+  +  GL +LH E     
Sbjct: 70  SDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQ 129
Query: 164 ---RKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSK----RNTFVGTPFWMAPEVI 216
                 HRD+K+ N+L+ + G   +AD G+A   + +T++     N  VGT  +MAPEV+
Sbjct: 130 GKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVL 189
Query: 217 KQS----AYDS--KADIWSLGITAIELAK----------GEPPNSELHP-------MRVL 253
            ++     +DS  + DIW+ G+   E+A+           +PP  ++ P       MR +
Sbjct: 190 DETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKV 249
Query: 254 FLIPKNNP---------PQLTGNYTKQFKEFVEACLNKDPENRPTAKELLK 295
             + +  P         P LT        + ++ C  ++P  R TA  + K
Sbjct: 250 VCVDQQRPNIPNRWFSDPTLTS-----LAKLMKECWYQNPSARLTALRIKK 295

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 72.0 bits (175), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 40/121 (33%), Positives = 66/121 (54%), Gaps = 3/121 (2%)
Query: 120 LWIIMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSE 179
           ++I+ME +       +    + E M  + +L ++L G+ +LHS   +HRD+K +N+++  
Sbjct: 106 VYIVMELMDANLCQVIQMELDHERM--SYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS 163
Query: 180 MGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAK 239
              +K+ DFG+A T   T+     FV T ++ APEVI    Y    DIWS+G    E+ K
Sbjct: 164 DCTLKILDFGLART-AGTSFMMVPFVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIK 222
Query: 240 G 240
           G
Sbjct: 223 G 223

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 72.0 bits (175), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 41/131 (31%), Positives = 67/131 (51%), Gaps = 4/131 (3%)
Query: 117 GTKLWIIMEYLGGGSALDLMKAG-NFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANV 175
           G   ++ +EY  GG   D ++      E        +++ G+ YLH     HRDIK  N+
Sbjct: 77  GNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENL 136
Query: 176 LLSEMGDVKLADFGVAGTLTNTTSKR--NTFVGTPFWMAPEVIKQSAYDSK-ADIWSLGI 232
           LL E  ++K++DFG+A        +R  N   GT  ++APE++K+  + ++  D+WS GI
Sbjct: 137 LLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGI 196
Query: 233 TAIELAKGEPP 243
               +  GE P
Sbjct: 197 VLTAMLAGELP 207

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 72.0 bits (175), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 41/131 (31%), Positives = 67/131 (51%), Gaps = 4/131 (3%)
Query: 117 GTKLWIIMEYLGGGSALDLMKAG-NFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANV 175
           G   ++ +EY  GG   D ++      E        +++ G+ YLH     HRDIK  N+
Sbjct: 77  GNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENL 136
Query: 176 LLSEMGDVKLADFGVAGTLTNTTSKR--NTFVGTPFWMAPEVIKQSAYDSK-ADIWSLGI 232
           LL E  ++K++DFG+A        +R  N   GT  ++APE++K+  + ++  D+WS GI
Sbjct: 137 LLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGI 196
Query: 233 TAIELAKGEPP 243
               +  GE P
Sbjct: 197 VLTAMLAGELP 207

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 72.0 bits (175), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 41/131 (31%), Positives = 67/131 (51%), Gaps = 4/131 (3%)
Query: 117 GTKLWIIMEYLGGGSALDLMKAG-NFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANV 175
           G   ++ +EY  GG   D ++      E        +++ G+ YLH     HRDIK  N+
Sbjct: 77  GNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENL 136
Query: 176 LLSEMGDVKLADFGVAGTLTNTTSKR--NTFVGTPFWMAPEVIKQSAYDSK-ADIWSLGI 232
           LL E  ++K++DFG+A        +R  N   GT  ++APE++K+  + ++  D+WS GI
Sbjct: 137 LLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGI 196
Query: 233 TAIELAKGEPP 243
               +  GE P
Sbjct: 197 VLTAMLAGELP 207

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 72.0 bits (175), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 41/131 (31%), Positives = 67/131 (51%), Gaps = 4/131 (3%)
Query: 117 GTKLWIIMEYLGGGSALDLMKAG-NFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANV 175
           G   ++ +EY  GG   D ++      E        +++ G+ YLH     HRDIK  N+
Sbjct: 76  GNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENL 135
Query: 176 LLSEMGDVKLADFGVAGTLTNTTSKR--NTFVGTPFWMAPEVIKQSAYDSK-ADIWSLGI 232
           LL E  ++K++DFG+A        +R  N   GT  ++APE++K+  + ++  D+WS GI
Sbjct: 136 LLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGI 195
Query: 233 TAIELAKGEPP 243
               +  GE P
Sbjct: 196 VLTAMLAGELP 206

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 72.0 bits (175), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 39/121 (32%), Positives = 67/121 (55%), Gaps = 3/121 (2%)
Query: 120 LWIIMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSE 179
           ++I+ME +    +  +    + E M  + +L ++L G+ +LHS   +HRD+K +N+++  
Sbjct: 104 VYIVMELMDANLSQVIQMELDHERM--SYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS 161
Query: 180 MGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAK 239
              +K+ DFG+A T   T+     +V T ++ APEVI    Y    DIWS+G    E+ K
Sbjct: 162 DATLKILDFGLART-AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIK 220
Query: 240 G 240
           G
Sbjct: 221 G 221

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 39/121 (32%), Positives = 67/121 (55%), Gaps = 3/121 (2%)
Query: 120 LWIIMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSE 179
           ++I+ME +    +  +    + E M  + +L ++L G+ +LHS   +HRD+K +N+++  
Sbjct: 104 VYIVMELMDANLSQVIQMELDHERM--SYLLYQMLVGIKHLHSAGIIHRDLKPSNIVVKS 161
Query: 180 MGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAK 239
              +K+ DFG+A T   T+     +V T ++ APEVI    Y    DIWS+G    E+ K
Sbjct: 162 DATLKILDFGLART-AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIK 220
Query: 240 G 240
           G
Sbjct: 221 G 221

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 71/291 (24%), Positives = 119/291 (40%), Gaps = 59/291 (20%)
Query: 59  FTKQERIGKGSFGEVFKGIDNRTQQVVXXXXXXXXXXXXXXXXXXXXXM---------VL 109
            T  E +GKG +GEV++G        V                     M         + 
Sbjct: 39  ITLLECVGKGRYGEVWRGSWQGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIA 98
Query: 110 SQCDSPYG-TKLWIIMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSE----- 163
           S   S +  T+LW+I  Y   GS  D ++    + +    I+  +  GL +LH E     
Sbjct: 99  SDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQ 158
Query: 164 ---RKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSK----RNTFVGTPFWMAPEVI 216
                 HRD+K+ N+L+ + G   +AD G+A   + +T++     N  VGT  +MAPEV+
Sbjct: 159 GKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVL 218
Query: 217 KQS----AYDS--KADIWSLGITAIELAK----------GEPPNSELHP-------MRVL 253
            ++     +DS  + DIW+ G+   E+A+           +PP  ++ P       MR +
Sbjct: 219 DETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKV 278
Query: 254 FLIPKNNP---------PQLTGNYTKQFKEFVEACLNKDPENRPTAKELLK 295
             + +  P         P LT        + ++ C  ++P  R TA  + K
Sbjct: 279 VCVDQQRPNIPNRWFSDPTLTS-----LAKLMKECWYQNPSARLTALRIKK 324

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 35/119 (29%), Positives = 68/119 (57%), Gaps = 4/119 (3%)
Query: 123 IMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGD 182
           ++ +L G    +++K     + H+  ++ ++L+GL Y+HS   +HRD+K +N+ ++E  +
Sbjct: 104 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCE 163
Query: 183 VKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEV-IKQSAYDSKADIWSLGITAIELAKG 240
           +K+  FG+A    +T  +   +V T ++ APE+ +    Y+   DIWS+G    EL  G
Sbjct: 164 LKILGFGLA---RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 35/119 (29%), Positives = 68/119 (57%), Gaps = 4/119 (3%)
Query: 123 IMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGD 182
           ++ +L G    +++K     + H+  ++ ++L+GL Y+HS   +HRD+K +N+ ++E  +
Sbjct: 104 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCE 163
Query: 183 VKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEV-IKQSAYDSKADIWSLGITAIELAKG 240
           +K+ DF +A    +T  +   +V T ++ APE+ +    Y+   DIWS+G    EL  G
Sbjct: 164 LKILDFYLA---RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 35/115 (30%), Positives = 66/115 (57%), Gaps = 4/115 (3%)
Query: 127 LGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLA 186
           L G    +++K+    + H+  ++ ++L+GL Y+HS   +HRD+K +NV ++E  ++++ 
Sbjct: 114 LMGADLNNIVKSQALSDEHVQFLVYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDSELRIL 173
Query: 187 DFGVAGTLTNTTSKRNTFVGTPFWMAPEV-IKQSAYDSKADIWSLGITAIELAKG 240
           DFG+A        +   +V T ++ APE+ +    Y+   DIWS+G    EL +G
Sbjct: 174 DFGLA---RQADEEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQG 225

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 41/131 (31%), Positives = 67/131 (51%), Gaps = 4/131 (3%)
Query: 117 GTKLWIIMEYLGGGSALDLMKAG-NFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANV 175
           G   ++ +EY  GG   D ++      E        +++ G+ YLH     HRDIK  N+
Sbjct: 77  GNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENL 136
Query: 176 LLSEMGDVKLADFGVAGTLTNTTSKR--NTFVGTPFWMAPEVIKQSAYDSK-ADIWSLGI 232
           LL E  ++K++DFG+A        +R  N   GT  ++APE++K+  + ++  D+WS GI
Sbjct: 137 LLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGI 196
Query: 233 TAIELAKGEPP 243
               +  GE P
Sbjct: 197 VLTAMLAGELP 207

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 39/121 (32%), Positives = 67/121 (55%), Gaps = 3/121 (2%)
Query: 120 LWIIMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSE 179
           ++I+ME +    +  +    + E M  + +L ++L G+ +LHS   +HRD+K +N+++  
Sbjct: 104 VYIVMELMDANLSQVIQMELDHERM--SYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS 161
Query: 180 MGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAK 239
              +K+ DFG+A T   T+     +V T ++ APEVI    Y    DIWS+G    E+ K
Sbjct: 162 DATLKILDFGLART-AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIK 220
Query: 240 G 240
           G
Sbjct: 221 G 221

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 41/131 (31%), Positives = 67/131 (51%), Gaps = 4/131 (3%)
Query: 117 GTKLWIIMEYLGGGSALDLMKAG-NFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANV 175
           G   ++ +EY  GG   D ++      E        +++ G+ YLH     HRDIK  N+
Sbjct: 76  GNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENL 135
Query: 176 LLSEMGDVKLADFGVAGTLTNTTSKR--NTFVGTPFWMAPEVIKQSAYDSK-ADIWSLGI 232
           LL E  ++K++DFG+A        +R  N   GT  ++APE++K+  + ++  D+WS GI
Sbjct: 136 LLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGI 195
Query: 233 TAIELAKGEPP 243
               +  GE P
Sbjct: 196 VLTAMLAGELP 206

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 35/115 (30%), Positives = 65/115 (56%), Gaps = 4/115 (3%)
Query: 127 LGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLA 186
           L G    +++K     + H+  ++ ++L+GL Y+HS   +HRD+K +NV ++E  ++++ 
Sbjct: 106 LMGADLNNIVKCQALSDEHVQFLVYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRIL 165
Query: 187 DFGVAGTLTNTTSKRNTFVGTPFWMAPEV-IKQSAYDSKADIWSLGITAIELAKG 240
           DFG+A        +   +V T ++ APE+ +    Y+   DIWS+G    EL +G
Sbjct: 166 DFGLA---RQADEEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQG 217

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 41/131 (31%), Positives = 67/131 (51%), Gaps = 4/131 (3%)
Query: 117 GTKLWIIMEYLGGGSALDLMKAG-NFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANV 175
           G   ++ +EY  GG   D ++      E        +++ G+ YLH     HRDIK  N+
Sbjct: 76  GNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENL 135
Query: 176 LLSEMGDVKLADFGVAGTLTNTTSKR--NTFVGTPFWMAPEVIKQSAYDSK-ADIWSLGI 232
           LL E  ++K++DFG+A        +R  N   GT  ++APE++K+  + ++  D+WS GI
Sbjct: 136 LLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGI 195
Query: 233 TAIELAKGEPP 243
               +  GE P
Sbjct: 196 VLTAMLAGELP 206

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 41/131 (31%), Positives = 67/131 (51%), Gaps = 4/131 (3%)
Query: 117 GTKLWIIMEYLGGGSALDLMKAG-NFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANV 175
           G   ++ +EY  GG   D ++      E        +++ G+ YLH     HRDIK  N+
Sbjct: 76  GNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENL 135
Query: 176 LLSEMGDVKLADFGVAGTLTNTTSKR--NTFVGTPFWMAPEVIKQSAYDSK-ADIWSLGI 232
           LL E  ++K++DFG+A        +R  N   GT  ++APE++K+  + ++  D+WS GI
Sbjct: 136 LLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGI 195
Query: 233 TAIELAKGEPP 243
               +  GE P
Sbjct: 196 VLTAMLAGELP 206

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 35/115 (30%), Positives = 65/115 (56%), Gaps = 4/115 (3%)
Query: 127 LGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLA 186
           L G    +++K     + H+  ++ ++L+GL Y+HS   +HRD+K +NV ++E  ++++ 
Sbjct: 114 LMGADLNNIVKCQALSDEHVQFLVYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDSELRIL 173
Query: 187 DFGVAGTLTNTTSKRNTFVGTPFWMAPEV-IKQSAYDSKADIWSLGITAIELAKG 240
           DFG+A        +   +V T ++ APE+ +    Y+   DIWS+G    EL +G
Sbjct: 174 DFGLA---RQADEEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQG 225

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 39/121 (32%), Positives = 66/121 (54%), Gaps = 3/121 (2%)
Query: 120 LWIIMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSE 179
           ++I+ME +       +    + E M  + +L ++L G+ +LHS   +HRD+K +N+++  
Sbjct: 104 VYIVMELMDANLCQVIQMELDHERM--SYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS 161
Query: 180 MGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAK 239
              +K+ DFG+A T   T+     +V T ++ APEVI    Y    DIWS+G    E+ K
Sbjct: 162 DCTLKILDFGLART-AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIK 220
Query: 240 G 240
           G
Sbjct: 221 G 221

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 66/271 (24%), Positives = 112/271 (41%), Gaps = 24/271 (8%)
Query: 45  ASRRNSLKVDPELIFTKQERIGKGSFGEVFKG---IDNRTQQVVXXXXXXXXXXXXXXXX 101
           A R  + ++D   I   ++ IG G FGEV  G   +  + +  V                
Sbjct: 18  AVREFAKEIDASCI-KIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRD 76
Query: 102 XXXXXMVLSQCDSPYGTKL----------WIIMEYLGGGSALDLMKA--GNFEEMHIAVI 149
                 ++ Q D P    L           II EY+  GS    ++   G F  + +  +
Sbjct: 77  FLSEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGM 136
Query: 150 LREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPF 209
           LR +  G+ YL     +HRD+ A N+L++     K++DFG++  L +      T  G   
Sbjct: 137 LRGIGSGMKYLSDMSAVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKI 196
Query: 210 ---WMAPEVIKQSAYDSKADIWSLGITAIE-LAKGEPPNSELHPMRVLFLIPKNN--PPQ 263
              W APE I    + S +D+WS GI   E ++ GE P  ++    V+  I +    PP 
Sbjct: 197 PIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEEGYRLPPP 256
Query: 264 LTGNYTKQFKEFVEACLNKDPENRPTAKELL 294
           +  +      + +  C  K+  +RP   +++
Sbjct: 257 M--DCPIALHQLMLDCWQKERSDRPKFGQIV 285

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 41/131 (31%), Positives = 67/131 (51%), Gaps = 4/131 (3%)
Query: 117 GTKLWIIMEYLGGGSALDLMKAG-NFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANV 175
           G   ++ +EY  GG   D ++      E        +++ G+ YLH     HRDIK  N+
Sbjct: 76  GNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENL 135
Query: 176 LLSEMGDVKLADFGVAGTLTNTTSKR--NTFVGTPFWMAPEVIKQSAYDSK-ADIWSLGI 232
           LL E  ++K++DFG+A        +R  N   GT  ++APE++K+  + ++  D+WS GI
Sbjct: 136 LLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAEPVDVWSCGI 195
Query: 233 TAIELAKGEPP 243
               +  GE P
Sbjct: 196 VLTAMLAGELP 206

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 41/131 (31%), Positives = 67/131 (51%), Gaps = 4/131 (3%)
Query: 117 GTKLWIIMEYLGGGSALDLMKAG-NFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANV 175
           G   ++ +EY  GG   D ++      E        +++ G+ YLH     HRDIK  N+
Sbjct: 76  GNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENL 135
Query: 176 LLSEMGDVKLADFGVAGTLTNTTSKR--NTFVGTPFWMAPEVIKQSAYDSK-ADIWSLGI 232
           LL E  ++K++DFG+A        +R  N   GT  ++APE++K+  + ++  D+WS GI
Sbjct: 136 LLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGI 195
Query: 233 TAIELAKGEPP 243
               +  GE P
Sbjct: 196 VLTAMLAGELP 206

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 41/131 (31%), Positives = 67/131 (51%), Gaps = 4/131 (3%)
Query: 117 GTKLWIIMEYLGGGSALDLMKAG-NFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANV 175
           G   ++ +EY  GG   D ++      E        +++ G+ YLH     HRDIK  N+
Sbjct: 77  GNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENL 136
Query: 176 LLSEMGDVKLADFGVAGTLTNTTSKR--NTFVGTPFWMAPEVIKQSAYDSK-ADIWSLGI 232
           LL E  ++K++DFG+A        +R  N   GT  ++APE++K+  + ++  D+WS GI
Sbjct: 137 LLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGI 196
Query: 233 TAIELAKGEPP 243
               +  GE P
Sbjct: 197 VLTAMLAGELP 207

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 39/121 (32%), Positives = 66/121 (54%), Gaps = 3/121 (2%)
Query: 120 LWIIMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSE 179
           ++I+ME +       +    + E M  + +L ++L G+ +LHS   +HRD+K +N+++  
Sbjct: 104 VYIVMELMDANLCQVIQMELDHERM--SYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS 161
Query: 180 MGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAK 239
              +K+ DFG+A T   T+     +V T ++ APEVI    Y    DIWS+G    E+ K
Sbjct: 162 DCTLKILDFGLART-AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIK 220
Query: 240 G 240
           G
Sbjct: 221 G 221

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 64/243 (26%), Positives = 104/243 (42%), Gaps = 17/243 (6%)
Query: 63  ERIGKGSFGEVFKGIDNRTQQV-VXXXXXXXXXXXXXXXXXXXXXMVLSQCDSPYGT--- 118
           + IGKG FG+V  G D R  +V V                     +  S      G    
Sbjct: 18  QTIGKGEFGDVMLG-DYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE 76
Query: 119 ---KLWIIMEYLGGGSALDLMKAGNFEEMHIAVILR---EVLKGLDYLHSERKLHRDIKA 172
               L+I+ EY+  GS +D +++     +    +L+   +V + ++YL     +HRD+ A
Sbjct: 77  EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAA 136
Query: 173 ANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPF-WMAPEVIKQSAYDSKADIWSLG 231
            NVL+SE    K++DFG    LT   S        P  W APE ++++A+ +K+D+WS G
Sbjct: 137 RNVLVSEDNVAKVSDFG----LTKEASSTQDTGKLPVKWTAPEALREAAFSTKSDVWSFG 192
Query: 232 ITAIELAK-GEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPENRPTA 290
           I   E+   G  P   +    V+  + K               E ++ C + D   RP+ 
Sbjct: 193 ILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSF 252
Query: 291 KEL 293
            +L
Sbjct: 253 LQL 255

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 39/121 (32%), Positives = 66/121 (54%), Gaps = 3/121 (2%)
Query: 120 LWIIMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSE 179
           ++I+ME +       +    + E M  + +L ++L G+ +LHS   +HRD+K +N+++  
Sbjct: 105 VYIVMELMDANLCQVIQMELDHERM--SYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS 162
Query: 180 MGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAK 239
              +K+ DFG+A T   T+     +V T ++ APEVI    Y    DIWS+G    E+ K
Sbjct: 163 DCTLKILDFGLART-AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIK 221
Query: 240 G 240
           G
Sbjct: 222 G 222

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 48/151 (31%), Positives = 78/151 (51%), Gaps = 10/151 (6%)
Query: 152 EVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLT-NTTSKRNTFVGTPF- 209
           +V +G+++L S + +HRD+ A N+LLSE   VK+ DFG+A  +  N    R      P  
Sbjct: 207 QVARGMEFLSSRKCIHRDLAARNILLSENNVVKICDFGLARDIYKNPDYVRKGDTRLPLK 266
Query: 210 WMAPEVIKQSAYDSKADIWSLGITAIELAK--GEP-PNSELHPMRVLFLIP--KNNPPQL 264
           WMAPE I    Y +K+D+WS G+   E+    G P P  ++       L    +   P+ 
Sbjct: 267 WMAPESIFDKIYSTKSDVWSYGVLLWEIFSLGGSPYPGVQMDEDFCSRLREGMRMRAPEY 326
Query: 265 TGNYTKQFKEFVEACLNKDPENRPTAKELLK 295
           +   T +  + +  C ++DP+ RP   EL++
Sbjct: 327 S---TPEIYQIMLDCWHRDPKERPRFAELVE 354

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 41/131 (31%), Positives = 67/131 (51%), Gaps = 4/131 (3%)
Query: 117 GTKLWIIMEYLGGGSALDLMKAG-NFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANV 175
           G   ++ +EY  GG   D ++      E        +++ G+ YLH     HRDIK  N+
Sbjct: 76  GNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENL 135
Query: 176 LLSEMGDVKLADFGVAGTLTNTTSKR--NTFVGTPFWMAPEVIKQSAYDSK-ADIWSLGI 232
           LL E  ++K++DFG+A        +R  N   GT  ++APE++K+  + ++  D+WS GI
Sbjct: 136 LLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAEPVDVWSCGI 195
Query: 233 TAIELAKGEPP 243
               +  GE P
Sbjct: 196 VLTAMLAGELP 206

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 41/131 (31%), Positives = 67/131 (51%), Gaps = 4/131 (3%)
Query: 117 GTKLWIIMEYLGGGSALDLMKAG-NFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANV 175
           G   ++ +EY  GG   D ++      E        +++ G+ YLH     HRDIK  N+
Sbjct: 76  GNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENL 135
Query: 176 LLSEMGDVKLADFGVAGTLTNTTSKR--NTFVGTPFWMAPEVIKQSAYDSK-ADIWSLGI 232
           LL E  ++K++DFG+A        +R  N   GT  ++APE++K+  + ++  D+WS GI
Sbjct: 136 LLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAEPVDVWSCGI 195
Query: 233 TAIELAKGEPP 243
               +  GE P
Sbjct: 196 VLTAMLAGELP 206

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 42/146 (28%), Positives = 71/146 (48%), Gaps = 3/146 (2%)
Query: 152 EVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVG-TPF- 209
           E+  G+ YL++ + +HRD+ A N  ++E   VK+ DFG+   +  T   R    G  P  
Sbjct: 133 EIADGMAYLNANKFVHRDLAARNCXVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 192
Query: 210 WMAPEVIKQSAYDSKADIWSLGITAIELAK-GEPPNSELHPMRVLFLIPKNNPPQLTGNY 268
           WM+PE +K   + + +D+WS G+   E+A   E P   L   +VL  + +        N 
Sbjct: 193 WMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPDNC 252
Query: 269 TKQFKEFVEACLNKDPENRPTAKELL 294
                E +  C   +P+ RP+  E++
Sbjct: 253 PDMLLELMRMCWQYNPKMRPSFLEII 278

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 41/131 (31%), Positives = 67/131 (51%), Gaps = 4/131 (3%)
Query: 117 GTKLWIIMEYLGGGSALDLMKAG-NFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANV 175
           G   ++ +EY  GG   D ++      E        +++ G+ YLH     HRDIK  N+
Sbjct: 77  GNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENL 136
Query: 176 LLSEMGDVKLADFGVAGTLTNTTSKR--NTFVGTPFWMAPEVIKQSAYDSK-ADIWSLGI 232
           LL E  ++K++DFG+A        +R  N   GT  ++APE++K+  + ++  D+WS GI
Sbjct: 137 LLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGI 196
Query: 233 TAIELAKGEPP 243
               +  GE P
Sbjct: 197 VLTAMLAGELP 207

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 39/121 (32%), Positives = 67/121 (55%), Gaps = 3/121 (2%)
Query: 120 LWIIMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSE 179
           ++I+ME +    +  +    + E M  + +L ++L G+ +LHS   +HRD+K +N+++  
Sbjct: 104 VYIVMELMDANLSQVIQMELDHERM--SYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS 161
Query: 180 MGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAK 239
              +K+ DFG+A T   T+     +V T ++ APEVI    Y    DIWS+G    E+ K
Sbjct: 162 DCTLKILDFGLART-AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIK 220
Query: 240 G 240
           G
Sbjct: 221 G 221

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 66/271 (24%), Positives = 112/271 (41%), Gaps = 24/271 (8%)
Query: 45  ASRRNSLKVDPELIFTKQERIGKGSFGEVFKG---IDNRTQQVVXXXXXXXXXXXXXXXX 101
           A R  + ++D   I   ++ IG G FGEV  G   +  + +  V                
Sbjct: 3   AVREFAKEIDASCI-KIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRD 61
Query: 102 XXXXXMVLSQCDSPYGTKL----------WIIMEYLGGGSALDLMKA--GNFEEMHIAVI 149
                 ++ Q D P    L           II EY+  GS    ++   G F  + +  +
Sbjct: 62  FLSEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGM 121
Query: 150 LREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPF 209
           LR +  G+ YL     +HRD+ A N+L++     K++DFG++  L +      T  G   
Sbjct: 122 LRGIGSGMKYLSDMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKI 181
Query: 210 ---WMAPEVIKQSAYDSKADIWSLGITAIE-LAKGEPPNSELHPMRVLFLIPKNN--PPQ 263
              W APE I    + S +D+WS GI   E ++ GE P  ++    V+  I +    PP 
Sbjct: 182 PIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEEGYRLPPP 241
Query: 264 LTGNYTKQFKEFVEACLNKDPENRPTAKELL 294
           +  +      + +  C  K+  +RP   +++
Sbjct: 242 M--DCPIALHQLMLDCWQKERSDRPKFGQIV 270

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 35/119 (29%), Positives = 68/119 (57%), Gaps = 4/119 (3%)
Query: 123 IMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGD 182
           ++ +L G    +++K     + H+  ++ ++L+GL Y+HS   +HRD+K +N+ ++E  +
Sbjct: 104 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCE 163
Query: 183 VKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEV-IKQSAYDSKADIWSLGITAIELAKG 240
           +K+ D G+A    +T  +   +V T ++ APE+ +    Y+   DIWS+G    EL  G
Sbjct: 164 LKILDAGLA---RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 70/273 (25%), Positives = 114/273 (41%), Gaps = 28/273 (10%)
Query: 44  TASRRNSLKVDPELIFTKQERIGKGSFGEVFKGI---DNRTQQV-VXXXXXXXXXXXXXX 99
           TA  +  L++  E    + + +G G+FG V+KGI   +  T ++ V              
Sbjct: 2   TAPNQAQLRILKETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKAN 61
Query: 100 XXXXXXXMVLSQCDSPYGTKLW---------IIMEYLGGGSALDLMKA--GNFEEMHIAV 148
                  ++++  D P+  +L          ++ + +  G  L+ +     N     +  
Sbjct: 62  VEFMDEALIMASMDHPHLVRLLGVCLSPTIQLVTQLMPHGCLLEYVHEHKDNIGSQLLLN 121
Query: 149 ILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVG-T 207
              ++ KG+ YL   R +HRD+ A NVL+     VK+ DFG+A  L     + N   G  
Sbjct: 122 WCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKM 181
Query: 208 PF-WMAPEVIKQSAYDSKADIWSLGITAIELAK-GEPPNSELHPMRVLFLIPKN----NP 261
           P  WMA E I    +  ++D+WS G+T  EL   G  P   +    +  L+ K      P
Sbjct: 182 PIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGERLPQP 241
Query: 262 PQLTGN-YTKQFKEFVEACLNKDPENRPTAKEL 293
           P  T + Y    K     C   D ++RP  KEL
Sbjct: 242 PICTIDVYMVMVK-----CWMIDADSRPKFKEL 269

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 93/205 (45%), Gaps = 18/205 (8%)
Query: 108 VLSQCDSPYGTKLWIIMEYLGGGSALDLMKAGNFEEM-------------HIAVILREVL 154
           +L  C  P G  L +I+E+   G+    +++   E +             H+     +V 
Sbjct: 96  LLGACTKP-GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLICYSFQVA 154
Query: 155 KGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLT-NTTSKRNTFVGTPF-WMA 212
           KG+++L S + +HRD+ A N+LLSE   VK+ DFG+A  +  +    R      P  WMA
Sbjct: 155 KGMEFLASRKXIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMA 214
Query: 213 PEVIKQSAYDSKADIWSLGITAIEL-AKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTK- 270
           PE I    Y  ++D+WS G+   E+ + G  P   +          K        +YT  
Sbjct: 215 PETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTP 274
Query: 271 QFKEFVEACLNKDPENRPTAKELLK 295
           +  + +  C + +P  RPT  EL++
Sbjct: 275 EMYQTMLDCWHGEPSQRPTFSELVE 299

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/260 (22%), Positives = 110/260 (42%), Gaps = 19/260 (7%)
Query: 63  ERIGKGSFGEVFKGIDNRTQQVVXXXXXXXXXXXXXXXXXXXXXMVLSQCDSPYGTKLW- 121
           E +G G+FG V + ++  T +V                       +++Q   P    L  
Sbjct: 57  EELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEIS-IMNQLHHPKLINLHD 115
Query: 122 ---------IIMEYLGGGSALDLMKAGNFEEMHIAVI--LREVLKGLDYLHSERKLHRDI 170
                    +I+E+L GG   D + A +++     VI  +R+  +GL ++H    +H DI
Sbjct: 116 AFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDI 175
Query: 171 KAANVLLS--EMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIW 228
           K  N++    +   VK+ DFG+A  L N          T  + APE++ +       D+W
Sbjct: 176 KPENIMCETKKASSVKIIDFGLATKL-NPDEIVKVTTATAEFAAPEIVDREPVGFYTDMW 234
Query: 229 SLGITAIELAKGEPPNSELHPMRVLFLIPKNN---PPQLTGNYTKQFKEFVEACLNKDPE 285
           ++G+    L  G  P +    +  L  + + +         + + + K+F++  L K+P 
Sbjct: 235 AIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPR 294
Query: 286 NRPTAKELLKFPFIRKAKKN 305
            R T  + L+ P+++    N
Sbjct: 295 KRLTVHDALEHPWLKGDHSN 314

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 41/131 (31%), Positives = 67/131 (51%), Gaps = 4/131 (3%)
Query: 117 GTKLWIIMEYLGGGSALDLMKAG-NFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANV 175
           G   ++ +EY  GG   D ++      E        +++ G+ YLH     HRDIK  N+
Sbjct: 76  GNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENL 135
Query: 176 LLSEMGDVKLADFGVAGTLTNTTSKR--NTFVGTPFWMAPEVIKQSAYDSK-ADIWSLGI 232
           LL E  ++K++DFG+A        +R  N   GT  ++APE++K+  + ++  D+WS GI
Sbjct: 136 LLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAEPVDVWSCGI 195
Query: 233 TAIELAKGEPP 243
               +  GE P
Sbjct: 196 VLTAMLAGELP 206

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 41/131 (31%), Positives = 67/131 (51%), Gaps = 4/131 (3%)
Query: 117 GTKLWIIMEYLGGGSALDLMKAG-NFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANV 175
           G   ++ +EY  GG   D ++      E        +++ G+ YLH     HRDIK  N+
Sbjct: 77  GNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENL 136
Query: 176 LLSEMGDVKLADFGVAGTLTNTTSKR--NTFVGTPFWMAPEVIKQSAYDSK-ADIWSLGI 232
           LL E  ++K++DFG+A        +R  N   GT  ++APE++K+  + ++  D+WS GI
Sbjct: 137 LLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAEPVDVWSCGI 196
Query: 233 TAIELAKGEPP 243
               +  GE P
Sbjct: 197 VLTAMLAGELP 207

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/251 (24%), Positives = 103/251 (41%), Gaps = 23/251 (9%)
Query: 65  IGKGSFGEVFKG---IDNRTQQVVXXXXXXXXXXXXXXXXXXXXXMVLSQCDSPYGTKL- 120
           IG G FGEV  G   +  + +  V                      ++ Q D P    L 
Sbjct: 16  IGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHLE 75
Query: 121 ---------WIIMEYLGGGSALDLMKA--GNFEEMHIAVILREVLKGLDYLHSERKLHRD 169
                     II EY+  GS    ++   G F  + +  +LR +  G+ YL     +HRD
Sbjct: 76  GVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSGMKYLSDMSYVHRD 135
Query: 170 IKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPF---WMAPEVIKQSAYDSKAD 226
           + A N+L++     K++DFG++  L +      T  G      W APE I    + S +D
Sbjct: 136 LAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASD 195
Query: 227 IWSLGITAIE-LAKGEPPNSELHPMRVLFLIPKNN--PPQLTGNYTKQFKEFVEACLNKD 283
           +WS GI   E ++ GE P  ++    V+  I +    PP +  +      + +  C  K+
Sbjct: 196 VWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEEGYRLPPPM--DCPIALHQLMLDCWQKE 253
Query: 284 PENRPTAKELL 294
             +RP   +++
Sbjct: 254 RSDRPKFGQIV 264

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 41/148 (27%), Positives = 72/148 (48%), Gaps = 3/148 (2%)
Query: 152 EVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVG-TPF- 209
           E+  G+ YL++++ +HRD+ A N +++    VK+ DFG+   +  T   R    G  P  
Sbjct: 135 EIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVR 194
Query: 210 WMAPEVIKQSAYDSKADIWSLGITAIELAK-GEPPNSELHPMRVLFLIPKNNPPQLTGNY 268
           WMAPE +K   + + +D+WS G+   E+    E P   L   +VL  +          N 
Sbjct: 195 WMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQPDNC 254
Query: 269 TKQFKEFVEACLNKDPENRPTAKELLKF 296
            ++  + +  C   +P+ RPT  E++  
Sbjct: 255 PERVTDLMRMCWQFNPKMRPTFLEIVNL 282

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 89/202 (44%), Gaps = 21/202 (10%)
Query: 59  FTKQERIGKGSFGEVFKGIDNRTQQVVXXXXXXXXXXXXXXXXXXXXXMVLSQ------- 111
           + K E+IG+G++G VFK  +  T ++V                     + L +       
Sbjct: 4   YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNI 63
Query: 112 ---CDSPYGTK-LWIIMEYLGGGSALDLMKA-----GNFEEMHIAVILREVLKGLDYLHS 162
               D  +  K L ++ E+       DL K      G+ +   +   L ++LKGL + HS
Sbjct: 64  VRLHDVLHSDKKLTLVFEFCDQ----DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHS 119
Query: 163 ERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVI-KQSAY 221
              LHRD+K  N+L++  G++KLADFG+A          +  V T ++  P+V+     Y
Sbjct: 120 RNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLY 179
Query: 222 DSKADIWSLGITAIELAKGEPP 243
            +  D+WS G    ELA    P
Sbjct: 180 STSIDMWSAGCIFAELANAARP 201

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 35/119 (29%), Positives = 68/119 (57%), Gaps = 4/119 (3%)
Query: 123 IMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGD 182
           ++ +L G    +++K     + H+  ++ ++L+GL Y+HS   +HRD+K +N+ ++E  +
Sbjct: 104 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCE 163
Query: 183 VKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEV-IKQSAYDSKADIWSLGITAIELAKG 240
           +K+ D G+A    +T  +   +V T ++ APE+ +    Y+   DIWS+G    EL  G
Sbjct: 164 LKILDRGLA---RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 41/148 (27%), Positives = 72/148 (48%), Gaps = 3/148 (2%)
Query: 152 EVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVG-TPF- 209
           E+  G+ YL++++ +HRD+ A N +++    VK+ DFG+   +  T   R    G  P  
Sbjct: 138 EIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVR 197
Query: 210 WMAPEVIKQSAYDSKADIWSLGITAIELAK-GEPPNSELHPMRVLFLIPKNNPPQLTGNY 268
           WMAPE +K   + + +D+WS G+   E+    E P   L   +VL  +          N 
Sbjct: 198 WMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQPDNC 257
Query: 269 TKQFKEFVEACLNKDPENRPTAKELLKF 296
            ++  + +  C   +P+ RPT  E++  
Sbjct: 258 PERVTDLMRMCWQFNPKMRPTFLEIVNL 285

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 35/119 (29%), Positives = 68/119 (57%), Gaps = 4/119 (3%)
Query: 123 IMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGD 182
           ++ +L G    +++K     + H+  ++ ++L+GL Y+HS   +HRD+K +N+ ++E  +
Sbjct: 104 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCE 163
Query: 183 VKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEV-IKQSAYDSKADIWSLGITAIELAKG 240
           +K+ D G+A    +T  +   +V T ++ APE+ +    Y+   DIWS+G    EL  G
Sbjct: 164 LKILDGGLA---RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 93/207 (44%), Gaps = 20/207 (9%)
Query: 108 VLSQCDSPYGTKLWIIMEYLGGGSALDLMKAGNFEEM---------------HIAVILRE 152
           +L  C  P G  L +I+E+   G+    +++   E +               H+     +
Sbjct: 98  LLGACTKP-GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKPEDLYKDFLTLEHLIXYSFQ 156
Query: 153 VLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLT-NTTSKRNTFVGTPF-W 210
           V KG+++L S + +HRD+ A N+LLSE   VK+ DFG+A  +  +    R      P  W
Sbjct: 157 VAKGMEFLASRKXIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLPLKW 216
Query: 211 MAPEVIKQSAYDSKADIWSLGITAIEL-AKGEPPNSELHPMRVLFLIPKNNPPQLTGNYT 269
           MAPE I    Y  ++D+WS G+   E+ + G  P   +          K        +YT
Sbjct: 217 MAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYT 276
Query: 270 K-QFKEFVEACLNKDPENRPTAKELLK 295
             +  + +  C + +P  RPT  EL++
Sbjct: 277 TPEMYQTMLDCWHGEPSQRPTFSELVE 303

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 41/148 (27%), Positives = 71/148 (47%), Gaps = 3/148 (2%)
Query: 152 EVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVG-TPF- 209
           E+  G+ YL++++ +HRD+ A N +++    VK+ DFG+   +  T   R    G  P  
Sbjct: 138 EIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVR 197
Query: 210 WMAPEVIKQSAYDSKADIWSLGITAIELAK-GEPPNSELHPMRVLFLIPKNNPPQLTGNY 268
           WMAPE +K   + + +D+WS G+   E+    E P   L   +VL  +          N 
Sbjct: 198 WMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQPDNC 257
Query: 269 TKQFKEFVEACLNKDPENRPTAKELLKF 296
            ++  + +  C   +P  RPT  E++  
Sbjct: 258 PERVTDLMRMCWQFNPNMRPTFLEIVNL 285

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 39/116 (33%), Positives = 64/116 (55%), Gaps = 8/116 (6%)
Query: 132 ALDLMKAGNFEEMHIAV-------ILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVK 184
            ++LM A   + +H+ +       +L ++L G+ +LHS   +HRD+K +N+++     +K
Sbjct: 105 VMELMDANLCQVIHMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLK 164
Query: 185 LADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKG 240
           + DFG+A T  +T      +V T ++ APEVI    Y    DIWS+G    EL KG
Sbjct: 165 ILDFGLART-ASTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKG 219

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 41/148 (27%), Positives = 72/148 (48%), Gaps = 3/148 (2%)
Query: 152 EVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVG-TPF- 209
           E+  G+ YL++++ +HRD+ A N +++    VK+ DFG+   +  T   R    G  P  
Sbjct: 138 EIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETAYYRKGGKGLLPVR 197
Query: 210 WMAPEVIKQSAYDSKADIWSLGITAIELAK-GEPPNSELHPMRVLFLIPKNNPPQLTGNY 268
           WMAPE +K   + + +D+WS G+   E+    E P   L   +VL  +          N 
Sbjct: 198 WMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQPDNC 257
Query: 269 TKQFKEFVEACLNKDPENRPTAKELLKF 296
            ++  + +  C   +P+ RPT  E++  
Sbjct: 258 PERVTDLMRMCWQFNPKMRPTFLEIVNL 285

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 47/155 (30%), Positives = 75/155 (48%), Gaps = 4/155 (2%)
Query: 145 HIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLT-NTTSKRNT 203
           H+     +V KG+++L S + +HRD+ A N+LLSE   VK+ DFG+A  +  +    R  
Sbjct: 140 HLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKG 199
Query: 204 FVGTPF-WMAPEVIKQSAYDSKADIWSLGITAIEL-AKGEPPNSELHPMRVLFLIPKNNP 261
               P  WMAPE I    Y  ++D+WS G+   E+ + G  P   +          K   
Sbjct: 200 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGT 259
Query: 262 PQLTGNYTK-QFKEFVEACLNKDPENRPTAKELLK 295
                +YT  +  + +  C + +P  RPT  EL++
Sbjct: 260 RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVE 294

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 47/155 (30%), Positives = 75/155 (48%), Gaps = 4/155 (2%)
Query: 145 HIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLT-NTTSKRNT 203
           H+     +V KG+++L S + +HRD+ A N+LLSE   VK+ DFG+A  +  +    R  
Sbjct: 140 HLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKG 199
Query: 204 FVGTPF-WMAPEVIKQSAYDSKADIWSLGITAIEL-AKGEPPNSELHPMRVLFLIPKNNP 261
               P  WMAPE I    Y  ++D+WS G+   E+ + G  P   +          K   
Sbjct: 200 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGT 259
Query: 262 PQLTGNYTK-QFKEFVEACLNKDPENRPTAKELLK 295
                +YT  +  + +  C + +P  RPT  EL++
Sbjct: 260 RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVE 294

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 39/116 (33%), Positives = 64/116 (55%), Gaps = 8/116 (6%)
Query: 132 ALDLMKAGNFEEMHIAV-------ILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVK 184
            ++LM A   + +H+ +       +L ++L G+ +LHS   +HRD+K +N+++     +K
Sbjct: 107 VMELMDANLCQVIHMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLK 166
Query: 185 LADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKG 240
           + DFG+A T   T      +V T ++ APEVI    Y +  DIWS+G    EL KG
Sbjct: 167 ILDFGLART-ACTNFMMTPYVVTRYYRAPEVILGMGYAANVDIWSVGCIMGELVKG 221

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 47/155 (30%), Positives = 75/155 (48%), Gaps = 4/155 (2%)
Query: 145 HIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLT-NTTSKRNT 203
           H+     +V KG+++L S + +HRD+ A N+LLSE   VK+ DFG+A  +  +    R  
Sbjct: 192 HLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG 251
Query: 204 FVGTPF-WMAPEVIKQSAYDSKADIWSLGITAIEL-AKGEPPNSELHPMRVLFLIPKNNP 261
               P  WMAPE I    Y  ++D+WS G+   E+ + G  P   +          K   
Sbjct: 252 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGT 311
Query: 262 PQLTGNYTK-QFKEFVEACLNKDPENRPTAKELLK 295
                +YT  +  + +  C + +P  RPT  EL++
Sbjct: 312 RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVE 346

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 47/155 (30%), Positives = 75/155 (48%), Gaps = 4/155 (2%)
Query: 145 HIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLT-NTTSKRNT 203
           H+     +V KG+++L S + +HRD+ A N+LLSE   VK+ DFG+A  +  +    R  
Sbjct: 149 HLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKG 208
Query: 204 FVGTPF-WMAPEVIKQSAYDSKADIWSLGITAIEL-AKGEPPNSELHPMRVLFLIPKNNP 261
               P  WMAPE I    Y  ++D+WS G+   E+ + G  P   +          K   
Sbjct: 209 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGT 268
Query: 262 PQLTGNYTK-QFKEFVEACLNKDPENRPTAKELLK 295
                +YT  +  + +  C + +P  RPT  EL++
Sbjct: 269 RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVE 303

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 61/242 (25%), Positives = 103/242 (42%), Gaps = 15/242 (6%)
Query: 63  ERIGKGSFGEVFKGIDNRTQQV-VXXXXXXXXXXXXXXXXXXXXXMVLSQCDSPYGT--- 118
           + IGKG FG+V  G D R  +V V                     +  S      G    
Sbjct: 199 QTIGKGEFGDVMLG-DYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE 257
Query: 119 ---KLWIIMEYLGGGSALDLMKAGNFEEMHIAVILR---EVLKGLDYLHSERKLHRDIKA 172
               L+I+ EY+  GS +D +++     +    +L+   +V + ++YL     +HRD+ A
Sbjct: 258 EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAA 317
Query: 173 ANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGI 232
            NVL+SE    K++DFG+    ++T       V    W APE +++  + +K+D+WS GI
Sbjct: 318 RNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVK---WTAPEALREKKFSTKSDVWSFGI 374
Query: 233 TAIELAK-GEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPENRPTAK 291
              E+   G  P   +    V+  + K               + ++ C + D   RPT  
Sbjct: 375 LLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYDVMKNCWHLDAATRPTFL 434
Query: 292 EL 293
           +L
Sbjct: 435 QL 436

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 37/120 (30%), Positives = 72/120 (60%), Gaps = 8/120 (6%)
Query: 145 HIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTF 204
           H+   L ++L+GL Y+HS + +HRD+K +N+L++E  ++K+ DFG+A  L  + ++   F
Sbjct: 160 HVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYF 219
Query: 205 ----VGTPFWMAPEV-IKQSAYDSKADIWSLGITAIE-LAKGE--PPNSELHPMRVLFLI 256
               V T ++ APE+ +    Y    D+WS+G    E LA+ +  P  + +H ++++ ++
Sbjct: 220 MTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMV 279

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 47/155 (30%), Positives = 75/155 (48%), Gaps = 4/155 (2%)
Query: 145 HIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLT-NTTSKRNT 203
           H+     +V KG+++L S + +HRD+ A N+LLSE   VK+ DFG+A  +  +    R  
Sbjct: 149 HLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKG 208
Query: 204 FVGTPF-WMAPEVIKQSAYDSKADIWSLGITAIEL-AKGEPPNSELHPMRVLFLIPKNNP 261
               P  WMAPE I    Y  ++D+WS G+   E+ + G  P   +          K   
Sbjct: 209 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGT 268
Query: 262 PQLTGNYTK-QFKEFVEACLNKDPENRPTAKELLK 295
                +YT  +  + +  C + +P  RPT  EL++
Sbjct: 269 RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVE 303

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 93/205 (45%), Gaps = 18/205 (8%)
Query: 108 VLSQCDSPYGTKLWIIMEYLGGGSALDLMKAGNFEEM-------------HIAVILREVL 154
           +L  C  P G  L +I+E+   G+    +++   E +             H+     +V 
Sbjct: 96  LLGACTKP-GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLIXYSFQVA 154
Query: 155 KGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLT-NTTSKRNTFVGTPF-WMA 212
           KG+++L S + +HRD+ A N+LLSE   VK+ DFG+A  +  +    R      P  WMA
Sbjct: 155 KGMEFLASRKXIHRDLAARNILLSEKNVVKIXDFGLARDIYKDPDYVRKGDARLPLKWMA 214
Query: 213 PEVIKQSAYDSKADIWSLGITAIEL-AKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTK- 270
           PE I    Y  ++D+WS G+   E+ + G  P   +          K        +YT  
Sbjct: 215 PETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFXRRLKEGTRMRAPDYTTP 274
Query: 271 QFKEFVEACLNKDPENRPTAKELLK 295
           +  + +  C + +P  RPT  EL++
Sbjct: 275 EMYQTMLDCWHGEPSQRPTFSELVE 299

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 41/148 (27%), Positives = 72/148 (48%), Gaps = 3/148 (2%)
Query: 152 EVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVG-TPF- 209
           E+  G+ YL++++ +HRD+ A N +++    VK+ DFG+   +  T   R    G  P  
Sbjct: 137 EIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 196
Query: 210 WMAPEVIKQSAYDSKADIWSLGITAIELAK-GEPPNSELHPMRVLFLIPKNNPPQLTGNY 268
           WMAPE +K   + + +D+WS G+   E+    E P   L   +VL  +          N 
Sbjct: 197 WMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQPDNC 256
Query: 269 TKQFKEFVEACLNKDPENRPTAKELLKF 296
            ++  + +  C   +P+ RPT  E++  
Sbjct: 257 PERVTDLMRMCWQFNPKMRPTFLEIVNL 284

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 47/155 (30%), Positives = 75/155 (48%), Gaps = 4/155 (2%)
Query: 145 HIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLT-NTTSKRNT 203
           H+     +V KG+++L S + +HRD+ A N+LLSE   VK+ DFG+A  +  +    R  
Sbjct: 199 HLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG 258
Query: 204 FVGTPF-WMAPEVIKQSAYDSKADIWSLGITAIEL-AKGEPPNSELHPMRVLFLIPKNNP 261
               P  WMAPE I    Y  ++D+WS G+   E+ + G  P   +          K   
Sbjct: 259 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGT 318
Query: 262 PQLTGNYTK-QFKEFVEACLNKDPENRPTAKELLK 295
                +YT  +  + +  C + +P  RPT  EL++
Sbjct: 319 RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVE 353

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 47/155 (30%), Positives = 75/155 (48%), Gaps = 4/155 (2%)
Query: 145 HIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLT-NTTSKRNT 203
           H+     +V KG+++L S + +HRD+ A N+LLSE   VK+ DFG+A  +  +    R  
Sbjct: 201 HLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG 260
Query: 204 FVGTPF-WMAPEVIKQSAYDSKADIWSLGITAIEL-AKGEPPNSELHPMRVLFLIPKNNP 261
               P  WMAPE I    Y  ++D+WS G+   E+ + G  P   +          K   
Sbjct: 261 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGT 320
Query: 262 PQLTGNYTK-QFKEFVEACLNKDPENRPTAKELLK 295
                +YT  +  + +  C + +P  RPT  EL++
Sbjct: 321 RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVE 355

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 101/214 (47%), Gaps = 45/214 (21%)
Query: 119 KLWIIMEYLGGGSALDLMKAGNFEEMH---------------IAVILREVLKGLDYLHSE 163
           +++II EY+   S L       F+E                 I  I++ VL    Y+H+E
Sbjct: 117 EVYIIYEYMENDSIL------KFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNE 170
Query: 164 RKL-HRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVI-KQSAY 221
           + + HRD+K +N+L+ + G VKL+DFG +  + +   K +   GT  +M PE    +S+Y
Sbjct: 171 KNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIKGSR--GTYEFMPPEFFSNESSY 228
Query: 222 D-SKADIWSLGITAIELAKGEPPNS------EL----------HPM-RVLFLIPKNNPPQ 263
           + +K DIWSLGI    +     P S      EL          +P+ R  FL P  N   
Sbjct: 229 NGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRTKNIEYPLDRNHFLYPLTNKKS 288
Query: 264 LTGN--YTKQFKEFVEACLNKDPENRPTAKELLK 295
              N   + +  +F++  L K+P  R T+++ LK
Sbjct: 289 TCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 47/155 (30%), Positives = 75/155 (48%), Gaps = 4/155 (2%)
Query: 145 HIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLT-NTTSKRNT 203
           H+     +V KG+++L S + +HRD+ A N+LLSE   VK+ DFG+A  +  +    R  
Sbjct: 194 HLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG 253
Query: 204 FVGTPF-WMAPEVIKQSAYDSKADIWSLGITAIEL-AKGEPPNSELHPMRVLFLIPKNNP 261
               P  WMAPE I    Y  ++D+WS G+   E+ + G  P   +          K   
Sbjct: 254 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGT 313
Query: 262 PQLTGNYTK-QFKEFVEACLNKDPENRPTAKELLK 295
                +YT  +  + +  C + +P  RPT  EL++
Sbjct: 314 RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVE 348

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 62/255 (24%), Positives = 101/255 (39%), Gaps = 19/255 (7%)
Query: 59  FTKQERIGKGSFGEVFKG---IDNRTQQVVXXXXXXXXXXXXXXXXXXXXXMVLSQCDSP 115
            T +  IG G FGEV  G   +  + +  V                      ++ Q D P
Sbjct: 24  ITIERVIGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYTEKQRRDFLGEASIMGQFDHP 83
Query: 116 YGTKL----------WIIMEYLGGGSALDLMKA--GNFEEMHIAVILREVLKGLDYLHSE 163
               L           I+ EY+  GS    +K   G F  + +  +LR +  G+ YL   
Sbjct: 84  NIIHLEGVVTKSKPVMIVTEYMENGSLDTFLKKNDGQFTVIQLVGMLRGISAGMKYLSDM 143
Query: 164 RKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPF---WMAPEVIKQSA 220
             +HRD+ A N+L++     K++DFG++  L +      T  G      W APE I    
Sbjct: 144 GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAFRK 203
Query: 221 YDSKADIWSLGITAIELAK-GEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEAC 279
           + S +D+WS GI   E+   GE P  E+    V+  + +        +      + +  C
Sbjct: 204 FTSASDVWSYGIVMWEVVSYGERPYWEMTNQDVIKAVEEGYRLPSPMDCPAALYQLMLDC 263
Query: 280 LNKDPENRPTAKELL 294
             K+  +RP   E++
Sbjct: 264 WQKERNSRPKFDEIV 278

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 41/148 (27%), Positives = 72/148 (48%), Gaps = 3/148 (2%)
Query: 152 EVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVG-TPF- 209
           E+  G+ YL++++ +HRD+ A N +++    VK+ DFG+   +  T   R    G  P  
Sbjct: 138 EIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 197
Query: 210 WMAPEVIKQSAYDSKADIWSLGITAIELAK-GEPPNSELHPMRVLFLIPKNNPPQLTGNY 268
           WMAPE +K   + + +D+WS G+   E+    E P   L   +VL  +          N 
Sbjct: 198 WMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQPDNC 257
Query: 269 TKQFKEFVEACLNKDPENRPTAKELLKF 296
            ++  + +  C   +P+ RPT  E++  
Sbjct: 258 PERVTDLMRMCWQFNPKMRPTFLEIVNL 285

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 47/155 (30%), Positives = 75/155 (48%), Gaps = 4/155 (2%)
Query: 145 HIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLT-NTTSKRNT 203
           H+     +V KG+++L S + +HRD+ A N+LLSE   VK+ DFG+A  +  +    R  
Sbjct: 149 HLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDXVRKG 208
Query: 204 FVGTPF-WMAPEVIKQSAYDSKADIWSLGITAIEL-AKGEPPNSELHPMRVLFLIPKNNP 261
               P  WMAPE I    Y  ++D+WS G+   E+ + G  P   +          K   
Sbjct: 209 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGT 268
Query: 262 PQLTGNYTK-QFKEFVEACLNKDPENRPTAKELLK 295
                +YT  +  + +  C + +P  RPT  EL++
Sbjct: 269 RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVE 303

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 47/155 (30%), Positives = 75/155 (48%), Gaps = 4/155 (2%)
Query: 145 HIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLT-NTTSKRNT 203
           H+     +V KG+++L S + +HRD+ A N+LLSE   VK+ DFG+A  +  +    R  
Sbjct: 140 HLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG 199
Query: 204 FVGTPF-WMAPEVIKQSAYDSKADIWSLGITAIEL-AKGEPPNSELHPMRVLFLIPKNNP 261
               P  WMAPE I    Y  ++D+WS G+   E+ + G  P   +          K   
Sbjct: 200 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGT 259
Query: 262 PQLTGNYTK-QFKEFVEACLNKDPENRPTAKELLK 295
                +YT  +  + +  C + +P  RPT  EL++
Sbjct: 260 RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVE 294

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 47/155 (30%), Positives = 75/155 (48%), Gaps = 4/155 (2%)
Query: 145 HIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLT-NTTSKRNT 203
           H+     +V KG+++L S + +HRD+ A N+LLSE   VK+ DFG+A  +  +    R  
Sbjct: 140 HLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG 199
Query: 204 FVGTPF-WMAPEVIKQSAYDSKADIWSLGITAIEL-AKGEPPNSELHPMRVLFLIPKNNP 261
               P  WMAPE I    Y  ++D+WS G+   E+ + G  P   +          K   
Sbjct: 200 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGT 259
Query: 262 PQLTGNYTK-QFKEFVEACLNKDPENRPTAKELLK 295
                +YT  +  + +  C + +P  RPT  EL++
Sbjct: 260 RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVE 294

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 37/120 (30%), Positives = 72/120 (60%), Gaps = 8/120 (6%)
Query: 145 HIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTF 204
           H+   L ++L+GL Y+HS + +HRD+K +N+L++E  ++K+ DFG+A  L  + ++   F
Sbjct: 159 HVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYF 218
Query: 205 ----VGTPFWMAPEV-IKQSAYDSKADIWSLGITAIE-LAKGE--PPNSELHPMRVLFLI 256
               V T ++ APE+ +    Y    D+WS+G    E LA+ +  P  + +H ++++ ++
Sbjct: 219 MTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMV 278

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 47/155 (30%), Positives = 75/155 (48%), Gaps = 4/155 (2%)
Query: 145 HIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLT-NTTSKRNT 203
           H+     +V KG+++L S + +HRD+ A N+LLSE   VK+ DFG+A  +  +    R  
Sbjct: 149 HLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG 208
Query: 204 FVGTPF-WMAPEVIKQSAYDSKADIWSLGITAIEL-AKGEPPNSELHPMRVLFLIPKNNP 261
               P  WMAPE I    Y  ++D+WS G+   E+ + G  P   +          K   
Sbjct: 209 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGT 268
Query: 262 PQLTGNYTK-QFKEFVEACLNKDPENRPTAKELLK 295
                +YT  +  + +  C + +P  RPT  EL++
Sbjct: 269 RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVE 303

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 59/251 (23%), Positives = 104/251 (41%), Gaps = 23/251 (9%)
Query: 65  IGKGSFGEVFKG---IDNRTQQVVXXXXXXXXXXXXXXXXXXXXXMVLSQCDSPYGTKL- 120
           +G G FGEV  G   + ++ +  V                      ++ Q D P   +L 
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 112
Query: 121 ---------WIIMEYLGGGSALDLMKA--GNFEEMHIAVILREVLKGLDYLHSERKLHRD 169
                     I+ E +  GS    ++     F  + +  +LR +  G+ YL     +HRD
Sbjct: 113 GVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGAVHRD 172
Query: 170 IKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPF---WMAPEVIKQSAYDSKAD 226
           + A N+L++     K++DFG++  L +      T  G      W +PE I    + S +D
Sbjct: 173 LAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASD 232
Query: 227 IWSLGITAIE-LAKGEPPNSELHPMRVLFLIPKNN--PPQLTGNYTKQFKEFVEACLNKD 283
           +WS GI   E ++ GE P  E+    V+  + +    PP +  +      + +  C  KD
Sbjct: 233 VWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPM--DCPAALYQLMLDCWQKD 290
Query: 284 PENRPTAKELL 294
             NRP  ++++
Sbjct: 291 RNNRPKFEQIV 301

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 70/291 (24%), Positives = 123/291 (42%), Gaps = 49/291 (16%)
Query: 41  GSTTASRRNSLKVDPELIFTKQERIGKGSFGEVFKGIDNRTQQVVXXXXXX------XXX 94
           GS     R     D E+ + KQ  IGKG FG V KG   + + VV               
Sbjct: 5   GSEFPKSRLPTLADNEIEYEKQ--IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETE 62
Query: 95  XXXXXXXXXXXXMVLSQCDSPYGTKLW--------IIMEYLGGGSALD--LMKAGNFEEM 144
                        ++S  + P   KL+        ++ME++  G      L KA   +  
Sbjct: 63  MIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPPRMVMEFVPCGDLYHRLLDKAHPIKWS 122
Query: 145 HIAVILREVLKGLDYLHSERK--LHRDIKAANVLLSEMGD-----VKLADFGVAGTLTNT 197
               ++ ++  G++Y+ ++    +HRD+++ N+ L  + +      K+ADFG++    ++
Sbjct: 123 VKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHS 182
Query: 198 TSKRNTFVGTPFWMAPEVI--KQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFL 255
            S     +G   WMAPE I  ++ +Y  KAD +S  +    +  GE P  E    ++ F+
Sbjct: 183 VS---GLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFI 239
Query: 256 -----------IPKNNPPQLTGNYTKQFKEFVEACLNKDPENRPTAKELLK 295
                      IP++ PP+L        +  +E C + DP+ RP    ++K
Sbjct: 240 NMIREEGLRPTIPEDCPPRL--------RNVIELCWSGDPKKRPHFSYIVK 282

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 48/185 (25%), Positives = 91/185 (49%), Gaps = 17/185 (9%)
Query: 119 KLWIIMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLS 178
           ++ +++EY G      +++     E       ++++  ++Y H  + +HRD+K  N+LL 
Sbjct: 87  EIIMVIEYAGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLD 146
Query: 179 EMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDS-KADIWSLG-ITAIE 236
           E  +VK+ADFG++  +T+    + T  G+P + APEVI    Y   + D+WS G I  + 
Sbjct: 147 EHLNVKIADFGLSNIMTDGNFLK-TSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVM 205
Query: 237 LAKGEPPNSELHPMRV------LFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPENRPTA 290
           L +  P + E  P+        ++ +PK   P   G         ++  L  +P NR + 
Sbjct: 206 LCRRLPFDDESIPVLFKNISNGVYTLPKFLSPGAAG--------LIKRMLIVNPLNRISI 257
Query: 291 KELLK 295
            E+++
Sbjct: 258 HEIMQ 262

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 47/155 (30%), Positives = 75/155 (48%), Gaps = 4/155 (2%)
Query: 145 HIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLT-NTTSKRNT 203
           H+     +V KG+++L S + +HRD+ A N+LLSE   VK+ DFG+A  +  +    R  
Sbjct: 151 HLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG 210
Query: 204 FVGTPF-WMAPEVIKQSAYDSKADIWSLGITAIEL-AKGEPPNSELHPMRVLFLIPKNNP 261
               P  WMAPE I    Y  ++D+WS G+   E+ + G  P   +          K   
Sbjct: 211 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGT 270
Query: 262 PQLTGNYTK-QFKEFVEACLNKDPENRPTAKELLK 295
                +YT  +  + +  C + +P  RPT  EL++
Sbjct: 271 RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVE 305

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 48/185 (25%), Positives = 91/185 (49%), Gaps = 17/185 (9%)
Query: 119 KLWIIMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLS 178
           ++ +++EY G      +++     E       ++++  ++Y H  + +HRD+K  N+LL 
Sbjct: 88  EIIMVIEYAGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLD 147
Query: 179 EMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDS-KADIWSLG-ITAIE 236
           E  +VK+ADFG++  +T+    + T  G+P + APEVI    Y   + D+WS G I  + 
Sbjct: 148 EHLNVKIADFGLSNIMTDGNFLK-TSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVM 206
Query: 237 LAKGEPPNSELHPMRV------LFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPENRPTA 290
           L +  P + E  P+        ++ +PK   P   G         ++  L  +P NR + 
Sbjct: 207 LCRRLPFDDESIPVLFKNISNGVYTLPKFLSPGAAG--------LIKRMLIVNPLNRISI 258
Query: 291 KELLK 295
            E+++
Sbjct: 259 HEIMQ 263

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 48/185 (25%), Positives = 91/185 (49%), Gaps = 17/185 (9%)
Query: 119 KLWIIMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLS 178
           ++ +++EY G      +++     E       ++++  ++Y H  + +HRD+K  N+LL 
Sbjct: 78  EIIMVIEYAGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLD 137
Query: 179 EMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDS-KADIWSLG-ITAIE 236
           E  +VK+ADFG++  +T+    + T  G+P + APEVI    Y   + D+WS G I  + 
Sbjct: 138 EHLNVKIADFGLSNIMTDGNFLK-TSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVM 196
Query: 237 LAKGEPPNSELHPMRV------LFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPENRPTA 290
           L +  P + E  P+        ++ +PK   P   G         ++  L  +P NR + 
Sbjct: 197 LCRRLPFDDESIPVLFKNISNGVYTLPKFLSPGAAG--------LIKRMLIVNPLNRISI 248
Query: 291 KELLK 295
            E+++
Sbjct: 249 HEIMQ 253

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 63/195 (32%), Positives = 89/195 (45%), Gaps = 12/195 (6%)
Query: 117 GTKLWIIMEYLGGGSALDLMKA--GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAAN 174
           G+ L ++ +YL  GS LD ++   G      +     ++ KG+ YL     +HR++ A N
Sbjct: 104 GSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARN 163
Query: 175 VLLSEMGDVKLADFGVAGTL-TNTTSKRNTFVGTPF-WMAPEVIKQSAYDSKADIWSLGI 232
           VLL     V++ADFGVA  L  +      +   TP  WMA E I    Y  ++D+WS G+
Sbjct: 164 VLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGV 223
Query: 233 TAIELAK-GEPPNSELHPMRVLFLIPKNN---PPQLTGNYTKQFKEFVEACLNKDPENRP 288
           T  EL   G  P + L    V  L+ K      PQ+    T      +  C   D   RP
Sbjct: 224 TVWELMTFGAEPYAGLRLAEVPDLLEKGERLAQPQIC---TIDVYMVMVKCWMIDENIRP 280
Query: 289 TAKELLKFPFIRKAK 303
           T KEL    F R A+
Sbjct: 281 TFKELAN-EFTRMAR 294

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 47/155 (30%), Positives = 75/155 (48%), Gaps = 4/155 (2%)
Query: 145 HIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLT-NTTSKRNT 203
           H+     +V KG+++L S + +HRD+ A N+LLSE   VK+ DFG+A  +  +    R  
Sbjct: 186 HLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG 245
Query: 204 FVGTPF-WMAPEVIKQSAYDSKADIWSLGITAIEL-AKGEPPNSELHPMRVLFLIPKNNP 261
               P  WMAPE I    Y  ++D+WS G+   E+ + G  P   +          K   
Sbjct: 246 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGT 305
Query: 262 PQLTGNYTK-QFKEFVEACLNKDPENRPTAKELLK 295
                +YT  +  + +  C + +P  RPT  EL++
Sbjct: 306 RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVE 340

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 91/213 (42%), Gaps = 35/213 (16%)
Query: 118 TKLWIIMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLL 177
           T  +++M ++G      LMK     E  I  ++ ++LKGL Y+H+   +HRD+K  N+ +
Sbjct: 103 TDFYLVMPFMGTDLG-KLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAV 161
Query: 178 SEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVI-KQSAYDSKADIWSLGITAIE 236
           +E  ++K+ DFG+A       S+    V T ++ APEVI     Y    DIWS+G    E
Sbjct: 162 NEDCELKILDFGLA---RQADSEMXGXVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAE 218
Query: 237 LAKGEP---PNSELHPMRVLFLIPKNNPPQLTG--------NYTKQFKE----------- 274
           +  G+     +  L  ++ +  +    P +           NY K   E           
Sbjct: 219 MITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILT 278
Query: 275 --------FVEACLNKDPENRPTAKELLKFPFI 299
                    +E  L  D E R TA E L  P+ 
Sbjct: 279 NASPLAVNLLEKMLVLDAEQRVTAGEALAHPYF 311

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 59/251 (23%), Positives = 104/251 (41%), Gaps = 23/251 (9%)
Query: 65  IGKGSFGEVFKG---IDNRTQQVVXXXXXXXXXXXXXXXXXXXXXMVLSQCDSPYGTKL- 120
           +G G FGEV  G   + ++ +  V                      ++ Q D P   +L 
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 112
Query: 121 ---------WIIMEYLGGGSALDLMKA--GNFEEMHIAVILREVLKGLDYLHSERKLHRD 169
                     I+ E +  GS    ++     F  + +  +LR +  G+ YL     +HRD
Sbjct: 113 GVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRD 172
Query: 170 IKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPF---WMAPEVIKQSAYDSKAD 226
           + A N+L++     K++DFG++  L +      T  G      W +PE I    + S +D
Sbjct: 173 LAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASD 232
Query: 227 IWSLGITAIE-LAKGEPPNSELHPMRVLFLIPKNN--PPQLTGNYTKQFKEFVEACLNKD 283
           +WS GI   E ++ GE P  E+    V+  + +    PP +  +      + +  C  KD
Sbjct: 233 VWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPM--DCPAALYQLMLDCWQKD 290
Query: 284 PENRPTAKELL 294
             NRP  ++++
Sbjct: 291 RNNRPKFEQIV 301

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 63/195 (32%), Positives = 89/195 (45%), Gaps = 12/195 (6%)
Query: 117 GTKLWIIMEYLGGGSALDLMKA--GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAAN 174
           G+ L ++ +YL  GS LD ++   G      +     ++ KG+ YL     +HR++ A N
Sbjct: 86  GSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARN 145
Query: 175 VLLSEMGDVKLADFGVAGTL-TNTTSKRNTFVGTPF-WMAPEVIKQSAYDSKADIWSLGI 232
           VLL     V++ADFGVA  L  +      +   TP  WMA E I    Y  ++D+WS G+
Sbjct: 146 VLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGV 205
Query: 233 TAIELAK-GEPPNSELHPMRVLFLIPKNN---PPQLTGNYTKQFKEFVEACLNKDPENRP 288
           T  EL   G  P + L    V  L+ K      PQ+    T      +  C   D   RP
Sbjct: 206 TVWELMTFGAEPYAGLRLAEVPDLLEKGERLAQPQIC---TIDVYMVMVKCWMIDENIRP 262
Query: 289 TAKELLKFPFIRKAK 303
           T KEL    F R A+
Sbjct: 263 TFKELAN-EFTRMAR 276

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 54/200 (27%), Positives = 84/200 (42%), Gaps = 18/200 (9%)
Query: 64  RIGKGSFGEVFKG-IDNRTQQVVXXXXXXXXXXXXXXXXXXXXXMVLSQCD--------- 113
           + G+G FG V+KG ++N T  V                       V ++C          
Sbjct: 29  KXGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVXAKCQHENLVELLG 88
Query: 114 -SPYGTKLWIIMEYLGGGSALDLMKAGN----FEEMHIAVILREVLKGLDYLHSERKLHR 168
            S  G  L ++  Y   GS LD +   +            I +    G+++LH    +HR
Sbjct: 89  FSSDGDDLCLVYVYXPNGSLLDRLSCLDGTPPLSWHXRCKIAQGAANGINFLHENHHIHR 148
Query: 169 DIKAANVLLSEMGDVKLADFGVAGTLTNTTS--KRNTFVGTPFWMAPEVIKQSAYDSKAD 226
           DIK+AN+LL E    K++DFG+A            +  VGT  + APE ++      K+D
Sbjct: 149 DIKSANILLDEAFTAKISDFGLARASEKFAQXVXXSRIVGTTAYXAPEALR-GEITPKSD 207
Query: 227 IWSLGITAIELAKGEPPNSE 246
           I+S G+  +E+  G P   E
Sbjct: 208 IYSFGVVLLEIITGLPAVDE 227

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 48/185 (25%), Positives = 91/185 (49%), Gaps = 17/185 (9%)
Query: 119 KLWIIMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLS 178
           ++ +++EY G      +++     E       ++++  ++Y H  + +HRD+K  N+LL 
Sbjct: 82  EIIMVIEYAGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLD 141
Query: 179 EMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDS-KADIWSLG-ITAIE 236
           E  +VK+ADFG++  +T+    + T  G+P + APEVI    Y   + D+WS G I  + 
Sbjct: 142 EHLNVKIADFGLSNIMTDGNFLK-TSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVM 200
Query: 237 LAKGEPPNSELHPMRV------LFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPENRPTA 290
           L +  P + E  P+        ++ +PK   P   G         ++  L  +P NR + 
Sbjct: 201 LCRRLPFDDESIPVLFKNISNGVYTLPKFLSPGAAG--------LIKRMLIVNPLNRISI 252
Query: 291 KELLK 295
            E+++
Sbjct: 253 HEIMQ 257

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 70/291 (24%), Positives = 122/291 (41%), Gaps = 49/291 (16%)
Query: 41  GSTTASRRNSLKVDPELIFTKQERIGKGSFGEVFKGIDNRTQQVVXXXXXX------XXX 94
           GS     R     D E+ + KQ  IGKG FG V KG   + + VV               
Sbjct: 5   GSEFPKSRLPTLADNEIEYEKQ--IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETE 62
Query: 95  XXXXXXXXXXXXMVLSQCDSPYGTKLW--------IIMEYLGGGSALD--LMKAGNFEEM 144
                        ++S  + P   KL+        ++ME++  G      L KA   +  
Sbjct: 63  MIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPPRMVMEFVPCGDLYHRLLDKAHPIKWS 122
Query: 145 HIAVILREVLKGLDYLHSERK--LHRDIKAANVLLSEMGD-----VKLADFGVAGTLTNT 197
               ++ ++  G++Y+ ++    +HRD+++ N+ L  + +      K+ADFG +    ++
Sbjct: 123 VKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQQSVHS 182
Query: 198 TSKRNTFVGTPFWMAPEVI--KQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFL 255
            S     +G   WMAPE I  ++ +Y  KAD +S  +    +  GE P  E    ++ F+
Sbjct: 183 VS---GLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFI 239
Query: 256 -----------IPKNNPPQLTGNYTKQFKEFVEACLNKDPENRPTAKELLK 295
                      IP++ PP+L        +  +E C + DP+ RP    ++K
Sbjct: 240 NMIREEGLRPTIPEDCPPRL--------RNVIELCWSGDPKKRPHFSYIVK 282

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 59/254 (23%), Positives = 105/254 (41%), Gaps = 20/254 (7%)
Query: 61  KQER-IGKGSFGEVFKG---IDNRTQQVVXXXXXXXXXXXXXXXXXXXXXMVLSQCDSP- 115
           K ER IG G FGEV  G   +  +    V                      ++ Q D P 
Sbjct: 46  KIERVIGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEKQRRDFLCEASIMGQFDHPN 105
Query: 116 ---------YGTKLWIIMEYLGGGSALDLMKA--GNFEEMHIAVILREVLKGLDYLHSER 164
                     G  + I++E++  G+    ++   G F  + +  +LR +  G+ YL    
Sbjct: 106 VVHLEGVVTRGKPVMIVIEFMENGALDAFLRKHDGQFTVIQLVGMLRGIAAGMRYLADMG 165
Query: 165 KLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPF---WMAPEVIKQSAY 221
            +HRD+ A N+L++     K++DFG++  + +      T  G      W APE I+   +
Sbjct: 166 YVHRDLAARNILVNSNLVCKVSDFGLSRVIEDDPEAVYTTTGGKIPVRWTAPEAIQYRKF 225
Query: 222 DSKADIWSLGITAIE-LAKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACL 280
            S +D+WS GI   E ++ GE P  ++    V+  I +        +      + +  C 
Sbjct: 226 TSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEEGYRLPAPMDCPAGLHQLMLDCW 285
Query: 281 NKDPENRPTAKELL 294
            K+   RP  ++++
Sbjct: 286 QKERAERPKFEQIV 299

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 59/251 (23%), Positives = 104/251 (41%), Gaps = 23/251 (9%)
Query: 65  IGKGSFGEVFKG---IDNRTQQVVXXXXXXXXXXXXXXXXXXXXXMVLSQCDSPYGTKL- 120
           +G G FGEV  G   + ++ +  V                      ++ Q D P   +L 
Sbjct: 24  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 83
Query: 121 ---------WIIMEYLGGGSALDLMKA--GNFEEMHIAVILREVLKGLDYLHSERKLHRD 169
                     I+ E +  GS    ++     F  + +  +LR +  G+ YL     +HRD
Sbjct: 84  GVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRD 143
Query: 170 IKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPF---WMAPEVIKQSAYDSKAD 226
           + A N+L++     K++DFG++  L +      T  G      W +PE I    + S +D
Sbjct: 144 LAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASD 203
Query: 227 IWSLGITAIE-LAKGEPPNSELHPMRVLFLIPKNN--PPQLTGNYTKQFKEFVEACLNKD 283
           +WS GI   E ++ GE P  E+    V+  + +    PP +  +      + +  C  KD
Sbjct: 204 VWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPM--DCPAALYQLMLDCWQKD 261
Query: 284 PENRPTAKELL 294
             NRP  ++++
Sbjct: 262 RNNRPKFEQIV 272

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 95/211 (45%), Gaps = 36/211 (17%)
Query: 120 LWIIMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSE 179
            +++M ++   + L  +    F E  I  ++ ++LKGL Y+HS   +HRD+K  N+ ++E
Sbjct: 122 FYLVMPFMQ--TDLQKIMGMEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNE 179
Query: 180 MGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVI-KQSAYDSKADIWSLGITAIELA 238
             ++K+ DFG+A    +  ++   +V T ++ APEVI     Y+   DIWS+G    E+ 
Sbjct: 180 DCELKILDFGLA---RHADAEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEML 236
Query: 239 KGEP--------------------PNSEL----------HPMRVLFLIPKNNPPQLTGNY 268
            G+                     P +E             ++ L   P+ +  QL    
Sbjct: 237 TGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRA 296
Query: 269 TKQFKEFVEACLNKDPENRPTAKELLKFPFI 299
           + Q  + +E  L  D + R TA + L  PF 
Sbjct: 297 SPQAADLLEKMLELDVDKRLTAAQALTHPFF 327

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 75/287 (26%), Positives = 131/287 (45%), Gaps = 42/287 (14%)
Query: 59  FTKQERIGKGSFGEVFKGIDNRTQQVVXXXXXXXXXXXXXXXXXXXXXMVLSQ------- 111
           + K  +IG+G+FGEVFK    +T Q V                     + + Q       
Sbjct: 20  YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENV 79
Query: 112 ------C---DSPYGT---KLWIIMEY----LGGGSALDLMKAGNFEEMHIAVILREVLK 155
                 C    SPY      ++++ ++    L G  +  L+K   F    I  +++ +L 
Sbjct: 80  VNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK---FTLSEIKRVMQMLLN 136
Query: 156 GLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLT-NTTSKRNTF---VGTPFWM 211
           GL Y+H  + LHRD+KAANVL++  G +KLADFG+A   +    S+ N +   V T ++ 
Sbjct: 137 GLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYR 196
Query: 212 APE-VIKQSAYDSKADIWSLGITAIELAKGEP---PNSELHPMRVLFLIPKNNPPQLTGN 267
            PE ++ +  Y    D+W  G    E+    P    N+E H + ++  +  +  P++  N
Sbjct: 197 PPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPN 256
Query: 268 YTKQFKEFVEACLNKDPENRPTAKELLKFPFIRKAKKNAYLIDLIDR 314
               ++ + +  L K  + +   K+ LK  ++R    + Y +DLID+
Sbjct: 257 -VDNYELYEKLELVKGQKRK--VKDRLK-AYVR----DPYALDLIDK 295

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 96/223 (43%), Gaps = 27/223 (12%)
Query: 59  FTKQERIGKGSFGEVFKGIDNRTQQVVXXXXXXXXXXXXXXXXXXXXXM----VLSQCDS 114
           + K + +G+G F  V+K  D  T Q+V                     +    +L +   
Sbjct: 12  YEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSH 71
Query: 115 P--------YGTKLWIIMEYLGGGSALDLMKAGN---FEEMHIAVILREVLKGLDYLHSE 163
           P        +G K  I + +    + L+++   N       HI   +   L+GL+YLH  
Sbjct: 72  PNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH 131
Query: 164 RKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQS-AYD 222
             LHRD+K  N+LL E G +KLADFG+A +  +        V T ++ APE++  +  Y 
Sbjct: 132 WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYXHQVVTRWYRAPELLFGARMYG 191
Query: 223 SKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLT 265
              D+W++G    EL            +RV FL   ++  QLT
Sbjct: 192 VGVDMWAVGCILAELL-----------LRVPFLPGDSDLDQLT 223

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 68.9 bits (167), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 39/121 (32%), Positives = 65/121 (53%), Gaps = 3/121 (2%)
Query: 120 LWIIMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSE 179
           ++I+ME +       +    + E M  + +L ++L G+ +LHS   +HRD+K +N+++  
Sbjct: 104 VYIVMELMDANLCQVIQMELDHERM--SYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS 161
Query: 180 MGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAK 239
              +K+ DFG+A T   T+      V T ++ APEVI    Y    DIWS+G    E+ K
Sbjct: 162 DCTLKILDFGLART-AGTSFMMTPEVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIK 220
Query: 240 G 240
           G
Sbjct: 221 G 221

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 68.9 bits (167), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 52/190 (27%), Positives = 86/190 (45%), Gaps = 34/190 (17%)
Query: 141 FEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSK 200
           F E  I  ++ ++LKGL Y+HS   +HRD+K  N+ ++E  ++K+ DFG+A    +  ++
Sbjct: 123 FSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLA---RHADAE 179
Query: 201 RNTFVGTPFWMAPEVI-KQSAYDSKADIWSLGITAIELAKGEP----------------- 242
              +V T ++ APEVI     Y+   DIWS+G    E+  G+                  
Sbjct: 180 MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKV 239
Query: 243 ---PNSEL----------HPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPENRPT 289
              P +E             ++ L   P+ +  QL    + Q  + +E  L  D + R T
Sbjct: 240 TGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLT 299
Query: 290 AKELLKFPFI 299
           A + L  PF 
Sbjct: 300 AAQALTHPFF 309

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 68.6 bits (166), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 44/165 (26%), Positives = 83/165 (50%), Gaps = 16/165 (9%)
Query: 151 REVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLT--NTTSKRNTFVGTP 208
           + +L+ +  +H    +H D+K AN L+ + G +KL DFG+A  +    T+  +++ VGT 
Sbjct: 162 KNMLEAVHTIHQHGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGTV 220
Query: 209 FWMAPEVIKQSA-----------YDSKADIWSLGITAIELAKGEPPNSEL--HPMRVLFL 255
            +M PE IK  +              K+D+WSLG     +  G+ P  ++     ++  +
Sbjct: 221 NYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAI 280
Query: 256 IPKNNPPQLTGNYTKQFKEFVEACLNKDPENRPTAKELLKFPFIR 300
           I  N+  +      K  ++ ++ CL +DP+ R +  ELL  P+++
Sbjct: 281 IDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ 325

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 44/165 (26%), Positives = 83/165 (50%), Gaps = 16/165 (9%)
Query: 151 REVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLT--NTTSKRNTFVGTP 208
           + +L+ +  +H    +H D+K AN L+ + G +KL DFG+A  +    T+  +++ VGT 
Sbjct: 162 KNMLEAVHTIHQHGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGTV 220
Query: 209 FWMAPEVIKQSA-----------YDSKADIWSLGITAIELAKGEPPNSEL--HPMRVLFL 255
            +M PE IK  +              K+D+WSLG     +  G+ P  ++     ++  +
Sbjct: 221 NYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAI 280
Query: 256 IPKNNPPQLTGNYTKQFKEFVEACLNKDPENRPTAKELLKFPFIR 300
           I  N+  +      K  ++ ++ CL +DP+ R +  ELL  P+++
Sbjct: 281 IDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ 325

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/242 (25%), Positives = 103/242 (42%), Gaps = 15/242 (6%)
Query: 63  ERIGKGSFGEVFKGIDNRTQQV-VXXXXXXXXXXXXXXXXXXXXXMVLSQCDSPYGT--- 118
           + IGKG FG+V  G D R  +V V                     +  S      G    
Sbjct: 12  QTIGKGEFGDVMLG-DYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE 70
Query: 119 ---KLWIIMEYLGGGSALDLMKAGNFEEMHIAVILR---EVLKGLDYLHSERKLHRDIKA 172
               L+I+ EY+  GS +D +++     +    +L+   +V + ++YL     +HRD+ A
Sbjct: 71  EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAA 130
Query: 173 ANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGI 232
            NVL+SE    K++DFG+    ++T       V    W APE +++  + +K+D+WS GI
Sbjct: 131 RNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVK---WTAPEALREKKFSTKSDVWSFGI 187
Query: 233 TAIELAK-GEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPENRPTAK 291
              E+   G  P   +    V+  + K               E ++ C + D   RP+  
Sbjct: 188 LLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFL 247
Query: 292 EL 293
           +L
Sbjct: 248 QL 249

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 63/243 (25%), Positives = 102/243 (41%), Gaps = 17/243 (6%)
Query: 63  ERIGKGSFGEVFKGIDNRTQQV-VXXXXXXXXXXXXXXXXXXXXXMVLSQCDSPYGT--- 118
           + IGKG FG+V  G D R  +V V                     +  S      G    
Sbjct: 27  QTIGKGEFGDVMLG-DYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE 85
Query: 119 ---KLWIIMEYLGGGSALDLMKAGNFEEMHIAVILR---EVLKGLDYLHSERKLHRDIKA 172
               L+I+ EY+  GS +D +++     +    +L+   +V + ++YL     +HRD+ A
Sbjct: 86  EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAA 145
Query: 173 ANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPF-WMAPEVIKQSAYDSKADIWSLG 231
            NVL+SE    K++DFG    LT   S        P  W APE +++  + +K+D+WS G
Sbjct: 146 RNVLVSEDNVAKVSDFG----LTKEASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFG 201
Query: 232 ITAIELAK-GEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPENRPTA 290
           I   E+   G  P   +    V+  + K               E ++ C + D   RP+ 
Sbjct: 202 ILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSF 261
Query: 291 KEL 293
            +L
Sbjct: 262 LQL 264

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 89/202 (44%), Gaps = 21/202 (10%)
Query: 59  FTKQERIGKGSFGEVFKGIDNRTQQVVXXXXXXXXXXXXXXXXXXXXXMVLSQ------- 111
           + K E+IG+G++G VFK  +  T ++V                     + L +       
Sbjct: 4   YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNI 63
Query: 112 ---CDSPYGTK-LWIIMEYLGGGSALDLMKA-----GNFEEMHIAVILREVLKGLDYLHS 162
               D  +  K L ++ E+       DL K      G+ +   +   L ++LKGL + HS
Sbjct: 64  VRLHDVLHSDKKLTLVFEFCDQ----DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHS 119
Query: 163 ERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVI-KQSAY 221
              LHRD+K  N+L++  G++KLA+FG+A          +  V T ++  P+V+     Y
Sbjct: 120 RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLY 179
Query: 222 DSKADIWSLGITAIELAKGEPP 243
            +  D+WS G    ELA    P
Sbjct: 180 STSIDMWSAGCIFAELANAGRP 201

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 36/120 (30%), Positives = 65/120 (54%), Gaps = 3/120 (2%)
Query: 120 LWIIMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSE 179
           ++++ME +       +    + E M  + +L ++L G+ +LHS   +HRD+K +N+++  
Sbjct: 142 VYLVMELMDANLCQVIQMELDHERM--SYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS 199
Query: 180 MGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAK 239
              +K+ DFG+A T   T+     +V T ++ APEVI    Y    DIWS+G    E+ +
Sbjct: 200 DCTLKILDFGLART-AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVR 258

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 75/287 (26%), Positives = 131/287 (45%), Gaps = 42/287 (14%)
Query: 59  FTKQERIGKGSFGEVFKGIDNRTQQVVXXXXXXXXXXXXXXXXXXXXXMVLSQ------- 111
           + K  +IG+G+FGEVFK    +T Q V                     + + Q       
Sbjct: 20  YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENV 79
Query: 112 ------C---DSPYG---TKLWIIMEY----LGGGSALDLMKAGNFEEMHIAVILREVLK 155
                 C    SPY      ++++ ++    L G  +  L+K   F    I  +++ +L 
Sbjct: 80  VNLIEICRTKASPYNRCKASIYLVFDFCEHDLAGLLSNVLVK---FTLSEIKRVMQMLLN 136
Query: 156 GLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLT-NTTSKRNTF---VGTPFWM 211
           GL Y+H  + LHRD+KAANVL++  G +KLADFG+A   +    S+ N +   V T ++ 
Sbjct: 137 GLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYR 196
Query: 212 APE-VIKQSAYDSKADIWSLGITAIELAKGEP---PNSELHPMRVLFLIPKNNPPQLTGN 267
            PE ++ +  Y    D+W  G    E+    P    N+E H + ++  +  +  P++  N
Sbjct: 197 PPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPN 256
Query: 268 YTKQFKEFVEACLNKDPENRPTAKELLKFPFIRKAKKNAYLIDLIDR 314
               ++ + +  L K  + +   K+ LK  ++R    + Y +DLID+
Sbjct: 257 -VDNYELYEKLELVKGQKRK--VKDRLK-AYVR----DPYALDLIDK 295

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 55/181 (30%), Positives = 81/181 (44%), Gaps = 21/181 (11%)
Query: 130 GSALDLMK--AGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLAD 187
           GS LD ++   G+F    ++    +V +G+ YL S+R +HRD+ A N+LL+    VK+ D
Sbjct: 99  GSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGD 158
Query: 188 FGVAGTLTNTTSK--RNTFVGTPF-WMAPEVIKQSAYDSKADIWSLGITAIEL-AKGEPP 243
           FG+   L               PF W APE +K   +   +D W  G+T  E+   G+ P
Sbjct: 159 FGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEP 218
Query: 244 NSELHPMRVLFLIPK--------NNPPQLTGNYTKQFKEFVEACLNKDPENRPTAKELLK 295
              L+  ++L  I K         + PQ   N   Q       C    PE+RPT   L  
Sbjct: 219 WIGLNGSQILHKIDKEGERLPRPEDCPQDIYNVMVQ-------CWAHKPEDRPTFVALRD 271
Query: 296 F 296
           F
Sbjct: 272 F 272

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 44/165 (26%), Positives = 83/165 (50%), Gaps = 16/165 (9%)
Query: 151 REVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLT--NTTSKRNTFVGTP 208
           + +L+ +  +H    +H D+K AN L+ + G +KL DFG+A  +    T+  +++ VGT 
Sbjct: 115 KNMLEAVHTIHQHGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGTV 173
Query: 209 FWMAPEVIKQSA-----------YDSKADIWSLGITAIELAKGEPPNSEL--HPMRVLFL 255
            +M PE IK  +              K+D+WSLG     +  G+ P  ++     ++  +
Sbjct: 174 NYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAI 233
Query: 256 IPKNNPPQLTGNYTKQFKEFVEACLNKDPENRPTAKELLKFPFIR 300
           I  N+  +      K  ++ ++ CL +DP+ R +  ELL  P+++
Sbjct: 234 IDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ 278

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 43/160 (26%), Positives = 79/160 (49%), Gaps = 16/160 (10%)
Query: 149 ILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTF---- 204
           I  ++ + +++LHS+  +HRD+K +N+  +    VK+ DFG+   +     ++       
Sbjct: 123 IFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMP 182
Query: 205 --------VGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLI 256
                   VGT  +M+PE I  ++Y  K DI+SLG+   EL    P ++++  +R L  +
Sbjct: 183 AYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY--PFSTQMERVRTLTDV 240
Query: 257 PK-NNPPQLTGNYTKQFKEFVEACLNKDPENRPTAKELLK 295
                PP  T  Y  ++   V+  L+  P  RP A  +++
Sbjct: 241 RNLKFPPLFTQKYPCEYV-MVQDMLSPSPMERPEAINIIE 279

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 55/181 (30%), Positives = 81/181 (44%), Gaps = 21/181 (11%)
Query: 130 GSALDLMK--AGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLAD 187
           GS LD ++   G+F    ++    +V +G+ YL S+R +HRD+ A N+LL+    VK+ D
Sbjct: 99  GSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGD 158
Query: 188 FGVAGTLTNTTSK--RNTFVGTPF-WMAPEVIKQSAYDSKADIWSLGITAIEL-AKGEPP 243
           FG+   L               PF W APE +K   +   +D W  G+T  E+   G+ P
Sbjct: 159 FGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEP 218
Query: 244 NSELHPMRVLFLIPK--------NNPPQLTGNYTKQFKEFVEACLNKDPENRPTAKELLK 295
              L+  ++L  I K         + PQ   N   Q       C    PE+RPT   L  
Sbjct: 219 WIGLNGSQILHKIDKEGERLPRPEDCPQDIYNVMVQ-------CWAHKPEDRPTFVALRD 271
Query: 296 F 296
           F
Sbjct: 272 F 272

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 36/120 (30%), Positives = 65/120 (54%), Gaps = 3/120 (2%)
Query: 120 LWIIMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSE 179
           ++++ME +       +    + E M  + +L ++L G+ +LHS   +HRD+K +N+++  
Sbjct: 142 VYLVMELMDANLCQVIQMELDHERM--SYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS 199
Query: 180 MGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAK 239
              +K+ DFG+A T   T+     +V T ++ APEVI    Y    DIWS+G    E+ +
Sbjct: 200 DCTLKILDFGLART-AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVR 258

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 55/181 (30%), Positives = 81/181 (44%), Gaps = 21/181 (11%)
Query: 130 GSALDLMK--AGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLAD 187
           GS LD ++   G+F    ++    +V +G+ YL S+R +HRD+ A N+LL+    VK+ D
Sbjct: 105 GSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGD 164
Query: 188 FGVAGTLTNTTSKR--NTFVGTPF-WMAPEVIKQSAYDSKADIWSLGITAIEL-AKGEPP 243
           FG+   L               PF W APE +K   +   +D W  G+T  E+   G+ P
Sbjct: 165 FGLMRALPQNDDHXVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEP 224
Query: 244 NSELHPMRVLFLIPK--------NNPPQLTGNYTKQFKEFVEACLNKDPENRPTAKELLK 295
              L+  ++L  I K         + PQ   N   Q       C    PE+RPT   L  
Sbjct: 225 WIGLNGSQILHKIDKEGERLPRPEDCPQDIYNVMVQ-------CWAHKPEDRPTFVALRD 277
Query: 296 F 296
           F
Sbjct: 278 F 278

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 43/148 (29%), Positives = 73/148 (49%), Gaps = 5/148 (3%)
Query: 152 EVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTN---TTSKRNTFVGTP 208
           +V KG+ YL S++ +HRD+ A N +L E   VK+ADFG+A  + +    +    T    P
Sbjct: 140 QVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEXXSVHNKTGAKLP 199
Query: 209 F-WMAPEVIKQSAYDSKADIWSLGITAIEL-AKGEPPNSELHPMRVLFLIPKNNPPQLTG 266
             WMA E ++   + +K+D+WS G+   EL  +G PP  +++   +   + +        
Sbjct: 200 VKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPE 259
Query: 267 NYTKQFKEFVEACLNKDPENRPTAKELL 294
                  E +  C +   E RP+  EL+
Sbjct: 260 YCPDPLYEVMLKCWHPKAEMRPSFSELV 287

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 43/148 (29%), Positives = 73/148 (49%), Gaps = 5/148 (3%)
Query: 152 EVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTN---TTSKRNTFVGTP 208
           +V KG+ YL S++ +HRD+ A N +L E   VK+ADFG+A  + +    +    T    P
Sbjct: 139 QVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLP 198
Query: 209 F-WMAPEVIKQSAYDSKADIWSLGITAIEL-AKGEPPNSELHPMRVLFLIPKNNPPQLTG 266
             WMA E ++   + +K+D+WS G+   EL  +G PP  +++   +   + +        
Sbjct: 199 VKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPE 258
Query: 267 NYTKQFKEFVEACLNKDPENRPTAKELL 294
                  E +  C +   E RP+  EL+
Sbjct: 259 YCPDPLYEVMLKCWHPKAEMRPSFSELV 286

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 75/287 (26%), Positives = 131/287 (45%), Gaps = 42/287 (14%)
Query: 59  FTKQERIGKGSFGEVFKGIDNRTQQVVXXXXXXXXXXXXXXXXXXXXXMVLSQ------- 111
           + K  +IG+G+FGEVFK    +T Q V                     + + Q       
Sbjct: 19  YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENV 78
Query: 112 ------C---DSPYGT---KLWIIMEY----LGGGSALDLMKAGNFEEMHIAVILREVLK 155
                 C    SPY      ++++ ++    L G  +  L+K   F    I  +++ +L 
Sbjct: 79  VNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK---FTLSEIKRVMQMLLN 135
Query: 156 GLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLT-NTTSKRNTF---VGTPFWM 211
           GL Y+H  + LHRD+KAANVL++  G +KLADFG+A   +    S+ N +   V T ++ 
Sbjct: 136 GLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYR 195
Query: 212 APE-VIKQSAYDSKADIWSLGITAIELAKGEP---PNSELHPMRVLFLIPKNNPPQLTGN 267
            PE ++ +  Y    D+W  G    E+    P    N+E H + ++  +  +  P++  N
Sbjct: 196 PPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPN 255
Query: 268 YTKQFKEFVEACLNKDPENRPTAKELLKFPFIRKAKKNAYLIDLIDR 314
               ++ + +  L K  + +   K+ LK  ++R    + Y +DLID+
Sbjct: 256 -VDNYELYEKLELVKGQKRK--VKDRLK-AYVR----DPYALDLIDK 294

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 44/165 (26%), Positives = 83/165 (50%), Gaps = 16/165 (9%)
Query: 151 REVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLT--NTTSKRNTFVGTP 208
           + +L+ +  +H    +H D+K AN L+ + G +KL DFG+A  +    T+  +++ VGT 
Sbjct: 118 KNMLEAVHTIHQHGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGTV 176
Query: 209 FWMAPEVIKQSA-----------YDSKADIWSLGITAIELAKGEPPNSEL--HPMRVLFL 255
            +M PE IK  +              K+D+WSLG     +  G+ P  ++     ++  +
Sbjct: 177 NYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAI 236
Query: 256 IPKNNPPQLTGNYTKQFKEFVEACLNKDPENRPTAKELLKFPFIR 300
           I  N+  +      K  ++ ++ CL +DP+ R +  ELL  P+++
Sbjct: 237 IDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ 281

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 55/181 (30%), Positives = 81/181 (44%), Gaps = 21/181 (11%)
Query: 130 GSALDLMK--AGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLAD 187
           GS LD ++   G+F    ++    +V +G+ YL S+R +HRD+ A N+LL+    VK+ D
Sbjct: 105 GSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGD 164
Query: 188 FGVAGTLTNTTSK--RNTFVGTPF-WMAPEVIKQSAYDSKADIWSLGITAIEL-AKGEPP 243
           FG+   L               PF W APE +K   +   +D W  G+T  E+   G+ P
Sbjct: 165 FGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEP 224
Query: 244 NSELHPMRVLFLIPK--------NNPPQLTGNYTKQFKEFVEACLNKDPENRPTAKELLK 295
              L+  ++L  I K         + PQ   N   Q       C    PE+RPT   L  
Sbjct: 225 WIGLNGSQILHKIDKEGERLPRPEDCPQDIYNVMVQ-------CWAHKPEDRPTFVALRD 277
Query: 296 F 296
           F
Sbjct: 278 F 278

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 43/148 (29%), Positives = 73/148 (49%), Gaps = 5/148 (3%)
Query: 152 EVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTN---TTSKRNTFVGTP 208
           +V KG+ YL S++ +HRD+ A N +L E   VK+ADFG+A  + +    +    T    P
Sbjct: 141 QVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLP 200
Query: 209 F-WMAPEVIKQSAYDSKADIWSLGITAIEL-AKGEPPNSELHPMRVLFLIPKNNPPQLTG 266
             WMA E ++   + +K+D+WS G+   EL  +G PP  +++   +   + +        
Sbjct: 201 VKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPE 260
Query: 267 NYTKQFKEFVEACLNKDPENRPTAKELL 294
                  E +  C +   E RP+  EL+
Sbjct: 261 YCPDPLYEVMLKCWHPKAEMRPSFSELV 288

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 44/165 (26%), Positives = 83/165 (50%), Gaps = 16/165 (9%)
Query: 151 REVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLT--NTTSKRNTFVGTP 208
           + +L+ +  +H    +H D+K AN L+ + G +KL DFG+A  +    T+  +++ VGT 
Sbjct: 114 KNMLEAVHTIHQHGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGTV 172
Query: 209 FWMAPEVIKQSA-----------YDSKADIWSLGITAIELAKGEPPNSEL--HPMRVLFL 255
            +M PE IK  +              K+D+WSLG     +  G+ P  ++     ++  +
Sbjct: 173 NYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAI 232
Query: 256 IPKNNPPQLTGNYTKQFKEFVEACLNKDPENRPTAKELLKFPFIR 300
           I  N+  +      K  ++ ++ CL +DP+ R +  ELL  P+++
Sbjct: 233 IDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ 277

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 44/165 (26%), Positives = 83/165 (50%), Gaps = 16/165 (9%)
Query: 151 REVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLT--NTTSKRNTFVGTP 208
           + +L+ +  +H    +H D+K AN L+ + G +KL DFG+A  +    T+  +++ VGT 
Sbjct: 134 KNMLEAVHTIHQHGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGTV 192
Query: 209 FWMAPEVIKQSA-----------YDSKADIWSLGITAIELAKGEPPNSEL--HPMRVLFL 255
            +M PE IK  +              K+D+WSLG     +  G+ P  ++     ++  +
Sbjct: 193 NYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAI 252
Query: 256 IPKNNPPQLTGNYTKQFKEFVEACLNKDPENRPTAKELLKFPFIR 300
           I  N+  +      K  ++ ++ CL +DP+ R +  ELL  P+++
Sbjct: 253 IDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ 297

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 43/148 (29%), Positives = 73/148 (49%), Gaps = 5/148 (3%)
Query: 152 EVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTN---TTSKRNTFVGTP 208
           +V KG+ YL S++ +HRD+ A N +L E   VK+ADFG+A  + +    +    T    P
Sbjct: 136 QVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLP 195
Query: 209 F-WMAPEVIKQSAYDSKADIWSLGITAIEL-AKGEPPNSELHPMRVLFLIPKNNPPQLTG 266
             WMA E ++   + +K+D+WS G+   EL  +G PP  +++   +   + +        
Sbjct: 196 VKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPE 255
Query: 267 NYTKQFKEFVEACLNKDPENRPTAKELL 294
                  E +  C +   E RP+  EL+
Sbjct: 256 YCPDPLYEVMLKCWHPKAEMRPSFSELV 283

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 43/148 (29%), Positives = 73/148 (49%), Gaps = 5/148 (3%)
Query: 152 EVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTN---TTSKRNTFVGTP 208
           +V KG+ YL S++ +HRD+ A N +L E   VK+ADFG+A  + +    +    T    P
Sbjct: 133 QVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLP 192
Query: 209 F-WMAPEVIKQSAYDSKADIWSLGITAIEL-AKGEPPNSELHPMRVLFLIPKNNPPQLTG 266
             WMA E ++   + +K+D+WS G+   EL  +G PP  +++   +   + +        
Sbjct: 193 VKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPE 252
Query: 267 NYTKQFKEFVEACLNKDPENRPTAKELL 294
                  E +  C +   E RP+  EL+
Sbjct: 253 YCPDPLYEVMLKCWHPKAEMRPSFSELV 280

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 40/148 (27%), Positives = 71/148 (47%), Gaps = 3/148 (2%)
Query: 152 EVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVG-TPF- 209
           E+  G+ YL++++ +HR++ A N +++    VK+ DFG+   +  T   R    G  P  
Sbjct: 139 EIADGMAYLNAKKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 198
Query: 210 WMAPEVIKQSAYDSKADIWSLGITAIELAK-GEPPNSELHPMRVLFLIPKNNPPQLTGNY 268
           WMAPE +K   + + +D+WS G+   E+    E P   L   +VL  +          N 
Sbjct: 199 WMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQPDNC 258
Query: 269 TKQFKEFVEACLNKDPENRPTAKELLKF 296
            ++  + +  C   +P  RPT  E++  
Sbjct: 259 PERVTDLMRMCWQFNPNMRPTFLEIVNL 286

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 43/148 (29%), Positives = 73/148 (49%), Gaps = 5/148 (3%)
Query: 152 EVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTN---TTSKRNTFVGTP 208
           +V KG+ YL S++ +HRD+ A N +L E   VK+ADFG+A  + +    +    T    P
Sbjct: 140 QVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLP 199
Query: 209 F-WMAPEVIKQSAYDSKADIWSLGITAIEL-AKGEPPNSELHPMRVLFLIPKNNPPQLTG 266
             WMA E ++   + +K+D+WS G+   EL  +G PP  +++   +   + +        
Sbjct: 200 VKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPE 259
Query: 267 NYTKQFKEFVEACLNKDPENRPTAKELL 294
                  E +  C +   E RP+  EL+
Sbjct: 260 YCPDPLYEVMLKCWHPKAEMRPSFSELV 287

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 75/287 (26%), Positives = 131/287 (45%), Gaps = 42/287 (14%)
Query: 59  FTKQERIGKGSFGEVFKGIDNRTQQVVXXXXXXXXXXXXXXXXXXXXXMVLSQ------- 111
           + K  +IG+G+FGEVFK    +T Q V                     + + Q       
Sbjct: 20  YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENV 79
Query: 112 ------C---DSPYGT---KLWIIMEY----LGGGSALDLMKAGNFEEMHIAVILREVLK 155
                 C    SPY      ++++ ++    L G  +  L+K   F    I  +++ +L 
Sbjct: 80  VNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK---FTLSEIKRVMQMLLN 136
Query: 156 GLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLT-NTTSKRNTF---VGTPFWM 211
           GL Y+H  + LHRD+KAANVL++  G +KLADFG+A   +    S+ N +   V T ++ 
Sbjct: 137 GLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYR 196
Query: 212 APE-VIKQSAYDSKADIWSLGITAIELAKGEP---PNSELHPMRVLFLIPKNNPPQLTGN 267
            PE ++ +  Y    D+W  G    E+    P    N+E H + ++  +  +  P++  N
Sbjct: 197 PPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPN 256
Query: 268 YTKQFKEFVEACLNKDPENRPTAKELLKFPFIRKAKKNAYLIDLIDR 314
               ++ + +  L K  + +   K+ LK  ++R    + Y +DLID+
Sbjct: 257 -VDNYELYEKLELVKGQKRK--VKDRLK-AYVR----DPYALDLIDK 295

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 44/150 (29%), Positives = 75/150 (50%), Gaps = 6/150 (4%)
Query: 152 EVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTS---KRNTFVGTP 208
           +V +G+ +L S+  +HRD+ A NVLL+     K+ DFG+A  + N ++   K N  +   
Sbjct: 172 QVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVK 231
Query: 209 FWMAPEVIKQSAYDSKADIWSLGITAIEL-AKGEPPNSELHPMRVLFLIPKNNPPQLTGN 267
            WMAPE I    Y  ++D+WS GI   E+ + G  P   +      + + K+        
Sbjct: 232 -WMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGYQMAQPA 290
Query: 268 YT-KQFKEFVEACLNKDPENRPTAKELLKF 296
           +  K     ++AC   +P +RPT +++  F
Sbjct: 291 FAPKNIYSIMQACWALEPTHRPTFQQICSF 320

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 43/148 (29%), Positives = 73/148 (49%), Gaps = 5/148 (3%)
Query: 152 EVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTN---TTSKRNTFVGTP 208
           +V KG+ YL S++ +HRD+ A N +L E   VK+ADFG+A  + +    +    T    P
Sbjct: 138 QVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLP 197
Query: 209 F-WMAPEVIKQSAYDSKADIWSLGITAIEL-AKGEPPNSELHPMRVLFLIPKNNPPQLTG 266
             WMA E ++   + +K+D+WS G+   EL  +G PP  +++   +   + +        
Sbjct: 198 VKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPE 257
Query: 267 NYTKQFKEFVEACLNKDPENRPTAKELL 294
                  E +  C +   E RP+  EL+
Sbjct: 258 YCPDPLYEVMLKCWHPKAEMRPSFSELV 285

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 55/181 (30%), Positives = 81/181 (44%), Gaps = 21/181 (11%)
Query: 130 GSALDLMK--AGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLAD 187
           GS LD ++   G+F    ++    +V +G+ YL S+R +HRD+ A N+LL+    VK+ D
Sbjct: 95  GSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGD 154
Query: 188 FGVAGTLTNTTSKR--NTFVGTPF-WMAPEVIKQSAYDSKADIWSLGITAIEL-AKGEPP 243
           FG+   L               PF W APE +K   +   +D W  G+T  E+   G+ P
Sbjct: 155 FGLMRALPQNDDHXVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEP 214
Query: 244 NSELHPMRVLFLIPK--------NNPPQLTGNYTKQFKEFVEACLNKDPENRPTAKELLK 295
              L+  ++L  I K         + PQ   N   Q       C    PE+RPT   L  
Sbjct: 215 WIGLNGSQILHKIDKEGERLPRPEDCPQDIYNVMVQ-------CWAHKPEDRPTFVALRD 267
Query: 296 F 296
           F
Sbjct: 268 F 268

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 36/120 (30%), Positives = 65/120 (54%), Gaps = 3/120 (2%)
Query: 120 LWIIMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSE 179
           ++++ME +       +    + E M  + +L ++L G+ +LHS   +HRD+K +N+++  
Sbjct: 103 VYLVMELMDANLCQVIQMELDHERM--SYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS 160
Query: 180 MGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAK 239
              +K+ DFG+A T   T+     +V T ++ APEVI    Y    DIWS+G    E+ +
Sbjct: 161 DCTLKILDFGLART-AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVR 219

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 43/148 (29%), Positives = 73/148 (49%), Gaps = 5/148 (3%)
Query: 152 EVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTN---TTSKRNTFVGTP 208
           +V KG+ YL S++ +HRD+ A N +L E   VK+ADFG+A  + +    +    T    P
Sbjct: 141 QVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLP 200
Query: 209 F-WMAPEVIKQSAYDSKADIWSLGITAIEL-AKGEPPNSELHPMRVLFLIPKNNPPQLTG 266
             WMA E ++   + +K+D+WS G+   EL  +G PP  +++   +   + +        
Sbjct: 201 VKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPE 260
Query: 267 NYTKQFKEFVEACLNKDPENRPTAKELL 294
                  E +  C +   E RP+  EL+
Sbjct: 261 YCPDPLYEVMLKCWHPKAEMRPSFSELV 288

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 36/120 (30%), Positives = 65/120 (54%), Gaps = 3/120 (2%)
Query: 120 LWIIMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSE 179
           ++++ME +       +    + E M  + +L ++L G+ +LHS   +HRD+K +N+++  
Sbjct: 104 VYLVMELMDANLCQVIQMELDHERM--SYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS 161
Query: 180 MGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAK 239
              +K+ DFG+A T   T+     +V T ++ APEVI    Y    DIWS+G    E+ +
Sbjct: 162 DCTLKILDFGLART-AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVR 220

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 55/181 (30%), Positives = 81/181 (44%), Gaps = 21/181 (11%)
Query: 130 GSALDLMK--AGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLAD 187
           GS LD ++   G+F    ++    +V +G+ YL S+R +HRD+ A N+LL+    VK+ D
Sbjct: 95  GSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGD 154
Query: 188 FGVAGTLTNTTSK--RNTFVGTPF-WMAPEVIKQSAYDSKADIWSLGITAIEL-AKGEPP 243
           FG+   L               PF W APE +K   +   +D W  G+T  E+   G+ P
Sbjct: 155 FGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEP 214
Query: 244 NSELHPMRVLFLIPK--------NNPPQLTGNYTKQFKEFVEACLNKDPENRPTAKELLK 295
              L+  ++L  I K         + PQ   N   Q       C    PE+RPT   L  
Sbjct: 215 WIGLNGSQILHKIDKEGERLPRPEDCPQDIYNVMVQ-------CWAHKPEDRPTFVALRD 267
Query: 296 F 296
           F
Sbjct: 268 F 268

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 55/181 (30%), Positives = 81/181 (44%), Gaps = 21/181 (11%)
Query: 130 GSALDLMK--AGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLAD 187
           GS LD ++   G+F    ++    +V +G+ YL S+R +HRD+ A N+LL+    VK+ D
Sbjct: 95  GSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGD 154
Query: 188 FGVAGTLTNTTSK--RNTFVGTPF-WMAPEVIKQSAYDSKADIWSLGITAIEL-AKGEPP 243
           FG+   L               PF W APE +K   +   +D W  G+T  E+   G+ P
Sbjct: 155 FGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEP 214
Query: 244 NSELHPMRVLFLIPK--------NNPPQLTGNYTKQFKEFVEACLNKDPENRPTAKELLK 295
              L+  ++L  I K         + PQ   N   Q       C    PE+RPT   L  
Sbjct: 215 WIGLNGSQILHKIDKEGERLPRPEDCPQDIYNVMVQ-------CWAHKPEDRPTFVALRD 267
Query: 296 F 296
           F
Sbjct: 268 F 268

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 43/148 (29%), Positives = 73/148 (49%), Gaps = 5/148 (3%)
Query: 152 EVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTN---TTSKRNTFVGTP 208
           +V KG+ YL S++ +HRD+ A N +L E   VK+ADFG+A  + +    +    T    P
Sbjct: 159 QVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLP 218
Query: 209 F-WMAPEVIKQSAYDSKADIWSLGITAIEL-AKGEPPNSELHPMRVLFLIPKNNPPQLTG 266
             WMA E ++   + +K+D+WS G+   EL  +G PP  +++   +   + +        
Sbjct: 219 VKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPE 278
Query: 267 NYTKQFKEFVEACLNKDPENRPTAKELL 294
                  E +  C +   E RP+  EL+
Sbjct: 279 YCPDPLYEVMLKCWHPKAEMRPSFSELV 306

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 40/148 (27%), Positives = 71/148 (47%), Gaps = 3/148 (2%)
Query: 152 EVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVG-TPF- 209
           E+  G+ YL++++ +HR++ A N +++    VK+ DFG+   +  T   R    G  P  
Sbjct: 138 EIADGMAYLNAKKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 197
Query: 210 WMAPEVIKQSAYDSKADIWSLGITAIELAK-GEPPNSELHPMRVLFLIPKNNPPQLTGNY 268
           WMAPE +K   + + +D+WS G+   E+    E P   L   +VL  +          N 
Sbjct: 198 WMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQPDNC 257
Query: 269 TKQFKEFVEACLNKDPENRPTAKELLKF 296
            ++  + +  C   +P  RPT  E++  
Sbjct: 258 PERVTDLMRMCWQFNPNMRPTFLEIVNL 285

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 36/120 (30%), Positives = 65/120 (54%), Gaps = 3/120 (2%)
Query: 120 LWIIMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSE 179
           ++++ME +       +    + E M  + +L ++L G+ +LHS   +HRD+K +N+++  
Sbjct: 105 VYLVMELMDANLCQVIQMELDHERM--SYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS 162
Query: 180 MGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAK 239
              +K+ DFG+A T   T+     +V T ++ APEVI    Y    DIWS+G    E+ +
Sbjct: 163 DCTLKILDFGLART-AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVR 221

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 36/120 (30%), Positives = 65/120 (54%), Gaps = 3/120 (2%)
Query: 120 LWIIMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSE 179
           ++++ME +       +    + E M  + +L ++L G+ +LHS   +HRD+K +N+++  
Sbjct: 104 VYLVMELMDANLCQVIQMELDHERM--SYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS 161
Query: 180 MGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAK 239
              +K+ DFG+A T   T+     +V T ++ APEVI    Y    DIWS+G    E+ +
Sbjct: 162 DCTLKILDFGLART-AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVR 220

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 43/148 (29%), Positives = 73/148 (49%), Gaps = 5/148 (3%)
Query: 152 EVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTN---TTSKRNTFVGTP 208
           +V KG+ YL S++ +HRD+ A N +L E   VK+ADFG+A  + +    +    T    P
Sbjct: 160 QVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLP 219
Query: 209 F-WMAPEVIKQSAYDSKADIWSLGITAIEL-AKGEPPNSELHPMRVLFLIPKNNPPQLTG 266
             WMA E ++   + +K+D+WS G+   EL  +G PP  +++   +   + +        
Sbjct: 220 VKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPE 279
Query: 267 NYTKQFKEFVEACLNKDPENRPTAKELL 294
                  E +  C +   E RP+  EL+
Sbjct: 280 YCPDPLYEVMLKCWHPKAEMRPSFSELV 307

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 36/120 (30%), Positives = 65/120 (54%), Gaps = 3/120 (2%)
Query: 120 LWIIMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSE 179
           ++++ME +       +    + E M  + +L ++L G+ +LHS   +HRD+K +N+++  
Sbjct: 105 VYLVMELMDANLCQVIQMELDHERM--SYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS 162
Query: 180 MGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAK 239
              +K+ DFG+A T   T+     +V T ++ APEVI    Y    DIWS+G    E+ +
Sbjct: 163 DCTLKILDFGLART-AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVR 221

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 44/150 (29%), Positives = 75/150 (50%), Gaps = 6/150 (4%)
Query: 152 EVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTS---KRNTFVGTP 208
           +V +G+ +L S+  +HRD+ A NVLL+     K+ DFG+A  + N ++   K N  +   
Sbjct: 172 QVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVK 231
Query: 209 FWMAPEVIKQSAYDSKADIWSLGITAIEL-AKGEPPNSELHPMRVLFLIPKNNPPQLTGN 267
            WMAPE I    Y  ++D+WS GI   E+ + G  P   +      + + K+        
Sbjct: 232 -WMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGYQMAQPA 290
Query: 268 YT-KQFKEFVEACLNKDPENRPTAKELLKF 296
           +  K     ++AC   +P +RPT +++  F
Sbjct: 291 FAPKNIYSIMQACWALEPTHRPTFQQICSF 320

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 36/120 (30%), Positives = 65/120 (54%), Gaps = 3/120 (2%)
Query: 120 LWIIMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSE 179
           ++++ME +       +    + E M  + +L ++L G+ +LHS   +HRD+K +N+++  
Sbjct: 97  VYLVMELMDANLCQVIQMELDHERM--SYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS 154
Query: 180 MGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAK 239
              +K+ DFG+A T   T+     +V T ++ APEVI    Y    DIWS+G    E+ +
Sbjct: 155 DCTLKILDFGLART-AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVR 213

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 36/120 (30%), Positives = 65/120 (54%), Gaps = 3/120 (2%)
Query: 120 LWIIMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSE 179
           ++++ME +       +    + E M  + +L ++L G+ +LHS   +HRD+K +N+++  
Sbjct: 98  VYLVMELMDANLCQVIQMELDHERM--SYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS 155
Query: 180 MGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAK 239
              +K+ DFG+A T   T+     +V T ++ APEVI    Y    DIWS+G    E+ +
Sbjct: 156 DCTLKILDFGLART-AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVR 214

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 44/150 (29%), Positives = 75/150 (50%), Gaps = 6/150 (4%)
Query: 152 EVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTS---KRNTFVGTP 208
           +V +G+ +L S+  +HRD+ A NVLL+     K+ DFG+A  + N ++   K N  +   
Sbjct: 174 QVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVK 233
Query: 209 FWMAPEVIKQSAYDSKADIWSLGITAIEL-AKGEPPNSELHPMRVLFLIPKNNPPQLTGN 267
            WMAPE I    Y  ++D+WS GI   E+ + G  P   +      + + K+        
Sbjct: 234 -WMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGYQMAQPA 292
Query: 268 YT-KQFKEFVEACLNKDPENRPTAKELLKF 296
           +  K     ++AC   +P +RPT +++  F
Sbjct: 293 FAPKNIYSIMQACWALEPTHRPTFQQICSF 322

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 36/120 (30%), Positives = 65/120 (54%), Gaps = 3/120 (2%)
Query: 120 LWIIMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSE 179
           ++++ME +       +    + E M  + +L ++L G+ +LHS   +HRD+K +N+++  
Sbjct: 98  VYLVMELMDANLCQVIQMELDHERM--SYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS 155
Query: 180 MGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAK 239
              +K+ DFG+A T   T+     +V T ++ APEVI    Y    DIWS+G    E+ +
Sbjct: 156 DCTLKILDFGLART-AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVR 214

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 36/120 (30%), Positives = 65/120 (54%), Gaps = 3/120 (2%)
Query: 120 LWIIMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSE 179
           ++++ME +       +    + E M  + +L ++L G+ +LHS   +HRD+K +N+++  
Sbjct: 104 VYLVMELMDANLXQVIQMELDHERM--SYLLYQMLXGIKHLHSAGIIHRDLKPSNIVVKS 161
Query: 180 MGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAK 239
              +K+ DFG+A T   T+     +V T ++ APEVI    Y    DIWS+G    E+ +
Sbjct: 162 DXTLKILDFGLART-AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVR 220

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 44/150 (29%), Positives = 75/150 (50%), Gaps = 6/150 (4%)
Query: 152 EVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTS---KRNTFVGTP 208
           +V +G+ +L S+  +HRD+ A NVLL+     K+ DFG+A  + N ++   K N  +   
Sbjct: 168 QVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVK 227
Query: 209 FWMAPEVIKQSAYDSKADIWSLGITAIEL-AKGEPPNSELHPMRVLFLIPKNNPPQLTGN 267
            WMAPE I    Y  ++D+WS GI   E+ + G  P   +      + + K+        
Sbjct: 228 -WMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGYQMAQPA 286
Query: 268 YT-KQFKEFVEACLNKDPENRPTAKELLKF 296
           +  K     ++AC   +P +RPT +++  F
Sbjct: 287 FAPKNIYSIMQACWALEPTHRPTFQQICSF 316

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 36/120 (30%), Positives = 65/120 (54%), Gaps = 3/120 (2%)
Query: 120 LWIIMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSE 179
           ++++ME +       +    + E M  + +L ++L G+ +LHS   +HRD+K +N+++  
Sbjct: 104 VYLVMELMDANLXQVIQMELDHERM--SYLLYQMLXGIKHLHSAGIIHRDLKPSNIVVKS 161
Query: 180 MGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAK 239
              +K+ DFG+A T   T+     +V T ++ APEVI    Y    DIWS+G    E+ +
Sbjct: 162 DXTLKILDFGLART-AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVR 220

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 36/120 (30%), Positives = 65/120 (54%), Gaps = 3/120 (2%)
Query: 120 LWIIMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSE 179
           ++++ME +       +    + E M  + +L ++L G+ +LHS   +HRD+K +N+++  
Sbjct: 97  VYLVMELMDANLXQVIQMELDHERM--SYLLYQMLXGIKHLHSAGIIHRDLKPSNIVVKS 154
Query: 180 MGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAK 239
              +K+ DFG+A T   T+     +V T ++ APEVI    Y    DIWS+G    E+ +
Sbjct: 155 DXTLKILDFGLART-AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVR 213

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 69/291 (23%), Positives = 122/291 (41%), Gaps = 49/291 (16%)
Query: 41  GSTTASRRNSLKVDPELIFTKQERIGKGSFGEVFKGIDNRTQQVVXXXXXX------XXX 94
           GS     R     D E+ + KQ  IGKG FG V KG   + + VV               
Sbjct: 5   GSEFPKSRLPTLADNEIEYEKQ--IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETE 62
Query: 95  XXXXXXXXXXXXMVLSQCDSPYGTKLW--------IIMEYLGGGSALD--LMKAGNFEEM 144
                        ++S  + P   KL+        ++ME++  G      L KA   +  
Sbjct: 63  MIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPPRMVMEFVPCGDLYHRLLDKAHPIKWS 122
Query: 145 HIAVILREVLKGLDYLHSERK--LHRDIKAANVLLSEMGD-----VKLADFGVAGTLTNT 197
               ++ ++  G++Y+ ++    +HRD+++ N+ L  + +      K+ADF ++    ++
Sbjct: 123 VKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQQSVHS 182
Query: 198 TSKRNTFVGTPFWMAPEVI--KQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFL 255
            S     +G   WMAPE I  ++ +Y  KAD +S  +    +  GE P  E    ++ F+
Sbjct: 183 VS---GLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFI 239
Query: 256 -----------IPKNNPPQLTGNYTKQFKEFVEACLNKDPENRPTAKELLK 295
                      IP++ PP+L        +  +E C + DP+ RP    ++K
Sbjct: 240 NMIREEGLRPTIPEDCPPRL--------RNVIELCWSGDPKKRPHFSYIVK 282

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 44/150 (29%), Positives = 75/150 (50%), Gaps = 6/150 (4%)
Query: 152 EVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTS---KRNTFVGTP 208
           +V +G+ +L S+  +HRD+ A NVLL+     K+ DFG+A  + N ++   K N  +   
Sbjct: 160 QVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVK 219
Query: 209 FWMAPEVIKQSAYDSKADIWSLGITAIEL-AKGEPPNSELHPMRVLFLIPKNNPPQLTGN 267
            WMAPE I    Y  ++D+WS GI   E+ + G  P   +      + + K+        
Sbjct: 220 -WMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGYQMAQPA 278
Query: 268 YT-KQFKEFVEACLNKDPENRPTAKELLKF 296
           +  K     ++AC   +P +RPT +++  F
Sbjct: 279 FAPKNIYSIMQACWALEPTHRPTFQQICSF 308

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 47/173 (27%), Positives = 80/173 (46%), Gaps = 17/173 (9%)
Query: 135 LMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLS-EMGDVKLADFGVAGT 193
           + + G  +E        +VL+ + + H+   LHRDIK  N+L+    G++KL DFG    
Sbjct: 101 ITERGALQEELARSFFWQVLEAVRHCHNXGVLHRDIKDENILIDLNRGELKLIDFGSGAL 160
Query: 194 LTNTTSKRNTFVGTPFWMAPEVIKQSAYDSK-ADIWSLGITAIELAKGEPP---NSELHP 249
           L +T      F GT  +  PE I+   Y  + A +WSLGI   ++  G+ P   + E+  
Sbjct: 161 LKDTVY--TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIR 218
Query: 250 MRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPENRPTAKELLKFPFIRKA 302
            +V F              + + +  +  CL   P +RPT +E+   P+++  
Sbjct: 219 GQVFF----------RQRVSXECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 261

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 47/173 (27%), Positives = 80/173 (46%), Gaps = 17/173 (9%)
Query: 135 LMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLS-EMGDVKLADFGVAGT 193
           + + G  +E        +VL+ + + H+   LHRDIK  N+L+    G++KL DFG    
Sbjct: 106 ITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGAL 165
Query: 194 LTNTTSKRNTFVGTPFWMAPEVIKQSAYDSK-ADIWSLGITAIELAKGEPP---NSELHP 249
           L +T      F GT  +  PE I+   Y  + A +WSLGI   ++  G+ P   + E+  
Sbjct: 166 LKDTVY--TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIR 223
Query: 250 MRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPENRPTAKELLKFPFIRKA 302
            +V F              + + +  +  CL   P +RPT +E+   P+++  
Sbjct: 224 GQVFF----------RQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 266

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 44/150 (29%), Positives = 75/150 (50%), Gaps = 6/150 (4%)
Query: 152 EVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTS---KRNTFVGTP 208
           +V +G+ +L S+  +HRD+ A NVLL+     K+ DFG+A  + N ++   K N  +   
Sbjct: 166 QVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVK 225
Query: 209 FWMAPEVIKQSAYDSKADIWSLGITAIEL-AKGEPPNSELHPMRVLFLIPKNNPPQLTGN 267
            WMAPE I    Y  ++D+WS GI   E+ + G  P   +      + + K+        
Sbjct: 226 -WMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGYQMAQPA 284
Query: 268 YT-KQFKEFVEACLNKDPENRPTAKELLKF 296
           +  K     ++AC   +P +RPT +++  F
Sbjct: 285 FAPKNIYSIMQACWALEPTHRPTFQQICSF 314

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 47/173 (27%), Positives = 80/173 (46%), Gaps = 17/173 (9%)
Query: 135 LMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLS-EMGDVKLADFGVAGT 193
           + + G  +E        +VL+ + + H+   LHRDIK  N+L+    G++KL DFG    
Sbjct: 134 ITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGAL 193
Query: 194 LTNTTSKRNTFVGTPFWMAPEVIKQSAYDSK-ADIWSLGITAIELAKGEPP---NSELHP 249
           L +T      F GT  +  PE I+   Y  + A +WSLGI   ++  G+ P   + E+  
Sbjct: 194 LKDTVY--TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIG 251
Query: 250 MRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPENRPTAKELLKFPFIRKA 302
            +V F              + + +  +  CL   P +RPT +E+   P+++  
Sbjct: 252 GQVFF----------RQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 294

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 47/173 (27%), Positives = 80/173 (46%), Gaps = 17/173 (9%)
Query: 135 LMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLS-EMGDVKLADFGVAGT 193
           + + G  +E        +VL+ + + H+   LHRDIK  N+L+    G++KL DFG    
Sbjct: 121 ITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGAL 180
Query: 194 LTNTTSKRNTFVGTPFWMAPEVIKQSAYDSK-ADIWSLGITAIELAKGEPP---NSELHP 249
           L +T      F GT  +  PE I+   Y  + A +WSLGI   ++  G+ P   + E+  
Sbjct: 181 LKDTVY--TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIR 238
Query: 250 MRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPENRPTAKELLKFPFIRKA 302
            +V F              + + +  +  CL   P +RPT +E+   P+++  
Sbjct: 239 GQVFF----------RQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 281

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 47/173 (27%), Positives = 80/173 (46%), Gaps = 17/173 (9%)
Query: 135 LMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLS-EMGDVKLADFGVAGT 193
           + + G  +E        +VL+ + + H+   LHRDIK  N+L+    G++KL DFG    
Sbjct: 134 ITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGAL 193
Query: 194 LTNTTSKRNTFVGTPFWMAPEVIKQSAYDSK-ADIWSLGITAIELAKGEPP---NSELHP 249
           L +T      F GT  +  PE I+   Y  + A +WSLGI   ++  G+ P   + E+  
Sbjct: 194 LKDTVY--TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIG 251
Query: 250 MRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPENRPTAKELLKFPFIRKA 302
            +V F              + + +  +  CL   P +RPT +E+   P+++  
Sbjct: 252 GQVFF----------RQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 294

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 47/173 (27%), Positives = 80/173 (46%), Gaps = 17/173 (9%)
Query: 135 LMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLS-EMGDVKLADFGVAGT 193
           + + G  +E        +VL+ + + H+   LHRDIK  N+L+    G++KL DFG    
Sbjct: 140 ITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGAL 199
Query: 194 LTNTTSKRNTFVGTPFWMAPEVIKQSAYDSK-ADIWSLGITAIELAKGEPP---NSELHP 249
           L +T      F GT  +  PE I+   Y  + A +WSLGI   ++  G+ P   + E+  
Sbjct: 200 LKDTVY--TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIR 257
Query: 250 MRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPENRPTAKELLKFPFIRKA 302
            +V F              + + +  +  CL   P +RPT +E+   P+++  
Sbjct: 258 GQVFF----------RQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 300

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 47/173 (27%), Positives = 80/173 (46%), Gaps = 17/173 (9%)
Query: 135 LMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLS-EMGDVKLADFGVAGT 193
           + + G  +E        +VL+ + + H+   LHRDIK  N+L+    G++KL DFG    
Sbjct: 105 ITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGAL 164
Query: 194 LTNTTSKRNTFVGTPFWMAPEVIKQSAYDSK-ADIWSLGITAIELAKGEPP---NSELHP 249
           L +T      F GT  +  PE I+   Y  + A +WSLGI   ++  G+ P   + E+  
Sbjct: 165 LKDTVY--TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIR 222
Query: 250 MRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPENRPTAKELLKFPFIRKA 302
            +V F              + + +  +  CL   P +RPT +E+   P+++  
Sbjct: 223 GQVFF----------RQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 265

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 47/173 (27%), Positives = 80/173 (46%), Gaps = 17/173 (9%)
Query: 135 LMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLS-EMGDVKLADFGVAGT 193
           + + G  +E        +VL+ + + H+   LHRDIK  N+L+    G++KL DFG    
Sbjct: 120 ITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGAL 179
Query: 194 LTNTTSKRNTFVGTPFWMAPEVIKQSAYDSK-ADIWSLGITAIELAKGEPP---NSELHP 249
           L +T      F GT  +  PE I+   Y  + A +WSLGI   ++  G+ P   + E+  
Sbjct: 180 LKDTVY--TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIR 237
Query: 250 MRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPENRPTAKELLKFPFIRKA 302
            +V F              + + +  +  CL   P +RPT +E+   P+++  
Sbjct: 238 GQVFF----------RQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 280

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 47/173 (27%), Positives = 80/173 (46%), Gaps = 17/173 (9%)
Query: 135 LMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLS-EMGDVKLADFGVAGT 193
           + + G  +E        +VL+ + + H+   LHRDIK  N+L+    G++KL DFG    
Sbjct: 133 ITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGAL 192
Query: 194 LTNTTSKRNTFVGTPFWMAPEVIKQSAYDSK-ADIWSLGITAIELAKGEPP---NSELHP 249
           L +T      F GT  +  PE I+   Y  + A +WSLGI   ++  G+ P   + E+  
Sbjct: 193 LKDTVY--TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIG 250
Query: 250 MRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPENRPTAKELLKFPFIRKA 302
            +V F              + + +  +  CL   P +RPT +E+   P+++  
Sbjct: 251 GQVFF----------RQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 293

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 47/173 (27%), Positives = 80/173 (46%), Gaps = 17/173 (9%)
Query: 135 LMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLS-EMGDVKLADFGVAGT 193
           + + G  +E        +VL+ + + H+   LHRDIK  N+L+    G++KL DFG    
Sbjct: 106 ITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGAL 165
Query: 194 LTNTTSKRNTFVGTPFWMAPEVIKQSAYDSK-ADIWSLGITAIELAKGEPP---NSELHP 249
           L +T      F GT  +  PE I+   Y  + A +WSLGI   ++  G+ P   + E+  
Sbjct: 166 LKDTVY--TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIR 223
Query: 250 MRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPENRPTAKELLKFPFIRKA 302
            +V F              + + +  +  CL   P +RPT +E+   P+++  
Sbjct: 224 GQVFF----------RQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 266

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 47/173 (27%), Positives = 80/173 (46%), Gaps = 17/173 (9%)
Query: 135 LMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLS-EMGDVKLADFGVAGT 193
           + + G  +E        +VL+ + + H+   LHRDIK  N+L+    G++KL DFG    
Sbjct: 133 ITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGAL 192
Query: 194 LTNTTSKRNTFVGTPFWMAPEVIKQSAYDSK-ADIWSLGITAIELAKGEPP---NSELHP 249
           L +T      F GT  +  PE I+   Y  + A +WSLGI   ++  G+ P   + E+  
Sbjct: 193 LKDTVY--TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIG 250
Query: 250 MRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPENRPTAKELLKFPFIRKA 302
            +V F              + + +  +  CL   P +RPT +E+   P+++  
Sbjct: 251 GQVFF----------RQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 293

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 47/173 (27%), Positives = 80/173 (46%), Gaps = 17/173 (9%)
Query: 135 LMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLS-EMGDVKLADFGVAGT 193
           + + G  +E        +VL+ + + H+   LHRDIK  N+L+    G++KL DFG    
Sbjct: 105 ITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGAL 164
Query: 194 LTNTTSKRNTFVGTPFWMAPEVIKQSAYDSK-ADIWSLGITAIELAKGEPP---NSELHP 249
           L +T      F GT  +  PE I+   Y  + A +WSLGI   ++  G+ P   + E+  
Sbjct: 165 LKDTVY--TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIR 222
Query: 250 MRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPENRPTAKELLKFPFIRKA 302
            +V F              + + +  +  CL   P +RPT +E+   P+++  
Sbjct: 223 GQVFF----------RQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 265

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 47/173 (27%), Positives = 80/173 (46%), Gaps = 17/173 (9%)
Query: 135 LMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLS-EMGDVKLADFGVAGT 193
           + + G  +E        +VL+ + + H+   LHRDIK  N+L+    G++KL DFG    
Sbjct: 134 ITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGAL 193
Query: 194 LTNTTSKRNTFVGTPFWMAPEVIKQSAYDSK-ADIWSLGITAIELAKGEPP---NSELHP 249
           L +T      F GT  +  PE I+   Y  + A +WSLGI   ++  G+ P   + E+  
Sbjct: 194 LKDTVY--TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIG 251
Query: 250 MRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPENRPTAKELLKFPFIRKA 302
            +V F              + + +  +  CL   P +RPT +E+   P+++  
Sbjct: 252 GQVFF----------RQRVSXECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 294

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 47/173 (27%), Positives = 80/173 (46%), Gaps = 17/173 (9%)
Query: 135 LMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLS-EMGDVKLADFGVAGT 193
           + + G  +E        +VL+ + + H+   LHRDIK  N+L+    G++KL DFG    
Sbjct: 133 ITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGAL 192
Query: 194 LTNTTSKRNTFVGTPFWMAPEVIKQSAYDSK-ADIWSLGITAIELAKGEPP---NSELHP 249
           L +T      F GT  +  PE I+   Y  + A +WSLGI   ++  G+ P   + E+  
Sbjct: 193 LKDTVY--TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIG 250
Query: 250 MRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPENRPTAKELLKFPFIRKA 302
            +V F              + + +  +  CL   P +RPT +E+   P+++  
Sbjct: 251 GQVFF----------RQRVSXECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 293

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 47/173 (27%), Positives = 80/173 (46%), Gaps = 17/173 (9%)
Query: 135 LMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLS-EMGDVKLADFGVAGT 193
           + + G  +E        +VL+ + + H+   LHRDIK  N+L+    G++KL DFG    
Sbjct: 134 ITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGAL 193
Query: 194 LTNTTSKRNTFVGTPFWMAPEVIKQSAYDSK-ADIWSLGITAIELAKGEPP---NSELHP 249
           L +T      F GT  +  PE I+   Y  + A +WSLGI   ++  G+ P   + E+  
Sbjct: 194 LKDTVY--TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIG 251
Query: 250 MRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPENRPTAKELLKFPFIRKA 302
            +V F              + + +  +  CL   P +RPT +E+   P+++  
Sbjct: 252 GQVFF----------RQRVSXECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 294

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 36/120 (30%), Positives = 65/120 (54%), Gaps = 3/120 (2%)
Query: 120 LWIIMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSE 179
           ++++ME +       +    + E M  + +L ++L G+ +LHS   +HRD+K +N+++  
Sbjct: 104 VYLVMELMDANLCQVIQMELDHERM--SYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS 161
Query: 180 MGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAK 239
              +K+ DFG+A T   T+     +V T ++ APEVI    Y    DIWS+G    E+ +
Sbjct: 162 DXTLKILDFGLART-AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVR 220

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 47/173 (27%), Positives = 80/173 (46%), Gaps = 17/173 (9%)
Query: 135 LMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLS-EMGDVKLADFGVAGT 193
           + + G  +E        +VL+ + + H+   LHRDIK  N+L+    G++KL DFG    
Sbjct: 121 ITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGAL 180
Query: 194 LTNTTSKRNTFVGTPFWMAPEVIKQSAYDSK-ADIWSLGITAIELAKGEPP---NSELHP 249
           L +T      F GT  +  PE I+   Y  + A +WSLGI   ++  G+ P   + E+  
Sbjct: 181 LKDTVY--TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIR 238
Query: 250 MRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPENRPTAKELLKFPFIRKA 302
            +V F              + + +  +  CL   P +RPT +E+   P+++  
Sbjct: 239 GQVFF----------RQRVSXECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 281

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 46/194 (23%), Positives = 84/194 (43%), Gaps = 21/194 (10%)
Query: 120 LWIIMEYLGGGSALDLMK-----------------AGNFEEMHIAVILREVLKGLDYLHS 162
           L++ +EY   G+ LD ++                 A       +     +V +G+DYL  
Sbjct: 91  LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ 150
Query: 163 ERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPF-WMAPEVIKQSAY 221
           ++ +HRD+ A N+L+ E    K+ADFG+  +       + T    P  WMA E +  S Y
Sbjct: 151 KQFIHRDLAARNILVGENYVAKIADFGL--SRGQEVYVKKTMGRLPVRWMAIESLNYSVY 208
Query: 222 DSKADIWSLGITAIELAK-GEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACL 280
            + +D+WS G+   E+   G  P   +    +   +P+    +   N   +  + +  C 
Sbjct: 209 TTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCW 268
Query: 281 NKDPENRPTAKELL 294
            + P  RP+  ++L
Sbjct: 269 REKPYERPSFAQIL 282

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 47/173 (27%), Positives = 80/173 (46%), Gaps = 17/173 (9%)
Query: 135 LMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLS-EMGDVKLADFGVAGT 193
           + + G  +E        +VL+ + + H+   LHRDIK  N+L+    G++KL DFG    
Sbjct: 133 ITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGAL 192
Query: 194 LTNTTSKRNTFVGTPFWMAPEVIKQSAYDSK-ADIWSLGITAIELAKGEPP---NSELHP 249
           L +T      F GT  +  PE I+   Y  + A +WSLGI   ++  G+ P   + E+  
Sbjct: 193 LKDTVY--TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIR 250
Query: 250 MRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPENRPTAKELLKFPFIRKA 302
            +V F              + + +  +  CL   P +RPT +E+   P+++  
Sbjct: 251 GQVFF----------RQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 293

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 36/119 (30%), Positives = 64/119 (53%), Gaps = 3/119 (2%)
Query: 120 LWIIMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSE 179
           ++I+ME +       +    + E M  + +L ++L G+ +LHS   +HRD+K +N+++  
Sbjct: 109 VYIVMELMDANLCQVIQMELDHERM--SYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS 166
Query: 180 MGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELA 238
              +K+ DFG+A T   T+     +V T ++ APEVI    Y    D+WS+G    E+ 
Sbjct: 167 DCTLKILDFGLART-AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDLWSVGCIMGEMV 224

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 47/173 (27%), Positives = 80/173 (46%), Gaps = 17/173 (9%)
Query: 135 LMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLS-EMGDVKLADFGVAGT 193
           + + G  +E        +VL+ + + H+   LHRDIK  N+L+    G++KL DFG    
Sbjct: 120 ITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGAL 179
Query: 194 LTNTTSKRNTFVGTPFWMAPEVIKQSAYDSK-ADIWSLGITAIELAKGEPP---NSELHP 249
           L +T      F GT  +  PE I+   Y  + A +WSLGI   ++  G+ P   + E+  
Sbjct: 180 LKDTVY--TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIR 237
Query: 250 MRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPENRPTAKELLKFPFIRKA 302
            +V F              + + +  +  CL   P +RPT +E+   P+++  
Sbjct: 238 GQVFF----------RQRVSXECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 280

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 47/173 (27%), Positives = 80/173 (46%), Gaps = 17/173 (9%)
Query: 135 LMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLS-EMGDVKLADFGVAGT 193
           + + G  +E        +VL+ + + H+   LHRDIK  N+L+    G++KL DFG    
Sbjct: 153 ITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGAL 212
Query: 194 LTNTTSKRNTFVGTPFWMAPEVIKQSAYDSK-ADIWSLGITAIELAKGEPP---NSELHP 249
           L +T      F GT  +  PE I+   Y  + A +WSLGI   ++  G+ P   + E+  
Sbjct: 213 LKDTVY--TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIR 270
Query: 250 MRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPENRPTAKELLKFPFIRKA 302
            +V F              + + +  +  CL   P +RPT +E+   P+++  
Sbjct: 271 GQVFF----------RQRVSXECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 313

>pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 69/286 (24%), Positives = 118/286 (41%), Gaps = 50/286 (17%)
Query: 59  FTKQERIGKGSFGEVFKGIDNRTQQVVXXXXX----XXXXXXXXXXXXXXXXMVLSQCD- 113
           F + E+IG G FG VFK +      +                           VL Q   
Sbjct: 9   FHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSH 68
Query: 114 -----SPYGT--KLWIIMEYLGGGSALDLMK-----AGNFEEMHIAVILREVLKGLDYLH 161
                S +     + I  EY  GGS  D +         F+E  +  +L +V +GL Y+H
Sbjct: 69  VVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH 128
Query: 162 SERKLHRDIKAANVLL---------SEMGD----------VKLADFGVAGTLTNTTSKRN 202
           S   +H DIK +N+ +         SE GD           K+ D G    +++   +  
Sbjct: 129 SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQVEE- 187
Query: 203 TFVGTPFWMAPEVIKQS-AYDSKADIWSLGITAIELAKGEP---PNSELHPMRVLFLIPK 258
              G   ++A EV++++  +  KADI++L +T +  A  EP      + H +R      +
Sbjct: 188 ---GDSRFLANEVLQENYTHLPKADIFALALTVVXAAGAEPLPRNGDQWHEIR------Q 238
Query: 259 NNPPQLTGNYTKQFKEFVEACLNKDPENRPTAKELLKFPFIRKAKK 304
              P++    +++F E ++  ++ DPE RP+A  L+K   +  A +
Sbjct: 239 GRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSASR 284

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 48/197 (24%), Positives = 86/197 (43%), Gaps = 27/197 (13%)
Query: 120 LWIIMEYLGGGSALDLMKAGNFEE--------------------MHIAVILREVLKGLDY 159
           L++ +EY   G+ LD ++     E                    +H A    +V +G+DY
Sbjct: 101 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA---DVARGMDY 157
Query: 160 LHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPF-WMAPEVIKQ 218
           L  ++ +HRD+ A N+L+ E    K+ADFG+  +       + T    P  WMA E +  
Sbjct: 158 LSQKQFIHRDLAARNILVGENYVAKIADFGL--SRGQEVYVKKTMGRLPVRWMAIESLNY 215
Query: 219 SAYDSKADIWSLGITAIELAK-GEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVE 277
           S Y + +D+WS G+   E+   G  P   +    +   +P+    +   N   +  + + 
Sbjct: 216 SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLNCDDEVYDLMR 275
Query: 278 ACLNKDPENRPTAKELL 294
            C  + P  RP+  ++L
Sbjct: 276 QCWREKPYERPSFAQIL 292

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 47/173 (27%), Positives = 80/173 (46%), Gaps = 17/173 (9%)
Query: 135 LMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLS-EMGDVKLADFGVAGT 193
           + + G  +E        +VL+ + + H+   LHRDIK  N+L+    G++KL DFG    
Sbjct: 148 ITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGAL 207
Query: 194 LTNTTSKRNTFVGTPFWMAPEVIKQSAYDSK-ADIWSLGITAIELAKGEPP---NSELHP 249
           L +T      F GT  +  PE I+   Y  + A +WSLGI   ++  G+ P   + E+  
Sbjct: 208 LKDTVY--TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIR 265
Query: 250 MRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPENRPTAKELLKFPFIRKA 302
            +V F              + + +  +  CL   P +RPT +E+   P+++  
Sbjct: 266 GQVFF----------RQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 308

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 47/173 (27%), Positives = 80/173 (46%), Gaps = 17/173 (9%)
Query: 135 LMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLS-EMGDVKLADFGVAGT 193
           + + G  +E        +VL+ + + H+   LHRDIK  N+L+    G++KL DFG    
Sbjct: 121 ITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGAL 180
Query: 194 LTNTTSKRNTFVGTPFWMAPEVIKQSAYDSK-ADIWSLGITAIELAKGEPP---NSELHP 249
           L +T      F GT  +  PE I+   Y  + A +WSLGI   ++  G+ P   + E+  
Sbjct: 181 LKDTVY--TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIR 238
Query: 250 MRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPENRPTAKELLKFPFIRKA 302
            +V F              + + +  +  CL   P +RPT +E+   P+++  
Sbjct: 239 GQVFF----------RQRVSXECQHLIRWCLALRPXDRPTFEEIQNHPWMQDV 281

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 47/173 (27%), Positives = 80/173 (46%), Gaps = 17/173 (9%)
Query: 135 LMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLS-EMGDVKLADFGVAGT 193
           + + G  +E        +VL+ + + H+   LHRDIK  N+L+    G++KL DFG    
Sbjct: 106 ITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGAL 165
Query: 194 LTNTTSKRNTFVGTPFWMAPEVIKQSAYDSK-ADIWSLGITAIELAKGEPP---NSELHP 249
           L +T      F GT  +  PE I+   Y  + A +WSLGI   ++  G+ P   + E+  
Sbjct: 166 LKDTVY--TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIR 223
Query: 250 MRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPENRPTAKELLKFPFIRKA 302
            +V F              + + +  +  CL   P +RPT +E+   P+++  
Sbjct: 224 GQVFF----------RQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 266

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 36/119 (30%), Positives = 64/119 (53%), Gaps = 3/119 (2%)
Query: 120 LWIIMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSE 179
           ++I+ME +       +    + E M  + +L ++L G+ +LHS   +HRD+K +N+++  
Sbjct: 98  VYIVMELMDANLCQVIQMELDHERM--SYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS 155
Query: 180 MGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELA 238
              +K+ DFG+A T   T+     +V T ++ APEVI    Y    D+WS+G    E+ 
Sbjct: 156 DCTLKILDFGLART-AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDLWSVGCIMGEMV 213

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 47/173 (27%), Positives = 80/173 (46%), Gaps = 17/173 (9%)
Query: 135 LMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLS-EMGDVKLADFGVAGT 193
           + + G  +E        +VL+ + + H+   LHRDIK  N+L+    G++KL DFG    
Sbjct: 101 ITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGAL 160
Query: 194 LTNTTSKRNTFVGTPFWMAPEVIKQSAYDSK-ADIWSLGITAIELAKGEPP---NSELHP 249
           L +T      F GT  +  PE I+   Y  + A +WSLGI   ++  G+ P   + E+  
Sbjct: 161 LKDTVY--TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIG 218
Query: 250 MRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPENRPTAKELLKFPFIRKA 302
            +V F              + + +  +  CL   P +RPT +E+   P+++  
Sbjct: 219 GQVFF----------RQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 261

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 43/165 (26%), Positives = 82/165 (49%), Gaps = 16/165 (9%)
Query: 151 REVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLT--NTTSKRNTFVGTP 208
           + +L+ +  +H    +H D+K AN L+ + G +KL DFG+A  +    T+  +++ VG  
Sbjct: 162 KNMLEAVHTIHQHGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGAV 220
Query: 209 FWMAPEVIKQSA-----------YDSKADIWSLGITAIELAKGEPPNSEL--HPMRVLFL 255
            +M PE IK  +              K+D+WSLG     +  G+ P  ++     ++  +
Sbjct: 221 NYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAI 280
Query: 256 IPKNNPPQLTGNYTKQFKEFVEACLNKDPENRPTAKELLKFPFIR 300
           I  N+  +      K  ++ ++ CL +DP+ R +  ELL  P+++
Sbjct: 281 IDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ 325

>pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 47/173 (27%), Positives = 80/173 (46%), Gaps = 17/173 (9%)
Query: 135 LMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLS-EMGDVKLADFGVAGT 193
           + + G  +E        +VL+ + + H+   LHRDIK  N+L+    G++KL DFG    
Sbjct: 148 ITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGAL 207
Query: 194 LTNTTSKRNTFVGTPFWMAPEVIKQSAYDSK-ADIWSLGITAIELAKGEPP---NSELHP 249
           L +T      F GT  +  PE I+   Y  + A +WSLGI   ++  G+ P   + E+  
Sbjct: 208 LKDTVY--TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIR 265
Query: 250 MRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPENRPTAKELLKFPFIRKA 302
            +V F              + + +  +  CL   P +RPT +E+   P+++  
Sbjct: 266 GQVFF----------RQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 308

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 47/173 (27%), Positives = 80/173 (46%), Gaps = 17/173 (9%)
Query: 135 LMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLS-EMGDVKLADFGVAGT 193
           + + G  +E        +VL+ + + H+   LHRDIK  N+L+    G++KL DFG    
Sbjct: 104 ITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGAL 163
Query: 194 LTNTTSKRNTFVGTPFWMAPEVIKQSAYDSK-ADIWSLGITAIELAKGEPP---NSELHP 249
           L +T      F GT  +  PE I+   Y  + A +WSLGI   ++  G+ P   + E+  
Sbjct: 164 LKDTVY--TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIR 221
Query: 250 MRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPENRPTAKELLKFPFIRKA 302
            +V F              + + +  +  CL   P +RPT +E+   P+++  
Sbjct: 222 GQVFF----------RQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 264

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 47/173 (27%), Positives = 80/173 (46%), Gaps = 17/173 (9%)
Query: 135 LMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLS-EMGDVKLADFGVAGT 193
           + + G  +E        +VL+ + + H+   LHRDIK  N+L+    G++KL DFG    
Sbjct: 101 ITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGAL 160
Query: 194 LTNTTSKRNTFVGTPFWMAPEVIKQSAYDSK-ADIWSLGITAIELAKGEPP---NSELHP 249
           L +T      F GT  +  PE I+   Y  + A +WSLGI   ++  G+ P   + E+  
Sbjct: 161 LKDTVY--TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIR 218
Query: 250 MRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPENRPTAKELLKFPFIRKA 302
            +V F              + + +  +  CL   P +RPT +E+   P+++  
Sbjct: 219 GQVFF----------RQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 261

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 54/191 (28%), Positives = 95/191 (49%), Gaps = 29/191 (15%)
Query: 149 ILREVLKGLDYLHSERKLHRDIKAANVLLS---EMGDVK--LADFGVAGTLT---NTTSK 200
           +L++   GL +LHS   +HRD+K  N+L+S     G +K  ++DFG+   L    ++ S+
Sbjct: 123 LLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSR 182
Query: 201 RNTFVGTPFWMAPEVIKQSAYDS---KADIWSLG-ITAIELAKGEPP---------NSEL 247
           R+   GT  W+APE++ +   ++     DI+S G +    +++G  P         N  L
Sbjct: 183 RSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILL 242
Query: 248 HPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPENRPTAKELLKFPFIRKAKKN-A 306
               +  L P+ +   +        +E +E  +  DP+ RP+AK +LK PF    +K   
Sbjct: 243 GACSLDCLHPEKHEDVIA-------RELIEKMIAMDPQKRPSAKHVLKHPFFWSLEKQLQ 295
Query: 307 YLIDLIDRYKK 317
           +  D+ DR +K
Sbjct: 296 FFQDVSDRIEK 306

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 36/120 (30%), Positives = 65/120 (54%), Gaps = 3/120 (2%)
Query: 120 LWIIMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSE 179
           ++++ME +       +    + E M  + +L ++L G+ +LHS   +HRD+K +N+++  
Sbjct: 104 VYLVMELMDANLXQVIQMELDHERM--SYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS 161
Query: 180 MGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAK 239
              +K+ DFG+A T   T+     +V T ++ APEVI    Y    DIWS+G    E+ +
Sbjct: 162 DXTLKILDFGLART-AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVR 220

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 47/173 (27%), Positives = 80/173 (46%), Gaps = 17/173 (9%)
Query: 135 LMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLS-EMGDVKLADFGVAGT 193
           + + G  +E        +VL+ + + H+   LHRDIK  N+L+    G++KL DFG    
Sbjct: 148 ITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGAL 207
Query: 194 LTNTTSKRNTFVGTPFWMAPEVIKQSAYDSK-ADIWSLGITAIELAKGEPP---NSELHP 249
           L +T      F GT  +  PE I+   Y  + A +WSLGI   ++  G+ P   + E+  
Sbjct: 208 LKDTVY--TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIR 265
Query: 250 MRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPENRPTAKELLKFPFIRKA 302
            +V F              + + +  +  CL   P +RPT +E+   P+++  
Sbjct: 266 GQVFF----------RQRVSXECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 308

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 47/173 (27%), Positives = 80/173 (46%), Gaps = 17/173 (9%)
Query: 135 LMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLS-EMGDVKLADFGVAGT 193
           + + G  +E        +VL+ + + H+   LHRDIK  N+L+    G++KL DFG    
Sbjct: 128 ITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGAL 187
Query: 194 LTNTTSKRNTFVGTPFWMAPEVIKQSAYDSK-ADIWSLGITAIELAKGEPP---NSELHP 249
           L +T      F GT  +  PE I+   Y  + A +WSLGI   ++  G+ P   + E+  
Sbjct: 188 LKDTVY--TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIR 245
Query: 250 MRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPENRPTAKELLKFPFIRKA 302
            +V F              + + +  +  CL   P +RPT +E+   P+++  
Sbjct: 246 GQVFF----------RQRVSXECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 288

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 40/145 (27%), Positives = 70/145 (48%), Gaps = 3/145 (2%)
Query: 148 VILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNT-TSKRNTFVG 206
            I R+V  G+ YL   + +HRD+   N L+ E   VK+ADFG++  + +    K +    
Sbjct: 178 CIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDA 237
Query: 207 TPF-WMAPEVIKQSAYDSKADIWSLGITAIEL-AKGEPPNSELHPMRVLFLIPKNNPPQL 264
            P  WM PE I  + Y +++D+W+ G+   E+ + G  P   +    V++ +   N    
Sbjct: 238 IPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGNILAC 297
Query: 265 TGNYTKQFKEFVEACLNKDPENRPT 289
             N   +    +  C +K P +RP+
Sbjct: 298 PENCPLELYNLMRLCWSKLPADRPS 322

>pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 53/197 (26%), Positives = 86/197 (43%), Gaps = 23/197 (11%)
Query: 65  IGKGSFGEVFKGIDNRTQQVVXXXXXXXXXXXXXXXXXXXXXM-------------VLSQ 111
           IGKGSFG+V K  D++  Q V                     +             V+  
Sbjct: 105 IGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHM 164
Query: 112 CDSPYGTKLWIIMEY-LGGGSALDLMKAGNFEEMHIAVILR---EVLKGLDYLHSERKLH 167
            ++ +  +  I M + L   +  +L+K   F+   + ++ +    +L+ LD LH  R +H
Sbjct: 165 LEN-FTFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIH 223
Query: 168 RDIKAANVLLSEMG--DVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKA 225
            D+K  N+LL + G   +K+ DFG +        +  T + + F+ APEVI  + Y    
Sbjct: 224 CDLKPENILLKQQGRSGIKVIDFGSS---CYEHQRVYTXIQSRFYRAPEVILGARYGMPI 280
Query: 226 DIWSLGITAIELAKGEP 242
           D+WSLG    EL  G P
Sbjct: 281 DMWSLGCILAELLTGYP 297

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 89/219 (40%), Gaps = 41/219 (18%)
Query: 59  FTKQERIGKGSFGEVFKGIDNRTQQVVXXXXXXXXXXXXXXXXXXXXXM-VLSQCDSPYG 117
           +  +  IG+GS+G V+   D  T++ V                     + +L++  S Y 
Sbjct: 28  YIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYI 87
Query: 118 TKLW---------------IIMEYLGGGSALDLMKAGNF-EEMHIAVILREVLKGLDYLH 161
            +L+               I++E +       L K   F  E HI  IL  +L G +++H
Sbjct: 88  IRLYDLIIPDDLLKFDELYIVLE-IADSDLKKLFKTPIFLTEEHIKTILYNLLLGENFIH 146
Query: 162 SERKLHRDIKAANVLLSEMGDVKLADFGVAGTLT----------------------NTTS 199
               +HRD+K AN LL++   VK+ DFG+A T+                       N   
Sbjct: 147 ESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKK 206
Query: 200 KRNTFVGTPFWMAPEVI-KQSAYDSKADIWSLGITAIEL 237
           +  + V T ++ APE+I  Q  Y    DIWS G    EL
Sbjct: 207 QLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAEL 245

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 38/147 (25%), Positives = 76/147 (51%), Gaps = 3/147 (2%)
Query: 152 EVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTS--KRNTFVGTPF 209
           ++ +G+ YL   + +HRD+ A N+L++E   +K++DFG++  +    S  KR+       
Sbjct: 158 QISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSXVKRSQGRIPVK 217
Query: 210 WMAPEVIKQSAYDSKADIWSLGITAIELAK-GEPPNSELHPMRVLFLIPKNNPPQLTGNY 268
           WMA E +    Y +++D+WS G+   E+   G  P   + P R+  L+   +  +   N 
Sbjct: 218 WMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERLFNLLKTGHRMERPDNC 277
Query: 269 TKQFKEFVEACLNKDPENRPTAKELLK 295
           +++    +  C  ++P+ RP   ++ K
Sbjct: 278 SEEMYRLMLQCWKQEPDKRPVFADISK 304

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 38/147 (25%), Positives = 76/147 (51%), Gaps = 3/147 (2%)
Query: 152 EVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTS--KRNTFVGTPF 209
           ++ +G+ YL   + +HRD+ A N+L++E   +K++DFG++  +    S  KR+       
Sbjct: 158 QISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVK 217
Query: 210 WMAPEVIKQSAYDSKADIWSLGITAIELAK-GEPPNSELHPMRVLFLIPKNNPPQLTGNY 268
           WMA E +    Y +++D+WS G+   E+   G  P   + P R+  L+   +  +   N 
Sbjct: 218 WMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERLFNLLKTGHRMERPDNC 277
Query: 269 TKQFKEFVEACLNKDPENRPTAKELLK 295
           +++    +  C  ++P+ RP   ++ K
Sbjct: 278 SEEMYRLMLQCWKQEPDKRPVFADISK 304

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 42/148 (28%), Positives = 73/148 (49%), Gaps = 5/148 (3%)
Query: 152 EVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTN---TTSKRNTFVGTP 208
           +V KG+ +L S++ +HRD+ A N +L E   VK+ADFG+A  + +    +    T    P
Sbjct: 200 QVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLP 259
Query: 209 F-WMAPEVIKQSAYDSKADIWSLGITAIEL-AKGEPPNSELHPMRVLFLIPKNNPPQLTG 266
             WMA E ++   + +K+D+WS G+   EL  +G PP  +++   +   + +        
Sbjct: 260 VKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPE 319
Query: 267 NYTKQFKEFVEACLNKDPENRPTAKELL 294
                  E +  C +   E RP+  EL+
Sbjct: 320 YCPDPLYEVMLKCWHPKAEMRPSFSELV 347

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 42/148 (28%), Positives = 73/148 (49%), Gaps = 5/148 (3%)
Query: 152 EVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTN---TTSKRNTFVGTP 208
           +V KG+ +L S++ +HRD+ A N +L E   VK+ADFG+A  + +    +    T    P
Sbjct: 142 QVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNKTGAKLP 201
Query: 209 F-WMAPEVIKQSAYDSKADIWSLGITAIEL-AKGEPPNSELHPMRVLFLIPKNNPPQLTG 266
             WMA E ++   + +K+D+WS G+   EL  +G PP  +++   +   + +        
Sbjct: 202 VKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPE 261
Query: 267 NYTKQFKEFVEACLNKDPENRPTAKELL 294
                  E +  C +   E RP+  EL+
Sbjct: 262 YCPDPLYEVMLKCWHPKAEMRPSFSELV 289

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 42/148 (28%), Positives = 73/148 (49%), Gaps = 5/148 (3%)
Query: 152 EVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTN---TTSKRNTFVGTP 208
           +V KG+ +L S++ +HRD+ A N +L E   VK+ADFG+A  + +    +    T    P
Sbjct: 141 QVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLP 200
Query: 209 F-WMAPEVIKQSAYDSKADIWSLGITAIEL-AKGEPPNSELHPMRVLFLIPKNNPPQLTG 266
             WMA E ++   + +K+D+WS G+   EL  +G PP  +++   +   + +        
Sbjct: 201 VKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPE 260
Query: 267 NYTKQFKEFVEACLNKDPENRPTAKELL 294
                  E +  C +   E RP+  EL+
Sbjct: 261 YCPDPLYEVMLKCWHPKAEMRPSFSELV 288

>pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 69/286 (24%), Positives = 118/286 (41%), Gaps = 50/286 (17%)
Query: 59  FTKQERIGKGSFGEVFKGIDNRTQQVVXXXXX----XXXXXXXXXXXXXXXXMVLSQCD- 113
           F + E+IG G FG VFK +      +                           VL Q   
Sbjct: 11  FHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSH 70
Query: 114 -----SPYGT--KLWIIMEYLGGGSALDLMK-----AGNFEEMHIAVILREVLKGLDYLH 161
                S +     + I  EY  GGS  D +         F+E  +  +L +V +GL Y+H
Sbjct: 71  VVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH 130
Query: 162 SERKLHRDIKAANVLL---------SEMGD----------VKLADFGVAGTLTNTTSKRN 202
           S   +H DIK +N+ +         SE GD           K+ D G    +++   +  
Sbjct: 131 SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQVEE- 189
Query: 203 TFVGTPFWMAPEVIKQS-AYDSKADIWSLGITAIELAKGEP---PNSELHPMRVLFLIPK 258
              G   ++A EV++++  +  KADI++L +T +  A  EP      + H +R      +
Sbjct: 190 ---GDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWHEIR------Q 240
Query: 259 NNPPQLTGNYTKQFKEFVEACLNKDPENRPTAKELLKFPFIRKAKK 304
              P++    +++F E ++  ++ DPE RP+A  L+K   +  A +
Sbjct: 241 GRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSASR 286

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 63/244 (25%), Positives = 93/244 (38%), Gaps = 41/244 (16%)
Query: 59  FTKQERIGKGSFGEVFKGIDNRTQQVVXXXXXXXXXXXXXXXXXXXXXMVLSQCDSPYGT 118
           +  +ER+G G FG V + I   T + V                      ++ + + P   
Sbjct: 17  WEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVV 76
Query: 119 ----------KL------WIIMEYLGGGSALDLMKAGN-------FEEMHIAVILREVLK 155
                     KL       + MEY  GG   DL K  N        +E  I  +L ++  
Sbjct: 77  SAREVPDGLQKLAPNDLPLLAMEYCEGG---DLRKYLNQFENCCGLKEGPIRTLLSDISS 133
Query: 156 GLDYLHSERKLHRDIKAANVLLS---EMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMA 212
            L YLH  R +HRD+K  N++L    +    K+ D G A  L +       FVGT  ++A
Sbjct: 134 ALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKEL-DQGELCTEFVGTLQYLA 192
Query: 213 PEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQF 272
           PE+++Q  Y    D WS G  A E   G  P            +P   P Q  G   ++ 
Sbjct: 193 PELLEQKKYTVTVDYWSFGTLAFECITGFRP-----------FLPNWQPVQWHGKVREKS 241
Query: 273 KEFV 276
            E +
Sbjct: 242 NEHI 245

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 42/148 (28%), Positives = 73/148 (49%), Gaps = 5/148 (3%)
Query: 152 EVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTN---TTSKRNTFVGTP 208
           +V KG+ +L S++ +HRD+ A N +L E   VK+ADFG+A  + +    +    T    P
Sbjct: 146 QVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLP 205
Query: 209 F-WMAPEVIKQSAYDSKADIWSLGITAIEL-AKGEPPNSELHPMRVLFLIPKNNPPQLTG 266
             WMA E ++   + +K+D+WS G+   EL  +G PP  +++   +   + +        
Sbjct: 206 VKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPE 265
Query: 267 NYTKQFKEFVEACLNKDPENRPTAKELL 294
                  E +  C +   E RP+  EL+
Sbjct: 266 YCPDPLYEVMLKCWHPKAEMRPSFSELV 293

>pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 69/286 (24%), Positives = 118/286 (41%), Gaps = 50/286 (17%)
Query: 59  FTKQERIGKGSFGEVFKGIDNRTQQVVXXXXX----XXXXXXXXXXXXXXXXMVLSQCD- 113
           F + E+IG G FG VFK +      +                           VL Q   
Sbjct: 13  FHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSH 72
Query: 114 -----SPYGT--KLWIIMEYLGGGSALDLMK-----AGNFEEMHIAVILREVLKGLDYLH 161
                S +     + I  EY  GGS  D +         F+E  +  +L +V +GL Y+H
Sbjct: 73  VVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH 132
Query: 162 SERKLHRDIKAANVLL---------SEMGD----------VKLADFGVAGTLTNTTSKRN 202
           S   +H DIK +N+ +         SE GD           K+ D G    +++   +  
Sbjct: 133 SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQVEE- 191
Query: 203 TFVGTPFWMAPEVIKQS-AYDSKADIWSLGITAIELAKGEP---PNSELHPMRVLFLIPK 258
              G   ++A EV++++  +  KADI++L +T +  A  EP      + H +R      +
Sbjct: 192 ---GDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWHEIR------Q 242
Query: 259 NNPPQLTGNYTKQFKEFVEACLNKDPENRPTAKELLKFPFIRKAKK 304
              P++    +++F E ++  ++ DPE RP+A  L+K   +  A +
Sbjct: 243 GRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSASR 288

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 63/244 (25%), Positives = 93/244 (38%), Gaps = 41/244 (16%)
Query: 59  FTKQERIGKGSFGEVFKGIDNRTQQVVXXXXXXXXXXXXXXXXXXXXXMVLSQCDSPYGT 118
           +  +ER+G G FG V + I   T + V                      ++ + + P   
Sbjct: 16  WEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVV 75
Query: 119 ----------KL------WIIMEYLGGGSALDLMKAGN-------FEEMHIAVILREVLK 155
                     KL       + MEY  GG   DL K  N        +E  I  +L ++  
Sbjct: 76  SAREVPDGLQKLAPNDLPLLAMEYCEGG---DLRKYLNQFENCCGLKEGPIRTLLSDISS 132
Query: 156 GLDYLHSERKLHRDIKAANVLLS---EMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMA 212
            L YLH  R +HRD+K  N++L    +    K+ D G A  L +       FVGT  ++A
Sbjct: 133 ALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKEL-DQGELCTEFVGTLQYLA 191
Query: 213 PEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQF 272
           PE+++Q  Y    D WS G  A E   G  P            +P   P Q  G   ++ 
Sbjct: 192 PELLEQKKYTVTVDYWSFGTLAFECITGFRP-----------FLPNWQPVQWHGKVREKS 240
Query: 273 KEFV 276
            E +
Sbjct: 241 NEHI 244

>pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 69/286 (24%), Positives = 118/286 (41%), Gaps = 50/286 (17%)
Query: 59  FTKQERIGKGSFGEVFKGIDNRTQQVVXXXXX----XXXXXXXXXXXXXXXXMVLSQCD- 113
           F + E+IG G FG VFK +      +                           VL Q   
Sbjct: 11  FHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSH 70
Query: 114 -----SPYGT--KLWIIMEYLGGGSALDLMK-----AGNFEEMHIAVILREVLKGLDYLH 161
                S +     + I  EY  GGS  D +         F+E  +  +L +V +GL Y+H
Sbjct: 71  VVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH 130
Query: 162 SERKLHRDIKAANVLL---------SEMGD----------VKLADFGVAGTLTNTTSKRN 202
           S   +H DIK +N+ +         SE GD           K+ D G    +++   +  
Sbjct: 131 SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQVEE- 189
Query: 203 TFVGTPFWMAPEVIKQS-AYDSKADIWSLGITAIELAKGEP---PNSELHPMRVLFLIPK 258
              G   ++A EV++++  +  KADI++L +T +  A  EP      + H +R      +
Sbjct: 190 ---GDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWHEIR------Q 240
Query: 259 NNPPQLTGNYTKQFKEFVEACLNKDPENRPTAKELLKFPFIRKAKK 304
              P++    +++F E ++  ++ DPE RP+A  L+K   +  A +
Sbjct: 241 GRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSASR 286

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 42/148 (28%), Positives = 73/148 (49%), Gaps = 5/148 (3%)
Query: 152 EVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTN---TTSKRNTFVGTP 208
           +V KG+ +L S++ +HRD+ A N +L E   VK+ADFG+A  + +    +    T    P
Sbjct: 139 QVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLP 198
Query: 209 F-WMAPEVIKQSAYDSKADIWSLGITAIEL-AKGEPPNSELHPMRVLFLIPKNNPPQLTG 266
             WMA E ++   + +K+D+WS G+   EL  +G PP  +++   +   + +        
Sbjct: 199 VKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPE 258
Query: 267 NYTKQFKEFVEACLNKDPENRPTAKELL 294
                  E +  C +   E RP+  EL+
Sbjct: 259 YCPDPLYEVMLKCWHPKAEMRPSFSELV 286

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 42/148 (28%), Positives = 73/148 (49%), Gaps = 5/148 (3%)
Query: 152 EVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTN---TTSKRNTFVGTP 208
           +V KG+ +L S++ +HRD+ A N +L E   VK+ADFG+A  + +    +    T    P
Sbjct: 142 QVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLP 201
Query: 209 F-WMAPEVIKQSAYDSKADIWSLGITAIEL-AKGEPPNSELHPMRVLFLIPKNNPPQLTG 266
             WMA E ++   + +K+D+WS G+   EL  +G PP  +++   +   + +        
Sbjct: 202 VKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPE 261
Query: 267 NYTKQFKEFVEACLNKDPENRPTAKELL 294
                  E +  C +   E RP+  EL+
Sbjct: 262 YCPDPLYEVMLKCWHPKAEMRPSFSELV 289

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 66.2 bits (160), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 42/148 (28%), Positives = 73/148 (49%), Gaps = 5/148 (3%)
Query: 152 EVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTN---TTSKRNTFVGTP 208
           +V KG+ +L S++ +HRD+ A N +L E   VK+ADFG+A  + +    +    T    P
Sbjct: 141 QVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLP 200
Query: 209 F-WMAPEVIKQSAYDSKADIWSLGITAIEL-AKGEPPNSELHPMRVLFLIPKNNPPQLTG 266
             WMA E ++   + +K+D+WS G+   EL  +G PP  +++   +   + +        
Sbjct: 201 VKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPE 260
Query: 267 NYTKQFKEFVEACLNKDPENRPTAKELL 294
                  E +  C +   E RP+  EL+
Sbjct: 261 YCPDPLYEVMLKCWHPKAEMRPSFSELV 288

>pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 53/197 (26%), Positives = 86/197 (43%), Gaps = 23/197 (11%)
Query: 65  IGKGSFGEVFKGIDNRTQQVVXXXXXXXXXXXXXXXXXXXXXM-------------VLSQ 111
           IGKGSFG+V K  D++  Q V                     +             V+  
Sbjct: 105 IGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHM 164
Query: 112 CDSPYGTKLWIIMEY-LGGGSALDLMKAGNFEEMHIAVILR---EVLKGLDYLHSERKLH 167
            ++ +  +  I M + L   +  +L+K   F+   + ++ +    +L+ LD LH  R +H
Sbjct: 165 LEN-FTFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIH 223
Query: 168 RDIKAANVLLSEMG--DVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKA 225
            D+K  N+LL + G   +K+ DFG +        +  T + + F+ APEVI  + Y    
Sbjct: 224 CDLKPENILLKQQGRSGIKVIDFGSS---CYEHQRVYTXIQSRFYRAPEVILGARYGMPI 280
Query: 226 DIWSLGITAIELAKGEP 242
           D+WSLG    EL  G P
Sbjct: 281 DMWSLGCILAELLTGYP 297

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 51/214 (23%), Positives = 99/214 (46%), Gaps = 35/214 (16%)
Query: 120 LWIIMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLL-S 178
           ++I+ EY+    A ++++ G   E H  + + ++L+GL Y+HS   LHRD+K AN+ + +
Sbjct: 97  VYIVQEYMETDLA-NVLEQGPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINT 155
Query: 179 EMGDVKLADFGVAGTLTNTTSKRNTF---VGTPFWMAPEVIKQ-SAYDSKADIWSLGITA 234
           E   +K+ DFG+A  +    S +      + T ++ +P ++   + Y    D+W+ G   
Sbjct: 156 EDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIF 215
Query: 235 IELAKGEPPNSELHPMRVLFLIPKNNP-----------------------------PQLT 265
            E+  G+   +  H +  + LI ++ P                              QL 
Sbjct: 216 AEMLTGKTLFAGAHELEQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLL 275
Query: 266 GNYTKQFKEFVEACLNKDPENRPTAKELLKFPFI 299
              +++  +F+E  L   P +R TA+E L  P++
Sbjct: 276 PGISREAVDFLEQILTFSPMDRLTAEEALSHPYM 309

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 43/151 (28%), Positives = 73/151 (48%), Gaps = 6/151 (3%)
Query: 144 MHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKR-N 202
           +HIA   +++  G+ YL S+  +HRD+   N L+ E   VK+ DFG++  + +T   R  
Sbjct: 131 LHIA---QQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVG 187
Query: 203 TFVGTPF-WMAPEVIKQSAYDSKADIWSLGITAIEL-AKGEPPNSELHPMRVLFLIPKNN 260
                P  WM PE I    + +++D+WSLG+   E+   G+ P  +L    V+  I +  
Sbjct: 188 GHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGR 247
Query: 261 PPQLTGNYTKQFKEFVEACLNKDPENRPTAK 291
             Q      ++  E +  C  ++P  R   K
Sbjct: 248 VLQRPRTCPQEVYELMLGCWQREPHMRKNIK 278

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 65.5 bits (158), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 63/266 (23%), Positives = 108/266 (40%), Gaps = 35/266 (13%)
Query: 62  QERIGKGSFGEVFKG---IDNRTQQVVXXXXXXXXXXXXXXXXXXXXXMVLSQCDSPYGT 118
           +E IG G FGEV +G      + +  V                      ++ Q + P   
Sbjct: 21  EEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNII 80
Query: 119 KL----------WIIMEYLGGGSALDLMKA--GNFEEMHIAVILREVLKGLDYLHSERKL 166
           +L           I+ E++  G+    ++   G F  + +  +LR +  G+ YL     +
Sbjct: 81  RLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLRGIASGMRYLAEMSYV 140
Query: 167 HRDIKAANVLLSEMGDVKLADFGVAGTLTNTTS--KRNTFVGTPF---WMAPEVIKQSAY 221
           HRD+ A N+L++     K++DFG++  L   +S     + +G      W APE I    +
Sbjct: 141 HRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGGKIPIRWTAPEAIAFRKF 200
Query: 222 DSKADIWSLGITAIE-LAKGEPPNSELHPMRVLFLIPKNN----PPQLTGNYTKQFKEFV 276
            S +D WS GI   E ++ GE P  ++    V+  I ++     PP    +      + +
Sbjct: 201 TSASDAWSYGIVMWEVMSFGERPYWDMSNQDVINAIEQDYRLPPPP----DCPTSLHQLM 256
Query: 277 EACLNKDPENRPTAKELLKFPFIRKA 302
             C  KD   RP      +FP +  A
Sbjct: 257 LDCWQKDRNARP------RFPQVVSA 276

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 65.5 bits (158), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 40/159 (25%), Positives = 76/159 (47%), Gaps = 14/159 (8%)
Query: 149 ILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTF---- 204
           I  ++ + +++LHS+  +HRD+K +N+  +    VK+ DFG+   +     ++       
Sbjct: 169 IFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMP 228
Query: 205 --------VGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLI 256
                   VGT  +M+PE I  + Y  K DI+SLG+   EL      ++++  +R++  +
Sbjct: 229 AYATHXGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSF--STQMERVRIITDV 286
Query: 257 PKNNPPQLTGNYTKQFKEFVEACLNKDPENRPTAKELLK 295
                P L      Q    V+  L+  P  RP A ++++
Sbjct: 287 RNLKFPLLFTQKYPQEHMMVQDMLSPSPTERPEATDIIE 325

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 65.5 bits (158), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 49/189 (25%), Positives = 89/189 (47%), Gaps = 7/189 (3%)
Query: 119 KLWIIMEYLGGG--SALDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVL 176
           K++++MEY   G    LD +    F          +++ GL+YLHS+  +H+DIK  N+L
Sbjct: 82  KMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLL 141
Query: 177 LSEMGDVKLADFGVAGTLTNTTSKRN--TFVGTPFWMAPEVIK--QSAYDSKADIWSLGI 232
           L+  G +K++  GVA  L    +     T  G+P +  PE+     +    K DIWS G+
Sbjct: 142 LTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGV 201
Query: 233 TAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPENRPTAKE 292
           T   +  G  P    +  ++   I K +   + G+      + ++  L  +P  R + ++
Sbjct: 202 TLYNITTGLYPFEGDNIYKLFENIGKGS-YAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQ 260
Query: 293 LLKFPFIRK 301
           + +  + RK
Sbjct: 261 IRQHSWFRK 269

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 65.5 bits (158), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 61/269 (22%), Positives = 110/269 (40%), Gaps = 38/269 (14%)
Query: 55  PELIFTKQERIGKGSFGEV----FKGIDNRTQQVVXXXXXXXXXXXXXXXXXXXXXMVLS 110
           PE  FT    +GKG FG V     K  D    +V                        + 
Sbjct: 21  PEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMK 80
Query: 111 QCDSPYGTKL----------------WIIMEYLGGGSALDLMKAGNFEE----MHIAVIL 150
           + D P+  KL                 +I+ ++  G     + A    E    + +  ++
Sbjct: 81  EFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLV 140
Query: 151 R---EVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVG- 206
           R   ++  G++YL S   +HRD+ A N +L+E   V +ADFG++  + +    R      
Sbjct: 141 RFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASK 200
Query: 207 TPF-WMAPEVIKQSAYDSKADIWSLGITAIE-LAKGEPPNSELHPMRVL-FLIPKN---N 260
            P  W+A E +  + Y   +D+W+ G+T  E + +G+ P + +    +  +LI  N    
Sbjct: 201 LPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGNRLKQ 260
Query: 261 PPQLTGNYTKQFKEFVEACLNKDPENRPT 289
           PP+      ++  + +  C + DP+ RP+
Sbjct: 261 PPEC----MEEVYDLMYQCWSADPKQRPS 285

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 38/147 (25%), Positives = 75/147 (51%), Gaps = 3/147 (2%)
Query: 152 EVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTS--KRNTFVGTPF 209
           ++ +G+ YL     +HRD+ A N+L++E   +K++DFG++  +    S  KR+       
Sbjct: 158 QISQGMQYLAEMSLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSXVKRSQGRIPVK 217
Query: 210 WMAPEVIKQSAYDSKADIWSLGITAIELAK-GEPPNSELHPMRVLFLIPKNNPPQLTGNY 268
           WMA E +    Y +++D+WS G+   E+   G  P   + P R+  L+   +  +   N 
Sbjct: 218 WMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERLFNLLKTGHRMERPDNC 277
Query: 269 TKQFKEFVEACLNKDPENRPTAKELLK 295
           +++    +  C  ++P+ RP   ++ K
Sbjct: 278 SEEMYRLMLQCWKQEPDKRPVFADISK 304

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 47/197 (23%), Positives = 86/197 (43%), Gaps = 27/197 (13%)
Query: 120 LWIIMEYLGGGSALDLMKAGNFEE--------------------MHIAVILREVLKGLDY 159
           L++ +EY   G+ LD ++     E                    +H A    +V +G+DY
Sbjct: 98  LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA---DVARGMDY 154
Query: 160 LHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPF-WMAPEVIKQ 218
           L  ++ +HR++ A N+L+ E    K+ADFG+  +       + T    P  WMA E +  
Sbjct: 155 LSQKQFIHRNLAARNILVGENYVAKIADFGL--SRGQEVYVKKTMGRLPVRWMAIESLNY 212
Query: 219 SAYDSKADIWSLGITAIELAK-GEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVE 277
           S Y + +D+WS G+   E+   G  P   +    +   +P+    +   N   +  + + 
Sbjct: 213 SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLNCDDEVYDLMR 272
Query: 278 ACLNKDPENRPTAKELL 294
            C  + P  RP+  ++L
Sbjct: 273 QCWREKPYERPSFAQIL 289

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 37/119 (31%), Positives = 63/119 (52%), Gaps = 3/119 (2%)
Query: 120 LWIIMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSE 179
           ++I+ME +       +    + E M  + +L ++L G+ +LHS   +HRD+K +N+++  
Sbjct: 104 VYIVMELMDANLCQVIQMELDHERM--SYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS 161
Query: 180 MGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELA 238
              +K+ DFG+A T   T+      V T ++ APEVI    Y    DIWS+G    E+ 
Sbjct: 162 DCTLKILDFGLART-AGTSFMMEPEVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 219

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 43/165 (26%), Positives = 81/165 (49%), Gaps = 16/165 (9%)
Query: 151 REVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLT--NTTSKRNTFVGTP 208
           + +L+ +  +H    +H D+K AN L+ + G +KL DFG+A  +        +++ VGT 
Sbjct: 134 KNMLEAVHTIHQHGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDXXXVVKDSQVGTV 192
Query: 209 FWMAPEVIKQSA-----------YDSKADIWSLGITAIELAKGEPPNSEL--HPMRVLFL 255
            +M PE IK  +              K+D+WSLG     +  G+ P  ++     ++  +
Sbjct: 193 NYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAI 252
Query: 256 IPKNNPPQLTGNYTKQFKEFVEACLNKDPENRPTAKELLKFPFIR 300
           I  N+  +      K  ++ ++ CL +DP+ R +  ELL  P+++
Sbjct: 253 IDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ 297

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 39/110 (35%), Positives = 58/110 (52%), Gaps = 16/110 (14%)
Query: 146 IAVILREVLKGLDYLHSERKLHRDIKAANVLLS--EMGDVKLADFGVA--------GTLT 195
           I+ I+R++   L YLH++   HRDIK  N L S  +  ++KL DFG++        G   
Sbjct: 170 ISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYY 229
Query: 196 NTTSKRNTFVGTPFWMAPEVIKQS--AYDSKADIWSLGITAIELAKGEPP 243
             T+K     GTP+++APEV+  +  +Y  K D WS G+    L  G  P
Sbjct: 230 GMTTK----AGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVP 275

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 47/185 (25%), Positives = 84/185 (45%), Gaps = 8/185 (4%)
Query: 122 IIMEYLGGGSALDLM--KAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLS- 178
           +I E++ GG   + +  +     E      +R+V KGL ++H    +H D+K  N++ + 
Sbjct: 125 MIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTT 184
Query: 179 -EMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIEL 237
               ++KL DFG+   L    S + T  GT  + APEV +        D+WS+G+ +  L
Sbjct: 185 KRSNELKLIDFGLTAHLDPKQSVKVT-TGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYIL 243
Query: 238 AKGEPP---NSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPENRPTAKELL 294
             G  P    ++   +R +     N         ++  K+F+   L  DP  R T  + L
Sbjct: 244 LSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQAL 303
Query: 295 KFPFI 299
           + P++
Sbjct: 304 EHPWL 308

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/252 (23%), Positives = 103/252 (40%), Gaps = 29/252 (11%)
Query: 62  QERIGKGSFGEVFKG---IDNRTQQVVXXXXXXXXXXXXXXXXXXXXXMVLSQCDSPYGT 118
           +E IG G FGEV +G      + +  V                      ++ Q + P   
Sbjct: 19  EEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNII 78
Query: 119 KL----------WIIMEYLGGGSALDLMKA--GNFEEMHIAVILREVLKGLDYLHSERKL 166
           +L           I+ E++  G+    ++   G F  + +  +LR +  G+ YL     +
Sbjct: 79  RLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLRGIASGMRYLAEMSYV 138
Query: 167 HRDIKAANVLLSEMGDVKLADFGVAGTLTNTTS--KRNTFVGTPF---WMAPEVIKQSAY 221
           HRD+ A N+L++     K++DFG++  L   +S     + +G      W APE I    +
Sbjct: 139 HRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLGGKIPIRWTAPEAIAFRKF 198
Query: 222 DSKADIWSLGITAIE-LAKGEPPNSELHPMRVLFLIPKNN----PPQLTGNYTKQFKEFV 276
            S +D WS GI   E ++ GE P  ++    V+  I ++     PP    +      + +
Sbjct: 199 TSASDAWSYGIVMWEVMSFGERPYWDMSNQDVINAIEQDYRLPPPP----DCPTSLHQLM 254
Query: 277 EACLNKDPENRP 288
             C  KD   RP
Sbjct: 255 LDCWQKDRNARP 266

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 71/296 (23%), Positives = 110/296 (37%), Gaps = 47/296 (15%)
Query: 38  NQCGSTTASRRNSLKVDPELIFTKQERIGKGSFGEVFKGI------DNRTQQVVXXXXXX 91
           N C +   S  + LK  P    T    +G G+FGEV++G       D    QV       
Sbjct: 11  NYCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPE 70
Query: 92  XXXXXXXXXXXXXXXMV-------LSQCDSPYGTKL-----WIIMEYLGGGSALDLMK-- 137
                          ++       + +C    G  L     +I+ME + GG     ++  
Sbjct: 71  VCSEQDELDFLMEALIISKFNHQNIVRC---IGVSLQSLPRFILMELMAGGDLKSFLRET 127
Query: 138 ---------AGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGD---VKL 185
                        + +H+A   R++  G  YL     +HRDI A N LL+  G     K+
Sbjct: 128 RPRPSQPSSLAMLDLLHVA---RDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKI 184
Query: 186 ADFGVAGTLTNTTSKRNTFVGT-PF-WMAPEVIKQSAYDSKADIWSLGITAIEL-AKGEP 242
            DFG+A  +   +  R       P  WM PE   +  + SK D WS G+   E+ + G  
Sbjct: 185 GDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYM 244
Query: 243 PNSELHPMRVLFLIP---KNNPPQLTGNYTKQFKEFVEACLNKDPENRPTAKELLK 295
           P        VL  +    + +PP+   N        +  C    PE+RP    +L+
Sbjct: 245 PYPSKSNQEVLEFVTSGGRMDPPK---NCPGPVYRIMTQCWQHQPEDRPNFAIILE 297

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 37/109 (33%), Positives = 56/109 (51%), Gaps = 11/109 (10%)
Query: 145 HIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTL---------- 194
           HI   + + L+ +  LH    +HRD+K +N+L++   D+K+ DFG+A  +          
Sbjct: 113 HIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEP 172
Query: 195 TNTTSKRNTFVGTPFWMAPEVIKQSAYDSKA-DIWSLGITAIELAKGEP 242
           T   S    FV T ++ APEV+  SA  S+A D+WS G    EL    P
Sbjct: 173 TGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRP 221

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 75/310 (24%), Positives = 115/310 (37%), Gaps = 50/310 (16%)
Query: 24  TQFLKFSNSGSSISNQCGSTTASRRNSLKVDPELIFTKQERIGKGSFGEVFKGI------ 77
           T+ L F  S     N C +   S  + LK  P    T    +G G+FGEV++G       
Sbjct: 15  TENLYFQGSNP---NYCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPN 71
Query: 78  DNRTQQVVXXXXXXXXXXXXXXXXXXXXXMV-------LSQCDSPYGTKL-----WIIME 125
           D    QV                      ++       + +C    G  L     +I+ME
Sbjct: 72  DPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRC---IGVSLQSLPRFILME 128
Query: 126 YLGGGSALDLMK-----------AGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAAN 174
            + GG     ++               + +H+A   R++  G  YL     +HRDI A N
Sbjct: 129 LMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVA---RDIACGCQYLEENHFIHRDIAARN 185
Query: 175 VLLSEMGD---VKLADFGVAGTLTNTTSKRNTFVGT-PF-WMAPEVIKQSAYDSKADIWS 229
            LL+  G     K+ DFG+A  +   +  R       P  WM PE   +  + SK D WS
Sbjct: 186 CLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWS 245
Query: 230 LGITAIEL-AKGEPPNSELHPMRVLFLIP---KNNPPQLTGNYTKQFKEFVEACLNKDPE 285
            G+   E+ + G  P        VL  +    + +PP+   N        +  C    PE
Sbjct: 246 FGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPK---NCPGPVYRIMTQCWQHQPE 302
Query: 286 NRPTAKELLK 295
           +RP    +L+
Sbjct: 303 DRPNFAIILE 312

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 42/146 (28%), Positives = 74/146 (50%), Gaps = 13/146 (8%)
Query: 152 EVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVG-TPF- 209
           ++  G++YL +   LHRD+ A N +L +   V +ADFG++  + +    R   +   P  
Sbjct: 155 DIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVK 214
Query: 210 WMAPEVIKQSAYDSKADIWSLGITAIELA-KGEPP-----NSELHPMRVLFLIPKNNPPQ 263
           W+A E +    Y SK+D+W+ G+T  E+A +G  P     N E++     +L+  +   Q
Sbjct: 215 WIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYD----YLLHGHRLKQ 270
Query: 264 LTGNYTKQFKEFVEACLNKDPENRPT 289
              +   +  E + +C   DP +RPT
Sbjct: 271 -PEDCLDELYEIMYSCWRTDPLDRPT 295

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 47/185 (25%), Positives = 84/185 (45%), Gaps = 8/185 (4%)
Query: 122 IIMEYLGGGSALDLM--KAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLS- 178
           +I E++ GG   + +  +     E      +R+V KGL ++H    +H D+K  N++ + 
Sbjct: 231 MIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTT 290
Query: 179 -EMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIEL 237
               ++KL DFG+   L    S + T  GT  + APEV +        D+WS+G+ +  L
Sbjct: 291 KRSNELKLIDFGLTAHLDPKQSVKVT-TGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYIL 349
Query: 238 AKGEPP---NSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPENRPTAKELL 294
             G  P    ++   +R +     N         ++  K+F+   L  DP  R T  + L
Sbjct: 350 LSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQAL 409
Query: 295 KFPFI 299
           + P++
Sbjct: 410 EHPWL 414

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 36/119 (30%), Positives = 63/119 (52%), Gaps = 3/119 (2%)
Query: 120 LWIIMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSE 179
           ++I+ME +       +    + E M  + +L ++L G+ +LHS   +HRD+K +N+++  
Sbjct: 104 VYIVMELMDANLCQVIQMELDHERM--SYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS 161
Query: 180 MGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELA 238
              +K+ DFG+A T   T+      V T ++ APEVI    Y    D+WS+G    E+ 
Sbjct: 162 DCTLKILDFGLART-AGTSFMMEPEVVTRYYRAPEVILGMGYKENVDLWSVGCIMGEMV 219

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 36/109 (33%), Positives = 56/109 (51%), Gaps = 11/109 (10%)
Query: 145 HIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTL---------- 194
           HI   + + L+ +  LH    +HRD+K +N+L++   D+K+ DFG+A  +          
Sbjct: 113 HIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEP 172
Query: 195 TNTTSKRNTFVGTPFWMAPEVIKQSAYDSKA-DIWSLGITAIELAKGEP 242
           T   S    +V T ++ APEV+  SA  S+A D+WS G    EL    P
Sbjct: 173 TGQQSGMTEYVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRP 221

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 43/161 (26%), Positives = 76/161 (47%), Gaps = 6/161 (3%)
Query: 139 GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTT 198
           G  + +HIA    ++  G+ YL S+  +HRD+   N L+     VK+ DFG++  + +T 
Sbjct: 131 GLSQMLHIA---SQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTD 187
Query: 199 SKR-NTFVGTPF-WMAPEVIKQSAYDSKADIWSLGITAIEL-AKGEPPNSELHPMRVLFL 255
             R       P  WM PE I    + +++D+WS G+   E+   G+ P  +L    V+  
Sbjct: 188 YYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIEC 247
Query: 256 IPKNNPPQLTGNYTKQFKEFVEACLNKDPENRPTAKELLKF 296
           I +    +      K+  + +  C  ++P+ R   KE+ K 
Sbjct: 248 ITQGRVLERPRVCPKEVYDVMLGCWQREPQQRLNIKEIYKI 288

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 85/216 (39%), Gaps = 44/216 (20%)
Query: 65  IGKGSFGEVFKGID-NRTQQVVXXXXXXXXXXXXXXXXXXXXXMVLSQCDSPYGTKL--- 120
           IG+GS+G V+   D N  + V                       +L++  S Y  +L   
Sbjct: 36  IGRGSYGYVYLAYDKNANKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLHDL 95
Query: 121 ------------WIIMEYLGGGSALDLMKAGNF-EEMHIAVILREVLKGLDYLHSERKLH 167
                       +I++E +       L K   F  E H+  IL  +L G  ++H    +H
Sbjct: 96  IIPEDLLKFDELYIVLE-IADSDLKKLFKTPIFLTEQHVKTILYNLLLGEKFIHESGIIH 154
Query: 168 RDIKAANVLLSEMGDVKLADFGVAGTLT-------------------------NTTSKRN 202
           RD+K AN LL++   VK+ DFG+A T+                          N   +  
Sbjct: 155 RDLKPANCLLNQDCSVKICDFGLARTINSDKDIHIVNDLEEKEENEEPGPHNKNLKKQLT 214
Query: 203 TFVGTPFWMAPEVI-KQSAYDSKADIWSLGITAIEL 237
           + V T ++ APE+I  Q  Y +  DIWS G    EL
Sbjct: 215 SHVVTRWYRAPELILLQENYTNSIDIWSTGCIFAEL 250

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 70/296 (23%), Positives = 110/296 (37%), Gaps = 47/296 (15%)
Query: 38  NQCGSTTASRRNSLKVDPELIFTKQERIGKGSFGEVFKGI------DNRTQQVVXXXXXX 91
           N C +   S  + LK  P    T    +G G+FGEV++G       D    QV       
Sbjct: 3   NYCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPE 62
Query: 92  XXXXXXXXXXXXXXXMV-------LSQCDSPYGTKL-----WIIMEYLGGGSALDLMK-- 137
                          ++       + +C    G  L     +I++E + GG     ++  
Sbjct: 63  VCSEQDELDFLMEALIISKFNHQNIVRC---IGVSLQSLPRFILLELMAGGDLKSFLRET 119
Query: 138 ---------AGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGD---VKL 185
                        + +H+A   R++  G  YL     +HRDI A N LL+  G     K+
Sbjct: 120 RPRPSQPSSLAMLDLLHVA---RDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKI 176
Query: 186 ADFGVAGTLTNTTSKRNTFVGT-PF-WMAPEVIKQSAYDSKADIWSLGITAIEL-AKGEP 242
            DFG+A  +   +  R       P  WM PE   +  + SK D WS G+   E+ + G  
Sbjct: 177 GDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYM 236
Query: 243 PNSELHPMRVLFLIP---KNNPPQLTGNYTKQFKEFVEACLNKDPENRPTAKELLK 295
           P        VL  +    + +PP+   N        +  C    PE+RP    +L+
Sbjct: 237 PYPSKSNQEVLEFVTSGGRMDPPK---NCPGPVYRIMTQCWQHQPEDRPNFAIILE 289

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 87/200 (43%), Gaps = 28/200 (14%)
Query: 119 KLWIIMEYLGGGSALDLMKAGNFE--EMHIAVILREVLKGLDYLHSERKLHRDIKAANVL 176
           +L +I E++ G    + +    FE  E  I   + +V + L +LHS    H DI+  N++
Sbjct: 75  ELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENII 134
Query: 177 LS--EMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITA 234
                   +K+ +FG A  L    + R  F   P + APEV +     +  D+WSLG   
Sbjct: 135 YQTRRSSTIKIIEFGQARQLKPGDNFRLLFTA-PEYYAPEVHQHDVVSTATDMWSLGTLV 193
Query: 235 IELAKGEPPNSELHPMRVLFLIPKNNPP---QLTGNYT---KQFKE-------FVEACLN 281
             L  G  P          FL   N       +   YT   + FKE       FV+  L 
Sbjct: 194 YVLLSGINP----------FLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRLLV 243
Query: 282 KDPENRPTAKELLKFPFIRK 301
           K+ ++R TA E L+ P++++
Sbjct: 244 KERKSRMTASEALQHPWLKQ 263

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 74/310 (23%), Positives = 115/310 (37%), Gaps = 50/310 (16%)
Query: 24  TQFLKFSNSGSSISNQCGSTTASRRNSLKVDPELIFTKQERIGKGSFGEVFKGI------ 77
           T+ L F  S     N C +   S  + LK  P    T    +G G+FGEV++G       
Sbjct: 15  TENLYFQGSNP---NYCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPN 71
Query: 78  DNRTQQVVXXXXXXXXXXXXXXXXXXXXXMV-------LSQCDSPYGTKL-----WIIME 125
           D    QV                      ++       + +C    G  L     +I++E
Sbjct: 72  DPSPLQVAVKTLPEVYSEQDELDFLMEALIISKFNHQNIVRC---IGVSLQSLPRFILLE 128
Query: 126 YLGGGSALDLMK-----------AGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAAN 174
            + GG     ++               + +H+A   R++  G  YL     +HRDI A N
Sbjct: 129 LMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVA---RDIACGCQYLEENHFIHRDIAARN 185
Query: 175 VLLSEMGD---VKLADFGVAGTLTNTTSKRNTFVGT-PF-WMAPEVIKQSAYDSKADIWS 229
            LL+  G     K+ DFG+A  +   +  R       P  WM PE   +  + SK D WS
Sbjct: 186 CLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWS 245
Query: 230 LGITAIEL-AKGEPPNSELHPMRVLFLIP---KNNPPQLTGNYTKQFKEFVEACLNKDPE 285
            G+   E+ + G  P        VL  +    + +PP+   N        +  C    PE
Sbjct: 246 FGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPK---NCPGPVYRIMTQCWQHQPE 302
Query: 286 NRPTAKELLK 295
           +RP    +L+
Sbjct: 303 DRPNFAIILE 312

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 72/307 (23%), Positives = 117/307 (38%), Gaps = 44/307 (14%)
Query: 24  TQFLKFSNSGSSISNQCGSTTASRRNSLKVDPELIFTKQERIGKGSFGEVFKGI-----D 78
           T+ L F  S     N C +   S  + LK  P    T    +G G+FGEV++G      +
Sbjct: 15  TENLYFQGSNP---NYCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPN 71
Query: 79  NRTQQVVXXXXXXXXXXXXXXXXXXXXXMVLSQCDSP-----YGTKL-----WIIMEYLG 128
           + +   V                     +++S+ +        G  L     +I++E + 
Sbjct: 72  DPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVRCIGVSLQSLPRFILLELMA 131
Query: 129 GGSALDLMK-----------AGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLL 177
           GG     ++               + +H+A   R++  G  YL     +HRDI A N LL
Sbjct: 132 GGDLKSFLRETRPRPSQPSSLAMLDLLHVA---RDIACGCQYLEENHFIHRDIAARNCLL 188
Query: 178 SEMGD---VKLADFGVAGTLTNTTSKRNTFVGT-PF-WMAPEVIKQSAYDSKADIWSLGI 232
           +  G     K+ DFG+A  +   +  R       P  WM PE   +  + SK D WS G+
Sbjct: 189 TCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGV 248
Query: 233 TAIEL-AKGEPPNSELHPMRVLFLIP---KNNPPQLTGNYTKQFKEFVEACLNKDPENRP 288
              E+ + G  P        VL  +    + +PP+   N        +  C    PE+RP
Sbjct: 249 LLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPK---NCPGPVYRIMTQCWQHQPEDRP 305
Query: 289 TAKELLK 295
               +L+
Sbjct: 306 NFAIILE 312

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 37/102 (36%), Positives = 58/102 (56%), Gaps = 8/102 (7%)
Query: 149 ILREVLKGLDYLHSERKLHRDIKAANVLLS----EMGDVKLADFGVAGTLTN---TTSKR 201
           +L ++L G+ YLH+   LHRD+K AN+L+     E G VK+AD G A    +     +  
Sbjct: 133 LLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADL 192
Query: 202 NTFVGTPFWMAPEVIKQSAYDSKA-DIWSLGITAIELAKGEP 242
           +  V T ++ APE++  + + +KA DIW++G    EL   EP
Sbjct: 193 DPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEP 234

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 44/161 (27%), Positives = 67/161 (41%), Gaps = 28/161 (17%)
Query: 119 KLWIIMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLS 178
           +L++++E                 E+HI  +L  +L G+ Y+HS   LHRD+K AN L++
Sbjct: 131 ELYVVLEIADSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVN 190
Query: 179 EMGDVKLADFGVAGTLT---------------------------NTTSKRNTFVGTPFWM 211
           +   VK+ DFG+A T+                            N   +    V T ++ 
Sbjct: 191 QDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYR 250
Query: 212 APEVIK-QSAYDSKADIWSLGITAIELAKGEPPNSELHPMR 251
           APE+I  Q  Y    D+WS+G    EL      N   H  R
Sbjct: 251 APELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHADR 291

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 70/296 (23%), Positives = 110/296 (37%), Gaps = 47/296 (15%)
Query: 38  NQCGSTTASRRNSLKVDPELIFTKQERIGKGSFGEVFKGI------DNRTQQVVXXXXXX 91
           N C +   S  + LK  P    T    +G G+FGEV++G       D    QV       
Sbjct: 11  NYCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPE 70
Query: 92  XXXXXXXXXXXXXXXMV-------LSQCDSPYGTKL-----WIIMEYLGGGSALDLMK-- 137
                          ++       + +C    G  L     +I++E + GG     ++  
Sbjct: 71  VCSEQDELDFLMEALIISKFNHQNIVRC---IGVSLQSLPRFILLELMAGGDLKSFLRET 127
Query: 138 ---------AGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGD---VKL 185
                        + +H+A   R++  G  YL     +HRDI A N LL+  G     K+
Sbjct: 128 RPRPSQPSSLAMLDLLHVA---RDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKI 184
Query: 186 ADFGVAGTLTNTTSKRNTFVGT-PF-WMAPEVIKQSAYDSKADIWSLGITAIEL-AKGEP 242
            DFG+A  +   +  R       P  WM PE   +  + SK D WS G+   E+ + G  
Sbjct: 185 GDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYM 244
Query: 243 PNSELHPMRVLFLIP---KNNPPQLTGNYTKQFKEFVEACLNKDPENRPTAKELLK 295
           P        VL  +    + +PP+   N        +  C    PE+RP    +L+
Sbjct: 245 PYPSKSNQEVLEFVTSGGRMDPPK---NCPGPVYRIMTQCWQHQPEDRPNFAIILE 297

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 51/206 (24%), Positives = 94/206 (45%), Gaps = 30/206 (14%)
Query: 113 DSPYGTKLWIIMEYLGGGSALDLMKA----GNFEEMHIAVILREVLKGLDYLHSERK--L 166
           +S  G   ++++  L  G  ++ +K     G      +  I  +  + + ++H ++   +
Sbjct: 101 ESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPII 160
Query: 167 HRDIKAANVLLSEMGDVKLADFGVAGTLTNT-----TSKRNTFV-------GTPFWMAPE 214
           HRD+K  N+LLS  G +KL DFG A T+++      +++R   V        TP +  PE
Sbjct: 161 HRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPE 220
Query: 215 VIKQSA---YDSKADIWSLGITAIELAKGEPPNSELHPMRVL---FLIPKNNPPQLTGNY 268
           +I   +      K DIW+LG     L   + P  +   +R++   + IP ++       Y
Sbjct: 221 IIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIVNGKYSIPPHDT-----QY 275
Query: 269 TKQFKEFVEACLNKDPENRPTAKELL 294
           T  F   + A L  +PE R +  E++
Sbjct: 276 TV-FHSLIRAMLQVNPEERLSIAEVV 300

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 70/296 (23%), Positives = 110/296 (37%), Gaps = 47/296 (15%)
Query: 38  NQCGSTTASRRNSLKVDPELIFTKQERIGKGSFGEVFKGI------DNRTQQVVXXXXXX 91
           N C +   S  + LK  P    T    +G G+FGEV++G       D    QV       
Sbjct: 28  NYCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPE 87
Query: 92  XXXXXXXXXXXXXXXMV-------LSQCDSPYGTKL-----WIIMEYLGGGSALDLMK-- 137
                          ++       + +C    G  L     +I++E + GG     ++  
Sbjct: 88  VCSEQDELDFLMEALIISKFNHQNIVRC---IGVSLQSLPRFILLELMAGGDLKSFLRET 144
Query: 138 ---------AGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGD---VKL 185
                        + +H+A   R++  G  YL     +HRDI A N LL+  G     K+
Sbjct: 145 RPRPSQPSSLAMLDLLHVA---RDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKI 201
Query: 186 ADFGVAGTLTNTTSKRNTFVGT-PF-WMAPEVIKQSAYDSKADIWSLGITAIEL-AKGEP 242
            DFG+A  +   +  R       P  WM PE   +  + SK D WS G+   E+ + G  
Sbjct: 202 GDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYM 261
Query: 243 PNSELHPMRVLFLIP---KNNPPQLTGNYTKQFKEFVEACLNKDPENRPTAKELLK 295
           P        VL  +    + +PP+   N        +  C    PE+RP    +L+
Sbjct: 262 PYPSKSNQEVLEFVTSGGRMDPPK---NCPGPVYRIMTQCWQHQPEDRPNFAIILE 314

>pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 51/197 (25%), Positives = 84/197 (42%), Gaps = 23/197 (11%)
Query: 65  IGKGSFGEVFKGIDNRTQQVVXXXXXXXXXXXXXXXXXXXXXM-------------VLSQ 111
           IGKG FG+V K  D++  Q V                     +             V+  
Sbjct: 105 IGKGXFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHM 164
Query: 112 CDSPYGTKLWIIMEY-LGGGSALDLMKAGNFEEMHIAVILR---EVLKGLDYLHSERKLH 167
            ++ +  +  I M + L   +  +L+K   F+   + ++ +    +L+ LD LH  R +H
Sbjct: 165 LEN-FTFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIH 223
Query: 168 RDIKAANVLLSEMG--DVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKA 225
            D+K  N+LL + G   +K+ DFG +        +    + + F+ APEVI  + Y    
Sbjct: 224 CDLKPENILLKQQGRSGIKVIDFGSS---CYEHQRVYXXIQSRFYRAPEVILGARYGMPI 280
Query: 226 DIWSLGITAIELAKGEP 242
           D+WSLG    EL  G P
Sbjct: 281 DMWSLGCILAELLTGYP 297

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 50/195 (25%), Positives = 80/195 (41%), Gaps = 26/195 (13%)
Query: 121 WIIMEYLGGGSALDLMK-----------AGNFEEMHIAVILREVLKGLDYLHSERKLHRD 169
           +I++E + GG     ++               + +H+A   R++  G  YL     +HRD
Sbjct: 110 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVA---RDIACGCQYLEENHFIHRD 166
Query: 170 IKAANVLLSEMGD---VKLADFGVAGTLTNTTSKRNTFVGT-PF-WMAPEVIKQSAYDSK 224
           I A N LL+  G     K+ DFG+A  +   +  R       P  WM PE   +  + SK
Sbjct: 167 IAARNCLLTCPGPGRVAKIGDFGMAQDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSK 226
Query: 225 ADIWSLGITAIEL-AKGEPPNSELHPMRVLFLIP---KNNPPQLTGNYTKQFKEFVEACL 280
            D WS G+   E+ + G  P        VL  +    + +PP+   N        +  C 
Sbjct: 227 TDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPK---NCPGPVYRIMTQCW 283
Query: 281 NKDPENRPTAKELLK 295
              PE+RP    +L+
Sbjct: 284 QHQPEDRPNFAIILE 298

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 92/207 (44%), Gaps = 30/207 (14%)
Query: 62  QERIGKGSFGEVFKGIDNRTQQVVXXXXXXXXXXXXXXXXXXXXXMVLSQ---------- 111
           QE IGKG FGEV++G   R ++V                      ++L            
Sbjct: 47  QESIGKGRFGEVWRG-KWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAAD 105
Query: 112 -CDSPYGTKLWIIMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSE------- 163
             D+   T+LW++ +Y   GS  D +         +  +      GL +LH E       
Sbjct: 106 NKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGK 165
Query: 164 -RKLHRDIKAANVLLSEMGDVKLADFGVA---GTLTNTTSKR-NTFVGTPFWMAPEVIKQ 218
               HRD+K+ N+L+ + G   +AD G+A    + T+T     N  VGT  +MAPEV+  
Sbjct: 166 PAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDD 225
Query: 219 SA----YDS--KADIWSLGITAIELAK 239
           S     ++S  +ADI+++G+   E+A+
Sbjct: 226 SINMKHFESFKRADIYAMGLVFWEIAR 252

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 62.0 bits (149), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 92/207 (44%), Gaps = 30/207 (14%)
Query: 62  QERIGKGSFGEVFKGIDNRTQQVVXXXXXXXXXXXXXXXXXXXXXMVLSQ---------- 111
           QE IGKG FGEV++G   R ++V                      ++L            
Sbjct: 8   QESIGKGRFGEVWRG-KWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAAD 66
Query: 112 -CDSPYGTKLWIIMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSE------- 163
             D+   T+LW++ +Y   GS  D +         +  +      GL +LH E       
Sbjct: 67  NKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGK 126
Query: 164 -RKLHRDIKAANVLLSEMGDVKLADFGVA---GTLTNTTSKR-NTFVGTPFWMAPEVIKQ 218
               HRD+K+ N+L+ + G   +AD G+A    + T+T     N  VGT  +MAPEV+  
Sbjct: 127 PAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDD 186
Query: 219 SA----YDS--KADIWSLGITAIELAK 239
           S     ++S  +ADI+++G+   E+A+
Sbjct: 187 SINMKHFESFKRADIYAMGLVFWEIAR 213

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 70/296 (23%), Positives = 109/296 (36%), Gaps = 47/296 (15%)
Query: 38  NQCGSTTASRRNSLKVDPELIFTKQERIGKGSFGEVFKGI------DNRTQQVVXXXXXX 91
           N C +   S  + LK  P    T    +G G+FGEV++G       D    QV       
Sbjct: 29  NYCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPE 88
Query: 92  XXXXXXXXXXXXXXXMV-------LSQCDSPYGTKL-----WIIMEYLGGGSALDLMK-- 137
                          ++       + +C    G  L     +I++E + GG     ++  
Sbjct: 89  VCSEQDELDFLMEALIISKFNHQNIVRC---IGVSLQSLPRFILLELMAGGDLKSFLRET 145
Query: 138 ---------AGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGD---VKL 185
                        + +H+A   R++  G  YL     +HRDI A N LL+  G     K+
Sbjct: 146 RPRPSQPSSLAMLDLLHVA---RDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKI 202
Query: 186 ADFGVAGTLTNTTSKRNTFVGT-PF-WMAPEVIKQSAYDSKADIWSLGITAIEL-AKGEP 242
            DFG+A  +      R       P  WM PE   +  + SK D WS G+   E+ + G  
Sbjct: 203 GDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYM 262
Query: 243 PNSELHPMRVLFLIP---KNNPPQLTGNYTKQFKEFVEACLNKDPENRPTAKELLK 295
           P        VL  +    + +PP+   N        +  C    PE+RP    +L+
Sbjct: 263 PYPSKSNQEVLEFVTSGGRMDPPK---NCPGPVYRIMTQCWQHQPEDRPNFAIILE 315

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 70/296 (23%), Positives = 109/296 (36%), Gaps = 47/296 (15%)
Query: 38  NQCGSTTASRRNSLKVDPELIFTKQERIGKGSFGEVFKGI------DNRTQQVVXXXXXX 91
           N C +   S  + LK  P    T    +G G+FGEV++G       D    QV       
Sbjct: 52  NYCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPE 111
Query: 92  XXXXXXXXXXXXXXXMV-------LSQCDSPYGTKL-----WIIMEYLGGGSALDLMK-- 137
                          ++       + +C    G  L     +I++E + GG     ++  
Sbjct: 112 VCSEQDELDFLMEALIISKFNHQNIVRC---IGVSLQSLPRFILLELMAGGDLKSFLRET 168
Query: 138 ---------AGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGD---VKL 185
                        + +H+A   R++  G  YL     +HRDI A N LL+  G     K+
Sbjct: 169 RPRPSQPSSLAMLDLLHVA---RDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKI 225
Query: 186 ADFGVAGTLTNTTSKRNTFVGT-PF-WMAPEVIKQSAYDSKADIWSLGITAIEL-AKGEP 242
            DFG+A  +      R       P  WM PE   +  + SK D WS G+   E+ + G  
Sbjct: 226 GDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYM 285
Query: 243 PNSELHPMRVLFLIP---KNNPPQLTGNYTKQFKEFVEACLNKDPENRPTAKELLK 295
           P        VL  +    + +PP+   N        +  C    PE+RP    +L+
Sbjct: 286 PYPSKSNQEVLEFVTSGGRMDPPK---NCPGPVYRIMTQCWQHQPEDRPNFAIILE 338

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 92/207 (44%), Gaps = 30/207 (14%)
Query: 62  QERIGKGSFGEVFKGIDNRTQQVVXXXXXXXXXXXXXXXXXXXXXMVLSQ---------- 111
           QE IGKG FGEV++G   R ++V                      ++L            
Sbjct: 9   QESIGKGRFGEVWRG-KWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAAD 67
Query: 112 -CDSPYGTKLWIIMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSE------- 163
             D+   T+LW++ +Y   GS  D +         +  +      GL +LH E       
Sbjct: 68  NKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGK 127
Query: 164 -RKLHRDIKAANVLLSEMGDVKLADFGVA---GTLTNTTSKR-NTFVGTPFWMAPEVIKQ 218
               HRD+K+ N+L+ + G   +AD G+A    + T+T     N  VGT  +MAPEV+  
Sbjct: 128 PAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDD 187
Query: 219 SA----YDS--KADIWSLGITAIELAK 239
           S     ++S  +ADI+++G+   E+A+
Sbjct: 188 SINMKHFESFKRADIYAMGLVFWEIAR 214

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 50/195 (25%), Positives = 80/195 (41%), Gaps = 26/195 (13%)
Query: 121 WIIMEYLGGGSALDLMK-----------AGNFEEMHIAVILREVLKGLDYLHSERKLHRD 169
           +I++E + GG     ++               + +H+A   R++  G  YL     +HRD
Sbjct: 110 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVA---RDIACGCQYLEENHFIHRD 166
Query: 170 IKAANVLLSEMGD---VKLADFGVAGTLTNTTSKRNTFVGT-PF-WMAPEVIKQSAYDSK 224
           I A N LL+  G     K+ DFG+A  +   +  R       P  WM PE   +  + SK
Sbjct: 167 IAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSK 226
Query: 225 ADIWSLGITAIEL-AKGEPPNSELHPMRVLFLIP---KNNPPQLTGNYTKQFKEFVEACL 280
            D WS G+   E+ + G  P        VL  +    + +PP+   N        +  C 
Sbjct: 227 TDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPK---NCPGPVYRIMTQCW 283
Query: 281 NKDPENRPTAKELLK 295
              PE+RP    +L+
Sbjct: 284 QHQPEDRPNFAIILE 298

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 36/109 (33%), Positives = 55/109 (50%), Gaps = 11/109 (10%)
Query: 145 HIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTL---------- 194
           HI   + + L+ +  LH    +HRD+K +N+L++   D+K+ DFG+A  +          
Sbjct: 113 HIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEP 172
Query: 195 TNTTSKRNTFVGTPFWMAPEVIKQSAYDSKA-DIWSLGITAIELAKGEP 242
           T   S     V T ++ APEV+  SA  S+A D+WS G    EL    P
Sbjct: 173 TGQQSGMTEXVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRP 221

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 50/195 (25%), Positives = 80/195 (41%), Gaps = 26/195 (13%)
Query: 121 WIIMEYLGGGSALDLMK-----------AGNFEEMHIAVILREVLKGLDYLHSERKLHRD 169
           +I++E + GG     ++               + +H+A   R++  G  YL     +HRD
Sbjct: 110 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVA---RDIACGCQYLEENHFIHRD 166
Query: 170 IKAANVLLSEMGD---VKLADFGVAGTLTNTTSKRNTFVGT-PF-WMAPEVIKQSAYDSK 224
           I A N LL+  G     K+ DFG+A  +   +  R       P  WM PE   +  + SK
Sbjct: 167 IAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSK 226
Query: 225 ADIWSLGITAIEL-AKGEPPNSELHPMRVLFLIP---KNNPPQLTGNYTKQFKEFVEACL 280
            D WS G+   E+ + G  P        VL  +    + +PP+   N        +  C 
Sbjct: 227 TDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPK---NCPGPVYRIMTQCW 283
Query: 281 NKDPENRPTAKELLK 295
              PE+RP    +L+
Sbjct: 284 QHQPEDRPNFAIILE 298

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 92/207 (44%), Gaps = 30/207 (14%)
Query: 62  QERIGKGSFGEVFKGIDNRTQQVVXXXXXXXXXXXXXXXXXXXXXMVLSQ---------- 111
           QE IGKG FGEV++G   R ++V                      ++L            
Sbjct: 11  QESIGKGRFGEVWRG-KWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAAD 69
Query: 112 -CDSPYGTKLWIIMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSE------- 163
             D+   T+LW++ +Y   GS  D +         +  +      GL +LH E       
Sbjct: 70  NKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGK 129
Query: 164 -RKLHRDIKAANVLLSEMGDVKLADFGVA---GTLTNTTSKR-NTFVGTPFWMAPEVIKQ 218
               HRD+K+ N+L+ + G   +AD G+A    + T+T     N  VGT  +MAPEV+  
Sbjct: 130 PAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDD 189
Query: 219 SA----YDS--KADIWSLGITAIELAK 239
           S     ++S  +ADI+++G+   E+A+
Sbjct: 190 SINMKHFESFKRADIYAMGLVFWEIAR 216

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 50/195 (25%), Positives = 80/195 (41%), Gaps = 26/195 (13%)
Query: 121 WIIMEYLGGGSALDLMK-----------AGNFEEMHIAVILREVLKGLDYLHSERKLHRD 169
           +I++E + GG     ++               + +H+A   R++  G  YL     +HRD
Sbjct: 136 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVA---RDIACGCQYLEENHFIHRD 192
Query: 170 IKAANVLLSEMGD---VKLADFGVAGTLTNTTSKRNTFVGT-PF-WMAPEVIKQSAYDSK 224
           I A N LL+  G     K+ DFG+A  +   +  R       P  WM PE   +  + SK
Sbjct: 193 IAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSK 252
Query: 225 ADIWSLGITAIEL-AKGEPPNSELHPMRVLFLIP---KNNPPQLTGNYTKQFKEFVEACL 280
            D WS G+   E+ + G  P        VL  +    + +PP+   N        +  C 
Sbjct: 253 TDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPK---NCPGPVYRIMTQCW 309
Query: 281 NKDPENRPTAKELLK 295
              PE+RP    +L+
Sbjct: 310 QHQPEDRPNFAIILE 324

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 50/195 (25%), Positives = 80/195 (41%), Gaps = 26/195 (13%)
Query: 121 WIIMEYLGGGSALDLMK-----------AGNFEEMHIAVILREVLKGLDYLHSERKLHRD 169
           +I++E + GG     ++               + +H+A   R++  G  YL     +HRD
Sbjct: 116 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVA---RDIACGCQYLEENHFIHRD 172
Query: 170 IKAANVLLSEMGD---VKLADFGVAGTLTNTTSKRNTFVGT-PF-WMAPEVIKQSAYDSK 224
           I A N LL+  G     K+ DFG+A  +   +  R       P  WM PE   +  + SK
Sbjct: 173 IAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSK 232
Query: 225 ADIWSLGITAIEL-AKGEPPNSELHPMRVLFLIP---KNNPPQLTGNYTKQFKEFVEACL 280
            D WS G+   E+ + G  P        VL  +    + +PP+   N        +  C 
Sbjct: 233 TDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPK---NCPGPVYRIMTQCW 289
Query: 281 NKDPENRPTAKELLK 295
              PE+RP    +L+
Sbjct: 290 QHQPEDRPNFAIILE 304

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 92/207 (44%), Gaps = 30/207 (14%)
Query: 62  QERIGKGSFGEVFKGIDNRTQQVVXXXXXXXXXXXXXXXXXXXXXMVLSQ---------- 111
           QE IGKG FGEV++G   R ++V                      ++L            
Sbjct: 34  QESIGKGRFGEVWRG-KWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAAD 92
Query: 112 -CDSPYGTKLWIIMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSE------- 163
             D+   T+LW++ +Y   GS  D +         +  +      GL +LH E       
Sbjct: 93  NKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGK 152
Query: 164 -RKLHRDIKAANVLLSEMGDVKLADFGVA---GTLTNTTSKR-NTFVGTPFWMAPEVIKQ 218
               HRD+K+ N+L+ + G   +AD G+A    + T+T     N  VGT  +MAPEV+  
Sbjct: 153 PAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDD 212
Query: 219 SA----YDS--KADIWSLGITAIELAK 239
           S     ++S  +ADI+++G+   E+A+
Sbjct: 213 SINMKHFESFKRADIYAMGLVFWEIAR 239

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 92/207 (44%), Gaps = 30/207 (14%)
Query: 62  QERIGKGSFGEVFKGIDNRTQQVVXXXXXXXXXXXXXXXXXXXXXMVLSQ---------- 111
           QE IGKG FGEV++G   R ++V                      ++L            
Sbjct: 14  QESIGKGRFGEVWRG-KWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAAD 72
Query: 112 -CDSPYGTKLWIIMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSE------- 163
             D+   T+LW++ +Y   GS  D +         +  +      GL +LH E       
Sbjct: 73  NKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGK 132
Query: 164 -RKLHRDIKAANVLLSEMGDVKLADFGVA---GTLTNTTSKR-NTFVGTPFWMAPEVIKQ 218
               HRD+K+ N+L+ + G   +AD G+A    + T+T     N  VGT  +MAPEV+  
Sbjct: 133 PAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDD 192
Query: 219 SA----YDS--KADIWSLGITAIELAK 239
           S     ++S  +ADI+++G+   E+A+
Sbjct: 193 SINMKHFESFKRADIYAMGLVFWEIAR 219

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 33/101 (32%), Positives = 55/101 (54%), Gaps = 3/101 (2%)
Query: 144 MHIAVILREVLKGLDYLHSERKLHRDIKAANVLLS-EMGDVKLADFGVAGTLTNTTSKRN 202
           +++ + + ++ + L Y+HS    HRDIK  N+LL  +   +KL DFG A  L        
Sbjct: 160 IYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR-GEPNV 218
Query: 203 TFVGTPFWMAPEVI-KQSAYDSKADIWSLGITAIELAKGEP 242
           +++ + ++ APE+I   + Y S  D+WS G    EL  G+P
Sbjct: 219 SYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQP 259

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 33/101 (32%), Positives = 55/101 (54%), Gaps = 3/101 (2%)
Query: 144 MHIAVILREVLKGLDYLHSERKLHRDIKAANVLLS-EMGDVKLADFGVAGTLTNTTSKRN 202
           +++ + + ++ + L Y+HS    HRDIK  N+LL  +   +KL DFG A  L        
Sbjct: 156 IYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR-GEPNV 214
Query: 203 TFVGTPFWMAPEVI-KQSAYDSKADIWSLGITAIELAKGEP 242
           +++ + ++ APE+I   + Y S  D+WS G    EL  G+P
Sbjct: 215 SYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQP 255

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 33/101 (32%), Positives = 55/101 (54%), Gaps = 3/101 (2%)
Query: 144 MHIAVILREVLKGLDYLHSERKLHRDIKAANVLLS-EMGDVKLADFGVAGTLTNTTSKRN 202
           +++ + + ++ + L Y+HS    HRDIK  N+LL  +   +KL DFG A  L        
Sbjct: 150 IYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR-GEPNV 208
Query: 203 TFVGTPFWMAPEVI-KQSAYDSKADIWSLGITAIELAKGEP 242
           +++ + ++ APE+I   + Y S  D+WS G    EL  G+P
Sbjct: 209 SYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQP 249

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 33/101 (32%), Positives = 55/101 (54%), Gaps = 3/101 (2%)
Query: 144 MHIAVILREVLKGLDYLHSERKLHRDIKAANVLLS-EMGDVKLADFGVAGTLTNTTSKRN 202
           +++ + + ++ + L Y+HS    HRDIK  N+LL  +   +KL DFG A  L        
Sbjct: 158 IYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR-GEPNV 216
Query: 203 TFVGTPFWMAPEVI-KQSAYDSKADIWSLGITAIELAKGEP 242
           +++ + ++ APE+I   + Y S  D+WS G    EL  G+P
Sbjct: 217 SYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQP 257

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 33/101 (32%), Positives = 55/101 (54%), Gaps = 3/101 (2%)
Query: 144 MHIAVILREVLKGLDYLHSERKLHRDIKAANVLLS-EMGDVKLADFGVAGTLTNTTSKRN 202
           +++ + + ++ + L Y+HS    HRDIK  N+LL  +   +KL DFG A  L        
Sbjct: 201 IYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR-GEPNV 259
Query: 203 TFVGTPFWMAPEVI-KQSAYDSKADIWSLGITAIELAKGEP 242
           +++ + ++ APE+I   + Y S  D+WS G    EL  G+P
Sbjct: 260 SYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQP 300

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 33/101 (32%), Positives = 55/101 (54%), Gaps = 3/101 (2%)
Query: 144 MHIAVILREVLKGLDYLHSERKLHRDIKAANVLLS-EMGDVKLADFGVAGTLTNTTSKRN 202
           +++ + + ++ + L Y+HS    HRDIK  N+LL  +   +KL DFG A  L        
Sbjct: 122 IYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR-GEPNV 180
Query: 203 TFVGTPFWMAPEVI-KQSAYDSKADIWSLGITAIELAKGEP 242
           +++ + ++ APE+I   + Y S  D+WS G    EL  G+P
Sbjct: 181 SYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQP 221

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 33/101 (32%), Positives = 55/101 (54%), Gaps = 3/101 (2%)
Query: 144 MHIAVILREVLKGLDYLHSERKLHRDIKAANVLLS-EMGDVKLADFGVAGTLTNTTSKRN 202
           +++ + + ++ + L Y+HS    HRDIK  N+LL  +   +KL DFG A  L        
Sbjct: 135 IYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR-GEPNV 193
Query: 203 TFVGTPFWMAPEVI-KQSAYDSKADIWSLGITAIELAKGEP 242
           +++ + ++ APE+I   + Y S  D+WS G    EL  G+P
Sbjct: 194 SYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQP 234

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 33/101 (32%), Positives = 55/101 (54%), Gaps = 3/101 (2%)
Query: 144 MHIAVILREVLKGLDYLHSERKLHRDIKAANVLLS-EMGDVKLADFGVAGTLTNTTSKRN 202
           +++ + + ++ + L Y+HS    HRDIK  N+LL  +   +KL DFG A  L        
Sbjct: 122 IYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR-GEPNV 180
Query: 203 TFVGTPFWMAPEVI-KQSAYDSKADIWSLGITAIELAKGEP 242
           +++ + ++ APE+I   + Y S  D+WS G    EL  G+P
Sbjct: 181 SYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQP 221

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 96/212 (45%), Gaps = 39/212 (18%)
Query: 118 TKLWIIMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSE--------RKLHRD 169
           T+L++I +Y   GS  D +K+   +   +  +    + GL +LH+E           HRD
Sbjct: 108 TQLYLITDYHENGSLYDYLKSTTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRD 167
Query: 170 IKAANVLLSEMGDVKLADFGVAGTLTNTTSKR----NTFVGTPFWMAPEVIKQSA----Y 221
           +K+ N+L+ + G   +AD G+A    + T++     NT VGT  +M PEV+ +S     +
Sbjct: 168 LKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHF 227
Query: 222 DS--KADIWSLGITAIELAK----------GEPPNSELHP-------MRVLFLIPKNNPP 262
            S   AD++S G+   E+A+           + P  +L P       MR +  I K  P 
Sbjct: 228 QSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPS 287
Query: 263 ----QLTGNYTKQFKEFVEACLNKDPENRPTA 290
                 +    +Q  + +  C   +P +R TA
Sbjct: 288 FPNRWSSDECLRQMGKLMTECWAHNPASRLTA 319

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 65/287 (22%), Positives = 114/287 (39%), Gaps = 46/287 (16%)
Query: 59  FTKQERIGKGSFGEVFKGIDNRTQQVVXXXXX-----------XXXXXXXXXXXXXXXXM 107
           + +  ++G+G++GEV+K ID  T + V                                +
Sbjct: 36  YRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNI 95
Query: 108 VLSQCDSPYGTKLWIIMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLH 167
           +  +    +  +L +I EY        + K  +     I   L +++ G+++ HS R LH
Sbjct: 96  IELKSVIHHNHRLHLIFEYAENDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLH 155
Query: 168 RDIKAANVLL-----SEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQS-AY 221
           RD+K  N+LL     SE   +K+ DFG+A        +    + T ++  PE++  S  Y
Sbjct: 156 RDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYRPPEILLGSRHY 215
Query: 222 DSKADIWSLGITAIELAKGE---PPNSELHPM----RVLFLIPKNNPPQLTG--NYTKQF 272
            +  DIWS+     E+       P +SE+  +     VL L      P +T   ++ + F
Sbjct: 216 STSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALPDWKQSF 275
Query: 273 KEF--------------------VEACLNKDPENRPTAKELLKFPFI 299
            +F                    + A L  DP  R +AK  L+ P+ 
Sbjct: 276 PKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYF 322

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 32/89 (35%), Positives = 52/89 (58%), Gaps = 4/89 (4%)
Query: 152 EVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTL---TNTTSKRNTFVGTP 208
           +V KG+++L  +  +HRD+ A NVL++    VK+ DFG+A  +   +N   + N  +   
Sbjct: 180 QVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVK 239
Query: 209 FWMAPEVIKQSAYDSKADIWSLGITAIEL 237
            WMAPE + +  Y  K+D+WS GI   E+
Sbjct: 240 -WMAPESLFEGIYTIKSDVWSYGILLWEI 267

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 33/101 (32%), Positives = 55/101 (54%), Gaps = 3/101 (2%)
Query: 144 MHIAVILREVLKGLDYLHSERKLHRDIKAANVLLS-EMGDVKLADFGVAGTLTNTTSKRN 202
           +++ + + ++ + L Y+HS    HRDIK  N+LL  +   +KL DFG A  L        
Sbjct: 122 IYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR-GEPNV 180
Query: 203 TFVGTPFWMAPEVI-KQSAYDSKADIWSLGITAIELAKGEP 242
           +++ + ++ APE+I   + Y S  D+WS G    EL  G+P
Sbjct: 181 SYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQP 221

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 33/101 (32%), Positives = 55/101 (54%), Gaps = 3/101 (2%)
Query: 144 MHIAVILREVLKGLDYLHSERKLHRDIKAANVLLS-EMGDVKLADFGVAGTLTNTTSKRN 202
           +++ + + ++ + L Y+HS    HRDIK  N+LL  +   +KL DFG A  L        
Sbjct: 127 IYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR-GEPNV 185
Query: 203 TFVGTPFWMAPEVI-KQSAYDSKADIWSLGITAIELAKGEP 242
           +++ + ++ APE+I   + Y S  D+WS G    EL  G+P
Sbjct: 186 SYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQP 226

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 37/101 (36%), Positives = 56/101 (55%), Gaps = 5/101 (4%)
Query: 146 IAVILREVLKGLDYLH--SERKLHRDIKAANVLLSEM-GDVKLADFGVAGTLTNTTSKRN 202
           I V L ++++ +  LH  S    HRDIK  NVL++E  G +KL DFG A  L+  +    
Sbjct: 131 IKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLS-PSEPNV 189
Query: 203 TFVGTPFWMAPEVI-KQSAYDSKADIWSLGITAIELAKGEP 242
            ++ + ++ APE+I     Y +  DIWS+G    E+  GEP
Sbjct: 190 AYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEP 230

>pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 65/251 (25%), Positives = 93/251 (37%), Gaps = 69/251 (27%)
Query: 120 LWIIMEYLGGGSALDLMKAGNFEEM---HIAVILREVLKGLDYLHSERKLHRDIKAANVL 176
           + I+ E LG  S  D +K   F      HI  +  ++ K +++LHS +  H D+K  N+L
Sbjct: 92  ICIVFELLGL-STYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENIL 150
Query: 177 LSEMG-------------------DVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIK 217
             +                     D+K+ DFG A   T      +T V T  + APEVI 
Sbjct: 151 FVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSA---TYDDEHHSTLVSTRHYRAPEVIL 207
Query: 218 QSAYDSKADIWSLGITAIELAKG------EPPNSELHPM-RVLFLIPKN----------- 259
              +    D+WS+G   IE   G            L  M R+L  +PK+           
Sbjct: 208 ALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYF 267
Query: 260 -------NPPQLTGNYT----KQFKEF--------------VEACLNKDPENRPTAKELL 294
                  +     G Y     K  KEF              ++  L  DP  R T +E L
Sbjct: 268 HHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREAL 327
Query: 295 KFPFIRKAKKN 305
           K PF    KK+
Sbjct: 328 KHPFFDLLKKS 338

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 36/101 (35%), Positives = 55/101 (54%), Gaps = 3/101 (2%)
Query: 144 MHIAVILREVLKGLDYLHSERKLHRDIKAANVLLS-EMGDVKLADFGVAGTLTNTTSKRN 202
           + I + + ++L+ L Y+HS    HRDIK  N+LL    G +KL DFG A  L        
Sbjct: 141 LLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILI-AGEPNV 199
Query: 203 TFVGTPFWMAPEVI-KQSAYDSKADIWSLGITAIELAKGEP 242
           + + + ++ APE+I   + Y +  DIWS G    EL +G+P
Sbjct: 200 SXICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQP 240
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	604
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	0.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	1e-169
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	1e-169
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	1e-167
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	1e-166
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	1e-164
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	1e-164
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	1e-161
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	1e-150
3aln_A	327	Dual specificity mitogen-activated protein kinase;	1e-130
2dyl_A	318	Dual specificity mitogen-activated protein kinase	1e-128
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	1e-127
3fme_A	290	Dual specificity mitogen-activated protein kinase;	1e-125
3an0_A	340	Dual specificity mitogen-activated protein kinase;	1e-121
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	1e-116
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	1e-116
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	1e-109
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	1e-101
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	1e-98
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	2e-98
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	2e-96
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	4e-92
2a19_B	284	Interferon-induced, double-stranded RNA-activated	7e-90
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	5e-79
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	7e-79
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	7e-71
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	1e-70
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	4e-69
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	5e-67
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	1e-60
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	3e-60
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	9e-60
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	1e-58
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	4e-58
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	5e-58
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	2e-57
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	2e-54
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	4e-54
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	8e-54
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	1e-53
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	5e-53
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	6e-53
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	2e-52
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	2e-09
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	1e-51
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	4e-51
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	5e-51
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	6e-51
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	7e-51
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	1e-50
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	2e-50
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	4e-50
3q4u_A	301	Activin receptor type-1; structural genomics conso	6e-50
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	8e-50
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	1e-49
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	2e-49
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	2e-49
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	2e-49
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	3e-49
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	6e-49
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	8e-49
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	1e-48
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	1e-48
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	2e-48
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	2e-48
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	3e-48
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	5e-48
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	7e-48
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	8e-48
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	9e-48
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	2e-47
3bhy_A	283	Death-associated protein kinase 3; death associate	5e-47
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	7e-47
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	1e-46
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	2e-46
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	3e-46
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	3e-46
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	8e-46
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	9e-46
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	2e-45
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	3e-45
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	3e-45
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	3e-45
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	5e-45
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	9e-45
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	1e-44
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	2e-44
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	3e-44
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	3e-44
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	5e-44
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	7e-44
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	2e-43
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	2e-43
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	3e-43
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	1e-42
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	2e-42
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	6e-42
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	9e-42
3soc_A	322	Activin receptor type-2A; structural genomics cons	1e-41
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	2e-41
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	2e-41
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	3e-41
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	9e-41
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	1e-40
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	1e-40
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	2e-40
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	2e-40
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	5e-40
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	6e-40
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	6e-40
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	7e-40
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	7e-40
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	1e-39
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	1e-39
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	1e-39
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	1e-39
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	4e-39
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	5e-39
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	5e-39
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	6e-39
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	6e-39
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	1e-38
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	2e-38
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	3e-38
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	3e-38
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	3e-38
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	4e-38
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	5e-38
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	6e-38
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	6e-38
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	7e-38
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	7e-38
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	7e-38
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	9e-38
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	9e-38
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	1e-37
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	1e-37
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	2e-37
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	2e-37
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	2e-37
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	2e-37
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	2e-37
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	2e-37
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	3e-37
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	3e-37
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	4e-37
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	4e-37
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	5e-37
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	5e-37
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	5e-37
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	6e-37
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	6e-37
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	1e-36
3niz_A	311	Rhodanese family protein; structural genomics, str	1e-36
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	1e-36
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	1e-36
3o0g_A	292	Cell division protein kinase 5; kinase activator c	2e-36
3ork_A	311	Serine/threonine protein kinase; structural genomi	2e-36
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	2e-36
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	2e-36
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	2e-36
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	3e-36
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	5e-36
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	7e-36
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	9e-36
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	9e-36
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	9e-36
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	1e-35
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	1e-35
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	1e-35
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	2e-35
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	2e-35
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	3e-35
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	3e-35
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	3e-35
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	4e-35
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	6e-35
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	3e-34
3pls_A	298	Macrophage-stimulating protein receptor; protein k	4e-34
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	8e-34
3uqc_A	286	Probable conserved transmembrane protein; structur	8e-34
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	4e-33
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	7e-33
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	1e-32
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	7e-32
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	2e-31
4aoj_A	329	High affinity nerve growth factor receptor; transf	5e-31
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	6e-31
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	2e-30
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	2e-30
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	2e-30
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	2e-30
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	2e-30
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	9e-30
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	1e-29
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	2e-29
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	5e-29
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	3e-28
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	9e-28
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	2e-27
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	3e-27
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	6e-27
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	7e-27
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	8e-27
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	9e-27
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	9e-27
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	1e-26
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	1e-26
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	1e-26
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	1e-26
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	1e-26
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	1e-26
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	2e-26
3rp9_A	458	Mitogen-activated protein kinase; structural genom	3e-26
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	3e-26
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	3e-26
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	5e-26
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	8e-26
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	1e-25
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	2e-25
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	4e-25
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	8e-25
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	1e-24
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	1e-24
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	2e-24
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	5e-24
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	2e-22
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	8e-20
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	1e-19
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	2e-18
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	1e-04
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	5e-18
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	3e-17
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	2e-16
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	6e-15
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	2e-13
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	6e-13
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	1e-10
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	3e-09
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	2e-05
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	2e-04

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  518 bits (1335), Expect = 0.0
 Identities = 224/287 (78%), Positives = 247/287 (86%), Gaps = 11/287 (3%)

Query: 50  SLKVDPELIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVL 109
           +LK DPE +FTK E+IGKGSFGEVFKGIDNRTQ+VVAIKIIDLEEAEDEIEDIQQEI VL
Sbjct: 15  NLKADPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVL 74

Query: 110 SQCDSPY----------GTKLWIIMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDY 159
           SQCDSPY           TKLWIIMEYLGGGSALDL++ G  +E  IA ILRE+LKGLDY
Sbjct: 75  SQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDY 134

Query: 160 LHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQS 219
           LHSE+K+HRDIKAANVLLSE G+VKLADFGVAG LT+T  KRNTFVGTPFWMAPEVIKQS
Sbjct: 135 LHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQS 194

Query: 220 AYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEAC 279
           AYDSKADIWSLGITAIELA+GEPP+SELHPM+VLFLIPKNNPP L GNY+K  KEFVEAC
Sbjct: 195 AYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEAC 254

Query: 280 LNKDPENRPTAKELLKFPFI-RKAKKNAYLIDLIDRYKKWKNSRNEE 325
           LNK+P  RPTAKELLK  FI R AKK +YL +LIDRYK+WK  ++ +
Sbjct: 255 LNKEPSFRPTAKELLKHKFILRNAKKTSYLTELIDRYKRWKAEQSHD 301

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  482 bits (1242), Expect = e-169
 Identities = 143/298 (47%), Positives = 194/298 (65%), Gaps = 17/298 (5%)

Query: 47  RRNSLKVDPELIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEI 106
             +SL   PE +F   E++G+GS+G V+K I   T Q+VAIK + +E    ++++I +EI
Sbjct: 19  DEDSLTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE---SDLQEIIKEI 75

Query: 107 MVLSQCDSPY----------GTKLWIIMEYLGGGSALDLMKA--GNFEEMHIAVILREVL 154
            ++ QCDSP+           T LWI+MEY G GS  D+++       E  IA IL+  L
Sbjct: 76  SIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTL 135

Query: 155 KGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPE 214
           KGL+YLH  RK+HRDIKA N+LL+  G  KLADFGVAG LT+T +KRNT +GTPFWMAPE
Sbjct: 136 KGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPE 195

Query: 215 VIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTG--NYTKQF 272
           VI++  Y+  ADIWSLGITAIE+A+G+PP +++HPMR +F+IP N PP       ++  F
Sbjct: 196 VIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELWSDNF 255

Query: 273 KEFVEACLNKDPENRPTAKELLKFPFIRKAKKNAYLIDLIDRYKKWKNSRNEESETES 330
            +FV+ CL K PE R TA +LL+ PF+R AK  + L DLI+     K  R E  + E 
Sbjct: 256 TDFVKQCLVKSPEQRATATQLLQHPFVRSAKGVSILRDLINEAMDVKLKRQESQQREE 313

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  481 bits (1240), Expect = e-169
 Identities = 118/287 (41%), Positives = 180/287 (62%), Gaps = 20/287 (6%)

Query: 52  KVDPELIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQ 111
            +DP  ++     +G G+FG+V+K  +  T  + A K+I+ +  E+E+ED   EI +L+ 
Sbjct: 14  DLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKS-EEELEDYIVEIEILAT 72

Query: 112 CDSPY----------GTKLWIIMEYLGGGSALDLMKA--GNFEEMHIAVILREVLKGLDY 159
           CD PY            KLWI++E+  GG+   +M        E  I V+ R++L+ L++
Sbjct: 73  CDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNF 132

Query: 160 LHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVI--- 216
           LHS+R +HRD+KA NVL++  GD++LADFGV+     T  KR++F+GTP+WMAPEV+   
Sbjct: 133 LHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCE 192

Query: 217 --KQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLT--GNYTKQF 272
             K + YD KADIWSLGIT IE+A+ EPP+ EL+PMRVL  I K++PP L     ++ +F
Sbjct: 193 TMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKWSVEF 252

Query: 273 KEFVEACLNKDPENRPTAKELLKFPFIRKAKKNAYLIDLIDRYKKWK 319
           ++F++  L+K+PE RP+A +LL+ PF+     N  L +L+   K   
Sbjct: 253 RDFLKIALDKNPETRPSAAQLLEHPFVSSITSNKALRELVAEAKAEV 299

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  478 bits (1232), Expect = e-167
 Identities = 117/282 (41%), Positives = 172/282 (60%), Gaps = 13/282 (4%)

Query: 54  DPELIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCD 113
           DP+  +T+ E+IG+G+ G V+  +D  T Q VAI+ ++L++   + E I  EI+V+ +  
Sbjct: 17  DPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKK-ELIINEILVMRENK 75

Query: 114 SPY----------GTKLWIIMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSE 163
           +P           G +LW++MEYL GGS  D++     +E  IA + RE L+ L++LHS 
Sbjct: 76  NPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSN 135

Query: 164 RKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDS 223
           + +HRDIK+ N+LL   G VKL DFG    +T   SKR+T VGTP+WMAPEV+ + AY  
Sbjct: 136 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGP 195

Query: 224 KADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTG--NYTKQFKEFVEACLN 281
           K DIWSLGI AIE+ +GEPP    +P+R L+LI  N  P+L      +  F++F+  CL 
Sbjct: 196 KVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLE 255

Query: 282 KDPENRPTAKELLKFPFIRKAKKNAYLIDLIDRYKKWKNSRN 323
            D E R +AKELL+  F++ AK  + L  LI   K+   + +
Sbjct: 256 MDVEKRGSAKELLQHQFLKIAKPLSSLTPLIAAAKEATKNNH 297

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  474 bits (1222), Expect = e-166
 Identities = 98/282 (34%), Positives = 160/282 (56%), Gaps = 13/282 (4%)

Query: 52  KVDPELIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQ 111
           + DP L+     +IG+GS G V    +  + + VA+K++DL + +   E +  E++++  
Sbjct: 40  QGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRR-ELLFNEVVIMRD 98

Query: 112 CDSPY----------GTKLWIIMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLH 161
                          G +LW++ME+L GG+  D++      E  IA +   VL+ L YLH
Sbjct: 99  YQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQVRLNEEQIATVCEAVLQALAYLH 158

Query: 162 SERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAY 221
           ++  +HRDIK+ ++LL+  G VKL+DFG    ++    KR + VGTP+WMAPEVI +S Y
Sbjct: 159 AQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRSLY 218

Query: 222 DSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGN--YTKQFKEFVEAC 279
            ++ DIWSLGI  IE+  GEPP     P++ +  +  + PP+L  +   +   ++F+E  
Sbjct: 219 ATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKVSPVLRDFLERM 278

Query: 280 LNKDPENRPTAKELLKFPFIRKAKKNAYLIDLIDRYKKWKNS 321
           L +DP+ R TA+ELL  PF+ +      L+ LI  Y+K  ++
Sbjct: 279 LVRDPQERATAQELLDHPFLLQTGLPECLVPLIQLYRKQTST 320

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  471 bits (1215), Expect = e-164
 Identities = 137/310 (44%), Positives = 188/310 (60%), Gaps = 35/310 (11%)

Query: 54  DPELIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQ-C 112
           DP  IF   E +G G++G+V+KG   +T Q+ AIK++D+    DE E+I+QEI +L +  
Sbjct: 21  DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG--DEEEEIKQEINMLKKYS 78

Query: 113 DSPY----------------GTKLWIIMEYLGGGSALDLMK---AGNFEEMHIAVILREV 153
                                 +LW++ME+ G GS  DL+K       +E  IA I RE+
Sbjct: 79  HHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREI 138

Query: 154 LKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAP 213
           L+GL +LH  + +HRDIK  NVLL+E  +VKL DFGV+  L  T  +RNTF+GTP+WMAP
Sbjct: 139 LRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAP 198

Query: 214 EVIK-----QSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTG-N 267
           EVI       + YD K+D+WSLGITAIE+A+G PP  ++HPMR LFLIP+N  P+L    
Sbjct: 199 EVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSKK 258

Query: 268 YTKQFKEFVEACLNKDPENRPTAKELLKFPFIRKAKKNAY----LIDLIDRYKKWKNSRN 323
           ++K+F+ F+E+CL K+   RP  ++L+K PFIR           L D IDR KK    R 
Sbjct: 259 WSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQPNERQVRIQLKDHIDRTKKK---RG 315

Query: 324 EESETESETS 333
           E+ ETE E S
Sbjct: 316 EKDETEYEYS 325

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  471 bits (1213), Expect = e-164
 Identities = 116/293 (39%), Positives = 169/293 (57%), Gaps = 23/293 (7%)

Query: 52  KVDPELIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDL--EEAEDEIEDIQQEIMVL 109
           K DPE +F+    IG GSFG V+   D R  +VVAIK +    +++ ++ +DI +E+  L
Sbjct: 49  KDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFL 108

Query: 110 SQCDSPY----------GTKLWIIMEYLGGGSALDLMKA--GNFEEMHIAVILREVLKGL 157
            +   P               W++MEY  G SA DL++      +E+ IA +    L+GL
Sbjct: 109 QKLRHPNTIQYRGCYLREHTAWLVMEYCLG-SASDLLEVHKKPLQEVEIAAVTHGALQGL 167

Query: 158 DYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVI- 216
            YLHS   +HRD+KA N+LLSE G VKL DFG A  +       N+FVGTP+WMAPEVI 
Sbjct: 168 AYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA----PANSFVGTPYWMAPEVIL 223

Query: 217 --KQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLT-GNYTKQFK 273
              +  YD K D+WSLGIT IELA+ +PP   ++ M  L+ I +N  P L  G++++ F+
Sbjct: 224 AMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFR 283

Query: 274 EFVEACLNKDPENRPTAKELLKFPFIRKAKKNAYLIDLIDRYKKWKNSRNEES 326
            FV++CL K P++RPT++ LLK  F+ + +    ++DLI R K      +   
Sbjct: 284 NFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPTVIMDLIQRTKDAVRELDNLQ 336

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  462 bits (1191), Expect = e-161
 Identities = 123/291 (42%), Positives = 166/291 (57%), Gaps = 34/291 (11%)

Query: 54  DPELIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCD 113
                +  QE IG G+   V        ++ VAIK I+LE+ +  ++++ +EI  +SQC 
Sbjct: 12  INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCH 71

Query: 114 SPY----------GTKLWIIMEYLGGGSALDLMK---------AGNFEEMHIAVILREVL 154
            P             +LW++M+ L GGS LD++K         +G  +E  IA ILREVL
Sbjct: 72  HPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVL 131

Query: 155 KGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNT-----TSKRNTFVGTPF 209
           +GL+YLH   ++HRD+KA N+LL E G V++ADFGV+  L           R TFVGTP 
Sbjct: 132 EGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPC 191

Query: 210 WMAPEVIKQ-SAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQL---- 264
           WMAPEV++Q   YD KADIWS GITAIELA G  P  +  PM+VL L  +N+PP L    
Sbjct: 192 WMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLETGV 251

Query: 265 -----TGNYTKQFKEFVEACLNKDPENRPTAKELLKFPFIRKAKKNAYLID 310
                   Y K F++ +  CL KDPE RPTA ELL+  F +KAK   +L +
Sbjct: 252 QDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAKNKEFLQE 302

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  438 bits (1128), Expect = e-150
 Identities = 88/365 (24%), Positives = 148/365 (40%), Gaps = 72/365 (19%)

Query: 54  DPELIFTKQERIGKG--SFGEVFKGIDNRTQQVVAIKIIDLEEAEDE-IEDIQQEIMVLS 110
                +     IGKG      V       T + V ++ I+LE   +E +  +Q E+ V  
Sbjct: 22  PEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSK 81

Query: 111 QCDSPY----------GTKLWIIMEYLGGGSALDLMKA---GNFEEMHIAVILREVLKGL 157
             + P             +LW++  ++  GSA DL+         E+ IA IL+ VLK L
Sbjct: 82  LFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKAL 141

Query: 158 DYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNT-------FVGTPFW 210
           DY+H    +HR +KA+++L+S  G V L+      ++ +   ++          V    W
Sbjct: 142 DYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPW 201

Query: 211 MAPEVIKQSA--YDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTG-- 266
           ++PEV++Q+   YD+K+DI+S+GITA ELA G  P  ++   ++L        P L    
Sbjct: 202 LSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTS 261

Query: 267 -------------------------------------------NYTKQFKEFVEACLNKD 283
                                                       ++  F  FVE CL ++
Sbjct: 262 TIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRN 321

Query: 284 PENRPTAKELLKFPFIRKAKKNA--YLIDLIDRYKKWKNSRNEESETESETSDNEDSIKT 341
           P+ RP+A  LL   F ++ K+ A   L +L+       N    +S+  S       +++ 
Sbjct: 322 PDARPSASTLLNHSFFKQIKRRASEALPELLRPVTPITNFEGSQSQDHSGIFGLVTNLEE 381

Query: 342 DGDLD 346
               D
Sbjct: 382 LEVDD 386

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  384 bits (989), Expect = e-130
 Identities = 95/314 (30%), Positives = 145/314 (46%), Gaps = 39/314 (12%)

Query: 46  SRRNSLKVDPELIFT-------KQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDE 98
                LK+ PE  +            IG+G++G V K +   + Q++A+K I     E E
Sbjct: 4   ESSGKLKISPEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKE 63

Query: 99  IEDIQQEI-MVLSQCDSPY----------GTKLWIIMEYLGGGSALDLMKA-----GNFE 142
            + +  ++ +V+   D PY              WI ME +                    
Sbjct: 64  QKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIP 123

Query: 143 EMHIAVILREVLKGLDYLHSERKL-HRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKR 201
           E  +  I    +K L++L    K+ HRDIK +N+LL   G++KL DFG++G L ++ +K 
Sbjct: 124 EEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKT 183

Query: 202 NTFVGTPFWMAPEVIKQSA----YDSKADIWSLGITAIELAKGEPPNSELHPM-RVLFLI 256
               G   +MAPE I  SA    YD ++D+WSLGIT  ELA G  P  + + +   L  +
Sbjct: 184 RD-AGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQV 242

Query: 257 PKNNPPQLT----GNYTKQFKEFVEACLNKDPENRPTAKELLKFPFIRKAKKN-----AY 307
            K +PPQL+      ++  F  FV  CL KD   RP  KELLK PFI   ++       Y
Sbjct: 243 VKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMYEERAVEVACY 302

Query: 308 LIDLIDRYKKWKNS 321
           +  ++D+     +S
Sbjct: 303 VCKILDQMPATPSS 316

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  377 bits (970), Expect = e-128
 Identities = 84/291 (28%), Positives = 145/291 (49%), Gaps = 27/291 (9%)

Query: 59  FTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVL-SQCDSPY- 116
                 +G G+ G+V+K    +T  V+A+K +     ++E + I  ++ V+    D PY 
Sbjct: 27  LENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYI 86

Query: 117 ---------GTKLWIIMEYLGGGS-ALDLMKAGNFEEMHIAVILREVLKGLDYLHSERK- 165
                     T ++I ME +G  +  L     G   E  +  +   ++K L YL  +   
Sbjct: 87  VQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGV 146

Query: 166 LHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIK-----QSA 220
           +HRD+K +N+LL E G +KL DFG++G L +  +K +   G   +MAPE I      +  
Sbjct: 147 IHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAK-DRSAGCAAYMAPERIDPPDPTKPD 205

Query: 221 YDSKADIWSLGITAIELAKGEPPNSELHP-MRVLFLIPKNNPPQLTGN--YTKQFKEFVE 277
           YD +AD+WSLGI+ +ELA G+ P         VL  + +  PP L G+  ++  F+ FV+
Sbjct: 206 YDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMGFSGDFQSFVK 265

Query: 278 ACLNKDPENRPTAKELLKFPFIRKAKKN-----AYLIDLIDRYKKWKNSRN 323
            CL KD   RP   +LL+  FI++ +       ++  D++ + +  ++  +
Sbjct: 266 DCLTKDHRKRPKYNKLLEHSFIKRYETLEVDVASWFKDVMAKTESPRSGPS 316

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  376 bits (967), Expect = e-127
 Identities = 86/311 (27%), Positives = 128/311 (41%), Gaps = 30/311 (9%)

Query: 30  SNSGSSISNQCGSTTASRRNSLKVDPELIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKI 89
            N G  ++ +        R     +     T Q R+G+GSFGEV +  D +T    A+K 
Sbjct: 36  DNEGVLLTEKLKPVDYEYR-----EEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKK 90

Query: 90  IDLEEAEDEIEDIQQEIMVLSQCDSPY----------GTKLWIIMEYLGGGSALDLMKA- 138
           + LE          +E++  +   SP           G  + I ME L GGS   L+K  
Sbjct: 91  VRLEVFR------VEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQM 144

Query: 139 GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMG-DVKLADFGVAGTLT-- 195
           G   E      L + L+GL+YLH+ R LH D+KA NVLLS  G    L DFG A  L   
Sbjct: 145 GCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPD 204

Query: 196 ---NTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRV 252
               +    +   GT   MAPEV+     D+K DIWS     + +  G  P ++     +
Sbjct: 205 GLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPL 264

Query: 253 LFLIPKNNPPQLT--GNYTKQFKEFVEACLNKDPENRPTAKELLKFPFIRKAKKNAYLID 310
              I    PP      +      + ++  L K+P +R +A EL +       +       
Sbjct: 265 CLKIASEPPPIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSP 324

Query: 311 LIDRYKKWKNS 321
               YK+ + +
Sbjct: 325 WKGEYKEPRGN 335

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  370 bits (951), Expect = e-125
 Identities = 82/277 (29%), Positives = 135/277 (48%), Gaps = 24/277 (8%)

Query: 50  SLKVDPELIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEI-MV 108
           S++V  +        +G+G++G V K     + Q++A+K I       E + +  ++ + 
Sbjct: 1   SMEVKAD-DLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDIS 59

Query: 109 LSQCDSPY----------GTKLWIIMEYLGGGSALDLM----KAGNFEEMHIAVILREVL 154
           +   D P+             +WI ME +             K     E  +  I   ++
Sbjct: 60  MRTVDCPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIV 119

Query: 155 KGLDYLHSERK-LHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAP 213
           K L++LHS+   +HRD+K +NVL++ +G VK+ DFG++G L +  +K +   G   +MAP
Sbjct: 120 KALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAK-DIDAGCKPYMAP 178

Query: 214 EVIK----QSAYDSKADIWSLGITAIELAKGEPP-NSELHPMRVLFLIPKNNPPQL-TGN 267
           E I     Q  Y  K+DIWSLGIT IELA    P +S   P + L  + +   PQL    
Sbjct: 179 ERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADK 238

Query: 268 YTKQFKEFVEACLNKDPENRPTAKELLKFPFIRKAKK 304
           ++ +F +F   CL K+ + RPT  EL++ PF    + 
Sbjct: 239 FSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLHES 275

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  347 bits (892), Expect = e-116
 Identities = 87/286 (30%), Positives = 139/286 (48%), Gaps = 23/286 (8%)

Query: 42  STTASRRNSLKVDPELIFTKQER---IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDE 98
           ST      S  ++ +  + +      +GKG++G V+ G D   Q  +AIK I   ++   
Sbjct: 4   STEEGDCESDLLEYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSR-Y 62

Query: 99  IEDIQQEIMVLSQCDSPY----------GTKLWIIMEYLGGGSALDLMKA--GNFE--EM 144
            + + +EI +                     + I ME + GGS   L+++  G  +  E 
Sbjct: 63  SQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQ 122

Query: 145 HIAVILREVLKGLDYLHSERKLHRDIKAANVLL-SEMGDVKLADFGVAGTLTNTTSKRNT 203
            I    +++L+GL YLH  + +HRDIK  NVL+ +  G +K++DFG +  L        T
Sbjct: 123 TIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET 182

Query: 204 FVGTPFWMAPEVIKQSA--YDSKADIWSLGITAIELAKGEPPNSEL-HPMRVLFLIPKNN 260
           F GT  +MAPE+I +    Y   ADIWSLG T IE+A G+PP  EL  P   +F +    
Sbjct: 183 FTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFK 242

Query: 261 -PPQLTGNYTKQFKEFVEACLNKDPENRPTAKELLKFPFIRKAKKN 305
             P++  + + + K F+  C   DP+ R  A +LL   F++ + K 
Sbjct: 243 VHPEIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVSSKK 288

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  349 bits (896), Expect = e-116
 Identities = 94/326 (28%), Positives = 154/326 (47%), Gaps = 62/326 (19%)

Query: 59  FTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPY-- 116
           F K   +G G+ G VFK     +  V+A K+I LE        I +E+ VL +C+SPY  
Sbjct: 35  FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 94

Query: 117 --------GTKLWIIMEYLGGGSALDLMK-AGNFEEMHIAVILREVLKGLDYLHSERK-L 166
                     ++ I ME++ GGS   ++K AG   E  +  +   V+KGL YL  + K +
Sbjct: 95  GFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIM 154

Query: 167 HRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKAD 226
           HRD+K +N+L++  G++KL DFGV+G L +  S  N+FVGT  +M+PE ++ + Y  ++D
Sbjct: 155 HRDVKPSNILVNSRGEIKLCDFGVSGQLID--SMANSFVGTRSYMSPERLQGTHYSVQSD 212

Query: 227 IWSLGITAIELAKGEPP--------------------------------------NSELH 248
           IWS+G++ +E+A G  P                                        +  
Sbjct: 213 IWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSR 272

Query: 249 PMRVLF----LIPKNNPPQL-TGNYTKQFKEFVEACLNKDPENRPTAKELLKFPFIRKAK 303
           P   +F     I    PP+L +G ++ +F++FV  CL K+P  R   K+L+   FI+++ 
Sbjct: 273 PPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSD 332

Query: 304 KN-----AYLIDLIDRYKKWKNSRNE 324
                   +L   I   +    +   
Sbjct: 333 AEEVDFAGWLCSTIGLNQPSTPTHAA 358

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  327 bits (840), Expect = e-109
 Identities = 66/283 (23%), Positives = 118/283 (41%), Gaps = 44/283 (15%)

Query: 59  FTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA-EDEIEDIQQEIMVLSQ-CDSPY 116
           F + E+IG G FG VFK +      + AIK      A   + ++  +E+   +      +
Sbjct: 13  FHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSH 72

Query: 117 ----------GTKLWIIMEYLGGGSALDLMKA-----GNFEEMHIAVILREVLKGLDYLH 161
                        + I  EY  GGS  D +         F+E  +  +L +V +GL Y+H
Sbjct: 73  VVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH 132

Query: 162 SERKLHRDIKAANVLLSEMGD-------------------VKLADFGVAGTLTNTTSKRN 202
           S   +H DIK +N+ +S                        K+ D G    +++      
Sbjct: 133 SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSP----Q 188

Query: 203 TFVGTPFWMAPEVIKQS-AYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNP 261
              G   ++A EV++++  +  KADI++L +T +  A  EP             I +   
Sbjct: 189 VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWHE---IRQGRL 245

Query: 262 PQLTGNYTKQFKEFVEACLNKDPENRPTAKELLKFPFIRKAKK 304
           P++    +++F E ++  ++ DPE RP+A  L+K   +  A +
Sbjct: 246 PRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSASR 288

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  308 bits (790), Expect = e-101
 Identities = 70/297 (23%), Positives = 132/297 (44%), Gaps = 43/297 (14%)

Query: 59  FTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPY-- 116
           F +   +G+G+FG+V K  +    +  AIK I   E  +++  I  E+M+L+  +  Y  
Sbjct: 8   FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTE--EKLSTILSEVMLLASLNHQYVV 65

Query: 117 ---------------------GTKLWIIMEYLGGGSALDLMKAGN--FEEMHIAVILREV 153
                                 + L+I MEY   G+  DL+ + N   +      + R++
Sbjct: 66  RYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQI 125

Query: 154 LKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTT--------------S 199
           L+ L Y+HS+  +HRD+K  N+ + E  +VK+ DFG+A  +  +                
Sbjct: 126 LEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSD 185

Query: 200 KRNTFVGTPFWMAPEVIKQSA-YDSKADIWSLGITAIELAKG-EPPNSELHPMRVLFLIP 257
              + +GT  ++A EV+  +  Y+ K D++SLGI   E+          ++ ++ L  + 
Sbjct: 186 NLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFSTGMERVNILKKLRSVS 245

Query: 258 KNNPPQLTGNYTKQFKEFVEACLNKDPENRPTAKELLKFPFIRKAKKNAYLIDLIDR 314
              PP    N  K  K+ +   ++ DP  RP A+ LL   ++    ++  + + +  
Sbjct: 246 IEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVKHQDEVIKEALKS 302

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  301 bits (774), Expect = 1e-98
 Identities = 71/256 (27%), Positives = 110/256 (42%), Gaps = 17/256 (6%)

Query: 59  FTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA--EDEIEDIQQEIMVLSQCDSPY 116
           F +  R+G GS+GEVFK       ++ A+K         +D    + +          P 
Sbjct: 59  FQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPC 118

Query: 117 ----------GTKLWIIMEYLGGGSALDLMKAGN-FEEMHIAVILREVLKGLDYLHSERK 165
                     G  L++  E  G          G    E  +   LR+ L  L +LHS+  
Sbjct: 119 CVRLEQAWEEGGILYLQTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGL 178

Query: 166 LHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKA 225
           +H D+K AN+ L   G  KL DFG+   L  T        G P +MAPE++ Q +Y + A
Sbjct: 179 VHLDVKPANIFLGPRGRCKLGDFGLLVEL-GTAGAGEVQEGDPRYMAPELL-QGSYGTAA 236

Query: 226 DIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPE 285
           D++SLG+T +E+A            + L       PP+ T   + + +  +   L  DP+
Sbjct: 237 DVFSLGLTILEVACNMELPHGGEGWQQLR--QGYLPPEFTAGLSSELRSVLVMMLEPDPK 294

Query: 286 NRPTAKELLKFPFIRK 301
            R TA+ LL  P +R+
Sbjct: 295 LRATAEALLALPVLRQ 310

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  300 bits (771), Expect = 2e-98
 Identities = 67/277 (24%), Positives = 125/277 (45%), Gaps = 25/277 (9%)

Query: 47  RRNSLKVDPELIFTK-QERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE-AEDEIEDIQQ 104
              ++ +  +  F K    IG+GSF  V+KG+D  T   VA   +   +  + E +  ++
Sbjct: 15  ETKAVGMSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKE 74

Query: 105 EIMVLSQCDSPY--------------GTKLWIIMEYLGGGSALDLMKA-GNFEEMHIAVI 149
           E  +L     P                  + ++ E +  G+    +K     +   +   
Sbjct: 75  EAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSW 134

Query: 150 LREVLKGLDYLHSERK--LHRDIKAANVLLSEM-GDVKLADFGVAGTLTNTTSKRNTFVG 206
            R++LKGL +LH+     +HRD+K  N+ ++   G VK+ D G+A     + +K    +G
Sbjct: 135 CRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK--AVIG 192

Query: 207 TPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLI--PKNNPPQL 264
           TP +MAPE+ ++  YD   D+++ G+  +E+A  E P SE      ++        P   
Sbjct: 193 TPEFMAPEMYEEK-YDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASF 251

Query: 265 TGNYTKQFKEFVEACLNKDPENRPTAKELLKFPFIRK 301
                 + KE +E C+ ++ + R + K+LL   F ++
Sbjct: 252 DKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  296 bits (760), Expect = 2e-96
 Identities = 77/299 (25%), Positives = 135/299 (45%), Gaps = 20/299 (6%)

Query: 30  SNSGSSISNQCGSTTASRRNSLKVDPELIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKI 89
           S               + R  +  +    F  +++IG+G F EV++         VA+K 
Sbjct: 5   SQGMQGPPVPQFQPQKALRPDMGYNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKK 64

Query: 90  IDLEEAED--EIEDIQQEIMVLSQCDSPY----------GTKLWIIMEYLGGGSALDLMK 137
           + + +  D     D  +EI +L Q + P             +L I++E    G    ++K
Sbjct: 65  VQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIK 124

Query: 138 A-----GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAG 192
                     E  +     ++   L+++HS R +HRDIK ANV ++  G VKL D G+  
Sbjct: 125 HFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGR 184

Query: 193 TLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPP-NSELHPMR 251
             ++ T+  ++ VGTP++M+PE I ++ Y+ K+DIWSLG    E+A  + P   +   + 
Sbjct: 185 FFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLY 244

Query: 252 VLFL--IPKNNPPQLTGNYTKQFKEFVEACLNKDPENRPTAKELLKFPFIRKAKKNAYL 308
            L       + PP  + +Y+++ ++ V  C+N DPE RP    +        A   + L
Sbjct: 245 SLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTASSL 303

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  286 bits (734), Expect = 4e-92
 Identities = 80/328 (24%), Positives = 145/328 (44%), Gaps = 21/328 (6%)

Query: 59  FTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE-AEDEIEDIQQEIMVLSQCDSPY- 116
           + + ++IG+GSFG+          +   IK I++   +  E E+ ++E+ VL+    P  
Sbjct: 26  YVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNI 85

Query: 117 ---------GTKLWIIMEYLGGGSALDLMKA---GNFEEMHIAVILREVLKGLDYLHSER 164
                       L+I+M+Y  GG     + A     F+E  I     ++   L ++H  +
Sbjct: 86  VQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRK 145

Query: 165 KLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSK 224
            LHRDIK+ N+ L++ G V+L DFG+A  L +T       +GTP++++PE+ +   Y++K
Sbjct: 146 ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICENKPYNNK 205

Query: 225 ADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDP 284
           +DIW+LG    EL   +          ++  I   + P ++ +Y+   +  V     ++P
Sbjct: 206 SDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPVSLHYSYDLRSLVSQLFKRNP 265

Query: 285 ENRPTAKELLKFPFIRKAKKNAYLIDLIDRYKKW----KNSRNEESETESETSDNEDSIK 340
            +RP+   +L+  FI K  +      LI          K            +  N  S+ 
Sbjct: 266 RDRPSVNSILEKGFIAKRIEKFLSPQLIAEEFCLKTFSKFGSQPIPAKRPASGQNSISVM 325

Query: 341 TDGDLDEPWIMTVKGKMPNEYGSSPNKK 368
               + +P     K  +P  Y    +KK
Sbjct: 326 PAQKITKP---AAKYGIPLAYKKYGDKK 350

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  278 bits (713), Expect = 7e-90
 Identities = 64/275 (23%), Positives = 115/275 (41%), Gaps = 40/275 (14%)

Query: 59  FTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPY-- 116
           F + E IG G FG+VFK       +   IK +         E  ++E+  L++ D     
Sbjct: 13  FKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-----EKAEREVKALAKLDHVNIV 67

Query: 117 ------------------------GTKLWIIMEYLGGGSALDLMKAGN---FEEMHIAVI 149
                                      L+I ME+   G+    ++       +++    +
Sbjct: 68  HYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALEL 127

Query: 150 LREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPF 209
             ++ KG+DY+HS++ ++RD+K +N+ L +   VK+ DFG+  +L N   KR    GT  
Sbjct: 128 FEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKN-DGKRTRSKGTLR 186

Query: 210 WMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNYT 269
           +M+PE I    Y  + D+++LG+   EL                          ++  + 
Sbjct: 187 YMSPEQISSQDYGKEVDLYALGLILAELLHVCDT-----AFETSKFFTDLRDGIISDIFD 241

Query: 270 KQFKEFVEACLNKDPENRPTAKELLKFPFIRKAKK 304
           K+ K  ++  L+K PE+RP   E+L+   + K   
Sbjct: 242 KKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSP 276

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  251 bits (642), Expect = 5e-79
 Identities = 64/281 (22%), Positives = 112/281 (39%), Gaps = 40/281 (14%)

Query: 59  FTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPY-- 116
           F   + +G+G FG VF+  +       AIK I L   E   E + +E+  L++ + P   
Sbjct: 7   FEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIV 66

Query: 117 --------------------GTKLWIIMEYLGGGSALDLMKAGN----FEEMHIAVILRE 152
                                  L+I M+     +  D M         E      I  +
Sbjct: 67  RYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQ 126

Query: 153 VLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTF-------- 204
           + + +++LHS+  +HRD+K +N+  +    VK+ DFG+   +     ++           
Sbjct: 127 IAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYAR 186

Query: 205 ----VGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNN 260
               VGT  +M+PE I  ++Y  K DI+SLG+   EL    P ++++  +R L  +    
Sbjct: 187 HTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY--PFSTQMERVRTLTDVRNLK 244

Query: 261 PPQLTGNYTKQFKEFVEACLNKDPENRPTAKELLKFPFIRK 301
            P L           V+  L+  P  RP A  +++      
Sbjct: 245 FPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFED 285

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  249 bits (639), Expect = 7e-79
 Identities = 75/272 (27%), Positives = 124/272 (45%), Gaps = 23/272 (8%)

Query: 59  FTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE-AEDEIEDIQQEIMVLSQCDSPY- 116
           +     IG GS+G   K       +++  K +D     E E + +  E+ +L +   P  
Sbjct: 8   YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNI 67

Query: 117 -----------GTKLWIIMEYLGGGSALDLMKA-----GNFEEMHIAVILREVLKGLDYL 160
                       T L+I+MEY  GG    ++          +E  +  ++ ++   L   
Sbjct: 68  VRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKEC 127

Query: 161 HSERK-----LHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEV 215
           H         LHRD+K ANV L    +VKL DFG+A  L + TS   TFVGTP++M+PE 
Sbjct: 128 HRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQ 187

Query: 216 IKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEF 275
           + + +Y+ K+DIWSLG    EL    PP +      +   I +    ++   Y+ +  E 
Sbjct: 188 MNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSDELNEI 247

Query: 276 VEACLNKDPENRPTAKELLKFPFIRKAKKNAY 307
           +   LN    +RP+ +E+L+ P I +   + +
Sbjct: 248 ITRMLNLKDYHRPSVEEILENPLILEHHHHHH 279

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  230 bits (588), Expect = 7e-71
 Identities = 73/300 (24%), Positives = 133/300 (44%), Gaps = 33/300 (11%)

Query: 31  NSGSSISNQCGSTTASRRNSLKVDPELIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKII 90
           +     S     T      S+ V    I++  ++IG G   +VF+ + N  +Q+ AIK +
Sbjct: 3   HHHHHSSGVDLGTENLYFQSMSVKGR-IYSILKQIGSGGSSKVFQVL-NEKKQIYAIKYV 60

Query: 91  DLEEA-EDEIEDIQQEIMVLSQCDSP-------YG-----TKLWIIMEYLGGGSALD-LM 136
           +LEEA    ++  + EI  L++           Y        ++++ME  G       L 
Sbjct: 61  NLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLK 119

Query: 137 KAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTN 196
           K  + +        + +L+ +  +H    +H D+K AN L+ + G +KL DFG+A  +  
Sbjct: 120 KKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQP 178

Query: 197 TTS--KRNTFVGTPFWMAPEVIKQSA-----------YDSKADIWSLGITAIELAKGEPP 243
            T+   +++ VGT  +M PE IK  +              K+D+WSLG     +  G+ P
Sbjct: 179 DTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 238

Query: 244 -NSELHPMRVLFLIPKNN-PPQLTGNYTKQFKEFVEACLNKDPENRPTAKELLKFPFIRK 301
               ++ +  L  I   N   +      K  ++ ++ CL +DP+ R +  ELL  P+++ 
Sbjct: 239 FQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQI 298

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  230 bits (589), Expect = 1e-70
 Identities = 67/275 (24%), Positives = 126/275 (45%), Gaps = 32/275 (11%)

Query: 59  FTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA-EDEIEDIQQEIMVLSQCDSP-- 115
           ++  ++IG G   +VF+ + N  +Q+ AIK ++LEEA    ++  + EI  L++      
Sbjct: 11  YSILKQIGSGGSSKVFQVL-NEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 69

Query: 116 -----YG-----TKLWIIMEYLGGGSALDLMKA-GNFEEMHIAVILREVLKGLDYLHSER 164
                Y        ++++ME  G       +K   + +        + +L+ +  +H   
Sbjct: 70  KIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG 128

Query: 165 KLHRDIKAANVLLSEMGDVKLADFGVAGTLTN--TTSKRNTFVGTPFWMAPEVIKQSA-- 220
            +H D+K AN L+ + G +KL DFG+A  +    T+  +++ VGT  +M PE IK  +  
Sbjct: 129 IVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSS 187

Query: 221 ---------YDSKADIWSLGITAIELAKGEPP-NSELHPMRVLFLIPKNN-PPQLTGNYT 269
                       K+D+WSLG     +  G+ P    ++ +  L  I   N   +      
Sbjct: 188 RENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPE 247

Query: 270 KQFKEFVEACLNKDPENRPTAKELLKFPFIRKAKK 304
           K  ++ ++ CL +DP+ R +  ELL  P+++    
Sbjct: 248 KDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTH 282

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  228 bits (582), Expect = 4e-69
 Identities = 72/320 (22%), Positives = 135/320 (42%), Gaps = 32/320 (10%)

Query: 11  AVSRKCDFLTLNPTQFLKFSNSGSSISNQCGSTTASRRNSLKVDPELIFTKQERIGKGSF 70
            V R          +F +       +        +S  N        I++  ++IG G  
Sbjct: 10  LVPRGSGMKETAAAKFERQHMDSPDLGTDDDDKASSSANECISVKGRIYSILKQIGSGGS 69

Query: 71  GEVFKGIDNRTQQVVAIKIIDLEEA-EDEIEDIQQEIMVLSQCDSP-------YG----- 117
            +VF+ + N  +Q+ AIK ++LEEA    ++  + EI  L++           Y      
Sbjct: 70  SKVFQVL-NEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD 128

Query: 118 TKLWIIMEYLGGGSALDLMKA-GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVL 176
             ++++ME  G       +K   + +        + +L+ +  +H    +H D+K AN L
Sbjct: 129 QYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFL 187

Query: 177 LSEMGDVKLADFGVAGTLTNTTS--KRNTFVGTPFWMAPEVIKQSA-----------YDS 223
           + + G +KL DFG+A  +   T+   +++ VG   +M PE IK  +              
Sbjct: 188 IVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISP 246

Query: 224 KADIWSLGITAIELAKGEPP-NSELHPMRVLFLIPKNN-PPQLTGNYTKQFKEFVEACLN 281
           K+D+WSLG     +  G+ P    ++ +  L  I   N   +      K  ++ ++ CL 
Sbjct: 247 KSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLK 306

Query: 282 KDPENRPTAKELLKFPFIRK 301
           +DP+ R +  ELL  P+++ 
Sbjct: 307 RDPKQRISIPELLAHPYVQI 326

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  223 bits (571), Expect = 5e-67
 Identities = 71/313 (22%), Positives = 131/313 (41%), Gaps = 36/313 (11%)

Query: 33  GSSISNQCGSTTASRRNSLKVDPELIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDL 92
           GSS S +          S+ +  ++ F  ++ +G G+ G +         + VA+K I  
Sbjct: 2   GSSPSLE--QDDGDEETSVVIVGKISFCPKDVLGHGAEGTIVYR-GMFDNRDVAVKRILP 58

Query: 93  EEAEDEIEDIQQEIMVLSQCDS-P-----YGT-----KLWIIMEYLGGGSALDLM--KAG 139
           E          +E+ +L + D  P     + T       +I +E        + +  K  
Sbjct: 59  EC----FSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCAATLQ-EYVEQKDF 113

Query: 140 NFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGD-----VKLADFGVAGTL 194
               +    +L++   GL +LHS   +HRD+K  N+L+S           ++DFG+   L
Sbjct: 114 AHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKL 173

Query: 195 TN---TTSKRNTFVGTPFWMAPEVIKQSA---YDSKADIWSLG-ITAIELAKGEPPNSEL 247
                + S+R+   GT  W+APE++ +          DI+S G +    +++G  P  + 
Sbjct: 174 AVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKS 233

Query: 248 HPMRVLFLIPKNN--PPQLTGNYTKQFKEFVEACLNKDPENRPTAKELLKFPFIR-KAKK 304
              +   L+   +        +     +E +E  +  DP+ RP+AK +LK PF     K+
Sbjct: 234 LQRQANILLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSLEKQ 293

Query: 305 NAYLIDLIDRYKK 317
             +  D+ DR +K
Sbjct: 294 LQFFQDVSDRIEK 306

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  203 bits (518), Expect = 1e-60
 Identities = 55/275 (20%), Positives = 101/275 (36%), Gaps = 36/275 (13%)

Query: 59  FTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPY-- 116
           +   +++G+G F  V            A+K I   E +D  E+ Q+E  +    + P   
Sbjct: 31  YLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDR-EEAQREADMHRLFNHPNIL 89

Query: 117 ------------GTKLWIIMEYLGGGSALDLMKA-----GNFEEMHIAVILREVLKGLDY 159
                         + W+++ +   G+  + ++          E  I  +L  + +GL+ 
Sbjct: 90  RLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEA 149

Query: 160 LHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRN---------TFVGTPFW 210
           +H++   HRD+K  N+LL + G   L D G                          T  +
Sbjct: 150 IHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISY 209

Query: 211 MAPEVIKQSAY---DSKADIWSLGITAIELAKGEPP-NSELHPMRVLFLIPKNN--PPQL 264
            APE+    ++   D + D+WSLG     +  GE P +        + L  +N    PQ 
Sbjct: 210 RAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQLSIPQS 269

Query: 265 TGNYTKQFKEFVEACLNKDPENRPTAKELLKFPFI 299
              ++    + + + +  DP  RP    LL     
Sbjct: 270 P-RHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEA 303

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  201 bits (514), Expect = 3e-60
 Identities = 74/269 (27%), Positives = 130/269 (48%), Gaps = 37/269 (13%)

Query: 53  VDPELIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE-AEDEIEDIQQEIMVLSQ 111
           +    +   +E+IG GSFG V +   +     VA+KI+  ++   + + +  +E+ ++ +
Sbjct: 34  IPWCDL-NIKEKIGAGSFGTVHRAEWH--GSDVAVKILMEQDFHAERVNEFLREVAIMKR 90

Query: 112 CDSP-----YGT-----KLWIIMEYLGGGSALD-LMKAGNFEEMHIAVILR---EVLKGL 157
              P      G       L I+ EYL  GS    L K+G  E++     L    +V KG+
Sbjct: 91  LRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGM 150

Query: 158 DYLHSERK--LHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEV 215
           +YLH+     +HR++K+ N+L+ +   VK+ DFG++    +T     +  GTP WMAPEV
Sbjct: 151 NYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEV 210

Query: 216 IKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFL---------IPKNNPPQLTG 266
           ++    + K+D++S G+   ELA  + P   L+P +V+           IP+N  PQ+  
Sbjct: 211 LRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQV-- 268

Query: 267 NYTKQFKEFVEACLNKDPENRPTAKELLK 295
                    +E C   +P  RP+   ++ 
Sbjct: 269 ------AAIIEGCWTNEPWKRPSFATIMD 291

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  199 bits (508), Expect = 9e-60
 Identities = 72/270 (26%), Positives = 125/270 (46%), Gaps = 30/270 (11%)

Query: 51  LKVDPELIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKII---DLEEAEDEIEDIQQEIM 107
           L++D   +  + E IG G FG+V++         VA+K       E+    IE+++QE  
Sbjct: 2   LEIDFAELTLE-EIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAK 58

Query: 108 VLSQCDSP-----YG--TK---LWIIMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGL 157
           + +    P      G   K   L ++ME+  GG    ++         +     ++ +G+
Sbjct: 59  LFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKRIPPDILVNWAVQIARGM 118

Query: 158 DYLHSERK---LHRDIKAANVLLSEMGD--------VKLADFGVAGTLTNTTSKRNTFVG 206
           +YLH E     +HRD+K++N+L+ +  +        +K+ DFG+A     TT    +  G
Sbjct: 119 NYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKM--SAAG 176

Query: 207 TPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNN-PPQLT 265
              WMAPEVI+ S +   +D+WS G+   EL  GE P   +  + V + +  N     + 
Sbjct: 177 AYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIP 236

Query: 266 GNYTKQFKEFVEACLNKDPENRPTAKELLK 295
               + F + +E C N DP +RP+   +L 
Sbjct: 237 STCPEPFAKLMEDCWNPDPHSRPSFTNILD 266

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  196 bits (501), Expect = 1e-58
 Identities = 72/291 (24%), Positives = 136/291 (46%), Gaps = 48/291 (16%)

Query: 41  GSTTASRRNSLKVDPELIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDE-- 98
           G +   +     +    I   +++IGKG FG V KG   + + VVAIK + L ++E E  
Sbjct: 4   GGSEFPKSRLPTLADNEI-EYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETE 62

Query: 99  ----IEDIQQEIMVLSQCDSP-----YG---TKLWIIMEYLGGGSALDLM--KAGNFEEM 144
                ++ Q+E+ ++S  + P     YG       ++ME++  G     +  KA   +  
Sbjct: 63  MIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPPRMVMEFVPCGDLYHRLLDKAHPIKWS 122

Query: 145 HIAVILREVLKGLDYLHSERK--LHRDIKAANVLLSEMGD-----VKLADFGVAGTLTNT 197
               ++ ++  G++Y+ ++    +HRD+++ N+ L  + +      K+ADFG++    ++
Sbjct: 123 VKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHS 182

Query: 198 TSKRNTFVGTPFWMAPEVI--KQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFL 255
            S     +G   WMAPE I  ++ +Y  KAD +S  +    +  GE P  E    ++ F+
Sbjct: 183 VS---GLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFI 239

Query: 256 -----------IPKNNPPQLTGNYTKQFKEFVEACLNKDPENRPTAKELLK 295
                      IP++ PP+L        +  +E C + DP+ RP    ++K
Sbjct: 240 NMIREEGLRPTIPEDCPPRL--------RNVIELCWSGDPKKRPHFSYIVK 282

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  196 bits (500), Expect = 4e-58
 Identities = 79/261 (30%), Positives = 125/261 (47%), Gaps = 27/261 (10%)

Query: 53  VDPELIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQC 112
           +D + I   +E +G+G+FG V K       + VAIK I   E+E E +    E+  LS+ 
Sbjct: 5   IDYKEI-EVEEVVGRGAFGVVCKAKWR--AKDVAIKQI---ESESERKAFIVELRQLSRV 58

Query: 113 DSP-----YGT---KLWIIMEYLGGGSALDLM----KAGNFEEMHIAVILREVLKGLDYL 160
           + P     YG     + ++MEY  GGS  +++        +   H      +  +G+ YL
Sbjct: 59  NHPNIVKLYGACLNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYL 118

Query: 161 HSERK---LHRDIKAANVLLSEMGDV-KLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVI 216
           HS +    +HRD+K  N+LL   G V K+ DFG A  +    +      G+  WMAPEV 
Sbjct: 119 HSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNN---KGSAAWMAPEVF 175

Query: 217 KQSAYDSKADIWSLGITAIELAKGEPPNSELH--PMRVLFLIPKNNPPQLTGNYTKQFKE 274
           + S Y  K D++S GI   E+     P  E+     R+++ +     P L  N  K  + 
Sbjct: 176 EGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPIES 235

Query: 275 FVEACLNKDPENRPTAKELLK 295
            +  C +KDP  RP+ +E++K
Sbjct: 236 LMTRCWSKDPSQRPSMEEIVK 256

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  196 bits (500), Expect = 5e-58
 Identities = 75/279 (26%), Positives = 116/279 (41%), Gaps = 46/279 (16%)

Query: 53  VDPELIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQC 112
             P  +    E +GKG FG+  K     T +V+ +K + +   E+      +E+ V+   
Sbjct: 7   FRPSDLIHG-EVLGKGCFGQAIKVTHRETGEVMVMKEL-IRFDEETQRTFLKEVKVMRCL 64

Query: 113 DSP-----YG--TK---LWIIMEYLGGGSALDLMK--AGNFEEMHIAVILREVLKGLDYL 160
           + P      G   K   L  I EY+ GG+   ++K     +         +++  G+ YL
Sbjct: 65  EHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYL 124

Query: 161 HSERKLHRDIKAANVLLSEMGDVKLADFGVA--------------GTLTNTTSKRNTFVG 206
           HS   +HRD+ + N L+ E  +V +ADFG+A                      KR T VG
Sbjct: 125 HSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVG 184

Query: 207 TPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFL----------I 256
            P+WMAPE+I   +YD K D++S GI   E+      + +  P  + F            
Sbjct: 185 NPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRYC 244

Query: 257 PKNNPPQLTGNYTKQFKEFVEACLNKDPENRPTAKELLK 295
           P N PP         F      C + DPE RP+  +L  
Sbjct: 245 PPNCPP--------SFFPITVRCCDLDPEKRPSFVKLEH 275

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  193 bits (493), Expect = 2e-57
 Identities = 48/270 (17%), Positives = 108/270 (40%), Gaps = 47/270 (17%)

Query: 56  ELIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE-AEDEIEDIQQEIMVLSQ--- 111
           +L F    ++ +   GE++KG        + +K++ + + +  +  D  +E   L     
Sbjct: 11  QLNF--LTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSH 66

Query: 112 ---------CDSPYGTKLWIIMEYLGGGSALDLMKAGNFEEMHIAVILR---EVLKGLDY 159
                    C SP      +I  ++  GS  +++  G    +  +  ++   ++ +G+ +
Sbjct: 67  PNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAF 126

Query: 160 LHSERK--LHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIK 217
           LH+         + + +V++ E    +++   V  +  +        +  P W+APE ++
Sbjct: 127 LHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQSPGR-----MYAPAWVAPEALQ 181

Query: 218 QSAYDS---KADIWSLGITAIELAKGEPPNSELHPMRVLFL---------IPKNNPPQLT 265
           +   D+    AD+WS  +   EL   E P ++L  M +            IP    P + 
Sbjct: 182 KKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPGISPHV- 240

Query: 266 GNYTKQFKEFVEACLNKDPENRPTAKELLK 295
                   + ++ C+N+DP  RP    ++ 
Sbjct: 241 -------SKLMKICMNEDPAKRPKFDMIVP 263

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  186 bits (475), Expect = 2e-54
 Identities = 70/298 (23%), Positives = 125/298 (41%), Gaps = 37/298 (12%)

Query: 30  SNSGSSISNQCGSTTASRRNSLK----VDPELIFTKQERIGKGSFGEVFKGIDNRTQQVV 85
             + S +S +     AS+ +       +  E +    E IGKG FG+V+ G  +     V
Sbjct: 3   EMNLSLLSARSFPRKASQTSIFLQEWDIPFEQLEIG-ELIGKGRFGQVYHGRWHGE---V 58

Query: 86  AIKIIDLEE-AEDEIEDIQQEIMVLSQCDSP-----YG-----TKLWIIMEYLGGGSALD 134
           AI++ID+E   ED+++  ++E+M   Q          G       L II     G +   
Sbjct: 59  AIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYS 118

Query: 135 LM--KAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAG 192
           ++       +      I +E++KG+ YLH++  LH+D+K+ NV   + G V + DFG+  
Sbjct: 119 VVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFY-DNGKVVITDFGLFS 177

Query: 193 TLTNTTSKRNT-----FVGTPFWMAPEVIKQSA---------YDSKADIWSLGITAIELA 238
                 + R         G    +APE+I+Q +         +   +D+++LG    EL 
Sbjct: 178 ISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELH 237

Query: 239 KGEPPNSELHPMRVLFLIPKNN-PPQLTGNYTKQFKEFVEACLNKDPENRPTAKELLK 295
             E P        +++ +     P        K+  + +  C   + E RPT  +L+ 
Sbjct: 238 AREWPFKTQPAEAIIWQMGTGMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMD 295

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  186 bits (473), Expect = 4e-54
 Identities = 56/309 (18%), Positives = 106/309 (34%), Gaps = 57/309 (18%)

Query: 59  FTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPY-- 116
           +   + +G+G+   VF+G   +T  + AIK+ +       ++   +E  VL + +     
Sbjct: 11  WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIV 70

Query: 117 ----------GTKLWIIMEYLGGGSALD-LMKAGN---FEEMHIAVILREVLKGLDYLHS 162
                          +IME+   GS    L +  N     E    ++LR+V+ G+++L  
Sbjct: 71  KLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE 130

Query: 163 ERKLHRDIKAANVLLSEMGD----VKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIK- 217
              +HR+IK  N++     D     KL DFG A  L +   +  +  GT  ++ P++ + 
Sbjct: 131 NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD-EQFVSLYGTEEYLHPDMYER 189

Query: 218 -------QSAYDSKADIWSLGITAIELAKGEPP--------------------------- 243
                  Q  Y +  D+WS+G+T    A G  P                           
Sbjct: 190 AVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAIS 249

Query: 244 -NSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPENRPTAKELLKFPFIRKA 302
              +     + +         L+          +   L  D E      +          
Sbjct: 250 GVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILH 309

Query: 303 KKNAYLIDL 311
           + N++    
Sbjct: 310 RGNSHHHHH 318

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  184 bits (469), Expect = 8e-54
 Identities = 72/273 (26%), Positives = 132/273 (48%), Gaps = 28/273 (10%)

Query: 53  VDPELIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE-AEDEIEDIQQEIMVLSQ 111
           +    I    +RIG GSFG V+KG  +     VA+K++++      +++  + E+ VL +
Sbjct: 21  IPDGQITVG-QRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRK 76

Query: 112 CDSP-----YG--TK--LWIIMEYLGGGSALDLM--KAGNFEEMHIAVILREVLKGLDYL 160
                     G  T   L I+ ++  G S    +      FE   +  I R+  +G+DYL
Sbjct: 77  TRHVNILLFMGYSTAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYL 136

Query: 161 HSERKLHRDIKAANVLLSEMGDVKLADFGVAG--TLTNTTSKRNTFVGTPFWMAPEVIKQ 218
           H++  +HRD+K+ N+ L E   VK+ DFG+A   +  + + +     G+  WMAPEVI+ 
Sbjct: 137 HAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRM 196

Query: 219 SA---YDSKADIWSLGITAIELAKGEPPNSELHPM-RVLFLIPKNN----PPQLTGNYTK 270
                Y  ++D+++ GI   EL  G+ P S ++   +++ ++ + +      ++  N  K
Sbjct: 197 QDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPK 256

Query: 271 QFKEFVEACLNKDPENRPTAKELLKF--PFIRK 301
           + K  +  CL K  + RP+   +L       R+
Sbjct: 257 RMKRLMAECLKKKRDERPSFPRILAEIEELARE 289

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  181 bits (462), Expect = 5e-53
 Identities = 77/281 (27%), Positives = 135/281 (48%), Gaps = 34/281 (12%)

Query: 65  IGKGSFGEVFKGIDNRTQQVVAIKIIDLEE--AEDEIEDIQQEIMVLSQCDSP-----YG 117
           +GKG FG V+   + +++ ++A+K++   +         +++E+ + S    P     YG
Sbjct: 17  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 76

Query: 118 -----TKLWIIMEYLGGGSALD-LMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIK 171
                T++++I+EY   G+    L K   F+E   A  + E+   L Y HS+R +HRDIK
Sbjct: 77  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIK 136

Query: 172 AANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLG 231
             N+LL   G++K+ADFG +    +  S+R    GT  ++ PE+I+   +D K D+WSLG
Sbjct: 137 PENLLLGSAGELKIADFGWSVHAPS--SRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLG 194

Query: 232 ITAIELAKGEPPNSELHPMRVLFLIPKNN---PPQLTGNYTKQFKEFVEACLNKDPENRP 288
           +   E   G+PP            I +     P  +    T+  ++ +   L  +P  RP
Sbjct: 195 VLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFV----TEGARDLISRLLKHNPSQRP 250

Query: 289 TAKELLKFPFIRKAKKNAYLIDLIDRYKKWKNSRNEESETE 329
             +E+L+ P+I                 K  N +N+ES ++
Sbjct: 251 MLREVLEHPWITA------------NSSKPSNCQNKESASK 279

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  182 bits (463), Expect = 6e-53
 Identities = 77/278 (27%), Positives = 122/278 (43%), Gaps = 30/278 (10%)

Query: 53  VDPELI--FTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLE--EAEDEIEDIQQEIMV 108
           VDP     + +   +GKG F + F+  D  T++V A KI+         + E +  EI +
Sbjct: 9   VDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISI 68

Query: 109 LSQCDSP-----YG-----TKLWIIMEYLGGGSALDLMKA-GNFEEMHIAVILREVLKGL 157
                       +G       +++++E     S L+L K      E      LR+++ G 
Sbjct: 69  HRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGC 128

Query: 158 DYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIK 217
            YLH  R +HRD+K  N+ L+E  +VK+ DFG+A  +     ++    GTP ++APEV+ 
Sbjct: 129 QYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLS 188

Query: 218 QSAYDSKADIWSLGITAIELAKGEPP--NSELHPM-----RVLFLIPKNNPPQLTGNYTK 270
           +  +  + D+WS+G     L  G+PP   S L        +  + IPK+  P        
Sbjct: 189 KKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVA------ 242

Query: 271 QFKEFVEACLNKDPENRPTAKELLKFPFIRKAKKNAYL 308
                ++  L  DP  RPT  ELL   F       A L
Sbjct: 243 --ASLIQKMLQTDPTARPTINELLNDEFFTSGYIPARL 278

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  182 bits (462), Expect = 2e-52
 Identities = 49/219 (22%), Positives = 87/219 (39%), Gaps = 18/219 (8%)

Query: 99  IEDIQQEIMVLSQCDSPYGTKLWIIMEYLGGGSALDLMKAGN----FEEMHIAVILREVL 154
           ++    +  V     S     L+I M+     +  D M         E      I  ++ 
Sbjct: 115 MDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIA 174

Query: 155 KGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTF---------- 204
           + +++LHS+  +HRD+K +N+  +    VK+ DFG+   +     ++             
Sbjct: 175 EAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHT 234

Query: 205 --VGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPP 262
             VGT  +M+PE I  + Y  K DI+SLG+   EL        E   +R++  +     P
Sbjct: 235 GQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMER--VRIITDVRNLKFP 292

Query: 263 QLTGNYTKQFKEFVEACLNKDPENRPTAKELLKFPFIRK 301
            L      Q    V+  L+  P  RP A ++++      
Sbjct: 293 LLFTQKYPQEHMMVQDMLSPSPTERPEATDIIENAIFEN 331

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 58.7 bits (142), Expect = 2e-09
 Identities = 17/58 (29%), Positives = 28/58 (48%)

Query: 59  FTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPY 116
           F   + +G+G FG VF+  +       AIK I L   E   E + +E+  L++ + P 
Sbjct: 8   FEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 65

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  179 bits (457), Expect = 1e-51
 Identities = 78/297 (26%), Positives = 126/297 (42%), Gaps = 30/297 (10%)

Query: 34  SSISNQCGSTTASRRNSLKVDPELI--FTKQERIGKGSFGEVFKGIDNRTQQVVAIKIID 91
           ++      +  A     + VDP     + +   +GKG F + F+  D  T++V A KI+ 
Sbjct: 16  AAPGAPAAAPPAKEIPEVLVDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVP 75

Query: 92  LEEAEDE--IEDIQQEIMVLSQCDSP-----YG-----TKLWIIMEYLGGGSALDLMKA- 138
                     E +  EI +            +G       +++++E     S L+L K  
Sbjct: 76  KSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRR 135

Query: 139 GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTT 198
               E      LR+++ G  YLH  R +HRD+K  N+ L+E  +VK+ DFG+A  +    
Sbjct: 136 KALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG 195

Query: 199 SKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPP--NSELHPM-----R 251
            ++    GTP ++APEV+ +  +  + D+WS+G     L  G+PP   S L        +
Sbjct: 196 ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKK 255

Query: 252 VLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPENRPTAKELLKFPFIRKAKKNAYL 308
             + IPK+  P             ++  L  DP  RPT  ELL   F       A L
Sbjct: 256 NEYSIPKHINPVA--------ASLIQKMLQTDPTARPTINELLNDEFFTSGYIPARL 304

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  179 bits (456), Expect = 4e-51
 Identities = 83/355 (23%), Positives = 154/355 (43%), Gaps = 53/355 (14%)

Query: 33  GSSISNQCGSTTASRRNSLKVDPELIFTKQ----ERIGKGSFGEVFKGIDNRTQQVVAIK 88
           G  +++  G     R +   ++    F+      E +GKG+F  V + +   T    A K
Sbjct: 1   GPHMASMTGGQQMGRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAK 60

Query: 89  IIDLEE-AEDEIEDIQQEIMVLSQCDSPY----------GTKLWIIMEYLGGGSALD-LM 136
           II+ ++ +  + + +++E  +  +   P            +  +++ + + GG   + ++
Sbjct: 61  IINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIV 120

Query: 137 KAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGD---VKLADFGVAGT 193
               + E   +  ++++L+ + Y HS   +HR++K  N+LL+       VKLADFG+A  
Sbjct: 121 AREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLA-I 179

Query: 194 LTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLG-ITAIELAKGEPPNSELHPMRV 252
             N +   + F GTP +++PEV+K+  Y    DIW+ G I  I L  G PP  +    R+
Sbjct: 180 EVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLV-GYPPFWDEDQHRL 238

Query: 253 LFLIPKNNPPQLTGNY----------TKQFKEFVEACLNKDPENRPTAKELLKFPFIR-- 300
              I         G Y          T + K  +++ L  +P+ R TA + LK P+I   
Sbjct: 239 YAQI-------KAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNR 291

Query: 301 -KAKKNAYLIDLIDRYKKWKNSRNE----------ESETESETSDNEDSIKTDGD 344
            +     +  D +D  KK+ N+R +           +   S    N  + K  G 
Sbjct: 292 ERVASAIHRQDTVDCLKKF-NARRKLKGAILTTMIATRNLSNLGRNLLNKKEQGP 345

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  182 bits (463), Expect = 5e-51
 Identities = 79/315 (25%), Positives = 142/315 (45%), Gaps = 40/315 (12%)

Query: 45  ASRRNSLKVDPELIFTKQ-----------ERIGKGSFGEVFKGIDNRTQQVVAIKIIDLE 93
            S  + L   P +                  +GKGSFGEV    D  T Q  A+K+I   
Sbjct: 3   GSMMDHLHATPGMFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKR 62

Query: 94  --EAEDEIEDIQQEIMVLSQCDSP-----YGT-----KLWIIMEYLGGGSALDLMKA-GN 140
             + + + E + +E+ +L Q D P     Y         +++ E   GG   D + +   
Sbjct: 63  QVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKR 122

Query: 141 FEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLL---SEMGDVKLADFGVAGTLTNT 197
           F E+  A I+R+VL G+ Y+H  + +HRD+K  N+LL   S+  ++++ DFG++ T    
Sbjct: 123 FSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLS-THFEA 181

Query: 198 TSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIP 257
           + K    +GT +++APEV+  + YD K D+WS G+    L  G PP +  +   +L  + 
Sbjct: 182 SKKMKDKIGTAYYIAPEVLHGT-YDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKV- 239

Query: 258 KNNPPQLTGNY----TKQFKEFVEACLNKDPENRPTAKELLKFPFIRKAKKNAYLID--- 310
           +              ++  K+ +   L   P  R +A++ L   +I+   K    +D   
Sbjct: 240 EKGKYTFELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTYTKEQISVDVPS 299

Query: 311 ---LIDRYKKWKNSR 322
               I   ++++ ++
Sbjct: 300 LDNAILNIRQFQGTQ 314

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  178 bits (452), Expect = 6e-51
 Identities = 61/289 (21%), Positives = 113/289 (39%), Gaps = 49/289 (16%)

Query: 59  FTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQC------ 112
              +  + +G F  V++  D  + +  A+K +   E E     I QE+  + +       
Sbjct: 30  LRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKN-RAIIQEVCFMKKLSGHPNI 88

Query: 113 ------------DSPYGTKLWIIMEYLGGGSALDLMKA----GNFEEMHIAVILREVLKG 156
                       +S  G   ++++  L  G  ++ +K     G      +  I  +  + 
Sbjct: 89  VQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRA 148

Query: 157 LDYLHSERK--LHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRN------------ 202
           + ++H ++   +HRD+K  N+LLS  G +KL DFG A T+++                  
Sbjct: 149 VQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEI 208

Query: 203 TFVGTPFWMAPEVI---KQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVL---FLI 256
           T   TP +  PE+I          K DIW+LG     L   + P  +   +R++   + I
Sbjct: 209 TRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIVNGKYSI 268

Query: 257 PKNNPPQLTGNYTKQFKEFVEACLNKDPENRPTAKELLKFPFIRKAKKN 305
           P ++           F   + A L  +PE R +  E++       A +N
Sbjct: 269 PPHDT------QYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARN 311

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  175 bits (447), Expect = 7e-51
 Identities = 68/258 (26%), Positives = 122/258 (47%), Gaps = 29/258 (11%)

Query: 65  IGKGSFGEVFKGIDNRTQQVVAIKIIDLEE--AEDEIEDIQQEIMVLSQCDSP-----YG 117
           +GKGSF  V++     T   VAIK+ID +       ++ +Q E+ +  Q   P     Y 
Sbjct: 19  LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYN 78

Query: 118 -----TKLWIIMEYLGGGSALDLMKA--GNFEEMHIAVILREVLKGLDYLHSERKLHRDI 170
                  +++++E    G     +K     F E      + +++ G+ YLHS   LHRD+
Sbjct: 79  YFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDL 138

Query: 171 KAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSL 230
             +N+LL+   ++K+ADFG+A  L     K  T  GTP +++PE+  +SA+  ++D+WSL
Sbjct: 139 TLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATRSAHGLESDVWSL 198

Query: 231 GITAIELAKGEPP-NSELHP------MRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKD 283
           G     L  G PP +++         +   + +P     +         K+ +   L ++
Sbjct: 199 GCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPSFLSIEA--------KDLIHQLLRRN 250

Query: 284 PENRPTAKELLKFPFIRK 301
           P +R +   +L  PF+ +
Sbjct: 251 PADRLSLSSVLDHPFMSR 268

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  178 bits (454), Expect = 1e-50
 Identities = 56/309 (18%), Positives = 106/309 (34%), Gaps = 57/309 (18%)

Query: 59  FTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPY-- 116
           +   + +G+G+   VF+G   +T  + AIK+ +       ++   +E  VL + +     
Sbjct: 11  WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIV 70

Query: 117 ----------GTKLWIIMEYLGGGSALD-LMKAGN---FEEMHIAVILREVLKGLDYLHS 162
                          +IME+   GS    L +  N     E    ++LR+V+ G+++L  
Sbjct: 71  KLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE 130

Query: 163 ERKLHRDIKAANVLLSEMGD----VKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIK- 217
              +HR+IK  N++     D     KL DFG A  L +   +  +  GT  ++ P++ + 
Sbjct: 131 NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD-EQFVSLYGTEEYLHPDMYER 189

Query: 218 -------QSAYDSKADIWSLGITAIELAKGEPP--------------------------- 243
                  Q  Y +  D+WS+G+T    A G  P                           
Sbjct: 190 AVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAIS 249

Query: 244 -NSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPENRPTAKELLKFPFIRKA 302
              +     + +         L+          +   L  D E      +          
Sbjct: 250 GVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILH 309

Query: 303 KKNAYLIDL 311
           +   ++  L
Sbjct: 310 RMVIHVFSL 318

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  174 bits (444), Expect = 2e-50
 Identities = 72/277 (25%), Positives = 130/277 (46%), Gaps = 35/277 (12%)

Query: 63  ERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE-AEDEIEDIQQEIMVLSQCDSPY----- 116
           E +GKG+F  V + +   T    A KII+ ++ +  + + +++E  +  +   P      
Sbjct: 12  EELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLH 71

Query: 117 -----GTKLWIIMEYLGGGSALD-LMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDI 170
                 +  +++ + + GG   + ++    + E   +  ++++L+ + Y HS   +HR++
Sbjct: 72  DSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNL 131

Query: 171 KAANVLLSEMGD---VKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADI 227
           K  N+LL+       VKLADFG+A    N +   + F GTP +++PEV+K+  Y    DI
Sbjct: 132 KPENLLLASKAKGAAVKLADFGLA-IEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDI 190

Query: 228 WSLG-ITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNY----------TKQFKEFV 276
           W+ G I  I L  G PP  +    R+   I         G Y          T + K  +
Sbjct: 191 WACGVILYILLV-GYPPFWDEDQHRLYAQI-------KAGAYDYPSPEWDTVTPEAKSLI 242

Query: 277 EACLNKDPENRPTAKELLKFPFIRKAKKNAYLIDLID 313
           ++ L  +P+ R TA + LK P+I   ++ A  I   D
Sbjct: 243 DSMLTVNPKKRITADQALKVPWICNRERVASAIHRQD 279

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  179 bits (457), Expect = 4e-50
 Identities = 76/298 (25%), Positives = 134/298 (44%), Gaps = 33/298 (11%)

Query: 38  NQCGSTTASRRNSLKVDPELIFTKQ-----------ERIGKGSFGEVFKGIDNRTQQVVA 86
           +  G      +  L+  P +  T +           +++G G++GEV    D  T    A
Sbjct: 7   HSSGRENLYFQGDLQATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERA 66

Query: 87  IKIIDLEE-AEDEIEDIQQEIMVLSQCDSP-----YGT-----KLWIIMEYLGGGSALDL 135
           IKII     +      + +E+ VL   D P     Y         +++ME   GG   D 
Sbjct: 67  IKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDE 126

Query: 136 MKA-GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLL---SEMGDVKLADFGVA 191
           +     F E+  AVI+++VL G+ YLH    +HRD+K  N+LL    +   +K+ DFG++
Sbjct: 127 IIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLS 186

Query: 192 GTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMR 251
             +     K    +GT +++APEV+++  YD K D+WS+G+    L  G PP        
Sbjct: 187 -AVFENQKKMKERLGTAYYIAPEVLRKK-YDEKCDVWSIGVILFILLAGYPPFGGQTDQE 244

Query: 252 VLFLIPKNNPPQLTGNY----TKQFKEFVEACLNKDPENRPTAKELLKFPFIRKAKKN 305
           +L  + +              ++  K+ ++  L  D + R +A++ L+ P+I++    
Sbjct: 245 ILRKV-EKGKYTFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEMCSK 301

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  174 bits (442), Expect = 6e-50
 Identities = 66/289 (22%), Positives = 117/289 (40%), Gaps = 57/289 (19%)

Query: 60  TKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSP---- 115
           T  E +GKG +GEV++G      + VA+KI    + +    +   E+             
Sbjct: 11  TLLECVGKGRYGEVWRGSWQ--GENVAVKIFSSRDEKSWFRE--TELYNTVMLRHENILG 66

Query: 116 -YG---------TKLWIIMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERK 165
                       T+LW+I  Y   GS  D ++    + +    I+  +  GL +LH E  
Sbjct: 67  FIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIF 126

Query: 166 --------LHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTS----KRNTFVGTPFWMAP 213
                    HRD+K+ N+L+ + G   +AD G+A   + +T+      N  VGT  +MAP
Sbjct: 127 GTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAP 186

Query: 214 EVIKQSA------YDSKADIWSLGITAIELAKGEPPNSELHPMRVLF--LIPKNN----- 260
           EV+ ++          + DIW+ G+   E+A+    N  +   +  F  ++P +      
Sbjct: 187 EVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDM 246

Query: 261 -------------PPQLTGNYT-KQFKEFVEACLNKDPENRPTAKELLK 295
                        P +   + T     + ++ C  ++P  R TA  + K
Sbjct: 247 RKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK 295

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score =  174 bits (443), Expect = 8e-50
 Identities = 64/273 (23%), Positives = 117/273 (42%), Gaps = 31/273 (11%)

Query: 58  IFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDS-PY 116
           +  K + +G+GSF    K +  ++ Q  A+KII     +    + Q+EI  L  C+  P 
Sbjct: 12  LDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIIS----KRMEANTQKEITALKLCEGHPN 67

Query: 117 ----------GTKLWIIMEYLGGGSALD-LMKAGNFEEMHIAVILREVLKGLDYLHSERK 165
                         +++ME L GG   + + K  +F E   + I+R+++  + ++H    
Sbjct: 68  IVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGV 127

Query: 166 LHRDIKAANVLL---SEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYD 222
           +HRD+K  N+L    ++  ++K+ DFG A           T   T  + APE++ Q+ YD
Sbjct: 128 VHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQNGYD 187

Query: 223 SKADIWSLG-ITAIELAKGEPP------NSELHPMRVLFLIPKNNPPQLTGNY----TKQ 271
              D+WSLG I    L+ G+ P      +        +    K       G      +++
Sbjct: 188 ESCDLWSLGVILYTMLS-GQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNVSQE 246

Query: 272 FKEFVEACLNKDPENRPTAKELLKFPFIRKAKK 304
            K+ ++  L  DP  R     L    +++   +
Sbjct: 247 AKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQ 279

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  177 bits (451), Expect = 1e-49
 Identities = 75/331 (22%), Positives = 137/331 (41%), Gaps = 55/331 (16%)

Query: 63  ERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE-AEDEIEDIQQEIMVLSQCDSP-----Y 116
           E +GKG+F  V + +     Q  A  II+ ++ +  + + +++E  +      P     +
Sbjct: 17  EELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLH 76

Query: 117 GT-----KLWIIMEYLGGGSALD-LMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDI 170
            +       ++I + + GG   + ++    + E   +  ++++L+ + + H    +HR++
Sbjct: 77  DSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNL 136

Query: 171 KAANVLLSEMGD---VKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADI 227
           K  N+LL+       VKLADFG+A  +         F GTP +++PEV+++  Y    D+
Sbjct: 137 KPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDL 196

Query: 228 WSLG-ITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNY----------TKQFKEFV 276
           W+ G I  I L  G PP  +    R+   I         G Y          T + K+ +
Sbjct: 197 WACGVILYILLV-GYPPFWDEDQHRLYQQI-------KAGAYDFPSPEWDTVTPEAKDLI 248

Query: 277 EACLNKDPENRPTAKELLKFPFIR---KAKKNAYLIDLIDRYK------KWK-------- 319
              L  +P  R TA E LK P+I          +  + +D  K      K K        
Sbjct: 249 NKMLTINPSKRITAAEALKHPWISHRSTVASCMHRQETVDCLKKFNARRKLKGAILTVML 308

Query: 320 ---NSRNEESETESETSDNEDSIKTDGDLDE 347
              N    + E    T    ++I  +GD + 
Sbjct: 309 ATRNFSVRKQEIIKVTEQLIEAIS-NGDFES 338

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  172 bits (439), Expect = 2e-49
 Identities = 70/295 (23%), Positives = 126/295 (42%), Gaps = 38/295 (12%)

Query: 36  ISNQCGSTTASRRNSLKVDPELIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA 95
           + +    ++       +   + +F  + ++G G+FG+V    +  +     IK I+ + +
Sbjct: 1   MHHHHHHSSGRENLYFQGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRS 60

Query: 96  EDEIEDIQQEIMVLSQCDSP-----YGT-----KLWIIMEYLGGGSALD-----LMKAGN 140
           +  +E I+ EI VL   D P     +        ++I+ME   GG  L+       +   
Sbjct: 61  QVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKA 120

Query: 141 FEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLL---SEMGDVKLADFGVAGTLTNT 197
             E ++A ++++++  L Y HS+  +H+D+K  N+L    S    +K+ DFG+A    + 
Sbjct: 121 LSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKS- 179

Query: 198 TSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLG-ITAIELAKGEPPNSELHPMRVLFLI 256
                   GT  +MAPEV K+     K DIWS G +    L  G  P +      V    
Sbjct: 180 DEHSTNAAGTALYMAPEVFKRD-VTFKCDIWSAGVVMYFLLT-GCLPFTGTSLEEVQQKA 237

Query: 257 PKNNPPQLTGNY---------TKQFKEFVEACLNKDPENRPTAKELLKFPFIRKA 302
                                T Q  + ++  L KDPE RP+A ++L   + ++A
Sbjct: 238 -------TYKEPNYAVECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQA 285

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  172 bits (438), Expect = 2e-49
 Identities = 63/261 (24%), Positives = 115/261 (44%), Gaps = 30/261 (11%)

Query: 65  IGKGSFGEVFKGIDNRTQQVVAIKIIDLEE--AEDEIEDIQQEIMVLSQCDSP-----YG 117
           +GKG FG V+   + + + ++A+K++   +   E     +++EI + S    P     Y 
Sbjct: 22  LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYN 81

Query: 118 -----TKLWIIMEYLGGGSALD-LMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIK 171
                 ++++++E+   G     L K G F+E   A  + E+   L Y H  + +HRDIK
Sbjct: 82  YFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIK 141

Query: 172 AANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLG 231
             N+L+   G++K+ADFG +  +   + +R T  GT  ++ PE+I+   +D K D+W  G
Sbjct: 142 PENLLMGYKGELKIADFGWS--VHAPSLRRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAG 199

Query: 232 ITAIELAKGEPPNSELHPM-------RVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDP 284
           +   E   G PP               V    P               K+ +   L   P
Sbjct: 200 VLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPPFLSDGS--------KDLISKLLRYHP 251

Query: 285 ENRPTAKELLKFPFIRKAKKN 305
             R   K +++ P+++   + 
Sbjct: 252 PQRLPLKGVMEHPWVKANSRR 272

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  172 bits (438), Expect = 2e-49
 Identities = 79/293 (26%), Positives = 132/293 (45%), Gaps = 30/293 (10%)

Query: 36  ISNQCGSTTASRRNSLKVDPELIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA 95
           + +    ++       +      +     +GKGSFGEV K  D  TQQ  A+K+I+   A
Sbjct: 1   MHHHHHHSSGRENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASA 60

Query: 96  E-DEIEDIQQEIMVLSQCDSP-----YGT-----KLWIIMEYLGGGSALD-LMKAGNFEE 143
           +  +   I +E+ +L + D P     +         +I+ E   GG   D ++K   F E
Sbjct: 61  KNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSE 120

Query: 144 MHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGD---VKLADFGVAGTLTNTTSK 200
              A I+++V  G+ Y+H    +HRD+K  N+LL        +K+ DFG++ T     +K
Sbjct: 121 HDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLS-TCFQQNTK 179

Query: 201 RNTFVGTPFWMAPEVIKQSAYDSKADIWSLG-ITAIELAKGEPP---NSELHPMRVLFLI 256
               +GT +++APEV++ + YD K D+WS G I  I L+ G PP    +E      +   
Sbjct: 180 MKDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLS-GTPPFYGKNE----YDILKR 233

Query: 257 PKNNPPQLTGNY----TKQFKEFVEACLNKDPENRPTAKELLKFPFIRKAKKN 305
            +              +   K+ +   L   P  R TA + L+ P+I+K    
Sbjct: 234 VETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSSE 286

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  176 bits (448), Expect = 3e-49
 Identities = 70/317 (22%), Positives = 140/317 (44%), Gaps = 55/317 (17%)

Query: 50  SLKVDPELIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVL 109
           + +   + +   ++ +G GS G V     +   + VA+K + +    D  +    EI +L
Sbjct: 8   NFEQSLKNLVVSEKILGYGSSGTVVFQ-GSFQGRPVAVKRMLI----DFCDIALMEIKLL 62

Query: 110 SQCDS-P-----YGT-----KLWIIMEYLGGGSALDLMKAGNF--------EEMHIAVIL 150
           ++ D  P     Y +      L+I +E     +  DL+++ N         +E +   +L
Sbjct: 63  TESDDHPNVIRYYCSETTDRFLYIALELCNL-NLQDLVESKNVSDENLKLQKEYNPISLL 121

Query: 151 REVLKGLDYLHSERKLHRDIKAANVLLS-------------EMGDVKLADFGVAGTLTN- 196
           R++  G+ +LHS + +HRD+K  N+L+S             E   + ++DFG+   L + 
Sbjct: 122 RQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSG 181

Query: 197 ---TTSKRNTFVGTPFWMAPEVIKQSA-------YDSKADIWSLG-ITAIELAKGEPPNS 245
                +  N   GT  W APE++++S             DI+S+G +    L+KG+ P  
Sbjct: 182 QSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFG 241

Query: 246 ELHPMRVLFLIPKNNPPQLTGNYTKQF----KEFVEACLNKDPENRPTAKELLKFPFIR- 300
           + +      +    +  ++   + +       + +   ++ DP  RPTA ++L+ P    
Sbjct: 242 DKYSRESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWP 301

Query: 301 KAKKNAYLIDLIDRYKK 317
           K+KK  +L+ + DR + 
Sbjct: 302 KSKKLEFLLKVSDRLEI 318

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  176 bits (448), Expect = 6e-49
 Identities = 77/293 (26%), Positives = 130/293 (44%), Gaps = 28/293 (9%)

Query: 36  ISNQCGSTTASRRNSLKVDPELIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE- 94
           + +    ++       +      +     +GKGSFGEV K  D  TQQ  A+K+I+    
Sbjct: 1   MHHHHHHSSGRENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASA 60

Query: 95  AEDEIEDIQQEIMVLSQCDSP-----YGT-----KLWIIMEYLGGGSALD-LMKAGNFEE 143
              +   I +E+ +L + D P     +         +I+ E   GG   D ++K   F E
Sbjct: 61  KNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSE 120

Query: 144 MHIAVILREVLKGLDYLHSERKLHRDIKAANVLL---SEMGDVKLADFGVAGTLTNTTSK 200
              A I+++V  G+ Y+H    +HRD+K  N+LL    +  D+K+ DFG++ T     +K
Sbjct: 121 HDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLS-TCFQQNTK 179

Query: 201 RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPP---NSELHPMRVLFLIP 257
               +GT +++APEV++ + YD K D+WS G+    L  G PP    +E      +    
Sbjct: 180 MKDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKNE----YDILKRV 234

Query: 258 KNNPPQLTGNY----TKQFKEFVEACLNKDPENRPTAKELLKFPFIRKAKKNA 306
           +              +   K+ +   L   P  R TA + L+ P+I+K     
Sbjct: 235 ETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSSET 287

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  172 bits (439), Expect = 8e-49
 Identities = 78/295 (26%), Positives = 128/295 (43%), Gaps = 42/295 (14%)

Query: 63  ERIGKGSFGEVFKGIDNRTQQVVAIKIID----LEEAEDEIEDIQQEIMVLSQCDSPY-- 116
           E IGKG F  V + I+  T Q  A+KI+D            ED+++E  +      P+  
Sbjct: 30  EVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIV 89

Query: 117 --------GTKLWIIMEYLGGGSALD-LMKAGN----FEEMHIAVILREVLKGLDYLHSE 163
                      L+++ E++ G      ++K  +    + E   +  +R++L+ L Y H  
Sbjct: 90  ELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN 149

Query: 164 RKLHRDIKAANVLLSEMGD---VKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSA 220
             +HRD+K   VLL+   +   VKL  FGVA  L  +       VGTP +MAPEV+K+  
Sbjct: 150 NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVVKREP 209

Query: 221 YDSKADIWSLG-ITAIELAKGEPP----NSELHPMRVLFLIPKNNPPQLTGNY----TKQ 271
           Y    D+W  G I  I L+ G  P             LF        ++        ++ 
Sbjct: 210 YGKPVDVWGCGVILFILLS-GCLPFYGTKER------LFEGIIKGKYKMNPRQWSHISES 262

Query: 272 FKEFVEACLNKDPENRPTAKELLKFPFIR---KAKKNAYLIDLIDRYKKWKNSRN 323
            K+ V   L  DP  R T  E L  P+++   +     +L + +++ +K+ N+R 
Sbjct: 263 AKDLVRRMLMLDPAERITVYEALNHPWLKERDRYAYKIHLPETVEQLRKF-NARR 316

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  174 bits (442), Expect = 1e-48
 Identities = 82/327 (25%), Positives = 138/327 (42%), Gaps = 52/327 (15%)

Query: 31  NSGSSISNQCGSTTASRRNSLKVDPELIFTKQ--------ERIGKGSFGEVFKGIDNRTQ 82
           N+ S I+             L VD + ++ K         + +G G+ GEV    + +T 
Sbjct: 101 NNNSEIALSLSRNKVFVFFDLTVDDQSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTC 160

Query: 83  QVVAIKIID-------LEEAEDEIEDIQQEIMVLSQCDSP-----YGT----KLWIIMEY 126
           + VAI+II             D   +++ EI +L + + P              +I++E 
Sbjct: 161 KKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAEDYYIVLEL 220

Query: 127 LGGGSALD-LMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGD--- 182
           + GG   D ++     +E    +   ++L  + YLH    +HRD+K  NVLLS   +   
Sbjct: 221 MEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCL 280

Query: 183 VKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSA---YDSKADIWSLG-ITAIELA 238
           +K+ DFG +  +   TS   T  GTP ++APEV+       Y+   D WSLG I  I L+
Sbjct: 281 IKITDFGHS-KILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLS 339

Query: 239 KGEPP-NSELHPMRVLFLIPKNNPPQLTGNYT----------KQFKEFVEACLNKDPENR 287
            G PP +     + +   I        +G Y           ++  + V+  L  DP+ R
Sbjct: 340 -GYPPFSEHRTQVSLKDQI-------TSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKAR 391

Query: 288 PTAKELLKFPFIRKAKKNAYLIDLIDR 314
            T +E L+ P+++         DL+  
Sbjct: 392 FTTEEALRHPWLQDEDMKRKFQDLLSE 418

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  171 bits (435), Expect = 1e-48
 Identities = 73/332 (21%), Positives = 126/332 (37%), Gaps = 69/332 (20%)

Query: 21  LNPTQFLKFSNSGSSISNQCGSTTASRRNSLKVDPELIFTKQERIGKGSFGEVFKGIDNR 80
           + P + L+     S  S   GS +       +   + I    ++IGKG +GEV+ G    
Sbjct: 5   IPPGESLRDLIEQSQSS---GSGSGLPLLVQRTIAKQI-QMVKQIGKGRYGEVWMGKWR- 59

Query: 81  TQQVVAIKIIDL-EEAEDEIEDIQQEIMVLSQCDSP-----YG---------TKLWIIME 125
             + VA+K+    EEA    E    EI                         T+L++I +
Sbjct: 60  -GEKVAVKVFFTTEEASWFRE---TEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITD 115

Query: 126 YLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERK--------LHRDIKAANVLL 177
           Y   GS  D +K+   +   +  +    + GL +LH+E           HRD+K+ N+L+
Sbjct: 116 YHENGSLYDYLKSTTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILV 175

Query: 178 SEMGDVKLADFGVAGTLTNTTSKR----NTFVGTPFWMAPEVIKQSA------YDSKADI 227
            + G   +AD G+A    + T++     NT VGT  +M PEV+ +S           AD+
Sbjct: 176 KKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADM 235

Query: 228 WSLGITAIELAKGEPPNSELHPMRVLFL------------------------IPKNNPPQ 263
           +S G+   E+A+       +   ++ +                          P      
Sbjct: 236 YSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSD 295

Query: 264 LTGNYTKQFKEFVEACLNKDPENRPTAKELLK 295
                 +Q  + +  C   +P +R TA  + K
Sbjct: 296 ---ECLRQMGKLMTECWAHNPASRLTALRVKK 324

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  175 bits (446), Expect = 2e-48
 Identities = 77/315 (24%), Positives = 137/315 (43%), Gaps = 44/315 (13%)

Query: 37  SNQCGSTTASRRNSLKVDPELIFTKQ-----------ERIGKGSFGEVFKGIDNRTQQVV 85
            +            + ++P +   K+            ++G G++GEV    +       
Sbjct: 5   HHHSSGRENLYFQGIAINPGMYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEK 64

Query: 86  AIKIID------------LEEAEDEIEDIQQEIMVLSQCDSPYGTKLW----------II 123
           AIK+I              +  E   E+I  EI +L   D P   KL+          ++
Sbjct: 65  AIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLV 124

Query: 124 MEYLGGGSALD-LMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLL---SE 179
            E+  GG   + ++    F+E   A I++++L G+ YLH    +HRDIK  N+LL   + 
Sbjct: 125 TEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNS 184

Query: 180 MGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAK 239
           + ++K+ DFG++ +  +   K    +GT +++APEV+K+  Y+ K D+WS G+    L  
Sbjct: 185 LLNIKIVDFGLS-SFFSKDYKLRDRLGTAYYIAPEVLKKK-YNEKCDVWSCGVIMYILLC 242

Query: 240 GEPPNSELHPMRVLFLIPKNNPPQLTGNY----TKQFKEFVEACLNKDPENRPTAKELLK 295
           G PP    +   ++  + +        N     + + KE ++  L  D   R TA+E L 
Sbjct: 243 GYPPFGGQNDQDIIKKV-EKGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALN 301

Query: 296 FPFIRKAKKNAYLID 310
             +I+K   N    D
Sbjct: 302 SRWIKKYANNINKSD 316

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  170 bits (432), Expect = 2e-48
 Identities = 76/288 (26%), Positives = 129/288 (44%), Gaps = 39/288 (13%)

Query: 63  ERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPY------ 116
           E +G G+F EVF      T ++ A+K I    A  +   ++ EI VL +           
Sbjct: 15  EVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRD-SSLENEIAVLKKIKHENIVTLED 73

Query: 117 ----GTKLWIIMEYLGGGSALD-LMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIK 171
                T  +++M+ + GG   D +++ G + E   ++++++VL  + YLH    +HRD+K
Sbjct: 74  IYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLK 133

Query: 172 AANVLLSEMGD---VKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIW 228
             N+L     +   + + DFG++    N     +T  GTP ++APEV+ Q  Y    D W
Sbjct: 134 PENLLYLTPEENSKIMITDFGLSKMEQN--GIMSTACGTPGYVAPEVLAQKPYSKAVDCW 191

Query: 229 SLG-ITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNY----------TKQFKEFVE 277
           S+G IT I L  G PP  E    ++   I         G Y          ++  K+F+ 
Sbjct: 192 SIGVITYILLC-GYPPFYEETESKLFEKI-------KEGYYEFESPFWDDISESAKDFIC 243

Query: 278 ACLNKDPENRPTAKELLKFPFIRK--AKKNAYLIDLIDRYKKWKNSRN 323
             L KDP  R T ++ L  P+I    A        +  + +K   +++
Sbjct: 244 HLLEKDPNERYTCEKALSHPWIDGNTALHRDIYPSVSLQIQKN-FAKS 290

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  168 bits (429), Expect = 3e-48
 Identities = 69/263 (26%), Positives = 115/263 (43%), Gaps = 26/263 (9%)

Query: 63  ERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSP-----YG 117
             IG+GS+GEV   +   T+   A K I     ED ++  +QEI ++   D P     Y 
Sbjct: 15  NTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVED-VDRFKQEIEIMKSLDHPNIIRLYE 73

Query: 118 T-----KLWIIMEYLGGGSALD-LMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIK 171
           T      ++++ME   GG   + ++    F E   A I+++VL  + Y H     HRD+K
Sbjct: 74  TFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLK 133

Query: 172 AANVLLSEMGD---VKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIW 228
             N L         +KL DFG+A           T VGTP++++P+V++   Y  + D W
Sbjct: 134 PENFLFLTDSPDSPLKLIDFGLA-ARFKPGKMMRTKVGTPYYVSPQVLEGL-YGPECDEW 191

Query: 229 SLG-ITAIELAKGEPP-NSELHPMRVLFLIPKNNPPQLTGNY----TKQFKEFVEACLNK 282
           S G +  + L  G PP ++       + L  +              + Q +  +   L K
Sbjct: 192 SAGVMMYVLLC-GYPPFSAPTDSE--VMLKIREGTFTFPEKDWLNVSPQAESLIRRLLTK 248

Query: 283 DPENRPTAKELLKFPFIRKAKKN 305
            P+ R T+ + L+  +  K   +
Sbjct: 249 SPKQRITSLQALEHEWFEKQLSS 271

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  170 bits (433), Expect = 5e-48
 Identities = 40/316 (12%), Positives = 86/316 (27%), Gaps = 58/316 (18%)

Query: 44  TASRRNSLKVDPELIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAED--EIED 101
             +  +SL    E      E +  G    VF   D    +  A+K+  +       E+E 
Sbjct: 49  AETTVDSLLSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELER 108

Query: 102 IQQEIMVLSQC------------------------------------DSPYGTKLWIIME 125
           + +     ++                                     D        ++M 
Sbjct: 109 LHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMP 168

Query: 126 YLGG-----GSALDLMKA--GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLS 178
                     S LD +    G+   + + ++  ++++    L S+  +H      N+ + 
Sbjct: 169 AASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIM 228

Query: 179 EMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSA--YDSKADIWSLGITAIE 236
             G + L D           ++         +   E +  S   +    + W LG++   
Sbjct: 229 PDGRLMLGDVSAL---WKVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYR 285

Query: 237 LAKGEPP------NSELHPMRVLFLIPKNNPPQLTG--NYTKQFKEFVEACLNKDPENRP 288
           +     P        +    R    +P  +              K  +   LN D   R 
Sbjct: 286 VWCLFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRL 345

Query: 289 TAKELLKFPFIRKAKK 304
              E ++ P   + + 
Sbjct: 346 LPLEAMETPEFLQLQN 361

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  169 bits (430), Expect = 7e-48
 Identities = 82/316 (25%), Positives = 134/316 (42%), Gaps = 54/316 (17%)

Query: 63  ERIGKGSFGEVFKGIDNRTQQVVAIKIID-------LEEAEDEIEDIQQEIMVLSQCDSP 115
           + +G G+ GEV    + +T + VAIKII             D   +++ EI +L + + P
Sbjct: 16  KTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHP 75

Query: 116 -----YGT----KLWIIMEYLGGGSALD-LMKAGNFEEMHIAVILREVLKGLDYLHSERK 165
                         +I++E + GG   D ++     +E    +   ++L  + YLH    
Sbjct: 76  CIIKIKNFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGI 135

Query: 166 LHRDIKAANVLLSEMGD---VKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSA-- 220
           +HRD+K  NVLLS   +   +K+ DFG +  L   TS   T  GTP ++APEV+      
Sbjct: 136 IHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE-TSLMRTLCGTPTYLAPEVLVSVGTA 194

Query: 221 -YDSKADIWSLG-ITAIELAKGEPP-NSELHPMRVLFLIPKNNPPQLTGNYT-------- 269
            Y+   D WSLG I  I L+ G PP +     + +   I        +G Y         
Sbjct: 195 GYNRAVDCWSLGVILFICLS-GYPPFSEHRTQVSLKDQI-------TSGKYNFIPEVWAE 246

Query: 270 --KQFKEFVEACLNKDPENRPTAKELLKFPFIRKAKKNAYLIDLIDRYK----------K 317
             ++  + V+  L  DP+ R T +E L+ P+++         DL+              +
Sbjct: 247 VSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRKFQDLLSEENESTALPQVLAQ 306

Query: 318 WKNSRNEESETESETS 333
              SR    E E+E +
Sbjct: 307 PSTSRKRPREGEAEGA 322

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  176 bits (448), Expect = 9e-48
 Identities = 61/266 (22%), Positives = 95/266 (35%), Gaps = 24/266 (9%)

Query: 59  FTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGT 118
           +  +ER+G G FG V + I   T + VAIK    E +    E    EI ++ + + P   
Sbjct: 16  WEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVV 75

Query: 119 KL----------------WIIMEYLGGGSALDLM----KAGNFEEMHIAVILREVLKGLD 158
                              + MEY  GG     +         +E  I  +L ++   L 
Sbjct: 76  SAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALR 135

Query: 159 YLHSERKLHRDIKAANVLLSEMGD---VKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEV 215
           YLH  R +HRD+K  N++L         K+ D G A  L         FVGT  ++APE+
Sbjct: 136 YLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQG-ELCTEFVGTLQYLAPEL 194

Query: 216 IKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEF 275
           ++Q  Y    D WS G  A E   G  P              +    +    Y       
Sbjct: 195 LEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTGAV 254

Query: 276 VEACLNKDPENRPTAKELLKFPFIRK 301
             + +   P +           +++ 
Sbjct: 255 KFSSVLPTPNHLSGILAGKLERWLQC 280

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score =  168 bits (428), Expect = 2e-47
 Identities = 72/276 (26%), Positives = 121/276 (43%), Gaps = 49/276 (17%)

Query: 62  QERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQC-DSPY---- 116
           +E IG GS+    + I   T    A+KIID         D  +EI +L +    P     
Sbjct: 27  KEDIGVGSYSVCKRCIHKATNMEFAVKIID-----KSKRDPTEEIEILLRYGQHPNIITL 81

Query: 117 ------GTKLWIIMEYLGGGSALD-LMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRD 169
                 G  ++++ E + GG  LD +++   F E   + +L  + K ++YLH++  +HRD
Sbjct: 82  KDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRD 141

Query: 170 IKAANVLLSEMGD----VKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKA 225
           +K +N+L  +       +++ DFG A  L        T   T  ++APEV+++  YD+  
Sbjct: 142 LKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLERQGYDAAC 201

Query: 226 DIWSLG-ITAIELAKGEPPNSELHPMRVLFLIPKNNPPQ------LTGNY---------- 268
           DIWSLG +    L  G  P          F    ++ P+       +G +          
Sbjct: 202 DIWSLGVLLYTMLT-GYTP----------FANGPDDTPEEILARIGSGKFSLSGGYWNSV 250

Query: 269 TKQFKEFVEACLNKDPENRPTAKELLKFPFIRKAKK 304
           +   K+ V   L+ DP  R TA  +L+ P+I    +
Sbjct: 251 SDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHWDQ 286

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  165 bits (421), Expect = 5e-47
 Identities = 74/280 (26%), Positives = 119/280 (42%), Gaps = 50/280 (17%)

Query: 63  ERIGKGSFGEVFKGIDNRTQQVVAIKIID-----LEEAEDEIEDIQQEIMVLSQCDSPY- 116
           E +G G F  V K     T +  A K I              E+I++E+ +L +   P  
Sbjct: 11  EELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNI 70

Query: 117 ---------GTKLWIIMEYLGGGSALD-LMKAGNFEEMHIAVILREVLKGLDYLHSERKL 166
                     T + +I+E + GG   D L +  +  E      L+++L G+ YLHS+R  
Sbjct: 71  ITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIA 130

Query: 167 HRDIKAANVLL----SEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYD 222
           H D+K  N++L         +KL DFG+A       ++     GTP ++APE++      
Sbjct: 131 HFDLKPENIMLLDKNVPNPRIKLIDFGIA-HKIEAGNEFKNIFGTPEFVAPEIVNYEPLG 189

Query: 223 SKADIWSLG-ITAIELAKGEPP-----NSELHPMRVLFLIPKNNPPQLTGNY-------- 268
            +AD+WS+G IT I L+ G  P       E      L  I          NY        
Sbjct: 190 LEADMWSIGVITYILLS-GASPFLGETKQET-----LTNI-------SAVNYDFDEEYFS 236

Query: 269 --TKQFKEFVEACLNKDPENRPTAKELLKFPFIRKAKKNA 306
             ++  K+F+   L KDP+ R T  + L+  +I+  ++  
Sbjct: 237 NTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRRN 276

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score =  166 bits (422), Expect = 7e-47
 Identities = 70/288 (24%), Positives = 125/288 (43%), Gaps = 48/288 (16%)

Query: 61  KQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQC-DSPY--- 116
           +++ +G+G+   V   I+  T Q  A+KII+ +        + +E+ +L QC        
Sbjct: 17  QEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIR-SRVFREVEMLYQCQGHRNVLE 75

Query: 117 -------GTKLWIIMEYLGGGSALD-LMKAGNFEEMHIAVILREVLKGLDYLHSERKLHR 168
                    + +++ E + GGS L  + K  +F E+  +V++++V   LD+LH++   HR
Sbjct: 76  LIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHR 135

Query: 169 DIKAANVLLSEMGD---VKLADFGVA-------GTLTNTTSKRNTFVGTPFWMAPEVIK- 217
           D+K  N+L         VK+ DF +             +T +  T  G+  +MAPEV++ 
Sbjct: 136 DLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEA 195

Query: 218 ----QSAYDSKADIWSLG-ITAIELAKGEPP-NSELHPMRVLFLIPKNNPPQ-------L 264
                S YD + D+WSLG I  I L+ G PP                    Q        
Sbjct: 196 FSEEASIYDKRCDLWSLGVILYILLS-GYPPFVGRCGSDCGWDRGEACPACQNMLFESIQ 254

Query: 265 TGNY----------TKQFKEFVEACLNKDPENRPTAKELLKFPFIRKA 302
            G Y          +   K+ +   L +D + R +A ++L+ P+++  
Sbjct: 255 EGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGC 302

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  165 bits (419), Expect = 1e-46
 Identities = 76/276 (27%), Positives = 121/276 (43%), Gaps = 46/276 (16%)

Query: 63  ERIGKGSFGEVFKGIDNRTQQVVAIKIID--------LEEAEDEIEDIQQEIMVLSQCDS 114
           E +G+G    V + I   T +  A+KIID         EE ++  E   +E+ +L +   
Sbjct: 23  EILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSG 82

Query: 115 -PY----------GTKLWIIMEYLGGGSALD-LMKAGNFEEMHIAVILREVLKGLDYLHS 162
            P            T  +++ + +  G   D L +     E     I+R +L+ +  LH 
Sbjct: 83  HPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHK 142

Query: 163 ERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSA-- 220
              +HRD+K  N+LL +  ++KL DFG +    +   K     GTP ++APE+I+ S   
Sbjct: 143 LNIVHRDLKPENILLDDDMNIKLTDFGFS-CQLDPGEKLREVCGTPSYLAPEIIECSMND 201

Query: 221 ----YDSKADIWSLG-ITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNY------- 268
               Y  + D+WS G I    LA G PP      M +L +I       ++GNY       
Sbjct: 202 NHPGYGKEVDMWSTGVIMYTLLA-GSPPFWHRKQMLMLRMI-------MSGNYQFGSPEW 253

Query: 269 ---TKQFKEFVEACLNKDPENRPTAKELLKFPFIRK 301
              +   K+ V   L   P+ R TA+E L  PF ++
Sbjct: 254 DDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 289

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  165 bits (419), Expect = 2e-46
 Identities = 71/299 (23%), Positives = 127/299 (42%), Gaps = 51/299 (17%)

Query: 63  ERIGKGSFGEVFKGIDNRTQQVVAIKIID-----LEEAEDEIEDIQQEIMVLSQCDSPY- 116
           E +G G F  V K  +  T    A K I              E+I++E+ +L Q      
Sbjct: 18  EELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNV 77

Query: 117 ---------GTKLWIIMEYLGGGSALD-LMKAGNFEEMHIAVILREVLKGLDYLHSERKL 166
                     T + +I+E + GG   D L +  +  E      ++++L G++YLH+++  
Sbjct: 78  ITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIA 137

Query: 167 HRDIKAANVLL----SEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYD 222
           H D+K  N++L      +  +KL DFG+A  + +    +    GTP ++APE++      
Sbjct: 138 HFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFK-NIFGTPEFVAPEIVNYEPLG 196

Query: 223 SKADIWSLG-ITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNY----------TKQ 271
            +AD+WS+G IT I L+ G  P         L  I        + +Y          ++ 
Sbjct: 197 LEADMWSIGVITYILLS-GASPFLGDTKQETLANI-------TSVSYDFDEEFFSHTSEL 248

Query: 272 FKEFVEACLNKDPENRPTAKELLKFPFIRKAKKNAYLIDL-----IDRYK------KWK 319
            K+F+   L K+   R T +E L+ P+I        ++       ++ ++      +WK
Sbjct: 249 AKDFIRKLLVKETRKRLTIQEALRHPWITPVDNQQAMVRRESVVNLENFRKQYVRRRWK 307

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  165 bits (420), Expect = 3e-46
 Identities = 67/289 (23%), Positives = 108/289 (37%), Gaps = 57/289 (19%)

Query: 60  TKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSP---- 115
             QE IGKG FGEV++G      + VA+KI    E        + EI             
Sbjct: 45  VLQESIGKGRFGEVWRGKWR--GEEVAVKIFSSREERSWFR--EAEIYQTVMLRHENILG 100

Query: 116 -YG---------TKLWIIMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERK 165
                       T+LW++ +Y   GS  D +         +  +      GL +LH E  
Sbjct: 101 FIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIV 160

Query: 166 --------LHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTS----KRNTFVGTPFWMAP 213
                    HRD+K+ N+L+ + G   +AD G+A    + T       N  VGT  +MAP
Sbjct: 161 GTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 220

Query: 214 EVIKQSA------YDSKADIWSLGITAIELAKG----------EPPNSELHPMRVLF--- 254
           EV+  S          +ADI+++G+   E+A+           + P  +L P        
Sbjct: 221 EVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEM 280

Query: 255 ---LIPKNNPPQLTGNYT-----KQFKEFVEACLNKDPENRPTAKELLK 295
              +  +   P +   +      +   + +  C   +   R TA  + K
Sbjct: 281 RKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 329

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  165 bits (420), Expect = 3e-46
 Identities = 78/324 (24%), Positives = 141/324 (43%), Gaps = 44/324 (13%)

Query: 32  SGSSISNQCGSTTASRRNSLKVDP------ELIFTKQERIGKGSFGEVFKGIDNRTQQVV 85
           S SS++      TAS      +D          F  +  +G+G+   V++     TQ+  
Sbjct: 22  SMSSVTASAAPGTASLVPDYWIDGSNRDALSDFFEVESELGRGATSIVYRCKQKGTQKPY 81

Query: 86  AIKIIDLEEAEDEIEDIQQEIMVLSQCDSPY----------GTKLWIIMEYLGGGSALD- 134
           A+K++     +   + ++ EI VL +   P            T++ +++E + GG   D 
Sbjct: 82  ALKVLKKTVDK---KIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDR 138

Query: 135 LMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGD---VKLADFGVA 191
           +++ G + E   A  ++++L+ + YLH    +HRD+K  N+L +       +K+ADFG++
Sbjct: 139 IVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLS 198

Query: 192 GTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLG-ITAIELAKGEPP-NSELHP 249
             +        T  GTP + APE+++  AY  + D+WS+G IT I L  G  P   E   
Sbjct: 199 -KIVEHQVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLC-GFEPFYDERGD 256

Query: 250 MRVLFLIPKNNPPQLTGNY----------TKQFKEFVEACLNKDPENRPTAKELLKFPFI 299
             +   I       L   Y          +   K+ V   +  DP+ R T  + L+ P++
Sbjct: 257 QFMFRRI-------LNCEYYFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWV 309

Query: 300 RKAKKNAYLIDLIDRYKKWKNSRN 323
                N   +D   +  +  N+R 
Sbjct: 310 TGKAANFVHMDTAQKKLQEFNARR 333

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score =  163 bits (416), Expect = 8e-46
 Identities = 77/323 (23%), Positives = 138/323 (42%), Gaps = 51/323 (15%)

Query: 59  FTKQERIGKGSFGEVFKGIDNRTQQVVAIKIID-----LEEAEDEIEDIQQEIMVLSQCD 113
           +   E +G G F  V K  +  T    A K I              EDI++E+ +L +  
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72

Query: 114 SPY----------GTKLWIIMEYLGGGSALD-LMKAGNFEEMHIAVILREVLKGLDYLHS 162
            P            T + +I+E + GG   D L +  +  E      L+++L G+ YLHS
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 132

Query: 163 ERKLHRDIKAANVLLS----EMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQ 218
            +  H D+K  N++L         +K+ DFG+A    +  ++     GTP ++APE++  
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA-HKIDFGNEFKNIFGTPEFVAPEIVNY 191

Query: 219 SAYDSKADIWSLG-ITAIELAKGEPP---NSELHPMRVLFLIPKNNPPQLTGNY------ 268
                +AD+WS+G IT I L+ G  P   +++      L  +          NY      
Sbjct: 192 EPLGLEADMWSIGVITYILLS-GASPFLGDTK---QETLANV-------SAVNYEFEDEY 240

Query: 269 ----TKQFKEFVEACLNKDPENRPTAKELLKFPFIRKAKKNAYLIDL-----IDRYKKWK 319
               +   K+F+   L KDP+ R T ++ L+ P+I+       L        ++++KK+ 
Sbjct: 241 FSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQALSRKASAVNMEKFKKFA 300

Query: 320 NSRNEESETESETSDNEDSIKTD 342
             +   + +    +D  ++ K +
Sbjct: 301 ARKKSNNGSGGGLNDIFEAQKIE 323

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score =  163 bits (415), Expect = 9e-46
 Identities = 66/276 (23%), Positives = 117/276 (42%), Gaps = 44/276 (15%)

Query: 63  ERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE-AEDEIEDIQQEIMVLSQCDS-PY---- 116
           + +G+G F  V + I   T Q  A K +      +D   +I  EI VL    S P     
Sbjct: 35  KELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINL 94

Query: 117 ------GTKLWIIMEYLGGGSALDLM---KAGNFEEMHIAVILREVLKGLDYLHSERKLH 167
                  +++ +I+EY  GG    L     A    E  +  +++++L+G+ YLH    +H
Sbjct: 95  HEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVH 154

Query: 168 RDIKAANVLL---SEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSK 224
            D+K  N+LL     +GD+K+ DFG++        +    +GTP ++APE++      + 
Sbjct: 155 LDLKPQNILLSSIYPLGDIKIVDFGMS-RKIGHACELREIMGTPEYLAPEILNYDPITTA 213

Query: 225 ADIWSLG-ITAIELAKGEPP---NSELHPMRVLFLIPKNNPPQLTGNY----------TK 270
            D+W++G I  + L     P               I          N           ++
Sbjct: 214 TDMWNIGIIAYMLLT-HTSPFVGEDN---QETYLNI-------SQVNVDYSEETFSSVSQ 262

Query: 271 QFKEFVEACLNKDPENRPTAKELLKFPFIRKAKKNA 306
              +F+++ L K+PE RPTA+  L   ++++     
Sbjct: 263 LATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDFEN 298

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  164 bits (416), Expect = 2e-45
 Identities = 77/336 (22%), Positives = 140/336 (41%), Gaps = 68/336 (20%)

Query: 63  ERIGKGSFGEVFKGIDNRTQQVVAIKIID-----LEEAEDEIEDIQQEIMVLSQCDSPY- 116
           E +G G F  V K  +  T    A K I              E+I++E+ +L Q   P  
Sbjct: 18  EELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNI 77

Query: 117 ---------GTKLWIIMEYLGGGSALD-LMKAGNFEEMHIAVILREVLKGLDYLHSERKL 166
                     T + +I+E + GG   D L +  +  E      ++++L G++YLH+++  
Sbjct: 78  ITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIA 137

Query: 167 HRDIKAANVLL----SEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYD 222
           H D+K  N++L      +  +KL DFG+A        +     GTP ++APE++      
Sbjct: 138 HFDLKPENIMLLDKNIPIPHIKLIDFGLA-HEIEDGVEFKNIFGTPEFVAPEIVNYEPLG 196

Query: 223 SKADIWSLG-ITAIELAKGEPP---NSELHPMRVLFLIPKNNPPQLTGNY---------- 268
            +AD+WS+G IT I L+ G  P   +++      L  I          +Y          
Sbjct: 197 LEADMWSIGVITYILLS-GASPFLGDTK---QETLANI-------TAVSYDFDEEFFSQT 245

Query: 269 TKQFKEFVEACLNKDPENRPTAKELLKFPFIRKAKKNAYLIDL-----IDRYK------K 317
           ++  K+F+   L K+   R T +E L+ P+I        ++       ++ +K      +
Sbjct: 246 SELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDTQQAMVRRESVVNLENFKKQYVRRR 305

Query: 318 WK-----------NSRNEESETESETSDNEDSIKTD 342
           WK            +R+   +    TS++  + ++D
Sbjct: 306 WKLSFSIVSLCNHLTRSLMKKVHLRTSEDLRNCESD 341

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  164 bits (417), Expect = 3e-45
 Identities = 41/313 (13%), Positives = 91/313 (29%), Gaps = 63/313 (20%)

Query: 44  TASRRNSLKVDPELIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE--AEDEIED 101
              R  S   +      +   +G+       +  D  T +   + +    E    + I+ 
Sbjct: 65  QPFRVESELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQ 124

Query: 102 IQQEIMVLSQ--------------------------------CDSPYGTKLWIIMEYL-- 127
           +++E++ L                                          +W++  +   
Sbjct: 125 MKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLY 184

Query: 128 ---------GGGSALDLMKAGNFEEMHIAV-ILREVLKGLDYLHSERKLHRDIKAANVLL 177
                     G   L           H  + +  +V++ L  LH    +H  ++  +++L
Sbjct: 185 PRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVL 244

Query: 178 SEMGDVKLADFGVAGTL-TNTTSKRNTFVGTPFWMAPEVIK-----QSAYDSKADIWSLG 231
            + G V L  F        +  S        P   A  ++       +      D W+LG
Sbjct: 245 DQRGGVFLTGFEHLVRDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLG 304

Query: 232 ITAIELAKGEPP---NSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPENRP 288
           +    +   + P   ++ L     +F   KN P  +        +  +E  L    E+R 
Sbjct: 305 LAIYWIWCADLPNTDDAALGGSEWIFRSCKNIPQPV--------RALLEGFLRYPKEDRL 356

Query: 289 TAKELLKFPFIRK 301
              + ++ P   +
Sbjct: 357 LPLQAMETPEYEQ 369

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score =  162 bits (412), Expect = 3e-45
 Identities = 70/272 (25%), Positives = 112/272 (41%), Gaps = 38/272 (13%)

Query: 62  QERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQC--------- 112
           ++ +G G  G+V +    RT Q  A+K++       +    +QE+    Q          
Sbjct: 34  KQVLGLGVNGKVLECFHRRTGQKCALKLLY------DSPKARQEVDHHWQASGGPHIVCI 87

Query: 113 ------DSPYGTKLWIIMEYLGGGSALD-LMKAGN--FEEMHIAVILREVLKGLDYLHSE 163
                        L IIME + GG     + + G+  F E   A I+R++   + +LHS 
Sbjct: 88  LDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSH 147

Query: 164 RKLHRDIKAANVLLSEMGD---VKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSA 220
              HRD+K  N+L +       +KL DFG A   T   +   T   TP+++APEV+    
Sbjct: 148 NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQ--NALQTPCYTPYYVAPEVLGPEK 205

Query: 221 YDSKADIWSLG-ITAIELAKGEPP---NSELHPMRVLFLIPKNNPPQLTGNY----TKQF 272
           YD   D+WSLG I  I L  G PP   N+       +    +              ++  
Sbjct: 206 YDKSCDMWSLGVIMYILLC-GFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSEVSEDA 264

Query: 273 KEFVEACLNKDPENRPTAKELLKFPFIRKAKK 304
           K+ +   L  DP  R T  + +  P+I ++  
Sbjct: 265 KQLIRLLLKTDPTERLTITQFMNHPWINQSMV 296

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  162 bits (412), Expect = 3e-45
 Identities = 67/344 (19%), Positives = 126/344 (36%), Gaps = 64/344 (18%)

Query: 34  SSISNQCGSTTASRRNSLKVDPELIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIID-- 91
           S+ SN        +     ++    +     + +G F ++         +  A+K  +  
Sbjct: 11  SNYSNLIYLNKYVKEKDKYIND---YRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKS 65

Query: 92  --------------LEEAEDEIEDIQQEIMVLSQCDSP-----YG-----TKLWIIMEYL 127
                             + + +D + E+ +++   +       G      +++II EY+
Sbjct: 66  LLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYM 125

Query: 128 GGG---------SALDLMKAGNFEEMHIAVILREVLKGLDYLHSERK-LHRDIKAANVLL 177
                         LD           I  I++ VL    Y+H+E+   HRD+K +N+L+
Sbjct: 126 ENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILM 185

Query: 178 SEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVI--KQSAYDSKADIWSLGITAI 235
            + G VKL+DFG +  + +   K     GT  +M PE    + S   +K DIWSLGI   
Sbjct: 186 DKNGRVKLSDFGESEYMVD--KKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLY 243

Query: 236 ELAKGEPP-NSELHPM-------RVLFLIPKNNPPQLTGNYTKQF-----------KEFV 276
            +     P + ++  +             P +    L     K+             +F+
Sbjct: 244 VMFYNVVPFSLKISLVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFL 303

Query: 277 EACLNKDPENRPTAKELLKFPFIRKAKKNAYLIDLIDRYKKWKN 320
           +  L K+P  R T+++ LK  ++             + YKK K 
Sbjct: 304 KLFLRKNPAERITSEDALKHEWLADTNIEDLREFSKELYKKRKK 347

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  163 bits (413), Expect = 5e-45
 Identities = 37/320 (11%), Positives = 94/320 (29%), Gaps = 72/320 (22%)

Query: 44  TASRRNSLKVDPELIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE--AEDEIED 101
              R  S   +      +   +G+       +  D  T +   + +    E    + I+ 
Sbjct: 60  QPFRVESELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQ 119

Query: 102 IQQEIMVLSQC-------------------------------------DSPYGTKLWIIM 124
           +++E++ L                                           +    + + 
Sbjct: 120 MKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLY 179

Query: 125 EYLGG--GSALDLMKA-----GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLL 177
             +     +  +++ +      +        +  +V++ L  LH    +H  ++  +++L
Sbjct: 180 PRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVL 239

Query: 178 SEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIK-----------QSAYDSKAD 226
            + G V L  F            R     +  +  PE+             ++      D
Sbjct: 240 DQRGGVFLTGFEHL----VRDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFD 295

Query: 227 IWSLGITAIELAKGEPP---NSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKD 283
            W+LG+    +   + P   ++ L     +F   KN P  +        +  +E  L   
Sbjct: 296 AWALGLVIYWIWCADLPITKDAALGGSEWIFRSCKNIPQPV--------RALLEGFLRYP 347

Query: 284 PENRPTAKELLKFPFIRKAK 303
            E+R    + ++ P   + +
Sbjct: 348 KEDRLLPLQAMETPEYEQLR 367

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  161 bits (409), Expect = 9e-45
 Identities = 70/318 (22%), Positives = 121/318 (38%), Gaps = 80/318 (25%)

Query: 63  ERIGKGSFGEVFKGIDNRTQQVVAIKIID----LEEAEDEIEDIQQEIMVLSQCDSPY-- 116
             IG+GS+G V   I+N+T+ + AIKI++     +    ++E I+ E+ ++ +   P   
Sbjct: 32  GAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIA 91

Query: 117 --------GTKLWIIMEYLGGGSALDLMKA------------------------------ 138
                      + ++ME   GG  LD +                                
Sbjct: 92  RLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAIN 151

Query: 139 -----------GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLS--EMGDVKL 185
                          E  I+ I+R++   L YLH++   HRDIK  N L S  +  ++KL
Sbjct: 152 GSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSFEIKL 211

Query: 186 ADFGVAGTLTNTT----SKRNTFVGTPFWMAPEVIKQSA--YDSKADIWSLGITAIELAK 239
            DFG++               T  GTP+++APEV+  +   Y  K D WS G+    L  
Sbjct: 212 VDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLM 271

Query: 240 GEPPNSELHPMRVLFLIPKNNPPQLTGNY----------TKQFKEFVEACLNKDPENRPT 289
           G  P   ++    +  +       L              +   ++ +   LN++ + R  
Sbjct: 272 GAVPFPGVNDADTISQV-------LNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFD 324

Query: 290 AKELLKFPFIRKAKKNAY 307
           A   L+ P+I +     Y
Sbjct: 325 AMRALQHPWISQFSDKIY 342

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  161 bits (410), Expect = 1e-44
 Identities = 69/275 (25%), Positives = 123/275 (44%), Gaps = 45/275 (16%)

Query: 63  ERIGKGSFGEVFKGIDNRTQQVVAIKIIDL-------EEAEDEIEDIQQEIMVLSQ-CDS 114
           + IG+G    V + +   T    A+KI+++       E+ E+  E  ++E  +L Q    
Sbjct: 100 DVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGH 159

Query: 115 PY----------GTKLWIIMEYLGGGSALD-LMKAGNFEEMHIAVILREVLKGLDYLHSE 163
           P+           + ++++ + +  G   D L +     E     I+R +L+ + +LH+ 
Sbjct: 160 PHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHAN 219

Query: 164 RKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSA--- 220
             +HRD+K  N+LL +   ++L+DFG +        K     GTP ++APE++K S    
Sbjct: 220 NIVHRDLKPENILLDDNMQIRLSDFGFS-CHLEPGEKLRELCGTPGYLAPEILKCSMDET 278

Query: 221 ---YDSKADIWSLG-ITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNY-------- 268
              Y  + D+W+ G I    LA G PP      + +L +I       + G Y        
Sbjct: 279 HPGYGKEVDLWACGVILFTLLA-GSPPFWHRRQILMLRMI-------MEGQYQFSSPEWD 330

Query: 269 --TKQFKEFVEACLNKDPENRPTAKELLKFPFIRK 301
             +   K+ +   L  DPE R TA++ L+ PF  +
Sbjct: 331 DRSSTVKDLISRLLQVDPEARLTAEQALQHPFFER 365

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  162 bits (411), Expect = 2e-44
 Identities = 62/287 (21%), Positives = 120/287 (41%), Gaps = 35/287 (12%)

Query: 59  FTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPY-- 116
           +   E +G G+FG V + ++  T +V   K I+     D    ++ EI +++Q   P   
Sbjct: 53  YDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLD-KYTVKNEISIMNQLHHPKLI 111

Query: 117 --------GTKLWIIMEYLGGGSALD--LMKAGNFEEMHIAVILREVLKGLDYLHSERKL 166
                     ++ +I+E+L GG   D    +     E  +   +R+  +GL ++H    +
Sbjct: 112 NLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIV 171

Query: 167 HRDIKAANVLLS--EMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSK 224
           H DIK  N++    +   VK+ DFG+A  L            T  + APE++ +      
Sbjct: 172 HLDIKPENIMCETKKASSVKIIDFGLATKLNPDE-IVKVTTATAEFAAPEIVDREPVGFY 230

Query: 225 ADIWSLG-ITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNY----------TKQFK 273
            D+W++G +  + L+ G  P +    +  L  +          ++          + + K
Sbjct: 231 TDMWAIGVLGYVLLS-GLSPFAGEDDLETLQNV-------KRCDWEFDEDAFSSVSPEAK 282

Query: 274 EFVEACLNKDPENRPTAKELLKFPFIRKAKKNAYLIDLIDRYKKWKN 320
           +F++  L K+P  R T  + L+ P+++    N        RY K + 
Sbjct: 283 DFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSRIPSSRYNKIRQ 329

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score =  158 bits (401), Expect = 3e-44
 Identities = 67/259 (25%), Positives = 117/259 (45%), Gaps = 28/259 (10%)

Query: 65  IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPY-------- 116
           +G+G++GEV   ++  T++ VA+KI+D++ A D  E+I++EI +    +           
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74

Query: 117 --GTKLWIIMEYLGGGSALD-LMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAA 173
             G   ++ +EY  GG   D +       E        +++ G+ YLH     HRDIK  
Sbjct: 75  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPE 134

Query: 174 NVLLSEMGDVKLADFGVAGTLTNTTSKR--NTFVGTPFWMAPEVIKQSAYD-SKADIWSL 230
           N+LL E  ++K++DFG+A        +R  N   GT  ++APE++K+  +     D+WS 
Sbjct: 135 NLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSC 194

Query: 231 GITAIELAKGEPP-NSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEAC-------LNK 282
           GI    +  GE P +      +      +         Y   +K+   A        L +
Sbjct: 195 GIVLTAMLAGELPWDQPSDSCQEYSDWKEK------KTYLNPWKKIDSAPLALLHKILVE 248

Query: 283 DPENRPTAKELLKFPFIRK 301
           +P  R T  ++ K  +  K
Sbjct: 249 NPSARITIPDIKKDRWYNK 267

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  160 bits (407), Expect = 3e-44
 Identities = 72/278 (25%), Positives = 127/278 (45%), Gaps = 45/278 (16%)

Query: 59  FTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPY-- 116
            +K E +G G FG+V K  +  T   +A KII     +D  E+++ EI V++Q D     
Sbjct: 91  VSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKD-KEEVKNEISVMNQLDHANLI 149

Query: 117 --------GTKLWIIMEYLGGGSALD--LMKAGNFEEMHIAVILREVLKGLDYLHSERKL 166
                      + ++MEY+ GG   D  + ++ N  E+   + ++++ +G+ ++H    L
Sbjct: 150 QLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYIL 209

Query: 167 HRDIKAANVLLS--EMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSK 224
           H D+K  N+L    +   +K+ DFG+A         +    GTP ++APEV+        
Sbjct: 210 HLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLK-VNFGTPEFLAPEVVNYDFVSFP 268

Query: 225 ADIWSLG-ITAIELAKGEPP-----NSELHPMRVLFLIPKNNPPQLTGNY---------- 268
            D+WS+G I  + L+ G  P     ++E      L  I       L   +          
Sbjct: 269 TDMWSVGVIAYMLLS-GLSPFLGDNDAET-----LNNI-------LACRWDLEDEEFQDI 315

Query: 269 TKQFKEFVEACLNKDPENRPTAKELLKFPFIRKAKKNA 306
           +++ KEF+   L K+   R +A E LK P++   K ++
Sbjct: 316 SEEAKEFISKLLIKEKSWRISASEALKHPWLSDHKLHS 353

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score =  159 bits (403), Expect = 5e-44
 Identities = 72/307 (23%), Positives = 124/307 (40%), Gaps = 32/307 (10%)

Query: 65  IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPY-------- 116
           +G+G++GEV   ++  T++ VA+KI+D++ A D  E+I++EI +    +           
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74

Query: 117 --GTKLWIIMEYLGGGSALD-LMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAA 173
             G   ++ +EY  GG   D +       E        +++ G+ YLH     HRDIK  
Sbjct: 75  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPE 134

Query: 174 NVLLSEMGDVKLADFGVAGTLTNTTSKR--NTFVGTPFWMAPEVIKQSAYD-SKADIWSL 230
           N+LL E  ++K++DFG+A        +R  N   GT  ++APE++K+  +     D+WS 
Sbjct: 135 NLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSC 194

Query: 231 GITAIELAKGEPP-NSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEAC-------LNK 282
           GI    +  GE P +      +      +         Y   +K+   A        L +
Sbjct: 195 GIVLTAMLAGELPWDQPSDSCQEYSDWKEK------KTYLNPWKKIDSAPLALLHKILVE 248

Query: 283 DPENRPTAKELLKFPFIRKAKKNAYLIDLIDRYKKWKNSRNEESETESETSDNEDSIKTD 342
           +P  R T  ++ K  +  K  K       +             S        N D    +
Sbjct: 249 NPSARITIPDIKKDRWYNKPLKKGAKRPRVTSG----GVSESPSGFSKHIQSNLDFSPVN 304

Query: 343 GDLDEPW 349
                P 
Sbjct: 305 SASRTPG 311

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  164 bits (416), Expect = 7e-44
 Identities = 65/295 (22%), Positives = 117/295 (39%), Gaps = 36/295 (12%)

Query: 54  DPELIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCD 113
                +   E +G G+FG V +  +  T    A K +      D  E +++EI  +S   
Sbjct: 154 HVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESD-KETVRKEIQTMSVLR 212

Query: 114 SPY----------GTKLWIIMEYLGGGSALD--LMKAGNFEEMHIAVILREVLKGLDYLH 161
            P             ++ +I E++ GG   +    +     E      +R+V KGL ++H
Sbjct: 213 HPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH 272

Query: 162 SERKLHRDIKAANVLLSEMGD--VKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQS 219
               +H D+K  N++ +      +KL DFG+   L    S +    GT  + APEV +  
Sbjct: 273 ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVK-VTTGTAEFAAPEVAEGK 331

Query: 220 AYDSKADIWSLG-ITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNY---------- 268
                 D+WS+G ++ I L+ G  P    +    L  +        + ++          
Sbjct: 332 PVGYYTDMWSVGVLSYILLS-GLSPFGGENDDETLRNV-------KSCDWNMDDSAFSGI 383

Query: 269 TKQFKEFVEACLNKDPENRPTAKELLKFPFIRKAKKNAYLIDL-IDRYKKWKNSR 322
           ++  K+F+   L  DP  R T  + L+ P++           +   RY K ++S 
Sbjct: 384 SEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIPSSRYTKIRDSI 438

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  158 bits (400), Expect = 2e-43
 Identities = 62/303 (20%), Positives = 114/303 (37%), Gaps = 72/303 (23%)

Query: 59  FTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQ------- 111
               E IG+G +G V+KG  +  ++ VA+K+      ++ I   ++ I  +         
Sbjct: 15  LKLLELIGRGRYGAVYKGSLD--ERPVAVKVFSFANRQNFIN--EKNIYRVPLMEHDNIA 70

Query: 112 --------CDSPYGTKLWIIMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSE 163
                     +    +  ++MEY   GS    +     + +    +   V +GL YLH+E
Sbjct: 71  RFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSDWVSSCRLAHSVTRGLAYLHTE 130

Query: 164 RKL---------HRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKR--------NTFVG 206
                       HRD+ + NVL+   G   ++DFG++  LT     R         + VG
Sbjct: 131 LPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVG 190

Query: 207 TPFWMAPEVIKQS-------AYDSKADIWSLGITAIELA---KGEPPNSELHPMRVLF-- 254
           T  +MAPEV++ +       +   + D+++LG+   E+        P   +   ++ F  
Sbjct: 191 TIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQT 250

Query: 255 ----------------------LIPKNNPPQLTGNYTKQFKEFVEACLNKDPENRPTAKE 292
                                   P+           +  KE +E C ++D E R TA+ 
Sbjct: 251 EVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLA--VRSLKETIEDCWDQDAEARLTAQX 308

Query: 293 LLK 295
             +
Sbjct: 309 AEE 311

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  157 bits (399), Expect = 2e-43
 Identities = 57/273 (20%), Positives = 113/273 (41%), Gaps = 46/273 (16%)

Query: 63  ERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPY------ 116
           E +G+G FG V + ++  +++    K + ++    +   +++EI +L+            
Sbjct: 11  EDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG--TDQVLVKKEISILNIARHRNILHLHE 68

Query: 117 ----GTKLWIIMEYLGGGSALD--LMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDI 170
                 +L +I E++ G    +     A    E  I   + +V + L +LHS    H DI
Sbjct: 69  SFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDI 128

Query: 171 KAANVLLS--EMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIW 228
           +  N++        +K+ +FG A  L             P + APEV +     +  D+W
Sbjct: 129 RPENIIYQTRRSSTIKIIEFGQARQLKPGD-NFRLLFTAPEYYAPEVHQHDVVSTATDMW 187

Query: 229 SLG-ITAIELAKGEPP-----NSELHPMRVLFLIPKNNPPQLTGNY----------TKQF 272
           SLG +  + L+ G  P     N ++     +  I       +   Y          + + 
Sbjct: 188 SLGTLVYVLLS-GINPFLAETNQQI-----IENI-------MNAEYTFDEEAFKEISIEA 234

Query: 273 KEFVEACLNKDPENRPTAKELLKFPFIRKAKKN 305
            +FV+  L K+ ++R TA E L+ P++++  + 
Sbjct: 235 MDFVDRLLVKERKSRMTASEALQHPWLKQKIER 267

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score =  156 bits (396), Expect = 3e-43
 Identities = 65/279 (23%), Positives = 123/279 (44%), Gaps = 43/279 (15%)

Query: 65  IGKGSFGEVFKGIDNRTQQVVAIKIID-------------------------LEEAEDEI 99
           IGKGS+G V    +       A+K++                            +    I
Sbjct: 21  IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80

Query: 100 EDIQQEIMVLSQCDSPY------------GTKLWIIMEYLGGGSALDLMKAGNFEEMHIA 147
           E + QEI +L + D P                L+++ E +  G  +++       E    
Sbjct: 81  EQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQAR 140

Query: 148 VILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGT 207
              ++++KG++YLH ++ +HRDIK +N+L+ E G +K+ADFGV+     + +  +  VGT
Sbjct: 141 FYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLSNTVGT 200

Query: 208 PFWMAPEVI--KQSAYD-SKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQL 264
           P +MAPE +   +  +     D+W++G+T      G+ P  +   +  L    K+   + 
Sbjct: 201 PAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDER-IMCLHSKIKSQALEF 259

Query: 265 --TGNYTKQFKEFVEACLNKDPENRPTAKELLKFPFIRK 301
               +  +  K+ +   L+K+PE+R    E+   P++ +
Sbjct: 260 PDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVTR 298

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score =  157 bits (399), Expect = 1e-42
 Identities = 71/314 (22%), Positives = 122/314 (38%), Gaps = 39/314 (12%)

Query: 22  NPTQFLKFSNSGSSISNQCGSTTASRRNSLKVDP--ELIFTKQERIGKGSFGEVFKGIDN 79
            P      +        Q           +K +   +      + +G G  G+V +  + 
Sbjct: 25  TPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNK 84

Query: 80  RTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQC---------------DSPYGTKLWIIM 124
           RTQ+  A+K++       +    ++E+ +  +                       L I+M
Sbjct: 85  RTQEKFALKMLQ------DCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVM 138

Query: 125 EYLGGGSALDLMKA---GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMG 181
           E L GG     ++      F E   + I++ + + + YLHS    HRD+K  N+L +   
Sbjct: 139 ECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKR 198

Query: 182 D---VKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLG-ITAIEL 237
               +KL DFG A   T + +   T   TP+++APEV+    YD   D+WSLG I  I L
Sbjct: 199 PNAILKLTDFGFA-KETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILL 257

Query: 238 AKGEPP---NSELHPMRVLFLIPKNNPPQLTGNY----TKQFKEFVEACLNKDPENRPTA 290
             G PP   N  L     +    +    +         +++ K  +   L  +P  R T 
Sbjct: 258 C-GYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTI 316

Query: 291 KELLKFPFIRKAKK 304
            E +  P+I ++ K
Sbjct: 317 TEFMNHPWIMQSTK 330

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score =  156 bits (396), Expect = 2e-42
 Identities = 70/256 (27%), Positives = 128/256 (50%), Gaps = 26/256 (10%)

Query: 65  IGKGSFGEVFKGIDNRTQQVVAIKIIDLEE--AEDEIEDIQQEIMVLSQCDSPYGTKLW- 121
           IGKGSFG+V     N T+++ A+K ++ ++    +E+ ++ +E+ ++   + P+   LW 
Sbjct: 23  IGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWY 82

Query: 122 ---------IIMEYLGGGSALDLM----KAGNFEEMHIAVILREVLKGLDYLHSERKLHR 168
                    ++++ L GG   DL     +  +F+E  + + + E++  LDYL ++R +HR
Sbjct: 83  SFQDEEDMFMVVDLLLGG---DLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHR 139

Query: 169 DIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVI---KQSAYDSKA 225
           D+K  N+LL E G V + DF +A  L   T +  T  GT  +MAPE+    K + Y    
Sbjct: 140 DMKPDNILLDEHGHVHITDFNIAAMLPRET-QITTMAGTKPYMAPEMFSSRKGAGYSFAV 198

Query: 226 DIWSLGITAIELAKGEPP--NSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKD 283
           D WSLG+TA EL +G  P         + +    +         ++++    ++  L  +
Sbjct: 199 DWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPSAWSQEMVSLLKKLLEPN 258

Query: 284 PENR-PTAKELLKFPF 298
           P+ R     ++  FP+
Sbjct: 259 PDQRFSQLSDVQNFPY 274

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score =  153 bits (388), Expect = 6e-42
 Identities = 75/306 (24%), Positives = 124/306 (40%), Gaps = 31/306 (10%)

Query: 65  IGKGSFGEVFKGIDNRTQQVVAIKIID----LEEAEDEIED---IQQEIMVLSQCDSPY- 116
           +G G+FG V+  +D    + V +K I     LE+   E      +  EI +LS+ +    
Sbjct: 32  LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91

Query: 117 ---------GTKLWIIMEYLGGGSAL-D-LMKAGNFEEMHIAVILREVLKGLDYLHSERK 165
                         ++ME  G G  L   + +    +E   + I R+++  + YL  +  
Sbjct: 92  IKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDI 151

Query: 166 LHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYD-SK 224
           +HRDIK  N++++E   +KL DFG A  L        TF GT  + APEV+  + Y   +
Sbjct: 152 IHRDIKDENIVIAEDFTIKLIDFGSAAYLER-GKLFYTFCGTIEYCAPEVLMGNPYRGPE 210

Query: 225 ADIWSLGITAIELAKGEPPNSELHP-MRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKD 283
            ++WSLG+T   L   E P  EL   +      P     +L           V   L   
Sbjct: 211 LEMWSLGVTLYTLVFEENPFCELEETVEAAIHPPYLVSKEL--------MSLVSGLLQPV 262

Query: 284 PENRPTAKELLKFPFIRKAKKNA-YLIDLIDRYKKWKNSRNEESETESETSDNEDSIKTD 342
           PE R T ++L+  P++ +    A Y  + + R  K ++     +  E       D  +  
Sbjct: 263 PERRTTLEKLVTDPWVTQPVNLADYTWEEVFRVNKPESGVLSAASLEMGNRSLSDVAQAQ 322

Query: 343 GDLDEP 348
                 
Sbjct: 323 ELCGGE 328

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score =  157 bits (399), Expect = 9e-42
 Identities = 68/262 (25%), Positives = 113/262 (43%), Gaps = 31/262 (11%)

Query: 65  IGKGSFGEVFKGIDNRTQQVVAIKIIDLEE--AEDEIEDIQQEIMVLSQCDSPY------ 116
           +G+G FGEVF      T ++ A K ++ +        +    E  +L++  S +      
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAY 252

Query: 117 ----GTKLWIIMEYLGGGSALDLM--------KAGNFEEMHIAVILREVLKGLDYLHSER 164
                T L ++M  + GG   D+             F+E        +++ GL++LH   
Sbjct: 253 AFETKTDLCLVMTIMNGG---DIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN 309

Query: 165 KLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSK 224
            ++RD+K  NVLL + G+V+++D G+A  L    +K   + GTP +MAPE++    YD  
Sbjct: 310 IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEEYDFS 369

Query: 225 ADIWSLGITAIELAKGEPP---NSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLN 281
            D ++LG+T  E+     P     E    + L              ++   K+F EA L 
Sbjct: 370 VDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKFSPASKDFCEALLQ 429

Query: 282 KDPENR-----PTAKELLKFPF 298
           KDPE R      +   L   P 
Sbjct: 430 KDPEKRLGFRDGSCDGLRTHPL 451

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  152 bits (385), Expect = 1e-41
 Identities = 71/316 (22%), Positives = 113/316 (35%), Gaps = 67/316 (21%)

Query: 41  GSTTASRRNSLKVDPELI------FTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDL-E 93
           G       + + +  E +          E   +G FG V+K       + VA+KI  + +
Sbjct: 2   GHHHHHHSSGVDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQD 59

Query: 94  EAEDEIEDIQQEIMVLSQ------------CDSPYG--TKLWIIMEYLGGGSALDLMKAG 139
           +   + E    E+  L                        LW+I  +   GS  D +KA 
Sbjct: 60  KQSWQNE---YEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN 116

Query: 140 NFEEMHIAVILREVLKGLDYLHSERK----------LHRDIKAANVLLSEMGDVKLADFG 189
                 +  I   + +GL YLH +             HRDIK+ NVLL       +ADFG
Sbjct: 117 VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFG 176

Query: 190 VAGTLTNTTSKRNT--FVGTPFWMAPEVI-----KQSAYDSKADIWSLGITAIELAKGEP 242
           +A       S  +T   VGT  +MAPEV+      Q     + D++++G+   ELA    
Sbjct: 177 LALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCT 236

Query: 243 PNSELHP------------------MRVLFLIPKNNPPQLTGNYTK-----QFKEFVEAC 279
                                    M+ + ++ K   P L   + K        E +E C
Sbjct: 237 AADGPVDEYMLPFEEEIGQHPSLEDMQEV-VVHKKKRPVLRDYWQKHAGMAMLCETIEEC 295

Query: 280 LNKDPENRPTAKELLK 295
            + D E R +A  + +
Sbjct: 296 WDHDAEARLSAGCVGE 311

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  152 bits (385), Expect = 2e-41
 Identities = 68/268 (25%), Positives = 117/268 (43%), Gaps = 34/268 (12%)

Query: 55  PELIFTKQERIGKGSFGEVFKGI----DNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLS 110
            E  F K + +G G+FG V+KG+      + +  VAIK +    +    ++I  E  V++
Sbjct: 13  KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMA 72

Query: 111 QCDSPY---------GTKLWIIMEYLGGGSALDLMKA--GNFEEMHIAVILREVLKGLDY 159
             D+P+          + + +I + +  G  LD ++    N    ++     ++ KG++Y
Sbjct: 73  SVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 132

Query: 160 LHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVG-TPF-WMAPEVIK 217
           L   R +HRD+ A NVL+     VK+ DFG+A  L     + +   G  P  WMA E I 
Sbjct: 133 LEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 192

Query: 218 QSAYDSKADIWSLGITAIELA-KGEPPNSELHPMRVLFLI--------PKNNPPQLTGNY 268
              Y  ++D+WS G+T  EL   G  P   +    +  ++        P      +   Y
Sbjct: 193 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDV---Y 249

Query: 269 TKQFKEFVEACLNKDPENRPTAKELLKF 296
                  +  C   D ++RP  +EL+  
Sbjct: 250 -----MIMRKCWMIDADSRPKFRELIIE 272

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score =  151 bits (383), Expect = 2e-41
 Identities = 64/261 (24%), Positives = 102/261 (39%), Gaps = 34/261 (13%)

Query: 65  IGKGSFGEVFKGIDNRTQQVVAIKIID----LEEAEDE-IEDIQQEIMVLSQCDSPYG-- 117
           +GKG FG VF G     +  VAIK+I     L  +          E+ +L +  +  G  
Sbjct: 39  LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98

Query: 118 ------------TKLWIIMEY-LGGGSALD-LMKAGNFEEMHIAVILREVLKGLDYLHSE 163
                           +++E  L      D + + G   E        +V+  + + HS 
Sbjct: 99  GVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSR 158

Query: 164 RKLHRDIKAANVLL-SEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYD 222
             +HRDIK  N+L+    G  KL DFG    L +       F GT  +  PE I +  Y 
Sbjct: 159 GVVHRDIKDENILIDLRRGCAKLIDFGSGALLHD--EPYTDFDGTRVYSPPEWISRHQYH 216

Query: 223 -SKADIWSLGITAIELAKGEPP-NSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACL 280
              A +WSLGI   ++  G+ P   +   +      P +  P             +  CL
Sbjct: 217 ALPATVWSLGILLYDMVCGDIPFERDQEILEAELHFPAHVSPDC--------CALIRRCL 268

Query: 281 NKDPENRPTAKELLKFPFIRK 301
              P +RP+ +E+L  P+++ 
Sbjct: 269 APKPSSRPSLEEILLDPWMQT 289

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  152 bits (384), Expect = 3e-41
 Identities = 36/294 (12%), Positives = 89/294 (30%), Gaps = 41/294 (13%)

Query: 46  SRRNSLKVDPELIFTKQERIGKGSFGEVFKGI-----DNRTQQVVAIKIIDLEEAEDEIE 100
             +   ++  + +      +G+G+F +V++       D + +Q   +K+        E  
Sbjct: 55  KPKTEFQLGSK-LVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQK-PANPWEFY 112

Query: 101 DIQQEIMVLSQCDSP----------YGTKLWIIMEYLGGGSALDLMKA------GNFEEM 144
              Q +  L                +     ++ E    G+ L+ +            + 
Sbjct: 113 IGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQG 172

Query: 145 HIAVILREVLKGLDYLHSERKLHRDIKAANVLLS-----------EMGDVKLADFGVAGT 193
            +      +L  ++ +H    +H DIK  N +L                + L D G +  
Sbjct: 173 LVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSID 232

Query: 194 LTN--TTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMR 251
           +      +       T  +   E++    ++ + D + +  T   +  G     +     
Sbjct: 233 MKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE 292

Query: 252 VLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPENRPTAKELLKFPFIRKAKKN 305
                     P         + EF    LN    +   + +LL+    +  +++
Sbjct: 293 CKPEGLFRRLPH-----LDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQH 341

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score =  149 bits (379), Expect = 9e-41
 Identities = 69/306 (22%), Positives = 118/306 (38%), Gaps = 34/306 (11%)

Query: 30  SNSGSSISNQCGSTTASRRNSLKVDPELI--FTKQERIGKGSFGEVFKGIDNRTQQVVAI 87
                S    C    A++    K    L   +     +G G FG V+ GI       VAI
Sbjct: 14  LVPRGSHMAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAI 73

Query: 88  KIIDLEEAEDEIED-----IQQEIMVLSQCDSPY------------GTKLWIIMEY-LGG 129
           K ++ +   D  E      +  E+++L +  S +                 +I+E     
Sbjct: 74  KHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPV 133

Query: 130 GSALD-LMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLL-SEMGDVKLAD 187
               D + + G  +E        +VL+ + + H+   LHRDIK  N+L+    G++KL D
Sbjct: 134 QDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLID 193

Query: 188 FGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYD-SKADIWSLGITAIELAKGEPP-NS 245
           FG    L +T      F GT  +  PE I+   Y    A +WSLGI   ++  G+ P   
Sbjct: 194 FGSGALLKDTVYT--DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH 251

Query: 246 ELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPENRPTAKELLKFPFIRKAKKN 305
           +   +R      +    +         +  +  CL   P +RPT +E+   P+++     
Sbjct: 252 DEEIIRGQVFFRQRVSSEC--------QHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLP 303

Query: 306 AYLIDL 311
               ++
Sbjct: 304 QETAEI 309

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  151 bits (383), Expect = 1e-40
 Identities = 66/267 (24%), Positives = 114/267 (42%), Gaps = 32/267 (11%)

Query: 53  VDPELIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQC 112
           ++ E +    E+IG+G+FGEVF G       +VA+K        D      QE  +L Q 
Sbjct: 111 LNHEDL-VLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQY 169

Query: 113 DSP-----YG--TK---LWIIMEYLGGGSALDLMKA--GNFEEMHIAVILREVLKGLDYL 160
             P      G  T+   ++I+ME + GG  L  ++          +  ++ +   G++YL
Sbjct: 170 SHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYL 229

Query: 161 HSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGT-PF-WMAPEVIKQ 218
            S+  +HRD+ A N L++E   +K++DFG++    +     +  +   P  W APE +  
Sbjct: 230 ESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNY 289

Query: 219 SAYDSKADIWSLGITAIELA-KGEPPNSELHPMRVLFLI--------PKNNPPQLTGNYT 269
             Y S++D+WS GI   E    G  P   L   +    +        P+  P  +     
Sbjct: 290 GRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLPCPELCPDAV----- 344

Query: 270 KQFKEFVEACLNKDPENRPTAKELLKF 296
                 +E C   +P  RP+   + + 
Sbjct: 345 ---FRLMEQCWAYEPGQRPSFSTIYQE 368

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score =  149 bits (379), Expect = 1e-40
 Identities = 73/276 (26%), Positives = 123/276 (44%), Gaps = 29/276 (10%)

Query: 65  IGKGSFGEVFKGIDNRTQQVVAIKIIDLEE-AEDEIEDIQQEIMVLSQCDSPY------- 116
           IGKG+F +V       T + VAIKIID  +     ++ + +E+ ++   + P        
Sbjct: 23  IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82

Query: 117 ---GTKLWIIMEYLGGGSALD-LMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKA 172
                 L++IMEY  GG   D L+  G  +E       R+++  + Y H +R +HRD+KA
Sbjct: 83  IETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKA 142

Query: 173 ANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYD-SKADIWSLG 231
            N+LL    ++K+ADFG +        K + F G P + APE+ +   YD  + D+WSLG
Sbjct: 143 ENLLLDADMNIKIADFGFS-NEFTVGGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLG 201

Query: 232 ITAIELAKGEPP-----NSELHP--MRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDP 284
           +    L  G  P       EL    +R  + IP               +  ++  L  +P
Sbjct: 202 VILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDC--------ENLLKRFLVLNP 253

Query: 285 ENRPTAKELLKFPFIRKAKKNAYLIDLIDRYKKWKN 320
             R T ++++K  +I    +   L   ++      +
Sbjct: 254 IKRGTLEQIMKDRWINAGHEEDELKPFVEPELDISD 289

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  148 bits (377), Expect = 2e-40
 Identities = 62/258 (24%), Positives = 109/258 (42%), Gaps = 33/258 (12%)

Query: 62  QERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDE--IEDIQQEIMVLSQCDSP---- 115
           +  +G+G  G+V++  D   +++VA+K++    + D      +Q+E     +   P    
Sbjct: 39  RRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVP 98

Query: 116 ------YGTKLWIIMEYLGGGSALDLMKA-GNFEEMHIAVILREVLKGLDYLHSERKLHR 168
                    +L++ M  + G     +++  G         I+R++   LD  H+    HR
Sbjct: 99  IHDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHR 158

Query: 169 DIKAANVLLSEMGDVKLADFGVA-----GTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDS 223
           D+K  N+L+S      L DFG+A       LT         VGT ++MAPE   +S    
Sbjct: 159 DVKPENILVSADDFAYLVDFGIASATTDEKLTQL----GNTVGTLYYMAPERFSESHATY 214

Query: 224 KADIWSLGITAIELAKGEPP-NSELHPMRVLF-----LIPKNNPPQLTGNYTKQFKEFVE 277
           +ADI++L     E   G PP   +   + V+       IP+  P  +       F   + 
Sbjct: 215 RADIYALTCVLYECLTGSPPYQGD--QLSVMGAHINQAIPR--PSTVRPGIPVAFDAVIA 270

Query: 278 ACLNKDPENR-PTAKELL 294
             + K+PE+R  T  +L 
Sbjct: 271 RGMAKNPEDRYVTCGDLS 288

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score =  148 bits (376), Expect = 2e-40
 Identities = 72/300 (24%), Positives = 120/300 (40%), Gaps = 71/300 (23%)

Query: 59  FTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQ----EIMVLSQC-- 112
           +     IG G++G V+K  D  +   VA+K + +         +      E+ +L +   
Sbjct: 11  YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEA 70

Query: 113 ----------------DSPYGTKLWIIMEYLGG--GSALDLMKAGNFEEMHIAVILREVL 154
                            +    K+ ++ E++     + LD           I  ++R+ L
Sbjct: 71  FEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFL 130

Query: 155 KGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVA------GTLTNTTSKRNTFVGTP 208
           +GLD+LH+   +HRD+K  N+L++  G VKLADFG+A        LT         V T 
Sbjct: 131 RGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPV-------VVTL 183

Query: 209 FWMAPEVIKQSAYDSKADIWSLG-ITAIELAKGEP--P-NSELHPMRVLFLI-------- 256
           ++ APEV+ QS Y +  D+WS+G I A E+ + +P    NSE      L  I        
Sbjct: 184 WYRAPEVLLQSTYATPVDMWSVGCIFA-EMFRRKPLFCGNSEADQ---LGKIFDLIGLPP 239

Query: 257 ----------PKNNPPQLTGNYTKQ-FKEFVEAC---LNK----DPENRPTAKELLKFPF 298
                     P+   P       +    E  E+    L +    +P  R +A   L+  +
Sbjct: 240 EDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSY 299

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  154 bits (391), Expect = 5e-40
 Identities = 53/250 (21%), Positives = 93/250 (37%), Gaps = 31/250 (12%)

Query: 62  QERIGKGSFGEVFKGIDNR-TQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSP----- 115
           +  I  G  G ++  +D     + V +K +      +       E   L++   P     
Sbjct: 85  KGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQI 144

Query: 116 --YG--------TKLWIIMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERK 165
             +            +I+MEY+GG S L   K            L E+L  L YLHS   
Sbjct: 145 FNFVEHTDRHGDPVGYIVMEYVGGQS-LKRSKGQKLPVAEAIAYLLEILPALSYLHSIGL 203

Query: 166 LHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKA 225
           ++ D+K  N++L+E   +KL D G    + +         GTP + APE+++        
Sbjct: 204 VYNDLKPENIMLTE-EQLKLIDLGAVSRINSF----GYLYGTPGFQAPEIVRTGP-TVAT 257

Query: 226 DIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPE 285
           DI+++G T   L    P  +  +   +                   +   +   ++ DP 
Sbjct: 258 DIYTVGRTLAALTLDLPTRNGRYVDGL-------PEDDPVLKTYDSYGRLLRRAIDPDPR 310

Query: 286 NRP-TAKELL 294
            R  TA+E+ 
Sbjct: 311 QRFTTAEEMS 320

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score =  147 bits (373), Expect = 6e-40
 Identities = 71/294 (24%), Positives = 120/294 (40%), Gaps = 65/294 (22%)

Query: 59  FTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQ-EIMVLSQCDSPY- 116
           + K  +IG+GS+G VFK  +  T Q+VAIK     E +  I+ I   EI +L Q   P  
Sbjct: 5   YEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNL 64

Query: 117 ---------GTKLWIIMEYLGGGSALDLMK-----AGNFEEMHIAVILREVLKGLDYLHS 162
                      +L ++ EY        ++           E  +  I  + L+ +++ H 
Sbjct: 65  VNLLEVFRRKRRLHLVFEYC----DHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHK 120

Query: 163 ERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTF---VGTPFWMAPEVI-KQ 218
              +HRD+K  N+L+++   +KL DFG A  L   T   + +   V T ++ +PE++   
Sbjct: 121 HNCIHRDVKPENILITKHSVIKLCDFGFARLL---TGPSDYYDDEVATRWYRSPELLVGD 177

Query: 219 SAYDSKADIWSLG-ITAIELAKGEP--P-NSELH-----------------------PMR 251
           + Y    D+W++G + A EL  G P  P  S++                           
Sbjct: 178 TQYGPPVDVWAIGCVFA-ELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYF 236

Query: 252 VLFLIPKNNPPQLTGNYTKQFK-------EFVEACLNKDPENRPTAKELLKFPF 298
               IP     +       +F          ++ CL+ DP  R T ++LL  P+
Sbjct: 237 SGVKIPDPEDME---PLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPY 287

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score =  153 bits (387), Expect = 6e-40
 Identities = 65/260 (25%), Positives = 109/260 (41%), Gaps = 30/260 (11%)

Query: 65  IGKGSFGEVFKGIDNRTQQVVAIKIIDLEE--AEDEIEDIQQEIMVLSQCDSPY------ 116
           +GKG FGEV       T ++ A K ++ +             E  +L + +S +      
Sbjct: 192 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAY 251

Query: 117 ----GTKLWIIMEYLGGGSALDLM------KAGNFEEMHIAVILREVLKGLDYLHSERKL 166
                  L +++  + GG   DL           F E        E+  GL+ LH ER +
Sbjct: 252 AYETKDALCLVLTLMNGG---DLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIV 308

Query: 167 HRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKAD 226
           +RD+K  N+LL + G ++++D G+A  +          VGT  +MAPEV+K   Y    D
Sbjct: 309 YRDLKPENILLDDHGHIRISDLGLAVHVPEGQ-TIKGRVGTVGYMAPEVVKNERYTFSPD 367

Query: 227 IWSLGITAIELAKGEPP---NSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKD 283
            W+LG    E+  G+ P     +      +  + K  P + +  ++ Q +      L KD
Sbjct: 368 WWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFSPQARSLCSQLLCKD 427

Query: 284 PENR-----PTAKELLKFPF 298
           P  R      +A+E+ + P 
Sbjct: 428 PAERLGCRGGSAREVKEHPL 447

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score =  147 bits (373), Expect = 7e-40
 Identities = 76/300 (25%), Positives = 134/300 (44%), Gaps = 73/300 (24%)

Query: 59  FTKQERIGKGSFGEVFKGIDNR-TQQVVAIKIIDLEEAED--------EIEDIQQ----- 104
           +     IG+G++G+VFK  D +   + VA+K + ++  E+        E+  ++      
Sbjct: 13  YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFE 72

Query: 105 --------EIMVLSQCDSPYGTKLWIIMEYLGG--GSALDLMKAGNFEEMHIAVILREVL 154
                   ++  +S+ D    TKL ++ E++     + LD +         I  ++ ++L
Sbjct: 73  HPNVVRLFDVCTVSRTDR--ETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLL 130

Query: 155 KGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVA------GTLTNTTSKRNTFVGTP 208
           +GLD+LHS R +HRD+K  N+L++  G +KLADFG+A        LT+        V T 
Sbjct: 131 RGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSV-------VVTL 183

Query: 209 FWMAPEVIKQSAYDSKADIWSLG-ITAIELAKGEP--P-NSELHPMRVLFLI-------- 256
           ++ APEV+ QS+Y +  D+WS+G I A E+ + +P    +S++     L  I        
Sbjct: 184 WYRAPEVLLQSSYATPVDLWSVGCIFA-EMFRRKPLFRGSSDVDQ---LGKILDVIGLPG 239

Query: 257 ----------PKNNPPQLTGN-YTKQFKEFVEAC---LNK----DPENRPTAKELLKFPF 298
                     P+      +     K   +  E     L K    +P  R +A   L  P+
Sbjct: 240 EEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPY 299

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score =  147 bits (373), Expect = 7e-40
 Identities = 70/265 (26%), Positives = 122/265 (46%), Gaps = 35/265 (13%)

Query: 65  IGKGSFGEVF---KGIDNRTQQVVAIKII---DLEEAEDEIEDIQQEIMVLSQCDSPY-- 116
           +GKG +G+VF   K     T ++ A+K++    +     +    + E  +L +   P+  
Sbjct: 25  LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIV 84

Query: 117 --------GTKLWIIMEYLGGGSALDLM----KAGNFEEMHIAVILREVLKGLDYLHSER 164
                   G KL++I+EYL GG   +L     + G F E      L E+   L +LH + 
Sbjct: 85  DLIYAFQTGGKLYLILEYLSGG---ELFMQLEREGIFMEDTACFYLAEISMALGHLHQKG 141

Query: 165 KLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSK 224
            ++RD+K  N++L+  G VKL DFG+     +  +  +TF GT  +MAPE++ +S ++  
Sbjct: 142 IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMRSGHNRA 201

Query: 225 ADIWSLGITAIELAKGEPP---NSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLN 281
            D WSLG    ++  G PP    +     +            L    T++ ++ ++  L 
Sbjct: 202 VDWWSLGALMYDMLTGAPPFTGENR----KKTIDKILKCKLNLPPYLTQEARDLLKKLLK 257

Query: 282 KDPENR----PT-AKELLKFPFIRK 301
           ++  +R    P  A E+   PF R 
Sbjct: 258 RNAASRLGAGPGDAGEVQAHPFFRH 282

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score =  146 bits (371), Expect = 1e-39
 Identities = 64/248 (25%), Positives = 118/248 (47%), Gaps = 16/248 (6%)

Query: 59  FTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE--AEDEIEDIQQEIMVLSQCDSPY 116
           F   + +G+GSF  V    +  T +  AIKI++      E+++  + +E  V+S+ D P+
Sbjct: 32  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 91

Query: 117 GTKLW----------IIMEYLGGGSALD-LMKAGNFEEMHIAVILREVLKGLDYLHSERK 165
             KL+            + Y   G  L  + K G+F+E        E++  L+YLH +  
Sbjct: 92  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 151

Query: 166 LHRDIKAANVLLSEMGDVKLADFGVA--GTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDS 223
           +HRD+K  N+LL+E   +++ DFG A   +  +  ++ N+FVGT  +++PE++ + +   
Sbjct: 152 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACK 211

Query: 224 KADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKD 283
            +D+W+LG    +L  G PP    +   +   I           +  + ++ VE  L  D
Sbjct: 212 SSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKI-IKLEYDFPEKFFPKARDLVEKLLVLD 270

Query: 284 PENRPTAK 291
              R   +
Sbjct: 271 ATKRLGCE 278

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score =  147 bits (373), Expect = 1e-39
 Identities = 74/258 (28%), Positives = 122/258 (47%), Gaps = 27/258 (10%)

Query: 65  IGKGSFGEVFKGIDNRTQQVVAIKII--DLEEAEDEIEDIQQEIMVLSQCDSPY------ 116
           +GKG+FG+V    +  T +  A+KI+  ++  A+DE+     E  VL     P+      
Sbjct: 13  LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKY 72

Query: 117 ----GTKLWIIMEYLGGGSALDLM----KAGNFEEMHIAVILREVLKGLDYLHSERKLHR 168
                 +L  +MEY  GG   +L     +   F E        E++  L+YLHS   ++R
Sbjct: 73  AFQTHDRLCFVMEYANGG---ELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYR 129

Query: 169 DIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIW 228
           DIK  N++L + G +K+ DFG+     +  +   TF GTP ++APEV++ + Y    D W
Sbjct: 130 DIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWW 189

Query: 229 SLGITAIELAKGEPP-NSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPENR 287
            LG+   E+  G  P  ++ H    LF +      +     + + K  +   L KDP+ R
Sbjct: 190 GLGVVMYEMMCGRLPFYNQDH--ERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQR 247

Query: 288 ----PT-AKELLKFPFIR 300
               P+ AKE+++  F  
Sbjct: 248 LGGGPSDAKEVMEHRFFL 265

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  146 bits (371), Expect = 1e-39
 Identities = 74/316 (23%), Positives = 134/316 (42%), Gaps = 37/316 (11%)

Query: 55  PELIFTKQERIGKGSFGEVFKGI----DNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLS 110
            E  F K + +G G+FG V+KG+      + +  VAIK +    +    ++I  E  V++
Sbjct: 13  KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMA 72

Query: 111 QCDSPY---------GTKLWIIMEYLGGGSALDLMKA--GNFEEMHIAVILREVLKGLDY 159
             D+P+          + + +I + +  G  LD ++    N    ++     ++ KG++Y
Sbjct: 73  SVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 132

Query: 160 LHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVG-TPF-WMAPEVIK 217
           L   R +HRD+ A NVL+     VK+ DFG+A  L     + +   G  P  WMA E I 
Sbjct: 133 LEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 192

Query: 218 QSAYDSKADIWSLGITAIELA-KGEPPNSELHPMRVLFLI--------PKNNPPQLTGNY 268
              Y  ++D+WS G+T  EL   G  P   +    +  ++        P      +   Y
Sbjct: 193 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDV---Y 249

Query: 269 TKQFKEFVEACLNKDPENRPTAKELLKFPFIRKAKKNAYLIDLIDRYKKWKNSRNEESET 328
                  +  C   D ++RP  +EL+   F + A+     + +    +    S  + +  
Sbjct: 250 -----MIMVKCWMIDADSRPKFRELIIE-FSKMARDPQRYLVIQGDERMHLPSPTDSNFY 303

Query: 329 ES--ETSDNEDSIKTD 342
            +  +  D +D +  D
Sbjct: 304 RALMDEEDMDDVVDAD 319

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score =  146 bits (370), Expect = 1e-39
 Identities = 64/265 (24%), Positives = 119/265 (44%), Gaps = 36/265 (13%)

Query: 65  IGKGSFGEVFKGIDNRTQQVVAIKIID---LEEAEDEIEDIQQEIMVLSQCDSPY----- 116
           +G+GS+G+V + +D+ T    A+KI+    L    +   ++++EI +L +          
Sbjct: 13  LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLV 72

Query: 117 -------GTKLWIIMEYLGGGSA--LDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLH 167
                    K++++MEY   G    LD +    F          +++ GL+YLHS+  +H
Sbjct: 73  DVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVH 132

Query: 168 RDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKR--NTFVGTPFWMAPEVIK-QSAYD-S 223
           +DIK  N+LL+  G +K++  GVA  L    +     T  G+P +  PE+      +   
Sbjct: 133 KDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGF 192

Query: 224 KADIWSLGITAIELAKGEPPNSELHPMRVL-------FLIPKNNPPQLTGNYTKQFKEFV 276
           K DIWS G+T   +  G  P    +  ++        + IP +  P L         + +
Sbjct: 193 KVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAIPGDCGPPL--------SDLL 244

Query: 277 EACLNKDPENRPTAKELLKFPFIRK 301
           +  L  +P  R + +++ +  + RK
Sbjct: 245 KGMLEYEPAKRFSIRQIRQHSWFRK 269

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score =  145 bits (369), Expect = 4e-39
 Identities = 68/291 (23%), Positives = 122/291 (41%), Gaps = 59/291 (20%)

Query: 59  FTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQ-EIMVLSQCDSPY- 116
           +     +G+GS+G V K  +  T ++VAIK     + +  ++ I   EI +L Q      
Sbjct: 27  YENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENL 86

Query: 117 ---------GTKLWIIMEYLGGGSALDLMK-----AGNFEEMHIAVILREVLKGLDYLHS 162
                      + +++ E++       ++          +   +   L +++ G+ + HS
Sbjct: 87  VNLLEVCKKKKRWYLVFEFV----DHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHS 142

Query: 163 ERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTF---VGTPFWMAPEVI-KQ 218
              +HRDIK  N+L+S+ G VKL DFG A TL    +    +   V T ++ APE++   
Sbjct: 143 HNIIHRDIKPENILVSQSGVVKLCDFGFARTLA---APGEVYDDEVATRWYRAPELLVGD 199

Query: 219 SAYDSKADIWSLG-ITAIELAKGEP--P-NSEL----HPMRVL----------------- 253
             Y    D+W++G +   E+  GEP  P +S++    H M  L                 
Sbjct: 200 VKYGKAVDVWAIGCLVT-EMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVF 258

Query: 254 --FLIPKNNPPQ----LTGNYTKQFKEFVEACLNKDPENRPTAKELLKFPF 298
               +P+    +         ++   +  + CL+ DP+ RP   ELL   F
Sbjct: 259 AGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDF 309

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score =  143 bits (363), Expect = 5e-39
 Identities = 73/258 (28%), Positives = 118/258 (45%), Gaps = 30/258 (11%)

Query: 65  IGKGSFGEVFKGIDNRTQQVVAIKIIDLE--EAEDEIEDIQQEIMVLSQCDSPY------ 116
           +G G+FG+V  G    T   VA+KI++ +   + D +  I++EI  L     P+      
Sbjct: 19  LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78

Query: 117 ----GTKLWIIMEYLGGGSALD-LMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIK 171
                T  +++MEY+ GG   D + K G  EEM    + +++L  +DY H    +HRD+K
Sbjct: 79  VISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLK 138

Query: 172 AANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYD-SKADIWSL 230
             NVLL    + K+ADFG++  + +      T  G+P + APEVI    Y   + DIWS 
Sbjct: 139 PENVLLDAHMNAKIADFGLS-NMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSC 197

Query: 231 GITAIELAKGEPPNSELHPMRVL-------FLIPKNNPPQLTGNYTKQFKEFVEACLNKD 283
           G+    L  G  P  + H   +        F IP+     +           +   L  D
Sbjct: 198 GVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEYLNRSV--------ATLLMHMLQVD 249

Query: 284 PENRPTAKELLKFPFIRK 301
           P  R T K++ +  + ++
Sbjct: 250 PLKRATIKDIREHEWFKQ 267

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score =  145 bits (368), Expect = 5e-39
 Identities = 66/248 (26%), Positives = 118/248 (47%), Gaps = 28/248 (11%)

Query: 65  IGKGSFGEVFKGIDNRTQQVVAIKII--DLEEAEDEIEDIQQEIMVLSQ-CDSPY----- 116
           IG+GS+ +V      +T ++ A+K++  +L   +++I+ +Q E  V  Q  + P+     
Sbjct: 17  IGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 76

Query: 117 -----GTKLWIIMEYLGGGSALDLM----KAGNFEEMHIAVILREVLKGLDYLHSERKLH 167
                 ++L+ ++EY+ GG   DLM    +     E H      E+   L+YLH    ++
Sbjct: 77  SCFQTESRLFFVIEYVNGG---DLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIY 133

Query: 168 RDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADI 227
           RD+K  NVLL   G +KL D+G+           +TF GTP ++APE+++   Y    D 
Sbjct: 134 RDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDW 193

Query: 228 WSLGITAIELAKGEPPNSELHPMRV--------LFLIPKNNPPQLTGNYTKQFKEFVEAC 279
           W+LG+   E+  G  P   +             LF +      ++  + + +    +++ 
Sbjct: 194 WALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLKSF 253

Query: 280 LNKDPENR 287
           LNKDP+ R
Sbjct: 254 LNKDPKER 261

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  143 bits (364), Expect = 6e-39
 Identities = 67/267 (25%), Positives = 112/267 (41%), Gaps = 37/267 (13%)

Query: 59  FTKQERIGKGSFGEVFKGI---DNRTQQVVAIKII--DLEEAEDEIEDIQQEIMVLSQCD 113
               E++G GSFG V +G     +     VA+K +  D+    + ++D  +E+  +   D
Sbjct: 20  LRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD 79

Query: 114 SPY---------GTKLWIIMEYLGGGSALDLMKA--GNFEEMHIAVILREVLKGLDYLHS 162
                          + ++ E    GS LD ++   G+F    ++    +V +G+ YL S
Sbjct: 80  HRNLIRLYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLES 139

Query: 163 ERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPF---WMAPEVIKQS 219
           +R +HRD+ A N+LL+    VK+ DFG+   L                  W APE +K  
Sbjct: 140 KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTR 199

Query: 220 AYDSKADIWSLGITAIELA-KGEPPNSELHPMRVLFLI---------PKNNPPQLTGNYT 269
            +   +D W  G+T  E+   G+ P   L+  ++L  I         P++ P  +   Y 
Sbjct: 200 TFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDI---Y- 255

Query: 270 KQFKEFVEACLNKDPENRPTAKELLKF 296
                 +  C    PE+RPT   L  F
Sbjct: 256 ----NVMVQCWAHKPEDRPTFVALRDF 278

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  143 bits (364), Expect = 6e-39
 Identities = 64/282 (22%), Positives = 114/282 (40%), Gaps = 54/282 (19%)

Query: 60  TKQERIGKGSFGEVFKG----IDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSP 115
              +++GKG+FG V       + + T +VVA+K +     E+ + D ++EI +L      
Sbjct: 13  KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-HSTEEHLRDFEREIEILKSLQHD 71

Query: 116 YGTKL------------WIIMEYLGGGSALDLMKA--GNFEEMHIAVILREVLKGLDYLH 161
              K              +IMEYL  GS  D ++      + + +     ++ KG++YL 
Sbjct: 72  NIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG 131

Query: 162 SERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGT--P-FWMAPEVIKQ 218
           ++R +HRD+   N+L+     VK+ DFG+   L               P FW APE + +
Sbjct: 132 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTE 191

Query: 219 SAYDSKADIWSLGITAIEL----------------AKGEPPNSELHPMRVLFLI------ 256
           S +   +D+WS G+   EL                  G     ++    ++ L+      
Sbjct: 192 SKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRL 251

Query: 257 --PKNNPPQLTGNYTKQFKEFVEACLNKDPENRPTAKELLKF 296
             P   P ++   Y       +  C N +   RP+ ++L   
Sbjct: 252 PRPDGCPDEI---Y-----MIMTECWNNNVNQRPSFRDLALR 285

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  144 bits (364), Expect = 1e-38
 Identities = 67/287 (23%), Positives = 115/287 (40%), Gaps = 50/287 (17%)

Query: 54  DPELI----FTKQERIGKGSFGEVFKGI----DNRTQQVVAIKIIDLEEAEDEIEDIQQE 105
           DP +       K   +G+G FG+V        ++ T ++VA+K +  +         +QE
Sbjct: 24  DPTVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQE 83

Query: 106 IMVLSQCDSPYGTKL------------WIIMEYLGGGSALDLMKAGNFEEMHIAVILREV 153
           I +L      +  K              ++MEY+  GS  D +   +     + +  +++
Sbjct: 84  IDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQI 143

Query: 154 LKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTS--KRNTFVGTP-FW 210
            +G+ YLH++  +HRD+ A NVLL     VK+ DFG+A  +       +      +P FW
Sbjct: 144 CEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFW 203

Query: 211 MAPEVIKQSAYDSKADIWSLGITAIELA-KGEPPNSELHPMRVLFLIPKNNPPQLTGNYT 269
            APE +K+  +   +D+WS G+T  EL    +   S       L  I      Q+T    
Sbjct: 204 YAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIA---QGQMTV--- 257

Query: 270 KQFKEFVEA--------------------CLNKDPENRPTAKELLKF 296
            +  E +E                     C   +   RPT + L+  
Sbjct: 258 LRLTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPI 304

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score =  143 bits (363), Expect = 2e-38
 Identities = 68/247 (27%), Positives = 115/247 (46%), Gaps = 34/247 (13%)

Query: 65  IGKGSFGEVF---KGIDNRTQQVVAIKII--DLEEAEDEIEDIQQEIMVLSQCDSPY--- 116
           +G+GSFG+VF   K   +  +Q+ A+K++     +  D +   + E  +L + + P+   
Sbjct: 32  LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVR-TKMERDILVEVNHPFIVK 90

Query: 117 -------GTKLWIIMEYLGGGSALDLM----KAGNFEEMHIAVILREVLKGLDYLHSERK 165
                    KL++I+++L GG   DL     K   F E  +   L E+   LD+LHS   
Sbjct: 91  LHYAFQTEGKLYLILDFLRGG---DLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGI 147

Query: 166 LHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKA 225
           ++RD+K  N+LL E G +KL DFG++    +   K  +F GT  +MAPEV+ +  +   A
Sbjct: 148 IYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSA 207

Query: 226 DIWSLGITAIELAKGEPP-----NSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACL 280
           D WS G+   E+  G  P       E   M +           +    + + +  +    
Sbjct: 208 DWWSFGVLMFEMLTGTLPFQGKDRKETMTMIL------KAKLGMPQFLSPEAQSLLRMLF 261

Query: 281 NKDPENR 287
            ++P NR
Sbjct: 262 KRNPANR 268

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  143 bits (362), Expect = 3e-38
 Identities = 64/282 (22%), Positives = 114/282 (40%), Gaps = 54/282 (19%)

Query: 60  TKQERIGKGSFGEVFKG----IDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSP 115
              +++GKG+FG V       + + T +VVA+K +     E+ + D ++EI +L      
Sbjct: 44  KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-HSTEEHLRDFEREIEILKSLQHD 102

Query: 116 YGTKL------------WIIMEYLGGGSALDLMKA--GNFEEMHIAVILREVLKGLDYLH 161
              K              +IMEYL  GS  D ++      + + +     ++ KG++YL 
Sbjct: 103 NIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG 162

Query: 162 SERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGT--P-FWMAPEVIKQ 218
           ++R +HRD+   N+L+     VK+ DFG+   L               P FW APE + +
Sbjct: 163 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTE 222

Query: 219 SAYDSKADIWSLGITAIEL----------------AKGEPPNSELHPMRVLFLI------ 256
           S +   +D+WS G+   EL                  G     ++    ++ L+      
Sbjct: 223 SKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRL 282

Query: 257 --PKNNPPQLTGNYTKQFKEFVEACLNKDPENRPTAKELLKF 296
             P   P ++   Y       +  C N +   RP+ ++L   
Sbjct: 283 PRPDGCPDEI---Y-----MIMTECWNNNVNQRPSFRDLALR 316

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  143 bits (362), Expect = 3e-38
 Identities = 73/282 (25%), Positives = 124/282 (43%), Gaps = 37/282 (13%)

Query: 43  TTASRRNSLKVDPELIFTKQERIGKGSFGEVFKGI----DNRTQQVVAIKIIDLEEAEDE 98
             A  + + ++ P  + T+Q+ IG G FGEV+KG+      + +  VAIK +     E +
Sbjct: 31  NQAVLKFTTEIHPSCV-TRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQ 89

Query: 99  IEDIQQEIMVLSQCDSP-----YG--TK---LWIIMEYLGGGSALDLMKA--GNFEEMHI 146
             D   E  ++ Q          G  +K   + II EY+  G+    ++   G F  + +
Sbjct: 90  RVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQL 149

Query: 147 AVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVG 206
             +LR +  G+ YL +   +HRD+ A N+L++     K++DFG++  L +      T  G
Sbjct: 150 VGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSG 209

Query: 207 TPF---WMAPEVIKQSAYDSKADIWSLGITAIELA-KGEPPNSELHPMRVLFLI------ 256
                 W APE I    + S +D+WS GI   E+   GE P  EL    V+  I      
Sbjct: 210 GKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRL 269

Query: 257 --PKNNPPQLTGNYTKQFKEFVEACLNKDPENRPTAKELLKF 296
             P + P  +   Y     + +  C  ++   RP   +++  
Sbjct: 270 PTPMDCPSAI---Y-----QLMMQCWQQERARRPKFADIVSI 303

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  142 bits (361), Expect = 3e-38
 Identities = 81/322 (25%), Positives = 127/322 (39%), Gaps = 37/322 (11%)

Query: 53  VDPELIFTKQERIGKGSFGEVFKGI----DNRTQQVVAIKIIDLEEAEDEIEDIQQEIMV 108
                +  K + +G G FG V KG+        +  V IK+I+ +      + +   ++ 
Sbjct: 10  FKETEL-RKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLA 68

Query: 109 LSQCDSPY---------GTKLWIIMEYLGGGSALDLMKA--GNFEEMHIAVILREVLKGL 157
           +   D  +         G+ L ++ +YL  GS LD ++   G      +     ++ KG+
Sbjct: 69  IGSLDHAHIVRLLGLCPGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGM 128

Query: 158 DYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVG-TPF-WMAPEV 215
            YL     +HR++ A NVLL     V++ADFGVA  L     +       TP  WMA E 
Sbjct: 129 YYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALES 188

Query: 216 IKQSAYDSKADIWSLGITAIELA-KGEPPNSELHPMRVLFLI--------PKNNPPQLTG 266
           I    Y  ++D+WS G+T  EL   G  P + L    V  L+        P+     +  
Sbjct: 189 IHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLAQPQICTIDV-- 246

Query: 267 NYTKQFKEFVEACLNKDPENRPTAKELLKFPFIRKAKKNAYLIDLIDRYKKWKNSRNEES 326
            Y       +  C   D   RPT KEL    F R A+     +  I R      +   E 
Sbjct: 247 -Y-----MVMVKCWMIDENIRPTFKELANE-FTRMARDPPRYLV-IKRESGPGIAPGPEP 298

Query: 327 ETESETSDNEDSIKTDGDLDEP 348
              +     E  ++ + DLD  
Sbjct: 299 HGLTNKKLEEVELEPELDLDLD 320

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  141 bits (358), Expect = 4e-38
 Identities = 63/252 (25%), Positives = 114/252 (45%), Gaps = 19/252 (7%)

Query: 62  QERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDE--IEDIQQEIMVLSQCDSPY--- 116
            +++G G    V+   D      VAIK I +   E E  ++  ++E+   SQ        
Sbjct: 16  VDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVS 75

Query: 117 -------GTKLWIIMEYLGGGSALDLMKA-GNFEEMHIAVILREVLKGLDYLHSERKLHR 168
                      +++MEY+ G +  + +++ G            ++L G+ + H  R +HR
Sbjct: 76  MIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHR 135

Query: 169 DIKAANVLLSEMGDVKLADFGVAGTLTNTT-SKRNTFVGTPFWMAPEVIKQSAYDSKADI 227
           DIK  N+L+     +K+ DFG+A  L+ T+ ++ N  +GT  + +PE  K  A D   DI
Sbjct: 136 DIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEATDECTDI 195

Query: 228 WSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNY----TKQFKEFVEACLNKD 283
           +S+GI   E+  GEPP +    + +     +++ P +T +      +     +     KD
Sbjct: 196 YSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQSLSNVILRATEKD 255

Query: 284 PENRP-TAKELL 294
             NR  T +E+ 
Sbjct: 256 KANRYKTIQEMK 267

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score =  143 bits (362), Expect = 5e-38
 Identities = 66/245 (26%), Positives = 114/245 (46%), Gaps = 23/245 (9%)

Query: 59  FTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE--AEDEIEDIQQEIMVLSQCDSPY 116
           F + + +G GSFG V       +    A+KI+D ++     +IE    E  +L   + P+
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102

Query: 117 GTKLW----------IIMEYLGGGSALDLM----KAGNFEEMHIAVILREVLKGLDYLHS 162
             KL           ++MEY+ GG   ++     + G F E H      +++   +YLHS
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVAGG---EMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159

Query: 163 ERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYD 222
              ++RD+K  N+L+ + G +++ DFG A  +   T    T  GTP  +APE+I    Y+
Sbjct: 160 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT---WTLCGTPEALAPEIILSKGYN 216

Query: 223 SKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNK 282
              D W+LG+   E+A G PP     P+++   I  +   +   +++   K+ +   L  
Sbjct: 217 KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI-VSGKVRFPSHFSSDLKDLLRNLLQV 275

Query: 283 DPENR 287
           D   R
Sbjct: 276 DLTKR 280

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score =  142 bits (361), Expect = 6e-38
 Identities = 68/240 (28%), Positives = 113/240 (47%), Gaps = 21/240 (8%)

Query: 65  IGKGSFGEVFKGIDNRTQQVVAIKII--DLEEAEDEIEDIQQEIMVLSQCDS-PY----- 116
           +GKGSFG+V       T  + A+K++  D+   +D++E    E  +LS   + P+     
Sbjct: 31  LGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLF 90

Query: 117 -----GTKLWIIMEYLGGGSALDLM----KAGNFEEMHIAVILREVLKGLDYLHSERKLH 167
                  +L+ +ME++ GG   DLM    K+  F+E        E++  L +LH +  ++
Sbjct: 91  CCFQTPDRLFFVMEFVNGG---DLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIY 147

Query: 168 RDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADI 227
           RD+K  NVLL   G  KLADFG+            TF GTP ++APE++++  Y    D 
Sbjct: 148 RDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFCGTPDYIAPEILQEMLYGPAVDW 207

Query: 228 WSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPENR 287
           W++G+   E+  G  P  E      LF    N+         +     +++ + K+P  R
Sbjct: 208 WAMGVLLYEMLCGHAP-FEAENEDDLFEAILNDEVVYPTWLHEDATGILKSFMTKNPTMR 266

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  141 bits (357), Expect = 6e-38
 Identities = 70/304 (23%), Positives = 121/304 (39%), Gaps = 56/304 (18%)

Query: 41  GSTTASRRNSLKVDPELI----FTKQERIGKGSFGEVFKGI----DNRTQQVVAIKIIDL 92
           G   + ++ + +VDP         +   +G+G FG+V         + T + VA+K +  
Sbjct: 1   GDIVSEKKPATEVDPTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKP 60

Query: 93  EEAEDEIEDIQQEIMVLSQCDSPYGTKL------------WIIMEYLGGGSALDLMKA-- 138
           E   + I D+++EI +L         K              +IME+L  GS  + +    
Sbjct: 61  ESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNK 120

Query: 139 GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTT 198
                        ++ KG+DYL S + +HRD+ A NVL+     VK+ DFG+   +    
Sbjct: 121 NKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDK 180

Query: 199 SKRNTFVGT--P-FWMAPEVIKQSAYDSKADIWSLGITAIEL---------------AKG 240
                      P FW APE + QS +   +D+WS G+T  EL                  
Sbjct: 181 EYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMI 240

Query: 241 EPPNSELHPMRVLFLI--------PKNNPPQLTGNYTKQFKEFVEACLNKDPENRPTAKE 292
            P + ++   R++  +        P N P ++   Y     + +  C    P NR + + 
Sbjct: 241 GPTHGQMTVTRLVNTLKEGKRLPCPPNCPDEV---Y-----QLMRKCWEFQPSNRTSFQN 292

Query: 293 LLKF 296
           L++ 
Sbjct: 293 LIEG 296

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score =  142 bits (360), Expect = 7e-38
 Identities = 79/257 (30%), Positives = 123/257 (47%), Gaps = 28/257 (10%)

Query: 65  IGKGSFGEVFKGIDNRTQQVVAIKII--DLEEAEDEIEDIQQEIMVLSQC-DSPY----- 116
           +GKGSFG+VF     +T Q  AIK +  D+   +D++E    E  VLS   + P+     
Sbjct: 25  LGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMF 84

Query: 117 -----GTKLWIIMEYLGGGSALDLM----KAGNFEEMHIAVILREVLKGLDYLHSERKLH 167
                   L+ +MEYL GG   DLM        F+         E++ GL +LHS+  ++
Sbjct: 85  CTFQTKENLFFVMEYLNGG---DLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVY 141

Query: 168 RDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADI 227
           RD+K  N+LL + G +K+ADFG+        +K NTF GTP ++APE++    Y+   D 
Sbjct: 142 RDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDW 201

Query: 228 WSLGITAIELAKGEPP---NSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDP 284
           WS G+   E+  G+ P     E      LF   + + P       K+ K+ +     ++P
Sbjct: 202 WSFGVLLYEMLIGQSPFHGQDE----EELFHSIRMDNPFYPRWLEKEAKDLLVKLFVREP 257

Query: 285 ENRPTAKELLKF-PFIR 300
           E R   +  ++  P  R
Sbjct: 258 EKRLGVRGDIRQHPLFR 274

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score =  143 bits (363), Expect = 7e-38
 Identities = 65/248 (26%), Positives = 118/248 (47%), Gaps = 28/248 (11%)

Query: 65  IGKGSFGEVFKGIDNRTQQVVAIKII--DLEEAEDEIEDIQQEIMVLSQ-CDSPY----- 116
           IG+GS+ +V      +T ++ A++++  +L   +++I+ +Q E  V  Q  + P+     
Sbjct: 60  IGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 119

Query: 117 -----GTKLWIIMEYLGGGSALDLM----KAGNFEEMHIAVILREVLKGLDYLHSERKLH 167
                 ++L+ ++EY+ GG   DLM    +     E H      E+   L+YLH    ++
Sbjct: 120 SCFQTESRLFFVIEYVNGG---DLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIY 176

Query: 168 RDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADI 227
           RD+K  NVLL   G +KL D+G+           +TF GTP ++APE+++   Y    D 
Sbjct: 177 RDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDW 236

Query: 228 WSLGITAIELAKGEPPNSELHPMRV--------LFLIPKNNPPQLTGNYTKQFKEFVEAC 279
           W+LG+   E+  G  P   +             LF +      ++  + + +    +++ 
Sbjct: 237 WALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLKSF 296

Query: 280 LNKDPENR 287
           LNKDP+ R
Sbjct: 297 LNKDPKER 304

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  141 bits (358), Expect = 9e-38
 Identities = 73/280 (26%), Positives = 115/280 (41%), Gaps = 36/280 (12%)

Query: 44  TASRRNSLKVDPELIFTKQERIGKGSFGEVFKGI---DNRTQQVVAIKIIDLEEAEDEIE 100
            A R  + +++   I   ++ IG G  GEV  G      +    VAIK +     E +  
Sbjct: 37  RAGRSFTREIEASRI-HIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRR 95

Query: 101 DIQQEIMVLSQCDSP-----YG--TK---LWIIMEYLGGGSALDLMKA--GNFEEMHIAV 148
           D   E  ++ Q D P      G  T+     I+ EY+  GS    ++   G F  M +  
Sbjct: 96  DFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVG 155

Query: 149 ILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTP 208
           +LR V  G+ YL     +HRD+ A NVL+      K++DFG++  L +      T  G  
Sbjct: 156 MLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGK 215

Query: 209 F---WMAPEVIKQSAYDSKADIWSLGITAIELA-KGEPPNSELHPMRVLFLI-------- 256
               W APE I    + S +D+WS G+   E+   GE P   +    V+  +        
Sbjct: 216 IPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLPA 275

Query: 257 PKNNPPQLTGNYTKQFKEFVEACLNKDPENRPTAKELLKF 296
           P   P  L   +     + +  C +KD   RP   +++  
Sbjct: 276 PMGCPHAL---H-----QLMLDCWHKDRAQRPRFSQIVSV 307

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score =  143 bits (363), Expect = 9e-38
 Identities = 65/219 (29%), Positives = 111/219 (50%), Gaps = 18/219 (8%)

Query: 42  STTASRRNSLKVDPELIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE--AEDEI 99
             T ++   L++  E  +   + IG+G+FGEV       T++V A+K++   E     + 
Sbjct: 55  KDTINKIRDLRMKAE-DYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDS 113

Query: 100 EDIQQEIMVLSQCDSPYGTKLW----------IIMEYLGGGSALDLMKAGNFEEMHIAVI 149
               +E  +++  +SP+  +L+          ++MEY+ GG  ++LM   +  E      
Sbjct: 114 AFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFY 173

Query: 150 LREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKR-NTFVGTP 208
             EV+  LD +HS   +HRD+K  N+LL + G +KLADFG    +      R +T VGTP
Sbjct: 174 TAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTP 233

Query: 209 FWMAPEVIK----QSAYDSKADIWSLGITAIELAKGEPP 243
            +++PEV+K       Y  + D WS+G+   E+  G+ P
Sbjct: 234 DYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 272

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  140 bits (354), Expect = 1e-37
 Identities = 64/271 (23%), Positives = 112/271 (41%), Gaps = 39/271 (14%)

Query: 53  VDPELIFTKQERIGKGSFGEVFKGI---DNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVL 109
           +  E +      +G+G FGEV++G+       +  VA+K    +   D  E    E +++
Sbjct: 9   IAREDV-VLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIM 67

Query: 110 SQCDSP-----YG--TK--LWIIMEYLGGGSALDLMKA--GNFEEMHIAVILREVLKGLD 158
              D P      G   +   WIIME    G     ++    + + + + +   ++ K + 
Sbjct: 68  KNLDHPHIVKLIGIIEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMA 127

Query: 159 YLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTN---TTSKRNTFVGTPF-WMAPE 214
           YL S   +HRDI   N+L++    VKL DFG++  + +     +        P  WM+PE
Sbjct: 128 YLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRL---PIKWMSPE 184

Query: 215 VIKQSAYDSKADIWSLGITAIELA-KGEPPNSELHPMRVLFLI--------PKNNPPQLT 265
            I    + + +D+W   +   E+   G+ P   L    V+ ++        P   PP L 
Sbjct: 185 SINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPKPDLCPPVL- 243

Query: 266 GNYTKQFKEFVEACLNKDPENRPTAKELLKF 296
             Y       +  C + DP +RP   EL+  
Sbjct: 244 --Y-----TLMTRCWDYDPSDRPRFTELVCS 267

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  140 bits (354), Expect = 1e-37
 Identities = 67/275 (24%), Positives = 119/275 (43%), Gaps = 33/275 (12%)

Query: 47  RRNSLKVDPELIFTKQERIGKGSFGEVFKGI--DNRTQQVVAIKIIDLEEAE-DEIEDIQ 103
           R   + +D +L+  + + +G G+FG V KG     +  + VA+KI+  E  +    +++ 
Sbjct: 7   RPKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELL 66

Query: 104 QEIMVLSQCDSPYGTKL---------WIIMEYLGGGSALD-LMKAGNFEEMHIAVILREV 153
            E  V+ Q D+PY  ++          ++ME    G     L +  + ++ +I  ++ +V
Sbjct: 67  AEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQV 126

Query: 154 LKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPF---W 210
             G+ YL     +HRD+ A NVLL      K++DFG++  L    +         +   W
Sbjct: 127 SMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKW 186

Query: 211 MAPEVIKQSAYDSKADIWSLGITAIELA-KGEPPNSELHPMRVLFLI--------PKNNP 261
            APE I    + SK+D+WS G+   E    G+ P   +    V  ++        P   P
Sbjct: 187 YAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCP 246

Query: 262 PQLTGNYTKQFKEFVEACLNKDPENRPTAKELLKF 296
            ++   Y     + +  C   D ENRP    +   
Sbjct: 247 REM---Y-----DLMNLCWTYDVENRPGFAAVELR 273

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score =  140 bits (356), Expect = 2e-37
 Identities = 67/245 (27%), Positives = 110/245 (44%), Gaps = 23/245 (9%)

Query: 59  FTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE--AEDEIEDIQQEIMVLSQCDSPY 116
           F     +G GSFG V         +  A+K++  E      ++E    E ++LS    P+
Sbjct: 8   FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPF 67

Query: 117 GTKLW----------IIMEYLGGGSALDLM----KAGNFEEMHIAVILREVLKGLDYLHS 162
             ++W          +IM+Y+ GG   +L     K+  F          EV   L+YLHS
Sbjct: 68  IIRMWGTFQDAQQIFMIMDYIEGG---ELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHS 124

Query: 163 ERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYD 222
           +  ++RD+K  N+LL + G +K+ DFG A  + + T    T  GTP ++APEV+    Y+
Sbjct: 125 KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT---YTLCGTPDYIAPEVVSTKPYN 181

Query: 223 SKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNK 282
              D WS GI   E+  G  P  + + M+    I  N   +    + +  K+ +   + +
Sbjct: 182 KSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKI-LNAELRFPPFFNEDVKDLLSRLITR 240

Query: 283 DPENR 287
           D   R
Sbjct: 241 DLSQR 245

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score =  143 bits (363), Expect = 2e-37
 Identities = 74/257 (28%), Positives = 120/257 (46%), Gaps = 28/257 (10%)

Query: 65  IGKGSFGEVFKGIDNRTQQVVAIKII--DLEEAEDEIEDIQQEIMVLSQCDSPY------ 116
           +GKG+FG+V    +  T +  A+KI+  ++  A+DE+     E  VL     P+      
Sbjct: 156 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKY 215

Query: 117 ----GTKLWIIMEYLGGGSALDLM----KAGNFEEMHIAVILREVLKGLDYLHSERK-LH 167
                 +L  +MEY  GG   +L     +   F E        E++  LDYLHSE+  ++
Sbjct: 216 SFQTHDRLCFVMEYANGG---ELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVY 272

Query: 168 RDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADI 227
           RD+K  N++L + G +K+ DFG+        +   TF GTP ++APEV++ + Y    D 
Sbjct: 273 RDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDW 332

Query: 228 WSLGITAIELAKGEPP-NSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPEN 286
           W LG+   E+  G  P  ++ H    LF +      +       + K  +   L KDP+ 
Sbjct: 333 WGLGVVMYEMMCGRLPFYNQDH--EKLFELILMEEIRFPRTLGPEAKSLLSGLLKKDPKQ 390

Query: 287 R----PT-AKELLKFPF 298
           R       AKE+++  F
Sbjct: 391 RLGGGSEDAKEIMQHRF 407

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  139 bits (353), Expect = 2e-37
 Identities = 67/269 (24%), Positives = 117/269 (43%), Gaps = 33/269 (12%)

Query: 53  VDPELIFTKQERIGKGSFGEVFKGIDNRTQQV--VAIKIIDLEEAEDEIEDIQQEIMVLS 110
           +  + +      +G G+FG V +G+    ++   VAIK++     + + E++ +E  ++ 
Sbjct: 6   LKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMH 65

Query: 111 QCDSPYGTKL---------WIIMEYLGGGSALDLMKA--GNFEEMHIAVILREVLKGLDY 159
           Q D+PY  +L          ++ME  GGG     +          ++A +L +V  G+ Y
Sbjct: 66  QLDNPYIVRLIGVCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKY 125

Query: 160 LHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPF---WMAPEVI 216
           L  +  +HRD+ A NVLL      K++DFG++  L    S         +   W APE I
Sbjct: 126 LEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECI 185

Query: 217 KQSAYDSKADIWSLGITAIELA-KGEPPNSELHPMRVLFLI--------PKNNPPQLTGN 267
               + S++D+WS G+T  E    G+ P  ++    V+  I        P   PP+L   
Sbjct: 186 NFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPEL--- 242

Query: 268 YTKQFKEFVEACLNKDPENRPTAKELLKF 296
           Y       +  C     E+RP    + + 
Sbjct: 243 Y-----ALMSDCWIYKWEDRPDFLTVEQR 266

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score =  141 bits (357), Expect = 2e-37
 Identities = 74/261 (28%), Positives = 119/261 (45%), Gaps = 32/261 (12%)

Query: 65  IGKGSFGEVFKGIDNRTQQVVAIKII--DLEEAEDEIEDIQQEIMVLSQCDS-PY----- 116
           +GKGSFG+V       T ++ A+KI+  D+   +D++E    E  VL+     P+     
Sbjct: 28  LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLH 87

Query: 117 -----GTKLWIIMEYLGGGSALDLM----KAGNFEEMHIAVILREVLKGLDYLHSERKLH 167
                  +L+ +MEY+ GG   DLM    + G F+E H      E+  GL +L S+  ++
Sbjct: 88  SCFQTMDRLYFVMEYVNGG---DLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIY 144

Query: 168 RDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADI 227
           RD+K  NV+L   G +K+ADFG+            TF GTP ++APE+I    Y    D 
Sbjct: 145 RDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDW 204

Query: 228 WSLGITAIELAKGEPP---NSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDP 284
           W+ G+   E+  G+ P     E      LF     +      + +K+     +  + K P
Sbjct: 205 WAFGVLLYEMLAGQAPFEGEDE----DELFQSIMEHNVAYPKSMSKEAVAICKGLMTKHP 260

Query: 285 ENR----PT-AKELLKFPFIR 300
             R    P   +++ +  F R
Sbjct: 261 GKRLGCGPEGERDIKEHAFFR 281

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score =  139 bits (353), Expect = 2e-37
 Identities = 66/311 (21%), Positives = 115/311 (36%), Gaps = 63/311 (20%)

Query: 48  RNSLKVDPELIFTK----QERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQ 103
           ++ L++    I        + +G G  G+V +  + RTQ+  A+K++       +    +
Sbjct: 5   KSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKML------QDCPKAR 58

Query: 104 QEIMVLSQC---------------DSPYGTKLWIIMEYLGGGSALD-LMKAGN--FEEMH 145
           +E+ +  +                       L I+ME L GG     +   G+  F E  
Sbjct: 59  REVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTERE 118

Query: 146 IAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGD---VKLADFGVAGTLTNTTSKRN 202
            + I++ + + + YLHS    HRD+K  N+L +       +KL DFG             
Sbjct: 119 ASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFG------------- 165

Query: 203 TFVGTPFWMAPEVIKQSAYDSKADIWSLG-ITAIELAKGEPP---NSELHPMRVLFLIPK 258
                    A E   +  YD   D+WSLG I  I L  G PP   N  L     +    +
Sbjct: 166 --------FAKETTGEK-YDKSCDMWSLGVIMYILLC-GYPPFYSNHGLAISPGMKTRIR 215

Query: 259 NNPPQLTGNY----TKQFKEFVEACLNKDPENRPTAKELLKFPFIRKAKK-NAYLIDLID 313
               +         +++ K  +   L  +P  R T  E +  P+I ++ K     +    
Sbjct: 216 MGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSR 275

Query: 314 RYKKWKNSRNE 324
             K+ K    +
Sbjct: 276 VLKEDKERWED 286

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  145 bits (368), Expect = 3e-37
 Identities = 72/318 (22%), Positives = 128/318 (40%), Gaps = 33/318 (10%)

Query: 4   NLTTKCFAVSRKCDFLTLNPTQFLKFSNSGSSISNQCGSTTASRRNSLKVDPELIFTKQE 63
            + T              +P +        S   +        +   L +  + +     
Sbjct: 283 RIDTLNSDGYTPEPARITSPDKPRPMPMDTSVFESPFSDPEELKDKKLFLKRDNLLIADI 342

Query: 64  RIGKGSFGEVFKGI-DNRTQQV-VAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTKL- 120
            +G G+FG V +G+   R +Q+ VAIK++     + + E++ +E  ++ Q D+PY  +L 
Sbjct: 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 402

Query: 121 --------WIIMEYLGGGSALDLMKA--GNFEEMHIAVILREVLKGLDYLHSERKLHRDI 170
                    ++ME  GGG     +          ++A +L +V  G+ YL  +  +HR++
Sbjct: 403 GVCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNL 462

Query: 171 KAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPF---WMAPEVIKQSAYDSKADI 227
            A NVLL      K++DFG++  L    S         +   W APE I    + S++D+
Sbjct: 463 AARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDV 522

Query: 228 WSLGITAIELA-KGEPPNSELHPMRVLFLI--------PKNNPPQLTGNYTKQFKEFVEA 278
           WS G+T  E    G+ P  ++    V+  I        P   PP+L   Y       +  
Sbjct: 523 WSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPEL---Y-----ALMSD 574

Query: 279 CLNKDPENRPTAKELLKF 296
           C     E+RP    + + 
Sbjct: 575 CWIYKWEDRPDFLTVEQR 592

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  140 bits (354), Expect = 3e-37
 Identities = 73/323 (22%), Positives = 126/323 (39%), Gaps = 58/323 (17%)

Query: 54  DPELI----FTKQERIGKGSFGEVFKGI----DNRTQQVVAIKIIDLEEAEDEIEDIQQE 105
           DP +          ++GKG+FG V         + T  +VA+K +      D+  D Q+E
Sbjct: 16  DPTIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQ-HSGPDQQRDFQRE 74

Query: 106 IMVLSQCDSPYGTKL------------WIIMEYLGGGSALDLMKA--GNFEEMHIAVILR 151
           I +L    S +  K              ++MEYL  G   D ++      +   + +   
Sbjct: 75  IQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSS 134

Query: 152 EVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTS--KRNTFVGTP- 208
           ++ KG++YL S R +HRD+ A N+L+     VK+ADFG+A  L              +P 
Sbjct: 135 QICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPI 194

Query: 209 FWMAPEVIKQSAYDSKADIWSLGITAIELA-KGEPPNSELHPMRVLFLIPKNNPP----- 262
           FW APE +  + +  ++D+WS G+   EL    +   S       +    ++ P      
Sbjct: 195 FWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLL 254

Query: 263 -QLTGNY--------TKQFKEFVEACLNKDPENRPTAKELLKFPFIRKAKKNAYLIDLID 313
             L              +  E ++ C    P++RP+      F         + L   +D
Sbjct: 255 ELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPS------F---------SALGPQLD 299

Query: 314 RYKKWKNSRNEESETESETSDNE 336
               W  SR  E+   +   + +
Sbjct: 300 ML--WSGSRGCETHAFTAHPEGK 320

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score =  141 bits (357), Expect = 4e-37
 Identities = 75/259 (28%), Positives = 110/259 (42%), Gaps = 33/259 (12%)

Query: 65  IGKGSFGEVFKGIDNRTQQVVAIKII--DLEEAEDEIEDIQQEIMVLSQ-CDSPY----- 116
           IGKGSFG+V        +   A+K++       + E + I  E  VL +    P+     
Sbjct: 46  IGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 105

Query: 117 -----GTKLWIIMEYLGGGSALDLM----KAGNFEEMHIAVILREVLKGLDYLHSERKLH 167
                  KL+ +++Y+ GG   +L     +   F E        E+   L YLHS   ++
Sbjct: 106 FSFQTADKLYFVLDYINGG---ELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVY 162

Query: 168 RDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADI 227
           RD+K  N+LL   G + L DFG+        S  +TF GTP ++APEV+ +  YD   D 
Sbjct: 163 RDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDW 222

Query: 228 WSLGITAIELAKGEPP----NSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKD 283
           W LG    E+  G PP    N+       ++    N P QL  N T   +  +E  L KD
Sbjct: 223 WCLGAVLYEMLYGLPPFYSRNTA-----EMYDNILNKPLQLKPNITNSARHLLEGLLQKD 277

Query: 284 PENR----PTAKELLKFPF 298
              R        E+    F
Sbjct: 278 RTKRLGAKDDFMEIKSHVF 296

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  138 bits (350), Expect = 4e-37
 Identities = 77/271 (28%), Positives = 111/271 (40%), Gaps = 39/271 (14%)

Query: 53  VDPELIFTKQERIGKGSFGEVFKGI---DNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVL 109
           +  E I      IG+G FG+V +GI          VAIK      ++   E   QE + +
Sbjct: 12  IQRERI-ELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTM 70

Query: 110 SQCDSPYGTKL---------WIIMEYLGGGSALDLMKA--GNFEEMHIAVILREVLKGLD 158
            Q D P+  KL         WIIME    G     ++    + +   + +   ++   L 
Sbjct: 71  RQFDHPHIVKLIGVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALA 130

Query: 159 YLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTN---TTSKRNTFVGTPF-WMAPE 214
           YL S+R +HRDI A NVL+S    VKL DFG++  + +     + +      P  WMAPE
Sbjct: 131 YLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL---PIKWMAPE 187

Query: 215 VIKQSAYDSKADIWSLGITAIELA-KGEPPNSELHPMRVLFLI--------PKNNPPQLT 265
            I    + S +D+W  G+   E+   G  P   +    V+  I        P N PP L 
Sbjct: 188 SINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTL- 246

Query: 266 GNYTKQFKEFVEACLNKDPENRPTAKELLKF 296
             Y       +  C   DP  RP   EL   
Sbjct: 247 --Y-----SLMTKCWAYDPSRRPRFTELKAQ 270

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score =  140 bits (355), Expect = 5e-37
 Identities = 77/304 (25%), Positives = 121/304 (39%), Gaps = 72/304 (23%)

Query: 59  FTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAED--------EIEDIQQ------ 104
           + K  +IG+G+FGEVFK    +T Q VA+K + +E  ++        EI+ +Q       
Sbjct: 19  YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENV 78

Query: 105 ----EIMVL-SQCDSPYGTKLWIIMEYLGGGSALDLMK-----AGNFEEMHIAVILREVL 154
               EI    +   +     ++++ ++       DL          F    I  +++ +L
Sbjct: 79  VNLIEICRTKASPYNRCKGSIYLVFDFC----EHDLAGLLSNVLVKFTLSEIKRVMQMLL 134

Query: 155 KGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVA---GTLTNTTSKRNT-FVGTPFW 210
            GL Y+H  + LHRD+KAANVL++  G +KLADFG+A       N+   R T  V T ++
Sbjct: 135 NGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWY 194

Query: 211 MAPEVIKQS-AYDSKADIWSLG-ITAIELAKGEP--P-NSELHPMRVLFLI--------- 256
             PE++     Y    D+W  G I A E+    P    N+E H    L LI         
Sbjct: 195 RPPELLLGERDYGPPIDLWGAGCIMA-EMWTRSPIMQGNTEQHQ---LALISQLCGSITP 250

Query: 257 -------------PKNNPPQLTGNYTKQFKEFV---------EACLNKDPENRPTAKELL 294
                                      + K +V         +  L  DP  R  + + L
Sbjct: 251 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDAL 310

Query: 295 KFPF 298
              F
Sbjct: 311 NHDF 314

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  138 bits (350), Expect = 5e-37
 Identities = 73/269 (27%), Positives = 133/269 (49%), Gaps = 38/269 (14%)

Query: 53  VDPELIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQC 112
           ++   I T + ++G G +GEV++G+  +    VA+K   L+E   E+E+  +E  V+ + 
Sbjct: 10  MERTDI-TMKHKLGGGQYGEVYEGVWKKYSLTVAVKT--LKEDTMEVEEFLKEAAVMKEI 66

Query: 113 DSP-----YG--TK---LWIIMEYLGGGSALDLMKAGNFEEMHIAVIL---REVLKGLDY 159
             P      G  T+    +II E++  G+ LD ++  N +E+   V+L    ++   ++Y
Sbjct: 67  KHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEY 126

Query: 160 LHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPF---WMAPEVI 216
           L  +  +HRD+ A N L+ E   VK+ADFG++  +T  T   +   G  F   W APE +
Sbjct: 127 LEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA--GAKFPIKWTAPESL 184

Query: 217 KQSAYDSKADIWSLGITAIELA-KGEPPNSELHPMRVLFLI--------PKNNPPQLTGN 267
             + +  K+D+W+ G+   E+A  G  P   +   +V  L+        P+  P ++   
Sbjct: 185 AYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKV--- 241

Query: 268 YTKQFKEFVEACLNKDPENRPTAKELLKF 296
           Y     E + AC   +P +RP+  E+ + 
Sbjct: 242 Y-----ELMRACWQWNPSDRPSFAEIHQA 265

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  142 bits (360), Expect = 5e-37
 Identities = 71/255 (27%), Positives = 115/255 (45%), Gaps = 23/255 (9%)

Query: 59  FTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSP--- 115
              + ++G+G FGEV+ G  N T +V AIK   L+      E   QE  V+ +       
Sbjct: 186 LRLEVKLGQGCFGEVWMGTWNGTTRV-AIKT--LKPGTMSPEAFLQEAQVMKKLRHEKLV 242

Query: 116 --YG--TK--LWIIMEYLGGGSALDLMKAGNFEEMHIAV---ILREVLKGLDYLHSERKL 166
             Y   ++  ++I+ EY+  GS LD +K    + + +     +  ++  G+ Y+     +
Sbjct: 243 QLYAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYV 302

Query: 167 HRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPF-WMAPEVIKQSAYDSKA 225
           HRD++AAN+L+ E    K+ADFG+A  + +           P  W APE      +  K+
Sbjct: 303 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 362

Query: 226 DIWSLGITAIELA-KGEPPNSELHPMRVLFLIPKN---NPPQLTGNYTKQFKEFVEACLN 281
           D+WS GI   EL  KG  P   +    VL  + +      P       +   + +  C  
Sbjct: 363 DVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPEC---PESLHDLMCQCWR 419

Query: 282 KDPENRPTAKELLKF 296
           K+PE RPT + L  F
Sbjct: 420 KEPEERPTFEYLQAF 434

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score =  138 bits (350), Expect = 6e-37
 Identities = 78/293 (26%), Positives = 123/293 (41%), Gaps = 66/293 (22%)

Query: 59  FTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQ--QEIMVLSQCDSPY 116
           +   E+IG+G++G V+K  +    +  A+K I LE  EDE       +EI +L +     
Sbjct: 4   YHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLE-KEDEGIPSTTIREISILKELKHSN 61

Query: 117 ----------GTKLWIIMEYLGGGSALDLMK-----AGNFEEMHIAVILREVLKGLDYLH 161
                       +L ++ E+L      DL K      G  E +     L ++L G+ Y H
Sbjct: 62  IVKLYDVIHTKKRLVLVFEHL----DQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH 117

Query: 162 SERKLHRDIKAANVLLSEMGDVKLADFGVA-------GTLTNTTSKRNTFVGTPFWMAPE 214
             R LHRD+K  N+L++  G++K+ADFG+A          T+        + T ++ AP+
Sbjct: 118 DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHE-------IVTLWYRAPD 170

Query: 215 VIKQS-AYDSKADIWSLGITAIELAKGEP--------------------PNSELHP-MRV 252
           V+  S  Y +  DIWS+G    E+  G P                    PNS+  P +  
Sbjct: 171 VLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTE 230

Query: 253 LFLIPKNNPPQLTGNYTKQFKEFVEAC---LNK----DPENRPTAKELLKFPF 298
           L     N        +    K   E+    L+K    DP  R TAK+ L+  +
Sbjct: 231 LPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAY 283

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score =  140 bits (354), Expect = 6e-37
 Identities = 79/297 (26%), Positives = 126/297 (42%), Gaps = 28/297 (9%)

Query: 65  IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPY-------- 116
           IG G+FG      D  T+++VA+K I+   A D  E++Q+EI+       P         
Sbjct: 28  IGSGNFGVARLMRDKLTKELVAVKYIERGAAID--ENVQREIINHRSLRHPNIVRFKEVI 85

Query: 117 --GTKLWIIMEYLGGGSALD-LMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAA 173
              T L IIMEY  GG   + +  AG F E       +++L G+ Y HS +  HRD+K  
Sbjct: 86  LTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLE 145

Query: 174 NVLL--SEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYD-SKADIWSL 230
           N LL  S    +K+ DFG +   +   S+  + VGTP ++APEV+ +  YD   AD+WS 
Sbjct: 146 NTLLDGSPAPRLKICDFGYS-KSSVLHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSC 204

Query: 231 GITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNYT--------KQFKEFVEACLNK 282
           G+T   +  G  P  +    R      K     L+  Y+         +    +      
Sbjct: 205 GVTLYVMLVGAYPFEDPEEPR---DYRKTIQRILSVKYSIPDDIRISPECCHLISRIFVA 261

Query: 283 DPENRPTAKELLKFPFIRKAKKNAYLIDLIDRYKKWKNSRNEESETESETSDNEDSI 339
           DP  R +  E+    +  K      + +     +  +  +  +S        +E +I
Sbjct: 262 DPATRISIPEIKTHSWFLKNLPADLMNESNTGSQFQEPEQPMQSLDTIMQIISEATI 318

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score =  139 bits (353), Expect = 1e-36
 Identities = 66/319 (20%), Positives = 112/319 (35%), Gaps = 86/319 (26%)

Query: 63  ERIGKGSFGEVFKGIDNRTQQVVAIKII-----DLEEAEDEIEDIQQEIMVLSQCDS--- 114
            ++G G F  V+   D      VA+KI+       E AEDEI+ + Q +           
Sbjct: 25  RKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIK-LLQRVNDADNTKEDSM 83

Query: 115 ----------------PYGTKLWIIMEYLGGGSALDLMKAGNFEEMHIAVI---LREVLK 155
                           P G  + ++ E LG  + L L+K      + +  +    +++L 
Sbjct: 84  GANHILKLLDHFNHKGPNGVHVVMVFEVLGE-NLLALIKKYEHRGIPLIYVKQISKQLLL 142

Query: 156 GLDYLHSERKL-HRDIKAANVLLSEMGD------VKLADFGVAGTLTNTTSKRNTFVGTP 208
           GLDY+H    + H DIK  NVL+  +        +K+AD G A             + T 
Sbjct: 143 GLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA---CWYDEHYTNSIQTR 199

Query: 209 FWMAPEVIKQSAYDSKADIWSLGITAIELAKGE---PPNSELHP----------MRVLFL 255
            + +PEV+  + +   ADIWS      EL  G+    P+               + +L  
Sbjct: 200 EYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGE 259

Query: 256 IPKN----------------------------------NPPQLTGNYTKQFKEFVEACLN 281
           +P                                       + + +  K+  +F+   L 
Sbjct: 260 LPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQ 319

Query: 282 KDPENRPTAKELLKFPFIR 300
            DP  R  A  L+  P+++
Sbjct: 320 LDPRKRADAGGLVNHPWLK 338

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score =  138 bits (349), Expect = 1e-36
 Identities = 73/294 (24%), Positives = 129/294 (43%), Gaps = 67/294 (22%)

Query: 59  FTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQ--QEIMVLSQCDSPY 116
           + K E++G+G++G V+K  D    ++VA+K I L+ AEDE       +EI +L +   P 
Sbjct: 23  YQKLEKVGEGTYGVVYKAKD-SQGRIVALKRIRLD-AEDEGIPSTAIREISLLKELHHPN 80

Query: 117 ----------GTKLWIIMEYLGGGSALDLMK-----AGNFEEMHIAVILREVLKGLDYLH 161
                        L ++ E++      DL K         ++  I + L ++L+G+ + H
Sbjct: 81  IVSLIDVIHSERCLTLVFEFM----EKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCH 136

Query: 162 SERKLHRDIKAANVLLSEMGDVKLADFGVA-------GTLTNTTSKRNTFVGTPFWMAPE 214
             R LHRD+K  N+L++  G +KLADFG+A        + T+        V T ++ AP+
Sbjct: 137 QHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHE-------VVTLWYRAPD 189

Query: 215 VIKQS-AYDSKADIWSLGITAIELAKGEP--P-NSELHPMRVLFLI-------------- 256
           V+  S  Y +  DIWS+G    E+  G+P  P  ++   +  +F I              
Sbjct: 190 VLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQE 249

Query: 257 -----PKNNPPQLTGNYTKQFKEFVEAC---LNK----DPENRPTAKELLKFPF 298
                 +         ++     F +     L+     DP  R +A++ +  P+
Sbjct: 250 LPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPY 303

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score =  138 bits (350), Expect = 1e-36
 Identities = 65/258 (25%), Positives = 118/258 (45%), Gaps = 31/258 (12%)

Query: 65  IGKGSFGEVFKGIDNRTQQVVAIKIIDLE--EAEDEIEDIQQEIMVLSQCDSPY------ 116
           +G+GSFG+V      +TQQ VA+K I  +  +  D    +++EI  L     P+      
Sbjct: 17  LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76

Query: 117 ----GTKLWIIMEYLGGGSALD-LMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIK 171
                T + +++EY GG    D +++     E       ++++  ++Y H  + +HRD+K
Sbjct: 77  VITTPTDIVMVIEYAGG-ELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLK 135

Query: 172 AANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYD-SKADIWSL 230
             N+LL +  +VK+ADFG++  +T+  +   T  G+P + APEVI    Y   + D+WS 
Sbjct: 136 PENLLLDDNLNVKIADFGLSNIMTD-GNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSC 194

Query: 231 GITAIELAKGEPPNSELHPMRVL-------FLIPKNNPPQLTGNYTKQFKEFVEACLNKD 283
           GI    +  G  P  +     +        +++P    P          +  +   +  D
Sbjct: 195 GIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMPDFLSPGA--------QSLIRRMIVAD 246

Query: 284 PENRPTAKELLKFPFIRK 301
           P  R T +E+ + P+   
Sbjct: 247 PMQRITIQEIRRDPWFNV 264

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score =  144 bits (364), Expect = 1e-36
 Identities = 73/261 (27%), Positives = 118/261 (45%), Gaps = 32/261 (12%)

Query: 65  IGKGSFGEVFKGIDNRTQQVVAIKII--DLEEAEDEIEDIQQEIMVLSQCDS-PY----- 116
           +GKGSFG+V       T ++ A+KI+  D+   +D++E    E  VL+     P+     
Sbjct: 349 LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLH 408

Query: 117 -----GTKLWIIMEYLGGGSALDLM----KAGNFEEMHIAVILREVLKGLDYLHSERKLH 167
                  +L+ +MEY+ GG   DLM    + G F+E H      E+  GL +L S+  ++
Sbjct: 409 SCFQTMDRLYFVMEYVNGG---DLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIY 465

Query: 168 RDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADI 227
           RD+K  NV+L   G +K+ADFG+            TF GTP ++APE+I    Y    D 
Sbjct: 466 RDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDW 525

Query: 228 WSLGITAIELAKGEPP---NSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDP 284
           W+ G+   E+  G+ P     E      LF     +      + +K+     +  + K P
Sbjct: 526 WAFGVLLYEMLAGQAPFEGEDE----DELFQSIMEHNVAYPKSMSKEAVAICKGLMTKHP 581

Query: 285 ENR-----PTAKELLKFPFIR 300
             R        +++ +  F R
Sbjct: 582 GKRLGCGPEGERDIKEHAFFR 602

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score =  137 bits (347), Expect = 2e-36
 Identities = 71/300 (23%), Positives = 119/300 (39%), Gaps = 78/300 (26%)

Query: 59  FTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQ--QEIMVLSQCDSPY 116
           + K E+IG+G++G VFK  +  T ++VA+K + L++ +DE       +EI +L +     
Sbjct: 4   YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDD-DDEGVPSSALREICLLKELKHKN 62

Query: 117 ----------GTKLWIIMEYLGGGSALDLMK-----AGNFEEMHIAVILREVLKGLDYLH 161
                       KL ++ E+       DL K      G+ +   +   L ++LKGL + H
Sbjct: 63  IVRLHDVLHSDKKLTLVFEFC----DQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCH 118

Query: 162 SERKLHRDIKAANVLLSEMGDVKLADFGVA-------GTLTNTTSKRNTFVGTPFWMAPE 214
           S   LHRD+K  N+L++  G++KLA+FG+A          +         V T ++  P+
Sbjct: 119 SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAE-------VVTLWYRPPD 171

Query: 215 VIKQS-AYDSKADIWSLGITAIELAKGEPP----NSELHPMRVLFLI------------- 256
           V+  +  Y +  D+WS G    ELA    P    N        L  I             
Sbjct: 172 VLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD---QLKRIFRLLGTPTEEQWP 228

Query: 257 -----------PKNNPPQLTGNYTKQFKEFVEAC---LNK----DPENRPTAKELLKFPF 298
                      P         +      +        L      +P  R +A+E L+ P+
Sbjct: 229 SMTKLPDYKPYPMYPATT---SLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPY 285

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  137 bits (347), Expect = 2e-36
 Identities = 67/263 (25%), Positives = 118/263 (44%), Gaps = 36/263 (13%)

Query: 62  QERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDE--IEDIQQEIM---VLS------ 110
            E +G G   EV    D R  + VA+K++  + A D       ++E      L+      
Sbjct: 17  GEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVA 76

Query: 111 -----QCDSPYGTKLWIIMEYLGGGSALDLMKA-GNFEEMHIAVILREVLKGLDYLHSER 164
                + ++P G   +I+MEY+ G +  D++   G         ++ +  + L++ H   
Sbjct: 77  VYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNG 136

Query: 165 KLHRDIKAANVLLSEMGDVKLADFGVA-------GTLTNTTSKRNTFVGTPFWMAPEVIK 217
            +HRD+K AN+++S    VK+ DFG+A        ++T T       +GT  +++PE  +
Sbjct: 137 IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQT----AAVIGTAQYLSPEQAR 192

Query: 218 QSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLF-----LIPKNNPPQLTGNYTKQF 272
             + D+++D++SLG    E+  GEPP +   P+ V +           P       +   
Sbjct: 193 GDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIP--PSARHEGLSADL 250

Query: 273 KEFVEACLNKDPENRP-TAKELL 294
              V   L K+PENR  TA E+ 
Sbjct: 251 DAVVLKALAKNPENRYQTAAEMR 273

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score =  138 bits (350), Expect = 2e-36
 Identities = 75/298 (25%), Positives = 117/298 (39%), Gaps = 73/298 (24%)

Query: 59  FTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQ----EIMVLSQCDS 114
           + K + +G+G F  V+K  D  T Q+VAIK I L    +  + I +    EI +L +   
Sbjct: 12  YEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSH 71

Query: 115 PY----------GTKLWIIMEYLGGGSALDLMK-----AGNFEEMHIAVILREVLKGLDY 159
           P            + + ++ +++      DL       +      HI   +   L+GL+Y
Sbjct: 72  PNIIGLLDAFGHKSNISLVFDFM----ETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEY 127

Query: 160 LHSERKLHRDIKAANVLLSEMGDVKLADFGVA-------GTLTNTTSKRNTFVGTPFWMA 212
           LH    LHRD+K  N+LL E G +KLADFG+A          T+        V T ++ A
Sbjct: 128 LHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQ-------VVTRWYRA 180

Query: 213 PEVIKQS-AYDSKADIWSLG-ITAIELAKGEP--P-NSELHPMRVLFLI------P---- 257
           PE++  +  Y    D+W++G I A EL    P  P +S+L     L  I      P    
Sbjct: 181 PELLFGARMYGVGVDMWAVGCILA-ELLLRVPFLPGDSDLD---QLTRIFETLGTPTEEQ 236

Query: 258 ----------KNNPPQLTGNYTKQFKEFVEAC---LNK----DPENRPTAKELLKFPF 298
                                   F    +     +      +P  R TA + LK  +
Sbjct: 237 WPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKY 294

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  138 bits (350), Expect = 2e-36
 Identities = 73/282 (25%), Positives = 121/282 (42%), Gaps = 36/282 (12%)

Query: 42  STTASRRNSLKVDPELIFTKQERIGKGSFGEVFKGI---DNRTQQVVAIKIIDLEEAEDE 98
            T      + ++D   I +  + +G G FGEV  G     ++ +  VAIK + +   E +
Sbjct: 31  PTQTVHEFAKELDATNI-SIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ 89

Query: 99  IEDIQQEIMVLSQCDSP-----YG--TK---LWIIMEYLGGGSALDLMKA--GNFEEMHI 146
             D   E  ++ Q D P      G  TK   + I+ EY+  GS    ++     F  + +
Sbjct: 90  RRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQL 149

Query: 147 AVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVG 206
             +LR +  G+ YL     +HRD+ A N+L++     K++DFG+   L +      T  G
Sbjct: 150 VGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRG 209

Query: 207 TPF---WMAPEVIKQSAYDSKADIWSLGITAIELA-KGEPPNSELHPMRVLFLI------ 256
                 W +PE I    + S +D+WS GI   E+   GE P  E+    V+  +      
Sbjct: 210 GKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRL 269

Query: 257 --PKNNPPQLTGNYTKQFKEFVEACLNKDPENRPTAKELLKF 296
             P + P  L   Y     + +  C  KD  NRP  ++++  
Sbjct: 270 PPPMDCPAAL---Y-----QLMLDCWQKDRNNRPKFEQIVSI 303

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  136 bits (344), Expect = 2e-36
 Identities = 74/268 (27%), Positives = 122/268 (45%), Gaps = 38/268 (14%)

Query: 53  VDPELIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQC 112
           V  E +    ER+G G FGEV+ G  N   +V A+K   L++     +    E  ++ Q 
Sbjct: 10  VPRETL-KLVERLGAGQFGEVWMGYYNGHTKV-AVKS--LKQGSMSPDAFLAEANLMKQL 65

Query: 113 DSP-----YG--TK--LWIIMEYLGGGSALDLMKAGNFEEMHIAVIL---REVLKGLDYL 160
                   Y   T+  ++II EY+  GS +D +K  +  ++ I  +L    ++ +G+ ++
Sbjct: 66  QHQRLVRLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI 125

Query: 161 HSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPF---WMAPEVIK 217
                +HRD++AAN+L+S+    K+ADFG+A  + +         G  F   W APE I 
Sbjct: 126 EERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTARE--GAKFPIKWTAPEAIN 183

Query: 218 QSAYDSKADIWSLGITAIELA-KGEPPNSELHPMRVLFLI--------PKNNPPQLTGNY 268
              +  K+D+WS GI   E+   G  P   +    V+  +        P N P +L   Y
Sbjct: 184 YGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEEL---Y 240

Query: 269 TKQFKEFVEACLNKDPENRPTAKELLKF 296
                + +  C  + PE+RPT   L   
Sbjct: 241 -----QLMRLCWKERPEDRPTFDYLRSV 263

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score =  138 bits (349), Expect = 3e-36
 Identities = 68/250 (27%), Positives = 119/250 (47%), Gaps = 30/250 (12%)

Query: 65  IGKGSFGEVF---KGIDNRTQQVVAIKII---DLEEAEDEIEDIQQEIMVLSQCD-SPY- 116
           +G G++G+VF   K   + T ++ A+K++    + +     E  + E  VL     SP+ 
Sbjct: 62  LGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFL 121

Query: 117 ---------GTKLWIIMEYLGGGSALDLM----KAGNFEEMHIAVILREVLKGLDYLHSE 163
                     TKL +I++Y+ GG   +L     +   F E  + + + E++  L++LH  
Sbjct: 122 VTLHYAFQTETKLHLILDYINGG---ELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKL 178

Query: 164 RKLHRDIKAANVLLSEMGDVKLADFGVA-GTLTNTTSKRNTFVGTPFWMAPEVIK--QSA 220
             ++RDIK  N+LL   G V L DFG++   + + T +   F GT  +MAP++++   S 
Sbjct: 179 GIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSG 238

Query: 221 YDSKADIWSLGITAIELAKGEPP---NSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVE 277
           +D   D WSLG+   EL  G  P   + E +    +      + P      +   K+ ++
Sbjct: 239 HDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDLIQ 298

Query: 278 ACLNKDPENR 287
             L KDP+ R
Sbjct: 299 RLLMKDPKKR 308

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  135 bits (341), Expect = 5e-36
 Identities = 72/268 (26%), Positives = 118/268 (44%), Gaps = 38/268 (14%)

Query: 53  VDPELIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQC 112
           +DP  + T  + IG G FG V  G      +V AIK   + E     ED  +E  V+ + 
Sbjct: 5   IDPSEL-TFVQEIGSGQFGLVHLGYWLNKDKV-AIKT--IREGAMSEEDFIEEAEVMMKL 60

Query: 113 DSP-----YG--TK---LWIIMEYLGGGSALDLMKA--GNFEEMHIAVILREVLKGLDYL 160
             P     YG   +   + ++ E++  G   D ++   G F    +  +  +V +G+ YL
Sbjct: 61  SHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYL 120

Query: 161 HSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPF---WMAPEVIK 217
                +HRD+ A N L+ E   +K++DFG+   + +     +T  GT F   W +PEV  
Sbjct: 121 EEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST--GTKFPVKWASPEVFS 178

Query: 218 QSAYDSKADIWSLGITAIELA-KGEPPNSELHPMRVLFLI--------PKNNPPQLTGNY 268
            S Y SK+D+WS G+   E+  +G+ P        V+  I        P+     +   Y
Sbjct: 179 FSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHV---Y 235

Query: 269 TKQFKEFVEACLNKDPENRPTAKELLKF 296
                + +  C  + PE+RP    LL+ 
Sbjct: 236 -----QIMNHCWRERPEDRPAFSRLLRQ 258

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score =  142 bits (359), Expect = 7e-36
 Identities = 67/245 (27%), Positives = 115/245 (46%), Gaps = 27/245 (11%)

Query: 65  IGKGSFGEVFKGIDNRTQQVVAIKIIDLEE--AEDEIEDIQQEIMVLSQCDSPY------ 116
           IG+G FGEV+      T ++ A+K +D +    +        E ++LS   +        
Sbjct: 197 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 256

Query: 117 -------GTKLWIIMEYLGGGSALDLM----KAGNFEEMHIAVILREVLKGLDYLHSERK 165
                    KL  I++ + GG   DL     + G F E  +     E++ GL+++H+   
Sbjct: 257 MSYAFHTPDKLSFILDLMNGG---DLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFV 313

Query: 166 LHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVI-KQSAYDSK 224
           ++RD+K AN+LL E G V+++D G+A   +      +  VGT  +MAPEV+ K  AYDS 
Sbjct: 314 VYRDLKPANILLDEHGHVRISDLGLACDFSKKKP--HASVGTHGYMAPEVLQKGVAYDSS 371

Query: 225 ADIWSLGITAIELAKGEPP--NSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNK 282
           AD +SLG    +L +G  P    +      +  +      +L  +++ + +  +E  L +
Sbjct: 372 ADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQR 431

Query: 283 DPENR 287
           D   R
Sbjct: 432 DVNRR 436

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  134 bits (339), Expect = 9e-36
 Identities = 69/268 (25%), Positives = 120/268 (44%), Gaps = 38/268 (14%)

Query: 53  VDPELIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQC 112
           +  E I T  + +G G FG V  G       V A+K+  ++E     ++  QE   + + 
Sbjct: 5   LKREEI-TLLKELGSGQFGVVKLGKWKGQYDV-AVKM--IKEGSMSEDEFFQEAQTMMKL 60

Query: 113 DSP-----YG--TK---LWIIMEYLGGGSALDLMKA--GNFEEMHIAVILREVLKGLDYL 160
             P     YG  +K   ++I+ EY+  G  L+ +++     E   +  +  +V +G+ +L
Sbjct: 61  SHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFL 120

Query: 161 HSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPF---WMAPEVIK 217
            S + +HRD+ A N L+     VK++DFG+   + +     +   GT F   W APEV  
Sbjct: 121 ESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSV--GTKFPVKWSAPEVFH 178

Query: 218 QSAYDSKADIWSLGITAIELA-KGEPPNSELHPMRVLFLI--------PKNNPPQLTGNY 268
              Y SK+D+W+ GI   E+   G+ P        V+  +        P      +   Y
Sbjct: 179 YFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYRPHLASDTI---Y 235

Query: 269 TKQFKEFVEACLNKDPENRPTAKELLKF 296
                + + +C ++ PE RPT ++LL  
Sbjct: 236 -----QIMYSCWHELPEKRPTFQQLLSS 258

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  139 bits (353), Expect = 9e-36
 Identities = 70/259 (27%), Positives = 129/259 (49%), Gaps = 29/259 (11%)

Query: 59  FTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSP--- 115
            T + ++G G +GEV++G+  +    VA+K   L+E   E+E+  +E  V+ +   P   
Sbjct: 222 ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKT--LKEDTMEVEEFLKEAAVMKEIKHPNLV 279

Query: 116 --YG--TK---LWIIMEYLGGGSALDLMKAGNFEEMHIAVIL---REVLKGLDYLHSERK 165
              G  T+    +II E++  G+ LD ++  N +E+   V+L    ++   ++YL  +  
Sbjct: 280 QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNF 339

Query: 166 LHRDIKAANVLLSEMGDVKLADFGVAGTLTN---TTSKRNTFVGTPF-WMAPEVIKQSAY 221
           +HR++ A N L+ E   VK+ADFG++  +T    T      F   P  W APE +  + +
Sbjct: 340 IHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF---PIKWTAPESLAYNKF 396

Query: 222 DSKADIWSLGITAIELA-KGEPPNSELHPMRVLFLIPKNN---PPQLTGNYTKQFKEFVE 277
             K+D+W+ G+   E+A  G  P   +   +V  L+ K+     P+      ++  E + 
Sbjct: 397 SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGC---PEKVYELMR 453

Query: 278 ACLNKDPENRPTAKELLKF 296
           AC   +P +RP+  E+ + 
Sbjct: 454 ACWQWNPSDRPSFAEIHQA 472

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score =  135 bits (343), Expect = 9e-36
 Identities = 69/303 (22%), Positives = 124/303 (40%), Gaps = 76/303 (25%)

Query: 59  FTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQ--QEIMVLSQCDSPY 116
           F + E++G G++  V+KG++  T   VA+K + L+ +E+        +EI ++ +     
Sbjct: 7   FKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLD-SEEGT-PSTAIREISLMKELKHEN 64

Query: 117 ----------GTKLWIIMEYLGGGSALDLMK----------AGNFEEMHIAVILREVLKG 156
                       KL ++ E++      DL K              E   +     ++L+G
Sbjct: 65  IVRLYDVIHTENKLTLVFEFM----DNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQG 120

Query: 157 LDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVA-------GTLTNTTSKRNTFVGTPF 209
           L + H  + LHRD+K  N+L+++ G +KL DFG+A        T ++        V T +
Sbjct: 121 LAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSE-------VVTLW 173

Query: 210 WMAPEVIKQS-AYDSKADIWSLGITAIELAKGEP--------------------PNSELH 248
           + AP+V+  S  Y +  DIWS G    E+  G+P                    PN  L 
Sbjct: 174 YRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLW 233

Query: 249 P-MRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNK------------DPENRPTAKELLK 295
           P +  L     N   +   +  +  +   +  L+             +P+ R +AK+ L 
Sbjct: 234 PSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH 293

Query: 296 FPF 298
            P+
Sbjct: 294 HPW 296

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score =  139 bits (351), Expect = 1e-35
 Identities = 71/258 (27%), Positives = 121/258 (46%), Gaps = 30/258 (11%)

Query: 65  IGKGSFGEVFKGIDNRTQQVVAIKIIDLE--EAEDEIEDIQQEIMVLSQCDSPY------ 116
           +G G+FG+V  G    T   VA+KI++ +   + D +  I++EI  L     P+      
Sbjct: 24  LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 83

Query: 117 ----GTKLWIIMEYLGGGSALD-LMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIK 171
                + ++++MEY+ GG   D + K G  +E     + +++L G+DY H    +HRD+K
Sbjct: 84  VISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLK 143

Query: 172 AANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYD-SKADIWSL 230
             NVLL    + K+ADFG++  +++      T  G+P + APEVI    Y   + DIWS 
Sbjct: 144 PENVLLDAHMNAKIADFGLSNMMSD-GEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSS 202

Query: 231 GITAIELAKGEPPNSELHPMRVL-------FLIPKNNPPQLTGNYTKQFKEFVEACLNKD 283
           G+    L  G  P  + H   +        F  P+   P +           ++  L  D
Sbjct: 203 GVILYALLCGTLPFDDDHVPTLFKKICDGIFYTPQYLNPSV--------ISLLKHMLQVD 254

Query: 284 PENRPTAKELLKFPFIRK 301
           P  R T K++ +  + ++
Sbjct: 255 PMKRATIKDIREHEWFKQ 272

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score =  138 bits (349), Expect = 1e-35
 Identities = 67/271 (24%), Positives = 118/271 (43%), Gaps = 31/271 (11%)

Query: 42  STTASRRNSLKVDPELIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE--AEDEI 99
               S+   +++  E  F   + IG+G+FGEV         +V A+KI++  E     E 
Sbjct: 60  KPFTSKVKQMRLHRE-DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAET 118

Query: 100 EDIQQEIMVLSQCDSPYGTKLW----------IIMEYLGGGSALDLM-----KAGNFEEM 144
              ++E  VL   DS + T L           ++M+Y  GG   DL+           E 
Sbjct: 119 ACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGG---DLLTLLSKFEDRLPEE 175

Query: 145 HIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVA-GTLTNTTSKRNT 203
                L E++  +D +H    +HRDIK  N+L+   G ++LADFG     + + T + + 
Sbjct: 176 MARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSV 235

Query: 204 FVGTPFWMAPEVIK-----QSAYDSKADIWSLGITAIELAKGEPP--NSELHPM--RVLF 254
            VGTP +++PE+++     +  Y  + D WSLG+   E+  GE P     L     +++ 
Sbjct: 236 AVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMN 295

Query: 255 LIPKNNPPQLTGNYTKQFKEFVEACLNKDPE 285
              +   P    + ++  K+ +   +     
Sbjct: 296 HKERFQFPTQVTDVSENAKDLIRRLICSREH 326

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score =  137 bits (347), Expect = 1e-35
 Identities = 62/204 (30%), Positives = 99/204 (48%), Gaps = 28/204 (13%)

Query: 65  IGKGSFGEVFKGIDNRTQQVVAIKIIDLEE--AEDEIEDIQQEIMVLSQCDSPY------ 116
           IG+G+F EV      +T QV A+KI++  +     E+   ++E  VL   D  +      
Sbjct: 69  IGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHF 128

Query: 117 ----GTKLWIIMEYLGGGSALDLM----KAGN-FEEMHIAVILREVLKGLDYLHSERKLH 167
                  L+++MEY  GG   DL+    K G           L E++  +D +H    +H
Sbjct: 129 AFQDENYLYLVMEYYVGG---DLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVH 185

Query: 168 RDIKAANVLLSEMGDVKLADFGVAGTL-TNTTSKRNTFVGTPFWMAPEVIK-------QS 219
           RDIK  N+LL   G ++LADFG    L  + T +    VGTP +++PE+++         
Sbjct: 186 RDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTG 245

Query: 220 AYDSKADIWSLGITAIELAKGEPP 243
           +Y  + D W+LG+ A E+  G+ P
Sbjct: 246 SYGPECDWWALGVFAYEMFYGQTP 269

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score =  135 bits (342), Expect = 2e-35
 Identities = 76/302 (25%), Positives = 120/302 (39%), Gaps = 78/302 (25%)

Query: 59  FTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDE------IEDIQQEIMVLSQC 112
           + +  ++G+G++GEV+K ID  T + VAIK I LE  E+E      I    +E+ +L + 
Sbjct: 36  YRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEH-EEEGVPGTAI----REVSLLKEL 90

Query: 113 DSPY----------GTKLWIIMEYLGGGSALDLMK----AGNFEEMHIAVILREVLKGLD 158
                           +L +I EY       DL K      +     I   L +++ G++
Sbjct: 91  QHRNIIELKSVIHHNHRLHLIFEYA----ENDLKKYMDKNPDVSMRVIKSFLYQLINGVN 146

Query: 159 YLHSERKLHRDIKAANVLLS-----EMGDVKLADFGVA-------GTLTNTTSKRNTFVG 206
           + HS R LHRD+K  N+LLS     E   +K+ DFG+A          T+        + 
Sbjct: 147 FCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHE-------II 199

Query: 207 TPFWMAPEVIKQS-AYDSKADIWSLGITAIELAKGEP--------------------PNS 245
           T ++  PE++  S  Y +  DIWS+     E+    P                    P+ 
Sbjct: 200 TLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDD 259

Query: 246 ELHP-MRVL----FLIPKNNPPQLTGNYTKQFKE----FVEACLNKDPENRPTAKELLKF 296
              P +  L       PK     L         +     + A L  DP  R +AK  L+ 
Sbjct: 260 TTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEH 319

Query: 297 PF 298
           P+
Sbjct: 320 PY 321

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  139 bits (351), Expect = 2e-35
 Identities = 71/255 (27%), Positives = 115/255 (45%), Gaps = 23/255 (9%)

Query: 59  FTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSP--- 115
              + ++G+G FGEV+ G  N T +V AIK   L+      E   QE  V+ +       
Sbjct: 269 LRLEVKLGQGCFGEVWMGTWNGTTRV-AIKT--LKPGTMSPEAFLQEAQVMKKLRHEKLV 325

Query: 116 --YG--TK--LWIIMEYLGGGSALDLMKAGNFEEMHIAV---ILREVLKGLDYLHSERKL 166
             Y   ++  ++I+ EY+  GS LD +K    + + +     +  ++  G+ Y+     +
Sbjct: 326 QLYAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYV 385

Query: 167 HRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPF-WMAPEVIKQSAYDSKA 225
           HRD++AAN+L+ E    K+ADFG+A  + +           P  W APE      +  K+
Sbjct: 386 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 445

Query: 226 DIWSLGITAIELA-KGEPPNSELHPMRVLFLIPKN---NPPQLTGNYTKQFKEFVEACLN 281
           D+WS GI   EL  KG  P   +    VL  + +      P       +   + +  C  
Sbjct: 446 DVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPEC---PESLHDLMCQCWR 502

Query: 282 KDPENRPTAKELLKF 296
           K+PE RPT + L  F
Sbjct: 503 KEPEERPTFEYLQAF 517

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  137 bits (347), Expect = 3e-35
 Identities = 66/262 (25%), Positives = 116/262 (44%), Gaps = 37/262 (14%)

Query: 59  FTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSP--- 115
              ++++G G FGEV+    N+  +V A+K   ++     +E    E  V+         
Sbjct: 190 LKLEKKLGAGQFGEVWMATYNKHTKV-AVKT--MKPGSMSVEAFLAEANVMKTLQHDKLV 246

Query: 116 --YG--TK--LWIIMEYLGGGSALDLMKAGNFEEMHIAV---ILREVLKGLDYLHSERKL 166
             +   TK  ++II E++  GS LD +K+    +  +        ++ +G+ ++     +
Sbjct: 247 KLHAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYI 306

Query: 167 HRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPF---WMAPEVIKQSAYDS 223
           HRD++AAN+L+S     K+ADFG+A  + +         G  F   W APE I   ++  
Sbjct: 307 HRDLRAANILVSASLVCKIADFGLARVIEDNEYTARE--GAKFPIKWTAPEAINFGSFTI 364

Query: 224 KADIWSLGITAIELA-KGEPPNSELHPMRVLFLI--------PKNNPPQLTGNYTKQFKE 274
           K+D+WS GI  +E+   G  P   +    V+  +        P+N P +L   Y      
Sbjct: 365 KSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEEL---Y-----N 416

Query: 275 FVEACLNKDPENRPTAKELLKF 296
            +  C    PE RPT + +   
Sbjct: 417 IMMRCWKNRPEERPTFEYIQSV 438

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  139 bits (353), Expect = 3e-35
 Identities = 78/268 (29%), Positives = 113/268 (42%), Gaps = 33/268 (12%)

Query: 53  VDPELIFTKQERIGKGSFGEVFKGI---DNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVL 109
           +  E I      IG+G FG+V +GI          VAIK      ++   E   QE + +
Sbjct: 387 IQRERI-ELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTM 445

Query: 110 SQCDSPYGTKL---------WIIMEYLGGGSALDLMKA--GNFEEMHIAVILREVLKGLD 158
            Q D P+  KL         WIIME    G     ++    + +   + +   ++   L 
Sbjct: 446 RQFDHPHIVKLIGVITENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALA 505

Query: 159 YLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPF-WMAPEVIK 217
           YL S+R +HRDI A NVL+S    VKL DFG++  + ++T  + +    P  WMAPE I 
Sbjct: 506 YLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESIN 565

Query: 218 QSAYDSKADIWSLGITAIELA-KGEPPNSELHPMRVLFLI--------PKNNPPQLTGNY 268
              + S +D+W  G+   E+   G  P   +    V+  I        P N PP L   Y
Sbjct: 566 FRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTL---Y 622

Query: 269 TKQFKEFVEACLNKDPENRPTAKELLKF 296
                  +  C   DP  RP   EL   
Sbjct: 623 -----SLMTKCWAYDPSRRPRFTELKAQ 645

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  133 bits (336), Expect = 3e-35
 Identities = 66/270 (24%), Positives = 118/270 (43%), Gaps = 46/270 (17%)

Query: 53  VDPELIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQC 112
           ++ + +    + IGKG FG+V  G     +  VA+K I   +A  +      E  V++Q 
Sbjct: 18  LNMKEL-KLLQTIGKGEFGDVMLGDYRGNK--VAVKCIK-NDATAQ--AFLAEASVMTQL 71

Query: 113 DSP-----YG--TK----LWIIMEYLGGGSALDLMKAGNFEEMHIAVIL---REVLKGLD 158
                    G   +    L+I+ EY+  GS +D +++     +    +L    +V + ++
Sbjct: 72  RHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAME 131

Query: 159 YLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPF---WMAPEV 215
           YL     +HRD+ A NVL+SE    K++DFG+    ++T               W APE 
Sbjct: 132 YLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD------TGKLPVKWTAPEA 185

Query: 216 IKQSAYDSKADIWSLGITAIELA-KGEPPNSELHPMRVLFLI--------PKNNPPQLTG 266
           +++  + +K+D+WS GI   E+   G  P   +    V+  +        P   PP +  
Sbjct: 186 LREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAV-- 243

Query: 267 NYTKQFKEFVEACLNKDPENRPTAKELLKF 296
            Y     E ++ C + D   RP+  +L + 
Sbjct: 244 -Y-----EVMKNCWHLDAAMRPSFLQLREQ 267

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  133 bits (336), Expect = 4e-35
 Identities = 72/268 (26%), Positives = 125/268 (46%), Gaps = 38/268 (14%)

Query: 53  VDPELIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQC 112
           +DP+ + T  + +G G FG V  G       V AIK+I  E +  E ++  +E  V+   
Sbjct: 21  IDPKDL-TFLKELGTGQFGVVKYGKWRGQYDV-AIKMIK-EGSMSE-DEFIEEAKVMMNL 76

Query: 113 DSP-----YG--TK---LWIIMEYLGGGSALDLMKA--GNFEEMHIAVILREVLKGLDYL 160
                   YG  TK   ++II EY+  G  L+ ++     F+   +  + ++V + ++YL
Sbjct: 77  SHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYL 136

Query: 161 HSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPF---WMAPEVIK 217
            S++ LHRD+ A N L+++ G VK++DFG++  + +     +   G+ F   W  PEV+ 
Sbjct: 137 ESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSV--GSKFPVRWSPPEVLM 194

Query: 218 QSAYDSKADIWSLGITAIELA-KGEPPNSELHPMRVLFLI--------PKNNPPQLTGNY 268
            S + SK+DIW+ G+   E+   G+ P            I        P     ++   Y
Sbjct: 195 YSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKV---Y 251

Query: 269 TKQFKEFVEACLNKDPENRPTAKELLKF 296
                  + +C ++  + RPT K LL  
Sbjct: 252 -----TIMYSCWHEKADERPTFKILLSN 274

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score =  133 bits (337), Expect = 6e-35
 Identities = 72/299 (24%), Positives = 120/299 (40%), Gaps = 77/299 (25%)

Query: 59  FTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDE----IEDIQQEIMVLSQCDS 114
           + K +++G+G++  V+KG    T  +VA+K I LE  E      I    +E+ +L     
Sbjct: 4   YIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAI----REVSLLKDLKH 59

Query: 115 PY----------GTKLWIIMEYLGGGSALDLMK-----AGNFEEMHIAVILREVLKGLDY 159
                          L ++ EYL      DL +            ++ + L ++L+GL Y
Sbjct: 60  ANIVTLHDIIHTEKSLTLVFEYL----DKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAY 115

Query: 160 LHSERKLHRDIKAANVLLSEMGDVKLADFGVA-------GTLTNTTSKRNTFVGTPFWMA 212
            H ++ LHRD+K  N+L++E G++KLADFG+A        T  N        V T ++  
Sbjct: 116 CHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNE-------VVTLWYRP 168

Query: 213 PEVIKQS-AYDSKADIWSLGITAIELAKGEP--P-NSELHPMRVLFLI------------ 256
           P+++  S  Y ++ D+W +G    E+A G P  P ++       L  I            
Sbjct: 169 PDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEE---QLHFIFRILGTPTEETW 225

Query: 257 ----------PKNNPPQLTGNYTKQFKEFVEAC---LNK----DPENRPTAKELLKFPF 298
                       N P                     L K    +  NR +A++ +K PF
Sbjct: 226 PGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPF 284

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  130 bits (330), Expect = 3e-34
 Identities = 65/269 (24%), Positives = 113/269 (42%), Gaps = 37/269 (13%)

Query: 56  ELIFTKQERIGKGSFGEVFKGI---DNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQC 112
            LI    E IG+G FG V+ G    ++  +   A+K ++      E+     E +++   
Sbjct: 24  SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF 83

Query: 113 DSP-----YG------TKLWIIMEYLGGGSALDLMKA--GNFEEMHIAVILREVLKGLDY 159
             P      G          +++ Y+  G   + ++    N     +     +V KG+ Y
Sbjct: 84  SHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKY 143

Query: 160 LHSERKLHRDIKAANVLLSEMGDVKLADFGVA-GTLTNTTSKRNTFVGTPF---WMAPEV 215
           L S++ +HRD+ A N +L E   VK+ADFG+A           +   G      WMA E 
Sbjct: 144 LASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES 203

Query: 216 IKQSAYDSKADIWSLGITAIELA-KGEPPNSELHPMRVLFLI--------PKNNPPQLTG 266
           ++   + +K+D+WS G+   EL  +G PP  +++   +   +        P+  P  L  
Sbjct: 204 LQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPL-- 261

Query: 267 NYTKQFKEFVEACLNKDPENRPTAKELLK 295
            Y     E +  C +   E RP+  EL+ 
Sbjct: 262 -Y-----EVMLKCWHPKAEMRPSFSELVS 284

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  130 bits (330), Expect = 4e-34
 Identities = 64/284 (22%), Positives = 119/284 (41%), Gaps = 41/284 (14%)

Query: 57  LIFTKQERIGKGSFGEVFKGI---DNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCD 113
           ++      IGKG FG V+ G      + +   AIK +       ++E   +E +++   +
Sbjct: 21  VVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLN 80

Query: 114 SP-----YG--TK----LWIIMEYLGGGSALDLMKA--GNFEEMHIAVILREVLKGLDYL 160
            P      G          +++ Y+  G  L  +++   N     +     +V +G++YL
Sbjct: 81  HPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYL 140

Query: 161 HSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNT--TSKRNTFVGTPF---WMAPEV 215
             ++ +HRD+ A N +L E   VK+ADFG+A  + +    S +           W A E 
Sbjct: 141 AEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQH-RHARLPVKWTALES 199

Query: 216 IKQSAYDSKADIWSLGITAIELA-KGEPPNSELHPMRVLFLI--------PKNNPPQLTG 266
           ++   + +K+D+WS G+   EL  +G PP   + P  +   +        P+  P  L  
Sbjct: 200 LQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRLPQPEYCPDSL-- 257

Query: 267 NYTKQFKEFVEACLNKDPENRPTAKELLKF--PFIRKAKKNAYL 308
            Y     + ++ C   DP  RPT + L+      +     + Y+
Sbjct: 258 -Y-----QVMQQCWEADPAVRPTFRVLVGEVEQIVSALLGDHYV 295

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  133 bits (336), Expect = 8e-34
 Identities = 64/264 (24%), Positives = 111/264 (42%), Gaps = 45/264 (17%)

Query: 59  FTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSP--- 115
               + IGKG FG+V  G     +  VA+K I  +      +    E  V++Q       
Sbjct: 195 LKLLQTIGKGEFGDVMLGDYRGNK--VAVKCIKNDATA---QAFLAEASVMTQLRHSNLV 249

Query: 116 --YG------TKLWIIMEYLGGGSALDLMKAGNFEEMHIAVIL---REVLKGLDYLHSER 164
              G        L+I+ EY+  GS +D +++     +    +L    +V + ++YL    
Sbjct: 250 QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN 309

Query: 165 KLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPF---WMAPEVIKQSAY 221
            +HRD+ A NVL+SE    K++DFG+    ++T               W APE +++  +
Sbjct: 310 FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD------TGKLPVKWTAPEALREKKF 363

Query: 222 DSKADIWSLGITAIELA-KGEPPNSELHPMRVLFLI--------PKNNPPQLTGNYTKQF 272
            +K+D+WS GI   E+   G  P   +    V+  +        P   PP +        
Sbjct: 364 STKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAV-------- 415

Query: 273 KEFVEACLNKDPENRPTAKELLKF 296
            + ++ C + D   RPT  +L + 
Sbjct: 416 YDVMKNCWHLDAATRPTFLQLREQ 439

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score =  129 bits (326), Expect = 8e-34
 Identities = 32/246 (13%), Positives = 67/246 (27%), Gaps = 46/246 (18%)

Query: 63  ERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDE--IEDIQQEIMVLSQCDSP----- 115
              G     + ++ +D    + VA+  +D +    +  +++     + LS+ D P     
Sbjct: 37  IFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARV 96

Query: 116 -----YGTKLWIIMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDI 170
                      ++ E++ GGS  ++        +     ++ +    D  H         
Sbjct: 97  LDVVHTRAGGLVVAEWIRGGSLQEVADTS-PSPVGAIRAMQSLAAAADAAHRAGVALSID 155

Query: 171 KAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSL 230
             + V +S  GDV LA                        M          + + DI  +
Sbjct: 156 HPSRVRVSIDGDVVLAYPAT--------------------MPDA-------NPQDDIRGI 188

Query: 231 GITAIELAKGEPP---NSELHPMRVLFLIPKNNPP---QLTGNYTKQFKEFVEACLNKDP 284
           G +   L     P         +          P     +  +   Q        +  D 
Sbjct: 189 GASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQISAVAARSVQGDG 248

Query: 285 ENRPTA 290
             R  +
Sbjct: 249 GIRSAS 254

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  127 bits (321), Expect = 4e-33
 Identities = 54/281 (19%), Positives = 110/281 (39%), Gaps = 51/281 (18%)

Query: 52  KVDPELIFTKQERIGKGSFGEVFKGIDNRTQQV-------VAIKIIDLEEAEDEIEDIQQ 104
           K+  E +    E +G+G+F ++FKG+              V +K++D +   +  E   +
Sbjct: 4   KIRNEDL-IFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLD-KAHRNYSESFFE 61

Query: 105 EIMVLSQCDSP-----YG--TK---LWIIMEYLGGGSALDLMKA--GNFEEMHIAVILRE 152
              ++S+         YG         ++ E++  GS    +K        +    + ++
Sbjct: 62  AASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQ 121

Query: 153 VLKGLDYLHSERKLHRDIKAANVLLSEMGD--------VKLADFGVAGTLTNTTSKRNTF 204
           +   + +L     +H ++ A N+LL    D        +KL+D G++ T+      +   
Sbjct: 122 LAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQ--- 178

Query: 205 VGTPF-WMAPEVIKQS-AYDSKADIWSLGITAIELA-KGEPPNSELHPMRVLFLI----- 256
                 W+ PE I+     +   D WS G T  E+   G+ P S L   R L        
Sbjct: 179 --ERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDRHQ 236

Query: 257 -PKNNPPQLTGNYTKQFKEFVEACLNKDPENRPTAKELLKF 296
            P     +L           +  C++ +P++RP+ + +++ 
Sbjct: 237 LPAPKAAEL---A-----NLINNCMDYEPDHRPSFRAIIRD 269

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  127 bits (321), Expect = 7e-33
 Identities = 63/273 (23%), Positives = 115/273 (42%), Gaps = 49/273 (17%)

Query: 62  QERIGKGSFGEVFKGI---DNRTQQVVAIKIIDLEEA-EDEIEDIQQE--IM-------- 107
            + +G+G FG V +G    ++ T   VA+K + L+ + + EIE+   E   M        
Sbjct: 39  GKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNV 98

Query: 108 -----VLSQCDSPYGTKLWIIMEYLGGGSALDLMKA-------GNFEEMHIAVILREVLK 155
                V  +  S    K  +I+ ++  G     +          +     +   + ++  
Sbjct: 99  IRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIAL 158

Query: 156 GLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNT---TSKRNTFVGTPF-WM 211
           G++YL +   LHRD+ A N +L +   V +ADFG++  + +       R   +  P  W+
Sbjct: 159 GMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKM--PVKWI 216

Query: 212 APEVIKQSAYDSKADIWSLGITAIELA-KGEPPNSELHPMRVLFLI--------PKNNPP 262
           A E +    Y SK+D+W+ G+T  E+A +G  P   +    +   +        P++   
Sbjct: 217 AIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHRLKQPEDCLD 276

Query: 263 QLTGNYTKQFKEFVEACLNKDPENRPTAKELLK 295
           +L   Y     E + +C   DP +RPT   L  
Sbjct: 277 EL---Y-----EIMYSCWRTDPLDRPTFSVLRL 301

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  128 bits (323), Expect = 1e-32
 Identities = 69/319 (21%), Positives = 127/319 (39%), Gaps = 40/319 (12%)

Query: 22  NPTQFLKFSNSGSSISNQCGSTTASRRNSLKVDPE-LIFTKQERIGKGSFGEVFKGI--- 77
           +   + + +N+     +            + + P  LI    E IG+G FG V+ G    
Sbjct: 53  SENLYFQGANTVHIDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLD 112

Query: 78  DNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSP-----YG------TKLWIIMEY 126
           ++  +   A+K ++      E+     E +++     P      G          +++ Y
Sbjct: 113 NDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPY 172

Query: 127 LGGGSALDLMKA--GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVK 184
           +  G   + ++    N     +     +V KG+ +L S++ +HRD+ A N +L E   VK
Sbjct: 173 MKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVK 232

Query: 185 LADFGVAGTL--TNTTSKRNTFVGT-PF-WMAPEVIKQSAYDSKADIWSLGITAIELA-K 239
           +ADFG+A  +      S  N      P  WMA E ++   + +K+D+WS G+   EL  +
Sbjct: 233 VADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTR 292

Query: 240 GEPPNSELHPMRVLFLI--------PKNNPPQLTGNYTKQFKEFVEACLNKDPENRPTAK 291
           G PP  +++   +   +        P+  P  L   Y     E +  C +   E RP+  
Sbjct: 293 GAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPL---Y-----EVMLKCWHPKAEMRPSFS 344

Query: 292 ELLKF--PFIRKAKKNAYL 308
           EL+              Y+
Sbjct: 345 ELVSRISAIFSTFIGEHYV 363

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  125 bits (315), Expect = 7e-32
 Identities = 56/274 (20%), Positives = 113/274 (41%), Gaps = 50/274 (18%)

Query: 62  QERIGKGSFGEVFKGI---DNRTQQVVAIKIIDLEEA-EDEIEDIQQEIMVLSQCDSP-- 115
              +GKG FG V +     ++ +   VA+K++  +     +IE+  +E   + + D P  
Sbjct: 28  GRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHV 87

Query: 116 ---YG-----------TKLWIIMEYLGGGSALDLMKAGNFEEMHIAVILREVL------- 154
               G               +I+ ++  G     + A    E    + L+ ++       
Sbjct: 88  AKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIA 147

Query: 155 KGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNT---TSKRNTFVGTPF-W 210
            G++YL S   +HRD+ A N +L+E   V +ADFG++  + +         + +  P  W
Sbjct: 148 CGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKL--PVKW 205

Query: 211 MAPEVIKQSAYDSKADIWSLGITAIELA-KGEPPNSELHPMRVLFLI--------PKNNP 261
           +A E +  + Y   +D+W+ G+T  E+  +G+ P + +    +   +        P    
Sbjct: 206 LALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGNRLKQPPECM 265

Query: 262 PQLTGNYTKQFKEFVEACLNKDPENRPTAKELLK 295
            ++   Y     + +  C + DP+ RP+   L  
Sbjct: 266 EEV---Y-----DLMYQCWSADPKQRPSFTCLRM 291

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score =  125 bits (317), Expect = 2e-31
 Identities = 74/321 (23%), Positives = 124/321 (38%), Gaps = 91/321 (28%)

Query: 63  ERIGKGSFGEVFKGIDNRTQQVVAIKII-----DLEEAEDEIEDIQQEIMVLSQCDSPYG 117
           + IGKGSFG+V K  D++  Q VA+K++        +A +EI  ++     L + D    
Sbjct: 103 KVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEH----LRKQD-KDN 157

Query: 118 TK--------------LWIIMEYLGGGSALDLMKAGNFEEMHIAVI---LREVLKGLDYL 160
           T               + +  E L   +  +L+K   F+   + ++      +L+ LD L
Sbjct: 158 TMNVIHMLENFTFRNHICMTFELLSM-NLYELIKKNKFQGFSLPLVRKFAHSILQCLDAL 216

Query: 161 HSERKLHRDIKAANVLLSEMG--DVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQ 218
           H  R +H D+K  N+LL + G   +K+ DFG +           T++ + F+ APEVI  
Sbjct: 217 HKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVY---TYIQSRFYRAPEVILG 273

Query: 219 SAYDSKADIWSLGITAIELA---------------------KGEPP-------------- 243
           + Y    D+WSLG    EL                       G P               
Sbjct: 274 ARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASKRAKNFV 333

Query: 244 NSELHPMRVLFLIPKNNPPQLTGNYTK-----------------------QFKEFVEACL 280
           +S+ +P         +    L G  ++                        F +F++ CL
Sbjct: 334 SSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCL 393

Query: 281 NKDPENRPTAKELLKFPFIRK 301
             DP  R T  + L+ P++R+
Sbjct: 394 EWDPAVRMTPGQALRHPWLRR 414

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  122 bits (309), Expect = 5e-31
 Identities = 70/323 (21%), Positives = 131/323 (40%), Gaps = 70/323 (21%)

Query: 31  NSGSSISNQCGSTTASRRNSLKVDPELIFTK------------QERIGKGSFGEVFKGI- 77
            SGSS+S   G  +  +   +  +P+                 +  +G+G+FG+VF    
Sbjct: 4   GSGSSLSPTEGKGSGLQ-GHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAEC 62

Query: 78  ----DNRTQQVVAIKIIDLEEA-EDEIEDIQQEIMVLSQCDSP-----YG--TK---LWI 122
                 + + +VA+K   L+EA E   +D Q+E  +L+          +G  T+   L +
Sbjct: 63  HNLLPEQDKMLVAVKA--LKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM 120

Query: 123 IMEYLGGGS----------------ALDLMKAGNFEEMHIAVILREVLKGLDYLHSERKL 166
           + EY+  G                   + +  G      +  +  +V  G+ YL     +
Sbjct: 121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFV 180

Query: 167 HRDIKAANVLLSEMGDVKLADFGVAGTLTNT---TSKRNTFVGTPF-WMAPEVIKQSAYD 222
           HRD+   N L+ +   VK+ DFG++  + +T        T +  P  WM PE I    + 
Sbjct: 181 HRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTML--PIRWMPPESILYRKFT 238

Query: 223 SKADIWSLGITAIELA-KGEPPNSELHPMRVLFLI--------PKNNPPQLTGNYTKQFK 273
           +++D+WS G+   E+   G+ P  +L     +  I        P+  PP++   Y     
Sbjct: 239 TESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEV---Y----- 290

Query: 274 EFVEACLNKDPENRPTAKELLKF 296
             +  C  ++P+ R + K++   
Sbjct: 291 AIMRGCWQREPQQRHSIKDVHAR 313

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  122 bits (308), Expect = 6e-31
 Identities = 73/297 (24%), Positives = 120/297 (40%), Gaps = 47/297 (15%)

Query: 37  SNQCGSTTASRRNSLK-VDPELIFTKQERIGKGSFGEVFKGI-----DNRTQQVVAIKII 90
            N C +   S  + LK V  + I T    +G G+FGEV++G      ++ +   VA+K +
Sbjct: 10  PNYCFAGKTSSISDLKEVPRKNI-TLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL 68

Query: 91  DLEEAEDEIEDIQQEIMVLSQCDSP-----YG--TK---LWIIMEYLGGGSALD------ 134
               +E +  D   E +++S+ +        G   +    +I+ME + GG          
Sbjct: 69  PEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETR 128

Query: 135 --LMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGD---VKLADFG 189
               +  +   + +  + R++  G  YL     +HRDI A N LL+  G     K+ DFG
Sbjct: 129 PRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFG 188

Query: 190 VA-GTLTNTTSKRNTFVGTPF-WMAPEVIKQSAYDSKADIWSLGITAIELA-KGEPPNSE 246
           +A      +  ++      P  WM PE   +  + SK D WS G+   E+   G  P   
Sbjct: 189 MARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS 248

Query: 247 LHPMRVLFLI--------PKNNPPQLTGNYTKQFKEFVEACLNKDPENRPTAKELLK 295
                VL  +        PKN P  +   Y       +  C    PE+RP    +L+
Sbjct: 249 KSNQEVLEFVTSGGRMDPPKNCPGPV---Y-----RIMTQCWQHQPEDRPNFAIILE 297

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score =  122 bits (309), Expect = 2e-30
 Identities = 79/294 (26%), Positives = 126/294 (42%), Gaps = 65/294 (22%)

Query: 59  FTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIM----------- 107
           +T  + IG GSFG VF+     + +V AIK + L++   +  ++Q  IM           
Sbjct: 42  YTNCKVIGNGSFGVVFQAKLVESDEV-AIKKV-LQDKRFKNRELQ--IMRIVKHPNVVDL 97

Query: 108 ---VLSQCDSPYGTKLWIIMEYLGGGSALDLMKA--------GNFEEMHIAVILREVLKG 156
                S  D      L +++EY+       + +A             + I + + ++L+ 
Sbjct: 98  KAFFYSNGDKKDEVFLNLVLEYVP----ETVYRASRHYAKLKQTMPMLLIKLYMYQLLRS 153

Query: 157 LDYLHSERKLHRDIKAANVLL-SEMGDVKLADFGVAGTLTNTTSKRNT-FVGTPFWMAPE 214
           L Y+HS    HRDIK  N+LL    G +KL DFG A  L     + N  ++ + ++ APE
Sbjct: 154 LAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAG--EPNVSYICSRYYRAPE 211

Query: 215 VI-KQSAYDSKADIWSLG-ITAIELAKGEP--P-NSELHPMRVLF---------LIPKNN 260
           +I   + Y +  DIWS G + A EL +G+P  P  S +  +  +           I   N
Sbjct: 212 LIFGATNYTTNIDIWSTGCVMA-ELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMN 270

Query: 261 P-------PQLTG-NYTKQFK--------EFVEACLNKDPENRPTAKELLKFPF 298
           P       PQ+    ++K F+        + +   L   P  R TA E L  PF
Sbjct: 271 PNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPF 324

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score =  123 bits (310), Expect = 2e-30
 Identities = 75/331 (22%), Positives = 133/331 (40%), Gaps = 64/331 (19%)

Query: 22  NPTQFLKFSNSGSSISNQCGSTTASRRNSLKVDPELIFTKQERIGKGSFGEVFKGIDNRT 81
            P+ F     S     ++  +  A+         E+ +T  + IG GSFG V++     +
Sbjct: 19  QPSAFGSMKVSRDKDGSKVTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDS 78

Query: 82  QQVVAIKIIDLEEAEDEIEDIQQEIM--------------VLSQCDSPYGTKLWIIMEYL 127
            ++VAIK + L++   +  ++Q  IM                S  +      L ++++Y+
Sbjct: 79  GELVAIKKV-LQDKRFKNRELQ--IMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV 135

Query: 128 GGGSALDLMK--------AGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLL-S 178
                  + +              +++ + + ++ + L Y+HS    HRDIK  N+LL  
Sbjct: 136 P----ETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDP 191

Query: 179 EMGDVKLADFGVAGTLTNTTSKRNT-FVGTPFWMAPEVI-KQSAYDSKADIWSLG-ITAI 235
           +   +KL DFG A  L     + N  ++ + ++ APE+I   + Y S  D+WS G + A 
Sbjct: 192 DTAVLKLCDFGSAKQLVRG--EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLA- 248

Query: 236 ELAKGEP--P-NSELHPMRVLF---------LIPKNNP-------PQLTG-NYTKQFK-- 273
           EL  G+P  P +S +  +  +           I + NP       PQ+    +TK F+  
Sbjct: 249 ELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPR 308

Query: 274 ------EFVEACLNKDPENRPTAKELLKFPF 298
                       L   P  R T  E     F
Sbjct: 309 TPPEAIALCSRLLEYTPTARLTPLEACAHSF 339

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  120 bits (304), Expect = 2e-30
 Identities = 63/273 (23%), Positives = 117/273 (42%), Gaps = 49/273 (17%)

Query: 63  ERIGKGSFGEVFKGI-----DNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSP-- 115
             +G+GSFG V++G+      +  +  VAIK ++   +  E  +   E  V+ + +    
Sbjct: 31  RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 90

Query: 116 ---YG--TK---LWIIMEYLGGGSALDLMKAGNFEEMHIAV-----------ILREVLKG 156
               G  ++     +IME +  G     +++      +  V           +  E+  G
Sbjct: 91  VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADG 150

Query: 157 LDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNT---TSKRNTFVGTPF-WMA 212
           + YL++ + +HRD+ A N +++E   VK+ DFG+   +  T          +  P  WM+
Sbjct: 151 MAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLL--PVRWMS 208

Query: 213 PEVIKQSAYDSKADIWSLGITAIELA-KGEPPNSELHPMRVLFLI--------PKNNPPQ 263
           PE +K   + + +D+WS G+   E+A   E P   L   +VL  +        P N P  
Sbjct: 209 PESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPDNCPDM 268

Query: 264 LTGNYTKQFKEFVEACLNKDPENRPTAKELLKF 296
           L   +     E +  C   +P+ RP+  E++  
Sbjct: 269 L---F-----ELMRMCWQYNPKMRPSFLEIISS 293

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  120 bits (302), Expect = 2e-30
 Identities = 62/280 (22%), Positives = 113/280 (40%), Gaps = 58/280 (20%)

Query: 63  ERIGKGSFGEVFKGI-----DNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSP-- 115
             +G+G+FG+VF          + + +VA+K +  +      +D Q+E  +L+       
Sbjct: 21  RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALK-DPTLAARKDFQREAELLTNLQHEHI 79

Query: 116 ---YG--TK---LWIIMEYLGGGSALDLMKA-----------------GNFEEMHIAVIL 150
              YG       L ++ EY+  G     ++A                 G      +  I 
Sbjct: 80  VKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIA 139

Query: 151 REVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNT--TSKRNTFVGTP 208
            ++  G+ YL S+  +HRD+   N L+     VK+ DFG++  + +T           T 
Sbjct: 140 SQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGG---HTM 196

Query: 209 F---WMAPEVIKQSAYDSKADIWSLGITAIELA-KGEPPNSELHPMRVLFLI-------- 256
               WM PE I    + +++D+WS G+   E+   G+ P  +L    V+  I        
Sbjct: 197 LPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQGRVLER 256

Query: 257 PKNNPPQLTGNYTKQFKEFVEACLNKDPENRPTAKELLKF 296
           P+  P ++   Y     + +  C  ++P+ R   KE+ K 
Sbjct: 257 PRVCPKEV---Y-----DVMLGCWQREPQQRLNIKEIYKI 288

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score =  120 bits (304), Expect = 2e-30
 Identities = 61/292 (20%), Positives = 119/292 (40%), Gaps = 59/292 (20%)

Query: 59  FTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQ------- 111
           +    ++G+G + EVF+ I+    + V +KI+   + +     I++EI +L         
Sbjct: 38  YQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKK----IKREIKILENLRGGPNI 93

Query: 112 ---CD---SPYGTKLWIIMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERK 165
               D    P      ++ E++       L +     +  I   + E+LK LDY HS   
Sbjct: 94  ITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT--LTDYDIRFYMYEILKALDYCHSMGI 151

Query: 166 LHRDIKAANVLL-SEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVI-KQSAYDS 223
           +HRD+K  NV++  E   ++L D+G+A    +   + N  V + ++  PE++     YD 
Sbjct: 152 MHRDVKPHNVMIDHEHRKLRLIDWGLAEF-YHPGQEYNVRVASRYFKGPELLVDYQMYDY 210

Query: 224 KADIWSLGITAIELAKGEPP----NSELH-------------PMRVLFLIPKNNPPQLT- 265
             D+WSLG     +   + P    +                     +        P+   
Sbjct: 211 SLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFND 270

Query: 266 --GNYTKQ-FKEFVEAC------------LNK----DPENRPTAKELLKFPF 298
             G ++++ ++ FV +             L+K    D ++R TA+E ++ P+
Sbjct: 271 ILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPY 322

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  118 bits (297), Expect = 9e-30
 Identities = 64/279 (22%), Positives = 108/279 (38%), Gaps = 55/279 (19%)

Query: 63  ERIGKGSFGEVFKGI-----DNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSP-- 115
           E +G+  FG+V+KG           Q VAIK +  +      E+ + E M+ ++   P  
Sbjct: 15  EELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNV 74

Query: 116 ---YG--TK---LWIIMEYLGGGSALDLMKA-----------------GNFEEMHIAVIL 150
               G  TK   L +I  Y   G   + +                      E      ++
Sbjct: 75  VCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLV 134

Query: 151 REVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNT---TSKRNTFVGT 207
            ++  G++YL S   +H+D+   NVL+ +  +VK++D G+   +          N+ +  
Sbjct: 135 AQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLL-- 192

Query: 208 PF-WMAPEVIKQSAYDSKADIWSLGITAIELA-KGEPPNSELHPMRVLFLI--------P 257
           P  WMAPE I    +   +DIWS G+   E+   G  P        V+ +I        P
Sbjct: 193 PIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIRNRQVLPCP 252

Query: 258 KNNPPQLTGNYTKQFKEFVEACLNKDPENRPTAKELLKF 296
            + P  +   Y       +  C N+ P  RP  K++   
Sbjct: 253 DDCPAWV---Y-----ALMIECWNEFPSRRPRFKDIHSR 283

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  119 bits (301), Expect = 1e-29
 Identities = 67/282 (23%), Positives = 112/282 (39%), Gaps = 50/282 (17%)

Query: 53  VDPELIFTKQERIGKGSFGEVFKGI-----DNRTQQVVAIKIIDLEEAEDEIEDIQQEIM 107
           V  + I T    +G G+FGEV++G      ++ +   VA+K +    +E +  D   E +
Sbjct: 68  VPRKNI-TLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEAL 126

Query: 108 VLSQCDSP-----YG--TK---LWIIMEYLGGGSALD--------LMKAGNFEEMHIAVI 149
           ++S+ +        G   +    +I++E + GG              +  +   + +  +
Sbjct: 127 IISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHV 186

Query: 150 LREVLKGLDYLHSERKLHRDIKAANVLLSEMGD---VKLADFGVAGTLTNT---TSKRNT 203
            R++  G  YL     +HRDI A N LL+  G     K+ DFG+A  +            
Sbjct: 187 ARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCA 246

Query: 204 FVGTPF-WMAPEVIKQSAYDSKADIWSLGITAIELA-KGEPPNSELHPMRVLFLI----- 256
            +  P  WM PE   +  + SK D WS G+   E+   G  P        VL  +     
Sbjct: 247 ML--PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGR 304

Query: 257 ---PKNNPPQLTGNYTKQFKEFVEACLNKDPENRPTAKELLK 295
              PKN P  +   Y       +  C    PE+RP    +L+
Sbjct: 305 MDPPKNCPGPV---Y-----RIMTQCWQHQPEDRPNFAIILE 338

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score =  118 bits (298), Expect = 2e-29
 Identities = 71/302 (23%), Positives = 116/302 (38%), Gaps = 71/302 (23%)

Query: 59  FTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSP--- 115
           F  +   G+G+FG V  G +  T   VAIK + +++      ++ Q +  L+    P   
Sbjct: 25  FQVERMAGQGTFGTVQLGKEKSTGMSVAIKKV-IQDPRFRNREL-QIMQDLAVLHHPNIV 82

Query: 116 --------------YGTKLWIIMEYLGGGSALDL---MKAGN-----FEEMHIAVILREV 153
                             L ++MEY+       L    +           + I V L ++
Sbjct: 83  QLQSYFYTLGERDRRDIYLNVVMEYVP----DTLHRCCRNYYRRQVAPPPILIKVFLFQL 138

Query: 154 LKGLDYLH--SERKLHRDIKAANVLL-SEMGDVKLADFGVAGTLTNTTSKRNT-FVGTPF 209
           ++ +  LH  S    HRDIK  NVL+    G +KL DFG A  L+ +    N  ++ + +
Sbjct: 139 IRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEP--NVAYICSRY 196

Query: 210 WMAPEVI-KQSAYDSKADIWSLG-ITAIELAKGEP--------------------PNSE- 246
           + APE+I     Y +  DIWS+G I A E+  GEP                    P+ E 
Sbjct: 197 YRAPELIFGNQHYTTAVDIWSVGCIFA-EMMLGEPIFRGDNSAGQLHEIVRVLGCPSREV 255

Query: 247 ---LHPMRVLFLIPKNNPPQLTGNYTKQFK-------EFVEACLNKDPENRPTAKELLKF 296
              L+P      +  +     +  ++           + + A L   PE R    E L  
Sbjct: 256 LRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCH 315

Query: 297 PF 298
           P+
Sbjct: 316 PY 317

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score =  116 bits (293), Expect = 5e-29
 Identities = 70/301 (23%), Positives = 122/301 (40%), Gaps = 64/301 (21%)

Query: 59  FTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAED------EI--------EDI-- 102
           +   + +G G  G VF  +DN   + VAIK I L + +       EI        ++I  
Sbjct: 13  YMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVK 72

Query: 103 -------QQEIMVLSQCDSPYGTKLWIIMEYLGGGSALDL---MKAGNFEEMHIAVILRE 152
                      +            ++I+ EY+      DL   ++ G   E H  + + +
Sbjct: 73  VFEILGPSGSQLTDDVGSLTELNSVYIVQEYME----TDLANVLEQGPLLEEHARLFMYQ 128

Query: 153 VLKGLDYLHSERKLHRDIKAANVLL-SEMGDVKLADFGVAGTLTNTTSKRNT---FVGTP 208
           +L+GL Y+HS   LHRD+K AN+ + +E   +K+ DFG+A  +    S +      + T 
Sbjct: 129 LLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTK 188

Query: 209 FWMAPEVI-KQSAYDSKADIWSLGITAIELAKGEP--P-NSELHPM-RVLFLIP------ 257
           ++ +P ++   + Y    D+W+ G    E+  G+       EL  M  +L  IP      
Sbjct: 189 WYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEED 248

Query: 258 ------------KNNPPQLTGNYTKQFKE-------FVEACLNKDPENRPTAKELLKFPF 298
                       +N+  +     T+           F+E  L   P +R TA+E L  P+
Sbjct: 249 RQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPY 308

Query: 299 I 299
           +
Sbjct: 309 M 309

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score =  115 bits (290), Expect = 3e-28
 Identities = 65/304 (21%), Positives = 112/304 (36%), Gaps = 70/304 (23%)

Query: 59  FTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQ---EIMVLSQCDSP 115
           F  +  +G+G++G V       T ++VAIK I+     D+     +   EI +L      
Sbjct: 13  FQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIE---PFDKPLFALRTLREIKILKHFKHE 69

Query: 116 YGTKL---------------WIIMEYLGGGSALDL---MKAGNFEEMHIAVILREVLKGL 157
               +               +II E +      DL   +      + HI   + + L+ +
Sbjct: 70  NIITIFNIQRPDSFENFNEVYIIQELMQ----TDLHRVISTQMLSDDHIQYFIYQTLRAV 125

Query: 158 DYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWM------ 211
             LH    +HRD+K +N+L++   D+K+ DFG+A  +  + +  +   G    M      
Sbjct: 126 KVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVAT 185

Query: 212 ----APEVI-KQSAYDSKADIWSLGITAIELAKGEP--------------------PNSE 246
               APEV+   + Y    D+WS G    EL    P                    P+S+
Sbjct: 186 RWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSD 245

Query: 247 L--------HPMRVLFLIPKNNPPQLTG---NYTKQFKEFVEACLNKDPENRPTAKELLK 295
                         +  +P      L         +  + ++  L  DP  R TAKE L+
Sbjct: 246 NDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE 305

Query: 296 FPFI 299
            P++
Sbjct: 306 HPYL 309

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score =  114 bits (287), Expect = 9e-28
 Identities = 70/328 (21%), Positives = 115/328 (35%), Gaps = 98/328 (29%)

Query: 63  ERIGKGSFGEVFKGIDNRTQQVVAIKIID-----LEEAEDEIEDIQQEIMVLSQCDSPYG 117
             IGKGSFG+V K  D   Q+ VAIKII      L +A+ E+  ++     +++ D    
Sbjct: 60  SLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLEL----MNKHD-TEM 114

Query: 118 TK--------------LWIIMEYLGGGSALDLMKAGNFEEMHIAVI---LREVLKGLDYL 160
                           L ++ E L   +  DL++  NF  + + +     +++   L +L
Sbjct: 115 KYYIVHLKRHFMFRNHLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFL 173

Query: 161 HSERK--LHRDIKAANVLLSEMG--DVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVI 216
            +     +H D+K  N+LL       +K+ DFG +  L         ++ + F+ +PEV+
Sbjct: 174 ATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIY---QYIQSRFYRSPEVL 230

Query: 217 KQSAYDSKADIWSLGITAIELA---------------------KGEPPNSELH------- 248
               YD   D+WSLG   +E+                       G PP   L        
Sbjct: 231 LGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPKARK 290

Query: 249 -------------------------PMRVLFLIPKNNPPQLTGNYTK----------QFK 273
                                      R L  I         G              +FK
Sbjct: 291 FFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFK 350

Query: 274 EFVEACLNKDPENRPTAKELLKFPFIRK 301
           + +   L+ DP+ R      L+  F +K
Sbjct: 351 DLILRMLDYDPKTRIQPYYALQHSFFKK 378

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  112 bits (282), Expect = 2e-27
 Identities = 74/327 (22%), Positives = 129/327 (39%), Gaps = 63/327 (19%)

Query: 53  VDPELIFTKQERIGKGSFGEVFKGI--DNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLS 110
           +D   I   Q+ IG+G+FG+V K     +  +   AIK +    ++D+  D   E+ VL 
Sbjct: 22  LDWNDI-KFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLC 80

Query: 111 Q-CDSP-----YG--TK---LWIIMEYLGGGSALDLMKAGNFEEMHIAV----------- 148
           +    P      G       L++ +EY   G+ LD ++     E   A            
Sbjct: 81  KLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLS 140

Query: 149 ------ILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRN 202
                    +V +G+DYL  ++ +HRD+ A N+L+ E    K+ADFG++        K  
Sbjct: 141 SQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTM 200

Query: 203 TFVGTPF-WMAPEVIKQSAYDSKADIWSLGITAIELA-KGEPPNSELHPMRVLFLI---- 256
             +  P  WMA E +  S Y + +D+WS G+   E+   G  P   +    +   +    
Sbjct: 201 GRL--PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY 258

Query: 257 ----PKNNPPQLTGNYTKQFKEFVEACLNKDPENRPTAKELLKFPFIRKAKKNAYLIDLI 312
               P N   ++   Y     + +  C  + P  RP+      F  I        L  ++
Sbjct: 259 RLEKPLNCDDEV---Y-----DLMRQCWREKPYERPS------FAQILV-----SLNRML 299

Query: 313 DRYKKWKN-SRNEESETESETSDNEDS 338
           +  K + N +  E+          E++
Sbjct: 300 EERKTYVNTTLYEKFTYAGIDCSAEEA 326

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  111 bits (280), Expect = 3e-27
 Identities = 65/287 (22%), Positives = 115/287 (40%), Gaps = 68/287 (23%)

Query: 63  ERIGKGSFGEVFKGI-----DNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCD---- 113
           + +G+G+FG+V +          T + VA+K++       E   +  E+ +L        
Sbjct: 33  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 92

Query: 114 --------SPYGTKLWIIMEYLGGGSALDLMKAGNFEEMHIAVIL--------------- 150
                   +  G  L +I+E+   G+    +++   E +   V                 
Sbjct: 93  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 152

Query: 151 --REVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNT---TSKRNTFV 205
              +V KG+++L S + +HRD+ A N+LLSE   VK+ DFG+A  +        K +  +
Sbjct: 153 YSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL 212

Query: 206 GTPF-WMAPEVIKQSAYDSKADIWSLGITAIELA-------KGEPPNSELHPMRVLFLI- 256
             P  WMAPE I    Y  ++D+WS G+   E+         G   + E         + 
Sbjct: 213 --PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE-----FCRRLK 265

Query: 257 -------PKNNPPQLTGNYTKQFKEFVEACLNKDPENRPTAKELLKF 296
                  P    P++   Y     + +  C + +P  RPT  EL++ 
Sbjct: 266 EGTRMRAPDYTTPEM---Y-----QTMLDCWHGEPSQRPTFSELVEH 304

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score =  111 bits (279), Expect = 6e-27
 Identities = 68/324 (20%), Positives = 110/324 (33%), Gaps = 94/324 (29%)

Query: 63  ERIGKGSFGEVFKGIDN-RTQQVVAIKIID-----LEEAEDEIEDIQQEIMVLSQCDSPY 116
             +G+G+FG+V + +D+ R +  VA+KII       E A  EI  +++    + + D   
Sbjct: 25  GNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKK----IKEKD-KE 79

Query: 117 GTK--------------LWIIMEYLGGGSALDLMKAGNFEEM---HIAVILREVLKGLDY 159
                            + I  E LG  +  + +K  NF+     H+  +  ++   L +
Sbjct: 80  NKFLCVLMSDWFNFHGHMCIAFELLGK-NTFEFLKENNFQPYPLPHVRHMAYQLCHALRF 138

Query: 160 LHSERKLHRDIKAANVLLSEMG-------------------DVKLADFGVAGTLTNTTSK 200
           LH  +  H D+K  N+L                         +++ADFG A       + 
Sbjct: 139 LHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEHHT- 197

Query: 201 RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEP--PNSE----LHPM-RVL 253
             T V T  +  PEVI +  +    D+WS+G    E  +G       E    L  M ++L
Sbjct: 198 --TIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKIL 255

Query: 254 FLIP--------------KNNPPQLTGNYTK----------------------QFKEFVE 277
             IP              K        +                         Q  + + 
Sbjct: 256 GPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMR 315

Query: 278 ACLNKDPENRPTAKELLKFPFIRK 301
             L  DP  R T  E L  PF   
Sbjct: 316 RMLEFDPAQRITLAEALLHPFFAG 339

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  110 bits (278), Expect = 7e-27
 Identities = 65/282 (23%), Positives = 121/282 (42%), Gaps = 58/282 (20%)

Query: 63  ERIGKGSFGEVFKGI-------DNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDS- 114
           + +G+G+FG+V             +    VA+K++  +  E ++ D+  E+ ++      
Sbjct: 41  KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100

Query: 115 P-----YG--TK---LWIIMEYLGGGSALDLMKA-----------------GNFEEMHIA 147
                  G  T+   L++I+EY   G+  + ++A                        + 
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160

Query: 148 VILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNT---TSKRNTF 204
               ++ +G++YL S++ +HRD+ A NVL++E   +K+ADFG+A  + N        N  
Sbjct: 161 SCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGR 220

Query: 205 VGTPF-WMAPEVIKQSAYDSKADIWSLGITAIELA-KGEPPNSELHPMRVLFLI------ 256
           +  P  WMAPE +    Y  ++D+WS G+   E+   G  P   +    +  L+      
Sbjct: 221 L--PVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRM 278

Query: 257 --PKNNPPQLTGNYTKQFKEFVEACLNKDPENRPTAKELLKF 296
             P N   +L   Y       +  C +  P  RPT K+L++ 
Sbjct: 279 DKPANCTNEL---Y-----MMMRDCWHAVPSQRPTFKQLVED 312

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  111 bits (279), Expect = 8e-27
 Identities = 72/334 (21%), Positives = 131/334 (39%), Gaps = 77/334 (23%)

Query: 30  SNSGSSISNQCGSTTASRRNSLKVDPELIFTKQ-------------------ERIGKGSF 70
            +S S  SN       +R +S    P L    +                   + +G+G F
Sbjct: 35  ESSSSMNSNTPLVRITTRLSSTADTPMLAGVSEYELPEDPKWEFPRDKLTLGKPLGEGCF 94

Query: 71  GEVFKGI-------DNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDS-P-----YG 117
           G+V             +    VA+K++  +  E ++ D+  E+ ++             G
Sbjct: 95  GQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLG 154

Query: 118 --TK---LWIIMEYLGGGS-----------------ALDLMKAGNFEEMHIAVILREVLK 155
             T+   L++I+EY   G+                  ++ +         +     ++ +
Sbjct: 155 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLAR 214

Query: 156 GLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNT---TSKRNTFVGTPF-WM 211
           G++YL S++ +HRD+ A NVL++E   +K+ADFG+A  + N        N  +  P  WM
Sbjct: 215 GMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRL--PVKWM 272

Query: 212 APEVIKQSAYDSKADIWSLGITAIELA-KGEPPNSELHPMRVLFLI--------PKNNPP 262
           APE +    Y  ++D+WS G+   E+   G  P   +    +  L+        P N   
Sbjct: 273 APEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKPANCTN 332

Query: 263 QLTGNYTKQFKEFVEACLNKDPENRPTAKELLKF 296
           +L   Y       +  C +  P  RPT K+L++ 
Sbjct: 333 EL---Y-----MMMRDCWHAVPSQRPTFKQLVED 358

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score =  110 bits (277), Expect = 9e-27
 Identities = 75/329 (22%), Positives = 120/329 (36%), Gaps = 94/329 (28%)

Query: 62  QERIGKGSFGEVFKGIDNRTQ-QVVAIKIID-----LEEAEDEIEDIQQEIMVLSQCDSP 115
            + +G+G+FG+V + ID++   + VA+KI+       E A  EI+ ++     L+  D P
Sbjct: 19  VDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEH----LNTTD-P 73

Query: 116 YGTK--------------LWIIMEYLGGGSALDLMKAGNFEEMHIAVI---LREVLKGLD 158
             T               + I+ E LG  S  D +K   F    +  I     ++ K ++
Sbjct: 74  NSTFRCVQMLEWFEHHGHICIVFELLGL-STYDFIKENGFLPFRLDHIRKMAYQICKSVN 132

Query: 159 YLHSERKLHRDIKAANVLLSEMG-------------------DVKLADFGVAGTLTNTTS 199
           +LHS +  H D+K  N+L  +                     D+K+ DFG A   T    
Sbjct: 133 FLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSA---TYDDE 189

Query: 200 KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEP--PN-SELHP----MRV 252
             +T V T  + APEVI    +    D+WS+G   IE   G    P            R+
Sbjct: 190 HHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERI 249

Query: 253 LFLIP--------------KNNPPQLTGNYTK----------------------QFKEFV 276
           L  +P               +       +                         +  + +
Sbjct: 250 LGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLI 309

Query: 277 EACLNKDPENRPTAKELLKFPFIRKAKKN 305
           +  L  DP  R T +E LK PF    KK+
Sbjct: 310 QKMLEYDPAKRITLREALKHPFFDLLKKS 338

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score =  110 bits (278), Expect = 9e-27
 Identities = 64/287 (22%), Positives = 116/287 (40%), Gaps = 63/287 (21%)

Query: 63  ERIGKGSFGEVFKGI-----DNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSP-- 115
             IG+G+FG VF+             +VA+K++  E + D   D Q+E  ++++ D+P  
Sbjct: 53  RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNI 112

Query: 116 ---YG--TK---LWIIMEYLGGGS-------------------------ALDLMKAGNFE 142
               G       + ++ EY+  G                           +         
Sbjct: 113 VKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLS 172

Query: 143 EMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNT---TS 199
                 I R+V  G+ YL   + +HRD+   N L+ E   VK+ADFG++  + +     +
Sbjct: 173 CAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKA 232

Query: 200 KRNTFVGTPF-WMAPEVIKQSAYDSKADIWSLGITAIELA-KGEPPNSELHPMRVLFLI- 256
             N  +  P  WM PE I  + Y +++D+W+ G+   E+   G  P   +    V++ + 
Sbjct: 233 DGNDAI--PIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVR 290

Query: 257 -------PKNNPPQLTGNYTKQFKEFVEACLNKDPENRPTAKELLKF 296
                  P+N P +L   Y       +  C +K P +RP+   + + 
Sbjct: 291 DGNILACPENCPLEL---Y-----NLMRLCWSKLPADRPSFCSIHRI 329

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score =  111 bits (279), Expect = 1e-26
 Identities = 61/306 (19%), Positives = 115/306 (37%), Gaps = 75/306 (24%)

Query: 59  FTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQ---EIMVLSQCD-- 113
           +   + IG G+ G V    D   ++ VAIK +            ++   E++++   +  
Sbjct: 27  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKL--SRPFQNQTHAKRAYRELVLMKCVNHK 84

Query: 114 ---------SPYGTK-----LWIIMEYLGGGSALDL---MKAGNFEEMHIAVILREVLKG 156
                    +P  +      ++I+ME +      +L   ++    +   ++ +L ++L G
Sbjct: 85  NIIGLLNVFTPQKSLEEFQDVYIVMELMDA----NLCQVIQM-ELDHERMSYLLYQMLCG 139

Query: 157 LDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVI 216
           + +LHS   +HRD+K +N+++     +K+ DFG+A T   +      +V T ++ APEVI
Sbjct: 140 IKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTP-YVVTRYYRAPEVI 198

Query: 217 KQSAYDSKADIWSLGITAIELAKGEP---------------------------------- 242
               Y    DIWS+G    E+ KG                                    
Sbjct: 199 LGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVR 258

Query: 243 ------PNSELHPMRVLFLIPKNNPPQLTGNYTKQFKE---FVEACLNKDPENRPTAKEL 293
                 P    +    LF  P    P  + +   +  +    +   L  D   R +  E 
Sbjct: 259 TYVENRPKYAGYSFEKLF--PDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEA 316

Query: 294 LKFPFI 299
           L+ P+I
Sbjct: 317 LQHPYI 322

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  110 bits (276), Expect = 1e-26
 Identities = 77/303 (25%), Positives = 127/303 (41%), Gaps = 77/303 (25%)

Query: 48  RNSLKVDPELIFTKQERIGKGSFGEVFKG-----IDNRTQQVVAIKIIDLEEAEDEIEDI 102
           RN L           + +G G+FG+V +      I +     VA+K++       E E +
Sbjct: 22  RNRLSFG--------KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREAL 73

Query: 103 QQEIMVLSQCDS-P-----YG--TK---LWIIMEYLGGGSALDLMKA------------G 139
             E+ VLS   +        G  T      +I EY   G  L+ ++              
Sbjct: 74  MSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPA 133

Query: 140 NFEEMHIAVILREVL-------KGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAG 192
             E+  +A+ L ++L       KG+ +L S+  +HRD+ A N+LL+     K+ DFG+A 
Sbjct: 134 IMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLAR 193

Query: 193 TLTNT---TSKRNTFVGTPF-WMAPEVIKQSAYDSKADIWSLGITAIELA-------KGE 241
            + N      K N  +  P  WMAPE I    Y  ++D+WS GI   EL         G 
Sbjct: 194 DIKNDSNYVVKGNARL--PVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGM 251

Query: 242 PPNSELHPMRVLFLI--------PKNNPPQLTGNYTKQFKEFVEACLNKDPENRPTAKEL 293
           P +S+        +I        P++ P ++   Y     + ++ C + DP  RPT K++
Sbjct: 252 PVDSK-----FYKMIKEGFRMLSPEHAPAEM---Y-----DIMKTCWDADPLKRPTFKQI 298

Query: 294 LKF 296
           ++ 
Sbjct: 299 VQL 301

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score =  110 bits (278), Expect = 1e-26
 Identities = 68/329 (20%), Positives = 113/329 (34%), Gaps = 100/329 (30%)

Query: 62  QERIGKGSFGEVFKGIDNRTQQVVAIKIID-----LEEAEDEIEDIQQEIMVLSQCDSPY 116
             ++G G+FG V        ++  A+K++         A+ E + +++    +   D   
Sbjct: 40  IRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKK----IQNDD-IN 94

Query: 117 GTK-------------LWIIMEYLGGGSALDLMKAGNFEEM---HIAVILREVLKGLDYL 160
                           + +I E LG  S  +++   N+       I +   E+LK L+YL
Sbjct: 95  NNNIVKYHGKFMYYDHMCLIFEPLGP-SLYEIITRNNYNGFHIEDIKLYCIEILKALNYL 153

Query: 161 HSERKLHRDIKAANVLLSEMG-------------------------DVKLADFGVAGTLT 195
                 H D+K  N+LL +                            +KL DFG A   T
Sbjct: 154 RKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCA---T 210

Query: 196 NTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGE---PPNSELHP--- 249
             +    + + T  + APEVI    +D  +D+WS G    EL  G      +  +     
Sbjct: 211 FKSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTHEHMEHLAM 270

Query: 250 -MRVLFLIPK----------------NNPPQLT-------GNYTK--------------- 270
              ++  IPK                 +  +L         N  K               
Sbjct: 271 MESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHE 330

Query: 271 QFKEFVEACLNKDPENRPTAKELLKFPFI 299
            F +F+ + L  DP  RP+  ELLK  F+
Sbjct: 331 LFCDFLYSILQIDPTLRPSPAELLKHKFL 359

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score =  109 bits (275), Expect = 1e-26
 Identities = 65/286 (22%), Positives = 116/286 (40%), Gaps = 63/286 (22%)

Query: 63  ERIGKGSFGEVFKGI-----DNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSP-- 115
           + +G+G FG+V K              VA+K++    +  E+ D+  E  VL Q + P  
Sbjct: 29  KTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHV 88

Query: 116 ---YG--TK---LWIIMEYLGGGSALD------------LMKAGNFEEMHIAVILREVL- 154
              YG  ++   L +I+EY   GS               L   G+     +       L 
Sbjct: 89  IKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALT 148

Query: 155 ------------KGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNT---TS 199
                       +G+ YL   + +HRD+ A N+L++E   +K++DFG++  +        
Sbjct: 149 MGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVK 208

Query: 200 KRNTFVGTPF-WMAPEVIKQSAYDSKADIWSLGITAIELA-KGEPPNSELHPMRVLFLI- 256
           +    +  P  WMA E +    Y +++D+WS G+   E+   G  P   + P R+  L+ 
Sbjct: 209 RSQGRI--PVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERLFNLLK 266

Query: 257 -------PKNNPPQLTGNYTKQFKEFVEACLNKDPENRPTAKELLK 295
                  P N   ++   Y       +  C  ++P+ RP   ++ K
Sbjct: 267 TGHRMERPDNCSEEM---Y-----RLMLQCWKQEPDKRPVFADISK 304

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score =  110 bits (278), Expect = 1e-26
 Identities = 68/296 (22%), Positives = 116/296 (39%), Gaps = 62/296 (20%)

Query: 59  FTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQ---EIMVLSQCDSP 115
           +T    IG+G++G V    DN  +  VAIK I      +     Q+   EI +L +    
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKIS---PFEHQTYCQRTLREIKILLRFRHE 85

Query: 116 YGTKL---------------WIIMEYLGGGSALDL---MKAGNFEEMHIAVILREVLKGL 157
               +               +I+ + +      DL   +K  +    HI   L ++L+GL
Sbjct: 86  NIIGINDIIRAPTIEQMKDVYIVQDLME----TDLYKLLKTQHLSNDHICYFLYQILRGL 141

Query: 158 DYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNT---FVGTPFWMAPE 214
            Y+HS   LHRD+K +N+LL+   D+K+ DFG+A               +V T ++ APE
Sbjct: 142 KYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 201

Query: 215 VI-KQSAYDSKADIWSLGITAIELAKGEP--P-NSELHPMRVLFLI---P---------- 257
           ++     Y    DIWS+G    E+    P  P    L  +  +  I   P          
Sbjct: 202 IMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN 261

Query: 258 -------KNNPPQLTGNYTKQFK-------EFVEACLNKDPENRPTAKELLKFPFI 299
                   + P +    + + F        + ++  L  +P  R   ++ L  P++
Sbjct: 262 LKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 317

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  110 bits (276), Expect = 1e-26
 Identities = 75/302 (24%), Positives = 119/302 (39%), Gaps = 79/302 (26%)

Query: 48  RNSLKVDPELIFTKQERIGKGSFGEVFKGI-----DNRTQQVVAIKIIDLEEAEDEIEDI 102
           RN+L+    L        G G+FG+V +              VA+K++      DE E +
Sbjct: 45  RNNLQFGKTL--------GAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEAL 96

Query: 103 QQEIMVLSQCDS-P-----YG--TK---LWIIMEYLGGGSALD-LMKAGNFEE------- 143
             E+ ++S            G  T    + +I EY   G  L+ L +     E       
Sbjct: 97  MSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAI 156

Query: 144 ----------MHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGT 193
                     +H +    +V +G+ +L S+  +HRD+ A NVLL+     K+ DFG+A  
Sbjct: 157 ANSTASTRDLLHFSS---QVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARD 213

Query: 194 LTNT---TSKRNTFVGTPF-WMAPEVIKQSAYDSKADIWSLGITAIELA-------KGEP 242
           + N      K N  +  P  WMAPE I    Y  ++D+WS GI   E+         G  
Sbjct: 214 IMNDSNYIVKGNARL--PVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGIL 271

Query: 243 PNSELHPMRVLFLI--------PKNNPPQLTGNYTKQFKEFVEACLNKDPENRPTAKELL 294
            NS+        L+        P   P  +   Y       ++AC   +P +RPT +++ 
Sbjct: 272 VNSK-----FYKLVKDGYQMAQPAFAPKNI---Y-----SIMQACWALEPTHRPTFQQIC 318

Query: 295 KF 296
            F
Sbjct: 319 SF 320

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score =  110 bits (277), Expect = 2e-26
 Identities = 64/333 (19%), Positives = 115/333 (34%), Gaps = 110/333 (33%)

Query: 59  FTKQERIGKGSFGEVFKGIDNRTQQVVAIK-----------------------IIDLEEA 95
           ++  + +G GSFG V +  D  + +  A+K                       II L + 
Sbjct: 9   YSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRELDIMKVLDHVNIIKLVDY 68

Query: 96  EDEIEDIQQEIMVLSQCDSPYGTK--------------------LWIIMEYLGGGSALDL 135
                D + +        +  G K                    L +IMEY+       L
Sbjct: 69  FYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP----DTL 124

Query: 136 -------MKAGN-FEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLL-SEMGDVKLA 186
                  +++G       I++ + ++ + + ++HS    HRDIK  N+L+ S+   +KL 
Sbjct: 125 HKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNTLKLC 184

Query: 187 DFGVAGTLTNTTSKRNT-FVGTPFWMAPEVI-KQSAYDSKADIWSLG-ITAIELAKGEP- 242
           DFG A  L  +    +  ++ + F+ APE++   + Y    D+WS+G +   EL  G+P 
Sbjct: 185 DFGSAKKLIPSEP--SVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFG-ELILGKPL 241

Query: 243 -------------------------------------PNSELHPMRVLFLIPKNNPPQLT 265
                                                P  +    R +   P+  P    
Sbjct: 242 FSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKIL--PEGTPSLAI 299

Query: 266 GNYTKQFKEFVEACLNKDPENRPTAKELLKFPF 298
                   + +E  L  +P+ R    E +  PF
Sbjct: 300 --------DLLEQILRYEPDLRINPYEAMAHPF 324

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score =  111 bits (279), Expect = 3e-26
 Identities = 63/247 (25%), Positives = 103/247 (41%), Gaps = 57/247 (23%)

Query: 59  FTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQ---EIMVLSQCDSP 115
           +  +  IG GS+G V +  D   ++VVAIK I     ED I D ++   EI +L++ +  
Sbjct: 55  YEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRV-FEDLI-DCKRILREIAILNRLNHD 112

Query: 116 YGTKL---------------WIIMEYLGGGSALDL---MKAGNF-EEMHIAVILREVLKG 156
           +  K+               ++++E        D     +   +  E+HI  +L  +L G
Sbjct: 113 HVVKVLDIVIPKDVEKFDELYVVLEIAD----SDFKKLFRTPVYLTELHIKTLLYNLLVG 168

Query: 157 LDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWM----- 211
           + Y+HS   LHRD+K AN L+++   VK+ DFG+A T+    +  +    +P        
Sbjct: 169 VKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLV 228

Query: 212 ----------------------APEVI-KQSAYDSKADIWSLG-ITAIELAKGEPPNSEL 247
                                 APE+I  Q  Y    D+WS+G I A  L   +   +  
Sbjct: 229 TFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYH 288

Query: 248 HPMRVLF 254
                LF
Sbjct: 289 ADRGPLF 295

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score =  109 bits (274), Expect = 3e-26
 Identities = 67/294 (22%), Positives = 116/294 (39%), Gaps = 63/294 (21%)

Query: 59  FTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQ---EIMVLSQCD-- 113
           +     +G G++G V   ID R+ + VAIK +            ++   E+++L      
Sbjct: 26  YVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKL--SRPFQSEIFAKRAYRELLLLKHMQHE 83

Query: 114 ----------SPYGTK----LWIIMEYLGGGSALDL---MKAGNFEEMHIAVILREVLKG 156
                          +     +++M ++      DL   M    F E  I  ++ ++LKG
Sbjct: 84  NVIGLLDVFTPASSLRNFYDFYLVMPFMQT----DLQKIMGL-KFSEEKIQYLVYQMLKG 138

Query: 157 LDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVI 216
           L Y+HS   +HRD+K  N+ ++E  ++K+ DFG+A       +    +V T ++ APEVI
Sbjct: 139 LKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTG---YVVTRWYRAPEVI 195

Query: 217 -KQSAYDSKADIWSLGITAIELAKGEP--------------------PNSEL-------H 248
                Y+   DIWS+G    E+  G+                     P +E         
Sbjct: 196 LSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKA 255

Query: 249 PMRVLFLIPKNNPPQLTG---NYTKQFKEFVEACLNKDPENRPTAKELLKFPFI 299
               +  +P+      T      + Q  + +E  L  D + R TA + L  PF 
Sbjct: 256 AKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFF 309

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score =  109 bits (275), Expect = 3e-26
 Identities = 70/343 (20%), Positives = 128/343 (37%), Gaps = 66/343 (19%)

Query: 10  FAVSRKCDFLTLN-PTQFLKFSNSG--SSISNQCGSTTASRRNSLKVDPELIF-----TK 61
              +    F  +               +      G         L  DP           
Sbjct: 14  IPTTENLYFNGMGYYHHHHHHDYDIPTTENLYFQGMLAGVSEYELPEDPRWELPRDRLVL 73

Query: 62  QERIGKGSFGEVFKGI-------DNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDS 114
            + +G+G+FG+V                  VA+K++  +  E ++ D+  E+ ++     
Sbjct: 74  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 133

Query: 115 -P-----YG--TK---LWIIMEYLGGGSALDLMKA-----------------GNFEEMHI 146
                   G  T+   L++I+EY   G+  + ++A                        +
Sbjct: 134 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 193

Query: 147 AVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNT---TSKRNT 203
                +V +G++YL S++ +HRD+ A NVL++E   +K+ADFG+A  + +        N 
Sbjct: 194 VSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 253

Query: 204 FVGTPF-WMAPEVIKQSAYDSKADIWSLGITAIELA-KGEPPNSELHPMRVLFLI----- 256
            +  P  WMAPE +    Y  ++D+WS G+   E+   G  P   +    +  L+     
Sbjct: 254 RL--PVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHR 311

Query: 257 ---PKNNPPQLTGNYTKQFKEFVEACLNKDPENRPTAKELLKF 296
              P N   +L   Y       +  C +  P  RPT K+L++ 
Sbjct: 312 MDKPSNCTNEL---Y-----MMMRDCWHAVPSQRPTFKQLVED 346

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score =  108 bits (273), Expect = 5e-26
 Identities = 70/295 (23%), Positives = 116/295 (39%), Gaps = 64/295 (21%)

Query: 59  FTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQ---EIMVLSQCD-- 113
           +   + +G G++G V   +D RT   VAIK +            ++   E+ +L      
Sbjct: 27  YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKL--YRPFQSELFAKRAYRELRLLKHMRHE 84

Query: 114 ---------SPYGTK-----LWIIMEYLGGGSALDL---MKAGNFEEMHIAVILREVLKG 156
                    +P  T       +++M ++G     DL   MK     E  I  ++ ++LKG
Sbjct: 85  NVIGLLDVFTPDETLDDFTDFYLVMPFMGT----DLGKLMKHEKLGEDRIQFLVYQMLKG 140

Query: 157 LDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVA-GTLTNTTSKRNTFVGTPFWMAPEV 215
           L Y+H+   +HRD+K  N+ ++E  ++K+ DFG+A    +  T     +V T ++ APEV
Sbjct: 141 LRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTG----YVVTRWYRAPEV 196

Query: 216 I-KQSAYDSKADIWSLGITAIELAKGEP--------------------PNSEL------- 247
           I     Y    DIWS+G    E+  G+                     P +E        
Sbjct: 197 ILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSD 256

Query: 248 HPMRVLFLIPKNNPPQLTG---NYTKQFKEFVEACLNKDPENRPTAKELLKFPFI 299
                +  +P+           N +      +E  L  D E R TA E L  P+ 
Sbjct: 257 EAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYF 311

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score =  108 bits (271), Expect = 8e-26
 Identities = 61/297 (20%), Positives = 115/297 (38%), Gaps = 64/297 (21%)

Query: 59  FTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQ---EIMVLSQCD-- 113
           +     +G G++G V    D +T   VA+K +        I   ++   E+ +L      
Sbjct: 31  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL--SRPFQSIIHAKRTYRELRLLKHMKHE 88

Query: 114 ---------SPYGTK-----LWIIMEYLGGGSALDL---MKAGNFEEMHIAVILREVLKG 156
                    +P  +      ++++   +G     DL   +K     + H+  ++ ++L+G
Sbjct: 89  NVIGLLDVFTPARSLEEFNDVYLVTHLMGA----DLNNIVKCQKLTDDHVQFLIYQILRG 144

Query: 157 LDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNT-FVGTPFWMAPEV 215
           L Y+HS   +HRD+K +N+ ++E  ++K+ DFG    L   T+   T +V T ++ APE+
Sbjct: 145 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFG----LARHTADEMTGYVATRWYRAPEI 200

Query: 216 I-KQSAYDSKADIWSLGITAIELAKGEP--------------------PNSEL------- 247
           +     Y+   DIWS+G    EL  G                      P +EL       
Sbjct: 201 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 260

Query: 248 HPMRVLFLIPKNNPPQLTG---NYTKQFKEFVEACLNKDPENRPTAKELLKFPFIRK 301
                +  + +                  + +E  L  D + R TA + L   +  +
Sbjct: 261 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 317

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score =  107 bits (270), Expect = 1e-25
 Identities = 54/305 (17%), Positives = 112/305 (36%), Gaps = 68/305 (22%)

Query: 59  FTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQ----------EIMV 108
           +T Q  I  GS+G V  G+D      VAIK +    ++    +I            EI +
Sbjct: 24  YTVQRFISSGSYGAVCAGVD-SEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRL 82

Query: 109 LSQCD-----------SPYGTK----LWIIMEYLGGGSALDL---MKAGN--FEEMHIAV 148
           L+                +       L+++ E +      DL   +          HI  
Sbjct: 83  LNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMR----TDLAQVIHDQRIVISPQHIQY 138

Query: 149 ILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTP 208
            +  +L GL  LH    +HRD+   N+LL++  D+ + DF +A   T   +K + +V   
Sbjct: 139 FMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTH-YVTHR 197

Query: 209 FWMAPEVI-KQSAYDSKADIWSLGITAIELAKGEP--P-NSELHPMRVLF-LIPKNNPPQ 263
           ++ APE++ +   +    D+WS G    E+   +     ++  + +  +  ++       
Sbjct: 198 WYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIED 257

Query: 264 LTGNYTKQFKEFVEACLNK---------------------------DPENRPTAKELLKF 296
           +    +   ++++   L+                            +P+ R + ++ L+ 
Sbjct: 258 VVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH 317

Query: 297 PFIRK 301
           P+   
Sbjct: 318 PYFES 322

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score =  107 bits (270), Expect = 2e-25
 Identities = 74/331 (22%), Positives = 135/331 (40%), Gaps = 95/331 (28%)

Query: 59  FTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQ---EIMVLSQ---- 111
           +   +++GKG++G V+K ID RT +VVA+K I   +A     D Q+   EIM+L++    
Sbjct: 11  YELVKKLGKGAYGIVWKSIDRRTGEVVAVKKI--FDAFQNSTDAQRTFREIMILTELSGH 68

Query: 112 ---------CDSPYGTKLWIIMEYLGGGSALDL---MKAGNFEEMHIAVILREVLKGLDY 159
                      +     ++++ +Y+      DL   ++A   E +H   ++ +++K + Y
Sbjct: 69  ENIVNLLNVLRADNDRDVYLVFDYME----TDLHAVIRANILEPVHKQYVVYQLIKVIKY 124

Query: 160 LHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWM-------- 211
           LHS   LHRD+K +N+LL+    VK+ADFG++ +  N     N    +            
Sbjct: 125 LHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQ 184

Query: 212 -------------APEVI-KQSAYDSKADIWSLG-ITAIELAKGEP-------------- 242
                        APE++   + Y    D+WSLG I   E+  G+P              
Sbjct: 185 PILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILG-EILCGKPIFPGSSTMNQLERI 243

Query: 243 ------PNSE-------------LHPMRVLFLIPKNNPPQLTGNYTKQFKE--------- 274
                 P++E             +  ++    I ++N   +   +     +         
Sbjct: 244 IGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNE 303

Query: 275 ----FVEACLNKDPENRPTAKELLKFPFIRK 301
                ++  L  +P  R +A + LK PF+  
Sbjct: 304 EALDLLDKLLQFNPNKRISANDALKHPFVSI 334

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score =  107 bits (268), Expect = 4e-25
 Identities = 68/315 (21%), Positives = 114/315 (36%), Gaps = 84/315 (26%)

Query: 63  ERIGKGSFGEVFKGI--DNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCD------- 113
            ++G+G++G V+K    D +  +  A+K I   E         +EI +L +         
Sbjct: 27  CKVGRGTYGHVYKAKRKDGKDDKDYALKQI---EGTGISMSACREIALLRELKHPNVISL 83

Query: 114 -----SPYGTKLWIIMEYL---------GGGSALDLMKAGNFEEMHIAVILREVLKGLDY 159
                S    K+W++ +Y             ++    K        +  +L ++L G+ Y
Sbjct: 84  QKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHY 143

Query: 160 LHSERKLHRDIKAANVLLS----EMGDVKLADFGVA---GTLTNTTSKRNTFVGTPFWM- 211
           LH+   LHRD+K AN+L+     E G VK+AD G A    +     +  +  V T FW  
Sbjct: 144 LHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVT-FWYR 202

Query: 212 APEVIKQSA-YDSKADIWSLG-ITAIELAKGEP--------------------------- 242
           APE++  +  Y    DIW++G I A EL   EP                           
Sbjct: 203 APELLLGARHYTKAIDIWAIGCIFA-ELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVM 261

Query: 243 --PNSEL----------HPMRVLFLIPKNNPPQLTGNYTKQFK-------EFVEACLNKD 283
             P  +             +   F         L     K            ++  L  D
Sbjct: 262 GFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMD 321

Query: 284 PENRPTAKELLKFPF 298
           P  R T+++ ++ P+
Sbjct: 322 PIKRITSEQAMQDPY 336

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score =  106 bits (266), Expect = 8e-25
 Identities = 65/243 (26%), Positives = 99/243 (40%), Gaps = 54/243 (22%)

Query: 59  FTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQ---EIMVLSQCDSP 115
           +  +  IG+GS+G V+   D  T++ VAIK +      +++ D ++   EI +L++  S 
Sbjct: 28  YIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKV--NRMFEDLIDCKRILREITILNRLKSD 85

Query: 116 YGTKL---------------WIIMEYLGGGSALDL---MKAGN-FEEMHIAVILREVLKG 156
           Y  +L               +I++E        DL    K      E HI  IL  +L G
Sbjct: 86  YIIRLYDLIIPDDLLKFDELYIVLEIAD----SDLKKLFKTPIFLTEEHIKTILYNLLLG 141

Query: 157 LDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWM----- 211
            +++H    +HRD+K AN LL++   VK+ DFG+A T+ +                    
Sbjct: 142 ENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHN 201

Query: 212 -----------------APEVI-KQSAYDSKADIWSLG-ITAIELAKGEPPNSELHPMRV 252
                            APE+I  Q  Y    DIWS G I A EL      +      R 
Sbjct: 202 KNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFA-ELLNMLQSHINDPTNRF 260

Query: 253 -LF 254
            LF
Sbjct: 261 PLF 263

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score =  105 bits (263), Expect = 1e-24
 Identities = 76/357 (21%), Positives = 121/357 (33%), Gaps = 126/357 (35%)

Query: 65  IGKGSFGEVFKGIDNRTQQVVAIKII-----DLEEAEDEIEDIQQEI-----------MV 108
           +G G F  V+   D + ++ VA+K++       E A DEI  + + +           MV
Sbjct: 45  LGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIR-LLKSVRNSDPNDPNREMV 103

Query: 109 LSQCDS-----PYGTKLWIIMEYLGGGSALDLMKAGNFEEMHIAV---ILREVLKGLDYL 160
           +   D        GT + ++ E LG    L  +   N++ + +     I+++VL+GLDYL
Sbjct: 104 VQLLDDFKISGVNGTHICMVFEVLGH-HLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYL 162

Query: 161 HSERKL-HRDIKAANVLL------------------------------------------ 177
           H++ ++ H DIK  N+LL                                          
Sbjct: 163 HTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLV 222

Query: 178 -------SEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSL 230
                  +E   VK+AD G A             + T  + + EV+  S Y++ ADIWS 
Sbjct: 223 NPLEPKNAEKLKVKIADLGNA---CWVHKHFTEDIQTRQYRSLEVLIGSGYNTPADIWST 279

Query: 231 GITAIELAKGEPP-----------------------------------------NSELHP 249
              A ELA G+                                             +   
Sbjct: 280 ACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDL 339

Query: 250 MRVLFLIPKNNPPQLTGNY------TKQFKEFVEACLNKDPENRPTAKELLKFPFIR 300
             +  L P      L   Y         F +F+   L   PE R TA E L+ P++ 
Sbjct: 340 KHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLN 396

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score =  106 bits (265), Expect = 1e-24
 Identities = 63/304 (20%), Positives = 116/304 (38%), Gaps = 71/304 (23%)

Query: 59  FTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQ---EIMVLSQCD-- 113
           +   + IG G+ G V    D    + VAIK +            ++   E++++   +  
Sbjct: 64  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKL--SRPFQNQTHAKRAYRELVLMKCVNHK 121

Query: 114 ---------SPYGTK-----LWIIMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDY 159
                    +P  T      ++++ME +   + L  +     +   ++ +L ++L G+ +
Sbjct: 122 NIISLLNVFTPQKTLEEFQDVYLVMELMD--ANLCQVIQMELDHERMSYLLYQMLCGIKH 179

Query: 160 LHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNT-FVGTPFWMAPEVIKQ 218
           LHS   +HRD+K +N+++     +K+ DFG+A T    TS   T +V T ++ APEVI  
Sbjct: 180 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRYYRAPEVILG 237

Query: 219 SAYDSKADIWSLGITAIELAKGEP------------------------------------ 242
             Y    DIWS+G    E+ + +                                     
Sbjct: 238 MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNY 297

Query: 243 ----PNSELHPMRVLFLIPKNNPP---QLTGNYTKQFKEFVEACLNKDPENRPTAKELLK 295
               P         LF  P +  P   +       Q ++ +   L  DP  R +  + L+
Sbjct: 298 VENRPKYAGLTFPKLF--PDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 355

Query: 296 FPFI 299
            P+I
Sbjct: 356 HPYI 359

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score =  104 bits (261), Expect = 2e-24
 Identities = 71/322 (22%), Positives = 122/322 (37%), Gaps = 84/322 (26%)

Query: 48  RNSLKVDPELIFTKQERIGKGSFGEVFKGI-----DNRTQQVVAIKIIDLEEAEDEIEDI 102
           R +L+          + +G G+FG+V                VA+K++  +    E E +
Sbjct: 44  RENLEFG--------KVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREAL 95

Query: 103 QQEIMVLSQCDS-P-----YG--TK---LWIIMEYLGGGSALD---------------LM 136
             E+ +++Q  S        G  T    +++I EY   G  L+                 
Sbjct: 96  MSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYE 155

Query: 137 KAGNFEEMHIAVIL---------REVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLAD 187
                EE     +L          +V KG+++L  +  +HRD+ A NVL++    VK+ D
Sbjct: 156 NQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICD 215

Query: 188 FGVAGTLTNT---TSKRNTFVGTPF-WMAPEVIKQSAYDSKADIWSLGITAIELA----- 238
           FG+A  + +      + N  +  P  WMAPE + +  Y  K+D+WS GI   E+      
Sbjct: 216 FGLARDIMSDSNYVVRGNARL--PVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVN 273

Query: 239 --KGEPPNSELHPMRVLFLI--------PKNNPPQLTGNYTKQFKEFVEACLNKDPENRP 288
              G P ++         LI        P     ++   Y       +++C   D   RP
Sbjct: 274 PYPGIPVDAN-----FYKLIQNGFKMDQPFYATEEI---Y-----IIMQSCWAFDSRKRP 320

Query: 289 TAKELLKF--PFIRKAKKNAYL 308
           +   L  F    +  A++  Y 
Sbjct: 321 SFPNLTSFLGCQLADAEEAMYQ 342

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  102 bits (256), Expect = 5e-24
 Identities = 74/310 (23%), Positives = 126/310 (40%), Gaps = 59/310 (19%)

Query: 28  KFSNSGSSISNQCGSTTASRRNSLKVD-PELI-----FTKQERIGKGSFGEVFKG-IDNR 80
           K+S + +SI++   S+      S +V   +L      F  +  IG G FG+V+KG + + 
Sbjct: 4   KYSKATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDG 63

Query: 81  TQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQ------------CDSPYGTKLWIIMEYLG 128
            +  VA+K    E ++   E  + EI  LS             CD     ++ +I +Y+ 
Sbjct: 64  AK--VALKRRTPESSQGIEE-FETEIETLSFCRHPHLVSLIGFCDE--RNEMILIYKYME 118

Query: 129 GGSALD-LMKAGNFEE-------MHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEM 180
            G+    L  +            + I +      +GL YLH+   +HRD+K+ N+LL E 
Sbjct: 119 NGNLKRHLYGSDLPTMSMSWEQRLEICI---GAARGLHYLHTRAIIHRDVKSINILLDEN 175

Query: 181 GDVKLADFGVA--GTLTNTT--SKRNTFV-GTPFWMAPEVIKQSAYDSKADIWSLGITAI 235
              K+ DFG++  GT  + T  S   T V GT  ++ PE   +     K+D++S G+   
Sbjct: 176 FVPKITDFGISKKGTELDQTHLS---TVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLF 232

Query: 236 ELAKGEPPNSELHPMR-------VLFLIPKNNP-----PQLTGNYT----KQFKEFVEAC 279
           E+        +  P          +             P L         ++F +    C
Sbjct: 233 EVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKC 292

Query: 280 LNKDPENRPT 289
           L    E+RP+
Sbjct: 293 LALSSEDRPS 302

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score = 97.2 bits (243), Expect = 2e-22
 Identities = 70/284 (24%), Positives = 111/284 (39%), Gaps = 66/284 (23%)

Query: 54  DPELIFTKQERIGKGSFGEVFKG-IDNRTQQVVAIKIIDLEEAEDEIEDIQ------QEI 106
           D   I     ++G+G FG V+KG ++N     VA+K +    A  +I   +      QEI
Sbjct: 28  DERPISVGGNKMGEGGFGVVYKGYVNN---TTVAVKKLA---AMVDITTEELKQQFDQEI 81

Query: 107 MVLSQCDSPY----------GTKLWIIMEYLGGGSALD--LMKAGNFEE------MHIAV 148
            V+++C              G  L ++  Y+  GS L   L                IA 
Sbjct: 82  KVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGS-LLDRLSCLDGTPPLSWHMRCKIAQ 140

Query: 149 ILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVA--GTLTNTT--SKRNTF 204
                  G+++LH    +HRDIK+AN+LL E    K++DFG+A        T  + R   
Sbjct: 141 ---GAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSR--I 195

Query: 205 VGTPFWMAPEVIKQSAYDS-----KADIWSLGITAIELAKGEPPNSELHPMRVL------ 253
           VGT  +MAPE              K+DI+S G+  +E+  G P   E    ++L      
Sbjct: 196 VGTTAYMAPE------ALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEE 249

Query: 254 FLIPKNN-----PPQLTGNYTKQFKEFVE---ACLNKDPENRPT 289
               +         ++    +   +        CL++    RP 
Sbjct: 250 IEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPD 293

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 91.6 bits (227), Expect = 8e-20
 Identities = 84/474 (17%), Positives = 163/474 (34%), Gaps = 66/474 (13%)

Query: 63  ERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGT-KLW 121
            +IG GSFGE++ G + +T + VAIK+   E  + +   +  E  +        G   + 
Sbjct: 13  RKIGSGSFGEIYLGTNIQTNEEVAIKL---ENVKTKHPQLLYESKIYRILQGGTGIPNVR 69

Query: 122 ----------IIMEYLGGGSALDLMKA--GNFEEMHIAVILREVLKGLDYLHSERKLHRD 169
                     ++M+ L G S  DL            + ++  +++  ++++HS+  LHRD
Sbjct: 70  WFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRD 128

Query: 170 IKAANVLLSEMGD---VKLADFGVAGTLTNTTSKR-------NTFVGTPFWM---APEVI 216
           IK  N L+        V + DFG+A    +T++ +           GT  +        I
Sbjct: 129 IKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGI 188

Query: 217 KQSAYDSKADIWSLGITAIELAKGEPP-------NSELHPMRVLFLIPKNNPPQLTGNYT 269
           +QS  D   D+ SLG   +   +G  P         +    ++       +   L   Y 
Sbjct: 189 EQSRRD---DLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIEALCRGYP 245

Query: 270 KQFKEFVEACLNKDPENRPTAKELLKFPFIRKAKKNAYLIDLI-DRYKKWKNSRNEESET 328
            +F  +   C +   +++P    L +  F     +  +  D + D    W   + ++S+ 
Sbjct: 246 TEFASYFHYCRSLRFDDKPDYSYLKRL-FRDLFIREGFQFDYVFD----WTILKYQQSQI 300

Query: 329 ESETSDNEDSIKTDGDLDEPWIMTVKGKMPNEYGSSPNKKSGGMNGADNIVNNNNLNNNN 388
            S              L  P                 +++SG   G  +  ++ +     
Sbjct: 301 ASAPPRAVGHGAGPSGLAPP-------------ALQNDRQSGVDEGRTSGWSSMDRRRAP 347

Query: 389 NHATFISSSEKSHSPAR---PLSIAPGPPSSAQEKRNSMTRSDSGEHKSNPTSPDREKHK 445
                + +  K  +P       S  P   +S    R+S +        S    P      
Sbjct: 348 PPIASVGTLAKQKAPVGNDASFSKEPVISASNFLGRSSGSSRRPAVSSSRDVMPIDT--- 404

Query: 446 IGSPEREKLKIGSPDREKLKSPDREKHKIGSPDREKNKIGSPDKKQQTRGSPVK 499
              P R +    SP   +  S  ++   + S + + +         +   S +K
Sbjct: 405 -SEPSRTRATDASPGAFRRTSGPQKSSPVNSAEPKHSSSARHSSNVKNYESALK 457

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score = 89.2 bits (222), Expect = 1e-19
 Identities = 65/274 (23%), Positives = 111/274 (40%), Gaps = 50/274 (18%)

Query: 59  FTKQERIGKGSFGEVFKGI--DNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPY 116
           F+ +  +G+G FG+V+KG   D     +VA+K +  E  +      Q E+ ++S      
Sbjct: 32  FSNKNILGRGGFGKVYKGRLADGT---LVAVKRLKEERTQGGELQFQTEVEMISMAVHRN 88

Query: 117 ----------GTKLWIIMEYLGGGSALD--LMKAGNFEE-------MHIAVILREVLKGL 157
                      T+  ++  Y+  GS +   L +    +          IA+      +GL
Sbjct: 89  LLRLRGFCMTPTERLLVYPYMANGS-VASCLRERPESQPPLDWPKRQRIAL---GSARGL 144

Query: 158 DYLHSE---RKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFV-GTPFWMAP 213
            YLH     + +HRD+KAAN+LL E  +  + DFG+A  +    +   T V GT   +AP
Sbjct: 145 AYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAP 204

Query: 214 EVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPM---------RVLFLIPKNNP--- 261
           E +       K D++  G+  +EL  G+                   V  L+ +      
Sbjct: 205 EYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEAL 264

Query: 262 --PQLTGNY-TKQFKEFVE---ACLNKDPENRPT 289
               L GNY  ++ ++ ++    C    P  RP 
Sbjct: 265 VDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPK 298

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 86.1 bits (213), Expect = 2e-18
 Identities = 46/162 (28%), Positives = 71/162 (43%), Gaps = 28/162 (17%)

Query: 151 REVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGT-PF 209
            +V KG+++L S + +HRD+ A N+LLSE   VK+ DFG+A  +              P 
Sbjct: 200 FQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPL 259

Query: 210 -WMAPEVIKQSAYDSKADIWSLGITAIELA-------KGEPPNSELHPMRVLFLI----- 256
            WMAPE I    Y  ++D+WS G+   E+         G   + E        L      
Sbjct: 260 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR----LKEGTRM 315

Query: 257 --PKNNPPQLTGNYTKQFKEFVEACLNKDPENRPTAKELLKF 296
             P    P++   Y     + +  C + +P  RPT  EL++ 
Sbjct: 316 RAPDYTTPEM---Y-----QTMLDCWHGEPSQRPTFSELVEH 349

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 43.8 bits (103), Expect = 1e-04
 Identities = 26/150 (17%), Positives = 56/150 (37%), Gaps = 28/150 (18%)

Query: 48  RNSLKVDPELIFTKQERIGKGSFGEVFKG-----IDNRTQQVVAIKIIDLEEAEDEIEDI 102
           R+ LK+         + +G+G+FG+V +          T + VA+K++       E   +
Sbjct: 21  RDRLKLG--------KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRAL 72

Query: 103 QQEIMVLSQ------------CDSPYGTKLWIIMEYLGGGSALDLMKAGNFEEMHIAVIL 150
             E+ +L                +  G  L +I+E+   G+    +++   E +      
Sbjct: 73  MSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKG 132

Query: 151 REVLKGLDYLHSERKLHRDIKAANVLLSEM 180
               +G DY+ +      D+K     ++  
Sbjct: 133 ARFRQGKDYVGAI---PVDLKRRLDSITSS 159

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 84.9 bits (209), Expect = 5e-18
 Identities = 54/250 (21%), Positives = 85/250 (34%), Gaps = 73/250 (29%)

Query: 52  KVDPELIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLE-------EAEDEIEDIQQ 104
              P     + E+IG+G FGEVF+ I + T   VAIKII +E         +   E+I  
Sbjct: 15  HCLPTEKLQRCEKIGEGVFGEVFQTIADHTP--VAIKIIAIEGPDLVNGSHQKTFEEILP 72

Query: 105 EIMVL----------------------------------------------SQCDSPY-- 116
           EI++                                               S  D P   
Sbjct: 73  EIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFF 132

Query: 117 -GTKLWIIMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERKL-HRDIKAAN 174
              +L+I++E+  GG  L+ M+           IL ++   L    +  +  HRD+   N
Sbjct: 133 KDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGN 192

Query: 175 VLLSEMGDVKLAD-----------FGVAGTLTNTTSKRNTFVGTPFWM---APEVIKQSA 220
           VLL +    KL              G+  ++ + T  R    G   +      E +    
Sbjct: 193 VLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIVVFCDVSMDEDLFTGD 252

Query: 221 YDSKADIWSL 230
            D + DI+ L
Sbjct: 253 GDYQFDIYRL 262

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 81.6 bits (202), Expect = 3e-17
 Identities = 55/259 (21%), Positives = 97/259 (37%), Gaps = 40/259 (15%)

Query: 63  ERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYG-TKLW 121
            +IG GSFG+++ G D    + VAIK+   E  + +   +  E  +        G   + 
Sbjct: 15  RKIGSGSFGDIYLGTDIAAGEEVAIKL---ECVKTKHPQLHIESKIYKMMQGGVGIPTIR 71

Query: 122 ----------IIMEYLGGGSALDLMKA--GNFEEMHIAVILREVLKGLDYLHSERKLHRD 169
                     ++ME L G S  DL       F    + ++  +++  ++Y+HS+  +HRD
Sbjct: 72  WCGAEGDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRD 130

Query: 170 IKAANVLLSEMGD---VKLADFGVAGTLTNTTSK-------RNTFVGTPFWM---APEVI 216
           +K  N L+        V + DFG+A    +  +             GT  +        I
Sbjct: 131 VKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGI 190

Query: 217 KQSAYDSKADIWSLGITAIELAKGEPP-------NSELHPMRVLFLIPKNNPPQLTGNYT 269
           +QS  D   D+ SLG   +    G  P              R+           L   Y 
Sbjct: 191 EQSRRD---DLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYP 247

Query: 270 KQFKEFVEACLNKDPENRP 288
            +F  ++  C +   +++P
Sbjct: 248 SEFATYLNFCRSLRFDDKP 266

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 79.3 bits (196), Expect = 2e-16
 Identities = 52/261 (19%), Positives = 100/261 (38%), Gaps = 42/261 (16%)

Query: 63  ERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGT-KLW 121
            RIG+GSFG +F+G +    Q VAIK    E    +   ++ E           G   ++
Sbjct: 16  RRIGEGSFGVIFEGTNLLNNQQVAIKF---EPRRSDAPQLRDEYRTYKLLAGCTGIPNVY 72

Query: 122 ----------IIMEYLGGGSALDLMKA--GNFEEMHIAVILREVLKGLDYLHSERKLHRD 169
                     ++++ L G S  DL+      F    +A+  +++L  +  +H +  ++RD
Sbjct: 73  YFGQEGLHNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRD 131

Query: 170 IKAANVLLSEMGD-----VKLADFGVAGTLTNTTSK-------RNTFVGTPFWM---APE 214
           IK  N L+          + + DFG+     +  +K       +    GT  +M      
Sbjct: 132 IKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHL 191

Query: 215 VIKQSAYDSKADIWSLGITAIELAKGEPP-------NSELHPMRVLFLIPKNNPPQLTGN 267
             +QS  D   D+ +LG   +   +G  P        ++    R+          +L   
Sbjct: 192 GREQSRRD---DLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAG 248

Query: 268 YTKQFKEFVEACLNKDPENRP 288
           + ++F +++    N   +  P
Sbjct: 249 FPEEFYKYMHYARNLAFDATP 269

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 75.1 bits (185), Expect = 6e-15
 Identities = 49/209 (23%), Positives = 89/209 (42%), Gaps = 35/209 (16%)

Query: 63  ERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGT-KLW 121
           ++IG G+FGE+  G +  T + VAIK   LE  +     +  E     Q  S  G  +++
Sbjct: 15  KKIGCGNFGELRLGKNLYTNEYVAIK---LEPMKSRAPQLHLEYRFYKQLGSGDGIPQVY 71

Query: 122 ----------IIMEYLGGGSALDLMKA--GNFEEMHIAVILREVLKGLDYLHSERKLHRD 169
                     +++E L G S  DL       F    + +I  +++  ++Y+HS+  ++RD
Sbjct: 72  YFGPCGKYNAMVLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRD 130

Query: 170 IKAANVLL-----SEMGDVKLADFGVAGTLTNTTSK-------RNTFVGTPFWMAPEV-- 215
           +K  N L+          + + DF +A    +  +K         +  GT  +M+     
Sbjct: 131 VKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHL 190

Query: 216 -IKQSAYDSKADIWSLGITAIELAKGEPP 243
             +QS  D   D+ +LG   +   +G  P
Sbjct: 191 GKEQSRRD---DLEALGHMFMYFLRGSLP 216

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 70.9 bits (174), Expect = 2e-13
 Identities = 49/267 (18%), Positives = 93/267 (34%), Gaps = 54/267 (20%)

Query: 63  ERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAE-----DEIE---DIQQEIMVLSQCDS 114
           ++IG G FG ++        +  A  ++ +E  E      E++    + ++  +    + 
Sbjct: 43  KKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIER 102

Query: 115 PYGTKL-------------------WIIMEYLGGGSALDLMKA-GNFEEMHIAVILREVL 154
                L                   +++ME LG      +    G F++  +  +   +L
Sbjct: 103 KQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGI-DLQKISGQNGTFKKSTVLQLGIRML 161

Query: 155 KGLDYLHSERKLHRDIKAANVLL--SEMGDVKLADFGVAGTLTNTTSK-------RNTFV 205
             L+Y+H    +H DIKAAN+LL       V LAD+G++       +        R    
Sbjct: 162 DVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHN 221

Query: 206 GTPFWM---APEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNN-- 260
           GT  +    A + +  S      D+  LG   +    G+ P  +     V     K N  
Sbjct: 222 GTIEFTSLDAHKGVALSRRS---DVEILGYCMLRWLCGKLPWEQNLKDPVAVQTAKTNLL 278

Query: 261 --------PPQLTGNYTKQFKEFVEAC 279
                       +G+   +  +F+   
Sbjct: 279 DELPQSVLKWAPSGSSCCEIAQFLVCA 305

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 69.4 bits (170), Expect = 6e-13
 Identities = 35/229 (15%), Positives = 72/229 (31%), Gaps = 57/229 (24%)

Query: 63  ERIGKGSFGEVFKGIDNRT--------QQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDS 114
               + + G +++     T        +Q  ++K+      + +   +  E     +   
Sbjct: 48  SFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKL------DAKDGRLFNEQNFFQRAAK 101

Query: 115 PYGTKLW--------------------------IIMEYLGG--GSALDLMKAGNFEEMHI 146
           P     W                          +++  LG    SALD+       E  +
Sbjct: 102 PLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGRSLQSALDVSPKHVLSERSV 161

Query: 147 AVILREVLKGLDYLHSERKLHRDIKAANVLL--SEMGDVKLADFGVAGTLTNTTS----- 199
             +   +L  L++LH    +H ++ A N+ +   +   V LA +G A     +       
Sbjct: 162 LQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYV 221

Query: 200 --KRNTFVGTPFWM---APEVIKQSAYDSKADIWSLGITAIELAKGEPP 243
              R+   G   ++     +    S      D+ SLG   ++   G  P
Sbjct: 222 EGSRSPHEGDLEFISMDLHKGCGPSRRS---DLQSLGYCMLKWLYGFLP 267

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 62.5 bits (152), Expect = 1e-10
 Identities = 52/329 (15%), Positives = 106/329 (32%), Gaps = 66/329 (20%)

Query: 63  ERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTKLW- 121
             IG+G FG ++    N ++ V +     ++    +   +  E+    +   P   + W 
Sbjct: 41  LPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWI 100

Query: 122 ----------------------------IIMEYLGGGSALDLMKAGN--FEEMHIAVILR 151
                                       +IM+  G      + +A    F    +  +  
Sbjct: 101 RTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGS-DLQKIYEANAKRFSRKTVLQLSL 159

Query: 152 EVLKGLDYLHSERKLHRDIKAANVLLS--EMGDVKLADFGVAGTLTNTTSK-------RN 202
            +L  L+Y+H    +H DIKA+N+LL+      V L D+G+A                + 
Sbjct: 160 RILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKR 219

Query: 203 TFVGTPFWM---APEVIKQSAYDSKADIWSLGITAIELAKGEPP-------NSELHPMRV 252
              GT  +    A   +  S      D+  LG   I+   G  P          +   ++
Sbjct: 220 CHDGTIEFTSIDAHNGVAPSRRG---DLEILGYCMIQWLTGHLPWEDNLKDPKYVRDSKI 276

Query: 253 LFLIPKNNPP-----QLTGNYTKQFKEFVEACLNKDPENRP---TAKELLKFPFIRKAKK 304
            +   +N            N   +  +++E     D   +P     +++L         K
Sbjct: 277 RYR--ENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGSK 334

Query: 305 NAYLID--LIDRYKKWKNSRNEESETESE 331
           +   +D  +++       +  ++   E E
Sbjct: 335 DDGKLDLSVVENGGLKAKTITKKRAAEIE 363

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 59.1 bits (142), Expect = 3e-09
 Identities = 62/400 (15%), Positives = 133/400 (33%), Gaps = 113/400 (28%)

Query: 88  KII-DLEEA--ED----EIEDIQQEIMVLSQCDSPYGTK---------LWIIM------- 124
            I+   E+A  ++    +++D+ + I+   + D    +K          W ++       
Sbjct: 20  DILSVFEDAFVDNFDCKDVQDMPKSILSKEEIDHIIMSKDAVSGTLRLFWTLLSKQEEMV 79

Query: 125 -EYLGGGSALD---LMKAGNFEEMHIAVILREVLKGLDYLHSE----------R-KLHRD 169
            +++     ++   LM     E+   +++ R  ++  D L+++          R + +  
Sbjct: 80  QKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLK 139

Query: 170 IKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVG-TPFWMAPEVIKQSAYDSKAD-- 226
           ++ A + L    +V +   GV G+            G T  W+A +V        K D  
Sbjct: 140 LRQALLELRPAKNVLI--DGVLGS------------GKT--WVALDVCLSYKVQCKMDFK 183

Query: 227 -IWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPE 285
             W      + L     P + L  ++ L         Q+  N+T +        L     
Sbjct: 184 IFW------LNLKNCNSPETVLEMLQKLLY-------QIDPNWTSRSDHSSNIKLRIH-- 228

Query: 286 NRPTAKELLKFPFIRKAKKNAYLI-D------------------LIDRYKKWKNSRNEES 326
              + +  L+     K  +N  L+                    L  R+K+  +  +  +
Sbjct: 229 ---SIQAELRRLLKSKPYENCLLVLLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAAT 285

Query: 327 ETESETSDNEDSIKTDGDLDE---PWIMTVKGKMPNE-YGSSPNKKSGGMNGA---DNIV 379
            T      +  ++ T  ++      ++      +P E   ++P + S  +      D + 
Sbjct: 286 TTHISLDHHSMTL-TPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLS--IIAESIRDGLA 342

Query: 380 NNNNLN--NNNNHATFISSSEKSHSPA------RPLSIAP 411
             +N    N +   T I SS     PA        LS+ P
Sbjct: 343 TWDNWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSVFP 382

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 46.4 bits (109), Expect = 2e-05
 Identities = 58/401 (14%), Positives = 107/401 (26%), Gaps = 121/401 (30%)

Query: 34  SSISNQCGSTTA------SRRNSLKVDPELIFTKQ--ERI-------------------- 65
           S I  +    +        +R+ L  D + +F K    R+                    
Sbjct: 96  SPIKTEQRQPSMMTRMYIEQRDRLYNDNQ-VFAKYNVSRLQPYLKLRQALLELRPAKNVL 154

Query: 66  --GKGSFG------EVFKGIDNRTQQVVAIKI--IDL---EEAEDEIEDIQQ-----EIM 107
             G    G      +V      + Q  +  KI  ++L      E  +E +Q+     +  
Sbjct: 155 IDGVLGSGKTWVALDVCL--SYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPN 212

Query: 108 VLSQCDSPYGTKLWI--IMEYLGGGSALDLMKAGNFEEMHIAVILREV-----LKGLDYL 160
             S+ D     KL I  I   L       L+K+  +E   +  +L  V         + L
Sbjct: 213 WTSRSDHSSNIKLRIHSIQAEL-----RRLLKSKPYENCLL--VLLNVQNAKAWNAFN-L 264

Query: 161 HSERKL--HRDIKAANVLLSE-MGDVKLADFGVAGTLTNTTSKR--NTFVGTPFWMAPEV 215
              + L   R  +  + L +     + L     + TLT    K     ++       P  
Sbjct: 265 SC-KILLTTRFKQVTDFLSAATTTHISLDHH--SMTLTPDEVKSLLLKYLDCRPQDLPRE 321

Query: 216 I-------------------------KQSAYDSKADIWSLGITAIELAKGEPPNSELHPM 250
           +                         K    D    I    +  +E      P       
Sbjct: 322 VLTTNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLE------PAEYRKMF 375

Query: 251 RVLFLIPKNN--PPQ----LTGNYTKQFKEFV------EACLNKDPENRPTAKELLKFPF 298
             L + P +   P      +  +  K     V       + + K P+    +   +    
Sbjct: 376 DRLSVFPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTISIPSIYLEL 435

Query: 299 IRKAKKNAYL-IDLIDRYKKWKNSRNEESETESETSDNEDS 338
             K +    L   ++D Y   K       +++       D 
Sbjct: 436 KVKLENEYALHRSIVDHYNIPKT-----FDSDDLIPPYLDQ 471

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 43.3 bits (101), Expect = 2e-04
 Identities = 59/508 (11%), Positives = 127/508 (25%), Gaps = 172/508 (33%)

Query: 157 LDYLHSERKLH-RDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEV 215
           +D+   E +   +DI      LS   D  + +F          S               +
Sbjct: 7   MDFETGEHQYQYKDI------LSVFEDAFVDNFDCKDVQDMPKS---------------I 45

Query: 216 IKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEF 275
           + +   D    I                         LF    +          +  ++F
Sbjct: 46  LSKEEID---HII-----------MSKDAVS--GTLRLFWTLLSKQ-------EEMVQKF 82

Query: 276 VEACLNKDPENRPTAKELLKFPFIRKAKKNAYLIDLIDRYKKWKNSRNEESETESETSDN 335
           VE  L  +            + F+                   K  + + S       + 
Sbjct: 83  VEEVLRIN------------YKFL---------------MSPIKTEQRQPSMMTRMYIEQ 115

Query: 336 EDSIKTDGDLDEPW-------IMTVKGKMPNEYGSSPNKKSG--GMNG------ADNIVN 380
            D +  D  +   +        + ++  +       P K     G+ G      A ++  
Sbjct: 116 RDRLYNDNQVFAKYNVSRLQPYLKLRQAL---LELRPAKNVLIDGVLGSGKTWVALDVCL 172

Query: 381 NNNLNNNNNHATF-ISSSEKSHSPARPLSIAPGPPSSAQEKRNSMTRSDSGEHKSNPTSP 439
           +  +    +   F ++     +SP   L           E    +         S     
Sbjct: 173 SYKVQCKMDFKIFWLNLKNC-NSPETVL-----------EMLQKLLYQIDPNWTSRSDHS 220

Query: 440 DREKHKIGSPEREKLK--IGSP-------------DREKLKSPD---------REKH--- 472
              K +I S  + +L+  + S              + +   + +         R K    
Sbjct: 221 SNIKLRIHS-IQAELRRLLKSKPYENCLLVLLNVQNAKAWNAFNLSCKILLTTRFKQVTD 279

Query: 473 KIGSPDREKNKIGSPDK---KQQTRG------------SPVKASARSPCLSFLIYPLISE 517
            + +       +          + +              P +    +P        +I+E
Sbjct: 280 FLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNP----RRLSIIAE 335

Query: 518 LQRRHHYTSNN-RTSNSGA-----DSSHKADAIEELKNAF-DLAERSAPGISGQFVKEV- 569
             R    T +N +  N        +SS       E +  F  L+      +   F     
Sbjct: 336 SIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLS------V---FPPSAH 386

Query: 570 ----VHKLL-PAMSEARVNSVVDKMIRS 592
               +  L+   + ++ V  VV+K+ + 
Sbjct: 387 IPTILLSLIWFDVIKSDVMVVVNKLHKY 414

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	604
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.97
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.93
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.91
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.83
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.71
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.12
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.03
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	99.0
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	98.98
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.77
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.38
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.16
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.16
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.16
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.08
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	97.78
3ats_A	357	Putative uncharacterized protein; hypothetical pro	97.77
3ajm_A	213	Programmed cell death protein 10; adaptor protein,	97.51
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.38
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.3
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.2
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.18
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.17
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	97.16
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.01
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	96.72
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	96.72
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	96.6
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	96.45
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	96.22
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	96.07
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	95.76
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	95.18
3mes_A	424	Choline kinase; malaria, structural genomics, stru	93.96

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=1.8e-59  Score=495.57  Aligned_cols=253  Identities=36%  Similarity=0.656  Sum_probs=227.2

Q ss_pred             ccccceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCCeE----------EEEE
Q psy1546          55 PELIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTKL----------WIIM  124 (604)
Q Consensus        55 ~~~~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~~l----------yLVm  124 (604)
                      +...|++.++||+|+||+||+|+++.+|+.||||++...... ..+.+.+|+.+|+.++|||++++          ||||
T Consensus        72 p~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~-~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivm  150 (346)
T 4fih_A           72 PRSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ-RRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVM  150 (346)
T ss_dssp             GGGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCS-SGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hhHhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchh-HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence            445699999999999999999999999999999999765432 23568899999999999997664          7999


Q ss_pred             EecCCCChhhHhhcCCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCCCCccc
Q psy1546         125 EYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTF  204 (604)
Q Consensus       125 Ey~~ggsL~~~l~~~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~~~~~  204 (604)
                      |||+||+|.+++..+.+++..++.|+.||+.||+|||++|||||||||+||||+.+|.+||+|||+|+.+........+.
T Consensus       151 Ey~~gg~L~~~l~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~  230 (346)
T 4fih_A          151 EFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSL  230 (346)
T ss_dssp             CCCTTEEHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBCCC
T ss_pred             eCCCCCcHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCCCCCccccc
Confidence            99999999999999999999999999999999999999999999999999999999999999999998887666667788


Q ss_pred             ccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCCCCCC--CCccchHHHHHHHHHHhcc
Q psy1546         205 VGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQ--LTGNYTKQFKEFVEACLNK  282 (604)
Q Consensus       205 ~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~--~~~~~s~~l~~Li~~~L~~  282 (604)
                      +||+.|||||++.+..|+.++|||||||+||||++|.+||.+.+..+++..+....++.  .+..+++++++||.+||..
T Consensus       231 ~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~~~L~~  310 (346)
T 4fih_A          231 VGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVR  310 (346)
T ss_dssp             CSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCSCGGGSCHHHHHHHHHHSCS
T ss_pred             ccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCccccCCHHHHHHHHHHcCC
Confidence            99999999999999999999999999999999999999999998888777765554333  3457899999999999999


Q ss_pred             CCCCCCCHHHHhcChhhhhhhhhhhH
Q psy1546         283 DPENRPTAKELLKFPFIRKAKKNAYL  308 (604)
Q Consensus       283 dP~~RpT~~elL~hp~f~~~~~~~~l  308 (604)
                      ||.+|||+.|||+||||++......+
T Consensus       311 dP~~R~ta~e~l~Hp~~~~~~~p~~l  336 (346)
T 4fih_A          311 DPAQRATAAELLKHPFLAKAGPPASI  336 (346)
T ss_dssp             STTTSCCHHHHTTCGGGGGCCCGGGT
T ss_pred             ChhHCcCHHHHhcCHhhcCCCCCccc
Confidence            99999999999999999876655443

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=2.6e-58  Score=498.37  Aligned_cols=254  Identities=35%  Similarity=0.658  Sum_probs=228.0

Q ss_pred             ccccceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCCeE----------EEEE
Q psy1546          55 PELIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTKL----------WIIM  124 (604)
Q Consensus        55 ~~~~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~~l----------yLVm  124 (604)
                      +...|+++++||+|+||+||+|+++.+|+.||||++...... ..+.+.+|+.+|+.++|||++++          ||||
T Consensus       149 p~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~-~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVm  227 (423)
T 4fie_A          149 PRSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ-RRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVM  227 (423)
T ss_dssp             GGGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCS-SGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hhHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchh-HHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEE
Confidence            345699999999999999999999999999999999765432 23668899999999999997664          7999


Q ss_pred             EecCCCChhhHhhcCCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCCCCccc
Q psy1546         125 EYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTF  204 (604)
Q Consensus       125 Ey~~ggsL~~~l~~~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~~~~~  204 (604)
                      |||+||+|.++++.+.+++..++.|+.||+.||+|||++|||||||||+||||+.+|.+||+|||+|+.+........+.
T Consensus       228 Ey~~gG~L~~~i~~~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~  307 (423)
T 4fie_A          228 EFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSL  307 (423)
T ss_dssp             ECCTTEEHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCCCBCCC
T ss_pred             eCCCCCcHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCCCCcccccc
Confidence            99999999999999999999999999999999999999999999999999999999999999999998887666667788


Q ss_pred             ccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCCCCC--CCCccchHHHHHHHHHHhcc
Q psy1546         205 VGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPP--QLTGNYTKQFKEFVEACLNK  282 (604)
Q Consensus       205 ~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~~~~--~~~~~~s~~l~~Li~~~L~~  282 (604)
                      +||+.|||||++.+..|+.++|||||||+||||++|.+||.+.+..+.+..+.....+  ..+..+++++++||.+||..
T Consensus       308 ~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~~~L~~  387 (423)
T 4fie_A          308 VGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVR  387 (423)
T ss_dssp             EECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSSCHHHHHHHHHHSCS
T ss_pred             ccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCcccccCCHHHHHHHHHHcCC
Confidence            9999999999999999999999999999999999999999999888887776555433  33457899999999999999


Q ss_pred             CCCCCCCHHHHhcChhhhhhhhhhhHH
Q psy1546         283 DPENRPTAKELLKFPFIRKAKKNAYLI  309 (604)
Q Consensus       283 dP~~RpT~~elL~hp~f~~~~~~~~l~  309 (604)
                      ||.+|||+.|||+||||++......+.
T Consensus       388 dP~~R~ta~ell~Hp~~~~~~~p~~l~  414 (423)
T 4fie_A          388 DPAQRATAAELLKHPFLAKAGPPASIV  414 (423)
T ss_dssp             STTTSCCHHHHTTCGGGGGCCCGGGTG
T ss_pred             ChhHCcCHHHHhcCHHhcCCCCCcccc
Confidence            999999999999999998876554443

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=3.4e-58  Score=486.52  Aligned_cols=245  Identities=28%  Similarity=0.523  Sum_probs=217.4

Q ss_pred             cceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhh-HHHHHHHHHHHHHHhhCCCCCCCeE----------EEEEEe
Q psy1546          58 IFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA-EDEIEDIQQEIMVLSQCDSPYGTKL----------WIIMEY  126 (604)
Q Consensus        58 ~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~-~~~~~~l~~Ei~iL~~l~hp~~~~l----------yLVmEy  126 (604)
                      .|+++++||+|+||+||+|+++.+|+.||||++.+... ....+.+.+|+.+|+.|+|||++++          ||||||
T Consensus        25 ~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmEy  104 (350)
T 4b9d_A           25 KYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDY  104 (350)
T ss_dssp             CEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             ceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEeC
Confidence            49999999999999999999999999999999976543 3456789999999999999997664          799999


Q ss_pred             cCCCChhhHhhc---CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCCCCcc
Q psy1546         127 LGGGSALDLMKA---GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNT  203 (604)
Q Consensus       127 ~~ggsL~~~l~~---~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~~~~  203 (604)
                      |+||+|.+++..   ..+++..++.|+.||+.||.|||++|||||||||+||||+.+|.+||+|||+|+.+........+
T Consensus       105 ~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~  184 (350)
T 4b9d_A          105 CEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARA  184 (350)
T ss_dssp             CTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHHHHHHHH
T ss_pred             CCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceeecCCcccccc
Confidence            999999999954   35799999999999999999999999999999999999999999999999999877544444456


Q ss_pred             cccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCCCCCCCCccchHHHHHHHHHHhccC
Q psy1546         204 FVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKD  283 (604)
Q Consensus       204 ~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~~L~~d  283 (604)
                      .+||+.|||||++.+..|+.++|||||||+||||++|.+||.+.+..++...+.....+.++..+++++++||.+||.+|
T Consensus       185 ~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~L~~d  264 (350)
T 4b9d_A          185 CIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPVSLHYSYDLRSLVSQLFKRN  264 (350)
T ss_dssp             HHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSS
T ss_pred             cCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHccCC
Confidence            78999999999999999999999999999999999999999999998888888777777788889999999999999999


Q ss_pred             CCCCCCHHHHhcChhhhhh
Q psy1546         284 PENRPTAKELLKFPFIRKA  302 (604)
Q Consensus       284 P~~RpT~~elL~hp~f~~~  302 (604)
                      |.+|||++|||+||||++.
T Consensus       265 P~~R~s~~e~l~hp~~~~~  283 (350)
T 4b9d_A          265 PRDRPSVNSILEKGFIAKR  283 (350)
T ss_dssp             GGGSCCHHHHHTSHHHHTT
T ss_pred             hhHCcCHHHHhcCHHhhcC
Confidence            9999999999999999764

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=1.3e-57  Score=474.71  Aligned_cols=246  Identities=28%  Similarity=0.479  Sum_probs=220.0

Q ss_pred             cceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhh--HHHHHHHHHHHHHHhhCCCCCCCeE----------EEEEE
Q psy1546          58 IFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA--EDEIEDIQQEIMVLSQCDSPYGTKL----------WIIME  125 (604)
Q Consensus        58 ~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~--~~~~~~l~~Ei~iL~~l~hp~~~~l----------yLVmE  125 (604)
                      .|+++++||+|+||+||+|+++.+++.||||++.+...  ....+.+.+|+.+|+.++|||++++          |||||
T Consensus        33 dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivmE  112 (311)
T 4aw0_A           33 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLS  112 (311)
T ss_dssp             GEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             ccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence            49999999999999999999999999999999976543  2345789999999999999997664          79999


Q ss_pred             ecCCCChhhHhhc-CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCC--CCCCc
Q psy1546         126 YLGGGSALDLMKA-GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNT--TSKRN  202 (604)
Q Consensus       126 y~~ggsL~~~l~~-~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~--~~~~~  202 (604)
                      ||+||+|.++++. +.+++..++.|+.||+.||+|||++|||||||||+||||+.+|.+||+|||+|+.+...  .....
T Consensus       113 y~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~~~~~  192 (311)
T 4aw0_A          113 YAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARAN  192 (311)
T ss_dssp             CCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTTCCCBC
T ss_pred             cCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCccccc
Confidence            9999999999865 78999999999999999999999999999999999999999999999999999877533  23456


Q ss_pred             ccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCCCCCCCCccchHHHHHHHHHHhcc
Q psy1546         203 TFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNK  282 (604)
Q Consensus       203 ~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~~L~~  282 (604)
                      +++||+.|||||++.+..|+.++|||||||+||+|++|.+||.+.+..++...+.... ..++..+++++++||.+||.+
T Consensus       193 ~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~-~~~p~~~s~~~~dli~~lL~~  271 (311)
T 4aw0_A          193 SFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLE-YDFPEKFFPKARDLVEKLLVL  271 (311)
T ss_dssp             CCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC-CCCCTTCCHHHHHHHHHHSCS
T ss_pred             CcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC-CCCCcccCHHHHHHHHHHccC
Confidence            7899999999999999999999999999999999999999999988888777776554 356678999999999999999


Q ss_pred             CCCCCCCHHH------HhcChhhhhhhh
Q psy1546         283 DPENRPTAKE------LLKFPFIRKAKK  304 (604)
Q Consensus       283 dP~~RpT~~e------lL~hp~f~~~~~  304 (604)
                      ||.+|||++|      |++||||+...+
T Consensus       272 dp~~R~t~~e~~~~~~i~~Hp~F~~idw  299 (311)
T 4aw0_A          272 DATKRLGCEEMEGYGPLKAHPFFESVTW  299 (311)
T ss_dssp             SGGGSTTSGGGTCHHHHHTSGGGTTCCC
T ss_pred             CHhHCcChHHHcCCHHHHCCCCcCCCCH
Confidence            9999999887      588999976543

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=1.5e-55  Score=455.77  Aligned_cols=240  Identities=27%  Similarity=0.498  Sum_probs=207.3

Q ss_pred             ceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhh-HHHHHHHHHHHHHHhhCCCCCCCeE--------------EEE
Q psy1546          59 FTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA-EDEIEDIQQEIMVLSQCDSPYGTKL--------------WII  123 (604)
Q Consensus        59 y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~-~~~~~~l~~Ei~iL~~l~hp~~~~l--------------yLV  123 (604)
                      |.+.++||+|+||+||+|.+..+++.||||++..... ....+.+.+|+.+|++++|||++++              |||
T Consensus        28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lv  107 (290)
T 3fpq_A           28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV  107 (290)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEE
T ss_pred             EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEE
Confidence            5778899999999999999999999999999965542 3456789999999999999997654              799


Q ss_pred             EEecCCCChhhHhhc-CCCcHHHHHHHHHHHHHHhHHhhhCC--ccccccccceeEec-CCCCeEEecccccccccCCCC
Q psy1546         124 MEYLGGGSALDLMKA-GNFEEMHIAVILREVLKGLDYLHSER--KLHRDIKAANVLLS-EMGDVKLADFGVAGTLTNTTS  199 (604)
Q Consensus       124 mEy~~ggsL~~~l~~-~~lse~~i~~i~~qIl~gL~yLHs~g--IiHrDLKp~NILl~-~~g~vKL~DFGlA~~~~~~~~  199 (604)
                      ||||+||+|.++++. +.+++..++.|+.||+.||.|||++|  ||||||||+||||+ .+|.+||+|||+|+...  ..
T Consensus       108 mEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~--~~  185 (290)
T 3fpq_A          108 TELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR--AS  185 (290)
T ss_dssp             EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCC--TT
T ss_pred             EeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCC--CC
Confidence            999999999999965 78999999999999999999999999  99999999999997 47999999999997543  23


Q ss_pred             CCcccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChh-hHhhhcCCCC-CCCCCccchHHHHHHHH
Q psy1546         200 KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPM-RVLFLIPKNN-PPQLTGNYTKQFKEFVE  277 (604)
Q Consensus       200 ~~~~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~-~~~~~i~~~~-~~~~~~~~s~~l~~Li~  277 (604)
                      ...+.+||+.|||||++.+ .|+.++|||||||+||||++|.+||.+.... .+...+.... +..++..+++++++||.
T Consensus       186 ~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~  264 (290)
T 3fpq_A          186 FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIE  264 (290)
T ss_dssp             SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHHHHH
T ss_pred             ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCCCCCCccCCHHHHHHHH
Confidence            4457899999999999875 6999999999999999999999999875544 3444444443 33455667889999999


Q ss_pred             HHhccCCCCCCCHHHHhcChhhhh
Q psy1546         278 ACLNKDPENRPTAKELLKFPFIRK  301 (604)
Q Consensus       278 ~~L~~dP~~RpT~~elL~hp~f~~  301 (604)
                      +||..||.+|||+.|||+||||++
T Consensus       265 ~~L~~dP~~R~s~~e~l~Hp~~~~  288 (290)
T 3fpq_A          265 GCIRQNKDERYSIKDLLNHAFFQE  288 (290)
T ss_dssp             HHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred             HHccCChhHCcCHHHHhcCccccC
Confidence            999999999999999999999975

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=8.1e-56  Score=454.26  Aligned_cols=240  Identities=27%  Similarity=0.418  Sum_probs=199.0

Q ss_pred             ceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhH--HHHHHHHHHHHHHhhCCCCCCCeE----------EEEEEe
Q psy1546          59 FTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAE--DEIEDIQQEIMVLSQCDSPYGTKL----------WIIMEY  126 (604)
Q Consensus        59 y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~--~~~~~l~~Ei~iL~~l~hp~~~~l----------yLVmEy  126 (604)
                      |++.+.||+|+||+||+|++..+++.||||++.+....  .....+.+|+.+|+.++|||++++          ||||||
T Consensus        15 Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmEy   94 (275)
T 3hyh_A           15 YQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIEY   94 (275)
T ss_dssp             CEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             eEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEeC
Confidence            99999999999999999999999999999999765432  234678999999999999997654          799999


Q ss_pred             cCCCChhhHhh-cCCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCCCCcccc
Q psy1546         127 LGGGSALDLMK-AGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFV  205 (604)
Q Consensus       127 ~~ggsL~~~l~-~~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~~~~~~  205 (604)
                      | +|+|.+++. .+.+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+|+..... ....+.+
T Consensus        95 ~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~-~~~~~~~  172 (275)
T 3hyh_A           95 A-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG-NFLKTSC  172 (275)
T ss_dssp             C-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC--------------
T ss_pred             C-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecCCC-CccCCee
Confidence            9 678888775 578999999999999999999999999999999999999999999999999999765433 3345689


Q ss_pred             cCCCCCChHHhhcCCC-CCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCCCCCCCCccchHHHHHHHHHHhccCC
Q psy1546         206 GTPFWMAPEVIKQSAY-DSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDP  284 (604)
Q Consensus       206 GT~~Y~APE~l~~~~~-~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~~L~~dP  284 (604)
                      ||+.|||||++.+..| +.++|||||||+||+|++|.+||.+.+...+...+.... ..++..+++++++||.+||+.||
T Consensus       173 GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~~~L~~dP  251 (275)
T 3hyh_A          173 GSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGV-YTLPKFLSPGAAGLIKRMLIVNP  251 (275)
T ss_dssp             --CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC-CCCCTTSCHHHHHHHHHHSCSSG
T ss_pred             ECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCC-CCCCCCCCHHHHHHHHHHccCCh
Confidence            9999999999998886 579999999999999999999999988777766665443 35667899999999999999999


Q ss_pred             CCCCCHHHHhcChhhhh
Q psy1546         285 ENRPTAKELLKFPFIRK  301 (604)
Q Consensus       285 ~~RpT~~elL~hp~f~~  301 (604)
                      .+|||++|+|+||||+.
T Consensus       252 ~~R~s~~eil~hpw~k~  268 (275)
T 3hyh_A          252 LNRISIHEIMQDDWFKV  268 (275)
T ss_dssp             GGSCCHHHHHHCHHHHT
T ss_pred             hHCcCHHHHHcCccccc
Confidence            99999999999999974

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=1.5e-56  Score=465.94  Aligned_cols=245  Identities=27%  Similarity=0.460  Sum_probs=209.8

Q ss_pred             cceeeeEEcccCcEEEEEEEEC---CCCcEEEEEEecchhhH-HHHHHHHHHHHHHhhCCCCCCCe----------EEEE
Q psy1546          58 IFTKQERIGKGSFGEVFKGIDN---RTQQVVAIKIIDLEEAE-DEIEDIQQEIMVLSQCDSPYGTK----------LWII  123 (604)
Q Consensus        58 ~y~i~~~LG~G~fG~Vy~a~~~---~t~~~vAVK~i~~~~~~-~~~~~l~~Ei~iL~~l~hp~~~~----------lyLV  123 (604)
                      .|+++++||+|+||+||+|++.   .+++.||||++.+.... .....+.+|+.+|++++|||+++          +|||
T Consensus        25 ~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~iv  104 (304)
T 3ubd_A           25 QFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLI  104 (304)
T ss_dssp             GEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEEE
T ss_pred             ccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence            4999999999999999999874   47889999999654321 12345788999999999999665          4799


Q ss_pred             EEecCCCChhhHhhc-CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCCCCc
Q psy1546         124 MEYLGGGSALDLMKA-GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRN  202 (604)
Q Consensus       124 mEy~~ggsL~~~l~~-~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~~~  202 (604)
                      ||||+||+|.+++.. +.+++..++.|+.||+.||+|||++|||||||||+|||++.+|.+||+|||+|+..........
T Consensus       105 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~  184 (304)
T 3ubd_A          105 LDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAY  184 (304)
T ss_dssp             ECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC-----CCCC
T ss_pred             EEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccceeccCCCcccc
Confidence            999999999999865 7899999999999999999999999999999999999999999999999999987766666667


Q ss_pred             ccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCCCCCCCCccchHHHHHHHHHHhcc
Q psy1546         203 TFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNK  282 (604)
Q Consensus       203 ~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~~L~~  282 (604)
                      +.+||+.|||||++.+..|+.++|||||||+||||++|.+||.+.+..++...+.... ..++..+++++++||.+||++
T Consensus       185 ~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~~~L~~  263 (304)
T 3ubd_A          185 SFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAK-LGMPQFLSPEAQSLLRMLFKR  263 (304)
T ss_dssp             SCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-CCCCTTSCHHHHHHHHHHTCS
T ss_pred             ccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCC-CCCCCcCCHHHHHHHHHHccc
Confidence            8899999999999999999999999999999999999999999998888877766544 346678999999999999999


Q ss_pred             CCCCCCC-----HHHHhcChhhhhhh
Q psy1546         283 DPENRPT-----AKELLKFPFIRKAK  303 (604)
Q Consensus       283 dP~~RpT-----~~elL~hp~f~~~~  303 (604)
                      ||.+|||     ++||++||||+...
T Consensus       264 dP~~R~ta~~~~~~eil~Hp~f~~id  289 (304)
T 3ubd_A          264 NPANRLGAGPDGVEEIKRHSFFSTID  289 (304)
T ss_dssp             SGGGSTTCSTTTHHHHHTSGGGTTCC
T ss_pred             CHHHCCCCCcCCHHHHHcCccccCCC
Confidence            9999998     68999999998754

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=2.3e-55  Score=462.69  Aligned_cols=239  Identities=34%  Similarity=0.465  Sum_probs=206.9

Q ss_pred             cceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCCeE----------EEEEEec
Q psy1546          58 IFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTKL----------WIIMEYL  127 (604)
Q Consensus        58 ~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~~l----------yLVmEy~  127 (604)
                      .|.+.++||+|+||+||+|+++.+|+.||||+++....      ..+|+.+|+.++|||++++          |||||||
T Consensus        59 ~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~------~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~  132 (336)
T 4g3f_A           59 WMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF------RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELL  132 (336)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC------CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             heEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh------HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEecc
Confidence            48899999999999999999999999999999976532      2479999999999997664          7999999


Q ss_pred             CCCChhhHhhc-CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCC-CeEEecccccccccCCCC-----C
Q psy1546         128 GGGSALDLMKA-GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMG-DVKLADFGVAGTLTNTTS-----K  200 (604)
Q Consensus       128 ~ggsL~~~l~~-~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g-~vKL~DFGlA~~~~~~~~-----~  200 (604)
                      +||+|.++++. +.+++..++.|+.||+.||+|||++|||||||||+||||+.+| .+||+|||+|+.+.....     .
T Consensus       133 ~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~~~~  212 (336)
T 4g3f_A          133 EGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLT  212 (336)
T ss_dssp             TTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC-----------
T ss_pred             CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcccceec
Confidence            99999999965 7899999999999999999999999999999999999999988 699999999987653321     2


Q ss_pred             CcccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCCCC--CCCCccchHHHHHHHHH
Q psy1546         201 RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNP--PQLTGNYTKQFKEFVEA  278 (604)
Q Consensus       201 ~~~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~~~--~~~~~~~s~~l~~Li~~  278 (604)
                      ...++||+.|||||++.+..|+.++|||||||+||||++|.+||.+.....+...+....+  ..++..+++++.+||.+
T Consensus       213 ~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~~li~~  292 (336)
T 4g3f_A          213 GDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCAPLTAQAIQE  292 (336)
T ss_dssp             -CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCCGGGGSCTTSCHHHHHHHHH
T ss_pred             CCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCCCchhcCccCCHHHHHHHHH
Confidence            3456899999999999999999999999999999999999999998877666665554443  24567899999999999


Q ss_pred             HhccCCCCCCCHHHHh-------------cChhhhhh
Q psy1546         279 CLNKDPENRPTAKELL-------------KFPFIRKA  302 (604)
Q Consensus       279 ~L~~dP~~RpT~~elL-------------~hp~f~~~  302 (604)
                      ||.+||.+|||+.||+             +|||+.+.
T Consensus       293 ~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~  329 (336)
T 4g3f_A          293 GLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEY  329 (336)
T ss_dssp             HTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSC
T ss_pred             HccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCCC
Confidence            9999999999999984             57777554

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=9e-54  Score=444.57  Aligned_cols=242  Identities=27%  Similarity=0.411  Sum_probs=194.9

Q ss_pred             ceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCCe-------------------
Q psy1546          59 FTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTK-------------------  119 (604)
Q Consensus        59 y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~~-------------------  119 (604)
                      |++++.||+|+||+||+|+++.+++.||||++.........+.+.+|+.+|++++|||+++                   
T Consensus         7 y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~~   86 (299)
T 4g31_A            7 FEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSP   86 (299)
T ss_dssp             EEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC----------
T ss_pred             CEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccccCC
Confidence            8999999999999999999999999999999977665566678999999999999999765                   


Q ss_pred             ---EEEEEEecCCCChhhHhhcC-CC---cHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccc
Q psy1546         120 ---LWIIMEYLGGGSALDLMKAG-NF---EEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAG  192 (604)
Q Consensus       120 ---lyLVmEy~~ggsL~~~l~~~-~l---se~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~  192 (604)
                         +|||||||+||+|.+++... .+   ++..++.|+.||+.||+|||++|||||||||+||||+.+|.+||+|||+|+
T Consensus        87 ~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl~DFGla~  166 (299)
T 4g31_A           87 KVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVT  166 (299)
T ss_dssp             CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCCCC-
T ss_pred             CcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEEccCccce
Confidence               47999999999999999753 33   345588899999999999999999999999999999999999999999998


Q ss_pred             cccCCCC------------CCcccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCCh-hhHhhhcCCC
Q psy1546         193 TLTNTTS------------KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHP-MRVLFLIPKN  259 (604)
Q Consensus       193 ~~~~~~~------------~~~~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~-~~~~~~i~~~  259 (604)
                      .+.....            ...+.+||+.|||||++.+..|+.++|||||||+||||++   ||..... ......+...
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~~~~~~~~~~~  243 (299)
T 4g31_A          167 AMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERVRTLTDVRNL  243 (299)
T ss_dssp             -------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHHHHHTT
T ss_pred             ecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHHHHHHHHHhcC
Confidence            7653321            2234689999999999999999999999999999999996   7765332 2333333344


Q ss_pred             CCCCCCccchHHHHHHHHHHhccCCCCCCCHHHHhcChhhhhhh
Q psy1546         260 NPPQLTGNYTKQFKEFVEACLNKDPENRPTAKELLKFPFIRKAK  303 (604)
Q Consensus       260 ~~~~~~~~~s~~l~~Li~~~L~~dP~~RpT~~elL~hp~f~~~~  303 (604)
                      ..+......++.+.+||.+||+.||.+|||+.|||+||||+...
T Consensus       244 ~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~~~  287 (299)
T 4g31_A          244 KFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLD  287 (299)
T ss_dssp             CCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCCC-
T ss_pred             CCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCCCC
Confidence            44434445567788999999999999999999999999997653

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=5.1e-53  Score=455.46  Aligned_cols=247  Identities=25%  Similarity=0.387  Sum_probs=208.6

Q ss_pred             cccceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhh-HHHHHHHHHHHHHHhhCCCCCCCe---------------
Q psy1546          56 ELIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA-EDEIEDIQQEIMVLSQCDSPYGTK---------------  119 (604)
Q Consensus        56 ~~~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~-~~~~~~l~~Ei~iL~~l~hp~~~~---------------  119 (604)
                      .+.|.++++||+|+||+||+|+++.+|+.||||++..... ....+.+.+|+.+|+.++|||+++               
T Consensus        53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~  132 (398)
T 4b99_A           53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK  132 (398)
T ss_dssp             CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred             CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence            3469999999999999999999999999999999965432 334577889999999999999654               


Q ss_pred             -EEEEEEecCCCChhhHhhc-CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCC
Q psy1546         120 -LWIIMEYLGGGSALDLMKA-GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNT  197 (604)
Q Consensus       120 -lyLVmEy~~ggsL~~~l~~-~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~  197 (604)
                       +|||||||+ |+|.+++.. +.+++..++.|++||+.||.|||++|||||||||+|||++.+|.+||+|||+|+.+...
T Consensus       133 ~~~ivmE~~~-g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~~  211 (398)
T 4b99_A          133 SVYVVLDLME-SDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTS  211 (398)
T ss_dssp             CEEEEEECCS-EEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC---
T ss_pred             EEEEEEeCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecceeeecccC
Confidence             479999996 568887754 78999999999999999999999999999999999999999999999999999876432


Q ss_pred             ----CCCCcccccCCCCCChHHhhcC-CCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCCC------------
Q psy1546         198 ----TSKRNTFVGTPFWMAPEVIKQS-AYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNN------------  260 (604)
Q Consensus       198 ----~~~~~~~~GT~~Y~APE~l~~~-~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~~------------  260 (604)
                          .....+.+||+.|||||++.+. .|+.++||||||||||||++|.+||.+.+..+.+..+....            
T Consensus       212 ~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~~~  291 (398)
T 4b99_A          212 PAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVG  291 (398)
T ss_dssp             ----CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC---
T ss_pred             ccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhh
Confidence                2334578999999999999875 56899999999999999999999999988766655432110            


Q ss_pred             -----------CC-------CCCccchHHHHHHHHHHhccCCCCCCCHHHHhcChhhhhhh
Q psy1546         261 -----------PP-------QLTGNYTKQFKEFVEACLNKDPENRPTAKELLKFPFIRKAK  303 (604)
Q Consensus       261 -----------~~-------~~~~~~s~~l~~Li~~~L~~dP~~RpT~~elL~hp~f~~~~  303 (604)
                                 +.       .+...+++++.+||.+||..||.+|||+.|+|+||||++..
T Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~  352 (398)
T 4b99_A          292 AERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYH  352 (398)
T ss_dssp             --CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTTC
T ss_pred             hhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcCC
Confidence                       00       01234678999999999999999999999999999998754

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=7e-53  Score=437.83  Aligned_cols=241  Identities=23%  Similarity=0.416  Sum_probs=211.0

Q ss_pred             cceeeeEEcccCcEEEEEEEEC-----CCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCCeE----------EE
Q psy1546          58 IFTKQERIGKGSFGEVFKGIDN-----RTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTKL----------WI  122 (604)
Q Consensus        58 ~y~i~~~LG~G~fG~Vy~a~~~-----~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~~l----------yL  122 (604)
                      .|.+.++||+|+||+||+|++.     .++..||||+++... ....+.+.+|+.+|++++|||++++          ||
T Consensus        14 ~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~-~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l   92 (299)
T 4asz_A           14 NIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS-DNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM   92 (299)
T ss_dssp             GEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCC-HHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCC-hHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence            4889999999999999999875     467899999997543 3445789999999999999997765          69


Q ss_pred             EEEecCCCChhhHhhc--------------CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecc
Q psy1546         123 IMEYLGGGSALDLMKA--------------GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADF  188 (604)
Q Consensus       123 VmEy~~ggsL~~~l~~--------------~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DF  188 (604)
                      |||||++|+|.++++.              ..+++.++..|+.||+.||.|||+++||||||||+||||+.++.+||+||
T Consensus        93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~~~Ki~DF  172 (299)
T 4asz_A           93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDF  172 (299)
T ss_dssp             EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCC
T ss_pred             EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCCcEEECCc
Confidence            9999999999999964              35899999999999999999999999999999999999999999999999


Q ss_pred             cccccccCCCC--CCcccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHhhhcCCCCCCCCC
Q psy1546         189 GVAGTLTNTTS--KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAK-GEPPNSELHPMRVLFLIPKNNPPQLT  265 (604)
Q Consensus       189 GlA~~~~~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~  265 (604)
                      |+|+.......  .....+||+.|||||++.+..|+.++|||||||+||||+| |+.||.+.+..++...+..+..+..+
T Consensus       173 Gla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p  252 (299)
T 4asz_A          173 GMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRVLQRP  252 (299)
T ss_dssp             SCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHHTCCCCCC
T ss_pred             ccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCC
Confidence            99986643332  2234579999999999999999999999999999999998 99999999998888888888777888


Q ss_pred             ccchHHHHHHHHHHhccCCCCCCCHHHHhcChhhhh
Q psy1546         266 GNYTKQFKEFVEACLNKDPENRPTAKELLKFPFIRK  301 (604)
Q Consensus       266 ~~~s~~l~~Li~~~L~~dP~~RpT~~elL~hp~f~~  301 (604)
                      ..+++++.+||.+||+.||.+|||+.||+  +|++.
T Consensus       253 ~~~~~~~~~li~~cl~~dP~~RPs~~~i~--~~L~~  286 (299)
T 4asz_A          253 RTCPQEVYELMLGCWQREPHMRKNIKGIH--TLLQN  286 (299)
T ss_dssp             TTCCHHHHHHHHHHTCSSGGGSCCHHHHH--HHHHH
T ss_pred             ccchHHHHHHHHHHcCCChhHCcCHHHHH--HHHHH
Confidence            89999999999999999999999999994  46654

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=2.3e-52  Score=435.73  Aligned_cols=239  Identities=23%  Similarity=0.377  Sum_probs=211.5

Q ss_pred             cceeeeEEcccCcEEEEEEEEC-----CCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCCeE----------EE
Q psy1546          58 IFTKQERIGKGSFGEVFKGIDN-----RTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTKL----------WI  122 (604)
Q Consensus        58 ~y~i~~~LG~G~fG~Vy~a~~~-----~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~~l----------yL  122 (604)
                      .+++.++||+|+||+||+|...     .+++.||||++.........+.+.+|+.+|++++|||++++          ||
T Consensus        27 ~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~l  106 (308)
T 4gt4_A           27 AVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSM  106 (308)
T ss_dssp             GEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred             HCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEE
Confidence            3788999999999999999853     46789999999765544455789999999999999998775          69


Q ss_pred             EEEecCCCChhhHhhc-----------------CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEE
Q psy1546         123 IMEYLGGGSALDLMKA-----------------GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKL  185 (604)
Q Consensus       123 VmEy~~ggsL~~~l~~-----------------~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL  185 (604)
                      |||||++|+|.+++..                 +.+++..+..|+.||+.||.|||+++||||||||+||||++++.+||
T Consensus       107 V~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~~~~~~Ki  186 (308)
T 4gt4_A          107 IFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKI  186 (308)
T ss_dssp             EEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEE
T ss_pred             EEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEECCCCCEEE
Confidence            9999999999999853                 35899999999999999999999999999999999999999999999


Q ss_pred             ecccccccccCCC--CCCcccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHhhhcCCCCCC
Q psy1546         186 ADFGVAGTLTNTT--SKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAK-GEPPNSELHPMRVLFLIPKNNPP  262 (604)
Q Consensus       186 ~DFGlA~~~~~~~--~~~~~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~  262 (604)
                      +|||+|+.+....  ......+||+.|||||++.+..|+.++|||||||+||||+| |..||.+....++...+..+...
T Consensus       187 ~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~~i~~~~~~  266 (308)
T 4gt4_A          187 SDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIRNRQVL  266 (308)
T ss_dssp             CCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHHHHHTTCCC
T ss_pred             CCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC
Confidence            9999998764332  23445689999999999999999999999999999999998 89999999999888888888777


Q ss_pred             CCCccchHHHHHHHHHHhccCCCCCCCHHHHhcC
Q psy1546         263 QLTGNYTKQFKEFVEACLNKDPENRPTAKELLKF  296 (604)
Q Consensus       263 ~~~~~~s~~l~~Li~~~L~~dP~~RpT~~elL~h  296 (604)
                      ..+..++.++.+|+.+||+.||.+|||+.||+++
T Consensus       267 ~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~  300 (308)
T 4gt4_A          267 PCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSR  300 (308)
T ss_dssp             CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCcccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            8888999999999999999999999999999874

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=5.3e-52  Score=436.80  Aligned_cols=238  Identities=21%  Similarity=0.388  Sum_probs=204.1

Q ss_pred             cceeeeEEcccCcEEEEEEEEC-----CCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCCeE----------EE
Q psy1546          58 IFTKQERIGKGSFGEVFKGIDN-----RTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTKL----------WI  122 (604)
Q Consensus        58 ~y~i~~~LG~G~fG~Vy~a~~~-----~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~~l----------yL  122 (604)
                      .|.+.++||+|+||+||+|++.     .+++.||||+++... ....+.+.+|+.+|++++|||++++          ||
T Consensus        42 d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~-~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l  120 (329)
T 4aoj_A           42 DIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS-ESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM  120 (329)
T ss_dssp             GEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCS-HHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCC-HHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence            4788999999999999999865     468899999997543 4456789999999999999997765          69


Q ss_pred             EEEecCCCChhhHhhc----------------CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEe
Q psy1546         123 IMEYLGGGSALDLMKA----------------GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLA  186 (604)
Q Consensus       123 VmEy~~ggsL~~~l~~----------------~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~  186 (604)
                      |||||++|+|.++++.                +.+++.++..|+.||+.||.|||+++||||||||+||||+.++.+||+
T Consensus       121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~~~~~Ki~  200 (329)
T 4aoj_A          121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIG  200 (329)
T ss_dssp             EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEEC
T ss_pred             EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECCCCcEEEc
Confidence            9999999999999854                358999999999999999999999999999999999999999999999


Q ss_pred             cccccccccCCCC--CCcccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHhhhcCCCCCCC
Q psy1546         187 DFGVAGTLTNTTS--KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAK-GEPPNSELHPMRVLFLIPKNNPPQ  263 (604)
Q Consensus       187 DFGlA~~~~~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~  263 (604)
                      |||+|+.+.....  .....+||+.|||||++.+..|+.++|||||||+||||+| |+.||.+....++...+..+..+.
T Consensus       201 DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~g~~~~  280 (329)
T 4aoj_A          201 DFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELE  280 (329)
T ss_dssp             CCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHHHHTCCCC
T ss_pred             ccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCC
Confidence            9999986643322  2345689999999999999999999999999999999998 999999999888888887777778


Q ss_pred             CCccchHHHHHHHHHHhccCCCCCCCHHHHhcC
Q psy1546         264 LTGNYTKQFKEFVEACLNKDPENRPTAKELLKF  296 (604)
Q Consensus       264 ~~~~~s~~l~~Li~~~L~~dP~~RpT~~elL~h  296 (604)
                      .+..+++++.+||.+||+.||++|||+.||+++
T Consensus       281 ~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~  313 (329)
T 4aoj_A          281 RPRACPPEVYAIMRGCWQREPQQRHSIKDVHAR  313 (329)
T ss_dssp             CCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHH
T ss_pred             CcccccHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence            888999999999999999999999999999874

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=2e-51  Score=428.00  Aligned_cols=242  Identities=29%  Similarity=0.512  Sum_probs=198.8

Q ss_pred             cccCccccceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchh-hHHHHHHHHHHHHHHhhCCCCCCCeE---------
Q psy1546          51 LKVDPELIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE-AEDEIEDIQQEIMVLSQCDSPYGTKL---------  120 (604)
Q Consensus        51 ~~~~~~~~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~-~~~~~~~l~~Ei~iL~~l~hp~~~~l---------  120 (604)
                      |.++.+ .|.+.++||+|+||+||+|++..   .||||+++... .....+.+.+|+.+|++++|||++++         
T Consensus        31 Wei~~~-~l~l~~~iG~G~fG~Vy~~~~~~---~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~  106 (307)
T 3omv_A           31 WEIEAS-EVMLSTRIGSGSFGTVYKGKWHG---DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNL  106 (307)
T ss_dssp             CBCCTT-SCCEEEECCCCSSSEEEEEESSS---EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSC
T ss_pred             cEEcHH-HeEEeeEEeeCCCcEEEEEEECC---cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEECCeE
Confidence            455443 36889999999999999998653   59999986543 34456889999999999999997765         


Q ss_pred             EEEEEecCCCChhhHhhc--CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCC-
Q psy1546         121 WIIMEYLGGGSALDLMKA--GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNT-  197 (604)
Q Consensus       121 yLVmEy~~ggsL~~~l~~--~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~-  197 (604)
                      |||||||+||+|.+++..  +.+++..+..|+.||+.||.|||+++||||||||+||||+.++.+||+|||+|+..... 
T Consensus       107 ~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~  186 (307)
T 3omv_A          107 AIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWS  186 (307)
T ss_dssp             EEEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSCBC-----
T ss_pred             EEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCceecccCC
Confidence            699999999999999854  57999999999999999999999999999999999999999999999999999766432 


Q ss_pred             -CCCCcccccCCCCCChHHhhc---CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhh-hcCCCC----CCCCCccc
Q psy1546         198 -TSKRNTFVGTPFWMAPEVIKQ---SAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLF-LIPKNN----PPQLTGNY  268 (604)
Q Consensus       198 -~~~~~~~~GT~~Y~APE~l~~---~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~-~i~~~~----~~~~~~~~  268 (604)
                       .......+||+.|||||++.+   ..|+.++|||||||+||||+||+.||.+.+...... .+..+.    .+.++..+
T Consensus       187 ~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~  266 (307)
T 3omv_A          187 GSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNC  266 (307)
T ss_dssp             -------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCSTTSCTTS
T ss_pred             cceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCCcccccccc
Confidence             223456789999999999974   358999999999999999999999998876544332 222221    23456678


Q ss_pred             hHHHHHHHHHHhccCCCCCCCHHHHhcC
Q psy1546         269 TKQFKEFVEACLNKDPENRPTAKELLKF  296 (604)
Q Consensus       269 s~~l~~Li~~~L~~dP~~RpT~~elL~h  296 (604)
                      ++++.+||.+||+.||.+|||+.||+++
T Consensus       267 ~~~l~~li~~cl~~dP~~RPs~~ei~~~  294 (307)
T 3omv_A          267 PKAMKRLVADCVKKVKEERPLFPQILSS  294 (307)
T ss_dssp             CHHHHHHHHHHTCSSSTTSCCHHHHHHH
T ss_pred             hHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            9999999999999999999999998765

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=7.7e-51  Score=433.26  Aligned_cols=241  Identities=24%  Similarity=0.377  Sum_probs=195.1

Q ss_pred             ccceeeeEEcccCcEEEEEEEEC---CCCcEEEEEEecchhhHHHHHHHHHHHHHHhhC-CCCCCC----------eEEE
Q psy1546          57 LIFTKQERIGKGSFGEVFKGIDN---RTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQC-DSPYGT----------KLWI  122 (604)
Q Consensus        57 ~~y~i~~~LG~G~fG~Vy~a~~~---~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l-~hp~~~----------~lyL  122 (604)
                      +.|++.++||+|+||+||+|+++   .+++.||||++.....   ...+.+|+.+|+.+ .|||++          .+||
T Consensus        21 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~---~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~l   97 (361)
T 4f9c_A           21 NVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSH---PIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVI   97 (361)
T ss_dssp             GTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSC---HHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEE
T ss_pred             CcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccC---HHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEE
Confidence            45999999999999999999875   4678999999865543   24578899999988 699865          4589


Q ss_pred             EEEecCCCChhhHhhcCCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCC-CCeEEecccccccccCCC---
Q psy1546         123 IMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEM-GDVKLADFGVAGTLTNTT---  198 (604)
Q Consensus       123 VmEy~~ggsL~~~l~~~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~-g~vKL~DFGlA~~~~~~~---  198 (604)
                      |||||+||+|.++++  .+++.+++.|++||+.||+|||++|||||||||+||||+.+ +.+||+|||+|+......   
T Consensus        98 vmE~~~g~~L~~~~~--~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~~~~~  175 (361)
T 4f9c_A           98 AMPYLEHESFLDILN--SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIEL  175 (361)
T ss_dssp             EEECCCCCCHHHHHT--TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECTTCSCGG
T ss_pred             EEeCCCcccHHHHHc--CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCccccc
Confidence            999999999999985  59999999999999999999999999999999999999876 799999999997554321   


Q ss_pred             -------------------------CCCcccccCCCCCChHHhhcC-CCCCcchhhhHHHHHHHHHhCCCCCCCCC-hhh
Q psy1546         199 -------------------------SKRNTFVGTPFWMAPEVIKQS-AYDSKADIWSLGITAIELAKGEPPNSELH-PMR  251 (604)
Q Consensus       199 -------------------------~~~~~~~GT~~Y~APE~l~~~-~~~~~sDVwSLGviL~eLltG~~Pf~~~~-~~~  251 (604)
                                               ....+.+||+.|||||++.+. .|+.++||||+|||||||++|+.||.... ...
T Consensus       176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~~~~~  255 (361)
T 4f9c_A          176 LKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKASDDLT  255 (361)
T ss_dssp             GGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHH
T ss_pred             cccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCCCCHHH
Confidence                                     112346899999999999876 58999999999999999999999985433 222


Q ss_pred             HhhhcCC-----------------------------------------------------CCCCCCCccchHHHHHHHHH
Q psy1546         252 VLFLIPK-----------------------------------------------------NNPPQLTGNYTKQFKEFVEA  278 (604)
Q Consensus       252 ~~~~i~~-----------------------------------------------------~~~~~~~~~~s~~l~~Li~~  278 (604)
                      .+..+..                                                     .........+++++++||.+
T Consensus       256 ~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a~DLl~~  335 (361)
T 4f9c_A          256 ALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEAYDLLDK  335 (361)
T ss_dssp             HHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHHHHHHHHH
T ss_pred             HHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHHHHHHHHH
Confidence            2211100                                                     00011234578899999999


Q ss_pred             HhccCCCCCCCHHHHhcChhhhhh
Q psy1546         279 CLNKDPENRPTAKELLKFPFIRKA  302 (604)
Q Consensus       279 ~L~~dP~~RpT~~elL~hp~f~~~  302 (604)
                      ||..||.+|+|++|+|+||||+..
T Consensus       336 lL~~dP~~R~ta~eaL~Hp~f~~i  359 (361)
T 4f9c_A          336 LLDLNPASRITAEEALLHPFFKDM  359 (361)
T ss_dssp             HTCSCTTTSCCHHHHHTSGGGTTC
T ss_pred             HCcCChhHCcCHHHHhcCcccCCC
Confidence            999999999999999999999753

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=5.7e-51  Score=432.76  Aligned_cols=240  Identities=24%  Similarity=0.400  Sum_probs=209.2

Q ss_pred             ccceeeeEEcccCcEEEEEEEECCC-----CcEEEEEEecchhhHHHHHHHHHHHHHHhhCCC-CCCCe-----------
Q psy1546          57 LIFTKQERIGKGSFGEVFKGIDNRT-----QQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDS-PYGTK-----------  119 (604)
Q Consensus        57 ~~y~i~~~LG~G~fG~Vy~a~~~~t-----~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~h-p~~~~-----------  119 (604)
                      +.|++.++||+|+||+||+|.+..+     ++.||||++.........+.+.+|+.+|.++.| ||+++           
T Consensus        64 ~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~~~  143 (353)
T 4ase_A           64 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP  143 (353)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSC
T ss_pred             HHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecCCE
Confidence            4589999999999999999987653     468999999876666667889999999999976 77654           


Q ss_pred             EEEEEEecCCCChhhHhhc-----------------CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCC
Q psy1546         120 LWIIMEYLGGGSALDLMKA-----------------GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGD  182 (604)
Q Consensus       120 lyLVmEy~~ggsL~~~l~~-----------------~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~  182 (604)
                      +|||||||++|+|.++|+.                 ..+++.++..|+.||+.||.|||+++||||||||+||||+.++.
T Consensus       144 ~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NILl~~~~~  223 (353)
T 4ase_A          144 LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNV  223 (353)
T ss_dssp             CEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC
T ss_pred             EEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccceeeCCCCC
Confidence            4799999999999999964                 24889999999999999999999999999999999999999999


Q ss_pred             eEEecccccccccCCCC--CCcccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChh-hHhhhcCC
Q psy1546         183 VKLADFGVAGTLTNTTS--KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAK-GEPPNSELHPM-RVLFLIPK  258 (604)
Q Consensus       183 vKL~DFGlA~~~~~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLlt-G~~Pf~~~~~~-~~~~~i~~  258 (604)
                      +||+|||+|+.+.....  .....+||+.|||||++.+..|+.++|||||||+||||+| |..||.+.... .+...+..
T Consensus       224 vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~~~~~i~~  303 (353)
T 4ase_A          224 VKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKE  303 (353)
T ss_dssp             EEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHH
T ss_pred             EEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHHHHHHHHHc
Confidence            99999999987654332  2345789999999999999999999999999999999998 99999887643 34445555


Q ss_pred             CCCCCCCccchHHHHHHHHHHhccCCCCCCCHHHHhcC
Q psy1546         259 NNPPQLTGNYTKQFKEFVEACLNKDPENRPTAKELLKF  296 (604)
Q Consensus       259 ~~~~~~~~~~s~~l~~Li~~~L~~dP~~RpT~~elL~h  296 (604)
                      +..+..+..+++++.+||.+||+.||.+|||+.||++|
T Consensus       304 g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~  341 (353)
T 4ase_A          304 GTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  341 (353)
T ss_dssp             TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence            66677788899999999999999999999999999987

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=1e-50  Score=458.69  Aligned_cols=245  Identities=29%  Similarity=0.469  Sum_probs=208.4

Q ss_pred             cceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhH-----HHHHHHHHHHHHHhhCCCCCCCe----------EEE
Q psy1546          58 IFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAE-----DEIEDIQQEIMVLSQCDSPYGTK----------LWI  122 (604)
Q Consensus        58 ~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~-----~~~~~l~~Ei~iL~~l~hp~~~~----------lyL  122 (604)
                      .|.++++||+|+||+||+|+++.+|+.||||++.+....     ........++.+++.++|||+++          +||
T Consensus       190 df~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~lyl  269 (689)
T 3v5w_A          190 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSF  269 (689)
T ss_dssp             GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEE
T ss_pred             HeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEEE
Confidence            399999999999999999999999999999999765322     12233345577888899999765          479


Q ss_pred             EEEecCCCChhhHhhc-CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCCCC
Q psy1546         123 IMEYLGGGSALDLMKA-GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKR  201 (604)
Q Consensus       123 VmEy~~ggsL~~~l~~-~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~~  201 (604)
                      |||||.||+|.+++.. +.|++..++.|+.||+.||.|||++|||||||||+||||+.+|++||+|||+|+.+...  ..
T Consensus       270 VmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~~~--~~  347 (689)
T 3v5w_A          270 ILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK--KP  347 (689)
T ss_dssp             EECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC--CC
T ss_pred             EEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecccceeeecCCC--CC
Confidence            9999999999999865 78999999999999999999999999999999999999999999999999999876533  34


Q ss_pred             cccccCCCCCChHHhh-cCCCCCcchhhhHHHHHHHHHhCCCCCCCCChh---hHhhhcCCCCCCCCCccchHHHHHHHH
Q psy1546         202 NTFVGTPFWMAPEVIK-QSAYDSKADIWSLGITAIELAKGEPPNSELHPM---RVLFLIPKNNPPQLTGNYTKQFKEFVE  277 (604)
Q Consensus       202 ~~~~GT~~Y~APE~l~-~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~---~~~~~i~~~~~~~~~~~~s~~l~~Li~  277 (604)
                      .+.+||+.|||||++. +..|+.++|||||||+||||++|.+||.+....   .+...+. .....++..+++++++||.
T Consensus       348 ~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~-~~~~~~p~~~S~~a~dLI~  426 (689)
T 3v5w_A          348 HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL-TMAVELPDSFSPELRSLLE  426 (689)
T ss_dssp             CSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHH-HCCCCCCTTSCHHHHHHHH
T ss_pred             CCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhc-CCCCCCCccCCHHHHHHHH
Confidence            5789999999999996 467999999999999999999999999764432   2222222 2334567789999999999


Q ss_pred             HHhccCCCCCCC-----HHHHhcChhhhhhhhh
Q psy1546         278 ACLNKDPENRPT-----AKELLKFPFIRKAKKN  305 (604)
Q Consensus       278 ~~L~~dP~~RpT-----~~elL~hp~f~~~~~~  305 (604)
                      +||..||.+|++     ++||++||||+...+.
T Consensus       427 ~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~idW~  459 (689)
T 3v5w_A          427 GLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQ  459 (689)
T ss_dssp             HHTCSCGGGCTTCSSSTHHHHTTSGGGTTCCHH
T ss_pred             HHccCCHhHCCCCCCCCHHHHhcCccccCCCHH
Confidence            999999999998     7999999999876543

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=8.6e-51  Score=457.56  Aligned_cols=244  Identities=24%  Similarity=0.399  Sum_probs=216.6

Q ss_pred             cceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCCeE----------EEEEEec
Q psy1546          58 IFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTKL----------WIIMEYL  127 (604)
Q Consensus        58 ~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~~l----------yLVmEy~  127 (604)
                      .|.+++.||+|+||+||+|.++.+|+.||||++..... ...+.+.+|+.+|+.++|||++++          |||||||
T Consensus       158 ~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~-~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~  236 (573)
T 3uto_A          158 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHE-SDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM  236 (573)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSH-HHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred             ccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccch-hhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeec
Confidence            49999999999999999999999999999999966543 335778899999999999997654          7999999


Q ss_pred             CCCChhhHhh--cCCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCC--CCeEEecccccccccCCCCCCcc
Q psy1546         128 GGGSALDLMK--AGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEM--GDVKLADFGVAGTLTNTTSKRNT  203 (604)
Q Consensus       128 ~ggsL~~~l~--~~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~--g~vKL~DFGlA~~~~~~~~~~~~  203 (604)
                      +||+|.+++.  .+.|++.+++.|++||+.||+|||++||+||||||+||||+.+  +.+||+|||+|+.+... ....+
T Consensus       237 ~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~-~~~~~  315 (573)
T 3uto_A          237 SGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK-QSVKV  315 (573)
T ss_dssp             CCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT-SEEEE
T ss_pred             CCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEccCC-Cceee
Confidence            9999999885  3679999999999999999999999999999999999999854  89999999999877533 33456


Q ss_pred             cccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCCCC---CCCCccchHHHHHHHHHHh
Q psy1546         204 FVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNP---PQLTGNYTKQFKEFVEACL  280 (604)
Q Consensus       204 ~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~~~---~~~~~~~s~~l~~Li~~~L  280 (604)
                      .+||+.|||||++.+..|+.++|||||||+||||++|.+||.+.+..+.+..+.....   ......+++++++||.+||
T Consensus       316 ~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~~L  395 (573)
T 3uto_A          316 TTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLL  395 (573)
T ss_dssp             ECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSGGGTTSCHHHHHHHHTTS
T ss_pred             eEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHHHHc
Confidence            7899999999999999999999999999999999999999999998888777655442   2334568999999999999


Q ss_pred             ccCCCCCCCHHHHhcChhhhhhh
Q psy1546         281 NKDPENRPTAKELLKFPFIRKAK  303 (604)
Q Consensus       281 ~~dP~~RpT~~elL~hp~f~~~~  303 (604)
                      ..||.+|||+.|+|+||||+...
T Consensus       396 ~~dp~~R~t~~e~l~Hpw~~~~~  418 (573)
T 3uto_A          396 LADPNTRMTIHQALEHPWLTPGN  418 (573)
T ss_dssp             CSSGGGSCCHHHHHHSTTTSCCC
T ss_pred             cCChhHCcCHHHHhcCcCcCCCC
Confidence            99999999999999999998643

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=2.7e-48  Score=400.88  Aligned_cols=259  Identities=43%  Similarity=0.734  Sum_probs=225.3

Q ss_pred             cccceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCCeE----------EEEEE
Q psy1546          56 ELIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTKL----------WIIME  125 (604)
Q Consensus        56 ~~~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~~l----------yLVmE  125 (604)
                      ...|++.++||+|+||+||+|.+..+++.||||++....... .+.+.+|+.+++.+.|||+.++          |+|||
T Consensus        19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   97 (297)
T 3fxz_A           19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK-KELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME   97 (297)
T ss_dssp             GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSC-HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccH-HHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEE
Confidence            445999999999999999999999999999999986554332 4678899999999999997654          79999


Q ss_pred             ecCCCChhhHhhcCCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCCCCcccc
Q psy1546         126 YLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFV  205 (604)
Q Consensus       126 y~~ggsL~~~l~~~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~~~~~~  205 (604)
                      ||++|+|.+++....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.............+
T Consensus        98 ~~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  177 (297)
T 3fxz_A           98 YLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV  177 (297)
T ss_dssp             CCTTCBHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCBCCCC
T ss_pred             CCCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCcccccCCcc
Confidence            99999999999998999999999999999999999999999999999999999999999999999987766555666778


Q ss_pred             cCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCCC--CCCCCccchHHHHHHHHHHhccC
Q psy1546         206 GTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNN--PPQLTGNYTKQFKEFVEACLNKD  283 (604)
Q Consensus       206 GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~~--~~~~~~~~s~~l~~Li~~~L~~d  283 (604)
                      ||+.|+|||++.+..++.++|||||||++|+|++|..||...........+....  ....+..++..+.+||.+||..|
T Consensus       178 gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~d  257 (297)
T 3fxz_A          178 GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLEMD  257 (297)
T ss_dssp             SCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSCGGGSCHHHHHHHHHHSCSS
T ss_pred             CCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCHHHHHHHHHHccCC
Confidence            9999999999999999999999999999999999999999887766554433222  23345678999999999999999


Q ss_pred             CCCCCCHHHHhcChhhhhhhhhhhHHHHHHHH
Q psy1546         284 PENRPTAKELLKFPFIRKAKKNAYLIDLIDRY  315 (604)
Q Consensus       284 P~~RpT~~elL~hp~f~~~~~~~~l~~~~~~~  315 (604)
                      |.+|||+.|+|+||||+...............
T Consensus       258 p~~Rps~~ell~h~~~~~~~~~~~~~p~~~~~  289 (297)
T 3fxz_A          258 VEKRGSAKELLQHQFLKIAKPLSSLTPLIAAA  289 (297)
T ss_dssp             TTTSCCHHHHTTCGGGGGCCCGGGGHHHHHHH
T ss_pred             hhHCcCHHHHhhChhhcccCcccccchHHHHH
Confidence            99999999999999998876655555444433

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=1.3e-47  Score=394.82  Aligned_cols=273  Identities=81%  Similarity=1.265  Sum_probs=244.4

Q ss_pred             cccCccccceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCCe----------E
Q psy1546          51 LKVDPELIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTK----------L  120 (604)
Q Consensus        51 ~~~~~~~~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~~----------l  120 (604)
                      +..+.+..|.+.+.||+|+||.||+|.+..+++.||||++.........+.+.+|+.+++.+.||++.+          +
T Consensus        16 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   95 (303)
T 3a7i_A           16 LKADPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKL   95 (303)
T ss_dssp             CEECGGGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred             CCCChHHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeE
Confidence            345667779999999999999999999999999999999977655556788999999999999998654          4


Q ss_pred             EEEEEecCCCChhhHhhcCCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCCC
Q psy1546         121 WIIMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSK  200 (604)
Q Consensus       121 yLVmEy~~ggsL~~~l~~~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~  200 (604)
                      |+||||+++++|.+++..+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+......
T Consensus        96 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  175 (303)
T 3a7i_A           96 WIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK  175 (303)
T ss_dssp             EEEEECCTTEEHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBCC
T ss_pred             EEEEEeCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecCccccc
Confidence            79999999999999999999999999999999999999999999999999999999999999999999999777655545


Q ss_pred             CcccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCCCCCCCCccchHHHHHHHHHHh
Q psy1546         201 RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACL  280 (604)
Q Consensus       201 ~~~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~~L  280 (604)
                      .....||+.|+|||++.+..++.++|||||||++|+|++|..||...........+.....+.+...++..+.+||.+||
T Consensus       176 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l  255 (303)
T 3a7i_A          176 RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACL  255 (303)
T ss_dssp             BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCSSCCHHHHHHHHHHC
T ss_pred             cCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCCCCCCccccCHHHHHHHHHHc
Confidence            56678999999999999999999999999999999999999999998888777776666677778889999999999999


Q ss_pred             ccCCCCCCCHHHHhcChhhhhhh-hhhhHHHHHHHHHHHhhhcc
Q psy1546         281 NKDPENRPTAKELLKFPFIRKAK-KNAYLIDLIDRYKKWKNSRN  323 (604)
Q Consensus       281 ~~dP~~RpT~~elL~hp~f~~~~-~~~~l~~~~~~~~~~~~~~~  323 (604)
                      ..||.+|||+.+|++||||.... ...++.++++++++|.....
T Consensus       256 ~~dp~~Rps~~~ll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (303)
T 3a7i_A          256 NKEPSFRPTAKELLKHKFILRNAKKTSYLTELIDRYKRWKAEQS  299 (303)
T ss_dssp             CSSGGGSCCHHHHTTCHHHHHHCCCGGGGHHHHHHHHHHHHHCC
T ss_pred             CCChhhCcCHHHHhhChhhhcCCCccHHHHHHHHHHHHhhhhcc
Confidence            99999999999999999996654 45677889999999977544

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=2.8e-48  Score=403.86  Aligned_cols=235  Identities=27%  Similarity=0.362  Sum_probs=186.8

Q ss_pred             cceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCCe--------------EEEE
Q psy1546          58 IFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTK--------------LWII  123 (604)
Q Consensus        58 ~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~~--------------lyLV  123 (604)
                      .|.+.++||+|+||+||+|++  +|+.||||++.......  .....|+..+..++|||+++              +|||
T Consensus         4 ~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~~~~--~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV   79 (303)
T 3hmm_A            4 TIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERS--WFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV   79 (303)
T ss_dssp             GEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGGHHH--HHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred             EEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccchhh--HHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEE
Confidence            378899999999999999987  58999999997654322  33456777788999999654              4799


Q ss_pred             EEecCCCChhhHhhcCCCcHHHHHHHHHHHHHHhHHhhhC--------CccccccccceeEecCCCCeEEeccccccccc
Q psy1546         124 MEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSE--------RKLHRDIKAANVLLSEMGDVKLADFGVAGTLT  195 (604)
Q Consensus       124 mEy~~ggsL~~~l~~~~lse~~i~~i~~qIl~gL~yLHs~--------gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~  195 (604)
                      ||||++|+|.++++...+++..+..++.|++.||.|||++        +||||||||+||||+.++.+||+|||+|+...
T Consensus        80 ~Ey~~~gsL~~~l~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~  159 (303)
T 3hmm_A           80 SDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHD  159 (303)
T ss_dssp             EECCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEEE
T ss_pred             ecCCCCCcHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCcccc
Confidence            9999999999999999999999999999999999999987        99999999999999999999999999998765


Q ss_pred             CCCC----CCcccccCCCCCChHHhhcC------CCCCcchhhhHHHHHHHHHhCCCCCCCCCh---------------h
Q psy1546         196 NTTS----KRNTFVGTPFWMAPEVIKQS------AYDSKADIWSLGITAIELAKGEPPNSELHP---------------M  250 (604)
Q Consensus       196 ~~~~----~~~~~~GT~~Y~APE~l~~~------~~~~~sDVwSLGviL~eLltG~~Pf~~~~~---------------~  250 (604)
                      ....    .....+||+.|||||++.+.      .|+.++|||||||+||||+||.+||.....               .
T Consensus       160 ~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~~  239 (303)
T 3hmm_A          160 SATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVE  239 (303)
T ss_dssp             TTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHH
T ss_pred             CCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccchHH
Confidence            4332    22346899999999999765      366789999999999999999876543211               1


Q ss_pred             hHhhhc-CCCCCCCCCcc-----chHHHHHHHHHHhccCCCCCCCHHHHhcC
Q psy1546         251 RVLFLI-PKNNPPQLTGN-----YTKQFKEFVEACLNKDPENRPTAKELLKF  296 (604)
Q Consensus       251 ~~~~~i-~~~~~~~~~~~-----~s~~l~~Li~~~L~~dP~~RpT~~elL~h  296 (604)
                      .....+ .....+.++..     .+..+.+|+.+||+.||.+|||+.||++.
T Consensus       240 ~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~  291 (303)
T 3hmm_A          240 EMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT  291 (303)
T ss_dssp             HHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence            122212 22233344432     34678999999999999999999999873

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=2.9e-47  Score=401.76  Aligned_cols=246  Identities=30%  Similarity=0.480  Sum_probs=217.4

Q ss_pred             cceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhh--HHHHHHHHHHHHHHhhCCCCCCCe----------EEEEEE
Q psy1546          58 IFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA--EDEIEDIQQEIMVLSQCDSPYGTK----------LWIIME  125 (604)
Q Consensus        58 ~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~--~~~~~~l~~Ei~iL~~l~hp~~~~----------lyLVmE  125 (604)
                      .|.+++.||+|+||+||+|++..+++.||||++.+...  ......+.+|+.+|+.+.||++.+          +|+|||
T Consensus         6 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~E   85 (337)
T 1o6l_A            6 DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVME   85 (337)
T ss_dssp             GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             HeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEEe
Confidence            49999999999999999999999999999999976532  233567889999999999998654          479999


Q ss_pred             ecCCCChhhHhhc-CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCCCCccc
Q psy1546         126 YLGGGSALDLMKA-GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTF  204 (604)
Q Consensus       126 y~~ggsL~~~l~~-~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~~~~~  204 (604)
                      |++||+|..++.. +.+++..++.++.||+.||.|||++||+||||||+||||+.+|.+||+|||+|+..........+.
T Consensus        86 ~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~~~~~  165 (337)
T 1o6l_A           86 YANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTF  165 (337)
T ss_dssp             CCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTCCBCCC
T ss_pred             CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhcccCCCccccc
Confidence            9999999998865 679999999999999999999999999999999999999999999999999997655444555678


Q ss_pred             ccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCCCCCCCCccchHHHHHHHHHHhccCC
Q psy1546         205 VGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDP  284 (604)
Q Consensus       205 ~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~~L~~dP  284 (604)
                      +||+.|+|||++.+..|+.++|||||||++|||++|..||...+.......+.... ..++..++.++.+||.+||..||
T Consensus       166 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~~lL~~dP  244 (337)
T 1o6l_A          166 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEE-IRFPRTLSPEAKSLLAGLLKKDP  244 (337)
T ss_dssp             EECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-CCCCTTSCHHHHHHHHHHTCSST
T ss_pred             ccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCC-CCCCCCCCHHHHHHHHHHhhcCH
Confidence            99999999999999999999999999999999999999999888776665554332 34567789999999999999999


Q ss_pred             CCCC-----CHHHHhcChhhhhhhh
Q psy1546         285 ENRP-----TAKELLKFPFIRKAKK  304 (604)
Q Consensus       285 ~~Rp-----T~~elL~hp~f~~~~~  304 (604)
                      .+||     ++.||++||||+...+
T Consensus       245 ~~R~g~~~~~~~ei~~h~~f~~~~~  269 (337)
T 1o6l_A          245 KQRLGGGPSDAKEVMEHRFFLSINW  269 (337)
T ss_dssp             TTSTTCSTTTHHHHHTSGGGTTCCH
T ss_pred             HHhcCCCCCCHHHHHcCCCcCCCCH
Confidence            9999     9999999999987543

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=4.5e-47  Score=398.50  Aligned_cols=244  Identities=28%  Similarity=0.484  Sum_probs=215.4

Q ss_pred             cceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhh-HHHHHHHHHHHHHHhhCCCCCCCe----------EEEEEEe
Q psy1546          58 IFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA-EDEIEDIQQEIMVLSQCDSPYGTK----------LWIIMEY  126 (604)
Q Consensus        58 ~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~-~~~~~~l~~Ei~iL~~l~hp~~~~----------lyLVmEy  126 (604)
                      .|.+.+.||+|+||.||+|.+..+|+.||||++..... ....+.+.+|+.+|+.++|||+.+          +|+||||
T Consensus        16 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~   95 (328)
T 3fe3_A           16 NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEY   95 (328)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             CEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEEC
Confidence            39999999999999999999999999999999976543 345677889999999999999665          4799999


Q ss_pred             cCCCChhhHhh-cCCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCCCCcccc
Q psy1546         127 LGGGSALDLMK-AGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFV  205 (604)
Q Consensus       127 ~~ggsL~~~l~-~~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~~~~~~  205 (604)
                      +++|+|.+++. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... ......+
T Consensus        96 ~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~-~~~~~~~  174 (328)
T 3fe3_A           96 ASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVG-GKLDAFC  174 (328)
T ss_dssp             CTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSS-CGGGTTS
T ss_pred             CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCceecCCC-Ccccccc
Confidence            99999999885 478999999999999999999999999999999999999999999999999999766433 3345678


Q ss_pred             cCCCCCChHHhhcCCCC-CcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCCCCCCCCccchHHHHHHHHHHhccCC
Q psy1546         206 GTPFWMAPEVIKQSAYD-SKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDP  284 (604)
Q Consensus       206 GT~~Y~APE~l~~~~~~-~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~~L~~dP  284 (604)
                      ||+.|+|||++.+..++ .++|||||||+||+|++|..||.+.+.......+..+.. .++..++.++.+||.+||..||
T Consensus       175 gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~li~~~L~~dP  253 (328)
T 3fe3_A          175 GAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKY-RIPFYMSTDCENLLKRFLVLNP  253 (328)
T ss_dssp             SSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-CCCTTSCHHHHHHHHHHCCSST
T ss_pred             CCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-CCCCCCCHHHHHHHHHHCCCCh
Confidence            99999999999988876 789999999999999999999999888777666554432 4556789999999999999999


Q ss_pred             CCCCCHHHHhcChhhhhhh
Q psy1546         285 ENRPTAKELLKFPFIRKAK  303 (604)
Q Consensus       285 ~~RpT~~elL~hp~f~~~~  303 (604)
                      .+|||++|+++||||+...
T Consensus       254 ~~R~t~~eil~h~~~~~~~  272 (328)
T 3fe3_A          254 IKRGTLEQIMKDRWINAGH  272 (328)
T ss_dssp             TTSCCHHHHTTCTTTTTTC
T ss_pred             hHCcCHHHHhcCHhhcCCC
Confidence            9999999999999997543

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=1.5e-47  Score=406.44  Aligned_cols=246  Identities=26%  Similarity=0.470  Sum_probs=212.2

Q ss_pred             cceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhh--HHHHHHHHHHHHHHhhC-CCCCCCe----------EEEEE
Q psy1546          58 IFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA--EDEIEDIQQEIMVLSQC-DSPYGTK----------LWIIM  124 (604)
Q Consensus        58 ~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~--~~~~~~l~~Ei~iL~~l-~hp~~~~----------lyLVm  124 (604)
                      .|.+.++||+|+||.||+|+++.+++.||||++.+...  ....+.+.+|+.+|..+ .||++++          +||||
T Consensus        24 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lv~  103 (353)
T 3txo_A           24 NFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVM  103 (353)
T ss_dssp             CEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             heEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEEEE
Confidence            39999999999999999999999999999999976532  23456788999999987 7998654          47999


Q ss_pred             EecCCCChhhHhhc-CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCCCCcc
Q psy1546         125 EYLGGGSALDLMKA-GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNT  203 (604)
Q Consensus       125 Ey~~ggsL~~~l~~-~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~~~~  203 (604)
                      |||+||+|..++.. +.+++..++.++.||+.||.|||++||+||||||+||||+.+|.+||+|||+|+..........+
T Consensus       104 E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~~~~~~~  183 (353)
T 3txo_A          104 EFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTAT  183 (353)
T ss_dssp             ECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC-------
T ss_pred             eCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceeecccCCccccc
Confidence            99999999998865 78999999999999999999999999999999999999999999999999999765545555667


Q ss_pred             cccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCCCCCCCCccchHHHHHHHHHHhccC
Q psy1546         204 FVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKD  283 (604)
Q Consensus       204 ~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~~L~~d  283 (604)
                      .+||+.|+|||++.+..|+.++|||||||++|||++|.+||...+..++...+.... ..++..++..+.+||.+||..|
T Consensus       184 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~~~~~~~li~~lL~~d  262 (353)
T 3txo_A          184 FCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDE-VVYPTWLHEDATGILKSFMTKN  262 (353)
T ss_dssp             --CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-CCCCTTSCHHHHHHHHHHTCSS
T ss_pred             cCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCC-CCCCCCCCHHHHHHHHHHhhhC
Confidence            899999999999999999999999999999999999999999988887777665543 3456678999999999999999


Q ss_pred             CCCCCCH------HHHhcChhhhhhhh
Q psy1546         284 PENRPTA------KELLKFPFIRKAKK  304 (604)
Q Consensus       284 P~~RpT~------~elL~hp~f~~~~~  304 (604)
                      |.+||++      .||++||||+...+
T Consensus       263 P~~R~~~~~~~~~~~il~hp~f~~~~w  289 (353)
T 3txo_A          263 PTMRLGSLTQGGEHAILRHPFFKEIDW  289 (353)
T ss_dssp             GGGSTTSGGGTCTHHHHTSGGGTTCCH
T ss_pred             HHHccCCcccCCHHHHhhCCcccCCCH
Confidence            9999998      99999999987543

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=1.2e-46  Score=393.07  Aligned_cols=259  Identities=36%  Similarity=0.677  Sum_probs=224.8

Q ss_pred             ccceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCCe----------EEEEEEe
Q psy1546          57 LIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTK----------LWIIMEY  126 (604)
Q Consensus        57 ~~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~~----------lyLVmEy  126 (604)
                      ..|...++||+|+||.||+|.+..+|+.||||++..... ...+.+.+|+.+++.+.||++.+          +|+||||
T Consensus        45 ~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  123 (321)
T 2c30_A           45 LLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQ-QRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEF  123 (321)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-CSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             hhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccch-hHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEec
Confidence            347888999999999999999999999999999965443 23467889999999999999655          4799999


Q ss_pred             cCCCChhhHhhcCCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCCCCccccc
Q psy1546         127 LGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVG  206 (604)
Q Consensus       127 ~~ggsL~~~l~~~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~~~~~~G  206 (604)
                      +++++|.+++....+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+..........+|
T Consensus       124 ~~~~~L~~~l~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g  203 (321)
T 2c30_A          124 LQGGALTDIVSQVRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVG  203 (321)
T ss_dssp             CCSCBHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBCCCCS
T ss_pred             CCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCccccccccC
Confidence            99999999999889999999999999999999999999999999999999999999999999999877655445566789


Q ss_pred             CCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCCCCCC--CCccchHHHHHHHHHHhccCC
Q psy1546         207 TPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQ--LTGNYTKQFKEFVEACLNKDP  284 (604)
Q Consensus       207 T~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~--~~~~~s~~l~~Li~~~L~~dP  284 (604)
                      |+.|+|||++.+..++.++|||||||++|+|++|..||...........+.....+.  ....++..+.+||.+||..||
T Consensus       204 t~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp  283 (321)
T 2c30_A          204 TPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKVSPVLRDFLERMLVRDP  283 (321)
T ss_dssp             CGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCTTGGGSCHHHHHHHHHHSCSST
T ss_pred             CccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCcCccccCCHHHHHHHHHHccCCh
Confidence            999999999999999999999999999999999999999887766655544433332  234678999999999999999


Q ss_pred             CCCCCHHHHhcChhhhhhhhhhhHHHHHHHHH
Q psy1546         285 ENRPTAKELLKFPFIRKAKKNAYLIDLIDRYK  316 (604)
Q Consensus       285 ~~RpT~~elL~hp~f~~~~~~~~l~~~~~~~~  316 (604)
                      .+|||+.|+++||||.+......+..++..++
T Consensus       284 ~~Rps~~ell~hp~~~~~~~~~~~~~~~~~~~  315 (321)
T 2c30_A          284 QERATAQELLDHPFLLQTGLPECLVPLIQLYR  315 (321)
T ss_dssp             TTSCCHHHHHTSGGGGGCCCGGGGHHHHHHC-
T ss_pred             hhCcCHHHHhcChhhccCCCcccchHHHHHHH
Confidence            99999999999999988776666666665554

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=6e-47  Score=400.68  Aligned_cols=246  Identities=31%  Similarity=0.534  Sum_probs=217.1

Q ss_pred             cceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhh--HHHHHHHHHHHHHHhhC-CCCCCCe----------EEEEE
Q psy1546          58 IFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA--EDEIEDIQQEIMVLSQC-DSPYGTK----------LWIIM  124 (604)
Q Consensus        58 ~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~--~~~~~~l~~Ei~iL~~l-~hp~~~~----------lyLVm  124 (604)
                      .|.+.+.||+|+||.||+|+++.+++.||||++.....  ......+..|..++..+ .||++.+          +|+||
T Consensus        18 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~lv~   97 (345)
T 1xjd_A           18 DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVM   97 (345)
T ss_dssp             TEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             HeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEEEEE
Confidence            39999999999999999999999999999999976532  22356678899998876 9998654          47999


Q ss_pred             EecCCCChhhHhhc-CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCCCCcc
Q psy1546         125 EYLGGGSALDLMKA-GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNT  203 (604)
Q Consensus       125 Ey~~ggsL~~~l~~-~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~~~~  203 (604)
                      |||+||+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+||||+.+|.+||+|||+|+...........
T Consensus        98 E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~~~~  177 (345)
T 1xjd_A           98 EYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT  177 (345)
T ss_dssp             ECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCCBCC
T ss_pred             eCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhhcccCCCcccC
Confidence            99999999999875 78999999999999999999999999999999999999999999999999999765544445567


Q ss_pred             cccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCCCCCCCCccchHHHHHHHHHHhccC
Q psy1546         204 FVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKD  283 (604)
Q Consensus       204 ~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~~L~~d  283 (604)
                      .+||+.|+|||++.+..|+.++|||||||++|||++|..||.+.+...+...+.... ..++..++.++.+||.+||..|
T Consensus       178 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~~lL~~d  256 (345)
T 1xjd_A          178 FCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDN-PFYPRWLEKEAKDLLVKLFVRE  256 (345)
T ss_dssp             CCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-CCCCTTSCHHHHHHHHHHSCSS
T ss_pred             CCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCC-CCCCcccCHHHHHHHHHHhcCC
Confidence            899999999999999999999999999999999999999999988877766654443 3456778999999999999999


Q ss_pred             CCCCCCHH-HHhcChhhhhhhh
Q psy1546         284 PENRPTAK-ELLKFPFIRKAKK  304 (604)
Q Consensus       284 P~~RpT~~-elL~hp~f~~~~~  304 (604)
                      |.+||++. +|++||||+...+
T Consensus       257 p~~R~~~~~~i~~hp~f~~~~w  278 (345)
T 1xjd_A          257 PEKRLGVRGDIRQHPLFREINW  278 (345)
T ss_dssp             GGGSBTTBSCGGGSGGGTTCCH
T ss_pred             HhHcCCChHHHHcCccccCCCH
Confidence            99999998 9999999987644

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.1e-46  Score=387.52  Aligned_cols=244  Identities=27%  Similarity=0.505  Sum_probs=206.3

Q ss_pred             cceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhH-------------------------HHHHHHHHHHHHHhhC
Q psy1546          58 IFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAE-------------------------DEIEDIQQEIMVLSQC  112 (604)
Q Consensus        58 ~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~-------------------------~~~~~l~~Ei~iL~~l  112 (604)
                      .|.+.+.||+|+||.||+|.+..+++.||||++......                         ...+.+.+|+.+|+.+
T Consensus        14 ~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l   93 (298)
T 2zv2_A           14 QYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKKL   93 (298)
T ss_dssp             TEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHTC
T ss_pred             ceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHhC
Confidence            399999999999999999999999999999998654321                         1235688999999999


Q ss_pred             CCCCCC------------eEEEEEEecCCCChhhHhhcCCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCC
Q psy1546         113 DSPYGT------------KLWIIMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEM  180 (604)
Q Consensus       113 ~hp~~~------------~lyLVmEy~~ggsL~~~l~~~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~  180 (604)
                      .|||+.            .+|+||||+++++|.+++..+.+++..++.++.||+.||.|||++||+||||||+|||++.+
T Consensus        94 ~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~  173 (298)
T 2zv2_A           94 DHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGED  173 (298)
T ss_dssp             CCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTT
T ss_pred             CCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCC
Confidence            999854            35899999999999999888899999999999999999999999999999999999999999


Q ss_pred             CCeEEecccccccccCCCCCCcccccCCCCCChHHhhcCC---CCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcC
Q psy1546         181 GDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSA---YDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIP  257 (604)
Q Consensus       181 g~vKL~DFGlA~~~~~~~~~~~~~~GT~~Y~APE~l~~~~---~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~  257 (604)
                      +.+||+|||+++.+..........+||+.|+|||++.+..   ++.++|||||||++|+|++|..||...........+.
T Consensus       174 ~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~  253 (298)
T 2zv2_A          174 GHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLHSKIK  253 (298)
T ss_dssp             SCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred             CCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHHHHHHHHh
Confidence            9999999999987665444445678999999999997765   3678999999999999999999999877665554443


Q ss_pred             CCCC-CCCCccchHHHHHHHHHHhccCCCCCCCHHHHhcChhhhh
Q psy1546         258 KNNP-PQLTGNYTKQFKEFVEACLNKDPENRPTAKELLKFPFIRK  301 (604)
Q Consensus       258 ~~~~-~~~~~~~s~~l~~Li~~~L~~dP~~RpT~~elL~hp~f~~  301 (604)
                      .... ......+++++.+||.+||..||.+|||+.|||+||||++
T Consensus       254 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~~~  298 (298)
T 2zv2_A          254 SQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVTR  298 (298)
T ss_dssp             HCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHHHHC
T ss_pred             cccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcCccccC
Confidence            3221 2223568899999999999999999999999999999963

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=1.4e-46  Score=405.16  Aligned_cols=246  Identities=27%  Similarity=0.492  Sum_probs=210.1

Q ss_pred             cceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhh--HHHHHHHHHHHHHHhhC-CCCCCCe----------EEEEE
Q psy1546          58 IFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA--EDEIEDIQQEIMVLSQC-DSPYGTK----------LWIIM  124 (604)
Q Consensus        58 ~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~--~~~~~~l~~Ei~iL~~l-~hp~~~~----------lyLVm  124 (604)
                      .|.++++||+|+||+||+|+++.+++.||||++.+...  ......+.+|+.+|.++ .||++++          +||||
T Consensus        53 ~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV~  132 (396)
T 4dc2_A           53 DFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVI  132 (396)
T ss_dssp             GEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             HcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEEEE
Confidence            49999999999999999999999999999999976543  23345678899999876 8998655          47999


Q ss_pred             EecCCCChhhHhhc-CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCCCCcc
Q psy1546         125 EYLGGGSALDLMKA-GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNT  203 (604)
Q Consensus       125 Ey~~ggsL~~~l~~-~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~~~~  203 (604)
                      |||+||+|..++.. +.+++..++.++.||+.||.|||++||+||||||+||||+.+|.+||+|||+|+..........+
T Consensus       133 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~~~~~~  212 (396)
T 4dc2_A          133 EYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST  212 (396)
T ss_dssp             ECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCCBCC
T ss_pred             EcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceeeecccCCCcccc
Confidence            99999999998865 78999999999999999999999999999999999999999999999999999865555555677


Q ss_pred             cccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCCh--------hh-HhhhcCCCCCCCCCccchHHHHH
Q psy1546         204 FVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHP--------MR-VLFLIPKNNPPQLTGNYTKQFKE  274 (604)
Q Consensus       204 ~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~--------~~-~~~~i~~~~~~~~~~~~s~~l~~  274 (604)
                      .+||+.|+|||++.+..|+.++|||||||+||||++|.+||.....        .. ....+ ......++..++.++++
T Consensus       213 ~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i-~~~~~~~p~~~s~~~~~  291 (396)
T 4dc2_A          213 FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVI-LEKQIRIPRSLSVKAAS  291 (396)
T ss_dssp             CCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHH-HHCCCCCCTTSCHHHHH
T ss_pred             ccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHH-hccccCCCCcCCHHHHH
Confidence            8999999999999999999999999999999999999999964321        11 22222 22334566788999999


Q ss_pred             HHHHHhccCCCCCCC------HHHHhcChhhhhhhh
Q psy1546         275 FVEACLNKDPENRPT------AKELLKFPFIRKAKK  304 (604)
Q Consensus       275 Li~~~L~~dP~~RpT------~~elL~hp~f~~~~~  304 (604)
                      ||.+||..||.+||+      +.||++||||+...+
T Consensus       292 li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i~w  327 (396)
T 4dc2_A          292 VLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDW  327 (396)
T ss_dssp             HHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTCCH
T ss_pred             HHHHHhcCCHhHcCCCCCCCCHHHHhcCccccCCCH
Confidence            999999999999998      489999999987644

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=1.8e-46  Score=398.29  Aligned_cols=246  Identities=28%  Similarity=0.479  Sum_probs=216.4

Q ss_pred             cceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhh--HHHHHHHHHHHHHHhhC-CCCCCC----------eEEEEE
Q psy1546          58 IFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA--EDEIEDIQQEIMVLSQC-DSPYGT----------KLWIIM  124 (604)
Q Consensus        58 ~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~--~~~~~~l~~Ei~iL~~l-~hp~~~----------~lyLVm  124 (604)
                      .|.+++.||+|+||.||+|++..+++.||||++.+...  ....+.+..|+.+|..+ .||++.          .+||||
T Consensus        21 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~  100 (353)
T 2i0e_A           21 DFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM  100 (353)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEEEE
Confidence            39999999999999999999999999999999976532  23356788999999987 789854          458999


Q ss_pred             EecCCCChhhHhhc-CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCCCCcc
Q psy1546         125 EYLGGGSALDLMKA-GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNT  203 (604)
Q Consensus       125 Ey~~ggsL~~~l~~-~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~~~~  203 (604)
                      |||+||+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+||||+.+|.+||+|||+|+...........
T Consensus       101 E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~~~~  180 (353)
T 2i0e_A          101 EYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKT  180 (353)
T ss_dssp             ECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCCBCC
T ss_pred             eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCcccccccCCccccc
Confidence            99999999999875 78999999999999999999999999999999999999999999999999999765444445567


Q ss_pred             cccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCCCCCCCCccchHHHHHHHHHHhccC
Q psy1546         204 FVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKD  283 (604)
Q Consensus       204 ~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~~L~~d  283 (604)
                      .+||+.|+|||++.+..|+.++|||||||++|||++|.+||.+.+...+...+.... ..++..++.++.+||.+||..|
T Consensus       181 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~~lL~~d  259 (353)
T 2i0e_A          181 FCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHN-VAYPKSMSKEAVAICKGLMTKH  259 (353)
T ss_dssp             CCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-CCCCTTSCHHHHHHHHHHTCSC
T ss_pred             ccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCC-CCCCCCCCHHHHHHHHHHhhcC
Confidence            899999999999999999999999999999999999999999988877766655443 3456788999999999999999


Q ss_pred             CCCCC-----CHHHHhcChhhhhhhh
Q psy1546         284 PENRP-----TAKELLKFPFIRKAKK  304 (604)
Q Consensus       284 P~~Rp-----T~~elL~hp~f~~~~~  304 (604)
                      |.+||     ++++|++||||+...+
T Consensus       260 P~~R~~~~~~~~~~i~~h~~f~~~~w  285 (353)
T 2i0e_A          260 PGKRLGCGPEGERDIKEHAFFRYIDW  285 (353)
T ss_dssp             TTSCTTCSTTHHHHHHTSGGGTTCCH
T ss_pred             HHHcCCCCCCCHHHHhcCccccCCCH
Confidence            99999     4799999999986543

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=3.3e-46  Score=394.58  Aligned_cols=246  Identities=27%  Similarity=0.493  Sum_probs=211.4

Q ss_pred             cceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchh--hHHHHHHHHHHHHHHhhC-CCCCCCe----------EEEEE
Q psy1546          58 IFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE--AEDEIEDIQQEIMVLSQC-DSPYGTK----------LWIIM  124 (604)
Q Consensus        58 ~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~--~~~~~~~l~~Ei~iL~~l-~hp~~~~----------lyLVm  124 (604)
                      .|.+.+.||+|+||.||+|++..+++.||||++.+..  .......+.+|+.++..+ .||++++          +|+||
T Consensus        10 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~   89 (345)
T 3a8x_A           10 DFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVI   89 (345)
T ss_dssp             GEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             heEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEEE
Confidence            3999999999999999999999999999999997653  234567788999999987 8998654          47999


Q ss_pred             EecCCCChhhHhhc-CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCCCCcc
Q psy1546         125 EYLGGGSALDLMKA-GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNT  203 (604)
Q Consensus       125 Ey~~ggsL~~~l~~-~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~~~~  203 (604)
                      |||+||+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+||||+.+|.+||+|||+|+...........
T Consensus        90 e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~~~~~~  169 (345)
T 3a8x_A           90 EYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST  169 (345)
T ss_dssp             CCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTTCCBCC
T ss_pred             eCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEeccccccccCCCCcccc
Confidence            99999999998865 78999999999999999999999999999999999999999999999999999765544455567


Q ss_pred             cccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCC---------ChhhHhhhcCCCCCCCCCccchHHHHH
Q psy1546         204 FVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSEL---------HPMRVLFLIPKNNPPQLTGNYTKQFKE  274 (604)
Q Consensus       204 ~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~---------~~~~~~~~i~~~~~~~~~~~~s~~l~~  274 (604)
                      .+||+.|+|||++.+..|+.++|||||||+||||++|..||...         ........+.. ....++..++.++++
T Consensus       170 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~-~~~~~p~~~s~~~~~  248 (345)
T 3a8x_A          170 FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE-KQIRIPRSLSVKAAS  248 (345)
T ss_dssp             CCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHH-CCCCCCTTSCHHHHH
T ss_pred             cCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHc-CCCCCCCCCCHHHHH
Confidence            89999999999999999999999999999999999999999752         11222222222 233456788999999


Q ss_pred             HHHHHhccCCCCCCCH------HHHhcChhhhhhhh
Q psy1546         275 FVEACLNKDPENRPTA------KELLKFPFIRKAKK  304 (604)
Q Consensus       275 Li~~~L~~dP~~RpT~------~elL~hp~f~~~~~  304 (604)
                      ||.+||..||.+||++      .||++||||+...+
T Consensus       249 li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~~w  284 (345)
T 3a8x_A          249 VLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDW  284 (345)
T ss_dssp             HHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTTCCH
T ss_pred             HHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCCCCH
Confidence            9999999999999994      89999999986543

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=4.3e-46  Score=396.44  Aligned_cols=247  Identities=26%  Similarity=0.452  Sum_probs=215.2

Q ss_pred             cccceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHH-----HHHHHHHHHHHHhhCCCCCCCe----------E
Q psy1546          56 ELIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAED-----EIEDIQQEIMVLSQCDSPYGTK----------L  120 (604)
Q Consensus        56 ~~~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~-----~~~~l~~Ei~iL~~l~hp~~~~----------l  120 (604)
                      ...|.+.+.||+|+||.||+|.+..+|+.||||++.......     ..+.+.+|+.+|+.+.|||+.+          +
T Consensus        11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~   90 (361)
T 2yab_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV   90 (361)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred             hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence            445999999999999999999999999999999997654321     2467899999999999999655          4


Q ss_pred             EEEEEecCCCChhhHhhc-CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCC----CeEEeccccccccc
Q psy1546         121 WIIMEYLGGGSALDLMKA-GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMG----DVKLADFGVAGTLT  195 (604)
Q Consensus       121 yLVmEy~~ggsL~~~l~~-~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g----~vKL~DFGlA~~~~  195 (604)
                      |||||||.||+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++    .+||+|||+++.+.
T Consensus        91 ~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~~  170 (361)
T 2yab_A           91 VLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE  170 (361)
T ss_dssp             EEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCEECC
T ss_pred             EEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCceEcC
Confidence            799999999999999865 6799999999999999999999999999999999999998877    79999999997765


Q ss_pred             CCCCCCcccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCCCCC---CCCccchHHH
Q psy1546         196 NTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPP---QLTGNYTKQF  272 (604)
Q Consensus       196 ~~~~~~~~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~~~~---~~~~~~s~~l  272 (604)
                      .. ......+||+.|+|||++.+..|+.++|||||||++|+|++|.+||.+....+....+......   ..+..++..+
T Consensus       171 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  249 (361)
T 2yab_A          171 DG-VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQTSELA  249 (361)
T ss_dssp             TT-CCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTTSCHHH
T ss_pred             CC-CccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCchhccCCCHHH
Confidence            43 3345678999999999999999999999999999999999999999998887777666554332   2235678999


Q ss_pred             HHHHHHHhccCCCCCCCHHHHhcChhhhhhh
Q psy1546         273 KEFVEACLNKDPENRPTAKELLKFPFIRKAK  303 (604)
Q Consensus       273 ~~Li~~~L~~dP~~RpT~~elL~hp~f~~~~  303 (604)
                      ++||.+||..||.+|||+.|+|+||||+...
T Consensus       250 ~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~  280 (361)
T 2yab_A          250 KDFIRKLLVKETRKRLTIQEALRHPWITPVD  280 (361)
T ss_dssp             HHHHHHHSCSSTTTSCCHHHHHTSTTTSCSS
T ss_pred             HHHHHHHCCCChhHCcCHHHHhcCcCcCCCc
Confidence            9999999999999999999999999997543

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=5e-46  Score=388.94  Aligned_cols=243  Identities=26%  Similarity=0.487  Sum_probs=214.9

Q ss_pred             cceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhH--HHHHHHHHHHHHHhhCCCCCCCe----------EEEEEE
Q psy1546          58 IFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAE--DEIEDIQQEIMVLSQCDSPYGTK----------LWIIME  125 (604)
Q Consensus        58 ~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~--~~~~~l~~Ei~iL~~l~hp~~~~----------lyLVmE  125 (604)
                      .|.+.+.||+|+||.||+|++..+++.||||++......  ...+.+.+|+.+++.+.||++.+          +|+|||
T Consensus         7 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~e   86 (318)
T 1fot_A            7 DFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMD   86 (318)
T ss_dssp             GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEEC
T ss_pred             HcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEEe
Confidence            399999999999999999999999999999999765322  23567889999999999999655          479999


Q ss_pred             ecCCCChhhHhhc-CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCCCCccc
Q psy1546         126 YLGGGSALDLMKA-GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTF  204 (604)
Q Consensus       126 y~~ggsL~~~l~~-~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~~~~~  204 (604)
                      ||+||+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++....   ...+.
T Consensus        87 ~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~---~~~~~  163 (318)
T 1fot_A           87 YIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD---VTYTL  163 (318)
T ss_dssp             CCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSS---CBCCC
T ss_pred             CCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceecCC---ccccc
Confidence            9999999999865 6799999999999999999999999999999999999999999999999999976543   23467


Q ss_pred             ccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCCCCCCCCccchHHHHHHHHHHhccCC
Q psy1546         205 VGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDP  284 (604)
Q Consensus       205 ~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~~L~~dP  284 (604)
                      +||+.|+|||++.+..|+.++|||||||++|||++|..||...+.......+.... ..++..++.++.+||.+||..||
T Consensus       164 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~-~~~p~~~~~~~~~li~~lL~~dp  242 (318)
T 1fot_A          164 CGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAE-LRFPPFFNEDVKDLLSRLITRDL  242 (318)
T ss_dssp             CSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCC-CCCCTTSCHHHHHHHHHHTCSCT
T ss_pred             cCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-CCCCCCCCHHHHHHHHHHhccCH
Confidence            89999999999999999999999999999999999999999888777666554433 34567789999999999999999


Q ss_pred             CCCC-----CHHHHhcChhhhhhhh
Q psy1546         285 ENRP-----TAKELLKFPFIRKAKK  304 (604)
Q Consensus       285 ~~Rp-----T~~elL~hp~f~~~~~  304 (604)
                      .+||     ++++|++||||+...+
T Consensus       243 ~~R~~~~~~~~~~i~~hp~f~~~~~  267 (318)
T 1fot_A          243 SQRLGNLQNGTEDVKNHPWFKEVVW  267 (318)
T ss_dssp             TTCTTSSTTTTHHHHTSGGGSSCCH
T ss_pred             HHcCCCcCCCHHHHhcCccccCCCH
Confidence            9999     9999999999986543

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=5.3e-46  Score=393.18  Aligned_cols=247  Identities=30%  Similarity=0.450  Sum_probs=208.7

Q ss_pred             cccceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHH----HHHHHHHHHHHHhhCCCCCCCeE----------E
Q psy1546          56 ELIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAED----EIEDIQQEIMVLSQCDSPYGTKL----------W  121 (604)
Q Consensus        56 ~~~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~----~~~~l~~Ei~iL~~l~hp~~~~l----------y  121 (604)
                      ...|.+.+.||+|+||.||+|.+..+++.||||++.......    ..+.+.+|+.+++.++|||+.++          |
T Consensus        23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  102 (351)
T 3c0i_A           23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY  102 (351)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence            345999999999999999999999999999999996543221    24678999999999999997654          7


Q ss_pred             EEEEecCCCChhhHhhc-----CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCC---eEEeccccccc
Q psy1546         122 IIMEYLGGGSALDLMKA-----GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGD---VKLADFGVAGT  193 (604)
Q Consensus       122 LVmEy~~ggsL~~~l~~-----~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~---vKL~DFGlA~~  193 (604)
                      ||||||+|++|.+++..     ..+++..++.++.||+.||.|||++||+||||||+|||++.++.   +||+|||++..
T Consensus       103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~  182 (351)
T 3c0i_A          103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQ  182 (351)
T ss_dssp             EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTTCEE
T ss_pred             EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCcceeE
Confidence            99999999999887743     24899999999999999999999999999999999999987655   99999999987


Q ss_pred             ccCCCCCCcccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCCCCCC---CCccchH
Q psy1546         194 LTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQ---LTGNYTK  270 (604)
Q Consensus       194 ~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~---~~~~~s~  270 (604)
                      +..........+||+.|+|||++.+..|+.++|||||||+||+|++|..||.+... .....+.......   ....++.
T Consensus       183 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-~~~~~i~~~~~~~~~~~~~~~s~  261 (351)
T 3c0i_A          183 LGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE-RLFEGIIKGKYKMNPRQWSHISE  261 (351)
T ss_dssp             CCTTSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHH-HHHHHHHHTCCCCCHHHHTTSCH
T ss_pred             ecCCCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHH-HHHHHHHcCCCCCCccccccCCH
Confidence            76554445567899999999999999999999999999999999999999987543 3333332222211   1246789


Q ss_pred             HHHHHHHHHhccCCCCCCCHHHHhcChhhhhhh
Q psy1546         271 QFKEFVEACLNKDPENRPTAKELLKFPFIRKAK  303 (604)
Q Consensus       271 ~l~~Li~~~L~~dP~~RpT~~elL~hp~f~~~~  303 (604)
                      ++++||.+||..||.+|||+.|+|+||||+...
T Consensus       262 ~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~~  294 (351)
T 3c0i_A          262 SAKDLVRRMLMLDPAERITVYEALNHPWLKERD  294 (351)
T ss_dssp             HHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTHH
T ss_pred             HHHHHHHHHCCCChhHCcCHHHHhcChhhcCCc
Confidence            999999999999999999999999999998643

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=7.8e-46  Score=392.66  Aligned_cols=243  Identities=27%  Similarity=0.508  Sum_probs=216.2

Q ss_pred             cceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhH--HHHHHHHHHHHHHhhCCCCCCCe----------EEEEEE
Q psy1546          58 IFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAE--DEIEDIQQEIMVLSQCDSPYGTK----------LWIIME  125 (604)
Q Consensus        58 ~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~--~~~~~l~~Ei~iL~~l~hp~~~~----------lyLVmE  125 (604)
                      .|.+++.||+|+||.||+|++..+++.||||++......  ...+.+.+|+.+|+.+.||++.+          +|||||
T Consensus        42 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e  121 (350)
T 1rdq_E           42 QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVME  121 (350)
T ss_dssp             GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             HCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEc
Confidence            499999999999999999999999999999999765422  23567889999999999998654          479999


Q ss_pred             ecCCCChhhHhhc-CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCCCCccc
Q psy1546         126 YLGGGSALDLMKA-GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTF  204 (604)
Q Consensus       126 y~~ggsL~~~l~~-~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~~~~~  204 (604)
                      |++||+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+||||+.+|.+||+|||+++.....   ....
T Consensus       122 ~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~---~~~~  198 (350)
T 1rdq_E          122 YVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR---TWTL  198 (350)
T ss_dssp             CCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC---BCCC
T ss_pred             CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccceeccCC---cccc
Confidence            9999999999865 78999999999999999999999999999999999999999999999999999766432   3467


Q ss_pred             ccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCCCCCCCCccchHHHHHHHHHHhccCC
Q psy1546         205 VGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDP  284 (604)
Q Consensus       205 ~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~~L~~dP  284 (604)
                      +||+.|+|||++.+..|+.++|||||||+||||++|.+||...........+.... ..++..++.++.+||.+||..||
T Consensus       199 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~-~~~p~~~~~~~~~li~~lL~~dp  277 (350)
T 1rdq_E          199 CGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK-VRFPSHFSSDLKDLLRNLLQVDL  277 (350)
T ss_dssp             EECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-CCCCTTCCHHHHHHHHHHSCSCT
T ss_pred             cCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCC-CCCCCCCCHHHHHHHHHHhhcCH
Confidence            89999999999999999999999999999999999999999988877766665443 34567789999999999999999


Q ss_pred             CCCCC-----HHHHhcChhhhhhhh
Q psy1546         285 ENRPT-----AKELLKFPFIRKAKK  304 (604)
Q Consensus       285 ~~RpT-----~~elL~hp~f~~~~~  304 (604)
                      .+||+     +++|++||||+...+
T Consensus       278 ~~R~~~~~~~~~ei~~h~~f~~~~w  302 (350)
T 1rdq_E          278 TKRFGNLKNGVNDIKNHKWFATTDW  302 (350)
T ss_dssp             TTCTTSSTTTTHHHHTSGGGTTCCH
T ss_pred             HhccCCccCCHHHHHhCcCcCCCCH
Confidence            99998     999999999986543

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=8.4e-46  Score=404.88  Aligned_cols=246  Identities=26%  Similarity=0.413  Sum_probs=214.5

Q ss_pred             ccceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhh-HHHHHHHHHHHHHHhhCCCCCCCeE----------EEEEE
Q psy1546          57 LIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA-EDEIEDIQQEIMVLSQCDSPYGTKL----------WIIME  125 (604)
Q Consensus        57 ~~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~-~~~~~~l~~Ei~iL~~l~hp~~~~l----------yLVmE  125 (604)
                      ..|.+.+.||+|+||.||+|.+..+++.||+|++..... ....+.+.+|+.+++.++|||++++          |+|||
T Consensus        11 ~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~E   90 (444)
T 3soa_A           11 EEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFD   90 (444)
T ss_dssp             HHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEEC
T ss_pred             CCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEEE
Confidence            349999999999999999999999999999999976543 3345778999999999999997654          79999


Q ss_pred             ecCCCChhhHhhc-CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEec---CCCCeEEecccccccccCCCCCC
Q psy1546         126 YLGGGSALDLMKA-GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLS---EMGDVKLADFGVAGTLTNTTSKR  201 (604)
Q Consensus       126 y~~ggsL~~~l~~-~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~---~~g~vKL~DFGlA~~~~~~~~~~  201 (604)
                      ||.||+|.+++.. +.+++..+..++.||+.||.|||++||+||||||+|||++   .++.+||+|||+|..........
T Consensus        91 ~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~~~~  170 (444)
T 3soa_A           91 LVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAW  170 (444)
T ss_dssp             CCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTCCBC
T ss_pred             eCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecCCCcee
Confidence            9999999888754 6799999999999999999999999999999999999998   46789999999998776555555


Q ss_pred             cccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCCCC---CCCCccchHHHHHHHHH
Q psy1546         202 NTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNP---PQLTGNYTKQFKEFVEA  278 (604)
Q Consensus       202 ~~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~~~---~~~~~~~s~~l~~Li~~  278 (604)
                      ...+||+.|+|||++.+..|+.++|||||||+||+|++|.+||.+.........+..+..   ......+++++++||.+
T Consensus       171 ~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~  250 (444)
T 3soa_A          171 FGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDLINK  250 (444)
T ss_dssp             CCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHHHHHH
T ss_pred             ecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCccccccCCHHHHHHHHH
Confidence            667899999999999999999999999999999999999999999887777666544432   23335789999999999


Q ss_pred             HhccCCCCCCCHHHHhcChhhhhh
Q psy1546         279 CLNKDPENRPTAKELLKFPFIRKA  302 (604)
Q Consensus       279 ~L~~dP~~RpT~~elL~hp~f~~~  302 (604)
                      ||..||.+|||+.|+|+||||+..
T Consensus       251 ~L~~dP~~Rpta~e~L~hp~~~~~  274 (444)
T 3soa_A          251 MLTINPSKRITAAEALKHPWISHR  274 (444)
T ss_dssp             HSCSSTTTSCCHHHHHHSCTTHHH
T ss_pred             HcCCChhHCCCHHHHhcCccccCC
Confidence            999999999999999999999764

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=1.8e-45  Score=391.39  Aligned_cols=245  Identities=27%  Similarity=0.478  Sum_probs=212.5

Q ss_pred             ccceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhh-HHHHHHHHHHHHHHhhCCCCCCCeE----------EEEEE
Q psy1546          57 LIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA-EDEIEDIQQEIMVLSQCDSPYGTKL----------WIIME  125 (604)
Q Consensus        57 ~~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~-~~~~~~l~~Ei~iL~~l~hp~~~~l----------yLVmE  125 (604)
                      ..|.+.+.||+|+||.||+|.+..+++.||||++..... ....+.+.+|+.+++.++|||+.++          |+|||
T Consensus        29 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~e  108 (362)
T 2bdw_A           29 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFD  108 (362)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             cCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence            359999999999999999999999999999999976543 3456788999999999999997654          79999


Q ss_pred             ecCCCChhhHhhc-CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCC---CeEEecccccccccCCCCCC
Q psy1546         126 YLGGGSALDLMKA-GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMG---DVKLADFGVAGTLTNTTSKR  201 (604)
Q Consensus       126 y~~ggsL~~~l~~-~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g---~vKL~DFGlA~~~~~~~~~~  201 (604)
                      ||.||+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++   .+||+|||++...... ...
T Consensus       109 ~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~-~~~  187 (362)
T 2bdw_A          109 LVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS-EAW  187 (362)
T ss_dssp             CCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTC-CSC
T ss_pred             cCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecCC-ccc
Confidence            9999999988754 6799999999999999999999999999999999999998654   5999999999766533 233


Q ss_pred             cccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCCCC---CCCCccchHHHHHHHHH
Q psy1546         202 NTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNP---PQLTGNYTKQFKEFVEA  278 (604)
Q Consensus       202 ~~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~~~---~~~~~~~s~~l~~Li~~  278 (604)
                      ...+||+.|+|||++.+..|+.++|||||||++|+|++|.+||.+.+.......+..+..   ......+++++.+||.+
T Consensus       188 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~  267 (362)
T 2bdw_A          188 HGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDS  267 (362)
T ss_dssp             CCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTGGGGSCHHHHHHHHH
T ss_pred             ccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHHH
Confidence            457899999999999999999999999999999999999999998887766665544332   22335678999999999


Q ss_pred             HhccCCCCCCCHHHHhcChhhhhh
Q psy1546         279 CLNKDPENRPTAKELLKFPFIRKA  302 (604)
Q Consensus       279 ~L~~dP~~RpT~~elL~hp~f~~~  302 (604)
                      ||..||.+|||+.|+|+||||...
T Consensus       268 ~L~~dP~~R~t~~e~l~hp~~~~~  291 (362)
T 2bdw_A          268 MLTVNPKKRITADQALKVPWICNR  291 (362)
T ss_dssp             HSCSSGGGSCCHHHHTTSHHHHTH
T ss_pred             HcCCChhhCcCHHHHhcCcccCCC
Confidence            999999999999999999999754

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=8e-46  Score=396.16  Aligned_cols=246  Identities=30%  Similarity=0.472  Sum_probs=208.5

Q ss_pred             cceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhh--HHHHHHHHHHHHH-HhhCCCCCCCe----------EEEEE
Q psy1546          58 IFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA--EDEIEDIQQEIMV-LSQCDSPYGTK----------LWIIM  124 (604)
Q Consensus        58 ~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~--~~~~~~l~~Ei~i-L~~l~hp~~~~----------lyLVm  124 (604)
                      .|.+++.||+|+||.||+|+++.+++.||||++.+...  ......+.+|..+ ++.+.||++++          +||||
T Consensus        39 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv~  118 (373)
T 2r5t_A           39 DFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVL  118 (373)
T ss_dssp             GEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             heEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEEE
Confidence            49999999999999999999999999999999976543  2334556677776 57799999655          47999


Q ss_pred             EecCCCChhhHhhc-CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCCCCcc
Q psy1546         125 EYLGGGSALDLMKA-GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNT  203 (604)
Q Consensus       125 Ey~~ggsL~~~l~~-~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~~~~  203 (604)
                      |||+||+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+||||+.+|.+||+|||+++...........
T Consensus       119 E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~~~~~~~  198 (373)
T 2r5t_A          119 DYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTST  198 (373)
T ss_dssp             ECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCCCCCCCS
T ss_pred             eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCccccccccCCCcccc
Confidence            99999999998865 67999999999999999999999999999999999999999999999999999875555555667


Q ss_pred             cccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCCCCCCCCccchHHHHHHHHHHhccC
Q psy1546         204 FVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKD  283 (604)
Q Consensus       204 ~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~~L~~d  283 (604)
                      .+||+.|+|||++.+..|+.++|||||||++|||++|.+||...+..++...+... ...++..++..+++||.+||..|
T Consensus       199 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~li~~lL~~d  277 (373)
T 2r5t_A          199 FCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNK-PLQLKPNITNSARHLLEGLLQKD  277 (373)
T ss_dssp             BSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHS-CCCCCSSSCHHHHHHHHHHTCSS
T ss_pred             ccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhc-ccCCCCCCCHHHHHHHHHHcccC
Confidence            89999999999999999999999999999999999999999998887776665443 23456778999999999999999


Q ss_pred             CCCCCCH----HHHhcChhhhhhhh
Q psy1546         284 PENRPTA----KELLKFPFIRKAKK  304 (604)
Q Consensus       284 P~~RpT~----~elL~hp~f~~~~~  304 (604)
                      |.+||++    .+|++||||+...+
T Consensus       278 p~~R~~~~~~~~~i~~h~~f~~~~w  302 (373)
T 2r5t_A          278 RTKRLGAKDDFMEIKSHVFFSLINW  302 (373)
T ss_dssp             GGGSTTTTTTHHHHHTSGGGTTCCH
T ss_pred             HHhCCCCCCCHHHHhCCccccCCCH
Confidence            9999986    79999999987644

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=1.1e-45  Score=386.94  Aligned_cols=247  Identities=28%  Similarity=0.470  Sum_probs=203.8

Q ss_pred             ccceeeeEEcccCcEEEEEEEEC---CCCcEEEEEEecchhh---HHHHHHHHHHHHHHhhCCCCCCCe----------E
Q psy1546          57 LIFTKQERIGKGSFGEVFKGIDN---RTQQVVAIKIIDLEEA---EDEIEDIQQEIMVLSQCDSPYGTK----------L  120 (604)
Q Consensus        57 ~~y~i~~~LG~G~fG~Vy~a~~~---~t~~~vAVK~i~~~~~---~~~~~~l~~Ei~iL~~l~hp~~~~----------l  120 (604)
                      ..|.+.+.||+|+||.||+|++.   .+++.||||++.....   ......+.+|+.+|+.+.||++.+          +
T Consensus        17 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~   96 (327)
T 3a62_A           17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKL   96 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSCE
T ss_pred             HHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCEE
Confidence            34999999999999999999985   6899999999976532   233466789999999999999665          4


Q ss_pred             EEEEEecCCCChhhHhhc-CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCC
Q psy1546         121 WIIMEYLGGGSALDLMKA-GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTS  199 (604)
Q Consensus       121 yLVmEy~~ggsL~~~l~~-~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~  199 (604)
                      |||||||+|++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+||||+.+|.+||+|||+++.......
T Consensus        97 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  176 (327)
T 3a62_A           97 YLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGT  176 (327)
T ss_dssp             EEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSCC--------
T ss_pred             EEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCcccccccCCc
Confidence            799999999999998865 6799999999999999999999999999999999999999999999999999976554444


Q ss_pred             CCcccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCCCCCCCCccchHHHHHHHHHH
Q psy1546         200 KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEAC  279 (604)
Q Consensus       200 ~~~~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~~  279 (604)
                      .....+||+.|+|||++.+..++.++|||||||+||+|++|..||...........+.... ..++..++.++.+||.+|
T Consensus       177 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~-~~~p~~~~~~~~~li~~~  255 (327)
T 3a62_A          177 VTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCK-LNLPPYLTQEARDLLKKL  255 (327)
T ss_dssp             --CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTC-CCCCTTSCHHHHHHHHHH
T ss_pred             cccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCC-CCCCCCCCHHHHHHHHHH
Confidence            4556789999999999999999999999999999999999999999888776665554432 345567899999999999


Q ss_pred             hccCCCCCC-----CHHHHhcChhhhhhhh
Q psy1546         280 LNKDPENRP-----TAKELLKFPFIRKAKK  304 (604)
Q Consensus       280 L~~dP~~Rp-----T~~elL~hp~f~~~~~  304 (604)
                      |..||.+||     ++.|+++||||+...+
T Consensus       256 L~~dp~~R~~~~~~~~~e~l~hp~f~~~~~  285 (327)
T 3a62_A          256 LKRNAASRLGAGPGDAGEVQAHPFFRHINW  285 (327)
T ss_dssp             SCSCGGGSTTSSTTTHHHHHHSGGGSSCCH
T ss_pred             HhcCHhhccCCCCCCHHHHHcCCcccCCCH
Confidence            999999999     8999999999986543

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=1.3e-45  Score=378.47  Aligned_cols=245  Identities=26%  Similarity=0.427  Sum_probs=203.0

Q ss_pred             cceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhh-HHHHHHHHHHHHHHhhCCCCCCCeE----------EEEEEe
Q psy1546          58 IFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA-EDEIEDIQQEIMVLSQCDSPYGTKL----------WIIMEY  126 (604)
Q Consensus        58 ~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~-~~~~~~l~~Ei~iL~~l~hp~~~~l----------yLVmEy  126 (604)
                      .|++.++||+|+||+||+|.+..+++.||||++..... ......+.+|+.+++.+.|||+.++          ||||||
T Consensus         3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   82 (292)
T 3o0g_A            3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF   82 (292)
T ss_dssp             SEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             CceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEec
Confidence            48999999999999999999999999999999965433 3345678899999999999996654          799999


Q ss_pred             cCCCChhhHhh-cCCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCCCCcccc
Q psy1546         127 LGGGSALDLMK-AGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFV  205 (604)
Q Consensus       127 ~~ggsL~~~l~-~~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~~~~~~  205 (604)
                      |+++.+..+.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+..........+
T Consensus        83 ~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  162 (292)
T 3o0g_A           83 CDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEV  162 (292)
T ss_dssp             CSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCSCCCSCC
T ss_pred             CCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecCCccccccCCc
Confidence            97654444443 46899999999999999999999999999999999999999999999999999987765555556678


Q ss_pred             cCCCCCChHHhhcCC-CCCcchhhhHHHHHHHHHhCCCC-CCCCChhhHhhhcCC-------------------------
Q psy1546         206 GTPFWMAPEVIKQSA-YDSKADIWSLGITAIELAKGEPP-NSELHPMRVLFLIPK-------------------------  258 (604)
Q Consensus       206 GT~~Y~APE~l~~~~-~~~~sDVwSLGviL~eLltG~~P-f~~~~~~~~~~~i~~-------------------------  258 (604)
                      ||+.|+|||++.+.. ++.++|||||||++|+|++|..| |...........+..                         
T Consensus       163 ~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (292)
T 3o0g_A          163 VTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMY  242 (292)
T ss_dssp             SCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCC
T ss_pred             cccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcccccccccccc
Confidence            999999999998766 89999999999999999988777 555444333322110                         


Q ss_pred             ---CCCCCCCccchHHHHHHHHHHhccCCCCCCCHHHHhcChhhhhh
Q psy1546         259 ---NNPPQLTGNYTKQFKEFVEACLNKDPENRPTAKELLKFPFIRKA  302 (604)
Q Consensus       259 ---~~~~~~~~~~s~~l~~Li~~~L~~dP~~RpT~~elL~hp~f~~~  302 (604)
                         .........++..+++||.+||+.||.+|||++|+|+||||+..
T Consensus       243 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~  289 (292)
T 3o0g_A          243 PATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF  289 (292)
T ss_dssp             CTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTC
T ss_pred             cCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcccccC
Confidence               00112234578899999999999999999999999999999764

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=6.2e-46  Score=388.29  Aligned_cols=245  Identities=26%  Similarity=0.408  Sum_probs=205.5

Q ss_pred             ccceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCCeE----------EEEEEe
Q psy1546          57 LIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTKL----------WIIMEY  126 (604)
Q Consensus        57 ~~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~~l----------yLVmEy  126 (604)
                      ..|.+.+.||+|+||.||+|.+..+++.||||++.........+.+.+|+.+++.+.|||+.++          |+||||
T Consensus         7 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~   86 (323)
T 3tki_A            7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY   86 (323)
T ss_dssp             TCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             hhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEc
Confidence            3499999999999999999999999999999999766555555778899999999999997654          799999


Q ss_pred             cCCCChhhHhhc-CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCC--CCCcc
Q psy1546         127 LGGGSALDLMKA-GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTT--SKRNT  203 (604)
Q Consensus       127 ~~ggsL~~~l~~-~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~--~~~~~  203 (604)
                      |++|+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.+....  .....
T Consensus        87 ~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~  166 (323)
T 3tki_A           87 CSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK  166 (323)
T ss_dssp             CTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCBCS
T ss_pred             CCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceeccCCcccccCC
Confidence            999999999875 479999999999999999999999999999999999999999999999999997654222  22345


Q ss_pred             cccCCCCCChHHhhcCCC-CCcchhhhHHHHHHHHHhCCCCCCCCChhhHh--hhcCCCCCCCCCccchHHHHHHHHHHh
Q psy1546         204 FVGTPFWMAPEVIKQSAY-DSKADIWSLGITAIELAKGEPPNSELHPMRVL--FLIPKNNPPQLTGNYTKQFKEFVEACL  280 (604)
Q Consensus       204 ~~GT~~Y~APE~l~~~~~-~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~--~~i~~~~~~~~~~~~s~~l~~Li~~~L  280 (604)
                      .+||+.|+|||++.+..+ +.++|||||||+||+|++|..||.........  ..............++..+.+||.+||
T Consensus       167 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L  246 (323)
T 3tki_A          167 MCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKIL  246 (323)
T ss_dssp             CCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTTSTTGGGSCHHHHHHHHHHS
T ss_pred             CccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccccCCccccCCHHHHHHHHHHc
Confidence            789999999999988776 67899999999999999999999876553222  222222223334678999999999999


Q ss_pred             ccCCCCCCCHHHHhcChhhhh
Q psy1546         281 NKDPENRPTAKELLKFPFIRK  301 (604)
Q Consensus       281 ~~dP~~RpT~~elL~hp~f~~  301 (604)
                      ..||.+|||+.||++||||++
T Consensus       247 ~~dP~~R~t~~eil~h~~~~~  267 (323)
T 3tki_A          247 VENPSARITIPDIKKDRWYNK  267 (323)
T ss_dssp             CSSTTTSCCHHHHTTCTTTTC
T ss_pred             cCChhhCcCHHHHhhChhhcc
Confidence            999999999999999999964

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=3.5e-46  Score=403.92  Aligned_cols=246  Identities=28%  Similarity=0.441  Sum_probs=213.2

Q ss_pred             cceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHH--HHHHHHHHHHHHhhCCCCCCCe----------EEEEEE
Q psy1546          58 IFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAED--EIEDIQQEIMVLSQCDSPYGTK----------LWIIME  125 (604)
Q Consensus        58 ~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~--~~~~l~~Ei~iL~~l~hp~~~~----------lyLVmE  125 (604)
                      .|.++++||+|+||+||+|++..+++.||||++.+.....  ....+.+|+.++..++||++++          +|||||
T Consensus        70 ~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~E  149 (410)
T 3v8s_A           70 DYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVME  149 (410)
T ss_dssp             GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             ccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence            4999999999999999999999999999999996543211  2345789999999999999665          479999


Q ss_pred             ecCCCChhhHhhcCCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCC-CCccc
Q psy1546         126 YLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTS-KRNTF  204 (604)
Q Consensus       126 y~~ggsL~~~l~~~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~-~~~~~  204 (604)
                      ||+||+|.+++..+.+++..++.++.||+.||.|||++||+||||||+||||+.+|.+||+|||+|+.+..... ...+.
T Consensus       150 ~~~gg~L~~~l~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~~~~~~~~  229 (410)
T 3v8s_A          150 YMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTA  229 (410)
T ss_dssp             CCTTEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSEEECCSC
T ss_pred             CCCCCcHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeEeeccCCcccccCC
Confidence            99999999999999999999999999999999999999999999999999999999999999999976654322 33467


Q ss_pred             ccCCCCCChHHhhcCC----CCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCCC---CCCCCccchHHHHHHHH
Q psy1546         205 VGTPFWMAPEVIKQSA----YDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNN---PPQLTGNYTKQFKEFVE  277 (604)
Q Consensus       205 ~GT~~Y~APE~l~~~~----~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~~---~~~~~~~~s~~l~~Li~  277 (604)
                      +||+.|+|||++.+..    |+.++|||||||+||||++|.+||.+.+.......+....   .......++.++++||.
T Consensus       230 ~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~  309 (410)
T 3v8s_A          230 VGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLIC  309 (410)
T ss_dssp             CSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCTTCCCCHHHHHHHH
T ss_pred             cCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccccCCCcccccHHHHHHHH
Confidence            8999999999998765    7889999999999999999999999988777766654421   11223468999999999


Q ss_pred             HHhccCCCC--CCCHHHHhcChhhhhhh
Q psy1546         278 ACLNKDPEN--RPTAKELLKFPFIRKAK  303 (604)
Q Consensus       278 ~~L~~dP~~--RpT~~elL~hp~f~~~~  303 (604)
                      +||..+|.+  |++++||++||||+...
T Consensus       310 ~lL~~~~~rlgR~~~~ei~~Hp~f~~~~  337 (410)
T 3v8s_A          310 AFLTDREVRLGRNGVEEIKRHLFFKNDQ  337 (410)
T ss_dssp             HHSSCGGGCTTSSCHHHHHTSGGGCCSS
T ss_pred             HHccChhhhCCCCCHHHHhcCccccCCC
Confidence            999999988  99999999999998654

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=6.5e-46  Score=404.90  Aligned_cols=246  Identities=30%  Similarity=0.481  Sum_probs=206.0

Q ss_pred             cceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchh--hHHHHHHHHHHHHHHhhCCCCCCCe----------EEEEEE
Q psy1546          58 IFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE--AEDEIEDIQQEIMVLSQCDSPYGTK----------LWIIME  125 (604)
Q Consensus        58 ~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~--~~~~~~~l~~Ei~iL~~l~hp~~~~----------lyLVmE  125 (604)
                      .|.+.++||+|+||.||+|.+..+++.||||++....  .......+.+|+.+|+.+.|||+.+          +|||||
T Consensus       149 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e  228 (446)
T 4ejn_A          149 EFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVME  228 (446)
T ss_dssp             GEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEEEC
T ss_pred             HcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEEEe
Confidence            4999999999999999999999999999999997553  2334567789999999999999655          479999


Q ss_pred             ecCCCChhhHhhc-CCCcHHHHHHHHHHHHHHhHHhhh-CCccccccccceeEecCCCCeEEecccccccccCCCCCCcc
Q psy1546         126 YLGGGSALDLMKA-GNFEEMHIAVILREVLKGLDYLHS-ERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNT  203 (604)
Q Consensus       126 y~~ggsL~~~l~~-~~lse~~i~~i~~qIl~gL~yLHs-~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~~~~  203 (604)
                      ||++|+|.+++.. +.+++..++.++.||+.||.|||+ +||+||||||+||||+.++.+||+|||+|+...........
T Consensus       229 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~  308 (446)
T 4ejn_A          229 YANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT  308 (446)
T ss_dssp             CCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC-----CC
T ss_pred             eCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCceeccCCCccccc
Confidence            9999999998864 679999999999999999999998 99999999999999999999999999999765555555567


Q ss_pred             cccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCCCCCCCCccchHHHHHHHHHHhccC
Q psy1546         204 FVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKD  283 (604)
Q Consensus       204 ~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~~L~~d  283 (604)
                      .+||+.|+|||++.+..|+.++|||||||+||||++|..||...........+.... ..++..+++++.+||.+||..|
T Consensus       309 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~-~~~p~~~~~~~~~li~~~L~~d  387 (446)
T 4ejn_A          309 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEE-IRFPRTLGPEAKSLLSGLLKKD  387 (446)
T ss_dssp             SSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-CCCCTTSCHHHHHHHHHHTCSS
T ss_pred             ccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCC-CCCCccCCHHHHHHHHHHcccC
Confidence            899999999999999999999999999999999999999999888777666554433 3456778999999999999999


Q ss_pred             CCCCC-----CHHHHhcChhhhhhhh
Q psy1546         284 PENRP-----TAKELLKFPFIRKAKK  304 (604)
Q Consensus       284 P~~Rp-----T~~elL~hp~f~~~~~  304 (604)
                      |.+||     +++|+++||||....+
T Consensus       388 P~~R~~~~~~t~~ell~hp~f~~~~~  413 (446)
T 4ejn_A          388 PKQRLGGGSEDAKEIMQHRFFAGIVW  413 (446)
T ss_dssp             TTTSTTCSTTTHHHHHTSGGGTTCCH
T ss_pred             HHHhCCCCCCCHHHHHhCccccCCCH
Confidence            99999     9999999999987543

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=9.6e-46  Score=386.73  Aligned_cols=244  Identities=22%  Similarity=0.364  Sum_probs=212.5

Q ss_pred             ccceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCCeE----------EEEEEe
Q psy1546          57 LIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTKL----------WIIMEY  126 (604)
Q Consensus        57 ~~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~~l----------yLVmEy  126 (604)
                      ..|.+.+.||+|+||.||+|.+..+++.||+|++....  .....+.+|+.+++.++|||+.++          |+||||
T Consensus         5 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~   82 (321)
T 1tki_A            5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG--TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF   82 (321)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT--HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             hceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc--ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence            45999999999999999999999999999999997543  234668899999999999996654          799999


Q ss_pred             cCCCChhhHhhc--CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecC--CCCeEEecccccccccCCCCCCc
Q psy1546         127 LGGGSALDLMKA--GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSE--MGDVKLADFGVAGTLTNTTSKRN  202 (604)
Q Consensus       127 ~~ggsL~~~l~~--~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~--~g~vKL~DFGlA~~~~~~~~~~~  202 (604)
                      |+||+|.+++..  ..+++..++.++.||+.||.|||++||+||||||+|||++.  ++.+||+|||+++.+... ....
T Consensus        83 ~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~-~~~~  161 (321)
T 1tki_A           83 ISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG-DNFR  161 (321)
T ss_dssp             CCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT-CEEE
T ss_pred             CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC-Cccc
Confidence            999999999975  36999999999999999999999999999999999999987  789999999999766433 2334


Q ss_pred             ccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCCCCCCC---CccchHHHHHHHHHH
Q psy1546         203 TFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQL---TGNYTKQFKEFVEAC  279 (604)
Q Consensus       203 ~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~---~~~~s~~l~~Li~~~  279 (604)
                      ...||+.|+|||++.+..++.++|||||||++|+|++|..||...........+........   ...++.++.+||.+|
T Consensus       162 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~  241 (321)
T 1tki_A          162 LLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRL  241 (321)
T ss_dssp             EEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHTT
T ss_pred             cccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhhhccCCHHHHHHHHHH
Confidence            56799999999999998899999999999999999999999999887776665544433221   246789999999999


Q ss_pred             hccCCCCCCCHHHHhcChhhhhhh
Q psy1546         280 LNKDPENRPTAKELLKFPFIRKAK  303 (604)
Q Consensus       280 L~~dP~~RpT~~elL~hp~f~~~~  303 (604)
                      |..||.+|||+.|+|+||||++..
T Consensus       242 L~~dp~~Rpt~~e~l~hp~~~~~~  265 (321)
T 1tki_A          242 LVKERKSRMTASEALQHPWLKQKI  265 (321)
T ss_dssp             SCSSGGGSCCHHHHHHSHHHHSCG
T ss_pred             cCCChhHCcCHHHHhcChhhccCc
Confidence            999999999999999999997643

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=2.8e-45  Score=383.60  Aligned_cols=246  Identities=27%  Similarity=0.461  Sum_probs=212.0

Q ss_pred             ccceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHH-----HHHHHHHHHHHHhhCCCCCCCe----------EE
Q psy1546          57 LIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAED-----EIEDIQQEIMVLSQCDSPYGTK----------LW  121 (604)
Q Consensus        57 ~~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~-----~~~~l~~Ei~iL~~l~hp~~~~----------ly  121 (604)
                      ..|.+.+.||+|+||.||+|.+..+++.||||++.......     ..+.+.+|+.+|+.+.|||+.+          +|
T Consensus        11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~   90 (326)
T 2y0a_A           11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI   90 (326)
T ss_dssp             HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence            45999999999999999999999999999999996543221     2467889999999999999655          47


Q ss_pred             EEEEecCCCChhhHhhc-CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCC----CeEEecccccccccC
Q psy1546         122 IIMEYLGGGSALDLMKA-GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMG----DVKLADFGVAGTLTN  196 (604)
Q Consensus       122 LVmEy~~ggsL~~~l~~-~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g----~vKL~DFGlA~~~~~  196 (604)
                      +|||||++++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++    .+||+|||+++.+..
T Consensus        91 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~  170 (326)
T 2y0a_A           91 LILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF  170 (326)
T ss_dssp             EEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCEECCT
T ss_pred             EEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeECCC
Confidence            99999999999999865 6799999999999999999999999999999999999999887    799999999976643


Q ss_pred             CCCCCcccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCCCCC---CCCccchHHHH
Q psy1546         197 TTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPP---QLTGNYTKQFK  273 (604)
Q Consensus       197 ~~~~~~~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~~~~---~~~~~~s~~l~  273 (604)
                      . ......+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.........+......   .....++..+.
T Consensus       171 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (326)
T 2y0a_A          171 G-NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAK  249 (326)
T ss_dssp             T-SCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHH
T ss_pred             C-CccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcCccccccCCHHHH
Confidence            3 2334568999999999999999999999999999999999999999988776665544333221   22346788999


Q ss_pred             HHHHHHhccCCCCCCCHHHHhcChhhhhhh
Q psy1546         274 EFVEACLNKDPENRPTAKELLKFPFIRKAK  303 (604)
Q Consensus       274 ~Li~~~L~~dP~~RpT~~elL~hp~f~~~~  303 (604)
                      +||.+||..||.+|||+.|+|+||||+...
T Consensus       250 ~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~  279 (326)
T 2y0a_A          250 DFIRRLLVKDPKKRMTIQDSLQHPWIKPKD  279 (326)
T ss_dssp             HHHHHHSCSSGGGSCCHHHHHHSTTTSCCS
T ss_pred             HHHHHHccCChhhCCCHHHHhcCCCccCCc
Confidence            999999999999999999999999997654

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=5.4e-46  Score=386.94  Aligned_cols=247  Identities=26%  Similarity=0.460  Sum_probs=195.7

Q ss_pred             cceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCCe----------EEEEEEec
Q psy1546          58 IFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTK----------LWIIMEYL  127 (604)
Q Consensus        58 ~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~~----------lyLVmEy~  127 (604)
                      .|.+.+.||+|+||.||+|.+..+++.||||++...........+.+|+.+++.+.|||+.+          +||||||+
T Consensus         6 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~   85 (317)
T 2pmi_A            6 QFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFEFM   85 (317)
T ss_dssp             -------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEECC
T ss_pred             ceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEEec
Confidence            48999999999999999999999999999999976554444467889999999999999655          47999999


Q ss_pred             CCCChhhHhhc-------CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCCC
Q psy1546         128 GGGSALDLMKA-------GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSK  200 (604)
Q Consensus       128 ~ggsL~~~l~~-------~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~  200 (604)
                      + ++|.+++..       ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+......
T Consensus        86 ~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~  164 (317)
T 2pmi_A           86 D-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNT  164 (317)
T ss_dssp             C-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSCEETTSCCCC
T ss_pred             C-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCccceecCCCccc
Confidence            7 588888754       35899999999999999999999999999999999999999999999999999876544444


Q ss_pred             CcccccCCCCCChHHhhc-CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCC------------------C-
Q psy1546         201 RNTFVGTPFWMAPEVIKQ-SAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKN------------------N-  260 (604)
Q Consensus       201 ~~~~~GT~~Y~APE~l~~-~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~------------------~-  260 (604)
                      ....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.........+...                  . 
T Consensus       165 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~  244 (317)
T 2pmi_A          165 FSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLPKYNP  244 (317)
T ss_dssp             CCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGGCTTCCT
T ss_pred             CCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhhhhhccc
Confidence            556789999999999976 46899999999999999999999999987765544322100                  0 


Q ss_pred             --------------CCCCCccchHHHHHHHHHHhccCCCCCCCHHHHhcChhhhhhhhh
Q psy1546         261 --------------PPQLTGNYTKQFKEFVEACLNKDPENRPTAKELLKFPFIRKAKKN  305 (604)
Q Consensus       261 --------------~~~~~~~~s~~l~~Li~~~L~~dP~~RpT~~elL~hp~f~~~~~~  305 (604)
                                    .+.....++.++.+||.+||..||.+|||+.|+|+||||++....
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~  303 (317)
T 2pmi_A          245 NIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYYHH  303 (317)
T ss_dssp             TCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCC-
T ss_pred             ccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhcccch
Confidence                          001123567899999999999999999999999999999876543

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=4.4e-45  Score=390.41  Aligned_cols=249  Identities=31%  Similarity=0.513  Sum_probs=207.0

Q ss_pred             ccccceeeeEEccc--CcEEEEEEEECCCCcEEEEEEecchhh-HHHHHHHHHHHHHHhhCCCCCCCeE----------E
Q psy1546          55 PELIFTKQERIGKG--SFGEVFKGIDNRTQQVVAIKIIDLEEA-EDEIEDIQQEIMVLSQCDSPYGTKL----------W  121 (604)
Q Consensus        55 ~~~~y~i~~~LG~G--~fG~Vy~a~~~~t~~~vAVK~i~~~~~-~~~~~~l~~Ei~iL~~l~hp~~~~l----------y  121 (604)
                      ....|++.++||+|  +||.||+|++..+++.||||++..... ....+.+.+|+.+++.++|||++++          |
T Consensus        23 ~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  102 (389)
T 3gni_B           23 EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELW  102 (389)
T ss_dssp             CGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             CCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEE
Confidence            34459999999999  999999999999999999999976543 3345778899999999999997654          7


Q ss_pred             EEEEecCCCChhhHhhc---CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCC
Q psy1546         122 IIMEYLGGGSALDLMKA---GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTT  198 (604)
Q Consensus       122 LVmEy~~ggsL~~~l~~---~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~  198 (604)
                      +|||||++|+|.+++..   +.+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++.......
T Consensus       103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~~~  182 (389)
T 3gni_B          103 VVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHG  182 (389)
T ss_dssp             EEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGGCEECEETT
T ss_pred             EEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccccceeecccc
Confidence            99999999999999865   579999999999999999999999999999999999999999999999999986543221


Q ss_pred             -------CCCcccccCCCCCChHHhhc--CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCCCC--------
Q psy1546         199 -------SKRNTFVGTPFWMAPEVIKQ--SAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNP--------  261 (604)
Q Consensus       199 -------~~~~~~~GT~~Y~APE~l~~--~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~~~--------  261 (604)
                             ......+||+.|+|||++.+  ..|+.++|||||||+||+|++|..||.+.........+.....        
T Consensus       183 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  262 (389)
T 3gni_B          183 QRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTST  262 (389)
T ss_dssp             EECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC-------------
T ss_pred             ccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCccccccc
Confidence                   12234579999999999987  6799999999999999999999999988665554443322111        


Q ss_pred             -------------------------------------CCCCccchHHHHHHHHHHhccCCCCCCCHHHHhcChhhhhhh
Q psy1546         262 -------------------------------------PQLTGNYTKQFKEFVEACLNKDPENRPTAKELLKFPFIRKAK  303 (604)
Q Consensus       262 -------------------------------------~~~~~~~s~~l~~Li~~~L~~dP~~RpT~~elL~hp~f~~~~  303 (604)
                                                           ..++..+++.+.+||.+||..||.+|||+.|+|+||||+...
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f~~~~  341 (389)
T 3gni_B          263 IPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIK  341 (389)
T ss_dssp             -------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGGGC-
T ss_pred             cccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHHHHHHh
Confidence                                                 123455788999999999999999999999999999998754

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.1e-45  Score=395.20  Aligned_cols=245  Identities=28%  Similarity=0.475  Sum_probs=197.2

Q ss_pred             cceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchh-hHHHHHHHHHHHHHHhhCC-CCCCCe------------EEEE
Q psy1546          58 IFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE-AEDEIEDIQQEIMVLSQCD-SPYGTK------------LWII  123 (604)
Q Consensus        58 ~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~-~~~~~~~l~~Ei~iL~~l~-hp~~~~------------lyLV  123 (604)
                      .|.+.++||+|+||.||+|.+..+++.||||++.... .......+.+|+.+|..+. |||+.+            +|||
T Consensus        10 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv   89 (388)
T 3oz6_A           10 KYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYLV   89 (388)
T ss_dssp             TEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEEEE
T ss_pred             ceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEEEE
Confidence            4999999999999999999999999999999985432 2344577889999999997 998543            5899


Q ss_pred             EEecCCCChhhHhhcCCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCC------
Q psy1546         124 MEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNT------  197 (604)
Q Consensus       124 mEy~~ggsL~~~l~~~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~------  197 (604)
                      ||||+ ++|..+++.+.+++..+..++.||+.||+|||++||+||||||+||||+.++.+||+|||+|+.+...      
T Consensus        90 ~e~~~-~~L~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~  168 (388)
T 3oz6_A           90 FDYME-TDLHAVIRANILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNN  168 (388)
T ss_dssp             EECCS-EEHHHHHHHTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEESSSCCCCCCC
T ss_pred             ecccC-cCHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCccccccccccccccc
Confidence            99997 68999999899999999999999999999999999999999999999999999999999999765321      


Q ss_pred             ---------------CCCCcccccCCCCCChHHhhc-CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCC--
Q psy1546         198 ---------------TSKRNTFVGTPFWMAPEVIKQ-SAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKN--  259 (604)
Q Consensus       198 ---------------~~~~~~~~GT~~Y~APE~l~~-~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~--  259 (604)
                                     .......+||+.|+|||++.+ ..|+.++|||||||+||||++|.+||.+.+....+..+...  
T Consensus       169 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~  248 (388)
T 3oz6_A          169 IPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERIIGVID  248 (388)
T ss_dssp             GGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred             ccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcC
Confidence                           112344689999999999986 67899999999999999999999999988766554433210  


Q ss_pred             -------------------------------CCCC-------------CCccchHHHHHHHHHHhccCCCCCCCHHHHhc
Q psy1546         260 -------------------------------NPPQ-------------LTGNYTKQFKEFVEACLNKDPENRPTAKELLK  295 (604)
Q Consensus       260 -------------------------------~~~~-------------~~~~~s~~l~~Li~~~L~~dP~~RpT~~elL~  295 (604)
                                                     ....             ....+++++.+||.+||..||.+|||+.|+|+
T Consensus       249 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t~~e~l~  328 (388)
T 3oz6_A          249 FPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISANDALK  328 (388)
T ss_dssp             CCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             CCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCCHHHHhC
Confidence                                           0000             01256789999999999999999999999999


Q ss_pred             Chhhhhhh
Q psy1546         296 FPFIRKAK  303 (604)
Q Consensus       296 hp~f~~~~  303 (604)
                      ||||+...
T Consensus       329 Hp~~~~~~  336 (388)
T 3oz6_A          329 HPFVSIFH  336 (388)
T ss_dssp             STTTTTTC
T ss_pred             CHHHHHhc
Confidence            99997643

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=8.3e-46  Score=384.24  Aligned_cols=242  Identities=26%  Similarity=0.408  Sum_probs=201.7

Q ss_pred             cceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCCe------------------
Q psy1546          58 IFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTK------------------  119 (604)
Q Consensus        58 ~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~~------------------  119 (604)
                      .|.+.+.||+|+||.||+|++..+++.||||++.........+.+.+|+.+|+.++|||+++                  
T Consensus         7 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~   86 (332)
T 3qd2_B            7 DFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEMD   86 (332)
T ss_dssp             HEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHHH
T ss_pred             cCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhhh
Confidence            38999999999999999999999999999999976655556688999999999999999664                  


Q ss_pred             -------------------------------------------------EEEEEEecCCCChhhHhhcC----CCcHHHH
Q psy1546         120 -------------------------------------------------LWIIMEYLGGGSALDLMKAG----NFEEMHI  146 (604)
Q Consensus       120 -------------------------------------------------lyLVmEy~~ggsL~~~l~~~----~lse~~i  146 (604)
                                                                       +|+|||||++++|.+++...    ..++..+
T Consensus        87 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~  166 (332)
T 3qd2_B           87 EIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVC  166 (332)
T ss_dssp             C--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHHHH
T ss_pred             hhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhHHH
Confidence                                                             57999999999999999763    2445568


Q ss_pred             HHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCC------------CCCcccccCCCCCChH
Q psy1546         147 AVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTT------------SKRNTFVGTPFWMAPE  214 (604)
Q Consensus       147 ~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~------------~~~~~~~GT~~Y~APE  214 (604)
                      +.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.+....            ......+||+.|+|||
T Consensus       167 ~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE  246 (332)
T 3qd2_B          167 LHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPE  246 (332)
T ss_dssp             HHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGGSCHH
T ss_pred             HHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCccChH
Confidence            8999999999999999999999999999999999999999999997765432            2234467999999999


Q ss_pred             HhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCCCCCCCCccchHHHHHHHHHHhccCCCCCCCHHHHh
Q psy1546         215 VIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPENRPTAKELL  294 (604)
Q Consensus       215 ~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~RpT~~elL  294 (604)
                      ++.+..++.++|||||||++|+|++|..|+...  ......+.....+.....+++.+.+||.+||..||.+|||+.|+|
T Consensus       247 ~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l  324 (332)
T 3qd2_B          247 QIHGNNYSHKVDIFSLGLILFELLYSFSTQMER--VRIITDVRNLKFPLLFTQKYPQEHMMVQDMLSPSPTERPEATDII  324 (332)
T ss_dssp             HHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHH--HHHHHHHHTTCCCHHHHHHCHHHHHHHHHHHCSSGGGSCCHHHHH
T ss_pred             HhcCCCCcchhhHHHHHHHHHHHHHcCCChhHH--HHHHHHhhccCCCcccccCChhHHHHHHHHccCCCCcCCCHHHHh
Confidence            999999999999999999999999997775322  122222223333333445677889999999999999999999999


Q ss_pred             cChhhhh
Q psy1546         295 KFPFIRK  301 (604)
Q Consensus       295 ~hp~f~~  301 (604)
                      +||||+.
T Consensus       325 ~~~~f~~  331 (332)
T 3qd2_B          325 ENAIFEN  331 (332)
T ss_dssp             HSTTCCC
T ss_pred             hchhhhc
Confidence            9999964

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=2.5e-45  Score=381.17  Aligned_cols=245  Identities=26%  Similarity=0.470  Sum_probs=200.1

Q ss_pred             ccceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhH-HHHHHHHHHHHHHhhCCCCCCCeE----------EEEEE
Q psy1546          57 LIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAE-DEIEDIQQEIMVLSQCDSPYGTKL----------WIIME  125 (604)
Q Consensus        57 ~~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~-~~~~~l~~Ei~iL~~l~hp~~~~l----------yLVmE  125 (604)
                      ..|.+.++||+|+||+||+|.+. +++.||||++...... .....+.+|+.+++.++|||+.++          |+|||
T Consensus        21 ~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   99 (311)
T 3niz_A           21 EKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFE   99 (311)
T ss_dssp             CEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEE
T ss_pred             hhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEc
Confidence            45999999999999999999985 5899999999655332 234678899999999999996654          79999


Q ss_pred             ecCCCChhhHhhc--CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCCCCcc
Q psy1546         126 YLGGGSALDLMKA--GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNT  203 (604)
Q Consensus       126 y~~ggsL~~~l~~--~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~~~~  203 (604)
                      ||++ +|.+++..  ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+.........
T Consensus       100 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~  178 (311)
T 3niz_A          100 FMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTH  178 (311)
T ss_dssp             CCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC---C
T ss_pred             CCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCceecCCCcccccC
Confidence            9975 67776654  45999999999999999999999999999999999999999999999999999877655555556


Q ss_pred             cccCCCCCChHHhhc-CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCC----CCCC----------------
Q psy1546         204 FVGTPFWMAPEVIKQ-SAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPK----NNPP----------------  262 (604)
Q Consensus       204 ~~GT~~Y~APE~l~~-~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~----~~~~----------------  262 (604)
                      .+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.........+..    ..+.                
T Consensus       179 ~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (311)
T 3niz_A          179 EVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQRTF  258 (311)
T ss_dssp             CCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHHHSCCC
T ss_pred             CcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccchhhhccc
Confidence            789999999999976 5689999999999999999999999987665544332211    0000                


Q ss_pred             ---------CCCccchHHHHHHHHHHhccCCCCCCCHHHHhcChhhhhhh
Q psy1546         263 ---------QLTGNYTKQFKEFVEACLNKDPENRPTAKELLKFPFIRKAK  303 (604)
Q Consensus       263 ---------~~~~~~s~~l~~Li~~~L~~dP~~RpT~~elL~hp~f~~~~  303 (604)
                               .+...+++++.+||.+||..||.+|||+.|+|+||||+...
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~  308 (311)
T 3niz_A          259 QVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDLD  308 (311)
T ss_dssp             CCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTSC
T ss_pred             ccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccCC
Confidence                     11234678999999999999999999999999999998653

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=2.7e-45  Score=375.57  Aligned_cols=242  Identities=28%  Similarity=0.471  Sum_probs=198.1

Q ss_pred             cceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHH-HHHHHHHHHHHHhhCCCCCCCe----------EEEEEEe
Q psy1546          58 IFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAED-EIEDIQQEIMVLSQCDSPYGTK----------LWIIMEY  126 (604)
Q Consensus        58 ~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~-~~~~l~~Ei~iL~~l~hp~~~~----------lyLVmEy  126 (604)
                      .|.+.+.||+|+||.||+|.+ .+++.||||++....... ....+.+|+.+++.+.|||+.+          +|+||||
T Consensus         3 ~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (288)
T 1ob3_A            3 KYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (288)
T ss_dssp             SEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             cchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence            489999999999999999998 678999999996553322 2366789999999999999665          4799999


Q ss_pred             cCCCChhhHhhc--CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCCCCccc
Q psy1546         127 LGGGSALDLMKA--GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTF  204 (604)
Q Consensus       127 ~~ggsL~~~l~~--~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~~~~~  204 (604)
                      +++ +|.+++..  +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++............
T Consensus        82 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~  160 (288)
T 1ob3_A           82 LDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHE  160 (288)
T ss_dssp             CSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--------
T ss_pred             cCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCccccccccc
Confidence            975 88888764  679999999999999999999999999999999999999999999999999997765444444556


Q ss_pred             ccCCCCCChHHhhcC-CCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCC----CC-------------------
Q psy1546         205 VGTPFWMAPEVIKQS-AYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPK----NN-------------------  260 (604)
Q Consensus       205 ~GT~~Y~APE~l~~~-~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~----~~-------------------  260 (604)
                      +||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.........+..    ..                   
T Consensus       161 ~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (288)
T 1ob3_A          161 IVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTV  240 (288)
T ss_dssp             -CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCC
T ss_pred             cccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhccccccccccc
Confidence            899999999999764 589999999999999999999999988766544332210    00                   


Q ss_pred             -----CCCCCccchHHHHHHHHHHhccCCCCCCCHHHHhcChhhhh
Q psy1546         261 -----PPQLTGNYTKQFKEFVEACLNKDPENRPTAKELLKFPFIRK  301 (604)
Q Consensus       261 -----~~~~~~~~s~~l~~Li~~~L~~dP~~RpT~~elL~hp~f~~  301 (604)
                           ...+...+++++.+||.+||..||.+|||+.|+|+||||++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~  286 (288)
T 1ob3_A          241 YEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE  286 (288)
T ss_dssp             CCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred             ccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhh
Confidence                 00122457899999999999999999999999999999975

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=5.4e-45  Score=376.84  Aligned_cols=259  Identities=53%  Similarity=0.946  Sum_probs=217.6

Q ss_pred             CccccceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCCe----------EEEE
Q psy1546          54 DPELIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTK----------LWII  123 (604)
Q Consensus        54 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~~----------lyLV  123 (604)
                      .....|.+.+.||+|+||.||+|.+..+++.||||++....   ..+.+.+|+.+++.+.||++.+          +|+|
T Consensus        26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv  102 (314)
T 3com_A           26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES---DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIV  102 (314)
T ss_dssp             ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS---CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH---HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEE
Confidence            34556999999999999999999999999999999997543   2356789999999999999654          4799


Q ss_pred             EEecCCCChhhHhh--cCCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCCCC
Q psy1546         124 MEYLGGGSALDLMK--AGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKR  201 (604)
Q Consensus       124 mEy~~ggsL~~~l~--~~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~~  201 (604)
                      |||+++++|.+++.  ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+.......
T Consensus       103 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~  182 (314)
T 3com_A          103 MEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKR  182 (314)
T ss_dssp             EECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTBSCB
T ss_pred             eecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhcccc
Confidence            99999999999986  4679999999999999999999999999999999999999999999999999997776554555


Q ss_pred             cccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCCCCC--CCCccchHHHHHHHHHH
Q psy1546         202 NTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPP--QLTGNYTKQFKEFVEAC  279 (604)
Q Consensus       202 ~~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~~~~--~~~~~~s~~l~~Li~~~  279 (604)
                      ....||+.|+|||++.+..++.++|||||||++|+|++|..||...........+......  ..+..++..+.+||.+|
T Consensus       183 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~  262 (314)
T 3com_A          183 NTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELWSDNFTDFVKQC  262 (314)
T ss_dssp             CCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCHHHHHHHHHH
T ss_pred             CccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCcccCCcccCCHHHHHHHHHH
Confidence            5678999999999999999999999999999999999999999988776655544333322  23456789999999999


Q ss_pred             hccCCCCCCCHHHHhcChhhhhhhhhhhHHHHHHHH
Q psy1546         280 LNKDPENRPTAKELLKFPFIRKAKKNAYLIDLIDRY  315 (604)
Q Consensus       280 L~~dP~~RpT~~elL~hp~f~~~~~~~~l~~~~~~~  315 (604)
                      |..||.+|||+.++|+||||+.......+.+++...
T Consensus       263 l~~dp~~Rpt~~~ll~~~~~~~~~~~~~~~~~~~~~  298 (314)
T 3com_A          263 LVKSPEQRATATQLLQHPFVRSAKGVSILRDLINEA  298 (314)
T ss_dssp             TCSCTTTSCCHHHHTTSHHHHTCCCGGGGHHHHHHH
T ss_pred             ccCChhhCcCHHHHHhCHHHhcCCcchHHHHHhhhh
Confidence            999999999999999999999887766666554443

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=1.6e-45  Score=401.76  Aligned_cols=249  Identities=27%  Similarity=0.434  Sum_probs=213.1

Q ss_pred             ccceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHH--HHHHHHHHHHHHhhCCCCCCCe----------EEEEE
Q psy1546          57 LIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAED--EIEDIQQEIMVLSQCDSPYGTK----------LWIIM  124 (604)
Q Consensus        57 ~~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~--~~~~l~~Ei~iL~~l~hp~~~~----------lyLVm  124 (604)
                      ..|.+.++||+|+||+||+|++..+++.||||++.+.....  ....+.+|+.++..+.||++++          +||||
T Consensus        74 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV~  153 (437)
T 4aw2_A           74 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVM  153 (437)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEE
T ss_pred             hheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEEEE
Confidence            34999999999999999999999999999999997543222  2234789999999999998655          47999


Q ss_pred             EecCCCChhhHhhc--CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCC-CC
Q psy1546         125 EYLGGGSALDLMKA--GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTS-KR  201 (604)
Q Consensus       125 Ey~~ggsL~~~l~~--~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~-~~  201 (604)
                      |||+||+|.+++..  +.+++..++.++.||+.||.|||++|||||||||+||||+.+|.+||+|||+|+.+..... ..
T Consensus       154 Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~  233 (437)
T 4aw2_A          154 DYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQS  233 (437)
T ss_dssp             CCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSCEEC
T ss_pred             ecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhhhhcccCCCccc
Confidence            99999999999975  6899999999999999999999999999999999999999999999999999976654332 23


Q ss_pred             cccccCCCCCChHHhh-----cCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCC----CCCCCCccchHHH
Q psy1546         202 NTFVGTPFWMAPEVIK-----QSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKN----NPPQLTGNYTKQF  272 (604)
Q Consensus       202 ~~~~GT~~Y~APE~l~-----~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~----~~~~~~~~~s~~l  272 (604)
                      ...+||+.|||||++.     ...|+.++|||||||+||||++|.+||.+.+..+....+...    ..+.....+++++
T Consensus       234 ~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~~~  313 (437)
T 4aw2_A          234 SVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVTDVSENA  313 (437)
T ss_dssp             CSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCSSCCCSCHHH
T ss_pred             ccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccccccCCcccccCCHHH
Confidence            4568999999999997     466899999999999999999999999998877766655332    2233335689999


Q ss_pred             HHHHHHHhccCCCC--CCCHHHHhcChhhhhhhhh
Q psy1546         273 KEFVEACLNKDPEN--RPTAKELLKFPFIRKAKKN  305 (604)
Q Consensus       273 ~~Li~~~L~~dP~~--RpT~~elL~hp~f~~~~~~  305 (604)
                      ++||.+||..+|++  |++++||++||||+...+.
T Consensus       314 ~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i~w~  348 (437)
T 4aw2_A          314 KDLIRRLICSREHRLGQNGIEDFKKHPFFSGIDWD  348 (437)
T ss_dssp             HHHHHTTSSCGGGCTTTTTTHHHHTSGGGTTCCTT
T ss_pred             HHHHHHHhcccccccCCCCHHHHhCCCccCCCCHH
Confidence            99999999998888  9999999999999876543

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=1.3e-45  Score=388.94  Aligned_cols=242  Identities=26%  Similarity=0.426  Sum_probs=208.6

Q ss_pred             cceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHH--HHHHHHHHHHHHhhCCCCCCCeE----------EEEEE
Q psy1546          58 IFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAED--EIEDIQQEIMVLSQCDSPYGTKL----------WIIME  125 (604)
Q Consensus        58 ~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~--~~~~l~~Ei~iL~~l~hp~~~~l----------yLVmE  125 (604)
                      .|.+.+.||+|+||.||+|.+..+++.||||++.......  ....+.+|+.+++.+.|||+.++          |+|||
T Consensus        10 ~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E   89 (336)
T 3h4j_B           10 PYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVIE   89 (336)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             CEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEE
Confidence            3999999999999999999999999999999997543222  23578899999999999997654          79999


Q ss_pred             ecCCCChhhHh-hcCCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCCCCccc
Q psy1546         126 YLGGGSALDLM-KAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTF  204 (604)
Q Consensus       126 y~~ggsL~~~l-~~~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~~~~~  204 (604)
                      |+ +|+|.+++ ..+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... ......
T Consensus        90 ~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~-~~~~~~  167 (336)
T 3h4j_B           90 YA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG-NFLKTS  167 (336)
T ss_dssp             CC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTS-BTTCCC
T ss_pred             CC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceeccCC-cccccc
Confidence            99 67777766 4578999999999999999999999999999999999999999999999999999765433 334567


Q ss_pred             ccCCCCCChHHhhcCCC-CCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCCCCCCCCccchHHHHHHHHHHhccC
Q psy1546         205 VGTPFWMAPEVIKQSAY-DSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKD  283 (604)
Q Consensus       205 ~GT~~Y~APE~l~~~~~-~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~~L~~d  283 (604)
                      +||+.|+|||++.+..+ +.++|||||||+||+|++|..||.+.........+... ...++..+++++.+||.+||..|
T Consensus       168 ~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~li~~~L~~d  246 (336)
T 3h4j_B          168 CGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSC-VYVMPDFLSPGAQSLIRRMIVAD  246 (336)
T ss_dssp             TTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCCCSS-CCCCCTTSCHHHHHHHHTTSCSS
T ss_pred             cCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHHHcC-CCCCcccCCHHHHHHHHHHcCCC
Confidence            89999999999988876 68999999999999999999999887665555444333 33456778999999999999999


Q ss_pred             CCCCCCHHHHhcChhhhhh
Q psy1546         284 PENRPTAKELLKFPFIRKA  302 (604)
Q Consensus       284 P~~RpT~~elL~hp~f~~~  302 (604)
                      |.+|||+.||++||||+..
T Consensus       247 P~~Rpt~~eil~hp~~~~~  265 (336)
T 3h4j_B          247 PMQRITIQEIRRDPWFNVN  265 (336)
T ss_dssp             GGGSCCHHHHTTCHHHHTT
T ss_pred             hhHCcCHHHHHhChhhccC
Confidence            9999999999999999753

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=4e-45  Score=377.29  Aligned_cols=248  Identities=28%  Similarity=0.450  Sum_probs=201.4

Q ss_pred             cceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhH-HHHHHHHHHHHHHhhCCCCCCCe----------EEEEEEe
Q psy1546          58 IFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAE-DEIEDIQQEIMVLSQCDSPYGTK----------LWIIMEY  126 (604)
Q Consensus        58 ~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~-~~~~~l~~Ei~iL~~l~hp~~~~----------lyLVmEy  126 (604)
                      .|.+.++||+|+||.||+|.+..+++.||||++...... ...+.+.+|+.+++.+.||++.+          +|+||||
T Consensus         4 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (311)
T 4agu_A            4 KYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEY   83 (311)
T ss_dssp             CEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             cceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEEe
Confidence            489999999999999999999999999999998655433 33567889999999999999665          4799999


Q ss_pred             cCCCChhhHhhc-CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCCCCcccc
Q psy1546         127 LGGGSALDLMKA-GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFV  205 (604)
Q Consensus       127 ~~ggsL~~~l~~-~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~~~~~~  205 (604)
                      +++++|.+++.. +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.............+
T Consensus        84 ~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  163 (311)
T 4agu_A           84 CDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEV  163 (311)
T ss_dssp             CSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC----------
T ss_pred             CCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcccccCCCc
Confidence            999999998864 6799999999999999999999999999999999999999999999999999987765555555678


Q ss_pred             cCCCCCChHHhhc-CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCC---------------------CCCC-
Q psy1546         206 GTPFWMAPEVIKQ-SAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPK---------------------NNPP-  262 (604)
Q Consensus       206 GT~~Y~APE~l~~-~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~---------------------~~~~-  262 (604)
                      ||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.........+..                     ...+ 
T Consensus       164 ~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (311)
T 4agu_A          164 ATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVKIPD  243 (311)
T ss_dssp             --GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTTCCCCC
T ss_pred             CCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccccccCcCCC
Confidence            9999999999976 6689999999999999999999999988776544332210                     0000 


Q ss_pred             --C------CCccchHHHHHHHHHHhccCCCCCCCHHHHhcChhhhhhhhh
Q psy1546         263 --Q------LTGNYTKQFKEFVEACLNKDPENRPTAKELLKFPFIRKAKKN  305 (604)
Q Consensus       263 --~------~~~~~s~~l~~Li~~~L~~dP~~RpT~~elL~hp~f~~~~~~  305 (604)
                        .      ....++..+.+||.+||..||.+|||++|||+||||+.....
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~  294 (311)
T 4agu_A          244 PEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIREI  294 (311)
T ss_dssp             CSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTCC--
T ss_pred             ccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhccCH
Confidence              0      013578889999999999999999999999999999876543

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=2.7e-45  Score=402.88  Aligned_cols=245  Identities=21%  Similarity=0.343  Sum_probs=198.6

Q ss_pred             ccceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchh-hHHHHHHHHHHHHHHhhCCCCCCC----------------e
Q psy1546          57 LIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE-AEDEIEDIQQEIMVLSQCDSPYGT----------------K  119 (604)
Q Consensus        57 ~~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~-~~~~~~~l~~Ei~iL~~l~hp~~~----------------~  119 (604)
                      ..|.++++||+|+||+||+|.+..+++.||||++.... .....+.+.+|+.+|+.++|||++                .
T Consensus        62 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~  141 (464)
T 3ttj_A           62 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD  141 (464)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred             CCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCCe
Confidence            34999999999999999999999999999999996543 234467788999999999999854                3


Q ss_pred             EEEEEEecCCCChhhHhhcCCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCC
Q psy1546         120 LWIIMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTS  199 (604)
Q Consensus       120 lyLVmEy~~ggsL~~~l~~~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~  199 (604)
                      +|||||||+++ |.+.+.. .+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+|+.... ..
T Consensus       142 ~~lv~E~~~~~-l~~~~~~-~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~-~~  218 (464)
T 3ttj_A          142 VYLVMELMDAN-LCQVIQM-ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT-SF  218 (464)
T ss_dssp             EEEEEECCSEE-HHHHHTS-CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCCC------CC
T ss_pred             EEEEEeCCCCC-HHHHHhh-cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEeeeecCC-Cc
Confidence            58999999765 5555543 599999999999999999999999999999999999999999999999999976643 23


Q ss_pred             CCcccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCC--------------------
Q psy1546         200 KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKN--------------------  259 (604)
Q Consensus       200 ~~~~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~--------------------  259 (604)
                      .....+||+.|+|||++.+..|+.++|||||||+||||++|.+||.+.+....+..+...                    
T Consensus       219 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~~~~~~~  298 (464)
T 3ttj_A          219 MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYV  298 (464)
T ss_dssp             CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCHHHHHHH
T ss_pred             ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcchhhhhHh
Confidence            345678999999999999999999999999999999999999999988765444332110                    


Q ss_pred             --C----CCCC----Cc-----------cchHHHHHHHHHHhccCCCCCCCHHHHhcChhhhhhhh
Q psy1546         260 --N----PPQL----TG-----------NYTKQFKEFVEACLNKDPENRPTAKELLKFPFIRKAKK  304 (604)
Q Consensus       260 --~----~~~~----~~-----------~~s~~l~~Li~~~L~~dP~~RpT~~elL~hp~f~~~~~  304 (604)
                        .    ...+    +.           ..+.++.+||.+||..||.+|||++|+|+||||+.+..
T Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~~~~  364 (464)
T 3ttj_A          299 ENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYD  364 (464)
T ss_dssp             TTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGCC
T ss_pred             hcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhhccC
Confidence              0    0000    00           01567999999999999999999999999999986544

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=8e-45  Score=386.86  Aligned_cols=244  Identities=27%  Similarity=0.427  Sum_probs=203.4

Q ss_pred             cccceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchh-hHHHHHHHHHHHHHHhhCCCCCCCe---------------
Q psy1546          56 ELIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE-AEDEIEDIQQEIMVLSQCDSPYGTK---------------  119 (604)
Q Consensus        56 ~~~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~-~~~~~~~l~~Ei~iL~~l~hp~~~~---------------  119 (604)
                      ...|.+.+.||+|+||.||+|.+..+|+.||||++.... .....+.+.+|+.+|+.++|||+.+               
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  103 (367)
T 1cm8_A           24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT  103 (367)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence            456999999999999999999999999999999985543 2334577899999999999998543               


Q ss_pred             -EEEEEEecCCCChhhHhhcCCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCC
Q psy1546         120 -LWIIMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTT  198 (604)
Q Consensus       120 -lyLVmEy~~ggsL~~~l~~~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~  198 (604)
                       +|+||||+ +++|.++++.+.+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++....  
T Consensus       104 ~~~lv~e~~-~~~L~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~--  180 (367)
T 1cm8_A          104 DFYLVMPFM-GTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADS--  180 (367)
T ss_dssp             CCEEEEECC-SEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCS--
T ss_pred             eEEEEEecC-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeeeccccccc--
Confidence             48999999 88999999989999999999999999999999999999999999999999999999999999976543  


Q ss_pred             CCCcccccCCCCCChHHhhc-CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCC-------------------
Q psy1546         199 SKRNTFVGTPFWMAPEVIKQ-SAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPK-------------------  258 (604)
Q Consensus       199 ~~~~~~~GT~~Y~APE~l~~-~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~-------------------  258 (604)
                       .....+||+.|+|||++.+ ..|+.++|||||||++|||++|.+||.+.+....+..+..                   
T Consensus       181 -~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~  259 (367)
T 1cm8_A          181 -EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAK  259 (367)
T ss_dssp             -SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHH
T ss_pred             -ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhHHHH
Confidence             2345689999999999987 6799999999999999999999999998776544332211                   


Q ss_pred             -----------CCCCCCCccchHHHHHHHHHHhccCCCCCCCHHHHhcChhhhhhh
Q psy1546         259 -----------NNPPQLTGNYTKQFKEFVEACLNKDPENRPTAKELLKFPFIRKAK  303 (604)
Q Consensus       259 -----------~~~~~~~~~~s~~l~~Li~~~L~~dP~~RpT~~elL~hp~f~~~~  303 (604)
                                 .....+...+++.+.+||.+||..||.+|||+.|+|+||||....
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~  315 (367)
T 1cm8_A          260 NYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH  315 (367)
T ss_dssp             HHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred             HHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhc
Confidence                       111123345688999999999999999999999999999998654

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.9e-45  Score=396.92  Aligned_cols=247  Identities=29%  Similarity=0.439  Sum_probs=209.6

Q ss_pred             ccceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhH--HHHHHHHHHHHHHhhCCCCCCCe----------EEEEE
Q psy1546          57 LIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAE--DEIEDIQQEIMVLSQCDSPYGTK----------LWIIM  124 (604)
Q Consensus        57 ~~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~--~~~~~l~~Ei~iL~~l~hp~~~~----------lyLVm  124 (604)
                      ..|.+.++||+|+||+||+|+++.+++.||||++.+....  .....+.+|+.++..+.||++++          +||||
T Consensus        61 ~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lVm  140 (412)
T 2vd5_A           61 DDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVM  140 (412)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEE
T ss_pred             hhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEE
Confidence            3499999999999999999999999999999999754322  22455789999999999998655          47999


Q ss_pred             EecCCCChhhHhhc--CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCC-CC
Q psy1546         125 EYLGGGSALDLMKA--GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTS-KR  201 (604)
Q Consensus       125 Ey~~ggsL~~~l~~--~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~-~~  201 (604)
                      |||+||+|.+++..  ..+++..++.++.||+.||.|||++||+||||||+||||+.+|++||+|||+|+.+..... ..
T Consensus       141 E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~~~~~~  220 (412)
T 2vd5_A          141 EYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRS  220 (412)
T ss_dssp             CCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSCEEC
T ss_pred             cCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechhheeccCCCcccc
Confidence            99999999999965  4799999999999999999999999999999999999999999999999999977654332 23


Q ss_pred             cccccCCCCCChHHhh-------cCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCC----CCCCCCccchH
Q psy1546         202 NTFVGTPFWMAPEVIK-------QSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKN----NPPQLTGNYTK  270 (604)
Q Consensus       202 ~~~~GT~~Y~APE~l~-------~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~----~~~~~~~~~s~  270 (604)
                      ...+||+.|+|||++.       ...|+.++|||||||++|||++|.+||...+..+....+...    ..+.+...++.
T Consensus       221 ~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~  300 (412)
T 2vd5_A          221 LVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLVDEGVPE  300 (412)
T ss_dssp             SSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCC----CCCH
T ss_pred             ceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCcCCCccccCCCH
Confidence            4578999999999997       356899999999999999999999999998877666554432    22334467899


Q ss_pred             HHHHHHHHHhccCCCCC---CCHHHHhcChhhhhhhh
Q psy1546         271 QFKEFVEACLNKDPENR---PTAKELLKFPFIRKAKK  304 (604)
Q Consensus       271 ~l~~Li~~~L~~dP~~R---pT~~elL~hp~f~~~~~  304 (604)
                      ++++||.+||. +|.+|   ++++||++||||+...+
T Consensus       301 ~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~i~w  336 (412)
T 2vd5_A          301 EARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGLDW  336 (412)
T ss_dssp             HHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTTCCS
T ss_pred             HHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCCCCH
Confidence            99999999999 99998   59999999999986543

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=1.4e-44  Score=367.93  Aligned_cols=241  Identities=28%  Similarity=0.522  Sum_probs=208.1

Q ss_pred             ceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHH--HHHHHHHHHHHHhhCCCCCCCe----------EEEEEEe
Q psy1546          59 FTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAED--EIEDIQQEIMVLSQCDSPYGTK----------LWIIMEY  126 (604)
Q Consensus        59 y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~--~~~~l~~Ei~iL~~l~hp~~~~----------lyLVmEy  126 (604)
                      |.+.+.||+|+||.||+|.+..+++.||||++.......  ....+.+|+.+++.+.||++.+          +|+||||
T Consensus        11 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   90 (279)
T 3fdn_A           11 FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEY   90 (279)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             EEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEEEec
Confidence            999999999999999999999999999999996554322  2467889999999999999655          4799999


Q ss_pred             cCCCChhhHhhc-CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCCCCcccc
Q psy1546         127 LGGGSALDLMKA-GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFV  205 (604)
Q Consensus       127 ~~ggsL~~~l~~-~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~~~~~~  205 (604)
                      +++++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++......  ......
T Consensus        91 ~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~--~~~~~~  168 (279)
T 3fdn_A           91 APLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS--RRTDLC  168 (279)
T ss_dssp             CTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESCC----------C
T ss_pred             CCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccccCCcc--cccccC
Confidence            999999998865 78999999999999999999999999999999999999999999999999998554322  234568


Q ss_pred             cCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCCCCCCCCccchHHHHHHHHHHhccCCC
Q psy1546         206 GTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPE  285 (604)
Q Consensus       206 GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~~L~~dP~  285 (604)
                      ||+.|+|||++.+..++.++|||||||++|+|++|..||...........+.... ..++..++..+.+||.+||..||.
T Consensus       169 ~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~  247 (279)
T 3fdn_A          169 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVE-FTFPDFVTEGARDLISRLLKHNPS  247 (279)
T ss_dssp             CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTC-CCCCTTSCHHHHHHHHHHCCSSGG
T ss_pred             CCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCC-CCCCCcCCHHHHHHHHHHhccChh
Confidence            9999999999999999999999999999999999999999887766665543332 345567889999999999999999


Q ss_pred             CCCCHHHHhcChhhhhh
Q psy1546         286 NRPTAKELLKFPFIRKA  302 (604)
Q Consensus       286 ~RpT~~elL~hp~f~~~  302 (604)
                      +|||+.|||+||||+..
T Consensus       248 ~Rps~~e~l~h~~~~~~  264 (279)
T 3fdn_A          248 QRPMLREVLEHPWITAN  264 (279)
T ss_dssp             GSCCHHHHHHCHHHHHH
T ss_pred             hCCCHHHHhhCccccCC
Confidence            99999999999999754

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=2.9e-45  Score=386.90  Aligned_cols=242  Identities=29%  Similarity=0.459  Sum_probs=204.3

Q ss_pred             cccceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhC-CCCCCCe----------EEEEE
Q psy1546          56 ELIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQC-DSPYGTK----------LWIIM  124 (604)
Q Consensus        56 ~~~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l-~hp~~~~----------lyLVm  124 (604)
                      ...|.+.+.||+|+||.||+|.++.+++.||||++.....     ...+|+.++.++ .|||+.+          +|+||
T Consensus        21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~   95 (342)
T 2qr7_A           21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR-----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVT   95 (342)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC-----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred             cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC-----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEE
Confidence            3459999999999999999999999999999999975532     234677788777 7998655          47999


Q ss_pred             EecCCCChhhHhhc-CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCC-C---CeEEecccccccccCCCC
Q psy1546         125 EYLGGGSALDLMKA-GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEM-G---DVKLADFGVAGTLTNTTS  199 (604)
Q Consensus       125 Ey~~ggsL~~~l~~-~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~-g---~vKL~DFGlA~~~~~~~~  199 (604)
                      |||+||+|.+++.. +.+++..+..++.||+.||.|||++||+||||||+|||+... +   .+||+|||+++.+.....
T Consensus        96 E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~~  175 (342)
T 2qr7_A           96 ELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENG  175 (342)
T ss_dssp             CCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTTC
T ss_pred             eCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCCC
Confidence            99999999998854 679999999999999999999999999999999999998543 3   599999999987765555


Q ss_pred             CCcccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCC---ChhhHhhhcCCCCC---CCCCccchHHHH
Q psy1546         200 KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSEL---HPMRVLFLIPKNNP---PQLTGNYTKQFK  273 (604)
Q Consensus       200 ~~~~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~---~~~~~~~~i~~~~~---~~~~~~~s~~l~  273 (604)
                      ...+.+||+.|+|||++.+..|+.++|||||||+||+|++|..||...   ...++...+..+..   ...+..++++++
T Consensus       176 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  255 (342)
T 2qr7_A          176 LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSVSDTAK  255 (342)
T ss_dssp             CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCSTTTTTSCHHHH
T ss_pred             ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCccccccCCHHHH
Confidence            556778999999999999888999999999999999999999999863   33344444433322   223457899999


Q ss_pred             HHHHHHhccCCCCCCCHHHHhcChhhhhh
Q psy1546         274 EFVEACLNKDPENRPTAKELLKFPFIRKA  302 (604)
Q Consensus       274 ~Li~~~L~~dP~~RpT~~elL~hp~f~~~  302 (604)
                      +||.+||..||.+|||+.++++||||..+
T Consensus       256 ~li~~~L~~dP~~R~t~~~il~hp~~~~~  284 (342)
T 2qr7_A          256 DLVSKMLHVDPHQRLTAALVLRHPWIVHW  284 (342)
T ss_dssp             HHHHHHTCSSTTTSCCHHHHTTSHHHHTG
T ss_pred             HHHHHHCCCChhHCcCHHHHhcCCeecCc
Confidence            99999999999999999999999999653

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=2.4e-44  Score=366.39  Aligned_cols=247  Identities=27%  Similarity=0.493  Sum_probs=212.6

Q ss_pred             ccceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchh-hHHHHHHHHHHHHHHhhCCCCCCCeE----------EEEEE
Q psy1546          57 LIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE-AEDEIEDIQQEIMVLSQCDSPYGTKL----------WIIME  125 (604)
Q Consensus        57 ~~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~-~~~~~~~l~~Ei~iL~~l~hp~~~~l----------yLVmE  125 (604)
                      ..|.+.+.||+|+||.||+|.+..+++.||||++.... .....+.+.+|+.+++.+.||++.++          |+|||
T Consensus         6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   85 (284)
T 3kk8_A            6 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFD   85 (284)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             hhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEEe
Confidence            45999999999999999999999999999999997654 33456778899999999999996654          79999


Q ss_pred             ecCCCChhhHhh-cCCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCC---eEEecccccccccCCCCCC
Q psy1546         126 YLGGGSALDLMK-AGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGD---VKLADFGVAGTLTNTTSKR  201 (604)
Q Consensus       126 y~~ggsL~~~l~-~~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~---vKL~DFGlA~~~~~~~~~~  201 (604)
                      |+.+++|.+++. .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.   +||+|||++...... ...
T Consensus        86 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~-~~~  164 (284)
T 3kk8_A           86 LVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS-EAW  164 (284)
T ss_dssp             CCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSS-CBC
T ss_pred             cCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccC-ccc
Confidence            999999988775 467999999999999999999999999999999999999986655   999999999765433 233


Q ss_pred             cccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCCC---CCCCCccchHHHHHHHHH
Q psy1546         202 NTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNN---PPQLTGNYTKQFKEFVEA  278 (604)
Q Consensus       202 ~~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~~---~~~~~~~~s~~l~~Li~~  278 (604)
                      ....||+.|+|||++.+..++.++|||||||++|+|++|..||...........+....   +......+++++.+||.+
T Consensus       165 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  244 (284)
T 3kk8_A          165 HGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDS  244 (284)
T ss_dssp             CCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHHHHHH
T ss_pred             cCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCchhhcccCHHHHHHHHH
Confidence            45689999999999999999999999999999999999999999888776665544332   223335688999999999


Q ss_pred             HhccCCCCCCCHHHHhcChhhhhhhh
Q psy1546         279 CLNKDPENRPTAKELLKFPFIRKAKK  304 (604)
Q Consensus       279 ~L~~dP~~RpT~~elL~hp~f~~~~~  304 (604)
                      ||..||.+|||+.|+|+||||+....
T Consensus       245 ~l~~dp~~Rps~~~~l~h~~~~~~~~  270 (284)
T 3kk8_A          245 MLTVNPKKRITADQALKVPWICNRER  270 (284)
T ss_dssp             HSCSSTTTSCCHHHHTTSHHHHSCCC
T ss_pred             HcccChhhCCCHHHHhcCccccCChh
Confidence            99999999999999999999976543

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.4e-44  Score=375.65  Aligned_cols=250  Identities=48%  Similarity=0.869  Sum_probs=205.4

Q ss_pred             ccccceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhC-CCCCCC---------------
Q psy1546          55 PELIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQC-DSPYGT---------------  118 (604)
Q Consensus        55 ~~~~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l-~hp~~~---------------  118 (604)
                      ....|.+.+.||+|+||.||+|.+..+++.||||++.....  ....+.+|+.+++.+ .||++.               
T Consensus        22 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~   99 (326)
T 2x7f_A           22 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD--EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD   99 (326)
T ss_dssp             CTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS--TTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCC
T ss_pred             CCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcc--cHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCcccc
Confidence            44569999999999999999999999999999999865432  236688999999998 799743               


Q ss_pred             -eEEEEEEecCCCChhhHhhc---CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccc
Q psy1546         119 -KLWIIMEYLGGGSALDLMKA---GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTL  194 (604)
Q Consensus       119 -~lyLVmEy~~ggsL~~~l~~---~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~  194 (604)
                       .+|+||||+++++|.+++..   ..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+
T Consensus       100 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~  179 (326)
T 2x7f_A          100 DQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL  179 (326)
T ss_dssp             CEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCTTTC--
T ss_pred             ceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEEEeeCcCceec
Confidence             45799999999999999865   56999999999999999999999999999999999999999999999999999776


Q ss_pred             cCCCCCCcccccCCCCCChHHhh-----cCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCCCC-CCCCccc
Q psy1546         195 TNTTSKRNTFVGTPFWMAPEVIK-----QSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNP-PQLTGNY  268 (604)
Q Consensus       195 ~~~~~~~~~~~GT~~Y~APE~l~-----~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~~~-~~~~~~~  268 (604)
                      ...........||+.|+|||++.     +..++.++|||||||++|+|++|..||...........+..... ......+
T Consensus       180 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (326)
T 2x7f_A          180 DRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSKKW  259 (326)
T ss_dssp             -----------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCSCS
T ss_pred             CcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccccCCcccc
Confidence            54444445678999999999997     56788999999999999999999999998877666655444332 2334578


Q ss_pred             hHHHHHHHHHHhccCCCCCCCHHHHhcChhhhhhhhhh
Q psy1546         269 TKQFKEFVEACLNKDPENRPTAKELLKFPFIRKAKKNA  306 (604)
Q Consensus       269 s~~l~~Li~~~L~~dP~~RpT~~elL~hp~f~~~~~~~  306 (604)
                      +..+.+||.+||..||.+|||+.+|++||||+......
T Consensus       260 ~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~~~~  297 (326)
T 2x7f_A          260 SKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQPNER  297 (326)
T ss_dssp             CHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCCTTHH
T ss_pred             CHHHHHHHHHHhccChhhCCCHHHHhhChHHhhCcccc
Confidence            99999999999999999999999999999998765543

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=4.6e-45  Score=391.86  Aligned_cols=246  Identities=27%  Similarity=0.536  Sum_probs=210.2

Q ss_pred             cceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhh--HHHHHHHHHHHHHHhhCCCCCCCeE----------EEEEE
Q psy1546          58 IFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA--EDEIEDIQQEIMVLSQCDSPYGTKL----------WIIME  125 (604)
Q Consensus        58 ~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~--~~~~~~l~~Ei~iL~~l~hp~~~~l----------yLVmE  125 (604)
                      .|.+.+.||+|+||.||+|.+..+++.||||++.....  ......+.+|+.+|+.+.||+++++          |+|||
T Consensus        16 ~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e   95 (384)
T 4fr4_A           16 HFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVD   95 (384)
T ss_dssp             GEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             HeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEe
Confidence            39999999999999999999999999999999975532  2235778899999999999997654          79999


Q ss_pred             ecCCCChhhHhhc-CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCCCCccc
Q psy1546         126 YLGGGSALDLMKA-GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTF  204 (604)
Q Consensus       126 y~~ggsL~~~l~~-~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~~~~~  204 (604)
                      ||.||+|.+++.. +.+++..++.|+.||+.||.|||++||+||||||+||||+.+|.+||+|||+|+.+.. .......
T Consensus        96 ~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~-~~~~~~~  174 (384)
T 4fr4_A           96 LLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPR-ETQITTM  174 (384)
T ss_dssp             CCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCT-TCCBCCC
T ss_pred             cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceeeeccC-CCceecc
Confidence            9999999999876 5799999999999999999999999999999999999999999999999999976643 3344577


Q ss_pred             ccCCCCCChHHhhc---CCCCCcchhhhHHHHHHHHHhCCCCCCCCCh---hhHhhhcCCCCCCCCCccchHHHHHHHHH
Q psy1546         205 VGTPFWMAPEVIKQ---SAYDSKADIWSLGITAIELAKGEPPNSELHP---MRVLFLIPKNNPPQLTGNYTKQFKEFVEA  278 (604)
Q Consensus       205 ~GT~~Y~APE~l~~---~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~---~~~~~~i~~~~~~~~~~~~s~~l~~Li~~  278 (604)
                      +||+.|+|||++.+   ..|+.++|||||||+||+|++|..||.....   ......+. .....++..++..+.+||.+
T Consensus       175 ~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~-~~~~~~p~~~s~~~~~li~~  253 (384)
T 4fr4_A          175 AGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFE-TTVVTYPSAWSQEMVSLLKK  253 (384)
T ss_dssp             CSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHH-HCCCCCCTTSCHHHHHHHHH
T ss_pred             CCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHh-hcccCCCCcCCHHHHHHHHH
Confidence            89999999999964   4589999999999999999999999975433   22222221 22344567789999999999


Q ss_pred             HhccCCCCCCC-HHHHhcChhhhhhhhh
Q psy1546         279 CLNKDPENRPT-AKELLKFPFIRKAKKN  305 (604)
Q Consensus       279 ~L~~dP~~RpT-~~elL~hp~f~~~~~~  305 (604)
                      ||..||.+||+ +++|++||||....+.
T Consensus       254 lL~~dP~~R~s~~~~l~~hp~f~~~~w~  281 (384)
T 4fr4_A          254 LLEPNPDQRFSQLSDVQNFPYMNDINWD  281 (384)
T ss_dssp             HSCSSGGGSCCSHHHHHTSGGGTTCCHH
T ss_pred             HhcCCHhHhcccHHHHHcChhhhcCCHH
Confidence            99999999998 9999999999876543

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=7.3e-45  Score=380.82  Aligned_cols=249  Identities=28%  Similarity=0.468  Sum_probs=207.1

Q ss_pred             cccceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhh----HHHHHHHHHHHHHHhhCCCCCCCeE----------E
Q psy1546          56 ELIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA----EDEIEDIQQEIMVLSQCDSPYGTKL----------W  121 (604)
Q Consensus        56 ~~~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~----~~~~~~l~~Ei~iL~~l~hp~~~~l----------y  121 (604)
                      ...|.+.+.||+|+||.||+|.+..+++.||||++.....    ....+.+.+|+.+++.++|||+.++          |
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~  104 (345)
T 3hko_A           25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYIC  104 (345)
T ss_dssp             HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             hhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEE
Confidence            3459999999999999999999999999999999975532    2346788999999999999997654          7


Q ss_pred             EEEEecCCCChhhHhhc-----------------------------------------CCCcHHHHHHHHHHHHHHhHHh
Q psy1546         122 IIMEYLGGGSALDLMKA-----------------------------------------GNFEEMHIAVILREVLKGLDYL  160 (604)
Q Consensus       122 LVmEy~~ggsL~~~l~~-----------------------------------------~~lse~~i~~i~~qIl~gL~yL  160 (604)
                      +|||||+||+|.+++..                                         ..+++..++.++.||+.||.||
T Consensus       105 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~L  184 (345)
T 3hko_A          105 LVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYL  184 (345)
T ss_dssp             EEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             EEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHH
Confidence            99999999999998851                                         1246788899999999999999


Q ss_pred             hhCCccccccccceeEecCCC--CeEEecccccccccCCCC----CCcccccCCCCCChHHhhc--CCCCCcchhhhHHH
Q psy1546         161 HSERKLHRDIKAANVLLSEMG--DVKLADFGVAGTLTNTTS----KRNTFVGTPFWMAPEVIKQ--SAYDSKADIWSLGI  232 (604)
Q Consensus       161 Hs~gIiHrDLKp~NILl~~~g--~vKL~DFGlA~~~~~~~~----~~~~~~GT~~Y~APE~l~~--~~~~~~sDVwSLGv  232 (604)
                      |++||+||||||+||||+.++  .+||+|||+++.+.....    ......||+.|+|||++.+  ..++.++|||||||
T Consensus       185 H~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~  264 (345)
T 3hko_A          185 HNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGV  264 (345)
T ss_dssp             HHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHHHH
T ss_pred             HHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHHHHH
Confidence            999999999999999998776  899999999976543221    2345679999999999975  67899999999999


Q ss_pred             HHHHHHhCCCCCCCCChhhHhhhcCCCCCC---CCCccchHHHHHHHHHHhccCCCCCCCHHHHhcChhhhhhhh
Q psy1546         233 TAIELAKGEPPNSELHPMRVLFLIPKNNPP---QLTGNYTKQFKEFVEACLNKDPENRPTAKELLKFPFIRKAKK  304 (604)
Q Consensus       233 iL~eLltG~~Pf~~~~~~~~~~~i~~~~~~---~~~~~~s~~l~~Li~~~L~~dP~~RpT~~elL~hp~f~~~~~  304 (604)
                      +||+|++|..||.+.........+......   .....+++.+.+||.+||..||.+|||+.|+|+||||+....
T Consensus       265 il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~hp~~~~~~~  339 (345)
T 3hko_A          265 LLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQFSD  339 (345)
T ss_dssp             HHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHSHHHHTTSS
T ss_pred             HHHHHHHCCCCCCCCChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhcChhhccChH
Confidence            999999999999988877666554433322   222347899999999999999999999999999999987543

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=1.3e-44  Score=370.39  Aligned_cols=244  Identities=29%  Similarity=0.489  Sum_probs=203.6

Q ss_pred             cccceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCCeE----------EEEEE
Q psy1546          56 ELIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTKL----------WIIME  125 (604)
Q Consensus        56 ~~~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~~l----------yLVmE  125 (604)
                      ...|.+.++||+|+||.||+|.+..++..||||++.........+.+.+|+.+|+.++||++.++          |+|||
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e  100 (285)
T 3is5_A           21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVME  100 (285)
T ss_dssp             HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEE
Confidence            45599999999999999999999999999999999766544456788999999999999996654          79999


Q ss_pred             ecCCCChhhHhhc-----CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEe---cCCCCeEEecccccccccCC
Q psy1546         126 YLGGGSALDLMKA-----GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLL---SEMGDVKLADFGVAGTLTNT  197 (604)
Q Consensus       126 y~~ggsL~~~l~~-----~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl---~~~g~vKL~DFGlA~~~~~~  197 (604)
                      |+++|+|.+++..     ..+++..++.++.||+.||.|||++||+||||||+||||   +.++.+||+|||++..+...
T Consensus       101 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~  180 (285)
T 3is5_A          101 TCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSD  180 (285)
T ss_dssp             CCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC----
T ss_pred             eCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecceecCCc
Confidence            9999999998743     579999999999999999999999999999999999999   45678999999999765432


Q ss_pred             CCCCcccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCCCC--CCCCccchHHHHHH
Q psy1546         198 TSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNP--PQLTGNYTKQFKEF  275 (604)
Q Consensus       198 ~~~~~~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~~~--~~~~~~~s~~l~~L  275 (604)
                       .......||+.|+|||++. ..++.++|||||||++|+|++|..||.+.........+.....  ......+++++.+|
T Consensus       181 -~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  258 (285)
T 3is5_A          181 -EHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECRPLTPQAVDL  258 (285)
T ss_dssp             -------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCC--CCCCHHHHHH
T ss_pred             -ccCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCcccccccCcCCHHHHHH
Confidence             2334567999999999986 5688999999999999999999999998877665544332221  22223478999999


Q ss_pred             HHHHhccCCCCCCCHHHHhcChhhhh
Q psy1546         276 VEACLNKDPENRPTAKELLKFPFIRK  301 (604)
Q Consensus       276 i~~~L~~dP~~RpT~~elL~hp~f~~  301 (604)
                      |.+||..||.+|||+.|||+||||++
T Consensus       259 i~~~L~~dP~~Rps~~e~l~hp~f~~  284 (285)
T 3is5_A          259 LKQMLTKDPERRPSAAQVLHHEWFKQ  284 (285)
T ss_dssp             HHHHTCSCTTTSCCHHHHHTSGGGGC
T ss_pred             HHHHccCChhhCcCHHHHhcCHHhhc
Confidence            99999999999999999999999975

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=7.8e-45  Score=373.20  Aligned_cols=261  Identities=44%  Similarity=0.840  Sum_probs=216.5

Q ss_pred             cCccccceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCCe----------EEE
Q psy1546          53 VDPELIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTK----------LWI  122 (604)
Q Consensus        53 ~~~~~~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~~----------lyL  122 (604)
                      ++....|.+.+.||+|+||.||+|.+..+++.||+|++.... ....+.+.+|+.+++.+.||++.+          +|+
T Consensus        15 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   93 (302)
T 2j7t_A           15 LDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKS-EEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWI   93 (302)
T ss_dssp             SCGGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC-----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEE
T ss_pred             cCCccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCC-HHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEE
Confidence            466677999999999999999999999999999999986543 233577889999999999999655          479


Q ss_pred             EEEecCCCChhhHhhc--CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCCC
Q psy1546         123 IMEYLGGGSALDLMKA--GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSK  200 (604)
Q Consensus       123 VmEy~~ggsL~~~l~~--~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~  200 (604)
                      ||||+++++|.+++..  +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.........
T Consensus        94 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  173 (302)
T 2j7t_A           94 MIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQK  173 (302)
T ss_dssp             EEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHHHC
T ss_pred             EEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCccccccccc
Confidence            9999999999998864  67999999999999999999999999999999999999999999999999998544332223


Q ss_pred             CcccccCCCCCChHHhh-----cCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCCCCC--CCCccchHHHH
Q psy1546         201 RNTFVGTPFWMAPEVIK-----QSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPP--QLTGNYTKQFK  273 (604)
Q Consensus       201 ~~~~~GT~~Y~APE~l~-----~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~~~~--~~~~~~s~~l~  273 (604)
                      .....||+.|+|||++.     +..++.++|||||||++|+|++|..||...........+.....+  ..+..++..+.
T Consensus       174 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  253 (302)
T 2j7t_A          174 RDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKWSVEFR  253 (302)
T ss_dssp             -----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCHHHH
T ss_pred             cccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCcccCCccccCHHHH
Confidence            34567999999999984     667889999999999999999999999988876665544433332  33567889999


Q ss_pred             HHHHHHhccCCCCCCCHHHHhcChhhhhhhhhhhHHHHHHH
Q psy1546         274 EFVEACLNKDPENRPTAKELLKFPFIRKAKKNAYLIDLIDR  314 (604)
Q Consensus       274 ~Li~~~L~~dP~~RpT~~elL~hp~f~~~~~~~~l~~~~~~  314 (604)
                      +||.+||..||.+|||+.+|++||||........+.+.+..
T Consensus       254 ~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~~~~~~~~~~  294 (302)
T 2j7t_A          254 DFLKIALDKNPETRPSAAQLLEHPFVSSITSNKALRELVAE  294 (302)
T ss_dssp             HHHHHHSCSCTTTSCCHHHHTTSTTTTTCCCCHHHHHHHHH
T ss_pred             HHHHHHcccChhhCCCHHHHhcChHHhhhccchhHHHHHHH
Confidence            99999999999999999999999999987766555554443

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=2.2e-44  Score=380.87  Aligned_cols=259  Identities=44%  Similarity=0.797  Sum_probs=219.2

Q ss_pred             CccccceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchh--hHHHHHHHHHHHHHHhhCCCCCCCeE----------E
Q psy1546          54 DPELIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE--AEDEIEDIQQEIMVLSQCDSPYGTKL----------W  121 (604)
Q Consensus        54 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~--~~~~~~~l~~Ei~iL~~l~hp~~~~l----------y  121 (604)
                      +....|.+.+.||+|+||.||+|.+..+++.||||++....  .....+.+.+|+.+|+.+.|||+.++          |
T Consensus        51 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~  130 (348)
T 1u5q_A           51 DPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAW  130 (348)
T ss_dssp             CHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             chhhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEE
Confidence            34456999999999999999999999999999999986543  23445778999999999999997654          7


Q ss_pred             EEEEecCCCChhhHhh--cCCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCC
Q psy1546         122 IIMEYLGGGSALDLMK--AGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTS  199 (604)
Q Consensus       122 LVmEy~~ggsL~~~l~--~~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~  199 (604)
                      ||||||. |+|.+++.  .+.+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++....   
T Consensus       131 lv~e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~---  206 (348)
T 1u5q_A          131 LVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP---  206 (348)
T ss_dssp             EEEECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS---
T ss_pred             EEEecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecCC---
Confidence            9999997 57777764  46799999999999999999999999999999999999999999999999999976542   


Q ss_pred             CCcccccCCCCCChHHhh---cCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCCC-CCCCCccchHHHHHH
Q psy1546         200 KRNTFVGTPFWMAPEVIK---QSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNN-PPQLTGNYTKQFKEF  275 (604)
Q Consensus       200 ~~~~~~GT~~Y~APE~l~---~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~~-~~~~~~~~s~~l~~L  275 (604)
                       ....+||+.|+|||++.   ...++.++|||||||+||||++|..||...........+.... +......+++.+.+|
T Consensus       207 -~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  285 (348)
T 1u5q_A          207 -ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNF  285 (348)
T ss_dssp             -BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCCTTSCHHHHHH
T ss_pred             -CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHHH
Confidence             23568999999999995   5678999999999999999999999998887766555443333 333456789999999


Q ss_pred             HHHHhccCCCCCCCHHHHhcChhhhhhhhhhhHHHHHHHHHH
Q psy1546         276 VEACLNKDPENRPTAKELLKFPFIRKAKKNAYLIDLIDRYKK  317 (604)
Q Consensus       276 i~~~L~~dP~~RpT~~elL~hp~f~~~~~~~~l~~~~~~~~~  317 (604)
                      |.+||..||.+|||+.+||+||||........+.+.+.+...
T Consensus       286 i~~~l~~dP~~Rps~~~ll~h~~~~~~~~~~~~~~~~~~~~~  327 (348)
T 1u5q_A          286 VDSCLQKIPQDRPTSEVLLKHRFVLRERPPTVIMDLIQRTKD  327 (348)
T ss_dssp             HHHHTCSSGGGSCCHHHHTTCHHHHSCCCTTHHHHHHHHHHH
T ss_pred             HHHHcccChhhCcCHHHHhhChhhhccCCcchhhHHHHHHHH
Confidence            999999999999999999999999887776666666665544

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=3.1e-45  Score=383.14  Aligned_cols=245  Identities=29%  Similarity=0.448  Sum_probs=194.5

Q ss_pred             cceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHH-HHHHHHHHHHHHhhCCCCCCCeE----------EEEEEe
Q psy1546          58 IFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAED-EIEDIQQEIMVLSQCDSPYGTKL----------WIIMEY  126 (604)
Q Consensus        58 ~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~-~~~~l~~Ei~iL~~l~hp~~~~l----------yLVmEy  126 (604)
                      .|.+.++||+|+||+||+|.+..+++.||||++....... ....+.+|+.+++.+.|||+.++          ||||||
T Consensus        35 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  114 (329)
T 3gbz_A           35 RYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEY  114 (329)
T ss_dssp             GEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             hEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEEec
Confidence            4999999999999999999999999999999997554332 34567899999999999996654          799999


Q ss_pred             cCCCChhhHhhc-CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEec-----CCCCeEEecccccccccCCCCC
Q psy1546         127 LGGGSALDLMKA-GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLS-----EMGDVKLADFGVAGTLTNTTSK  200 (604)
Q Consensus       127 ~~ggsL~~~l~~-~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~-----~~g~vKL~DFGlA~~~~~~~~~  200 (604)
                      ++ |+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+||||+     ..+.+||+|||+++.+......
T Consensus       115 ~~-~~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~~~~~~  193 (329)
T 3gbz_A          115 AE-NDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQ  193 (329)
T ss_dssp             CS-EEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC-----
T ss_pred             CC-CCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCccccCCcccc
Confidence            97 488888865 5799999999999999999999999999999999999994     4456999999999877655555


Q ss_pred             CcccccCCCCCChHHhhcC-CCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCC----CC--------------
Q psy1546         201 RNTFVGTPFWMAPEVIKQS-AYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKN----NP--------------  261 (604)
Q Consensus       201 ~~~~~GT~~Y~APE~l~~~-~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~----~~--------------  261 (604)
                      ....+||+.|+|||++.+. .++.++|||||||++|+|++|..||...........+...    ..              
T Consensus       194 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (329)
T 3gbz_A          194 FTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALPDWKQ  273 (329)
T ss_dssp             ------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCT
T ss_pred             cCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhhhhhhhhhh
Confidence            5567899999999999875 4899999999999999999999999987765544432110    00              


Q ss_pred             --CC---------CCccchHHHHHHHHHHhccCCCCCCCHHHHhcChhhhhhh
Q psy1546         262 --PQ---------LTGNYTKQFKEFVEACLNKDPENRPTAKELLKFPFIRKAK  303 (604)
Q Consensus       262 --~~---------~~~~~s~~l~~Li~~~L~~dP~~RpT~~elL~hp~f~~~~  303 (604)
                        +.         +...+++++.+||.+||..||.+|||+.|+|+||||+...
T Consensus       274 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  326 (329)
T 3gbz_A          274 SFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHND  326 (329)
T ss_dssp             TCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSSC
T ss_pred             hhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCCC
Confidence              00         0112678999999999999999999999999999997643

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=1.5e-44  Score=383.82  Aligned_cols=243  Identities=29%  Similarity=0.419  Sum_probs=193.4

Q ss_pred             ccceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCCe----------EEEEEEe
Q psy1546          57 LIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTK----------LWIIMEY  126 (604)
Q Consensus        57 ~~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~~----------lyLVmEy  126 (604)
                      ..|.+.+.||+|+||+||+|++..+++.||||++......  .+.+.+|+.+++.+.|||+.+          +|+||||
T Consensus        20 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~   97 (361)
T 3uc3_A           20 DRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAI--DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEY   97 (361)
T ss_dssp             TTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTS--CHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             CcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccc--cHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEe
Confidence            4599999999999999999999999999999999654332  256789999999999999665          4799999


Q ss_pred             cCCCChhhHhhc-CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCC--eEEecccccccccCCCCCCcc
Q psy1546         127 LGGGSALDLMKA-GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGD--VKLADFGVAGTLTNTTSKRNT  203 (604)
Q Consensus       127 ~~ggsL~~~l~~-~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~--vKL~DFGlA~~~~~~~~~~~~  203 (604)
                      |.+|+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+||||+.++.  +||+|||+++.... ......
T Consensus        98 ~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~-~~~~~~  176 (361)
T 3uc3_A           98 ASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQPKS  176 (361)
T ss_dssp             CCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC------------
T ss_pred             CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCccccccc-cCCCCC
Confidence            999999998854 78999999999999999999999999999999999999987765  99999999964432 223345


Q ss_pred             cccCCCCCChHHhhcCCCCCc-chhhhHHHHHHHHHhCCCCCCCCChh----hHhhhcCCC-CCCCCCccchHHHHHHHH
Q psy1546         204 FVGTPFWMAPEVIKQSAYDSK-ADIWSLGITAIELAKGEPPNSELHPM----RVLFLIPKN-NPPQLTGNYTKQFKEFVE  277 (604)
Q Consensus       204 ~~GT~~Y~APE~l~~~~~~~~-sDVwSLGviL~eLltG~~Pf~~~~~~----~~~~~i~~~-~~~~~~~~~s~~l~~Li~  277 (604)
                      .+||+.|+|||++.+..++.+ +|||||||+||+|++|..||......    .....+... ........++..+.+||.
T Consensus       177 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~  256 (361)
T 3uc3_A          177 TVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISPECCHLIS  256 (361)
T ss_dssp             ----CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCCTTSCCCHHHHHHHH
T ss_pred             CcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCCCcCCCCHHHHHHHH
Confidence            679999999999998888766 89999999999999999999875432    222222111 112223357899999999


Q ss_pred             HHhccCCCCCCCHHHHhcChhhhhh
Q psy1546         278 ACLNKDPENRPTAKELLKFPFIRKA  302 (604)
Q Consensus       278 ~~L~~dP~~RpT~~elL~hp~f~~~  302 (604)
                      +||..||.+|||+.||++||||.+.
T Consensus       257 ~~L~~dP~~Rps~~ell~hp~f~~~  281 (361)
T 3uc3_A          257 RIFVADPATRISIPEIKTHSWFLKN  281 (361)
T ss_dssp             HHSCSCTTTSCCHHHHHTSHHHHTT
T ss_pred             HHccCChhHCcCHHHHHhCcchhcC
Confidence            9999999999999999999999654

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=1.4e-44  Score=383.39  Aligned_cols=247  Identities=27%  Similarity=0.435  Sum_probs=209.9

Q ss_pred             cccceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCC---------------eE
Q psy1546          56 ELIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGT---------------KL  120 (604)
Q Consensus        56 ~~~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~---------------~l  120 (604)
                      ...|++.+.||+|+||.||+|.+..+++.||||++...........+.+|+.+|..+.|||+.               .+
T Consensus        26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  105 (364)
T 3qyz_A           26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV  105 (364)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred             cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence            345999999999999999999999999999999997665566668889999999999999854               36


Q ss_pred             EEEEEecCCCChhhHhhcCCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCC-
Q psy1546         121 WIIMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTS-  199 (604)
Q Consensus       121 yLVmEy~~ggsL~~~l~~~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~-  199 (604)
                      |+||||++ ++|.++++.+.+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++....... 
T Consensus       106 ~iv~e~~~-~~L~~~l~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~  184 (364)
T 3qyz_A          106 YIVQDLME-TDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDH  184 (364)
T ss_dssp             EEEEECCS-EEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGCB
T ss_pred             EEEEcccC-cCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceEecCCCCCc
Confidence            89999996 5899999999999999999999999999999999999999999999999999999999999976543322 


Q ss_pred             --CCcccccCCCCCChHHhhc-CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCC------------------
Q psy1546         200 --KRNTFVGTPFWMAPEVIKQ-SAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPK------------------  258 (604)
Q Consensus       200 --~~~~~~GT~~Y~APE~l~~-~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~------------------  258 (604)
                        .....+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+....+....+..                  
T Consensus       185 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  264 (364)
T 3qyz_A          185 TGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA  264 (364)
T ss_dssp             CCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCCCHHH
T ss_pred             cccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhH
Confidence              2345689999999998764 4589999999999999999999999988776554433211                  


Q ss_pred             ---------CCC---CCCCccchHHHHHHHHHHhccCCCCCCCHHHHhcChhhhhhh
Q psy1546         259 ---------NNP---PQLTGNYTKQFKEFVEACLNKDPENRPTAKELLKFPFIRKAK  303 (604)
Q Consensus       259 ---------~~~---~~~~~~~s~~l~~Li~~~L~~dP~~RpT~~elL~hp~f~~~~  303 (604)
                               ...   ..+...++.++.+||.+||..||.+|||+.|+|+||||+...
T Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~  321 (364)
T 3qyz_A          265 RNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYY  321 (364)
T ss_dssp             HHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTTC
T ss_pred             HHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhcc
Confidence                     000   011245688999999999999999999999999999998653

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=1.2e-44  Score=367.85  Aligned_cols=244  Identities=28%  Similarity=0.470  Sum_probs=186.0

Q ss_pred             cceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhH--HHHHHHHHHHHHHhhCCCCCCCe----------EEEEEE
Q psy1546          58 IFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAE--DEIEDIQQEIMVLSQCDSPYGTK----------LWIIME  125 (604)
Q Consensus        58 ~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~--~~~~~l~~Ei~iL~~l~hp~~~~----------lyLVmE  125 (604)
                      .|.+.+.||+|+||.||+|.+..+++.||||++......  ...+.+.+|+.+++.+.||++.+          +|+|||
T Consensus        12 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   91 (278)
T 3cok_A           12 DFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVLE   91 (278)
T ss_dssp             GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             cceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEEe
Confidence            499999999999999999999999999999999654322  22467889999999999999655          479999


Q ss_pred             ecCCCChhhHhhc--CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCCCCcc
Q psy1546         126 YLGGGSALDLMKA--GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNT  203 (604)
Q Consensus       126 y~~ggsL~~~l~~--~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~~~~  203 (604)
                      |+++++|.+++..  +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++............
T Consensus        92 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~  171 (278)
T 3cok_A           92 MCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT  171 (278)
T ss_dssp             CCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC--------
T ss_pred             cCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCCCCccee
Confidence            9999999999876  56999999999999999999999999999999999999999999999999999776544444456


Q ss_pred             cccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCCCCCCCCccchHHHHHHHHHHhccC
Q psy1546         204 FVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKD  283 (604)
Q Consensus       204 ~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~~L~~d  283 (604)
                      ..||+.|+|||++.+..++.++|||||||++|+|++|..||...........+... ...++..++.++.+||.+||..|
T Consensus       172 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~d  250 (278)
T 3cok_A          172 LCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLA-DYEMPSFLSIEAKDLIHQLLRRN  250 (278)
T ss_dssp             --------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCSS-CCCCCTTSCHHHHHHHHHHSCSS
T ss_pred             ccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhhc-ccCCccccCHHHHHHHHHHcccC
Confidence            78999999999999999999999999999999999999999876655444433322 22455678999999999999999


Q ss_pred             CCCCCCHHHHhcChhhhhh
Q psy1546         284 PENRPTAKELLKFPFIRKA  302 (604)
Q Consensus       284 P~~RpT~~elL~hp~f~~~  302 (604)
                      |.+|||+.++|+||||...
T Consensus       251 p~~Rps~~~~l~h~~~~~~  269 (278)
T 3cok_A          251 PADRLSLSSVLDHPFMSRN  269 (278)
T ss_dssp             GGGSCCHHHHTTSTTTC--
T ss_pred             HhhCCCHHHHhcCccccCC
Confidence            9999999999999999754

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=3.6e-44  Score=364.14  Aligned_cols=245  Identities=29%  Similarity=0.453  Sum_probs=211.0

Q ss_pred             cccceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCCe----------EEEEEE
Q psy1546          56 ELIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTK----------LWIIME  125 (604)
Q Consensus        56 ~~~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~~----------lyLVmE  125 (604)
                      ...|.+.++||+|+||.||+|.+..++..||+|++...... ..+.+.+|+.+++.+.||++.+          +|+|||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   86 (277)
T 3f3z_A            8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVE-DVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVME   86 (277)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCS-CHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccc-hHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEe
Confidence            34599999999999999999999999999999998654332 3467889999999999999665          479999


Q ss_pred             ecCCCChhhHhhc-CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEe---cCCCCeEEecccccccccCCCCCC
Q psy1546         126 YLGGGSALDLMKA-GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLL---SEMGDVKLADFGVAGTLTNTTSKR  201 (604)
Q Consensus       126 y~~ggsL~~~l~~-~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl---~~~g~vKL~DFGlA~~~~~~~~~~  201 (604)
                      |+++++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++..+... ...
T Consensus        87 ~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~-~~~  165 (277)
T 3f3z_A           87 LCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG-KMM  165 (277)
T ss_dssp             CCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTT-SCB
T ss_pred             ccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCc-cch
Confidence            9999999988754 679999999999999999999999999999999999999   77889999999999766533 334


Q ss_pred             cccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCCCCCCCC---ccchHHHHHHHHH
Q psy1546         202 NTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLT---GNYTKQFKEFVEA  278 (604)
Q Consensus       202 ~~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~---~~~s~~l~~Li~~  278 (604)
                      ....||+.|+|||++.+. ++.++|||||||++|+|++|..||...........+.........   ..+++.+.+||.+
T Consensus       166 ~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  244 (277)
T 3f3z_A          166 RTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSPQAESLIRR  244 (277)
T ss_dssp             CCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHH
T ss_pred             hccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCchhhhcCCHHHHHHHHH
Confidence            456799999999998765 899999999999999999999999988877766665544332222   2578999999999


Q ss_pred             HhccCCCCCCCHHHHhcChhhhhhh
Q psy1546         279 CLNKDPENRPTAKELLKFPFIRKAK  303 (604)
Q Consensus       279 ~L~~dP~~RpT~~elL~hp~f~~~~  303 (604)
                      ||..||.+|||+.++|+||||++..
T Consensus       245 ~l~~dp~~R~s~~~~l~h~~~~~~~  269 (277)
T 3f3z_A          245 LLTKSPKQRITSLQALEHEWFEKQL  269 (277)
T ss_dssp             HTCSSTTTSCCHHHHTTSHHHHHHH
T ss_pred             HccCChhhCcCHHHHhcCHHHhccc
Confidence            9999999999999999999997643

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=9.1e-45  Score=416.05  Aligned_cols=246  Identities=28%  Similarity=0.479  Sum_probs=218.6

Q ss_pred             cceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhh--HHHHHHHHHHHHHHhhC-CCCCCC----------eEEEEE
Q psy1546          58 IFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA--EDEIEDIQQEIMVLSQC-DSPYGT----------KLWIIM  124 (604)
Q Consensus        58 ~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~--~~~~~~l~~Ei~iL~~l-~hp~~~----------~lyLVm  124 (604)
                      .|.++++||+|+||.||+|.+..+++.||||++.+...  ....+.+..|+.+|..+ .||++.          .+||||
T Consensus       342 ~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~lV~  421 (674)
T 3pfq_A          342 DFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM  421 (674)
T ss_dssp             TEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEEEE
T ss_pred             ceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEEEE
Confidence            49999999999999999999999999999999976432  23356778899999987 677754          468999


Q ss_pred             EecCCCChhhHhhc-CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCCCCcc
Q psy1546         125 EYLGGGSALDLMKA-GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNT  203 (604)
Q Consensus       125 Ey~~ggsL~~~l~~-~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~~~~  203 (604)
                      ||++||+|.+++.. +.+++..++.|+.||+.||.|||++|||||||||+||||+.+|.+||+|||+|+..........+
T Consensus       422 E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~~~~~~  501 (674)
T 3pfq_A          422 EYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKT  501 (674)
T ss_dssp             ECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCEECCCTTCCBCC
T ss_pred             eCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceeeccccCCccccc
Confidence            99999999999876 78999999999999999999999999999999999999999999999999999865555555667


Q ss_pred             cccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCCCCCCCCccchHHHHHHHHHHhccC
Q psy1546         204 FVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKD  283 (604)
Q Consensus       204 ~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~~L~~d  283 (604)
                      ++||+.|||||++.+..|+.++|||||||+||||++|.+||.+.+..++...+.... ..++..++.++.+||.+||..|
T Consensus       502 ~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~~lL~~d  580 (674)
T 3pfq_A          502 FCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHN-VAYPKSMSKEAVAICKGLMTKH  580 (674)
T ss_dssp             CCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSC-CCCCTTSCHHHHHHHHHHSCSS
T ss_pred             ccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCC-CCCCccCCHHHHHHHHHHccCC
Confidence            899999999999999999999999999999999999999999998888777776544 3566789999999999999999


Q ss_pred             CCCCCCH-----HHHhcChhhhhhhh
Q psy1546         284 PENRPTA-----KELLKFPFIRKAKK  304 (604)
Q Consensus       284 P~~RpT~-----~elL~hp~f~~~~~  304 (604)
                      |.+||++     +||++||||+...+
T Consensus       581 P~~R~~~~~~~~~ei~~h~ff~~i~w  606 (674)
T 3pfq_A          581 PGKRLGCGPEGERDIKEHAFFRYIDW  606 (674)
T ss_dssp             STTCTTCSTTHHHHHHSSGGGSSCCH
T ss_pred             HHHCCCCCCCcHHHHhcCccccCCCH
Confidence            9999997     99999999987544

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=6.5e-45  Score=386.97  Aligned_cols=242  Identities=14%  Similarity=0.125  Sum_probs=191.4

Q ss_pred             cceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhh--HHHHHHHHHHH---HHHhhCCCCCCCe-------------
Q psy1546          58 IFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA--EDEIEDIQQEI---MVLSQCDSPYGTK-------------  119 (604)
Q Consensus        58 ~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~--~~~~~~l~~Ei---~iL~~l~hp~~~~-------------  119 (604)
                      .|.+.+.||+|+||.||+|.+..+++.||||++.....  ....+.+.+|+   .+|+. .||++.+             
T Consensus        63 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~~~p~d~~~  141 (371)
T 3q60_A           63 KLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG-ESPEEARDRRRLLLPSDAVA  141 (371)
T ss_dssp             EEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-----------CBCCCCEEEE
T ss_pred             eeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc-cChhhhhhceeEEeeehhee
Confidence            48999999999999999999999999999999976542  33456677785   45555 6998432             


Q ss_pred             ---------------------EEEEEEecCCCChhhHhhc--CCCcHHHH------HHHHHHHHHHhHHhhhCCcccccc
Q psy1546         120 ---------------------LWIIMEYLGGGSALDLMKA--GNFEEMHI------AVILREVLKGLDYLHSERKLHRDI  170 (604)
Q Consensus       120 ---------------------lyLVmEy~~ggsL~~~l~~--~~lse~~i------~~i~~qIl~gL~yLHs~gIiHrDL  170 (604)
                                           +|||||||+ |+|.+++..  ..+++..+      ..++.||+.||.|||++||+||||
T Consensus       142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrDi  220 (371)
T 3q60_A          142 VQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHF  220 (371)
T ss_dssp             ETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETTC
T ss_pred             cCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCcC
Confidence                                 699999998 899999975  34555555      577799999999999999999999


Q ss_pred             ccceeEecCCCCeEEecccccccccCCCCCCcccccCCCCCChHHhhc--CCCCCcchhhhHHHHHHHHHhCCCCCCCCC
Q psy1546         171 KAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQ--SAYDSKADIWSLGITAIELAKGEPPNSELH  248 (604)
Q Consensus       171 Kp~NILl~~~g~vKL~DFGlA~~~~~~~~~~~~~~GT~~Y~APE~l~~--~~~~~~sDVwSLGviL~eLltG~~Pf~~~~  248 (604)
                      ||+||||+.+|.+||+|||+|+.....   .....+|+.|+|||++.+  ..|+.++|||||||+||||++|..||....
T Consensus       221 kp~NIll~~~~~~kL~DFG~a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~  297 (371)
T 3q60_A          221 TPDNLFIMPDGRLMLGDVSALWKVGTR---GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVT  297 (371)
T ss_dssp             SGGGEEECTTSCEEECCGGGEEETTCE---EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTBCC
T ss_pred             CHHHEEECCCCCEEEEecceeeecCCC---ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCCcC
Confidence            999999999999999999999765422   114567799999999987  679999999999999999999999998764


Q ss_pred             hhhHhhh-----c---CCCCCCCCCccchHHHHHHHHHHhccCCCCCCCHHHHhcChhhhhhhh
Q psy1546         249 PMRVLFL-----I---PKNNPPQLTGNYTKQFKEFVEACLNKDPENRPTAKELLKFPFIRKAKK  304 (604)
Q Consensus       249 ~~~~~~~-----i---~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~RpT~~elL~hp~f~~~~~  304 (604)
                      .......     .   ...........+++.+.+||.+||..||.+|||+.|+|+||||+....
T Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~  361 (371)
T 3q60_A          298 PGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQLQN  361 (371)
T ss_dssp             TTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHHHHH
T ss_pred             cccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHHHHH
Confidence            3211110     0   001112223478999999999999999999999999999999987643

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=2.6e-45  Score=382.93  Aligned_cols=245  Identities=26%  Similarity=0.445  Sum_probs=195.7

Q ss_pred             cceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCCeE----------EEEEEec
Q psy1546          58 IFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTKL----------WIIMEYL  127 (604)
Q Consensus        58 ~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~~l----------yLVmEy~  127 (604)
                      .|.+.++||+|+||.||+|.+..+++.||||++...........+.+|+.+++.+.|||+.++          |+||||+
T Consensus         3 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   82 (324)
T 3mtl_A            3 TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYL   82 (324)
T ss_dssp             SEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEECC
T ss_pred             ceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEeccc
Confidence            489999999999999999999999999999999765433333345689999999999996654          7999999


Q ss_pred             CCCChhhHhhc--CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCCCCcccc
Q psy1546         128 GGGSALDLMKA--GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFV  205 (604)
Q Consensus       128 ~ggsL~~~l~~--~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~~~~~~  205 (604)
                      + |+|.+++..  ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++............+
T Consensus        83 ~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~  161 (324)
T 3mtl_A           83 D-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEV  161 (324)
T ss_dssp             S-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC-----------
T ss_pred             c-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccCCcccccccc
Confidence            7 578887754  4599999999999999999999999999999999999999999999999999976655544555668


Q ss_pred             cCCCCCChHHhhc-CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCC----CCCC------------------
Q psy1546         206 GTPFWMAPEVIKQ-SAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPK----NNPP------------------  262 (604)
Q Consensus       206 GT~~Y~APE~l~~-~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~----~~~~------------------  262 (604)
                      ||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+....+....+..    ....                  
T Consensus       162 ~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (324)
T 3mtl_A          162 VTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTYNYPK  241 (324)
T ss_dssp             -CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHHHTCCCC
T ss_pred             CcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhccccccc
Confidence            9999999999976 5689999999999999999999999998876654433211    0000                  


Q ss_pred             -------CCCccchHHHHHHHHHHhccCCCCCCCHHHHhcChhhhhhh
Q psy1546         263 -------QLTGNYTKQFKEFVEACLNKDPENRPTAKELLKFPFIRKAK  303 (604)
Q Consensus       263 -------~~~~~~s~~l~~Li~~~L~~dP~~RpT~~elL~hp~f~~~~  303 (604)
                             .....++.++.+||.+||..||.+|||+.|+|+||||....
T Consensus       242 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  289 (324)
T 3mtl_A          242 YRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLG  289 (324)
T ss_dssp             CCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGC
T ss_pred             ccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhcc
Confidence                   01124678899999999999999999999999999997653

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=2e-44  Score=397.31  Aligned_cols=243  Identities=29%  Similarity=0.483  Sum_probs=213.7

Q ss_pred             cceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhH--HHHHHHHHHHHHHhhCCCCCCCeE----------EEEEE
Q psy1546          58 IFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAE--DEIEDIQQEIMVLSQCDSPYGTKL----------WIIME  125 (604)
Q Consensus        58 ~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~--~~~~~l~~Ei~iL~~l~hp~~~~l----------yLVmE  125 (604)
                      .|.+.+.||+|+||.||+|.+..+|+.||||++......  .....+.+|+.+|+.+.|||+.++          |||||
T Consensus        17 ~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E   96 (476)
T 2y94_A           17 HYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVME   96 (476)
T ss_dssp             TEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence            399999999999999999999999999999999765432  235678999999999999996654          79999


Q ss_pred             ecCCCChhhHhhc-CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCCCCccc
Q psy1546         126 YLGGGSALDLMKA-GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTF  204 (604)
Q Consensus       126 y~~ggsL~~~l~~-~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~~~~~  204 (604)
                      ||+||+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... ....+.
T Consensus        97 ~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~-~~~~~~  175 (476)
T 2y94_A           97 YVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG-EFLRTS  175 (476)
T ss_dssp             CCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCEECCTT-CCBCCC
T ss_pred             CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchhhcccc-cccccc
Confidence            9999999999865 67999999999999999999999999999999999999999999999999999766433 334567


Q ss_pred             ccCCCCCChHHhhcCCC-CCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCCCCCCCCccchHHHHHHHHHHhccC
Q psy1546         205 VGTPFWMAPEVIKQSAY-DSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKD  283 (604)
Q Consensus       205 ~GT~~Y~APE~l~~~~~-~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~~L~~d  283 (604)
                      +||+.|+|||++.+..+ +.++|||||||+||+|++|..||.+.........+..+. ...+..+++++.+||.+||..|
T Consensus       176 ~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~Li~~~L~~d  254 (476)
T 2y94_A          176 CGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGI-FYTPQYLNPSVISLLKHMLQVD  254 (476)
T ss_dssp             CSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTC-CCCCTTCCHHHHHHHHHHTCSS
T ss_pred             CCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCC-cCCCccCCHHHHHHHHHHcCCC
Confidence            89999999999998776 679999999999999999999999887776666655443 2345678899999999999999


Q ss_pred             CCCCCCHHHHhcChhhhhh
Q psy1546         284 PENRPTAKELLKFPFIRKA  302 (604)
Q Consensus       284 P~~RpT~~elL~hp~f~~~  302 (604)
                      |.+|||+.||++||||++.
T Consensus       255 P~~Rpt~~eil~hp~~~~~  273 (476)
T 2y94_A          255 PMKRATIKDIREHEWFKQD  273 (476)
T ss_dssp             TTTSCCHHHHHTCHHHHTT
T ss_pred             chhCcCHHHHHhCHHhhhc
Confidence            9999999999999999864

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=3e-44  Score=373.78  Aligned_cols=247  Identities=26%  Similarity=0.445  Sum_probs=213.2

Q ss_pred             ccceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHH-----HHHHHHHHHHHHhhCCCCCCCe----------EE
Q psy1546          57 LIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAED-----EIEDIQQEIMVLSQCDSPYGTK----------LW  121 (604)
Q Consensus        57 ~~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~-----~~~~l~~Ei~iL~~l~hp~~~~----------ly  121 (604)
                      ..|.+.+.||+|+||.||+|.+..+++.||||++.......     ..+.+.+|+.+++.+.||++.+          +|
T Consensus        12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   91 (321)
T 2a2a_A           12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVV   91 (321)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             ccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence            45999999999999999999999999999999996543221     2467889999999999999654          47


Q ss_pred             EEEEecCCCChhhHhhc-CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCC----CeEEecccccccccC
Q psy1546         122 IIMEYLGGGSALDLMKA-GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMG----DVKLADFGVAGTLTN  196 (604)
Q Consensus       122 LVmEy~~ggsL~~~l~~-~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g----~vKL~DFGlA~~~~~  196 (604)
                      +||||+++++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++    .+||+|||++.....
T Consensus        92 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~~~  171 (321)
T 2a2a_A           92 LILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIED  171 (321)
T ss_dssp             EEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCEECCT
T ss_pred             EEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCccceecCc
Confidence            99999999999999865 5799999999999999999999999999999999999999888    799999999976654


Q ss_pred             CCCCCcccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCCCCC---CCCccchHHHH
Q psy1546         197 TTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPP---QLTGNYTKQFK  273 (604)
Q Consensus       197 ~~~~~~~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~~~~---~~~~~~s~~l~  273 (604)
                      .. ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.........+......   .+...++..+.
T Consensus       172 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  250 (321)
T 2a2a_A          172 GV-EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTSELAK  250 (321)
T ss_dssp             TC-CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTTCCHHHH
T ss_pred             cc-cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccChhhhcccCHHHH
Confidence            32 334567999999999999999999999999999999999999999988777666555443322   22246788999


Q ss_pred             HHHHHHhccCCCCCCCHHHHhcChhhhhhhh
Q psy1546         274 EFVEACLNKDPENRPTAKELLKFPFIRKAKK  304 (604)
Q Consensus       274 ~Li~~~L~~dP~~RpT~~elL~hp~f~~~~~  304 (604)
                      +||.+||..||.+|||+.|+|+||||.....
T Consensus       251 ~li~~~l~~dp~~Rps~~e~l~hp~~~~~~~  281 (321)
T 2a2a_A          251 DFIRKLLVKETRKRLTIQEALRHPWITPVDN  281 (321)
T ss_dssp             HHHHTTSCSSTTTSCCHHHHHHSTTTSCSSH
T ss_pred             HHHHHHcCCChhhCcCHHHHhcCccccCCCc
Confidence            9999999999999999999999999976543

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=1e-44  Score=374.51  Aligned_cols=244  Identities=25%  Similarity=0.397  Sum_probs=198.5

Q ss_pred             cceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhH----HHHHHHHHHHHHHhhC---CCCCCCe-----------
Q psy1546          58 IFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAE----DEIEDIQQEIMVLSQC---DSPYGTK-----------  119 (604)
Q Consensus        58 ~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~----~~~~~l~~Ei~iL~~l---~hp~~~~-----------  119 (604)
                      .|++.++||+|+||+||+|.+..+++.||||++......    .....+.+|+.+++.+   .|||+.+           
T Consensus        10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~~~   89 (308)
T 3g33_A           10 RYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSRTD   89 (308)
T ss_dssp             CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECCSS
T ss_pred             ceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccCCC
Confidence            499999999999999999999999999999998643211    1123455666666555   5998543           


Q ss_pred             ----EEEEEEecCCCChhhHhhcC---CCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccc
Q psy1546         120 ----LWIIMEYLGGGSALDLMKAG---NFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAG  192 (604)
Q Consensus       120 ----lyLVmEy~~ggsL~~~l~~~---~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~  192 (604)
                          +|+||||++ ++|.+++...   .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus        90 ~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~  168 (308)
T 3g33_A           90 REIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLAR  168 (308)
T ss_dssp             SEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEEECSCSCTT
T ss_pred             CceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEEeeCcccc
Confidence                579999996 5899988663   39999999999999999999999999999999999999999999999999997


Q ss_pred             cccCCCCCCcccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCC----CCC------
Q psy1546         193 TLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKN----NPP------  262 (604)
Q Consensus       193 ~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~----~~~------  262 (604)
                      .+.. .......+||+.|+|||++.+..++.++|||||||++|+|++|.+||.+.........+...    ...      
T Consensus       169 ~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  247 (308)
T 3g33_A          169 IYSY-QMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDV  247 (308)
T ss_dssp             TSTT-CCCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTTTSCSSC
T ss_pred             ccCC-CcccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccchh
Confidence            6543 23345678999999999999999999999999999999999999999988776554432110    000      


Q ss_pred             ----------------CCCccchHHHHHHHHHHhccCCCCCCCHHHHhcChhhhhhh
Q psy1546         263 ----------------QLTGNYTKQFKEFVEACLNKDPENRPTAKELLKFPFIRKAK  303 (604)
Q Consensus       263 ----------------~~~~~~s~~l~~Li~~~L~~dP~~RpT~~elL~hp~f~~~~  303 (604)
                                      .+...+++.+.+||.+||..||.+|||+.|+|+||||++..
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~~  304 (308)
T 3g33_A          248 SLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKDE  304 (308)
T ss_dssp             SSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC----
T ss_pred             hccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCCC
Confidence                            01235778999999999999999999999999999997643

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=1.6e-44  Score=388.02  Aligned_cols=244  Identities=24%  Similarity=0.437  Sum_probs=210.9

Q ss_pred             ccceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCCe----------EEEEEEe
Q psy1546          57 LIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTK----------LWIIMEY  126 (604)
Q Consensus        57 ~~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~~----------lyLVmEy  126 (604)
                      ..|.+.+.||+|+||.||+|.+..+++.||+|++...... ....+.+|+.+|+.+.|||+.+          +|+||||
T Consensus        51 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~-~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~  129 (387)
T 1kob_A           51 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPL-DKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF  129 (387)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHH-HHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred             cceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchh-hHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence            3599999999999999999999999999999999755432 3467889999999999999655          4799999


Q ss_pred             cCCCChhhHhhc--CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecC--CCCeEEecccccccccCCCCCCc
Q psy1546         127 LGGGSALDLMKA--GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSE--MGDVKLADFGVAGTLTNTTSKRN  202 (604)
Q Consensus       127 ~~ggsL~~~l~~--~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~--~g~vKL~DFGlA~~~~~~~~~~~  202 (604)
                      |.+|+|.+++..  ..+++..++.++.||+.||.|||++||+||||||+|||++.  .+.+||+|||+++.+... ....
T Consensus       130 ~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~-~~~~  208 (387)
T 1kob_A          130 LSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD-EIVK  208 (387)
T ss_dssp             CCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT-SCEE
T ss_pred             CCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecCCC-ccee
Confidence            999999999865  36999999999999999999999999999999999999974  477999999999766433 2334


Q ss_pred             ccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCCC---CCCCCccchHHHHHHHHHH
Q psy1546         203 TFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNN---PPQLTGNYTKQFKEFVEAC  279 (604)
Q Consensus       203 ~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~~---~~~~~~~~s~~l~~Li~~~  279 (604)
                      ..+||+.|+|||++.+..++.++|||||||+||+|++|..||.+.........+....   .......++.++.+||.+|
T Consensus       209 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~  288 (387)
T 1kob_A          209 VTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNL  288 (387)
T ss_dssp             EECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHHHHHHTT
T ss_pred             eeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccccccCCHHHHHHHHHH
Confidence            5679999999999999999999999999999999999999999887766655443332   2334457899999999999


Q ss_pred             hccCCCCCCCHHHHhcChhhhhh
Q psy1546         280 LNKDPENRPTAKELLKFPFIRKA  302 (604)
Q Consensus       280 L~~dP~~RpT~~elL~hp~f~~~  302 (604)
                      |..||.+|||+.|+|+||||+..
T Consensus       289 L~~dP~~Rpt~~ell~hp~~~~~  311 (387)
T 1kob_A          289 LQKEPRKRLTVHDALEHPWLKGD  311 (387)
T ss_dssp             SCSSGGGSCCHHHHHTSTTTSSC
T ss_pred             cCCChhHCcCHHHHhhCccccCC
Confidence            99999999999999999999653

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=2.2e-44  Score=384.53  Aligned_cols=243  Identities=29%  Similarity=0.439  Sum_probs=203.8

Q ss_pred             eeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCCeE----------EEEEEecCC
Q psy1546          60 TKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTKL----------WIIMEYLGG  129 (604)
Q Consensus        60 ~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~~l----------yLVmEy~~g  129 (604)
                      ...+.||+|+||.||+|.+..+++.||||++..... ...+.+.+|+.+|+.++|||+.++          |||||||++
T Consensus        92 ~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~  170 (373)
T 2x4f_A           92 SKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGM-KDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDG  170 (373)
T ss_dssp             EEEEECC-----CEEEEEETTTCCEEEEEEEECCSH-HHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTT
T ss_pred             ecceEEecCcCEEEEEEEEcCCCcEEEEEEEccccc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCC
Confidence            346789999999999999999999999999976543 344778999999999999996654          799999999


Q ss_pred             CChhhHhhc--CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEe--cCCCCeEEecccccccccCCCCCCcccc
Q psy1546         130 GSALDLMKA--GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLL--SEMGDVKLADFGVAGTLTNTTSKRNTFV  205 (604)
Q Consensus       130 gsL~~~l~~--~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl--~~~g~vKL~DFGlA~~~~~~~~~~~~~~  205 (604)
                      ++|.+++..  ..+++..++.++.||+.||.|||++||+||||||+||||  +.++.+||+|||+++.+... ......+
T Consensus       171 ~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~-~~~~~~~  249 (373)
T 2x4f_A          171 GELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPR-EKLKVNF  249 (373)
T ss_dssp             CEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTT-CBCCCCC
T ss_pred             CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCc-ccccccc
Confidence            999998854  469999999999999999999999999999999999999  56678999999999766533 2334567


Q ss_pred             cCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCCCC---CCCCccchHHHHHHHHHHhcc
Q psy1546         206 GTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNP---PQLTGNYTKQFKEFVEACLNK  282 (604)
Q Consensus       206 GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~~~---~~~~~~~s~~l~~Li~~~L~~  282 (604)
                      ||+.|+|||++.+..++.++|||||||+||+|++|..||.+.........+.....   ......+++++.+||.+||..
T Consensus       250 gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~  329 (373)
T 2x4f_A          250 GTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEAKEFISKLLIK  329 (373)
T ss_dssp             SSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCSGGGTTSCHHHHHHHHTTSCS
T ss_pred             CCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCChhhhccCCHHHHHHHHHHcCC
Confidence            99999999999999999999999999999999999999998887766555443322   222346789999999999999


Q ss_pred             CCCCCCCHHHHhcChhhhhhhh
Q psy1546         283 DPENRPTAKELLKFPFIRKAKK  304 (604)
Q Consensus       283 dP~~RpT~~elL~hp~f~~~~~  304 (604)
                      ||.+|||+.|+|+||||+....
T Consensus       330 dp~~Rps~~e~l~hp~~~~~~~  351 (373)
T 2x4f_A          330 EKSWRISASEALKHPWLSDHKL  351 (373)
T ss_dssp             SGGGSCCHHHHHHSHHHHCHHH
T ss_pred             ChhhCCCHHHHhcCcCcCCCch
Confidence            9999999999999999987644

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=1.8e-44  Score=394.43  Aligned_cols=247  Identities=29%  Similarity=0.421  Sum_probs=187.3

Q ss_pred             ccceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchh-hHHHHHHHHHHHHHHhhCCCCCCCe---------------E
Q psy1546          57 LIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE-AEDEIEDIQQEIMVLSQCDSPYGTK---------------L  120 (604)
Q Consensus        57 ~~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~-~~~~~~~l~~Ei~iL~~l~hp~~~~---------------l  120 (604)
                      ..|.++++||+|+||+||+|.+..+++.||||++.... .....+.+.+|+.+|+.++|||+++               +
T Consensus        53 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  132 (458)
T 3rp9_A           53 DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDEL  132 (458)
T ss_dssp             TTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCE
T ss_pred             CCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceE
Confidence            45999999999999999999999999999999986532 2344578899999999999998543               5


Q ss_pred             EEEEEecCCCChhhHhhc-CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCC-
Q psy1546         121 WIIMEYLGGGSALDLMKA-GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTT-  198 (604)
Q Consensus       121 yLVmEy~~ggsL~~~l~~-~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~-  198 (604)
                      ||||||+ +++|..+++. +.+++..++.|+.||+.||+|||++|||||||||+||||+.++.+||+|||+|+.+.... 
T Consensus       133 ~lv~e~~-~~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~  211 (458)
T 3rp9_A          133 YVVLEIA-DSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPEN  211 (458)
T ss_dssp             EEEECCC-SEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCTTSCTT
T ss_pred             EEEEecc-ccchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccchhccCccc
Confidence            8999998 5788888866 569999999999999999999999999999999999999999999999999997664221 


Q ss_pred             --------------------------CCCcccccCCCCCChHHh-hcCCCCCcchhhhHHHHHHHHHh-----------C
Q psy1546         199 --------------------------SKRNTFVGTPFWMAPEVI-KQSAYDSKADIWSLGITAIELAK-----------G  240 (604)
Q Consensus       199 --------------------------~~~~~~~GT~~Y~APE~l-~~~~~~~~sDVwSLGviL~eLlt-----------G  240 (604)
                                                ......+||+.|+|||++ .+..|+.++||||||||||||++           |
T Consensus       212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~~~~~  291 (458)
T 3rp9_A          212 GNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHADR  291 (458)
T ss_dssp             CCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSSGGGC
T ss_pred             cccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccccccccccc
Confidence                                      123456789999999987 56679999999999999999998           6


Q ss_pred             CCCCCCCChh--------------------hHhhh---------------------------cCCCCC---CCCCccchH
Q psy1546         241 EPPNSELHPM--------------------RVLFL---------------------------IPKNNP---PQLTGNYTK  270 (604)
Q Consensus       241 ~~Pf~~~~~~--------------------~~~~~---------------------------i~~~~~---~~~~~~~s~  270 (604)
                      .++|.+....                    ..+..                           ......   ......++.
T Consensus       292 ~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~  371 (458)
T 3rp9_A          292 GPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFPASSA  371 (458)
T ss_dssp             CCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGSTTSCH
T ss_pred             cccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHCCCCCH
Confidence            7777654310                    00000                           000000   111234588


Q ss_pred             HHHHHHHHHhccCCCCCCCHHHHhcChhhhhhhh
Q psy1546         271 QFKEFVEACLNKDPENRPTAKELLKFPFIRKAKK  304 (604)
Q Consensus       271 ~l~~Li~~~L~~dP~~RpT~~elL~hp~f~~~~~  304 (604)
                      ++.+||.+||..||.+|||++|+|+||||+....
T Consensus       372 ~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~~~  405 (458)
T 3rp9_A          372 DAIHLLKRMLVFNPNKRITINECLAHPFFKEVRI  405 (458)
T ss_dssp             HHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTCC
T ss_pred             HHHHHHHHHhccCccccCCHHHHhcCHhhhhcCC
Confidence            9999999999999999999999999999987643

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=7.6e-44  Score=365.21  Aligned_cols=245  Identities=28%  Similarity=0.453  Sum_probs=215.5

Q ss_pred             ccceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchh--hHHHHHHHHHHHHHHhhCCCCCCCeE----------EEEE
Q psy1546          57 LIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE--AEDEIEDIQQEIMVLSQCDSPYGTKL----------WIIM  124 (604)
Q Consensus        57 ~~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~--~~~~~~~l~~Ei~iL~~l~hp~~~~l----------yLVm  124 (604)
                      ..|.+.+.||+|+||.||+|.+..+++.||+|++....  .....+.+.+|+.+++.+.|||+.++          |+||
T Consensus        15 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   94 (294)
T 2rku_A           15 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVL   94 (294)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEE
Confidence            45999999999999999999999999999999986553  23445778899999999999996654          7999


Q ss_pred             EecCCCChhhHhhc-CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCCCCcc
Q psy1546         125 EYLGGGSALDLMKA-GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNT  203 (604)
Q Consensus       125 Ey~~ggsL~~~l~~-~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~~~~  203 (604)
                      ||+++++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++............
T Consensus        95 e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~  174 (294)
T 2rku_A           95 ELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV  174 (294)
T ss_dssp             ECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSTTCCBCC
T ss_pred             ecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCceecccCcccccc
Confidence            99999999998865 67999999999999999999999999999999999999999999999999999776544444556


Q ss_pred             cccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCCCCCCCCccchHHHHHHHHHHhccC
Q psy1546         204 FVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKD  283 (604)
Q Consensus       204 ~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~~L~~d  283 (604)
                      ..||+.|+|||++.+..++.++|||||||++|+|++|..||......+....+.... ..++..++..+.+||.+||..|
T Consensus       175 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~  253 (294)
T 2rku_A          175 LCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNE-YSIPKHINPVAASLIQKMLQTD  253 (294)
T ss_dssp             CCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTC-CCCCTTSCHHHHHHHHHHTCSS
T ss_pred             ccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcc-CCCccccCHHHHHHHHHHcccC
Confidence            789999999999999999999999999999999999999999887766555544332 3456678899999999999999


Q ss_pred             CCCCCCHHHHhcChhhhhh
Q psy1546         284 PENRPTAKELLKFPFIRKA  302 (604)
Q Consensus       284 P~~RpT~~elL~hp~f~~~  302 (604)
                      |.+|||+.|+++||||...
T Consensus       254 p~~Rps~~~ll~~~~~~~~  272 (294)
T 2rku_A          254 PTARPTINELLNDEFFTSG  272 (294)
T ss_dssp             GGGSCCGGGGGGSHHHHTS
T ss_pred             hhhCcCHHHHhhChheecC
Confidence            9999999999999999653

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=2.4e-44  Score=402.13  Aligned_cols=247  Identities=27%  Similarity=0.426  Sum_probs=212.4

Q ss_pred             ccceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhH--HHHHHHHHHHHHHhhCCCCCCCe----------EEEEE
Q psy1546          57 LIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAE--DEIEDIQQEIMVLSQCDSPYGTK----------LWIIM  124 (604)
Q Consensus        57 ~~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~--~~~~~l~~Ei~iL~~l~hp~~~~----------lyLVm  124 (604)
                      ..|.+.++||+|+||.||+|+++.+++.||||++.+....  .....+.+|+.+|..+.||++++          +||||
T Consensus       185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm  264 (543)
T 3c4z_A          185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVM  264 (543)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEE
Confidence            3599999999999999999999999999999999765432  23567889999999999998654          47999


Q ss_pred             EecCCCChhhHhhc-----CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCC
Q psy1546         125 EYLGGGSALDLMKA-----GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTS  199 (604)
Q Consensus       125 Ey~~ggsL~~~l~~-----~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~  199 (604)
                      |||+||+|.+++..     ..+++..++.++.||+.||.|||++||+||||||+||||+.+|.+||+|||+++.+.....
T Consensus       265 E~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~~~~  344 (543)
T 3c4z_A          265 TIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQT  344 (543)
T ss_dssp             CCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTTCC
T ss_pred             EeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecceeeeccCCCc
Confidence            99999999998864     3599999999999999999999999999999999999999999999999999987765544


Q ss_pred             CCcccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCCh----hhHhhhcCCCCCCCCCccchHHHHHH
Q psy1546         200 KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHP----MRVLFLIPKNNPPQLTGNYTKQFKEF  275 (604)
Q Consensus       200 ~~~~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~----~~~~~~i~~~~~~~~~~~~s~~l~~L  275 (604)
                      .....+||+.|+|||++.+..|+.++|||||||+||||++|.+||.....    ..+...+.. ....++..++..+++|
T Consensus       345 ~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~-~~~~~p~~~s~~~~~l  423 (543)
T 3c4z_A          345 KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLE-QAVTYPDKFSPASKDF  423 (543)
T ss_dssp             CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHH-CCCCCCTTSCHHHHHH
T ss_pred             ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhh-cccCCCcccCHHHHHH
Confidence            45567999999999999999999999999999999999999999987532    233333322 2234567889999999


Q ss_pred             HHHHhccCCCCCCC-----HHHHhcChhhhhhhh
Q psy1546         276 VEACLNKDPENRPT-----AKELLKFPFIRKAKK  304 (604)
Q Consensus       276 i~~~L~~dP~~RpT-----~~elL~hp~f~~~~~  304 (604)
                      |.+||..||.+||+     +++|++||||+...+
T Consensus       424 i~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~i~w  457 (543)
T 3c4z_A          424 CEALLQKDPEKRLGFRDGSCDGLRTHPLFRDISW  457 (543)
T ss_dssp             HHHHSCSSGGGSCCCBTTBSHHHHTSGGGTTCCH
T ss_pred             HHHhccCCHhHCCCCcccCHHHHHcCccccCCCH
Confidence            99999999999996     589999999987543

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=5.1e-44  Score=374.85  Aligned_cols=246  Identities=28%  Similarity=0.451  Sum_probs=215.9

Q ss_pred             cccceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchh--hHHHHHHHHHHHHHHhhCCCCCCCe----------EEEE
Q psy1546          56 ELIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE--AEDEIEDIQQEIMVLSQCDSPYGTK----------LWII  123 (604)
Q Consensus        56 ~~~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~--~~~~~~~l~~Ei~iL~~l~hp~~~~----------lyLV  123 (604)
                      ...|.+.+.||+|+||.||+|.+..+++.||+|++....  .....+.+.+|+.+++.+.|+|+.+          +|+|
T Consensus        40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  119 (335)
T 2owb_A           40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV  119 (335)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence            345999999999999999999999999999999986553  2344577889999999999999655          4799


Q ss_pred             EEecCCCChhhHhhc-CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCCCCc
Q psy1546         124 MEYLGGGSALDLMKA-GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRN  202 (604)
Q Consensus       124 mEy~~ggsL~~~l~~-~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~~~  202 (604)
                      |||+++++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...........
T Consensus       120 ~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~  199 (335)
T 2owb_A          120 LELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKK  199 (335)
T ss_dssp             ECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSTTCCBC
T ss_pred             EecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCceecccCccccc
Confidence            999999999998865 6799999999999999999999999999999999999999999999999999987654444455


Q ss_pred             ccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCCCCCCCCccchHHHHHHHHHHhcc
Q psy1546         203 TFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNK  282 (604)
Q Consensus       203 ~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~~L~~  282 (604)
                      ...||+.|+|||++.+..++.++|||||||+||+|++|..||...........+.... ..++..++..+.+||.+||..
T Consensus       200 ~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~  278 (335)
T 2owb_A          200 VLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNE-YSIPKHINPVAASLIQKMLQT  278 (335)
T ss_dssp             CCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTC-CCCCTTSCHHHHHHHHHHTCS
T ss_pred             ccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCC-CCCCccCCHHHHHHHHHHccC
Confidence            6789999999999999999999999999999999999999999877666555443332 345567889999999999999


Q ss_pred             CCCCCCCHHHHhcChhhhhh
Q psy1546         283 DPENRPTAKELLKFPFIRKA  302 (604)
Q Consensus       283 dP~~RpT~~elL~hp~f~~~  302 (604)
                      ||.+|||+.|+|+||||...
T Consensus       279 dp~~Rps~~ell~~~~~~~~  298 (335)
T 2owb_A          279 DPTARPTINELLNDEFFTSG  298 (335)
T ss_dssp             SGGGSCCGGGGGGSHHHHTS
T ss_pred             ChhHCcCHHHHhcCccccCC
Confidence            99999999999999999754

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=1.2e-44  Score=367.62  Aligned_cols=245  Identities=30%  Similarity=0.497  Sum_probs=214.1

Q ss_pred             cceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhh-HHHHHHHHHHHHHHhhCCCCCCCe------------EEEEE
Q psy1546          58 IFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA-EDEIEDIQQEIMVLSQCDSPYGTK------------LWIIM  124 (604)
Q Consensus        58 ~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~-~~~~~~l~~Ei~iL~~l~hp~~~~------------lyLVm  124 (604)
                      .|++.+.||+|+||.||+|.+..+++.||||++..... ....+.+.+|+.+++.+.||++.+            +|+||
T Consensus         7 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~   86 (279)
T 2w5a_A            7 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVM   86 (279)
T ss_dssp             GEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEEEE
T ss_pred             heeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEEEE
Confidence            49999999999999999999999999999999976542 344577899999999999998554            47999


Q ss_pred             EecCCCChhhHhhc-----CCCcHHHHHHHHHHHHHHhHHhhhCC-----ccccccccceeEecCCCCeEEecccccccc
Q psy1546         125 EYLGGGSALDLMKA-----GNFEEMHIAVILREVLKGLDYLHSER-----KLHRDIKAANVLLSEMGDVKLADFGVAGTL  194 (604)
Q Consensus       125 Ey~~ggsL~~~l~~-----~~lse~~i~~i~~qIl~gL~yLHs~g-----IiHrDLKp~NILl~~~g~vKL~DFGlA~~~  194 (604)
                      ||+++++|.+++..     ..+++..++.++.||+.||.|||++|     |+||||||+|||++.++.+||+|||+++..
T Consensus        87 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~~~  166 (279)
T 2w5a_A           87 EYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL  166 (279)
T ss_dssp             ECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHHHC
T ss_pred             eCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchheee
Confidence            99999999999864     23999999999999999999999999     999999999999999999999999999766


Q ss_pred             cCCCCCCcccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCCCCCCCCccchHHHHH
Q psy1546         195 TNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKE  274 (604)
Q Consensus       195 ~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~  274 (604)
                      ...........||+.|+|||++.+..++.++|||||||++|+|++|..||...........+.......++..++.++.+
T Consensus       167 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~  246 (279)
T 2w5a_A          167 NHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSDELNE  246 (279)
T ss_dssp             ---CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCCTTSCHHHHH
T ss_pred             ccccccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhcccccCCcccCHHHHH
Confidence            54333334567999999999999999999999999999999999999999998887777666666666777789999999


Q ss_pred             HHHHHhccCCCCCCCHHHHhcChhhhhh
Q psy1546         275 FVEACLNKDPENRPTAKELLKFPFIRKA  302 (604)
Q Consensus       275 Li~~~L~~dP~~RpT~~elL~hp~f~~~  302 (604)
                      ||.+||..||.+|||+.|||+|+|+...
T Consensus       247 li~~~l~~~p~~Rps~~~ll~~~~~~~~  274 (279)
T 2w5a_A          247 IITRMLNLKDYHRPSVEEILENPLILEH  274 (279)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHTSTTCCGG
T ss_pred             HHHHHcCCCcccCCCHHHHHhChhhhhh
Confidence            9999999999999999999999999654

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=7.6e-44  Score=363.39  Aligned_cols=242  Identities=25%  Similarity=0.470  Sum_probs=211.3

Q ss_pred             cceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHH--HHHHHHHHHHHHhhCCCCCCCe----------EEEEEE
Q psy1546          58 IFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAED--EIEDIQQEIMVLSQCDSPYGTK----------LWIIME  125 (604)
Q Consensus        58 ~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~--~~~~l~~Ei~iL~~l~hp~~~~----------lyLVmE  125 (604)
                      .|.+.+.||+|+||.||+|.+..+++.||||++.......  ....+.+|+.+++.+.||++.+          +|+|||
T Consensus        15 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   94 (284)
T 2vgo_A           15 DFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLE   94 (284)
T ss_dssp             GEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             hceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEEE
Confidence            4999999999999999999999999999999996543222  2467889999999999999654          479999


Q ss_pred             ecCCCChhhHhhc-CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCCCCccc
Q psy1546         126 YLGGGSALDLMKA-GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTF  204 (604)
Q Consensus       126 y~~ggsL~~~l~~-~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~~~~~  204 (604)
                      |+++++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......  .....
T Consensus        95 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~~~  172 (284)
T 2vgo_A           95 FAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSL--RRRTM  172 (284)
T ss_dssp             CCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCEECSSS--CBCCC
T ss_pred             eCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccccccCccc--ccccc
Confidence            9999999998865 67999999999999999999999999999999999999999999999999998655432  23456


Q ss_pred             ccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCCCCCCCCccchHHHHHHHHHHhccCC
Q psy1546         205 VGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDP  284 (604)
Q Consensus       205 ~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~~L~~dP  284 (604)
                      .||+.|+|||++.+..++.++|||||||++|+|++|..||...........+.... ..++..++..+.+||.+||..||
T Consensus       173 ~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~p  251 (284)
T 2vgo_A          173 CGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVD-LKFPPFLSDGSKDLISKLLRYHP  251 (284)
T ss_dssp             CSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTC-CCCCTTSCHHHHHHHHHHSCSSG
T ss_pred             cCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhccc-cCCCCcCCHHHHHHHHHHhhcCH
Confidence            89999999999999999999999999999999999999999887766655444332 34556789999999999999999


Q ss_pred             CCCCCHHHHhcChhhhhh
Q psy1546         285 ENRPTAKELLKFPFIRKA  302 (604)
Q Consensus       285 ~~RpT~~elL~hp~f~~~  302 (604)
                      .+|||+.++++||||+..
T Consensus       252 ~~Rps~~~ll~h~~~~~~  269 (284)
T 2vgo_A          252 PQRLPLKGVMEHPWVKAN  269 (284)
T ss_dssp             GGSCCHHHHHTCHHHHHH
T ss_pred             hhCCCHHHHhhCHHHHhh
Confidence            999999999999999754

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=2.4e-44  Score=380.40  Aligned_cols=244  Identities=26%  Similarity=0.426  Sum_probs=193.2

Q ss_pred             ccceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCCeE----------EEEEEe
Q psy1546          57 LIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTKL----------WIIMEY  126 (604)
Q Consensus        57 ~~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~~l----------yLVmEy  126 (604)
                      ..|.+.+.||+|+||.||+|.+..+++.||||++....   ..+.+.+|+.+|+.+.||++.++          |+||||
T Consensus        53 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  129 (349)
T 2w4o_A           53 DFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV---DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLEL  129 (349)
T ss_dssp             GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC-------------CHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             CcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch---hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEe
Confidence            45999999999999999999999999999999997543   23567899999999999996654          799999


Q ss_pred             cCCCChhhHhhc-CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecC---CCCeEEecccccccccCCCCCCc
Q psy1546         127 LGGGSALDLMKA-GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSE---MGDVKLADFGVAGTLTNTTSKRN  202 (604)
Q Consensus       127 ~~ggsL~~~l~~-~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~---~g~vKL~DFGlA~~~~~~~~~~~  202 (604)
                      +++++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+||||+.   ++.+||+|||+++..... ....
T Consensus       130 ~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~-~~~~  208 (349)
T 2w4o_A          130 VTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ-VLMK  208 (349)
T ss_dssp             CCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC-------------
T ss_pred             CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccCcc-cccc
Confidence            999999998865 56899999999999999999999999999999999999975   789999999999765432 2334


Q ss_pred             ccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhh-HhhhcCCCC---CCCCCccchHHHHHHHHH
Q psy1546         203 TFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMR-VLFLIPKNN---PPQLTGNYTKQFKEFVEA  278 (604)
Q Consensus       203 ~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~-~~~~i~~~~---~~~~~~~~s~~l~~Li~~  278 (604)
                      ..+||+.|+|||++.+..++.++|||||||+||+|++|..||....... ....+....   .......++.++.+||.+
T Consensus       209 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~  288 (349)
T 2w4o_A          209 TVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLNAKDLVRK  288 (349)
T ss_dssp             ----CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTTTTTTSCHHHHHHHHT
T ss_pred             cccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCchhhhCCHHHHHHHHH
Confidence            5689999999999999999999999999999999999999998765543 232332222   223345788999999999


Q ss_pred             HhccCCCCCCCHHHHhcChhhhhhhh
Q psy1546         279 CLNKDPENRPTAKELLKFPFIRKAKK  304 (604)
Q Consensus       279 ~L~~dP~~RpT~~elL~hp~f~~~~~  304 (604)
                      ||..||.+|||+.|+|+||||.....
T Consensus       289 ~L~~dP~~Rpt~~e~l~hp~~~~~~~  314 (349)
T 2w4o_A          289 LIVLDPKKRLTTFQALQHPWVTGKAA  314 (349)
T ss_dssp             TSCSSGGGSCCHHHHHHSTTTTSTTC
T ss_pred             HccCChhhCcCHHHHhcCcccCCCcc
Confidence            99999999999999999999986543

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=1.2e-44  Score=378.76  Aligned_cols=237  Identities=27%  Similarity=0.469  Sum_probs=182.1

Q ss_pred             eeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCC-CCCCCe----------EEEEEEecCCC
Q psy1546          62 QERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCD-SPYGTK----------LWIIMEYLGGG  130 (604)
Q Consensus        62 ~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~-hp~~~~----------lyLVmEy~~gg  130 (604)
                      .++||+|+||.||+|.+..+++.||||++....    ...+.+|+.+++.+. |||+.+          +|||||||++|
T Consensus        16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~   91 (325)
T 3kn6_A           16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKRM----EANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGG   91 (325)
T ss_dssp             SCCSEEETTEEEEEEEETTTCCEEEEEEEEGGG----HHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSC
T ss_pred             CCccccCCCeEEEEEEECCCCCEEEEEEEChhh----hhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCC
Confidence            378999999999999999999999999996542    356778999999997 999665          47999999999


Q ss_pred             ChhhHhhc-CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCC---CeEEecccccccccCCCCCCccccc
Q psy1546         131 SALDLMKA-GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMG---DVKLADFGVAGTLTNTTSKRNTFVG  206 (604)
Q Consensus       131 sL~~~l~~-~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g---~vKL~DFGlA~~~~~~~~~~~~~~G  206 (604)
                      +|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++   .+||+|||+++............+|
T Consensus        92 ~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~  171 (325)
T 3kn6_A           92 ELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCF  171 (325)
T ss_dssp             BHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC----------
T ss_pred             cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCCcccccCC
Confidence            99998865 5799999999999999999999999999999999999998766   7999999999776555555567789


Q ss_pred             CCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCCh-------hhHhhhcCCCCCCCC---CccchHHHHHHH
Q psy1546         207 TPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHP-------MRVLFLIPKNNPPQL---TGNYTKQFKEFV  276 (604)
Q Consensus       207 T~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~-------~~~~~~i~~~~~~~~---~~~~s~~l~~Li  276 (604)
                      |+.|+|||++.+..|+.++|||||||++|+|++|..||.....       .+....+..+.....   ...+++++++||
T Consensus       172 t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li  251 (325)
T 3kn6_A          172 TLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNVSQEAKDLI  251 (325)
T ss_dssp             ------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCCSHHHHTSCHHHHHHH
T ss_pred             CcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCCcccccCCCHHHHHHH
Confidence            9999999999999999999999999999999999999986443       334444444432221   135789999999


Q ss_pred             HHHhccCCCCCCCHHHHhcChhhhhh
Q psy1546         277 EACLNKDPENRPTAKELLKFPFIRKA  302 (604)
Q Consensus       277 ~~~L~~dP~~RpT~~elL~hp~f~~~  302 (604)
                      .+||..||.+|||+.|+++||||+..
T Consensus       252 ~~~L~~dP~~Rpt~~ell~h~w~~~~  277 (325)
T 3kn6_A          252 QGLLTVDPNKRLKMSGLRYNEWLQDG  277 (325)
T ss_dssp             HHHHCCCTTTCCCTTTSTTCGGGCTT
T ss_pred             HHHCCCChhHCCCHHHHhcChhhccC
Confidence            99999999999999999999999754

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=5.1e-44  Score=361.99  Aligned_cols=246  Identities=26%  Similarity=0.410  Sum_probs=208.7

Q ss_pred             cceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCCeE----------EEEEEec
Q psy1546          58 IFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTKL----------WIIMEYL  127 (604)
Q Consensus        58 ~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~~l----------yLVmEy~  127 (604)
                      .|.+.+.||+|+||.||+|.+..+++.||||++.........+.+.+|+.+++.+.||++.++          |+||||+
T Consensus         8 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   87 (276)
T 2yex_A            8 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYC   87 (276)
T ss_dssp             HEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             ceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEec
Confidence            489999999999999999999999999999999766555566788999999999999996554          7999999


Q ss_pred             CCCChhhHhhc-CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCC--CCCccc
Q psy1546         128 GGGSALDLMKA-GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTT--SKRNTF  204 (604)
Q Consensus       128 ~ggsL~~~l~~-~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~--~~~~~~  204 (604)
                      ++++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+....  ......
T Consensus        88 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~  167 (276)
T 2yex_A           88 SGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM  167 (276)
T ss_dssp             TTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCBCCC
T ss_pred             CCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcchhcccCC
Confidence            99999999875 579999999999999999999999999999999999999999999999999997654322  223456


Q ss_pred             ccCCCCCChHHhhcCCC-CCcchhhhHHHHHHHHHhCCCCCCCCChhhHh-h-hcCCCCCCCCCccchHHHHHHHHHHhc
Q psy1546         205 VGTPFWMAPEVIKQSAY-DSKADIWSLGITAIELAKGEPPNSELHPMRVL-F-LIPKNNPPQLTGNYTKQFKEFVEACLN  281 (604)
Q Consensus       205 ~GT~~Y~APE~l~~~~~-~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~-~-~i~~~~~~~~~~~~s~~l~~Li~~~L~  281 (604)
                      +||+.|+|||++.+..+ +.++|||||||++|+|++|..||......... . .............++..+.+||.+||.
T Consensus       168 ~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~  247 (276)
T 2yex_A          168 CGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILV  247 (276)
T ss_dssp             CSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTTSTTGGGSCHHHHHHHHHHSC
T ss_pred             ccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccccCchhhcCHHHHHHHHHHCC
Confidence            79999999999987765 67899999999999999999999876543221 1 111122222345688999999999999


Q ss_pred             cCCCCCCCHHHHhcChhhhhhh
Q psy1546         282 KDPENRPTAKELLKFPFIRKAK  303 (604)
Q Consensus       282 ~dP~~RpT~~elL~hp~f~~~~  303 (604)
                      .||.+|||+.||++||||++..
T Consensus       248 ~~p~~Rps~~~il~~~~~~~~~  269 (276)
T 2yex_A          248 ENPSARITIPDIKKDRWYNKPL  269 (276)
T ss_dssp             SSTTTSCCHHHHTTCTTTTCCC
T ss_pred             CCchhCCCHHHHhcCccccChh
Confidence            9999999999999999997653

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=4.2e-44  Score=378.28  Aligned_cols=247  Identities=34%  Similarity=0.615  Sum_probs=209.2

Q ss_pred             ccceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCCeE----------EEEEEe
Q psy1546          57 LIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTKL----------WIIMEY  126 (604)
Q Consensus        57 ~~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~~l----------yLVmEy  126 (604)
                      ..|.+.+.||+|+||.||+|.+..+++.||+|++.........+.+.+|+.+++.+.||++.++          |+||||
T Consensus        33 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  112 (360)
T 3eqc_A           33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH  112 (360)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             ccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEEC
Confidence            3599999999999999999999999999999999776555566789999999999999996654          799999


Q ss_pred             cCCCChhhHhhc-CCCcHHHHHHHHHHHHHHhHHhhhC-CccccccccceeEecCCCCeEEecccccccccCCCCCCccc
Q psy1546         127 LGGGSALDLMKA-GNFEEMHIAVILREVLKGLDYLHSE-RKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTF  204 (604)
Q Consensus       127 ~~ggsL~~~l~~-~~lse~~i~~i~~qIl~gL~yLHs~-gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~~~~~  204 (604)
                      +++++|.+++.. +.+++..+..++.||+.||.|||++ ||+||||||+||||+.++.+||+|||++..+...  .....
T Consensus       113 ~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~~~  190 (360)
T 3eqc_A          113 MDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--MANSF  190 (360)
T ss_dssp             CTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH--C----
T ss_pred             CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCcccccc--cccCC
Confidence            999999999865 6899999999999999999999996 9999999999999999999999999999755332  23356


Q ss_pred             ccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhc----------------------------
Q psy1546         205 VGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLI----------------------------  256 (604)
Q Consensus       205 ~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i----------------------------  256 (604)
                      .||+.|+|||++.+..++.++|||||||++|+|++|..||...........+                            
T Consensus       191 ~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  270 (360)
T 3eqc_A          191 VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMD  270 (360)
T ss_dssp             CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC---------------------------
T ss_pred             CCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCcccccccC
Confidence            8999999999999999999999999999999999999999876654332211                            


Q ss_pred             --------------CCCC-CCCCCccchHHHHHHHHHHhccCCCCCCCHHHHhcChhhhhhhhh
Q psy1546         257 --------------PKNN-PPQLTGNYTKQFKEFVEACLNKDPENRPTAKELLKFPFIRKAKKN  305 (604)
Q Consensus       257 --------------~~~~-~~~~~~~~s~~l~~Li~~~L~~dP~~RpT~~elL~hp~f~~~~~~  305 (604)
                                    .... +......++.++.+||.+||..||.+|||+.|+|+||||+.....
T Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~  334 (360)
T 3eqc_A          271 SRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAE  334 (360)
T ss_dssp             ---CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHHHHS
T ss_pred             CCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcchHh
Confidence                          0111 112223478899999999999999999999999999999876543

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=3.9e-45  Score=389.79  Aligned_cols=238  Identities=13%  Similarity=0.175  Sum_probs=195.1

Q ss_pred             cccceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchh--hHHHHHHHHHHH---HHHhhCCCCCCC------------
Q psy1546          56 ELIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE--AEDEIEDIQQEI---MVLSQCDSPYGT------------  118 (604)
Q Consensus        56 ~~~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~--~~~~~~~l~~Ei---~iL~~l~hp~~~------------  118 (604)
                      ...|.+.+.||+|+||+||+|++..+++.||||++....  .....+.+.+|+   .+|+.+.|||++            
T Consensus        72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~  151 (377)
T 3byv_A           72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  151 (377)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred             CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence            355999999999999999999999999999999996432  233457788999   556666898742            


Q ss_pred             ----------------------eEEEEEEecCCCChhhHhhc-CCCcH-------HHHHHHHHHHHHHhHHhhhCCcccc
Q psy1546         119 ----------------------KLWIIMEYLGGGSALDLMKA-GNFEE-------MHIAVILREVLKGLDYLHSERKLHR  168 (604)
Q Consensus       119 ----------------------~lyLVmEy~~ggsL~~~l~~-~~lse-------~~i~~i~~qIl~gL~yLHs~gIiHr  168 (604)
                                            ..||||||+ +|+|.+++.. +.+++       ..++.|+.||+.||.|||++||+||
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHr  230 (377)
T 3byv_A          152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHT  230 (377)
T ss_dssp             EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred             hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence                                  278999999 6899999864 33444       7788899999999999999999999


Q ss_pred             ccccceeEecCCCCeEEecccccccccCCCCCCcccccCCCCCChHHhhcC-----------CCCCcchhhhHHHHHHHH
Q psy1546         169 DIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQS-----------AYDSKADIWSLGITAIEL  237 (604)
Q Consensus       169 DLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~~~~~~GT~~Y~APE~l~~~-----------~~~~~sDVwSLGviL~eL  237 (604)
                      ||||+||||+.++.+||+|||+|+....   .....+| +.|+|||++.+.           .|+.++|||||||+||||
T Consensus       231 Dikp~NIll~~~~~~kL~DFG~a~~~~~---~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~el  306 (377)
T 3byv_A          231 YLRPVDIVLDQRGGVFLTGFEHLVRDGA---RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWI  306 (377)
T ss_dssp             CCCGGGEEECTTCCEEECCGGGCEETTC---EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHH
T ss_pred             CCCHHHEEEcCCCCEEEEechhheecCC---cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHHH
Confidence            9999999999999999999999975432   3345678 999999999887           899999999999999999


Q ss_pred             HhCCCCCCCCChhhHhhhcCCCCCCCCCccchHHHHHHHHHHhccCCCCCCCHHHHhcChhhhhhh
Q psy1546         238 AKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPENRPTAKELLKFPFIRKAK  303 (604)
Q Consensus       238 ltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~RpT~~elL~hp~f~~~~  303 (604)
                      ++|..||...........+...     ...+++++.+||.+||..||.+|||+.|+|+||||+...
T Consensus       307 ltg~~Pf~~~~~~~~~~~~~~~-----~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~  367 (377)
T 3byv_A          307 WCADLPITKDAALGGSEWIFRS-----CKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLR  367 (377)
T ss_dssp             HHSSCCC------CCSGGGGSS-----CCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHHHH
T ss_pred             HHCCCCCcccccccchhhhhhh-----ccCCCHHHHHHHHHHcCCCchhCCCHHHHhhChHHHHHH
Confidence            9999999876655444433322     256789999999999999999999999999999998654

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=2.5e-44  Score=389.82  Aligned_cols=249  Identities=29%  Similarity=0.471  Sum_probs=197.8

Q ss_pred             ccceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhh-------HHHHHHHHHHHHHHhhCCCCCCCe---------E
Q psy1546          57 LIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA-------EDEIEDIQQEIMVLSQCDSPYGTK---------L  120 (604)
Q Consensus        57 ~~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~-------~~~~~~l~~Ei~iL~~l~hp~~~~---------l  120 (604)
                      ..|.+.++||+|+||.||+|.+..+++.||||++.....       ......+.+|+.+|+++.|||+.+         +
T Consensus       135 ~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~  214 (419)
T 3i6u_A          135 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAEDY  214 (419)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEESSEE
T ss_pred             ccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEecCce
Confidence            348999999999999999999999999999999975432       122345789999999999999654         4


Q ss_pred             EEEEEecCCCChhhHhhc-CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCC---CeEEecccccccccC
Q psy1546         121 WIIMEYLGGGSALDLMKA-GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMG---DVKLADFGVAGTLTN  196 (604)
Q Consensus       121 yLVmEy~~ggsL~~~l~~-~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g---~vKL~DFGlA~~~~~  196 (604)
                      |+|||||++|+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+||||+.++   .+||+|||+|+.+..
T Consensus       215 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~  294 (419)
T 3i6u_A          215 YIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE  294 (419)
T ss_dssp             EEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTTTSCC-
T ss_pred             EEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecccceecCC
Confidence            899999999999998754 6799999999999999999999999999999999999997544   599999999976643


Q ss_pred             CCCCCcccccCCCCCChHHhhc---CCCCCcchhhhHHHHHHHHHhCCCCCCCCChh-hHhhhcCCCCCCC---CCccch
Q psy1546         197 TTSKRNTFVGTPFWMAPEVIKQ---SAYDSKADIWSLGITAIELAKGEPPNSELHPM-RVLFLIPKNNPPQ---LTGNYT  269 (604)
Q Consensus       197 ~~~~~~~~~GT~~Y~APE~l~~---~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~-~~~~~i~~~~~~~---~~~~~s  269 (604)
                       .......+||+.|+|||++.+   ..|+.++|||||||+||+|++|.+||...... .....+.......   ....++
T Consensus       295 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~  373 (419)
T 3i6u_A          295 -TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVS  373 (419)
T ss_dssp             -----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCCCCHHHHTTSC
T ss_pred             -CccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCCCCchhhcccC
Confidence             233446789999999999853   56888999999999999999999999865433 2222222222222   224578


Q ss_pred             HHHHHHHHHHhccCCCCCCCHHHHhcChhhhhhhhhh
Q psy1546         270 KQFKEFVEACLNKDPENRPTAKELLKFPFIRKAKKNA  306 (604)
Q Consensus       270 ~~l~~Li~~~L~~dP~~RpT~~elL~hp~f~~~~~~~  306 (604)
                      +.+.+||.+||..||.+|||+.|+|+||||+......
T Consensus       374 ~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~~~~  410 (419)
T 3i6u_A          374 EKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKR  410 (419)
T ss_dssp             HHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCCHHHHH
T ss_pred             HHHHHHHHHHccCChhHCcCHHHHhCCcccCChhHHH
Confidence            9999999999999999999999999999997654443

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=9.8e-45  Score=371.78  Aligned_cols=249  Identities=48%  Similarity=0.820  Sum_probs=185.4

Q ss_pred             ccceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCCeE----------EEEEEe
Q psy1546          57 LIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTKL----------WIIMEY  126 (604)
Q Consensus        57 ~~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~~l----------yLVmEy  126 (604)
                      ..|.+.+.||+|+||.||+|.+..+++.||||++...........+.+|+.+++.+.||++.++          |+||||
T Consensus        15 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   94 (303)
T 2vwi_A           15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKL   94 (303)
T ss_dssp             CCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEEEC
T ss_pred             hhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEehh
Confidence            3499999999999999999999999999999999766555556778899999999999996654          799999


Q ss_pred             cCCCChhhHhhc---------CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCC
Q psy1546         127 LGGGSALDLMKA---------GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNT  197 (604)
Q Consensus       127 ~~ggsL~~~l~~---------~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~  197 (604)
                      +++++|.+++..         +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+...
T Consensus        95 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~  174 (303)
T 2vwi_A           95 LSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATG  174 (303)
T ss_dssp             CTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCHHHHHCC--
T ss_pred             ccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEEEeccchheeccC
Confidence            999999998862         45999999999999999999999999999999999999999999999999999765432


Q ss_pred             C-----CCCcccccCCCCCChHHhhc-CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCCCC---------C
Q psy1546         198 T-----SKRNTFVGTPFWMAPEVIKQ-SAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNP---------P  262 (604)
Q Consensus       198 ~-----~~~~~~~GT~~Y~APE~l~~-~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~~~---------~  262 (604)
                      .     .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.................         .
T Consensus       175 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (303)
T 2vwi_A          175 GDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLETGVQDK  254 (303)
T ss_dssp             -------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCCCTTC-----
T ss_pred             CCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCCccccccccc
Confidence            1     12345679999999999976 5689999999999999999999999988776554433222221         2


Q ss_pred             CCCccchHHHHHHHHHHhccCCCCCCCHHHHhcChhhhhhhhh
Q psy1546         263 QLTGNYTKQFKEFVEACLNKDPENRPTAKELLKFPFIRKAKKN  305 (604)
Q Consensus       263 ~~~~~~s~~l~~Li~~~L~~dP~~RpT~~elL~hp~f~~~~~~  305 (604)
                      .....++.++.+||.+||..||.+|||+.++++||||++....
T Consensus       255 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~  297 (303)
T 2vwi_A          255 EMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAKNK  297 (303)
T ss_dssp             CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC------
T ss_pred             hhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcCCCC
Confidence            2335678999999999999999999999999999999876544

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=1.4e-43  Score=385.38  Aligned_cols=250  Identities=30%  Similarity=0.438  Sum_probs=198.1

Q ss_pred             CccccceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchh-hHHHHHHHHHHHHHHhhCCCCCCC--------------
Q psy1546          54 DPELIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE-AEDEIEDIQQEIMVLSQCDSPYGT--------------  118 (604)
Q Consensus        54 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~-~~~~~~~l~~Ei~iL~~l~hp~~~--------------  118 (604)
                      .....|.+.+.||+|+||.||+|.+..+++.||||++.... .....+.+.+|+.+|+.++|+|+.              
T Consensus        23 ~i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~  102 (432)
T 3n9x_A           23 HVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKF  102 (432)
T ss_dssp             CCCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTC
T ss_pred             eecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcC
Confidence            33456999999999999999999999999999999996542 233457889999999999999854              


Q ss_pred             -eEEEEEEecCCCChhhHhhc-CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccC
Q psy1546         119 -KLWIIMEYLGGGSALDLMKA-GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTN  196 (604)
Q Consensus       119 -~lyLVmEy~~ggsL~~~l~~-~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~  196 (604)
                       .+||||||++ ++|.++++. +.+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+|+....
T Consensus       103 ~~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGla~~~~~  181 (432)
T 3n9x_A          103 DELYIVLEIAD-SDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINS  181 (432)
T ss_dssp             CCEEEEEECCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC--
T ss_pred             CeEEEEEecCC-cCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCCcccccc
Confidence             3689999996 589998876 4699999999999999999999999999999999999999999999999999976643


Q ss_pred             CCC----------------------CCcccccCCCCCChHHh-hcCCCCCcchhhhHHHHHHHHHhCC-----------C
Q psy1546         197 TTS----------------------KRNTFVGTPFWMAPEVI-KQSAYDSKADIWSLGITAIELAKGE-----------P  242 (604)
Q Consensus       197 ~~~----------------------~~~~~~GT~~Y~APE~l-~~~~~~~~sDVwSLGviL~eLltG~-----------~  242 (604)
                      ...                      .....+||+.|+|||++ ....|+.++|||||||+||||++|.           +
T Consensus       182 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~p  261 (432)
T 3n9x_A          182 EKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFP  261 (432)
T ss_dssp             -----------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGGCCC
T ss_pred             cccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccccccccccc
Confidence            321                      23567899999999987 5667999999999999999999844           4


Q ss_pred             CCCCCCh-----------------hhHhh---------------------------hcCCCCCC---CCCccchHHHHHH
Q psy1546         243 PNSELHP-----------------MRVLF---------------------------LIPKNNPP---QLTGNYTKQFKEF  275 (604)
Q Consensus       243 Pf~~~~~-----------------~~~~~---------------------------~i~~~~~~---~~~~~~s~~l~~L  275 (604)
                      +|.+...                 ...+.                           ......+.   .....+++++.+|
T Consensus       262 ~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dL  341 (432)
T 3n9x_A          262 LFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGINL  341 (432)
T ss_dssp             SCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHH
T ss_pred             cCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHH
Confidence            4444321                 00000                           00000000   0113578899999


Q ss_pred             HHHHhccCCCCCCCHHHHhcChhhhhhhh
Q psy1546         276 VEACLNKDPENRPTAKELLKFPFIRKAKK  304 (604)
Q Consensus       276 i~~~L~~dP~~RpT~~elL~hp~f~~~~~  304 (604)
                      |.+||..||.+|||++|+|+||||+....
T Consensus       342 l~~mL~~dP~~R~ta~e~L~Hp~f~~~~~  370 (432)
T 3n9x_A          342 LESMLKFNPNKRITIDQALDHPYLKDVRK  370 (432)
T ss_dssp             HHHHSCSSTTTSCCHHHHHTCGGGTTTCC
T ss_pred             HHHHhcCCcccCCCHHHHhcChhhhhccC
Confidence            99999999999999999999999987644

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=5.1e-44  Score=377.30  Aligned_cols=238  Identities=27%  Similarity=0.409  Sum_probs=198.8

Q ss_pred             ccceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCC-----CCCCCe----------EE
Q psy1546          57 LIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCD-----SPYGTK----------LW  121 (604)
Q Consensus        57 ~~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~-----hp~~~~----------ly  121 (604)
                      ..|.+.++||+|+||.||+|.+..+++.||||++....  .....+..|+.+++.+.     |||+.+          +|
T Consensus        35 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~~~~  112 (360)
T 3llt_A           35 NAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIK--KYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDHMC  112 (360)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCH--HHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETTEEE
T ss_pred             CEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccch--hhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECCeeE
Confidence            35999999999999999999999999999999996432  33466778999999987     888654          47


Q ss_pred             EEEEecCCCChhhHhhcC---CCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecC-------------------
Q psy1546         122 IIMEYLGGGSALDLMKAG---NFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSE-------------------  179 (604)
Q Consensus       122 LVmEy~~ggsL~~~l~~~---~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~-------------------  179 (604)
                      |||||+ +++|.+++...   .+++..++.++.||+.||.|||++||+||||||+||||+.                   
T Consensus       113 lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~~~  191 (360)
T 3llt_A          113 LIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKI  191 (360)
T ss_dssp             EEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEECTTTCCEE
T ss_pred             EEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccchhcccccccc
Confidence            999999 99999998764   4999999999999999999999999999999999999975                   


Q ss_pred             ------CCCeEEecccccccccCCCCCCcccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHh
Q psy1546         180 ------MGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVL  253 (604)
Q Consensus       180 ------~g~vKL~DFGlA~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~  253 (604)
                            ++.+||+|||+|+....   .....+||+.|+|||++.+..++.++|||||||+||+|++|..||......+..
T Consensus       192 ~~~~~~~~~~kl~DFG~a~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~  268 (360)
T 3llt_A          192 QIYRTKSTGIKLIDFGCATFKSD---YHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTHEHMEHL  268 (360)
T ss_dssp             EEEEESCCCEEECCCTTCEETTS---CCCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred             cccccCCCCEEEEeccCceecCC---CCcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCCCCcHHHHH
Confidence                  78999999999975433   234568999999999999999999999999999999999999999887665443


Q ss_pred             hhcCCCCCC---------------------------------------------CCCccchHHHHHHHHHHhccCCCCCC
Q psy1546         254 FLIPKNNPP---------------------------------------------QLTGNYTKQFKEFVEACLNKDPENRP  288 (604)
Q Consensus       254 ~~i~~~~~~---------------------------------------------~~~~~~s~~l~~Li~~~L~~dP~~Rp  288 (604)
                      ..+.....+                                             .+....++.+.+||.+||+.||.+||
T Consensus       269 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp  348 (360)
T 3llt_A          269 AMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDPTLRP  348 (360)
T ss_dssp             HHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCCSSGGGSC
T ss_pred             HHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhcCChhhCC
Confidence            322111000                                             00011236788999999999999999


Q ss_pred             CHHHHhcChhhh
Q psy1546         289 TAKELLKFPFIR  300 (604)
Q Consensus       289 T~~elL~hp~f~  300 (604)
                      |+.|||+||||+
T Consensus       349 ta~elL~hp~f~  360 (360)
T 3llt_A          349 SPAELLKHKFLE  360 (360)
T ss_dssp             CHHHHTTSGGGC
T ss_pred             CHHHHhcCcccC
Confidence            999999999994

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=2.7e-44  Score=395.66  Aligned_cols=245  Identities=31%  Similarity=0.530  Sum_probs=212.7

Q ss_pred             ccceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhh--HHHHHHHHHHHHHHhhCCCCCCCeE----------EEEE
Q psy1546          57 LIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA--EDEIEDIQQEIMVLSQCDSPYGTKL----------WIIM  124 (604)
Q Consensus        57 ~~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~--~~~~~~l~~Ei~iL~~l~hp~~~~l----------yLVm  124 (604)
                      ..|.+.++||+|+||.||+|.+..+++.||||++.....  ......+.+|+.+++++.|||++++          |+||
T Consensus        26 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  105 (484)
T 3nyv_A           26 DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVG  105 (484)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence            459999999999999999999999999999999965432  2335778999999999999997654          7999


Q ss_pred             EecCCCChhhHhhc-CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEe---cCCCCeEEecccccccccCCCCC
Q psy1546         125 EYLGGGSALDLMKA-GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLL---SEMGDVKLADFGVAGTLTNTTSK  200 (604)
Q Consensus       125 Ey~~ggsL~~~l~~-~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl---~~~g~vKL~DFGlA~~~~~~~~~  200 (604)
                      |||.+|+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+||||   +.++.+||+|||+++.+... ..
T Consensus       106 e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~-~~  184 (484)
T 3nyv_A          106 EVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS-KK  184 (484)
T ss_dssp             CCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCC-CS
T ss_pred             ecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcccc-cc
Confidence            99999999988754 789999999999999999999999999999999999999   56789999999999766433 23


Q ss_pred             CcccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCCCCC---CCCccchHHHHHHHH
Q psy1546         201 RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPP---QLTGNYTKQFKEFVE  277 (604)
Q Consensus       201 ~~~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~~~~---~~~~~~s~~l~~Li~  277 (604)
                      ....+||+.|+|||++.+ .|+.++|||||||++|+|++|.+||.+.........+......   .....+++.+++||.
T Consensus       185 ~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~  263 (484)
T 3nyv_A          185 MKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDLIR  263 (484)
T ss_dssp             HHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGGGSCHHHHHHHH
T ss_pred             cccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCcccccCCHHHHHHHH
Confidence            345689999999999976 6999999999999999999999999998888777766554422   223568899999999


Q ss_pred             HHhccCCCCCCCHHHHhcChhhhhhh
Q psy1546         278 ACLNKDPENRPTAKELLKFPFIRKAK  303 (604)
Q Consensus       278 ~~L~~dP~~RpT~~elL~hp~f~~~~  303 (604)
                      +||..||.+|||+.|+|+||||+...
T Consensus       264 ~~L~~dp~~R~s~~e~l~h~~~~~~~  289 (484)
T 3nyv_A          264 KMLTYVPSMRISARDALDHEWIQTYT  289 (484)
T ss_dssp             HHTCSSGGGSCCHHHHHTSHHHHHHT
T ss_pred             HHCCCChhHCcCHHHHhhChhhcccc
Confidence            99999999999999999999998654

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=2.7e-44  Score=403.43  Aligned_cols=246  Identities=27%  Similarity=0.424  Sum_probs=210.7

Q ss_pred             ccceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhH--HHHHHHHHHHHHHhhCCCCCCCe----------EEEEE
Q psy1546          57 LIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAE--DEIEDIQQEIMVLSQCDSPYGTK----------LWIIM  124 (604)
Q Consensus        57 ~~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~--~~~~~l~~Ei~iL~~l~hp~~~~----------lyLVm  124 (604)
                      ..|.+.++||+|+||.||+|.+..+++.||||++......  .....+.+|+.+|..+.||++++          +||||
T Consensus       184 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm  263 (576)
T 2acx_A          184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVL  263 (576)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEEE
Confidence            3499999999999999999999999999999999765332  23466789999999999999655          47999


Q ss_pred             EecCCCChhhHhhcC---CCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCCCC
Q psy1546         125 EYLGGGSALDLMKAG---NFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKR  201 (604)
Q Consensus       125 Ey~~ggsL~~~l~~~---~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~~  201 (604)
                      |||+||+|.+++...   .+++..++.++.||+.||.|||++|||||||||+||||+.+|.+||+|||+|+.+.... ..
T Consensus       264 Ey~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~~-~~  342 (576)
T 2acx_A          264 TLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ-TI  342 (576)
T ss_dssp             CCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTTC-CE
T ss_pred             EcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEecccceecccCc-cc
Confidence            999999999988652   39999999999999999999999999999999999999999999999999997664332 23


Q ss_pred             cccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCCh----hhHhhhcCCCCCCCCCccchHHHHHHHH
Q psy1546         202 NTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHP----MRVLFLIPKNNPPQLTGNYTKQFKEFVE  277 (604)
Q Consensus       202 ~~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~----~~~~~~i~~~~~~~~~~~~s~~l~~Li~  277 (604)
                      ...+||+.|+|||++.+..|+.++|||||||+||||++|.+||.....    ..+...+. ..+..++..++.++++||.
T Consensus       343 ~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~-~~~~~~p~~~s~~~~dLI~  421 (576)
T 2acx_A          343 KGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVK-EVPEEYSERFSPQARSLCS  421 (576)
T ss_dssp             ECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHH-HCCCCCCTTSCHHHHHHHH
T ss_pred             cccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhh-cccccCCccCCHHHHHHHH
Confidence            456899999999999999999999999999999999999999987642    22222222 2234556788999999999


Q ss_pred             HHhccCCCCCC-----CHHHHhcChhhhhhhh
Q psy1546         278 ACLNKDPENRP-----TAKELLKFPFIRKAKK  304 (604)
Q Consensus       278 ~~L~~dP~~Rp-----T~~elL~hp~f~~~~~  304 (604)
                      +||..||.+||     ++.||++||||+...+
T Consensus       422 ~lL~~dP~~R~g~~~~sa~eil~HpfF~~i~w  453 (576)
T 2acx_A          422 QLLCKDPAERLGCRGGSAREVKEHPLFKKLNF  453 (576)
T ss_dssp             HHTCSSGGGSTTCSSSHHHHHHTSGGGTTCCH
T ss_pred             HhccCCHHHcCCCCCCCHHHHHhChhhccCCH
Confidence            99999999999     8999999999987543

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=6.5e-44  Score=384.44  Aligned_cols=238  Identities=28%  Similarity=0.467  Sum_probs=192.6

Q ss_pred             ceee-eEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHH-hhCCCCCCCe--------------EEE
Q psy1546          59 FTKQ-ERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVL-SQCDSPYGTK--------------LWI  122 (604)
Q Consensus        59 y~i~-~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL-~~l~hp~~~~--------------lyL  122 (604)
                      |.+. ++||+|+||+||+|.+..+++.||||++...      ..+.+|+.++ +...|||+.+              +||
T Consensus        63 y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~l  136 (400)
T 1nxk_A           63 YKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLI  136 (400)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEE
T ss_pred             ceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc------hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEE
Confidence            6665 7899999999999999999999999999643      3456788776 5568998554              479


Q ss_pred             EEEecCCCChhhHhhcC---CCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecC---CCCeEEecccccccccC
Q psy1546         123 IMEYLGGGSALDLMKAG---NFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSE---MGDVKLADFGVAGTLTN  196 (604)
Q Consensus       123 VmEy~~ggsL~~~l~~~---~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~---~g~vKL~DFGlA~~~~~  196 (604)
                      |||||+||+|.+++...   .+++..++.|+.||+.||.|||++||+||||||+||||+.   ++.+||+|||+++....
T Consensus       137 v~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~  216 (400)
T 1nxk_A          137 VMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS  216 (400)
T ss_dssp             EEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCTTCEECC-
T ss_pred             EEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEecccccccCC
Confidence            99999999999999753   4999999999999999999999999999999999999987   78999999999976543


Q ss_pred             CCCCCcccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhh----HhhhcCCC---CCCCCCccch
Q psy1546         197 TTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMR----VLFLIPKN---NPPQLTGNYT  269 (604)
Q Consensus       197 ~~~~~~~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~----~~~~i~~~---~~~~~~~~~s  269 (604)
                      . ......+||+.|+|||++.+..|+.++|||||||+||+|++|..||.......    ....+..+   .+......++
T Consensus       217 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s  295 (400)
T 1nxk_A          217 H-NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVS  295 (400)
T ss_dssp             -----------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCCTTTTTTSC
T ss_pred             C-CccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCCCcccccCC
Confidence            2 23456789999999999999999999999999999999999999998765322    11111111   1222335689


Q ss_pred             HHHHHHHHHHhccCCCCCCCHHHHhcChhhhhhh
Q psy1546         270 KQFKEFVEACLNKDPENRPTAKELLKFPFIRKAK  303 (604)
Q Consensus       270 ~~l~~Li~~~L~~dP~~RpT~~elL~hp~f~~~~  303 (604)
                      .++.+||.+||..||.+|||+.|||+||||....
T Consensus       296 ~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~  329 (400)
T 1nxk_A          296 EEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST  329 (400)
T ss_dssp             HHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTTT
T ss_pred             HHHHHHHHHHCCCChhHCcCHHHHhcCccccCCC
Confidence            9999999999999999999999999999997654

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=9.3e-44  Score=392.01  Aligned_cols=245  Identities=32%  Similarity=0.532  Sum_probs=209.6

Q ss_pred             ccceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhh-HHHHHHHHHHHHHHhhCCCCCCCeE----------EEEEE
Q psy1546          57 LIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA-EDEIEDIQQEIMVLSQCDSPYGTKL----------WIIME  125 (604)
Q Consensus        57 ~~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~-~~~~~~l~~Ei~iL~~l~hp~~~~l----------yLVmE  125 (604)
                      ..|.+.++||+|+||+||+|.+..+++.||||++..... ......+.+|+.+|+++.|||++++          |+|||
T Consensus        22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  101 (486)
T 3mwu_A           22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGE  101 (486)
T ss_dssp             HHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             cceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEEE
Confidence            459999999999999999999999999999999965432 2235678899999999999997654          79999


Q ss_pred             ecCCCChhhHhh-cCCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEec---CCCCeEEecccccccccCCCCCC
Q psy1546         126 YLGGGSALDLMK-AGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLS---EMGDVKLADFGVAGTLTNTTSKR  201 (604)
Q Consensus       126 y~~ggsL~~~l~-~~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~---~~g~vKL~DFGlA~~~~~~~~~~  201 (604)
                      ||.+|+|.+++. .+.+++..++.++.||+.||.|||++||+||||||+||||+   .++.+||+|||+++.+... ...
T Consensus       102 ~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~-~~~  180 (486)
T 3mwu_A          102 LYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN-TKM  180 (486)
T ss_dssp             CCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC----
T ss_pred             cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCC-Ccc
Confidence            999999988774 47899999999999999999999999999999999999995   4567999999999765433 334


Q ss_pred             cccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCCCCC---CCCccchHHHHHHHHH
Q psy1546         202 NTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPP---QLTGNYTKQFKEFVEA  278 (604)
Q Consensus       202 ~~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~~~~---~~~~~~s~~l~~Li~~  278 (604)
                      ...+||+.|+|||++.+ .|+.++|||||||++|+|++|.+||.+.........+......   .....+++++++||.+
T Consensus       181 ~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~  259 (486)
T 3mwu_A          181 KDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRK  259 (486)
T ss_dssp             -CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSGGGGGSCHHHHHHHHH
T ss_pred             CCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcccCCCCHHHHHHHHH
Confidence            45689999999999976 5999999999999999999999999998887777665544322   2235678999999999


Q ss_pred             HhccCCCCCCCHHHHhcChhhhhhh
Q psy1546         279 CLNKDPENRPTAKELLKFPFIRKAK  303 (604)
Q Consensus       279 ~L~~dP~~RpT~~elL~hp~f~~~~  303 (604)
                      ||..||.+|||+.|+|+||||++..
T Consensus       260 ~L~~dp~~R~t~~~~l~hp~~~~~~  284 (486)
T 3mwu_A          260 MLTFHPSLRITATQCLEHPWIQKYS  284 (486)
T ss_dssp             HTCSSTTTSCCHHHHHHCHHHHHTC
T ss_pred             HcCCChhhCcCHHHHhcCHhhccCc
Confidence            9999999999999999999998754

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=1.8e-43  Score=361.72  Aligned_cols=242  Identities=26%  Similarity=0.493  Sum_probs=206.0

Q ss_pred             ccceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhh-HHHHHHHHHHHHHHhhCCCCCCCe--------------EE
Q psy1546          57 LIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA-EDEIEDIQQEIMVLSQCDSPYGTK--------------LW  121 (604)
Q Consensus        57 ~~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~-~~~~~~l~~Ei~iL~~l~hp~~~~--------------ly  121 (604)
                      ..|.+.+.||+|+||.||+|.+..++..||+|++..... ....+.+.+|+.+++.+.||++.+              +|
T Consensus        26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  105 (290)
T 1t4h_A           26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV  105 (290)
T ss_dssp             CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred             eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEE
Confidence            448999999999999999999999999999999875542 345678899999999999998654              47


Q ss_pred             EEEEecCCCChhhHhhc-CCCcHHHHHHHHHHHHHHhHHhhhCC--ccccccccceeEec-CCCCeEEecccccccccCC
Q psy1546         122 IIMEYLGGGSALDLMKA-GNFEEMHIAVILREVLKGLDYLHSER--KLHRDIKAANVLLS-EMGDVKLADFGVAGTLTNT  197 (604)
Q Consensus       122 LVmEy~~ggsL~~~l~~-~~lse~~i~~i~~qIl~gL~yLHs~g--IiHrDLKp~NILl~-~~g~vKL~DFGlA~~~~~~  197 (604)
                      +||||+++++|.+++.. +.+++..++.++.||+.||.|||++|  |+||||||+||||+ .++.+||+|||++......
T Consensus       106 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~~~  185 (290)
T 1t4h_A          106 LVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS  185 (290)
T ss_dssp             EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTT
T ss_pred             EEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCccccccc
Confidence            99999999999999976 78999999999999999999999999  99999999999997 7899999999999654322


Q ss_pred             CCCCcccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhh-HhhhcCCC-CCCCCCccchHHHHHH
Q psy1546         198 TSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMR-VLFLIPKN-NPPQLTGNYTKQFKEF  275 (604)
Q Consensus       198 ~~~~~~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~-~~~~i~~~-~~~~~~~~~s~~l~~L  275 (604)
                        ......||+.|+|||++.+ .++.++|||||||++|+|++|..||....... ....+... .+..+...+++++.+|
T Consensus       186 --~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  262 (290)
T 1t4h_A          186 --FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEI  262 (290)
T ss_dssp             --SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHHH
T ss_pred             --ccccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCccccCCCCCHHHHHH
Confidence              3345679999999998874 58999999999999999999999998754433 33333333 2334455677899999


Q ss_pred             HHHHhccCCCCCCCHHHHhcChhhhh
Q psy1546         276 VEACLNKDPENRPTAKELLKFPFIRK  301 (604)
Q Consensus       276 i~~~L~~dP~~RpT~~elL~hp~f~~  301 (604)
                      |.+||..||.+|||+.|||+||||+.
T Consensus       263 i~~~l~~dp~~Rps~~ell~h~~f~~  288 (290)
T 1t4h_A          263 IEGCIRQNKDERYSIKDLLNHAFFQE  288 (290)
T ss_dssp             HHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred             HHHHccCChhhCCCHHHHhhCccccc
Confidence            99999999999999999999999964

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=7.8e-44  Score=379.63  Aligned_cols=240  Identities=25%  Similarity=0.456  Sum_probs=211.5

Q ss_pred             ccceeeeEEcccCcEEEEEEEEC-------CCCcEEEEEEecchhhHHHHHHHHHHHHHHhhC-CCCCCCeE--------
Q psy1546          57 LIFTKQERIGKGSFGEVFKGIDN-------RTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQC-DSPYGTKL--------  120 (604)
Q Consensus        57 ~~y~i~~~LG~G~fG~Vy~a~~~-------~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l-~hp~~~~l--------  120 (604)
                      ..|.+.+.||+|+||.||+|.+.       .++..||||++.........+.+.+|+.+|+.+ +|||+.++        
T Consensus        81 ~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~  160 (370)
T 2psq_A           81 DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG  160 (370)
T ss_dssp             GGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSSS
T ss_pred             HHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccCC
Confidence            45899999999999999999874       345689999998766666678899999999999 89997665        


Q ss_pred             --EEEEEecCCCChhhHhhcC-----------------CCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCC
Q psy1546         121 --WIIMEYLGGGSALDLMKAG-----------------NFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMG  181 (604)
Q Consensus       121 --yLVmEy~~ggsL~~~l~~~-----------------~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g  181 (604)
                        |+||||+++|+|.+++...                 .+++..++.++.||+.||.|||++||+||||||+||||+.++
T Consensus       161 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~  240 (370)
T 2psq_A          161 PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENN  240 (370)
T ss_dssp             SCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTC
T ss_pred             CEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhEEECCCC
Confidence              7999999999999998653                 378899999999999999999999999999999999999999


Q ss_pred             CeEEecccccccccCCCC--CCcccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHhhhcCC
Q psy1546         182 DVKLADFGVAGTLTNTTS--KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAK-GEPPNSELHPMRVLFLIPK  258 (604)
Q Consensus       182 ~vKL~DFGlA~~~~~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~~i~~  258 (604)
                      .+||+|||+++.+.....  ......+|+.|+|||++.+..|+.++|||||||+||||++ |..||.+....+....+..
T Consensus       241 ~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~~~~~~~  320 (370)
T 2psq_A          241 VMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKE  320 (370)
T ss_dssp             CEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHT
T ss_pred             CEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhc
Confidence            999999999976654322  2234567889999999999999999999999999999999 9999999888877777777


Q ss_pred             CCCCCCCccchHHHHHHHHHHhccCCCCCCCHHHHhcC
Q psy1546         259 NNPPQLTGNYTKQFKEFVEACLNKDPENRPTAKELLKF  296 (604)
Q Consensus       259 ~~~~~~~~~~s~~l~~Li~~~L~~dP~~RpT~~elL~h  296 (604)
                      ......+..++.++.+||.+||..||.+|||+.||+++
T Consensus       321 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~  358 (370)
T 2psq_A          321 GHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED  358 (370)
T ss_dssp             TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            76677778899999999999999999999999999874

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=1.2e-43  Score=393.12  Aligned_cols=247  Identities=30%  Similarity=0.500  Sum_probs=210.0

Q ss_pred             cccceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhH------------HHHHHHHHHHHHHhhCCCCCCCeE---
Q psy1546          56 ELIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAE------------DEIEDIQQEIMVLSQCDSPYGTKL---  120 (604)
Q Consensus        56 ~~~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~------------~~~~~l~~Ei~iL~~l~hp~~~~l---  120 (604)
                      ...|.++++||+|+||+||+|.+..+++.||||++......            ...+.+.+|+.+|+.++|||++++   
T Consensus        35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~  114 (504)
T 3q5i_A           35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV  114 (504)
T ss_dssp             GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred             ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence            34599999999999999999999999999999999754322            224678899999999999997654   


Q ss_pred             -------EEEEEecCCCChhhHhh-cCCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCC---CeEEeccc
Q psy1546         121 -------WIIMEYLGGGSALDLMK-AGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMG---DVKLADFG  189 (604)
Q Consensus       121 -------yLVmEy~~ggsL~~~l~-~~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g---~vKL~DFG  189 (604)
                             |||||||+||+|.+++. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++   .+||+|||
T Consensus       115 ~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg  194 (504)
T 3q5i_A          115 FEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFG  194 (504)
T ss_dssp             EECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEECCCT
T ss_pred             EEcCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEEEECC
Confidence                   79999999999988775 47899999999999999999999999999999999999998776   69999999


Q ss_pred             ccccccCCCCCCcccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCCCCCCC---Cc
Q psy1546         190 VAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQL---TG  266 (604)
Q Consensus       190 lA~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~---~~  266 (604)
                      +|+.+... ......+||+.|+|||++. ..|+.++|||||||++|+|++|.+||.+.....+...+........   ..
T Consensus       195 ~a~~~~~~-~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  272 (504)
T 3q5i_A          195 LSSFFSKD-YKLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFNDWK  272 (504)
T ss_dssp             TCEECCTT-SCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHHT
T ss_pred             CCEEcCCC-CccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccccC
Confidence            99766433 3345668999999999987 4699999999999999999999999999888877776655543221   24


Q ss_pred             cchHHHHHHHHHHhccCCCCCCCHHHHhcChhhhhhhh
Q psy1546         267 NYTKQFKEFVEACLNKDPENRPTAKELLKFPFIRKAKK  304 (604)
Q Consensus       267 ~~s~~l~~Li~~~L~~dP~~RpT~~elL~hp~f~~~~~  304 (604)
                      .+++++++||.+||..||.+|||+.|+|+||||++...
T Consensus       273 ~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~  310 (504)
T 3q5i_A          273 NISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYAN  310 (504)
T ss_dssp             TSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHTCC
T ss_pred             CCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhchh
Confidence            67899999999999999999999999999999987543

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=3.4e-44  Score=375.02  Aligned_cols=247  Identities=27%  Similarity=0.430  Sum_probs=202.0

Q ss_pred             ccceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhh-HHHHHHHHHHHHHHhhCCCCCCCeE----------EEEEE
Q psy1546          57 LIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA-EDEIEDIQQEIMVLSQCDSPYGTKL----------WIIME  125 (604)
Q Consensus        57 ~~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~-~~~~~~l~~Ei~iL~~l~hp~~~~l----------yLVmE  125 (604)
                      ..|++.+.||+|+||.||+|.+..+++.||||++..... ....+.+.+|+.+++.+.||++.++          |+|||
T Consensus        25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  104 (331)
T 4aaa_A           25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFE  104 (331)
T ss_dssp             GGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             hhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEe
Confidence            459999999999999999999999999999999865433 2334667899999999999996654          79999


Q ss_pred             ecCCCChhhHhh-cCCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCCCCccc
Q psy1546         126 YLGGGSALDLMK-AGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTF  204 (604)
Q Consensus       126 y~~ggsL~~~l~-~~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~~~~~  204 (604)
                      |+++++|.+++. .+.+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.+..........
T Consensus       105 ~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~  184 (331)
T 4aaa_A          105 FVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDE  184 (331)
T ss_dssp             CCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC------------C
T ss_pred             cCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCceeecCCccccCCC
Confidence            999999998865 4679999999999999999999999999999999999999999999999999997766555555567


Q ss_pred             ccCCCCCChHHhhcC-CCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCC---------------------CCCC
Q psy1546         205 VGTPFWMAPEVIKQS-AYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPK---------------------NNPP  262 (604)
Q Consensus       205 ~GT~~Y~APE~l~~~-~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~---------------------~~~~  262 (604)
                      +||+.|+|||++.+. .++.++|||||||++|+|++|.+||...........+..                     ...+
T Consensus       185 ~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  264 (331)
T 4aaa_A          185 VATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRLP  264 (331)
T ss_dssp             CCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGGTTCCCC
T ss_pred             cCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhccccccccCc
Confidence            899999999999875 789999999999999999999999988776544332210                     0000


Q ss_pred             C---------CCccchHHHHHHHHHHhccCCCCCCCHHHHhcChhhhhhh
Q psy1546         263 Q---------LTGNYTKQFKEFVEACLNKDPENRPTAKELLKFPFIRKAK  303 (604)
Q Consensus       263 ~---------~~~~~s~~l~~Li~~~L~~dP~~RpT~~elL~hp~f~~~~  303 (604)
                      .         ....+++.+.+||.+||..||.+|||+.|||+||||+...
T Consensus       265 ~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~  314 (331)
T 4aaa_A          265 EIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMDG  314 (331)
T ss_dssp             CCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHGGG
T ss_pred             cccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhccCC
Confidence            0         1135688999999999999999999999999999997653

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=1.6e-43  Score=367.67  Aligned_cols=237  Identities=28%  Similarity=0.508  Sum_probs=197.1

Q ss_pred             ccceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhh-HHHHHHHHHHHHHHhhCCCCCCCeE----------EEEEE
Q psy1546          57 LIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA-EDEIEDIQQEIMVLSQCDSPYGTKL----------WIIME  125 (604)
Q Consensus        57 ~~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~-~~~~~~l~~Ei~iL~~l~hp~~~~l----------yLVmE  125 (604)
                      ..|.+.++||+|+||.||+|.+  +++.||||++..... ....+.+.+|+.++++++|||+.++          |+|||
T Consensus        37 ~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e  114 (309)
T 3p86_A           37 CDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTE  114 (309)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEE
T ss_pred             hHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEe
Confidence            3489999999999999999986  588999999865542 3445778999999999999997664          79999


Q ss_pred             ecCCCChhhHhhcCC----CcHHHHHHHHHHHHHHhHHhhhCC--ccccccccceeEecCCCCeEEecccccccccCCCC
Q psy1546         126 YLGGGSALDLMKAGN----FEEMHIAVILREVLKGLDYLHSER--KLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTS  199 (604)
Q Consensus       126 y~~ggsL~~~l~~~~----lse~~i~~i~~qIl~gL~yLHs~g--IiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~  199 (604)
                      |+++|+|.+++....    +++..++.++.||+.||.|||++|  |+||||||+||||+.++.+||+|||+++.......
T Consensus       115 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~~  194 (309)
T 3p86_A          115 YLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFL  194 (309)
T ss_dssp             CCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC----------
T ss_pred             cCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCCCcccccccc
Confidence            999999999997643    999999999999999999999999  99999999999999999999999999976554444


Q ss_pred             CCcccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcC-CCCCCCCCccchHHHHHHHHH
Q psy1546         200 KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIP-KNNPPQLTGNYTKQFKEFVEA  278 (604)
Q Consensus       200 ~~~~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~-~~~~~~~~~~~s~~l~~Li~~  278 (604)
                      ......||+.|+|||++.+..++.++|||||||++|+|++|..||...........+. ......++..++..+.+||.+
T Consensus       195 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  274 (309)
T 3p86_A          195 SSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQVAAIIEG  274 (309)
T ss_dssp             -------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCCCCCCTTSCHHHHHHHHH
T ss_pred             ccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCccCCHHHHHHHHH
Confidence            4556789999999999999999999999999999999999999999888776655442 334456677899999999999


Q ss_pred             HhccCCCCCCCHHHHhc
Q psy1546         279 CLNKDPENRPTAKELLK  295 (604)
Q Consensus       279 ~L~~dP~~RpT~~elL~  295 (604)
                      ||..||.+|||+.+|++
T Consensus       275 ~l~~dP~~Rps~~~ll~  291 (309)
T 3p86_A          275 CWTNEPWKRPSFATIMD  291 (309)
T ss_dssp             HTCSSGGGSCCHHHHHH
T ss_pred             HccCChhhCcCHHHHHH
Confidence            99999999999999987

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.8e-44  Score=375.58  Aligned_cols=244  Identities=27%  Similarity=0.415  Sum_probs=201.0

Q ss_pred             cceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHH----HHHHHHHHHHHHhhCCCCCCCeE----------EEE
Q psy1546          58 IFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAED----EIEDIQQEIMVLSQCDSPYGTKL----------WII  123 (604)
Q Consensus        58 ~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~----~~~~l~~Ei~iL~~l~hp~~~~l----------yLV  123 (604)
                      .|.+.+.||+|+||.||+|.+..+++.||||++.......    ....+.+|+.+++.+.|||+.++          |+|
T Consensus        11 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv   90 (346)
T 1ua2_A           11 RYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLV   90 (346)
T ss_dssp             --CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEE
T ss_pred             ccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceEEE
Confidence            4999999999999999999999999999999996543221    12467899999999999997665          699


Q ss_pred             EEecCCCChhhHhhc--CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCCCC
Q psy1546         124 MEYLGGGSALDLMKA--GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKR  201 (604)
Q Consensus       124 mEy~~ggsL~~~l~~--~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~~  201 (604)
                      |||+++ +|.+++..  ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+.......
T Consensus        91 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~  169 (346)
T 1ua2_A           91 FDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAY  169 (346)
T ss_dssp             EECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCCC
T ss_pred             EEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEecccceeccCCcccC
Confidence            999976 78887765  358999999999999999999999999999999999999999999999999998776555555


Q ss_pred             cccccCCCCCChHHhhcC-CCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCC----CC---------------
Q psy1546         202 NTFVGTPFWMAPEVIKQS-AYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKN----NP---------------  261 (604)
Q Consensus       202 ~~~~GT~~Y~APE~l~~~-~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~----~~---------------  261 (604)
                      ...+||+.|+|||++.+. .++.++|||||||++|+|++|.+||.+.........+...    ..               
T Consensus       170 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  249 (346)
T 1ua2_A          170 THQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTF  249 (346)
T ss_dssp             CCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCC
T ss_pred             CcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhccCcccccc
Confidence            667899999999999764 5889999999999999999999999987765544332110    00               


Q ss_pred             ---CC-----CCccchHHHHHHHHHHhccCCCCCCCHHHHhcChhhhhh
Q psy1546         262 ---PQ-----LTGNYTKQFKEFVEACLNKDPENRPTAKELLKFPFIRKA  302 (604)
Q Consensus       262 ---~~-----~~~~~s~~l~~Li~~~L~~dP~~RpT~~elL~hp~f~~~  302 (604)
                         +.     +...++.++.+||.+||..||.+|||+.|+|+||||...
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~  298 (346)
T 1ua2_A          250 KSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNR  298 (346)
T ss_dssp             CCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSS
T ss_pred             cccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcC
Confidence               00     114567899999999999999999999999999999753

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=1.3e-43  Score=359.59  Aligned_cols=239  Identities=28%  Similarity=0.419  Sum_probs=200.9

Q ss_pred             ccceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhh-HHHHHHHHHHHHHHhhC-CCCCCCeE----------EEEE
Q psy1546          57 LIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA-EDEIEDIQQEIMVLSQC-DSPYGTKL----------WIIM  124 (604)
Q Consensus        57 ~~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~-~~~~~~l~~Ei~iL~~l-~hp~~~~l----------yLVm  124 (604)
                      ..|.+.+.||+|+||.||+|.+..+++.||||++..... ......+.+|+.++..+ .||++.++          |+||
T Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv~   90 (289)
T 1x8b_A           11 TEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQN   90 (289)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEEE
T ss_pred             chhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence            349999999999999999999999999999999875422 23456778999999998 99996654          7999


Q ss_pred             EecCCCChhhHhhc-----CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCC-------------------
Q psy1546         125 EYLGGGSALDLMKA-----GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEM-------------------  180 (604)
Q Consensus       125 Ey~~ggsL~~~l~~-----~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~-------------------  180 (604)
                      ||+++++|.+++..     +.+++..++.++.||+.||.|||++||+||||||+|||++.+                   
T Consensus        91 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~  170 (289)
T 1x8b_A           91 EYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNK  170 (289)
T ss_dssp             ECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC--------------------C
T ss_pred             EecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccccccCCc
Confidence            99999999999865     569999999999999999999999999999999999999844                   


Q ss_pred             CCeEEecccccccccCCCCCCcccccCCCCCChHHhhcC-CCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCC
Q psy1546         181 GDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQS-AYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKN  259 (604)
Q Consensus       181 g~vKL~DFGlA~~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~  259 (604)
                      ..+||+|||++.......    ...||+.|+|||++.+. .++.++|||||||++|+|++|.+++......   ..+...
T Consensus       171 ~~~kl~Dfg~~~~~~~~~----~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~---~~~~~~  243 (289)
T 1x8b_A          171 VMFKIGDLGHVTRISSPQ----VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQW---HEIRQG  243 (289)
T ss_dssp             CCEEECCCTTCEETTCSC----CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHHH---HHHHTT
T ss_pred             eEEEEcccccccccCCcc----ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhHH---HHHHcC
Confidence            479999999997664332    34699999999999876 5668999999999999999999887654432   233344


Q ss_pred             CCCCCCccchHHHHHHHHHHhccCCCCCCCHHHHhcChhhhhh
Q psy1546         260 NPPQLTGNYTKQFKEFVEACLNKDPENRPTAKELLKFPFIRKA  302 (604)
Q Consensus       260 ~~~~~~~~~s~~l~~Li~~~L~~dP~~RpT~~elL~hp~f~~~  302 (604)
                      ..+.++..++..+.+||.+||..||.+|||+.|+++||||...
T Consensus       244 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  286 (289)
T 1x8b_A          244 RLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSA  286 (289)
T ss_dssp             CCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC---
T ss_pred             CCCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhhh
Confidence            4556677899999999999999999999999999999999764

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=1e-43  Score=373.84  Aligned_cols=243  Identities=27%  Similarity=0.499  Sum_probs=197.5

Q ss_pred             ccceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhh-HHHHHHHHHHHHHHhhCCC--CCCCe----------EEEE
Q psy1546          57 LIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA-EDEIEDIQQEIMVLSQCDS--PYGTK----------LWII  123 (604)
Q Consensus        57 ~~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~-~~~~~~l~~Ei~iL~~l~h--p~~~~----------lyLV  123 (604)
                      ..|.+.+.||+|+||.||+|.+ .+++.||||++..... ....+.+.+|+.+|..+.|  +++.+          +|||
T Consensus         9 ~~y~i~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv   87 (343)
T 3dbq_A            9 RIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV   87 (343)
T ss_dssp             CEEEEEEEESCCSSEEEEEEEC-TTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CEEEEEEEEecCCCeEEEEEEe-CCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEE
Confidence            4599999999999999999987 4688999999875543 3445788999999999987  77554          4799


Q ss_pred             EEecCCCChhhHhhc-CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCC--C
Q psy1546         124 MEYLGGGSALDLMKA-GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTS--K  200 (604)
Q Consensus       124 mEy~~ggsL~~~l~~-~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~--~  200 (604)
                      || +.+++|.+++.. +.+++..++.|+.||+.||.|||++||+||||||+||||+ ++.+||+|||+++.+.....  .
T Consensus        88 ~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~~~~~  165 (343)
T 3dbq_A           88 ME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVV  165 (343)
T ss_dssp             EC-CCSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC--------
T ss_pred             Ee-CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeecccccccCccccccc
Confidence            99 458899998865 5799999999999999999999999999999999999997 58899999999976643322  2


Q ss_pred             CcccccCCCCCChHHhhc-----------CCCCCcchhhhHHHHHHHHHhCCCCCCCCChh--hHhhhcCCCCCCCCCcc
Q psy1546         201 RNTFVGTPFWMAPEVIKQ-----------SAYDSKADIWSLGITAIELAKGEPPNSELHPM--RVLFLIPKNNPPQLTGN  267 (604)
Q Consensus       201 ~~~~~GT~~Y~APE~l~~-----------~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~--~~~~~i~~~~~~~~~~~  267 (604)
                      ....+||+.|+|||++.+           ..++.++|||||||+||+|++|..||......  .....+.......++..
T Consensus       166 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  245 (343)
T 3dbq_A          166 KDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDI  245 (343)
T ss_dssp             ----CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCCCCCCC
T ss_pred             CCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcCCcccCCccc
Confidence            345689999999999975           67889999999999999999999999875432  22223333344456667


Q ss_pred             chHHHHHHHHHHhccCCCCCCCHHHHhcChhhhhh
Q psy1546         268 YTKQFKEFVEACLNKDPENRPTAKELLKFPFIRKA  302 (604)
Q Consensus       268 ~s~~l~~Li~~~L~~dP~~RpT~~elL~hp~f~~~  302 (604)
                      .+..+.+||.+||..||.+|||+.|+|+||||+..
T Consensus       246 ~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~  280 (343)
T 3dbq_A          246 PEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ  280 (343)
T ss_dssp             SCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSC
T ss_pred             CCHHHHHHHHHHcCCChhHCCCHHHHHhCcccccc
Confidence            78899999999999999999999999999999754

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=1.5e-43  Score=376.60  Aligned_cols=243  Identities=26%  Similarity=0.493  Sum_probs=207.6

Q ss_pred             cceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchh-------hHHHHHHHHHHHHHHhhC-CCCCCCe----------
Q psy1546          58 IFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE-------AEDEIEDIQQEIMVLSQC-DSPYGTK----------  119 (604)
Q Consensus        58 ~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~-------~~~~~~~l~~Ei~iL~~l-~hp~~~~----------  119 (604)
                      .|.+.+.||+|+||.||+|.+..+|+.||||++....       .....+.+.+|+.+++.+ .||++.+          
T Consensus        95 ~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~  174 (365)
T 2y7j_A           95 KYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSF  174 (365)
T ss_dssp             HEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSSE
T ss_pred             hcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCCE
Confidence            4899999999999999999999999999999986542       122346778999999998 7998654          


Q ss_pred             EEEEEEecCCCChhhHhhc-CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCC
Q psy1546         120 LWIIMEYLGGGSALDLMKA-GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTT  198 (604)
Q Consensus       120 lyLVmEy~~ggsL~~~l~~-~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~  198 (604)
                      +|+||||++|++|.+++.. ..+++..+..++.||+.||.|||+.||+||||||+||||+.+|.+||+|||++..+... 
T Consensus       175 ~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~~~-  253 (365)
T 2y7j_A          175 MFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPG-  253 (365)
T ss_dssp             EEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTT-
T ss_pred             EEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecCcccccCCC-
Confidence            4799999999999999865 67999999999999999999999999999999999999999999999999999766533 


Q ss_pred             CCCcccccCCCCCChHHhhcC------CCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCCCCCCC---Cccch
Q psy1546         199 SKRNTFVGTPFWMAPEVIKQS------AYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQL---TGNYT  269 (604)
Q Consensus       199 ~~~~~~~GT~~Y~APE~l~~~------~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~---~~~~s  269 (604)
                      ......+||+.|+|||++.+.      .++.++|||||||+||+|++|..||...........+........   ...++
T Consensus       254 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  333 (365)
T 2y7j_A          254 EKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEWDDRS  333 (365)
T ss_dssp             CCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCHHHHSSSC
T ss_pred             cccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCcccccCC
Confidence            334467899999999999743      588899999999999999999999998877666555444332211   24578


Q ss_pred             HHHHHHHHHHhccCCCCCCCHHHHhcChhhhh
Q psy1546         270 KQFKEFVEACLNKDPENRPTAKELLKFPFIRK  301 (604)
Q Consensus       270 ~~l~~Li~~~L~~dP~~RpT~~elL~hp~f~~  301 (604)
                      ..+.+||.+||..||.+|||+.|+|+||||++
T Consensus       334 ~~~~~li~~~L~~dP~~Rps~~ell~hp~f~r  365 (365)
T 2y7j_A          334 STVKDLISRLLQVDPEARLTAEQALQHPFFER  365 (365)
T ss_dssp             HHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred             HHHHHHHHHHcCCChhHCcCHHHHhcCcccCC
Confidence            89999999999999999999999999999963

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=3e-44  Score=372.17  Aligned_cols=245  Identities=24%  Similarity=0.440  Sum_probs=204.2

Q ss_pred             ccceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchh--hHHHHHHHHHHHHHHhhCCCCCCCeE--------------
Q psy1546          57 LIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE--AEDEIEDIQQEIMVLSQCDSPYGTKL--------------  120 (604)
Q Consensus        57 ~~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~--~~~~~~~l~~Ei~iL~~l~hp~~~~l--------------  120 (604)
                      ..|.+.+.||+|+||.||+|.+..+++.||||++....  .......+.+|+.++..+.|||+.++              
T Consensus        12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~   91 (311)
T 3ork_A           12 DRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP   91 (311)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred             CcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCccc
Confidence            34999999999999999999999999999999997653  23445778999999999999997654              


Q ss_pred             EEEEEecCCCChhhHhhc-CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCC-
Q psy1546         121 WIIMEYLGGGSALDLMKA-GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTT-  198 (604)
Q Consensus       121 yLVmEy~~ggsL~~~l~~-~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~-  198 (604)
                      |+||||++|++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.+.... 
T Consensus        92 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~  171 (311)
T 3ork_A           92 YIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGN  171 (311)
T ss_dssp             EEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC--------
T ss_pred             EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCccccccccc
Confidence            799999999999999864 679999999999999999999999999999999999999999999999999997654332 


Q ss_pred             --CCCcccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCCCCC---CCCccchHHHH
Q psy1546         199 --SKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPP---QLTGNYTKQFK  273 (604)
Q Consensus       199 --~~~~~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~~~~---~~~~~~s~~l~  273 (604)
                        ......+||+.|+|||++.+..++.++|||||||++|+|++|..||..................   .....++.++.
T Consensus       172 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  251 (311)
T 3ork_A          172 SVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLD  251 (311)
T ss_dssp             ----------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCHHHHSTTCCHHHH
T ss_pred             ccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCcccccCCCCHHHH
Confidence              2233467999999999999999999999999999999999999999988876665443333221   12345789999


Q ss_pred             HHHHHHhccCCCCCCCHHHHhcChhhhh
Q psy1546         274 EFVEACLNKDPENRPTAKELLKFPFIRK  301 (604)
Q Consensus       274 ~Li~~~L~~dP~~RpT~~elL~hp~f~~  301 (604)
                      +||.+||..||.+||+..++|.|+|++.
T Consensus       252 ~li~~~l~~dP~~R~~~~~~l~~~l~~~  279 (311)
T 3ork_A          252 AVVLKALAKNPENRYQTAAEMRADLVRV  279 (311)
T ss_dssp             HHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred             HHHHHHHhcCHhhChhhHHHHHHHHHHH
Confidence            9999999999999999999999999854

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=3.5e-44  Score=382.27  Aligned_cols=244  Identities=23%  Similarity=0.397  Sum_probs=189.2

Q ss_pred             ccceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchh-hHHHHHHHHHHHHHHhhCCCCCCCe----------------
Q psy1546          57 LIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE-AEDEIEDIQQEIMVLSQCDSPYGTK----------------  119 (604)
Q Consensus        57 ~~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~-~~~~~~~l~~Ei~iL~~l~hp~~~~----------------  119 (604)
                      ..|.+.+.||+|+||.||+|.+..+++.||||++.... .......+.+|+.+|+.+.|||+.+                
T Consensus        29 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~  108 (367)
T 2fst_X           29 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND  108 (367)
T ss_dssp             TTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred             CceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCe
Confidence            45999999999999999999999999999999986542 2344577889999999999998533                


Q ss_pred             EEEEEEecCCCChhhHhhcCCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCC
Q psy1546         120 LWIIMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTS  199 (604)
Q Consensus       120 lyLVmEy~~ggsL~~~l~~~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~  199 (604)
                      +|+||||+ +++|.++++.+.+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.....  
T Consensus       109 ~~lv~e~~-~~~L~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~--  185 (367)
T 2fst_X          109 VYLVTHLM-GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTADE--  185 (367)
T ss_dssp             CEEEEECC-CEECC-----CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC------------
T ss_pred             EEEEeccc-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeecccccccccc--
Confidence            48999999 789999998889999999999999999999999999999999999999999999999999999765432  


Q ss_pred             CCcccccCCCCCChHHhhc-CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCC--------------------
Q psy1546         200 KRNTFVGTPFWMAPEVIKQ-SAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPK--------------------  258 (604)
Q Consensus       200 ~~~~~~GT~~Y~APE~l~~-~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~--------------------  258 (604)
                       ....+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+....+..+..                    
T Consensus       186 -~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~  264 (367)
T 2fst_X          186 -MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN  264 (367)
T ss_dssp             ------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCCHHHHH
T ss_pred             -CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHHH
Confidence             345689999999999987 6799999999999999999999999998776544332211                    


Q ss_pred             -------CCCC---CCCccchHHHHHHHHHHhccCCCCCCCHHHHhcChhhhhhhh
Q psy1546         259 -------NNPP---QLTGNYTKQFKEFVEACLNKDPENRPTAKELLKFPFIRKAKK  304 (604)
Q Consensus       259 -------~~~~---~~~~~~s~~l~~Li~~~L~~dP~~RpT~~elL~hp~f~~~~~  304 (604)
                             ....   .+...+++.+.+||.+||..||.+|||+.|+|+||||.....
T Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~~~  320 (367)
T 2fst_X          265 YIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD  320 (367)
T ss_dssp             HHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCC
T ss_pred             HHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhccC
Confidence                   0000   111345788999999999999999999999999999986543

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=1.4e-43  Score=377.23  Aligned_cols=244  Identities=23%  Similarity=0.344  Sum_probs=195.1

Q ss_pred             ccceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchh-hHHHHHHHHHHHHHHhhCCCCCCC----------------e
Q psy1546          57 LIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE-AEDEIEDIQQEIMVLSQCDSPYGT----------------K  119 (604)
Q Consensus        57 ~~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~-~~~~~~~l~~Ei~iL~~l~hp~~~----------------~  119 (604)
                      ..|.+.+.||+|+||.||+|.+..+++.||||++.... .......+.+|+.+++.+.|||+.                .
T Consensus        25 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~  104 (371)
T 2xrw_A           25 KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQD  104 (371)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCE
T ss_pred             hheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccc
Confidence            34999999999999999999999999999999996543 234457788999999999999854                4


Q ss_pred             EEEEEEecCCCChhhHhhcCCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCC
Q psy1546         120 LWIIMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTS  199 (604)
Q Consensus       120 lyLVmEy~~ggsL~~~l~~~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~  199 (604)
                      +|+|||||++ +|.+++. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..... .
T Consensus       105 ~~lv~e~~~~-~l~~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~-~  181 (371)
T 2xrw_A          105 VYIVMELMDA-NLCQVIQ-MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS-F  181 (371)
T ss_dssp             EEEEEECCSE-EHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC---------
T ss_pred             eEEEEEcCCC-CHHHHHh-hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeecccccccc-c
Confidence            5899999975 6777775 46999999999999999999999999999999999999999999999999999765432 2


Q ss_pred             CCcccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCCCCC-----------------
Q psy1546         200 KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPP-----------------  262 (604)
Q Consensus       200 ~~~~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~~~~-----------------  262 (604)
                      .....+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+......                 
T Consensus       182 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~  261 (371)
T 2xrw_A          182 MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYV  261 (371)
T ss_dssp             --------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCHHHHHHH
T ss_pred             ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHHHH
Confidence            334568999999999999999999999999999999999999999988765544433221100                 


Q ss_pred             ----CC--------------------CccchHHHHHHHHHHhccCCCCCCCHHHHhcChhhhhhh
Q psy1546         263 ----QL--------------------TGNYTKQFKEFVEACLNKDPENRPTAKELLKFPFIRKAK  303 (604)
Q Consensus       263 ----~~--------------------~~~~s~~l~~Li~~~L~~dP~~RpT~~elL~hp~f~~~~  303 (604)
                          .+                    ....+.++++||.+||..||.+|||++|+|+||||+...
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~  326 (371)
T 2xrw_A          262 ENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWY  326 (371)
T ss_dssp             HSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTTC
T ss_pred             hhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhhhc
Confidence                00                    011267899999999999999999999999999997653

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=1.1e-43  Score=366.08  Aligned_cols=244  Identities=29%  Similarity=0.475  Sum_probs=208.6

Q ss_pred             ccceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCCe----------EEEEEEe
Q psy1546          57 LIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTK----------LWIIMEY  126 (604)
Q Consensus        57 ~~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~~----------lyLVmEy  126 (604)
                      ..|.+.+.||+|+||.||+|.+..+++.||||++...... ....+.+|+.+++.+.||++.+          +|+||||
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   87 (304)
T 2jam_A            9 KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAF-RDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQL   87 (304)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC-------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             ccceeeeeccCCCCceEEEEEECCCCCEEEEEEEeccccc-chHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEc
Confidence            3599999999999999999999999999999999754322 2356889999999999999655          4799999


Q ss_pred             cCCCChhhHhh-cCCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEe---cCCCCeEEecccccccccCCCCCCc
Q psy1546         127 LGGGSALDLMK-AGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLL---SEMGDVKLADFGVAGTLTNTTSKRN  202 (604)
Q Consensus       127 ~~ggsL~~~l~-~~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl---~~~g~vKL~DFGlA~~~~~~~~~~~  202 (604)
                      +++++|.+++. .+.+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++......  ...
T Consensus        88 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~--~~~  165 (304)
T 2jam_A           88 VSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG--IMS  165 (304)
T ss_dssp             CCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB--TTH
T ss_pred             CCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCCC--ccc
Confidence            99999999875 4779999999999999999999999999999999999999   77889999999999654322  234


Q ss_pred             ccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCCC---CCCCCccchHHHHHHHHHH
Q psy1546         203 TFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNN---PPQLTGNYTKQFKEFVEAC  279 (604)
Q Consensus       203 ~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~~---~~~~~~~~s~~l~~Li~~~  279 (604)
                      ..+||+.|+|||++.+..++.++|||||||++|+|++|..||...........+....   .......++..+.+||.+|
T Consensus       166 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~  245 (304)
T 2jam_A          166 TACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISESAKDFICHL  245 (304)
T ss_dssp             HHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCCTTTTTTSCHHHHHHHHHH
T ss_pred             cccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccccCCHHHHHHHHHH
Confidence            5679999999999999999999999999999999999999999887766655544332   2234467889999999999


Q ss_pred             hccCCCCCCCHHHHhcChhhhhhh
Q psy1546         280 LNKDPENRPTAKELLKFPFIRKAK  303 (604)
Q Consensus       280 L~~dP~~RpT~~elL~hp~f~~~~  303 (604)
                      |..||.+|||+.|+|+||||....
T Consensus       246 l~~dp~~Rps~~~~l~h~~~~~~~  269 (304)
T 2jam_A          246 LEKDPNERYTCEKALSHPWIDGNT  269 (304)
T ss_dssp             HCSSTTTSCCHHHHHTSHHHHSSC
T ss_pred             cCCChhHCcCHHHHhcCccccCCC
Confidence            999999999999999999997643

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=4.3e-44  Score=382.53  Aligned_cols=239  Identities=25%  Similarity=0.387  Sum_probs=199.3

Q ss_pred             cceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCCe------------------
Q psy1546          58 IFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTK------------------  119 (604)
Q Consensus        58 ~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~~------------------  119 (604)
                      .|.+.++||+|+||+||+|.+..+++.||||++....     ....+|+.+|+.++|||+++                  
T Consensus         8 ~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~-----~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~   82 (383)
T 3eb0_A            8 KYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDP-----RYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQP   82 (383)
T ss_dssp             TEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCT-----TSCCHHHHHHTTCCCTTBCCEEEEEEEC----------
T ss_pred             eEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCc-----chHHHHHHHHHHcCCCCccchhheeeecCccccccccc
Confidence            4999999999999999999999999999999986543     22347999999999998654                  


Q ss_pred             ------------------------------EEEEEEecCCCChhhHhh-----cCCCcHHHHHHHHHHHHHHhHHhhhCC
Q psy1546         120 ------------------------------LWIIMEYLGGGSALDLMK-----AGNFEEMHIAVILREVLKGLDYLHSER  164 (604)
Q Consensus       120 ------------------------------lyLVmEy~~ggsL~~~l~-----~~~lse~~i~~i~~qIl~gL~yLHs~g  164 (604)
                                                    +|+|||||+ |+|.+.+.     .+.+++..++.++.||+.||.|||++|
T Consensus        83 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g  161 (383)
T 3eb0_A           83 PDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLG  161 (383)
T ss_dssp             ---------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT
T ss_pred             ccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCc
Confidence                                          569999997 57766654     267999999999999999999999999


Q ss_pred             ccccccccceeEec-CCCCeEEecccccccccCCCCCCcccccCCCCCChHHhhcC-CCCCcchhhhHHHHHHHHHhCCC
Q psy1546         165 KLHRDIKAANVLLS-EMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQS-AYDSKADIWSLGITAIELAKGEP  242 (604)
Q Consensus       165 IiHrDLKp~NILl~-~~g~vKL~DFGlA~~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~~~~sDVwSLGviL~eLltG~~  242 (604)
                      |+||||||+||||+ .++.+||+|||+|+.+... ......+||+.|+|||++.+. .++.++|||||||++|+|++|.+
T Consensus       162 i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~  240 (383)
T 3eb0_A          162 ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPS-EPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKP  240 (383)
T ss_dssp             EECSCCCGGGEEEETTTTEEEECCCTTCEECCTT-SCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSC
T ss_pred             CccCccCHHHEEEcCCCCcEEEEECCCCcccCCC-CCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhCCC
Confidence            99999999999997 6889999999999766433 334456789999999999875 48999999999999999999999


Q ss_pred             CCCCCChhhHhhhcCCC-------------------CC---------CCCCccchHHHHHHHHHHhccCCCCCCCHHHHh
Q psy1546         243 PNSELHPMRVLFLIPKN-------------------NP---------PQLTGNYTKQFKEFVEACLNKDPENRPTAKELL  294 (604)
Q Consensus       243 Pf~~~~~~~~~~~i~~~-------------------~~---------~~~~~~~s~~l~~Li~~~L~~dP~~RpT~~elL  294 (604)
                      ||.+....+....+...                   ..         ..++..++.++.+||.+||..||.+|||+.|+|
T Consensus       241 pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l  320 (383)
T 3eb0_A          241 LFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEAM  320 (383)
T ss_dssp             SSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHH
T ss_pred             CCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCCHHHHh
Confidence            99988766544433110                   00         013445788999999999999999999999999


Q ss_pred             cChhhhhhh
Q psy1546         295 KFPFIRKAK  303 (604)
Q Consensus       295 ~hp~f~~~~  303 (604)
                      +||||+...
T Consensus       321 ~hp~f~~~~  329 (383)
T 3eb0_A          321 AHPFFDHLR  329 (383)
T ss_dssp             TSGGGHHHH
T ss_pred             cCHHHHHHH
Confidence            999997653

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=1.3e-43  Score=391.86  Aligned_cols=244  Identities=31%  Similarity=0.552  Sum_probs=206.2

Q ss_pred             ccceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhh-HHHHHHHHHHHHHHhhCCCCCCCeE----------EEEEE
Q psy1546          57 LIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA-EDEIEDIQQEIMVLSQCDSPYGTKL----------WIIME  125 (604)
Q Consensus        57 ~~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~-~~~~~~l~~Ei~iL~~l~hp~~~~l----------yLVmE  125 (604)
                      ..|.++++||+|+||+||+|++..++..||||++..... ......+.+|+.+|+.+.|||++++          |+|||
T Consensus        37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  116 (494)
T 3lij_A           37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVME  116 (494)
T ss_dssp             HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence            359999999999999999999999999999999975532 2224678899999999999997654          79999


Q ss_pred             ecCCCChhhHhh-cCCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCC---CCeEEecccccccccCCCCCC
Q psy1546         126 YLGGGSALDLMK-AGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEM---GDVKLADFGVAGTLTNTTSKR  201 (604)
Q Consensus       126 y~~ggsL~~~l~-~~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~---g~vKL~DFGlA~~~~~~~~~~  201 (604)
                      ||.+|+|.+++. .+.+++..++.++.||+.||.|||++||+||||||+||||+..   +.+||+|||+|+.+... ...
T Consensus       117 ~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~-~~~  195 (494)
T 3lij_A          117 CYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQ-KKM  195 (494)
T ss_dssp             CCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTT-BCB
T ss_pred             cCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCC-ccc
Confidence            999999988775 4789999999999999999999999999999999999999764   45999999999766533 334


Q ss_pred             cccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCCCCC---CCCccchHHHHHHHHH
Q psy1546         202 NTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPP---QLTGNYTKQFKEFVEA  278 (604)
Q Consensus       202 ~~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~~~~---~~~~~~s~~l~~Li~~  278 (604)
                      ...+||+.|+|||++. ..|+.++|||||||++|+|++|.+||.+....++...+......   .....++..+++||.+
T Consensus       196 ~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~  274 (494)
T 3lij_A          196 KERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGAKDLIKQ  274 (494)
T ss_dssp             CCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSGGGTTSCHHHHHHHHH
T ss_pred             cccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCchhcccCCHHHHHHHHH
Confidence            5678999999999986 46999999999999999999999999998888777666554432   2234678999999999


Q ss_pred             HhccCCCCCCCHHHHhcChhhhhh
Q psy1546         279 CLNKDPENRPTAKELLKFPFIRKA  302 (604)
Q Consensus       279 ~L~~dP~~RpT~~elL~hp~f~~~  302 (604)
                      ||..||.+|||+.|+|+||||++.
T Consensus       275 ~L~~dp~~R~s~~e~l~hp~~~~~  298 (494)
T 3lij_A          275 MLQFDSQRRISAQQALEHPWIKEM  298 (494)
T ss_dssp             HTCSSTTTSCCHHHHHTCHHHHHH
T ss_pred             HCCCChhhCccHHHHhcCcccccC
Confidence            999999999999999999999764

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=1.5e-43  Score=360.22  Aligned_cols=245  Identities=28%  Similarity=0.464  Sum_probs=207.7

Q ss_pred             cceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHH-----HHHHHHHHHHHHhhCCCCCCCe----------EEE
Q psy1546          58 IFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAED-----EIEDIQQEIMVLSQCDSPYGTK----------LWI  122 (604)
Q Consensus        58 ~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~-----~~~~l~~Ei~iL~~l~hp~~~~----------lyL  122 (604)
                      .|.+.+.||+|+||.||+|.+..+++.||||++.......     ..+.+.+|+.+++.+.||++.+          +|+
T Consensus         6 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l   85 (283)
T 3bhy_A            6 HYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVVL   85 (283)
T ss_dssp             HEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             hhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEEE
Confidence            4899999999999999999999999999999986543221     2467899999999999999654          479


Q ss_pred             EEEecCCCChhhHhhc-CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCC----CeEEecccccccccCC
Q psy1546         123 IMEYLGGGSALDLMKA-GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMG----DVKLADFGVAGTLTNT  197 (604)
Q Consensus       123 VmEy~~ggsL~~~l~~-~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g----~vKL~DFGlA~~~~~~  197 (604)
                      ||||+++++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++    .+||+|||++......
T Consensus        86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~~~~  165 (283)
T 3bhy_A           86 ILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAG  165 (283)
T ss_dssp             EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEECC--
T ss_pred             EEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccceeccCC
Confidence            9999999999999864 6799999999999999999999999999999999999998877    7999999999765433


Q ss_pred             CCCCcccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCCCCC---CCCccchHHHHH
Q psy1546         198 TSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPP---QLTGNYTKQFKE  274 (604)
Q Consensus       198 ~~~~~~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~~~~---~~~~~~s~~l~~  274 (604)
                      . ......||+.|+|||++.+..++.++|||||||++|+|++|..||...........+......   .....++..+.+
T Consensus       166 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (283)
T 3bhy_A          166 N-EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSELAKD  244 (283)
T ss_dssp             -------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCHHHHTTCCHHHHH
T ss_pred             C-cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcchhcccCCHHHHH
Confidence            2 234557999999999999999999999999999999999999999988776665554433221   223467889999


Q ss_pred             HHHHHhccCCCCCCCHHHHhcChhhhhhh
Q psy1546         275 FVEACLNKDPENRPTAKELLKFPFIRKAK  303 (604)
Q Consensus       275 Li~~~L~~dP~~RpT~~elL~hp~f~~~~  303 (604)
                      ||.+||..||.+|||+.|+|+||||+...
T Consensus       245 li~~~l~~dp~~Rps~~~~l~h~~~~~~~  273 (283)
T 3bhy_A          245 FIRRLLVKDPKRRMTIAQSLEHSWIKAIR  273 (283)
T ss_dssp             HHHTTSCSSGGGSCCHHHHHHCHHHHHHH
T ss_pred             HHHHHccCCHhHCcCHHHHHhCHHHHHHH
Confidence            99999999999999999999999997654

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=5.2e-44  Score=380.38  Aligned_cols=245  Identities=24%  Similarity=0.417  Sum_probs=213.2

Q ss_pred             ccceeeeEEcccCcEEEEEEE-----ECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCCeE----------E
Q psy1546          57 LIFTKQERIGKGSFGEVFKGI-----DNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTKL----------W  121 (604)
Q Consensus        57 ~~y~i~~~LG~G~fG~Vy~a~-----~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~~l----------y  121 (604)
                      ..|.+.++||+|+||.||+|.     +..+++.||||++...........+.+|+.+++.++|||++++          |
T Consensus        71 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  150 (367)
T 3l9p_A           71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRF  150 (367)
T ss_dssp             GGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred             hHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCE
Confidence            459999999999999999999     4567889999999765555566778899999999999997665          7


Q ss_pred             EEEEecCCCChhhHhhc--------CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCC---CeEEecccc
Q psy1546         122 IIMEYLGGGSALDLMKA--------GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMG---DVKLADFGV  190 (604)
Q Consensus       122 LVmEy~~ggsL~~~l~~--------~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g---~vKL~DFGl  190 (604)
                      +|||||++|+|.+++..        ..+++..++.++.||+.||.|||++||+||||||+||||+.+|   .+||+|||+
T Consensus       151 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~kL~DFG~  230 (367)
T 3l9p_A          151 ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGM  230 (367)
T ss_dssp             EEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECCCHH
T ss_pred             EEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEEECCCcc
Confidence            99999999999999965        2489999999999999999999999999999999999999555   499999999


Q ss_pred             cccccCC--CCCCcccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHhhhcCCCCCCCCCcc
Q psy1546         191 AGTLTNT--TSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAK-GEPPNSELHPMRVLFLIPKNNPPQLTGN  267 (604)
Q Consensus       191 A~~~~~~--~~~~~~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~  267 (604)
                      |+.+...  ........||+.|+|||++.+..++.++|||||||+||||++ |..||...........+........+..
T Consensus       231 a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  310 (367)
T 3l9p_A          231 ARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPKN  310 (367)
T ss_dssp             HHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCCCTT
T ss_pred             ccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCcc
Confidence            9755322  223345678999999999999999999999999999999998 9999999988888887777776777788


Q ss_pred             chHHHHHHHHHHhccCCCCCCCHHHHhcChhhhh
Q psy1546         268 YTKQFKEFVEACLNKDPENRPTAKELLKFPFIRK  301 (604)
Q Consensus       268 ~s~~l~~Li~~~L~~dP~~RpT~~elL~hp~f~~  301 (604)
                      ++..+.+||.+||+.||.+|||+.+|+++.++..
T Consensus       311 ~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~  344 (367)
T 3l9p_A          311 CPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT  344 (367)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence            9999999999999999999999999999877643

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=7.7e-44  Score=368.54  Aligned_cols=246  Identities=26%  Similarity=0.450  Sum_probs=195.8

Q ss_pred             cccceee-eEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhh-CCCCCCCe----------EEEE
Q psy1546          56 ELIFTKQ-ERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQ-CDSPYGTK----------LWII  123 (604)
Q Consensus        56 ~~~y~i~-~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~-l~hp~~~~----------lyLV  123 (604)
                      ...|.+. +.||+|+||.||+|.+..+++.||||++..... .....+.+|+.++.+ +.|||+.+          +|+|
T Consensus        11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv   89 (316)
T 2ac3_A           11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPG-HIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLV   89 (316)
T ss_dssp             TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSS-CCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcc-hhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEE
Confidence            3458885 789999999999999999999999999965432 234678899999988 47999655          4799


Q ss_pred             EEecCCCChhhHhhc-CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCC---eEEecccccccccCCC-
Q psy1546         124 MEYLGGGSALDLMKA-GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGD---VKLADFGVAGTLTNTT-  198 (604)
Q Consensus       124 mEy~~ggsL~~~l~~-~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~---vKL~DFGlA~~~~~~~-  198 (604)
                      ||||++++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.   +||+|||++..+.... 
T Consensus        90 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~  169 (316)
T 2ac3_A           90 FEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGD  169 (316)
T ss_dssp             EECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-------
T ss_pred             EEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCccccccCCc
Confidence            999999999999865 67999999999999999999999999999999999999998776   9999999997553221 


Q ss_pred             ------CCCcccccCCCCCChHHhhc-----CCCCCcchhhhHHHHHHHHHhCCCCCCCCChh---------------hH
Q psy1546         199 ------SKRNTFVGTPFWMAPEVIKQ-----SAYDSKADIWSLGITAIELAKGEPPNSELHPM---------------RV  252 (604)
Q Consensus       199 ------~~~~~~~GT~~Y~APE~l~~-----~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~---------------~~  252 (604)
                            ......+||+.|+|||++.+     ..++.++|||||||++|+|++|..||......               ..
T Consensus       170 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  249 (316)
T 2ac3_A          170 CSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNML  249 (316)
T ss_dssp             ------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHHHH
T ss_pred             cccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHHHH
Confidence                  12234569999999999975     55889999999999999999999999875421               12


Q ss_pred             hhhcCCCCCCCCC----ccchHHHHHHHHHHhccCCCCCCCHHHHhcChhhhhhh
Q psy1546         253 LFLIPKNNPPQLT----GNYTKQFKEFVEACLNKDPENRPTAKELLKFPFIRKAK  303 (604)
Q Consensus       253 ~~~i~~~~~~~~~----~~~s~~l~~Li~~~L~~dP~~RpT~~elL~hp~f~~~~  303 (604)
                      ...+..... .++    ..++..+.+||.+||..||.+|||+.|+|+||||+...
T Consensus       250 ~~~i~~~~~-~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~  303 (316)
T 2ac3_A          250 FESIQEGKY-EFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCA  303 (316)
T ss_dssp             HHHHHHCCC-CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC---
T ss_pred             HHHHhccCc-ccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcCCC
Confidence            222222221 111    35788999999999999999999999999999998654

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=1.3e-43  Score=361.51  Aligned_cols=245  Identities=31%  Similarity=0.531  Sum_probs=189.8

Q ss_pred             ccceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHH-HHHHHHHHHHHhhCCCCCCCe----------EEEEEE
Q psy1546          57 LIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDE-IEDIQQEIMVLSQCDSPYGTK----------LWIIME  125 (604)
Q Consensus        57 ~~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~-~~~l~~Ei~iL~~l~hp~~~~----------lyLVmE  125 (604)
                      ..|++.+.||+|+||.||+|.+..+++.||||++........ ...+.++...++.+.||++.+          +|+|||
T Consensus         7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~e   86 (290)
T 3fme_A            7 DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICME   86 (290)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEEE
T ss_pred             HhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEEe
Confidence            349999999999999999999999999999999976543333 344555666688999999655          479999


Q ss_pred             ecCCCChhhHhh-----cCCCcHHHHHHHHHHHHHHhHHhhhC-CccccccccceeEecCCCCeEEecccccccccCCCC
Q psy1546         126 YLGGGSALDLMK-----AGNFEEMHIAVILREVLKGLDYLHSE-RKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTS  199 (604)
Q Consensus       126 y~~ggsL~~~l~-----~~~lse~~i~~i~~qIl~gL~yLHs~-gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~  199 (604)
                      |++ |+|.+++.     .+.+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||+++...... 
T Consensus        87 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-  164 (290)
T 3fme_A           87 LMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDV-  164 (290)
T ss_dssp             CCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC-----------
T ss_pred             hhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCCcccccccc-
Confidence            997 47777664     25799999999999999999999998 99999999999999999999999999997664332 


Q ss_pred             CCcccccCCCCCChHHh----hcCCCCCcchhhhHHHHHHHHHhCCCCCCCCC-hhh-HhhhcCCCCCCCCCccchHHHH
Q psy1546         200 KRNTFVGTPFWMAPEVI----KQSAYDSKADIWSLGITAIELAKGEPPNSELH-PMR-VLFLIPKNNPPQLTGNYTKQFK  273 (604)
Q Consensus       200 ~~~~~~GT~~Y~APE~l----~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~-~~~-~~~~i~~~~~~~~~~~~s~~l~  273 (604)
                      ......||+.|+|||++    .+..++.++|||||||++|+|++|..||.... ... ....+....+......++.++.
T Consensus       165 ~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (290)
T 3fme_A          165 AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKFSAEFV  244 (290)
T ss_dssp             -----CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCCCCCTTTSCHHHH
T ss_pred             cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCCCcccccCCHHHH
Confidence            23345799999999997    56678899999999999999999999998632 222 2222333333334457899999


Q ss_pred             HHHHHHhccCCCCCCCHHHHhcChhhhhhh
Q psy1546         274 EFVEACLNKDPENRPTAKELLKFPFIRKAK  303 (604)
Q Consensus       274 ~Li~~~L~~dP~~RpT~~elL~hp~f~~~~  303 (604)
                      +||.+||..||.+|||+.|+++||||+...
T Consensus       245 ~li~~~l~~~p~~Rpt~~e~l~hp~f~~~~  274 (290)
T 3fme_A          245 DFTSQCLKKNSKERPTYPELMQHPFFTLHE  274 (290)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHTTSHHHHHHH
T ss_pred             HHHHHHhhcChhhCcCHHHHHhCcccccCc
Confidence            999999999999999999999999997654

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=1.2e-43  Score=372.75  Aligned_cols=246  Identities=25%  Similarity=0.381  Sum_probs=205.9

Q ss_pred             ccceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCC---------------eEE
Q psy1546          57 LIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGT---------------KLW  121 (604)
Q Consensus        57 ~~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~---------------~ly  121 (604)
                      ..|.+.+.||+|+||.||+|.+..+++.||||++...........+.+|+.+++.+.||++.               .+|
T Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   90 (353)
T 2b9h_A           11 SDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVY   90 (353)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCEE
T ss_pred             cceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceEE
Confidence            45999999999999999999999999999999997655555567788999999999999854               358


Q ss_pred             EEEEecCCCChhhHhhcCCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCC--
Q psy1546         122 IIMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTS--  199 (604)
Q Consensus       122 LVmEy~~ggsL~~~l~~~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~--  199 (604)
                      +||||+. ++|.+++..+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+.....  
T Consensus        91 lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~  169 (353)
T 2b9h_A           91 IIQELMQ-TDLHRVISTQMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADN  169 (353)
T ss_dssp             EEECCCS-EEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECC------
T ss_pred             EEEeccC-ccHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEecccccccccccccc
Confidence            9999996 6899999888999999999999999999999999999999999999999999999999999976643221  


Q ss_pred             --------CCcccccCCCCCChHHhhc-CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCC------------
Q psy1546         200 --------KRNTFVGTPFWMAPEVIKQ-SAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPK------------  258 (604)
Q Consensus       200 --------~~~~~~GT~~Y~APE~l~~-~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~------------  258 (604)
                              .....+||+.|+|||++.+ ..++.++|||||||+||+|++|.+||.+.........+..            
T Consensus       170 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (353)
T 2b9h_A          170 SEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLR  249 (353)
T ss_dssp             ----------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCSTTTTT
T ss_pred             cCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCchhcccc
Confidence                    1234578999999999865 6789999999999999999999999988765443322100            


Q ss_pred             ----------------CCC---CCCCccchHHHHHHHHHHhccCCCCCCCHHHHhcChhhhhhh
Q psy1546         259 ----------------NNP---PQLTGNYTKQFKEFVEACLNKDPENRPTAKELLKFPFIRKAK  303 (604)
Q Consensus       259 ----------------~~~---~~~~~~~s~~l~~Li~~~L~~dP~~RpT~~elL~hp~f~~~~  303 (604)
                                      ...   ......++.++.+||.+||..||.+|||+.|||+||||+...
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~  313 (353)
T 2b9h_A          250 CIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYH  313 (353)
T ss_dssp             TCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred             ccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccC
Confidence                            000   011236788999999999999999999999999999997653

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=8.2e-44  Score=369.90  Aligned_cols=241  Identities=23%  Similarity=0.378  Sum_probs=201.6

Q ss_pred             ccceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCCe------------EEEEE
Q psy1546          57 LIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTK------------LWIIM  124 (604)
Q Consensus        57 ~~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~~------------lyLVm  124 (604)
                      ..|.+.++||+|+||+||+|.+..+++.||||++.........+.+.+|+.+++.+.||++.+            +||||
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   88 (319)
T 4euu_A            9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM   88 (319)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred             CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEE
Confidence            459999999999999999999999999999999976655555677889999999999998654            47999


Q ss_pred             EecCCCChhhHhhcC----CCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEe----cCCCCeEEecccccccccC
Q psy1546         125 EYLGGGSALDLMKAG----NFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLL----SEMGDVKLADFGVAGTLTN  196 (604)
Q Consensus       125 Ey~~ggsL~~~l~~~----~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl----~~~g~vKL~DFGlA~~~~~  196 (604)
                      ||+++++|.+++...    .+++..++.++.||+.||.|||++||+||||||+||||    +..+.+||+|||+++.+..
T Consensus        89 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~~~  168 (319)
T 4euu_A           89 EFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELED  168 (319)
T ss_dssp             ECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTTCEECCT
T ss_pred             eCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCCceecCC
Confidence            999999999999653    29999999999999999999999999999999999999    7778899999999976654


Q ss_pred             CCCCCcccccCCCCCChHHhh--------cCCCCCcchhhhHHHHHHHHHhCCCCCCCCCh----hhHhhhcCCCC----
Q psy1546         197 TTSKRNTFVGTPFWMAPEVIK--------QSAYDSKADIWSLGITAIELAKGEPPNSELHP----MRVLFLIPKNN----  260 (604)
Q Consensus       197 ~~~~~~~~~GT~~Y~APE~l~--------~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~----~~~~~~i~~~~----  260 (604)
                      .. .....+||+.|+|||++.        +..++.++|||||||++|||++|..||.....    ......+....    
T Consensus       169 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~p~~~  247 (319)
T 4euu_A          169 DE-QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGA  247 (319)
T ss_dssp             TC-CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHCCTTC
T ss_pred             CC-ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCCCccc
Confidence            33 334567999999999997        57789999999999999999999999964332    12221111111    


Q ss_pred             --------------------CCCCCccchHHHHHHHHHHhccCCCCCCCHHHHhcChh
Q psy1546         261 --------------------PPQLTGNYTKQFKEFVEACLNKDPENRPTAKELLKFPF  298 (604)
Q Consensus       261 --------------------~~~~~~~~s~~l~~Li~~~L~~dP~~RpT~~elL~hp~  298 (604)
                                          ...+...++..+.+||.+||..||.+|||++|+|+||-
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~  305 (319)
T 4euu_A          248 ISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETS  305 (319)
T ss_dssp             CEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHH
T ss_pred             chhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccH
Confidence                                11234456788999999999999999999999999974

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=1.4e-43  Score=367.75  Aligned_cols=240  Identities=29%  Similarity=0.425  Sum_probs=192.2

Q ss_pred             ccceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhh-HHHHHHHHHHHHHH-hhCCCCCCCe----------EEEEE
Q psy1546          57 LIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA-EDEIEDIQQEIMVL-SQCDSPYGTK----------LWIIM  124 (604)
Q Consensus        57 ~~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~-~~~~~~l~~Ei~iL-~~l~hp~~~~----------lyLVm  124 (604)
                      ..|.+.++||+|+||+||+|.+..+++.||||++..... .........|+..+ +...|+++.+          +||||
T Consensus        57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~  136 (311)
T 3p1a_A           57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT  136 (311)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence            349999999999999999999999999999999854322 22233444455444 4459998665          47999


Q ss_pred             EecCCCChhhHhhc--CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCCCCc
Q psy1546         125 EYLGGGSALDLMKA--GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRN  202 (604)
Q Consensus       125 Ey~~ggsL~~~l~~--~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~~~  202 (604)
                      ||+ +++|.+++..  ..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++...... ....
T Consensus       137 e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~-~~~~  214 (311)
T 3p1a_A          137 ELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTA-GAGE  214 (311)
T ss_dssp             ECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEECC-------
T ss_pred             ecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeeecccC-CCCc
Confidence            999 6688887754  46999999999999999999999999999999999999999999999999999766433 2334


Q ss_pred             ccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCCCCCCCCccchHHHHHHHHHHhcc
Q psy1546         203 TFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNK  282 (604)
Q Consensus       203 ~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~~L~~  282 (604)
                      ...||+.|+|||++.+ .++.++|||||||++|||++|..|+..........  ....++.++..+++++.+||.+||..
T Consensus       215 ~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~l~~li~~~L~~  291 (311)
T 3p1a_A          215 VQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEGWQQLR--QGYLPPEFTAGLSSELRSVLVMMLEP  291 (311)
T ss_dssp             CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHHHHHHT--TTCCCHHHHTTSCHHHHHHHHHHSCS
T ss_pred             ccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHh--ccCCCcccccCCCHHHHHHHHHHcCC
Confidence            5679999999999876 79999999999999999999977665543322221  11122334456789999999999999


Q ss_pred             CCCCCCCHHHHhcChhhhh
Q psy1546         283 DPENRPTAKELLKFPFIRK  301 (604)
Q Consensus       283 dP~~RpT~~elL~hp~f~~  301 (604)
                      ||.+|||+.|||+||||++
T Consensus       292 dP~~Rpt~~ell~hp~~~~  310 (311)
T 3p1a_A          292 DPKLRATAEALLALPVLRQ  310 (311)
T ss_dssp             STTTSCCHHHHHTSGGGSC
T ss_pred             ChhhCcCHHHHHhCccccC
Confidence            9999999999999999964

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=2.3e-43  Score=378.77  Aligned_cols=243  Identities=27%  Similarity=0.503  Sum_probs=198.5

Q ss_pred             ccceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhh-HHHHHHHHHHHHHHhhCCC--CCCCe----------EEEE
Q psy1546          57 LIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA-EDEIEDIQQEIMVLSQCDS--PYGTK----------LWII  123 (604)
Q Consensus        57 ~~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~-~~~~~~l~~Ei~iL~~l~h--p~~~~----------lyLV  123 (604)
                      ..|.+.++||+|+||.||+|.+.. ++.||||++..... ....+.+.+|+.+|..+.|  |++++          +|||
T Consensus        56 ~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv  134 (390)
T 2zmd_A           56 RIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV  134 (390)
T ss_dssp             EEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEE
Confidence            349999999999999999999865 89999999976543 3456788999999999975  77554          4799


Q ss_pred             EEecCCCChhhHhhc-CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCC--C
Q psy1546         124 MEYLGGGSALDLMKA-GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTS--K  200 (604)
Q Consensus       124 mEy~~ggsL~~~l~~-~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~--~  200 (604)
                      || +.+++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+||||+ ++.+||+|||+++.+.....  .
T Consensus       135 ~E-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~~~~  212 (390)
T 2zmd_A          135 ME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVV  212 (390)
T ss_dssp             EE-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC--------
T ss_pred             Ee-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCccccccCCCcccc
Confidence            99 568899998865 5789999999999999999999999999999999999996 58999999999977643322  2


Q ss_pred             CcccccCCCCCChHHhhc-----------CCCCCcchhhhHHHHHHHHHhCCCCCCCCChh-hHhh-hcCCCCCCCCCcc
Q psy1546         201 RNTFVGTPFWMAPEVIKQ-----------SAYDSKADIWSLGITAIELAKGEPPNSELHPM-RVLF-LIPKNNPPQLTGN  267 (604)
Q Consensus       201 ~~~~~GT~~Y~APE~l~~-----------~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~-~~~~-~i~~~~~~~~~~~  267 (604)
                      ....+||+.|+|||++.+           ..|+.++|||||||+||||++|..||...... .... .+.......++..
T Consensus       213 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  292 (390)
T 2zmd_A          213 KDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDI  292 (390)
T ss_dssp             -CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCTTSCCCCCCC
T ss_pred             CCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCccccCCCCcc
Confidence            345689999999999975           46889999999999999999999999875432 2222 2222333445566


Q ss_pred             chHHHHHHHHHHhccCCCCCCCHHHHhcChhhhhh
Q psy1546         268 YTKQFKEFVEACLNKDPENRPTAKELLKFPFIRKA  302 (604)
Q Consensus       268 ~s~~l~~Li~~~L~~dP~~RpT~~elL~hp~f~~~  302 (604)
                      .+.++.+||.+||..||.+|||+.|||+||||+..
T Consensus       293 ~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~  327 (390)
T 2zmd_A          293 PEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ  327 (390)
T ss_dssp             SCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSC
T ss_pred             chHHHHHHHHHHcccChhhCCCHHHHhhCcCcccc
Confidence            78899999999999999999999999999999754

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=1.7e-43  Score=358.60  Aligned_cols=244  Identities=29%  Similarity=0.485  Sum_probs=202.5

Q ss_pred             cceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhH--HHHHHHHHHHHHHhhCCCCCCCe----------EEEEEE
Q psy1546          58 IFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAE--DEIEDIQQEIMVLSQCDSPYGTK----------LWIIME  125 (604)
Q Consensus        58 ~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~--~~~~~l~~Ei~iL~~l~hp~~~~----------lyLVmE  125 (604)
                      .|.+.+.||+|+||.||+|.+..+++.||||++......  ...+.+.+|+.+++.+.||++.+          +|+|||
T Consensus        12 ~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   91 (276)
T 2h6d_A           12 HYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVME   91 (276)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             cEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEEe
Confidence            399999999999999999999999999999999654322  23567889999999999999655          479999


Q ss_pred             ecCCCChhhHhhc-CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCCCCccc
Q psy1546         126 YLGGGSALDLMKA-GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTF  204 (604)
Q Consensus       126 y~~ggsL~~~l~~-~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~~~~~  204 (604)
                      |+++++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... ......
T Consensus        92 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~-~~~~~~  170 (276)
T 2h6d_A           92 YVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG-EFLRTS  170 (276)
T ss_dssp             CCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC--------
T ss_pred             ccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeecccccccCCC-cceecc
Confidence            9999999999864 67999999999999999999999999999999999999999999999999999765432 223456


Q ss_pred             ccCCCCCChHHhhcCCC-CCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCCCCCCCCccchHHHHHHHHHHhccC
Q psy1546         205 VGTPFWMAPEVIKQSAY-DSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKD  283 (604)
Q Consensus       205 ~GT~~Y~APE~l~~~~~-~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~~L~~d  283 (604)
                      .||+.|+|||++.+..+ +.++||||||+++|+|++|..||...........+.... ..++..++..+.+||.+||..|
T Consensus       171 ~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~~  249 (276)
T 2h6d_A          171 CGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGV-FYIPEYLNRSVATLLMHMLQVD  249 (276)
T ss_dssp             ------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-CCCCTTSCHHHHHHHHHHTCSS
T ss_pred             cCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCc-ccCchhcCHHHHHHHHHHccCC
Confidence            79999999999988766 588999999999999999999999877766655543332 2345678899999999999999


Q ss_pred             CCCCCCHHHHhcChhhhhhh
Q psy1546         284 PENRPTAKELLKFPFIRKAK  303 (604)
Q Consensus       284 P~~RpT~~elL~hp~f~~~~  303 (604)
                      |.+|||+.||++||||++..
T Consensus       250 p~~Rps~~~~l~h~~~~~~~  269 (276)
T 2h6d_A          250 PLKRATIKDIREHEWFKQDL  269 (276)
T ss_dssp             GGGSCCHHHHHHSHHHHTTC
T ss_pred             hhhCCCHHHHHhChhhccCc
Confidence            99999999999999997643

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=1.3e-43  Score=365.87  Aligned_cols=246  Identities=27%  Similarity=0.459  Sum_probs=201.0

Q ss_pred             ccceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCCeE----------------
Q psy1546          57 LIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTKL----------------  120 (604)
Q Consensus        57 ~~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~~l----------------  120 (604)
                      ..|.+.+.||+|+||.||+|.+..+++.||||++.... ....+.+.+|+.+++.+.||++.++                
T Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   89 (320)
T 2i6l_A           11 SRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTD-PQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG   89 (320)
T ss_dssp             TTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCS-HHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred             CceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCC-hHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence            45999999999999999999999999999999986543 3445788999999999999986544                


Q ss_pred             --------EEEEEecCCCChhhHhhcCCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEec-CCCCeEEeccccc
Q psy1546         121 --------WIIMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLS-EMGDVKLADFGVA  191 (604)
Q Consensus       121 --------yLVmEy~~ggsL~~~l~~~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~-~~g~vKL~DFGlA  191 (604)
                              |+||||++ |+|.+++..+.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++
T Consensus        90 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~Dfg~~  168 (320)
T 2i6l_A           90 SLTELNSVYIVQEYME-TDLANVLEQGPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLA  168 (320)
T ss_dssp             -CCSCSEEEEEEECCS-EEHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEEEECCCTTC
T ss_pred             cccccCceeEEeeccC-CCHHHHhhcCCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeEEEccCccc
Confidence                    69999997 6999999999999999999999999999999999999999999999997 5679999999999


Q ss_pred             ccccCCC---CCCcccccCCCCCChHHhhc-CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCCCC------
Q psy1546         192 GTLTNTT---SKRNTFVGTPFWMAPEVIKQ-SAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNP------  261 (604)
Q Consensus       192 ~~~~~~~---~~~~~~~GT~~Y~APE~l~~-~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~~~------  261 (604)
                      +......   .......+|+.|+|||++.+ ..++.++|||||||++|+|++|..||...........+....+      
T Consensus       169 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  248 (320)
T 2i6l_A          169 RIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEED  248 (320)
T ss_dssp             BCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCCCCHHH
T ss_pred             cccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCchhh
Confidence            7654321   22344568999999999876 6789999999999999999999999998776544433211100      


Q ss_pred             -----------------------CCCCccchHHHHHHHHHHhccCCCCCCCHHHHhcChhhhhhhh
Q psy1546         262 -----------------------PQLTGNYTKQFKEFVEACLNKDPENRPTAKELLKFPFIRKAKK  304 (604)
Q Consensus       262 -----------------------~~~~~~~s~~l~~Li~~~L~~dP~~RpT~~elL~hp~f~~~~~  304 (604)
                                             ..+...++.++.+||.+||..||.+|||+.|+|+||||+....
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~  314 (320)
T 2i6l_A          249 RQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIYSF  314 (320)
T ss_dssp             HHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTTCC
T ss_pred             hhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcccccccC
Confidence                                   0122457899999999999999999999999999999986544

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=7.1e-44  Score=386.39  Aligned_cols=240  Identities=25%  Similarity=0.388  Sum_probs=197.8

Q ss_pred             ccceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCCe----------------E
Q psy1546          57 LIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTK----------------L  120 (604)
Q Consensus        57 ~~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~~----------------l  120 (604)
                      ..|.+.++||+|+||.||+|++..+++.||||++....     ....+|+.+|+.++|||+++                +
T Consensus        54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~  128 (420)
T 1j1b_A           54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL  128 (420)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT-----TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEE
T ss_pred             ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc-----hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeE
Confidence            35999999999999999999999999999999986542     22347999999999999765                3


Q ss_pred             EEEEEecCCCChhhHhh-----cCCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCC-CCeEEecccccccc
Q psy1546         121 WIIMEYLGGGSALDLMK-----AGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEM-GDVKLADFGVAGTL  194 (604)
Q Consensus       121 yLVmEy~~ggsL~~~l~-----~~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~-g~vKL~DFGlA~~~  194 (604)
                      ++||||+++ +|.+++.     ...+++..++.++.||+.||.|||++||+||||||+||||+.+ +.+||+|||+|+.+
T Consensus       129 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~  207 (420)
T 1j1b_A          129 NLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL  207 (420)
T ss_dssp             EEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred             Eeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchhhhhc
Confidence            589999975 5555543     3679999999999999999999999999999999999999965 56899999999866


Q ss_pred             cCCCCCCcccccCCCCCChHHhhcC-CCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCC---------------
Q psy1546         195 TNTTSKRNTFVGTPFWMAPEVIKQS-AYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPK---------------  258 (604)
Q Consensus       195 ~~~~~~~~~~~GT~~Y~APE~l~~~-~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~---------------  258 (604)
                      .... .....+||+.|+|||++.+. .|+.++|||||||+||||++|.+||.+....+.+..+..               
T Consensus       208 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~~~  286 (420)
T 1j1b_A          208 VRGE-PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNP  286 (420)
T ss_dssp             CTTC-CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHHCS
T ss_pred             ccCC-CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhCh
Confidence            4332 33456899999999999765 799999999999999999999999998776544332211               


Q ss_pred             ----CCCCC---------CCccchHHHHHHHHHHhccCCCCCCCHHHHhcChhhhhhh
Q psy1546         259 ----NNPPQ---------LTGNYTKQFKEFVEACLNKDPENRPTAKELLKFPFIRKAK  303 (604)
Q Consensus       259 ----~~~~~---------~~~~~s~~l~~Li~~~L~~dP~~RpT~~elL~hp~f~~~~  303 (604)
                          ...+.         +...++.++.+||.+||..||.+|||+.|+|+||||....
T Consensus       287 ~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~~  344 (420)
T 1j1b_A          287 NYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR  344 (420)
T ss_dssp             CCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGG
T ss_pred             hhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhcccc
Confidence                00111         2245688999999999999999999999999999997543

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=2e-43  Score=369.08  Aligned_cols=246  Identities=26%  Similarity=0.486  Sum_probs=206.0

Q ss_pred             cceee-eEEcccCcEEEEEEEECCCCcEEEEEEecchhhH-HHHHHHHHHHHHHhhCC-CCCCCe----------EEEEE
Q psy1546          58 IFTKQ-ERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAE-DEIEDIQQEIMVLSQCD-SPYGTK----------LWIIM  124 (604)
Q Consensus        58 ~y~i~-~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~-~~~~~l~~Ei~iL~~l~-hp~~~~----------lyLVm  124 (604)
                      .|.+. +.||+|+||.||+|.+..+++.||||++...... .....+.+|+.++..+. ||++.+          +|+||
T Consensus        29 ~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~lv~  108 (327)
T 3lm5_A           29 FYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILIL  108 (327)
T ss_dssp             HEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             EEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEEEE
Confidence            47776 8999999999999999999999999998654322 23467889999999985 587554          47999


Q ss_pred             EecCCCChhhHhhc---CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecC---CCCeEEecccccccccCCC
Q psy1546         125 EYLGGGSALDLMKA---GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSE---MGDVKLADFGVAGTLTNTT  198 (604)
Q Consensus       125 Ey~~ggsL~~~l~~---~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~---~g~vKL~DFGlA~~~~~~~  198 (604)
                      |||.+|+|.+++..   +.+++..++.++.||+.||.|||++||+||||||+||||+.   ++.+||+|||+++.+... 
T Consensus       109 e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~-  187 (327)
T 3lm5_A          109 EYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHA-  187 (327)
T ss_dssp             ECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC----
T ss_pred             EecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCccccccCCc-
Confidence            99999999999854   67999999999999999999999999999999999999987   789999999999766433 


Q ss_pred             CCCcccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCC---CCCCCCCccchHHHHHH
Q psy1546         199 SKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPK---NNPPQLTGNYTKQFKEF  275 (604)
Q Consensus       199 ~~~~~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~---~~~~~~~~~~s~~l~~L  275 (604)
                      ......+||+.|+|||++.+..++.++|||||||+||+|++|..||...........+..   .........++..+.+|
T Consensus       188 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~l  267 (327)
T 3lm5_A          188 CELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSSVSQLATDF  267 (327)
T ss_dssp             ------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHHH
T ss_pred             cccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCchhhcccCHHHHHH
Confidence            223456899999999999999999999999999999999999999998877665544332   22334446789999999


Q ss_pred             HHHHhccCCCCCCCHHHHhcChhhhhhhh
Q psy1546         276 VEACLNKDPENRPTAKELLKFPFIRKAKK  304 (604)
Q Consensus       276 i~~~L~~dP~~RpT~~elL~hp~f~~~~~  304 (604)
                      |.+||..||.+|||++|||+||||+....
T Consensus       268 i~~~L~~dP~~Rpt~~~ll~h~~~~~~~~  296 (327)
T 3lm5_A          268 IQSLLVKNPEKRPTAEICLSHSWLQQWDF  296 (327)
T ss_dssp             HHHHSCSSGGGSCCHHHHTTCGGGCCCCT
T ss_pred             HHHHcCCChhhCcCHHHHhCCHhhccccc
Confidence            99999999999999999999999976543

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=1.9e-43  Score=367.56  Aligned_cols=247  Identities=30%  Similarity=0.489  Sum_probs=201.1

Q ss_pred             ccceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhh-------HHHHHHHHHHHHHHhhCCCCCCCe---------E
Q psy1546          57 LIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA-------EDEIEDIQQEIMVLSQCDSPYGTK---------L  120 (604)
Q Consensus        57 ~~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~-------~~~~~~l~~Ei~iL~~l~hp~~~~---------l  120 (604)
                      ..|.+.+.||+|+||.||+|.+..+++.||||++.....       ......+.+|+.+|+.+.||++.+         +
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~   89 (322)
T 2ycf_A           10 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAEDY   89 (322)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSSE
T ss_pred             hceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCce
Confidence            349999999999999999999999999999999865432       122345789999999999999665         4


Q ss_pred             EEEEEecCCCChhhHhhc-CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCC---eEEecccccccccC
Q psy1546         121 WIIMEYLGGGSALDLMKA-GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGD---VKLADFGVAGTLTN  196 (604)
Q Consensus       121 yLVmEy~~ggsL~~~l~~-~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~---vKL~DFGlA~~~~~  196 (604)
                      |+||||+++++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+||||+.++.   +||+|||+++....
T Consensus        90 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~  169 (322)
T 2ycf_A           90 YIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE  169 (322)
T ss_dssp             EEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTCEECCC
T ss_pred             EEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCccceeccc
Confidence            799999999999998754 67999999999999999999999999999999999999987664   99999999976543


Q ss_pred             CCCCCcccccCCCCCChHHhh---cCCCCCcchhhhHHHHHHHHHhCCCCCCCCChh-hHhhhcCCCCCC---CCCccch
Q psy1546         197 TTSKRNTFVGTPFWMAPEVIK---QSAYDSKADIWSLGITAIELAKGEPPNSELHPM-RVLFLIPKNNPP---QLTGNYT  269 (604)
Q Consensus       197 ~~~~~~~~~GT~~Y~APE~l~---~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~-~~~~~i~~~~~~---~~~~~~s  269 (604)
                      . .......||+.|+|||++.   ...++.++|||||||++|+|++|..||...... .....+......   .....++
T Consensus       170 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (322)
T 2ycf_A          170 T-SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVS  248 (322)
T ss_dssp             C-HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCCCCHHHHTTSC
T ss_pred             c-cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCccccCchhhhhcC
Confidence            2 2223467999999999985   466889999999999999999999999765432 222222222221   2234578


Q ss_pred             HHHHHHHHHHhccCCCCCCCHHHHhcChhhhhhhh
Q psy1546         270 KQFKEFVEACLNKDPENRPTAKELLKFPFIRKAKK  304 (604)
Q Consensus       270 ~~l~~Li~~~L~~dP~~RpT~~elL~hp~f~~~~~  304 (604)
                      ..+.+||.+||..||.+|||+.++|+||||.....
T Consensus       249 ~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~~~~  283 (322)
T 2ycf_A          249 EKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDM  283 (322)
T ss_dssp             HHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCCHHH
T ss_pred             HHHHHHHHHHcccCHhhCCCHHHHhhCcCcCCHHH
Confidence            89999999999999999999999999999976543

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=2.6e-43  Score=368.48  Aligned_cols=239  Identities=27%  Similarity=0.414  Sum_probs=209.2

Q ss_pred             ccceeeeEEcccCcEEEEEEEECCCCc---EEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCCeE----------EEE
Q psy1546          57 LIFTKQERIGKGSFGEVFKGIDNRTQQ---VVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTKL----------WII  123 (604)
Q Consensus        57 ~~y~i~~~LG~G~fG~Vy~a~~~~t~~---~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~~l----------yLV  123 (604)
                      ..|.+.+.||+|+||.||+|.+..+++   .||||++.........+.+.+|+.+++.++|||+.++          |||
T Consensus        49 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  128 (325)
T 3kul_A           49 SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIV  128 (325)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEEE
T ss_pred             hHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEEE
Confidence            459999999999999999999986554   5999999766556666889999999999999997765          699


Q ss_pred             EEecCCCChhhHhhc--CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCCC-
Q psy1546         124 MEYLGGGSALDLMKA--GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSK-  200 (604)
Q Consensus       124 mEy~~ggsL~~~l~~--~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~-  200 (604)
                      |||+++++|.++++.  +.+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.+...... 
T Consensus       129 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~  208 (325)
T 3kul_A          129 TEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAA  208 (325)
T ss_dssp             EECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSSCEECC----CC
T ss_pred             eeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCcccccccCccce
Confidence            999999999999954  57999999999999999999999999999999999999999999999999999776543222 


Q ss_pred             --CcccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHhhhcCCCCCCCCCccchHHHHHHHH
Q psy1546         201 --RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAK-GEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVE  277 (604)
Q Consensus       201 --~~~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~  277 (604)
                        .....+|+.|+|||++.+..++.++|||||||+||+|++ |..||...........+........+..++..+.+||.
T Consensus       209 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  288 (325)
T 3kul_A          209 YTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLPAPMGCPHALHQLML  288 (325)
T ss_dssp             EECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHH
T ss_pred             eeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCCCCCCCCcCHHHHHHHH
Confidence              223346788999999999999999999999999999999 99999999888888777777666777889999999999


Q ss_pred             HHhccCCCCCCCHHHHhc
Q psy1546         278 ACLNKDPENRPTAKELLK  295 (604)
Q Consensus       278 ~~L~~dP~~RpT~~elL~  295 (604)
                      +||..||.+|||+.+|++
T Consensus       289 ~~l~~dp~~Rps~~eil~  306 (325)
T 3kul_A          289 DCWHKDRAQRPRFSQIVS  306 (325)
T ss_dssp             HHTCSSGGGSCCHHHHHH
T ss_pred             HHccCChhhCcCHHHHHH
Confidence            999999999999999987

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=7.4e-44  Score=375.12  Aligned_cols=248  Identities=27%  Similarity=0.419  Sum_probs=202.1

Q ss_pred             ccceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhH-HHHHHHHHHHHHHhhCCCCCCCe----------------
Q psy1546          57 LIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAE-DEIEDIQQEIMVLSQCDSPYGTK----------------  119 (604)
Q Consensus        57 ~~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~-~~~~~l~~Ei~iL~~l~hp~~~~----------------  119 (604)
                      ..|.+.++||+|+||.||+|.+..+++.||||++...... .....+.+|+.+++.+.||++.+                
T Consensus        17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   96 (351)
T 3mi9_A           17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK   96 (351)
T ss_dssp             GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------
T ss_pred             cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCC
Confidence            3499999999999999999999999999999998654322 22356779999999999998543                


Q ss_pred             --EEEEEEecCCCChhhHhhc--CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEeccccccccc
Q psy1546         120 --LWIIMEYLGGGSALDLMKA--GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLT  195 (604)
Q Consensus       120 --lyLVmEy~~ggsL~~~l~~--~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~  195 (604)
                        +|+|||||++ +|.+.+..  +.+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+|+.+.
T Consensus        97 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~  175 (351)
T 3mi9_A           97 GSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFS  175 (351)
T ss_dssp             CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred             ceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccchhccccc
Confidence              5799999975 66666644  579999999999999999999999999999999999999999999999999997654


Q ss_pred             CC----CCCCcccccCCCCCChHHhhc-CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCC---CCCCCCCcc
Q psy1546         196 NT----TSKRNTFVGTPFWMAPEVIKQ-SAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPK---NNPPQLTGN  267 (604)
Q Consensus       196 ~~----~~~~~~~~GT~~Y~APE~l~~-~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~---~~~~~~~~~  267 (604)
                      ..    .......+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.........+..   ...+.....
T Consensus       176 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  255 (351)
T 3mi9_A          176 LAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPN  255 (351)
T ss_dssp             CCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTT
T ss_pred             ccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhccc
Confidence            22    222345678999999999976 4589999999999999999999999998776554433211   111111111


Q ss_pred             ----------------------------chHHHHHHHHHHhccCCCCCCCHHHHhcChhhhhhhhh
Q psy1546         268 ----------------------------YTKQFKEFVEACLNKDPENRPTAKELLKFPFIRKAKKN  305 (604)
Q Consensus       268 ----------------------------~s~~l~~Li~~~L~~dP~~RpT~~elL~hp~f~~~~~~  305 (604)
                                                  .++.+.+||.+||..||.+|||+.|+|+||||......
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~  321 (351)
T 3mi9_A          256 VDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPMP  321 (351)
T ss_dssp             GGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSSSCC
T ss_pred             cccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCCCCc
Confidence                                        25679999999999999999999999999999765443

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=1.7e-43  Score=369.72  Aligned_cols=240  Identities=25%  Similarity=0.446  Sum_probs=211.6

Q ss_pred             ccceeeeEEcccCcEEEEEEEEC-----CCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCCeE----------E
Q psy1546          57 LIFTKQERIGKGSFGEVFKGIDN-----RTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTKL----------W  121 (604)
Q Consensus        57 ~~y~i~~~LG~G~fG~Vy~a~~~-----~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~~l----------y  121 (604)
                      ..|.+.+.||+|+||.||+|.+.     .+++.||||++.........+.+.+|+.+++.+.|||+.++          |
T Consensus        47 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~  126 (343)
T 1luf_A           47 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMC  126 (343)
T ss_dssp             GGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCE
T ss_pred             HHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCceE
Confidence            45999999999999999999987     45589999999876656667889999999999999997664          7


Q ss_pred             EEEEecCCCChhhHhhc-------------------------CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeE
Q psy1546         122 IIMEYLGGGSALDLMKA-------------------------GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVL  176 (604)
Q Consensus       122 LVmEy~~ggsL~~~l~~-------------------------~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NIL  176 (604)
                      +||||+++|+|.+++..                         ..+++..++.++.||+.||.|||++||+||||||+|||
T Consensus       127 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl  206 (343)
T 1luf_A          127 LLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCL  206 (343)
T ss_dssp             EEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred             EEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEE
Confidence            99999999999999865                         56899999999999999999999999999999999999


Q ss_pred             ecCCCCeEEecccccccccCCC--CCCcccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHh
Q psy1546         177 LSEMGDVKLADFGVAGTLTNTT--SKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAK-GEPPNSELHPMRVL  253 (604)
Q Consensus       177 l~~~g~vKL~DFGlA~~~~~~~--~~~~~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLlt-G~~Pf~~~~~~~~~  253 (604)
                      |+.++.+||+|||+++.+....  .......||+.|+|||++.+..++.++|||||||++|+|++ |..||.+.......
T Consensus       207 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~  286 (343)
T 1luf_A          207 VGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVI  286 (343)
T ss_dssp             ECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHH
T ss_pred             ECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCCChHHHH
Confidence            9999999999999997654322  22334568999999999999999999999999999999999 99999998888887


Q ss_pred             hhcCCCCCCCCCccchHHHHHHHHHHhccCCCCCCCHHHHhcC
Q psy1546         254 FLIPKNNPPQLTGNYTKQFKEFVEACLNKDPENRPTAKELLKF  296 (604)
Q Consensus       254 ~~i~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~RpT~~elL~h  296 (604)
                      ..+.......++..++..+.+||.+||..||.+|||+.+|+++
T Consensus       287 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~  329 (343)
T 1luf_A          287 YYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRI  329 (343)
T ss_dssp             HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHhCCCcCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHH
Confidence            7777777667778899999999999999999999999999873

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=5.7e-43  Score=358.62  Aligned_cols=246  Identities=28%  Similarity=0.465  Sum_probs=210.1

Q ss_pred             ccceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchh--------hHHHHHHHHHHHHHHhhCC-CCCCCe--------
Q psy1546          57 LIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE--------AEDEIEDIQQEIMVLSQCD-SPYGTK--------  119 (604)
Q Consensus        57 ~~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~--------~~~~~~~l~~Ei~iL~~l~-hp~~~~--------  119 (604)
                      ..|.+.+.||+|+||.||+|.+..+++.||||++....        .....+.+.+|+.+++++. ||++.+        
T Consensus        17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~   96 (298)
T 1phk_A           17 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN   96 (298)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred             hccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeeccC
Confidence            34999999999999999999999999999999986542        1233467889999999995 998655        


Q ss_pred             --EEEEEEecCCCChhhHhhc-CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccC
Q psy1546         120 --LWIIMEYLGGGSALDLMKA-GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTN  196 (604)
Q Consensus       120 --lyLVmEy~~ggsL~~~l~~-~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~  196 (604)
                        +|+||||+++++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+..
T Consensus        97 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~  176 (298)
T 1phk_A           97 TFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDP  176 (298)
T ss_dssp             SEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCT
T ss_pred             CeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEecccchhhcCC
Confidence              4799999999999999865 5799999999999999999999999999999999999999999999999999976543


Q ss_pred             CCCCCcccccCCCCCChHHhh------cCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCCCC---CCCCcc
Q psy1546         197 TTSKRNTFVGTPFWMAPEVIK------QSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNP---PQLTGN  267 (604)
Q Consensus       197 ~~~~~~~~~GT~~Y~APE~l~------~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~~~---~~~~~~  267 (604)
                      . .......||+.|+|||++.      ...++.++|||||||++|+|++|..||...........+.....   ......
T Consensus       177 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (298)
T 1phk_A          177 G-EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDD  255 (298)
T ss_dssp             T-CCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTGGG
T ss_pred             C-cccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCcccCcccccc
Confidence            2 2334567999999999986      45688899999999999999999999988877665554433322   222356


Q ss_pred             chHHHHHHHHHHhccCCCCCCCHHHHhcChhhhhhh
Q psy1546         268 YTKQFKEFVEACLNKDPENRPTAKELLKFPFIRKAK  303 (604)
Q Consensus       268 ~s~~l~~Li~~~L~~dP~~RpT~~elL~hp~f~~~~  303 (604)
                      ++..+.+||.+||..||.+|||+.|+|+||||++..
T Consensus       256 ~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  291 (298)
T 1phk_A          256 YSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYV  291 (298)
T ss_dssp             SCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTTC
T ss_pred             cCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhcc
Confidence            889999999999999999999999999999997654

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=1.7e-43  Score=367.53  Aligned_cols=249  Identities=23%  Similarity=0.425  Sum_probs=195.0

Q ss_pred             cccceeeeEEcccCcEEEEEEEECCCCc---EEEEEEecchh-hHHHHHHHHHHHHHHhhCCCCCCCeE-----------
Q psy1546          56 ELIFTKQERIGKGSFGEVFKGIDNRTQQ---VVAIKIIDLEE-AEDEIEDIQQEIMVLSQCDSPYGTKL-----------  120 (604)
Q Consensus        56 ~~~y~i~~~LG~G~fG~Vy~a~~~~t~~---~vAVK~i~~~~-~~~~~~~l~~Ei~iL~~l~hp~~~~l-----------  120 (604)
                      ...|.+.+.||+|+||.||+|.+..++.   .||||++.... .....+.+.+|+.+++.++||++.++           
T Consensus        22 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  101 (323)
T 3qup_A           22 EQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKG  101 (323)
T ss_dssp             ---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC----
T ss_pred             hhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecccccc
Confidence            3459999999999999999999887765   89999996543 23446788999999999999985432           


Q ss_pred             -----EEEEEecCCCChhhHhhcC-------CCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecc
Q psy1546         121 -----WIIMEYLGGGSALDLMKAG-------NFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADF  188 (604)
Q Consensus       121 -----yLVmEy~~ggsL~~~l~~~-------~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DF  188 (604)
                           |+||||+.+|+|.+++...       .+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+||
T Consensus       102 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~~~kl~Df  181 (323)
T 3qup_A          102 RLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADF  181 (323)
T ss_dssp             ---CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCC
T ss_pred             CCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCCCEEEeec
Confidence                 7999999999999998542       5899999999999999999999999999999999999999999999999


Q ss_pred             cccccccCCCC--CCcccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHhhhcCCCCCCCCC
Q psy1546         189 GVAGTLTNTTS--KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAK-GEPPNSELHPMRVLFLIPKNNPPQLT  265 (604)
Q Consensus       189 GlA~~~~~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~  265 (604)
                      |+++.......  ......+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+.........+........+
T Consensus       182 g~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~  261 (323)
T 3qup_A          182 GLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGNRLKQP  261 (323)
T ss_dssp             CC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCC
T ss_pred             cccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhcCCCCCCC
Confidence            99976543322  1223457788999999999999999999999999999999 99999998888877777666666777


Q ss_pred             ccchHHHHHHHHHHhccCCCCCCC-------HHHHhcChhhhhhhh
Q psy1546         266 GNYTKQFKEFVEACLNKDPENRPT-------AKELLKFPFIRKAKK  304 (604)
Q Consensus       266 ~~~s~~l~~Li~~~L~~dP~~RpT-------~~elL~hp~f~~~~~  304 (604)
                      ..++.++.+||.+||..||.+|||       +++++.|+|+.....
T Consensus       262 ~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~~~  307 (323)
T 3qup_A          262 PECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTSQ  307 (323)
T ss_dssp             TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC--------
T ss_pred             CccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCCCC
Confidence            889999999999999999999999       777888999876543

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=7e-44  Score=374.79  Aligned_cols=238  Identities=28%  Similarity=0.459  Sum_probs=203.4

Q ss_pred             ccceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhH-------HHHHHHHHHHHHHhhCCCCCCCeE---------
Q psy1546          57 LIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAE-------DEIEDIQQEIMVLSQCDSPYGTKL---------  120 (604)
Q Consensus        57 ~~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~-------~~~~~l~~Ei~iL~~l~hp~~~~l---------  120 (604)
                      ..|.+.+.||+|+||.||+|.+..+++.||||++......       .....+.+|+.+|+.++|||+.++         
T Consensus        24 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~  103 (335)
T 3dls_A           24 QKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGF  103 (335)
T ss_dssp             HHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred             cceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCCE
Confidence            3499999999999999999999999999999999765321       123456789999999999996654         


Q ss_pred             -EEEEEecCCC-ChhhHhhc-CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCC
Q psy1546         121 -WIIMEYLGGG-SALDLMKA-GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNT  197 (604)
Q Consensus       121 -yLVmEy~~gg-sL~~~l~~-~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~  197 (604)
                       |+||||+.+| +|.+++.. +.+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.+...
T Consensus       104 ~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~  183 (335)
T 3dls_A          104 FQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERG  183 (335)
T ss_dssp             EEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred             EEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeecccceECCCC
Confidence             6999999766 99998876 47999999999999999999999999999999999999999999999999999766533


Q ss_pred             CCCCcccccCCCCCChHHhhcCCC-CCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCCCCCCCCccchHHHHHHH
Q psy1546         198 TSKRNTFVGTPFWMAPEVIKQSAY-DSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFV  276 (604)
Q Consensus       198 ~~~~~~~~GT~~Y~APE~l~~~~~-~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li  276 (604)
                       ......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.......       ......+..+++++.+||
T Consensus       184 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-------~~~~~~~~~~~~~l~~li  255 (335)
T 3dls_A          184 -KLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETV-------EAAIHPPYLVSKELMSLV  255 (335)
T ss_dssp             -CCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGGT-------TTCCCCSSCCCHHHHHHH
T ss_pred             -CceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHHH-------hhccCCCcccCHHHHHHH
Confidence             33446789999999999998877 788999999999999999999997643211       111233456789999999


Q ss_pred             HHHhccCCCCCCCHHHHhcChhhhhh
Q psy1546         277 EACLNKDPENRPTAKELLKFPFIRKA  302 (604)
Q Consensus       277 ~~~L~~dP~~RpT~~elL~hp~f~~~  302 (604)
                      .+||..||.+|||+.+|++||||+..
T Consensus       256 ~~~L~~dP~~Rps~~ell~hp~~~~~  281 (335)
T 3dls_A          256 SGLLQPVPERRTTLEKLVTDPWVTQP  281 (335)
T ss_dssp             HHHTCSSGGGSCCHHHHHHCTTTTCC
T ss_pred             HHHccCChhhCcCHHHHhcCccccCC
Confidence            99999999999999999999999764

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=1.6e-43  Score=372.70  Aligned_cols=240  Identities=25%  Similarity=0.415  Sum_probs=205.3

Q ss_pred             ccceeeeEEcccCcEEEEEEE-----ECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhC-CCCCCCe-----------
Q psy1546          57 LIFTKQERIGKGSFGEVFKGI-----DNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQC-DSPYGTK-----------  119 (604)
Q Consensus        57 ~~y~i~~~LG~G~fG~Vy~a~-----~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l-~hp~~~~-----------  119 (604)
                      ..|.+.+.||+|+||.||+|.     +..+++.||||++.........+.+.+|+.++.++ .|||+.+           
T Consensus        22 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~  101 (359)
T 3vhe_A           22 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP  101 (359)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSC
T ss_pred             cceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecCCCc
Confidence            459999999999999999998     55677999999998766666678899999999999 7898655           


Q ss_pred             EEEEEEecCCCChhhHhhcCC-----------------------------------------------------------
Q psy1546         120 LWIIMEYLGGGSALDLMKAGN-----------------------------------------------------------  140 (604)
Q Consensus       120 lyLVmEy~~ggsL~~~l~~~~-----------------------------------------------------------  140 (604)
                      +|+|||||++|+|.+++....                                                           
T Consensus       102 ~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  181 (359)
T 3vhe_A          102 LMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEA  181 (359)
T ss_dssp             CEEEEECCTTEEHHHHHHTTTTSBCSCC----------------------------------------------------
T ss_pred             eEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhhccc
Confidence            469999999999999986532                                                           


Q ss_pred             --------CcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCC--CCcccccCCCC
Q psy1546         141 --------FEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTS--KRNTFVGTPFW  210 (604)
Q Consensus       141 --------lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~--~~~~~~GT~~Y  210 (604)
                              +++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.+.....  ......||+.|
T Consensus       182 ~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y  261 (359)
T 3vhe_A          182 PEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKW  261 (359)
T ss_dssp             --CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CEECGGG
T ss_pred             ccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccCCCcee
Confidence                    89999999999999999999999999999999999999999999999999976643322  23456789999


Q ss_pred             CChHHhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhh-HhhhcCCCCCCCCCccchHHHHHHHHHHhccCCCCCC
Q psy1546         211 MAPEVIKQSAYDSKADIWSLGITAIELAK-GEPPNSELHPMR-VLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPENRP  288 (604)
Q Consensus       211 ~APE~l~~~~~~~~sDVwSLGviL~eLlt-G~~Pf~~~~~~~-~~~~i~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rp  288 (604)
                      +|||++.+..++.++|||||||++|+|++ |..||.+..... ....+........+..+++++.+||.+||..||.+||
T Consensus       262 ~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp  341 (359)
T 3vhe_A          262 MAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRP  341 (359)
T ss_dssp             CCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSC
T ss_pred             EChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHccCChhhCC
Confidence            99999999999999999999999999998 999998766433 3333334445556677899999999999999999999


Q ss_pred             CHHHHhcC
Q psy1546         289 TAKELLKF  296 (604)
Q Consensus       289 T~~elL~h  296 (604)
                      |+.||++|
T Consensus       342 s~~ell~~  349 (359)
T 3vhe_A          342 TFSELVEH  349 (359)
T ss_dssp             CHHHHHHH
T ss_pred             CHHHHHHH
Confidence            99999986

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=6.6e-43  Score=359.84  Aligned_cols=242  Identities=25%  Similarity=0.407  Sum_probs=199.5

Q ss_pred             ccceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchh--hHHHHHHHHHHHHHHhhCCCCCCCe----------EEEEE
Q psy1546          57 LIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE--AEDEIEDIQQEIMVLSQCDSPYGTK----------LWIIM  124 (604)
Q Consensus        57 ~~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~--~~~~~~~l~~Ei~iL~~l~hp~~~~----------lyLVm  124 (604)
                      ..|.+.+.||+|+||.||+|.+..+++.||||++....  .....+.+.+|+.+++.+.|||+.+          +|+||
T Consensus        11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   90 (294)
T 4eqm_A           11 ERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVM   90 (294)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             ccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEE
Confidence            45999999999999999999999999999999985432  3445678899999999999999655          47999


Q ss_pred             EecCCCChhhHhhc-CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCC-CCCc
Q psy1546         125 EYLGGGSALDLMKA-GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTT-SKRN  202 (604)
Q Consensus       125 Ey~~ggsL~~~l~~-~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~-~~~~  202 (604)
                      ||++|++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+.... ....
T Consensus        91 e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~  170 (294)
T 4eqm_A           91 EYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTN  170 (294)
T ss_dssp             ECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC---------
T ss_pred             eCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCccccccccccccC
Confidence            99999999999865 679999999999999999999999999999999999999999999999999997664332 2234


Q ss_pred             ccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCCCCC----CCCccchHHHHHHHHH
Q psy1546         203 TFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPP----QLTGNYTKQFKEFVEA  278 (604)
Q Consensus       203 ~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~~~~----~~~~~~s~~l~~Li~~  278 (604)
                      ..+||+.|+|||++.+..++.++|||||||++|+|++|..||.+...............+    .....+++.+.++|.+
T Consensus       171 ~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  250 (294)
T 4eqm_A          171 HVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQSLSNVILR  250 (294)
T ss_dssp             ----CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCHHHHSCTTSCHHHHHHHHH
T ss_pred             ccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCcchhcccCCCHHHHHHHHH
Confidence            567999999999999999999999999999999999999999988776554433333222    2345688999999999


Q ss_pred             HhccCCCCCCCHHHHhcChh
Q psy1546         279 CLNKDPENRPTAKELLKFPF  298 (604)
Q Consensus       279 ~L~~dP~~RpT~~elL~hp~  298 (604)
                      ||..||.+||+..+.+.+.|
T Consensus       251 ~l~~dp~~R~~~~~~l~~~l  270 (294)
T 4eqm_A          251 ATEKDKANRYKTIQEMKDDL  270 (294)
T ss_dssp             HSCSSGGGSCSSHHHHHHHH
T ss_pred             HhcCCHhHccccHHHHHHHH
Confidence            99999999995555544444

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=3e-43  Score=366.30  Aligned_cols=242  Identities=25%  Similarity=0.408  Sum_probs=199.9

Q ss_pred             cccceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCC-CCCCCe------------EEE
Q psy1546          56 ELIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCD-SPYGTK------------LWI  122 (604)
Q Consensus        56 ~~~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~-hp~~~~------------lyL  122 (604)
                      ...|.+.++||+|+||.||+|.+..+++.||||++....    .+.+.+|+.+++.+. ||++.+            +|+
T Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~l  110 (330)
T 3nsz_A           35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK----KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPAL  110 (330)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC----HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEE
T ss_pred             CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc----hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEE
Confidence            456999999999999999999999999999999997443    256889999999997 998544            479


Q ss_pred             EEEecCCCChhhHhhcCCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCC-CeEEecccccccccCCCCCC
Q psy1546         123 IMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMG-DVKLADFGVAGTLTNTTSKR  201 (604)
Q Consensus       123 VmEy~~ggsL~~~l~~~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g-~vKL~DFGlA~~~~~~~~~~  201 (604)
                      ||||+.+++|.++++.  +++..++.++.||+.||.|||++||+||||||+||||+.++ .+||+|||+|+.+... ...
T Consensus       111 v~e~~~~~~l~~~~~~--~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~-~~~  187 (330)
T 3nsz_A          111 VFEHVNNTDFKQLYQT--LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG-QEY  187 (330)
T ss_dssp             EEECCCCCCHHHHGGG--CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTT-CCC
T ss_pred             EEeccCchhHHHHHHh--CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCC-Ccc
Confidence            9999999999999864  89999999999999999999999999999999999999777 8999999999765433 334


Q ss_pred             cccccCCCCCChHHhhc-CCCCCcchhhhHHHHHHHHHhCCCCCCCCCh-hhHhhhc-------------CCC-------
Q psy1546         202 NTFVGTPFWMAPEVIKQ-SAYDSKADIWSLGITAIELAKGEPPNSELHP-MRVLFLI-------------PKN-------  259 (604)
Q Consensus       202 ~~~~GT~~Y~APE~l~~-~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~-~~~~~~i-------------~~~-------  259 (604)
                      ...+||+.|+|||++.+ ..++.++|||||||+||+|++|..||..... ...+..+             ...       
T Consensus       188 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~  267 (330)
T 3nsz_A          188 NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPR  267 (330)
T ss_dssp             CSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCTH
T ss_pred             ccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhccccccc
Confidence            45689999999999987 6789999999999999999999999854321 1111100             000       


Q ss_pred             ----------------CCCCCCccchHHHHHHHHHHhccCCCCCCCHHHHhcChhhhhhhh
Q psy1546         260 ----------------NPPQLTGNYTKQFKEFVEACLNKDPENRPTAKELLKFPFIRKAKK  304 (604)
Q Consensus       260 ----------------~~~~~~~~~s~~l~~Li~~~L~~dP~~RpT~~elL~hp~f~~~~~  304 (604)
                                      ........+++++.+||.+||..||.+|||++|+|+||||+...+
T Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~~  328 (330)
T 3nsz_A          268 FNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVK  328 (330)
T ss_dssp             HHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTCC-
T ss_pred             hhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhhcc
Confidence                            011122337899999999999999999999999999999986543

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=6.2e-43  Score=372.21  Aligned_cols=242  Identities=28%  Similarity=0.444  Sum_probs=200.4

Q ss_pred             ccceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhh-HHHHHHHHHHHHHHhhCCCCCCCe----------------
Q psy1546          57 LIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA-EDEIEDIQQEIMVLSQCDSPYGTK----------------  119 (604)
Q Consensus        57 ~~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~-~~~~~~l~~Ei~iL~~l~hp~~~~----------------  119 (604)
                      ..|.+.+.||+|+||.||+|.+..+++.||||++..... ......+.+|+.+++.+.|||+.+                
T Consensus        42 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  121 (371)
T 4exu_A           42 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD  121 (371)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCC
T ss_pred             ccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCccccee
Confidence            459999999999999999999999999999999975432 334577889999999999998543                


Q ss_pred             EEEEEEecCCCChhhHhhcCCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCC
Q psy1546         120 LWIIMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTS  199 (604)
Q Consensus       120 lyLVmEy~~ggsL~~~l~~~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~  199 (604)
                      +|+||||+. ++|.+++.. .+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.....  
T Consensus       122 ~~lv~e~~~-~~l~~~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~--  197 (371)
T 4exu_A          122 FYLVMPFMQ-TDLQKIMGM-EFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAE--  197 (371)
T ss_dssp             CEEEEECCC-EEHHHHTTS-CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSTTCC--------
T ss_pred             EEEEEcccc-ccHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEecCcccccccC--
Confidence            289999996 678877744 5999999999999999999999999999999999999999999999999999755432  


Q ss_pred             CCcccccCCCCCChHHhhc-CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCC--------------------
Q psy1546         200 KRNTFVGTPFWMAPEVIKQ-SAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPK--------------------  258 (604)
Q Consensus       200 ~~~~~~GT~~Y~APE~l~~-~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~--------------------  258 (604)
                       ....+||+.|+|||++.+ ..++.++|||||||+||+|++|..||.+....+....+..                    
T Consensus       198 -~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  276 (371)
T 4exu_A          198 -MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKS  276 (371)
T ss_dssp             ---CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSCHHHHH
T ss_pred             -cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhhhhhhh
Confidence             345679999999999987 7799999999999999999999999998775544333211                    


Q ss_pred             -------CCC---CCCCccchHHHHHHHHHHhccCCCCCCCHHHHhcChhhhhhh
Q psy1546         259 -------NNP---PQLTGNYTKQFKEFVEACLNKDPENRPTAKELLKFPFIRKAK  303 (604)
Q Consensus       259 -------~~~---~~~~~~~s~~l~~Li~~~L~~dP~~RpT~~elL~hp~f~~~~  303 (604)
                             ...   ..+...+++.+.+||.+||..||.+|||+.|+|+||||+...
T Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~  331 (371)
T 4exu_A          277 YIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFR  331 (371)
T ss_dssp             HHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTC
T ss_pred             hhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccCC
Confidence                   000   011235688999999999999999999999999999997643

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=5.1e-43  Score=361.25  Aligned_cols=240  Identities=25%  Similarity=0.459  Sum_probs=211.4

Q ss_pred             ccceeeeEEcccCcEEEEEEEEC-----CCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCCeE----------E
Q psy1546          57 LIFTKQERIGKGSFGEVFKGIDN-----RTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTKL----------W  121 (604)
Q Consensus        57 ~~y~i~~~LG~G~fG~Vy~a~~~-----~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~~l----------y  121 (604)
                      ..|.+.+.||+|+||.||+|.+.     .+++.||||++.........+.+.+|+.+++.+.|||+.++          |
T Consensus        23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~  102 (314)
T 2ivs_A           23 KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLL  102 (314)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCE
T ss_pred             hheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCceE
Confidence            34899999999999999999873     45689999999876666667889999999999999997665          6


Q ss_pred             EEEEecCCCChhhHhhcC-------------------------CCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeE
Q psy1546         122 IIMEYLGGGSALDLMKAG-------------------------NFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVL  176 (604)
Q Consensus       122 LVmEy~~ggsL~~~l~~~-------------------------~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NIL  176 (604)
                      +||||+++++|.+++...                         .+++..++.++.||+.||.|||++||+||||||+|||
T Consensus       103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~NIl  182 (314)
T 2ivs_A          103 LIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNIL  182 (314)
T ss_dssp             EEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEE
T ss_pred             EEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcccccchheEE
Confidence            999999999999998652                         2889999999999999999999999999999999999


Q ss_pred             ecCCCCeEEecccccccccCCCC--CCcccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHh
Q psy1546         177 LSEMGDVKLADFGVAGTLTNTTS--KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAK-GEPPNSELHPMRVL  253 (604)
Q Consensus       177 l~~~g~vKL~DFGlA~~~~~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLlt-G~~Pf~~~~~~~~~  253 (604)
                      ++.++.+||+|||+++.......  ......+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+.......
T Consensus       183 i~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~  262 (314)
T 2ivs_A          183 VAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERLF  262 (314)
T ss_dssp             EETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHH
T ss_pred             EcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence            99999999999999976643322  2334567889999999999999999999999999999999 99999998887777


Q ss_pred             hhcCCCCCCCCCccchHHHHHHHHHHhccCCCCCCCHHHHhcC
Q psy1546         254 FLIPKNNPPQLTGNYTKQFKEFVEACLNKDPENRPTAKELLKF  296 (604)
Q Consensus       254 ~~i~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~RpT~~elL~h  296 (604)
                      ..+........+..+++.+.+||.+||..||.+|||+.+|+++
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~  305 (314)
T 2ivs_A          263 NLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKD  305 (314)
T ss_dssp             HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHhhcCCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            7776666667778899999999999999999999999999885

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=3.2e-43  Score=382.39  Aligned_cols=241  Identities=30%  Similarity=0.473  Sum_probs=196.6

Q ss_pred             ccceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhC------CCCCCC----------eE
Q psy1546          57 LIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQC------DSPYGT----------KL  120 (604)
Q Consensus        57 ~~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l------~hp~~~----------~l  120 (604)
                      ..|.+.++||+|+||.||+|.+..+++.||||++....  .....+.+|+.+++.+      .|+++.          .+
T Consensus        97 ~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~--~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~  174 (429)
T 3kvw_A           97 YRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK--RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHI  174 (429)
T ss_dssp             TTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCH--HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEE
T ss_pred             CcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCcc--chHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeE
Confidence            34999999999999999999999999999999997543  2335667788888776      445544          35


Q ss_pred             EEEEEecCCCChhhHhhcC---CCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCC--eEEeccccccccc
Q psy1546         121 WIIMEYLGGGSALDLMKAG---NFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGD--VKLADFGVAGTLT  195 (604)
Q Consensus       121 yLVmEy~~ggsL~~~l~~~---~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~--vKL~DFGlA~~~~  195 (604)
                      ||||||+. ++|.+++...   .+++..++.|+.||+.||.|||++||+||||||+||||+.++.  +||+|||+|....
T Consensus       175 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~~~  253 (429)
T 3kvw_A          175 CMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEH  253 (429)
T ss_dssp             EEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCTTCEETT
T ss_pred             EEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeecccceecC
Confidence            79999995 6888888653   4899999999999999999999999999999999999999887  9999999996543


Q ss_pred             CCCCCCcccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCC----------------
Q psy1546         196 NTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKN----------------  259 (604)
Q Consensus       196 ~~~~~~~~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~----------------  259 (604)
                      .   ...+.+||+.|+|||++.+..|+.++|||||||+||||++|.+||.+.+..+.+..+...                
T Consensus       254 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~~~~~~~~  330 (429)
T 3kvw_A          254 Q---RVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASKRAK  330 (429)
T ss_dssp             C---CCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTBTTHH
T ss_pred             C---cccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHhhhhhh
Confidence            2   234568999999999999999999999999999999999999999887765443221100                


Q ss_pred             ------CCC------------------------------------CCCccchHHHHHHHHHHhccCCCCCCCHHHHhcCh
Q psy1546         260 ------NPP------------------------------------QLTGNYTKQFKEFVEACLNKDPENRPTAKELLKFP  297 (604)
Q Consensus       260 ------~~~------------------------------------~~~~~~s~~l~~Li~~~L~~dP~~RpT~~elL~hp  297 (604)
                            ..+                                    .+....++.+.+||.+||..||.+|||+.|+|+||
T Consensus       331 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta~e~L~Hp  410 (429)
T 3kvw_A          331 NFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQALRHP  410 (429)
T ss_dssp             HHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCHHHHHTST
T ss_pred             hccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCHHHHhCCh
Confidence                  000                                    01123467899999999999999999999999999


Q ss_pred             hhhhhh
Q psy1546         298 FIRKAK  303 (604)
Q Consensus       298 ~f~~~~  303 (604)
                      ||++..
T Consensus       411 w~~~~~  416 (429)
T 3kvw_A          411 WLRRRL  416 (429)
T ss_dssp             TTC---
T ss_pred             hhccCC
Confidence            998653

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=9.1e-43  Score=356.28  Aligned_cols=244  Identities=30%  Similarity=0.533  Sum_probs=197.2

Q ss_pred             cceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCCe------------------
Q psy1546          58 IFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTK------------------  119 (604)
Q Consensus        58 ~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~~------------------  119 (604)
                      .|.+.+.||+|+||.||+|.+..+++.||||++...  ....+.+.+|+.+++.+.||++.+                  
T Consensus         7 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~   84 (303)
T 1zy4_A            7 DFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT--EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAV   84 (303)
T ss_dssp             HEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE--HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC-----
T ss_pred             cchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc--HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhccc
Confidence            489999999999999999999999999999999643  344578899999999999998643                  


Q ss_pred             -----EEEEEEecCCCChhhHhhcC--CCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccc
Q psy1546         120 -----LWIIMEYLGGGSALDLMKAG--NFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAG  192 (604)
Q Consensus       120 -----lyLVmEy~~ggsL~~~l~~~--~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~  192 (604)
                           +|+||||+++++|.+++...  .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus        85 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~  164 (303)
T 1zy4_A           85 KKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAK  164 (303)
T ss_dssp             -CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCCCS
T ss_pred             ccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEEeeCcchh
Confidence                 47999999999999999753  57788999999999999999999999999999999999999999999999997


Q ss_pred             cccCC--------------CCCCcccccCCCCCChHHhhcC-CCCCcchhhhHHHHHHHHHhCCCCCCCC-ChhhHhhhc
Q psy1546         193 TLTNT--------------TSKRNTFVGTPFWMAPEVIKQS-AYDSKADIWSLGITAIELAKGEPPNSEL-HPMRVLFLI  256 (604)
Q Consensus       193 ~~~~~--------------~~~~~~~~GT~~Y~APE~l~~~-~~~~~sDVwSLGviL~eLltG~~Pf~~~-~~~~~~~~i  256 (604)
                      .....              ........||+.|+|||++.+. .++.++|||||||++|+|++   ||... ........+
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~~~~~~  241 (303)
T 1zy4_A          165 NVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVNILKKL  241 (303)
T ss_dssp             CTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHHHH
T ss_pred             hcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHHHHHhc
Confidence            65422              1223456799999999999865 68999999999999999998   55432 222222222


Q ss_pred             ---CCCCCCCCCccchHHHHHHHHHHhccCCCCCCCHHHHhcChhhhhhhhhh
Q psy1546         257 ---PKNNPPQLTGNYTKQFKEFVEACLNKDPENRPTAKELLKFPFIRKAKKNA  306 (604)
Q Consensus       257 ---~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~RpT~~elL~hp~f~~~~~~~  306 (604)
                         ....++.+...++..+.+||.+||..||.+|||+.++++||||.......
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~~  294 (303)
T 1zy4_A          242 RSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVKHQDE  294 (303)
T ss_dssp             HSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCCCCHHH
T ss_pred             cccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCCCChHH
Confidence               12234455567788999999999999999999999999999998765544

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=8.3e-43  Score=358.59  Aligned_cols=243  Identities=24%  Similarity=0.435  Sum_probs=207.2

Q ss_pred             cceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhH---HHHHHHHHHHHHHhhCCCCCCCe------------EEE
Q psy1546          58 IFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAE---DEIEDIQQEIMVLSQCDSPYGTK------------LWI  122 (604)
Q Consensus        58 ~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~---~~~~~l~~Ei~iL~~l~hp~~~~------------lyL  122 (604)
                      .|.+.+.||+|+||.||+|.+..+++.||||++......   .....+.+|+.+++.+.||++.+            +|+
T Consensus         6 ~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (305)
T 2wtk_C            6 KYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYM   85 (305)
T ss_dssp             CBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEEE
T ss_pred             ceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEEE
Confidence            389999999999999999999999999999999765432   34577899999999999998544            479


Q ss_pred             EEEecCCCChhhHhh---cCCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCC--
Q psy1546         123 IMEYLGGGSALDLMK---AGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNT--  197 (604)
Q Consensus       123 VmEy~~ggsL~~~l~---~~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~--  197 (604)
                      ||||++++ |.+++.   .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......  
T Consensus        86 v~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~~  164 (305)
T 2wtk_C           86 VMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAA  164 (305)
T ss_dssp             EEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTTCS
T ss_pred             EehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeeccccccccCcccc
Confidence            99999877 666554   367999999999999999999999999999999999999999999999999999765432  


Q ss_pred             CCCCcccccCCCCCChHHhhcCCC--CCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCCCCCCCCccchHHHHHH
Q psy1546         198 TSKRNTFVGTPFWMAPEVIKQSAY--DSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEF  275 (604)
Q Consensus       198 ~~~~~~~~GT~~Y~APE~l~~~~~--~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~L  275 (604)
                      ........||+.|+|||++.+...  +.++|||||||++|+|++|..||...........+.... ..++..++..+.+|
T Consensus       165 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~-~~~~~~~~~~l~~l  243 (305)
T 2wtk_C          165 DDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGS-YAIPGDCGPPLSDL  243 (305)
T ss_dssp             SCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCC-CCCCSSSCHHHHHH
T ss_pred             ccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCC-CCCCCccCHHHHHH
Confidence            122335679999999999986543  678999999999999999999999887776665554433 34566789999999


Q ss_pred             HHHHhccCCCCCCCHHHHhcChhhhhh
Q psy1546         276 VEACLNKDPENRPTAKELLKFPFIRKA  302 (604)
Q Consensus       276 i~~~L~~dP~~RpT~~elL~hp~f~~~  302 (604)
                      |.+||..||.+|||+.|+++||||++.
T Consensus       244 i~~~l~~dp~~Rps~~~ll~~~~~~~~  270 (305)
T 2wtk_C          244 LKGMLEYEPAKRFSIRQIRQHSWFRKK  270 (305)
T ss_dssp             HHHHTCSSTTTSCCHHHHHHSHHHHSC
T ss_pred             HHHHccCChhhCCCHHHHhcCcccccC
Confidence            999999999999999999999999754

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=6e-43  Score=356.58  Aligned_cols=240  Identities=30%  Similarity=0.423  Sum_probs=200.4

Q ss_pred             ccceeeeEEcccCcEEEEEEEECCC---CcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCCeE---------EEEE
Q psy1546          57 LIFTKQERIGKGSFGEVFKGIDNRT---QQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTKL---------WIIM  124 (604)
Q Consensus        57 ~~y~i~~~LG~G~fG~Vy~a~~~~t---~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~~l---------yLVm  124 (604)
                      ..|.+.+.||+|+||.||+|.+..+   +..||||++.........+.+.+|+.+++.+.|||+.++         |+||
T Consensus        15 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~lv~   94 (281)
T 1mp8_A           15 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPVWIIM   94 (281)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSCEEEE
T ss_pred             HHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEccCccEEEE
Confidence            3599999999999999999998654   457999998766555666789999999999999997664         6999


Q ss_pred             EecCCCChhhHhhcC--CCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCC-CC
Q psy1546         125 EYLGGGSALDLMKAG--NFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTS-KR  201 (604)
Q Consensus       125 Ey~~ggsL~~~l~~~--~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~-~~  201 (604)
                      ||+++++|.+++...  .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....... ..
T Consensus        95 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~  174 (281)
T 1mp8_A           95 ELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKA  174 (281)
T ss_dssp             ECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC---------------
T ss_pred             ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECccccccccCccccccc
Confidence            999999999999753  599999999999999999999999999999999999999999999999999976643322 22


Q ss_pred             cccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHhhhcCCCCCCCCCccchHHHHHHHHHHh
Q psy1546         202 NTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAK-GEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACL  280 (604)
Q Consensus       202 ~~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~~L  280 (604)
                      ....+|+.|+|||++.+..++.++|||||||++|+|++ |..||...........+.......++..++..+.+||.+||
T Consensus       175 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~l  254 (281)
T 1mp8_A          175 SKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTKCW  254 (281)
T ss_dssp             ----CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTCCHHHHHHHHHHT
T ss_pred             ccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHc
Confidence            33457889999999999999999999999999999996 99999988887777777666666777889999999999999


Q ss_pred             ccCCCCCCCHHHHhcC
Q psy1546         281 NKDPENRPTAKELLKF  296 (604)
Q Consensus       281 ~~dP~~RpT~~elL~h  296 (604)
                      ..||.+|||+.||+++
T Consensus       255 ~~~p~~Rps~~~l~~~  270 (281)
T 1mp8_A          255 AYDPSRRPRFTELKAQ  270 (281)
T ss_dssp             CSSGGGSCCHHHHHHH
T ss_pred             cCChhhCcCHHHHHHH
Confidence            9999999999999874

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=4.3e-43  Score=358.60  Aligned_cols=244  Identities=33%  Similarity=0.536  Sum_probs=200.8

Q ss_pred             ceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCCeE----------EEEEEecC
Q psy1546          59 FTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTKL----------WIIMEYLG  128 (604)
Q Consensus        59 y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~~l----------yLVmEy~~  128 (604)
                      |.....||+|+||.||+|.+..+++.||||++.... ....+.+.+|+.+++.+.||++.++          |+||||++
T Consensus        24 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~  102 (295)
T 2clq_A           24 NGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD-SRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVP  102 (295)
T ss_dssp             TSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCC-C---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred             CCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCc-hHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCC
Confidence            455568999999999999999999999999986553 2345778899999999999996654          79999999


Q ss_pred             CCChhhHhhcC----CCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecC-CCCeEEecccccccccCCCCCCcc
Q psy1546         129 GGSALDLMKAG----NFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSE-MGDVKLADFGVAGTLTNTTSKRNT  203 (604)
Q Consensus       129 ggsL~~~l~~~----~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~-~g~vKL~DFGlA~~~~~~~~~~~~  203 (604)
                      +++|.+++...    .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||++..+.........
T Consensus       103 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~  182 (295)
T 2clq_A          103 GGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET  182 (295)
T ss_dssp             EEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC-----CC
T ss_pred             CCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecccccccCCCCCcccc
Confidence            99999998753    4678889999999999999999999999999999999987 899999999999776544444456


Q ss_pred             cccCCCCCChHHhhcCC--CCCcchhhhHHHHHHHHHhCCCCCCCCChhhH--hhhcCCCCCCCCCccchHHHHHHHHHH
Q psy1546         204 FVGTPFWMAPEVIKQSA--YDSKADIWSLGITAIELAKGEPPNSELHPMRV--LFLIPKNNPPQLTGNYTKQFKEFVEAC  279 (604)
Q Consensus       204 ~~GT~~Y~APE~l~~~~--~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~--~~~i~~~~~~~~~~~~s~~l~~Li~~~  279 (604)
                      ..||+.|+|||++.+..  ++.++|||||||++|+|++|..||........  .........+.++..++.++.+||.+|
T Consensus       183 ~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  262 (295)
T 2clq_A          183 FTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAEAKAFILKC  262 (295)
T ss_dssp             CCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCCCCCCTTSCHHHHHHHHHT
T ss_pred             cCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccccccccccccCCHHHHHHHHHH
Confidence            78999999999997654  88999999999999999999999976543221  111112234456678899999999999


Q ss_pred             hccCCCCCCCHHHHhcChhhhhhh
Q psy1546         280 LNKDPENRPTAKELLKFPFIRKAK  303 (604)
Q Consensus       280 L~~dP~~RpT~~elL~hp~f~~~~  303 (604)
                      |..||.+|||+.++|+||||+...
T Consensus       263 l~~dp~~Rps~~~ll~~~~~~~~~  286 (295)
T 2clq_A          263 FEPDPDKRACANDLLVDEFLKVSS  286 (295)
T ss_dssp             TCSSTTTSCCHHHHHTSGGGCC--
T ss_pred             ccCChhhCCCHHHHhcChhhhhcc
Confidence            999999999999999999997543

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=2e-42  Score=364.87  Aligned_cols=242  Identities=27%  Similarity=0.441  Sum_probs=201.0

Q ss_pred             ccceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhh-HHHHHHHHHHHHHHhhCCCCCCCe----------------
Q psy1546          57 LIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA-EDEIEDIQQEIMVLSQCDSPYGTK----------------  119 (604)
Q Consensus        57 ~~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~-~~~~~~l~~Ei~iL~~l~hp~~~~----------------  119 (604)
                      ..|.+.+.||+|+||.||+|.+..+|+.||||++..... ......+.+|+.+++.+.|||+.+                
T Consensus        24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  103 (353)
T 3coi_A           24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD  103 (353)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred             ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEeccccccccee
Confidence            359999999999999999999999999999999965432 334577889999999999998543                


Q ss_pred             EEEEEEecCCCChhhHhhcCCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCC
Q psy1546         120 LWIIMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTS  199 (604)
Q Consensus       120 lyLVmEy~~ggsL~~~l~~~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~  199 (604)
                      +|+||||+. ++|.+++.. .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....  
T Consensus       104 ~~lv~e~~~-~~l~~~~~~-~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~--  179 (353)
T 3coi_A          104 FYLVMPFMQ-TDLQKIMGL-KFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAE--  179 (353)
T ss_dssp             CEEEEECCS-EEGGGTTTS-CCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTTCTTC------
T ss_pred             EEEEecccc-CCHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeecccccCCCCC--
Confidence            389999996 688887754 5999999999999999999999999999999999999999999999999999765422  


Q ss_pred             CCcccccCCCCCChHHhhc-CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcC---------------------
Q psy1546         200 KRNTFVGTPFWMAPEVIKQ-SAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIP---------------------  257 (604)
Q Consensus       200 ~~~~~~GT~~Y~APE~l~~-~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~---------------------  257 (604)
                       ....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.......+.                     
T Consensus       180 -~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  258 (353)
T 3coi_A          180 -MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKS  258 (353)
T ss_dssp             -----CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSCHHHHH
T ss_pred             -ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhhHHHHH
Confidence             335679999999999987 678999999999999999999999998876544332211                     


Q ss_pred             ------C---CCCCCCCccchHHHHHHHHHHhccCCCCCCCHHHHhcChhhhhhh
Q psy1546         258 ------K---NNPPQLTGNYTKQFKEFVEACLNKDPENRPTAKELLKFPFIRKAK  303 (604)
Q Consensus       258 ------~---~~~~~~~~~~s~~l~~Li~~~L~~dP~~RpT~~elL~hp~f~~~~  303 (604)
                            .   .....+...++..+.+||.+||..||.+|||+.|+|+||||....
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~  313 (353)
T 3coi_A          259 YIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFR  313 (353)
T ss_dssp             HHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTC
T ss_pred             HHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhcc
Confidence                  1   111233456789999999999999999999999999999997543

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.3e-42  Score=371.26  Aligned_cols=240  Identities=25%  Similarity=0.447  Sum_probs=212.7

Q ss_pred             ccceeeeEEcccCcEEEEEEEECC-------CCcEEEEEEecchhhHHHHHHHHHHHHHHhhC-CCCCCCeE--------
Q psy1546          57 LIFTKQERIGKGSFGEVFKGIDNR-------TQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQC-DSPYGTKL--------  120 (604)
Q Consensus        57 ~~y~i~~~LG~G~fG~Vy~a~~~~-------t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l-~hp~~~~l--------  120 (604)
                      ..|.+.++||+|+||.||+|.+..       .+..||||++...........+.+|+.+++.+ .||+++++        
T Consensus        69 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~  148 (382)
T 3tt0_A           69 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG  148 (382)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             hheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccCC
Confidence            459999999999999999999753       33579999998776666778899999999999 99997665        


Q ss_pred             --EEEEEecCCCChhhHhhcC-----------------CCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCC
Q psy1546         121 --WIIMEYLGGGSALDLMKAG-----------------NFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMG  181 (604)
Q Consensus       121 --yLVmEy~~ggsL~~~l~~~-----------------~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g  181 (604)
                        |+||||+++|+|.+++...                 .+++..++.|+.||+.||.|||++||+||||||+||||+.++
T Consensus       149 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~  228 (382)
T 3tt0_A          149 PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDN  228 (382)
T ss_dssp             SCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTC
T ss_pred             ceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcceEEEcCCC
Confidence              6999999999999999753                 389999999999999999999999999999999999999999


Q ss_pred             CeEEecccccccccCCC--CCCcccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHhhhcCC
Q psy1546         182 DVKLADFGVAGTLTNTT--SKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAK-GEPPNSELHPMRVLFLIPK  258 (604)
Q Consensus       182 ~vKL~DFGlA~~~~~~~--~~~~~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~~i~~  258 (604)
                      .+||+|||+|+.+....  .......||+.|+|||++.+..++.++|||||||+||+|++ |..||......+....+..
T Consensus       229 ~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~~~~~~~~  308 (382)
T 3tt0_A          229 VMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKE  308 (382)
T ss_dssp             CEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHT
T ss_pred             cEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc
Confidence            99999999997665332  22334567889999999999999999999999999999999 9999999888888877777


Q ss_pred             CCCCCCCccchHHHHHHHHHHhccCCCCCCCHHHHhcC
Q psy1546         259 NNPPQLTGNYTKQFKEFVEACLNKDPENRPTAKELLKF  296 (604)
Q Consensus       259 ~~~~~~~~~~s~~l~~Li~~~L~~dP~~RpT~~elL~h  296 (604)
                      ......+..++.++.+||.+||..||.+|||+.||+++
T Consensus       309 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  346 (382)
T 3tt0_A          309 GHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED  346 (382)
T ss_dssp             TCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            76777778899999999999999999999999999984

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=1.5e-42  Score=360.36  Aligned_cols=241  Identities=29%  Similarity=0.431  Sum_probs=199.2

Q ss_pred             cceeeeEEcccCcEEEEEEEE-CCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCC------C----------CeE
Q psy1546          58 IFTKQERIGKGSFGEVFKGID-NRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPY------G----------TKL  120 (604)
Q Consensus        58 ~y~i~~~LG~G~fG~Vy~a~~-~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~------~----------~~l  120 (604)
                      .|.+.+.||+|+||.||+|.+ ..+++.||||++....  ...+.+.+|+.++..+.|++      .          ..+
T Consensus        15 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~   92 (339)
T 1z57_A           15 RYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVD--RYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHI   92 (339)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSH--HHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEE
T ss_pred             ceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCC--chhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcE
Confidence            499999999999999999998 5688999999996542  34567888999998887654      2          345


Q ss_pred             EEEEEecCCCChhhHhhcC---CCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecC------------------
Q psy1546         121 WIIMEYLGGGSALDLMKAG---NFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSE------------------  179 (604)
Q Consensus       121 yLVmEy~~ggsL~~~l~~~---~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~------------------  179 (604)
                      |+||||+ +++|.+++...   .+++..++.++.||+.||.|||++||+||||||+||||+.                  
T Consensus        93 ~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~~~  171 (339)
T 1z57_A           93 CIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTL  171 (339)
T ss_dssp             EEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC----CEEEEE
T ss_pred             EEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCccccccccc
Confidence            8999999 88999988653   5899999999999999999999999999999999999987                  


Q ss_pred             -CCCeEEecccccccccCCCCCCcccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCC
Q psy1546         180 -MGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPK  258 (604)
Q Consensus       180 -~g~vKL~DFGlA~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~  258 (604)
                       ++.+||+|||+++....   .....+||+.|+|||++.+..++.++|||||||++|||++|..||...+.......+..
T Consensus       172 ~~~~~kl~Dfg~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~  248 (339)
T 1z57_A          172 INPDIKVVDFGSATYDDE---HHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMER  248 (339)
T ss_dssp             SCCCEEECCCSSCEETTS---CCCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHHHHHHHH
T ss_pred             cCCCceEeeCcccccCcc---ccccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Confidence             66899999999975432   23456899999999999999999999999999999999999999988766543322110


Q ss_pred             C---C----------------------------------------CCCCCccchHHHHHHHHHHhccCCCCCCCHHHHhc
Q psy1546         259 N---N----------------------------------------PPQLTGNYTKQFKEFVEACLNKDPENRPTAKELLK  295 (604)
Q Consensus       259 ~---~----------------------------------------~~~~~~~~s~~l~~Li~~~L~~dP~~RpT~~elL~  295 (604)
                      .   .                                        ........++.+.+||.+||..||.+|||+.|||+
T Consensus       249 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~  328 (339)
T 1z57_A          249 ILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALK  328 (339)
T ss_dssp             HHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             HhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccCHHHHhc
Confidence            0   0                                        00112234678999999999999999999999999


Q ss_pred             Chhhhhhhh
Q psy1546         296 FPFIRKAKK  304 (604)
Q Consensus       296 hp~f~~~~~  304 (604)
                      ||||+..+.
T Consensus       329 hp~f~~~~~  337 (339)
T 1z57_A          329 HPFFDLLKK  337 (339)
T ss_dssp             SGGGGGGGC
T ss_pred             CHHHHHHhc
Confidence            999987543

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=2.1e-43  Score=379.37  Aligned_cols=240  Identities=28%  Similarity=0.424  Sum_probs=196.0

Q ss_pred             ccceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCCe----------------E
Q psy1546          57 LIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTK----------------L  120 (604)
Q Consensus        57 ~~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~~----------------l  120 (604)
                      ..|.+.++||+|+||.||+|++..+++ ||+|++....     ....+|+.+|+.++|||+++                +
T Consensus        40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~-----~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~  113 (394)
T 4e7w_A           40 IAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDK-----RFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFL  113 (394)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCT-----TSCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEE
T ss_pred             ceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCc-----chHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEE
Confidence            349999999999999999999988776 7777764432     12247999999999999765                5


Q ss_pred             EEEEEecCCCChhhHhh----cCCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEec-CCCCeEEeccccccccc
Q psy1546         121 WIIMEYLGGGSALDLMK----AGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLS-EMGDVKLADFGVAGTLT  195 (604)
Q Consensus       121 yLVmEy~~ggsL~~~l~----~~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~-~~g~vKL~DFGlA~~~~  195 (604)
                      |+|||||+++.+..+..    .+.+++..++.++.||+.||.|||++||+||||||+||||+ .++.+||+|||+|+.+.
T Consensus       114 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~  193 (394)
T 4e7w_A          114 NLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILI  193 (394)
T ss_dssp             EEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred             EEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeCCCccccc
Confidence            69999998765544332    46799999999999999999999999999999999999998 78999999999997664


Q ss_pred             CCCCCCcccccCCCCCChHHhhcC-CCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCC----------------
Q psy1546         196 NTTSKRNTFVGTPFWMAPEVIKQS-AYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPK----------------  258 (604)
Q Consensus       196 ~~~~~~~~~~GT~~Y~APE~l~~~-~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~----------------  258 (604)
                      ... .....+||+.|+|||++.+. .|+.++|||||||+||||++|.+||.+......+..+..                
T Consensus       194 ~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~  272 (394)
T 4e7w_A          194 AGE-PNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNPN  272 (394)
T ss_dssp             TTC-CCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCGG
T ss_pred             CCC-CCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChh
Confidence            332 33456899999999999765 589999999999999999999999998876544432211                


Q ss_pred             ---CCCC---------CCCccchHHHHHHHHHHhccCCCCCCCHHHHhcChhhhhhh
Q psy1546         259 ---NNPP---------QLTGNYTKQFKEFVEACLNKDPENRPTAKELLKFPFIRKAK  303 (604)
Q Consensus       259 ---~~~~---------~~~~~~s~~l~~Li~~~L~~dP~~RpT~~elL~hp~f~~~~  303 (604)
                         ...+         .+...+++++.+||.+||..||.+|||+.|+|+||||+...
T Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  329 (394)
T 4e7w_A          273 YMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELR  329 (394)
T ss_dssp             GSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTT
T ss_pred             hhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhc
Confidence               0000         12234788999999999999999999999999999998654

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.3e-43  Score=373.62  Aligned_cols=246  Identities=28%  Similarity=0.469  Sum_probs=202.2

Q ss_pred             ccceeeeEEcccCcEEEEEEEEC---CCCcEEEEEEecchhh---HHHHHHHHHHHHHHhhC-CCCCCCe----------
Q psy1546          57 LIFTKQERIGKGSFGEVFKGIDN---RTQQVVAIKIIDLEEA---EDEIEDIQQEIMVLSQC-DSPYGTK----------  119 (604)
Q Consensus        57 ~~y~i~~~LG~G~fG~Vy~a~~~---~t~~~vAVK~i~~~~~---~~~~~~l~~Ei~iL~~l-~hp~~~~----------  119 (604)
                      ..|.+.+.||+|+||.||+|++.   .+++.||||++.....   ....+.+.+|+.+|..+ .||++.+          
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~  133 (355)
T 1vzo_A           54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK  133 (355)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred             cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCce
Confidence            35999999999999999999984   5899999999865431   12235567899999998 6998654          


Q ss_pred             EEEEEEecCCCChhhHhhc-CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCC
Q psy1546         120 LWIIMEYLGGGSALDLMKA-GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTT  198 (604)
Q Consensus       120 lyLVmEy~~ggsL~~~l~~-~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~  198 (604)
                      +|||||||++++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.+....
T Consensus       134 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~  213 (355)
T 1vzo_A          134 LHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADE  213 (355)
T ss_dssp             EEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEECCGGG
T ss_pred             EEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCCCeecccCC
Confidence            4799999999999999865 679999999999999999999999999999999999999999999999999997654322


Q ss_pred             -CCCcccccCCCCCChHHhhc--CCCCCcchhhhHHHHHHHHHhCCCCCCCCCh----hhHhhhcCCCCCCCCCccchHH
Q psy1546         199 -SKRNTFVGTPFWMAPEVIKQ--SAYDSKADIWSLGITAIELAKGEPPNSELHP----MRVLFLIPKNNPPQLTGNYTKQ  271 (604)
Q Consensus       199 -~~~~~~~GT~~Y~APE~l~~--~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~----~~~~~~i~~~~~~~~~~~~s~~  271 (604)
                       ......+||+.|+|||++.+  ..++.++|||||||+||+|++|..||.....    ..+...+.. ..+.++..++..
T Consensus       214 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~  292 (355)
T 1vzo_A          214 TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILK-SEPPYPQEMSAL  292 (355)
T ss_dssp             GGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHH-CCCCCCTTSCHH
T ss_pred             CCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhc-cCCCCCcccCHH
Confidence             23345689999999999986  3478899999999999999999999975432    222222211 233456778899


Q ss_pred             HHHHHHHHhccCCCCCC-----CHHHHhcChhhhhhh
Q psy1546         272 FKEFVEACLNKDPENRP-----TAKELLKFPFIRKAK  303 (604)
Q Consensus       272 l~~Li~~~L~~dP~~Rp-----T~~elL~hp~f~~~~  303 (604)
                      +.+||.+||..||.+||     |+.|+++||||.+..
T Consensus       293 ~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~~  329 (355)
T 1vzo_A          293 AKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKIN  329 (355)
T ss_dssp             HHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCC
T ss_pred             HHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcCC
Confidence            99999999999999999     999999999998653

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=5.6e-43  Score=361.80  Aligned_cols=242  Identities=28%  Similarity=0.484  Sum_probs=200.9

Q ss_pred             cceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCCeE----------EEEEEec
Q psy1546          58 IFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTKL----------WIIMEYL  127 (604)
Q Consensus        58 ~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~~l----------yLVmEy~  127 (604)
                      .|.+.++||+|+||+||+|.+..+++.||+|++... .....+.+.+|+.+++.+.|||+.++          |+||||+
T Consensus        11 ~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~   89 (310)
T 3s95_A           11 DLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRF-DEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYI   89 (310)
T ss_dssp             GEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             HeeccceecCCCCEEEEEEEECCCCcEEEEEEeccC-CHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEec
Confidence            489999999999999999999999999999998543 34456788999999999999997654          7999999


Q ss_pred             CCCChhhHhhc--CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCCC-----
Q psy1546         128 GGGSALDLMKA--GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSK-----  200 (604)
Q Consensus       128 ~ggsL~~~l~~--~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~-----  200 (604)
                      ++++|.++++.  +.+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.+......     
T Consensus        90 ~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  169 (310)
T 3s95_A           90 KGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLR  169 (310)
T ss_dssp             TTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEECC----------
T ss_pred             CCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceecccccccccccc
Confidence            99999999976  67999999999999999999999999999999999999999999999999999765433221     


Q ss_pred             ---------CcccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcC--CCCCCCCCccch
Q psy1546         201 ---------RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIP--KNNPPQLTGNYT  269 (604)
Q Consensus       201 ---------~~~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~--~~~~~~~~~~~s  269 (604)
                               ....+||+.|+|||++.+..++.++|||||||+||+|++|..||.............  .......+..++
T Consensus       170 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (310)
T 3s95_A          170 SLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRYCPPNCP  249 (310)
T ss_dssp             ----------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHHHTCCTTCC
T ss_pred             cccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhccccccCCCCCC
Confidence                     125689999999999999999999999999999999999999987643322111000  000112345677


Q ss_pred             HHHHHHHHHHhccCCCCCCCHHHHhcChhhhhh
Q psy1546         270 KQFKEFVEACLNKDPENRPTAKELLKFPFIRKA  302 (604)
Q Consensus       270 ~~l~~Li~~~L~~dP~~RpT~~elL~hp~f~~~  302 (604)
                      +.+.+||.+||..||.+|||+.+|++  |+...
T Consensus       250 ~~l~~li~~~l~~dP~~Rps~~~l~~--~L~~l  280 (310)
T 3s95_A          250 PSFFPITVRCCDLDPEKRPSFVKLEH--WLETL  280 (310)
T ss_dssp             TTHHHHHHHHTCSSGGGSCCHHHHHH--HHHHH
T ss_pred             HHHHHHHHHHccCChhhCcCHHHHHH--HHHHH
Confidence            89999999999999999999999987  55543

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=4.3e-43  Score=374.45  Aligned_cols=239  Identities=26%  Similarity=0.436  Sum_probs=210.2

Q ss_pred             ccceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCCeE----------EEEEEe
Q psy1546          57 LIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTKL----------WIIMEY  126 (604)
Q Consensus        57 ~~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~~l----------yLVmEy  126 (604)
                      ..|.+.+.||+|+||.||+|.+..+++.||||++...........+.+|+.+|+.+.|||+.++          ||||||
T Consensus       114 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~  193 (377)
T 3cbl_A          114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMEL  193 (377)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred             HHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEEc
Confidence            3589999999999999999999999999999999765445555678899999999999997664          799999


Q ss_pred             cCCCChhhHhhc--CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCCC--Cc
Q psy1546         127 LGGGSALDLMKA--GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSK--RN  202 (604)
Q Consensus       127 ~~ggsL~~~l~~--~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~--~~  202 (604)
                      |++|+|.++++.  ..+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++........  ..
T Consensus       194 ~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~~~~~  273 (377)
T 3cbl_A          194 VQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGG  273 (377)
T ss_dssp             CTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEECCSS
T ss_pred             CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCCceecCCCceeecCC
Confidence            999999999865  35999999999999999999999999999999999999999999999999999764432111  12


Q ss_pred             ccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHhhhcCCCCCCCCCccchHHHHHHHHHHhc
Q psy1546         203 TFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAK-GEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLN  281 (604)
Q Consensus       203 ~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~~L~  281 (604)
                      ...+++.|+|||++.+..++.++|||||||+||||++ |..||...........+..+.....+..+++.+.+||.+||.
T Consensus       274 ~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~  353 (377)
T 3cbl_A          274 LRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLPCPELCPDAVFRLMEQCWA  353 (377)
T ss_dssp             CCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTC
T ss_pred             CCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcC
Confidence            2346778999999999999999999999999999998 999999988887777777766667778899999999999999


Q ss_pred             cCCCCCCCHHHHhc
Q psy1546         282 KDPENRPTAKELLK  295 (604)
Q Consensus       282 ~dP~~RpT~~elL~  295 (604)
                      .||.+|||+.+|++
T Consensus       354 ~dP~~Rps~~~i~~  367 (377)
T 3cbl_A          354 YEPGQRPSFSTIYQ  367 (377)
T ss_dssp             SSGGGSCCHHHHHH
T ss_pred             CCchhCcCHHHHHH
Confidence            99999999999986

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=4.2e-43  Score=373.26  Aligned_cols=239  Identities=29%  Similarity=0.403  Sum_probs=192.8

Q ss_pred             ccceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCC--------CCCCC----------
Q psy1546          57 LIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCD--------SPYGT----------  118 (604)
Q Consensus        57 ~~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~--------hp~~~----------  118 (604)
                      ..|.+.++||+|+||+||+|++..+++.||||++....  ...+.+.+|+.+|+.+.        |+++.          
T Consensus        37 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~  114 (397)
T 1wak_A           37 GRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAE--HYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG  114 (397)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH--HHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred             CeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCC--cchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence            35999999999999999999999999999999996542  34467889999999886        44432          


Q ss_pred             ----eEEEEEEecCCCChhhHhhc--CCCcHHHHHHHHHHHHHHhHHhhhC-CccccccccceeEecCCC----------
Q psy1546         119 ----KLWIIMEYLGGGSALDLMKA--GNFEEMHIAVILREVLKGLDYLHSE-RKLHRDIKAANVLLSEMG----------  181 (604)
Q Consensus       119 ----~lyLVmEy~~ggsL~~~l~~--~~lse~~i~~i~~qIl~gL~yLHs~-gIiHrDLKp~NILl~~~g----------  181 (604)
                          .+||||||+.++.+..++..  +.+++..++.|+.||+.||.|||++ ||+||||||+||||+.++          
T Consensus       115 ~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~~~~~~~  194 (397)
T 1wak_A          115 VNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEA  194 (397)
T ss_dssp             TTEEEEEEEECCCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHHHHHHHH
T ss_pred             CCCceEEEEEeccCccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhhhhhhhh
Confidence                45899999954444444443  4699999999999999999999999 999999999999999775          


Q ss_pred             ---------------------------------------CeEEecccccccccCCCCCCcccccCCCCCChHHhhcCCCC
Q psy1546         182 ---------------------------------------DVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYD  222 (604)
Q Consensus       182 ---------------------------------------~vKL~DFGlA~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~  222 (604)
                                                             .+||+|||+|......   ....+||+.|+|||++.+..|+
T Consensus       195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~  271 (397)
T 1wak_A          195 TEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH---FTEDIQTRQYRSLEVLIGSGYN  271 (397)
T ss_dssp             C---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC---SCSCCSCGGGCCHHHHHTSCCC
T ss_pred             HHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc---CccCCCCCcccCChhhcCCCCC
Confidence                                                   7999999999765432   3355799999999999999999


Q ss_pred             CcchhhhHHHHHHHHHhCCCCCCCCChhh------Hhhhc---CCC--------------------C-------------
Q psy1546         223 SKADIWSLGITAIELAKGEPPNSELHPMR------VLFLI---PKN--------------------N-------------  260 (604)
Q Consensus       223 ~~sDVwSLGviL~eLltG~~Pf~~~~~~~------~~~~i---~~~--------------------~-------------  260 (604)
                      .++|||||||+||+|++|..||.......      ....+   ...                    .             
T Consensus       272 ~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  351 (397)
T 1wak_A          272 TPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLF  351 (397)
T ss_dssp             THHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCCCHH
T ss_pred             cHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCCcchh
Confidence            99999999999999999999997644211      10000   000                    0             


Q ss_pred             -----CCCCCccchHHHHHHHHHHhccCCCCCCCHHHHhcChhhh
Q psy1546         261 -----PPQLTGNYTKQFKEFVEACLNKDPENRPTAKELLKFPFIR  300 (604)
Q Consensus       261 -----~~~~~~~~s~~l~~Li~~~L~~dP~~RpT~~elL~hp~f~  300 (604)
                           ...++...+..+.+||.+||..||.+|||+.|||+||||+
T Consensus       352 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~  396 (397)
T 1wak_A          352 EVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLN  396 (397)
T ss_dssp             HHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGG
T ss_pred             HhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCcccc
Confidence                 0012344567899999999999999999999999999996

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=1.9e-42  Score=353.95  Aligned_cols=245  Identities=32%  Similarity=0.534  Sum_probs=208.1

Q ss_pred             ccceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhh-HHHHHHHHHHHHHHhhCCCCCCCeE----------EEEEE
Q psy1546          57 LIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA-EDEIEDIQQEIMVLSQCDSPYGTKL----------WIIME  125 (604)
Q Consensus        57 ~~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~-~~~~~~l~~Ei~iL~~l~hp~~~~l----------yLVmE  125 (604)
                      ..|.+.+.||+|+||.||+|.+..+++.||||++..... ......+.+|+.+++.+.||++.++          |+|||
T Consensus        22 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  101 (287)
T 2wei_A           22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGE  101 (287)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             hcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEEE
Confidence            349999999999999999999999999999999865432 2235678899999999999996554          79999


Q ss_pred             ecCCCChhhHhh-cCCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCC---CCeEEecccccccccCCCCCC
Q psy1546         126 YLGGGSALDLMK-AGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEM---GDVKLADFGVAGTLTNTTSKR  201 (604)
Q Consensus       126 y~~ggsL~~~l~-~~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~---g~vKL~DFGlA~~~~~~~~~~  201 (604)
                      |+.+++|.+++. .+.+++..++.++.||+.||.|||++||+||||||+||||+.+   +.+||+|||++...... ...
T Consensus       102 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~-~~~  180 (287)
T 2wei_A          102 LYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN-TKM  180 (287)
T ss_dssp             CCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCC-SSC
T ss_pred             ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeecCC-Ccc
Confidence            999999988774 4789999999999999999999999999999999999999754   46999999999765433 233


Q ss_pred             cccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCCCCC---CCCccchHHHHHHHHH
Q psy1546         202 NTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPP---QLTGNYTKQFKEFVEA  278 (604)
Q Consensus       202 ~~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~~~~---~~~~~~s~~l~~Li~~  278 (604)
                      ....||+.|+|||++.+. ++.++|||||||++|+|++|..||...........+......   .....++.++.+||.+
T Consensus       181 ~~~~~~~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  259 (287)
T 2wei_A          181 KDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRK  259 (287)
T ss_dssp             SCHHHHHTTCCHHHHTTC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGTTSCHHHHHHHHH
T ss_pred             ccccCcccccChHHhcCC-CCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCchhhhhcCHHHHHHHHH
Confidence            455799999999998764 899999999999999999999999988877666555443322   1224678999999999


Q ss_pred             HhccCCCCCCCHHHHhcChhhhhhh
Q psy1546         279 CLNKDPENRPTAKELLKFPFIRKAK  303 (604)
Q Consensus       279 ~L~~dP~~RpT~~elL~hp~f~~~~  303 (604)
                      ||..||.+|||+.|+|+||||++..
T Consensus       260 ~l~~dp~~Rps~~ell~hp~~~~~~  284 (287)
T 2wei_A          260 MLTFHPSLRITATQCLEHPWIQKYS  284 (287)
T ss_dssp             HTCSSGGGSCCHHHHHHSHHHHHHC
T ss_pred             HcccChhhCcCHHHHhcCHHHhccc
Confidence            9999999999999999999997653

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=1.6e-42  Score=350.75  Aligned_cols=236  Identities=27%  Similarity=0.413  Sum_probs=207.2

Q ss_pred             cceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCCeE----------EEEEEec
Q psy1546          58 IFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTKL----------WIIMEYL  127 (604)
Q Consensus        58 ~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~~l----------yLVmEy~  127 (604)
                      .|.+.+.||+|+||.||+|.+. +++.||||++.......  +.+.+|+.+++++.||++.++          |+||||+
T Consensus        11 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~--~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   87 (269)
T 4hcu_A           11 ELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSE--EDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM   87 (269)
T ss_dssp             GEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSBCH--HHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred             hceeeheecCCCccEEEEEEec-CCCeEEEEEecccccCH--HHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeC
Confidence            4899999999999999999987 46789999997654332  568899999999999996654          7999999


Q ss_pred             CCCChhhHhhc--CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCC-CCCccc
Q psy1546         128 GGGSALDLMKA--GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTT-SKRNTF  204 (604)
Q Consensus       128 ~ggsL~~~l~~--~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~-~~~~~~  204 (604)
                      ++++|.+++..  +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...... ......
T Consensus        88 ~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  167 (269)
T 4hcu_A           88 EHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGT  167 (269)
T ss_dssp             TTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHHSTTST
T ss_pred             CCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEeccccccccccccccccccCc
Confidence            99999999965  459999999999999999999999999999999999999999999999999997654322 122344


Q ss_pred             ccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHhhhcCCCCCCCCCccchHHHHHHHHHHhccC
Q psy1546         205 VGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAK-GEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKD  283 (604)
Q Consensus       205 ~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~~L~~d  283 (604)
                      .+|+.|+|||++.+..++.++|||||||++|+|++ |..||...........+........+..++..+.+||.+||..|
T Consensus       168 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~  247 (269)
T 4hcu_A          168 KFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWRER  247 (269)
T ss_dssp             TCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHHHHHHTCSS
T ss_pred             ccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCccCCCCCcCCHHHHHHHHHHccCC
Confidence            57888999999999999999999999999999999 99999998888887777776666677788999999999999999


Q ss_pred             CCCCCCHHHHhcC
Q psy1546         284 PENRPTAKELLKF  296 (604)
Q Consensus       284 P~~RpT~~elL~h  296 (604)
                      |.+|||+.++++|
T Consensus       248 p~~Rps~~~ll~~  260 (269)
T 4hcu_A          248 PEDRPAFSRLLRQ  260 (269)
T ss_dssp             GGGSCCHHHHHHH
T ss_pred             cccCcCHHHHHHH
Confidence            9999999999985

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=8.5e-43  Score=364.39  Aligned_cols=241  Identities=28%  Similarity=0.419  Sum_probs=202.4

Q ss_pred             cccceeeeEEcccCcEEEEEEEECCCCcE----EEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCCeE---------EE
Q psy1546          56 ELIFTKQERIGKGSFGEVFKGIDNRTQQV----VAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTKL---------WI  122 (604)
Q Consensus        56 ~~~y~i~~~LG~G~fG~Vy~a~~~~t~~~----vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~~l---------yL  122 (604)
                      ...|.+.++||+|+||.||+|.+..+++.    ||+|.+.........+.+.+|+.+++.++|||+.++         ++
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   93 (327)
T 3poz_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQL   93 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSSEEE
T ss_pred             HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEE
Confidence            44599999999999999999999887765    477777554444445788999999999999997665         59


Q ss_pred             EEEecCCCChhhHhhc--CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCCC
Q psy1546         123 IMEYLGGGSALDLMKA--GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSK  200 (604)
Q Consensus       123 VmEy~~ggsL~~~l~~--~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~  200 (604)
                      |+||+.+|+|.+++..  +.+++..++.|+.||+.||.|||++||+||||||+||||+.++.+||+|||+|+.+......
T Consensus        94 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  173 (327)
T 3poz_A           94 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE  173 (327)
T ss_dssp             EEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHHHHHTTTCC-
T ss_pred             EEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCcceeEccCCccc
Confidence            9999999999999865  56999999999999999999999999999999999999999999999999999766533322


Q ss_pred             --CcccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHhhhcCCCCCCCCCccchHHHHHHHH
Q psy1546         201 --RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAK-GEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVE  277 (604)
Q Consensus       201 --~~~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~  277 (604)
                        .....||+.|+|||++.+..++.++|||||||++|||++ |..||...........+........+..++..+.+|+.
T Consensus       174 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  253 (327)
T 3poz_A          174 YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMV  253 (327)
T ss_dssp             ------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTBCHHHHHHHH
T ss_pred             ccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCCCCCCCccCCHHHHHHHH
Confidence              223457889999999999999999999999999999999 99999998887777777666666677789999999999


Q ss_pred             HHhccCCCCCCCHHHHhcC
Q psy1546         278 ACLNKDPENRPTAKELLKF  296 (604)
Q Consensus       278 ~~L~~dP~~RpT~~elL~h  296 (604)
                      +||..||.+|||+.|++++
T Consensus       254 ~~l~~~p~~Rps~~ell~~  272 (327)
T 3poz_A          254 KCWMIDADSRPKFRELIIE  272 (327)
T ss_dssp             HHTCSCGGGSCCHHHHHHH
T ss_pred             HHcCCChhhCCCHHHHHHH
Confidence            9999999999999999985

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=3.5e-43  Score=366.74  Aligned_cols=240  Identities=28%  Similarity=0.401  Sum_probs=206.5

Q ss_pred             ccceeeeEEcccCcEEEEEEEECCCCcE----EEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCCeE---------EEE
Q psy1546          57 LIFTKQERIGKGSFGEVFKGIDNRTQQV----VAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTKL---------WII  123 (604)
Q Consensus        57 ~~y~i~~~LG~G~fG~Vy~a~~~~t~~~----vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~~l---------yLV  123 (604)
                      ..|.+.++||+|+||.||+|.+..+++.    ||+|++...........+.+|+.++..+.|||+.++         |+|
T Consensus        13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~v   92 (325)
T 3kex_A           13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPGSSLQLV   92 (325)
T ss_dssp             TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEECBSSEEEE
T ss_pred             hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCccEEE
Confidence            4599999999999999999999888876    777777544333334567789999999999997665         699


Q ss_pred             EEecCCCChhhHhhc--CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCC--
Q psy1546         124 MEYLGGGSALDLMKA--GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTS--  199 (604)
Q Consensus       124 mEy~~ggsL~~~l~~--~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~--  199 (604)
                      |||+.+|+|.+++..  +.+++..++.|+.||+.||.|||++||+||||||+||||+.++.+||+|||+++.+.....  
T Consensus        93 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~  172 (325)
T 3kex_A           93 TQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQL  172 (325)
T ss_dssp             EECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSGGGGSCCCTTCC
T ss_pred             EEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCcccccCcccccc
Confidence            999999999999865  4799999999999999999999999999999999999999999999999999987643322  


Q ss_pred             CCcccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHhhhcCCCCCCCCCccchHHHHHHHHH
Q psy1546         200 KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAK-GEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEA  278 (604)
Q Consensus       200 ~~~~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~  278 (604)
                      ......||+.|+|||++.+..++.++|||||||++|+|++ |..||.+.........+........+..++.++.+||.+
T Consensus       173 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  252 (325)
T 3kex_A          173 LYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLAQPQICTIDVYMVMVK  252 (325)
T ss_dssp             C-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTCBCCCCTTBCTTTTHHHHH
T ss_pred             cccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCCCcCcHHHHHHHHH
Confidence            2345568889999999999999999999999999999999 999999988777777776666666677788899999999


Q ss_pred             HhccCCCCCCCHHHHhcC
Q psy1546         279 CLNKDPENRPTAKELLKF  296 (604)
Q Consensus       279 ~L~~dP~~RpT~~elL~h  296 (604)
                      ||..||.+|||+.+|+++
T Consensus       253 ~l~~dp~~Rps~~el~~~  270 (325)
T 3kex_A          253 CWMIDENIRPTFKELANE  270 (325)
T ss_dssp             HTCSCTTTSCCHHHHHHH
T ss_pred             HcCCChhhCcCHHHHHHH
Confidence            999999999999999986

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=1.7e-42  Score=355.30  Aligned_cols=238  Identities=25%  Similarity=0.449  Sum_probs=198.0

Q ss_pred             ccceeeeEEcccCcEEEEEEE----ECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCCeE------------
Q psy1546          57 LIFTKQERIGKGSFGEVFKGI----DNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTKL------------  120 (604)
Q Consensus        57 ~~y~i~~~LG~G~fG~Vy~a~----~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~~l------------  120 (604)
                      ..|++.++||+|+||.||+|+    +..+++.||||++.... ....+.+.+|+.+++.+.|||+.++            
T Consensus        10 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   88 (295)
T 3ugc_A           10 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST-EEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL   88 (295)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCC-HHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred             HHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence            459999999999999999998    56789999999997543 3445788999999999999997654            


Q ss_pred             EEEEEecCCCChhhHhhc--CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCC
Q psy1546         121 WIIMEYLGGGSALDLMKA--GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTT  198 (604)
Q Consensus       121 yLVmEy~~ggsL~~~l~~--~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~  198 (604)
                      |+||||+++|+|.+++..  ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+....
T Consensus        89 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~  168 (295)
T 3ugc_A           89 KLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK  168 (295)
T ss_dssp             EEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCSCC------
T ss_pred             EEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCcccccccCCc
Confidence            699999999999999965  349999999999999999999999999999999999999999999999999997664332


Q ss_pred             C---CCcccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChh----------------hHhhhcCCC
Q psy1546         199 S---KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPM----------------RVLFLIPKN  259 (604)
Q Consensus       199 ~---~~~~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~----------------~~~~~i~~~  259 (604)
                      .   ......+|+.|+|||++.+..++.++|||||||++|+|++|..||......                .....+...
T Consensus       169 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (295)
T 3ugc_A          169 EFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNN  248 (295)
T ss_dssp             -------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHHHHHTT
T ss_pred             ceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHHHHhcc
Confidence            1   223345788899999999999999999999999999999999988653221                122223334


Q ss_pred             CCCCCCccchHHHHHHHHHHhccCCCCCCCHHHHhc
Q psy1546         260 NPPQLTGNYTKQFKEFVEACLNKDPENRPTAKELLK  295 (604)
Q Consensus       260 ~~~~~~~~~s~~l~~Li~~~L~~dP~~RpT~~elL~  295 (604)
                      .....+..+++++.+||.+||..||.+|||+.||++
T Consensus       249 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~  284 (295)
T 3ugc_A          249 GRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL  284 (295)
T ss_dssp             CCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             CcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            445566788999999999999999999999999987

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.2e-42  Score=353.43  Aligned_cols=245  Identities=26%  Similarity=0.453  Sum_probs=211.1

Q ss_pred             cCccccceeeeEEcccCcEEEEEEEEC--CCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCCeE---------E
Q psy1546          53 VDPELIFTKQERIGKGSFGEVFKGIDN--RTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTKL---------W  121 (604)
Q Consensus        53 ~~~~~~y~i~~~LG~G~fG~Vy~a~~~--~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~~l---------y  121 (604)
                      +..+..+.+.+.||+|+||.||+|.+.  .++..||||++.........+.+.+|+.+++.+.||++.++         |
T Consensus         6 ~~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   85 (287)
T 1u59_A            6 LKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEALM   85 (287)
T ss_dssp             CCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESSSEE
T ss_pred             ccHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEecCCCcE
Confidence            334444444459999999999999864  46788999999876556667889999999999999996654         7


Q ss_pred             EEEEecCCCChhhHhhc--CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCC
Q psy1546         122 IIMEYLGGGSALDLMKA--GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTS  199 (604)
Q Consensus       122 LVmEy~~ggsL~~~l~~--~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~  199 (604)
                      +||||+++++|.+++..  +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+.....
T Consensus        86 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~  165 (287)
T 1u59_A           86 LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDS  165 (287)
T ss_dssp             EEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSC
T ss_pred             EEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECcccceeeeccCcc
Confidence            99999999999999854  5699999999999999999999999999999999999999999999999999976643322


Q ss_pred             ---CCcccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHhhhcCCCCCCCCCccchHHHHHH
Q psy1546         200 ---KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAK-GEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEF  275 (604)
Q Consensus       200 ---~~~~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~L  275 (604)
                         ......||+.|+|||++.+..++.++|||||||++|+|++ |..||...........+.......++..++..+.+|
T Consensus       166 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~l  245 (287)
T 1u59_A          166 YYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELYAL  245 (287)
T ss_dssp             EECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCCCTTCCHHHHHH
T ss_pred             eeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCCcCCCCCCcCHHHHHH
Confidence               1233457899999999999999999999999999999998 999999888877777776766677778899999999


Q ss_pred             HHHHhccCCCCCCCHHHHhcCh
Q psy1546         276 VEACLNKDPENRPTAKELLKFP  297 (604)
Q Consensus       276 i~~~L~~dP~~RpT~~elL~hp  297 (604)
                      |.+||..||.+||++.+++++.
T Consensus       246 i~~~l~~~p~~Rps~~~l~~~l  267 (287)
T 1u59_A          246 MSDCWIYKWEDRPDFLTVEQRM  267 (287)
T ss_dssp             HHHTTCSSGGGSCCHHHHHHHH
T ss_pred             HHHHcCCChhhCcCHHHHHHHH
Confidence            9999999999999999999864

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=1.1e-42  Score=364.69  Aligned_cols=243  Identities=25%  Similarity=0.430  Sum_probs=206.1

Q ss_pred             cceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHH----------------HHHHHHHHHHHHhhCCCCCCC---
Q psy1546          58 IFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAED----------------EIEDIQQEIMVLSQCDSPYGT---  118 (604)
Q Consensus        58 ~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~----------------~~~~l~~Ei~iL~~l~hp~~~---  118 (604)
                      .|.+.+.||+|+||.||+|.+  +++.||||++.......                ..+.+.+|+.+++.++||++.   
T Consensus        32 ~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~  109 (348)
T 2pml_X           32 DYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCE  109 (348)
T ss_dssp             TEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCCS
T ss_pred             ceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceEE
Confidence            499999999999999999998  89999999986543221                127789999999999999854   


Q ss_pred             -------eEEEEEEecCCCChhhH------hh---cCCCcHHHHHHHHHHHHHHhHHhhh-CCccccccccceeEecCCC
Q psy1546         119 -------KLWIIMEYLGGGSALDL------MK---AGNFEEMHIAVILREVLKGLDYLHS-ERKLHRDIKAANVLLSEMG  181 (604)
Q Consensus       119 -------~lyLVmEy~~ggsL~~~------l~---~~~lse~~i~~i~~qIl~gL~yLHs-~gIiHrDLKp~NILl~~~g  181 (604)
                             .+|+||||+++++|.++      +.   .+.+++..++.++.||+.||.|||+ +||+||||||+|||++.++
T Consensus       110 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil~~~~~  189 (348)
T 2pml_X          110 GIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNG  189 (348)
T ss_dssp             EEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGEEECTTS
T ss_pred             EEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhEEEcCCC
Confidence                   45899999999999998      64   3679999999999999999999999 9999999999999999999


Q ss_pred             CeEEecccccccccCCCCCCcccccCCCCCChHHhhcC-CCCC-cchhhhHHHHHHHHHhCCCCCCCCCh-hhHhhhcCC
Q psy1546         182 DVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQS-AYDS-KADIWSLGITAIELAKGEPPNSELHP-MRVLFLIPK  258 (604)
Q Consensus       182 ~vKL~DFGlA~~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~~~-~sDVwSLGviL~eLltG~~Pf~~~~~-~~~~~~i~~  258 (604)
                      .+||+|||++......  ......||+.|+|||++.+. .++. ++|||||||++|+|++|..||..... ......+..
T Consensus       190 ~~kl~dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~i~~  267 (348)
T 2pml_X          190 RVKLSDFGESEYMVDK--KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRT  267 (348)
T ss_dssp             CEEECCCTTCEECBTT--EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHHHHHHTS
T ss_pred             cEEEeccccccccccc--cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhc
Confidence            9999999999765433  33456799999999999877 6666 89999999999999999999988766 444444433


Q ss_pred             CCCCCCC-------------------ccchHHHHHHHHHHhccCCCCCCCHHHHhcChhhhhhhhh
Q psy1546         259 NNPPQLT-------------------GNYTKQFKEFVEACLNKDPENRPTAKELLKFPFIRKAKKN  305 (604)
Q Consensus       259 ~~~~~~~-------------------~~~s~~l~~Li~~~L~~dP~~RpT~~elL~hp~f~~~~~~  305 (604)
                      ... .++                   ..++..+.+||.+||..||.+|||+.|+++||||......
T Consensus       268 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~~~~~  332 (348)
T 2pml_X          268 KNI-EYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADTNIE  332 (348)
T ss_dssp             CCC-CCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTTCCHH
T ss_pred             cCc-CCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccCCCHH
Confidence            322 122                   5688999999999999999999999999999999876543

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=1.1e-42  Score=362.64  Aligned_cols=246  Identities=24%  Similarity=0.408  Sum_probs=207.9

Q ss_pred             cccceeeeEEcccCcEEEEEEE-----ECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCCeE----------
Q psy1546          56 ELIFTKQERIGKGSFGEVFKGI-----DNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTKL----------  120 (604)
Q Consensus        56 ~~~y~i~~~LG~G~fG~Vy~a~-----~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~~l----------  120 (604)
                      ...|.+.+.||+|+||.||+|.     +..+++.||||++...........+.+|+.+++.+.||++.++          
T Consensus        29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  108 (327)
T 2yfx_A           29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR  108 (327)
T ss_dssp             GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence            3459999999999999999998     5567889999999765555566788999999999999997654          


Q ss_pred             EEEEEecCCCChhhHhhcC--------CCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecC---CCCeEEeccc
Q psy1546         121 WIIMEYLGGGSALDLMKAG--------NFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSE---MGDVKLADFG  189 (604)
Q Consensus       121 yLVmEy~~ggsL~~~l~~~--------~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~---~g~vKL~DFG  189 (604)
                      |+||||+++++|.+++...        .+++..++.++.||+.||.|||++||+||||||+||||+.   ++.+||+|||
T Consensus       109 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~kl~Dfg  188 (327)
T 2yfx_A          109 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFG  188 (327)
T ss_dssp             EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECCCH
T ss_pred             EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEEECccc
Confidence            7999999999999999753        3889999999999999999999999999999999999984   4469999999


Q ss_pred             ccccccCCC--CCCcccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHhhhcCCCCCCCCCc
Q psy1546         190 VAGTLTNTT--SKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAK-GEPPNSELHPMRVLFLIPKNNPPQLTG  266 (604)
Q Consensus       190 lA~~~~~~~--~~~~~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~  266 (604)
                      ++.......  .......||+.|+|||++.+..++.++|||||||++|+|++ |..||...........+........+.
T Consensus       189 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~  268 (327)
T 2yfx_A          189 MARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPK  268 (327)
T ss_dssp             HHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCCCT
T ss_pred             cccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhcCCCCCCCC
Confidence            997554322  22334578999999999999999999999999999999998 999999888877777776666666777


Q ss_pred             cchHHHHHHHHHHhccCCCCCCCHHHHhcChhhhh
Q psy1546         267 NYTKQFKEFVEACLNKDPENRPTAKELLKFPFIRK  301 (604)
Q Consensus       267 ~~s~~l~~Li~~~L~~dP~~RpT~~elL~hp~f~~  301 (604)
                      .++..+.+||.+||..||.+|||+.+|+++.|+..
T Consensus       269 ~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~  303 (327)
T 2yfx_A          269 NCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT  303 (327)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHh
Confidence            89999999999999999999999999999987643

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=9.4e-43  Score=366.93  Aligned_cols=244  Identities=27%  Similarity=0.354  Sum_probs=188.3

Q ss_pred             cceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCCe-----------------E
Q psy1546          58 IFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTK-----------------L  120 (604)
Q Consensus        58 ~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~~-----------------l  120 (604)
                      .|.+.++||+|+||.||+|.+..+++.||||++.....  ......+++..+..+.|||+.+                 +
T Consensus        24 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~  101 (360)
T 3e3p_A           24 RFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPR--FRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYL  101 (360)
T ss_dssp             TEEEC----------CEEEEETTTCCEEEEEEEECCTT--CCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCEEE
T ss_pred             ceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcc--ccHHHHHHHHHHHhcCCCCcccHHHhhhccccccccceeE
Confidence            49999999999999999999999999999999854422  1234567788888899999665                 5


Q ss_pred             EEEEEecCCCChhhHh----hcCCCcHHHHHHHHHHHHHHhHHhh--hCCccccccccceeEecC-CCCeEEeccccccc
Q psy1546         121 WIIMEYLGGGSALDLM----KAGNFEEMHIAVILREVLKGLDYLH--SERKLHRDIKAANVLLSE-MGDVKLADFGVAGT  193 (604)
Q Consensus       121 yLVmEy~~ggsL~~~l----~~~~lse~~i~~i~~qIl~gL~yLH--s~gIiHrDLKp~NILl~~-~g~vKL~DFGlA~~  193 (604)
                      |+||||++++.+..+.    ....+++..++.++.||+.||.|||  ++||+||||||+||||+. ++.+||+|||+++.
T Consensus       102 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl~Dfg~a~~  181 (360)
T 3e3p_A          102 NVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKK  181 (360)
T ss_dssp             EEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEECCCTTCBC
T ss_pred             EEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEEeeCCCcee
Confidence            7899999875433322    2357899999999999999999999  999999999999999996 89999999999976


Q ss_pred             ccCCCCCCcccccCCCCCChHHhhcCC-CCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCC-------------
Q psy1546         194 LTNTTSKRNTFVGTPFWMAPEVIKQSA-YDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKN-------------  259 (604)
Q Consensus       194 ~~~~~~~~~~~~GT~~Y~APE~l~~~~-~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~-------------  259 (604)
                      +.... ......||+.|+|||++.+.. ++.++|||||||++|+|++|..||...........+...             
T Consensus       182 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  260 (360)
T 3e3p_A          182 LSPSE-PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKLN  260 (360)
T ss_dssp             CCTTS-CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHC
T ss_pred             cCCCC-CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHHHHHhcc
Confidence            65332 334567999999999997654 899999999999999999999999987765444332110             


Q ss_pred             ------------------CCCCCCccchHHHHHHHHHHhccCCCCCCCHHHHhcChhhhhhhh
Q psy1546         260 ------------------NPPQLTGNYTKQFKEFVEACLNKDPENRPTAKELLKFPFIRKAKK  304 (604)
Q Consensus       260 ------------------~~~~~~~~~s~~l~~Li~~~L~~dP~~RpT~~elL~hp~f~~~~~  304 (604)
                                        ........++.++.+||.+||+.||.+|||+.|+|+||||+....
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~  323 (360)
T 3e3p_A          261 PSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELHD  323 (360)
T ss_dssp             TTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGGC
T ss_pred             cchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccCC
Confidence                              001122236789999999999999999999999999999987643

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=1.8e-42  Score=359.22  Aligned_cols=240  Identities=25%  Similarity=0.438  Sum_probs=210.5

Q ss_pred             ccceeeeEEcccCcEEEEEEEEC-----CCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCCeE----------E
Q psy1546          57 LIFTKQERIGKGSFGEVFKGIDN-----RTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTKL----------W  121 (604)
Q Consensus        57 ~~y~i~~~LG~G~fG~Vy~a~~~-----~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~~l----------y  121 (604)
                      ..|.+.+.||+|+||.||+|.+.     .+++.||||++...........+.+|+.+++.+.||++.++          |
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~  104 (322)
T 1p4o_A           25 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTL  104 (322)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCE
T ss_pred             hheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCCccE
Confidence            34999999999999999999876     46788999999766555566778999999999999997654          6


Q ss_pred             EEEEecCCCChhhHhhc-----------CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccc
Q psy1546         122 IIMEYLGGGSALDLMKA-----------GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGV  190 (604)
Q Consensus       122 LVmEy~~ggsL~~~l~~-----------~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGl  190 (604)
                      +||||+++|+|.+++..           ..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+
T Consensus       105 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~kl~Dfg~  184 (322)
T 1p4o_A          105 VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGM  184 (322)
T ss_dssp             EEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEEECCTTC
T ss_pred             EEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCCeEEECcCcc
Confidence            99999999999999864           4568999999999999999999999999999999999999999999999999


Q ss_pred             cccccCCCC--CCcccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHhhhcCCCCCCCCCcc
Q psy1546         191 AGTLTNTTS--KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAK-GEPPNSELHPMRVLFLIPKNNPPQLTGN  267 (604)
Q Consensus       191 A~~~~~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~  267 (604)
                      ++.......  ......||+.|+|||++.+..++.++|||||||++|+|++ |..||...........+........+..
T Consensus       185 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  264 (322)
T 1p4o_A          185 TRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPDN  264 (322)
T ss_dssp             CCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTCCCCCCTT
T ss_pred             ccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHHcCCcCCCCCC
Confidence            976543322  2234467899999999999999999999999999999999 8999999888777777666666667778


Q ss_pred             chHHHHHHHHHHhccCCCCCCCHHHHhcC
Q psy1546         268 YTKQFKEFVEACLNKDPENRPTAKELLKF  296 (604)
Q Consensus       268 ~s~~l~~Li~~~L~~dP~~RpT~~elL~h  296 (604)
                      ++..+.+||.+||..||.+|||+.|++++
T Consensus       265 ~~~~l~~li~~~l~~dp~~Rps~~e~l~~  293 (322)
T 1p4o_A          265 CPDMLFELMRMCWQYNPKMRPSFLEIISS  293 (322)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            99999999999999999999999999985

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=2.1e-42  Score=361.95  Aligned_cols=242  Identities=25%  Similarity=0.371  Sum_probs=195.8

Q ss_pred             ccceeeeEEcccCcEEEEEEEECCCC-cEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCC------C----------Ce
Q psy1546          57 LIFTKQERIGKGSFGEVFKGIDNRTQ-QVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPY------G----------TK  119 (604)
Q Consensus        57 ~~y~i~~~LG~G~fG~Vy~a~~~~t~-~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~------~----------~~  119 (604)
                      ..|.+.+.||+|+||.||+|.+..++ +.||||++....  ...+.+.+|+.+++.+.|++      .          ..
T Consensus        19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~   96 (355)
T 2eu9_A           19 ERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVG--KYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGH   96 (355)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCH--HHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTE
T ss_pred             ccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccc--cchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCe
Confidence            34999999999999999999998777 789999996542  33467788999998887654      2          34


Q ss_pred             EEEEEEecCCCChhhHhhc---CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEe-------------------
Q psy1546         120 LWIIMEYLGGGSALDLMKA---GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLL-------------------  177 (604)
Q Consensus       120 lyLVmEy~~ggsL~~~l~~---~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl-------------------  177 (604)
                      +||||||+ +++|.+++..   ..+++..++.++.||+.||.|||++||+||||||+||||                   
T Consensus        97 ~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~~  175 (355)
T 2eu9_A           97 MCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKS  175 (355)
T ss_dssp             EEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-CCCEEE
T ss_pred             EEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecccccccccccccccccc
Confidence            58999999 5556565543   369999999999999999999999999999999999999                   


Q ss_pred             cCCCCeEEecccccccccCCCCCCcccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcC
Q psy1546         178 SEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIP  257 (604)
Q Consensus       178 ~~~g~vKL~DFGlA~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~  257 (604)
                      +.++.+||+|||+++....   .....+||+.|+|||++.+..++.++|||||||+||||++|..||...........+.
T Consensus       176 ~~~~~~kl~Dfg~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~  252 (355)
T 2eu9_A          176 VKNTSIRVADFGSATFDHE---HHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMME  252 (355)
T ss_dssp             ESCCCEEECCCTTCEETTS---CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred             cCCCcEEEeecCccccccc---cccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            5678999999999975432   2345689999999999999999999999999999999999999998876554332211


Q ss_pred             CCC---C----------------------------------------CCCCccchHHHHHHHHHHhccCCCCCCCHHHHh
Q psy1546         258 KNN---P----------------------------------------PQLTGNYTKQFKEFVEACLNKDPENRPTAKELL  294 (604)
Q Consensus       258 ~~~---~----------------------------------------~~~~~~~s~~l~~Li~~~L~~dP~~RpT~~elL  294 (604)
                      ...   +                                        .......+.++.+||.+||..||.+|||+.|+|
T Consensus       253 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l  332 (355)
T 2eu9_A          253 KILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEAL  332 (355)
T ss_dssp             HHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHT
T ss_pred             HHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcCHHHHh
Confidence            100   0                                        001122356899999999999999999999999


Q ss_pred             cChhhhhhhh
Q psy1546         295 KFPFIRKAKK  304 (604)
Q Consensus       295 ~hp~f~~~~~  304 (604)
                      +||||.....
T Consensus       333 ~hp~f~~~~~  342 (355)
T 2eu9_A          333 LHPFFAGLTP  342 (355)
T ss_dssp             TSGGGGGCCH
T ss_pred             cChhhcCCCh
Confidence            9999987543

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=3e-42  Score=350.99  Aligned_cols=236  Identities=26%  Similarity=0.414  Sum_probs=204.4

Q ss_pred             cceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCCe----------EEEEEEec
Q psy1546          58 IFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTK----------LWIIMEYL  127 (604)
Q Consensus        58 ~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~~----------lyLVmEy~  127 (604)
                      .|.+.+.||+|+||.||+|.+. ++..||||++.......  +.+.+|+.++..+.||++.+          +|+||||+
T Consensus        25 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~--~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~  101 (283)
T 3gen_A           25 DLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSE--DEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM  101 (283)
T ss_dssp             GEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSBCH--HHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCC
T ss_pred             HHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCCCH--HHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEecc
Confidence            4999999999999999999876 57789999997654332  56889999999999999655          47999999


Q ss_pred             CCCChhhHhhc--CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCC-CCCccc
Q psy1546         128 GGGSALDLMKA--GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTT-SKRNTF  204 (604)
Q Consensus       128 ~ggsL~~~l~~--~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~-~~~~~~  204 (604)
                      ++++|.+++..  +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...... ......
T Consensus       102 ~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  181 (283)
T 3gen_A          102 ANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGS  181 (283)
T ss_dssp             TTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHHHSTTST
T ss_pred             CCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEccccccccccccccccccCC
Confidence            99999999965  679999999999999999999999999999999999999999999999999997654321 122334


Q ss_pred             ccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHhhhcCCCCCCCCCccchHHHHHHHHHHhccC
Q psy1546         205 VGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAK-GEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKD  283 (604)
Q Consensus       205 ~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~~L~~d  283 (604)
                      .+|+.|+|||++.+..++.++|||||||++|+|++ |..||...........+........+..+++.+.+||.+||..|
T Consensus       182 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~  261 (283)
T 3gen_A          182 KFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCWHEK  261 (283)
T ss_dssp             TSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSS
T ss_pred             ccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccCCCCCCcCCHHHHHHHHHHccCC
Confidence            57888999999999999999999999999999998 99999998888877777776666667788999999999999999


Q ss_pred             CCCCCCHHHHhcC
Q psy1546         284 PENRPTAKELLKF  296 (604)
Q Consensus       284 P~~RpT~~elL~h  296 (604)
                      |.+|||+.++++|
T Consensus       262 p~~Rps~~~ll~~  274 (283)
T 3gen_A          262 ADERPTFKILLSN  274 (283)
T ss_dssp             GGGSCCHHHHHHH
T ss_pred             hhHCcCHHHHHHH
Confidence            9999999999986

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=1.8e-42  Score=369.78  Aligned_cols=240  Identities=28%  Similarity=0.411  Sum_probs=194.1

Q ss_pred             ccceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCC-CCC-----C----------CeE
Q psy1546          57 LIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCD-SPY-----G----------TKL  120 (604)
Q Consensus        57 ~~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~-hp~-----~----------~~l  120 (604)
                      ..|.+.++||+|+||+||+|.+..+++.||||++....  .....+.+|+.++..+. |++     +          ..+
T Consensus        54 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~  131 (382)
T 2vx3_A           54 DRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKK--AFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHL  131 (382)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSH--HHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEE
T ss_pred             eeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccH--HHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCce
Confidence            34999999999999999999999999999999997543  33466777888888775 332     2          345


Q ss_pred             EEEEEecCCCChhhHhhc---CCCcHHHHHHHHHHHHHHhHHhh--hCCccccccccceeEec--CCCCeEEeccccccc
Q psy1546         121 WIIMEYLGGGSALDLMKA---GNFEEMHIAVILREVLKGLDYLH--SERKLHRDIKAANVLLS--EMGDVKLADFGVAGT  193 (604)
Q Consensus       121 yLVmEy~~ggsL~~~l~~---~~lse~~i~~i~~qIl~gL~yLH--s~gIiHrDLKp~NILl~--~~g~vKL~DFGlA~~  193 (604)
                      ||||||++ ++|.+++..   +.+++..++.++.||+.||.|||  +.||+||||||+||||+  .++.+||+|||+|+.
T Consensus       132 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~~  210 (382)
T 2vx3_A          132 CLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQ  210 (382)
T ss_dssp             EEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCCTTCEE
T ss_pred             EEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEeccCcee
Confidence            89999996 589998865   45899999999999999999999  57999999999999995  467899999999976


Q ss_pred             ccCCCCCCcccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCCC--C----------
Q psy1546         194 LTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNN--P----------  261 (604)
Q Consensus       194 ~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~~--~----------  261 (604)
                      ....   ....+||+.|+|||++.+..++.++|||||||+||||++|.+||.+.+.......+....  +          
T Consensus       211 ~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  287 (382)
T 2vx3_A          211 LGQR---IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPK  287 (382)
T ss_dssp             TTCC---CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTCTT
T ss_pred             cccc---cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhHH
Confidence            6432   345689999999999999999999999999999999999999999877654433221100  0          


Q ss_pred             --------------------------CCCC-------------------------ccchHHHHHHHHHHhccCCCCCCCH
Q psy1546         262 --------------------------PQLT-------------------------GNYTKQFKEFVEACLNKDPENRPTA  290 (604)
Q Consensus       262 --------------------------~~~~-------------------------~~~s~~l~~Li~~~L~~dP~~RpT~  290 (604)
                                                +...                         ....+++.+||.+||..||.+|||+
T Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~Rpta  367 (382)
T 2vx3_A          288 ARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQP  367 (382)
T ss_dssp             HHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSCTTTSCCH
T ss_pred             HHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCChhhCCCH
Confidence                                      0000                         0012478999999999999999999


Q ss_pred             HHHhcChhhhhh
Q psy1546         291 KELLKFPFIRKA  302 (604)
Q Consensus       291 ~elL~hp~f~~~  302 (604)
                      .|+|+||||++.
T Consensus       368 ~e~L~hp~f~~~  379 (382)
T 2vx3_A          368 YYALQHSFFKKT  379 (382)
T ss_dssp             HHHTTSGGGCC-
T ss_pred             HHHhcCcccccC
Confidence            999999999764

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=1e-42  Score=374.58  Aligned_cols=241  Identities=25%  Similarity=0.418  Sum_probs=178.7

Q ss_pred             ccee-eeEEcccCcEEEEEEEEC--CCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCC------------eEEE
Q psy1546          58 IFTK-QERIGKGSFGEVFKGIDN--RTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGT------------KLWI  122 (604)
Q Consensus        58 ~y~i-~~~LG~G~fG~Vy~a~~~--~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~------------~lyL  122 (604)
                      .|.+ .++||+|+||.||+|++.  .+++.||||++......   ..+.+|+.+|+.+.|||++            .+||
T Consensus        21 ~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~---~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~l   97 (405)
T 3rgf_A           21 LFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGIS---MSACREIALLRELKHPNVISLQKVFLSHADRKVWL   97 (405)
T ss_dssp             HEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCC---HHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEE
T ss_pred             hhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCC---HHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEE
Confidence            4666 568999999999999966  57889999999755432   3577899999999999854            3579


Q ss_pred             EEEecCCCChhhHhhc----------CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEe----cCCCCeEEecc
Q psy1546         123 IMEYLGGGSALDLMKA----------GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLL----SEMGDVKLADF  188 (604)
Q Consensus       123 VmEy~~ggsL~~~l~~----------~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl----~~~g~vKL~DF  188 (604)
                      ||||++ ++|.+++..          ..+++..++.|+.||+.||.|||++||+||||||+||||    +.++.+||+||
T Consensus        98 v~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Df  176 (405)
T 3rgf_A           98 LFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADM  176 (405)
T ss_dssp             EEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCEEECCT
T ss_pred             EEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcEEEEEC
Confidence            999996 467776642          249999999999999999999999999999999999999    67789999999


Q ss_pred             cccccccCCC---CCCcccccCCCCCChHHhhcC-CCCCcchhhhHHHHHHHHHhCCCCCCCCChh---------hHhhh
Q psy1546         189 GVAGTLTNTT---SKRNTFVGTPFWMAPEVIKQS-AYDSKADIWSLGITAIELAKGEPPNSELHPM---------RVLFL  255 (604)
Q Consensus       189 GlA~~~~~~~---~~~~~~~GT~~Y~APE~l~~~-~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~---------~~~~~  255 (604)
                      |+|+.+....   ......+||+.|+|||++.+. .|+.++|||||||+||+|++|.+||......         ..+..
T Consensus       177 g~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~~  256 (405)
T 3rgf_A          177 GFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDR  256 (405)
T ss_dssp             TCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHHH
T ss_pred             CCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHHH
Confidence            9997664322   233457899999999999874 5899999999999999999999999765431         11110


Q ss_pred             cC---CCCCCC----------------------------------CCccchHHHHHHHHHHhccCCCCCCCHHHHhcChh
Q psy1546         256 IP---KNNPPQ----------------------------------LTGNYTKQFKEFVEACLNKDPENRPTAKELLKFPF  298 (604)
Q Consensus       256 i~---~~~~~~----------------------------------~~~~~s~~l~~Li~~~L~~dP~~RpT~~elL~hp~  298 (604)
                      +.   ......                                  .....+..+.+||.+||..||.+|||++|||+|||
T Consensus       257 i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~hp~  336 (405)
T 3rgf_A          257 IFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPY  336 (405)
T ss_dssp             HHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred             HHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChh
Confidence            00   000000                                  00112668899999999999999999999999999


Q ss_pred             hhhh
Q psy1546         299 IRKA  302 (604)
Q Consensus       299 f~~~  302 (604)
                      |...
T Consensus       337 f~~~  340 (405)
T 3rgf_A          337 FLED  340 (405)
T ss_dssp             GTSS
T ss_pred             hccC
Confidence            9754

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=4.8e-42  Score=356.26  Aligned_cols=245  Identities=27%  Similarity=0.445  Sum_probs=200.2

Q ss_pred             ccceeeeEEcccCcEEEEEEEEC-CCCcEEEEEEecchhhHH-HHHHHHHHHHHHhhC---CCCCCCe------------
Q psy1546          57 LIFTKQERIGKGSFGEVFKGIDN-RTQQVVAIKIIDLEEAED-EIEDIQQEIMVLSQC---DSPYGTK------------  119 (604)
Q Consensus        57 ~~y~i~~~LG~G~fG~Vy~a~~~-~t~~~vAVK~i~~~~~~~-~~~~l~~Ei~iL~~l---~hp~~~~------------  119 (604)
                      ..|.+.+.||+|+||.||+|.+. .+++.||||++....... ....+.+|+.+++.+   .||++.+            
T Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~   90 (326)
T 1blx_A           11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   90 (326)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSS
T ss_pred             hceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccCC
Confidence            45999999999999999999995 678999999986543221 123445666666655   8998654            


Q ss_pred             ---EEEEEEecCCCChhhHhhc---CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEeccccccc
Q psy1546         120 ---LWIIMEYLGGGSALDLMKA---GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGT  193 (604)
Q Consensus       120 ---lyLVmEy~~ggsL~~~l~~---~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~  193 (604)
                         +|+||||++ |+|.+++..   ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus        91 ~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~Dfg~~~~  169 (326)
T 1blx_A           91 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARI  169 (326)
T ss_dssp             EEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCCC
T ss_pred             CceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEecCccccc
Confidence               469999997 689998865   3499999999999999999999999999999999999999999999999999976


Q ss_pred             ccCCCCCCcccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCC---------------
Q psy1546         194 LTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPK---------------  258 (604)
Q Consensus       194 ~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~---------------  258 (604)
                      .... .......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.........+..               
T Consensus       170 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  248 (326)
T 1blx_A          170 YSFQ-MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVA  248 (326)
T ss_dssp             CCGG-GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCS
T ss_pred             ccCC-CCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcccCccccc
Confidence            5432 233456799999999999999999999999999999999999999998776544332210               


Q ss_pred             -----------CCCCCCCccchHHHHHHHHHHhccCCCCCCCHHHHhcChhhhhhh
Q psy1546         259 -----------NNPPQLTGNYTKQFKEFVEACLNKDPENRPTAKELLKFPFIRKAK  303 (604)
Q Consensus       259 -----------~~~~~~~~~~s~~l~~Li~~~L~~dP~~RpT~~elL~hp~f~~~~  303 (604)
                                 .....+...++..+.+||.+||..||.+|||+.|+|+||||+...
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~  304 (326)
T 1blx_A          249 LPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLE  304 (326)
T ss_dssp             SCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred             cchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccccc
Confidence                       001123356789999999999999999999999999999997643

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=4.7e-42  Score=346.85  Aligned_cols=237  Identities=26%  Similarity=0.403  Sum_probs=206.7

Q ss_pred             ccceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCCeE----------EEEEEe
Q psy1546          57 LIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTKL----------WIIMEY  126 (604)
Q Consensus        57 ~~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~~l----------yLVmEy  126 (604)
                      ..|++.+.||+|+||.||+|.+. ++..||||++.......  +.+.+|+.++..+.||++.++          |+||||
T Consensus         8 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~--~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (268)
T 3sxs_A            8 EEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSMSE--DEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEY   84 (268)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTBCH--HHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred             hheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCCcH--HHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEc
Confidence            34999999999999999999876 56779999997654332  568899999999999996654          799999


Q ss_pred             cCCCChhhHhhc--CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCC-CCcc
Q psy1546         127 LGGGSALDLMKA--GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTS-KRNT  203 (604)
Q Consensus       127 ~~ggsL~~~l~~--~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~-~~~~  203 (604)
                      +++++|.+++..  ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++........ ....
T Consensus        85 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~  164 (268)
T 3sxs_A           85 ISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVG  164 (268)
T ss_dssp             CTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEEECCS
T ss_pred             cCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCccceecchhhhhcccC
Confidence            999999999865  3599999999999999999999999999999999999999999999999999976543322 2233


Q ss_pred             cccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHhhhcCCCCCCCCCccchHHHHHHHHHHhcc
Q psy1546         204 FVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAK-GEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNK  282 (604)
Q Consensus       204 ~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~~L~~  282 (604)
                      ..+|+.|+|||++.+..++.++|||||||++|+|++ |..||...........+........+..+++.+.+||.+||..
T Consensus       165 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~  244 (268)
T 3sxs_A          165 TKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYRPHLASDTIYQIMYSCWHE  244 (268)
T ss_dssp             CCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTTSCHHHHHHHHHTTCS
T ss_pred             CCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCCCCCCCcChHHHHHHHHHHcCC
Confidence            456778999999999999999999999999999999 9999999888877777766666666777899999999999999


Q ss_pred             CCCCCCCHHHHhcC
Q psy1546         283 DPENRPTAKELLKF  296 (604)
Q Consensus       283 dP~~RpT~~elL~h  296 (604)
                      ||.+|||+.|++++
T Consensus       245 ~p~~Rps~~~ll~~  258 (268)
T 3sxs_A          245 LPEKRPTFQQLLSS  258 (268)
T ss_dssp             SGGGSCCHHHHHHH
T ss_pred             ChhhCcCHHHHHHH
Confidence            99999999999985

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=3.8e-42  Score=359.94  Aligned_cols=240  Identities=25%  Similarity=0.458  Sum_probs=208.5

Q ss_pred             ccceeeeEEcccCcEEEEEEEEC-------CCCcEEEEEEecchhhHHHHHHHHHHHHHHhhC-CCCCCCeE--------
Q psy1546          57 LIFTKQERIGKGSFGEVFKGIDN-------RTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQC-DSPYGTKL--------  120 (604)
Q Consensus        57 ~~y~i~~~LG~G~fG~Vy~a~~~-------~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l-~hp~~~~l--------  120 (604)
                      ..|.+.+.||+|+||.||+|.+.       .++..||||++...........+.+|+.+++.+ .||++.++        
T Consensus        35 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~  114 (334)
T 2pvf_A           35 DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG  114 (334)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             hHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccCC
Confidence            45999999999999999999976       467789999998766666678899999999999 89997654        


Q ss_pred             --EEEEEecCCCChhhHhhcC-----------------CCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCC
Q psy1546         121 --WIIMEYLGGGSALDLMKAG-----------------NFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMG  181 (604)
Q Consensus       121 --yLVmEy~~ggsL~~~l~~~-----------------~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g  181 (604)
                        |+||||+++|+|.+++...                 .+++..++.++.||+.||.|||++||+||||||+||||+.++
T Consensus       115 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~  194 (334)
T 2pvf_A          115 PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENN  194 (334)
T ss_dssp             CCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC
T ss_pred             ceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccceEEEcCCC
Confidence              7999999999999998753                 388999999999999999999999999999999999999999


Q ss_pred             CeEEecccccccccCCCC--CCcccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHhhhcCC
Q psy1546         182 DVKLADFGVAGTLTNTTS--KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAK-GEPPNSELHPMRVLFLIPK  258 (604)
Q Consensus       182 ~vKL~DFGlA~~~~~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~~i~~  258 (604)
                      .+||+|||+++.......  ......+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+....+....+..
T Consensus       195 ~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~  274 (334)
T 2pvf_A          195 VMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKE  274 (334)
T ss_dssp             CEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHH
T ss_pred             CEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHHHHHHhc
Confidence            999999999976654322  2233457889999999999999999999999999999999 9999998887777766666


Q ss_pred             CCCCCCCccchHHHHHHHHHHhccCCCCCCCHHHHhcC
Q psy1546         259 NNPPQLTGNYTKQFKEFVEACLNKDPENRPTAKELLKF  296 (604)
Q Consensus       259 ~~~~~~~~~~s~~l~~Li~~~L~~dP~~RpT~~elL~h  296 (604)
                      ......+..++..+.+||.+||..||.+|||+.||+++
T Consensus       275 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  312 (334)
T 2pvf_A          275 GHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED  312 (334)
T ss_dssp             TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            65666677889999999999999999999999999874

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.9e-42  Score=361.28  Aligned_cols=241  Identities=25%  Similarity=0.388  Sum_probs=201.4

Q ss_pred             ccceeeeEEcccCcEEEEEEEE-----CCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhC-CCCCCCeE----------
Q psy1546          57 LIFTKQERIGKGSFGEVFKGID-----NRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQC-DSPYGTKL----------  120 (604)
Q Consensus        57 ~~y~i~~~LG~G~fG~Vy~a~~-----~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l-~hp~~~~l----------  120 (604)
                      ..|.+.+.||+|+||.||+|.+     ..++..||||++.........+.+.+|+.++.++ .||++.++          
T Consensus        45 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~  124 (344)
T 1rjb_A           45 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPI  124 (344)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             HHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCCcc
Confidence            4589999999999999999997     3466789999997655455567889999999999 99997654          


Q ss_pred             EEEEEecCCCChhhHhhcC------------------------CCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeE
Q psy1546         121 WIIMEYLGGGSALDLMKAG------------------------NFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVL  176 (604)
Q Consensus       121 yLVmEy~~ggsL~~~l~~~------------------------~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NIL  176 (604)
                      |+||||+++|+|.+++...                        .+++..++.++.||+.||.|||++||+||||||+|||
T Consensus       125 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl  204 (344)
T 1rjb_A          125 YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVL  204 (344)
T ss_dssp             EEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGEE
T ss_pred             EEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEE
Confidence            7999999999999999653                        2789999999999999999999999999999999999


Q ss_pred             ecCCCCeEEecccccccccCCCC--CCcccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHh
Q psy1546         177 LSEMGDVKLADFGVAGTLTNTTS--KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAK-GEPPNSELHPMRVL  253 (604)
Q Consensus       177 l~~~g~vKL~DFGlA~~~~~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLlt-G~~Pf~~~~~~~~~  253 (604)
                      |+.++.+||+|||++..+.....  ......||+.|+|||++.+..++.++|||||||+||+|++ |..||.+.......
T Consensus       205 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~  284 (344)
T 1rjb_A          205 VTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANF  284 (344)
T ss_dssp             EETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHH
T ss_pred             EcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCCcHHHH
Confidence            99999999999999976643322  2234567889999999999999999999999999999998 99999887644333


Q ss_pred             -hhcCCCCCCCCCccchHHHHHHHHHHhccCCCCCCCHHHHhcCh
Q psy1546         254 -FLIPKNNPPQLTGNYTKQFKEFVEACLNKDPENRPTAKELLKFP  297 (604)
Q Consensus       254 -~~i~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~RpT~~elL~hp  297 (604)
                       ..+........+..+++++.+||.+||..||.+|||+.+|++|.
T Consensus       285 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l  329 (344)
T 1rjb_A          285 YKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFL  329 (344)
T ss_dssp             HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             HHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHH
Confidence             33333444555677899999999999999999999999999863

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=1.8e-42  Score=365.77  Aligned_cols=245  Identities=23%  Similarity=0.374  Sum_probs=193.6

Q ss_pred             ccceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchh----------hHHHHHHHHHHHHHHhhCCCCCCC--------
Q psy1546          57 LIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE----------AEDEIEDIQQEIMVLSQCDSPYGT--------  118 (604)
Q Consensus        57 ~~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~----------~~~~~~~l~~Ei~iL~~l~hp~~~--------  118 (604)
                      ..|.+.+.||+|+||.||+|.+.. ++.||||++....          .....+.+.+|+.+++.+.|||+.        
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~  100 (362)
T 3pg1_A           22 SPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVH  100 (362)
T ss_dssp             CSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEEE
T ss_pred             cceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEEe
Confidence            349999999999999999999865 8999999985432          122357889999999999999854        


Q ss_pred             -------eEEEEEEecCCCChhhHhhc--CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEeccc
Q psy1546         119 -------KLWIIMEYLGGGSALDLMKA--GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFG  189 (604)
Q Consensus       119 -------~lyLVmEy~~ggsL~~~l~~--~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFG  189 (604)
                             .+|+||||++ |+|.+++..  ..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||
T Consensus       101 ~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg  179 (362)
T 3pg1_A          101 FEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFN  179 (362)
T ss_dssp             CCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCTT
T ss_pred             ccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCCEEEEecC
Confidence                   3589999997 577777754  369999999999999999999999999999999999999999999999999


Q ss_pred             ccccccCCCCCCcccccCCCCCChHHhhc-CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCC----------
Q psy1546         190 VAGTLTNTTSKRNTFVGTPFWMAPEVIKQ-SAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPK----------  258 (604)
Q Consensus       190 lA~~~~~~~~~~~~~~GT~~Y~APE~l~~-~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~----------  258 (604)
                      +++..... .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.........+..          
T Consensus       180 ~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  258 (362)
T 3pg1_A          180 LAREDTAD-ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDV  258 (362)
T ss_dssp             C----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred             cccccccc-cccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChHHh
Confidence            99654332 23345679999999999987 6789999999999999999999999998765443332210          


Q ss_pred             -------------CC----C----CCCCccchHHHHHHHHHHhccCCCCCCCHHHHhcChhhhhhhh
Q psy1546         259 -------------NN----P----PQLTGNYTKQFKEFVEACLNKDPENRPTAKELLKFPFIRKAKK  304 (604)
Q Consensus       259 -------------~~----~----~~~~~~~s~~l~~Li~~~L~~dP~~RpT~~elL~hp~f~~~~~  304 (604)
                                   ..    +    ......+++.+.+||.+||..||.+|||+.|+|+||||+....
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~  325 (362)
T 3pg1_A          259 VMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESLFD  325 (362)
T ss_dssp             HHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTTCC
T ss_pred             hhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhccC
Confidence                         00    0    0112345788999999999999999999999999999987643

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=3.4e-42  Score=358.58  Aligned_cols=246  Identities=35%  Similarity=0.599  Sum_probs=182.4

Q ss_pred             ccceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHH-HHhhCCCCCCCeE----------EEEEE
Q psy1546          57 LIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIM-VLSQCDSPYGTKL----------WIIME  125 (604)
Q Consensus        57 ~~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~-iL~~l~hp~~~~l----------yLVmE  125 (604)
                      ..|.+.+.||+|+||.||+|.+..+++.||||++...........+.+|+. +++.+.|||+.++          |+|||
T Consensus        22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e  101 (327)
T 3aln_A           22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICME  101 (327)
T ss_dssp             CSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             HHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEe
Confidence            348999999999999999999999999999999976554444455666665 7888999996654          69999


Q ss_pred             ecCCCChhhHhh------cCCCcHHHHHHHHHHHHHHhHHhhhC-CccccccccceeEecCCCCeEEecccccccccCCC
Q psy1546         126 YLGGGSALDLMK------AGNFEEMHIAVILREVLKGLDYLHSE-RKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTT  198 (604)
Q Consensus       126 y~~ggsL~~~l~------~~~lse~~i~~i~~qIl~gL~yLHs~-gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~  198 (604)
                      |+++ +|.+++.      .+.+++..+..++.||+.||.|||+. ||+||||||+||||+.++.+||+|||+++.+....
T Consensus       102 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~  180 (327)
T 3aln_A          102 LMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSI  180 (327)
T ss_dssp             CCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEECCCSSSCC-----
T ss_pred             ecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEEccCCCceeccccc
Confidence            9975 7777765      46799999999999999999999999 99999999999999999999999999997664332


Q ss_pred             CCCcccccCCCCCChHHh----hcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChh-hHhhhcCCCCCCCC----Cccch
Q psy1546         199 SKRNTFVGTPFWMAPEVI----KQSAYDSKADIWSLGITAIELAKGEPPNSELHPM-RVLFLIPKNNPPQL----TGNYT  269 (604)
Q Consensus       199 ~~~~~~~GT~~Y~APE~l----~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~-~~~~~i~~~~~~~~----~~~~s  269 (604)
                       ......||+.|+|||++    .+..++.++|||||||++|+|++|..||...... .....+.....+.+    ...++
T Consensus       181 -~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (327)
T 3aln_A          181 -AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNSEEREFS  259 (327)
T ss_dssp             --------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCCSCCCCCCCCSSCCCC
T ss_pred             -ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhcCCCCCCCCcccccCC
Confidence             23345799999999999    4667899999999999999999999999875432 23333333333322    24688


Q ss_pred             HHHHHHHHHHhccCCCCCCCHHHHhcChhhhhhhh
Q psy1546         270 KQFKEFVEACLNKDPENRPTAKELLKFPFIRKAKK  304 (604)
Q Consensus       270 ~~l~~Li~~~L~~dP~~RpT~~elL~hp~f~~~~~  304 (604)
                      ..+.+||.+||..||.+|||+.+|++||||.....
T Consensus       260 ~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~~~  294 (327)
T 3aln_A          260 PSFINFVNLCLTKDESKRPKYKELLKHPFILMYEE  294 (327)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHHH
T ss_pred             HHHHHHHHHHhhCChhhCcCHHHHHhChHHHHhHh
Confidence            99999999999999999999999999999986543

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.1e-41  Score=348.54  Aligned_cols=238  Identities=25%  Similarity=0.449  Sum_probs=207.3

Q ss_pred             cceeeeEEcccCcEEEEEEEECCCCc---EEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCCeE-----------EEE
Q psy1546          58 IFTKQERIGKGSFGEVFKGIDNRTQQ---VVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTKL-----------WII  123 (604)
Q Consensus        58 ~y~i~~~LG~G~fG~Vy~a~~~~t~~---~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~~l-----------yLV  123 (604)
                      .|.+.++||+|+||.||+|.+..+++   .||+|++.........+.+.+|+.+++.+.|||+.++           |+|
T Consensus        22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v  101 (298)
T 3pls_A           22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL  101 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred             EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence            47888999999999999999765544   7999999766666667889999999999999985543           799


Q ss_pred             EEecCCCChhhHhhc--CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCC----
Q psy1546         124 MEYLGGGSALDLMKA--GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNT----  197 (604)
Q Consensus       124 mEy~~ggsL~~~l~~--~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~----  197 (604)
                      |||+.+|+|.+++..  ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+...    
T Consensus       102 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~  181 (298)
T 3pls_A          102 LPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYS  181 (298)
T ss_dssp             ECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGGGC
T ss_pred             EecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCCcccc
Confidence            999999999999975  56899999999999999999999999999999999999999999999999999755432    


Q ss_pred             CCCCcccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHhhhcCCCCCCCCCccchHHHHHHH
Q psy1546         198 TSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAK-GEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFV  276 (604)
Q Consensus       198 ~~~~~~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li  276 (604)
                      ........+|+.|+|||++.+..++.++|||||||++|+|++ |.+||...........+........+..+++.+.+||
T Consensus       182 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  261 (298)
T 3pls_A          182 VQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRLPQPEYCPDSLYQVM  261 (298)
T ss_dssp             SCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCCCCCCTTCCHHHHHHH
T ss_pred             cccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCCCCCCccchHHHHHHH
Confidence            122344578899999999999999999999999999999999 6666777777777776666666667778899999999


Q ss_pred             HHHhccCCCCCCCHHHHhc
Q psy1546         277 EACLNKDPENRPTAKELLK  295 (604)
Q Consensus       277 ~~~L~~dP~~RpT~~elL~  295 (604)
                      .+||..||.+|||+.++++
T Consensus       262 ~~~l~~~p~~Rps~~~ll~  280 (298)
T 3pls_A          262 QQCWEADPAVRPTFRVLVG  280 (298)
T ss_dssp             HHHTCSSGGGSCCHHHHHH
T ss_pred             HHHccCChhhCcCHHHHHH
Confidence            9999999999999999987

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=4.1e-42  Score=354.32  Aligned_cols=240  Identities=26%  Similarity=0.418  Sum_probs=204.7

Q ss_pred             ccceeeeEEcccCcEEEEEEEE-----CCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhC-CCCCCCeE----------
Q psy1546          57 LIFTKQERIGKGSFGEVFKGID-----NRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQC-DSPYGTKL----------  120 (604)
Q Consensus        57 ~~y~i~~~LG~G~fG~Vy~a~~-----~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l-~hp~~~~l----------  120 (604)
                      ..|.+.+.||+|+||.||+|.+     ..+++.||||++.........+.+.+|+.+++++ .||++.++          
T Consensus        23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~  102 (313)
T 1t46_A           23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPT  102 (313)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             hhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCCc
Confidence            4599999999999999999985     4578899999998766555668899999999999 99997665          


Q ss_pred             EEEEEecCCCChhhHhhcC-------------------CCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCC
Q psy1546         121 WIIMEYLGGGSALDLMKAG-------------------NFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMG  181 (604)
Q Consensus       121 yLVmEy~~ggsL~~~l~~~-------------------~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g  181 (604)
                      |+||||+++|+|.+++...                   .+++..++.++.||+.||.|||++||+||||||+|||++.++
T Consensus       103 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~  182 (313)
T 1t46_A          103 LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGR  182 (313)
T ss_dssp             EEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEETTT
T ss_pred             EEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEcCCC
Confidence            6999999999999998653                   389999999999999999999999999999999999999999


Q ss_pred             CeEEecccccccccCCCC--CCcccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHh-hhcC
Q psy1546         182 DVKLADFGVAGTLTNTTS--KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAK-GEPPNSELHPMRVL-FLIP  257 (604)
Q Consensus       182 ~vKL~DFGlA~~~~~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLlt-G~~Pf~~~~~~~~~-~~i~  257 (604)
                      .+||+|||++........  ......||+.|+|||++.+..++.++|||||||++|+|++ |..||......... ..+.
T Consensus       183 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~  262 (313)
T 1t46_A          183 ITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIK  262 (313)
T ss_dssp             EEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHHHHH
T ss_pred             CEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhHHHHHhc
Confidence            999999999976654332  1234567889999999999999999999999999999998 99999876643332 2222


Q ss_pred             CCCCCCCCccchHHHHHHHHHHhccCCCCCCCHHHHhcC
Q psy1546         258 KNNPPQLTGNYTKQFKEFVEACLNKDPENRPTAKELLKF  296 (604)
Q Consensus       258 ~~~~~~~~~~~s~~l~~Li~~~L~~dP~~RpT~~elL~h  296 (604)
                      .......+..++..+.+||.+||..||.+|||+.||+++
T Consensus       263 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  301 (313)
T 1t46_A          263 EGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL  301 (313)
T ss_dssp             HTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             cCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence            333344456789999999999999999999999999984

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=2.8e-42  Score=368.14  Aligned_cols=239  Identities=26%  Similarity=0.441  Sum_probs=196.8

Q ss_pred             ccceeeeEEcccCcEEEEEEEEC---CCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCCeE----------EEE
Q psy1546          57 LIFTKQERIGKGSFGEVFKGIDN---RTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTKL----------WII  123 (604)
Q Consensus        57 ~~y~i~~~LG~G~fG~Vy~a~~~---~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~~l----------yLV  123 (604)
                      ..|.+.+.||+|+||.||+|++.   .++..||||++.........+.+.+|+.+++++.|||+.++          |||
T Consensus        45 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  124 (373)
T 2qol_A           45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIV  124 (373)
T ss_dssp             GGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred             hhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEE
Confidence            35899999999999999999876   46778999999766555566789999999999999997665          699


Q ss_pred             EEecCCCChhhHhhc--CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCCC-
Q psy1546         124 MEYLGGGSALDLMKA--GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSK-  200 (604)
Q Consensus       124 mEy~~ggsL~~~l~~--~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~-  200 (604)
                      ||||++|+|.+++..  ..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.+...... 
T Consensus       125 ~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~  204 (373)
T 2qol_A          125 TEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAA  204 (373)
T ss_dssp             EECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-------------
T ss_pred             EeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCccccccccCCccc
Confidence            999999999999975  36999999999999999999999999999999999999999999999999999766543221 


Q ss_pred             --CcccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHhhhcCCCCCCCCCccchHHHHHHHH
Q psy1546         201 --RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAK-GEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVE  277 (604)
Q Consensus       201 --~~~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~  277 (604)
                        .....+|+.|+|||++.+..++.++|||||||+||||++ |..||...........+........+..++..+.+||.
T Consensus       205 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~  284 (373)
T 2qol_A          205 YTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAALYQLML  284 (373)
T ss_dssp             ---------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTEECCCCTTCBHHHHHHHH
T ss_pred             eeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCccccHHHHHHHH
Confidence              112345788999999999999999999999999999998 99999988887777766655545556678999999999


Q ss_pred             HHhccCCCCCCCHHHHhc
Q psy1546         278 ACLNKDPENRPTAKELLK  295 (604)
Q Consensus       278 ~~L~~dP~~RpT~~elL~  295 (604)
                      +||..||.+||++.+|++
T Consensus       285 ~cl~~dp~~RPs~~~i~~  302 (373)
T 2qol_A          285 DCWQKDRNNRPKFEQIVS  302 (373)
T ss_dssp             HHTCSSGGGSCCHHHHHH
T ss_pred             HHhCcChhhCcCHHHHHH
Confidence            999999999999999987

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=7.1e-42  Score=345.69  Aligned_cols=235  Identities=29%  Similarity=0.521  Sum_probs=194.7

Q ss_pred             cceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhH---HHHHHHHHHHHHHhhCCCCCCCeE----------EEEE
Q psy1546          58 IFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAE---DEIEDIQQEIMVLSQCDSPYGTKL----------WIIM  124 (604)
Q Consensus        58 ~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~---~~~~~l~~Ei~iL~~l~hp~~~~l----------yLVm  124 (604)
                      .|.+.+.||+|+||.||+|.+.  ++.||||++......   ...+.+.+|+.+++.+.||++.++          |+||
T Consensus         8 ~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   85 (271)
T 3dtc_A            8 ELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVM   85 (271)
T ss_dssp             SEEEEEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEE
T ss_pred             heeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEE
Confidence            4899999999999999999975  889999998654322   235678899999999999997654          7999


Q ss_pred             EecCCCChhhHhhcCCCcHHHHHHHHHHHHHHhHHhhhCC---ccccccccceeEecC--------CCCeEEeccccccc
Q psy1546         125 EYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSER---KLHRDIKAANVLLSE--------MGDVKLADFGVAGT  193 (604)
Q Consensus       125 Ey~~ggsL~~~l~~~~lse~~i~~i~~qIl~gL~yLHs~g---IiHrDLKp~NILl~~--------~g~vKL~DFGlA~~  193 (604)
                      ||+++++|.+++..+.+++..++.++.||+.||.|||++|   |+||||||+|||++.        ++.+||+|||++..
T Consensus        86 e~~~~~~L~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~~~~  165 (271)
T 3dtc_A           86 EFARGGPLNRVLSGKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLARE  165 (271)
T ss_dssp             ECCTTEEHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC---
T ss_pred             EcCCCCCHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCCcccc
Confidence            9999999999999899999999999999999999999999   899999999999986        67899999999976


Q ss_pred             ccCCCCCCcccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCC-CCCCCCCccchHHH
Q psy1546         194 LTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPK-NNPPQLTGNYTKQF  272 (604)
Q Consensus       194 ~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~-~~~~~~~~~~s~~l  272 (604)
                      +....  .....||+.|+|||++.+..++.++|||||||++|+|++|..||...........+.. ......+..+++.+
T Consensus       166 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (271)
T 3dtc_A          166 WHRTT--KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIPSTCPEPF  243 (271)
T ss_dssp             ------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCCCCCCCTTCCHHH
T ss_pred             ccccc--ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCCCCCCCcccCHHH
Confidence            54332  2345799999999999999999999999999999999999999998877665554433 33445667889999


Q ss_pred             HHHHHHHhccCCCCCCCHHHHhcC
Q psy1546         273 KEFVEACLNKDPENRPTAKELLKF  296 (604)
Q Consensus       273 ~~Li~~~L~~dP~~RpT~~elL~h  296 (604)
                      .+||.+||..||.+|||+.|++++
T Consensus       244 ~~li~~~l~~~p~~Rps~~e~l~~  267 (271)
T 3dtc_A          244 AKLMEDCWNPDPHSRPSFTNILDQ  267 (271)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHhcCCcccCcCHHHHHHH
Confidence            999999999999999999999875

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=4.5e-42  Score=349.75  Aligned_cols=239  Identities=25%  Similarity=0.411  Sum_probs=205.3

Q ss_pred             cceeeeEEcccCcEEEEEEEECC---CCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCCeE---------EEEEE
Q psy1546          58 IFTKQERIGKGSFGEVFKGIDNR---TQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTKL---------WIIME  125 (604)
Q Consensus        58 ~y~i~~~LG~G~fG~Vy~a~~~~---t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~~l---------yLVmE  125 (604)
                      .|.+.+.||+|+||.||+|.+..   ++..||||++.........+.+.+|+.+++.+.||++.++         |+|||
T Consensus        13 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~v~e   92 (281)
T 3cc6_A           13 DVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEEPTWIIME   92 (281)
T ss_dssp             GEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSSSCEEEEE
T ss_pred             ceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCEEEEe
Confidence            49999999999999999998653   3456999999876555666889999999999999997665         69999


Q ss_pred             ecCCCChhhHhhc--CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCC-CCc
Q psy1546         126 YLGGGSALDLMKA--GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTS-KRN  202 (604)
Q Consensus       126 y~~ggsL~~~l~~--~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~-~~~  202 (604)
                      |+++++|.+++..  ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++........ ...
T Consensus        93 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~  172 (281)
T 3cc6_A           93 LYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKAS  172 (281)
T ss_dssp             CCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC---------
T ss_pred             cCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccCCCcccccccccccc
Confidence            9999999999965  4599999999999999999999999999999999999999999999999999976643322 223


Q ss_pred             ccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHhhhcCCCCCCCCCccchHHHHHHHHHHhc
Q psy1546         203 TFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAK-GEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLN  281 (604)
Q Consensus       203 ~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~~L~  281 (604)
                      ...+|+.|+|||++.+..++.++|||||||++|+|++ |..||...........+........+..+++.+.+||.+||.
T Consensus       173 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~  252 (281)
T 3cc6_A          173 VTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPKPDLCPPVLYTLMTRCWD  252 (281)
T ss_dssp             CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCCCCCCTTCCHHHHHHHHHHTC
T ss_pred             cCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcc
Confidence            4467889999999999999999999999999999998 999998877776666655555556667789999999999999


Q ss_pred             cCCCCCCCHHHHhcC
Q psy1546         282 KDPENRPTAKELLKF  296 (604)
Q Consensus       282 ~dP~~RpT~~elL~h  296 (604)
                      .||.+|||+.|++++
T Consensus       253 ~~p~~Rps~~ell~~  267 (281)
T 3cc6_A          253 YDPSDRPRFTELVCS  267 (281)
T ss_dssp             SSGGGSCCHHHHHHH
T ss_pred             CCchhCcCHHHHHHH
Confidence            999999999999985

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=1.1e-41  Score=349.51  Aligned_cols=239  Identities=25%  Similarity=0.419  Sum_probs=205.2

Q ss_pred             ccceeeeEEcccCcEEEEEEEECCC---CcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCCe-----------EEE
Q psy1546          57 LIFTKQERIGKGSFGEVFKGIDNRT---QQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTK-----------LWI  122 (604)
Q Consensus        57 ~~y~i~~~LG~G~fG~Vy~a~~~~t---~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~~-----------lyL  122 (604)
                      ..|.+.++||+|+||.||+|.+..+   ...||||.+.........+.+.+|+.+++++.||++.+           +|+
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  104 (298)
T 3f66_A           25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV  104 (298)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred             eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEE
Confidence            4589999999999999999997543   34689999977666666788999999999999998544           379


Q ss_pred             EEEecCCCChhhHhhc--CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCC--
Q psy1546         123 IMEYLGGGSALDLMKA--GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTT--  198 (604)
Q Consensus       123 VmEy~~ggsL~~~l~~--~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~--  198 (604)
                      ||||+++|+|.+++..  ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+....  
T Consensus       105 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~  184 (298)
T 3f66_A          105 VLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYY  184 (298)
T ss_dssp             EEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCGGGC
T ss_pred             EEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECcccccccccccchh
Confidence            9999999999999965  568999999999999999999999999999999999999999999999999997654322  


Q ss_pred             --CCCcccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHhhhcCCCCCCCCCccchHHHHHH
Q psy1546         199 --SKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAK-GEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEF  275 (604)
Q Consensus       199 --~~~~~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~L  275 (604)
                        .......||+.|+|||++.+..++.++|||||||++|+|++ |.+||...........+........+..++..+.+|
T Consensus       185 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  264 (298)
T 3f66_A          185 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEV  264 (298)
T ss_dssp             BC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCCCCCCTTCCHHHHHH
T ss_pred             ccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCCCCCCccCCHHHHHH
Confidence              12234567889999999999999999999999999999999 777888877777776666666666677889999999


Q ss_pred             HHHHhccCCCCCCCHHHHhc
Q psy1546         276 VEACLNKDPENRPTAKELLK  295 (604)
Q Consensus       276 i~~~L~~dP~~RpT~~elL~  295 (604)
                      |.+||..||.+|||+.|+++
T Consensus       265 i~~~l~~~p~~Rps~~ell~  284 (298)
T 3f66_A          265 MLKCWHPKAEMRPSFSELVS  284 (298)
T ss_dssp             HHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHcCCChhhCcCHHHHHH
Confidence            99999999999999999987

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=4.3e-42  Score=354.68  Aligned_cols=240  Identities=25%  Similarity=0.414  Sum_probs=204.7

Q ss_pred             ccceeeeEEcccCcEEEEEEEE-----CCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhC-CCCCCCe-----------
Q psy1546          57 LIFTKQERIGKGSFGEVFKGID-----NRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQC-DSPYGTK-----------  119 (604)
Q Consensus        57 ~~y~i~~~LG~G~fG~Vy~a~~-----~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l-~hp~~~~-----------  119 (604)
                      ..|.+.+.||+|+||.||+|.+     ..+++.||||++...........+.+|+.++..+ .||++.+           
T Consensus        27 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~  106 (316)
T 2xir_A           27 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP  106 (316)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSC
T ss_pred             hheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecCCCc
Confidence            4599999999999999999985     4577899999998766666667899999999999 6898544           


Q ss_pred             EEEEEEecCCCChhhHhhcCC-----------------CcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCC
Q psy1546         120 LWIIMEYLGGGSALDLMKAGN-----------------FEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGD  182 (604)
Q Consensus       120 lyLVmEy~~ggsL~~~l~~~~-----------------lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~  182 (604)
                      +|+||||+++++|.+++....                 +++..++.++.||+.||.|||++||+||||||+||||+.++.
T Consensus       107 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~  186 (316)
T 2xir_A          107 LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNV  186 (316)
T ss_dssp             CEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC
T ss_pred             eEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCC
Confidence            479999999999999997532                 899999999999999999999999999999999999999999


Q ss_pred             eEEecccccccccCCCC--CCcccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhh-HhhhcCC
Q psy1546         183 VKLADFGVAGTLTNTTS--KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAK-GEPPNSELHPMR-VLFLIPK  258 (604)
Q Consensus       183 vKL~DFGlA~~~~~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLlt-G~~Pf~~~~~~~-~~~~i~~  258 (604)
                      +||+|||+++.+.....  ......||+.|+|||++.+..++.++|||||||++|+|++ |..||....... ....+..
T Consensus       187 ~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~  266 (316)
T 2xir_A          187 VKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKE  266 (316)
T ss_dssp             EEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHHHHH
T ss_pred             EEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchhHHHHHHhcc
Confidence            99999999976543322  2334568899999999999999999999999999999998 999998765433 2333333


Q ss_pred             CCCCCCCccchHHHHHHHHHHhccCCCCCCCHHHHhcC
Q psy1546         259 NNPPQLTGNYTKQFKEFVEACLNKDPENRPTAKELLKF  296 (604)
Q Consensus       259 ~~~~~~~~~~s~~l~~Li~~~L~~dP~~RpT~~elL~h  296 (604)
                      ......+..++..+.++|.+||..||.+|||+.||++|
T Consensus       267 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  304 (316)
T 2xir_A          267 GTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  304 (316)
T ss_dssp             TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            44445567789999999999999999999999999986

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=1.8e-41  Score=350.35  Aligned_cols=245  Identities=33%  Similarity=0.597  Sum_probs=185.8

Q ss_pred             cceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHH-HHHHHHHHHHHhhCCCCCCCe----------EEEEEEe
Q psy1546          58 IFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDE-IEDIQQEIMVLSQCDSPYGTK----------LWIIMEY  126 (604)
Q Consensus        58 ~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~-~~~l~~Ei~iL~~l~hp~~~~----------lyLVmEy  126 (604)
                      .|.+.+.||+|+||.||+|.+..+++.||||++........ .+.+..+..+++.+.||++.+          +|+||||
T Consensus        26 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~e~  105 (318)
T 2dyl_A           26 DLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMEL  105 (318)
T ss_dssp             GEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECC
T ss_pred             cccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEec
Confidence            48999999999999999999999999999999976544333 344455566788999998655          4799999


Q ss_pred             cCCCChhhHhh--cCCCcHHHHHHHHHHHHHHhHHhhhC-CccccccccceeEecCCCCeEEecccccccccCCCCCCcc
Q psy1546         127 LGGGSALDLMK--AGNFEEMHIAVILREVLKGLDYLHSE-RKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNT  203 (604)
Q Consensus       127 ~~ggsL~~~l~--~~~lse~~i~~i~~qIl~gL~yLHs~-gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~~~~  203 (604)
                      + ++.+..+..  .+.+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||++..+.... ....
T Consensus       106 ~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~-~~~~  183 (318)
T 2dyl_A          106 M-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDK-AKDR  183 (318)
T ss_dssp             C-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC------------
T ss_pred             c-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCchhccCCc-cccc
Confidence            9 566666654  36799999999999999999999995 99999999999999999999999999997654322 2335


Q ss_pred             cccCCCCCChHHhh-----cCCCCCcchhhhHHHHHHHHHhCCCCCCCC-ChhhHhhhcCCCCCCCCC--ccchHHHHHH
Q psy1546         204 FVGTPFWMAPEVIK-----QSAYDSKADIWSLGITAIELAKGEPPNSEL-HPMRVLFLIPKNNPPQLT--GNYTKQFKEF  275 (604)
Q Consensus       204 ~~GT~~Y~APE~l~-----~~~~~~~sDVwSLGviL~eLltG~~Pf~~~-~~~~~~~~i~~~~~~~~~--~~~s~~l~~L  275 (604)
                      ..||+.|+|||++.     ...++.++|||||||++|+|++|..||... ........+.....+.++  ..++.++.+|
T Consensus       184 ~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  263 (318)
T 2dyl_A          184 SAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMGFSGDFQSF  263 (318)
T ss_dssp             ---CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCCCCCSSSCCCHHHHHH
T ss_pred             cCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCCCCCccCCCCHHHHHH
Confidence            67999999999994     566889999999999999999999999874 333333333333333332  3578999999


Q ss_pred             HHHHhccCCCCCCCHHHHhcChhhhhhhh
Q psy1546         276 VEACLNKDPENRPTAKELLKFPFIRKAKK  304 (604)
Q Consensus       276 i~~~L~~dP~~RpT~~elL~hp~f~~~~~  304 (604)
                      |.+||..||.+|||+.+|++||||+....
T Consensus       264 i~~~l~~dp~~Rps~~~ll~h~~~~~~~~  292 (318)
T 2dyl_A          264 VKDCLTKDHRKRPKYNKLLEHSFIKRYET  292 (318)
T ss_dssp             HHHHTCSCTTTSCCHHHHTTSHHHHHHHH
T ss_pred             HHHHccCChhHCcCHHHHhhCHHHHhccc
Confidence            99999999999999999999999987543

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=4e-42  Score=359.82  Aligned_cols=240  Identities=28%  Similarity=0.425  Sum_probs=202.5

Q ss_pred             cccceeeeEEcccCcEEEEEEEECCCCcEE----EEEEecchhhHHHHHHHHHHHHHHhhCCCCCCCe---------EEE
Q psy1546          56 ELIFTKQERIGKGSFGEVFKGIDNRTQQVV----AIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTK---------LWI  122 (604)
Q Consensus        56 ~~~y~i~~~LG~G~fG~Vy~a~~~~t~~~v----AVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~~---------lyL  122 (604)
                      ...|.+.++||+|+||.||+|.+..+++.|    |+|.+...........+.+|+.+++.+.|||+.+         .++
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~   93 (327)
T 3lzb_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQL   93 (327)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSSEEE
T ss_pred             HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCCceE
Confidence            345999999999999999999998888765    6666644433344577899999999999999655         469


Q ss_pred             EEEecCCCChhhHhhc--CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCC-
Q psy1546         123 IMEYLGGGSALDLMKA--GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTS-  199 (604)
Q Consensus       123 VmEy~~ggsL~~~l~~--~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~-  199 (604)
                      |+||+.+|+|.+++..  +.+++..++.|+.||+.||.|||++||+||||||+||||+.++.+||+|||+++.+..... 
T Consensus        94 v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~~~~~  173 (327)
T 3lzb_A           94 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE  173 (327)
T ss_dssp             EECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC----------
T ss_pred             EEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCcceeEccCcccc
Confidence            9999999999999865  5699999999999999999999999999999999999999999999999999976643322 


Q ss_pred             -CCcccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHhhhcCCCCCCCCCccchHHHHHHHH
Q psy1546         200 -KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAK-GEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVE  277 (604)
Q Consensus       200 -~~~~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~  277 (604)
                       ......||+.|+|||++.+..++.++|||||||+||+|++ |..||...........+........+..++.++.+||.
T Consensus       174 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  253 (327)
T 3lzb_A          174 YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMR  253 (327)
T ss_dssp             ------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTBCHHHHHHHH
T ss_pred             ccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHHHHHH
Confidence             2233457889999999999999999999999999999999 99999998888877777777666777889999999999


Q ss_pred             HHhccCCCCCCCHHHHhc
Q psy1546         278 ACLNKDPENRPTAKELLK  295 (604)
Q Consensus       278 ~~L~~dP~~RpT~~elL~  295 (604)
                      +||..||.+|||+.||++
T Consensus       254 ~~l~~dp~~Rps~~ell~  271 (327)
T 3lzb_A          254 KCWMIDADSRPKFRELII  271 (327)
T ss_dssp             HHTCSSGGGSCCHHHHHH
T ss_pred             HHcCCChhHCcCHHHHHH
Confidence            999999999999999997

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=9.5e-42  Score=347.83  Aligned_cols=237  Identities=26%  Similarity=0.476  Sum_probs=209.6

Q ss_pred             ccceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCCeE----------EEEEEe
Q psy1546          57 LIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTKL----------WIIMEY  126 (604)
Q Consensus        57 ~~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~~l----------yLVmEy  126 (604)
                      ..|.+.+.||+|+||.||+|.+..++..||||++.....  ..+.+.+|+.+++.+.||++.++          |+||||
T Consensus        13 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   90 (288)
T 3kfa_A           13 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM--EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF   90 (288)
T ss_dssp             GGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCST--HHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred             cceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHH--HHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEEc
Confidence            348999999999999999999999999999999975432  35778899999999999996554          799999


Q ss_pred             cCCCChhhHhhc---CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCC-CCc
Q psy1546         127 LGGGSALDLMKA---GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTS-KRN  202 (604)
Q Consensus       127 ~~ggsL~~~l~~---~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~-~~~  202 (604)
                      +++++|.+++..   ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++........ ...
T Consensus        91 ~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~  170 (288)
T 3kfa_A           91 MTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA  170 (288)
T ss_dssp             CTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSSSEEET
T ss_pred             CCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCccceeccCCcccccc
Confidence            999999999965   4599999999999999999999999999999999999999999999999999976653322 223


Q ss_pred             ccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHhhhcCCCCCCCCCccchHHHHHHHHHHhc
Q psy1546         203 TFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAK-GEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLN  281 (604)
Q Consensus       203 ~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~~L~  281 (604)
                      ...+|+.|+|||++.+..++.++|||||||++|+|++ |..||...........+........+..+++.+.+||.+||.
T Consensus       171 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~  250 (288)
T 3kfa_A          171 GAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQ  250 (288)
T ss_dssp             TEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCCTTCCHHHHHHHHHHTC
T ss_pred             CCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccCCCCCCCCCCHHHHHHHHHHhC
Confidence            4567889999999999999999999999999999999 999999888877777666666666777899999999999999


Q ss_pred             cCCCCCCCHHHHhc
Q psy1546         282 KDPENRPTAKELLK  295 (604)
Q Consensus       282 ~dP~~RpT~~elL~  295 (604)
                      .||.+|||+.++++
T Consensus       251 ~dp~~Rps~~~~~~  264 (288)
T 3kfa_A          251 WNPSDRPSFAEIHQ  264 (288)
T ss_dssp             SSGGGSCCHHHHHH
T ss_pred             CChhhCcCHHHHHH
Confidence            99999999999987

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=1e-41  Score=347.88  Aligned_cols=237  Identities=26%  Similarity=0.508  Sum_probs=200.8

Q ss_pred             cccceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHH------HHHHHHHHHHHHhhCCCCCCCeE--------E
Q psy1546          56 ELIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAED------EIEDIQQEIMVLSQCDSPYGTKL--------W  121 (604)
Q Consensus        56 ~~~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~------~~~~l~~Ei~iL~~l~hp~~~~l--------y  121 (604)
                      ...|.+.+.||+|+||.||+|.+..+++.||||++.......      ..+.+.+|+.+++.+.|||+.++        +
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~   97 (287)
T 4f0f_A           18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPPR   97 (287)
T ss_dssp             STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTTE
T ss_pred             hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCCe
Confidence            345999999999999999999999999999999986543221      12678899999999999998776        5


Q ss_pred             EEEEecCCCChhhHhhc--CCCcHHHHHHHHHHHHHHhHHhhhCC--ccccccccceeEecCCCC-----eEEecccccc
Q psy1546         122 IIMEYLGGGSALDLMKA--GNFEEMHIAVILREVLKGLDYLHSER--KLHRDIKAANVLLSEMGD-----VKLADFGVAG  192 (604)
Q Consensus       122 LVmEy~~ggsL~~~l~~--~~lse~~i~~i~~qIl~gL~yLHs~g--IiHrDLKp~NILl~~~g~-----vKL~DFGlA~  192 (604)
                      +||||+++|+|.+++..  ..+++..++.++.||+.||.|||++|  |+||||||+|||++.++.     +||+|||+++
T Consensus        98 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg~~~  177 (287)
T 4f0f_A           98 MVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ  177 (287)
T ss_dssp             EEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEECCCTTCB
T ss_pred             EEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeCCCCccc
Confidence            99999999999888744  57999999999999999999999999  999999999999988776     9999999996


Q ss_pred             cccCCCCCCcccccCCCCCChHHhh--cCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhH--h-hhcCCCCCCCCCcc
Q psy1546         193 TLTNTTSKRNTFVGTPFWMAPEVIK--QSAYDSKADIWSLGITAIELAKGEPPNSELHPMRV--L-FLIPKNNPPQLTGN  267 (604)
Q Consensus       193 ~~~~~~~~~~~~~GT~~Y~APE~l~--~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~--~-~~i~~~~~~~~~~~  267 (604)
                      ....   ......||+.|+|||++.  ...++.++|||||||++|+|++|..||........  . ........+.++..
T Consensus       178 ~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (287)
T 4f0f_A          178 QSVH---SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPTIPED  254 (287)
T ss_dssp             CCSS---CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSCCCCCCCTT
T ss_pred             cccc---cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccCCCCCCCcc
Confidence            5432   234567999999999994  45578899999999999999999999987654333  1 22233445566778


Q ss_pred             chHHHHHHHHHHhccCCCCCCCHHHHhc
Q psy1546         268 YTKQFKEFVEACLNKDPENRPTAKELLK  295 (604)
Q Consensus       268 ~s~~l~~Li~~~L~~dP~~RpT~~elL~  295 (604)
                      +++.+.+||.+||..||.+|||+.||++
T Consensus       255 ~~~~l~~li~~~l~~dp~~Rps~~~ll~  282 (287)
T 4f0f_A          255 CPPRLRNVIELCWSGDPKKRPHFSYIVK  282 (287)
T ss_dssp             SCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             cCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence            8999999999999999999999999986

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=6e-42  Score=351.70  Aligned_cols=239  Identities=26%  Similarity=0.431  Sum_probs=200.6

Q ss_pred             ccceeeeEEcccCcEEEEEEE----ECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCCe------------E
Q psy1546          57 LIFTKQERIGKGSFGEVFKGI----DNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTK------------L  120 (604)
Q Consensus        57 ~~y~i~~~LG~G~fG~Vy~a~----~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~~------------l  120 (604)
                      ..|++.++||+|+||.||+|.    +..+++.||||++...........+.+|+.+++.+.||++.+            +
T Consensus        21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~  100 (302)
T 4e5w_A           21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI  100 (302)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred             hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence            348999999999999999998    577899999999976655555678899999999999998544            4


Q ss_pred             EEEEEecCCCChhhHhhc--CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCC
Q psy1546         121 WIIMEYLGGGSALDLMKA--GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTT  198 (604)
Q Consensus       121 yLVmEy~~ggsL~~~l~~--~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~  198 (604)
                      |+||||+++++|.+++..  +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+....
T Consensus       101 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~  180 (302)
T 4e5w_A          101 KLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDK  180 (302)
T ss_dssp             EEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTC
T ss_pred             EEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECcccccccccCCC
Confidence            799999999999999843  569999999999999999999999999999999999999999999999999997665433


Q ss_pred             ---CCCcccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCC---------------hhhHhhhcCCCC
Q psy1546         199 ---SKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELH---------------PMRVLFLIPKNN  260 (604)
Q Consensus       199 ---~~~~~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~---------------~~~~~~~i~~~~  260 (604)
                         .......||..|+|||++.+..++.++|||||||++|+|++|..|+....               .......+....
T Consensus       181 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  260 (302)
T 4e5w_A          181 EYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEGK  260 (302)
T ss_dssp             CEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHHHHTTC
T ss_pred             cceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHHHhccC
Confidence               22345578889999999999999999999999999999999998754321               122233334444


Q ss_pred             CCCCCccchHHHHHHHHHHhccCCCCCCCHHHHhc
Q psy1546         261 PPQLTGNYTKQFKEFVEACLNKDPENRPTAKELLK  295 (604)
Q Consensus       261 ~~~~~~~~s~~l~~Li~~~L~~dP~~RpT~~elL~  295 (604)
                      ....+..+++.+.+||.+||..||.+|||+.++++
T Consensus       261 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  295 (302)
T 4e5w_A          261 RLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE  295 (302)
T ss_dssp             CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred             CCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence            55667788999999999999999999999999987

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=4.8e-42  Score=357.78  Aligned_cols=239  Identities=26%  Similarity=0.428  Sum_probs=204.5

Q ss_pred             ccceeeeEEcccCcEEEEEEEECCCCcEE--EEEEecchhhHHHHHHHHHHHHHHhhC-CCCCCCe----------EEEE
Q psy1546          57 LIFTKQERIGKGSFGEVFKGIDNRTQQVV--AIKIIDLEEAEDEIEDIQQEIMVLSQC-DSPYGTK----------LWII  123 (604)
Q Consensus        57 ~~y~i~~~LG~G~fG~Vy~a~~~~t~~~v--AVK~i~~~~~~~~~~~l~~Ei~iL~~l-~hp~~~~----------lyLV  123 (604)
                      ..|.+.+.||+|+||.||+|++..++..+  |||.+.........+.+.+|+.+++.+ .||++.+          +|+|
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv  104 (327)
T 1fvr_A           25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA  104 (327)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence            45999999999999999999999888865  999987655455567789999999999 9999655          4799


Q ss_pred             EEecCCCChhhHhhcC-----------------CCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEe
Q psy1546         124 MEYLGGGSALDLMKAG-----------------NFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLA  186 (604)
Q Consensus       124 mEy~~ggsL~~~l~~~-----------------~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~  186 (604)
                      |||+++++|.+++...                 .+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+
T Consensus       105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kL~  184 (327)
T 1fvr_A          105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIA  184 (327)
T ss_dssp             ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEEC
T ss_pred             EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCCCeEEEc
Confidence            9999999999998653                 58999999999999999999999999999999999999999999999


Q ss_pred             cccccccccCCCCCCcccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHhhhcCCCCCCCCC
Q psy1546         187 DFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAK-GEPPNSELHPMRVLFLIPKNNPPQLT  265 (604)
Q Consensus       187 DFGlA~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~  265 (604)
                      |||+++..... .......+++.|+|||++.+..++.++|||||||++|+|++ |..||...........+........+
T Consensus       185 Dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~~  263 (327)
T 1fvr_A          185 DFGLSRGQEVY-VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKP  263 (327)
T ss_dssp             CTTCEESSCEE-CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTCCCCCC
T ss_pred             ccCcCcccccc-ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhhcCCCCCCC
Confidence            99999643321 22234567899999999999999999999999999999998 99999998888777777766666667


Q ss_pred             ccchHHHHHHHHHHhccCCCCCCCHHHHhcC
Q psy1546         266 GNYTKQFKEFVEACLNKDPENRPTAKELLKF  296 (604)
Q Consensus       266 ~~~s~~l~~Li~~~L~~dP~~RpT~~elL~h  296 (604)
                      ..++..+.+||.+||..||.+|||+.|++++
T Consensus       264 ~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  294 (327)
T 1fvr_A          264 LNCDDEVYDLMRQCWREKPYERPSFAQILVS  294 (327)
T ss_dssp             TTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            7889999999999999999999999999885

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=6.9e-42  Score=359.32  Aligned_cols=241  Identities=28%  Similarity=0.408  Sum_probs=173.9

Q ss_pred             cccceeee-EEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCCe--------------E
Q psy1546          56 ELIFTKQE-RIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTK--------------L  120 (604)
Q Consensus        56 ~~~y~i~~-~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~~--------------l  120 (604)
                      ...|.+.+ .||+|+||.||+|.+..+++.||||++....     .........++.+.||++.+              +
T Consensus        27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~  101 (336)
T 3fhr_A           27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP-----KARQEVDHHWQASGGPHIVCILDVYENMHHGKRCL  101 (336)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH-----HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH-----HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceE
Confidence            34588855 6999999999999999999999999986532     11222333466778888543              5


Q ss_pred             EEEEEecCCCChhhHhhcC---CCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecC---CCCeEEecccccccc
Q psy1546         121 WIIMEYLGGGSALDLMKAG---NFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSE---MGDVKLADFGVAGTL  194 (604)
Q Consensus       121 yLVmEy~~ggsL~~~l~~~---~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~---~g~vKL~DFGlA~~~  194 (604)
                      |||||||++|+|.+++...   .+++..++.++.||+.||.|||++||+||||||+||||+.   ++.+||+|||+++..
T Consensus       102 ~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~  181 (336)
T 3fhr_A          102 LIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKET  181 (336)
T ss_dssp             EEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC
T ss_pred             EEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEeccccceec
Confidence            7999999999999999763   5999999999999999999999999999999999999976   455999999999765


Q ss_pred             cCCCCCCcccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhh----hcCC---CCCCCCCcc
Q psy1546         195 TNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLF----LIPK---NNPPQLTGN  267 (604)
Q Consensus       195 ~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~----~i~~---~~~~~~~~~  267 (604)
                      ...  .....+||+.|+|||++.+..++.++|||||||++|+|++|..||..........    .+..   ..+......
T Consensus       182 ~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (336)
T 3fhr_A          182 TQN--ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSE  259 (336)
T ss_dssp             ------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------CCCTTTSTT
T ss_pred             ccc--ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccccccCchhhcc
Confidence            432  2345678999999999988889999999999999999999999997765443311    1111   112223356


Q ss_pred             chHHHHHHHHHHhccCCCCCCCHHHHhcChhhhhhh
Q psy1546         268 YTKQFKEFVEACLNKDPENRPTAKELLKFPFIRKAK  303 (604)
Q Consensus       268 ~s~~l~~Li~~~L~~dP~~RpT~~elL~hp~f~~~~  303 (604)
                      ++.++.+||.+||..||.+|||+.|+|+||||+...
T Consensus       260 ~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~  295 (336)
T 3fhr_A          260 VSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSM  295 (336)
T ss_dssp             CCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTGG
T ss_pred             CCHHHHHHHHHHCCCChhHCcCHHHHhcCccccccc
Confidence            899999999999999999999999999999998643

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=5e-42  Score=357.77  Aligned_cols=234  Identities=27%  Similarity=0.361  Sum_probs=191.9

Q ss_pred             cceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCCe--------------EEEE
Q psy1546          58 IFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTK--------------LWII  123 (604)
Q Consensus        58 ~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~~--------------lyLV  123 (604)
                      .|.+.++||+|+||.||+|++.  ++.||||++.....  ......+|+.+++.+.|||+++              +|+|
T Consensus        25 ~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv  100 (322)
T 3soc_A           25 PLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQDK--QSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLI  100 (322)
T ss_dssp             EEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGGH--HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred             hchhhheecccCceEEEEEEEC--CCEEEEEEeecCch--HHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEE
Confidence            4999999999999999999876  78999999965432  2345567999999999999655              4799


Q ss_pred             EEecCCCChhhHhhcCCCcHHHHHHHHHHHHHHhHHhhhC----------CccccccccceeEecCCCCeEEeccccccc
Q psy1546         124 MEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSE----------RKLHRDIKAANVLLSEMGDVKLADFGVAGT  193 (604)
Q Consensus       124 mEy~~ggsL~~~l~~~~lse~~i~~i~~qIl~gL~yLHs~----------gIiHrDLKp~NILl~~~g~vKL~DFGlA~~  193 (604)
                      ||||++|+|.++++.+.+++..++.++.||+.||.|||+.          ||+||||||+||||+.++.+||+|||+|+.
T Consensus       101 ~e~~~~g~L~~~l~~~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg~a~~  180 (322)
T 3soc_A          101 TAFHEKGSLSDFLKANVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALK  180 (322)
T ss_dssp             EECCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred             EecCCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccCCcccc
Confidence            9999999999999999999999999999999999999999          999999999999999999999999999976


Q ss_pred             ccCCCC--CCcccccCCCCCChHHhhcC-----CCCCcchhhhHHHHHHHHHhCCCCCCCCChh----------------
Q psy1546         194 LTNTTS--KRNTFVGTPFWMAPEVIKQS-----AYDSKADIWSLGITAIELAKGEPPNSELHPM----------------  250 (604)
Q Consensus       194 ~~~~~~--~~~~~~GT~~Y~APE~l~~~-----~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~----------------  250 (604)
                      +.....  .....+||+.|+|||++.+.     .++.++|||||||+||||++|..||.+....                
T Consensus       181 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~  260 (322)
T 3soc_A          181 FEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLE  260 (322)
T ss_dssp             ECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSCCHH
T ss_pred             cccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCCchh
Confidence            654332  23346799999999999873     4556789999999999999999999754321                


Q ss_pred             hHhhh-cCCCCCCCCCc-----cchHHHHHHHHHHhccCCCCCCCHHHHhc
Q psy1546         251 RVLFL-IPKNNPPQLTG-----NYTKQFKEFVEACLNKDPENRPTAKELLK  295 (604)
Q Consensus       251 ~~~~~-i~~~~~~~~~~-----~~s~~l~~Li~~~L~~dP~~RpT~~elL~  295 (604)
                      ..... ......+.+..     ..+.++.+||.+||+.||.+|||+.||++
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~  311 (322)
T 3soc_A          261 DMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGE  311 (322)
T ss_dssp             HHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             hhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            11111 11222222222     23566999999999999999999999987

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=4.7e-42  Score=362.96  Aligned_cols=239  Identities=26%  Similarity=0.392  Sum_probs=193.6

Q ss_pred             cceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCC-----------CCCCC--------
Q psy1546          58 IFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCD-----------SPYGT--------  118 (604)
Q Consensus        58 ~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~-----------hp~~~--------  118 (604)
                      .|.+.+.||+|+||.||+|.+..+++.||||++....  .....+.+|+.+++.+.           |+++.        
T Consensus        20 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~   97 (373)
T 1q8y_A           20 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK--VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH   97 (373)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH--HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred             eEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCc--cchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhc
Confidence            4999999999999999999999999999999997543  23466788888888876           55532        


Q ss_pred             ------eEEEEEEecCCCChhhHhhc---CCCcHHHHHHHHHHHHHHhHHhhhC-CccccccccceeEec------CCCC
Q psy1546         119 ------KLWIIMEYLGGGSALDLMKA---GNFEEMHIAVILREVLKGLDYLHSE-RKLHRDIKAANVLLS------EMGD  182 (604)
Q Consensus       119 ------~lyLVmEy~~ggsL~~~l~~---~~lse~~i~~i~~qIl~gL~yLHs~-gIiHrDLKp~NILl~------~~g~  182 (604)
                            .+|+||||+ +++|.+++..   +.+++..++.++.||+.||.|||++ ||+||||||+||||+      ..+.
T Consensus        98 ~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~~~~~~  176 (373)
T 1q8y_A           98 KGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQ  176 (373)
T ss_dssp             EETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEE
T ss_pred             cCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCCcCcce
Confidence                  568999999 8999998865   5699999999999999999999998 999999999999995      3347


Q ss_pred             eEEecccccccccCCCCCCcccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChh------hHhhhc
Q psy1546         183 VKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPM------RVLFLI  256 (604)
Q Consensus       183 vKL~DFGlA~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~------~~~~~i  256 (604)
                      +||+|||+++.....   ....+||+.|+|||++.+..++.++|||||||+||+|++|..||......      .....+
T Consensus       177 ~kl~Dfg~a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~  253 (373)
T 1q8y_A          177 IKIADLGNACWYDEH---YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQI  253 (373)
T ss_dssp             EEECCCTTCEETTBC---CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHH
T ss_pred             EEEcccccccccCCC---CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHHHHH
Confidence            999999999766432   23457999999999999999999999999999999999999999865421      100000


Q ss_pred             ----C---------------------------CC----------CCCCCCccchHHHHHHHHHHhccCCCCCCCHHHHhc
Q psy1546         257 ----P---------------------------KN----------NPPQLTGNYTKQFKEFVEACLNKDPENRPTAKELLK  295 (604)
Q Consensus       257 ----~---------------------------~~----------~~~~~~~~~s~~l~~Li~~~L~~dP~~RpT~~elL~  295 (604)
                          .                           ..          ....++..++.++.+||.+||..||.+|||+.|||+
T Consensus       254 ~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  333 (373)
T 1q8y_A          254 IELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVN  333 (373)
T ss_dssp             HHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHT
T ss_pred             HHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHHHHhh
Confidence                0                           00          011234556788999999999999999999999999


Q ss_pred             Chhhhhh
Q psy1546         296 FPFIRKA  302 (604)
Q Consensus       296 hp~f~~~  302 (604)
                      ||||+..
T Consensus       334 hp~f~~~  340 (373)
T 1q8y_A          334 HPWLKDT  340 (373)
T ss_dssp             CGGGTTC
T ss_pred             Chhhhcc
Confidence            9999764

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.9e-41  Score=355.25  Aligned_cols=240  Identities=27%  Similarity=0.445  Sum_probs=201.6

Q ss_pred             ccceeeeEEcccCcEEEEEEEECCCC----cEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCCeE----------EE
Q psy1546          57 LIFTKQERIGKGSFGEVFKGIDNRTQ----QVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTKL----------WI  122 (604)
Q Consensus        57 ~~y~i~~~LG~G~fG~Vy~a~~~~t~----~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~~l----------yL  122 (604)
                      ..|.+.+.||+|+||.||+|.+..++    ..||||++...........+.+|+.+++.+.||++.++          ||
T Consensus        44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  123 (333)
T 1mqb_A           44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI  123 (333)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEE
Confidence            35899999999999999999876553    45999999766555566788999999999999996654          79


Q ss_pred             EEEecCCCChhhHhhc--CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCCC
Q psy1546         123 IMEYLGGGSALDLMKA--GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSK  200 (604)
Q Consensus       123 VmEy~~ggsL~~~l~~--~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~  200 (604)
                      ||||+++++|.+++..  +.+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.+......
T Consensus       124 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~  203 (333)
T 1mqb_A          124 ITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEA  203 (333)
T ss_dssp             EEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC----------
T ss_pred             EEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCCcchhhcccccc
Confidence            9999999999999865  57999999999999999999999999999999999999999999999999999766433221


Q ss_pred             ---CcccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHhhhcCCCCCCCCCccchHHHHHHH
Q psy1546         201 ---RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAK-GEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFV  276 (604)
Q Consensus       201 ---~~~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li  276 (604)
                         .....+|+.|+|||++.+..++.++|||||||++|+|++ |..||...........+........+..++..+.+||
T Consensus       204 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  283 (333)
T 1mqb_A          204 TYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSAIYQLM  283 (333)
T ss_dssp             -------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTCBHHHHHHH
T ss_pred             ccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCCcCCCcccCCHHHHHHH
Confidence               122346788999999999999999999999999999998 9999998888777777666655566678899999999


Q ss_pred             HHHhccCCCCCCCHHHHhcC
Q psy1546         277 EACLNKDPENRPTAKELLKF  296 (604)
Q Consensus       277 ~~~L~~dP~~RpT~~elL~h  296 (604)
                      .+||..||.+||++.+|+++
T Consensus       284 ~~~l~~~p~~Rps~~~l~~~  303 (333)
T 1mqb_A          284 MQCWQQERARRPKFADIVSI  303 (333)
T ss_dssp             HHHTCSSTTTSCCHHHHHHH
T ss_pred             HHHcCCChhhCcCHHHHHHH
Confidence            99999999999999999874

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=3.8e-42  Score=359.29  Aligned_cols=234  Identities=22%  Similarity=0.333  Sum_probs=195.2

Q ss_pred             ccceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhC-CCCCCCeE----------EEEEE
Q psy1546          57 LIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQC-DSPYGTKL----------WIIME  125 (604)
Q Consensus        57 ~~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l-~hp~~~~l----------yLVmE  125 (604)
                      ..|.+.+.||+|+||.||+|.+..+++.||||++.....   ...+.+|+.+++.+ .||++.++          |+|||
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e   85 (330)
T 2izr_A            9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR---APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE   85 (330)
T ss_dssp             TTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS---SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred             CCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc---hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence            349999999999999999999999999999999865432   24578899999999 99986654          79999


Q ss_pred             ecCCCChhhHhhc--CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCC-----eEEecccccccccCCC
Q psy1546         126 YLGGGSALDLMKA--GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGD-----VKLADFGVAGTLTNTT  198 (604)
Q Consensus       126 y~~ggsL~~~l~~--~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~-----vKL~DFGlA~~~~~~~  198 (604)
                      |+ +++|.+++..  +.+++..++.++.||+.||.|||++||+||||||+||||+.++.     +||+|||+|+.+....
T Consensus        86 ~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~~~  164 (330)
T 2izr_A           86 LL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPE  164 (330)
T ss_dssp             CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBCTT
T ss_pred             eC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceeeecCC
Confidence            99 9999999974  68999999999999999999999999999999999999998887     9999999998765433


Q ss_pred             CC-------CcccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhH---hhhcCCCC----CCCC
Q psy1546         199 SK-------RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRV---LFLIPKNN----PPQL  264 (604)
Q Consensus       199 ~~-------~~~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~---~~~i~~~~----~~~~  264 (604)
                      ..       ....+||+.|+|||++.+..++.++|||||||+||||++|..||.+......   ...+....    ...+
T Consensus       165 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~  244 (330)
T 2izr_A          165 TKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATPIEVL  244 (330)
T ss_dssp             TCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSCHHHH
T ss_pred             CCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccCCHHHH
Confidence            21       2467899999999999999999999999999999999999999987543222   22211110    0111


Q ss_pred             CccchHHHHHHHHHHhccCCCCCCCHHHHhc
Q psy1546         265 TGNYTKQFKEFVEACLNKDPENRPTAKELLK  295 (604)
Q Consensus       265 ~~~~s~~l~~Li~~~L~~dP~~RpT~~elL~  295 (604)
                      ...++ ++.+||.+||..||.+||++.+|++
T Consensus       245 ~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~  274 (330)
T 2izr_A          245 CENFP-EMATYLRYVRRLDFFEKPDYDYLRK  274 (330)
T ss_dssp             TTTCH-HHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred             hccCh-HHHHHHHHHHhCCCCCCCCHHHHHH
Confidence            22355 9999999999999999999999986

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=4.7e-42  Score=371.33  Aligned_cols=236  Identities=14%  Similarity=0.187  Sum_probs=196.2

Q ss_pred             cceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHH--HHHHHHHHHHHHhhCCCCC-------------------
Q psy1546          58 IFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAED--EIEDIQQEIMVLSQCDSPY-------------------  116 (604)
Q Consensus        58 ~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~--~~~~l~~Ei~iL~~l~hp~-------------------  116 (604)
                      .|.+.++||+|+||+||+|.+..+++.||||++.......  ..+.+.+|+.++..+.|..                   
T Consensus        79 ~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~  158 (413)
T 3dzo_A           79 TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVK  158 (413)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEE
T ss_pred             eEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhcc
Confidence            4788899999999999999999999999999987443222  2577889999999987721                   


Q ss_pred             ------------------CCeEEEEEEecCCCChhhHhh--------cCCCcHHHHHHHHHHHHHHhHHhhhCCcccccc
Q psy1546         117 ------------------GTKLWIIMEYLGGGSALDLMK--------AGNFEEMHIAVILREVLKGLDYLHSERKLHRDI  170 (604)
Q Consensus       117 ------------------~~~lyLVmEy~~ggsL~~~l~--------~~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDL  170 (604)
                                        ...+|++|+++ +++|.++++        .+.+++..+..++.||+.||.|||++|||||||
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHrDi  237 (413)
T 3dzo_A          159 DPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYL  237 (413)
T ss_dssp             CCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECSCC
T ss_pred             cCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCc
Confidence                              22356777766 788998884        345788899999999999999999999999999


Q ss_pred             ccceeEecCCCCeEEecccccccccCCCCCCcccccCCCCCChHHh----------hcCCCCCcchhhhHHHHHHHHHhC
Q psy1546         171 KAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVI----------KQSAYDSKADIWSLGITAIELAKG  240 (604)
Q Consensus       171 Kp~NILl~~~g~vKL~DFGlA~~~~~~~~~~~~~~GT~~Y~APE~l----------~~~~~~~~sDVwSLGviL~eLltG  240 (604)
                      ||+||||+.++.+||+|||+++.....   ....+| +.|||||++          .+..|+.++|||||||+||||++|
T Consensus       238 Kp~NILl~~~~~~kL~DFG~a~~~~~~---~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~elltg  313 (413)
T 3dzo_A          238 RPVDIVLDQRGGVFLTGFEHLVRDGAS---AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCA  313 (413)
T ss_dssp             CGGGEEECTTCCEEECCGGGCEETTEE---ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHHS
T ss_pred             ccceEEEecCCeEEEEeccceeecCCc---cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHHC
Confidence            999999999999999999999765433   345678 999999999          455588899999999999999999


Q ss_pred             CCCCCCCChhhHhhhcCCCCCCCCCccchHHHHHHHHHHhccCCCCCCCHHHHhcChhhhhhh
Q psy1546         241 EPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPENRPTAKELLKFPFIRKAK  303 (604)
Q Consensus       241 ~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~RpT~~elL~hp~f~~~~  303 (604)
                      ..||...........+....     ..+++.+.+||.+||..||.+|||+.++++||||+...
T Consensus       314 ~~Pf~~~~~~~~~~~~~~~~-----~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~~~~~~~~  371 (413)
T 3dzo_A          314 DLPNTDDAALGGSEWIFRSC-----KNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLR  371 (413)
T ss_dssp             SCCCCTTGGGSCSGGGGSSC-----CCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHH
T ss_pred             CCCCCCcchhhhHHHHHhhc-----ccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHHHHH
Confidence            99998876655444433221     35789999999999999999999999999999997653

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=1.7e-41  Score=347.58  Aligned_cols=239  Identities=26%  Similarity=0.441  Sum_probs=205.3

Q ss_pred             ccceeee-EEcccCcEEEEEEE--ECCCCcEEEEEEecchhh-HHHHHHHHHHHHHHhhCCCCCCCeE---------EEE
Q psy1546          57 LIFTKQE-RIGKGSFGEVFKGI--DNRTQQVVAIKIIDLEEA-EDEIEDIQQEIMVLSQCDSPYGTKL---------WII  123 (604)
Q Consensus        57 ~~y~i~~-~LG~G~fG~Vy~a~--~~~t~~~vAVK~i~~~~~-~~~~~~l~~Ei~iL~~l~hp~~~~l---------yLV  123 (604)
                      ..|.+.+ .||+|+||.||+|.  +..+++.||||++..... ....+.+.+|+.+++.+.||++.++         |+|
T Consensus        16 ~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~lv   95 (291)
T 1xbb_A           16 KLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESWMLV   95 (291)
T ss_dssp             GGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESSSEEEE
T ss_pred             hhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEECCCCcEEE
Confidence            3478887 99999999999995  456788999999975533 2335778999999999999996654         799


Q ss_pred             EEecCCCChhhHhhc-CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCCC--
Q psy1546         124 MEYLGGGSALDLMKA-GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSK--  200 (604)
Q Consensus       124 mEy~~ggsL~~~l~~-~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~--  200 (604)
                      |||+++++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.........  
T Consensus        96 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~  175 (291)
T 1xbb_A           96 MEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK  175 (291)
T ss_dssp             EECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEE
T ss_pred             EEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCcceeeccCCCccc
Confidence            999999999999976 56999999999999999999999999999999999999999999999999999766433221  


Q ss_pred             -CcccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHhhhcCCCCCCCCCccchHHHHHHHHH
Q psy1546         201 -RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAK-GEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEA  278 (604)
Q Consensus       201 -~~~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~  278 (604)
                       .....+|+.|+|||++.+..++.++|||||||++|+|++ |..||...........+.......++..++..+.+||.+
T Consensus       176 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  255 (291)
T 1xbb_A          176 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNL  255 (291)
T ss_dssp             C----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHH
T ss_pred             ccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHH
Confidence             223456788999999999899999999999999999999 999999988888777777777777778899999999999


Q ss_pred             HhccCCCCCCCHHHHhc
Q psy1546         279 CLNKDPENRPTAKELLK  295 (604)
Q Consensus       279 ~L~~dP~~RpT~~elL~  295 (604)
                      ||..||.+|||+.+|++
T Consensus       256 ~l~~dp~~Rps~~~l~~  272 (291)
T 1xbb_A          256 CWTYDVENRPGFAAVEL  272 (291)
T ss_dssp             HTCSSTTTSCCHHHHHH
T ss_pred             HcCCChhhCcCHHHHHH
Confidence            99999999999999987

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=1.7e-41  Score=350.86  Aligned_cols=240  Identities=23%  Similarity=0.404  Sum_probs=199.4

Q ss_pred             ccceeeeEEcccCcEEEEEEEECC---CCcEEEEEEecchh-hHHHHHHHHHHHHHHhhCCCCCCCe-------------
Q psy1546          57 LIFTKQERIGKGSFGEVFKGIDNR---TQQVVAIKIIDLEE-AEDEIEDIQQEIMVLSQCDSPYGTK-------------  119 (604)
Q Consensus        57 ~~y~i~~~LG~G~fG~Vy~a~~~~---t~~~vAVK~i~~~~-~~~~~~~l~~Ei~iL~~l~hp~~~~-------------  119 (604)
                      ..|.+.+.||+|+||.||+|.+..   +++.||||++.... .....+.+.+|+.+++.+.||++.+             
T Consensus        34 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~  113 (313)
T 3brb_A           34 NLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGI  113 (313)
T ss_dssp             GGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC------
T ss_pred             HHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccccCC
Confidence            459999999999999999998765   56689999987553 2345678899999999999998543             


Q ss_pred             --EEEEEEecCCCChhhHhh-------cCCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccc
Q psy1546         120 --LWIIMEYLGGGSALDLMK-------AGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGV  190 (604)
Q Consensus       120 --lyLVmEy~~ggsL~~~l~-------~~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGl  190 (604)
                        +|+||||+++++|.+++.       ...+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+
T Consensus       114 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kl~Dfg~  193 (313)
T 3brb_A          114 PKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGL  193 (313)
T ss_dssp             -CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSCEEECSCSC
T ss_pred             cccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEEeecCc
Confidence              389999999999999883       24699999999999999999999999999999999999999999999999999


Q ss_pred             cccccCCC--CCCcccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHhhhcCCCCCCCCCcc
Q psy1546         191 AGTLTNTT--SKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAK-GEPPNSELHPMRVLFLIPKNNPPQLTGN  267 (604)
Q Consensus       191 A~~~~~~~--~~~~~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~  267 (604)
                      ++.+....  .......+++.|+|||++.+..++.++|||||||++|+|++ |..||...........+........+..
T Consensus       194 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  273 (313)
T 3brb_A          194 SKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHRLKQPED  273 (313)
T ss_dssp             C----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCBTT
T ss_pred             ceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHcCCCCCCCcc
Confidence            97664332  12233457889999999999999999999999999999999 9999998888777776666666677788


Q ss_pred             chHHHHHHHHHHhccCCCCCCCHHHHhcC
Q psy1546         268 YTKQFKEFVEACLNKDPENRPTAKELLKF  296 (604)
Q Consensus       268 ~s~~l~~Li~~~L~~dP~~RpT~~elL~h  296 (604)
                      ++..+.+||.+||..||.+|||+.+|+++
T Consensus       274 ~~~~l~~li~~~l~~dp~~Rps~~~l~~~  302 (313)
T 3brb_A          274 CLDELYEIMYSCWRTDPLDRPTFSVLRLQ  302 (313)
T ss_dssp             CCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             ccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            99999999999999999999999999874

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=1.6e-41  Score=347.45  Aligned_cols=235  Identities=20%  Similarity=0.317  Sum_probs=195.2

Q ss_pred             ccceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhC-CCCCCCe----------EEEEEE
Q psy1546          57 LIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQC-DSPYGTK----------LWIIME  125 (604)
Q Consensus        57 ~~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l-~hp~~~~----------lyLVmE  125 (604)
                      ..|.+.+.||+|+||.||+|.+..+++.||||++.....   ...+.+|+.++..+ .|+++.+          +|+|||
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e   86 (298)
T 1csn_A           10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD---APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID   86 (298)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT---SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred             cceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCc---cHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEE
Confidence            349999999999999999999999999999999865432   24577899999998 6777543          479999


Q ss_pred             ecCCCChhhHhhc--CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCC-----eEEecccccccccCCC
Q psy1546         126 YLGGGSALDLMKA--GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGD-----VKLADFGVAGTLTNTT  198 (604)
Q Consensus       126 y~~ggsL~~~l~~--~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~-----vKL~DFGlA~~~~~~~  198 (604)
                      |+ +++|.+++..  ..+++..++.++.||+.||.|||++||+||||||+||||+.++.     +||+|||+++.+....
T Consensus        87 ~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~~  165 (298)
T 1csn_A           87 LL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPV  165 (298)
T ss_dssp             CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTT
T ss_pred             ec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECcccccccccc
Confidence            99 9999999975  46999999999999999999999999999999999999987776     9999999997665432


Q ss_pred             C-------CCcccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChh---hHhhhcCC----CCCCCC
Q psy1546         199 S-------KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPM---RVLFLIPK----NNPPQL  264 (604)
Q Consensus       199 ~-------~~~~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~---~~~~~i~~----~~~~~~  264 (604)
                      .       ......||+.|+|||++.+..++.++|||||||+||+|++|..||......   .....+..    .....+
T Consensus       166 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (298)
T 1csn_A          166 TKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLREL  245 (298)
T ss_dssp             TCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHHHH
T ss_pred             ccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCccHHHH
Confidence            2       234567999999999999999999999999999999999999999875422   22211111    111122


Q ss_pred             CccchHHHHHHHHHHhccCCCCCCCHHHHhc
Q psy1546         265 TGNYTKQFKEFVEACLNKDPENRPTAKELLK  295 (604)
Q Consensus       265 ~~~~s~~l~~Li~~~L~~dP~~RpT~~elL~  295 (604)
                      ...+++++.+||.+||..||.+|||+.+|++
T Consensus       246 ~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~  276 (298)
T 1csn_A          246 CAGFPEEFYKYMHYARNLAFDATPDYDYLQG  276 (298)
T ss_dssp             TTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred             HhhCcHHHHHHHHHHhcCCcccCCCHHHHHH
Confidence            3467899999999999999999999999987

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=3.5e-41  Score=342.47  Aligned_cols=236  Identities=27%  Similarity=0.465  Sum_probs=205.8

Q ss_pred             ccceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCCeE---------EEEEEec
Q psy1546          57 LIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTKL---------WIIMEYL  127 (604)
Q Consensus        57 ~~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~~l---------yLVmEy~  127 (604)
                      ..|.+.+.||+|+||.||+|.+. ++..||||++......  .+.+.+|+.+++.+.||++.++         |+||||+
T Consensus        13 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~v~e~~   89 (279)
T 1qpc_A           13 ETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMS--PDAFLAEANLMKQLQHQRLVRLYAVVTQEPIYIITEYM   89 (279)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSC--HHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEEEECC
T ss_pred             HhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCccc--HHHHHHHHHHHHhCCCcCcceEEEEEcCCCcEEEEecC
Confidence            45999999999999999999975 5678999998654322  3678899999999999996654         6999999


Q ss_pred             CCCChhhHhhcC---CCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCC-CCcc
Q psy1546         128 GGGSALDLMKAG---NFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTS-KRNT  203 (604)
Q Consensus       128 ~ggsL~~~l~~~---~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~-~~~~  203 (604)
                      ++++|.+++...   .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++........ ....
T Consensus        90 ~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~  169 (279)
T 1qpc_A           90 ENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREG  169 (279)
T ss_dssp             TTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEECCTT
T ss_pred             CCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCcccccccCcccccccC
Confidence            999999999753   699999999999999999999999999999999999999999999999999976643321 2234


Q ss_pred             cccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHhhhcCCCCCCCCCccchHHHHHHHHHHhcc
Q psy1546         204 FVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAK-GEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNK  282 (604)
Q Consensus       204 ~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~~L~~  282 (604)
                      ..+++.|+|||++.+..++.++|||||||++|+|++ |..||.+....+....+........+..++..+.+||.+||..
T Consensus       170 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~  249 (279)
T 1qpc_A          170 AKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWKE  249 (279)
T ss_dssp             CCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCS
T ss_pred             CCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcccCCCCcccccHHHHHHHHHHhcc
Confidence            457889999999999999999999999999999999 9999998888777776666655666778899999999999999


Q ss_pred             CCCCCCCHHHHhc
Q psy1546         283 DPENRPTAKELLK  295 (604)
Q Consensus       283 dP~~RpT~~elL~  295 (604)
                      ||.+|||+.+|++
T Consensus       250 ~p~~Rps~~~l~~  262 (279)
T 1qpc_A          250 RPEDRPTFDYLRS  262 (279)
T ss_dssp             SGGGSCCHHHHHH
T ss_pred             ChhhCCCHHHHHH
Confidence            9999999999986

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=2e-41  Score=341.23  Aligned_cols=236  Identities=27%  Similarity=0.410  Sum_probs=205.9

Q ss_pred             cceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCCeE----------EEEEEec
Q psy1546          58 IFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTKL----------WIIMEYL  127 (604)
Q Consensus        58 ~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~~l----------yLVmEy~  127 (604)
                      .|.+.+.||+|+||.||+|.+. +++.||||++.......  +.+.+|+.+++.+.||++.++          |+||||+
T Consensus         9 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~--~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   85 (267)
T 3t9t_A            9 ELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSE--EDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFM   85 (267)
T ss_dssp             GEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTBCH--HHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCC
T ss_pred             heeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCCCH--HHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCC
Confidence            4899999999999999999986 57789999997654332  568899999999999997654          6999999


Q ss_pred             CCCChhhHhhc--CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCC-CCCccc
Q psy1546         128 GGGSALDLMKA--GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTT-SKRNTF  204 (604)
Q Consensus       128 ~ggsL~~~l~~--~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~-~~~~~~  204 (604)
                      ++++|.+++..  +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... ......
T Consensus        86 ~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~  165 (267)
T 3t9t_A           86 EHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGT  165 (267)
T ss_dssp             TTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHHSTTST
T ss_pred             CCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEcccccccccccccccccccc
Confidence            99999999975  458999999999999999999999999999999999999999999999999997653221 122334


Q ss_pred             ccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHhhhcCCCCCCCCCccchHHHHHHHHHHhccC
Q psy1546         205 VGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAK-GEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKD  283 (604)
Q Consensus       205 ~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~~L~~d  283 (604)
                      .+|+.|+|||++.+..++.++|||||||++|+|++ |..||...........+........+..++..+.+||.+||..|
T Consensus       166 ~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~~  245 (267)
T 3t9t_A          166 KFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWRER  245 (267)
T ss_dssp             TCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHHHHHHTCSS
T ss_pred             cccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCcCCCCccCcHHHHHHHHHHccCC
Confidence            57889999999999999999999999999999999 99999998887777766666556666778999999999999999


Q ss_pred             CCCCCCHHHHhcC
Q psy1546         284 PENRPTAKELLKF  296 (604)
Q Consensus       284 P~~RpT~~elL~h  296 (604)
                      |.+|||+.+++++
T Consensus       246 p~~Rps~~~ll~~  258 (267)
T 3t9t_A          246 PEDRPAFSRLLRQ  258 (267)
T ss_dssp             GGGSCCHHHHHHH
T ss_pred             hhhCcCHHHHHHH
Confidence            9999999999874

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=1.9e-41  Score=346.60  Aligned_cols=236  Identities=22%  Similarity=0.364  Sum_probs=196.4

Q ss_pred             cccceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCC-----------CeEEEEE
Q psy1546          56 ELIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYG-----------TKLWIIM  124 (604)
Q Consensus        56 ~~~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~-----------~~lyLVm  124 (604)
                      ...|.+.+.||+|+||.||+|++..+++.||||++......   ..+.+|+.+++.+.|++.           ..+|+||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~   84 (296)
T 3uzp_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH---PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM   84 (296)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC---CHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred             ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch---hHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEE
Confidence            34599999999999999999999999999999998654432   357889999999998763           3358999


Q ss_pred             EecCCCChhhHhh--cCCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEe---cCCCCeEEecccccccccCCCC
Q psy1546         125 EYLGGGSALDLMK--AGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLL---SEMGDVKLADFGVAGTLTNTTS  199 (604)
Q Consensus       125 Ey~~ggsL~~~l~--~~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl---~~~g~vKL~DFGlA~~~~~~~~  199 (604)
                      ||+ +++|.+++.  .+.+++..++.++.||+.||.|||++||+||||||+||||   +.++.+||+|||+++.+.....
T Consensus        85 e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~  163 (296)
T 3uzp_A           85 ELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDART  163 (296)
T ss_dssp             ECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTT
T ss_pred             Eec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccccccc
Confidence            999 999999997  4679999999999999999999999999999999999999   4788999999999976654332


Q ss_pred             -------CCcccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChh---hHhhhcC----CCCCCCCC
Q psy1546         200 -------KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPM---RVLFLIP----KNNPPQLT  265 (604)
Q Consensus       200 -------~~~~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~---~~~~~i~----~~~~~~~~  265 (604)
                             ......||+.|+|||++.+..++.++|||||||+||+|++|..||......   .....+.    ......+.
T Consensus       164 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (296)
T 3uzp_A          164 HQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLC  243 (296)
T ss_dssp             CCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHHHT
T ss_pred             ccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCchHHHH
Confidence                   234568999999999999999999999999999999999999999864321   1111111    11111223


Q ss_pred             ccchHHHHHHHHHHhccCCCCCCCHHHHhc
Q psy1546         266 GNYTKQFKEFVEACLNKDPENRPTAKELLK  295 (604)
Q Consensus       266 ~~~s~~l~~Li~~~L~~dP~~RpT~~elL~  295 (604)
                      ..+++.+.+||.+||+.||.+|||+.+|++
T Consensus       244 ~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  273 (296)
T 3uzp_A          244 KGYPSEFATYLNFCRSLRFDDKPDYSYLRQ  273 (296)
T ss_dssp             TTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred             hhCCHHHHHHHHHHHhcCcCcCCCHHHHHH
Confidence            567899999999999999999999999987

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=8.3e-42  Score=364.80  Aligned_cols=240  Identities=24%  Similarity=0.405  Sum_probs=197.8

Q ss_pred             ccceeeeEEcccCcEEEEEEEECCC---CcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCCe-----------EEE
Q psy1546          57 LIFTKQERIGKGSFGEVFKGIDNRT---QQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTK-----------LWI  122 (604)
Q Consensus        57 ~~y~i~~~LG~G~fG~Vy~a~~~~t---~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~~-----------lyL  122 (604)
                      ..|.+.++||+|+||.||+|.+..+   +..||||.+.........+.+.+|+.+++.+.|||+.+           +|+
T Consensus        89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~l  168 (373)
T 3c1x_A           89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV  168 (373)
T ss_dssp             EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEE
T ss_pred             ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEE
Confidence            3488899999999999999987543   34689999876555566788999999999999998544           479


Q ss_pred             EEEecCCCChhhHhhc--CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCC-
Q psy1546         123 IMEYLGGGSALDLMKA--GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTS-  199 (604)
Q Consensus       123 VmEy~~ggsL~~~l~~--~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~-  199 (604)
                      ||||+++|+|.++++.  ..+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.+..... 
T Consensus       169 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~  248 (373)
T 3c1x_A          169 VLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD  248 (373)
T ss_dssp             EEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC------------
T ss_pred             EEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeeccccccccccccc
Confidence            9999999999999975  4589999999999999999999999999999999999999999999999999976543221 


Q ss_pred             ---CCcccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHhhhcCCCCCCCCCccchHHHHHH
Q psy1546         200 ---KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAK-GEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEF  275 (604)
Q Consensus       200 ---~~~~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~L  275 (604)
                         ......+|+.|+|||++.+..++.++|||||||+||||++ |.+||......+....+..+.....+..++..+.+|
T Consensus       249 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~~~~~p~~~~~~l~~l  328 (373)
T 3c1x_A          249 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEV  328 (373)
T ss_dssp             ---------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTCCCCCCTTCCHHHHHH
T ss_pred             cccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHH
Confidence               1233457889999999999999999999999999999999 788998877776666666666666677889999999


Q ss_pred             HHHHhccCCCCCCCHHHHhcC
Q psy1546         276 VEACLNKDPENRPTAKELLKF  296 (604)
Q Consensus       276 i~~~L~~dP~~RpT~~elL~h  296 (604)
                      |.+||..||.+|||+.||+++
T Consensus       329 i~~cl~~dp~~RPs~~ell~~  349 (373)
T 3c1x_A          329 MLKCWHPKAEMRPSFSELVSR  349 (373)
T ss_dssp             HHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHcCCChhhCcCHHHHHHH
Confidence            999999999999999999874

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=1.3e-41  Score=347.49  Aligned_cols=237  Identities=22%  Similarity=0.354  Sum_probs=193.4

Q ss_pred             ccccceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCC-----------CeEEEE
Q psy1546          55 PELIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYG-----------TKLWII  123 (604)
Q Consensus        55 ~~~~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~-----------~~lyLV  123 (604)
                      ....|.+.+.||+|+||.||+|.+..+++.||||++......   ..+.+|+.+++.+.|++.           ..+|+|
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv   83 (296)
T 4hgt_A            7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH---PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV   83 (296)
T ss_dssp             ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C---CCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEE
T ss_pred             cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc---hHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEE
Confidence            345599999999999999999999999999999987554322   357789999999998863           335799


Q ss_pred             EEecCCCChhhHhh--cCCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEe---cCCCCeEEecccccccccCCC
Q psy1546         124 MEYLGGGSALDLMK--AGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLL---SEMGDVKLADFGVAGTLTNTT  198 (604)
Q Consensus       124 mEy~~ggsL~~~l~--~~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl---~~~g~vKL~DFGlA~~~~~~~  198 (604)
                      |||+ +++|.+++.  .+.+++..++.++.||+.||.|||++||+||||||+||||   +.++.+||+|||+++.+....
T Consensus        84 ~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~  162 (296)
T 4hgt_A           84 MELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR  162 (296)
T ss_dssp             EECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTT
T ss_pred             EEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceeccCcc
Confidence            9999 999999987  4679999999999999999999999999999999999999   788999999999997665432


Q ss_pred             C-------CCcccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhh---Hhhhc----CCCCCCCC
Q psy1546         199 S-------KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMR---VLFLI----PKNNPPQL  264 (604)
Q Consensus       199 ~-------~~~~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~---~~~~i----~~~~~~~~  264 (604)
                      .       ......||+.|+|||++.+..++.++|||||||++|+|++|..||.......   ....+    .......+
T Consensus       163 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (296)
T 4hgt_A          163 THQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL  242 (296)
T ss_dssp             TCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHHH
T ss_pred             cCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchhhhh
Confidence            2       2335689999999999999999999999999999999999999998754321   11111    01111112


Q ss_pred             CccchHHHHHHHHHHhccCCCCCCCHHHHhc
Q psy1546         265 TGNYTKQFKEFVEACLNKDPENRPTAKELLK  295 (604)
Q Consensus       265 ~~~~s~~l~~Li~~~L~~dP~~RpT~~elL~  295 (604)
                      ...+++.+.+||.+||+.||.+|||+.+|++
T Consensus       243 ~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~  273 (296)
T 4hgt_A          243 CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ  273 (296)
T ss_dssp             TTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred             hccCCHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence            2457889999999999999999999999987

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=3.2e-41  Score=349.11  Aligned_cols=244  Identities=27%  Similarity=0.502  Sum_probs=195.5

Q ss_pred             ccceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhh-HHHHHHHHHHHHHHhhCCC--CCCCe----------EEEE
Q psy1546          57 LIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA-EDEIEDIQQEIMVLSQCDS--PYGTK----------LWII  123 (604)
Q Consensus        57 ~~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~-~~~~~~l~~Ei~iL~~l~h--p~~~~----------lyLV  123 (604)
                      ..|.+.+.||+|+||.||+|.+. +++.||||++..... ......+.+|+.++..+.|  +++.+          +|+|
T Consensus        28 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv  106 (313)
T 3cek_A           28 RIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV  106 (313)
T ss_dssp             EEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEEE
T ss_pred             ceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEEE
Confidence            34999999999999999999985 588999999965432 3456788999999999975  77544          4799


Q ss_pred             EEecCCCChhhHhhc-CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCC--C
Q psy1546         124 MEYLGGGSALDLMKA-GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTS--K  200 (604)
Q Consensus       124 mEy~~ggsL~~~l~~-~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~--~  200 (604)
                      || +.+++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||+++ +.+||+|||+++.+.....  .
T Consensus       107 ~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~~~~~~~~  184 (313)
T 3cek_A          107 ME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVV  184 (313)
T ss_dssp             EC-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEET-TEEEECCCSSSCC---------
T ss_pred             Ee-cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEEC-CeEEEeeccccccccCcccccc
Confidence            99 568899998865 67999999999999999999999999999999999999965 8999999999976643322  2


Q ss_pred             CcccccCCCCCChHHhhc-----------CCCCCcchhhhHHHHHHHHHhCCCCCCCCChh-h-HhhhcCCCCCCCCCcc
Q psy1546         201 RNTFVGTPFWMAPEVIKQ-----------SAYDSKADIWSLGITAIELAKGEPPNSELHPM-R-VLFLIPKNNPPQLTGN  267 (604)
Q Consensus       201 ~~~~~GT~~Y~APE~l~~-----------~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~-~-~~~~i~~~~~~~~~~~  267 (604)
                      ....+||+.|+|||++.+           ..++.++|||||||++|+|++|..||...... . ....+.......++..
T Consensus       185 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  264 (313)
T 3cek_A          185 KDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDI  264 (313)
T ss_dssp             -----CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCCCCCCC
T ss_pred             ccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHHhcccccCCccc
Confidence            235579999999999976           46888999999999999999999999875432 2 2222333333455666


Q ss_pred             chHHHHHHHHHHhccCCCCCCCHHHHhcChhhhhhh
Q psy1546         268 YTKQFKEFVEACLNKDPENRPTAKELLKFPFIRKAK  303 (604)
Q Consensus       268 ~s~~l~~Li~~~L~~dP~~RpT~~elL~hp~f~~~~  303 (604)
                      ++..+.+||.+||..||.+|||+.|+|+||||+...
T Consensus       265 ~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~~  300 (313)
T 3cek_A          265 PEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT  300 (313)
T ss_dssp             SCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC-
T ss_pred             chHHHHHHHHHHccCCcccCcCHHHHhcCccccCCC
Confidence            789999999999999999999999999999997643

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=3.2e-41  Score=345.70  Aligned_cols=233  Identities=27%  Similarity=0.450  Sum_probs=188.5

Q ss_pred             ccceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhh--CCCCCCCeE--------------
Q psy1546          57 LIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQ--CDSPYGTKL--------------  120 (604)
Q Consensus        57 ~~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~--l~hp~~~~l--------------  120 (604)
                      ..|.+.+.||+|+||+||+|.+  +++.||||++.....    ..+.+|..++..  +.|||+.++              
T Consensus         8 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~----~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~   81 (301)
T 3q4u_A            8 RDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSRDE----KSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQL   81 (301)
T ss_dssp             GGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGGGH----HHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred             CcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEeccccc----hhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCcee
Confidence            3599999999999999999987  589999999865432    334455555555  899996554              


Q ss_pred             EEEEEecCCCChhhHhhcCCCcHHHHHHHHHHHHHHhHHhh--------hCCccccccccceeEecCCCCeEEecccccc
Q psy1546         121 WIIMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLH--------SERKLHRDIKAANVLLSEMGDVKLADFGVAG  192 (604)
Q Consensus       121 yLVmEy~~ggsL~~~l~~~~lse~~i~~i~~qIl~gL~yLH--------s~gIiHrDLKp~NILl~~~g~vKL~DFGlA~  192 (604)
                      |+||||+++|+|.++++.+.+++..++.++.||+.||.|||        ++||+||||||+||||+.++.+||+|||+|+
T Consensus        82 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~  161 (301)
T 3q4u_A           82 WLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAV  161 (301)
T ss_dssp             EEEECCCTTCBHHHHHTTCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred             EEehhhccCCCHHHHHhhcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEeeCCCee
Confidence            69999999999999999999999999999999999999999        9999999999999999999999999999997


Q ss_pred             cccCCCCC----CcccccCCCCCChHHhhcC------CCCCcchhhhHHHHHHHHHhC----------CCCCCCCChh--
Q psy1546         193 TLTNTTSK----RNTFVGTPFWMAPEVIKQS------AYDSKADIWSLGITAIELAKG----------EPPNSELHPM--  250 (604)
Q Consensus       193 ~~~~~~~~----~~~~~GT~~Y~APE~l~~~------~~~~~sDVwSLGviL~eLltG----------~~Pf~~~~~~--  250 (604)
                      ........    ....+||+.|+|||++.+.      .++.++|||||||++|||++|          ..||......  
T Consensus       162 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~~~  241 (301)
T 3q4u_A          162 MHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDP  241 (301)
T ss_dssp             EEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred             ecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCCCc
Confidence            65443322    2345899999999999876      344689999999999999999          8888654321  


Q ss_pred             ---hHhh-hcCCCCCCCCC-----ccchHHHHHHHHHHhccCCCCCCCHHHHhc
Q psy1546         251 ---RVLF-LIPKNNPPQLT-----GNYTKQFKEFVEACLNKDPENRPTAKELLK  295 (604)
Q Consensus       251 ---~~~~-~i~~~~~~~~~-----~~~s~~l~~Li~~~L~~dP~~RpT~~elL~  295 (604)
                         .... .......+.++     ..++..+.+||.+||..||.+|||+.||++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~  295 (301)
T 3q4u_A          242 SFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK  295 (301)
T ss_dssp             CHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred             chhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHH
Confidence               1111 11122222222     236688999999999999999999999987

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=2.7e-41  Score=369.26  Aligned_cols=231  Identities=26%  Similarity=0.427  Sum_probs=202.6

Q ss_pred             ccceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCCe-----------EEEEEE
Q psy1546          57 LIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTK-----------LWIIME  125 (604)
Q Consensus        57 ~~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~~-----------lyLVmE  125 (604)
                      ..|.+.++||+|+||.||+|.+.  ++.||||++....   ..+.+.+|+.+|++++|||+++           +|||||
T Consensus       193 ~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e  267 (450)
T 1k9a_A          193 KELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE  267 (450)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCT---TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEE
T ss_pred             HHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCch---HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEE
Confidence            34899999999999999999875  7799999997654   3467889999999999998544           579999


Q ss_pred             ecCCCChhhHhhcC---CCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCCCCc
Q psy1546         126 YLGGGSALDLMKAG---NFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRN  202 (604)
Q Consensus       126 y~~ggsL~~~l~~~---~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~~~  202 (604)
                      ||++|+|.++++..   .+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.....   ..
T Consensus       268 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~---~~  344 (450)
T 1k9a_A          268 YMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST---QD  344 (450)
T ss_dssp             CCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCTTCEECC-------
T ss_pred             ecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCCCccccccc---cc
Confidence            99999999999752   3789999999999999999999999999999999999999999999999999754322   22


Q ss_pred             ccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHhhhcCCCCCCCCCccchHHHHHHHHHHhc
Q psy1546         203 TFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAK-GEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLN  281 (604)
Q Consensus       203 ~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~~L~  281 (604)
                      ...+++.|+|||++.+..++.++|||||||+||||++ |..||......++...+..+.....+..+++.+.+||.+||.
T Consensus       345 ~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~  424 (450)
T 1k9a_A          345 TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYDVMKNCWH  424 (450)
T ss_dssp             --CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTCCCCCCTTCCHHHHHHHHHHTC
T ss_pred             CCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHHHHHHcC
Confidence            3467899999999999999999999999999999998 999999888877777777776677778899999999999999


Q ss_pred             cCCCCCCCHHHHhc
Q psy1546         282 KDPENRPTAKELLK  295 (604)
Q Consensus       282 ~dP~~RpT~~elL~  295 (604)
                      .||.+|||+.+|++
T Consensus       425 ~dp~~Rpt~~~l~~  438 (450)
T 1k9a_A          425 LDAATRPTFLQLRE  438 (450)
T ss_dssp             SSGGGSCCHHHHHH
T ss_pred             CChhHCcCHHHHHH
Confidence            99999999999986

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=2.3e-41  Score=370.12  Aligned_cols=236  Identities=26%  Similarity=0.450  Sum_probs=206.1

Q ss_pred             ccceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCCeE---------EEEEEec
Q psy1546          57 LIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTKL---------WIIMEYL  127 (604)
Q Consensus        57 ~~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~~l---------yLVmEy~  127 (604)
                      ..|.+.++||+|+||.||+|.+. ++..||||++.....  ..+.+.+|+.+|+.+.|||++++         |||||||
T Consensus       188 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~lv~e~~  264 (454)
T 1qcf_A          188 ESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSM--SVEAFLAEANVMKTLQHDKLVKLHAVVTKEPIYIITEFM  264 (454)
T ss_dssp             GGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTSB--CHHHHHHHHHHHTTCCCTTBCCEEEEECSSSCEEEECCC
T ss_pred             HHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCCc--cHHHHHHHHHHHhhCCCCCEeeEEEEEeCCccEEEEeec
Confidence            45899999999999999999986 467899999976442  34678999999999999997665         7999999


Q ss_pred             CCCChhhHhhc---CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCC-CCCcc
Q psy1546         128 GGGSALDLMKA---GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTT-SKRNT  203 (604)
Q Consensus       128 ~ggsL~~~l~~---~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~-~~~~~  203 (604)
                      .+|+|.++++.   ..+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.+.... .....
T Consensus       265 ~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~  344 (454)
T 1qcf_A          265 AKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREG  344 (454)
T ss_dssp             TTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHHHTTCS
T ss_pred             CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCceeccCC
Confidence            99999999975   368899999999999999999999999999999999999999999999999997654321 11223


Q ss_pred             cccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHhhhcCCCCCCCCCccchHHHHHHHHHHhcc
Q psy1546         204 FVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAK-GEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNK  282 (604)
Q Consensus       204 ~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~~L~~  282 (604)
                      ..+|+.|+|||++....++.++|||||||+||||++ |..||.+....++...+..+.....+..+++++.+||.+||..
T Consensus       345 ~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~  424 (454)
T 1qcf_A          345 AKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELYNIMMRCWKN  424 (454)
T ss_dssp             SSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCS
T ss_pred             CcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHccC
Confidence            456788999999999999999999999999999999 9999999888877777666666666778999999999999999


Q ss_pred             CCCCCCCHHHHhc
Q psy1546         283 DPENRPTAKELLK  295 (604)
Q Consensus       283 dP~~RpT~~elL~  295 (604)
                      ||.+|||+.+|++
T Consensus       425 dp~~RPt~~~i~~  437 (454)
T 1qcf_A          425 RPEERPTFEYIQS  437 (454)
T ss_dssp             SGGGSCCHHHHHH
T ss_pred             ChhHCcCHHHHHH
Confidence            9999999999976

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=1.2e-41  Score=354.06  Aligned_cols=238  Identities=26%  Similarity=0.414  Sum_probs=202.2

Q ss_pred             cceeeeEEcccCcEEEEEEEE----CCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCCe------------EE
Q psy1546          58 IFTKQERIGKGSFGEVFKGID----NRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTK------------LW  121 (604)
Q Consensus        58 ~y~i~~~LG~G~fG~Vy~a~~----~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~~------------ly  121 (604)
                      .|+++++||+|+||.||+|..    ..+++.||||++.........+.+.+|+.+|+.+.||++.+            +|
T Consensus        32 ~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  111 (318)
T 3lxp_A           32 YLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQ  111 (318)
T ss_dssp             GEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEE
T ss_pred             HHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEE
Confidence            369999999999999988753    45789999999987665666788999999999999998544            47


Q ss_pred             EEEEecCCCChhhHhhcCCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCC--
Q psy1546         122 IIMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTS--  199 (604)
Q Consensus       122 LVmEy~~ggsL~~~l~~~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~--  199 (604)
                      +||||+++++|.+++....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++........  
T Consensus       112 lv~e~~~~~~L~~~l~~~~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~  191 (318)
T 3lxp_A          112 LVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYY  191 (318)
T ss_dssp             EEECCCTTCBHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECCTTCSEE
T ss_pred             EEEecccCCcHHHHHhhCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCcccccccccccccc
Confidence            999999999999999998899999999999999999999999999999999999999999999999999977654322  


Q ss_pred             -CCcccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChh---------------hHhhhcCCCCCCC
Q psy1546         200 -KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPM---------------RVLFLIPKNNPPQ  263 (604)
Q Consensus       200 -~~~~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~---------------~~~~~i~~~~~~~  263 (604)
                       ......||+.|+|||++.+..++.++|||||||++|+|++|..||......               .....+.......
T Consensus       192 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  271 (318)
T 3lxp_A          192 RVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGERLP  271 (318)
T ss_dssp             EC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHHTTCCCC
T ss_pred             ccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHhcccCCC
Confidence             233456888999999999999999999999999999999999998754321               1222333444556


Q ss_pred             CCccchHHHHHHHHHHhccCCCCCCCHHHHhc
Q psy1546         264 LTGNYTKQFKEFVEACLNKDPENRPTAKELLK  295 (604)
Q Consensus       264 ~~~~~s~~l~~Li~~~L~~dP~~RpT~~elL~  295 (604)
                      .+..++..+.+||.+||..||.+|||+.||++
T Consensus       272 ~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~  303 (318)
T 3lxp_A          272 RPDKCPAEVYHLMKNCWETEASFRPTFENLIP  303 (318)
T ss_dssp             CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCccccHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence            67788999999999999999999999999986

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=4.9e-41  Score=338.33  Aligned_cols=231  Identities=18%  Similarity=0.360  Sum_probs=199.3

Q ss_pred             cceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhh-HHHHHHHHHHHHHHhhCCCCCCCe------------EEEEE
Q psy1546          58 IFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA-EDEIEDIQQEIMVLSQCDSPYGTK------------LWIIM  124 (604)
Q Consensus        58 ~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~-~~~~~~l~~Ei~iL~~l~hp~~~~------------lyLVm  124 (604)
                      .|.+.+.||+|+||.||+|.+.  ++.||||++..... ....+.+.+|+.++++++|||+.+            +|+||
T Consensus        11 ~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   88 (271)
T 3kmu_A           11 QLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLIT   88 (271)
T ss_dssp             GCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEE
T ss_pred             HhHHHHHhcCCCcceEEEEEEC--CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeee
Confidence            4899999999999999999985  88999999976542 344577899999999999998544            47999


Q ss_pred             EecCCCChhhHhhcC---CCcHHHHHHHHHHHHHHhHHhhhCC--ccccccccceeEecCCCCeEEecccccccccCCCC
Q psy1546         125 EYLGGGSALDLMKAG---NFEEMHIAVILREVLKGLDYLHSER--KLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTS  199 (604)
Q Consensus       125 Ey~~ggsL~~~l~~~---~lse~~i~~i~~qIl~gL~yLHs~g--IiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~  199 (604)
                      ||+++|+|.+++...   .+++..++.++.||+.||.|||++|  |+||||||+|||++.++.++|+|||++....    
T Consensus        89 e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~----  164 (271)
T 3kmu_A           89 HWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQ----  164 (271)
T ss_dssp             ECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS----
T ss_pred             cccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEeccceeeec----
Confidence            999999999999764   3899999999999999999999999  9999999999999999999999999874422    


Q ss_pred             CCcccccCCCCCChHHhhcCCCCC---cchhhhHHHHHHHHHhCCCCCCCCChhhHhhhc-CCCCCCCCCccchHHHHHH
Q psy1546         200 KRNTFVGTPFWMAPEVIKQSAYDS---KADIWSLGITAIELAKGEPPNSELHPMRVLFLI-PKNNPPQLTGNYTKQFKEF  275 (604)
Q Consensus       200 ~~~~~~GT~~Y~APE~l~~~~~~~---~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i-~~~~~~~~~~~~s~~l~~L  275 (604)
                       .....||+.|+|||++.+..++.   ++|||||||++|+|++|..||...........+ .....+.++..++..+.+|
T Consensus       165 -~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  243 (271)
T 3kmu_A          165 -SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPGISPHVSKL  243 (271)
T ss_dssp             -CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCCCCCTTCCHHHHHH
T ss_pred             -ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCCCCCCCCCHHHHHH
Confidence             23457899999999998766554   799999999999999999999988776654433 3344556777899999999


Q ss_pred             HHHHhccCCCCCCCHHHHhc
Q psy1546         276 VEACLNKDPENRPTAKELLK  295 (604)
Q Consensus       276 i~~~L~~dP~~RpT~~elL~  295 (604)
                      |.+||..||.+|||+.++++
T Consensus       244 i~~~l~~~p~~Rps~~~il~  263 (271)
T 3kmu_A          244 MKICMNEDPAKRPKFDMIVP  263 (271)
T ss_dssp             HHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHcCCChhhCcCHHHHHH
Confidence            99999999999999999987

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=4.6e-42  Score=357.75  Aligned_cols=241  Identities=26%  Similarity=0.454  Sum_probs=201.8

Q ss_pred             cccceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHH-----HHHHHHHHHHHHhhCCC--CCCCe---------
Q psy1546          56 ELIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAED-----EIEDIQQEIMVLSQCDS--PYGTK---------  119 (604)
Q Consensus        56 ~~~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~-----~~~~l~~Ei~iL~~l~h--p~~~~---------  119 (604)
                      ...|.+.+.||+|+||.||+|.+..+++.||||++.......     ....+.+|+.+++.+.|  +++.+         
T Consensus        42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~~  121 (320)
T 3a99_A           42 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD  121 (320)
T ss_dssp             TTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred             cCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecCC
Confidence            345999999999999999999999999999999996553221     22456689999999865  77544         


Q ss_pred             -EEEEEEecCC-CChhhHhhc-CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEec-CCCCeEEeccccccccc
Q psy1546         120 -LWIIMEYLGG-GSALDLMKA-GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLS-EMGDVKLADFGVAGTLT  195 (604)
Q Consensus       120 -lyLVmEy~~g-gsL~~~l~~-~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~-~~g~vKL~DFGlA~~~~  195 (604)
                       +|+||||+.+ ++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+||||+ .++.+||+|||+++.+.
T Consensus       122 ~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~~~~  201 (320)
T 3a99_A          122 SFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK  201 (320)
T ss_dssp             EEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred             cEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEeeCccccccc
Confidence             4799999976 899998864 7799999999999999999999999999999999999998 78999999999997665


Q ss_pred             CCCCCCcccccCCCCCChHHhhcCCC-CCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCCCCCCCCccchHHHHH
Q psy1546         196 NTTSKRNTFVGTPFWMAPEVIKQSAY-DSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKE  274 (604)
Q Consensus       196 ~~~~~~~~~~GT~~Y~APE~l~~~~~-~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~  274 (604)
                      ..  ......||+.|+|||++.+..+ +.++|||||||++|||++|..||......  ..     ....+...++.++.+
T Consensus       202 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~--~~-----~~~~~~~~~~~~~~~  272 (320)
T 3a99_A          202 DT--VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI--IR-----GQVFFRQRVSSECQH  272 (320)
T ss_dssp             SS--CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHH--HH-----CCCCCSSCCCHHHHH
T ss_pred             cc--cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhhh--hc-----ccccccccCCHHHHH
Confidence            32  2345679999999999987776 67889999999999999999999764321  11     112344678899999


Q ss_pred             HHHHHhccCCCCCCCHHHHhcChhhhhhhhh
Q psy1546         275 FVEACLNKDPENRPTAKELLKFPFIRKAKKN  305 (604)
Q Consensus       275 Li~~~L~~dP~~RpT~~elL~hp~f~~~~~~  305 (604)
                      ||.+||..||.+|||+.||++||||+.....
T Consensus       273 li~~~l~~dp~~Rps~~~ll~hp~~~~~~~~  303 (320)
T 3a99_A          273 LIRWCLALRPSDRPTFEEIQNHPWMQDVLLP  303 (320)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHTSGGGSSCCCH
T ss_pred             HHHHHccCChhhCcCHHHHhcCHhhcCccCc
Confidence            9999999999999999999999999876543

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=5.8e-41  Score=346.37  Aligned_cols=238  Identities=30%  Similarity=0.505  Sum_probs=188.2

Q ss_pred             cceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchh--hHHHHHHHHHHHHHHhhCCCCCCCeE----------EEEEE
Q psy1546          58 IFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE--AEDEIEDIQQEIMVLSQCDSPYGTKL----------WIIME  125 (604)
Q Consensus        58 ~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~--~~~~~~~l~~Ei~iL~~l~hp~~~~l----------yLVmE  125 (604)
                      .|.+.+.||+|+||.||+|.+..+++.||||++....  .......+.+|+.+++.+.||++.++          |+|||
T Consensus        33 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  112 (310)
T 2wqm_A           33 NFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLE  112 (310)
T ss_dssp             GEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             ceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEEe
Confidence            4999999999999999999999999999999997532  23455778899999999999996554          69999


Q ss_pred             ecCCCChhhHhhc-----CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCCC
Q psy1546         126 YLGGGSALDLMKA-----GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSK  200 (604)
Q Consensus       126 y~~ggsL~~~l~~-----~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~  200 (604)
                      |+++++|.+++..     ..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++.........
T Consensus       113 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~~~~~  192 (310)
T 2wqm_A          113 LADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTA  192 (310)
T ss_dssp             CCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC------------
T ss_pred             cCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccceeeecCCCcc
Confidence            9999999998853     56899999999999999999999999999999999999999999999999999766544444


Q ss_pred             CcccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCCh--hhHhhhcCCCCCC-CCCccchHHHHHHHH
Q psy1546         201 RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHP--MRVLFLIPKNNPP-QLTGNYTKQFKEFVE  277 (604)
Q Consensus       201 ~~~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~--~~~~~~i~~~~~~-~~~~~~s~~l~~Li~  277 (604)
                      .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+...  ......+.....+ .....++.++.+||.
T Consensus       193 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  272 (310)
T 2wqm_A          193 AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVN  272 (310)
T ss_dssp             ------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSCCCCTTTSCHHHHHHHH
T ss_pred             ccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCCCCcccccCHHHHHHHH
Confidence            4556799999999999999999999999999999999999999976432  2333333333222 233678999999999


Q ss_pred             HHhccCCCCCCCHHHHhc
Q psy1546         278 ACLNKDPENRPTAKELLK  295 (604)
Q Consensus       278 ~~L~~dP~~RpT~~elL~  295 (604)
                      +||..||.+|||+.+|++
T Consensus       273 ~~l~~dp~~Rps~~~il~  290 (310)
T 2wqm_A          273 MCINPDPEKRPDVTYVYD  290 (310)
T ss_dssp             HHTCSSGGGSCCHHHHHH
T ss_pred             HHcCCChhhCCCHHHHHH
Confidence            999999999999999987

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=1.7e-41  Score=353.67  Aligned_cols=240  Identities=28%  Similarity=0.470  Sum_probs=203.8

Q ss_pred             cccceeeeEEcccCcEEEEEEE----ECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCCe------------
Q psy1546          56 ELIFTKQERIGKGSFGEVFKGI----DNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTK------------  119 (604)
Q Consensus        56 ~~~y~i~~~LG~G~fG~Vy~a~----~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~~------------  119 (604)
                      ...|.+.+.||+|+||.||+|.    +..+++.||||++.... ....+.+.+|+.+++.+.||++.+            
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~  100 (327)
T 3lxl_A           22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSG-PDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQS  100 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCC-HHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCE
T ss_pred             hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCC-HHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCce
Confidence            4459999999999999999998    56789999999997653 344577899999999999998554            


Q ss_pred             EEEEEEecCCCChhhHhhc--CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCC
Q psy1546         120 LWIIMEYLGGGSALDLMKA--GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNT  197 (604)
Q Consensus       120 lyLVmEy~~ggsL~~~l~~--~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~  197 (604)
                      +|+||||+++++|.+++..  +.+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++......
T Consensus       101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~  180 (327)
T 3lxl_A          101 LRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLD  180 (327)
T ss_dssp             EEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGGGCEECCTT
T ss_pred             EEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEcccccceecccC
Confidence            4699999999999999865  56999999999999999999999999999999999999999999999999999766433


Q ss_pred             CC---CCcccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChh---------------hHhhhcCCC
Q psy1546         198 TS---KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPM---------------RVLFLIPKN  259 (604)
Q Consensus       198 ~~---~~~~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~---------------~~~~~i~~~  259 (604)
                      ..   ......||+.|+|||++.+..++.++|||||||++|+|++|..||......               .....+...
T Consensus       181 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  260 (327)
T 3lxl_A          181 KDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLEEG  260 (327)
T ss_dssp             CSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHHHTT
T ss_pred             CccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHHhhcc
Confidence            22   233456888999999999999999999999999999999999998654332               222233344


Q ss_pred             CCCCCCccchHHHHHHHHHHhccCCCCCCCHHHHhcC
Q psy1546         260 NPPQLTGNYTKQFKEFVEACLNKDPENRPTAKELLKF  296 (604)
Q Consensus       260 ~~~~~~~~~s~~l~~Li~~~L~~dP~~RpT~~elL~h  296 (604)
                      .....+..+++.+.+||.+||..||.+|||+.||+++
T Consensus       261 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  297 (327)
T 3lxl_A          261 QRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQ  297 (327)
T ss_dssp             CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             cCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            4455667889999999999999999999999999874

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=1.6e-41  Score=352.99  Aligned_cols=239  Identities=26%  Similarity=0.397  Sum_probs=198.7

Q ss_pred             ccceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCCeE----------EEEEEe
Q psy1546          57 LIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTKL----------WIIMEY  126 (604)
Q Consensus        57 ~~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~~l----------yLVmEy  126 (604)
                      ..|.+.+.||+|+||.||+|.+. +++.||||++..... ...+.+.+|+.+++.++|||+.++          |+||||
T Consensus        39 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  116 (321)
T 2qkw_B           39 NNFDHKFLIGHGVFGKVYKGVLR-DGAKVALKRRTPESS-QGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKY  116 (321)
T ss_dssp             CCCSCCCCSCBCSSSEEEEEECT-TCCEEEEEECCSCCS-SHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEEEEC
T ss_pred             hccCccceeecCCCeeEEEEEEC-CCCEEEEEEecccCh-HHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEEc
Confidence            45899999999999999999964 688999999865533 345778999999999999997654          799999


Q ss_pred             cCCCChhhHhhcC-----CCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCC--C
Q psy1546         127 LGGGSALDLMKAG-----NFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTT--S  199 (604)
Q Consensus       127 ~~ggsL~~~l~~~-----~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~--~  199 (604)
                      +++|+|.+++...     .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......  .
T Consensus       117 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  196 (321)
T 2qkw_B          117 MENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTH  196 (321)
T ss_dssp             CTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTTCEECSSSSCCC
T ss_pred             CCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeecccccccccccccc
Confidence            9999999998653     48999999999999999999999999999999999999999999999999997654322  2


Q ss_pred             CCcccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhh----------------cCCCCCCC
Q psy1546         200 KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFL----------------IPKNNPPQ  263 (604)
Q Consensus       200 ~~~~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~----------------i~~~~~~~  263 (604)
                      ......||+.|+|||++.+..++.++|||||||++|+|++|..||...........                +.......
T Consensus       197 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (321)
T 2qkw_B          197 LSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADK  276 (321)
T ss_dssp             CBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSSSSCTTC
T ss_pred             cccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhcChhhccc
Confidence            23345699999999999999999999999999999999999999976543221100                01111223


Q ss_pred             CCccchHHHHHHHHHHhccCCCCCCCHHHHhcCh
Q psy1546         264 LTGNYTKQFKEFVEACLNKDPENRPTAKELLKFP  297 (604)
Q Consensus       264 ~~~~~s~~l~~Li~~~L~~dP~~RpT~~elL~hp  297 (604)
                      +...++..+.+|+.+||..||.+|||+.|++++.
T Consensus       277 ~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L  310 (321)
T 2qkw_B          277 IRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL  310 (321)
T ss_dssp             SCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             cCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence            4456678899999999999999999999999863

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=1.5e-41  Score=375.88  Aligned_cols=237  Identities=25%  Similarity=0.473  Sum_probs=209.1

Q ss_pred             ccceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCCeE----------EEEEEe
Q psy1546          57 LIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTKL----------WIIMEY  126 (604)
Q Consensus        57 ~~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~~l----------yLVmEy  126 (604)
                      ..|.+.++||+|+||.||+|.+..++..||||++.....  ..+.+.+|+.+|+++.|||++++          ||||||
T Consensus       220 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~  297 (495)
T 1opk_A          220 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM--EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF  297 (495)
T ss_dssp             GGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSS--CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred             HHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCccc--chHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEc
Confidence            348999999999999999999999999999999975533  24678999999999999997665          699999


Q ss_pred             cCCCChhhHhhc---CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCC-CCc
Q psy1546         127 LGGGSALDLMKA---GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTS-KRN  202 (604)
Q Consensus       127 ~~ggsL~~~l~~---~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~-~~~  202 (604)
                      |.+|+|.++++.   ..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.+..... ...
T Consensus       298 ~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~  377 (495)
T 1opk_A          298 MTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA  377 (495)
T ss_dssp             CTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEECCTTCCEECCT
T ss_pred             cCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeecccceeccCCceeecC
Confidence            999999999965   4589999999999999999999999999999999999999999999999999976643221 222


Q ss_pred             ccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHhhhcCCCCCCCCCccchHHHHHHHHHHhc
Q psy1546         203 TFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAK-GEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLN  281 (604)
Q Consensus       203 ~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~~L~  281 (604)
                      ...+++.|+|||++.+..++.++|||||||+||||++ |..||.+.....+...+........+..++..+.+||.+||.
T Consensus       378 ~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~  457 (495)
T 1opk_A          378 GAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQ  457 (495)
T ss_dssp             TCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCCTTCCHHHHHHHHHHTC
T ss_pred             CCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcC
Confidence            3456788999999999999999999999999999999 999999988877777776666666778899999999999999


Q ss_pred             cCCCCCCCHHHHhc
Q psy1546         282 KDPENRPTAKELLK  295 (604)
Q Consensus       282 ~dP~~RpT~~elL~  295 (604)
                      .||.+|||+.+|++
T Consensus       458 ~dP~~RPs~~el~~  471 (495)
T 1opk_A          458 WNPSDRPSFAEIHQ  471 (495)
T ss_dssp             SSGGGSCCHHHHHH
T ss_pred             cChhHCcCHHHHHH
Confidence            99999999999986

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=1.8e-41  Score=346.01  Aligned_cols=233  Identities=21%  Similarity=0.406  Sum_probs=195.8

Q ss_pred             ccceeeeEEcccCcEEEEEEEECCCC-------cEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCCeE---------
Q psy1546          57 LIFTKQERIGKGSFGEVFKGIDNRTQ-------QVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTKL---------  120 (604)
Q Consensus        57 ~~y~i~~~LG~G~fG~Vy~a~~~~t~-------~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~~l---------  120 (604)
                      ..|.+.+.||+|+||.||+|.+..++       ..||+|++.... ....+.+.+|+.+++.+.|||+.++         
T Consensus         8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   86 (289)
T 4fvq_A            8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH-RNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE   86 (289)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGG-GGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred             hHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhccccc-HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence            45999999999999999999998877       469999996543 2344778999999999999997665         


Q ss_pred             -EEEEEecCCCChhhHhhcCC--CcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCC--------eEEeccc
Q psy1546         121 -WIIMEYLGGGSALDLMKAGN--FEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGD--------VKLADFG  189 (604)
Q Consensus       121 -yLVmEy~~ggsL~~~l~~~~--lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~--------vKL~DFG  189 (604)
                       |+||||+++++|.+++....  +++..++.++.||+.||.|||++||+||||||+||||+.++.        +||+|||
T Consensus        87 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~Dfg  166 (289)
T 4fvq_A           87 NILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPG  166 (289)
T ss_dssp             CEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEEEECCCC
T ss_pred             CEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccceeeeccCc
Confidence             69999999999999997643  999999999999999999999999999999999999998887        9999999


Q ss_pred             ccccccCCCCCCcccccCCCCCChHHhhc-CCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHhhhcCCCCCCCCCcc
Q psy1546         190 VAGTLTNTTSKRNTFVGTPFWMAPEVIKQ-SAYDSKADIWSLGITAIELAK-GEPPNSELHPMRVLFLIPKNNPPQLTGN  267 (604)
Q Consensus       190 lA~~~~~~~~~~~~~~GT~~Y~APE~l~~-~~~~~~sDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~  267 (604)
                      ++.....    .....||+.|+|||++.+ ..++.++|||||||++|+|++ |.+||..............  ...++..
T Consensus       167 ~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~~~--~~~~~~~  240 (289)
T 4fvq_A          167 ISITVLP----KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYED--RHQLPAP  240 (289)
T ss_dssp             SCTTTSC----HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHT--TCCCCCC
T ss_pred             ccccccC----ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHhhc--cCCCCCC
Confidence            9865432    234568999999999987 679999999999999999999 5566666555444433322  2334455


Q ss_pred             chHHHHHHHHHHhccCCCCCCCHHHHhcC
Q psy1546         268 YTKQFKEFVEACLNKDPENRPTAKELLKF  296 (604)
Q Consensus       268 ~s~~l~~Li~~~L~~dP~~RpT~~elL~h  296 (604)
                      ++.++.+||.+||..||.+|||+.+++++
T Consensus       241 ~~~~l~~li~~~l~~dp~~Rps~~~ll~~  269 (289)
T 4fvq_A          241 KAAELANLINNCMDYEPDHRPSFRAIIRD  269 (289)
T ss_dssp             SSCTTHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred             CCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            67889999999999999999999999985

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=3.1e-41  Score=351.89  Aligned_cols=239  Identities=25%  Similarity=0.415  Sum_probs=203.0

Q ss_pred             ccceeeeEEcccCcEEEEEEEECCCCc-----EEEEEEecchhhHHHHHHHHHHHHHHhhC-CCCCCCeE----------
Q psy1546          57 LIFTKQERIGKGSFGEVFKGIDNRTQQ-----VVAIKIIDLEEAEDEIEDIQQEIMVLSQC-DSPYGTKL----------  120 (604)
Q Consensus        57 ~~y~i~~~LG~G~fG~Vy~a~~~~t~~-----~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l-~hp~~~~l----------  120 (604)
                      ..|.+.+.||+|+||.||+|.+..+++     .||||++.........+.+.+|+.+++.+ .|||+.++          
T Consensus        46 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~  125 (333)
T 2i1m_A           46 NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPV  125 (333)
T ss_dssp             TSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             HHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCce
Confidence            458999999999999999999877664     79999997766556678899999999999 89997665          


Q ss_pred             EEEEEecCCCChhhHhhc---------------CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEE
Q psy1546         121 WIIMEYLGGGSALDLMKA---------------GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKL  185 (604)
Q Consensus       121 yLVmEy~~ggsL~~~l~~---------------~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL  185 (604)
                      |+||||+++|+|.+++..               ..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||
T Consensus       126 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl  205 (333)
T 2i1m_A          126 LVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKI  205 (333)
T ss_dssp             EEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEEGGGEEEB
T ss_pred             EEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEECCCCeEEE
Confidence            699999999999998853               35799999999999999999999999999999999999999999999


Q ss_pred             ecccccccccCCCC--CCcccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHhh-hcCCCCC
Q psy1546         186 ADFGVAGTLTNTTS--KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAK-GEPPNSELHPMRVLF-LIPKNNP  261 (604)
Q Consensus       186 ~DFGlA~~~~~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~-~i~~~~~  261 (604)
                      +|||+++.+.....  ......||+.|+|||++.+..++.++|||||||++|+|++ |..||.+........ .+.....
T Consensus       206 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~  285 (333)
T 2i1m_A          206 GDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGYQ  285 (333)
T ss_dssp             CCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHHHHHHHTCC
T ss_pred             CccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHHHHHhcCCC
Confidence            99999976543322  2234567889999999999999999999999999999998 999998765443332 2222333


Q ss_pred             CCCCccchHHHHHHHHHHhccCCCCCCCHHHHhc
Q psy1546         262 PQLTGNYTKQFKEFVEACLNKDPENRPTAKELLK  295 (604)
Q Consensus       262 ~~~~~~~s~~l~~Li~~~L~~dP~~RpT~~elL~  295 (604)
                      ...+..++..+.+||.+||..||.+|||+.||++
T Consensus       286 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~  319 (333)
T 2i1m_A          286 MAQPAFAPKNIYSIMQACWALEPTHRPTFQQICS  319 (333)
T ss_dssp             CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence            4455667899999999999999999999999987

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=4.7e-41  Score=341.66  Aligned_cols=231  Identities=26%  Similarity=0.423  Sum_probs=197.5

Q ss_pred             ccceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCCe-----------EEEEEE
Q psy1546          57 LIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTK-----------LWIIME  125 (604)
Q Consensus        57 ~~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~~-----------lyLVmE  125 (604)
                      ..|.+.+.||+|+||.||+|.+.  ++.||||++....   ..+.+.+|+.+++.+.||++.+           +|+|||
T Consensus        21 ~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e   95 (278)
T 1byg_A           21 KELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE   95 (278)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC-----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEEC
T ss_pred             hhceEEeEEecCCCceEEEEEEc--CCEEEEEEecchh---HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEe
Confidence            34999999999999999999874  8899999997543   3467889999999999998554           479999


Q ss_pred             ecCCCChhhHhhcC---CCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCCCCc
Q psy1546         126 YLGGGSALDLMKAG---NFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRN  202 (604)
Q Consensus       126 y~~ggsL~~~l~~~---~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~~~  202 (604)
                      |+++++|.+++...   .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......   ..
T Consensus        96 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~---~~  172 (278)
T 1byg_A           96 YMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST---QD  172 (278)
T ss_dssp             CCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC------------
T ss_pred             cCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeecccccccccc---cc
Confidence            99999999998653   3889999999999999999999999999999999999999999999999999755432   22


Q ss_pred             ccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHhhhcCCCCCCCCCccchHHHHHHHHHHhc
Q psy1546         203 TFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAK-GEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLN  281 (604)
Q Consensus       203 ~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~~L~  281 (604)
                      ...+++.|+|||++.+..++.++|||||||++|+|++ |..||...........+........+..+++.+.+||.+||.
T Consensus       173 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~  252 (278)
T 1byg_A          173 TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEVMKNCWH  252 (278)
T ss_dssp             ---CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCCCCTTCCHHHHHHHHHHTC
T ss_pred             CCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCcccCCHHHHHHHHHHhc
Confidence            4468899999999999999999999999999999998 999999888777777776666667778899999999999999


Q ss_pred             cCCCCCCCHHHHhc
Q psy1546         282 KDPENRPTAKELLK  295 (604)
Q Consensus       282 ~dP~~RpT~~elL~  295 (604)
                      .||.+|||+.|+++
T Consensus       253 ~~p~~Rps~~~l~~  266 (278)
T 1byg_A          253 LDAAMRPSFLQLRE  266 (278)
T ss_dssp             SSGGGSCCHHHHHH
T ss_pred             CChhhCCCHHHHHH
Confidence            99999999999987

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=2.5e-41  Score=343.17  Aligned_cols=233  Identities=28%  Similarity=0.482  Sum_probs=199.8

Q ss_pred             cceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCCe------------------
Q psy1546          58 IFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTK------------------  119 (604)
Q Consensus        58 ~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~~------------------  119 (604)
                      .|.+.+.||+|+||.||+|.+..+++.||||++....     ..+.+|+.+++.+.||++.+                  
T Consensus        12 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~   86 (284)
T 2a19_B           12 DFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKN   86 (284)
T ss_dssp             HEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS-----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-------
T ss_pred             ccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc-----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccccc
Confidence            4899999999999999999999999999999997543     34678999999999999654                  


Q ss_pred             --------EEEEEEecCCCChhhHhhc---CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecc
Q psy1546         120 --------LWIIMEYLGGGSALDLMKA---GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADF  188 (604)
Q Consensus       120 --------lyLVmEy~~ggsL~~~l~~---~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DF  188 (604)
                              +|+||||+++++|.+++..   ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+||
T Consensus        87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Df  166 (284)
T 2a19_B           87 SSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDF  166 (284)
T ss_dssp             --CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCC
T ss_pred             ccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCCEEECcc
Confidence                    4799999999999999854   57999999999999999999999999999999999999999999999999


Q ss_pred             cccccccCCCCCCcccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCCCCCCCCccc
Q psy1546         189 GVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNY  268 (604)
Q Consensus       189 GlA~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~  268 (604)
                      |++..+.... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.....  ....+..   ..++..+
T Consensus       167 g~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~--~~~~~~~---~~~~~~~  240 (284)
T 2a19_B          167 GLVTSLKNDG-KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSK--FFTDLRD---GIISDIF  240 (284)
T ss_dssp             TTCEESSCCS-CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHHH--HHHHHHT---TCCCTTS
T ss_pred             hhheeccccc-cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHHH--HHHHhhc---ccccccC
Confidence            9997665432 33456799999999999999999999999999999999999988753221  1111211   1234567


Q ss_pred             hHHHHHHHHHHhccCCCCCCCHHHHhcChhhhh
Q psy1546         269 TKQFKEFVEACLNKDPENRPTAKELLKFPFIRK  301 (604)
Q Consensus       269 s~~l~~Li~~~L~~dP~~RpT~~elL~hp~f~~  301 (604)
                      +..+.+||.+||..||.+|||+.|++++.|..+
T Consensus       241 ~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~  273 (284)
T 2a19_B          241 DKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWK  273 (284)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHT
T ss_pred             CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence            889999999999999999999999999987643

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=6e-41  Score=343.45  Aligned_cols=236  Identities=29%  Similarity=0.547  Sum_probs=187.4

Q ss_pred             ccceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchh-hHHHHHHHHHHHHHHhhCCCCCCCeE---------EEEEEe
Q psy1546          57 LIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE-AEDEIEDIQQEIMVLSQCDSPYGTKL---------WIIMEY  126 (604)
Q Consensus        57 ~~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~-~~~~~~~l~~Ei~iL~~l~hp~~~~l---------yLVmEy  126 (604)
                      ..|++.++||+|+||.||+|.+..   .||||++.... .....+.+.+|+.+++.+.||++..+         |+||||
T Consensus        24 ~~y~~~~~lG~G~~g~Vy~~~~~~---~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~lv~e~  100 (289)
T 3og7_A           24 GQITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTAPQLAIVTQW  100 (289)
T ss_dssp             TSCEEEEEEEECSSEEEEEEESSS---EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSCEEEEEC
T ss_pred             cceeeeeEecCCCCeEEEEEEEcC---ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeeccCCccEEEEEe
Confidence            349999999999999999997653   59999986553 23456788999999999999997654         699999


Q ss_pred             cCCCChhhHhhc--CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCC--CCCCc
Q psy1546         127 LGGGSALDLMKA--GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNT--TSKRN  202 (604)
Q Consensus       127 ~~ggsL~~~l~~--~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~--~~~~~  202 (604)
                      |++++|.+++..  ..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++......  .....
T Consensus       101 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~  180 (289)
T 3og7_A          101 CEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFE  180 (289)
T ss_dssp             CCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC---------------
T ss_pred             cCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEccceecccccccccccccc
Confidence            999999999853  56999999999999999999999999999999999999999999999999999755421  22234


Q ss_pred             ccccCCCCCChHHhh---cCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhh-hcCC----CCCCCCCccchHHHHH
Q psy1546         203 TFVGTPFWMAPEVIK---QSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLF-LIPK----NNPPQLTGNYTKQFKE  274 (604)
Q Consensus       203 ~~~GT~~Y~APE~l~---~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~-~i~~----~~~~~~~~~~s~~l~~  274 (604)
                      ...||+.|+|||++.   +..++.++|||||||++|+|++|..||.......... .+..    .....+...+++.+.+
T Consensus       181 ~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  260 (289)
T 3og7_A          181 QLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKRMKR  260 (289)
T ss_dssp             ---CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCCTTSSCTTSCHHHHH
T ss_pred             ccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcchhhccccCCHHHHH
Confidence            567999999999996   6678889999999999999999999998765543332 2211    1223345578899999


Q ss_pred             HHHHHhccCCCCCCCHHHHhc
Q psy1546         275 FVEACLNKDPENRPTAKELLK  295 (604)
Q Consensus       275 Li~~~L~~dP~~RpT~~elL~  295 (604)
                      ||.+||..||.+|||+.+|++
T Consensus       261 li~~~l~~~p~~Rps~~ell~  281 (289)
T 3og7_A          261 LMAECLKKKRDERPSFPRILA  281 (289)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHccCChhhCCCHHHHHH
Confidence            999999999999999999987

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.9e-41  Score=350.24  Aligned_cols=238  Identities=26%  Similarity=0.442  Sum_probs=199.2

Q ss_pred             ccceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHH-----HHHHHHHHHHHHhhC----CCCCCCeE-------
Q psy1546          57 LIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAED-----EIEDIQQEIMVLSQC----DSPYGTKL-------  120 (604)
Q Consensus        57 ~~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~-----~~~~l~~Ei~iL~~l----~hp~~~~l-------  120 (604)
                      ..|.+.+.||+|+||.||+|.+..+++.||||++.......     ....+.+|+.++.++    .|+++.++       
T Consensus        31 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~~~  110 (312)
T 2iwi_A           31 AEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQ  110 (312)
T ss_dssp             --CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC---
T ss_pred             hceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEecC
Confidence            45999999999999999999999999999999996554321     223456799999888    89997665       


Q ss_pred             ---EEEEEe-cCCCChhhHhhc-CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEec-CCCCeEEecccccccc
Q psy1546         121 ---WIIMEY-LGGGSALDLMKA-GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLS-EMGDVKLADFGVAGTL  194 (604)
Q Consensus       121 ---yLVmEy-~~ggsL~~~l~~-~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~-~~g~vKL~DFGlA~~~  194 (604)
                         |+|||| +.+++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++..+
T Consensus       111 ~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~dfg~~~~~  190 (312)
T 2iwi_A          111 EGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALL  190 (312)
T ss_dssp             --CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEECCCSSCEEC
T ss_pred             CeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEEEcchhhhc
Confidence               699999 789999999865 6799999999999999999999999999999999999999 8899999999999766


Q ss_pred             cCCCCCCcccccCCCCCChHHhhcCCCC-CcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCCCCCCCCccchHHHH
Q psy1546         195 TNTTSKRNTFVGTPFWMAPEVIKQSAYD-SKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFK  273 (604)
Q Consensus       195 ~~~~~~~~~~~GT~~Y~APE~l~~~~~~-~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~  273 (604)
                      ...  ......||+.|+|||++.+..+. .++|||||||++|+|++|..||.....  ...     ....++..++..+.
T Consensus       191 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--~~~-----~~~~~~~~~~~~~~  261 (312)
T 2iwi_A          191 HDE--PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE--ILE-----AELHFPAHVSPDCC  261 (312)
T ss_dssp             CSS--CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH--HHH-----TCCCCCTTSCHHHH
T ss_pred             ccC--cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHH--Hhh-----hccCCcccCCHHHH
Confidence            533  23456799999999999877765 489999999999999999999976432  111     12234567889999


Q ss_pred             HHHHHHhccCCCCCCCHHHHhcChhhhhhh
Q psy1546         274 EFVEACLNKDPENRPTAKELLKFPFIRKAK  303 (604)
Q Consensus       274 ~Li~~~L~~dP~~RpT~~elL~hp~f~~~~  303 (604)
                      +||.+||..||.+|||+.|+++||||+...
T Consensus       262 ~li~~~l~~~p~~Rps~~e~l~~~~~~~~~  291 (312)
T 2iwi_A          262 ALIRRCLAPKPSSRPSLEEILLDPWMQTPA  291 (312)
T ss_dssp             HHHHHHTCSSTTTSCCHHHHHHSTTTCC--
T ss_pred             HHHHHHccCChhhCcCHHHHhcChhhcCch
Confidence            999999999999999999999999997654

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.6e-41  Score=364.67  Aligned_cols=239  Identities=23%  Similarity=0.393  Sum_probs=198.1

Q ss_pred             ccceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCCe------------EEEEE
Q psy1546          57 LIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTK------------LWIIM  124 (604)
Q Consensus        57 ~~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~~------------lyLVm  124 (604)
                      ..|.+.++||+|+||.||+|.+..+++.||||++.........+.+.+|+.+++.+.|||+.+            +|+||
T Consensus         9 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~   88 (396)
T 4eut_A            9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM   88 (396)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred             CceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEE
Confidence            459999999999999999999999999999999976655555677889999999999998654            47999


Q ss_pred             EecCCCChhhHhhcC----CCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEe----cCCCCeEEecccccccccC
Q psy1546         125 EYLGGGSALDLMKAG----NFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLL----SEMGDVKLADFGVAGTLTN  196 (604)
Q Consensus       125 Ey~~ggsL~~~l~~~----~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl----~~~g~vKL~DFGlA~~~~~  196 (604)
                      |||++|+|.+++...    .+++..++.++.||+.||.|||++||+||||||+||||    +.++.+||+|||+++.+..
T Consensus        89 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~~~  168 (396)
T 4eut_A           89 EFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELED  168 (396)
T ss_dssp             CCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCEECCC
T ss_pred             ecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCCceEccC
Confidence            999999999999653    39999999999999999999999999999999999999    7777899999999976653


Q ss_pred             CCCCCcccccCCCCCChHHhhc--------CCCCCcchhhhHHHHHHHHHhCCCCCCCCCh----hhHhhhcCCCCC---
Q psy1546         197 TTSKRNTFVGTPFWMAPEVIKQ--------SAYDSKADIWSLGITAIELAKGEPPNSELHP----MRVLFLIPKNNP---  261 (604)
Q Consensus       197 ~~~~~~~~~GT~~Y~APE~l~~--------~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~----~~~~~~i~~~~~---  261 (604)
                      .. .....+||+.|+|||++.+        ..++.++|||||||++|||++|..||.....    .+....+....+   
T Consensus       169 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~p~~~  247 (396)
T 4eut_A          169 DE-QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGA  247 (396)
T ss_dssp             GG-GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHSCCTTC
T ss_pred             CC-ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcCCCccc
Confidence            32 3345679999999999875        5677899999999999999999999964322    222222211111   


Q ss_pred             ---------------------CCCCccchHHHHHHHHHHhccCCCCCCCHHHHhcC
Q psy1546         262 ---------------------PQLTGNYTKQFKEFVEACLNKDPENRPTAKELLKF  296 (604)
Q Consensus       262 ---------------------~~~~~~~s~~l~~Li~~~L~~dP~~RpT~~elL~h  296 (604)
                                           ..+...++..+.+||.+||..||++|||+.|++++
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~  303 (396)
T 4eut_A          248 ISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAE  303 (396)
T ss_dssp             CEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHH
T ss_pred             chhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHH
Confidence                                 12334567789999999999999999999998764

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=1e-41  Score=354.53  Aligned_cols=241  Identities=23%  Similarity=0.365  Sum_probs=194.3

Q ss_pred             ccceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCCeE----------EEEEEe
Q psy1546          57 LIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTKL----------WIIMEY  126 (604)
Q Consensus        57 ~~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~~l----------yLVmEy  126 (604)
                      ..|.+.+.||+|+||.||+|.+ .+++.||||++...........+.+|+.+++.+.|||+.++          |+||||
T Consensus        30 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  108 (326)
T 3uim_A           30 DNFSNKNILGRGGFGKVYKGRL-ADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPY  108 (326)
T ss_dssp             TSSCSTTEEECCSSSEEEEECC-SSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEECCSSCCEEEEEC
T ss_pred             hccccceeEecCCCcEEEEEEe-cCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEEecCCceEEEEEe
Confidence            4589999999999999999975 46889999999765444333468899999999999996553          799999


Q ss_pred             cCCCChhhHhhcC-----CCcHHHHHHHHHHHHHHhHHhhhC---CccccccccceeEecCCCCeEEecccccccccCCC
Q psy1546         127 LGGGSALDLMKAG-----NFEEMHIAVILREVLKGLDYLHSE---RKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTT  198 (604)
Q Consensus       127 ~~ggsL~~~l~~~-----~lse~~i~~i~~qIl~gL~yLHs~---gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~  198 (604)
                      +++|+|.+++...     .+++..++.++.||+.||.|||++   ||+||||||+|||++.++.+||+|||+++......
T Consensus       109 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  188 (326)
T 3uim_A          109 MANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD  188 (326)
T ss_dssp             CTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCSSCEECCSSS
T ss_pred             ccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCccccccCccc
Confidence            9999999999653     389999999999999999999999   99999999999999999999999999997664333


Q ss_pred             C-CCcccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCCh--------hhHhhh----------cCCC
Q psy1546         199 S-KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHP--------MRVLFL----------IPKN  259 (604)
Q Consensus       199 ~-~~~~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~--------~~~~~~----------i~~~  259 (604)
                      . ......||+.|+|||++.+..++.++|||||||++|+|++|..||.....        ......          ....
T Consensus       189 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  268 (326)
T 3uim_A          189 THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVD  268 (326)
T ss_dssp             SCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSSCCSTTSSCTT
T ss_pred             ccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhhchhhhhhcChh
Confidence            2 23345699999999999999999999999999999999999999952110        000000          0011


Q ss_pred             CCCCCCccchHHHHHHHHHHhccCCCCCCCHHHHhcChh
Q psy1546         260 NPPQLTGNYTKQFKEFVEACLNKDPENRPTAKELLKFPF  298 (604)
Q Consensus       260 ~~~~~~~~~s~~l~~Li~~~L~~dP~~RpT~~elL~hp~  298 (604)
                      .........+..+.+|+.+||..||.+|||+.||++|.+
T Consensus       269 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~  307 (326)
T 3uim_A          269 LQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE  307 (326)
T ss_dssp             CTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHH
T ss_pred             hccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhc
Confidence            112333455678999999999999999999999998743

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=9.8e-41  Score=378.79  Aligned_cols=235  Identities=27%  Similarity=0.469  Sum_probs=202.3

Q ss_pred             eeeEEcccCcEEEEEEEEC--CCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCCeE---------EEEEEecCC
Q psy1546          61 KQERIGKGSFGEVFKGIDN--RTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTKL---------WIIMEYLGG  129 (604)
Q Consensus        61 i~~~LG~G~fG~Vy~a~~~--~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~~l---------yLVmEy~~g  129 (604)
                      ....||+|+||.||+|.+.  .++..||||++.........+.+.+|+.+|+.++|||++++         |||||||++
T Consensus       340 ~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~lv~E~~~~  419 (613)
T 2ozo_A          340 ADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEALMLVMEMAGG  419 (613)
T ss_dssp             EEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEESSSEEEEEECCTT
T ss_pred             cCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEeccCCeEEEEEeCCC
Confidence            3348999999999999875  35677999999765444456789999999999999997664         699999999


Q ss_pred             CChhhHhhc--CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCC---CCccc
Q psy1546         130 GSALDLMKA--GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTS---KRNTF  204 (604)
Q Consensus       130 gsL~~~l~~--~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~---~~~~~  204 (604)
                      |+|.+++..  +.+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.+.....   .....
T Consensus       420 g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~  499 (613)
T 2ozo_A          420 GPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAG  499 (613)
T ss_dssp             CBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC------------
T ss_pred             CcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeeeccCC
Confidence            999999854  5699999999999999999999999999999999999999999999999999976643322   12233


Q ss_pred             ccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHhhhcCCCCCCCCCccchHHHHHHHHHHhccC
Q psy1546         205 VGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAK-GEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKD  283 (604)
Q Consensus       205 ~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~~L~~d  283 (604)
                      .+|+.|+|||++.+..++.++|||||||+||||++ |..||.+....++...+..+.....+..+++++.+||.+||..|
T Consensus       500 ~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~d  579 (613)
T 2ozo_A          500 KWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELYALMSDCWIYK  579 (613)
T ss_dssp             --CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSS
T ss_pred             CCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHHHHHHcCCC
Confidence            46789999999999999999999999999999998 99999999888888888777777788889999999999999999


Q ss_pred             CCCCCCHHHHhc
Q psy1546         284 PENRPTAKELLK  295 (604)
Q Consensus       284 P~~RpT~~elL~  295 (604)
                      |.+||++.+|++
T Consensus       580 P~~RPs~~~l~~  591 (613)
T 2ozo_A          580 WEDRPDFLTVEQ  591 (613)
T ss_dssp             TTTSCCHHHHHH
T ss_pred             hhHCcCHHHHHH
Confidence            999999999975

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=1.6e-40  Score=344.10  Aligned_cols=232  Identities=32%  Similarity=0.555  Sum_probs=193.3

Q ss_pred             ccceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCCeE--------EEEEEecC
Q psy1546          57 LIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTKL--------WIIMEYLG  128 (604)
Q Consensus        57 ~~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~~l--------yLVmEy~~  128 (604)
                      ..|.+.+.||+|+||.||+|.+.  ++.||||++....   ..+.+.+|+.+++.+.|||+.++        |+||||++
T Consensus         8 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~---~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~lv~e~~~   82 (307)
T 2eva_A            8 KEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIESES---ERKAFIVELRQLSRVNHPNIVKLYGACLNPVCLVMEYAE   82 (307)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEET--TEEEEEEECSSTT---HHHHHHHHHHHHHHCCCTTBCCEEEBCTTTTEEEEECCT
T ss_pred             hHeeeeeEeecCCCceEEEEEEC--CeeEEEEEecChh---HHHHHHHHHHHHhcCCCCCcCeEEEEEcCCcEEEEEcCC
Confidence            34899999999999999999875  7889999986443   34678899999999999998776        69999999


Q ss_pred             CCChhhHhhcC----CCcHHHHHHHHHHHHHHhHHhhh---CCccccccccceeEecCCCC-eEEecccccccccCCCCC
Q psy1546         129 GGSALDLMKAG----NFEEMHIAVILREVLKGLDYLHS---ERKLHRDIKAANVLLSEMGD-VKLADFGVAGTLTNTTSK  200 (604)
Q Consensus       129 ggsL~~~l~~~----~lse~~i~~i~~qIl~gL~yLHs---~gIiHrDLKp~NILl~~~g~-vKL~DFGlA~~~~~~~~~  200 (604)
                      +|+|.+++...    .+++..+..++.||+.||.|||+   +||+||||||+|||++.++. +||+|||++......   
T Consensus        83 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~---  159 (307)
T 2eva_A           83 GGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH---  159 (307)
T ss_dssp             TCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC----------
T ss_pred             CCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc---
Confidence            99999999763    37888999999999999999999   89999999999999998887 799999999655422   


Q ss_pred             CcccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCCh--hhHhhhcCCCCCCCCCccchHHHHHHHHH
Q psy1546         201 RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHP--MRVLFLIPKNNPPQLTGNYTKQFKEFVEA  278 (604)
Q Consensus       201 ~~~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~--~~~~~~i~~~~~~~~~~~~s~~l~~Li~~  278 (604)
                      .....||+.|+|||++.+..++.++|||||||++|+|++|..||.....  ......+.....+.+...++..+.+||.+
T Consensus       160 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  239 (307)
T 2eva_A          160 MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPIESLMTR  239 (307)
T ss_dssp             -----CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTCCCCCBTTCCHHHHHHHHH
T ss_pred             cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCCCCCcccccCHHHHHHHHH
Confidence            2345699999999999999999999999999999999999999986433  23333444455566677889999999999


Q ss_pred             HhccCCCCCCCHHHHhcC
Q psy1546         279 CLNKDPENRPTAKELLKF  296 (604)
Q Consensus       279 ~L~~dP~~RpT~~elL~h  296 (604)
                      ||..||.+|||+.+|+++
T Consensus       240 ~l~~dp~~Rps~~ell~~  257 (307)
T 2eva_A          240 CWSKDPSQRPSMEEIVKI  257 (307)
T ss_dssp             HTCSSGGGSCCHHHHHHH
T ss_pred             HhcCChhhCcCHHHHHHH
Confidence            999999999999999873

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=8e-41  Score=365.77  Aligned_cols=236  Identities=28%  Similarity=0.444  Sum_probs=202.0

Q ss_pred             ccceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCCeE---------EEEEEec
Q psy1546          57 LIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTKL---------WIIMEYL  127 (604)
Q Consensus        57 ~~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~~l---------yLVmEy~  127 (604)
                      ..|.+.++||+|+||.||+|.+.. +..||||++......  .+.+.+|+.+|+++.|||+.++         |||||||
T Consensus       184 ~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~iv~e~~  260 (452)
T 1fmk_A          184 ESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMS--PEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYM  260 (452)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSSC--HHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEEECCC
T ss_pred             hHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCCC--HHHHHHHHHHHHhCCCCCEeeEEEEEcCCceEEEehhh
Confidence            458999999999999999999875 467999999765432  3578899999999999997665         6999999


Q ss_pred             CCCChhhHhhc---CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCC-CCCcc
Q psy1546         128 GGGSALDLMKA---GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTT-SKRNT  203 (604)
Q Consensus       128 ~ggsL~~~l~~---~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~-~~~~~  203 (604)
                      ++|+|.++++.   ..+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++...... .....
T Consensus       261 ~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~  340 (452)
T 1fmk_A          261 SKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG  340 (452)
T ss_dssp             TTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC------------
T ss_pred             cCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCccceecCCCceecccC
Confidence            99999999964   459999999999999999999999999999999999999999999999999997664322 12233


Q ss_pred             cccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHhhhcCCCCCCCCCccchHHHHHHHHHHhcc
Q psy1546         204 FVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAK-GEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNK  282 (604)
Q Consensus       204 ~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~~L~~  282 (604)
                      ..+++.|+|||++.+..++.++|||||||+||||++ |..||.+....++...+..+.....+..+++.+.+||.+||..
T Consensus       341 ~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~  420 (452)
T 1fmk_A          341 AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRK  420 (452)
T ss_dssp             --CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHHHHHHTCS
T ss_pred             CcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHccC
Confidence            457789999999999999999999999999999999 9999999888888777777766677788999999999999999


Q ss_pred             CCCCCCCHHHHhc
Q psy1546         283 DPENRPTAKELLK  295 (604)
Q Consensus       283 dP~~RpT~~elL~  295 (604)
                      ||.+|||+.+|++
T Consensus       421 dP~~Rpt~~~l~~  433 (452)
T 1fmk_A          421 EPEERPTFEYLQA  433 (452)
T ss_dssp             SGGGSCCHHHHHH
T ss_pred             ChhhCcCHHHHHH
Confidence            9999999999986

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=1.1e-40  Score=345.26  Aligned_cols=238  Identities=24%  Similarity=0.384  Sum_probs=193.1

Q ss_pred             cceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhh--HHHHHHHHHHHHHHhhCCCCCCCe----------EEEEEE
Q psy1546          58 IFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA--EDEIEDIQQEIMVLSQCDSPYGTK----------LWIIME  125 (604)
Q Consensus        58 ~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~--~~~~~~l~~Ei~iL~~l~hp~~~~----------lyLVmE  125 (604)
                      .|.+.+.||+|+||.||+|.+..+++.||||++.....  ....+.+.+|+.+++.+.||++.+          +|+|||
T Consensus        35 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e  114 (309)
T 2h34_A           35 PYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVDMR  114 (309)
T ss_dssp             CEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             cEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEEEE
Confidence            49999999999999999999999999999999975533  233577899999999999999655          479999


Q ss_pred             ecCCCChhhHhhc-CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCC-CCCcc
Q psy1546         126 YLGGGSALDLMKA-GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTT-SKRNT  203 (604)
Q Consensus       126 y~~ggsL~~~l~~-~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~-~~~~~  203 (604)
                      |+++++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... .....
T Consensus       115 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~  194 (309)
T 2h34_A          115 LINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGN  194 (309)
T ss_dssp             CCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC--------------
T ss_pred             ecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCccccccccccccc
Confidence            9999999999875 679999999999999999999999999999999999999999999999999997654332 22335


Q ss_pred             cccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCCC--CCCCCccchHHHHHHHHHHhc
Q psy1546         204 FVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNN--PPQLTGNYTKQFKEFVEACLN  281 (604)
Q Consensus       204 ~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~~--~~~~~~~~s~~l~~Li~~~L~  281 (604)
                      ..||+.|+|||++.+..++.++|||||||++|+|++|..||...........+....  .......++..+.+||.+||.
T Consensus       195 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~  274 (309)
T 2h34_A          195 TVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQAIPRPSTVRPGIPVAFDAVIARGMA  274 (309)
T ss_dssp             --CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHHHSCCCCGGGTSTTCCTHHHHHHHHHTC
T ss_pred             cCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHhccCCCCccccCCCCCHHHHHHHHHhcc
Confidence            679999999999999999999999999999999999999998876654443333222  223456788999999999999


Q ss_pred             cCCCCCC-CHHHHhc
Q psy1546         282 KDPENRP-TAKELLK  295 (604)
Q Consensus       282 ~dP~~Rp-T~~elL~  295 (604)
                      .||.+|| +++++++
T Consensus       275 ~dP~~Rp~s~~~l~~  289 (309)
T 2h34_A          275 KNPEDRYVTCGDLSA  289 (309)
T ss_dssp             SSGGGSCSSHHHHHH
T ss_pred             CCHHHHHHhHHHHHH
Confidence            9999999 8888876

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=1.7e-40  Score=378.26  Aligned_cols=234  Identities=26%  Similarity=0.446  Sum_probs=202.8

Q ss_pred             eeEEcccCcEEEEEEEE--CCCCcEEEEEEecchhh-HHHHHHHHHHHHHHhhCCCCCCCeE---------EEEEEecCC
Q psy1546          62 QERIGKGSFGEVFKGID--NRTQQVVAIKIIDLEEA-EDEIEDIQQEIMVLSQCDSPYGTKL---------WIIMEYLGG  129 (604)
Q Consensus        62 ~~~LG~G~fG~Vy~a~~--~~t~~~vAVK~i~~~~~-~~~~~~l~~Ei~iL~~l~hp~~~~l---------yLVmEy~~g  129 (604)
                      .++||+|+||.||+|.+  ..+++.||||++..... ....+.+.+|+.+|+.++|||++++         |||||||++
T Consensus       374 ~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~lv~E~~~~  453 (635)
T 4fl3_A          374 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAEL  453 (635)
T ss_dssp             EEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEESSSEEEEEECCTT
T ss_pred             CCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEEEccCC
Confidence            45899999999999954  46678999999976533 2335778999999999999997765         599999999


Q ss_pred             CChhhHhhc-CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCC---CCcccc
Q psy1546         130 GSALDLMKA-GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTS---KRNTFV  205 (604)
Q Consensus       130 gsL~~~l~~-~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~---~~~~~~  205 (604)
                      |+|.+++.. +.+++..++.|+.||+.||.|||++|||||||||+||||+.++.+||+|||+|+.+.....   ......
T Consensus       454 g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~  533 (635)
T 4fl3_A          454 GPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGK  533 (635)
T ss_dssp             EEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC------------
T ss_pred             CCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccccccCCC
Confidence            999999965 5699999999999999999999999999999999999999999999999999976643322   222345


Q ss_pred             cCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHhhhcCCCCCCCCCccchHHHHHHHHHHhccCC
Q psy1546         206 GTPFWMAPEVIKQSAYDSKADIWSLGITAIELAK-GEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDP  284 (604)
Q Consensus       206 GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~~L~~dP  284 (604)
                      +|+.|+|||++.+..++.++|||||||+||||++ |..||.+....++...+........+..++.++.+||.+||..||
T Consensus       534 ~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP  613 (635)
T 4fl3_A          534 WPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDV  613 (635)
T ss_dssp             -CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSST
T ss_pred             CceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCH
Confidence            7889999999999999999999999999999998 999999999888888887777777888999999999999999999


Q ss_pred             CCCCCHHHHhc
Q psy1546         285 ENRPTAKELLK  295 (604)
Q Consensus       285 ~~RpT~~elL~  295 (604)
                      .+|||+.+|++
T Consensus       614 ~~RPs~~~l~~  624 (635)
T 4fl3_A          614 ENRPGFAAVEL  624 (635)
T ss_dssp             TTSCCHHHHHH
T ss_pred             hHCcCHHHHHH
Confidence            99999999986

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=5e-41  Score=347.59  Aligned_cols=240  Identities=21%  Similarity=0.331  Sum_probs=194.6

Q ss_pred             cccceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCCe--------------EE
Q psy1546          56 ELIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTK--------------LW  121 (604)
Q Consensus        56 ~~~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~~--------------ly  121 (604)
                      ...|.+.+.||+|+||.||+|.+..+++.||||++.... ....+.+.+|+.+++.+.||++.+              +|
T Consensus        28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  106 (317)
T 2buj_A           28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHE-QQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAW  106 (317)
T ss_dssp             TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESS-HHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEE
T ss_pred             CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCC-HHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeE
Confidence            345999999999999999999999999999999986543 344578899999999999998543              46


Q ss_pred             EEEEecCCCChhhHhhc-----CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccC
Q psy1546         122 IIMEYLGGGSALDLMKA-----GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTN  196 (604)
Q Consensus       122 LVmEy~~ggsL~~~l~~-----~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~  196 (604)
                      +||||+.+|+|.+++..     +.+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++.....
T Consensus       107 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~~  186 (317)
T 2buj_A          107 LLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACI  186 (317)
T ss_dssp             EEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCSSCEESCE
T ss_pred             EEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEEecCcchhccc
Confidence            99999999999998864     5699999999999999999999999999999999999999999999999999865432


Q ss_pred             CCCC---------CcccccCCCCCChHHhhcCC---CCCcchhhhHHHHHHHHHhCCCCCCCCCh--hhHhhhcCCCCCC
Q psy1546         197 TTSK---------RNTFVGTPFWMAPEVIKQSA---YDSKADIWSLGITAIELAKGEPPNSELHP--MRVLFLIPKNNPP  262 (604)
Q Consensus       197 ~~~~---------~~~~~GT~~Y~APE~l~~~~---~~~~sDVwSLGviL~eLltG~~Pf~~~~~--~~~~~~i~~~~~~  262 (604)
                      ....         .....||+.|+|||++.+..   ++.++|||||||++|+|++|..||.....  ......+......
T Consensus       187 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~  266 (317)
T 2buj_A          187 HVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQLSI  266 (317)
T ss_dssp             EEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHHCC--C
T ss_pred             ccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhhccCCC
Confidence            1111         12345799999999997654   68899999999999999999999864211  1111111122222


Q ss_pred             CCCccchHHHHHHHHHHhccCCCCCCCHHHHhcC
Q psy1546         263 QLTGNYTKQFKEFVEACLNKDPENRPTAKELLKF  296 (604)
Q Consensus       263 ~~~~~~s~~l~~Li~~~L~~dP~~RpT~~elL~h  296 (604)
                      .....++..+.+||.+||..||.+|||+.+|+++
T Consensus       267 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  300 (317)
T 2buj_A          267 PQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQ  300 (317)
T ss_dssp             CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CccccCCHHHHHHHHHHhhcChhhCCCHHHHHHH
Confidence            3345688999999999999999999999999985

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=8.9e-41  Score=347.10  Aligned_cols=236  Identities=24%  Similarity=0.386  Sum_probs=178.6

Q ss_pred             ccceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCC-CCCCCeE---------------
Q psy1546          57 LIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCD-SPYGTKL---------------  120 (604)
Q Consensus        57 ~~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~-hp~~~~l---------------  120 (604)
                      ..|++.++||+|+||.||+|.+..+++.||||++.... ......+.+|+.++..+. |||+.++               
T Consensus        28 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~  106 (337)
T 3ll6_A           28 LRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNE-EEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQ  106 (337)
T ss_dssp             EEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESS-HHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSS
T ss_pred             ceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCc-hHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCC
Confidence            35999999999999999999999999999999985543 334577889999999996 9997654               


Q ss_pred             ---EEEEEecCCCChhhHhhc----CCCcHHHHHHHHHHHHHHhHHhhhCC--ccccccccceeEecCCCCeEEeccccc
Q psy1546         121 ---WIIMEYLGGGSALDLMKA----GNFEEMHIAVILREVLKGLDYLHSER--KLHRDIKAANVLLSEMGDVKLADFGVA  191 (604)
Q Consensus       121 ---yLVmEy~~ggsL~~~l~~----~~lse~~i~~i~~qIl~gL~yLHs~g--IiHrDLKp~NILl~~~g~vKL~DFGlA  191 (604)
                         |+||||+. |+|.+++..    +.+++..++.++.||+.||.|||++|  |+||||||+||||+.++.+||+|||++
T Consensus       107 ~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~  185 (337)
T 3ll6_A          107 AEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSA  185 (337)
T ss_dssp             EEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCEEBCCCTTC
T ss_pred             ceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCEEEecCccc
Confidence               79999995 788887753    57999999999999999999999999  999999999999999999999999999


Q ss_pred             ccccCCCC------------CCcccccCCCCCChHHh---hcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhc
Q psy1546         192 GTLTNTTS------------KRNTFVGTPFWMAPEVI---KQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLI  256 (604)
Q Consensus       192 ~~~~~~~~------------~~~~~~GT~~Y~APE~l---~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i  256 (604)
                      +.+.....            .....+||+.|+|||++   .+..++.++|||||||++|+|++|..||............
T Consensus       186 ~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~  265 (337)
T 3ll6_A          186 TTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIVNGK  265 (337)
T ss_dssp             BCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC------------
T ss_pred             eeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHhhcCc
Confidence            76643221            11245699999999999   5667889999999999999999999999876554433322


Q ss_pred             CCCCCCCCCccchHHHHHHHHHHhccCCCCCCCHHHHhcCh
Q psy1546         257 PKNNPPQLTGNYTKQFKEFVEACLNKDPENRPTAKELLKFP  297 (604)
Q Consensus       257 ~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~RpT~~elL~hp  297 (604)
                         ........++..+.+||.+||+.||.+|||+.|++++.
T Consensus       266 ---~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l  303 (337)
T 3ll6_A          266 ---YSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQL  303 (337)
T ss_dssp             ---CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHH
T ss_pred             ---ccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence               12223345667899999999999999999999999864

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=8e-41  Score=369.15  Aligned_cols=235  Identities=23%  Similarity=0.382  Sum_probs=195.9

Q ss_pred             ccceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCC-----------CeEEEEEE
Q psy1546          57 LIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYG-----------TKLWIIME  125 (604)
Q Consensus        57 ~~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~-----------~~lyLVmE  125 (604)
                      ..|.+.++||+|+||.||+|.+..+++.||||++......   ..+.+|+.+++.+.|.+.           ...|||||
T Consensus         7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~---~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme   83 (483)
T 3sv0_A            7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH---PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD   83 (483)
T ss_dssp             TTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS---CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             CcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc---HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence            4599999999999999999999999999999998654432   347789999999988642           23479999


Q ss_pred             ecCCCChhhHhh--cCCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEe---cCCCCeEEecccccccccCCCC-
Q psy1546         126 YLGGGSALDLMK--AGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLL---SEMGDVKLADFGVAGTLTNTTS-  199 (604)
Q Consensus       126 y~~ggsL~~~l~--~~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl---~~~g~vKL~DFGlA~~~~~~~~-  199 (604)
                      |+ +++|.+++.  .+.+++..++.|+.||+.||.|||++|||||||||+||||   +.++.+||+|||+++.+..... 
T Consensus        84 ~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~  162 (483)
T 3sv0_A           84 LL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTH  162 (483)
T ss_dssp             CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTC
T ss_pred             CC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccCCccc
Confidence            99 999999997  4689999999999999999999999999999999999999   5889999999999987654332 


Q ss_pred             ------CCcccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhH---hhhcC----CCCCCCCCc
Q psy1546         200 ------KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRV---LFLIP----KNNPPQLTG  266 (604)
Q Consensus       200 ------~~~~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~---~~~i~----~~~~~~~~~  266 (604)
                            .....+||+.|+|||++.+..++.++||||||||||||++|..||.+......   ...+.    ......+..
T Consensus       163 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~  242 (483)
T 3sv0_A          163 QHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIEALCR  242 (483)
T ss_dssp             CBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCHHHHHT
T ss_pred             cccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccHHHHhc
Confidence                  12367899999999999999999999999999999999999999987554211   11111    111112235


Q ss_pred             cchHHHHHHHHHHhccCCCCCCCHHHHhc
Q psy1546         267 NYTKQFKEFVEACLNKDPENRPTAKELLK  295 (604)
Q Consensus       267 ~~s~~l~~Li~~~L~~dP~~RpT~~elL~  295 (604)
                      .++.++.+||.+||..||.+||++.+|++
T Consensus       243 ~~p~~l~~li~~cl~~dP~~RPs~~el~~  271 (483)
T 3sv0_A          243 GYPTEFASYFHYCRSLRFDDKPDYSYLKR  271 (483)
T ss_dssp             TSCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             CCcHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence            67889999999999999999999999876

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=5.8e-41  Score=355.59  Aligned_cols=238  Identities=20%  Similarity=0.251  Sum_probs=189.9

Q ss_pred             ccceeeeEEcccCcEEEEEEEECCC-----CcEEEEEEecchhhH--HHH--------HHHHHHHHHHhhCCCCCCCe--
Q psy1546          57 LIFTKQERIGKGSFGEVFKGIDNRT-----QQVVAIKIIDLEEAE--DEI--------EDIQQEIMVLSQCDSPYGTK--  119 (604)
Q Consensus        57 ~~y~i~~~LG~G~fG~Vy~a~~~~t-----~~~vAVK~i~~~~~~--~~~--------~~l~~Ei~iL~~l~hp~~~~--  119 (604)
                      ..|.+.++||+|+||.||+|.+..+     ++.||||++......  .+.        ..+..|+..+..+.||++.+  
T Consensus        35 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~  114 (364)
T 3op5_A           35 AAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYW  114 (364)
T ss_dssp             CEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCEE
T ss_pred             CeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeEE
Confidence            3599999999999999999998765     588999998654321  111        22345677888899998654  


Q ss_pred             ------------EEEEEEecCCCChhhHhhc--CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEec--CCCCe
Q psy1546         120 ------------LWIIMEYLGGGSALDLMKA--GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLS--EMGDV  183 (604)
Q Consensus       120 ------------lyLVmEy~~ggsL~~~l~~--~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~--~~g~v  183 (604)
                                  +||||||| |++|.+++..  +.+++..++.|+.||+.||.|||++||+||||||+||||+  .++.+
T Consensus       115 ~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~~~~  193 (364)
T 3op5_A          115 GSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQV  193 (364)
T ss_dssp             EEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCTTCE
T ss_pred             eeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCCCeE
Confidence                        47999999 9999999965  5799999999999999999999999999999999999998  88999


Q ss_pred             EEecccccccccCCCC-------CCcccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhh-
Q psy1546         184 KLADFGVAGTLTNTTS-------KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFL-  255 (604)
Q Consensus       184 KL~DFGlA~~~~~~~~-------~~~~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~-  255 (604)
                      ||+|||+|+.+.....       .....+||+.|||||++.+..++.++|||||||+||||++|..||.+......... 
T Consensus       194 kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~~~~~  273 (364)
T 3op5_A          194 YLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKYVRD  273 (364)
T ss_dssp             EECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHHHH
T ss_pred             EEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCHHHHHH
Confidence            9999999976643221       12345699999999999999999999999999999999999999986432211110 


Q ss_pred             cCCC---CCC------CCCccchHHHHHHHHHHhccCCCCCCCHHHHhc
Q psy1546         256 IPKN---NPP------QLTGNYTKQFKEFVEACLNKDPENRPTAKELLK  295 (604)
Q Consensus       256 i~~~---~~~------~~~~~~s~~l~~Li~~~L~~dP~~RpT~~elL~  295 (604)
                      ....   ...      .....++.++.+||..||..||.+||++.+|++
T Consensus       274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~  322 (364)
T 3op5_A          274 SKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRD  322 (364)
T ss_dssp             HHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             HHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHH
Confidence            0000   000      011456889999999999999999999999986

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.2e-40  Score=343.69  Aligned_cols=234  Identities=28%  Similarity=0.429  Sum_probs=186.2

Q ss_pred             ccceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHh--hCCCCCCC--------------eE
Q psy1546          57 LIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLS--QCDSPYGT--------------KL  120 (604)
Q Consensus        57 ~~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~--~l~hp~~~--------------~l  120 (604)
                      ..|.+.++||+|+||.||+|++.  ++.||||++.....    ....+|..++.  .+.|||+.              .+
T Consensus        37 ~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~----~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~  110 (337)
T 3mdy_A           37 KQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTEE----ASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQL  110 (337)
T ss_dssp             HHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGGGH----HHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEE
T ss_pred             cceEEEeEeecCCCeEEEEEEEC--CceEEEEEEecccc----chhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCce
Confidence            45999999999999999999875  89999999864432    23334444444  45999854              45


Q ss_pred             EEEEEecCCCChhhHhhcCCCcHHHHHHHHHHHHHHhHHhhhC--------CccccccccceeEecCCCCeEEecccccc
Q psy1546         121 WIIMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSE--------RKLHRDIKAANVLLSEMGDVKLADFGVAG  192 (604)
Q Consensus       121 yLVmEy~~ggsL~~~l~~~~lse~~i~~i~~qIl~gL~yLHs~--------gIiHrDLKp~NILl~~~g~vKL~DFGlA~  192 (604)
                      |+|||||++|+|.++++...+++..++.++.||+.||.|||++        ||+||||||+||||+.++.+||+|||+|+
T Consensus       111 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~  190 (337)
T 3mdy_A          111 YLITDYHENGSLYDYLKSTTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV  190 (337)
T ss_dssp             EEEECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred             EEEEeccCCCcHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEeCCCce
Confidence            7999999999999999999999999999999999999999999        99999999999999999999999999997


Q ss_pred             cccCCCCC----CcccccCCCCCChHHhhcCCCCCc------chhhhHHHHHHHHHhC----------CCCCCCCChh--
Q psy1546         193 TLTNTTSK----RNTFVGTPFWMAPEVIKQSAYDSK------ADIWSLGITAIELAKG----------EPPNSELHPM--  250 (604)
Q Consensus       193 ~~~~~~~~----~~~~~GT~~Y~APE~l~~~~~~~~------sDVwSLGviL~eLltG----------~~Pf~~~~~~--  250 (604)
                      .+......    ....+||+.|+|||++.+..+...      +|||||||++|||++|          ..||......  
T Consensus       191 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~  270 (337)
T 3mdy_A          191 KFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDP  270 (337)
T ss_dssp             ECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred             eeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhcCCCC
Confidence            66433222    235689999999999988777765      9999999999999999          6777653221  


Q ss_pred             ---hHhhh-cCCCCCCCCC-----ccchHHHHHHHHHHhccCCCCCCCHHHHhcC
Q psy1546         251 ---RVLFL-IPKNNPPQLT-----GNYTKQFKEFVEACLNKDPENRPTAKELLKF  296 (604)
Q Consensus       251 ---~~~~~-i~~~~~~~~~-----~~~s~~l~~Li~~~L~~dP~~RpT~~elL~h  296 (604)
                         ..... ......+.++     ..+++++.+||.+||..||.+|||+.||++|
T Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  325 (337)
T 3mdy_A          271 SYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKT  325 (337)
T ss_dssp             CHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred             chhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHH
Confidence               11111 1122222232     2567889999999999999999999999985

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=1.2e-40  Score=347.58  Aligned_cols=234  Identities=25%  Similarity=0.388  Sum_probs=183.8

Q ss_pred             cceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCCeE---------------EE
Q psy1546          58 IFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTKL---------------WI  122 (604)
Q Consensus        58 ~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~~l---------------yL  122 (604)
                      .|.+.++||+|+||.||+|++  +++.||||++.......  .....|+..+..+.|+++.++               ||
T Consensus        14 ~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~--~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~l   89 (336)
T 3g2f_A           14 NLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFANRQN--FINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLL   89 (336)
T ss_dssp             SEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGGHHH--HHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEEE
T ss_pred             HhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccchhh--HHHHHHHHHHHhccCcchhhheecccccccCCCceEEE
Confidence            399999999999999999976  58999999996544222  222345555667999986654               69


Q ss_pred             EEEecCCCChhhHhhcCCCcHHHHHHHHHHHHHHhHHhhhC---------CccccccccceeEecCCCCeEEeccccccc
Q psy1546         123 IMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSE---------RKLHRDIKAANVLLSEMGDVKLADFGVAGT  193 (604)
Q Consensus       123 VmEy~~ggsL~~~l~~~~lse~~i~~i~~qIl~gL~yLHs~---------gIiHrDLKp~NILl~~~g~vKL~DFGlA~~  193 (604)
                      |||||++|+|.+++....+++..++.++.||+.||.|||++         ||+||||||+||||+.++.+||+|||+++.
T Consensus        90 v~e~~~~g~L~~~l~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DFG~a~~  169 (336)
T 3g2f_A           90 VMEYYPNGSLXKYLSLHTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMR  169 (336)
T ss_dssp             EECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             EEecCCCCcHHHHHhhcccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEeeccceee
Confidence            99999999999999988899999999999999999999999         999999999999999999999999999976


Q ss_pred             ccCCC--------CCCcccccCCCCCChHHhhc-------CCCCCcchhhhHHHHHHHHHhCCCCCCCCChh--------
Q psy1546         194 LTNTT--------SKRNTFVGTPFWMAPEVIKQ-------SAYDSKADIWSLGITAIELAKGEPPNSELHPM--------  250 (604)
Q Consensus       194 ~~~~~--------~~~~~~~GT~~Y~APE~l~~-------~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~--------  250 (604)
                      +....        ......+||+.|+|||++.+       ..++.++|||||||+||||++|..||......        
T Consensus       170 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~  249 (336)
T 3g2f_A          170 LTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQ  249 (336)
T ss_dssp             CSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCCCTTH
T ss_pred             cccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHHHHhhh
Confidence            64321        12234579999999999987       34567899999999999999997765332110        


Q ss_pred             ----------hHhh-hcCCCCCCCCCc------cchHHHHHHHHHHhccCCCCCCCHHHHhc
Q psy1546         251 ----------RVLF-LIPKNNPPQLTG------NYTKQFKEFVEACLNKDPENRPTAKELLK  295 (604)
Q Consensus       251 ----------~~~~-~i~~~~~~~~~~------~~s~~l~~Li~~~L~~dP~~RpT~~elL~  295 (604)
                                .... .......+.++.      .+++.+.+||.+||..||.+|||+.||++
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~  311 (336)
T 3g2f_A          250 TEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEE  311 (336)
T ss_dssp             HHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             cccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHH
Confidence                      0000 111111222222      25668999999999999999999999986

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=9.1e-41  Score=351.57  Aligned_cols=238  Identities=22%  Similarity=0.302  Sum_probs=186.5

Q ss_pred             ccceeeeEEcccCcEEEEEEEECC---CCcEEEEEEecchhhH--HH--------HHHHHHHHHHHhhCCCCCCCe----
Q psy1546          57 LIFTKQERIGKGSFGEVFKGIDNR---TQQVVAIKIIDLEEAE--DE--------IEDIQQEIMVLSQCDSPYGTK----  119 (604)
Q Consensus        57 ~~y~i~~~LG~G~fG~Vy~a~~~~---t~~~vAVK~i~~~~~~--~~--------~~~l~~Ei~iL~~l~hp~~~~----  119 (604)
                      ..|.+.+.||+|+||.||+|.+..   ++..||||++......  .+        ...+.+|+.+++.+.||++.+    
T Consensus        37 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~  116 (345)
T 2v62_A           37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGS  116 (345)
T ss_dssp             CEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEE
T ss_pred             ceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecc
Confidence            459999999999999999999987   7889999998654321  11        123568899999999998543    


Q ss_pred             ----------EEEEEEecCCCChhhHhhc-CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCC--CeEEe
Q psy1546         120 ----------LWIIMEYLGGGSALDLMKA-GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMG--DVKLA  186 (604)
Q Consensus       120 ----------lyLVmEy~~ggsL~~~l~~-~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g--~vKL~  186 (604)
                                +||||||| +++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+||||+.++  .+||+
T Consensus       117 ~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kL~  195 (345)
T 2v62_A          117 GLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLA  195 (345)
T ss_dssp             EEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTTSEEEC
T ss_pred             cccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCCcEEEE
Confidence                      58999999 9999999865 5799999999999999999999999999999999999998877  99999


Q ss_pred             cccccccccCCCC-------CCcccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCC--hhhHhhh--
Q psy1546         187 DFGVAGTLTNTTS-------KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELH--PMRVLFL--  255 (604)
Q Consensus       187 DFGlA~~~~~~~~-------~~~~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~--~~~~~~~--  255 (604)
                      |||+|+.+.....       ......||+.|+|||++.+..++.++|||||||+||||++|..||....  .......  
T Consensus       196 Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~  275 (345)
T 2v62_A          196 DYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQTAKT  275 (345)
T ss_dssp             CCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHHHHHH
T ss_pred             eCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHHHHHHHH
Confidence            9999976643221       1245679999999999999999999999999999999999999996522  1111111  


Q ss_pred             -cCCCCCCC-----CCccchHHHHHHHHHHhccCCCCCCCHHHHhc
Q psy1546         256 -IPKNNPPQ-----LTGNYTKQFKEFVEACLNKDPENRPTAKELLK  295 (604)
Q Consensus       256 -i~~~~~~~-----~~~~~s~~l~~Li~~~L~~dP~~RpT~~elL~  295 (604)
                       .....+..     ....++.++.+||.+||..||.+|||+.+|++
T Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  321 (345)
T 2v62_A          276 NLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKK  321 (345)
T ss_dssp             HHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             hhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence             00000100     01267889999999999999999999999987

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=1.9e-40  Score=338.40  Aligned_cols=240  Identities=27%  Similarity=0.430  Sum_probs=194.8

Q ss_pred             cccceeeeEEcccCcEEEEEEEECC-CCc--EEEEEEecchh--hHHHHHHHHHHHHHHhhCCCCCCCeE---------E
Q psy1546          56 ELIFTKQERIGKGSFGEVFKGIDNR-TQQ--VVAIKIIDLEE--AEDEIEDIQQEIMVLSQCDSPYGTKL---------W  121 (604)
Q Consensus        56 ~~~y~i~~~LG~G~fG~Vy~a~~~~-t~~--~vAVK~i~~~~--~~~~~~~l~~Ei~iL~~l~hp~~~~l---------y  121 (604)
                      ...|.+.+.||+|+||.||+|.+.. +++  .||||++....  .....+.+.+|+.+++.+.||++.++         +
T Consensus        17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   96 (291)
T 1u46_A           17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMK   96 (291)
T ss_dssp             GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCE
T ss_pred             hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCCce
Confidence            3459999999999999999998643 333  68999986543  23456788999999999999997665         6


Q ss_pred             EEEEecCCCChhhHhhc--CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCC
Q psy1546         122 IIMEYLGGGSALDLMKA--GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTS  199 (604)
Q Consensus       122 LVmEy~~ggsL~~~l~~--~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~  199 (604)
                      +||||+.+++|.+++..  +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus        97 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~  176 (291)
T 1u46_A           97 MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDD  176 (291)
T ss_dssp             EEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-CC
T ss_pred             eeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEcccccccccccccc
Confidence            99999999999999865  5699999999999999999999999999999999999999999999999999976643322


Q ss_pred             ---CCcccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHhhhcCCC-CCCCCCccchHHHHH
Q psy1546         200 ---KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAK-GEPPNSELHPMRVLFLIPKN-NPPQLTGNYTKQFKE  274 (604)
Q Consensus       200 ---~~~~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~~s~~l~~  274 (604)
                         ......+|+.|+|||++.+..++.++|||||||++|+|++ |..||...........+... .....+..++..+.+
T Consensus       177 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  256 (291)
T 1u46_A          177 HYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIYN  256 (291)
T ss_dssp             EEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTTCCHHHHH
T ss_pred             chhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCCCCCCcCcCHHHHH
Confidence               1234467889999999999999999999999999999999 99999988877766655333 334455678999999


Q ss_pred             HHHHHhccCCCCCCCHHHHhc
Q psy1546         275 FVEACLNKDPENRPTAKELLK  295 (604)
Q Consensus       275 Li~~~L~~dP~~RpT~~elL~  295 (604)
                      ||.+||..||.+|||+.++++
T Consensus       257 li~~~l~~~p~~Rps~~~l~~  277 (291)
T 1u46_A          257 VMVQCWAHKPEDRPTFVALRD  277 (291)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHccCCcccCcCHHHHHH
Confidence            999999999999999999997

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=3.6e-40  Score=358.75  Aligned_cols=243  Identities=24%  Similarity=0.359  Sum_probs=185.5

Q ss_pred             ccccceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhC-CCCCCCeE----------EEE
Q psy1546          55 PELIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQC-DSPYGTKL----------WII  123 (604)
Q Consensus        55 ~~~~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l-~hp~~~~l----------yLV  123 (604)
                      ....|.+.+.||+|+||+||.+ ...+|+.||||++....    .+.+.+|+.+|..+ .|||++++          |||
T Consensus        13 l~~~~~~~~~LG~G~~g~V~~~-~~~~g~~vAvK~~~~~~----~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv   87 (434)
T 2rio_A           13 LKNLVVSEKILGYGSSGTVVFQ-GSFQGRPVAVKRMLIDF----CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIA   87 (434)
T ss_dssp             CSSCEEEEEEEEECSTTCEEEE-EESSSSEEEEEEEEGGG----HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEE
T ss_pred             hhheeeccCeEeeCCCeEEEEE-EEECCeEEEEEEEcHHH----HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEE
Confidence            3455788899999999999875 34679999999986543    24567899999875 89997654          799


Q ss_pred             EEecCCCChhhHhhcCCC--------cHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCC-------------CC
Q psy1546         124 MEYLGGGSALDLMKAGNF--------EEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEM-------------GD  182 (604)
Q Consensus       124 mEy~~ggsL~~~l~~~~l--------se~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~-------------g~  182 (604)
                      ||||+ |+|.+++.....        .+..++.++.||+.||.|||++||+||||||+||||+.+             +.
T Consensus        88 ~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~  166 (434)
T 2rio_A           88 LELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLR  166 (434)
T ss_dssp             ECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCE
T ss_pred             EecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCceE
Confidence            99995 699999976432        333457799999999999999999999999999999754             47


Q ss_pred             eEEecccccccccCCCC----CCcccccCCCCCChHHhhc-------CCCCCcchhhhHHHHHHHHHh-CCCCCCCCChh
Q psy1546         183 VKLADFGVAGTLTNTTS----KRNTFVGTPFWMAPEVIKQ-------SAYDSKADIWSLGITAIELAK-GEPPNSELHPM  250 (604)
Q Consensus       183 vKL~DFGlA~~~~~~~~----~~~~~~GT~~Y~APE~l~~-------~~~~~~sDVwSLGviL~eLlt-G~~Pf~~~~~~  250 (604)
                      +||+|||+|+.+.....    .....+||+.|+|||++.+       ..++.++|||||||++|||++ |..||......
T Consensus       167 ~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~  246 (434)
T 2rio_A          167 ILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSR  246 (434)
T ss_dssp             EEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTH
T ss_pred             EEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhh
Confidence            99999999987654322    1234689999999999976       668999999999999999999 99999765443


Q ss_pred             hHhhhcCCCCC----CCCCccchHHHHHHHHHHhccCCCCCCCHHHHhcChhhhhhh
Q psy1546         251 RVLFLIPKNNP----PQLTGNYTKQFKEFVEACLNKDPENRPTAKELLKFPFIRKAK  303 (604)
Q Consensus       251 ~~~~~i~~~~~----~~~~~~~s~~l~~Li~~~L~~dP~~RpT~~elL~hp~f~~~~  303 (604)
                      ...........    ......++.++.+||.+||..||.+|||+.||++||||....
T Consensus       247 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~~~~  303 (434)
T 2rio_A          247 ESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWPKS  303 (434)
T ss_dssp             HHHHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSCHH
T ss_pred             HHHHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCccCCcH
Confidence            32211111111    111235678999999999999999999999999999997543

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=1.3e-40  Score=350.98  Aligned_cols=233  Identities=15%  Similarity=0.244  Sum_probs=191.3

Q ss_pred             cccceeeeEEcccCcEEEEEEEECCC--------CcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCC----------
Q psy1546          56 ELIFTKQERIGKGSFGEVFKGIDNRT--------QQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYG----------  117 (604)
Q Consensus        56 ~~~y~i~~~LG~G~fG~Vy~a~~~~t--------~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~----------  117 (604)
                      ...|.+.+.||+|+||.||+|++..+        ++.||||++...      ..+.+|+.+++.+.||++          
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~  114 (352)
T 2jii_A           41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD------GRLFNEQNFFQRAAKPLQVNKWKKLYST  114 (352)
T ss_dssp             SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT------STHHHHHHHHHHHCCHHHHHHHHHHTTC
T ss_pred             CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc------chHHHHHHHHHHhcccchhhhhhhhccC
Confidence            34699999999999999999999874        889999998654      356788888888888652          


Q ss_pred             ----------------CeEEEEEEecCCCChhhHhhc---CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEec
Q psy1546         118 ----------------TKLWIIMEYLGGGSALDLMKA---GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLS  178 (604)
Q Consensus       118 ----------------~~lyLVmEy~~ggsL~~~l~~---~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~  178 (604)
                                      ..+||||||+ +++|.+++..   +.+++..++.++.||+.||.|||++||+||||||+|||++
T Consensus       115 ~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl~~  193 (352)
T 2jii_A          115 PLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVD  193 (352)
T ss_dssp             TTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEEEE
T ss_pred             CccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEEc
Confidence                            4568999999 9999999975   5799999999999999999999999999999999999999


Q ss_pred             CCC--CeEEecccccccccCCCC-------CCcccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCC-
Q psy1546         179 EMG--DVKLADFGVAGTLTNTTS-------KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELH-  248 (604)
Q Consensus       179 ~~g--~vKL~DFGlA~~~~~~~~-------~~~~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~-  248 (604)
                      .++  .+||+|||+++.+.....       ......||+.|+|||++.+..++.++|||||||+||+|++|..||.... 
T Consensus       194 ~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~  273 (352)
T 2jii_A          194 PEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLP  273 (352)
T ss_dssp             TTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTT
T ss_pred             CCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCCc
Confidence            988  899999999976643221       2234589999999999999999999999999999999999999998764 


Q ss_pred             -hhhHhhhcC--CCCCCCC------CccchHHHHHHHHHHhccCCCCCCCHHHHhc
Q psy1546         249 -PMRVLFLIP--KNNPPQL------TGNYTKQFKEFVEACLNKDPENRPTAKELLK  295 (604)
Q Consensus       249 -~~~~~~~i~--~~~~~~~------~~~~s~~l~~Li~~~L~~dP~~RpT~~elL~  295 (604)
                       ...+.....  ......+      ...++.++.+||.+||..||.+|||+.+|++
T Consensus       274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  329 (352)
T 2jii_A          274 NTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRN  329 (352)
T ss_dssp             CHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             CHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHH
Confidence             222211110  0111111      2356899999999999999999999999987

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=2.2e-40  Score=370.10  Aligned_cols=236  Identities=28%  Similarity=0.444  Sum_probs=206.3

Q ss_pred             ccceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCCeE---------EEEEEec
Q psy1546          57 LIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTKL---------WIIMEYL  127 (604)
Q Consensus        57 ~~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~~l---------yLVmEy~  127 (604)
                      ..|.+.++||+|+||.||+|.+.. +..||||++......  .+.+.+|+.+|+.+.|+|++++         |||||||
T Consensus       267 ~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~lv~e~~  343 (535)
T 2h8h_A          267 ESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMS--PEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYM  343 (535)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSSC--HHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEEECCC
T ss_pred             hhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCCC--HHHHHHHHHHHHhCCCCCEeeEEEEEeeccceEeeehh
Confidence            348999999999999999999875 467999999765432  3578899999999999997765         6999999


Q ss_pred             CCCChhhHhhc---CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCC-CCCcc
Q psy1546         128 GGGSALDLMKA---GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTT-SKRNT  203 (604)
Q Consensus       128 ~ggsL~~~l~~---~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~-~~~~~  203 (604)
                      .+|+|.++++.   ..+++..+..|+.||+.||.|||++||+||||||+||||+.++.+||+|||+++.+.... .....
T Consensus       344 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~  423 (535)
T 2h8h_A          344 SKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG  423 (535)
T ss_dssp             TTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHHHTTCS
T ss_pred             cCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEcccccceecCCCceecccC
Confidence            99999999964   459999999999999999999999999999999999999999999999999997654321 11223


Q ss_pred             cccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHhhhcCCCCCCCCCccchHHHHHHHHHHhcc
Q psy1546         204 FVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAK-GEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNK  282 (604)
Q Consensus       204 ~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~~L~~  282 (604)
                      ..+++.|+|||++.+..++.++|||||||+||||++ |..||.+....++...+..+.....+..++..+.+||.+||..
T Consensus       424 ~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~  503 (535)
T 2h8h_A          424 AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRK  503 (535)
T ss_dssp             TTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCS
T ss_pred             CcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCC
Confidence            457788999999999999999999999999999999 9999999888888777776666667778999999999999999


Q ss_pred             CCCCCCCHHHHhc
Q psy1546         283 DPENRPTAKELLK  295 (604)
Q Consensus       283 dP~~RpT~~elL~  295 (604)
                      ||.+|||+.+|++
T Consensus       504 dP~~RPt~~~l~~  516 (535)
T 2h8h_A          504 EPEERPTFEYLQA  516 (535)
T ss_dssp             SGGGSCCHHHHHH
T ss_pred             ChhHCcCHHHHHH
Confidence            9999999999986

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=2.5e-40  Score=350.58  Aligned_cols=230  Identities=14%  Similarity=0.157  Sum_probs=183.4

Q ss_pred             ccceeeeEEcccCcEEEEEE-----EECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCC---CCCCC----------
Q psy1546          57 LIFTKQERIGKGSFGEVFKG-----IDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCD---SPYGT----------  118 (604)
Q Consensus        57 ~~y~i~~~LG~G~fG~Vy~a-----~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~---hp~~~----------  118 (604)
                      ..|.+.++||+|+||.||+|     .+..+++.||||++....    ...+.+|+.++..+.   |+++.          
T Consensus        65 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~  140 (365)
T 3e7e_A           65 KLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN----PWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQN  140 (365)
T ss_dssp             SEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC----HHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSS
T ss_pred             EEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC----hhHHHHHHHHHHHhhhhhhhhhhhhheeeecCC
Confidence            45999999999999999999     467789999999997543    234667777777776   77644          


Q ss_pred             eEEEEEEecCCCChhhHhh------cCCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecC-----------CC
Q psy1546         119 KLWIIMEYLGGGSALDLMK------AGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSE-----------MG  181 (604)
Q Consensus       119 ~lyLVmEy~~ggsL~~~l~------~~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~-----------~g  181 (604)
                      .+|||||||++|+|.+++.      .+.+++..++.|+.||+.||+|||++|||||||||+||||+.           ++
T Consensus       141 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~~~~~~~  220 (365)
T 3e7e_A          141 GSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSA  220 (365)
T ss_dssp             CEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC------CT
T ss_pred             CcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCccccccccC
Confidence            3479999999999999995      356999999999999999999999999999999999999998           89


Q ss_pred             CeEEecccccccccC--CCCCCcccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCC
Q psy1546         182 DVKLADFGVAGTLTN--TTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKN  259 (604)
Q Consensus       182 ~vKL~DFGlA~~~~~--~~~~~~~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~  259 (604)
                      .+||+|||+|+.+..  ........+||+.|||||++.+..|+.++|||||||+||||++|..||.........  +.. 
T Consensus       221 ~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~--~~~-  297 (365)
T 3e7e_A          221 GLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECK--PEG-  297 (365)
T ss_dssp             TEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEEE--ECS-
T ss_pred             CEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCcee--ech-
Confidence            999999999975532  223345678999999999999999999999999999999999999998654332111  111 


Q ss_pred             CCCCCCccchHHHHHHHHHHhccCCCCCCCHHHHhc
Q psy1546         260 NPPQLTGNYTKQFKEFVEACLNKDPENRPTAKELLK  295 (604)
Q Consensus       260 ~~~~~~~~~s~~l~~Li~~~L~~dP~~RpT~~elL~  295 (604)
                      ....  ...++.+.+++..||..+|.+|++..+.|.
T Consensus       298 ~~~~--~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~  331 (365)
T 3e7e_A          298 LFRR--LPHLDMWNEFFHVMLNIPDCHHLPSLDLLR  331 (365)
T ss_dssp             CCTT--CSSHHHHHHHHHHHHCCCCTTCCCCHHHHH
T ss_pred             hccc--cCcHHHHHHHHHHHcCCCCCCcchHHHHHH
Confidence            1111  134778999999999999999965444443

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=7.9e-40  Score=337.06  Aligned_cols=239  Identities=27%  Similarity=0.470  Sum_probs=194.8

Q ss_pred             ccccceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchh---hHHHHHHHHHHHHHHhhCCCCCCCeE----------E
Q psy1546          55 PELIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE---AEDEIEDIQQEIMVLSQCDSPYGTKL----------W  121 (604)
Q Consensus        55 ~~~~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~---~~~~~~~l~~Ei~iL~~l~hp~~~~l----------y  121 (604)
                      ....|...+.||+|+||.||+|.+  +++.||||++....   .....+.+.+|+.+++.+.||++.++          |
T Consensus        29 ~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~  106 (307)
T 2nru_A           29 ERPISVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLC  106 (307)
T ss_dssp             CSBTTTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred             cccccccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceE
Confidence            334567779999999999999985  58899999986432   23345778999999999999997654          7


Q ss_pred             EEEEecCCCChhhHhhc----CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCC
Q psy1546         122 IIMEYLGGGSALDLMKA----GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNT  197 (604)
Q Consensus       122 LVmEy~~ggsL~~~l~~----~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~  197 (604)
                      +||||+++++|.+++..    ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus       107 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~  186 (307)
T 2nru_A          107 LVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKF  186 (307)
T ss_dssp             EEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSC
T ss_pred             EEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeecccccccccc
Confidence            99999999999998863    45999999999999999999999999999999999999999999999999999765432


Q ss_pred             CC--CCcccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhh----c----------CCCCC
Q psy1546         198 TS--KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFL----I----------PKNNP  261 (604)
Q Consensus       198 ~~--~~~~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~----i----------~~~~~  261 (604)
                      ..  ......||+.|+|||++.+ .++.++|||||||++|+|++|..||...........    +          .....
T Consensus       187 ~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  265 (307)
T 2nru_A          187 AQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKM  265 (307)
T ss_dssp             SSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCSSC
T ss_pred             cccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhccccc
Confidence            22  2334579999999999875 488999999999999999999999987543221111    0          11112


Q ss_pred             CCCCccchHHHHHHHHHHhccCCCCCCCHHHHhcC
Q psy1546         262 PQLTGNYTKQFKEFVEACLNKDPENRPTAKELLKF  296 (604)
Q Consensus       262 ~~~~~~~s~~l~~Li~~~L~~dP~~RpT~~elL~h  296 (604)
                      ......++..+.+|+.+||..||.+|||+.+|+++
T Consensus       266 ~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~  300 (307)
T 2nru_A          266 NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL  300 (307)
T ss_dssp             SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            23345567889999999999999999999999874

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=5.8e-40  Score=342.24  Aligned_cols=238  Identities=26%  Similarity=0.455  Sum_probs=199.8

Q ss_pred             ccceeeeEEcccCcEEEEEEE----ECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCCe------------E
Q psy1546          57 LIFTKQERIGKGSFGEVFKGI----DNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTK------------L  120 (604)
Q Consensus        57 ~~y~i~~~LG~G~fG~Vy~a~----~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~~------------l  120 (604)
                      ..|.+.+.||+|+||.||+|.    +..+++.||||++.... ....+.+.+|+.+++.+.||++.+            +
T Consensus        41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  119 (326)
T 2w1i_A           41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST-EEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL  119 (326)
T ss_dssp             GGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCC-SHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred             HHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCC-HHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence            448999999999999999998    46789999999997643 344578899999999999998654            3


Q ss_pred             EEEEEecCCCChhhHhhc--CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCC
Q psy1546         121 WIIMEYLGGGSALDLMKA--GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTT  198 (604)
Q Consensus       121 yLVmEy~~ggsL~~~l~~--~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~  198 (604)
                      |+||||+++++|.+++..  +.+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++.......
T Consensus       120 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~~~~  199 (326)
T 2w1i_A          120 KLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK  199 (326)
T ss_dssp             EEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCSSC
T ss_pred             EEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecCcchhhccccc
Confidence            799999999999999976  459999999999999999999999999999999999999999999999999997665432


Q ss_pred             C---CCcccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChh----------------hHhhhcCCC
Q psy1546         199 S---KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPM----------------RVLFLIPKN  259 (604)
Q Consensus       199 ~---~~~~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~----------------~~~~~i~~~  259 (604)
                      .   ......++..|+|||++.+..++.++|||||||++|+|++|..||......                .....+...
T Consensus       200 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (326)
T 2w1i_A          200 EYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNN  279 (326)
T ss_dssp             SEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHHHHHTT
T ss_pred             cccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHHHhhcC
Confidence            2   123346788899999999999999999999999999999999987643110                111222233


Q ss_pred             CCCCCCccchHHHHHHHHHHhccCCCCCCCHHHHhc
Q psy1546         260 NPPQLTGNYTKQFKEFVEACLNKDPENRPTAKELLK  295 (604)
Q Consensus       260 ~~~~~~~~~s~~l~~Li~~~L~~dP~~RpT~~elL~  295 (604)
                      .....+..++.++.+||.+||..||.+|||+.||++
T Consensus       280 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~  315 (326)
T 2w1i_A          280 GRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL  315 (326)
T ss_dssp             CCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             CCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            344556778999999999999999999999999986

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=3.9e-40  Score=358.67  Aligned_cols=242  Identities=24%  Similarity=0.367  Sum_probs=188.1

Q ss_pred             ccceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhC-CCCCCCeE----------EEEEE
Q psy1546          57 LIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQC-DSPYGTKL----------WIIME  125 (604)
Q Consensus        57 ~~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l-~hp~~~~l----------yLVmE  125 (604)
                      ..|.+.++||+|+||+||. ....+++.||||++.....    ..+.+|+.+|+.+ .|||++++          |||||
T Consensus        24 ~~y~~~~~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~~~----~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E   98 (432)
T 3p23_A           24 ISFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPECF----SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIE   98 (432)
T ss_dssp             EEEEEEEEEEECGGGCEEE-EEESSSSEEEEEEECTTTE----EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             EEEecCCeeecCcCEEEEE-EEEeCCeEEEEEEECHHHH----HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEE
Confidence            3589999999999999764 3346789999999865432    2356899999999 79997665          79999


Q ss_pred             ecCCCChhhHhhcC--CCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecC---C--CCeEEecccccccccCCC
Q psy1546         126 YLGGGSALDLMKAG--NFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSE---M--GDVKLADFGVAGTLTNTT  198 (604)
Q Consensus       126 y~~ggsL~~~l~~~--~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~---~--g~vKL~DFGlA~~~~~~~  198 (604)
                      ||+ |+|.+++...  .+.+..++.++.||+.||.|||++||+||||||+||||+.   +  ..+||+|||+|+.+....
T Consensus        99 ~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~  177 (432)
T 3p23_A           99 LCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGR  177 (432)
T ss_dssp             CCS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC----
T ss_pred             CCC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCCC
Confidence            996 6899998764  4566678899999999999999999999999999999953   2  257899999997765332


Q ss_pred             ---CCCcccccCCCCCChHHhh---cCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHhhhcCCCCCC--CCCccch
Q psy1546         199 ---SKRNTFVGTPFWMAPEVIK---QSAYDSKADIWSLGITAIELAK-GEPPNSELHPMRVLFLIPKNNPP--QLTGNYT  269 (604)
Q Consensus       199 ---~~~~~~~GT~~Y~APE~l~---~~~~~~~sDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~--~~~~~~s  269 (604)
                         ......+||+.|+|||++.   ...++.++|||||||+||||++ |..||...........+......  ......+
T Consensus       178 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (432)
T 3p23_A          178 HSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPEKHED  257 (432)
T ss_dssp             --------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHHTTCCCCTTSCTTCHHH
T ss_pred             cceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHHhccCCccccCcccccc
Confidence               2334568999999999997   4567889999999999999999 99999766554444333222221  2223456


Q ss_pred             HHHHHHHHHHhccCCCCCCCHHHHhcChhhhhhhh
Q psy1546         270 KQFKEFVEACLNKDPENRPTAKELLKFPFIRKAKK  304 (604)
Q Consensus       270 ~~l~~Li~~~L~~dP~~RpT~~elL~hp~f~~~~~  304 (604)
                      ..+.+||.+||..||.+|||+.||++||||....+
T Consensus       258 ~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~~~~  292 (432)
T 3p23_A          258 VIARELIEKMIAMDPQKRPSAKHVLKHPFFWSLEK  292 (432)
T ss_dssp             HHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCCHHH
T ss_pred             HHHHHHHHHHHhCCHhhCCCHHHHHhCccccChHH
Confidence            77899999999999999999999999999976543

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=5.5e-39  Score=330.81  Aligned_cols=217  Identities=27%  Similarity=0.460  Sum_probs=177.4

Q ss_pred             ceee-eEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHH-hhCCCCCCCe--------------EEE
Q psy1546          59 FTKQ-ERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVL-SQCDSPYGTK--------------LWI  122 (604)
Q Consensus        59 y~i~-~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL-~~l~hp~~~~--------------lyL  122 (604)
                      |.+. +.||+|+||.||+|.+..+++.||||++...      ..+.+|+.++ +.+.|||+.+              +||
T Consensus        19 y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~l   92 (299)
T 3m2w_A           19 YKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLI   92 (299)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEE
T ss_pred             hhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc------HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEE
Confidence            6666 7899999999999999999999999998643      3456788877 6779998544              479


Q ss_pred             EEEecCCCChhhHhhcC---CCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecC---CCCeEEecccccccccC
Q psy1546         123 IMEYLGGGSALDLMKAG---NFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSE---MGDVKLADFGVAGTLTN  196 (604)
Q Consensus       123 VmEy~~ggsL~~~l~~~---~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~---~g~vKL~DFGlA~~~~~  196 (604)
                      ||||+++|+|.+++...   .+++..++.++.||+.||.|||++||+||||||+||||+.   ++.+||+|||++.... 
T Consensus        93 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~-  171 (299)
T 3m2w_A           93 VMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT-  171 (299)
T ss_dssp             EECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECT-
T ss_pred             EEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEeccccccccc-
Confidence            99999999999999753   5999999999999999999999999999999999999998   7889999999985432 


Q ss_pred             CCCCCcccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCC---CCCCCC----ccch
Q psy1546         197 TTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKN---NPPQLT----GNYT  269 (604)
Q Consensus       197 ~~~~~~~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~---~~~~~~----~~~s  269 (604)
                                           +..++.++|||||||+||+|++|..||...............   ....++    ..++
T Consensus       172 ---------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (299)
T 3m2w_A          172 ---------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVS  230 (299)
T ss_dssp             ---------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTTCCSSCHHHHTTSC
T ss_pred             ---------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhccccCCchhcccCC
Confidence                                 234677899999999999999999999876654433222111   111112    4578


Q ss_pred             HHHHHHHHHHhccCCCCCCCHHHHhcChhhhhhh
Q psy1546         270 KQFKEFVEACLNKDPENRPTAKELLKFPFIRKAK  303 (604)
Q Consensus       270 ~~l~~Li~~~L~~dP~~RpT~~elL~hp~f~~~~  303 (604)
                      .++.+||.+||..||.+|||+.|+|+||||.+..
T Consensus       231 ~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~  264 (299)
T 3m2w_A          231 EEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST  264 (299)
T ss_dssp             HHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGG
T ss_pred             HHHHHHHHHHcccChhhCCCHHHHhcChhhcccc
Confidence            9999999999999999999999999999998654

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=7.5e-41  Score=350.41  Aligned_cols=231  Identities=25%  Similarity=0.337  Sum_probs=186.7

Q ss_pred             ccceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhh-------HHHHHHHHHHHHHHhhCC---------CCC----
Q psy1546          57 LIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA-------EDEIEDIQQEIMVLSQCD---------SPY----  116 (604)
Q Consensus        57 ~~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~-------~~~~~~l~~Ei~iL~~l~---------hp~----  116 (604)
                      ..|.+.++||+|+||+||+|++  +++.||||++.....       ....+.+.+|+.+|+.+.         ||+    
T Consensus        20 ~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l   97 (336)
T 2vuw_A           20 EKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL   97 (336)
T ss_dssp             HHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred             ccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence            3489999999999999999998  689999999976532       223467788888888875         443    


Q ss_pred             ------------------------------------CCeEEEEEEecCCCChhhHhhcCCCcHHHHHHHHHHHHHHhHHh
Q psy1546         117 ------------------------------------GTKLWIIMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYL  160 (604)
Q Consensus       117 ------------------------------------~~~lyLVmEy~~ggsL~~~l~~~~lse~~i~~i~~qIl~gL~yL  160 (604)
                                                          ...+|||||||++|++.+.+..+.+++..++.|+.||+.||.||
T Consensus        98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~~~~~~~~~~~i~~qi~~aL~~l  177 (336)
T 2vuw_A           98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVA  177 (336)
T ss_dssp             EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTTTCCCHHHHHHHHHHHHHHHHHH
T ss_pred             cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHhcCCCHHHHHHHHHHHHHHHHHH
Confidence                                                35689999999999877777778899999999999999999999


Q ss_pred             h-hCCccccccccceeEecCCC--------------------CeEEecccccccccCCCCCCcccccCCCCCChHHhhcC
Q psy1546         161 H-SERKLHRDIKAANVLLSEMG--------------------DVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQS  219 (604)
Q Consensus       161 H-s~gIiHrDLKp~NILl~~~g--------------------~vKL~DFGlA~~~~~~~~~~~~~~GT~~Y~APE~l~~~  219 (604)
                      | ++||+||||||+||||+.++                    .+||+|||+|+.....     ..+||+.|||||++.+.
T Consensus       178 H~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-----~~~gt~~y~aPE~~~g~  252 (336)
T 2vuw_A          178 EASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-----IVVFCDVSMDEDLFTGD  252 (336)
T ss_dssp             HHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-----EEECCCCTTCSGGGCCC
T ss_pred             HHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-----cEEEeecccChhhhcCC
Confidence            9 99999999999999999887                    8999999999766532     45899999999999876


Q ss_pred             CCCCcchhhhHHHH-HHHHHhCCCCCCCCCh----h-hHhhhcCC--CCCCCCCccchHHHHHHHHHHhccCCCCCCCHH
Q psy1546         220 AYDSKADIWSLGIT-AIELAKGEPPNSELHP----M-RVLFLIPK--NNPPQLTGNYTKQFKEFVEACLNKDPENRPTAK  291 (604)
Q Consensus       220 ~~~~~sDVwSLGvi-L~eLltG~~Pf~~~~~----~-~~~~~i~~--~~~~~~~~~~s~~l~~Li~~~L~~dP~~RpT~~  291 (604)
                      . +.++||||||++ .++++.|..||.....    . .....+..  .........+++++.+||.+||..|     |+.
T Consensus       253 ~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d-----sa~  326 (336)
T 2vuw_A          253 G-DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS-----SAT  326 (336)
T ss_dssp             S-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS-----SHH
T ss_pred             C-ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC-----CHH
Confidence            6 889999998777 7778899999865311    1 11111111  1112223467899999999999987     999


Q ss_pred             HHh-cChhhh
Q psy1546         292 ELL-KFPFIR  300 (604)
Q Consensus       292 elL-~hp~f~  300 (604)
                      |+| +||||+
T Consensus       327 e~l~~Hp~f~  336 (336)
T 2vuw_A          327 DLLCQHSLFK  336 (336)
T ss_dssp             HHHHHCGGGC
T ss_pred             HHHhcCCCcC
Confidence            999 999994

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=2.3e-39  Score=370.19  Aligned_cols=239  Identities=30%  Similarity=0.430  Sum_probs=206.9

Q ss_pred             ccceeeeEEcccCcEEEEEEEECCC---CcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCCeE---------EEEE
Q psy1546          57 LIFTKQERIGKGSFGEVFKGIDNRT---QQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTKL---------WIIM  124 (604)
Q Consensus        57 ~~y~i~~~LG~G~fG~Vy~a~~~~t---~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~~l---------yLVm  124 (604)
                      ..|.+.+.||+|+||.||+|.+..+   +..||||++.........+.+.+|+.+++.+.|||+.++         |+||
T Consensus       390 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~lv~  469 (656)
T 2j0j_A          390 ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPVWIIM  469 (656)
T ss_dssp             GGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEEE
T ss_pred             ccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCceEEEE
Confidence            3489999999999999999998643   467999998766555566789999999999999997665         7999


Q ss_pred             EecCCCChhhHhhcC--CCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCC-CC
Q psy1546         125 EYLGGGSALDLMKAG--NFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTS-KR  201 (604)
Q Consensus       125 Ey~~ggsL~~~l~~~--~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~-~~  201 (604)
                      ||+++|+|.++++..  .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+..... ..
T Consensus       470 E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~  549 (656)
T 2j0j_A          470 ELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKA  549 (656)
T ss_dssp             ECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCCCCSCCC------
T ss_pred             EcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCCCeecCCCcceec
Confidence            999999999999753  589999999999999999999999999999999999999999999999999976643322 22


Q ss_pred             cccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHhhhcCCCCCCCCCccchHHHHHHHHHHh
Q psy1546         202 NTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAK-GEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACL  280 (604)
Q Consensus       202 ~~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~~L  280 (604)
                      ....+|+.|||||++.+..++.++|||||||++|||++ |..||.+....+....+.......++..++..+.+||.+||
T Consensus       550 ~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~l  629 (656)
T 2j0j_A          550 SKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTKCW  629 (656)
T ss_dssp             ----CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHT
T ss_pred             cCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCccccHHHHHHHHHHc
Confidence            33457889999999999999999999999999999997 99999998888777777666666777889999999999999


Q ss_pred             ccCCCCCCCHHHHhc
Q psy1546         281 NKDPENRPTAKELLK  295 (604)
Q Consensus       281 ~~dP~~RpT~~elL~  295 (604)
                      ..||.+|||+.+|++
T Consensus       630 ~~dP~~RPs~~el~~  644 (656)
T 2j0j_A          630 AYDPSRRPRFTELKA  644 (656)
T ss_dssp             CSSGGGSCCHHHHHH
T ss_pred             CCChhHCcCHHHHHH
Confidence            999999999999987

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=2.9e-39  Score=337.51  Aligned_cols=234  Identities=27%  Similarity=0.404  Sum_probs=191.8

Q ss_pred             ccceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhh--CCCCCCC--------------eE
Q psy1546          57 LIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQ--CDSPYGT--------------KL  120 (604)
Q Consensus        57 ~~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~--l~hp~~~--------------~l  120 (604)
                      ..|.+.+.||+|+||.||+|.+  +++.||||++....    ...+.+|+.++..  +.|||+.              .+
T Consensus        42 ~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~----~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~  115 (342)
T 1b6c_B           42 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE----ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL  115 (342)
T ss_dssp             HHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGGG----HHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCE
T ss_pred             ccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCchh----HHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCcccee
Confidence            3599999999999999999987  48999999996543    2456778888877  7899843              46


Q ss_pred             EEEEEecCCCChhhHhhcCCCcHHHHHHHHHHHHHHhHHhh--------hCCccccccccceeEecCCCCeEEecccccc
Q psy1546         121 WIIMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLH--------SERKLHRDIKAANVLLSEMGDVKLADFGVAG  192 (604)
Q Consensus       121 yLVmEy~~ggsL~~~l~~~~lse~~i~~i~~qIl~gL~yLH--------s~gIiHrDLKp~NILl~~~g~vKL~DFGlA~  192 (604)
                      |+||||+++|+|.+++....+++..++.++.||+.||.|||        ++||+||||||+||||+.++.+||+|||++.
T Consensus       116 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~  195 (342)
T 1b6c_B          116 WLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV  195 (342)
T ss_dssp             EEEECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             EEEEeecCCCcHHHHHhccCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEEECCCce
Confidence            89999999999999999889999999999999999999999        8999999999999999999999999999997


Q ss_pred             cccCCCC----CCcccccCCCCCChHHhhcCC------CCCcchhhhHHHHHHHHHhC----------CCCCCCCCh---
Q psy1546         193 TLTNTTS----KRNTFVGTPFWMAPEVIKQSA------YDSKADIWSLGITAIELAKG----------EPPNSELHP---  249 (604)
Q Consensus       193 ~~~~~~~----~~~~~~GT~~Y~APE~l~~~~------~~~~sDVwSLGviL~eLltG----------~~Pf~~~~~---  249 (604)
                      .......    ......||+.|+|||++.+..      ++.++|||||||+||||++|          ..||.....   
T Consensus       196 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~  275 (342)
T 1b6c_B          196 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP  275 (342)
T ss_dssp             EEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred             eccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccCcCcc
Confidence            6654332    234567999999999998763      33689999999999999999          788876532   


Q ss_pred             --hhHhhhc-CCCCCCCCCc-----cchHHHHHHHHHHhccCCCCCCCHHHHhcC
Q psy1546         250 --MRVLFLI-PKNNPPQLTG-----NYTKQFKEFVEACLNKDPENRPTAKELLKF  296 (604)
Q Consensus       250 --~~~~~~i-~~~~~~~~~~-----~~s~~l~~Li~~~L~~dP~~RpT~~elL~h  296 (604)
                        ......+ .....+.++.     .+++.+.+||.+||..||.+|||+.+|++|
T Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~  330 (342)
T 1b6c_B          276 SVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT  330 (342)
T ss_dssp             CHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred             cHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence              2222222 2222333332     445789999999999999999999999985

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=3.4e-40  Score=374.69  Aligned_cols=244  Identities=27%  Similarity=0.381  Sum_probs=202.3

Q ss_pred             cceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCCeE----------------E
Q psy1546          58 IFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTKL----------------W  121 (604)
Q Consensus        58 ~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~~l----------------y  121 (604)
                      .|.+.++||+|+||.||+|.+..+++.||||++.........+.+.+|+.+++.+.|||+.++                |
T Consensus        15 rY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~~   94 (676)
T 3qa8_A           15 PWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPL   94 (676)
T ss_dssp             --CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSCC
T ss_pred             CeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeEE
Confidence            499999999999999999999999999999998766555566789999999999999986554                6


Q ss_pred             EEEEecCCCChhhHhhcC----CCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCC---eEEecccccccc
Q psy1546         122 IIMEYLGGGSALDLMKAG----NFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGD---VKLADFGVAGTL  194 (604)
Q Consensus       122 LVmEy~~ggsL~~~l~~~----~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~---vKL~DFGlA~~~  194 (604)
                      +|||||+||+|.+++...    .+++..++.++.||+.||.|||++||+||||||+|||++.++.   +||+|||++...
T Consensus        95 LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a~~~  174 (676)
T 3qa8_A           95 LAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKEL  174 (676)
T ss_dssp             CEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCCCCCBT
T ss_pred             EEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEccccccccc
Confidence            999999999999999752    5999999999999999999999999999999999999997765   999999999766


Q ss_pred             cCCCCCCcccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhh--------------hcCC--
Q psy1546         195 TNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLF--------------LIPK--  258 (604)
Q Consensus       195 ~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~--------------~i~~--  258 (604)
                      ... .......||+.|+|||++.+..++.++|||||||++|+|++|..||..........              ....  
T Consensus       175 ~~~-~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~l~g~  253 (676)
T 3qa8_A          175 DQG-ELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTGA  253 (676)
T ss_dssp             TSC-CCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSCCCCSSS
T ss_pred             ccc-cccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhhhhhccc
Confidence            433 33445789999999999999999999999999999999999999997542211100              0000  


Q ss_pred             -------CCCCCCCccchHHHHHHHHHHhccCCCCCCCHHHHhcChhhhhh
Q psy1546         259 -------NNPPQLTGNYTKQFKEFVEACLNKDPENRPTAKELLKFPFIRKA  302 (604)
Q Consensus       259 -------~~~~~~~~~~s~~l~~Li~~~L~~dP~~RpT~~elL~hp~f~~~  302 (604)
                             ..+..+...+++.+.+||.+||..||.+|||+.|+++||||...
T Consensus       254 ~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l  304 (676)
T 3qa8_A          254 VKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQAL  304 (676)
T ss_dssp             CCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHH
T ss_pred             cccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHH
Confidence                   01223445678999999999999999999999999999999764

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=1.6e-39  Score=336.30  Aligned_cols=234  Identities=28%  Similarity=0.445  Sum_probs=192.5

Q ss_pred             cceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhh-HHHHHHHHHHHHHHhhCCCCCCCe----------EEEEEEe
Q psy1546          58 IFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA-EDEIEDIQQEIMVLSQCDSPYGTK----------LWIIMEY  126 (604)
Q Consensus        58 ~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~-~~~~~~l~~Ei~iL~~l~hp~~~~----------lyLVmEy  126 (604)
                      .|.+.+.||+|+||.||+|.+..   .||||++..... ....+.+.+|+.+++.+.||++.+          +|+||||
T Consensus        34 ~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~  110 (319)
T 2y4i_B           34 QLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSL  110 (319)
T ss_dssp             CEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEECBC
T ss_pred             HeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEeec
Confidence            48999999999999999998764   499999865432 222355778999999999998543          5899999


Q ss_pred             cCCCChhhHhhcC--CCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCC-----CC
Q psy1546         127 LGGGSALDLMKAG--NFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNT-----TS  199 (604)
Q Consensus       127 ~~ggsL~~~l~~~--~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~-----~~  199 (604)
                      +++++|.+++...  .+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||+++.....     ..
T Consensus       111 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~~~~~~  189 (319)
T 2y4i_B          111 CKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRRED  189 (319)
T ss_dssp             CCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECCCSCCC----------CC
T ss_pred             ccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEEEeecCCcccccccccccccc
Confidence            9999999999764  599999999999999999999999999999999999998 689999999998654321     12


Q ss_pred             CCcccccCCCCCChHHhhc---------CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCCCCCCC-Cccch
Q psy1546         200 KRNTFVGTPFWMAPEVIKQ---------SAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQL-TGNYT  269 (604)
Q Consensus       200 ~~~~~~GT~~Y~APE~l~~---------~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~-~~~~s  269 (604)
                      ......||+.|+|||++.+         ..++.++|||||||++|+|++|..||...........+.....+.. ...++
T Consensus       190 ~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  269 (319)
T 2y4i_B          190 KLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKPNLSQIGMG  269 (319)
T ss_dssp             SCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTTCCCCCCCSSCC
T ss_pred             ccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccCCCCCCCcCCCC
Confidence            2334569999999999974         4578899999999999999999999998887776665554443333 34678


Q ss_pred             HHHHHHHHHHhccCCCCCCCHHHHhc
Q psy1546         270 KQFKEFVEACLNKDPENRPTAKELLK  295 (604)
Q Consensus       270 ~~l~~Li~~~L~~dP~~RpT~~elL~  295 (604)
                      .++.+||.+||..||.+|||+.+|++
T Consensus       270 ~~l~~li~~~l~~~p~~Rpt~~~l~~  295 (319)
T 2y4i_B          270 KEISDILLFCWAFEQEERPTFTKLMD  295 (319)
T ss_dssp             TTHHHHHHHHHCSSTTTSCCHHHHHH
T ss_pred             HHHHHHHHHHhcCChhhCcCHHHHHH
Confidence            89999999999999999999999987

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=3.3e-38  Score=362.09  Aligned_cols=231  Identities=22%  Similarity=0.330  Sum_probs=192.5

Q ss_pred             ccceeeeEEcccCcEEEEEEEECC-CCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCCe---------------E
Q psy1546          57 LIFTKQERIGKGSFGEVFKGIDNR-TQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTK---------------L  120 (604)
Q Consensus        57 ~~y~i~~~LG~G~fG~Vy~a~~~~-t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~~---------------l  120 (604)
                      ..|.+.++||+|+||.||+|.+.. +++.||||++...........+.+|+.++..+.|||+++               +
T Consensus        80 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~  159 (681)
T 2pzi_A           80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVG  159 (681)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred             CceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCcee
Confidence            459999999999999999999976 789999999876555555678899999999999999654               4


Q ss_pred             EEEEEecCCCChhhHhhcCCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCCC
Q psy1546         121 WIIMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSK  200 (604)
Q Consensus       121 yLVmEy~~ggsL~~~l~~~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~  200 (604)
                      ||||||++|++|.+++.. .+++..++.|+.||+.||.|||++|||||||||+||||+. +.+||+|||+++.....   
T Consensus       160 ~lv~E~~~g~~L~~~~~~-~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~-~~~kl~DFG~a~~~~~~---  234 (681)
T 2pzi_A          160 YIVMEYVGGQSLKRSKGQ-KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTE-EQLKLIDLGAVSRINSF---  234 (681)
T ss_dssp             EEEEECCCCEECC----C-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECS-SCEEECCCTTCEETTCC---
T ss_pred             EEEEEeCCCCcHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeC-CcEEEEecccchhcccC---
Confidence            899999999999998766 7999999999999999999999999999999999999998 49999999999766433   


Q ss_pred             CcccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCCCCCCCCccchHHHHHHHHHHh
Q psy1546         201 RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACL  280 (604)
Q Consensus       201 ~~~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~~L  280 (604)
                       ...+||+.|+|||++.+.. +.++|||||||+||+|++|.+||........    .   .......+++.+.+||.+||
T Consensus       235 -~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~----~---~~~~~~~~~~~l~~li~~~l  305 (681)
T 2pzi_A          235 -GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDGL----P---EDDPVLKTYDSYGRLLRRAI  305 (681)
T ss_dssp             -SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSSC----C---TTCHHHHHCHHHHHHHHHHT
T ss_pred             -CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCcccccccc----c---ccccccccCHHHHHHHhhhc
Confidence             4567999999999997754 8899999999999999999998875321110    0   00111234578999999999


Q ss_pred             ccCCCCCCCHHHHhcChhhhh
Q psy1546         281 NKDPENRPTAKELLKFPFIRK  301 (604)
Q Consensus       281 ~~dP~~RpT~~elL~hp~f~~  301 (604)
                      ..||.+||+..+++.|+|+.-
T Consensus       306 ~~dP~~R~~~~~~l~~~l~~~  326 (681)
T 2pzi_A          306 DPDPRQRFTTAEEMSAQLTGV  326 (681)
T ss_dssp             CSSGGGSCSSHHHHHHHHHHH
T ss_pred             cCChhhCCCHHHHHHHHHHHH
Confidence            999999999999999988753

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=6.2e-37  Score=315.02  Aligned_cols=209  Identities=18%  Similarity=0.191  Sum_probs=176.1

Q ss_pred             cceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhh--HHHHHHHHHHHHHHhhCCCCCCCe----------EEEEEE
Q psy1546          58 IFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA--EDEIEDIQQEIMVLSQCDSPYGTK----------LWIIME  125 (604)
Q Consensus        58 ~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~--~~~~~~l~~Ei~iL~~l~hp~~~~----------lyLVmE  125 (604)
                      .|.+.+.||+|+||.||+|.+..+++.||||++.....  ....+.+.+|+.++..+.|||+.+          +|||||
T Consensus        32 ~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e  111 (286)
T 3uqc_A           32 RYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVAE  111 (286)
T ss_dssp             TEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             cEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEEE
Confidence            49999999999999999999999999999999976533  345678899999999999999655          479999


Q ss_pred             ecCCCChhhHhhcCCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCCCCcccc
Q psy1546         126 YLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFV  205 (604)
Q Consensus       126 y~~ggsL~~~l~~~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~~~~~~  205 (604)
                      |++|++|.++++.+. ...++..|+.||+.||.|||++||+||||||+||||+.+|.+||+++|.               
T Consensus       112 ~~~g~~L~~~l~~~~-~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~~---------------  175 (286)
T 3uqc_A          112 WIRGGSLQEVADTSP-SPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPAT---------------  175 (286)
T ss_dssp             CCCEEEHHHHHTTCC-CHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCCC---------------
T ss_pred             ecCCCCHHHHHhcCC-ChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEeccc---------------
Confidence            999999999997764 5557888999999999999999999999999999999999999985543               


Q ss_pred             cCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhh---hcCCCCCC---CCCccchHHHHHHHHHH
Q psy1546         206 GTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLF---LIPKNNPP---QLTGNYTKQFKEFVEAC  279 (604)
Q Consensus       206 GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~---~i~~~~~~---~~~~~~s~~l~~Li~~~  279 (604)
                           ++       .++.++|||||||+||+|++|..||.+........   ........   .+...+++++.+||.+|
T Consensus       176 -----~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~  243 (286)
T 3uqc_A          176 -----MP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQISAVAARS  243 (286)
T ss_dssp             -----CT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCHHHHCTTSCHHHHHHHHHH
T ss_pred             -----cC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCChhhcccCCCHHHHHHHHHH
Confidence                 33       36789999999999999999999998876544221   11111111   22356889999999999


Q ss_pred             hccCCCCCCCHHHHhc
Q psy1546         280 LNKDPENRPTAKELLK  295 (604)
Q Consensus       280 L~~dP~~RpT~~elL~  295 (604)
                      |..||.+| |+.|+++
T Consensus       244 l~~dP~~R-s~~el~~  258 (286)
T 3uqc_A          244 VQGDGGIR-SASTLLN  258 (286)
T ss_dssp             HCTTSSCC-CHHHHHH
T ss_pred             cccCCccC-CHHHHHH
Confidence            99999999 9999987

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.97  E-value=2.1e-32  Score=307.65  Aligned_cols=220  Identities=17%  Similarity=0.141  Sum_probs=150.4

Q ss_pred             eEEcccCcEEEEEEEECCCCcEEEEEEecchh---------hHHHHHHHHHHHHHHhhC-CCCCCCe----------EEE
Q psy1546          63 ERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE---------AEDEIEDIQQEIMVLSQC-DSPYGTK----------LWI  122 (604)
Q Consensus        63 ~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~---------~~~~~~~l~~Ei~iL~~l-~hp~~~~----------lyL  122 (604)
                      ..++.|++|.+..++....|+.||||++.+..         .+...+.+.+|+.+|+++ .|+++.+          +||
T Consensus       240 ~~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yL  319 (569)
T 4azs_A          240 NQPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWL  319 (569)
T ss_dssp             CC-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEE
T ss_pred             hccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEE
Confidence            45778888988888888889999999986431         233457799999999999 6887654          589


Q ss_pred             EEEecCCCChhhHhhc-CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCCCC
Q psy1546         123 IMEYLGGGSALDLMKA-GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKR  201 (604)
Q Consensus       123 VmEy~~ggsL~~~l~~-~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~~  201 (604)
                      |||||+|++|.++|+. +.+++.   .|+.||+.||+|||++|||||||||+||||+.+|.+||+|||+|+.+.......
T Consensus       320 VMEyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~~~~  396 (569)
T 4azs_A          320 VMEKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDCSWP  396 (569)
T ss_dssp             EEECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC---CCS
T ss_pred             EEecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCCCCCccc
Confidence            9999999999999976 456654   588999999999999999999999999999999999999999998877666666


Q ss_pred             cccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCCCCCCCCccchHHHHHHHHHHhc
Q psy1546         202 NTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLN  281 (604)
Q Consensus       202 ~~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~~L~  281 (604)
                      .+.+||+.|||||++.+. +...+|+|++|+++++|.++..++.     ........       .  ...+..+...++.
T Consensus       397 ~t~vGTp~YmAPE~l~g~-~~~~~d~~s~g~~~~~l~~~~~~~~-----~~l~~~~~-------~--~~~~~~l~~~l~~  461 (569)
T 4azs_A          397 TNLVQSFFVFVNELFAEN-KSWNGFWRSAPVHPFNLPQPWSNWL-----YAVWQEPV-------E--RWNFVLLLALFEK  461 (569)
T ss_dssp             HHHHHHHHHHHHHHC------------------CCCCTTHHHHH-----HHHHTSCG-------G--GCSHHHHHHHHHT
T ss_pred             cCceechhhccHHHhCCC-CCCcccccccccchhhhccccchhH-----HHhhcCCC-------C--CCcHHHHHHHHhC
Confidence            788999999999999764 6678999999999988876654421     11111100       1  1124567777888


Q ss_pred             cCCCCCCCHHHHhcChhhh
Q psy1546         282 KDPENRPTAKELLKFPFIR  300 (604)
Q Consensus       282 ~dP~~RpT~~elL~hp~f~  300 (604)
                      .+|..|+.......++|..
T Consensus       462 ~~~~~~~~~~~~~~~~~~~  480 (569)
T 4azs_A          462 KAKLPSAEQQRGATEQWII  480 (569)
T ss_dssp             GGGSCCGGGSSCCHHHHHH
T ss_pred             CCCCCCCChhhhccchhHH
Confidence            8888888877777777764

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.93  E-value=8.2e-27  Score=260.68  Aligned_cols=175  Identities=18%  Similarity=0.210  Sum_probs=138.6

Q ss_pred             eeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhh-------HHHHHHHHHHHHHHhhCCCCCCC--e--------EEE
Q psy1546          60 TKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA-------EDEIEDIQQEIMVLSQCDSPYGT--K--------LWI  122 (604)
Q Consensus        60 ~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~-------~~~~~~l~~Ei~iL~~l~hp~~~--~--------lyL  122 (604)
                      ...++||+|+||.||+|.  ..+..+|+|++.....       ....+.+.+|+.+|++++|||+.  .        .||
T Consensus       339 ~~~~~LG~G~fg~Vy~~~--~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~l  416 (540)
T 3en9_A          339 IPEHLIGKGAEADIKRDS--YLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRI  416 (540)
T ss_dssp             ---------CCEEEEEEE--CSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEE
T ss_pred             CCCCEEeeCCCEEEEEEE--ECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEE
Confidence            345689999999999994  4577899998643321       11245689999999999999987  3        379


Q ss_pred             EEEecCCCChhhHhhcCCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCCC--
Q psy1546         123 IMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSK--  200 (604)
Q Consensus       123 VmEy~~ggsL~~~l~~~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~--  200 (604)
                      |||||+|++|.+++..       +..++.||+.||.|||++||+||||||+|||++.  .+||+|||+|+........  
T Consensus       417 VmE~~~ggsL~~~l~~-------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~~~  487 (540)
T 3en9_A          417 MMSYINGKLAKDVIED-------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDKAV  487 (540)
T ss_dssp             EEECCCSEEHHHHSTT-------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTTCEECCCHHHHHH
T ss_pred             EEECCCCCCHHHHHHH-------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECccCEECCCcccccc
Confidence            9999999999999976       6689999999999999999999999999999998  9999999999876543221  


Q ss_pred             -----CcccccCCCCCChHHhhc--CCCCCcchhhhHHHHHHHHHhCCCCCC
Q psy1546         201 -----RNTFVGTPFWMAPEVIKQ--SAYDSKADIWSLGITAIELAKGEPPNS  245 (604)
Q Consensus       201 -----~~~~~GT~~Y~APE~l~~--~~~~~~sDVwSLGviL~eLltG~~Pf~  245 (604)
                           ...++||+.|||||++..  ..|+..+|+|+..+-..+.+.++.+|.
T Consensus       488 ~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~  539 (540)
T 3en9_A          488 DLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV  539 (540)
T ss_dssp             HHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred             chhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence                 236789999999999987  567888999999999988887776653

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.91  E-value=2.7e-24  Score=220.84  Aligned_cols=152  Identities=16%  Similarity=0.177  Sum_probs=120.9

Q ss_pred             ccceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhH-----------------HHHHHHHHHHHHHhhCCCCCCC-
Q psy1546          57 LIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAE-----------------DEIEDIQQEIMVLSQCDSPYGT-  118 (604)
Q Consensus        57 ~~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~-----------------~~~~~l~~Ei~iL~~l~hp~~~-  118 (604)
                      ..|.+.+.||+|+||.||+|.+ .+|+.||||++......                 .....+.+|+.+|+.+.|+... 
T Consensus        90 ~~~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~~~~v~~  168 (282)
T 1zar_A           90 KVDAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPK  168 (282)
T ss_dssp             SCSEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCC
T ss_pred             eEEEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhccCCCcCe
Confidence            3466779999999999999999 88999999999643211                 1346788999999999864322 


Q ss_pred             -----eEEEEEEecCCCChhhHhhcCCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEeccccccc
Q psy1546         119 -----KLWIIMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGT  193 (604)
Q Consensus       119 -----~lyLVmEy~~ggsL~~~l~~~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~  193 (604)
                           .+|+|||||+|++|.+ +..     .....++.||+.||.|||++||+||||||+||||+ ++.+||+|||+|+ 
T Consensus       169 ~~~~~~~~lvmE~~~g~~L~~-l~~-----~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~vkl~DFG~a~-  240 (282)
T 1zar_A          169 VYAWEGNAVLMELIDAKELYR-VRV-----ENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIWIIDFPQSV-  240 (282)
T ss_dssp             EEEEETTEEEEECCCCEEGGG-CCC-----SCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTEEEECCCTTCE-
T ss_pred             EEeccceEEEEEecCCCcHHH-cch-----hhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCcEEEEECCCCe-
Confidence                 2379999999999998 422     34557999999999999999999999999999999 9999999999984 


Q ss_pred             ccCCCCCCcccccCCCCCChHHhhc----------CCCCCcchhhh
Q psy1546         194 LTNTTSKRNTFVGTPFWMAPEVIKQ----------SAYDSKADIWS  229 (604)
Q Consensus       194 ~~~~~~~~~~~~GT~~Y~APE~l~~----------~~~~~~sDVwS  229 (604)
                                  .+..|+|||++..          ..|+..+|+|.
T Consensus       241 ------------~~~~~~a~e~l~rdv~~i~~~f~~~~~~~~~~~~  274 (282)
T 1zar_A          241 ------------EVGEEGWREILERDVRNIITYFSRTYRTEKDINS  274 (282)
T ss_dssp             ------------ETTSTTHHHHHHHHHHHHHHHHHHHHCCCCCHHH
T ss_pred             ------------ECCCCCHHHHHHHHHHHHHHHHHHhcCCCCChHH
Confidence                        3456899999854          33455556654

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.83  E-value=1.1e-20  Score=191.15  Aligned_cols=135  Identities=22%  Similarity=0.309  Sum_probs=107.0

Q ss_pred             cccceeeeEEcccCcEEEEEEEECCCCcE--EEEEEecchhhH-----------------------HHHHHHHHHHHHHh
Q psy1546          56 ELIFTKQERIGKGSFGEVFKGIDNRTQQV--VAIKIIDLEEAE-----------------------DEIEDIQQEIMVLS  110 (604)
Q Consensus        56 ~~~y~i~~~LG~G~fG~Vy~a~~~~t~~~--vAVK~i~~~~~~-----------------------~~~~~l~~Ei~iL~  110 (604)
                      ...|.+.+.||+|+||.||+|.+..+|+.  ||||++......                       .....+.+|+.+|.
T Consensus        46 ~~~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~  125 (258)
T 1zth_A           46 GYITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLE  125 (258)
T ss_dssp             TSEEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHH
T ss_pred             CCchhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHH
Confidence            34588999999999999999998778989  999997543111                       11235788999999


Q ss_pred             hCCCCCC--C------eEEEEEEecCC-C----ChhhHhhcCCCcHHHHHHHHHHHHHHhHHhh-hCCccccccccceeE
Q psy1546         111 QCDSPYG--T------KLWIIMEYLGG-G----SALDLMKAGNFEEMHIAVILREVLKGLDYLH-SERKLHRDIKAANVL  176 (604)
Q Consensus       111 ~l~hp~~--~------~lyLVmEy~~g-g----sL~~~l~~~~lse~~i~~i~~qIl~gL~yLH-s~gIiHrDLKp~NIL  176 (604)
                      .+.|++.  .      ..||||||+++ |    .|.++...  +++..+..++.||+.||.||| +.||+||||||+|||
T Consensus       126 ~l~~~~i~~p~~~~~~~~~lVmE~~g~~g~~~~~L~~~~~~--~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp~NIL  203 (258)
T 1zth_A          126 RAKEAGVSVPQPYTYMKNVLLMEFIGEDELPAPTLVELGRE--LKELDVEGIFNDVVENVKRLYQEAELVHADLSEYNIM  203 (258)
T ss_dssp             HHHHTTCCCCCEEEEETTEEEEECCEETTEECCBHHHHGGG--GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCSTTSEE
T ss_pred             HHHhCCCCCCeEEEcCCCEEEEEecCCCCCccccHHHHhhc--cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEE
Confidence            9877642  1      23699999942 3    66665432  346678899999999999999 999999999999999


Q ss_pred             ecCCCCeEEecccccccc
Q psy1546         177 LSEMGDVKLADFGVAGTL  194 (604)
Q Consensus       177 l~~~g~vKL~DFGlA~~~  194 (604)
                      ++.  .++|+|||+|...
T Consensus       204 l~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          204 YID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             ESS--SEEECCCTTCEET
T ss_pred             EcC--cEEEEECcccccC
Confidence            998  9999999999654

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.71  E-value=1.4e-17  Score=177.56  Aligned_cols=131  Identities=15%  Similarity=0.151  Sum_probs=100.1

Q ss_pred             cccceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhh-----------------HHH--HH--HHHHHHHHHhhCCC
Q psy1546          56 ELIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA-----------------EDE--IE--DIQQEIMVLSQCDS  114 (604)
Q Consensus        56 ~~~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~-----------------~~~--~~--~l~~Ei~iL~~l~h  114 (604)
                      +.+|.+..+||.|+||.||+|.+. +|+.||||++.....                 ...  ..  ...+|...|.++.+
T Consensus        94 g~iY~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~  172 (397)
T 4gyi_A           94 KDVYSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYE  172 (397)
T ss_dssp             TSCSEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             CCEEEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHh
Confidence            346999999999999999999875 689999999753210                 011  11  12467778877754


Q ss_pred             CCC--Ce------EEEEEEecCCCChhhHhhcCCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCC----
Q psy1546         115 PYG--TK------LWIIMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGD----  182 (604)
Q Consensus       115 p~~--~~------lyLVmEy~~ggsL~~~l~~~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~----  182 (604)
                      ...  ..      .+|||||++|+.|..+...     .....++.||+.+|.|||+.|||||||||.||||+++|.    
T Consensus       173 ~gv~vp~p~~~~~~~LVME~i~G~~L~~l~~~-----~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~~d~  247 (397)
T 4gyi_A          173 EGFPVPEPIAQSRHTIVMSLVDALPMRQVSSV-----PDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDAEDP  247 (397)
T ss_dssp             TTCSCCCEEEEETTEEEEECCSCEEGGGCCCC-----SCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECSSCT
T ss_pred             cCCCCCeeeeccCceEEEEecCCccHhhhccc-----HHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCcccc
Confidence            432  11      2699999999988766432     345678899999999999999999999999999988773    


Q ss_pred             ------eEEecccccc
Q psy1546         183 ------VKLADFGVAG  192 (604)
Q Consensus       183 ------vKL~DFGlA~  192 (604)
                            +.|+||+-+-
T Consensus       248 ~~~~~~~~iID~~Q~V  263 (397)
T 4gyi_A          248 SSITLTPIIIXFPQMV  263 (397)
T ss_dssp             TSEEEEEEECCCTTCE
T ss_pred             cccccceEEEEeCCcc
Confidence                  8999999763

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.12  E-value=9.1e-11  Score=117.44  Aligned_cols=126  Identities=14%  Similarity=0.125  Sum_probs=96.1

Q ss_pred             ceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCC-CC----------CCeEEEEEEec
Q psy1546          59 FTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDS-PY----------GTKLWIIMEYL  127 (604)
Q Consensus        59 y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~h-p~----------~~~lyLVmEy~  127 (604)
                      |++...+|.|+++.||++...  ++.|+||+....... ....+.+|+.+++.+.. ..          ....|+||||+
T Consensus        16 ~~~~~~~~g~s~~~v~~~~~~--~~~~vlK~~~~~~~~-~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i   92 (263)
T 3tm0_A           16 YRCVKDTEGMSPAKVYKLVGE--NENLYLKMTDSRYKG-TTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEA   92 (263)
T ss_dssp             SEEEECCSCCSSSEEEEEECS--SCEEEEEEECGGGTT-STTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECC
T ss_pred             ceeEeeccCCCCCeEEEEECC--CCcEEEEeCCcccCC-CHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEec
Confidence            788888999999999999743  678999998643211 12357888888887753 22          22457999999


Q ss_pred             CCCChhhHhhcCCCcHHHHHHHHHHHHHHhHHhhh---------------------------------------------
Q psy1546         128 GGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHS---------------------------------------------  162 (604)
Q Consensus       128 ~ggsL~~~l~~~~lse~~i~~i~~qIl~gL~yLHs---------------------------------------------  162 (604)
                      +|.+|.+.+.    +......++.+++.+|..||+                                             
T Consensus        93 ~G~~l~~~~~----~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  168 (263)
T 3tm0_A           93 DGVLCSEEYE----DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPR  168 (263)
T ss_dssp             SSEEHHHHCC----TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSSHH
T ss_pred             CCeehhhccC----CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCCHH
Confidence            9999887642    223345778899999999998                                             


Q ss_pred             --------------CCccccccccceeEecCCCCeEEeccccc
Q psy1546         163 --------------ERKLHRDIKAANVLLSEMGDVKLADFGVA  191 (604)
Q Consensus       163 --------------~gIiHrDLKp~NILl~~~g~vKL~DFGlA  191 (604)
                                    ..++|+|++|.|||++.++.+.|+||+.+
T Consensus       169 ~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a  211 (263)
T 3tm0_A          169 ELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRS  211 (263)
T ss_dssp             HHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTC
T ss_pred             HHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhc
Confidence                          44899999999999987555679999987

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.03  E-value=2.8e-10  Score=112.73  Aligned_cols=122  Identities=17%  Similarity=0.172  Sum_probs=84.6

Q ss_pred             ceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCC------------CCeEEEEEEe
Q psy1546          59 FTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPY------------GTKLWIIMEY  126 (604)
Q Consensus        59 y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~------------~~~lyLVmEy  126 (604)
                      |.+....+.|.++.||++.. .+|..|+||+.....    ...+.+|+.+++.+.+..            ....|+||||
T Consensus        22 ~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~~----~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~   96 (264)
T 1nd4_A           22 YDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSGA----LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGE   96 (264)
T ss_dssp             CEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSCT----TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEEC
T ss_pred             CceEecccCCCCceEEEEec-CCCCeEEEEeCCccc----chhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEe
Confidence            34433334566699999964 456789999975431    234667777777664322            1234899999


Q ss_pred             cCCCChhhHhhcCCCcHHHHHHHHHHHHHHhHHhhhCC------------------------------------------
Q psy1546         127 LGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSER------------------------------------------  164 (604)
Q Consensus       127 ~~ggsL~~~l~~~~lse~~i~~i~~qIl~gL~yLHs~g------------------------------------------  164 (604)
                      ++|.+|.  ...  .   ....++.+++..|..||...                                          
T Consensus        97 i~G~~l~--~~~--~---~~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  169 (264)
T 1nd4_A           97 VPGQDLL--SSH--L---APAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAE  169 (264)
T ss_dssp             CSSEETT--TSC--C---CHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHH
T ss_pred             cCCcccC--cCc--C---CHhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHH
Confidence            9999884  211  1   12356677777788887643                                          


Q ss_pred             ----------------ccccccccceeEecCCCCeEEecccccc
Q psy1546         165 ----------------KLHRDIKAANVLLSEMGDVKLADFGVAG  192 (604)
Q Consensus       165 ----------------IiHrDLKp~NILl~~~g~vKL~DFGlA~  192 (604)
                                      ++|+|++|.|||++.++.+.|+|||.+.
T Consensus       170 ~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~  213 (264)
T 1nd4_A          170 LFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG  213 (264)
T ss_dssp             HHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             HHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence                            9999999999999876666799999873

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=99.00  E-value=4.2e-10  Score=115.57  Aligned_cols=170  Identities=15%  Similarity=0.133  Sum_probs=114.4

Q ss_pred             eeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCC-CC---------------CCeEEEEEE
Q psy1546          62 QERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDS-PY---------------GTKLWIIME  125 (604)
Q Consensus        62 ~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~h-p~---------------~~~lyLVmE  125 (604)
                      .+.|+.|.+..||++.     ..+++|+....   .....+.+|..+|+.+.. ..               ...-|+|||
T Consensus        25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~~---~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~   96 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN-----RDFIFKFPKHS---RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFT   96 (304)
T ss_dssp             CCEEEECSSEEEEEST-----TSEEEEEESSH---HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEE
T ss_pred             eEecCCCCcceEEEEC-----CEEEEEecCCc---chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEc
Confidence            3569999999999873     45889986533   334678889999887632 11               012278999


Q ss_pred             ecCCCChhhHhhcCCCcHHHHHHHHHHHHHHhHHhhh-------------------------------------------
Q psy1546         126 YLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHS-------------------------------------------  162 (604)
Q Consensus       126 y~~ggsL~~~l~~~~lse~~i~~i~~qIl~gL~yLHs-------------------------------------------  162 (604)
                      |++|..|..... ..++..+...++.+++..|..||.                                           
T Consensus        97 ~i~G~~l~~~~~-~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  175 (304)
T 3sg8_A           97 KIKGVPLTPLLL-NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDD  175 (304)
T ss_dssp             CCCCEECCHHHH-HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHH
T ss_pred             ccCCeECCcccc-ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHH
Confidence            999998875332 346677777778888888888775                                           


Q ss_pred             ---------------CCccccccccceeEecC--CCCeEEecccccccccCCCCCCcccccCCCC---CChHHhhc----
Q psy1546         163 ---------------ERKLHRDIKAANVLLSE--MGDVKLADFGVAGTLTNTTSKRNTFVGTPFW---MAPEVIKQ----  218 (604)
Q Consensus       163 ---------------~gIiHrDLKp~NILl~~--~g~vKL~DFGlA~~~~~~~~~~~~~~GT~~Y---~APE~l~~----  218 (604)
                                     ..++|+|++|.|||++.  .+.+.|+||+.+..- +...   .+.....+   ..|+.+..    
T Consensus       176 ~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~-~~~~---Dl~~~~~~~~~~~~~~~~~~l~~  251 (304)
T 3sg8_A          176 FYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAIS-DPDN---DFISLMEDDEEYGMEFVSKILNH  251 (304)
T ss_dssp             HHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEE-CTTH---HHHTTCCTTTSCCHHHHHHHHHH
T ss_pred             HHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccC-ChHH---HHHHHHhhccccCHHHHHHHHHH
Confidence                           13699999999999998  456799999998532 2211   11111111   33443211    


Q ss_pred             -CCC---------CCcchhhhHHHHHHHHHhCCCCC
Q psy1546         219 -SAY---------DSKADIWSLGITAIELAKGEPPN  244 (604)
Q Consensus       219 -~~~---------~~~sDVwSLGviL~eLltG~~Pf  244 (604)
                       ...         ....++|++|.++|.+.+|..+|
T Consensus       252 Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~  287 (304)
T 3sg8_A          252 YKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW  287 (304)
T ss_dssp             HTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred             cCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence             111         11258999999999999998775

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=98.98  E-value=9.4e-10  Score=115.58  Aligned_cols=129  Identities=16%  Similarity=0.220  Sum_probs=94.4

Q ss_pred             eeeEEcccCcEEEEEEEECCCCcEEEEEEec--chhhHHHHHHHHHHHHHHhhCCCCC---------------CCeEEEE
Q psy1546          61 KQERIGKGSFGEVFKGIDNRTQQVVAIKIID--LEEAEDEIEDIQQEIMVLSQCDSPY---------------GTKLWII  123 (604)
Q Consensus        61 i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~--~~~~~~~~~~l~~Ei~iL~~l~hp~---------------~~~lyLV  123 (604)
                      ..+.|+.|.++.||++...  +..+++|+..  ..........+.+|+.+++.+....               ....|+|
T Consensus        42 ~~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~v  119 (359)
T 3dxp_A           42 SVEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYI  119 (359)
T ss_dssp             EEEECCC-CCSCEEEEECS--SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEE
T ss_pred             eEEEcCCcccceEEEEEEC--CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEE
Confidence            4578999999999998754  4678899876  4332223356788999988876421               1235799


Q ss_pred             EEecCCCChhhHhhcCCCcHHHHHHHHHHHHHHhHHhhh-----------------------------------------
Q psy1546         124 MEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHS-----------------------------------------  162 (604)
Q Consensus       124 mEy~~ggsL~~~l~~~~lse~~i~~i~~qIl~gL~yLHs-----------------------------------------  162 (604)
                      |||++|..+.+... ..+++.....++.+++..|..||.                                         
T Consensus       120 me~v~G~~l~~~~~-~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  198 (359)
T 3dxp_A          120 MEFVSGRVLWDQSL-PGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAMD  198 (359)
T ss_dssp             EECCCCBCCCCTTC-TTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHHH
T ss_pred             EEecCCeecCCCcc-ccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHHH
Confidence            99999988754221 246788888899999999999997                                         


Q ss_pred             -----------------CCccccccccceeEecCCCC--eEEecccccc
Q psy1546         163 -----------------ERKLHRDIKAANVLLSEMGD--VKLADFGVAG  192 (604)
Q Consensus       163 -----------------~gIiHrDLKp~NILl~~~g~--vKL~DFGlA~  192 (604)
                                       ..++|+|+++.|||++.++.  +.|+||+.+.
T Consensus       199 ~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~  247 (359)
T 3dxp_A          199 SLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELST  247 (359)
T ss_dssp             HHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCE
T ss_pred             HHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccc
Confidence                             35899999999999997753  6999999884

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.38  E-value=2.3e-06  Score=87.92  Aligned_cols=122  Identities=13%  Similarity=0.116  Sum_probs=82.7

Q ss_pred             eeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCC--------------CCeEEEEEEec
Q psy1546          62 QERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPY--------------GTKLWIIMEYL  127 (604)
Q Consensus        62 ~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~--------------~~~lyLVmEy~  127 (604)
                      .+.++.|....||+.     +..++||+...   ......+.+|..+|..+.+..              ....|+||||+
T Consensus        24 v~~l~~G~~n~v~~v-----g~~~VlR~~~~---~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i   95 (306)
T 3tdw_A           24 VESLGEGFRNYAILV-----NGDWVFRFPKS---QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKV   95 (306)
T ss_dssp             EEEEEECSSEEEEEE-----TTTEEEEEESS---HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECC
T ss_pred             eeecCCCcceeEEEE-----CCEEEEEecCC---chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEecc
Confidence            456899999999998     46688998532   233467889999999886521              12257999999


Q ss_pred             CCCChhhHhhcCCCcHHHHHHHHHHHHHHhHHhhh---------------------------------------------
Q psy1546         128 GGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHS---------------------------------------------  162 (604)
Q Consensus       128 ~ggsL~~~l~~~~lse~~i~~i~~qIl~gL~yLHs---------------------------------------------  162 (604)
                      +|..|....- ..++......++.++...|..||+                                             
T Consensus        96 ~G~~l~~~~~-~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~  174 (306)
T 3tdw_A           96 QGQILGEDGM-AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTL  174 (306)
T ss_dssp             CSEECHHHHH-TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHH
T ss_pred             CCeECchhhh-hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHH
Confidence            9988765311 123333344444444444444443                                             


Q ss_pred             ---------------CCccccccccceeEecC---CCC-eEEecccccc
Q psy1546         163 ---------------ERKLHRDIKAANVLLSE---MGD-VKLADFGVAG  192 (604)
Q Consensus       163 ---------------~gIiHrDLKp~NILl~~---~g~-vKL~DFGlA~  192 (604)
                                     ..++|+|+++.|||++.   ++. +.|+||+.+.
T Consensus       175 ~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~  223 (306)
T 3tdw_A          175 RFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAA  223 (306)
T ss_dssp             HHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCE
T ss_pred             HHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcC
Confidence                           24599999999999987   455 4899999874

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.16  E-value=1.4e-05  Score=79.76  Aligned_cols=122  Identities=19%  Similarity=0.235  Sum_probs=82.3

Q ss_pred             EEcccCcE-EEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCC----CC-------CCeEEEEEEecCCCC
Q psy1546          64 RIGKGSFG-EVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDS----PY-------GTKLWIIMEYLGGGS  131 (604)
Q Consensus        64 ~LG~G~fG-~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~h----p~-------~~~lyLVmEy~~ggs  131 (604)
                      .+..|..| .||+......+..++||+-....    ...+.+|..+|+.+..    |.       ...-|+|||+++|.+
T Consensus        31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~~----~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~  106 (272)
T 4gkh_A           31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGSV----ANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKT  106 (272)
T ss_dssp             EEECSSSSCEEEEEECCTTCCCEEEEEEETHH----HHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEE
T ss_pred             EccCCCcCCeEEEEEecCCCeEEEEEECCCCC----HhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCcc
Confidence            44555554 79998877777889999875432    3567788888887643    11       233489999999988


Q ss_pred             hhhHhhcCCCcHHHHHHHHHHHHHHhHHhhhC------------------------------------------------
Q psy1546         132 ALDLMKAGNFEEMHIAVILREVLKGLDYLHSE------------------------------------------------  163 (604)
Q Consensus       132 L~~~l~~~~lse~~i~~i~~qIl~gL~yLHs~------------------------------------------------  163 (604)
                      +.+.....   ......++.++...|..||..                                                
T Consensus       107 ~~~~~~~~---~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  183 (272)
T 4gkh_A          107 AFQVLEEY---PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKEM  183 (272)
T ss_dssp             HHHHHHHC---GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHHH
T ss_pred             ccccccCC---HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHHH
Confidence            77654321   122233444444445545431                                                


Q ss_pred             ----------CccccccccceeEecCCCCeEEecccccc
Q psy1546         164 ----------RKLHRDIKAANVLLSEMGDVKLADFGVAG  192 (604)
Q Consensus       164 ----------gIiHrDLKp~NILl~~~g~vKL~DFGlA~  192 (604)
                                .++|+|+.+.|||++.++.+-|+||+.+.
T Consensus       184 ~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~  222 (272)
T 4gkh_A          184 HKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG  222 (272)
T ss_dssp             HTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             HhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence                      26899999999999987777899999873

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.08  E-value=4.7e-06  Score=88.49  Aligned_cols=69  Identities=22%  Similarity=0.168  Sum_probs=42.6

Q ss_pred             eeEEcccCcEEEEEEEECCCCcEEEEEEecchhh--H----HHHHHHHHHHHHHhhCCC--CC-C--------CeEEEEE
Q psy1546          62 QERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA--E----DEIEDIQQEIMVLSQCDS--PY-G--------TKLWIIM  124 (604)
Q Consensus        62 ~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~--~----~~~~~l~~Ei~iL~~l~h--p~-~--------~~lyLVm  124 (604)
                      .+.||.|.++.||++.+..+++.|+||.......  .    .....+..|..+|..+..  +. .        ...++||
T Consensus        35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~d~~~~~lvm  114 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSDTEMAVTVM  114 (397)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEETTTTEEEE
T ss_pred             EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEEcCCccEEEE
Confidence            4679999999999997666678899998653211  0    112345677777776532  11 1        1236999


Q ss_pred             EecCCC
Q psy1546         125 EYLGGG  130 (604)
Q Consensus       125 Ey~~gg  130 (604)
                      ||+++.
T Consensus       115 E~l~g~  120 (397)
T 2olc_A          115 EDLSHL  120 (397)
T ss_dssp             CCCTTS
T ss_pred             EeCCCc
Confidence            999764

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=97.78  E-value=0.00014  Score=74.59  Aligned_cols=29  Identities=24%  Similarity=0.334  Sum_probs=26.8

Q ss_pred             CCccccccccceeEecCCCCeEEeccccc
Q psy1546         163 ERKLHRDIKAANVLLSEMGDVKLADFGVA  191 (604)
Q Consensus       163 ~gIiHrDLKp~NILl~~~g~vKL~DFGlA  191 (604)
                      ..++|+|+++.|||++.++.+.|+||+.+
T Consensus       222 ~~l~HgD~~~~Nil~~~~~~~~lIDfe~a  250 (346)
T 2q83_A          222 PNLCHQDYGTGNTLLGENEQIWVIDLDTV  250 (346)
T ss_dssp             CCEECSSCSTTSEEECGGGCEEECCCTTC
T ss_pred             CceecCCCCcccEEEeCCCcEEEEehhhc
Confidence            57999999999999987789999999977

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=97.77  E-value=0.0001  Score=76.72  Aligned_cols=31  Identities=23%  Similarity=0.344  Sum_probs=25.9

Q ss_pred             hCCccccccccceeEecCCCCeEEecccccc
Q psy1546         162 SERKLHRDIKAANVLLSEMGDVKLADFGVAG  192 (604)
Q Consensus       162 s~gIiHrDLKp~NILl~~~g~vKL~DFGlA~  192 (604)
                      ...++|+|+++.|||+++++.+.|+||+.+.
T Consensus       221 ~~~l~HgDl~~~Nil~~~~~~~~vIDwe~a~  251 (357)
T 3ats_A          221 EPVLLWGDARVGNVLYRDFQPVAVLDWEMVA  251 (357)
T ss_dssp             CCEEECSSCSGGGEEEETTEEEEECCGGGCE
T ss_pred             CceEEeCCCCCCeEEEeCCcEEEEEcccccc
Confidence            3468999999999999964457999999883

>3ajm_A Programmed cell death protein 10; adaptor protein, dimerization, four-helix bundle, apoptosis; HET: 4IP; 2.30A {Homo sapiens} PDB: 3l8i_A 3rqe_A 3rqf_A 3rqg_A 3l8j_A

Probab=97.51  E-value=9.1e-05  Score=70.38  Aligned_cols=49  Identities=31%  Similarity=0.584  Sum_probs=45.3

Q ss_pred             hhhhHHHHHHHHHHhccccCCCCCCCCCCCCCCCcchHHHHHHHHHHHHhhCCCChHHHHHHHHHHh
Q psy1546         507 LSFLIYPLISELQRRHHYTSNNRTSNSGADSSHKADAIEELKNAFDLAERSAPGISGQFVKEVVHKL  573 (604)
Q Consensus       507 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ae~~~pg~~~~~~~~~~~~~  573 (604)
                      |..++.|+|.+|.++                  ..+|..-|+.||.-||.+.||+|..||..|+++.
T Consensus        15 L~~l~~P~l~kle~~------------------D~~a~qtLRaAf~kAE~~~PGf~~dfi~~iL~~~   63 (213)
T 3ajm_A           15 LYAVMYPVFNELERV------------------NLSAAQTLRAAFIKAEKENPGLTQDIIMKILEKK   63 (213)
T ss_dssp             HHHTHHHHHHHHHHH------------------CHHHHHHHHHHHHHHHHHSTTHHHHHHHHHHHTH
T ss_pred             chhhHHHHHHHHHhh------------------CHHHHHHHHHHHHHHHhcCCChHHHHHHHHHHHh
Confidence            778999999999997                  5677899999999999999999999999999884

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.38  E-value=0.00069  Score=68.37  Aligned_cols=72  Identities=8%  Similarity=0.049  Sum_probs=49.7

Q ss_pred             ceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCC---CCeE------EEEEEecCC
Q psy1546          59 FTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPY---GTKL------WIIMEYLGG  129 (604)
Q Consensus        59 y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~---~~~l------yLVmEy~~g  129 (604)
                      ..-.+.+|.|..+.||++.. .+|+.|+||+....... ....+..|...|+.|....   ..++      ++||||+++
T Consensus        17 v~~v~~~g~G~~~~vyrv~l-~DG~~~~vK~~~~~~~~-~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~~~~lv~e~l~~   94 (288)
T 3f7w_A           17 VAAVAERGHSHRWHLYRVEL-ADGTPLFVKALPDDAPA-LDGLFRAEALGLDWLGRSFGSPVPQVAGWDDRTLAMEWVDE   94 (288)
T ss_dssp             EEEEEEEEEETTEEEEEEEE-TTSCEEEEEECCTTCCC-CTTHHHHHHHHHHHHTCSTTCCSCCEEEEETTEEEEECCCC
T ss_pred             eEEEEecCCCCCeEEEEEEE-CCCCEEEEEEeCCCCcc-hhhHHHHHHHHHHHHHhhCCCCcceEEeccCceEEEEeecc
Confidence            35567899999999999975 46788999986533211 1245678888888774322   1122      699999987


Q ss_pred             CCh
Q psy1546         130 GSA  132 (604)
Q Consensus       130 gsL  132 (604)
                      +..
T Consensus        95 ~~~   97 (288)
T 3f7w_A           95 RPP   97 (288)
T ss_dssp             CCC
T ss_pred             cCC
Confidence            653

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.30  E-value=0.00065  Score=72.61  Aligned_cols=31  Identities=13%  Similarity=0.279  Sum_probs=27.4

Q ss_pred             hhCCccccccccceeEecCCCCeEEecccccc
Q psy1546         161 HSERKLHRDIKAANVLLSEMGDVKLADFGVAG  192 (604)
Q Consensus       161 Hs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~  192 (604)
                      +...++|+|+++.|||++.++ ++|+||+.+.
T Consensus       230 ~~~~liHGDl~~~Nil~~~~~-~~lID~e~a~  260 (420)
T 2pyw_A          230 RAQALIHGDLHTGSVMVTQDS-TQVIDPEFSF  260 (420)
T ss_dssp             BCCEEECSCCSGGGEEECSSC-EEECCCTTCE
T ss_pred             CCCeEEecCCCCCcEEEeCCC-CEEEeCcccc
Confidence            456799999999999999876 9999999883

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.20  E-value=0.00038  Score=70.81  Aligned_cols=28  Identities=21%  Similarity=0.247  Sum_probs=24.1

Q ss_pred             CccccccccceeEecCCCCeEEecccccc
Q psy1546         164 RKLHRDIKAANVLLSEMGDVKLADFGVAG  192 (604)
Q Consensus       164 gIiHrDLKp~NILl~~~g~vKL~DFGlA~  192 (604)
                      .++|+|+.+.||| ..++.+.|+||+.+.
T Consensus       174 ~l~HgDl~~~Nil-~~~~~~~lID~e~a~  201 (301)
T 3dxq_A          174 AACHCDPLCENFL-DTGERMWIVDWEYSG  201 (301)
T ss_dssp             EEECSCCCGGGEE-ECSSCEEECCCTTCE
T ss_pred             eeeccCCCcCCEE-ECCCCEEEEeccccc
Confidence            4799999999999 556789999999873

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.18  E-value=0.0012  Score=68.18  Aligned_cols=66  Identities=20%  Similarity=0.242  Sum_probs=47.3

Q ss_pred             eeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCC------CC-------CCeEEEEEEec
Q psy1546          61 KQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDS------PY-------GTKLWIIMEYL  127 (604)
Q Consensus        61 i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~h------p~-------~~~lyLVmEy~  127 (604)
                      -.+.|+.|.+..+|+...  .+..|+||+.....    ...+..|...|+.|..      |.       ....|+||||+
T Consensus        40 ~~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~~----~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l  113 (312)
T 3jr1_A           40 HKEKLYSGEMNEIWLIND--EVQTVFVKINERSY----RSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEAL  113 (312)
T ss_dssp             EEEEECCSSSSEEEEEES--SSCEEEEEEEEGGG----HHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECC
T ss_pred             eeEEeCCccceeeeEEEE--CCCeEEEEeCCccc----HHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEec
Confidence            456799999999999874  46788899875432    3567788777776632      11       13458999999


Q ss_pred             CCCCh
Q psy1546         128 GGGSA  132 (604)
Q Consensus       128 ~ggsL  132 (604)
                      +|..+
T Consensus       114 ~G~~~  118 (312)
T 3jr1_A          114 NKSKN  118 (312)
T ss_dssp             CCCCC
T ss_pred             cCCCC
Confidence            98765

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.17  E-value=0.0016  Score=66.41  Aligned_cols=126  Identities=18%  Similarity=0.215  Sum_probs=69.3

Q ss_pred             eeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCC-----CCC-------------CCeEEE
Q psy1546          61 KQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCD-----SPY-------------GTKLWI  122 (604)
Q Consensus        61 i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~-----hp~-------------~~~lyL  122 (604)
                      ..+.|+.|....||++...  +..+++|+.......   ..+..|+.++..+.     -|.             ....++
T Consensus        26 ~~~~i~~G~~n~~~~v~~~--~g~~vlk~~~~~~~~---~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~  100 (322)
T 2ppq_A           26 SYKGIAEGVENSNFLLHTT--KDPLILTLYEKRVEK---NDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAA  100 (322)
T ss_dssp             EEEEECC---EEEEEEEES--SCCEEEEEECC---C---CHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEE
T ss_pred             EeeccCCCcccceEEEEeC--CccEEEEEeCCCCCH---HHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEE
Confidence            3467888999999998754  236889998652111   23344555544332     121             124589


Q ss_pred             EEEecCCCChhh----H----------hhc--CCCc--------HHHHHHH---------------HHHHHHHhHHhhh-
Q psy1546         123 IMEYLGGGSALD----L----------MKA--GNFE--------EMHIAVI---------------LREVLKGLDYLHS-  162 (604)
Q Consensus       123 VmEy~~ggsL~~----~----------l~~--~~ls--------e~~i~~i---------------~~qIl~gL~yLHs-  162 (604)
                      ||+|++|..+..    .          +..  ..+.        .......               ...+...+.+|+. 
T Consensus       101 l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~  180 (322)
T 2ppq_A          101 LISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAH  180 (322)
T ss_dssp             EEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHH
T ss_pred             EEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhh
Confidence            999998865421    0          000  0110        0000000               0113334444442 


Q ss_pred             ------CCccccccccceeEecCCCCeEEeccccc
Q psy1546         163 ------ERKLHRDIKAANVLLSEMGDVKLADFGVA  191 (604)
Q Consensus       163 ------~gIiHrDLKp~NILl~~~g~vKL~DFGlA  191 (604)
                            .+++|+|+++.|||++.++.+.|+||+.+
T Consensus       181 ~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a  215 (322)
T 2ppq_A          181 WPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFA  215 (322)
T ss_dssp             CCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTC
T ss_pred             CcccCCcccCCCCCCccCEEEeCCceEEEecchhc
Confidence                  36899999999999988665689999977

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=97.16  E-value=0.0022  Score=62.53  Aligned_cols=134  Identities=16%  Similarity=0.128  Sum_probs=89.6

Q ss_pred             CChhhHhh--cCCCcHHHHHHHHHHHHHHhHHh-hhCCccccccccceeEecCCCCeEEecccccccccCCCCCCccccc
Q psy1546         130 GSALDLMK--AGNFEEMHIAVILREVLKGLDYL-HSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVG  206 (604)
Q Consensus       130 gsL~~~l~--~~~lse~~i~~i~~qIl~gL~yL-Hs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~~~~~~G  206 (604)
                      .+|.++++  ..+++|.++|.++.|.+.+|.-+ +...-..+=+-|..|+|..+|.|-+.+ +.+.            ..
T Consensus        33 vSL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~------------~~   99 (229)
T 2yle_A           33 LSLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP-AADD------------AG   99 (229)
T ss_dssp             EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC-C-----------------
T ss_pred             ccHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc-cccc------------cc
Confidence            36888875  47899999999999999998876 212222344457899999999988764 2110            11


Q ss_pred             CCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCCCCCCCCccchHHHHHHHHHHhcc----
Q psy1546         207 TPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNK----  282 (604)
Q Consensus       207 T~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~~L~~----  282 (604)
                      ...+.|||... ...+.+.=|||||++||.-+--..|                  +.-...+++.+..||..|...    
T Consensus       100 ~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~------------------e~eE~eLS~~LE~LL~~Mt~~~~d~  160 (229)
T 2yle_A          100 EPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK------------------ENEERELSPPLEQLIDHMANTVEAD  160 (229)
T ss_dssp             -------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC------------------TTEEECCCHHHHHHHHHHTTCCC--
T ss_pred             ccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC------------------cccchhhCHHHHHHHHHHHhccccc
Confidence            22355777652 2334667899999999998763332                  122356788999999999866    


Q ss_pred             ---------------------CCCCCCCHHHHhc
Q psy1546         283 ---------------------DPENRPTAKELLK  295 (604)
Q Consensus       283 ---------------------dP~~RpT~~elL~  295 (604)
                                           .+..|.++++||+
T Consensus       161 ~~~DeG~~~~~eg~~d~~~~~~~~~~~sl~~Vi~  194 (229)
T 2yle_A          161 GSNDEGYEAAEEGLGDEDEKRKISAIRSYRDVMK  194 (229)
T ss_dssp             ------------------CCSCCCCCCSHHHHHH
T ss_pred             ccccccccccccccccccccccccCcCCHHHHHH
Confidence                                 2467889999986

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.01  E-value=0.00084  Score=69.10  Aligned_cols=31  Identities=32%  Similarity=0.336  Sum_probs=26.8

Q ss_pred             hCCccccccccceeEecCC----CCeEEecccccc
Q psy1546         162 SERKLHRDIKAANVLLSEM----GDVKLADFGVAG  192 (604)
Q Consensus       162 s~gIiHrDLKp~NILl~~~----g~vKL~DFGlA~  192 (604)
                      ...++|||+.+.|||++.+    +.+.|+||+.+.
T Consensus       182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~  216 (333)
T 3csv_A          182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAK  216 (333)
T ss_dssp             CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCE
T ss_pred             CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcC
Confidence            3469999999999999874    679999999884

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=96.72  E-value=0.0062  Score=62.15  Aligned_cols=28  Identities=29%  Similarity=0.311  Sum_probs=24.7

Q ss_pred             CCccccccccceeEecCCCCeEEecccccc
Q psy1546         163 ERKLHRDIKAANVLLSEMGDVKLADFGVAG  192 (604)
Q Consensus       163 ~gIiHrDLKp~NILl~~~g~vKL~DFGlA~  192 (604)
                      ..++|+|+++.|||++ + .+.|+||+.+.
T Consensus       195 ~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~  222 (328)
T 1zyl_A          195 VLRLHGDCHAGNILWR-D-GPMFVDLDDAR  222 (328)
T ss_dssp             CEECCSSCSGGGEEES-S-SEEECCCTTCC
T ss_pred             eeeeeCCCCcccEeEc-C-CCEEEECCCCC
Confidence            4589999999999999 4 89999999873

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=96.72  E-value=0.0036  Score=66.30  Aligned_cols=129  Identities=16%  Similarity=0.169  Sum_probs=74.6

Q ss_pred             eeEEcccCcEEEEEEEECC-------CCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCC-CCeE------EEEEEec
Q psy1546          62 QERIGKGSFGEVFKGIDNR-------TQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPY-GTKL------WIIMEYL  127 (604)
Q Consensus        62 ~~~LG~G~fG~Vy~a~~~~-------t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~-~~~l------yLVmEy~  127 (604)
                      .+.|..|-...+|++....       .++.|++|+.....  .....+.+|..+++.+.... ..++      .+||||+
T Consensus        55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~--~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~g~v~e~i  132 (379)
T 3feg_A           55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAIL--QGVDSLVLESVMFAILAERSLGPQLYGVFPEGRLEQYI  132 (379)
T ss_dssp             CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC-----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETTEEEEECC
T ss_pred             EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCcc--chHHHHHHHHHHHHHHHhcCCCCeEEEEcCCccEEEEe
Confidence            3567778888999997642       35789999863321  12345568888877653211 1222      2899999


Q ss_pred             CCCChhh--------------Hhh---c-----C-CC--cHHHHHHHHHHHHH-------------------HhHHhh--
Q psy1546         128 GGGSALD--------------LMK---A-----G-NF--EEMHIAVILREVLK-------------------GLDYLH--  161 (604)
Q Consensus       128 ~ggsL~~--------------~l~---~-----~-~l--se~~i~~i~~qIl~-------------------gL~yLH--  161 (604)
                      +|..|..              .|.   .     + ..  -+.++..++.++..                   .+..|.  
T Consensus       133 ~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~~  212 (379)
T 3feg_A          133 PSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLRKL  212 (379)
T ss_dssp             SEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHHHH
T ss_pred             cCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHHHH
Confidence            9865531              010   0     1 11  23445555544422                   123332  


Q ss_pred             --h----CCccccccccceeEecCC----CCeEEecccccc
Q psy1546         162 --S----ERKLHRDIKAANVLLSEM----GDVKLADFGVAG  192 (604)
Q Consensus       162 --s----~gIiHrDLKp~NILl~~~----g~vKL~DFGlA~  192 (604)
                        .    ..++|+|+.+.|||++.+    +.+.|+||..|.
T Consensus       213 L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~  253 (379)
T 3feg_A          213 LESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS  253 (379)
T ss_dssp             HHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred             HhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence              2    258999999999999876    789999999883

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=96.60  E-value=0.0036  Score=65.44  Aligned_cols=69  Identities=19%  Similarity=0.140  Sum_probs=38.2

Q ss_pred             eeEEcccCcEEEEEEEECC--------CCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCC-CCeE------EEEEEe
Q psy1546          62 QERIGKGSFGEVFKGIDNR--------TQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPY-GTKL------WIIMEY  126 (604)
Q Consensus        62 ~~~LG~G~fG~Vy~a~~~~--------t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~-~~~l------yLVmEy  126 (604)
                      .+.|+.|....||++....        .+..|++|+......  .+.....|..+++.+.... ..++      ++||||
T Consensus        38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~--~~~~~~~E~~~l~~L~~~g~~P~~~~~~~~~~v~e~  115 (369)
T 3c5i_A           38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVD--ELYNTISEFEVYKTMSKYKIAPQLLNTFNGGRIEEW  115 (369)
T ss_dssp             EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGG--GTSCHHHHHHHHHHHHHTTSSCCEEEEETTEEEEEC
T ss_pred             EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCcc--ceecHHHHHHHHHHHHhcCCCCceEEecCCcEEEEE
Confidence            4578888889999997643        136789998754321  1112345666665543211 1122      589999


Q ss_pred             cCCCCh
Q psy1546         127 LGGGSA  132 (604)
Q Consensus       127 ~~ggsL  132 (604)
                      ++|..+
T Consensus       116 i~G~~l  121 (369)
T 3c5i_A          116 LYGDPL  121 (369)
T ss_dssp             CCSEEC
T ss_pred             ecCCcC
Confidence            987543

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=96.45  E-value=0.006  Score=65.56  Aligned_cols=69  Identities=17%  Similarity=0.175  Sum_probs=43.5

Q ss_pred             eeeEEcccCcEEEEEEEECC-------CCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCC-CCeE------EEEEEe
Q psy1546          61 KQERIGKGSFGEVFKGIDNR-------TQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPY-GTKL------WIIMEY  126 (604)
Q Consensus        61 i~~~LG~G~fG~Vy~a~~~~-------t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~-~~~l------yLVmEy  126 (604)
                      ..+.|+.|-...||++....       .+..|++|+......   ...+.+|..++..+.... ..++      .+|+||
T Consensus        77 ~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~---~~~li~E~~~l~~L~~~g~~P~l~~~~~~g~v~e~  153 (429)
T 1nw1_A           77 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPET---ESHLVAESVIFTLLSERHLGPKLYGIFSGGRLEEY  153 (429)
T ss_dssp             EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCC---HHHHHHHHHHHHHHHHTTSSSCEEEEETTEEEECC
T ss_pred             EEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCCc---HHHHHHHHHHHHHHHhCCCCCcEEEEeCCCEEEEE
Confidence            35678999999999998653       257899999843211   123346777776653221 2222      279999


Q ss_pred             cCCCCh
Q psy1546         127 LGGGSA  132 (604)
Q Consensus       127 ~~ggsL  132 (604)
                      ++|..|
T Consensus       154 l~G~~l  159 (429)
T 1nw1_A          154 IPSRPL  159 (429)
T ss_dssp             CCEEEC
T ss_pred             eCCccc
Confidence            986443

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=96.22  E-value=0.013  Score=60.64  Aligned_cols=30  Identities=27%  Similarity=0.313  Sum_probs=26.9

Q ss_pred             CCccccccccceeEecCCCCeEEecccccc
Q psy1546         163 ERKLHRDIKAANVLLSEMGDVKLADFGVAG  192 (604)
Q Consensus       163 ~gIiHrDLKp~NILl~~~g~vKL~DFGlA~  192 (604)
                      ..++|+|+.+.|||++.++.+.|+||+.+.
T Consensus       206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~  235 (339)
T 3i1a_A          206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPM  235 (339)
T ss_dssp             CEEECSCCCGGGEEECGGGCEEECCCSSCE
T ss_pred             ceeEeCCCCcCCEEEeCCCeEEEEECCCCe
Confidence            368999999999999988889999998874

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=96.07  E-value=0.0091  Score=64.79  Aligned_cols=70  Identities=19%  Similarity=0.152  Sum_probs=43.0

Q ss_pred             eeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCC-CCeE------EEEEEecCCCCh
Q psy1546          61 KQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPY-GTKL------WIIMEYLGGGSA  132 (604)
Q Consensus        61 i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~-~~~l------yLVmEy~~ggsL  132 (604)
                      ..+.|+.|-...+|++.....+..|++|+..... . .+-...+|..++..|.... ..++      .+||||++|..|
T Consensus       112 ~i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~-~-~~idR~~E~~vl~~L~~~gl~P~ll~~~~~G~v~e~I~G~~l  188 (458)
T 2qg7_A          112 EFQIINGGITNILIKVKDMSKQAKYLIRLYGPKT-D-EIINREREKKISCILYNKNIAKKIYVFFTNGRIEEFMDGYAL  188 (458)
T ss_dssp             EEEEECC--CEEEEEEEETTTTEEEEEEEECC-C-C-SCSCHHHHHHHHHHHTTSSSBCCEEEEETTEEEEECCCSEEC
T ss_pred             EEEEcCCCeEeEEEEEEECCCCceEEEEECCCCh-h-hhcCHHHHHHHHHHHHhcCCCCCEEEEeCCeEEEEeeCCccC
Confidence            3467888999999999876545789999874321 1 1111257777777765432 1223      269999987554

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=95.76  E-value=0.014  Score=62.00  Aligned_cols=28  Identities=36%  Similarity=0.487  Sum_probs=24.3

Q ss_pred             ccccccccceeEe------cCCCCeEEecccccc
Q psy1546         165 KLHRDIKAANVLL------SEMGDVKLADFGVAG  192 (604)
Q Consensus       165 IiHrDLKp~NILl------~~~g~vKL~DFGlA~  192 (604)
                      ++|+|+.+.|||+      ++++.+.|+||.+|.
T Consensus       246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~  279 (401)
T 3g15_A          246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSS  279 (401)
T ss_dssp             EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCE
T ss_pred             eEEecCCCCeEEEecCcccCcCCeEEEechHhcc
Confidence            6899999999999      456779999999883

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=93.96  E-value=0.03  Score=60.08  Aligned_cols=70  Identities=14%  Similarity=0.139  Sum_probs=43.1

Q ss_pred             eeeEEcccCcEEEEEEEECCC-------CcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCC-CCCeE------EEEEEe
Q psy1546          61 KQERIGKGSFGEVFKGIDNRT-------QQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSP-YGTKL------WIIMEY  126 (604)
Q Consensus        61 i~~~LG~G~fG~Vy~a~~~~t-------~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp-~~~~l------yLVmEy  126 (604)
                      ..+.|..|-...+|++.....       ++.|++|+.....  ...-...+|..+++.+... ...++      ++||||
T Consensus        74 ~v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t--~~~idR~~E~~~l~~L~~~gi~P~l~~~~~~~~I~ef  151 (424)
T 3mes_A           74 EVKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV--GKFYDSKVELDVFRYLSNINIAPNIIADFPEGRIEEF  151 (424)
T ss_dssp             EEEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC---CCCCHHHHHHHHHHHHHTTSSCCEEEEETTEEEEEC
T ss_pred             EEEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc--chhcCHHHHHHHHHHHHhcCCCCCEEEEcCCCEEEEE
Confidence            346778888899999986521       5789999974422  1112234666666655321 12222      589999


Q ss_pred             cCCCCh
Q psy1546         127 LGGGSA  132 (604)
Q Consensus       127 ~~ggsL  132 (604)
                      ++|..|
T Consensus       152 I~G~~l  157 (424)
T 3mes_A          152 IDGEPL  157 (424)
T ss_dssp             CCSEEC
T ss_pred             eCCccC
Confidence            998664

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	604
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	4e-82
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	4e-81
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	4e-80
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	9e-76
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	3e-73
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	6e-72
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	2e-71
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	2e-70
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	6e-69
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	1e-67
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	3e-67
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	1e-66
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	2e-66
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	3e-66
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	2e-63
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	1e-62
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	3e-61
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	5e-61
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	6e-61
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	7e-61
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	2e-60
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	3e-60
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	8e-60
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	3e-59
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	3e-59
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	4e-59
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	2e-58
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	2e-58
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	3e-58
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	8e-58
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	9e-58
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	2e-57
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	2e-57
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	3e-57
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	4e-57
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	1e-56
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	1e-56
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	2e-56
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	5e-56
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	8e-56
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	1e-55
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	1e-55
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	3e-55
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	2e-54
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	8e-54
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	1e-53
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	4e-53
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	9e-53
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	1e-52
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	6e-52
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	6e-51
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	2e-50
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	4e-50
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	2e-49
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	3e-49
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	7e-49
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	8e-49
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	2e-48
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	1e-46
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	3e-46
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	3e-45
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	1e-33
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	1e-21

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  257 bits (659), Expect = 4e-82
 Identities = 117/276 (42%), Positives = 171/276 (61%), Gaps = 13/276 (4%)

Query: 54  DPELIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCD 113
           DP+  +T+ E+IG+G+ G V+  +D  T Q VAI+ ++L++   + E I  EI+V+ +  
Sbjct: 17  DPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKK-ELIINEILVMRENK 75

Query: 114 SPY----------GTKLWIIMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSE 163
           +P           G +LW++MEYL GGS  D++     +E  IA + RE L+ L++LHS 
Sbjct: 76  NPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSN 135

Query: 164 RKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDS 223
           + +HRDIK+ N+LL   G VKL DFG    +T   SKR+T VGTP+WMAPEV+ + AY  
Sbjct: 136 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGP 195

Query: 224 KADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTG--NYTKQFKEFVEACLN 281
           K DIWSLGI AIE+ +GEPP    +P+R L+LI  N  P+L      +  F++F+  CL+
Sbjct: 196 KVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLD 255

Query: 282 KDPENRPTAKELLKFPFIRKAKKNAYLIDLIDRYKK 317
            D E R +AKELL+  F++ AK  + L  LI   K+
Sbjct: 256 MDVEKRGSAKELLQHQFLKIAKPLSSLTPLIAAAKE 291

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  254 bits (651), Expect = 4e-81
 Identities = 113/284 (39%), Positives = 169/284 (59%), Gaps = 21/284 (7%)

Query: 52  KVDPELIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQ 111
            ++PE  +     +G G+FG+V+K  +  T  + A K+ID + +E+E+ED   EI +L+ 
Sbjct: 7   DLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTK-SEEELEDYMVEIDILAS 65

Query: 112 CDSPY----------GTKLWIIMEYLGGGSALDLM--KAGNFEEMHIAVILREVLKGLDY 159
           CD P              LWI++E+  GG+   +M        E  I V+ ++ L  L+Y
Sbjct: 66  CDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNY 125

Query: 160 LHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVI--- 216
           LH  + +HRD+KA N+L +  GD+KLADFGV+   T T  +R++F+GTP+WMAPEV+   
Sbjct: 126 LHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCE 185

Query: 217 --KQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLT--GNYTKQF 272
             K   YD KAD+WSLGIT IE+A+ EPP+ EL+PMRVL  I K+ PP L     ++  F
Sbjct: 186 TSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNF 245

Query: 273 KEFVEACLNKDPENRPTAKELLKFPFIRKAKKNAYLIDLIDRYK 316
           K+F++ CL K+ + R T  +LL+ PF+     N  + +LI   K
Sbjct: 246 KDFLKKCLEKNVDARWTTSQLLQHPFV-TVDSNKPIRELIAEAK 288

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  252 bits (646), Expect = 4e-80
 Identities = 113/283 (39%), Positives = 162/283 (57%), Gaps = 21/283 (7%)

Query: 52  KVDPELIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDE--IEDIQQEIMVL 109
           K DPE +F+    IG GSFG V+   D R  +VVAIK +     +     +DI +E+  L
Sbjct: 10  KDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFL 69

Query: 110 SQCDSPY----------GTKLWIIMEYLGGGS-ALDLMKAGNFEEMHIAVILREVLKGLD 158
            +   P               W++MEY  G +  L  +     +E+ IA +    L+GL 
Sbjct: 70  QKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLA 129

Query: 159 YLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVI-- 216
           YLHS   +HRD+KA N+LLSE G VKL DFG A  +       N+FVGTP+WMAPEVI  
Sbjct: 130 YLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA----NSFVGTPYWMAPEVILA 185

Query: 217 -KQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQL-TGNYTKQFKE 274
             +  YD K D+WSLGIT IELA+ +PP   ++ M  L+ I +N  P L +G++++ F+ 
Sbjct: 186 MDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRN 245

Query: 275 FVEACLNKDPENRPTAKELLKFPFIRKAKKNAYLIDLIDRYKK 317
           FV++CL K P++RPT++ LLK  F+ + +    ++DLI R K 
Sbjct: 246 FVDSCLQKIPQDRPTSEVLLKHRFVLRERPPTVIMDLIQRTKD 288

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  240 bits (613), Expect = 9e-76
 Identities = 74/264 (28%), Positives = 120/264 (45%), Gaps = 23/264 (8%)

Query: 59  FTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA-EDEIEDIQQEIMVLSQCDSPY- 116
           +     IG GS+G   K       +++  K +D     E E + +  E+ +L +   P  
Sbjct: 6   YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNI 65

Query: 117 -----------GTKLWIIMEYLGGGSALDLMKA-----GNFEEMHIAVILREVLKGLDYL 160
                       T L+I+MEY  GG    ++          +E  +  ++ ++   L   
Sbjct: 66  VRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKEC 125

Query: 161 HSERK-----LHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEV 215
           H         LHRD+K ANV L    +VKL DFG+A  L + TS    FVGTP++M+PE 
Sbjct: 126 HRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQ 185

Query: 216 IKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEF 275
           + + +Y+ K+DIWSLG    EL    PP +      +   I +    ++   Y+ +  E 
Sbjct: 186 MNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSDELNEI 245

Query: 276 VEACLNKDPENRPTAKELLKFPFI 299
           +   LN    +RP+ +E+L+ P I
Sbjct: 246 ITRMLNLKDYHRPSVEEILENPLI 269

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  233 bits (596), Expect = 3e-73
 Identities = 69/265 (26%), Positives = 120/265 (45%), Gaps = 17/265 (6%)

Query: 59  FTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPY-- 116
           +   + +G+G++GEV   ++  T++ VA+KI+D++ A D  E+I++EI +    +     
Sbjct: 7   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 66

Query: 117 --------GTKLWIIMEYLGGGSALDLMKA-GNFEEMHIAVILREVLKGLDYLHSERKLH 167
                   G   ++ +EY  GG   D ++      E        +++ G+ YLH     H
Sbjct: 67  KFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITH 126

Query: 168 RDIKAANVLLSEMGDVKLADFGVAGTL--TNTTSKRNTFVGTPFWMAPEVIKQSAYDS-K 224
           RDIK  N+LL E  ++K++DFG+A      N     N   GT  ++APE++K+  + +  
Sbjct: 127 RDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEP 186

Query: 225 ADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLT--GNYTKQFKEFVEACLNK 282
            D+WS GI    +  GE P  +       +   K     L             +   L +
Sbjct: 187 VDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVE 246

Query: 283 DPENRPTAKELLKFPFIRKA-KKNA 306
           +P  R T  ++ K  +  K  KK A
Sbjct: 247 NPSARITIPDIKKDRWYNKPLKKGA 271

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  230 bits (587), Expect = 6e-72
 Identities = 71/256 (27%), Positives = 124/256 (48%), Gaps = 16/256 (6%)

Query: 59  FTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDE--IEDIQQEIMVLSQCDSPY 116
           F     +GKG FG V+   + +++ ++A+K++   + E       +++E+ + S    P 
Sbjct: 8   FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 67

Query: 117 ----------GTKLWIIMEYLGGGSALD-LMKAGNFEEMHIAVILREVLKGLDYLHSERK 165
                      T++++I+EY   G+    L K   F+E   A  + E+   L Y HS+R 
Sbjct: 68  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRV 127

Query: 166 LHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKA 225
           +HRDIK  N+LL   G++K+ADFG +    ++  +R T  GT  ++ PE+I+   +D K 
Sbjct: 128 IHRDIKPENLLLGSAGELKIADFGWSVHAPSS--RRTTLCGTLDYLPPEMIEGRMHDEKV 185

Query: 226 DIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPE 285
           D+WSLG+   E   G+PP            I            T+  ++ +   L  +P 
Sbjct: 186 DLWSLGVLCYEFLVGKPPFEANTYQETYKRI-SRVEFTFPDFVTEGARDLISRLLKHNPS 244

Query: 286 NRPTAKELLKFPFIRK 301
            RP  +E+L+ P+I  
Sbjct: 245 QRPMLREVLEHPWITA 260

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  230 bits (588), Expect = 2e-71
 Identities = 90/302 (29%), Positives = 149/302 (49%), Gaps = 57/302 (18%)

Query: 59  FTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPY-- 116
           F K   +G G+ G VFK     +  V+A K+I LE        I +E+ VL +C+SPY  
Sbjct: 8   FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 67

Query: 117 --------GTKLWIIMEYLGGGSALDLM-KAGNFEEMHIAVILREVLKGLDYLHSERKL- 166
                     ++ I ME++ GGS   ++ KAG   E  +  +   V+KGL YL  + K+ 
Sbjct: 68  GFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIM 127

Query: 167 HRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKAD 226
           HRD+K +N+L++  G++KL DFGV+G L ++ +  N+FVGT  +M+PE ++ + Y  ++D
Sbjct: 128 HRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA--NSFVGTRSYMSPERLQGTHYSVQSD 185

Query: 227 IWSLGITAIELAKGEPP------------------------------------------N 244
           IWS+G++ +E+A G  P                                           
Sbjct: 186 IWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSR 245

Query: 245 SELHPMRVLFLIPKNNPPQL-TGNYTKQFKEFVEACLNKDPENRPTAKELLKFPFIRKAK 303
             +    +L  I    PP+L +G ++ +F++FV  CL K+P  R   K+L+   FI+++ 
Sbjct: 246 PPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSD 305

Query: 304 KN 305
             
Sbjct: 306 AE 307

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  226 bits (577), Expect = 2e-70
 Identities = 64/260 (24%), Positives = 118/260 (45%), Gaps = 24/260 (9%)

Query: 62  QERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA-EDEIEDIQQEIMVLSQCDSPYGTKL 120
              IG+GSF  V+KG+D  T   VA   +   +  + E +  ++E  +L     P   + 
Sbjct: 14  DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 73

Query: 121 --------------WIIMEYLGGGSALDLM-KAGNFEEMHIAVILREVLKGLDYLHSERK 165
                          ++ E +  G+    + +    +   +    R++LKGL +LH+   
Sbjct: 74  YDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTP 133

Query: 166 --LHRDIKAANVLL-SEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYD 222
             +HRD+K  N+ +    G VK+ D G+A     + +K    +GTP +MAPE+ ++  YD
Sbjct: 134 PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK--AVIGTPEFMAPEMYEEK-YD 190

Query: 223 SKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNN--PPQLTGNYTKQFKEFVEACL 280
              D+++ G+  +E+A  E P SE      ++    +   P         + KE +E C+
Sbjct: 191 ESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCI 250

Query: 281 NKDPENRPTAKELLKFPFIR 300
            ++ + R + K+LL   F +
Sbjct: 251 RQNKDERYSIKDLLNHAFFQ 270

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  223 bits (568), Expect = 6e-69
 Identities = 71/272 (26%), Positives = 118/272 (43%), Gaps = 30/272 (11%)

Query: 59  FTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDL--------EEAEDEIEDIQQEIMVLS 110
           +  +E +G+G    V + I   T +  A+KIID+        EE ++  E   +E+ +L 
Sbjct: 5   YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR 64

Query: 111 QCDSPY-----------GTKLWIIMEYLGGGSALDLMKA-GNFEEMHIAVILREVLKGLD 158
           +                 T  +++ + +  G   D +       E     I+R +L+ + 
Sbjct: 65  KVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVIC 124

Query: 159 YLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVI-- 216
            LH    +HRD+K  N+LL +  ++KL DFG +  L +   K     GTP ++APE+I  
Sbjct: 125 ALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQL-DPGEKLREVCGTPSYLAPEIIEC 183

Query: 217 ----KQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNN---PPQLTGNYT 269
                   Y  + D+WS G+    L  G PP      M +L +I   N         +Y+
Sbjct: 184 SMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYS 243

Query: 270 KQFKEFVEACLNKDPENRPTAKELLKFPFIRK 301
              K+ V   L   P+ R TA+E L  PF ++
Sbjct: 244 DTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 275

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  220 bits (561), Expect = 1e-67
 Identities = 82/289 (28%), Positives = 137/289 (47%), Gaps = 20/289 (6%)

Query: 54  DPELIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCD 113
           D   I+  ++ +G G+F EV    D RTQ++VAIK I  +  E +   ++ EI VL +  
Sbjct: 6   DIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIK 65

Query: 114 SPY----------GTKLWIIMEYLGGGSALDLMKA-GNFEEMHIAVILREVLKGLDYLHS 162
            P           G  L++IM+ + GG   D +   G + E   + ++ +VL  + YLH 
Sbjct: 66  HPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHD 125

Query: 163 ERKLHRDIKAANVLLS---EMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQS 219
              +HRD+K  N+L     E   + ++DFG++  + +  S  +T  GTP ++APEV+ Q 
Sbjct: 126 LGIVHRDLKPENLLYYSLDEDSKIMISDFGLS-KMEDPGSVLSTACGTPGYVAPEVLAQK 184

Query: 220 AYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNN---PPQLTGNYTKQFKEFV 276
            Y    D WS+G+ A  L  G PP  + +  ++   I K           + +   K+F+
Sbjct: 185 PYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFI 244

Query: 277 EACLNKDPENRPTAKELLKFPFIRKAKKNAYLID--LIDRYKKWKNSRN 323
              + KDPE R T ++ L+ P+I         I   + ++ KK      
Sbjct: 245 RHLMEKDPEKRFTCEQALQHPWIAGDTALDKNIHQSVSEQIKKNFAKSK 293

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  218 bits (556), Expect = 3e-67
 Identities = 69/259 (26%), Positives = 125/259 (48%), Gaps = 25/259 (9%)

Query: 59  FTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA-EDEIEDIQQEIMVLSQCDSPY- 116
            T  +RIG GSFG V+KG  +     VA+K++++      +++  + E+ VL +      
Sbjct: 10  ITVGQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNI 66

Query: 117 --------GTKLWIIMEYLGGGSALDLMKA--GNFEEMHIAVILREVLKGLDYLHSERKL 166
                     +L I+ ++  G S    +      FE + +  I R+  +G+DYLH++  +
Sbjct: 67  LLFMGYSTAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSII 126

Query: 167 HRDIKAANVLLSEMGDVKLADFGVAGTLT--NTTSKRNTFVGTPFWMAPEVIK---QSAY 221
           HRD+K+ N+ L E   VK+ DFG+A   +  + + +     G+  WMAPEVI+   ++ Y
Sbjct: 127 HRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPY 186

Query: 222 DSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNN-----PPQLTGNYTKQFKEFV 276
             ++D+++ GI   EL  G+ P S ++    +  +           ++  N  K  K  +
Sbjct: 187 SFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLM 246

Query: 277 EACLNKDPENRPTAKELLK 295
             CL K  + RP   ++L 
Sbjct: 247 AECLKKKRDERPLFPQILA 265

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  219 bits (558), Expect = 1e-66
 Identities = 66/301 (21%), Positives = 119/301 (39%), Gaps = 20/301 (6%)

Query: 59  FTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPY-- 116
           +   E +G G+FG V +  +  T    A K +      D+ E +++EI  +S    P   
Sbjct: 28  YDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDK-ETVRKEIQTMSVLRHPTLV 86

Query: 117 --------GTKLWIIMEYLGGGSALDLM--KAGNFEEMHIAVILREVLKGLDYLHSERKL 166
                     ++ +I E++ GG   + +  +     E      +R+V KGL ++H    +
Sbjct: 87  NLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYV 146

Query: 167 HRDIKAANVLLS--EMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSK 224
           H D+K  N++ +     ++KL DFG+   L    S      GT  + APEV +       
Sbjct: 147 HLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS-VKVTTGTAEFAAPEVAEGKPVGYY 205

Query: 225 ADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNN---PPQLTGNYTKQFKEFVEACLN 281
            D+WS+G+ +  L  G  P    +    L  +   +           ++  K+F+   L 
Sbjct: 206 TDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLL 265

Query: 282 KDPENRPTAKELLKFPFIRKAKKNAYLIDL-IDRYKKWKNSRNEESETESETSDNEDSIK 340
            DP  R T  + L+ P++           +   RY K ++S   + +   E       I 
Sbjct: 266 ADPNTRMTIHQALEHPWLTPGNAPGRDSQIPSSRYTKIRDSIKTKYDAWPEPLPPLGRIS 325

Query: 341 T 341
            
Sbjct: 326 N 326

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  216 bits (552), Expect = 2e-66
 Identities = 66/258 (25%), Positives = 124/258 (48%), Gaps = 16/258 (6%)

Query: 59  FTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA--EDEIEDIQQEIMVLSQCDSPY 116
           F   + +G+GSF  V    +  T +  AIKI++      E+++  + +E  V+S+ D P+
Sbjct: 10  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 69

Query: 117 ----------GTKLWIIMEYLGGGSALD-LMKAGNFEEMHIAVILREVLKGLDYLHSERK 165
                       KL+  + Y   G  L  + K G+F+E        E++  L+YLH +  
Sbjct: 70  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 129

Query: 166 LHRDIKAANVLLSEMGDVKLADFGVAGTLT--NTTSKRNTFVGTPFWMAPEVIKQSAYDS 223
           +HRD+K  N+LL+E   +++ DFG A  L+  +  ++ N+FVGT  +++PE++ + +   
Sbjct: 130 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACK 189

Query: 224 KADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKD 283
            +D+W+LG    +L  G PP    +   +   I           +  + ++ VE  L  D
Sbjct: 190 SSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKI-IKLEYDFPEKFFPKARDLVEKLLVLD 248

Query: 284 PENRPTAKELLKFPFIRK 301
              R   +E+  +  ++ 
Sbjct: 249 ATKRLGCEEMEGYGPLKA 266

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  218 bits (556), Expect = 3e-66
 Identities = 66/299 (22%), Positives = 125/299 (41%), Gaps = 19/299 (6%)

Query: 59  FTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPY-- 116
           +   E +G G+FG V + ++  T +V   K I+     D+   ++ EI +++Q   P   
Sbjct: 31  YDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDK-YTVKNEISIMNQLHHPKLI 89

Query: 117 --------GTKLWIIMEYLGGGSALDLMKA--GNFEEMHIAVILREVLKGLDYLHSERKL 166
                     ++ +I+E+L GG   D + A      E  +   +R+  +GL ++H    +
Sbjct: 90  NLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIV 149

Query: 167 HRDIKAANVLLS--EMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSK 224
           H DIK  N++    +   VK+ DFG+A T  N          T  + APE++ +      
Sbjct: 150 HLDIKPENIMCETKKASSVKIIDFGLA-TKLNPDEIVKVTTATAEFAAPEIVDREPVGFY 208

Query: 225 ADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNN---PPQLTGNYTKQFKEFVEACLN 281
            D+W++G+    L  G  P +    +  L  + + +         + + + K+F++  L 
Sbjct: 209 TDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQ 268

Query: 282 KDPENRPTAKELLKFPFIRKAKKNAYLIDLIDRYKKWKNSRNEESETESETSDNEDSIK 340
           K+P  R T  + L+ P+++    N        RY K +    E+             I 
Sbjct: 269 KEPRKRLTVHDALEHPWLKGDHSNLTSRIPSSRYNKIRQKIKEKYADWPAPQPAIGRIA 327

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  208 bits (529), Expect = 2e-63
 Identities = 65/260 (25%), Positives = 115/260 (44%), Gaps = 17/260 (6%)

Query: 53  VDPELIFTKQERIGKGSFGEVFKGI--DNRTQQVVAIKIIDLE-EAEDEIEDIQQEIMVL 109
           +D +L+  + + +G G+FG V KG     +  + VA+KI+  E       +++  E  V+
Sbjct: 3   LDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVM 62

Query: 110 SQCDSPYGTKL---------WIIMEYLGGGSALD-LMKAGNFEEMHIAVILREVLKGLDY 159
            Q D+PY  ++          ++ME    G     L +  + ++ +I  ++ +V  G+ Y
Sbjct: 63  QQLDNPYIVRMIGICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKY 122

Query: 160 LHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLT---NTTSKRNTFVGTPFWMAPEVI 216
           L     +HRD+ A NVLL      K++DFG++  L    N    +        W APE I
Sbjct: 123 LEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI 182

Query: 217 KQSAYDSKADIWSLGITAIE-LAKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEF 275
               + SK+D+WS G+   E  + G+ P   +    V  ++ K           ++  + 
Sbjct: 183 NYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDL 242

Query: 276 VEACLNKDPENRPTAKELLK 295
           +  C   D ENRP    +  
Sbjct: 243 MNLCWTYDVENRPGFAAVEL 262

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  206 bits (526), Expect = 1e-62
 Identities = 67/274 (24%), Positives = 122/274 (44%), Gaps = 20/274 (7%)

Query: 51  LKVDPELIFTKQERIGKGSFGEVFKGID--NRTQQVVAIKIIDLEEAEDEIEDIQQEIMV 108
           L +  + +      +G G+FG V +G+    + Q  VAIK++     + + E++ +E  +
Sbjct: 3   LFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQI 62

Query: 109 LSQCDSPY---------GTKLWIIMEYLGGGSALDLMKA--GNFEEMHIAVILREVLKGL 157
           + Q D+PY            L ++ME  GGG     +          ++A +L +V  G+
Sbjct: 63  MHQLDNPYIVRLIGVCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGM 122

Query: 158 DYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLT---NTTSKRNTFVGTPFWMAPE 214
            YL  +  +HRD+ A NVLL      K++DFG++  L    +  + R+       W APE
Sbjct: 123 KYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPE 182

Query: 215 VIKQSAYDSKADIWSLGITAIE-LAKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFK 273
            I    + S++D+WS G+T  E L+ G+ P  ++    V+  I +    +       +  
Sbjct: 183 CINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELY 242

Query: 274 EFVEACLNKDPENRPTAKEL---LKFPFIRKAKK 304
             +  C     E+RP    +   ++  +   A K
Sbjct: 243 ALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASK 276

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  201 bits (513), Expect = 3e-61
 Identities = 61/252 (24%), Positives = 107/252 (42%), Gaps = 23/252 (9%)

Query: 59  FTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPY-- 116
               + IGKG FG+V  G        VA+K I  +      +    E  V++Q       
Sbjct: 9   LKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLV 63

Query: 117 ---------GTKLWIIMEYLGGGSALDLMKAGN---FEEMHIAVILREVLKGLDYLHSER 164
                       L+I+ EY+  GS +D +++          +     +V + ++YL    
Sbjct: 64  QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN 123

Query: 165 KLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSK 224
            +HRD+ A NVL+SE    K++DFG+    ++T   ++T      W APE +++  + +K
Sbjct: 124 FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST---QDTGKLPVKWTAPEALREKKFSTK 180

Query: 225 ADIWSLGITAIE-LAKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKD 283
           +D+WS GI   E  + G  P   +    V+  + K               E ++ C + D
Sbjct: 181 SDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEVMKNCWHLD 240

Query: 284 PENRPTAKELLK 295
              RP+  +L +
Sbjct: 241 AAMRPSFLQLRE 252

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  201 bits (513), Expect = 5e-61
 Identities = 71/253 (28%), Positives = 106/253 (41%), Gaps = 16/253 (6%)

Query: 59  FTKQERIGKGSFGEVFKGIDNRTQQ---VVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSP 115
                 IG+G FG+V +GI    +     VAIK      ++   E   QE + + Q D P
Sbjct: 9   IELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHP 68

Query: 116 YGTKL---------WIIMEYLGGGSALDLM--KAGNFEEMHIAVILREVLKGLDYLHSER 164
           +  KL         WIIME    G     +  +  + +   + +   ++   L YL S+R
Sbjct: 69  HIVKLIGVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR 128

Query: 165 KLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNT-FVGTPFWMAPEVIKQSAYDS 223
            +HRDI A NVL+S    VKL DFG++  + ++T  + +       WMAPE I    + S
Sbjct: 129 FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTS 188

Query: 224 KADIWSLGITAIE-LAKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNK 282
            +D+W  G+   E L  G  P   +    V+  I       +  N        +  C   
Sbjct: 189 ASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTKCWAY 248

Query: 283 DPENRPTAKELLK 295
           DP  RP   EL  
Sbjct: 249 DPSRRPRFTELKA 261

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  203 bits (516), Expect = 6e-61
 Identities = 74/258 (28%), Positives = 126/258 (48%), Gaps = 16/258 (6%)

Query: 59  FTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA--EDEIEDIQQEIMVLS-QCDSP 115
           F   + +GKGSFG+VF     +T Q  AIK +  +    +D++E    E  VLS   + P
Sbjct: 4   FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP 63

Query: 116 Y----------GTKLWIIMEYLGGGSALDLMKA-GNFEEMHIAVILREVLKGLDYLHSER 164
           +             L+ +MEYL GG  +  +++   F+         E++ GL +LHS+ 
Sbjct: 64  FLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKG 123

Query: 165 KLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSK 224
            ++RD+K  N+LL + G +K+ADFG+        +K NTF GTP ++APE++    Y+  
Sbjct: 124 IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYNHS 183

Query: 225 ADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDP 284
            D WS G+   E+  G+ P        +   I + + P       K+ K+ +     ++P
Sbjct: 184 VDWWSFGVLLYEMLIGQSPFHGQDEEELFHSI-RMDNPFYPRWLEKEAKDLLVKLFVREP 242

Query: 285 ENRPTAK-ELLKFPFIRK 301
           E R   + ++ + P  R+
Sbjct: 243 EKRLGVRGDIRQHPLFRE 260

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  202 bits (516), Expect = 7e-61
 Identities = 57/286 (19%), Positives = 117/286 (40%), Gaps = 21/286 (7%)

Query: 59  FTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPY-- 116
           +   E +G+G FG V + ++  +++    K + ++  +  +  +++EI +L+        
Sbjct: 7   YMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVL--VKKEISILNIARHRNIL 64

Query: 117 --------GTKLWIIMEYLGGGSALDLMKA--GNFEEMHIAVILREVLKGLDYLHSERKL 166
                     +L +I E++ G    + +        E  I   + +V + L +LHS    
Sbjct: 65  HLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIG 124

Query: 167 HRDIKAANVLLSEMGD--VKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSK 224
           H DI+  N++        +K+ +FG A  L    + R      P + APEV +     + 
Sbjct: 125 HFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFR-LLFTAPEYYAPEVHQHDVVSTA 183

Query: 225 ADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNN---PPQLTGNYTKQFKEFVEACLN 281
            D+WSLG     L  G  P       +++  I         +     + +  +FV+  L 
Sbjct: 184 TDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRLLV 243

Query: 282 KDPENRPTAKELLKFPFIRKAKKNAYLIDLIDRYKKWKNSRNEESE 327
           K+ ++R TA E L+ P++++  +      +I   K  +       +
Sbjct: 244 KERKSRMTASEALQHPWLKQKIERV-STKVIRTLKHRRYYHTLIKK 288

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  202 bits (514), Expect = 2e-60
 Identities = 76/306 (24%), Positives = 135/306 (44%), Gaps = 28/306 (9%)

Query: 62  QERIGKGSFGEVFKGIDNRTQQVVAIKII-DLEEAEDEIEDIQQE------IMVLSQCDS 114
            + +G G  G+V +  + RTQ+  A+K++ D  +A  E+E   +       + ++   ++
Sbjct: 17  SQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYEN 76

Query: 115 PY--GTKLWIIMEYLGGGSALDLMKAGN---FEEMHIAVILREVLKGLDYLHSERKLHRD 169
            Y     L I+ME L GG     ++      F E   + I++ + + + YLHS    HRD
Sbjct: 77  LYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRD 136

Query: 170 IKAANVLLSEM---GDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKAD 226
           +K  N+L +       +KL DFG A   T+  S   T   TP+++APEV+    YD   D
Sbjct: 137 VKPENLLYTSKRPNAILKLTDFGFAKETTSHNS-LTTPCYTPYYVAPEVLGPEKYDKSCD 195

Query: 227 IWSLGITAIELAKGEPPNSELHPMRVLFLIPKNN-------PPQLTGNYTKQFKEFVEAC 279
           +WSLG+    L  G PP    H + +   +           P       +++ K  +   
Sbjct: 196 MWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNL 255

Query: 280 LNKDPENRPTAKELLKFPFIRKAKKNAYL-----IDLIDRYKKWKNSRNEESETESETSD 334
           L  +P  R T  E +  P+I ++ K           L +  ++W++ + E +   +    
Sbjct: 256 LKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRV 315

Query: 335 NEDSIK 340
           + + IK
Sbjct: 316 DYEQIK 321

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  199 bits (508), Expect = 3e-60
 Identities = 63/265 (23%), Positives = 119/265 (44%), Gaps = 23/265 (8%)

Query: 59  FTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDE--IEDIQQEIMVLSQCDSPY 116
           +   E +G G   EV    D R  + VA+K++  + A D       ++E    +  + P 
Sbjct: 9   YELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPA 68

Query: 117 --------------GTKLWIIMEYLGGGSALDLMKA-GNFEEMHIAVILREVLKGLDYLH 161
                         G   +I+MEY+ G +  D++   G         ++ +  + L++ H
Sbjct: 69  IVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSH 128

Query: 162 SERKLHRDIKAANVLLSEMGDVKLADFGVAGTL---TNTTSKRNTFVGTPFWMAPEVIKQ 218
               +HRD+K AN+++S    VK+ DFG+A  +    N+ ++    +GT  +++PE  + 
Sbjct: 129 QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARG 188

Query: 219 SAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNN---PPQLTGNYTKQFKEF 275
            + D+++D++SLG    E+  GEPP +   P+ V +   + +   P       +      
Sbjct: 189 DSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLDAV 248

Query: 276 VEACLNKDPENRPTAKELLKFPFIR 300
           V   L K+PENR      ++   +R
Sbjct: 249 VLKALAKNPENRYQTAAEMRADLVR 273

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  197 bits (503), Expect = 8e-60
 Identities = 64/257 (24%), Positives = 116/257 (45%), Gaps = 18/257 (7%)

Query: 53  VDPELIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQC 112
           +DP+   T  + +G G FG V  G   R Q  VAIK+I      ++  +  +E  V+   
Sbjct: 1   IDPKD-LTFLKELGTGQFGVVKYGKW-RGQYDVAIKMIKEGSMSED--EFIEEAKVMMNL 56

Query: 113 DSPY----------GTKLWIIMEYLGGGSALDL--MKAGNFEEMHIAVILREVLKGLDYL 160
                            ++II EY+  G  L+        F+   +  + ++V + ++YL
Sbjct: 57  SHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYL 116

Query: 161 HSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNT-FVGTPFWMAPEVIKQS 219
            S++ LHRD+ A N L+++ G VK++DFG++  + +     +        W  PEV+  S
Sbjct: 117 ESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYS 176

Query: 220 AYDSKADIWSLGITAIEL-AKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEA 278
            + SK+DIW+ G+   E+ + G+ P            I +          +++    + +
Sbjct: 177 KFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYS 236

Query: 279 CLNKDPENRPTAKELLK 295
           C ++  + RPT K LL 
Sbjct: 237 CWHEKADERPTFKILLS 253

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  197 bits (501), Expect = 3e-59
 Identities = 61/251 (24%), Positives = 105/251 (41%), Gaps = 17/251 (6%)

Query: 59  FTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSP--- 115
               ER+G G FGEV+ G        VA+K +       +      E  ++ Q       
Sbjct: 15  LKLVERLGAGQFGEVWMGYY-NGHTKVAVKSLKQGSMSPD--AFLAEANLMKQLQHQRLV 71

Query: 116 --YG----TKLWIIMEYLGGGSALDLMK---AGNFEEMHIAVILREVLKGLDYLHSERKL 166
             Y       ++II EY+  GS +D +K           +  +  ++ +G+ ++     +
Sbjct: 72  RLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYI 131

Query: 167 HRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNT-FVGTPFWMAPEVIKQSAYDSKA 225
           HRD++AAN+L+S+    K+ADFG+A  + +              W APE I    +  K+
Sbjct: 132 HRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKS 191

Query: 226 DIWSLGITAIELA-KGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDP 284
           D+WS GI   E+   G  P   +    V+  + +        N  ++  + +  C  + P
Sbjct: 192 DVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWKERP 251

Query: 285 ENRPTAKELLK 295
           E+RPT   L  
Sbjct: 252 EDRPTFDYLRS 262

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  197 bits (502), Expect = 3e-59
 Identities = 69/280 (24%), Positives = 123/280 (43%), Gaps = 24/280 (8%)

Query: 52  KVDPELIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDE-----IEDIQQEI 106
           + + +  +   E +G G F  V K  +  T    A K I     +        EDI++E+
Sbjct: 5   QENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREV 64

Query: 107 MVLSQCDSPY----------GTKLWIIMEYLGGGSALDLM-KAGNFEEMHIAVILREVLK 155
            +L +   P            T + +I+E + GG   D + +  +  E      L+++L 
Sbjct: 65  SILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILN 124

Query: 156 GLDYLHSERKLHRDIKAANVLLSEMGD----VKLADFGVAGTLTNTTSKRNTFVGTPFWM 211
           G+ YLHS +  H D+K  N++L +       +K+ DFG+A  + +  ++     GTP ++
Sbjct: 125 GVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI-DFGNEFKNIFGTPEFV 183

Query: 212 APEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNN---PPQLTGNY 268
           APE++       +AD+WS+G+    L  G  P         L  +   N     +   N 
Sbjct: 184 APEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNT 243

Query: 269 TKQFKEFVEACLNKDPENRPTAKELLKFPFIRKAKKNAYL 308
           +   K+F+   L KDP+ R T ++ L+ P+I+       L
Sbjct: 244 SALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQAL 283

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  197 bits (501), Expect = 4e-59
 Identities = 70/252 (27%), Positives = 110/252 (43%), Gaps = 17/252 (6%)

Query: 59  FTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGT 118
              + ++G+G FGEV+ G  N T +V AIK +       E     QE  V+ +       
Sbjct: 19  LRLEVKLGQGCFGEVWMGTWNGTTRV-AIKTLKPGTMSPE--AFLQEAQVMKKLRHEKLV 75

Query: 119 KL---------WIIMEYLGGGSALDLMKA---GNFEEMHIAVILREVLKGLDYLHSERKL 166
           +L         +I+ EY+  GS LD +K           +  +  ++  G+ Y+     +
Sbjct: 76  QLYAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYV 135

Query: 167 HRDIKAANVLLSEMGDVKLADFGVAGTLT-NTTSKRNTFVGTPFWMAPEVIKQSAYDSKA 225
           HRD++AAN+L+ E    K+ADFG+A  +  N  + R        W APE      +  K+
Sbjct: 136 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 195

Query: 226 DIWSLGITAIELA-KGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDP 284
           D+WS GI   EL  KG  P   +    VL  + +           +   + +  C  K+P
Sbjct: 196 DVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEP 255

Query: 285 ENRPTAKELLKF 296
           E RPT + L  F
Sbjct: 256 EERPTFEYLQAF 267

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  194 bits (494), Expect = 2e-58
 Identities = 63/257 (24%), Positives = 105/257 (40%), Gaps = 18/257 (7%)

Query: 53  VDPELIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQC 112
           +DP    T  + IG G FG V  G     +  VAIK I      +E  D  +E  V+ + 
Sbjct: 2   IDPSE-LTFVQEIGSGQFGLVHLGYW-LNKDKVAIKTIREGAMSEE--DFIEEAEVMMKL 57

Query: 113 DSPY----------GTKLWIIMEYLGGGSALDLMKAGN--FEEMHIAVILREVLKGLDYL 160
             P              + ++ E++  G   D ++     F    +  +  +V +G+ YL
Sbjct: 58  SHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYL 117

Query: 161 HSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKR-NTFVGTPFWMAPEVIKQS 219
                +HRD+ A N L+ E   +K++DFG+   + +              W +PEV   S
Sbjct: 118 EEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFS 177

Query: 220 AYDSKADIWSLGITAIE-LAKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEA 278
            Y SK+D+WS G+   E  ++G+ P        V+  I            +    + +  
Sbjct: 178 RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNH 237

Query: 279 CLNKDPENRPTAKELLK 295
           C  + PE+RP    LL+
Sbjct: 238 CWKERPEDRPAFSRLLR 254

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  195 bits (497), Expect = 2e-58
 Identities = 61/295 (20%), Positives = 119/295 (40%), Gaps = 51/295 (17%)

Query: 53  VDPELI--------FTKQERIGKGSFGEVFKG-----IDNRTQQVVAIKIIDLEEAEDEI 99
           ++P+L+              IG+G+FG VF+      +      +VA+K++  E + D  
Sbjct: 1   LNPKLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQ 60

Query: 100 EDIQQEIMVLSQCDSPY----------GTKLWIIMEYLGGGSALDLMKAGN--------- 140
            D Q+E  ++++ D+P           G  + ++ EY+  G   + +++ +         
Sbjct: 61  ADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSH 120

Query: 141 ----------------FEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVK 184
                                   I R+V  G+ YL   + +HRD+   N L+ E   VK
Sbjct: 121 SDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVK 180

Query: 185 LADFGVAGTL--TNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIE-LAKGE 241
           +ADFG++  +   +             WM PE I  + Y +++D+W+ G+   E  + G 
Sbjct: 181 IADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGL 240

Query: 242 PPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPENRPTAKELLKF 296
            P   +    V++ +   N      N   +    +  C +K P +RP+   + + 
Sbjct: 241 QPYYGMAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRI 295

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  195 bits (496), Expect = 3e-58
 Identities = 65/258 (25%), Positives = 110/258 (42%), Gaps = 21/258 (8%)

Query: 59  FTKQERIGKGSFGEVFKGID---NRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSP 115
              ++ IG G FGEV  G      + +  VAIK +     E +  D   E  ++ Q D P
Sbjct: 28  VKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHP 87

Query: 116 Y----------GTKLWIIMEYLGGGSALDLM--KAGNFEEMHIAVILREVLKGLDYLHSE 163
                       T + II E++  GS    +    G F  + +  +LR +  G+ YL   
Sbjct: 88  NVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADM 147

Query: 164 RKLHRDIKAANVLLSEMGDVKLADFGVA-----GTLTNTTSKRNTFVGTPFWMAPEVIKQ 218
             +HRD+ A N+L++     K++DFG++      T   T +          W APE I+ 
Sbjct: 148 NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQY 207

Query: 219 SAYDSKADIWSLGITAIE-LAKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVE 277
             + S +D+WS GI   E ++ GE P  ++    V+  I ++       +      + + 
Sbjct: 208 RKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPMDCPSALHQLML 267

Query: 278 ACLNKDPENRPTAKELLK 295
            C  KD  +RP   +++ 
Sbjct: 268 DCWQKDRNHRPKFGQIVN 285

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  193 bits (491), Expect = 8e-58
 Identities = 66/259 (25%), Positives = 109/259 (42%), Gaps = 21/259 (8%)

Query: 59  FTKQERIGKGSFGEVFKGIDNRT---QQVVAIKIIDLEEAEDE--IEDIQQEIMVLSQCD 113
               E++G GSFG V +G  +        VA+K +  +       ++D  +E+  +   D
Sbjct: 10  LRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD 69

Query: 114 SP-----YGT----KLWIIMEYLGGGSALDLM--KAGNFEEMHIAVILREVLKGLDYLHS 162
                  YG      + ++ E    GS LD +    G+F    ++    +V +G+ YL S
Sbjct: 70  HRNLIRLYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLES 129

Query: 163 ERKLHRDIKAANVLLSEMGDVKLADFGVAGTLT---NTTSKRNTFVGTPFWMAPEVIKQS 219
           +R +HRD+ A N+LL+    VK+ DFG+   L    +    +        W APE +K  
Sbjct: 130 KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTR 189

Query: 220 AYDSKADIWSLGITAIE-LAKGEPPNSELHPMRVLFLIPKNNP-PQLTGNYTKQFKEFVE 277
            +   +D W  G+T  E    G+ P   L+  ++L  I K         +  +     + 
Sbjct: 190 TFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIYNVMV 249

Query: 278 ACLNKDPENRPTAKELLKF 296
            C    PE+RPT   L  F
Sbjct: 250 QCWAHKPEDRPTFVALRDF 268

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  195 bits (496), Expect = 9e-58
 Identities = 76/307 (24%), Positives = 128/307 (41%), Gaps = 24/307 (7%)

Query: 59  FTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLE--EAEDEIEDIQQEIMVLSQCDSPY 116
           F   + +GKG+FG+V    +  T +  A+KI+  E   A+DE+     E  VL     P+
Sbjct: 7   FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPF 66

Query: 117 GTKLWIIME-----------YLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERK 165
            T L    +             GG     L +   F E        E++  L+YLHS   
Sbjct: 67  LTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDV 126

Query: 166 LHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKA 225
           ++RDIK  N++L + G +K+ DFG+     +  +   TF GTP ++APEV++ + Y    
Sbjct: 127 VYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAV 186

Query: 226 DIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPE 285
           D W LG+   E+  G  P       R+  LI      +     + + K  +   L KDP+
Sbjct: 187 DWWGLGVVMYEMMCGRLPFYNQDHERLFELI-LMEEIRFPRTLSPEAKSLLAGLLKKDPK 245

Query: 286 NRP-----TAKELLKFPFIRKAKKNAYLIDLID-----RYKKWKNSRNEESETESETSDN 335
            R       AKE+++  F         +   +      +     ++R  + E  +++   
Sbjct: 246 QRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLLPPFKPQVTSEVDTRYFDDEFTAQSITI 305

Query: 336 EDSIKTD 342
               + D
Sbjct: 306 TPPDRYD 312

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  193 bits (491), Expect = 2e-57
 Identities = 72/303 (23%), Positives = 125/303 (41%), Gaps = 19/303 (6%)

Query: 59  FTKQERIGKGSFGEVFKGIDNRTQQV----VAIKIIDLEEAEDEIEDIQQEIMVLSQCDS 114
           F K + +G G+FG V+KG+     +     VAIK +    +    ++I  E  V++  D+
Sbjct: 11  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70

Query: 115 PYGTKL---------WIIMEYLGGGSALDLM--KAGNFEEMHIAVILREVLKGLDYLHSE 163
           P+  +L          +I + +  G  LD +     N    ++     ++ KG++YL   
Sbjct: 71  PHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 130

Query: 164 RKLHRDIKAANVLLSEMGDVKLADFGVAGTL--TNTTSKRNTFVGTPFWMAPEVIKQSAY 221
           R +HRD+ A NVL+     VK+ DFG+A  L                 WMA E I    Y
Sbjct: 131 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIY 190

Query: 222 DSKADIWSLGITAIEL-AKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACL 280
             ++D+WS G+T  EL   G  P   +    +  ++ K          T      +  C 
Sbjct: 191 THQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCW 250

Query: 281 NKDPENRPTAKELLK-FPFIRKAKKNAYLIDLIDRYKKWKNSRNEESETESETSDNEDSI 339
             D ++RP  +EL+  F  + +  +   +I   +R      + +       +  D +D +
Sbjct: 251 MIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVV 310

Query: 340 KTD 342
             D
Sbjct: 311 DAD 313

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  193 bits (491), Expect = 2e-57
 Identities = 65/261 (24%), Positives = 113/261 (43%), Gaps = 22/261 (8%)

Query: 59  FTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAED--EIEDIQQEIMVLSQCDSPY 116
           F     +G GSFG V         +  A+K++  E      ++E    E ++LS    P+
Sbjct: 6   FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPF 65

Query: 117 ----------GTKLWIIMEYLGGGSALDLMKAGN-FEEMHIAVILREVLKGLDYLHSERK 165
                       ++++IM+Y+ GG    L++    F          EV   L+YLHS+  
Sbjct: 66  IIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDI 125

Query: 166 LHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKA 225
           ++RD+K  N+LL + G +K+ DFG A           T  GTP ++APEV+    Y+   
Sbjct: 126 IYRDLKPENILLDKNGHIKITDFGFA---KYVPDVTYTLCGTPDYIAPEVVSTKPYNKSI 182

Query: 226 DIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPE 285
           D WS GI   E+  G  P  + + M+    I  N   +    + +  K+ +   + +D  
Sbjct: 183 DWWSFGILIYEMLAGYTPFYDSNTMKTYEKI-LNAELRFPPFFNEDVKDLLSRLITRDLS 241

Query: 286 NR-----PTAKELLKFPFIRK 301
            R        +++   P+ ++
Sbjct: 242 QRLGNLQNGTEDVKNHPWFKE 262

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  192 bits (489), Expect = 3e-57
 Identities = 53/284 (18%), Positives = 105/284 (36%), Gaps = 35/284 (12%)

Query: 59  FTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPY-- 116
           +    +IG GSFG+++ G D    + VAIK+  ++    ++     E  +          
Sbjct: 9   YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQL---HIESKIYKMMQGGVGI 65

Query: 117 ---------GTKLWIIMEYLGGGS-ALDLMKAGNFEEMHIAVILREVLKGLDYLHSERKL 166
                    G    ++ME LG     L    +  F    + ++  +++  ++Y+HS+  +
Sbjct: 66  PTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFI 125

Query: 167 HRDIKAANVLLSEMGD---VKLADFGVAGTLTNTTS-------KRNTFVGTPFWMAPEVI 216
           HRD+K  N L+        V + DFG+A    +  +       +     GT  + +    
Sbjct: 126 HRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTH 185

Query: 217 KQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNN-------PPQLTGNYT 269
                  + D+ SLG   +    G  P   L          + +          L   Y 
Sbjct: 186 LGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYP 245

Query: 270 KQFKEFVEACLNKDPENRPTA---KELLKFPFIRKAKKNAYLID 310
            +F  ++  C +   +++P     ++L +  F R+     Y+ D
Sbjct: 246 SEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFD 289

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  191 bits (486), Expect = 4e-57
 Identities = 63/263 (23%), Positives = 108/263 (41%), Gaps = 30/263 (11%)

Query: 59  FTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIE-----DIQQEIMVLSQCD 113
           +     +G G FG V+ GI       VAIK ++ +   D  E      +  E+++L +  
Sbjct: 6   YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 65

Query: 114 SPY------------GTKLWIIMEYLGGGSALD--LMKAGNFEEMHIAVILREVLKGLDY 159
           S +                 +I+E       L   + + G  +E        +VL+ + +
Sbjct: 66  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 125

Query: 160 LHSERKLHRDIKAANVLLS-EMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQ 218
            H+   LHRDIK  N+L+    G++KL DFG    L +T      F GT  +  PE I+ 
Sbjct: 126 CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT--VYTDFDGTRVYSPPEWIRY 183

Query: 219 SAYDSK-ADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVE 277
             Y  + A +WSLGI   ++  G+ P      +                  + + +  + 
Sbjct: 184 HRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI-------IRGQVFFRQRVSSECQHLIR 236

Query: 278 ACLNKDPENRPTAKELLKFPFIR 300
            CL   P +RPT +E+   P+++
Sbjct: 237 WCLALRPSDRPTFEEIQNHPWMQ 259

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  192 bits (488), Expect = 1e-56
 Identities = 69/291 (23%), Positives = 117/291 (40%), Gaps = 48/291 (16%)

Query: 59  FTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGT 118
           +T    IG+G++G V    DN  +  VAIK I   E +   +   +EI +L +       
Sbjct: 10  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 69

Query: 119 KL--------------WIIMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSER 164
            +                ++ +L G     L+K  +    HI   L ++L+GL Y+HS  
Sbjct: 70  GINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN 129

Query: 165 KLHRDIKAANVLLSEMGDVKLADFGVAGTLT---NTTSKRNTFVGTPFWMAPEVIKQSAY 221
            LHRD+K +N+LL+   D+K+ DFG+A       + T     +V T ++ APE++  S  
Sbjct: 130 VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 189

Query: 222 DS-KADIWSLGITAIELAKGEPPNSELHPMRVLFLI------------------------ 256
            +   DIWS+G    E+    P     H +  L  I                        
Sbjct: 190 YTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYL 249

Query: 257 ------PKNNPPQLTGNYTKQFKEFVEACLNKDPENRPTAKELLKFPFIRK 301
                  K    +L  N   +  + ++  L  +P  R   ++ L  P++ +
Sbjct: 250 LSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 300

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  190 bits (483), Expect = 1e-56
 Identities = 67/264 (25%), Positives = 112/264 (42%), Gaps = 21/264 (7%)

Query: 52  KVDPELIFTKQERIGKGSFGEVFKGI----DNRTQQVVAIKIIDLEEAEDEIEDIQQEIM 107
           ++ P    T+Q+ IG G FGEV+KG+      + +  VAIK +     E +  D   E  
Sbjct: 3   EIHPS-CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAG 61

Query: 108 VLSQCDSPY----------GTKLWIIMEYLGGGSALDLM--KAGNFEEMHIAVILREVLK 155
           ++ Q                  + II EY+  G+    +  K G F  + +  +LR +  
Sbjct: 62  IMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAA 121

Query: 156 GLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTF---VGTPFWMA 212
           G+ YL +   +HRD+ A N+L++     K++DFG++  L +      T         W A
Sbjct: 122 GMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTA 181

Query: 213 PEVIKQSAYDSKADIWSLGITAIE-LAKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQ 271
           PE I    + S +D+WS GI   E +  GE P  EL    V+  I          +    
Sbjct: 182 PEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSA 241

Query: 272 FKEFVEACLNKDPENRPTAKELLK 295
             + +  C  ++   RP   +++ 
Sbjct: 242 IYQLMMQCWQQERARRPKFADIVS 265

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  190 bits (483), Expect = 2e-56
 Identities = 65/281 (23%), Positives = 107/281 (38%), Gaps = 43/281 (15%)

Query: 63  ERIGKGSFGEVFKGIDNRTQQVVAIKIIDL----EEAEDEIEDIQQEIMVLSQCDSPY-- 116
           + +G+G F  V+K  D  T Q+VAIK I L    E  +       +EI +L +   P   
Sbjct: 4   DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63

Query: 117 --------GTKLWIIMEYLGGGSALDLMKAGN-FEEMHIAVILREVLKGLDYLHSERKLH 167
                    + + ++ +++     + +          HI   +   L+GL+YLH    LH
Sbjct: 64  GLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILH 123

Query: 168 RDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQ-SAYDSKAD 226
           RD+K  N+LL E G +KLADFG+A +  +        V T ++ APE++     Y    D
Sbjct: 124 RDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVD 183

Query: 227 IWSLGITAIELAKGEPPNSELHPMRVLFLI---------------------------PKN 259
           +W++G    EL    P       +  L  I                           P  
Sbjct: 184 MWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGI 243

Query: 260 NPPQLTGNYTKQFKEFVEACLNKDPENRPTAKELLKFPFIR 300
               +         + ++     +P  R TA + LK  +  
Sbjct: 244 PLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFS 284

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  189 bits (480), Expect = 5e-56
 Identities = 62/271 (22%), Positives = 127/271 (46%), Gaps = 19/271 (7%)

Query: 59  FTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPY-- 116
            T + ++G G +GEV++G+  +    VA+K +  +  E  +E+  +E  V+ +   P   
Sbjct: 19  ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME--VEEFLKEAAVMKEIKHPNLV 76

Query: 117 --------GTKLWIIMEYLGGGSALDLMKAGN---FEEMHIAVILREVLKGLDYLHSERK 165
                       +II E++  G+ LD ++  N      + +  +  ++   ++YL  +  
Sbjct: 77  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNF 136

Query: 166 LHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFV-GTPFWMAPEVIKQSAYDSK 224
           +HRD+ A N L+ E   VK+ADFG++  +T  T   +        W APE +  + +  K
Sbjct: 137 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIK 196

Query: 225 ADIWSLGITAIELA-KGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKD 283
           +D+W+ G+   E+A  G  P   +   +V  L+ K+   +      ++  E + AC   +
Sbjct: 197 SDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWN 256

Query: 284 PENRPTAKELLKFPFIRKAKKNAYLIDLIDR 314
           P +RP+  E+ +        + + + D +++
Sbjct: 257 PSDRPSFAEIHQ--AFETMFQESSISDEVEK 285

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  189 bits (480), Expect = 8e-56
 Identities = 63/289 (21%), Positives = 121/289 (41%), Gaps = 33/289 (11%)

Query: 59  FTKQERIGKGSFGEVFKGIDNRT--QQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDS-- 114
              Q+ IG+G+FG+V K    +   +   AIK +    ++D+  D   E+ VL +     
Sbjct: 12  IKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHP 71

Query: 115 ---------PYGTKLWIIMEYLGGGSALDLMK-----------------AGNFEEMHIAV 148
                     +   L++ +EY   G+ LD ++                 A       +  
Sbjct: 72  NIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLH 131

Query: 149 ILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTP 208
              +V +G+DYL  ++ +HRD+ A N+L+ E    K+ADFG++        K+       
Sbjct: 132 FAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLS-RGQEVYVKKTMGRLPV 190

Query: 209 FWMAPEVIKQSAYDSKADIWSLGITAIE-LAKGEPPNSELHPMRVLFLIPKNNPPQLTGN 267
            WMA E +  S Y + +D+WS G+   E ++ G  P   +    +   +P+    +   N
Sbjct: 191 RWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLN 250

Query: 268 YTKQFKEFVEACLNKDPENRPTAKELLK-FPFIRKAKKNAYLIDLIDRY 315
              +  + +  C  + P  RP+  ++L     + + +K      L +++
Sbjct: 251 CDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTYVNTTLYEKF 299

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  188 bits (479), Expect = 1e-55
 Identities = 57/261 (21%), Positives = 109/261 (41%), Gaps = 21/261 (8%)

Query: 56  ELIFTKQERIGKGSFGEVFKGID---NRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQC 112
            LI    E IG+G FG V+ G     +  +   A+K ++      E+     E +++   
Sbjct: 26  SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF 85

Query: 113 DSPY-----------GTKLWIIMEYLGGGSALDLM--KAGNFEEMHIAVILREVLKGLDY 159
             P                 +++ Y+  G   + +  +  N     +     +V KG+ +
Sbjct: 86  SHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKF 145

Query: 160 LHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTL----TNTTSKRNTFVGTPFWMAPEV 215
           L S++ +HRD+ A N +L E   VK+ADFG+A  +     ++   +        WMA E 
Sbjct: 146 LASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALES 205

Query: 216 IKQSAYDSKADIWSLGITAIE-LAKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKE 274
           ++   + +K+D+WS G+   E + +G PP  +++   +   + +               E
Sbjct: 206 LQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYE 265

Query: 275 FVEACLNKDPENRPTAKELLK 295
            +  C +   E RP+  EL+ 
Sbjct: 266 VMLKCWHPKAEMRPSFSELVS 286

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  188 bits (477), Expect = 1e-55
 Identities = 51/266 (19%), Positives = 98/266 (36%), Gaps = 28/266 (10%)

Query: 59  FTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPY-- 116
           +    RIG+GSFG +F+G +    Q VAIK         ++ D  +   +L+ C      
Sbjct: 7   YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNV 66

Query: 117 ------GTKLWIIMEYLGGGSALDLMKAGN-FEEMHIAVILREVLKGLDYLHSERKLHRD 169
                 G    ++++ LG      L   G  F    +A+  +++L  +  +H +  ++RD
Sbjct: 67  YYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRD 126

Query: 170 IKAANVLLSE-----MGDVKLADFGVAGTLTNTTSK-------RNTFVGTPFWMAPEVIK 217
           IK  N L+          + + DFG+     +  +K       +    GT  +M+     
Sbjct: 127 IKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHL 186

Query: 218 QSAYDSKADIWSLGITAIELAKGEPPNSELHPM-------RVLFLIPKNNPPQLTGNYTK 270
                 + D+ +LG   +   +G  P   L          R+          +L   + +
Sbjct: 187 GREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAGFPE 246

Query: 271 QFKEFVEACLNKDPENRPTAKELLKF 296
           +F +++    N   +  P    L   
Sbjct: 247 EFYKYMHYARNLAFDATPDYDYLQGL 272

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  189 bits (480), Expect = 3e-55
 Identities = 74/266 (27%), Positives = 130/266 (48%), Gaps = 26/266 (9%)

Query: 59  FTKQERIGKGSFGEVFKGIDNRTQQVVAIKIID-----LEEAEDEIEDIQQEIMVLSQCD 113
           F+    IG+G FGEV+      T ++ A+K +D     +++ E    + +  + ++S  D
Sbjct: 6   FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 65

Query: 114 SPY----------GTKLWIIMEYLGGGSALD-LMKAGNFEEMHIAVILREVLKGLDYLHS 162
            P+            KL  I++ + GG     L + G F E  +     E++ GL+++H+
Sbjct: 66  CPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHN 125

Query: 163 ERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVI-KQSAY 221
              ++RD+K AN+LL E G V+++D G+A   +    K +  VGT  +MAPEV+ K  AY
Sbjct: 126 RFVVYRDLKPANILLDEHGHVRISDLGLACDFSK--KKPHASVGTHGYMAPEVLQKGVAY 183

Query: 222 DSKADIWSLGITAIELAKGEPPNSELHP--MRVLFLIPKNNPPQLTGNYTKQFKEFVEAC 279
           DS AD +SLG    +L +G  P  +        +  +      +L  +++ + +  +E  
Sbjct: 184 DSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGL 243

Query: 280 LNKDPENRPT-----AKELLKFPFIR 300
           L +D   R       A+E+ + PF R
Sbjct: 244 LQRDVNRRLGCLGRGAQEVKESPFFR 269

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  185 bits (471), Expect = 2e-54
 Identities = 59/282 (20%), Positives = 109/282 (38%), Gaps = 44/282 (15%)

Query: 59  FTKQERIGKGSFGEVFKGIDNRTQQ-----VVAIKIIDLEEAEDEIEDIQQEIMVLSQCD 113
               + +G G+FG+V         +      VA+K++  +    E E +  E+ +++Q  
Sbjct: 39  LEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLG 98

Query: 114 S-PY----------GTKLWIIMEYLGGGSALDLMKA------------------------ 138
           S                +++I EY   G  L+ +++                        
Sbjct: 99  SHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDL 158

Query: 139 GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLT--N 196
                  +     +V KG+++L  +  +HRD+ A NVL++    VK+ DFG+A  +   +
Sbjct: 159 NVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDS 218

Query: 197 TTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIE-LAKGEPPNSELHPMRVLFL 255
               R        WMAPE + +  Y  K+D+WS GI   E  + G  P   +      + 
Sbjct: 219 NYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYK 278

Query: 256 IPKNN-PPQLTGNYTKQFKEFVEACLNKDPENRPTAKELLKF 296
           + +N          T++    +++C   D   RP+   L  F
Sbjct: 279 LIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  183 bits (464), Expect = 8e-54
 Identities = 68/284 (23%), Positives = 113/284 (39%), Gaps = 42/284 (14%)

Query: 59  FTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLE-EAEDEIEDIQQEIMVLSQCDSPY- 116
           +   E+IG+G++G V+K  +    +  A+K I LE E E       +EI +L +      
Sbjct: 4   YHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNI 62

Query: 117 ---------GTKLWIIMEYLGGGSALDLMKA-GNFEEMHIAVILREVLKGLDYLHSERKL 166
                      +L ++ E+L       L    G  E +     L ++L G+ Y H  R L
Sbjct: 63  VKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVL 122

Query: 167 HRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQS-AYDSKA 225
           HRD+K  N+L++  G++K+ADFG+A        K    + T ++ AP+V+  S  Y +  
Sbjct: 123 HRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTI 182

Query: 226 DIWSLGITAIELAKGEPPNSELHPMRVLFLI----------------------------P 257
           DIWS+G    E+  G P    +     L  I                             
Sbjct: 183 DIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYE 242

Query: 258 KNNPPQLTGNYTKQFKEFVEACLNKDPENRPTAKELLKFPFIRK 301
                       +   + +   L  DP  R TAK+ L+  + ++
Sbjct: 243 PLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  183 bits (464), Expect = 1e-53
 Identities = 77/288 (26%), Positives = 121/288 (42%), Gaps = 42/288 (14%)

Query: 59  FTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLE-EAEDEIEDIQQEIMVLSQCDSPY- 116
           F K E+IG+G++G V+K  +  T +VVA+K I L+ E E       +EI +L + + P  
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63

Query: 117 ---------GTKLWIIMEYLGGGSA--LDLMKAGNFEEMHIAVILREVLKGLDYLHSERK 165
                      KL+++ E+L       +D           I   L ++L+GL + HS R 
Sbjct: 64  VKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV 123

Query: 166 LHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDS-K 224
           LHRD+K  N+L++  G +KLADFG+A             V T ++ APE++    Y S  
Sbjct: 124 LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTA 183

Query: 225 ADIWSLGITAIELAKGEPPNSELHPMRVLFLI---------------------------- 256
            DIWSLG    E+            +  LF I                            
Sbjct: 184 VDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKW 243

Query: 257 PKNNPPQLTGNYTKQFKEFVEACLNKDPENRPTAKELLKFPFIRKAKK 304
            + +  ++     +  +  +   L+ DP  R +AK  L  PF +   K
Sbjct: 244 ARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 291

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  181 bits (460), Expect = 4e-53
 Identities = 71/298 (23%), Positives = 132/298 (44%), Gaps = 52/298 (17%)

Query: 59  FTKQERIGKGSFGEVFKGIDNRT-QQVVAIKIIDLEEAEDEIE-DIQQEIMVLSQCDS-- 114
           +     IG+G++G+VFK  D +   + VA+K + ++  E+ +     +E+ VL   ++  
Sbjct: 9   YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFE 68

Query: 115 ----------------PYGTKLWIIMEYLGGG--SALDLMKAGNFEEMHIAVILREVLKG 156
                              TKL ++ E++     + LD +         I  ++ ++L+G
Sbjct: 69  HPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRG 128

Query: 157 LDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVI 216
           LD+LHS R +HRD+K  N+L++  G +KLADFG+A  + +      + V T ++ APEV+
Sbjct: 129 LDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLA-RIYSFQMALTSVVVTLWYRAPEVL 187

Query: 217 KQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLI-------------------- 256
            QS+Y +  D+WS+G    E+ + +P       +  L  I                    
Sbjct: 188 LQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPR 247

Query: 257 ------PKNNPPQLTGNYTKQFKEFVEACLNKDPENRPTAKELLKFPF---IRKAKKN 305
                       +   +  +  K+ +  CL  +P  R +A   L  P+   + + K+N
Sbjct: 248 QAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLERCKEN 305

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  180 bits (458), Expect = 9e-53
 Identities = 59/275 (21%), Positives = 115/275 (41%), Gaps = 38/275 (13%)

Query: 59  FTKQERIGKGSFGEVFKGIDNRTQQ-------VVAIKIIDLEEAEDEIEDIQQEIMVLSQ 111
               + +G+G+FG+V         +        VA+K++  +  E ++ D+  E+ ++  
Sbjct: 15  LVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKM 74

Query: 112 CDSPY-----------GTKLWIIMEYLGGGSALDLMK-----------------AGNFEE 143
                              L++I+EY   G+  + ++                       
Sbjct: 75  IGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSS 134

Query: 144 MHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNT 203
             +     +V +G++YL S++ +HRD+ A NVL++E   +K+ADFG+A  + +    + T
Sbjct: 135 KDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 194

Query: 204 FV--GTPFWMAPEVIKQSAYDSKADIWSLGITAIE-LAKGEPPNSELHPMRVLFLIPKNN 260
                   WMAPE +    Y  ++D+WS G+   E    G  P   +    +  L+ + +
Sbjct: 195 TNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGH 254

Query: 261 PPQLTGNYTKQFKEFVEACLNKDPENRPTAKELLK 295
                 N T +    +  C +  P  RPT K+L++
Sbjct: 255 RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 289

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  180 bits (458), Expect = 1e-52
 Identities = 60/266 (22%), Positives = 113/266 (42%), Gaps = 29/266 (10%)

Query: 59  FTKQERIGKGSFGEVFKGID-----NRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCD 113
            T    +G+GSFG V++G+      +  +  VAIK ++   +  E  +   E  V+ + +
Sbjct: 22  ITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFN 81

Query: 114 SPY----------GTKLWIIMEYLGGGSALDLMK-----------AGNFEEMHIAVILRE 152
             +          G    +IME +  G     ++                   +  +  E
Sbjct: 82  CHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGE 141

Query: 153 VLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTL--TNTTSKRNTFVGTPFW 210
           +  G+ YL++ + +HRD+ A N +++E   VK+ DFG+   +  T+   K    +    W
Sbjct: 142 IADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRW 201

Query: 211 MAPEVIKQSAYDSKADIWSLGITAIELA-KGEPPNSELHPMRVLFLIPKNNPPQLTGNYT 269
           M+PE +K   + + +D+WS G+   E+A   E P   L   +VL  + +        N  
Sbjct: 202 MSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPDNCP 261

Query: 270 KQFKEFVEACLNKDPENRPTAKELLK 295
               E +  C   +P+ RP+  E++ 
Sbjct: 262 DMLFELMRMCWQYNPKMRPSFLEIIS 287

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  180 bits (456), Expect = 6e-52
 Identities = 68/303 (22%), Positives = 123/303 (40%), Gaps = 27/303 (8%)

Query: 59  FTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAED--EIEDIQQEIMVLSQCDSPY 116
           F + + +G GSFG V       +    A+KI+D ++     +IE    E  +L   + P+
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102

Query: 117 GTKL-----------WIIMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERK 165
             KL            ++    GG     L + G F E H      +++   +YLHS   
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDL 162

Query: 166 LHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKA 225
           ++RD+K  N+L+ + G +++ DFG A        +  T  GTP  +APE+I    Y+   
Sbjct: 163 IYRDLKPENLLIDQQGYIQVTDFGFA---KRVKGRTWTLCGTPEALAPEIILSKGYNKAV 219

Query: 226 DIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPE 285
           D W+LG+   E+A G PP     P+++   I          +++   K+ +   L  D  
Sbjct: 220 DWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR-FPSHFSSDLKDLLRNLLQVDLT 278

Query: 286 NR-----PTAKELLKFPFIRKAKKNAYLIDLID-----RYKKWKNSRNEESETESETSDN 335
            R         ++    +       A     ++     ++K   ++ N +   E E   +
Sbjct: 279 KRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTSNFDDYEEEEIRVS 338

Query: 336 EDS 338
            + 
Sbjct: 339 INE 341

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  176 bits (446), Expect = 6e-51
 Identities = 69/299 (23%), Positives = 119/299 (39%), Gaps = 56/299 (18%)

Query: 59  FTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLE-EAEDEIEDIQQEIMVLSQCDSP-- 115
           + K  +IG+G+FGEVFK    +T Q VA+K + +E E E       +EI +L        
Sbjct: 12  YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENV 71

Query: 116 ----------------YGTKLWIIMEYLGGGSA-LDLMKAGNFEEMHIAVILREVLKGLD 158
                               ++++ ++     A L       F    I  +++ +L GL 
Sbjct: 72  VNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLY 131

Query: 159 YLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTL----TNTTSKRNTFVGTPFWMAPE 214
           Y+H  + LHRD+KAANVL++  G +KLADFG+A        +  ++    V T ++  PE
Sbjct: 132 YIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPE 191

Query: 215 VI-KQSAYDSKADIWSLGITAIELAKGEPP---NSELHPMRVLFLIPKNNPPQLTGNYTK 270
           ++  +  Y    D+W  G    E+    P    N+E H + ++  +  +  P++  N   
Sbjct: 192 LLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDN 251

Query: 271 ----------------------------QFKEFVEACLNKDPENRPTAKELLKFPFIRK 301
                                          + ++  L  DP  R  + + L   F   
Sbjct: 252 YELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWS 310

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  175 bits (445), Expect = 2e-50
 Identities = 73/321 (22%), Positives = 129/321 (40%), Gaps = 56/321 (17%)

Query: 59  FTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLE-EAEDEIEDIQQEIMVLSQCDSPY- 116
           +   + +G G++G V   +D RT   VAIK +    ++E   +   +E+ +L        
Sbjct: 20  YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENV 79

Query: 117 ---------------GTKLWIIMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLH 161
                           T  +++M ++G      LMK     E  I  ++ ++LKGL Y+H
Sbjct: 80  IGLLDVFTPDETLDDFTDFYLVMPFMGTDL-GKLMKHEKLGEDRIQFLVYQMLKGLRYIH 138

Query: 162 SERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVI-KQSA 220
           +   +HRD+K  N+ ++E  ++K+ DFG+A       S+   +V T ++ APEVI     
Sbjct: 139 AAGIIHRDLKPGNLAVNEDCELKILDFGLA---RQADSEMTGYVVTRWYRAPEVILNWMR 195

Query: 221 YDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLI------------------------ 256
           Y    DIWS+G    E+  G+        +  L  I                        
Sbjct: 196 YTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYM 255

Query: 257 ------PKNNPPQLTGNYTKQFKEFVEACLNKDPENRPTAKELLKFPFIRKAKKNAYLID 310
                  K +   +  N +      +E  L  D E R TA E L  P+     ++ +  +
Sbjct: 256 KGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYF----ESLHDTE 311

Query: 311 LIDRYKKWKNSRNEESETESE 331
              + +K+ +S ++   T  E
Sbjct: 312 DEPQVQKYDDSFDDVDRTLDE 332

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  174 bits (441), Expect = 4e-50
 Identities = 62/277 (22%), Positives = 111/277 (40%), Gaps = 39/277 (14%)

Query: 59  FTKQERIGKGSFGEVFKG-----IDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCD 113
            +  + +G G+FG+V +      I +     VA+K++       E E +  E+ VLS   
Sbjct: 25  LSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLG 84

Query: 114 SP-----------YGTKLWIIMEYLGGGSALDLMK-------------------AGNFEE 143
           +             G    +I EY   G  L+ ++                       + 
Sbjct: 85  NHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDL 144

Query: 144 MHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNT 203
             +     +V KG+ +L S+  +HRD+ A N+LL+     K+ DFG+A  + N ++    
Sbjct: 145 EDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVK 204

Query: 204 --FVGTPFWMAPEVIKQSAYDSKADIWSLGITAIE-LAKGEPPNSELHPMRVLFLIPKNN 260
                   WMAPE I    Y  ++D+WS GI   E  + G  P   +      + + K  
Sbjct: 205 GNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEG 264

Query: 261 -PPQLTGNYTKQFKEFVEACLNKDPENRPTAKELLKF 296
                  +   +  + ++ C + DP  RPT K++++ 
Sbjct: 265 FRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL 301

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  171 bits (434), Expect = 2e-49
 Identities = 62/287 (21%), Positives = 103/287 (35%), Gaps = 57/287 (19%)

Query: 62  QERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSP------ 115
           QE IGKG FGEV++G      + VA+KI    E        + EI               
Sbjct: 8   QESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFR--EAEIYQTVMLRHENILGFI 63

Query: 116 --------YGTKLWIIMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERK-- 165
                     T+LW++ +Y   GS  D +         +  +      GL +LH E    
Sbjct: 64  AADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGT 123

Query: 166 ------LHRDIKAANVLLSEMGDVKLADFGV----AGTLTNTTSKRNTFVGTPFWMAPEV 215
                  HRD+K+ N+L+ + G   +AD G+               N  VGT  +MAPEV
Sbjct: 124 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEV 183

Query: 216 I------KQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLF--------------- 254
           +      K      +ADI+++G+   E+A+           ++ +               
Sbjct: 184 LDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRK 243

Query: 255 -LIPKNNPPQLTGNYT-----KQFKEFVEACLNKDPENRPTAKELLK 295
            +  +   P +   +      +   + +  C   +   R TA  + K
Sbjct: 244 VVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 290

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  172 bits (437), Expect = 3e-49
 Identities = 59/325 (18%), Positives = 109/325 (33%), Gaps = 54/325 (16%)

Query: 56  ELIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSP 115
           E+ +T  + IG GSFG V++     + ++VAIK +  ++         +E+ ++ + D  
Sbjct: 19  EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-----RFKNRELQIMRKLDHC 73

Query: 116 Y----------------GTKLWIIMEYLGGGSALDLM----KAGNFEEMHIAVILREVLK 155
                               L ++++Y+                    +++ + + ++ +
Sbjct: 74  NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 133

Query: 156 GLDYLHSERKLHRDIKAANVLL-SEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPE 214
            L Y+HS    HRDIK  N+LL  +   +KL DFG A  L       +      +     
Sbjct: 134 SLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPEL 193

Query: 215 VIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLI-------PKNNPPQLTGN 267
           +   + Y S  D+WS G    EL  G+P       +  L  I        +    ++  N
Sbjct: 194 IFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPN 253

Query: 268 YTK---------------------QFKEFVEACLNKDPENRPTAKELLKFPFIRKAKKNA 306
           YT+                     +        L   P  R T  E     F  + +   
Sbjct: 254 YTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPN 313

Query: 307 YLIDLIDRYKKWKNSRNEESETESE 331
             +          N   +E  +   
Sbjct: 314 VKLPNGRDTPALFNFTTQELSSNPP 338

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  170 bits (430), Expect = 7e-49
 Identities = 59/275 (21%), Positives = 109/275 (39%), Gaps = 38/275 (13%)

Query: 59  FTKQERIGKGSFGEVFKGID-----NRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCD 113
               + +G+G+FG+V +          T + VA+K++       E   +  E+ +L    
Sbjct: 15  LKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIG 74

Query: 114 SPY------------GTKLWIIMEYLGGGSALDLMKA-----------------GNFEEM 144
                          G  L +I+E+   G+    +++                       
Sbjct: 75  HHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLE 134

Query: 145 HIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTN--TTSKRN 202
           H+     +V KG+++L S + +HRD+ A N+LLSE   VK+ DFG+A  +       ++ 
Sbjct: 135 HLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG 194

Query: 203 TFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKG-EPPNSELHPMRVLF-LIPKNN 260
                  WMAPE I    Y  ++D+WS G+   E+      P   +         + +  
Sbjct: 195 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGT 254

Query: 261 PPQLTGNYTKQFKEFVEACLNKDPENRPTAKELLK 295
             +     T +  + +  C + +P  RPT  EL++
Sbjct: 255 RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVE 289

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  169 bits (429), Expect = 8e-49
 Identities = 65/285 (22%), Positives = 119/285 (41%), Gaps = 42/285 (14%)

Query: 59  FTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA-EDEIEDIQQEIMVLSQCDSPY- 116
           + K E+IG+G++G VFK  +  T ++VA+K + L++  E       +EI +L +      
Sbjct: 4   YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNI 63

Query: 117 ---------GTKLWIIMEYLGGGSALDLMKA-GNFEEMHIAVILREVLKGLDYLHSERKL 166
                      KL ++ E+             G+ +   +   L ++LKGL + HS   L
Sbjct: 64  VRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVL 123

Query: 167 HRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVI-KQSAYDSKA 225
           HRD+K  N+L++  G++KLA+FG+A          +  V T ++  P+V+     Y +  
Sbjct: 124 HRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSI 183

Query: 226 DIWSLGITAIELAKGEPP----NSELHPMRVLFLI------------------------- 256
           D+WS G    ELA    P    N     ++ +F +                         
Sbjct: 184 DMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYP 243

Query: 257 PKNNPPQLTGNYTKQFKEFVEACLNKDPENRPTAKELLKFPFIRK 301
              +   +        ++ ++  L  +P  R +A+E L+ P+   
Sbjct: 244 ATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSD 288

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  170 bits (431), Expect = 2e-48
 Identities = 61/290 (21%), Positives = 115/290 (39%), Gaps = 50/290 (17%)

Query: 59  FTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLE-EAEDEIEDIQQEIMVLSQCDSPYG 117
           +     +G G++G V    D +T   VA+K +    ++    +   +E+ +L        
Sbjct: 20  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 79

Query: 118 TKL---------------WIIMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHS 162
             L                 ++ +L G    +++K     + H+  ++ ++L+GL Y+HS
Sbjct: 80  IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 139

Query: 163 ERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVI-KQSAY 221
              +HRD+K +N+ ++E  ++K+ DFG+A    +T  +   +V T ++ APE++     Y
Sbjct: 140 ADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDEMTGYVATRWYRAPEIMLNWMHY 196

Query: 222 DSKADIWSLGITAIELAKGEPPNSELHPMRVLFLI------------------------- 256
           +   DIWS+G    EL  G         +  L LI                         
Sbjct: 197 NQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ 256

Query: 257 -----PKNNPPQLTGNYTKQFKEFVEACLNKDPENRPTAKELLKFPFIRK 301
                PK N   +         + +E  L  D + R TA + L   +  +
Sbjct: 257 SLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 306

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  165 bits (417), Expect = 1e-46
 Identities = 57/299 (19%), Positives = 115/299 (38%), Gaps = 59/299 (19%)

Query: 59  FTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQ------- 111
           +    ++G+G + EVF+ I+    + V +KI+       + + I++EI +L         
Sbjct: 37  YQLVRKLGRGKYSEVFEAINITNNEKVVVKILK----PVKKKKIKREIKILENLRGGPNI 92

Query: 112 ------CDSPYGTKLWIIMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERK 165
                    P      ++ E++       L +     +  I   + E+LK LDY HS   
Sbjct: 93  ITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ--TLTDYDIRFYMYEILKALDYCHSMGI 150

Query: 166 LHRDIKAANVLL-SEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEV-IKQSAYDS 223
           +HRD+K  NV++  E   ++L D+G+A    +   + N  V + ++  PE+ +    YD 
Sbjct: 151 MHRDVKPHNVMIDHEHRKLRLIDWGLA-EFYHPGQEYNVRVASRYFKGPELLVDYQMYDY 209

Query: 224 KADIWSLGITAIELAKGEPP-------------------------------------NSE 246
             D+WSLG     +   + P                                      ++
Sbjct: 210 SLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFND 269

Query: 247 LHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPENRPTAKELLKFPFIRKAKKN 305
           +          +    +     + +  +F++  L  D ++R TA+E ++ P+     K+
Sbjct: 270 ILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVKD 328

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  163 bits (414), Expect = 3e-46
 Identities = 72/288 (25%), Positives = 124/288 (43%), Gaps = 33/288 (11%)

Query: 47  RRNSLKVDPELI----FTKQERIGKGSFGEVFKGID---NRTQQVVAIKIID---LEEAE 96
           R  +L    E +    F   + +G G++G+VF       + T ++ A+K++    + +  
Sbjct: 10  RTANLTGHAEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKA 69

Query: 97  DEIEDIQQEIMVLSQCDSP-----------YGTKLWIIMEYLGGGSALDLMKAGN-FEEM 144
              E  + E  VL                   TKL +I++Y+ GG     +     F E 
Sbjct: 70  KTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEH 129

Query: 145 HIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLT-NTTSKRNT 203
            + + + E++  L++LH    ++RDIK  N+LL   G V L DFG++     + T +   
Sbjct: 130 EVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYD 189

Query: 204 FVGTPFWMAPEVI--KQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPK--- 258
           F GT  +MAP+++    S +D   D WSLG+   EL  G  P +          I +   
Sbjct: 190 FCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRIL 249

Query: 259 NNPPQLTGNYTKQFKEFVEACLNKDPENRP-----TAKELLKFPFIRK 301
            + P      +   K+ ++  L KDP+ R       A E+ +  F +K
Sbjct: 250 KSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK 297

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  162 bits (409), Expect = 3e-45
 Identities = 60/329 (18%), Positives = 117/329 (35%), Gaps = 61/329 (18%)

Query: 59  FTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA-EDEIEDIQQEIMVLSQCDSPY- 116
           +   + IG G+ G V    D    + VAIK +      +   +   +E++++   +    
Sbjct: 19  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 78

Query: 117 ---------------GTKLWIIMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLH 161
                             ++++ME +       +      +   ++ +L ++L G+ +LH
Sbjct: 79  ISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQM--ELDHERMSYLLYQMLCGIKHLH 136

Query: 162 SERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAY 221
           S   +HRD+K +N+++     +K+ DFG+A T   T+     +V T ++ APEVI    Y
Sbjct: 137 SAGIIHRDLKPSNIVVKSDCTLKILDFGLART-AGTSFMMTPYVVTRYYRAPEVILGMGY 195

Query: 222 DSKADIWSLGITAIELAKGEPPNSELHPMRVLFLI------------------------- 256
               DIWS+G    E+ + +        +     +                         
Sbjct: 196 KENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVEN 255

Query: 257 ---------PKNNPPQLT-------GNYTKQFKEFVEACLNKDPENRPTAKELLKFPFIR 300
                    PK  P  L             Q ++ +   L  DP  R +  + L+ P+I 
Sbjct: 256 RPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYIN 315

Query: 301 KAKKNAYLIDLIDRYKKWKNSRNEESETE 329
                A +     +    +    E +  E
Sbjct: 316 VWYDPAEVEAPPPQIYDKQLDEREHTIEE 344

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  129 bits (325), Expect = 1e-33
 Identities = 61/321 (19%), Positives = 113/321 (35%), Gaps = 82/321 (25%)

Query: 59  FTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDL-----EEAEDEIEDIQQ--------- 104
           +    ++G G F  V+   D      VA+KI+       E AEDEI+ +Q+         
Sbjct: 15  YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKE 74

Query: 105 -------EIMVLSQCDSPYGTKLWIIMEYLGGG----SALDLMKAGNFEEMHIAVILREV 153
                   + +L   +      + ++M +   G    + +   +      +++  I +++
Sbjct: 75  DSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQL 134

Query: 154 LKGLDYLHSERKL-HRDIKAANVLLSEMG------DVKLADFGVAGTLTNTTSKRNTFVG 206
           L GLDY+H    + H DIK  NVL+  +        +K+AD G A             + 
Sbjct: 135 LLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEH---YTNSIQ 191

Query: 207 TPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPP-------------NSELHPMRVL 253
           T  + +PEV+  + +   ADIWS      EL  G+               +     + +L
Sbjct: 192 TREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELL 251

Query: 254 FLIPK----------------------------------NNPPQLTGNYTKQFKEFVEAC 279
             +P                                       + + +  K+  +F+   
Sbjct: 252 GELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPM 311

Query: 280 LNKDPENRPTAKELLKFPFIR 300
           L  DP  R  A  L+  P+++
Sbjct: 312 LQLDPRKRADAGGLVNHPWLK 332

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 90.6 bits (224), Expect = 1e-21
 Identities = 28/200 (14%), Positives = 59/200 (29%), Gaps = 40/200 (20%)

Query: 63  ERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDE-----------------IEDIQQE 105
           + +G+G    VF            +K   +     +                 I   + E
Sbjct: 6   KLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNE 64

Query: 106 IMVLSQCDSPYGTKL------WIIMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDY 159
              L +       K+       ++ME +         +       +   +L  +L+ +  
Sbjct: 65  FRALQKLQGLAVPKVYAWEGNAVLMELIDAK------ELYRVRVENPDEVLDMILEEVAK 118

Query: 160 LHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQS 219
            +    +H D+   NVL+SE G + + DF  +  +     +               I   
Sbjct: 119 FYHRGIVHGDLSQYNVLVSEEG-IWIIDFPQSVEVGEEGWREI------LERDVRNIITY 171

Query: 220 ---AYDSKADIWSLGITAIE 236
               Y ++ DI S     ++
Sbjct: 172 FSRTYRTEKDINSAIDRILQ 191

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	604
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.91
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	97.93
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.75
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	97.35
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	96.96
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	96.58
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	96.22

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.9e-57  Score=463.09  Aligned_cols=258  Identities=43%  Similarity=0.753  Sum_probs=226.9

Q ss_pred             ccccceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCCeE----------EEEE
Q psy1546          55 PELIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTKL----------WIIM  124 (604)
Q Consensus        55 ~~~~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~~l----------yLVm  124 (604)
                      +...|++.++||+|+||+||+|.+..+|+.||||++...... ..+.+.+|+.+|+.++|||++++          ||||
T Consensus        18 p~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~-~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm   96 (293)
T d1yhwa1          18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP-KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM   96 (293)
T ss_dssp             TTTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCS-CHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             cccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccCh-HHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEE
Confidence            345699999999999999999999999999999999765433 24678999999999999997654          7999


Q ss_pred             EecCCCChhhHhhcCCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCCCCccc
Q psy1546         125 EYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTF  204 (604)
Q Consensus       125 Ey~~ggsL~~~l~~~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~~~~~  204 (604)
                      |||+||+|.+++..+.+++..++.|+.||+.||.|||++|||||||||+||||+.+|.+||+|||+|+.+..........
T Consensus        97 Ey~~gg~L~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~  176 (293)
T d1yhwa1          97 EYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM  176 (293)
T ss_dssp             ECCTTCBHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCBCCC
T ss_pred             EecCCCcHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeecccccccccc
Confidence            99999999999998999999999999999999999999999999999999999999999999999998876655566678


Q ss_pred             ccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCCC--CCCCCccchHHHHHHHHHHhcc
Q psy1546         205 VGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNN--PPQLTGNYTKQFKEFVEACLNK  282 (604)
Q Consensus       205 ~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~~--~~~~~~~~s~~l~~Li~~~L~~  282 (604)
                      +||+.|||||++.+..|+.++|||||||+||+|++|.+||.+.+.......+....  ....+..+++++++||.+||..
T Consensus       177 ~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~  256 (293)
T d1yhwa1         177 VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDM  256 (293)
T ss_dssp             CSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSSGGGSCHHHHHHHHHHTCS
T ss_pred             ccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCcccCCHHHHHHHHHHccC
Confidence            89999999999999999999999999999999999999999888776665543332  2344577899999999999999


Q ss_pred             CCCCCCCHHHHhcChhhhhhhhhhhHHHHHH
Q psy1546         283 DPENRPTAKELLKFPFIRKAKKNAYLIDLID  313 (604)
Q Consensus       283 dP~~RpT~~elL~hp~f~~~~~~~~l~~~~~  313 (604)
                      ||.+|||+.|+|+||||+.......+..++.
T Consensus       257 dP~~R~s~~eil~Hp~~~~~~~~~~l~p~~~  287 (293)
T d1yhwa1         257 DVEKRGSAKELLQHQFLKIAKPLSSLTPLIA  287 (293)
T ss_dssp             STTTSCCHHHHTTCGGGGGCCCGGGGHHHHH
T ss_pred             ChhHCcCHHHHhcCHhhCCCCCCCcCCCCCc
Confidence            9999999999999999987665555554443

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-55  Score=446.86  Aligned_cols=240  Identities=29%  Similarity=0.530  Sum_probs=215.7

Q ss_pred             ceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhH--HHHHHHHHHHHHHhhCCCCCCCeE----------EEEEEe
Q psy1546          59 FTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAE--DEIEDIQQEIMVLSQCDSPYGTKL----------WIIMEY  126 (604)
Q Consensus        59 y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~--~~~~~l~~Ei~iL~~l~hp~~~~l----------yLVmEy  126 (604)
                      |++++.||+|+||+||+|+++.+++.||||++.+....  ...+.+.+|+.+|+.++|||++++          ||||||
T Consensus         8 y~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivmEy   87 (263)
T d2j4za1           8 FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEY   87 (263)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             eEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEEee
Confidence            99999999999999999999999999999999765432  234678899999999999997664          799999


Q ss_pred             cCCCChhhHhhc-CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCCCCcccc
Q psy1546         127 LGGGSALDLMKA-GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFV  205 (604)
Q Consensus       127 ~~ggsL~~~l~~-~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~~~~~~  205 (604)
                      |++|+|.+++.. +.+++..++.|+.||+.||+|||++|||||||||+||||+.+|.+||+|||+|+.....  .....+
T Consensus        88 ~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~--~~~~~~  165 (263)
T d2j4za1          88 APLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS--RRTTLC  165 (263)
T ss_dssp             CTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC--CCEETT
T ss_pred             cCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeecCCC--cccccC
Confidence            999999998865 78999999999999999999999999999999999999999999999999999766432  344678


Q ss_pred             cCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCCCCCCCCccchHHHHHHHHHHhccCCC
Q psy1546         206 GTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPE  285 (604)
Q Consensus       206 GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~~L~~dP~  285 (604)
                      ||+.|||||++.+..|+.++|||||||+||||++|+.||.+.+..+....+.... ..++..+++++++||.+||..||.
T Consensus       166 Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~~~L~~dp~  244 (263)
T d2j4za1         166 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVE-FTFPDFVTEGARDLISRLLKHNPS  244 (263)
T ss_dssp             EEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTC-CCCCTTSCHHHHHHHHHHTCSSGG
T ss_pred             CCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCC-CCCCccCCHHHHHHHHHHccCCHh
Confidence            9999999999999999999999999999999999999999988887777665544 346678899999999999999999


Q ss_pred             CCCCHHHHhcChhhhh
Q psy1546         286 NRPTAKELLKFPFIRK  301 (604)
Q Consensus       286 ~RpT~~elL~hp~f~~  301 (604)
                      +|||++|||+||||..
T Consensus       245 ~R~t~~eil~hp~~~~  260 (263)
T d2j4za1         245 QRPMLREVLEHPWITA  260 (263)
T ss_dssp             GSCCHHHHHTCHHHHH
T ss_pred             HCcCHHHHHcCcCcCC
Confidence            9999999999999975

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-55  Score=449.84  Aligned_cols=242  Identities=30%  Similarity=0.503  Sum_probs=208.6

Q ss_pred             cceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhh-HHHHHHHHHHHHHHhhCCCCCCCe------------EEEEE
Q psy1546          58 IFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA-EDEIEDIQQEIMVLSQCDSPYGTK------------LWIIM  124 (604)
Q Consensus        58 ~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~-~~~~~~l~~Ei~iL~~l~hp~~~~------------lyLVm  124 (604)
                      .|++.+.||+|+||+||+|+++.+|+.||||++..... +...+.+.+|+.+|++++|||+++            +||||
T Consensus         5 dy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ivm   84 (269)
T d2java1           5 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVM   84 (269)
T ss_dssp             GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEEE
T ss_pred             hCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEEE
Confidence            49999999999999999999999999999999976543 445677899999999999999654            47999


Q ss_pred             EecCCCChhhHhhc-----CCCcHHHHHHHHHHHHHHhHHhhhCC-----ccccccccceeEecCCCCeEEecccccccc
Q psy1546         125 EYLGGGSALDLMKA-----GNFEEMHIAVILREVLKGLDYLHSER-----KLHRDIKAANVLLSEMGDVKLADFGVAGTL  194 (604)
Q Consensus       125 Ey~~ggsL~~~l~~-----~~lse~~i~~i~~qIl~gL~yLHs~g-----IiHrDLKp~NILl~~~g~vKL~DFGlA~~~  194 (604)
                      |||++|+|.+++..     +.+++..++.++.||+.||.|||++|     ||||||||+||||+.++.+||+|||+|+.+
T Consensus        85 Ey~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~~  164 (269)
T d2java1          85 EYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL  164 (269)
T ss_dssp             ECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHHC
T ss_pred             ecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceeec
Confidence            99999999998853     56999999999999999999999976     999999999999999999999999999887


Q ss_pred             cCCCCCCcccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCCCCCCCCccchHHHHH
Q psy1546         195 TNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKE  274 (604)
Q Consensus       195 ~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~  274 (604)
                      ..........+||+.|||||++.+..|+.++|||||||+||||++|..||.+.+..++...+.......++..+++++.+
T Consensus       165 ~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~  244 (269)
T d2java1         165 NHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSDELNE  244 (269)
T ss_dssp             -----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCCTTSCHHHHH
T ss_pred             ccCCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHH
Confidence            65555556789999999999999999999999999999999999999999999888888877777777788889999999


Q ss_pred             HHHHHhccCCCCCCCHHHHhcChhh
Q psy1546         275 FVEACLNKDPENRPTAKELLKFPFI  299 (604)
Q Consensus       275 Li~~~L~~dP~~RpT~~elL~hp~f  299 (604)
                      ||.+||..||.+|||+.|||+|||+
T Consensus       245 li~~~L~~dp~~Rps~~ell~hp~i  269 (269)
T d2java1         245 IITRMLNLKDYHRPSVEEILENPLI  269 (269)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred             HHHHHcCCChhHCcCHHHHHhCCcC
Confidence            9999999999999999999999995

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-55  Score=450.25  Aligned_cols=245  Identities=26%  Similarity=0.425  Sum_probs=207.3

Q ss_pred             cceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCCeE----------EEEEEec
Q psy1546          58 IFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTKL----------WIIMEYL  127 (604)
Q Consensus        58 ~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~~l----------yLVmEy~  127 (604)
                      .|+++++||+|+||+||+|+++.+|+.||||++.........+.+.+|+.+|+.++|||++++          |||||||
T Consensus         6 dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy~   85 (271)
T d1nvra_           6 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYC   85 (271)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             ceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEecc
Confidence            499999999999999999999999999999999776555556778999999999999997765          6999999


Q ss_pred             CCCChhhHhhc-CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCC--CCCccc
Q psy1546         128 GGGSALDLMKA-GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTT--SKRNTF  204 (604)
Q Consensus       128 ~ggsL~~~l~~-~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~--~~~~~~  204 (604)
                      +||+|.+++.. +.+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+|+.+....  ......
T Consensus        86 ~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~~~~~~  165 (271)
T d1nvra_          86 SGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM  165 (271)
T ss_dssp             TTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEECCBCCC
T ss_pred             CCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeeccCCccccccce
Confidence            99999999865 679999999999999999999999999999999999999999999999999998764332  234567


Q ss_pred             ccCCCCCChHHhhcCCC-CCcchhhhHHHHHHHHHhCCCCCCCCChhhHhh--hcCCCCCCCCCccchHHHHHHHHHHhc
Q psy1546         205 VGTPFWMAPEVIKQSAY-DSKADIWSLGITAIELAKGEPPNSELHPMRVLF--LIPKNNPPQLTGNYTKQFKEFVEACLN  281 (604)
Q Consensus       205 ~GT~~Y~APE~l~~~~~-~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~--~i~~~~~~~~~~~~s~~l~~Li~~~L~  281 (604)
                      +||+.|||||++.+..+ +.++|||||||+||||++|.+||..........  .............+++++.+||.+||+
T Consensus       166 ~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~  245 (271)
T d1nvra_         166 CGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILV  245 (271)
T ss_dssp             CSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTSTTGGGSCHHHHHHHHHHSC
T ss_pred             eeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCCHHHHHHHHHHcC
Confidence            89999999999998886 577999999999999999999997765433222  222222333446789999999999999


Q ss_pred             cCCCCCCCHHHHhcChhhhhh
Q psy1546         282 KDPENRPTAKELLKFPFIRKA  302 (604)
Q Consensus       282 ~dP~~RpT~~elL~hp~f~~~  302 (604)
                      .||.+|||++|||+||||++.
T Consensus       246 ~dP~~R~t~~eil~hpwf~~~  266 (271)
T d1nvra_         246 ENPSARITIPDIKKDRWYNKP  266 (271)
T ss_dssp             SSTTTSCCHHHHTTCTTTTCC
T ss_pred             CChhHCcCHHHHhcCHhhCcC
Confidence            999999999999999999753

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-55  Score=453.75  Aligned_cols=249  Identities=43%  Similarity=0.822  Sum_probs=219.4

Q ss_pred             cCccccceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCCeE----------EE
Q psy1546          53 VDPELIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTKL----------WI  122 (604)
Q Consensus        53 ~~~~~~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~~l----------yL  122 (604)
                      +++++.|++++.||+|+||+||+|++..+++.||||++.... ....+.+.+|+.+|++++|||++++          ||
T Consensus         8 ~~p~d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~l   86 (288)
T d2jfla1           8 LNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS-EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWI   86 (288)
T ss_dssp             SCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSS-SGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             CCcccCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCC-HHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEE
Confidence            567778999999999999999999999999999999997653 2345778899999999999997765          69


Q ss_pred             EEEecCCCChhhHhhc--CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCCC
Q psy1546         123 IMEYLGGGSALDLMKA--GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSK  200 (604)
Q Consensus       123 VmEy~~ggsL~~~l~~--~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~  200 (604)
                      |||||+||+|.+++..  +.+++..++.|+.||+.||.|||++||+||||||+||||+.+|.+||+|||+|+........
T Consensus        87 vmEy~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~~  166 (288)
T d2jfla1          87 LIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQR  166 (288)
T ss_dssp             EEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHHHH
T ss_pred             EEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccCCCccc
Confidence            9999999999998753  56999999999999999999999999999999999999999999999999999766544444


Q ss_pred             CcccccCCCCCChHHhh-----cCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCCCCC--CCCccchHHHH
Q psy1546         201 RNTFVGTPFWMAPEVIK-----QSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPP--QLTGNYTKQFK  273 (604)
Q Consensus       201 ~~~~~GT~~Y~APE~l~-----~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~~~~--~~~~~~s~~l~  273 (604)
                      ..+.+||+.|||||++.     +..|+.++|||||||+||||++|.+||.+.+..+....+....++  ..+..++++++
T Consensus       167 ~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~  246 (288)
T d2jfla1         167 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFK  246 (288)
T ss_dssp             HTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCCCSSGGGSCHHHH
T ss_pred             ccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCccccCCHHHH
Confidence            45678999999999984     456889999999999999999999999998888877766655443  33567899999


Q ss_pred             HHHHHHhccCCCCCCCHHHHhcChhhhhh
Q psy1546         274 EFVEACLNKDPENRPTAKELLKFPFIRKA  302 (604)
Q Consensus       274 ~Li~~~L~~dP~~RpT~~elL~hp~f~~~  302 (604)
                      +||.+||+.||.+|||+.|||+||||+..
T Consensus       247 ~li~~~L~~dp~~R~t~~ell~hp~~~~~  275 (288)
T d2jfla1         247 DFLKKCLEKNVDARWTTSQLLQHPFVTVD  275 (288)
T ss_dssp             HHHHHHSCSSTTTSCCHHHHTTSGGGCCC
T ss_pred             HHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence            99999999999999999999999999743

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.5e-54  Score=448.29  Aligned_cols=259  Identities=43%  Similarity=0.766  Sum_probs=222.7

Q ss_pred             CccccceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhh--HHHHHHHHHHHHHHhhCCCCCCCeE----------E
Q psy1546          54 DPELIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA--EDEIEDIQQEIMVLSQCDSPYGTKL----------W  121 (604)
Q Consensus        54 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~--~~~~~~l~~Ei~iL~~l~hp~~~~l----------y  121 (604)
                      +++..|+++++||+|+||+||+|++..+++.||||++.....  ....+.+.+|+.+|++++|||++++          |
T Consensus        12 dp~~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~   91 (309)
T d1u5ra_          12 DPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAW   91 (309)
T ss_dssp             CHHHHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEE
T ss_pred             CcHHhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEE
Confidence            456679999999999999999999999999999999976542  3445778999999999999997664          7


Q ss_pred             EEEEecCCCChhhHhh-cCCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCCC
Q psy1546         122 IIMEYLGGGSALDLMK-AGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSK  200 (604)
Q Consensus       122 LVmEy~~ggsL~~~l~-~~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~  200 (604)
                      ||||||.+|+|..++. .+.+++..++.|+.||+.||.|||++|||||||||+||||+.++.+||+|||+|+....    
T Consensus        92 iv~E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~----  167 (309)
T d1u5ra_          92 LVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP----  167 (309)
T ss_dssp             EEEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS----
T ss_pred             EEEEecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccCC----
Confidence            9999999999977654 47899999999999999999999999999999999999999999999999999976543    


Q ss_pred             CcccccCCCCCChHHhhc---CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCCCCC-CCCccchHHHHHHH
Q psy1546         201 RNTFVGTPFWMAPEVIKQ---SAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPP-QLTGNYTKQFKEFV  276 (604)
Q Consensus       201 ~~~~~GT~~Y~APE~l~~---~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~~~~-~~~~~~s~~l~~Li  276 (604)
                      ....+||+.|||||++.+   ..|+.++|||||||+||||++|..||.+.........+.....+ .....+++++++||
T Consensus       168 ~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li  247 (309)
T d1u5ra_         168 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFV  247 (309)
T ss_dssp             BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSCHHHHHHH
T ss_pred             CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCCCCCCHHHHHHH
Confidence            245689999999999964   45899999999999999999999999988887776655544433 34556899999999


Q ss_pred             HHHhccCCCCCCCHHHHhcChhhhhhhhhhhHHHHHHHHH
Q psy1546         277 EACLNKDPENRPTAKELLKFPFIRKAKKNAYLIDLIDRYK  316 (604)
Q Consensus       277 ~~~L~~dP~~RpT~~elL~hp~f~~~~~~~~l~~~~~~~~  316 (604)
                      .+||..||.+|||++|||+||||.+......+.++..+..
T Consensus       248 ~~~L~~dP~~Rpt~~ell~Hp~~~~~~~~~~~~~~~~~~~  287 (309)
T d1u5ra_         248 DSCLQKIPQDRPTSEVLLKHRFVLRERPPTVIMDLIQRTK  287 (309)
T ss_dssp             HHHTCSSGGGSCCHHHHTTCHHHHSCCCTTHHHHHHHHHH
T ss_pred             HHHCcCChhHCcCHHHHHhCHHhcCCCCchhhHHHHHHHH
Confidence            9999999999999999999999987766655555554443

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.1e-54  Score=448.47  Aligned_cols=245  Identities=31%  Similarity=0.509  Sum_probs=198.8

Q ss_pred             cccceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCCeE----------EEEEE
Q psy1546          56 ELIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTKL----------WIIME  125 (604)
Q Consensus        56 ~~~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~~l----------yLVmE  125 (604)
                      .+.|++.++||+|+||+||+|+++.+++.||||++...........+.+|+.+|+.++|||++++          |||||
T Consensus         8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE   87 (307)
T d1a06a_           8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ   87 (307)
T ss_dssp             GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence            45599999999999999999999999999999999876655555678899999999999997654          79999


Q ss_pred             ecCCCChhhHhhc-CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEec---CCCCeEEecccccccccCCCCCC
Q psy1546         126 YLGGGSALDLMKA-GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLS---EMGDVKLADFGVAGTLTNTTSKR  201 (604)
Q Consensus       126 y~~ggsL~~~l~~-~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~---~~g~vKL~DFGlA~~~~~~~~~~  201 (604)
                      ||+||+|.+++.. +.+++..+..++.||+.||.|||++|||||||||+|||+.   +++.+||+|||+|+.... ....
T Consensus        88 ~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~-~~~~  166 (307)
T d1a06a_          88 LVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDP-GSVL  166 (307)
T ss_dssp             CCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC-------------
T ss_pred             ccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEccC-CCee
Confidence            9999999998855 6899999999999999999999999999999999999995   578999999999976543 3334


Q ss_pred             cccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCCCC---CCCCccchHHHHHHHHH
Q psy1546         202 NTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNP---PQLTGNYTKQFKEFVEA  278 (604)
Q Consensus       202 ~~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~~~---~~~~~~~s~~l~~Li~~  278 (604)
                      .+.+||+.|||||++.+..|+.++|||||||+||||++|.+||.+....+....+.....   ......+++++++||.+
T Consensus       167 ~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~  246 (307)
T d1a06a_         167 STACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRH  246 (307)
T ss_dssp             ------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCTTTTTTSCHHHHHHHHH
T ss_pred             eeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCccccCCCHHHHHHHHH
Confidence            567899999999999999999999999999999999999999999888777666555432   23446789999999999


Q ss_pred             HhccCCCCCCCHHHHhcChhhhh
Q psy1546         279 CLNKDPENRPTAKELLKFPFIRK  301 (604)
Q Consensus       279 ~L~~dP~~RpT~~elL~hp~f~~  301 (604)
                      ||..||.+|||+.|+|+||||+.
T Consensus       247 ~L~~dP~~R~s~~eil~hp~~~~  269 (307)
T d1a06a_         247 LMEKDPEKRFTCEQALQHPWIAG  269 (307)
T ss_dssp             HSCSSGGGSCCHHHHHHSTTTTS
T ss_pred             HccCCHhHCcCHHHHhcCHhhCC
Confidence            99999999999999999999975

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-53  Score=448.88  Aligned_cols=244  Identities=30%  Similarity=0.493  Sum_probs=220.7

Q ss_pred             ceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhh--HHHHHHHHHHHHHHhhCCCCCCCe----------EEEEEEe
Q psy1546          59 FTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA--EDEIEDIQQEIMVLSQCDSPYGTK----------LWIIMEY  126 (604)
Q Consensus        59 y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~--~~~~~~l~~Ei~iL~~l~hp~~~~----------lyLVmEy  126 (604)
                      |.+++.||+|+||.||+|+++.+++.||||++.+...  ....+.+.+|+.+|+.++||++++          +|+||||
T Consensus         7 y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ey   86 (337)
T d1o6la_           7 FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEY   86 (337)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             cEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccceec
Confidence            9999999999999999999999999999999976543  234577889999999999999765          4799999


Q ss_pred             cCCCChhhHhhc-CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCCCCcccc
Q psy1546         127 LGGGSALDLMKA-GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFV  205 (604)
Q Consensus       127 ~~ggsL~~~l~~-~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~~~~~~  205 (604)
                      |+||+|.+++.. +.+++..++.++.||+.||+|||++|||||||||+||||+.+|.+||+|||+|+..........+.+
T Consensus        87 ~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~~~~~~~~  166 (337)
T d1o6la_          87 ANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC  166 (337)
T ss_dssp             CTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTCCBCCCE
T ss_pred             cCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeecccccccccCCcccccce
Confidence            999999998865 7899999999999999999999999999999999999999999999999999987766566667789


Q ss_pred             cCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCCCCCCCCccchHHHHHHHHHHhccCCC
Q psy1546         206 GTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPE  285 (604)
Q Consensus       206 GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~~L~~dP~  285 (604)
                      ||+.|||||++.+..|+.++|||||||+||||++|.+||.+.+...+...+.... ..++..+++++++||.+||++||.
T Consensus       167 GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~dli~~~L~~dP~  245 (337)
T d1o6la_         167 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEE-IRFPRTLSPEAKSLLAGLLKKDPK  245 (337)
T ss_dssp             ECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-CCCCTTSCHHHHHHHHHHTCSSTT
T ss_pred             eCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCC-CCCCccCCHHHHHHHHhhccCCch
Confidence            9999999999999999999999999999999999999999998887776665544 456778999999999999999999


Q ss_pred             CCC-----CHHHHhcChhhhhhh
Q psy1546         286 NRP-----TAKELLKFPFIRKAK  303 (604)
Q Consensus       286 ~Rp-----T~~elL~hp~f~~~~  303 (604)
                      +|+     +++||++||||+...
T Consensus       246 ~R~~~~~~~~~eil~Hp~f~~i~  268 (337)
T d1o6la_         246 QRLGGGPSDAKEVMEHRFFLSIN  268 (337)
T ss_dssp             TSTTCSTTTHHHHHTSGGGTTCC
T ss_pred             hhcccccccHHHHHcCcccccCC
Confidence            999     499999999997653

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.8e-54  Score=449.14  Aligned_cols=245  Identities=36%  Similarity=0.644  Sum_probs=207.5

Q ss_pred             ccceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCCeE----------EEEEEe
Q psy1546          57 LIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTKL----------WIIMEY  126 (604)
Q Consensus        57 ~~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~~l----------yLVmEy  126 (604)
                      +.|.++++||+|+||+||+|++..+|+.||||++...........+.+|+.+|+.++|||++++          ||||||
T Consensus         6 d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmEy   85 (322)
T d1s9ja_           6 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH   85 (322)
T ss_dssp             GGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             cCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            4599999999999999999999999999999999766545556788999999999999997654          799999


Q ss_pred             cCCCChhhHhhc-CCCcHHHHHHHHHHHHHHhHHhhh-CCccccccccceeEecCCCCeEEecccccccccCCCCCCccc
Q psy1546         127 LGGGSALDLMKA-GNFEEMHIAVILREVLKGLDYLHS-ERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTF  204 (604)
Q Consensus       127 ~~ggsL~~~l~~-~~lse~~i~~i~~qIl~gL~yLHs-~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~~~~~  204 (604)
                      |+||+|.+++.. +.+++..++.++.||+.||.|||+ +||+||||||+||||+.+|.+||+|||+|+.+...  ...+.
T Consensus        86 ~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~--~~~~~  163 (322)
T d1s9ja_          86 MDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--MANSF  163 (322)
T ss_dssp             CTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH--TC---
T ss_pred             CCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccccCCC--ccccc
Confidence            999999998854 789999999999999999999997 59999999999999999999999999999866432  23467


Q ss_pred             ccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhh-----------------------------
Q psy1546         205 VGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFL-----------------------------  255 (604)
Q Consensus       205 ~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~-----------------------------  255 (604)
                      +||+.|||||++.+..|+.++|||||||+||||++|+.||...+.......                             
T Consensus       164 ~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (322)
T d1s9ja_         164 VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMD  243 (322)
T ss_dssp             CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC----------------------------
T ss_pred             cCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccccccccccc
Confidence            999999999999999999999999999999999999999976543322111                             


Q ss_pred             -------------cCCCCCCCCC-ccchHHHHHHHHHHhccCCCCCCCHHHHhcChhhhhhh
Q psy1546         256 -------------IPKNNPPQLT-GNYTKQFKEFVEACLNKDPENRPTAKELLKFPFIRKAK  303 (604)
Q Consensus       256 -------------i~~~~~~~~~-~~~s~~l~~Li~~~L~~dP~~RpT~~elL~hp~f~~~~  303 (604)
                                   +....++.++ ..++.++++||.+||..||.+|||++|+|+||||++..
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~~  305 (322)
T d1s9ja_         244 SRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSD  305 (322)
T ss_dssp             --CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHHH
T ss_pred             cccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcCC
Confidence                         0111111222 34678999999999999999999999999999998654

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.4e-54  Score=442.99  Aligned_cols=244  Identities=28%  Similarity=0.493  Sum_probs=213.2

Q ss_pred             cceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhh--HHHHHHHHHHHHHHhhCCCCCCCeE----------EEEEE
Q psy1546          58 IFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA--EDEIEDIQQEIMVLSQCDSPYGTKL----------WIIME  125 (604)
Q Consensus        58 ~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~--~~~~~~l~~Ei~iL~~l~hp~~~~l----------yLVmE  125 (604)
                      .|++++.||+|+||+||+|+++.+++.||||++.+...  ....+.+.+|+.+|++++|||++++          |||||
T Consensus         9 dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmE   88 (288)
T d1uu3a_           9 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLS   88 (288)
T ss_dssp             GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEEC
T ss_pred             CCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEEE
Confidence            49999999999999999999999999999999976543  2335778999999999999996654          79999


Q ss_pred             ecCCCChhhHhhc-CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCC--CCCc
Q psy1546         126 YLGGGSALDLMKA-GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTT--SKRN  202 (604)
Q Consensus       126 y~~ggsL~~~l~~-~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~--~~~~  202 (604)
                      ||+||+|.+++.. +.+++..++.++.||+.||+|||++|||||||||+||||+.+|.+||+|||+|+.+....  ....
T Consensus        89 y~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~  168 (288)
T d1uu3a_          89 YAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARAN  168 (288)
T ss_dssp             CCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC---------
T ss_pred             ccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceecccCCcccccc
Confidence            9999999998764 789999999999999999999999999999999999999999999999999998765332  2344


Q ss_pred             ccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCCCCCCCCccchHHHHHHHHHHhcc
Q psy1546         203 TFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNK  282 (604)
Q Consensus       203 ~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~~L~~  282 (604)
                      +.+||+.|||||++.+..|+.++|||||||+||||++|..||.+.+...+...+.... ..++..+++++++||.+||..
T Consensus       169 ~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~~~L~~  247 (288)
T d1uu3a_         169 SFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLE-YDFPEKFFPKARDLVEKLLVL  247 (288)
T ss_dssp             -CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTC-CCCCTTCCHHHHHHHHTTSCS
T ss_pred             cccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCC-CCCCccCCHHHHHHHHHHccC
Confidence            6789999999999999999999999999999999999999999988888777765554 346678999999999999999


Q ss_pred             CCCCCCCHHH------HhcChhhhhh
Q psy1546         283 DPENRPTAKE------LLKFPFIRKA  302 (604)
Q Consensus       283 dP~~RpT~~e------lL~hp~f~~~  302 (604)
                      ||.+|||++|      |++||||+..
T Consensus       248 dP~~R~t~~e~~~~~~i~~Hpff~~i  273 (288)
T d1uu3a_         248 DATKRLGCEEMEGYGPLKAHPFFESV  273 (288)
T ss_dssp             SGGGSTTSGGGTCHHHHHTSGGGTTC
T ss_pred             CHhHCcCHHHHcCCHHHHcCCccCCC
Confidence            9999999987      5778888654

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-53  Score=432.73  Aligned_cols=239  Identities=27%  Similarity=0.500  Sum_probs=206.1

Q ss_pred             ceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchh-hHHHHHHHHHHHHHHhhCCCCCCCeE--------------EEE
Q psy1546          59 FTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE-AEDEIEDIQQEIMVLSQCDSPYGTKL--------------WII  123 (604)
Q Consensus        59 y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~-~~~~~~~l~~Ei~iL~~l~hp~~~~l--------------yLV  123 (604)
                      |++.++||+|+||+||+|++..+++.||||++.... .....+.+.+|+.+|++++|||++++              |||
T Consensus        11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~iv   90 (270)
T d1t4ha_          11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV   90 (270)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred             EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEE
Confidence            577789999999999999999999999999987654 34456788999999999999997654              699


Q ss_pred             EEecCCCChhhHhhc-CCCcHHHHHHHHHHHHHHhHHhhhCC--ccccccccceeEec-CCCCeEEecccccccccCCCC
Q psy1546         124 MEYLGGGSALDLMKA-GNFEEMHIAVILREVLKGLDYLHSER--KLHRDIKAANVLLS-EMGDVKLADFGVAGTLTNTTS  199 (604)
Q Consensus       124 mEy~~ggsL~~~l~~-~~lse~~i~~i~~qIl~gL~yLHs~g--IiHrDLKp~NILl~-~~g~vKL~DFGlA~~~~~~~~  199 (604)
                      ||||++|+|.+++.. +.+++..++.|+.||+.||+|||+++  |+||||||+||||+ .++.+||+|||+|+....  .
T Consensus        91 mE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~--~  168 (270)
T d1t4ha_          91 TELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA--S  168 (270)
T ss_dssp             EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT--T
T ss_pred             EeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceeccC--C
Confidence            999999999999865 68999999999999999999999998  99999999999996 578999999999975432  2


Q ss_pred             CCcccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChh-hHhhhcCCCC-CCCCCccchHHHHHHHH
Q psy1546         200 KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPM-RVLFLIPKNN-PPQLTGNYTKQFKEFVE  277 (604)
Q Consensus       200 ~~~~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~-~~~~~i~~~~-~~~~~~~~s~~l~~Li~  277 (604)
                      .....+||+.|||||++.+ .|+.++|||||||+||||++|+.||.+.... .+...+..+. +..++..+++++++||.
T Consensus       169 ~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~  247 (270)
T d1t4ha_         169 FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIE  247 (270)
T ss_dssp             SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHHHHH
T ss_pred             ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCCcccCccCCHHHHHHHH
Confidence            3446789999999999875 5999999999999999999999999876543 3444444433 33455667899999999


Q ss_pred             HHhccCCCCCCCHHHHhcChhhh
Q psy1546         278 ACLNKDPENRPTAKELLKFPFIR  300 (604)
Q Consensus       278 ~~L~~dP~~RpT~~elL~hp~f~  300 (604)
                      +||..||++|||++|||+||||+
T Consensus       248 ~~l~~dp~~R~s~~ell~Hp~fk  270 (270)
T d1t4ha_         248 GCIRQNKDERYSIKDLLNHAFFQ  270 (270)
T ss_dssp             HHSCSSGGGSCCHHHHHTSGGGC
T ss_pred             HHccCCHhHCcCHHHHhCCcccC
Confidence            99999999999999999999995

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=5.6e-53  Score=445.45  Aligned_cols=243  Identities=24%  Similarity=0.400  Sum_probs=213.9

Q ss_pred             cceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCCeE----------EEEEEec
Q psy1546          58 IFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTKL----------WIIMEYL  127 (604)
Q Consensus        58 ~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~~l----------yLVmEy~  127 (604)
                      .|+++++||+|+||+||+|++..+|+.||||++..... ...+.+.+|+.+|++++|||++++          |||||||
T Consensus        27 ~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~  105 (350)
T d1koaa2          27 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHE-SDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM  105 (350)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSH-HHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             CeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccch-hhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence            39999999999999999999999999999999976543 345788999999999999997654          7999999


Q ss_pred             CCCChhhHhh--cCCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecC--CCCeEEecccccccccCCCCCCcc
Q psy1546         128 GGGSALDLMK--AGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSE--MGDVKLADFGVAGTLTNTTSKRNT  203 (604)
Q Consensus       128 ~ggsL~~~l~--~~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~--~g~vKL~DFGlA~~~~~~~~~~~~  203 (604)
                      +||+|.+++.  .+.+++..++.|+.||+.||.|||++|||||||||+||||+.  ++.+||+|||+|+.+... ....+
T Consensus       106 ~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~-~~~~~  184 (350)
T d1koaa2         106 SGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK-QSVKV  184 (350)
T ss_dssp             CSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT-SCEEE
T ss_pred             CCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheecccc-cccce
Confidence            9999999884  367999999999999999999999999999999999999964  578999999999776533 33456


Q ss_pred             cccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCCCC---CCCCccchHHHHHHHHHHh
Q psy1546         204 FVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNP---PQLTGNYTKQFKEFVEACL  280 (604)
Q Consensus       204 ~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~~~---~~~~~~~s~~l~~Li~~~L  280 (604)
                      .+||+.|||||++.+..|+.++|||||||+||+|++|..||.+.+..+....+.....   ......+++++++||.+||
T Consensus       185 ~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L  264 (350)
T d1koaa2         185 TTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLL  264 (350)
T ss_dssp             ECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCGGGGGCCHHHHHHHHHHC
T ss_pred             ecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHHHHc
Confidence            7899999999999999999999999999999999999999999888777766544432   2334568999999999999


Q ss_pred             ccCCCCCCCHHHHhcChhhhhh
Q psy1546         281 NKDPENRPTAKELLKFPFIRKA  302 (604)
Q Consensus       281 ~~dP~~RpT~~elL~hp~f~~~  302 (604)
                      ..||.+|||++|||+||||+..
T Consensus       265 ~~dP~~R~t~~eil~hp~~~~~  286 (350)
T d1koaa2         265 LADPNTRMTIHQALEHPWLTPG  286 (350)
T ss_dssp             CSSGGGSCCHHHHHHSTTTSCT
T ss_pred             cCChhHCcCHHHHhcCcccCCC
Confidence            9999999999999999999754

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=1.4e-52  Score=436.42  Aligned_cols=242  Identities=26%  Similarity=0.495  Sum_probs=216.2

Q ss_pred             ceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhh--HHHHHHHHHHHHHHhhCCCCCCCeE----------EEEEEe
Q psy1546          59 FTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA--EDEIEDIQQEIMVLSQCDSPYGTKL----------WIIMEY  126 (604)
Q Consensus        59 y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~--~~~~~~l~~Ei~iL~~l~hp~~~~l----------yLVmEy  126 (604)
                      |+++++||+|+||+||+|+++.+|+.||||++.+...  ....+.+.+|+.+|+.++|||++++          |+||||
T Consensus         6 y~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~   85 (316)
T d1fota_           6 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDY   85 (316)
T ss_dssp             EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECC
T ss_pred             eEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEeee
Confidence            9999999999999999999999999999999976533  2335778999999999999997654          799999


Q ss_pred             cCCCChhhHhhc-CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCCCCcccc
Q psy1546         127 LGGGSALDLMKA-GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFV  205 (604)
Q Consensus       127 ~~ggsL~~~l~~-~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~~~~~~  205 (604)
                      |.||+|..++.. +.+++..++.++.||+.||.|||++|||||||||+||||+.+|.+||+|||+|+.+...   ..+.+
T Consensus        86 ~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~---~~~~~  162 (316)
T d1fota_          86 IEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV---TYTLC  162 (316)
T ss_dssp             CCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC---BCCCC
T ss_pred             cCCccccccccccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEeccc---ccccc
Confidence            999999998865 57899999999999999999999999999999999999999999999999999876533   34678


Q ss_pred             cCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCCCCCCCCccchHHHHHHHHHHhccCCC
Q psy1546         206 GTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPE  285 (604)
Q Consensus       206 GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~~L~~dP~  285 (604)
                      ||+.|||||++.+..|+.++|||||||+||+|++|..||.+.+..+....+.... ..++..++++++++|.+||..||.
T Consensus       163 Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~~~L~~dp~  241 (316)
T d1fota_         163 GTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAE-LRFPPFFNEDVKDLLSRLITRDLS  241 (316)
T ss_dssp             SCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCC-CCCCTTSCHHHHHHHHHHTCSCTT
T ss_pred             CcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCC-CCCCCCCCHHHHHHHHHHhhhCHH
Confidence            9999999999999999999999999999999999999999998887777665544 345677899999999999999999


Q ss_pred             CCC-----CHHHHhcChhhhhhhh
Q psy1546         286 NRP-----TAKELLKFPFIRKAKK  304 (604)
Q Consensus       286 ~Rp-----T~~elL~hp~f~~~~~  304 (604)
                      +|+     |+++||+||||++..+
T Consensus       242 ~R~~~~r~t~~~il~Hp~f~~i~~  265 (316)
T d1fota_         242 QRLGNLQNGTEDVKNHPWFKEVVW  265 (316)
T ss_dssp             TCTTSSTTTTHHHHTSGGGSSCCH
T ss_pred             hccccchhhHHHHHcCcccccCCH
Confidence            996     9999999999987543

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=7.7e-53  Score=444.71  Aligned_cols=243  Identities=24%  Similarity=0.447  Sum_probs=214.5

Q ss_pred             cceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCCeE----------EEEEEec
Q psy1546          58 IFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTKL----------WIIMEYL  127 (604)
Q Consensus        58 ~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~~l----------yLVmEy~  127 (604)
                      .|+++++||+|+||+||+|++..+|+.||||++...... ....+.+|+.+|++++|||++++          |||||||
T Consensus        30 ~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~-~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~  108 (352)
T d1koba_          30 YYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPL-DKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL  108 (352)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHH-HHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred             ceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchh-HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence            499999999999999999999999999999999765433 34678899999999999997654          7999999


Q ss_pred             CCCChhhHhhc--CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEec--CCCCeEEecccccccccCCCCCCcc
Q psy1546         128 GGGSALDLMKA--GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLS--EMGDVKLADFGVAGTLTNTTSKRNT  203 (604)
Q Consensus       128 ~ggsL~~~l~~--~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~--~~g~vKL~DFGlA~~~~~~~~~~~~  203 (604)
                      +||+|.+++..  ..+++.+++.|+.||+.||.|||++|||||||||+||||+  .++.+||+|||+|+.+.. .....+
T Consensus       109 ~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~-~~~~~~  187 (352)
T d1koba_         109 SGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP-DEIVKV  187 (352)
T ss_dssp             CCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCT-TSCEEE
T ss_pred             CCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecCC-CCceee
Confidence            99999987754  4699999999999999999999999999999999999997  578999999999977653 333456


Q ss_pred             cccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCCC---CCCCCccchHHHHHHHHHHh
Q psy1546         204 FVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNN---PPQLTGNYTKQFKEFVEACL  280 (604)
Q Consensus       204 ~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~~---~~~~~~~~s~~l~~Li~~~L  280 (604)
                      .+||+.|||||++.+..|+.++|||||||+||+|++|.+||.+.+..+.+..+....   +......+++++++||.+||
T Consensus       188 ~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L  267 (352)
T d1koba_         188 TTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLL  267 (352)
T ss_dssp             ECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHHHHHHTTS
T ss_pred             ccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHHHHc
Confidence            789999999999999999999999999999999999999999988887776654443   23445678999999999999


Q ss_pred             ccCCCCCCCHHHHhcChhhhhh
Q psy1546         281 NKDPENRPTAKELLKFPFIRKA  302 (604)
Q Consensus       281 ~~dP~~RpT~~elL~hp~f~~~  302 (604)
                      ..||.+|||+.|||+||||+..
T Consensus       268 ~~dp~~R~s~~eil~Hp~~~~~  289 (352)
T d1koba_         268 QKEPRKRLTVHDALEHPWLKGD  289 (352)
T ss_dssp             CSSGGGSCCHHHHHTSTTTSSC
T ss_pred             cCChhHCcCHHHHhcCHhhCCC
Confidence            9999999999999999999753

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-52  Score=432.00  Aligned_cols=247  Identities=28%  Similarity=0.461  Sum_probs=215.5

Q ss_pred             cccceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhH-----HHHHHHHHHHHHHhhCCCCCCCeE----------
Q psy1546          56 ELIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAE-----DEIEDIQQEIMVLSQCDSPYGTKL----------  120 (604)
Q Consensus        56 ~~~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~-----~~~~~l~~Ei~iL~~l~hp~~~~l----------  120 (604)
                      ++.|++++.||+|+||+||+|+++.+|+.||||++.+....     ...+.+.+|+.+|++++|||++++          
T Consensus         9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~   88 (293)
T d1jksa_           9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV   88 (293)
T ss_dssp             GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence            45699999999999999999999999999999999654322     135778999999999999997664          


Q ss_pred             EEEEEecCCCChhhHhhc-CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCC----CeEEeccccccccc
Q psy1546         121 WIIMEYLGGGSALDLMKA-GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMG----DVKLADFGVAGTLT  195 (604)
Q Consensus       121 yLVmEy~~ggsL~~~l~~-~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g----~vKL~DFGlA~~~~  195 (604)
                      |||||||+||+|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.++    .+||+|||+|+.+.
T Consensus        89 ~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~~  168 (293)
T d1jksa_          89 ILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID  168 (293)
T ss_dssp             EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEECT
T ss_pred             EEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhhhcC
Confidence            799999999999999865 6899999999999999999999999999999999999998776    49999999997765


Q ss_pred             CCCCCCcccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCCCCC---CCCccchHHH
Q psy1546         196 NTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPP---QLTGNYTKQF  272 (604)
Q Consensus       196 ~~~~~~~~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~~~~---~~~~~~s~~l  272 (604)
                      .. ....+..||+.|||||++.+..|+.++|||||||+||||++|..||.+.+..+....+......   ..+..++..+
T Consensus       169 ~~-~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  247 (293)
T d1jksa_         169 FG-NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALA  247 (293)
T ss_dssp             TS-CBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCHHHHTTSCHHH
T ss_pred             CC-ccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCchhcCCCCHHH
Confidence            33 3345678999999999999999999999999999999999999999998888877766554432   2335688999


Q ss_pred             HHHHHHHhccCCCCCCCHHHHhcChhhhhhh
Q psy1546         273 KEFVEACLNKDPENRPTAKELLKFPFIRKAK  303 (604)
Q Consensus       273 ~~Li~~~L~~dP~~RpT~~elL~hp~f~~~~  303 (604)
                      ++||.+||..||.+|||++|||+||||+...
T Consensus       248 ~~li~~~L~~dP~~R~s~~eil~hp~~~~~~  278 (293)
T d1jksa_         248 KDFIRRLLVKDPKKRMTIQDSLQHPWIKPKD  278 (293)
T ss_dssp             HHHHHTTSCSSGGGSCCHHHHHHSTTTCC--
T ss_pred             HHHHHHHccCChhHCcCHHHHhcCcccCCCC
Confidence            9999999999999999999999999997543

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=3.8e-52  Score=439.09  Aligned_cols=242  Identities=27%  Similarity=0.514  Sum_probs=216.3

Q ss_pred             cceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhH--HHHHHHHHHHHHHhhCCCCCCCeE----------EEEEE
Q psy1546          58 IFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAE--DEIEDIQQEIMVLSQCDSPYGTKL----------WIIME  125 (604)
Q Consensus        58 ~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~--~~~~~l~~Ei~iL~~l~hp~~~~l----------yLVmE  125 (604)
                      .|+++++||+|+||+||+|+++.+|+.||||++.+....  ...+.+.+|+.+|+.++|||++++          |+|||
T Consensus        42 ~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~e  121 (350)
T d1rdqe_          42 QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVME  121 (350)
T ss_dssp             GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccccccccc
Confidence            499999999999999999999999999999999755432  335778999999999999997665          69999


Q ss_pred             ecCCCChhhHhhc-CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCCCCccc
Q psy1546         126 YLGGGSALDLMKA-GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTF  204 (604)
Q Consensus       126 y~~ggsL~~~l~~-~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~~~~~  204 (604)
                      |+.||+|..++.. +.+++..++.|+.||+.||.|||++|||||||||+||||+.+|.+||+|||+|+.+...   ..+.
T Consensus       122 ~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~---~~~~  198 (350)
T d1rdqe_         122 YVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR---TWTL  198 (350)
T ss_dssp             CCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC---BCCC
T ss_pred             cccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeecccc---cccc
Confidence            9999999998854 78999999999999999999999999999999999999999999999999999876533   3467


Q ss_pred             ccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCCCCCCCCccchHHHHHHHHHHhccCC
Q psy1546         205 VGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDP  284 (604)
Q Consensus       205 ~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~~L~~dP  284 (604)
                      +||+.|||||++.+..|+.++|||||||+||||++|.+||.+.+.......+.... ..++..+++++.+||.+||..||
T Consensus       199 ~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~~~L~~dP  277 (350)
T d1rdqe_         199 CGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK-VRFPSHFSSDLKDLLRNLLQVDL  277 (350)
T ss_dssp             EECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-CCCCTTCCHHHHHHHHHHSCSCT
T ss_pred             cCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCC-CCCCccCCHHHHHHHHHHhhhCH
Confidence            89999999999999999999999999999999999999999988877777665544 34567889999999999999999


Q ss_pred             CCCC-----CHHHHhcChhhhhhh
Q psy1546         285 ENRP-----TAKELLKFPFIRKAK  303 (604)
Q Consensus       285 ~~Rp-----T~~elL~hp~f~~~~  303 (604)
                      .+|+     |+++|++||||+...
T Consensus       278 ~kR~~~~r~t~~ell~Hp~f~~~~  301 (350)
T d1rdqe_         278 TKRFGNLKNGVNDIKNHKWFATTD  301 (350)
T ss_dssp             TTCTTSSTTTTHHHHTSGGGTTCC
T ss_pred             HhccccccccHHHHHcCccccCCC
Confidence            9994     999999999998754

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-52  Score=435.07  Aligned_cols=245  Identities=31%  Similarity=0.541  Sum_probs=217.1

Q ss_pred             cceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhh--HHHHHHHHHHHHHHh-hCCCCCCCe----------EEEEE
Q psy1546          58 IFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA--EDEIEDIQQEIMVLS-QCDSPYGTK----------LWIIM  124 (604)
Q Consensus        58 ~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~--~~~~~~l~~Ei~iL~-~l~hp~~~~----------lyLVm  124 (604)
                      .|.++++||+|+||+||+|+++.+++.||||++.+...  ....+.+.+|+.++. .++|||+++          +||||
T Consensus         3 dy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yivm   82 (320)
T d1xjda_           3 DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVM   82 (320)
T ss_dssp             TEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             CeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEEE
Confidence            39999999999999999999999999999999976532  223456667777665 799999665          47999


Q ss_pred             EecCCCChhhHhhc-CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCCCCcc
Q psy1546         125 EYLGGGSALDLMKA-GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNT  203 (604)
Q Consensus       125 Ey~~ggsL~~~l~~-~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~~~~  203 (604)
                      |||++|+|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+...........
T Consensus        83 Ey~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~~~~~~  162 (320)
T d1xjda_          83 EYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT  162 (320)
T ss_dssp             ECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCCBCC
T ss_pred             eecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhcccccccccc
Confidence            99999999999965 78999999999999999999999999999999999999999999999999999877665566667


Q ss_pred             cccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCCCCCCCCccchHHHHHHHHHHhccC
Q psy1546         204 FVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKD  283 (604)
Q Consensus       204 ~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~~L~~d  283 (604)
                      .+||+.|||||++.+..|+.++|||||||+||+|++|..||.+.+...+...+.... +.++..+++++++||.+||..|
T Consensus       163 ~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~-~~~p~~~s~~~~dli~~~L~~d  241 (320)
T d1xjda_         163 FCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDN-PFYPRWLEKEAKDLLVKLFVRE  241 (320)
T ss_dssp             CCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-CCCCTTSCHHHHHHHHHHSCSS
T ss_pred             cCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcCC-CCCCccCCHHHHHHHHHhcccC
Confidence            789999999999999999999999999999999999999999998888777665543 4667789999999999999999


Q ss_pred             CCCCCCHH-HHhcChhhhhhh
Q psy1546         284 PENRPTAK-ELLKFPFIRKAK  303 (604)
Q Consensus       284 P~~RpT~~-elL~hp~f~~~~  303 (604)
                      |.+|||+. ||++||||++..
T Consensus       242 P~~R~s~~~~l~~hpff~~~~  262 (320)
T d1xjda_         242 PEKRLGVRGDIRQHPLFREIN  262 (320)
T ss_dssp             GGGSBTTBSCGGGSGGGTTCC
T ss_pred             CCCCcCHHHHHHhCchhccCC
Confidence            99999995 899999998643

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=2.8e-51  Score=434.63  Aligned_cols=244  Identities=29%  Similarity=0.472  Sum_probs=207.3

Q ss_pred             ceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHH-----HHHHHHHHHHHHhhCCCCCCCe----------EEEE
Q psy1546          59 FTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAED-----EIEDIQQEIMVLSQCDSPYGTK----------LWII  123 (604)
Q Consensus        59 y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~-----~~~~l~~Ei~iL~~l~hp~~~~----------lyLV  123 (604)
                      |.++++||+|+||.||+|++..+|+.||||++.+.....     .......|+.+++.++|||+++          +|||
T Consensus         6 y~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~iv   85 (364)
T d1omwa3           6 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFI   85 (364)
T ss_dssp             EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEE
T ss_pred             CeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEEEE
Confidence            999999999999999999999999999999996543321     1233345678888999999765          4799


Q ss_pred             EEecCCCChhhHhhc-CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCCCCc
Q psy1546         124 MEYLGGGSALDLMKA-GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRN  202 (604)
Q Consensus       124 mEy~~ggsL~~~l~~-~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~~~  202 (604)
                      ||||+||+|.+++.. +.+++..++.|+.||+.||.|||++|||||||||+||||+.+|.+||+|||+|+.+...  ...
T Consensus        86 mE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~--~~~  163 (364)
T d1omwa3          86 LDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK--KPH  163 (364)
T ss_dssp             ECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEECSSS--CCC
T ss_pred             EEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeeecCCC--ccc
Confidence            999999999998854 77999999999999999999999999999999999999999999999999999876543  344


Q ss_pred             ccccCCCCCChHHhhc-CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhH--hhhcCCCCCCCCCccchHHHHHHHHHH
Q psy1546         203 TFVGTPFWMAPEVIKQ-SAYDSKADIWSLGITAIELAKGEPPNSELHPMRV--LFLIPKNNPPQLTGNYTKQFKEFVEAC  279 (604)
Q Consensus       203 ~~~GT~~Y~APE~l~~-~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~--~~~i~~~~~~~~~~~~s~~l~~Li~~~  279 (604)
                      ..+||+.|||||++.. ..|+.++|||||||+||||++|..||.+......  ...........++..+++++++||.+|
T Consensus       164 ~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~  243 (364)
T d1omwa3         164 ASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGL  243 (364)
T ss_dssp             SCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSCCCCCCSSSCHHHHHHHHHH
T ss_pred             ccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCHHHHHHHHHH
Confidence            6689999999999964 5689999999999999999999999987654322  222233344566778999999999999


Q ss_pred             hccCCCCCCC-----HHHHhcChhhhhhhh
Q psy1546         280 LNKDPENRPT-----AKELLKFPFIRKAKK  304 (604)
Q Consensus       280 L~~dP~~RpT-----~~elL~hp~f~~~~~  304 (604)
                      |..||.+|||     ++||++||||+...+
T Consensus       244 L~~dP~~R~t~~~~~a~eil~Hp~f~~i~~  273 (364)
T d1omwa3         244 LQRDVNRRLGCLGRGAQEVKESPFFRSLDW  273 (364)
T ss_dssp             TCSSTTTSTTTSSSTHHHHHTSGGGTTCCH
T ss_pred             cccCHHHhCCCcccCHHHHHcCccccCCCH
Confidence            9999999999     799999999987543

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.2e-52  Score=425.86  Aligned_cols=242  Identities=27%  Similarity=0.407  Sum_probs=202.8

Q ss_pred             eeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHH----HHHHHHHHHHHHhhCCCCCCCeE----------EEEEEe
Q psy1546          61 KQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAED----EIEDIQQEIMVLSQCDSPYGTKL----------WIIMEY  126 (604)
Q Consensus        61 i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~----~~~~l~~Ei~iL~~l~hp~~~~l----------yLVmEy  126 (604)
                      .+++||+|+||+||+|+++.+|+.||||++.......    ..+.+.+|+.+|++++|||++++          ||||||
T Consensus         2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~   81 (299)
T d1ua2a_           2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF   81 (299)
T ss_dssp             EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred             cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence            4688999999999999999999999999996553322    13468899999999999997765          799999


Q ss_pred             cCCCChhhHhhc-CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCCCCcccc
Q psy1546         127 LGGGSALDLMKA-GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFV  205 (604)
Q Consensus       127 ~~ggsL~~~l~~-~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~~~~~~  205 (604)
                      |.++++..++.. +.+++..++.+++||+.||+|||++||+||||||+|||++.++.+||+|||+|+............+
T Consensus        82 ~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~~~~~~  161 (299)
T d1ua2a_          82 METDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQV  161 (299)
T ss_dssp             CSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCCCCCSC
T ss_pred             hcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCCCccccccee
Confidence            999988877764 5799999999999999999999999999999999999999999999999999988776666666778


Q ss_pred             cCCCCCChHHhhc-CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCC----------------------CCC
Q psy1546         206 GTPFWMAPEVIKQ-SAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKN----------------------NPP  262 (604)
Q Consensus       206 GT~~Y~APE~l~~-~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~----------------------~~~  262 (604)
                      ||+.|||||++.+ ..|+.++|||||||+||||++|.+||.+....+.+..+...                      ..+
T Consensus       162 gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (299)
T d1ua2a_         162 VTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFP  241 (299)
T ss_dssp             CCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCC
T ss_pred             cChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhhccCC
Confidence            9999999999875 45899999999999999999999999988776655432110                      000


Q ss_pred             -----CCCccchHHHHHHHHHHhccCCCCCCCHHHHhcChhhhhh
Q psy1546         263 -----QLTGNYTKQFKEFVEACLNKDPENRPTAKELLKFPFIRKA  302 (604)
Q Consensus       263 -----~~~~~~s~~l~~Li~~~L~~dP~~RpT~~elL~hp~f~~~  302 (604)
                           .+...+++++.+||.+||..||++|||++|+|+||||+..
T Consensus       242 ~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~  286 (299)
T d1ua2a_         242 GIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNR  286 (299)
T ss_dssp             CCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSS
T ss_pred             CCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCC
Confidence                 0113467899999999999999999999999999999753

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=3.4e-51  Score=418.24  Aligned_cols=244  Identities=28%  Similarity=0.471  Sum_probs=212.2

Q ss_pred             ccceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhh--------HHHHHHHHHHHHHHhhCC-CCCCCe--------
Q psy1546          57 LIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA--------EDEIEDIQQEIMVLSQCD-SPYGTK--------  119 (604)
Q Consensus        57 ~~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~--------~~~~~~l~~Ei~iL~~l~-hp~~~~--------  119 (604)
                      +.|++.+.||+|+||+||+|++..+++.||||++.+...        ....+.+.+|+.+|+++. |||+++        
T Consensus         3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~   82 (277)
T d1phka_           3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN   82 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred             ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence            359999999999999999999999999999999865421        223456889999999997 999665        


Q ss_pred             --EEEEEEecCCCChhhHhhc-CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccC
Q psy1546         120 --LWIIMEYLGGGSALDLMKA-GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTN  196 (604)
Q Consensus       120 --lyLVmEy~~ggsL~~~l~~-~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~  196 (604)
                        +|||||||+||+|.++++. +.+++..++.|+.||+.||+|||++||+||||||+||||+.++.+||+|||+|+.+..
T Consensus        83 ~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~  162 (277)
T d1phka_          83 TFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDP  162 (277)
T ss_dssp             SEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCT
T ss_pred             cceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchheeEccC
Confidence              4799999999999999954 7899999999999999999999999999999999999999999999999999987654


Q ss_pred             CCCCCcccccCCCCCChHHhhc------CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCCC---CCCCCcc
Q psy1546         197 TTSKRNTFVGTPFWMAPEVIKQ------SAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNN---PPQLTGN  267 (604)
Q Consensus       197 ~~~~~~~~~GT~~Y~APE~l~~------~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~~---~~~~~~~  267 (604)
                      . ......+||+.|+|||++.+      ..++.++|||||||+||+|++|..||.+.+.......+....   +......
T Consensus       163 ~-~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~  241 (277)
T d1phka_         163 G-EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDD  241 (277)
T ss_dssp             T-CCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTGGG
T ss_pred             C-CceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCCCCCccccc
Confidence            3 33455789999999999963      346789999999999999999999999998877766554443   2234457


Q ss_pred             chHHHHHHHHHHhccCCCCCCCHHHHhcChhhhh
Q psy1546         268 YTKQFKEFVEACLNKDPENRPTAKELLKFPFIRK  301 (604)
Q Consensus       268 ~s~~l~~Li~~~L~~dP~~RpT~~elL~hp~f~~  301 (604)
                      +++++++||.+||+.||.+|||++|||+||||++
T Consensus       242 ~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~  275 (277)
T d1phka_         242 YSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ  275 (277)
T ss_dssp             SCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCT
T ss_pred             CCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHH
Confidence            8999999999999999999999999999999975

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-51  Score=428.28  Aligned_cols=242  Identities=22%  Similarity=0.384  Sum_probs=212.3

Q ss_pred             cceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCCeE----------EEEEEec
Q psy1546          58 IFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTKL----------WIIMEYL  127 (604)
Q Consensus        58 ~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~~l----------yLVmEy~  127 (604)
                      .|.+++.||+|+||+||+|.++.+++.||||+++.....  ...+.+|+.+|+.++|||++++          |||||||
T Consensus         6 rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~--~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~   83 (321)
T d1tkia_           6 KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD--QVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFI   83 (321)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHH--HHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             ceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCccc--HHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecC
Confidence            499999999999999999999999999999999766433  3567899999999999996654          7999999


Q ss_pred             CCCChhhHhhc--CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCC--CCeEEecccccccccCCCCCCcc
Q psy1546         128 GGGSALDLMKA--GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEM--GDVKLADFGVAGTLTNTTSKRNT  203 (604)
Q Consensus       128 ~ggsL~~~l~~--~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~--g~vKL~DFGlA~~~~~~~~~~~~  203 (604)
                      +||+|.+++..  ..+++.+++.|+.||+.||+|||++||+||||||+|||++.+  +.+||+|||+++.... .....+
T Consensus        84 ~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~-~~~~~~  162 (321)
T d1tkia_          84 SGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP-GDNFRL  162 (321)
T ss_dssp             CCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCT-TCEEEE
T ss_pred             CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhcccc-CCcccc
Confidence            99999999965  369999999999999999999999999999999999999854  4799999999976643 333456


Q ss_pred             cccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCCCCC---CCCccchHHHHHHHHHHh
Q psy1546         204 FVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPP---QLTGNYTKQFKEFVEACL  280 (604)
Q Consensus       204 ~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~~~~---~~~~~~s~~l~~Li~~~L  280 (604)
                      .+||+.|+|||++.+..|+.++|||||||+||+|++|.+||...+..++...+......   .....+++++++||.+||
T Consensus       163 ~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L  242 (321)
T d1tkia_         163 LFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRLL  242 (321)
T ss_dssp             EESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHTTS
T ss_pred             cccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhhccCCCHHHHHHHHHHc
Confidence            78999999999999999999999999999999999999999999888777766554432   222467899999999999


Q ss_pred             ccCCCCCCCHHHHhcChhhhhh
Q psy1546         281 NKDPENRPTAKELLKFPFIRKA  302 (604)
Q Consensus       281 ~~dP~~RpT~~elL~hp~f~~~  302 (604)
                      ..||.+|||++|+|+||||++.
T Consensus       243 ~~dp~~R~s~~eil~hp~~~~~  264 (321)
T d1tkia_         243 VKERKSRMTASEALQHPWLKQK  264 (321)
T ss_dssp             CSSGGGSCCHHHHHHSHHHHSC
T ss_pred             cCChhHCcCHHHHhcCHhhccC
Confidence            9999999999999999999753

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-50  Score=416.36  Aligned_cols=242  Identities=26%  Similarity=0.462  Sum_probs=212.8

Q ss_pred             cceeee-EEcccCcEEEEEEEECC--CCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCCeE---------EEEEE
Q psy1546          58 IFTKQE-RIGKGSFGEVFKGIDNR--TQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTKL---------WIIME  125 (604)
Q Consensus        58 ~y~i~~-~LG~G~fG~Vy~a~~~~--t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~~l---------yLVmE  125 (604)
                      .|.+.+ +||+|+||+||+|.++.  ++..||||+++........+.+.+|+.+|++++|||++++         |||||
T Consensus         9 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~lvmE   88 (285)
T d1u59a_           9 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEALMLVME   88 (285)
T ss_dssp             GEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESSSEEEEEE
T ss_pred             CeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeeccCeEEEEEE
Confidence            366666 49999999999998764  4557999999776666667889999999999999997665         69999


Q ss_pred             ecCCCChhhHhhc--CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCC---C
Q psy1546         126 YLGGGSALDLMKA--GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTS---K  200 (604)
Q Consensus       126 y~~ggsL~~~l~~--~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~---~  200 (604)
                      ||++|+|.+++..  +.+++..+..|+.||+.||.|||++||+||||||+||||+.++.+||+|||+|+.+.....   .
T Consensus        89 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~  168 (285)
T d1u59a_          89 MAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTA  168 (285)
T ss_dssp             CCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECC
T ss_pred             eCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhhccccccccccc
Confidence            9999999998754  5799999999999999999999999999999999999999999999999999987654322   2


Q ss_pred             CcccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHhhhcCCCCCCCCCccchHHHHHHHHHH
Q psy1546         201 RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAK-GEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEAC  279 (604)
Q Consensus       201 ~~~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~~  279 (604)
                      ....+||+.|||||++.+..|+.++|||||||+||||++ |..||.+....++...+..+..+.++..+++++.+||.+|
T Consensus       169 ~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~c  248 (285)
T d1u59a_         169 RSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELYALMSDC  248 (285)
T ss_dssp             CCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCCCTTCCHHHHHHHHHT
T ss_pred             ccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHHHHHH
Confidence            334578999999999999999999999999999999998 9999999888888888888888888899999999999999


Q ss_pred             hccCCCCCCCHHHH---hcChhh
Q psy1546         280 LNKDPENRPTAKEL---LKFPFI  299 (604)
Q Consensus       280 L~~dP~~RpT~~el---L~hp~f  299 (604)
                      |+.||++|||+.+|   |+|+|+
T Consensus       249 l~~~p~~RPs~~~i~~~L~~~~~  271 (285)
T d1u59a_         249 WIYKWEDRPDFLTVEQRMRACYY  271 (285)
T ss_dssp             TCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             cCCCHhHCcCHHHHHHHHHHHHH
Confidence            99999999999988   456665

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.3e-50  Score=415.94  Aligned_cols=249  Identities=24%  Similarity=0.440  Sum_probs=213.2

Q ss_pred             cccCccccceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCCeE----------
Q psy1546          51 LKVDPELIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTKL----------  120 (604)
Q Consensus        51 ~~~~~~~~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~~l----------  120 (604)
                      |.++.+ .|++.++||+|+||+||+|.+..+++.||||++.....  ..+.+.+|+.+|++++|||++++          
T Consensus        12 wei~~~-~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~--~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~   88 (287)
T d1opja_          12 WEMERT-DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM--EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPF   88 (287)
T ss_dssp             TBCCGG-GEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCS--CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             cEecHH-HeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccc--hHHHHHHHHHHHHhCCCCCEecCCccEeeCCee
Confidence            444443 48999999999999999999999999999999975543  24678999999999999997765          


Q ss_pred             EEEEEecCCCChhhHhhc---CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCC
Q psy1546         121 WIIMEYLGGGSALDLMKA---GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNT  197 (604)
Q Consensus       121 yLVmEy~~ggsL~~~l~~---~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~  197 (604)
                      |||||||++|+|.+++..   ..+++..+..|+.||+.||+|||++||+||||||+||||+.++.+||+|||+|+.....
T Consensus        89 ~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~  168 (287)
T d1opja_          89 YIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD  168 (287)
T ss_dssp             EEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSS
T ss_pred             EEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEccccceeecCCC
Confidence            699999999999999864   46899999999999999999999999999999999999999999999999999876543


Q ss_pred             CCC-CcccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCC-CCCCCChhhHhhhcCCCCCCCCCccchHHHHHH
Q psy1546         198 TSK-RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEP-PNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEF  275 (604)
Q Consensus       198 ~~~-~~~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~-Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~L  275 (604)
                      ... .....||+.|||||++.+..|+.++|||||||+||||++|.. ||.+.+...+...+..+..+.++..+++++.+|
T Consensus       169 ~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~l  248 (287)
T d1opja_         169 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYEL  248 (287)
T ss_dssp             SSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHH
T ss_pred             CceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCCCCCCCccchHHHHHH
Confidence            322 233458999999999999999999999999999999999655 566666666666666666777888899999999


Q ss_pred             HHHHhccCCCCCCCHHHHhcChhhhhhhh
Q psy1546         276 VEACLNKDPENRPTAKELLKFPFIRKAKK  304 (604)
Q Consensus       276 i~~~L~~dP~~RpT~~elL~hp~f~~~~~  304 (604)
                      |.+||..||++|||+.||++  +|.....
T Consensus       249 i~~cl~~dP~~Rps~~ei~~--~L~~~~~  275 (287)
T d1opja_         249 MRACWQWNPSDRPSFAEIHQ--AFETMFQ  275 (287)
T ss_dssp             HHHHTCSSGGGSCCHHHHHH--HHHHTTS
T ss_pred             HHHHcCCCHhHCcCHHHHHH--HHHHHHH
Confidence            99999999999999999976  5554433

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-50  Score=417.25  Aligned_cols=247  Identities=30%  Similarity=0.462  Sum_probs=204.6

Q ss_pred             cceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHH-HHHHHHHHHHHHhhCCCCCCCeE----------EEEEEe
Q psy1546          58 IFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAED-EIEDIQQEIMVLSQCDSPYGTKL----------WIIMEY  126 (604)
Q Consensus        58 ~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~-~~~~l~~Ei~iL~~l~hp~~~~l----------yLVmEy  126 (604)
                      .|.++++||+|+||+||+|++..+++.||||++....... ..+.+.+|+.+|++++|||++++          |+||||
T Consensus         3 ~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e~   82 (298)
T d1gz8a_           3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF   82 (298)
T ss_dssp             TEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             CCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEee
Confidence            4999999999999999999999999999999996554322 24678899999999999996654          799999


Q ss_pred             cCCCChhhHhh--cCCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCCCCccc
Q psy1546         127 LGGGSALDLMK--AGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTF  204 (604)
Q Consensus       127 ~~ggsL~~~l~--~~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~~~~~  204 (604)
                      |.++.+..+..  .+.+++..++.++.||+.||+|||++|||||||||+|||++.++.+||+|||+|+............
T Consensus        83 ~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~~~~~~  162 (298)
T d1gz8a_          83 LHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHE  162 (298)
T ss_dssp             CSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSBCTTCC
T ss_pred             cCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceeccCCcccceee
Confidence            97665544433  3569999999999999999999999999999999999999999999999999998776666666677


Q ss_pred             ccCCCCCChHHhhcCC-CCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCC-----------------CCC----
Q psy1546         205 VGTPFWMAPEVIKQSA-YDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKN-----------------NPP----  262 (604)
Q Consensus       205 ~GT~~Y~APE~l~~~~-~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~-----------------~~~----  262 (604)
                      +||+.|+|||++.... ++.++|||||||+||+|++|+.||.+.+.......+...                 ...    
T Consensus       163 ~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (298)
T d1gz8a_         163 VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPK  242 (298)
T ss_dssp             BCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTSCC
T ss_pred             cccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccccccccccccccc
Confidence            8999999999987766 478999999999999999999999987765544332100                 000    


Q ss_pred             -------CCCccchHHHHHHHHHHhccCCCCCCCHHHHhcChhhhhhhh
Q psy1546         263 -------QLTGNYTKQFKEFVEACLNKDPENRPTAKELLKFPFIRKAKK  304 (604)
Q Consensus       263 -------~~~~~~s~~l~~Li~~~L~~dP~~RpT~~elL~hp~f~~~~~  304 (604)
                             .....+++++++||.+||..||.+|||+.|||+||||+....
T Consensus       243 ~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~~  291 (298)
T d1gz8a_         243 WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK  291 (298)
T ss_dssp             CCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCCC
T ss_pred             ccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCCC
Confidence                   011245789999999999999999999999999999976543

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-50  Score=410.68  Aligned_cols=248  Identities=26%  Similarity=0.454  Sum_probs=215.1

Q ss_pred             CccccCccccceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCCeE--------
Q psy1546          49 NSLKVDPELIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTKL--------  120 (604)
Q Consensus        49 ~~~~~~~~~~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~~l--------  120 (604)
                      ..|.++. ..|++.++||+|+||+||+|.++ +++.||||++......  .+.+.+|+.+|++++|||++++        
T Consensus         6 ~~wei~~-~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~--~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~   81 (272)
T d1qpca_           6 DEWEVPR-ETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMS--PDAFLAEANLMKQLQHQRLVRLYAVVTQEP   81 (272)
T ss_dssp             CTTBCCG-GGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSC--HHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             CCeecCH-HHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCcCC--HHHHHHHHHHHHhCCCCCEeEEEeeeccCC
Confidence            3444443 35899999999999999999976 5778999999755432  3578999999999999997776        


Q ss_pred             -EEEEEecCCCChhhHhhc---CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccC
Q psy1546         121 -WIIMEYLGGGSALDLMKA---GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTN  196 (604)
Q Consensus       121 -yLVmEy~~ggsL~~~l~~---~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~  196 (604)
                       |||||||++|+|.+++..   ..+++..+..|+.||+.||.|||++||+||||||+||||+.++.+||+|||+|+.+..
T Consensus        82 ~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~  161 (272)
T d1qpca_          82 IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIED  161 (272)
T ss_dssp             CEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred             eEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccceEEccC
Confidence             699999999999997754   3699999999999999999999999999999999999999999999999999987754


Q ss_pred             CC-CCCcccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHhhhcCCCCCCCCCccchHHHHH
Q psy1546         197 TT-SKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAK-GEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKE  274 (604)
Q Consensus       197 ~~-~~~~~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~  274 (604)
                      .. .......||+.|||||++.+..|+.++|||||||+||||+| |.+||......++...+..+..+..+..+++++.+
T Consensus       162 ~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~  241 (272)
T d1qpca_         162 NEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQ  241 (272)
T ss_dssp             SCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHH
T ss_pred             CccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCcccChHHHHH
Confidence            33 23345679999999999999999999999999999999999 56677777777777777777777788899999999


Q ss_pred             HHHHHhccCCCCCCCHHHHhc--Chhhh
Q psy1546         275 FVEACLNKDPENRPTAKELLK--FPFIR  300 (604)
Q Consensus       275 Li~~~L~~dP~~RpT~~elL~--hp~f~  300 (604)
                      ||.+||+.||++|||+.||++  ++||.
T Consensus       242 li~~cl~~~P~~Rpt~~ei~~~L~~~ft  269 (272)
T d1qpca_         242 LMRLCWKERPEDRPTFDYLRSVLEDFFT  269 (272)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHHcCCCHhHCcCHHHHHHHhhhhhh
Confidence            999999999999999999998  77875

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-50  Score=413.39  Aligned_cols=237  Identities=26%  Similarity=0.443  Sum_probs=205.1

Q ss_pred             eEEcccCcEEEEEEEEC--CCCcEEEEEEecchhh-HHHHHHHHHHHHHHhhCCCCCCCeE---------EEEEEecCCC
Q psy1546          63 ERIGKGSFGEVFKGIDN--RTQQVVAIKIIDLEEA-EDEIEDIQQEIMVLSQCDSPYGTKL---------WIIMEYLGGG  130 (604)
Q Consensus        63 ~~LG~G~fG~Vy~a~~~--~t~~~vAVK~i~~~~~-~~~~~~l~~Ei~iL~~l~hp~~~~l---------yLVmEy~~gg  130 (604)
                      ++||+|+||+||+|.+.  .+++.||||++..... ....+.+.+|+.+|++++|||++++         |||||||++|
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~~~~lvmE~~~~g   92 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELG   92 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESSSEEEEEECCTTE
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccCCEEEEEEcCCCC
Confidence            57999999999999864  4567899999965433 2345678999999999999997665         6999999999


Q ss_pred             ChhhHhhc-CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCC---CCccccc
Q psy1546         131 SALDLMKA-GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTS---KRNTFVG  206 (604)
Q Consensus       131 sL~~~l~~-~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~---~~~~~~G  206 (604)
                      +|.++++. +.+++..+..|+.||+.||.|||++|||||||||+||||+.++.+||+|||+|+.+.....   ......|
T Consensus        93 ~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~g  172 (277)
T d1xbba_          93 PLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKW  172 (277)
T ss_dssp             EHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC----CC
T ss_pred             cHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhccccccccccccccCC
Confidence            99999876 6799999999999999999999999999999999999999999999999999987653322   2234579


Q ss_pred             CCCCCChHHhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHhhhcCCCCCCCCCccchHHHHHHHHHHhccCCC
Q psy1546         207 TPFWMAPEVIKQSAYDSKADIWSLGITAIELAK-GEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKDPE  285 (604)
Q Consensus       207 T~~Y~APE~l~~~~~~~~sDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~~L~~dP~  285 (604)
                      |+.|||||++.+..|+.++|||||||++|||++ |.+||.+....++...+..+..+.++..+++++.+||.+||+.||.
T Consensus       173 t~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~~~~li~~cl~~dp~  252 (277)
T d1xbba_         173 PVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVE  252 (277)
T ss_dssp             CGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSTT
T ss_pred             CceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHHHHHHHcCCCHh
Confidence            999999999999999999999999999999997 8999999988888888888888888889999999999999999999


Q ss_pred             CCCCHHHHh---cChhh
Q psy1546         286 NRPTAKELL---KFPFI  299 (604)
Q Consensus       286 ~RpT~~elL---~hp~f  299 (604)
                      +|||+.+|+   +|+|+
T Consensus       253 ~RPs~~~i~~~L~~~~~  269 (277)
T d1xbba_         253 NRPGFAAVELRLRNYYY  269 (277)
T ss_dssp             TSCCHHHHHHHHHHHHH
T ss_pred             HCcCHHHHHHHhhCHHh
Confidence            999999984   55554

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=2.9e-50  Score=415.55  Aligned_cols=239  Identities=28%  Similarity=0.445  Sum_probs=201.4

Q ss_pred             cceeeeEEcccCcEEEEEEEECCCCc---EEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCCeE----------EEEE
Q psy1546          58 IFTKQERIGKGSFGEVFKGIDNRTQQ---VVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTKL----------WIIM  124 (604)
Q Consensus        58 ~y~i~~~LG~G~fG~Vy~a~~~~t~~---~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~~l----------yLVm  124 (604)
                      .|.+.++||+|+||+||+|++..+++   .||||.+.........+.+.+|+.+|++++|||++++          ||||
T Consensus        27 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv~  106 (299)
T d1jpaa_          27 CVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIIT  106 (299)
T ss_dssp             GEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred             hcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEE
Confidence            48999999999999999999887664   6899998766666667889999999999999998765          6999


Q ss_pred             EecCCCChhhHhhc--CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCCC--
Q psy1546         125 EYLGGGSALDLMKA--GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSK--  200 (604)
Q Consensus       125 Ey~~ggsL~~~l~~--~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~--  200 (604)
                      |||++|+|.+++..  +.+++.++..|+.||+.||.|||++||+||||||+||||+.++.+||+|||+|+.+......  
T Consensus       107 Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~  186 (299)
T d1jpaa_         107 EFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPT  186 (299)
T ss_dssp             ECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC--------------
T ss_pred             EecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccceEccCCCCcce
Confidence            99999999998865  46999999999999999999999999999999999999999999999999999876533221  


Q ss_pred             ---CcccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHhhhcCCCCCCCCCccchHHHHHHH
Q psy1546         201 ---RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAK-GEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFV  276 (604)
Q Consensus       201 ---~~~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li  276 (604)
                         .....||+.|||||++.+..|+.++|||||||+||||++ |.+||.+....++...+..+.....+..+++++.+||
T Consensus       187 ~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li  266 (299)
T d1jpaa_         187 YTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPMDCPSALHQLM  266 (299)
T ss_dssp             ---------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHH
T ss_pred             eeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCccchHHHHHHH
Confidence               122458999999999999999999999999999999998 8999999998888888877777777888999999999


Q ss_pred             HHHhccCCCCCCCHHHHhcC
Q psy1546         277 EACLNKDPENRPTAKELLKF  296 (604)
Q Consensus       277 ~~~L~~dP~~RpT~~elL~h  296 (604)
                      .+||+.||.+|||+.||+++
T Consensus       267 ~~cl~~~P~~RPs~~ei~~~  286 (299)
T d1jpaa_         267 LDCWQKDRNHRPKFGQIVNT  286 (299)
T ss_dssp             HHHTCSSTTTSCCHHHHHHH
T ss_pred             HHHcCCCHhHCcCHHHHHHH
Confidence            99999999999999999874

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-50  Score=423.22  Aligned_cols=238  Identities=28%  Similarity=0.447  Sum_probs=199.1

Q ss_pred             cceee-eEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHh-hCCCCCCCe--------------EE
Q psy1546          58 IFTKQ-ERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLS-QCDSPYGTK--------------LW  121 (604)
Q Consensus        58 ~y~i~-~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~-~l~hp~~~~--------------ly  121 (604)
                      .|.+. +.||+|+||+||+|++..+++.||||++...      ..+.+|+.++. .++|||+++              +|
T Consensus        12 ~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~   85 (335)
T d2ozaa1          12 DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL   85 (335)
T ss_dssp             TEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred             CEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc------HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEE
Confidence            37776 4699999999999999999999999998643      45678998865 568999654              48


Q ss_pred             EEEEecCCCChhhHhhc---CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecC---CCCeEEeccccccccc
Q psy1546         122 IIMEYLGGGSALDLMKA---GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSE---MGDVKLADFGVAGTLT  195 (604)
Q Consensus       122 LVmEy~~ggsL~~~l~~---~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~---~g~vKL~DFGlA~~~~  195 (604)
                      ||||||+||+|.+++..   ..|++.+++.|+.||+.||+|||++||+||||||+|||++.   .+.+||+|||+|+...
T Consensus        86 ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~  165 (335)
T d2ozaa1          86 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT  165 (335)
T ss_dssp             EEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTTCEECC
T ss_pred             EEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccccceeeecc
Confidence            99999999999999965   36999999999999999999999999999999999999975   5679999999997765


Q ss_pred             CCCCCCcccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhh----hcCCCCC---CCCCccc
Q psy1546         196 NTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLF----LIPKNNP---PQLTGNY  268 (604)
Q Consensus       196 ~~~~~~~~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~----~i~~~~~---~~~~~~~  268 (604)
                      .. ......+||+.|||||++.+..|+.++|||||||+||+|++|.+||.+.+......    .+.....   ......+
T Consensus       166 ~~-~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~  244 (335)
T d2ozaa1         166 SH-NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEV  244 (335)
T ss_dssp             CC-CCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSSCCTTHHHHS
T ss_pred             CC-CccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCcccccC
Confidence            43 33456789999999999999999999999999999999999999998766544332    2222211   1122367


Q ss_pred             hHHHHHHHHHHhccCCCCCCCHHHHhcChhhhhh
Q psy1546         269 TKQFKEFVEACLNKDPENRPTAKELLKFPFIRKA  302 (604)
Q Consensus       269 s~~l~~Li~~~L~~dP~~RpT~~elL~hp~f~~~  302 (604)
                      ++++++||.+||..||.+|||+.|||+||||.+.
T Consensus       245 s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~  278 (335)
T d2ozaa1         245 SEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS  278 (335)
T ss_dssp             CHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTT
T ss_pred             CHHHHHHHHHHccCChhHCcCHHHHHcCHHhhCC
Confidence            8999999999999999999999999999999754

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.2e-50  Score=413.15  Aligned_cols=245  Identities=27%  Similarity=0.441  Sum_probs=200.7

Q ss_pred             ccceeeeEEcccCcEEEEEEEECCC-CcEEEEEEecchhhHH-HHHHHHHHHHHHhh---CCCCCCCe------------
Q psy1546          57 LIFTKQERIGKGSFGEVFKGIDNRT-QQVVAIKIIDLEEAED-EIEDIQQEIMVLSQ---CDSPYGTK------------  119 (604)
Q Consensus        57 ~~y~i~~~LG~G~fG~Vy~a~~~~t-~~~vAVK~i~~~~~~~-~~~~l~~Ei~iL~~---l~hp~~~~------------  119 (604)
                      ..|+++++||+|+||+||+|++..+ ++.||||++....... ....+.+|+.+|+.   ++|||+.+            
T Consensus         7 ~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~   86 (305)
T d1blxa_           7 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   86 (305)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSS
T ss_pred             CCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccccc
Confidence            4599999999999999999999765 6789999986543221 12345566666655   48999654            


Q ss_pred             ---EEEEEEecCCCChhhHh--hcCCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccc
Q psy1546         120 ---LWIIMEYLGGGSALDLM--KAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTL  194 (604)
Q Consensus       120 ---lyLVmEy~~ggsL~~~l--~~~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~  194 (604)
                         +|++||||+++.+....  ....+++..++.++.||+.||+|||++|||||||||+|||++.++.+||+|||+++..
T Consensus        87 ~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg~~~~~  166 (305)
T d1blxa_          87 ETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIY  166 (305)
T ss_dssp             EEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCCCC
T ss_pred             CceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecchhhhhhh
Confidence               47999999988776544  3367999999999999999999999999999999999999999999999999999655


Q ss_pred             cCCCCCCcccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCC----------------
Q psy1546         195 TNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPK----------------  258 (604)
Q Consensus       195 ~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~----------------  258 (604)
                      .. .......+||+.|||||++.+..|+.++|||||||+||||++|.+||.+.+..+.+..+..                
T Consensus       167 ~~-~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  245 (305)
T d1blxa_         167 SF-QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVAL  245 (305)
T ss_dssp             CG-GGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCSS
T ss_pred             cc-cccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcccccccc
Confidence            42 3344567899999999999999999999999999999999999999998876554433210                


Q ss_pred             ----------CCCCCCCccchHHHHHHHHHHhccCCCCCCCHHHHhcChhhhhh
Q psy1546         259 ----------NNPPQLTGNYTKQFKEFVEACLNKDPENRPTAKELLKFPFIRKA  302 (604)
Q Consensus       259 ----------~~~~~~~~~~s~~l~~Li~~~L~~dP~~RpT~~elL~hp~f~~~  302 (604)
                                .....+...+++.+++||.+||..||.+|||+.|+|+||||+..
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i  299 (305)
T d1blxa_         246 PRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDL  299 (305)
T ss_dssp             CGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTC
T ss_pred             hhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCc
Confidence                      00112345678899999999999999999999999999999764

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-50  Score=410.91  Aligned_cols=239  Identities=26%  Similarity=0.443  Sum_probs=200.2

Q ss_pred             ccceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHH-----HHHHHHHHHHHHhhCC--CCCCCeE---------
Q psy1546          57 LIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAED-----EIEDIQQEIMVLSQCD--SPYGTKL---------  120 (604)
Q Consensus        57 ~~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~-----~~~~l~~Ei~iL~~l~--hp~~~~l---------  120 (604)
                      ..|++.++||+|+||+||+|++..+++.||||++.......     ....+.+|+.+|+++.  |||++++         
T Consensus         4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~   83 (273)
T d1xwsa_           4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS   83 (273)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred             CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence            35999999999999999999999999999999996543211     1234668999999987  7886654         


Q ss_pred             -EEEEEecCC-CChhhHhh-cCCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecC-CCCeEEecccccccccC
Q psy1546         121 -WIIMEYLGG-GSALDLMK-AGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSE-MGDVKLADFGVAGTLTN  196 (604)
Q Consensus       121 -yLVmEy~~g-gsL~~~l~-~~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~-~g~vKL~DFGlA~~~~~  196 (604)
                       |+||||+.+ +++.+++. .+.+++..++.++.||+.||.|||++||+||||||+||||+. ++.+||+|||+|+....
T Consensus        84 ~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~~~  163 (273)
T d1xwsa_          84 FVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKD  163 (273)
T ss_dssp             EEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCS
T ss_pred             EEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECccccceeccc
Confidence             799999976 67777775 478999999999999999999999999999999999999985 47999999999976543


Q ss_pred             CCCCCcccccCCCCCChHHhhcCCC-CCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCCCCCCCCccchHHHHHH
Q psy1546         197 TTSKRNTFVGTPFWMAPEVIKQSAY-DSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEF  275 (604)
Q Consensus       197 ~~~~~~~~~GT~~Y~APE~l~~~~~-~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~L  275 (604)
                        ....+.+||+.|||||++.+..+ +.++|||||||+||||++|..||.....  +..     ....++..+++++++|
T Consensus       164 --~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~--i~~-----~~~~~~~~~s~~~~~l  234 (273)
T d1xwsa_         164 --TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE--IIR-----GQVFFRQRVSSECQHL  234 (273)
T ss_dssp             --SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH--HHH-----CCCCCSSCCCHHHHHH
T ss_pred             --ccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchH--Hhh-----cccCCCCCCCHHHHHH
Confidence              23456789999999999988776 5678999999999999999999976432  211     1223556789999999


Q ss_pred             HHHHhccCCCCCCCHHHHhcChhhhhhhh
Q psy1546         276 VEACLNKDPENRPTAKELLKFPFIRKAKK  304 (604)
Q Consensus       276 i~~~L~~dP~~RpT~~elL~hp~f~~~~~  304 (604)
                      |.+||..||.+|||++|+|+||||++...
T Consensus       235 i~~~L~~dp~~R~s~~eil~hp~~~~~~~  263 (273)
T d1xwsa_         235 IRWCLALRPSDRPTFEEIQNHPWMQDVLL  263 (273)
T ss_dssp             HHHHTCSSGGGSCCHHHHHTSGGGSSCCC
T ss_pred             HHHHccCCHhHCcCHHHHhcCHhhCCCCC
Confidence            99999999999999999999999987543

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.6e-50  Score=403.99  Aligned_cols=236  Identities=27%  Similarity=0.402  Sum_probs=198.5

Q ss_pred             cceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCCeE----------EEEEEec
Q psy1546          58 IFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTKL----------WIIMEYL  127 (604)
Q Consensus        58 ~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~~l----------yLVmEy~  127 (604)
                      .|+++++||+|+||+||+|.+. +++.||||++......  .+.+.+|+.++++++|||++++          |||||||
T Consensus         6 ~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~--~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~   82 (263)
T d1sm2a_           6 ELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS--EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM   82 (263)
T ss_dssp             CEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSSC--HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred             HcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcCc--HHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEec
Confidence            3899999999999999999986 5678999999764433  2568999999999999998776          6999999


Q ss_pred             CCCChhhHhhc--CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCC-CCccc
Q psy1546         128 GGGSALDLMKA--GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTS-KRNTF  204 (604)
Q Consensus       128 ~ggsL~~~l~~--~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~-~~~~~  204 (604)
                      ++|+|.+++..  ..+++..+..|+.||+.||+|||+++|+||||||+||||+.++.+||+|||+|+.+..... .....
T Consensus        83 ~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~  162 (263)
T d1sm2a_          83 EHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGT  162 (263)
T ss_dssp             TTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC----------------
T ss_pred             CCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheeccCCCceeecce
Confidence            99999998855  5688999999999999999999999999999999999999999999999999987654332 23346


Q ss_pred             ccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHhhhcCCCCCCCCCccchHHHHHHHHHHhccC
Q psy1546         205 VGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAK-GEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKD  283 (604)
Q Consensus       205 ~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~~L~~d  283 (604)
                      .||+.|||||++.+..|+.++|||||||+||||++ |.+||......++...+..+.....+..+++++.+||.+||+.|
T Consensus       163 ~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~~  242 (263)
T d1sm2a_         163 KFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWKER  242 (263)
T ss_dssp             --CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSS
T ss_pred             ecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCCCCccccCHHHHHHHHHHccCC
Confidence            79999999999999999999999999999999999 67778887777777777777777777888999999999999999


Q ss_pred             CCCCCCHHHHhcC
Q psy1546         284 PENRPTAKELLKF  296 (604)
Q Consensus       284 P~~RpT~~elL~h  296 (604)
                      |.+|||++||++|
T Consensus       243 p~~Rps~~~il~~  255 (263)
T d1sm2a_         243 PEDRPAFSRLLRQ  255 (263)
T ss_dssp             GGGSCCHHHHHHH
T ss_pred             HhHCcCHHHHHHH
Confidence            9999999999986

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=1.4e-49  Score=406.68  Aligned_cols=243  Identities=28%  Similarity=0.442  Sum_probs=200.8

Q ss_pred             cceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhh-HHHHHHHHHHHHHHhhCCCCCCCeE----------EEEEEe
Q psy1546          58 IFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA-EDEIEDIQQEIMVLSQCDSPYGTKL----------WIIMEY  126 (604)
Q Consensus        58 ~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~-~~~~~~l~~Ei~iL~~l~hp~~~~l----------yLVmEy  126 (604)
                      .|.++++||+|+||+||+|+++ +++.||||++..... ....+.+.+|+.+|++++|||++++          |+||||
T Consensus         3 ~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~   81 (286)
T d1ob3a_           3 KYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (286)
T ss_dssp             SEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence            4899999999999999999986 789999999976543 2235778999999999999997765          699999


Q ss_pred             cCCCChhhHhh-cCCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCCCCcccc
Q psy1546         127 LGGGSALDLMK-AGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFV  205 (604)
Q Consensus       127 ~~ggsL~~~l~-~~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~~~~~~  205 (604)
                      +.++.+..+.. .+.+++..++.++.||+.||+|||++|||||||||+||||+.++.+||+|||+|..............
T Consensus        82 ~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~  161 (286)
T d1ob3a_          82 LDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEI  161 (286)
T ss_dssp             CSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---------
T ss_pred             ehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceecccCccccceec
Confidence            98888877766 47799999999999999999999999999999999999999999999999999987765555556678


Q ss_pred             cCCCCCChHHhhcC-CCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCC--------------------------
Q psy1546         206 GTPFWMAPEVIKQS-AYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPK--------------------------  258 (604)
Q Consensus       206 GT~~Y~APE~l~~~-~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~--------------------------  258 (604)
                      |++.|+|||++.+. .++.++|||||||++|||++|++||.+.+..+....+..                          
T Consensus       162 ~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (286)
T d1ob3a_         162 VTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVY  241 (286)
T ss_dssp             CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCC
T ss_pred             ccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhcccccccc
Confidence            99999999999765 468999999999999999999999988766544332110                          


Q ss_pred             --CCCCCCCccchHHHHHHHHHHhccCCCCCCCHHHHhcChhhhh
Q psy1546         259 --NNPPQLTGNYTKQFKEFVEACLNKDPENRPTAKELLKFPFIRK  301 (604)
Q Consensus       259 --~~~~~~~~~~s~~l~~Li~~~L~~dP~~RpT~~elL~hp~f~~  301 (604)
                        .........+++.+.+||.+||..||++|||+.|||+||||++
T Consensus       242 ~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~  286 (286)
T d1ob3a_         242 EPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE  286 (286)
T ss_dssp             CCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred             cCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence              0001223456889999999999999999999999999999974

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.7e-50  Score=416.57  Aligned_cols=240  Identities=25%  Similarity=0.405  Sum_probs=203.4

Q ss_pred             ccceeeeEEcccCcEEEEEEEECCCCc-----EEEEEEecchhhHHHHHHHHHHHHHHhhC-CCCCCCeE----------
Q psy1546          57 LIFTKQERIGKGSFGEVFKGIDNRTQQ-----VVAIKIIDLEEAEDEIEDIQQEIMVLSQC-DSPYGTKL----------  120 (604)
Q Consensus        57 ~~y~i~~~LG~G~fG~Vy~a~~~~t~~-----~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l-~hp~~~~l----------  120 (604)
                      +.|.++++||+|+||+||+|++..+++     .||||++...........+.+|+.+|.++ +|||++++          
T Consensus        37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~  116 (325)
T d1rjba_          37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPI  116 (325)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeE
Confidence            358999999999999999999876543     69999987665555567889999999988 89997775          


Q ss_pred             EEEEEecCCCChhhHhhcC------------------------CCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeE
Q psy1546         121 WIIMEYLGGGSALDLMKAG------------------------NFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVL  176 (604)
Q Consensus       121 yLVmEy~~ggsL~~~l~~~------------------------~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NIL  176 (604)
                      |||||||++|+|.++++..                        .+++..++.|+.||+.||.|||++|||||||||+|||
T Consensus       117 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlKp~Nil  196 (325)
T d1rjba_         117 YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVL  196 (325)
T ss_dssp             EEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGEE
T ss_pred             EEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCchhccc
Confidence            6999999999999998642                        3888999999999999999999999999999999999


Q ss_pred             ecCCCCeEEecccccccccCCCC--CCcccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHh
Q psy1546         177 LSEMGDVKLADFGVAGTLTNTTS--KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAK-GEPPNSELHPMRVL  253 (604)
Q Consensus       177 l~~~g~vKL~DFGlA~~~~~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLlt-G~~Pf~~~~~~~~~  253 (604)
                      ++.++.+||+|||+|+.......  ...+..||+.|||||++.+..|+.++|||||||+||||++ |.+||.+......+
T Consensus       197 l~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~~~~  276 (325)
T d1rjba_         197 VTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANF  276 (325)
T ss_dssp             EETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHH
T ss_pred             cccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCHHHHH
Confidence            99999999999999987654332  2345678999999999999999999999999999999997 89999887665444


Q ss_pred             h-hcCCCCCCCCCccchHHHHHHHHHHhccCCCCCCCHHHHhcC
Q psy1546         254 F-LIPKNNPPQLTGNYTKQFKEFVEACLNKDPENRPTAKELLKF  296 (604)
Q Consensus       254 ~-~i~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~RpT~~elL~h  296 (604)
                      . .+.....+..+..+++++++||.+||+.||++|||++||++|
T Consensus       277 ~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~  320 (325)
T d1rjba_         277 YKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF  320 (325)
T ss_dssp             HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            3 344445566778899999999999999999999999999986

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.3e-50  Score=409.09  Aligned_cols=236  Identities=29%  Similarity=0.531  Sum_probs=195.4

Q ss_pred             cceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchh-hHHHHHHHHHHHHHHhhCCCCCCCeE---------EEEEEec
Q psy1546          58 IFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE-AEDEIEDIQQEIMVLSQCDSPYGTKL---------WIIMEYL  127 (604)
Q Consensus        58 ~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~-~~~~~~~l~~Ei~iL~~l~hp~~~~l---------yLVmEy~  127 (604)
                      .|.+.++||+|+||+||+|+..   ..||||++.... .....+.+.+|+.+|++++|||++++         |||||||
T Consensus         9 ~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~lv~Ey~   85 (276)
T d1uwha_           9 QITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTAPQLAIVTQWC   85 (276)
T ss_dssp             CCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSCEEEEECC
T ss_pred             cEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEeccEEEEEEecC
Confidence            4889999999999999999754   359999986543 23456789999999999999997765         6999999


Q ss_pred             CCCChhhHhhc--CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCC--CCCcc
Q psy1546         128 GGGSALDLMKA--GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTT--SKRNT  203 (604)
Q Consensus       128 ~ggsL~~~l~~--~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~--~~~~~  203 (604)
                      ++|+|.+++..  +.+++..+..|+.||+.||+|||++|||||||||+||||+.++.+||+|||+|+......  .....
T Consensus        86 ~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~~~~~~  165 (276)
T d1uwha_          86 EGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQ  165 (276)
T ss_dssp             CEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC------------
T ss_pred             CCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccceeeccccCCcccccc
Confidence            99999999853  569999999999999999999999999999999999999999999999999997664322  23346


Q ss_pred             cccCCCCCChHHhhcC---CCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhh-hcCCCC----CCCCCccchHHHHHH
Q psy1546         204 FVGTPFWMAPEVIKQS---AYDSKADIWSLGITAIELAKGEPPNSELHPMRVLF-LIPKNN----PPQLTGNYTKQFKEF  275 (604)
Q Consensus       204 ~~GT~~Y~APE~l~~~---~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~-~i~~~~----~~~~~~~~s~~l~~L  275 (604)
                      ..||+.|||||++.+.   .|+.++|||||||+||||++|..||.+........ .+..+.    ...++..+++++.+|
T Consensus       166 ~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~l~~l  245 (276)
T d1uwha_         166 LSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRL  245 (276)
T ss_dssp             CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGGGSCTTCCHHHHHH
T ss_pred             cccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcchhccccchHHHHHH
Confidence            7899999999999643   58899999999999999999999999876554332 222221    223456789999999


Q ss_pred             HHHHhccCCCCCCCHHHHhcC
Q psy1546         276 VEACLNKDPENRPTAKELLKF  296 (604)
Q Consensus       276 i~~~L~~dP~~RpT~~elL~h  296 (604)
                      |.+||..||.+|||+.||+++
T Consensus       246 i~~cl~~dp~~RPt~~~il~~  266 (276)
T d1uwha_         246 MAECLKKKRDERPLFPQILAS  266 (276)
T ss_dssp             HHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHcCCCHhHCcCHHHHHHH
Confidence            999999999999999999986

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=2.8e-49  Score=403.09  Aligned_cols=243  Identities=26%  Similarity=0.461  Sum_probs=201.1

Q ss_pred             ccceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhh--HHHHHHHHHHHHHHhhCCCCCCCe--------------E
Q psy1546          57 LIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA--EDEIEDIQQEIMVLSQCDSPYGTK--------------L  120 (604)
Q Consensus        57 ~~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~--~~~~~~l~~Ei~iL~~l~hp~~~~--------------l  120 (604)
                      +.|++.+.||+|+||+||+|++..+++.||||++.....  ......+.+|+.+|+.++|||+++              +
T Consensus         7 drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~   86 (277)
T d1o6ya_           7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP   86 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred             ceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceE
Confidence            349999999999999999999999999999999976543  344577899999999999999654              4


Q ss_pred             EEEEEecCCCChhhHhhc-CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCC-
Q psy1546         121 WIIMEYLGGGSALDLMKA-GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTT-  198 (604)
Q Consensus       121 yLVmEy~~ggsL~~~l~~-~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~-  198 (604)
                      |||||||+|++|.+++.. +.+++.+++.|+.||+.||.|||++|||||||||+||||+.++.++|+|||.++...... 
T Consensus        87 ~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~~~  166 (277)
T d1o6ya_          87 YIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGN  166 (277)
T ss_dssp             EEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEECC----
T ss_pred             EEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhhhccccc
Confidence            799999999999988754 689999999999999999999999999999999999999999999999999986554322 


Q ss_pred             --CCCcccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCCCC---CCCCccchHHHH
Q psy1546         199 --SKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNP---PQLTGNYTKQFK  273 (604)
Q Consensus       199 --~~~~~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~~~---~~~~~~~s~~l~  273 (604)
                        ......+||+.|||||++.+..|+.++|||||||+||||++|.+||.+.+..+....+....+   ......+++++.
T Consensus       167 ~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~  246 (277)
T d1o6ya_         167 SVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLD  246 (277)
T ss_dssp             ------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGGGTSSSCCHHHH
T ss_pred             cccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCCchhccCCCHHHH
Confidence              234456899999999999999999999999999999999999999999888776655443332   234467899999


Q ss_pred             HHHHHHhccCCCCCC-CHHHHhcChhhh
Q psy1546         274 EFVEACLNKDPENRP-TAKELLKFPFIR  300 (604)
Q Consensus       274 ~Li~~~L~~dP~~Rp-T~~elL~hp~f~  300 (604)
                      +||.+||..||.+|| |++++ .|+|++
T Consensus       247 ~li~~~L~~dp~~R~~sa~~l-~~~l~r  273 (277)
T d1o6ya_         247 AVVLKALAKNPENRYQTAAEM-RADLVR  273 (277)
T ss_dssp             HHHHHHTCSSGGGSCSSHHHH-HHHHHH
T ss_pred             HHHHHHccCCHhHCHhHHHHH-HHHHHH
Confidence            999999999999999 55555 566664

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-49  Score=402.30  Aligned_cols=239  Identities=30%  Similarity=0.425  Sum_probs=203.1

Q ss_pred             cceeeeEEcccCcEEEEEEEECCC---CcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCCeE---------EEEEE
Q psy1546          58 IFTKQERIGKGSFGEVFKGIDNRT---QQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTKL---------WIIME  125 (604)
Q Consensus        58 ~y~i~~~LG~G~fG~Vy~a~~~~t---~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~~l---------yLVmE  125 (604)
                      .|.++++||+|+||+||+|++..+   +..||||++.........+.+.+|+.+|++++|||++++         |||||
T Consensus         8 ~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~iv~E   87 (273)
T d1mp8a_           8 RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPVWIIME   87 (273)
T ss_dssp             GEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSCEEEEE
T ss_pred             HeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCeEEEEEE
Confidence            499999999999999999998654   356899998766666667889999999999999997765         69999


Q ss_pred             ecCCCChhhHhhc--CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCC-CCc
Q psy1546         126 YLGGGSALDLMKA--GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTS-KRN  202 (604)
Q Consensus       126 y~~ggsL~~~l~~--~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~-~~~  202 (604)
                      ||.+|+|.+++..  +.+++..++.++.||+.||.|||++|||||||||+|||++.++.+||+|||+|+.+..... ...
T Consensus        88 ~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~~~~~~~  167 (273)
T d1mp8a_          88 LCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKAS  167 (273)
T ss_dssp             CCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC----------------
T ss_pred             eccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchhheeccCCcceecc
Confidence            9999999998754  5699999999999999999999999999999999999999999999999999987654332 234


Q ss_pred             ccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHhhhcCCCCCCCCCccchHHHHHHHHHHhc
Q psy1546         203 TFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAK-GEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLN  281 (604)
Q Consensus       203 ~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~~L~  281 (604)
                      ...||+.|||||++.+..|+.++|||||||+||||++ |.+||......++...+..+....++..+++++.+||.+||.
T Consensus       168 ~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~cl~  247 (273)
T d1mp8a_         168 KGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTKCWA  247 (273)
T ss_dssp             ---CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTCCHHHHHHHHHHTC
T ss_pred             ceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcC
Confidence            5578999999999999999999999999999999998 899999999988888888887778888999999999999999


Q ss_pred             cCCCCCCCHHHHhcC
Q psy1546         282 KDPENRPTAKELLKF  296 (604)
Q Consensus       282 ~dP~~RpT~~elL~h  296 (604)
                      .||.+|||+.||++|
T Consensus       248 ~dp~~Rps~~ei~~~  262 (273)
T d1mp8a_         248 YDPSRRPRFTELKAQ  262 (273)
T ss_dssp             SSGGGSCCHHHHHHH
T ss_pred             CCHhHCcCHHHHHHH
Confidence            999999999999885

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.7e-49  Score=398.20  Aligned_cols=236  Identities=26%  Similarity=0.411  Sum_probs=211.2

Q ss_pred             cceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCCeE----------EEEEEec
Q psy1546          58 IFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTKL----------WIIMEYL  127 (604)
Q Consensus        58 ~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~~l----------yLVmEy~  127 (604)
                      .|+++++||+|+||+||+|+++ +++.||||+++......  +.+.+|+.++++++|||++++          |+||||+
T Consensus         5 ~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~~--~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~   81 (258)
T d1k2pa_           5 DLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSE--DEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM   81 (258)
T ss_dssp             CCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSSCH--HHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECC
T ss_pred             HCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcCCH--HHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEcc
Confidence            4889999999999999999985 77899999997654332  578999999999999997665          6999999


Q ss_pred             CCCChhhHhhc--CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCC-CCccc
Q psy1546         128 GGGSALDLMKA--GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTS-KRNTF  204 (604)
Q Consensus       128 ~ggsL~~~l~~--~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~-~~~~~  204 (604)
                      ++|+|..++..  ..+++..+..|+.||+.||.|||++||+||||||+||||+.++.+||+|||+|+.+..... .....
T Consensus        82 ~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~  161 (258)
T d1k2pa_          82 ANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGS  161 (258)
T ss_dssp             TTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCCCCCS
T ss_pred             CCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheeccCCCceeeccc
Confidence            99999998643  6799999999999999999999999999999999999999999999999999976654332 23346


Q ss_pred             ccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHhhhcCCCCCCCCCccchHHHHHHHHHHhccC
Q psy1546         205 VGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAK-GEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEACLNKD  283 (604)
Q Consensus       205 ~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~~L~~d  283 (604)
                      .||+.|||||++.+..|+.++|||||||++|||+| |..||.+....++...+..+.....+..+++++.+||.+||+.|
T Consensus       162 ~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~d  241 (258)
T d1k2pa_         162 KFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCWHEK  241 (258)
T ss_dssp             CCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSS
T ss_pred             CCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCCCCCcccccHHHHHHHHHHccCC
Confidence            79999999999999999999999999999999998 89999999998888888887777888899999999999999999


Q ss_pred             CCCCCCHHHHhcC
Q psy1546         284 PENRPTAKELLKF  296 (604)
Q Consensus       284 P~~RpT~~elL~h  296 (604)
                      |.+|||++||++|
T Consensus       242 P~~RPt~~eil~~  254 (258)
T d1k2pa_         242 ADERPTFKILLSN  254 (258)
T ss_dssp             GGGSCCHHHHHHH
T ss_pred             HhHCcCHHHHHHH
Confidence            9999999999986

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.8e-49  Score=413.99  Aligned_cols=247  Identities=28%  Similarity=0.439  Sum_probs=204.5

Q ss_pred             ccceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCCeE--------------EE
Q psy1546          57 LIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTKL--------------WI  122 (604)
Q Consensus        57 ~~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~~l--------------yL  122 (604)
                      ..|+++++||+|+||+||+|.++.+|+.||||++.+.......+.+.+|+.+|+.++||+++++              ++
T Consensus         8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~   87 (345)
T d1pmea_           8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVY   87 (345)
T ss_dssp             TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEE
T ss_pred             CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEE
Confidence            3499999999999999999999999999999999876666667889999999999999986542              35


Q ss_pred             EEEecCCCChhhHhhcCCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCC---C
Q psy1546         123 IMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTT---S  199 (604)
Q Consensus       123 VmEy~~ggsL~~~l~~~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~---~  199 (604)
                      +++|+.+|+|.++++.+.+++..++.++.||+.||+|||++|||||||||+||||+.++.+||+|||+|+......   .
T Consensus        88 l~~~~~~g~L~~~l~~~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~~~~~  167 (345)
T d1pmea_          88 LVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTG  167 (345)
T ss_dssp             EEEECCCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGCBCC
T ss_pred             EEEeecCCchhhhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCceeeccCCCccce
Confidence            5666779999999999999999999999999999999999999999999999999999999999999997654332   2


Q ss_pred             CCcccccCCCCCChHHhh-cCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhc----------------------
Q psy1546         200 KRNTFVGTPFWMAPEVIK-QSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLI----------------------  256 (604)
Q Consensus       200 ~~~~~~GT~~Y~APE~l~-~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i----------------------  256 (604)
                      .....+||+.|+|||++. +..|+.++||||+||++|+|++|..||............                      
T Consensus       168 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (345)
T d1pmea_         168 FLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARN  247 (345)
T ss_dssp             TTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCCHHHHH
T ss_pred             eeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhhhhhhc
Confidence            245568999999999984 556789999999999999999999999877653332211                      


Q ss_pred             -----CCCCCC---CCCccchHHHHHHHHHHhccCCCCCCCHHHHhcChhhhhhh
Q psy1546         257 -----PKNNPP---QLTGNYTKQFKEFVEACLNKDPENRPTAKELLKFPFIRKAK  303 (604)
Q Consensus       257 -----~~~~~~---~~~~~~s~~l~~Li~~~L~~dP~~RpT~~elL~hp~f~~~~  303 (604)
                           ......   .+...++.++++||.+||..||.+|||+.|+|+||||+...
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~  302 (345)
T d1pmea_         248 YLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYY  302 (345)
T ss_dssp             HHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTC
T ss_pred             ccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCC
Confidence                 111110   12235678899999999999999999999999999997543

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-48  Score=411.18  Aligned_cols=245  Identities=27%  Similarity=0.419  Sum_probs=203.1

Q ss_pred             ccccceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchh-hHHHHHHHHHHHHHHhhCCCCCCCe--------------
Q psy1546          55 PELIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE-AEDEIEDIQQEIMVLSQCDSPYGTK--------------  119 (604)
Q Consensus        55 ~~~~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~-~~~~~~~l~~Ei~iL~~l~hp~~~~--------------  119 (604)
                      ....|.++++||+|+||+||+|.++.+|+.||||++.... .....+.+.+|+.+|+.++|||+++              
T Consensus        16 ~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~   95 (346)
T d1cm8a_          16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF   95 (346)
T ss_dssp             CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred             cCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCcccccc
Confidence            3456999999999999999999999999999999997543 2344678899999999999998543              


Q ss_pred             --EEEEEEecCCCChhhHhhcCCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCC
Q psy1546         120 --LWIIMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNT  197 (604)
Q Consensus       120 --lyLVmEy~~ggsL~~~l~~~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~  197 (604)
                        +||||||| +.+|..+++.+.+++..++.++.||+.||.|||++|||||||||+|||++.++.+||+|||+|+.....
T Consensus        96 ~~~~lv~e~~-~~~l~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~~~  174 (346)
T d1cm8a_          96 TDFYLVMPFM-GTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE  174 (346)
T ss_dssp             CCCEEEEECC-SEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSS
T ss_pred             ceEEEEEecc-cccHHHHHHhccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccccccccccceeccCCc
Confidence              48999999 778888998899999999999999999999999999999999999999999999999999999766432


Q ss_pred             CCCCcccccCCCCCChHHhhcC-CCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcC-------------------
Q psy1546         198 TSKRNTFVGTPFWMAPEVIKQS-AYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIP-------------------  257 (604)
Q Consensus       198 ~~~~~~~~GT~~Y~APE~l~~~-~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~-------------------  257 (604)
                         ....+||+.|+|||++.+. .++.++|||||||+||+|++|.+||.+.+....+..+.                   
T Consensus       175 ---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (346)
T d1cm8a_         175 ---MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEA  251 (346)
T ss_dssp             ---CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHH
T ss_pred             ---cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcchhh
Confidence               3456899999999999764 56899999999999999999999998876544332110                   


Q ss_pred             -----------CCCCCCCCccchHHHHHHHHHHhccCCCCCCCHHHHhcChhhhhhh
Q psy1546         258 -----------KNNPPQLTGNYTKQFKEFVEACLNKDPENRPTAKELLKFPFIRKAK  303 (604)
Q Consensus       258 -----------~~~~~~~~~~~s~~l~~Li~~~L~~dP~~RpT~~elL~hp~f~~~~  303 (604)
                                 ......+...+++++.+||.+||..||.+|||+.|||+||||+...
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~  308 (346)
T d1cm8a_         252 KNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH  308 (346)
T ss_dssp             HHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred             hhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCC
Confidence                       1111223346788999999999999999999999999999998654

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-48  Score=399.92  Aligned_cols=238  Identities=27%  Similarity=0.437  Sum_probs=201.3

Q ss_pred             cceeeeEEcccCcEEEEEEEECCCC----cEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCCeE----------EEE
Q psy1546          58 IFTKQERIGKGSFGEVFKGIDNRTQ----QVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTKL----------WII  123 (604)
Q Consensus        58 ~y~i~~~LG~G~fG~Vy~a~~~~t~----~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~~l----------yLV  123 (604)
                      .|.+.++||+|+||+||+|.+..++    ..||||++...........+.+|+.+|++++|||++++          |+|
T Consensus         8 ~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~v   87 (283)
T d1mqba_           8 CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMII   87 (283)
T ss_dssp             TEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEE
T ss_pred             HeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEEE
Confidence            3899999999999999999987654    47999999776666666788999999999999997665          699


Q ss_pred             EEecCCCChhhHhhc--CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCC--
Q psy1546         124 MEYLGGGSALDLMKA--GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTS--  199 (604)
Q Consensus       124 mEy~~ggsL~~~l~~--~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~--  199 (604)
                      ||||.++++.+++..  +.+++..+..++.||+.||.|||+++|+||||||+||||+.++.+||+|||+|+.+.....  
T Consensus        88 ~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~  167 (283)
T d1mqba_          88 TEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAT  167 (283)
T ss_dssp             EECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-----------
T ss_pred             EEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccchhhcccCCCccc
Confidence            999999999998754  5799999999999999999999999999999999999999999999999999987654322  


Q ss_pred             -CCcccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhC-CCCCCCCChhhHhhhcCCCCCCCCCccchHHHHHHHH
Q psy1546         200 -KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKG-EPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVE  277 (604)
Q Consensus       200 -~~~~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG-~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~  277 (604)
                       ......||+.|||||++.+..|+.++|||||||+||||++| .+||......++...+..+..+..+..++..+.+||.
T Consensus       168 ~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~  247 (283)
T d1mqba_         168 YTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSAIYQLMM  247 (283)
T ss_dssp             ------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTCBHHHHHHHH
T ss_pred             eEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccCCCCCchhhHHHHHHHHH
Confidence             22335689999999999999999999999999999999984 6667777777777777777777788889999999999


Q ss_pred             HHhccCCCCCCCHHHHhc
Q psy1546         278 ACLNKDPENRPTAKELLK  295 (604)
Q Consensus       278 ~~L~~dP~~RpT~~elL~  295 (604)
                      +||..||.+|||+.||++
T Consensus       248 ~cl~~~p~~RPt~~eil~  265 (283)
T d1mqba_         248 QCWQQERARRPKFADIVS  265 (283)
T ss_dssp             HHTCSSTTTSCCHHHHHH
T ss_pred             HHCcCCHhHCcCHHHHHH
Confidence            999999999999999987

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.2e-49  Score=407.28  Aligned_cols=241  Identities=27%  Similarity=0.408  Sum_probs=206.5

Q ss_pred             ccceeeeEEcccCcEEEEEEEECCCCc----EEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCCeE---------EEE
Q psy1546          57 LIFTKQERIGKGSFGEVFKGIDNRTQQ----VVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTKL---------WII  123 (604)
Q Consensus        57 ~~y~i~~~LG~G~fG~Vy~a~~~~t~~----~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~~l---------yLV  123 (604)
                      ..|+++++||+|+||+||+|.+..+|+    .||||.+.........+.+.+|+.+|++++|||++++         ++|
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~v   88 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLI   88 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESSSEEEE
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeeEE
Confidence            349999999999999999999988876    5888888655444456789999999999999998876         589


Q ss_pred             EEecCCCChhhHhhc--CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCCC-
Q psy1546         124 MEYLGGGSALDLMKA--GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSK-  200 (604)
Q Consensus       124 mEy~~ggsL~~~l~~--~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~-  200 (604)
                      |||+.+|+|.+++..  ..+++..++.|+.||+.||.|||++|||||||||+||||+.++.+||+|||+|+.+...... 
T Consensus        89 ~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~~~~~  168 (317)
T d1xkka_          89 TQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEY  168 (317)
T ss_dssp             EECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTTCC--
T ss_pred             EEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccceecccccccc
Confidence            999999999987754  57999999999999999999999999999999999999999999999999999876543322 


Q ss_pred             -CcccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHhhhcCCCCCCCCCccchHHHHHHHHH
Q psy1546         201 -RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAK-GEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEA  278 (604)
Q Consensus       201 -~~~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~  278 (604)
                       .....||+.|||||++.+..|+.++|||||||+||||+| |.+||.+....++...+..+..+..+..+++++.+||.+
T Consensus       169 ~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~p~~~~~~~~~li~~  248 (317)
T d1xkka_         169 HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVK  248 (317)
T ss_dssp             ------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCCCCCCTTBCHHHHHHHHH
T ss_pred             cccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHHHHHH
Confidence             234568999999999999999999999999999999998 899999988888877777777777788899999999999


Q ss_pred             HhccCCCCCCCHHHHhcCh
Q psy1546         279 CLNKDPENRPTAKELLKFP  297 (604)
Q Consensus       279 ~L~~dP~~RpT~~elL~hp  297 (604)
                      ||..||.+|||+.||+.|.
T Consensus       249 cl~~dP~~RPs~~eil~~l  267 (317)
T d1xkka_         249 CWMIDADSRPKFRELIIEF  267 (317)
T ss_dssp             HTCSSGGGSCCHHHHHHHH
T ss_pred             hCCCChhhCcCHHHHHHHH
Confidence            9999999999999999873

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.7e-49  Score=413.22  Aligned_cols=241  Identities=24%  Similarity=0.345  Sum_probs=199.6

Q ss_pred             ccceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCCe----------------E
Q psy1546          57 LIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTK----------------L  120 (604)
Q Consensus        57 ~~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~~----------------l  120 (604)
                      ..|+.+++||+|+||+||+|++..+|+.||||++....     ....+|+.+|++++|||+++                +
T Consensus        20 ~~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~-----~~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~   94 (350)
T d1q5ka_          20 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL   94 (350)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-----SSCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEE
T ss_pred             CCcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccc-----hHHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEE
Confidence            35999999999999999999999999999999996543     22347999999999999655                4


Q ss_pred             EEEEEecCCCChhhHhh----cCCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCC-CeEEeccccccccc
Q psy1546         121 WIIMEYLGGGSALDLMK----AGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMG-DVKLADFGVAGTLT  195 (604)
Q Consensus       121 yLVmEy~~ggsL~~~l~----~~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g-~vKL~DFGlA~~~~  195 (604)
                      |||||||+++.+..+..    ...+++..++.|++||+.||+|||++||+||||||+||||+.++ .+||+|||+|+.+.
T Consensus        95 ~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~  174 (350)
T d1q5ka_          95 NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV  174 (350)
T ss_dssp             EEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCEECC
T ss_pred             EEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchhhcc
Confidence            79999998775444432    35799999999999999999999999999999999999999775 89999999997665


Q ss_pred             CCCCCCcccccCCCCCChHHhhc-CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCC----------------
Q psy1546         196 NTTSKRNTFVGTPFWMAPEVIKQ-SAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPK----------------  258 (604)
Q Consensus       196 ~~~~~~~~~~GT~~Y~APE~l~~-~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~----------------  258 (604)
                      .. ....+.+||+.|+|||++.+ ..|+.++|||||||++|||++|.+||........+..+..                
T Consensus       175 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~  253 (350)
T d1q5ka_         175 RG-EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPN  253 (350)
T ss_dssp             TT-SCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC-
T ss_pred             CC-cccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhccc
Confidence            33 33456789999999999875 5689999999999999999999999988776554433210                


Q ss_pred             ---CCC---------CCCCccchHHHHHHHHHHhccCCCCCCCHHHHhcChhhhhhh
Q psy1546         259 ---NNP---------PQLTGNYTKQFKEFVEACLNKDPENRPTAKELLKFPFIRKAK  303 (604)
Q Consensus       259 ---~~~---------~~~~~~~s~~l~~Li~~~L~~dP~~RpT~~elL~hp~f~~~~  303 (604)
                         ...         ......+++++.+||.+||..||.+|||+.|+|+||||+...
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~  310 (350)
T d1q5ka_         254 YTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR  310 (350)
T ss_dssp             --CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGG
T ss_pred             hhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcccc
Confidence               000         011235788999999999999999999999999999997653

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-48  Score=400.24  Aligned_cols=250  Identities=27%  Similarity=0.442  Sum_probs=209.4

Q ss_pred             cCCccccCccccceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCCeE------
Q psy1546          47 RRNSLKVDPELIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTKL------  120 (604)
Q Consensus        47 ~~~~~~~~~~~~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~~l------  120 (604)
                      .+..|.++.+ .|++.+.||+|+||+||+|++..+ +.||||++......  .+.+.+|+.++++++|||++++      
T Consensus         8 ~~~~~~i~~~-~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~~~--~~~~~~E~~~l~~l~h~nIv~~~g~~~~   83 (285)
T d1fmka3           8 AKDAWEIPRE-SLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMS--PEAFLQEAQVMKKLRHEKLVQLYAVVSE   83 (285)
T ss_dssp             STTCSBCCGG-GEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSSC--HHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             CCcceEcCHH-HEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECcccCC--HHHHHHHHHHHHhcccCCEeEEEEEEec
Confidence            3455666654 499999999999999999998765 56999999755433  3678999999999999998776      


Q ss_pred             ---EEEEEecCCCChhhHhhc---CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccc
Q psy1546         121 ---WIIMEYLGGGSALDLMKA---GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTL  194 (604)
Q Consensus       121 ---yLVmEy~~ggsL~~~l~~---~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~  194 (604)
                         |+|||||++|+|..++..   +.+++.+++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+|+.+
T Consensus        84 ~~~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~  163 (285)
T d1fmka3          84 EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLI  163 (285)
T ss_dssp             SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC--
T ss_pred             CCeEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccchhhhc
Confidence               599999999999988753   56999999999999999999999999999999999999999999999999999766


Q ss_pred             cCCC-CCCcccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHhhhcCCCCCCCCCccchHHH
Q psy1546         195 TNTT-SKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAK-GEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQF  272 (604)
Q Consensus       195 ~~~~-~~~~~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l  272 (604)
                      .... .......||+.|+|||++....++.++|||||||+||||++ |.+|+......+++..+..+.....+..+++++
T Consensus       164 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l  243 (285)
T d1fmka3         164 EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESL  243 (285)
T ss_dssp             ------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTSCHHH
T ss_pred             cCCCceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCcccCHHH
Confidence            4332 23334679999999999999999999999999999999999 566677777777777777777777888999999


Q ss_pred             HHHHHHHhccCCCCCCCHHHHhc--Chhhh
Q psy1546         273 KEFVEACLNKDPENRPTAKELLK--FPFIR  300 (604)
Q Consensus       273 ~~Li~~~L~~dP~~RpT~~elL~--hp~f~  300 (604)
                      ++||.+||+.||++|||+++|+.  ++||.
T Consensus       244 ~~li~~cl~~dP~~Rps~~~i~~~L~~~~~  273 (285)
T d1fmka3         244 HDLMCQCWRKEPEERPTFEYLQAFLEDYFT  273 (285)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred             HHHHHHHcccCHhHCcCHHHHHHHHhhhhc
Confidence            99999999999999999999987  55664

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-48  Score=400.37  Aligned_cols=240  Identities=24%  Similarity=0.390  Sum_probs=194.3

Q ss_pred             ccceeeeEEcccCcEEEEEEEECC-----CCcEEEEEEecchhhHHHHHHHHHHHHHHhhC-CCCCCCe-----------
Q psy1546          57 LIFTKQERIGKGSFGEVFKGIDNR-----TQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQC-DSPYGTK-----------  119 (604)
Q Consensus        57 ~~y~i~~~LG~G~fG~Vy~a~~~~-----t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l-~hp~~~~-----------  119 (604)
                      +.|.++++||+|+||.||+|.+..     +++.||||++.........+.+.+|+.++.++ .|++++.           
T Consensus        13 ~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~   92 (299)
T d1ywna1          13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP   92 (299)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSC
T ss_pred             HHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCCe
Confidence            349999999999999999999754     45789999997666566667788888888776 5666433           


Q ss_pred             EEEEEEecCCCChhhHhhc-----------------CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCC
Q psy1546         120 LWIIMEYLGGGSALDLMKA-----------------GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGD  182 (604)
Q Consensus       120 lyLVmEy~~ggsL~~~l~~-----------------~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~  182 (604)
                      +|+|||||++|+|.++++.                 ..+++..++.++.||+.||.|||++|||||||||+||||+.++.
T Consensus        93 ~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl~~~~~  172 (299)
T d1ywna1          93 LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNV  172 (299)
T ss_dssp             CEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGC
T ss_pred             EEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeECCCCc
Confidence            5799999999999999853                 24889999999999999999999999999999999999999999


Q ss_pred             eEEecccccccccCCCC--CCcccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhC-CCCCCCCChhh-HhhhcCC
Q psy1546         183 VKLADFGVAGTLTNTTS--KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKG-EPPNSELHPMR-VLFLIPK  258 (604)
Q Consensus       183 vKL~DFGlA~~~~~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG-~~Pf~~~~~~~-~~~~i~~  258 (604)
                      +||+|||+|+.......  .....+||+.|||||++.+..|+.++|||||||++|||++| .+||....... ....+..
T Consensus       173 ~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~~~~~~~  252 (299)
T d1ywna1         173 VKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKE  252 (299)
T ss_dssp             EEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHHHHH
T ss_pred             EEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHHHHHHHhc
Confidence            99999999976643332  33456899999999999999999999999999999999986 56787765433 3344455


Q ss_pred             CCCCCCCccchHHHHHHHHHHhccCCCCCCCHHHHhcC
Q psy1546         259 NNPPQLTGNYTKQFKEFVEACLNKDPENRPTAKELLKF  296 (604)
Q Consensus       259 ~~~~~~~~~~s~~l~~Li~~~L~~dP~~RpT~~elL~h  296 (604)
                      +..+..+..+++++.+||.+||+.||.+|||+.||++|
T Consensus       253 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~  290 (299)
T d1ywna1         253 GTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  290 (299)
T ss_dssp             TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            55667778899999999999999999999999999987

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=3.9e-48  Score=399.51  Aligned_cols=239  Identities=25%  Similarity=0.432  Sum_probs=211.1

Q ss_pred             ccceeeeEEcccCcEEEEEEEEC-----CCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCCeE----------E
Q psy1546          57 LIFTKQERIGKGSFGEVFKGIDN-----RTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTKL----------W  121 (604)
Q Consensus        57 ~~y~i~~~LG~G~fG~Vy~a~~~-----~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~~l----------y  121 (604)
                      +.|++++.||+|+||+||+|+++     .+++.||||++.........+.+.+|+.+|++++|||+.++          +
T Consensus        13 ~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~   92 (301)
T d1lufa_          13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMC   92 (301)
T ss_dssp             GGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCE
T ss_pred             HHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCceE
Confidence            45999999999999999999875     35688999999876666667889999999999999997665          6


Q ss_pred             EEEEecCCCChhhHhhcC-------------------------CCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeE
Q psy1546         122 IIMEYLGGGSALDLMKAG-------------------------NFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVL  176 (604)
Q Consensus       122 LVmEy~~ggsL~~~l~~~-------------------------~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NIL  176 (604)
                      +||||+++|+|.+++...                         .+++..+..|+.||+.||+|||+++||||||||+|||
T Consensus        93 ~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlKp~NIL  172 (301)
T d1lufa_          93 LLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCL  172 (301)
T ss_dssp             EEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred             EEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEEcccceE
Confidence            999999999999988532                         3788899999999999999999999999999999999


Q ss_pred             ecCCCCeEEecccccccccCCC--CCCcccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCC-CCCCCCChhhHh
Q psy1546         177 LSEMGDVKLADFGVAGTLTNTT--SKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGE-PPNSELHPMRVL  253 (604)
Q Consensus       177 l~~~g~vKL~DFGlA~~~~~~~--~~~~~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~-~Pf~~~~~~~~~  253 (604)
                      |+.++.+||+|||+|+.+....  ....+..||+.|||||++.+..|+.++|||||||+||||++|. +||.+.+..++.
T Consensus       173 ld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~~e~~  252 (301)
T d1lufa_         173 VGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVI  252 (301)
T ss_dssp             ECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHH
T ss_pred             ECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCCCHHHHH
Confidence            9999999999999997664332  2234567999999999999999999999999999999999985 789999999888


Q ss_pred             hhcCCCCCCCCCccchHHHHHHHHHHhccCCCCCCCHHHHhc
Q psy1546         254 FLIPKNNPPQLTGNYTKQFKEFVEACLNKDPENRPTAKELLK  295 (604)
Q Consensus       254 ~~i~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~RpT~~elL~  295 (604)
                      ..+..+..+.++..+++++.+||.+||+.||.+|||+.||++
T Consensus       253 ~~v~~~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~  294 (301)
T d1lufa_         253 YYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHR  294 (301)
T ss_dssp             HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            888888888888899999999999999999999999999966

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-48  Score=403.03  Aligned_cols=245  Identities=27%  Similarity=0.400  Sum_probs=198.9

Q ss_pred             ccceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhH-HHHHHHHHHHHHHhhCCCCCCCe----------------
Q psy1546          57 LIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAE-DEIEDIQQEIMVLSQCDSPYGTK----------------  119 (604)
Q Consensus        57 ~~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~-~~~~~l~~Ei~iL~~l~hp~~~~----------------  119 (604)
                      ..|.++++||+|+||+||+|++..+|+.||||++...... .....+.+|+.+|+.++||++.+                
T Consensus        10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~   89 (318)
T d3blha1          10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK   89 (318)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred             CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccC
Confidence            3499999999999999999999999999999998655332 23466889999999999998544                


Q ss_pred             --EEEEEEecCCCChhhHhhc-CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccC
Q psy1546         120 --LWIIMEYLGGGSALDLMKA-GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTN  196 (604)
Q Consensus       120 --lyLVmEy~~ggsL~~~l~~-~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~  196 (604)
                        +|+|||||.++++..+... ..+++..++.+++||+.||.|||++||+||||||+||||+.++.+||+|||+|+.+..
T Consensus        90 ~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~~~~~  169 (318)
T d3blha1          90 GSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSL  169 (318)
T ss_dssp             -CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCC
T ss_pred             ceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeecceeeeccc
Confidence              5799999988877655543 6799999999999999999999999999999999999999999999999999976543


Q ss_pred             CC----CCCcccccCCCCCChHHhhcC-CCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCC---CCCC-----
Q psy1546         197 TT----SKRNTFVGTPFWMAPEVIKQS-AYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKN---NPPQ-----  263 (604)
Q Consensus       197 ~~----~~~~~~~GT~~Y~APE~l~~~-~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~---~~~~-----  263 (604)
                      ..    ......+||+.|+|||++.+. .|+.++|||||||++|||++|++||.+.+.......+...   ....     
T Consensus       170 ~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  249 (318)
T d3blha1         170 AKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNV  249 (318)
T ss_dssp             -----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTC
T ss_pred             ccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhhcccc
Confidence            22    233456899999999999765 6899999999999999999999999887765544332110   0000     


Q ss_pred             --------------CC---------ccchHHHHHHHHHHhccCCCCCCCHHHHhcChhhhh
Q psy1546         264 --------------LT---------GNYTKQFKEFVEACLNKDPENRPTAKELLKFPFIRK  301 (604)
Q Consensus       264 --------------~~---------~~~s~~l~~Li~~~L~~dP~~RpT~~elL~hp~f~~  301 (604)
                                    ..         ...++++.+||.+||..||++|||++|+|+||||+.
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~  310 (318)
T d3blha1         250 DNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWS  310 (318)
T ss_dssp             CCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSS
T ss_pred             chhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhcc
Confidence                          00         012567889999999999999999999999999974

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-47  Score=391.59  Aligned_cols=245  Identities=26%  Similarity=0.421  Sum_probs=206.7

Q ss_pred             cceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhh-HHHHHHHHHHHHHHhhCCCCCCCeE----------EEEEEe
Q psy1546          58 IFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA-EDEIEDIQQEIMVLSQCDSPYGTKL----------WIIMEY  126 (604)
Q Consensus        58 ~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~-~~~~~~l~~Ei~iL~~l~hp~~~~l----------yLVmEy  126 (604)
                      .|+++++||+|+||+||+|++..+++.||||+++.... ......+.+|+.+|+.++|||+.++          ++|||+
T Consensus         3 ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~~   82 (292)
T d1unla_           3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF   82 (292)
T ss_dssp             SEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             CCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEeee
Confidence            49999999999999999999999999999999965533 3456888999999999999997654          699999


Q ss_pred             cCCCChhhHhhc-CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCCCCcccc
Q psy1546         127 LGGGSALDLMKA-GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKRNTFV  205 (604)
Q Consensus       127 ~~ggsL~~~l~~-~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~~~~~~  205 (604)
                      +.+++|..++.. +.+++..++.++.|++.||+|||++|||||||||+|||++.++.+||+|||.|+.............
T Consensus        83 ~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~~~~~~  162 (292)
T d1unla_          83 CDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEV  162 (292)
T ss_dssp             CSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSCCCSCC
T ss_pred             ccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccCCCccceeec
Confidence            999999888755 6899999999999999999999999999999999999999999999999999988766655556667


Q ss_pred             cCCCCCChHHhhcCC-CCCcchhhhHHHHHHHHHhCCCCCCC-CChhhHhhhcC--------------------------
Q psy1546         206 GTPFWMAPEVIKQSA-YDSKADIWSLGITAIELAKGEPPNSE-LHPMRVLFLIP--------------------------  257 (604)
Q Consensus       206 GT~~Y~APE~l~~~~-~~~~sDVwSLGviL~eLltG~~Pf~~-~~~~~~~~~i~--------------------------  257 (604)
                      +++.|+|||++.+.. ++.++|||||||++|||++|..||.. .+..+....+.                          
T Consensus       163 ~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (292)
T d1unla_         163 VTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMY  242 (292)
T ss_dssp             SCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCC
T ss_pred             cccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhcccccccccc
Confidence            889999999997665 68999999999999999999988643 33332222110                          


Q ss_pred             --CCCCCCCCccchHHHHHHHHHHhccCCCCCCCHHHHhcChhhhhh
Q psy1546         258 --KNNPPQLTGNYTKQFKEFVEACLNKDPENRPTAKELLKFPFIRKA  302 (604)
Q Consensus       258 --~~~~~~~~~~~s~~l~~Li~~~L~~dP~~RpT~~elL~hp~f~~~  302 (604)
                        ..........+++.+.+||.+||+.||.+|||++|||+||||++.
T Consensus       243 ~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~~  289 (292)
T d1unla_         243 PATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF  289 (292)
T ss_dssp             CTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSSC
T ss_pred             cccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcCC
Confidence              011122344678899999999999999999999999999999753

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=1.3e-47  Score=399.48  Aligned_cols=242  Identities=24%  Similarity=0.391  Sum_probs=199.6

Q ss_pred             ccccceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCC-CCCCCe------------EE
Q psy1546          55 PELIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCD-SPYGTK------------LW  121 (604)
Q Consensus        55 ~~~~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~-hp~~~~------------ly  121 (604)
                      ..+.|+++++||+|+||+||+|++..+++.||||+++...    .+.+.+|+.+|+.+. |||+.+            +|
T Consensus        33 ~~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~----~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~  108 (328)
T d3bqca1          33 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK----KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPA  108 (328)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC----HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEE
T ss_pred             CCcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH----HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCcee
Confidence            3456999999999999999999999999999999997543    356789999999985 998654            47


Q ss_pred             EEEEecCCCChhhHhhcCCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCC-CeEEecccccccccCCCCC
Q psy1546         122 IIMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMG-DVKLADFGVAGTLTNTTSK  200 (604)
Q Consensus       122 LVmEy~~ggsL~~~l~~~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g-~vKL~DFGlA~~~~~~~~~  200 (604)
                      +|||||.+++|..+.  +.+++..++.+++||+.||.|||++|||||||||+||||+.++ .+||+|||+|+..... ..
T Consensus       109 ~v~e~~~~~~L~~~~--~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~-~~  185 (328)
T d3bqca1         109 LVFEHVNNTDFKQLY--QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG-QE  185 (328)
T ss_dssp             EEEECCCSCBGGGTT--TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTT-CC
T ss_pred             EEEeecCCCcHHHHh--cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccceeccCC-Cc
Confidence            999999999998875  4699999999999999999999999999999999999998655 5999999999766533 33


Q ss_pred             CcccccCCCCCChHHhhcC-CCCCcchhhhHHHHHHHHHhCCCCCCCCChhh-Hhhh-----------------------
Q psy1546         201 RNTFVGTPFWMAPEVIKQS-AYDSKADIWSLGITAIELAKGEPPNSELHPMR-VLFL-----------------------  255 (604)
Q Consensus       201 ~~~~~GT~~Y~APE~l~~~-~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~-~~~~-----------------------  255 (604)
                      ....+||+.|+|||++.+. .|+.++|||||||++|+|++|..||....... ....                       
T Consensus       186 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~  265 (328)
T d3bqca1         186 YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDP  265 (328)
T ss_dssp             CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCG
T ss_pred             ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccccCc
Confidence            4567899999999998765 47999999999999999999999987654221 1000                       


Q ss_pred             -----cCCC--------CCCCCCccchHHHHHHHHHHhccCCCCCCCHHHHhcChhhhhhh
Q psy1546         256 -----IPKN--------NPPQLTGNYTKQFKEFVEACLNKDPENRPTAKELLKFPFIRKAK  303 (604)
Q Consensus       256 -----i~~~--------~~~~~~~~~s~~l~~Li~~~L~~dP~~RpT~~elL~hp~f~~~~  303 (604)
                           ....        ........+++++.+||.+||..||.+|||++|||+||||+...
T Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~v~  326 (328)
T d3bqca1         266 RFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVV  326 (328)
T ss_dssp             GGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTSC
T ss_pred             ccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCC
Confidence                 0000        01112245688999999999999999999999999999997653

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.4e-48  Score=405.27  Aligned_cols=243  Identities=24%  Similarity=0.395  Sum_probs=202.1

Q ss_pred             cceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhh-HHHHHHHHHHHHHHhhCCCCCCCeE---------------E
Q psy1546          58 IFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA-EDEIEDIQQEIMVLSQCDSPYGTKL---------------W  121 (604)
Q Consensus        58 ~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~-~~~~~~l~~Ei~iL~~l~hp~~~~l---------------y  121 (604)
                      .|+++++||+|+||+||+|++..+|+.||||++..... ....+.+.+|+.+|+.++||+++++               +
T Consensus        19 rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~~   98 (348)
T d2gfsa1          19 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV   98 (348)
T ss_dssp             TEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCCC
T ss_pred             CeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCceE
Confidence            49999999999999999999999999999999976533 3345678899999999999986542               4


Q ss_pred             EEEEecCCCChhhHhhcCCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCCCC
Q psy1546         122 IIMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSKR  201 (604)
Q Consensus       122 LVmEy~~ggsL~~~l~~~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~~  201 (604)
                      +||+|+.||+|.+++..+++++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|.....   ..
T Consensus        99 ~i~~~~~gg~L~~~~~~~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~---~~  175 (348)
T d2gfsa1          99 YLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD---EM  175 (348)
T ss_dssp             EEEEECCSEEHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC----CCTG---GG
T ss_pred             EEEEeecCCchhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccchhcccCc---cc
Confidence            677888899999999999999999999999999999999999999999999999999999999999999965432   33


Q ss_pred             cccccCCCCCChHHhhcCC-CCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCCC---------------------
Q psy1546         202 NTFVGTPFWMAPEVIKQSA-YDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPKN---------------------  259 (604)
Q Consensus       202 ~~~~GT~~Y~APE~l~~~~-~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~~---------------------  259 (604)
                      .+..||+.|+|||++.+.. ++.++|||||||++|+|++|.+||.+.+.......+...                     
T Consensus       176 ~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  255 (348)
T d2gfsa1         176 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI  255 (348)
T ss_dssp             SSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCHHHHHHH
T ss_pred             ccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccchhhhhhh
Confidence            4568999999999987654 688999999999999999999999887655443322110                     


Q ss_pred             ----CCC-----CCCccchHHHHHHHHHHhccCCCCCCCHHHHhcChhhhhhh
Q psy1546         260 ----NPP-----QLTGNYTKQFKEFVEACLNKDPENRPTAKELLKFPFIRKAK  303 (604)
Q Consensus       260 ----~~~-----~~~~~~s~~l~~Li~~~L~~dP~~RpT~~elL~hp~f~~~~  303 (604)
                          ...     .....+++++++||.+||..||.+|||+.|||+||||++..
T Consensus       256 ~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~  308 (348)
T d2gfsa1         256 QSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH  308 (348)
T ss_dssp             TTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred             hhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCC
Confidence                000     01234678999999999999999999999999999998653

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-47  Score=385.67  Aligned_cols=236  Identities=26%  Similarity=0.416  Sum_probs=202.8

Q ss_pred             ccCccccceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCCeE-----------
Q psy1546          52 KVDPELIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTKL-----------  120 (604)
Q Consensus        52 ~~~~~~~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~~l-----------  120 (604)
                      .++.+ .|+++++||+|+||.||+|.++  |..||||+++...   ..+.+.+|+.++++++|||++++           
T Consensus         3 ~i~~~-~~~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~i~~~~---~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~   76 (262)
T d1byga_           3 ALNMK-ELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGL   76 (262)
T ss_dssp             BCCGG-GEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC-----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CC
T ss_pred             ccCHH-HeEEeEEEecCCCeEEEEEEEC--CeEEEEEEECcHH---HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcE
Confidence            34444 3899999999999999999974  7789999996543   33678899999999999996554           


Q ss_pred             EEEEEecCCCChhhHhhcC---CCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCC
Q psy1546         121 WIIMEYLGGGSALDLMKAG---NFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNT  197 (604)
Q Consensus       121 yLVmEy~~ggsL~~~l~~~---~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~  197 (604)
                      ||||||+++|+|.+++...   .+++..++.|+.||+.||.|||+++|+||||||+|||++.+|.+||+|||+++.....
T Consensus        77 ~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~  156 (262)
T d1byga_          77 YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST  156 (262)
T ss_dssp             EEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC-------
T ss_pred             EEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeecccccceecCCC
Confidence            7999999999999998642   4899999999999999999999999999999999999999999999999999765432


Q ss_pred             CCCCcccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHhhhcCCCCCCCCCccchHHHHHHH
Q psy1546         198 TSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAK-GEPPNSELHPMRVLFLIPKNNPPQLTGNYTKQFKEFV  276 (604)
Q Consensus       198 ~~~~~~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li  276 (604)
                         .....+|+.|+|||++.+..++.++|||||||++|||++ |.+||......++...+..+..+.++..+++++.+||
T Consensus       157 ---~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li  233 (262)
T d1byga_         157 ---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEVM  233 (262)
T ss_dssp             --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCCCCTTCCHHHHHHH
T ss_pred             ---CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHHHHH
Confidence               334578999999999999999999999999999999998 7999999988888888888888888889999999999


Q ss_pred             HHHhccCCCCCCCHHHHhcC
Q psy1546         277 EACLNKDPENRPTAKELLKF  296 (604)
Q Consensus       277 ~~~L~~dP~~RpT~~elL~h  296 (604)
                      .+||..||.+|||+.+|+++
T Consensus       234 ~~cl~~dP~~Rps~~~l~~~  253 (262)
T d1byga_         234 KNCWHLDAAMRPSFLQLREQ  253 (262)
T ss_dssp             HHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHcccCHhHCcCHHHHHHH
Confidence            99999999999999999873

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.7e-48  Score=401.47  Aligned_cols=245  Identities=27%  Similarity=0.472  Sum_probs=205.0

Q ss_pred             ceeeeEEcccCcEEEEEEEE---CCCCcEEEEEEecchhh---HHHHHHHHHHHHHHhhCCC-CCCCe----------EE
Q psy1546          59 FTKQERIGKGSFGEVFKGID---NRTQQVVAIKIIDLEEA---EDEIEDIQQEIMVLSQCDS-PYGTK----------LW  121 (604)
Q Consensus        59 y~i~~~LG~G~fG~Vy~a~~---~~t~~~vAVK~i~~~~~---~~~~~~l~~Ei~iL~~l~h-p~~~~----------ly  121 (604)
                      |.++++||+|+||+||+|++   ..+|+.||||++++...   ....+.+.+|+.+|++++| |++.+          +|
T Consensus        26 y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~~~  105 (322)
T d1vzoa_          26 FELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLH  105 (322)
T ss_dssp             EEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEE
T ss_pred             eEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCcee
Confidence            99999999999999999987   44789999999865432   2234667899999999987 67655          47


Q ss_pred             EEEEecCCCChhhHhhc-CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCC-CC
Q psy1546         122 IIMEYLGGGSALDLMKA-GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNT-TS  199 (604)
Q Consensus       122 LVmEy~~ggsL~~~l~~-~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~-~~  199 (604)
                      +||||+.+|+|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+.+... ..
T Consensus       106 ~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~~~~~~  185 (322)
T d1vzoa_         106 LILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETE  185 (322)
T ss_dssp             EEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEECCGGGGG
T ss_pred             eeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccchhhhcccccc
Confidence            99999999999998865 67899999999999999999999999999999999999999999999999999866433 23


Q ss_pred             CCcccccCCCCCChHHhhcC--CCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcC---CCCCCCCCccchHHHHH
Q psy1546         200 KRNTFVGTPFWMAPEVIKQS--AYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIP---KNNPPQLTGNYTKQFKE  274 (604)
Q Consensus       200 ~~~~~~GT~~Y~APE~l~~~--~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~---~~~~~~~~~~~s~~l~~  274 (604)
                      ...+..|++.|+|||.+.+.  .++.++|||||||+||+|++|..||.+.........+.   ....+.++..+++++.+
T Consensus       186 ~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~  265 (322)
T d1vzoa_         186 RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKD  265 (322)
T ss_dssp             GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCTTSCHHHHH
T ss_pred             cccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCCCCcccCCHHHHH
Confidence            34567899999999999765  46789999999999999999999998765543332222   12234556789999999


Q ss_pred             HHHHHhccCCCCCC-----CHHHHhcChhhhhhh
Q psy1546         275 FVEACLNKDPENRP-----TAKELLKFPFIRKAK  303 (604)
Q Consensus       275 Li~~~L~~dP~~Rp-----T~~elL~hp~f~~~~  303 (604)
                      ||.+||..||.+||     |++|||+||||++..
T Consensus       266 li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i~  299 (322)
T d1vzoa_         266 LIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKIN  299 (322)
T ss_dssp             HHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCC
T ss_pred             HHHHHcccCHHHcCCCCcccHHHHHcCHhhcCCC
Confidence            99999999999999     589999999998653

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.1e-47  Score=390.88  Aligned_cols=239  Identities=25%  Similarity=0.454  Sum_probs=207.4

Q ss_pred             ccceeeeEEcccCcEEEEEEEECCCC-------cEEEEEEecchhhHHHHHHHHHHHHHHhhC-CCCCCCeE--------
Q psy1546          57 LIFTKQERIGKGSFGEVFKGIDNRTQ-------QVVAIKIIDLEEAEDEIEDIQQEIMVLSQC-DSPYGTKL--------  120 (604)
Q Consensus        57 ~~y~i~~~LG~G~fG~Vy~a~~~~t~-------~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l-~hp~~~~l--------  120 (604)
                      +.|.++++||+|+||.||+|++..++       ..||||++...........+.+|...+.++ +|||++++        
T Consensus        13 ~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~   92 (299)
T d1fgka_          13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG   92 (299)
T ss_dssp             GGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             HHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccCC
Confidence            35899999999999999999876544       479999998777666678888999888887 89997765        


Q ss_pred             --EEEEEecCCCChhhHhhcC-----------------CCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCC
Q psy1546         121 --WIIMEYLGGGSALDLMKAG-----------------NFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMG  181 (604)
Q Consensus       121 --yLVmEy~~ggsL~~~l~~~-----------------~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g  181 (604)
                        |+|||||++|+|.+++...                 .+++..++.++.||+.||+|||+++||||||||+|||++.++
T Consensus        93 ~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~NiLl~~~~  172 (299)
T d1fgka_          93 PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDN  172 (299)
T ss_dssp             SCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTC
T ss_pred             eEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccceeecCCC
Confidence              6999999999999999643                 489999999999999999999999999999999999999999


Q ss_pred             CeEEecccccccccCCCC--CCcccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHhhhcCC
Q psy1546         182 DVKLADFGVAGTLTNTTS--KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAK-GEPPNSELHPMRVLFLIPK  258 (604)
Q Consensus       182 ~vKL~DFGlA~~~~~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~~i~~  258 (604)
                      .+||+|||+++.......  ......||+.|+|||++.+..|+.++|||||||+||||++ |.+||.+.....+...+..
T Consensus       173 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~~~~i~~  252 (299)
T d1fgka_         173 VMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKE  252 (299)
T ss_dssp             CEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHT
T ss_pred             CeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHHHHHHHHc
Confidence            999999999987654332  2344679999999999999999999999999999999998 7999999998888888777


Q ss_pred             CCCCCCCccchHHHHHHHHHHhccCCCCCCCHHHHhc
Q psy1546         259 NNPPQLTGNYTKQFKEFVEACLNKDPENRPTAKELLK  295 (604)
Q Consensus       259 ~~~~~~~~~~s~~l~~Li~~~L~~dP~~RpT~~elL~  295 (604)
                      +..+..+..+++++.+||.+||+.||.+|||+.||++
T Consensus       253 ~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~  289 (299)
T d1fgka_         253 GHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE  289 (299)
T ss_dssp             TCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence            7778888899999999999999999999999999987

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-47  Score=394.89  Aligned_cols=239  Identities=25%  Similarity=0.411  Sum_probs=205.3

Q ss_pred             ccceeeeEEcccCcEEEEEEEECCCCcE--EEEEEecchhhHHHHHHHHHHHHHHhhC-CCCCCCeE----------EEE
Q psy1546          57 LIFTKQERIGKGSFGEVFKGIDNRTQQV--VAIKIIDLEEAEDEIEDIQQEIMVLSQC-DSPYGTKL----------WII  123 (604)
Q Consensus        57 ~~y~i~~~LG~G~fG~Vy~a~~~~t~~~--vAVK~i~~~~~~~~~~~l~~Ei~iL~~l-~hp~~~~l----------yLV  123 (604)
                      +.|++.++||+|+||+||+|+++.++..  ||||.+.........+.+.+|+.+|+++ +|||++++          |||
T Consensus        10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV   89 (309)
T d1fvra_          10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA   89 (309)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence            3489999999999999999999888764  6777776554455567899999999998 79997665          699


Q ss_pred             EEecCCCChhhHhhc-----------------CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEe
Q psy1546         124 MEYLGGGSALDLMKA-----------------GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLA  186 (604)
Q Consensus       124 mEy~~ggsL~~~l~~-----------------~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~  186 (604)
                      ||||++|+|.+++..                 ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+
T Consensus        90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~~~kl~  169 (309)
T d1fvra_          90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIA  169 (309)
T ss_dssp             ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEEC
T ss_pred             EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCCCceEEc
Confidence            999999999999853                 468999999999999999999999999999999999999999999999


Q ss_pred             cccccccccCCCCCCcccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhC-CCCCCCCChhhHhhhcCCCCCCCCC
Q psy1546         187 DFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKG-EPPNSELHPMRVLFLIPKNNPPQLT  265 (604)
Q Consensus       187 DFGlA~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG-~~Pf~~~~~~~~~~~i~~~~~~~~~  265 (604)
                      |||+|+..... .......||..|+|||.+.+..|+.++|||||||+||||++| .+||.+.+..++...+..+..+..+
T Consensus       170 DfG~a~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~~~~~~~~  248 (309)
T d1fvra_         170 DFGLSRGQEVY-VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKP  248 (309)
T ss_dssp             CTTCEESSCEE-CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTCCCCCC
T ss_pred             ccccccccccc-ccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcCCCCCC
Confidence            99999755432 233456799999999999999999999999999999999996 5689998888888888887778888


Q ss_pred             ccchHHHHHHHHHHhccCCCCCCCHHHHhcC
Q psy1546         266 GNYTKQFKEFVEACLNKDPENRPTAKELLKF  296 (604)
Q Consensus       266 ~~~s~~l~~Li~~~L~~dP~~RpT~~elL~h  296 (604)
                      ..+++++++||.+||+.||++|||+.||+++
T Consensus       249 ~~~~~~~~~li~~cl~~dP~~RPs~~eil~~  279 (309)
T d1fvra_         249 LNCDDEVYDLMRQCWREKPYERPSFAQILVS  279 (309)
T ss_dssp             TTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            8999999999999999999999999999985

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.6e-47  Score=399.65  Aligned_cols=243  Identities=22%  Similarity=0.349  Sum_probs=191.6

Q ss_pred             cceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhh-HHHHHHHHHHHHHHhhCCCCCCC----------------eE
Q psy1546          58 IFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA-EDEIEDIQQEIMVLSQCDSPYGT----------------KL  120 (604)
Q Consensus        58 ~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~-~~~~~~l~~Ei~iL~~l~hp~~~----------------~l  120 (604)
                      .|+++++||+|+||+||+|.+..+|+.||||++..... ......+.+|+.+|++++||+++                .+
T Consensus        18 ~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~~   97 (355)
T d2b1pa1          18 RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDV   97 (355)
T ss_dssp             TEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEE
T ss_pred             CeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCcee
Confidence            49999999999999999999999999999999975533 34456789999999999999843                45


Q ss_pred             EEEEEecCCCChhhHhhcCCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCCC
Q psy1546         121 WIIMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTSK  200 (604)
Q Consensus       121 yLVmEy~~ggsL~~~l~~~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~~  200 (604)
                      |+|||||.++++..+  .+.+++..++.+++||+.||.|||++||+||||||+|||++.++.+||+|||+++.... ...
T Consensus        98 ~iv~Ey~~~~l~~~~--~~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~-~~~  174 (355)
T d2b1pa1          98 YLVMELMDANLCQVI--QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT-SFM  174 (355)
T ss_dssp             EEEEECCSEEHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC----------
T ss_pred             EEEEeccchHHHHhh--hcCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechhhhhcccc-ccc
Confidence            899999977655544  34699999999999999999999999999999999999999999999999999876543 334


Q ss_pred             CcccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcCC----------------------
Q psy1546         201 RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIPK----------------------  258 (604)
Q Consensus       201 ~~~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~~----------------------  258 (604)
                      ....+||+.|+|||++.+..++.++||||+||++|+|++|.+||.+.+.......+..                      
T Consensus       175 ~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  254 (355)
T d2b1pa1         175 MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVE  254 (355)
T ss_dssp             ------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHHHHHHHH
T ss_pred             cccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhhHHHHhh
Confidence            4566899999999999999999999999999999999999999987765433222100                      


Q ss_pred             CCCC-------------------CCCccchHHHHHHHHHHhccCCCCCCCHHHHhcChhhhhhh
Q psy1546         259 NNPP-------------------QLTGNYTKQFKEFVEACLNKDPENRPTAKELLKFPFIRKAK  303 (604)
Q Consensus       259 ~~~~-------------------~~~~~~s~~l~~Li~~~L~~dP~~RpT~~elL~hp~f~~~~  303 (604)
                      ....                   .....++.++.+||.+||..||++|||++|||+||||+...
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~~~  318 (355)
T d2b1pa1         255 NRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWY  318 (355)
T ss_dssp             TSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGC
T ss_pred             cCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCCC
Confidence            0000                   00112467899999999999999999999999999998654

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.5e-47  Score=390.95  Aligned_cols=244  Identities=25%  Similarity=0.430  Sum_probs=213.6

Q ss_pred             cccCccccceeeeEEcccCcEEEEEEEECC-----CCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCCeE-----
Q psy1546          51 LKVDPELIFTKQERIGKGSFGEVFKGIDNR-----TQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTKL-----  120 (604)
Q Consensus        51 ~~~~~~~~y~i~~~LG~G~fG~Vy~a~~~~-----t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~~l-----  120 (604)
                      |.++. +.|.+.++||+|+||+||+|.+..     ++..||||+++..........+.+|+.+++++.|||++++     
T Consensus        15 ~ei~~-~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~   93 (308)
T d1p4oa_          15 WEVAR-EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS   93 (308)
T ss_dssp             TBCCG-GGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEEC
T ss_pred             eeecH-HHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEe
Confidence            44443 358999999999999999998752     4578999999876666666788999999999999997765     


Q ss_pred             -----EEEEEecCCCChhhHhhc-----------CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeE
Q psy1546         121 -----WIIMEYLGGGSALDLMKA-----------GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVK  184 (604)
Q Consensus       121 -----yLVmEy~~ggsL~~~l~~-----------~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vK  184 (604)
                           |+|||||++|+|.+++..           ..+++..+..++.||+.||.|||+++|+||||||+||||+.++.+|
T Consensus        94 ~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~~~K  173 (308)
T d1p4oa_          94 QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVK  173 (308)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEE
T ss_pred             cCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCceEE
Confidence                 699999999999998753           2368889999999999999999999999999999999999999999


Q ss_pred             EecccccccccCCCC--CCcccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhC-CCCCCCCChhhHhhhcCCCCC
Q psy1546         185 LADFGVAGTLTNTTS--KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKG-EPPNSELHPMRVLFLIPKNNP  261 (604)
Q Consensus       185 L~DFGlA~~~~~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG-~~Pf~~~~~~~~~~~i~~~~~  261 (604)
                      |+|||+|+.+.....  ......||+.|+|||.+.+..++.++|||||||+||||++| .+||.+....+....+..+..
T Consensus       174 l~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~~~~  253 (308)
T d1p4oa_         174 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGL  253 (308)
T ss_dssp             ECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTCC
T ss_pred             EeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCCC
Confidence            999999986654322  22345789999999999999999999999999999999998 588999998888888877777


Q ss_pred             CCCCccchHHHHHHHHHHhccCCCCCCCHHHHhc
Q psy1546         262 PQLTGNYTKQFKEFVEACLNKDPENRPTAKELLK  295 (604)
Q Consensus       262 ~~~~~~~s~~l~~Li~~~L~~dP~~RpT~~elL~  295 (604)
                      +..+..+++.+.+||.+||+.||.+|||+.+|++
T Consensus       254 ~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~  287 (308)
T d1p4oa_         254 LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIIS  287 (308)
T ss_dssp             CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCcccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            7788899999999999999999999999999997

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.8e-47  Score=385.31  Aligned_cols=242  Identities=27%  Similarity=0.431  Sum_probs=197.3

Q ss_pred             cceeeeEEcccCcEEEEEEEECC-CC--cEEEEEEecchhh--HHHHHHHHHHHHHHhhCCCCCCCeE---------EEE
Q psy1546          58 IFTKQERIGKGSFGEVFKGIDNR-TQ--QVVAIKIIDLEEA--EDEIEDIQQEIMVLSQCDSPYGTKL---------WII  123 (604)
Q Consensus        58 ~y~i~~~LG~G~fG~Vy~a~~~~-t~--~~vAVK~i~~~~~--~~~~~~l~~Ei~iL~~l~hp~~~~l---------yLV  123 (604)
                      .|++.+.||+|+||+||+|++.. ++  ..||||++.....  ....+.+.+|+.+|++++|||++++         |+|
T Consensus         9 d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~~~~lv   88 (273)
T d1u46a_           9 DLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMKMV   88 (273)
T ss_dssp             GEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEE
T ss_pred             HeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeecchhee
Confidence            49999999999999999998643 33  3689999865432  3345788999999999999997765         599


Q ss_pred             EEecCCCChhhHhhc--CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCC--
Q psy1546         124 MEYLGGGSALDLMKA--GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTS--  199 (604)
Q Consensus       124 mEy~~ggsL~~~l~~--~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~--  199 (604)
                      ||||++|+|.+++..  +.+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.+.....  
T Consensus        89 ~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~~~~~~  168 (273)
T d1u46a_          89 TELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHY  168 (273)
T ss_dssp             EECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-CCEE
T ss_pred             eeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhhhhcccCCCcc
Confidence            999999999987643  5799999999999999999999999999999999999999999999999999987644332  


Q ss_pred             -CCcccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHhhhcCCC-CCCCCCccchHHHHHHH
Q psy1546         200 -KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAK-GEPPNSELHPMRVLFLIPKN-NPPQLTGNYTKQFKEFV  276 (604)
Q Consensus       200 -~~~~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~~s~~l~~Li  276 (604)
                       ......||..|+|||++.+..++.++|||||||++|||++ |..||.+.+..+....+... ..+..+..++..+.+||
T Consensus       169 ~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li  248 (273)
T d1u46a_         169 VMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIYNVM  248 (273)
T ss_dssp             EC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTTCCHHHHHHH
T ss_pred             eecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCCCCcccccHHHHHHH
Confidence             2234568889999999999999999999999999999998 89999999888877766443 45566778999999999


Q ss_pred             HHHhccCCCCCCCHHHHhcChhhhh
Q psy1546         277 EACLNKDPENRPTAKELLKFPFIRK  301 (604)
Q Consensus       277 ~~~L~~dP~~RpT~~elL~hp~f~~  301 (604)
                      .+||..||++|||+.||++  ++++
T Consensus       249 ~~cl~~dp~~RPt~~ei~~--~L~~  271 (273)
T d1u46a_         249 VQCWAHKPEDRPTFVALRD--FLLE  271 (273)
T ss_dssp             HHHTCSSGGGSCCHHHHHH--HHHH
T ss_pred             HHHcCCChhHCcCHHHHHH--HHHh
Confidence            9999999999999999974  5543

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.6e-46  Score=386.16  Aligned_cols=237  Identities=23%  Similarity=0.374  Sum_probs=198.9

Q ss_pred             eeeeEEcccCcEEEEEEEECCCC---cEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCCe-----------EEEEEE
Q psy1546          60 TKQERIGKGSFGEVFKGIDNRTQ---QVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTK-----------LWIIME  125 (604)
Q Consensus        60 ~i~~~LG~G~fG~Vy~a~~~~t~---~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~~-----------lyLVmE  125 (604)
                      ...++||+|+||+||+|++..++   ..||||+++........+.+.+|+.+|++++|||+++           +|+|||
T Consensus        30 ~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E  109 (311)
T d1r0pa_          30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLP  109 (311)
T ss_dssp             EEEEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEE
T ss_pred             ccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEE
Confidence            44678999999999999986543   3699999976666667788999999999999999544           479999


Q ss_pred             ecCCCChhhHhhc--CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEecccccccccCCCC----
Q psy1546         126 YLGGGSALDLMKA--GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLTNTTS----  199 (604)
Q Consensus       126 y~~ggsL~~~l~~--~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~~~~~----  199 (604)
                      ||++|+|.+++..  ..+++..+..++.||+.||.|||+.+|+||||||+||||++++.+||+|||+++.+.....    
T Consensus       110 ~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~~  189 (311)
T d1r0pa_         110 YMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVH  189 (311)
T ss_dssp             CCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCTT
T ss_pred             EeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhccccccccce
Confidence            9999999998865  3577888999999999999999999999999999999999999999999999987654322    


Q ss_pred             CCcccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCC-CCChhhHhhhcCCCCCCCCCccchHHHHHHHHH
Q psy1546         200 KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNS-ELHPMRVLFLIPKNNPPQLTGNYTKQFKEFVEA  278 (604)
Q Consensus       200 ~~~~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~-~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~  278 (604)
                      ......||+.|+|||++.+..++.++|||||||+||||++|..||. .....+....+..+..+..+..+++++.+||.+
T Consensus       190 ~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~~~~p~~~~~~l~~li~~  269 (311)
T d1r0pa_         190 NKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLK  269 (311)
T ss_dssp             CTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCCCCCCTTCCHHHHHHHHH
T ss_pred             ecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCcccCcHHHHHHHHH
Confidence            2233568999999999999999999999999999999999666654 444555555566666777788899999999999


Q ss_pred             HhccCCCCCCCHHHHhcC
Q psy1546         279 CLNKDPENRPTAKELLKF  296 (604)
Q Consensus       279 ~L~~dP~~RpT~~elL~h  296 (604)
                      ||..||++|||+.||++|
T Consensus       270 cl~~dP~~RPs~~ei~~~  287 (311)
T d1r0pa_         270 CWHPKAEMRPSFSELVSR  287 (311)
T ss_dssp             HTCSSGGGSCCHHHHHHH
T ss_pred             HcCCCHhHCcCHHHHHHH
Confidence            999999999999999975

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.4e-46  Score=383.82  Aligned_cols=239  Identities=26%  Similarity=0.414  Sum_probs=206.1

Q ss_pred             ccceeeeEEcccCcEEEEEEEEC-----CCCcEEEEEEecchhhHHHHHHHHHHHHHHhhC-CCCCCCeE----------
Q psy1546          57 LIFTKQERIGKGSFGEVFKGIDN-----RTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQC-DSPYGTKL----------  120 (604)
Q Consensus        57 ~~y~i~~~LG~G~fG~Vy~a~~~-----~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l-~hp~~~~l----------  120 (604)
                      +.|.++++||+|+||.||+|++.     .+++.||||++...........+.+|+.+++.+ +|||++++          
T Consensus        23 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~  102 (311)
T d1t46a_          23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPT  102 (311)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             HHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCEE
Confidence            45899999999999999999863     567899999998766666667889999999998 69997765          


Q ss_pred             EEEEEecCCCChhhHhhcC-------------------CCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCC
Q psy1546         121 WIIMEYLGGGSALDLMKAG-------------------NFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMG  181 (604)
Q Consensus       121 yLVmEy~~ggsL~~~l~~~-------------------~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g  181 (604)
                      |||||||++|+|.++++..                   .+++..+..|+.||+.||+|||++|||||||||+|||++.++
T Consensus       103 ~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl~~~~~  182 (311)
T d1t46a_         103 LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGR  182 (311)
T ss_dssp             EEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEETTT
T ss_pred             EEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeecccccccccccccC
Confidence            6999999999999998642                   488999999999999999999999999999999999999999


Q ss_pred             CeEEecccccccccCCCC--CCcccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHh-hhcC
Q psy1546         182 DVKLADFGVAGTLTNTTS--KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAK-GEPPNSELHPMRVL-FLIP  257 (604)
Q Consensus       182 ~vKL~DFGlA~~~~~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLlt-G~~Pf~~~~~~~~~-~~i~  257 (604)
                      .+||+|||+++.......  .....+||+.|+|||++.+..++.++|||||||+||||++ |.+||........+ ..+.
T Consensus       183 ~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~~~~i~  262 (311)
T d1t46a_         183 ITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIK  262 (311)
T ss_dssp             EEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHHHHH
T ss_pred             cccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHHHHHHHh
Confidence            999999999987654332  2334679999999999999999999999999999999998 67777776654443 3444


Q ss_pred             CCCCCCCCccchHHHHHHHHHHhccCCCCCCCHHHHhc
Q psy1546         258 KNNPPQLTGNYTKQFKEFVEACLNKDPENRPTAKELLK  295 (604)
Q Consensus       258 ~~~~~~~~~~~s~~l~~Li~~~L~~dP~~RpT~~elL~  295 (604)
                      .+..+..+..+++.+.+||.+||+.||.+|||+.||++
T Consensus       263 ~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~  300 (311)
T d1t46a_         263 EGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ  300 (311)
T ss_dssp             HTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             cCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            55566667788999999999999999999999999987

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.1e-45  Score=380.16  Aligned_cols=242  Identities=22%  Similarity=0.355  Sum_probs=192.7

Q ss_pred             ccceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCC-----------eEEEEEE
Q psy1546          57 LIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGT-----------KLWIIME  125 (604)
Q Consensus        57 ~~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~-----------~lyLVmE  125 (604)
                      +.|+++++||+|+||+||+|++..+++.||||++......   ..+.+|+.+++.+.|++..           ..|+|||
T Consensus         7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~---~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme   83 (299)
T d1ckia_           7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH---PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME   83 (299)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS---CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC---HHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEE
Confidence            3599999999999999999999999999999998654332   3477899999999888633           3479999


Q ss_pred             ecCCCChhhHhh--cCCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecC---CCCeEEecccccccccCCCC-
Q psy1546         126 YLGGGSALDLMK--AGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSE---MGDVKLADFGVAGTLTNTTS-  199 (604)
Q Consensus       126 y~~ggsL~~~l~--~~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~---~g~vKL~DFGlA~~~~~~~~-  199 (604)
                      ||+ ++|...+.  .+.+++..+..++.||+.||+|||++|||||||||+|||++.   +..+||+|||+|+.+..... 
T Consensus        84 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~  162 (299)
T d1ckia_          84 LLG-PSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTH  162 (299)
T ss_dssp             CCC-CBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTTC
T ss_pred             EcC-CchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceeccccccc
Confidence            995 45555443  367999999999999999999999999999999999999853   45799999999987654322 


Q ss_pred             ------CCcccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHhhhcC-------CCCCCCCCc
Q psy1546         200 ------KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRVLFLIP-------KNNPPQLTG  266 (604)
Q Consensus       200 ------~~~~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~~~~i~-------~~~~~~~~~  266 (604)
                            .....+||+.|||||++.+..|+.++|||||||++|||++|..||...........+.       ....+.+..
T Consensus       163 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (299)
T d1ckia_         163 QHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCK  242 (299)
T ss_dssp             CBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCHHHHTT
T ss_pred             cceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCChhHhcc
Confidence                  2345689999999999999999999999999999999999999998765433222111       111122345


Q ss_pred             cchHHHHHHHHHHhccCCCCCCCHHHH---hcChhhhhh
Q psy1546         267 NYTKQFKEFVEACLNKDPENRPTAKEL---LKFPFIRKA  302 (604)
Q Consensus       267 ~~s~~l~~Li~~~L~~dP~~RpT~~el---L~hp~f~~~  302 (604)
                      .+|+++.+||.+||..||.+||++.+|   |+|+|.+..
T Consensus       243 ~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~~  281 (299)
T d1ckia_         243 GYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG  281 (299)
T ss_dssp             TSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHHT
T ss_pred             CCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHcC
Confidence            688999999999999999999998754   666665443

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-44  Score=372.18  Aligned_cols=235  Identities=26%  Similarity=0.352  Sum_probs=185.9

Q ss_pred             cceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCCCCe--------------EEEE
Q psy1546          58 IFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPYGTK--------------LWII  123 (604)
Q Consensus        58 ~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~~~~--------------lyLV  123 (604)
                      .|.+.++||+|+||+||+|++  +|+.||||++.......  ...+.|+..+.+++|||+++              +|||
T Consensus         4 ~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~~~~--~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv   79 (303)
T d1vjya_           4 TIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERS--WFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV   79 (303)
T ss_dssp             GEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGGHHH--HHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred             EEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccchhH--HHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEE
Confidence            478899999999999999986  58899999997554322  23345777778899999654              4799


Q ss_pred             EEecCCCChhhHhhcCCCcHHHHHHHHHHHHHHhHHhhh--------CCccccccccceeEecCCCCeEEeccccccccc
Q psy1546         124 MEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHS--------ERKLHRDIKAANVLLSEMGDVKLADFGVAGTLT  195 (604)
Q Consensus       124 mEy~~ggsL~~~l~~~~lse~~i~~i~~qIl~gL~yLHs--------~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~  195 (604)
                      ||||.+|+|.++++...+++..+..++.|++.||.|||+        +|||||||||+||||+.++.+||+|||+++.+.
T Consensus        80 ~Ey~~~g~L~~~l~~~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~~  159 (303)
T d1vjya_          80 SDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHD  159 (303)
T ss_dssp             EECCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEE
T ss_pred             EecccCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcccccc
Confidence            999999999999999899999999999999999999996        599999999999999999999999999998765


Q ss_pred             CCCC----CCcccccCCCCCChHHhhcCC------CCCcchhhhHHHHHHHHHhCCCCCCCCChh---------------
Q psy1546         196 NTTS----KRNTFVGTPFWMAPEVIKQSA------YDSKADIWSLGITAIELAKGEPPNSELHPM---------------  250 (604)
Q Consensus       196 ~~~~----~~~~~~GT~~Y~APE~l~~~~------~~~~sDVwSLGviL~eLltG~~Pf~~~~~~---------------  250 (604)
                      ....    .....+||+.|||||++.+..      ++.++|||||||+||||++|.+||......               
T Consensus       160 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~  239 (303)
T d1vjya_         160 SATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVE  239 (303)
T ss_dssp             TTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHH
T ss_pred             CCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccchHH
Confidence            4332    234568999999999997653      567899999999999999998876432211               


Q ss_pred             hHhhh-cCCCCCCCCCcc-----chHHHHHHHHHHhccCCCCCCCHHHHhcC
Q psy1546         251 RVLFL-IPKNNPPQLTGN-----YTKQFKEFVEACLNKDPENRPTAKELLKF  296 (604)
Q Consensus       251 ~~~~~-i~~~~~~~~~~~-----~s~~l~~Li~~~L~~dP~~RpT~~elL~h  296 (604)
                      ..... ......+.++..     ....+.+|+.+||..||.+|||+.||+++
T Consensus       240 ~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~  291 (303)
T d1vjya_         240 EMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT  291 (303)
T ss_dssp             HHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence            11111 111222333322     34568999999999999999999999873

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=1.5e-43  Score=363.69  Aligned_cols=235  Identities=20%  Similarity=0.310  Sum_probs=190.5

Q ss_pred             ccceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCC-CCCC----------eEEEEEE
Q psy1546          57 LIFTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDS-PYGT----------KLWIIME  125 (604)
Q Consensus        57 ~~y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~h-p~~~----------~lyLVmE  125 (604)
                      ..|.++++||+|+||+||+|++..+|+.||||++......   ..+.+|+.++..+.| +++.          ..|+|||
T Consensus         5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~---~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme   81 (293)
T d1csna_           5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA---PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID   81 (293)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS---CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred             CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCc---HHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEE
Confidence            3599999999999999999999999999999998654332   345677888888776 4533          3479999


Q ss_pred             ecCCCChhhHhhc--CCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecC-----CCCeEEecccccccccCCC
Q psy1546         126 YLGGGSALDLMKA--GNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSE-----MGDVKLADFGVAGTLTNTT  198 (604)
Q Consensus       126 y~~ggsL~~~l~~--~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~-----~g~vKL~DFGlA~~~~~~~  198 (604)
                      || +++|.+++..  +.+++..+..++.|++.||+|||++|||||||||+||||+.     .+.+||+|||+|+.+....
T Consensus        82 ~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~  160 (293)
T d1csna_          82 LL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPV  160 (293)
T ss_dssp             CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTT
T ss_pred             ec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEcccCc
Confidence            99 7888888754  56999999999999999999999999999999999999964     5789999999998765332


Q ss_pred             -------CCCcccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhH---hhhc----CCCCCCCC
Q psy1546         199 -------SKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMRV---LFLI----PKNNPPQL  264 (604)
Q Consensus       199 -------~~~~~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~~---~~~i----~~~~~~~~  264 (604)
                             .....++||+.|||||++.+..++.++|||||||++|||++|..||.+......   ...+    .......+
T Consensus       161 ~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l  240 (293)
T d1csna_         161 TKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLREL  240 (293)
T ss_dssp             TCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHHHH
T ss_pred             cccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCChHHh
Confidence                   223457899999999999999999999999999999999999999986543211   1111    11112223


Q ss_pred             CccchHHHHHHHHHHhccCCCCCCCHHHHhc
Q psy1546         265 TGNYTKQFKEFVEACLNKDPENRPTAKELLK  295 (604)
Q Consensus       265 ~~~~s~~l~~Li~~~L~~dP~~RpT~~elL~  295 (604)
                      ...+|+++.+|+..|+..+|.+||+++.+.+
T Consensus       241 ~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~  271 (293)
T d1csna_         241 CAGFPEEFYKYMHYARNLAFDATPDYDYLQG  271 (293)
T ss_dssp             TTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred             cCCCCHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence            4567899999999999999999999877644

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=8.3e-42  Score=359.06  Aligned_cols=239  Identities=25%  Similarity=0.388  Sum_probs=185.7

Q ss_pred             ceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCCC-----------CCeE-------
Q psy1546          59 FTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSPY-----------GTKL-------  120 (604)
Q Consensus        59 y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp~-----------~~~l-------  120 (604)
                      |+++++||+|+||+||+|++..+|+.||||+++....  ..+.+.+|+.+++.+.|++           +.++       
T Consensus        15 Y~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~--~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~   92 (362)
T d1q8ya_          15 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV--YTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK   92 (362)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHH--HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred             EEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecccc--chHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeec
Confidence            9999999999999999999999999999999976542  2356788999988887654           3322       


Q ss_pred             -----EEEEEecCCCChhhH-h---hcCCCcHHHHHHHHHHHHHHhHHhhh-CCccccccccceeEecCCCC------eE
Q psy1546         121 -----WIIMEYLGGGSALDL-M---KAGNFEEMHIAVILREVLKGLDYLHS-ERKLHRDIKAANVLLSEMGD------VK  184 (604)
Q Consensus       121 -----yLVmEy~~ggsL~~~-l---~~~~lse~~i~~i~~qIl~gL~yLHs-~gIiHrDLKp~NILl~~~g~------vK  184 (604)
                           ++||+++..+..... .   ....+++..++.++.||+.||.|||+ .||+||||||+||||+.++.      ++
T Consensus        93 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~~~~k  172 (362)
T d1q8ya_          93 GPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIK  172 (362)
T ss_dssp             ETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEEEE
T ss_pred             cccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCcccccceee
Confidence                 466666654433322 2   23678999999999999999999997 89999999999999986654      99


Q ss_pred             EecccccccccCCCCCCcccccCCCCCChHHhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhh------Hh----h
Q psy1546         185 LADFGVAGTLTNTTSKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPNSELHPMR------VL----F  254 (604)
Q Consensus       185 L~DFGlA~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~sDVwSLGviL~eLltG~~Pf~~~~~~~------~~----~  254 (604)
                      |+|||.|.....   .....+||+.|+|||++.+..|+.++|||||||++++|++|+.||.......      ..    .
T Consensus       173 l~dfg~s~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~~~~  249 (362)
T d1q8ya_         173 IADLGNACWYDE---HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIE  249 (362)
T ss_dssp             ECCCTTCEETTB---CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHH
T ss_pred             Eeeccccccccc---ccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHHHHH
Confidence            999999976543   2345689999999999999999999999999999999999999987543210      00    0


Q ss_pred             h-----------------------cCCC----C----------CCCCCccchHHHHHHHHHHhccCCCCCCCHHHHhcCh
Q psy1546         255 L-----------------------IPKN----N----------PPQLTGNYTKQFKEFVEACLNKDPENRPTAKELLKFP  297 (604)
Q Consensus       255 ~-----------------------i~~~----~----------~~~~~~~~s~~l~~Li~~~L~~dP~~RpT~~elL~hp  297 (604)
                      .                       ....    .          ........++++.+||.+||..||.+|||++|||+||
T Consensus       250 ~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L~Hp  329 (362)
T d1q8ya_         250 LLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHP  329 (362)
T ss_dssp             HHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTCG
T ss_pred             HhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHhcCc
Confidence            0                       0000    0          1122334577899999999999999999999999999


Q ss_pred             hhhhh
Q psy1546         298 FIRKA  302 (604)
Q Consensus       298 ~f~~~  302 (604)
                      ||+..
T Consensus       330 ~f~~~  334 (362)
T d1q8ya_         330 WLKDT  334 (362)
T ss_dssp             GGTTC
T ss_pred             ccCCC
Confidence            99743

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.91  E-value=2.1e-24  Score=206.19  Aligned_cols=160  Identities=16%  Similarity=0.154  Sum_probs=119.1

Q ss_pred             ceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhh-----------------HHHHHHHHHHHHHHhhCCCCCCCeE-
Q psy1546          59 FTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA-----------------EDEIEDIQQEIMVLSQCDSPYGTKL-  120 (604)
Q Consensus        59 y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~-----------------~~~~~~l~~Ei~iL~~l~hp~~~~l-  120 (604)
                      +.++++||+|+||+||+|.+. +|+.||||++.....                 ........+|...+.++.|.+.... 
T Consensus         2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~   80 (191)
T d1zara2           2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY   80 (191)
T ss_dssp             SEEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred             chhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence            678999999999999999985 689999998753211                 0112345678899999999886655 


Q ss_pred             -----EEEEEecCCCChhhHhhcCCCcHHHHHHHHHHHHHHhHHhhhCCccccccccceeEecCCCCeEEeccccccccc
Q psy1546         121 -----WIIMEYLGGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHSERKLHRDIKAANVLLSEMGDVKLADFGVAGTLT  195 (604)
Q Consensus       121 -----yLVmEy~~ggsL~~~l~~~~lse~~i~~i~~qIl~gL~yLHs~gIiHrDLKp~NILl~~~g~vKL~DFGlA~~~~  195 (604)
                           ++||||++++.+..      ++...+..++.||+.+|.|||++||+||||||+|||++++ .++|+|||.|....
T Consensus        81 ~~~~~~lvme~~~~~~~~~------l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~-~~~liDFG~a~~~~  153 (191)
T d1zara2          81 AWEGNAVLMELIDAKELYR------VRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEE-GIWIIDFPQSVEVG  153 (191)
T ss_dssp             EEETTEEEEECCCCEEGGG------CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETT-EEEECCCTTCEETT
T ss_pred             EecCCEEEEEeeccccccc------hhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCC-CEEEEECCCcccCC
Confidence                 49999998876543      4556678899999999999999999999999999999974 59999999996554


Q ss_pred             CCCCCCcccccCCCCCCh--H---HhhcCCCCCcchhhhHHHHH
Q psy1546         196 NTTSKRNTFVGTPFWMAP--E---VIKQSAYDSKADIWSLGITA  234 (604)
Q Consensus       196 ~~~~~~~~~~GT~~Y~AP--E---~l~~~~~~~~sDVwSLGviL  234 (604)
                      .+...        .|...  +   .+....|+.++|+||+.--+
T Consensus       154 ~~~~~--------~~l~rd~~~~~~~f~r~y~~~~d~~s~~~~~  189 (191)
T d1zara2         154 EEGWR--------EILERDVRNIITYFSRTYRTEKDINSAIDRI  189 (191)
T ss_dssp             STTHH--------HHHHHHHHHHHHHHHHHHCCCCCHHHHHHHH
T ss_pred             CCCcH--------HHHHHHHHHHHHHHcCCCCCcccHHHHHHHH
Confidence            32211        01111  0   12245688899999976544

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=97.93  E-value=9.5e-06  Score=78.11  Aligned_cols=127  Identities=15%  Similarity=0.142  Sum_probs=76.3

Q ss_pred             ceeeeEEcccCcEEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCC----CCC-------CCeEEEEEEec
Q psy1546          59 FTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCD----SPY-------GTKLWIIMEYL  127 (604)
Q Consensus        59 y~i~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~----hp~-------~~~lyLVmEy~  127 (604)
                      |+..+..+-++.+.||+..  ..++.++||+........ ...+.+|..++..+.    -|.       ....|+||+++
T Consensus        16 ~~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~~~-~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l   92 (263)
T d1j7la_          16 YRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYKGT-TYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEA   92 (263)
T ss_dssp             SEEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGGTTS-TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECC
T ss_pred             eEEEEcCCCCCCCcEEEEE--eCCCeEEEEEcCCCcccc-hhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEec
Confidence            4555544445557999885  446667889875443221 234567777766543    222       23458999999


Q ss_pred             CCCChhhHhhcCCCcHHHHHHHHHHHHHHhHHhhh---------------------------------------------
Q psy1546         128 GGGSALDLMKAGNFEEMHIAVILREVLKGLDYLHS---------------------------------------------  162 (604)
Q Consensus       128 ~ggsL~~~l~~~~lse~~i~~i~~qIl~gL~yLHs---------------------------------------------  162 (604)
                      +|..+.......    .....++.++...|..||+                                             
T Consensus        93 ~G~~~~~~~~~~----~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  168 (263)
T d1j7la_          93 DGVLCSEEYEDE----QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPR  168 (263)
T ss_dssp             SSEEHHHHTTTC----SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSHH
T ss_pred             cccccccccccc----ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchHHH
Confidence            998875543211    1111122223333333331                                             


Q ss_pred             --------------CCccccccccceeEecCCCCeEEecccccc
Q psy1546         163 --------------ERKLHRDIKAANVLLSEMGDVKLADFGVAG  192 (604)
Q Consensus       163 --------------~gIiHrDLKp~NILl~~~g~vKL~DFGlA~  192 (604)
                                    ..++|+|+.|.|||+++++.+-|+||+.+.
T Consensus       169 ~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T d1j7la_         169 ELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             HHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             HHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence                          127899999999999986666799999873

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.75  E-value=2.5e-05  Score=80.66  Aligned_cols=71  Identities=21%  Similarity=0.177  Sum_probs=42.5

Q ss_pred             eeEEcccCcEEEEEEEECCCCcEEEEEEecchh------hHHHHHHHHHHHHHHhhCCC--C-CCCe--------EEEEE
Q psy1546          62 QERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE------AEDEIEDIQQEIMVLSQCDS--P-YGTK--------LWIIM  124 (604)
Q Consensus        62 ~~~LG~G~fG~Vy~a~~~~t~~~vAVK~i~~~~------~~~~~~~l~~Ei~iL~~l~h--p-~~~~--------lyLVm  124 (604)
                      .+.||.|....||++.+..+++.|+||.-....      ......+...|..+|+.+.-  | ...+        -++||
T Consensus        31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d~~~~~lvm  110 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSDTEMAVTVM  110 (392)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEETTTTEEEE
T ss_pred             EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEcCCCCEEEE
Confidence            456899999999999887778889999753211      11123345567777765421  1 1222        25899


Q ss_pred             EecCCCCh
Q psy1546         125 EYLGGGSA  132 (604)
Q Consensus       125 Ey~~ggsL  132 (604)
                      |++++..+
T Consensus       111 E~L~~~~~  118 (392)
T d2pula1         111 EDLSHLKI  118 (392)
T ss_dssp             CCCTTSEE
T ss_pred             eccCCccc
Confidence            99976543

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=97.35  E-value=0.00017  Score=68.65  Aligned_cols=28  Identities=18%  Similarity=0.124  Sum_probs=24.8

Q ss_pred             CccccccccceeEecCCCCeEEeccccc
Q psy1546         164 RKLHRDIKAANVLLSEMGDVKLADFGVA  191 (604)
Q Consensus       164 gIiHrDLKp~NILl~~~g~vKL~DFGlA  191 (604)
                      .++|+|+.|.|||++.++.+-|+||+.+
T Consensus       176 ~liHgD~~~~Nvl~~~~~~~~iID~~~~  203 (255)
T d1nd4a_         176 VVTHGDACLPNIMVENGRFSGFIDCGRL  203 (255)
T ss_dssp             EEECSSCCGGGEEEETTEEEEECCCTTC
T ss_pred             eEEeCCCCCcceEEeCCceEEEEEchhc
Confidence            3799999999999998766789999987

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=96.96  E-value=0.00063  Score=67.75  Aligned_cols=58  Identities=17%  Similarity=0.214  Sum_probs=37.2

Q ss_pred             EEEEEEEECCCCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCC---C--------------CCCeEEEEEEecCCCC
Q psy1546          71 GEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDS---P--------------YGTKLWIIMEYLGGGS  131 (604)
Q Consensus        71 G~Vy~a~~~~t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~h---p--------------~~~~lyLVmEy~~ggs  131 (604)
                      -.||++.. .+|..|++|+.......  .+.+..|+..+..|..   |              .....|.|++|++|..
T Consensus        36 N~vy~v~~-~dg~~~VlK~~rp~~~s--~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~  110 (325)
T d1zyla1          36 NRVYQFQD-EDRRRFVVKFYRPERWT--ADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQ  110 (325)
T ss_dssp             SEEEEECC-TTCCCEEEEEECTTTSC--HHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEE
T ss_pred             ceeEEEEc-CCCCEEEEEEeCCCCCC--HHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcC
Confidence            58999875 46788999998654221  2445566666655431   1              1344688999997744

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=96.58  E-value=0.0053  Score=60.03  Aligned_cols=29  Identities=28%  Similarity=0.243  Sum_probs=26.4

Q ss_pred             CCccccccccceeEecCCCCeEEeccccc
Q psy1546         163 ERKLHRDIKAANVLLSEMGDVKLADFGVA  191 (604)
Q Consensus       163 ~gIiHrDLKp~NILl~~~g~vKL~DFGlA  191 (604)
                      .|+||+|+.+.||+++.+...-|+||+.|
T Consensus       183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~  211 (316)
T d2ppqa1         183 AGVIHADLFQDNVFFLGDELSGLIDFYFA  211 (316)
T ss_dssp             EEEECSCCCGGGEEEETTEEEEECCCTTC
T ss_pred             cccccCCcchhhhhcccccceeEeccccc
Confidence            47999999999999998777789999987

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=96.22  E-value=0.017  Score=58.53  Aligned_cols=68  Identities=18%  Similarity=0.175  Sum_probs=43.9

Q ss_pred             eeEEcccCcEEEEEEEECC-------CCcEEEEEEecchhhHHHHHHHHHHHHHHhhCCCC-CCCeE------EEEEEec
Q psy1546          62 QERIGKGSFGEVFKGIDNR-------TQQVVAIKIIDLEEAEDEIEDIQQEIMVLSQCDSP-YGTKL------WIIMEYL  127 (604)
Q Consensus        62 ~~~LG~G~fG~Vy~a~~~~-------t~~~vAVK~i~~~~~~~~~~~l~~Ei~iL~~l~hp-~~~~l------yLVmEy~  127 (604)
                      ++.|+.|-.-.+|++....       ..+.|.+++......   .....+|..+++.+.-. ...++      .+||||+
T Consensus        47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~~---~idr~~E~~i~~~ls~~gl~Pkll~~~~~g~I~efi  123 (395)
T d1nw1a_          47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPET---ESHLVAESVIFTLLSERHLGPKLYGIFSGGRLEEYI  123 (395)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCC---HHHHHHHHHHHHHHHHTTSSSCEEEEETTEEEECCC
T ss_pred             EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcch---hhHHHHHHHHHHHHHhCCCCCeEEEEcCCceEEEEe
Confidence            4678999999999998643       345688888753221   23455777777765422 22344      3789999


Q ss_pred             CCCCh
Q psy1546         128 GGGSA  132 (604)
Q Consensus       128 ~ggsL  132 (604)
                      +|..|
T Consensus       124 ~g~~l  128 (395)
T d1nw1a_         124 PSRPL  128 (395)
T ss_dssp             CEEEC
T ss_pred             ccccC
Confidence            87554